id|nct_id|result_group_id|ctgov_group_code|period|reason|count|drop_withdraw_comment|reason_comment|count_units
49007526|NCT03044431|157865637|FG000|Overall Study|Lost to Follow-up|59|||
49007527|NCT00569231|157865638|FG000|Overall Study|Study unrelated surgery|1|||
49007528|NCT00569231|157865638|FG000|Overall Study|Airfare expense|2|||
49007529|NCT00569231|157865638|FG000|Overall Study|Withdrawal by Subject|1|||
49007530|NCT00569231|157865638|FG000|Overall Study|Car accident injury|1|||
49007531|NCT00569231|157865638|FG000|Overall Study|Non-compliance|2|||
49007532|NCT00700310|157865639|FG000|Overall Study|Adverse Event|6|||
49007533|NCT00700310|157865640|FG001|Overall Study|Adverse Event|10|||
49007534|NCT00700310|157865641|FG002|Overall Study|Adverse Event|5|||
49007535|NCT00700310|157865642|FG003|Overall Study|Adverse Event|11|||
49007536|NCT00700310|157865639|FG000|Overall Study|Lost to Follow-up|4|||
49007537|NCT00700310|157865640|FG001|Overall Study|Lost to Follow-up|1|||
49007538|NCT00700310|157865641|FG002|Overall Study|Lost to Follow-up|0|||
49007539|NCT00700310|157865642|FG003|Overall Study|Lost to Follow-up|1|||
49007540|NCT00700310|157865639|FG000|Overall Study|Withdrawal by Subject|8|||
49007541|NCT00700310|157865640|FG001|Overall Study|Withdrawal by Subject|9|||
49007542|NCT00700310|157865641|FG002|Overall Study|Withdrawal by Subject|8|||
49112689|NCT00908596|158248437|FG000|Overall Study|Other reasons|46|||
49007543|NCT00700310|157865642|FG003|Overall Study|Withdrawal by Subject|8|||
49007544|NCT00700310|157865639|FG000|Overall Study|Lack of Efficacy|0|||
49007545|NCT00700310|157865640|FG001|Overall Study|Lack of Efficacy|3|||
49007546|NCT00700310|157865641|FG002|Overall Study|Lack of Efficacy|0|||
49007547|NCT00700310|157865642|FG003|Overall Study|Lack of Efficacy|1|||
49007548|NCT00700310|157865639|FG000|Overall Study|Administrative/Other|1|||
49007549|NCT00700310|157865640|FG001|Overall Study|Administrative/Other|3|||
49007550|NCT00700310|157865641|FG002|Overall Study|Administrative/Other|1|||
49007551|NCT00700310|157865642|FG003|Overall Study|Administrative/Other|3|||
49007552|NCT00700310|157865639|FG000|Overall Study|Randomized, Not Treated|2|||
49007553|NCT00700310|157865640|FG001|Overall Study|Randomized, Not Treated|0|||
49007554|NCT00700310|157865641|FG002|Overall Study|Randomized, Not Treated|2|||
49007555|NCT00700310|157865642|FG003|Overall Study|Randomized, Not Treated|2|||
49007556|NCT00766506|157865645|FG000|Overall Study|Use rescue medication after 3 hours|3|||
49007557|NCT00766506|157865646|FG001|Overall Study|Use rescue medication after 3 hours|0|||
49007558|NCT00766506|157865645|FG000|Overall Study|Other|2|||
49007559|NCT00766506|157865646|FG001|Overall Study|Other|2|||
49007560|NCT03053622|157865650|FG000|Overall Study|Lost to Follow-up|0|||
49007561|NCT03053622|157865651|FG001|Overall Study|Lost to Follow-up|0|||
49007562|NCT03053622|157865652|FG002|Overall Study|Lost to Follow-up|0|||
49007563|NCT03053622|157865653|FG003|Overall Study|Lost to Follow-up|1|||
49007564|NCT02598622|157865654|FG000|Overall Study|Withdrawal by Subject|3|||
49007565|NCT02598622|157865655|FG001|Overall Study|Withdrawal by Subject|0|||
49007566|NCT02598622|157865654|FG000|Overall Study|Physician Decision|3|||
49007567|NCT02598622|157865655|FG001|Overall Study|Physician Decision|0|||
49007568|NCT01896700|157865667|FG000|Overall Study|Adverse Event|4|||
49007569|NCT01896700|157865668|FG001|Overall Study|Adverse Event|5|||
49007570|NCT01896700|157865667|FG000|Overall Study|Withdrawal by Subject|0|||
49007571|NCT01896700|157865668|FG001|Overall Study|Withdrawal by Subject|1|||
49007572|NCT00267007|157865669|FG000|Overall Study|Withdrawal by Subject|6|||
49007573|NCT00267007|157865670|FG001|Overall Study|Withdrawal by Subject|0|||
49007574|NCT00267007|157865669|FG000|Overall Study|Lost to Follow-up|1|||
49007575|NCT00267007|157865670|FG001|Overall Study|Lost to Follow-up|0|||
49007576|NCT00267007|157865669|FG000|Overall Study|Non-compliance|0|||
49007577|NCT00267007|157865670|FG001|Overall Study|Non-compliance|1|||
49007578|NCT00267007|157865669|FG000|Overall Study|Adverse Event|1|||
49007579|NCT00267007|157865670|FG001|Overall Study|Adverse Event|0|||
49007580|NCT00886782|157865671|FG000|Overall Study|Disease progression|3|||
49007581|NCT00886782|157865672|FG001|Overall Study|Disease progression|3|||
49007582|NCT00886782|157865673|FG002|Overall Study|Disease progression|3|||
49007583|NCT00886782|157865671|FG000|Overall Study|Study drug toxicity|0|||
49007584|NCT00886782|157865672|FG001|Overall Study|Study drug toxicity|0|||
49007585|NCT00886782|157865673|FG002|Overall Study|Study drug toxicity|1|||
49007586|NCT00886782|157865671|FG000|Overall Study|Adverse event unrelated to Study drug|0|||
49007587|NCT00886782|157865672|FG001|Overall Study|Adverse event unrelated to Study drug|0|||
49007588|NCT00886782|157865673|FG002|Overall Study|Adverse event unrelated to Study drug|1|||
49007589|NCT03118765|157865674|FG000|Overall Study|Withdrawal by Subject|0|||
49112690|NCT00908596|158248438|FG001|Overall Study|Other reasons|6|||
49112691|NCT00908596|158248439|FG002|Overall Study|Other reasons|2|||
49007590|NCT03118765|157865675|FG001|Overall Study|Withdrawal by Subject|0|||
49007591|NCT03118765|157865676|FG002|Overall Study|Withdrawal by Subject|1|||
49007592|NCT03118765|157865677|FG003|Overall Study|Withdrawal by Subject|0|||
49007593|NCT03118765|157865678|FG004|Overall Study|Withdrawal by Subject|0|||
49007594|NCT03118765|157865674|FG000|Overall Study|Adverse Event|1|||
49007595|NCT03118765|157865675|FG001|Overall Study|Adverse Event|1|||
49007596|NCT03118765|157865676|FG002|Overall Study|Adverse Event|1|||
49007597|NCT03118765|157865677|FG003|Overall Study|Adverse Event|1|||
49007598|NCT03118765|157865678|FG004|Overall Study|Adverse Event|1|||
49007599|NCT03118765|157865674|FG000|Overall Study|Non compliance with Study Procedures|0|||
49007600|NCT03118765|157865675|FG001|Overall Study|Non compliance with Study Procedures|0|||
49007601|NCT03118765|157865676|FG002|Overall Study|Non compliance with Study Procedures|0|||
49007602|NCT03118765|157865677|FG003|Overall Study|Non compliance with Study Procedures|1|||
49007603|NCT03118765|157865678|FG004|Overall Study|Non compliance with Study Procedures|0|||
49007604|NCT03118765|157865674|FG000|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
49007605|NCT03118765|157865675|FG001|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
49007606|NCT03118765|157865676|FG002|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
49007607|NCT03118765|157865677|FG003|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
49007608|NCT03118765|157865678|FG004|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
49007609|NCT03118765|157865674|FG000|Overall Study|COPD Exacerbation|1|||
49007610|NCT03118765|157865675|FG001|Overall Study|COPD Exacerbation|0|||
49007611|NCT03118765|157865676|FG002|Overall Study|COPD Exacerbation|0|||
49007612|NCT03118765|157865677|FG003|Overall Study|COPD Exacerbation|1|||
49007613|NCT03118765|157865678|FG004|Overall Study|COPD Exacerbation|0|||
49007614|NCT03118765|157865674|FG000|Overall Study|Lost to Follow-up|1|||
49007615|NCT03118765|157865675|FG001|Overall Study|Lost to Follow-up|0|||
49007616|NCT03118765|157865676|FG002|Overall Study|Lost to Follow-up|1|||
49007617|NCT03118765|157865677|FG003|Overall Study|Lost to Follow-up|0|||
49007618|NCT03118765|157865678|FG004|Overall Study|Lost to Follow-up|0|||
49007619|NCT03118765|157865674|FG000|Overall Study|Sponsor Decision|1|||
49007620|NCT03118765|157865675|FG001|Overall Study|Sponsor Decision|0|||
49007621|NCT03118765|157865676|FG002|Overall Study|Sponsor Decision|1|||
49007622|NCT03118765|157865677|FG003|Overall Study|Sponsor Decision|0|||
49007623|NCT03118765|157865678|FG004|Overall Study|Sponsor Decision|1|||
49007624|NCT00849524|157865679|FG000|Overall Study|Lack of Efficacy|3|||
49007625|NCT01418352|157865682|FG000|Overall Study|Lost to Follow-up|2|||
49007626|NCT01418352|157865683|FG001|Overall Study|Lost to Follow-up|0|||
49007627|NCT01418352|157865684|FG002|Overall Study|Lost to Follow-up|0|||
49007628|NCT01418352|157865685|FG003|Overall Study|Lost to Follow-up|0|||
49007629|NCT01418352|157865682|FG000|Overall Study|Adverse Event|0|||
49007630|NCT01418352|157865683|FG001|Overall Study|Adverse Event|1|||
49007631|NCT01418352|157865684|FG002|Overall Study|Adverse Event|0|||
49007632|NCT01418352|157865685|FG003|Overall Study|Adverse Event|0|||
49007633|NCT01418352|157865682|FG000|Overall Study|Sponsor Discontinued Trial Site|0|||
49007634|NCT01418352|157865683|FG001|Overall Study|Sponsor Discontinued Trial Site|2|||
49007635|NCT01418352|157865684|FG002|Overall Study|Sponsor Discontinued Trial Site|2|||
49007636|NCT01418352|157865685|FG003|Overall Study|Sponsor Discontinued Trial Site|2|||
49007637|NCT01418352|157865682|FG000|Overall Study|Subject Withdrew Consent|0|||
49007638|NCT01418352|157865683|FG001|Overall Study|Subject Withdrew Consent|1|||
49007639|NCT01418352|157865684|FG002|Overall Study|Subject Withdrew Consent|2|||
49007640|NCT01418352|157865685|FG003|Overall Study|Subject Withdrew Consent|1|||
49007641|NCT01418352|157865682|FG000|Overall Study|Protocol Deviation|0|||
49007642|NCT01418352|157865683|FG001|Overall Study|Protocol Deviation|0|||
49007643|NCT01418352|157865684|FG002|Overall Study|Protocol Deviation|1|||
49007644|NCT01418352|157865685|FG003|Overall Study|Protocol Deviation|0|||
49007645|NCT01418352|157865682|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|1|||
49007646|NCT01418352|157865683|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
49007647|NCT01418352|157865684|FG002|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
49007648|NCT01418352|157865685|FG003|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
49007649|NCT01255722|157865686|FG000|Overall Study|Adverse Event|0|||
49007650|NCT01255722|157865687|FG001|Overall Study|Adverse Event|1|||
49007651|NCT01255722|157865688|FG002|Overall Study|Adverse Event|1|||
49007652|NCT01255722|157865686|FG000|Overall Study|asymptomatic patient|1|||
49007653|NCT01255722|157865687|FG001|Overall Study|asymptomatic patient|0|||
49007654|NCT01255722|157865688|FG002|Overall Study|asymptomatic patient|0|||
49007655|NCT01255722|157865686|FG000|Overall Study|beta-blocker contraindicated|2|||
49007656|NCT01255722|157865687|FG001|Overall Study|beta-blocker contraindicated|0|||
49007657|NCT01255722|157865688|FG002|Overall Study|beta-blocker contraindicated|0|||
49007658|NCT02059187|157865691|FG000|Overall Study|Adverse Event|0|||
49007659|NCT02059187|157865692|FG001|Overall Study|Adverse Event|3|||
49007660|NCT02059187|157865691|FG000|Overall Study|Death|1|||
49007661|NCT02059187|157865692|FG001|Overall Study|Death|1|||
49007662|NCT02059187|157865691|FG000|Overall Study|Lost to Follow-up|9|||
49007663|NCT02059187|157865692|FG001|Overall Study|Lost to Follow-up|8|||
49007664|NCT02059187|157865691|FG000|Overall Study|Non-compliance with study drug|1|||
49007665|NCT02059187|157865692|FG001|Overall Study|Non-compliance with study drug|0|||
49007666|NCT02059187|157865691|FG000|Overall Study|Physician Decision|1|||
49112692|NCT00908596|158248440|FG003|Overall Study|Other reasons|0|||
49007667|NCT02059187|157865692|FG001|Overall Study|Physician Decision|2|||
49007668|NCT02059187|157865691|FG000|Overall Study|Protocol Violation|1|||
49112693|NCT00908596|158248437|FG000|Overall Study|Lost to Follow-up|0|||
49112694|NCT00908596|158248438|FG001|Overall Study|Lost to Follow-up|1|||
49007669|NCT02059187|157865692|FG001|Overall Study|Protocol Violation|0|||
49007670|NCT02059187|157865691|FG000|Overall Study|Withdrawal by Subject|12|||
48693081|NCT01602224|156726338|FG000|Overall Study|Adverse Event|0|||
49007671|NCT02059187|157865692|FG001|Overall Study|Withdrawal by Subject|8|||
49007672|NCT03712228|157865695|FG000|Treatment Period 1|Lack of Efficacy|0|||
49007673|NCT03712228|157865696|FG001|Treatment Period 1|Lack of Efficacy|0|||
49007674|NCT03712228|157865697|FG002|Treatment Period 1|Lack of Efficacy|0|||
49007675|NCT03712228|157865698|FG003|Treatment Period 1|Lack of Efficacy|0|||
49007676|NCT03712228|157865699|FG004|Treatment Period 1|Lack of Efficacy|0|||
49007677|NCT03712228|157865700|FG005|Treatment Period 1|Lack of Efficacy|1|||
49007678|NCT03712228|157865695|FG000|Treatment Period 2|Pregnancy|0|||
49007679|NCT03712228|157865696|FG001|Treatment Period 2|Pregnancy|0|||
49007680|NCT03712228|157865697|FG002|Treatment Period 2|Pregnancy|0|||
49007681|NCT03712228|157865698|FG003|Treatment Period 2|Pregnancy|1|||
49007682|NCT03712228|157865699|FG004|Treatment Period 2|Pregnancy|0|||
49007683|NCT03712228|157865700|FG005|Treatment Period 2|Pregnancy|0|||
49007684|NCT03712228|157865695|FG000|Treatment Period 2|Withdrawal by Subject|0|||
49007685|NCT03712228|157865696|FG001|Treatment Period 2|Withdrawal by Subject|0|||
49007686|NCT03712228|157865697|FG002|Treatment Period 2|Withdrawal by Subject|0|||
49007687|NCT03712228|157865698|FG003|Treatment Period 2|Withdrawal by Subject|1|||
49007688|NCT03712228|157865699|FG004|Treatment Period 2|Withdrawal by Subject|0|||
49007689|NCT03712228|157865700|FG005|Treatment Period 2|Withdrawal by Subject|0|||
49007690|NCT02746705|157865701|FG000|Overall Study|Physician Decision|1|||
49007691|NCT02746705|157865702|FG001|Overall Study|Physician Decision|1|||
49007692|NCT02746705|157865701|FG000|Overall Study|Lost to Follow-up|1|||
49007693|NCT02746705|157865702|FG001|Overall Study|Lost to Follow-up|0|||
49007694|NCT02746705|157865701|FG000|Overall Study|outlier scores deemed not valid|0|||
49007695|NCT02746705|157865702|FG001|Overall Study|outlier scores deemed not valid|1|||
49007696|NCT00283686|157865703|FG000|Overall Study|Death|1|||
49007697|NCT00283686|157865704|FG001|Overall Study|Death|1|||
49007698|NCT00283686|157865705|FG002|Overall Study|Death|1|||
49007699|NCT00283686|157865706|FG003|Overall Study|Death|0|||
49112695|NCT00908596|158248439|FG002|Overall Study|Lost to Follow-up|12|||
49112696|NCT00908596|158248440|FG003|Overall Study|Lost to Follow-up|4|||
49112697|NCT00908596|158248437|FG000|Overall Study|Death|0|||
49112698|NCT00908596|158248438|FG001|Overall Study|Death|5|||
49112699|NCT00908596|158248439|FG002|Overall Study|Death|57|||
49007700|NCT00283686|157865703|FG000|Overall Study|Lost to Follow-up|21|||
49007701|NCT00283686|157865704|FG001|Overall Study|Lost to Follow-up|31|||
49007702|NCT00283686|157865705|FG002|Overall Study|Lost to Follow-up|26|||
49007703|NCT00283686|157865706|FG003|Overall Study|Lost to Follow-up|20|||
49007704|NCT00283686|157865703|FG000|Overall Study|Less than full participation|7|||
49007705|NCT00283686|157865704|FG001|Overall Study|Less than full participation|9|||
49007706|NCT00283686|157865705|FG002|Overall Study|Less than full participation|6|||
49007707|NCT00283686|157865706|FG003|Overall Study|Less than full participation|12|||
49007708|NCT00479401|157865707|FG000|Overall Study|Adverse Event|24|||
49007709|NCT00479401|157865708|FG001|Overall Study|Adverse Event|20|||
49007710|NCT00479401|157865709|FG002|Overall Study|Adverse Event|4|||
49007711|NCT00479401|157865707|FG000|Overall Study|Lack of Efficacy|2|||
49007712|NCT00479401|157865708|FG001|Overall Study|Lack of Efficacy|2|||
49007713|NCT00479401|157865709|FG002|Overall Study|Lack of Efficacy|4|||
49007714|NCT00479401|157865707|FG000|Overall Study|Protocol Violation|2|||
49007715|NCT00479401|157865708|FG001|Overall Study|Protocol Violation|1|||
49007716|NCT00479401|157865709|FG002|Overall Study|Protocol Violation|1|||
49007717|NCT00479401|157865707|FG000|Overall Study|Lost to Follow-up|1|||
49007718|NCT00479401|157865708|FG001|Overall Study|Lost to Follow-up|1|||
49007719|NCT00479401|157865709|FG002|Overall Study|Lost to Follow-up|1|||
49007720|NCT00479401|157865707|FG000|Overall Study|Withdrawal by Subject|16|||
49007721|NCT00479401|157865708|FG001|Overall Study|Withdrawal by Subject|10|||
49007722|NCT00479401|157865709|FG002|Overall Study|Withdrawal by Subject|2|||
49007723|NCT00479401|157865707|FG000|Overall Study|Exclusion criteria, relocation|4|||
49007724|NCT00479401|157865708|FG001|Overall Study|Exclusion criteria, relocation|3|||
49007725|NCT00479401|157865709|FG002|Overall Study|Exclusion criteria, relocation|0|||
49007726|NCT03296553|157865711|FG000|Overall Study|Withdrawal by Subject|1|||
49007727|NCT03296553|157865712|FG001|Overall Study|Withdrawal by Subject|1|||
49007728|NCT03296553|157865711|FG000|Overall Study|Death|1|||
49007729|NCT03296553|157865712|FG001|Overall Study|Death|0|||
49007730|NCT03707522|157865713|FG000|Overall Study|Lost to Follow-up|24|||
49007731|NCT03707522|157865714|FG001|Overall Study|Lost to Follow-up|27|||
49112700|NCT00908596|158248440|FG003|Overall Study|Death|32|||
49007732|NCT03707522|157865715|FG002|Overall Study|Lost to Follow-up|41|||
49007733|NCT03707522|157865716|FG003|Overall Study|Lost to Follow-up|36|||
49007734|NCT00558519|157865717|FG000|Overall Study|Ph+|20|||
49007735|NCT00558519|157865717|FG000|Overall Study|Ineligible|1|||
49007736|NCT00558519|157865717|FG000|Overall Study|Insufficient data|1|||
49007737|NCT00558519|157865717|FG000|Overall Study|Never received treatment|1|||
49007738|NCT00575328|157865718|FG000|Overall Study|Adverse Event|1|||
49007739|NCT00575328|157865719|FG001|Overall Study|Adverse Event|1|||
49007740|NCT00575328|157865718|FG000|Overall Study|Lost to Follow-up|2|||
49007741|NCT00575328|157865719|FG001|Overall Study|Lost to Follow-up|1|||
49007742|NCT03001011|157865720|FG000|Overall Study|Adverse Event|9|||
49007743|NCT03001011|157865721|FG001|Overall Study|Adverse Event|3|||
49007744|NCT03001011|157865720|FG000|Overall Study|Chronic kidney disease lead to dialysis|15|||
49112701|NCT00908596|158248437|FG000|Overall Study|Protocol Violation|1|||
49007745|NCT03001011|157865721|FG001|Overall Study|Chronic kidney disease lead to dialysis|10|||
49007746|NCT03001011|157865720|FG000|Overall Study|Other than specified above|3|||
49007747|NCT03001011|157865721|FG001|Overall Study|Other than specified above|8|||
49007748|NCT02875067|157865722|FG000|Overall Study|Withdrawal by Subject|1|||
49007749|NCT02875067|157865722|FG000|Overall Study|Withdrawal by Termination of Study|5|||
49007750|NCT03797222|157865723|FG000|Overall Study|Withdrawal by Subject|1|||
49007751|NCT02862535|157865724|FG000|Overall Study|Death|7|||
49007752|NCT02862535|157865725|FG001|Overall Study|Death|3|||
49007753|NCT02862535|157865726|FG002|Overall Study|Death|2|||
49007754|NCT02862535|157865727|FG003|Overall Study|Death|5|||
49007755|NCT02862535|157865724|FG000|Overall Study|Study Terminated by Sponsor|1|||
49007756|NCT02862535|157865725|FG001|Overall Study|Study Terminated by Sponsor|3|||
49007757|NCT02862535|157865726|FG002|Overall Study|Study Terminated by Sponsor|8|||
49007758|NCT02862535|157865727|FG003|Overall Study|Study Terminated by Sponsor|5|||
49007759|NCT02862535|157865724|FG000|Overall Study|Enrolled, not Treated|1|||
49007760|NCT02862535|157865725|FG001|Overall Study|Enrolled, not Treated|0|||
49007761|NCT02862535|157865726|FG002|Overall Study|Enrolled, not Treated|0|||
49007762|NCT02862535|157865727|FG003|Overall Study|Enrolled, not Treated|1|||
49007763|NCT00964223|157865729|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
49007764|NCT02278952|157865730|FG000|Overall Study|Insufficient Sample|6|||
49007765|NCT03264066|157865731|FG000|Overall Study|Adverse Event|1|||
49007766|NCT03264066|157865732|FG001|Overall Study|Adverse Event|1|||
49007767|NCT03264066|157865733|FG002|Overall Study|Adverse Event|0|||
49007768|NCT03264066|157865734|FG003|Overall Study|Adverse Event|0|||
49007769|NCT03264066|157865735|FG004|Overall Study|Adverse Event|0|||
49007770|NCT03264066|157865736|FG005|Overall Study|Adverse Event|0|||
49007771|NCT03264066|157865731|FG000|Overall Study|Death|12|||
49007772|NCT03264066|157865732|FG001|Overall Study|Death|12|||
49007773|NCT03264066|157865733|FG002|Overall Study|Death|8|||
49007774|NCT03264066|157865734|FG003|Overall Study|Death|10|||
49007775|NCT03264066|157865735|FG004|Overall Study|Death|6|||
49007776|NCT03264066|157865736|FG005|Overall Study|Death|1|||
49007777|NCT03264066|157865731|FG000|Overall Study|Lost to Follow-up|1|||
49007778|NCT03264066|157865732|FG001|Overall Study|Lost to Follow-up|0|||
49007779|NCT03264066|157865733|FG002|Overall Study|Lost to Follow-up|0|||
49007780|NCT03264066|157865734|FG003|Overall Study|Lost to Follow-up|0|||
49007781|NCT03264066|157865735|FG004|Overall Study|Lost to Follow-up|0|||
49007782|NCT03264066|157865736|FG005|Overall Study|Lost to Follow-up|0|||
49007783|NCT03264066|157865731|FG000|Overall Study|Progressive Disease|0|||
49007784|NCT03264066|157865732|FG001|Overall Study|Progressive Disease|2|||
49007785|NCT03264066|157865733|FG002|Overall Study|Progressive Disease|1|||
49007786|NCT03264066|157865734|FG003|Overall Study|Progressive Disease|0|||
49007787|NCT03264066|157865735|FG004|Overall Study|Progressive Disease|0|||
49007788|NCT03264066|157865736|FG005|Overall Study|Progressive Disease|0|||
49007789|NCT03264066|157865731|FG000|Overall Study|Study Terminated by Sponsor|5|||
49007790|NCT03264066|157865732|FG001|Overall Study|Study Terminated by Sponsor|5|||
49007791|NCT03264066|157865733|FG002|Overall Study|Study Terminated by Sponsor|8|||
49007792|NCT03264066|157865734|FG003|Overall Study|Study Terminated by Sponsor|5|||
49007793|NCT03264066|157865735|FG004|Overall Study|Study Terminated by Sponsor|1|||
49007794|NCT03264066|157865736|FG005|Overall Study|Study Terminated by Sponsor|2|||
49007795|NCT03264066|157865731|FG000|Overall Study|Withdrawal by Subject|1|||
49007796|NCT03264066|157865732|FG001|Overall Study|Withdrawal by Subject|0|||
49007797|NCT03264066|157865733|FG002|Overall Study|Withdrawal by Subject|0|||
49007798|NCT03264066|157865734|FG003|Overall Study|Withdrawal by Subject|5|||
49007799|NCT03264066|157865735|FG004|Overall Study|Withdrawal by Subject|0|||
49007800|NCT03264066|157865736|FG005|Overall Study|Withdrawal by Subject|0|||
49007801|NCT03439293|157865737|FG000|Overall Study|Death|22|||
49007802|NCT03439293|157865737|FG000|Overall Study|Withdrawal by Subject|8|||
49007803|NCT03439293|157865737|FG000|Overall Study|Lost to Follow-up|2|||
49007804|NCT03439293|157865737|FG000|Overall Study|Reason Not Specified|28|||
49007805|NCT03439293|157865737|FG000|Overall Study|Missing|1|||
49007806|NCT00871728|157865738|FG000|Overall Study|Adverse Event|1|||
49007807|NCT00871728|157865738|FG000|Overall Study|Protocol Violation|7|||
49007808|NCT00871728|157865738|FG000|Overall Study|Lost to Follow-up|2|||
49007809|NCT00871728|157865738|FG000|Overall Study|Failed to Visit Hospital|4|||
48693082|NCT01602224|156726339|FG001|Overall Study|Adverse Event|1|||
49007810|NCT00871728|157865738|FG000|Overall Study|Participant Non-compliance|1|||
49007811|NCT00871728|157865738|FG000|Overall Study|Withdrawal of Informed Consent|5|||
49007812|NCT03182686|157865739|FG000|Overall Study|Lost to Follow-up|2|||
49007813|NCT03182686|157865740|FG001|Overall Study|Lost to Follow-up|0|||
49007814|NCT03182686|157865739|FG000|Overall Study|Adverse Event|2|||
49007815|NCT03182686|157865740|FG001|Overall Study|Adverse Event|0|||
49007816|NCT03182686|157865739|FG000|Overall Study|Withdrawal by Subject|3|||
49007817|NCT03182686|157865740|FG001|Overall Study|Withdrawal by Subject|0|||
49007818|NCT00729365|157865741|FG000|Overall Study|Physician Decision|33|||
49007819|NCT00729365|157865742|FG001|Overall Study|Physician Decision|6|||
49007820|NCT00729365|157865743|FG002|Overall Study|Physician Decision|7|||
49007821|NCT01154127|157865745|FG000|Period 1 (21 Days)|Adverse Event|3|||
49007822|NCT01154127|157865746|FG001|Period 1 (21 Days)|Adverse Event|4|||
49007823|NCT01154127|157865745|FG000|Period 1 (21 Days)|Withdrawal by Subject|0|||
49007824|NCT01154127|157865746|FG001|Period 1 (21 Days)|Withdrawal by Subject|2|||
49007825|NCT01154127|157865745|FG000|Washout (14 - 28 Days)|Adverse Event|2|||
49007826|NCT01154127|157865746|FG001|Washout (14 - 28 Days)|Adverse Event|0|||
49007827|NCT01154127|157865745|FG000|Washout (14 - 28 Days)|Abnormal Test Procedure|1|||
49007828|NCT01154127|157865746|FG001|Washout (14 - 28 Days)|Abnormal Test Procedure|0|||
49007829|NCT01154127|157865745|FG000|Period 2 (21 Days)|Protocol Deviation|0|||
49007830|NCT01154127|157865746|FG001|Period 2 (21 Days)|Protocol Deviation|1|||
49007831|NCT01697449|157865747|FG000|Overall Study|Disease progression|47|||
49007832|NCT01697449|157865747|FG000|Overall Study|Adverse Event|7|||
49007833|NCT01697449|157865747|FG000|Overall Study|Lost to Follow-up|5|||
49007834|NCT01697449|157865747|FG000|Overall Study|Withdrawal by Subject|2|||
49007835|NCT01697449|157865747|FG000|Overall Study|Physician Decision|1|||
49007836|NCT01697449|157865747|FG000|Overall Study|Death|2|||
49007837|NCT01697449|157865747|FG000|Overall Study|Other|1|||
49007838|NCT01697449|157865747|FG000|Overall Study|Missing|25|||
49007839|NCT01169844|157865748|FG000|Overall Study|Adverse Event|0|||
49007840|NCT01169844|157865749|FG001|Overall Study|Adverse Event|1|||
49007841|NCT01169844|157865748|FG000|Overall Study|Patient withdrew consent|4|||
49007842|NCT01169844|157865749|FG001|Overall Study|Patient withdrew consent|0|||
49007843|NCT01169844|157865748|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
49007844|NCT01169844|157865749|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
49007845|NCT00743119|157865758|FG000|Overall Study|unreliable|3|||
49007846|NCT00743119|157865758|FG000|Overall Study|Withdrawal by Subject|1|||
49007847|NCT04071626|157865760|FG000|Overall Study|Withdrawal by Subject|1|||
49007848|NCT04071626|157865761|FG001|Overall Study|Withdrawal by Subject|1|||
49007849|NCT04071626|157865760|FG000|Overall Study|Protocol Violation|0|||
49007850|NCT04071626|157865761|FG001|Overall Study|Protocol Violation|1|||
49007851|NCT02176642|157865762|FG000|Overall Study|Withdrawal by Subject|0|||
49007852|NCT02176642|157865763|FG001|Overall Study|Withdrawal by Subject|1|||
49007853|NCT01309828|157865765|FG000|Overall Study|Adverse Event|10|||
49007854|NCT01309828|157865766|FG001|Overall Study|Adverse Event|11|||
49007855|NCT01309828|157865765|FG000|Overall Study|Voluntary Withdrawal|5|||
49007856|NCT01309828|157865766|FG001|Overall Study|Voluntary Withdrawal|4|||
49007857|NCT01309828|157865765|FG000|Overall Study|Major Protocol Deviation|0|||
49007858|NCT01309828|157865766|FG001|Overall Study|Major Protocol Deviation|1|||
49007859|NCT01309828|157865765|FG000|Overall Study|Other|1|||
49007860|NCT01309828|157865766|FG001|Overall Study|Other|0|||
49007861|NCT02556632|157865767|FG000|Overall Study|Lost to Follow-up|1|||
49007862|NCT02556632|157865768|FG001|Overall Study|Lost to Follow-up|0|||
49007863|NCT02556632|157865769|FG002|Overall Study|Lost to Follow-up|0|||
49007864|NCT02556632|157865767|FG000|Overall Study|Disliked Intervention|1|||
49007865|NCT02556632|157865768|FG001|Overall Study|Disliked Intervention|1|||
49007866|NCT02556632|157865769|FG002|Overall Study|Disliked Intervention|1|||
49007867|NCT02556632|157865767|FG000|Overall Study|No Reason|1|||
49007868|NCT02556632|157865768|FG001|Overall Study|No Reason|0|||
49007869|NCT02556632|157865769|FG002|Overall Study|No Reason|1|||
49007870|NCT02556632|157865767|FG000|Overall Study|Personal Issues|0|||
49007871|NCT02556632|157865768|FG001|Overall Study|Personal Issues|1|||
49007872|NCT02556632|157865769|FG002|Overall Study|Personal Issues|1|||
49007873|NCT02556632|157865767|FG000|Overall Study|Changed Mind|0|||
49007874|NCT02556632|157865768|FG001|Overall Study|Changed Mind|1|||
49007875|NCT02556632|157865769|FG002|Overall Study|Changed Mind|0|||
49007876|NCT02556632|157865767|FG000|Overall Study|Withdrew (Unrelated Medical)|1|||
49007877|NCT02556632|157865768|FG001|Overall Study|Withdrew (Unrelated Medical)|0|||
49007878|NCT02556632|157865769|FG002|Overall Study|Withdrew (Unrelated Medical)|0|||
49007879|NCT02556632|157865767|FG000|Overall Study|Unrelated Adverse Event|1|||
49007880|NCT02556632|157865768|FG001|Overall Study|Unrelated Adverse Event|0|||
49007881|NCT02556632|157865769|FG002|Overall Study|Unrelated Adverse Event|3|||
49007882|NCT02556632|157865767|FG000|Overall Study|Related Adverse Event|0|||
49007883|NCT02556632|157865768|FG001|Overall Study|Related Adverse Event|1|||
49007884|NCT02556632|157865769|FG002|Overall Study|Related Adverse Event|0|||
49007885|NCT02556632|157865767|FG000|Overall Study|Possibly Related Adverse Event|0|||
49007886|NCT02556632|157865768|FG001|Overall Study|Possibly Related Adverse Event|0|||
49112702|NCT00908596|158248438|FG001|Overall Study|Protocol Violation|0|||
49112703|NCT00908596|158248439|FG002|Overall Study|Protocol Violation|0|||
49112704|NCT00908596|158248440|FG003|Overall Study|Protocol Violation|0|||
49112705|NCT00908596|158248437|FG000|Overall Study|Withdrawal by Subject|0|||
49112706|NCT00908596|158248438|FG001|Overall Study|Withdrawal by Subject|1|||
49007887|NCT02556632|157865769|FG002|Overall Study|Possibly Related Adverse Event|1|||
49007888|NCT02556632|157865767|FG000|Overall Study|Did Not Start RT|0|||
49007889|NCT02556632|157865768|FG001|Overall Study|Did Not Start RT|1|||
49007890|NCT02556632|157865769|FG002|Overall Study|Did Not Start RT|0|||
49007891|NCT02556632|157865767|FG000|Overall Study|Ineligible|0|||
49007892|NCT02556632|157865768|FG001|Overall Study|Ineligible|1|||
49007893|NCT02556632|157865769|FG002|Overall Study|Ineligible|0|||
49007894|NCT02556632|157865767|FG000|Overall Study|Disliked Study Procedures|0|||
49007895|NCT02556632|157865768|FG001|Overall Study|Disliked Study Procedures|0|||
49007896|NCT02556632|157865769|FG002|Overall Study|Disliked Study Procedures|1|||
49007897|NCT02556632|157865767|FG000|Overall Study|Treatment or Change Delay|0|||
49007898|NCT02556632|157865768|FG001|Overall Study|Treatment or Change Delay|0|||
49007899|NCT02556632|157865769|FG002|Overall Study|Treatment or Change Delay|1|||
49007900|NCT02574260|157865770|FG000|Overall Study|Disease Progression|1|||
49007901|NCT04523831|157865771|FG000|Overall Study|Lost to Follow-up|15|||
49007902|NCT04523831|157865772|FG001|Overall Study|Lost to Follow-up|17|||
49007903|NCT04523831|157865771|FG000|Overall Study|Death|0|||
49007904|NCT04523831|157865772|FG001|Overall Study|Death|3|||
49007905|NCT04523831|157865771|FG000|Overall Study|Adverse Event|2|||
49007906|NCT04523831|157865772|FG001|Overall Study|Adverse Event|0|||
49007907|NCT04385199|157865773|FG000|Overall Study|Withdrawal by Subject|1|||
49007908|NCT04385199|157865774|FG001|Overall Study|Withdrawal by Subject|0|||
49007909|NCT04444752|157865778|FG000|Overall Study|Adverse Event|1|||
49007910|NCT04444752|157865779|FG001|Overall Study|Adverse Event|0|||
49007911|NCT04444752|157865780|FG002|Overall Study|Adverse Event|0|||
49007912|NCT04444752|157865781|FG003|Overall Study|Adverse Event|2|||
49007913|NCT04444752|157865778|FG000|Overall Study|Lost to Follow-up|2|||
49007914|NCT04444752|157865779|FG001|Overall Study|Lost to Follow-up|6|||
49007915|NCT04444752|157865780|FG002|Overall Study|Lost to Follow-up|2|||
49007916|NCT04444752|157865781|FG003|Overall Study|Lost to Follow-up|5|||
49007917|NCT04444752|157865778|FG000|Overall Study|Physician Decision|0|||
49007918|NCT04444752|157865779|FG001|Overall Study|Physician Decision|0|||
49007919|NCT04444752|157865780|FG002|Overall Study|Physician Decision|0|||
49007920|NCT04444752|157865781|FG003|Overall Study|Physician Decision|2|||
49007921|NCT04444752|157865778|FG000|Overall Study|Pregnancy|0|||
49007922|NCT04444752|157865779|FG001|Overall Study|Pregnancy|0|||
49007923|NCT04444752|157865780|FG002|Overall Study|Pregnancy|0|||
49007924|NCT04444752|157865781|FG003|Overall Study|Pregnancy|1|||
49007925|NCT04444752|157865778|FG000|Overall Study|Withdrawal by Subject|6|||
49007926|NCT04444752|157865779|FG001|Overall Study|Withdrawal by Subject|5|||
49007927|NCT04444752|157865780|FG002|Overall Study|Withdrawal by Subject|3|||
49007928|NCT04444752|157865781|FG003|Overall Study|Withdrawal by Subject|4|||
49007929|NCT04444752|157865778|FG000|Overall Study|Protocol Violation|1|||
49007930|NCT04444752|157865779|FG001|Overall Study|Protocol Violation|1|||
49007931|NCT04444752|157865780|FG002|Overall Study|Protocol Violation|0|||
49007932|NCT04444752|157865781|FG003|Overall Study|Protocol Violation|0|||
49007933|NCT04444752|157865778|FG000|Overall Study|Patient moving out of town|1|||
49007934|NCT04444752|157865779|FG001|Overall Study|Patient moving out of town|0|||
49007935|NCT04444752|157865780|FG002|Overall Study|Patient moving out of town|0|||
49007936|NCT04444752|157865781|FG003|Overall Study|Patient moving out of town|1|||
49007937|NCT04444752|157865778|FG000|Overall Study|Lack of Efficacy|0|||
49007938|NCT04444752|157865779|FG001|Overall Study|Lack of Efficacy|0|||
49007939|NCT04444752|157865780|FG002|Overall Study|Lack of Efficacy|0|||
49007940|NCT04444752|157865781|FG003|Overall Study|Lack of Efficacy|1|||
49007941|NCT04444752|157865778|FG000|Overall Study|Death|0|||
49007942|NCT04444752|157865779|FG001|Overall Study|Death|0|||
49007943|NCT04444752|157865780|FG002|Overall Study|Death|1|||
49007944|NCT04444752|157865781|FG003|Overall Study|Death|0|||
49007945|NCT02133352|157865782|FG000|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6|||
49007946|NCT00579254|157865783|FG000|Overall Study|Lost to Follow-up|39|||
49007947|NCT00579254|157865783|FG000|Overall Study|Discontinued when study terminated|73|||
49007948|NCT00628745|157865787|FG000|Overall Study|Withdrawal by Subject|63|||
49007949|NCT00628745|157865788|FG001|Overall Study|Withdrawal by Subject|3|||
49007950|NCT00628745|157865789|FG002|Overall Study|Withdrawal by Subject|9|||
49007951|NCT00628745|157865790|FG003|Overall Study|Withdrawal by Subject|2|||
49007952|NCT00628745|157865791|FG004|Overall Study|Withdrawal by Subject|69|||
49007953|NCT00628745|157865787|FG000|Overall Study|Does not meet inclusion criteria|0|||
49007954|NCT00628745|157865788|FG001|Overall Study|Does not meet inclusion criteria|12|||
49007955|NCT00628745|157865789|FG002|Overall Study|Does not meet inclusion criteria|0|||
49007956|NCT00628745|157865790|FG003|Overall Study|Does not meet inclusion criteria|0|||
49007957|NCT00628745|157865791|FG004|Overall Study|Does not meet inclusion criteria|18|||
49007958|NCT00628745|157865787|FG000|Overall Study|Participation in an interventional clinical trial|81|||
49007959|NCT00628745|157865788|FG001|Overall Study|Participation in an interventional clinical trial|4|||
49007960|NCT00628745|157865789|FG002|Overall Study|Participation in an interventional clinical trial|7|||
49007961|NCT00628745|157865790|FG003|Overall Study|Participation in an interventional clinical trial|0|||
49007962|NCT00628745|157865791|FG004|Overall Study|Participation in an interventional clinical trial|63|||
49007963|NCT00628745|157865787|FG000|Overall Study|Physician Decision|8|||
49007964|NCT00628745|157865788|FG001|Overall Study|Physician Decision|4|||
49007965|NCT00628745|157865789|FG002|Overall Study|Physician Decision|3|||
49007966|NCT00628745|157865790|FG003|Overall Study|Physician Decision|0|||
49007967|NCT00628745|157865791|FG004|Overall Study|Physician Decision|30|||
49007968|NCT00628745|157865787|FG000|Overall Study|Lost to Follow-up|109|||
49007969|NCT00628745|157865788|FG001|Overall Study|Lost to Follow-up|7|||
49007970|NCT00628745|157865789|FG002|Overall Study|Lost to Follow-up|7|||
49007971|NCT00628745|157865790|FG003|Overall Study|Lost to Follow-up|0|||
49007972|NCT00628745|157865791|FG004|Overall Study|Lost to Follow-up|498|||
49007973|NCT00628745|157865787|FG000|Overall Study|Death|197|||
49007974|NCT00628745|157865788|FG001|Overall Study|Death|81|||
49007975|NCT00628745|157865789|FG002|Overall Study|Death|12|||
49007976|NCT00628745|157865790|FG003|Overall Study|Death|4|||
49007977|NCT00628745|157865791|FG004|Overall Study|Death|939|||
49007978|NCT00628745|157865787|FG000|Overall Study|Participant transferred to another THAOS site|6|||
49007979|NCT00628745|157865788|FG001|Overall Study|Participant transferred to another THAOS site|0|||
49007980|NCT00628745|157865789|FG002|Overall Study|Participant transferred to another THAOS site|0|||
49007981|NCT00628745|157865790|FG003|Overall Study|Participant transferred to another THAOS site|0|||
49007982|NCT00628745|157865791|FG004|Overall Study|Participant transferred to another THAOS site|7|||
49007983|NCT00628745|157865787|FG000|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|37|||
49007984|NCT00628745|157865788|FG001|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|29|||
49007985|NCT00628745|157865789|FG002|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|46|||
49007986|NCT00628745|157865790|FG003|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|0|||
49007987|NCT00628745|157865791|FG004|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|91|||
49007988|NCT00628745|157865787|FG000|Overall Study|Site closure|152|||
49007989|NCT00628745|157865788|FG001|Overall Study|Site closure|146|||
49007990|NCT00628745|157865789|FG002|Overall Study|Site closure|6|||
49007991|NCT00628745|157865790|FG003|Overall Study|Site closure|8|||
49007992|NCT00628745|157865791|FG004|Overall Study|Site closure|691|||
49007993|NCT00628745|157865787|FG000|Overall Study|Duplicate participant|0|||
49007994|NCT00628745|157865788|FG001|Overall Study|Duplicate participant|0|||
49007995|NCT00628745|157865789|FG002|Overall Study|Duplicate participant|0|||
49007996|NCT00628745|157865790|FG003|Overall Study|Duplicate participant|0|||
49007997|NCT00628745|157865791|FG004|Overall Study|Duplicate participant|1|||
49007998|NCT00628745|157865787|FG000|Overall Study|Missing|4|||
49007999|NCT00628745|157865788|FG001|Overall Study|Missing|3|||
49008000|NCT00628745|157865789|FG002|Overall Study|Missing|0|||
49008001|NCT00628745|157865790|FG003|Overall Study|Missing|0|||
49008002|NCT00628745|157865791|FG004|Overall Study|Missing|10|||
49008003|NCT00628745|157865787|FG000|Overall Study|Othe reasons|987|||
49008004|NCT00628745|157865788|FG001|Overall Study|Othe reasons|373|||
49008005|NCT00628745|157865789|FG002|Overall Study|Othe reasons|105|||
49008006|NCT00628745|157865790|FG003|Overall Study|Othe reasons|1|||
49008007|NCT00628745|157865791|FG004|Overall Study|Othe reasons|1772|||
49008008|NCT00860574|157866926|FG000|Overall Study|Death|2|||
49008009|NCT00860574|157866926|FG000|Overall Study|Relapse|1|||
49008010|NCT01246986|157866930|FG000|Overall Study|Lost to Follow-up|0|||
49008011|NCT01246986|157866931|FG001|Overall Study|Lost to Follow-up|1|||
49008012|NCT01246986|157866932|FG002|Overall Study|Lost to Follow-up|3|||
49008013|NCT01246986|157866933|FG003|Overall Study|Lost to Follow-up|0|||
49008014|NCT01246986|157866934|FG004|Overall Study|Lost to Follow-up|0|||
49008015|NCT01246986|157866935|FG005|Overall Study|Lost to Follow-up|1|||
49008016|NCT01246986|157866936|FG006|Overall Study|Lost to Follow-up|0|||
49008017|NCT01246986|157866930|FG000|Overall Study|Withdrawal by Subject|3|||
49008018|NCT01246986|157866931|FG001|Overall Study|Withdrawal by Subject|4|||
49112707|NCT00908596|158248439|FG002|Overall Study|Withdrawal by Subject|3|||
49112708|NCT00908596|158248440|FG003|Overall Study|Withdrawal by Subject|1|||
49112709|NCT02570750|158248444|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
49112710|NCT02570750|158248445|FG001|Overall Study|Inclusion/exclusion criteria deviation|0|||
49112711|NCT02570750|158248444|FG000|Overall Study|Protocol deviation|4|||
49112712|NCT02570750|158248445|FG001|Overall Study|Protocol deviation|2|||
49112713|NCT02570750|158248444|FG000|Overall Study|Withdrawal by Subject|5|||
49112714|NCT02570750|158248445|FG001|Overall Study|Withdrawal by Subject|0|||
49112715|NCT02570750|158248444|FG000|Overall Study|Lost to Follow-up|2|||
49112716|NCT02570750|158248445|FG001|Overall Study|Lost to Follow-up|2|||
49112717|NCT02570750|158248444|FG000|Overall Study|Adverse Event|2|||
49112718|NCT02570750|158248445|FG001|Overall Study|Adverse Event|1|||
49112719|NCT01125813|158248447|FG000|Overall Study|Death|1|||
49112720|NCT01125813|158248447|FG000|Overall Study|Withdrawal by Subject|1|||
49112721|NCT01125813|158248447|FG000|Overall Study|Screen Failures|4|||
49112722|NCT04165135|158248448|FG000|Overall Study|Protocol Violation|10|||
49112723|NCT04165135|158248448|FG000|Overall Study|Participants withdrawal of consent|5|||
49112724|NCT00530790|158248449|FG000|Overall Study|Adverse Event|2|||
49112725|NCT00530790|158248449|FG000|Overall Study|Withdrawal by Subject|2|||
49112726|NCT00530790|158248449|FG000|Overall Study|Physician Decision|1|||
49112727|NCT02003924|158248458|FG000|Double-blind Phase|Lost to Follow-up|2|||
48693083|NCT01602224|156726340|FG002|Overall Study|Adverse Event|0|||
48798449|NCT03076970|157100471|FG000|Washout Period 2|Adverse Event|0|||
49112728|NCT02003924|158248459|FG001|Double-blind Phase|Lost to Follow-up|1|||
49112729|NCT02003924|158248460|FG002|Double-blind Phase|Lost to Follow-up|0|||
49008019|NCT01246986|157866932|FG002|Overall Study|Withdrawal by Subject|3|||
49008020|NCT01246986|157866933|FG003|Overall Study|Withdrawal by Subject|0|||
49008021|NCT01246986|157866934|FG004|Overall Study|Withdrawal by Subject|4|||
49008022|NCT01246986|157866935|FG005|Overall Study|Withdrawal by Subject|0|||
49008023|NCT01246986|157866936|FG006|Overall Study|Withdrawal by Subject|0|||
49112730|NCT02003924|158248458|FG000|Double-blind Phase|Protocol Violation|1|||
49112731|NCT02003924|158248459|FG001|Double-blind Phase|Protocol Violation|2|||
49112732|NCT02003924|158248460|FG002|Double-blind Phase|Protocol Violation|0|||
49112733|NCT02003924|158248458|FG000|Double-blind Phase|Withdrawal Consent to Continue Treatment|71|||
49112734|NCT02003924|158248459|FG001|Double-blind Phase|Withdrawal Consent to Continue Treatment|47|||
49112735|NCT02003924|158248460|FG002|Double-blind Phase|Withdrawal Consent to Continue Treatment|0|||
49112736|NCT02003924|158248458|FG000|Double-blind Phase|Disease Progression|229|||
49112737|NCT02003924|158248459|FG001|Double-blind Phase|Disease Progression|247|||
49112738|NCT02003924|158248460|FG002|Double-blind Phase|Disease Progression|0|||
49112739|NCT02003924|158248458|FG000|Double-blind Phase|Adverse Event|120|||
49008024|NCT00681824|157866937|FG000|Overall Study|withdrawn by investigator|0|||
49008025|NCT00681824|157866938|FG001|Overall Study|withdrawn by investigator|0|||
49008026|NCT00681824|157866939|FG002|Overall Study|withdrawn by investigator|1|||
49008027|NCT00681824|157866937|FG000|Overall Study|scheduling conflict|1|||
49008028|NCT00681824|157866938|FG001|Overall Study|scheduling conflict|0|||
49008029|NCT00681824|157866939|FG002|Overall Study|scheduling conflict|0|||
49008030|NCT00681824|157866937|FG000|Overall Study|Death|0|||
49008031|NCT00681824|157866938|FG001|Overall Study|Death|1|||
49008032|NCT00681824|157866939|FG002|Overall Study|Death|0|||
49008033|NCT03724916|157866940|FG000|Overall Study|Withdrawal by Subject|0|||
49008034|NCT03724916|157866941|FG001|Overall Study|Withdrawal by Subject|1|||
49112740|NCT02003924|158248459|FG001|Double-blind Phase|Adverse Event|31|||
49112741|NCT02003924|158248460|FG002|Double-blind Phase|Adverse Event|0|||
49112742|NCT02003924|158248458|FG000|Double-blind Phase|Randomized But not Treated|3|||
49112743|NCT02003924|158248459|FG001|Double-blind Phase|Randomized But not Treated|3|||
49112744|NCT02003924|158248460|FG002|Double-blind Phase|Randomized But not Treated|0|||
49112745|NCT02003924|158248458|FG000|Double-blind Phase|Other|29|||
49112746|NCT02003924|158248459|FG001|Double-blind Phase|Other|50|||
49112747|NCT02003924|158248460|FG002|Double-blind Phase|Other|0|||
49112748|NCT02003924|158248458|FG000|Open-label Phase|Lost to Follow-up|0|||
49112749|NCT02003924|158248459|FG001|Open-label Phase|Lost to Follow-up|0|||
49112750|NCT02003924|158248460|FG002|Open-label Phase|Lost to Follow-up|1|||
49112751|NCT02003924|158248458|FG000|Open-label Phase|Withdrawal Consent to Continue Treatment|9|||
49112752|NCT02003924|158248459|FG001|Open-label Phase|Withdrawal Consent to Continue Treatment|0|||
49112753|NCT02003924|158248460|FG002|Open-label Phase|Withdrawal Consent to Continue Treatment|1|||
49112754|NCT02003924|158248458|FG000|Open-label Phase|Disease Progression|59|||
49112755|NCT02003924|158248459|FG001|Open-label Phase|Disease Progression|0|||
49112756|NCT02003924|158248460|FG002|Open-label Phase|Disease Progression|5|||
49112757|NCT02003924|158248458|FG000|Open-label Phase|Adverse Event|25|||
49112758|NCT02003924|158248459|FG001|Open-label Phase|Adverse Event|0|||
49112759|NCT02003924|158248460|FG002|Open-label Phase|Adverse Event|10|||
49112760|NCT02003924|158248458|FG000|Open-label Phase|Other|7|||
49112761|NCT02003924|158248459|FG001|Open-label Phase|Other|0|||
49112762|NCT02003924|158248460|FG002|Open-label Phase|Other|0|||
49112763|NCT02003924|158248458|FG000|Long-term Follow-up Phase|Death|288|||
49112764|NCT02003924|158248459|FG001|Long-term Follow-up Phase|Death|174|||
49112765|NCT02003924|158248460|FG002|Long-term Follow-up Phase|Death|4|||
49112766|NCT02003924|158248458|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
49112767|NCT02003924|158248459|FG001|Long-term Follow-up Phase|Lost to Follow-up|6|||
49112768|NCT02003924|158248460|FG002|Long-term Follow-up Phase|Lost to Follow-up|1|||
49112769|NCT02003924|158248458|FG000|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66|||
49112770|NCT02003924|158248459|FG001|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55|||
49112771|NCT02003924|158248460|FG002|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1|||
49112772|NCT02003924|158248458|FG000|Long-term Follow-up Phase|Other|5|||
49112773|NCT02003924|158248459|FG001|Long-term Follow-up Phase|Other|2|||
49112774|NCT02003924|158248460|FG002|Long-term Follow-up Phase|Other|1|||
49112775|NCT00048165|158248461|FG000|Completed 6 Months Study|Administration/Other|8|||
49112776|NCT00048165|158248462|FG001|Completed 6 Months Study|Administration/Other|8|||
49112777|NCT00048165|158248461|FG000|Completed 6 Months Study|Abnormality of laboratory test|1|||
49112778|NCT00048165|158248462|FG001|Completed 6 Months Study|Abnormality of laboratory test|0|||
49112779|NCT00048165|158248461|FG000|Completed 6 Months Study|Adverse event/intermittent illness|14|||
49112780|NCT00048165|158248462|FG001|Completed 6 Months Study|Adverse event/intermittent illness|11|||
49112781|NCT00048165|158248461|FG000|Completed 6 Months Study|Death|12|||
49112782|NCT00048165|158248462|FG001|Completed 6 Months Study|Death|6|||
49112783|NCT00048165|158248461|FG000|Completed 6 Months Study|Insufficient therapy|1|||
49112784|NCT00048165|158248462|FG001|Completed 6 Months Study|Insufficient therapy|4|||
49112785|NCT00048165|158248461|FG000|Completed 6 Months Study|Other violation|4|||
49112786|NCT00048165|158248462|FG001|Completed 6 Months Study|Other violation|6|||
49112787|NCT00048165|158248461|FG000|Completed 6 Months Study|Refused treatment|5|||
49112788|NCT00048165|158248462|FG001|Completed 6 Months Study|Refused treatment|5|||
49112789|NCT00048165|158248461|FG000|Completed 6 Months Study|Violation criteria|0|||
49112790|NCT00048165|158248462|FG001|Completed 6 Months Study|Violation criteria|2|||
49008035|NCT03724916|157866942|FG002|Overall Study|Withdrawal by Subject|1|||
49008036|NCT03724916|157866943|FG003|Overall Study|Withdrawal by Subject|2|||
49112791|NCT00048165|158248461|FG000|Completed 6 Months Study|Did not receive study drug|6|||
49112792|NCT00048165|158248462|FG001|Completed 6 Months Study|Did not receive study drug|6|||
49112793|NCT00048165|158248461|FG000|Completed 12 Months Study|Administration/Other|0|||
49112794|NCT00048165|158248462|FG001|Completed 12 Months Study|Administration/Other|2|||
49112795|NCT00048165|158248461|FG000|Completed 12 Months Study|Death|2|||
49112796|NCT00048165|158248462|FG001|Completed 12 Months Study|Death|1|||
49112797|NCT00048165|158248461|FG000|Completed 12 Months Study|Did not co-operate/Withdrew|1|||
49112798|NCT00048165|158248462|FG001|Completed 12 Months Study|Did not co-operate/Withdrew|0|||
49112799|NCT01370616|158248467|FG000|Overall Study|Adverse Event|11|||
49112800|NCT01370616|158248468|FG001|Overall Study|Adverse Event|16|||
49112801|NCT01370616|158248467|FG000|Overall Study|Death|1|||
49112802|NCT01370616|158248468|FG001|Overall Study|Death|0|||
49112803|NCT01370616|158248467|FG000|Overall Study|Lack of Efficacy|6|||
49112804|NCT01370616|158248468|FG001|Overall Study|Lack of Efficacy|2|||
49112805|NCT01370616|158248467|FG000|Overall Study|Lost to Follow-up|0|||
49112806|NCT01370616|158248468|FG001|Overall Study|Lost to Follow-up|3|||
49112807|NCT01370616|158248467|FG000|Overall Study|Physician Decision|6|||
49112808|NCT01370616|158248468|FG001|Overall Study|Physician Decision|6|||
49112809|NCT01370616|158248467|FG000|Overall Study|Progressive Disease|0|||
49112810|NCT01370616|158248468|FG001|Overall Study|Progressive Disease|1|||
49112811|NCT01370616|158248467|FG000|Overall Study|Recovery|1|||
49112812|NCT01370616|158248468|FG001|Overall Study|Recovery|0|||
49112813|NCT01370616|158248467|FG000|Overall Study|Technical Problems|3|||
49112814|NCT01370616|158248468|FG001|Overall Study|Technical Problems|5|||
49112815|NCT01370616|158248467|FG000|Overall Study|Withdrawal by Subject|34|||
49112816|NCT01370616|158248468|FG001|Overall Study|Withdrawal by Subject|34|||
49112817|NCT04292743|158248469|FG000|Overall Study|Physician Decision|1|||
49112818|NCT04292743|158248470|FG001|Overall Study|Physician Decision|3|||
49112819|NCT04292743|158248471|FG002|Overall Study|Physician Decision|0|||
49112820|NCT04292743|158248472|FG003|Overall Study|Physician Decision|0|||
49112821|NCT04292743|158248469|FG000|Overall Study|Withdrawal by Subject|0|||
49112822|NCT04292743|158248470|FG001|Overall Study|Withdrawal by Subject|5|||
49112823|NCT04292743|158248471|FG002|Overall Study|Withdrawal by Subject|0|||
49112824|NCT04292743|158248472|FG003|Overall Study|Withdrawal by Subject|0|||
49112825|NCT04292743|158248469|FG000|Overall Study|Death|0|||
49112826|NCT04292743|158248470|FG001|Overall Study|Death|1|||
49112827|NCT04292743|158248471|FG002|Overall Study|Death|0|||
49112828|NCT04292743|158248472|FG003|Overall Study|Death|0|||
49112829|NCT04292743|158248469|FG000|Overall Study|Progression of Disease|2|||
49112830|NCT04292743|158248470|FG001|Overall Study|Progression of Disease|5|||
49112831|NCT04292743|158248471|FG002|Overall Study|Progression of Disease|0|||
49112832|NCT04292743|158248472|FG003|Overall Study|Progression of Disease|0|||
49112833|NCT04292743|158248469|FG000|Overall Study|No Treatment per protocol|0|||
49112834|NCT04292743|158248470|FG001|Overall Study|No Treatment per protocol|2|||
49112835|NCT04292743|158248471|FG002|Overall Study|No Treatment per protocol|0|||
49112836|NCT04292743|158248472|FG003|Overall Study|No Treatment per protocol|0|||
49112837|NCT00460746|158248475|FG000|Overall Study|Adverse Event|1|||
49112838|NCT00460746|158248475|FG000|Overall Study|Lost to Follow-up|1|||
49112839|NCT02598661|158248478|FG000|Overall Study|Death|27|||
49112840|NCT02598661|158248479|FG001|Overall Study|Death|34|||
49112841|NCT02598661|158248480|FG002|Overall Study|Death|14|||
49112842|NCT02598661|158248481|FG003|Overall Study|Death|1|||
49112843|NCT02598661|158248482|FG004|Overall Study|Death|0|||
49112844|NCT02598661|158248478|FG000|Overall Study|Lost to Follow-up|2|||
49112845|NCT02598661|158248479|FG001|Overall Study|Lost to Follow-up|3|||
49112846|NCT02598661|158248480|FG002|Overall Study|Lost to Follow-up|2|||
49112847|NCT02598661|158248481|FG003|Overall Study|Lost to Follow-up|0|||
49112848|NCT02598661|158248482|FG004|Overall Study|Lost to Follow-up|0|||
49112849|NCT02598661|158248478|FG000|Overall Study|Withdrawal by Subject|13|||
49112850|NCT02598661|158248479|FG001|Overall Study|Withdrawal by Subject|24|||
49112851|NCT02598661|158248480|FG002|Overall Study|Withdrawal by Subject|14|||
49112852|NCT02598661|158248481|FG003|Overall Study|Withdrawal by Subject|1|||
49112853|NCT02598661|158248482|FG004|Overall Study|Withdrawal by Subject|1|||
49112854|NCT02598661|158248478|FG000|Overall Study|Adverse Event|0|||
49112855|NCT02598661|158248479|FG001|Overall Study|Adverse Event|0|||
49112856|NCT02598661|158248480|FG002|Overall Study|Adverse Event|1|||
49112857|NCT02598661|158248481|FG003|Overall Study|Adverse Event|0|||
49112858|NCT02598661|158248482|FG004|Overall Study|Adverse Event|0|||
49112859|NCT02598661|158248478|FG000|Overall Study|Randomized, Never Treated|0|||
49112860|NCT02598661|158248479|FG001|Overall Study|Randomized, Never Treated|0|||
49112861|NCT02598661|158248480|FG002|Overall Study|Randomized, Never Treated|0|||
49112862|NCT02598661|158248481|FG003|Overall Study|Randomized, Never Treated|0|||
49112863|NCT02598661|158248482|FG004|Overall Study|Randomized, Never Treated|1|||
48693084|NCT01602224|156726338|FG000|Overall Study|Investigator Decison|1|||
49112864|NCT01905592|158248493|FG000|Overall Study|Disease Progression|51|||
49112865|NCT01905592|158248494|FG001|Overall Study|Disease Progression|110|||
49112866|NCT01905592|158248493|FG000|Overall Study|Toxicity|1|||
49112867|NCT01905592|158248494|FG001|Overall Study|Toxicity|16|||
49112868|NCT01905592|158248493|FG000|Overall Study|Physician Decision|0|||
49112869|NCT01905592|158248494|FG001|Overall Study|Physician Decision|2|||
49112870|NCT01905592|158248493|FG000|Overall Study|Start of New anti-cancer Treatment|1|||
49112871|NCT01905592|158248494|FG001|Overall Study|Start of New anti-cancer Treatment|0|||
49112872|NCT01905592|158248493|FG000|Overall Study|Protocol Violation|0|||
49112873|NCT01905592|158248494|FG001|Overall Study|Protocol Violation|1|||
49112874|NCT01905592|158248493|FG000|Overall Study|Sponsor's decision|1|||
49112875|NCT01905592|158248494|FG001|Overall Study|Sponsor's decision|1|||
49112876|NCT01905592|158248493|FG000|Overall Study|Not treated|7|||
49112877|NCT01905592|158248494|FG001|Overall Study|Not treated|3|||
49112878|NCT01905592|158248493|FG000|Overall Study|Withdrawal by Subject|10|||
49112879|NCT01905592|158248494|FG001|Overall Study|Withdrawal by Subject|2|||
49112880|NCT00792116|158248496|FG000|Overall Study|Lost to Follow-up|0|||
49112881|NCT00792116|158248497|FG001|Overall Study|Lost to Follow-up|1|||
49112882|NCT00792116|158248496|FG000|Overall Study|Discontnued intervention|1|||
49112883|NCT00792116|158248497|FG001|Overall Study|Discontnued intervention|0|||
49112884|NCT03628716|158248498|FG000|Overall Study|Adverse Event|1|||
49112885|NCT03628716|158248499|FG001|Overall Study|Adverse Event|1|||
49112886|NCT03628716|158248498|FG000|Overall Study|Death|1|||
49112887|NCT03628716|158248499|FG001|Overall Study|Death|0|||
49112888|NCT03628716|158248498|FG000|Overall Study|Lack of Efficacy|15|||
49112889|NCT03628716|158248499|FG001|Overall Study|Lack of Efficacy|20|||
49112890|NCT03628716|158248498|FG000|Overall Study|Withdrawal by Subject|1|||
49112891|NCT03628716|158248499|FG001|Overall Study|Withdrawal by Subject|2|||
49112892|NCT03628716|158248498|FG000|Overall Study|Study Terminated by Sponsor|1|||
49112893|NCT03628716|158248499|FG001|Overall Study|Study Terminated by Sponsor|0|||
49112894|NCT03034135|158248500|FG000|Overall Study|Withdrawal by Subject|2|||
49112895|NCT02669043|158248505|FG000|Overall Study|Didn't meet I/E criteria|4|||
49112896|NCT05601882|158248506|FG000|Period 1 (Baseline - Week 16)|Lost to Follow-up|2|||
49112897|NCT05601882|158248507|FG001|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
49112898|NCT05601882|158248508|FG002|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
49112899|NCT05601882|158248509|FG003|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
49112900|NCT05601882|158248506|FG000|Period 1 (Baseline - Week 16)|Withdrawal by Subject|21|||
49112901|NCT05601882|158248507|FG001|Period 1 (Baseline - Week 16)|Withdrawal by Subject|24|||
49112902|NCT05601882|158248508|FG002|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
49112903|NCT05601882|158248509|FG003|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
49112904|NCT05601882|158248506|FG000|Period 1 (Baseline - Week 16)|Other, not specified|16|||
49112905|NCT05601882|158248507|FG001|Period 1 (Baseline - Week 16)|Other, not specified|16|||
49112906|NCT05601882|158248508|FG002|Period 1 (Baseline - Week 16)|Other, not specified|0|||
49112907|NCT05601882|158248509|FG003|Period 1 (Baseline - Week 16)|Other, not specified|0|||
49112908|NCT05601882|158248506|FG000|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
49112909|NCT05601882|158248507|FG001|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
49112910|NCT05601882|158248508|FG002|Period 2 (Week 16 - Week 32)|Lost to Follow-up|3|||
49112911|NCT05601882|158248509|FG003|Period 2 (Week 16 - Week 32)|Lost to Follow-up|1|||
49112912|NCT05601882|158248506|FG000|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
49112913|NCT05601882|158248507|FG001|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
49112914|NCT05601882|158248508|FG002|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|3|||
49112915|NCT05601882|158248509|FG003|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|4|||
49112916|NCT05601882|158248506|FG000|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
49112917|NCT05601882|158248507|FG001|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
49112918|NCT05601882|158248508|FG002|Period 2 (Week 16 - Week 32)|Other, not specified|4|||
49112919|NCT05601882|158248509|FG003|Period 2 (Week 16 - Week 32)|Other, not specified|11|||
49112920|NCT05792423|158248533|FG000|Overall Study|Withdrawal by Subject|2|||
49112921|NCT02000882|158250087|FG000|Overall Study|Adverse Event|3|||
49112922|NCT02000882|158250087|FG000|Overall Study|Physician Decision|2|||
49112923|NCT02000882|158250087|FG000|Overall Study|Withdrawal by Subject|1|||
49112924|NCT03055494|158250088|FG000|Overall Study|Lost to Follow-up|6|||
49112925|NCT03055494|158250089|FG001|Overall Study|Lost to Follow-up|0|||
49112926|NCT03055494|158250088|FG000|Overall Study|Physician Decision|2|||
49112927|NCT03055494|158250089|FG001|Overall Study|Physician Decision|0|||
49112928|NCT03055494|158250088|FG000|Overall Study|Withdrawal by Subject|1|||
49112929|NCT03055494|158250089|FG001|Overall Study|Withdrawal by Subject|0|||
49112930|NCT03055494|158250088|FG000|Overall Study|Adverse Event|0|||
49112931|NCT03055494|158250089|FG001|Overall Study|Adverse Event|1|||
49112932|NCT03055494|158250088|FG000|Overall Study|Non-compliance with study treatment|1|||
49112933|NCT03055494|158250089|FG001|Overall Study|Non-compliance with study treatment|0|||
49112934|NCT02178358|158250090|FG000|Overall Study|Withdrawal by Subject|0|||
49112935|NCT02178358|158250091|FG001|Overall Study|Withdrawal by Subject|2|||
49112936|NCT02178358|158250092|FG002|Overall Study|Withdrawal by Subject|2|||
49112937|NCT02178358|158250090|FG000|Overall Study|Lost to Follow-up|1|||
49112938|NCT02178358|158250091|FG001|Overall Study|Lost to Follow-up|0|||
48742912|NCT00745823|156910413|FG000|Overall Study|Adverse Event|5|||
49112939|NCT02178358|158250092|FG002|Overall Study|Lost to Follow-up|0|||
49112940|NCT02187029|158250093|FG000|Overall Study|Adverse Event|0|||
49112941|NCT02187029|158250094|FG001|Overall Study|Adverse Event|1|||
49112942|NCT02187029|158250095|FG002|Overall Study|Adverse Event|1|||
49112943|NCT02187029|158250096|FG003|Overall Study|Adverse Event|0|||
49112944|NCT02187029|158250093|FG000|Overall Study|Study Terminated by Sponsor|0|||
49112945|NCT02187029|158250094|FG001|Overall Study|Study Terminated by Sponsor|0|||
49112946|NCT02187029|158250095|FG002|Overall Study|Study Terminated by Sponsor|10|||
49112947|NCT02187029|158250096|FG003|Overall Study|Study Terminated by Sponsor|3|||
49112948|NCT02187029|158250093|FG000|Overall Study|Withdrawal by Subject|1|||
49112949|NCT02187029|158250094|FG001|Overall Study|Withdrawal by Subject|0|||
49112950|NCT02187029|158250095|FG002|Overall Study|Withdrawal by Subject|0|||
49112951|NCT02187029|158250096|FG003|Overall Study|Withdrawal by Subject|0|||
49112952|NCT04607135|158250097|FG000|Overall Study|Physician Decision|1|||
49112953|NCT04607135|158250097|FG000|Overall Study|Withdrawal by Subject|1|||
49112954|NCT04607135|158250097|FG000|Overall Study|Equipment not working|3|||
49112955|NCT02173379|158250098|FG000|Overall Study|Lost to Follow-up|89|||
49112956|NCT02173379|158250099|FG001|Overall Study|Lost to Follow-up|81|||
49112957|NCT02173379|158250098|FG000|Overall Study|Withdrawal by Subject|24|||
49112958|NCT02173379|158250099|FG001|Overall Study|Withdrawal by Subject|29|||
49112959|NCT02173379|158250098|FG000|Overall Study|Physician Decision|8|||
49112960|NCT02173379|158250099|FG001|Overall Study|Physician Decision|8|||
49112961|NCT02173379|158250098|FG000|Overall Study|Death|75|||
49112962|NCT02173379|158250099|FG001|Overall Study|Death|72|||
49112963|NCT02173379|158250098|FG000|Overall Study|Other Reason|1|||
49112964|NCT02173379|158250099|FG001|Overall Study|Other Reason|0|||
49112965|NCT01690299|158250100|FG000|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
49112966|NCT01690299|158250101|FG001|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
49112967|NCT01690299|158250102|FG002|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1|||
49112968|NCT01690299|158250103|FG003|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
49112969|NCT01690299|158250104|FG004|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
49112970|NCT01690299|158250105|FG005|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
49112971|NCT01690299|158250100|FG000|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4|||
49112972|NCT01690299|158250101|FG001|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
49112973|NCT01690299|158250102|FG002|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
49112974|NCT01690299|158250103|FG003|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
49112975|NCT01690299|158250104|FG004|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
49112976|NCT01690299|158250105|FG005|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
49112977|NCT01690299|158250100|FG000|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1|||
49112978|NCT01690299|158250101|FG001|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3|||
49112979|NCT01690299|158250102|FG002|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
49112980|NCT01690299|158250103|FG003|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
49112981|NCT01690299|158250104|FG004|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
49112982|NCT01690299|158250105|FG005|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
49112983|NCT01690299|158250100|FG000|Placebo-controlled Phase (Weeks 0-16)|Other|2|||
49112984|NCT01690299|158250101|FG001|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
49112985|NCT01690299|158250102|FG002|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
49112986|NCT01690299|158250103|FG003|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
49112987|NCT01690299|158250104|FG004|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
49112988|NCT01690299|158250105|FG005|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
49112989|NCT01690299|158250100|FG000|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
49112990|NCT01690299|158250101|FG001|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
49112991|NCT01690299|158250102|FG002|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
49112992|NCT01690299|158250103|FG003|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
49112993|NCT01690299|158250104|FG004|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4|||
49112994|NCT01690299|158250105|FG005|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
49112995|NCT01690299|158250100|FG000|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
49112996|NCT01690299|158250101|FG001|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
49008037|NCT03724916|157866940|FG000|Overall Study|Randomized but not Treated|1|||
49112997|NCT01690299|158250102|FG002|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
49008038|NCT03724916|157866941|FG001|Overall Study|Randomized but not Treated|0|||
49008039|NCT03724916|157866942|FG002|Overall Study|Randomized but not Treated|0|||
49008040|NCT03724916|157866943|FG003|Overall Study|Randomized but not Treated|0|||
49112998|NCT01690299|158250103|FG003|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9|||
49112999|NCT01690299|158250104|FG004|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10|||
49113000|NCT01690299|158250105|FG005|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8|||
49113001|NCT01690299|158250100|FG000|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
49113002|NCT01690299|158250101|FG001|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
49113003|NCT01690299|158250102|FG002|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
49113004|NCT01690299|158250103|FG003|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
49113005|NCT01690299|158250104|FG004|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
49113006|NCT01690299|158250105|FG005|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
49113007|NCT01690299|158250100|FG000|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
49113008|NCT01690299|158250101|FG001|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
49113009|NCT01690299|158250102|FG002|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
49113010|NCT01690299|158250103|FG003|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8|||
49113011|NCT01690299|158250104|FG004|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5|||
49113012|NCT01690299|158250105|FG005|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11|||
49113013|NCT01690299|158250100|FG000|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
49113014|NCT01690299|158250101|FG001|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
49113015|NCT01690299|158250102|FG002|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
49113016|NCT01690299|158250103|FG003|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
49113017|NCT01690299|158250104|FG004|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13|||
49113018|NCT01690299|158250105|FG005|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
49113019|NCT01690299|158250100|FG000|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
49113020|NCT01690299|158250101|FG001|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
49113021|NCT01690299|158250102|FG002|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
49113022|NCT01690299|158250103|FG003|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
49113023|NCT01690299|158250104|FG004|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
49113024|NCT01690299|158250105|FG005|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1|||
49113025|NCT04214288|158250106|FG000|Overall Study|Ongoing in the study|41|||
49113026|NCT04214288|158250107|FG001|Overall Study|Ongoing in the study|51|||
49113027|NCT04214288|158250108|FG002|Overall Study|Ongoing in the study|12|||
49113028|NCT04214288|158250109|FG003|Overall Study|Ongoing in the study|39|||
49113029|NCT04214288|158250106|FG000|Overall Study|Adverse Event|1|||
49113030|NCT04214288|158250107|FG001|Overall Study|Adverse Event|0|||
49113031|NCT04214288|158250108|FG002|Overall Study|Adverse Event|0|||
49113032|NCT04214288|158250109|FG003|Overall Study|Adverse Event|0|||
49113033|NCT04214288|158250106|FG000|Overall Study|Death|22|||
49113034|NCT04214288|158250107|FG001|Overall Study|Death|13|||
49113035|NCT04214288|158250108|FG002|Overall Study|Death|7|||
49113036|NCT04214288|158250109|FG003|Overall Study|Death|19|||
49113037|NCT04214288|158250106|FG000|Overall Study|Lost to Follow-up|1|||
49113038|NCT04214288|158250107|FG001|Overall Study|Lost to Follow-up|2|||
49113039|NCT04214288|158250108|FG002|Overall Study|Lost to Follow-up|1|||
49113040|NCT04214288|158250109|FG003|Overall Study|Lost to Follow-up|0|||
49113041|NCT04214288|158250106|FG000|Overall Study|Other|1|||
49113042|NCT04214288|158250107|FG001|Overall Study|Other|2|||
49113043|NCT04214288|158250108|FG002|Overall Study|Other|0|||
49113044|NCT04214288|158250109|FG003|Overall Study|Other|6|||
49113045|NCT04214288|158250106|FG000|Overall Study|Protocol Violation|0|||
49113046|NCT04214288|158250107|FG001|Overall Study|Protocol Violation|1|||
49113047|NCT04214288|158250108|FG002|Overall Study|Protocol Violation|0|||
49113048|NCT04214288|158250109|FG003|Overall Study|Protocol Violation|0|||
49113049|NCT04214288|158250106|FG000|Overall Study|Withdrawal by Subject|8|||
49113050|NCT04214288|158250107|FG001|Overall Study|Withdrawal by Subject|4|||
49113051|NCT04214288|158250108|FG002|Overall Study|Withdrawal by Subject|0|||
49113052|NCT04214288|158250109|FG003|Overall Study|Withdrawal by Subject|9|||
49113053|NCT03317405|158250110|FG000|Overall Study|Withdrawal by Subject|1|||
49113054|NCT03317405|158250111|FG001|Overall Study|Withdrawal by Subject|0|||
49113055|NCT03317405|158250112|FG002|Overall Study|Withdrawal by Subject|0|||
49113056|NCT03317405|158250110|FG000|Overall Study|Physician Decision|0|||
49113057|NCT03317405|158250111|FG001|Overall Study|Physician Decision|0|||
49113058|NCT03317405|158250112|FG002|Overall Study|Physician Decision|1|||
49113059|NCT03317405|158250110|FG000|Overall Study|Surgery Rescheduled|0|||
49113060|NCT03317405|158250111|FG001|Overall Study|Surgery Rescheduled|1|||
49113061|NCT03317405|158250112|FG002|Overall Study|Surgery Rescheduled|0|||
49113062|NCT03871829|158250114|FG000|Overall Study|Lost to Follow-up|0|||
49113063|NCT03871829|158250115|FG001|Overall Study|Lost to Follow-up|1|||
49113064|NCT03871829|158250114|FG000|Overall Study|Withdrawal by Subject|1|||
49113065|NCT03871829|158250115|FG001|Overall Study|Withdrawal by Subject|1|||
49113066|NCT03871829|158250114|FG000|Overall Study|Death|12|||
49113067|NCT03871829|158250115|FG001|Overall Study|Death|8|||
49113068|NCT03871829|158250114|FG000|Overall Study|Study terminated by sponsor|31|||
49113069|NCT03871829|158250115|FG001|Overall Study|Study terminated by sponsor|34|||
49113070|NCT00715520|158250116|FG000|Overall Study|Screen failure|8|||
49113071|NCT00715520|158250117|FG001|Overall Study|Screen failure|1|||
49113072|NCT00715520|158250118|FG002|Overall Study|Screen failure|1|||
49113073|NCT00715520|158250116|FG000|Overall Study|Withdrawal by Subject|2|||
49113074|NCT00715520|158250117|FG001|Overall Study|Withdrawal by Subject|0|||
49113075|NCT00715520|158250118|FG002|Overall Study|Withdrawal by Subject|1|||
49113076|NCT01006590|158250119|FG000|Overall Study|Adverse Event|2|||
49113077|NCT01006590|158250120|FG001|Overall Study|Adverse Event|3|||
49113078|NCT01006590|158250119|FG000|Overall Study|Death|1|||
49113079|NCT01006590|158250120|FG001|Overall Study|Death|1|||
49113080|NCT01006590|158250119|FG000|Overall Study|Lost to Follow-up|1|||
49113081|NCT01006590|158250120|FG001|Overall Study|Lost to Follow-up|1|||
49113082|NCT01006590|158250119|FG000|Overall Study|Protocol Violation|1|||
49113083|NCT01006590|158250120|FG001|Overall Study|Protocol Violation|0|||
49113084|NCT01006590|158250119|FG000|Overall Study|Withdrawal by Subject|4|||
49113085|NCT01006590|158250120|FG001|Overall Study|Withdrawal by Subject|2|||
49113086|NCT01006590|158250119|FG000|Overall Study|Study specific discontinuation criteria|16|||
49113087|NCT01006590|158250120|FG001|Overall Study|Study specific discontinuation criteria|23|||
49113088|NCT01006590|158250119|FG000|Overall Study|Other|3|||
49113089|NCT01006590|158250120|FG001|Overall Study|Other|2|||
49113090|NCT01597492|158250125|FG000|Overall Study|Withdrawal by Subject|1|||
49113091|NCT01597492|158250126|FG001|Overall Study|Withdrawal by Subject|2|||
49113092|NCT01597492|158250125|FG000|Overall Study|Adverse Event|3|||
49113093|NCT01597492|158250126|FG001|Overall Study|Adverse Event|0|||
49113094|NCT01597492|158250125|FG000|Overall Study|Lost to Follow-up|0|||
49113095|NCT01597492|158250126|FG001|Overall Study|Lost to Follow-up|2|||
49113096|NCT01597492|158250125|FG000|Overall Study|Other Reason|2|||
49113097|NCT01597492|158250126|FG001|Overall Study|Other Reason|0|||
49113098|NCT00791700|158250127|FG000|Overall Study|Insufficient clinical response|1|||
49113099|NCT00791700|158250128|FG001|Overall Study|Insufficient clinical response|4|||
49113100|NCT00791700|158250129|FG002|Overall Study|Insufficient clinical response|1|||
49113101|NCT00791700|158250130|FG003|Overall Study|Insufficient clinical response|8|||
49113102|NCT00791700|158250127|FG000|Overall Study|No longer willing to participate|1|||
49113103|NCT00791700|158250128|FG001|Overall Study|No longer willing to participate|1|||
49113104|NCT00791700|158250129|FG002|Overall Study|No longer willing to participate|0|||
49113105|NCT00791700|158250130|FG003|Overall Study|No longer willing to participate|8|||
49113106|NCT00791700|158250127|FG000|Overall Study|Non-compliance with study treatment|0|||
49113107|NCT00791700|158250128|FG001|Overall Study|Non-compliance with study treatment|2|||
49113108|NCT00791700|158250129|FG002|Overall Study|Non-compliance with study treatment|0|||
49113109|NCT00791700|158250130|FG003|Overall Study|Non-compliance with study treatment|4|||
49113110|NCT00791700|158250127|FG000|Overall Study|Withdrawn due to pregnancy|0|||
49113111|NCT00791700|158250128|FG001|Overall Study|Withdrawn due to pregnancy|0|||
49113112|NCT00791700|158250129|FG002|Overall Study|Withdrawn due to pregnancy|0|||
49113113|NCT00791700|158250130|FG003|Overall Study|Withdrawn due to pregnancy|1|||
49113114|NCT00791700|158250127|FG000|Overall Study|Other|0|||
49113115|NCT00791700|158250128|FG001|Overall Study|Other|1|||
49113116|NCT00791700|158250129|FG002|Overall Study|Other|0|||
49113117|NCT00791700|158250130|FG003|Overall Study|Other|1|||
49113118|NCT00791700|158250127|FG000|Overall Study|Death|0|||
49113119|NCT00791700|158250128|FG001|Overall Study|Death|0|||
49113120|NCT00791700|158250129|FG002|Overall Study|Death|0|||
49113121|NCT00791700|158250130|FG003|Overall Study|Death|1|||
49113122|NCT00791700|158250127|FG000|Overall Study|Lost to Follow-up|4|||
49113123|NCT00791700|158250128|FG001|Overall Study|Lost to Follow-up|3|||
49113124|NCT00791700|158250129|FG002|Overall Study|Lost to Follow-up|4|||
49113125|NCT00791700|158250130|FG003|Overall Study|Lost to Follow-up|6|||
49113126|NCT00791700|158250127|FG000|Overall Study|Adverse Event|0|||
49113127|NCT00791700|158250128|FG001|Overall Study|Adverse Event|0|||
49113128|NCT00791700|158250129|FG002|Overall Study|Adverse Event|1|||
49113129|NCT00791700|158250130|FG003|Overall Study|Adverse Event|1|||
49113133|NCT02112877|158250140|FG000|Overall Study|Withdrawal by Subject|1|||
49113134|NCT02112877|158250141|FG001|Overall Study|Withdrawal by Subject|7|||
49113135|NCT02112877|158250140|FG000|Overall Study|Visit Missed|1|||
49113136|NCT02112877|158250141|FG001|Overall Study|Visit Missed|6|||
49113137|NCT00419159|158250142|FG000|Overall Study|Adverse Event|7|||
49113138|NCT00419159|158250143|FG001|Overall Study|Adverse Event|15|||
48903366|NCT01912456|157482391|FG000|Period 1|Physician Decision|0|||
48903367|NCT01912456|157482392|FG001|Period 1|Physician Decision|0|||
48903368|NCT01912456|157482393|FG002|Period 1|Physician Decision|1|||
48903369|NCT01912456|157482394|FG003|Period 1|Physician Decision|0|||
48903370|NCT01912456|157482391|FG000|Period 1|non-compliance|1|||
48903371|NCT01912456|157482392|FG001|Period 1|non-compliance|0|||
48903372|NCT01912456|157482393|FG002|Period 1|non-compliance|0|||
48903373|NCT01912456|157482394|FG003|Period 1|non-compliance|1|||
48903374|NCT01912456|157482391|FG000|Period 1|Adverse Event|1|||
48903375|NCT01912456|157482392|FG001|Period 1|Adverse Event|0|||
48903376|NCT01912456|157482393|FG002|Period 1|Adverse Event|0|||
48903377|NCT01912456|157482394|FG003|Period 1|Adverse Event|1|||
48903378|NCT01912456|157482391|FG000|Period 1|Withdrawal by Subject|0|||
48903379|NCT01912456|157482392|FG001|Period 1|Withdrawal by Subject|1|||
48903380|NCT01912456|157482393|FG002|Period 1|Withdrawal by Subject|1|||
48903381|NCT01912456|157482394|FG003|Period 1|Withdrawal by Subject|1|||
48903382|NCT01912456|157482391|FG000|Period 2|Lack of Efficacy|0|||
48903383|NCT01912456|157482392|FG001|Period 2|Lack of Efficacy|2|||
48903384|NCT01912456|157482393|FG002|Period 2|Lack of Efficacy|0|||
48903385|NCT01912456|157482394|FG003|Period 2|Lack of Efficacy|0|||
48903386|NCT01912456|157482391|FG000|Period 2|Adverse Event|0|||
48903387|NCT01912456|157482392|FG001|Period 2|Adverse Event|0|||
48903388|NCT01912456|157482393|FG002|Period 2|Adverse Event|0|||
48903389|NCT01912456|157482394|FG003|Period 2|Adverse Event|1|||
49008041|NCT04575038|157866944|FG000|Overall Study|Withdrawal by Subject|1|||
49008042|NCT04575038|157866945|FG001|Overall Study|Withdrawal by Subject|1|||
49008043|NCT01422720|157866947|FG000|Overall Study|Adverse Event|16|||
49008044|NCT01422720|157866947|FG000|Overall Study|Lack of Efficacy|1|||
49008045|NCT01422720|157866947|FG000|Overall Study|Withdrawal by Subject|4|||
49008046|NCT01422720|157866947|FG000|Overall Study|Ineligibility|1|||
49008047|NCT00303316|157866950|FG000|Overall Study|Protocol Violation|1|||
49008048|NCT00303316|157866951|FG001|Overall Study|Protocol Violation|0|||
49008049|NCT00303316|157866950|FG000|Overall Study|Lost to Follow-up|0|||
49008050|NCT00303316|157866951|FG001|Overall Study|Lost to Follow-up|1|||
49008051|NCT00303316|157866950|FG000|Overall Study|Withdrawal by Subject|1|||
49008052|NCT00303316|157866951|FG001|Overall Study|Withdrawal by Subject|2|||
49008053|NCT01726335|157866952|FG000|Overall Study|Lost to Follow-up|2|||
49008054|NCT01726335|157866952|FG000|Overall Study|Withdrawal by Subject|15|||
49008055|NCT01726335|157866952|FG000|Overall Study|Adverse Event|4|||
49008056|NCT01726335|157866952|FG000|Overall Study|Lost to Follow-up|2|||
49008057|NCT01726335|157866952|FG000|Overall Study|Exacerbation of psychotic symptoms|1|||
49008058|NCT01586624|157866953|FG000|Overall Study|Adverse Event|3|||
49008059|NCT01586624|157866954|FG001|Overall Study|Adverse Event|0|||
49008060|NCT01586624|157866955|FG002|Overall Study|Adverse Event|2|||
49008061|NCT01586624|157866956|FG003|Overall Study|Adverse Event|1|||
49008062|NCT01586624|157866957|FG004|Overall Study|Adverse Event|3|||
49008063|NCT01586624|157866958|FG005|Overall Study|Adverse Event|3|||
49008064|NCT01586624|157866959|FG006|Overall Study|Adverse Event|2|||
49008065|NCT01586624|157866960|FG007|Overall Study|Adverse Event|3|||
49008066|NCT01586624|157866953|FG000|Overall Study|Physician Decision|0|||
49008067|NCT01586624|157866954|FG001|Overall Study|Physician Decision|1|||
49008068|NCT01586624|157866955|FG002|Overall Study|Physician Decision|1|||
49008069|NCT01586624|157866956|FG003|Overall Study|Physician Decision|0|||
49008070|NCT01586624|157866957|FG004|Overall Study|Physician Decision|2|||
49008071|NCT01586624|157866958|FG005|Overall Study|Physician Decision|0|||
49008072|NCT01586624|157866959|FG006|Overall Study|Physician Decision|1|||
49008073|NCT01586624|157866960|FG007|Overall Study|Physician Decision|1|||
49008074|NCT01586624|157866953|FG000|Overall Study|Withdrawal by Subject|0|||
49008075|NCT01586624|157866954|FG001|Overall Study|Withdrawal by Subject|0|||
49008076|NCT01586624|157866955|FG002|Overall Study|Withdrawal by Subject|0|||
49008077|NCT01586624|157866956|FG003|Overall Study|Withdrawal by Subject|1|||
49008078|NCT01586624|157866957|FG004|Overall Study|Withdrawal by Subject|0|||
49008079|NCT01586624|157866958|FG005|Overall Study|Withdrawal by Subject|0|||
49113139|NCT00419159|158250142|FG000|Overall Study|Abnormal laboratory value(s)|0|||
49113140|NCT00419159|158250143|FG001|Overall Study|Abnormal laboratory value(s)|2|||
49113141|NCT00419159|158250142|FG000|Overall Study|Subject's no longer requires study drug|0|||
49113142|NCT00419159|158250143|FG001|Overall Study|Subject's no longer requires study drug|1|||
49113143|NCT00419159|158250142|FG000|Overall Study|Protocol Violation|1|||
49113144|NCT00419159|158250143|FG001|Overall Study|Protocol Violation|0|||
49113145|NCT00419159|158250142|FG000|Overall Study|Withdrawal by Subject|10|||
49113146|NCT00419159|158250143|FG001|Overall Study|Withdrawal by Subject|3|||
49113147|NCT00419159|158250142|FG000|Overall Study|Lost to Follow-up|0|||
49113148|NCT00419159|158250143|FG001|Overall Study|Lost to Follow-up|1|||
49113149|NCT00419159|158250142|FG000|Overall Study|Death|2|||
49113150|NCT00419159|158250143|FG001|Overall Study|Death|2|||
49113151|NCT00419159|158250142|FG000|Overall Study|Disease progression|79|||
49113152|NCT00419159|158250143|FG001|Overall Study|Disease progression|76|||
49113153|NCT00076999|158250148|FG000|Overall Study|Adverse Event|2|||
49113154|NCT00076999|158250149|FG001|Overall Study|Adverse Event|8|||
49113155|NCT00076999|158250150|FG002|Overall Study|Adverse Event|6|||
49113156|NCT00076999|158250151|FG003|Overall Study|Adverse Event|0|||
49113157|NCT00076999|158250152|FG004|Overall Study|Adverse Event|2|||
49113158|NCT00076999|158250148|FG000|Overall Study|Protocol Violation|0|||
49113159|NCT00076999|158250149|FG001|Overall Study|Protocol Violation|3|||
49113160|NCT00076999|158250150|FG002|Overall Study|Protocol Violation|4|||
49113161|NCT00076999|158250151|FG003|Overall Study|Protocol Violation|0|||
49113162|NCT00076999|158250152|FG004|Overall Study|Protocol Violation|9|||
49113163|NCT00076999|158250148|FG000|Overall Study|Lost to Follow-up|2|||
49113164|NCT00076999|158250149|FG001|Overall Study|Lost to Follow-up|1|||
49113165|NCT00076999|158250150|FG002|Overall Study|Lost to Follow-up|0|||
49113166|NCT00076999|158250151|FG003|Overall Study|Lost to Follow-up|0|||
49113167|NCT00076999|158250152|FG004|Overall Study|Lost to Follow-up|0|||
49113168|NCT00076999|158250148|FG000|Overall Study|Withdrawal by Subject|0|||
49008080|NCT01586624|157866959|FG006|Overall Study|Withdrawal by Subject|0|||
49008081|NCT01586624|157866960|FG007|Overall Study|Withdrawal by Subject|0|||
49113169|NCT00076999|158250149|FG001|Overall Study|Withdrawal by Subject|4|||
49113170|NCT00076999|158250150|FG002|Overall Study|Withdrawal by Subject|3|||
49113171|NCT00076999|158250151|FG003|Overall Study|Withdrawal by Subject|0|||
49113172|NCT00076999|158250152|FG004|Overall Study|Withdrawal by Subject|1|||
49113173|NCT00076999|158250148|FG000|Overall Study|Other reason (not specified)|8|||
49113174|NCT00076999|158250149|FG001|Overall Study|Other reason (not specified)|8|||
49113175|NCT00076999|158250150|FG002|Overall Study|Other reason (not specified)|4|||
49113176|NCT00076999|158250151|FG003|Overall Study|Other reason (not specified)|1|||
49113177|NCT00076999|158250152|FG004|Overall Study|Other reason (not specified)|13|||
49113178|NCT02182830|158250157|FG000|Overall Study|Not Treated|1|||
49113179|NCT02182830|158250158|FG001|Overall Study|Not Treated|1|||
49113180|NCT02182830|158250157|FG000|Overall Study|Trial stopped, reason missing|3|||
49113181|NCT02182830|158250158|FG001|Overall Study|Trial stopped, reason missing|3|||
49113182|NCT02182830|158250157|FG000|Overall Study|Consent withdrawn|8|||
49113183|NCT02182830|158250158|FG001|Overall Study|Consent withdrawn|8|||
49113184|NCT02182830|158250157|FG000|Overall Study|Lost to Follow-up|3|||
49113185|NCT02182830|158250158|FG001|Overall Study|Lost to Follow-up|3|||
49113186|NCT00913770|158250166|FG000|Overall Study|Unable to contact|24|||
49113187|NCT00913770|158250167|FG001|Overall Study|Unable to contact|19|||
49113188|NCT00913770|158250168|FG002|Overall Study|Unable to contact|13|||
49113189|NCT00913770|158250166|FG000|Overall Study|Refused|11|||
49113190|NCT00913770|158250167|FG001|Overall Study|Refused|10|||
49113191|NCT00913770|158250168|FG002|Overall Study|Refused|8|||
49113192|NCT03337048|158250172|FG000|Overall Study|Withdrawal by Subject|2|||
49113193|NCT03337048|158250173|FG001|Overall Study|Withdrawal by Subject|0|||
49113194|NCT03337048|158250174|FG002|Overall Study|Withdrawal by Subject|0|||
49113195|NCT00893971|158250175|FG000|Overall Study|Physician Decision|3|||
49113204|NCT05139992|158250179|FG000|Overall Study|Withdrawal by Subject|12|||
49113205|NCT05139992|158250179|FG000|Overall Study|Lost to Follow-up|6|||
49113206|NCT03593226|158250181|FG000|Overall Study|Disease progression|6|||
49113207|NCT03593226|158250182|FG001|Overall Study|Disease progression|13|||
49113208|NCT03593226|158250183|FG002|Overall Study|Disease progression|5|||
48903390|NCT00001962|157482396|FG000|Overall Study|Lack of Efficacy|18|||
48903391|NCT00001962|157482396|FG000|Overall Study|Lack of Accrual|6|||
48903392|NCT00001962|157482396|FG000|Overall Study|Death|1|||
48903393|NCT00001962|157482396|FG000|Overall Study|Lost to Follow-up|2|||
48903394|NCT00001962|157482396|FG000|Overall Study|Adverse Event|1|||
48903395|NCT01485354|157482397|FG000|Overall Study|Withdrawal by Subject|5|||
48903396|NCT02594163|157482398|FG000|Treatment Period|Progressive disease|2|||
48903397|NCT02594163|157482399|FG001|Treatment Period|Progressive disease|3|||
48903398|NCT02594163|157482398|FG000|Treatment Period|Adverse Event|1|||
48903399|NCT02594163|157482399|FG001|Treatment Period|Adverse Event|5|||
48903400|NCT02594163|157482398|FG000|Treatment Period|Physician Decision|1|||
48903401|NCT02594163|157482399|FG001|Treatment Period|Physician Decision|3|||
48903402|NCT02594163|157482398|FG000|Treatment Period|Study termination by sponsor|2|||
48903403|NCT02594163|157482399|FG001|Treatment Period|Study termination by sponsor|1|||
48903404|NCT02594163|157482398|FG000|Treatment Period|Other, Non-AE|1|||
48903405|NCT02594163|157482399|FG001|Treatment Period|Other, Non-AE|0|||
48903406|NCT02594163|157482398|FG000|Follow-up Period|Withdrawal by Subject|0|||
48903407|NCT02594163|157482399|FG001|Follow-up Period|Withdrawal by Subject|1|||
48903408|NCT02594163|157482398|FG000|Follow-up Period|Study Termination by Sponsor|6|||
48903409|NCT02594163|157482399|FG001|Follow-up Period|Study Termination by Sponsor|4|||
48903410|NCT02594163|157482398|FG000|Follow-up Period|Lost to Follow-up|1|||
48903411|NCT02594163|157482399|FG001|Follow-up Period|Lost to Follow-up|0|||
48903412|NCT02594163|157482398|FG000|Follow-up Period|Death|2|||
48903413|NCT02594163|157482399|FG001|Follow-up Period|Death|5|||
48903414|NCT02594163|157482398|FG000|Follow-up Period|Adverse Event|0|||
48903415|NCT02594163|157482399|FG001|Follow-up Period|Adverse Event|1|||
48903416|NCT02594163|157482398|FG000|Follow-up Period|Progressive Disease|2|||
48903417|NCT02594163|157482399|FG001|Follow-up Period|Progressive Disease|0|||
48903418|NCT02594163|157482398|FG000|Follow-up Period|Physician Decision|0|||
48903419|NCT02594163|157482399|FG001|Follow-up Period|Physician Decision|1|||
48903420|NCT03566810|157482402|FG000|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
48903421|NCT03566810|157482403|FG001|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1|||
48903422|NCT03566810|157482404|FG002|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
48903423|NCT03566810|157482405|FG003|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
48903424|NCT00171704|157482408|FG000|Overall Study|Adverse Event|24|||
48903425|NCT00171704|157482409|FG001|Overall Study|Adverse Event|33|||
49113209|NCT03593226|158250184|FG003|Overall Study|Disease progression|6|||
49008082|NCT01586624|157866953|FG000|Overall Study|Evidence of disease progression|1|||
49008083|NCT01586624|157866954|FG001|Overall Study|Evidence of disease progression|3|||
49008084|NCT01586624|157866955|FG002|Overall Study|Evidence of disease progression|2|||
49008085|NCT01586624|157866956|FG003|Overall Study|Evidence of disease progression|5|||
49008086|NCT01586624|157866957|FG004|Overall Study|Evidence of disease progression|3|||
49008087|NCT01586624|157866958|FG005|Overall Study|Evidence of disease progression|5|||
49008088|NCT01586624|157866959|FG006|Overall Study|Evidence of disease progression|4|||
49008089|NCT01586624|157866960|FG007|Overall Study|Evidence of disease progression|6|||
49008090|NCT01586624|157866953|FG000|Overall Study|Screen failure (no treatment received)|0|||
49008091|NCT01586624|157866954|FG001|Overall Study|Screen failure (no treatment received)|0|||
49008092|NCT01586624|157866955|FG002|Overall Study|Screen failure (no treatment received)|0|||
49008093|NCT01586624|157866956|FG003|Overall Study|Screen failure (no treatment received)|0|||
49008094|NCT01586624|157866957|FG004|Overall Study|Screen failure (no treatment received)|0|||
49008095|NCT01586624|157866958|FG005|Overall Study|Screen failure (no treatment received)|0|||
49008096|NCT01586624|157866959|FG006|Overall Study|Screen failure (no treatment received)|1|||
49008097|NCT01586624|157866960|FG007|Overall Study|Screen failure (no treatment received)|0|||
49008098|NCT02496221|157866967|FG000|Treatment Period 2 - 4 Days|Adverse Event|0|||
49008099|NCT02496221|157866968|FG001|Treatment Period 2 - 4 Days|Adverse Event|1|||
49008100|NCT02496221|157866967|FG000|Treatment Period 2 - 4 Days|Protocol Violation|1|||
49008101|NCT02496221|157866968|FG001|Treatment Period 2 - 4 Days|Protocol Violation|0|||
49008102|NCT02496221|157866967|FG000|Treatment Period 2 - 4 Days|Physician Decision|1|||
49008103|NCT02496221|157866968|FG001|Treatment Period 2 - 4 Days|Physician Decision|0|||
49008104|NCT01335399|157866970|FG000|Pre-treatment Period|No longer meeting study criteria|0|||
49008105|NCT01335399|157866971|FG001|Pre-treatment Period|No longer meeting study criteria|1|||
49113210|NCT03593226|158250181|FG000|Overall Study|Adverse Event|0|||
49113211|NCT03593226|158250182|FG001|Overall Study|Adverse Event|1|||
49113212|NCT03593226|158250183|FG002|Overall Study|Adverse Event|0|||
49113213|NCT03593226|158250184|FG003|Overall Study|Adverse Event|0|||
49113214|NCT03593226|158250181|FG000|Overall Study|Withdrawal by Subject|0|||
49113215|NCT03593226|158250182|FG001|Overall Study|Withdrawal by Subject|4|||
49113216|NCT03593226|158250183|FG002|Overall Study|Withdrawal by Subject|1|||
49113217|NCT03593226|158250184|FG003|Overall Study|Withdrawal by Subject|0|||
49113218|NCT03593226|158250181|FG000|Overall Study|Physician Decision|0|||
49113219|NCT03593226|158250182|FG001|Overall Study|Physician Decision|1|||
49113220|NCT03593226|158250183|FG002|Overall Study|Physician Decision|0|||
49113221|NCT03593226|158250184|FG003|Overall Study|Physician Decision|0|||
49113222|NCT03593226|158250181|FG000|Overall Study|Clinical disease progression|0|||
49113223|NCT03593226|158250182|FG001|Overall Study|Clinical disease progression|0|||
49113224|NCT03593226|158250183|FG002|Overall Study|Clinical disease progression|1|||
49113225|NCT03593226|158250184|FG003|Overall Study|Clinical disease progression|0|||
49113226|NCT03777657|158250201|FG000|Overall Study|Death|397|||
49113227|NCT03777657|158250202|FG001|Overall Study|Death|431|||
49113228|NCT03777657|158250201|FG000|Overall Study|Study Closed by Sponsor|77|||
49113229|NCT03777657|158250202|FG001|Overall Study|Study Closed by Sponsor|38|||
49113230|NCT03777657|158250201|FG000|Overall Study|Withdrawal by Subject|20|||
49113231|NCT03777657|158250202|FG001|Overall Study|Withdrawal by Subject|17|||
49113232|NCT03777657|158250201|FG000|Overall Study|Lost to Follow-up|6|||
49113233|NCT03777657|158250202|FG001|Overall Study|Lost to Follow-up|10|||
49113234|NCT02401815|158250207|FG000|Dose Escalation (up to 670 Days)|Adverse Event|0|||
49113235|NCT02401815|158250208|FG001|Dose Escalation (up to 670 Days)|Adverse Event|0|||
49113236|NCT02401815|158250209|FG002|Dose Escalation (up to 670 Days)|Adverse Event|0|||
49113237|NCT02401815|158250210|FG003|Dose Escalation (up to 670 Days)|Adverse Event|1|||
49113238|NCT02401815|158250211|FG004|Dose Escalation (up to 670 Days)|Adverse Event|0|||
49113239|NCT02401815|158250212|FG005|Dose Escalation (up to 670 Days)|Adverse Event|0|||
49113240|NCT02401815|158250213|FG006|Dose Escalation (up to 670 Days)|Adverse Event|0|||
49113241|NCT02401815|158250214|FG007|Dose Escalation (up to 670 Days)|Adverse Event|0|||
49113242|NCT02401815|158250215|FG008|Dose Escalation (up to 670 Days)|Adverse Event|0|||
49113243|NCT02401815|158250216|FG009|Dose Escalation (up to 670 Days)|Adverse Event|0|||
49113244|NCT02401815|158250207|FG000|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
49113245|NCT02401815|158250208|FG001|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
49113246|NCT02401815|158250209|FG002|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
49113247|NCT02401815|158250210|FG003|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
49113248|NCT02401815|158250211|FG004|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
49008106|NCT01335399|157866970|FG000|Pre-treatment Period|Participant request to discontinue|0|||
49008107|NCT01335399|157866971|FG001|Pre-treatment Period|Participant request to discontinue|1|||
49008108|NCT01335399|157866970|FG000|Pre-treatment Period|Adverse event unrelated to study drug|0|||
49008109|NCT01335399|157866971|FG001|Pre-treatment Period|Adverse event unrelated to study drug|1|||
49113249|NCT02401815|158250212|FG005|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
49113250|NCT02401815|158250213|FG006|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
49113251|NCT02401815|158250214|FG007|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
49113252|NCT02401815|158250215|FG008|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
49113253|NCT02401815|158250216|FG009|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
49113254|NCT02401815|158250207|FG000|Dose Escalation (up to 670 Days)|Death|1|||
49113255|NCT02401815|158250208|FG001|Dose Escalation (up to 670 Days)|Death|2|||
49113256|NCT02401815|158250209|FG002|Dose Escalation (up to 670 Days)|Death|3|||
49113257|NCT02401815|158250210|FG003|Dose Escalation (up to 670 Days)|Death|5|||
49113258|NCT02401815|158250211|FG004|Dose Escalation (up to 670 Days)|Death|4|||
49113259|NCT02401815|158250212|FG005|Dose Escalation (up to 670 Days)|Death|0|||
49113260|NCT02401815|158250213|FG006|Dose Escalation (up to 670 Days)|Death|0|||
49113261|NCT02401815|158250214|FG007|Dose Escalation (up to 670 Days)|Death|0|||
49113262|NCT02401815|158250215|FG008|Dose Escalation (up to 670 Days)|Death|0|||
49113263|NCT02401815|158250216|FG009|Dose Escalation (up to 670 Days)|Death|0|||
49113264|NCT02401815|158250207|FG000|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
49113265|NCT02401815|158250208|FG001|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
49113266|NCT02401815|158250209|FG002|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
49113267|NCT02401815|158250210|FG003|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
49113268|NCT02401815|158250211|FG004|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
49113269|NCT02401815|158250212|FG005|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
49113270|NCT02401815|158250213|FG006|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
49113271|NCT02401815|158250214|FG007|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
49113272|NCT02401815|158250215|FG008|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
49113273|NCT02401815|158250216|FG009|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
49113274|NCT02401815|158250207|FG000|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
49113275|NCT02401815|158250208|FG001|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
49113276|NCT02401815|158250209|FG002|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
49113277|NCT02401815|158250210|FG003|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
49113278|NCT02401815|158250211|FG004|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
49113279|NCT02401815|158250212|FG005|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
49113280|NCT02401815|158250213|FG006|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
49113281|NCT02401815|158250214|FG007|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
49113282|NCT02401815|158250215|FG008|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
49113283|NCT02401815|158250216|FG009|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
49113284|NCT02401815|158250207|FG000|Dose Extension Part 2b (up to 868 Days)|Death|0|||
49113285|NCT02401815|158250208|FG001|Dose Extension Part 2b (up to 868 Days)|Death|0|||
49113286|NCT02401815|158250209|FG002|Dose Extension Part 2b (up to 868 Days)|Death|0|||
49113287|NCT02401815|158250210|FG003|Dose Extension Part 2b (up to 868 Days)|Death|0|||
49113288|NCT02401815|158250211|FG004|Dose Extension Part 2b (up to 868 Days)|Death|0|||
49113289|NCT02401815|158250212|FG005|Dose Extension Part 2b (up to 868 Days)|Death|2|||
49113290|NCT02401815|158250213|FG006|Dose Extension Part 2b (up to 868 Days)|Death|0|||
49113291|NCT02401815|158250214|FG007|Dose Extension Part 2b (up to 868 Days)|Death|0|||
49008110|NCT01335399|157866970|FG000|Pre-treatment Period|Consent withdrawal|3|||
49008111|NCT01335399|157866971|FG001|Pre-treatment Period|Consent withdrawal|0|||
49008112|NCT01335399|157866970|FG000|Treatment Period|Disease progression|117|||
49008113|NCT01335399|157866971|FG001|Treatment Period|Disease progression|145|||
49008114|NCT01335399|157866970|FG000|Treatment Period|Adverse event unrelated to study drug|110|||
49008115|NCT01335399|157866971|FG001|Treatment Period|Adverse event unrelated to study drug|73|||
49008116|NCT01335399|157866970|FG000|Treatment Period|Study drug toxicity|52|||
49008117|NCT01335399|157866971|FG001|Treatment Period|Study drug toxicity|64|||
49008118|NCT01335399|157866970|FG000|Treatment Period|Participant request to discontinue|30|||
49008119|NCT01335399|157866971|FG001|Treatment Period|Participant request to discontinue|22|||
49008120|NCT01335399|157866970|FG000|Treatment Period|Other reasons|30|||
49008121|NCT01335399|157866971|FG001|Treatment Period|Other reasons|30|||
49008122|NCT01335399|157866970|FG000|Treatment Period|Consent withdrawal|10|||
49008123|NCT01335399|157866971|FG001|Treatment Period|Consent withdrawal|7|||
49008124|NCT01335399|157866970|FG000|Treatment Period|Death|7|||
49008125|NCT01335399|157866971|FG001|Treatment Period|Death|6|||
49008126|NCT01335399|157866970|FG000|Treatment Period|Poor/Non-compliance|3|||
49008127|NCT01335399|157866971|FG001|Treatment Period|Poor/Non-compliance|4|||
49008128|NCT01335399|157866970|FG000|Treatment Period|Lost to Follow-up|2|||
49008129|NCT01335399|157866971|FG001|Treatment Period|Lost to Follow-up|2|||
49008130|NCT01335399|157866970|FG000|Treatment Period|Maximum clinical benefit|1|||
49008131|NCT01335399|157866971|FG001|Treatment Period|Maximum clinical benefit|1|||
49008132|NCT01335399|157866970|FG000|Treatment Period|No longer meet study criteria|1|||
49008133|NCT01335399|157866971|FG001|Treatment Period|No longer meet study criteria|1|||
49008134|NCT01335399|157866970|FG000|Treatment Period|Administrative reasons by Sponsor|8|||
49008135|NCT01335399|157866971|FG001|Treatment Period|Administrative reasons by Sponsor|16|||
49008136|NCT01416142|157866972|FG000|PureVision2 HD|Inability to maintain lens wear|0|||
49008137|NCT01416142|157866973|FG001|PureVision2 HD|Inability to maintain lens wear|0|||
49008138|NCT01416142|157866974|FG002|PureVision2 HD|Inability to maintain lens wear|1|||
49008139|NCT02464059|157866975|FG000|Overall Study|Lost to Follow-up|6|||
49008140|NCT01074307|157866976|FG000|Overall Study|No primary endpoint evaluation|14|||
49113292|NCT02401815|158250215|FG008|Dose Extension Part 2b (up to 868 Days)|Death|0|||
49113293|NCT02401815|158250216|FG009|Dose Extension Part 2b (up to 868 Days)|Death|0|||
49113294|NCT02401815|158250207|FG000|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
49113295|NCT02401815|158250208|FG001|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
49113296|NCT02401815|158250209|FG002|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
49113297|NCT02401815|158250210|FG003|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
49113298|NCT02401815|158250211|FG004|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
49113299|NCT02401815|158250212|FG005|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
49113300|NCT02401815|158250213|FG006|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|5|||
49113301|NCT02401815|158250214|FG007|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
49113302|NCT02401815|158250215|FG008|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
49113303|NCT02401815|158250216|FG009|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
49113304|NCT02401815|158250207|FG000|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
49113305|NCT02401815|158250208|FG001|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
49113306|NCT02401815|158250209|FG002|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
49113307|NCT02401815|158250210|FG003|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
49113308|NCT02401815|158250211|FG004|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
49113309|NCT02401815|158250212|FG005|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|1|||
49113310|NCT02401815|158250213|FG006|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|3|||
49113311|NCT02401815|158250214|FG007|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
49113312|NCT02401815|158250215|FG008|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
49113313|NCT02401815|158250216|FG009|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
49113314|NCT02401815|158250207|FG000|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
49113315|NCT02401815|158250208|FG001|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
49113316|NCT02401815|158250209|FG002|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
49113317|NCT02401815|158250210|FG003|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
49113318|NCT02401815|158250211|FG004|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
49113319|NCT02401815|158250212|FG005|Dose Extension Part 2b (up to 868 Days)|Other than specified|1|||
49113320|NCT02401815|158250213|FG006|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
49113321|NCT02401815|158250214|FG007|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
49113322|NCT02401815|158250215|FG008|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
49113323|NCT02401815|158250216|FG009|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
49113324|NCT02401815|158250207|FG000|Dose Extension Part 2e (up to 868 Days)|Death|0|||
49113325|NCT02401815|158250208|FG001|Dose Extension Part 2e (up to 868 Days)|Death|0|||
49113326|NCT02401815|158250209|FG002|Dose Extension Part 2e (up to 868 Days)|Death|0|||
49113327|NCT02401815|158250210|FG003|Dose Extension Part 2e (up to 868 Days)|Death|0|||
49113328|NCT02401815|158250211|FG004|Dose Extension Part 2e (up to 868 Days)|Death|0|||
49113329|NCT02401815|158250212|FG005|Dose Extension Part 2e (up to 868 Days)|Death|0|||
49113330|NCT02401815|158250213|FG006|Dose Extension Part 2e (up to 868 Days)|Death|0|||
49113331|NCT02401815|158250214|FG007|Dose Extension Part 2e (up to 868 Days)|Death|1|||
49113332|NCT02401815|158250215|FG008|Dose Extension Part 2e (up to 868 Days)|Death|2|||
49113333|NCT02401815|158250216|FG009|Dose Extension Part 2e (up to 868 Days)|Death|4|||
49113334|NCT02401815|158250207|FG000|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
49113335|NCT02401815|158250208|FG001|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
49113336|NCT02401815|158250209|FG002|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
49113337|NCT02401815|158250210|FG003|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
49113338|NCT02401815|158250211|FG004|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
49113339|NCT02401815|158250212|FG005|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
49113340|NCT02401815|158250213|FG006|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
49113341|NCT02401815|158250214|FG007|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
49113342|NCT02401815|158250215|FG008|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|2|||
49113343|NCT02401815|158250216|FG009|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|1|||
49113344|NCT02401815|158250207|FG000|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
49113345|NCT02401815|158250208|FG001|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
49113346|NCT02401815|158250209|FG002|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
49113347|NCT02401815|158250210|FG003|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
49113348|NCT02401815|158250211|FG004|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
49113349|NCT02401815|158250212|FG005|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
49113350|NCT02401815|158250213|FG006|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
49113351|NCT02401815|158250214|FG007|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
49113352|NCT02401815|158250215|FG008|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
49113353|NCT02401815|158250216|FG009|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|2|||
49113354|NCT02401815|158250207|FG000|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
49113355|NCT02401815|158250208|FG001|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
49113356|NCT02401815|158250209|FG002|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
49113357|NCT02401815|158250210|FG003|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
49113358|NCT02401815|158250211|FG004|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
49113359|NCT02401815|158250212|FG005|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
49113360|NCT02401815|158250213|FG006|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
49113361|NCT02401815|158250214|FG007|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
49113362|NCT02401815|158250215|FG008|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|1|||
49113363|NCT02401815|158250216|FG009|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
49113364|NCT02401815|158250207|FG000|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
49113365|NCT02401815|158250208|FG001|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
49008141|NCT01074307|157866977|FG001|Overall Study|No primary endpoint evaluation|6|||
49008142|NCT01074307|157866976|FG000|Overall Study|Exclusion criterion|0|||
49008143|NCT01074307|157866977|FG001|Overall Study|Exclusion criterion|1|||
49008144|NCT01074307|157866976|FG000|Overall Study|Protocol Violation|8|||
49113366|NCT02401815|158250209|FG002|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
49008145|NCT01074307|157866977|FG001|Overall Study|Protocol Violation|5|||
49008146|NCT01440595|157866984|FG000|Overall Study|Lost to Follow-up|0|||
49008147|NCT01440595|157866985|FG001|Overall Study|Lost to Follow-up|1|||
49008148|NCT01440595|157866986|FG002|Overall Study|Lost to Follow-up|0|||
49008149|NCT01440595|157866984|FG000|Overall Study|Study terminated by sponsor.|1|||
49008150|NCT01440595|157866985|FG001|Overall Study|Study terminated by sponsor.|2|||
49113367|NCT02401815|158250210|FG003|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
49113368|NCT02401815|158250211|FG004|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
49113369|NCT02401815|158250212|FG005|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
49113370|NCT02401815|158250213|FG006|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
49113371|NCT02401815|158250214|FG007|Dose Extension Part 2e (up to 868 Days)|Other than specified|2|||
49113372|NCT02401815|158250215|FG008|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
49113373|NCT02401815|158250216|FG009|Dose Extension Part 2e (up to 868 Days)|Other than specified|3|||
49113374|NCT03829332|158250219|FG000|Overall Study|Death|145|||
49113375|NCT03829332|158250220|FG001|Overall Study|Death|135|||
49113376|NCT03829332|158250219|FG000|Overall Study|Withdrawal by Subject|10|||
49113377|NCT03829332|158250220|FG001|Overall Study|Withdrawal by Subject|4|||
49113378|NCT03829332|158250219|FG000|Overall Study|Ongoing in Study|154|||
49113379|NCT03829332|158250220|FG001|Overall Study|Ongoing in Study|175|||
49008151|NCT01440595|157866986|FG002|Overall Study|Study terminated by sponsor.|1|||
49113380|NCT04912856|158250221|FG000|Overall Study|Sponsor Decision; not due to safety reasons|4|||
49113381|NCT04912856|158250222|FG001|Overall Study|Sponsor Decision; not due to safety reasons|2|||
49113382|NCT04912856|158250221|FG000|Overall Study|Not reported in synoptic CSR.|0|||
49113383|NCT04912856|158250222|FG001|Overall Study|Not reported in synoptic CSR.|1|||
49113384|NCT05613907|158250223|FG000|Overall Study|Lost to Follow-up|5|||
49113385|NCT05613907|158250223|FG000|Overall Study|Death|3|||
49113386|NCT05613907|158250223|FG000|Overall Study|Withdrawal by Subject|2|||
49008152|NCT04126733|157866987|FG000|Treatment Period|Progressive Disease - Radiological Progression|47|||
48693085|NCT01602224|156726339|FG001|Overall Study|Investigator Decison|0|||
49008153|NCT04126733|157866987|FG000|Treatment Period|Adverse Event|8|||
49008154|NCT04126733|157866987|FG000|Treatment Period|Progressive Disease - Clinical Assessment|7|||
49008155|NCT04126733|157866987|FG000|Treatment Period|Physician Decision|5|||
49113387|NCT00549601|158251670|FG000|Randomized|Protocol Violation|0|||
49113388|NCT00549601|158251671|FG001|Randomized|Protocol Violation|0|||
49008156|NCT04126733|157866987|FG000|Treatment Period|Death|1|||
49008157|NCT04126733|157866987|FG000|Treatment Period|Other Reasons|2|||
49008158|NCT04126733|157866987|FG000|Active Follow-up Period|Death|13|||
49008159|NCT04126733|157866987|FG000|Active Follow-up Period|Progressive Disease - Clinical Assessment|4|||
49008160|NCT04126733|157866987|FG000|Active Follow-up Period|Withdrawal by Subject|2|||
49008161|NCT04126733|157866987|FG000|Active Follow-up Period|Other Reasons|1|||
49008162|NCT04126733|157866987|FG000|Long-term Follow-up Period|Death|22|||
49008163|NCT04126733|157866987|FG000|Long-term Follow-up Period|Withdrawal by Subject|1|||
49008164|NCT04126733|157866987|FG000|Long-term Follow-up Period|Ongoing with Long Term Follow-up|6|||
49008165|NCT01205529|157866990|FG000|Overall Study|Procedure Cancelled|4|||
49008166|NCT01205529|157866990|FG000|Overall Study|Withdrawal by Subject|2|||
49008167|NCT01205529|157866990|FG000|Overall Study|Physician Decision|4|||
49008168|NCT01205529|157866990|FG000|Overall Study|Unstable post op|15|||
49008169|NCT01205529|157866990|FG000|Overall Study|No longer met criteria|30|||
49008170|NCT01271933|157866996|FG000|Single-Blind Phase|Lack of Efficacy|37|||
49008171|NCT01271933|157866997|FG001|Single-Blind Phase|Lack of Efficacy|0|||
49008172|NCT01271933|157866998|FG002|Single-Blind Phase|Lack of Efficacy|0|||
49008173|NCT01271933|157866996|FG000|Single-Blind Phase|Lost to Follow-up|10|||
49008174|NCT01271933|157866997|FG001|Single-Blind Phase|Lost to Follow-up|0|||
49008175|NCT01271933|157866998|FG002|Single-Blind Phase|Lost to Follow-up|0|||
49008176|NCT01271933|157866996|FG000|Single-Blind Phase|Withdrawal by Subject|15|||
49008177|NCT01271933|157866997|FG001|Single-Blind Phase|Withdrawal by Subject|0|||
49008178|NCT01271933|157866998|FG002|Single-Blind Phase|Withdrawal by Subject|0|||
49008179|NCT01271933|157866996|FG000|Single-Blind Phase|Protocol Violation|3|||
49008180|NCT01271933|157866997|FG001|Single-Blind Phase|Protocol Violation|0|||
49008181|NCT01271933|157866998|FG002|Single-Blind Phase|Protocol Violation|0|||
49008182|NCT01271933|157866996|FG000|Single-Blind Phase|Adverse Event|52|||
49008183|NCT01271933|157866997|FG001|Single-Blind Phase|Adverse Event|0|||
49008184|NCT01271933|157866998|FG002|Single-Blind Phase|Adverse Event|0|||
49008185|NCT01271933|157866996|FG000|Single-Blind Phase|(Failed to meet dosing requirement)|1|||
49008186|NCT01271933|157866997|FG001|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
49008187|NCT01271933|157866998|FG002|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
49008188|NCT01271933|157866996|FG000|Single-Blind Phase|(Protocol non-compliance)|2|||
49008189|NCT01271933|157866997|FG001|Single-Blind Phase|(Protocol non-compliance)|0|||
49008190|NCT01271933|157866998|FG002|Single-Blind Phase|(Protocol non-compliance)|0|||
49008191|NCT01271933|157866996|FG000|Single-Blind Phase|(Participant request-personal reason)|1|||
49008192|NCT01271933|157866997|FG001|Single-Blind Phase|(Participant request-personal reason)|0|||
49008193|NCT01271933|157866998|FG002|Single-Blind Phase|(Participant request-personal reason)|0|||
49008194|NCT01271933|157866996|FG000|Double-Blind Phase|Randomized but not treated|0|||
49008195|NCT01271933|157866997|FG001|Double-Blind Phase|Randomized but not treated|0|||
49008196|NCT01271933|157866998|FG002|Double-Blind Phase|Randomized but not treated|1|||
49008197|NCT01271933|157866996|FG000|Double-Blind Phase|Lack of Efficacy|0|||
49008198|NCT01271933|157866997|FG001|Double-Blind Phase|Lack of Efficacy|6|||
49008199|NCT01271933|157866998|FG002|Double-Blind Phase|Lack of Efficacy|9|||
49008200|NCT01271933|157866996|FG000|Double-Blind Phase|Lost to Follow-up|0|||
49008201|NCT01271933|157866997|FG001|Double-Blind Phase|Lost to Follow-up|1|||
49008202|NCT01271933|157866998|FG002|Double-Blind Phase|Lost to Follow-up|1|||
49008203|NCT01271933|157866996|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
49008204|NCT01271933|157866997|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
49008205|NCT01271933|157866998|FG002|Double-Blind Phase|Withdrawal by Subject|1|||
49008206|NCT01271933|157866996|FG000|Double-Blind Phase|Adverse Event|0|||
49008207|NCT01271933|157866997|FG001|Double-Blind Phase|Adverse Event|3|||
49008208|NCT01271933|157866998|FG002|Double-Blind Phase|Adverse Event|0|||
49008209|NCT01271933|157866996|FG000|Double-Blind Phase|Participant request-personal reason|0|||
49008210|NCT01271933|157866997|FG001|Double-Blind Phase|Participant request-personal reason|1|||
49008211|NCT01271933|157866998|FG002|Double-Blind Phase|Participant request-personal reason|0|||
49008212|NCT00065065|157866999|FG000|Overall Study|Adverse Event|3|||
49008213|NCT00065065|157867000|FG001|Overall Study|Adverse Event|2|||
49008214|NCT00065065|157866999|FG000|Overall Study|Withdrawal by Subject|1|||
49008215|NCT00065065|157867000|FG001|Overall Study|Withdrawal by Subject|5|||
49008216|NCT00065065|157866999|FG000|Overall Study|Lack of Efficacy|4|||
48798450|NCT03076970|157100472|FG001|Washout Period 2|Adverse Event|0|||
48798451|NCT03076970|157100473|FG002|Washout Period 2|Adverse Event|0|||
49008217|NCT00065065|157867000|FG001|Overall Study|Lack of Efficacy|11|||
49008218|NCT00065065|157866999|FG000|Overall Study|Other|2|||
49008219|NCT00065065|157867000|FG001|Overall Study|Other|2|||
49008220|NCT03634488|157867001|FG000|Overall Study|Death|1|||
49008221|NCT03634488|157867002|FG001|Overall Study|Death|0|||
49008222|NCT03634488|157867003|FG002|Overall Study|Death|0|||
49008223|NCT03634488|157867001|FG000|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|1|||
49008224|NCT03634488|157867002|FG001|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
49015353|NCT00673790|157892153|FG001|Overall Study|Unconfirmed pregnancy|1|||
49008225|NCT03634488|157867003|FG002|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
49008226|NCT00869089|157867004|FG000|Overall Study|Lost to Follow-up|1|||
49008227|NCT00869089|157867004|FG000|Overall Study|Withdrawal by Subject|1|||
49008228|NCT00869089|157867004|FG000|Overall Study|Screen Fail|1|||
49008229|NCT02340078|157867005|FG000|Overall Study|Protocol Violation|1|||
49008230|NCT02766400|157867007|FG000|Overall Study|Death|1|||
49008231|NCT02766400|157867008|FG001|Overall Study|Death|2|||
49008232|NCT02766400|157867007|FG000|Overall Study|Withdrawal by Subject|1|||
49008233|NCT02766400|157867008|FG001|Overall Study|Withdrawal by Subject|0|||
49008234|NCT02390219|157867009|FG000|Overall Study|Death|1|||
49008235|NCT02390219|157867009|FG000|Overall Study|Physician Decision|1|||
49008236|NCT02390219|157867009|FG000|Overall Study|Adverse Event|6|||
49008237|NCT02390219|157867009|FG000|Overall Study|Withdrawal by Subject|1|||
49008238|NCT02390219|157867009|FG000|Overall Study|Lost to Follow-up|2|||
49008239|NCT02390219|157867009|FG000|Overall Study|Other|2|||
49008240|NCT00529568|157867012|FG000|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5|||
49008241|NCT00529568|157867013|FG001|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
49008242|NCT00529568|157867014|FG002|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
49008243|NCT00529568|157867012|FG000|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12|||
49008244|NCT00529568|157867013|FG001|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
49008245|NCT00529568|157867014|FG002|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
49008246|NCT00529568|157867012|FG000|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5|||
49008247|NCT00529568|157867013|FG001|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
49008248|NCT00529568|157867014|FG002|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
49008249|NCT00529568|157867012|FG000|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8|||
49008250|NCT00529568|157867013|FG001|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
49008251|NCT00529568|157867014|FG002|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
49008252|NCT00529568|157867012|FG000|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13|||
49008253|NCT00529568|157867013|FG001|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
49008254|NCT00529568|157867014|FG002|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
49008255|NCT00529568|157867012|FG000|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3|||
49008256|NCT00529568|157867013|FG001|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
49008257|NCT00529568|157867014|FG002|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
49008258|NCT00529568|157867012|FG000|Double-bilnd Antiviral Treatment Phase|Adverse Event|0|||
49008259|NCT00529568|157867013|FG001|Double-bilnd Antiviral Treatment Phase|Adverse Event|10|||
49008260|NCT00529568|157867014|FG002|Double-bilnd Antiviral Treatment Phase|Adverse Event|27|||
49008261|NCT00529568|157867012|FG000|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
49008262|NCT00529568|157867013|FG001|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1|||
49008263|NCT00529568|157867014|FG002|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
49008264|NCT00529568|157867012|FG000|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0|||
49008265|NCT00529568|157867013|FG001|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15|||
49008266|NCT00529568|157867014|FG002|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48|||
49008267|NCT00529568|157867012|FG000|Double-bilnd Antiviral Treatment Phase|Physician Decision|0|||
49008268|NCT00529568|157867013|FG001|Double-bilnd Antiviral Treatment Phase|Physician Decision|5|||
49008269|NCT00529568|157867014|FG002|Double-bilnd Antiviral Treatment Phase|Physician Decision|8|||
49008270|NCT00529568|157867012|FG000|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0|||
49008271|NCT00529568|157867013|FG001|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17|||
48798452|NCT03076970|157100474|FG003|Washout Period 2|Adverse Event|0|||
48798453|NCT03076970|157100475|FG004|Washout Period 2|Adverse Event|1|||
48798454|NCT03076970|157100476|FG005|Washout Period 2|Adverse Event|0|||
48798455|NCT03076970|157100471|FG000|Period 3|Withdrawal by Subject|0|||
48798456|NCT03076970|157100472|FG001|Period 3|Withdrawal by Subject|0|||
48798457|NCT03076970|157100473|FG002|Period 3|Withdrawal by Subject|0|||
48798458|NCT03076970|157100474|FG003|Period 3|Withdrawal by Subject|0|||
48798459|NCT03076970|157100475|FG004|Period 3|Withdrawal by Subject|0|||
48798460|NCT03076970|157100476|FG005|Period 3|Withdrawal by Subject|1|||
48798461|NCT03076970|157100471|FG000|Period 3|Failure to meet I/E criteria|0|||
48798462|NCT03076970|157100472|FG001|Period 3|Failure to meet I/E criteria|0|||
48798463|NCT03076970|157100473|FG002|Period 3|Failure to meet I/E criteria|0|||
48798464|NCT03076970|157100474|FG003|Period 3|Failure to meet I/E criteria|0|||
48798465|NCT03076970|157100475|FG004|Period 3|Failure to meet I/E criteria|1|||
48798466|NCT03076970|157100476|FG005|Period 3|Failure to meet I/E criteria|0|||
48798467|NCT01345630|157100478|FG000|Overall Study|Adverse Event|22|||
49008272|NCT00529568|157867014|FG002|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19|||
49008273|NCT00738920|157867022|FG000|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
49008274|NCT00738920|157867023|FG001|Baseline to 2-Week Follow-Up|Lost to Follow-up|9|||
49008275|NCT00738920|157867024|FG002|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
48798468|NCT01345630|157100479|FG001|Overall Study|Adverse Event|23|||
48798469|NCT01345630|157100478|FG000|Overall Study|Lost to Follow-up|17|||
48798470|NCT01345630|157100479|FG001|Overall Study|Lost to Follow-up|16|||
49008276|NCT00738920|157867022|FG000|Baseline to 2-Week Follow-Up|Withdrawal by Subject|8|||
49008277|NCT00738920|157867023|FG001|Baseline to 2-Week Follow-Up|Withdrawal by Subject|14|||
49008278|NCT00738920|157867024|FG002|Baseline to 2-Week Follow-Up|Withdrawal by Subject|7|||
49008279|NCT00738920|157867022|FG000|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|3|||
49008280|NCT00738920|157867023|FG001|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|5|||
48693086|NCT01602224|156726340|FG002|Overall Study|Investigator Decison|0|||
48798471|NCT01345630|157100478|FG000|Overall Study|Protocol Violation|4|||
48798472|NCT01345630|157100479|FG001|Overall Study|Protocol Violation|1|||
48798473|NCT01345630|157100478|FG000|Overall Study|Medication error without associated AE|0|||
48798474|NCT01345630|157100479|FG001|Overall Study|Medication error without associated AE|1|||
48798475|NCT01345630|157100478|FG000|Overall Study|Study terminated by sponsor|254|||
48798476|NCT01345630|157100479|FG001|Overall Study|Study terminated by sponsor|285|||
48798477|NCT01345630|157100478|FG000|Overall Study|Other reasons|6|||
48798478|NCT01345630|157100479|FG001|Overall Study|Other reasons|8|||
48798479|NCT01345630|157100478|FG000|Overall Study|Withdrawn due to pregnancy|1|||
48798480|NCT01345630|157100479|FG001|Overall Study|Withdrawn due to pregnancy|2|||
48798481|NCT01345630|157100478|FG000|Overall Study|No longer willing to participate|9|||
48798482|NCT01345630|157100479|FG001|Overall Study|No longer willing to participate|12|||
48798483|NCT01345630|157100478|FG000|Overall Study|Insufficient clinical response|48|||
48798484|NCT01345630|157100479|FG001|Overall Study|Insufficient clinical response|11|||
48798485|NCT02119260|157100482|FG000|Overall Study|Adverse Event|1|||
48798486|NCT02119260|157100483|FG001|Overall Study|Adverse Event|0|||
48798487|NCT02119260|157100484|FG002|Overall Study|Adverse Event|0|||
48798488|NCT02119260|157100485|FG003|Overall Study|Adverse Event|0|||
48798489|NCT02119260|157100486|FG004|Overall Study|Adverse Event|0|||
48798490|NCT02119260|157100487|FG005|Overall Study|Adverse Event|0|||
48798491|NCT02119260|157100488|FG006|Overall Study|Adverse Event|0|||
48798492|NCT02119260|157100482|FG000|Overall Study|Withdrew consent|0|||
48798493|NCT02119260|157100483|FG001|Overall Study|Withdrew consent|1|||
48798494|NCT02119260|157100484|FG002|Overall Study|Withdrew consent|1|||
48798495|NCT02119260|157100485|FG003|Overall Study|Withdrew consent|0|||
48798496|NCT02119260|157100486|FG004|Overall Study|Withdrew consent|0|||
48798497|NCT02119260|157100487|FG005|Overall Study|Withdrew consent|0|||
48798498|NCT02119260|157100488|FG006|Overall Study|Withdrew consent|0|||
48798499|NCT02057874|157100489|FG000|Overall Study|participant did not return for scan|1|||
48798500|NCT01266850|157100513|FG000|Overall Study|Lost to Follow-up|19|||
48798501|NCT01266850|157100514|FG001|Overall Study|Lost to Follow-up|19|||
48798502|NCT01266850|157100515|FG002|Overall Study|Lost to Follow-up|13|||
48798503|NCT01266850|157100516|FG003|Overall Study|Lost to Follow-up|13|||
48798504|NCT01266850|157100517|FG004|Overall Study|Lost to Follow-up|12|||
48798505|NCT01266850|157100513|FG000|Overall Study|Withdrawal by Subject|8|||
48798506|NCT01266850|157100514|FG001|Overall Study|Withdrawal by Subject|9|||
48798507|NCT01266850|157100515|FG002|Overall Study|Withdrawal by Subject|6|||
48798508|NCT01266850|157100516|FG003|Overall Study|Withdrawal by Subject|9|||
48798509|NCT01266850|157100517|FG004|Overall Study|Withdrawal by Subject|12|||
48798510|NCT01266850|157100513|FG000|Overall Study|Physician Decision|3|||
48798511|NCT01266850|157100514|FG001|Overall Study|Physician Decision|6|||
48798512|NCT01266850|157100515|FG002|Overall Study|Physician Decision|4|||
48798513|NCT01266850|157100516|FG003|Overall Study|Physician Decision|4|||
48798514|NCT01266850|157100517|FG004|Overall Study|Physician Decision|3|||
48798515|NCT01266850|157100513|FG000|Overall Study|Protocol Violation|0|||
48798516|NCT01266850|157100514|FG001|Overall Study|Protocol Violation|1|||
48798517|NCT01266850|157100515|FG002|Overall Study|Protocol Violation|0|||
48798518|NCT01266850|157100516|FG003|Overall Study|Protocol Violation|1|||
48798519|NCT01266850|157100517|FG004|Overall Study|Protocol Violation|2|||
48798520|NCT01266850|157100513|FG000|Overall Study|Adverse Event|0|||
48798521|NCT01266850|157100514|FG001|Overall Study|Adverse Event|0|||
48798522|NCT01266850|157100515|FG002|Overall Study|Adverse Event|0|||
48798523|NCT01266850|157100516|FG003|Overall Study|Adverse Event|0|||
48798524|NCT01266850|157100517|FG004|Overall Study|Adverse Event|1|||
48798525|NCT01266850|157100513|FG000|Overall Study|Site Closure|0|||
48798526|NCT01266850|157100514|FG001|Overall Study|Site Closure|1|||
48798527|NCT01266850|157100515|FG002|Overall Study|Site Closure|1|||
48798528|NCT01266850|157100516|FG003|Overall Study|Site Closure|1|||
48798529|NCT01266850|157100517|FG004|Overall Study|Site Closure|0|||
48798530|NCT02586025|157100520|FG000|Neoadjuvant Treatment|Withdrawal by Subject|4|||
48798531|NCT02586025|157100521|FG001|Neoadjuvant Treatment|Withdrawal by Subject|3|||
48798532|NCT02586025|157100520|FG000|Neoadjuvant Treatment|Progression of Disease|2|||
48693087|NCT01602224|156726338|FG000|Overall Study|Lost to Follow-up|0|||
48798533|NCT02586025|157100521|FG001|Neoadjuvant Treatment|Progression of Disease|3|||
48798534|NCT02586025|157100520|FG000|Neoadjuvant Treatment|Did Not Receive Study Drug|1|||
48798535|NCT02586025|157100521|FG001|Neoadjuvant Treatment|Did Not Receive Study Drug|0|||
48798536|NCT02586025|157100520|FG000|Neoadjuvant Treatment|Death|1|||
49113389|NCT00549601|158251672|FG002|Randomized|Protocol Violation|1|||
48798537|NCT02586025|157100521|FG001|Neoadjuvant Treatment|Death|0|||
48798538|NCT02586025|157100520|FG000|Neoadjuvant Treatment|Adverse Event|1|||
48798539|NCT02586025|157100521|FG001|Neoadjuvant Treatment|Adverse Event|0|||
48798540|NCT02586025|157100520|FG000|Neoadjuvant Treatment|Physician Decision|2|||
48798541|NCT02586025|157100521|FG001|Neoadjuvant Treatment|Physician Decision|1|||
48798542|NCT02586025|157100520|FG000|Adjuvant Treatment|Withdrawal by Subject|5|||
48798543|NCT02586025|157100521|FG001|Adjuvant Treatment|Withdrawal by Subject|3|||
48798544|NCT02586025|157100520|FG000|Adjuvant Treatment|Recurrent Disease|4|||
48798545|NCT02586025|157100521|FG001|Adjuvant Treatment|Recurrent Disease|5|||
48798546|NCT02586025|157100520|FG000|Adjuvant Treatment|Physician Decision|0|||
48798547|NCT02586025|157100521|FG001|Adjuvant Treatment|Physician Decision|1|||
48798548|NCT02586025|157100520|FG000|Adjuvant Treatment|Pregnancy|1|||
48798549|NCT02586025|157100521|FG001|Adjuvant Treatment|Pregnancy|0|||
48798550|NCT02586025|157100520|FG000|Treatment-Free Follow-Up|Death|11|||
48798551|NCT02586025|157100521|FG001|Treatment-Free Follow-Up|Death|11|||
48798552|NCT02586025|157100520|FG000|Treatment-Free Follow-Up|Lost to Follow-up|9|||
48798553|NCT02586025|157100521|FG001|Treatment-Free Follow-Up|Lost to Follow-up|4|||
48798554|NCT02586025|157100520|FG000|Treatment-Free Follow-Up|Withdrawal by Subject|13|||
48798555|NCT02586025|157100521|FG001|Treatment-Free Follow-Up|Withdrawal by Subject|3|||
48798556|NCT02586025|157100520|FG000|Treatment-Free Follow-Up|Non-compliance|0|||
48798557|NCT02586025|157100521|FG001|Treatment-Free Follow-Up|Non-compliance|1|||
48798558|NCT02586025|157100520|FG000|Treatment-Free Follow-Up|Reason Not Specified|0|||
48798559|NCT02586025|157100521|FG001|Treatment-Free Follow-Up|Reason Not Specified|3|||
48798560|NCT03014674|157100523|FG000|Overall Study|Withdrawal by Subject|1|||
48798561|NCT03014674|157100524|FG001|Overall Study|Withdrawal by Subject|0|||
48798562|NCT03014674|157100525|FG002|Overall Study|Withdrawal by Subject|0|||
48798563|NCT02173548|157100531|FG000|Overall Study|Lost to Follow-up|0|||
48798564|NCT02173548|157100532|FG001|Overall Study|Lost to Follow-up|2|||
48798565|NCT02173548|157100531|FG000|Overall Study|Withdrawal by Subject|1|||
48798566|NCT02173548|157100532|FG001|Overall Study|Withdrawal by Subject|0|||
48798567|NCT01621126|157100533|FG000|Overall Study|Physician Decision|6|||
48798568|NCT03751631|157100534|FG000|Overall Study|Withdrawal by Subject|0|||
48798569|NCT03751631|157100535|FG001|Overall Study|Withdrawal by Subject|0|||
48798570|NCT03751631|157100536|FG002|Overall Study|Withdrawal by Subject|1|||
48798571|NCT03751631|157100537|FG003|Overall Study|Withdrawal by Subject|1|||
48798572|NCT03751631|157100538|FG004|Overall Study|Withdrawal by Subject|0|||
48798573|NCT03751631|157100539|FG005|Overall Study|Withdrawal by Subject|0|||
48798574|NCT03382782|157100540|FG000|Cohort 1|Withdrawal by Subject|11|||
48798575|NCT03382782|157100541|FG001|Cohort 1|Withdrawal by Subject|5|||
48798576|NCT03382782|157100542|FG002|Cohort 1|Withdrawal by Subject|0|||
48798577|NCT03382782|157100540|FG000|Cohort 2|Withdrawal by Subject|1|||
48798578|NCT03382782|157100541|FG001|Cohort 2|Withdrawal by Subject|1|||
48798579|NCT03382782|157100542|FG002|Cohort 2|Withdrawal by Subject|0|||
48798580|NCT03382782|157100540|FG000|Cohort 3|Withdrawal by Subject|1|||
48798581|NCT03382782|157100541|FG001|Cohort 3|Withdrawal by Subject|2|||
48798582|NCT03382782|157100542|FG002|Cohort 3|Withdrawal by Subject|0|||
48798583|NCT00428090|157100545|FG000|Overall Study|Adverse Event|10|||
48798584|NCT00428090|157100546|FG001|Overall Study|Adverse Event|8|||
48798585|NCT00428090|157100547|FG002|Overall Study|Adverse Event|10|||
48798586|NCT00428090|157100548|FG003|Overall Study|Adverse Event|11|||
48798587|NCT00428090|157100545|FG000|Overall Study|Lost to Follow-up|3|||
48798588|NCT00428090|157100546|FG001|Overall Study|Lost to Follow-up|6|||
48798589|NCT00428090|157100547|FG002|Overall Study|Lost to Follow-up|1|||
48693088|NCT01602224|156726339|FG001|Overall Study|Lost to Follow-up|0|||
48798590|NCT00428090|157100548|FG003|Overall Study|Lost to Follow-up|4|||
48798591|NCT00428090|157100545|FG000|Overall Study|Protocol Violation|3|||
48798592|NCT00428090|157100546|FG001|Overall Study|Protocol Violation|1|||
48798593|NCT00428090|157100547|FG002|Overall Study|Protocol Violation|3|||
48798594|NCT00428090|157100548|FG003|Overall Study|Protocol Violation|3|||
48798595|NCT00428090|157100545|FG000|Overall Study|Withdrawal by Subject|10|||
48798596|NCT00428090|157100546|FG001|Overall Study|Withdrawal by Subject|12|||
48798597|NCT00428090|157100547|FG002|Overall Study|Withdrawal by Subject|15|||
48798598|NCT00428090|157100548|FG003|Overall Study|Withdrawal by Subject|5|||
48798599|NCT00428090|157100545|FG000|Overall Study|Sponsor terminated study|0|||
48798600|NCT00428090|157100546|FG001|Overall Study|Sponsor terminated study|1|||
48798601|NCT00428090|157100547|FG002|Overall Study|Sponsor terminated study|0|||
48798602|NCT00428090|157100548|FG003|Overall Study|Sponsor terminated study|0|||
48798603|NCT00428090|157100545|FG000|Overall Study|Non-compliance|4|||
48798604|NCT00428090|157100546|FG001|Overall Study|Non-compliance|0|||
48798605|NCT00428090|157100547|FG002|Overall Study|Non-compliance|1|||
48798606|NCT00428090|157100548|FG003|Overall Study|Non-compliance|3|||
48798607|NCT00428090|157100545|FG000|Overall Study|Par. did not returned to visit|1|||
48798608|NCT00428090|157100546|FG001|Overall Study|Par. did not returned to visit|0|||
48798609|NCT00428090|157100547|FG002|Overall Study|Par. did not returned to visit|0|||
48798610|NCT00428090|157100548|FG003|Overall Study|Par. did not returned to visit|1|||
48693089|NCT01602224|156726340|FG002|Overall Study|Lost to Follow-up|1|||
48798611|NCT00428090|157100545|FG000|Overall Study|Follow-Up visit not possible|1|||
48798612|NCT00428090|157100546|FG001|Overall Study|Follow-Up visit not possible|0|||
48798613|NCT00428090|157100547|FG002|Overall Study|Follow-Up visit not possible|0|||
48798614|NCT00428090|157100548|FG003|Overall Study|Follow-Up visit not possible|0|||
48693090|NCT01602224|156726338|FG000|Overall Study|Protocol Violation|0|||
48693091|NCT01602224|156726339|FG001|Overall Study|Protocol Violation|1|||
48693092|NCT01602224|156726340|FG002|Overall Study|Protocol Violation|0|||
48693093|NCT01602224|156726338|FG000|Overall Study|Sponsor Decision|2|||
48693094|NCT01602224|156726339|FG001|Overall Study|Sponsor Decision|3|||
48693095|NCT01602224|156726340|FG002|Overall Study|Sponsor Decision|2|||
48693096|NCT01602224|156726338|FG000|Overall Study|Withdrawal by Subject|5|||
48693097|NCT01602224|156726339|FG001|Overall Study|Withdrawal by Subject|3|||
48693098|NCT01602224|156726340|FG002|Overall Study|Withdrawal by Subject|3|||
48693099|NCT04564846|156726343|FG000|Overall Study|Withdrawal by Subject|2|||
48693100|NCT04564846|156726344|FG001|Overall Study|Withdrawal by Subject|1|||
48693101|NCT04564846|156726343|FG000|Overall Study|Physician Decision|0|||
48693102|NCT04564846|156726344|FG001|Overall Study|Physician Decision|1|||
48693103|NCT04564846|156726343|FG000|Overall Study|Lost to Follow-up|0|||
48693104|NCT04564846|156726344|FG001|Overall Study|Lost to Follow-up|1|||
48693105|NCT04564846|156726343|FG000|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
48693106|NCT04564846|156726344|FG001|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
48693107|NCT04564846|156726343|FG000|Overall Study|Subject non-compliance|1|||
48693108|NCT04564846|156726344|FG001|Overall Study|Subject non-compliance|0|||
48693109|NCT01766050|156726347|FG000|Overall Study|Adverse Event|1|||
48693110|NCT01766050|156726347|FG000|Overall Study|Lost to Follow-up|1|||
48693111|NCT01766050|156726347|FG000|Overall Study|Withdrawal by Subject|2|||
48693112|NCT03811340|156726348|FG000|Overall Study|subjects did not complete the survey.|90|||
48693113|NCT03212326|156726349|FG000|Overall Study|Physician Decision|4|||
48693114|NCT00308139|156726359|FG000|Overall Study|Adverse Event|20|||
48798615|NCT00428090|157100545|FG000|Overall Study|Prohibited medication used for SAE|1|||
48798616|NCT00428090|157100546|FG001|Overall Study|Prohibited medication used for SAE|0|||
48693115|NCT00308139|156726360|FG001|Overall Study|Adverse Event|14|||
48798617|NCT00428090|157100547|FG002|Overall Study|Prohibited medication used for SAE|0|||
48798618|NCT00428090|157100548|FG003|Overall Study|Prohibited medication used for SAE|0|||
48798619|NCT00428090|157100545|FG000|Overall Study|Death of par.|1|||
48798620|NCT00428090|157100546|FG001|Overall Study|Death of par.|0|||
48798621|NCT00428090|157100547|FG002|Overall Study|Death of par.|1|||
48798622|NCT00428090|157100548|FG003|Overall Study|Death of par.|0|||
48798623|NCT00428090|157100545|FG000|Overall Study|Visit 7 exceed the visit window|0|||
48798624|NCT00428090|157100546|FG001|Overall Study|Visit 7 exceed the visit window|1|||
48798625|NCT00428090|157100547|FG002|Overall Study|Visit 7 exceed the visit window|0|||
48798626|NCT00428090|157100548|FG003|Overall Study|Visit 7 exceed the visit window|0|||
48798627|NCT00428090|157100545|FG000|Overall Study|Medical monitor terminated par.|0|||
48798628|NCT00428090|157100546|FG001|Overall Study|Medical monitor terminated par.|1|||
48798629|NCT00428090|157100547|FG002|Overall Study|Medical monitor terminated par.|0|||
49008281|NCT00738920|157867024|FG002|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|6|||
49008282|NCT00738920|157867022|FG000|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|5|||
49008283|NCT00738920|157867023|FG001|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|7|||
49008284|NCT00738920|157867024|FG002|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|6|||
49008285|NCT00738920|157867022|FG000|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|3|||
49008286|NCT00738920|157867023|FG001|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|0|||
49008287|NCT00738920|157867024|FG002|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|2|||
49008288|NCT00738920|157867022|FG000|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
48798630|NCT00428090|157100548|FG003|Overall Study|Medical monitor terminated par.|0|||
48798631|NCT00428090|157100545|FG000|Overall Study|Mental status of par. was|0|||
48798632|NCT00428090|157100546|FG001|Overall Study|Mental status of par. was|1|||
48798633|NCT00428090|157100547|FG002|Overall Study|Mental status of par. was|0|||
48798634|NCT00428090|157100548|FG003|Overall Study|Mental status of par. was|0|||
48798635|NCT00428090|157100545|FG000|Overall Study|Worsening of AD|0|||
48798636|NCT00428090|157100546|FG001|Overall Study|Worsening of AD|0|||
48798637|NCT00428090|157100547|FG002|Overall Study|Worsening of AD|1|||
49008289|NCT00738920|157867023|FG001|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|0|||
48798638|NCT00428090|157100548|FG003|Overall Study|Worsening of AD|0|||
48798639|NCT00428090|157100545|FG000|Overall Study|Excluded for concerning QTc value|0|||
48798640|NCT00428090|157100546|FG001|Overall Study|Excluded for concerning QTc value|0|||
49008290|NCT00738920|157867024|FG002|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
49008291|NCT00738920|157867022|FG000|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|2|||
49008292|NCT00738920|157867023|FG001|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|4|||
49008293|NCT00738920|157867024|FG002|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|7|||
48798641|NCT00428090|157100547|FG002|Overall Study|Excluded for concerning QTc value|1|||
48798642|NCT00428090|157100548|FG003|Overall Study|Excluded for concerning QTc value|0|||
49008294|NCT00738920|157867022|FG000|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|2|||
48798643|NCT00428090|157100545|FG000|Overall Study|Insufficient AD documentation|0|||
48693116|NCT00308139|156726359|FG000|Overall Study|Lost to Follow-up|13|||
48798644|NCT00428090|157100546|FG001|Overall Study|Insufficient AD documentation|0|||
48798645|NCT00428090|157100547|FG002|Overall Study|Insufficient AD documentation|1|||
48798646|NCT00428090|157100548|FG003|Overall Study|Insufficient AD documentation|0|||
48798647|NCT00428090|157100545|FG000|Overall Study|High MMSE scores|0|||
48798648|NCT00428090|157100546|FG001|Overall Study|High MMSE scores|0|||
48798649|NCT00428090|157100547|FG002|Overall Study|High MMSE scores|1|||
48798650|NCT00428090|157100548|FG003|Overall Study|High MMSE scores|0|||
48798651|NCT00428090|157100545|FG000|Overall Study|Deterioration of cognitive status|0|||
48798652|NCT00428090|157100546|FG001|Overall Study|Deterioration of cognitive status|0|||
48798653|NCT00428090|157100547|FG002|Overall Study|Deterioration of cognitive status|1|||
48798654|NCT00428090|157100548|FG003|Overall Study|Deterioration of cognitive status|0|||
48798655|NCT00428090|157100545|FG000|Overall Study|Serious adverse event|0|||
48798656|NCT00428090|157100546|FG001|Overall Study|Serious adverse event|0|||
48798657|NCT00428090|157100547|FG002|Overall Study|Serious adverse event|1|||
48798658|NCT00428090|157100548|FG003|Overall Study|Serious adverse event|0|||
48798659|NCT00428090|157100545|FG000|Overall Study|Excluded for heart insufficiency|0|||
48798660|NCT00428090|157100546|FG001|Overall Study|Excluded for heart insufficiency|0|||
48798661|NCT00428090|157100547|FG002|Overall Study|Excluded for heart insufficiency|1|||
48798662|NCT00428090|157100548|FG003|Overall Study|Excluded for heart insufficiency|0|||
48798663|NCT00428090|157100545|FG000|Overall Study|Raised Creatinine Value|0|||
48798664|NCT00428090|157100546|FG001|Overall Study|Raised Creatinine Value|0|||
48798665|NCT00428090|157100547|FG002|Overall Study|Raised Creatinine Value|0|||
48798666|NCT00428090|157100548|FG003|Overall Study|Raised Creatinine Value|1|||
48798667|NCT03255824|157100555|FG000|Overall Study|Under-sedation|2|||
48798668|NCT03255824|157100556|FG001|Overall Study|Under-sedation|1|||
48798669|NCT03432364|157100558|FG000|Follow Up (Weeks 52-156 Post Infusion)|Withdrawal by Subject|1|||
48798670|NCT04493216|157100559|FG000|Overall Study|Study terminated by sponsor|30|||
48798671|NCT04493216|157100560|FG001|Overall Study|Study terminated by sponsor|33|||
48798672|NCT04493216|157100561|FG002|Overall Study|Study terminated by sponsor|28|||
48798673|NCT04493216|157100562|FG003|Overall Study|Study terminated by sponsor|27|||
48798674|NCT04493216|157100559|FG000|Overall Study|Withdrawal by Subject|2|||
48798675|NCT04493216|157100560|FG001|Overall Study|Withdrawal by Subject|1|||
48798676|NCT04493216|157100561|FG002|Overall Study|Withdrawal by Subject|1|||
48798677|NCT04493216|157100562|FG003|Overall Study|Withdrawal by Subject|2|||
48798678|NCT04493216|157100559|FG000|Overall Study|Protocol Violation|1|||
48798679|NCT04493216|157100560|FG001|Overall Study|Protocol Violation|2|||
48798680|NCT04493216|157100561|FG002|Overall Study|Protocol Violation|0|||
48798681|NCT04493216|157100562|FG003|Overall Study|Protocol Violation|2|||
48798682|NCT04493216|157100559|FG000|Overall Study|Physician Decision|0|||
48798683|NCT04493216|157100560|FG001|Overall Study|Physician Decision|0|||
48798684|NCT04493216|157100561|FG002|Overall Study|Physician Decision|1|||
49008295|NCT00738920|157867023|FG001|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|3|||
49008296|NCT00738920|157867024|FG002|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|5|||
49008297|NCT00738920|157867022|FG000|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
49008298|NCT00738920|157867023|FG001|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|0|||
49008299|NCT00738920|157867024|FG002|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
49008300|NCT00738920|157867022|FG000|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
49008301|NCT00738920|157867023|FG001|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|1|||
49008302|NCT00738920|157867024|FG002|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
49008303|NCT04128696|157867027|FG000|Overall Study|Lost to Follow-up|3|||
49008304|NCT04128696|157867028|FG001|Overall Study|Lost to Follow-up|7|||
49008305|NCT04128696|157867027|FG000|Overall Study|Withdrawal by Subject|12|||
49008306|NCT04128696|157867028|FG001|Overall Study|Withdrawal by Subject|11|||
49008307|NCT04128696|157867027|FG000|Overall Study|Study Closed/Terminated|26|||
49008308|NCT04128696|157867028|FG001|Overall Study|Study Closed/Terminated|38|||
49008309|NCT04128696|157867027|FG000|Overall Study|Physician Decision|2|||
49008310|NCT04128696|157867028|FG001|Overall Study|Physician Decision|3|||
49008311|NCT01458119|157867035|FG000|Overall Study|Physician Decision|4|||
49008312|NCT01458119|157867035|FG000|Overall Study|Withdrawal Due to Nonamenable Mutation|1|||
49008313|NCT01458119|157867035|FG000|Overall Study|Pregnancy|1|||
49008314|NCT01458119|157867035|FG000|Overall Study|Death|2|||
49008315|NCT01458119|157867035|FG000|Overall Study|Adverse Event|1|||
49008316|NCT01458119|157867035|FG000|Overall Study|Consent Withdrawn by Participant|8|||
49008317|NCT01458119|157867035|FG000|Overall Study|Non-compliance With Study Drug|3|||
49008318|NCT01225991|157867036|FG000|Overall Study|Withdrawal by Subject|6|||
48798685|NCT04493216|157100562|FG003|Overall Study|Physician Decision|0|||
48798686|NCT04493216|157100559|FG000|Overall Study|Lost to Follow-up|2|||
48798687|NCT04493216|157100560|FG001|Overall Study|Lost to Follow-up|1|||
48798688|NCT04493216|157100561|FG002|Overall Study|Lost to Follow-up|0|||
48798689|NCT04493216|157100562|FG003|Overall Study|Lost to Follow-up|1|||
48798690|NCT04493216|157100559|FG000|Overall Study|Adverse Event|1|||
48798691|NCT04493216|157100560|FG001|Overall Study|Adverse Event|4|||
48798692|NCT04493216|157100561|FG002|Overall Study|Adverse Event|5|||
49008319|NCT02196506|157867037|FG000|Phase A|Participant Met Withdrawal Criteria|34|||
49008320|NCT02196506|157867038|FG001|Phase A|Participant Met Withdrawal Criteria|0|||
49008321|NCT02196506|157867039|FG002|Phase A|Participant Met Withdrawal Criteria|0|||
49113390|NCT00549601|158251670|FG000|Randomized|Withdrawal by Subject|0|||
49008322|NCT02196506|157867040|FG003|Phase A|Participant Met Withdrawal Criteria|0|||
49008323|NCT02196506|157867037|FG000|Phase A|Withdrawal by Subject|34|||
49008324|NCT02196506|157867038|FG001|Phase A|Withdrawal by Subject|0|||
49008325|NCT02196506|157867039|FG002|Phase A|Withdrawal by Subject|0|||
49008326|NCT02196506|157867040|FG003|Phase A|Withdrawal by Subject|0|||
49008327|NCT02196506|157867037|FG000|Phase A|Adverse Event|22|||
48798693|NCT04493216|157100562|FG003|Overall Study|Adverse Event|2|||
48798694|NCT04493216|157100559|FG000|Overall Study|Subject reached protocol-defined stopping criteria|4|||
48798695|NCT04493216|157100560|FG001|Overall Study|Subject reached protocol-defined stopping criteria|2|||
48798696|NCT04493216|157100561|FG002|Overall Study|Subject reached protocol-defined stopping criteria|7|||
48798697|NCT04493216|157100562|FG003|Overall Study|Subject reached protocol-defined stopping criteria|2|||
48798698|NCT02623322|157100565|FG000|Overall Study|Lost to Follow-up|2|||
48798699|NCT02623322|157100566|FG001|Overall Study|Lost to Follow-up|1|||
48798700|NCT02623322|157100567|FG002|Overall Study|Lost to Follow-up|0|||
48798701|NCT03232983|157100574|FG000|Period 1|Physician Decision|0|||
48798702|NCT03232983|157100575|FG001|Period 1|Physician Decision|0|||
48798703|NCT03232983|157100576|FG002|Period 1|Physician Decision|1|||
48798704|NCT03232983|157100577|FG003|Period 1|Physician Decision|0|||
48798705|NCT03232983|157100574|FG000|Washout Period 2|Physician Decision|0|||
48798706|NCT03232983|157100575|FG001|Washout Period 2|Physician Decision|0|||
48798707|NCT03232983|157100576|FG002|Washout Period 2|Physician Decision|1|||
49008328|NCT02196506|157867038|FG001|Phase A|Adverse Event|0|||
49008329|NCT02196506|157867039|FG002|Phase A|Adverse Event|0|||
49008330|NCT02196506|157867040|FG003|Phase A|Adverse Event|0|||
49008331|NCT02196506|157867037|FG000|Phase A|Lost to Follow-up|9|||
49008332|NCT02196506|157867038|FG001|Phase A|Lost to Follow-up|0|||
49008333|NCT02196506|157867039|FG002|Phase A|Lost to Follow-up|0|||
49008334|NCT02196506|157867040|FG003|Phase A|Lost to Follow-up|0|||
49008335|NCT02196506|157867037|FG000|Phase A|Protocol deviation|12|||
49008336|NCT02196506|157867038|FG001|Phase A|Protocol deviation|0|||
49008337|NCT02196506|157867039|FG002|Phase A|Protocol deviation|0|||
49008338|NCT02196506|157867040|FG003|Phase A|Protocol deviation|0|||
49008339|NCT02196506|157867037|FG000|Phase A|Participant withdrawn by investigator|10|||
49008340|NCT02196506|157867038|FG001|Phase A|Participant withdrawn by investigator|0|||
48798708|NCT03232983|157100577|FG003|Washout Period 2|Physician Decision|0|||
48798709|NCT03232983|157100574|FG000|Washout Period 2|Withdrawal by Subject|0|||
48798710|NCT03232983|157100575|FG001|Washout Period 2|Withdrawal by Subject|0|||
48798711|NCT03232983|157100576|FG002|Washout Period 2|Withdrawal by Subject|0|||
48798712|NCT03232983|157100577|FG003|Washout Period 2|Withdrawal by Subject|1|||
48798713|NCT03232983|157100574|FG000|Period 4|Withdrawal by Subject|1|||
48798714|NCT03232983|157100575|FG001|Period 4|Withdrawal by Subject|0|||
48798715|NCT03232983|157100576|FG002|Period 4|Withdrawal by Subject|0|||
48798716|NCT03232983|157100577|FG003|Period 4|Withdrawal by Subject|0|||
48798717|NCT02157779|157100578|FG000|Overall Study|Logistical|9|||
48798718|NCT02157779|157100579|FG001|Overall Study|Logistical|3|||
48798719|NCT02157779|157100578|FG000|Overall Study|Stopped attending, reason unknown|11|||
48798720|NCT02157779|157100579|FG001|Overall Study|Stopped attending, reason unknown|7|||
48798721|NCT02157779|157100578|FG000|Overall Study|No response to outreach after Baseline|1|||
48798722|NCT02157779|157100579|FG001|Overall Study|No response to outreach after Baseline|1|||
48798723|NCT02157779|157100578|FG000|Overall Study|Moved|1|||
48798724|NCT02157779|157100579|FG001|Overall Study|Moved|0|||
48798725|NCT02157779|157100578|FG000|Overall Study|Medical|1|||
48798726|NCT02157779|157100579|FG001|Overall Study|Medical|0|||
48798727|NCT02157779|157100578|FG000|Overall Study|Legal issue|1|||
48798728|NCT02157779|157100579|FG001|Overall Study|Legal issue|0|||
48798729|NCT01494584|157100591|FG000|Overall Study|Study Closed/Terminated|1|||
48798730|NCT01666808|157100592|FG000|Overall Study|Lost to Follow-up|9|||
48798731|NCT01666808|157100593|FG001|Overall Study|Lost to Follow-up|15|||
48798732|NCT01666808|157100592|FG000|Overall Study|Withdrawal by Subject|3|||
48798733|NCT01666808|157100593|FG001|Overall Study|Withdrawal by Subject|1|||
49008341|NCT02196506|157867039|FG002|Phase A|Participant withdrawn by investigator|0|||
49008342|NCT02196506|157867040|FG003|Phase A|Participant withdrawn by investigator|0|||
49008343|NCT02196506|157867037|FG000|Phase B|Participant Met Withdrawal Criteria|0|||
48798734|NCT01666808|157100592|FG000|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|4|||
48798735|NCT01666808|157100593|FG001|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|0|||
48798736|NCT01235403|157100594|FG000|Overall Study|Adverse Event|14|||
48798737|NCT01235403|157100594|FG000|Overall Study|Lost to Follow-up|2|||
48798738|NCT01235403|157100594|FG000|Overall Study|Withdrawal by Subject|4|||
48798739|NCT01235403|157100594|FG000|Overall Study|Lack of Efficacy|2|||
48798740|NCT01235403|157100594|FG000|Overall Study|Other reasons for premature termination|4|||
49008344|NCT02196506|157867038|FG001|Phase B|Participant Met Withdrawal Criteria|0|||
49008345|NCT02196506|157867039|FG002|Phase B|Participant Met Withdrawal Criteria|1|||
49008346|NCT02196506|157867040|FG003|Phase B|Participant Met Withdrawal Criteria|0|||
49008347|NCT02196506|157867037|FG000|Phase B|Lack of Efficacy|0|||
49008348|NCT02196506|157867038|FG001|Phase B|Lack of Efficacy|1|||
49008349|NCT02196506|157867039|FG002|Phase B|Lack of Efficacy|2|||
49008350|NCT02196506|157867040|FG003|Phase B|Lack of Efficacy|0|||
48798741|NCT04123067|157100597|FG000|Overall Study|Lost to Follow-up|0|||
48798742|NCT04123067|157100598|FG001|Overall Study|Lost to Follow-up|1|||
48798743|NCT03248375|157100599|FG000|Overall Study|Lost to Follow-up|5|||
49008351|NCT02196506|157867037|FG000|Phase B|Withdrawal by Participant|0|||
49008352|NCT02196506|157867038|FG001|Phase B|Withdrawal by Participant|8|||
49008353|NCT02196506|157867039|FG002|Phase B|Withdrawal by Participant|1|||
49008354|NCT02196506|157867040|FG003|Phase B|Withdrawal by Participant|0|||
49008355|NCT02196506|157867037|FG000|Phase B|Adverse Event|0|||
49008356|NCT02196506|157867038|FG001|Phase B|Adverse Event|4|||
49008357|NCT02196506|157867039|FG002|Phase B|Adverse Event|1|||
49008358|NCT02196506|157867040|FG003|Phase B|Adverse Event|0|||
49008359|NCT02196506|157867037|FG000|Phase B|Lost to Follow-up|0|||
49008360|NCT02196506|157867038|FG001|Phase B|Lost to Follow-up|2|||
49008361|NCT02196506|157867039|FG002|Phase B|Lost to Follow-up|1|||
48798744|NCT00633464|157100606|FG000|Overall Study|Never Treated (Not met study criteria)|0|||
48798745|NCT00633464|157100607|FG001|Overall Study|Never Treated (Not met study criteria)|1|||
48798746|NCT00633464|157100606|FG000|Overall Study|Never Treated (Randomized in error)|0|||
48798747|NCT00633464|157100607|FG001|Overall Study|Never Treated (Randomized in error)|1|||
48798748|NCT01563536|157100610|FG000|Overall Study|Withdrawal by Subject|0|||
48798749|NCT01563536|157100611|FG001|Overall Study|Withdrawal by Subject|2|||
48798750|NCT01563536|157100610|FG000|Overall Study|Lost to Follow-up|1|||
48798751|NCT01563536|157100611|FG001|Overall Study|Lost to Follow-up|0|||
48798752|NCT00696410|157100613|FG000|Overall Study|Lost to Follow-up|2|||
48798753|NCT00696410|157100614|FG001|Overall Study|Lost to Follow-up|0|||
48798754|NCT00696410|157100613|FG000|Overall Study|Withdrawal by Subject|8|||
49008362|NCT02196506|157867040|FG003|Phase B|Lost to Follow-up|0|||
48798755|NCT00696410|157100614|FG001|Overall Study|Withdrawal by Subject|0|||
49008363|NCT02196506|157867037|FG000|Phase A+|Participant Met Withdrawal Criteria|0|||
49008364|NCT02196506|157867038|FG001|Phase A+|Participant Met Withdrawal Criteria|0|||
49008365|NCT02196506|157867039|FG002|Phase A+|Participant Met Withdrawal Criteria|0|||
49008366|NCT02196506|157867040|FG003|Phase A+|Participant Met Withdrawal Criteria|1|||
49008367|NCT02196506|157867037|FG000|Phase A+|Withdrawal by Participant|0|||
49008368|NCT02196506|157867038|FG001|Phase A+|Withdrawal by Participant|0|||
49008369|NCT02196506|157867039|FG002|Phase A+|Withdrawal by Participant|0|||
49008370|NCT02196506|157867040|FG003|Phase A+|Withdrawal by Participant|5|||
49008371|NCT02196506|157867037|FG000|Phase A+|Adverse Event|0|||
49008372|NCT02196506|157867038|FG001|Phase A+|Adverse Event|0|||
49008373|NCT02196506|157867039|FG002|Phase A+|Adverse Event|0|||
49008374|NCT02196506|157867040|FG003|Phase A+|Adverse Event|1|||
49008375|NCT02196506|157867037|FG000|Phase A+|Lost to Follow-up|0|||
49008376|NCT02196506|157867038|FG001|Phase A+|Lost to Follow-up|0|||
49008377|NCT02196506|157867039|FG002|Phase A+|Lost to Follow-up|0|||
48693117|NCT00308139|156726360|FG001|Overall Study|Lost to Follow-up|8|||
48693118|NCT00308139|156726359|FG000|Overall Study|Protocol Violation|3|||
48693119|NCT00308139|156726360|FG001|Overall Study|Protocol Violation|2|||
48693120|NCT00308139|156726359|FG000|Overall Study|Withdrawal of Consent|40|||
49008378|NCT02196506|157867040|FG003|Phase A+|Lost to Follow-up|6|||
48693121|NCT00308139|156726360|FG001|Overall Study|Withdrawal of Consent|42|||
48798756|NCT00696410|157100613|FG000|Overall Study|Physician Decision|3|||
49008379|NCT02196506|157867037|FG000|Phase A+|Participant withdrawn by investigator|0|||
49008380|NCT02196506|157867038|FG001|Phase A+|Participant withdrawn by investigator|0|||
49008381|NCT02196506|157867039|FG002|Phase A+|Participant withdrawn by investigator|0|||
49008382|NCT02196506|157867040|FG003|Phase A+|Participant withdrawn by investigator|1|||
48798757|NCT00696410|157100614|FG001|Overall Study|Physician Decision|0|||
48798758|NCT00567190|157100620|FG000|Overall Study|Death|235|||
48798759|NCT00567190|157100621|FG001|Overall Study|Death|280|||
48798760|NCT00567190|157100620|FG000|Overall Study|Withdrew Consent or Lost to Follow-up|48|||
48798761|NCT00567190|157100621|FG001|Overall Study|Withdrew Consent or Lost to Follow-up|53|||
48798762|NCT01971723|157100622|FG000|Overall Study|Withdrawal by Subject|1|||
49008383|NCT00789828|157867041|FG000|Core Period (48 Weeks)|Administrative problems|0|||
49008384|NCT00789828|157867042|FG001|Core Period (48 Weeks)|Administrative problems|1|||
49008385|NCT00789828|157867041|FG000|Core Period (48 Weeks)|Withdrawal by Subject|0|||
49008386|NCT00789828|157867042|FG001|Core Period (48 Weeks)|Withdrawal by Subject|4|||
49008387|NCT00789828|157867041|FG000|Core Period (48 Weeks)|Lost to Follow-up|0|||
48693122|NCT00308139|156726359|FG000|Overall Study|Investigator Decision|11|||
48798763|NCT01971723|157100623|FG001|Overall Study|Withdrawal by Subject|1|||
48798764|NCT01971723|157100622|FG000|Overall Study|Protocol Violation|1|||
48798765|NCT01971723|157100623|FG001|Overall Study|Protocol Violation|2|||
48798766|NCT00696384|157100624|FG000|Open Label Phase|Adverse Event|27|||
48798767|NCT00696384|157100625|FG001|Open Label Phase|Adverse Event|0|||
48798768|NCT00696384|157100626|FG002|Open Label Phase|Adverse Event|0|||
48798769|NCT00696384|157100624|FG000|Open Label Phase|Protocol Violation|18|||
49008388|NCT00789828|157867042|FG001|Core Period (48 Weeks)|Lost to Follow-up|1|||
49008389|NCT00789828|157867041|FG000|Open-label Extension Period (4 Years)|Adverse Event|10|||
49008390|NCT00789828|157867042|FG001|Open-label Extension Period (4 Years)|Adverse Event|0|||
48693123|NCT00308139|156726360|FG001|Overall Study|Investigator Decision|10|||
48798770|NCT00696384|157100625|FG001|Open Label Phase|Protocol Violation|0|||
49008391|NCT00789828|157867041|FG000|Open-label Extension Period (4 Years)|Withdrawal by Subject|6|||
49008392|NCT00789828|157867042|FG001|Open-label Extension Period (4 Years)|Withdrawal by Subject|0|||
49008393|NCT00789828|157867041|FG000|Open-label Extension Period (4 Years)|Lost to Follow-up|3|||
48798771|NCT00696384|157100626|FG002|Open Label Phase|Protocol Violation|0|||
48798772|NCT00696384|157100624|FG000|Open Label Phase|Lost to Follow-up|24|||
48798773|NCT00696384|157100625|FG001|Open Label Phase|Lost to Follow-up|0|||
48798774|NCT00696384|157100626|FG002|Open Label Phase|Lost to Follow-up|0|||
48798775|NCT00696384|157100624|FG000|Open Label Phase|Withdrawal by Subject|37|||
48798776|NCT00696384|157100625|FG001|Open Label Phase|Withdrawal by Subject|0|||
48798777|NCT00696384|157100626|FG002|Open Label Phase|Withdrawal by Subject|0|||
48798778|NCT00696384|157100624|FG000|Open Label Phase|Other|6|||
48798779|NCT00696384|157100625|FG001|Open Label Phase|Other|0|||
48798780|NCT00696384|157100626|FG002|Open Label Phase|Other|0|||
48798781|NCT00696384|157100624|FG000|Open Label Phase|Lack of Efficacy|3|||
48798782|NCT00696384|157100625|FG001|Open Label Phase|Lack of Efficacy|0|||
48798783|NCT00696384|157100626|FG002|Open Label Phase|Lack of Efficacy|0|||
48798784|NCT00696384|157100624|FG000|Open Label Phase|Physician Decision|4|||
48798785|NCT00696384|157100625|FG001|Open Label Phase|Physician Decision|0|||
48798786|NCT00696384|157100626|FG002|Open Label Phase|Physician Decision|0|||
48798787|NCT00696384|157100624|FG000|Double Blind Phase|Adverse Event|0|||
48798788|NCT00696384|157100625|FG001|Double Blind Phase|Adverse Event|2|||
48798789|NCT00696384|157100626|FG002|Double Blind Phase|Adverse Event|2|||
48798790|NCT00696384|157100624|FG000|Double Blind Phase|Lost to Follow-up|0|||
48798791|NCT00696384|157100625|FG001|Double Blind Phase|Lost to Follow-up|2|||
48798792|NCT00696384|157100626|FG002|Double Blind Phase|Lost to Follow-up|1|||
48798793|NCT00696384|157100624|FG000|Double Blind Phase|Withdrawal by Subject|0|||
48798794|NCT00696384|157100625|FG001|Double Blind Phase|Withdrawal by Subject|4|||
48798795|NCT00696384|157100626|FG002|Double Blind Phase|Withdrawal by Subject|3|||
48798796|NCT00696384|157100624|FG000|Double Blind Phase|Lack of Efficacy|0|||
48798797|NCT00696384|157100625|FG001|Double Blind Phase|Lack of Efficacy|1|||
48798798|NCT00696384|157100626|FG002|Double Blind Phase|Lack of Efficacy|0|||
48798799|NCT00696384|157100624|FG000|Double Blind Phase|Physician Decision|0|||
48798800|NCT00696384|157100625|FG001|Double Blind Phase|Physician Decision|2|||
48798801|NCT00696384|157100626|FG002|Double Blind Phase|Physician Decision|0|||
48798802|NCT02027402|157100627|FG000|Overall Study|Withdrawal by Subject|4|||
48798803|NCT02027402|157100628|FG001|Overall Study|Withdrawal by Subject|1|||
48798804|NCT03645759|157100630|FG000|Overall Study|Lost to Follow-up|3|||
48798805|NCT03645759|157100631|FG001|Overall Study|Lost to Follow-up|2|||
48798806|NCT03538951|157100632|FG000|Overall Study|Withdrawal by Subject|1|||
48798807|NCT03538951|157100633|FG001|Overall Study|Withdrawal by Subject|2|||
48798808|NCT01323530|157102129|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
48798809|NCT01323530|157102130|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
48798810|NCT01323530|157102131|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
48798811|NCT01323530|157102132|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
48798812|NCT01323530|157102133|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
48798813|NCT01323530|157102134|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
48798814|NCT01323530|157102135|FG006|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
48798815|NCT01323530|157102129|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
48798816|NCT01323530|157102130|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
48798817|NCT01323530|157102131|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
48798818|NCT01323530|157102132|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
48798819|NCT01323530|157102133|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2|||
49008394|NCT00789828|157867042|FG001|Open-label Extension Period (4 Years)|Lost to Follow-up|0|||
49008395|NCT00789828|157867041|FG000|Open-label Extension Period (4 Years)|Administrative problems|7|||
48798820|NCT01323530|157102134|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
48798821|NCT01323530|157102135|FG006|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
48798822|NCT01323530|157102129|FG000|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
48798823|NCT01323530|157102130|FG001|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
48798824|NCT01323530|157102131|FG002|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
48798825|NCT01323530|157102132|FG003|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
49008396|NCT00789828|157867042|FG001|Open-label Extension Period (4 Years)|Administrative problems|0|||
48693124|NCT00308139|156726359|FG000|Overall Study|Loss of Glucose Control|5|||
48693125|NCT00308139|156726360|FG001|Overall Study|Loss of Glucose Control|7|||
48693126|NCT00308139|156726359|FG000|Overall Study|Administrative|1|||
48798826|NCT01323530|157102133|FG004|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
48798827|NCT01323530|157102134|FG005|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
48798828|NCT01323530|157102135|FG006|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
48798829|NCT01323530|157102129|FG000|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
48798830|NCT01323530|157102130|FG001|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
48798831|NCT01323530|157102131|FG002|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
48798832|NCT01323530|157102132|FG003|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
48798833|NCT01323530|157102133|FG004|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
48798834|NCT01323530|157102134|FG005|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
48798835|NCT01323530|157102135|FG006|Phase 2 (Dose-confirmation Phase)|Adverse Event|2|||
48798836|NCT01323530|157102129|FG000|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
48798837|NCT01323530|157102130|FG001|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
48798838|NCT01323530|157102131|FG002|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
48798839|NCT01323530|157102132|FG003|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
48798840|NCT01323530|157102133|FG004|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
48798841|NCT01323530|157102134|FG005|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
48798842|NCT01323530|157102135|FG006|Phase 2 (Dose-confirmation Phase)|Clinical progression|3|||
48798843|NCT01323530|157102129|FG000|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
48798844|NCT01323530|157102130|FG001|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
48798845|NCT01323530|157102131|FG002|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
48798846|NCT01323530|157102132|FG003|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
48798847|NCT01323530|157102133|FG004|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
48798848|NCT01323530|157102134|FG005|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
48798849|NCT01323530|157102135|FG006|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8|||
48798850|NCT01323530|157102129|FG000|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
48798851|NCT01323530|157102130|FG001|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
48798852|NCT01323530|157102131|FG002|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
48798853|NCT01323530|157102132|FG003|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
48798854|NCT01323530|157102133|FG004|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
48798855|NCT01323530|157102134|FG005|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
49008397|NCT00789828|157867041|FG000|Open-label Extension Period (4 Years)|Death|1|||
49008398|NCT00789828|157867042|FG001|Open-label Extension Period (4 Years)|Death|0|||
49008399|NCT00789828|157867041|FG000|Open-label Extension Period (4 Years)|Disease progression|1|||
49008400|NCT00789828|157867042|FG001|Open-label Extension Period (4 Years)|Disease progression|0|||
48693127|NCT00308139|156726360|FG001|Overall Study|Administrative|4|||
48693128|NCT00308139|156726359|FG000|Overall Study|Other|1|||
48693129|NCT00308139|156726360|FG001|Overall Study|Other|0|||
48693130|NCT01702844|156726361|FG000|Overall Study|Adverse Event|9|||
48693131|NCT01702844|156726361|FG000|Overall Study|Death|1|||
48693132|NCT01702844|156726361|FG000|Overall Study|Withdrawal by Subject|3|||
48693133|NCT01702844|156726361|FG000|Overall Study|Physician Decision|6|||
48693134|NCT02193776|156726362|FG000|Overall Study|Consent withdrawn|1|||
48693135|NCT02193776|156726363|FG001|Overall Study|Consent withdrawn|0|||
48693136|NCT02193776|156726364|FG002|Overall Study|Consent withdrawn|0|||
48693137|NCT02193776|156726365|FG003|Overall Study|Consent withdrawn|0|||
48693138|NCT02193776|156726362|FG000|Overall Study|Failure to comply with protocol|0|||
48693139|NCT02193776|156726363|FG001|Overall Study|Failure to comply with protocol|1|||
48693140|NCT02193776|156726364|FG002|Overall Study|Failure to comply with protocol|0|||
48693141|NCT02193776|156726365|FG003|Overall Study|Failure to comply with protocol|0|||
48693142|NCT02193776|156726362|FG000|Overall Study|Investigator/Sponsor decision|1|||
48693143|NCT02193776|156726363|FG001|Overall Study|Investigator/Sponsor decision|1|||
48693144|NCT02193776|156726364|FG002|Overall Study|Investigator/Sponsor decision|0|||
48693145|NCT02193776|156726365|FG003|Overall Study|Investigator/Sponsor decision|0|||
48693146|NCT02193776|156726362|FG000|Overall Study|Death|1|||
48693147|NCT02193776|156726363|FG001|Overall Study|Death|0|||
48693148|NCT02193776|156726364|FG002|Overall Study|Death|0|||
48693149|NCT02193776|156726365|FG003|Overall Study|Death|0|||
48693150|NCT02193776|156726362|FG000|Overall Study|Adverse event/Specific toxicity|5|||
48693151|NCT02193776|156726363|FG001|Overall Study|Adverse event/Specific toxicity|5|||
48693152|NCT02193776|156726364|FG002|Overall Study|Adverse event/Specific toxicity|2|||
48693153|NCT02193776|156726365|FG003|Overall Study|Adverse event/Specific toxicity|2|||
48693154|NCT04479787|156726366|FG000|Through 6 Months|Withdrawal by Subject|16|||
48693155|NCT04479787|156726367|FG001|Through 6 Months|Withdrawal by Subject|14|||
48693156|NCT04479787|156726366|FG000|Through 6 Months|Unsuccessful Trial|17|||
48693157|NCT04479787|156726367|FG001|Through 6 Months|Unsuccessful Trial|0|||
48693158|NCT04479787|156726366|FG000|Through 6 Months|Subject Participation Terminated By Investigator|12|||
49008401|NCT00789828|157867041|FG000|Open-label Extension Period (4 Years)|New treatment for indication under study|1|||
48693159|NCT04479787|156726367|FG001|Through 6 Months|Subject Participation Terminated By Investigator|3|||
48693160|NCT04479787|156726366|FG000|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
48693161|NCT04479787|156726367|FG001|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|0|||
49008402|NCT00789828|157867042|FG001|Open-label Extension Period (4 Years)|New treatment for indication under study|0|||
49015354|NCT00673790|157892154|FG002|Overall Study|Unconfirmed pregnancy|0|||
49015355|NCT00673790|157892152|FG000|Overall Study|Randomization criteria not met|0|||
48693162|NCT04479787|156726366|FG000|Through 6 Months|Lost to Follow-up|3|||
48693163|NCT04479787|156726367|FG001|Through 6 Months|Lost to Follow-up|2|||
48693164|NCT04479787|156726366|FG000|Through 6 Months|Death|3|||
48693165|NCT04479787|156726367|FG001|Through 6 Months|Death|0|||
48693166|NCT04479787|156726366|FG000|Through 6 Months|Inclusion/Exclusion|2|||
48742913|NCT00745823|156910414|FG001|Overall Study|Adverse Event|3|||
48693167|NCT04479787|156726367|FG001|Through 6 Months|Inclusion/Exclusion|1|||
48693168|NCT04479787|156726366|FG000|Through 6 Months|Subject Became Pregnant|1|||
49008403|NCT01355523|157868266|FG000|Overall Study|Withdrawal by Subject|1|||
48693169|NCT04479787|156726367|FG001|Through 6 Months|Subject Became Pregnant|1|||
48693170|NCT04479787|156726366|FG000|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|0|||
48693171|NCT04479787|156726367|FG001|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|1|||
48693172|NCT04479787|156726366|FG000|Through 6 Months|Withdrawn At Sponsor's Request|1|||
48693173|NCT04479787|156726367|FG001|Through 6 Months|Withdrawn At Sponsor's Request|0|||
48693174|NCT04479787|156726366|FG000|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
48693175|NCT04479787|156726367|FG001|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
48693176|NCT04479787|156726366|FG000|After 6 Months|Withdrawal by Subject|3|||
48693177|NCT04479787|156726367|FG001|After 6 Months|Withdrawal by Subject|13|||
48693178|NCT04479787|156726366|FG000|After 6 Months|Unsuccessful Trial|0|||
48693179|NCT04479787|156726367|FG001|After 6 Months|Unsuccessful Trial|7|||
48693180|NCT04479787|156726366|FG000|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
48693181|NCT04479787|156726367|FG001|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|4|||
48693182|NCT04479787|156726366|FG000|After 6 Months|Subject Participation Terminated By Investigator|2|||
48693183|NCT04479787|156726367|FG001|After 6 Months|Subject Participation Terminated By Investigator|2|||
48693184|NCT04479787|156726366|FG000|After 6 Months|Death|2|||
48693185|NCT04479787|156726367|FG001|After 6 Months|Death|0|||
48693186|NCT04479787|156726366|FG000|After 6 Months|Lost to Follow-up|1|||
48693187|NCT04479787|156726367|FG001|After 6 Months|Lost to Follow-up|1|||
48693188|NCT04479787|156726366|FG000|After 6 Months|Patient Was Withdrawn Due To Study Timelines|0|||
48693189|NCT04479787|156726367|FG001|After 6 Months|Patient Was Withdrawn Due To Study Timelines|1|||
48693190|NCT04479787|156726366|FG000|After 6 Months|Patient's Health Significantly Declined|0|||
48693191|NCT04479787|156726367|FG001|After 6 Months|Patient's Health Significantly Declined|1|||
48798856|NCT01323530|157102135|FG006|Phase 2 (Dose-confirmation Phase)|Investigators decision|3|||
48798857|NCT01323530|157102129|FG000|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
48798858|NCT01323530|157102130|FG001|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
48798859|NCT01323530|157102131|FG002|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
48798860|NCT01323530|157102132|FG003|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
48798861|NCT01323530|157102133|FG004|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
48798862|NCT01323530|157102134|FG005|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
48798863|NCT01323530|157102135|FG006|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1|||
48798864|NCT01194570|157102136|FG000|Overall Study|Adverse Event|22|||
48798865|NCT01194570|157102137|FG001|Overall Study|Adverse Event|40|||
48798866|NCT01194570|157102136|FG000|Overall Study|Death|6|||
48798867|NCT01194570|157102137|FG001|Overall Study|Death|20|||
48798868|NCT01194570|157102136|FG000|Overall Study|Lack of Efficacy|32|||
48798869|NCT01194570|157102137|FG001|Overall Study|Lack of Efficacy|33|||
48798870|NCT01194570|157102136|FG000|Overall Study|Lost to Follow-up|4|||
48798871|NCT01194570|157102137|FG001|Overall Study|Lost to Follow-up|15|||
48798872|NCT01194570|157102136|FG000|Overall Study|Non-Compliance|2|||
48798873|NCT01194570|157102137|FG001|Overall Study|Non-Compliance|2|||
48798874|NCT01194570|157102136|FG000|Overall Study|Non-Compliance With Study Drug|2|||
48798875|NCT01194570|157102137|FG001|Overall Study|Non-Compliance With Study Drug|2|||
48798876|NCT01194570|157102136|FG000|Overall Study|Other|18|||
48798877|NCT01194570|157102137|FG001|Overall Study|Other|47|||
49008404|NCT01355523|157868267|FG001|Overall Study|Withdrawal by Subject|4|||
49008405|NCT01355523|157868266|FG000|Overall Study|Lost to Follow-up|0|||
49008406|NCT01355523|157868267|FG001|Overall Study|Lost to Follow-up|2|||
49008407|NCT01355523|157868266|FG000|Overall Study|Protocol Violation|0|||
49008408|NCT01355523|157868267|FG001|Overall Study|Protocol Violation|2|||
49008409|NCT01355523|157868266|FG000|Overall Study|Adverse Event|0|||
49008410|NCT01355523|157868267|FG001|Overall Study|Adverse Event|2|||
49008411|NCT00084617|157868269|FG000|Overall Study|Withdrawal by Subject|7|||
49113391|NCT00549601|158251671|FG001|Randomized|Withdrawal by Subject|1|||
49113392|NCT00549601|158251672|FG002|Randomized|Withdrawal by Subject|1|||
49113393|NCT00549601|158251670|FG000|Received Study Drug|Adverse Event|2|||
49113394|NCT00549601|158251671|FG001|Received Study Drug|Adverse Event|5|||
49113395|NCT00549601|158251672|FG002|Received Study Drug|Adverse Event|1|||
49113396|NCT00549601|158251670|FG000|Received Study Drug|Death|0|||
49008412|NCT00084617|157868269|FG000|Overall Study|Lack of Efficacy|1|||
49008413|NCT00084617|157868269|FG000|Overall Study|Protocol Violation|1|||
49113397|NCT00549601|158251671|FG001|Received Study Drug|Death|1|||
49113398|NCT00549601|158251672|FG002|Received Study Drug|Death|0|||
48798878|NCT01194570|157102136|FG000|Overall Study|Physician Decision|10|||
48798879|NCT01194570|157102137|FG001|Overall Study|Physician Decision|25|||
48798880|NCT01194570|157102136|FG000|Overall Study|Protocol Violation|1|||
48798881|NCT01194570|157102137|FG001|Overall Study|Protocol Violation|2|||
48798882|NCT01194570|157102136|FG000|Overall Study|Study Terminated By Sponsor|0|||
49008414|NCT00606801|157868270|FG000|Intervention|Protocol Violation|3|||
49008415|NCT00606801|157868271|FG001|Intervention|Protocol Violation|3|||
49113399|NCT00549601|158251670|FG000|Received Study Drug|Lost to Follow-up|0|||
49113400|NCT00549601|158251671|FG001|Received Study Drug|Lost to Follow-up|1|||
49113401|NCT00549601|158251672|FG002|Received Study Drug|Lost to Follow-up|1|||
49113402|NCT00549601|158251670|FG000|Received Study Drug|Protocol Violation|3|||
49113403|NCT00549601|158251671|FG001|Received Study Drug|Protocol Violation|4|||
49113404|NCT00549601|158251672|FG002|Received Study Drug|Protocol Violation|1|||
49113405|NCT00549601|158251670|FG000|Received Study Drug|Withdrawal by Subject|2|||
49113406|NCT00549601|158251671|FG001|Received Study Drug|Withdrawal by Subject|0|||
49113407|NCT00549601|158251672|FG002|Received Study Drug|Withdrawal by Subject|1|||
49113408|NCT02227368|158251673|FG000|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0|||
49113409|NCT02227368|158251674|FG001|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4|||
49113410|NCT02227368|158251673|FG000|Overall Study|Lost to Follow-up|1|||
49113411|NCT02227368|158251674|FG001|Overall Study|Lost to Follow-up|0|||
49113412|NCT02227368|158251673|FG000|Overall Study|Adverse Event|1|||
49113413|NCT02227368|158251674|FG001|Overall Study|Adverse Event|0|||
49113414|NCT02824562|158251675|FG000|Overall Study|Lost to Follow-up|3|||
49113415|NCT02824562|158251676|FG001|Overall Study|Lost to Follow-up|4|||
48798883|NCT01194570|157102137|FG001|Overall Study|Study Terminated By Sponsor|1|||
48798884|NCT01194570|157102136|FG000|Overall Study|Withdrawal by Subject|57|||
48798885|NCT01194570|157102137|FG001|Overall Study|Withdrawal by Subject|82|||
48798886|NCT01194570|157102136|FG000|Overall Study|Pregnancy|1|||
48798887|NCT01194570|157102137|FG001|Overall Study|Pregnancy|1|||
48798888|NCT00003508|157102138|FG000|Overall Study|Not evaluable|5|||
48798889|NCT01357616|157102139|FG000|Overall Study|Adverse Event|1|||
48798890|NCT01357616|157102140|FG001|Overall Study|Adverse Event|1|||
48798891|NCT01357616|157102139|FG000|Overall Study|Lost to Follow-up|4|||
48798892|NCT01357616|157102140|FG001|Overall Study|Lost to Follow-up|3|||
48798893|NCT01357616|157102139|FG000|Overall Study|Protocol Violation|0|||
48798894|NCT01357616|157102140|FG001|Overall Study|Protocol Violation|2|||
48798895|NCT01357616|157102139|FG000|Overall Study|Inadequate Control of IOP|1|||
48903426|NCT00171704|157482408|FG000|Overall Study|Disease Progression|14|||
48903427|NCT00171704|157482409|FG001|Overall Study|Disease Progression|9|||
48903428|NCT00171704|157482408|FG000|Overall Study|New therapy for 2nd non-breast prim canc|1|||
48903429|NCT00171704|157482409|FG001|Overall Study|New therapy for 2nd non-breast prim canc|0|||
48903430|NCT00171704|157482408|FG000|Overall Study|Administrative Problems|2|||
48903431|NCT00171704|157482409|FG001|Overall Study|Administrative Problems|1|||
48903432|NCT00171704|157482408|FG000|Overall Study|Death|2|||
48903433|NCT00171704|157482409|FG001|Overall Study|Death|2|||
48903434|NCT00171704|157482408|FG000|Overall Study|Withdrawal by Subject|1|||
48903435|NCT00171704|157482409|FG001|Overall Study|Withdrawal by Subject|3|||
48903436|NCT00171704|157482408|FG000|Overall Study|Protocol Violation|0|||
48903437|NCT00171704|157482409|FG001|Overall Study|Protocol Violation|1|||
48903438|NCT02101034|157482410|FG000|Overall Study|Enrolled but did not start treatment|0|||
48903439|NCT02101034|157482411|FG001|Overall Study|Enrolled but did not start treatment|0|||
48903440|NCT02101034|157482412|FG002|Overall Study|Enrolled but did not start treatment|1|||
48903441|NCT02101034|157482413|FG003|Overall Study|Enrolled but did not start treatment|0|||
48903442|NCT02101034|157482414|FG004|Overall Study|Enrolled but did not start treatment|0|||
48903443|NCT00117845|157482415|FG000|Overall Study|stopped treatment/drug supplyinterrupted|1|||
48903444|NCT02647320|157482420|FG000|Overall Study|Adverse Event|0|||
48903445|NCT02647320|157482421|FG001|Overall Study|Adverse Event|1|||
48903446|NCT02647320|157482422|FG002|Overall Study|Adverse Event|3|||
48903447|NCT02647320|157482423|FG003|Overall Study|Adverse Event|2|||
48903448|NCT02647320|157482424|FG004|Overall Study|Adverse Event|1|||
48903449|NCT02647320|157482420|FG000|Overall Study|Protocol Violation|0|||
48903450|NCT02647320|157482421|FG001|Overall Study|Protocol Violation|0|||
48903451|NCT02647320|157482422|FG002|Overall Study|Protocol Violation|3|||
48903452|NCT02647320|157482423|FG003|Overall Study|Protocol Violation|0|||
48903453|NCT02647320|157482424|FG004|Overall Study|Protocol Violation|0|||
48903454|NCT02647320|157482420|FG000|Overall Study|Withdrawal by Subject|7|||
48903455|NCT02647320|157482421|FG001|Overall Study|Withdrawal by Subject|4|||
48903456|NCT02647320|157482422|FG002|Overall Study|Withdrawal by Subject|2|||
48903457|NCT02647320|157482423|FG003|Overall Study|Withdrawal by Subject|2|||
48903458|NCT02647320|157482424|FG004|Overall Study|Withdrawal by Subject|7|||
48903459|NCT02647320|157482420|FG000|Overall Study|Persistent hyperglycemia|0|||
48903460|NCT02647320|157482421|FG001|Overall Study|Persistent hyperglycemia|1|||
48903461|NCT02647320|157482422|FG002|Overall Study|Persistent hyperglycemia|1|||
48903462|NCT02647320|157482423|FG003|Overall Study|Persistent hyperglycemia|1|||
48903463|NCT02647320|157482424|FG004|Overall Study|Persistent hyperglycemia|1|||
48903464|NCT02647320|157482420|FG000|Overall Study|Study terminated by sponsor|1|||
48903465|NCT02647320|157482421|FG001|Overall Study|Study terminated by sponsor|1|||
48903466|NCT02647320|157482422|FG002|Overall Study|Study terminated by sponsor|1|||
48903467|NCT02647320|157482423|FG003|Overall Study|Study terminated by sponsor|1|||
48903468|NCT02647320|157482424|FG004|Overall Study|Study terminated by sponsor|2|||
48903469|NCT02647320|157482420|FG000|Overall Study|Reason not provided|0|||
48903470|NCT02647320|157482421|FG001|Overall Study|Reason not provided|0|||
48903471|NCT02647320|157482422|FG002|Overall Study|Reason not provided|1|||
48903472|NCT02647320|157482423|FG003|Overall Study|Reason not provided|0|||
48903473|NCT02647320|157482424|FG004|Overall Study|Reason not provided|2|||
48798896|NCT01357616|157102140|FG001|Overall Study|Inadequate Control of IOP|2|||
48798897|NCT01357616|157102139|FG000|Overall Study|Decision Unrelated to Adverse Event|3|||
48798898|NCT01357616|157102140|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
48798899|NCT01357616|157102139|FG000|Overall Study|Withdrawal by Subject|1|||
48798900|NCT01357616|157102140|FG001|Overall Study|Withdrawal by Subject|0|||
48798901|NCT02001194|157102144|FG000|Intervention Period (13 Weeks)|No longer interested|1|||
48798902|NCT02001194|157102145|FG001|Intervention Period (13 Weeks)|No longer interested|0|||
48798903|NCT02001194|157102146|FG002|Intervention Period (13 Weeks)|No longer interested|2|||
48798904|NCT02001194|157102147|FG003|Intervention Period (13 Weeks)|No longer interested|2|||
48798905|NCT02001194|157102144|FG000|Follow-Up Period (13 Weeks)|No longer interested|3|||
48798906|NCT02001194|157102145|FG001|Follow-Up Period (13 Weeks)|No longer interested|2|||
48798907|NCT02001194|157102146|FG002|Follow-Up Period (13 Weeks)|No longer interested|1|||
48798908|NCT02001194|157102147|FG003|Follow-Up Period (13 Weeks)|No longer interested|0|||
48798909|NCT00522301|157102148|FG000|Overall Study|Withdrawal by Subject|1|||
48798910|NCT00522301|157102148|FG000|Overall Study|Adverse Event|5|||
48798911|NCT03040713|157102149|FG000|Overall Study|Positive amyloid scan|3|||
48798912|NCT03395405|157102150|FG000|Overall Study|Death|0|||
48798913|NCT03395405|157102151|FG001|Overall Study|Death|2|||
48798914|NCT03395405|157102150|FG000|Overall Study|Lost to Follow-up|0|||
48798915|NCT03395405|157102151|FG001|Overall Study|Lost to Follow-up|1|||
48798916|NCT03395405|157102150|FG000|Overall Study|Protocol Violation|0|||
48798917|NCT03395405|157102151|FG001|Overall Study|Protocol Violation|1|||
48798918|NCT03395405|157102150|FG000|Overall Study|Withdrawal by Subject|3|||
48798919|NCT03395405|157102151|FG001|Overall Study|Withdrawal by Subject|1|||
48798920|NCT03395405|157102150|FG000|Overall Study|COVID-19 Pandemic|1|||
48798921|NCT03395405|157102151|FG001|Overall Study|COVID-19 Pandemic|0|||
48798922|NCT01649232|157102152|FG000|Overall Study|Physician Decision|2|||
48798923|NCT01649232|157102153|FG001|Overall Study|Physician Decision|0|||
48798924|NCT00430248|157102166|FG000|Overall Study|Adverse Event|49|||
48798925|NCT00430248|157102167|FG001|Overall Study|Adverse Event|61|||
48798926|NCT00430248|157102168|FG002|Overall Study|Adverse Event|64|||
48798927|NCT00430248|157102166|FG000|Overall Study|Protocol Violation|10|||
48798928|NCT00430248|157102167|FG001|Overall Study|Protocol Violation|2|||
48798929|NCT00430248|157102168|FG002|Overall Study|Protocol Violation|4|||
48798930|NCT00430248|157102166|FG000|Overall Study|Personal Reasons|12|||
48798931|NCT00430248|157102167|FG001|Overall Study|Personal Reasons|24|||
48798932|NCT00430248|157102168|FG002|Overall Study|Personal Reasons|9|||
48798933|NCT00430248|157102166|FG000|Overall Study|Lost to Follow-up|28|||
48798934|NCT00430248|157102167|FG001|Overall Study|Lost to Follow-up|33|||
48798935|NCT00430248|157102168|FG002|Overall Study|Lost to Follow-up|28|||
48798936|NCT00430248|157102166|FG000|Overall Study|Therapeutic Failure|1|||
48798937|NCT00430248|157102167|FG001|Overall Study|Therapeutic Failure|1|||
48798938|NCT00430248|157102168|FG002|Overall Study|Therapeutic Failure|1|||
49008416|NCT02082262|157868272|FG000|Overall Study|Withdrawal by Subject|3|||
49008417|NCT02082262|157868272|FG000|Overall Study|Adverse Event|48|||
49008418|NCT02162511|157868277|FG000|Overall Study|Lack of Efficacy|0|||
49008419|NCT02162511|157868278|FG001|Overall Study|Lack of Efficacy|0|||
49008420|NCT02162511|157868279|FG002|Overall Study|Lack of Efficacy|2|||
49008421|NCT03262233|157868280|FG000|Overall Study|Withdrawal by Subject|12|||
49008422|NCT03262233|157868281|FG001|Overall Study|Withdrawal by Subject|8|||
49008423|NCT03262233|157868282|FG002|Overall Study|Withdrawal by Subject|21|||
49008424|NCT03262233|157868283|FG003|Overall Study|Withdrawal by Subject|13|||
49008425|NCT03262233|157868280|FG000|Overall Study|Declined due to shock|1|||
49008426|NCT03262233|157868281|FG001|Overall Study|Declined due to shock|2|||
49008427|NCT03262233|157868282|FG002|Overall Study|Declined due to shock|2|||
49008428|NCT03262233|157868283|FG003|Overall Study|Declined due to shock|3|||
49008429|NCT03262233|157868280|FG000|Overall Study|Protocol Violation|5|||
49008430|NCT03262233|157868281|FG001|Overall Study|Protocol Violation|10|||
49008431|NCT03262233|157868282|FG002|Overall Study|Protocol Violation|2|||
49008432|NCT03262233|157868283|FG003|Overall Study|Protocol Violation|13|||
49008433|NCT03262233|157868280|FG000|Overall Study|data collection artifact|0|||
49008434|NCT03262233|157868281|FG001|Overall Study|data collection artifact|1|||
49008435|NCT03262233|157868282|FG002|Overall Study|data collection artifact|0|||
49008436|NCT03262233|157868283|FG003|Overall Study|data collection artifact|0|||
49008437|NCT01160198|157868286|FG000|Overall Study|Withdrawal by Subject|2|||
49008438|NCT01160198|157868287|FG001|Overall Study|Withdrawal by Subject|1|||
49008439|NCT01160198|157868288|FG002|Overall Study|Withdrawal by Subject|0|||
49008440|NCT01160198|157868286|FG000|Overall Study|Adverse Event|0|||
49008441|NCT01160198|157868287|FG001|Overall Study|Adverse Event|1|||
49008442|NCT01160198|157868288|FG002|Overall Study|Adverse Event|0|||
49008443|NCT01160198|157868286|FG000|Overall Study|Lost to Follow-up|0|||
49008444|NCT01160198|157868287|FG001|Overall Study|Lost to Follow-up|1|||
49008445|NCT01160198|157868288|FG002|Overall Study|Lost to Follow-up|0|||
49008446|NCT01160198|157868286|FG000|Overall Study|Participant lost drug; withdrew consent|0|||
49008447|NCT01160198|157868287|FG001|Overall Study|Participant lost drug; withdrew consent|0|||
49008448|NCT01160198|157868288|FG002|Overall Study|Participant lost drug; withdrew consent|1|||
49008449|NCT01796860|157868291|FG000|Overall Study|Withdrawal by Subject|3|||
48798939|NCT00430248|157102166|FG000|Overall Study|Withdrawal by Subject|14|||
48798940|NCT00430248|157102167|FG001|Overall Study|Withdrawal by Subject|20|||
48798941|NCT00430248|157102168|FG002|Overall Study|Withdrawal by Subject|16|||
48798942|NCT00430248|157102166|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
48798943|NCT00430248|157102167|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
48798944|NCT00430248|157102168|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
48798945|NCT00430248|157102166|FG000|Overall Study|Gout Flare|3|||
48798946|NCT00430248|157102167|FG001|Overall Study|Gout Flare|7|||
48798947|NCT00430248|157102168|FG002|Overall Study|Gout Flare|2|||
48798948|NCT00430248|157102166|FG000|Overall Study|Reason Not Specified|8|||
48798949|NCT00430248|157102167|FG001|Overall Study|Reason Not Specified|8|||
48798950|NCT00430248|157102168|FG002|Overall Study|Reason Not Specified|11|||
48798951|NCT01301391|157102169|FG000|Overall Study|Death|13|||
48798952|NCT01301391|157102169|FG000|Overall Study|Lost to Follow-up|3|||
48798953|NCT01301391|157102169|FG000|Overall Study|Physician Decision|2|||
48798954|NCT01301391|157102169|FG000|Overall Study|Sponsor's decision|8|||
48798955|NCT02182973|157102174|FG000|Overall Study|Withdrawal by Subject|3|||
48798956|NCT02182973|157102175|FG001|Overall Study|Withdrawal by Subject|0|||
49008450|NCT01408576|157868292|FG000|Overall Study|Lack of Efficacy|17|||
49008451|NCT01408576|157868293|FG001|Overall Study|Lack of Efficacy|30|||
49008452|NCT01408576|157868294|FG002|Overall Study|Lack of Efficacy|48|||
49008453|NCT01408576|157868292|FG000|Overall Study|Protocol Violation|1|||
49008454|NCT01408576|157868293|FG001|Overall Study|Protocol Violation|2|||
49008455|NCT01408576|157868294|FG002|Overall Study|Protocol Violation|2|||
49008456|NCT01408576|157868292|FG000|Overall Study|Lost to Follow-up|10|||
49008457|NCT01408576|157868293|FG001|Overall Study|Lost to Follow-up|9|||
49008458|NCT01408576|157868294|FG002|Overall Study|Lost to Follow-up|17|||
49008459|NCT01408576|157868292|FG000|Overall Study|Withdrawal by Subject|34|||
49008460|NCT01408576|157868293|FG001|Overall Study|Withdrawal by Subject|60|||
49008461|NCT01408576|157868294|FG002|Overall Study|Withdrawal by Subject|66|||
49008462|NCT01408576|157868292|FG000|Overall Study|Sponsor terminated study|89|||
49008463|NCT01408576|157868293|FG001|Overall Study|Sponsor terminated study|333|||
49008464|NCT01408576|157868294|FG002|Overall Study|Sponsor terminated study|330|||
49008465|NCT01408576|157868292|FG000|Overall Study|AE, serious fatal|4|||
49008466|NCT01408576|157868293|FG001|Overall Study|AE, serious fatal|4|||
49008467|NCT01408576|157868294|FG002|Overall Study|AE, serious fatal|1|||
49008468|NCT01408576|157868292|FG000|Overall Study|SAE, non-fatal|11|||
49008469|NCT01408576|157868293|FG001|Overall Study|SAE, non-fatal|23|||
49008470|NCT01408576|157868294|FG002|Overall Study|SAE, non-fatal|14|||
49008471|NCT01408576|157868292|FG000|Overall Study|AE, non-serious non-fatal|12|||
49008472|NCT01408576|157868293|FG001|Overall Study|AE, non-serious non-fatal|19|||
49008473|NCT01408576|157868294|FG002|Overall Study|AE, non-serious non-fatal|11|||
49008474|NCT01408576|157868292|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
49008475|NCT01408576|157868293|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
49008476|NCT01408576|157868294|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
49008477|NCT01408576|157868292|FG000|Overall Study|AE, unknown type|0|||
49008478|NCT01408576|157868293|FG001|Overall Study|AE, unknown type|1|||
49008479|NCT01408576|157868294|FG002|Overall Study|AE, unknown type|0|||
49008480|NCT01408576|157868292|FG000|Overall Study|Other|10|||
49008481|NCT01408576|157868293|FG001|Overall Study|Other|16|||
49008482|NCT01408576|157868294|FG002|Overall Study|Other|18|||
49008483|NCT01347879|157868320|FG000|Overall Study|Adverse Event|0|||
49008484|NCT01347879|157868321|FG001|Overall Study|Adverse Event|12|||
49008485|NCT01347879|157868320|FG000|Overall Study|Lost to Follow-up|2|||
49008486|NCT01347879|157868321|FG001|Overall Study|Lost to Follow-up|0|||
49008487|NCT01347879|157868320|FG000|Overall Study|Withdrawal by Subject|3|||
49008488|NCT01347879|157868321|FG001|Overall Study|Withdrawal by Subject|2|||
49008489|NCT01347879|157868320|FG000|Overall Study|Other|2|||
49008490|NCT01347879|157868321|FG001|Overall Study|Other|3|||
49008491|NCT02981602|157868323|FG000|Overall Study|Adverse Event|0|||
49008492|NCT02981602|157868324|FG001|Overall Study|Adverse Event|0|||
49008493|NCT02981602|157868325|FG002|Overall Study|Adverse Event|0|||
49008494|NCT02981602|157868326|FG003|Overall Study|Adverse Event|1|||
49008495|NCT02981602|157868327|FG004|Overall Study|Adverse Event|0|||
49008496|NCT02164539|157868328|FG000|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
49008497|NCT02164539|157868329|FG001|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
49008498|NCT02164539|157868330|FG002|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
49008499|NCT02164539|157868331|FG003|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
49008500|NCT02164539|157868332|FG004|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3|||
49008501|NCT02164539|157868333|FG005|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
49008502|NCT02164539|157868334|FG006|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
49008503|NCT02164539|157868328|FG000|Treatment Phase B (1 Week)|Adverse Event|0|||
49008504|NCT02164539|157868329|FG001|Treatment Phase B (1 Week)|Adverse Event|0|||
49008505|NCT02164539|157868330|FG002|Treatment Phase B (1 Week)|Adverse Event|0|||
49008506|NCT02164539|157868331|FG003|Treatment Phase B (1 Week)|Adverse Event|0|||
49008507|NCT02164539|157868332|FG004|Treatment Phase B (1 Week)|Adverse Event|2|||
49008508|NCT02164539|157868333|FG005|Treatment Phase B (1 Week)|Adverse Event|0|||
49008509|NCT02164539|157868334|FG006|Treatment Phase B (1 Week)|Adverse Event|0|||
49008510|NCT02164539|157868328|FG000|Treatment Phase B (1 Week)|Physician Decision|0|||
49008511|NCT02164539|157868329|FG001|Treatment Phase B (1 Week)|Physician Decision|0|||
49008512|NCT02164539|157868330|FG002|Treatment Phase B (1 Week)|Physician Decision|0|||
49008513|NCT02164539|157868331|FG003|Treatment Phase B (1 Week)|Physician Decision|0|||
49008514|NCT02164539|157868332|FG004|Treatment Phase B (1 Week)|Physician Decision|1|||
49008515|NCT02164539|157868333|FG005|Treatment Phase B (1 Week)|Physician Decision|0|||
49008516|NCT02164539|157868334|FG006|Treatment Phase B (1 Week)|Physician Decision|1|||
49008517|NCT02164539|157868328|FG000|Treatment Phase C (1 Week)|Withdrawal by Subject|1|||
49008518|NCT02164539|157868329|FG001|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
49008519|NCT02164539|157868330|FG002|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
49008520|NCT02164539|157868331|FG003|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
49008521|NCT02164539|157868332|FG004|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
49008522|NCT02164539|157868333|FG005|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
49008523|NCT02164539|157868334|FG006|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
49008524|NCT02164539|157868328|FG000|Treatment Phase C (1 Week)|Adverse Event|0|||
49008525|NCT02164539|157868329|FG001|Treatment Phase C (1 Week)|Adverse Event|0|||
48798957|NCT01132326|157102178|FG000|Overall Study|Lack of Efficacy|25|||
48798958|NCT01132326|157102178|FG000|Overall Study|Adverse Event|37|||
48798959|NCT01132326|157102178|FG000|Overall Study|Protocol Violation|1|||
48798960|NCT01132326|157102178|FG000|Overall Study|Lost to Follow-up|16|||
48798961|NCT01132326|157102178|FG000|Overall Study|Withdrawal by Subject|40|||
48798962|NCT01132326|157102178|FG000|Overall Study|Physician Decision|10|||
48798963|NCT01132326|157102178|FG000|Overall Study|Study Termination|80|||
48798964|NCT01132326|157102178|FG000|Overall Study|Declining Health|1|||
48798965|NCT01132326|157102178|FG000|Overall Study|Pregnancy|1|||
49008526|NCT02164539|157868330|FG002|Treatment Phase C (1 Week)|Adverse Event|0|||
49008527|NCT02164539|157868331|FG003|Treatment Phase C (1 Week)|Adverse Event|0|||
49008528|NCT02164539|157868332|FG004|Treatment Phase C (1 Week)|Adverse Event|0|||
49008529|NCT02164539|157868333|FG005|Treatment Phase C (1 Week)|Adverse Event|0|||
49008530|NCT02164539|157868334|FG006|Treatment Phase C (1 Week)|Adverse Event|1|||
49008531|NCT02164539|157868328|FG000|Treatment Phase C (1 Week)|Physician Decision|0|||
49008532|NCT02164539|157868329|FG001|Treatment Phase C (1 Week)|Physician Decision|0|||
49008533|NCT02164539|157868330|FG002|Treatment Phase C (1 Week)|Physician Decision|0|||
49008534|NCT02164539|157868331|FG003|Treatment Phase C (1 Week)|Physician Decision|0|||
49008535|NCT02164539|157868332|FG004|Treatment Phase C (1 Week)|Physician Decision|0|||
49008536|NCT02164539|157868333|FG005|Treatment Phase C (1 Week)|Physician Decision|0|||
49008537|NCT02164539|157868334|FG006|Treatment Phase C (1 Week)|Physician Decision|1|||
49008538|NCT02643966|157868335|FG000|First Screening Round|ineligible|1|||
49008539|NCT02643966|157868335|FG000|First Screening Round|excluded from analysis|2|||
49008540|NCT02643966|157868335|FG000|First Screening Round|Lost to Follow-up|56|||
49008541|NCT02643966|157868335|FG000|First Screening Round|Withdrawal by Subject|28|||
49008542|NCT02643966|157868335|FG000|First Screening Round|Death|1|||
49008543|NCT02643966|157868335|FG000|Between First and Second Screening|Lost to Follow-up|65|||
49008544|NCT02643966|157868335|FG000|Between First and Second Screening|Withdrawal by Subject|82|||
49008545|NCT02643966|157868335|FG000|Between First and Second Screening|women who skipped year 2 exam|11|||
49008546|NCT02643966|157868335|FG000|Second Screening Round|Withdrawal by Subject|20|||
49008547|NCT02643966|157868335|FG000|Second Screening Round|Lost to Follow-up|57|||
49008548|NCT02643966|157868335|FG000|Second Screening Round|Physician Decision|2|||
49008549|NCT02643966|157868335|FG000|Second Screening Round|Death|4|||
49008550|NCT02643966|157868335|FG000|Between Second and Third Screening|Lost to Follow-up|75|||
49008551|NCT02643966|157868335|FG000|Between Second and Third Screening|Death|1|||
49008552|NCT02643966|157868335|FG000|Between Second and Third Screening|Withdrawal by Subject|181|||
49008553|NCT02643966|157868335|FG000|Third Screening Round|PI excluded|2|||
49008554|NCT02643966|157868335|FG000|Third Screening Round|Lost to Follow-up|241|||
49008555|NCT01493531|157868336|FG000|Overall Study|Adverse Event|4|||
49008556|NCT01493531|157868337|FG001|Overall Study|Adverse Event|12|||
49008557|NCT01493531|157868338|FG002|Overall Study|Adverse Event|9|||
49008558|NCT01493531|157868336|FG000|Overall Study|Gout flare|3|||
48798966|NCT01132326|157102178|FG000|Overall Study|Caregiver Withdrew Consent|1|||
49008559|NCT01493531|157868337|FG001|Overall Study|Gout flare|0|||
49008560|NCT01493531|157868338|FG002|Overall Study|Gout flare|2|||
49008561|NCT01493531|157868336|FG000|Overall Study|Protocol Violation|8|||
49008562|NCT01493531|157868337|FG001|Overall Study|Protocol Violation|15|||
48798967|NCT01132326|157102178|FG000|Overall Study|Death|5|||
48798968|NCT01132326|157102178|FG000|Overall Study|Subject Unable to Come To Visits|1|||
49008563|NCT01493531|157868338|FG002|Overall Study|Protocol Violation|12|||
49008564|NCT01493531|157868336|FG000|Overall Study|Sponsor terminated study|5|||
49008565|NCT01493531|157868337|FG001|Overall Study|Sponsor terminated study|2|||
49008566|NCT01493531|157868338|FG002|Overall Study|Sponsor terminated study|3|||
49113416|NCT02824562|158251675|FG000|Overall Study|Death|0|||
48798969|NCT02355002|157102181|FG000|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|1|||
48798970|NCT02355002|157102182|FG001|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|0|||
48798971|NCT02355002|157102181|FG000|Period 1: Phase 1, Randomized-Controlled|Adverse Event|1|||
48798972|NCT02355002|157102182|FG001|Period 1: Phase 1, Randomized-Controlled|Adverse Event|0|||
48798973|NCT02355002|157102181|FG000|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
48798974|NCT02355002|157102182|FG001|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
48798975|NCT02355002|157102181|FG000|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|0|||
48798976|NCT02355002|157102182|FG001|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|1|||
48798977|NCT02355002|157102181|FG000|Period 2: Phase 2 Open-Label|Withdrawal by Subject|2|||
48798978|NCT02355002|157102182|FG001|Period 2: Phase 2 Open-Label|Withdrawal by Subject|0|||
48798979|NCT02355002|157102181|FG000|Period 2: Phase 2 Open-Label|Participant left country|1|||
48798980|NCT02355002|157102182|FG001|Period 2: Phase 2 Open-Label|Participant left country|0|||
48798981|NCT02355002|157102181|FG000|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
48798982|NCT02355002|157102182|FG001|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
48798983|NCT00708916|157102183|FG000|Overall Study|Subject Noncompliance|2|||
48798984|NCT00708916|157102183|FG000|Overall Study|Adverse Event|2|||
48798985|NCT02657317|157102184|FG000|Overall Study|Withdrawal by Subject|2|||
48798986|NCT02657317|157102185|FG001|Overall Study|Withdrawal by Subject|0|||
48798987|NCT02657317|157102184|FG000|Overall Study|Lost to Follow-up|3|||
48798988|NCT02657317|157102185|FG001|Overall Study|Lost to Follow-up|3|||
48798989|NCT02110901|157102186|FG000|Overall Study|Death|6|||
48798990|NCT02110901|157102187|FG001|Overall Study|Death|3|||
48798991|NCT02110901|157102186|FG000|Overall Study|Lost to Follow-up|12|||
48798992|NCT02110901|157102187|FG001|Overall Study|Lost to Follow-up|8|||
48798993|NCT02110901|157102186|FG000|Overall Study|Withdrawal by Subject|7|||
48798994|NCT02110901|157102187|FG001|Overall Study|Withdrawal by Subject|3|||
49008567|NCT01493531|157868336|FG000|Overall Study|Lost to Follow-up|5|||
49008568|NCT01493531|157868337|FG001|Overall Study|Lost to Follow-up|7|||
49008569|NCT01493531|157868338|FG002|Overall Study|Lost to Follow-up|11|||
49008570|NCT01493531|157868336|FG000|Overall Study|Withdrawal by Subject|16|||
49008571|NCT01493531|157868337|FG001|Overall Study|Withdrawal by Subject|13|||
49008572|NCT01493531|157868338|FG002|Overall Study|Withdrawal by Subject|11|||
49008573|NCT01493531|157868336|FG000|Overall Study|Death|0|||
49008574|NCT01493531|157868337|FG001|Overall Study|Death|1|||
49008575|NCT01493531|157868338|FG002|Overall Study|Death|0|||
49008576|NCT01946282|157868339|FG000|Year 1|Did not return FIT kit|4186|||
49008577|NCT01946282|157868340|FG001|Year 1|Did not return FIT kit|608|||
49008578|NCT01946282|157868341|FG002|Year 1|Did not return FIT kit|654|||
49008579|NCT01946282|157868339|FG000|Year 2|Did not return FIT kit|803|||
49008580|NCT01946282|157868340|FG001|Year 2|Did not return FIT kit|131|||
49008581|NCT01946282|157868341|FG002|Year 2|Did not return FIT kit|115|||
49008582|NCT01946282|157868339|FG000|Year 3|Did not return FIT kit|288|||
49008583|NCT01946282|157868340|FG001|Year 3|Did not return FIT kit|43|||
49008584|NCT01946282|157868341|FG002|Year 3|Did not return FIT kit|30|||
49008585|NCT03812679|157868344|FG000|Overall Study|Adverse Event|2|||
49008586|NCT03812679|157868344|FG000|Overall Study|Missed >4 consecutive therapy days|1|||
49008587|NCT03812679|157868344|FG000|Overall Study|Renal transplant|1|||
49008588|NCT03812679|157868344|FG000|Overall Study|Withdrawal by Subject|1|||
49008589|NCT03812679|157868344|FG000|Overall Study|Termination of study|2|||
49008590|NCT03812679|157868344|FG000|Overall Study|Water device replacement|1|||
49008591|NCT03835975|157868345|FG000|Overall Study|Lost to Follow-up|1|||
49008592|NCT03835975|157868346|FG001|Overall Study|Lost to Follow-up|1|||
49008593|NCT03835975|157868347|FG002|Overall Study|Lost to Follow-up|0|||
49008594|NCT03835975|157868348|FG003|Overall Study|Lost to Follow-up|0|||
49008595|NCT03835975|157868349|FG004|Overall Study|Lost to Follow-up|0|||
49008596|NCT03835975|157868345|FG000|Overall Study|No longer met eligibility criteria|0|||
49008597|NCT03835975|157868346|FG001|Overall Study|No longer met eligibility criteria|1|||
49008598|NCT03835975|157868347|FG002|Overall Study|No longer met eligibility criteria|0|||
49008599|NCT03835975|157868348|FG003|Overall Study|No longer met eligibility criteria|0|||
49008600|NCT03835975|157868349|FG004|Overall Study|No longer met eligibility criteria|0|||
49008601|NCT03835975|157868345|FG000|Overall Study|Protocol Violation|1|||
49008602|NCT03835975|157868346|FG001|Overall Study|Protocol Violation|1|||
49008603|NCT03835975|157868347|FG002|Overall Study|Protocol Violation|2|||
49008604|NCT03835975|157868348|FG003|Overall Study|Protocol Violation|0|||
49008605|NCT03835975|157868349|FG004|Overall Study|Protocol Violation|0|||
49008606|NCT03835975|157868345|FG000|Overall Study|Withdrawal by Subject|1|||
49008607|NCT03835975|157868346|FG001|Overall Study|Withdrawal by Subject|0|||
49008608|NCT03835975|157868347|FG002|Overall Study|Withdrawal by Subject|1|||
49008609|NCT03835975|157868348|FG003|Overall Study|Withdrawal by Subject|1|||
49008610|NCT03835975|157868349|FG004|Overall Study|Withdrawal by Subject|0|||
49008611|NCT00827359|157868350|FG000|Overall Study|Progressive Diseas|19|||
49008612|NCT00827359|157868350|FG000|Overall Study|Unacceptable Toxicity|5|||
49008613|NCT00827359|157868350|FG000|Overall Study|Ineligible|1|||
49008614|NCT03031431|157868351|FG000|Overall Study|Infant removed by maternal request|1|||
49008615|NCT01825876|157868352|FG000|Period 2|Withdrawal by Subject|0|||
49008616|NCT01825876|157868353|FG001|Period 2|Withdrawal by Subject|1|||
49008617|NCT01612702|157868355|FG000|Overall Study|Protocol Violation|11|||
48798995|NCT02110901|157102186|FG000|Overall Study|received a kidney transplant|5|||
48798996|NCT02110901|157102187|FG001|Overall Study|received a kidney transplant|0|||
49008618|NCT01612702|157868356|FG001|Overall Study|Protocol Violation|11|||
49008619|NCT01027884|157868357|FG000|Overall Study|Adverse Event|2|||
48798997|NCT01844284|157102188|FG000|Overall Study|Lost to Follow-up|12|||
48798998|NCT01844284|157102189|FG001|Overall Study|Lost to Follow-up|7|||
48798999|NCT00166296|157102190|FG000|Overall Study|Withdrawal by Subject|1|||
48799000|NCT00166296|157102191|FG001|Overall Study|Withdrawal by Subject|3|||
48799001|NCT00166296|157102190|FG000|Overall Study|Adverse Event|2|||
48799002|NCT00166296|157102191|FG001|Overall Study|Adverse Event|4|||
48799003|NCT00166296|157102190|FG000|Overall Study|Lost to Follow-up|4|||
48799004|NCT00166296|157102191|FG001|Overall Study|Lost to Follow-up|2|||
48799005|NCT04259450|157102194|FG000|Overall Study|Adverse event/ Toxicity|0|||
48799006|NCT04259450|157102195|FG001|Overall Study|Adverse event/ Toxicity|3|||
48799007|NCT04259450|157102196|FG002|Overall Study|Adverse event/ Toxicity|0|||
48799008|NCT04259450|157102197|FG003|Overall Study|Adverse event/ Toxicity|1|||
48799009|NCT04259450|157102198|FG004|Overall Study|Adverse event/ Toxicity|0|||
48799010|NCT04259450|157102199|FG005|Overall Study|Adverse event/ Toxicity|0|||
48799011|NCT04259450|157102200|FG006|Overall Study|Adverse event/ Toxicity|0|||
48799012|NCT04259450|157102201|FG007|Overall Study|Adverse event/ Toxicity|1|||
48799013|NCT04259450|157102202|FG008|Overall Study|Adverse event/ Toxicity|0|||
48799014|NCT04259450|157102203|FG009|Overall Study|Adverse event/ Toxicity|3|||
48799015|NCT04259450|157102194|FG000|Overall Study|Disease progression|2|||
48799016|NCT04259450|157102195|FG001|Overall Study|Disease progression|3|||
48799017|NCT04259450|157102196|FG002|Overall Study|Disease progression|4|||
48799018|NCT04259450|157102197|FG003|Overall Study|Disease progression|4|||
48799019|NCT04259450|157102198|FG004|Overall Study|Disease progression|6|||
48799020|NCT04259450|157102199|FG005|Overall Study|Disease progression|6|||
48799021|NCT04259450|157102200|FG006|Overall Study|Disease progression|5|||
48799022|NCT04259450|157102201|FG007|Overall Study|Disease progression|15|||
48799023|NCT04259450|157102202|FG008|Overall Study|Disease progression|6|||
48799024|NCT04259450|157102203|FG009|Overall Study|Disease progression|17|||
48799025|NCT04259450|157102194|FG000|Overall Study|Death|0|||
48799026|NCT04259450|157102195|FG001|Overall Study|Death|0|||
48799027|NCT04259450|157102196|FG002|Overall Study|Death|0|||
48799028|NCT04259450|157102197|FG003|Overall Study|Death|0|||
48799029|NCT04259450|157102198|FG004|Overall Study|Death|0|||
48799030|NCT04259450|157102199|FG005|Overall Study|Death|0|||
48799031|NCT04259450|157102200|FG006|Overall Study|Death|0|||
48799032|NCT04259450|157102201|FG007|Overall Study|Death|1|||
48799033|NCT04259450|157102202|FG008|Overall Study|Death|1|||
48799034|NCT04259450|157102203|FG009|Overall Study|Death|0|||
48799035|NCT04259450|157102194|FG000|Overall Study|Withdrawal by Subject|0|||
48799036|NCT04259450|157102195|FG001|Overall Study|Withdrawal by Subject|0|||
48799037|NCT04259450|157102196|FG002|Overall Study|Withdrawal by Subject|0|||
48799038|NCT04259450|157102197|FG003|Overall Study|Withdrawal by Subject|0|||
48799039|NCT04259450|157102198|FG004|Overall Study|Withdrawal by Subject|0|||
48799040|NCT04259450|157102199|FG005|Overall Study|Withdrawal by Subject|0|||
48799041|NCT04259450|157102200|FG006|Overall Study|Withdrawal by Subject|0|||
48799042|NCT04259450|157102201|FG007|Overall Study|Withdrawal by Subject|1|||
48799043|NCT04259450|157102202|FG008|Overall Study|Withdrawal by Subject|0|||
48799044|NCT04259450|157102203|FG009|Overall Study|Withdrawal by Subject|0|||
48799045|NCT04259450|157102194|FG000|Overall Study|Long Term Adverse Event|0|||
48799046|NCT04259450|157102195|FG001|Overall Study|Long Term Adverse Event|0|||
48799047|NCT04259450|157102196|FG002|Overall Study|Long Term Adverse Event|0|||
48799048|NCT04259450|157102197|FG003|Overall Study|Long Term Adverse Event|0|||
49008620|NCT01027884|157868358|FG001|Overall Study|Adverse Event|1|||
49008621|NCT01027884|157868357|FG000|Overall Study|Protocol Violation|1|||
49008622|NCT01027884|157868358|FG001|Overall Study|Protocol Violation|0|||
49008623|NCT01027884|157868357|FG000|Overall Study|Non-compliance|1|||
49008624|NCT01027884|157868358|FG001|Overall Study|Non-compliance|1|||
49008625|NCT01027884|157868357|FG000|Overall Study|Withdrawal by Subject|0|||
49008626|NCT01027884|157868358|FG001|Overall Study|Withdrawal by Subject|1|||
49008627|NCT01027884|157868357|FG000|Overall Study|Lost to Follow-up|0|||
48799049|NCT04259450|157102198|FG004|Overall Study|Long Term Adverse Event|0|||
48799050|NCT04259450|157102199|FG005|Overall Study|Long Term Adverse Event|0|||
48799051|NCT04259450|157102200|FG006|Overall Study|Long Term Adverse Event|0|||
48799052|NCT04259450|157102201|FG007|Overall Study|Long Term Adverse Event|0|||
48799053|NCT04259450|157102202|FG008|Overall Study|Long Term Adverse Event|0|||
48799054|NCT04259450|157102203|FG009|Overall Study|Long Term Adverse Event|1|||
48799055|NCT02782169|157102222|FG000|Overall Study|Lost to Follow-up|1|||
49008628|NCT01027884|157868358|FG001|Overall Study|Lost to Follow-up|1|||
49008629|NCT01027884|157868357|FG000|Overall Study|Spinal fixation surgery|0|||
48799056|NCT02782169|157102223|FG001|Overall Study|Lost to Follow-up|2|||
48799057|NCT03185481|157102227|FG000|Overall Study|Adverse Event|1|||
48799058|NCT03185481|157102227|FG000|Overall Study|Study Terminated by Sponsor|4|||
48799059|NCT01422408|157102228|FG000|Overall Study|Adverse Event|1|||
48799060|NCT01422408|157102228|FG000|Overall Study|Withdrawal by Subject|3|||
48856256|NCT01480258|157312799|FG001|Infant Series|Physician Decision|1|||
49008630|NCT01027884|157868358|FG001|Overall Study|Spinal fixation surgery|3|||
49008631|NCT03636542|157868359|FG000|Overall Study|Lost to Follow-up|1|||
49008632|NCT03636542|157868360|FG001|Overall Study|Lost to Follow-up|1|||
49008633|NCT03636542|157868359|FG000|Overall Study|Physician Decision|0|||
48799061|NCT01936857|157102239|FG000|Overall Study|Sent to prison or 06 center|11|||
48799062|NCT01936857|157102240|FG001|Overall Study|Sent to prison or 06 center|12|||
49008634|NCT03636542|157868360|FG001|Overall Study|Physician Decision|1|||
49008635|NCT03636542|157868359|FG000|Overall Study|Withdrawal by Subject|1|||
49008636|NCT03636542|157868360|FG001|Overall Study|Withdrawal by Subject|0|||
49008637|NCT03670537|157868361|FG000|Overall Study|Protocol Violation|1|||
49008638|NCT03751020|157868362|FG000|Overall Study|Withdrawal by Subject|2|||
49008639|NCT03751020|157868363|FG001|Overall Study|Withdrawal by Subject|0|||
49008640|NCT03751020|157868364|FG002|Overall Study|Withdrawal by Subject|0|||
49008641|NCT03751020|157868362|FG000|Overall Study|Lost to Follow-up|7|||
49008642|NCT03751020|157868363|FG001|Overall Study|Lost to Follow-up|4|||
49008643|NCT03751020|157868364|FG002|Overall Study|Lost to Follow-up|10|||
49008644|NCT03070431|157868365|FG000|Overall Study|Withdrawal by Subject|2|||
49008645|NCT03070431|157868365|FG000|Overall Study|Lost to Follow-up|2|||
48799063|NCT01936857|157102239|FG000|Overall Study|Lost to Follow-up|10|||
48799064|NCT01936857|157102240|FG001|Overall Study|Lost to Follow-up|7|||
48799065|NCT01936857|157102239|FG000|Overall Study|Death|7|||
48799066|NCT01936857|157102240|FG001|Overall Study|Death|3|||
49113417|NCT02824562|158251676|FG001|Overall Study|Death|1|||
49113418|NCT00224406|158251680|FG000|Overall Study|Re-transplant|0|||
49113419|NCT00224406|158251681|FG001|Overall Study|Re-transplant|2|||
49113420|NCT00224406|158251680|FG000|Overall Study|Death|0|||
49113421|NCT00224406|158251681|FG001|Overall Study|Death|1|||
49113422|NCT00224406|158251680|FG000|Overall Study|Transplant cancelled|0|||
48799067|NCT01936857|157102239|FG000|Overall Study|Moved|2|||
48799068|NCT01936857|157102240|FG001|Overall Study|Moved|1|||
48799069|NCT01936857|157102239|FG000|Overall Study|Withdrawal by Subject|1|||
48799070|NCT01936857|157102240|FG001|Overall Study|Withdrawal by Subject|0|||
48799071|NCT01936857|157102239|FG000|Overall Study|Side effect of medication|1|||
48799072|NCT01936857|157102240|FG001|Overall Study|Side effect of medication|0|||
48799073|NCT01936857|157102239|FG000|Overall Study|Other|2|||
48799074|NCT01936857|157102240|FG001|Overall Study|Other|2|||
48799075|NCT01693068|157102247|FG000|Randomization Period|On-study|2|||
48799076|NCT01693068|157102248|FG001|Randomization Period|On-study|5|||
48799077|NCT01693068|157102249|FG002|Randomization Period|On-study|0|||
48799078|NCT01693068|157102247|FG000|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
48799079|NCT01693068|157102248|FG001|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
48799080|NCT01693068|157102249|FG002|Cross-over (Dacarbazine To Pimasertib)|On-study|1|||
48799081|NCT01687257|157102250|FG000|Overall Study|Efficacy Failure|6|||
48799082|NCT01687257|157102251|FG001|Overall Study|Efficacy Failure|0|||
48799083|NCT01687257|157102252|FG002|Overall Study|Efficacy Failure|5|||
48799084|NCT01687257|157102250|FG000|Overall Study|Subject Withdrew Consent|1|||
48799085|NCT01687257|157102251|FG001|Overall Study|Subject Withdrew Consent|1|||
48799086|NCT01687257|157102252|FG002|Overall Study|Subject Withdrew Consent|1|||
48799087|NCT01687257|157102250|FG000|Overall Study|Adverse Event|1|||
48799088|NCT01687257|157102251|FG001|Overall Study|Adverse Event|0|||
48799089|NCT01687257|157102252|FG002|Overall Study|Adverse Event|0|||
48799090|NCT01687257|157102250|FG000|Overall Study|Investigator's Discretion|0|||
48799091|NCT01687257|157102251|FG001|Overall Study|Investigator's Discretion|3|||
48799092|NCT01687257|157102252|FG002|Overall Study|Investigator's Discretion|0|||
48799093|NCT00736645|157102254|FG000|Overall Study|Adverse Event|0|||
48799094|NCT00736645|157102255|FG001|Overall Study|Adverse Event|2|||
48799095|NCT00736645|157102256|FG002|Overall Study|Adverse Event|0|||
48799096|NCT00736645|157102257|FG003|Overall Study|Adverse Event|0|||
48799097|NCT00168038|157102258|FG000|Overall Study|Adverse Event|1|||
49008646|NCT00033631|157868366|FG000|Overall Study|Protocol Violation|14|||
49008647|NCT00033631|157868367|FG001|Overall Study|Protocol Violation|11|||
49008648|NCT00033631|157868366|FG000|Overall Study|Withdrawal by Subject|4|||
49008649|NCT00033631|157868367|FG001|Overall Study|Withdrawal by Subject|4|||
49008650|NCT01889862|157868368|FG000|Part 1 (Up to 13 Weeks)|Adverse Event|4|||
49008651|NCT01889862|157868369|FG001|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
49008652|NCT01889862|157868370|FG002|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
49008653|NCT01889862|157868371|FG003|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
48799098|NCT00168038|157102258|FG000|Overall Study|Therapy failure|1|||
48799099|NCT00717860|157102264|FG000|Overall Study|Clinical adverse experience|5|||
48799100|NCT00717860|157102265|FG001|Overall Study|Clinical adverse experience|9|||
48799101|NCT00717860|157102264|FG000|Overall Study|Laboratory adverse experience|2|||
48799102|NCT00717860|157102265|FG001|Overall Study|Laboratory adverse experience|2|||
48799103|NCT00717860|157102264|FG000|Overall Study|Lack of Efficacy|7|||
48799104|NCT00717860|157102265|FG001|Overall Study|Lack of Efficacy|13|||
48799105|NCT00717860|157102264|FG000|Overall Study|Discontinued for other reason|6|||
48799106|NCT00717860|157102265|FG001|Overall Study|Discontinued for other reason|1|||
48799107|NCT00717860|157102264|FG000|Overall Study|Withdrew consent|7|||
49008654|NCT01889862|157868372|FG004|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
49113423|NCT00224406|158251681|FG001|Overall Study|Transplant cancelled|4|||
49113424|NCT00224406|158251680|FG000|Overall Study|Drug not delivered|2|||
49113425|NCT00224406|158251681|FG001|Overall Study|Drug not delivered|0|||
49113426|NCT00224406|158251680|FG000|Overall Study|Other|4|||
49113427|NCT00224406|158251681|FG001|Overall Study|Other|0|||
49113428|NCT00224406|158251680|FG000|Overall Study|Transplant cancelled|3|||
49113429|NCT00224406|158251681|FG001|Overall Study|Transplant cancelled|0|||
49113430|NCT01390428|158251682|FG000|Overall Study|Elective Surgery|0|||
49113431|NCT01390428|158251683|FG001|Overall Study|Elective Surgery|0|||
49113432|NCT01390428|158251684|FG002|Overall Study|Elective Surgery|0|||
49113433|NCT01390428|158251685|FG003|Overall Study|Elective Surgery|0|||
49113434|NCT01390428|158251686|FG004|Overall Study|Elective Surgery|1|||
49113435|NCT01390428|158251687|FG005|Overall Study|Elective Surgery|0|||
49113436|NCT01390428|158251682|FG000|Overall Study|Withdrawal by Subject|0|||
49113437|NCT01390428|158251683|FG001|Overall Study|Withdrawal by Subject|0|||
49113438|NCT01390428|158251684|FG002|Overall Study|Withdrawal by Subject|1|||
49113439|NCT01390428|158251685|FG003|Overall Study|Withdrawal by Subject|0|||
49113440|NCT01390428|158251686|FG004|Overall Study|Withdrawal by Subject|0|||
49113441|NCT01390428|158251687|FG005|Overall Study|Withdrawal by Subject|0|||
49113442|NCT01687283|158251688|FG000|Overall Study|Adverse Event|11|||
49113443|NCT01687283|158251689|FG001|Overall Study|Adverse Event|4|||
49113444|NCT01687283|158251688|FG000|Overall Study|Lack of Efficacy|3|||
49113445|NCT01687283|158251689|FG001|Overall Study|Lack of Efficacy|1|||
49113446|NCT01687283|158251688|FG000|Overall Study|Protocol Violation|1|||
49113447|NCT01687283|158251689|FG001|Overall Study|Protocol Violation|3|||
49113448|NCT01687283|158251688|FG000|Overall Study|protocol defined stopping criteria|8|||
49113449|NCT01687283|158251689|FG001|Overall Study|protocol defined stopping criteria|10|||
49113450|NCT01687283|158251688|FG000|Overall Study|Lost to Follow-up|1|||
49113451|NCT01687283|158251689|FG001|Overall Study|Lost to Follow-up|1|||
49113452|NCT01687283|158251688|FG000|Overall Study|Investigator discretion|2|||
49113453|NCT01687283|158251689|FG001|Overall Study|Investigator discretion|0|||
49113454|NCT01687283|158251688|FG000|Overall Study|Withdrawal by Subject|9|||
49113455|NCT01687283|158251689|FG001|Overall Study|Withdrawal by Subject|8|||
49113456|NCT02913105|158251690|FG000|Overall Study|Adverse Event|11|||
49113457|NCT02913105|158251691|FG001|Overall Study|Adverse Event|0|||
49113458|NCT02913105|158251692|FG002|Overall Study|Adverse Event|4|||
49113459|NCT02913105|158251690|FG000|Overall Study|Non-Compliance With Study Drug|0|||
49113460|NCT02913105|158251691|FG001|Overall Study|Non-Compliance With Study Drug|0|||
49113461|NCT02913105|158251692|FG002|Overall Study|Non-Compliance With Study Drug|1|||
49113462|NCT02913105|158251690|FG000|Overall Study|Reason Not Specified|3|||
49113463|NCT02913105|158251691|FG001|Overall Study|Reason Not Specified|1|||
49113464|NCT02913105|158251692|FG002|Overall Study|Reason Not Specified|1|||
49113465|NCT02913105|158251690|FG000|Overall Study|Physician Decision|1|||
49113466|NCT02913105|158251691|FG001|Overall Study|Physician Decision|1|||
49113467|NCT02913105|158251692|FG002|Overall Study|Physician Decision|0|||
49113468|NCT02913105|158251690|FG000|Overall Study|Withdrawal by Subject|0|||
49113469|NCT02913105|158251691|FG001|Overall Study|Withdrawal by Subject|3|||
49113470|NCT02913105|158251692|FG002|Overall Study|Withdrawal by Subject|1|||
48799108|NCT00717860|157102265|FG001|Overall Study|Withdrew consent|3|||
48799109|NCT04058353|157102266|FG000|Overall Study|Adverse Event|2|||
48799110|NCT04058353|157102267|FG001|Overall Study|Adverse Event|1|||
48799111|NCT04058353|157102266|FG000|Overall Study|Physician Decision|1|||
48799112|NCT04058353|157102267|FG001|Overall Study|Physician Decision|0|||
48799113|NCT04058353|157102266|FG000|Overall Study|Other|1|||
49113471|NCT01556997|158251693|FG000|Overall Study|Adverse Event|10|||
49113472|NCT01556997|158251694|FG001|Overall Study|Adverse Event|12|||
48799114|NCT04058353|157102267|FG001|Overall Study|Other|0|||
48799115|NCT02495025|157102270|FG000|Overall Study|Lost to Follow-up|21|||
48799116|NCT02495025|157102271|FG001|Overall Study|Lost to Follow-up|14|||
48799117|NCT02495025|157102270|FG000|Overall Study|Withdrawal by Subject|5|||
48799118|NCT02495025|157102271|FG001|Overall Study|Withdrawal by Subject|0|||
48799119|NCT02365519|157102272|FG000|Randomized and Treated|Adverse Event|0|||
48799120|NCT02365519|157102273|FG001|Randomized and Treated|Adverse Event|1|||
48799121|NCT02365519|157102274|FG002|Randomized and Treated|Adverse Event|0|||
48799122|NCT02365519|157102272|FG000|Randomized and Treated|Withdrawal by Subject|0|||
48799123|NCT02365519|157102273|FG001|Randomized and Treated|Withdrawal by Subject|1|||
48799124|NCT02365519|157102274|FG002|Randomized and Treated|Withdrawal by Subject|1|||
48799125|NCT01353222|157102276|FG000|Overall Study|Death|30|||
48799126|NCT01353222|157102277|FG001|Overall Study|Death|30|||
48799127|NCT01353222|157102276|FG000|Overall Study|Withdrawal by Subject|8|||
49113473|NCT01556997|158251695|FG002|Overall Study|Adverse Event|12|||
49113474|NCT01556997|158251693|FG000|Overall Study|Lost to Follow-up|6|||
49113475|NCT01556997|158251694|FG001|Overall Study|Lost to Follow-up|6|||
49113476|NCT01556997|158251695|FG002|Overall Study|Lost to Follow-up|4|||
48799128|NCT01353222|157102277|FG001|Overall Study|Withdrawal by Subject|5|||
48799129|NCT01353222|157102276|FG000|Overall Study|Study Terminated|31|||
48799130|NCT01353222|157102277|FG001|Overall Study|Study Terminated|37|||
48856257|NCT01480258|157312798|FG000|Infant Series|Not Vaccinated|3|||
48799131|NCT01353222|157102276|FG000|Overall Study|Site closed research department|1|||
48799132|NCT01353222|157102277|FG001|Overall Study|Site closed research department|0|||
48799133|NCT04179721|157102278|FG000|Overall Study|COVID-19 Related Lost of Followup|11|||
48799134|NCT04179721|157102279|FG001|Overall Study|COVID-19 Related Lost of Followup|13|||
48799135|NCT04179721|157102278|FG000|Overall Study|Lost to Follow-up|0|||
48799136|NCT04179721|157102279|FG001|Overall Study|Lost to Follow-up|1|||
48799137|NCT04398537|157102282|FG000|Overall Study|Physician Decision|10|||
48799138|NCT04398537|157102283|FG001|Overall Study|Physician Decision|15|||
48799139|NCT04870710|157102284|FG000|Overall Study|Lost to Follow-up|3|||
48799140|NCT02332720|157104082|FG000|Part A and Part B|Lost to Follow-up|1|||
48799141|NCT02332720|157104083|FG001|Part A and Part B|Lost to Follow-up|0|||
48799142|NCT02332720|157104084|FG002|Part A and Part B|Lost to Follow-up|0|||
48799143|NCT02332720|157104085|FG003|Part A and Part B|Lost to Follow-up|0|||
48799144|NCT02332720|157104086|FG004|Part A and Part B|Lost to Follow-up|0|||
48799145|NCT02332720|157104087|FG005|Part A and Part B|Lost to Follow-up|2|||
48799146|NCT02332720|157104088|FG006|Part A and Part B|Lost to Follow-up|1|||
48799147|NCT02332720|157104089|FG007|Part A and Part B|Lost to Follow-up|1|||
48799148|NCT02332720|157104090|FG008|Part A and Part B|Lost to Follow-up|0|||
48799149|NCT02332720|157104091|FG009|Part A and Part B|Lost to Follow-up|0|||
48799150|NCT02332720|157104092|FG010|Part A and Part B|Lost to Follow-up|0|||
48799151|NCT02332720|157104093|FG011|Part A and Part B|Lost to Follow-up|0|||
48799152|NCT02332720|157104094|FG012|Part A and Part B|Lost to Follow-up|0|||
48799153|NCT02332720|157104095|FG013|Part A and Part B|Lost to Follow-up|0|||
48799154|NCT02332720|157104096|FG014|Part A and Part B|Lost to Follow-up|0|||
48799155|NCT02332720|157104097|FG015|Part A and Part B|Lost to Follow-up|1|||
48799156|NCT02332720|157104098|FG016|Part A and Part B|Lost to Follow-up|0|||
48799157|NCT02332720|157104099|FG017|Part A and Part B|Lost to Follow-up|0|||
48799158|NCT02332720|157104100|FG018|Part A and Part B|Lost to Follow-up|0|||
48799159|NCT02332720|157104101|FG019|Part A and Part B|Lost to Follow-up|0|||
48799160|NCT02332720|157104102|FG020|Part A and Part B|Lost to Follow-up|0|||
48799161|NCT02332720|157104103|FG021|Part A and Part B|Lost to Follow-up|0|||
48799162|NCT02332720|157104104|FG022|Part A and Part B|Lost to Follow-up|0|||
48799163|NCT02332720|157104082|FG000|Part A and Part B|Adverse Event|0|||
48799164|NCT02332720|157104083|FG001|Part A and Part B|Adverse Event|0|||
48799165|NCT02332720|157104084|FG002|Part A and Part B|Adverse Event|0|||
48799166|NCT02332720|157104085|FG003|Part A and Part B|Adverse Event|0|||
48799167|NCT02332720|157104086|FG004|Part A and Part B|Adverse Event|0|||
48799168|NCT02332720|157104087|FG005|Part A and Part B|Adverse Event|0|||
48799169|NCT02332720|157104088|FG006|Part A and Part B|Adverse Event|0|||
48799170|NCT02332720|157104089|FG007|Part A and Part B|Adverse Event|0|||
48799171|NCT02332720|157104090|FG008|Part A and Part B|Adverse Event|0|||
48799172|NCT02332720|157104091|FG009|Part A and Part B|Adverse Event|0|||
48799173|NCT02332720|157104092|FG010|Part A and Part B|Adverse Event|0|||
48799174|NCT02332720|157104093|FG011|Part A and Part B|Adverse Event|0|||
48799175|NCT02332720|157104094|FG012|Part A and Part B|Adverse Event|0|||
48799176|NCT02332720|157104095|FG013|Part A and Part B|Adverse Event|0|||
48799177|NCT02332720|157104096|FG014|Part A and Part B|Adverse Event|0|||
48799178|NCT02332720|157104097|FG015|Part A and Part B|Adverse Event|0|||
48799179|NCT02332720|157104098|FG016|Part A and Part B|Adverse Event|0|||
48799180|NCT02332720|157104099|FG017|Part A and Part B|Adverse Event|1|||
48799181|NCT02332720|157104100|FG018|Part A and Part B|Adverse Event|0|||
48799182|NCT02332720|157104101|FG019|Part A and Part B|Adverse Event|0|||
48799183|NCT02332720|157104102|FG020|Part A and Part B|Adverse Event|0|||
48799184|NCT02332720|157104103|FG021|Part A and Part B|Adverse Event|0|||
48799185|NCT02332720|157104104|FG022|Part A and Part B|Adverse Event|0|||
48799186|NCT02332720|157104082|FG000|Part A and Part B|Physician Decision|0|||
48799187|NCT02332720|157104083|FG001|Part A and Part B|Physician Decision|0|||
48799188|NCT02332720|157104084|FG002|Part A and Part B|Physician Decision|0|||
48799189|NCT02332720|157104085|FG003|Part A and Part B|Physician Decision|0|||
48799190|NCT02332720|157104086|FG004|Part A and Part B|Physician Decision|0|||
48799191|NCT02332720|157104087|FG005|Part A and Part B|Physician Decision|0|||
48799192|NCT02332720|157104088|FG006|Part A and Part B|Physician Decision|0|||
48799193|NCT02332720|157104089|FG007|Part A and Part B|Physician Decision|0|||
48799194|NCT02332720|157104090|FG008|Part A and Part B|Physician Decision|0|||
48799195|NCT02332720|157104091|FG009|Part A and Part B|Physician Decision|0|||
48799196|NCT02332720|157104092|FG010|Part A and Part B|Physician Decision|0|||
48799197|NCT02332720|157104093|FG011|Part A and Part B|Physician Decision|0|||
48799198|NCT02332720|157104094|FG012|Part A and Part B|Physician Decision|0|||
48799199|NCT02332720|157104095|FG013|Part A and Part B|Physician Decision|0|||
48799200|NCT02332720|157104096|FG014|Part A and Part B|Physician Decision|0|||
48799201|NCT02332720|157104097|FG015|Part A and Part B|Physician Decision|0|||
48799202|NCT02332720|157104098|FG016|Part A and Part B|Physician Decision|0|||
48799203|NCT02332720|157104099|FG017|Part A and Part B|Physician Decision|0|||
49008655|NCT01889862|157868368|FG000|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2|||
48799204|NCT02332720|157104100|FG018|Part A and Part B|Physician Decision|1|||
48799205|NCT02332720|157104101|FG019|Part A and Part B|Physician Decision|0|||
48799206|NCT02332720|157104102|FG020|Part A and Part B|Physician Decision|0|||
48799207|NCT02332720|157104103|FG021|Part A and Part B|Physician Decision|0|||
48799208|NCT02332720|157104104|FG022|Part A and Part B|Physician Decision|0|||
48799209|NCT02332720|157104082|FG000|Part A and Part B|Withdrawal by Subject|0|||
48799210|NCT02332720|157104083|FG001|Part A and Part B|Withdrawal by Subject|0|||
48799211|NCT02332720|157104084|FG002|Part A and Part B|Withdrawal by Subject|0|||
48799212|NCT02332720|157104085|FG003|Part A and Part B|Withdrawal by Subject|0|||
48799213|NCT02332720|157104086|FG004|Part A and Part B|Withdrawal by Subject|0|||
48799214|NCT02332720|157104087|FG005|Part A and Part B|Withdrawal by Subject|1|||
48799215|NCT02332720|157104088|FG006|Part A and Part B|Withdrawal by Subject|0|||
48799216|NCT02332720|157104089|FG007|Part A and Part B|Withdrawal by Subject|0|||
48799217|NCT02332720|157104090|FG008|Part A and Part B|Withdrawal by Subject|0|||
48799218|NCT02332720|157104091|FG009|Part A and Part B|Withdrawal by Subject|0|||
48799219|NCT02332720|157104092|FG010|Part A and Part B|Withdrawal by Subject|0|||
48799220|NCT02332720|157104093|FG011|Part A and Part B|Withdrawal by Subject|0|||
48799221|NCT02332720|157104094|FG012|Part A and Part B|Withdrawal by Subject|0|||
48799222|NCT02332720|157104095|FG013|Part A and Part B|Withdrawal by Subject|0|||
48799223|NCT02332720|157104096|FG014|Part A and Part B|Withdrawal by Subject|0|||
48799224|NCT02332720|157104097|FG015|Part A and Part B|Withdrawal by Subject|0|||
48799225|NCT02332720|157104098|FG016|Part A and Part B|Withdrawal by Subject|0|||
48799226|NCT02332720|157104099|FG017|Part A and Part B|Withdrawal by Subject|0|||
48799227|NCT02332720|157104100|FG018|Part A and Part B|Withdrawal by Subject|0|||
48799228|NCT02332720|157104101|FG019|Part A and Part B|Withdrawal by Subject|1|||
48799229|NCT02332720|157104102|FG020|Part A and Part B|Withdrawal by Subject|0|||
48799230|NCT02332720|157104103|FG021|Part A and Part B|Withdrawal by Subject|0|||
48799231|NCT02332720|157104104|FG022|Part A and Part B|Withdrawal by Subject|0|||
48799232|NCT03338894|157104105|FG000|Overall Study|Withdrew, or not able to attend 9 or more classes, or did not complete final survey.|22|||
48799233|NCT01972529|157104106|FG000|Overall Study|Adverse Event|0|||
48799234|NCT01972529|157104107|FG001|Overall Study|Adverse Event|1|||
49113477|NCT01556997|158251693|FG000|Overall Study|Physician Decision|1|||
49113478|NCT01556997|158251694|FG001|Overall Study|Physician Decision|1|||
49113479|NCT01556997|158251695|FG002|Overall Study|Physician Decision|1|||
49113480|NCT01556997|158251693|FG000|Overall Study|Withdrawal by Subject|7|||
49113481|NCT01556997|158251694|FG001|Overall Study|Withdrawal by Subject|6|||
49113482|NCT01556997|158251695|FG002|Overall Study|Withdrawal by Subject|8|||
49113483|NCT01556997|158251693|FG000|Overall Study|Other|2|||
49113484|NCT01556997|158251694|FG001|Overall Study|Other|3|||
49113485|NCT01556997|158251695|FG002|Overall Study|Other|7|||
49113486|NCT00994214|158251696|FG000|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
49113487|NCT00994214|158251697|FG001|ITT (Intention-to-Treat) - Part A|Adverse Event|1|||
49113488|NCT00994214|158251698|FG002|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
49113489|NCT00994214|158251699|FG003|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
49113490|NCT00994214|158251696|FG000|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
49113491|NCT00994214|158251697|FG001|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
49113492|NCT00994214|158251698|FG002|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
49113493|NCT00994214|158251699|FG003|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1|||
49113494|NCT00994214|158251696|FG000|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1|||
49113495|NCT00994214|158251697|FG001|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
49113496|NCT00994214|158251698|FG002|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
49113497|NCT00994214|158251699|FG003|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
49113498|NCT00994214|158251696|FG000|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
49113499|NCT00994214|158251697|FG001|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12|||
49113500|NCT00994214|158251698|FG002|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
49113501|NCT00994214|158251699|FG003|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14|||
49113502|NCT00994214|158251696|FG000|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
49113503|NCT00994214|158251697|FG001|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
49113504|NCT00994214|158251698|FG002|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
49113505|NCT00994214|158251699|FG003|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1|||
49113506|NCT00994214|158251696|FG000|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4|||
49113507|NCT00994214|158251697|FG001|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3|||
48799235|NCT01972529|157104108|FG002|Overall Study|Adverse Event|0|||
48799236|NCT01972529|157104109|FG003|Overall Study|Adverse Event|0|||
48799237|NCT01972529|157104106|FG000|Overall Study|Lost to Follow-up|1|||
48799238|NCT01972529|157104107|FG001|Overall Study|Lost to Follow-up|0|||
48799239|NCT01972529|157104108|FG002|Overall Study|Lost to Follow-up|0|||
48799240|NCT01972529|157104109|FG003|Overall Study|Lost to Follow-up|0|||
49008656|NCT01889862|157868369|FG001|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
49008657|NCT01889862|157868370|FG002|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
49113508|NCT00994214|158251698|FG002|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
49113509|NCT00994214|158251699|FG003|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
49113510|NCT00290693|158251705|FG000|Overall Study|Withdrawal by Subject|2|||
48799241|NCT01972529|157104106|FG000|Overall Study|Participant Choice|0|||
48799242|NCT01972529|157104107|FG001|Overall Study|Participant Choice|1|||
48799243|NCT01972529|157104108|FG002|Overall Study|Participant Choice|0|||
48799244|NCT01972529|157104109|FG003|Overall Study|Participant Choice|0|||
48799245|NCT01972529|157104106|FG000|Overall Study|Withdrawl of Consent|1|||
48799246|NCT01972529|157104107|FG001|Overall Study|Withdrawl of Consent|2|||
48799247|NCT01972529|157104108|FG002|Overall Study|Withdrawl of Consent|0|||
48799248|NCT01972529|157104109|FG003|Overall Study|Withdrawl of Consent|1|||
48799249|NCT01972529|157104106|FG000|Overall Study|Other|0|||
48799250|NCT01972529|157104107|FG001|Overall Study|Other|0|||
48799251|NCT01972529|157104108|FG002|Overall Study|Other|0|||
48799252|NCT01972529|157104109|FG003|Overall Study|Other|2|||
48799253|NCT01972529|157104106|FG000|Overall Study|Not treated|0|||
48799254|NCT01972529|157104107|FG001|Overall Study|Not treated|1|||
48799255|NCT01972529|157104108|FG002|Overall Study|Not treated|2|||
48799256|NCT01972529|157104109|FG003|Overall Study|Not treated|1|||
48799257|NCT01896869|157104111|FG000|Overall Study|Withdrawal by Subject|0|||
48799258|NCT01896869|157104112|FG001|Overall Study|Withdrawal by Subject|6|||
48799259|NCT01896869|157104111|FG000|Overall Study|Lost to Follow-up|1|||
48799260|NCT01896869|157104112|FG001|Overall Study|Lost to Follow-up|0|||
48799261|NCT00077064|157104113|FG000|Overall Study|Adverse Event|0|||
48799262|NCT00077064|157104114|FG001|Overall Study|Adverse Event|4|||
48799263|NCT00077064|157104113|FG000|Overall Study|Patient refusal|0|||
48799264|NCT00077064|157104114|FG001|Overall Study|Patient refusal|2|||
48799265|NCT00118716|157104122|FG000|Overall Study|Adverse Event|2|||
48799266|NCT00118716|157104123|FG001|Overall Study|Adverse Event|7|||
48799267|NCT00118716|157104122|FG000|Overall Study|Protocol Violation|5|||
48799268|NCT00118716|157104123|FG001|Overall Study|Protocol Violation|4|||
48799269|NCT00118716|157104122|FG000|Overall Study|Withdrawal by Subject|0|||
48799270|NCT00118716|157104123|FG001|Overall Study|Withdrawal by Subject|1|||
48799271|NCT00118716|157104122|FG000|Overall Study|Exacerbation|2|||
48799272|NCT00118716|157104123|FG001|Overall Study|Exacerbation|2|||
48799273|NCT00118716|157104122|FG000|Overall Study|Discontinued by sponsor|1|||
48799274|NCT00118716|157104123|FG001|Overall Study|Discontinued by sponsor|1|||
48799275|NCT00118716|157104122|FG000|Overall Study|Non-compliance|1|||
48799276|NCT00118716|157104123|FG001|Overall Study|Non-compliance|3|||
48799277|NCT00118716|157104122|FG000|Overall Study|misrandomized|1|||
48799278|NCT00118716|157104123|FG001|Overall Study|misrandomized|1|||
48799279|NCT00118716|157104122|FG000|Overall Study|Expired drug use|1|||
48799280|NCT00118716|157104123|FG001|Overall Study|Expired drug use|2|||
48799281|NCT00118716|157104122|FG000|Overall Study|Investigator discretion|0|||
48799282|NCT00118716|157104123|FG001|Overall Study|Investigator discretion|1|||
48799283|NCT02230956|157104124|FG000|Overall Study|Adverse Event|1|||
48799284|NCT02230956|157104125|FG001|Overall Study|Adverse Event|1|||
48799285|NCT02230956|157104126|FG002|Overall Study|Adverse Event|0|||
48799286|NCT02230956|157104124|FG000|Overall Study|Lack of Efficacy|1|||
48799287|NCT02230956|157104125|FG001|Overall Study|Lack of Efficacy|1|||
48799288|NCT02230956|157104126|FG002|Overall Study|Lack of Efficacy|1|||
48799289|NCT02230956|157104124|FG000|Overall Study|Lost to Follow-up|1|||
48799290|NCT02230956|157104125|FG001|Overall Study|Lost to Follow-up|1|||
48799291|NCT02230956|157104126|FG002|Overall Study|Lost to Follow-up|2|||
48799292|NCT02230956|157104124|FG000|Overall Study|Personal Reasons|2|||
48799293|NCT02230956|157104125|FG001|Overall Study|Personal Reasons|1|||
48799294|NCT02230956|157104126|FG002|Overall Study|Personal Reasons|1|||
48799295|NCT02230956|157104124|FG000|Overall Study|Protocol Violation|0|||
48799296|NCT02230956|157104125|FG001|Overall Study|Protocol Violation|1|||
48799297|NCT02230956|157104126|FG002|Overall Study|Protocol Violation|1|||
48799298|NCT02230956|157104124|FG000|Overall Study|Other Miscellaneous Reason|0|||
48799299|NCT02230956|157104125|FG001|Overall Study|Other Miscellaneous Reason|1|||
48799300|NCT02230956|157104126|FG002|Overall Study|Other Miscellaneous Reason|2|||
48799301|NCT00621543|157104128|FG000|Overall Study|Lost to Follow-up|23|||
48799302|NCT00763958|157104129|FG000|Overall Study|did not meet final criteria|4|||
48799303|NCT00763958|157104130|FG001|Overall Study|did not meet final criteria|4|||
48799304|NCT00763958|157104129|FG000|Overall Study|Lost to Follow-up|10|||
48799305|NCT00763958|157104130|FG001|Overall Study|Lost to Follow-up|2|||
48799306|NCT00763958|157104129|FG000|Overall Study|Believed they were receiving placebo|0|||
48799307|NCT00763958|157104130|FG001|Overall Study|Believed they were receiving placebo|5|||
48799308|NCT02709005|157104131|FG000|Overall Study|Lost to Follow-up|1|||
48799309|NCT02709005|157104132|FG001|Overall Study|Lost to Follow-up|1|||
48799310|NCT02709005|157104131|FG000|Overall Study|Withdrawal by Subject|3|||
48799311|NCT02709005|157104132|FG001|Overall Study|Withdrawal by Subject|0|||
48799312|NCT01428076|157104136|FG000|Overall Study|Adverse Event|0|||
48799313|NCT01428076|157104137|FG001|Overall Study|Adverse Event|1|||
48799314|NCT02216773|157104158|FG000|Overall Study|Disease progression|4|||
48799315|NCT02216773|157104159|FG001|Overall Study|Disease progression|2|||
48799316|NCT02216773|157104158|FG000|Overall Study|Insufficient FLRV|4|||
48799317|NCT02216773|157104159|FG001|Overall Study|Insufficient FLRV|0|||
48799318|NCT02216773|157104158|FG000|Overall Study|Abandoned|4|||
48903474|NCT02647320|157482420|FG000|Overall Study|Lost to Follow-up|1|||
48799319|NCT02216773|157104159|FG001|Overall Study|Abandoned|3|||
48799320|NCT03266770|157104160|FG000|Overall Study|Physician Decision|3|||
48799321|NCT03266770|157104160|FG000|Overall Study|Insufficient study supplies|1|||
48799322|NCT03266770|157104160|FG000|Overall Study|Adverse Event|1|||
48799323|NCT04274894|157104161|FG000|Overall Study|Adverse Event|7|||
48799324|NCT04274894|157104161|FG000|Overall Study|Withdrew consent|5|||
48799325|NCT04274894|157104161|FG000|Overall Study|Lost to Follow-up|9|||
48799326|NCT04274894|157104161|FG000|Overall Study|COVID-19 infection|1|||
48799327|NCT04274894|157104161|FG000|Overall Study|Other, not specified|20|||
48799328|NCT03649230|157104169|FG000|Overall Study|Adverse Event|12|||
48799329|NCT03649230|157104169|FG000|Overall Study|Death|8|||
48799330|NCT03649230|157104169|FG000|Overall Study|Withdrawal by Subject|6|||
48799331|NCT03649230|157104169|FG000|Overall Study|Physician Decision|5|||
48799332|NCT03649230|157104169|FG000|Overall Study|Disease progression|5|||
48799333|NCT03649230|157104169|FG000|Overall Study|Switched to non-HEC|5|||
48799334|NCT03649230|157104169|FG000|Overall Study|Chemotherapy discontinued|4|||
48799335|NCT03649230|157104169|FG000|Overall Study|Received only 3 HEC cycles|4|||
48799336|NCT03649230|157104169|FG000|Overall Study|Screen Failure|3|||
48799337|NCT03649230|157104169|FG000|Overall Study|Patient stopped treatment|2|||
48799338|NCT03649230|157104169|FG000|Overall Study|Protocol Violation|1|||
48799339|NCT03649230|157104169|FG000|Overall Study|Non-compliance|1|||
48799340|NCT03649230|157104169|FG000|Overall Study|Patient Received Cisplatin days 1-3 q 3 weeks|1|||
48799341|NCT03848403|157104170|FG000|Period 2 (Day 8)|Adverse Event|1|||
48799342|NCT03848403|157104171|FG001|Period 2 (Day 8)|Adverse Event|2|||
48799343|NCT03848403|157104172|FG002|Period 2 (Day 8)|Adverse Event|2|||
48799344|NCT03848403|157104170|FG000|Period 2 (Day 8)|Physician Decision|0|||
48799345|NCT03848403|157104171|FG001|Period 2 (Day 8)|Physician Decision|1|||
48799346|NCT03848403|157104172|FG002|Period 2 (Day 8)|Physician Decision|0|||
48799347|NCT03848403|157104170|FG000|Period 2 (Day 8)|Sponsor Decision|8|||
48799348|NCT03848403|157104171|FG001|Period 2 (Day 8)|Sponsor Decision|6|||
48799349|NCT03848403|157104172|FG002|Period 2 (Day 8)|Sponsor Decision|5|||
48799350|NCT03685591|157104173|FG000|Overall Study|Global Deterioration of Health Status|0|||
48799351|NCT03685591|157104174|FG001|Overall Study|Global Deterioration of Health Status|0|||
48799352|NCT03685591|157104175|FG002|Overall Study|Global Deterioration of Health Status|0|||
48799353|NCT03685591|157104176|FG003|Overall Study|Global Deterioration of Health Status|1|||
48799354|NCT03685591|157104177|FG004|Overall Study|Global Deterioration of Health Status|2|||
48799355|NCT03685591|157104178|FG005|Overall Study|Global Deterioration of Health Status|4|||
48799356|NCT03685591|157104179|FG006|Overall Study|Global Deterioration of Health Status|1|||
48799357|NCT03685591|157104180|FG007|Overall Study|Global Deterioration of Health Status|1|||
48799358|NCT03685591|157104181|FG008|Overall Study|Global Deterioration of Health Status|0|||
48903475|NCT02647320|157482421|FG001|Overall Study|Lost to Follow-up|1|||
48903476|NCT02647320|157482422|FG002|Overall Study|Lost to Follow-up|0|||
48903477|NCT02647320|157482423|FG003|Overall Study|Lost to Follow-up|0|||
48903478|NCT02647320|157482424|FG004|Overall Study|Lost to Follow-up|0|||
48903479|NCT02647320|157482420|FG000|Overall Study|Develop anemia|1|||
48903480|NCT02647320|157482421|FG001|Overall Study|Develop anemia|0|||
48903481|NCT02647320|157482422|FG002|Overall Study|Develop anemia|0|||
48903482|NCT02647320|157482423|FG003|Overall Study|Develop anemia|0|||
48903483|NCT02647320|157482424|FG004|Overall Study|Develop anemia|0|||
48903484|NCT02647320|157482420|FG000|Overall Study|Lack of Efficacy|0|||
48903485|NCT02647320|157482421|FG001|Overall Study|Lack of Efficacy|0|||
48903486|NCT02647320|157482422|FG002|Overall Study|Lack of Efficacy|0|||
48903487|NCT02647320|157482423|FG003|Overall Study|Lack of Efficacy|1|||
48903488|NCT02647320|157482424|FG004|Overall Study|Lack of Efficacy|0|||
48903489|NCT02647320|157482420|FG000|Overall Study|Disposition Missing Due to Fire at Site|2|||
48903490|NCT02647320|157482421|FG001|Overall Study|Disposition Missing Due to Fire at Site|3|||
48903491|NCT02647320|157482422|FG002|Overall Study|Disposition Missing Due to Fire at Site|4|||
48903492|NCT02647320|157482423|FG003|Overall Study|Disposition Missing Due to Fire at Site|3|||
48903493|NCT02647320|157482424|FG004|Overall Study|Disposition Missing Due to Fire at Site|4|||
48903494|NCT03057977|157482425|FG000|Discontinuation From Treatment|Withdrawal by Subject|124|||
48903495|NCT03057977|157482426|FG001|Discontinuation From Treatment|Withdrawal by Subject|92|||
48903496|NCT03057977|157482425|FG000|Discontinuation From Treatment|Lost to Follow-up|11|||
48903497|NCT03057977|157482426|FG001|Discontinuation From Treatment|Lost to Follow-up|17|||
48903498|NCT03057977|157482425|FG000|Discontinuation From Treatment|Protocol Violation|6|||
48903499|NCT03057977|157482426|FG001|Discontinuation From Treatment|Protocol Violation|5|||
48903500|NCT03057977|157482425|FG000|Discontinuation From Treatment|Not treated|4|||
48903501|NCT03057977|157482426|FG001|Discontinuation From Treatment|Not treated|0|||
48903502|NCT03057977|157482425|FG000|Discontinuation From Treatment|Adverse Event|343|||
48903503|NCT03057977|157482426|FG001|Discontinuation From Treatment|Adverse Event|337|||
48903504|NCT03057977|157482425|FG000|Discontinuation From Treatment|Reason Unknown|0|||
48903505|NCT03057977|157482426|FG001|Discontinuation From Treatment|Reason Unknown|1|||
48903506|NCT03057977|157482425|FG000|Discontinuation From Treatment|Personal Reasons|1|||
48903507|NCT03057977|157482426|FG001|Discontinuation From Treatment|Personal Reasons|1|||
48903508|NCT03057977|157482425|FG000|Discontinuation From Treatment|Unblinded medication|1|||
48903509|NCT03057977|157482426|FG001|Discontinuation From Treatment|Unblinded medication|0|||
48903510|NCT03057977|157482425|FG000|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
48903511|NCT03057977|157482426|FG001|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
48903512|NCT03057977|157482425|FG000|Discontinuation From Treatment|Principle Investigator Decision|2|||
48903513|NCT03057977|157482426|FG001|Discontinuation From Treatment|Principle Investigator Decision|0|||
48903514|NCT03057977|157482425|FG000|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2|||
48903515|NCT03057977|157482426|FG001|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4|||
48903516|NCT03057977|157482425|FG000|Discontinuation From Treatment|Patient moved away/being abroad|4|||
48903517|NCT03057977|157482426|FG001|Discontinuation From Treatment|Patient moved away/being abroad|3|||
48903518|NCT03057977|157482425|FG000|Discontinuation From Treatment|Unable to continue treatment|4|||
48903519|NCT03057977|157482426|FG001|Discontinuation From Treatment|Unable to continue treatment|1|||
48903520|NCT03057977|157482425|FG000|Discontinuation From Treatment|Not attending study visit|3|||
48903521|NCT03057977|157482426|FG001|Discontinuation From Treatment|Not attending study visit|10|||
48903522|NCT03057977|157482425|FG000|Discontinuation From Treatment|Due to Covid-19 Pandemic|1|||
48903523|NCT03057977|157482426|FG001|Discontinuation From Treatment|Due to Covid-19 Pandemic|4|||
48903524|NCT03057977|157482425|FG000|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8|||
48903525|NCT03057977|157482426|FG001|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6|||
48903526|NCT03057977|157482425|FG000|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
48903527|NCT03057977|157482426|FG001|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
48903528|NCT03057977|157482425|FG000|Discontinuation From Trial|Limited follow-up agreed|2|||
48903529|NCT03057977|157482426|FG001|Discontinuation From Trial|Limited follow-up agreed|2|||
48903530|NCT03057977|157482425|FG000|Discontinuation From Trial|Withdrawal by Subject|9|||
48903531|NCT03057977|157482426|FG001|Discontinuation From Trial|Withdrawal by Subject|11|||
49008658|NCT01889862|157868371|FG003|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
48903532|NCT01072877|157482428|FG000|Overall Study|Lost to Follow-up|1|||
48903533|NCT01072877|157482429|FG001|Overall Study|Lost to Follow-up|1|||
48903534|NCT01072877|157482430|FG002|Overall Study|Lost to Follow-up|0|||
48903535|NCT01072877|157482431|FG003|Overall Study|Lost to Follow-up|2|||
48903536|NCT01072877|157482432|FG004|Overall Study|Lost to Follow-up|0|||
48903537|NCT01786174|157482433|FG000|Overall Study|Discontinued Study Drug|2|||
48903538|NCT01786174|157482434|FG001|Overall Study|Discontinued Study Drug|0|||
48903539|NCT01929980|157482435|FG000|Overall Study|Physician Decision|1|||
48903540|NCT00995020|157482436|FG000|Overall Study|margin analysis not performed|2|||
48903541|NCT00995020|157482437|FG001|Overall Study|margin analysis not performed|5|||
48903542|NCT00995020|157482436|FG000|Overall Study|specimen fragmentation, thermal damage|1|||
48903543|NCT00995020|157482437|FG001|Overall Study|specimen fragmentation, thermal damage|2|||
48903544|NCT01765192|157482439|FG000|Treatment Period 1|Adverse Event|0|||
48903545|NCT01765192|157482440|FG001|Treatment Period 1|Adverse Event|1|||
48903546|NCT01765192|157482439|FG000|Washout Period|Voluntary Withdrawal|1|||
48903547|NCT01765192|157482440|FG001|Washout Period|Voluntary Withdrawal|1|||
48903548|NCT01765192|157482439|FG000|Washout Period|Reason not specified|1|||
48903549|NCT01765192|157482440|FG001|Washout Period|Reason not specified|0|||
48903550|NCT01765192|157482439|FG000|Treatment Period 2|Reason not specified|0|||
48903551|NCT01765192|157482440|FG001|Treatment Period 2|Reason not specified|2|||
48903552|NCT01765192|157482439|FG000|End of Treatment Period 2 to Final Visit|Adverse Event|0|||
48903553|NCT01765192|157482440|FG001|End of Treatment Period 2 to Final Visit|Adverse Event|1|||
48903554|NCT03645057|157482441|FG000|Randomization to Baseline|Lost to Follow-up|1|||
48903555|NCT03645057|157482442|FG001|Randomization to Baseline|Lost to Follow-up|0|||
48903556|NCT03645057|157482443|FG002|Randomization to Baseline|Lost to Follow-up|1|||
48903557|NCT03645057|157482444|FG003|Randomization to Baseline|Lost to Follow-up|0|||
48903558|NCT03645057|157482441|FG000|Baseline to Six Weeks|Withdrawal by Subject|1|||
48903559|NCT03645057|157482442|FG001|Baseline to Six Weeks|Withdrawal by Subject|0|||
48903560|NCT03645057|157482443|FG002|Baseline to Six Weeks|Withdrawal by Subject|1|||
48903561|NCT03645057|157482444|FG003|Baseline to Six Weeks|Withdrawal by Subject|0|||
48903562|NCT03645057|157482441|FG000|Baseline to Six Weeks|Lost to Follow-up|5|||
48903563|NCT03645057|157482442|FG001|Baseline to Six Weeks|Lost to Follow-up|2|||
48903564|NCT03645057|157482443|FG002|Baseline to Six Weeks|Lost to Follow-up|5|||
48903565|NCT03645057|157482444|FG003|Baseline to Six Weeks|Lost to Follow-up|2|||
48903566|NCT03645057|157482441|FG000|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
48903567|NCT03645057|157482442|FG001|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
48903568|NCT03645057|157482443|FG002|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
48903569|NCT03645057|157482444|FG003|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
48903570|NCT01206777|157482445|FG000|Overall Study|Death|1|||
48903571|NCT01206777|157482445|FG000|Overall Study|Adverse Event|1|||
48903572|NCT00876694|157482446|FG000|Overall Study|Adverse Event|10|||
48903573|NCT00876694|157482447|FG001|Overall Study|Adverse Event|7|||
48903574|NCT00876694|157482446|FG000|Overall Study|Subject withdrew consent|6|||
48903575|NCT00876694|157482447|FG001|Overall Study|Subject withdrew consent|4|||
48903576|NCT00876694|157482446|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
48903577|NCT00876694|157482447|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
48903578|NCT00876694|157482446|FG000|Overall Study|Abnormal test procedure result(s)|1|||
49008659|NCT01889862|157868372|FG004|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
48903579|NCT00876694|157482447|FG001|Overall Study|Abnormal test procedure result(s)|0|||
48903580|NCT00876694|157482446|FG000|Overall Study|Administrative problems|1|||
48903581|NCT00876694|157482447|FG001|Overall Study|Administrative problems|1|||
48903582|NCT00876694|157482446|FG000|Overall Study|Death|1|||
48903583|NCT00876694|157482447|FG001|Overall Study|Death|0|||
48903584|NCT00288509|157482448|FG000|Treatment Cycle 1|Adverse Event|1|||
48903585|NCT00288509|157482448|FG000|Treatment Cycle 1|Lack of Efficacy|1|||
48903586|NCT00288509|157482448|FG000|Treatment Cycle 1|Withdrawal by Subject|1|||
48903587|NCT00288509|157482448|FG000|Treatment Cycle 1|Lost to Follow-up|2|||
48903588|NCT00288509|157482448|FG000|Treatment Cycle 1|Treatment stopped according to protocol|1|||
48903589|NCT00288509|157482448|FG000|Treatment Cycle 2|Lack of Efficacy|1|||
48903590|NCT00288509|157482448|FG000|Treatment Cycle 2|Withdrawal by Subject|2|||
48903591|NCT00288509|157482448|FG000|Treatment Cycle 3|Lack of Efficacy|1|||
48903592|NCT00288509|157482448|FG000|Treatment Cycle 3|Withdrawal by Subject|1|||
48903593|NCT00288509|157482448|FG000|Treatment Cycle 3|Lost to Follow-up|2|||
48903594|NCT00288509|157482448|FG000|Treatment Cycle 3|Treatment stopped according to protocol|1|||
48903595|NCT00288509|157482448|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
48903596|NCT00288509|157482448|FG000|Treatment Cycle 4|Physician Decision|4|||
48903597|NCT00288509|157482448|FG000|Treatment Cycle 4|Treatment stopped according to protocol|1|||
48903598|NCT00730171|157482454|FG000|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5|||
48903599|NCT00730171|157482454|FG000|Overall Study|Adverse Event|193|||
48903600|NCT00730171|157482454|FG000|Overall Study|Protocol Violation|48|||
48903601|NCT00730171|157482454|FG000|Overall Study|Withdrawal by Subject|202|||
48903602|NCT00730171|157482454|FG000|Overall Study|Lost to Follow-up|121|||
48903603|NCT00730171|157482454|FG000|Overall Study|Insufficient Therapeutic Response|141|||
48903604|NCT00730171|157482454|FG000|Overall Study|Other|61|||
48903605|NCT01215422|157482455|FG000|Overall Study|Relocation|1|||
48903606|NCT01215422|157482456|FG001|Overall Study|Relocation|0|||
48903607|NCT01215422|157482457|FG002|Overall Study|Relocation|0|||
48903608|NCT01215422|157482458|FG003|Overall Study|Relocation|0|||
48903609|NCT01215422|157482455|FG000|Overall Study|Failed intubations|0|||
48903610|NCT01215422|157482456|FG001|Overall Study|Failed intubations|0|||
48903611|NCT01215422|157482457|FG002|Overall Study|Failed intubations|3|||
48903612|NCT01215422|157482458|FG003|Overall Study|Failed intubations|8|||
48903613|NCT01215422|157482455|FG000|Overall Study|Did not complete all intubations|7|||
48903614|NCT01215422|157482456|FG001|Overall Study|Did not complete all intubations|0|||
48903615|NCT01215422|157482457|FG002|Overall Study|Did not complete all intubations|0|||
48903616|NCT01215422|157482458|FG003|Overall Study|Did not complete all intubations|0|||
48903617|NCT00294554|157482459|FG000|Overall Study|Lack of Efficacy|0|||
48903618|NCT00294554|157482460|FG001|Overall Study|Lack of Efficacy|1|||
48903619|NCT00294554|157482459|FG000|Overall Study|Physician Decision|0|||
48903620|NCT00294554|157482460|FG001|Overall Study|Physician Decision|1|||
48903621|NCT02170389|157482463|FG000|Overall Study|Study terminated prior to start of treat|1|||
48903622|NCT02824263|157482464|FG000|Washout (1 to 4 Weeks)|Withdrawal by Subject|2|||
48903623|NCT02824263|157482465|FG001|Washout (1 to 4 Weeks)|Withdrawal by Subject|6|||
48903624|NCT02824263|157482464|FG000|Second Intervention (1 Night)|Withdrawal by Subject|4|||
48903625|NCT02824263|157482465|FG001|Second Intervention (1 Night)|Withdrawal by Subject|3|||
48903626|NCT01313637|157482466|FG000|Overall Study|Adverse Event|17|||
48903627|NCT01313637|157482467|FG001|Overall Study|Adverse Event|24|||
48903628|NCT01313637|157482468|FG002|Overall Study|Adverse Event|25|||
48903629|NCT01313637|157482469|FG003|Overall Study|Adverse Event|18|||
48903630|NCT01313637|157482466|FG000|Overall Study|Lack of Efficacy|44|||
48903631|NCT01313637|157482467|FG001|Overall Study|Lack of Efficacy|38|||
48903632|NCT01313637|157482468|FG002|Overall Study|Lack of Efficacy|37|||
48903633|NCT01313637|157482469|FG003|Overall Study|Lack of Efficacy|24|||
48903634|NCT01313637|157482466|FG000|Overall Study|Protocol Violation|4|||
48903635|NCT01313637|157482467|FG001|Overall Study|Protocol Violation|3|||
48903636|NCT01313637|157482468|FG002|Overall Study|Protocol Violation|11|||
48903637|NCT01313637|157482469|FG003|Overall Study|Protocol Violation|5|||
48903638|NCT01313637|157482466|FG000|Overall Study|Met Protocol- Defined Stopping Criteria|16|||
48903639|NCT01313637|157482467|FG001|Overall Study|Met Protocol- Defined Stopping Criteria|15|||
48903640|NCT01313637|157482468|FG002|Overall Study|Met Protocol- Defined Stopping Criteria|14|||
48903641|NCT01313637|157482469|FG003|Overall Study|Met Protocol- Defined Stopping Criteria|13|||
48903642|NCT01313637|157482466|FG000|Overall Study|Lost to Follow-up|0|||
48903643|NCT01313637|157482467|FG001|Overall Study|Lost to Follow-up|2|||
48903644|NCT01313637|157482468|FG002|Overall Study|Lost to Follow-up|1|||
48903645|NCT01313637|157482469|FG003|Overall Study|Lost to Follow-up|3|||
48903646|NCT01313637|157482466|FG000|Overall Study|Withdrawal by Subject|11|||
48903647|NCT01313637|157482467|FG001|Overall Study|Withdrawal by Subject|13|||
48903648|NCT01313637|157482468|FG002|Overall Study|Withdrawal by Subject|18|||
48903649|NCT01313637|157482469|FG003|Overall Study|Withdrawal by Subject|15|||
48903650|NCT03421431|157482474|FG000|Overall Study|Adverse Event|2|||
48903651|NCT03421431|157482475|FG001|Overall Study|Adverse Event|1|||
48903652|NCT03421431|157482476|FG002|Overall Study|Adverse Event|12|||
48903653|NCT03421431|157482474|FG000|Overall Study|Lost to Follow-up|1|||
48903654|NCT03421431|157482475|FG001|Overall Study|Lost to Follow-up|1|||
48903655|NCT03421431|157482476|FG002|Overall Study|Lost to Follow-up|1|||
48903656|NCT03421431|157482474|FG000|Overall Study|Withdrawal by Subject|3|||
48903657|NCT03421431|157482475|FG001|Overall Study|Withdrawal by Subject|2|||
48903658|NCT03421431|157482476|FG002|Overall Study|Withdrawal by Subject|1|||
48903659|NCT03421431|157482474|FG000|Overall Study|Protocol Violation|0|||
48903660|NCT03421431|157482475|FG001|Overall Study|Protocol Violation|1|||
48903661|NCT03421431|157482476|FG002|Overall Study|Protocol Violation|0|||
48903662|NCT03421431|157482474|FG000|Overall Study|Participant met Stopping Rules|0|||
48903663|NCT03421431|157482475|FG001|Overall Study|Participant met Stopping Rules|1|||
48903664|NCT03421431|157482476|FG002|Overall Study|Participant met Stopping Rules|0|||
48903665|NCT02604433|157482477|FG000|Overall Study|Withdrawal by Subject|37|||
48903666|NCT02604433|157482478|FG001|Overall Study|Withdrawal by Subject|16|||
48903667|NCT02604433|157482477|FG000|Overall Study|Adverse Event|4|||
48903668|NCT02604433|157482478|FG001|Overall Study|Adverse Event|0|||
48903669|NCT02604433|157482477|FG000|Overall Study|Other reasons|3|||
48903670|NCT02604433|157482478|FG001|Overall Study|Other reasons|5|||
48903671|NCT02604433|157482477|FG000|Overall Study|Death|4|||
48903672|NCT02604433|157482478|FG001|Overall Study|Death|1|||
48903673|NCT02604433|157482477|FG000|Overall Study|Transition to Rollover Protocol|169|||
48903674|NCT02604433|157482478|FG001|Overall Study|Transition to Rollover Protocol|82|||
48903675|NCT02604433|157482477|FG000|Overall Study|Physician Decision|1|||
48903676|NCT02604433|157482478|FG001|Overall Study|Physician Decision|1|||
48903677|NCT02604433|157482477|FG000|Overall Study|Lack of Efficacy|0|||
48903678|NCT02604433|157482478|FG001|Overall Study|Lack of Efficacy|1|||
48903679|NCT04508023|157482487|FG000|Overall Study|Withdrawal by Subject|1|||
48903680|NCT04508023|157482488|FG001|Overall Study|Withdrawal by Subject|2|||
48903681|NCT00796120|157482492|FG000|Overall Study|Death|3|||
48903682|NCT00796120|157482493|FG001|Overall Study|Death|0|||
48903683|NCT00796120|157482492|FG000|Overall Study|Adverse Event|11|||
48903684|NCT00796120|157482493|FG001|Overall Study|Adverse Event|6|||
48903685|NCT00796120|157482492|FG000|Overall Study|Progressive disease|22|||
48903686|NCT00796120|157482493|FG001|Overall Study|Progressive disease|13|||
48903687|NCT00796120|157482492|FG000|Overall Study|Participant refusal|3|||
48903688|NCT00796120|157482493|FG001|Overall Study|Participant refusal|4|||
48903689|NCT00796120|157482492|FG000|Overall Study|Other|6|||
48903690|NCT00796120|157482493|FG001|Overall Study|Other|17|||
48903691|NCT00796120|157482492|FG000|Overall Study|Physician Decision|16|||
48903692|NCT00796120|157482493|FG001|Overall Study|Physician Decision|17|||
48903693|NCT00796120|157482492|FG000|Overall Study|Randomized but not treated|0|||
48903694|NCT00796120|157482493|FG001|Overall Study|Randomized but not treated|3|||
48903695|NCT04526197|157482497|FG000|Period 1|Adverse Event|0|||
48903696|NCT04526197|157482498|FG001|Period 1|Adverse Event|1|||
48903697|NCT04526197|157482497|FG000|Period 1|Withdrawal by Subject|1|||
48903698|NCT04526197|157482498|FG001|Period 1|Withdrawal by Subject|0|||
48903699|NCT04526197|157482497|FG000|Period 2|Adverse Event|0|||
48903700|NCT04526197|157482498|FG001|Period 2|Adverse Event|1|||
48903701|NCT04526197|157482497|FG000|Period 2|Withdrawal by Subject|0|||
48903702|NCT04526197|157482498|FG001|Period 2|Withdrawal by Subject|1|||
48903703|NCT00838929|157482499|FG000|Overall Study|Protocol Violation|0|||
48903704|NCT00838929|157482500|FG001|Overall Study|Protocol Violation|1|||
48903705|NCT00838929|157482501|FG002|Overall Study|Protocol Violation|0|||
48903706|NCT00838929|157482499|FG000|Overall Study|Disease progression|0|||
48903707|NCT00838929|157482500|FG001|Overall Study|Disease progression|2|||
48903708|NCT00838929|157482501|FG002|Overall Study|Disease progression|1|||
48903709|NCT01231516|157482504|FG000|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|4|||
48903710|NCT01231516|157482505|FG001|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|11|||
48903711|NCT01231516|157482504|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|20|||
48903712|NCT01231516|157482505|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|42|||
48903713|NCT01231516|157482504|FG000|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|9|||
48903714|NCT01231516|157482505|FG001|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|6|||
48903715|NCT01231516|157482504|FG000|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|5|||
48903716|NCT01231516|157482505|FG001|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|3|||
48903717|NCT01231516|157482504|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|5|||
48903718|NCT01231516|157482505|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|10|||
48903719|NCT01231516|157482504|FG000|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
48903720|NCT01231516|157482505|FG001|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
48903721|NCT01231516|157482504|FG000|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|11|||
48903722|NCT01231516|157482505|FG001|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|5|||
48903723|NCT01231516|157482504|FG000|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|3|||
48903724|NCT01231516|157482505|FG001|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|1|||
48903725|NCT01231516|157482504|FG000|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|3|||
48903726|NCT01231516|157482505|FG001|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|2|||
49008660|NCT01889862|157868368|FG000|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4|||
49008661|NCT01889862|157868369|FG001|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
48799359|NCT03685591|157104173|FG000|Overall Study|Progressive Disease|1|||
48799360|NCT03685591|157104174|FG001|Overall Study|Progressive Disease|1|||
48799361|NCT03685591|157104175|FG002|Overall Study|Progressive Disease|0|||
48799362|NCT03685591|157104176|FG003|Overall Study|Progressive Disease|3|||
48799363|NCT03685591|157104177|FG004|Overall Study|Progressive Disease|5|||
48799364|NCT03685591|157104178|FG005|Overall Study|Progressive Disease|4|||
48799365|NCT03685591|157104179|FG006|Overall Study|Progressive Disease|3|||
48799366|NCT03685591|157104180|FG007|Overall Study|Progressive Disease|2|||
48799367|NCT03685591|157104181|FG008|Overall Study|Progressive Disease|1|||
48799368|NCT03685591|157104173|FG000|Overall Study|Other|0|||
48799369|NCT03685591|157104174|FG001|Overall Study|Other|0|||
48799370|NCT03685591|157104175|FG002|Overall Study|Other|1|||
48799371|NCT03685591|157104176|FG003|Overall Study|Other|0|||
48799372|NCT03685591|157104177|FG004|Overall Study|Other|2|||
48799373|NCT03685591|157104178|FG005|Overall Study|Other|3|||
48799374|NCT03685591|157104179|FG006|Overall Study|Other|0|||
48799375|NCT03685591|157104180|FG007|Overall Study|Other|0|||
48799376|NCT03685591|157104181|FG008|Overall Study|Other|0|||
48799377|NCT03685591|157104173|FG000|Overall Study|Withdrawal by Subject|0|||
48799378|NCT03685591|157104174|FG001|Overall Study|Withdrawal by Subject|0|||
48799379|NCT03685591|157104175|FG002|Overall Study|Withdrawal by Subject|0|||
48799380|NCT03685591|157104176|FG003|Overall Study|Withdrawal by Subject|0|||
48799381|NCT03685591|157104177|FG004|Overall Study|Withdrawal by Subject|3|||
48799382|NCT03685591|157104178|FG005|Overall Study|Withdrawal by Subject|2|||
48799383|NCT03685591|157104179|FG006|Overall Study|Withdrawal by Subject|0|||
48799384|NCT03685591|157104180|FG007|Overall Study|Withdrawal by Subject|0|||
48799385|NCT03685591|157104181|FG008|Overall Study|Withdrawal by Subject|1|||
48799386|NCT03685591|157104173|FG000|Overall Study|Adverse Event|0|||
48799387|NCT03685591|157104174|FG001|Overall Study|Adverse Event|0|||
48799388|NCT03685591|157104175|FG002|Overall Study|Adverse Event|0|||
48799389|NCT03685591|157104176|FG003|Overall Study|Adverse Event|1|||
48799390|NCT03685591|157104177|FG004|Overall Study|Adverse Event|1|||
48799391|NCT03685591|157104178|FG005|Overall Study|Adverse Event|4|||
48799392|NCT03685591|157104179|FG006|Overall Study|Adverse Event|0|||
48799393|NCT03685591|157104180|FG007|Overall Study|Adverse Event|1|||
48799394|NCT03685591|157104181|FG008|Overall Study|Adverse Event|1|||
48799395|NCT00490282|157104182|FG000|Overall Study|Withdrawal by Subject|3|||
48799396|NCT04510675|157104183|FG000|Overall Study|Withdrawal by Subject|5|||
48799397|NCT00734630|157104187|FG000|Overall Study|Lack of Efficacy|4|||
48799398|NCT00734630|157104188|FG001|Overall Study|Lack of Efficacy|4|||
48799399|NCT00734630|157104187|FG000|Overall Study|Withdrawal by Subject|7|||
48799400|NCT00734630|157104188|FG001|Overall Study|Withdrawal by Subject|9|||
48799401|NCT00734630|157104187|FG000|Overall Study|Lost to Follow-up|13|||
48799402|NCT00734630|157104188|FG001|Overall Study|Lost to Follow-up|7|||
48799403|NCT00734630|157104187|FG000|Overall Study|Protocol Violation|0|||
48799404|NCT00734630|157104188|FG001|Overall Study|Protocol Violation|3|||
48799405|NCT00734630|157104187|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
48799406|NCT00734630|157104188|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
48799407|NCT00734630|157104187|FG000|Overall Study|Adverse Event|3|||
48799408|NCT00734630|157104188|FG001|Overall Study|Adverse Event|6|||
48799409|NCT00734630|157104187|FG000|Overall Study|Randomized in Error|0|||
48799410|NCT00734630|157104188|FG001|Overall Study|Randomized in Error|1|||
48799411|NCT00734630|157104187|FG000|Overall Study|Tested Positive for Illegal Drug Use|1|||
48799412|NCT00734630|157104188|FG001|Overall Study|Tested Positive for Illegal Drug Use|1|||
48799413|NCT00734630|157104187|FG000|Overall Study|Poor Compliance|1|||
48799414|NCT00734630|157104188|FG001|Overall Study|Poor Compliance|1|||
48799415|NCT02034708|157104189|FG000|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2|||
48799416|NCT02034708|157104190|FG001|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5|||
48799417|NCT02034708|157104189|FG000|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1|||
48856258|NCT01480258|157312799|FG001|Infant Series|Not Vaccinated|0|||
48856259|NCT01480258|157312798|FG000|Infant Series|Adverse Event|1|||
48856260|NCT01480258|157312799|FG001|Infant Series|Adverse Event|1|||
48856261|NCT01480258|157312798|FG000|Infant Series|Withdrawal by Subject|1|||
48856262|NCT01480258|157312799|FG001|Infant Series|Withdrawal by Subject|6|||
48856263|NCT01480258|157312798|FG000|Interim Period|Lost to Follow-up|0|||
48856264|NCT01480258|157312799|FG001|Interim Period|Lost to Follow-up|2|||
48856265|NCT01480258|157312798|FG000|Interim Period|Physician Decision|1|||
48856266|NCT01480258|157312799|FG001|Interim Period|Physician Decision|0|||
48856267|NCT01480258|157312798|FG000|Interim Period|Protocol Violation|0|||
48856268|NCT01480258|157312799|FG001|Interim Period|Protocol Violation|1|||
48856269|NCT01480258|157312798|FG000|Interim Period|Withdrawal by Subject|9|||
48856270|NCT01480258|157312799|FG001|Interim Period|Withdrawal by Subject|6|||
48856271|NCT03746015|157312800|FG000|Overall Study|Withdrawal of Consent|1|||
48856272|NCT03746015|157312801|FG001|Overall Study|Withdrawal of Consent|0|||
48856273|NCT03746015|157312802|FG002|Overall Study|Withdrawal of Consent|0|||
48856274|NCT04803734|157312807|FG000|Overall Study|Withdrawal by Subject|0|||
48856275|NCT04803734|157312808|FG001|Overall Study|Withdrawal by Subject|1|||
48799418|NCT02034708|157104190|FG001|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0|||
48799419|NCT02034708|157104189|FG000|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
48799420|NCT02034708|157104190|FG001|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
48799421|NCT02034708|157104189|FG000|Wash-out (From 2 Days up to 14 Days)|other reason|3|||
48799422|NCT02034708|157104190|FG001|Wash-out (From 2 Days up to 14 Days)|other reason|2|||
48799423|NCT00733980|157104191|FG000|Overall Study|Adverse Event|5|||
48799424|NCT00733980|157104192|FG001|Overall Study|Adverse Event|2|||
48799425|NCT00733980|157104191|FG000|Overall Study|Lack of Efficacy|0|||
48799426|NCT00733980|157104192|FG001|Overall Study|Lack of Efficacy|1|||
48799427|NCT00733980|157104191|FG000|Overall Study|Protocol Violation|2|||
48799428|NCT00733980|157104192|FG001|Overall Study|Protocol Violation|1|||
48799429|NCT00733980|157104191|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
48799430|NCT00733980|157104192|FG001|Overall Study|Protocol defined stopping criteria reach|1|||
48799431|NCT00733980|157104191|FG000|Overall Study|Lost to Follow-up|6|||
48799432|NCT00733980|157104192|FG001|Overall Study|Lost to Follow-up|11|||
48799433|NCT00733980|157104191|FG000|Overall Study|Physician Decision|2|||
48799434|NCT00733980|157104192|FG001|Overall Study|Physician Decision|3|||
48799435|NCT00733980|157104191|FG000|Overall Study|Withdrawal by Subject|6|||
48799436|NCT00733980|157104192|FG001|Overall Study|Withdrawal by Subject|2|||
48799437|NCT00977665|157104195|FG000|Overall Study|Withdrawal by Subject|1|||
48799438|NCT00977665|157104196|FG001|Overall Study|Withdrawal by Subject|3|||
48799439|NCT00977665|157104195|FG000|Overall Study|Physician Decision|2|||
48799440|NCT00977665|157104196|FG001|Overall Study|Physician Decision|1|||
48799441|NCT00977665|157104195|FG000|Overall Study|Sponsor requested withdrawal|0|||
48799442|NCT00977665|157104196|FG001|Overall Study|Sponsor requested withdrawal|1|||
48799443|NCT00977665|157104195|FG000|Overall Study|Lost to Follow-up|1|||
48799444|NCT00977665|157104196|FG001|Overall Study|Lost to Follow-up|0|||
48799445|NCT00977665|157104195|FG000|Overall Study|Death|3|||
48799446|NCT00977665|157104196|FG001|Overall Study|Death|2|||
48799447|NCT00977665|157104195|FG000|Overall Study|Adverse Event|14|||
48799448|NCT00977665|157104196|FG001|Overall Study|Adverse Event|7|||
48799449|NCT00977665|157104195|FG000|Overall Study|Treatment failure|0|||
48799450|NCT00977665|157104196|FG001|Overall Study|Treatment failure|1|||
48799451|NCT00689026|157104197|FG000|Overall Study|Withdrawal by Subject|13|||
48799452|NCT00689026|157104198|FG001|Overall Study|Withdrawal by Subject|6|||
48799453|NCT01330433|157104199|FG000|Overall Study|Death|1|||
48799454|NCT01330433|157104200|FG001|Overall Study|Death|3|||
48799455|NCT01330433|157104199|FG000|Overall Study|Lost to Follow-up|1|||
48799456|NCT01330433|157104200|FG001|Overall Study|Lost to Follow-up|0|||
48799457|NCT01552954|157104201|FG000|Overall Study|Adverse Event|1|||
48799458|NCT01552954|157104202|FG001|Overall Study|Adverse Event|2|||
48799459|NCT01552954|157104201|FG000|Overall Study|Lost to Follow-up|1|||
48799460|NCT01552954|157104202|FG001|Overall Study|Lost to Follow-up|1|||
48799461|NCT01552954|157104201|FG000|Overall Study|Withdrawal by Subject|1|||
48799462|NCT01552954|157104202|FG001|Overall Study|Withdrawal by Subject|1|||
48799463|NCT01552954|157104201|FG000|Overall Study|Protocol Violation|1|||
48799464|NCT01552954|157104202|FG001|Overall Study|Protocol Violation|2|||
48799465|NCT01552954|157104201|FG000|Overall Study|diagnosed DM|1|||
48799466|NCT01552954|157104202|FG001|Overall Study|diagnosed DM|0|||
48799467|NCT04843930|157104203|FG000|Randomization|Withdrawal by Subject|6|||
48903727|NCT01231516|157482504|FG000|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|5|||
48903728|NCT01231516|157482505|FG001|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|0|||
48903729|NCT01231516|157482504|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|27|||
49008662|NCT01889862|157868370|FG002|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
49113511|NCT02907619|158251710|FG000|Overall Study|Study terminated by sponsor|18|||
48903730|NCT01231516|157482505|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|11|||
48903731|NCT01231516|157482504|FG000|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|10|||
48903732|NCT01231516|157482505|FG001|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|0|||
48903733|NCT01231516|157482504|FG000|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|6|||
48903734|NCT01231516|157482505|FG001|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|3|||
48903735|NCT01231516|157482504|FG000|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|2|||
48903736|NCT01231516|157482505|FG001|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|0|||
48903737|NCT01231516|157482504|FG000|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|6|||
48903738|NCT01231516|157482505|FG001|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|1|||
48903739|NCT01231516|157482504|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|12|||
48903740|NCT01231516|157482505|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|2|||
48903741|NCT02225353|157482512|FG000|Overall Study|Lost to Follow-up|0|||
48799468|NCT04843930|157104204|FG001|Randomization|Withdrawal by Subject|6|||
48799469|NCT04843930|157104205|FG002|Randomization|Withdrawal by Subject|0|||
48799470|NCT04843930|157104206|FG003|Randomization|Withdrawal by Subject|0|||
48799471|NCT04843930|157104203|FG000|Week 6 Assessment|Adverse Event|3|||
48799472|NCT04843930|157104204|FG001|Week 6 Assessment|Adverse Event|0|||
48799473|NCT04843930|157104205|FG002|Week 6 Assessment|Adverse Event|0|||
48903742|NCT02225353|157482513|FG001|Overall Study|Lost to Follow-up|1|||
48903743|NCT02225353|157482514|FG002|Overall Study|Lost to Follow-up|3|||
48903744|NCT02225353|157482512|FG000|Overall Study|Protocol Violation|4|||
48903745|NCT02225353|157482513|FG001|Overall Study|Protocol Violation|5|||
48903746|NCT02225353|157482514|FG002|Overall Study|Protocol Violation|12|||
48903747|NCT01395316|157482515|FG000|Overall Study|Lost to Follow-up|2|||
48903748|NCT01395316|157482515|FG000|Overall Study|poor MRI quality|1|||
48903749|NCT02374021|157482517|FG000|Overall Study|Adverse Event|1|||
48903750|NCT02374021|157482518|FG001|Overall Study|Adverse Event|0|||
48903751|NCT02374021|157482517|FG000|Overall Study|Lost to Follow-up|3|||
48903752|NCT02374021|157482518|FG001|Overall Study|Lost to Follow-up|2|||
48903753|NCT02374021|157482517|FG000|Overall Study|Physician Decision|0|||
48903754|NCT02374021|157482518|FG001|Overall Study|Physician Decision|3|||
48903755|NCT02374021|157482517|FG000|Overall Study|Withdrawal by Subject|6|||
48903756|NCT02374021|157482518|FG001|Overall Study|Withdrawal by Subject|5|||
48903757|NCT02374021|157482517|FG000|Overall Study|Poor Adherence|0|||
48903758|NCT02374021|157482518|FG001|Overall Study|Poor Adherence|1|||
48903759|NCT02374021|157482517|FG000|Overall Study|Scan protocol not followed|0|||
48903760|NCT02374021|157482518|FG001|Overall Study|Scan protocol not followed|1|||
48903761|NCT02374021|157482517|FG000|Overall Study|Poor quality scan/scan not able to be analyzed|13|||
48903762|NCT02374021|157482518|FG001|Overall Study|Poor quality scan/scan not able to be analyzed|9|||
48903763|NCT01295281|157482519|FG000|First Intervention (7 Days)|Death|0|||
48903764|NCT01295281|157482520|FG001|First Intervention (7 Days)|Death|1|||
48903765|NCT00954421|157482521|FG000|Screening|screen failures|3|||
48903766|NCT00954421|157482521|FG000|6 Months of DBS|Withdrawal by Subject|1|||
48903767|NCT00954421|157482521|FG000|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1|||
48903768|NCT01298518|157482522|FG000|Overall Study|Withdrawal by Subject|0|||
48903769|NCT01298518|157482523|FG001|Overall Study|Withdrawal by Subject|0|||
48903770|NCT01298518|157482524|FG002|Overall Study|Withdrawal by Subject|1|||
48903771|NCT03610165|157482525|FG000|Overall Study|Device didn't work|0|||
48903772|NCT03610165|157482526|FG001|Overall Study|Device didn't work|1|||
48903773|NCT04484831|157482533|FG000|Overall Study|Withdrawal by Subject|1|||
48903774|NCT04484831|157482534|FG001|Overall Study|Withdrawal by Subject|0|||
48903775|NCT04751656|157484163|FG000|Overall Study|Lost to Follow-up|1|||
48903776|NCT01340196|157484164|FG000|Treat. Period 3 (Faldaprevir)|Adverse Event|2|||
48903777|NCT02141984|157484166|FG000|Overall Study|Lack of Efficacy|2|||
48903778|NCT01177722|157484167|FG000|Overall Study|Serious Adverse Event|0|||
48903779|NCT01177722|157484168|FG001|Overall Study|Serious Adverse Event|0|||
48903780|NCT01177722|157484169|FG002|Overall Study|Serious Adverse Event|1|||
48903781|NCT01177722|157484170|FG003|Overall Study|Serious Adverse Event|0|||
48903782|NCT01177722|157484167|FG000|Overall Study|Protocol Violation|0|||
48903783|NCT01177722|157484168|FG001|Overall Study|Protocol Violation|0|||
48903784|NCT01177722|157484169|FG002|Overall Study|Protocol Violation|1|||
48903785|NCT01177722|157484170|FG003|Overall Study|Protocol Violation|0|||
48903786|NCT01177722|157484167|FG000|Overall Study|Lost to Follow-up|3|||
48903787|NCT01177722|157484168|FG001|Overall Study|Lost to Follow-up|4|||
48903788|NCT01177722|157484169|FG002|Overall Study|Lost to Follow-up|3|||
48903789|NCT01177722|157484170|FG003|Overall Study|Lost to Follow-up|1|||
48903790|NCT01177722|157484167|FG000|Overall Study|Withdrawal by Subject|10|||
49008663|NCT01889862|157868371|FG003|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
49008664|NCT01889862|157868372|FG004|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
49008665|NCT01889862|157868368|FG000|Part 1 (Up to 13 Weeks)|Physician Decision|2|||
49008666|NCT01889862|157868369|FG001|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
49008667|NCT01889862|157868370|FG002|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
49008668|NCT01889862|157868371|FG003|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
49008669|NCT01889862|157868372|FG004|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
49008670|NCT01889862|157868368|FG000|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
49008671|NCT01889862|157868369|FG001|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
49008672|NCT01889862|157868370|FG002|Part 2 (8 Weeks)|Withdrawal by Subject|1|||
49008673|NCT01889862|157868371|FG003|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
49008674|NCT01889862|157868372|FG004|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
49008675|NCT01889862|157868368|FG000|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
49008676|NCT01889862|157868369|FG001|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
49008677|NCT01889862|157868370|FG002|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
49008678|NCT01889862|157868371|FG003|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
49008679|NCT01889862|157868372|FG004|Part 4 (Up to 274 Weeks)|Adverse Event|5|||
49008680|NCT01889862|157868368|FG000|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
49008681|NCT01889862|157868369|FG001|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
49008682|NCT01889862|157868370|FG002|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
48903791|NCT01177722|157484168|FG001|Overall Study|Withdrawal by Subject|6|||
48903792|NCT01177722|157484169|FG002|Overall Study|Withdrawal by Subject|4|||
48903793|NCT01177722|157484170|FG003|Overall Study|Withdrawal by Subject|6|||
48903794|NCT00604279|157484171|FG000|Overall Study|Lack of Efficacy|22|||
48903795|NCT00604279|157484172|FG001|Overall Study|Lack of Efficacy|9|||
48903796|NCT00604279|157484171|FG000|Overall Study|Lost to Follow-up|9|||
48903797|NCT00604279|157484172|FG001|Overall Study|Lost to Follow-up|14|||
48903798|NCT00604279|157484171|FG000|Overall Study|Pregnancy|2|||
49008683|NCT01889862|157868371|FG003|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
49008684|NCT01889862|157868372|FG004|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14|||
49008685|NCT01889862|157868368|FG000|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
49008686|NCT01889862|157868369|FG001|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
49008687|NCT01889862|157868370|FG002|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
49008688|NCT01889862|157868371|FG003|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
49008689|NCT01889862|157868372|FG004|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4|||
49008690|NCT01889862|157868368|FG000|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
49008691|NCT01889862|157868369|FG001|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
49008692|NCT01889862|157868370|FG002|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
49008693|NCT01889862|157868371|FG003|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
49008694|NCT01889862|157868372|FG004|Part 4 (Up to 274 Weeks)|Physician Decision|5|||
49008695|NCT01889862|157868368|FG000|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
49008696|NCT01889862|157868369|FG001|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
49008697|NCT01889862|157868370|FG002|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
49008698|NCT01889862|157868371|FG003|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
49008699|NCT01889862|157868372|FG004|Part 4 (Up to 274 Weeks)|Protocol deviations|2|||
49008700|NCT01159769|157868373|FG000|Overall Study|Adverse Event|1|||
49008701|NCT01542736|157868374|FG000|Overall Study|Death|1|||
49008702|NCT00527397|157868375|FG000|Overall Study|Adverse Event|3|||
49008703|NCT00527397|157868375|FG000|Overall Study|Lack of Efficacy|1|||
49008704|NCT00527397|157868375|FG000|Overall Study|Protocol Violation|1|||
49008705|NCT00527397|157868375|FG000|Overall Study|Withdrawal by Subject|6|||
49008706|NCT00527397|157868375|FG000|Overall Study|Study terminated by sponsor|13|||
49008707|NCT00972153|157868376|FG000|Overall Study|Equipment malfunction during case|0|||
49008708|NCT00972153|157868377|FG001|Overall Study|Equipment malfunction during case|1|||
49008709|NCT00972153|157868378|FG002|Overall Study|Equipment malfunction during case|0|||
49008710|NCT00449930|157868379|FG000|Overall Study|Adverse Event|9|||
49008711|NCT00449930|157868380|FG001|Overall Study|Adverse Event|19|||
49008712|NCT00449930|157868379|FG000|Overall Study|Trial Terminated ( Site Closed)|1|||
49008713|NCT00449930|157868380|FG001|Overall Study|Trial Terminated ( Site Closed)|0|||
49008714|NCT00449930|157868379|FG000|Overall Study|Lack of Efficacy|10|||
49008715|NCT00449930|157868380|FG001|Overall Study|Lack of Efficacy|1|||
49008716|NCT00449930|157868379|FG000|Overall Study|Lost to Follow-up|9|||
49008717|NCT00449930|157868380|FG001|Overall Study|Lost to Follow-up|14|||
49008718|NCT00449930|157868379|FG000|Overall Study|Physician Decision|1|||
49008719|NCT00449930|157868380|FG001|Overall Study|Physician Decision|2|||
49008720|NCT00449930|157868379|FG000|Overall Study|Protocol Violation|14|||
49008721|NCT00449930|157868380|FG001|Overall Study|Protocol Violation|15|||
49008722|NCT00449930|157868379|FG000|Overall Study|Withdrawal by Subject|16|||
49008723|NCT00449930|157868380|FG001|Overall Study|Withdrawal by Subject|23|||
49008724|NCT00449930|157868379|FG000|Overall Study|Glycemic discontinuation criteria|1|||
49008725|NCT00449930|157868380|FG001|Overall Study|Glycemic discontinuation criteria|1|||
49008726|NCT00363129|157868381|FG000|Overall Study|Withdrawal by Subject|11|||
49008727|NCT00363129|157868382|FG001|Overall Study|Withdrawal by Subject|18|||
49008728|NCT00363129|157868381|FG000|Overall Study|Adverse Event|8|||
49008729|NCT00363129|157868382|FG001|Overall Study|Adverse Event|3|||
49008730|NCT00363129|157868381|FG000|Overall Study|Alternate Treatment|2|||
49008731|NCT00363129|157868382|FG001|Overall Study|Alternate Treatment|4|||
49008732|NCT00363129|157868381|FG000|Overall Study|Other Medical Problems|2|||
49008733|NCT00363129|157868382|FG001|Overall Study|Other Medical Problems|4|||
49008734|NCT00363129|157868381|FG000|Overall Study|Death|0|||
49008735|NCT00363129|157868382|FG001|Overall Study|Death|1|||
49008736|NCT00363129|157868381|FG000|Overall Study|Other Reasons|6|||
49008737|NCT00363129|157868382|FG001|Overall Study|Other Reasons|3|||
49008738|NCT01201356|157868383|FG000|Overall Study|Adverse Event|170|||
49008739|NCT01201356|157868383|FG000|Overall Study|Abnormal laboratory value(s)|51|||
49008740|NCT01201356|157868383|FG000|Overall Study|Abnormal test procedure result(s)|3|||
49008741|NCT01201356|157868383|FG000|Overall Study|Unsatisfactory therapeutic effect|112|||
49008742|NCT01201356|157868383|FG000|Overall Study|Condition no longer requires study drug|12|||
49008743|NCT01201356|157868383|FG000|Overall Study|Withdrawal by Subject|144|||
49008744|NCT01201356|157868383|FG000|Overall Study|Lost to Follow-up|50|||
49008745|NCT01201356|157868383|FG000|Overall Study|administrative problems|74|||
49008746|NCT01201356|157868383|FG000|Overall Study|Death|16|||
49008747|NCT01201356|157868383|FG000|Overall Study|Protocol Violation|12|||
49008748|NCT00217971|157868384|FG000|Overall Study|Adverse Event|1|||
49008749|NCT00217971|157868385|FG001|Overall Study|Adverse Event|1|||
49008750|NCT00217971|157868384|FG000|Overall Study|Lost to Follow-up|15|||
49008751|NCT00217971|157868385|FG001|Overall Study|Lost to Follow-up|19|||
49008752|NCT00217971|157868384|FG000|Overall Study|Physician Decision|0|||
49008753|NCT00217971|157868385|FG001|Overall Study|Physician Decision|1|||
49008754|NCT00217971|157868384|FG000|Overall Study|Withdrawal by Subject|7|||
49008755|NCT00217971|157868385|FG001|Overall Study|Withdrawal by Subject|12|||
49008756|NCT00217971|157868384|FG000|Overall Study|non compliant|1|||
49008757|NCT00217971|157868385|FG001|Overall Study|non compliant|0|||
49008758|NCT01625286|157868386|FG000|Overall Study|Adverse Event|0|||
49008759|NCT01625286|157868387|FG001|Overall Study|Adverse Event|0|||
49008760|NCT01625286|157868388|FG002|Overall Study|Adverse Event|0|||
49008761|NCT01625286|157868389|FG003|Overall Study|Adverse Event|0|||
49008762|NCT01625286|157868390|FG004|Overall Study|Adverse Event|1|||
49008763|NCT01625286|157868391|FG005|Overall Study|Adverse Event|2|||
49008764|NCT01625286|157868392|FG006|Overall Study|Adverse Event|1|||
49008765|NCT01625286|157868386|FG000|Overall Study|Death|0|||
49008766|NCT01625286|157868387|FG001|Overall Study|Death|0|||
49008767|NCT01625286|157868388|FG002|Overall Study|Death|1|||
49008768|NCT01625286|157868389|FG003|Overall Study|Death|1|||
49008769|NCT01625286|157868390|FG004|Overall Study|Death|0|||
49008770|NCT01625286|157868391|FG005|Overall Study|Death|11|||
49008771|NCT01625286|157868392|FG006|Overall Study|Death|16|||
49008772|NCT01625286|157868386|FG000|Overall Study|Withdrawal by Subject|0|||
49008773|NCT01625286|157868387|FG001|Overall Study|Withdrawal by Subject|1|||
49008774|NCT01625286|157868388|FG002|Overall Study|Withdrawal by Subject|0|||
49008775|NCT01625286|157868389|FG003|Overall Study|Withdrawal by Subject|1|||
49008776|NCT01625286|157868390|FG004|Overall Study|Withdrawal by Subject|0|||
49008777|NCT01625286|157868391|FG005|Overall Study|Withdrawal by Subject|0|||
49008778|NCT01625286|157868392|FG006|Overall Study|Withdrawal by Subject|1|||
49008779|NCT01625286|157868386|FG000|Overall Study|Any reason not specifically recorded|0|||
49008780|NCT01625286|157868387|FG001|Overall Study|Any reason not specifically recorded|0|||
49008781|NCT01625286|157868388|FG002|Overall Study|Any reason not specifically recorded|0|||
49008782|NCT01625286|157868389|FG003|Overall Study|Any reason not specifically recorded|0|||
49008783|NCT01625286|157868390|FG004|Overall Study|Any reason not specifically recorded|0|||
49008784|NCT01625286|157868391|FG005|Overall Study|Any reason not specifically recorded|1|||
49008785|NCT01625286|157868392|FG006|Overall Study|Any reason not specifically recorded|0|||
49008786|NCT01625286|157868386|FG000|Overall Study|Progressive disease|6|||
49008787|NCT01625286|157868387|FG001|Overall Study|Progressive disease|3|||
49008788|NCT01625286|157868388|FG002|Overall Study|Progressive disease|4|||
49008789|NCT01625286|157868389|FG003|Overall Study|Progressive disease|5|||
49008790|NCT01625286|157868390|FG004|Overall Study|Progressive disease|5|||
49008791|NCT01625286|157868391|FG005|Overall Study|Progressive disease|0|||
49008792|NCT01625286|157868392|FG006|Overall Study|Progressive disease|0|||
49008793|NCT01625286|157868386|FG000|Overall Study|Lost to Follow-up|0|||
49008794|NCT01625286|157868387|FG001|Overall Study|Lost to Follow-up|0|||
49008795|NCT01625286|157868388|FG002|Overall Study|Lost to Follow-up|0|||
49008796|NCT01625286|157868389|FG003|Overall Study|Lost to Follow-up|0|||
49008797|NCT01625286|157868390|FG004|Overall Study|Lost to Follow-up|0|||
49008798|NCT01625286|157868391|FG005|Overall Study|Lost to Follow-up|0|||
49008799|NCT01625286|157868392|FG006|Overall Study|Lost to Follow-up|1|||
49008800|NCT04147611|157868393|FG000|Overall Study|Physician Decision|0|||
49008801|NCT04147611|157868394|FG001|Overall Study|Physician Decision|1|||
49008802|NCT00802529|157869751|FG000|Overall Study|Lost to Follow-up|0|||
49008803|NCT00802529|157869752|FG001|Overall Study|Lost to Follow-up|1|||
49008804|NCT01399125|157869760|FG000|Overall Study|Adverse Event|32|||
49008805|NCT01399125|157869761|FG001|Overall Study|Adverse Event|30|||
49008806|NCT01399125|157869760|FG000|Overall Study|Abnormal Lab values|0|||
49008807|NCT01399125|157869761|FG001|Overall Study|Abnormal Lab values|1|||
49008808|NCT01399125|157869760|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
49008809|NCT01399125|157869761|FG001|Overall Study|Unsatisfactory Therapeutic Effect|4|||
49008810|NCT01399125|157869760|FG000|Overall Study|Withdrawal by Subject|5|||
49008811|NCT01399125|157869761|FG001|Overall Study|Withdrawal by Subject|8|||
49008812|NCT01399125|157869760|FG000|Overall Study|Lost to Follow-up|2|||
49008813|NCT01399125|157869761|FG001|Overall Study|Lost to Follow-up|3|||
49008814|NCT01399125|157869760|FG000|Overall Study|Administrative Problems|7|||
49008815|NCT01399125|157869761|FG001|Overall Study|Administrative Problems|11|||
49008816|NCT01399125|157869760|FG000|Overall Study|Death|0|||
49008817|NCT01399125|157869761|FG001|Overall Study|Death|1|||
49008818|NCT01399125|157869760|FG000|Overall Study|Protocol Deviation|5|||
49008819|NCT01399125|157869761|FG001|Overall Study|Protocol Deviation|2|||
49008820|NCT01902134|157869762|FG000|Overall Study|Adverse Event|3|||
49008821|NCT01902134|157869763|FG001|Overall Study|Adverse Event|1|||
49008822|NCT01902134|157869764|FG002|Overall Study|Adverse Event|2|||
49008823|NCT01902134|157869765|FG003|Overall Study|Adverse Event|1|||
49008824|NCT01902134|157869766|FG004|Overall Study|Adverse Event|1|||
49008825|NCT01902134|157869767|FG005|Overall Study|Adverse Event|3|||
49008826|NCT01902134|157869762|FG000|Overall Study|Lack of Efficacy|0|||
48693192|NCT04479787|156726366|FG000|After 6 Months|Subject Had Back Surgery On March 1st|0|||
49008827|NCT01902134|157869763|FG001|Overall Study|Lack of Efficacy|0|||
49008828|NCT01902134|157869764|FG002|Overall Study|Lack of Efficacy|2|||
49008829|NCT01902134|157869765|FG003|Overall Study|Lack of Efficacy|0|||
49008830|NCT01902134|157869766|FG004|Overall Study|Lack of Efficacy|0|||
49008831|NCT01902134|157869767|FG005|Overall Study|Lack of Efficacy|1|||
49008832|NCT01902134|157869762|FG000|Overall Study|Physician Decision|0|||
49008833|NCT01902134|157869763|FG001|Overall Study|Physician Decision|1|||
49008834|NCT01902134|157869764|FG002|Overall Study|Physician Decision|0|||
49008835|NCT01902134|157869765|FG003|Overall Study|Physician Decision|0|||
49008836|NCT01902134|157869766|FG004|Overall Study|Physician Decision|0|||
49008837|NCT01902134|157869767|FG005|Overall Study|Physician Decision|0|||
49008838|NCT01902134|157869762|FG000|Overall Study|Protocol Violation|0|||
49008839|NCT01902134|157869763|FG001|Overall Study|Protocol Violation|0|||
49008840|NCT01902134|157869764|FG002|Overall Study|Protocol Violation|0|||
49008841|NCT01902134|157869765|FG003|Overall Study|Protocol Violation|0|||
49008842|NCT01902134|157869766|FG004|Overall Study|Protocol Violation|0|||
49008843|NCT01902134|157869767|FG005|Overall Study|Protocol Violation|1|||
49008844|NCT01902134|157869762|FG000|Overall Study|Withdrawal by Subject|4|||
49008845|NCT01902134|157869763|FG001|Overall Study|Withdrawal by Subject|8|||
49008846|NCT01902134|157869764|FG002|Overall Study|Withdrawal by Subject|9|||
49008847|NCT01902134|157869765|FG003|Overall Study|Withdrawal by Subject|1|||
49008848|NCT01902134|157869766|FG004|Overall Study|Withdrawal by Subject|5|||
49008849|NCT01902134|157869767|FG005|Overall Study|Withdrawal by Subject|4|||
49008850|NCT01902134|157869762|FG000|Overall Study|no compliance|1|||
49008851|NCT01902134|157869763|FG001|Overall Study|no compliance|0|||
49008852|NCT01902134|157869764|FG002|Overall Study|no compliance|0|||
49008853|NCT01902134|157869765|FG003|Overall Study|no compliance|0|||
49008854|NCT01902134|157869766|FG004|Overall Study|no compliance|0|||
49008855|NCT01902134|157869767|FG005|Overall Study|no compliance|0|||
49008856|NCT01902134|157869762|FG000|Overall Study|Other|0|||
49008857|NCT01902134|157869763|FG001|Overall Study|Other|1|||
49008858|NCT01902134|157869764|FG002|Overall Study|Other|2|||
49008859|NCT01902134|157869765|FG003|Overall Study|Other|0|||
49008860|NCT01902134|157869766|FG004|Overall Study|Other|1|||
49008861|NCT01902134|157869767|FG005|Overall Study|Other|0|||
49008862|NCT00305110|157869768|FG000|Overall Study|Missing data|29|||
49008863|NCT00420290|157869771|FG000|Overall Study|Adverse Event|3|||
49008864|NCT00420290|157869772|FG001|Overall Study|Adverse Event|1|||
49008865|NCT00420290|157869771|FG000|Overall Study|Withdrawal by Subject|0|||
49008866|NCT00420290|157869772|FG001|Overall Study|Withdrawal by Subject|2|||
49008867|NCT00420290|157869771|FG000|Overall Study|did not meet inclusion/exclusion|1|||
49008868|NCT00420290|157869772|FG001|Overall Study|did not meet inclusion/exclusion|1|||
49008869|NCT00678379|157869773|FG000|Overall Study|Injection performed after tonsillectomy|2|||
49008870|NCT00678379|157869774|FG001|Overall Study|Injection performed after tonsillectomy|0|||
49008871|NCT00678379|157869775|FG002|Overall Study|Injection performed after tonsillectomy|1|||
49008872|NCT00678379|157869773|FG000|Overall Study|Incomplete Data|4|||
49008873|NCT00678379|157869774|FG001|Overall Study|Incomplete Data|3|||
49008874|NCT00678379|157869775|FG002|Overall Study|Incomplete Data|3|||
49008875|NCT01467570|157869778|FG000|Overall Study|Lost to Follow-up|8|||
49008876|NCT01467570|157869779|FG001|Overall Study|Lost to Follow-up|9|||
49008877|NCT01835470|157869780|FG000|Long Term Treatment Period|Subject Request to Discontinue|1|||
49008878|NCT01835470|157869780|FG000|Long Term Treatment Period|Lack of Efficacy|3|||
49008879|NCT01120600|157869781|FG000|Overall Study|Adverse Event|7|||
49008880|NCT01120600|157869782|FG001|Overall Study|Adverse Event|7|||
49008881|NCT01120600|157869781|FG000|Overall Study|Excessive Bone Loss|0|||
49008882|NCT01120600|157869782|FG001|Overall Study|Excessive Bone Loss|4|||
49008883|NCT01120600|157869781|FG000|Overall Study|Lost to Follow-up|1|||
49008884|NCT01120600|157869782|FG001|Overall Study|Lost to Follow-up|3|||
49008885|NCT01120600|157869781|FG000|Overall Study|Physician Decision|1|||
49008886|NCT01120600|157869782|FG001|Overall Study|Physician Decision|3|||
49008887|NCT01120600|157869781|FG000|Overall Study|Protocol Violation|0|||
49008888|NCT01120600|157869782|FG001|Overall Study|Protocol Violation|4|||
49008889|NCT01120600|157869781|FG000|Overall Study|Withdrawal by Subject|10|||
49008890|NCT01120600|157869782|FG001|Overall Study|Withdrawal by Subject|11|||
49008891|NCT01011907|157869783|FG000|Overall Study|Withdrawal by Subject|13|||
49008892|NCT01011907|157869784|FG001|Overall Study|Withdrawal by Subject|11|||
49008893|NCT01011907|157869783|FG000|Overall Study|Adverse Event|1|||
49008894|NCT01011907|157869784|FG001|Overall Study|Adverse Event|4|||
49008895|NCT01272193|157869787|FG000|Overall Study|Adverse Event|1|||
49008896|NCT01272193|157869788|FG001|Overall Study|Adverse Event|1|||
49008897|NCT01272193|157869787|FG000|Overall Study|Lack of Efficacy|0|||
49008898|NCT01272193|157869788|FG001|Overall Study|Lack of Efficacy|3|||
49008899|NCT01272193|157869787|FG000|Overall Study|Withdrawal Criteria|1|||
49008900|NCT01272193|157869788|FG001|Overall Study|Withdrawal Criteria|1|||
49008901|NCT01272193|157869787|FG000|Overall Study|Unclassified|8|||
49008902|NCT01272193|157869788|FG001|Overall Study|Unclassified|7|||
49008903|NCT00304954|157869793|FG000|Overall Study|Withdrawal by Subject|0|||
49008904|NCT00304954|157869794|FG001|Overall Study|Withdrawal by Subject|0|||
49008905|NCT00304954|157869795|FG002|Overall Study|Withdrawal by Subject|1|||
49113512|NCT02907619|158251711|FG001|Overall Study|Study terminated by sponsor|18|||
49113513|NCT02907619|158251712|FG002|Overall Study|Study terminated by sponsor|19|||
49008906|NCT00304954|157869796|FG003|Overall Study|Withdrawal by Subject|0|||
49008907|NCT00304954|157869793|FG000|Overall Study|Adverse Event|1|||
49008908|NCT00304954|157869794|FG001|Overall Study|Adverse Event|0|||
49008909|NCT00304954|157869795|FG002|Overall Study|Adverse Event|0|||
49008910|NCT00304954|157869796|FG003|Overall Study|Adverse Event|0|||
49008911|NCT01440647|157869797|FG000|Overall Study|Death|2|||
49008912|NCT01440647|157869798|FG001|Overall Study|Death|3|||
49008913|NCT01406873|157869805|FG000|Overall Study|Withdrawal by Subject|1|||
49008914|NCT01406873|157869806|FG001|Overall Study|Withdrawal by Subject|1|||
49008915|NCT03990389|157869807|FG000|Overall Study|Lost to Follow-up|3|||
49008916|NCT03990389|157869808|FG001|Overall Study|Lost to Follow-up|0|||
49008917|NCT03066440|157869817|FG000|Overall Study|Physician Decision|1|||
49008918|NCT03066440|157869818|FG001|Overall Study|Physician Decision|1|||
49008919|NCT03066440|157869817|FG000|Overall Study|Protocol Violation|0|||
49008920|NCT03066440|157869818|FG001|Overall Study|Protocol Violation|2|||
49008921|NCT02117479|157869823|FG000|Overall Study|Death|13|||
49008922|NCT02117479|157869824|FG001|Overall Study|Death|8|||
49008923|NCT02117479|157869823|FG000|Overall Study|Adverse Event|8|||
49008924|NCT02117479|157869824|FG001|Overall Study|Adverse Event|16|||
49008925|NCT02117479|157869823|FG000|Overall Study|Subject decision|8|||
49008926|NCT02117479|157869824|FG001|Overall Study|Subject decision|9|||
49008927|NCT02117479|157869823|FG000|Overall Study|Disease progression|104|||
49008928|NCT02117479|157869824|FG001|Overall Study|Disease progression|108|||
49008929|NCT02117479|157869823|FG000|Overall Study|Noncompliance with study treatment|1|||
49008930|NCT02117479|157869824|FG001|Overall Study|Noncompliance with study treatment|0|||
49008931|NCT02117479|157869823|FG000|Overall Study|Study terminated by the sponsor|4|||
49008932|NCT02117479|157869824|FG001|Overall Study|Study terminated by the sponsor|6|||
49008933|NCT02117479|157869823|FG000|Overall Study|Physician Decision|7|||
48693193|NCT04479787|156726367|FG001|After 6 Months|Subject Had Back Surgery On March 1st|1|||
49008934|NCT02117479|157869824|FG001|Overall Study|Physician Decision|2|||
49008935|NCT02117479|157869823|FG000|Overall Study|Other unspecified|11|||
49008936|NCT02117479|157869824|FG001|Overall Study|Other unspecified|7|||
49008937|NCT02725671|157869825|FG000|Overall Study|Lost to Follow-up|1|||
49008938|NCT01965535|157869826|FG000|Overall Study|Lack of Efficacy|2|||
49008939|NCT01965535|157869827|FG001|Overall Study|Lack of Efficacy|1|||
49008940|NCT00528879|157869828|FG000|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3|||
49008941|NCT00528879|157869829|FG001|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
49008942|NCT00528879|157869830|FG002|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1|||
49008943|NCT00528879|157869831|FG003|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
49008944|NCT00528879|157869828|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
49008945|NCT00528879|157869829|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
49008946|NCT00528879|157869830|FG002|Short-term Period (Day 1 to Week 24)|Adverse Event|2|||
49008947|NCT00528879|157869831|FG003|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
49008948|NCT00528879|157869828|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7|||
49008949|NCT00528879|157869829|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
49008950|NCT00528879|157869830|FG002|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
49008951|NCT00528879|157869831|FG003|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3|||
49008952|NCT00528879|157869828|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
49008953|NCT00528879|157869829|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
49008954|NCT00528879|157869830|FG002|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
49008955|NCT00528879|157869831|FG003|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
49008956|NCT00528879|157869828|FG000|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
49008957|NCT00528879|157869829|FG001|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
49008958|NCT00528879|157869830|FG002|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2|||
49008959|NCT00528879|157869831|FG003|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
49008960|NCT00528879|157869828|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
49008961|NCT00528879|157869829|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3|||
49008962|NCT00528879|157869830|FG002|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
49008963|NCT00528879|157869831|FG003|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
49008964|NCT00528879|157869828|FG000|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
49008965|NCT00528879|157869829|FG001|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
49008966|NCT00528879|157869830|FG002|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0|||
49008967|NCT00528879|157869831|FG003|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
49008968|NCT00528879|157869828|FG000|Short-term Period (Day 1 to Week 24)|Other|0|||
49008969|NCT00528879|157869829|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
49008970|NCT00528879|157869830|FG002|Short-term Period (Day 1 to Week 24)|Other|1|||
49008971|NCT00528879|157869831|FG003|Short-term Period (Day 1 to Week 24)|Other|1|||
49008972|NCT00528879|157869828|FG000|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27|||
49008973|NCT00528879|157869829|FG001|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16|||
49008974|NCT00528879|157869830|FG002|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17|||
49008975|NCT00528879|157869831|FG003|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9|||
49008976|NCT00528879|157869828|FG000|Long-term Period (Weeks 24 to 102)|Adverse Event|5|||
49008977|NCT00528879|157869829|FG001|Long-term Period (Weeks 24 to 102)|Adverse Event|4|||
49008978|NCT00528879|157869830|FG002|Long-term Period (Weeks 24 to 102)|Adverse Event|3|||
49008979|NCT00528879|157869831|FG003|Long-term Period (Weeks 24 to 102)|Adverse Event|2|||
49008980|NCT00528879|157869828|FG000|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
49008981|NCT00528879|157869829|FG001|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6|||
49008982|NCT00528879|157869830|FG002|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8|||
49008983|NCT00528879|157869831|FG003|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
49008984|NCT00528879|157869828|FG000|Long-term Period (Weeks 24 to 102)|Death|0|||
49008985|NCT00528879|157869829|FG001|Long-term Period (Weeks 24 to 102)|Death|1|||
49008986|NCT00528879|157869830|FG002|Long-term Period (Weeks 24 to 102)|Death|0|||
49008987|NCT00528879|157869831|FG003|Long-term Period (Weeks 24 to 102)|Death|0|||
49008988|NCT00528879|157869828|FG000|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4|||
49008989|NCT00528879|157869829|FG001|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5|||
49008990|NCT00528879|157869830|FG002|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3|||
49008991|NCT00528879|157869831|FG003|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7|||
49008992|NCT00528879|157869828|FG000|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0|||
49008993|NCT00528879|157869829|FG001|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5|||
49008994|NCT00528879|157869830|FG002|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1|||
49008995|NCT00528879|157869831|FG003|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2|||
49008996|NCT00528879|157869828|FG000|Long-term Period (Weeks 24 to 102)|Pregnancy|1|||
49008997|NCT00528879|157869829|FG001|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
49008998|NCT00528879|157869830|FG002|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
49008999|NCT00528879|157869831|FG003|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
49009000|NCT00528879|157869828|FG000|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
49009001|NCT00528879|157869829|FG001|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
49009002|NCT00528879|157869830|FG002|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
49009003|NCT00528879|157869831|FG003|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0|||
49009004|NCT04133519|157869836|FG000|Overall Study|Withdrawal by Subject|5|||
49009005|NCT04133519|157869837|FG001|Overall Study|Withdrawal by Subject|4|||
49009006|NCT04133519|157869836|FG000|Overall Study|Protocol Violation|0|||
49009007|NCT04133519|157869837|FG001|Overall Study|Protocol Violation|1|||
49009008|NCT04133519|157869836|FG000|Overall Study|Never started treatment|1|||
49009009|NCT04133519|157869837|FG001|Overall Study|Never started treatment|1|||
49009010|NCT00619619|157869838|FG000|Overall Study|Physician Decision|0|||
49009011|NCT00619619|157869839|FG001|Overall Study|Physician Decision|0|||
49009012|NCT00619619|157869840|FG002|Overall Study|Physician Decision|1|||
49009013|NCT00619619|157869841|FG003|Overall Study|Physician Decision|0|||
49009014|NCT00619619|157869842|FG004|Overall Study|Physician Decision|0|||
49009015|NCT00619619|157869843|FG005|Overall Study|Physician Decision|0|||
49009016|NCT00619619|157869844|FG006|Overall Study|Physician Decision|0|||
49009017|NCT00619619|157869845|FG007|Overall Study|Physician Decision|0|||
49009018|NCT00619619|157869838|FG000|Overall Study|Protocol Violation|0|||
49009019|NCT00619619|157869839|FG001|Overall Study|Protocol Violation|0|||
49009020|NCT00619619|157869840|FG002|Overall Study|Protocol Violation|0|||
49009021|NCT00619619|157869841|FG003|Overall Study|Protocol Violation|1|||
49009022|NCT00619619|157869842|FG004|Overall Study|Protocol Violation|0|||
49009023|NCT00619619|157869843|FG005|Overall Study|Protocol Violation|0|||
49009024|NCT00619619|157869844|FG006|Overall Study|Protocol Violation|1|||
49009025|NCT00619619|157869845|FG007|Overall Study|Protocol Violation|1|||
49009026|NCT00619619|157869838|FG000|Overall Study|Adverse Event|0|||
49009027|NCT00619619|157869839|FG001|Overall Study|Adverse Event|0|||
49009028|NCT00619619|157869840|FG002|Overall Study|Adverse Event|0|||
49009029|NCT00619619|157869841|FG003|Overall Study|Adverse Event|0|||
49009030|NCT00619619|157869842|FG004|Overall Study|Adverse Event|2|||
49009031|NCT00619619|157869843|FG005|Overall Study|Adverse Event|0|||
49009032|NCT00619619|157869844|FG006|Overall Study|Adverse Event|0|||
49009033|NCT00619619|157869845|FG007|Overall Study|Adverse Event|2|||
49009034|NCT00078819|157869846|FG000|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
49009035|NCT00078819|157869847|FG001|Double-blind Treatment Period: Week 1-12|Adverse Event|1|||
49009036|NCT00078819|157869848|FG002|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
49009037|NCT00078819|157869849|FG003|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
49009038|NCT00078819|157869846|FG000|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1|||
49009039|NCT00078819|157869847|FG001|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
49009040|NCT00078819|157869848|FG002|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
49009041|NCT00078819|157869849|FG003|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
49009042|NCT00078819|157869846|FG000|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
49009043|NCT00078819|157869847|FG001|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
49009044|NCT00078819|157869848|FG002|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
49009045|NCT00078819|157869849|FG003|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
49009046|NCT00078819|157869846|FG000|Open-label Treatment Period: Weeks 13-36|Adverse Event|3|||
49009047|NCT00078819|157869847|FG001|Open-label Treatment Period: Weeks 13-36|Adverse Event|2|||
49009048|NCT00078819|157869848|FG002|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
49009049|NCT00078819|157869849|FG003|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
49009050|NCT00078819|157869846|FG000|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
49113514|NCT02907619|158251710|FG000|Overall Study|Death|0|||
49009051|NCT00078819|157869847|FG001|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
49009052|NCT00078819|157869848|FG002|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
49009053|NCT00078819|157869849|FG003|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
49009054|NCT00078819|157869846|FG000|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34|||
49009055|NCT00078819|157869847|FG001|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25|||
49009056|NCT00078819|157869848|FG002|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
49009057|NCT00078819|157869849|FG003|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
49009058|NCT00078819|157869846|FG000|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
49009059|NCT00078819|157869847|FG001|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
49009060|NCT00078819|157869848|FG002|Withdrawal Period: Weeks 37-48|Entered Retreatment|29|||
49009061|NCT00078819|157869849|FG003|Withdrawal Period: Weeks 37-48|Entered Retreatment|13|||
49009062|NCT00078819|157869846|FG000|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
49009063|NCT00078819|157869847|FG001|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
49113515|NCT02907619|158251711|FG001|Overall Study|Death|0|||
49113516|NCT02907619|158251712|FG002|Overall Study|Death|1|||
49113517|NCT02907619|158251710|FG000|Overall Study|Withdrawal by Subject|1|||
49113518|NCT02907619|158251711|FG001|Overall Study|Withdrawal by Subject|1|||
49009064|NCT00078819|157869848|FG002|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
49009065|NCT00078819|157869849|FG003|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1|||
49009066|NCT03840135|157869850|FG000|Overall Study|Protocol Violation|6|||
49009067|NCT03840135|157869851|FG001|Overall Study|Protocol Violation|1|||
49009068|NCT03840135|157869850|FG000|Overall Study|Withdrawal by Subject|1|||
49009069|NCT03840135|157869851|FG001|Overall Study|Withdrawal by Subject|0|||
49009070|NCT00667719|157869852|FG000|Overall Study|Adverse Event|39|||
49009071|NCT00667719|157869852|FG000|Overall Study|Abnormal Test Procedure|1|||
49009072|NCT00667719|157869852|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
49009073|NCT00667719|157869852|FG000|Overall Study|Protocol Violation|3|||
49009074|NCT00667719|157869852|FG000|Overall Study|Withdrawal by Subject|17|||
49009075|NCT00667719|157869852|FG000|Overall Study|Lost to Follow-up|8|||
49009076|NCT02555618|157869853|FG000|Overall Study|Sponsor's Circumstances|1|||
49009077|NCT02555618|157869854|FG001|Overall Study|Sponsor's Circumstances|0|||
49009078|NCT00323609|157869855|FG000|Overall Study|Death|16|||
49009079|NCT00323609|157869856|FG001|Overall Study|Death|21|||
49009080|NCT00323609|157869857|FG002|Overall Study|Death|0|||
49009081|NCT00323609|157869858|FG003|Overall Study|Death|0|||
49009082|NCT00323609|157869855|FG000|Overall Study|Lost to Follow-up|9|||
49113519|NCT02907619|158251712|FG002|Overall Study|Withdrawal by Subject|0|||
49113520|NCT02907619|158251710|FG000|Overall Study|Other|0|||
49113521|NCT02907619|158251711|FG001|Overall Study|Other|1|||
49113522|NCT02907619|158251712|FG002|Overall Study|Other|0|||
49113523|NCT04126317|158251713|FG000|Overall Study|Adverse Event|0|||
49113524|NCT04126317|158251714|FG001|Overall Study|Adverse Event|1|||
49113525|NCT04126317|158251713|FG000|Overall Study|Withdrawal by Subject|4|||
49113526|NCT04126317|158251714|FG001|Overall Study|Withdrawal by Subject|1|||
49113527|NCT01375374|158251715|FG000|Overall Study|Adverse Event|1|||
49113528|NCT01908582|158251716|FG000|Period 2|Physician Decision|1|||
49113529|NCT01908582|158251716|FG000|Period 2|Withdrawal by Subject|1|||
49113530|NCT01066663|158251718|FG000|Overall Study|Adverse Event|0|||
49113531|NCT01066663|158251719|FG001|Overall Study|Adverse Event|0|||
49113532|NCT01066663|158251720|FG002|Overall Study|Adverse Event|1|||
49113533|NCT00707980|158251721|FG000|Overall Study|Adverse Event|49|||
49113534|NCT00707980|158251721|FG000|Overall Study|Lack of Efficacy|35|||
49113535|NCT00707980|158251721|FG000|Overall Study|Non-Compliance with Study Drug|28|||
49113536|NCT00707980|158251721|FG000|Overall Study|Protocol Deviations|19|||
49113537|NCT00707980|158251721|FG000|Overall Study|Withdrawal of Consent|81|||
49113538|NCT00707980|158251721|FG000|Overall Study|Lost to Follow-up|59|||
49113539|NCT00707980|158251721|FG000|Overall Study|Other|39|||
49113540|NCT04401202|158251722|FG000|Overall Study|Lost to Follow-up|2|||
49113541|NCT04401202|158251723|FG001|Overall Study|Lost to Follow-up|2|||
49113542|NCT04401202|158251722|FG000|Overall Study|Adverse Event|0|||
49113543|NCT04401202|158251723|FG001|Overall Study|Adverse Event|1|||
49113544|NCT04401202|158251722|FG000|Overall Study|Hospitalized|4|||
49113545|NCT04401202|158251723|FG001|Overall Study|Hospitalized|1|||
49113546|NCT00631163|158251724|FG000|Number of Participants in Year 1|Adverse Event|12|||
49113547|NCT00631163|158251724|FG000|Number of Participants in Year 1|Withdrawal by Subject|8|||
49113548|NCT00631163|158251724|FG000|Number of Participants in Year 1|Death|6|||
49113549|NCT00631163|158251724|FG000|Number of Participants in Year 1|Lost to Follow-up|1|||
49113550|NCT00631163|158251724|FG000|Number of Participants in Year 1|Patient's condition no longer requires study drug|1|||
49113551|NCT00631163|158251724|FG000|Number of Participants in Year 1|Administrative problems|6|||
49113552|NCT00631163|158251724|FG000|Number of Participants in Year 2|Withdrawal by Subject|2|||
49113553|NCT00631163|158251724|FG000|Number of Participants in Year 2|Adverse Event|1|||
49113554|NCT00631163|158251724|FG000|Number of Participants in Year 2|Protocol Violation|1|||
49113555|NCT00631163|158251724|FG000|Number of Participants in Year 2|Abnormal laboratory value|1|||
49009083|NCT00323609|157869856|FG001|Overall Study|Lost to Follow-up|10|||
49009084|NCT00323609|157869857|FG002|Overall Study|Lost to Follow-up|0|||
49009085|NCT00323609|157869858|FG003|Overall Study|Lost to Follow-up|0|||
49009086|NCT00323609|157869855|FG000|Overall Study|Physician Decision|2|||
49009087|NCT00323609|157869856|FG001|Overall Study|Physician Decision|0|||
49009088|NCT00323609|157869857|FG002|Overall Study|Physician Decision|0|||
49009089|NCT00323609|157869858|FG003|Overall Study|Physician Decision|1|||
49009090|NCT00323609|157869855|FG000|Overall Study|Withdrawal by Subject|11|||
49009091|NCT00323609|157869856|FG001|Overall Study|Withdrawal by Subject|23|||
49009092|NCT00323609|157869857|FG002|Overall Study|Withdrawal by Subject|4|||
49009093|NCT00323609|157869858|FG003|Overall Study|Withdrawal by Subject|4|||
49009094|NCT00323609|157869855|FG000|Overall Study|Other non-VCF-related medical condition|3|||
49009095|NCT00323609|157869856|FG001|Overall Study|Other non-VCF-related medical condition|2|||
49009096|NCT00323609|157869857|FG002|Overall Study|Other non-VCF-related medical condition|0|||
49009097|NCT00323609|157869858|FG003|Overall Study|Other non-VCF-related medical condition|0|||
49009098|NCT00323609|157869855|FG000|Overall Study|Sponsor discontinued trial|29|||
49009099|NCT00323609|157869856|FG001|Overall Study|Sponsor discontinued trial|29|||
49009100|NCT00323609|157869857|FG002|Overall Study|Sponsor discontinued trial|0|||
49009101|NCT00323609|157869858|FG003|Overall Study|Sponsor discontinued trial|0|||
49009102|NCT00323609|157869855|FG000|Overall Study|Unrelenting or severe back pain|1|||
49009103|NCT00323609|157869856|FG001|Overall Study|Unrelenting or severe back pain|1|||
49009104|NCT00323609|157869857|FG002|Overall Study|Unrelenting or severe back pain|0|||
49009105|NCT00323609|157869858|FG003|Overall Study|Unrelenting or severe back pain|0|||
49009106|NCT00323609|157869855|FG000|Overall Study|Logistical withdrawal|9|||
49009107|NCT00323609|157869856|FG001|Overall Study|Logistical withdrawal|5|||
49009108|NCT00323609|157869857|FG002|Overall Study|Logistical withdrawal|0|||
49009109|NCT00323609|157869858|FG003|Overall Study|Logistical withdrawal|1|||
49009110|NCT00323609|157869855|FG000|Overall Study|Other reason|11|||
49009111|NCT00323609|157869856|FG001|Overall Study|Other reason|8|||
49009112|NCT00323609|157869857|FG002|Overall Study|Other reason|4|||
49009113|NCT00323609|157869858|FG003|Overall Study|Other reason|9|||
49009114|NCT01827371|157869860|FG000|Overall Study|Adverse Event|0|||
49009115|NCT01827371|157869861|FG001|Overall Study|Adverse Event|0|||
49009116|NCT01827371|157869862|FG002|Overall Study|Adverse Event|4|||
49009117|NCT01827371|157869863|FG003|Overall Study|Adverse Event|2|||
49009118|NCT01827371|157869860|FG000|Overall Study|Lost to Follow-up|0|||
49009119|NCT01827371|157869861|FG001|Overall Study|Lost to Follow-up|2|||
49009120|NCT01827371|157869862|FG002|Overall Study|Lost to Follow-up|0|||
49009121|NCT01827371|157869863|FG003|Overall Study|Lost to Follow-up|4|||
49009122|NCT01827371|157869860|FG000|Overall Study|Protocol Violation|1|||
49009123|NCT01827371|157869861|FG001|Overall Study|Protocol Violation|0|||
49009124|NCT01827371|157869862|FG002|Overall Study|Protocol Violation|0|||
49009125|NCT01827371|157869863|FG003|Overall Study|Protocol Violation|0|||
49009126|NCT01827371|157869860|FG000|Overall Study|Withdrawal by Subject|1|||
49009127|NCT01827371|157869861|FG001|Overall Study|Withdrawal by Subject|2|||
49009128|NCT01827371|157869862|FG002|Overall Study|Withdrawal by Subject|2|||
49009129|NCT01827371|157869863|FG003|Overall Study|Withdrawal by Subject|3|||
49009130|NCT01827371|157869860|FG000|Overall Study|Physician Decision|0|||
49009131|NCT01827371|157869861|FG001|Overall Study|Physician Decision|1|||
49009132|NCT01827371|157869862|FG002|Overall Study|Physician Decision|0|||
49009133|NCT01827371|157869863|FG003|Overall Study|Physician Decision|1|||
49009134|NCT01827371|157869860|FG000|Overall Study|Temporary study halt to vaccinations|11|||
49009135|NCT01827371|157869861|FG001|Overall Study|Temporary study halt to vaccinations|2|||
49009136|NCT01827371|157869862|FG002|Overall Study|Temporary study halt to vaccinations|5|||
49009137|NCT01827371|157869863|FG003|Overall Study|Temporary study halt to vaccinations|13|||
49009138|NCT01783483|157869864|FG000|Overall Study|Death|3|||
49009139|NCT01783483|157869865|FG001|Overall Study|Death|3|||
49009140|NCT01783483|157869864|FG000|Overall Study|Lost to Follow-up|14|||
49009141|NCT01783483|157869865|FG001|Overall Study|Lost to Follow-up|10|||
49009142|NCT01783483|157869864|FG000|Overall Study|Withdrawal by Subject|2|||
49009143|NCT01783483|157869865|FG001|Overall Study|Withdrawal by Subject|1|||
49009144|NCT01783483|157869864|FG000|Overall Study|Physician Decision|1|||
49009145|NCT01783483|157869865|FG001|Overall Study|Physician Decision|1|||
49009146|NCT02217345|157869869|FG000|Overall Study|Lost to Follow-up|2|||
49009147|NCT02217345|157869870|FG001|Overall Study|Lost to Follow-up|1|||
49009148|NCT02217345|157869869|FG000|Overall Study|Withdrawal by Subject|3|||
49009149|NCT02217345|157869870|FG001|Overall Study|Withdrawal by Subject|2|||
49009150|NCT02217345|157869869|FG000|Overall Study|Adverse Event|2|||
49009151|NCT02217345|157869870|FG001|Overall Study|Adverse Event|1|||
49009152|NCT02217345|157869869|FG000|Overall Study|Physician Decision|0|||
49009153|NCT02217345|157869870|FG001|Overall Study|Physician Decision|1|||
49009154|NCT02295280|157869876|FG000|Overall Study|Adverse Event|0|||
49009155|NCT02295280|157869877|FG001|Overall Study|Adverse Event|1|||
49009156|NCT01430104|157869878|FG000|28-Day Teriparatide Treatment Period|Adverse Event|1|||
49009157|NCT02124746|157869879|FG000|Overall Study|Adverse Event|2|||
49009158|NCT02124746|157869880|FG001|Overall Study|Adverse Event|1|||
49009159|NCT02124746|157869881|FG002|Overall Study|Adverse Event|2|||
49009160|NCT02124746|157869879|FG000|Overall Study|Death|2|||
49009161|NCT02124746|157869880|FG001|Overall Study|Death|1|||
49009162|NCT02124746|157869881|FG002|Overall Study|Death|3|||
49113556|NCT00253370|158251727|FG000|Overall Study|Adverse Event|18|||
49009163|NCT02124746|157869879|FG000|Overall Study|Lack of Efficacy|3|||
49009164|NCT02124746|157869880|FG001|Overall Study|Lack of Efficacy|2|||
49009165|NCT02124746|157869881|FG002|Overall Study|Lack of Efficacy|2|||
49009166|NCT02124746|157869879|FG000|Overall Study|Physician Decision|6|||
49009167|NCT02124746|157869880|FG001|Overall Study|Physician Decision|4|||
49009168|NCT02124746|157869881|FG002|Overall Study|Physician Decision|5|||
49009169|NCT02124746|157869879|FG000|Overall Study|Non-Compliance with Study Drug|0|||
49009170|NCT02124746|157869880|FG001|Overall Study|Non-Compliance with Study Drug|1|||
49009171|NCT02124746|157869881|FG002|Overall Study|Non-Compliance with Study Drug|0|||
49009172|NCT02124746|157869879|FG000|Overall Study|Withdrawal by Subject|3|||
49009173|NCT02124746|157869880|FG001|Overall Study|Withdrawal by Subject|3|||
49009174|NCT02124746|157869881|FG002|Overall Study|Withdrawal by Subject|0|||
49009175|NCT02124746|157869879|FG000|Overall Study|Study Terminated by Sponsor|0|||
49009176|NCT02124746|157869880|FG001|Overall Study|Study Terminated by Sponsor|0|||
49009177|NCT02124746|157869881|FG002|Overall Study|Study Terminated by Sponsor|6|||
49009178|NCT02124746|157869879|FG000|Overall Study|Disease Progression|3|||
49009179|NCT02124746|157869880|FG001|Overall Study|Disease Progression|6|||
49009180|NCT02124746|157869881|FG002|Overall Study|Disease Progression|4|||
49009181|NCT01076166|157869882|FG000|Overall Study|Adverse Event|3|||
49009182|NCT01076166|157869882|FG000|Overall Study|Symptoms improved/resolved|6|||
49009183|NCT02713243|157869886|FG000|Overall Study|Abnormal laboratory value(s)#|1|||
49009184|NCT02713243|157869887|FG001|Overall Study|Abnormal laboratory value(s)#|0|||
49009185|NCT02713243|157869886|FG000|Overall Study|Administrative problems|0|||
49009186|NCT02713243|157869887|FG001|Overall Study|Administrative problems|1|||
49009187|NCT02713243|157869886|FG000|Overall Study|Protocol deviation|0|||
49009188|NCT02713243|157869887|FG001|Overall Study|Protocol deviation|1|||
49009189|NCT01050673|157869888|FG000|Overall Study|Physician Decision|4|||
49009190|NCT01050673|157869889|FG001|Overall Study|Physician Decision|5|||
49009191|NCT05288673|157869891|FG000|Overall Study|Consent withdrawn by subject|0|||
49009192|NCT05288673|157869892|FG001|Overall Study|Consent withdrawn by subject|0|||
49009193|NCT05288673|157869893|FG002|Overall Study|Consent withdrawn by subject|1|||
49009194|NCT04363736|157869894|FG000|Overall Study|Withdrawal by Subject|1|||
49009195|NCT04363736|157869895|FG001|Overall Study|Withdrawal by Subject|0|||
49009196|NCT04363736|157869894|FG000|Overall Study|Lost to Follow-up|10|||
49009197|NCT04363736|157869895|FG001|Overall Study|Lost to Follow-up|7|||
49009198|NCT04363736|157869894|FG000|Overall Study|Death|8|||
49009199|NCT04363736|157869895|FG001|Overall Study|Death|6|||
49009200|NCT01208402|157869896|FG000|Overall Study|Withdrawal by Subject|1|||
49009201|NCT01208402|157869897|FG001|Overall Study|Withdrawal by Subject|0|||
49009202|NCT01571635|157869898|FG000|Overall Study|Adverse Event|3|||
49009203|NCT01571635|157869899|FG001|Overall Study|Adverse Event|0|||
49009204|NCT01571635|157869900|FG002|Overall Study|Adverse Event|2|||
49009205|NCT01571635|157869901|FG003|Overall Study|Adverse Event|3|||
49009206|NCT01571635|157869902|FG004|Overall Study|Adverse Event|5|||
49009207|NCT01571635|157869898|FG000|Overall Study|Other reasons|2|||
49009208|NCT01571635|157869899|FG001|Overall Study|Other reasons|1|||
49009209|NCT01571635|157869900|FG002|Overall Study|Other reasons|2|||
49009210|NCT01571635|157869901|FG003|Overall Study|Other reasons|2|||
49009211|NCT01571635|157869902|FG004|Overall Study|Other reasons|1|||
49009212|NCT01571635|157869898|FG000|Overall Study|Study terminated by sponsor|0|||
49009213|NCT01571635|157869899|FG001|Overall Study|Study terminated by sponsor|4|||
49009214|NCT01571635|157869900|FG002|Overall Study|Study terminated by sponsor|1|||
49009215|NCT01571635|157869901|FG003|Overall Study|Study terminated by sponsor|3|||
49009216|NCT01571635|157869902|FG004|Overall Study|Study terminated by sponsor|1|||
49009217|NCT01571635|157869898|FG000|Overall Study|Withdrew consent|1|||
49009218|NCT01571635|157869899|FG001|Overall Study|Withdrew consent|1|||
49009219|NCT01571635|157869900|FG002|Overall Study|Withdrew consent|2|||
49009220|NCT01571635|157869901|FG003|Overall Study|Withdrew consent|3|||
49009221|NCT01571635|157869902|FG004|Overall Study|Withdrew consent|0|||
49009222|NCT01571635|157869898|FG000|Overall Study|Lack of Efficacy|0|||
49009223|NCT01571635|157869899|FG001|Overall Study|Lack of Efficacy|2|||
49009224|NCT01571635|157869900|FG002|Overall Study|Lack of Efficacy|0|||
49009225|NCT01571635|157869901|FG003|Overall Study|Lack of Efficacy|1|||
49009226|NCT01571635|157869902|FG004|Overall Study|Lack of Efficacy|2|||
49009227|NCT01261325|157869903|FG000|Overall Study|Lack of Efficacy|1|||
49009228|NCT01261325|157869904|FG001|Overall Study|Lack of Efficacy|1|||
49009229|NCT01261325|157869905|FG002|Overall Study|Lack of Efficacy|0|||
49009230|NCT01261325|157869903|FG000|Overall Study|Withdrawal by Subject|2|||
49009231|NCT01261325|157869904|FG001|Overall Study|Withdrawal by Subject|2|||
49009232|NCT01261325|157869905|FG002|Overall Study|Withdrawal by Subject|4|||
49009233|NCT01261325|157869903|FG000|Overall Study|SAE, non-fatal|1|||
49009234|NCT01261325|157869904|FG001|Overall Study|SAE, non-fatal|5|||
49009235|NCT01261325|157869905|FG002|Overall Study|SAE, non-fatal|1|||
49009236|NCT01261325|157869903|FG000|Overall Study|AE, non-serious non-fatal|9|||
49009237|NCT01261325|157869904|FG001|Overall Study|AE, non-serious non-fatal|15|||
49009238|NCT01261325|157869905|FG002|Overall Study|AE, non-serious non-fatal|13|||
49009239|NCT01261325|157869903|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
49009240|NCT01261325|157869904|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
49009241|NCT01261325|157869905|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
49009242|NCT01261325|157869903|FG000|Overall Study|Non Compliance|2|||
49009243|NCT01261325|157869904|FG001|Overall Study|Non Compliance|0|||
49009244|NCT01261325|157869905|FG002|Overall Study|Non Compliance|0|||
49009245|NCT01261325|157869903|FG000|Overall Study|Patient Randomized by Mistake|0|||
49009246|NCT01261325|157869904|FG001|Overall Study|Patient Randomized by Mistake|1|||
49009247|NCT01261325|157869905|FG002|Overall Study|Patient Randomized by Mistake|0|||
49009248|NCT01261325|157869903|FG000|Overall Study|Erroneously Randomized|1|||
49009249|NCT01261325|157869904|FG001|Overall Study|Erroneously Randomized|0|||
49009250|NCT01261325|157869905|FG002|Overall Study|Erroneously Randomized|0|||
49009251|NCT01261325|157869903|FG000|Overall Study|Screen Failure|1|||
49009252|NCT01261325|157869904|FG001|Overall Study|Screen Failure|0|||
49009253|NCT01261325|157869905|FG002|Overall Study|Screen Failure|0|||
49009254|NCT01261325|157869903|FG000|Overall Study|Randomized in Error|0|||
49009255|NCT01261325|157869904|FG001|Overall Study|Randomized in Error|0|||
49009256|NCT01261325|157869905|FG002|Overall Study|Randomized in Error|1|||
49009257|NCT01261325|157869903|FG000|Overall Study|Protocol Violation|0|||
49009258|NCT01261325|157869904|FG001|Overall Study|Protocol Violation|3|||
49009259|NCT01261325|157869905|FG002|Overall Study|Protocol Violation|1|||
49009260|NCT01261325|157869903|FG000|Overall Study|Lost to Follow-up|0|||
49009261|NCT01261325|157869904|FG001|Overall Study|Lost to Follow-up|1|||
49009262|NCT01261325|157869905|FG002|Overall Study|Lost to Follow-up|3|||
49009263|NCT01261325|157869903|FG000|Overall Study|AE, serious fatal|0|||
49009264|NCT01261325|157869904|FG001|Overall Study|AE, serious fatal|0|||
49009265|NCT01261325|157869905|FG002|Overall Study|AE, serious fatal|2|||
49009266|NCT01328054|157869910|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0|||
49009267|NCT01328054|157869911|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2|||
49009268|NCT01328054|157869910|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0|||
49009269|NCT01328054|157869911|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1|||
49009270|NCT01328054|157869910|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0|||
49009271|NCT01328054|157869911|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2|||
49009272|NCT01298596|157869913|FG000|Overall Study|Withdrawal by Subject|1|||
49009273|NCT01298596|157869914|FG001|Overall Study|Withdrawal by Subject|1|||
49009274|NCT01298596|157869913|FG000|Overall Study|Death|5|||
49009275|NCT01298596|157869914|FG001|Overall Study|Death|3|||
49009276|NCT01298596|157869913|FG000|Overall Study|Lost to Follow-up|6|||
49009277|NCT01298596|157869914|FG001|Overall Study|Lost to Follow-up|14|||
49009278|NCT01298596|157869913|FG000|Overall Study|Referred for further management|16|||
49009279|NCT01298596|157869914|FG001|Overall Study|Referred for further management|15|||
49009280|NCT00096486|157869915|FG000|Overall Study|Withdrawal by Subject|0|||
49009281|NCT00096486|157869916|FG001|Overall Study|Withdrawal by Subject|0|||
49009282|NCT00096486|157869917|FG002|Overall Study|Withdrawal by Subject|1|||
49009283|NCT00096486|157869918|FG003|Overall Study|Withdrawal by Subject|1|||
49009284|NCT00096486|157869915|FG000|Overall Study|Not Treated|0|||
49009285|NCT00096486|157869916|FG001|Overall Study|Not Treated|0|||
49009286|NCT00096486|157869917|FG002|Overall Study|Not Treated|1|||
49009287|NCT00096486|157869918|FG003|Overall Study|Not Treated|1|||
49009288|NCT01559818|157869919|FG000|Overall Study|Physician Decision|1|||
49009289|NCT01559818|157869919|FG000|Overall Study|Pregnancy|1|||
49009290|NCT01559818|157869919|FG000|Overall Study|Study terminated by Sponsor|4|||
49009291|NCT01559818|157869919|FG000|Overall Study|Withdrawal by Subject|1|||
49009292|NCT02475980|157869920|FG000|Overall Study|Lost to Follow-up|4|||
49009293|NCT02475980|157869920|FG000|Overall Study|Withdrawal by Subject|1|||
49009294|NCT05028751|157869921|FG000|Overall Study|Study Terminated by Sponsor|3|||
49009295|NCT05028751|157869922|FG001|Overall Study|Study Terminated by Sponsor|0|||
49009296|NCT05028751|157869923|FG002|Overall Study|Study Terminated by Sponsor|0|||
49009297|NCT05028751|157869924|FG003|Overall Study|Study Terminated by Sponsor|0|||
49009298|NCT05028751|157869921|FG000|Overall Study|Death|9|||
49009299|NCT05028751|157869922|FG001|Overall Study|Death|3|||
49009300|NCT05028751|157869923|FG002|Overall Study|Death|2|||
49009301|NCT05028751|157869924|FG003|Overall Study|Death|4|||
49009302|NCT05028751|157869921|FG000|Overall Study|Withdrawal by Subject|0|||
49009303|NCT05028751|157869922|FG001|Overall Study|Withdrawal by Subject|0|||
49009304|NCT05028751|157869923|FG002|Overall Study|Withdrawal by Subject|1|||
49113557|NCT00253370|158251727|FG000|Overall Study|Disease progression|13|||
49113558|NCT00253370|158251727|FG000|Overall Study|Death|2|||
49113559|NCT00253370|158251727|FG000|Overall Study|Withdrawal by Subject|6|||
49113560|NCT00253370|158251727|FG000|Overall Study|Non-protocol therapy|1|||
49009305|NCT05028751|157869924|FG003|Overall Study|Withdrawal by Subject|0|||
49009306|NCT05028751|157869921|FG000|Overall Study|Miscellaneous|2|||
49009307|NCT05028751|157869922|FG001|Overall Study|Miscellaneous|0|||
49009308|NCT05028751|157869923|FG002|Overall Study|Miscellaneous|0|||
49009309|NCT05028751|157869924|FG003|Overall Study|Miscellaneous|0|||
49009310|NCT03578276|157871992|FG000|Overall Study|Subjects did not comply with study protocol instructions.|2|||
49009311|NCT03578276|157871993|FG001|Overall Study|Subjects did not comply with study protocol instructions.|2|||
49009312|NCT02626182|157871994|FG000|Overall Study|Adverse Event|2|||
49009313|NCT02626182|157871995|FG001|Overall Study|Adverse Event|0|||
49009314|NCT01084603|157872002|FG000|Baseline|Withdrawal by Subject|2|||
49009315|NCT01084603|157872002|FG000|NiQuitinTM Lozenge|Withdrawal by Subject|1|||
49009316|NCT01084603|157872002|FG000|Nicorette® Gum|Withdrawal by Subject|1|||
49009317|NCT01084603|157872002|FG000|Oral Nicotine 1|Withdrawal by Subject|1|||
49009318|NCT01084603|157872002|FG000|Washout Period 4|Adverse Event|1|||
49009319|NCT00207714|157872003|FG000|Overall Study|Adverse Event|6|||
49009320|NCT00207714|157872004|FG001|Overall Study|Adverse Event|2|||
49009321|NCT00207714|157872005|FG002|Overall Study|Adverse Event|4|||
49009322|NCT00207714|157872006|FG003|Overall Study|Adverse Event|3|||
49009323|NCT00207714|157872007|FG004|Overall Study|Adverse Event|1|||
49009324|NCT00207714|157872003|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
49009325|NCT00207714|157872004|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
49009326|NCT00207714|157872005|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
49009327|NCT00207714|157872006|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
49009328|NCT00207714|157872007|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
49009329|NCT00207714|157872003|FG000|Overall Study|Other|3|||
49009330|NCT00207714|157872004|FG001|Overall Study|Other|2|||
49009331|NCT00207714|157872005|FG002|Overall Study|Other|5|||
49009332|NCT00207714|157872006|FG003|Overall Study|Other|1|||
49009333|NCT00207714|157872007|FG004|Overall Study|Other|0|||
49009334|NCT03627195|157872008|FG000|Overall Study|OTHER (LACK OF EFFICACY)|1|||
49009335|NCT03627195|157872009|FG001|Overall Study|OTHER (LACK OF EFFICACY)|0|||
49009336|NCT03627195|157872010|FG002|Overall Study|OTHER (LACK OF EFFICACY)|0|||
49009337|NCT03627195|157872011|FG003|Overall Study|OTHER (LACK OF EFFICACY)|0|||
49009338|NCT03627195|157872012|FG004|Overall Study|OTHER (LACK OF EFFICACY)|0|||
49009339|NCT03627195|157872013|FG005|Overall Study|OTHER (LACK OF EFFICACY)|0|||
49009340|NCT04335110|157872014|FG000|Overall Study|Withdrawal by Subject|1|||
49009341|NCT04335110|157872015|FG001|Overall Study|Withdrawal by Subject|1|||
49009342|NCT04335110|157872014|FG000|Overall Study|Death|0|||
49009343|NCT04335110|157872015|FG001|Overall Study|Death|1|||
49009344|NCT00350519|157872017|FG000|Overall Study|Death|0|||
49009345|NCT00350519|157872018|FG001|Overall Study|Death|1|||
49009346|NCT00350519|157872017|FG000|Overall Study|Physician Decision|0|||
49009347|NCT00350519|157872018|FG001|Overall Study|Physician Decision|1|||
49009348|NCT00350519|157872017|FG000|Overall Study|Protocol Violation|1|||
49009349|NCT00350519|157872018|FG001|Overall Study|Protocol Violation|2|||
49009350|NCT00350519|157872017|FG000|Overall Study|Withdrawal by Subject|3|||
49009351|NCT00350519|157872018|FG001|Overall Study|Withdrawal by Subject|2|||
49009352|NCT00736099|157872023|FG000|Overall Study|Adverse Event|61|||
49009353|NCT00736099|157872024|FG001|Overall Study|Adverse Event|18|||
49009354|NCT00736099|157872023|FG000|Overall Study|Protocol Violation|10|||
49009355|NCT00736099|157872024|FG001|Overall Study|Protocol Violation|4|||
49009356|NCT00736099|157872023|FG000|Overall Study|Lost to Follow-up|12|||
49009357|NCT00736099|157872024|FG001|Overall Study|Lost to Follow-up|5|||
49009358|NCT00736099|157872023|FG000|Overall Study|Withdrawal by Subject|42|||
49009359|NCT00736099|157872024|FG001|Overall Study|Withdrawal by Subject|13|||
49009360|NCT00736099|157872023|FG000|Overall Study|Lack of Efficacy|15|||
49009361|NCT00736099|157872024|FG001|Overall Study|Lack of Efficacy|8|||
49009362|NCT00736099|157872023|FG000|Overall Study|Other reason|43|||
49009363|NCT00736099|157872024|FG001|Overall Study|Other reason|10|||
49009364|NCT01165242|157872025|FG000|Overall Study|Unreachable Subjects|1|||
49009365|NCT01165242|157872026|FG001|Overall Study|Unreachable Subjects|0|||
49009366|NCT01165242|157872027|FG002|Overall Study|Unreachable Subjects|0|||
49009367|NCT01165242|157872025|FG000|Overall Study|Incarcerated Subjects|0|||
49009368|NCT01165242|157872026|FG001|Overall Study|Incarcerated Subjects|1|||
49009369|NCT01165242|157872027|FG002|Overall Study|Incarcerated Subjects|0|||
49009370|NCT01165242|157872025|FG000|Overall Study|Visit 2 Declined by Subject|0|||
49009371|NCT01165242|157872026|FG001|Overall Study|Visit 2 Declined by Subject|0|||
49009372|NCT01165242|157872027|FG002|Overall Study|Visit 2 Declined by Subject|1|||
49009373|NCT01165242|157872025|FG000|Overall Study|Withdrawal by Subject|0|||
49009374|NCT01165242|157872026|FG001|Overall Study|Withdrawal by Subject|2|||
49009375|NCT01165242|157872027|FG002|Overall Study|Withdrawal by Subject|2|||
49009376|NCT01165242|157872025|FG000|Overall Study|Extended Holiday|0|||
49009377|NCT01165242|157872026|FG001|Overall Study|Extended Holiday|0|||
49009378|NCT01165242|157872027|FG002|Overall Study|Extended Holiday|1|||
49009379|NCT01165242|157872025|FG000|Overall Study|Lost to Follow-up|9|||
49009380|NCT01165242|157872026|FG001|Overall Study|Lost to Follow-up|7|||
49009381|NCT01165242|157872027|FG002|Overall Study|Lost to Follow-up|10|||
49009382|NCT03770000|157872031|FG000|Overall Study|Premature discontinuation due to PD|0|||
49009383|NCT03770000|157872032|FG001|Overall Study|Premature discontinuation due to PD|0|||
49009384|NCT03770000|157872033|FG002|Overall Study|Premature discontinuation due to PD|1|||
49009385|NCT03770000|157872034|FG003|Overall Study|Premature discontinuation due to PD|3|||
49009386|NCT03770000|157872035|FG004|Overall Study|Premature discontinuation due to PD|2|||
49009387|NCT03877237|157872036|FG000|Overall Study|Adverse Event|1|||
49009388|NCT03877237|157872037|FG001|Overall Study|Adverse Event|2|||
49009389|NCT03877237|157872036|FG000|Overall Study|Death|3|||
49009390|NCT03877237|157872037|FG001|Overall Study|Death|2|||
49009391|NCT03877237|157872036|FG000|Overall Study|Physician Decision|1|||
49009392|NCT03877237|157872037|FG001|Overall Study|Physician Decision|0|||
49009393|NCT03877237|157872036|FG000|Overall Study|Withdrawal by Subject|0|||
49009394|NCT03877237|157872037|FG001|Overall Study|Withdrawal by Subject|2|||
49009395|NCT02766088|157872038|FG000|Overall Study|Sponsor study termination|498|||
49009396|NCT02766088|157872038|FG000|Overall Study|Migrated/moved from the study area|1|||
49009397|NCT02766088|157872038|FG000|Overall Study|Lost to Follow-up|5|||
49009398|NCT02766088|157872038|FG000|Overall Study|Other|1|||
49009399|NCT02766088|157872038|FG000|Overall Study|Death|1|||
49009400|NCT01222715|157872039|FG000|Overall Study|Adverse Event|0|||
49009401|NCT01222715|157872040|FG001|Overall Study|Adverse Event|4|||
49009402|NCT01222715|157872039|FG000|Overall Study|Death|0|||
49009403|NCT01222715|157872040|FG001|Overall Study|Death|1|||
49009404|NCT01222715|157872039|FG000|Overall Study|Lack of Efficacy|22|||
49009405|NCT01222715|157872040|FG001|Overall Study|Lack of Efficacy|14|||
49009406|NCT01222715|157872039|FG000|Overall Study|Physician Decision|12|||
49009407|NCT01222715|157872040|FG001|Overall Study|Physician Decision|2|||
49009408|NCT01222715|157872039|FG000|Overall Study|Refusal of further protocol therapy|0|||
49009409|NCT01222715|157872040|FG001|Overall Study|Refusal of further protocol therapy|4|||
49009410|NCT01222715|157872039|FG000|Overall Study|Pt cannot receive treatment for >9 wks|1|||
49009411|NCT01222715|157872040|FG001|Overall Study|Pt cannot receive treatment for >9 wks|1|||
49009412|NCT01222715|157872039|FG000|Overall Study|Ineligible|0|||
49009413|NCT01222715|157872040|FG001|Overall Study|Ineligible|1|||
49009414|NCT01222715|157872039|FG000|Overall Study|Surgery or radiation therapy in 1st 6 wk|1|||
49009415|NCT01222715|157872040|FG001|Overall Study|Surgery or radiation therapy in 1st 6 wk|0|||
49009416|NCT00096382|157872045|FG000|Overall Study|Not treated|1|||
49009417|NCT00096382|157872046|FG001|Overall Study|Not treated|0|||
49009418|NCT00096382|157872045|FG000|Overall Study|Death during treatment|1|||
49009419|NCT00096382|157872046|FG001|Overall Study|Death during treatment|0|||
49009420|NCT03836729|157872047|FG000|Treatment Period 2 (Up to Day 7)|Adverse Event|1|||
49009421|NCT00948025|157872049|FG000|Phase 1 (Pilot Phase)|Adverse Event|1|||
49009422|NCT00948025|157872050|FG001|Phase 1 (Pilot Phase)|Adverse Event|1|||
49009423|NCT00948025|157872049|FG000|Phase 1 (Pilot Phase)|Lost to Follow-up|7|||
49009424|NCT00948025|157872050|FG001|Phase 1 (Pilot Phase)|Lost to Follow-up|1|||
49009425|NCT00948025|157872049|FG000|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
49009426|NCT00948025|157872050|FG001|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
49009427|NCT01537549|157872051|FG000|Overall Study|Lost to Follow-up|1|||
49009428|NCT01537549|157872051|FG000|Overall Study|Withdrawal by Subject|2|||
49009429|NCT01637961|157872054|FG000|Overall Study|Ineligible: wrong primary|1|||
49009430|NCT01637961|157872054|FG000|Overall Study|Ineligible: inadequate pathology|1|||
49009431|NCT02236754|157872055|FG000|Overall Study|Withdrawal by Subject|1|||
49009432|NCT02236754|157872056|FG001|Overall Study|Withdrawal by Subject|0|||
49009433|NCT04006847|157872057|FG000|Overall Study|Product issue|1|||
49009434|NCT03101293|157872061|FG000|Washout Period (at Least 7 Days)|Positive drug urine screen|1|||
49009435|NCT03101293|157872062|FG001|Washout Period (at Least 7 Days)|Positive drug urine screen|0|||
49009436|NCT02614703|157872068|FG000|Overall Study|Withdrawal by Subject|7|||
49009437|NCT02614703|157872069|FG001|Overall Study|Withdrawal by Subject|1|||
49009438|NCT01977352|157872070|FG000|Overall Study|Lost to Follow-up|1|||
49009439|NCT01977352|157872071|FG001|Overall Study|Lost to Follow-up|2|||
49009440|NCT02410837|157872074|FG000|Overall Study|Death|387|||
49009441|NCT02410837|157872074|FG000|Overall Study|Lost to Follow-up|50|||
49009442|NCT02410837|157872074|FG000|Overall Study|Withdrawal by Subject|44|||
49009443|NCT02410837|157872074|FG000|Overall Study|Physician Decision|6|||
49009444|NCT02410837|157872074|FG000|Overall Study|Moved to nursing home, cannot communicat|1|||
49009445|NCT00950599|157872076|FG000|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
49009446|NCT00950599|157872077|FG001|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
49009447|NCT00950599|157872078|FG002|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
49009448|NCT00950599|157872079|FG003|Double-Blind Treatment Period|Administrative reason by sponsor|1|||
49009449|NCT00950599|157872080|FG004|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
49009450|NCT00950599|157872081|FG005|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
49009451|NCT00950599|157872082|FG006|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
49009452|NCT00950599|157872083|FG007|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
49009453|NCT00950599|157872084|FG008|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
49009454|NCT00950599|157872085|FG009|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
49009455|NCT00950599|157872076|FG000|Double-Blind Treatment Period|Adverse Event|0|||
49009456|NCT00950599|157872077|FG001|Double-Blind Treatment Period|Adverse Event|1|||
49009457|NCT00950599|157872078|FG002|Double-Blind Treatment Period|Adverse Event|1|||
49009458|NCT00950599|157872079|FG003|Double-Blind Treatment Period|Adverse Event|1|||
49009459|NCT00950599|157872080|FG004|Double-Blind Treatment Period|Adverse Event|1|||
49009460|NCT00950599|157872081|FG005|Double-Blind Treatment Period|Adverse Event|1|||
49009461|NCT00950599|157872082|FG006|Double-Blind Treatment Period|Adverse Event|0|||
49009462|NCT00950599|157872083|FG007|Double-Blind Treatment Period|Adverse Event|0|||
49009463|NCT00950599|157872084|FG008|Double-Blind Treatment Period|Adverse Event|0|||
49009464|NCT00950599|157872085|FG009|Double-Blind Treatment Period|Adverse Event|0|||
49009465|NCT00950599|157872076|FG000|Double-Blind Treatment Period|Lack of Efficacy|2|||
49009466|NCT00950599|157872077|FG001|Double-Blind Treatment Period|Lack of Efficacy|5|||
49009467|NCT00950599|157872078|FG002|Double-Blind Treatment Period|Lack of Efficacy|5|||
49009468|NCT00950599|157872079|FG003|Double-Blind Treatment Period|Lack of Efficacy|7|||
49009469|NCT00950599|157872080|FG004|Double-Blind Treatment Period|Lack of Efficacy|3|||
49009470|NCT00950599|157872081|FG005|Double-Blind Treatment Period|Lack of Efficacy|6|||
49009471|NCT00950599|157872082|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
49009472|NCT00950599|157872083|FG007|Double-Blind Treatment Period|Lack of Efficacy|1|||
49009473|NCT00950599|157872084|FG008|Double-Blind Treatment Period|Lack of Efficacy|0|||
49009474|NCT00950599|157872085|FG009|Double-Blind Treatment Period|Lack of Efficacy|0|||
49009475|NCT00950599|157872076|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
49009476|NCT00950599|157872077|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
49009477|NCT00950599|157872078|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
49009478|NCT00950599|157872079|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
49009479|NCT00950599|157872080|FG004|Double-Blind Treatment Period|Lost to Follow-up|1|||
49009480|NCT00950599|157872081|FG005|Double-Blind Treatment Period|Lost to Follow-up|2|||
49009481|NCT00950599|157872082|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
49009482|NCT00950599|157872083|FG007|Double-Blind Treatment Period|Lost to Follow-up|1|||
49009483|NCT00950599|157872084|FG008|Double-Blind Treatment Period|Lost to Follow-up|0|||
49009484|NCT00950599|157872085|FG009|Double-Blind Treatment Period|Lost to Follow-up|0|||
49009485|NCT00950599|157872076|FG000|Double-Blind Treatment Period|Poor/Noncompliance|1|||
49009486|NCT00950599|157872077|FG001|Double-Blind Treatment Period|Poor/Noncompliance|1|||
49009487|NCT00950599|157872078|FG002|Double-Blind Treatment Period|Poor/Noncompliance|0|||
49009488|NCT00950599|157872079|FG003|Double-Blind Treatment Period|Poor/Noncompliance|0|||
49009489|NCT00950599|157872080|FG004|Double-Blind Treatment Period|Poor/Noncompliance|0|||
49009490|NCT00950599|157872081|FG005|Double-Blind Treatment Period|Poor/Noncompliance|0|||
49009491|NCT00950599|157872082|FG006|Double-Blind Treatment Period|Poor/Noncompliance|0|||
49009492|NCT00950599|157872083|FG007|Double-Blind Treatment Period|Poor/Noncompliance|1|||
49009493|NCT00950599|157872084|FG008|Double-Blind Treatment Period|Poor/Noncompliance|0|||
49009494|NCT00950599|157872085|FG009|Double-Blind Treatment Period|Poor/Noncompliance|0|||
49009495|NCT00950599|157872076|FG000|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
49009496|NCT00950599|157872077|FG001|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
49009497|NCT00950599|157872078|FG002|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
49009498|NCT00950599|157872079|FG003|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
49009499|NCT00950599|157872080|FG004|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
49009500|NCT00950599|157872081|FG005|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
49009501|NCT00950599|157872082|FG006|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
49009502|NCT00950599|157872083|FG007|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
49009503|NCT00950599|157872084|FG008|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
49009504|NCT00950599|157872085|FG009|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
49009505|NCT00950599|157872076|FG000|Double-Blind Treatment Period|Subject Withdrew consent|4|||
49009506|NCT00950599|157872077|FG001|Double-Blind Treatment Period|Subject Withdrew consent|3|||
49009507|NCT00950599|157872078|FG002|Double-Blind Treatment Period|Subject Withdrew consent|3|||
49009508|NCT00950599|157872079|FG003|Double-Blind Treatment Period|Subject Withdrew consent|1|||
49009509|NCT00950599|157872080|FG004|Double-Blind Treatment Period|Subject Withdrew consent|1|||
49009510|NCT00950599|157872081|FG005|Double-Blind Treatment Period|Subject Withdrew consent|2|||
49009511|NCT00950599|157872082|FG006|Double-Blind Treatment Period|Subject Withdrew consent|0|||
49009512|NCT00950599|157872083|FG007|Double-Blind Treatment Period|Subject Withdrew consent|3|||
49009513|NCT00950599|157872084|FG008|Double-Blind Treatment Period|Subject Withdrew consent|0|||
49009514|NCT00950599|157872085|FG009|Double-Blind Treatment Period|Subject Withdrew consent|0|||
49009515|NCT00950599|157872076|FG000|Follow-Up Period|Adverse Event|0|||
49009516|NCT00950599|157872077|FG001|Follow-Up Period|Adverse Event|0|||
49009517|NCT00950599|157872078|FG002|Follow-Up Period|Adverse Event|0|||
49009518|NCT00950599|157872079|FG003|Follow-Up Period|Adverse Event|0|||
49009519|NCT00950599|157872080|FG004|Follow-Up Period|Adverse Event|0|||
49009520|NCT00950599|157872081|FG005|Follow-Up Period|Adverse Event|0|||
49009521|NCT00950599|157872082|FG006|Follow-Up Period|Adverse Event|0|||
49009522|NCT00950599|157872083|FG007|Follow-Up Period|Adverse Event|0|||
49009523|NCT00950599|157872084|FG008|Follow-Up Period|Adverse Event|1|||
49009524|NCT00950599|157872085|FG009|Follow-Up Period|Adverse Event|0|||
49009525|NCT00950599|157872076|FG000|Follow-Up Period|Lack of Efficacy|0|||
49009526|NCT00950599|157872077|FG001|Follow-Up Period|Lack of Efficacy|0|||
49009527|NCT00950599|157872078|FG002|Follow-Up Period|Lack of Efficacy|0|||
49009528|NCT00950599|157872079|FG003|Follow-Up Period|Lack of Efficacy|0|||
49009529|NCT00950599|157872080|FG004|Follow-Up Period|Lack of Efficacy|0|||
49009530|NCT00950599|157872081|FG005|Follow-Up Period|Lack of Efficacy|0|||
49009531|NCT00950599|157872082|FG006|Follow-Up Period|Lack of Efficacy|0|||
49009532|NCT00950599|157872083|FG007|Follow-Up Period|Lack of Efficacy|0|||
49009533|NCT00950599|157872084|FG008|Follow-Up Period|Lack of Efficacy|3|||
49009534|NCT00950599|157872085|FG009|Follow-Up Period|Lack of Efficacy|0|||
49009535|NCT00950599|157872076|FG000|Follow-Up Period|Lost to Follow-up|0|||
49009536|NCT00950599|157872077|FG001|Follow-Up Period|Lost to Follow-up|0|||
49009537|NCT00950599|157872078|FG002|Follow-Up Period|Lost to Follow-up|0|||
49009538|NCT00950599|157872079|FG003|Follow-Up Period|Lost to Follow-up|0|||
49009539|NCT00950599|157872080|FG004|Follow-Up Period|Lost to Follow-up|0|||
49009540|NCT00950599|157872081|FG005|Follow-Up Period|Lost to Follow-up|0|||
49009541|NCT00950599|157872082|FG006|Follow-Up Period|Lost to Follow-up|0|||
49009542|NCT00950599|157872083|FG007|Follow-Up Period|Lost to Follow-up|0|||
49009543|NCT00950599|157872084|FG008|Follow-Up Period|Lost to Follow-up|5|||
49009544|NCT00950599|157872085|FG009|Follow-Up Period|Lost to Follow-up|1|||
49009545|NCT00950599|157872076|FG000|Follow-Up Period|Physician Decision|0|||
49009546|NCT00950599|157872077|FG001|Follow-Up Period|Physician Decision|0|||
49009547|NCT00950599|157872078|FG002|Follow-Up Period|Physician Decision|0|||
49009548|NCT00950599|157872079|FG003|Follow-Up Period|Physician Decision|0|||
49009549|NCT00950599|157872080|FG004|Follow-Up Period|Physician Decision|0|||
49009550|NCT00950599|157872081|FG005|Follow-Up Period|Physician Decision|0|||
49009551|NCT00950599|157872082|FG006|Follow-Up Period|Physician Decision|0|||
49009552|NCT00950599|157872083|FG007|Follow-Up Period|Physician Decision|0|||
49009553|NCT00950599|157872084|FG008|Follow-Up Period|Physician Decision|1|||
49009554|NCT00950599|157872085|FG009|Follow-Up Period|Physician Decision|0|||
49009555|NCT00950599|157872076|FG000|Follow-Up Period|Poor/Noncompliance|0|||
49009556|NCT00950599|157872077|FG001|Follow-Up Period|Poor/Noncompliance|0|||
49009557|NCT00950599|157872078|FG002|Follow-Up Period|Poor/Noncompliance|0|||
49009558|NCT00950599|157872079|FG003|Follow-Up Period|Poor/Noncompliance|0|||
49009559|NCT00950599|157872080|FG004|Follow-Up Period|Poor/Noncompliance|0|||
49009560|NCT00950599|157872081|FG005|Follow-Up Period|Poor/Noncompliance|0|||
49009561|NCT00950599|157872082|FG006|Follow-Up Period|Poor/Noncompliance|0|||
49009562|NCT00950599|157872083|FG007|Follow-Up Period|Poor/Noncompliance|0|||
49009563|NCT00950599|157872084|FG008|Follow-Up Period|Poor/Noncompliance|1|||
49009564|NCT00950599|157872085|FG009|Follow-Up Period|Poor/Noncompliance|0|||
49009565|NCT00950599|157872076|FG000|Follow-Up Period|Subject withdrew Consent|0|||
49009566|NCT00950599|157872077|FG001|Follow-Up Period|Subject withdrew Consent|0|||
49009567|NCT00950599|157872078|FG002|Follow-Up Period|Subject withdrew Consent|0|||
49009568|NCT00950599|157872079|FG003|Follow-Up Period|Subject withdrew Consent|0|||
49009569|NCT00950599|157872080|FG004|Follow-Up Period|Subject withdrew Consent|0|||
49009570|NCT00950599|157872081|FG005|Follow-Up Period|Subject withdrew Consent|0|||
49009571|NCT00950599|157872082|FG006|Follow-Up Period|Subject withdrew Consent|0|||
49009572|NCT00950599|157872083|FG007|Follow-Up Period|Subject withdrew Consent|0|||
49009573|NCT00950599|157872084|FG008|Follow-Up Period|Subject withdrew Consent|2|||
49009574|NCT00950599|157872085|FG009|Follow-Up Period|Subject withdrew Consent|1|||
49009575|NCT02482571|157872086|FG000|Overall Study|Adverse Event|1|||
49009576|NCT02482571|157872086|FG000|Overall Study|Scanner or Respiract failure|3|||
49009577|NCT02482571|157872086|FG000|Overall Study|Withdrawal by Subject|4|||
49009578|NCT02268045|157872089|FG000|Overall Study|Death|4|||
49009579|NCT02268045|157872090|FG001|Overall Study|Death|4|||
49009580|NCT02268045|157872089|FG000|Overall Study|Disease Progression|2|||
49009581|NCT02268045|157872090|FG001|Overall Study|Disease Progression|1|||
49009582|NCT02268045|157872089|FG000|Overall Study|Adverse Event|7|||
49009583|NCT02268045|157872090|FG001|Overall Study|Adverse Event|7|||
49009584|NCT02268045|157872089|FG000|Overall Study|Withdrawal by Subject|2|||
49009585|NCT02268045|157872090|FG001|Overall Study|Withdrawal by Subject|6|||
49009586|NCT02268045|157872089|FG000|Overall Study|Physician Decision|0|||
49009587|NCT02268045|157872090|FG001|Overall Study|Physician Decision|1|||
49009588|NCT02268045|157872089|FG000|Overall Study|Protocol Violation|1|||
49009589|NCT02268045|157872090|FG001|Overall Study|Protocol Violation|1|||
49009590|NCT00971204|157872091|FG000|Overall Study|Did not meet all criteria-not treated|14|||
49009591|NCT00971204|157872091|FG000|Overall Study|Lost to Follow-up|10|||
49009592|NCT04130919|157872093|FG000|Blinded Treatment Phase|Study terminated by sponsor|1|||
49009593|NCT04130919|157872094|FG001|Blinded Treatment Phase|Study terminated by sponsor|1|||
49009594|NCT04130919|157872095|FG002|Blinded Treatment Phase|Study terminated by sponsor|1|||
49009595|NCT04130919|157872096|FG003|Blinded Treatment Phase|Study terminated by sponsor|0|||
49009596|NCT04130919|157872097|FG004|Blinded Treatment Phase|Study terminated by sponsor|0|||
49113561|NCT00253370|158251727|FG000|Overall Study|Physician Decision|1|||
49009597|NCT04130919|157872098|FG005|Blinded Treatment Phase|Study terminated by sponsor|0|||
49009598|NCT04130919|157872093|FG000|Blinded Treatment Phase|Adverse Event|0|||
49009599|NCT04130919|157872094|FG001|Blinded Treatment Phase|Adverse Event|0|||
49009600|NCT04130919|157872095|FG002|Blinded Treatment Phase|Adverse Event|1|||
49009601|NCT04130919|157872096|FG003|Blinded Treatment Phase|Adverse Event|0|||
49009602|NCT04130919|157872097|FG004|Blinded Treatment Phase|Adverse Event|0|||
49009603|NCT04130919|157872098|FG005|Blinded Treatment Phase|Adverse Event|0|||
49009604|NCT04130919|157872093|FG000|Blinded Treatment Phase|Disease worsening|0|||
49009605|NCT04130919|157872094|FG001|Blinded Treatment Phase|Disease worsening|0|||
49009606|NCT04130919|157872095|FG002|Blinded Treatment Phase|Disease worsening|1|||
49009607|NCT04130919|157872096|FG003|Blinded Treatment Phase|Disease worsening|0|||
49009608|NCT04130919|157872097|FG004|Blinded Treatment Phase|Disease worsening|0|||
49009609|NCT04130919|157872098|FG005|Blinded Treatment Phase|Disease worsening|0|||
49009610|NCT04130919|157872093|FG000|Blinded Treatment Phase|Investigator's decision|0|||
49009611|NCT04130919|157872094|FG001|Blinded Treatment Phase|Investigator's decision|1|||
49009612|NCT04130919|157872095|FG002|Blinded Treatment Phase|Investigator's decision|0|||
49009613|NCT04130919|157872096|FG003|Blinded Treatment Phase|Investigator's decision|0|||
49009614|NCT04130919|157872097|FG004|Blinded Treatment Phase|Investigator's decision|0|||
49009615|NCT04130919|157872098|FG005|Blinded Treatment Phase|Investigator's decision|0|||
49009616|NCT04130919|157872093|FG000|Blinded Treatment Phase|Withdrew consent|1|||
49009617|NCT04130919|157872094|FG001|Blinded Treatment Phase|Withdrew consent|0|||
49009618|NCT04130919|157872095|FG002|Blinded Treatment Phase|Withdrew consent|0|||
49009619|NCT04130919|157872096|FG003|Blinded Treatment Phase|Withdrew consent|0|||
49009620|NCT04130919|157872097|FG004|Blinded Treatment Phase|Withdrew consent|0|||
49009621|NCT04130919|157872098|FG005|Blinded Treatment Phase|Withdrew consent|0|||
49009622|NCT04130919|157872093|FG000|Open-label Treatment Phase|Withdrew consent|0|||
49009623|NCT04130919|157872094|FG001|Open-label Treatment Phase|Withdrew consent|0|||
49009624|NCT04130919|157872095|FG002|Open-label Treatment Phase|Withdrew consent|0|||
49009625|NCT04130919|157872096|FG003|Open-label Treatment Phase|Withdrew consent|1|||
49009626|NCT04130919|157872097|FG004|Open-label Treatment Phase|Withdrew consent|1|||
49009627|NCT04130919|157872098|FG005|Open-label Treatment Phase|Withdrew consent|1|||
49009628|NCT04130919|157872093|FG000|Open-label Treatment Phase|Disease worsening|0|||
49009629|NCT04130919|157872094|FG001|Open-label Treatment Phase|Disease worsening|0|||
49009630|NCT04130919|157872095|FG002|Open-label Treatment Phase|Disease worsening|0|||
49009631|NCT04130919|157872096|FG003|Open-label Treatment Phase|Disease worsening|1|||
49009632|NCT04130919|157872097|FG004|Open-label Treatment Phase|Disease worsening|0|||
49009633|NCT04130919|157872098|FG005|Open-label Treatment Phase|Disease worsening|1|||
49009634|NCT04130919|157872093|FG000|Open-label Treatment Phase|Investigator's decision|0|||
49009635|NCT04130919|157872094|FG001|Open-label Treatment Phase|Investigator's decision|0|||
49009636|NCT04130919|157872095|FG002|Open-label Treatment Phase|Investigator's decision|0|||
49009637|NCT04130919|157872096|FG003|Open-label Treatment Phase|Investigator's decision|1|||
49009638|NCT04130919|157872097|FG004|Open-label Treatment Phase|Investigator's decision|0|||
49009639|NCT04130919|157872098|FG005|Open-label Treatment Phase|Investigator's decision|0|||
49009640|NCT04130919|157872093|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
49009641|NCT04130919|157872094|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
49009642|NCT04130919|157872095|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
49009643|NCT04130919|157872096|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
49009644|NCT04130919|157872097|FG004|Open-label Treatment Phase|Lost to Follow-up|0|||
49009645|NCT04130919|157872098|FG005|Open-label Treatment Phase|Lost to Follow-up|1|||
49009646|NCT04130919|157872093|FG000|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
49009647|NCT04130919|157872094|FG001|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
49009648|NCT04130919|157872095|FG002|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
49009649|NCT04130919|157872096|FG003|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
49009650|NCT04130919|157872097|FG004|Open-label Treatment Phase|MCS response not achieved at open-label week 10|1|||
49009651|NCT04130919|157872098|FG005|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
49009652|NCT02624518|157872099|FG000|Overall Study|Physician Decision|1|||
49009653|NCT00457665|157872100|FG000|12 Months|Drug allergy|1|||
49009654|NCT00457665|157872101|FG001|12 Months|Drug allergy|1|||
49009655|NCT00457665|157872100|FG000|12 Months|High HIV viral load|5|||
49009656|NCT00457665|157872101|FG001|12 Months|High HIV viral load|1|||
49009657|NCT00457665|157872100|FG000|12 Months|Lipodystrophy|2|||
49009658|NCT00457665|157872101|FG001|12 Months|Lipodystrophy|0|||
49009659|NCT00457665|157872100|FG000|12 Months|Withdrawal by Subject|0|||
49009660|NCT00457665|157872101|FG001|12 Months|Withdrawal by Subject|2|||
49009661|NCT00457665|157872100|FG000|12 Months|Abnormal Liver function tests|0|||
49009662|NCT00457665|157872101|FG001|12 Months|Abnormal Liver function tests|5|||
49009663|NCT00457665|157872100|FG000|24 Months|Withdrawal by Subject|3|||
49009664|NCT00457665|157872101|FG001|24 Months|Withdrawal by Subject|2|||
49009665|NCT00457665|157872100|FG000|24 Months|Lipodystrophy|1|||
49009666|NCT00457665|157872101|FG001|24 Months|Lipodystrophy|1|||
49009667|NCT00457665|157872100|FG000|24 Months|Abnormal liver function tests|1|||
49009668|NCT00457665|157872101|FG001|24 Months|Abnormal liver function tests|5|||
49009669|NCT03056352|157872103|FG000|Overall Study|Lost to Follow-up|1|||
49009670|NCT04304950|157872104|FG000|Overall Study|Lost to Follow-up|1|||
49009671|NCT04304950|157872105|FG001|Overall Study|Lost to Follow-up|1|||
49009672|NCT00543439|157872106|FG000|Period 1|Adverse Event|0|||
49009673|NCT00543439|157872107|FG001|Period 1|Adverse Event|2|||
49009674|NCT00543439|157872108|FG002|Period 1|Adverse Event|1|||
49009675|NCT00543439|157872106|FG000|Period 1|Withdrawal by Subject|1|||
49009676|NCT00543439|157872107|FG001|Period 1|Withdrawal by Subject|1|||
49009677|NCT00543439|157872108|FG002|Period 1|Withdrawal by Subject|0|||
49009678|NCT00543439|157872106|FG000|Period 1|Physician Decision|0|||
49009679|NCT00543439|157872107|FG001|Period 1|Physician Decision|0|||
49009680|NCT00543439|157872108|FG002|Period 1|Physician Decision|1|||
49009681|NCT00543439|157872106|FG000|Period 2|Protocol Violation|1|||
49009682|NCT00543439|157872107|FG001|Period 2|Protocol Violation|0|||
49009683|NCT00543439|157872108|FG002|Period 2|Protocol Violation|1|||
49009684|NCT00543439|157872106|FG000|Period 2|Adverse Event|0|||
49009685|NCT00543439|157872107|FG001|Period 2|Adverse Event|1|||
49009686|NCT00543439|157872108|FG002|Period 2|Adverse Event|1|||
49009687|NCT03586830|157872110|FG000|Overall Study|Site terminated by Sponsor|1|||
49009688|NCT03586830|157872111|FG001|Overall Study|Site terminated by Sponsor|4|||
49009689|NCT03586830|157872112|FG002|Overall Study|Site terminated by Sponsor|3|||
49009690|NCT03586830|157872113|FG003|Overall Study|Site terminated by Sponsor|3|||
49009691|NCT03586830|157872110|FG000|Overall Study|Lost to Follow-up|0|||
49009692|NCT03586830|157872111|FG001|Overall Study|Lost to Follow-up|2|||
49009693|NCT03586830|157872112|FG002|Overall Study|Lost to Follow-up|2|||
49009694|NCT03586830|157872113|FG003|Overall Study|Lost to Follow-up|1|||
49009695|NCT03586830|157872110|FG000|Overall Study|Withdrawal by Subject|1|||
49009696|NCT03586830|157872111|FG001|Overall Study|Withdrawal by Subject|0|||
49009697|NCT03586830|157872112|FG002|Overall Study|Withdrawal by Subject|3|||
49009698|NCT03586830|157872113|FG003|Overall Study|Withdrawal by Subject|1|||
49009699|NCT00931385|157872119|FG000|Overall Study|Adverse Event|2|||
49009700|NCT00931385|157872120|FG001|Overall Study|Adverse Event|1|||
49009701|NCT00931385|157872121|FG002|Overall Study|Adverse Event|0|||
49009702|NCT00931385|157872122|FG003|Overall Study|Adverse Event|3|||
49009703|NCT00931385|157872119|FG000|Overall Study|Protocol Violation|0|||
49009704|NCT00931385|157872120|FG001|Overall Study|Protocol Violation|0|||
49009705|NCT00931385|157872121|FG002|Overall Study|Protocol Violation|1|||
49009706|NCT00931385|157872122|FG003|Overall Study|Protocol Violation|0|||
49009707|NCT00931385|157872119|FG000|Overall Study|Withdrawal by Subject|0|||
49009708|NCT00931385|157872120|FG001|Overall Study|Withdrawal by Subject|1|||
49009709|NCT00931385|157872121|FG002|Overall Study|Withdrawal by Subject|0|||
49009710|NCT00931385|157872122|FG003|Overall Study|Withdrawal by Subject|1|||
49009711|NCT00931385|157872119|FG000|Overall Study|Lost to Follow-up|0|||
49009712|NCT00931385|157872120|FG001|Overall Study|Lost to Follow-up|0|||
49009713|NCT00931385|157872121|FG002|Overall Study|Lost to Follow-up|0|||
49009714|NCT00931385|157872122|FG003|Overall Study|Lost to Follow-up|1|||
49009715|NCT02094937|157872126|FG000|8 Weeks in Period 1|Adverse Event|9|||
49009716|NCT02094937|157872127|FG001|8 Weeks in Period 1|Adverse Event|0|||
49009717|NCT02094937|157872128|FG002|8 Weeks in Period 1|Adverse Event|0|||
49009718|NCT02094937|157872129|FG003|8 Weeks in Period 1|Adverse Event|0|||
49009719|NCT02094937|157872126|FG000|8 Weeks in Period 1|Lack of Efficacy|3|||
49009720|NCT02094937|157872127|FG001|8 Weeks in Period 1|Lack of Efficacy|0|||
49009721|NCT02094937|157872128|FG002|8 Weeks in Period 1|Lack of Efficacy|0|||
49009722|NCT02094937|157872129|FG003|8 Weeks in Period 1|Lack of Efficacy|0|||
49009723|NCT02094937|157872126|FG000|8 Weeks in Period 1|Protocol Violation|2|||
49009724|NCT02094937|157872127|FG001|8 Weeks in Period 1|Protocol Violation|0|||
49009725|NCT02094937|157872128|FG002|8 Weeks in Period 1|Protocol Violation|0|||
49009726|NCT02094937|157872129|FG003|8 Weeks in Period 1|Protocol Violation|0|||
49009727|NCT02094937|157872126|FG000|8 Weeks in Period 1|Protocol defined stopping criteria|41|||
49009728|NCT02094937|157872127|FG001|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
49009729|NCT02094937|157872128|FG002|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
49009730|NCT02094937|157872129|FG003|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
49009731|NCT02094937|157872126|FG000|8 Weeks in Period 1|Physician Decision|1|||
49009732|NCT02094937|157872127|FG001|8 Weeks in Period 1|Physician Decision|0|||
49009733|NCT02094937|157872128|FG002|8 Weeks in Period 1|Physician Decision|0|||
49009734|NCT02094937|157872129|FG003|8 Weeks in Period 1|Physician Decision|0|||
49009735|NCT02094937|157872126|FG000|8 Weeks in Period 1|Withdrawal by Subject|4|||
49009736|NCT02094937|157872127|FG001|8 Weeks in Period 1|Withdrawal by Subject|0|||
49009737|NCT02094937|157872128|FG002|8 Weeks in Period 1|Withdrawal by Subject|0|||
49009738|NCT02094937|157872129|FG003|8 Weeks in Period 1|Withdrawal by Subject|0|||
49009739|NCT02094937|157872126|FG000|12 Weeks in Period 2|Adverse Event|0|||
49009740|NCT02094937|157872127|FG001|12 Weeks in Period 2|Adverse Event|2|||
49009741|NCT02094937|157872128|FG002|12 Weeks in Period 2|Adverse Event|4|||
49009742|NCT02094937|157872129|FG003|12 Weeks in Period 2|Adverse Event|1|||
49009743|NCT02094937|157872126|FG000|12 Weeks in Period 2|Lack of Efficacy|0|||
49009744|NCT02094937|157872127|FG001|12 Weeks in Period 2|Lack of Efficacy|1|||
49009745|NCT02094937|157872128|FG002|12 Weeks in Period 2|Lack of Efficacy|0|||
49009746|NCT02094937|157872129|FG003|12 Weeks in Period 2|Lack of Efficacy|0|||
49009747|NCT02094937|157872126|FG000|12 Weeks in Period 2|Protocol defined stopping criteria|0|||
49009748|NCT02094937|157872127|FG001|12 Weeks in Period 2|Protocol defined stopping criteria|5|||
49009749|NCT02094937|157872128|FG002|12 Weeks in Period 2|Protocol defined stopping criteria|6|||
49009750|NCT02094937|157872129|FG003|12 Weeks in Period 2|Protocol defined stopping criteria|11|||
49009751|NCT02094937|157872126|FG000|12 Weeks in Period 2|Withdrawal by Subject|0|||
49009752|NCT02094937|157872127|FG001|12 Weeks in Period 2|Withdrawal by Subject|2|||
49113562|NCT00253370|158251727|FG000|Overall Study|Protocol Violation|1|||
49113563|NCT00253370|158251727|FG000|Overall Study|Abdominal pain due to disease|1|||
49113564|NCT00004088|158251728|FG000|Overall Study|No C2 given due to study on hold by IRB|4|||
49113565|NCT00004088|158251728|FG000|Overall Study|Withdrawal by Subject|1|||
49009753|NCT02094937|157872128|FG002|12 Weeks in Period 2|Withdrawal by Subject|2|||
49009754|NCT02094937|157872129|FG003|12 Weeks in Period 2|Withdrawal by Subject|0|||
49009755|NCT02094937|157872126|FG000|12 Weeks in Period 2|Randomized incorrectly|0|||
49009756|NCT02094937|157872127|FG001|12 Weeks in Period 2|Randomized incorrectly|1|||
49009757|NCT02094937|157872128|FG002|12 Weeks in Period 2|Randomized incorrectly|0|||
49009758|NCT02094937|157872129|FG003|12 Weeks in Period 2|Randomized incorrectly|0|||
49009759|NCT01015612|157872136|FG000|Overall Study|Death|113|||
49009760|NCT01015612|157872136|FG000|Overall Study|Withdrawal by Subject|40|||
49009761|NCT02595528|157873734|FG000|Overall Study|Withdrawal by Subject|1|||
49009762|NCT02595528|157873735|FG001|Overall Study|Withdrawal by Subject|2|||
49009763|NCT02595528|157873736|FG002|Overall Study|Withdrawal by Subject|1|||
49009764|NCT02595528|157873737|FG003|Overall Study|Withdrawal by Subject|3|||
49009765|NCT02595528|157873734|FG000|Overall Study|Lost to Follow-up|1|||
49009766|NCT02595528|157873735|FG001|Overall Study|Lost to Follow-up|1|||
49009767|NCT02595528|157873736|FG002|Overall Study|Lost to Follow-up|0|||
49009768|NCT02595528|157873737|FG003|Overall Study|Lost to Follow-up|1|||
49009769|NCT02290028|157873738|FG000|Overall Study|Death|217|||
49009770|NCT02290028|157873738|FG000|Overall Study|Sentus lead or required CRT-D was not implanted|186|||
49009771|NCT02290028|157873738|FG000|Overall Study|No longer under care of study physician|76|||
49009772|NCT02290028|157873738|FG000|Overall Study|Sentus lead or required CRT-D explanted|55|||
49009773|NCT02290028|157873738|FG000|Overall Study|Withdrawal by Subject|52|||
49009774|NCT02290028|157873738|FG000|Overall Study|Study site closure|44|||
49009775|NCT02290028|157873738|FG000|Overall Study|Lost to Follow-up|34|||
49009776|NCT02290028|157873738|FG000|Overall Study|Miscellaneous|10|||
49009777|NCT02290028|157873738|FG000|Overall Study|Transition to EP PASSION|1295|||
49009778|NCT02290028|157873738|FG000|Overall Study|Planned study completion at 12 months|257|||
49009779|NCT02360397|157873739|FG000|Overall Study|Incomplete screening|3|||
49009780|NCT02360397|157873739|FG000|Overall Study|Adverse Event|1|||
49009781|NCT03372083|157873740|FG000|Overall Study|Adverse Event|3|||
49009782|NCT03372083|157873740|FG000|Overall Study|Physician Decision|1|||
49009783|NCT03372083|157873740|FG000|Overall Study|Withdrawal by Subject|1|||
49009784|NCT03202511|157873741|FG000|Overall Study|Withdrawal by Subject|1|||
49009785|NCT03202511|157873742|FG001|Overall Study|Withdrawal by Subject|0|||
49009786|NCT00833547|157873743|FG000|Overall Study|Withdrawal by Subject|2|||
49009787|NCT00833547|157873744|FG001|Overall Study|Withdrawal by Subject|2|||
49009788|NCT00566098|157873748|FG000|Collection of MILs|Withdrawal by Subject|1|||
49009789|NCT00566098|157873748|FG000|Collection of MILs|Relapsed|1|||
49009790|NCT00566098|157873748|FG000|Generation of MILs Product|Relapsed|1|||
49009791|NCT00566098|157873748|FG000|Administration of ASCT+MILs|Death|10|||
49009792|NCT00566098|157873748|FG000|Administration of ASCT+MILs|Lack of Efficacy|8|||
49009793|NCT01991977|157873749|FG000|Overall Study|Withdrew prior to receiving treatment|7|||
49009794|NCT01991977|157873749|FG000|Overall Study|Withdrew after start of treatment|5|||
49009795|NCT00686790|157873750|FG000|Overall Study|Adverse Event|2|||
49009796|NCT00686790|157873750|FG000|Overall Study|Withdrawal by Subject|1|||
49009797|NCT00686790|157873750|FG000|Overall Study|Death|1|||
49009798|NCT00686790|157873750|FG000|Overall Study|Lost to Follow-up|12|||
49009799|NCT01690520|157873751|FG000|Overall Study|Death|25|||
49009800|NCT01690520|157873752|FG001|Overall Study|Death|21|||
49009801|NCT01690520|157873751|FG000|Overall Study|Lost to Follow-up|2|||
49009802|NCT01690520|157873752|FG001|Overall Study|Lost to Follow-up|3|||
49009803|NCT01690520|157873751|FG000|Overall Study|Withdrawal by Subject|2|||
49009804|NCT01690520|157873752|FG001|Overall Study|Withdrawal by Subject|0|||
49009805|NCT01690520|157873751|FG000|Overall Study|Relapse|0|||
49009806|NCT01690520|157873752|FG001|Overall Study|Relapse|1|||
49009807|NCT01690520|157873751|FG000|Overall Study|Other|0|||
49009808|NCT01690520|157873752|FG001|Overall Study|Other|1|||
49009809|NCT01690520|157873751|FG000|Overall Study|Ongoing Follow-Up at time of Analysis|22|||
49009810|NCT01690520|157873752|FG001|Overall Study|Ongoing Follow-Up at time of Analysis|21|||
49009811|NCT00382291|157873753|FG000|Overall Study|Adverse Event|1|||
49009812|NCT00382291|157873754|FG001|Overall Study|Adverse Event|2|||
49009813|NCT00382291|157873755|FG002|Overall Study|Adverse Event|2|||
49009814|NCT00382291|157873753|FG000|Overall Study|Protocol Violation|1|||
49009815|NCT00382291|157873754|FG001|Overall Study|Protocol Violation|0|||
49009816|NCT00382291|157873755|FG002|Overall Study|Protocol Violation|0|||
49009817|NCT00382291|157873753|FG000|Overall Study|Temporary study suspension|2|||
48903799|NCT00604279|157484172|FG001|Overall Study|Pregnancy|0|||
48903800|NCT00604279|157484171|FG000|Overall Study|Protocol Violation|3|||
49009818|NCT00382291|157873754|FG001|Overall Study|Temporary study suspension|2|||
48903801|NCT00604279|157484172|FG001|Overall Study|Protocol Violation|1|||
48903802|NCT00604279|157484171|FG000|Overall Study|Withdrawal by Subject|16|||
49009819|NCT00382291|157873755|FG002|Overall Study|Temporary study suspension|5|||
49009820|NCT00382291|157873753|FG000|Overall Study|Withdrawal by Subject|0|||
49009821|NCT00382291|157873754|FG001|Overall Study|Withdrawal by Subject|2|||
49009822|NCT00382291|157873755|FG002|Overall Study|Withdrawal by Subject|0|||
49009823|NCT00382291|157873753|FG000|Overall Study|Physician Decision|0|||
49009824|NCT00382291|157873754|FG001|Overall Study|Physician Decision|1|||
49009825|NCT00382291|157873755|FG002|Overall Study|Physician Decision|0|||
49009826|NCT00382291|157873753|FG000|Overall Study|Lack of Efficacy|0|||
49009827|NCT00382291|157873754|FG001|Overall Study|Lack of Efficacy|0|||
49009828|NCT00382291|157873755|FG002|Overall Study|Lack of Efficacy|1|||
49009829|NCT02266706|157873756|FG000|Overall Study|Withdrawal by Subject|0|||
49009830|NCT02266706|157873757|FG001|Overall Study|Withdrawal by Subject|1|||
49009831|NCT02266706|157873758|FG002|Overall Study|Withdrawal by Subject|1|||
49009832|NCT02266706|157873759|FG003|Overall Study|Withdrawal by Subject|0|||
49009833|NCT02266706|157873760|FG004|Overall Study|Withdrawal by Subject|0|||
49009834|NCT02266706|157873761|FG005|Overall Study|Withdrawal by Subject|1|||
49009835|NCT02266706|157873762|FG006|Overall Study|Withdrawal by Subject|0|||
49009836|NCT02266706|157873763|FG007|Overall Study|Withdrawal by Subject|0|||
49009837|NCT02266706|157873764|FG008|Overall Study|Withdrawal by Subject|0|||
49009838|NCT02266706|157873756|FG000|Overall Study|Screen failure|0|||
49009839|NCT02266706|157873757|FG001|Overall Study|Screen failure|0|||
49009840|NCT02266706|157873758|FG002|Overall Study|Screen failure|0|||
49009841|NCT02266706|157873759|FG003|Overall Study|Screen failure|0|||
49009842|NCT02266706|157873760|FG004|Overall Study|Screen failure|0|||
49009843|NCT02266706|157873761|FG005|Overall Study|Screen failure|1|||
49009844|NCT02266706|157873762|FG006|Overall Study|Screen failure|1|||
49009845|NCT02266706|157873763|FG007|Overall Study|Screen failure|0|||
49009846|NCT02266706|157873764|FG008|Overall Study|Screen failure|0|||
49009847|NCT02266706|157873756|FG000|Overall Study|Enrollment in another study|0|||
49009848|NCT02266706|157873757|FG001|Overall Study|Enrollment in another study|0|||
49009849|NCT02266706|157873758|FG002|Overall Study|Enrollment in another study|0|||
49009850|NCT02266706|157873759|FG003|Overall Study|Enrollment in another study|1|||
49009851|NCT02266706|157873760|FG004|Overall Study|Enrollment in another study|0|||
49009852|NCT02266706|157873761|FG005|Overall Study|Enrollment in another study|0|||
49009853|NCT02266706|157873762|FG006|Overall Study|Enrollment in another study|0|||
49009854|NCT02266706|157873763|FG007|Overall Study|Enrollment in another study|0|||
49009855|NCT02266706|157873764|FG008|Overall Study|Enrollment in another study|0|||
49009856|NCT02402933|157873766|FG000|Overall Study|Withdrawal by Subject|4|||
49009857|NCT02402933|157873766|FG000|Overall Study|Discontinued; Site Termination|10|||
49009858|NCT02544633|157873777|FG000|Treatment Period|Patient Still on Treatment/Study|0|||
49009859|NCT02544633|157873778|FG001|Treatment Period|Patient Still on Treatment/Study|1|||
49009860|NCT02544633|157873779|FG002|Treatment Period|Patient Still on Treatment/Study|1|||
49009861|NCT02544633|157873780|FG003|Treatment Period|Patient Still on Treatment/Study|0|||
49009862|NCT02544633|157873777|FG000|Treatment Period|Adverse Event|7|||
49009863|NCT02544633|157873778|FG001|Treatment Period|Adverse Event|4|||
49009864|NCT02544633|157873779|FG002|Treatment Period|Adverse Event|0|||
49009865|NCT02544633|157873780|FG003|Treatment Period|Adverse Event|5|||
49009866|NCT02544633|157873777|FG000|Treatment Period|Lack of Efficacy|17|||
49009867|NCT02544633|157873778|FG001|Treatment Period|Lack of Efficacy|11|||
49009868|NCT02544633|157873779|FG002|Treatment Period|Lack of Efficacy|5|||
49009869|NCT02544633|157873780|FG003|Treatment Period|Lack of Efficacy|5|||
49009870|NCT02544633|157873777|FG000|Treatment Period|Global Deterioration of Health|3|||
49009871|NCT02544633|157873778|FG001|Treatment Period|Global Deterioration of Health|3|||
49009872|NCT02544633|157873779|FG002|Treatment Period|Global Deterioration of Health|0|||
49009873|NCT02544633|157873780|FG003|Treatment Period|Global Deterioration of Health|1|||
49009874|NCT02544633|157873777|FG000|Treatment Period|Withdrawal by Subject|1|||
49009875|NCT02544633|157873778|FG001|Treatment Period|Withdrawal by Subject|0|||
49009876|NCT02544633|157873779|FG002|Treatment Period|Withdrawal by Subject|0|||
49009877|NCT02544633|157873780|FG003|Treatment Period|Withdrawal by Subject|0|||
49009878|NCT02544633|157873777|FG000|Treatment Period|Lost to Follow-up|0|||
49009879|NCT02544633|157873778|FG001|Treatment Period|Lost to Follow-up|1|||
49009880|NCT02544633|157873779|FG002|Treatment Period|Lost to Follow-up|0|||
49009881|NCT02544633|157873780|FG003|Treatment Period|Lost to Follow-up|0|||
49009882|NCT02544633|157873777|FG000|Treatment Period|Death|0|||
49009883|NCT02544633|157873778|FG001|Treatment Period|Death|0|||
49009884|NCT02544633|157873779|FG002|Treatment Period|Death|1|||
49009885|NCT02544633|157873780|FG003|Treatment Period|Death|0|||
49009886|NCT02544633|157873777|FG000|Treatment Period|Non-compliance|0|||
49009887|NCT02544633|157873778|FG001|Treatment Period|Non-compliance|0|||
49009888|NCT02544633|157873779|FG002|Treatment Period|Non-compliance|1|||
49009889|NCT02544633|157873780|FG003|Treatment Period|Non-compliance|0|||
49009890|NCT02544633|157873777|FG000|Treatment Period|Clinical Disease Progression|0|||
49009891|NCT02544633|157873778|FG001|Treatment Period|Clinical Disease Progression|0|||
49009892|NCT02544633|157873779|FG002|Treatment Period|Clinical Disease Progression|0|||
49009893|NCT02544633|157873780|FG003|Treatment Period|Clinical Disease Progression|1|||
49009894|NCT02544633|157873777|FG000|Survival Follow-up Period|Death|12|||
49009895|NCT02544633|157873778|FG001|Survival Follow-up Period|Death|14|||
49009896|NCT02544633|157873779|FG002|Survival Follow-up Period|Death|3|||
49009897|NCT02544633|157873780|FG003|Survival Follow-up Period|Death|9|||
49009898|NCT02544633|157873777|FG000|Survival Follow-up Period|Lost to Follow-up|0|||
49009899|NCT02544633|157873778|FG001|Survival Follow-up Period|Lost to Follow-up|1|||
49009900|NCT02544633|157873779|FG002|Survival Follow-up Period|Lost to Follow-up|1|||
49009901|NCT02544633|157873780|FG003|Survival Follow-up Period|Lost to Follow-up|0|||
49113566|NCT00004088|158251728|FG000|Overall Study|Protocol Violation|3|||
49009902|NCT02544633|157873777|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
49009903|NCT02544633|157873778|FG001|Survival Follow-up Period|Withdrawal by Subject|0|||
49009904|NCT02544633|157873779|FG002|Survival Follow-up Period|Withdrawal by Subject|1|||
49009905|NCT02544633|157873780|FG003|Survival Follow-up Period|Withdrawal by Subject|0|||
49009906|NCT02544633|157873777|FG000|Survival Follow-up Period|Study Terminated by Sponsor|12|||
49009907|NCT02544633|157873778|FG001|Survival Follow-up Period|Study Terminated by Sponsor|4|||
49009908|NCT02544633|157873779|FG002|Survival Follow-up Period|Study Terminated by Sponsor|2|||
49009909|NCT02544633|157873780|FG003|Survival Follow-up Period|Study Terminated by Sponsor|3|||
49009910|NCT01967888|157873783|FG000|Overall Study|Lost to Follow-up|6|||
49009911|NCT01967888|157873784|FG001|Overall Study|Lost to Follow-up|4|||
49009912|NCT01967888|157873783|FG000|Overall Study|Withdrawal by Subject|1|||
49009913|NCT01967888|157873784|FG001|Overall Study|Withdrawal by Subject|1|||
49009914|NCT01967888|157873783|FG000|Overall Study|Did Not Have Transplant|1|||
49009915|NCT01967888|157873784|FG001|Overall Study|Did Not Have Transplant|0|||
49009916|NCT01967888|157873783|FG000|Overall Study|Research visit not done, data recorded|1|||
49009917|NCT01967888|157873784|FG001|Overall Study|Research visit not done, data recorded|0|||
49009918|NCT01967888|157873783|FG000|Overall Study|Subject excluded after randomization|1|||
49009919|NCT01967888|157873784|FG001|Overall Study|Subject excluded after randomization|0|||
49009920|NCT01967888|157873783|FG000|Overall Study|Patient didn't proceed to pancreatectomy|0|||
49009921|NCT01967888|157873784|FG001|Overall Study|Patient didn't proceed to pancreatectomy|1|||
49009922|NCT01967888|157873783|FG000|Overall Study|Subject Unable To Comply With Final Day|0|||
49009923|NCT01967888|157873784|FG001|Overall Study|Subject Unable To Comply With Final Day|1|||
49009924|NCT02436135|157873787|FG000|Overall Study|Progressive Disease|3|||
49009925|NCT02436135|157873788|FG001|Overall Study|Progressive Disease|1|||
49009926|NCT02436135|157873787|FG000|Overall Study|Investigator Discretion|1|||
49009927|NCT02436135|157873788|FG001|Overall Study|Investigator Discretion|2|||
49009928|NCT02436135|157873787|FG000|Overall Study|Adverse Event|1|||
49009929|NCT02436135|157873788|FG001|Overall Study|Adverse Event|0|||
49009930|NCT02436135|157873787|FG000|Overall Study|Withdrawal by Participant|1|||
49009931|NCT02436135|157873788|FG001|Overall Study|Withdrawal by Participant|0|||
49009932|NCT02436135|157873787|FG000|Overall Study|Study Terminated By Sponsor|0|||
49009933|NCT02436135|157873788|FG001|Overall Study|Study Terminated By Sponsor|1|||
49009934|NCT02729194|157873792|FG000|Overall Study|Withdrawal by Subject|3|||
49009935|NCT00845026|157873797|FG000|Study Period III|Adverse Event|23|||
49009936|NCT00845026|157873798|FG001|Study Period III|Adverse Event|19|||
49009937|NCT00845026|157873797|FG000|Study Period III|Perceived lack of efficacy|27|||
49009938|NCT00845026|157873798|FG001|Study Period III|Perceived lack of efficacy|15|||
49009939|NCT00845026|157873797|FG000|Study Period III|Withdrawal by Subject|19|||
49009940|NCT00845026|157873798|FG001|Study Period III|Withdrawal by Subject|15|||
49009941|NCT00845026|157873797|FG000|Study Period III|Entry Criteria not met|8|||
49009942|NCT00845026|157873798|FG001|Study Period III|Entry Criteria not met|11|||
49009943|NCT00845026|157873797|FG000|Study Period III|Lost to Follow-up|4|||
49009944|NCT00845026|157873798|FG001|Study Period III|Lost to Follow-up|5|||
49009945|NCT00845026|157873797|FG000|Study Period III|Protocol Violation|8|||
49009946|NCT00845026|157873798|FG001|Study Period III|Protocol Violation|1|||
49009947|NCT00845026|157873797|FG000|Study Period III|Scheduled conflict|3|||
49009948|NCT00845026|157873798|FG001|Study Period III|Scheduled conflict|1|||
49009949|NCT00845026|157873797|FG000|Study Period III|Subject is moving or has moved|2|||
49009950|NCT00845026|157873798|FG001|Study Period III|Subject is moving or has moved|4|||
49009951|NCT00845026|157873797|FG000|Study Period III|Transportation issues|1|||
49009952|NCT00845026|157873798|FG001|Study Period III|Transportation issues|1|||
49009953|NCT00845026|157873797|FG000|Study Period IV|Adverse Event|4|||
49009954|NCT00845026|157873798|FG001|Study Period IV|Adverse Event|0|||
49009955|NCT00845026|157873797|FG000|Study Period IV|Perceived lack of efficacy|2|||
49009956|NCT00845026|157873798|FG001|Study Period IV|Perceived lack of efficacy|1|||
49009957|NCT00845026|157873797|FG000|Study Period IV|Protocol Violation|3|||
49009958|NCT00845026|157873798|FG001|Study Period IV|Protocol Violation|1|||
49009959|NCT00845026|157873797|FG000|Study Period IV|Lost to Follow-up|1|||
49009960|NCT00845026|157873798|FG001|Study Period IV|Lost to Follow-up|0|||
49009961|NCT00845026|157873797|FG000|Study Period IV|Withdrawal by Subject|4|||
49009962|NCT00845026|157873798|FG001|Study Period IV|Withdrawal by Subject|1|||
49009963|NCT00845026|157873797|FG000|Study Period IV|Entry Criteria Not Met|1|||
49009964|NCT00845026|157873798|FG001|Study Period IV|Entry Criteria Not Met|0|||
49009965|NCT00845026|157873797|FG000|Study Period IV|Subject is moving or has moved|0|||
49009966|NCT00845026|157873798|FG001|Study Period IV|Subject is moving or has moved|1|||
49009967|NCT00845026|157873797|FG000|Study Period IV|Scheduling conflict|1|||
49009968|NCT00845026|157873798|FG001|Study Period IV|Scheduling conflict|0|||
49009969|NCT00370396|157873801|FG000|Overall Study|Withdrawal by Subject|0|||
49009970|NCT00370396|157873802|FG001|Overall Study|Withdrawal by Subject|0|||
49009971|NCT00370396|157873803|FG002|Overall Study|Withdrawal by Subject|1|||
49009972|NCT00370396|157873801|FG000|Overall Study|Lost to Follow-up|11|||
49009973|NCT00370396|157873802|FG001|Overall Study|Lost to Follow-up|1|||
49009974|NCT00370396|157873803|FG002|Overall Study|Lost to Follow-up|0|||
49009975|NCT01325532|157873804|FG000|Overall Study|Withdrawal by Subject|2|||
49009976|NCT01325532|157873805|FG001|Overall Study|Withdrawal by Subject|0|||
49009977|NCT03012815|157873811|FG000|Overall Study|Lost to Follow-up|1|||
49009978|NCT03012815|157873812|FG001|Overall Study|Lost to Follow-up|0|||
49009979|NCT03012815|157873811|FG000|Overall Study|Physician Decision|3|||
49009980|NCT03012815|157873812|FG001|Overall Study|Physician Decision|2|||
49009981|NCT03012815|157873811|FG000|Overall Study|Adverse Event|1|||
49009982|NCT03012815|157873812|FG001|Overall Study|Adverse Event|0|||
49009983|NCT01252238|157873816|FG000|Overall Study|Sponsor terminated study|4|||
49009984|NCT01252238|157873817|FG001|Overall Study|Sponsor terminated study|4|||
49009985|NCT01252238|157873818|FG002|Overall Study|Sponsor terminated study|4|||
49009986|NCT00475852|157873819|FG000|Overall Study|Death|444|||
49009987|NCT00475852|157873820|FG001|Overall Study|Death|456|||
49009988|NCT00475852|157873819|FG000|Overall Study|Withdrawal by Subject|19|||
49009989|NCT00475852|157873820|FG001|Overall Study|Withdrawal by Subject|24|||
49009990|NCT00475852|157873819|FG000|Overall Study|Lost to Follow-up|54|||
49009991|NCT00475852|157873820|FG001|Overall Study|Lost to Follow-up|68|||
49009992|NCT02065791|157873821|FG000|Overall Study|Closed Site|1|||
49009993|NCT02065791|157873822|FG001|Overall Study|Closed Site|1|||
49009994|NCT02065791|157873821|FG000|Overall Study|Withdrawal by Subject|11|||
49009995|NCT02065791|157873822|FG001|Overall Study|Withdrawal by Subject|5|||
49009996|NCT02065791|157873821|FG000|Overall Study|Lost to Follow-up|13|||
49009997|NCT02065791|157873822|FG001|Overall Study|Lost to Follow-up|9|||
49009998|NCT00272961|157873823|FG000|Placebo Run-in Phase: Up to Week 2|Physician Decision|1|||
49009999|NCT00272961|157873824|FG001|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
49010000|NCT00272961|157873825|FG002|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
49010001|NCT00272961|157873826|FG003|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
49010002|NCT00272961|157873827|FG004|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
49010003|NCT00272961|157873823|FG000|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1|||
49010004|NCT00272961|157873824|FG001|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
49010005|NCT00272961|157873825|FG002|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
49010006|NCT00272961|157873826|FG003|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
49010007|NCT00272961|157873827|FG004|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
49010008|NCT00272961|157873823|FG000|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5|||
49010009|NCT00272961|157873824|FG001|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
49010010|NCT00272961|157873825|FG002|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
49010011|NCT00272961|157873826|FG003|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
49010012|NCT00272961|157873827|FG004|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
49010013|NCT00272961|157873823|FG000|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2|||
49010014|NCT00272961|157873824|FG001|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
49010015|NCT00272961|157873825|FG002|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
49010016|NCT00272961|157873826|FG003|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
49010017|NCT00272961|157873827|FG004|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
49010018|NCT00272961|157873823|FG000|Placebo Run-in Phase: Up to Week 2|Other|2|||
49010019|NCT00272961|157873824|FG001|Placebo Run-in Phase: Up to Week 2|Other|0|||
49010020|NCT00272961|157873825|FG002|Placebo Run-in Phase: Up to Week 2|Other|0|||
49010021|NCT00272961|157873826|FG003|Placebo Run-in Phase: Up to Week 2|Other|0|||
49010022|NCT00272961|157873827|FG004|Placebo Run-in Phase: Up to Week 2|Other|0|||
49010023|NCT00272961|157873823|FG000|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
49010024|NCT00272961|157873824|FG001|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
49010025|NCT00272961|157873825|FG002|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
49010026|NCT00272961|157873826|FG003|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
49010027|NCT00272961|157873827|FG004|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2|||
49010028|NCT00272961|157873823|FG000|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
49010029|NCT00272961|157873824|FG001|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
49010030|NCT00272961|157873825|FG002|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
49010031|NCT00272961|157873826|FG003|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
49010032|NCT00272961|157873827|FG004|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
49010033|NCT00272961|157873823|FG000|Treatment Phase: Week 3 Up to Week 12|Other|1|||
49010034|NCT00272961|157873824|FG001|Treatment Phase: Week 3 Up to Week 12|Other|3|||
49010035|NCT00272961|157873825|FG002|Treatment Phase: Week 3 Up to Week 12|Other|3|||
49010036|NCT00272961|157873826|FG003|Treatment Phase: Week 3 Up to Week 12|Other|2|||
49010037|NCT00272961|157873827|FG004|Treatment Phase: Week 3 Up to Week 12|Other|2|||
49010038|NCT02063698|157873828|FG000|Overall Study|did not complete booklet for days 2-8|1|||
49010039|NCT02063698|157873829|FG001|Overall Study|did not complete booklet for days 2-8|2|||
49010040|NCT01361607|157873831|FG000|Overall Study|Adverse Event|38|||
49010041|NCT01361607|157873832|FG001|Overall Study|Adverse Event|29|||
49010042|NCT01361607|157873831|FG000|Overall Study|Withdrawal by Subject|19|||
49113567|NCT00004088|158251728|FG000|Overall Study|Physician Decision|1|||
49010043|NCT01361607|157873832|FG001|Overall Study|Withdrawal by Subject|8|||
49010044|NCT01361607|157873831|FG000|Overall Study|Withdrawal by Investigator|5|||
49010045|NCT01361607|157873832|FG001|Overall Study|Withdrawal by Investigator|3|||
49010046|NCT01361607|157873831|FG000|Overall Study|Lost to Follow-up|1|||
49010047|NCT01361607|157873832|FG001|Overall Study|Lost to Follow-up|0|||
49010048|NCT01361607|157873831|FG000|Overall Study|Met Withdrawal Criteria|1|||
49010049|NCT01361607|157873832|FG001|Overall Study|Met Withdrawal Criteria|1|||
49010050|NCT01401478|157873833|FG000|Overall Study|Study drug not available|6|||
49010051|NCT01401478|157873833|FG000|Overall Study|Adverse Event|5|||
49010052|NCT01401478|157873833|FG000|Overall Study|Hyperphosphatemia|5|||
49010053|NCT01401478|157873833|FG000|Overall Study|Lost to Follow-up|5|||
49010054|NCT01401478|157873833|FG000|Overall Study|Kidney transplantation|3|||
49010055|NCT01401478|157873833|FG000|Overall Study|Withdrawal by Subject|3|||
49010056|NCT01401478|157873833|FG000|Overall Study|Blood samples not available|1|||
49010057|NCT01401478|157873833|FG000|Overall Study|Hyperphosphatemia and adverse event|1|||
49010058|NCT01401478|157873833|FG000|Overall Study|Low intact parathyroid hormone|1|||
49010059|NCT01401478|157873833|FG000|Overall Study|Serious adverse event|1|||
49010060|NCT00297479|157873834|FG000|Overall Study|Lost to Follow-up|37|||
49010061|NCT00297479|157873835|FG001|Overall Study|Lost to Follow-up|54|||
49010062|NCT00297479|157873836|FG002|Overall Study|Lost to Follow-up|51|||
49010063|NCT00068237|157873847|FG000|Overall Study|Ineligible|3|||
49010064|NCT00068237|157873847|FG000|Overall Study|No protocol treatment received|2|||
49010065|NCT02868281|157873848|FG000|Overall Study|Adverse Event|2|||
49010066|NCT02868281|157873849|FG001|Overall Study|Adverse Event|2|||
49010067|NCT02868281|157873848|FG000|Overall Study|Protocol Violation|13|||
49010068|NCT02868281|157873849|FG001|Overall Study|Protocol Violation|10|||
49010069|NCT02868281|157873848|FG000|Overall Study|Lost to Follow-up|3|||
49010070|NCT02868281|157873849|FG001|Overall Study|Lost to Follow-up|6|||
49010071|NCT02868281|157873848|FG000|Overall Study|Withdrawal by Subject|11|||
49010072|NCT02868281|157873849|FG001|Overall Study|Withdrawal by Subject|15|||
49010073|NCT02868281|157873848|FG000|Overall Study|Physician Decision|2|||
49010074|NCT02868281|157873849|FG001|Overall Study|Physician Decision|0|||
49010075|NCT02868281|157873848|FG000|Overall Study|Had protocol-defined asthma exacerbation|8|||
49010076|NCT02868281|157873849|FG001|Overall Study|Had protocol-defined asthma exacerbation|8|||
49010077|NCT02868281|157873848|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
49010078|NCT02868281|157873849|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
49010079|NCT02868281|157873848|FG000|Overall Study|Long journey/moving away|1|||
49010080|NCT02868281|157873849|FG001|Overall Study|Long journey/moving away|1|||
49010081|NCT01722266|157873854|FG000|Overall Study|Withdrawal by Subject|1|||
49010082|NCT01722266|157873855|FG001|Overall Study|Withdrawal by Subject|2|||
49010083|NCT01722266|157873856|FG002|Overall Study|Withdrawal by Subject|0|||
49010084|NCT01722266|157873857|FG003|Overall Study|Withdrawal by Subject|0|||
49010085|NCT01722266|157873854|FG000|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
49010086|NCT01722266|157873855|FG001|Overall Study|Tolerated only 0.6 mg liraglutide|1|||
49010087|NCT01722266|157873856|FG002|Overall Study|Tolerated only 0.6 mg liraglutide|3|||
49010088|NCT01722266|157873857|FG003|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
49010089|NCT01722266|157873854|FG000|Overall Study|Dropped out due to Nausea|0|||
49010090|NCT01722266|157873855|FG001|Overall Study|Dropped out due to Nausea|0|||
49010091|NCT01722266|157873856|FG002|Overall Study|Dropped out due to Nausea|2|||
49010092|NCT01722266|157873857|FG003|Overall Study|Dropped out due to Nausea|0|||
49010093|NCT01335464|157873858|FG000|Overall Study|Adverse Event|15|||
49010094|NCT01335464|157873859|FG001|Overall Study|Adverse Event|25|||
49010095|NCT01335464|157873858|FG000|Overall Study|Non compliant with protocol|2|||
49010096|NCT01335464|157873859|FG001|Overall Study|Non compliant with protocol|0|||
49010097|NCT01335464|157873858|FG000|Overall Study|Consent withdrawn, not due to AE|12|||
49010098|NCT01335464|157873859|FG001|Overall Study|Consent withdrawn, not due to AE|23|||
49010099|NCT01335464|157873858|FG000|Overall Study|Not treated|2|||
49010100|NCT01335464|157873859|FG001|Overall Study|Not treated|0|||
49010101|NCT01335464|157873858|FG000|Overall Study|Reason other than those stated above|1|||
49010102|NCT01335464|157873859|FG001|Overall Study|Reason other than those stated above|1|||
49010103|NCT03156270|157873860|FG000|Overall Study|Failed pre-treatment screening|1|||
49010104|NCT03156270|157873860|FG000|Overall Study|Lost to Follow-up|1|||
49010105|NCT02535000|157873868|FG000|Overall Study|Cancellation of surgery.|1|||
49010106|NCT02535000|157873869|FG001|Overall Study|Cancellation of surgery.|2|||
49010107|NCT02191579|157873870|FG000|Treatment 1|Multiple Reasons Specified|27|||
49010108|NCT02191579|157873871|FG001|Treatment 1|Multiple Reasons Specified|58|||
49010109|NCT02191579|157873870|FG000|Treatment 2|Multiple Reasons Specified|0|||
49010110|NCT02191579|157873871|FG001|Treatment 2|Multiple Reasons Specified|25|||
49010111|NCT01021137|157873875|FG000|Overall Study|Lost to Follow-up|9|||
49010112|NCT01021137|157873876|FG001|Overall Study|Lost to Follow-up|4|||
49010113|NCT01021137|157873877|FG002|Overall Study|Lost to Follow-up|2|||
49010114|NCT01021137|157873878|FG003|Overall Study|Lost to Follow-up|6|||
49010115|NCT01021137|157873875|FG000|Overall Study|Withdrawal by Subject|1|||
49010116|NCT01021137|157873876|FG001|Overall Study|Withdrawal by Subject|0|||
49010117|NCT01021137|157873877|FG002|Overall Study|Withdrawal by Subject|0|||
49010118|NCT01021137|157873878|FG003|Overall Study|Withdrawal by Subject|3|||
48742914|NCT00745823|156910413|FG000|Overall Study|Lack of Efficacy|20|||
49010119|NCT02280356|157873879|FG000|Overall Study|Not Treated|2|||
49010120|NCT02280356|157873879|FG000|Overall Study|Withdrawal by Subject|1|||
49010121|NCT02280356|157873879|FG000|Overall Study|Not evaluable|2|||
49010122|NCT00066807|157873882|FG000|Overall Study|Study was terminated early|14|||
49010123|NCT00066807|157873883|FG001|Overall Study|Study was terminated early|15|||
49010124|NCT03077828|157873886|FG000|Treatment Cycles|Death|1|||
49010125|NCT03077828|157873886|FG000|Treatment Cycles|Withdrawal by Subject|1|||
49010126|NCT03077828|157873886|FG000|Treatment Cycles|Screen Fail|2|||
49010127|NCT03077828|157873886|FG000|Autologous Stem Cell Transplant|Adverse Event|1|||
49010128|NCT03077828|157873886|FG000|Autologous Stem Cell Transplant|Withdrawal by Subject|2|||
49113568|NCT00099632|158251737|FG000|Overall Study|Lost to Follow-up|1|||
49113569|NCT00099632|158251738|FG001|Overall Study|Lost to Follow-up|0|||
49113570|NCT00099632|158251739|FG002|Overall Study|Lost to Follow-up|3|||
49113571|NCT00099632|158251740|FG003|Overall Study|Lost to Follow-up|1|||
49113572|NCT00099632|158251741|FG004|Overall Study|Lost to Follow-up|1|||
49113573|NCT00099632|158251742|FG005|Overall Study|Lost to Follow-up|0|||
49113574|NCT00099632|158251737|FG000|Overall Study|Withdrawal by Subject|0|||
49113575|NCT00099632|158251738|FG001|Overall Study|Withdrawal by Subject|1|||
49113576|NCT00099632|158251739|FG002|Overall Study|Withdrawal by Subject|0|||
49113577|NCT00099632|158251740|FG003|Overall Study|Withdrawal by Subject|0|||
49113578|NCT00099632|158251741|FG004|Overall Study|Withdrawal by Subject|0|||
49113579|NCT00099632|158251742|FG005|Overall Study|Withdrawal by Subject|1|||
49113580|NCT00099632|158251737|FG000|Overall Study|Protocol Violation|0|||
49113581|NCT00099632|158251738|FG001|Overall Study|Protocol Violation|0|||
49113582|NCT00099632|158251739|FG002|Overall Study|Protocol Violation|0|||
49113583|NCT00099632|158251740|FG003|Overall Study|Protocol Violation|0|||
49113584|NCT00099632|158251741|FG004|Overall Study|Protocol Violation|0|||
49113585|NCT00099632|158251742|FG005|Overall Study|Protocol Violation|1|||
49113586|NCT00369161|158251747|FG000|Overall Study|Adverse Event|15|||
49113587|NCT00369161|158251748|FG001|Overall Study|Adverse Event|13|||
49113588|NCT00369161|158251747|FG000|Overall Study|Abnormal laboratory value|0|||
49113589|NCT00369161|158251748|FG001|Overall Study|Abnormal laboratory value|1|||
49113590|NCT00369161|158251747|FG000|Overall Study|Lack of Efficacy|3|||
49113591|NCT00369161|158251748|FG001|Overall Study|Lack of Efficacy|1|||
49113592|NCT00369161|158251747|FG000|Overall Study|Protocol Violation|0|||
49113593|NCT00369161|158251748|FG001|Overall Study|Protocol Violation|2|||
49113594|NCT00369161|158251747|FG000|Overall Study|Withdrawal by Subject|2|||
49113595|NCT00369161|158251748|FG001|Overall Study|Withdrawal by Subject|3|||
49113596|NCT00369161|158251747|FG000|Overall Study|Death|1|||
49113597|NCT00369161|158251748|FG001|Overall Study|Death|2|||
49113598|NCT00369161|158251747|FG000|Overall Study|Graft loss|4|||
49113599|NCT00369161|158251748|FG001|Overall Study|Graft loss|0|||
49113600|NCT00369161|158251747|FG000|Overall Study|Administrative Problem|2|||
49113601|NCT00369161|158251748|FG001|Overall Study|Administrative Problem|2|||
49113602|NCT02191046|158251749|FG000|Overall Study|low compliance|5|||
49113603|NCT02191046|158251750|FG001|Overall Study|low compliance|1|||
49113604|NCT01964716|158251751|FG000|Overall Study|Withdrawal by Subject|2|||
49113605|NCT01964716|158251752|FG001|Overall Study|Withdrawal by Subject|3|||
49113606|NCT01964716|158251751|FG000|Overall Study|Lost to Follow-up|1|||
49113607|NCT01964716|158251752|FG001|Overall Study|Lost to Follow-up|2|||
49113608|NCT01964716|158251751|FG000|Overall Study|No longer met eligibility criteria|1|||
49113609|NCT01964716|158251752|FG001|Overall Study|No longer met eligibility criteria|1|||
49113610|NCT01964716|158251751|FG000|Overall Study|Death|1|||
49113611|NCT01964716|158251752|FG001|Overall Study|Death|0|||
49113612|NCT02347072|158251753|FG000|Overall Study|Adverse Event|2|||
49113613|NCT02347072|158251753|FG000|Overall Study|Withdrawal by Subject|6|||
49113614|NCT02347072|158251753|FG000|Overall Study|Physician Decision|1|||
49113615|NCT02347072|158251753|FG000|Overall Study|Lost to Follow-up|2|||
49113616|NCT02347072|158251753|FG000|Overall Study|Protocol Violation|1|||
49113617|NCT02347072|158251753|FG000|Overall Study|Disc due to Protocol-specified Criteria|6|||
49113618|NCT01464619|158251757|FG000|Overall Study|Lost to Follow-up|3|||
49113619|NCT01464619|158251758|FG001|Overall Study|Lost to Follow-up|4|||
49113620|NCT00404924|158251759|FG000|Overall Study|Adverse Event|75|||
49113621|NCT00404924|158251760|FG001|Overall Study|Adverse Event|16|||
49113622|NCT00404924|158251759|FG000|Overall Study|Condition under investigation worsened|475|||
49113623|NCT00404924|158251760|FG001|Overall Study|Condition under investigation worsened|264|||
49113624|NCT00404924|158251759|FG000|Overall Study|Lost to Follow-up|1|||
49113625|NCT00404924|158251760|FG001|Overall Study|Lost to Follow-up|1|||
49113626|NCT00404924|158251759|FG000|Overall Study|Withdrawal by Subject|26|||
49113627|NCT00404924|158251760|FG001|Overall Study|Withdrawal by Subject|13|||
49113628|NCT00404924|158251759|FG000|Overall Study|Other|25|||
49113629|NCT00404924|158251760|FG001|Overall Study|Other|11|||
49010129|NCT03077828|157873886|FG000|Autologous Stem Cell Transplant|Physician Decision|1|||
49113630|NCT00404924|158251759|FG000|Overall Study|Randomised but not received treatment|1|||
49113631|NCT00404924|158251760|FG001|Overall Study|Randomised but not received treatment|1|||
49113632|NCT03148067|158251762|FG000|Overall Study|Lost to Follow-up|3|||
49113633|NCT03148067|158251762|FG000|Overall Study|Death|1|||
49113634|NCT01404949|158251770|FG000|Overall Study|Not Treated|1|||
49113635|NCT04074330|158251771|FG000|Dose Escalation (up to 19.36 Months)|Death|0|||
49010130|NCT03077828|157873886|FG000|Follow-up|Patients still in follow-up|15|||
49010131|NCT03493698|157873887|FG000|Treatment Period C|Adverse Event|1|||
49010132|NCT03493698|157873887|FG000|Treatment Period C|Withdrawal by Subject|1|||
49010133|NCT02629965|157873888|FG000|Period 1|Adverse Event|1|||
49010134|NCT02629965|157873889|FG001|Period 1|Adverse Event|0|||
49010135|NCT02629965|157873888|FG000|Period 1|Unexpected worsening of disease|2|||
49010136|NCT02629965|157873889|FG001|Period 1|Unexpected worsening of disease|0|||
49010137|NCT02629965|157873888|FG000|Period 1|Other than listed above|1|||
49010138|NCT02629965|157873889|FG001|Period 1|Other than listed above|2|||
49010139|NCT02629965|157873888|FG000|Period 2|Adverse Event|1|||
49010140|NCT02629965|157873889|FG001|Period 2|Adverse Event|0|||
49010141|NCT01360632|157873890|FG000|Phase A (8 Weeks)|Lost to Follow-up|27|||
49010142|NCT01360632|157873891|FG001|Phase A (8 Weeks)|Lost to Follow-up|0|||
49010143|NCT01360632|157873892|FG002|Phase A (8 Weeks)|Lost to Follow-up|0|||
49010144|NCT01360632|157873893|FG003|Phase A (8 Weeks)|Lost to Follow-up|0|||
49010145|NCT01360632|157873894|FG004|Phase A (8 Weeks)|Lost to Follow-up|0|||
49010146|NCT01360632|157873890|FG000|Phase A (8 Weeks)|Adverse Event|60|||
49010147|NCT01360632|157873891|FG001|Phase A (8 Weeks)|Adverse Event|0|||
49010148|NCT01360632|157873892|FG002|Phase A (8 Weeks)|Adverse Event|0|||
49010149|NCT01360632|157873893|FG003|Phase A (8 Weeks)|Adverse Event|0|||
49010150|NCT01360632|157873894|FG004|Phase A (8 Weeks)|Adverse Event|0|||
49010151|NCT01360632|157873890|FG000|Phase A (8 Weeks)|Met Withdrawal Criteria|45|||
49010152|NCT01360632|157873891|FG001|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
49010153|NCT01360632|157873892|FG002|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
49010154|NCT01360632|157873893|FG003|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
49010155|NCT01360632|157873894|FG004|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
49010156|NCT01360632|157873890|FG000|Phase A (8 Weeks)|Physician Decision|10|||
49010157|NCT01360632|157873891|FG001|Phase A (8 Weeks)|Physician Decision|0|||
49010158|NCT01360632|157873892|FG002|Phase A (8 Weeks)|Physician Decision|0|||
49010159|NCT01360632|157873893|FG003|Phase A (8 Weeks)|Physician Decision|0|||
49010160|NCT01360632|157873894|FG004|Phase A (8 Weeks)|Physician Decision|0|||
49010161|NCT01360632|157873890|FG000|Phase A (8 Weeks)|Withdrawal by Subject|74|||
49010162|NCT01360632|157873891|FG001|Phase A (8 Weeks)|Withdrawal by Subject|0|||
49010163|NCT01360632|157873892|FG002|Phase A (8 Weeks)|Withdrawal by Subject|0|||
49010164|NCT01360632|157873893|FG003|Phase A (8 Weeks)|Withdrawal by Subject|0|||
49010165|NCT01360632|157873894|FG004|Phase A (8 Weeks)|Withdrawal by Subject|0|||
49010166|NCT01360632|157873890|FG000|Phase A (8 Weeks)|Protocol Deviation|39|||
49010167|NCT01360632|157873891|FG001|Phase A (8 Weeks)|Protocol Deviation|0|||
49010168|NCT01360632|157873892|FG002|Phase A (8 Weeks)|Protocol Deviation|0|||
49010169|NCT01360632|157873893|FG003|Phase A (8 Weeks)|Protocol Deviation|0|||
49010170|NCT01360632|157873894|FG004|Phase A (8 Weeks)|Protocol Deviation|0|||
49010171|NCT01360632|157873890|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
49010172|NCT01360632|157873891|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
49010173|NCT01360632|157873892|FG002|Phase B (6 Weeks)|Lost to Follow-up|1|||
49010174|NCT01360632|157873893|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
49010175|NCT01360632|157873894|FG004|Phase B (6 Weeks)|Lost to Follow-up|0|||
49010176|NCT01360632|157873890|FG000|Phase B (6 Weeks)|Adverse Event|0|||
49010177|NCT01360632|157873891|FG001|Phase B (6 Weeks)|Adverse Event|3|||
49010178|NCT01360632|157873892|FG002|Phase B (6 Weeks)|Adverse Event|9|||
49010179|NCT01360632|157873893|FG003|Phase B (6 Weeks)|Adverse Event|3|||
49010180|NCT01360632|157873894|FG004|Phase B (6 Weeks)|Adverse Event|0|||
49010181|NCT01360632|157873890|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
49010182|NCT01360632|157873891|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
49010183|NCT01360632|157873892|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
49010184|NCT01360632|157873893|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|1|||
49010185|NCT01360632|157873894|FG004|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
49010186|NCT01360632|157873890|FG000|Phase B (6 Weeks)|Physician Decision|0|||
49010187|NCT01360632|157873891|FG001|Phase B (6 Weeks)|Physician Decision|0|||
49010188|NCT01360632|157873892|FG002|Phase B (6 Weeks)|Physician Decision|0|||
49010189|NCT01360632|157873893|FG003|Phase B (6 Weeks)|Physician Decision|1|||
49010190|NCT01360632|157873894|FG004|Phase B (6 Weeks)|Physician Decision|0|||
49010191|NCT01360632|157873890|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
49010192|NCT01360632|157873891|FG001|Phase B (6 Weeks)|Withdrawal by Subject|4|||
49010193|NCT01360632|157873892|FG002|Phase B (6 Weeks)|Withdrawal by Subject|4|||
49010194|NCT01360632|157873893|FG003|Phase B (6 Weeks)|Withdrawal by Subject|7|||
49010195|NCT01360632|157873894|FG004|Phase B (6 Weeks)|Withdrawal by Subject|0|||
49010196|NCT01360632|157873890|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
49010197|NCT01360632|157873891|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
49010198|NCT01360632|157873892|FG002|Phase B (6 Weeks)|Protocol Deviation|4|||
49010199|NCT01360632|157873893|FG003|Phase B (6 Weeks)|Protocol Deviation|1|||
49010200|NCT01360632|157873894|FG004|Phase B (6 Weeks)|Protocol Deviation|0|||
49010201|NCT01360632|157873890|FG000|Phase B (6 Weeks)|Lack of Efficacy|0|||
49010202|NCT01360632|157873891|FG001|Phase B (6 Weeks)|Lack of Efficacy|1|||
49010203|NCT01360632|157873892|FG002|Phase B (6 Weeks)|Lack of Efficacy|0|||
49010204|NCT01360632|157873893|FG003|Phase B (6 Weeks)|Lack of Efficacy|0|||
49010205|NCT01360632|157873894|FG004|Phase B (6 Weeks)|Lack of Efficacy|0|||
49010206|NCT01360632|157873890|FG000|Phase A+|Lost to Follow-up|0|||
49010207|NCT01360632|157873891|FG001|Phase A+|Lost to Follow-up|0|||
49010208|NCT01360632|157873892|FG002|Phase A+|Lost to Follow-up|0|||
49010209|NCT01360632|157873893|FG003|Phase A+|Lost to Follow-up|0|||
49010210|NCT01360632|157873894|FG004|Phase A+|Lost to Follow-up|2|||
49010211|NCT01360632|157873890|FG000|Phase A+|Adverse Event|0|||
49010212|NCT01360632|157873891|FG001|Phase A+|Adverse Event|0|||
49010213|NCT01360632|157873892|FG002|Phase A+|Adverse Event|0|||
49010214|NCT01360632|157873893|FG003|Phase A+|Adverse Event|0|||
49010215|NCT01360632|157873894|FG004|Phase A+|Adverse Event|2|||
49010216|NCT01360632|157873890|FG000|Phase A+|Met Withdrawal Criteria|0|||
49010217|NCT01360632|157873891|FG001|Phase A+|Met Withdrawal Criteria|0|||
49010218|NCT01360632|157873892|FG002|Phase A+|Met Withdrawal Criteria|0|||
49010219|NCT01360632|157873893|FG003|Phase A+|Met Withdrawal Criteria|0|||
49010220|NCT01360632|157873894|FG004|Phase A+|Met Withdrawal Criteria|7|||
49010221|NCT01360632|157873890|FG000|Phase A+|Physician Decision|0|||
49010222|NCT01360632|157873891|FG001|Phase A+|Physician Decision|0|||
49010223|NCT01360632|157873892|FG002|Phase A+|Physician Decision|0|||
49010224|NCT01360632|157873893|FG003|Phase A+|Physician Decision|0|||
49010225|NCT01360632|157873894|FG004|Phase A+|Physician Decision|3|||
49010226|NCT01360632|157873890|FG000|Phase A+|Withdrawal by Subject|0|||
49010227|NCT01360632|157873891|FG001|Phase A+|Withdrawal by Subject|0|||
49010228|NCT01360632|157873892|FG002|Phase A+|Withdrawal by Subject|0|||
49010229|NCT01360632|157873893|FG003|Phase A+|Withdrawal by Subject|0|||
49010230|NCT01360632|157873894|FG004|Phase A+|Withdrawal by Subject|8|||
49010231|NCT01360632|157873890|FG000|Phase A+|Protocol Deviation|0|||
49010232|NCT01360632|157873891|FG001|Phase A+|Protocol Deviation|0|||
49010233|NCT01360632|157873892|FG002|Phase A+|Protocol Deviation|0|||
49010234|NCT01360632|157873893|FG003|Phase A+|Protocol Deviation|0|||
49010235|NCT01360632|157873894|FG004|Phase A+|Protocol Deviation|3|||
49010236|NCT02230085|157873895|FG000|Overall Study|Physician Decision|1|||
49010237|NCT02230085|157873895|FG000|Overall Study|Withdrawal by Subject|3|||
49010238|NCT03083132|157873901|FG000|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0|||
49010239|NCT03083132|157873902|FG001|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2|||
49010240|NCT03083132|157873901|FG000|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1|||
49010241|NCT03083132|157873902|FG001|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0|||
49010242|NCT03083132|157873901|FG000|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0|||
49010243|NCT03083132|157873902|FG001|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1|||
49010244|NCT01270841|157875548|FG000|Overall Study|Adverse Event|0|||
49010245|NCT01270841|157875549|FG001|Overall Study|Adverse Event|1|||
49010246|NCT01270841|157875550|FG002|Overall Study|Adverse Event|0|||
49010247|NCT01270841|157875551|FG003|Overall Study|Adverse Event|3|||
49010248|NCT01270841|157875548|FG000|Overall Study|Withdrawal by Subject|3|||
49010249|NCT01270841|157875549|FG001|Overall Study|Withdrawal by Subject|2|||
49010250|NCT01270841|157875550|FG002|Overall Study|Withdrawal by Subject|3|||
49010251|NCT01270841|157875551|FG003|Overall Study|Withdrawal by Subject|3|||
49010252|NCT01270841|157875548|FG000|Overall Study|Lost to Follow-up|3|||
49010253|NCT01270841|157875549|FG001|Overall Study|Lost to Follow-up|1|||
49010254|NCT01270841|157875550|FG002|Overall Study|Lost to Follow-up|4|||
49010255|NCT01270841|157875551|FG003|Overall Study|Lost to Follow-up|2|||
49010256|NCT01270841|157875548|FG000|Overall Study|Physician Decision|0|||
49010257|NCT01270841|157875549|FG001|Overall Study|Physician Decision|1|||
49010258|NCT01270841|157875550|FG002|Overall Study|Physician Decision|0|||
49010259|NCT01270841|157875551|FG003|Overall Study|Physician Decision|0|||
49010260|NCT01270841|157875548|FG000|Overall Study|Did not qualify|6|||
49010261|NCT01270841|157875549|FG001|Overall Study|Did not qualify|3|||
49010262|NCT01270841|157875550|FG002|Overall Study|Did not qualify|4|||
49010263|NCT01270841|157875551|FG003|Overall Study|Did not qualify|5|||
49010264|NCT01270841|157875548|FG000|Overall Study|Protocol Violation|1|||
49010265|NCT01270841|157875549|FG001|Overall Study|Protocol Violation|5|||
49010266|NCT01270841|157875550|FG002|Overall Study|Protocol Violation|0|||
49010267|NCT01270841|157875551|FG003|Overall Study|Protocol Violation|0|||
49010268|NCT01270841|157875548|FG000|Overall Study|Enrolled in error|0|||
49010269|NCT01270841|157875549|FG001|Overall Study|Enrolled in error|1|||
49010270|NCT01270841|157875550|FG002|Overall Study|Enrolled in error|0|||
49010271|NCT01270841|157875551|FG003|Overall Study|Enrolled in error|0|||
49010272|NCT01326702|157875552|FG000|Overall Study|Other|1|||
49010273|NCT01326702|157875553|FG001|Overall Study|Other|0|||
49010274|NCT01326702|157875554|FG002|Overall Study|Other|0|||
49010275|NCT01326702|157875555|FG003|Overall Study|Other|0|||
49010276|NCT01326702|157875556|FG004|Overall Study|Other|0|||
49010277|NCT01326702|157875557|FG005|Overall Study|Other|1|||
49010278|NCT01326702|157875558|FG006|Overall Study|Other|0|||
49010279|NCT01326702|157875552|FG000|Overall Study|progressive disease|1|||
49010280|NCT01326702|157875553|FG001|Overall Study|progressive disease|1|||
49010281|NCT01326702|157875554|FG002|Overall Study|progressive disease|3|||
49010282|NCT01326702|157875555|FG003|Overall Study|progressive disease|1|||
49010283|NCT01326702|157875556|FG004|Overall Study|progressive disease|3|||
49010284|NCT01326702|157875557|FG005|Overall Study|progressive disease|2|||
49010285|NCT01326702|157875558|FG006|Overall Study|progressive disease|3|||
49010286|NCT01326702|157875552|FG000|Overall Study|Death|0|||
49010287|NCT01326702|157875553|FG001|Overall Study|Death|1|||
49010288|NCT01326702|157875554|FG002|Overall Study|Death|0|||
49010289|NCT01326702|157875555|FG003|Overall Study|Death|0|||
49010290|NCT01326702|157875556|FG004|Overall Study|Death|0|||
49010291|NCT01326702|157875557|FG005|Overall Study|Death|0|||
49010292|NCT01326702|157875558|FG006|Overall Study|Death|0|||
49010293|NCT01326702|157875552|FG000|Overall Study|Adverse Event|0|||
49010294|NCT01326702|157875553|FG001|Overall Study|Adverse Event|0|||
49010295|NCT01326702|157875554|FG002|Overall Study|Adverse Event|1|||
49010296|NCT01326702|157875555|FG003|Overall Study|Adverse Event|1|||
49010297|NCT01326702|157875556|FG004|Overall Study|Adverse Event|0|||
49010298|NCT01326702|157875557|FG005|Overall Study|Adverse Event|3|||
49010299|NCT01326702|157875558|FG006|Overall Study|Adverse Event|1|||
49010300|NCT01326702|157875552|FG000|Overall Study|Withdrawal by Subject|0|||
49010301|NCT01326702|157875553|FG001|Overall Study|Withdrawal by Subject|0|||
49010302|NCT01326702|157875554|FG002|Overall Study|Withdrawal by Subject|1|||
49010303|NCT01326702|157875555|FG003|Overall Study|Withdrawal by Subject|0|||
49010304|NCT01326702|157875556|FG004|Overall Study|Withdrawal by Subject|1|||
49010305|NCT01326702|157875557|FG005|Overall Study|Withdrawal by Subject|1|||
49010306|NCT01326702|157875558|FG006|Overall Study|Withdrawal by Subject|3|||
49010307|NCT01326702|157875552|FG000|Overall Study|Not Treated|0|||
49010308|NCT01326702|157875553|FG001|Overall Study|Not Treated|0|||
49010309|NCT01326702|157875554|FG002|Overall Study|Not Treated|0|||
49010310|NCT01326702|157875555|FG003|Overall Study|Not Treated|1|||
49010311|NCT01326702|157875556|FG004|Overall Study|Not Treated|0|||
49010312|NCT01326702|157875557|FG005|Overall Study|Not Treated|1|||
49010313|NCT01326702|157875558|FG006|Overall Study|Not Treated|0|||
49010314|NCT03555890|157875559|FG000|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
49010315|NCT03555890|157875560|FG001|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
49010316|NCT03555890|157875561|FG002|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
49010317|NCT03555890|157875562|FG003|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
49010318|NCT01375010|157875563|FG000|Overall Study|Lost to Follow-up|8|||
49010319|NCT01375010|157875564|FG001|Overall Study|Lost to Follow-up|2|||
49010320|NCT01375010|157875563|FG000|Overall Study|Withdrawal by Subject|4|||
49010321|NCT01375010|157875564|FG001|Overall Study|Withdrawal by Subject|2|||
49010322|NCT02082912|157875565|FG000|Overall Study|Physician Decision|0|||
49010323|NCT02082912|157875566|FG001|Overall Study|Physician Decision|1|||
49010324|NCT01835132|157875570|FG000|Initial Phase|Insufficient Therapeutic Response|2|||
49010325|NCT00409188|157875571|FG000|Overall Study|Ongoing at data cut-off|383|||
49010326|NCT00409188|157875572|FG001|Overall Study|Ongoing at data cut-off|175|||
49010327|NCT00856778|157875573|FG000|Overall Study|Adverse Event|7|||
49010328|NCT00856778|157875573|FG000|Overall Study|Withdrawal by Subject|10|||
49010329|NCT00856778|157875573|FG000|Overall Study|Study deviation|2|||
49010330|NCT00856778|157875573|FG000|Overall Study|Lost to Follow-up|5|||
49010331|NCT01681771|157875574|FG000|Overall Study|Lost to Follow-up|4|||
49010332|NCT01681771|157875575|FG001|Overall Study|Lost to Follow-up|2|||
49010333|NCT02092961|157875576|FG000|Overall Study|Not reported|1|||
49010334|NCT02092961|157875577|FG001|Overall Study|Not reported|0|||
49010335|NCT02092961|157875578|FG002|Overall Study|Not reported|1|||
49010336|NCT02092961|157875576|FG000|Overall Study|Study stopped|13|||
49010337|NCT02092961|157875577|FG001|Overall Study|Study stopped|9|||
49010338|NCT02092961|157875578|FG002|Overall Study|Study stopped|12|||
49010339|NCT02092961|157875576|FG000|Overall Study|Lack of therapeutic response|2|||
49010340|NCT02092961|157875577|FG001|Overall Study|Lack of therapeutic response|1|||
49010341|NCT02092961|157875578|FG002|Overall Study|Lack of therapeutic response|3|||
49010342|NCT02092961|157875576|FG000|Overall Study|Dev. of study specific discont. criteria|3|||
49010343|NCT02092961|157875577|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
49010344|NCT02092961|157875578|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
49010345|NCT02092961|157875576|FG000|Overall Study|Adverse Event|2|||
49010346|NCT02092961|157875577|FG001|Overall Study|Adverse Event|4|||
49010347|NCT02092961|157875578|FG002|Overall Study|Adverse Event|0|||
49010348|NCT02270983|157875579|FG000|Overall Study|Adverse Event|3|||
49010349|NCT02270983|157875580|FG001|Overall Study|Adverse Event|2|||
49010350|NCT02270983|157875581|FG002|Overall Study|Adverse Event|6|||
49010351|NCT02270983|157875579|FG000|Overall Study|Lack of Efficacy|2|||
49010352|NCT02270983|157875580|FG001|Overall Study|Lack of Efficacy|1|||
49010353|NCT02270983|157875581|FG002|Overall Study|Lack of Efficacy|1|||
49010354|NCT02270983|157875579|FG000|Overall Study|Withdrawal by Subject|1|||
49010355|NCT02270983|157875580|FG001|Overall Study|Withdrawal by Subject|0|||
49010356|NCT02270983|157875581|FG002|Overall Study|Withdrawal by Subject|2|||
49010357|NCT02270983|157875579|FG000|Overall Study|Lost to Follow-up|1|||
49010358|NCT02270983|157875580|FG001|Overall Study|Lost to Follow-up|1|||
49010359|NCT02270983|157875581|FG002|Overall Study|Lost to Follow-up|2|||
49010360|NCT02270983|157875579|FG000|Overall Study|Protocol Violation|1|||
49010361|NCT02270983|157875580|FG001|Overall Study|Protocol Violation|1|||
49010362|NCT02270983|157875581|FG002|Overall Study|Protocol Violation|1|||
49010363|NCT02270983|157875579|FG000|Overall Study|family emergency|0|||
49010364|NCT02270983|157875580|FG001|Overall Study|family emergency|1|||
49010365|NCT02270983|157875581|FG002|Overall Study|family emergency|0|||
49010366|NCT02270983|157875579|FG000|Overall Study|study procedure non-compliance|1|||
49010367|NCT02270983|157875580|FG001|Overall Study|study procedure non-compliance|0|||
49010368|NCT02270983|157875581|FG002|Overall Study|study procedure non-compliance|0|||
49010369|NCT02270983|157875579|FG000|Overall Study|moved away from study site|0|||
49010370|NCT02270983|157875580|FG001|Overall Study|moved away from study site|1|||
49010371|NCT02270983|157875581|FG002|Overall Study|moved away from study site|0|||
49010372|NCT00265083|157875582|FG000|Overall Study|Adverse Event|5|||
49010373|NCT00265083|157875583|FG001|Overall Study|Adverse Event|13|||
49010374|NCT00265083|157875584|FG002|Overall Study|Adverse Event|15|||
49010375|NCT00265083|157875582|FG000|Overall Study|Lost to Follow-up|3|||
49010376|NCT00265083|157875583|FG001|Overall Study|Lost to Follow-up|4|||
49010377|NCT00265083|157875584|FG002|Overall Study|Lost to Follow-up|4|||
49010378|NCT00265083|157875582|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
49010379|NCT00265083|157875583|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
49010380|NCT00265083|157875584|FG002|Overall Study|Unsatisfactory therapeutic effect|14|||
49010381|NCT00265083|157875582|FG000|Overall Study|Other|1|||
49010382|NCT00265083|157875583|FG001|Overall Study|Other|12|||
49010383|NCT00265083|157875584|FG002|Overall Study|Other|9|||
49010384|NCT03208933|157875588|FG000|Overall Study|Death|3|||
49010385|NCT03208933|157875588|FG000|Overall Study|Withdrawal by Subject|3|||
49010386|NCT03208933|157875588|FG000|Overall Study|Adverse Event|1|||
49010387|NCT03208933|157875588|FG000|Overall Study|Lost to Follow-up|2|||
49010388|NCT03208933|157875588|FG000|Overall Study|Physician Decision|3|||
49010389|NCT03208933|157875588|FG000|Overall Study|Protocol Violation|1|||
49010390|NCT03372369|157875589|FG000|Qualification Period|Withdrawal by Subject|16|||
49010391|NCT03372369|157875590|FG001|Qualification Period|Withdrawal by Subject|13|||
49010392|NCT03372369|157875589|FG000|Qualification Period|Inconsistent Eligibility Results|10|||
49010393|NCT03372369|157875590|FG001|Qualification Period|Inconsistent Eligibility Results|9|||
49010394|NCT03372369|157875589|FG000|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
49010395|NCT03372369|157875590|FG001|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
49010396|NCT00854620|157875593|FG000|Overall Study|Adverse Event|1|||
49010397|NCT04242186|157875594|FG000|Overall Study|Death|5|||
49010398|NCT02019979|157875595|FG000|Overall Study|study terminated|14|||
49010399|NCT00379587|157875597|FG000|Overall Study|Lost to Follow-up|2|||
49010400|NCT02257632|157875598|FG000|Overall Study|Withdrawal by Subject|0|||
49010401|NCT02257632|157875599|FG001|Overall Study|Withdrawal by Subject|1|||
49010402|NCT02257632|157875598|FG000|Overall Study|Adverse Event|1|||
49010403|NCT02257632|157875599|FG001|Overall Study|Adverse Event|2|||
49010404|NCT00534092|157875600|FG000|Overall Study|Lost to Follow-up|1|||
49010405|NCT00534092|157875601|FG001|Overall Study|Lost to Follow-up|0|||
49010406|NCT00534092|157875600|FG000|Overall Study|personal reasons/family concerns|1|||
49010407|NCT00534092|157875601|FG001|Overall Study|personal reasons/family concerns|0|||
49010408|NCT01169649|157875602|FG000|Overall Study|Patient Not Treated|3|||
49010409|NCT00736333|157875603|FG000|Overall Study|Did Not Receive Drug or Not Documented|7|||
49010410|NCT00736333|157875603|FG000|Overall Study|Data Missing|2|||
49010411|NCT00736333|157875603|FG000|Overall Study|Tumor Progression|75|||
49010412|NCT00736333|157875603|FG000|Overall Study|Toxicity|6|||
49010413|NCT00736333|157875603|FG000|Overall Study|Withdrawal by Subject|10|||
49010414|NCT00736333|157875603|FG000|Overall Study|Death|7|||
49010415|NCT00736333|157875603|FG000|Overall Study|Other|4|||
49010416|NCT02598193|157875604|FG000|Overall Study|Adverse Event|13|||
49010417|NCT02598193|157875604|FG000|Overall Study|Withdrawal by Subject|1|||
49010418|NCT02598193|157875604|FG000|Overall Study|Listed in active lung transplant list|1|||
49010419|NCT02598193|157875604|FG000|Overall Study|Does not want to take Nintedanib|1|||
49010420|NCT03255031|157875605|FG000|Overall Study|Adverse Event|5|||
49010421|NCT03255031|157875606|FG001|Overall Study|Adverse Event|3|||
49010422|NCT03255031|157875605|FG000|Overall Study|Physician Decision|2|||
49010423|NCT03255031|157875606|FG001|Overall Study|Physician Decision|1|||
49010424|NCT03255031|157875605|FG000|Overall Study|Withdrawal by Subject|9|||
49010425|NCT03255031|157875606|FG001|Overall Study|Withdrawal by Subject|3|||
49010426|NCT01809314|157875607|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
49010427|NCT01809314|157875607|FG000|Overall Study|Adverse Event|6|||
49010428|NCT01809314|157875607|FG000|Overall Study|Insufficient Therapeutic Response|14|||
49010429|NCT01809314|157875607|FG000|Overall Study|Lost to Follow-up|724|||
49010430|NCT02400905|157875608|FG000|Overall Study|Death|24|||
49010431|NCT02400905|157875608|FG000|Overall Study|Lost to Follow-up|18|||
49010432|NCT02400905|157875608|FG000|Overall Study|Withdrawal by Subject|16|||
49113636|NCT04074330|158251772|FG001|Dose Escalation (up to 19.36 Months)|Death|2|||
49113637|NCT04074330|158251773|FG002|Dose Escalation (up to 19.36 Months)|Death|0|||
49113638|NCT04074330|158251774|FG003|Dose Escalation (up to 19.36 Months)|Death|1|||
49113639|NCT04074330|158251775|FG004|Dose Escalation (up to 19.36 Months)|Death|4|||
49113640|NCT04074330|158251776|FG005|Dose Escalation (up to 19.36 Months)|Death|1|||
49113641|NCT04074330|158251777|FG006|Dose Escalation (up to 19.36 Months)|Death|0|||
49113642|NCT04074330|158251778|FG007|Dose Escalation (up to 19.36 Months)|Death|0|||
49113643|NCT04074330|158251779|FG008|Dose Escalation (up to 19.36 Months)|Death|0|||
49113644|NCT04074330|158251780|FG009|Dose Escalation (up to 19.36 Months)|Death|0|||
49113645|NCT04074330|158251771|FG000|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
49113646|NCT04074330|158251772|FG001|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
49113647|NCT04074330|158251773|FG002|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
49113648|NCT04074330|158251774|FG003|Dose Escalation (up to 19.36 Months)|Progressive Disease|5|||
49113649|NCT04074330|158251775|FG004|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
49113650|NCT04074330|158251776|FG005|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
49113651|NCT04074330|158251777|FG006|Dose Escalation (up to 19.36 Months)|Progressive Disease|1|||
49113652|NCT04074330|158251778|FG007|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
49113653|NCT04074330|158251779|FG008|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
49113654|NCT04074330|158251780|FG009|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
49113655|NCT04074330|158251771|FG000|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
49113656|NCT04074330|158251772|FG001|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
49113657|NCT04074330|158251773|FG002|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|1|||
49113658|NCT04074330|158251774|FG003|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
49113659|NCT04074330|158251775|FG004|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
49113660|NCT04074330|158251776|FG005|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
49113661|NCT04074330|158251777|FG006|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
49113662|NCT04074330|158251778|FG007|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
49113663|NCT04074330|158251779|FG008|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
49113664|NCT04074330|158251780|FG009|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
49113665|NCT04074330|158251771|FG000|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
49113666|NCT04074330|158251772|FG001|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
49113667|NCT04074330|158251773|FG002|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
49113668|NCT04074330|158251774|FG003|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
49113669|NCT04074330|158251775|FG004|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
49113670|NCT04074330|158251776|FG005|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
49113671|NCT04074330|158251777|FG006|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
49113672|NCT04074330|158251778|FG007|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
49113673|NCT04074330|158251779|FG008|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
49113674|NCT04074330|158251780|FG009|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
49113675|NCT04074330|158251771|FG000|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
49113676|NCT04074330|158251772|FG001|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
49113677|NCT04074330|158251773|FG002|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
49113678|NCT04074330|158251774|FG003|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
49113679|NCT04074330|158251775|FG004|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|2|||
49113680|NCT04074330|158251776|FG005|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
49113681|NCT04074330|158251777|FG006|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
49113682|NCT04074330|158251778|FG007|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
49113683|NCT04074330|158251779|FG008|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
49113684|NCT04074330|158251780|FG009|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
49113685|NCT04074330|158251771|FG000|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
49113686|NCT04074330|158251772|FG001|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
49113687|NCT04074330|158251773|FG002|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
49113688|NCT04074330|158251774|FG003|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
49113689|NCT04074330|158251775|FG004|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
49113690|NCT04074330|158251776|FG005|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
49113691|NCT04074330|158251777|FG006|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
49113692|NCT04074330|158251778|FG007|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
49113693|NCT04074330|158251779|FG008|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
49113694|NCT04074330|158251780|FG009|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
49113695|NCT04074330|158251771|FG000|Dose Expansion (up to 42 Months)|Death|0|||
49113696|NCT04074330|158251772|FG001|Dose Expansion (up to 42 Months)|Death|0|||
49113697|NCT04074330|158251773|FG002|Dose Expansion (up to 42 Months)|Death|0|||
49113698|NCT04074330|158251774|FG003|Dose Expansion (up to 42 Months)|Death|0|||
49113699|NCT04074330|158251775|FG004|Dose Expansion (up to 42 Months)|Death|0|||
49113700|NCT04074330|158251776|FG005|Dose Expansion (up to 42 Months)|Death|0|||
49113701|NCT04074330|158251777|FG006|Dose Expansion (up to 42 Months)|Death|0|||
49113702|NCT04074330|158251778|FG007|Dose Expansion (up to 42 Months)|Death|0|||
49113703|NCT04074330|158251779|FG008|Dose Expansion (up to 42 Months)|Death|1|||
49113704|NCT04074330|158251780|FG009|Dose Expansion (up to 42 Months)|Death|0|||
49113705|NCT04074330|158251771|FG000|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
49113706|NCT04074330|158251772|FG001|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
49113707|NCT04074330|158251773|FG002|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
49113708|NCT04074330|158251774|FG003|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
49113709|NCT04074330|158251775|FG004|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
49113710|NCT04074330|158251776|FG005|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
49113711|NCT04074330|158251777|FG006|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
49113712|NCT04074330|158251778|FG007|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
49113713|NCT04074330|158251779|FG008|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
49113714|NCT04074330|158251780|FG009|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
49113715|NCT00791492|158251781|FG000|Overall Study|Withdrawal by Subject|1|||
49113716|NCT00791492|158251782|FG001|Overall Study|Withdrawal by Subject|2|||
49113717|NCT00791492|158251781|FG000|Overall Study|Liver transplantation|5|||
49113718|NCT00791492|158251782|FG001|Overall Study|Liver transplantation|1|||
49113719|NCT02282163|158251783|FG000|Overall Study|Protocol Violation|1|||
49113720|NCT00731731|158251784|FG000|Overall Study|Protocol Violation|0|||
49113721|NCT00731731|158251785|FG001|Overall Study|Protocol Violation|0|||
49113722|NCT00731731|158251786|FG002|Overall Study|Protocol Violation|1|||
49113723|NCT00731731|158251784|FG000|Overall Study|Cancel prior to treatment|0|||
49113724|NCT00731731|158251785|FG001|Overall Study|Cancel prior to treatment|0|||
49113725|NCT00731731|158251786|FG002|Overall Study|Cancel prior to treatment|2|||
49113726|NCT02324699|158251787|FG000|Overall Study|study terminated|1|||
49113727|NCT03970200|158251788|FG000|Overall Study|Death|2|||
49113728|NCT03970200|158251789|FG001|Overall Study|Death|2|||
49113729|NCT03970200|158251790|FG002|Overall Study|Death|1|||
49113730|NCT03970200|158251788|FG000|Overall Study|Subject re-enrolled into Upper GI|0|||
49113731|NCT03970200|158251789|FG001|Overall Study|Subject re-enrolled into Upper GI|0|||
49113732|NCT03970200|158251790|FG002|Overall Study|Subject re-enrolled into Upper GI|1|||
49113733|NCT01216332|158251791|FG000|Overall Study|Withdrawal by Subject|4|||
49113734|NCT01216332|158251792|FG001|Overall Study|Withdrawal by Subject|0|||
49113735|NCT02510820|158254057|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
49113736|NCT02510820|158254058|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
49113737|NCT02510820|158254057|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
49113738|NCT02510820|158254058|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
49113739|NCT02417961|158254064|FG000|Overall Study|Adverse Event|1|||
49113740|NCT02417961|158254064|FG000|Overall Study|Lost to Follow-up|1|||
49113741|NCT02417961|158254064|FG000|Overall Study|Withdrawal by Subject|2|||
49113742|NCT03046056|158254065|FG000|Overall Study|Non-responder at Week 10|6|||
49113743|NCT03046056|158254066|FG001|Overall Study|Non-responder at Week 10|6|||
49113744|NCT03046056|158254067|FG002|Overall Study|Non-responder at Week 10|4|||
49113745|NCT03046056|158254065|FG000|Overall Study|Protocol-specified Disease Worsening|3|||
49113746|NCT03046056|158254066|FG001|Overall Study|Protocol-specified Disease Worsening|3|||
49113747|NCT03046056|158254067|FG002|Overall Study|Protocol-specified Disease Worsening|1|||
49113748|NCT03046056|158254065|FG000|Overall Study|Adverse Event|1|||
49113749|NCT03046056|158254066|FG001|Overall Study|Adverse Event|5|||
49113750|NCT03046056|158254067|FG002|Overall Study|Adverse Event|0|||
49113751|NCT03046056|158254065|FG000|Overall Study|Non-compliance With Study Drug|0|||
49113752|NCT03046056|158254066|FG001|Overall Study|Non-compliance With Study Drug|0|||
49113753|NCT03046056|158254067|FG002|Overall Study|Non-compliance With Study Drug|2|||
49113754|NCT03046056|158254065|FG000|Overall Study|Protocol Violation|1|||
49113755|NCT03046056|158254066|FG001|Overall Study|Protocol Violation|1|||
49113756|NCT03046056|158254067|FG002|Overall Study|Protocol Violation|0|||
49113757|NCT03046056|158254065|FG000|Overall Study|Investigator's Discretion|0|||
49113758|NCT03046056|158254066|FG001|Overall Study|Investigator's Discretion|1|||
49113759|NCT03046056|158254067|FG002|Overall Study|Investigator's Discretion|0|||
49113760|NCT03046056|158254065|FG000|Overall Study|Withdrew Consent|1|||
49113761|NCT03046056|158254066|FG001|Overall Study|Withdrew Consent|0|||
49113762|NCT03046056|158254067|FG002|Overall Study|Withdrew Consent|0|||
49113763|NCT03089853|158254068|FG000|Overall Study|Lost to Follow-up|2|||
49113764|NCT03089853|158254069|FG001|Overall Study|Lost to Follow-up|1|||
49113765|NCT00642954|158254070|FG000|Overall Study|Progressive Disease|3|||
49113766|NCT00642954|158254071|FG001|Overall Study|Progressive Disease|3|||
49113767|NCT00642954|158254072|FG002|Overall Study|Progressive Disease|3|||
49113768|NCT00642954|158254073|FG003|Overall Study|Progressive Disease|3|||
49113769|NCT00642954|158254074|FG004|Overall Study|Progressive Disease|9|||
49113770|NCT00642954|158254070|FG000|Overall Study|Withdrawal by Subject|0|||
49113771|NCT00642954|158254071|FG001|Overall Study|Withdrawal by Subject|0|||
49113772|NCT00642954|158254072|FG002|Overall Study|Withdrawal by Subject|0|||
49113773|NCT00642954|158254073|FG003|Overall Study|Withdrawal by Subject|0|||
49113774|NCT00642954|158254074|FG004|Overall Study|Withdrawal by Subject|1|||
49113775|NCT00642954|158254070|FG000|Overall Study|Adverse Event|1|||
49113776|NCT00642954|158254071|FG001|Overall Study|Adverse Event|1|||
49113777|NCT00642954|158254072|FG002|Overall Study|Adverse Event|0|||
49113778|NCT00642954|158254073|FG003|Overall Study|Adverse Event|0|||
49113779|NCT00642954|158254074|FG004|Overall Study|Adverse Event|6|||
49113780|NCT01317004|158254075|FG000|Overall Study|Withdrawal by Subject|1|||
49113781|NCT01317004|158254076|FG001|Overall Study|Withdrawal by Subject|4|||
49113782|NCT01317004|158254075|FG000|Overall Study|Protocol Violation|0|||
49113783|NCT01317004|158254076|FG001|Overall Study|Protocol Violation|2|||
49113784|NCT01317004|158254075|FG000|Overall Study|Adverse Event|3|||
49113785|NCT01317004|158254076|FG001|Overall Study|Adverse Event|3|||
49113786|NCT02437188|158254079|FG000|Overall Study|Randomized but did not receive surgery|4|||
49113787|NCT02437188|158254080|FG001|Overall Study|Randomized but did not receive surgery|8|||
49113788|NCT02437188|158254079|FG000|Overall Study|Adverse Event|0|||
49113789|NCT02437188|158254080|FG001|Overall Study|Adverse Event|1|||
49113790|NCT01172808|158254083|FG000|Overall Study|Adverse Event|8|||
49113791|NCT01172808|158254084|FG001|Overall Study|Adverse Event|4|||
49113792|NCT01172808|158254085|FG002|Overall Study|Adverse Event|8|||
49113793|NCT01172808|158254086|FG003|Overall Study|Adverse Event|3|||
49113794|NCT01172808|158254083|FG000|Overall Study|Lack of Efficacy|1|||
49113795|NCT01172808|158254084|FG001|Overall Study|Lack of Efficacy|0|||
49113796|NCT01172808|158254085|FG002|Overall Study|Lack of Efficacy|0|||
49113797|NCT01172808|158254086|FG003|Overall Study|Lack of Efficacy|0|||
49113798|NCT01172808|158254083|FG000|Overall Study|Protocol Violation|2|||
49113799|NCT01172808|158254084|FG001|Overall Study|Protocol Violation|2|||
49113800|NCT01172808|158254085|FG002|Overall Study|Protocol Violation|2|||
49113801|NCT01172808|158254086|FG003|Overall Study|Protocol Violation|0|||
49113802|NCT01172808|158254083|FG000|Overall Study|Lost to Follow-up|0|||
49113803|NCT01172808|158254084|FG001|Overall Study|Lost to Follow-up|1|||
49113804|NCT01172808|158254085|FG002|Overall Study|Lost to Follow-up|1|||
49113805|NCT01172808|158254086|FG003|Overall Study|Lost to Follow-up|3|||
49113806|NCT01172808|158254083|FG000|Overall Study|Withdrawal by Subject|4|||
49113807|NCT01172808|158254084|FG001|Overall Study|Withdrawal by Subject|1|||
49113808|NCT01172808|158254085|FG002|Overall Study|Withdrawal by Subject|3|||
49113809|NCT01172808|158254086|FG003|Overall Study|Withdrawal by Subject|2|||
49113810|NCT01172808|158254083|FG000|Overall Study|Other|6|||
49113811|NCT01172808|158254084|FG001|Overall Study|Other|5|||
49113812|NCT01172808|158254085|FG002|Overall Study|Other|9|||
49113813|NCT01172808|158254086|FG003|Overall Study|Other|7|||
49113814|NCT02661061|158254090|FG000|Overall Study|Lack of Efficacy|1|||
49113815|NCT02661061|158254091|FG001|Overall Study|Lack of Efficacy|1|||
49113816|NCT02661061|158254090|FG000|Overall Study|Withdrawal by Subject|1|||
49113817|NCT02661061|158254091|FG001|Overall Study|Withdrawal by Subject|1|||
49113818|NCT01393106|158254093|FG000|Overall Study|Adverse Event|3|||
49113819|NCT01393106|158254093|FG000|Overall Study|Withdrawal by Subject|1|||
49113820|NCT01393106|158254093|FG000|Overall Study|Lack of Efficacy|1|||
49113821|NCT03041467|158254094|FG000|Overall Study|Death|46|||
49113822|NCT03041467|158254095|FG001|Overall Study|Death|39|||
49113823|NCT03041467|158254094|FG000|Overall Study|Withdrawal by Subject|36|||
49113824|NCT03041467|158254095|FG001|Overall Study|Withdrawal by Subject|37|||
49113825|NCT03041467|158254094|FG000|Overall Study|Lost to Follow-up|6|||
49113826|NCT03041467|158254095|FG001|Overall Study|Lost to Follow-up|8|||
49113827|NCT03041467|158254094|FG000|Overall Study|Declined consent for study extension|21|||
49113828|NCT03041467|158254095|FG001|Overall Study|Declined consent for study extension|33|||
49113829|NCT03041467|158254094|FG000|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|4|||
49113830|NCT03041467|158254095|FG001|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|2|||
49113831|NCT03396822|158254096|FG000|Overall Study|No meningeal enhancement on baseline scan|8|||
49113832|NCT03396822|158254096|FG000|Overall Study|Physician Decision|1|||
49113833|NCT02578940|158254103|FG000|Overall Study|Screening failure|5|||
49113834|NCT02578940|158254103|FG000|Overall Study|Lost to Follow-up|1|||
49113835|NCT03774394|158254107|FG000|Overall Study|Withdrawal by Subject|2|||
49113836|NCT03774394|158254108|FG001|Overall Study|Withdrawal by Subject|0|||
49113837|NCT03334422|158254109|FG000|Overall Study|Adverse Event|1|||
49113838|NCT03334422|158254110|FG001|Overall Study|Adverse Event|3|||
49113839|NCT03334422|158254111|FG002|Overall Study|Adverse Event|2|||
49113840|NCT03334422|158254112|FG003|Overall Study|Adverse Event|2|||
49113841|NCT03334422|158254109|FG000|Overall Study|Lack of Efficacy|10|||
49113842|NCT03334422|158254110|FG001|Overall Study|Lack of Efficacy|2|||
49113843|NCT03334422|158254111|FG002|Overall Study|Lack of Efficacy|7|||
49113844|NCT03334422|158254112|FG003|Overall Study|Lack of Efficacy|3|||
49113845|NCT03334422|158254109|FG000|Overall Study|Withdrawal by Subject|8|||
49113846|NCT03334422|158254110|FG001|Overall Study|Withdrawal by Subject|3|||
49113847|NCT03334422|158254111|FG002|Overall Study|Withdrawal by Subject|1|||
49113848|NCT03334422|158254112|FG003|Overall Study|Withdrawal by Subject|0|||
49113849|NCT03334422|158254109|FG000|Overall Study|Lost to Follow-up|0|||
49113850|NCT03334422|158254110|FG001|Overall Study|Lost to Follow-up|0|||
49113851|NCT03334422|158254111|FG002|Overall Study|Lost to Follow-up|0|||
49113852|NCT03334422|158254112|FG003|Overall Study|Lost to Follow-up|1|||
49113853|NCT03334422|158254109|FG000|Overall Study|Inability to obtain laboratory samples|0|||
49113854|NCT03334422|158254110|FG001|Overall Study|Inability to obtain laboratory samples|1|||
49113855|NCT03334422|158254111|FG002|Overall Study|Inability to obtain laboratory samples|0|||
49113856|NCT03334422|158254112|FG003|Overall Study|Inability to obtain laboratory samples|0|||
49113857|NCT03334422|158254109|FG000|Overall Study|Pregnancy|0|||
49113858|NCT03334422|158254110|FG001|Overall Study|Pregnancy|1|||
49113859|NCT03334422|158254111|FG002|Overall Study|Pregnancy|0|||
49113860|NCT03334422|158254112|FG003|Overall Study|Pregnancy|0|||
49113861|NCT02362425|158254113|FG000|Phase 1 (up to 6 Months)|Withdrawal by Subject|2|||
49113862|NCT02362425|158254114|FG001|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
49113863|NCT02362425|158254115|FG002|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
49113864|NCT02362425|158254116|FG003|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
49113865|NCT02362425|158254113|FG000|Phase 1 (up to 6 Months)|Medicinal contraindication|1|||
49113866|NCT02362425|158254114|FG001|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
49113867|NCT02362425|158254115|FG002|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
49113868|NCT02362425|158254116|FG003|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
49113869|NCT02362425|158254113|FG000|Phase 1 (up to 6 Months)|Screening failure|1|||
49113870|NCT02362425|158254114|FG001|Phase 1 (up to 6 Months)|Screening failure|0|||
49113871|NCT02362425|158254115|FG002|Phase 1 (up to 6 Months)|Screening failure|0|||
49113872|NCT02362425|158254116|FG003|Phase 1 (up to 6 Months)|Screening failure|0|||
49113873|NCT02362425|158254113|FG000|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3|||
49113874|NCT02362425|158254114|FG001|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
49113875|NCT02362425|158254115|FG002|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
49113876|NCT02362425|158254116|FG003|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
49113877|NCT02362425|158254113|FG000|Phase 1 (up to 6 Months)|Study closure|9|||
49113878|NCT02362425|158254114|FG001|Phase 1 (up to 6 Months)|Study closure|0|||
49113879|NCT02362425|158254115|FG002|Phase 1 (up to 6 Months)|Study closure|0|||
49113880|NCT02362425|158254116|FG003|Phase 1 (up to 6 Months)|Study closure|0|||
49113881|NCT02362425|158254113|FG000|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
49113882|NCT02362425|158254114|FG001|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
49113883|NCT02362425|158254115|FG002|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
49113884|NCT02362425|158254116|FG003|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2|||
49113885|NCT02362425|158254113|FG000|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
49113886|NCT02362425|158254114|FG001|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
49113887|NCT02362425|158254115|FG002|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
49113888|NCT02362425|158254116|FG003|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1|||
49113889|NCT02362425|158254113|FG000|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
49113890|NCT02362425|158254114|FG001|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
49113891|NCT02362425|158254115|FG002|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1|||
49113892|NCT02362425|158254116|FG003|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
49113893|NCT01313221|158254121|FG000|Overall Study|Protocol Violation|0|||
49113894|NCT01313221|158254122|FG001|Overall Study|Protocol Violation|1|||
49113895|NCT01313221|158254123|FG002|Overall Study|Protocol Violation|1|||
49113896|NCT01313221|158254121|FG000|Overall Study|Non-compliance|3|||
49113897|NCT01313221|158254122|FG001|Overall Study|Non-compliance|0|||
49113898|NCT01313221|158254123|FG002|Overall Study|Non-compliance|2|||
49113899|NCT01313221|158254121|FG000|Overall Study|Withdrawal by Subject|2|||
49113900|NCT01313221|158254122|FG001|Overall Study|Withdrawal by Subject|3|||
49113901|NCT01313221|158254123|FG002|Overall Study|Withdrawal by Subject|5|||
49113902|NCT01313221|158254121|FG000|Overall Study|Requirement for alternative therapy|0|||
49113903|NCT01313221|158254122|FG001|Overall Study|Requirement for alternative therapy|1|||
49113904|NCT01313221|158254123|FG002|Overall Study|Requirement for alternative therapy|1|||
49113905|NCT01313221|158254121|FG000|Overall Study|Lost to Follow-up|6|||
49113906|NCT01313221|158254122|FG001|Overall Study|Lost to Follow-up|3|||
49113907|NCT01313221|158254123|FG002|Overall Study|Lost to Follow-up|1|||
49113908|NCT01313221|158254121|FG000|Overall Study|Other|1|||
49113909|NCT01313221|158254122|FG001|Overall Study|Other|0|||
49113910|NCT01313221|158254123|FG002|Overall Study|Other|0|||
49113911|NCT01313221|158254121|FG000|Overall Study|Adverse Event|0|||
49113912|NCT01313221|158254122|FG001|Overall Study|Adverse Event|0|||
49113913|NCT01313221|158254123|FG002|Overall Study|Adverse Event|7|||
49113914|NCT01313221|158254121|FG000|Overall Study|Disease progression|0|||
49113915|NCT01313221|158254122|FG001|Overall Study|Disease progression|0|||
49113916|NCT01313221|158254123|FG002|Overall Study|Disease progression|2|||
49113917|NCT01313221|158254121|FG000|Overall Study|Physician Decision|0|||
49113918|NCT01313221|158254122|FG001|Overall Study|Physician Decision|0|||
49113919|NCT01313221|158254123|FG002|Overall Study|Physician Decision|2|||
49113920|NCT01313221|158254121|FG000|Overall Study|Pregnancy|0|||
49113921|NCT01313221|158254122|FG001|Overall Study|Pregnancy|0|||
49113922|NCT01313221|158254123|FG002|Overall Study|Pregnancy|2|||
49113923|NCT01937715|158254134|FG000|Overall Study|Death|0|||
49113924|NCT01937715|158254135|FG001|Overall Study|Death|0|||
49113925|NCT01937715|158254136|FG002|Overall Study|Death|0|||
49113926|NCT01937715|158254137|FG003|Overall Study|Death|1|||
49113927|NCT01937715|158254138|FG004|Overall Study|Death|0|||
49113928|NCT01937715|158254134|FG000|Overall Study|Withdrawal by Subject|0|||
49113929|NCT01937715|158254135|FG001|Overall Study|Withdrawal by Subject|1|||
49113930|NCT01937715|158254136|FG002|Overall Study|Withdrawal by Subject|0|||
49113931|NCT01937715|158254137|FG003|Overall Study|Withdrawal by Subject|0|||
49113932|NCT01937715|158254138|FG004|Overall Study|Withdrawal by Subject|2|||
49113933|NCT01937715|158254134|FG000|Overall Study|Other|0|||
49113934|NCT01937715|158254135|FG001|Overall Study|Other|0|||
49113935|NCT01937715|158254136|FG002|Overall Study|Other|0|||
49113936|NCT01937715|158254137|FG003|Overall Study|Other|3|||
49113937|NCT01937715|158254138|FG004|Overall Study|Other|0|||
49113938|NCT02864316|158254141|FG000|Overall Study|Progressive Disease|2|||
49113939|NCT02864316|158254142|FG001|Overall Study|Progressive Disease|1|||
49113940|NCT02864316|158254141|FG000|Overall Study|Adverse Event|0|||
49113941|NCT02864316|158254142|FG001|Overall Study|Adverse Event|1|||
49113942|NCT05459558|158254145|FG000|Overall Study|Adverse Event|1|||
49113943|NCT05459558|158254146|FG001|Overall Study|Adverse Event|0|||
49113944|NCT05459558|158254147|FG002|Overall Study|Adverse Event|0|||
49113945|NCT05459558|158254145|FG000|Overall Study|Scheduling issue|0|||
49113946|NCT05459558|158254146|FG001|Overall Study|Scheduling issue|1|||
49113947|NCT05459558|158254147|FG002|Overall Study|Scheduling issue|3|||
49113948|NCT05459558|158254145|FG000|Overall Study|Withdrawal by Subject|0|||
49113949|NCT05459558|158254146|FG001|Overall Study|Withdrawal by Subject|0|||
49113950|NCT05459558|158254147|FG002|Overall Study|Withdrawal by Subject|2|||
49113951|NCT02412878|158254148|FG000|Overall Study|Withdrawal by Subject|19|||
49113952|NCT02412878|158254149|FG001|Overall Study|Withdrawal by Subject|10|||
49113953|NCT02412878|158254148|FG000|Overall Study|Lost to Follow-up|2|||
49113954|NCT02412878|158254149|FG001|Overall Study|Lost to Follow-up|3|||
49113955|NCT02190721|158254150|FG000|Overall Study|Patient was out of the city|0|||
49113956|NCT02190721|158254151|FG001|Overall Study|Patient was out of the city|1|||
49113957|NCT02190721|158254152|FG002|Overall Study|Patient was out of the city|0|||
49113958|NCT04571385|158254153|FG000|Overall Study|Participant non-compliance|1|||
49113959|NCT04571385|158254154|FG001|Overall Study|Participant non-compliance|0|||
49113960|NCT04571385|158254155|FG002|Overall Study|Participant non-compliance|0|||
49113961|NCT04571385|158254153|FG000|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
49113962|NCT04571385|158254154|FG001|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|1|||
49113963|NCT04571385|158254155|FG002|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
49113964|NCT04571385|158254153|FG000|Overall Study|Screen failure|0|||
49113965|NCT04571385|158254154|FG001|Overall Study|Screen failure|0|||
49113966|NCT04571385|158254155|FG002|Overall Study|Screen failure|1|||
49113967|NCT01777139|158254157|FG000|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7|||
49113968|NCT01777139|158254158|FG001|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0|||
49113969|NCT01777139|158254157|FG000|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6|||
49113970|NCT01777139|158254158|FG001|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0|||
49113971|NCT01777139|158254157|FG000|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8|||
49113972|NCT01777139|158254158|FG001|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0|||
49113973|NCT01777139|158254157|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3|||
49113974|NCT01777139|158254158|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0|||
49113975|NCT01777139|158254157|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2|||
49113976|NCT01777139|158254158|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0|||
49113977|NCT01777139|158254157|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4|||
49113978|NCT01777139|158254158|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0|||
49113979|NCT01777139|158254157|FG000|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0|||
49113980|NCT01777139|158254158|FG001|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1|||
49113981|NCT01777139|158254157|FG000|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0|||
49113982|NCT01777139|158254158|FG001|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3|||
49113983|NCT03326518|158254161|FG000|Overall Study|Protocol Violation|1|||
49113984|NCT03326518|158254162|FG001|Overall Study|Protocol Violation|0|||
49113985|NCT03326518|158254163|FG002|Overall Study|Protocol Violation|0|||
49113986|NCT03326518|158254161|FG000|Overall Study|Withdrawal by Subject|1|||
49113987|NCT03326518|158254162|FG001|Overall Study|Withdrawal by Subject|0|||
49113988|NCT03326518|158254163|FG002|Overall Study|Withdrawal by Subject|0|||
49113989|NCT03326518|158254161|FG000|Overall Study|Lost to Follow-up|1|||
49113990|NCT03326518|158254162|FG001|Overall Study|Lost to Follow-up|0|||
49113991|NCT03326518|158254163|FG002|Overall Study|Lost to Follow-up|1|||
49113992|NCT00496587|158254164|FG000|Overall Study|Adverse Event|2|||
48903803|NCT00604279|157484172|FG001|Overall Study|Withdrawal by Subject|5|||
49113993|NCT00496587|158254164|FG000|Overall Study|Progressive Disease|24|||
49113994|NCT00496587|158254164|FG000|Overall Study|Withdrawal by Subject|2|||
49113995|NCT00496587|158254164|FG000|Overall Study|Death|1|||
49113996|NCT00496587|158254164|FG000|Overall Study|Complications unrelated|2|||
49113997|NCT00162097|158254166|FG000|Overall Study|Participant no longer met study criteria|0|||
49113998|NCT00162097|158254167|FG001|Overall Study|Participant no longer met study criteria|0|||
49113999|NCT00162097|158254168|FG002|Overall Study|Participant no longer met study criteria|0|||
49114000|NCT00162097|158254169|FG003|Overall Study|Participant no longer met study criteria|1|||
49114001|NCT03882957|158254170|FG000|Overall Study|Did not complete all three arms|1|||
49114002|NCT00080483|158254172|FG000|Overall Study|Lost to Follow-up|1|||
49114003|NCT00080483|158254173|FG001|Overall Study|Lost to Follow-up|1|||
49114004|NCT00080483|158254172|FG000|Overall Study|Physician Decision|1|||
49114005|NCT00080483|158254173|FG001|Overall Study|Physician Decision|1|||
49114006|NCT03333486|158254174|FG000|Overall Study|Withdrawal by Subject|1|||
49114007|NCT03333486|158254174|FG000|Overall Study|Lost to Follow-up|1|||
49114008|NCT01087203|158254175|FG000|Overall Study|Lost to Follow-up|2|||
49114009|NCT01087203|158254176|FG001|Overall Study|Lost to Follow-up|0|||
49114010|NCT01087203|158254175|FG000|Overall Study|Withdrawal by Subject|2|||
49114011|NCT01087203|158254176|FG001|Overall Study|Withdrawal by Subject|6|||
49114012|NCT01087203|158254175|FG000|Overall Study|Lack of Efficacy|1|||
49114013|NCT01087203|158254176|FG001|Overall Study|Lack of Efficacy|2|||
49114014|NCT01087203|158254175|FG000|Overall Study|Study terminated by sponsor|27|||
49114015|NCT01087203|158254176|FG001|Overall Study|Study terminated by sponsor|27|||
49114016|NCT01693185|158254177|FG000|Overall Study|diagnostic procedure after colonoscopy|0|||
49114017|NCT01693185|158254178|FG001|Overall Study|diagnostic procedure after colonoscopy|6|||
49114018|NCT01017601|158254181|FG000|Overall Study|Disease Progression|12|||
49114019|NCT01017601|158254182|FG001|Overall Study|Disease Progression|12|||
49114020|NCT01017601|158254181|FG000|Overall Study|Withdrawal by Subject|0|||
49114021|NCT01017601|158254182|FG001|Overall Study|Withdrawal by Subject|1|||
49114022|NCT02787083|158254187|FG000|Overall Study|Adverse Event|1|||
49114023|NCT02787083|158254188|FG001|Overall Study|Adverse Event|0|||
49114024|NCT02787083|158254187|FG000|Overall Study|Withdrawal by Subject|2|||
49114025|NCT02787083|158254188|FG001|Overall Study|Withdrawal by Subject|2|||
49114026|NCT00069823|158254189|FG000|Overall Study|Did not have follow-up diary cards|6|||
49114027|NCT00069823|158254190|FG001|Overall Study|Did not have follow-up diary cards|3|||
49114028|NCT00187278|158254191|FG000|Overall Study|Protocol Violation|10|||
49114029|NCT00187278|158254192|FG001|Overall Study|Protocol Violation|13|||
49114030|NCT01990768|158254194|FG000|Intervention Started|Found to be ineligible|14|||
49114031|NCT01990768|158254195|FG001|Intervention Started|Found to be ineligible|13|||
49114032|NCT01990768|158254196|FG002|Intervention Started|Found to be ineligible|11|||
49114033|NCT01990768|158254194|FG000|Intervention Started|Study drug issue or kit malfunction|9|||
49114034|NCT01990768|158254195|FG001|Intervention Started|Study drug issue or kit malfunction|6|||
49114035|NCT01990768|158254196|FG002|Intervention Started|Study drug issue or kit malfunction|7|||
49114036|NCT01990768|158254194|FG000|Intervention Started|Patient became ineligible due to vitals|5|||
49114037|NCT01990768|158254195|FG001|Intervention Started|Patient became ineligible due to vitals|5|||
49114038|NCT01990768|158254196|FG002|Intervention Started|Patient became ineligible due to vitals|2|||
49114039|NCT01990768|158254194|FG000|Intervention Started|Not enough time for EMS to enroll|4|||
49114040|NCT01990768|158254195|FG001|Intervention Started|Not enough time for EMS to enroll|3|||
49114041|NCT01990768|158254196|FG002|Intervention Started|Not enough time for EMS to enroll|0|||
49114042|NCT01990768|158254194|FG000|Intervention Started|Patient care priority|1|||
49114043|NCT01990768|158254195|FG001|Intervention Started|Patient care priority|2|||
49114044|NCT01990768|158254196|FG002|Intervention Started|Patient care priority|3|||
49114045|NCT01990768|158254194|FG000|Intervention Started|IV lost|2|||
49114046|NCT01990768|158254195|FG001|Intervention Started|IV lost|2|||
49114047|NCT01990768|158254196|FG002|Intervention Started|IV lost|2|||
49114048|NCT01990768|158254194|FG000|Intervention Started|Required CPR|1|||
49114049|NCT01990768|158254195|FG001|Intervention Started|Required CPR|1|||
49114050|NCT01990768|158254196|FG002|Intervention Started|Required CPR|0|||
49114051|NCT01990768|158254194|FG000|Intervention Started|Seizure or hx of seizure|0|||
49114052|NCT01990768|158254195|FG001|Intervention Started|Seizure or hx of seizure|0|||
49114053|NCT01990768|158254196|FG002|Intervention Started|Seizure or hx of seizure|2|||
49114054|NCT01990768|158254194|FG000|Intervention Started|Discovered to be pregnant|0|||
49114055|NCT01990768|158254195|FG001|Intervention Started|Discovered to be pregnant|1|||
49114056|NCT01990768|158254196|FG002|Intervention Started|Discovered to be pregnant|0|||
49114057|NCT01990768|158254194|FG000|Prehospital Study Drug Infusion|Protocol non-compliance|4|||
49114058|NCT01990768|158254195|FG001|Prehospital Study Drug Infusion|Protocol non-compliance|11|||
49114059|NCT01990768|158254196|FG002|Prehospital Study Drug Infusion|Protocol non-compliance|10|||
49114060|NCT01990768|158254194|FG000|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
49114061|NCT01990768|158254195|FG001|Prehospital Study Drug Infusion|Seizure or concern for seizure|3|||
49114062|NCT01990768|158254196|FG002|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
49114063|NCT01990768|158254194|FG000|Prehospital Study Drug Infusion|Required CPR|2|||
49114064|NCT01990768|158254195|FG001|Prehospital Study Drug Infusion|Required CPR|6|||
49114065|NCT01990768|158254196|FG002|Prehospital Study Drug Infusion|Required CPR|0|||
49114066|NCT01990768|158254194|FG000|Prehospital Study Drug Infusion|Other safety concern|2|||
49114067|NCT01990768|158254195|FG001|Prehospital Study Drug Infusion|Other safety concern|1|||
49114068|NCT01990768|158254196|FG002|Prehospital Study Drug Infusion|Other safety concern|1|||
49114069|NCT01990768|158254194|FG000|Prehospital Study Drug Infusion|Death|3|||
48742915|NCT00745823|156910414|FG001|Overall Study|Lack of Efficacy|6|||
49114070|NCT01990768|158254195|FG001|Prehospital Study Drug Infusion|Death|1|||
49114071|NCT01990768|158254196|FG002|Prehospital Study Drug Infusion|Death|1|||
49114072|NCT01990768|158254194|FG000|Prehospital Study Drug Infusion|Discharged|2|||
49114073|NCT01990768|158254195|FG001|Prehospital Study Drug Infusion|Discharged|1|||
49114074|NCT01990768|158254196|FG002|Prehospital Study Drug Infusion|Discharged|0|||
49114075|NCT01990768|158254194|FG000|Prehospital Study Drug Infusion|Withdrawal by Subject|1|||
49114076|NCT01990768|158254195|FG001|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
49114077|NCT01990768|158254196|FG002|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
49114078|NCT01990768|158254194|FG000|Prehospital Study Drug Infusion|Emergency unblinding|0|||
49114079|NCT01990768|158254195|FG001|Prehospital Study Drug Infusion|Emergency unblinding|0|||
49114080|NCT01990768|158254196|FG002|Prehospital Study Drug Infusion|Emergency unblinding|1|||
49114081|NCT01990768|158254194|FG000|Prehospital Study Drug Infusion|Unknown if completed|1|||
49114082|NCT01990768|158254195|FG001|Prehospital Study Drug Infusion|Unknown if completed|4|||
49114083|NCT01990768|158254196|FG002|Prehospital Study Drug Infusion|Unknown if completed|2|||
49114084|NCT01990768|158254194|FG000|In-Hospital Study Drug Infusion|Discharged|19|||
49114085|NCT01990768|158254195|FG001|In-Hospital Study Drug Infusion|Discharged|18|||
49114086|NCT01990768|158254196|FG002|In-Hospital Study Drug Infusion|Discharged|13|||
49114087|NCT01990768|158254194|FG000|In-Hospital Study Drug Infusion|Protocol non-compliance|14|||
49114088|NCT01990768|158254195|FG001|In-Hospital Study Drug Infusion|Protocol non-compliance|17|||
49114089|NCT01990768|158254196|FG002|In-Hospital Study Drug Infusion|Protocol non-compliance|10|||
49114090|NCT01990768|158254194|FG000|In-Hospital Study Drug Infusion|Withdrawal by Subject|13|||
49114091|NCT01990768|158254195|FG001|In-Hospital Study Drug Infusion|Withdrawal by Subject|7|||
49114092|NCT01990768|158254196|FG002|In-Hospital Study Drug Infusion|Withdrawal by Subject|12|||
49114093|NCT01990768|158254194|FG000|In-Hospital Study Drug Infusion|Death or comfort care|12|||
49114094|NCT01990768|158254195|FG001|In-Hospital Study Drug Infusion|Death or comfort care|11|||
49114095|NCT01990768|158254196|FG002|In-Hospital Study Drug Infusion|Death or comfort care|6|||
49114096|NCT01990768|158254194|FG000|In-Hospital Study Drug Infusion|Emergency unblinding|11|||
49114097|NCT01990768|158254195|FG001|In-Hospital Study Drug Infusion|Emergency unblinding|4|||
49114098|NCT01990768|158254196|FG002|In-Hospital Study Drug Infusion|Emergency unblinding|7|||
49114099|NCT01990768|158254194|FG000|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8|||
49114100|NCT01990768|158254195|FG001|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9|||
49114101|NCT01990768|158254196|FG002|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17|||
49114102|NCT01990768|158254194|FG000|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
49114103|NCT01990768|158254195|FG001|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
49114104|NCT01990768|158254196|FG002|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4|||
49114105|NCT01990768|158254194|FG000|In-Hospital Study Drug Infusion|Required CPR|3|||
49114106|NCT01990768|158254195|FG001|In-Hospital Study Drug Infusion|Required CPR|7|||
49114107|NCT01990768|158254196|FG002|In-Hospital Study Drug Infusion|Required CPR|1|||
49114108|NCT01990768|158254194|FG000|In-Hospital Study Drug Infusion|Other safety concern|4|||
49114109|NCT01990768|158254195|FG001|In-Hospital Study Drug Infusion|Other safety concern|2|||
49114110|NCT01990768|158254196|FG002|In-Hospital Study Drug Infusion|Other safety concern|3|||
49114111|NCT01990768|158254194|FG000|In-Hospital Study Drug Infusion|Taken into police custody|4|||
49114112|NCT01990768|158254195|FG001|In-Hospital Study Drug Infusion|Taken into police custody|0|||
49114113|NCT01990768|158254196|FG002|In-Hospital Study Drug Infusion|Taken into police custody|3|||
49114114|NCT01990768|158254194|FG000|In-Hospital Study Drug Infusion|Found not to be injured|1|||
49114115|NCT01990768|158254195|FG001|In-Hospital Study Drug Infusion|Found not to be injured|1|||
49114116|NCT01990768|158254196|FG002|In-Hospital Study Drug Infusion|Found not to be injured|1|||
49114117|NCT01990768|158254194|FG000|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
49114118|NCT01990768|158254195|FG001|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
49114119|NCT01990768|158254196|FG002|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0|||
49114120|NCT01990768|158254194|FG000|In-Hospital Study Drug Infusion|Other procoagulant administered|0|||
49114121|NCT01990768|158254195|FG001|In-Hospital Study Drug Infusion|Other procoagulant administered|1|||
49114122|NCT01990768|158254196|FG002|In-Hospital Study Drug Infusion|Other procoagulant administered|2|||
49114123|NCT01990768|158254194|FG000|In-Hospital Study Drug Infusion|Unknown if completed|0|||
49114124|NCT01990768|158254195|FG001|In-Hospital Study Drug Infusion|Unknown if completed|0|||
49114125|NCT01990768|158254196|FG002|In-Hospital Study Drug Infusion|Unknown if completed|1|||
49114126|NCT01990768|158254194|FG000|6-Month Follow-up|Withdrawal by Subject|25|||
49114127|NCT01990768|158254195|FG001|6-Month Follow-up|Withdrawal by Subject|25|||
49114128|NCT01990768|158254196|FG002|6-Month Follow-up|Withdrawal by Subject|26|||
49114129|NCT01990768|158254194|FG000|6-Month Follow-up|Calls unreturned or refused contact|4|||
49114130|NCT01990768|158254195|FG001|6-Month Follow-up|Calls unreturned or refused contact|15|||
49114131|NCT01990768|158254196|FG002|6-Month Follow-up|Calls unreturned or refused contact|20|||
49114132|NCT01990768|158254194|FG000|6-Month Follow-up|No contact information|5|||
49114133|NCT01990768|158254195|FG001|6-Month Follow-up|No contact information|6|||
49114134|NCT01990768|158254196|FG002|6-Month Follow-up|No contact information|5|||
49114135|NCT01990768|158254194|FG000|6-Month Follow-up|Homeless|4|||
49114136|NCT01990768|158254195|FG001|6-Month Follow-up|Homeless|3|||
49114137|NCT01990768|158254196|FG002|6-Month Follow-up|Homeless|6|||
49114138|NCT01990768|158254194|FG000|6-Month Follow-up|Prisoner at time of enrollment|0|||
49114139|NCT01990768|158254195|FG001|6-Month Follow-up|Prisoner at time of enrollment|0|||
49114140|NCT01990768|158254196|FG002|6-Month Follow-up|Prisoner at time of enrollment|1|||
49114141|NCT01990768|158254194|FG000|6-Month Follow-up|Prisoner at time of follow-up|0|||
49114142|NCT01990768|158254195|FG001|6-Month Follow-up|Prisoner at time of follow-up|2|||
49114143|NCT01990768|158254196|FG002|6-Month Follow-up|Prisoner at time of follow-up|0|||
49114144|NCT01990768|158254194|FG000|6-Month Follow-up|Patient at psychiatric hospital|1|||
49114145|NCT01990768|158254195|FG001|6-Month Follow-up|Patient at psychiatric hospital|0|||
49114146|NCT01990768|158254196|FG002|6-Month Follow-up|Patient at psychiatric hospital|0|||
49114147|NCT01778751|158254197|FG000|Overall Study|Lost to Follow-up|1|||
49114148|NCT01778751|158254198|FG001|Overall Study|Lost to Follow-up|0|||
49114149|NCT01778751|158254197|FG000|Overall Study|Withdrawal by Subject|0|||
49114150|NCT01778751|158254198|FG001|Overall Study|Withdrawal by Subject|2|||
49114151|NCT01778751|158254197|FG000|Overall Study|Transfered care|1|||
49114152|NCT01778751|158254198|FG001|Overall Study|Transfered care|0|||
49114153|NCT00154375|158254201|FG000|Overall Study|Unsatisfactory therapeutic effect|25|||
49114154|NCT00154375|158254202|FG001|Overall Study|Unsatisfactory therapeutic effect|26|||
49114155|NCT00154375|158254201|FG000|Overall Study|Adverse Event|18|||
49114156|NCT00154375|158254202|FG001|Overall Study|Adverse Event|20|||
49114157|NCT00154375|158254201|FG000|Overall Study|Withdrawal by Subject|14|||
49114158|NCT00154375|158254202|FG001|Overall Study|Withdrawal by Subject|10|||
49114159|NCT00154375|158254201|FG000|Overall Study|Death|5|||
49114160|NCT00154375|158254202|FG001|Overall Study|Death|13|||
49114161|NCT00154375|158254201|FG000|Overall Study|Study drug no longer required|5|||
49114162|NCT00154375|158254202|FG001|Overall Study|Study drug no longer required|3|||
49114163|NCT00154375|158254201|FG000|Overall Study|Lost to Follow-up|2|||
49114164|NCT00154375|158254202|FG001|Overall Study|Lost to Follow-up|1|||
49114165|NCT00154375|158254201|FG000|Overall Study|Abnormal laboratory value(s)|0|||
49114166|NCT00154375|158254202|FG001|Overall Study|Abnormal laboratory value(s)|2|||
49114167|NCT00154375|158254201|FG000|Overall Study|Protocol Violation|0|||
49114168|NCT00154375|158254202|FG001|Overall Study|Protocol Violation|1|||
49114169|NCT00154375|158254201|FG000|Overall Study|Suspected progression of disease|44|||
49114170|NCT00154375|158254202|FG001|Overall Study|Suspected progression of disease|30|||
49114171|NCT03816007|158254204|FG000|End of 12-week Intervention|Withdrawal by Subject|0|||
49114172|NCT03816007|158254205|FG001|End of 12-week Intervention|Withdrawal by Subject|2|||
49114173|NCT03816007|158254204|FG000|End of 12-week Intervention|Lost to Follow-up|3|||
49114174|NCT03816007|158254205|FG001|End of 12-week Intervention|Lost to Follow-up|4|||
49114175|NCT03816007|158254204|FG000|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
49114176|NCT03816007|158254205|FG001|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
49114177|NCT01588405|158254207|FG000|Overall Study|Adverse Event|1|||
49114178|NCT01588405|158254207|FG000|Overall Study|Clinical Worsening|1|||
49114179|NCT02453256|158254208|FG000|Double Blind Period|Death|1|||
49114180|NCT02453256|158254209|FG001|Double Blind Period|Death|1|||
49114181|NCT02453256|158254208|FG000|Double Blind Period|Adverse Event|3|||
49114182|NCT02453256|158254209|FG001|Double Blind Period|Adverse Event|2|||
49114183|NCT02453256|158254208|FG000|Double Blind Period|Withdrawal by Subject|9|||
49114184|NCT02453256|158254209|FG001|Double Blind Period|Withdrawal by Subject|5|||
49114185|NCT02453256|158254208|FG000|Double Blind Period|Other|0|||
49114186|NCT02453256|158254209|FG001|Double Blind Period|Other|1|||
49114187|NCT02453256|158254208|FG000|Open Label Period|Adverse Event|1|||
49114188|NCT02453256|158254209|FG001|Open Label Period|Adverse Event|3|||
49114189|NCT02453256|158254208|FG000|Open Label Period|Death|0|||
49114190|NCT02453256|158254209|FG001|Open Label Period|Death|1|||
49114191|NCT02453256|158254208|FG000|Open Label Period|Lost to Follow-up|1|||
49114192|NCT02453256|158254209|FG001|Open Label Period|Lost to Follow-up|0|||
49114193|NCT02453256|158254208|FG000|Open Label Period|Other|0|||
49114194|NCT02453256|158254209|FG001|Open Label Period|Other|2|||
49114195|NCT02453256|158254208|FG000|Open Label Period|Withdrawal by Subject|5|||
49114196|NCT02453256|158254209|FG001|Open Label Period|Withdrawal by Subject|1|||
49114197|NCT01066871|158254212|FG000|Overall Study|Lost to Follow-up|0|||
49114198|NCT01066871|158254213|FG001|Overall Study|Lost to Follow-up|2|||
49114199|NCT01066871|158254214|FG002|Overall Study|Lost to Follow-up|2|||
49114200|NCT01066871|158254215|FG003|Overall Study|Lost to Follow-up|0|||
49114201|NCT01066871|158254212|FG000|Overall Study|Protocol Violation|1|||
49114202|NCT01066871|158254213|FG001|Overall Study|Protocol Violation|0|||
49114203|NCT01066871|158254214|FG002|Overall Study|Protocol Violation|3|||
49114204|NCT01066871|158254215|FG003|Overall Study|Protocol Violation|2|||
49114205|NCT01066871|158254212|FG000|Overall Study|Lack of Efficacy|0|||
49114206|NCT01066871|158254213|FG001|Overall Study|Lack of Efficacy|0|||
49114207|NCT01066871|158254214|FG002|Overall Study|Lack of Efficacy|0|||
49114208|NCT01066871|158254215|FG003|Overall Study|Lack of Efficacy|1|||
49114209|NCT01066871|158254212|FG000|Overall Study|Withdrawal by Subject|3|||
49114210|NCT01066871|158254213|FG001|Overall Study|Withdrawal by Subject|1|||
49114211|NCT01066871|158254214|FG002|Overall Study|Withdrawal by Subject|0|||
49114212|NCT01066871|158254215|FG003|Overall Study|Withdrawal by Subject|0|||
49114213|NCT01066871|158254212|FG000|Overall Study|Other|0|||
49114214|NCT01066871|158254213|FG001|Overall Study|Other|2|||
49114215|NCT01066871|158254214|FG002|Overall Study|Other|1|||
49114216|NCT01066871|158254215|FG003|Overall Study|Other|2|||
49114217|NCT04114656|158256624|FG000|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|0|||
49114218|NCT04114656|158256625|FG001|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|1|||
49114219|NCT04114656|158256624|FG000|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|0|||
49114220|NCT04114656|158256625|FG001|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|2|||
49114221|NCT04114656|158256624|FG000|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
49114222|NCT04114656|158256625|FG001|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
49114223|NCT04114656|158256624|FG000|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|1|||
49114224|NCT04114656|158256625|FG001|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|0|||
49114225|NCT04114656|158256624|FG000|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
49114226|NCT04114656|158256625|FG001|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
49114227|NCT03307837|158256626|FG000|Overall Study|Withdrawal by Subject|0|||
49114228|NCT03307837|158256627|FG001|Overall Study|Withdrawal by Subject|0|||
49114229|NCT03307837|158256628|FG002|Overall Study|Withdrawal by Subject|1|||
49114230|NCT03307837|158256629|FG003|Overall Study|Withdrawal by Subject|0|||
49114231|NCT03307837|158256630|FG004|Overall Study|Withdrawal by Subject|0|||
49114232|NCT03307837|158256631|FG005|Overall Study|Withdrawal by Subject|1|||
49114233|NCT03307837|158256626|FG000|Overall Study|Lost to Follow-up|1|||
49114234|NCT03307837|158256627|FG001|Overall Study|Lost to Follow-up|1|||
49114235|NCT03307837|158256628|FG002|Overall Study|Lost to Follow-up|0|||
49114236|NCT03307837|158256629|FG003|Overall Study|Lost to Follow-up|0|||
49114237|NCT03307837|158256630|FG004|Overall Study|Lost to Follow-up|0|||
49114238|NCT03307837|158256631|FG005|Overall Study|Lost to Follow-up|1|||
49114239|NCT02732015|158256632|FG000|Overall Study|Lost to Follow-up|0|||
49114240|NCT02732015|158256633|FG001|Overall Study|Lost to Follow-up|1|||
49114241|NCT02474355|158256634|FG000|Overall Study|Other|43|||
49114242|NCT02474355|158256634|FG000|Overall Study|Eligibility Criteria not Fulfilled|2|||
49114243|NCT02474355|158256634|FG000|Overall Study|Lost to Follow-up|98|||
49114244|NCT02474355|158256634|FG000|Overall Study|Withdrawal by Subject|124|||
49114245|NCT02474355|158256634|FG000|Overall Study|Death|1361|||
49114246|NCT00904917|158256635|FG000|Overall Study|Lost to Follow-up|2|||
49114247|NCT00904917|158256636|FG001|Overall Study|Lost to Follow-up|2|||
49114248|NCT00904917|158256637|FG002|Overall Study|Lost to Follow-up|2|||
49114249|NCT00904917|158256638|FG003|Overall Study|Lost to Follow-up|2|||
49114250|NCT01066793|158256639|FG000|Overall Study|Death|4|||
49114251|NCT01066793|158256640|FG001|Overall Study|Death|1|||
49114252|NCT01066793|158256641|FG002|Overall Study|Death|1|||
49114253|NCT01066793|158256642|FG003|Overall Study|Death|0|||
49114254|NCT01066793|158256643|FG004|Overall Study|Death|0|||
49114255|NCT01066793|158256644|FG005|Overall Study|Death|0|||
49114256|NCT01066793|158256639|FG000|Overall Study|Lack of Efficacy|2|||
49114257|NCT01066793|158256640|FG001|Overall Study|Lack of Efficacy|1|||
49114258|NCT01066793|158256641|FG002|Overall Study|Lack of Efficacy|0|||
49114259|NCT01066793|158256642|FG003|Overall Study|Lack of Efficacy|0|||
49114260|NCT01066793|158256643|FG004|Overall Study|Lack of Efficacy|0|||
49114261|NCT01066793|158256644|FG005|Overall Study|Lack of Efficacy|0|||
49114262|NCT01066793|158256639|FG000|Overall Study|Lost to Follow-up|180|||
49114263|NCT01066793|158256640|FG001|Overall Study|Lost to Follow-up|39|||
49114264|NCT01066793|158256641|FG002|Overall Study|Lost to Follow-up|82|||
49114265|NCT01066793|158256642|FG003|Overall Study|Lost to Follow-up|16|||
49114266|NCT01066793|158256643|FG004|Overall Study|Lost to Follow-up|0|||
49114267|NCT01066793|158256644|FG005|Overall Study|Lost to Follow-up|1|||
49114268|NCT01066793|158256639|FG000|Overall Study|Physician Decision|3|||
49114269|NCT01066793|158256640|FG001|Overall Study|Physician Decision|0|||
49114270|NCT01066793|158256641|FG002|Overall Study|Physician Decision|0|||
49114271|NCT01066793|158256642|FG003|Overall Study|Physician Decision|0|||
49114272|NCT01066793|158256643|FG004|Overall Study|Physician Decision|0|||
49114273|NCT01066793|158256644|FG005|Overall Study|Physician Decision|0|||
49114274|NCT01066793|158256639|FG000|Overall Study|Protocol Violation|3|||
49114275|NCT01066793|158256640|FG001|Overall Study|Protocol Violation|2|||
49114276|NCT01066793|158256641|FG002|Overall Study|Protocol Violation|2|||
49114277|NCT01066793|158256642|FG003|Overall Study|Protocol Violation|0|||
49114278|NCT01066793|158256643|FG004|Overall Study|Protocol Violation|0|||
49114279|NCT01066793|158256644|FG005|Overall Study|Protocol Violation|0|||
49114280|NCT01066793|158256639|FG000|Overall Study|Withdrawal by Subject|7|||
49114281|NCT01066793|158256640|FG001|Overall Study|Withdrawal by Subject|4|||
49114282|NCT01066793|158256641|FG002|Overall Study|Withdrawal by Subject|1|||
49114283|NCT01066793|158256642|FG003|Overall Study|Withdrawal by Subject|0|||
49114284|NCT01066793|158256643|FG004|Overall Study|Withdrawal by Subject|0|||
49114285|NCT01066793|158256644|FG005|Overall Study|Withdrawal by Subject|0|||
49114286|NCT01066793|158256639|FG000|Overall Study|Early Termination|3|||
49114287|NCT01066793|158256640|FG001|Overall Study|Early Termination|0|||
49114288|NCT01066793|158256641|FG002|Overall Study|Early Termination|0|||
49114289|NCT01066793|158256642|FG003|Overall Study|Early Termination|0|||
49114290|NCT01066793|158256643|FG004|Overall Study|Early Termination|0|||
49114291|NCT01066793|158256644|FG005|Overall Study|Early Termination|0|||
49114292|NCT01066793|158256639|FG000|Overall Study|Lab test not done|7|||
49114293|NCT01066793|158256640|FG001|Overall Study|Lab test not done|0|||
49114294|NCT01066793|158256641|FG002|Overall Study|Lab test not done|0|||
49114295|NCT01066793|158256642|FG003|Overall Study|Lab test not done|1|||
49114296|NCT01066793|158256643|FG004|Overall Study|Lab test not done|0|||
49114297|NCT01066793|158256644|FG005|Overall Study|Lab test not done|0|||
49114298|NCT01066793|158256639|FG000|Overall Study|Miscellaneous|4|||
49114299|NCT01066793|158256640|FG001|Overall Study|Miscellaneous|5|||
49114300|NCT01066793|158256641|FG002|Overall Study|Miscellaneous|6|||
49114301|NCT01066793|158256642|FG003|Overall Study|Miscellaneous|0|||
49114302|NCT01066793|158256643|FG004|Overall Study|Miscellaneous|0|||
49114303|NCT01066793|158256644|FG005|Overall Study|Miscellaneous|0|||
49114304|NCT01066793|158256639|FG000|Overall Study|Non-responders|104|||
49114305|NCT01066793|158256640|FG001|Overall Study|Non-responders|5|||
49114306|NCT01066793|158256641|FG002|Overall Study|Non-responders|11|||
49114307|NCT01066793|158256642|FG003|Overall Study|Non-responders|25|||
49114308|NCT01066793|158256643|FG004|Overall Study|Non-responders|0|||
49114309|NCT01066793|158256644|FG005|Overall Study|Non-responders|0|||
49114310|NCT01066793|158256639|FG000|Overall Study|Other|15|||
49114311|NCT01066793|158256640|FG001|Overall Study|Other|5|||
49114312|NCT01066793|158256641|FG002|Overall Study|Other|6|||
49114313|NCT01066793|158256642|FG003|Overall Study|Other|2|||
49114314|NCT01066793|158256643|FG004|Overall Study|Other|0|||
49114315|NCT01066793|158256644|FG005|Overall Study|Other|0|||
49114316|NCT01066793|158256639|FG000|Overall Study|Relapse|20|||
49114317|NCT01066793|158256640|FG001|Overall Study|Relapse|8|||
49114318|NCT01066793|158256641|FG002|Overall Study|Relapse|2|||
49114319|NCT01066793|158256642|FG003|Overall Study|Relapse|3|||
49114320|NCT01066793|158256643|FG004|Overall Study|Relapse|0|||
49114321|NCT01066793|158256644|FG005|Overall Study|Relapse|0|||
49114322|NCT01066793|158256639|FG000|Overall Study|Result Not Available|1|||
49114323|NCT01066793|158256640|FG001|Overall Study|Result Not Available|0|||
49114324|NCT01066793|158256641|FG002|Overall Study|Result Not Available|0|||
49114325|NCT01066793|158256642|FG003|Overall Study|Result Not Available|0|||
49114326|NCT01066793|158256643|FG004|Overall Study|Result Not Available|0|||
49114327|NCT01066793|158256644|FG005|Overall Study|Result Not Available|0|||
49114328|NCT01066793|158256639|FG000|Overall Study|Treatment Interrupted|1|||
49114329|NCT01066793|158256640|FG001|Overall Study|Treatment Interrupted|1|||
49114330|NCT01066793|158256641|FG002|Overall Study|Treatment Interrupted|0|||
49114331|NCT01066793|158256642|FG003|Overall Study|Treatment Interrupted|0|||
49114332|NCT01066793|158256643|FG004|Overall Study|Treatment Interrupted|0|||
49114333|NCT01066793|158256644|FG005|Overall Study|Treatment Interrupted|0|||
49114334|NCT01066793|158256639|FG000|Overall Study|Treatment Never Started|18|||
49114335|NCT01066793|158256640|FG001|Overall Study|Treatment Never Started|5|||
49114336|NCT01066793|158256641|FG002|Overall Study|Treatment Never Started|4|||
49114337|NCT01066793|158256642|FG003|Overall Study|Treatment Never Started|1|||
49114338|NCT01066793|158256643|FG004|Overall Study|Treatment Never Started|0|||
49114339|NCT01066793|158256644|FG005|Overall Study|Treatment Never Started|0|||
49114340|NCT01066793|158256639|FG000|Overall Study|Treatment Stopped|2|||
49114341|NCT01066793|158256640|FG001|Overall Study|Treatment Stopped|1|||
49114342|NCT01066793|158256641|FG002|Overall Study|Treatment Stopped|0|||
49114343|NCT01066793|158256642|FG003|Overall Study|Treatment Stopped|1|||
49114344|NCT01066793|158256643|FG004|Overall Study|Treatment Stopped|0|||
49114345|NCT01066793|158256644|FG005|Overall Study|Treatment Stopped|0|||
49114346|NCT03015194|158256647|FG000|Overall Study|Death|10|||
49114347|NCT03015194|158256647|FG000|Overall Study|Withdrawal by Subject|2|||
49114348|NCT03246061|158256648|FG000|Overall Study|Still in follow-up|15|||
49114349|NCT03246061|158256649|FG001|Overall Study|Still in follow-up|21|||
49114350|NCT01754766|158256650|FG000|Overall Study|Personal reasons|1|||
49114351|NCT01754766|158256651|FG001|Overall Study|Personal reasons|1|||
49114352|NCT01754766|158256652|FG002|Overall Study|Personal reasons|0|||
49114353|NCT02469168|158256654|FG000|Overall Study|Trial closed|1|||
49114354|NCT02469168|158256655|FG001|Overall Study|Trial closed|0|||
49114355|NCT00298363|158256656|FG000|Overall Study|Lost to Follow-up|0|||
49114356|NCT00298363|158256657|FG001|Overall Study|Lost to Follow-up|0|||
49114357|NCT00298363|158256658|FG002|Overall Study|Lost to Follow-up|1|||
49114358|NCT00298363|158256656|FG000|Overall Study|Physician Decision|4|||
49114359|NCT00298363|158256657|FG001|Overall Study|Physician Decision|1|||
49114360|NCT00298363|158256658|FG002|Overall Study|Physician Decision|0|||
49114361|NCT00298363|158256656|FG000|Overall Study|Protocol Violation|1|||
49114362|NCT00298363|158256657|FG001|Overall Study|Protocol Violation|1|||
49114363|NCT00298363|158256658|FG002|Overall Study|Protocol Violation|0|||
49114364|NCT00298363|158256656|FG000|Overall Study|Withdrawal by Subject|5|||
49114365|NCT00298363|158256657|FG001|Overall Study|Withdrawal by Subject|1|||
49114366|NCT00298363|158256658|FG002|Overall Study|Withdrawal by Subject|3|||
49114367|NCT00298363|158256656|FG000|Overall Study|Adverse Event|5|||
49114368|NCT00298363|158256657|FG001|Overall Study|Adverse Event|2|||
49114369|NCT00298363|158256658|FG002|Overall Study|Adverse Event|2|||
49114370|NCT00298363|158256656|FG000|Overall Study|Lack of Efficacy|2|||
49114371|NCT00298363|158256657|FG001|Overall Study|Lack of Efficacy|3|||
49114372|NCT00298363|158256658|FG002|Overall Study|Lack of Efficacy|0|||
49114373|NCT00433017|158256659|FG000|Overall Study|Adverse Event|5|||
49114374|NCT00433017|158256660|FG001|Overall Study|Adverse Event|3|||
49114375|NCT00433017|158256659|FG000|Overall Study|Withdrawal by Subject|4|||
49114376|NCT00433017|158256660|FG001|Overall Study|Withdrawal by Subject|5|||
49114377|NCT00433017|158256659|FG000|Overall Study|Lost to Follow-up|3|||
49114378|NCT00433017|158256660|FG001|Overall Study|Lost to Follow-up|4|||
49114379|NCT00433017|158256659|FG000|Overall Study|Administrative problems|80|||
49114380|NCT00433017|158256660|FG001|Overall Study|Administrative problems|86|||
49114381|NCT00433017|158256659|FG000|Overall Study|Protocol Violation|1|||
49114382|NCT00433017|158256660|FG001|Overall Study|Protocol Violation|0|||
49114383|NCT00433017|158256659|FG000|Overall Study|Death|2|||
49114384|NCT00433017|158256660|FG001|Overall Study|Death|2|||
49114385|NCT00433017|158256659|FG000|Overall Study|Subject no longer requires study drug|1|||
49114386|NCT00433017|158256660|FG001|Overall Study|Subject no longer requires study drug|1|||
49114387|NCT04710368|158256661|FG000|Overall Study|Withdrawal by Subject|9|||
49114388|NCT04710368|158256661|FG000|Overall Study|Lost to Follow-up|4|||
49114389|NCT04710368|158256661|FG000|Overall Study|Death|2|||
49114390|NCT04710368|158256661|FG000|Overall Study|Patient preference|11|||
49114391|NCT04710368|158256661|FG000|Overall Study|Treatment discontinuation|1|||
49114392|NCT00135356|158256662|FG000|Overall Study|Adverse Event|6|||
49114393|NCT00135356|158256663|FG001|Overall Study|Adverse Event|2|||
49114394|NCT00135356|158256662|FG000|Overall Study|Lack of Efficacy|2|||
49114395|NCT00135356|158256663|FG001|Overall Study|Lack of Efficacy|0|||
49114396|NCT00135356|158256662|FG000|Overall Study|Lost to Follow-up|3|||
49114397|NCT00135356|158256663|FG001|Overall Study|Lost to Follow-up|1|||
49114398|NCT00135356|158256662|FG000|Overall Study|Surgery for abdominal fat|1|||
49114399|NCT00135356|158256663|FG001|Overall Study|Surgery for abdominal fat|0|||
49114400|NCT00135356|158256662|FG000|Overall Study|Change in antiviral regimen|0|||
49114401|NCT00135356|158256663|FG001|Overall Study|Change in antiviral regimen|1|||
49114402|NCT00135356|158256662|FG000|Overall Study|Poor/noncompliance|1|||
49114403|NCT00135356|158256663|FG001|Overall Study|Poor/noncompliance|1|||
49114404|NCT00135356|158256662|FG000|Overall Study|No longer meets study criteria|2|||
49114405|NCT00135356|158256663|FG001|Overall Study|No longer meets study criteria|0|||
49114406|NCT00135356|158256662|FG000|Overall Study|Withdrawal by Subject|2|||
49114407|NCT00135356|158256663|FG001|Overall Study|Withdrawal by Subject|4|||
49114408|NCT00153816|158256664|FG000|Overall Study|Death|6|||
49114409|NCT00153816|158256665|FG001|Overall Study|Death|5|||
49114410|NCT00153816|158256666|FG002|Overall Study|Death|4|||
49114411|NCT00153816|158256667|FG003|Overall Study|Death|6|||
49114412|NCT00153816|158256668|FG004|Overall Study|Death|0|||
49114413|NCT00153816|158256669|FG005|Overall Study|Death|2|||
49114414|NCT00153816|158256664|FG000|Overall Study|Lost to Follow-up|7|||
49114415|NCT00153816|158256665|FG001|Overall Study|Lost to Follow-up|8|||
49114416|NCT00153816|158256666|FG002|Overall Study|Lost to Follow-up|5|||
49114417|NCT00153816|158256667|FG003|Overall Study|Lost to Follow-up|8|||
49114418|NCT00153816|158256668|FG004|Overall Study|Lost to Follow-up|7|||
49114419|NCT00153816|158256669|FG005|Overall Study|Lost to Follow-up|9|||
49114420|NCT00153816|158256664|FG000|Overall Study|Withdrawal by Subject|9|||
49114421|NCT00153816|158256665|FG001|Overall Study|Withdrawal by Subject|9|||
49114422|NCT00153816|158256666|FG002|Overall Study|Withdrawal by Subject|9|||
49114423|NCT00153816|158256667|FG003|Overall Study|Withdrawal by Subject|4|||
49114424|NCT00153816|158256668|FG004|Overall Study|Withdrawal by Subject|1|||
49114425|NCT00153816|158256669|FG005|Overall Study|Withdrawal by Subject|5|||
49114426|NCT00153816|158256664|FG000|Overall Study|Follow-up exam not done|8|||
49114427|NCT00153816|158256665|FG001|Overall Study|Follow-up exam not done|7|||
49114428|NCT00153816|158256666|FG002|Overall Study|Follow-up exam not done|11|||
49114429|NCT00153816|158256667|FG003|Overall Study|Follow-up exam not done|10|||
49114430|NCT00153816|158256668|FG004|Overall Study|Follow-up exam not done|8|||
49114431|NCT00153816|158256669|FG005|Overall Study|Follow-up exam not done|9|||
49114432|NCT00153816|158256664|FG000|Overall Study|Follow-up exam done, histology missing|2|||
49114433|NCT00153816|158256665|FG001|Overall Study|Follow-up exam done, histology missing|3|||
49114434|NCT00153816|158256666|FG002|Overall Study|Follow-up exam done, histology missing|3|||
49114435|NCT00153816|158256667|FG003|Overall Study|Follow-up exam done, histology missing|3|||
49114436|NCT00153816|158256668|FG004|Overall Study|Follow-up exam done, histology missing|1|||
49114437|NCT00153816|158256669|FG005|Overall Study|Follow-up exam done, histology missing|2|||
49114438|NCT00885378|158256670|FG000|Overall Study|Lack of Efficacy|2|||
49114439|NCT00885378|158256671|FG001|Overall Study|Lack of Efficacy|2|||
49114440|NCT00885378|158256670|FG000|Overall Study|Withdrawal by Subject|1|||
49114441|NCT00885378|158256671|FG001|Overall Study|Withdrawal by Subject|2|||
49114442|NCT00885378|158256670|FG000|Overall Study|Lost to Follow-up|1|||
49114443|NCT00885378|158256671|FG001|Overall Study|Lost to Follow-up|2|||
49114444|NCT00885378|158256670|FG000|Overall Study|Poor/Noncompliance|2|||
49114445|NCT00885378|158256671|FG001|Overall Study|Poor/Noncompliance|2|||
49114446|NCT00885378|158256670|FG000|Overall Study|Protocol Violation|2|||
49114447|NCT00885378|158256671|FG001|Overall Study|Protocol Violation|0|||
49114448|NCT01533688|158256672|FG000|Overall Study|Withdrawal by Subject|5|||
49114449|NCT01533688|158256673|FG001|Overall Study|Withdrawal by Subject|4|||
49114450|NCT01533688|158256674|FG002|Overall Study|Withdrawal by Subject|3|||
49114451|NCT01533688|158256672|FG000|Overall Study|Medically unstable|1|||
49114452|NCT01533688|158256673|FG001|Overall Study|Medically unstable|3|||
49114453|NCT01533688|158256674|FG002|Overall Study|Medically unstable|3|||
49114454|NCT01533688|158256672|FG000|Overall Study|Had colonoscopy at outside hospital|2|||
49114455|NCT01533688|158256673|FG001|Overall Study|Had colonoscopy at outside hospital|3|||
49114456|NCT01533688|158256674|FG002|Overall Study|Had colonoscopy at outside hospital|2|||
49114457|NCT02509078|158256679|FG000|Overall Study|Protocol Violation|1|||
49114458|NCT02509078|158256680|FG001|Overall Study|Protocol Violation|1|||
49114459|NCT03959488|158256682|FG000|Season 1|Other|6|||
49114460|NCT03959488|158256683|FG001|Season 1|Other|7|||
49114461|NCT03959488|158256684|FG002|Season 1|Other|0|||
49114462|NCT03959488|158256685|FG003|Season 1|Other|0|||
49114463|NCT03959488|158256686|FG004|Season 1|Other|0|||
49114464|NCT03959488|158256682|FG000|Season 1|Withdrawal by parent/guardian|43|||
49114465|NCT03959488|158256683|FG001|Season 1|Withdrawal by parent/guardian|28|||
49114466|NCT03959488|158256684|FG002|Season 1|Withdrawal by parent/guardian|0|||
49114467|NCT03959488|158256685|FG003|Season 1|Withdrawal by parent/guardian|0|||
49114468|NCT03959488|158256686|FG004|Season 1|Withdrawal by parent/guardian|0|||
49114469|NCT03959488|158256682|FG000|Season 1|Due to COVID-19 pandemic|2|||
49114470|NCT03959488|158256683|FG001|Season 1|Due to COVID-19 pandemic|3|||
49114471|NCT03959488|158256684|FG002|Season 1|Due to COVID-19 pandemic|0|||
49114472|NCT03959488|158256685|FG003|Season 1|Due to COVID-19 pandemic|0|||
49114473|NCT03959488|158256686|FG004|Season 1|Due to COVID-19 pandemic|0|||
49114474|NCT03959488|158256682|FG000|Season 1|Lost to Follow-up|17|||
49114475|NCT03959488|158256683|FG001|Season 1|Lost to Follow-up|7|||
49114476|NCT03959488|158256684|FG002|Season 1|Lost to Follow-up|0|||
49114477|NCT03959488|158256685|FG003|Season 1|Lost to Follow-up|0|||
49114478|NCT03959488|158256686|FG004|Season 1|Lost to Follow-up|0|||
49114479|NCT03959488|158256682|FG000|Season 1|Death|5|||
49114480|NCT03959488|158256683|FG001|Season 1|Death|1|||
49114481|NCT03959488|158256684|FG002|Season 1|Death|0|||
49114482|NCT03959488|158256685|FG003|Season 1|Death|0|||
49114483|NCT03959488|158256686|FG004|Season 1|Death|0|||
49114484|NCT03959488|158256682|FG000|Season 2|Other|0|||
49114485|NCT03959488|158256683|FG001|Season 2|Other|0|||
49114486|NCT03959488|158256684|FG002|Season 2|Other|2|||
49114487|NCT03959488|158256685|FG003|Season 2|Other|0|||
49114488|NCT03959488|158256686|FG004|Season 2|Other|0|||
49114489|NCT03959488|158256682|FG000|Season 2|Withdrawal by parent/guardian|0|||
49114490|NCT03959488|158256683|FG001|Season 2|Withdrawal by parent/guardian|0|||
49114491|NCT03959488|158256684|FG002|Season 2|Withdrawal by parent/guardian|3|||
49114492|NCT03959488|158256685|FG003|Season 2|Withdrawal by parent/guardian|1|||
49114493|NCT03959488|158256686|FG004|Season 2|Withdrawal by parent/guardian|1|||
49114494|NCT03959488|158256682|FG000|Season 2|Lost to Follow-up|0|||
49114495|NCT03959488|158256683|FG001|Season 2|Lost to Follow-up|0|||
49114496|NCT03959488|158256684|FG002|Season 2|Lost to Follow-up|1|||
49114497|NCT03959488|158256685|FG003|Season 2|Lost to Follow-up|0|||
49114498|NCT03959488|158256686|FG004|Season 2|Lost to Follow-up|1|||
49114499|NCT04575584|158256687|FG000|Overall Study|Death|6|||
49114500|NCT04575584|158256688|FG001|Overall Study|Death|4|||
49114501|NCT04575584|158256689|FG002|Overall Study|Death|6|||
49114502|NCT04575584|158256690|FG003|Overall Study|Death|2|||
49114503|NCT04575584|158256691|FG004|Overall Study|Death|0|||
49114504|NCT04575584|158256692|FG005|Overall Study|Death|0|||
49114505|NCT04575584|158256687|FG000|Overall Study|Lost to Follow-up|1|||
49114506|NCT04575584|158256688|FG001|Overall Study|Lost to Follow-up|1|||
49114507|NCT04575584|158256689|FG002|Overall Study|Lost to Follow-up|1|||
49114508|NCT04575584|158256690|FG003|Overall Study|Lost to Follow-up|1|||
49114509|NCT04575584|158256691|FG004|Overall Study|Lost to Follow-up|0|||
49114510|NCT04575584|158256692|FG005|Overall Study|Lost to Follow-up|0|||
49114511|NCT04575584|158256687|FG000|Overall Study|Physician Decision|0|||
49114512|NCT04575584|158256688|FG001|Overall Study|Physician Decision|1|||
49114513|NCT04575584|158256689|FG002|Overall Study|Physician Decision|1|||
49114514|NCT04575584|158256690|FG003|Overall Study|Physician Decision|1|||
49114515|NCT04575584|158256691|FG004|Overall Study|Physician Decision|0|||
49114516|NCT04575584|158256692|FG005|Overall Study|Physician Decision|0|||
49114517|NCT04575584|158256687|FG000|Overall Study|Withdrawal by Subject|7|||
49114518|NCT04575584|158256688|FG001|Overall Study|Withdrawal by Subject|9|||
49114519|NCT04575584|158256689|FG002|Overall Study|Withdrawal by Subject|5|||
49114520|NCT04575584|158256690|FG003|Overall Study|Withdrawal by Subject|3|||
49114521|NCT04575584|158256691|FG004|Overall Study|Withdrawal by Subject|0|||
49114522|NCT04575584|158256692|FG005|Overall Study|Withdrawal by Subject|0|||
49114523|NCT04575584|158256687|FG000|Overall Study|Not recorded|0|||
49114524|NCT04575584|158256688|FG001|Overall Study|Not recorded|0|||
49114525|NCT04575584|158256689|FG002|Overall Study|Not recorded|0|||
49114526|NCT04575584|158256690|FG003|Overall Study|Not recorded|1|||
49114527|NCT04575584|158256691|FG004|Overall Study|Not recorded|0|||
49114528|NCT04575584|158256692|FG005|Overall Study|Not recorded|0|||
49114529|NCT00582426|158256693|FG000|Overall Study|Lost to Follow-up|0|||
49114530|NCT00582426|158256694|FG001|Overall Study|Lost to Follow-up|2|||
49114531|NCT00582426|158256693|FG000|Overall Study|Adverse Event|4|||
49114532|NCT00582426|158256694|FG001|Overall Study|Adverse Event|2|||
49114533|NCT00582426|158256693|FG000|Overall Study|Protocol Violation|6|||
49114534|NCT00582426|158256694|FG001|Overall Study|Protocol Violation|2|||
49114535|NCT00582426|158256693|FG000|Overall Study|Death|4|||
49114536|NCT00582426|158256694|FG001|Overall Study|Death|3|||
49114537|NCT00582426|158256693|FG000|Overall Study|Withdrawal by Subject|3|||
49114538|NCT00582426|158256694|FG001|Overall Study|Withdrawal by Subject|2|||
49114539|NCT00582426|158256693|FG000|Overall Study|Disease Progression|2|||
49114540|NCT00582426|158256694|FG001|Overall Study|Disease Progression|2|||
49114541|NCT00582426|158256693|FG000|Overall Study|Use of illicit drugs|1|||
49114542|NCT00582426|158256694|FG001|Overall Study|Use of illicit drugs|0|||
49114543|NCT02815267|158256695|FG000|Double-Blind Phase|Adverse Event|0|||
49114544|NCT02815267|158256696|FG001|Double-Blind Phase|Adverse Event|3|||
49114545|NCT02815267|158256695|FG000|Double-Blind Phase|Lost to Follow-up|17|||
49114546|NCT02815267|158256696|FG001|Double-Blind Phase|Lost to Follow-up|9|||
49114547|NCT02815267|158256695|FG000|Double-Blind Phase|Withdrawal by Subject|11|||
49114548|NCT02815267|158256696|FG001|Double-Blind Phase|Withdrawal by Subject|10|||
49114549|NCT02815267|158256695|FG000|Double-Blind Phase|Protocol Violation|3|||
49114550|NCT02815267|158256696|FG001|Double-Blind Phase|Protocol Violation|2|||
49114551|NCT02815267|158256695|FG000|Double-Blind Phase|Site withdrawal|1|||
49114552|NCT02815267|158256696|FG001|Double-Blind Phase|Site withdrawal|6|||
49114553|NCT02815267|158256695|FG000|Double-Blind Phase|Received a disallowed medication|1|||
49114554|NCT02815267|158256696|FG001|Double-Blind Phase|Received a disallowed medication|1|||
49114555|NCT02815267|158256695|FG000|Open-Label Phase|Adverse Event|1|||
49114556|NCT02815267|158256696|FG001|Open-Label Phase|Adverse Event|1|||
49114557|NCT02815267|158256695|FG000|Open-Label Phase|Lost to Follow-up|23|||
49114558|NCT02815267|158256696|FG001|Open-Label Phase|Lost to Follow-up|9|||
49114559|NCT02815267|158256695|FG000|Open-Label Phase|Withdrawal by Subject|24|||
49114560|NCT02815267|158256696|FG001|Open-Label Phase|Withdrawal by Subject|13|||
49114561|NCT02815267|158256695|FG000|Open-Label Phase|Protocol Violation|0|||
49114562|NCT02815267|158256696|FG001|Open-Label Phase|Protocol Violation|1|||
49114563|NCT02815267|158256695|FG000|Open-Label Phase|Administrative|21|||
49114564|NCT02815267|158256696|FG001|Open-Label Phase|Administrative|12|||
49114565|NCT02815267|158256695|FG000|Open-Label Phase|Other|2|||
49114566|NCT02815267|158256696|FG001|Open-Label Phase|Other|5|||
49114567|NCT00255840|158256701|FG000|Overall Study|Lost to Follow-up|10|||
49114568|NCT00255840|158256702|FG001|Overall Study|Lost to Follow-up|14|||
49114569|NCT00255840|158256701|FG000|Overall Study|Discontinued intervention|53|||
49114570|NCT00255840|158256702|FG001|Overall Study|Discontinued intervention|56|||
49114571|NCT03465709|158256703|FG000|Overall Study|Study/Site Terminated by Sponsor|14|||
49114572|NCT03465709|158256703|FG000|Overall Study|Withdrawal by Subject|3|||
49114573|NCT00329745|158256704|FG000|Overall Study|Protocol Violation|1|||
49114574|NCT00329745|158256705|FG001|Overall Study|Protocol Violation|0|||
49114575|NCT00329745|158256704|FG000|Overall Study|Withdrawal by Subject|0|||
49114576|NCT00329745|158256705|FG001|Overall Study|Withdrawal by Subject|1|||
49114577|NCT00329745|158256704|FG000|Overall Study|Lost to Follow-up|86|||
49114578|NCT00329745|158256705|FG001|Overall Study|Lost to Follow-up|101|||
49114579|NCT02290925|158256706|FG000|First Period of Three Months|Lost to Follow-up|2|||
49114580|NCT02290925|158256707|FG001|First Period of Three Months|Lost to Follow-up|1|||
49114581|NCT02290925|158256706|FG000|First Period of Three Months|Death|1|||
49114582|NCT02290925|158256707|FG001|First Period of Three Months|Death|0|||
49114583|NCT02290925|158256706|FG000|First Period of Three Months|Insulin Started|1|||
49114584|NCT02290925|158256707|FG001|First Period of Three Months|Insulin Started|1|||
49114585|NCT02290925|158256706|FG000|Second Period of 3 Months|Lost to Follow-up|1|||
49114586|NCT02290925|158256707|FG001|Second Period of 3 Months|Lost to Follow-up|3|||
49114587|NCT02290925|158256706|FG000|Second Period of 3 Months|insulin started|0|||
49114588|NCT02290925|158256707|FG001|Second Period of 3 Months|insulin started|1|||
49114589|NCT01716520|158256708|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
49114590|NCT01716520|158256709|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
49114591|NCT01716520|158256710|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
49114592|NCT01716520|158256711|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
49114593|NCT01716520|158256712|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
49114594|NCT01716520|158256713|FG005|Treatment Period 1 (14 Days)|Adverse Event|0|||
49114595|NCT01716520|158256708|FG000|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
49114596|NCT01716520|158256709|FG001|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
49114597|NCT01716520|158256710|FG002|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2|||
49114598|NCT01716520|158256711|FG003|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
49114599|NCT01716520|158256712|FG004|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
49114600|NCT01716520|158256713|FG005|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
49114601|NCT01716520|158256708|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
49114602|NCT01716520|158256709|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
49114603|NCT01716520|158256710|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
49114604|NCT01716520|158256711|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
49114605|NCT01716520|158256712|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
49114606|NCT01716520|158256713|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
49114607|NCT01716520|158256708|FG000|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
49114608|NCT01716520|158256709|FG001|Washout Period 1 (10 to 14 Days)|Adverse Event|1|||
49114609|NCT01716520|158256710|FG002|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
49114610|NCT01716520|158256711|FG003|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
49114611|NCT01716520|158256712|FG004|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
49114612|NCT01716520|158256713|FG005|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
49114613|NCT01716520|158256708|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
49114614|NCT01716520|158256709|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
49114615|NCT01716520|158256710|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
49114616|NCT01716520|158256711|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
49114617|NCT01716520|158256712|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
49114618|NCT01716520|158256713|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
49114619|NCT01716520|158256708|FG000|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
49114620|NCT01716520|158256709|FG001|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
49114621|NCT01716520|158256710|FG002|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
49114622|NCT01716520|158256711|FG003|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
49114623|NCT01716520|158256712|FG004|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
49114624|NCT01716520|158256713|FG005|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
49114625|NCT01716520|158256708|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
49114626|NCT01716520|158256709|FG001|Treatment Period 2 (14 Days)|Adverse Event|0|||
49114627|NCT01716520|158256710|FG002|Treatment Period 2 (14 Days)|Adverse Event|0|||
49114628|NCT01716520|158256711|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
49114629|NCT01716520|158256712|FG004|Treatment Period 2 (14 Days)|Adverse Event|1|||
49114630|NCT01716520|158256713|FG005|Treatment Period 2 (14 Days)|Adverse Event|0|||
49114631|NCT01716520|158256708|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
49114632|NCT01716520|158256709|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
49114633|NCT01716520|158256710|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
49114634|NCT01716520|158256711|FG003|Treatment Period 2 (14 Days)|Protocol Violation|0|||
49114635|NCT01716520|158256712|FG004|Treatment Period 2 (14 Days)|Protocol Violation|1|||
49114636|NCT01716520|158256713|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
49114637|NCT01716520|158256708|FG000|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
49114638|NCT01716520|158256709|FG001|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
49114639|NCT01716520|158256710|FG002|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
49114640|NCT01716520|158256711|FG003|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1|||
49114641|NCT01716520|158256712|FG004|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
49114642|NCT01716520|158256713|FG005|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
49114643|NCT01716520|158256708|FG000|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
49114644|NCT01716520|158256709|FG001|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
49114645|NCT01716520|158256710|FG002|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
49114646|NCT01716520|158256711|FG003|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
49114647|NCT01716520|158256712|FG004|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
49114648|NCT01716520|158256713|FG005|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
49114649|NCT01716520|158256708|FG000|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1|||
49114650|NCT01716520|158256709|FG001|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
49114651|NCT01716520|158256710|FG002|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
49114652|NCT01716520|158256711|FG003|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
49114653|NCT01716520|158256712|FG004|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
49114654|NCT01716520|158256713|FG005|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
49114655|NCT01716520|158256708|FG000|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
49114656|NCT01716520|158256709|FG001|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
49114657|NCT01716520|158256710|FG002|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
49114658|NCT01716520|158256711|FG003|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
49114659|NCT01716520|158256712|FG004|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
49114660|NCT01716520|158256713|FG005|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1|||
49114661|NCT01716520|158256708|FG000|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
49114662|NCT01716520|158256709|FG001|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1|||
49114663|NCT01716520|158256710|FG002|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
49114664|NCT01716520|158256711|FG003|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
49114665|NCT01716520|158256712|FG004|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
49114666|NCT01716520|158256713|FG005|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
49114667|NCT01716520|158256708|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
49114668|NCT01716520|158256709|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
49114669|NCT01716520|158256710|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
49114670|NCT01716520|158256711|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
49114671|NCT01716520|158256712|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
49114672|NCT01716520|158256713|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
48742916|NCT00745823|156910413|FG000|Overall Study|Lost to Follow-up|10|||
49114673|NCT01716520|158256708|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
49010433|NCT02400905|157875608|FG000|Overall Study|Physician Decision|4|||
49010434|NCT02400905|157875608|FG000|Overall Study|Other|1|||
49010435|NCT01684722|157875609|FG000|Overall Study|Lost to Follow-up|78|||
49010436|NCT01684722|157875610|FG001|Overall Study|Lost to Follow-up|56|||
49010437|NCT01684722|157875611|FG002|Overall Study|Lost to Follow-up|75|||
49010438|NCT01684722|157875612|FG003|Overall Study|Lost to Follow-up|89|||
49010439|NCT01684722|157875609|FG000|Overall Study|Death|19|||
49010440|NCT01684722|157875610|FG001|Overall Study|Death|21|||
49010441|NCT01684722|157875611|FG002|Overall Study|Death|19|||
49010442|NCT01684722|157875612|FG003|Overall Study|Death|21|||
49010443|NCT01092702|157875613|FG000|Overall Study|Withdrawal by Subject|7|||
49010444|NCT01092702|157875613|FG000|Overall Study|Lost to Follow-up|2|||
49010445|NCT00446654|157875618|FG000|Overall Study|Withdrawal by Subject|1|||
49010446|NCT00446654|157875619|FG001|Overall Study|Withdrawal by Subject|0|||
49010447|NCT00446654|157875618|FG000|Overall Study|Adverse Event|1|||
49010448|NCT00446654|157875619|FG001|Overall Study|Adverse Event|0|||
49010449|NCT01716754|157875620|FG000|Overall Study|Death|0|||
49010450|NCT01716754|157875621|FG001|Overall Study|Death|0|||
49010451|NCT01716754|157875622|FG002|Overall Study|Death|0|||
49010452|NCT01716754|157875623|FG003|Overall Study|Death|1|||
49010453|NCT01716754|157875620|FG000|Overall Study|Protocol deviation|0|||
49010454|NCT01716754|157875621|FG001|Overall Study|Protocol deviation|2|||
49010455|NCT01716754|157875622|FG002|Overall Study|Protocol deviation|7|||
49010456|NCT01716754|157875623|FG003|Overall Study|Protocol deviation|2|||
49010457|NCT01716754|157875620|FG000|Overall Study|Non-compliance with study treatment|0|||
49010458|NCT01716754|157875621|FG001|Overall Study|Non-compliance with study treatment|0|||
49010459|NCT01716754|157875622|FG002|Overall Study|Non-compliance with study treatment|1|||
49010460|NCT01716754|157875623|FG003|Overall Study|Non-compliance with study treatment|0|||
49010461|NCT01716754|157875620|FG000|Overall Study|Physician Decision|1|||
49010462|NCT01716754|157875621|FG001|Overall Study|Physician Decision|0|||
49010463|NCT01716754|157875622|FG002|Overall Study|Physician Decision|0|||
49010464|NCT01716754|157875623|FG003|Overall Study|Physician Decision|0|||
49010465|NCT01716754|157875620|FG000|Overall Study|Lost to Follow-up|1|||
49010466|NCT01716754|157875621|FG001|Overall Study|Lost to Follow-up|0|||
49010467|NCT01716754|157875622|FG002|Overall Study|Lost to Follow-up|0|||
49010468|NCT01716754|157875623|FG003|Overall Study|Lost to Follow-up|1|||
49010469|NCT01716754|157875620|FG000|Overall Study|Adverse Event|4|||
49010470|NCT01716754|157875621|FG001|Overall Study|Adverse Event|2|||
49010471|NCT01716754|157875622|FG002|Overall Study|Adverse Event|2|||
49010472|NCT01716754|157875623|FG003|Overall Study|Adverse Event|1|||
49010473|NCT01716754|157875620|FG000|Overall Study|Withdrawal by Subject|5|||
49010474|NCT01716754|157875621|FG001|Overall Study|Withdrawal by Subject|0|||
49010475|NCT01716754|157875622|FG002|Overall Study|Withdrawal by Subject|4|||
49010476|NCT01716754|157875623|FG003|Overall Study|Withdrawal by Subject|3|||
49010477|NCT01484028|157875625|FG000|Period 1|Lost to Follow-up|0|||
49010478|NCT01484028|157875626|FG001|Period 1|Lost to Follow-up|1|||
49010479|NCT01484028|157875627|FG002|Period 1|Lost to Follow-up|0|||
49010480|NCT01484028|157875628|FG003|Period 1|Lost to Follow-up|0|||
49010481|NCT01484028|157875625|FG000|Period 1|Non-Compliance to Protocol|0|||
49010482|NCT01484028|157875626|FG001|Period 1|Non-Compliance to Protocol|1|||
49010483|NCT01484028|157875627|FG002|Period 1|Non-Compliance to Protocol|0|||
49010484|NCT01484028|157875628|FG003|Period 1|Non-Compliance to Protocol|1|||
49010485|NCT01484028|157875625|FG000|Period 1|Lens Discomfort|0|||
49010486|NCT01484028|157875626|FG001|Period 1|Lens Discomfort|1|||
49010487|NCT01484028|157875627|FG002|Period 1|Lens Discomfort|0|||
49010488|NCT01484028|157875628|FG003|Period 1|Lens Discomfort|0|||
49010489|NCT00408876|157875629|FG000|Overall Study|Adverse Event|9|||
49010490|NCT00408876|157875630|FG001|Overall Study|Adverse Event|17|||
49010491|NCT00408876|157875631|FG002|Overall Study|Adverse Event|27|||
49010492|NCT00408876|157875632|FG003|Overall Study|Adverse Event|10|||
49010493|NCT00408876|157875629|FG000|Overall Study|Withdrawal by Subject|3|||
49010494|NCT00408876|157875630|FG001|Overall Study|Withdrawal by Subject|6|||
49010495|NCT00408876|157875631|FG002|Overall Study|Withdrawal by Subject|6|||
49010496|NCT00408876|157875632|FG003|Overall Study|Withdrawal by Subject|14|||
49010497|NCT00408876|157875629|FG000|Overall Study|Lack of Efficacy|2|||
49010498|NCT00408876|157875630|FG001|Overall Study|Lack of Efficacy|4|||
49010499|NCT00408876|157875631|FG002|Overall Study|Lack of Efficacy|5|||
49010500|NCT00408876|157875632|FG003|Overall Study|Lack of Efficacy|6|||
49010501|NCT00408876|157875629|FG000|Overall Study|Lost to Follow-up|1|||
49010502|NCT00408876|157875630|FG001|Overall Study|Lost to Follow-up|6|||
49010503|NCT00408876|157875631|FG002|Overall Study|Lost to Follow-up|5|||
49010504|NCT00408876|157875632|FG003|Overall Study|Lost to Follow-up|2|||
49010505|NCT00408876|157875629|FG000|Overall Study|Protocol Violation|0|||
49010506|NCT00408876|157875630|FG001|Overall Study|Protocol Violation|3|||
49010507|NCT00408876|157875631|FG002|Overall Study|Protocol Violation|4|||
49010508|NCT00408876|157875632|FG003|Overall Study|Protocol Violation|3|||
49010509|NCT00408876|157875629|FG000|Overall Study|Physician Decision|1|||
49114674|NCT01716520|158256709|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
49114675|NCT01716520|158256710|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
49114676|NCT01716520|158256711|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
49114677|NCT01716520|158256712|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
49114678|NCT01716520|158256713|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
49114679|NCT01410240|158256719|FG000|Overall Study|Physician Decision|0|||
49114680|NCT01410240|158256720|FG001|Overall Study|Physician Decision|0|||
49114681|NCT01410240|158256721|FG002|Overall Study|Physician Decision|1|||
49114682|NCT01410240|158256719|FG000|Overall Study|Missed week 6 assessments|1|||
49114683|NCT01410240|158256720|FG001|Overall Study|Missed week 6 assessments|1|||
49114684|NCT01410240|158256721|FG002|Overall Study|Missed week 6 assessments|1|||
49114685|NCT04348500|158256722|FG000|Overall Study|Death|2|||
49114686|NCT04348500|158256723|FG001|Overall Study|Death|2|||
49114687|NCT04348500|158256722|FG000|Overall Study|Withdrawn by subject due to dementia|0|||
49114688|NCT04348500|158256723|FG001|Overall Study|Withdrawn by subject due to dementia|1|||
49114689|NCT02776670|158256724|FG000|Overall Study|Adverse Event|0|||
49114690|NCT02776670|158256725|FG001|Overall Study|Adverse Event|2|||
49114691|NCT02776670|158256724|FG000|Overall Study|Protocol Violation|0|||
49114692|NCT02776670|158256725|FG001|Overall Study|Protocol Violation|2|||
49114693|NCT02776670|158256724|FG000|Overall Study|Withdrawal by Subject|0|||
49114694|NCT02776670|158256725|FG001|Overall Study|Withdrawal by Subject|1|||
49114695|NCT02776670|158256724|FG000|Overall Study|Other - Reason not given|0|||
49114696|NCT02776670|158256725|FG001|Overall Study|Other - Reason not given|1|||
49114697|NCT03699540|158256726|FG000|Overall Study|Lost to Follow-up|1|||
49114698|NCT01937884|158256731|FG000|Overall Study|Withdrawal by Subject|1|||
49114699|NCT01937884|158256732|FG001|Overall Study|Withdrawal by Subject|0|||
49114700|NCT03544281|158256733|FG000|Overall Study|Death|3|||
49114701|NCT03544281|158256734|FG001|Overall Study|Death|2|||
49114702|NCT03544281|158256735|FG002|Overall Study|Death|6|||
49114703|NCT03544281|158256736|FG003|Overall Study|Death|8|||
49114704|NCT03544281|158256737|FG004|Overall Study|Death|4|||
49114705|NCT03544281|158256738|FG005|Overall Study|Death|2|||
49114706|NCT03544281|158256739|FG006|Overall Study|Death|4|||
49114707|NCT03544281|158256740|FG007|Overall Study|Death|5|||
49114708|NCT03544281|158256741|FG008|Overall Study|Death|5|||
49114709|NCT03544281|158256742|FG009|Overall Study|Death|8|||
49114710|NCT03544281|158256743|FG010|Overall Study|Death|6|||
49114711|NCT03544281|158256744|FG011|Overall Study|Death|4|||
49114712|NCT03544281|158256733|FG000|Overall Study|Lost to Follow-up|0|||
49114713|NCT03544281|158256734|FG001|Overall Study|Lost to Follow-up|0|||
49114714|NCT03544281|158256735|FG002|Overall Study|Lost to Follow-up|0|||
49114715|NCT03544281|158256736|FG003|Overall Study|Lost to Follow-up|0|||
49114716|NCT03544281|158256737|FG004|Overall Study|Lost to Follow-up|0|||
49114717|NCT03544281|158256738|FG005|Overall Study|Lost to Follow-up|0|||
49114718|NCT03544281|158256739|FG006|Overall Study|Lost to Follow-up|0|||
49114719|NCT03544281|158256740|FG007|Overall Study|Lost to Follow-up|0|||
49114720|NCT03544281|158256741|FG008|Overall Study|Lost to Follow-up|0|||
49114721|NCT03544281|158256742|FG009|Overall Study|Lost to Follow-up|0|||
49114722|NCT03544281|158256743|FG010|Overall Study|Lost to Follow-up|1|||
49114723|NCT03544281|158256744|FG011|Overall Study|Lost to Follow-up|0|||
49114724|NCT03544281|158256733|FG000|Overall Study|Physician Decision|0|||
49114725|NCT03544281|158256734|FG001|Overall Study|Physician Decision|0|||
49114726|NCT03544281|158256735|FG002|Overall Study|Physician Decision|0|||
49114727|NCT03544281|158256736|FG003|Overall Study|Physician Decision|0|||
49114728|NCT03544281|158256737|FG004|Overall Study|Physician Decision|0|||
49114729|NCT03544281|158256738|FG005|Overall Study|Physician Decision|0|||
49114730|NCT03544281|158256739|FG006|Overall Study|Physician Decision|0|||
49114731|NCT03544281|158256740|FG007|Overall Study|Physician Decision|1|||
49114732|NCT03544281|158256741|FG008|Overall Study|Physician Decision|0|||
49114733|NCT03544281|158256742|FG009|Overall Study|Physician Decision|0|||
49114734|NCT03544281|158256743|FG010|Overall Study|Physician Decision|0|||
49114735|NCT03544281|158256744|FG011|Overall Study|Physician Decision|0|||
49114736|NCT03544281|158256733|FG000|Overall Study|Withdrawal by Subject|2|||
49114737|NCT03544281|158256734|FG001|Overall Study|Withdrawal by Subject|0|||
49114738|NCT03544281|158256735|FG002|Overall Study|Withdrawal by Subject|1|||
49114739|NCT03544281|158256736|FG003|Overall Study|Withdrawal by Subject|2|||
49114740|NCT03544281|158256737|FG004|Overall Study|Withdrawal by Subject|0|||
49114741|NCT03544281|158256738|FG005|Overall Study|Withdrawal by Subject|0|||
49114742|NCT03544281|158256739|FG006|Overall Study|Withdrawal by Subject|0|||
49114743|NCT03544281|158256740|FG007|Overall Study|Withdrawal by Subject|0|||
49114744|NCT03544281|158256741|FG008|Overall Study|Withdrawal by Subject|2|||
49114745|NCT03544281|158256742|FG009|Overall Study|Withdrawal by Subject|3|||
49114746|NCT03544281|158256743|FG010|Overall Study|Withdrawal by Subject|0|||
49114747|NCT03544281|158256744|FG011|Overall Study|Withdrawal by Subject|4|||
49114748|NCT03544281|158256733|FG000|Overall Study|Ongoing at the time of analysis|7|||
49114749|NCT03544281|158256734|FG001|Overall Study|Ongoing at the time of analysis|2|||
49114750|NCT03544281|158256735|FG002|Overall Study|Ongoing at the time of analysis|6|||
49114751|NCT03544281|158256736|FG003|Overall Study|Ongoing at the time of analysis|6|||
49114752|NCT03544281|158256737|FG004|Overall Study|Ongoing at the time of analysis|8|||
49114753|NCT03544281|158256738|FG005|Overall Study|Ongoing at the time of analysis|10|||
49114754|NCT03544281|158256739|FG006|Overall Study|Ongoing at the time of analysis|8|||
49114755|NCT03544281|158256740|FG007|Overall Study|Ongoing at the time of analysis|6|||
49114756|NCT03544281|158256741|FG008|Overall Study|Ongoing at the time of analysis|6|||
49114757|NCT03544281|158256742|FG009|Overall Study|Ongoing at the time of analysis|6|||
49114758|NCT03544281|158256743|FG010|Overall Study|Ongoing at the time of analysis|5|||
49114759|NCT03544281|158256744|FG011|Overall Study|Ongoing at the time of analysis|8|||
49114760|NCT03544281|158256733|FG000|Overall Study|Investigator Site Closed|0|||
49114761|NCT03544281|158256734|FG001|Overall Study|Investigator Site Closed|0|||
49114762|NCT03544281|158256735|FG002|Overall Study|Investigator Site Closed|0|||
49114763|NCT03544281|158256736|FG003|Overall Study|Investigator Site Closed|0|||
49114764|NCT03544281|158256737|FG004|Overall Study|Investigator Site Closed|0|||
49114765|NCT03544281|158256738|FG005|Overall Study|Investigator Site Closed|0|||
49114766|NCT03544281|158256739|FG006|Overall Study|Investigator Site Closed|0|||
49114767|NCT03544281|158256740|FG007|Overall Study|Investigator Site Closed|0|||
49114768|NCT03544281|158256741|FG008|Overall Study|Investigator Site Closed|0|||
49114769|NCT03544281|158256742|FG009|Overall Study|Investigator Site Closed|1|||
49114770|NCT03544281|158256743|FG010|Overall Study|Investigator Site Closed|0|||
49114771|NCT03544281|158256744|FG011|Overall Study|Investigator Site Closed|0|||
49114772|NCT03544281|158256733|FG000|Overall Study|Did not receive study treatment|0|||
49114773|NCT03544281|158256734|FG001|Overall Study|Did not receive study treatment|0|||
49114774|NCT03544281|158256735|FG002|Overall Study|Did not receive study treatment|0|||
49114775|NCT03544281|158256736|FG003|Overall Study|Did not receive study treatment|0|||
49114776|NCT03544281|158256737|FG004|Overall Study|Did not receive study treatment|0|||
49114777|NCT03544281|158256738|FG005|Overall Study|Did not receive study treatment|0|||
49114778|NCT03544281|158256739|FG006|Overall Study|Did not receive study treatment|1|||
49114779|NCT03544281|158256740|FG007|Overall Study|Did not receive study treatment|0|||
49114780|NCT03544281|158256741|FG008|Overall Study|Did not receive study treatment|0|||
49114781|NCT03544281|158256742|FG009|Overall Study|Did not receive study treatment|0|||
49114782|NCT03544281|158256743|FG010|Overall Study|Did not receive study treatment|0|||
49114783|NCT03544281|158256744|FG011|Overall Study|Did not receive study treatment|0|||
49114784|NCT00624832|158256751|FG000|Overall Study|Adverse Event|0|||
49114785|NCT00624832|158256752|FG001|Overall Study|Adverse Event|1|||
49114786|NCT00624832|158256753|FG002|Overall Study|Adverse Event|0|||
49114787|NCT00624832|158256754|FG003|Overall Study|Adverse Event|1|||
49114788|NCT00624832|158256751|FG000|Overall Study|Abnormal Laboratory Value|2|||
49114789|NCT00624832|158256752|FG001|Overall Study|Abnormal Laboratory Value|0|||
49114790|NCT00624832|158256753|FG002|Overall Study|Abnormal Laboratory Value|0|||
49114791|NCT00624832|158256754|FG003|Overall Study|Abnormal Laboratory Value|0|||
49114792|NCT02937636|158256755|FG000|Overall Study|Other (Not specified)|3|||
49114793|NCT02937636|158256756|FG001|Overall Study|Other (Not specified)|2|||
49114794|NCT01030718|158256760|FG000|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
49114795|NCT01030718|158256761|FG001|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
49114796|NCT01030718|158256762|FG002|Studies CA180-031 and -036 Combined|Insufficient effect|11|||
49114797|NCT01030718|158256760|FG000|Studies CA180-031 and -036 Combined|Adverse Event|3|||
49114798|NCT01030718|158256761|FG001|Studies CA180-031 and -036 Combined|Adverse Event|5|||
49114799|NCT01030718|158256762|FG002|Studies CA180-031 and -036 Combined|Adverse Event|1|||
49114800|NCT01030718|158256760|FG000|Studies CA180-031 and -036 Combined|Death|0|||
49114801|NCT01030718|158256761|FG001|Studies CA180-031 and -036 Combined|Death|1|||
49114802|NCT01030718|158256762|FG002|Studies CA180-031 and -036 Combined|Death|0|||
49114803|NCT01030718|158256760|FG000|Studies CA180-031 and -036 Combined|other reasons|0|||
49114804|NCT01030718|158256761|FG001|Studies CA180-031 and -036 Combined|other reasons|2|||
49114805|NCT01030718|158256762|FG002|Studies CA180-031 and -036 Combined|other reasons|0|||
49114806|NCT01030718|158256760|FG000|Study CA180-036 Only|insufficient effect|1|||
49114807|NCT01030718|158256761|FG001|Study CA180-036 Only|insufficient effect|1|||
49114808|NCT01030718|158256762|FG002|Study CA180-036 Only|insufficient effect|5|||
49114809|NCT01030718|158256760|FG000|Study CA180-036 Only|Adverse Event|2|||
49114810|NCT01030718|158256761|FG001|Study CA180-036 Only|Adverse Event|3|||
49114811|NCT01030718|158256762|FG002|Study CA180-036 Only|Adverse Event|0|||
49114812|NCT01030718|158256760|FG000|Study CA180-036 Only|Death|0|||
49114813|NCT01030718|158256761|FG001|Study CA180-036 Only|Death|1|||
49114814|NCT01030718|158256762|FG002|Study CA180-036 Only|Death|0|||
49114815|NCT01030718|158256760|FG000|Study CA180-036 Only|Other Reasons|0|||
49114816|NCT01030718|158256761|FG001|Study CA180-036 Only|Other Reasons|2|||
49114817|NCT01030718|158256762|FG002|Study CA180-036 Only|Other Reasons|0|||
49114818|NCT00423813|158256763|FG000|Overall Study|Adverse Event|11|||
49114819|NCT00423813|158256764|FG001|Overall Study|Adverse Event|30|||
49114820|NCT00423813|158256765|FG002|Overall Study|Adverse Event|40|||
49114821|NCT00423813|158256763|FG000|Overall Study|Withdrawal by Subject|6|||
49114822|NCT00423813|158256764|FG001|Overall Study|Withdrawal by Subject|8|||
49114823|NCT00423813|158256765|FG002|Overall Study|Withdrawal by Subject|5|||
49114824|NCT00423813|158256763|FG000|Overall Study|Lost to Follow-up|5|||
49114825|NCT00423813|158256764|FG001|Overall Study|Lost to Follow-up|4|||
49114826|NCT00423813|158256765|FG002|Overall Study|Lost to Follow-up|4|||
49114827|NCT00423813|158256763|FG000|Overall Study|Lack of Efficacy|23|||
49114828|NCT00423813|158256764|FG001|Overall Study|Lack of Efficacy|18|||
49114829|NCT00423813|158256765|FG002|Overall Study|Lack of Efficacy|19|||
49114830|NCT00423813|158256763|FG000|Overall Study|Physician Decision|2|||
49114831|NCT00423813|158256764|FG001|Overall Study|Physician Decision|0|||
49114832|NCT00423813|158256765|FG002|Overall Study|Physician Decision|0|||
49114833|NCT00423813|158256763|FG000|Overall Study|Sponsor Decision|0|||
49114834|NCT00423813|158256764|FG001|Overall Study|Sponsor Decision|1|||
49114835|NCT00423813|158256765|FG002|Overall Study|Sponsor Decision|0|||
49114836|NCT00423813|158256763|FG000|Overall Study|Protocol Violation|9|||
49114837|NCT00423813|158256764|FG001|Overall Study|Protocol Violation|4|||
49114838|NCT00423813|158256765|FG002|Overall Study|Protocol Violation|4|||
49114839|NCT00423813|158256763|FG000|Overall Study|Pregnancy|0|||
49114840|NCT00423813|158256764|FG001|Overall Study|Pregnancy|0|||
49114841|NCT00423813|158256765|FG002|Overall Study|Pregnancy|1|||
49114842|NCT00423813|158256763|FG000|Overall Study|Subject started night shift work|1|||
49114843|NCT00423813|158256764|FG001|Overall Study|Subject started night shift work|0|||
49114844|NCT00423813|158256765|FG002|Overall Study|Subject started night shift work|0|||
49114845|NCT00423813|158256763|FG000|Overall Study|Will start exclusionary medications|0|||
49114846|NCT00423813|158256764|FG001|Overall Study|Will start exclusionary medications|1|||
49114847|NCT00423813|158256765|FG002|Overall Study|Will start exclusionary medications|0|||
49114848|NCT00423813|158256763|FG000|Overall Study|Undergoing tests for Cushings Syndrome|0|||
49114849|NCT00423813|158256764|FG001|Overall Study|Undergoing tests for Cushings Syndrome|0|||
49114850|NCT00423813|158256765|FG002|Overall Study|Undergoing tests for Cushings Syndrome|1|||
49114851|NCT01119846|158256778|FG000|Overall Study|Adverse Event|1|||
49114852|NCT01119846|158256779|FG001|Overall Study|Adverse Event|0|||
49114853|NCT01119846|158256780|FG002|Overall Study|Adverse Event|6|||
49114854|NCT01119846|158256778|FG000|Overall Study|Physician Decision|1|||
49114855|NCT01119846|158256779|FG001|Overall Study|Physician Decision|0|||
49114856|NCT01119846|158256780|FG002|Overall Study|Physician Decision|0|||
49114857|NCT01119846|158256778|FG000|Overall Study|Protocol Violation|0|||
49114858|NCT01119846|158256779|FG001|Overall Study|Protocol Violation|0|||
49114859|NCT01119846|158256780|FG002|Overall Study|Protocol Violation|1|||
49114860|NCT01119846|158256778|FG000|Overall Study|Withdrawal by Subject|0|||
49114861|NCT01119846|158256779|FG001|Overall Study|Withdrawal by Subject|0|||
49114862|NCT01119846|158256780|FG002|Overall Study|Withdrawal by Subject|4|||
49114863|NCT00048997|158256781|FG000|Overall Study|Protocol Violation|7|||
49114864|NCT00048997|158256782|FG001|Overall Study|Protocol Violation|2|||
49114865|NCT00048997|158256781|FG000|Overall Study|Withdrawal by Subject|6|||
49114866|NCT00048997|158256782|FG001|Overall Study|Withdrawal by Subject|1|||
49114867|NCT02385110|158256784|FG000|Overall Study|Early Death|1|||
49114868|NCT02385110|158256785|FG001|Overall Study|Early Death|0|||
49114869|NCT03472521|158256786|FG000|Overall Study|Lost to Follow-up|3|||
49114870|NCT03472521|158256787|FG001|Overall Study|Lost to Follow-up|2|||
49114871|NCT03472521|158256786|FG000|Overall Study|Discontinued intervention|3|||
49114872|NCT03472521|158256787|FG001|Overall Study|Discontinued intervention|1|||
49114873|NCT01663857|158258657|FG000|Overall Study|Withdrew Consent to Study Participation|0|||
49114874|NCT01663857|158258658|FG001|Overall Study|Withdrew Consent to Study Participation|1|||
49114875|NCT01663857|158258659|FG002|Overall Study|Withdrew Consent to Study Participation|7|||
49114876|NCT01663857|158258660|FG003|Overall Study|Withdrew Consent to Study Participation|3|||
49114877|NCT01663857|158258657|FG000|Overall Study|Lost to Follow-up|0|||
49114878|NCT01663857|158258658|FG001|Overall Study|Lost to Follow-up|0|||
49114879|NCT01663857|158258659|FG002|Overall Study|Lost to Follow-up|3|||
49114880|NCT01663857|158258660|FG003|Overall Study|Lost to Follow-up|1|||
49114881|NCT01026818|158258667|FG000|Screening Period|Entry Criteria Not Met|105|||
49114882|NCT01026818|158258668|FG001|Screening Period|Entry Criteria Not Met|0|||
49114883|NCT01026818|158258669|FG002|Screening Period|Entry Criteria Not Met|0|||
49114884|NCT01026818|158258670|FG003|Screening Period|Entry Criteria Not Met|0|||
49114885|NCT01026818|158258667|FG000|Screening Period|Withdrawal by Subject|49|||
49114886|NCT01026818|158258668|FG001|Screening Period|Withdrawal by Subject|0|||
49114887|NCT01026818|158258669|FG002|Screening Period|Withdrawal by Subject|0|||
49114888|NCT01026818|158258670|FG003|Screening Period|Withdrawal by Subject|0|||
49114889|NCT01026818|158258667|FG000|Screening Period|Protocol Deviation|3|||
49114890|NCT01026818|158258668|FG001|Screening Period|Protocol Deviation|0|||
49114891|NCT01026818|158258669|FG002|Screening Period|Protocol Deviation|0|||
49114892|NCT01026818|158258670|FG003|Screening Period|Protocol Deviation|0|||
49114893|NCT01026818|158258667|FG000|Screening Period|Adverse Event|2|||
49114894|NCT01026818|158258668|FG001|Screening Period|Adverse Event|0|||
49114895|NCT01026818|158258669|FG002|Screening Period|Adverse Event|0|||
49114896|NCT01026818|158258670|FG003|Screening Period|Adverse Event|0|||
49114897|NCT01026818|158258667|FG000|Screening Period|Physician Decision|1|||
49114898|NCT01026818|158258668|FG001|Screening Period|Physician Decision|0|||
49114899|NCT01026818|158258669|FG002|Screening Period|Physician Decision|0|||
49114900|NCT01026818|158258670|FG003|Screening Period|Physician Decision|0|||
49114901|NCT01026818|158258667|FG000|DB Treatment Period (Month 0 - 9)|Adverse Event|0|||
49114902|NCT01026818|158258668|FG001|DB Treatment Period (Month 0 - 9)|Adverse Event|10|||
49114903|NCT01026818|158258669|FG002|DB Treatment Period (Month 0 - 9)|Adverse Event|6|||
49114904|NCT01026818|158258670|FG003|DB Treatment Period (Month 0 - 9)|Adverse Event|4|||
49114905|NCT01026818|158258667|FG000|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0|||
49114906|NCT01026818|158258668|FG001|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7|||
49114907|NCT01026818|158258669|FG002|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
49114908|NCT01026818|158258670|FG003|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
49114909|NCT01026818|158258667|FG000|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0|||
49114910|NCT01026818|158258668|FG001|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3|||
49114911|NCT01026818|158258669|FG002|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2|||
49114912|NCT01026818|158258670|FG003|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6|||
49114913|NCT01026818|158258667|FG000|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
49114914|NCT01026818|158258668|FG001|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3|||
49114915|NCT01026818|158258669|FG002|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
49114916|NCT01026818|158258670|FG003|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4|||
49114917|NCT01026818|158258667|FG000|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0|||
49114918|NCT01026818|158258668|FG001|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2|||
49114919|NCT01026818|158258669|FG002|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9|||
49114920|NCT01026818|158258670|FG003|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7|||
49114921|NCT01026818|158258667|FG000|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
49114922|NCT01026818|158258668|FG001|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
49114923|NCT01026818|158258669|FG002|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1|||
49114924|NCT01026818|158258670|FG003|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2|||
49114925|NCT01026818|158258667|FG000|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0|||
49114926|NCT01026818|158258668|FG001|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
49114927|NCT01026818|158258669|FG002|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1|||
49114928|NCT01026818|158258670|FG003|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
49114929|NCT01026818|158258667|FG000|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0|||
49114930|NCT01026818|158258668|FG001|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
49114931|NCT01026818|158258669|FG002|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1|||
49114932|NCT01026818|158258670|FG003|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
49114933|NCT01026818|158258667|FG000|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
49114934|NCT01026818|158258668|FG001|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1|||
49114935|NCT01026818|158258669|FG002|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
49114936|NCT01026818|158258670|FG003|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
49114937|NCT01026818|158258667|FG000|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
49114938|NCT01026818|158258668|FG001|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1|||
49114939|NCT01026818|158258669|FG002|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
49114940|NCT01026818|158258670|FG003|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2|||
49114941|NCT01026818|158258667|FG000|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
49114942|NCT01026818|158258668|FG001|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
49114943|NCT01026818|158258669|FG002|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
49114944|NCT01026818|158258670|FG003|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
49114945|NCT01026818|158258667|FG000|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
49114946|NCT01026818|158258668|FG001|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1|||
49114947|NCT01026818|158258669|FG002|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
49114948|NCT01026818|158258670|FG003|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
49114949|NCT01026818|158258667|FG000|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
49114950|NCT01026818|158258668|FG001|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1|||
49114951|NCT01026818|158258669|FG002|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2|||
49114952|NCT01026818|158258670|FG003|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
49114953|NCT01026818|158258667|FG000|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
49114954|NCT01026818|158258668|FG001|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
49114955|NCT01026818|158258669|FG002|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
49114956|NCT01026818|158258670|FG003|Drug-Free Washout Period (Month 9-10.5)|Death|1|||
49114957|NCT01026818|158258667|FG000|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
49114958|NCT01026818|158258668|FG001|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2|||
49114959|NCT01026818|158258669|FG002|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
49114960|NCT01026818|158258670|FG003|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
49114961|NCT01026818|158258667|FG000|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
49114962|NCT01026818|158258668|FG001|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1|||
49114963|NCT01026818|158258669|FG002|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
49114964|NCT01026818|158258670|FG003|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
49114965|NCT01026818|158258667|FG000|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0|||
49114966|NCT01026818|158258668|FG001|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
49114967|NCT01026818|158258669|FG002|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2|||
49114968|NCT01026818|158258670|FG003|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
49114969|NCT01026818|158258667|FG000|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0|||
49114970|NCT01026818|158258668|FG001|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
49114971|NCT01026818|158258669|FG002|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3|||
49114972|NCT01026818|158258670|FG003|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
49114973|NCT01026818|158258667|FG000|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
49114974|NCT01026818|158258668|FG001|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2|||
49114975|NCT01026818|158258669|FG002|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
49114976|NCT01026818|158258670|FG003|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1|||
49114977|NCT01760447|158258671|FG000|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
49114978|NCT01760447|158258672|FG001|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
49114979|NCT01760447|158258673|FG002|Weeks 0-20|Consent withdrawn by Parent/Guardian|1|||
49114980|NCT01760447|158258674|FG003|Weeks 0-20|Consent withdrawn by Parent/Guardian|3|||
49114981|NCT01760447|158258671|FG000|Weeks 0-20|Withdrawal by Subject|2|||
49114982|NCT01760447|158258672|FG001|Weeks 0-20|Withdrawal by Subject|0|||
49114983|NCT01760447|158258673|FG002|Weeks 0-20|Withdrawal by Subject|1|||
49114984|NCT01760447|158258674|FG003|Weeks 0-20|Withdrawal by Subject|0|||
49114985|NCT01760447|158258671|FG000|Weeks 0-20|Lost to Follow-up|1|||
49114986|NCT01760447|158258672|FG001|Weeks 0-20|Lost to Follow-up|0|||
49114987|NCT01760447|158258673|FG002|Weeks 0-20|Lost to Follow-up|1|||
49114988|NCT01760447|158258674|FG003|Weeks 0-20|Lost to Follow-up|1|||
49114989|NCT01760447|158258671|FG000|Weeks 0-20|Randomized but not treated|0|||
49114990|NCT01760447|158258672|FG001|Weeks 0-20|Randomized but not treated|0|||
49114991|NCT01760447|158258673|FG002|Weeks 0-20|Randomized but not treated|2|||
49114992|NCT01760447|158258674|FG003|Weeks 0-20|Randomized but not treated|0|||
49114993|NCT01760447|158258671|FG000|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
49114994|NCT01760447|158258672|FG001|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
49114995|NCT01760447|158258673|FG002|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
49114996|NCT01760447|158258674|FG003|Weeks 20-54|Consent withdrawn by Parent/Guardian|0|||
49114997|NCT01760447|158258671|FG000|Weeks 20-54|Withdrawal by Subject|2|||
49114998|NCT01760447|158258672|FG001|Weeks 20-54|Withdrawal by Subject|1|||
49114999|NCT01760447|158258673|FG002|Weeks 20-54|Withdrawal by Subject|1|||
49115000|NCT01760447|158258674|FG003|Weeks 20-54|Withdrawal by Subject|2|||
49115001|NCT01760447|158258671|FG000|Weeks 20-54|Lost to Follow-up|0|||
49115002|NCT01760447|158258672|FG001|Weeks 20-54|Lost to Follow-up|0|||
49115003|NCT01760447|158258673|FG002|Weeks 20-54|Lost to Follow-up|1|||
49115004|NCT01760447|158258674|FG003|Weeks 20-54|Lost to Follow-up|2|||
49115005|NCT01031004|158258675|FG000|Overall Study|Protocol Violation|0|||
49115006|NCT01031004|158258676|FG001|Overall Study|Protocol Violation|1|||
49115007|NCT01031004|158258675|FG000|Overall Study|Lost to Follow-up|1|||
49115008|NCT01031004|158258676|FG001|Overall Study|Lost to Follow-up|0|||
49115009|NCT01887288|158258677|FG000|Overall Study|The study was terminated and the PI has|16|||
49115010|NCT02164318|158258678|FG000|Overall Study|Withdrawal by Subject|0|||
49115011|NCT02164318|158258679|FG001|Overall Study|Withdrawal by Subject|1|||
49115012|NCT02164318|158258680|FG002|Overall Study|Withdrawal by Subject|0|||
49115013|NCT02164318|158258681|FG003|Overall Study|Withdrawal by Subject|1|||
49115014|NCT02335346|158258682|FG000|Overall Study|Adverse Event|11|||
49115015|NCT02335346|158258682|FG000|Overall Study|Withdrawal by Subject|1|||
49115016|NCT01548768|158258683|FG000|Overall Study|Withdrawal by Subject|0|||
49115017|NCT01548768|158258684|FG001|Overall Study|Withdrawal by Subject|2|||
49115018|NCT01548768|158258685|FG002|Overall Study|Withdrawal by Subject|1|||
49115019|NCT01548768|158258686|FG003|Overall Study|Withdrawal by Subject|0|||
49115020|NCT01548768|158258683|FG000|Overall Study|Physician Decision|1|||
49115021|NCT01548768|158258684|FG001|Overall Study|Physician Decision|0|||
49115022|NCT01548768|158258685|FG002|Overall Study|Physician Decision|0|||
49115023|NCT01548768|158258686|FG003|Overall Study|Physician Decision|0|||
49115024|NCT01548768|158258683|FG000|Overall Study|Adverse Event|0|||
49115025|NCT01548768|158258684|FG001|Overall Study|Adverse Event|0|||
49115026|NCT01548768|158258685|FG002|Overall Study|Adverse Event|0|||
49115027|NCT01548768|158258686|FG003|Overall Study|Adverse Event|1|||
49115028|NCT01548768|158258683|FG000|Overall Study|Non-Compliance|0|||
49115029|NCT01548768|158258684|FG001|Overall Study|Non-Compliance|0|||
49115030|NCT01548768|158258685|FG002|Overall Study|Non-Compliance|0|||
49115031|NCT01548768|158258686|FG003|Overall Study|Non-Compliance|3|||
49115032|NCT00524771|158258687|FG000|Overall Study|Protocol Violation|220|||
49115033|NCT00524771|158258688|FG001|Overall Study|Protocol Violation|585|||
49115034|NCT01796301|158258691|FG000|Overall Study|Withdrawal by Subject|15|||
49115035|NCT01796301|158258692|FG001|Overall Study|Withdrawal by Subject|15|||
49115036|NCT01796301|158258691|FG000|Overall Study|Lost to Follow-up|3|||
49115037|NCT01796301|158258692|FG001|Overall Study|Lost to Follow-up|3|||
49115038|NCT01796301|158258691|FG000|Overall Study|Death|0|||
49115039|NCT01796301|158258692|FG001|Overall Study|Death|1|||
49115040|NCT01796301|158258691|FG000|Overall Study|Decision by Sponsor|0|||
49115041|NCT01796301|158258692|FG001|Overall Study|Decision by Sponsor|1|||
49115042|NCT01108237|158258693|FG000|Overall Study|No alignment data|2|||
49115043|NCT01108237|158258694|FG001|Overall Study|No alignment data|15|||
49115044|NCT01108237|158258693|FG000|Overall Study|Did not meet criteria for analysis|7|||
49115045|NCT01108237|158258694|FG001|Overall Study|Did not meet criteria for analysis|0|||
49115046|NCT03754972|158258701|FG000|Overall Study|Protocol Violation|25|||
49115047|NCT04105842|158258702|FG000|Overall Study|Withdrawal by Subject|2|||
49115048|NCT02734862|158258704|FG000|Part A|Death|3|||
49115049|NCT02734862|158258705|FG001|Part A|Death|4|||
49115050|NCT02734862|158258706|FG002|Part A|Death|6|||
49115051|NCT02734862|158258704|FG000|Part A|Lost to Follow-up|2|||
49115052|NCT02734862|158258705|FG001|Part A|Lost to Follow-up|1|||
49115053|NCT02734862|158258706|FG002|Part A|Lost to Follow-up|1|||
49115054|NCT02734862|158258704|FG000|Part A|Withdrawal by Subject|1|||
49115055|NCT02734862|158258705|FG001|Part A|Withdrawal by Subject|1|||
49115056|NCT02734862|158258706|FG002|Part A|Withdrawal by Subject|2|||
49115057|NCT02734862|158258704|FG000|Part A|Physician Decision|2|||
49115058|NCT02734862|158258705|FG001|Part A|Physician Decision|0|||
49115059|NCT02734862|158258706|FG002|Part A|Physician Decision|1|||
49115060|NCT02734862|158258704|FG000|Part A|Adverse Event|2|||
49115061|NCT02734862|158258705|FG001|Part A|Adverse Event|0|||
49115062|NCT02734862|158258706|FG002|Part A|Adverse Event|1|||
49115063|NCT02734862|158258704|FG000|Part A|Noncompliance|1|||
49115064|NCT02734862|158258705|FG001|Part A|Noncompliance|1|||
49115065|NCT02734862|158258706|FG002|Part A|Noncompliance|0|||
49115066|NCT02734862|158258704|FG000|Part A|Other|1|||
49115067|NCT02734862|158258705|FG001|Part A|Other|1|||
49115068|NCT02734862|158258706|FG002|Part A|Other|3|||
49115069|NCT02734862|158258704|FG000|Part B|Death|8|||
49115070|NCT02734862|158258705|FG001|Part B|Death|3|||
49115071|NCT02734862|158258706|FG002|Part B|Death|5|||
49115072|NCT02734862|158258704|FG000|Part B|Lost to Follow-up|2|||
49115073|NCT02734862|158258705|FG001|Part B|Lost to Follow-up|2|||
49115074|NCT02734862|158258706|FG002|Part B|Lost to Follow-up|0|||
49115075|NCT02734862|158258704|FG000|Part B|Withdrawal by Subject|3|||
49115076|NCT02734862|158258705|FG001|Part B|Withdrawal by Subject|1|||
49115077|NCT02734862|158258706|FG002|Part B|Withdrawal by Subject|0|||
49115078|NCT02734862|158258704|FG000|Part B|Other|0|||
49115079|NCT02734862|158258705|FG001|Part B|Other|1|||
49115080|NCT02734862|158258706|FG002|Part B|Other|0|||
49115081|NCT00564278|158258707|FG000|Overall Study|Lost to Follow-up|35|||
49115082|NCT00564278|158258708|FG001|Overall Study|Lost to Follow-up|33|||
49115083|NCT00564278|158258707|FG000|Overall Study|Physician Decision|1|||
49115084|NCT00564278|158258708|FG001|Overall Study|Physician Decision|2|||
49115085|NCT00564278|158258707|FG000|Overall Study|Withdrawal by Subject|11|||
49115086|NCT00564278|158258708|FG001|Overall Study|Withdrawal by Subject|7|||
49115087|NCT04854057|158258709|FG000|Overall Study|Adverse Event|0|||
49115088|NCT04854057|158258710|FG001|Overall Study|Adverse Event|1|||
49115089|NCT03519919|158258711|FG000|Overall Study|Withdrawal by Subject|1|||
49115090|NCT03519919|158258711|FG000|Overall Study|Lack of Efficacy|1|||
49115091|NCT03519919|158258711|FG000|Overall Study|Screen Failure|1|||
49115092|NCT00560703|158258712|FG000|Overall Study|Adverse Event|0|||
49115093|NCT00560703|158258713|FG001|Overall Study|Adverse Event|2|||
49115094|NCT00560703|158258712|FG000|Overall Study|Protocol Violation|0|||
49115095|NCT00560703|158258713|FG001|Overall Study|Protocol Violation|2|||
49115096|NCT00560703|158258712|FG000|Overall Study|Withdrawal by Subject|0|||
49115097|NCT00560703|158258713|FG001|Overall Study|Withdrawal by Subject|1|||
49115098|NCT00560703|158258712|FG000|Overall Study|non-compliance|0|||
49115099|NCT00560703|158258713|FG001|Overall Study|non-compliance|1|||
49115100|NCT03374488|158258714|FG000|Overall Study|Death|13|||
49115101|NCT03374488|158258715|FG001|Overall Study|Death|13|||
49115102|NCT03374488|158258714|FG000|Overall Study|Withdrawal by Subject|3|||
49115103|NCT03374488|158258715|FG001|Overall Study|Withdrawal by Subject|1|||
49115104|NCT03374488|158258714|FG000|Overall Study|Physician Decision|3|||
49115105|NCT03374488|158258715|FG001|Overall Study|Physician Decision|0|||
49115106|NCT01556932|158258718|FG000|Time Point 60 Minutes|Withdrawal by Subject|1|||
49115107|NCT01556932|158258719|FG001|Time Point 60 Minutes|Withdrawal by Subject|1|||
49115108|NCT01563913|158258721|FG000|Overall Study|Physician Decision|1|||
49115109|NCT01563913|158258722|FG001|Overall Study|Physician Decision|0|||
49115110|NCT01563913|158258721|FG000|Overall Study|Spouse Passed Away|1|||
49115111|NCT01563913|158258722|FG001|Overall Study|Spouse Passed Away|0|||
49115112|NCT03066778|158258723|FG000|Overall Study|Death|195|||
49115113|NCT03066778|158258724|FG001|Overall Study|Death|205|||
49115114|NCT03066778|158258723|FG000|Overall Study|Withdrawal by Subject|5|||
49115115|NCT03066778|158258724|FG001|Overall Study|Withdrawal by Subject|7|||
49115116|NCT03332095|158258725|FG000|Overall Study|Lost to Follow-up|1|||
49115117|NCT03332095|158258726|FG001|Overall Study|Lost to Follow-up|0|||
49115118|NCT03332095|158258725|FG000|Overall Study|Pregnancy|0|||
49115119|NCT03332095|158258726|FG001|Overall Study|Pregnancy|1|||
49115120|NCT04122625|158258727|FG000|Part A (up to 2.92 Years)|Death|2|||
49115121|NCT04122625|158258728|FG001|Part A (up to 2.92 Years)|Death|4|||
49115122|NCT04122625|158258729|FG002|Part A (up to 2.92 Years)|Death|0|||
49115123|NCT04122625|158258730|FG003|Part A (up to 2.92 Years)|Death|0|||
49115124|NCT04122625|158258731|FG004|Part A (up to 2.92 Years)|Death|0|||
49115125|NCT04122625|158258732|FG005|Part A (up to 2.92 Years)|Death|0|||
49115126|NCT04122625|158258727|FG000|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
49115127|NCT04122625|158258728|FG001|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
49115128|NCT04122625|158258729|FG002|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
49115129|NCT04122625|158258730|FG003|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
49115130|NCT04122625|158258731|FG004|Part B (up to 2.33 Years)|Patient lost to follow-up|2|||
49115131|NCT04122625|158258732|FG005|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
49115132|NCT04122625|158258727|FG000|Part B (up to 2.33 Years)|Death|0|||
49115133|NCT04122625|158258728|FG001|Part B (up to 2.33 Years)|Death|0|||
49115134|NCT04122625|158258729|FG002|Part B (up to 2.33 Years)|Death|5|||
49115135|NCT04122625|158258730|FG003|Part B (up to 2.33 Years)|Death|7|||
49115136|NCT04122625|158258731|FG004|Part B (up to 2.33 Years)|Death|6|||
49115137|NCT04122625|158258732|FG005|Part B (up to 2.33 Years)|Death|7|||
49115138|NCT01884545|158258733|FG000|Overall Study|Lost to Follow-up|6|||
49115139|NCT01884545|158258734|FG001|Overall Study|Lost to Follow-up|4|||
49115140|NCT01884545|158258735|FG002|Overall Study|Lost to Follow-up|9|||
49115141|NCT01884545|158258736|FG003|Overall Study|Lost to Follow-up|4|||
49115142|NCT01884545|158258733|FG000|Overall Study|Patient withdrawn|7|||
49115143|NCT01884545|158258734|FG001|Overall Study|Patient withdrawn|12|||
49115144|NCT01884545|158258735|FG002|Overall Study|Patient withdrawn|5|||
49115145|NCT01884545|158258736|FG003|Overall Study|Patient withdrawn|5|||
49115146|NCT01884545|158258733|FG000|Overall Study|Non-adherence|0|||
49115147|NCT01884545|158258734|FG001|Overall Study|Non-adherence|2|||
49115148|NCT01884545|158258735|FG002|Overall Study|Non-adherence|0|||
49115149|NCT01884545|158258736|FG003|Overall Study|Non-adherence|0|||
49115150|NCT02081001|158258739|FG000|Overall Study|Adverse Event|0|||
49115151|NCT02081001|158258740|FG001|Overall Study|Adverse Event|0|||
49115152|NCT02081001|158258741|FG002|Overall Study|Adverse Event|0|||
49115153|NCT02081001|158258742|FG003|Overall Study|Adverse Event|0|||
49115154|NCT02081001|158258743|FG004|Overall Study|Adverse Event|1|||
49115155|NCT02081001|158258744|FG005|Overall Study|Adverse Event|0|||
49115156|NCT02081001|158258745|FG006|Overall Study|Adverse Event|0|||
49115157|NCT02081001|158258746|FG007|Overall Study|Adverse Event|0|||
49115158|NCT02081001|158258747|FG008|Overall Study|Adverse Event|0|||
49115159|NCT02081001|158258748|FG009|Overall Study|Adverse Event|0|||
49115160|NCT02081001|158258749|FG010|Overall Study|Adverse Event|0|||
49115161|NCT02081001|158258750|FG011|Overall Study|Adverse Event|0|||
49115162|NCT03585712|158258757|FG000|Treatment Period 1|Protocol Violation|1|||
49115163|NCT03585712|158258758|FG001|Treatment Period 1|Protocol Violation|0|||
49115164|NCT03585712|158258759|FG002|Treatment Period 1|Protocol Violation|0|||
49115165|NCT03585712|158258757|FG000|Treatment Periods 2 and 3|Protocol Violation|0|||
49115166|NCT03585712|158258758|FG001|Treatment Periods 2 and 3|Protocol Violation|1|||
49115167|NCT03585712|158258759|FG002|Treatment Periods 2 and 3|Protocol Violation|1|||
49115168|NCT03585712|158258757|FG000|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
49115169|NCT03585712|158258758|FG001|Treatment Periods 2 and 3|Withdrawal by Subject|2|||
49115170|NCT03585712|158258759|FG002|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
49115171|NCT03585712|158258757|FG000|Treatment Periods 2 and 3|Physician Decision|0|||
49115172|NCT03585712|158258758|FG001|Treatment Periods 2 and 3|Physician Decision|0|||
49115173|NCT03585712|158258759|FG002|Treatment Periods 2 and 3|Physician Decision|2|||
49115174|NCT00548249|158258760|FG000|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3|||
49115175|NCT00548249|158258761|FG001|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
49115176|NCT00548249|158258762|FG002|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
49115177|NCT00548249|158258763|FG003|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2|||
49115178|NCT00548249|158258764|FG004|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
49115179|NCT00548249|158258760|FG000|Overall Study|Transferrin Saturation (TSAT) <20%|5|||
49115180|NCT00548249|158258761|FG001|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
49115181|NCT00548249|158258762|FG002|Overall Study|Transferrin Saturation (TSAT) <20%|3|||
49115182|NCT00548249|158258763|FG003|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
49115183|NCT00548249|158258764|FG004|Overall Study|Transferrin Saturation (TSAT) <20%|2|||
49115184|NCT00548249|158258760|FG000|Overall Study|Protocol Violation|1|||
49115185|NCT00548249|158258761|FG001|Overall Study|Protocol Violation|1|||
49115186|NCT00548249|158258762|FG002|Overall Study|Protocol Violation|4|||
49115187|NCT00548249|158258763|FG003|Overall Study|Protocol Violation|0|||
49115188|NCT00548249|158258764|FG004|Overall Study|Protocol Violation|3|||
49115189|NCT00548249|158258760|FG000|Overall Study|Miscellaneous|2|||
49115190|NCT00548249|158258761|FG001|Overall Study|Miscellaneous|3|||
49115191|NCT00548249|158258762|FG002|Overall Study|Miscellaneous|2|||
49115192|NCT00548249|158258763|FG003|Overall Study|Miscellaneous|0|||
49115193|NCT00548249|158258764|FG004|Overall Study|Miscellaneous|2|||
49115194|NCT00548249|158258760|FG000|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
49115195|NCT00548249|158258761|FG001|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
49115196|NCT00548249|158258762|FG002|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2|||
49115197|NCT00548249|158258763|FG003|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1|||
49115198|NCT00548249|158258764|FG004|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4|||
49115199|NCT00548249|158258760|FG000|Overall Study|Adverse Event|2|||
49115200|NCT00548249|158258761|FG001|Overall Study|Adverse Event|2|||
49115201|NCT00548249|158258762|FG002|Overall Study|Adverse Event|0|||
49115202|NCT00548249|158258763|FG003|Overall Study|Adverse Event|1|||
49115203|NCT00548249|158258764|FG004|Overall Study|Adverse Event|1|||
49115204|NCT00548249|158258760|FG000|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
49115205|NCT00548249|158258761|FG001|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
49115206|NCT00548249|158258762|FG002|Overall Study|Post-dialysis high TSAT or low UIBC|1|||
49115207|NCT00548249|158258763|FG003|Overall Study|Post-dialysis high TSAT or low UIBC|3|||
49115208|NCT00548249|158258764|FG004|Overall Study|Post-dialysis high TSAT or low UIBC|2|||
49115209|NCT00548249|158258760|FG000|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
49115210|NCT00548249|158258761|FG001|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
49115211|NCT00548249|158258762|FG002|Overall Study|Erythropoietin (ESA)Dose Change Required|1|||
49115212|NCT00548249|158258763|FG003|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
49115213|NCT00548249|158258764|FG004|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
49115214|NCT00548249|158258760|FG000|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
49115215|NCT00548249|158258761|FG001|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
49115216|NCT00548249|158258762|FG002|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
49115217|NCT00548249|158258763|FG003|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
49115218|NCT00548249|158258764|FG004|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0|||
49115219|NCT00548249|158258760|FG000|Overall Study|Prolonged hospitalization|0|||
49115220|NCT00548249|158258761|FG001|Overall Study|Prolonged hospitalization|0|||
49115221|NCT00548249|158258762|FG002|Overall Study|Prolonged hospitalization|2|||
49115222|NCT00548249|158258763|FG003|Overall Study|Prolonged hospitalization|1|||
49115223|NCT00548249|158258764|FG004|Overall Study|Prolonged hospitalization|0|||
49115224|NCT00548249|158258760|FG000|Overall Study|Withdrawal by Subject|2|||
49115225|NCT00548249|158258761|FG001|Overall Study|Withdrawal by Subject|0|||
49115226|NCT00548249|158258762|FG002|Overall Study|Withdrawal by Subject|0|||
49115227|NCT00548249|158258763|FG003|Overall Study|Withdrawal by Subject|0|||
49115228|NCT00548249|158258764|FG004|Overall Study|Withdrawal by Subject|0|||
49115229|NCT00548249|158258760|FG000|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
49115230|NCT00548249|158258761|FG001|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
49115231|NCT00548249|158258762|FG002|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
49115232|NCT00548249|158258763|FG003|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
49115233|NCT00548249|158258764|FG004|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
49115234|NCT00548249|158258760|FG000|Overall Study|Sponsor's request|0|||
49115235|NCT00548249|158258761|FG001|Overall Study|Sponsor's request|0|||
49115236|NCT00548249|158258762|FG002|Overall Study|Sponsor's request|0|||
49115237|NCT00548249|158258763|FG003|Overall Study|Sponsor's request|1|||
49115238|NCT00548249|158258764|FG004|Overall Study|Sponsor's request|0|||
49115239|NCT00849290|158258765|FG000|Overall Study|Adverse Event|3|||
49115240|NCT00849290|158258765|FG000|Overall Study|Death|14|||
49115241|NCT00849290|158258765|FG000|Overall Study|Withdrawal by Subject|11|||
49115242|NCT00849290|158258765|FG000|Overall Study|Lost to Follow-up|2|||
49115243|NCT00849290|158258765|FG000|Overall Study|Protocol Violation|5|||
49115244|NCT00849290|158258765|FG000|Overall Study|Disease Progression|20|||
49115245|NCT03853291|158258767|FG000|Overall Study|Lost to Follow-up|1|||
49115246|NCT03853291|158258768|FG001|Overall Study|Lost to Follow-up|2|||
49115247|NCT03853291|158258769|FG002|Overall Study|Lost to Follow-up|0|||
49115248|NCT03853291|158258770|FG003|Overall Study|Lost to Follow-up|0|||
49115249|NCT03853291|158258771|FG004|Overall Study|Lost to Follow-up|0|||
49115250|NCT03853291|158258772|FG005|Overall Study|Lost to Follow-up|0|||
49115251|NCT03853291|158258767|FG000|Overall Study|Determined to be ineligible|1|||
49115252|NCT03853291|158258768|FG001|Overall Study|Determined to be ineligible|1|||
49115253|NCT03853291|158258769|FG002|Overall Study|Determined to be ineligible|0|||
49115254|NCT03853291|158258770|FG003|Overall Study|Determined to be ineligible|0|||
49115255|NCT03853291|158258771|FG004|Overall Study|Determined to be ineligible|0|||
49115256|NCT03853291|158258772|FG005|Overall Study|Determined to be ineligible|0|||
49115257|NCT03131687|158258775|FG000|Overall Study|Adverse Event|0|||
49115258|NCT03131687|158258776|FG001|Overall Study|Adverse Event|1|||
49115259|NCT03131687|158258777|FG002|Overall Study|Adverse Event|0|||
49115260|NCT03131687|158258778|FG003|Overall Study|Adverse Event|1|||
49115261|NCT03131687|158258779|FG004|Overall Study|Adverse Event|2|||
49115262|NCT03131687|158258780|FG005|Overall Study|Adverse Event|2|||
49115263|NCT03131687|158258775|FG000|Overall Study|Death|1|||
49115264|NCT03131687|158258776|FG001|Overall Study|Death|0|||
49115265|NCT03131687|158258777|FG002|Overall Study|Death|0|||
49115266|NCT03131687|158258778|FG003|Overall Study|Death|0|||
49115267|NCT03131687|158258779|FG004|Overall Study|Death|0|||
49115268|NCT03131687|158258780|FG005|Overall Study|Death|0|||
49115269|NCT03131687|158258775|FG000|Overall Study|Withdrawal by Subject|3|||
49115270|NCT03131687|158258776|FG001|Overall Study|Withdrawal by Subject|3|||
49115271|NCT03131687|158258777|FG002|Overall Study|Withdrawal by Subject|3|||
49115272|NCT03131687|158258778|FG003|Overall Study|Withdrawal by Subject|1|||
49115273|NCT03131687|158258779|FG004|Overall Study|Withdrawal by Subject|2|||
49115274|NCT03131687|158258780|FG005|Overall Study|Withdrawal by Subject|1|||
49115275|NCT03131687|158258775|FG000|Overall Study|Lost to Follow-up|1|||
49115276|NCT03131687|158258776|FG001|Overall Study|Lost to Follow-up|4|||
49115277|NCT03131687|158258777|FG002|Overall Study|Lost to Follow-up|0|||
49115278|NCT03131687|158258778|FG003|Overall Study|Lost to Follow-up|1|||
49115279|NCT03131687|158258779|FG004|Overall Study|Lost to Follow-up|4|||
49115280|NCT03131687|158258780|FG005|Overall Study|Lost to Follow-up|2|||
49115281|NCT03131687|158258775|FG000|Overall Study|Participant Started New Diabetic Drug|1|||
49115282|NCT03131687|158258776|FG001|Overall Study|Participant Started New Diabetic Drug|0|||
49115283|NCT03131687|158258777|FG002|Overall Study|Participant Started New Diabetic Drug|0|||
49115284|NCT03131687|158258778|FG003|Overall Study|Participant Started New Diabetic Drug|0|||
49115285|NCT03131687|158258779|FG004|Overall Study|Participant Started New Diabetic Drug|0|||
49115286|NCT03131687|158258780|FG005|Overall Study|Participant Started New Diabetic Drug|0|||
49115287|NCT03131687|158258775|FG000|Overall Study|Principle Investigator Decision|0|||
49115288|NCT03131687|158258776|FG001|Overall Study|Principle Investigator Decision|1|||
49115289|NCT03131687|158258777|FG002|Overall Study|Principle Investigator Decision|0|||
49115290|NCT03131687|158258778|FG003|Overall Study|Principle Investigator Decision|0|||
49115291|NCT03131687|158258779|FG004|Overall Study|Principle Investigator Decision|0|||
49115292|NCT03131687|158258780|FG005|Overall Study|Principle Investigator Decision|0|||
49115293|NCT03131687|158258775|FG000|Overall Study|Inadvertent Enrollment|0|||
49115294|NCT03131687|158258776|FG001|Overall Study|Inadvertent Enrollment|0|||
49115295|NCT03131687|158258777|FG002|Overall Study|Inadvertent Enrollment|0|||
49115296|NCT03131687|158258778|FG003|Overall Study|Inadvertent Enrollment|1|||
49115297|NCT03131687|158258779|FG004|Overall Study|Inadvertent Enrollment|0|||
49115298|NCT03131687|158258780|FG005|Overall Study|Inadvertent Enrollment|0|||
49115299|NCT02797678|158258781|FG000|Screening Phase|Meeting Inclusion/Exclusion criteria|25|||
49115300|NCT02797678|158258782|FG001|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
49115301|NCT02797678|158258783|FG002|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
49115302|NCT02797678|158258784|FG003|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
49115303|NCT02797678|158258781|FG000|First Intervention (5 Nights)|study/device use non-compliance|0|||
49115304|NCT02797678|158258782|FG001|First Intervention (5 Nights)|study/device use non-compliance|1|||
49115305|NCT02797678|158258783|FG002|First Intervention (5 Nights)|study/device use non-compliance|0|||
49115306|NCT02797678|158258784|FG003|First Intervention (5 Nights)|study/device use non-compliance|0|||
49115307|NCT02797678|158258781|FG000|Second Intervention (5 Nights)|study/device use non-compliance|0|||
49115308|NCT02797678|158258782|FG001|Second Intervention (5 Nights)|study/device use non-compliance|0|||
49115309|NCT02797678|158258783|FG002|Second Intervention (5 Nights)|study/device use non-compliance|1|||
49115310|NCT02797678|158258784|FG003|Second Intervention (5 Nights)|study/device use non-compliance|0|||
49115311|NCT03762681|158258789|FG000|Part 1|Withdrawal by Subject|0|||
49115312|NCT03762681|158258790|FG001|Part 1|Withdrawal by Subject|0|||
49115313|NCT03762681|158258791|FG002|Part 1|Withdrawal by Subject|0|||
49115314|NCT03762681|158258792|FG003|Part 1|Withdrawal by Subject|1|||
49115315|NCT03762681|158258793|FG004|Part 1|Withdrawal by Subject|0|||
49115316|NCT03762681|158258794|FG005|Part 1|Withdrawal by Subject|0|||
49115317|NCT03762681|158258795|FG006|Part 1|Withdrawal by Subject|0|||
49115318|NCT03762681|158258796|FG007|Part 1|Withdrawal by Subject|0|||
49115319|NCT03762681|158258789|FG000|Part 2a|Pandemic Travel Restrictions|0|||
49115320|NCT03762681|158258790|FG001|Part 2a|Pandemic Travel Restrictions|0|||
49115321|NCT03762681|158258791|FG002|Part 2a|Pandemic Travel Restrictions|0|||
49115322|NCT03762681|158258792|FG003|Part 2a|Pandemic Travel Restrictions|0|||
49115323|NCT03762681|158258793|FG004|Part 2a|Pandemic Travel Restrictions|0|||
49115324|NCT03762681|158258794|FG005|Part 2a|Pandemic Travel Restrictions|0|||
49115325|NCT03762681|158258795|FG006|Part 2a|Pandemic Travel Restrictions|0|||
49115326|NCT03762681|158258796|FG007|Part 2a|Pandemic Travel Restrictions|1|||
49115327|NCT00003896|158258799|FG000|Overall Study|Adverse Event|16|||
49115328|NCT00003896|158258799|FG000|Overall Study|Withdrawal by Subject|1|||
49115329|NCT00003896|158258799|FG000|Overall Study|Lack of Efficacy|1|||
49115330|NCT00003896|158258799|FG000|Overall Study|Death|3|||
49115331|NCT00003896|158258799|FG000|Overall Study|not protocol specified|3|||
49115332|NCT00003896|158258799|FG000|Overall Study|ineligible|5|||
49115333|NCT01118663|158258800|FG000|Overall Study|Adverse Event|2|||
49115334|NCT01118663|158258801|FG001|Overall Study|Adverse Event|1|||
49115335|NCT01118663|158258800|FG000|Overall Study|Withdrawal by Subject|0|||
49115336|NCT01118663|158258801|FG001|Overall Study|Withdrawal by Subject|1|||
49115337|NCT02383355|158258802|FG000|Overall Study|Adverse Event|2|||
49115338|NCT02383355|158258803|FG001|Overall Study|Adverse Event|0|||
49115339|NCT01603407|158258815|FG000|Overall Study|Adverse Event|1|||
49115340|NCT01603407|158258816|FG001|Overall Study|Adverse Event|1|||
49115341|NCT01603407|158258817|FG002|Overall Study|Adverse Event|1|||
49115342|NCT01603407|158258815|FG000|Overall Study|Protocol Violation|2|||
49115343|NCT01603407|158258816|FG001|Overall Study|Protocol Violation|2|||
49115344|NCT01603407|158258817|FG002|Overall Study|Protocol Violation|0|||
49115345|NCT01603407|158258815|FG000|Overall Study|Withdrawal by Subject|8|||
49115346|NCT01603407|158258816|FG001|Overall Study|Withdrawal by Subject|5|||
49115347|NCT01603407|158258817|FG002|Overall Study|Withdrawal by Subject|7|||
49115348|NCT01603407|158258815|FG000|Overall Study|Lost to Follow-up|0|||
49115349|NCT01603407|158258816|FG001|Overall Study|Lost to Follow-up|3|||
49115350|NCT01603407|158258817|FG002|Overall Study|Lost to Follow-up|2|||
49115351|NCT03162328|158258820|FG000|Screening Period|Did not meet inclusion/exclusion|21|||
49115352|NCT03162328|158258821|FG001|Screening Period|Did not meet inclusion/exclusion|0|||
49115353|NCT03162328|158258822|FG002|Screening Period|Did not meet inclusion/exclusion|0|||
49115354|NCT03162328|158258820|FG000|Screening Period|Withdrawal by Subject|1|||
49115355|NCT03162328|158258821|FG001|Screening Period|Withdrawal by Subject|0|||
49115356|NCT03162328|158258822|FG002|Screening Period|Withdrawal by Subject|0|||
49115357|NCT03162328|158258820|FG000|Study Period|Withdrawal by Subject|0|||
49115358|NCT03162328|158258821|FG001|Study Period|Withdrawal by Subject|0|||
49115359|NCT03162328|158258822|FG002|Study Period|Withdrawal by Subject|1|||
49115360|NCT00441363|158260752|FG000|Overall Study|Adverse Event|4|||
49115361|NCT00441363|158260753|FG001|Overall Study|Adverse Event|2|||
49115362|NCT00441363|158260752|FG000|Overall Study|Withdrawal by Subject|3|||
49115363|NCT00441363|158260753|FG001|Overall Study|Withdrawal by Subject|4|||
49115364|NCT00441363|158260752|FG000|Overall Study|Physician Decision|6|||
49115365|NCT00441363|158260753|FG001|Overall Study|Physician Decision|7|||
49115366|NCT00441363|158260752|FG000|Overall Study|Lost to Follow-up|2|||
49115367|NCT00441363|158260753|FG001|Overall Study|Lost to Follow-up|2|||
49115368|NCT00441363|158260752|FG000|Overall Study|Other|2|||
49115369|NCT00441363|158260753|FG001|Overall Study|Other|0|||
49115370|NCT01048944|158260754|FG000|Overall Study|Protocol Violation|8|||
49115371|NCT01048944|158260755|FG001|Overall Study|Protocol Violation|10|||
49115372|NCT01048944|158260756|FG002|Overall Study|Protocol Violation|10|||
49115373|NCT01048944|158260757|FG003|Overall Study|Protocol Violation|2|||
49115374|NCT01709864|158260758|FG000|Overall Study|Physician Decision|0|||
49115375|NCT01709864|158260759|FG001|Overall Study|Physician Decision|1|||
49115376|NCT01709864|158260758|FG000|Overall Study|subject/guardian decision|5|||
49115377|NCT01709864|158260759|FG001|Overall Study|subject/guardian decision|6|||
49115378|NCT01709864|158260758|FG000|Overall Study|Lost to Follow-up|1|||
49115379|NCT01709864|158260759|FG001|Overall Study|Lost to Follow-up|0|||
49115380|NCT01709864|158260758|FG000|Overall Study|non-compliance with study treatment|1|||
49115381|NCT01709864|158260759|FG001|Overall Study|non-compliance with study treatment|1|||
49115382|NCT01709864|158260758|FG000|Overall Study|Adverse Event|0|||
49115383|NCT01709864|158260759|FG001|Overall Study|Adverse Event|2|||
49115384|NCT01709864|158260758|FG000|Overall Study|Death|0|||
49115385|NCT01709864|158260759|FG001|Overall Study|Death|1|||
49115386|NCT01421147|158260761|FG000|Treatment Period|Adverse Event|2|||
49115387|NCT01421147|158260762|FG001|Treatment Period|Adverse Event|3|||
49115388|NCT01421147|158260761|FG000|Treatment Period|Lost to Follow-up|2|||
49115389|NCT01421147|158260762|FG001|Treatment Period|Lost to Follow-up|1|||
49115390|NCT01421147|158260761|FG000|Treatment Period|Physician Decision|2|||
49115391|NCT01421147|158260762|FG001|Treatment Period|Physician Decision|2|||
49115392|NCT01421147|158260761|FG000|Treatment Period|Withdrawal by Subject|10|||
49115393|NCT01421147|158260762|FG001|Treatment Period|Withdrawal by Subject|5|||
49115394|NCT01421147|158260761|FG000|Extension Period|Adverse Event|0|||
49115395|NCT01421147|158260762|FG001|Extension Period|Adverse Event|2|||
49115396|NCT01421147|158260761|FG000|Extension Period|Death|0|||
49115397|NCT01421147|158260762|FG001|Extension Period|Death|1|||
49115398|NCT01421147|158260761|FG000|Extension Period|Lost to Follow-up|2|||
49115399|NCT01421147|158260762|FG001|Extension Period|Lost to Follow-up|5|||
49115400|NCT01421147|158260761|FG000|Extension Period|Physician Decision|1|||
49115401|NCT01421147|158260762|FG001|Extension Period|Physician Decision|0|||
49115402|NCT01421147|158260761|FG000|Extension Period|Withdrawal by Subject|5|||
49115403|NCT01421147|158260762|FG001|Extension Period|Withdrawal by Subject|3|||
49115404|NCT01270321|158260763|FG000|Overall Study|Death|3|||
49115405|NCT01270321|158260764|FG001|Overall Study|Death|1|||
49115406|NCT01270321|158260765|FG002|Overall Study|Death|4|||
49115407|NCT01270321|158260763|FG000|Overall Study|Adverse Event|7|||
49115408|NCT01270321|158260764|FG001|Overall Study|Adverse Event|9|||
49115409|NCT01270321|158260765|FG002|Overall Study|Adverse Event|5|||
49115410|NCT00703326|158260766|FG000|Overall Study|Lost to Follow-up|47|||
49115411|NCT00703326|158260767|FG001|Overall Study|Lost to Follow-up|18|||
49115412|NCT00703326|158260766|FG000|Overall Study|Withdrawal by Subject|54|||
49115413|NCT00703326|158260767|FG001|Overall Study|Withdrawal by Subject|20|||
49115414|NCT00703326|158260766|FG000|Overall Study|Adverse Event|1|||
49115415|NCT00703326|158260767|FG001|Overall Study|Adverse Event|0|||
49115416|NCT00802672|158260769|FG000|Overall Study|Lack of fungal pathogen at baseline|56|||
49115417|NCT00802672|158260770|FG001|Overall Study|Lack of fungal pathogen at baseline|43|||
49115418|NCT00802672|158260771|FG002|Overall Study|Lack of fungal pathogen at baseline|25|||
49115419|NCT00802672|158260769|FG000|Overall Study|Adverse Event|1|||
49115420|NCT00802672|158260770|FG001|Overall Study|Adverse Event|1|||
49115421|NCT00802672|158260771|FG002|Overall Study|Adverse Event|1|||
49115422|NCT00802672|158260769|FG000|Overall Study|Protocol Violation|2|||
49115423|NCT00802672|158260770|FG001|Overall Study|Protocol Violation|1|||
49115424|NCT00802672|158260771|FG002|Overall Study|Protocol Violation|1|||
49115425|NCT00802672|158260769|FG000|Overall Study|Lost to Follow-up|5|||
49115426|NCT00802672|158260770|FG001|Overall Study|Lost to Follow-up|5|||
49115427|NCT00802672|158260771|FG002|Overall Study|Lost to Follow-up|3|||
49115428|NCT00802672|158260769|FG000|Overall Study|Withdrawal by Subject|1|||
49115429|NCT00802672|158260770|FG001|Overall Study|Withdrawal by Subject|1|||
49115430|NCT00802672|158260771|FG002|Overall Study|Withdrawal by Subject|2|||
49115431|NCT00802672|158260769|FG000|Overall Study|other|3|||
49115432|NCT00802672|158260770|FG001|Overall Study|other|1|||
49115433|NCT00802672|158260771|FG002|Overall Study|other|2|||
49115434|NCT04750278|158260772|FG000|Overall Study|Death|9|||
49115435|NCT04750278|158260773|FG001|Overall Study|Death|10|||
49115436|NCT04750278|158260774|FG002|Overall Study|Death|10|||
49115437|NCT04750278|158260772|FG000|Overall Study|Withdrawal by Subject|4|||
49115438|NCT04750278|158260773|FG001|Overall Study|Withdrawal by Subject|1|||
49115439|NCT04750278|158260774|FG002|Overall Study|Withdrawal by Subject|2|||
49115440|NCT04750278|158260772|FG000|Overall Study|Lost to Follow-up|1|||
49115441|NCT04750278|158260773|FG001|Overall Study|Lost to Follow-up|1|||
49115442|NCT04750278|158260774|FG002|Overall Study|Lost to Follow-up|1|||
49115443|NCT04750278|158260772|FG000|Overall Study|Pregnancy|1|||
49115444|NCT04750278|158260773|FG001|Overall Study|Pregnancy|0|||
49115445|NCT04750278|158260774|FG002|Overall Study|Pregnancy|0|||
49115446|NCT04750278|158260772|FG000|Overall Study|Withdrawal by Legally Authorized Representative|0|||
49115447|NCT04750278|158260773|FG001|Overall Study|Withdrawal by Legally Authorized Representative|1|||
49115448|NCT04750278|158260774|FG002|Overall Study|Withdrawal by Legally Authorized Representative|0|||
49115449|NCT04750278|158260772|FG000|Overall Study|Non-compliance|0|||
49115450|NCT04750278|158260773|FG001|Overall Study|Non-compliance|0|||
49115451|NCT04750278|158260774|FG002|Overall Study|Non-compliance|1|||
49115452|NCT04750278|158260772|FG000|Overall Study|Transfer to Outside Facility|0|||
49115453|NCT04750278|158260773|FG001|Overall Study|Transfer to Outside Facility|2|||
49115454|NCT04750278|158260774|FG002|Overall Study|Transfer to Outside Facility|1|||
49115455|NCT04750278|158260772|FG000|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
49115456|NCT04750278|158260773|FG001|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|1|||
49115457|NCT04750278|158260774|FG002|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
49115458|NCT04750278|158260772|FG000|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
49115459|NCT04750278|158260773|FG001|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
49115460|NCT04750278|158260774|FG002|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|1|||
49115461|NCT02263729|158260775|FG000|Overall Study|Lost to Follow-up|1|||
49115462|NCT02263729|158260776|FG001|Overall Study|Lost to Follow-up|1|||
49115463|NCT01306214|158260778|FG000|Overall Study|Death|0|||
49115464|NCT01306214|158260779|FG001|Overall Study|Death|0|||
49115465|NCT01306214|158260780|FG002|Overall Study|Death|1|||
49115466|NCT01306214|158260778|FG000|Overall Study|Lost to Follow-up|3|||
49115467|NCT01306214|158260779|FG001|Overall Study|Lost to Follow-up|5|||
49115468|NCT01306214|158260780|FG002|Overall Study|Lost to Follow-up|4|||
49115469|NCT01306214|158260778|FG000|Overall Study|Withdrawal by Subject|24|||
49115470|NCT01306214|158260779|FG001|Overall Study|Withdrawal by Subject|22|||
49115471|NCT01306214|158260780|FG002|Overall Study|Withdrawal by Subject|16|||
49115472|NCT01306214|158260778|FG000|Overall Study|Not treated|1|||
49115473|NCT01306214|158260779|FG001|Overall Study|Not treated|1|||
49115474|NCT01306214|158260780|FG002|Overall Study|Not treated|1|||
49115475|NCT01928199|158260783|FG000|Overall Study|Lost to Follow-up|2|||
49115476|NCT01928199|158260784|FG001|Overall Study|Lost to Follow-up|1|||
49115477|NCT01928199|158260783|FG000|Overall Study|Withdrawal by Subject|3|||
49115478|NCT01928199|158260784|FG001|Overall Study|Withdrawal by Subject|5|||
49115479|NCT01616758|158260785|FG000|Overall Study|Adverse Event|1|||
49115480|NCT01616758|158260785|FG000|Overall Study|Withdrawal by Subject|2|||
49115481|NCT01616758|158260785|FG000|Overall Study|Disease progression|18|||
49115482|NCT01616758|158260785|FG000|Overall Study|Study termination by Sponsor|1|||
49115483|NCT02107313|158260786|FG000|Overall Study|One participant did not do the FED cohor|0|||
49115484|NCT02107313|158260787|FG001|Overall Study|One participant did not do the FED cohor|1|||
49115485|NCT02315664|158260788|FG000|Overall Study|Lost to Follow-up|1|||
49115486|NCT02315664|158260789|FG001|Overall Study|Lost to Follow-up|1|||
49115487|NCT02315664|158260788|FG000|Overall Study|Withdrawal by Subject|0|||
49115488|NCT02315664|158260789|FG001|Overall Study|Withdrawal by Subject|3|||
49115489|NCT03488563|158260790|FG000|Overall Study|Lost to Follow-up|7|||
49115490|NCT03488563|158260791|FG001|Overall Study|Lost to Follow-up|6|||
49115491|NCT03488563|158260792|FG002|Overall Study|Lost to Follow-up|7|||
49115492|NCT03488563|158260790|FG000|Overall Study|Withdrawal by Subject|8|||
49115493|NCT03488563|158260791|FG001|Overall Study|Withdrawal by Subject|7|||
49115494|NCT03488563|158260792|FG002|Overall Study|Withdrawal by Subject|7|||
49115495|NCT03488563|158260790|FG000|Overall Study|Physician Decision|0|||
49115496|NCT03488563|158260791|FG001|Overall Study|Physician Decision|0|||
49115497|NCT03488563|158260792|FG002|Overall Study|Physician Decision|1|||
49115498|NCT03488563|158260790|FG000|Overall Study|Protocol Violation|3|||
49115499|NCT03488563|158260791|FG001|Overall Study|Protocol Violation|2|||
49115500|NCT03488563|158260792|FG002|Overall Study|Protocol Violation|6|||
49115501|NCT03488563|158260790|FG000|Overall Study|Subject did not meet minimum number of migraines per month|1|||
49115502|NCT03488563|158260791|FG001|Overall Study|Subject did not meet minimum number of migraines per month|0|||
49115503|NCT03488563|158260792|FG002|Overall Study|Subject did not meet minimum number of migraines per month|0|||
49115504|NCT03488563|158260790|FG000|Overall Study|Use of prohibited medication|2|||
49115505|NCT03488563|158260791|FG001|Overall Study|Use of prohibited medication|0|||
49115506|NCT03488563|158260792|FG002|Overall Study|Use of prohibited medication|0|||
49115507|NCT03488563|158260790|FG000|Overall Study|Adverse Event|1|||
49115508|NCT03488563|158260791|FG001|Overall Study|Adverse Event|0|||
49115509|NCT03488563|158260792|FG002|Overall Study|Adverse Event|1|||
49115510|NCT03488563|158260790|FG000|Overall Study|Subject returned for ET visit|0|||
49115511|NCT03488563|158260791|FG001|Overall Study|Subject returned for ET visit|1|||
49115512|NCT03488563|158260792|FG002|Overall Study|Subject returned for ET visit|0|||
49115513|NCT03488563|158260790|FG000|Overall Study|Sponsor's decision|0|||
49115514|NCT03488563|158260791|FG001|Overall Study|Sponsor's decision|0|||
49115515|NCT03488563|158260792|FG002|Overall Study|Sponsor's decision|1|||
49115516|NCT04336475|158260793|FG000|Overall Study|pain|1|||
49115517|NCT04336475|158260794|FG001|Overall Study|pain|0|||
49115518|NCT04336475|158260793|FG000|Overall Study|upper respiratory infection|1|||
49115519|NCT04336475|158260794|FG001|Overall Study|upper respiratory infection|0|||
49115520|NCT04336475|158260793|FG000|Overall Study|Lost to Follow-up|0|||
49115521|NCT04336475|158260794|FG001|Overall Study|Lost to Follow-up|2|||
49115522|NCT04153565|158260799|FG000|Overall Study|Death|13|||
49115523|NCT02626000|158260814|FG000|Overall Study|Decision by Sponsor|1|||
49115524|NCT02626000|158260814|FG000|Overall Study|Death|29|||
49115525|NCT00199849|158260815|FG000|Overall Study|Unrelated illness or complication|0|||
49115526|NCT00199849|158260816|FG001|Overall Study|Unrelated illness or complication|1|||
49115527|NCT00199849|158260817|FG002|Overall Study|Unrelated illness or complication|0|||
49115528|NCT00199849|158260815|FG000|Overall Study|Progressive disease requiring intervention|0|||
49115529|NCT00199849|158260816|FG001|Overall Study|Progressive disease requiring intervention|0|||
49115530|NCT00199849|158260817|FG002|Overall Study|Progressive disease requiring intervention|1|||
49115531|NCT00199849|158260815|FG000|Overall Study|Did not meet eligibility criteria - not dosed|0|||
49115532|NCT00199849|158260816|FG001|Overall Study|Did not meet eligibility criteria - not dosed|0|||
49115533|NCT00199849|158260817|FG002|Overall Study|Did not meet eligibility criteria - not dosed|1|||
49115534|NCT00662311|158260818|FG000|Overall Study|Respiratory Infection|1|||
49115535|NCT00662311|158260819|FG001|Overall Study|Respiratory Infection|0|||
49115536|NCT00662311|158260820|FG002|Overall Study|Respiratory Infection|0|||
49115537|NCT01490840|158260821|FG000|Phase 1|Lost to Follow-up|1|||
49115538|NCT01490840|158260822|FG001|Phase 1|Lost to Follow-up|0|||
49115539|NCT01490840|158260821|FG000|Phase 1|Adverse Event|2|||
49115540|NCT01490840|158260822|FG001|Phase 1|Adverse Event|1|||
49115541|NCT01490840|158260821|FG000|Phase 1|Withdrawal by Subject|6|||
49115542|NCT01490840|158260822|FG001|Phase 1|Withdrawal by Subject|5|||
49115543|NCT01490840|158260821|FG000|Phase 1|Visit 6a omitted|1|||
49115544|NCT01490840|158260822|FG001|Phase 1|Visit 6a omitted|0|||
49115545|NCT01490840|158260821|FG000|Phase 2|Withdrawal by Subject|4|||
49115546|NCT01490840|158260822|FG001|Phase 2|Withdrawal by Subject|3|||
49115547|NCT01490840|158260821|FG000|Phase 2|Permanent interruption of fingolimod|0|||
49115548|NCT01490840|158260822|FG001|Phase 2|Permanent interruption of fingolimod|1|||
49115549|NCT01490840|158260821|FG000|Phase 2|Lost to Follow-up|1|||
49115550|NCT01490840|158260822|FG001|Phase 2|Lost to Follow-up|1|||
49115551|NCT01490840|158260821|FG000|Phase 2|Adverse Event|1|||
49115552|NCT01490840|158260822|FG001|Phase 2|Adverse Event|1|||
49115553|NCT03594955|158260823|FG000|Overall Study|Adverse Event|1|||
49115554|NCT03594955|158260823|FG000|Overall Study|Progressive disease|5|||
49115555|NCT03594955|158260823|FG000|Overall Study|Sponsor's decision|1|||
49115556|NCT01148459|158260836|FG000|Overall Study|Serious Adverse Event|5|||
49115557|NCT01148459|158260837|FG001|Overall Study|Serious Adverse Event|4|||
49115558|NCT01148459|158260836|FG000|Overall Study|Withdrawal by Subject|1|||
49115559|NCT01148459|158260837|FG001|Overall Study|Withdrawal by Subject|0|||
49115560|NCT01148459|158260836|FG000|Overall Study|Migrated/moved from study area|3|||
49115561|NCT01148459|158260837|FG001|Overall Study|Migrated/moved from study area|6|||
49115562|NCT01148459|158260836|FG000|Overall Study|Lost to Follow-up|2|||
49115563|NCT01148459|158260837|FG001|Overall Study|Lost to Follow-up|0|||
49115564|NCT01148459|158260836|FG000|Overall Study|Refusal|1|||
49115565|NCT01148459|158260837|FG001|Overall Study|Refusal|0|||
49115566|NCT01148459|158260836|FG000|Overall Study|Failure to comply with study procedures|0|||
49115567|NCT01148459|158260837|FG001|Overall Study|Failure to comply with study procedures|1|||
49115568|NCT00694356|158260839|FG000|Overall Study|Adverse Event|1|||
49115569|NCT00694356|158260840|FG001|Overall Study|Adverse Event|0|||
49115570|NCT00694356|158260841|FG002|Overall Study|Adverse Event|0|||
49115571|NCT00694356|158260839|FG000|Overall Study|Progressive Disease|2|||
49115572|NCT00694356|158260840|FG001|Overall Study|Progressive Disease|6|||
49115573|NCT00694356|158260841|FG002|Overall Study|Progressive Disease|6|||
49115574|NCT03042910|158260846|FG000|Overall Study|Adverse Event|1|||
49115575|NCT03042910|158260846|FG000|Overall Study|Disease Progression|2|||
49115576|NCT03042910|158260846|FG000|Overall Study|Withdrawal by Subject|3|||
49115577|NCT03042910|158260846|FG000|Overall Study|Enrolled but not treated|1|||
49115578|NCT01763203|158260848|FG000|Overall Study|Death|4|||
49115579|NCT01763203|158260849|FG001|Overall Study|Death|7|||
49115580|NCT01763203|158260848|FG000|Overall Study|Lost to Follow-up|12|||
49115581|NCT01763203|158260849|FG001|Overall Study|Lost to Follow-up|12|||
49115582|NCT01763203|158260848|FG000|Overall Study|Withdrawal by Subject|8|||
49115583|NCT01763203|158260849|FG001|Overall Study|Withdrawal by Subject|12|||
49115584|NCT01763203|158260848|FG000|Overall Study|Moved out of study region|7|||
49115585|NCT01763203|158260849|FG001|Overall Study|Moved out of study region|10|||
49115586|NCT01763203|158260848|FG000|Overall Study|Physician Decision|2|||
49115587|NCT01763203|158260849|FG001|Overall Study|Physician Decision|1|||
49115588|NCT02756819|158260853|FG000|Overall Study|Lost for observation|23|||
49115589|NCT02756819|158260853|FG000|Overall Study|Patient's unwillingness|16|||
49115590|NCT02756819|158260853|FG000|Overall Study|Insufficient efficacy|2|||
49115591|NCT02756819|158260853|FG000|Overall Study|Adverse Event|2|||
49115592|NCT02756819|158260853|FG000|Overall Study|Reason not Specified|9|||
49115593|NCT01090050|158260857|FG000|Overall Study|Lost to Follow-up|0|||
49115594|NCT01090050|158260858|FG001|Overall Study|Lost to Follow-up|1|||
49115595|NCT01090050|158260857|FG000|Overall Study|Lack of Efficacy|1|||
49115596|NCT01090050|158260858|FG001|Overall Study|Lack of Efficacy|5|||
49115597|NCT01090050|158260857|FG000|Overall Study|Physician Decision|0|||
49115598|NCT01090050|158260858|FG001|Overall Study|Physician Decision|1|||
49115599|NCT01491841|158260859|FG000|Overall Study|Screen Failure|10|||
49115600|NCT01491841|158260859|FG000|Overall Study|Withdrawal by Subject|1|||
49115601|NCT02933528|158260860|FG000|Overall Study|Lost to Follow-up|2|||
49115602|NCT03539484|158260861|FG000|Overall Study|Death|1|||
49115603|NCT03539484|158260862|FG001|Overall Study|Death|0|||
49115604|NCT03539484|158260863|FG002|Overall Study|Death|0|||
49115605|NCT03539484|158260864|FG003|Overall Study|Death|2|||
49115606|NCT03539484|158260865|FG004|Overall Study|Death|8|||
49115607|NCT03539484|158260866|FG005|Overall Study|Death|3|||
49115608|NCT03539484|158260867|FG006|Overall Study|Death|0|||
49115609|NCT03539484|158260861|FG000|Overall Study|Lost to Follow-up|0|||
49115610|NCT03539484|158260862|FG001|Overall Study|Lost to Follow-up|1|||
49115611|NCT03539484|158260863|FG002|Overall Study|Lost to Follow-up|0|||
49115612|NCT03539484|158260864|FG003|Overall Study|Lost to Follow-up|0|||
49115613|NCT03539484|158260865|FG004|Overall Study|Lost to Follow-up|1|||
49115614|NCT03539484|158260866|FG005|Overall Study|Lost to Follow-up|0|||
49115615|NCT03539484|158260867|FG006|Overall Study|Lost to Follow-up|0|||
49115616|NCT03539484|158260861|FG000|Overall Study|Withdrawal by Subject|0|||
49115617|NCT03539484|158260862|FG001|Overall Study|Withdrawal by Subject|0|||
49115618|NCT03539484|158260863|FG002|Overall Study|Withdrawal by Subject|0|||
49115619|NCT03539484|158260864|FG003|Overall Study|Withdrawal by Subject|0|||
49115620|NCT03539484|158260865|FG004|Overall Study|Withdrawal by Subject|2|||
49115621|NCT03539484|158260866|FG005|Overall Study|Withdrawal by Subject|0|||
49115622|NCT03539484|158260867|FG006|Overall Study|Withdrawal by Subject|1|||
49115623|NCT03539484|158260861|FG000|Overall Study|Study Terminated by Sponsor|0|||
49115624|NCT03539484|158260862|FG001|Overall Study|Study Terminated by Sponsor|0|||
49115625|NCT03539484|158260863|FG002|Overall Study|Study Terminated by Sponsor|1|||
49115626|NCT03539484|158260864|FG003|Overall Study|Study Terminated by Sponsor|1|||
49115627|NCT03539484|158260865|FG004|Overall Study|Study Terminated by Sponsor|2|||
49115628|NCT03539484|158260866|FG005|Overall Study|Study Terminated by Sponsor|2|||
49115629|NCT03539484|158260867|FG006|Overall Study|Study Terminated by Sponsor|1|||
49115630|NCT00741598|158260868|FG000|Overall Study|Lost to Follow-up|3|||
49115631|NCT00741598|158260869|FG001|Overall Study|Lost to Follow-up|4|||
49115632|NCT00741598|158260868|FG000|Overall Study|Lack of Efficacy|1|||
49115633|NCT00741598|158260869|FG001|Overall Study|Lack of Efficacy|2|||
49115634|NCT00741598|158260868|FG000|Overall Study|Physician Decision|1|||
49115635|NCT00741598|158260869|FG001|Overall Study|Physician Decision|1|||
49115636|NCT00741598|158260868|FG000|Overall Study|Pregnancy|1|||
49115637|NCT00741598|158260869|FG001|Overall Study|Pregnancy|0|||
49115638|NCT00741598|158260868|FG000|Overall Study|Withdrawal by Subject|3|||
49115639|NCT00741598|158260869|FG001|Overall Study|Withdrawal by Subject|2|||
49115640|NCT03297021|158260870|FG000|Overall Study|Incomplete/illegible data sheet|4|||
49115641|NCT03297021|158260871|FG001|Overall Study|Incomplete/illegible data sheet|2|||
49115642|NCT03297021|158260872|FG002|Overall Study|Incomplete/illegible data sheet|3|||
49115643|NCT03297021|158260870|FG000|Overall Study|Missing Post-Op Data|1|||
49115644|NCT03297021|158260871|FG001|Overall Study|Missing Post-Op Data|2|||
49115645|NCT03297021|158260872|FG002|Overall Study|Missing Post-Op Data|1|||
49115646|NCT02779075|158260873|FG000|Overall Study|Withdrawal by Subject|1|||
49115647|NCT02779075|158260874|FG001|Overall Study|Withdrawal by Subject|3|||
49115648|NCT02779075|158260873|FG000|Overall Study|IV lost during 2nd study|1|||
49115649|NCT02779075|158260874|FG001|Overall Study|IV lost during 2nd study|0|||
49115650|NCT00482170|158260881|FG000|Overall Study|Adverse Event|5|||
49115651|NCT00482170|158260882|FG001|Overall Study|Adverse Event|14|||
49115652|NCT00482170|158260881|FG000|Overall Study|Withdrawal by Subject|6|||
49115653|NCT00482170|158260882|FG001|Overall Study|Withdrawal by Subject|1|||
49115654|NCT00482170|158260881|FG000|Overall Study|Protocol Violation|2|||
49115655|NCT00482170|158260882|FG001|Overall Study|Protocol Violation|3|||
49115656|NCT00482170|158260881|FG000|Overall Study|Lost to Follow-up|2|||
49115657|NCT00482170|158260882|FG001|Overall Study|Lost to Follow-up|0|||
49115658|NCT00482170|158260881|FG000|Overall Study|Unspecified reason|0|||
49115659|NCT00482170|158260882|FG001|Overall Study|Unspecified reason|2|||
49115660|NCT05446142|158260885|FG000|Period 2|Adverse Event|1|||
49115661|NCT05446142|158260886|FG001|Period 2|Adverse Event|0|||
49115662|NCT05446142|158260887|FG002|Period 2|Adverse Event|0|||
49115663|NCT05446142|158260888|FG003|Period 2|Adverse Event|0|||
49115664|NCT05446142|158260889|FG004|Period 2|Adverse Event|0|||
49115665|NCT05446142|158260890|FG005|Period 2|Adverse Event|0|||
49115666|NCT00627926|158260900|FG000|Overall Study|Adverse Event|26|||
49115667|NCT00627926|158260901|FG001|Overall Study|Adverse Event|37|||
49115668|NCT00627926|158260902|FG002|Overall Study|Adverse Event|36|||
49115669|NCT00627926|158260900|FG000|Overall Study|Death|1|||
49115670|NCT00627926|158260901|FG001|Overall Study|Death|0|||
49115671|NCT00627926|158260902|FG002|Overall Study|Death|0|||
49115672|NCT00627926|158260900|FG000|Overall Study|Lost to Follow-up|4|||
49115673|NCT00627926|158260901|FG001|Overall Study|Lost to Follow-up|3|||
49115674|NCT00627926|158260902|FG002|Overall Study|Lost to Follow-up|4|||
49115675|NCT00627926|158260900|FG000|Overall Study|Withdrawal by Subject|2|||
49115676|NCT00627926|158260901|FG001|Overall Study|Withdrawal by Subject|1|||
49115677|NCT00627926|158260902|FG002|Overall Study|Withdrawal by Subject|0|||
49115678|NCT00627926|158260900|FG000|Overall Study|Lack of Efficacy|118|||
49115679|NCT00627926|158260901|FG001|Overall Study|Lack of Efficacy|40|||
49115680|NCT00627926|158260902|FG002|Overall Study|Lack of Efficacy|38|||
49115681|NCT00627926|158260900|FG000|Overall Study|Noncompliance/unspecified|8|||
49115682|NCT00627926|158260901|FG001|Overall Study|Noncompliance/unspecified|23|||
49115683|NCT00627926|158260902|FG002|Overall Study|Noncompliance/unspecified|17|||
49115684|NCT02588092|158260903|FG000|Overall Study|Death|4|||
49115685|NCT02588092|158260904|FG001|Overall Study|Death|3|||
49115686|NCT02588092|158260905|FG002|Overall Study|Death|3|||
49115687|NCT02588092|158260906|FG003|Overall Study|Death|3|||
49115688|NCT02588092|158260907|FG004|Overall Study|Death|2|||
49115689|NCT02588092|158260908|FG005|Overall Study|Death|2|||
49115690|NCT02588092|158260909|FG006|Overall Study|Death|2|||
49115691|NCT02588092|158260910|FG007|Overall Study|Death|1|||
49115692|NCT02588092|158260911|FG008|Overall Study|Death|5|||
49115693|NCT02588092|158260912|FG009|Overall Study|Death|2|||
49115694|NCT02588092|158260903|FG000|Overall Study|Withdrawal by Subject|0|||
49115695|NCT02588092|158260904|FG001|Overall Study|Withdrawal by Subject|0|||
49115696|NCT02588092|158260905|FG002|Overall Study|Withdrawal by Subject|0|||
49115697|NCT02588092|158260906|FG003|Overall Study|Withdrawal by Subject|0|||
49115698|NCT02588092|158260907|FG004|Overall Study|Withdrawal by Subject|0|||
49115699|NCT02588092|158260908|FG005|Overall Study|Withdrawal by Subject|1|||
49115700|NCT02588092|158260909|FG006|Overall Study|Withdrawal by Subject|1|||
49115701|NCT02588092|158260910|FG007|Overall Study|Withdrawal by Subject|2|||
49115702|NCT02588092|158260911|FG008|Overall Study|Withdrawal by Subject|0|||
49115703|NCT02588092|158260912|FG009|Overall Study|Withdrawal by Subject|0|||
49115704|NCT02588092|158260903|FG000|Overall Study|Started Another Treatment|0|||
49115705|NCT02588092|158260904|FG001|Overall Study|Started Another Treatment|0|||
49115706|NCT02588092|158260905|FG002|Overall Study|Started Another Treatment|0|||
49115707|NCT02588092|158260906|FG003|Overall Study|Started Another Treatment|0|||
49115708|NCT02588092|158260907|FG004|Overall Study|Started Another Treatment|1|||
49115709|NCT02588092|158260908|FG005|Overall Study|Started Another Treatment|0|||
49115710|NCT02588092|158260909|FG006|Overall Study|Started Another Treatment|0|||
49115711|NCT02588092|158260910|FG007|Overall Study|Started Another Treatment|1|||
49115712|NCT02588092|158260911|FG008|Overall Study|Started Another Treatment|0|||
49115713|NCT02588092|158260912|FG009|Overall Study|Started Another Treatment|0|||
49115714|NCT02588092|158260903|FG000|Overall Study|Sponsor Decision|0|||
49115715|NCT02588092|158260904|FG001|Overall Study|Sponsor Decision|0|||
49115716|NCT02588092|158260905|FG002|Overall Study|Sponsor Decision|0|||
49115717|NCT02588092|158260906|FG003|Overall Study|Sponsor Decision|0|||
49115718|NCT02588092|158260907|FG004|Overall Study|Sponsor Decision|0|||
49115719|NCT02588092|158260908|FG005|Overall Study|Sponsor Decision|0|||
49115720|NCT02588092|158260909|FG006|Overall Study|Sponsor Decision|0|||
49115721|NCT02588092|158260910|FG007|Overall Study|Sponsor Decision|0|||
49115722|NCT02588092|158260911|FG008|Overall Study|Sponsor Decision|1|||
49115723|NCT02588092|158260912|FG009|Overall Study|Sponsor Decision|1|||
49115724|NCT01386944|158260913|FG000|Overall Study|Adverse Event|26|||
49115725|NCT01386944|158260913|FG000|Overall Study|Lack of Efficacy|14|||
49115726|NCT01386944|158260913|FG000|Overall Study|Lost to Follow-up|8|||
49115727|NCT01386944|158260913|FG000|Overall Study|Unspecified reason|8|||
49115728|NCT01348100|158260914|FG000|Overall Study|Subject Withdrew Consent|0|||
49115729|NCT01348100|158260915|FG001|Overall Study|Subject Withdrew Consent|0|||
49115730|NCT01348100|158260916|FG002|Overall Study|Subject Withdrew Consent|2|||
49115731|NCT01348100|158260917|FG003|Overall Study|Subject Withdrew Consent|0|||
49115732|NCT01348100|158260918|FG004|Overall Study|Subject Withdrew Consent|1|||
49115733|NCT01348100|158260919|FG005|Overall Study|Subject Withdrew Consent|0|||
49115734|NCT01348100|158260920|FG006|Overall Study|Subject Withdrew Consent|1|||
49115735|NCT01348100|158260914|FG000|Overall Study|Protocol Deviation|0|||
49115736|NCT01348100|158260915|FG001|Overall Study|Protocol Deviation|0|||
49115737|NCT01348100|158260916|FG002|Overall Study|Protocol Deviation|0|||
49115738|NCT01348100|158260917|FG003|Overall Study|Protocol Deviation|1|||
49115739|NCT01348100|158260918|FG004|Overall Study|Protocol Deviation|0|||
49115740|NCT01348100|158260919|FG005|Overall Study|Protocol Deviation|0|||
49115741|NCT01348100|158260920|FG006|Overall Study|Protocol Deviation|0|||
49115742|NCT01348100|158260914|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
49115743|NCT01348100|158260915|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
49115744|NCT01348100|158260916|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
49115745|NCT01348100|158260917|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
49115746|NCT01348100|158260918|FG004|Overall Study|Unsatisfactory Therapeutic Effect|0|||
49115747|NCT01348100|158260919|FG005|Overall Study|Unsatisfactory Therapeutic Effect|1|||
49115748|NCT01348100|158260920|FG006|Overall Study|Unsatisfactory Therapeutic Effect|0|||
49115749|NCT01348100|158260914|FG000|Overall Study|Lost to Follow-up|0|||
49115750|NCT01348100|158260915|FG001|Overall Study|Lost to Follow-up|0|||
49115751|NCT01348100|158260916|FG002|Overall Study|Lost to Follow-up|0|||
49115752|NCT01348100|158260917|FG003|Overall Study|Lost to Follow-up|0|||
49115753|NCT01348100|158260918|FG004|Overall Study|Lost to Follow-up|0|||
49115754|NCT01348100|158260919|FG005|Overall Study|Lost to Follow-up|0|||
49115755|NCT01348100|158260920|FG006|Overall Study|Lost to Follow-up|1|||
49115756|NCT01348100|158260914|FG000|Overall Study|Administrative Problems|0|||
49115757|NCT01348100|158260915|FG001|Overall Study|Administrative Problems|0|||
49115758|NCT01348100|158260916|FG002|Overall Study|Administrative Problems|0|||
49115759|NCT01348100|158260917|FG003|Overall Study|Administrative Problems|0|||
49115760|NCT01348100|158260918|FG004|Overall Study|Administrative Problems|0|||
49115761|NCT01348100|158260919|FG005|Overall Study|Administrative Problems|1|||
49115762|NCT01348100|158260920|FG006|Overall Study|Administrative Problems|1|||
49115763|NCT01904032|158260938|FG000|Overall Study|Adverse Event|3|||
49115764|NCT01904032|158260939|FG001|Overall Study|Adverse Event|1|||
49115765|NCT01904032|158260938|FG000|Overall Study|Lost to Follow-up|4|||
49115766|NCT01904032|158260939|FG001|Overall Study|Lost to Follow-up|2|||
49115767|NCT01808222|158260945|FG000|Overall Study|mpMR scan was not performed|1|||
49115768|NCT01398358|158260948|FG000|Overall Study|Lost to Follow-up|11|||
49115769|NCT01398358|158260949|FG001|Overall Study|Lost to Follow-up|21|||
49115770|NCT01398358|158260950|FG002|Overall Study|Lost to Follow-up|18|||
49115771|NCT01398358|158260948|FG000|Overall Study|Withdrawal by Subject|3|||
49115772|NCT01398358|158260949|FG001|Overall Study|Withdrawal by Subject|2|||
49115773|NCT01398358|158260950|FG002|Overall Study|Withdrawal by Subject|2|||
49115774|NCT01398358|158260948|FG000|Overall Study|no longer eligible|1|||
49115775|NCT01398358|158260949|FG001|Overall Study|no longer eligible|0|||
49115776|NCT01398358|158260950|FG002|Overall Study|no longer eligible|1|||
49115777|NCT02819440|158260958|FG000|Overall Study|Adverse Event|3|||
49115778|NCT02819440|158260959|FG001|Overall Study|Adverse Event|1|||
49115779|NCT02819440|158260958|FG000|Overall Study|Lost to Follow-up|1|||
49115780|NCT02819440|158260959|FG001|Overall Study|Lost to Follow-up|3|||
49115781|NCT02819440|158260958|FG000|Overall Study|Withdrawal by Subject|9|||
49115782|NCT02819440|158260959|FG001|Overall Study|Withdrawal by Subject|8|||
49115783|NCT02348008|158260962|FG000|Overall Study|Adverse Event|2|||
49115784|NCT02348008|158260963|FG001|Overall Study|Adverse Event|3|||
49115785|NCT02348008|158260964|FG002|Overall Study|Adverse Event|3|||
49115786|NCT02348008|158260962|FG000|Overall Study|Disease Progression|1|||
49115787|NCT02348008|158260963|FG001|Overall Study|Disease Progression|5|||
49115788|NCT02348008|158260964|FG002|Overall Study|Disease Progression|16|||
49115789|NCT02348008|158260962|FG000|Overall Study|Withdrawal by Subject|0|||
49115790|NCT02348008|158260963|FG001|Overall Study|Withdrawal by Subject|1|||
49115791|NCT02348008|158260964|FG002|Overall Study|Withdrawal by Subject|0|||
49115792|NCT02348008|158260962|FG000|Overall Study|Symptomatic Deterioration|0|||
49115793|NCT02348008|158260963|FG001|Overall Study|Symptomatic Deterioration|1|||
49115794|NCT02348008|158260964|FG002|Overall Study|Symptomatic Deterioration|0|||
49115795|NCT02168777|158262921|FG000|Overall Study|Withdrawal by Subject|1|||
49115796|NCT02168777|158262922|FG001|Overall Study|Withdrawal by Subject|0|||
49115797|NCT02168777|158262923|FG002|Overall Study|Withdrawal by Subject|2|||
49115798|NCT02168777|158262921|FG000|Overall Study|Adverse Event|1|||
49115799|NCT02168777|158262922|FG001|Overall Study|Adverse Event|0|||
49115800|NCT02168777|158262923|FG002|Overall Study|Adverse Event|1|||
49115801|NCT02168777|158262921|FG000|Overall Study|Disease recurrence|0|||
49115802|NCT02168777|158262922|FG001|Overall Study|Disease recurrence|0|||
49115803|NCT02168777|158262923|FG002|Overall Study|Disease recurrence|1|||
49115804|NCT02168777|158262921|FG000|Overall Study|Radiological disease progression|0|||
49115805|NCT02168777|158262922|FG001|Overall Study|Radiological disease progression|5|||
49115806|NCT02168777|158262923|FG002|Overall Study|Radiological disease progression|5|||
49115807|NCT02168777|158262921|FG000|Overall Study|Clinical disease progression|0|||
49115808|NCT02168777|158262922|FG001|Overall Study|Clinical disease progression|1|||
49115809|NCT02168777|158262923|FG002|Overall Study|Clinical disease progression|2|||
49115810|NCT02168777|158262921|FG000|Overall Study|Other reason|0|||
49115811|NCT02168777|158262922|FG001|Overall Study|Other reason|1|||
49115812|NCT02168777|158262923|FG002|Overall Study|Other reason|0|||
49115813|NCT00314808|158262928|FG000|Overall Study|Disease Progression without AE|4|||
49115814|NCT00314808|158262928|FG000|Overall Study|Withdrawal by Subject/PI without AE|4|||
49115815|NCT01698268|158262929|FG000|Overall Study|Physician Decision|2|||
49115816|NCT01698268|158262930|FG001|Overall Study|Physician Decision|1|||
49115817|NCT01342445|158262935|FG000|Overall Study|Experienced side effects|0|||
49115818|NCT01342445|158262936|FG001|Overall Study|Experienced side effects|2|||
49115819|NCT01709409|158262937|FG000|Overall Study|Protocol Violation|1|||
49115820|NCT01709409|158262938|FG001|Overall Study|Protocol Violation|0|||
49115821|NCT04676152|158262942|FG000|Overall Study|screen fail|9|||
49115849|NCT00759655|158262952|FG000|Overall Study|Termination of the study by sponsor|1|||
49115850|NCT03300050|158262971|FG000|Overall Study|Lost to Follow-up|2|||
49115851|NCT03300050|158262972|FG001|Overall Study|Lost to Follow-up|1|||
49115852|NCT03300050|158262973|FG002|Overall Study|Lost to Follow-up|0|||
49115853|NCT03300050|158262974|FG003|Overall Study|Lost to Follow-up|0|||
49115854|NCT03300050|158262975|FG004|Overall Study|Lost to Follow-up|1|||
49115855|NCT03300050|158262971|FG000|Overall Study|Withdrawal by Subject|1|||
49115856|NCT03300050|158262972|FG001|Overall Study|Withdrawal by Subject|1|||
49115857|NCT03300050|158262973|FG002|Overall Study|Withdrawal by Subject|1|||
49115858|NCT03300050|158262974|FG003|Overall Study|Withdrawal by Subject|0|||
49115859|NCT03300050|158262975|FG004|Overall Study|Withdrawal by Subject|0|||
49115860|NCT03300050|158262971|FG000|Overall Study|Death|0|||
49115861|NCT03300050|158262972|FG001|Overall Study|Death|0|||
49115862|NCT03300050|158262973|FG002|Overall Study|Death|1|||
49115863|NCT03300050|158262974|FG003|Overall Study|Death|0|||
49115864|NCT03300050|158262975|FG004|Overall Study|Death|0|||
49115865|NCT03300050|158262971|FG000|Overall Study|Not Eligible at Randomization|0|||
49115866|NCT03300050|158262972|FG001|Overall Study|Not Eligible at Randomization|0|||
49115867|NCT03300050|158262973|FG002|Overall Study|Not Eligible at Randomization|1|||
49115868|NCT03300050|158262974|FG003|Overall Study|Not Eligible at Randomization|1|||
49115869|NCT03300050|158262975|FG004|Overall Study|Not Eligible at Randomization|0|||
49115870|NCT02849171|158262976|FG000|Overall Study|Withdrawal by Subject|1|||
49115871|NCT02849171|158262976|FG000|Overall Study|Not treated|1|||
49115872|NCT02372383|158262977|FG000|First Intervention (1 Day)|Unable to collect blood|0|||
49115873|NCT02372383|158262978|FG001|First Intervention (1 Day)|Unable to collect blood|1|||
49115874|NCT02372383|158262979|FG002|First Intervention (1 Day)|Unable to collect blood|0|||
49115875|NCT02769312|158262980|FG000|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
49115876|NCT02769312|158262981|FG001|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
49115877|NCT02769312|158262980|FG000|Double-Blind (0-2 Weeks)|Adverse Event|1|||
49115878|NCT02769312|158262981|FG001|Double-Blind (0-2 Weeks)|Adverse Event|0|||
49115879|NCT02769312|158262980|FG000|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1|||
49115880|NCT02769312|158262981|FG001|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0|||
49115881|NCT02769312|158262980|FG000|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0|||
49115882|NCT02769312|158262981|FG001|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1|||
49115883|NCT02769312|158262980|FG000|Follow-up|Lost to Follow-up|1|||
49115884|NCT02769312|158262981|FG001|Follow-up|Lost to Follow-up|1|||
49115885|NCT02065518|158263003|FG000|Overall Study|Lost to Follow-up|3|||
49115886|NCT02065518|158263004|FG001|Overall Study|Lost to Follow-up|4|||
49115887|NCT02065518|158263005|FG002|Overall Study|Lost to Follow-up|0|||
49115888|NCT02065518|158263006|FG003|Overall Study|Lost to Follow-up|3|||
49115889|NCT02065518|158263003|FG000|Overall Study|Withdrawal by Subject|3|||
49115890|NCT02065518|158263004|FG001|Overall Study|Withdrawal by Subject|4|||
49115891|NCT02065518|158263005|FG002|Overall Study|Withdrawal by Subject|9|||
49115892|NCT02065518|158263006|FG003|Overall Study|Withdrawal by Subject|2|||
49115893|NCT00660595|158263007|FG000|Overall Study|Lost to Follow-up|0|||
49115894|NCT00660595|158263008|FG001|Overall Study|Lost to Follow-up|1|||
49115895|NCT00660595|158263007|FG000|Overall Study|Did not consent to participate in study|12|||
49115896|NCT00660595|158263008|FG001|Overall Study|Did not consent to participate in study|8|||
49115897|NCT00660595|158263007|FG000|Overall Study|Participant left hospital|1|||
49115898|NCT00660595|158263008|FG001|Overall Study|Participant left hospital|0|||
49115899|NCT00660595|158263007|FG000|Overall Study|Non Specified reasons|5|||
49115900|NCT00660595|158263008|FG001|Overall Study|Non Specified reasons|0|||
49115901|NCT04446429|158263010|FG000|Overall Study|Lost to Follow-up|6|||
49115902|NCT04446429|158263011|FG001|Overall Study|Lost to Follow-up|0|||
49115903|NCT02187861|158263012|FG000|Overall Study|Adverse Event|2|||
49115904|NCT02187861|158263013|FG001|Overall Study|Adverse Event|1|||
49115905|NCT02187861|158263014|FG002|Overall Study|Adverse Event|2|||
49115906|NCT02187861|158263015|FG003|Overall Study|Adverse Event|1|||
49115907|NCT02187861|158263012|FG000|Overall Study|Death|0|||
49115908|NCT02187861|158263013|FG001|Overall Study|Death|3|||
49115909|NCT02187861|158263014|FG002|Overall Study|Death|1|||
49115910|NCT02187861|158263015|FG003|Overall Study|Death|2|||
49115911|NCT02187861|158263012|FG000|Overall Study|Physician Decision|0|||
49115912|NCT02187861|158263013|FG001|Overall Study|Physician Decision|1|||
49115913|NCT02187861|158263014|FG002|Overall Study|Physician Decision|0|||
49115914|NCT02187861|158263015|FG003|Overall Study|Physician Decision|3|||
49115915|NCT02187861|158263012|FG000|Overall Study|Progressive Disease|4|||
49115916|NCT02187861|158263013|FG001|Overall Study|Progressive Disease|42|||
49115917|NCT02187861|158263014|FG002|Overall Study|Progressive Disease|19|||
49115918|NCT02187861|158263015|FG003|Overall Study|Progressive Disease|22|||
49115919|NCT02187861|158263012|FG000|Overall Study|Withdrawal by Subject|0|||
49115920|NCT02187861|158263013|FG001|Overall Study|Withdrawal by Subject|0|||
49115921|NCT02187861|158263014|FG002|Overall Study|Withdrawal by Subject|3|||
49115922|NCT02187861|158263015|FG003|Overall Study|Withdrawal by Subject|3|||
49115923|NCT02187861|158263012|FG000|Overall Study|Other|0|||
49115924|NCT02187861|158263013|FG001|Overall Study|Other|1|||
49115925|NCT02187861|158263014|FG002|Overall Study|Other|7|||
49115926|NCT02187861|158263015|FG003|Overall Study|Other|1|||
49115927|NCT01301079|158263018|FG000|Overall Study|Lost to Follow-up|2|||
49115928|NCT01301079|158263019|FG001|Overall Study|Lost to Follow-up|2|||
49115929|NCT00313586|158263020|FG000|Overall Study|Disease progression|14|||
49115930|NCT00313586|158263021|FG001|Overall Study|Disease progression|19|||
49115931|NCT00313586|158263022|FG002|Overall Study|Disease progression|10|||
49115932|NCT00313586|158263023|FG003|Overall Study|Disease progression|3|||
49115933|NCT00313586|158263020|FG000|Overall Study|Adverse Event|12|||
49115934|NCT00313586|158263021|FG001|Overall Study|Adverse Event|18|||
49115935|NCT00313586|158263022|FG002|Overall Study|Adverse Event|3|||
49115936|NCT00313586|158263023|FG003|Overall Study|Adverse Event|10|||
49115937|NCT00313586|158263020|FG000|Overall Study|Death|11|||
49115938|NCT00313586|158263021|FG001|Overall Study|Death|8|||
49115939|NCT00313586|158263022|FG002|Overall Study|Death|1|||
49115940|NCT00313586|158263023|FG003|Overall Study|Death|7|||
49115941|NCT00313586|158263020|FG000|Overall Study|Withdrawal by Subject|13|||
49115942|NCT00313586|158263021|FG001|Overall Study|Withdrawal by Subject|6|||
49115943|NCT00313586|158263022|FG002|Overall Study|Withdrawal by Subject|6|||
49115944|NCT00313586|158263023|FG003|Overall Study|Withdrawal by Subject|2|||
49115945|NCT00313586|158263020|FG000|Overall Study|Alternative therapy|3|||
49115946|NCT00313586|158263021|FG001|Overall Study|Alternative therapy|6|||
49115947|NCT00313586|158263022|FG002|Overall Study|Alternative therapy|2|||
49115948|NCT00313586|158263023|FG003|Overall Study|Alternative therapy|0|||
49115949|NCT00313586|158263020|FG000|Overall Study|Other complicating disease|2|||
49115950|NCT00313586|158263021|FG001|Overall Study|Other complicating disease|2|||
49115951|NCT00313586|158263022|FG002|Overall Study|Other complicating disease|0|||
49115952|NCT00313586|158263023|FG003|Overall Study|Other complicating disease|0|||
49115953|NCT00313586|158263020|FG000|Overall Study|Did not achieve HI-major/better response|10|||
49115954|NCT00313586|158263021|FG001|Overall Study|Did not achieve HI-major/better response|7|||
49115955|NCT00313586|158263022|FG002|Overall Study|Did not achieve HI-major/better response|2|||
49115956|NCT00313586|158263023|FG003|Overall Study|Did not achieve HI-major/better response|1|||
49115957|NCT00313586|158263020|FG000|Overall Study|Physician Decision|2|||
49115958|NCT00313586|158263021|FG001|Overall Study|Physician Decision|1|||
49115959|NCT00313586|158263022|FG002|Overall Study|Physician Decision|0|||
49115960|NCT00313586|158263023|FG003|Overall Study|Physician Decision|0|||
49115961|NCT00313586|158263020|FG000|Overall Study|Absolute neutrophil count not recovered|2|||
49115962|NCT00313586|158263021|FG001|Overall Study|Absolute neutrophil count not recovered|1|||
49115963|NCT00313586|158263022|FG002|Overall Study|Absolute neutrophil count not recovered|0|||
49115964|NCT00313586|158263023|FG003|Overall Study|Absolute neutrophil count not recovered|0|||
49115965|NCT00313586|158263020|FG000|Overall Study|Lost insurance|0|||
49115966|NCT00313586|158263021|FG001|Overall Study|Lost insurance|1|||
49115967|NCT00313586|158263022|FG002|Overall Study|Lost insurance|0|||
49115968|NCT00313586|158263023|FG003|Overall Study|Lost insurance|0|||
49115969|NCT00313586|158263020|FG000|Overall Study|Moved|0|||
49115970|NCT00313586|158263021|FG001|Overall Study|Moved|1|||
49115971|NCT00313586|158263022|FG002|Overall Study|Moved|0|||
49115972|NCT00313586|158263023|FG003|Overall Study|Moved|0|||
49115973|NCT00313586|158263020|FG000|Overall Study|Death before starting treatment|1|||
49115974|NCT00313586|158263021|FG001|Overall Study|Death before starting treatment|0|||
49115975|NCT00313586|158263022|FG002|Overall Study|Death before starting treatment|0|||
49115976|NCT00313586|158263023|FG003|Overall Study|Death before starting treatment|0|||
49115977|NCT00264290|158263024|FG000|Intervention (8 Weeks)|Adverse Event|1|||
49115978|NCT00264290|158263025|FG001|Intervention (8 Weeks)|Adverse Event|0|||
49115979|NCT04472494|158263026|FG000|Pre-treatment|Other reasons|2|||
49115980|NCT04472494|158263027|FG001|Pre-treatment|Other reasons|0|||
49115981|NCT04472494|158263026|FG000|Treatment|Death|5|||
49115982|NCT04472494|158263027|FG001|Treatment|Death|2|||
49115983|NCT04472494|158263026|FG000|Treatment|Hospital discharge|1|||
49115984|NCT04472494|158263027|FG001|Treatment|Hospital discharge|1|||
49115985|NCT00948922|158263029|FG000|Overall Study|Did not start study treatment|2|||
49115986|NCT00948922|158263030|FG001|Overall Study|Did not start study treatment|5|||
49115987|NCT00948922|158263031|FG002|Overall Study|Did not start study treatment|0|||
49115988|NCT00948922|158263029|FG000|Overall Study|Withdrawal by Subject|0|||
49115989|NCT00948922|158263030|FG001|Overall Study|Withdrawal by Subject|2|||
49115990|NCT00948922|158263031|FG002|Overall Study|Withdrawal by Subject|1|||
49115991|NCT00948922|158263029|FG000|Overall Study|Death|3|||
49115992|NCT00948922|158263030|FG001|Overall Study|Death|0|||
49115993|NCT00948922|158263031|FG002|Overall Study|Death|0|||
49115994|NCT00948922|158263029|FG000|Overall Study|Disease progression|0|||
49115995|NCT00948922|158263030|FG001|Overall Study|Disease progression|1|||
49115996|NCT00948922|158263031|FG002|Overall Study|Disease progression|0|||
49115997|NCT00948922|158263029|FG000|Overall Study|Insurance issues|1|||
49115998|NCT00948922|158263030|FG001|Overall Study|Insurance issues|0|||
49115999|NCT00948922|158263031|FG002|Overall Study|Insurance issues|0|||
49116000|NCT00948922|158263029|FG000|Overall Study|Transplant eligibility issues|2|||
49116001|NCT00948922|158263030|FG001|Overall Study|Transplant eligibility issues|3|||
49116002|NCT00948922|158263031|FG002|Overall Study|Transplant eligibility issues|0|||
49116003|NCT00948922|158263029|FG000|Overall Study|Not evaluable at time of analysis|0|||
49116004|NCT00948922|158263030|FG001|Overall Study|Not evaluable at time of analysis|3|||
49116005|NCT00948922|158263031|FG002|Overall Study|Not evaluable at time of analysis|0|||
49116006|NCT02784288|158263032|FG000|Overall Study|Patients neck dissection had spillage and therefore needed to come off protocol|1|||
49116007|NCT03334188|158263033|FG000|Overall Study|Withdrawal by Subject|0|||
49116008|NCT03334188|158263034|FG001|Overall Study|Withdrawal by Subject|1|||
49116009|NCT03334188|158263033|FG000|Overall Study|Death|1|||
49116010|NCT03334188|158263034|FG001|Overall Study|Death|0|||
49116011|NCT03334188|158263033|FG000|Overall Study|Never had qualifying clinic visit|7|||
49116012|NCT03334188|158263034|FG001|Overall Study|Never had qualifying clinic visit|7|||
49116013|NCT00645671|158263035|FG000|Overall Study|Protocol Violation|1|||
49116014|NCT00645671|158263036|FG001|Overall Study|Protocol Violation|0|||
49116015|NCT00645671|158263035|FG000|Overall Study|Withdrawal by Subject|0|||
49116016|NCT00645671|158263036|FG001|Overall Study|Withdrawal by Subject|4|||
49116017|NCT00645671|158263035|FG000|Overall Study|Adverse Event|0|||
49116018|NCT00645671|158263036|FG001|Overall Study|Adverse Event|1|||
49116019|NCT00645671|158263035|FG000|Overall Study|Physician Decision|0|||
49116020|NCT00645671|158263036|FG001|Overall Study|Physician Decision|1|||
49116021|NCT05114564|158263038|FG000|First Intervention|Vision with study contact lens subjectively unacceptable|1|||
49116022|NCT05114564|158263039|FG001|First Intervention|Vision with study contact lens subjectively unacceptable|0|||
49116023|NCT05114564|158263038|FG000|First Intervention|Adverse Event|0|||
49116024|NCT05114564|158263039|FG001|First Intervention|Adverse Event|1|||
49116025|NCT03117361|158263040|FG000|Overall Study|Progressive disease|5|||
49116026|NCT03117361|158263040|FG000|Overall Study|Death|1|||
49116027|NCT03117361|158263040|FG000|Overall Study|Physician Decision|2|||
49116028|NCT03117361|158263040|FG000|Overall Study|On study treatment at the end of study|1|||
49116029|NCT03117361|158263040|FG000|Overall Study|Treatment-related adverse event|1|||
49116030|NCT00790556|158263041|FG000|Treatment Period 1|Physician Decision|1|||
48693194|NCT04479787|156726366|FG000|After 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
49010510|NCT00408876|157875630|FG001|Overall Study|Physician Decision|0|||
49010511|NCT00408876|157875631|FG002|Overall Study|Physician Decision|3|||
49010512|NCT00408876|157875632|FG003|Overall Study|Physician Decision|0|||
48693195|NCT04479787|156726367|FG001|After 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
48693196|NCT04062448|156726374|FG000|Overall Study|Lost to Follow-up|1|||
48693197|NCT04062448|156726374|FG000|Overall Study|Withdrawal by Subject|2|||
48693200|NCT01038778|156726382|FG000|Overall Study|Withdrawal by Subject|0|||
48693201|NCT01038778|156726383|FG001|Overall Study|Withdrawal by Subject|2|||
48903804|NCT00604279|157484171|FG000|Overall Study|Adverse Event|4|||
48903805|NCT00604279|157484172|FG001|Overall Study|Adverse Event|5|||
48903806|NCT00604279|157484171|FG000|Overall Study|Other|8|||
48903807|NCT00604279|157484172|FG001|Overall Study|Other|4|||
48903808|NCT03442985|157484173|FG000|Overall Study|Sponsor Request|55|||
49116031|NCT00790556|158263042|FG001|Treatment Period 1|Physician Decision|0|||
49116032|NCT00790556|158263041|FG000|Treatment Period 1|Withdrawal by Subject|1|||
49116033|NCT00790556|158263042|FG001|Treatment Period 1|Withdrawal by Subject|0|||
49116034|NCT02020889|158263045|FG000|Overall Study|Adverse Event|0|||
49116035|NCT02020889|158263046|FG001|Overall Study|Adverse Event|1|||
49116036|NCT02020889|158263045|FG000|Overall Study|Lack of Efficacy|1|||
49116037|NCT02020889|158263046|FG001|Overall Study|Lack of Efficacy|0|||
49116038|NCT02020889|158263045|FG000|Overall Study|Lost to Follow-up|1|||
49116039|NCT02020889|158263046|FG001|Overall Study|Lost to Follow-up|0|||
49116040|NCT02020889|158263045|FG000|Overall Study|Physician Decision|2|||
49116041|NCT02020889|158263046|FG001|Overall Study|Physician Decision|0|||
49116042|NCT02020889|158263045|FG000|Overall Study|Withdrawal by Subject|3|||
49116043|NCT02020889|158263046|FG001|Overall Study|Withdrawal by Subject|2|||
49116044|NCT00809094|158263047|FG000|Overall Study|Lost to Follow-up|0|||
49116045|NCT00809094|158263048|FG001|Overall Study|Lost to Follow-up|1|||
49116046|NCT00272844|158263049|FG000|Overall Study|Withdrawal by Subject|5|||
49116047|NCT01509664|158263052|FG000|Overall Study|Lost to Follow-up|15|||
49116048|NCT01509664|158263053|FG001|Overall Study|Lost to Follow-up|21|||
49116049|NCT02869893|158263054|FG000|Overall Study|participant aversion to IV|5|||
49116050|NCT02869893|158263054|FG000|Overall Study|participant fear of MRI scanner|2|||
49116051|NCT03665077|158263057|FG000|Overall Study|Lost to Follow-up|2|||
49116052|NCT03665077|158263057|FG000|Overall Study|Physician Decision|2|||
49116053|NCT00435461|158263058|FG000|Overall Study|Visit changed to EarlyWithdrawn Visit|1|||
49116054|NCT00435461|158263059|FG001|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
49116055|NCT00435461|158263060|FG002|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
49116056|NCT00435461|158263058|FG000|Overall Study|Protocol Violation|6|||
49116057|NCT00435461|158263059|FG001|Overall Study|Protocol Violation|9|||
49116058|NCT00435461|158263060|FG002|Overall Study|Protocol Violation|10|||
49116059|NCT00435461|158263058|FG000|Overall Study|Participant randomized(inadequate score)|1|||
49116060|NCT00435461|158263059|FG001|Overall Study|Participant randomized(inadequate score)|0|||
49116061|NCT00435461|158263060|FG002|Overall Study|Participant randomized(inadequate score)|0|||
49116062|NCT00435461|158263058|FG000|Overall Study|Compliance less than 80 percent|1|||
49116063|NCT00435461|158263059|FG001|Overall Study|Compliance less than 80 percent|0|||
49116064|NCT00435461|158263060|FG002|Overall Study|Compliance less than 80 percent|0|||
49116065|NCT00435461|158263058|FG000|Overall Study|In error, two study medications switched|1|||
49116066|NCT00435461|158263059|FG001|Overall Study|In error, two study medications switched|0|||
49116067|NCT00435461|158263060|FG002|Overall Study|In error, two study medications switched|0|||
49116068|NCT00435461|158263058|FG000|Overall Study|Lack of Efficacy|2|||
49116069|NCT00435461|158263059|FG001|Overall Study|Lack of Efficacy|1|||
49116070|NCT00435461|158263060|FG002|Overall Study|Lack of Efficacy|0|||
49116071|NCT00435461|158263058|FG000|Overall Study|Withdrawal by Subject|1|||
49116072|NCT00435461|158263059|FG001|Overall Study|Withdrawal by Subject|0|||
49116073|NCT00435461|158263060|FG002|Overall Study|Withdrawal by Subject|2|||
49116074|NCT00435461|158263058|FG000|Overall Study|Randomized in error|1|||
49116075|NCT00435461|158263059|FG001|Overall Study|Randomized in error|0|||
49116076|NCT00435461|158263060|FG002|Overall Study|Randomized in error|0|||
49116077|NCT00435461|158263058|FG000|Overall Study|Participant could not tolerate symptoms|0|||
49116078|NCT00435461|158263059|FG001|Overall Study|Participant could not tolerate symptoms|0|||
49116079|NCT00435461|158263060|FG002|Overall Study|Participant could not tolerate symptoms|1|||
49116080|NCT00435461|158263058|FG000|Overall Study|Participant could not swallow capsule|0|||
49116081|NCT00435461|158263059|FG001|Overall Study|Participant could not swallow capsule|0|||
49116082|NCT00435461|158263060|FG002|Overall Study|Participant could not swallow capsule|1|||
49116083|NCT00435461|158263058|FG000|Overall Study|Pregnancy|2|||
49116084|NCT00435461|158263059|FG001|Overall Study|Pregnancy|0|||
49116085|NCT00435461|158263060|FG002|Overall Study|Pregnancy|0|||
49116086|NCT00435461|158263058|FG000|Overall Study|Participant moved eDiary,studymedication|1|||
49116087|NCT00435461|158263059|FG001|Overall Study|Participant moved eDiary,studymedication|0|||
49116088|NCT00435461|158263060|FG002|Overall Study|Participant moved eDiary,studymedication|0|||
49116089|NCT00435461|158263058|FG000|Overall Study|Participant ended study one day early|1|||
49116090|NCT00435461|158263059|FG001|Overall Study|Participant ended study one day early|0|||
49116091|NCT00435461|158263060|FG002|Overall Study|Participant ended study one day early|0|||
49116092|NCT00435461|158263058|FG000|Overall Study|Noncompliance with study requirements|1|||
49116093|NCT00435461|158263059|FG001|Overall Study|Noncompliance with study requirements|1|||
49116094|NCT00435461|158263060|FG002|Overall Study|Noncompliance with study requirements|1|||
48903809|NCT03442985|157484174|FG001|Overall Study|Sponsor Request|60|||
48903810|NCT03442985|157484175|FG002|Overall Study|Sponsor Request|54|||
48903811|NCT03442985|157484173|FG000|Overall Study|Lost to Follow-up|5|||
48903812|NCT03442985|157484174|FG001|Overall Study|Lost to Follow-up|2|||
48903813|NCT03442985|157484175|FG002|Overall Study|Lost to Follow-up|7|||
48903814|NCT03442985|157484173|FG000|Overall Study|Withdrawal by Subject|2|||
48903815|NCT03442985|157484174|FG001|Overall Study|Withdrawal by Subject|3|||
48903816|NCT03442985|157484175|FG002|Overall Study|Withdrawal by Subject|4|||
48903817|NCT03442985|157484173|FG000|Overall Study|Adverse Event|0|||
48903818|NCT03442985|157484174|FG001|Overall Study|Adverse Event|1|||
48903819|NCT03442985|157484175|FG002|Overall Study|Adverse Event|0|||
48903820|NCT03224325|157484178|FG000|Overall Study|Adverse Event|1|||
48903821|NCT03224325|157484179|FG001|Overall Study|Adverse Event|0|||
48903822|NCT03224325|157484180|FG002|Overall Study|Adverse Event|0|||
48903823|NCT03224325|157484181|FG003|Overall Study|Adverse Event|0|||
48903824|NCT03224325|157484182|FG004|Overall Study|Adverse Event|0|||
48903825|NCT03224325|157484183|FG005|Overall Study|Adverse Event|0|||
48693202|NCT01038778|156726384|FG002|Overall Study|Withdrawal by Subject|3|||
48693203|NCT03502707|156726386|FG000|Overall Study|Adverse Event|0|||
48693204|NCT03502707|156726387|FG001|Overall Study|Adverse Event|0|||
48693205|NCT03502707|156726388|FG002|Overall Study|Adverse Event|0|||
48693206|NCT03502707|156726389|FG003|Overall Study|Adverse Event|0|||
48693207|NCT03502707|156726390|FG004|Overall Study|Adverse Event|0|||
48693208|NCT03502707|156726391|FG005|Overall Study|Adverse Event|0|||
48693209|NCT03502707|156726392|FG006|Overall Study|Adverse Event|0|||
48693210|NCT03502707|156726393|FG007|Overall Study|Adverse Event|0|||
48903826|NCT03224325|157484184|FG006|Overall Study|Adverse Event|1|||
48903827|NCT03224325|157484178|FG000|Overall Study|Withdrawal by Subject|0|||
48693211|NCT03502707|156726394|FG008|Overall Study|Adverse Event|0|||
48903828|NCT03224325|157484179|FG001|Overall Study|Withdrawal by Subject|0|||
48903829|NCT03224325|157484180|FG002|Overall Study|Withdrawal by Subject|0|||
48903830|NCT03224325|157484181|FG003|Overall Study|Withdrawal by Subject|1|||
48903831|NCT03224325|157484182|FG004|Overall Study|Withdrawal by Subject|0|||
48903832|NCT03224325|157484183|FG005|Overall Study|Withdrawal by Subject|0|||
48903833|NCT03224325|157484184|FG006|Overall Study|Withdrawal by Subject|0|||
48903834|NCT02986334|157484185|FG000|Overall Study|Withdrawal by Subject|0|||
48903835|NCT02986334|157484186|FG001|Overall Study|Withdrawal by Subject|1|||
48903836|NCT02986334|157484187|FG002|Overall Study|Withdrawal by Subject|2|||
48903837|NCT02986334|157484185|FG000|Overall Study|Lost to Follow-up|1|||
48903838|NCT02986334|157484186|FG001|Overall Study|Lost to Follow-up|2|||
48903839|NCT02986334|157484187|FG002|Overall Study|Lost to Follow-up|1|||
48903840|NCT02986334|157484185|FG000|Overall Study|Adverse Event|0|||
48903841|NCT02986334|157484186|FG001|Overall Study|Adverse Event|2|||
48903842|NCT02986334|157484187|FG002|Overall Study|Adverse Event|1|||
48903843|NCT02986334|157484185|FG000|Overall Study|non compliance in phone ratings|2|||
48903844|NCT02986334|157484186|FG001|Overall Study|non compliance in phone ratings|1|||
48903845|NCT02986334|157484187|FG002|Overall Study|non compliance in phone ratings|2|||
48903846|NCT02986334|157484185|FG000|Overall Study|undisclosed comorbidities|0|||
48903847|NCT02986334|157484186|FG001|Overall Study|undisclosed comorbidities|1|||
48903848|NCT02986334|157484187|FG002|Overall Study|undisclosed comorbidities|1|||
48903849|NCT00120406|157484188|FG000|Overall Study|Death|9|||
48903850|NCT00120406|157484189|FG001|Overall Study|Death|4|||
48903851|NCT00120406|157484188|FG000|Overall Study|Withdrawal by Subject|5|||
48903852|NCT00120406|157484189|FG001|Overall Study|Withdrawal by Subject|7|||
48903853|NCT00120406|157484188|FG000|Overall Study|Lost to Follow-up|5|||
48903854|NCT00120406|157484189|FG001|Overall Study|Lost to Follow-up|2|||
48903855|NCT00120406|157484188|FG000|Overall Study|received non-study stent|0|||
48903856|NCT00120406|157484189|FG001|Overall Study|received non-study stent|2|||
48903857|NCT00120406|157484188|FG000|Overall Study|patient moved but has not withdrawn|0|||
48903858|NCT00120406|157484189|FG001|Overall Study|patient moved but has not withdrawn|1|||
48903859|NCT01177787|157484196|FG000|Cryolipolysis on Thigh|Protocol Violation|4|||
48903860|NCT01177787|157484196|FG000|Cryolipolysis on Thigh|Lack of Efficacy|9|||
48903861|NCT01177787|157484196|FG000|Cryolipolysis on Thigh|Lost to Follow-up|1|||
48903862|NCT02901041|157484197|FG000|Overall Study|Withdrawal by PI|4|||
48903863|NCT02901041|157484198|FG001|Overall Study|Withdrawal by PI|8|||
48903864|NCT02901041|157484197|FG000|Overall Study|Withdrawal by Subject|7|||
48903865|NCT02901041|157484198|FG001|Overall Study|Withdrawal by Subject|3|||
48903866|NCT01480674|157484199|FG000|Overall Study|Death|23|||
48903867|NCT01480674|157484199|FG000|Overall Study|Lost to Follow-up|2|||
48903868|NCT01480674|157484199|FG000|Overall Study|visit not done|10|||
48903869|NCT00975507|157484203|FG000|Overall Study|Adverse Event|1|||
48903870|NCT00975507|157484204|FG001|Overall Study|Adverse Event|0|||
48903871|NCT00975507|157484203|FG000|Overall Study|Lost to Follow-up|7|||
48903872|NCT00975507|157484204|FG001|Overall Study|Lost to Follow-up|1|||
48903873|NCT00975507|157484203|FG000|Overall Study|Protocol Violation|2|||
48903874|NCT00975507|157484204|FG001|Overall Study|Protocol Violation|0|||
48903875|NCT00975507|157484203|FG000|Overall Study|Withdrawal by Subject|10|||
48903876|NCT00975507|157484204|FG001|Overall Study|Withdrawal by Subject|3|||
48903877|NCT01174160|157484206|FG000|Overall Study|Adverse Event|1|||
48903878|NCT01174160|157484207|FG001|Overall Study|Adverse Event|0|||
48903879|NCT01174160|157484206|FG000|Overall Study|Lost to Follow-up|1|||
48903880|NCT01174160|157484207|FG001|Overall Study|Lost to Follow-up|0|||
48903881|NCT01174160|157484206|FG000|Overall Study|Physician Decision|1|||
48903882|NCT01174160|157484207|FG001|Overall Study|Physician Decision|0|||
48903883|NCT01174160|157484206|FG000|Overall Study|Protocol Violation|4|||
48903884|NCT01174160|157484207|FG001|Overall Study|Protocol Violation|6|||
49116095|NCT00435461|158263058|FG000|Overall Study|Adverse Event|1|||
48903885|NCT01174160|157484206|FG000|Overall Study|Withdrawal by Subject|1|||
48903886|NCT01174160|157484207|FG001|Overall Study|Withdrawal by Subject|0|||
48903887|NCT00795951|157484210|FG000|Overall Study|Lost to Follow-up|1|||
48903888|NCT00795951|157484210|FG000|Overall Study|Withdrawal by Subject|1|||
48903889|NCT01000636|157484211|FG000|Overall Study|Withdrawal by Subject|1|||
48903890|NCT01000636|157484211|FG000|Overall Study|Adverse Event|1|||
48903891|NCT01128738|157484212|FG000|First Treatment Phase (TP)|Lost to Follow-up|1|||
48903892|NCT01128738|157484213|FG001|First Treatment Phase (TP)|Lost to Follow-up|0|||
48903893|NCT01128738|157484212|FG000|First Treatment Phase (TP)|Withdrawal by Subject|3|||
48903894|NCT01128738|157484213|FG001|First Treatment Phase (TP)|Withdrawal by Subject|1|||
49116096|NCT00435461|158263059|FG001|Overall Study|Adverse Event|2|||
48903895|NCT01128738|157484212|FG000|Second TP|Lost to Follow-up|0|||
48903896|NCT01128738|157484213|FG001|Second TP|Lost to Follow-up|1|||
48903897|NCT01128738|157484212|FG000|Second TP|Withdrawal by Subject|0|||
48903898|NCT01128738|157484213|FG001|Second TP|Withdrawal by Subject|2|||
48903899|NCT01178671|157484214|FG000|Overall Study|Adverse Event|4|||
49116097|NCT00435461|158263060|FG002|Overall Study|Adverse Event|6|||
49116098|NCT00435461|158263058|FG000|Overall Study|Non-Compliance of diary|2|||
49116099|NCT00435461|158263059|FG001|Overall Study|Non-Compliance of diary|0|||
49116100|NCT00435461|158263060|FG002|Overall Study|Non-Compliance of diary|1|||
49116101|NCT00435461|158263058|FG000|Overall Study|Lost to Follow-up|1|||
49116102|NCT00435461|158263059|FG001|Overall Study|Lost to Follow-up|1|||
49116103|NCT00435461|158263060|FG002|Overall Study|Lost to Follow-up|2|||
49116104|NCT02697591|158263061|FG000|Overall Study|Lost to Follow-up|0|||
49116105|NCT02697591|158263062|FG001|Overall Study|Lost to Follow-up|0|||
49116106|NCT02697591|158263063|FG002|Overall Study|Lost to Follow-up|0|||
49116107|NCT02697591|158263064|FG003|Overall Study|Lost to Follow-up|0|||
49116108|NCT02697591|158263065|FG004|Overall Study|Lost to Follow-up|0|||
49116109|NCT02697591|158263066|FG005|Overall Study|Lost to Follow-up|1|||
49116110|NCT02697591|158263067|FG006|Overall Study|Lost to Follow-up|1|||
49116111|NCT02697591|158263068|FG007|Overall Study|Lost to Follow-up|0|||
49116112|NCT02697591|158263069|FG008|Overall Study|Lost to Follow-up|0|||
49116113|NCT02697591|158263070|FG009|Overall Study|Lost to Follow-up|1|||
49116114|NCT02697591|158263061|FG000|Overall Study|Withdrawal by Subject|1|||
49116115|NCT02697591|158263062|FG001|Overall Study|Withdrawal by Subject|1|||
49116116|NCT02697591|158263063|FG002|Overall Study|Withdrawal by Subject|2|||
49116117|NCT02697591|158263064|FG003|Overall Study|Withdrawal by Subject|1|||
49116118|NCT02697591|158263065|FG004|Overall Study|Withdrawal by Subject|7|||
49116119|NCT02697591|158263066|FG005|Overall Study|Withdrawal by Subject|6|||
49116120|NCT02697591|158263067|FG006|Overall Study|Withdrawal by Subject|9|||
49116121|NCT02697591|158263068|FG007|Overall Study|Withdrawal by Subject|1|||
49116122|NCT02697591|158263069|FG008|Overall Study|Withdrawal by Subject|6|||
49116123|NCT02697591|158263070|FG009|Overall Study|Withdrawal by Subject|10|||
49116124|NCT02697591|158263061|FG000|Overall Study|Physician Decision|1|||
49116125|NCT02697591|158263062|FG001|Overall Study|Physician Decision|0|||
49116126|NCT02697591|158263063|FG002|Overall Study|Physician Decision|0|||
49116127|NCT02697591|158263064|FG003|Overall Study|Physician Decision|0|||
49116128|NCT02697591|158263065|FG004|Overall Study|Physician Decision|1|||
49116129|NCT02697591|158263066|FG005|Overall Study|Physician Decision|2|||
49116130|NCT02697591|158263067|FG006|Overall Study|Physician Decision|0|||
49116131|NCT02697591|158263068|FG007|Overall Study|Physician Decision|0|||
49116132|NCT02697591|158263069|FG008|Overall Study|Physician Decision|1|||
49116133|NCT02697591|158263070|FG009|Overall Study|Physician Decision|1|||
49116134|NCT02697591|158263061|FG000|Overall Study|Death|2|||
49116135|NCT02697591|158263062|FG001|Overall Study|Death|3|||
49116136|NCT02697591|158263063|FG002|Overall Study|Death|1|||
49116137|NCT02697591|158263064|FG003|Overall Study|Death|1|||
49116138|NCT02697591|158263065|FG004|Overall Study|Death|4|||
48903900|NCT01178671|157484215|FG001|Overall Study|Adverse Event|6|||
48903901|NCT01178671|157484214|FG000|Overall Study|Protocol Violation|1|||
48903902|NCT01178671|157484215|FG001|Overall Study|Protocol Violation|1|||
48903903|NCT01178671|157484214|FG000|Overall Study|Lack of Efficacy|0|||
48903904|NCT01178671|157484215|FG001|Overall Study|Lack of Efficacy|1|||
48903905|NCT01178671|157484214|FG000|Overall Study|Lost to Follow-up|3|||
48903906|NCT01178671|157484215|FG001|Overall Study|Lost to Follow-up|1|||
48903907|NCT01178671|157484214|FG000|Overall Study|Physician Decision|4|||
48693212|NCT03502707|156726395|FG009|Overall Study|Adverse Event|0|||
48693213|NCT03502707|156726396|FG010|Overall Study|Adverse Event|0|||
48693214|NCT03502707|156726397|FG011|Overall Study|Adverse Event|0|||
48693215|NCT03502707|156726398|FG012|Overall Study|Adverse Event|0|||
48693216|NCT03502707|156726399|FG013|Overall Study|Adverse Event|0|||
48693217|NCT03502707|156726400|FG014|Overall Study|Adverse Event|0|||
48693218|NCT03502707|156726401|FG015|Overall Study|Adverse Event|1|||
48693219|NCT03502707|156726402|FG016|Overall Study|Adverse Event|5|||
48693220|NCT03502707|156726403|FG017|Overall Study|Adverse Event|0|||
48693221|NCT03502707|156726386|FG000|Overall Study|Death|0|||
48693222|NCT03502707|156726387|FG001|Overall Study|Death|0|||
48693223|NCT03502707|156726388|FG002|Overall Study|Death|0|||
48693224|NCT03502707|156726389|FG003|Overall Study|Death|1|||
48693225|NCT03502707|156726390|FG004|Overall Study|Death|0|||
48693226|NCT03502707|156726391|FG005|Overall Study|Death|0|||
48693227|NCT03502707|156726392|FG006|Overall Study|Death|0|||
48693228|NCT03502707|156726393|FG007|Overall Study|Death|0|||
48693229|NCT03502707|156726394|FG008|Overall Study|Death|1|||
48693230|NCT03502707|156726395|FG009|Overall Study|Death|1|||
48693231|NCT03502707|156726396|FG010|Overall Study|Death|0|||
48693232|NCT03502707|156726397|FG011|Overall Study|Death|0|||
48693233|NCT03502707|156726398|FG012|Overall Study|Death|1|||
48693234|NCT03502707|156726399|FG013|Overall Study|Death|0|||
48693235|NCT03502707|156726400|FG014|Overall Study|Death|0|||
48693236|NCT03502707|156726401|FG015|Overall Study|Death|1|||
48693237|NCT03502707|156726402|FG016|Overall Study|Death|0|||
48693238|NCT03502707|156726403|FG017|Overall Study|Death|0|||
48693239|NCT03502707|156726386|FG000|Overall Study|Lost to Follow-up|0|||
48693240|NCT03502707|156726387|FG001|Overall Study|Lost to Follow-up|0|||
48693241|NCT03502707|156726388|FG002|Overall Study|Lost to Follow-up|0|||
48693242|NCT03502707|156726389|FG003|Overall Study|Lost to Follow-up|0|||
48693243|NCT03502707|156726390|FG004|Overall Study|Lost to Follow-up|0|||
48693244|NCT03502707|156726391|FG005|Overall Study|Lost to Follow-up|0|||
48693245|NCT03502707|156726392|FG006|Overall Study|Lost to Follow-up|0|||
48693246|NCT03502707|156726393|FG007|Overall Study|Lost to Follow-up|5|||
48693247|NCT03502707|156726394|FG008|Overall Study|Lost to Follow-up|0|||
48693248|NCT03502707|156726395|FG009|Overall Study|Lost to Follow-up|2|||
48693249|NCT03502707|156726396|FG010|Overall Study|Lost to Follow-up|1|||
48693250|NCT03502707|156726397|FG011|Overall Study|Lost to Follow-up|2|||
48693251|NCT03502707|156726398|FG012|Overall Study|Lost to Follow-up|1|||
48693252|NCT03502707|156726399|FG013|Overall Study|Lost to Follow-up|1|||
48693253|NCT03502707|156726400|FG014|Overall Study|Lost to Follow-up|0|||
48693254|NCT03502707|156726401|FG015|Overall Study|Lost to Follow-up|4|||
48693255|NCT03502707|156726402|FG016|Overall Study|Lost to Follow-up|9|||
48693256|NCT03502707|156726403|FG017|Overall Study|Lost to Follow-up|2|||
48693257|NCT03502707|156726386|FG000|Overall Study|Physician Decision|0|||
48693258|NCT03502707|156726387|FG001|Overall Study|Physician Decision|0|||
48903908|NCT01178671|157484215|FG001|Overall Study|Physician Decision|6|||
49116139|NCT02697591|158263066|FG005|Overall Study|Death|5|||
49116140|NCT02697591|158263067|FG006|Overall Study|Death|3|||
49116141|NCT02697591|158263068|FG007|Overall Study|Death|1|||
49116142|NCT02697591|158263069|FG008|Overall Study|Death|1|||
49116143|NCT02697591|158263070|FG009|Overall Study|Death|5|||
49116144|NCT02697591|158263061|FG000|Overall Study|Reason not Specified|0|||
49116145|NCT02697591|158263062|FG001|Overall Study|Reason not Specified|0|||
49116146|NCT02697591|158263063|FG002|Overall Study|Reason not Specified|0|||
49116147|NCT02697591|158263064|FG003|Overall Study|Reason not Specified|1|||
49116148|NCT02697591|158263065|FG004|Overall Study|Reason not Specified|1|||
49116149|NCT02697591|158263066|FG005|Overall Study|Reason not Specified|2|||
49116150|NCT02697591|158263067|FG006|Overall Study|Reason not Specified|3|||
49116151|NCT02697591|158263068|FG007|Overall Study|Reason not Specified|1|||
49116152|NCT02697591|158263069|FG008|Overall Study|Reason not Specified|1|||
49116153|NCT02697591|158263070|FG009|Overall Study|Reason not Specified|3|||
49116154|NCT02609984|158263071|FG000|Overall Study|Death|29|||
49116155|NCT02609984|158263072|FG001|Overall Study|Death|26|||
49116156|NCT02609984|158263071|FG000|Overall Study|Participation Discontinued by Sponsor|12|||
49116157|NCT02609984|158263072|FG001|Overall Study|Participation Discontinued by Sponsor|10|||
49116158|NCT02609984|158263071|FG000|Overall Study|Lost to Follow-up|1|||
49116159|NCT02609984|158263072|FG001|Overall Study|Lost to Follow-up|2|||
49116160|NCT02609984|158263071|FG000|Overall Study|Withdrawal by Subject|0|||
49116161|NCT02609984|158263072|FG001|Overall Study|Withdrawal by Subject|1|||
49116162|NCT02609984|158263071|FG000|Overall Study|Disease Progression|2|||
49116163|NCT02609984|158263072|FG001|Overall Study|Disease Progression|0|||
49116164|NCT02080364|158263073|FG000|Baseline Period|Protocol Violation|2|||
48693259|NCT03502707|156726388|FG002|Overall Study|Physician Decision|0|||
48693260|NCT03502707|156726389|FG003|Overall Study|Physician Decision|0|||
48693261|NCT03502707|156726390|FG004|Overall Study|Physician Decision|0|||
48693262|NCT03502707|156726391|FG005|Overall Study|Physician Decision|0|||
48693263|NCT03502707|156726392|FG006|Overall Study|Physician Decision|0|||
48693264|NCT03502707|156726393|FG007|Overall Study|Physician Decision|0|||
48693265|NCT03502707|156726394|FG008|Overall Study|Physician Decision|2|||
48693266|NCT03502707|156726395|FG009|Overall Study|Physician Decision|1|||
48693267|NCT03502707|156726396|FG010|Overall Study|Physician Decision|0|||
48693268|NCT03502707|156726397|FG011|Overall Study|Physician Decision|0|||
48693269|NCT03502707|156726398|FG012|Overall Study|Physician Decision|0|||
48693270|NCT03502707|156726399|FG013|Overall Study|Physician Decision|0|||
48693271|NCT03502707|156726400|FG014|Overall Study|Physician Decision|1|||
48693272|NCT03502707|156726401|FG015|Overall Study|Physician Decision|3|||
48693273|NCT03502707|156726402|FG016|Overall Study|Physician Decision|0|||
48693274|NCT03502707|156726403|FG017|Overall Study|Physician Decision|0|||
48693275|NCT03502707|156726386|FG000|Overall Study|Protocol Violation|0|||
48693276|NCT03502707|156726387|FG001|Overall Study|Protocol Violation|0|||
48693277|NCT03502707|156726388|FG002|Overall Study|Protocol Violation|0|||
48693278|NCT03502707|156726389|FG003|Overall Study|Protocol Violation|0|||
48693279|NCT03502707|156726390|FG004|Overall Study|Protocol Violation|0|||
48693280|NCT03502707|156726391|FG005|Overall Study|Protocol Violation|0|||
48693281|NCT03502707|156726392|FG006|Overall Study|Protocol Violation|0|||
48693282|NCT03502707|156726393|FG007|Overall Study|Protocol Violation|0|||
48693283|NCT03502707|156726394|FG008|Overall Study|Protocol Violation|0|||
48693284|NCT03502707|156726395|FG009|Overall Study|Protocol Violation|0|||
48693285|NCT03502707|156726396|FG010|Overall Study|Protocol Violation|0|||
48693286|NCT03502707|156726397|FG011|Overall Study|Protocol Violation|0|||
48693287|NCT03502707|156726398|FG012|Overall Study|Protocol Violation|0|||
48693288|NCT03502707|156726399|FG013|Overall Study|Protocol Violation|0|||
48693289|NCT03502707|156726400|FG014|Overall Study|Protocol Violation|0|||
48693290|NCT03502707|156726401|FG015|Overall Study|Protocol Violation|1|||
48693291|NCT03502707|156726402|FG016|Overall Study|Protocol Violation|0|||
48693292|NCT03502707|156726403|FG017|Overall Study|Protocol Violation|0|||
48693293|NCT03502707|156726386|FG000|Overall Study|Withdrawal by Subject|1|||
48693294|NCT03502707|156726387|FG001|Overall Study|Withdrawal by Subject|1|||
48693295|NCT03502707|156726388|FG002|Overall Study|Withdrawal by Subject|0|||
48693296|NCT03502707|156726389|FG003|Overall Study|Withdrawal by Subject|0|||
48693297|NCT03502707|156726390|FG004|Overall Study|Withdrawal by Subject|0|||
48693298|NCT03502707|156726391|FG005|Overall Study|Withdrawal by Subject|2|||
48693299|NCT03502707|156726392|FG006|Overall Study|Withdrawal by Subject|0|||
48693300|NCT03502707|156726393|FG007|Overall Study|Withdrawal by Subject|3|||
48693301|NCT03502707|156726394|FG008|Overall Study|Withdrawal by Subject|1|||
48693302|NCT03502707|156726395|FG009|Overall Study|Withdrawal by Subject|2|||
48693303|NCT03502707|156726396|FG010|Overall Study|Withdrawal by Subject|12|||
48693304|NCT03502707|156726397|FG011|Overall Study|Withdrawal by Subject|23|||
48693305|NCT03502707|156726398|FG012|Overall Study|Withdrawal by Subject|5|||
48693306|NCT03502707|156726399|FG013|Overall Study|Withdrawal by Subject|3|||
48693307|NCT03502707|156726400|FG014|Overall Study|Withdrawal by Subject|3|||
48693308|NCT03502707|156726401|FG015|Overall Study|Withdrawal by Subject|43|||
48693309|NCT03502707|156726402|FG016|Overall Study|Withdrawal by Subject|44|||
48693310|NCT03502707|156726403|FG017|Overall Study|Withdrawal by Subject|18|||
48693311|NCT03502707|156726386|FG000|Overall Study|Sponsor's Decision|1|||
48693312|NCT03502707|156726387|FG001|Overall Study|Sponsor's Decision|0|||
48693313|NCT03502707|156726388|FG002|Overall Study|Sponsor's Decision|0|||
48693314|NCT03502707|156726389|FG003|Overall Study|Sponsor's Decision|0|||
48693315|NCT03502707|156726390|FG004|Overall Study|Sponsor's Decision|0|||
48693316|NCT03502707|156726391|FG005|Overall Study|Sponsor's Decision|0|||
48693317|NCT03502707|156726392|FG006|Overall Study|Sponsor's Decision|0|||
48693318|NCT03502707|156726393|FG007|Overall Study|Sponsor's Decision|0|||
48693319|NCT03502707|156726394|FG008|Overall Study|Sponsor's Decision|0|||
48693320|NCT03502707|156726395|FG009|Overall Study|Sponsor's Decision|1|||
48693321|NCT03502707|156726396|FG010|Overall Study|Sponsor's Decision|0|||
48903909|NCT02435966|157484216|FG000|Overall Study|Withdrawal by Subject|0|||
48903910|NCT02435966|157484217|FG001|Overall Study|Withdrawal by Subject|1|||
48903911|NCT02435966|157484218|FG002|Overall Study|Withdrawal by Subject|0|||
48693322|NCT03502707|156726397|FG011|Overall Study|Sponsor's Decision|0|||
48693323|NCT03502707|156726398|FG012|Overall Study|Sponsor's Decision|0|||
48693324|NCT03502707|156726399|FG013|Overall Study|Sponsor's Decision|0|||
48693325|NCT03502707|156726400|FG014|Overall Study|Sponsor's Decision|0|||
48693326|NCT03502707|156726401|FG015|Overall Study|Sponsor's Decision|2|||
48693327|NCT03502707|156726402|FG016|Overall Study|Sponsor's Decision|1|||
48693328|NCT03502707|156726403|FG017|Overall Study|Sponsor's Decision|0|||
48693329|NCT03502707|156726386|FG000|Overall Study|Initiated Prohibited Medication|0|||
48693330|NCT03502707|156726387|FG001|Overall Study|Initiated Prohibited Medication|0|||
48693331|NCT03502707|156726388|FG002|Overall Study|Initiated Prohibited Medication|0|||
48951820|NCT00950690|157654905|FG000|Overall Study|Adverse Event|15|||
48693332|NCT03502707|156726389|FG003|Overall Study|Initiated Prohibited Medication|0|||
48693333|NCT03502707|156726390|FG004|Overall Study|Initiated Prohibited Medication|0|||
48903912|NCT00973362|157484219|FG000|Baseline Evaluation|W/D, later determined to be ineligible|25|||
48903913|NCT00973362|157484220|FG001|Baseline Evaluation|W/D, later determined to be ineligible|0|||
48903914|NCT00973362|157484219|FG000|Baseline Evaluation|No colposcopy visit|62|||
48903915|NCT00973362|157484220|FG001|Baseline Evaluation|No colposcopy visit|0|||
48903916|NCT00973362|157484219|FG000|Baseline Evaluation|Inevaluable|686|||
48903917|NCT00973362|157484220|FG001|Baseline Evaluation|Inevaluable|223|||
48903918|NCT00973362|157484219|FG000|3-Year Follow-up|Lost to Follow-up|17|||
48693334|NCT03502707|156726391|FG005|Overall Study|Initiated Prohibited Medication|0|||
48693335|NCT03502707|156726392|FG006|Overall Study|Initiated Prohibited Medication|0|||
48693336|NCT03502707|156726393|FG007|Overall Study|Initiated Prohibited Medication|0|||
48693337|NCT03502707|156726394|FG008|Overall Study|Initiated Prohibited Medication|0|||
48693338|NCT03502707|156726395|FG009|Overall Study|Initiated Prohibited Medication|0|||
48693339|NCT03502707|156726396|FG010|Overall Study|Initiated Prohibited Medication|0|||
48693340|NCT03502707|156726397|FG011|Overall Study|Initiated Prohibited Medication|0|||
48693341|NCT03502707|156726398|FG012|Overall Study|Initiated Prohibited Medication|0|||
48693342|NCT03502707|156726399|FG013|Overall Study|Initiated Prohibited Medication|0|||
48693343|NCT03502707|156726400|FG014|Overall Study|Initiated Prohibited Medication|0|||
48693344|NCT03502707|156726401|FG015|Overall Study|Initiated Prohibited Medication|0|||
48693345|NCT03502707|156726402|FG016|Overall Study|Initiated Prohibited Medication|1|||
48693346|NCT03502707|156726403|FG017|Overall Study|Initiated Prohibited Medication|0|||
48693347|NCT03502707|156726386|FG000|Overall Study|Other|0|||
48693348|NCT03502707|156726387|FG001|Overall Study|Other|0|||
48693349|NCT03502707|156726388|FG002|Overall Study|Other|0|||
48693350|NCT03502707|156726389|FG003|Overall Study|Other|0|||
48693351|NCT03502707|156726390|FG004|Overall Study|Other|0|||
48693352|NCT03502707|156726391|FG005|Overall Study|Other|0|||
48693353|NCT03502707|156726392|FG006|Overall Study|Other|0|||
48693354|NCT03502707|156726393|FG007|Overall Study|Other|0|||
48693355|NCT03502707|156726394|FG008|Overall Study|Other|1|||
48693356|NCT03502707|156726395|FG009|Overall Study|Other|1|||
48693357|NCT03502707|156726396|FG010|Overall Study|Other|2|||
48693358|NCT03502707|156726397|FG011|Overall Study|Other|0|||
48693359|NCT03502707|156726398|FG012|Overall Study|Other|0|||
48693360|NCT03502707|156726399|FG013|Overall Study|Other|0|||
48693361|NCT03502707|156726400|FG014|Overall Study|Other|0|||
48693362|NCT03502707|156726401|FG015|Overall Study|Other|4|||
48693363|NCT03502707|156726402|FG016|Overall Study|Other|1|||
48693364|NCT03502707|156726403|FG017|Overall Study|Other|0|||
48693365|NCT03502707|156726386|FG000|Overall Study|Randomized but not vaccinated|0|||
48693366|NCT03502707|156726387|FG001|Overall Study|Randomized but not vaccinated|0|||
48693367|NCT03502707|156726388|FG002|Overall Study|Randomized but not vaccinated|0|||
48693368|NCT03502707|156726389|FG003|Overall Study|Randomized but not vaccinated|0|||
48693369|NCT03502707|156726390|FG004|Overall Study|Randomized but not vaccinated|0|||
48693370|NCT03502707|156726391|FG005|Overall Study|Randomized but not vaccinated|0|||
48693371|NCT03502707|156726392|FG006|Overall Study|Randomized but not vaccinated|0|||
48693372|NCT03502707|156726393|FG007|Overall Study|Randomized but not vaccinated|0|||
48693373|NCT03502707|156726394|FG008|Overall Study|Randomized but not vaccinated|0|||
48693374|NCT03502707|156726395|FG009|Overall Study|Randomized but not vaccinated|0|||
48693375|NCT03502707|156726396|FG010|Overall Study|Randomized but not vaccinated|0|||
48693376|NCT03502707|156726397|FG011|Overall Study|Randomized but not vaccinated|1|||
48693377|NCT03502707|156726398|FG012|Overall Study|Randomized but not vaccinated|0|||
48693378|NCT03502707|156726399|FG013|Overall Study|Randomized but not vaccinated|0|||
48693379|NCT03502707|156726400|FG014|Overall Study|Randomized but not vaccinated|0|||
48693380|NCT03502707|156726401|FG015|Overall Study|Randomized but not vaccinated|0|||
48693381|NCT03502707|156726402|FG016|Overall Study|Randomized but not vaccinated|0|||
48693382|NCT03502707|156726403|FG017|Overall Study|Randomized but not vaccinated|1|||
48693383|NCT01018030|156726409|FG000|Overall Study|Adverse Event|10|||
48693384|NCT01018030|156726410|FG001|Overall Study|Adverse Event|5|||
48693385|NCT01018030|156726411|FG002|Overall Study|Adverse Event|5|||
48693386|NCT01018030|156726409|FG000|Overall Study|Withdrawal by Subject|2|||
48693387|NCT01018030|156726410|FG001|Overall Study|Withdrawal by Subject|2|||
48693388|NCT01018030|156726411|FG002|Overall Study|Withdrawal by Subject|4|||
48693389|NCT01018030|156726409|FG000|Overall Study|Lost to Follow-up|2|||
48693390|NCT01018030|156726410|FG001|Overall Study|Lost to Follow-up|0|||
48693391|NCT01018030|156726411|FG002|Overall Study|Lost to Follow-up|3|||
48693392|NCT01018030|156726409|FG000|Overall Study|Protocol Violation|2|||
48693393|NCT01018030|156726410|FG001|Overall Study|Protocol Violation|1|||
48693394|NCT01018030|156726411|FG002|Overall Study|Protocol Violation|0|||
48693395|NCT01018030|156726409|FG000|Overall Study|Physician Decision|1|||
48693396|NCT01018030|156726410|FG001|Overall Study|Physician Decision|0|||
48693397|NCT01018030|156726411|FG002|Overall Study|Physician Decision|1|||
48693398|NCT01018030|156726409|FG000|Overall Study|Lack of Efficacy|1|||
48693399|NCT01018030|156726410|FG001|Overall Study|Lack of Efficacy|0|||
48693400|NCT01018030|156726411|FG002|Overall Study|Lack of Efficacy|0|||
48693401|NCT01018030|156726409|FG000|Overall Study|Did Not Receive Study Drug|1|||
48693402|NCT01018030|156726410|FG001|Overall Study|Did Not Receive Study Drug|3|||
48903919|NCT00973362|157484220|FG001|3-Year Follow-up|Lost to Follow-up|0|||
48903920|NCT01078675|157484221|FG000|Overall Study|Withdrawal by Subject|7|||
48903921|NCT01078675|157484222|FG001|Overall Study|Withdrawal by Subject|3|||
48903922|NCT01078675|157484221|FG000|Overall Study|Protocol Violation|56|||
48903923|NCT01078675|157484222|FG001|Overall Study|Protocol Violation|0|||
48903924|NCT01078675|157484221|FG000|Overall Study|Provided in CRF for specific reasons|2|||
48903925|NCT01078675|157484222|FG001|Overall Study|Provided in CRF for specific reasons|3|||
48903926|NCT01078675|157484221|FG000|Overall Study|Adverse Event|3|||
48903927|NCT01078675|157484222|FG001|Overall Study|Adverse Event|0|||
48903928|NCT01211197|157484223|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
48903929|NCT01211197|157484224|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
48903930|NCT01211197|157484225|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
48903931|NCT01211197|157484226|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
48903932|NCT01211197|157484227|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
48903933|NCT01211197|157484228|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
48903934|NCT01211197|157484223|FG000|Washout Period 2 (7 Days)|Adverse Event|1|||
48903935|NCT01211197|157484224|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
48903936|NCT01211197|157484225|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
48903937|NCT01211197|157484226|FG003|Washout Period 2 (7 Days)|Adverse Event|0|||
48903938|NCT01211197|157484227|FG004|Washout Period 2 (7 Days)|Adverse Event|0|||
48903939|NCT01211197|157484228|FG005|Washout Period 2 (7 Days)|Adverse Event|0|||
48903940|NCT00887679|157484229|FG000|Overall Study|Withdrawal by Subject|1|||
48903941|NCT00887679|157484229|FG000|Overall Study|Lost to Follow-up|4|||
48903942|NCT00887679|157484229|FG000|Overall Study|Physician Decision|5|||
48903943|NCT04223830|157484235|FG000|Overall Study|Lost to Follow-up|9|||
48903944|NCT04223830|157484235|FG000|Overall Study|Adverse Event|1|||
48903945|NCT02974088|157484239|FG000|Overall Study|Lost to Follow-up|0|||
48903946|NCT02974088|157484240|FG001|Overall Study|Lost to Follow-up|2|||
48903947|NCT02974088|157484239|FG000|Overall Study|Adverse Event|0|||
48903948|NCT02974088|157484240|FG001|Overall Study|Adverse Event|1|||
48903949|NCT01776424|157484241|FG000|Antithrombotic Part (Double Blind)|Lost to Follow-up|10|||
48903950|NCT01776424|157484242|FG001|Antithrombotic Part (Double Blind)|Lost to Follow-up|8|||
48903951|NCT01776424|157484243|FG002|Antithrombotic Part (Double Blind)|Lost to Follow-up|9|||
48903952|NCT01776424|157484241|FG000|Antithrombotic Part (Double Blind)|Withdrawal by Subject|10|||
48903953|NCT01776424|157484242|FG001|Antithrombotic Part (Double Blind)|Withdrawal by Subject|11|||
48903954|NCT01776424|157484243|FG002|Antithrombotic Part (Double Blind)|Withdrawal by Subject|15|||
48903955|NCT01776424|157484241|FG000|LTOLE Part (Open Label)|Lost to Follow-up|6|||
48903956|NCT01776424|157484242|FG001|LTOLE Part (Open Label)|Lost to Follow-up|2|||
48903957|NCT01776424|157484243|FG002|LTOLE Part (Open Label)|Lost to Follow-up|5|||
48903958|NCT01776424|157484241|FG000|LTOLE Part (Open Label)|Refused|5|||
48903959|NCT01776424|157484242|FG001|LTOLE Part (Open Label)|Refused|2|||
48903960|NCT01776424|157484243|FG002|LTOLE Part (Open Label)|Refused|11|||
48903961|NCT01776424|157484241|FG000|LTOLE Part (Open Label)|Missing final visit|68|||
48903962|NCT01776424|157484242|FG001|LTOLE Part (Open Label)|Missing final visit|58|||
48903963|NCT01776424|157484243|FG002|LTOLE Part (Open Label)|Missing final visit|62|||
48903964|NCT00559585|157484244|FG000|Double Blind ST Period Main Study|Adverse Event|17|||
48903965|NCT00559585|157484245|FG001|Double Blind ST Period Main Study|Adverse Event|25|||
48903966|NCT00559585|157484244|FG000|Double Blind ST Period Main Study|Withdrawal by Subject|11|||
48693403|NCT01018030|156726411|FG002|Overall Study|Did Not Receive Study Drug|0|||
48693404|NCT00097500|156726412|FG000|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
48693405|NCT00097500|156726413|FG001|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
48693406|NCT00097500|156726412|FG000|On-drug Period (Week 0 to Week 52)|Adverse Event|5|||
48693407|NCT00097500|156726413|FG001|On-drug Period (Week 0 to Week 52)|Adverse Event|0|||
48693408|NCT00097500|156726412|FG000|On-drug Period (Week 0 to Week 52)|Physician Decision|0|||
48693409|NCT00097500|156726413|FG001|On-drug Period (Week 0 to Week 52)|Physician Decision|1|||
48693410|NCT00097500|156726412|FG000|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0|||
48693411|NCT00097500|156726413|FG001|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1|||
48693412|NCT00097500|156726412|FG000|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2|||
48693413|NCT00097500|156726413|FG001|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1|||
48693414|NCT00097500|156726412|FG000|Off-drug Period (Week 52 to Week 64)|Physician Decision|0|||
48693415|NCT00097500|156726413|FG001|Off-drug Period (Week 52 to Week 64)|Physician Decision|1|||
48693416|NCT00097500|156726412|FG000|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3|||
48693417|NCT00097500|156726413|FG001|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2|||
48693418|NCT01600885|156726422|FG000|First Period|Adverse Event|1|||
48693419|NCT01600885|156726423|FG001|First Period|Adverse Event|1|||
48693420|NCT01600885|156726422|FG000|First Period|moved out of area|1|||
48693421|NCT01600885|156726423|FG001|First Period|moved out of area|0|||
48693422|NCT02399215|156726424|FG000|Overall Study|bowel obstruction (unrelated to dis-ease)|1|||
48693423|NCT02399215|156726424|FG000|Overall Study|Withdrawal by Subject|1|||
48693424|NCT03617172|156726425|FG000|Overall Study|Lost to Follow-up|1|||
48903967|NCT00559585|157484245|FG001|Double Blind ST Period Main Study|Withdrawal by Subject|5|||
48903968|NCT00559585|157484244|FG000|Double Blind ST Period Main Study|Lost to Follow-up|0|||
48903969|NCT00559585|157484245|FG001|Double Blind ST Period Main Study|Lost to Follow-up|6|||
48903970|NCT00559585|157484244|FG000|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1|||
48903971|NCT00559585|157484245|FG001|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0|||
48903972|NCT00559585|157484244|FG000|Double Blind ST Period Main Study|Death|1|||
48903973|NCT00559585|157484245|FG001|Double Blind ST Period Main Study|Death|1|||
48903974|NCT00559585|157484244|FG000|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2|||
48903975|NCT00559585|157484245|FG001|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1|||
48903976|NCT00559585|157484244|FG000|Double Blind ST Period Main Study|Lack of Efficacy|6|||
48903977|NCT00559585|157484245|FG001|Double Blind ST Period Main Study|Lack of Efficacy|1|||
48903978|NCT00559585|157484244|FG000|Double Blind ST Period Main Study|Poor/Non-Compliance|3|||
48903979|NCT00559585|157484245|FG001|Double Blind ST Period Main Study|Poor/Non-Compliance|0|||
48903980|NCT00559585|157484244|FG000|Double Blind ST Period Main Study|Missed Doses|0|||
48903981|NCT00559585|157484245|FG001|Double Blind ST Period Main Study|Missed Doses|1|||
48903982|NCT00559585|157484244|FG000|Double Blind ST Period Main Study|Incomplete Breast Exam|0|||
48903983|NCT00559585|157484245|FG001|Double Blind ST Period Main Study|Incomplete Breast Exam|1|||
48903984|NCT00559585|157484244|FG000|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0|||
48903985|NCT00559585|157484245|FG001|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1|||
48903986|NCT00559585|157484244|FG000|Double Blind ST Period Main Study|Early Discontinuation|0|||
48693425|NCT03617172|156726426|FG001|Overall Study|Lost to Follow-up|0|||
48693426|NCT00001832|156726427|FG000|Apheresis Period|not able to manufacture treatment cells|60|||
48693427|NCT00001832|156726428|FG001|Apheresis Period|not able to manufacture treatment cells|0|||
48693428|NCT00001832|156726429|FG002|Apheresis Period|not able to manufacture treatment cells|0|||
48693429|NCT00001832|156726430|FG003|Apheresis Period|not able to manufacture treatment cells|0|||
48693430|NCT00001832|156726431|FG004|Apheresis Period|not able to manufacture treatment cells|0|||
48693431|NCT00001832|156726432|FG005|Apheresis Period|not able to manufacture treatment cells|0|||
48693432|NCT00001832|156726433|FG006|Apheresis Period|not able to manufacture treatment cells|0|||
48693433|NCT00001832|156726434|FG007|Apheresis Period|not able to manufacture treatment cells|0|||
48693434|NCT00001832|156726435|FG008|Apheresis Period|not able to manufacture treatment cells|0|||
48693435|NCT00001832|156726436|FG009|Apheresis Period|not able to manufacture treatment cells|0|||
48693436|NCT00001832|156726437|FG010|Apheresis Period|not able to manufacture treatment cells|0|||
48693437|NCT00001832|156726438|FG011|Apheresis Period|not able to manufacture treatment cells|0|||
48693438|NCT00001832|156726439|FG012|Apheresis Period|not able to manufacture treatment cells|0|||
48693439|NCT00001832|156726440|FG013|Apheresis Period|not able to manufacture treatment cells|0|||
48693440|NCT00001832|156726441|FG014|Apheresis Period|not able to manufacture treatment cells|0|||
48693441|NCT00001832|156726427|FG000|Treatment Period|Death during treatment|0|||
48693442|NCT00001832|156726428|FG001|Treatment Period|Death during treatment|0|||
48693443|NCT00001832|156726429|FG002|Treatment Period|Death during treatment|0|||
48693444|NCT00001832|156726430|FG003|Treatment Period|Death during treatment|0|||
48693445|NCT00001832|156726431|FG004|Treatment Period|Death during treatment|0|||
48903987|NCT00559585|157484245|FG001|Double Blind ST Period Main Study|Early Discontinuation|1|||
48903988|NCT00559585|157484244|FG000|Double Blind ST Period Main Study|Participant Weight Gain|1|||
48693446|NCT00001832|156726432|FG005|Treatment Period|Death during treatment|1|||
48693447|NCT00001832|156726433|FG006|Treatment Period|Death during treatment|0|||
48693448|NCT00001832|156726434|FG007|Treatment Period|Death during treatment|0|||
48693449|NCT00001832|156726435|FG008|Treatment Period|Death during treatment|0|||
48903989|NCT00559585|157484245|FG001|Double Blind ST Period Main Study|Participant Weight Gain|0|||
48903990|NCT00559585|157484244|FG000|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0|||
48903991|NCT00559585|157484245|FG001|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1|||
48903992|NCT00559585|157484244|FG000|Double Blind ST Period Main Study|Investigator Decision|0|||
48903993|NCT00559585|157484245|FG001|Double Blind ST Period Main Study|Investigator Decision|1|||
48903994|NCT00559585|157484244|FG000|Double Blind ST Period Main Study|Ongoing Infection Risk|1|||
48903995|NCT00559585|157484245|FG001|Double Blind ST Period Main Study|Ongoing Infection Risk|0|||
48903996|NCT00559585|157484244|FG000|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
48903997|NCT00559585|157484245|FG001|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
48903998|NCT00559585|157484244|FG000|Open Label LT Period Main + Sub-Study|Adverse Event|100|||
48903999|NCT00559585|157484245|FG001|Open Label LT Period Main + Sub-Study|Adverse Event|0|||
48904000|NCT00559585|157484244|FG000|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81|||
48693450|NCT00001832|156726436|FG009|Treatment Period|Death during treatment|0|||
48693451|NCT00001832|156726437|FG010|Treatment Period|Death during treatment|0|||
48693452|NCT00001832|156726438|FG011|Treatment Period|Death during treatment|0|||
48693453|NCT00001832|156726439|FG012|Treatment Period|Death during treatment|0|||
48693454|NCT00001832|156726440|FG013|Treatment Period|Death during treatment|0|||
48693455|NCT00001832|156726441|FG014|Treatment Period|Death during treatment|0|||
48904001|NCT00559585|157484245|FG001|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0|||
48693456|NCT00001832|156726427|FG000|Treatment Period|Not treated|0|||
48693457|NCT00001832|156726428|FG001|Treatment Period|Not treated|0|||
48693458|NCT00001832|156726429|FG002|Treatment Period|Not treated|0|||
48693459|NCT00001832|156726430|FG003|Treatment Period|Not treated|0|||
48904002|NCT00559585|157484244|FG000|Open Label LT Period Main + Sub-Study|Pregnancy|16|||
48904003|NCT00559585|157484245|FG001|Open Label LT Period Main + Sub-Study|Pregnancy|0|||
48904004|NCT00559585|157484244|FG000|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32|||
48904005|NCT00559585|157484245|FG001|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0|||
48904006|NCT00559585|157484244|FG000|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9|||
48904007|NCT00559585|157484245|FG001|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0|||
48904008|NCT00559585|157484244|FG000|Open Label LT Period Main + Sub-Study|Death|20|||
48904009|NCT00559585|157484245|FG001|Open Label LT Period Main + Sub-Study|Death|0|||
48904010|NCT00559585|157484244|FG000|Open Label LT Period Main + Sub-Study|No longer met criteria|1|||
48904011|NCT00559585|157484245|FG001|Open Label LT Period Main + Sub-Study|No longer met criteria|0|||
48904012|NCT00559585|157484244|FG000|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89|||
48904013|NCT00559585|157484245|FG001|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0|||
48904014|NCT00559585|157484244|FG000|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8|||
48904015|NCT00559585|157484245|FG001|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0|||
48904016|NCT00559585|157484244|FG000|Open Label LT Period Main + Sub-Study|non-specified|71|||
48904017|NCT00559585|157484245|FG001|Open Label LT Period Main + Sub-Study|non-specified|0|||
48904018|NCT00559585|157484244|FG000|Open Label LT Period Main + Sub-Study|no end of study status page|1|||
48904019|NCT00559585|157484245|FG001|Open Label LT Period Main + Sub-Study|no end of study status page|0|||
48904020|NCT04209621|157484246|FG000|Overall Study|Death|1|||
48904021|NCT04209621|157484246|FG000|Overall Study|Study Terminated Early|2|||
48904022|NCT02465463|157484248|FG000|Overall Study|Lost to Follow-up|2|||
48904023|NCT02465463|157484249|FG001|Overall Study|Lost to Follow-up|1|||
48904024|NCT02465463|157484248|FG000|Overall Study|Death|1|||
48904025|NCT02465463|157484249|FG001|Overall Study|Death|0|||
48904026|NCT02465463|157484248|FG000|Overall Study|Protocol Violation|1|||
48904027|NCT02465463|157484249|FG001|Overall Study|Protocol Violation|0|||
48904028|NCT01630434|157484252|FG000|Overall Study|Donor lungs turned down|1|||
48904029|NCT01630434|157484253|FG001|Overall Study|Donor lungs turned down|0|||
48904030|NCT01630434|157484252|FG000|Overall Study|Protocol Violation|9|||
48904031|NCT01630434|157484253|FG001|Overall Study|Protocol Violation|4|||
48904032|NCT01630434|157484252|FG000|Overall Study|Death|20|||
48904033|NCT01630434|157484253|FG001|Overall Study|Death|26|||
48904034|NCT01026454|157484256|FG000|Second Intervention|Pregnancy|1|||
48904035|NCT01026454|157484257|FG001|Second Intervention|Pregnancy|1|||
48904036|NCT03740997|157484258|FG000|Overall Study|Withdrawal by Subject|1|||
48904037|NCT03740997|157484259|FG001|Overall Study|Withdrawal by Subject|0|||
48904038|NCT03740997|157484258|FG000|Overall Study|Participant was unable to complete study procedures|1|||
48904039|NCT03740997|157484259|FG001|Overall Study|Participant was unable to complete study procedures|0|||
48904040|NCT01975428|157484266|FG000|Overall Study|Lost to Follow-up|17|||
48904041|NCT01975428|157484267|FG001|Overall Study|Lost to Follow-up|4|||
48904042|NCT01975428|157484266|FG000|Overall Study|Withdrawal by Subject|3|||
48904043|NCT01975428|157484267|FG001|Overall Study|Withdrawal by Subject|10|||
48904044|NCT02804178|157484269|FG000|Overall Study|Adverse Event|1|||
48904045|NCT03370471|157484279|FG000|Overall Study|Withdrawal by Subject|6|||
48904046|NCT03370471|157484280|FG001|Overall Study|Withdrawal by Subject|1|||
48904047|NCT03370471|157484279|FG000|Overall Study|Unable to access veins for blood draw|0|||
48904048|NCT03370471|157484280|FG001|Overall Study|Unable to access veins for blood draw|1|||
48904049|NCT03370471|157484279|FG000|Overall Study|Screen fail|1|||
48904050|NCT03370471|157484280|FG001|Overall Study|Screen fail|0|||
48904051|NCT01765179|157484281|FG000|Overall Study|Adverse Event|3|||
48904052|NCT01765179|157484281|FG000|Overall Study|Lost to Follow-up|5|||
48904053|NCT01765179|157484281|FG000|Overall Study|Non-compliance with study drug|2|||
48904054|NCT01765179|157484281|FG000|Overall Study|Protocol Violation|1|||
48904055|NCT01765179|157484281|FG000|Overall Study|Withdrawal by Subject|8|||
48904056|NCT01765179|157484281|FG000|Overall Study|Hematocrit >54%|3|||
48904057|NCT01765179|157484281|FG000|Overall Study|prohibited med|1|||
48904058|NCT01765179|157484281|FG000|Overall Study|Out of country unable to finish study|1|||
48904059|NCT01765179|157484281|FG000|Overall Study|lack of venous access|1|||
48693460|NCT00001832|156726431|FG004|Treatment Period|Not treated|0|||
48693461|NCT00001832|156726432|FG005|Treatment Period|Not treated|0|||
48693462|NCT00001832|156726433|FG006|Treatment Period|Not treated|0|||
48693463|NCT00001832|156726434|FG007|Treatment Period|Not treated|1|||
48693464|NCT00001832|156726435|FG008|Treatment Period|Not treated|0|||
48693465|NCT00001832|156726436|FG009|Treatment Period|Not treated|0|||
48693466|NCT00001832|156726437|FG010|Treatment Period|Not treated|0|||
48693467|NCT00001832|156726438|FG011|Treatment Period|Not treated|0|||
48693468|NCT00001832|156726439|FG012|Treatment Period|Not treated|0|||
48693469|NCT00001832|156726440|FG013|Treatment Period|Not treated|0|||
48693470|NCT00001832|156726441|FG014|Treatment Period|Not treated|0|||
48693471|NCT01785719|156726442|FG000|4-week Baseline Evaluation|Physician Decision|1|||
48904060|NCT01765179|157484281|FG000|Overall Study|work conflict|1|||
48904061|NCT01765179|157484281|FG000|Overall Study|Ca elevated 10.6|1|||
48904062|NCT01699789|157484288|FG000|Overall Study|Withdrawal by Subject|18|||
48904063|NCT01699789|157484289|FG001|Overall Study|Withdrawal by Subject|23|||
48904064|NCT01699789|157484288|FG000|Overall Study|Death|1|||
48904065|NCT01699789|157484289|FG001|Overall Study|Death|2|||
48904066|NCT01699789|157484288|FG000|Overall Study|Lost to Follow-up|83|||
48904067|NCT01699789|157484289|FG001|Overall Study|Lost to Follow-up|101|||
48904068|NCT02411578|157484290|FG000|Crossover Trial Phase|Pregnancy|0|||
48904069|NCT02411578|157484291|FG001|Crossover Trial Phase|Pregnancy|1|||
48904070|NCT05266586|157484292|FG000|Overall Study|Adverse Event|2|||
48693472|NCT01785719|156726443|FG001|4-week Baseline Evaluation|Physician Decision|0|||
48693473|NCT01785719|156726442|FG000|4-week Baseline Evaluation|Withdrawal by Subject|1|||
48693474|NCT01785719|156726443|FG001|4-week Baseline Evaluation|Withdrawal by Subject|2|||
48693475|NCT01785719|156726442|FG000|4-week Baseline Evaluation|Lost to Follow-up|0|||
48693476|NCT01785719|156726443|FG001|4-week Baseline Evaluation|Lost to Follow-up|1|||
48693477|NCT01785719|156726442|FG000|4-week Baseline Evaluation|Pregnancy|0|||
48693478|NCT01785719|156726443|FG001|4-week Baseline Evaluation|Pregnancy|2|||
48693479|NCT01785719|156726442|FG000|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|4|||
48693480|NCT01785719|156726443|FG001|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|8|||
48904071|NCT05266586|157484293|FG001|Overall Study|Adverse Event|2|||
48904072|NCT05266586|157484294|FG002|Overall Study|Adverse Event|1|||
48904073|NCT05266586|157484292|FG000|Overall Study|Withdrawal by Subject|1|||
48904074|NCT05266586|157484293|FG001|Overall Study|Withdrawal by Subject|0|||
48904075|NCT05266586|157484294|FG002|Overall Study|Withdrawal by Subject|1|||
48904076|NCT05266586|157484292|FG000|Overall Study|Non-compliance with study drug|0|||
48904077|NCT05266586|157484293|FG001|Overall Study|Non-compliance with study drug|1|||
48904078|NCT05266586|157484294|FG002|Overall Study|Non-compliance with study drug|0|||
48904079|NCT05266586|157484292|FG000|Overall Study|Subject unable to adhere to all protocol requirements|1|||
48904080|NCT05266586|157484293|FG001|Overall Study|Subject unable to adhere to all protocol requirements|0|||
48904081|NCT05266586|157484294|FG002|Overall Study|Subject unable to adhere to all protocol requirements|0|||
48693481|NCT01785719|156726442|FG000|4-week Baseline Evaluation|Exclusionary medication|2|||
48693482|NCT01785719|156726443|FG001|4-week Baseline Evaluation|Exclusionary medication|0|||
48693483|NCT01785719|156726442|FG000|Hypocaloric Dietary Intervention|Adverse Event|1|||
48693484|NCT01785719|156726443|FG001|Hypocaloric Dietary Intervention|Adverse Event|0|||
48693485|NCT01785719|156726442|FG000|Hypocaloric Dietary Intervention|Physician Decision|1|||
48904082|NCT02244996|157484295|FG000|Overall Study|Lack of Efficacy|2|||
48693486|NCT01785719|156726443|FG001|Hypocaloric Dietary Intervention|Physician Decision|0|||
48693487|NCT01785719|156726442|FG000|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|1|||
48904083|NCT02244996|157484296|FG001|Overall Study|Lack of Efficacy|6|||
48693488|NCT01785719|156726443|FG001|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|2|||
48693489|NCT01785719|156726442|FG000|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|1|||
48904084|NCT04051827|157484297|FG000|Overall Study|Death|1|||
48904085|NCT04051827|157484297|FG000|Overall Study|Withdrawal by Subject|4|||
48904086|NCT04051827|157484297|FG000|Overall Study|Progressive disease|16|||
48904087|NCT04051827|157484297|FG000|Overall Study|Physician Decision|1|||
48904088|NCT04051827|157484297|FG000|Overall Study|Other|4|||
48904089|NCT02038920|157484299|FG000|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3|||
48904090|NCT02038920|157484300|FG001|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11|||
48904091|NCT02038920|157484301|FG002|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
48904092|NCT02038920|157484302|FG003|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
48904093|NCT02038920|157484303|FG004|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
48904094|NCT02038920|157484304|FG005|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
48904095|NCT02038920|157484299|FG000|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2|||
48904096|NCT02038920|157484300|FG001|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
48904097|NCT02038920|157484301|FG002|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
48904098|NCT02038920|157484302|FG003|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
48904099|NCT02038920|157484303|FG004|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
48904100|NCT02038920|157484304|FG005|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
48904101|NCT02038920|157484299|FG000|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
48904102|NCT02038920|157484300|FG001|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
48904103|NCT02038920|157484301|FG002|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
48904104|NCT02038920|157484302|FG003|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
48904105|NCT02038920|157484303|FG004|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
48904106|NCT02038920|157484304|FG005|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
48904107|NCT02038920|157484299|FG000|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
48904108|NCT02038920|157484300|FG001|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
48904109|NCT02038920|157484301|FG002|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
48904110|NCT02038920|157484302|FG003|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4|||
48904111|NCT02038920|157484303|FG004|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
48904112|NCT02038920|157484304|FG005|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
48904113|NCT02038920|157484299|FG000|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
48904114|NCT02038920|157484300|FG001|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
48904115|NCT02038920|157484301|FG002|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1|||
48904116|NCT02038920|157484302|FG003|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
48904117|NCT02038920|157484303|FG004|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
48904118|NCT02038920|157484304|FG005|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
48904119|NCT02038920|157484299|FG000|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
48904120|NCT02038920|157484300|FG001|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
48904121|NCT02038920|157484301|FG002|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2|||
48904122|NCT02038920|157484302|FG003|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4|||
48904123|NCT02038920|157484303|FG004|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10|||
48904124|NCT02038920|157484304|FG005|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
48904125|NCT02038920|157484299|FG000|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
48904126|NCT02038920|157484300|FG001|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
48904127|NCT02038920|157484301|FG002|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
48904128|NCT02038920|157484302|FG003|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
48904129|NCT02038920|157484303|FG004|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
48904130|NCT02038920|157484304|FG005|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43|||
48904131|NCT02038920|157484299|FG000|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
48904132|NCT02038920|157484300|FG001|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
48904133|NCT02038920|157484301|FG002|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
48904134|NCT02038920|157484302|FG003|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
48904135|NCT02038920|157484303|FG004|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
48904136|NCT02038920|157484304|FG005|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1|||
48904137|NCT02038920|157484299|FG000|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
48904138|NCT02038920|157484300|FG001|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
48904139|NCT02038920|157484301|FG002|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
48904140|NCT02038920|157484302|FG003|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
48904141|NCT02038920|157484303|FG004|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
48904142|NCT02038920|157484304|FG005|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7|||
48904143|NCT02038920|157484299|FG000|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
48904144|NCT02038920|157484300|FG001|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
48904145|NCT02038920|157484301|FG002|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
48904146|NCT02038920|157484302|FG003|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
48904147|NCT02038920|157484303|FG004|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
48904148|NCT02038920|157484304|FG005|Open Label Cohort (Week 10 to 154)|Pregnancy|1|||
48693490|NCT01785719|156726443|FG001|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|2|||
48693491|NCT01785719|156726442|FG000|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|0|||
48693492|NCT01785719|156726443|FG001|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|1|||
48693493|NCT01785719|156726442|FG000|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|0|||
48693494|NCT01785719|156726443|FG001|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|1|||
48693495|NCT01785719|156726442|FG000|6-month Post-intervention Follow-up|Lost to Follow-up|12|||
48693496|NCT01785719|156726443|FG001|6-month Post-intervention Follow-up|Lost to Follow-up|2|||
48693497|NCT01785719|156726442|FG000|6-month Post-intervention Follow-up|Pregnancy|0|||
48693498|NCT01785719|156726443|FG001|6-month Post-intervention Follow-up|Pregnancy|1|||
48693499|NCT01785719|156726442|FG000|6-month Post-intervention Follow-up|Exclusionary medication|0|||
48693500|NCT01785719|156726443|FG001|6-month Post-intervention Follow-up|Exclusionary medication|1|||
48693501|NCT04492007|156726444|FG000|Overall Study|Lost to Follow-up|1|||
48693502|NCT04492007|156726445|FG001|Overall Study|Lost to Follow-up|1|||
48693503|NCT04492007|156726446|FG002|Overall Study|Lost to Follow-up|2|||
48693504|NCT04492007|156726447|FG003|Overall Study|Lost to Follow-up|2|||
48693505|NCT04492007|156726444|FG000|Overall Study|Protocol Violation|1|||
48693506|NCT04492007|156726445|FG001|Overall Study|Protocol Violation|1|||
48693507|NCT04492007|156726446|FG002|Overall Study|Protocol Violation|1|||
48693508|NCT04492007|156726447|FG003|Overall Study|Protocol Violation|1|||
48693509|NCT04492007|156726444|FG000|Overall Study|Withdrawal by Subject|0|||
48693510|NCT04492007|156726445|FG001|Overall Study|Withdrawal by Subject|0|||
48693511|NCT04492007|156726446|FG002|Overall Study|Withdrawal by Subject|1|||
48693512|NCT04492007|156726447|FG003|Overall Study|Withdrawal by Subject|1|||
48742917|NCT00745823|156910414|FG001|Overall Study|Lost to Follow-up|11|||
48904149|NCT02038920|157484299|FG000|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
48904150|NCT02038920|157484300|FG001|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
48904151|NCT02038920|157484301|FG002|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
48904152|NCT02038920|157484302|FG003|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
48904153|NCT02038920|157484303|FG004|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
48904154|NCT02038920|157484304|FG005|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23|||
48904155|NCT02038920|157484299|FG000|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
48904156|NCT02038920|157484300|FG001|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
48904157|NCT02038920|157484301|FG002|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
48904158|NCT02038920|157484302|FG003|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
48904159|NCT02038920|157484303|FG004|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
48904160|NCT02038920|157484304|FG005|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2|||
48904161|NCT04824521|157484305|FG000|Overall Study|Lost to Follow-up|1|||
48904162|NCT01390181|157486198|FG000|Overall Study|Lost to Follow-up|1|||
48904163|NCT01390181|157486198|FG000|Overall Study|Study Terminated due to Low Accrual|3|||
48904164|NCT01101477|157486200|FG000|Overall Study|Protocol Violation|5|||
48904165|NCT01101477|157486201|FG001|Overall Study|Protocol Violation|3|||
48904166|NCT01101477|157486202|FG002|Overall Study|Protocol Violation|1|||
48904167|NCT00355056|157486205|FG000|Randomization Period|Early Termination|4|||
48904168|NCT00355056|157486206|FG001|Randomization Period|Early Termination|6|||
48904169|NCT02720536|157486207|FG000|Overall Study|Primary reason (PR) - subject withdrawal|11|||
48904170|NCT02720536|157486207|FG000|Overall Study|PR - pregnancy|2|||
48904171|NCT02720536|157486207|FG000|Overall Study|PR - unsatisfactory therapeutic effect|2|||
48904172|NCT02720536|157486207|FG000|Overall Study|PR - death|1|||
48904173|NCT02720536|157486207|FG000|Overall Study|PR - adverse event|1|||
48904174|NCT02720536|157486207|FG000|Overall Study|PR - abnormal lab value(s)|1|||
48904175|NCT02720536|157486207|FG000|Overall Study|PR- unwilling to comply with procedures|1|||
48904176|NCT00985166|157486208|FG000|Overall Study|Lost to Follow-up|3|||
48904177|NCT00985166|157486209|FG001|Overall Study|Lost to Follow-up|2|||
48904178|NCT00985166|157486210|FG002|Overall Study|Lost to Follow-up|2|||
48904179|NCT00985166|157486208|FG000|Overall Study|Withdrawal by Subject|3|||
48904180|NCT00985166|157486209|FG001|Overall Study|Withdrawal by Subject|2|||
48904181|NCT00985166|157486210|FG002|Overall Study|Withdrawal by Subject|0|||
48904182|NCT00985166|157486208|FG000|Overall Study|Test not done|2|||
48904183|NCT00985166|157486209|FG001|Overall Study|Test not done|0|||
48904184|NCT00985166|157486210|FG002|Overall Study|Test not done|4|||
48904185|NCT00985166|157486208|FG000|Overall Study|Other|1|||
48904186|NCT00985166|157486209|FG001|Overall Study|Other|0|||
48904187|NCT00985166|157486210|FG002|Overall Study|Other|1|||
48904188|NCT03646656|157486216|FG000|Overall Study|Lost to Follow-up|1|||
48904189|NCT03646656|157486217|FG001|Overall Study|Lost to Follow-up|0|||
48904190|NCT03646656|157486216|FG000|Overall Study|Withdrawal by Subject|2|||
48904191|NCT03646656|157486217|FG001|Overall Study|Withdrawal by Subject|0|||
48904192|NCT00084266|157486220|FG000|Overall Study|Death|42|||
48904193|NCT00084266|157486221|FG001|Overall Study|Death|39|||
48904194|NCT00084266|157486220|FG000|Overall Study|Adverse Event|8|||
48904195|NCT00084266|157486221|FG001|Overall Study|Adverse Event|5|||
48904196|NCT00084266|157486220|FG000|Overall Study|Lack of Efficacy|2|||
48904197|NCT00084266|157486221|FG001|Overall Study|Lack of Efficacy|4|||
48904198|NCT00084266|157486220|FG000|Overall Study|Lost to Follow-up|5|||
48904199|NCT00084266|157486221|FG001|Overall Study|Lost to Follow-up|3|||
48904200|NCT00084266|157486220|FG000|Overall Study|Participant not willing to participate|3|||
48904201|NCT00084266|157486221|FG001|Overall Study|Participant not willing to participate|8|||
48904202|NCT00084266|157486220|FG000|Overall Study|Other|360|||
48904203|NCT00084266|157486221|FG001|Overall Study|Other|344|||
48904204|NCT00084266|157486220|FG000|Overall Study|Randomized not treated|21|||
48904205|NCT00084266|157486221|FG001|Overall Study|Randomized not treated|20|||
48904206|NCT00300781|157486222|FG000|Overall Study|Disease Progression|55|||
48904207|NCT00300781|157486223|FG001|Overall Study|Disease Progression|52|||
48904208|NCT00300781|157486222|FG000|Overall Study|Adverse Event|5|||
48904209|NCT00300781|157486223|FG001|Overall Study|Adverse Event|6|||
48904210|NCT00300781|157486222|FG000|Overall Study|Withdrawal by Subject|1|||
48904211|NCT00300781|157486223|FG001|Overall Study|Withdrawal by Subject|2|||
48904212|NCT00300781|157486222|FG000|Overall Study|Physician Decision|1|||
48904213|NCT00300781|157486223|FG001|Overall Study|Physician Decision|0|||
48904214|NCT00300781|157486222|FG000|Overall Study|Not Recorded|0|||
48904215|NCT00300781|157486223|FG001|Overall Study|Not Recorded|1|||
48904216|NCT00300781|157486222|FG000|Overall Study|Symptomatic Deterioration|1|||
48904217|NCT00300781|157486223|FG001|Overall Study|Symptomatic Deterioration|0|||
48904218|NCT00300781|157486222|FG000|Overall Study|Lost to Follow-up|0|||
48904219|NCT00300781|157486223|FG001|Overall Study|Lost to Follow-up|1|||
48904220|NCT01717989|157486232|FG000|Overall Study|Ineligibility determined|6|||
48904221|NCT01717989|157486232|FG000|Overall Study|Protocol deviation|6|||
48904222|NCT01717989|157486232|FG000|Overall Study|Withdrawal by Subject|11|||
48904223|NCT01717989|157486232|FG000|Overall Study|Physician Decision|2|||
48904224|NCT01717989|157486232|FG000|Overall Study|Lost to Follow-up|11|||
48904225|NCT01717989|157486232|FG000|Overall Study|Death|439|||
48904226|NCT01717989|157486232|FG000|Overall Study|Protocol-specified criteria|551|||
48904227|NCT01717989|157486232|FG000|Overall Study|Other|40|||
48904228|NCT00792805|157486233|FG000|Overall Study|Adverse Event|12|||
48904229|NCT00792805|157486234|FG001|Overall Study|Adverse Event|10|||
48904230|NCT00792805|157486235|FG002|Overall Study|Adverse Event|10|||
48904231|NCT00792805|157486233|FG000|Overall Study|Subject withdrew consent|5|||
48904232|NCT00792805|157486234|FG001|Overall Study|Subject withdrew consent|6|||
48904233|NCT00792805|157486235|FG002|Overall Study|Subject withdrew consent|5|||
48904234|NCT00792805|157486233|FG000|Overall Study|Administrative problems|2|||
48904235|NCT00792805|157486234|FG001|Overall Study|Administrative problems|0|||
48904236|NCT00792805|157486235|FG002|Overall Study|Administrative problems|4|||
48904237|NCT00792805|157486233|FG000|Overall Study|Abnormal test procedure result(s)|1|||
48904238|NCT00792805|157486234|FG001|Overall Study|Abnormal test procedure result(s)|2|||
48904239|NCT00792805|157486235|FG002|Overall Study|Abnormal test procedure result(s)|0|||
48904240|NCT00792805|157486233|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
48904241|NCT00792805|157486234|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
48904242|NCT00792805|157486235|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
48904243|NCT00792805|157486233|FG000|Overall Study|Lost to Follow-up|1|||
48904244|NCT00792805|157486234|FG001|Overall Study|Lost to Follow-up|1|||
48904245|NCT00792805|157486235|FG002|Overall Study|Lost to Follow-up|6|||
48904246|NCT00792805|157486233|FG000|Overall Study|Abnormal laboratory value(s)|0|||
48904247|NCT00792805|157486234|FG001|Overall Study|Abnormal laboratory value(s)|0|||
48904248|NCT00792805|157486235|FG002|Overall Study|Abnormal laboratory value(s)|1|||
48904249|NCT00792805|157486233|FG000|Overall Study|Protocol deviation|0|||
48904250|NCT00792805|157486234|FG001|Overall Study|Protocol deviation|1|||
48904251|NCT00792805|157486235|FG002|Overall Study|Protocol deviation|1|||
48904252|NCT00887250|157486236|FG000|Overall Study|Adverse Event|3|||
48904253|NCT00887250|157486237|FG001|Overall Study|Adverse Event|0|||
48904254|NCT00887250|157486238|FG002|Overall Study|Adverse Event|7|||
48904255|NCT00887250|157486236|FG000|Overall Study|Lack of Efficacy|9|||
48904256|NCT00887250|157486237|FG001|Overall Study|Lack of Efficacy|6|||
48904257|NCT00887250|157486238|FG002|Overall Study|Lack of Efficacy|1|||
48904258|NCT00887250|157486236|FG000|Overall Study|Lost to Follow-up|2|||
48904259|NCT00887250|157486237|FG001|Overall Study|Lost to Follow-up|3|||
48904260|NCT00887250|157486238|FG002|Overall Study|Lost to Follow-up|1|||
48904261|NCT00887250|157486236|FG000|Overall Study|Protocol Violation|2|||
48904262|NCT00887250|157486237|FG001|Overall Study|Protocol Violation|2|||
48904263|NCT00887250|157486238|FG002|Overall Study|Protocol Violation|1|||
48904264|NCT00887250|157486236|FG000|Overall Study|Withdrawal by Subject|2|||
48904265|NCT00887250|157486237|FG001|Overall Study|Withdrawal by Subject|1|||
48904266|NCT00887250|157486238|FG002|Overall Study|Withdrawal by Subject|2|||
48904267|NCT00887250|157486236|FG000|Overall Study|Patient uncooperative|0|||
48904268|NCT00887250|157486237|FG001|Overall Study|Patient uncooperative|0|||
48904269|NCT00887250|157486238|FG002|Overall Study|Patient uncooperative|1|||
48904270|NCT04615247|157486239|FG000|Overall Study|Adverse Event|0|||
48904271|NCT04615247|157486240|FG001|Overall Study|Adverse Event|2|||
48904272|NCT04615247|157486239|FG000|Overall Study|Withdrawal by Subject|1|||
48904273|NCT04615247|157486240|FG001|Overall Study|Withdrawal by Subject|1|||
48904274|NCT03278106|157486243|FG000|Overall Study|No protocol treatment|1|||
48904275|NCT00823901|157486244|FG000|Overall Study|Adverse Event|1|||
48904276|NCT00823901|157486245|FG001|Overall Study|Adverse Event|1|||
48904277|NCT00823901|157486244|FG000|Overall Study|Lack of Efficacy|1|||
48904278|NCT00823901|157486245|FG001|Overall Study|Lack of Efficacy|0|||
48904279|NCT00823901|157486244|FG000|Overall Study|Lost to Follow-up|2|||
48904280|NCT00823901|157486245|FG001|Overall Study|Lost to Follow-up|1|||
48904281|NCT01369511|157486246|FG000|Overall Study|Adverse Event|1|||
48904282|NCT01369511|157486247|FG001|Overall Study|Adverse Event|1|||
48904283|NCT01369511|157486248|FG002|Overall Study|Adverse Event|5|||
48904284|NCT01369511|157486249|FG003|Overall Study|Adverse Event|0|||
48904285|NCT01369511|157486246|FG000|Overall Study|Entry criteria not met|2|||
48904286|NCT01369511|157486247|FG001|Overall Study|Entry criteria not met|0|||
48904287|NCT01369511|157486248|FG002|Overall Study|Entry criteria not met|0|||
48904288|NCT01369511|157486249|FG003|Overall Study|Entry criteria not met|1|||
48904289|NCT01369511|157486246|FG000|Overall Study|Lost to Follow-up|0|||
48904290|NCT01369511|157486247|FG001|Overall Study|Lost to Follow-up|1|||
48904291|NCT01369511|157486248|FG002|Overall Study|Lost to Follow-up|1|||
48904292|NCT01369511|157486249|FG003|Overall Study|Lost to Follow-up|2|||
48904293|NCT01369511|157486246|FG000|Overall Study|Protocol Violation|0|||
48904294|NCT01369511|157486247|FG001|Overall Study|Protocol Violation|1|||
48904295|NCT01369511|157486248|FG002|Overall Study|Protocol Violation|0|||
48904296|NCT01369511|157486249|FG003|Overall Study|Protocol Violation|2|||
48904297|NCT01369511|157486246|FG000|Overall Study|Physician Decision|3|||
48904298|NCT01369511|157486247|FG001|Overall Study|Physician Decision|4|||
48904299|NCT01369511|157486248|FG002|Overall Study|Physician Decision|0|||
48904300|NCT01369511|157486249|FG003|Overall Study|Physician Decision|0|||
48904301|NCT01369511|157486246|FG000|Overall Study|Sponsor decision|2|||
48904302|NCT01369511|157486247|FG001|Overall Study|Sponsor decision|0|||
48904303|NCT01369511|157486248|FG002|Overall Study|Sponsor decision|1|||
48904304|NCT01369511|157486249|FG003|Overall Study|Sponsor decision|0|||
48904305|NCT01369511|157486246|FG000|Overall Study|Withdrawal by Subject|5|||
48904306|NCT01369511|157486247|FG001|Overall Study|Withdrawal by Subject|6|||
48904307|NCT01369511|157486248|FG002|Overall Study|Withdrawal by Subject|4|||
48904308|NCT01369511|157486249|FG003|Overall Study|Withdrawal by Subject|6|||
48904309|NCT03952806|157486250|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|26|||
48904310|NCT03952806|157486251|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|15|||
48904311|NCT03952806|157486250|FG000|Randomization Phase (Weeks 1 Through 48)|Disease progression|5|||
48904312|NCT03952806|157486251|FG001|Randomization Phase (Weeks 1 Through 48)|Disease progression|0|||
48904313|NCT03952806|157486250|FG000|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
48904314|NCT03952806|157486251|FG001|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
48904315|NCT03952806|157486250|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|4|||
48904316|NCT03952806|157486251|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|2|||
48904317|NCT03952806|157486250|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
48904318|NCT03952806|157486251|FG001|Randomization Phase (Weeks 1 Through 48)|Other|0|||
48904319|NCT03952806|157486250|FG000|OLE Phase (48 Weeks)|Adverse Event|18|||
48904320|NCT03952806|157486251|FG001|OLE Phase (48 Weeks)|Adverse Event|29|||
48904321|NCT03952806|157486250|FG000|OLE Phase (48 Weeks)|Disease Progression|6|||
48904322|NCT03952806|157486251|FG001|OLE Phase (48 Weeks)|Disease Progression|9|||
48904323|NCT03952806|157486250|FG000|OLE Phase (48 Weeks)|Participant Request to Discontinue|35|||
48904324|NCT03952806|157486251|FG001|OLE Phase (48 Weeks)|Participant Request to Discontinue|38|||
48904325|NCT03952806|157486250|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|4|||
48904326|NCT03952806|157486251|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|5|||
48904327|NCT03952806|157486250|FG000|OLE Phase (48 Weeks)|Other|16|||
48904328|NCT03952806|157486251|FG001|OLE Phase (48 Weeks)|Other|13|||
48904329|NCT01774110|157486252|FG000|Overall Study|Lost to Follow-up|7|||
48904330|NCT00640016|157486253|FG000|Overall Study|Withdrawal by Subject|0|||
48904331|NCT00640016|157486254|FG001|Overall Study|Withdrawal by Subject|1|||
48904332|NCT00640016|157486255|FG002|Overall Study|Withdrawal by Subject|0|||
48904333|NCT00640016|157486256|FG003|Overall Study|Withdrawal by Subject|0|||
48904334|NCT00640016|157486253|FG000|Overall Study|Study termination|2|||
48904335|NCT00640016|157486254|FG001|Overall Study|Study termination|1|||
48904336|NCT00640016|157486255|FG002|Overall Study|Study termination|3|||
48904337|NCT00640016|157486256|FG003|Overall Study|Study termination|2|||
48904338|NCT00640016|157486253|FG000|Overall Study|Adverse Event|0|||
48904339|NCT00640016|157486254|FG001|Overall Study|Adverse Event|0|||
48904340|NCT00640016|157486255|FG002|Overall Study|Adverse Event|0|||
48904341|NCT00640016|157486256|FG003|Overall Study|Adverse Event|1|||
48904342|NCT02569957|157486257|FG000|Overall Study|Withdrawal by Subject|0|||
48904343|NCT02569957|157486258|FG001|Overall Study|Withdrawal by Subject|1|||
48904344|NCT00846391|157486259|FG000|Overall Study|Physician Decision|0|||
48904345|NCT00846391|157486260|FG001|Overall Study|Physician Decision|0|||
48904346|NCT00846391|157486261|FG002|Overall Study|Physician Decision|1|||
48904347|NCT00846391|157486259|FG000|Overall Study|Study Terminated by Sponsor|1|||
48904348|NCT00846391|157486260|FG001|Overall Study|Study Terminated by Sponsor|2|||
48904349|NCT00846391|157486261|FG002|Overall Study|Study Terminated by Sponsor|2|||
48904350|NCT02027701|157486262|FG000|Overall Study|Adverse Event|3|||
48904351|NCT02027701|157486262|FG000|Overall Study|Lack of Efficacy|8|||
48904352|NCT02027701|157486262|FG000|Overall Study|Physician Decision|2|||
48904353|NCT02027701|157486262|FG000|Overall Study|Withdrawal by Subject|3|||
48904354|NCT01287065|157486263|FG000|Treatment Period 1|Adverse Event|0|||
48904355|NCT01287065|157486264|FG001|Treatment Period 1|Adverse Event|0|||
48904356|NCT01287065|157486265|FG002|Treatment Period 1|Adverse Event|0|||
48904357|NCT01287065|157486266|FG003|Treatment Period 1|Adverse Event|0|||
48904358|NCT01287065|157486267|FG004|Treatment Period 1|Adverse Event|1|||
48904359|NCT01287065|157486268|FG005|Treatment Period 1|Adverse Event|0|||
48904360|NCT01287065|157486263|FG000|Treatment Period 1|Withdrawal by Subject|0|||
48904361|NCT01287065|157486264|FG001|Treatment Period 1|Withdrawal by Subject|0|||
48904362|NCT01287065|157486265|FG002|Treatment Period 1|Withdrawal by Subject|0|||
48904363|NCT01287065|157486266|FG003|Treatment Period 1|Withdrawal by Subject|0|||
48904364|NCT01287065|157486267|FG004|Treatment Period 1|Withdrawal by Subject|0|||
48904365|NCT01287065|157486268|FG005|Treatment Period 1|Withdrawal by Subject|1|||
48904366|NCT01214187|157486269|FG000|Overall Study|Adverse Event|6|||
48904367|NCT01214187|157486270|FG001|Overall Study|Adverse Event|2|||
48904368|NCT01214187|157486269|FG000|Overall Study|Death|1|||
48904369|NCT01214187|157486270|FG001|Overall Study|Death|1|||
48904370|NCT01214187|157486269|FG000|Overall Study|Withdrawal by Subject|0|||
48904371|NCT01214187|157486270|FG001|Overall Study|Withdrawal by Subject|3|||
48904372|NCT00820027|157486273|FG000|Overall Study|Adverse Event|15|||
48904373|NCT00820027|157486274|FG001|Overall Study|Adverse Event|8|||
48904374|NCT00820027|157486275|FG002|Overall Study|Adverse Event|10|||
48904375|NCT00820027|157486276|FG003|Overall Study|Adverse Event|5|||
48904376|NCT00820027|157486273|FG000|Overall Study|Lack of Efficacy|2|||
48904377|NCT00820027|157486274|FG001|Overall Study|Lack of Efficacy|1|||
48904378|NCT00820027|157486275|FG002|Overall Study|Lack of Efficacy|2|||
48904379|NCT00820027|157486276|FG003|Overall Study|Lack of Efficacy|2|||
48904380|NCT00820027|157486273|FG000|Overall Study|Physician Decision|0|||
48904381|NCT00820027|157486274|FG001|Overall Study|Physician Decision|1|||
48904382|NCT00820027|157486275|FG002|Overall Study|Physician Decision|1|||
48904383|NCT00820027|157486276|FG003|Overall Study|Physician Decision|0|||
48904384|NCT00820027|157486273|FG000|Overall Study|Protocol Violation|3|||
48904385|NCT00820027|157486274|FG001|Overall Study|Protocol Violation|0|||
48904386|NCT00820027|157486275|FG002|Overall Study|Protocol Violation|4|||
48904387|NCT00820027|157486276|FG003|Overall Study|Protocol Violation|0|||
48904388|NCT00820027|157486273|FG000|Overall Study|Withdrawal by Subject|6|||
48904389|NCT00820027|157486274|FG001|Overall Study|Withdrawal by Subject|4|||
48904390|NCT00820027|157486275|FG002|Overall Study|Withdrawal by Subject|4|||
48904391|NCT00820027|157486276|FG003|Overall Study|Withdrawal by Subject|6|||
48904392|NCT01388790|157486281|FG000|Overall Study|Ongoing at data cut-off date|8|||
48904393|NCT00908232|157486282|FG000|Cycle 1 to 4|Death|5|||
48904394|NCT00908232|157486283|FG001|Cycle 1 to 4|Death|0|||
48904395|NCT00908232|157486284|FG002|Cycle 1 to 4|Death|0|||
48904396|NCT00908232|157486285|FG003|Cycle 1 to 4|Death|0|||
48904397|NCT00908232|157486282|FG000|Cycle 1 to 4|Withdrawal by Subject|4|||
48904398|NCT00908232|157486283|FG001|Cycle 1 to 4|Withdrawal by Subject|0|||
48904399|NCT00908232|157486284|FG002|Cycle 1 to 4|Withdrawal by Subject|0|||
48904400|NCT00908232|157486285|FG003|Cycle 1 to 4|Withdrawal by Subject|0|||
48904401|NCT00908232|157486282|FG000|Cycle 1 to 4|Progressive Disease|6|||
48904402|NCT00908232|157486283|FG001|Cycle 1 to 4|Progressive Disease|0|||
48904403|NCT00908232|157486284|FG002|Cycle 1 to 4|Progressive Disease|0|||
48904404|NCT00908232|157486285|FG003|Cycle 1 to 4|Progressive Disease|0|||
48904405|NCT00908232|157486282|FG000|Cycle 1 to 4|Adverse Event|12|||
48904406|NCT00908232|157486283|FG001|Cycle 1 to 4|Adverse Event|0|||
48904407|NCT00908232|157486284|FG002|Cycle 1 to 4|Adverse Event|0|||
48904408|NCT00908232|157486285|FG003|Cycle 1 to 4|Adverse Event|0|||
48904409|NCT00908232|157486282|FG000|Cycle 1 to 4|Other|1|||
48904410|NCT00908232|157486283|FG001|Cycle 1 to 4|Other|0|||
48904411|NCT00908232|157486284|FG002|Cycle 1 to 4|Other|0|||
48904412|NCT00908232|157486285|FG003|Cycle 1 to 4|Other|0|||
48904413|NCT00908232|157486282|FG000|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1|||
48904414|NCT00908232|157486283|FG001|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
48904415|NCT00908232|157486284|FG002|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
48904416|NCT00908232|157486285|FG003|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
48904417|NCT00908232|157486282|FG000|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5|||
48904418|NCT00908232|157486283|FG001|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
48904419|NCT00908232|157486284|FG002|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
48904420|NCT00908232|157486285|FG003|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
48904421|NCT00908232|157486282|FG000|Randomization (Cycle 5) to Cycle 8|Death|2|||
48904422|NCT00908232|157486283|FG001|Randomization (Cycle 5) to Cycle 8|Death|0|||
48904423|NCT00908232|157486284|FG002|Randomization (Cycle 5) to Cycle 8|Death|0|||
48904424|NCT00908232|157486285|FG003|Randomization (Cycle 5) to Cycle 8|Death|0|||
48904425|NCT00908232|157486282|FG000|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4|||
48904426|NCT00908232|157486283|FG001|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
48904427|NCT00908232|157486284|FG002|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1|||
48904428|NCT00908232|157486285|FG003|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
48904429|NCT00908232|157486282|FG000|Randomization (Cycle 5) to Cycle 8|Adverse Event|17|||
48904430|NCT00908232|157486283|FG001|Randomization (Cycle 5) to Cycle 8|Adverse Event|2|||
48904431|NCT00908232|157486284|FG002|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
48904432|NCT00908232|157486285|FG003|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
48904433|NCT00908232|157486282|FG000|Randomization (Cycle 5) to Cycle 8|Physician Decision|2|||
48904434|NCT00908232|157486283|FG001|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
48904435|NCT00908232|157486284|FG002|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
48904436|NCT00908232|157486285|FG003|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
48904437|NCT00908232|157486282|FG000|Randomization (Cycle 5) to Cycle 8|Other|3|||
48904438|NCT00908232|157486283|FG001|Randomization (Cycle 5) to Cycle 8|Other|1|||
48904439|NCT00908232|157486284|FG002|Randomization (Cycle 5) to Cycle 8|Other|0|||
48904440|NCT00908232|157486285|FG003|Randomization (Cycle 5) to Cycle 8|Other|0|||
48904441|NCT00908232|157486282|FG000|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1|||
48904442|NCT00908232|157486283|FG001|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
48904443|NCT00908232|157486284|FG002|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
48904444|NCT00908232|157486285|FG003|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
48904445|NCT00537485|157486286|FG000|Overall Study|Adverse Event|10|||
48904446|NCT00537485|157486287|FG001|Overall Study|Adverse Event|5|||
48904447|NCT00537485|157486286|FG000|Overall Study|Withdrawal by Subject|3|||
48904448|NCT00537485|157486287|FG001|Overall Study|Withdrawal by Subject|2|||
48904449|NCT00537485|157486286|FG000|Overall Study|Withdrawal by Subject|1|||
48904450|NCT00537485|157486287|FG001|Overall Study|Withdrawal by Subject|3|||
48904451|NCT00537485|157486286|FG000|Overall Study|Physician Decision|1|||
48904452|NCT00537485|157486287|FG001|Overall Study|Physician Decision|0|||
48904453|NCT02349451|157486290|FG000|Overall Study|Withdrawal by Subject|0|||
48904454|NCT02349451|157486291|FG001|Overall Study|Withdrawal by Subject|1|||
48904455|NCT02349451|157486292|FG002|Overall Study|Withdrawal by Subject|2|||
48904456|NCT02349451|157486293|FG003|Overall Study|Withdrawal by Subject|1|||
48904457|NCT05116046|157486296|FG000|Overall Study|Withdrawal by parent/guardian|2|||
48904458|NCT05116046|157486297|FG001|Overall Study|Withdrawal by parent/guardian|1|||
48904459|NCT05116046|157486298|FG002|Overall Study|Withdrawal by parent/guardian|1|||
48904460|NCT05116046|157486296|FG000|Overall Study|Study terminated by sponsor|14|||
48904461|NCT05116046|157486297|FG001|Overall Study|Study terminated by sponsor|16|||
48904462|NCT05116046|157486298|FG002|Overall Study|Study terminated by sponsor|1|||
48904463|NCT00928746|157486299|FG000|Overall Study|Adverse Event|2|||
48904464|NCT00928746|157486299|FG000|Overall Study|Protocol Violation|1|||
48904465|NCT00928746|157486299|FG000|Overall Study|Withdrawal by Subject|1|||
48904466|NCT00928746|157486299|FG000|Overall Study|Other|2|||
48904467|NCT00261846|157486300|FG000|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
48904468|NCT00261846|157486301|FG001|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
48904469|NCT00261846|157486302|FG002|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12|||
48904470|NCT00261846|157486303|FG003|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
48904471|NCT00261846|157486304|FG004|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
48904472|NCT00261846|157486305|FG005|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
48904473|NCT00261846|157486306|FG006|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
48904474|NCT00261846|157486307|FG007|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
48904475|NCT00261846|157486308|FG008|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
48904476|NCT00261846|157486309|FG009|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
48904477|NCT00261846|157486310|FG010|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
48904478|NCT00261846|157486311|FG011|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
48904479|NCT00261846|157486300|FG000|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
48904480|NCT00261846|157486301|FG001|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
48904481|NCT00261846|157486302|FG002|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
48904482|NCT00261846|157486303|FG003|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
48904483|NCT00261846|157486304|FG004|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
48904484|NCT00261846|157486305|FG005|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
48951821|NCT00950690|157654905|FG000|Overall Study|Lack of Efficacy|22|||
48904485|NCT00261846|157486306|FG006|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
48904486|NCT00261846|157486307|FG007|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
48904487|NCT00261846|157486308|FG008|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
48904488|NCT00261846|157486309|FG009|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
48904489|NCT00261846|157486310|FG010|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
48904490|NCT00261846|157486311|FG011|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
48904491|NCT00261846|157486300|FG000|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
48904492|NCT00261846|157486301|FG001|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
48904493|NCT00261846|157486302|FG002|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
48904494|NCT00261846|157486303|FG003|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9|||
48904495|NCT00261846|157486304|FG004|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8|||
48904496|NCT00261846|157486305|FG005|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1|||
48904497|NCT00261846|157486306|FG006|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
48904498|NCT00261846|157486307|FG007|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
48904499|NCT00261846|157486308|FG008|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
48904500|NCT00261846|157486309|FG009|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2|||
48904501|NCT00261846|157486310|FG010|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
48904502|NCT00261846|157486311|FG011|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
48904503|NCT00261846|157486300|FG000|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
48904504|NCT00261846|157486301|FG001|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
48904505|NCT00261846|157486302|FG002|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
48904506|NCT00261846|157486303|FG003|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12|||
48904507|NCT00261846|157486304|FG004|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
48904508|NCT00261846|157486305|FG005|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
48904509|NCT00261846|157486306|FG006|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
48904510|NCT00261846|157486307|FG007|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
48904511|NCT00261846|157486308|FG008|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1|||
48904512|NCT00261846|157486309|FG009|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
48904513|NCT00261846|157486310|FG010|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
48904514|NCT00261846|157486311|FG011|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
48904515|NCT00261846|157486300|FG000|Period 2: Part 2 (Efficacy)|Other|0|||
48904516|NCT00261846|157486301|FG001|Period 2: Part 2 (Efficacy)|Other|0|||
48904517|NCT00261846|157486302|FG002|Period 2: Part 2 (Efficacy)|Other|0|||
48904518|NCT00261846|157486303|FG003|Period 2: Part 2 (Efficacy)|Other|15|||
48904519|NCT00261846|157486304|FG004|Period 2: Part 2 (Efficacy)|Other|4|||
48904520|NCT00261846|157486305|FG005|Period 2: Part 2 (Efficacy)|Other|0|||
48904521|NCT00261846|157486306|FG006|Period 2: Part 2 (Efficacy)|Other|1|||
48904522|NCT00261846|157486307|FG007|Period 2: Part 2 (Efficacy)|Other|5|||
48904523|NCT00261846|157486308|FG008|Period 2: Part 2 (Efficacy)|Other|4|||
48904524|NCT00261846|157486309|FG009|Period 2: Part 2 (Efficacy)|Other|4|||
48904525|NCT00261846|157486310|FG010|Period 2: Part 2 (Efficacy)|Other|0|||
48904526|NCT00261846|157486311|FG011|Period 2: Part 2 (Efficacy)|Other|0|||
48904527|NCT00261846|157486300|FG000|Period 2: Part 2 (Efficacy)|Death|0|||
48904528|NCT00261846|157486301|FG001|Period 2: Part 2 (Efficacy)|Death|0|||
48904529|NCT00261846|157486302|FG002|Period 2: Part 2 (Efficacy)|Death|0|||
48904530|NCT00261846|157486303|FG003|Period 2: Part 2 (Efficacy)|Death|37|||
48904531|NCT00261846|157486304|FG004|Period 2: Part 2 (Efficacy)|Death|7|||
48904532|NCT00261846|157486305|FG005|Period 2: Part 2 (Efficacy)|Death|1|||
48904533|NCT00261846|157486306|FG006|Period 2: Part 2 (Efficacy)|Death|10|||
48904534|NCT00261846|157486307|FG007|Period 2: Part 2 (Efficacy)|Death|12|||
48904535|NCT00261846|157486308|FG008|Period 2: Part 2 (Efficacy)|Death|3|||
48904536|NCT00261846|157486309|FG009|Period 2: Part 2 (Efficacy)|Death|30|||
48904537|NCT00261846|157486310|FG010|Period 2: Part 2 (Efficacy)|Death|44|||
48904538|NCT00261846|157486311|FG011|Period 2: Part 2 (Efficacy)|Death|22|||
48904539|NCT00261846|157486300|FG000|Period 2: Part 2 (Efficacy)|Extension study|0|||
48904540|NCT00261846|157486301|FG001|Period 2: Part 2 (Efficacy)|Extension study|0|||
48904541|NCT00261846|157486302|FG002|Period 2: Part 2 (Efficacy)|Extension study|0|||
48904542|NCT00261846|157486303|FG003|Period 2: Part 2 (Efficacy)|Extension study|61|||
48904543|NCT00261846|157486304|FG004|Period 2: Part 2 (Efficacy)|Extension study|27|||
48904544|NCT00261846|157486305|FG005|Period 2: Part 2 (Efficacy)|Extension study|0|||
48904545|NCT00261846|157486306|FG006|Period 2: Part 2 (Efficacy)|Extension study|4|||
48904546|NCT00261846|157486307|FG007|Period 2: Part 2 (Efficacy)|Extension study|9|||
48904547|NCT00261846|157486308|FG008|Period 2: Part 2 (Efficacy)|Extension study|5|||
48904548|NCT00261846|157486309|FG009|Period 2: Part 2 (Efficacy)|Extension study|9|||
48904549|NCT00261846|157486310|FG010|Period 2: Part 2 (Efficacy)|Extension study|1|||
48904550|NCT00261846|157486311|FG011|Period 2: Part 2 (Efficacy)|Extension study|1|||
48904551|NCT00325039|157486312|FG000|Overall Study|Lost to Follow-up|18|||
48904552|NCT00325039|157486313|FG001|Overall Study|Lost to Follow-up|14|||
48904553|NCT03093350|157486314|FG000|Overall Study|Death|1|||
48904554|NCT03093350|157486314|FG000|Overall Study|Signed consent, never began treartment|1|||
48904555|NCT00711529|157486323|FG000|Overall Study|Protocol Violation|2|||
48904556|NCT00711529|157486324|FG001|Overall Study|Protocol Violation|0|||
48904557|NCT00711529|157486323|FG000|Overall Study|Withdrawal by Subject|2|||
48904558|NCT00711529|157486324|FG001|Overall Study|Withdrawal by Subject|6|||
48904559|NCT01740323|157486325|FG000|Overall Study|Adverse Event|1|||
48904560|NCT01740323|157486326|FG001|Overall Study|Adverse Event|0|||
48904561|NCT01740323|157486325|FG000|Overall Study|Randomized but did not take study drug|1|||
48904562|NCT01740323|157486326|FG001|Overall Study|Randomized but did not take study drug|0|||
48904563|NCT00323297|157486327|FG000|Part A (Double Blind Randomized)|Reason unspecified|0|||
48904564|NCT00323297|157486328|FG001|Part A (Double Blind Randomized)|Reason unspecified|1|||
48904565|NCT00323297|157486327|FG000|Part A (Double Blind Randomized)|Death|0|||
48904566|NCT00323297|157486328|FG001|Part A (Double Blind Randomized)|Death|1|||
48904567|NCT00323297|157486327|FG000|Part A (Double Blind Randomized)|Protocol Violation|1|||
48904568|NCT00323297|157486328|FG001|Part A (Double Blind Randomized)|Protocol Violation|3|||
48904569|NCT00323297|157486327|FG000|Part A (Double Blind Randomized)|Unrelated adverse event|1|||
48904570|NCT00323297|157486328|FG001|Part A (Double Blind Randomized)|Unrelated adverse event|0|||
48904571|NCT00323297|157486327|FG000|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1|||
48904572|NCT00323297|157486328|FG001|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0|||
48904573|NCT00323297|157486327|FG000|Part A (Double Blind Randomized)|Related adverse event|2|||
48904574|NCT00323297|157486328|FG001|Part A (Double Blind Randomized)|Related adverse event|2|||
48904575|NCT00323297|157486327|FG000|Part B (Open-label)|Death|0|||
48904576|NCT00323297|157486328|FG001|Part B (Open-label)|Death|1|||
48904577|NCT00323297|157486327|FG000|Part B (Open-label)|Reason unspecified|0|||
48904578|NCT00323297|157486328|FG001|Part B (Open-label)|Reason unspecified|1|||
48904579|NCT00323297|157486327|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
48904580|NCT00323297|157486328|FG001|Part B (Open-label)|Withdrawal by Subject|3|||
48904581|NCT00323297|157486327|FG000|Part B (Open-label)|Lack of Efficacy|3|||
48904582|NCT00323297|157486328|FG001|Part B (Open-label)|Lack of Efficacy|1|||
48904583|NCT00323297|157486327|FG000|Part B (Open-label)|Adverse Event|5|||
48904584|NCT00323297|157486328|FG001|Part B (Open-label)|Adverse Event|5|||
48904585|NCT00323297|157486327|FG000|Part B (Open-label)|Protocol Violation|0|||
48904586|NCT00323297|157486328|FG001|Part B (Open-label)|Protocol Violation|1|||
48904587|NCT01176773|157486329|FG000|Overall Study|Screen Failure|2|||
48904588|NCT01176773|157486329|FG000|Overall Study|Withdrew consent|1|||
48904589|NCT03181451|157486335|FG000|Overall Study|Adverse Event|0|||
48904590|NCT03181451|157486336|FG001|Overall Study|Adverse Event|1|||
48904591|NCT03181451|157486337|FG002|Overall Study|Adverse Event|0|||
48904592|NCT03181451|157486335|FG000|Overall Study|Withdrawal by Subject|0|||
48904593|NCT03181451|157486336|FG001|Overall Study|Withdrawal by Subject|1|||
48904594|NCT03181451|157486337|FG002|Overall Study|Withdrawal by Subject|0|||
48904595|NCT03681951|157486346|FG000|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1|||
48904596|NCT03681951|157486347|FG001|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
48904597|NCT03681951|157486348|FG002|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
48904598|NCT03681951|157486349|FG003|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
48904599|NCT03681951|157486350|FG004|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
48904600|NCT03681951|157486351|FG005|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
48904601|NCT03681951|157486352|FG006|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
48904602|NCT03681951|157486353|FG007|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
48904603|NCT03681951|157486346|FG000|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4|||
48904604|NCT03681951|157486347|FG001|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
48904605|NCT03681951|157486348|FG002|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
48904606|NCT03681951|157486349|FG003|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
48904607|NCT03681951|157486350|FG004|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
48904608|NCT03681951|157486351|FG005|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
48904609|NCT03681951|157486352|FG006|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
48904610|NCT03681951|157486353|FG007|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
48904611|NCT03681951|157486346|FG000|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3|||
48904612|NCT03681951|157486347|FG001|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
48904613|NCT03681951|157486348|FG002|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
48904614|NCT03681951|157486349|FG003|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
48904615|NCT03681951|157486350|FG004|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
48904616|NCT03681951|157486351|FG005|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
48904617|NCT03681951|157486352|FG006|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
48904618|NCT03681951|157486353|FG007|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
48904619|NCT00628251|157486354|FG000|Randomised Part|Withdrawal by Subject|0|||
48904620|NCT00628251|157486355|FG001|Randomised Part|Withdrawal by Subject|0|||
48904621|NCT00628251|157486356|FG002|Randomised Part|Withdrawal by Subject|1|||
48904622|NCT00628251|157486354|FG000|Ongoing Initial Study Treatment at DCO|Adverse Event|1|||
48904623|NCT00628251|157486355|FG001|Ongoing Initial Study Treatment at DCO|Adverse Event|2|||
48904624|NCT00628251|157486356|FG002|Ongoing Initial Study Treatment at DCO|Adverse Event|3|||
48904625|NCT00628251|157486354|FG000|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19|||
48904626|NCT00628251|157486355|FG001|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15|||
48904627|NCT00628251|157486356|FG002|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13|||
48904628|NCT00628251|157486354|FG000|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
48904629|NCT00628251|157486355|FG001|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2|||
48904630|NCT00628251|157486356|FG002|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
48904631|NCT00628251|157486354|FG000|Ongoing Initial Study Treatment at DCO|Other reason|0|||
48904632|NCT00628251|157486355|FG001|Ongoing Initial Study Treatment at DCO|Other reason|1|||
48904633|NCT00628251|157486356|FG002|Ongoing Initial Study Treatment at DCO|Other reason|6|||
48904634|NCT00628251|157486354|FG000|Ongoing Initial Study Treatment at DCO|Other|1|||
48904635|NCT00628251|157486355|FG001|Ongoing Initial Study Treatment at DCO|Other|0|||
48904636|NCT00628251|157486356|FG002|Ongoing Initial Study Treatment at DCO|Other|2|||
48904637|NCT02743819|157486357|FG000|Overall Study|Lack of Efficacy|5|||
48904638|NCT02743819|157486357|FG000|Overall Study|Death|2|||
48904639|NCT02743819|157486357|FG000|Overall Study|Adverse Event|1|||
48904640|NCT01290601|157486359|FG000|Overall Study|Adverse Event|0|||
48904641|NCT01290601|157486360|FG001|Overall Study|Adverse Event|2|||
48904642|NCT01290601|157486361|FG002|Overall Study|Adverse Event|0|||
48904643|NCT01290601|157486362|FG003|Overall Study|Adverse Event|0|||
48904644|NCT01290601|157486359|FG000|Overall Study|Lack of Efficacy|2|||
48904645|NCT01290601|157486360|FG001|Overall Study|Lack of Efficacy|1|||
48904646|NCT01290601|157486361|FG002|Overall Study|Lack of Efficacy|0|||
48904647|NCT01290601|157486362|FG003|Overall Study|Lack of Efficacy|0|||
48904648|NCT01290601|157486359|FG000|Overall Study|Lost to Follow-up|7|||
48904649|NCT01290601|157486360|FG001|Overall Study|Lost to Follow-up|2|||
48904650|NCT01290601|157486361|FG002|Overall Study|Lost to Follow-up|0|||
48904651|NCT01290601|157486362|FG003|Overall Study|Lost to Follow-up|0|||
48904652|NCT01290601|157486359|FG000|Overall Study|Other|1|||
48904653|NCT01290601|157486360|FG001|Overall Study|Other|0|||
48904654|NCT01290601|157486361|FG002|Overall Study|Other|0|||
48904655|NCT01290601|157486362|FG003|Overall Study|Other|0|||
48904656|NCT01290601|157486359|FG000|Overall Study|Protocol Violation|1|||
48904657|NCT01290601|157486360|FG001|Overall Study|Protocol Violation|0|||
48904658|NCT01290601|157486361|FG002|Overall Study|Protocol Violation|0|||
48904659|NCT01290601|157486362|FG003|Overall Study|Protocol Violation|0|||
48904660|NCT01431534|157486364|FG000|Treatment Phase|Adverse Event|0|||
48904661|NCT01431534|157486365|FG001|Treatment Phase|Adverse Event|0|||
48904662|NCT01431534|157486366|FG002|Treatment Phase|Adverse Event|1|||
48904663|NCT01431534|157486364|FG000|Treatment Phase|Progressive Disease|4|||
48904664|NCT01431534|157486365|FG001|Treatment Phase|Progressive Disease|3|||
48904665|NCT01431534|157486366|FG002|Treatment Phase|Progressive Disease|10|||
48904666|NCT00752622|157486378|FG000|Induction Phase|Adverse Event|3|||
48904667|NCT00752622|157486378|FG000|Induction Phase|Other|3|||
48904668|NCT00752622|157486378|FG000|Induction Phase|Non-responder|14|||
48904669|NCT00752622|157486378|FG000|Induction Phase|Withdrawal by Subject|1|||
48904670|NCT00752622|157486378|FG000|Induction Phase|Premature study termination|14|||
48904671|NCT00752622|157486378|FG000|Observational Phase|Premature Study Termination|36|||
48904672|NCT00752622|157486378|FG000|Observational Phase|Non-responder|2|||
48904673|NCT00752622|157486378|FG000|Observational Phase|Withdrawal by Subject|2|||
48904674|NCT00752622|157486378|FG000|Observational Phase|Adverse Event|1|||
48904675|NCT00752622|157486378|FG000|Observational Phase|Other|2|||
48904676|NCT00752622|157486378|FG000|Interventional Phase|Non-responder|2|||
48904677|NCT00752622|157486378|FG000|Interventional Phase|Physician Decision|1|||
48904678|NCT00752622|157486378|FG000|Interventional Phase|Premature Study Termination|5|||
48904679|NCT00576836|157486379|FG000|Overall Study|Death|0|||
48904680|NCT00576836|157486380|FG001|Overall Study|Death|1|||
48904681|NCT00576836|157486379|FG000|Overall Study|Physician Decision|0|||
48904682|NCT00576836|157486380|FG001|Overall Study|Physician Decision|1|||
48904683|NCT01272947|157486381|FG000|Overall Study|Abnormal Laboratory Value|2|||
48904684|NCT01272947|157486382|FG001|Overall Study|Abnormal Laboratory Value|2|||
48904685|NCT00909792|157488648|FG000|Period 1|Did not meet inclusion criteria|0|||
48904686|NCT00909792|157488649|FG001|Period 1|Did not meet inclusion criteria|1|||
48904687|NCT00909792|157488648|FG000|Period 2|Biomicroscopy|1|||
48904688|NCT00909792|157488649|FG001|Period 2|Biomicroscopy|0|||
48904689|NCT00909792|157488648|FG000|Period 2|Lost to Follow-up|0|||
48904690|NCT00909792|157488649|FG001|Period 2|Lost to Follow-up|1|||
48904691|NCT02544217|157488655|FG000|Overall Study|Withdrawal by Subject|1|||
48904692|NCT02544217|157488656|FG001|Overall Study|Withdrawal by Subject|1|||
48904693|NCT02544217|157488657|FG002|Overall Study|Withdrawal by Subject|0|||
48904694|NCT02544217|157488658|FG003|Overall Study|Withdrawal by Subject|0|||
48904695|NCT02544217|157488659|FG004|Overall Study|Withdrawal by Subject|0|||
48904696|NCT02544217|157488660|FG005|Overall Study|Withdrawal by Subject|0|||
48904697|NCT02808143|157488661|FG000|Maintenance Phase|Disease recurrence|1|||
48904698|NCT02808143|157488662|FG001|Maintenance Phase|Disease recurrence|3|||
48904699|NCT02808143|157488661|FG000|Maintenance Phase|Disease progression|1|||
48904700|NCT02808143|157488662|FG001|Maintenance Phase|Disease progression|2|||
48904701|NCT02808143|157488661|FG000|Survival Follow-Up|Still in survival Follow-up|2|||
48951822|NCT00950690|157654905|FG000|Overall Study|Lost to Follow-up|40|||
48904702|NCT02808143|157488662|FG001|Survival Follow-Up|Still in survival Follow-up|3|||
48904703|NCT02808143|157488661|FG000|Survival Follow-Up|Disease recurrence|0|||
48904704|NCT02808143|157488662|FG001|Survival Follow-Up|Disease recurrence|2|||
48904705|NCT02808143|157488661|FG000|Survival Follow-Up|Adverse Event|0|||
48904706|NCT02808143|157488662|FG001|Survival Follow-Up|Adverse Event|1|||
48904707|NCT02808143|157488661|FG000|Survival Follow-Up|Death|1|||
48904708|NCT02808143|157488662|FG001|Survival Follow-Up|Death|0|||
48904709|NCT00293722|157488671|FG000|Overall Study|Other|427|||
48904710|NCT00667355|157488675|FG000|Overall Study|Adverse Event|5|||
48904711|NCT00667355|157488675|FG000|Overall Study|Lost to Follow-up|1|||
48904712|NCT00667355|157488675|FG000|Overall Study|Other reason was not specified|5|||
48904713|NCT01376349|157488676|FG000|Raondomized Treatment|Withdrawal by Subject|10|||
48904714|NCT01376349|157488677|FG001|Raondomized Treatment|Withdrawal by Subject|16|||
48904715|NCT01376349|157488678|FG002|Raondomized Treatment|Withdrawal by Subject|13|||
48904716|NCT01376349|157488676|FG000|Raondomized Treatment|Adverse Event|13|||
48904717|NCT01376349|157488677|FG001|Raondomized Treatment|Adverse Event|17|||
48904718|NCT01376349|157488678|FG002|Raondomized Treatment|Adverse Event|14|||
48904719|NCT01376349|157488676|FG000|Raondomized Treatment|Unkown|1|||
48904720|NCT01376349|157488677|FG001|Raondomized Treatment|Unkown|2|||
48904721|NCT01376349|157488678|FG002|Raondomized Treatment|Unkown|1|||
48904722|NCT01376349|157488676|FG000|Raondomized Treatment|Alternative Treatment|0|||
48904723|NCT01376349|157488677|FG001|Raondomized Treatment|Alternative Treatment|0|||
48904724|NCT01376349|157488678|FG002|Raondomized Treatment|Alternative Treatment|1|||
48904725|NCT00833911|157488679|FG000|Titration|Adverse Event|18|||
48904726|NCT00833911|157488679|FG000|Titration|Withdrawal by Subject|3|||
48904727|NCT00833911|157488679|FG000|Maintenance Phase I|Adverse Event|73|||
48904728|NCT00833911|157488679|FG000|Maintenance Phase I|Withdrawal by Subject|11|||
48904729|NCT00833911|157488679|FG000|Maintenance Phase I|Physician Decision|10|||
48904730|NCT00833911|157488679|FG000|Maintenance Phase I|Lack of Efficacy|4|||
48904731|NCT00833911|157488679|FG000|Maintenance Phase II|Adverse Event|6|||
48904732|NCT00833911|157488679|FG000|Maintenance Phase II|Physician Decision|2|||
48904733|NCT00833911|157488679|FG000|Maintenance Phase II|Withdrawal by Subject|1|||
48904734|NCT00833911|157488679|FG000|Maintenance Phase II|Lack of Efficacy|1|||
48904735|NCT00059839|157488680|FG000|Overall Study|Death|1|||
48904736|NCT00059839|157488681|FG001|Overall Study|Death|1|||
48904737|NCT00059839|157488680|FG000|Overall Study|Lack of Efficacy|6|||
48904738|NCT00059839|157488681|FG001|Overall Study|Lack of Efficacy|5|||
48904739|NCT00059839|157488680|FG000|Overall Study|Lost to Follow-up|2|||
48904740|NCT00059839|157488681|FG001|Overall Study|Lost to Follow-up|0|||
48904741|NCT00059839|157488680|FG000|Overall Study|Physician Decision|1|||
48904742|NCT00059839|157488681|FG001|Overall Study|Physician Decision|2|||
48904743|NCT00059839|157488680|FG000|Overall Study|Withdrawal by Subject|1|||
48904744|NCT00059839|157488681|FG001|Overall Study|Withdrawal by Subject|6|||
48904745|NCT00059839|157488680|FG000|Overall Study|Ineligible|1|||
48904746|NCT00059839|157488681|FG001|Overall Study|Ineligible|3|||
48904747|NCT01138007|157488692|FG000|Overall Study|Adverse Event|4|||
48904748|NCT01138007|157488693|FG001|Overall Study|Adverse Event|12|||
48904749|NCT01138007|157488694|FG002|Overall Study|Adverse Event|9|||
48904750|NCT01138007|157488692|FG000|Overall Study|Lack of Efficacy|2|||
48904751|NCT01138007|157488693|FG001|Overall Study|Lack of Efficacy|0|||
48904752|NCT01138007|157488694|FG002|Overall Study|Lack of Efficacy|6|||
48904753|NCT01138007|157488692|FG000|Overall Study|Protocol Violation|2|||
48904754|NCT01138007|157488693|FG001|Overall Study|Protocol Violation|3|||
48904755|NCT01138007|157488694|FG002|Overall Study|Protocol Violation|2|||
48904756|NCT01138007|157488692|FG000|Overall Study|Protocol-Defined Stopping Criteria|6|||
48904757|NCT01138007|157488693|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
48904758|NCT01138007|157488694|FG002|Overall Study|Protocol-Defined Stopping Criteria|8|||
48904759|NCT01138007|157488692|FG000|Overall Study|Lost to Follow-up|3|||
48904760|NCT01138007|157488693|FG001|Overall Study|Lost to Follow-up|3|||
48904761|NCT01138007|157488694|FG002|Overall Study|Lost to Follow-up|5|||
48904762|NCT01138007|157488692|FG000|Overall Study|Physician Decision|0|||
48904763|NCT01138007|157488693|FG001|Overall Study|Physician Decision|5|||
48904764|NCT01138007|157488694|FG002|Overall Study|Physician Decision|3|||
48904765|NCT01138007|157488692|FG000|Overall Study|Withdrawal by Subject|5|||
48904766|NCT01138007|157488693|FG001|Overall Study|Withdrawal by Subject|6|||
48904767|NCT01138007|157488694|FG002|Overall Study|Withdrawal by Subject|15|||
48904768|NCT03548987|157488695|FG000|Run-in Period (Week 0 to Week 20)|Other|9|||
48904769|NCT03548987|157488696|FG001|Run-in Period (Week 0 to Week 20)|Other|0|||
48904770|NCT03548987|157488695|FG000|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8|||
49116165|NCT02080364|158263074|FG001|Baseline Period|Protocol Violation|1|||
48904771|NCT03548987|157488696|FG001|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0|||
48904772|NCT03548987|157488695|FG000|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11|||
49116166|NCT02080364|158263075|FG002|Baseline Period|Protocol Violation|0|||
49116167|NCT02080364|158263076|FG003|Baseline Period|Protocol Violation|0|||
48904773|NCT03548987|157488696|FG001|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0|||
48904774|NCT03548987|157488695|FG000|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2|||
48951823|NCT00950690|157654905|FG000|Overall Study|Other|163|||
48904775|NCT03548987|157488696|FG001|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0|||
48904776|NCT03548987|157488695|FG000|Run-in Period (Week 0 to Week 20)|Run-in failure|19|||
48904777|NCT03548987|157488696|FG001|Run-in Period (Week 0 to Week 20)|Run-in failure|0|||
48904778|NCT03548987|157488695|FG000|Run-in Period (Week 0 to Week 20)|Pregnancy|1|||
48904779|NCT03548987|157488696|FG001|Run-in Period (Week 0 to Week 20)|Pregnancy|0|||
48904780|NCT03548987|157488695|FG000|Run-in Period (Week 0 to Week 20)|Protocol Violation|1|||
48904781|NCT03548987|157488696|FG001|Run-in Period (Week 0 to Week 20)|Protocol Violation|0|||
48904782|NCT03548987|157488695|FG000|Run-in Period (Week 0 to Week 20)|Adverse Event|48|||
48904783|NCT03548987|157488696|FG001|Run-in Period (Week 0 to Week 20)|Adverse Event|0|||
48904784|NCT03548987|157488695|FG000|Maintenance Period (Week 20 to Week 68)|other|12|||
48904785|NCT03548987|157488696|FG001|Maintenance Period (Week 20 to Week 68)|other|23|||
48904786|NCT03548987|157488695|FG000|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2|||
48904787|NCT03548987|157488696|FG001|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1|||
48904788|NCT03548987|157488695|FG000|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
48904789|NCT03548987|157488696|FG001|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
48904790|NCT03548987|157488695|FG000|Maintenance Period (Week 20 to Week 68)|Pregnancy|2|||
48904791|NCT03548987|157488696|FG001|Maintenance Period (Week 20 to Week 68)|Pregnancy|0|||
48904792|NCT03548987|157488695|FG000|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1|||
48904793|NCT03548987|157488696|FG001|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0|||
48904794|NCT03548987|157488695|FG000|Maintenance Period (Week 20 to Week 68)|Adverse Event|13|||
48904795|NCT03548987|157488696|FG001|Maintenance Period (Week 20 to Week 68)|Adverse Event|6|||
48904796|NCT00235326|157488702|FG000|Overall Study|Lost to Follow-up|746|||
48904797|NCT00235326|157488703|FG001|Overall Study|Lost to Follow-up|1400|||
48904798|NCT03334409|157488704|FG000|Overall Study|Did not meet inclusion criteria|1|||
48904799|NCT03334409|157488705|FG001|Overall Study|Did not meet inclusion criteria|0|||
48904800|NCT01324323|157488706|FG000|Overall Study|Withdrawal by Subject|1|||
48904801|NCT01790126|157488712|FG000|Overall Study|PSA Progression|12|||
48904802|NCT01790126|157488713|FG001|Overall Study|PSA Progression|16|||
48904803|NCT01790126|157488714|FG002|Overall Study|PSA Progression|16|||
48904804|NCT01790126|157488712|FG000|Overall Study|Other|5|||
48904805|NCT01790126|157488713|FG001|Overall Study|Other|4|||
48904806|NCT01790126|157488714|FG002|Overall Study|Other|8|||
48904807|NCT01790126|157488712|FG000|Overall Study|Initiation of Non-Protocol Therapy|3|||
48904808|NCT01790126|157488713|FG001|Overall Study|Initiation of Non-Protocol Therapy|4|||
48904809|NCT01790126|157488714|FG002|Overall Study|Initiation of Non-Protocol Therapy|2|||
48904810|NCT01790126|157488712|FG000|Overall Study|Withdrawal by Physician|1|||
48904811|NCT01790126|157488713|FG001|Overall Study|Withdrawal by Physician|1|||
48904812|NCT01790126|157488714|FG002|Overall Study|Withdrawal by Physician|2|||
48904813|NCT01790126|157488712|FG000|Overall Study|Withdrawal by Subject|3|||
48904814|NCT01790126|157488713|FG001|Overall Study|Withdrawal by Subject|1|||
48904815|NCT01790126|157488714|FG002|Overall Study|Withdrawal by Subject|2|||
48904816|NCT01790126|157488712|FG000|Overall Study|Lost to Follow-up|1|||
48904817|NCT01790126|157488713|FG001|Overall Study|Lost to Follow-up|0|||
48904818|NCT01790126|157488714|FG002|Overall Study|Lost to Follow-up|1|||
48904819|NCT01790126|157488712|FG000|Overall Study|Adverse Event|0|||
48904820|NCT01790126|157488713|FG001|Overall Study|Adverse Event|2|||
48904821|NCT01790126|157488714|FG002|Overall Study|Adverse Event|0|||
48904822|NCT01790126|157488712|FG000|Overall Study|Death|2|||
48904823|NCT01790126|157488713|FG001|Overall Study|Death|0|||
48904824|NCT01790126|157488714|FG002|Overall Study|Death|0|||
48904825|NCT01790126|157488712|FG000|Overall Study|Radiographic Progression|3|||
48904826|NCT01790126|157488713|FG001|Overall Study|Radiographic Progression|1|||
48904827|NCT01790126|157488714|FG002|Overall Study|Radiographic Progression|0|||
48904828|NCT00455325|157488715|FG000|Cohort 1: Placebo|Started exclusionary drug|1|||
48904829|NCT00455325|157488716|FG001|Cohort 1: Placebo|Started exclusionary drug|0|||
48904830|NCT00455325|157488717|FG002|Cohort 1: Placebo|Started exclusionary drug|0|||
48904831|NCT00455325|157488718|FG003|Cohort 1: Placebo|Started exclusionary drug|0|||
48904832|NCT00455325|157488715|FG000|Cohort 1: Placebo|Withdrawal by Subject|4|||
48904833|NCT00455325|157488716|FG001|Cohort 1: Placebo|Withdrawal by Subject|0|||
48904834|NCT00455325|157488717|FG002|Cohort 1: Placebo|Withdrawal by Subject|0|||
48904835|NCT00455325|157488718|FG003|Cohort 1: Placebo|Withdrawal by Subject|0|||
48904836|NCT00455325|157488715|FG000|Cohort 1: Placebo|Lost to Follow-up|1|||
48904837|NCT00455325|157488716|FG001|Cohort 1: Placebo|Lost to Follow-up|0|||
48904838|NCT00455325|157488717|FG002|Cohort 1: Placebo|Lost to Follow-up|0|||
48904839|NCT00455325|157488718|FG003|Cohort 1: Placebo|Lost to Follow-up|0|||
48904840|NCT00455325|157488715|FG000|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|1|||
48904841|NCT00455325|157488716|FG001|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
48904842|NCT00455325|157488717|FG002|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
48904843|NCT00455325|157488718|FG003|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
48904844|NCT00455325|157488715|FG000|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|1|||
49116168|NCT02080364|158263073|FG000|Baseline Period|Other|0|||
48904845|NCT00455325|157488716|FG001|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
48904846|NCT00455325|157488717|FG002|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
48904847|NCT00455325|157488718|FG003|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
48904848|NCT00455325|157488715|FG000|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
48904849|NCT00455325|157488716|FG001|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|1|||
48904850|NCT00455325|157488717|FG002|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
48904851|NCT00455325|157488718|FG003|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
48904852|NCT00455325|157488715|FG000|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
48904853|NCT00455325|157488716|FG001|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
48904854|NCT00455325|157488717|FG002|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|1|||
48904855|NCT00455325|157488718|FG003|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
48904856|NCT04620811|157488719|FG000|Overall Study|Withdrawal by Subject|18|||
48904857|NCT04620811|157488720|FG001|Overall Study|Withdrawal by Subject|15|||
48904858|NCT04620811|157488719|FG000|Overall Study|Adverse Event|6|||
48904859|NCT04620811|157488720|FG001|Overall Study|Adverse Event|11|||
48904860|NCT04620811|157488719|FG000|Overall Study|Lost to Follow-up|4|||
48904861|NCT04620811|157488720|FG001|Overall Study|Lost to Follow-up|8|||
48904862|NCT04620811|157488719|FG000|Overall Study|Physician Decision|1|||
48904863|NCT04620811|157488720|FG001|Overall Study|Physician Decision|4|||
48904864|NCT04620811|157488719|FG000|Overall Study|Sponsor Decision|0|||
48904865|NCT04620811|157488720|FG001|Overall Study|Sponsor Decision|1|||
48904866|NCT04620811|157488719|FG000|Overall Study|Elevation of ALT or AST|1|||
48904867|NCT04620811|157488720|FG001|Overall Study|Elevation of ALT or AST|0|||
48904868|NCT04620811|157488719|FG000|Overall Study|Other|3|||
48904869|NCT04620811|157488720|FG001|Overall Study|Other|5|||
48904870|NCT01230788|157488725|FG000|Overall Study|Prescribed exclusion drug|1|||
48904871|NCT01271803|157488728|FG000|Overall Study|Progressive disease|0|||
48904872|NCT01271803|157488729|FG001|Overall Study|Progressive disease|0|||
48904873|NCT01271803|157488730|FG002|Overall Study|Progressive disease|2|||
48904874|NCT01271803|157488728|FG000|Overall Study|Death|53|||
48904875|NCT01271803|157488729|FG001|Overall Study|Death|34|||
48904876|NCT01271803|157488730|FG002|Overall Study|Death|0|||
48904877|NCT01271803|157488728|FG000|Overall Study|Withdrawal by Subject|1|||
48904878|NCT01271803|157488729|FG001|Overall Study|Withdrawal by Subject|5|||
48904879|NCT01271803|157488730|FG002|Overall Study|Withdrawal by Subject|0|||
48904880|NCT01271803|157488728|FG000|Overall Study|Lost to Follow-up|1|||
48904881|NCT01271803|157488729|FG001|Overall Study|Lost to Follow-up|0|||
48904882|NCT01271803|157488730|FG002|Overall Study|Lost to Follow-up|0|||
48904883|NCT05211739|157488732|FG000|First Wear Period (Approx 30 Days)|Adverse Event|0|||
48904884|NCT05211739|157488733|FG001|First Wear Period (Approx 30 Days)|Adverse Event|1|||
48904885|NCT05211739|157488732|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|1|||
48904886|NCT05211739|157488733|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|0|||
48904887|NCT05211739|157488732|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
48904888|NCT05211739|157488733|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
48904889|NCT05211739|157488732|FG000|Second Wear Period (Approx 30 Days)|Adverse Event|1|||
48904890|NCT05211739|157488733|FG001|Second Wear Period (Approx 30 Days)|Adverse Event|0|||
48904891|NCT01019317|157488734|FG000|Overall Study|Not Eligible|4|||
48904892|NCT01971203|157488735|FG000|Overall Study|Protocol Violation|3|||
48904893|NCT01971203|157488736|FG001|Overall Study|Protocol Violation|2|||
48904894|NCT01971203|157488735|FG000|Overall Study|Withdrawal by Subject|5|||
48904895|NCT01971203|157488736|FG001|Overall Study|Withdrawal by Subject|6|||
48904896|NCT01971203|157488735|FG000|Overall Study|Adverse Event|1|||
48904897|NCT01971203|157488736|FG001|Overall Study|Adverse Event|0|||
48904898|NCT00307125|157488739|FG000|Screening Phase|Adverse Event|1|||
48904899|NCT00307125|157488740|FG001|Screening Phase|Adverse Event|0|||
48904900|NCT00307125|157488741|FG002|Screening Phase|Adverse Event|0|||
48904901|NCT00307125|157488739|FG000|Screening Phase|Protocol Violation|27|||
48904902|NCT00307125|157488740|FG001|Screening Phase|Protocol Violation|0|||
48904903|NCT00307125|157488741|FG002|Screening Phase|Protocol Violation|0|||
48904904|NCT00307125|157488739|FG000|Screening Phase|Lost to Follow-up|87|||
48904905|NCT00307125|157488740|FG001|Screening Phase|Lost to Follow-up|0|||
48904906|NCT00307125|157488741|FG002|Screening Phase|Lost to Follow-up|0|||
49116169|NCT02080364|158263074|FG001|Baseline Period|Other|1|||
48904907|NCT00307125|157488739|FG000|Screening Phase|Death|10|||
48904908|NCT00307125|157488740|FG001|Screening Phase|Death|0|||
48904909|NCT00307125|157488741|FG002|Screening Phase|Death|0|||
48904910|NCT00307125|157488739|FG000|Screening Phase|Withdrawal by Subject|77|||
48904911|NCT00307125|157488740|FG001|Screening Phase|Withdrawal by Subject|0|||
48904912|NCT00307125|157488741|FG002|Screening Phase|Withdrawal by Subject|0|||
48904913|NCT00307125|157488739|FG000|Screening Phase|Physician Decision|26|||
48904914|NCT00307125|157488740|FG001|Screening Phase|Physician Decision|0|||
48904915|NCT00307125|157488741|FG002|Screening Phase|Physician Decision|0|||
48904916|NCT00307125|157488739|FG000|Screening Phase|Sponsor Decision|4|||
48904917|NCT00307125|157488740|FG001|Screening Phase|Sponsor Decision|0|||
48904918|NCT00307125|157488741|FG002|Screening Phase|Sponsor Decision|0|||
48904919|NCT00307125|157488739|FG000|Screening Phase|Study Terminated|17|||
48904920|NCT00307125|157488740|FG001|Screening Phase|Study Terminated|0|||
48904921|NCT00307125|157488741|FG002|Screening Phase|Study Terminated|0|||
48904922|NCT00307125|157488739|FG000|Screening Phase|Graft Loss|3|||
48904923|NCT00307125|157488740|FG001|Screening Phase|Graft Loss|0|||
48904924|NCT00307125|157488741|FG002|Screening Phase|Graft Loss|0|||
48904925|NCT00307125|157488739|FG000|Screening Phase|Graft Failure|8|||
48904926|NCT00307125|157488740|FG001|Screening Phase|Graft Failure|0|||
48904927|NCT00307125|157488741|FG002|Screening Phase|Graft Failure|0|||
48904928|NCT00307125|157488739|FG000|Screening Phase|Follow-up period ended on Dec 31, 2011|83|||
48904929|NCT00307125|157488740|FG001|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
48904930|NCT00307125|157488741|FG002|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
48904931|NCT00307125|157488739|FG000|Screening Phase|Scheduling issues/Non-compliance|55|||
48904932|NCT00307125|157488740|FG001|Screening Phase|Scheduling issues/Non-compliance|0|||
48904933|NCT00307125|157488741|FG002|Screening Phase|Scheduling issues/Non-compliance|0|||
48904934|NCT00307125|157488739|FG000|Screening Phase|Moved or transferred facilities|34|||
48904935|NCT00307125|157488740|FG001|Screening Phase|Moved or transferred facilities|0|||
48904936|NCT00307125|157488741|FG002|Screening Phase|Moved or transferred facilities|0|||
48904937|NCT00307125|157488739|FG000|Screening Phase|Received Pancreas Transplant|8|||
48904938|NCT00307125|157488740|FG001|Screening Phase|Received Pancreas Transplant|0|||
48904939|NCT00307125|157488741|FG002|Screening Phase|Received Pancreas Transplant|0|||
48904940|NCT00307125|157488739|FG000|Screening Phase|Ineligible for pilot|4|||
48904941|NCT00307125|157488740|FG001|Screening Phase|Ineligible for pilot|0|||
48904942|NCT00307125|157488741|FG002|Screening Phase|Ineligible for pilot|0|||
48904943|NCT00307125|157488739|FG000|Screening Phase|Try to get pregnant|1|||
48904944|NCT00307125|157488740|FG001|Screening Phase|Try to get pregnant|0|||
48904945|NCT00307125|157488741|FG002|Screening Phase|Try to get pregnant|0|||
48904946|NCT00307125|157488739|FG000|Screening Phase|Developed acute leukemia|1|||
48904947|NCT00307125|157488740|FG001|Screening Phase|Developed acute leukemia|0|||
48904948|NCT00307125|157488741|FG002|Screening Phase|Developed acute leukemia|0|||
48904949|NCT00307125|157488739|FG000|Screening Phase|Metastatic colon cancer|1|||
48904950|NCT00307125|157488740|FG001|Screening Phase|Metastatic colon cancer|0|||
48904951|NCT00307125|157488741|FG002|Screening Phase|Metastatic colon cancer|0|||
48904952|NCT00307125|157488739|FG000|Screening Phase|Malignancy|1|||
48904953|NCT00307125|157488740|FG001|Screening Phase|Malignancy|0|||
48904954|NCT00307125|157488741|FG002|Screening Phase|Malignancy|0|||
48904955|NCT00307125|157488739|FG000|Screening Phase|PAK|1|||
48904956|NCT00307125|157488740|FG001|Screening Phase|PAK|0|||
48904957|NCT00307125|157488741|FG002|Screening Phase|PAK|0|||
48904958|NCT00307125|157488739|FG000|Screening Phase|Ineligible|1|||
48904959|NCT00307125|157488740|FG001|Screening Phase|Ineligible|0|||
48904960|NCT00307125|157488741|FG002|Screening Phase|Ineligible|0|||
48904961|NCT00307125|157488739|FG000|Screening Phase|Screen Error|1|||
48904962|NCT00307125|157488740|FG001|Screening Phase|Screen Error|0|||
48904963|NCT00307125|157488741|FG002|Screening Phase|Screen Error|0|||
48904964|NCT00307125|157488739|FG000|Screening Phase|Sample of Anti-HLA Ab was not obtained|1|||
48904965|NCT00307125|157488740|FG001|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
48904966|NCT00307125|157488741|FG002|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
48904967|NCT00307125|157488739|FG000|Screening Phase|AMR and treated with rituximab|1|||
48904968|NCT00307125|157488740|FG001|Screening Phase|AMR and treated with rituximab|0|||
48904969|NCT00307125|157488741|FG002|Screening Phase|AMR and treated with rituximab|0|||
48904970|NCT00307125|157488739|FG000|Screening Phase|Coronary artery bypass|1|||
48904971|NCT00307125|157488740|FG001|Screening Phase|Coronary artery bypass|0|||
48904972|NCT00307125|157488741|FG002|Screening Phase|Coronary artery bypass|0|||
48904973|NCT00307125|157488739|FG000|Pilot Phase|Lost to Follow-up|0|||
48904974|NCT00307125|157488740|FG001|Pilot Phase|Lost to Follow-up|1|||
48904975|NCT00307125|157488741|FG002|Pilot Phase|Lost to Follow-up|0|||
48904976|NCT00307125|157488739|FG000|Pilot Phase|Withdrawal by Subject|0|||
48904977|NCT00307125|157488740|FG001|Pilot Phase|Withdrawal by Subject|1|||
48904978|NCT00307125|157488741|FG002|Pilot Phase|Withdrawal by Subject|1|||
48904979|NCT03267940|157488752|FG000|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1|||
48904980|NCT03267940|157488753|FG001|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2|||
48904981|NCT03267940|157488754|FG002|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
48904982|NCT03267940|157488755|FG003|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
48904983|NCT03267940|157488756|FG004|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
48904984|NCT03267940|157488757|FG005|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
48904985|NCT03267940|157488752|FG000|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
48904986|NCT03267940|157488753|FG001|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1|||
48904987|NCT03267940|157488754|FG002|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
48904988|NCT03267940|157488755|FG003|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
48904989|NCT03267940|157488756|FG004|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
48904990|NCT03267940|157488757|FG005|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
48904991|NCT03267940|157488752|FG000|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
48904992|NCT03267940|157488753|FG001|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1|||
49010513|NCT03760510|157875633|FG000|Overall Study|Not ventilated for 24 hours|105|||
48904993|NCT03267940|157488754|FG002|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
48904994|NCT03267940|157488755|FG003|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
48904995|NCT03267940|157488756|FG004|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
48904996|NCT03267940|157488757|FG005|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
48904997|NCT03267940|157488752|FG000|Run-in Portion (Max. Exposure: 508 Days)|Death|7|||
48904998|NCT03267940|157488753|FG001|Run-in Portion (Max. Exposure: 508 Days)|Death|3|||
48904999|NCT03267940|157488754|FG002|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
48905000|NCT03267940|157488755|FG003|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
48905001|NCT03267940|157488756|FG004|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
48905002|NCT03267940|157488757|FG005|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
48905003|NCT03267940|157488752|FG000|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
48905004|NCT03267940|157488753|FG001|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
48905005|NCT03267940|157488754|FG002|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
48905006|NCT03267940|157488755|FG003|Expansion (Maximum Exposure: 421 Days)|Other than specified|3|||
48905007|NCT03267940|157488756|FG004|Expansion (Maximum Exposure: 421 Days)|Other than specified|2|||
48905008|NCT03267940|157488757|FG005|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
48905009|NCT03267940|157488752|FG000|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
48905010|NCT03267940|157488753|FG001|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
48905011|NCT03267940|157488754|FG002|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
48905012|NCT03267940|157488755|FG003|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1|||
48905013|NCT03267940|157488756|FG004|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
48905014|NCT03267940|157488757|FG005|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
48905015|NCT03267940|157488752|FG000|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
48905016|NCT03267940|157488753|FG001|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
48905017|NCT03267940|157488754|FG002|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2|||
48905018|NCT03267940|157488755|FG003|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
48905019|NCT03267940|157488756|FG004|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
48905020|NCT03267940|157488757|FG005|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
48905021|NCT03267940|157488752|FG000|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
48905022|NCT03267940|157488753|FG001|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
48905023|NCT03267940|157488754|FG002|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7|||
48905024|NCT03267940|157488755|FG003|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4|||
48905025|NCT03267940|157488756|FG004|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5|||
48905026|NCT03267940|157488757|FG005|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3|||
48905027|NCT03267940|157488752|FG000|Expansion (Maximum Exposure: 421 Days)|Death|0|||
48905028|NCT03267940|157488753|FG001|Expansion (Maximum Exposure: 421 Days)|Death|0|||
48905029|NCT03267940|157488754|FG002|Expansion (Maximum Exposure: 421 Days)|Death|10|||
48905030|NCT03267940|157488755|FG003|Expansion (Maximum Exposure: 421 Days)|Death|13|||
48905031|NCT03267940|157488756|FG004|Expansion (Maximum Exposure: 421 Days)|Death|0|||
48905032|NCT03267940|157488757|FG005|Expansion (Maximum Exposure: 421 Days)|Death|6|||
48905033|NCT01136811|157488764|FG000|Overall Study|Physician Decision|11|||
48905034|NCT00803270|157488765|FG000|Overall Study|Lost to Follow-up|1|||
48905035|NCT00803270|157488766|FG001|Overall Study|Lost to Follow-up|2|||
48905036|NCT01605253|157488768|FG000|Overall Study|Physician Decision|3|||
48905037|NCT01605253|157488769|FG001|Overall Study|Physician Decision|2|||
48905038|NCT01605253|157488768|FG000|Overall Study|Lost to Follow-up|3|||
48905039|NCT01605253|157488769|FG001|Overall Study|Lost to Follow-up|1|||
48905040|NCT02742766|157488776|FG000|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
48905041|NCT02742766|157488777|FG001|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
48905042|NCT02742766|157488778|FG002|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
48905043|NCT02742766|157488779|FG003|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
48905044|NCT02742766|157488780|FG004|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
48905045|NCT02742766|157488781|FG005|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
48905046|NCT02742766|157488782|FG006|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
48905047|NCT02742766|157488783|FG007|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
48905048|NCT02742766|157488784|FG008|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
48905049|NCT02742766|157488785|FG009|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
48905050|NCT02742766|157488786|FG010|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
48905051|NCT02742766|157488787|FG011|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
48905052|NCT02742766|157488788|FG012|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
48905053|NCT02742766|157488789|FG013|Part 2 (Up to 22 Days)|Withdrawal by Subject|1|||
48905054|NCT02742766|157488790|FG014|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
48905055|NCT02742766|157488791|FG015|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
48905056|NCT02742766|157488792|FG016|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
48905057|NCT02742766|157488793|FG017|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
48905058|NCT02742766|157488794|FG018|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
48905059|NCT02742766|157488776|FG000|Part 2 (Up to 22 Days)|Physician Decision|0|||
48905060|NCT02742766|157488777|FG001|Part 2 (Up to 22 Days)|Physician Decision|0|||
48905061|NCT02742766|157488778|FG002|Part 2 (Up to 22 Days)|Physician Decision|0|||
48905062|NCT02742766|157488779|FG003|Part 2 (Up to 22 Days)|Physician Decision|0|||
48905063|NCT02742766|157488780|FG004|Part 2 (Up to 22 Days)|Physician Decision|0|||
48905064|NCT02742766|157488781|FG005|Part 2 (Up to 22 Days)|Physician Decision|0|||
48905065|NCT02742766|157488782|FG006|Part 2 (Up to 22 Days)|Physician Decision|0|||
48905066|NCT02742766|157488783|FG007|Part 2 (Up to 22 Days)|Physician Decision|0|||
48905067|NCT02742766|157488784|FG008|Part 2 (Up to 22 Days)|Physician Decision|0|||
48905068|NCT02742766|157488785|FG009|Part 2 (Up to 22 Days)|Physician Decision|0|||
48905069|NCT02742766|157488786|FG010|Part 2 (Up to 22 Days)|Physician Decision|0|||
48905070|NCT02742766|157488787|FG011|Part 2 (Up to 22 Days)|Physician Decision|0|||
48905071|NCT02742766|157488788|FG012|Part 2 (Up to 22 Days)|Physician Decision|2|||
48905072|NCT02742766|157488789|FG013|Part 2 (Up to 22 Days)|Physician Decision|5|||
48905073|NCT02742766|157488790|FG014|Part 2 (Up to 22 Days)|Physician Decision|0|||
48905074|NCT02742766|157488791|FG015|Part 2 (Up to 22 Days)|Physician Decision|1|||
48905075|NCT02742766|157488792|FG016|Part 2 (Up to 22 Days)|Physician Decision|0|||
48905076|NCT02742766|157488793|FG017|Part 2 (Up to 22 Days)|Physician Decision|0|||
48905077|NCT02742766|157488794|FG018|Part 2 (Up to 22 Days)|Physician Decision|0|||
48905078|NCT00999713|157488795|FG000|Overall Study|Physician Decision|2|||
48905079|NCT00999713|157488796|FG001|Overall Study|Physician Decision|0|||
48905080|NCT01906346|157488799|FG000|Overall Study|AEs|1|||
48905081|NCT03707925|157488800|FG000|Overall Study|Inevaluable|1|||
48905082|NCT01891721|157488807|FG000|Overall Study|Lost to Follow-up|10|||
48905083|NCT01891721|157488808|FG001|Overall Study|Lost to Follow-up|5|||
48905084|NCT01891721|157488809|FG002|Overall Study|Lost to Follow-up|1|||
48905085|NCT04014361|157488810|FG000|Period 2|Physician Decision|0|||
48905086|NCT04014361|157488811|FG001|Period 2|Physician Decision|0|||
48905087|NCT04014361|157488812|FG002|Period 2|Physician Decision|0|||
48905088|NCT04014361|157488813|FG003|Period 2|Physician Decision|1|||
48905089|NCT04014361|157488814|FG004|Period 2|Physician Decision|0|||
48905090|NCT04014361|157488815|FG005|Period 2|Physician Decision|0|||
48905091|NCT04014361|157488816|FG006|Period 2|Physician Decision|0|||
48905092|NCT04014361|157488817|FG007|Period 2|Physician Decision|0|||
48905093|NCT01422850|157488822|FG000|Overall Study|Physician Decision|3|||
48905094|NCT03040622|157488826|FG000|Overall Study|unable to implant device|3|||
48905095|NCT00826111|157490282|FG000|Overall Study|Lost to Follow-up|0|||
48905096|NCT00826111|157490283|FG001|Overall Study|Lost to Follow-up|1|||
48905097|NCT00826111|157490282|FG000|Overall Study|Protocol Violation|1|||
48905098|NCT00826111|157490283|FG001|Overall Study|Protocol Violation|0|||
48905099|NCT00826111|157490282|FG000|Overall Study|Withdrawal by Subject|5|||
48905100|NCT00826111|157490283|FG001|Overall Study|Withdrawal by Subject|0|||
48905101|NCT00826111|157490282|FG000|Overall Study|Physician Decision|1|||
48905102|NCT00826111|157490283|FG001|Overall Study|Physician Decision|1|||
48905103|NCT01672788|157490284|FG000|Washout Period 2 (7 Days)|Adverse Event|0|||
48905104|NCT01672788|157490285|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
48905105|NCT01672788|157490286|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
48905106|NCT01672788|157490287|FG003|Washout Period 2 (7 Days)|Adverse Event|1|||
48905107|NCT01222507|157490288|FG000|Overall Study|Physician Decision|1|||
48905108|NCT01222507|157490288|FG000|Overall Study|Withdrawal by Subject|1|||
48905109|NCT01557283|157490289|FG000|Overall Study|Lost to Follow-up|7|||
48905110|NCT01557283|157490289|FG000|Overall Study|Non-responder|19|||
48905111|NCT01557283|157490289|FG000|Overall Study|Adverse Event|7|||
48905112|NCT01557283|157490289|FG000|Overall Study|Lack of Efficacy|1|||
48905113|NCT01557283|157490289|FG000|Overall Study|Non-compliance|1|||
48905114|NCT01557283|157490289|FG000|Overall Study|Withdrawal by Subject|1|||
48905115|NCT01557283|157490289|FG000|Overall Study|Participant's weight too high for dose|1|||
48905116|NCT01557283|157490289|FG000|Overall Study|Worsening of psoriasis|1|||
48905117|NCT01557283|157490289|FG000|Overall Study|Other|6|||
48905118|NCT00352885|157490291|FG000|Overall Study|Withdrawal by Subject|0|||
48905119|NCT00352885|157490292|FG001|Overall Study|Withdrawal by Subject|3|||
48905120|NCT00352885|157490291|FG000|Overall Study|Development of major depression|0|||
48905121|NCT00352885|157490292|FG001|Overall Study|Development of major depression|1|||
48905122|NCT00352885|157490291|FG000|Overall Study|Progression of metastatic melanoma|5|||
48905123|NCT00352885|157490292|FG001|Overall Study|Progression of metastatic melanoma|3|||
48905124|NCT00352885|157490291|FG000|Overall Study|Side effects of IL-2 administration|1|||
48905125|NCT00352885|157490292|FG001|Overall Study|Side effects of IL-2 administration|0|||
48905126|NCT01678209|157490293|FG000|Overall Study|could not scan twice|1|||
48905127|NCT01678209|157490294|FG001|Overall Study|could not scan twice|1|||
48905128|NCT01678209|157490295|FG002|Overall Study|could not scan twice|1|||
48905129|NCT01678209|157490293|FG000|Overall Study|scheduling conflicts|0|||
48905130|NCT01678209|157490294|FG001|Overall Study|scheduling conflicts|0|||
48905131|NCT01678209|157490295|FG002|Overall Study|scheduling conflicts|1|||
48905132|NCT01678209|157490293|FG000|Overall Study|screen fail|16|||
48905133|NCT01678209|157490294|FG001|Overall Study|screen fail|17|||
48905134|NCT01678209|157490295|FG002|Overall Study|screen fail|16|||
48905135|NCT02120625|157490296|FG000|Overall Study|Physician Decision|2|||
48905136|NCT00892177|157490299|FG000|Phase II|Ineligible|0|||
48905137|NCT00892177|157490300|FG001|Phase II|Ineligible|0|||
48905138|NCT00892177|157490301|FG002|Phase II|Ineligible|0|||
48905139|NCT00892177|157490302|FG003|Phase II|Ineligible|0|||
48905140|NCT00892177|157490303|FG004|Phase II|Ineligible|1|||
48905141|NCT00892177|157490304|FG005|Phase II|Ineligible|1|||
48905142|NCT00892177|157490299|FG000|Phase II|Withdrawal by Subject|0|||
48905143|NCT00892177|157490300|FG001|Phase II|Withdrawal by Subject|0|||
48905144|NCT00892177|157490301|FG002|Phase II|Withdrawal by Subject|0|||
48905145|NCT00892177|157490302|FG003|Phase II|Withdrawal by Subject|0|||
48905146|NCT00892177|157490303|FG004|Phase II|Withdrawal by Subject|4|||
48905147|NCT00892177|157490304|FG005|Phase II|Withdrawal by Subject|1|||
48905148|NCT01009203|157490305|FG000|Overall Study|Withdrawal by Subject|1|||
48905149|NCT01009203|157490305|FG000|Overall Study|Adverse Event|5|||
48905150|NCT01009203|157490305|FG000|Overall Study|Treatment-unrelated death|1|||
48905151|NCT02249767|157490306|FG000|Overall Study|Did not use medication|8|||
48905152|NCT02249767|157490307|FG001|Overall Study|Did not use medication|9|||
48905153|NCT02249767|157490308|FG002|Overall Study|Did not use medication|8|||
48905154|NCT01372410|157490309|FG000|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
48905155|NCT01372410|157490310|FG001|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
48905156|NCT01372410|157490311|FG002|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
48905157|NCT01372410|157490312|FG003|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
48905158|NCT01372410|157490313|FG004|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
48905159|NCT01372410|157490314|FG005|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
48905160|NCT01372410|157490315|FG006|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
48905161|NCT01372410|157490316|FG007|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
48905162|NCT01372410|157490309|FG000|Treatment Period 1 (7 Days)|Adverse Event|0|||
48905163|NCT01372410|157490310|FG001|Treatment Period 1 (7 Days)|Adverse Event|1|||
48905164|NCT01372410|157490311|FG002|Treatment Period 1 (7 Days)|Adverse Event|0|||
48905165|NCT01372410|157490312|FG003|Treatment Period 1 (7 Days)|Adverse Event|0|||
48905166|NCT01372410|157490313|FG004|Treatment Period 1 (7 Days)|Adverse Event|0|||
48905167|NCT01372410|157490314|FG005|Treatment Period 1 (7 Days)|Adverse Event|0|||
48905168|NCT01372410|157490315|FG006|Treatment Period 1 (7 Days)|Adverse Event|1|||
48905169|NCT01372410|157490316|FG007|Treatment Period 1 (7 Days)|Adverse Event|0|||
48905170|NCT01372410|157490309|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
48905171|NCT01372410|157490310|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
48905172|NCT01372410|157490311|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
48905173|NCT01372410|157490312|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
48905174|NCT01372410|157490313|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
48905175|NCT01372410|157490314|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
48905176|NCT01372410|157490315|FG006|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
48905177|NCT01372410|157490316|FG007|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
48905178|NCT01372410|157490309|FG000|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
48905179|NCT01372410|157490310|FG001|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
48905180|NCT01372410|157490311|FG002|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
48905181|NCT01372410|157490312|FG003|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
48905182|NCT01372410|157490313|FG004|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
48905183|NCT01372410|157490314|FG005|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
48905184|NCT01372410|157490315|FG006|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1|||
48905185|NCT01372410|157490316|FG007|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
48905186|NCT01372410|157490309|FG000|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
48905187|NCT01372410|157490310|FG001|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
48905188|NCT01372410|157490311|FG002|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
48905189|NCT01372410|157490312|FG003|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
48905190|NCT01372410|157490313|FG004|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
48905191|NCT01372410|157490314|FG005|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
48905192|NCT01372410|157490315|FG006|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
48905193|NCT01372410|157490316|FG007|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
48905194|NCT01372410|157490309|FG000|Washout Period 2 (10-14 Days)|Adverse Event|0|||
48905195|NCT01372410|157490310|FG001|Washout Period 2 (10-14 Days)|Adverse Event|0|||
48905196|NCT01372410|157490311|FG002|Washout Period 2 (10-14 Days)|Adverse Event|0|||
48905197|NCT01372410|157490312|FG003|Washout Period 2 (10-14 Days)|Adverse Event|0|||
48905198|NCT01372410|157490313|FG004|Washout Period 2 (10-14 Days)|Adverse Event|1|||
48905199|NCT01372410|157490314|FG005|Washout Period 2 (10-14 Days)|Adverse Event|0|||
48905200|NCT01372410|157490315|FG006|Washout Period 2 (10-14 Days)|Adverse Event|0|||
48905201|NCT01372410|157490316|FG007|Washout Period 2 (10-14 Days)|Adverse Event|0|||
48905202|NCT01372410|157490309|FG000|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
48905203|NCT01372410|157490310|FG001|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
48905204|NCT01372410|157490311|FG002|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
48905205|NCT01372410|157490312|FG003|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
48905206|NCT01372410|157490313|FG004|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
48905207|NCT01372410|157490314|FG005|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
48905208|NCT01372410|157490315|FG006|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
48905209|NCT01372410|157490316|FG007|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
48905210|NCT01372410|157490309|FG000|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
48905211|NCT01372410|157490310|FG001|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
48905212|NCT01372410|157490311|FG002|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
48905213|NCT01372410|157490312|FG003|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
48905214|NCT01372410|157490313|FG004|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
48905215|NCT01372410|157490314|FG005|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
48905216|NCT01372410|157490315|FG006|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
48905217|NCT01372410|157490316|FG007|Washout Period 2 (10-14 Days)|Lack of Efficacy|1|||
48905218|NCT01372410|157490309|FG000|Treatment Period 3 (7 Days)|Adverse Event|0|||
48905219|NCT01372410|157490310|FG001|Treatment Period 3 (7 Days)|Adverse Event|0|||
48905220|NCT01372410|157490311|FG002|Treatment Period 3 (7 Days)|Adverse Event|1|||
48905221|NCT01372410|157490312|FG003|Treatment Period 3 (7 Days)|Adverse Event|0|||
48905222|NCT01372410|157490313|FG004|Treatment Period 3 (7 Days)|Adverse Event|0|||
48905223|NCT01372410|157490314|FG005|Treatment Period 3 (7 Days)|Adverse Event|0|||
48905224|NCT01372410|157490315|FG006|Treatment Period 3 (7 Days)|Adverse Event|0|||
48905225|NCT01372410|157490316|FG007|Treatment Period 3 (7 Days)|Adverse Event|0|||
48905226|NCT01372410|157490309|FG000|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
49116170|NCT02080364|158263075|FG002|Baseline Period|Other|1|||
49116171|NCT02080364|158263076|FG003|Baseline Period|Other|0|||
49116172|NCT02080364|158263073|FG000|Treatment Period|Adverse Event|10|||
48905227|NCT01372410|157490310|FG001|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
48905228|NCT01372410|157490311|FG002|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
48905229|NCT01372410|157490312|FG003|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
48905230|NCT01372410|157490313|FG004|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
48905231|NCT01372410|157490314|FG005|Treatment Period 3 (7 Days)|Protocol Deviation|1|||
48905232|NCT01372410|157490315|FG006|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
49116173|NCT02080364|158263074|FG001|Treatment Period|Adverse Event|15|||
48905233|NCT01372410|157490316|FG007|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
48905234|NCT05395104|157490318|FG000|Overall Study|Met Liver Stopping Criteria|1|||
48905235|NCT05395104|157490318|FG000|Overall Study|Withdrawal by Subject|1|||
48905236|NCT05105789|157490324|FG000|Overall Study|Laboratory's lab collection device damaged|1|||
48905237|NCT01067326|157490331|FG000|Overall Study|Adverse Event|0|||
48905238|NCT01067326|157490332|FG001|Overall Study|Adverse Event|2|||
48905239|NCT01067326|157490331|FG000|Overall Study|Withdrawal by Subject|1|||
48905240|NCT01067326|157490332|FG001|Overall Study|Withdrawal by Subject|0|||
48905241|NCT01067326|157490331|FG000|Overall Study|Early Study Termination|1|||
48905242|NCT01067326|157490332|FG001|Overall Study|Early Study Termination|1|||
48905243|NCT00634010|157490335|FG000|Overall Study|Adverse Event|2|||
48905244|NCT00634010|157490336|FG001|Overall Study|Adverse Event|5|||
48905245|NCT00634010|157490335|FG000|Overall Study|Withdrawal by Subject|5|||
48905246|NCT00634010|157490336|FG001|Overall Study|Withdrawal by Subject|6|||
48905247|NCT00634010|157490335|FG000|Overall Study|Physician Decision|1|||
48905248|NCT00634010|157490336|FG001|Overall Study|Physician Decision|1|||
48905249|NCT00634010|157490335|FG000|Overall Study|Disease Progression|1|||
48905250|NCT00634010|157490336|FG001|Overall Study|Disease Progression|1|||
48905251|NCT00634010|157490335|FG000|Overall Study|Non-Compliant|1|||
48905252|NCT00634010|157490336|FG001|Overall Study|Non-Compliant|1|||
48905253|NCT01862640|157490337|FG000|Overall Study|Adverse Event|4|||
48905254|NCT01862640|157490338|FG001|Overall Study|Adverse Event|10|||
48905255|NCT01862640|157490339|FG002|Overall Study|Adverse Event|6|||
48905256|NCT01862640|157490340|FG003|Overall Study|Adverse Event|8|||
48905257|NCT01862640|157490337|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
48905258|NCT01862640|157490338|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
48905259|NCT01862640|157490339|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
48905260|NCT01862640|157490340|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
48905261|NCT01862640|157490337|FG000|Overall Study|Participant Withdrawn by Investigator|0|||
48905262|NCT01862640|157490338|FG001|Overall Study|Participant Withdrawn by Investigator|1|||
48905263|NCT01862640|157490339|FG002|Overall Study|Participant Withdrawn by Investigator|1|||
48905264|NCT01862640|157490340|FG003|Overall Study|Participant Withdrawn by Investigator|1|||
48905265|NCT01862640|157490337|FG000|Overall Study|Withdrawal by Subject|2|||
48905266|NCT01862640|157490338|FG001|Overall Study|Withdrawal by Subject|4|||
48905267|NCT01862640|157490339|FG002|Overall Study|Withdrawal by Subject|8|||
48905268|NCT01862640|157490340|FG003|Overall Study|Withdrawal by Subject|5|||
48905269|NCT01862640|157490337|FG000|Overall Study|Protocol Deviation|0|||
48905270|NCT01862640|157490338|FG001|Overall Study|Protocol Deviation|0|||
48905271|NCT01862640|157490339|FG002|Overall Study|Protocol Deviation|1|||
48905272|NCT01862640|157490340|FG003|Overall Study|Protocol Deviation|0|||
48905273|NCT01326533|157490348|FG000|Overall Study|Lost to Follow-up|2|||
48905274|NCT01326533|157490349|FG001|Overall Study|Lost to Follow-up|0|||
48905275|NCT01326533|157490348|FG000|Overall Study|Withdrawal by Subject|1|||
48905276|NCT01326533|157490349|FG001|Overall Study|Withdrawal by Subject|0|||
48905277|NCT01326533|157490348|FG000|Overall Study|Adverse Event|1|||
48905278|NCT01326533|157490349|FG001|Overall Study|Adverse Event|0|||
48905279|NCT01717768|157490358|FG000|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
48905280|NCT01717768|157490359|FG001|Part 1 (Duration of 15 Days)|Lost to Follow-up|1|||
48905281|NCT01717768|157490360|FG002|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
48905282|NCT01717768|157490361|FG003|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
48905283|NCT01717768|157490362|FG004|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
48905284|NCT01717768|157490363|FG005|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
48905285|NCT01717768|157490364|FG006|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
48905286|NCT01717768|157490365|FG007|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
48905287|NCT01717768|157490366|FG008|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
48905288|NCT01717768|157490367|FG009|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
48905289|NCT01717768|157490368|FG010|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
48905290|NCT01717768|157490369|FG011|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
48905291|NCT01717768|157490358|FG000|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
48905292|NCT01717768|157490359|FG001|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
48905293|NCT01717768|157490360|FG002|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
48905294|NCT01717768|157490361|FG003|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
48905295|NCT01717768|157490362|FG004|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
48905296|NCT01717768|157490363|FG005|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
48905297|NCT01717768|157490364|FG006|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
48905298|NCT01717768|157490365|FG007|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
48905299|NCT01717768|157490366|FG008|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
48905300|NCT01717768|157490367|FG009|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
48905301|NCT01717768|157490368|FG010|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
48905302|NCT01717768|157490369|FG011|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1|||
48905303|NCT01717768|157490358|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
48905304|NCT01717768|157490359|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
48905305|NCT01717768|157490360|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
48905306|NCT01717768|157490361|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
48905307|NCT01717768|157490362|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
48905308|NCT01717768|157490363|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
48905309|NCT01717768|157490364|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
48905310|NCT01717768|157490365|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2|||
48905311|NCT01717768|157490366|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
48905312|NCT01717768|157490367|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
48905313|NCT01717768|157490368|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
48905314|NCT01717768|157490369|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
48905315|NCT01717768|157490358|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
48905316|NCT01717768|157490359|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
48905317|NCT01717768|157490360|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
48905318|NCT01717768|157490361|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
48905319|NCT01717768|157490362|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
48905320|NCT01717768|157490363|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
48905321|NCT01717768|157490364|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
48905322|NCT01717768|157490365|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
48905323|NCT01717768|157490366|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
48905324|NCT01717768|157490367|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1|||
48905325|NCT01717768|157490368|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
48905326|NCT01717768|157490369|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
48905327|NCT01251120|157490371|FG000|Overall Study|Lack of Efficacy|0|||
48905328|NCT01251120|157490372|FG001|Overall Study|Lack of Efficacy|1|||
48905329|NCT01968070|157490373|FG000|Period 1|Withdrawal by Subject|0|||
48905330|NCT01968070|157490374|FG001|Period 1|Withdrawal by Subject|1|||
48905331|NCT01968070|157490375|FG002|Period 1|Withdrawal by Subject|0|||
48905332|NCT01968070|157490376|FG003|Period 1|Withdrawal by Subject|0|||
48905333|NCT01968070|157490377|FG004|Period 1|Withdrawal by Subject|0|||
48905334|NCT01968070|157490378|FG005|Period 1|Withdrawal by Subject|0|||
48905335|NCT01968070|157490379|FG006|Period 1|Withdrawal by Subject|1|||
48905336|NCT01968070|157490380|FG007|Period 1|Withdrawal by Subject|0|||
48905337|NCT01968070|157490381|FG008|Period 1|Withdrawal by Subject|0|||
48905338|NCT01968070|157490382|FG009|Period 1|Withdrawal by Subject|0|||
48905339|NCT01968070|157490383|FG010|Period 1|Withdrawal by Subject|0|||
48905340|NCT01968070|157490384|FG011|Period 1|Withdrawal by Subject|0|||
48905341|NCT01968070|157490385|FG012|Period 1|Withdrawal by Subject|0|||
48905342|NCT01968070|157490386|FG013|Period 1|Withdrawal by Subject|0|||
48905343|NCT01968070|157490387|FG014|Period 1|Withdrawal by Subject|0|||
48905344|NCT01968070|157490388|FG015|Period 1|Withdrawal by Subject|1|||
48905345|NCT01968070|157490389|FG016|Period 1|Withdrawal by Subject|0|||
48905346|NCT01968070|157490390|FG017|Period 1|Withdrawal by Subject|0|||
48905347|NCT01968070|157490373|FG000|Period 1|Protocol Violation|0|||
48905348|NCT01968070|157490374|FG001|Period 1|Protocol Violation|0|||
48905349|NCT01968070|157490375|FG002|Period 1|Protocol Violation|0|||
48905350|NCT01968070|157490376|FG003|Period 1|Protocol Violation|1|||
48905351|NCT01968070|157490377|FG004|Period 1|Protocol Violation|1|||
48905352|NCT01968070|157490378|FG005|Period 1|Protocol Violation|0|||
48905353|NCT01968070|157490379|FG006|Period 1|Protocol Violation|0|||
48905354|NCT01968070|157490380|FG007|Period 1|Protocol Violation|0|||
48905355|NCT01968070|157490381|FG008|Period 1|Protocol Violation|0|||
48905356|NCT01968070|157490382|FG009|Period 1|Protocol Violation|0|||
48905357|NCT01968070|157490383|FG010|Period 1|Protocol Violation|0|||
48905358|NCT01968070|157490384|FG011|Period 1|Protocol Violation|0|||
48905359|NCT01968070|157490385|FG012|Period 1|Protocol Violation|0|||
48905360|NCT01968070|157490386|FG013|Period 1|Protocol Violation|0|||
48905361|NCT01968070|157490387|FG014|Period 1|Protocol Violation|0|||
48905362|NCT01968070|157490388|FG015|Period 1|Protocol Violation|0|||
48905363|NCT01968070|157490389|FG016|Period 1|Protocol Violation|0|||
48905364|NCT01968070|157490390|FG017|Period 1|Protocol Violation|0|||
48905365|NCT01968070|157490373|FG000|Period 1|Lost to Follow-up|0|||
48905366|NCT01968070|157490374|FG001|Period 1|Lost to Follow-up|0|||
48905367|NCT01968070|157490375|FG002|Period 1|Lost to Follow-up|0|||
48905368|NCT01968070|157490376|FG003|Period 1|Lost to Follow-up|1|||
48905369|NCT01968070|157490377|FG004|Period 1|Lost to Follow-up|0|||
48905370|NCT01968070|157490378|FG005|Period 1|Lost to Follow-up|0|||
48905371|NCT01968070|157490379|FG006|Period 1|Lost to Follow-up|0|||
48905372|NCT01968070|157490380|FG007|Period 1|Lost to Follow-up|0|||
48905373|NCT01968070|157490381|FG008|Period 1|Lost to Follow-up|0|||
48905374|NCT01968070|157490382|FG009|Period 1|Lost to Follow-up|0|||
48905375|NCT01968070|157490383|FG010|Period 1|Lost to Follow-up|0|||
48905376|NCT01968070|157490384|FG011|Period 1|Lost to Follow-up|0|||
48905377|NCT01968070|157490385|FG012|Period 1|Lost to Follow-up|0|||
48905378|NCT01968070|157490386|FG013|Period 1|Lost to Follow-up|0|||
48905379|NCT01968070|157490387|FG014|Period 1|Lost to Follow-up|0|||
48905380|NCT01968070|157490388|FG015|Period 1|Lost to Follow-up|0|||
48905381|NCT01968070|157490389|FG016|Period 1|Lost to Follow-up|0|||
48905382|NCT01968070|157490390|FG017|Period 1|Lost to Follow-up|0|||
48905383|NCT01968070|157490373|FG000|Period 1|Adverse Event|0|||
48905384|NCT01968070|157490374|FG001|Period 1|Adverse Event|0|||
48905385|NCT01968070|157490375|FG002|Period 1|Adverse Event|0|||
48905386|NCT01968070|157490376|FG003|Period 1|Adverse Event|0|||
48905387|NCT01968070|157490377|FG004|Period 1|Adverse Event|0|||
48905388|NCT01968070|157490378|FG005|Period 1|Adverse Event|0|||
48905389|NCT01968070|157490379|FG006|Period 1|Adverse Event|1|||
48905390|NCT01968070|157490380|FG007|Period 1|Adverse Event|0|||
48905391|NCT01968070|157490381|FG008|Period 1|Adverse Event|0|||
48905392|NCT01968070|157490382|FG009|Period 1|Adverse Event|0|||
48905393|NCT01968070|157490383|FG010|Period 1|Adverse Event|0|||
48905394|NCT01968070|157490384|FG011|Period 1|Adverse Event|0|||
48905395|NCT01968070|157490385|FG012|Period 1|Adverse Event|0|||
48905396|NCT01968070|157490386|FG013|Period 1|Adverse Event|0|||
48905397|NCT01968070|157490387|FG014|Period 1|Adverse Event|0|||
48905398|NCT01968070|157490388|FG015|Period 1|Adverse Event|0|||
48905399|NCT01968070|157490389|FG016|Period 1|Adverse Event|0|||
48905400|NCT01968070|157490390|FG017|Period 1|Adverse Event|0|||
48905401|NCT01968070|157490373|FG000|Period 1|Physician Decision|0|||
48905402|NCT01968070|157490374|FG001|Period 1|Physician Decision|0|||
48905403|NCT01968070|157490375|FG002|Period 1|Physician Decision|0|||
48905404|NCT01968070|157490376|FG003|Period 1|Physician Decision|0|||
48905405|NCT01968070|157490377|FG004|Period 1|Physician Decision|0|||
48905406|NCT01968070|157490378|FG005|Period 1|Physician Decision|0|||
48905407|NCT01968070|157490379|FG006|Period 1|Physician Decision|0|||
48905408|NCT01968070|157490380|FG007|Period 1|Physician Decision|0|||
48905409|NCT01968070|157490381|FG008|Period 1|Physician Decision|0|||
48905410|NCT01968070|157490382|FG009|Period 1|Physician Decision|0|||
48905411|NCT01968070|157490383|FG010|Period 1|Physician Decision|0|||
48905412|NCT01968070|157490384|FG011|Period 1|Physician Decision|1|||
48905413|NCT01968070|157490385|FG012|Period 1|Physician Decision|0|||
48905414|NCT01968070|157490386|FG013|Period 1|Physician Decision|0|||
48905415|NCT01968070|157490387|FG014|Period 1|Physician Decision|0|||
48905416|NCT01968070|157490388|FG015|Period 1|Physician Decision|0|||
48905417|NCT01968070|157490389|FG016|Period 1|Physician Decision|0|||
48905418|NCT01968070|157490390|FG017|Period 1|Physician Decision|0|||
48905419|NCT01968070|157490373|FG000|Period 2|Withdrawal by Subject|0|||
48905420|NCT01968070|157490374|FG001|Period 2|Withdrawal by Subject|0|||
48905421|NCT01968070|157490375|FG002|Period 2|Withdrawal by Subject|0|||
48905422|NCT01968070|157490376|FG003|Period 2|Withdrawal by Subject|0|||
48905423|NCT01968070|157490377|FG004|Period 2|Withdrawal by Subject|1|||
48905424|NCT01968070|157490378|FG005|Period 2|Withdrawal by Subject|0|||
48905425|NCT01968070|157490379|FG006|Period 2|Withdrawal by Subject|0|||
48905426|NCT01968070|157490380|FG007|Period 2|Withdrawal by Subject|0|||
48905427|NCT01968070|157490381|FG008|Period 2|Withdrawal by Subject|0|||
48905428|NCT01968070|157490382|FG009|Period 2|Withdrawal by Subject|0|||
48905429|NCT01968070|157490383|FG010|Period 2|Withdrawal by Subject|0|||
48905430|NCT01968070|157490384|FG011|Period 2|Withdrawal by Subject|0|||
48905431|NCT01968070|157490385|FG012|Period 2|Withdrawal by Subject|0|||
48905432|NCT01968070|157490386|FG013|Period 2|Withdrawal by Subject|0|||
48905433|NCT01968070|157490387|FG014|Period 2|Withdrawal by Subject|0|||
48905434|NCT01968070|157490388|FG015|Period 2|Withdrawal by Subject|0|||
48905435|NCT01968070|157490389|FG016|Period 2|Withdrawal by Subject|0|||
48905436|NCT01968070|157490390|FG017|Period 2|Withdrawal by Subject|0|||
48905437|NCT01774084|157490391|FG000|Overall Study|Personal reasons|1|||
48905438|NCT01774084|157490392|FG001|Overall Study|Personal reasons|0|||
48905439|NCT00821431|157490393|FG000|Overall Study|Adverse Event|6|||
48905440|NCT00821431|157490394|FG001|Overall Study|Adverse Event|3|||
48905441|NCT00821431|157490393|FG000|Overall Study|Withdrawal by Subject|5|||
48905442|NCT00821431|157490394|FG001|Overall Study|Withdrawal by Subject|0|||
48905443|NCT00821431|157490393|FG000|Overall Study|Lost to Follow-up|1|||
48905444|NCT00821431|157490394|FG001|Overall Study|Lost to Follow-up|0|||
48905445|NCT00821431|157490393|FG000|Overall Study|Protocol Violation|3|||
48905446|NCT00821431|157490394|FG001|Overall Study|Protocol Violation|1|||
48905447|NCT00821431|157490393|FG000|Overall Study|Physician Decision|0|||
48905448|NCT00821431|157490394|FG001|Overall Study|Physician Decision|1|||
48905449|NCT01822522|157490395|FG000|Overall Study|Adverse Event|1|||
48905450|NCT01822522|157490396|FG001|Overall Study|Adverse Event|1|||
48905451|NCT01822522|157490397|FG002|Overall Study|Adverse Event|1|||
48905452|NCT01822522|157490398|FG003|Overall Study|Adverse Event|0|||
48905453|NCT01822522|157490399|FG004|Overall Study|Adverse Event|0|||
48905454|NCT01822522|157490400|FG005|Overall Study|Adverse Event|1|||
48905455|NCT01822522|157490395|FG000|Overall Study|Death|3|||
48905456|NCT01822522|157490396|FG001|Overall Study|Death|0|||
48905457|NCT01822522|157490397|FG002|Overall Study|Death|2|||
48905458|NCT01822522|157490398|FG003|Overall Study|Death|0|||
48905459|NCT01822522|157490399|FG004|Overall Study|Death|0|||
48905460|NCT01822522|157490400|FG005|Overall Study|Death|0|||
48905461|NCT01822522|157490395|FG000|Overall Study|Lost to Follow-up|0|||
48905462|NCT01822522|157490396|FG001|Overall Study|Lost to Follow-up|0|||
48905463|NCT01822522|157490397|FG002|Overall Study|Lost to Follow-up|1|||
48905464|NCT01822522|157490398|FG003|Overall Study|Lost to Follow-up|1|||
48905465|NCT01822522|157490399|FG004|Overall Study|Lost to Follow-up|0|||
48905466|NCT01822522|157490400|FG005|Overall Study|Lost to Follow-up|1|||
48905467|NCT01822522|157490395|FG000|Overall Study|Withdrawal by Subject|0|||
48905468|NCT01822522|157490396|FG001|Overall Study|Withdrawal by Subject|0|||
48905469|NCT01822522|157490397|FG002|Overall Study|Withdrawal by Subject|0|||
48905470|NCT01822522|157490398|FG003|Overall Study|Withdrawal by Subject|1|||
48905471|NCT01822522|157490399|FG004|Overall Study|Withdrawal by Subject|0|||
48905472|NCT01822522|157490400|FG005|Overall Study|Withdrawal by Subject|0|||
48905473|NCT01822522|157490395|FG000|Overall Study|Lack of Efficacy|0|||
48905474|NCT01822522|157490396|FG001|Overall Study|Lack of Efficacy|0|||
48905475|NCT01822522|157490397|FG002|Overall Study|Lack of Efficacy|0|||
48905476|NCT01822522|157490398|FG003|Overall Study|Lack of Efficacy|0|||
48905477|NCT01822522|157490399|FG004|Overall Study|Lack of Efficacy|0|||
48905478|NCT01822522|157490400|FG005|Overall Study|Lack of Efficacy|2|||
48905479|NCT01387230|157490401|FG000|Overall Study|Adverse Event|0|||
48905480|NCT01387230|157490402|FG001|Overall Study|Adverse Event|1|||
48905481|NCT01387230|157490403|FG002|Overall Study|Adverse Event|3|||
48905482|NCT01387230|157490401|FG000|Overall Study|Lack of Efficacy|8|||
48905483|NCT01387230|157490402|FG001|Overall Study|Lack of Efficacy|5|||
48905484|NCT01387230|157490403|FG002|Overall Study|Lack of Efficacy|4|||
48905485|NCT01387230|157490401|FG000|Overall Study|Protocol-defined Stopping Criteria|6|||
48905486|NCT01387230|157490402|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
48905487|NCT01387230|157490403|FG002|Overall Study|Protocol-defined Stopping Criteria|5|||
48905488|NCT01387230|157490401|FG000|Overall Study|Lost to Follow-up|0|||
48905489|NCT01387230|157490402|FG001|Overall Study|Lost to Follow-up|0|||
48905490|NCT01387230|157490403|FG002|Overall Study|Lost to Follow-up|1|||
48905491|NCT01387230|157490401|FG000|Overall Study|Withdrawal by Subject|4|||
48905492|NCT01387230|157490402|FG001|Overall Study|Withdrawal by Subject|1|||
48905493|NCT01387230|157490403|FG002|Overall Study|Withdrawal by Subject|0|||
48905494|NCT01055262|157490409|FG000|Overall Study|Adverse Event|5|||
48905495|NCT01055262|157490409|FG000|Overall Study|Protocol Violation|3|||
48905496|NCT01055262|157490409|FG000|Overall Study|Uncooperativeness|1|||
48905497|NCT02678416|157490412|FG000|Part 1|Withdrawal by Subject|1|||
48905498|NCT02678416|157490412|FG000|Part 2|Adverse Event|2|||
48905499|NCT02678416|157490412|FG000|Part 2|Withdrawal by Subject|1|||
48905500|NCT04556136|157490413|FG000|Overall Study|Lost to Follow-up|6|||
48905501|NCT04556136|157490414|FG001|Overall Study|Lost to Follow-up|6|||
48905502|NCT04556136|157490413|FG000|Overall Study|Physician Decision|2|||
48905503|NCT04556136|157490414|FG001|Overall Study|Physician Decision|1|||
48905504|NCT04556136|157490413|FG000|Overall Study|Withdrawal by Subject|2|||
48905505|NCT04556136|157490414|FG001|Overall Study|Withdrawal by Subject|1|||
48905506|NCT02030405|157490419|FG000|Overall Study|Withdrawal by Subject|1|||
48905507|NCT02030405|157490419|FG000|Overall Study|Lost to Follow-up|1|||
48905508|NCT00972777|157490420|FG000|Overall Study|Adverse Event|3|||
48905509|NCT00972777|157490421|FG001|Overall Study|Adverse Event|2|||
48905510|NCT00972777|157490420|FG000|Overall Study|Lost to Follow-up|0|||
48905511|NCT00972777|157490421|FG001|Overall Study|Lost to Follow-up|4|||
48905512|NCT00972777|157490420|FG000|Overall Study|Withdrawal by Subject|4|||
48905513|NCT00972777|157490421|FG001|Overall Study|Withdrawal by Subject|5|||
48905514|NCT00972777|157490420|FG000|Overall Study|Physician Decision|4|||
48905515|NCT00972777|157490421|FG001|Overall Study|Physician Decision|0|||
48905516|NCT00972777|157490420|FG000|Overall Study|Protocol Violation|0|||
48905517|NCT00972777|157490421|FG001|Overall Study|Protocol Violation|2|||
48905518|NCT00972777|157490420|FG000|Overall Study|Screening Failure|2|||
48905519|NCT00972777|157490421|FG001|Overall Study|Screening Failure|1|||
48905520|NCT00972777|157490420|FG000|Overall Study|Missed visit|1|||
48905521|NCT00972777|157490421|FG001|Overall Study|Missed visit|0|||
48905522|NCT02279862|157490425|FG000|Overall Study|Study drug toxicity|3|||
48905523|NCT02279862|157490426|FG001|Overall Study|Study drug toxicity|6|||
48905524|NCT02279862|157490425|FG000|Overall Study|No longer meets criteria|0|||
48905525|NCT02279862|157490426|FG001|Overall Study|No longer meets criteria|1|||
48905526|NCT02279862|157490425|FG000|Overall Study|Administrative reason by sponsor|0|||
48905527|NCT02279862|157490426|FG001|Overall Study|Administrative reason by sponsor|1|||
48905528|NCT02279862|157490425|FG000|Overall Study|Disease progression|5|||
48905529|NCT02279862|157490426|FG001|Overall Study|Disease progression|2|||
48905530|NCT02279862|157490425|FG000|Overall Study|Study closed by sponsor|16|||
48905531|NCT02279862|157490426|FG001|Overall Study|Study closed by sponsor|13|||
48905532|NCT02279862|157490425|FG000|Overall Study|Other|1|||
48905533|NCT02279862|157490426|FG001|Overall Study|Other|2|||
48905534|NCT02279862|157490425|FG000|Overall Study|Withdrawal by Subject|1|||
48905535|NCT02279862|157490426|FG001|Overall Study|Withdrawal by Subject|0|||
48905536|NCT02921269|157490427|FG000|Overall Study|Did not complete DLT period|1|||
48905537|NCT00633061|157490428|FG000|Overall Study|Study closed|86|||
48905538|NCT00633061|157490429|FG001|Overall Study|Study closed|0|||
48905539|NCT03211247|157490430|FG000|Overall Study|Adverse Event|8|||
48905540|NCT03211247|157490431|FG001|Overall Study|Adverse Event|0|||
48905541|NCT03211247|157490432|FG002|Overall Study|Adverse Event|1|||
48905542|NCT03211247|157490433|FG003|Overall Study|Adverse Event|0|||
48905543|NCT03211247|157490434|FG004|Overall Study|Adverse Event|0|||
48905544|NCT03211247|157490430|FG000|Overall Study|Lost to Follow-up|2|||
48905545|NCT03211247|157490431|FG001|Overall Study|Lost to Follow-up|1|||
48905546|NCT03211247|157490432|FG002|Overall Study|Lost to Follow-up|0|||
48905547|NCT03211247|157490433|FG003|Overall Study|Lost to Follow-up|0|||
48905548|NCT03211247|157490434|FG004|Overall Study|Lost to Follow-up|0|||
48905549|NCT03211247|157490430|FG000|Overall Study|Physician Decision|1|||
48905550|NCT03211247|157490431|FG001|Overall Study|Physician Decision|2|||
48905551|NCT03211247|157490432|FG002|Overall Study|Physician Decision|0|||
48905552|NCT03211247|157490433|FG003|Overall Study|Physician Decision|0|||
48905553|NCT03211247|157490434|FG004|Overall Study|Physician Decision|0|||
48905554|NCT03211247|157490430|FG000|Overall Study|Non-compliance with study drug|2|||
48905555|NCT03211247|157490431|FG001|Overall Study|Non-compliance with study drug|0|||
48905556|NCT03211247|157490432|FG002|Overall Study|Non-compliance with study drug|0|||
48905557|NCT03211247|157490433|FG003|Overall Study|Non-compliance with study drug|0|||
48905558|NCT03211247|157490434|FG004|Overall Study|Non-compliance with study drug|0|||
48905559|NCT03211247|157490430|FG000|Overall Study|Participant withdrawal by Parent or Caregiver|18|||
48905560|NCT03211247|157490431|FG001|Overall Study|Participant withdrawal by Parent or Caregiver|13|||
48905561|NCT03211247|157490432|FG002|Overall Study|Participant withdrawal by Parent or Caregiver|2|||
48905562|NCT03211247|157490433|FG003|Overall Study|Participant withdrawal by Parent or Caregiver|1|||
48905563|NCT03211247|157490434|FG004|Overall Study|Participant withdrawal by Parent or Caregiver|0|||
48905564|NCT03211247|157490430|FG000|Overall Study|Participant did not want to complete oral food challenge|5|||
48905565|NCT03211247|157490431|FG001|Overall Study|Participant did not want to complete oral food challenge|2|||
48905566|NCT03211247|157490432|FG002|Overall Study|Participant did not want to complete oral food challenge|1|||
48905567|NCT03211247|157490433|FG003|Overall Study|Participant did not want to complete oral food challenge|3|||
48905568|NCT03211247|157490434|FG004|Overall Study|Participant did not want to complete oral food challenge|1|||
48905569|NCT03211247|157490430|FG000|Overall Study|Protocol Violation|0|||
48905570|NCT03211247|157490431|FG001|Overall Study|Protocol Violation|1|||
48905571|NCT03211247|157490432|FG002|Overall Study|Protocol Violation|0|||
48905572|NCT03211247|157490433|FG003|Overall Study|Protocol Violation|0|||
48905573|NCT03211247|157490434|FG004|Overall Study|Protocol Violation|0|||
48905574|NCT04683731|157490435|FG000|Overall Study|Withdrawal by Subject|1|||
48905575|NCT04683731|157490436|FG001|Overall Study|Withdrawal by Subject|0|||
48905576|NCT04683731|157490437|FG002|Overall Study|Withdrawal by Subject|3|||
48905577|NCT04683731|157490438|FG003|Overall Study|Withdrawal by Subject|2|||
48905578|NCT04683731|157490435|FG000|Overall Study|Determined patient was not eligible|3|||
48905579|NCT04683731|157490436|FG001|Overall Study|Determined patient was not eligible|3|||
48905580|NCT04683731|157490437|FG002|Overall Study|Determined patient was not eligible|12|||
48905581|NCT04683731|157490438|FG003|Overall Study|Determined patient was not eligible|3|||
48905582|NCT00671554|157490439|FG000|Overall Study|Disease progression|3|||
48905583|NCT00708175|157490441|FG000|Overall Study|Adverse Event|4|||
48905584|NCT00708175|157490442|FG001|Overall Study|Adverse Event|5|||
48905585|NCT00708175|157490441|FG000|Overall Study|Protocol Violation|2|||
48905586|NCT00708175|157490442|FG001|Overall Study|Protocol Violation|3|||
48905587|NCT00708175|157490441|FG000|Overall Study|Lost to Follow-up|5|||
48905588|NCT00708175|157490442|FG001|Overall Study|Lost to Follow-up|3|||
48905589|NCT00708175|157490441|FG000|Overall Study|Withdrawal by Subject|5|||
48905590|NCT00708175|157490442|FG001|Overall Study|Withdrawal by Subject|7|||
48905591|NCT00708175|157490441|FG000|Overall Study|BMD loss >7%|2|||
48905592|NCT00708175|157490442|FG001|Overall Study|BMD loss >7%|3|||
48905593|NCT03471871|157490443|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
48905594|NCT03471871|157490444|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
48905595|NCT03471871|157490445|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1|||
48905596|NCT03471871|157490446|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
48905597|NCT03471871|157490447|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
48905598|NCT03471871|157490443|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
48905599|NCT03471871|157490444|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
48905600|NCT03471871|157490445|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
48905601|NCT03471871|157490446|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
49116174|NCT02080364|158263075|FG002|Treatment Period|Adverse Event|11|||
48742918|NCT00745823|156910413|FG000|Overall Study|Physician Decision|10|||
48905602|NCT03471871|157490447|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
48905603|NCT03471871|157490443|FG000|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
48905604|NCT03471871|157490444|FG001|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
48905605|NCT03471871|157490445|FG002|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
48905606|NCT03471871|157490446|FG003|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
48905607|NCT03471871|157490447|FG004|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1|||
48905608|NCT03471871|157490443|FG000|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
48905609|NCT03471871|157490444|FG001|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
48905610|NCT03471871|157490445|FG002|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
48905611|NCT03471871|157490446|FG003|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
48905612|NCT03471871|157490447|FG004|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1|||
48905613|NCT03471871|157490443|FG000|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
48905614|NCT03471871|157490444|FG001|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
48905615|NCT03471871|157490445|FG002|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
48905616|NCT03471871|157490446|FG003|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1|||
48905617|NCT03471871|157490447|FG004|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
48905618|NCT02673619|157490448|FG000|Overall Study|Lost to Follow-up|1|||
48905619|NCT02673619|157490449|FG001|Overall Study|Lost to Follow-up|0|||
48905620|NCT02673619|157490450|FG002|Overall Study|Lost to Follow-up|0|||
48905621|NCT02673619|157490451|FG003|Overall Study|Lost to Follow-up|0|||
48905622|NCT02673619|157490448|FG000|Overall Study|Withdrawal by Subject|1|||
48905623|NCT02673619|157490449|FG001|Overall Study|Withdrawal by Subject|1|||
48905624|NCT02673619|157490450|FG002|Overall Study|Withdrawal by Subject|1|||
48905625|NCT02673619|157490451|FG003|Overall Study|Withdrawal by Subject|0|||
48905626|NCT02673619|157490448|FG000|Overall Study|Adverse Event|0|||
48905627|NCT02673619|157490449|FG001|Overall Study|Adverse Event|0|||
48905628|NCT02673619|157490450|FG002|Overall Study|Adverse Event|1|||
48905629|NCT02673619|157490451|FG003|Overall Study|Adverse Event|0|||
48905630|NCT02673619|157490448|FG000|Overall Study|Lack of Efficacy|0|||
48905631|NCT02673619|157490449|FG001|Overall Study|Lack of Efficacy|0|||
48905632|NCT02673619|157490450|FG002|Overall Study|Lack of Efficacy|1|||
48905633|NCT02673619|157490451|FG003|Overall Study|Lack of Efficacy|0|||
48905634|NCT01791803|157490452|FG000|Overall Study|Withdrawal by Subject|0|||
48905635|NCT01791803|157490453|FG001|Overall Study|Withdrawal by Subject|0|||
48905636|NCT01791803|157490454|FG002|Overall Study|Withdrawal by Subject|0|||
48905637|NCT01791803|157490455|FG003|Overall Study|Withdrawal by Subject|2|||
48905638|NCT01791803|157490452|FG000|Overall Study|Physician Decision|0|||
48905639|NCT01791803|157490453|FG001|Overall Study|Physician Decision|2|||
48905640|NCT01791803|157490454|FG002|Overall Study|Physician Decision|0|||
48905641|NCT01791803|157490455|FG003|Overall Study|Physician Decision|1|||
48905642|NCT01791803|157490452|FG000|Overall Study|Death|0|||
48905643|NCT01791803|157490453|FG001|Overall Study|Death|0|||
48905644|NCT01791803|157490454|FG002|Overall Study|Death|2|||
48905645|NCT01791803|157490455|FG003|Overall Study|Death|2|||
48905646|NCT01444456|157490456|FG000|Overall Study|Withdrawal by Subject|21|||
48905647|NCT01444456|157490456|FG000|Overall Study|Physician Decision|9|||
48905648|NCT01444456|157490456|FG000|Overall Study|Lost to Follow-up|37|||
48905649|NCT01444456|157490456|FG000|Overall Study|Death|73|||
48905650|NCT01444456|157490456|FG000|Overall Study|Ineligibility determined|23|||
48905651|NCT01444456|157490456|FG000|Overall Study|Other|18|||
48905652|NCT01444456|157490456|FG000|Overall Study|Not treated|104|||
48905653|NCT04752475|157492623|FG000|Overall Study|Withdrawal by Subject|1|||
48905654|NCT04752475|157492624|FG001|Overall Study|Withdrawal by Subject|1|||
48905655|NCT01940354|157492630|FG000|Overall Study|Withdrawal by Subject|4|||
48905656|NCT01940354|157492631|FG001|Overall Study|Withdrawal by Subject|2|||
48905657|NCT01873495|157492632|FG000|Overall Study|Withdrawal by Subject|1|||
48905658|NCT01873495|157492632|FG000|Overall Study|Physician Decision|3|||
48905659|NCT01873495|157492632|FG000|Overall Study|Adverse Event|1|||
48905660|NCT01873495|157492632|FG000|Overall Study|Removed for Transplantation|1|||
48905661|NCT01873495|157492632|FG000|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1|||
48905662|NCT01256658|157492633|FG000|Period 1|Lost to Follow-up|837|||
48905663|NCT01256658|157492634|FG001|Period 1|Lost to Follow-up|661|||
48905664|NCT01256658|157492633|FG000|Period 1|Withdrawal by Subject|35|||
48905665|NCT01256658|157492634|FG001|Period 1|Withdrawal by Subject|43|||
48905666|NCT01256658|157492633|FG000|Period 1|Death|48|||
48905667|NCT01256658|157492634|FG001|Period 1|Death|44|||
48905668|NCT00719563|157492635|FG000|Overall Study|Adverse Event|16|||
48905669|NCT00719563|157492636|FG001|Overall Study|Adverse Event|13|||
48905670|NCT00719563|157492635|FG000|Overall Study|Medical condition changed|3|||
48905671|NCT00719563|157492636|FG001|Overall Study|Medical condition changed|5|||
48905672|NCT00719563|157492635|FG000|Overall Study|Lack of Efficacy|3|||
48905673|NCT00719563|157492636|FG001|Overall Study|Lack of Efficacy|7|||
48905674|NCT00719563|157492635|FG000|Overall Study|Personal reasons|6|||
48905675|NCT00719563|157492636|FG001|Overall Study|Personal reasons|7|||
48905676|NCT00719563|157492635|FG000|Overall Study|Unknown reasons|4|||
48905677|NCT00719563|157492636|FG001|Overall Study|Unknown reasons|6|||
48905678|NCT00719563|157492635|FG000|Overall Study|Noncompliant|1|||
48905679|NCT00719563|157492636|FG001|Overall Study|Noncompliant|1|||
48905680|NCT00719563|157492635|FG000|Overall Study|Lost to Follow-up|5|||
48905681|NCT00719563|157492636|FG001|Overall Study|Lost to Follow-up|3|||
48905682|NCT00462865|157492639|FG000|Overall Study|Adverse Event|1|||
48905683|NCT02864381|157492640|FG000|Overall Study|Death|58|||
48905684|NCT02864381|157492641|FG001|Overall Study|Death|61|||
48905685|NCT02864381|157492640|FG000|Overall Study|Withdrew Consent|5|||
48905686|NCT02864381|157492641|FG001|Overall Study|Withdrew Consent|6|||
48905687|NCT02864381|157492640|FG000|Overall Study|Reason Unknown|7|||
48905688|NCT02864381|157492641|FG001|Overall Study|Reason Unknown|3|||
48905689|NCT02864381|157492640|FG000|Overall Study|Lost to Follow-up|1|||
48905690|NCT02864381|157492641|FG001|Overall Study|Lost to Follow-up|1|||
48905691|NCT02864381|157492640|FG000|Overall Study|Investigator's Discretion|1|||
48905692|NCT02864381|157492641|FG001|Overall Study|Investigator's Discretion|0|||
48905693|NCT02864381|157492640|FG000|Overall Study|Protocol Violation|0|||
48905694|NCT02864381|157492641|FG001|Overall Study|Protocol Violation|1|||
48905695|NCT04142450|157492642|FG000|Overall Study|Screen Failure|1|||
48905696|NCT04142450|157492642|FG000|Overall Study|Lost to Follow-up|1|||
48905697|NCT00234494|157492643|FG000|Overall Study|Protocol Violation|2|||
48905698|NCT00888433|157492646|FG000|Overall Study|Withdrawal by Subject|1|||
48905699|NCT00888433|157492647|FG001|Overall Study|Withdrawal by Subject|2|||
48905700|NCT00888433|157492646|FG000|Overall Study|Missed Visit|2|||
48905701|NCT00888433|157492647|FG001|Overall Study|Missed Visit|1|||
48905702|NCT01521897|157492648|FG000|Overall Study|Protocol Violation|18|||
48905703|NCT01521897|157492648|FG000|Overall Study|Lost to Follow-up|5|||
48905704|NCT00402363|157492654|FG000|Overall Study|Adverse Event|9|||
49116175|NCT02080364|158263076|FG003|Treatment Period|Adverse Event|14|||
48905705|NCT00402363|157492655|FG001|Overall Study|Adverse Event|14|||
48905706|NCT00402363|157492656|FG002|Overall Study|Adverse Event|2|||
48905707|NCT00402363|157492657|FG003|Overall Study|Adverse Event|2|||
48905708|NCT00402363|157492654|FG000|Overall Study|Withdrew Consent|10|||
48905709|NCT00402363|157492655|FG001|Overall Study|Withdrew Consent|5|||
48905710|NCT00402363|157492656|FG002|Overall Study|Withdrew Consent|2|||
48905711|NCT00402363|157492657|FG003|Overall Study|Withdrew Consent|1|||
48905712|NCT00402363|157492654|FG000|Overall Study|Protocol Violation|3|||
48905713|NCT00402363|157492655|FG001|Overall Study|Protocol Violation|5|||
48905714|NCT00402363|157492656|FG002|Overall Study|Protocol Violation|0|||
48905715|NCT00402363|157492657|FG003|Overall Study|Protocol Violation|3|||
48905716|NCT00402363|157492654|FG000|Overall Study|Lost to Follow-up|5|||
48905717|NCT00402363|157492655|FG001|Overall Study|Lost to Follow-up|4|||
48905718|NCT00402363|157492656|FG002|Overall Study|Lost to Follow-up|0|||
48905719|NCT00402363|157492657|FG003|Overall Study|Lost to Follow-up|2|||
48905720|NCT00402363|157492654|FG000|Overall Study|"Captured as Other"|6|||
48905721|NCT00402363|157492655|FG001|Overall Study|"Captured as Other"|2|||
48905722|NCT00402363|157492656|FG002|Overall Study|"Captured as Other"|2|||
48905723|NCT00402363|157492657|FG003|Overall Study|"Captured as Other"|2|||
48905724|NCT01446016|157492661|FG000|Overall Study|Lost to Follow-up|3|||
48905725|NCT01446016|157492661|FG000|Overall Study|Withdrawal by Subject|1|||
48905726|NCT01446016|157492661|FG000|Overall Study|Toxicity|3|||
48905727|NCT05323084|157492663|FG000|Period 2 - Washout|Lost to Follow-up|0|||
48905728|NCT05323084|157492664|FG001|Period 2 - Washout|Lost to Follow-up|1|||
48905729|NCT00568321|157492665|FG000|Overall Study|Adverse Event|1|||
48905730|NCT00568321|157492666|FG001|Overall Study|Adverse Event|0|||
48905731|NCT00568321|157492667|FG002|Overall Study|Adverse Event|0|||
48905732|NCT00568321|157492665|FG000|Overall Study|Lack of Efficacy|8|||
48905733|NCT00568321|157492666|FG001|Overall Study|Lack of Efficacy|5|||
48905734|NCT00568321|157492667|FG002|Overall Study|Lack of Efficacy|6|||
48905735|NCT00568321|157492665|FG000|Overall Study|Lost to Follow-up|0|||
48905736|NCT00568321|157492666|FG001|Overall Study|Lost to Follow-up|0|||
48905737|NCT00568321|157492667|FG002|Overall Study|Lost to Follow-up|1|||
48905738|NCT00568321|157492665|FG000|Overall Study|Withdrawal by Subject|2|||
48905739|NCT00568321|157492666|FG001|Overall Study|Withdrawal by Subject|0|||
48905740|NCT00568321|157492667|FG002|Overall Study|Withdrawal by Subject|0|||
48905741|NCT00568321|157492665|FG000|Overall Study|Protocol Violation|0|||
48905742|NCT00568321|157492666|FG001|Overall Study|Protocol Violation|0|||
48905743|NCT00568321|157492667|FG002|Overall Study|Protocol Violation|1|||
48905744|NCT00568321|157492665|FG000|Overall Study|Randomized, not treated|2|||
48905745|NCT00568321|157492666|FG001|Overall Study|Randomized, not treated|0|||
48905746|NCT00568321|157492667|FG002|Overall Study|Randomized, not treated|1|||
48905747|NCT00937833|157492670|FG000|Overall Study|Protocol Violation|1|||
48905748|NCT00937833|157492671|FG001|Overall Study|Protocol Violation|2|||
48905749|NCT00937833|157492670|FG000|Overall Study|Procedure delayed; enrollment closed|0|||
48905750|NCT00937833|157492671|FG001|Overall Study|Procedure delayed; enrollment closed|1|||
48905751|NCT00937833|157492670|FG000|Overall Study|Lost to Follow-up|10|||
49116176|NCT02080364|158263073|FG000|Treatment Period|Lost to Follow-up|2|||
48905752|NCT00937833|157492671|FG001|Overall Study|Lost to Follow-up|8|||
48905753|NCT00937833|157492670|FG000|Overall Study|Withdrawal by Subject|4|||
48905754|NCT00937833|157492671|FG001|Overall Study|Withdrawal by Subject|6|||
48905755|NCT00992511|157492674|FG000|Overall Study|Migrated/moved from study area|1|||
48905756|NCT00992511|157492675|FG001|Overall Study|Migrated/moved from study area|0|||
48905757|NCT00992511|157492676|FG002|Overall Study|Migrated/moved from study area|1|||
48905758|NCT00992511|157492677|FG003|Overall Study|Migrated/moved from study area|2|||
48905759|NCT00992511|157492674|FG000|Overall Study|Lost to Follow-up|1|||
48905760|NCT00992511|157492675|FG001|Overall Study|Lost to Follow-up|0|||
48905761|NCT00992511|157492676|FG002|Overall Study|Lost to Follow-up|0|||
48905762|NCT00992511|157492677|FG003|Overall Study|Lost to Follow-up|2|||
48905763|NCT00992511|157492674|FG000|Overall Study|Withdrawal by Subject|0|||
48905764|NCT00992511|157492675|FG001|Overall Study|Withdrawal by Subject|0|||
48905765|NCT00992511|157492676|FG002|Overall Study|Withdrawal by Subject|1|||
48905766|NCT00992511|157492677|FG003|Overall Study|Withdrawal by Subject|1|||
48905767|NCT03942406|157492684|FG000|Overall Study|Lost to Follow-up|4|||
48905768|NCT03942406|157492685|FG001|Overall Study|Lost to Follow-up|5|||
48905769|NCT03942406|157492686|FG002|Overall Study|Lost to Follow-up|3|||
48905770|NCT03942406|157492687|FG003|Overall Study|Lost to Follow-up|7|||
48905771|NCT03942406|157492688|FG004|Overall Study|Lost to Follow-up|1|||
48905772|NCT03942406|157492689|FG005|Overall Study|Lost to Follow-up|0|||
48905773|NCT03942406|157492690|FG006|Overall Study|Lost to Follow-up|0|||
48905774|NCT03942406|157492684|FG000|Overall Study|Withdrawal by Subject|3|||
48905775|NCT03942406|157492685|FG001|Overall Study|Withdrawal by Subject|1|||
48905776|NCT03942406|157492686|FG002|Overall Study|Withdrawal by Subject|1|||
48905777|NCT03942406|157492687|FG003|Overall Study|Withdrawal by Subject|3|||
48905778|NCT03942406|157492688|FG004|Overall Study|Withdrawal by Subject|0|||
48905779|NCT03942406|157492689|FG005|Overall Study|Withdrawal by Subject|0|||
48905780|NCT03942406|157492690|FG006|Overall Study|Withdrawal by Subject|0|||
48905781|NCT03942406|157492684|FG000|Overall Study|Other: early termination, telemedicine visits|4|||
48905782|NCT03942406|157492685|FG001|Overall Study|Other: early termination, telemedicine visits|1|||
48905783|NCT03942406|157492686|FG002|Overall Study|Other: early termination, telemedicine visits|1|||
48905784|NCT03942406|157492687|FG003|Overall Study|Other: early termination, telemedicine visits|0|||
48905785|NCT03942406|157492688|FG004|Overall Study|Other: early termination, telemedicine visits|1|||
48905786|NCT03942406|157492689|FG005|Overall Study|Other: early termination, telemedicine visits|1|||
48905787|NCT03942406|157492690|FG006|Overall Study|Other: early termination, telemedicine visits|0|||
48905788|NCT01207596|157492691|FG000|Overall Study|Physician Decision|4|||
48905789|NCT01207596|157492691|FG000|Overall Study|Lack of Efficacy|1|||
48905790|NCT01207596|157492691|FG000|Overall Study|Adverse Event|3|||
48905791|NCT01207596|157492691|FG000|Overall Study|Withdrawal by Subject|1|||
48905792|NCT02982187|157492692|FG000|Overall Study|Withdrawal by Subject|0|||
48905793|NCT02982187|157492693|FG001|Overall Study|Withdrawal by Subject|0|||
48905794|NCT02982187|157492694|FG002|Overall Study|Withdrawal by Subject|0|||
48905795|NCT02982187|157492695|FG003|Overall Study|Withdrawal by Subject|0|||
48905796|NCT02982187|157492696|FG004|Overall Study|Withdrawal by Subject|0|||
48905797|NCT02982187|157492697|FG005|Overall Study|Withdrawal by Subject|0|||
48905798|NCT02982187|157492698|FG006|Overall Study|Withdrawal by Subject|1|||
48905799|NCT02982187|157492699|FG007|Overall Study|Withdrawal by Subject|0|||
48905800|NCT01601847|157492705|FG000|Overall Study|Death|1|||
48905801|NCT01601847|157492706|FG001|Overall Study|Death|0|||
48905802|NCT01601847|157492705|FG000|Overall Study|Withdrawal by Subject|11|||
48905803|NCT01601847|157492706|FG001|Overall Study|Withdrawal by Subject|7|||
48905804|NCT01601847|157492705|FG000|Overall Study|Lost to Follow-up|1|||
48905805|NCT01601847|157492706|FG001|Overall Study|Lost to Follow-up|3|||
48905806|NCT01284062|157492707|FG000|Overall Study|Adverse Event|4|||
48905807|NCT01284062|157492708|FG001|Overall Study|Adverse Event|5|||
48905808|NCT01284062|157492709|FG002|Overall Study|Adverse Event|0|||
48905809|NCT01284062|157492710|FG003|Overall Study|Adverse Event|5|||
48905810|NCT01284062|157492707|FG000|Overall Study|Lack of Efficacy|3|||
48905811|NCT01284062|157492708|FG001|Overall Study|Lack of Efficacy|2|||
48905812|NCT01284062|157492709|FG002|Overall Study|Lack of Efficacy|2|||
48905813|NCT01284062|157492710|FG003|Overall Study|Lack of Efficacy|1|||
48905814|NCT01284062|157492707|FG000|Overall Study|Medication error without adverse event|0|||
48905815|NCT01284062|157492708|FG001|Overall Study|Medication error without adverse event|0|||
48905816|NCT01284062|157492709|FG002|Overall Study|Medication error without adverse event|1|||
48905817|NCT01284062|157492710|FG003|Overall Study|Medication error without adverse event|0|||
48905818|NCT01284062|157492707|FG000|Overall Study|Protocol Violation|1|||
48905819|NCT01284062|157492708|FG001|Overall Study|Protocol Violation|0|||
48905820|NCT01284062|157492709|FG002|Overall Study|Protocol Violation|0|||
48905821|NCT01284062|157492710|FG003|Overall Study|Protocol Violation|2|||
48905822|NCT01284062|157492707|FG000|Overall Study|Withdrawal by Subject|3|||
48905823|NCT01284062|157492708|FG001|Overall Study|Withdrawal by Subject|1|||
48905824|NCT01284062|157492709|FG002|Overall Study|Withdrawal by Subject|2|||
48905825|NCT01284062|157492710|FG003|Overall Study|Withdrawal by Subject|5|||
48905826|NCT01284062|157492707|FG000|Overall Study|Other|0|||
48905827|NCT01284062|157492708|FG001|Overall Study|Other|0|||
48905828|NCT01284062|157492709|FG002|Overall Study|Other|0|||
48905829|NCT01284062|157492710|FG003|Overall Study|Other|1|||
48905830|NCT01284062|157492707|FG000|Overall Study|Site Closed|0|||
48905831|NCT01284062|157492708|FG001|Overall Study|Site Closed|0|||
48905832|NCT01284062|157492709|FG002|Overall Study|Site Closed|1|||
48905833|NCT01284062|157492710|FG003|Overall Study|Site Closed|0|||
48905834|NCT00954174|157492711|FG000|Overall Study|Adverse Event|28|||
48905835|NCT00954174|157492712|FG001|Overall Study|Adverse Event|23|||
48905836|NCT00954174|157492713|FG002|Overall Study|Adverse Event|4|||
48905837|NCT00954174|157492714|FG003|Overall Study|Adverse Event|9|||
48905838|NCT00954174|157492711|FG000|Overall Study|Death|4|||
48905839|NCT00954174|157492712|FG001|Overall Study|Death|2|||
48905840|NCT00954174|157492713|FG002|Overall Study|Death|0|||
48905841|NCT00954174|157492714|FG003|Overall Study|Death|0|||
48905842|NCT00954174|157492711|FG000|Overall Study|Lack of Efficacy|32|||
48905843|NCT00954174|157492712|FG001|Overall Study|Lack of Efficacy|22|||
48905844|NCT00954174|157492713|FG002|Overall Study|Lack of Efficacy|8|||
48905845|NCT00954174|157492714|FG003|Overall Study|Lack of Efficacy|6|||
48905846|NCT00954174|157492711|FG000|Overall Study|Withdrawal by Subject|14|||
48905847|NCT00954174|157492712|FG001|Overall Study|Withdrawal by Subject|10|||
48905848|NCT00954174|157492713|FG002|Overall Study|Withdrawal by Subject|4|||
48905849|NCT00954174|157492714|FG003|Overall Study|Withdrawal by Subject|3|||
48905850|NCT00954174|157492711|FG000|Overall Study|Medical Reason|4|||
48905851|NCT00954174|157492712|FG001|Overall Study|Medical Reason|2|||
48905852|NCT00954174|157492713|FG002|Overall Study|Medical Reason|1|||
48905853|NCT00954174|157492714|FG003|Overall Study|Medical Reason|0|||
48905854|NCT00954174|157492711|FG000|Overall Study|Ineligible|40|||
48905855|NCT00954174|157492712|FG001|Overall Study|Ineligible|47|||
48905856|NCT00954174|157492713|FG002|Overall Study|Ineligible|7|||
48905857|NCT00954174|157492714|FG003|Overall Study|Ineligible|4|||
48905858|NCT00954174|157492711|FG000|Overall Study|Never Treated|4|||
48905859|NCT00954174|157492712|FG001|Overall Study|Never Treated|17|||
48905860|NCT00954174|157492713|FG002|Overall Study|Never Treated|0|||
48905861|NCT00954174|157492714|FG003|Overall Study|Never Treated|3|||
48905862|NCT01829425|157492719|FG000|Overall Study|Withdrawal by Subject|4|||
48905863|NCT01829425|157492720|FG001|Overall Study|Withdrawal by Subject|3|||
48905864|NCT01829425|157492719|FG000|Overall Study|Lost to Follow-up|2|||
48905865|NCT01829425|157492720|FG001|Overall Study|Lost to Follow-up|1|||
48905866|NCT02187809|157492721|FG000|Overall Study|The study was terminated|3|||
48905867|NCT00728481|157492722|FG000|Overall Study|Withdrawal by Subject|0|||
48905868|NCT00728481|157492723|FG001|Overall Study|Withdrawal by Subject|1|||
48905869|NCT00728481|157492722|FG000|Overall Study|Adverse Event|0|||
48905870|NCT00728481|157492723|FG001|Overall Study|Adverse Event|1|||
48905871|NCT00728481|157492722|FG000|Overall Study|Study medication non-compliance|0|||
48905872|NCT00728481|157492723|FG001|Overall Study|Study medication non-compliance|2|||
48905873|NCT00728481|157492722|FG000|Overall Study|Incorrectly assigned to opposite arm|1|||
48905874|NCT00728481|157492723|FG001|Overall Study|Incorrectly assigned to opposite arm|0|||
48905875|NCT00778622|157492724|FG000|Overall Study|Adverse Event|5|||
48905876|NCT00778622|157492725|FG001|Overall Study|Adverse Event|4|||
48905877|NCT00778622|157492726|FG002|Overall Study|Adverse Event|7|||
48905878|NCT00778622|157492724|FG000|Overall Study|Withdrawal by Subject|4|||
48905879|NCT00778622|157492725|FG001|Overall Study|Withdrawal by Subject|5|||
48905880|NCT00778622|157492726|FG002|Overall Study|Withdrawal by Subject|5|||
48905881|NCT00778622|157492724|FG000|Overall Study|Lost to Follow-up|3|||
48905882|NCT00778622|157492725|FG001|Overall Study|Lost to Follow-up|3|||
48905883|NCT00778622|157492726|FG002|Overall Study|Lost to Follow-up|2|||
48905884|NCT00778622|157492724|FG000|Overall Study|Protocol Violation|0|||
48905885|NCT00778622|157492725|FG001|Overall Study|Protocol Violation|3|||
48905886|NCT00778622|157492726|FG002|Overall Study|Protocol Violation|0|||
48905887|NCT00778622|157492724|FG000|Overall Study|Lack of Efficacy|2|||
48905888|NCT00778622|157492725|FG001|Overall Study|Lack of Efficacy|0|||
48905889|NCT00778622|157492726|FG002|Overall Study|Lack of Efficacy|0|||
48905890|NCT00778622|157492724|FG000|Overall Study|immigration|1|||
48905891|NCT00778622|157492725|FG001|Overall Study|immigration|0|||
48905892|NCT00778622|157492726|FG002|Overall Study|immigration|0|||
48905893|NCT00778622|157492724|FG000|Overall Study|Other|1|||
48905894|NCT00778622|157492725|FG001|Overall Study|Other|0|||
48905895|NCT00778622|157492726|FG002|Overall Study|Other|1|||
48905896|NCT01032382|157492727|FG000|Overall Study|Disease dissemination|1|||
48905897|NCT01032382|157492728|FG001|Overall Study|Disease dissemination|1|||
48905898|NCT01032382|157492727|FG000|Overall Study|Treatment failure|3|||
48905899|NCT01032382|157492728|FG001|Overall Study|Treatment failure|1|||
48905900|NCT01032382|157492727|FG000|Overall Study|Index lesion relapse|1|||
48905901|NCT01032382|157492728|FG001|Overall Study|Index lesion relapse|3|||
48905902|NCT00775450|157492729|FG000|Overall Study|Serious Adverse Event|2|||
48905903|NCT00775450|157492730|FG001|Overall Study|Serious Adverse Event|0|||
48905904|NCT00775450|157492731|FG002|Overall Study|Serious Adverse Event|0|||
48905905|NCT00775450|157492732|FG003|Overall Study|Serious Adverse Event|0|||
48905906|NCT00775450|157492733|FG004|Overall Study|Serious Adverse Event|0|||
48905907|NCT00775450|157492729|FG000|Overall Study|Protocol Violation|0|||
48905908|NCT00775450|157492730|FG001|Overall Study|Protocol Violation|0|||
48905909|NCT00775450|157492731|FG002|Overall Study|Protocol Violation|0|||
48905910|NCT00775450|157492732|FG003|Overall Study|Protocol Violation|0|||
48905911|NCT00775450|157492733|FG004|Overall Study|Protocol Violation|1|||
48905912|NCT00775450|157492729|FG000|Overall Study|Withdrawal by Subject|1|||
48905913|NCT00775450|157492730|FG001|Overall Study|Withdrawal by Subject|0|||
48905914|NCT00775450|157492731|FG002|Overall Study|Withdrawal by Subject|0|||
48905915|NCT00775450|157492732|FG003|Overall Study|Withdrawal by Subject|0|||
48905916|NCT00775450|157492733|FG004|Overall Study|Withdrawal by Subject|1|||
48905917|NCT00995007|157492734|FG000|Overall Study|Withdrew consent|1|||
48905918|NCT00995007|157492735|FG001|Overall Study|Withdrew consent|0|||
48905919|NCT00995007|157492734|FG000|Overall Study|Refused further treatment|8|||
48905920|NCT00995007|157492735|FG001|Overall Study|Refused further treatment|2|||
48905921|NCT00995007|157492734|FG000|Overall Study|Toxicity|8|||
48905922|NCT00995007|157492735|FG001|Overall Study|Toxicity|0|||
48905923|NCT03933397|157492736|FG000|Overall Study|No emergency department visit|65|||
48905924|NCT03933397|157492737|FG001|Overall Study|No emergency department visit|71|||
48905925|NCT03933397|157492736|FG000|Overall Study|Missed emergency department visit|25|||
48905926|NCT03933397|157492737|FG001|Overall Study|Missed emergency department visit|30|||
48905927|NCT03933397|157492736|FG000|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|18|||
48905928|NCT03933397|157492737|FG001|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|15|||
48905929|NCT03933397|157492736|FG000|Overall Study|Withdrawal by Subject|1|||
48905930|NCT03933397|157492737|FG001|Overall Study|Withdrawal by Subject|0|||
48905931|NCT03933397|157492736|FG000|Overall Study|Physician Decision|1|||
48905932|NCT03933397|157492737|FG001|Overall Study|Physician Decision|1|||
48905933|NCT03933397|157492736|FG000|Overall Study|missing pain score|1|||
48905934|NCT03933397|157492737|FG001|Overall Study|missing pain score|1|||
48905935|NCT03933397|157492736|FG000|Overall Study|Confirmed COVID-19|1|||
48905936|NCT03933397|157492737|FG001|Overall Study|Confirmed COVID-19|2|||
48905937|NCT02066051|157492744|FG000|Overall Study|Subject developed active GVHD|1|||
48905938|NCT02469896|157492753|FG000|Overall Study|Withdrawal by Subject|2|||
48905939|NCT02469896|157492754|FG001|Overall Study|Withdrawal by Subject|0|||
48905940|NCT02401412|157492758|FG000|Overall Study|Lost to Follow-up|1|||
48905941|NCT02401412|157492759|FG001|Overall Study|Lost to Follow-up|0|||
48905942|NCT02401412|157492758|FG000|Overall Study|Discontinued Intervention|15|||
48905943|NCT02401412|157492759|FG001|Overall Study|Discontinued Intervention|21|||
48905944|NCT02401412|157492758|FG000|Overall Study|Withdrawal by Subject|4|||
48905945|NCT02401412|157492759|FG001|Overall Study|Withdrawal by Subject|4|||
48905946|NCT02401412|157492758|FG000|Overall Study|Subject withdrawal prior to intervention|0|||
48905947|NCT02401412|157492759|FG001|Overall Study|Subject withdrawal prior to intervention|1|||
48905948|NCT02401412|157492758|FG000|Overall Study|Improper Enrollment per In/Ex Criteria|10|||
48905949|NCT02401412|157492759|FG001|Overall Study|Improper Enrollment per In/Ex Criteria|6|||
48905950|NCT00564018|157492760|FG000|Overall Study|Withdrawal by Subject|2|||
48905951|NCT00564018|157492761|FG001|Overall Study|Withdrawal by Subject|3|||
48905952|NCT00564018|157492762|FG002|Overall Study|Withdrawal by Subject|1|||
48905953|NCT01494350|157492763|FG000|Overall Study|Worsening of lesion|1|||
48905954|NCT01009554|157492769|FG000|Overall Study|Adverse Event|1|||
48905955|NCT01009554|157492770|FG001|Overall Study|Adverse Event|1|||
48905956|NCT01009554|157492769|FG000|Overall Study|Withdrawal by Subject|1|||
48905957|NCT01009554|157492770|FG001|Overall Study|Withdrawal by Subject|3|||
48905958|NCT01009554|157492769|FG000|Overall Study|Noncompliant with Study Product|0|||
48905959|NCT01009554|157492770|FG001|Overall Study|Noncompliant with Study Product|3|||
48905960|NCT01840605|157492774|FG000|Overall Study|Adverse Event|0|||
48905961|NCT01840605|157492775|FG001|Overall Study|Adverse Event|1|||
48905962|NCT01840605|157492774|FG000|Overall Study|Physician Decision|2|||
48905963|NCT01840605|157492775|FG001|Overall Study|Physician Decision|1|||
48905964|NCT04201821|157492776|FG000|Overall Study|Withdrawal by Subject|2|||
48905965|NCT02456662|157492777|FG000|Overall Study|Lost to Follow-up|2|||
48905966|NCT02456662|157492778|FG001|Overall Study|Lost to Follow-up|1|||
49116177|NCT02080364|158263074|FG001|Treatment Period|Lost to Follow-up|3|||
49116178|NCT02080364|158263075|FG002|Treatment Period|Lost to Follow-up|5|||
49116179|NCT02080364|158263076|FG003|Treatment Period|Lost to Follow-up|0|||
49116180|NCT02080364|158263073|FG000|Treatment Period|Protocol Violation|5|||
49116181|NCT02080364|158263074|FG001|Treatment Period|Protocol Violation|3|||
49116182|NCT02080364|158263075|FG002|Treatment Period|Protocol Violation|5|||
49116183|NCT02080364|158263076|FG003|Treatment Period|Protocol Violation|1|||
49116184|NCT02080364|158263073|FG000|Treatment Period|Withdrawal by Subject|16|||
48905967|NCT02540538|157492779|FG000|Overall Study|Pregnancy|0|||
48905968|NCT02540538|157492780|FG001|Overall Study|Pregnancy|1|||
48905969|NCT02540538|157492781|FG002|Overall Study|Pregnancy|0|||
48905970|NCT01472380|157492785|FG000|Efavirenz Alone|Withdrawal by Subject|1|||
48905971|NCT01472380|157492785|FG000|1 Day Period Between Dosing|Protocol Violation|1|||
48905972|NCT03250832|157492786|FG000|Part 1 (Up to Approximately 51 Months)|Death|1|||
48905973|NCT03250832|157492787|FG001|Part 1 (Up to Approximately 51 Months)|Death|6|||
48905974|NCT03250832|157492788|FG002|Part 1 (Up to Approximately 51 Months)|Death|5|||
48905975|NCT03250832|157492789|FG003|Part 1 (Up to Approximately 51 Months)|Death|5|||
48905976|NCT03250832|157492790|FG004|Part 1 (Up to Approximately 51 Months)|Death|3|||
48905977|NCT03250832|157492791|FG005|Part 1 (Up to Approximately 51 Months)|Death|6|||
48905978|NCT03250832|157492792|FG006|Part 1 (Up to Approximately 51 Months)|Death|3|||
48905979|NCT03250832|157492793|FG007|Part 1 (Up to Approximately 51 Months)|Death|0|||
49116185|NCT02080364|158263074|FG001|Treatment Period|Withdrawal by Subject|16|||
49116186|NCT02080364|158263075|FG002|Treatment Period|Withdrawal by Subject|15|||
49116187|NCT02080364|158263076|FG003|Treatment Period|Withdrawal by Subject|10|||
49116188|NCT02080364|158263073|FG000|Treatment Period|Study Terminated by Sponsor|0|||
49116189|NCT02080364|158263074|FG001|Treatment Period|Study Terminated by Sponsor|0|||
49116190|NCT02080364|158263075|FG002|Treatment Period|Study Terminated by Sponsor|180|||
49116191|NCT02080364|158263076|FG003|Treatment Period|Study Terminated by Sponsor|183|||
49116192|NCT02080364|158263073|FG000|Treatment Period|Other|14|||
49116193|NCT02080364|158263074|FG001|Treatment Period|Other|12|||
49116194|NCT02080364|158263075|FG002|Treatment Period|Other|21|||
49116195|NCT02080364|158263076|FG003|Treatment Period|Other|16|||
49116196|NCT00398047|158263077|FG000|Overall Study|all patient progressed before completion|3|||
49116197|NCT00303472|158263078|FG000|Treatment Period|Adverse Event|0|||
49116198|NCT00303472|158263079|FG001|Treatment Period|Adverse Event|0|||
49116199|NCT00303472|158263080|FG002|Treatment Period|Adverse Event|0|||
49116200|NCT00303472|158263081|FG003|Treatment Period|Adverse Event|0|||
49116201|NCT00303472|158263082|FG004|Treatment Period|Adverse Event|1|||
49116202|NCT00303472|158263083|FG005|Treatment Period|Adverse Event|0|||
49116203|NCT00303472|158263084|FG006|Treatment Period|Adverse Event|0|||
49116204|NCT00303472|158263078|FG000|Treatment Period|Death|0|||
49116205|NCT00303472|158263079|FG001|Treatment Period|Death|0|||
49116206|NCT00303472|158263080|FG002|Treatment Period|Death|0|||
49116207|NCT00303472|158263081|FG003|Treatment Period|Death|1|||
49116208|NCT00303472|158263082|FG004|Treatment Period|Death|0|||
49116209|NCT00303472|158263083|FG005|Treatment Period|Death|0|||
49116210|NCT00303472|158263084|FG006|Treatment Period|Death|1|||
49116211|NCT00303472|158263078|FG000|Treatment Period|Withdrawal by Subject|0|||
49116212|NCT00303472|158263079|FG001|Treatment Period|Withdrawal by Subject|0|||
49116213|NCT00303472|158263080|FG002|Treatment Period|Withdrawal by Subject|0|||
49116214|NCT00303472|158263081|FG003|Treatment Period|Withdrawal by Subject|1|||
49116215|NCT00303472|158263082|FG004|Treatment Period|Withdrawal by Subject|0|||
49116216|NCT00303472|158263083|FG005|Treatment Period|Withdrawal by Subject|1|||
49116217|NCT00303472|158263084|FG006|Treatment Period|Withdrawal by Subject|0|||
49116218|NCT00303472|158263078|FG000|Treatment Period|Other|0|||
49116219|NCT00303472|158263079|FG001|Treatment Period|Other|0|||
49116220|NCT00303472|158263080|FG002|Treatment Period|Other|0|||
49116221|NCT00303472|158263081|FG003|Treatment Period|Other|0|||
49116222|NCT00303472|158263082|FG004|Treatment Period|Other|1|||
49116223|NCT00303472|158263083|FG005|Treatment Period|Other|0|||
49116224|NCT00303472|158263084|FG006|Treatment Period|Other|1|||
49116225|NCT00303472|158263078|FG000|Treatment Period|Disease Progression (to AML)|0|||
49116226|NCT00303472|158263079|FG001|Treatment Period|Disease Progression (to AML)|0|||
49116227|NCT00303472|158263080|FG002|Treatment Period|Disease Progression (to AML)|0|||
49116228|NCT00303472|158263081|FG003|Treatment Period|Disease Progression (to AML)|0|||
49116229|NCT00303472|158263082|FG004|Treatment Period|Disease Progression (to AML)|1|||
49116230|NCT00303472|158263083|FG005|Treatment Period|Disease Progression (to AML)|0|||
49116231|NCT00303472|158263084|FG006|Treatment Period|Disease Progression (to AML)|0|||
49116232|NCT00303472|158263078|FG000|Treatment Extension (Optional)|Adverse Event|1|||
49116233|NCT00303472|158263079|FG001|Treatment Extension (Optional)|Adverse Event|0|||
49116234|NCT00303472|158263080|FG002|Treatment Extension (Optional)|Adverse Event|1|||
49116235|NCT00303472|158263081|FG003|Treatment Extension (Optional)|Adverse Event|0|||
49116236|NCT00303472|158263082|FG004|Treatment Extension (Optional)|Adverse Event|0|||
49116237|NCT00303472|158263083|FG005|Treatment Extension (Optional)|Adverse Event|0|||
49116238|NCT00303472|158263084|FG006|Treatment Extension (Optional)|Adverse Event|0|||
49116239|NCT00303472|158263078|FG000|Treatment Extension (Optional)|Death|2|||
49116240|NCT00303472|158263079|FG001|Treatment Extension (Optional)|Death|0|||
49116241|NCT00303472|158263080|FG002|Treatment Extension (Optional)|Death|1|||
49116242|NCT00303472|158263081|FG003|Treatment Extension (Optional)|Death|0|||
49116243|NCT00303472|158263082|FG004|Treatment Extension (Optional)|Death|0|||
49116244|NCT00303472|158263083|FG005|Treatment Extension (Optional)|Death|0|||
49116245|NCT00303472|158263084|FG006|Treatment Extension (Optional)|Death|0|||
49116246|NCT00303472|158263078|FG000|Treatment Extension (Optional)|Lost to Follow-up|0|||
49116247|NCT00303472|158263079|FG001|Treatment Extension (Optional)|Lost to Follow-up|0|||
49116248|NCT00303472|158263080|FG002|Treatment Extension (Optional)|Lost to Follow-up|0|||
49116249|NCT00303472|158263081|FG003|Treatment Extension (Optional)|Lost to Follow-up|1|||
49116250|NCT00303472|158263082|FG004|Treatment Extension (Optional)|Lost to Follow-up|0|||
49116251|NCT00303472|158263083|FG005|Treatment Extension (Optional)|Lost to Follow-up|0|||
49116252|NCT00303472|158263084|FG006|Treatment Extension (Optional)|Lost to Follow-up|0|||
49116253|NCT00303472|158263078|FG000|Treatment Extension (Optional)|Physician Decision|0|||
49116254|NCT00303472|158263079|FG001|Treatment Extension (Optional)|Physician Decision|4|||
49116255|NCT00303472|158263080|FG002|Treatment Extension (Optional)|Physician Decision|2|||
49116256|NCT00303472|158263081|FG003|Treatment Extension (Optional)|Physician Decision|3|||
49116257|NCT00303472|158263082|FG004|Treatment Extension (Optional)|Physician Decision|2|||
49116258|NCT00303472|158263083|FG005|Treatment Extension (Optional)|Physician Decision|0|||
49116259|NCT00303472|158263084|FG006|Treatment Extension (Optional)|Physician Decision|0|||
49116260|NCT00303472|158263078|FG000|Treatment Extension (Optional)|Withdrawal by Subject|1|||
48905980|NCT03250832|157492794|FG008|Part 1 (Up to Approximately 51 Months)|Death|0|||
48905981|NCT03250832|157492795|FG009|Part 1 (Up to Approximately 51 Months)|Death|0|||
48905982|NCT03250832|157492796|FG010|Part 1 (Up to Approximately 51 Months)|Death|0|||
48905983|NCT03250832|157492797|FG011|Part 1 (Up to Approximately 51 Months)|Death|0|||
48905984|NCT03250832|157492786|FG000|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
48905985|NCT03250832|157492787|FG001|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|4|||
48905986|NCT03250832|157492788|FG002|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
48905987|NCT03250832|157492789|FG003|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
48905988|NCT03250832|157492790|FG004|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
48905989|NCT03250832|157492791|FG005|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|1|||
48905990|NCT03250832|157492792|FG006|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|3|||
48905991|NCT03250832|157492793|FG007|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
48905992|NCT03250832|157492794|FG008|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
48905993|NCT03250832|157492795|FG009|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
48905994|NCT03250832|157492796|FG010|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
48905995|NCT03250832|157492797|FG011|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
48905996|NCT03250832|157492786|FG000|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
48905997|NCT03250832|157492787|FG001|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
48905998|NCT03250832|157492788|FG002|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|1|||
48905999|NCT03250832|157492789|FG003|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
48906000|NCT03250832|157492790|FG004|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
48906001|NCT03250832|157492791|FG005|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
48906002|NCT03250832|157492792|FG006|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
48906003|NCT03250832|157492793|FG007|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
48906004|NCT03250832|157492794|FG008|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
48906005|NCT03250832|157492795|FG009|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
48906006|NCT03250832|157492796|FG010|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
48906007|NCT03250832|157492797|FG011|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
48906008|NCT03250832|157492786|FG000|Part 2A (Up to Approximately 30 Months)|Death|0|||
48906009|NCT03250832|157492787|FG001|Part 2A (Up to Approximately 30 Months)|Death|0|||
48906010|NCT03250832|157492788|FG002|Part 2A (Up to Approximately 30 Months)|Death|0|||
48906011|NCT03250832|157492789|FG003|Part 2A (Up to Approximately 30 Months)|Death|0|||
48906012|NCT03250832|157492790|FG004|Part 2A (Up to Approximately 30 Months)|Death|0|||
48906013|NCT03250832|157492791|FG005|Part 2A (Up to Approximately 30 Months)|Death|0|||
48906014|NCT03250832|157492792|FG006|Part 2A (Up to Approximately 30 Months)|Death|0|||
48906015|NCT03250832|157492793|FG007|Part 2A (Up to Approximately 30 Months)|Death|18|||
48906016|NCT03250832|157492794|FG008|Part 2A (Up to Approximately 30 Months)|Death|0|||
48906017|NCT03250832|157492795|FG009|Part 2A (Up to Approximately 30 Months)|Death|0|||
48906018|NCT03250832|157492796|FG010|Part 2A (Up to Approximately 30 Months)|Death|0|||
48906019|NCT03250832|157492797|FG011|Part 2A (Up to Approximately 30 Months)|Death|0|||
48906020|NCT03250832|157492786|FG000|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
48906021|NCT03250832|157492787|FG001|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
48906022|NCT03250832|157492788|FG002|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
48906023|NCT03250832|157492789|FG003|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
48906024|NCT03250832|157492790|FG004|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
48906025|NCT03250832|157492791|FG005|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
48906026|NCT03250832|157492792|FG006|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
48906027|NCT03250832|157492793|FG007|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|3|||
48906028|NCT03250832|157492794|FG008|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
48906029|NCT03250832|157492795|FG009|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
48906030|NCT03250832|157492796|FG010|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
48906031|NCT03250832|157492797|FG011|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
49116261|NCT00303472|158263079|FG001|Treatment Extension (Optional)|Withdrawal by Subject|0|||
49116262|NCT00303472|158263080|FG002|Treatment Extension (Optional)|Withdrawal by Subject|1|||
48906032|NCT03250832|157492786|FG000|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
48906033|NCT03250832|157492787|FG001|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
48906034|NCT03250832|157492788|FG002|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
48906035|NCT03250832|157492789|FG003|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
48906036|NCT03250832|157492790|FG004|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
48906037|NCT03250832|157492791|FG005|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
48906038|NCT03250832|157492792|FG006|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
48693835|NCT00001959|156726465|FG000|Overall Study|newly diagnosed colon cancer|1|||
48693836|NCT00001959|156726465|FG000|Overall Study|disabling sedation|1|||
48693837|NCT00001959|156726465|FG000|Overall Study|non-compliance|1|||
48693838|NCT00730158|156726467|FG000|Overall Study|Withdrawal by Subject|1|||
48693839|NCT00730158|156726468|FG001|Overall Study|Withdrawal by Subject|1|||
48693840|NCT02738008|156726469|FG000|Overall Study|Study Terminated by Sponsor|1|||
48693841|NCT02738008|156726470|FG001|Overall Study|Study Terminated by Sponsor|5|||
48693842|NCT02738008|156726471|FG002|Overall Study|Study Terminated by Sponsor|3|||
48693843|NCT02738008|156726469|FG000|Overall Study|Adverse Event|0|||
48693844|NCT02738008|156726470|FG001|Overall Study|Adverse Event|1|||
48693845|NCT02738008|156726471|FG002|Overall Study|Adverse Event|2|||
48693846|NCT02888106|156726478|FG000|Overall Study|Withdrawal by Subject|1|||
48693847|NCT02888106|156726479|FG001|Overall Study|Withdrawal by Subject|2|||
48693848|NCT02888106|156726480|FG002|Overall Study|Withdrawal by Subject|0|||
48693849|NCT02888106|156726481|FG003|Overall Study|Withdrawal by Subject|1|||
48693850|NCT02888106|156726482|FG004|Overall Study|Withdrawal by Subject|0|||
48693851|NCT02888106|156726483|FG005|Overall Study|Withdrawal by Subject|0|||
48693852|NCT02888106|156726478|FG000|Overall Study|Lost to Follow-up|1|||
48693853|NCT02888106|156726479|FG001|Overall Study|Lost to Follow-up|0|||
48693854|NCT02888106|156726480|FG002|Overall Study|Lost to Follow-up|0|||
48693855|NCT02888106|156726481|FG003|Overall Study|Lost to Follow-up|1|||
48693856|NCT02888106|156726482|FG004|Overall Study|Lost to Follow-up|0|||
48693857|NCT02888106|156726483|FG005|Overall Study|Lost to Follow-up|1|||
48693858|NCT02888106|156726478|FG000|Overall Study|Adverse Event|2|||
48693859|NCT02888106|156726479|FG001|Overall Study|Adverse Event|0|||
48693860|NCT02888106|156726480|FG002|Overall Study|Adverse Event|0|||
48693861|NCT02888106|156726481|FG003|Overall Study|Adverse Event|0|||
48693862|NCT02888106|156726482|FG004|Overall Study|Adverse Event|0|||
48693863|NCT02888106|156726483|FG005|Overall Study|Adverse Event|0|||
48693864|NCT02888106|156726478|FG000|Overall Study|Withdrawal of consent|0|||
48693865|NCT02888106|156726479|FG001|Overall Study|Withdrawal of consent|0|||
48693866|NCT02888106|156726480|FG002|Overall Study|Withdrawal of consent|0|||
48693867|NCT02888106|156726481|FG003|Overall Study|Withdrawal of consent|0|||
48693868|NCT02888106|156726482|FG004|Overall Study|Withdrawal of consent|1|||
48693869|NCT02888106|156726483|FG005|Overall Study|Withdrawal of consent|0|||
48693870|NCT02888106|156726478|FG000|Overall Study|Pregnancy|1|||
48693871|NCT02888106|156726479|FG001|Overall Study|Pregnancy|0|||
48693872|NCT02888106|156726480|FG002|Overall Study|Pregnancy|0|||
48693873|NCT02888106|156726481|FG003|Overall Study|Pregnancy|0|||
48693874|NCT02888106|156726482|FG004|Overall Study|Pregnancy|0|||
48693875|NCT02888106|156726483|FG005|Overall Study|Pregnancy|0|||
48693876|NCT01943409|156726490|FG000|Overall Study|resumed oral/entral|24|||
48693877|NCT01943409|156726491|FG001|Overall Study|resumed oral/entral|20|||
48693878|NCT01943409|156726490|FG000|Overall Study|Protocol Violation|14|||
48693879|NCT01943409|156726491|FG001|Overall Study|Protocol Violation|24|||
48693880|NCT01943409|156726490|FG000|Overall Study|Death|3|||
48693881|NCT01943409|156726491|FG001|Overall Study|Death|1|||
48693882|NCT01943409|156726490|FG000|Overall Study|Withdrawal by Subject|4|||
48693883|NCT01943409|156726491|FG001|Overall Study|Withdrawal by Subject|3|||
48693884|NCT00601835|156726495|FG000|Overall Study|Withdrawal by Subject|9|||
48693885|NCT00601835|156726496|FG001|Overall Study|Withdrawal by Subject|6|||
48693886|NCT00601835|156726495|FG000|Overall Study|Physician Decision|1|||
48693887|NCT00601835|156726496|FG001|Overall Study|Physician Decision|0|||
48693888|NCT00601835|156726495|FG000|Overall Study|Lost to Follow-up|37|||
48693889|NCT00601835|156726496|FG001|Overall Study|Lost to Follow-up|5|||
48693890|NCT00601835|156726495|FG000|Overall Study|Adverse Event|1|||
48693891|NCT00601835|156726496|FG001|Overall Study|Adverse Event|1|||
48693892|NCT00601835|156726495|FG000|Overall Study|Relocate|12|||
48693893|NCT00601835|156726496|FG001|Overall Study|Relocate|2|||
48693894|NCT01927497|156726497|FG000|Overall Study|Death|0|||
48693895|NCT01927497|156726498|FG001|Overall Study|Death|1|||
48693896|NCT01927497|156726497|FG000|Overall Study|Protocol Violation|2|||
48693897|NCT01927497|156726498|FG001|Overall Study|Protocol Violation|0|||
48693898|NCT00152503|156726500|FG000|Overall Study|Adverse Event|4|||
48693899|NCT05070546|156726501|FG000|Overall Study|Death|0|||
48693900|NCT05070546|156726502|FG001|Overall Study|Death|0|||
48693901|NCT05070546|156726503|FG002|Overall Study|Death|0|||
48693902|NCT05070546|156726504|FG003|Overall Study|Death|0|||
48693903|NCT05070546|156726505|FG004|Overall Study|Death|0|||
48693904|NCT05070546|156726506|FG005|Overall Study|Death|1|||
48693905|NCT05070546|156726501|FG000|Overall Study|Lost to Follow-up|8|||
48693906|NCT05070546|156726502|FG001|Overall Study|Lost to Follow-up|2|||
48693907|NCT05070546|156726503|FG002|Overall Study|Lost to Follow-up|7|||
48693908|NCT05070546|156726504|FG003|Overall Study|Lost to Follow-up|1|||
48693909|NCT05070546|156726505|FG004|Overall Study|Lost to Follow-up|2|||
48693910|NCT05070546|156726506|FG005|Overall Study|Lost to Follow-up|0|||
48693911|NCT05070546|156726501|FG000|Overall Study|Withdrawal by Subject|1|||
48693912|NCT05070546|156726502|FG001|Overall Study|Withdrawal by Subject|1|||
48693913|NCT05070546|156726503|FG002|Overall Study|Withdrawal by Subject|3|||
48693914|NCT05070546|156726504|FG003|Overall Study|Withdrawal by Subject|0|||
48693915|NCT05070546|156726505|FG004|Overall Study|Withdrawal by Subject|0|||
48693916|NCT05070546|156726506|FG005|Overall Study|Withdrawal by Subject|0|||
48693917|NCT05070546|156726501|FG000|Overall Study|Other|0|||
48693918|NCT05070546|156726502|FG001|Overall Study|Other|0|||
48693919|NCT05070546|156726503|FG002|Overall Study|Other|0|||
48693920|NCT05070546|156726504|FG003|Overall Study|Other|0|||
48693921|NCT05070546|156726505|FG004|Overall Study|Other|3|||
48693922|NCT05070546|156726506|FG005|Overall Study|Other|0|||
48693923|NCT05070546|156726501|FG000|Overall Study|Randomized but not vaccinated|1|||
48693924|NCT05070546|156726502|FG001|Overall Study|Randomized but not vaccinated|0|||
48693925|NCT05070546|156726503|FG002|Overall Study|Randomized but not vaccinated|1|||
48693926|NCT05070546|156726504|FG003|Overall Study|Randomized but not vaccinated|1|||
48693927|NCT05070546|156726505|FG004|Overall Study|Randomized but not vaccinated|3|||
48693928|NCT05070546|156726506|FG005|Overall Study|Randomized but not vaccinated|0|||
48693929|NCT01420861|156726509|FG000|Overall Study|Adverse Event|2|||
48693930|NCT01420861|156726509|FG000|Overall Study|Study terminated by Sponsor|7|||
48693931|NCT01420861|156726509|FG000|Overall Study|Screen failure|7|||
48693932|NCT01420861|156726509|FG000|Overall Study|Randomized not Treated|2|||
48693933|NCT01247324|156726510|FG000|Overall Study|Death|6|||
48693934|NCT01247324|156726511|FG001|Overall Study|Death|10|||
48693935|NCT01247324|156726510|FG000|Overall Study|Physician Decision|2|||
48693936|NCT01247324|156726511|FG001|Overall Study|Physician Decision|3|||
48693937|NCT01247324|156726510|FG000|Overall Study|Non-compliance with study drug|3|||
48693938|NCT01247324|156726511|FG001|Overall Study|Non-compliance with study drug|0|||
48693939|NCT01247324|156726510|FG000|Overall Study|Lack of Efficacy|24|||
48693940|NCT01247324|156726511|FG001|Overall Study|Lack of Efficacy|14|||
48693941|NCT01247324|156726510|FG000|Overall Study|Non-compliance|3|||
48693942|NCT01247324|156726511|FG001|Overall Study|Non-compliance|2|||
48693943|NCT01247324|156726510|FG000|Overall Study|Pregnancy|5|||
48693944|NCT01247324|156726511|FG001|Overall Study|Pregnancy|10|||
48693945|NCT01247324|156726510|FG000|Overall Study|Protocol Violation|1|||
48693946|NCT01247324|156726511|FG001|Overall Study|Protocol Violation|1|||
48693947|NCT01247324|156726510|FG000|Overall Study|Reason not specified|42|||
48693948|NCT01247324|156726511|FG001|Overall Study|Reason not specified|32|||
48693949|NCT01247324|156726510|FG000|Overall Study|Consent withdrawn by participant|41|||
48693950|NCT01247324|156726511|FG001|Overall Study|Consent withdrawn by participant|56|||
48693951|NCT01247324|156726510|FG000|Overall Study|Adverse Event|49|||
48693952|NCT01247324|156726511|FG001|Overall Study|Adverse Event|35|||
48693953|NCT01247324|156726510|FG000|Overall Study|Lost to Follow-up|3|||
48693954|NCT01247324|156726511|FG001|Overall Study|Lost to Follow-up|6|||
48693955|NCT01247324|156726510|FG000|Overall Study|Study Terminated by Sponsor|4|||
48693956|NCT01247324|156726511|FG001|Overall Study|Study Terminated by Sponsor|1|||
48693957|NCT01247324|156726510|FG000|Overall Study|Missing|2|||
48693958|NCT01247324|156726511|FG001|Overall Study|Missing|1|||
48693959|NCT03384654|156726512|FG000|Overall Study|Withdrawal by Subject|0|||
48693960|NCT03384654|156726513|FG001|Overall Study|Withdrawal by Subject|0|||
48693961|NCT03384654|156726514|FG002|Overall Study|Withdrawal by Subject|1|||
48693962|NCT03384654|156726515|FG003|Overall Study|Withdrawal by Subject|0|||
48693963|NCT02888743|156726516|FG000|Overall Study|Withdrawal by Subject|1|||
48693964|NCT02888743|156726517|FG001|Overall Study|Withdrawal by Subject|2|||
48693965|NCT02888743|156726518|FG002|Overall Study|Withdrawal by Subject|2|||
48693966|NCT02888743|156726519|FG003|Overall Study|Withdrawal by Subject|0|||
48693967|NCT02888743|156726520|FG004|Overall Study|Withdrawal by Subject|1|||
48693968|NCT02888743|156726516|FG000|Overall Study|Disease progression before treatment|2|||
48693969|NCT02888743|156726517|FG001|Overall Study|Disease progression before treatment|0|||
48693970|NCT02888743|156726518|FG002|Overall Study|Disease progression before treatment|2|||
48693971|NCT02888743|156726519|FG003|Overall Study|Disease progression before treatment|0|||
48693972|NCT02888743|156726520|FG004|Overall Study|Disease progression before treatment|0|||
48693973|NCT02888743|156726516|FG000|Overall Study|Patient ineligible|1|||
48693974|NCT02888743|156726517|FG001|Overall Study|Patient ineligible|2|||
48693975|NCT02888743|156726518|FG002|Overall Study|Patient ineligible|0|||
48693976|NCT02888743|156726519|FG003|Overall Study|Patient ineligible|0|||
48693977|NCT02888743|156726520|FG004|Overall Study|Patient ineligible|0|||
48742919|NCT00745823|156910414|FG001|Overall Study|Physician Decision|5|||
48742920|NCT00745823|156910413|FG000|Overall Study|Pregnancy|0|||
48742921|NCT00745823|156910414|FG001|Overall Study|Pregnancy|4|||
48742922|NCT00745823|156910413|FG000|Overall Study|Withdrawal by Subject|14|||
48742923|NCT00745823|156910414|FG001|Overall Study|Withdrawal by Subject|8|||
48742924|NCT00745823|156910413|FG000|Overall Study|Study Terminated by Sponsor|326|||
48742925|NCT00745823|156910414|FG001|Overall Study|Study Terminated by Sponsor|349|||
48742926|NCT00717197|156910415|FG000|Overall Study|Unable to purchase study drug|5|||
48742927|NCT00717197|156910415|FG000|Overall Study|Tumor Progression|1|||
48693978|NCT02791230|156727963|FG000|Overall Study|Adverse Event|10|||
48693979|NCT02791230|156727964|FG001|Overall Study|Adverse Event|9|||
48693980|NCT02791230|156727965|FG002|Overall Study|Adverse Event|66|||
48693981|NCT02791230|156727963|FG000|Overall Study|Death|38|||
48693982|NCT02791230|156727964|FG001|Overall Study|Death|25|||
48693983|NCT02791230|156727965|FG002|Overall Study|Death|184|||
48693984|NCT02791230|156727963|FG000|Overall Study|Lack of Efficacy|1|||
48693985|NCT02791230|156727964|FG001|Overall Study|Lack of Efficacy|0|||
48693986|NCT02791230|156727965|FG002|Overall Study|Lack of Efficacy|3|||
48693987|NCT02791230|156727963|FG000|Overall Study|Lost to Follow-up|0|||
48693988|NCT02791230|156727964|FG001|Overall Study|Lost to Follow-up|0|||
48693989|NCT02791230|156727965|FG002|Overall Study|Lost to Follow-up|10|||
48693990|NCT02791230|156727963|FG000|Overall Study|Failure to Meet Randomization Criteria|3|||
48693991|NCT02791230|156727964|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
48693992|NCT02791230|156727965|FG002|Overall Study|Failure to Meet Randomization Criteria|15|||
48693993|NCT02791230|156727963|FG000|Overall Study|Medication Error Without Associated Adverse Event|0|||
48693994|NCT02791230|156727964|FG001|Overall Study|Medication Error Without Associated Adverse Event|1|||
48693995|NCT02791230|156727965|FG002|Overall Study|Medication Error Without Associated Adverse Event|1|||
48693996|NCT02791230|156727963|FG000|Overall Study|Study sites terminated by sponsor|1|||
48693997|NCT02791230|156727964|FG001|Overall Study|Study sites terminated by sponsor|0|||
48693998|NCT02791230|156727965|FG002|Overall Study|Study sites terminated by sponsor|5|||
48693999|NCT02791230|156727963|FG000|Overall Study|Other|9|||
48694000|NCT02791230|156727964|FG001|Overall Study|Other|1|||
48694001|NCT02791230|156727965|FG002|Overall Study|Other|28|||
48694002|NCT02791230|156727963|FG000|Overall Study|Protocol Violation|0|||
48694003|NCT02791230|156727964|FG001|Overall Study|Protocol Violation|0|||
48694004|NCT02791230|156727965|FG002|Overall Study|Protocol Violation|4|||
48694005|NCT02791230|156727963|FG000|Overall Study|Withdrawal by Subject|24|||
48694006|NCT02791230|156727964|FG001|Overall Study|Withdrawal by Subject|13|||
48694007|NCT02791230|156727965|FG002|Overall Study|Withdrawal by Subject|172|||
48694008|NCT02791230|156727963|FG000|Overall Study|Enrolled but not treated|0|||
48694009|NCT02791230|156727964|FG001|Overall Study|Enrolled but not treated|0|||
48694010|NCT02791230|156727965|FG002|Overall Study|Enrolled but not treated|5|||
48694011|NCT03253393|156727968|FG000|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|6|||
48694012|NCT03253393|156727969|FG001|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|7|||
48694013|NCT03253393|156727970|FG002|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|0|||
48694014|NCT01005251|156727971|FG000|Overall Study|Withdrawal by Subject|2|||
48694015|NCT01005251|156727972|FG001|Overall Study|Withdrawal by Subject|5|||
48694016|NCT01005251|156727973|FG002|Overall Study|Withdrawal by Subject|3|||
48694017|NCT01005251|156727974|FG003|Overall Study|Withdrawal by Subject|4|||
48694018|NCT01005251|156727975|FG004|Overall Study|Withdrawal by Subject|9|||
48694019|NCT01005251|156727971|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
48694020|NCT01005251|156727972|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
48694021|NCT01005251|156727973|FG002|Overall Study|Eligibility criteria not fulfilled|4|||
48694022|NCT01005251|156727974|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
48694023|NCT01005251|156727975|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
48694024|NCT01005251|156727971|FG000|Overall Study|Adverse Event|2|||
48694025|NCT01005251|156727972|FG001|Overall Study|Adverse Event|6|||
48694026|NCT01005251|156727973|FG002|Overall Study|Adverse Event|8|||
48694027|NCT01005251|156727974|FG003|Overall Study|Adverse Event|5|||
48694028|NCT01005251|156727975|FG004|Overall Study|Adverse Event|4|||
48694029|NCT01005251|156727971|FG000|Overall Study|Protocol Violation|1|||
48694030|NCT01005251|156727972|FG001|Overall Study|Protocol Violation|0|||
48694031|NCT01005251|156727973|FG002|Overall Study|Protocol Violation|0|||
48694032|NCT01005251|156727974|FG003|Overall Study|Protocol Violation|0|||
48694033|NCT01005251|156727975|FG004|Overall Study|Protocol Violation|2|||
48694034|NCT01005251|156727971|FG000|Overall Study|Developed study-specific withdrawal crit|2|||
48694035|NCT01005251|156727972|FG001|Overall Study|Developed study-specific withdrawal crit|0|||
48694036|NCT01005251|156727973|FG002|Overall Study|Developed study-specific withdrawal crit|3|||
48694037|NCT01005251|156727974|FG003|Overall Study|Developed study-specific withdrawal crit|0|||
48694038|NCT01005251|156727975|FG004|Overall Study|Developed study-specific withdrawal crit|1|||
48694039|NCT01005251|156727971|FG000|Overall Study|Lost to Follow-up|1|||
48694040|NCT01005251|156727972|FG001|Overall Study|Lost to Follow-up|4|||
48694041|NCT01005251|156727973|FG002|Overall Study|Lost to Follow-up|2|||
48694042|NCT01005251|156727974|FG003|Overall Study|Lost to Follow-up|0|||
48694043|NCT01005251|156727975|FG004|Overall Study|Lost to Follow-up|0|||
48694044|NCT01005251|156727971|FG000|Overall Study|Physician Decision|0|||
48694045|NCT01005251|156727972|FG001|Overall Study|Physician Decision|0|||
48694046|NCT01005251|156727973|FG002|Overall Study|Physician Decision|0|||
48694047|NCT01005251|156727974|FG003|Overall Study|Physician Decision|0|||
48694048|NCT01005251|156727975|FG004|Overall Study|Physician Decision|2|||
48694049|NCT01005251|156727971|FG000|Overall Study|Patient moved|1|||
48694050|NCT01005251|156727972|FG001|Overall Study|Patient moved|0|||
48694051|NCT01005251|156727973|FG002|Overall Study|Patient moved|0|||
48694052|NCT01005251|156727974|FG003|Overall Study|Patient moved|0|||
48694053|NCT01005251|156727975|FG004|Overall Study|Patient moved|0|||
48694054|NCT01005251|156727971|FG000|Overall Study|Wrong drug dispensed|0|||
48694055|NCT01005251|156727972|FG001|Overall Study|Wrong drug dispensed|1|||
48694056|NCT01005251|156727973|FG002|Overall Study|Wrong drug dispensed|0|||
48694057|NCT01005251|156727974|FG003|Overall Study|Wrong drug dispensed|0|||
48694058|NCT01005251|156727975|FG004|Overall Study|Wrong drug dispensed|0|||
48694059|NCT01005251|156727971|FG000|Overall Study|Randomized in error|0|||
48694060|NCT01005251|156727972|FG001|Overall Study|Randomized in error|0|||
48694061|NCT01005251|156727973|FG002|Overall Study|Randomized in error|1|||
48694062|NCT01005251|156727974|FG003|Overall Study|Randomized in error|1|||
48694063|NCT01005251|156727975|FG004|Overall Study|Randomized in error|0|||
48694064|NCT01005251|156727971|FG000|Overall Study|Lack of Efficacy|0|||
48694065|NCT01005251|156727972|FG001|Overall Study|Lack of Efficacy|0|||
48694066|NCT01005251|156727973|FG002|Overall Study|Lack of Efficacy|1|||
48694067|NCT01005251|156727974|FG003|Overall Study|Lack of Efficacy|1|||
48694068|NCT01005251|156727975|FG004|Overall Study|Lack of Efficacy|0|||
48694069|NCT01884077|156727976|FG000|Overall Study|screen fail|0|||
48694070|NCT01884077|156727977|FG001|Overall Study|screen fail|2|||
48694071|NCT01884077|156727976|FG000|Overall Study|canceled surgery|2|||
48694072|NCT01884077|156727977|FG001|Overall Study|canceled surgery|0|||
48694073|NCT01884077|156727976|FG000|Overall Study|Lost to Follow-up|0|||
48694074|NCT01884077|156727977|FG001|Overall Study|Lost to Follow-up|4|||
48694075|NCT01884077|156727976|FG000|Overall Study|study closed|6|||
48694076|NCT01884077|156727977|FG001|Overall Study|study closed|4|||
48694077|NCT02648204|156727978|FG000|Overall Study|Withdrawal by Subject|12|||
48694078|NCT02648204|156727979|FG001|Overall Study|Withdrawal by Subject|8|||
48694079|NCT02648204|156727980|FG002|Overall Study|Withdrawal by Subject|2|||
48694080|NCT02648204|156727981|FG003|Overall Study|Withdrawal by Subject|6|||
48694081|NCT02648204|156727978|FG000|Overall Study|Lost to Follow-up|5|||
48694082|NCT02648204|156727979|FG001|Overall Study|Lost to Follow-up|8|||
48694083|NCT02648204|156727980|FG002|Overall Study|Lost to Follow-up|4|||
48694084|NCT02648204|156727981|FG003|Overall Study|Lost to Follow-up|6|||
48694085|NCT02648204|156727978|FG000|Overall Study|Missing follow-up information|4|||
48694086|NCT02648204|156727979|FG001|Overall Study|Missing follow-up information|4|||
48694087|NCT02648204|156727980|FG002|Overall Study|Missing follow-up information|4|||
48694088|NCT02648204|156727981|FG003|Overall Study|Missing follow-up information|2|||
48694089|NCT02648204|156727978|FG000|Overall Study|Death|1|||
48694090|NCT02648204|156727979|FG001|Overall Study|Death|1|||
48694091|NCT02648204|156727980|FG002|Overall Study|Death|2|||
48694092|NCT02648204|156727981|FG003|Overall Study|Death|2|||
48694093|NCT02648204|156727978|FG000|Overall Study|Adverse Event|0|||
48694094|NCT02648204|156727979|FG001|Overall Study|Adverse Event|0|||
48694095|NCT02648204|156727980|FG002|Overall Study|Adverse Event|1|||
48694096|NCT02648204|156727981|FG003|Overall Study|Adverse Event|0|||
48694097|NCT03161379|156727983|FG000|Overall Study|Withdrawal by Subject|4|||
48694098|NCT03161379|156727983|FG000|Overall Study|disease progression during chemotherapy|5|||
48694099|NCT03161379|156727983|FG000|Overall Study|no longer surgical candidate after chemotherapy|2|||
48694100|NCT03161379|156727983|FG000|Overall Study|not eligible to start study drug after chemotherapy|2|||
48694101|NCT04606771|156727984|FG000|Overall Study|Patients ongoing study at data cut-off|9|||
48694102|NCT04606771|156727985|FG001|Overall Study|Patients ongoing study at data cut-off|9|||
48694103|NCT04606771|156727984|FG000|Overall Study|Death|5|||
48694104|NCT04606771|156727985|FG001|Overall Study|Death|6|||
48694105|NCT04606771|156727984|FG000|Overall Study|Wrong randomisation|0|||
48694106|NCT04606771|156727985|FG001|Overall Study|Wrong randomisation|1|||
48694107|NCT02201524|156727986|FG000|Overall Study|Adverse Event|0|||
48694108|NCT02201524|156727987|FG001|Overall Study|Adverse Event|2|||
48694109|NCT02201524|156727988|FG002|Overall Study|Adverse Event|1|||
48694110|NCT02201524|156727989|FG003|Overall Study|Adverse Event|0|||
48694111|NCT02201524|156727986|FG000|Overall Study|Insufficient clinical response|1|||
48694112|NCT02201524|156727987|FG001|Overall Study|Insufficient clinical response|0|||
48694113|NCT02201524|156727988|FG002|Overall Study|Insufficient clinical response|0|||
48694114|NCT02201524|156727989|FG003|Overall Study|Insufficient clinical response|0|||
48694115|NCT02201524|156727986|FG000|Overall Study|Lost to Follow-up|0|||
48906039|NCT03250832|157492793|FG007|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|8|||
48694116|NCT02201524|156727987|FG001|Overall Study|Lost to Follow-up|0|||
48694117|NCT02201524|156727988|FG002|Overall Study|Lost to Follow-up|2|||
48694118|NCT02201524|156727989|FG003|Overall Study|Lost to Follow-up|0|||
48694119|NCT02201524|156727986|FG000|Overall Study|No longer meets eligibility criteria|0|||
48694120|NCT02201524|156727987|FG001|Overall Study|No longer meets eligibility criteria|0|||
48694121|NCT02201524|156727988|FG002|Overall Study|No longer meets eligibility criteria|0|||
48694122|NCT02201524|156727989|FG003|Overall Study|No longer meets eligibility criteria|2|||
48694123|NCT02201524|156727986|FG000|Overall Study|Protocol Violation|0|||
48694124|NCT02201524|156727987|FG001|Overall Study|Protocol Violation|0|||
48694125|NCT02201524|156727988|FG002|Overall Study|Protocol Violation|0|||
48694126|NCT02201524|156727989|FG003|Overall Study|Protocol Violation|1|||
48694127|NCT02201524|156727986|FG000|Overall Study|Withdrawal by Subject|0|||
48694128|NCT02201524|156727987|FG001|Overall Study|Withdrawal by Subject|0|||
48694129|NCT02201524|156727988|FG002|Overall Study|Withdrawal by Subject|1|||
48694130|NCT02201524|156727989|FG003|Overall Study|Withdrawal by Subject|1|||
48694131|NCT02201524|156727986|FG000|Overall Study|Other|1|||
48694132|NCT02201524|156727987|FG001|Overall Study|Other|1|||
48694133|NCT02201524|156727988|FG002|Overall Study|Other|0|||
48694134|NCT02201524|156727989|FG003|Overall Study|Other|0|||
48694135|NCT00074711|156727997|FG000|Overall Study|Withdrawal by Subject|1|||
48694136|NCT00074711|156727998|FG001|Overall Study|Withdrawal by Subject|1|||
48694137|NCT00074711|156727997|FG000|Overall Study|Lost to Follow-up|10|||
48694138|NCT00074711|156727998|FG001|Overall Study|Lost to Follow-up|8|||
48694139|NCT00074711|156727997|FG000|Overall Study|Participant stopped study drug|4|||
48694140|NCT00074711|156727998|FG001|Overall Study|Participant stopped study drug|6|||
48694141|NCT02269124|156727999|FG000|Overall Study|Lost to Follow-up|1|||
48694142|NCT02269124|156728000|FG001|Overall Study|Lost to Follow-up|0|||
48694143|NCT02269124|156727999|FG000|Overall Study|Withdrawal by Subject|0|||
48694144|NCT02269124|156728000|FG001|Overall Study|Withdrawal by Subject|2|||
48694145|NCT02903914|156728001|FG000|Overall Study|Adverse Event|0|||
48694146|NCT02903914|156728002|FG001|Overall Study|Adverse Event|0|||
48694147|NCT02903914|156728003|FG002|Overall Study|Adverse Event|1|||
48694148|NCT02903914|156728004|FG003|Overall Study|Adverse Event|0|||
48694149|NCT02903914|156728005|FG004|Overall Study|Adverse Event|0|||
48694150|NCT02903914|156728006|FG005|Overall Study|Adverse Event|0|||
48694151|NCT02903914|156728007|FG006|Overall Study|Adverse Event|2|||
48694152|NCT02903914|156728008|FG007|Overall Study|Adverse Event|0|||
48694153|NCT02903914|156728001|FG000|Overall Study|Withdrawal by Subject|3|||
48694154|NCT02903914|156728002|FG001|Overall Study|Withdrawal by Subject|1|||
48694155|NCT02903914|156728003|FG002|Overall Study|Withdrawal by Subject|28|||
48694156|NCT02903914|156728004|FG003|Overall Study|Withdrawal by Subject|0|||
48694157|NCT02903914|156728005|FG004|Overall Study|Withdrawal by Subject|1|||
48694158|NCT02903914|156728006|FG005|Overall Study|Withdrawal by Subject|2|||
48694159|NCT02903914|156728007|FG006|Overall Study|Withdrawal by Subject|12|||
48694160|NCT02903914|156728008|FG007|Overall Study|Withdrawal by Subject|0|||
48694161|NCT02903914|156728001|FG000|Overall Study|Progressive Disease|1|||
48694162|NCT02903914|156728002|FG001|Overall Study|Progressive Disease|0|||
48694163|NCT02903914|156728003|FG002|Overall Study|Progressive Disease|4|||
48694164|NCT02903914|156728004|FG003|Overall Study|Progressive Disease|0|||
48694165|NCT02903914|156728005|FG004|Overall Study|Progressive Disease|0|||
48694166|NCT02903914|156728006|FG005|Overall Study|Progressive Disease|0|||
48694167|NCT02903914|156728007|FG006|Overall Study|Progressive Disease|2|||
48694168|NCT02903914|156728008|FG007|Overall Study|Progressive Disease|0|||
48694169|NCT02903914|156728001|FG000|Overall Study|Death|0|||
48694170|NCT02903914|156728002|FG001|Overall Study|Death|0|||
48694171|NCT02903914|156728003|FG002|Overall Study|Death|9|||
48694172|NCT02903914|156728004|FG003|Overall Study|Death|0|||
48694173|NCT02903914|156728005|FG004|Overall Study|Death|1|||
48694174|NCT02903914|156728006|FG005|Overall Study|Death|3|||
48694175|NCT02903914|156728007|FG006|Overall Study|Death|24|||
48694176|NCT02903914|156728008|FG007|Overall Study|Death|2|||
48694177|NCT02903914|156728001|FG000|Overall Study|Lost to Follow-up|0|||
48694178|NCT02903914|156728002|FG001|Overall Study|Lost to Follow-up|1|||
48694179|NCT02903914|156728003|FG002|Overall Study|Lost to Follow-up|0|||
48694180|NCT02903914|156728004|FG003|Overall Study|Lost to Follow-up|0|||
48694181|NCT02903914|156728005|FG004|Overall Study|Lost to Follow-up|2|||
48694182|NCT02903914|156728006|FG005|Overall Study|Lost to Follow-up|0|||
48694183|NCT02903914|156728007|FG006|Overall Study|Lost to Follow-up|1|||
48694184|NCT02903914|156728008|FG007|Overall Study|Lost to Follow-up|0|||
48694185|NCT02903914|156728001|FG000|Overall Study|Physician Decision|0|||
48694186|NCT02903914|156728002|FG001|Overall Study|Physician Decision|0|||
48694187|NCT02903914|156728003|FG002|Overall Study|Physician Decision|1|||
48694188|NCT02903914|156728004|FG003|Overall Study|Physician Decision|0|||
48694189|NCT02903914|156728005|FG004|Overall Study|Physician Decision|0|||
49116263|NCT00303472|158263081|FG003|Treatment Extension (Optional)|Withdrawal by Subject|2|||
48694190|NCT02903914|156728006|FG005|Overall Study|Physician Decision|0|||
48694191|NCT02903914|156728007|FG006|Overall Study|Physician Decision|1|||
48694192|NCT02903914|156728008|FG007|Overall Study|Physician Decision|0|||
48694193|NCT02903914|156728001|FG000|Overall Study|Symptomatic Deterioration|0|||
48694194|NCT02903914|156728002|FG001|Overall Study|Symptomatic Deterioration|0|||
49116264|NCT00303472|158263082|FG004|Treatment Extension (Optional)|Withdrawal by Subject|1|||
48694195|NCT02903914|156728003|FG002|Overall Study|Symptomatic Deterioration|1|||
48694196|NCT02903914|156728004|FG003|Overall Study|Symptomatic Deterioration|0|||
48694197|NCT02903914|156728005|FG004|Overall Study|Symptomatic Deterioration|0|||
48694198|NCT02903914|156728006|FG005|Overall Study|Symptomatic Deterioration|0|||
48694199|NCT02903914|156728007|FG006|Overall Study|Symptomatic Deterioration|0|||
48694200|NCT02903914|156728008|FG007|Overall Study|Symptomatic Deterioration|0|||
48694201|NCT02903914|156728001|FG000|Overall Study|New Cancer Therapy|2|||
48694202|NCT02903914|156728002|FG001|Overall Study|New Cancer Therapy|2|||
48694203|NCT02903914|156728003|FG002|Overall Study|New Cancer Therapy|21|||
48694204|NCT02903914|156728004|FG003|Overall Study|New Cancer Therapy|4|||
48694205|NCT02903914|156728005|FG004|Overall Study|New Cancer Therapy|3|||
48694206|NCT02903914|156728006|FG005|Overall Study|New Cancer Therapy|6|||
48694207|NCT02903914|156728007|FG006|Overall Study|New Cancer Therapy|56|||
48694208|NCT02903914|156728008|FG007|Overall Study|New Cancer Therapy|3|||
48694209|NCT02903914|156728001|FG000|Overall Study|Didn't Return to Site|1|||
48694210|NCT02903914|156728002|FG001|Overall Study|Didn't Return to Site|0|||
48694211|NCT02903914|156728003|FG002|Overall Study|Didn't Return to Site|1|||
48694212|NCT02903914|156728004|FG003|Overall Study|Didn't Return to Site|1|||
48694213|NCT02903914|156728005|FG004|Overall Study|Didn't Return to Site|0|||
48694214|NCT02903914|156728006|FG005|Overall Study|Didn't Return to Site|0|||
48694215|NCT02903914|156728007|FG006|Overall Study|Didn't Return to Site|2|||
48694216|NCT02903914|156728008|FG007|Overall Study|Didn't Return to Site|0|||
48694217|NCT02903914|156728001|FG000|Overall Study|Entered/Referred to Hospice Care|1|||
48694218|NCT02903914|156728002|FG001|Overall Study|Entered/Referred to Hospice Care|1|||
48694219|NCT02903914|156728003|FG002|Overall Study|Entered/Referred to Hospice Care|8|||
48694220|NCT02903914|156728004|FG003|Overall Study|Entered/Referred to Hospice Care|0|||
48694221|NCT02903914|156728005|FG004|Overall Study|Entered/Referred to Hospice Care|0|||
48694222|NCT02903914|156728006|FG005|Overall Study|Entered/Referred to Hospice Care|0|||
48694223|NCT02903914|156728007|FG006|Overall Study|Entered/Referred to Hospice Care|4|||
48694224|NCT02903914|156728008|FG007|Overall Study|Entered/Referred to Hospice Care|0|||
48694225|NCT02903914|156728001|FG000|Overall Study|Follow-up Did Not Occur|0|||
48694226|NCT02903914|156728002|FG001|Overall Study|Follow-up Did Not Occur|1|||
48694227|NCT02903914|156728003|FG002|Overall Study|Follow-up Did Not Occur|1|||
48694228|NCT02903914|156728004|FG003|Overall Study|Follow-up Did Not Occur|0|||
48694229|NCT02903914|156728005|FG004|Overall Study|Follow-up Did Not Occur|2|||
48694230|NCT02903914|156728006|FG005|Overall Study|Follow-up Did Not Occur|0|||
48694231|NCT02903914|156728007|FG006|Overall Study|Follow-up Did Not Occur|8|||
48694232|NCT02903914|156728008|FG007|Overall Study|Follow-up Did Not Occur|0|||
48694233|NCT02903914|156728001|FG000|Overall Study|Systemic Treatment Options Necessary|0|||
48694234|NCT02903914|156728002|FG001|Overall Study|Systemic Treatment Options Necessary|1|||
48694235|NCT02903914|156728003|FG002|Overall Study|Systemic Treatment Options Necessary|0|||
48694236|NCT02903914|156728004|FG003|Overall Study|Systemic Treatment Options Necessary|0|||
48694237|NCT02903914|156728005|FG004|Overall Study|Systemic Treatment Options Necessary|0|||
48694238|NCT02903914|156728006|FG005|Overall Study|Systemic Treatment Options Necessary|0|||
48694239|NCT02903914|156728007|FG006|Overall Study|Systemic Treatment Options Necessary|0|||
48694240|NCT02903914|156728008|FG007|Overall Study|Systemic Treatment Options Necessary|0|||
48694241|NCT02903914|156728001|FG000|Overall Study|Consented to/Considered Other Clinical Study|0|||
48694242|NCT02903914|156728002|FG001|Overall Study|Consented to/Considered Other Clinical Study|0|||
48694243|NCT02903914|156728003|FG002|Overall Study|Consented to/Considered Other Clinical Study|2|||
48694244|NCT02903914|156728004|FG003|Overall Study|Consented to/Considered Other Clinical Study|0|||
48694245|NCT02903914|156728005|FG004|Overall Study|Consented to/Considered Other Clinical Study|0|||
48694246|NCT02903914|156728006|FG005|Overall Study|Consented to/Considered Other Clinical Study|2|||
48694247|NCT02903914|156728007|FG006|Overall Study|Consented to/Considered Other Clinical Study|0|||
48694248|NCT02903914|156728008|FG007|Overall Study|Consented to/Considered Other Clinical Study|0|||
48694249|NCT02903914|156728001|FG000|Overall Study|Clinical Disease Progression|0|||
48694250|NCT02903914|156728002|FG001|Overall Study|Clinical Disease Progression|0|||
48694251|NCT02903914|156728003|FG002|Overall Study|Clinical Disease Progression|2|||
48694252|NCT02903914|156728004|FG003|Overall Study|Clinical Disease Progression|0|||
48694253|NCT02903914|156728005|FG004|Overall Study|Clinical Disease Progression|0|||
48694254|NCT02903914|156728006|FG005|Overall Study|Clinical Disease Progression|0|||
48694255|NCT02903914|156728007|FG006|Overall Study|Clinical Disease Progression|0|||
48694256|NCT02903914|156728008|FG007|Overall Study|Clinical Disease Progression|0|||
48694257|NCT02903914|156728001|FG000|Overall Study|Completed Follow-up Period|0|||
48694258|NCT02903914|156728002|FG001|Overall Study|Completed Follow-up Period|0|||
48694259|NCT02903914|156728003|FG002|Overall Study|Completed Follow-up Period|6|||
48694260|NCT02903914|156728004|FG003|Overall Study|Completed Follow-up Period|2|||
48694261|NCT02903914|156728005|FG004|Overall Study|Completed Follow-up Period|1|||
48694262|NCT02903914|156728006|FG005|Overall Study|Completed Follow-up Period|0|||
48694263|NCT02903914|156728007|FG006|Overall Study|Completed Follow-up Period|9|||
48694264|NCT02903914|156728008|FG007|Overall Study|Completed Follow-up Period|1|||
48694265|NCT02903914|156728001|FG000|Overall Study|Taken off Treatment per Protocol|0|||
48694266|NCT02903914|156728002|FG001|Overall Study|Taken off Treatment per Protocol|0|||
48694267|NCT02903914|156728003|FG002|Overall Study|Taken off Treatment per Protocol|0|||
48694268|NCT02903914|156728004|FG003|Overall Study|Taken off Treatment per Protocol|0|||
48694269|NCT02903914|156728005|FG004|Overall Study|Taken off Treatment per Protocol|0|||
48694270|NCT02903914|156728006|FG005|Overall Study|Taken off Treatment per Protocol|1|||
48694271|NCT02903914|156728007|FG006|Overall Study|Taken off Treatment per Protocol|0|||
48694272|NCT02903914|156728008|FG007|Overall Study|Taken off Treatment per Protocol|0|||
48906040|NCT03250832|157492794|FG008|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
49116265|NCT00303472|158263083|FG005|Treatment Extension (Optional)|Withdrawal by Subject|0|||
49116266|NCT00303472|158263084|FG006|Treatment Extension (Optional)|Withdrawal by Subject|0|||
48694273|NCT02903914|156728001|FG000|Overall Study|Refused Further Treatment/Contact|0|||
48694274|NCT02903914|156728002|FG001|Overall Study|Refused Further Treatment/Contact|0|||
48694275|NCT02903914|156728003|FG002|Overall Study|Refused Further Treatment/Contact|0|||
48694276|NCT02903914|156728004|FG003|Overall Study|Refused Further Treatment/Contact|0|||
48694277|NCT02903914|156728005|FG004|Overall Study|Refused Further Treatment/Contact|0|||
48694278|NCT02903914|156728006|FG005|Overall Study|Refused Further Treatment/Contact|0|||
48694279|NCT02903914|156728007|FG006|Overall Study|Refused Further Treatment/Contact|1|||
48694280|NCT02903914|156728008|FG007|Overall Study|Refused Further Treatment/Contact|0|||
48694281|NCT02903914|156728001|FG000|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
48694282|NCT02903914|156728002|FG001|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
48694283|NCT02903914|156728003|FG002|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
48694284|NCT02903914|156728004|FG003|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
48694285|NCT02903914|156728005|FG004|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
48694286|NCT02903914|156728006|FG005|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
48694287|NCT02903914|156728007|FG006|Overall Study|Discontinued per Sponsor/Participant Agreement|1|||
48694288|NCT02903914|156728008|FG007|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
48694289|NCT03305666|156728009|FG000|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2|||
48694290|NCT03305666|156728010|FG001|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0|||
48694291|NCT06414213|156728011|FG000|Overall Study|Lost to Follow-up|1|||
48694292|NCT06414213|156728012|FG001|Overall Study|Lost to Follow-up|1|||
48694293|NCT06414213|156728013|FG002|Overall Study|Lost to Follow-up|3|||
48694294|NCT04423718|156728014|FG000|Overall Study|Adverse Event|6|||
48694295|NCT04423718|156728015|FG001|Overall Study|Adverse Event|2|||
48694296|NCT04423718|156728016|FG002|Overall Study|Adverse Event|5|||
48694297|NCT04423718|156728014|FG000|Overall Study|Physician Decision|1|||
48694298|NCT04423718|156728015|FG001|Overall Study|Physician Decision|4|||
48694299|NCT04423718|156728016|FG002|Overall Study|Physician Decision|1|||
48694300|NCT04423718|156728014|FG000|Overall Study|Protocol Violation|0|||
48694301|NCT04423718|156728015|FG001|Overall Study|Protocol Violation|1|||
48694302|NCT04423718|156728016|FG002|Overall Study|Protocol Violation|1|||
48694303|NCT04423718|156728014|FG000|Overall Study|Lost to Follow-up|1|||
48694304|NCT04423718|156728015|FG001|Overall Study|Lost to Follow-up|1|||
48694305|NCT04423718|156728016|FG002|Overall Study|Lost to Follow-up|2|||
48694306|NCT04423718|156728014|FG000|Overall Study|Lack of Efficacy|2|||
48694307|NCT04423718|156728015|FG001|Overall Study|Lack of Efficacy|0|||
48694308|NCT04423718|156728016|FG002|Overall Study|Lack of Efficacy|0|||
48694309|NCT04423718|156728014|FG000|Overall Study|Withdrawal by Subject|6|||
48694310|NCT04423718|156728015|FG001|Overall Study|Withdrawal by Subject|8|||
48694311|NCT04423718|156728016|FG002|Overall Study|Withdrawal by Subject|14|||
48694312|NCT04423718|156728014|FG000|Overall Study|Death|5|||
48694313|NCT04423718|156728015|FG001|Overall Study|Death|3|||
48694314|NCT04423718|156728016|FG002|Overall Study|Death|2|||
48694315|NCT04423718|156728014|FG000|Overall Study|COVID-19 pandemic|2|||
48694316|NCT04423718|156728015|FG001|Overall Study|COVID-19 pandemic|2|||
48694317|NCT04423718|156728016|FG002|Overall Study|COVID-19 pandemic|2|||
48694318|NCT04423718|156728014|FG000|Overall Study|Other|6|||
48694319|NCT04423718|156728015|FG001|Overall Study|Other|2|||
48694320|NCT04423718|156728016|FG002|Overall Study|Other|2|||
48694321|NCT04423718|156728014|FG000|Overall Study|Unknown if completed study treatment until Week 60|3|||
48694322|NCT04423718|156728015|FG001|Overall Study|Unknown if completed study treatment until Week 60|3|||
48694323|NCT04423718|156728016|FG002|Overall Study|Unknown if completed study treatment until Week 60|1|||
48694324|NCT04952909|156728017|FG000|Overall Study|Death|3|||
48694325|NCT00753545|156728019|FG000|Overall Study|Death|98|||
48694326|NCT00753545|156728020|FG001|Overall Study|Death|112|||
48694327|NCT00753545|156728019|FG000|Overall Study|Lost to Follow-up|2|||
48694328|NCT00753545|156728020|FG001|Overall Study|Lost to Follow-up|3|||
48694329|NCT00753545|156728019|FG000|Overall Study|Protocol Violation|1|||
48694330|NCT00753545|156728020|FG001|Overall Study|Protocol Violation|0|||
48694331|NCT00753545|156728019|FG000|Overall Study|Voluntary Discontinuation of Patient|7|||
48694332|NCT00753545|156728020|FG001|Overall Study|Voluntary Discontinuation of Patient|3|||
48694333|NCT05327816|156728021|FG000|Overall Study|Lost to Follow-up|1|||
48694334|NCT05327816|156728022|FG001|Overall Study|Lost to Follow-up|0|||
48694335|NCT05327816|156728023|FG002|Overall Study|Lost to Follow-up|0|||
48694336|NCT05327816|156728024|FG003|Overall Study|Lost to Follow-up|0|||
48694337|NCT05327816|156728025|FG004|Overall Study|Lost to Follow-up|0|||
48694338|NCT05327816|156728026|FG005|Overall Study|Lost to Follow-up|0|||
48906041|NCT03250832|157492795|FG009|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
48694339|NCT05327816|156728027|FG006|Overall Study|Lost to Follow-up|0|||
48694340|NCT05327816|156728028|FG007|Overall Study|Lost to Follow-up|0|||
48694341|NCT05327816|156728029|FG008|Overall Study|Lost to Follow-up|0|||
48694342|NCT05327816|156728030|FG009|Overall Study|Lost to Follow-up|1|||
48694343|NCT05327816|156728031|FG010|Overall Study|Lost to Follow-up|0|||
48694344|NCT05327816|156728021|FG000|Overall Study|Withdrawal by Subject|0|||
48694345|NCT05327816|156728022|FG001|Overall Study|Withdrawal by Subject|0|||
48694346|NCT05327816|156728023|FG002|Overall Study|Withdrawal by Subject|0|||
48694347|NCT05327816|156728024|FG003|Overall Study|Withdrawal by Subject|0|||
48694348|NCT05327816|156728025|FG004|Overall Study|Withdrawal by Subject|1|||
48694349|NCT05327816|156728026|FG005|Overall Study|Withdrawal by Subject|1|||
48694350|NCT05327816|156728027|FG006|Overall Study|Withdrawal by Subject|0|||
48694351|NCT05327816|156728028|FG007|Overall Study|Withdrawal by Subject|0|||
48694352|NCT05327816|156728029|FG008|Overall Study|Withdrawal by Subject|0|||
48694353|NCT05327816|156728030|FG009|Overall Study|Withdrawal by Subject|0|||
48694354|NCT05327816|156728031|FG010|Overall Study|Withdrawal by Subject|0|||
48694355|NCT05327816|156728021|FG000|Overall Study|Study Terminated by Sponsor|11|||
48694356|NCT05327816|156728022|FG001|Overall Study|Study Terminated by Sponsor|12|||
48694357|NCT05327816|156728023|FG002|Overall Study|Study Terminated by Sponsor|12|||
48694358|NCT05327816|156728024|FG003|Overall Study|Study Terminated by Sponsor|12|||
48694359|NCT05327816|156728025|FG004|Overall Study|Study Terminated by Sponsor|11|||
48694360|NCT05327816|156728026|FG005|Overall Study|Study Terminated by Sponsor|11|||
48694361|NCT05327816|156728027|FG006|Overall Study|Study Terminated by Sponsor|11|||
48694362|NCT05327816|156728028|FG007|Overall Study|Study Terminated by Sponsor|11|||
48694363|NCT05327816|156728029|FG008|Overall Study|Study Terminated by Sponsor|11|||
48694364|NCT05327816|156728030|FG009|Overall Study|Study Terminated by Sponsor|11|||
48694365|NCT05327816|156728031|FG010|Overall Study|Study Terminated by Sponsor|12|||
48694366|NCT05327816|156728021|FG000|Overall Study|Randomized but not treated|0|||
48694367|NCT05327816|156728022|FG001|Overall Study|Randomized but not treated|0|||
48694368|NCT05327816|156728023|FG002|Overall Study|Randomized but not treated|0|||
48694369|NCT05327816|156728024|FG003|Overall Study|Randomized but not treated|0|||
48694370|NCT05327816|156728025|FG004|Overall Study|Randomized but not treated|0|||
48694371|NCT05327816|156728026|FG005|Overall Study|Randomized but not treated|0|||
48694372|NCT05327816|156728027|FG006|Overall Study|Randomized but not treated|1|||
48694373|NCT05327816|156728028|FG007|Overall Study|Randomized but not treated|1|||
48694374|NCT05327816|156728029|FG008|Overall Study|Randomized but not treated|1|||
48694375|NCT05327816|156728030|FG009|Overall Study|Randomized but not treated|0|||
48694376|NCT05327816|156728031|FG010|Overall Study|Randomized but not treated|0|||
48694377|NCT04819945|156728032|FG000|Overall Study|Lost to Follow-up|1|||
48694378|NCT05071313|156728037|FG000|Overall Study|Lost to Follow-up|17|||
48694379|NCT05071313|156728038|FG001|Overall Study|Lost to Follow-up|10|||
48694380|NCT05071313|156728037|FG000|Overall Study|Physician Decision|1|||
48694381|NCT05071313|156728038|FG001|Overall Study|Physician Decision|6|||
48694382|NCT05071313|156728037|FG000|Overall Study|Death|1|||
48694383|NCT05071313|156728038|FG001|Overall Study|Death|0|||
48694384|NCT05071313|156728037|FG000|Overall Study|Withdrawal by Subject|10|||
48694385|NCT05071313|156728038|FG001|Overall Study|Withdrawal by Subject|15|||
48694386|NCT05071313|156728037|FG000|Overall Study|Other|1|||
48694387|NCT05071313|156728038|FG001|Overall Study|Other|0|||
48694388|NCT05071313|156728037|FG000|Overall Study|Randomized but not vaccinated|4|||
48694389|NCT05071313|156728038|FG001|Overall Study|Randomized but not vaccinated|2|||
48694390|NCT03550378|156728043|FG000|Overall Study|Death|0|||
48694391|NCT03550378|156728044|FG001|Overall Study|Death|1|||
48694392|NCT04716426|156728045|FG000|Overall Study|Vaccination|1|||
48694393|NCT04716426|156728046|FG001|Overall Study|Vaccination|1|||
49116267|NCT00303472|158263078|FG000|Treatment Extension (Optional)|Other|0|||
48694394|NCT04716426|156728045|FG000|Overall Study|Contamination|1|||
48694395|NCT04716426|156728046|FG001|Overall Study|Contamination|0|||
48694396|NCT02146378|156728047|FG000|Overall Study|No information of administration|2|||
48694397|NCT02559622|156728048|FG000|Overall Study|Progressive disease|0|||
48694398|NCT02559622|156728049|FG001|Overall Study|Progressive disease|1|||
48694399|NCT02559622|156728050|FG002|Overall Study|Progressive disease|0|||
48694400|NCT02559622|156728051|FG003|Overall Study|Progressive disease|0|||
48906042|NCT03250832|157492796|FG010|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
48906043|NCT03250832|157492797|FG011|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
48906044|NCT03250832|157492786|FG000|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
48906045|NCT03250832|157492787|FG001|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
48906046|NCT03250832|157492788|FG002|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
48694401|NCT02559622|156728048|FG000|Overall Study|Adverse Event|0|||
48694402|NCT02559622|156728049|FG001|Overall Study|Adverse Event|2|||
48694403|NCT02559622|156728050|FG002|Overall Study|Adverse Event|2|||
48694404|NCT02559622|156728051|FG003|Overall Study|Adverse Event|2|||
48694405|NCT02559622|156728048|FG000|Overall Study|Patient/guardian decision|1|||
48694406|NCT02559622|156728049|FG001|Overall Study|Patient/guardian decision|2|||
48694407|NCT02559622|156728050|FG002|Overall Study|Patient/guardian decision|0|||
48694408|NCT02559622|156728051|FG003|Overall Study|Patient/guardian decision|1|||
48694409|NCT03836625|156728057|FG000|Overall Study|Lost to Follow-up|9|||
48694410|NCT03836625|156728058|FG001|Overall Study|Lost to Follow-up|9|||
48694411|NCT03836625|156728057|FG000|Overall Study|Investigator withdrawn at/near time of enrollment|6|||
48694412|NCT03836625|156728058|FG001|Overall Study|Investigator withdrawn at/near time of enrollment|1|||
48694413|NCT03836625|156728057|FG000|Overall Study|Death|0|||
48694414|NCT03836625|156728058|FG001|Overall Study|Death|1|||
48694415|NCT03836625|156728057|FG000|Overall Study|Refused follow-up|0|||
48694416|NCT03836625|156728058|FG001|Overall Study|Refused follow-up|1|||
48694417|NCT02091960|156728065|FG000|Overall Study|Death|7|||
48694418|NCT02091960|156728065|FG000|Overall Study|Withdrawal by Subject|1|||
48694419|NCT02091960|156728065|FG000|Overall Study|Miscellaneous Reasons|37|||
48694420|NCT03905096|156728066|FG000|Period 2 for Trial Part 1 and 2|Adverse Event|1|||
48694421|NCT03905096|156728067|FG001|Period 2 for Trial Part 1 and 2|Adverse Event|0|||
48694422|NCT02887521|156728068|FG000|Overall Study|Withdrawal by Subject|0|||
48694423|NCT02887521|156728069|FG001|Overall Study|Withdrawal by Subject|3|||
48694424|NCT02329847|156728075|FG000|Overall Study|Death|4|||
48694425|NCT02329847|156728076|FG001|Overall Study|Death|4|||
48694426|NCT02329847|156728077|FG002|Overall Study|Death|22|||
48694427|NCT02329847|156728078|FG003|Overall Study|Death|12|||
48694428|NCT02329847|156728079|FG004|Overall Study|Death|20|||
48694429|NCT02329847|156728080|FG005|Overall Study|Death|13|||
48694430|NCT02329847|156728075|FG000|Overall Study|Lost to Follow-up|0|||
48694431|NCT02329847|156728076|FG001|Overall Study|Lost to Follow-up|0|||
48694432|NCT02329847|156728077|FG002|Overall Study|Lost to Follow-up|2|||
48694433|NCT02329847|156728078|FG003|Overall Study|Lost to Follow-up|3|||
48694434|NCT02329847|156728079|FG004|Overall Study|Lost to Follow-up|0|||
48694435|NCT02329847|156728080|FG005|Overall Study|Lost to Follow-up|1|||
48694436|NCT02329847|156728075|FG000|Overall Study|Physician Decision|0|||
48694437|NCT02329847|156728076|FG001|Overall Study|Physician Decision|0|||
48694438|NCT02329847|156728077|FG002|Overall Study|Physician Decision|0|||
48694439|NCT02329847|156728078|FG003|Overall Study|Physician Decision|0|||
48694440|NCT02329847|156728079|FG004|Overall Study|Physician Decision|1|||
48694441|NCT02329847|156728080|FG005|Overall Study|Physician Decision|0|||
48694442|NCT02329847|156728075|FG000|Overall Study|Withdrawal by Subject|2|||
48694443|NCT02329847|156728076|FG001|Overall Study|Withdrawal by Subject|1|||
48694444|NCT02329847|156728077|FG002|Overall Study|Withdrawal by Subject|5|||
48694445|NCT02329847|156728078|FG003|Overall Study|Withdrawal by Subject|7|||
48694446|NCT02329847|156728079|FG004|Overall Study|Withdrawal by Subject|8|||
48694447|NCT02329847|156728080|FG005|Overall Study|Withdrawal by Subject|3|||
48694448|NCT02329847|156728075|FG000|Overall Study|Other|1|||
48694449|NCT02329847|156728076|FG001|Overall Study|Other|2|||
48694450|NCT02329847|156728077|FG002|Overall Study|Other|6|||
48694451|NCT02329847|156728078|FG003|Overall Study|Other|13|||
48694452|NCT02329847|156728079|FG004|Overall Study|Other|10|||
48694453|NCT02329847|156728080|FG005|Overall Study|Other|3|||
48694454|NCT04113018|156728081|FG000|Overall Study|Death|2|||
48694455|NCT04113018|156728081|FG000|Overall Study|Lost to Follow-up|1|||
48694456|NCT04113018|156728081|FG000|Overall Study|Still On Study (on study treatment)|24|||
48694457|NCT04113018|156728081|FG000|Overall Study|Still On Study (in follow up)|12|||
48694458|NCT03142009|156728085|FG000|Overall Study|Lost to Follow-up|45|||
48694459|NCT03142009|156728086|FG001|Overall Study|Lost to Follow-up|30|||
48694460|NCT04018495|156728087|FG000|Overall Study|Physician Decision|1|||
48694461|NCT04481243|156729447|FG000|Overall Study|Withdrawal by Subject|4|||
48694462|NCT04002960|156729448|FG000|Overall Study|Withdrawn prior to Completion|2|||
48694463|NCT00865345|156729450|FG000|Overall Study|Withdrawal by Subject|2|||
48694464|NCT00383552|156729451|FG000|Overall Study|Adverse Event|7|||
48694465|NCT00383552|156729452|FG001|Overall Study|Adverse Event|6|||
48694466|NCT00383552|156729453|FG002|Overall Study|Adverse Event|9|||
48694467|NCT00383552|156729454|FG003|Overall Study|Adverse Event|6|||
48694468|NCT00383552|156729451|FG000|Overall Study|Lack of Efficacy|4|||
48694469|NCT00383552|156729452|FG001|Overall Study|Lack of Efficacy|13|||
48694470|NCT00383552|156729453|FG002|Overall Study|Lack of Efficacy|29|||
48694471|NCT00383552|156729454|FG003|Overall Study|Lack of Efficacy|42|||
48694472|NCT00383552|156729451|FG000|Overall Study|Lost to Follow-up|0|||
48694473|NCT00383552|156729452|FG001|Overall Study|Lost to Follow-up|1|||
48694474|NCT00383552|156729453|FG002|Overall Study|Lost to Follow-up|5|||
48694475|NCT00383552|156729454|FG003|Overall Study|Lost to Follow-up|1|||
48694476|NCT00383552|156729451|FG000|Overall Study|Did not wish to continue (unrelated)|4|||
48694477|NCT00383552|156729452|FG001|Overall Study|Did not wish to continue (unrelated)|9|||
48694478|NCT00383552|156729453|FG002|Overall Study|Did not wish to continue (unrelated)|5|||
48694479|NCT00383552|156729454|FG003|Overall Study|Did not wish to continue (unrelated)|6|||
48694480|NCT00383552|156729451|FG000|Overall Study|Did not wish to continue (related)|1|||
48694481|NCT00383552|156729452|FG001|Overall Study|Did not wish to continue (related)|0|||
48694482|NCT00383552|156729453|FG002|Overall Study|Did not wish to continue (related)|2|||
48694483|NCT00383552|156729454|FG003|Overall Study|Did not wish to continue (related)|3|||
48694484|NCT00383552|156729451|FG000|Overall Study|Noncompliance with the protocol|11|||
48694485|NCT00383552|156729452|FG001|Overall Study|Noncompliance with the protocol|6|||
48694486|NCT00383552|156729453|FG002|Overall Study|Noncompliance with the protocol|8|||
48694487|NCT00383552|156729454|FG003|Overall Study|Noncompliance with the protocol|10|||
48694488|NCT00383552|156729451|FG000|Overall Study|Did not meet protocol eligibility|8|||
48694489|NCT00383552|156729452|FG001|Overall Study|Did not meet protocol eligibility|6|||
48694490|NCT00383552|156729453|FG002|Overall Study|Did not meet protocol eligibility|2|||
48694491|NCT00383552|156729454|FG003|Overall Study|Did not meet protocol eligibility|3|||
48694492|NCT00383552|156729451|FG000|Overall Study|Administrative|1|||
48694493|NCT00383552|156729452|FG001|Overall Study|Administrative|0|||
48694494|NCT00383552|156729453|FG002|Overall Study|Administrative|1|||
48694495|NCT00383552|156729454|FG003|Overall Study|Administrative|1|||
48694496|NCT01517750|156729455|FG000|Overall Study|Lost to Follow-up|1|||
48694497|NCT01517750|156729456|FG001|Overall Study|Lost to Follow-up|2|||
48694498|NCT01517750|156729457|FG002|Overall Study|Lost to Follow-up|4|||
48694499|NCT01517750|156729458|FG003|Overall Study|Lost to Follow-up|1|||
48694500|NCT01405768|156729459|FG000|Overall Study|Didn't complete questionnaire correctly|4|||
48694501|NCT01405768|156729460|FG001|Overall Study|Didn't complete questionnaire correctly|0|||
48694502|NCT03924622|156729463|FG000|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|2|||
48694503|NCT03924622|156729464|FG001|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
48694504|NCT03924622|156729465|FG002|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
48694505|NCT03924622|156729466|FG003|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|4|||
48694506|NCT03924622|156729467|FG004|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
48694507|NCT03924622|156729468|FG005|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
48694508|NCT00962208|156729469|FG000|Overall Study|Could not achieve good vision|9|||
48694509|NCT00962208|156729470|FG001|Overall Study|Could not achieve good vision|0|||
48694510|NCT00962208|156729469|FG000|Overall Study|Contraindicated to continue study|5|||
48694511|NCT00962208|156729470|FG001|Overall Study|Contraindicated to continue study|1|||
48694512|NCT00962208|156729469|FG000|Overall Study|Lost to Follow-up|0|||
48694513|NCT00962208|156729470|FG001|Overall Study|Lost to Follow-up|9|||
48694514|NCT01064440|156729473|FG000|Overall Study|Lost to Follow-up|1|||
48694515|NCT01064440|156729474|FG001|Overall Study|Lost to Follow-up|1|||
48694516|NCT01064440|156729475|FG002|Overall Study|Lost to Follow-up|1|||
48694517|NCT01064440|156729473|FG000|Overall Study|Non-compliance|0|||
48694518|NCT01064440|156729474|FG001|Overall Study|Non-compliance|1|||
48906047|NCT03250832|157492789|FG003|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
48906048|NCT03250832|157492790|FG004|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
48906049|NCT03250832|157492791|FG005|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
48906050|NCT03250832|157492792|FG006|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
48906051|NCT03250832|157492793|FG007|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|3|||
48906052|NCT03250832|157492794|FG008|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
48906053|NCT03250832|157492795|FG009|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
48906054|NCT03250832|157492796|FG010|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
48906055|NCT03250832|157492797|FG011|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
48694519|NCT01064440|156729475|FG002|Overall Study|Non-compliance|0|||
48694520|NCT01064440|156729473|FG000|Overall Study|Death|1|||
48694521|NCT01064440|156729474|FG001|Overall Study|Death|0|||
48694522|NCT01064440|156729475|FG002|Overall Study|Death|1|||
48694523|NCT01064440|156729473|FG000|Overall Study|Withdrawal by Subject|0|||
48694524|NCT01064440|156729474|FG001|Overall Study|Withdrawal by Subject|1|||
48694525|NCT01064440|156729475|FG002|Overall Study|Withdrawal by Subject|1|||
48694526|NCT01064440|156729473|FG000|Overall Study|Other: amputation|1|||
48694527|NCT01064440|156729474|FG001|Overall Study|Other: amputation|0|||
48694528|NCT01064440|156729475|FG002|Overall Study|Other: amputation|0|||
48694529|NCT03833245|156729483|FG000|Overall Study|Death|0|||
48694530|NCT03833245|156729484|FG001|Overall Study|Death|1|||
48694531|NCT05091307|156729485|FG000|Overall Study|Death|0|||
48694532|NCT05091307|156729486|FG001|Overall Study|Death|0|||
48694533|NCT05091307|156729487|FG002|Overall Study|Death|1|||
48694534|NCT05091307|156729488|FG003|Overall Study|Death|0|||
48694535|NCT05091307|156729485|FG000|Overall Study|Lost to Follow-up|33|||
48694536|NCT05091307|156729486|FG001|Overall Study|Lost to Follow-up|33|||
48694537|NCT05091307|156729487|FG002|Overall Study|Lost to Follow-up|2|||
48694538|NCT05091307|156729488|FG003|Overall Study|Lost to Follow-up|0|||
48694539|NCT05091307|156729485|FG000|Overall Study|Physician Decision|1|||
48694540|NCT05091307|156729486|FG001|Overall Study|Physician Decision|0|||
48694541|NCT05091307|156729487|FG002|Overall Study|Physician Decision|0|||
48694542|NCT05091307|156729488|FG003|Overall Study|Physician Decision|0|||
48694543|NCT05091307|156729485|FG000|Overall Study|Protocol Violation|1|||
48694544|NCT05091307|156729486|FG001|Overall Study|Protocol Violation|0|||
48694545|NCT05091307|156729487|FG002|Overall Study|Protocol Violation|0|||
48694546|NCT05091307|156729488|FG003|Overall Study|Protocol Violation|0|||
48694547|NCT05091307|156729485|FG000|Overall Study|Withdrawal by Subject|16|||
48694548|NCT05091307|156729486|FG001|Overall Study|Withdrawal by Subject|16|||
48694549|NCT05091307|156729487|FG002|Overall Study|Withdrawal by Subject|0|||
48694550|NCT05091307|156729488|FG003|Overall Study|Withdrawal by Subject|1|||
48694551|NCT05091307|156729485|FG000|Overall Study|Covid-19 Vaccine/Treatment|14|||
48694552|NCT05091307|156729486|FG001|Overall Study|Covid-19 Vaccine/Treatment|15|||
48694553|NCT05091307|156729487|FG002|Overall Study|Covid-19 Vaccine/Treatment|1|||
48694554|NCT05091307|156729488|FG003|Overall Study|Covid-19 Vaccine/Treatment|1|||
48694555|NCT05091307|156729485|FG000|Overall Study|Initiated Prohibited Medication|1|||
48694556|NCT05091307|156729486|FG001|Overall Study|Initiated Prohibited Medication|0|||
48694557|NCT05091307|156729487|FG002|Overall Study|Initiated Prohibited Medication|0|||
48694558|NCT05091307|156729488|FG003|Overall Study|Initiated Prohibited Medication|0|||
48694559|NCT05091307|156729485|FG000|Overall Study|Other|4|||
48694560|NCT05091307|156729486|FG001|Overall Study|Other|4|||
48694561|NCT05091307|156729487|FG002|Overall Study|Other|0|||
48694562|NCT05091307|156729488|FG003|Overall Study|Other|0|||
48694563|NCT05091307|156729485|FG000|Overall Study|Randomized but not vaccinated|0|||
48694564|NCT05091307|156729486|FG001|Overall Study|Randomized but not vaccinated|2|||
48694565|NCT05091307|156729487|FG002|Overall Study|Randomized but not vaccinated|0|||
48694566|NCT05091307|156729488|FG003|Overall Study|Randomized but not vaccinated|0|||
48694567|NCT01706458|156729489|FG000|Overall Study|Physician Decision|3|||
48694568|NCT01706458|156729490|FG001|Overall Study|Physician Decision|4|||
48694569|NCT02529852|156729493|FG000|Overall Study|Withdrawal by Subject|2|||
48694570|NCT04034927|156729497|FG000|Overall Study|Adverse Event|4|||
48694571|NCT04034927|156729498|FG001|Overall Study|Adverse Event|9|||
48694572|NCT04034927|156729497|FG000|Overall Study|Death|0|||
48694573|NCT04034927|156729498|FG001|Overall Study|Death|1|||
48694574|NCT04034927|156729497|FG000|Overall Study|Withdrawal by Subject|0|||
48694575|NCT04034927|156729498|FG001|Overall Study|Withdrawal by Subject|3|||
48694576|NCT04034927|156729497|FG000|Overall Study|Still on Treatment|2|||
48694577|NCT04034927|156729498|FG001|Overall Study|Still on Treatment|1|||
48694578|NCT04034927|156729497|FG000|Overall Study|Other|1|||
48694579|NCT04034927|156729498|FG001|Overall Study|Other|1|||
48694580|NCT03582215|156729499|FG000|Overall Study|Adverse Event|1|||
48694581|NCT03582215|156729500|FG001|Overall Study|Adverse Event|0|||
48694582|NCT03582215|156729501|FG002|Overall Study|Adverse Event|0|||
48694583|NCT03582215|156729502|FG003|Overall Study|Adverse Event|0|||
48694584|NCT03582215|156729503|FG004|Overall Study|Adverse Event|0|||
48694585|NCT03582215|156729504|FG005|Overall Study|Adverse Event|0|||
48694586|NCT03582215|156729505|FG006|Overall Study|Adverse Event|2|||
48694587|NCT03582215|156729506|FG007|Overall Study|Adverse Event|2|||
48694588|NCT02913872|156729507|FG000|Overall Study|Withdrawal by Subject|1|||
48694589|NCT02174731|156729508|FG000|Overall Study|Participant decision|67|||
48694590|NCT02174731|156729509|FG001|Overall Study|Participant decision|64|||
48694591|NCT02174731|156729508|FG000|Overall Study|Incorrect enrolment before randomization|0|||
48694592|NCT02174731|156729509|FG001|Overall Study|Incorrect enrolment before randomization|1|||
48694593|NCT02174731|156729508|FG000|Overall Study|Missing|2|||
48694594|NCT02174731|156729509|FG001|Overall Study|Missing|0|||
48694595|NCT01277744|156729510|FG000|Overall Study|Physician Decision|2|||
48694596|NCT03796728|156729511|FG000|Overall Study|Lost to Follow-up|8|||
48694597|NCT03796728|156729511|FG000|Overall Study|Reason not Specified|16|||
48742928|NCT00717197|156910415|FG000|Overall Study|Physician Decision|1|||
48694598|NCT05076708|156729514|FG000|Overall Study|Withdrawal by Subject|4|||
48694599|NCT05076708|156729514|FG000|Overall Study|Lost to study during switch phase|8|||
48694600|NCT00551759|156729519|FG000|Overall Study|Adverse Event|7|||
48694601|NCT00551759|156729519|FG000|Overall Study|Death|5|||
48694602|NCT00551759|156729519|FG000|Overall Study|Ineligible|1|||
48694603|NCT01643668|156729522|FG000|Overall Study|Death|1|||
48694604|NCT00625131|156729525|FG000|Overall Study|Lost to Follow-up|3|||
48694605|NCT00625131|156729526|FG001|Overall Study|Lost to Follow-up|2|||
48694606|NCT00625131|156729527|FG002|Overall Study|Lost to Follow-up|0|||
48694607|NCT00625131|156729525|FG000|Overall Study|Withdrawal by Subject|1|||
48694608|NCT00625131|156729526|FG001|Overall Study|Withdrawal by Subject|0|||
48694609|NCT00625131|156729527|FG002|Overall Study|Withdrawal by Subject|5|||
48694610|NCT03461276|156729529|FG000|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
48694611|NCT03461276|156729530|FG001|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
48694612|NCT03461276|156729529|FG000|Part A (18-24 Months Duration)|Physician Decision|1|||
48694613|NCT03461276|156729530|FG001|Part A (18-24 Months Duration)|Physician Decision|0|||
48694614|NCT03461276|156729529|FG000|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
48694615|NCT03461276|156729530|FG001|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
48694616|NCT03461276|156729529|FG000|Part A (18-24 Months Duration)|Adverse event, non-fatal|3|||
48694617|NCT03461276|156729530|FG001|Part A (18-24 Months Duration)|Adverse event, non-fatal|1|||
48694618|NCT03461276|156729529|FG000|Part A (18-24 Months Duration)|Patient heath status|0|||
48694619|NCT03461276|156729530|FG001|Part A (18-24 Months Duration)|Patient heath status|1|||
48694620|NCT03461276|156729529|FG000|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
48694621|NCT03461276|156729530|FG001|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
48694622|NCT03461276|156729529|FG000|Part B (18 Months Duration)|Lost to Follow-up|1|||
48694623|NCT03461276|156729530|FG001|Part B (18 Months Duration)|Lost to Follow-up|0|||
48694624|NCT03461276|156729529|FG000|Part B (18 Months Duration)|Withdrawal by Subject|0|||
48694625|NCT03461276|156729530|FG001|Part B (18 Months Duration)|Withdrawal by Subject|1|||
48694626|NCT03461276|156729529|FG000|Part B (18 Months Duration)|Adverse event, non-fatal|0|||
48694627|NCT03461276|156729530|FG001|Part B (18 Months Duration)|Adverse event, non-fatal|1|||
48694628|NCT03461276|156729529|FG000|Part B (18 Months Duration)|Patient/caregiver's decision|3|||
48694629|NCT03461276|156729530|FG001|Part B (18 Months Duration)|Patient/caregiver's decision|0|||
48694630|NCT05083585|156729531|FG000|Overall Study|Death|1|||
48694631|NCT05083585|156729532|FG001|Overall Study|Death|1|||
48694632|NCT05083585|156729531|FG000|Overall Study|Lost to Follow-up|1|||
48694633|NCT05083585|156729532|FG001|Overall Study|Lost to Follow-up|1|||
48694634|NCT05083585|156729531|FG000|Overall Study|Withdrawal by Subject|2|||
48694635|NCT05083585|156729532|FG001|Overall Study|Withdrawal by Subject|0|||
48694636|NCT05083585|156729531|FG000|Overall Study|Randomized but not vaccinated|2|||
48694637|NCT05083585|156729532|FG001|Overall Study|Randomized but not vaccinated|0|||
48694638|NCT03929757|156729533|FG000|Main Study: Up to Day 365|Withdrawal by parent/guardian|2|||
48694639|NCT03929757|156729534|FG001|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
48694640|NCT03929757|156729535|FG002|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
48694641|NCT03929757|156729533|FG000|Main Study: Up to Day 365|Other|1|||
48694642|NCT03929757|156729534|FG001|Main Study: Up to Day 365|Other|0|||
48694643|NCT03929757|156729535|FG002|Main Study: Up to Day 365|Other|0|||
48694644|NCT03929757|156729533|FG000|Extension Study: Up to Extension Day 85|Adverse Event|0|||
48694645|NCT03929757|156729534|FG001|Extension Study: Up to Extension Day 85|Adverse Event|0|||
48694646|NCT03929757|156729535|FG002|Extension Study: Up to Extension Day 85|Adverse Event|1|||
48694647|NCT01576341|156729536|FG000|Overall Study|Withdrawal by Subject|24|||
48694648|NCT01576341|156729536|FG000|Overall Study|Adverse Event|10|||
48694649|NCT01576341|156729536|FG000|Overall Study|Death|21|||
48694650|NCT01576341|156729536|FG000|Overall Study|Physician Decision|2|||
48694651|NCT01576341|156729536|FG000|Overall Study|Lost to Follow-up|2|||
48694652|NCT01576341|156729536|FG000|Overall Study|Kidney transplantation|10|||
48694653|NCT01576341|156729536|FG000|Overall Study|Protocol Violation|12|||
49116268|NCT00303472|158263079|FG001|Treatment Extension (Optional)|Other|2|||
49116269|NCT00303472|158263080|FG002|Treatment Extension (Optional)|Other|4|||
48694654|NCT01576341|156729536|FG000|Overall Study|Other|12|||
48694655|NCT03605667|156729537|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|18|||
48694656|NCT03605667|156729538|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|19|||
48694657|NCT03605667|156729537|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|14|||
48694658|NCT03605667|156729538|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|3|||
48694659|NCT03605667|156729537|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
48694660|NCT03605667|156729538|FG001|Randomization Phase (Weeks 1 Through 48)|Other|4|||
48694661|NCT03605667|156729537|FG000|Randomization Phase (Weeks 1 Through 48)|Progressive disease|3|||
48694662|NCT03605667|156729538|FG001|Randomization Phase (Weeks 1 Through 48)|Progressive disease|2|||
48694663|NCT03605667|156729537|FG000|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
48694664|NCT03605667|156729538|FG001|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
48694665|NCT03605667|156729537|FG000|Randomization Phase (Weeks 1 Through 48)|Physician Decision|2|||
48694666|NCT03605667|156729538|FG001|Randomization Phase (Weeks 1 Through 48)|Physician Decision|3|||
48694667|NCT03605667|156729537|FG000|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|4|||
48694668|NCT03605667|156729538|FG001|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|0|||
48694669|NCT03605667|156729537|FG000|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
48694670|NCT03605667|156729538|FG001|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
48694671|NCT03605667|156729537|FG000|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|2|||
48694672|NCT03605667|156729538|FG001|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|3|||
48694673|NCT03605667|156729537|FG000|Randomization Phase (Weeks 1 Through 48)|Death|1|||
48694674|NCT03605667|156729538|FG001|Randomization Phase (Weeks 1 Through 48)|Death|2|||
48694675|NCT03605667|156729537|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|30|||
48694676|NCT03605667|156729538|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|51|||
48694677|NCT03605667|156729537|FG000|OLE Phase (48 Weeks)|Other|6|||
48694678|NCT03605667|156729538|FG001|OLE Phase (48 Weeks)|Other|8|||
48694679|NCT03605667|156729537|FG000|OLE Phase (48 Weeks)|Lack of Efficacy|6|||
48694680|NCT03605667|156729538|FG001|OLE Phase (48 Weeks)|Lack of Efficacy|5|||
48694681|NCT03605667|156729537|FG000|OLE Phase (48 Weeks)|Adverse Event|5|||
48694682|NCT03605667|156729538|FG001|OLE Phase (48 Weeks)|Adverse Event|5|||
48694683|NCT03605667|156729537|FG000|OLE Phase (48 Weeks)|Progressive Disease|2|||
48694684|NCT03605667|156729538|FG001|OLE Phase (48 Weeks)|Progressive Disease|0|||
48694685|NCT03605667|156729537|FG000|OLE Phase (48 Weeks)|Physician Decision|5|||
48694686|NCT03605667|156729538|FG001|OLE Phase (48 Weeks)|Physician Decision|7|||
48694687|NCT03605667|156729537|FG000|OLE Phase (48 Weeks)|Protocol Violation|0|||
48694688|NCT03605667|156729538|FG001|OLE Phase (48 Weeks)|Protocol Violation|1|||
48694689|NCT03605667|156729537|FG000|OLE Phase (48 Weeks)|Study Terminated By Sponsor|0|||
48694690|NCT03605667|156729538|FG001|OLE Phase (48 Weeks)|Study Terminated By Sponsor|1|||
48694691|NCT03605667|156729537|FG000|OLE Phase (48 Weeks)|Death|0|||
48694692|NCT03605667|156729538|FG001|OLE Phase (48 Weeks)|Death|2|||
48694693|NCT03605667|156729537|FG000|OLE Phase (48 Weeks)|Lost to Follow-up|1|||
48694694|NCT03605667|156729538|FG001|OLE Phase (48 Weeks)|Lost to Follow-up|0|||
48694695|NCT00517296|156729539|FG000|Overall Study|Withdrawal by Subject|1|||
48694696|NCT00517296|156729540|FG001|Overall Study|Withdrawal by Subject|0|||
48694697|NCT05827068|156729543|FG000|Overall Study|Lost to Follow-up|1|||
48694698|NCT05827068|156729544|FG001|Overall Study|Lost to Follow-up|4|||
48694699|NCT05827068|156729545|FG002|Overall Study|Lost to Follow-up|1|||
48694700|NCT05827068|156729546|FG003|Overall Study|Lost to Follow-up|1|||
48694701|NCT05827068|156729547|FG004|Overall Study|Lost to Follow-up|2|||
48694702|NCT05827068|156729548|FG005|Overall Study|Lost to Follow-up|4|||
48694703|NCT05827068|156729549|FG006|Overall Study|Lost to Follow-up|1|||
48694704|NCT05827068|156729543|FG000|Overall Study|Withdrawal by Subject|4|||
48694705|NCT05827068|156729544|FG001|Overall Study|Withdrawal by Subject|0|||
48694706|NCT05827068|156729545|FG002|Overall Study|Withdrawal by Subject|1|||
48694707|NCT05827068|156729546|FG003|Overall Study|Withdrawal by Subject|2|||
48694708|NCT05827068|156729547|FG004|Overall Study|Withdrawal by Subject|3|||
48694709|NCT05827068|156729548|FG005|Overall Study|Withdrawal by Subject|0|||
48694710|NCT05827068|156729549|FG006|Overall Study|Withdrawal by Subject|1|||
48694711|NCT05827068|156729543|FG000|Overall Study|Physician Decision|0|||
48694712|NCT05827068|156729544|FG001|Overall Study|Physician Decision|0|||
48694713|NCT05827068|156729545|FG002|Overall Study|Physician Decision|0|||
48694714|NCT05827068|156729546|FG003|Overall Study|Physician Decision|0|||
48694715|NCT05827068|156729547|FG004|Overall Study|Physician Decision|1|||
48694716|NCT05827068|156729548|FG005|Overall Study|Physician Decision|0|||
48694717|NCT05827068|156729549|FG006|Overall Study|Physician Decision|1|||
48694718|NCT05827068|156729543|FG000|Overall Study|Other Than Specified|0|||
48694719|NCT05827068|156729544|FG001|Overall Study|Other Than Specified|1|||
48694720|NCT05827068|156729545|FG002|Overall Study|Other Than Specified|0|||
48694721|NCT05827068|156729546|FG003|Overall Study|Other Than Specified|0|||
48694722|NCT05827068|156729547|FG004|Overall Study|Other Than Specified|0|||
48694723|NCT05827068|156729548|FG005|Overall Study|Other Than Specified|0|||
48694724|NCT05827068|156729549|FG006|Overall Study|Other Than Specified|0|||
48694725|NCT00098475|156729550|FG000|Step 1|Progressive disease|33|||
48694726|NCT00098475|156729551|FG001|Step 1|Progressive disease|35|||
48694727|NCT00098475|156729552|FG002|Step 1|Progressive disease|2|||
48694728|NCT00098475|156729553|FG003|Step 1|Progressive disease|1|||
48694729|NCT00098475|156729550|FG000|Step 1|Adverse Event|56|||
48694730|NCT00098475|156729551|FG001|Step 1|Adverse Event|37|||
48694731|NCT00098475|156729552|FG002|Step 1|Adverse Event|0|||
48694732|NCT00098475|156729553|FG003|Step 1|Adverse Event|1|||
48694733|NCT00098475|156729550|FG000|Step 1|Death|8|||
48694734|NCT00098475|156729551|FG001|Step 1|Death|5|||
48694735|NCT00098475|156729552|FG002|Step 1|Death|0|||
48694736|NCT00098475|156729553|FG003|Step 1|Death|1|||
48694737|NCT00098475|156729550|FG000|Step 1|Withdrawal by Subject|14|||
48694738|NCT00098475|156729551|FG001|Step 1|Withdrawal by Subject|11|||
48906056|NCT03250832|157492786|FG000|Part 2A (Up to Approximately 30 Months)|Other|0|||
49010514|NCT03760510|157875634|FG001|Overall Study|Not ventilated for 24 hours|97|||
48694739|NCT00098475|156729552|FG002|Step 1|Withdrawal by Subject|0|||
48694740|NCT00098475|156729553|FG003|Step 1|Withdrawal by Subject|0|||
48694741|NCT00098475|156729550|FG000|Step 1|Physician Decision|5|||
48694742|NCT00098475|156729551|FG001|Step 1|Physician Decision|2|||
48694743|NCT00098475|156729552|FG002|Step 1|Physician Decision|0|||
48694744|NCT00098475|156729553|FG003|Step 1|Physician Decision|0|||
48694745|NCT00098475|156729550|FG000|Step 1|Alternative therapy|31|||
48694746|NCT00098475|156729551|FG001|Step 1|Alternative therapy|43|||
48694747|NCT00098475|156729552|FG002|Step 1|Alternative therapy|1|||
48694748|NCT00098475|156729553|FG003|Step 1|Alternative therapy|0|||
48694749|NCT00098475|156729550|FG000|Step 1|Other disease|2|||
48694750|NCT00098475|156729551|FG001|Step 1|Other disease|1|||
48694751|NCT00098475|156729552|FG002|Step 1|Other disease|1|||
48694752|NCT00098475|156729553|FG003|Step 1|Other disease|0|||
48694753|NCT00098475|156729550|FG000|Step 1|Never started treatment|0|||
48694754|NCT00098475|156729551|FG001|Step 1|Never started treatment|2|||
48694755|NCT00098475|156729552|FG002|Step 1|Never started treatment|0|||
48694756|NCT00098475|156729553|FG003|Step 1|Never started treatment|0|||
48694757|NCT00098475|156729550|FG000|Step 1|Still on treatment as of this analysis|14|||
48694758|NCT00098475|156729551|FG001|Step 1|Still on treatment as of this analysis|27|||
48694759|NCT00098475|156729552|FG002|Step 1|Still on treatment as of this analysis|0|||
48694760|NCT00098475|156729553|FG003|Step 1|Still on treatment as of this analysis|0|||
48694761|NCT00098475|156729550|FG000|Step 1|Knee surgery|1|||
48694762|NCT00098475|156729551|FG001|Step 1|Knee surgery|0|||
48694763|NCT00098475|156729552|FG002|Step 1|Knee surgery|0|||
48694764|NCT00098475|156729553|FG003|Step 1|Knee surgery|0|||
48694765|NCT00098475|156729550|FG000|Step 1|Complications|1|||
48694766|NCT00098475|156729551|FG001|Step 1|Complications|0|||
48694767|NCT00098475|156729552|FG002|Step 1|Complications|0|||
48694768|NCT00098475|156729553|FG003|Step 1|Complications|0|||
48694769|NCT00098475|156729550|FG000|Step 1|Cannot comply due to other tx|0|||
48694770|NCT00098475|156729551|FG001|Step 1|Cannot comply due to other tx|1|||
48694771|NCT00098475|156729552|FG002|Step 1|Cannot comply due to other tx|0|||
48694772|NCT00098475|156729553|FG003|Step 1|Cannot comply due to other tx|0|||
48694773|NCT00098475|156729550|FG000|Step 1|Both patient and physician's decision|2|||
48694774|NCT00098475|156729551|FG001|Step 1|Both patient and physician's decision|1|||
48694775|NCT00098475|156729552|FG002|Step 1|Both patient and physician's decision|0|||
48694776|NCT00098475|156729553|FG003|Step 1|Both patient and physician's decision|0|||
48694777|NCT00098475|156729550|FG000|Step 1|Incorrect disease assessment|2|||
48694778|NCT00098475|156729551|FG001|Step 1|Incorrect disease assessment|0|||
48694779|NCT00098475|156729552|FG002|Step 1|Incorrect disease assessment|0|||
48694780|NCT00098475|156729553|FG003|Step 1|Incorrect disease assessment|0|||
48694781|NCT00098475|156729550|FG000|Step 1|Off treatment for > specified timeframe|1|||
48694782|NCT00098475|156729551|FG001|Step 1|Off treatment for > specified timeframe|1|||
48694783|NCT00098475|156729552|FG002|Step 1|Off treatment for > specified timeframe|0|||
48694784|NCT00098475|156729553|FG003|Step 1|Off treatment for > specified timeframe|0|||
48694785|NCT00098475|156729550|FG000|Step 1|Declining performance status|0|||
48694786|NCT00098475|156729551|FG001|Step 1|Declining performance status|1|||
48694787|NCT00098475|156729552|FG002|Step 1|Declining performance status|0|||
48694788|NCT00098475|156729553|FG003|Step 1|Declining performance status|0|||
48694789|NCT00098475|156729550|FG000|Step 1|Insurance issue|0|||
48694790|NCT00098475|156729551|FG001|Step 1|Insurance issue|1|||
48694791|NCT00098475|156729552|FG002|Step 1|Insurance issue|0|||
48694792|NCT00098475|156729553|FG003|Step 1|Insurance issue|0|||
48694793|NCT00098475|156729550|FG000|Step 1|Rising paraprotein|0|||
48694794|NCT00098475|156729551|FG001|Step 1|Rising paraprotein|1|||
48694795|NCT00098475|156729552|FG002|Step 1|Rising paraprotein|0|||
48694796|NCT00098475|156729553|FG003|Step 1|Rising paraprotein|0|||
48694797|NCT00098475|156729550|FG000|Step 1|Referred to other physicians|0|||
48694798|NCT00098475|156729551|FG001|Step 1|Referred to other physicians|1|||
48694799|NCT00098475|156729552|FG002|Step 1|Referred to other physicians|0|||
48694800|NCT00098475|156729553|FG003|Step 1|Referred to other physicians|0|||
48694801|NCT00098475|156729550|FG000|Step 1|Criteria to continue treatment not met|0|||
48694802|NCT00098475|156729551|FG001|Step 1|Criteria to continue treatment not met|1|||
48694803|NCT00098475|156729552|FG002|Step 1|Criteria to continue treatment not met|0|||
48694804|NCT00098475|156729553|FG003|Step 1|Criteria to continue treatment not met|0|||
48694805|NCT00098475|156729550|FG000|Step 1|Misinterpretation of lab data|0|||
48694806|NCT00098475|156729551|FG001|Step 1|Misinterpretation of lab data|1|||
48906057|NCT03250832|157492787|FG001|Part 2A (Up to Approximately 30 Months)|Other|0|||
48906058|NCT03250832|157492788|FG002|Part 2A (Up to Approximately 30 Months)|Other|0|||
48906059|NCT03250832|157492789|FG003|Part 2A (Up to Approximately 30 Months)|Other|0|||
48906060|NCT03250832|157492790|FG004|Part 2A (Up to Approximately 30 Months)|Other|0|||
48906061|NCT03250832|157492791|FG005|Part 2A (Up to Approximately 30 Months)|Other|0|||
48906062|NCT03250832|157492792|FG006|Part 2A (Up to Approximately 30 Months)|Other|0|||
48906063|NCT03250832|157492793|FG007|Part 2A (Up to Approximately 30 Months)|Other|1|||
48906064|NCT03250832|157492794|FG008|Part 2A (Up to Approximately 30 Months)|Other|0|||
48906065|NCT03250832|157492795|FG009|Part 2A (Up to Approximately 30 Months)|Other|0|||
48906066|NCT03250832|157492796|FG010|Part 2A (Up to Approximately 30 Months)|Other|0|||
48694807|NCT00098475|156729552|FG002|Step 1|Misinterpretation of lab data|0|||
48694808|NCT00098475|156729553|FG003|Step 1|Misinterpretation of lab data|0|||
48694809|NCT00098475|156729550|FG000|Step 1|Patient fell with fracture|1|||
48694810|NCT00098475|156729551|FG001|Step 1|Patient fell with fracture|0|||
48694811|NCT00098475|156729552|FG002|Step 1|Patient fell with fracture|0|||
48694812|NCT00098475|156729553|FG003|Step 1|Patient fell with fracture|0|||
48694813|NCT00098475|156729550|FG000|Step 1|Not documented|0|||
48694814|NCT00098475|156729551|FG001|Step 1|Not documented|1|||
48694815|NCT00098475|156729552|FG002|Step 1|Not documented|0|||
48694816|NCT00098475|156729553|FG003|Step 1|Not documented|0|||
48694817|NCT00098475|156729550|FG000|Step 2|Disease progression|1|||
48694818|NCT00098475|156729551|FG001|Step 2|Disease progression|4|||
48694819|NCT00098475|156729552|FG002|Step 2|Disease progression|0|||
48694820|NCT00098475|156729553|FG003|Step 2|Disease progression|0|||
48694821|NCT00098475|156729550|FG000|Step 2|Adverse Event|2|||
48694822|NCT00098475|156729551|FG001|Step 2|Adverse Event|0|||
48906067|NCT03250832|157492797|FG011|Part 2A (Up to Approximately 30 Months)|Other|0|||
48906068|NCT03250832|157492786|FG000|Part 2B (Up to Approximately 29 Months)|Death|0|||
48906069|NCT03250832|157492787|FG001|Part 2B (Up to Approximately 29 Months)|Death|0|||
48906070|NCT03250832|157492788|FG002|Part 2B (Up to Approximately 29 Months)|Death|0|||
48906071|NCT03250832|157492789|FG003|Part 2B (Up to Approximately 29 Months)|Death|0|||
48906072|NCT03250832|157492790|FG004|Part 2B (Up to Approximately 29 Months)|Death|0|||
48906073|NCT03250832|157492791|FG005|Part 2B (Up to Approximately 29 Months)|Death|0|||
48906074|NCT03250832|157492792|FG006|Part 2B (Up to Approximately 29 Months)|Death|0|||
48906075|NCT03250832|157492793|FG007|Part 2B (Up to Approximately 29 Months)|Death|0|||
48906076|NCT03250832|157492794|FG008|Part 2B (Up to Approximately 29 Months)|Death|1|||
48906077|NCT03250832|157492795|FG009|Part 2B (Up to Approximately 29 Months)|Death|7|||
48906078|NCT03250832|157492796|FG010|Part 2B (Up to Approximately 29 Months)|Death|0|||
48906079|NCT03250832|157492797|FG011|Part 2B (Up to Approximately 29 Months)|Death|0|||
48906080|NCT03250832|157492786|FG000|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
48906081|NCT03250832|157492787|FG001|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
48906082|NCT03250832|157492788|FG002|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
48906083|NCT03250832|157492789|FG003|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
48906084|NCT03250832|157492790|FG004|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
48906085|NCT03250832|157492791|FG005|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
48906086|NCT03250832|157492792|FG006|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
48906087|NCT03250832|157492793|FG007|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
48906088|NCT03250832|157492794|FG008|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|2|||
48906089|NCT03250832|157492795|FG009|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|7|||
48906090|NCT03250832|157492796|FG010|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
48906091|NCT03250832|157492797|FG011|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
48906092|NCT03250832|157492786|FG000|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
48906093|NCT03250832|157492787|FG001|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
48906094|NCT03250832|157492788|FG002|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
48906095|NCT03250832|157492789|FG003|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
48906096|NCT03250832|157492790|FG004|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
48906097|NCT03250832|157492791|FG005|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
48906098|NCT03250832|157492792|FG006|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
48694823|NCT00098475|156729552|FG002|Step 2|Adverse Event|0|||
48694824|NCT00098475|156729553|FG003|Step 2|Adverse Event|0|||
48694825|NCT00098475|156729550|FG000|Step 2|Withdrawal by Subject|0|||
48694826|NCT00098475|156729551|FG001|Step 2|Withdrawal by Subject|2|||
48906099|NCT03250832|157492793|FG007|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
48906100|NCT03250832|157492794|FG008|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|1|||
48694827|NCT00098475|156729552|FG002|Step 2|Withdrawal by Subject|0|||
48694828|NCT00098475|156729553|FG003|Step 2|Withdrawal by Subject|0|||
48694829|NCT00098475|156729550|FG000|Step 2|Physician Decision|0|||
48694830|NCT00098475|156729551|FG001|Step 2|Physician Decision|1|||
48906101|NCT03250832|157492795|FG009|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|6|||
48906102|NCT03250832|157492796|FG010|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
48694831|NCT00098475|156729552|FG002|Step 2|Physician Decision|0|||
48694832|NCT00098475|156729553|FG003|Step 2|Physician Decision|0|||
48694833|NCT00098475|156729550|FG000|Step 2|Alternative therapy|1|||
48694834|NCT00098475|156729551|FG001|Step 2|Alternative therapy|2|||
48694835|NCT00098475|156729552|FG002|Step 2|Alternative therapy|0|||
48694836|NCT00098475|156729553|FG003|Step 2|Alternative therapy|0|||
48694837|NCT00098475|156729550|FG000|Step 2|Never started treatment|1|||
48694838|NCT00098475|156729551|FG001|Step 2|Never started treatment|1|||
48694839|NCT00098475|156729552|FG002|Step 2|Never started treatment|0|||
48694840|NCT00098475|156729553|FG003|Step 2|Never started treatment|0|||
48694841|NCT01974440|156729554|FG000|Overall Study|Lost to Follow-up|7|||
48694842|NCT01974440|156729555|FG001|Overall Study|Lost to Follow-up|7|||
48694843|NCT01974440|156729554|FG000|Overall Study|Withdrawal by Subject|24|||
48694844|NCT01974440|156729555|FG001|Overall Study|Withdrawal by Subject|20|||
48694845|NCT01974440|156729554|FG000|Overall Study|Sponsor decision|109|||
48694846|NCT01974440|156729555|FG001|Overall Study|Sponsor decision|110|||
48694847|NCT02336282|156729563|FG000|Overall Study|Unrelated illness|1|||
48694848|NCT02336282|156729563|FG000|Overall Study|Uncomfortable with technology|1|||
48694849|NCT02336282|156729563|FG000|Overall Study|Lost to Follow-up|1|||
48694850|NCT02336282|156729563|FG000|Overall Study|Not enough time to complete sessions|2|||
48906103|NCT03250832|157492797|FG011|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
48906104|NCT03250832|157492786|FG000|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
48906105|NCT03250832|157492787|FG001|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
48906106|NCT03250832|157492788|FG002|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
48906107|NCT03250832|157492789|FG003|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
48906108|NCT03250832|157492790|FG004|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
49010515|NCT00926289|157875639|FG000|Overall Study|Adverse Event|9|||
48906109|NCT03250832|157492791|FG005|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
48906110|NCT03250832|157492792|FG006|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
48906111|NCT03250832|157492793|FG007|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
48694861|NCT02946996|156729568|FG000|Overall Study|non-evaluable|3|||
48694862|NCT02946996|156729569|FG001|Overall Study|non-evaluable|6|||
48694863|NCT02946996|156729570|FG002|Overall Study|non-evaluable|5|||
48694864|NCT02994108|156732078|FG000|Intervention Messages|Withdrawal by Subject|2|||
48694865|NCT02994108|156732079|FG001|Intervention Messages|Withdrawal by Subject|0|||
48694866|NCT02994108|156732078|FG000|Phase 1 Assessment|Lost to Follow-up|5|||
48694867|NCT02994108|156732079|FG001|Phase 1 Assessment|Lost to Follow-up|3|||
48694868|NCT02994108|156732078|FG000|Phase 2 Assessment|Lost to Follow-up|8|||
48694869|NCT02994108|156732079|FG001|Phase 2 Assessment|Lost to Follow-up|7|||
48694870|NCT02994108|156732078|FG000|Phase 2 Assessment|Withdrawal by Subject|1|||
48694871|NCT02994108|156732079|FG001|Phase 2 Assessment|Withdrawal by Subject|0|||
48694872|NCT03346434|156732086|FG000|Overall Study|Randomized in Error|0|||
48694873|NCT03346434|156732087|FG001|Overall Study|Randomized in Error|0|||
48694874|NCT03346434|156732088|FG002|Overall Study|Randomized in Error|0|||
48694875|NCT03346434|156732089|FG003|Overall Study|Randomized in Error|0|||
48694876|NCT03346434|156732090|FG004|Overall Study|Randomized in Error|1|||
48694877|NCT03346434|156732091|FG005|Overall Study|Randomized in Error|0|||
48694878|NCT03346434|156732086|FG000|Overall Study|Withdrawal by Subject|0|||
48694879|NCT03346434|156732087|FG001|Overall Study|Withdrawal by Subject|0|||
48694880|NCT03346434|156732088|FG002|Overall Study|Withdrawal by Subject|1|||
48906112|NCT03250832|157492794|FG008|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
48906113|NCT03250832|157492795|FG009|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
48906114|NCT03250832|157492796|FG010|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
48906115|NCT03250832|157492797|FG011|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|1|||
48906116|NCT01119001|157492798|FG000|Overall Study|Withdrawal by Subject|2|||
48906117|NCT03231943|157492799|FG000|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
48906118|NCT03231943|157492800|FG001|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
48906119|NCT03231943|157492801|FG002|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
48906120|NCT03231943|157492802|FG003|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
48906121|NCT03231943|157492803|FG004|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
48906122|NCT03231943|157492804|FG005|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
49116270|NCT00303472|158263081|FG003|Treatment Extension (Optional)|Other|2|||
49116271|NCT00303472|158263082|FG004|Treatment Extension (Optional)|Other|1|||
49116272|NCT00303472|158263083|FG005|Treatment Extension (Optional)|Other|0|||
49116273|NCT00303472|158263084|FG006|Treatment Extension (Optional)|Other|0|||
49116274|NCT00303472|158263078|FG000|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
49116275|NCT00303472|158263079|FG001|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
49116276|NCT00303472|158263080|FG002|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
49116277|NCT00303472|158263081|FG003|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
48694881|NCT03346434|156732089|FG003|Overall Study|Withdrawal by Subject|0|||
48694882|NCT03346434|156732090|FG004|Overall Study|Withdrawal by Subject|1|||
48694883|NCT03346434|156732091|FG005|Overall Study|Withdrawal by Subject|0|||
48906123|NCT03231943|157492805|FG006|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
48906124|NCT03231943|157492806|FG007|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
48906125|NCT03231943|157492807|FG008|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
48906126|NCT03231943|157492808|FG009|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
48906127|NCT03231943|157492809|FG010|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
48906128|NCT03231943|157492810|FG011|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
48906129|NCT03231943|157492811|FG012|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
48906130|NCT03231943|157492799|FG000|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
48906131|NCT03231943|157492800|FG001|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1|||
48906132|NCT03231943|157492801|FG002|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
48906133|NCT03231943|157492802|FG003|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
48906134|NCT03231943|157492803|FG004|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
48906135|NCT03231943|157492804|FG005|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
48906136|NCT03231943|157492805|FG006|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
48906137|NCT03231943|157492806|FG007|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
48906138|NCT03231943|157492807|FG008|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
48906139|NCT03231943|157492808|FG009|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
48906140|NCT03231943|157492809|FG010|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
48906141|NCT03231943|157492810|FG011|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
48906142|NCT03231943|157492811|FG012|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
48906143|NCT03231943|157492799|FG000|Part 1, Period 3 (up to Day 45)|Adverse Event|1|||
48906144|NCT03231943|157492800|FG001|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
48906145|NCT03231943|157492801|FG002|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
48906146|NCT03231943|157492802|FG003|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
48906147|NCT03231943|157492803|FG004|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
48906148|NCT03231943|157492804|FG005|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
48906149|NCT03231943|157492805|FG006|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
48906150|NCT03231943|157492806|FG007|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
48906151|NCT03231943|157492807|FG008|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
48906152|NCT03231943|157492808|FG009|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
48906153|NCT03231943|157492809|FG010|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
48906154|NCT03231943|157492810|FG011|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
48906155|NCT03231943|157492811|FG012|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
48906156|NCT03231943|157492799|FG000|Part 2|Adverse Event|0|||
48906157|NCT03231943|157492800|FG001|Part 2|Adverse Event|0|||
48906158|NCT03231943|157492801|FG002|Part 2|Adverse Event|0|||
48906159|NCT03231943|157492802|FG003|Part 2|Adverse Event|0|||
48906160|NCT03231943|157492803|FG004|Part 2|Adverse Event|0|||
48906161|NCT03231943|157492804|FG005|Part 2|Adverse Event|0|||
48906162|NCT03231943|157492805|FG006|Part 2|Adverse Event|0|||
48906163|NCT03231943|157492806|FG007|Part 2|Adverse Event|0|||
48906164|NCT03231943|157492807|FG008|Part 2|Adverse Event|0|||
48906165|NCT03231943|157492808|FG009|Part 2|Adverse Event|0|||
48906166|NCT03231943|157492809|FG010|Part 2|Adverse Event|1|||
48906167|NCT03231943|157492810|FG011|Part 2|Adverse Event|0|||
48906168|NCT03231943|157492811|FG012|Part 2|Adverse Event|0|||
48906169|NCT03231943|157492799|FG000|Part 2|Withdrawal by Subject|0|||
48906170|NCT03231943|157492800|FG001|Part 2|Withdrawal by Subject|0|||
48906171|NCT03231943|157492801|FG002|Part 2|Withdrawal by Subject|0|||
48906172|NCT03231943|157492802|FG003|Part 2|Withdrawal by Subject|0|||
48906173|NCT03231943|157492803|FG004|Part 2|Withdrawal by Subject|0|||
48906174|NCT03231943|157492804|FG005|Part 2|Withdrawal by Subject|0|||
48906175|NCT03231943|157492805|FG006|Part 2|Withdrawal by Subject|0|||
48906176|NCT03231943|157492806|FG007|Part 2|Withdrawal by Subject|0|||
48906177|NCT03231943|157492807|FG008|Part 2|Withdrawal by Subject|0|||
48906178|NCT03231943|157492808|FG009|Part 2|Withdrawal by Subject|0|||
48906179|NCT03231943|157492809|FG010|Part 2|Withdrawal by Subject|0|||
48906180|NCT03231943|157492810|FG011|Part 2|Withdrawal by Subject|1|||
48906181|NCT03231943|157492811|FG012|Part 2|Withdrawal by Subject|0|||
48906182|NCT05505045|157494319|FG000|Overall Study|Withdrawal by Subject|2|||
48906183|NCT05505045|157494320|FG001|Overall Study|Withdrawal by Subject|1|||
48906184|NCT04104321|157494321|FG000|Overall Study|didn't take the study drug|3|||
48906185|NCT03873493|157494325|FG000|Overall Study|Withdrawal by Subject|1|||
48906186|NCT03873493|157494325|FG000|Overall Study|Death|9|||
48906187|NCT03873493|157494325|FG000|Overall Study|Lost to Follow-up|1|||
48906188|NCT03873493|157494325|FG000|Overall Study|Study Terminated by Sponsor|1|||
48906189|NCT03873493|157494325|FG000|Overall Study|Other|2|||
48906190|NCT03756350|157494327|FG000|Overall Study|Lost to Follow-up|1|||
48906191|NCT00702845|157494331|FG000|Overall Study|No/too few/bad quality oocytes retrieved|2|||
48906192|NCT00702845|157494332|FG001|Overall Study|No/too few/bad quality oocytes retrieved|2|||
48906193|NCT00702845|157494331|FG000|Overall Study|Too high ovarian response|5|||
48906194|NCT00702845|157494332|FG001|Overall Study|Too high ovarian response|1|||
48906195|NCT00702845|157494331|FG000|Overall Study|Risk of ovarian hyperstimulation synd.|1|||
48906196|NCT00702845|157494332|FG001|Overall Study|Risk of ovarian hyperstimulation synd.|0|||
48906197|NCT00702845|157494331|FG000|Overall Study|Insufficient ovarian response|1|||
48906198|NCT00702845|157494332|FG001|Overall Study|Insufficient ovarian response|0|||
48906199|NCT00702845|157494331|FG000|Overall Study|No/too few/bad quality embryos retrieved|7|||
48906200|NCT00702845|157494332|FG001|Overall Study|No/too few/bad quality embryos retrieved|1|||
48906201|NCT00702845|157494331|FG000|Overall Study|No or abnormal fertilization|4|||
48906202|NCT00702845|157494332|FG001|Overall Study|No or abnormal fertilization|2|||
48906203|NCT00702845|157494331|FG000|Overall Study|Patient's decision|2|||
48906204|NCT00702845|157494332|FG001|Overall Study|Patient's decision|1|||
48906205|NCT00702845|157494331|FG000|Overall Study|Not randomized|0|||
48906206|NCT00702845|157494332|FG001|Overall Study|Not randomized|1|||
48906207|NCT00928564|157494333|FG000|Overall Study|Lost to Follow-up|6|||
48906208|NCT00928564|157494334|FG001|Overall Study|Lost to Follow-up|0|||
48906209|NCT02460497|157494337|FG000|Overall Study|Participant Requested Withdrawal|4|||
48906210|NCT02460497|157494337|FG000|Overall Study|Non-Compliance|1|||
48906211|NCT02460497|157494337|FG000|Overall Study|Did not Meet Protocol Criteria|1|||
48906212|NCT02460497|157494337|FG000|Overall Study|Lost to Follow-up|2|||
48906213|NCT02460497|157494337|FG000|Overall Study|Investigator Decision|1|||
48906214|NCT01096342|157494338|FG000|Overall Study|Protocol Violation|1|||
48906215|NCT01729156|157494339|FG000|Overall Study|Withdrawal by Subject|1|||
48906216|NCT01729156|157494340|FG001|Overall Study|Withdrawal by Subject|0|||
48906217|NCT01729156|157494341|FG002|Overall Study|Withdrawal by Subject|0|||
48906218|NCT00146328|157494342|FG000|Overall Study|Adverse Event|39|||
48906219|NCT00146328|157494343|FG001|Overall Study|Adverse Event|48|||
48906220|NCT00146328|157494344|FG002|Overall Study|Adverse Event|79|||
48906221|NCT00146328|157494342|FG000|Overall Study|Protocol Violation|11|||
48906222|NCT00146328|157494343|FG001|Overall Study|Protocol Violation|6|||
48906223|NCT00146328|157494344|FG002|Overall Study|Protocol Violation|12|||
48906224|NCT00146328|157494342|FG000|Overall Study|Lost to Follow-up|7|||
48906225|NCT00146328|157494343|FG001|Overall Study|Lost to Follow-up|4|||
48906226|NCT00146328|157494344|FG002|Overall Study|Lost to Follow-up|7|||
48906227|NCT00146328|157494342|FG000|Overall Study|Withdrawal by Subject|16|||
48906228|NCT00146328|157494343|FG001|Overall Study|Withdrawal by Subject|16|||
48906229|NCT00146328|157494344|FG002|Overall Study|Withdrawal by Subject|22|||
48906230|NCT00146328|157494342|FG000|Overall Study|Virologic Failure/lack of efficacy|54|||
48906231|NCT00146328|157494343|FG001|Overall Study|Virologic Failure/lack of efficacy|72|||
48906232|NCT00146328|157494344|FG002|Overall Study|Virologic Failure/lack of efficacy|142|||
48906233|NCT00146328|157494342|FG000|Overall Study|Trial ended/site closed|8|||
48906234|NCT00146328|157494343|FG001|Overall Study|Trial ended/site closed|2|||
48906235|NCT00146328|157494344|FG002|Overall Study|Trial ended/site closed|19|||
48906236|NCT00146328|157494342|FG000|Overall Study|Patient decision to end|0|||
48906237|NCT00146328|157494343|FG001|Overall Study|Patient decision to end|1|||
48906238|NCT00146328|157494344|FG002|Overall Study|Patient decision to end|6|||
48906239|NCT00146328|157494342|FG000|Overall Study|Enroll into other trial|2|||
48906240|NCT00146328|157494343|FG001|Overall Study|Enroll into other trial|4|||
48906241|NCT00146328|157494344|FG002|Overall Study|Enroll into other trial|2|||
48906242|NCT00146328|157494342|FG000|Overall Study|Death|0|||
48906243|NCT00146328|157494343|FG001|Overall Study|Death|1|||
48906244|NCT00146328|157494344|FG002|Overall Study|Death|1|||
48906245|NCT00146328|157494342|FG000|Overall Study|Moved|2|||
48906246|NCT00146328|157494343|FG001|Overall Study|Moved|0|||
48906247|NCT00146328|157494344|FG002|Overall Study|Moved|0|||
48906248|NCT00146328|157494342|FG000|Overall Study|Interaction with other medication|2|||
48906249|NCT00146328|157494343|FG001|Overall Study|Interaction with other medication|0|||
48906250|NCT00146328|157494344|FG002|Overall Study|Interaction with other medication|1|||
48906251|NCT00567268|157494345|FG000|Overall Study|Protocol Violation|7|||
48906252|NCT00567268|157494345|FG000|Overall Study|Lost to Follow-up|36|||
48906253|NCT00567268|157494345|FG000|Overall Study|No Visit After First Day of Treatment|2|||
48906254|NCT00567268|157494345|FG000|Overall Study|No Drug Administration|4|||
48906255|NCT00567268|157494345|FG000|Overall Study|"Safety Evaluation Not Assessable"|1|||
48906256|NCT03236246|157494346|FG000|24-Week Dose Titration Period|Withdrawal by Subject|8|||
48906257|NCT03236246|157494347|FG001|24-Week Dose Titration Period|Withdrawal by Subject|7|||
48906258|NCT03236246|157494346|FG000|24-Week Dose Titration Period|Lost to Follow-up|0|||
48906259|NCT03236246|157494347|FG001|24-Week Dose Titration Period|Lost to Follow-up|2|||
48906260|NCT03236246|157494346|FG000|24-Week Dose Titration Period|Study Drug Non-Compliance|3|||
48906261|NCT03236246|157494347|FG001|24-Week Dose Titration Period|Study Drug Non-Compliance|2|||
48906262|NCT03236246|157494346|FG000|24-Week Dose Titration Period|Investigator Judgement|1|||
48906263|NCT03236246|157494347|FG001|24-Week Dose Titration Period|Investigator Judgement|1|||
48906264|NCT03236246|157494346|FG000|24-Week Dose Titration Period|Prohibited Therapy|1|||
48906265|NCT03236246|157494347|FG001|24-Week Dose Titration Period|Prohibited Therapy|1|||
48906266|NCT03236246|157494346|FG000|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0|||
48906267|NCT03236246|157494347|FG001|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1|||
48906268|NCT03236246|157494346|FG000|24-Week Dose Titration Period|Death|3|||
48906269|NCT03236246|157494347|FG001|24-Week Dose Titration Period|Death|1|||
48906270|NCT03236246|157494346|FG000|24-Week Dose Titration Period|Protocol Violation|0|||
48906271|NCT03236246|157494347|FG001|24-Week Dose Titration Period|Protocol Violation|2|||
48906272|NCT03236246|157494346|FG000|24-Week Dose Titration Period|Adverse Event|7|||
48906273|NCT03236246|157494347|FG001|24-Week Dose Titration Period|Adverse Event|8|||
48906274|NCT03236246|157494346|FG000|24-Week Dose Titration Period|Captured as Other|1|||
48906275|NCT03236246|157494347|FG001|24-Week Dose Titration Period|Captured as Other|2|||
48906276|NCT03236246|157494346|FG000|24-Week Dose Maintenance Period|Withdrawal by Subject|1|||
48906277|NCT03236246|157494347|FG001|24-Week Dose Maintenance Period|Withdrawal by Subject|3|||
48906278|NCT03236246|157494346|FG000|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
48906279|NCT03236246|157494347|FG001|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
48906280|NCT03236246|157494346|FG000|24-Week Dose Maintenance Period|Prohibited Therapy|1|||
48906281|NCT03236246|157494347|FG001|24-Week Dose Maintenance Period|Prohibited Therapy|0|||
48906282|NCT03236246|157494346|FG000|24-Week Dose Maintenance Period|Death|0|||
48906283|NCT03236246|157494347|FG001|24-Week Dose Maintenance Period|Death|1|||
48906284|NCT03236246|157494346|FG000|24-Week Dose Maintenance Period|Adverse Event|0|||
48906285|NCT03236246|157494347|FG001|24-Week Dose Maintenance Period|Adverse Event|1|||
48906286|NCT01330914|157494348|FG000|Overall Study|Withdrawal by Subject|4|||
48906287|NCT01330914|157494348|FG000|Overall Study|No longer eligible (sleeve gastrectomy)|3|||
48906288|NCT02952001|157494351|FG000|Overall Study|Adverse Event|3|||
48906289|NCT02952001|157494352|FG001|Overall Study|Adverse Event|0|||
48906290|NCT02952001|157494351|FG000|Overall Study|Prohibited therapy|10|||
48906291|NCT02952001|157494352|FG001|Overall Study|Prohibited therapy|3|||
48906292|NCT02952001|157494351|FG000|Overall Study|Due to Posterior Capsular Opacity|1|||
48906293|NCT02952001|157494352|FG001|Overall Study|Due to Posterior Capsular Opacity|0|||
48906294|NCT01008696|157494364|FG000|Overall Study|Participant's evasion of hospital visit|5|||
49116278|NCT00303472|158263082|FG004|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
48906295|NCT01008696|157494365|FG001|Overall Study|Participant's evasion of hospital visit|4|||
48906296|NCT01008696|157494364|FG000|Overall Study|Withdrawal by Subject|2|||
48906297|NCT01008696|157494365|FG001|Overall Study|Withdrawal by Subject|4|||
48906298|NCT01008696|157494364|FG000|Overall Study|Physician Decision|5|||
48906299|NCT01008696|157494365|FG001|Overall Study|Physician Decision|1|||
48906300|NCT01008696|157494364|FG000|Overall Study|Adverse Event|1|||
48906301|NCT01008696|157494365|FG001|Overall Study|Adverse Event|0|||
48906302|NCT01008696|157494364|FG000|Overall Study|Participants' non-cooperation|2|||
48906303|NCT01008696|157494365|FG001|Overall Study|Participants' non-cooperation|3|||
48906304|NCT01008696|157494364|FG000|Overall Study|Other|2|||
48906305|NCT01008696|157494365|FG001|Overall Study|Other|3|||
48906306|NCT01008696|157494364|FG000|Overall Study|Other|0|||
48906307|NCT01008696|157494365|FG001|Overall Study|Other|2|||
48906308|NCT02366728|157494366|FG000|Overall Study|Death|0|||
48906309|NCT02366728|157494367|FG001|Overall Study|Death|0|||
48906310|NCT02366728|157494368|FG002|Overall Study|Death|1|||
48906311|NCT02366728|157494366|FG000|Overall Study|Adverse Event|1|||
48906312|NCT02366728|157494367|FG001|Overall Study|Adverse Event|0|||
48906313|NCT02366728|157494368|FG002|Overall Study|Adverse Event|0|||
48906314|NCT02366728|157494366|FG000|Overall Study|Screen Failure|2|||
48906315|NCT02366728|157494367|FG001|Overall Study|Screen Failure|1|||
48906316|NCT02366728|157494368|FG002|Overall Study|Screen Failure|0|||
48906317|NCT02366728|157494366|FG000|Overall Study|Only yielded 2 vaccines|1|||
48906318|NCT02366728|157494367|FG001|Overall Study|Only yielded 2 vaccines|0|||
48906319|NCT02366728|157494368|FG002|Overall Study|Only yielded 2 vaccines|0|||
48906320|NCT00616434|157494369|FG000|Overall Study|Adverse Event|5|||
48906321|NCT00616434|157494370|FG001|Overall Study|Adverse Event|2|||
48906322|NCT00616434|157494369|FG000|Overall Study|Physician Decision|0|||
48906323|NCT00616434|157494370|FG001|Overall Study|Physician Decision|4|||
48906324|NCT00616434|157494369|FG000|Overall Study|Withdrawal by Subject|1|||
48906325|NCT00616434|157494370|FG001|Overall Study|Withdrawal by Subject|1|||
48906326|NCT00616434|157494369|FG000|Overall Study|Protocol deviation|0|||
48906327|NCT00616434|157494370|FG001|Overall Study|Protocol deviation|1|||
48906328|NCT05097716|157494371|FG000|Period 1|Adverse Event|1|||
48906329|NCT05097716|157494371|FG000|Period 1|Close contact with highly-transmissible infection|1|||
48906330|NCT01949155|157494377|FG000|Overall Study|Lost to Follow-up|1|||
48906331|NCT01949155|157494378|FG001|Overall Study|Lost to Follow-up|0|||
48906332|NCT01949155|157494377|FG000|Overall Study|Protocol Violation|1|||
48906333|NCT01949155|157494378|FG001|Overall Study|Protocol Violation|0|||
48906334|NCT00129623|157494379|FG000|Overall Study|Adverse Event|3|||
48906335|NCT00129623|157494380|FG001|Overall Study|Adverse Event|7|||
48906336|NCT00129623|157494379|FG000|Overall Study|Refused Treatment|5|||
48906337|NCT00129623|157494380|FG001|Overall Study|Refused Treatment|3|||
48906338|NCT00129623|157494379|FG000|Overall Study|Failure to Return|1|||
48906339|NCT00129623|157494380|FG001|Overall Study|Failure to Return|1|||
48906340|NCT00129623|157494379|FG000|Overall Study|Relocated job out of state|1|||
48906341|NCT00129623|157494380|FG001|Overall Study|Relocated job out of state|0|||
48906342|NCT00129623|157494379|FG000|Overall Study|Uncertainty to return|0|||
48906343|NCT00129623|157494380|FG001|Overall Study|Uncertainty to return|1|||
48906344|NCT02202551|157494382|FG000|Overall Study|Adverse Event|8|||
48906345|NCT02202551|157494383|FG001|Overall Study|Adverse Event|19|||
48906346|NCT02202551|157494384|FG002|Overall Study|Adverse Event|5|||
48906347|NCT02202551|157494385|FG003|Overall Study|Adverse Event|9|||
48906348|NCT02202551|157494382|FG000|Overall Study|Death|3|||
48906349|NCT02202551|157494383|FG001|Overall Study|Death|2|||
48906350|NCT02202551|157494384|FG002|Overall Study|Death|1|||
48906351|NCT02202551|157494385|FG003|Overall Study|Death|1|||
48906352|NCT02202551|157494382|FG000|Overall Study|Lost to Follow-up|0|||
48906353|NCT02202551|157494383|FG001|Overall Study|Lost to Follow-up|1|||
48906354|NCT02202551|157494384|FG002|Overall Study|Lost to Follow-up|0|||
48906355|NCT02202551|157494385|FG003|Overall Study|Lost to Follow-up|1|||
48906356|NCT02202551|157494382|FG000|Overall Study|Needed to take excluded medication|0|||
48906357|NCT02202551|157494383|FG001|Overall Study|Needed to take excluded medication|2|||
48906358|NCT02202551|157494384|FG002|Overall Study|Needed to take excluded medication|0|||
48906359|NCT02202551|157494385|FG003|Overall Study|Needed to take excluded medication|1|||
48906360|NCT02202551|157494382|FG000|Overall Study|Subject moved away|0|||
48906361|NCT02202551|157494383|FG001|Overall Study|Subject moved away|1|||
48906362|NCT02202551|157494384|FG002|Overall Study|Subject moved away|0|||
48906363|NCT02202551|157494385|FG003|Overall Study|Subject moved away|0|||
48906364|NCT02202551|157494382|FG000|Overall Study|DBS surgery|3|||
48906365|NCT02202551|157494383|FG001|Overall Study|DBS surgery|0|||
48906366|NCT02202551|157494384|FG002|Overall Study|DBS surgery|0|||
48906367|NCT02202551|157494385|FG003|Overall Study|DBS surgery|0|||
48906368|NCT02202551|157494382|FG000|Overall Study|Dyskinesia upon taper|1|||
48906369|NCT02202551|157494383|FG001|Overall Study|Dyskinesia upon taper|0|||
48906370|NCT02202551|157494384|FG002|Overall Study|Dyskinesia upon taper|0|||
48906371|NCT02202551|157494385|FG003|Overall Study|Dyskinesia upon taper|0|||
48906372|NCT02202551|157494382|FG000|Overall Study|Lack of Efficacy|0|||
48906373|NCT02202551|157494383|FG001|Overall Study|Lack of Efficacy|1|||
49116279|NCT00303472|158263083|FG005|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
48906374|NCT02202551|157494384|FG002|Overall Study|Lack of Efficacy|0|||
49116280|NCT00303472|158263084|FG006|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
48906375|NCT02202551|157494385|FG003|Overall Study|Lack of Efficacy|0|||
48906376|NCT02202551|157494382|FG000|Overall Study|Physician Decision|1|||
48906377|NCT02202551|157494383|FG001|Overall Study|Physician Decision|0|||
48906378|NCT02202551|157494384|FG002|Overall Study|Physician Decision|0|||
48906379|NCT02202551|157494385|FG003|Overall Study|Physician Decision|0|||
48906380|NCT02202551|157494382|FG000|Overall Study|Site closure|3|||
48906381|NCT02202551|157494383|FG001|Overall Study|Site closure|0|||
48906382|NCT02202551|157494384|FG002|Overall Study|Site closure|0|||
48906383|NCT02202551|157494385|FG003|Overall Study|Site closure|1|||
49010516|NCT00926289|157875640|FG001|Overall Study|Adverse Event|11|||
48906384|NCT02202551|157494382|FG000|Overall Study|Unable to complete visits per protocol|1|||
48906385|NCT02202551|157494383|FG001|Overall Study|Unable to complete visits per protocol|0|||
48906386|NCT02202551|157494384|FG002|Overall Study|Unable to complete visits per protocol|0|||
48906387|NCT02202551|157494385|FG003|Overall Study|Unable to complete visits per protocol|0|||
48906388|NCT02202551|157494382|FG000|Overall Study|Worsening Dyskinesia|0|||
48906389|NCT02202551|157494383|FG001|Overall Study|Worsening Dyskinesia|0|||
48906390|NCT02202551|157494384|FG002|Overall Study|Worsening Dyskinesia|0|||
48906391|NCT02202551|157494385|FG003|Overall Study|Worsening Dyskinesia|1|||
48906392|NCT02202551|157494382|FG000|Overall Study|Protocol Violation|0|||
48906393|NCT02202551|157494383|FG001|Overall Study|Protocol Violation|1|||
48906394|NCT02202551|157494384|FG002|Overall Study|Protocol Violation|0|||
48906395|NCT02202551|157494385|FG003|Overall Study|Protocol Violation|0|||
48906396|NCT02202551|157494382|FG000|Overall Study|Sponsor's decision|2|||
48906397|NCT02202551|157494383|FG001|Overall Study|Sponsor's decision|0|||
48906398|NCT02202551|157494384|FG002|Overall Study|Sponsor's decision|0|||
48906399|NCT02202551|157494385|FG003|Overall Study|Sponsor's decision|0|||
48906400|NCT02202551|157494382|FG000|Overall Study|Subject unwilling to proceed|1|||
48906401|NCT02202551|157494383|FG001|Overall Study|Subject unwilling to proceed|5|||
48906402|NCT02202551|157494384|FG002|Overall Study|Subject unwilling to proceed|3|||
48906403|NCT02202551|157494385|FG003|Overall Study|Subject unwilling to proceed|5|||
48906404|NCT02202551|157494382|FG000|Overall Study|Subject consent withdrawn|0|||
48906405|NCT02202551|157494383|FG001|Overall Study|Subject consent withdrawn|3|||
48906406|NCT02202551|157494384|FG002|Overall Study|Subject consent withdrawn|1|||
48906407|NCT02202551|157494385|FG003|Overall Study|Subject consent withdrawn|2|||
48906408|NCT02202551|157494382|FG000|Overall Study|eGFR<50mL/min/m2|2|||
48906409|NCT02202551|157494383|FG001|Overall Study|eGFR<50mL/min/m2|2|||
48906410|NCT02202551|157494384|FG002|Overall Study|eGFR<50mL/min/m2|0|||
48906411|NCT02202551|157494385|FG003|Overall Study|eGFR<50mL/min/m2|1|||
48906412|NCT02234323|157494386|FG000|All Enrolled|Not Treated: Completed study in database|2|||
48906413|NCT02234323|157494386|FG000|All Enrolled|Not Treated:Consent withdrawn by subject|2|||
48906414|NCT02234323|157494386|FG000|All Enrolled|Not Treated: Exceeded lab value limit|1|||
48906415|NCT02234323|157494386|FG000|All Treated|Death|1|||
48906416|NCT02234323|157494386|FG000|All Treated|Physician Decision|5|||
48906417|NCT02234323|157494386|FG000|All Treated|Lack of Efficacy|3|||
48906418|NCT02234323|157494386|FG000|All Treated|Exceeded lab value limit|2|||
48906419|NCT02234323|157494386|FG000|All Treated|Other|7|||
48906420|NCT00867113|157494389|FG000|Treatment Period|Adverse Event|15|||
48906421|NCT00867113|157494389|FG000|Treatment Period|Death|2|||
48906422|NCT00867113|157494389|FG000|Treatment Period|Withdrawal by Subject|19|||
48906423|NCT00867113|157494389|FG000|Treatment Period|Lost to Follow-up|3|||
48906424|NCT00867113|157494389|FG000|Treatment Period|Administrative problems|1|||
48906425|NCT00867113|157494389|FG000|Treatment Period|Disease progression/relapse|1|||
48906426|NCT00867113|157494389|FG000|Treatment Period|Protocol Violation|4|||
48906427|NCT00867113|157494389|FG000|Post Treatment After Survival Follow-up|Death|1|||
48906428|NCT00867113|157494389|FG000|Post Treatment After Survival Follow-up|Withdrawal by Subject|1|||
48906429|NCT00867113|157494389|FG000|Post Treatment After Survival Follow-up|Lost to Follow-up|5|||
48906430|NCT00867113|157494389|FG000|Post Treatment After Survival Follow-up|Administrative problems|4|||
48906431|NCT04178967|157494390|FG000|Induction Period|Adverse Event|4|||
48906432|NCT04178967|157494391|FG001|Induction Period|Adverse Event|6|||
48906433|NCT04178967|157494392|FG002|Induction Period|Adverse Event|0|||
48906434|NCT04178967|157494393|FG003|Induction Period|Adverse Event|0|||
48906435|NCT04178967|157494394|FG004|Induction Period|Adverse Event|0|||
48906436|NCT04178967|157494395|FG005|Induction Period|Adverse Event|0|||
48906437|NCT04178967|157494396|FG006|Induction Period|Adverse Event|0|||
48906438|NCT04178967|157494397|FG007|Induction Period|Adverse Event|0|||
48906439|NCT04178967|157494398|FG008|Induction Period|Adverse Event|0|||
48906440|NCT04178967|157494399|FG009|Induction Period|Adverse Event|0|||
48906441|NCT04178967|157494400|FG010|Induction Period|Adverse Event|0|||
48906442|NCT04178967|157494390|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
48906443|NCT04178967|157494391|FG001|Induction Period|Due to Epidemic/Pandemic|4|||
48906444|NCT04178967|157494392|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
48906445|NCT04178967|157494393|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
48906446|NCT04178967|157494394|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
48906447|NCT04178967|157494395|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
48906448|NCT04178967|157494396|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
48694884|NCT03346434|156732086|FG000|Overall Study|Lost to Follow-up|0|||
48906449|NCT04178967|157494397|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
48906450|NCT04178967|157494398|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
48906451|NCT04178967|157494399|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
48906452|NCT04178967|157494400|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
48906453|NCT04178967|157494390|FG000|Induction Period|Lack of Efficacy|4|||
48906454|NCT04178967|157494391|FG001|Induction Period|Lack of Efficacy|1|||
48906455|NCT04178967|157494392|FG002|Induction Period|Lack of Efficacy|0|||
48906456|NCT04178967|157494393|FG003|Induction Period|Lack of Efficacy|0|||
48906457|NCT04178967|157494394|FG004|Induction Period|Lack of Efficacy|0|||
48906458|NCT04178967|157494395|FG005|Induction Period|Lack of Efficacy|0|||
48906459|NCT04178967|157494396|FG006|Induction Period|Lack of Efficacy|0|||
48694885|NCT03346434|156732087|FG001|Overall Study|Lost to Follow-up|0|||
48694886|NCT03346434|156732088|FG002|Overall Study|Lost to Follow-up|0|||
48694887|NCT03346434|156732089|FG003|Overall Study|Lost to Follow-up|0|||
48694888|NCT03346434|156732090|FG004|Overall Study|Lost to Follow-up|1|||
48694889|NCT03346434|156732091|FG005|Overall Study|Lost to Follow-up|1|||
48694890|NCT03346434|156732086|FG000|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
48694891|NCT03346434|156732087|FG001|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
48694892|NCT03346434|156732088|FG002|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
48694893|NCT03346434|156732089|FG003|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
48694894|NCT03346434|156732090|FG004|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|75|||
48694895|NCT03346434|156732091|FG005|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|81|||
48694896|NCT03525444|156732092|FG000|Overall Study|Adverse Event|0|||
48694897|NCT03525444|156732093|FG001|Overall Study|Adverse Event|1|||
48694898|NCT03525444|156732092|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
48694899|NCT03525444|156732093|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
48694900|NCT03525444|156732092|FG000|Overall Study|Other|0|||
48694901|NCT03525444|156732093|FG001|Overall Study|Other|1|||
48694902|NCT02973100|156732096|FG000|Overall Study|Adverse Event|1|||
48694903|NCT02973100|156732097|FG001|Overall Study|Adverse Event|2|||
48694904|NCT02973100|156732098|FG002|Overall Study|Adverse Event|1|||
48694905|NCT02973100|156732099|FG003|Overall Study|Adverse Event|2|||
48694906|NCT02973100|156732096|FG000|Overall Study|Lost to Follow-up|3|||
48694907|NCT02973100|156732097|FG001|Overall Study|Lost to Follow-up|1|||
48694908|NCT02973100|156732098|FG002|Overall Study|Lost to Follow-up|1|||
48694909|NCT02973100|156732099|FG003|Overall Study|Lost to Follow-up|0|||
48694910|NCT02973100|156732096|FG000|Overall Study|Withdrawal by Subject|3|||
48694911|NCT02973100|156732097|FG001|Overall Study|Withdrawal by Subject|5|||
48694912|NCT02973100|156732098|FG002|Overall Study|Withdrawal by Subject|1|||
48694913|NCT02973100|156732099|FG003|Overall Study|Withdrawal by Subject|4|||
48694914|NCT02973100|156732096|FG000|Overall Study|Notification of change in address|0|||
48694915|NCT02973100|156732097|FG001|Overall Study|Notification of change in address|0|||
48906460|NCT04178967|157494397|FG007|Induction Period|Lack of Efficacy|0|||
48906461|NCT04178967|157494398|FG008|Induction Period|Lack of Efficacy|0|||
48906462|NCT04178967|157494399|FG009|Induction Period|Lack of Efficacy|0|||
48906463|NCT04178967|157494400|FG010|Induction Period|Lack of Efficacy|0|||
48906464|NCT04178967|157494390|FG000|Induction Period|Protocol Violation|0|||
48906465|NCT04178967|157494391|FG001|Induction Period|Protocol Violation|6|||
48906466|NCT04178967|157494392|FG002|Induction Period|Protocol Violation|0|||
48906467|NCT04178967|157494393|FG003|Induction Period|Protocol Violation|0|||
48906468|NCT04178967|157494394|FG004|Induction Period|Protocol Violation|0|||
48694916|NCT02973100|156732098|FG002|Overall Study|Notification of change in address|0|||
48694917|NCT02973100|156732099|FG003|Overall Study|Notification of change in address|1|||
48694918|NCT02973100|156732096|FG000|Overall Study|Failed to attend Safety followup period|0|||
48694919|NCT02973100|156732097|FG001|Overall Study|Failed to attend Safety followup period|0|||
48694920|NCT02973100|156732098|FG002|Overall Study|Failed to attend Safety followup period|1|||
48694921|NCT02973100|156732099|FG003|Overall Study|Failed to attend Safety followup period|0|||
48694922|NCT03095651|156732100|FG000|Overall Study|Lost to Follow-up|1|||
48694923|NCT03095651|156732101|FG001|Overall Study|Lost to Follow-up|1|||
48694924|NCT03095651|156732102|FG002|Overall Study|Lost to Follow-up|0|||
48694925|NCT03095651|156732103|FG003|Overall Study|Lost to Follow-up|1|||
48694926|NCT03095651|156732104|FG004|Overall Study|Lost to Follow-up|0|||
48694927|NCT03095651|156732105|FG005|Overall Study|Lost to Follow-up|0|||
48694928|NCT03095651|156732106|FG006|Overall Study|Lost to Follow-up|0|||
48694929|NCT03095651|156732107|FG007|Overall Study|Lost to Follow-up|0|||
48694930|NCT03095651|156732100|FG000|Overall Study|Withdrawal by Subject|0|||
48694931|NCT03095651|156732101|FG001|Overall Study|Withdrawal by Subject|0|||
48694932|NCT03095651|156732102|FG002|Overall Study|Withdrawal by Subject|0|||
48694933|NCT03095651|156732103|FG003|Overall Study|Withdrawal by Subject|0|||
48694934|NCT03095651|156732104|FG004|Overall Study|Withdrawal by Subject|0|||
48694935|NCT03095651|156732105|FG005|Overall Study|Withdrawal by Subject|1|||
48694936|NCT03095651|156732106|FG006|Overall Study|Withdrawal by Subject|0|||
48906469|NCT04178967|157494395|FG005|Induction Period|Protocol Violation|0|||
48906470|NCT04178967|157494396|FG006|Induction Period|Protocol Violation|0|||
48906471|NCT04178967|157494397|FG007|Induction Period|Protocol Violation|0|||
48906472|NCT04178967|157494398|FG008|Induction Period|Protocol Violation|0|||
48694937|NCT03095651|156732107|FG007|Overall Study|Withdrawal by Subject|0|||
48694938|NCT03115359|156732111|FG000|Overall Study|Withdrawal by Subject|29|||
48694939|NCT03115359|156732112|FG001|Overall Study|Withdrawal by Subject|39|||
48694940|NCT03115359|156732111|FG000|Overall Study|Scheduling conflict|25|||
48694941|NCT03115359|156732112|FG001|Overall Study|Scheduling conflict|23|||
48694942|NCT03115359|156732111|FG000|Overall Study|Personal reasons including health|12|||
48694943|NCT03115359|156732112|FG001|Overall Study|Personal reasons including health|9|||
48906473|NCT04178967|157494399|FG009|Induction Period|Protocol Violation|0|||
48906474|NCT04178967|157494400|FG010|Induction Period|Protocol Violation|0|||
48906475|NCT04178967|157494390|FG000|Induction Period|Withdrawal by Subject|6|||
48906476|NCT04178967|157494391|FG001|Induction Period|Withdrawal by Subject|4|||
48906477|NCT04178967|157494392|FG002|Induction Period|Withdrawal by Subject|0|||
48906478|NCT04178967|157494393|FG003|Induction Period|Withdrawal by Subject|0|||
48906479|NCT04178967|157494394|FG004|Induction Period|Withdrawal by Subject|0|||
48906480|NCT04178967|157494395|FG005|Induction Period|Withdrawal by Subject|0|||
48906481|NCT04178967|157494396|FG006|Induction Period|Withdrawal by Subject|0|||
48906482|NCT04178967|157494397|FG007|Induction Period|Withdrawal by Subject|0|||
48906483|NCT04178967|157494398|FG008|Induction Period|Withdrawal by Subject|0|||
48906484|NCT04178967|157494399|FG009|Induction Period|Withdrawal by Subject|0|||
48906485|NCT04178967|157494400|FG010|Induction Period|Withdrawal by Subject|0|||
48906486|NCT04178967|157494390|FG000|Induction Period|Lost to Follow-up|2|||
48906487|NCT04178967|157494391|FG001|Induction Period|Lost to Follow-up|0|||
48906488|NCT04178967|157494392|FG002|Induction Period|Lost to Follow-up|0|||
48906489|NCT04178967|157494393|FG003|Induction Period|Lost to Follow-up|0|||
48906490|NCT04178967|157494394|FG004|Induction Period|Lost to Follow-up|0|||
48906491|NCT04178967|157494395|FG005|Induction Period|Lost to Follow-up|0|||
48906492|NCT04178967|157494396|FG006|Induction Period|Lost to Follow-up|0|||
48906493|NCT04178967|157494397|FG007|Induction Period|Lost to Follow-up|0|||
48906494|NCT04178967|157494398|FG008|Induction Period|Lost to Follow-up|0|||
48906495|NCT04178967|157494399|FG009|Induction Period|Lost to Follow-up|0|||
48906496|NCT04178967|157494400|FG010|Induction Period|Lost to Follow-up|0|||
48906497|NCT04178967|157494390|FG000|Induction Period|Participant Missed Study Visits|0|||
48906498|NCT04178967|157494391|FG001|Induction Period|Participant Missed Study Visits|1|||
48906499|NCT04178967|157494392|FG002|Induction Period|Participant Missed Study Visits|0|||
48906500|NCT04178967|157494393|FG003|Induction Period|Participant Missed Study Visits|0|||
48906501|NCT04178967|157494394|FG004|Induction Period|Participant Missed Study Visits|0|||
48906502|NCT04178967|157494395|FG005|Induction Period|Participant Missed Study Visits|0|||
48906503|NCT04178967|157494396|FG006|Induction Period|Participant Missed Study Visits|0|||
48906504|NCT04178967|157494397|FG007|Induction Period|Participant Missed Study Visits|0|||
48906505|NCT04178967|157494398|FG008|Induction Period|Participant Missed Study Visits|0|||
48906506|NCT04178967|157494399|FG009|Induction Period|Participant Missed Study Visits|0|||
48906507|NCT04178967|157494400|FG010|Induction Period|Participant Missed Study Visits|0|||
48906508|NCT04178967|157494390|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
48906509|NCT04178967|157494391|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
48906510|NCT04178967|157494392|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
48906511|NCT04178967|157494393|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
48906512|NCT04178967|157494394|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
48906513|NCT04178967|157494395|FG005|Maintenance Blinded Treatment Period|Adverse Event|1|||
48906514|NCT04178967|157494396|FG006|Maintenance Blinded Treatment Period|Adverse Event|2|||
48906515|NCT04178967|157494397|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
48906516|NCT04178967|157494398|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
48906517|NCT04178967|157494399|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
48906518|NCT04178967|157494400|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
48906519|NCT04178967|157494390|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
48906520|NCT04178967|157494391|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
48906521|NCT04178967|157494392|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
48906522|NCT04178967|157494393|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
48906523|NCT04178967|157494394|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
48906524|NCT04178967|157494395|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
48906525|NCT04178967|157494396|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
48906526|NCT04178967|157494397|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
48906527|NCT04178967|157494398|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
48906528|NCT04178967|157494399|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
48906529|NCT04178967|157494400|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
48906530|NCT04178967|157494390|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
48906531|NCT04178967|157494391|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
48906532|NCT04178967|157494392|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
48906533|NCT04178967|157494393|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
48906534|NCT04178967|157494394|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
48906535|NCT04178967|157494395|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
48906536|NCT04178967|157494396|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
48906537|NCT04178967|157494397|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
48906538|NCT04178967|157494398|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
48906539|NCT04178967|157494399|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
48906540|NCT04178967|157494400|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
48906541|NCT04178967|157494390|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
48906542|NCT04178967|157494391|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
48906543|NCT04178967|157494392|FG002|Maintenance Blinded Treatment Period|Physician Decision|0|||
48906544|NCT04178967|157494393|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
48906545|NCT04178967|157494394|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
48906546|NCT04178967|157494395|FG005|Maintenance Blinded Treatment Period|Physician Decision|0|||
48906547|NCT04178967|157494396|FG006|Maintenance Blinded Treatment Period|Physician Decision|1|||
48906548|NCT04178967|157494397|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
48906549|NCT04178967|157494398|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
48906550|NCT04178967|157494399|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
48906551|NCT04178967|157494400|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
48906552|NCT04178967|157494390|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
48906553|NCT04178967|157494391|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
48906554|NCT04178967|157494392|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
48906555|NCT04178967|157494393|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
48906556|NCT04178967|157494394|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
48906557|NCT04178967|157494395|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
48906558|NCT04178967|157494396|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
48906559|NCT04178967|157494397|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|4|||
48906560|NCT04178967|157494398|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
48906561|NCT04178967|157494399|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
48906562|NCT04178967|157494400|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
48906563|NCT04178967|157494390|FG000|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
48906564|NCT04178967|157494391|FG001|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
48906565|NCT04178967|157494392|FG002|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
48906566|NCT04178967|157494393|FG003|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
48906567|NCT04178967|157494394|FG004|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
48906568|NCT04178967|157494395|FG005|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
48906569|NCT04178967|157494396|FG006|Maintenance Blinded Treatment Period|Sponsor Decision|4|||
48906570|NCT04178967|157494397|FG007|Maintenance Blinded Treatment Period|Sponsor Decision|6|||
48906571|NCT04178967|157494398|FG008|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
48906572|NCT04178967|157494399|FG009|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
48906573|NCT04178967|157494400|FG010|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
48906574|NCT04178967|157494390|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
48906575|NCT04178967|157494391|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
48906576|NCT04178967|157494392|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
48906577|NCT04178967|157494393|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
48906578|NCT04178967|157494394|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
48906579|NCT04178967|157494395|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|3|||
48906580|NCT04178967|157494396|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
48906581|NCT04178967|157494397|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
48906582|NCT04178967|157494398|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
48906583|NCT04178967|157494399|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
48906584|NCT04178967|157494400|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
48906585|NCT04178967|157494390|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
48906586|NCT04178967|157494391|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
48906587|NCT04178967|157494392|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
48906588|NCT04178967|157494393|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
48906589|NCT04178967|157494394|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
48906590|NCT04178967|157494395|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
48906591|NCT04178967|157494396|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
48906592|NCT04178967|157494397|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
48906593|NCT04178967|157494398|FG008|Maintenance Open Label Escape Arm|Adverse Event|3|||
48906594|NCT04178967|157494399|FG009|Maintenance Open Label Escape Arm|Adverse Event|3|||
48906595|NCT04178967|157494400|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
48906596|NCT04178967|157494390|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
48906597|NCT04178967|157494391|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
48906598|NCT04178967|157494392|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
48906599|NCT04178967|157494393|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
48906600|NCT04178967|157494394|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
48906601|NCT04178967|157494395|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
48906602|NCT04178967|157494396|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
48906603|NCT04178967|157494397|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
48906604|NCT04178967|157494398|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|16|||
48906605|NCT04178967|157494399|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|27|||
48906606|NCT04178967|157494400|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|2|||
48742929|NCT00126191|156910416|FG000|Overall Study|Physician Decision|0|||
48906607|NCT04178967|157494390|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
48906608|NCT04178967|157494391|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
48906609|NCT04178967|157494392|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
48906610|NCT04178967|157494393|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
48906611|NCT04178967|157494394|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
48906612|NCT04178967|157494395|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
48906613|NCT04178967|157494396|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
48906614|NCT04178967|157494397|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
48906615|NCT04178967|157494398|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
48906616|NCT04178967|157494399|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
48906617|NCT04178967|157494400|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
48906618|NCT04178967|157494390|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
48906619|NCT04178967|157494391|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
48906620|NCT04178967|157494392|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
48906621|NCT04178967|157494393|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
48906622|NCT04178967|157494394|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
48906623|NCT04178967|157494395|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
48906624|NCT04178967|157494396|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
48906625|NCT04178967|157494397|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
48906626|NCT04178967|157494398|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|4|||
48906627|NCT04178967|157494399|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|9|||
48906628|NCT04178967|157494400|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
48906629|NCT04178967|157494390|FG000|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
48906630|NCT04178967|157494391|FG001|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
48906631|NCT04178967|157494392|FG002|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
48906632|NCT04178967|157494393|FG003|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
48906633|NCT04178967|157494394|FG004|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
48906634|NCT04178967|157494395|FG005|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
48906635|NCT04178967|157494396|FG006|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
48906636|NCT04178967|157494397|FG007|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
48906637|NCT04178967|157494398|FG008|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
48906638|NCT04178967|157494399|FG009|Maintenance Open Label Escape Arm|Sponsor Decision|1|||
48906639|NCT04178967|157494400|FG010|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
48906640|NCT04178967|157494390|FG000|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
48906641|NCT04178967|157494391|FG001|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
48906642|NCT04178967|157494392|FG002|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
48906643|NCT04178967|157494393|FG003|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
48906644|NCT04178967|157494394|FG004|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
48906645|NCT04178967|157494395|FG005|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
48906646|NCT04178967|157494396|FG006|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
48906647|NCT04178967|157494397|FG007|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
48906648|NCT04178967|157494398|FG008|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
48906649|NCT04178967|157494399|FG009|Maintenance Open Label Escape Arm|Participant Missed Study Visits|1|||
48906650|NCT04178967|157494400|FG010|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
48906651|NCT03037619|157494401|FG000|Overall Study|Lost to Follow-up|0|||
48906652|NCT03037619|157494402|FG001|Overall Study|Lost to Follow-up|1|||
48906653|NCT01106027|157494403|FG000|Overall Study|Lost graft early, discontinued|1|||
48906654|NCT02545322|157494404|FG000|Overall Study|Withdrawal by Subject|3|||
48906655|NCT01423253|157494405|FG000|Overall Study|Adverse Event|2|||
48906656|NCT01423253|157494405|FG000|Overall Study|Lack of Efficacy|2|||
48906657|NCT01423253|157494405|FG000|Overall Study|Lost to Follow-up|1|||
48906658|NCT01423253|157494405|FG000|Overall Study|Protocol Violation|2|||
48906659|NCT01423253|157494405|FG000|Overall Study|Withdrawal by Subject|2|||
48906660|NCT00147823|157494409|FG000|Overall Study|Lost to Follow-up|6|||
48906661|NCT00147823|157494410|FG001|Overall Study|Lost to Follow-up|12|||
48906662|NCT00147823|157494409|FG000|Overall Study|Physician Decision|1|||
48906663|NCT00147823|157494410|FG001|Overall Study|Physician Decision|0|||
48906664|NCT00147823|157494409|FG000|Overall Study|Withdrawal by Subject|0|||
48906665|NCT00147823|157494410|FG001|Overall Study|Withdrawal by Subject|1|||
48906666|NCT00147823|157494409|FG000|Overall Study|Did not receive vitoss due to infection|6|||
48906667|NCT00147823|157494410|FG001|Overall Study|Did not receive vitoss due to infection|2|||
48906668|NCT00986440|157494413|FG000|Overall Study|Progressive disease|27|||
48906669|NCT00986440|157494414|FG001|Overall Study|Progressive disease|37|||
48906670|NCT00986440|157494413|FG000|Overall Study|Serious adverse event or adverse event|9|||
48906671|NCT00986440|157494414|FG001|Overall Study|Serious adverse event or adverse event|2|||
48906672|NCT00986440|157494413|FG000|Overall Study|Withdrawal by Subject|1|||
48906673|NCT00986440|157494414|FG001|Overall Study|Withdrawal by Subject|2|||
48906674|NCT00986440|157494413|FG000|Overall Study|Screen failure (not dosed)|4|||
48906675|NCT00986440|157494414|FG001|Overall Study|Screen failure (not dosed)|2|||
48906676|NCT02608879|157494415|FG000|Overall Study|Lost to Follow-up|1|||
48906677|NCT02608879|157494416|FG001|Overall Study|Lost to Follow-up|0|||
48906678|NCT02608879|157494417|FG002|Overall Study|Lost to Follow-up|0|||
48906679|NCT02608879|157494415|FG000|Overall Study|Did not meet continuation criteria|0|||
48906680|NCT02608879|157494416|FG001|Overall Study|Did not meet continuation criteria|0|||
48906681|NCT02608879|157494417|FG002|Overall Study|Did not meet continuation criteria|3|||
48906682|NCT00760669|157494420|FG000|Overall Study|Not assessed for overall improvement|18|||
48906683|NCT00760669|157494420|FG000|Overall Study|Participants missing efficacy assessment|6|||
48906684|NCT00760669|157494420|FG000|Overall Study|Participants with overlapping cases|1|||
48906685|NCT00760669|157494420|FG000|Overall Study|Took drug before entering in contract|5|||
48906686|NCT00639223|157494426|FG000|Overall Study|Lost to Follow-up|0|||
48906687|NCT00639223|157494427|FG001|Overall Study|Lost to Follow-up|2|||
48906688|NCT01130974|157494428|FG000|Overall Study|Protocol Violation|10|||
48906689|NCT01130974|157494429|FG001|Overall Study|Protocol Violation|10|||
48906690|NCT01130974|157494428|FG000|Overall Study|Withdrawal by Subject|0|||
48906691|NCT01130974|157494429|FG001|Overall Study|Withdrawal by Subject|1|||
48906692|NCT01130974|157494428|FG000|Overall Study|Ineligibility criteria|5|||
48906693|NCT01130974|157494429|FG001|Overall Study|Ineligibility criteria|2|||
48906694|NCT03431857|157494430|FG000|Overall Study|Death|6|||
48906695|NCT03431857|157494430|FG000|Overall Study|Lost to Follow-up|41|||
48906696|NCT03431857|157494430|FG000|Overall Study|Adverse Event|6|||
48906697|NCT03431857|157494430|FG000|Overall Study|Withdrawal by Subject|1|||
48906698|NCT01184053|157494431|FG000|Overall Study|progression while on treatment|3|||
48906699|NCT01159912|157494432|FG000|Overall Study|Adverse Event|2|||
48906700|NCT01159912|157494433|FG001|Overall Study|Adverse Event|2|||
48906701|NCT01159912|157494434|FG002|Overall Study|Adverse Event|3|||
48906702|NCT01159912|157494432|FG000|Overall Study|Lack of Efficacy|23|||
48906703|NCT01159912|157494433|FG001|Overall Study|Lack of Efficacy|15|||
48906704|NCT01159912|157494434|FG002|Overall Study|Lack of Efficacy|14|||
48906705|NCT01159912|157494432|FG000|Overall Study|Protocol Violation|1|||
48906706|NCT01159912|157494433|FG001|Overall Study|Protocol Violation|2|||
48906707|NCT01159912|157494434|FG002|Overall Study|Protocol Violation|3|||
48906708|NCT01159912|157494432|FG000|Overall Study|Lost to Follow-up|4|||
48906709|NCT01159912|157494433|FG001|Overall Study|Lost to Follow-up|0|||
48906710|NCT01159912|157494434|FG002|Overall Study|Lost to Follow-up|0|||
48906711|NCT01159912|157494432|FG000|Overall Study|Physician Decision|0|||
48906712|NCT01159912|157494433|FG001|Overall Study|Physician Decision|0|||
48906713|NCT01159912|157494434|FG002|Overall Study|Physician Decision|3|||
48906714|NCT01159912|157494432|FG000|Overall Study|Withdrawal by Subject|10|||
48906715|NCT01159912|157494433|FG001|Overall Study|Withdrawal by Subject|3|||
48906716|NCT01159912|157494434|FG002|Overall Study|Withdrawal by Subject|3|||
48906717|NCT03359590|157494436|FG000|First Intervention|Withdrawal by Subject|1|||
48906718|NCT03359590|157494437|FG001|First Intervention|Withdrawal by Subject|1|||
48906719|NCT03359590|157494436|FG000|First Intervention|Protocol Violation|0|||
48906720|NCT03359590|157494437|FG001|First Intervention|Protocol Violation|1|||
48906721|NCT04226833|157494438|FG000|Overall Study|Death|0|||
48906722|NCT04226833|157494439|FG001|Overall Study|Death|0|||
48906723|NCT04226833|157494440|FG002|Overall Study|Death|1|||
48906724|NCT04226833|157494441|FG003|Overall Study|Death|0|||
48906725|NCT04399122|157494442|FG000|Overall Study|Lost to Follow-up|2|||
48906726|NCT04399122|157494443|FG001|Overall Study|Lost to Follow-up|0|||
48906727|NCT04399122|157494442|FG000|Overall Study|Withdrawal by Subject|1|||
48906728|NCT04399122|157494443|FG001|Overall Study|Withdrawal by Subject|0|||
48906729|NCT01174238|157494447|FG000|Overall Study|Lost to Follow-up|2|||
48906730|NCT02301936|157494448|FG000|Overall Study|Lost to Follow-up|1|||
48906731|NCT02301936|157494449|FG001|Overall Study|Lost to Follow-up|0|||
48906732|NCT00898443|157494450|FG000|Overall Study|Withdrawal by Subject|1|||
48906733|NCT00898443|157494451|FG001|Overall Study|Withdrawal by Subject|0|||
48906734|NCT01050205|157494453|FG000|Overall Study|Lost to Follow-up|7|||
48906735|NCT01050205|157494454|FG001|Overall Study|Lost to Follow-up|1|||
48906736|NCT01050205|157494453|FG000|Overall Study|Withdrawal by Subject|1|||
48906737|NCT01050205|157494454|FG001|Overall Study|Withdrawal by Subject|1|||
48906738|NCT01050205|157494453|FG000|Overall Study|Relocated from area|1|||
48906739|NCT01050205|157494454|FG001|Overall Study|Relocated from area|2|||
48906740|NCT01050205|157494453|FG000|Overall Study|Discontinued Intervention|2|||
48906741|NCT01050205|157494454|FG001|Overall Study|Discontinued Intervention|0|||
48906742|NCT00375219|157494455|FG000|Overall Study|Failure to achieve a response|16|||
48906743|NCT00375219|157494456|FG001|Overall Study|Failure to achieve a response|2|||
48906744|NCT00375219|157494457|FG002|Overall Study|Failure to achieve a response|0|||
48906745|NCT00375219|157494455|FG000|Overall Study|Adverse Event|8|||
48906746|NCT00375219|157494456|FG001|Overall Study|Adverse Event|2|||
48906747|NCT00375219|157494457|FG002|Overall Study|Adverse Event|1|||
48906748|NCT00375219|157494455|FG000|Overall Study|Protocol Violation|1|||
48906749|NCT00375219|157494456|FG001|Overall Study|Protocol Violation|0|||
48906750|NCT00375219|157494457|FG002|Overall Study|Protocol Violation|1|||
48906751|NCT00375219|157494455|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|5|||
48906752|NCT00375219|157494456|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|3|||
48906753|NCT00375219|157494457|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|0|||
48906754|NCT00375219|157494455|FG000|Overall Study|Lost to Follow-up|1|||
48906755|NCT00375219|157494456|FG001|Overall Study|Lost to Follow-up|1|||
48906756|NCT00375219|157494457|FG002|Overall Study|Lost to Follow-up|0|||
48906757|NCT00375219|157494455|FG000|Overall Study|Disease progression|18|||
48906758|NCT00375219|157494456|FG001|Overall Study|Disease progression|9|||
48906759|NCT00375219|157494457|FG002|Overall Study|Disease progression|12|||
48906760|NCT00375219|157494455|FG000|Overall Study|Death|4|||
48906761|NCT00375219|157494456|FG001|Overall Study|Death|3|||
48906762|NCT00375219|157494457|FG002|Overall Study|Death|7|||
48906763|NCT00375219|157494455|FG000|Overall Study|Hematologic resistance|1|||
48906764|NCT00375219|157494456|FG001|Overall Study|Hematologic resistance|0|||
48906765|NCT00375219|157494457|FG002|Overall Study|Hematologic resistance|0|||
48906766|NCT00375219|157494455|FG000|Overall Study|Specific tyrosine kinase inhibitor avail|1|||
48906767|NCT00375219|157494456|FG001|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
48906768|NCT00375219|157494457|FG002|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
48906769|NCT00375219|157494455|FG000|Overall Study|Allograft|2|||
48906770|NCT00375219|157494456|FG001|Overall Study|Allograft|0|||
48906771|NCT00375219|157494457|FG002|Overall Study|Allograft|0|||
48906772|NCT00375219|157494455|FG000|Overall Study|Cord blood transplantation|1|||
48906773|NCT00375219|157494456|FG001|Overall Study|Cord blood transplantation|0|||
48906774|NCT00375219|157494457|FG002|Overall Study|Cord blood transplantation|0|||
48906775|NCT00375219|157494455|FG000|Overall Study|Withdrawal by Subject|1|||
48906776|NCT00375219|157494456|FG001|Overall Study|Withdrawal by Subject|0|||
48906777|NCT00375219|157494457|FG002|Overall Study|Withdrawal by Subject|0|||
48906778|NCT04029961|157494460|FG000|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1|||
48906779|NCT04029961|157494461|FG001|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0|||
48906780|NCT04029961|157494460|FG000|Overall Study|Change in Treatment Course|0|||
48906781|NCT04029961|157494461|FG001|Overall Study|Change in Treatment Course|1|||
48906782|NCT01557348|157494462|FG000|Overall Study|Adverse Event|6|||
48906783|NCT01557348|157494463|FG001|Overall Study|Adverse Event|16|||
48906784|NCT01557348|157494462|FG000|Overall Study|Infusion reaction event|5|||
48906785|NCT01557348|157494463|FG001|Overall Study|Infusion reaction event|5|||
48906786|NCT01557348|157494462|FG000|Overall Study|Death|7|||
48906787|NCT01557348|157494463|FG001|Overall Study|Death|4|||
48906788|NCT01557348|157494462|FG000|Overall Study|Insufficient Therapeutic Response|13|||
48906789|NCT01557348|157494463|FG001|Overall Study|Insufficient Therapeutic Response|28|||
48906790|NCT01557348|157494462|FG000|Overall Study|Withdrawal by Subject|5|||
48906791|NCT01557348|157494463|FG001|Overall Study|Withdrawal by Subject|4|||
48906792|NCT01557348|157494462|FG000|Overall Study|Lost to Follow-up|26|||
48906793|NCT01557348|157494463|FG001|Overall Study|Lost to Follow-up|22|||
48906794|NCT01557348|157494462|FG000|Overall Study|Administrative|18|||
48906795|NCT01557348|157494463|FG001|Overall Study|Administrative|11|||
48906796|NCT02684279|157494464|FG000|Overall Study|Adverse Event|87|||
48906797|NCT02684279|157494464|FG000|Overall Study|Lack of Efficacy|4|||
48906798|NCT02684279|157494464|FG000|Overall Study|Lost to Follow-up|61|||
48906799|NCT02684279|157494464|FG000|Overall Study|Protocol Violation|6|||
48906800|NCT02684279|157494464|FG000|Overall Study|Pregnancy|8|||
48906801|NCT02684279|157494464|FG000|Overall Study|Withdrawal by Subject|92|||
48906802|NCT02684279|157494464|FG000|Overall Study|non-compliance with study drug|9|||
48906803|NCT02684279|157494464|FG000|Overall Study|non compliance with study visits|2|||
48906804|NCT02684279|157494464|FG000|Overall Study|subject to have surgery|1|||
48906805|NCT02684279|157494464|FG000|Overall Study|family emergency|1|||
48906806|NCT02684279|157494464|FG000|Overall Study|Site closures|7|||
48906807|NCT02684279|157494464|FG000|Overall Study|Physician Decision|1|||
48906808|NCT00458341|157494465|FG000|Cycle 1|Adverse Event|1|||
48906809|NCT00458341|157494466|FG001|Cycle 1|Adverse Event|0|||
48906810|NCT01890148|157496554|FG000|Overall Study|Adverse Event|1|||
48906811|NCT02020863|157496555|FG000|Overall Study|Discovery of Metastatic disease|4|||
48906812|NCT02020863|157496555|FG000|Overall Study|Team chose not to place an a line|1|||
48906813|NCT01215175|157496556|FG000|Overall Study|Lost to Follow-up|0|||
48906814|NCT01215175|157496557|FG001|Overall Study|Lost to Follow-up|1|||
48906815|NCT01215175|157496558|FG002|Overall Study|Lost to Follow-up|0|||
48906816|NCT01215175|157496559|FG003|Overall Study|Lost to Follow-up|1|||
48906817|NCT01215175|157496560|FG004|Overall Study|Lost to Follow-up|0|||
48906818|NCT01016964|157496561|FG000|Overall Study|Lost to Follow-up|3|||
48906819|NCT01016964|157496562|FG001|Overall Study|Lost to Follow-up|3|||
48906820|NCT03872453|157496563|FG000|Overall Study|Adverse Event|1|||
48906821|NCT03872453|157496564|FG001|Overall Study|Adverse Event|1|||
48906822|NCT03872453|157496565|FG002|Overall Study|Adverse Event|0|||
48906823|NCT03872453|157496566|FG003|Overall Study|Adverse Event|0|||
48906824|NCT03872453|157496563|FG000|Overall Study|Lost to Follow-up|8|||
48906825|NCT03872453|157496564|FG001|Overall Study|Lost to Follow-up|7|||
48906826|NCT03872453|157496565|FG002|Overall Study|Lost to Follow-up|4|||
48906827|NCT03872453|157496566|FG003|Overall Study|Lost to Follow-up|4|||
48906828|NCT03872453|157496563|FG000|Overall Study|Never Treated Migraine|19|||
48906829|NCT03872453|157496564|FG001|Overall Study|Never Treated Migraine|17|||
48906830|NCT03872453|157496565|FG002|Overall Study|Never Treated Migraine|13|||
48906831|NCT03872453|157496566|FG003|Overall Study|Never Treated Migraine|12|||
48906832|NCT03872453|157496563|FG000|Overall Study|Pregnancy|1|||
48906833|NCT03872453|157496564|FG001|Overall Study|Pregnancy|0|||
48906834|NCT03872453|157496565|FG002|Overall Study|Pregnancy|0|||
48906835|NCT03872453|157496566|FG003|Overall Study|Pregnancy|0|||
48906836|NCT03872453|157496563|FG000|Overall Study|Protocol Deviation|2|||
48906837|NCT03872453|157496564|FG001|Overall Study|Protocol Deviation|0|||
48906838|NCT03872453|157496565|FG002|Overall Study|Protocol Deviation|0|||
48906839|NCT03872453|157496566|FG003|Overall Study|Protocol Deviation|2|||
48906840|NCT03872453|157496563|FG000|Overall Study|Withdrawal by Subject|0|||
48906841|NCT03872453|157496564|FG001|Overall Study|Withdrawal by Subject|1|||
48906842|NCT03872453|157496565|FG002|Overall Study|Withdrawal by Subject|2|||
48906843|NCT03872453|157496566|FG003|Overall Study|Withdrawal by Subject|0|||
48906844|NCT03872453|157496563|FG000|Overall Study|Other Than Specified|1|||
48906845|NCT03872453|157496564|FG001|Overall Study|Other Than Specified|0|||
48906846|NCT03872453|157496565|FG002|Overall Study|Other Than Specified|0|||
48906847|NCT03872453|157496566|FG003|Overall Study|Other Than Specified|0|||
48906848|NCT01920594|157496567|FG000|Overall Study|Adverse Event|4|||
48906849|NCT01920594|157496568|FG001|Overall Study|Adverse Event|2|||
48906850|NCT01920594|157496567|FG000|Overall Study|Lost to Follow-up|1|||
48906851|NCT01920594|157496568|FG001|Overall Study|Lost to Follow-up|0|||
48906852|NCT01920594|157496567|FG000|Overall Study|Recovery|2|||
48906853|NCT01920594|157496568|FG001|Overall Study|Recovery|0|||
48906854|NCT01920594|157496567|FG000|Overall Study|Investigator discretion|0|||
48906855|NCT01920594|157496568|FG001|Overall Study|Investigator discretion|1|||
48906856|NCT01176968|157496578|FG000|Overall Study|Adverse Event|10|||
48906857|NCT01176968|157496579|FG001|Overall Study|Adverse Event|11|||
48906858|NCT01176968|157496578|FG000|Overall Study|Death|2|||
48906859|NCT01176968|157496579|FG001|Overall Study|Death|3|||
48906860|NCT01176968|157496578|FG000|Overall Study|Lack of Efficacy|0|||
48906861|NCT01176968|157496579|FG001|Overall Study|Lack of Efficacy|1|||
48906862|NCT01176968|157496578|FG000|Overall Study|Lost to Follow-up|16|||
48906863|NCT01176968|157496579|FG001|Overall Study|Lost to Follow-up|14|||
48906864|NCT01176968|157496578|FG000|Overall Study|Withdrawal by Subject|48|||
48906865|NCT01176968|157496579|FG001|Overall Study|Withdrawal by Subject|48|||
48906866|NCT01176968|157496578|FG000|Overall Study|Protocol Violation|2|||
48906867|NCT01176968|157496579|FG001|Overall Study|Protocol Violation|1|||
48906868|NCT01176968|157496578|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
48906869|NCT01176968|157496579|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
48906870|NCT01176968|157496578|FG000|Overall Study|Study terminated by sponsor|0|||
48906871|NCT01176968|157496579|FG001|Overall Study|Study terminated by sponsor|1|||
48906872|NCT01176968|157496578|FG000|Overall Study|Reason not defined|5|||
48906873|NCT01176968|157496579|FG001|Overall Study|Reason not defined|3|||
48906874|NCT00818389|157496586|FG000|Overall Study|Death|1|||
48906875|NCT00818389|157496587|FG001|Overall Study|Death|3|||
48906876|NCT00818389|157496586|FG000|Overall Study|ALS Disease Progression|1|||
48906877|NCT00818389|157496587|FG001|Overall Study|ALS Disease Progression|0|||
48906878|NCT00818389|157496586|FG000|Overall Study|Withdrawal by Subject|2|||
48906879|NCT00818389|157496587|FG001|Overall Study|Withdrawal by Subject|2|||
48906880|NCT00818389|157496586|FG000|Overall Study|Adverse Event|0|||
48906881|NCT00818389|157496587|FG001|Overall Study|Adverse Event|1|||
48906882|NCT01137955|157496588|FG000|Overall Study|Withdrawal by Subject|5|||
48906883|NCT01137955|157496589|FG001|Overall Study|Withdrawal by Subject|4|||
48906884|NCT03953508|157496590|FG000|Baseline|Lost to Follow-up|3|||
48906885|NCT03953508|157496591|FG001|Baseline|Lost to Follow-up|2|||
48906886|NCT03953508|157496590|FG000|6-month Follow-up|Lost to Follow-up|62|||
48906887|NCT03953508|157496591|FG001|6-month Follow-up|Lost to Follow-up|70|||
48906888|NCT03678103|157496594|FG000|Overall Study|Withdrawn prior to completion|4|||
48906889|NCT00975715|157496595|FG000|Titration Period|Adverse Event|6|||
48906890|NCT00975715|157496596|FG001|Titration Period|Adverse Event|0|||
48906891|NCT00975715|157496595|FG000|Titration Period|Protocol Violation|1|||
48906892|NCT00975715|157496596|FG001|Titration Period|Protocol Violation|0|||
48906893|NCT00975715|157496595|FG000|Maintenance Period|Adverse Event|2|||
48906894|NCT00975715|157496596|FG001|Maintenance Period|Adverse Event|1|||
48906895|NCT01241552|157496597|FG000|Overall Study|Lack of Efficacy|1|||
48906896|NCT01241552|157496598|FG001|Overall Study|Lack of Efficacy|0|||
48906897|NCT01241552|157496599|FG002|Overall Study|Lack of Efficacy|0|||
48906898|NCT01241552|157496600|FG003|Overall Study|Lack of Efficacy|0|||
48906899|NCT01241552|157496597|FG000|Overall Study|Death|26|||
48906900|NCT01241552|157496598|FG001|Overall Study|Death|30|||
48906901|NCT01241552|157496599|FG002|Overall Study|Death|20|||
48906902|NCT01241552|157496600|FG003|Overall Study|Death|25|||
48906903|NCT01241552|157496597|FG000|Overall Study|Adverse Event|1|||
48906904|NCT01241552|157496598|FG001|Overall Study|Adverse Event|1|||
48906905|NCT01241552|157496599|FG002|Overall Study|Adverse Event|0|||
48906906|NCT01241552|157496600|FG003|Overall Study|Adverse Event|0|||
48906907|NCT01241552|157496597|FG000|Overall Study|Technical Problems|2|||
48906908|NCT01241552|157496598|FG001|Overall Study|Technical Problems|0|||
48906909|NCT01241552|157496599|FG002|Overall Study|Technical Problems|2|||
48906910|NCT01241552|157496600|FG003|Overall Study|Technical Problems|2|||
48906911|NCT01241552|157496597|FG000|Overall Study|Progressive Disease|0|||
48906912|NCT01241552|157496598|FG001|Overall Study|Progressive Disease|0|||
48906913|NCT01241552|157496599|FG002|Overall Study|Progressive Disease|1|||
48906914|NCT01241552|157496600|FG003|Overall Study|Progressive Disease|2|||
48906915|NCT01241552|157496597|FG000|Overall Study|Protocol Violation|0|||
48906916|NCT01241552|157496598|FG001|Overall Study|Protocol Violation|2|||
48906917|NCT01241552|157496599|FG002|Overall Study|Protocol Violation|6|||
48906918|NCT01241552|157496600|FG003|Overall Study|Protocol Violation|1|||
48906919|NCT01241552|157496597|FG000|Overall Study|Withdrawal by Subject|7|||
48906920|NCT01241552|157496598|FG001|Overall Study|Withdrawal by Subject|15|||
48906921|NCT01241552|157496599|FG002|Overall Study|Withdrawal by Subject|14|||
48906922|NCT01241552|157496600|FG003|Overall Study|Withdrawal by Subject|15|||
48906923|NCT01241552|157496597|FG000|Overall Study|Physician Decision|2|||
48906924|NCT01241552|157496598|FG001|Overall Study|Physician Decision|4|||
48906925|NCT01241552|157496599|FG002|Overall Study|Physician Decision|2|||
48906926|NCT01241552|157496600|FG003|Overall Study|Physician Decision|3|||
48906927|NCT01241552|157496597|FG000|Overall Study|Lost to Follow-up|2|||
48906928|NCT01241552|157496598|FG001|Overall Study|Lost to Follow-up|11|||
48906929|NCT01241552|157496599|FG002|Overall Study|Lost to Follow-up|15|||
48906930|NCT01241552|157496600|FG003|Overall Study|Lost to Follow-up|16|||
48906931|NCT00528866|157496601|FG000|Overall Study|Protocol Violation|6|||
48906932|NCT01674712|157496602|FG000|Overall Study|Adverse Event|5|||
48906933|NCT01674712|157496603|FG001|Overall Study|Adverse Event|6|||
48906934|NCT01674712|157496604|FG002|Overall Study|Adverse Event|3|||
48906935|NCT01674712|157496605|FG003|Overall Study|Adverse Event|4|||
48906936|NCT01674712|157496606|FG004|Overall Study|Adverse Event|6|||
48906937|NCT01674712|157496602|FG000|Overall Study|Lost to Follow-up|1|||
48906938|NCT01674712|157496603|FG001|Overall Study|Lost to Follow-up|0|||
48906939|NCT01674712|157496604|FG002|Overall Study|Lost to Follow-up|0|||
48906940|NCT01674712|157496605|FG003|Overall Study|Lost to Follow-up|0|||
48906941|NCT01674712|157496606|FG004|Overall Study|Lost to Follow-up|0|||
48906942|NCT01674712|157496602|FG000|Overall Study|Protocol Violation|2|||
48906943|NCT01674712|157496603|FG001|Overall Study|Protocol Violation|0|||
48906944|NCT01674712|157496604|FG002|Overall Study|Protocol Violation|0|||
48906945|NCT01674712|157496605|FG003|Overall Study|Protocol Violation|0|||
48906946|NCT01674712|157496606|FG004|Overall Study|Protocol Violation|0|||
48906947|NCT01674712|157496602|FG000|Overall Study|Withdrawal by Subject|2|||
48906948|NCT01674712|157496603|FG001|Overall Study|Withdrawal by Subject|2|||
48906949|NCT01674712|157496604|FG002|Overall Study|Withdrawal by Subject|5|||
48906950|NCT01674712|157496605|FG003|Overall Study|Withdrawal by Subject|4|||
48906951|NCT01674712|157496606|FG004|Overall Study|Withdrawal by Subject|3|||
48906952|NCT01674712|157496602|FG000|Overall Study|Administrative|0|||
48906953|NCT01674712|157496603|FG001|Overall Study|Administrative|1|||
48906954|NCT01674712|157496604|FG002|Overall Study|Administrative|0|||
48906955|NCT01674712|157496605|FG003|Overall Study|Administrative|0|||
48906956|NCT01674712|157496606|FG004|Overall Study|Administrative|1|||
48906957|NCT01674712|157496602|FG000|Overall Study|Lack of Efficacy|0|||
48906958|NCT01674712|157496603|FG001|Overall Study|Lack of Efficacy|0|||
48906959|NCT01674712|157496604|FG002|Overall Study|Lack of Efficacy|1|||
48906960|NCT01674712|157496605|FG003|Overall Study|Lack of Efficacy|0|||
48906961|NCT01674712|157496606|FG004|Overall Study|Lack of Efficacy|1|||
48906962|NCT00233363|157496607|FG000|Overall Study|Adverse Event|1|||
48906963|NCT00233363|157496608|FG001|Overall Study|Adverse Event|2|||
48906964|NCT00233363|157496607|FG000|Overall Study|Lack of Efficacy|0|||
48906965|NCT00233363|157496608|FG001|Overall Study|Lack of Efficacy|2|||
48906966|NCT00233363|157496607|FG000|Overall Study|Withdrawal by Subject|1|||
48906967|NCT00233363|157496608|FG001|Overall Study|Withdrawal by Subject|1|||
48906968|NCT00233363|157496607|FG000|Overall Study|Aggravation of complication|1|||
48906969|NCT00233363|157496608|FG001|Overall Study|Aggravation of complication|0|||
48906970|NCT00993915|157496609|FG000|Overall Study|Insufficient clinical response|3|||
48906971|NCT00993915|157496609|FG000|Overall Study|Withdrawal by Subject|2|||
48906972|NCT00993915|157496609|FG000|Overall Study|Other|1|||
48906973|NCT00993915|157496609|FG000|Overall Study|Ongoing|3|||
48906974|NCT01526551|157496610|FG000|Overall Study|Lack of returned parental consent form|424|||
48906975|NCT00146757|157496611|FG000|Overall Study|Death|1|||
48694944|NCT03115359|156732111|FG000|Overall Study|Transportation barriers|3|||
48694945|NCT03115359|156732112|FG001|Overall Study|Transportation barriers|0|||
48906976|NCT00146757|157496612|FG001|Overall Study|Death|0|||
48906977|NCT00146757|157496611|FG000|Overall Study|Adverse Event|1|||
48906978|NCT00146757|157496612|FG001|Overall Study|Adverse Event|0|||
48906979|NCT01970488|157496613|FG000|Part 1: Through Week 16|Protocol-specified Criteria|1|||
48906980|NCT01970488|157496614|FG001|Part 1: Through Week 16|Protocol-specified Criteria|2|||
48906981|NCT01970488|157496615|FG002|Part 1: Through Week 16|Protocol-specified Criteria|0|||
48906982|NCT01970488|157496616|FG003|Part 1: Through Week 16|Protocol-specified Criteria|0|||
48906983|NCT01970488|157496617|FG004|Part 1: Through Week 16|Protocol-specified Criteria|0|||
49010517|NCT00926289|157875639|FG000|Overall Study|Protocol Violation|8|||
48906984|NCT01970488|157496613|FG000|Part 1: Through Week 16|Protocol Violation|1|||
48906985|NCT01970488|157496614|FG001|Part 1: Through Week 16|Protocol Violation|2|||
48906986|NCT01970488|157496615|FG002|Part 1: Through Week 16|Protocol Violation|0|||
48906987|NCT01970488|157496616|FG003|Part 1: Through Week 16|Protocol Violation|0|||
48906988|NCT01970488|157496617|FG004|Part 1: Through Week 16|Protocol Violation|0|||
48906989|NCT01970488|157496613|FG000|Part 1: Through Week 16|Adverse Event|6|||
48906990|NCT01970488|157496614|FG001|Part 1: Through Week 16|Adverse Event|5|||
48906991|NCT01970488|157496615|FG002|Part 1: Through Week 16|Adverse Event|0|||
48906992|NCT01970488|157496616|FG003|Part 1: Through Week 16|Adverse Event|0|||
48906993|NCT01970488|157496617|FG004|Part 1: Through Week 16|Adverse Event|0|||
48906994|NCT01970488|157496613|FG000|Part 1: Through Week 16|Withdrawal by Subject|3|||
48906995|NCT01970488|157496614|FG001|Part 1: Through Week 16|Withdrawal by Subject|2|||
48906996|NCT01970488|157496615|FG002|Part 1: Through Week 16|Withdrawal by Subject|0|||
48906997|NCT01970488|157496616|FG003|Part 1: Through Week 16|Withdrawal by Subject|0|||
48906998|NCT01970488|157496617|FG004|Part 1: Through Week 16|Withdrawal by Subject|0|||
48906999|NCT01970488|157496613|FG000|Part 1: Through Week 16|Lost to Follow-up|0|||
48907000|NCT01970488|157496614|FG001|Part 1: Through Week 16|Lost to Follow-up|2|||
48907001|NCT01970488|157496615|FG002|Part 1: Through Week 16|Lost to Follow-up|0|||
48907002|NCT01970488|157496616|FG003|Part 1: Through Week 16|Lost to Follow-up|0|||
48907003|NCT01970488|157496617|FG004|Part 1: Through Week 16|Lost to Follow-up|0|||
48907004|NCT01970488|157496613|FG000|Part 2: Post Week 16|Physician Decision|0|||
48907005|NCT01970488|157496614|FG001|Part 2: Post Week 16|Physician Decision|0|||
48907006|NCT01970488|157496615|FG002|Part 2: Post Week 16|Physician Decision|0|||
48907007|NCT01970488|157496616|FG003|Part 2: Post Week 16|Physician Decision|0|||
48907008|NCT01970488|157496617|FG004|Part 2: Post Week 16|Physician Decision|1|||
48907009|NCT01970488|157496613|FG000|Part 2: Post Week 16|Non-compliance|0|||
48907010|NCT01970488|157496614|FG001|Part 2: Post Week 16|Non-compliance|0|||
48907011|NCT01970488|157496615|FG002|Part 2: Post Week 16|Non-compliance|1|||
48907012|NCT01970488|157496616|FG003|Part 2: Post Week 16|Non-compliance|0|||
48907013|NCT01970488|157496617|FG004|Part 2: Post Week 16|Non-compliance|0|||
48907014|NCT01970488|157496613|FG000|Part 2: Post Week 16|Lack of Efficacy|0|||
48907015|NCT01970488|157496614|FG001|Part 2: Post Week 16|Lack of Efficacy|0|||
48907016|NCT01970488|157496615|FG002|Part 2: Post Week 16|Lack of Efficacy|2|||
48907017|NCT01970488|157496616|FG003|Part 2: Post Week 16|Lack of Efficacy|3|||
48907018|NCT01970488|157496617|FG004|Part 2: Post Week 16|Lack of Efficacy|1|||
48907019|NCT01970488|157496613|FG000|Part 2: Post Week 16|Adverse Event|0|||
48907020|NCT01970488|157496614|FG001|Part 2: Post Week 16|Adverse Event|0|||
48907021|NCT01970488|157496615|FG002|Part 2: Post Week 16|Adverse Event|5|||
48907022|NCT01970488|157496616|FG003|Part 2: Post Week 16|Adverse Event|1|||
48907023|NCT01970488|157496617|FG004|Part 2: Post Week 16|Adverse Event|1|||
48907024|NCT01970488|157496613|FG000|Part 2: Post Week 16|Withdrawal by Subject|0|||
48907025|NCT01970488|157496614|FG001|Part 2: Post Week 16|Withdrawal by Subject|0|||
48907026|NCT01970488|157496615|FG002|Part 2: Post Week 16|Withdrawal by Subject|8|||
48907027|NCT01970488|157496616|FG003|Part 2: Post Week 16|Withdrawal by Subject|3|||
48907028|NCT01970488|157496617|FG004|Part 2: Post Week 16|Withdrawal by Subject|3|||
48907029|NCT01970488|157496613|FG000|Part 2: Post Week 16|Lost to Follow-up|0|||
48907030|NCT01970488|157496614|FG001|Part 2: Post Week 16|Lost to Follow-up|0|||
48907031|NCT01970488|157496615|FG002|Part 2: Post Week 16|Lost to Follow-up|1|||
48907032|NCT01970488|157496616|FG003|Part 2: Post Week 16|Lost to Follow-up|1|||
48907033|NCT01970488|157496617|FG004|Part 2: Post Week 16|Lost to Follow-up|2|||
48907034|NCT01287364|157496620|FG000|Overall Study|Adverse Event|0|||
48907035|NCT01287364|157496621|FG001|Overall Study|Adverse Event|3|||
48907036|NCT01287364|157496620|FG000|Overall Study|Protocol Violation|5|||
48907037|NCT01287364|157496621|FG001|Overall Study|Protocol Violation|5|||
48907038|NCT01287364|157496620|FG000|Overall Study|Other Reason|4|||
48907039|NCT01287364|157496621|FG001|Overall Study|Other Reason|2|||
48907040|NCT00769860|157496622|FG000|Overall Study|Withdrawal by Subject|2|||
48907041|NCT00769860|157496623|FG001|Overall Study|Withdrawal by Subject|0|||
48907042|NCT01026142|157496624|FG000|Overall Study|Death|136|||
48907043|NCT01026142|157496625|FG001|Overall Study|Death|134|||
48907044|NCT01026142|157496624|FG000|Overall Study|Withdrew consent or lost to follow-up|36|||
48907045|NCT01026142|157496625|FG001|Overall Study|Withdrew consent or lost to follow-up|29|||
48907046|NCT01641809|157496626|FG000|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
48907047|NCT01641809|157496627|FG001|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
48907048|NCT01641809|157496628|FG002|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0|||
48907049|NCT01641809|157496629|FG003|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
48907050|NCT01641809|157496626|FG000|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
48907051|NCT01641809|157496627|FG001|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
48907052|NCT01641809|157496628|FG002|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
48907053|NCT01641809|157496629|FG003|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
48907054|NCT01641809|157496626|FG000|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1|||
48907055|NCT01641809|157496627|FG001|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2|||
48907056|NCT01641809|157496628|FG002|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0|||
48694946|NCT03115359|156732111|FG000|Overall Study|No longer interested|5|||
48694947|NCT03115359|156732112|FG001|Overall Study|No longer interested|4|||
48694948|NCT03115359|156732111|FG000|Overall Study|No reason provided|45|||
48694949|NCT03115359|156732112|FG001|Overall Study|No reason provided|47|||
48694950|NCT01731912|156732113|FG000|Overall Study|noncompliance|2|||
48694951|NCT01169103|156732114|FG000|Overall Study|Lost to Follow-up|3|||
48694952|NCT01169103|156732115|FG001|Overall Study|Lost to Follow-up|3|||
48694953|NCT01169103|156732114|FG000|Overall Study|Withdrawal by Subject|3|||
48694954|NCT01169103|156732115|FG001|Overall Study|Withdrawal by Subject|1|||
48694955|NCT03192176|156732120|FG000|Overall Study|Adverse Event|1|||
48694956|NCT03192176|156732121|FG001|Overall Study|Adverse Event|0|||
48694957|NCT03192176|156732122|FG002|Overall Study|Adverse Event|4|||
48694958|NCT03192176|156732123|FG003|Overall Study|Adverse Event|5|||
48694959|NCT03192176|156732124|FG004|Overall Study|Adverse Event|3|||
48694960|NCT03192176|156732125|FG005|Overall Study|Adverse Event|2|||
48694961|NCT03192176|156732126|FG006|Overall Study|Adverse Event|3|||
48694962|NCT03192176|156732127|FG007|Overall Study|Adverse Event|3|||
48694963|NCT03192176|156732120|FG000|Overall Study|Lost to Follow-up|0|||
48694964|NCT03192176|156732121|FG001|Overall Study|Lost to Follow-up|0|||
48694965|NCT03192176|156732122|FG002|Overall Study|Lost to Follow-up|1|||
48694966|NCT03192176|156732123|FG003|Overall Study|Lost to Follow-up|2|||
48694967|NCT03192176|156732124|FG004|Overall Study|Lost to Follow-up|3|||
48694968|NCT03192176|156732125|FG005|Overall Study|Lost to Follow-up|1|||
48694969|NCT03192176|156732126|FG006|Overall Study|Lost to Follow-up|1|||
48694970|NCT03192176|156732127|FG007|Overall Study|Lost to Follow-up|1|||
48694971|NCT03192176|156732120|FG000|Overall Study|Physician Decision|1|||
48694972|NCT03192176|156732121|FG001|Overall Study|Physician Decision|0|||
48694973|NCT03192176|156732122|FG002|Overall Study|Physician Decision|0|||
48694974|NCT03192176|156732123|FG003|Overall Study|Physician Decision|0|||
48694975|NCT03192176|156732124|FG004|Overall Study|Physician Decision|0|||
48694976|NCT03192176|156732125|FG005|Overall Study|Physician Decision|2|||
48694977|NCT03192176|156732126|FG006|Overall Study|Physician Decision|1|||
48694978|NCT03192176|156732127|FG007|Overall Study|Physician Decision|0|||
48694979|NCT03192176|156732120|FG000|Overall Study|Protocol Deviation|1|||
48694980|NCT03192176|156732121|FG001|Overall Study|Protocol Deviation|1|||
48694981|NCT03192176|156732122|FG002|Overall Study|Protocol Deviation|0|||
48694982|NCT03192176|156732123|FG003|Overall Study|Protocol Deviation|0|||
48694983|NCT03192176|156732124|FG004|Overall Study|Protocol Deviation|2|||
48694984|NCT03192176|156732125|FG005|Overall Study|Protocol Deviation|0|||
48694985|NCT03192176|156732126|FG006|Overall Study|Protocol Deviation|0|||
48694986|NCT03192176|156732127|FG007|Overall Study|Protocol Deviation|0|||
48694987|NCT03192176|156732120|FG000|Overall Study|Withdrawal by Subject|3|||
48694988|NCT03192176|156732121|FG001|Overall Study|Withdrawal by Subject|4|||
48694989|NCT03192176|156732122|FG002|Overall Study|Withdrawal by Subject|0|||
48694990|NCT03192176|156732123|FG003|Overall Study|Withdrawal by Subject|4|||
48694991|NCT03192176|156732124|FG004|Overall Study|Withdrawal by Subject|3|||
48694992|NCT03192176|156732125|FG005|Overall Study|Withdrawal by Subject|4|||
48694993|NCT03192176|156732126|FG006|Overall Study|Withdrawal by Subject|4|||
48694994|NCT03192176|156732127|FG007|Overall Study|Withdrawal by Subject|2|||
48694995|NCT03192176|156732120|FG000|Overall Study|Miscellaneous|1|||
48694996|NCT03192176|156732121|FG001|Overall Study|Miscellaneous|0|||
48694997|NCT03192176|156732122|FG002|Overall Study|Miscellaneous|1|||
48694998|NCT03192176|156732123|FG003|Overall Study|Miscellaneous|1|||
48694999|NCT03192176|156732124|FG004|Overall Study|Miscellaneous|1|||
48695000|NCT03192176|156732125|FG005|Overall Study|Miscellaneous|2|||
48695001|NCT03192176|156732126|FG006|Overall Study|Miscellaneous|0|||
48695002|NCT03192176|156732127|FG007|Overall Study|Miscellaneous|1|||
48695003|NCT03532542|156732128|FG000|Overall Study|Death|1|||
48695004|NCT03532542|156732129|FG001|Overall Study|Death|0|||
48695005|NCT03532542|156732128|FG000|Overall Study|Study Terminated by Sponsor|41|||
48695006|NCT03532542|156732129|FG001|Overall Study|Study Terminated by Sponsor|65|||
48695007|NCT03532542|156732128|FG000|Overall Study|Withdrawal by Subject|6|||
48695008|NCT03532542|156732129|FG001|Overall Study|Withdrawal by Subject|5|||
48695009|NCT00614575|156732132|FG000|Overall Study|Adverse Event|106|||
48695010|NCT00614575|156732132|FG000|Overall Study|Lost to Follow-up|55|||
48695011|NCT00614575|156732132|FG000|Overall Study|Lack of Efficacy|14|||
48695012|NCT00614575|156732132|FG000|Overall Study|Withdrawal by Subject|6|||
48695013|NCT00614575|156732132|FG000|Overall Study|Death|3|||
48695014|NCT00614575|156732132|FG000|Overall Study|Physician Decision|2|||
48695015|NCT00614575|156732132|FG000|Overall Study|No data were collected.|18|||
48695016|NCT00614575|156732132|FG000|Overall Study|Irregularly enrolled patients|23|||
48695017|NCT00614575|156732132|FG000|Overall Study|No treatment|1|||
48695018|NCT03452540|156732133|FG000|Overall Study|Adverse Event|1|||
48695019|NCT03452540|156732133|FG000|Overall Study|Withdrawal by Subject|1|||
48695020|NCT03452540|156732133|FG000|Overall Study|Other SAE and AE|2|||
48695021|NCT01045460|156732142|FG000|Overall Study|Physician Decision|3|||
48695022|NCT01045460|156732143|FG001|Overall Study|Physician Decision|2|||
48695023|NCT01045460|156732142|FG000|Overall Study|Lost to Follow-up|0|||
48695024|NCT01045460|156732143|FG001|Overall Study|Lost to Follow-up|1|||
48695025|NCT01045460|156732142|FG000|Overall Study|Lack of Efficacy|3|||
48907057|NCT01641809|157496629|FG003|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3|||
48907058|NCT01641809|157496626|FG000|Induction Phase (Day 1 to Week 24)|Protocol Violation|2|||
48907059|NCT01641809|157496627|FG001|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
48907060|NCT01641809|157496628|FG002|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
48907061|NCT01641809|157496629|FG003|Induction Phase (Day 1 to Week 24)|Protocol Violation|0|||
48907062|NCT01641809|157496626|FG000|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4|||
48907063|NCT01641809|157496627|FG001|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1|||
48907064|NCT01641809|157496628|FG002|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2|||
48907065|NCT01641809|157496629|FG003|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3|||
48907066|NCT01641809|157496626|FG000|Induction Phase (Day 1 to Week 24)|Adverse Event|0|||
48907067|NCT01641809|157496627|FG001|Induction Phase (Day 1 to Week 24)|Adverse Event|1|||
48907068|NCT01641809|157496628|FG002|Induction Phase (Day 1 to Week 24)|Adverse Event|3|||
48907069|NCT01641809|157496629|FG003|Induction Phase (Day 1 to Week 24)|Adverse Event|7|||
48907070|NCT01641809|157496626|FG000|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2|||
48907071|NCT01641809|157496627|FG001|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3|||
48907072|NCT01641809|157496628|FG002|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1|||
48907073|NCT01641809|157496629|FG003|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0|||
48907074|NCT01641809|157496626|FG000|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
48907075|NCT01641809|157496627|FG001|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1|||
48907076|NCT01641809|157496628|FG002|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
48907077|NCT01641809|157496629|FG003|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
48907078|NCT01641809|157496626|FG000|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
48907079|NCT01641809|157496627|FG001|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0|||
48907080|NCT01641809|157496628|FG002|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1|||
48907081|NCT01641809|157496629|FG003|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
48907082|NCT01641809|157496626|FG000|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
48907083|NCT01641809|157496627|FG001|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
48907084|NCT01641809|157496628|FG002|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0|||
48907085|NCT01641809|157496629|FG003|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2|||
48907086|NCT01641809|157496626|FG000|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
48907087|NCT01641809|157496627|FG001|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0|||
48907088|NCT01641809|157496628|FG002|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
48907089|NCT01641809|157496629|FG003|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2|||
48907090|NCT01641809|157496626|FG000|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2|||
48907091|NCT01641809|157496627|FG001|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3|||
48907092|NCT01641809|157496628|FG002|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1|||
48907093|NCT01641809|157496629|FG003|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0|||
48907094|NCT01641809|157496626|FG000|Open-label (Week 96 to Week 324)|Physician Decision|0|||
48907095|NCT01641809|157496627|FG001|Open-label (Week 96 to Week 324)|Physician Decision|1|||
48907096|NCT01641809|157496628|FG002|Open-label (Week 96 to Week 324)|Physician Decision|1|||
48907097|NCT01641809|157496629|FG003|Open-label (Week 96 to Week 324)|Physician Decision|0|||
48907098|NCT01641809|157496626|FG000|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
48907099|NCT01641809|157496627|FG001|Open-label (Week 96 to Week 324)|Lost to Follow-up|4|||
48907100|NCT01641809|157496628|FG002|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
48907101|NCT01641809|157496629|FG003|Open-label (Week 96 to Week 324)|Lost to Follow-up|0|||
48907102|NCT01641809|157496626|FG000|Open-label (Week 96 to Week 324)|Site closed|1|||
48907103|NCT01641809|157496627|FG001|Open-label (Week 96 to Week 324)|Site closed|0|||
48907104|NCT01641809|157496628|FG002|Open-label (Week 96 to Week 324)|Site closed|0|||
48907105|NCT01641809|157496629|FG003|Open-label (Week 96 to Week 324)|Site closed|0|||
48907106|NCT01641809|157496626|FG000|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
48907107|NCT01641809|157496627|FG001|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
48907108|NCT01641809|157496628|FG002|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
48907109|NCT01641809|157496629|FG003|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
48907110|NCT01641809|157496626|FG000|Open-label (Week 96 to Week 324)|Lack of Efficacy|4|||
48907111|NCT01641809|157496627|FG001|Open-label (Week 96 to Week 324)|Lack of Efficacy|1|||
48907112|NCT01641809|157496628|FG002|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
48907113|NCT01641809|157496629|FG003|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
48907114|NCT01641809|157496626|FG000|Open-label (Week 96 to Week 324)|Adverse Event|3|||
48907115|NCT01641809|157496627|FG001|Open-label (Week 96 to Week 324)|Adverse Event|2|||
48907116|NCT01641809|157496628|FG002|Open-label (Week 96 to Week 324)|Adverse Event|1|||
48907117|NCT01641809|157496629|FG003|Open-label (Week 96 to Week 324)|Adverse Event|0|||
48907118|NCT01294683|157496630|FG000|Precrossover (Periods I/II)|Adverse Event|49|||
48907119|NCT01294683|157496631|FG001|Precrossover (Periods I/II)|Adverse Event|52|||
49116281|NCT01607346|158263085|FG000|Overall Study|Adverse Event|3|||
49116282|NCT00534638|158263086|FG000|Overall Study|Withdrawal by Subject|3|||
48907120|NCT01294683|157496630|FG000|Precrossover (Periods I/II)|Lost to Follow-up|3|||
49116283|NCT00534638|158263087|FG001|Overall Study|Withdrawal by Subject|4|||
48907121|NCT01294683|157496631|FG001|Precrossover (Periods I/II)|Lost to Follow-up|6|||
48907122|NCT01294683|157496630|FG000|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
48907123|NCT01294683|157496631|FG001|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
48907124|NCT01294683|157496630|FG000|Precrossover (Periods I/II)|Physician Decision|1|||
48907125|NCT01294683|157496631|FG001|Precrossover (Periods I/II)|Physician Decision|0|||
48907126|NCT01294683|157496630|FG000|Precrossover (Periods I/II)|Protocol Violation|5|||
48907127|NCT01294683|157496631|FG001|Precrossover (Periods I/II)|Protocol Violation|5|||
48907128|NCT01294683|157496630|FG000|Precrossover (Periods I/II)|Study Terminated by Sponsor|187|||
48907129|NCT01294683|157496631|FG001|Precrossover (Periods I/II)|Study Terminated by Sponsor|192|||
48907130|NCT01294683|157496630|FG000|Precrossover (Periods I/II)|Technical Problems|0|||
48907131|NCT01294683|157496631|FG001|Precrossover (Periods I/II)|Technical Problems|1|||
48907132|NCT01294683|157496630|FG000|Precrossover (Periods I/II)|Withdrawal by Subject|11|||
48907133|NCT01294683|157496631|FG001|Precrossover (Periods I/II)|Withdrawal by Subject|9|||
48907134|NCT01294683|157496630|FG000|Post Crossover (Period III)|Adverse Event|6|||
48907135|NCT01294683|157496631|FG001|Post Crossover (Period III)|Adverse Event|6|||
48907136|NCT01294683|157496630|FG000|Post Crossover (Period III)|Lost to Follow-up|1|||
48907137|NCT01294683|157496631|FG001|Post Crossover (Period III)|Lost to Follow-up|3|||
48907138|NCT01294683|157496630|FG000|Post Crossover (Period III)|Study Terminated by Sponsor|23|||
48907139|NCT01294683|157496631|FG001|Post Crossover (Period III)|Study Terminated by Sponsor|21|||
48907140|NCT01294683|157496630|FG000|Post Crossover (Period III)|Withdrawal by Subject|3|||
48907141|NCT01294683|157496631|FG001|Post Crossover (Period III)|Withdrawal by Subject|2|||
48907142|NCT01749540|157496632|FG000|Overall Study|Protocol Violation|0|||
48907143|NCT01749540|157496633|FG001|Overall Study|Protocol Violation|0|||
48907144|NCT01749540|157496634|FG002|Overall Study|Protocol Violation|0|||
48907145|NCT01749540|157496635|FG003|Overall Study|Protocol Violation|0|||
48907146|NCT01749540|157496636|FG004|Overall Study|Protocol Violation|0|||
48907147|NCT01749540|157496637|FG005|Overall Study|Protocol Violation|1|||
48907148|NCT01749540|157496638|FG006|Overall Study|Protocol Violation|1|||
48907149|NCT01749540|157496632|FG000|Overall Study|Withdrawal by Subject|0|||
48907150|NCT01749540|157496633|FG001|Overall Study|Withdrawal by Subject|0|||
48907151|NCT01749540|157496634|FG002|Overall Study|Withdrawal by Subject|0|||
48907152|NCT01749540|157496635|FG003|Overall Study|Withdrawal by Subject|1|||
48907153|NCT01749540|157496636|FG004|Overall Study|Withdrawal by Subject|0|||
48907154|NCT01749540|157496637|FG005|Overall Study|Withdrawal by Subject|0|||
48907155|NCT01749540|157496638|FG006|Overall Study|Withdrawal by Subject|0|||
48907156|NCT01749540|157496632|FG000|Overall Study|Initiated into extension study A536-06|0|||
48907157|NCT01749540|157496633|FG001|Overall Study|Initiated into extension study A536-06|0|||
48907158|NCT01749540|157496634|FG002|Overall Study|Initiated into extension study A536-06|0|||
48907159|NCT01749540|157496635|FG003|Overall Study|Initiated into extension study A536-06|0|||
48907160|NCT01749540|157496636|FG004|Overall Study|Initiated into extension study A536-06|0|||
48907161|NCT01749540|157496637|FG005|Overall Study|Initiated into extension study A536-06|2|||
48907162|NCT01749540|157496638|FG006|Overall Study|Initiated into extension study A536-06|24|||
48907163|NCT01807923|157496639|FG000|Overall Study|Adverse Event|2|||
48907164|NCT01807923|157496640|FG001|Overall Study|Adverse Event|1|||
48907165|NCT01807923|157496641|FG002|Overall Study|Adverse Event|2|||
48907166|NCT01807923|157496639|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
48907167|NCT01807923|157496640|FG001|Overall Study|Withdrawal of Consent (not due to AE)|3|||
48907168|NCT01807923|157496641|FG002|Overall Study|Withdrawal of Consent (not due to AE)|2|||
48907169|NCT01807923|157496639|FG000|Overall Study|Physician Decision|0|||
48907170|NCT01807923|157496640|FG001|Overall Study|Physician Decision|0|||
48907171|NCT01807923|157496641|FG002|Overall Study|Physician Decision|1|||
48907172|NCT01807923|157496639|FG000|Overall Study|Not Eligible (Genotype)|0|||
48907173|NCT01807923|157496640|FG001|Overall Study|Not Eligible (Genotype)|0|||
48907174|NCT01807923|157496641|FG002|Overall Study|Not Eligible (Genotype)|1|||
48907175|NCT01807923|157496639|FG000|Overall Study|Randomized But Not Treated|3|||
48907176|NCT01807923|157496640|FG001|Overall Study|Randomized But Not Treated|2|||
48907177|NCT01807923|157496641|FG002|Overall Study|Randomized But Not Treated|5|||
48907178|NCT00890929|157496642|FG000|Overall Study|Death before treatment|2|||
48907179|NCT00890929|157496642|FG000|Overall Study|Withdrawal by Subject|3|||
48907180|NCT00890929|157496642|FG000|Overall Study|Physician Decision|1|||
48907181|NCT03027557|157496643|FG000|Overall Study|Adverse Event|1|||
48907182|NCT03027557|157496644|FG001|Overall Study|Adverse Event|0|||
48907183|NCT03027557|157496645|FG002|Overall Study|Adverse Event|0|||
48907184|NCT03836807|157496646|FG000|Overall Study|Physician Decision|1|||
48907185|NCT03836807|157496647|FG001|Overall Study|Physician Decision|0|||
48907186|NCT01289821|157496651|FG000|Treatment Period|Withdrawal by Subject|1|||
48907187|NCT01289821|157496651|FG000|Treatment Period|Physician Decision|3|||
48907188|NCT01289821|157496651|FG000|Treatment Period|Adverse Event|4|||
48907189|NCT01289821|157496651|FG000|Treatment Period|Radiological Progression|43|||
48907190|NCT01289821|157496651|FG000|Treatment Period|Clinical Progression|2|||
48907191|NCT01289821|157496651|FG000|Treatment Period|Therapeutic procedure required|1|||
48907192|NCT01289821|157496651|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
48907193|NCT01289821|157496651|FG000|Safety Follow-up Period|Protocol Violation|3|||
48907194|NCT01289821|157496651|FG000|Safety Follow-up Period|Unspecified reason|1|||
48907195|NCT01289821|157496651|FG000|Survival Follow-up Period|Protocol Violation|1|||
48907196|NCT01289821|157496651|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
48907197|NCT01289821|157496651|FG000|Survival Follow-up Period|Clinical endpoint reached|16|||
48907198|NCT01668719|157496654|FG000|Phase I|On treatment|1|||
48907199|NCT01668719|157496655|FG001|Phase I|On treatment|0|||
48907200|NCT01668719|157496656|FG002|Phase I|On treatment|0|||
48907201|NCT01668719|157496654|FG000|Phase I|Adverse Event|2|||
48907202|NCT01668719|157496655|FG001|Phase I|Adverse Event|0|||
48907203|NCT01668719|157496656|FG002|Phase I|Adverse Event|0|||
48907204|NCT01668719|157496654|FG000|Phase I|Progression/relapse|1|||
48907205|NCT01668719|157496655|FG001|Phase I|Progression/relapse|0|||
48907206|NCT01668719|157496656|FG002|Phase I|Progression/relapse|0|||
48907207|NCT01668719|157496654|FG000|Phase I|not protocol specified|2|||
48907208|NCT01668719|157496655|FG001|Phase I|not protocol specified|0|||
48907209|NCT01668719|157496656|FG002|Phase I|not protocol specified|0|||
48907210|NCT01668719|157496654|FG000|Phase II|On treatment|0|||
48907211|NCT01668719|157496655|FG001|Phase II|On treatment|4|||
48907212|NCT01668719|157496656|FG002|Phase II|On treatment|3|||
48907213|NCT01668719|157496654|FG000|Phase II|Adverse Event|0|||
48907214|NCT01668719|157496655|FG001|Phase II|Adverse Event|18|||
48907215|NCT01668719|157496656|FG002|Phase II|Adverse Event|18|||
48907216|NCT01668719|157496654|FG000|Phase II|Refusal unrelated to adverse event|0|||
48907217|NCT01668719|157496655|FG001|Phase II|Refusal unrelated to adverse event|4|||
48907218|NCT01668719|157496656|FG002|Phase II|Refusal unrelated to adverse event|1|||
48907219|NCT01668719|157496654|FG000|Phase II|Progression/relapse|0|||
48907220|NCT01668719|157496655|FG001|Phase II|Progression/relapse|13|||
48907221|NCT01668719|157496656|FG002|Phase II|Progression/relapse|17|||
48907222|NCT01668719|157496654|FG000|Phase II|Death|0|||
48907223|NCT01668719|157496655|FG001|Phase II|Death|0|||
48907224|NCT01668719|157496656|FG002|Phase II|Death|2|||
48907225|NCT01668719|157496654|FG000|Phase II|not protocol specified|0|||
48907226|NCT01668719|157496655|FG001|Phase II|not protocol specified|13|||
48907227|NCT01668719|157496656|FG002|Phase II|not protocol specified|7|||
48907228|NCT02243865|157496657|FG000|Overall Study|Protocol Violation|1|||
48907229|NCT02243865|157496658|FG001|Overall Study|Protocol Violation|3|||
48907230|NCT02243865|157496657|FG000|Overall Study|Lost to Follow-up|1|||
48907231|NCT02243865|157496658|FG001|Overall Study|Lost to Follow-up|1|||
48907232|NCT02243865|157496657|FG000|Overall Study|Withdrawal by Subject|1|||
48907233|NCT02243865|157496658|FG001|Overall Study|Withdrawal by Subject|0|||
48907234|NCT02243865|157496657|FG000|Overall Study|Adverse Event|1|||
48907235|NCT02243865|157496658|FG001|Overall Study|Adverse Event|1|||
48907236|NCT01351623|157496659|FG000|Overall Study|Protocol Violation|2|||
48907237|NCT01351623|157496659|FG000|Overall Study|Adverse Event|4|||
48907238|NCT01351623|157496659|FG000|Overall Study|Withdrawal by Subject|1|||
48907239|NCT01351623|157496659|FG000|Overall Study|Death|2|||
48907240|NCT02054325|157496660|FG000|Overall Study|Lost to Follow-up|8|||
48907241|NCT02054325|157496661|FG001|Overall Study|Lost to Follow-up|5|||
48907242|NCT00387764|157496662|FG000|Overall Study|Adverse Event|12|||
48907243|NCT00387764|157496662|FG000|Overall Study|Withdrawal by Subject|8|||
48907244|NCT00387764|157496662|FG000|Overall Study|Sponsor Terminated Study|1|||
48907245|NCT00387764|157496662|FG000|Overall Study|Physician Decision|1|||
48907246|NCT00387764|157496662|FG000|Overall Study|Other|2|||
48907247|NCT00387764|157496662|FG000|Overall Study|Death|7|||
48907248|NCT01326728|157496663|FG000|Overall Study|Death|13|||
48907249|NCT01326728|157496664|FG001|Overall Study|Death|0|||
48907250|NCT01326728|157496663|FG000|Overall Study|Early closure of study|34|||
48907251|NCT01326728|157496664|FG001|Overall Study|Early closure of study|9|||
48907252|NCT01323621|157496665|FG000|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121|||
48907253|NCT01323621|157496666|FG001|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
48907254|NCT01323621|157496667|FG002|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
48907255|NCT01323621|157496665|FG000|2-week, Single-blind Run In Period|Physician Decision|7|||
48907256|NCT01323621|157496666|FG001|2-week, Single-blind Run In Period|Physician Decision|0|||
48907257|NCT01323621|157496667|FG002|2-week, Single-blind Run In Period|Physician Decision|0|||
48907258|NCT01323621|157496665|FG000|2-week, Single-blind Run In Period|Withdrawal by Subject|12|||
48695026|NCT01045460|156732143|FG001|Overall Study|Lack of Efficacy|0|||
48907259|NCT01323621|157496666|FG001|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
48907260|NCT01323621|157496667|FG002|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
48907261|NCT01323621|157496665|FG000|2-week, Single-blind Run In Period|Protocol Violation|1|||
48907262|NCT01323621|157496666|FG001|2-week, Single-blind Run In Period|Protocol Violation|0|||
48907263|NCT01323621|157496667|FG002|2-week, Single-blind Run In Period|Protocol Violation|0|||
48907264|NCT01323621|157496665|FG000|2-week, Single-blind Run In Period|Lost to Follow-up|1|||
48907265|NCT01323621|157496666|FG001|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
48907266|NCT01323621|157496667|FG002|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
48907267|NCT01323621|157496665|FG000|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86|||
48907268|NCT01323621|157496666|FG001|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
48907269|NCT01323621|157496667|FG002|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
48907270|NCT01323621|157496665|FG000|12-week, Double-blind Treatment Period|Adverse Event|0|||
48907271|NCT01323621|157496666|FG001|12-week, Double-blind Treatment Period|Adverse Event|1|||
48907272|NCT01323621|157496667|FG002|12-week, Double-blind Treatment Period|Adverse Event|5|||
48907273|NCT01323621|157496665|FG000|12-week, Double-blind Treatment Period|Lack of Efficacy|0|||
48907274|NCT01323621|157496666|FG001|12-week, Double-blind Treatment Period|Lack of Efficacy|2|||
48907275|NCT01323621|157496667|FG002|12-week, Double-blind Treatment Period|Lack of Efficacy|6|||
48907276|NCT01323621|157496665|FG000|12-week, Double-blind Treatment Period|Protocol Violation|0|||
48907277|NCT01323621|157496666|FG001|12-week, Double-blind Treatment Period|Protocol Violation|4|||
48907278|NCT01323621|157496667|FG002|12-week, Double-blind Treatment Period|Protocol Violation|4|||
48907279|NCT01323621|157496665|FG000|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
48907280|NCT01323621|157496666|FG001|12-week, Double-blind Treatment Period|Lost to Follow-up|1|||
48907281|NCT01323621|157496667|FG002|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
48907282|NCT01323621|157496665|FG000|12-week, Double-blind Treatment Period|Physician Decision|0|||
48907283|NCT01323621|157496666|FG001|12-week, Double-blind Treatment Period|Physician Decision|2|||
48907284|NCT01323621|157496667|FG002|12-week, Double-blind Treatment Period|Physician Decision|1|||
48907285|NCT01323621|157496665|FG000|12-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
48907286|NCT01323621|157496666|FG001|12-week, Double-blind Treatment Period|Withdrawal by Subject|5|||
48907287|NCT01323621|157496667|FG002|12-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
48907288|NCT00651157|157496669|FG000|Overall Study|Death|1|||
48907289|NCT00651157|157496669|FG000|Overall Study|Protocol Violation|1|||
48907290|NCT04540133|157496676|FG000|Overall Study|Lost to Follow-up|1|||
48907291|NCT04540133|157496677|FG001|Overall Study|Lost to Follow-up|0|||
48907292|NCT02141074|157496678|FG000|Pre-prophylaxis|Adverse Event|3|||
48907293|NCT02141074|157496679|FG001|Pre-prophylaxis|Adverse Event|0|||
48907294|NCT02141074|157496678|FG000|Prophylaxis|Withdrawal by parent/guardian|0|||
48907295|NCT02141074|157496679|FG001|Prophylaxis|Withdrawal by parent/guardian|2|||
48907296|NCT02141074|157496678|FG000|Prophylaxis|Adverse Event|0|||
48907297|NCT02141074|157496679|FG001|Prophylaxis|Adverse Event|4|||
48907298|NCT02141074|157496678|FG000|Prophylaxis|Withdrawn due to closure of trial|0|||
48907299|NCT02141074|157496679|FG001|Prophylaxis|Withdrawn due to closure of trial|3|||
48907300|NCT02141074|157496678|FG000|Prophylaxis|Withdrawal by Subject|0|||
48907301|NCT02141074|157496679|FG001|Prophylaxis|Withdrawal by Subject|1|||
48907302|NCT02593786|157496680|FG000|Overall Study|Disease progression|12|||
48907303|NCT02593786|157496681|FG001|Overall Study|Disease progression|16|||
48907304|NCT02593786|157496682|FG002|Overall Study|Disease progression|10|||
48907305|NCT02593786|157496683|FG003|Overall Study|Disease progression|7|||
48907306|NCT02593786|157496680|FG000|Overall Study|Study drug toxicity|1|||
48907307|NCT02593786|157496681|FG001|Overall Study|Study drug toxicity|0|||
48907308|NCT02593786|157496682|FG002|Overall Study|Study drug toxicity|0|||
48907309|NCT02593786|157496683|FG003|Overall Study|Study drug toxicity|0|||
48907310|NCT02593786|157496680|FG000|Overall Study|Adverse event unrelated to study drug|1|||
48907311|NCT02593786|157496681|FG001|Overall Study|Adverse event unrelated to study drug|1|||
48907312|NCT02593786|157496682|FG002|Overall Study|Adverse event unrelated to study drug|1|||
48907313|NCT02593786|157496683|FG003|Overall Study|Adverse event unrelated to study drug|0|||
48907314|NCT02593786|157496680|FG000|Overall Study|Participant request to discontinue study therapy|0|||
48907315|NCT02593786|157496681|FG001|Overall Study|Participant request to discontinue study therapy|2|||
48907316|NCT02593786|157496682|FG002|Overall Study|Participant request to discontinue study therapy|0|||
48907317|NCT02593786|157496683|FG003|Overall Study|Participant request to discontinue study therapy|0|||
48907318|NCT02593786|157496680|FG000|Overall Study|Other reasons|1|||
48907319|NCT02593786|157496681|FG001|Overall Study|Other reasons|1|||
48907320|NCT02593786|157496682|FG002|Overall Study|Other reasons|0|||
48907321|NCT02593786|157496683|FG003|Overall Study|Other reasons|5|||
48907322|NCT03049735|157496684|FG000|Overall Study|Discontinued due to AE (not dosed)|0|||
48907323|NCT03049735|157496685|FG001|Overall Study|Discontinued due to AE (not dosed)|0|||
48907324|NCT03049735|157496686|FG002|Overall Study|Discontinued due to AE (not dosed)|1|||
48907325|NCT03049735|157496684|FG000|Overall Study|Other|5|||
48907326|NCT03049735|157496685|FG001|Overall Study|Other|3|||
48907327|NCT03049735|157496686|FG002|Overall Study|Other|1|||
48907328|NCT03049735|157496684|FG000|Overall Study|Lack of Efficacy|4|||
48907329|NCT03049735|157496685|FG001|Overall Study|Lack of Efficacy|0|||
48907330|NCT03049735|157496686|FG002|Overall Study|Lack of Efficacy|3|||
48907331|NCT03049735|157496684|FG000|Overall Study|Protocol deviation|1|||
48907332|NCT03049735|157496685|FG001|Overall Study|Protocol deviation|0|||
48907333|NCT03049735|157496686|FG002|Overall Study|Protocol deviation|0|||
48907334|NCT03049735|157496684|FG000|Overall Study|Pregnancy|0|||
48907335|NCT03049735|157496685|FG001|Overall Study|Pregnancy|0|||
48907336|NCT03049735|157496686|FG002|Overall Study|Pregnancy|1|||
48907337|NCT03049735|157496684|FG000|Overall Study|Adverse Event|7|||
48907338|NCT03049735|157496685|FG001|Overall Study|Adverse Event|18|||
48907339|NCT03049735|157496686|FG002|Overall Study|Adverse Event|5|||
48907340|NCT03049735|157496684|FG000|Overall Study|Withdrawal by Subject|10|||
48907341|NCT03049735|157496685|FG001|Overall Study|Withdrawal by Subject|3|||
49010518|NCT00926289|157875640|FG001|Overall Study|Protocol Violation|12|||
48907342|NCT03049735|157496686|FG002|Overall Study|Withdrawal by Subject|7|||
48907343|NCT03049735|157496684|FG000|Overall Study|Lost to Follow-up|1|||
48907344|NCT03049735|157496685|FG001|Overall Study|Lost to Follow-up|5|||
48907345|NCT03049735|157496686|FG002|Overall Study|Lost to Follow-up|5|||
48907346|NCT04448756|157496688|FG000|Overall Study|Adverse Event|0|||
48907347|NCT04448756|157496689|FG001|Overall Study|Adverse Event|1|||
48907348|NCT04448756|157496690|FG002|Overall Study|Adverse Event|0|||
48907349|NCT04448756|157496688|FG000|Overall Study|Participant unable to attend Day 60 visit|1|||
48907350|NCT04448756|157496689|FG001|Overall Study|Participant unable to attend Day 60 visit|0|||
48907351|NCT04448756|157496690|FG002|Overall Study|Participant unable to attend Day 60 visit|0|||
48907352|NCT04448756|157496688|FG000|Overall Study|Withdrawal by Subject|0|||
48907353|NCT04448756|157496689|FG001|Overall Study|Withdrawal by Subject|3|||
48907354|NCT04448756|157496690|FG002|Overall Study|Withdrawal by Subject|1|||
48907355|NCT04448756|157496688|FG000|Overall Study|Death|2|||
48907356|NCT04448756|157496689|FG001|Overall Study|Death|1|||
48907357|NCT04448756|157496690|FG002|Overall Study|Death|0|||
48907358|NCT00174265|157496691|FG000|Overall Study|Adverse Event|7|||
48907359|NCT00174265|157496692|FG001|Overall Study|Adverse Event|4|||
48907360|NCT00174265|157496691|FG000|Overall Study|Lack of Efficacy|2|||
48907361|NCT00174265|157496692|FG001|Overall Study|Lack of Efficacy|2|||
48907362|NCT00174265|157496691|FG000|Overall Study|Withdrawal by Subject|3|||
48907363|NCT00174265|157496692|FG001|Overall Study|Withdrawal by Subject|5|||
48907364|NCT00174265|157496691|FG000|Overall Study|Lost to Follow-up|1|||
48907365|NCT00174265|157496692|FG001|Overall Study|Lost to Follow-up|0|||
48907366|NCT00174265|157496691|FG000|Overall Study|Other (Not specified)|16|||
48907367|NCT00174265|157496692|FG001|Overall Study|Other (Not specified)|10|||
48907368|NCT00447382|157496693|FG000|Overall Study|Adverse Event|1|||
48907369|NCT00447382|157496694|FG001|Overall Study|Adverse Event|1|||
48907370|NCT00447382|157496693|FG000|Overall Study|Lack of Efficacy|1|||
48907371|NCT00447382|157496694|FG001|Overall Study|Lack of Efficacy|0|||
48907372|NCT00447382|157496693|FG000|Overall Study|Protocol Violation|2|||
48907373|NCT00447382|157496694|FG001|Overall Study|Protocol Violation|0|||
48907374|NCT00447382|157496693|FG000|Overall Study|Unclassified|2|||
48907375|NCT00447382|157496694|FG001|Overall Study|Unclassified|5|||
48907376|NCT03144804|157496695|FG000|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4|||
48907377|NCT01399190|157498174|FG000|Overall Study|Not Eligible for Final Analysis|5|||
48907378|NCT01399190|157498174|FG000|Overall Study|Adverse Event|8|||
48907379|NCT01399190|157498174|FG000|Overall Study|Participant's Request|5|||
48907380|NCT01399190|157498174|FG000|Overall Study|Physician Decision|2|||
48907381|NCT03781323|157498177|FG000|Overall Study|Withdrawal by Subject|1|||
48907382|NCT02308007|157498178|FG000|Overall Study|Normal Gram stain or neg yeast culture|66|||
48907383|NCT02308007|157498179|FG001|Overall Study|Normal Gram stain or neg yeast culture|64|||
48907384|NCT02308007|157498180|FG002|Overall Study|Normal Gram stain or neg yeast culture|67|||
48907385|NCT02308007|157498178|FG000|Overall Study|Positive for STD at Baseline|7|||
48907386|NCT02308007|157498179|FG001|Overall Study|Positive for STD at Baseline|11|||
48907387|NCT02308007|157498180|FG002|Overall Study|Positive for STD at Baseline|7|||
48907388|NCT02308007|157498178|FG000|Overall Study|Lost to Follow-up|3|||
48907389|NCT02308007|157498179|FG001|Overall Study|Lost to Follow-up|0|||
48907390|NCT02308007|157498180|FG002|Overall Study|Lost to Follow-up|1|||
48907391|NCT01296035|157498185|FG000|Overall Study|Withdrawal by Subject|1|||
48907392|NCT04004429|157498186|FG000|Overall Study|Protocol Violation|1|||
48907393|NCT04004429|157498187|FG001|Overall Study|Protocol Violation|0|||
48907394|NCT04004429|157498188|FG002|Overall Study|Protocol Violation|0|||
48907395|NCT04004429|157498186|FG000|Overall Study|Physician Decision|0|||
48907396|NCT04004429|157498187|FG001|Overall Study|Physician Decision|1|||
48907397|NCT04004429|157498188|FG002|Overall Study|Physician Decision|1|||
48907398|NCT04004429|157498186|FG000|Overall Study|Withdrawal by Subject|1|||
48907399|NCT04004429|157498187|FG001|Overall Study|Withdrawal by Subject|1|||
48907400|NCT04004429|157498188|FG002|Overall Study|Withdrawal by Subject|1|||
48907401|NCT03085758|157498189|FG000|Overall Study|Death|26|||
48907402|NCT03085758|157498190|FG001|Overall Study|Death|24|||
48907403|NCT03085758|157498191|FG002|Overall Study|Death|53|||
48907404|NCT03085758|157498189|FG000|Overall Study|Lost to Follow-up|1|||
48907405|NCT03085758|157498190|FG001|Overall Study|Lost to Follow-up|1|||
48907406|NCT03085758|157498191|FG002|Overall Study|Lost to Follow-up|1|||
48907407|NCT03085758|157498189|FG000|Overall Study|Withdrawal by Subject|2|||
48907408|NCT03085758|157498190|FG001|Overall Study|Withdrawal by Subject|2|||
48907409|NCT03085758|157498191|FG002|Overall Study|Withdrawal by Subject|1|||
48907410|NCT03085758|157498189|FG000|Overall Study|Refusal to recall it up to day 90|0|||
48907411|NCT03085758|157498190|FG001|Overall Study|Refusal to recall it up to day 90|0|||
48907412|NCT03085758|157498191|FG002|Overall Study|Refusal to recall it up to day 90|1|||
48907413|NCT03085758|157498189|FG000|Overall Study|Pt seen by doctor in digestive surgery|0|||
48907414|NCT03085758|157498190|FG001|Overall Study|Pt seen by doctor in digestive surgery|1|||
48907415|NCT03085758|157498191|FG002|Overall Study|Pt seen by doctor in digestive surgery|0|||
48907416|NCT00056862|157498197|FG000|Overall Study|Protocol Violation|1|||
48907417|NCT00056862|157498198|FG001|Overall Study|Protocol Violation|0|||
48907418|NCT04880447|157498200|FG000|Overall Study|No vaccination information|1|||
48907419|NCT04880447|157498200|FG000|Overall Study|No adverse event information (missing information)|1|||
48907420|NCT04880447|157498200|FG000|Overall Study|Disease not covered in this study|35|||
48907421|NCT04585646|157498201|FG000|First Intervention|Physician Decision|1|||
48907422|NCT04585646|157498202|FG001|First Intervention|Physician Decision|0|||
48907423|NCT04585646|157498201|FG000|First Intervention|Lost to Follow-up|0|||
48907424|NCT04585646|157498202|FG001|First Intervention|Lost to Follow-up|3|||
48907425|NCT04585646|157498201|FG000|First Intervention|Withdrawal by Subject|0|||
48907426|NCT04585646|157498202|FG001|First Intervention|Withdrawal by Subject|1|||
48907427|NCT02092350|157498203|FG000|Overall Study|Adverse Event|0|||
48907428|NCT02092350|157498204|FG001|Overall Study|Adverse Event|3|||
48907429|NCT02092350|157498203|FG000|Overall Study|Death|2|||
48907430|NCT02092350|157498204|FG001|Overall Study|Death|5|||
48907431|NCT02092350|157498203|FG000|Overall Study|Lost to Follow-up|3|||
48907432|NCT02092350|157498204|FG001|Overall Study|Lost to Follow-up|1|||
48907433|NCT02092350|157498203|FG000|Overall Study|Protocol Violation|1|||
48907434|NCT02092350|157498204|FG001|Overall Study|Protocol Violation|0|||
48907435|NCT02092350|157498203|FG000|Overall Study|Physician Decision|1|||
48907436|NCT02092350|157498204|FG001|Overall Study|Physician Decision|1|||
48907437|NCT02092350|157498203|FG000|Overall Study|Screen Failure|1|||
48907438|NCT02092350|157498204|FG001|Overall Study|Screen Failure|0|||
48907439|NCT02092350|157498203|FG000|Overall Study|Withdrawal by Subject|2|||
48907440|NCT02092350|157498204|FG001|Overall Study|Withdrawal by Subject|2|||
48907441|NCT01603082|157498209|FG000|Overall Study|Adverse Event|0|||
48907442|NCT01603082|157498210|FG001|Overall Study|Adverse Event|1|||
48907443|NCT01603082|157498209|FG000|Overall Study|Withdrawal by Subject|1|||
48907444|NCT01603082|157498210|FG001|Overall Study|Withdrawal by Subject|0|||
48907445|NCT01603082|157498209|FG000|Overall Study|Failed inclusion criterion after dosed|1|||
48907446|NCT01603082|157498210|FG001|Overall Study|Failed inclusion criterion after dosed|0|||
48907447|NCT03690141|157498218|FG000|Overall Study|Adverse Event|5|||
48907448|NCT03690141|157498218|FG000|Overall Study|Withdrawal by Subject|3|||
48907449|NCT03690141|157498218|FG000|Overall Study|Physician Decision|4|||
48907450|NCT03690141|157498218|FG000|Overall Study|Disease progression|4|||
48907451|NCT00041067|157498219|FG000|Overall Study|Adverse Event|20|||
48907452|NCT00041067|157498219|FG000|Overall Study|Progression|19|||
48907453|NCT00041067|157498219|FG000|Overall Study|Patient refusal|12|||
48907454|NCT00041067|157498219|FG000|Overall Study|Other reasons|23|||
48907455|NCT00041067|157498219|FG000|Overall Study|Ineligible|2|||
48907456|NCT00529451|157498228|FG000|Overall Study|Subject withdrew consent|16|||
48907457|NCT00529451|157498229|FG001|Overall Study|Subject withdrew consent|21|||
48907458|NCT00529451|157498230|FG002|Overall Study|Subject withdrew consent|13|||
48907459|NCT00529451|157498231|FG003|Overall Study|Subject withdrew consent|12|||
48907460|NCT00529451|157498228|FG000|Overall Study|Adverse Event|9|||
48907461|NCT00529451|157498229|FG001|Overall Study|Adverse Event|16|||
48907462|NCT00529451|157498230|FG002|Overall Study|Adverse Event|14|||
48907463|NCT00529451|157498231|FG003|Overall Study|Adverse Event|8|||
48907464|NCT00529451|157498228|FG000|Overall Study|Unsatisfactory therapeutic response|6|||
48907465|NCT00529451|157498229|FG001|Overall Study|Unsatisfactory therapeutic response|2|||
48907466|NCT00529451|157498230|FG002|Overall Study|Unsatisfactory therapeutic response|5|||
48907467|NCT00529451|157498231|FG003|Overall Study|Unsatisfactory therapeutic response|4|||
48907468|NCT00529451|157498228|FG000|Overall Study|Lost to Follow-up|4|||
48907469|NCT00529451|157498229|FG001|Overall Study|Lost to Follow-up|7|||
48907470|NCT00529451|157498230|FG002|Overall Study|Lost to Follow-up|4|||
48907471|NCT00529451|157498231|FG003|Overall Study|Lost to Follow-up|4|||
48907472|NCT00529451|157498228|FG000|Overall Study|Protocol deviation|1|||
48907473|NCT00529451|157498229|FG001|Overall Study|Protocol deviation|1|||
48907474|NCT00529451|157498230|FG002|Overall Study|Protocol deviation|4|||
48907475|NCT00529451|157498231|FG003|Overall Study|Protocol deviation|1|||
48907476|NCT00529451|157498228|FG000|Overall Study|Administrative problems|1|||
48907477|NCT00529451|157498229|FG001|Overall Study|Administrative problems|1|||
48907478|NCT00529451|157498230|FG002|Overall Study|Administrative problems|0|||
48907479|NCT00529451|157498231|FG003|Overall Study|Administrative problems|2|||
48907480|NCT02019420|157498232|FG000|Overall Study|Did not receive study drug|2|||
48907481|NCT02019420|157498233|FG001|Overall Study|Did not receive study drug|2|||
49116284|NCT00534638|158263086|FG000|Overall Study|Migrated/moved from study area|13|||
48907482|NCT02019420|157498232|FG000|Overall Study|Withdrawal by Subject|1|||
48907483|NCT02019420|157498233|FG001|Overall Study|Withdrawal by Subject|3|||
48907484|NCT02019420|157498232|FG000|Overall Study|At request of sponsor or investigator|0|||
48907485|NCT02019420|157498233|FG001|Overall Study|At request of sponsor or investigator|1|||
48907486|NCT02019420|157498232|FG000|Overall Study|Death|104|||
48907487|NCT02019420|157498233|FG001|Overall Study|Death|99|||
48907488|NCT02019420|157498232|FG000|Overall Study|Transferred to other care facility|1|||
48907489|NCT02019420|157498233|FG001|Overall Study|Transferred to other care facility|1|||
48907490|NCT00894686|157498234|FG000|Overall Study|Withdrawal by Subject|50|||
48907491|NCT00894686|157498234|FG000|Overall Study|Physician Decision|1|||
48907492|NCT00894686|157498234|FG000|Overall Study|Other|5|||
48907493|NCT02322229|157498249|FG000|Overall Study|Physician Decision|2|||
48907494|NCT00617604|157498250|FG000|Overall Study|Death|2|||
48907495|NCT00617604|157498251|FG001|Overall Study|Death|1|||
48907496|NCT00617604|157498250|FG000|Overall Study|Lost to Follow-up|1|||
48907497|NCT00617604|157498251|FG001|Overall Study|Lost to Follow-up|0|||
48907498|NCT00617604|157498250|FG000|Overall Study|Miscellaneous Reasons|8|||
48907499|NCT00617604|157498251|FG001|Overall Study|Miscellaneous Reasons|10|||
48907500|NCT00617604|157498250|FG000|Overall Study|Withdrawal by Subject|4|||
48907501|NCT00617604|157498251|FG001|Overall Study|Withdrawal by Subject|6|||
48907502|NCT00617604|157498250|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
48907503|NCT00617604|157498251|FG001|Overall Study|Randomized but Never Received Study Drug|3|||
48907504|NCT02511678|157498252|FG000|Overall Study|Withdrawal by Subject|2|||
48907505|NCT02511678|157498252|FG000|Overall Study|Lost to Follow-up|4|||
48907506|NCT02511678|157498252|FG000|Overall Study|Death|19|||
48907507|NCT02511678|157498252|FG000|Overall Study|Adverse Event|1|||
48907508|NCT02511678|157498252|FG000|Overall Study|Targeted Therapy to Index Tumor Required|5|||
48907509|NCT02511678|157498252|FG000|Overall Study|Oncologist Cancelled Study Cryoablation|1|||
48907510|NCT02511678|157498252|FG000|Overall Study|Required Radiofrequency Ablation|1|||
48907511|NCT02511678|157498252|FG000|Overall Study|Biopsy was Negative|1|||
48907512|NCT02511678|157498252|FG000|Overall Study|Protocol Violation|1|||
48907513|NCT02511678|157498252|FG000|Overall Study|Received Radiation Treatment|1|||
48907514|NCT03065023|157498253|FG000|Overall Study|Progressive Disease|0|||
48907515|NCT03065023|157498254|FG001|Overall Study|Progressive Disease|1|||
48907516|NCT03065023|157498255|FG002|Overall Study|Progressive Disease|0|||
48907517|NCT03065023|157498256|FG003|Overall Study|Progressive Disease|0|||
48907518|NCT03065023|157498257|FG004|Overall Study|Progressive Disease|0|||
48907519|NCT03065023|157498253|FG000|Overall Study|Death|2|||
48907520|NCT03065023|157498254|FG001|Overall Study|Death|0|||
48907521|NCT03065023|157498255|FG002|Overall Study|Death|1|||
48907522|NCT03065023|157498256|FG003|Overall Study|Death|1|||
48907523|NCT03065023|157498257|FG004|Overall Study|Death|0|||
48907524|NCT03065023|157498253|FG000|Overall Study|Lost to Follow-up|0|||
48907525|NCT03065023|157498254|FG001|Overall Study|Lost to Follow-up|1|||
48907526|NCT03065023|157498255|FG002|Overall Study|Lost to Follow-up|0|||
48907527|NCT03065023|157498256|FG003|Overall Study|Lost to Follow-up|0|||
48907528|NCT03065023|157498257|FG004|Overall Study|Lost to Follow-up|0|||
48907529|NCT03065023|157498253|FG000|Overall Study|Participant Decision|0|||
48907530|NCT03065023|157498254|FG001|Overall Study|Participant Decision|0|||
48907531|NCT03065023|157498255|FG002|Overall Study|Participant Decision|0|||
48907532|NCT03065023|157498256|FG003|Overall Study|Participant Decision|1|||
48907533|NCT03065023|157498257|FG004|Overall Study|Participant Decision|0|||
48907534|NCT03065023|157498253|FG000|Overall Study|Withdrawal by Subject|0|||
48907535|NCT03065023|157498254|FG001|Overall Study|Withdrawal by Subject|0|||
48907536|NCT03065023|157498255|FG002|Overall Study|Withdrawal by Subject|0|||
48907537|NCT03065023|157498256|FG003|Overall Study|Withdrawal by Subject|1|||
48907538|NCT03065023|157498257|FG004|Overall Study|Withdrawal by Subject|0|||
48907539|NCT00705432|157498258|FG000|Treatment Period|Adverse Event|45|||
48907540|NCT00705432|157498259|FG001|Treatment Period|Adverse Event|37|||
48907541|NCT00705432|157498260|FG002|Treatment Period|Adverse Event|51|||
48907542|NCT00705432|157498261|FG003|Treatment Period|Adverse Event|12|||
48907543|NCT00705432|157498262|FG004|Treatment Period|Adverse Event|8|||
48907544|NCT00705432|157498263|FG005|Treatment Period|Adverse Event|9|||
48907545|NCT00705432|157498258|FG000|Treatment Period|Treatment failure|92|||
48907546|NCT00705432|157498259|FG001|Treatment Period|Treatment failure|42|||
48907547|NCT00705432|157498260|FG002|Treatment Period|Treatment failure|33|||
48907548|NCT00705432|157498261|FG003|Treatment Period|Treatment failure|25|||
48907549|NCT00705432|157498262|FG004|Treatment Period|Treatment failure|13|||
48907550|NCT00705432|157498263|FG005|Treatment Period|Treatment failure|14|||
48907551|NCT00705432|157498258|FG000|Treatment Period|Non medical reason|26|||
48907552|NCT00705432|157498259|FG001|Treatment Period|Non medical reason|32|||
48907553|NCT00705432|157498260|FG002|Treatment Period|Non medical reason|37|||
48907554|NCT00705432|157498261|FG003|Treatment Period|Non medical reason|4|||
48907555|NCT00705432|157498262|FG004|Treatment Period|Non medical reason|7|||
48907556|NCT00705432|157498263|FG005|Treatment Period|Non medical reason|7|||
48907557|NCT00705432|157498258|FG000|Follow-up Period (Upto Week 72)|Adverse Event|2|||
48907558|NCT00705432|157498259|FG001|Follow-up Period (Upto Week 72)|Adverse Event|1|||
48907559|NCT00705432|157498260|FG002|Follow-up Period (Upto Week 72)|Adverse Event|1|||
48907560|NCT00705432|157498261|FG003|Follow-up Period (Upto Week 72)|Adverse Event|0|||
48907561|NCT00705432|157498262|FG004|Follow-up Period (Upto Week 72)|Adverse Event|0|||
48907562|NCT00705432|157498263|FG005|Follow-up Period (Upto Week 72)|Adverse Event|0|||
48907563|NCT00705432|157498258|FG000|Follow-up Period (Upto Week 72)|Non medical reason|69|||
48907564|NCT00705432|157498259|FG001|Follow-up Period (Upto Week 72)|Non medical reason|42|||
48907565|NCT00705432|157498260|FG002|Follow-up Period (Upto Week 72)|Non medical reason|24|||
48907566|NCT00705432|157498261|FG003|Follow-up Period (Upto Week 72)|Non medical reason|14|||
48907567|NCT00705432|157498262|FG004|Follow-up Period (Upto Week 72)|Non medical reason|6|||
49010519|NCT00926289|157875639|FG000|Overall Study|Lost to Follow-up|3|||
48907568|NCT00705432|157498263|FG005|Follow-up Period (Upto Week 72)|Non medical reason|7|||
48907569|NCT01102803|157498264|FG000|Baseline to Post-Treatment|Lost to Follow-up|3|||
48907570|NCT01102803|157498265|FG001|Baseline to Post-Treatment|Lost to Follow-up|0|||
48907571|NCT01102803|157498264|FG000|Post to Follow-Up|Lost to Follow-up|1|||
48907572|NCT01102803|157498265|FG001|Post to Follow-Up|Lost to Follow-up|3|||
48907573|NCT01667107|157498272|FG000|Overall Study|Adverse Event|4|||
48907574|NCT01667107|157498273|FG001|Overall Study|Adverse Event|3|||
48907575|NCT01667107|157498272|FG000|Overall Study|Tolerability issues|0|||
48907576|NCT01667107|157498273|FG001|Overall Study|Tolerability issues|2|||
48907577|NCT01667107|157498272|FG000|Overall Study|Protocol Violation|0|||
48907578|NCT01667107|157498273|FG001|Overall Study|Protocol Violation|1|||
48907579|NCT01667107|157498272|FG000|Overall Study|Lack of Efficacy|0|||
48907580|NCT01667107|157498273|FG001|Overall Study|Lack of Efficacy|1|||
48907581|NCT01252810|157498274|FG000|Overall Study|Withdrawal by Subject|4|||
48907582|NCT01252810|157498275|FG001|Overall Study|Withdrawal by Subject|1|||
48907583|NCT01252810|157498274|FG000|Overall Study|Lost to Follow-up|0|||
48907584|NCT01252810|157498275|FG001|Overall Study|Lost to Follow-up|1|||
48907585|NCT01252810|157498274|FG000|Overall Study|Physician Decision|2|||
48907586|NCT01252810|157498275|FG001|Overall Study|Physician Decision|1|||
48907587|NCT01252810|157498274|FG000|Overall Study|Various reasons|8|||
48907588|NCT01252810|157498275|FG001|Overall Study|Various reasons|0|||
48907589|NCT03427125|157498276|FG000|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
48907590|NCT03427125|157498277|FG001|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|995|||
48907591|NCT03427125|157498278|FG002|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
48907592|NCT02708095|157498279|FG000|Overall Study|Adverse Event|4|||
48907593|NCT02708095|157498280|FG001|Overall Study|Adverse Event|10|||
48907594|NCT02708095|157498281|FG002|Overall Study|Adverse Event|11|||
48907595|NCT02708095|157498279|FG000|Overall Study|Lack of Efficacy|9|||
48907596|NCT02708095|157498280|FG001|Overall Study|Lack of Efficacy|3|||
48907597|NCT02708095|157498281|FG002|Overall Study|Lack of Efficacy|0|||
48907598|NCT02708095|157498279|FG000|Overall Study|Lost to Follow-up|2|||
48907599|NCT02708095|157498280|FG001|Overall Study|Lost to Follow-up|0|||
48907600|NCT02708095|157498281|FG002|Overall Study|Lost to Follow-up|0|||
48907601|NCT02708095|157498279|FG000|Overall Study|Physician Decision|2|||
48907602|NCT02708095|157498280|FG001|Overall Study|Physician Decision|3|||
48907603|NCT02708095|157498281|FG002|Overall Study|Physician Decision|2|||
48907604|NCT02708095|157498279|FG000|Overall Study|Protocol Violation|0|||
48907605|NCT02708095|157498280|FG001|Overall Study|Protocol Violation|0|||
48907606|NCT02708095|157498281|FG002|Overall Study|Protocol Violation|1|||
48907607|NCT02708095|157498279|FG000|Overall Study|Withdrawal by Subject|5|||
48907608|NCT02708095|157498280|FG001|Overall Study|Withdrawal by Subject|3|||
48907609|NCT02708095|157498281|FG002|Overall Study|Withdrawal by Subject|4|||
48907610|NCT03952338|157498282|FG000|Overall Study|Lost to Follow-up|11|||
48907611|NCT03952338|157498283|FG001|Overall Study|Lost to Follow-up|17|||
48907612|NCT03952338|157498282|FG000|Overall Study|Withdrawal by Subject|1|||
48907613|NCT03952338|157498283|FG001|Overall Study|Withdrawal by Subject|1|||
48907614|NCT03952338|157498282|FG000|Overall Study|Protocol Violation|1|||
48907615|NCT03952338|157498283|FG001|Overall Study|Protocol Violation|0|||
48907616|NCT03701763|157498284|FG000|Placebo-controlled Phase|Adverse Event|1|||
48907617|NCT03701763|157498285|FG001|Placebo-controlled Phase|Adverse Event|5|||
48907618|NCT03701763|157498286|FG002|Placebo-controlled Phase|Adverse Event|0|||
48907619|NCT03701763|157498287|FG003|Placebo-controlled Phase|Adverse Event|0|||
48907620|NCT03701763|157498284|FG000|Placebo-controlled Phase|Lack of Efficacy|2|||
48907621|NCT03701763|157498285|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
48907622|NCT03701763|157498286|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
48907623|NCT03701763|157498287|FG003|Placebo-controlled Phase|Lack of Efficacy|0|||
48907624|NCT03701763|157498284|FG000|Placebo-controlled Phase|Miscellaneous|2|||
48907625|NCT03701763|157498285|FG001|Placebo-controlled Phase|Miscellaneous|0|||
48907626|NCT03701763|157498286|FG002|Placebo-controlled Phase|Miscellaneous|0|||
48907627|NCT03701763|157498287|FG003|Placebo-controlled Phase|Miscellaneous|0|||
48907628|NCT03701763|157498284|FG000|Placebo-controlled Phase|Withdrawal by Parent/Guardian|3|||
48907629|NCT03701763|157498285|FG001|Placebo-controlled Phase|Withdrawal by Parent/Guardian|5|||
48907630|NCT03701763|157498286|FG002|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
48907631|NCT03701763|157498287|FG003|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
48907632|NCT03701763|157498284|FG000|Placebo-controlled Phase|Lost to Follow-up|0|||
48907633|NCT03701763|157498285|FG001|Placebo-controlled Phase|Lost to Follow-up|1|||
48907634|NCT03701763|157498286|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
48907635|NCT03701763|157498287|FG003|Placebo-controlled Phase|Lost to Follow-up|0|||
48907636|NCT03701763|157498284|FG000|Placebo-controlled Phase|Withdrawal by Subject|2|||
48907637|NCT03701763|157498285|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
48907638|NCT03701763|157498286|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
48907639|NCT03701763|157498287|FG003|Placebo-controlled Phase|Withdrawal by Subject|0|||
48907640|NCT03701763|157498284|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
48907641|NCT03701763|157498285|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
48907642|NCT03701763|157498286|FG002|Apremilast Extension Phase|Withdrawal by Subject|1|||
48907643|NCT03701763|157498287|FG003|Apremilast Extension Phase|Withdrawal by Subject|3|||
48907644|NCT03701763|157498284|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
48907645|NCT03701763|157498285|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
48907646|NCT03701763|157498286|FG002|Apremilast Extension Phase|Lack of Efficacy|3|||
48907647|NCT03701763|157498287|FG003|Apremilast Extension Phase|Lack of Efficacy|8|||
48907648|NCT03701763|157498284|FG000|Apremilast Extension Phase|Adverse Event|0|||
48907649|NCT03701763|157498285|FG001|Apremilast Extension Phase|Adverse Event|0|||
48907650|NCT03701763|157498286|FG002|Apremilast Extension Phase|Adverse Event|3|||
48907651|NCT03701763|157498287|FG003|Apremilast Extension Phase|Adverse Event|1|||
48907652|NCT03701763|157498284|FG000|Apremilast Extension Phase|Miscellaneous|0|||
48907653|NCT03701763|157498285|FG001|Apremilast Extension Phase|Miscellaneous|0|||
48907654|NCT03701763|157498286|FG002|Apremilast Extension Phase|Miscellaneous|2|||
48907655|NCT03701763|157498287|FG003|Apremilast Extension Phase|Miscellaneous|1|||
48907656|NCT03701763|157498284|FG000|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
48907657|NCT03701763|157498285|FG001|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
48907658|NCT03701763|157498286|FG002|Apremilast Extension Phase|Withdrawal by Parent/Guardian|1|||
48907659|NCT03701763|157498287|FG003|Apremilast Extension Phase|Withdrawal by Parent/Guardian|8|||
48907660|NCT03701763|157498284|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
48907661|NCT03701763|157498285|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
48907662|NCT03701763|157498286|FG002|Apremilast Extension Phase|Lost to Follow-up|0|||
48907663|NCT03701763|157498287|FG003|Apremilast Extension Phase|Lost to Follow-up|2|||
48907664|NCT03701763|157498284|FG000|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
48907665|NCT03701763|157498285|FG001|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
48907666|NCT03701763|157498286|FG002|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
48907667|NCT03701763|157498287|FG003|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
48907668|NCT03701763|157498284|FG000|14-Week Observational Follow-up Phase|Miscellaneous|0|||
48907669|NCT03701763|157498285|FG001|14-Week Observational Follow-up Phase|Miscellaneous|0|||
48907670|NCT03701763|157498286|FG002|14-Week Observational Follow-up Phase|Miscellaneous|1|||
48907671|NCT03701763|157498287|FG003|14-Week Observational Follow-up Phase|Miscellaneous|0|||
48907672|NCT03701763|157498284|FG000|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
48907673|NCT03701763|157498285|FG001|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
48907674|NCT03701763|157498286|FG002|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
48907675|NCT03701763|157498287|FG003|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
48907676|NCT03701763|157498284|FG000|14-Week Observational Follow-up Phase|Other|0|||
48907677|NCT03701763|157498285|FG001|14-Week Observational Follow-up Phase|Other|0|||
48907678|NCT03701763|157498286|FG002|14-Week Observational Follow-up Phase|Other|1|||
48907679|NCT03701763|157498287|FG003|14-Week Observational Follow-up Phase|Other|0|||
48907680|NCT03701763|157498284|FG000|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
48907681|NCT03701763|157498285|FG001|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
48907682|NCT03701763|157498286|FG002|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
48907683|NCT03701763|157498287|FG003|14-Week Observational Follow-up Phase|Lost to Follow-up|1|||
48907684|NCT03701763|157498284|FG000|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
48907685|NCT03701763|157498285|FG001|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
48907686|NCT03701763|157498286|FG002|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
48907687|NCT03701763|157498287|FG003|14-Week Observational Follow-up Phase|Withdrawal by Subject|2|||
48907688|NCT01019980|157498296|FG000|Overall Study|Drug not available.|2|||
48907689|NCT01019980|157498297|FG001|Overall Study|Drug not available.|0|||
48907690|NCT02273726|157498298|FG000|Overall Study|Death|70|||
48907691|NCT02273726|157498299|FG001|Overall Study|Death|62|||
48907692|NCT02273726|157498298|FG000|Overall Study|Withdrawal by Subject|41|||
48907693|NCT02273726|157498299|FG001|Overall Study|Withdrawal by Subject|29|||
48907694|NCT02273726|157498298|FG000|Overall Study|Kidney transplant|31|||
48907695|NCT02273726|157498299|FG001|Overall Study|Kidney transplant|39|||
48907696|NCT02273726|157498298|FG000|Overall Study|Physician Decision|30|||
48907697|NCT02273726|157498299|FG001|Overall Study|Physician Decision|15|||
48907698|NCT02273726|157498298|FG000|Overall Study|Adverse Event|27|||
48907699|NCT02273726|157498299|FG001|Overall Study|Adverse Event|9|||
48907700|NCT02273726|157498298|FG000|Overall Study|Lost to Follow-up|6|||
48907701|NCT02273726|157498299|FG001|Overall Study|Lost to Follow-up|3|||
48907702|NCT02273726|157498298|FG000|Overall Study|Lack of Efficacy|6|||
48907703|NCT02273726|157498299|FG001|Overall Study|Lack of Efficacy|1|||
48907704|NCT02273726|157498298|FG000|Overall Study|Protocol Violation|4|||
48907705|NCT02273726|157498299|FG001|Overall Study|Protocol Violation|0|||
48907706|NCT02273726|157498298|FG000|Overall Study|Other than specified|28|||
48907707|NCT02273726|157498299|FG001|Overall Study|Other than specified|30|||
48907708|NCT01979835|157498303|FG000|Primary Outcome SA Measurment|failed insertion|18|||
48907709|NCT01979835|157498303|FG000|Follow-up|Lost to Follow-up|32|||
48907710|NCT00601250|157498306|FG000|Overall Study|Adverse Event|3|||
48907711|NCT00601250|157498307|FG001|Overall Study|Adverse Event|9|||
48907712|NCT00601250|157498306|FG000|Overall Study|Protocol Violation|3|||
48907713|NCT00601250|157498307|FG001|Overall Study|Protocol Violation|2|||
48907714|NCT00601250|157498306|FG000|Overall Study|Lost to Follow-up|2|||
48907715|NCT00601250|157498307|FG001|Overall Study|Lost to Follow-up|6|||
48907716|NCT00601250|157498306|FG000|Overall Study|Withdrawal by Subject|4|||
48907717|NCT00601250|157498307|FG001|Overall Study|Withdrawal by Subject|13|||
48907718|NCT00601250|157498306|FG000|Overall Study|Other incl. lack of efficacy|2|||
48907719|NCT00601250|157498307|FG001|Overall Study|Other incl. lack of efficacy|9|||
48907720|NCT00047320|157498309|FG000|Overall Study|Lack of Efficacy|8|||
48907721|NCT00047320|157498309|FG000|Overall Study|Lost to Follow-up|1|||
48907722|NCT00047320|157498309|FG000|Overall Study|Physician Decision|8|||
48907723|NCT00047320|157498309|FG000|Overall Study|Withdrawal by Subject|9|||
48907724|NCT00047320|157498309|FG000|Overall Study|Ineligible|2|||
48907725|NCT00866697|157498311|FG000|Overall Study|Study closed/terminated|156|||
48907726|NCT00866697|157498312|FG001|Overall Study|Study closed/terminated|138|||
48907727|NCT00866697|157498311|FG000|Overall Study|Lost to Follow-up|22|||
48907728|NCT00866697|157498312|FG001|Overall Study|Lost to Follow-up|28|||
48907729|NCT00866697|157498311|FG000|Overall Study|Physician Decision|3|||
48907730|NCT00866697|157498312|FG001|Overall Study|Physician Decision|5|||
48907731|NCT00866697|157498311|FG000|Overall Study|Withdrawal by Subject|33|||
48907732|NCT00866697|157498312|FG001|Overall Study|Withdrawal by Subject|57|||
48907733|NCT01572922|157498313|FG000|Overall Study|Adverse Event|1|||
48907734|NCT01572922|157498313|FG000|Overall Study|Protocol Violation|1|||
48907735|NCT01572922|157498313|FG000|Overall Study|Death|1|||
48907736|NCT01428661|157498314|FG000|Double-Masked Phase|Protocol Violation|9|||
48907737|NCT01428661|157498315|FG001|Double-Masked Phase|Protocol Violation|4|||
48907738|NCT01428661|157498316|FG002|Double-Masked Phase|Protocol Violation|0|||
48907739|NCT01428661|157498314|FG000|Double-Masked Phase|Adverse Event|13|||
48907740|NCT01428661|157498315|FG001|Double-Masked Phase|Adverse Event|4|||
48907741|NCT01428661|157498316|FG002|Double-Masked Phase|Adverse Event|0|||
48907742|NCT01428661|157498314|FG000|Double-Masked Phase|Lost to Follow-up|14|||
48907743|NCT01428661|157498315|FG001|Double-Masked Phase|Lost to Follow-up|14|||
48907744|NCT01428661|157498316|FG002|Double-Masked Phase|Lost to Follow-up|0|||
48907745|NCT01428661|157498314|FG000|Double-Masked Phase|Withdrawal by Subject|18|||
48907746|NCT01428661|157498315|FG001|Double-Masked Phase|Withdrawal by Subject|20|||
48907747|NCT01428661|157498316|FG002|Double-Masked Phase|Withdrawal by Subject|0|||
48907748|NCT01428661|157498314|FG000|Double-Masked Phase|Lack of Efficacy|2|||
48907749|NCT01428661|157498315|FG001|Double-Masked Phase|Lack of Efficacy|1|||
48907750|NCT01428661|157498316|FG002|Double-Masked Phase|Lack of Efficacy|0|||
48907751|NCT01428661|157498314|FG000|Double-Masked Phase|*Various|1|||
48907752|NCT01428661|157498315|FG001|Double-Masked Phase|*Various|6|||
48907753|NCT01428661|157498316|FG002|Double-Masked Phase|*Various|0|||
48907754|NCT01428661|157498314|FG000|Open Label Extension|Protocol Violation|0|||
48907755|NCT01428661|157498315|FG001|Open Label Extension|Protocol Violation|0|||
48907756|NCT01428661|157498316|FG002|Open Label Extension|Protocol Violation|9|||
48907757|NCT01428661|157498314|FG000|Open Label Extension|Adverse Event|0|||
48907758|NCT01428661|157498315|FG001|Open Label Extension|Adverse Event|0|||
48907759|NCT01428661|157498316|FG002|Open Label Extension|Adverse Event|15|||
48907760|NCT01428661|157498314|FG000|Open Label Extension|Lost to Follow-up|0|||
48907761|NCT01428661|157498315|FG001|Open Label Extension|Lost to Follow-up|0|||
48907762|NCT01428661|157498316|FG002|Open Label Extension|Lost to Follow-up|38|||
48907763|NCT01428661|157498314|FG000|Open Label Extension|Withdrawal by Subject|0|||
48907764|NCT01428661|157498315|FG001|Open Label Extension|Withdrawal by Subject|0|||
48907765|NCT01428661|157498316|FG002|Open Label Extension|Withdrawal by Subject|49|||
48907766|NCT01428661|157498314|FG000|Open Label Extension|Lack of Efficacy|0|||
48907767|NCT01428661|157498315|FG001|Open Label Extension|Lack of Efficacy|0|||
48907768|NCT01428661|157498316|FG002|Open Label Extension|Lack of Efficacy|24|||
48907769|NCT01428661|157498314|FG000|Open Label Extension|**Various|0|||
48907770|NCT01428661|157498315|FG001|Open Label Extension|**Various|0|||
48907771|NCT01428661|157498316|FG002|Open Label Extension|**Various|185|||
48907772|NCT02818920|157498317|FG000|Overall Study|Unresectable|4|||
48907773|NCT02818920|157498317|FG000|Overall Study|Progressed After Neoadjuvant Therapy|1|||
48907774|NCT02818920|157498317|FG000|Overall Study|Went Off Study Prior to Adjuvant Therapy|8|||
48907775|NCT02818920|157498317|FG000|Overall Study|Adverse Event|3|||
48907776|NCT02818920|157498317|FG000|Overall Study|Developed Other Disease|1|||
48907777|NCT02818920|157498317|FG000|Overall Study|Refused Further Treatment|1|||
48907778|NCT00445068|157498318|FG000|Overall Study|Disease progression|26|||
48907779|NCT00445068|157498318|FG000|Overall Study|Adverse Event|5|||
48907780|NCT00445068|157498318|FG000|Overall Study|Abnormal laboratory value|2|||
48907781|NCT00445068|157498318|FG000|Overall Study|Withdrawal by Subject|2|||
48907782|NCT00445068|157498318|FG000|Overall Study|Death|1|||
48907783|NCT00583024|157498320|FG000|Overall Study|Lost to Follow-up|4|||
48907784|NCT01563185|157498321|FG000|Overall Study|Withdrawal by Subject|1|||
48907785|NCT01563185|157498321|FG000|Overall Study|Non-Compliance with study drug|1|||
48907786|NCT01103245|157500233|FG000|Overall Study|Withdrawal by Subject|1|||
48907787|NCT01103245|157500234|FG001|Overall Study|Withdrawal by Subject|0|||
49116285|NCT00534638|158263087|FG001|Overall Study|Migrated/moved from study area|11|||
49116286|NCT00534638|158263086|FG000|Overall Study|Lost to follow-up,incomplete vaccination|83|||
48907788|NCT01103245|157500235|FG002|Overall Study|Withdrawal by Subject|3|||
48907789|NCT01103245|157500236|FG003|Overall Study|Withdrawal by Subject|0|||
48907790|NCT01103245|157500233|FG000|Overall Study|Inadequate IV access|1|||
48907791|NCT01103245|157500234|FG001|Overall Study|Inadequate IV access|0|||
48907792|NCT01103245|157500235|FG002|Overall Study|Inadequate IV access|0|||
48907793|NCT01103245|157500236|FG003|Overall Study|Inadequate IV access|0|||
48907794|NCT01103245|157500233|FG000|Overall Study|Adverse Event|0|||
48907795|NCT01103245|157500234|FG001|Overall Study|Adverse Event|2|||
48907796|NCT01103245|157500235|FG002|Overall Study|Adverse Event|1|||
48907797|NCT01103245|157500236|FG003|Overall Study|Adverse Event|0|||
48907798|NCT01103245|157500233|FG000|Overall Study|Physician Decision|1|||
48907799|NCT01103245|157500234|FG001|Overall Study|Physician Decision|0|||
48907800|NCT01103245|157500235|FG002|Overall Study|Physician Decision|0|||
48907801|NCT01103245|157500236|FG003|Overall Study|Physician Decision|0|||
48907802|NCT01436071|157500244|FG000|Overall Study|Adverse Event|1|||
48907803|NCT01436071|157500245|FG001|Overall Study|Adverse Event|0|||
48907804|NCT01436071|157500244|FG000|Overall Study|Lack of Efficacy|16|||
48907805|NCT01436071|157500245|FG001|Overall Study|Lack of Efficacy|7|||
48907806|NCT01436071|157500244|FG000|Overall Study|Protocol Violation|0|||
48907807|NCT01436071|157500245|FG001|Overall Study|Protocol Violation|1|||
48907808|NCT01436071|157500244|FG000|Overall Study|Lost to Follow-up|3|||
48907809|NCT01436071|157500245|FG001|Overall Study|Lost to Follow-up|1|||
48907810|NCT01436071|157500244|FG000|Overall Study|Physician Decision|1|||
48907811|NCT01436071|157500245|FG001|Overall Study|Physician Decision|0|||
48907812|NCT01436071|157500244|FG000|Overall Study|Withdrawal by Subject|2|||
48907813|NCT01436071|157500245|FG001|Overall Study|Withdrawal by Subject|2|||
48907814|NCT01436071|157500244|FG000|Overall Study|Did Not Receive Trial Medication|3|||
48907815|NCT01436071|157500245|FG001|Overall Study|Did Not Receive Trial Medication|3|||
48907816|NCT01955122|157500246|FG000|Overall Study|Physician Decision|5|||
48907817|NCT01955122|157500247|FG001|Overall Study|Physician Decision|5|||
48907818|NCT02805725|157500248|FG000|Phase I (Dose Escalation Part)|Clinical progression|0|||
48907819|NCT02805725|157500249|FG001|Phase I (Dose Escalation Part)|Clinical progression|0|||
48907820|NCT02805725|157500250|FG002|Phase I (Dose Escalation Part)|Clinical progression|1|||
48907821|NCT02805725|157500251|FG003|Phase I (Dose Escalation Part)|Clinical progression|0|||
48907822|NCT02805725|157500252|FG004|Phase I (Dose Escalation Part)|Clinical progression|0|||
48907823|NCT02805725|157500248|FG000|Phase I (Dose Escalation Part)|Adverse Event|0|||
48907824|NCT02805725|157500249|FG001|Phase I (Dose Escalation Part)|Adverse Event|0|||
48907825|NCT02805725|157500250|FG002|Phase I (Dose Escalation Part)|Adverse Event|1|||
48907826|NCT02805725|157500251|FG003|Phase I (Dose Escalation Part)|Adverse Event|2|||
48907827|NCT02805725|157500252|FG004|Phase I (Dose Escalation Part)|Adverse Event|0|||
48907828|NCT02805725|157500248|FG000|Phase II|Protocol Violation|0|||
48907829|NCT02805725|157500249|FG001|Phase II|Protocol Violation|0|||
48907830|NCT02805725|157500250|FG002|Phase II|Protocol Violation|0|||
48907831|NCT02805725|157500251|FG003|Phase II|Protocol Violation|0|||
48907832|NCT02805725|157500252|FG004|Phase II|Protocol Violation|6|||
48907833|NCT01195545|157500253|FG000|Overall Study|Protocol Violation|4|||
48907834|NCT01028222|157500260|FG000|Overall Study|Protocol deviation|1|||
48907835|NCT01028222|157500261|FG001|Overall Study|Protocol deviation|0|||
48907836|NCT01028222|157500260|FG000|Overall Study|Disease progression|33|||
48907837|NCT01028222|157500261|FG001|Overall Study|Disease progression|9|||
48907838|NCT01028222|157500260|FG000|Overall Study|Administrative problems|1|||
48907839|NCT01028222|157500261|FG001|Overall Study|Administrative problems|1|||
48907840|NCT01028222|157500260|FG000|Overall Study|Lost to Follow-up|0|||
48907841|NCT01028222|157500261|FG001|Overall Study|Lost to Follow-up|1|||
48907842|NCT01028222|157500260|FG000|Overall Study|Withdrawal by Subject|1|||
48907843|NCT01028222|157500261|FG001|Overall Study|Withdrawal by Subject|0|||
48907844|NCT01028222|157500260|FG000|Overall Study|Crossover to nilotinib w/out progression|0|||
48907845|NCT01028222|157500261|FG001|Overall Study|Crossover to nilotinib w/out progression|2|||
48907846|NCT01028222|157500260|FG000|Overall Study|Adverse Event|2|||
48907847|NCT01028222|157500261|FG001|Overall Study|Adverse Event|0|||
48907848|NCT02973425|157500265|FG000|Overall Study|Lost to Follow-up|49|||
48907849|NCT02973425|157500266|FG001|Overall Study|Lost to Follow-up|53|||
48907850|NCT01448213|157500267|FG000|Overall Study|Lost to Follow-up|12|||
48907851|NCT01448213|157500268|FG001|Overall Study|Lost to Follow-up|10|||
48907852|NCT01448213|157500267|FG000|Overall Study|Adverse Event|4|||
48907853|NCT01448213|157500268|FG001|Overall Study|Adverse Event|10|||
48907854|NCT01448213|157500267|FG000|Overall Study|Protocol Violation|1|||
48907855|NCT01448213|157500268|FG001|Overall Study|Protocol Violation|2|||
48907856|NCT03876171|157500269|FG000|Overall Study|Withdrawal by Subject|3|||
48907857|NCT03876171|157500270|FG001|Overall Study|Withdrawal by Subject|3|||
48907858|NCT03876171|157500269|FG000|Overall Study|Re-arrest|0|||
48907859|NCT03876171|157500270|FG001|Overall Study|Re-arrest|4|||
48907860|NCT03434353|157500271|FG000|Overall Study|Started commercial Hepatitis B virus therapy|10|||
48907861|NCT03434353|157500272|FG001|Overall Study|Started commercial Hepatitis B virus therapy|3|||
48907862|NCT03434353|157500273|FG002|Overall Study|Started commercial Hepatitis B virus therapy|11|||
48907863|NCT03434353|157500274|FG003|Overall Study|Started commercial Hepatitis B virus therapy|3|||
48907864|NCT03434353|157500275|FG004|Overall Study|Started commercial Hepatitis B virus therapy|17|||
48907865|NCT03434353|157500271|FG000|Overall Study|Withdrew consent|1|||
48907866|NCT03434353|157500272|FG001|Overall Study|Withdrew consent|0|||
48907867|NCT03434353|157500273|FG002|Overall Study|Withdrew consent|3|||
48907868|NCT03434353|157500274|FG003|Overall Study|Withdrew consent|0|||
48907869|NCT03434353|157500275|FG004|Overall Study|Withdrew consent|0|||
48907870|NCT03434353|157500271|FG000|Overall Study|Adverse Event|1|||
48907871|NCT03434353|157500272|FG001|Overall Study|Adverse Event|0|||
48907872|NCT03434353|157500273|FG002|Overall Study|Adverse Event|0|||
48907873|NCT03434353|157500274|FG003|Overall Study|Adverse Event|0|||
48907874|NCT03434353|157500275|FG004|Overall Study|Adverse Event|1|||
48907875|NCT03434353|157500271|FG000|Overall Study|Lost to Follow-up|2|||
48907876|NCT03434353|157500272|FG001|Overall Study|Lost to Follow-up|0|||
48907877|NCT03434353|157500273|FG002|Overall Study|Lost to Follow-up|0|||
48907878|NCT03434353|157500274|FG003|Overall Study|Lost to Follow-up|0|||
48907879|NCT03434353|157500275|FG004|Overall Study|Lost to Follow-up|0|||
48907880|NCT02525861|157500276|FG000|Overall Study|Adverse Event|1|||
48907881|NCT02525861|157500277|FG001|Overall Study|Adverse Event|0|||
48907882|NCT02525861|157500276|FG000|Overall Study|Withdrawal by Subject|0|||
48907883|NCT02525861|157500277|FG001|Overall Study|Withdrawal by Subject|1|||
48907884|NCT02525861|157500276|FG000|Overall Study|Physician Decision|0|||
48907885|NCT02525861|157500277|FG001|Overall Study|Physician Decision|1|||
48907886|NCT04439071|157500285|FG000|Overall Study|Lost to Follow-up|0|||
48907887|NCT04439071|157500286|FG001|Overall Study|Lost to Follow-up|3|||
48907888|NCT04439071|157500285|FG000|Overall Study|Withdrawal by Subject|3|||
48907889|NCT04439071|157500286|FG001|Overall Study|Withdrawal by Subject|8|||
48907890|NCT04439071|157500285|FG000|Overall Study|Death|6|||
48907891|NCT04439071|157500286|FG001|Overall Study|Death|4|||
48907892|NCT04439071|157500285|FG000|Overall Study|Other than specified|3|||
48907893|NCT04439071|157500286|FG001|Overall Study|Other than specified|3|||
48907894|NCT04439071|157500285|FG000|Overall Study|Randomized but not treated|2|||
48907895|NCT04439071|157500286|FG001|Overall Study|Randomized but not treated|0|||
48907896|NCT01118325|157500294|FG000|Overall Study|Adverse Event|1|||
48907897|NCT01118325|157500295|FG001|Overall Study|Adverse Event|0|||
48907898|NCT01118325|157500296|FG002|Overall Study|Adverse Event|1|||
48907899|NCT01309230|157500297|FG000|Overall Study|Withdrawal by Subject|0|||
48907900|NCT01309230|157500298|FG001|Overall Study|Withdrawal by Subject|2|||
48907901|NCT01309230|157500297|FG000|Overall Study|Observation arm closed|0|||
48907902|NCT01309230|157500298|FG001|Overall Study|Observation arm closed|2|||
48907903|NCT00536809|157500299|FG000|Phase II|Adverse Event|1|||
48907904|NCT00536809|157500299|FG000|Phase II|Referred for surgical resection|1|||
48907905|NCT01386658|157500306|FG000|Initial Icatibant Exposure|Withdrawal by Subject|0|||
48907906|NCT01386658|157500307|FG001|Initial Icatibant Exposure|Withdrawal by Subject|9|||
48907907|NCT01386658|157500306|FG000|Initial Icatibant Exposure|Lack of adherence and poor compliance|0|||
48907908|NCT01386658|157500307|FG001|Initial Icatibant Exposure|Lack of adherence and poor compliance|3|||
48907909|NCT00631189|157500308|FG000|Initial Phase|Protocol Violation|347|||
48907910|NCT00631189|157500309|FG001|Initial Phase|Protocol Violation|0|||
48907911|NCT00631189|157500310|FG002|Initial Phase|Protocol Violation|0|||
48907912|NCT00631189|157500311|FG003|Initial Phase|Protocol Violation|0|||
48907913|NCT00631189|157500308|FG000|Initial Phase|Withdrawal by Subject|4|||
48907914|NCT00631189|157500309|FG001|Initial Phase|Withdrawal by Subject|0|||
48907915|NCT00631189|157500310|FG002|Initial Phase|Withdrawal by Subject|0|||
48907916|NCT00631189|157500311|FG003|Initial Phase|Withdrawal by Subject|0|||
48907917|NCT00631189|157500308|FG000|Treatment Phase|Withdrawal by Subject|0|||
48907918|NCT00631189|157500309|FG001|Treatment Phase|Withdrawal by Subject|2|||
48907919|NCT00631189|157500310|FG002|Treatment Phase|Withdrawal by Subject|1|||
48907920|NCT00631189|157500311|FG003|Treatment Phase|Withdrawal by Subject|1|||
48907921|NCT00631189|157500308|FG000|Treatment Phase|Protocol Violation|0|||
48907922|NCT00631189|157500309|FG001|Treatment Phase|Protocol Violation|1|||
48907923|NCT00631189|157500310|FG002|Treatment Phase|Protocol Violation|6|||
48907924|NCT00631189|157500311|FG003|Treatment Phase|Protocol Violation|2|||
48907925|NCT00631189|157500308|FG000|Treatment Phase|Adverse Event|0|||
48907926|NCT00631189|157500309|FG001|Treatment Phase|Adverse Event|3|||
48907927|NCT00631189|157500310|FG002|Treatment Phase|Adverse Event|2|||
48907928|NCT00631189|157500311|FG003|Treatment Phase|Adverse Event|4|||
48907929|NCT00631189|157500308|FG000|Treatment Phase|Lost to Follow-up|0|||
48907930|NCT00631189|157500309|FG001|Treatment Phase|Lost to Follow-up|1|||
48907931|NCT00631189|157500310|FG002|Treatment Phase|Lost to Follow-up|0|||
48907932|NCT00631189|157500311|FG003|Treatment Phase|Lost to Follow-up|0|||
48907933|NCT00631189|157500308|FG000|Treatment Phase|Pregnancy|0|||
48907934|NCT00631189|157500309|FG001|Treatment Phase|Pregnancy|0|||
48907935|NCT00631189|157500310|FG002|Treatment Phase|Pregnancy|1|||
48907936|NCT00631189|157500311|FG003|Treatment Phase|Pregnancy|0|||
48907937|NCT00631189|157500308|FG000|Treatment Phase|patient did not take pravastatin|0|||
48907938|NCT00631189|157500309|FG001|Treatment Phase|patient did not take pravastatin|0|||
48907939|NCT00631189|157500310|FG002|Treatment Phase|patient did not take pravastatin|1|||
48907940|NCT00631189|157500311|FG003|Treatment Phase|patient did not take pravastatin|0|||
48907941|NCT04464265|157500312|FG000|Overall Study|Physician Decision|2|||
48907942|NCT00874770|157500313|FG000|Overall Study|Lack of Efficacy|2|||
48907943|NCT00874770|157500314|FG001|Overall Study|Lack of Efficacy|0|||
48907944|NCT00874770|157500315|FG002|Overall Study|Lack of Efficacy|0|||
48907945|NCT00874770|157500316|FG003|Overall Study|Lack of Efficacy|2|||
48907946|NCT00874770|157500313|FG000|Overall Study|Adverse Event|1|||
48907947|NCT00874770|157500314|FG001|Overall Study|Adverse Event|1|||
48907948|NCT00874770|157500315|FG002|Overall Study|Adverse Event|4|||
48907949|NCT00874770|157500316|FG003|Overall Study|Adverse Event|2|||
48907950|NCT00874770|157500313|FG000|Overall Study|Lost to Follow-up|1|||
48907951|NCT00874770|157500314|FG001|Overall Study|Lost to Follow-up|0|||
48907952|NCT00874770|157500315|FG002|Overall Study|Lost to Follow-up|0|||
48907953|NCT00874770|157500316|FG003|Overall Study|Lost to Follow-up|1|||
48907954|NCT00874770|157500313|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
48907955|NCT00874770|157500314|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
48907956|NCT00874770|157500315|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
48907957|NCT00874770|157500316|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
48907958|NCT00974090|157500321|FG000|Period 1: Double Blind Period|Adverse Event|2|||
48907959|NCT00974090|157500322|FG001|Period 1: Double Blind Period|Adverse Event|1|||
48907960|NCT00974090|157500321|FG000|Period 1: Double Blind Period|Physician Decision|1|||
48907961|NCT00974090|157500322|FG001|Period 1: Double Blind Period|Physician Decision|0|||
48907962|NCT00974090|157500321|FG000|Period 2: Open-label Period|Adverse Event|4|||
48907963|NCT00974090|157500322|FG001|Period 2: Open-label Period|Adverse Event|6|||
48907964|NCT00974090|157500321|FG000|Period 2: Open-label Period|Lack of Efficacy|3|||
48907965|NCT00974090|157500322|FG001|Period 2: Open-label Period|Lack of Efficacy|1|||
48907966|NCT00974090|157500321|FG000|Period 2: Open-label Period|Physician Decision|0|||
48907967|NCT00974090|157500322|FG001|Period 2: Open-label Period|Physician Decision|3|||
48907968|NCT00974090|157500321|FG000|Period 2: Open-label Period|Withdrawal by Subject|1|||
48907969|NCT00974090|157500322|FG001|Period 2: Open-label Period|Withdrawal by Subject|0|||
48907970|NCT01145495|157500324|FG000|Overall Study|Adverse Event|6|||
48907971|NCT01145495|157500324|FG000|Overall Study|Withdrawal by Subject|6|||
48907972|NCT01145495|157500324|FG000|Overall Study|Disease progression after respone|2|||
48907973|NCT01438151|157500325|FG000|Overall Study|study terminated|8|||
48907974|NCT01303965|157500326|FG000|Overall Study|Adverse Event|1|||
48907975|NCT01303965|157500327|FG001|Overall Study|Adverse Event|1|||
48907976|NCT01303965|157500326|FG000|Overall Study|Death|0|||
48907977|NCT01303965|157500327|FG001|Overall Study|Death|3|||
48907978|NCT01303965|157500326|FG000|Overall Study|Withdrawal by Subject|1|||
48907979|NCT01303965|157500327|FG001|Overall Study|Withdrawal by Subject|0|||
48907980|NCT01303965|157500326|FG000|Overall Study|Disease Progression|1|||
48907981|NCT01303965|157500327|FG001|Overall Study|Disease Progression|6|||
48907982|NCT02448225|157500328|FG000|Overall Study|Withdrawal by Subject|1|||
48907983|NCT02448225|157500328|FG000|Overall Study|Did not get FSPG scan|18|||
48907984|NCT02448225|157500328|FG000|Overall Study|Treated between the FDG and FSPG scan|1|||
48907985|NCT00962390|157500331|FG000|Overall Study|Adverse Event|0|||
48907986|NCT00962390|157500332|FG001|Overall Study|Adverse Event|0|||
48907987|NCT00962390|157500333|FG002|Overall Study|Adverse Event|3|||
48907988|NCT00962390|157500334|FG003|Overall Study|Adverse Event|1|||
48907989|NCT00962390|157500331|FG000|Overall Study|Lost to Follow-up|2|||
48907990|NCT00962390|157500332|FG001|Overall Study|Lost to Follow-up|2|||
48907991|NCT00962390|157500333|FG002|Overall Study|Lost to Follow-up|0|||
48907992|NCT00962390|157500334|FG003|Overall Study|Lost to Follow-up|0|||
48907993|NCT00962390|157500331|FG000|Overall Study|Protocol Violation|1|||
48907994|NCT00962390|157500332|FG001|Overall Study|Protocol Violation|0|||
48907995|NCT00962390|157500333|FG002|Overall Study|Protocol Violation|0|||
48907996|NCT00962390|157500334|FG003|Overall Study|Protocol Violation|0|||
48907997|NCT00962390|157500331|FG000|Overall Study|Withdrawal by Subject|1|||
48907998|NCT00962390|157500332|FG001|Overall Study|Withdrawal by Subject|1|||
48907999|NCT00962390|157500333|FG002|Overall Study|Withdrawal by Subject|1|||
48908000|NCT00962390|157500334|FG003|Overall Study|Withdrawal by Subject|0|||
48908001|NCT00578786|157500337|FG000|Overall Study|Adverse Event|27|||
48908002|NCT00578786|157500338|FG001|Overall Study|Adverse Event|37|||
48908003|NCT00578786|157500339|FG002|Overall Study|Adverse Event|17|||
48908004|NCT00578786|157500337|FG000|Overall Study|Lack of Efficacy|2|||
48908005|NCT00578786|157500338|FG001|Overall Study|Lack of Efficacy|5|||
48908006|NCT00578786|157500339|FG002|Overall Study|Lack of Efficacy|2|||
48908007|NCT00578786|157500337|FG000|Overall Study|Early Escape from Prior Study|2|||
48908008|NCT00578786|157500338|FG001|Overall Study|Early Escape from Prior Study|1|||
48908009|NCT00578786|157500339|FG002|Overall Study|Early Escape from Prior Study|2|||
48908010|NCT00578786|157500337|FG000|Overall Study|Withdrawal by Subject|7|||
48908011|NCT00578786|157500338|FG001|Overall Study|Withdrawal by Subject|8|||
48908012|NCT00578786|157500339|FG002|Overall Study|Withdrawal by Subject|5|||
48908013|NCT00578786|157500337|FG000|Overall Study|Protocol Violation|0|||
48908014|NCT00578786|157500338|FG001|Overall Study|Protocol Violation|3|||
48908015|NCT00578786|157500339|FG002|Overall Study|Protocol Violation|1|||
48908016|NCT00578786|157500337|FG000|Overall Study|Physician Decision|1|||
48908017|NCT00578786|157500338|FG001|Overall Study|Physician Decision|0|||
48908018|NCT00578786|157500339|FG002|Overall Study|Physician Decision|1|||
48908019|NCT00578786|157500337|FG000|Overall Study|Sponsor Decision|0|||
48908020|NCT00578786|157500338|FG001|Overall Study|Sponsor Decision|0|||
48908021|NCT00578786|157500339|FG002|Overall Study|Sponsor Decision|1|||
48908022|NCT00578786|157500337|FG000|Overall Study|Lost to Follow-up|0|||
48908023|NCT00578786|157500338|FG001|Overall Study|Lost to Follow-up|4|||
48908024|NCT00578786|157500339|FG002|Overall Study|Lost to Follow-up|0|||
48908025|NCT00578786|157500337|FG000|Overall Study|Pregnancy|0|||
48908026|NCT00578786|157500338|FG001|Overall Study|Pregnancy|1|||
48908027|NCT00578786|157500339|FG002|Overall Study|Pregnancy|0|||
48908028|NCT00578786|157500337|FG000|Overall Study|Not Otherwise Specified|0|||
48908029|NCT00578786|157500338|FG001|Overall Study|Not Otherwise Specified|4|||
48908030|NCT00578786|157500339|FG002|Overall Study|Not Otherwise Specified|1|||
48908031|NCT00578786|157500337|FG000|Overall Study|Qualified but Not Enrolled in Extension|0|||
48908032|NCT00578786|157500338|FG001|Overall Study|Qualified but Not Enrolled in Extension|3|||
48908033|NCT00578786|157500339|FG002|Overall Study|Qualified but Not Enrolled in Extension|0|||
48908034|NCT02178553|157500342|FG000|Overall Study|Did not proceed to open thoracotomy|7|||
48908035|NCT02178553|157500343|FG001|Overall Study|Did not proceed to open thoracotomy|3|||
48908036|NCT02178553|157500342|FG000|Overall Study|Physician Decision|0|||
48908037|NCT02178553|157500343|FG001|Overall Study|Physician Decision|4|||
48908038|NCT02178553|157500342|FG000|Overall Study|Technical problem with injection|1|||
48908039|NCT02178553|157500343|FG001|Overall Study|Technical problem with injection|3|||
48908040|NCT05085665|157500344|FG000|Overall Study|Physician Decision|2|||
48908041|NCT01478360|157500346|FG000|Overall Study|Lost to Follow-up|1|||
48908042|NCT01478360|157500347|FG001|Overall Study|Lost to Follow-up|0|||
48908043|NCT01478360|157500346|FG000|Overall Study|Adverse Event|0|||
48908044|NCT01478360|157500347|FG001|Overall Study|Adverse Event|1|||
48908045|NCT01478360|157500346|FG000|Overall Study|Administrative problems|1|||
48908046|NCT01478360|157500347|FG001|Overall Study|Administrative problems|2|||
48908047|NCT02941926|157500371|FG000|Core Phase|Progressive disease|1109|||
48908048|NCT02941926|157500371|FG000|Core Phase|Adverse Event|504|||
48908049|NCT02941926|157500371|FG000|Core Phase|Subject/guardian decision|127|||
48908050|NCT02941926|157500371|FG000|Core Phase|Physician Decision|112|||
48908051|NCT02941926|157500371|FG000|Core Phase|Death|46|||
48908052|NCT02941926|157500371|FG000|Core Phase|Protocol deviation|34|||
48908053|NCT02941926|157500371|FG000|Core Phase|Lost to Follow-up|8|||
48908054|NCT02941926|157500371|FG000|Core Phase|Technical problems|5|||
48908055|NCT02941926|157500371|FG000|Extension Phase|Physician Decision|155|||
48908056|NCT02941926|157500371|FG000|Extension Phase|Progressive disease|115|||
48908057|NCT02941926|157500371|FG000|Extension Phase|Adverse Event|13|||
48908058|NCT02941926|157500371|FG000|Extension Phase|Subject/Guardian decision|12|||
48908059|NCT02941926|157500371|FG000|Extension Phase|Death|6|||
48908060|NCT03675776|157500372|FG000|Double Blind Treatment Period|Study Terminated by Sponsor|5|||
48908061|NCT03675776|157500373|FG001|Double Blind Treatment Period|Study Terminated by Sponsor|6|||
48908062|NCT03675776|157500374|FG002|Double Blind Treatment Period|Study Terminated by Sponsor|8|||
48908063|NCT03675776|157500372|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
48908064|NCT03675776|157500373|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
48908065|NCT03675776|157500374|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
48908066|NCT01009034|157500375|FG000|Overall Study|Lost to Follow-up|2|||
48908067|NCT01009034|157500375|FG000|Overall Study|Withdrawal by Subject|2|||
48908068|NCT02536755|157500377|FG000|Overall Study|Adverse Event|4|||
48908069|NCT04136184|157500382|FG000|Overall Study|Lost to Follow-up|0|||
48908070|NCT04136184|157500383|FG001|Overall Study|Lost to Follow-up|3|||
48908071|NCT04136184|157500382|FG000|Overall Study|Voluntary Withdrawal (including enrolled OLE)|23|||
48908072|NCT04136184|157500383|FG001|Overall Study|Voluntary Withdrawal (including enrolled OLE)|119|||
48908073|NCT02129205|157500386|FG000|Overall Study|Withdrawal by Subject|0|||
48908074|NCT02129205|157500387|FG001|Overall Study|Withdrawal by Subject|0|||
48908075|NCT02129205|157500388|FG002|Overall Study|Withdrawal by Subject|0|||
48908076|NCT02129205|157500389|FG003|Overall Study|Withdrawal by Subject|0|||
48908077|NCT02129205|157500390|FG004|Overall Study|Withdrawal by Subject|1|||
48908078|NCT02129205|157500391|FG005|Overall Study|Withdrawal by Subject|1|||
48908079|NCT02129205|157500392|FG006|Overall Study|Withdrawal by Subject|1|||
48908080|NCT02129205|157500393|FG007|Overall Study|Withdrawal by Subject|0|||
48908081|NCT02129205|157500394|FG008|Overall Study|Withdrawal by Subject|1|||
48908082|NCT02129205|157500395|FG009|Overall Study|Withdrawal by Subject|0|||
48908083|NCT02129205|157500386|FG000|Overall Study|Other|1|||
48908084|NCT02129205|157500387|FG001|Overall Study|Other|0|||
48908085|NCT02129205|157500388|FG002|Overall Study|Other|0|||
48908086|NCT02129205|157500389|FG003|Overall Study|Other|0|||
48695027|NCT00472108|156732146|FG000|Overall Study|Lost to Follow-up|0|||
48695028|NCT00472108|156732147|FG001|Overall Study|Lost to Follow-up|1|||
48908087|NCT02129205|157500390|FG004|Overall Study|Other|2|||
48908088|NCT02129205|157500391|FG005|Overall Study|Other|3|||
48908089|NCT02129205|157500392|FG006|Overall Study|Other|3|||
48908090|NCT02129205|157500393|FG007|Overall Study|Other|2|||
48908091|NCT02129205|157500394|FG008|Overall Study|Other|1|||
48908092|NCT02129205|157500395|FG009|Overall Study|Other|0|||
48908093|NCT01479829|157500396|FG000|Overall Study|Withdrawal by Subject|8|||
48908094|NCT01479829|157500397|FG001|Overall Study|Withdrawal by Subject|10|||
48908095|NCT02877927|157500398|FG000|Overall Study|Adverse Event|1|||
48908096|NCT02877927|157500399|FG001|Overall Study|Adverse Event|0|||
48908097|NCT02877927|157500398|FG000|Overall Study|Lost to Follow-up|37|||
48908098|NCT02877927|157500399|FG001|Overall Study|Lost to Follow-up|38|||
48908099|NCT02877927|157500398|FG000|Overall Study|Withdrawal by Subject|11|||
48908100|NCT02877927|157500399|FG001|Overall Study|Withdrawal by Subject|12|||
48908101|NCT02877927|157500398|FG000|Overall Study|Physician Decision|0|||
48908102|NCT02877927|157500399|FG001|Overall Study|Physician Decision|1|||
49116287|NCT00534638|158263087|FG001|Overall Study|Lost to follow-up,incomplete vaccination|117|||
49116288|NCT00534638|158263086|FG000|Overall Study|Lost to follow-up, complete vaccination|4707|||
49116289|NCT00534638|158263087|FG001|Overall Study|Lost to follow-up, complete vaccination|10757|||
49116290|NCT00534638|158263086|FG000|Overall Study|Other|1685|||
49116291|NCT00534638|158263087|FG001|Overall Study|Other|902|||
49116292|NCT01084538|158263088|FG000|Overall Study|Drug not available|30|||
48908103|NCT02877927|157500398|FG000|Overall Study|Missed EOT/PTE Visit|5|||
48908104|NCT02877927|157500399|FG001|Overall Study|Missed EOT/PTE Visit|6|||
48908105|NCT01810016|157500400|FG000|Overall Study|Progressive disease|1|||
48908106|NCT01810016|157500401|FG001|Overall Study|Progressive disease|1|||
48908107|NCT01810016|157500402|FG002|Overall Study|Progressive disease|0|||
48908108|NCT01810016|157500400|FG000|Overall Study|Death|0|||
48908109|NCT01810016|157500401|FG001|Overall Study|Death|0|||
48908110|NCT01810016|157500402|FG002|Overall Study|Death|1|||
48908111|NCT06065735|157500403|FG000|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|2|||
48908112|NCT06065735|157500404|FG001|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
48908113|NCT06065735|157500405|FG002|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
48908114|NCT06065735|157500403|FG000|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|2|||
48908115|NCT06065735|157500404|FG001|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
48908116|NCT06065735|157500405|FG002|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
48908117|NCT06065735|157500403|FG000|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|1|||
48908118|NCT06065735|157500404|FG001|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
48908119|NCT06065735|157500405|FG002|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
48908120|NCT06065735|157500403|FG000|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
48908121|NCT06065735|157500404|FG001|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|1|||
48908122|NCT06065735|157500405|FG002|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
48908123|NCT06065735|157500403|FG000|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
48908124|NCT06065735|157500404|FG001|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
48908125|NCT06065735|157500405|FG002|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|1|||
48908126|NCT01310803|157501757|FG000|Overall Study|Subject terminated by Sponsor|1|||
48908127|NCT01310803|157501758|FG001|Overall Study|Subject terminated by Sponsor|0|||
48908128|NCT01306890|157501761|FG000|Overall Study|Adverse Event|2|||
48908129|NCT01306890|157501761|FG000|Overall Study|Death|1223|||
48908130|NCT01306890|157501761|FG000|Overall Study|Lost to Follow-up|58|||
48908131|NCT01306890|157501761|FG000|Overall Study|Withdrawal by Subject|88|||
48908132|NCT01306890|157501761|FG000|Overall Study|Unspecified reasons|104|||
48908133|NCT01306890|157501761|FG000|Overall Study|Study Termination|3|||
48908134|NCT01306890|157501761|FG000|Overall Study|No discontinuation documentation|41|||
48908135|NCT01444651|157501762|FG000|Overall Study|Adverse Event|3|||
48908136|NCT01444651|157501763|FG001|Overall Study|Adverse Event|2|||
48908137|NCT01444651|157501762|FG000|Overall Study|Lost to Follow-up|5|||
48908138|NCT01444651|157501763|FG001|Overall Study|Lost to Follow-up|5|||
48908139|NCT01444651|157501762|FG000|Overall Study|Non-fasting|2|||
48908140|NCT01444651|157501763|FG001|Overall Study|Non-fasting|1|||
48908141|NCT01444651|157501762|FG000|Overall Study|Missing data|1|||
48908142|NCT01444651|157501763|FG001|Overall Study|Missing data|1|||
48908143|NCT03047551|157501767|FG000|Overall Study|Did not receive TAS|1|||
48908144|NCT03047551|157501768|FG001|Overall Study|Did not receive TAS|0|||
48908145|NCT03047551|157501767|FG000|Overall Study|Physician Decision|1|||
48908146|NCT03047551|157501768|FG001|Overall Study|Physician Decision|0|||
48908147|NCT03047551|157501767|FG000|Overall Study|Withdrawal by Subject|0|||
48908148|NCT03047551|157501768|FG001|Overall Study|Withdrawal by Subject|1|||
48908149|NCT03047551|157501767|FG000|Overall Study|Probe malfunction|0|||
48908150|NCT03047551|157501768|FG001|Overall Study|Probe malfunction|1|||
48908151|NCT03047551|157501767|FG000|Overall Study|Ineligible|0|||
48908152|NCT03047551|157501768|FG001|Overall Study|Ineligible|1|||
48908153|NCT00726622|157501769|FG000|Overall Study|Withdrawal by Subject|16|||
48908154|NCT00726622|157501770|FG001|Overall Study|Withdrawal by Subject|2|||
48908155|NCT00726622|157501769|FG000|Overall Study|Physician Decision|0|||
48908156|NCT00726622|157501770|FG001|Overall Study|Physician Decision|1|||
48908157|NCT00726622|157501769|FG000|Overall Study|Metastasis|2|||
48908158|NCT00726622|157501770|FG001|Overall Study|Metastasis|0|||
48908159|NCT02462928|157501773|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
48908160|NCT02462928|157501774|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
49010520|NCT00926289|157875640|FG001|Overall Study|Lost to Follow-up|6|||
48908161|NCT02462928|157501775|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|2|||
48908162|NCT02462928|157501773|FG000|Overall Study|Adverse Event|47|||
49116293|NCT01084538|158263088|FG000|Overall Study|Adverse Event|9|||
49116294|NCT01084538|158263088|FG000|Overall Study|Kidney transplant|6|||
48908163|NCT02462928|157501774|FG001|Overall Study|Adverse Event|51|||
48908164|NCT02462928|157501775|FG002|Overall Study|Adverse Event|25|||
48908165|NCT02462928|157501773|FG000|Overall Study|Lack of Efficacy|3|||
48908166|NCT02462928|157501774|FG001|Overall Study|Lack of Efficacy|8|||
48908167|NCT02462928|157501775|FG002|Overall Study|Lack of Efficacy|3|||
48908168|NCT02462928|157501773|FG000|Overall Study|Lost to Follow-up|4|||
48908169|NCT02462928|157501774|FG001|Overall Study|Lost to Follow-up|4|||
48908170|NCT02462928|157501775|FG002|Overall Study|Lost to Follow-up|1|||
48908171|NCT02462928|157501773|FG000|Overall Study|Withdrawal by Patient|31|||
48908172|NCT02462928|157501774|FG001|Overall Study|Withdrawal by Patient|21|||
48908173|NCT02462928|157501775|FG002|Overall Study|Withdrawal by Patient|21|||
48908174|NCT02462928|157501773|FG000|Overall Study|Protocol Violation|0|||
48908175|NCT02462928|157501774|FG001|Overall Study|Protocol Violation|1|||
48908176|NCT02462928|157501775|FG002|Overall Study|Protocol Violation|0|||
48908177|NCT02462928|157501773|FG000|Overall Study|Reason not Specified|4|||
48908178|NCT02462928|157501774|FG001|Overall Study|Reason not Specified|6|||
48908179|NCT02462928|157501775|FG002|Overall Study|Reason not Specified|5|||
48908180|NCT01493557|157501776|FG000|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
48908181|NCT01493557|157501777|FG001|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
48908182|NCT01493557|157501778|FG002|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1|||
48908183|NCT01493557|157501776|FG000|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
48908184|NCT01493557|157501777|FG001|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
48908185|NCT01493557|157501778|FG002|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9|||
48908186|NCT01493557|157501776|FG000|Not Randomized to Management Strategies|Other adverse event|0|||
48908187|NCT01493557|157501777|FG001|Not Randomized to Management Strategies|Other adverse event|0|||
48908188|NCT01493557|157501778|FG002|Not Randomized to Management Strategies|Other adverse event|54|||
48908189|NCT01493557|157501776|FG000|Not Randomized to Management Strategies|Protocol Violation|0|||
48908190|NCT01493557|157501777|FG001|Not Randomized to Management Strategies|Protocol Violation|0|||
48908191|NCT01493557|157501778|FG002|Not Randomized to Management Strategies|Protocol Violation|1|||
48908192|NCT01493557|157501776|FG000|Not Randomized to Management Strategies|Lost to Follow-up|0|||
48908193|NCT01493557|157501777|FG001|Not Randomized to Management Strategies|Lost to Follow-up|0|||
48908194|NCT01493557|157501778|FG002|Not Randomized to Management Strategies|Lost to Follow-up|4|||
48908195|NCT01493557|157501776|FG000|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
48908196|NCT01493557|157501777|FG001|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
48908197|NCT01493557|157501778|FG002|Not Randomized to Management Strategies|Withdrawal by Subject|10|||
48908198|NCT01493557|157501776|FG000|Not Randomized to Management Strategies|Early termination|0|||
48908199|NCT01493557|157501777|FG001|Not Randomized to Management Strategies|Early termination|0|||
48908200|NCT01493557|157501778|FG002|Not Randomized to Management Strategies|Early termination|34|||
48908201|NCT01493557|157501776|FG000|Not Randomized to Management Strategies|Other than stated above|0|||
48908202|NCT01493557|157501777|FG001|Not Randomized to Management Strategies|Other than stated above|0|||
48908203|NCT01493557|157501778|FG002|Not Randomized to Management Strategies|Other than stated above|21|||
48908204|NCT01493557|157501776|FG000|Randomized to Management Strategies|Worsening of events associate with GIS|3|||
48908205|NCT01493557|157501777|FG001|Randomized to Management Strategies|Worsening of events associate with GIS|2|||
48908206|NCT01493557|157501778|FG002|Randomized to Management Strategies|Worsening of events associate with GIS|0|||
48908207|NCT01493557|157501776|FG000|Randomized to Management Strategies|Other adverse event|8|||
48908208|NCT01493557|157501777|FG001|Randomized to Management Strategies|Other adverse event|5|||
48908209|NCT01493557|157501778|FG002|Randomized to Management Strategies|Other adverse event|0|||
48908210|NCT01493557|157501776|FG000|Randomized to Management Strategies|Protocol Violation|3|||
48908211|NCT01493557|157501777|FG001|Randomized to Management Strategies|Protocol Violation|0|||
48908212|NCT01493557|157501778|FG002|Randomized to Management Strategies|Protocol Violation|0|||
48908213|NCT01493557|157501776|FG000|Randomized to Management Strategies|Withdrawal by Subject|0|||
48908214|NCT01493557|157501777|FG001|Randomized to Management Strategies|Withdrawal by Subject|1|||
48908215|NCT01493557|157501778|FG002|Randomized to Management Strategies|Withdrawal by Subject|0|||
48908216|NCT01493557|157501776|FG000|Randomized to Management Strategies|Other than stated above|1|||
48908217|NCT01493557|157501777|FG001|Randomized to Management Strategies|Other than stated above|3|||
48908218|NCT01493557|157501778|FG002|Randomized to Management Strategies|Other than stated above|0|||
48908219|NCT01493557|157501776|FG000|Adding the Second Strategy|Worsening of events associate with GIS|1|||
48908220|NCT01493557|157501777|FG001|Adding the Second Strategy|Worsening of events associate with GIS|1|||
48908221|NCT01493557|157501778|FG002|Adding the Second Strategy|Worsening of events associate with GIS|0|||
48908222|NCT01493557|157501776|FG000|Adding the Second Strategy|Other adverse event|1|||
48908223|NCT01493557|157501777|FG001|Adding the Second Strategy|Other adverse event|2|||
48908224|NCT01493557|157501778|FG002|Adding the Second Strategy|Other adverse event|0|||
48908225|NCT01493557|157501776|FG000|Adding the Second Strategy|Withdrawal by Subject|0|||
48908226|NCT01493557|157501777|FG001|Adding the Second Strategy|Withdrawal by Subject|1|||
48908227|NCT01493557|157501778|FG002|Adding the Second Strategy|Withdrawal by Subject|0|||
48908228|NCT03503513|157501781|FG000|Overall Study|First cohort faced a clinical hold which caused disruption in treatment;|4|||
48908229|NCT03503513|157501781|FG000|Overall Study|Second cohort faced changes due to pandemic, resulting in declining participant count|2|||
48908230|NCT03503513|157501781|FG000|Overall Study|Physician Decision|3|||
48908231|NCT03503513|157501781|FG000|Overall Study|Withdrawal by Subject|2|||
48908232|NCT03503513|157501781|FG000|Overall Study|Lost to Follow-up|1|||
48908233|NCT04906616|157501786|FG000|Overall Study|Divorce|3|||
48908234|NCT04906616|157501787|FG001|Overall Study|Divorce|2|||
48908235|NCT03739762|157501788|FG000|Overall Study|Lost to Follow-up|1|||
48908236|NCT03739762|157501789|FG001|Overall Study|Lost to Follow-up|1|||
48908237|NCT03739762|157501788|FG000|Overall Study|Withdrawal by Subject|2|||
48908238|NCT03739762|157501789|FG001|Overall Study|Withdrawal by Subject|6|||
48908239|NCT02598557|157501790|FG000|Overall Study|Withdrawal by Subject|1|||
48908240|NCT02598557|157501791|FG001|Overall Study|Withdrawal by Subject|0|||
48908241|NCT02598557|157501792|FG002|Overall Study|Withdrawal by Subject|1|||
48908242|NCT02598557|157501790|FG000|Overall Study|Participant did not start treatment|2|||
48908243|NCT02598557|157501791|FG001|Overall Study|Participant did not start treatment|1|||
48908244|NCT02598557|157501792|FG002|Overall Study|Participant did not start treatment|1|||
48908245|NCT02598557|157501790|FG000|Overall Study|Unavailable specimen for endpoint evaluations|0|||
48908246|NCT02598557|157501791|FG001|Overall Study|Unavailable specimen for endpoint evaluations|0|||
48908247|NCT02598557|157501792|FG002|Overall Study|Unavailable specimen for endpoint evaluations|1|||
48908248|NCT02598557|157501790|FG000|Overall Study|Adverse Event|1|||
48908249|NCT02598557|157501791|FG001|Overall Study|Adverse Event|1|||
48908250|NCT02598557|157501792|FG002|Overall Study|Adverse Event|0|||
48908251|NCT00908583|157501793|FG000|Phase 1|Withdrawal by Subject|1|||
48908252|NCT00908583|157501793|FG000|Phase 1|Adverse Event|4|||
48908253|NCT00908583|157501793|FG000|Phase 2|Physician Decision|1|||
48908254|NCT00908583|157501793|FG000|Phase 2|Adverse Event|1|||
48908255|NCT00908583|157501793|FG000|Phase 3|Adverse Event|2|||
48908256|NCT00908583|157501793|FG000|Phase 4|Adverse Event|1|||
48908257|NCT00908583|157501793|FG000|Phase 4|Physician Decision|1|||
48908258|NCT00908583|157501793|FG000|Phase 5|Adverse Event|3|||
48908259|NCT02072434|157501794|FG000|Overall Study|Protocol Violation|10|||
48908260|NCT02072434|157501795|FG001|Overall Study|Protocol Violation|9|||
48908261|NCT02072434|157501794|FG000|Overall Study|Physician Decision|5|||
48908262|NCT02072434|157501795|FG001|Overall Study|Physician Decision|10|||
48908263|NCT02072434|157501794|FG000|Overall Study|Adverse event, serious fatal|1|||
48908264|NCT02072434|157501795|FG001|Overall Study|Adverse event, serious fatal|6|||
48908265|NCT02072434|157501794|FG000|Overall Study|Adverse Event|7|||
48908266|NCT02072434|157501795|FG001|Overall Study|Adverse Event|6|||
48908267|NCT02072434|157501794|FG000|Overall Study|Withdrawal by Subject|17|||
48908268|NCT02072434|157501795|FG001|Overall Study|Withdrawal by Subject|29|||
48908269|NCT02072434|157501794|FG000|Overall Study|Other|14|||
48908270|NCT02072434|157501795|FG001|Overall Study|Other|29|||
48908271|NCT02072434|157501794|FG000|Overall Study|Lost to Follow-up|0|||
48908272|NCT02072434|157501795|FG001|Overall Study|Lost to Follow-up|1|||
48908273|NCT00993954|157501796|FG000|Overall Study|Protocol Violation|21|||
48908274|NCT00993954|157501797|FG001|Overall Study|Protocol Violation|2|||
48908275|NCT01990534|157501800|FG000|Overall Study|Death|22|||
48908276|NCT01990534|157501800|FG000|Overall Study|Progressive disease|3|||
48908277|NCT01990534|157501800|FG000|Overall Study|Protocol Violation|1|||
48908278|NCT01990534|157501800|FG000|Overall Study|Withdrawal of Informed Consent|2|||
48908279|NCT01990534|157501800|FG000|Overall Study|Symptomatic Deterioration|1|||
48908280|NCT01990534|157501800|FG000|Overall Study|Withdrawal by Subject|3|||
48908281|NCT01990534|157501800|FG000|Overall Study|Reason not Specified|2|||
48908282|NCT01990534|157501800|FG000|Overall Study|Lost to Follow-up|1|||
48908283|NCT00727649|157501803|FG000|First Intervention (4-weeks)|Lost to Follow-up|1|||
48908284|NCT00727649|157501804|FG001|First Intervention (4-weeks)|Lost to Follow-up|2|||
48908285|NCT00727649|157501803|FG000|First Intervention (4-weeks)|Withdrawal by Subject|2|||
48908286|NCT00727649|157501804|FG001|First Intervention (4-weeks)|Withdrawal by Subject|1|||
48908287|NCT00727649|157501803|FG000|Wash-out (2-weeks)|Lost to Follow-up|3|||
48908288|NCT00727649|157501804|FG001|Wash-out (2-weeks)|Lost to Follow-up|1|||
48908289|NCT00727649|157501803|FG000|Wash-out (2-weeks)|Withdrawal by Subject|1|||
48908290|NCT00727649|157501804|FG001|Wash-out (2-weeks)|Withdrawal by Subject|2|||
48908291|NCT00727649|157501803|FG000|Second Intervention (4-weeks)|Death|1|||
48908292|NCT00727649|157501804|FG001|Second Intervention (4-weeks)|Death|0|||
48908293|NCT00727649|157501803|FG000|Second Intervention (4-weeks)|Lost to Follow-up|0|||
48908294|NCT00727649|157501804|FG001|Second Intervention (4-weeks)|Lost to Follow-up|1|||
48908295|NCT00727649|157501803|FG000|Second Intervention (4-weeks)|Withdrawal by Subject|0|||
48908296|NCT00727649|157501804|FG001|Second Intervention (4-weeks)|Withdrawal by Subject|2|||
48908297|NCT01681628|157501805|FG000|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14|||
48908298|NCT01681628|157501806|FG001|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6|||
48908299|NCT01681628|157501805|FG000|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0|||
48908300|NCT01681628|157501806|FG001|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15|||
48908301|NCT01681628|157501805|FG000|19 Months Follow-up|Death|1|||
48908302|NCT01681628|157501806|FG001|19 Months Follow-up|Death|0|||
48908303|NCT01681628|157501805|FG000|19 Months Follow-up|Lost to Follow-up|61|||
48908304|NCT01681628|157501806|FG001|19 Months Follow-up|Lost to Follow-up|43|||
48908305|NCT00659529|157501807|FG000|Overall Study|Withdrawal by Subject|4|||
48908306|NCT00659529|157501807|FG000|Overall Study|Protocol Violation|3|||
48908307|NCT00659529|157501807|FG000|Overall Study|Screen failure|9|||
48908308|NCT00907257|157501809|FG000|Overall Study|Adverse Event|0|||
48908309|NCT00907257|157501810|FG001|Overall Study|Adverse Event|4|||
48908310|NCT00907257|157501809|FG000|Overall Study|Protocol Violation|1|||
48908311|NCT00907257|157501810|FG001|Overall Study|Protocol Violation|2|||
48908312|NCT00907257|157501809|FG000|Overall Study|Lost to Follow-up|3|||
48908313|NCT00907257|157501810|FG001|Overall Study|Lost to Follow-up|3|||
48908314|NCT00907257|157501809|FG000|Overall Study|Withdrawal by Subject|1|||
48908315|NCT00907257|157501810|FG001|Overall Study|Withdrawal by Subject|2|||
48908316|NCT00907257|157501809|FG000|Overall Study|Per IRB-Subject became vulnerable|1|||
48908317|NCT00907257|157501810|FG001|Overall Study|Per IRB-Subject became vulnerable|0|||
48908318|NCT00907257|157501809|FG000|Overall Study|Moved|1|||
48908319|NCT00907257|157501810|FG001|Overall Study|Moved|0|||
48908320|NCT00907257|157501809|FG000|Overall Study|Personal Reasons|6|||
48908321|NCT00907257|157501810|FG001|Overall Study|Personal Reasons|1|||
48908322|NCT04163900|157501811|FG000|Overall Study|Radiological disease progression|112|||
48908323|NCT04163900|157501812|FG001|Overall Study|Radiological disease progression|127|||
48908324|NCT04163900|157501811|FG000|Overall Study|Study closure|98|||
48908325|NCT04163900|157501812|FG001|Overall Study|Study closure|133|||
48908326|NCT04163900|157501811|FG000|Overall Study|Adverse Event|78|||
48908327|NCT04163900|157501812|FG001|Overall Study|Adverse Event|32|||
48908328|NCT04163900|157501811|FG000|Overall Study|Withdrawal by Subject|37|||
48908329|NCT04163900|157501812|FG001|Overall Study|Withdrawal by Subject|34|||
48908330|NCT04163900|157501811|FG000|Overall Study|Death|29|||
48908331|NCT04163900|157501812|FG001|Overall Study|Death|16|||
48908332|NCT04163900|157501811|FG000|Overall Study|Physician Decision|17|||
48908333|NCT04163900|157501812|FG001|Overall Study|Physician Decision|25|||
48908334|NCT04163900|157501811|FG000|Overall Study|Clinical disease progression|14|||
48908335|NCT04163900|157501812|FG001|Overall Study|Clinical disease progression|13|||
48908336|NCT04163900|157501811|FG000|Overall Study|Protocol Violation|3|||
48908337|NCT04163900|157501812|FG001|Overall Study|Protocol Violation|4|||
48908338|NCT04163900|157501811|FG000|Overall Study|Lost to Follow-up|0|||
48908339|NCT04163900|157501812|FG001|Overall Study|Lost to Follow-up|1|||
48908340|NCT04196803|157501813|FG000|Overall Study|Withdrawal by Subject|1|||
48908341|NCT04196803|157501814|FG001|Overall Study|Withdrawal by Subject|3|||
48908342|NCT04196803|157501813|FG000|Overall Study|Adverse Event|4|||
48908343|NCT04196803|157501814|FG001|Overall Study|Adverse Event|2|||
48908344|NCT04196803|157501813|FG000|Overall Study|Lost to Follow-up|0|||
48908345|NCT04196803|157501814|FG001|Overall Study|Lost to Follow-up|1|||
48908346|NCT03308942|157501816|FG000|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
48908347|NCT03308942|157501817|FG001|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
48908348|NCT03308942|157501818|FG002|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|2|||
48908349|NCT03308942|157501819|FG003|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
48908350|NCT03308942|157501820|FG004|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
48908351|NCT03308942|157501816|FG000|Stage 1 (Up to a Maximum of 45 Months)|Death|11|||
48908352|NCT03308942|157501817|FG001|Stage 1 (Up to a Maximum of 45 Months)|Death|16|||
48908353|NCT03308942|157501818|FG002|Stage 1 (Up to a Maximum of 45 Months)|Death|1|||
48908354|NCT03308942|157501819|FG003|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
48908355|NCT03308942|157501820|FG004|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
48908356|NCT03308942|157501816|FG000|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
48908357|NCT03308942|157501817|FG001|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|1|||
48908358|NCT03308942|157501818|FG002|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
48908359|NCT03308942|157501819|FG003|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
48908360|NCT03308942|157501820|FG004|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
48908361|NCT03308942|157501816|FG000|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|3|||
48908362|NCT03308942|157501817|FG001|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|1|||
48908363|NCT03308942|157501818|FG002|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
48908364|NCT03308942|157501819|FG003|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
48908365|NCT03308942|157501820|FG004|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
48908366|NCT03308942|157501816|FG000|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
48908367|NCT03308942|157501817|FG001|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
48908368|NCT03308942|157501818|FG002|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
48908369|NCT03308942|157501819|FG003|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|3|||
48908370|NCT03308942|157501820|FG004|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
48908371|NCT03308942|157501816|FG000|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
48908372|NCT03308942|157501817|FG001|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
48908373|NCT03308942|157501818|FG002|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
48695029|NCT02694744|156732150|FG000|Overall Study|Adverse Event|2|||
48695030|NCT02694744|156732151|FG001|Overall Study|Adverse Event|1|||
48695031|NCT02694744|156732150|FG000|Overall Study|Withdrawal by Subject|2|||
48908374|NCT03308942|157501819|FG003|Stage 2 (Up to a Maximum of 29 Months)|Death|6|||
48908375|NCT03308942|157501820|FG004|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
48908376|NCT03308942|157501816|FG000|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
48908377|NCT03308942|157501817|FG001|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
48908378|NCT03308942|157501818|FG002|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
48908379|NCT03308942|157501819|FG003|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|3|||
48908380|NCT03308942|157501820|FG004|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
48908381|NCT02294682|157501821|FG000|Overall Study|Could not swallow pills|1|||
48908382|NCT02294682|157501822|FG001|Overall Study|Could not swallow pills|0|||
48908383|NCT00763971|157501823|FG000|Overall Study|Adverse Event|5|||
48908384|NCT00763971|157501824|FG001|Overall Study|Adverse Event|2|||
48908385|NCT00763971|157501825|FG002|Overall Study|Adverse Event|4|||
48908386|NCT00763971|157501823|FG000|Overall Study|Protocol Violation|3|||
48908387|NCT00763971|157501824|FG001|Overall Study|Protocol Violation|3|||
48908388|NCT00763971|157501825|FG002|Overall Study|Protocol Violation|2|||
48908389|NCT00763971|157501823|FG000|Overall Study|Withdrawal by Subject|4|||
48908390|NCT00763971|157501824|FG001|Overall Study|Withdrawal by Subject|5|||
48908391|NCT00763971|157501825|FG002|Overall Study|Withdrawal by Subject|5|||
48908392|NCT00763971|157501823|FG000|Overall Study|Lost to Follow-up|0|||
48908393|NCT00763971|157501824|FG001|Overall Study|Lost to Follow-up|1|||
48908394|NCT00763971|157501825|FG002|Overall Study|Lost to Follow-up|0|||
48908395|NCT00763971|157501823|FG000|Overall Study|Lack of Efficacy|11|||
48908396|NCT00763971|157501824|FG001|Overall Study|Lack of Efficacy|22|||
48908397|NCT00763971|157501825|FG002|Overall Study|Lack of Efficacy|54|||
48908398|NCT00763971|157501823|FG000|Overall Study|Unable to swallow capsule|2|||
48908399|NCT00763971|157501824|FG001|Overall Study|Unable to swallow capsule|1|||
48908400|NCT00763971|157501825|FG002|Overall Study|Unable to swallow capsule|1|||
48908401|NCT00763971|157501823|FG000|Overall Study|Personal reason|3|||
48908402|NCT00763971|157501824|FG001|Overall Study|Personal reason|0|||
48908403|NCT00763971|157501825|FG002|Overall Study|Personal reason|0|||
48908404|NCT00763971|157501823|FG000|Overall Study|Exclusion criteria met|1|||
48908405|NCT00763971|157501824|FG001|Overall Study|Exclusion criteria met|0|||
48908406|NCT00763971|157501825|FG002|Overall Study|Exclusion criteria met|0|||
48908407|NCT00763971|157501823|FG000|Overall Study|Sponsor decision|1|||
48908408|NCT00763971|157501824|FG001|Overall Study|Sponsor decision|0|||
48908409|NCT00763971|157501825|FG002|Overall Study|Sponsor decision|0|||
48908410|NCT00763971|157501823|FG000|Overall Study|Due to holiday season|2|||
48908411|NCT00763971|157501824|FG001|Overall Study|Due to holiday season|0|||
48908412|NCT00763971|157501825|FG002|Overall Study|Due to holiday season|1|||
48908413|NCT00763971|157501823|FG000|Overall Study|Randomization error|0|||
48908414|NCT00763971|157501824|FG001|Overall Study|Randomization error|0|||
48908415|NCT00763971|157501825|FG002|Overall Study|Randomization error|1|||
48908416|NCT00763971|157501823|FG000|Overall Study|Medical monitor decision|0|||
48908417|NCT00763971|157501824|FG001|Overall Study|Medical monitor decision|0|||
48908418|NCT00763971|157501825|FG002|Overall Study|Medical monitor decision|1|||
48908419|NCT00763971|157501823|FG000|Overall Study|Moved to another country|0|||
48908420|NCT00763971|157501824|FG001|Overall Study|Moved to another country|1|||
48908421|NCT00763971|157501825|FG002|Overall Study|Moved to another country|0|||
48908422|NCT00763971|157501823|FG000|Overall Study|Subject wanted dose reduction|0|||
48908423|NCT00763971|157501824|FG001|Overall Study|Subject wanted dose reduction|1|||
48908424|NCT00763971|157501825|FG002|Overall Study|Subject wanted dose reduction|0|||
48908425|NCT00763971|157501823|FG000|Overall Study|Lack of availability|0|||
48908426|NCT00763971|157501824|FG001|Overall Study|Lack of availability|1|||
48908427|NCT00763971|157501825|FG002|Overall Study|Lack of availability|0|||
48908428|NCT00763971|157501823|FG000|Overall Study|Performed final visit on phone|0|||
48908429|NCT00763971|157501824|FG001|Overall Study|Performed final visit on phone|1|||
48908430|NCT00763971|157501825|FG002|Overall Study|Performed final visit on phone|0|||
48908431|NCT00763971|157501823|FG000|Overall Study|Participation in 489-326 required|1|||
48908432|NCT00763971|157501824|FG001|Overall Study|Participation in 489-326 required|0|||
48908433|NCT00763971|157501825|FG002|Overall Study|Participation in 489-326 required|0|||
48908434|NCT03422172|157501830|FG000|Oral lead-in Phase (4 Weeks)|Adverse Event|1|||
48908435|NCT03422172|157501830|FG000|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1|||
48908436|NCT03422172|157501830|FG000|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3|||
48908437|NCT04047797|157501831|FG000|Overall Study|Progressive Disease|1|||
48908438|NCT01480284|157501838|FG000|Overall Study|Withdrawal by Subject|2|||
48908439|NCT01480284|157501839|FG001|Overall Study|Withdrawal by Subject|0|||
48908440|NCT01480284|157501838|FG000|Overall Study|Adverse Event|1|||
48908441|NCT01480284|157501839|FG001|Overall Study|Adverse Event|0|||
48742930|NCT00126191|156910417|FG001|Overall Study|Physician Decision|1|||
48908442|NCT01480284|157501838|FG000|Overall Study|Study closed/terminated|3|||
48908443|NCT01480284|157501839|FG001|Overall Study|Study closed/terminated|0|||
48908444|NCT01480284|157501838|FG000|Overall Study|Lost to Follow-up|1|||
48908445|NCT01480284|157501839|FG001|Overall Study|Lost to Follow-up|0|||
48908446|NCT01480284|157501838|FG000|Overall Study|Physician Decision|1|||
48908447|NCT01480284|157501839|FG001|Overall Study|Physician Decision|0|||
48908448|NCT00066742|157501840|FG000|Induction Chemoradiotherapy|Did not receive any protocol treatment|1|||
48908449|NCT00066742|157501840|FG000|Induction Chemoradiotherapy|Adverse Event|21|||
48695032|NCT02694744|156732151|FG001|Overall Study|Withdrawal by Subject|1|||
48908450|NCT00066742|157501840|FG000|Induction Chemoradiotherapy|Withdrawal by Subject|2|||
48908451|NCT00066742|157501840|FG000|Induction Chemoradiotherapy|not protocol specified|2|||
48908452|NCT00066742|157501840|FG000|Induction Chemoradiotherapy|Ineligible|3|||
48908453|NCT00066742|157501840|FG000|Consolidation Chemotherapy|not protocol specified|1|||
48908454|NCT00066742|157501840|FG000|Consolidation Chemotherapy|Ineligible|2|||
48908455|NCT00832117|157501842|FG000|Overall Study|Death|1|||
48908456|NCT00832117|157501842|FG000|Overall Study|Disease Progression|11|||
48908457|NCT03374995|157501843|FG000|Overall Study|Withdrawal by Subject|0|||
48908458|NCT03374995|157501844|FG001|Overall Study|Withdrawal by Subject|1|||
48908459|NCT01383096|157501845|FG000|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
48908460|NCT01383096|157501846|FG001|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
48908461|NCT01383096|157501847|FG002|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
48908462|NCT01383096|157501845|FG000|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
48908463|NCT01383096|157501846|FG001|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
48908464|NCT01383096|157501847|FG002|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
48908465|NCT01383096|157501845|FG000|Third Intervention (8 Days)|Elevated AST|0|||
48908466|NCT01383096|157501846|FG001|Third Intervention (8 Days)|Elevated AST|1|||
48908467|NCT01383096|157501847|FG002|Third Intervention (8 Days)|Elevated AST|0|||
48908468|NCT01383096|157501845|FG000|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
48908469|NCT01383096|157501846|FG001|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3|||
48908470|NCT01383096|157501847|FG002|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
48908471|NCT01383096|157501845|FG000|Third Intervention (8 Days)|Adverse Event|1|||
48908472|NCT01383096|157501846|FG001|Third Intervention (8 Days)|Adverse Event|0|||
48908473|NCT01383096|157501847|FG002|Third Intervention (8 Days)|Adverse Event|0|||
48908474|NCT01383096|157501845|FG000|Third Intervention (8 Days)|Withdrawal by Subject|1|||
48908475|NCT01383096|157501846|FG001|Third Intervention (8 Days)|Withdrawal by Subject|0|||
48908476|NCT01383096|157501847|FG002|Third Intervention (8 Days)|Withdrawal by Subject|0|||
48908477|NCT01383096|157501845|FG000|Third Intervention (8 Days)|QTcF was greater than 450 msec|1|||
48908478|NCT01383096|157501846|FG001|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
48908479|NCT01383096|157501847|FG002|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
48908480|NCT01383096|157501845|FG000|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
48908481|NCT01383096|157501846|FG001|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
48908482|NCT01383096|157501847|FG002|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
48908483|NCT01383096|157501845|FG000|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1|||
48908484|NCT01383096|157501846|FG001|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
48908485|NCT01383096|157501847|FG002|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
48908486|NCT01383096|157501845|FG000|Fifth Intervention (8 Days)|Withdrawal by Subject|1|||
48908487|NCT01383096|157501846|FG001|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
48908488|NCT01383096|157501847|FG002|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
48908489|NCT01383096|157501845|FG000|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1|||
48908490|NCT01383096|157501846|FG001|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
48908491|NCT01383096|157501847|FG002|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
48908492|NCT01186939|157501853|FG000|Overall Study|Death|7|||
48908493|NCT01186939|157501853|FG000|Overall Study|Withdrawal by Subject|2|||
48908494|NCT01186939|157501853|FG000|Overall Study|No longer receiving clinical benefit|17|||
48908495|NCT01186939|157501853|FG000|Overall Study|Program closed|5|||
48908496|NCT01186939|157501853|FG000|Overall Study|Sponsor decision|4|||
48908497|NCT01186939|157501853|FG000|Overall Study|Started additional treatment|1|||
48908498|NCT01186939|157501853|FG000|Overall Study|NCI CTC Grade 3 or 4 toxicity|1|||
48908499|NCT01186939|157501853|FG000|Overall Study|Myocardial infarction|1|||
48908500|NCT01186939|157501853|FG000|Overall Study|Bone marrow transplant|1|||
48908501|NCT01186939|157501853|FG000|Overall Study|Transformation to AML|1|||
48908502|NCT00597753|157501854|FG000|Overall Study|Adverse Event|6|||
48908503|NCT00597753|157501855|FG001|Overall Study|Adverse Event|2|||
48908504|NCT00597753|157501854|FG000|Overall Study|Death|55|||
48908505|NCT00597753|157501855|FG001|Overall Study|Death|29|||
48908506|NCT00597753|157501854|FG000|Overall Study|Lack of Efficacy|2|||
48908507|NCT00597753|157501855|FG001|Overall Study|Lack of Efficacy|0|||
48908508|NCT00597753|157501854|FG000|Overall Study|Lost to Follow-up|10|||
48908509|NCT00597753|157501855|FG001|Overall Study|Lost to Follow-up|3|||
48908510|NCT00597753|157501854|FG000|Overall Study|Physician Decision|5|||
48908511|NCT00597753|157501855|FG001|Overall Study|Physician Decision|1|||
48908512|NCT00597753|157501854|FG000|Overall Study|Pregnancy|1|||
48908513|NCT00597753|157501855|FG001|Overall Study|Pregnancy|0|||
48908514|NCT00597753|157501854|FG000|Overall Study|Withdrawal by Subject|35|||
48908515|NCT00597753|157501855|FG001|Overall Study|Withdrawal by Subject|12|||
48908516|NCT00597753|157501854|FG000|Overall Study|Discontinued Dialysis|0|||
48908517|NCT00597753|157501855|FG001|Overall Study|Discontinued Dialysis|1|||
48908518|NCT00597753|157501854|FG000|Overall Study|Never dosed|2|||
48908519|NCT00597753|157501855|FG001|Overall Study|Never dosed|0|||
48908520|NCT00597753|157501854|FG000|Overall Study|Noncompliance|2|||
48908521|NCT00597753|157501855|FG001|Overall Study|Noncompliance|1|||
48908522|NCT00597753|157501854|FG000|Overall Study|Relocation|17|||
48908523|NCT00597753|157501855|FG001|Overall Study|Relocation|6|||
48908524|NCT00597753|157501854|FG000|Overall Study|Renal transplant|10|||
48908525|NCT00597753|157501855|FG001|Overall Study|Renal transplant|3|||
48908526|NCT00597753|157501854|FG000|Overall Study|Site closed by sponsor|19|||
48908527|NCT00597753|157501855|FG001|Overall Study|Site closed by sponsor|7|||
48908528|NCT00597753|157501854|FG000|Overall Study|Site elected to close|2|||
48908529|NCT00597753|157501855|FG001|Overall Study|Site elected to close|4|||
48908530|NCT03239483|157501856|FG000|Overall Study|Lost to Follow-up|1|||
48908531|NCT03239483|157501857|FG001|Overall Study|Lost to Follow-up|0|||
48908532|NCT03239483|157501856|FG000|Overall Study|Withdrawal by Subject|1|||
48908533|NCT03239483|157501857|FG001|Overall Study|Withdrawal by Subject|0|||
48908534|NCT01179672|157501859|FG000|Overall Study|Adverse Event|17|||
48908535|NCT01179672|157501860|FG001|Overall Study|Adverse Event|8|||
48908536|NCT01179672|157501859|FG000|Overall Study|Withdrawal by Subject|10|||
48908537|NCT01179672|157501860|FG001|Overall Study|Withdrawal by Subject|12|||
48908538|NCT01179672|157501859|FG000|Overall Study|Entry Criteria Not Met|0|||
48908539|NCT01179672|157501860|FG001|Overall Study|Entry Criteria Not Met|2|||
48908540|NCT01179672|157501859|FG000|Overall Study|Lost to Follow-up|0|||
48908541|NCT01179672|157501860|FG001|Overall Study|Lost to Follow-up|1|||
48908542|NCT01179672|157501859|FG000|Overall Study|Protocol Violation|2|||
48908543|NCT01179672|157501860|FG001|Overall Study|Protocol Violation|2|||
48908544|NCT01179672|157501859|FG000|Overall Study|Physician Decision|1|||
48908545|NCT01179672|157501860|FG001|Overall Study|Physician Decision|1|||
48908546|NCT00596934|157501862|FG000|Overall Study|Protocol Violation|1|||
48908547|NCT00596934|157501862|FG000|Overall Study|Withdrawal by Subject|1|||
48908548|NCT00528567|157501866|FG000|Overall Study|Death|4|||
48908549|NCT00528567|157501867|FG001|Overall Study|Death|5|||
48908550|NCT00528567|157501866|FG000|Overall Study|Breast Cancer Recurrence/2nd Primary|30|||
48908551|NCT00528567|157501867|FG001|Overall Study|Breast Cancer Recurrence/2nd Primary|60|||
48908552|NCT00528567|157501866|FG000|Overall Study|Adverse Event/Intermittent Illness|255|||
48908553|NCT00528567|157501867|FG001|Overall Study|Adverse Event/Intermittent Illness|29|||
48908554|NCT00528567|157501866|FG000|Overall Study|Violation Criteria at Entry|3|||
48908555|NCT00528567|157501867|FG001|Overall Study|Violation Criteria at Entry|17|||
48908556|NCT00528567|157501866|FG000|Overall Study|Withdrew Consent|59|||
48908557|NCT00528567|157501867|FG001|Overall Study|Withdrew Consent|55|||
48908558|NCT00528567|157501866|FG000|Overall Study|Refused Treatment/Did Not Cooperate|52|||
48908559|NCT00528567|157501867|FG001|Overall Study|Refused Treatment/Did Not Cooperate|42|||
48908560|NCT00528567|157501866|FG000|Overall Study|Failure to Return|1|||
48908561|NCT00528567|157501867|FG001|Overall Study|Failure to Return|4|||
48908562|NCT00528567|157501866|FG000|Overall Study|Other Protocol Violation|5|||
48908563|NCT00528567|157501867|FG001|Overall Study|Other Protocol Violation|21|||
48908564|NCT00528567|157501866|FG000|Overall Study|Administrative/Other|22|||
48908565|NCT00528567|157501867|FG001|Overall Study|Administrative/Other|75|||
48908566|NCT02119325|157501868|FG000|Washout Period 1|Adverse Event|0|||
48908567|NCT02119325|157501869|FG001|Washout Period 1|Adverse Event|1|||
48908568|NCT00448435|157501874|FG000|Washout Period - 2 Weeks|Withdrawal by Subject|1|||
48908569|NCT00448435|157501875|FG001|Washout Period - 2 Weeks|Withdrawal by Subject|0|||
48908570|NCT00108069|157501876|FG000|Overall Study|Never rec'd study drug|0|||
48908571|NCT00108069|157501877|FG001|Overall Study|Never rec'd study drug|1|||
48908572|NCT00108069|157501876|FG000|Overall Study|Adverse Event|1|||
48908573|NCT00108069|157501877|FG001|Overall Study|Adverse Event|1|||
48908574|NCT00108069|157501876|FG000|Overall Study|Withdrawal by Subject|1|||
48908575|NCT00108069|157501877|FG001|Overall Study|Withdrawal by Subject|0|||
48908576|NCT00108069|157501876|FG000|Overall Study|Death|1|||
48908577|NCT00108069|157501877|FG001|Overall Study|Death|0|||
48908578|NCT00108069|157501876|FG000|Overall Study|Progessive disease|27|||
48908579|NCT00108069|157501877|FG001|Overall Study|Progessive disease|11|||
48908580|NCT03606980|157501878|FG000|Overall Study|Lost to Follow-up|3|||
48908581|NCT03606980|157501879|FG001|Overall Study|Lost to Follow-up|2|||
48908582|NCT03606980|157501880|FG002|Overall Study|Lost to Follow-up|3|||
48908583|NCT03606980|157501878|FG000|Overall Study|Withdrawal by Subject|1|||
48908584|NCT03606980|157501879|FG001|Overall Study|Withdrawal by Subject|0|||
48908585|NCT03606980|157501880|FG002|Overall Study|Withdrawal by Subject|4|||
48908586|NCT01849497|157501881|FG000|Overall Study|Withdrawal by Subject|1|||
49116295|NCT01084538|158263088|FG000|Overall Study|Serious Adverse Event|3|||
48908587|NCT01849497|157501882|FG001|Overall Study|Withdrawal by Subject|2|||
48908588|NCT01849497|157501881|FG000|Overall Study|Sponsor Decision|0|||
48908589|NCT01849497|157501882|FG001|Overall Study|Sponsor Decision|1|||
48908590|NCT01849497|157501881|FG000|Overall Study|Lost to Follow-up|0|||
48908591|NCT01849497|157501882|FG001|Overall Study|Lost to Follow-up|1|||
48908592|NCT00911625|157501883|FG000|Overall Study|Lost to Follow-up|7|||
48908593|NCT00911625|157501884|FG001|Overall Study|Lost to Follow-up|0|||
48908594|NCT03785678|157501885|FG000|Overall Study|Death|44|||
48908595|NCT03785678|157501886|FG001|Overall Study|Death|42|||
48908596|NCT03785678|157501885|FG000|Overall Study|Lost to Follow-up|4|||
48908597|NCT03785678|157501886|FG001|Overall Study|Lost to Follow-up|2|||
48908598|NCT03785678|157501885|FG000|Overall Study|Physician Decision|0|||
48908599|NCT03785678|157501886|FG001|Overall Study|Physician Decision|2|||
48908600|NCT03785678|157501885|FG000|Overall Study|Withdrawal by Subject|5|||
48908601|NCT03785678|157501886|FG001|Overall Study|Withdrawal by Subject|3|||
48908602|NCT04343248|157501887|FG000|Overall Study|Withdrawal by Subject|5|||
48908603|NCT04343248|157501888|FG001|Overall Study|Withdrawal by Subject|6|||
48908604|NCT04343248|157501887|FG000|Overall Study|Death|1|||
48908605|NCT04343248|157501888|FG001|Overall Study|Death|2|||
48908606|NCT04343248|157501887|FG000|Overall Study|Lost to Follow-up|9|||
48908607|NCT04343248|157501888|FG001|Overall Study|Lost to Follow-up|6|||
48908608|NCT04343248|157501887|FG000|Overall Study|Physician Decision|0|||
48908609|NCT04343248|157501888|FG001|Overall Study|Physician Decision|1|||
48908610|NCT04343248|157501887|FG000|Overall Study|Adverse Event|1|||
48908611|NCT04343248|157501888|FG001|Overall Study|Adverse Event|0|||
48908612|NCT01162239|157501890|FG000|Treatment Phase|Withdrawal by Subject|1|||
48908613|NCT01162239|157501891|FG001|Treatment Phase|Withdrawal by Subject|3|||
48908614|NCT01162239|157501892|FG002|Treatment Phase|Withdrawal by Subject|2|||
48908615|NCT01162239|157501893|FG003|Treatment Phase|Withdrawal by Subject|3|||
48908616|NCT01162239|157501890|FG000|Treatment Phase|Death|0|||
48908617|NCT01162239|157501891|FG001|Treatment Phase|Death|0|||
48908618|NCT01162239|157501892|FG002|Treatment Phase|Death|0|||
48908619|NCT01162239|157501893|FG003|Treatment Phase|Death|1|||
48908620|NCT01162239|157501890|FG000|Treatment Phase|Lost to Follow-up|5|||
48908621|NCT01162239|157501891|FG001|Treatment Phase|Lost to Follow-up|4|||
48908622|NCT01162239|157501892|FG002|Treatment Phase|Lost to Follow-up|2|||
48908623|NCT01162239|157501893|FG003|Treatment Phase|Lost to Follow-up|1|||
48908624|NCT01162239|157501890|FG000|Extended Follow-up|Lost to Follow-up|8|||
48908625|NCT01162239|157501891|FG001|Extended Follow-up|Lost to Follow-up|13|||
48908626|NCT01162239|157501892|FG002|Extended Follow-up|Lost to Follow-up|8|||
48908627|NCT01162239|157501893|FG003|Extended Follow-up|Lost to Follow-up|6|||
48908628|NCT01889238|157501894|FG000|Overall Study|Death|1|||
48908629|NCT01889238|157501894|FG000|Overall Study|Withdrawal by Subject|1|||
48908630|NCT01889238|157501894|FG000|Overall Study|Adverse Event|6|||
48908631|NCT01889238|157501894|FG000|Overall Study|Disease Progression|104|||
48908632|NCT01889238|157501894|FG000|Overall Study|Other|6|||
48908633|NCT01200238|157501895|FG000|Overall Study|Adverse Event|2|||
48908634|NCT01200238|157501896|FG001|Overall Study|Adverse Event|1|||
48908635|NCT01200238|157501895|FG000|Overall Study|Progressive Disease|5|||
48908636|NCT01200238|157501896|FG001|Overall Study|Progressive Disease|8|||
48908637|NCT01200238|157501895|FG000|Overall Study|Withdrawal by Subject|0|||
48908638|NCT01200238|157501896|FG001|Overall Study|Withdrawal by Subject|1|||
48908639|NCT02717754|157501897|FG000|Overall Study|Incorrect Infusion Duration|0|||
48908640|NCT02717754|157501898|FG001|Overall Study|Incorrect Infusion Duration|0|||
48908641|NCT02717754|157501899|FG002|Overall Study|Incorrect Infusion Duration|0|||
48908642|NCT02717754|157501900|FG003|Overall Study|Incorrect Infusion Duration|10|||
48908643|NCT02717754|157501901|FG004|Overall Study|Incorrect Infusion Duration|20|||
48908644|NCT02717754|157501902|FG005|Overall Study|Incorrect Infusion Duration|20|||
48908645|NCT01383161|157502968|FG000|Overall Study|Adverse Event|5|||
48908646|NCT01383161|157502969|FG001|Overall Study|Adverse Event|1|||
48908647|NCT01383161|157502968|FG000|Overall Study|Withdrawal by Subject|0|||
48908648|NCT01383161|157502969|FG001|Overall Study|Withdrawal by Subject|2|||
48908649|NCT01383161|157502968|FG000|Overall Study|Lack of Efficacy|0|||
48908650|NCT01383161|157502969|FG001|Overall Study|Lack of Efficacy|1|||
48908651|NCT00436618|157502970|FG000|Overall Study|Withdrawal by Subject|5|||
48908652|NCT00436618|157502971|FG001|Overall Study|Withdrawal by Subject|8|||
48908653|NCT00436618|157502972|FG002|Overall Study|Withdrawal by Subject|11|||
48908654|NCT00436618|157502970|FG000|Overall Study|Adverse Event|8|||
48908655|NCT00436618|157502971|FG001|Overall Study|Adverse Event|8|||
48908656|NCT00436618|157502972|FG002|Overall Study|Adverse Event|9|||
48908657|NCT00436618|157502970|FG000|Overall Study|Alternate Treatment|3|||
48908658|NCT00436618|157502971|FG001|Overall Study|Alternate Treatment|4|||
48908659|NCT00436618|157502972|FG002|Overall Study|Alternate Treatment|12|||
48908660|NCT00436618|157502970|FG000|Overall Study|Other Medical Problems|3|||
48908661|NCT00436618|157502971|FG001|Overall Study|Other Medical Problems|1|||
48908662|NCT00436618|157502972|FG002|Overall Study|Other Medical Problems|7|||
48908663|NCT00436618|157502970|FG000|Overall Study|Death|4|||
48908664|NCT00436618|157502971|FG001|Overall Study|Death|2|||
48908665|NCT00436618|157502972|FG002|Overall Study|Death|3|||
48908666|NCT00436618|157502970|FG000|Overall Study|New Primary or Other Reasons|6|||
48908667|NCT00436618|157502971|FG001|Overall Study|New Primary or Other Reasons|2|||
48908668|NCT00436618|157502972|FG002|Overall Study|New Primary or Other Reasons|12|||
48908669|NCT00436618|157502970|FG000|Overall Study|Still on treatment|1|||
48908670|NCT00436618|157502971|FG001|Overall Study|Still on treatment|2|||
48908671|NCT00436618|157502972|FG002|Overall Study|Still on treatment|7|||
48908672|NCT00698451|157502973|FG000|Overall Study|Adverse Event|22|||
48908673|NCT00698451|157502973|FG000|Overall Study|Physician Decision|2|||
48908674|NCT00698451|157502973|FG000|Overall Study|Protocol Violation|6|||
48908675|NCT00698451|157502973|FG000|Overall Study|Withdrawal by Subject|6|||
48908676|NCT00698451|157502973|FG000|Overall Study|Disease progression|3|||
48908677|NCT03039023|157502974|FG000|Overall Study|Withdrawal by Subject|1|||
48908678|NCT03039023|157502975|FG001|Overall Study|Withdrawal by Subject|0|||
48908679|NCT03039023|157502976|FG002|Overall Study|Withdrawal by Subject|1|||
48908680|NCT03039023|157502977|FG003|Overall Study|Withdrawal by Subject|1|||
48908681|NCT03039023|157502978|FG004|Overall Study|Withdrawal by Subject|0|||
48908682|NCT03039023|157502974|FG000|Overall Study|Physician Decision|0|||
48908683|NCT03039023|157502975|FG001|Overall Study|Physician Decision|0|||
48908684|NCT03039023|157502976|FG002|Overall Study|Physician Decision|0|||
48908685|NCT03039023|157502977|FG003|Overall Study|Physician Decision|1|||
48908686|NCT03039023|157502978|FG004|Overall Study|Physician Decision|0|||
48908687|NCT02596620|157502979|FG000|Overall Study|Lost to Follow-up|1|||
48908688|NCT02596620|157502980|FG001|Overall Study|Lost to Follow-up|1|||
48908689|NCT00450658|157502981|FG000|Overall Study|Adverse Event|24|||
48908690|NCT00450658|157502982|FG001|Overall Study|Adverse Event|15|||
48908691|NCT00450658|157502981|FG000|Overall Study|Withdrawal by Subject|43|||
48908692|NCT00450658|157502982|FG001|Overall Study|Withdrawal by Subject|26|||
48908693|NCT00450658|157502981|FG000|Overall Study|Lost to Follow-up|22|||
48908694|NCT00450658|157502982|FG001|Overall Study|Lost to Follow-up|5|||
48908695|NCT00450658|157502981|FG000|Overall Study|UGI ulcer|33|||
48908696|NCT00450658|157502982|FG001|Overall Study|UGI ulcer|34|||
48908697|NCT00450658|157502981|FG000|Overall Study|misc|21|||
48908698|NCT00450658|157502982|FG001|Overall Study|misc|10|||
48908699|NCT01829360|157502996|FG000|Overall Study|Protocol Violation|0|||
48908700|NCT01829360|157502997|FG001|Overall Study|Protocol Violation|0|||
48908701|NCT01829360|157502998|FG002|Overall Study|Protocol Violation|1|||
48908702|NCT01829360|157502999|FG003|Overall Study|Protocol Violation|0|||
48908703|NCT02606461|157503003|FG000|Period 1: Double-blinded Period|Randomized but no treatment|0|||
48908704|NCT02606461|157503004|FG001|Period 1: Double-blinded Period|Randomized but no treatment|0|||
48908705|NCT02606461|157503005|FG002|Period 1: Double-blinded Period|Randomized but no treatment|1|||
48908706|NCT02606461|157503006|FG003|Period 1: Double-blinded Period|Randomized but no treatment|0|||
48908707|NCT02606461|157503007|FG004|Period 1: Double-blinded Period|Randomized but no treatment|0|||
48908708|NCT02606461|157503008|FG005|Period 1: Double-blinded Period|Randomized but no treatment|0|||
48908709|NCT00024167|157503015|FG000|Overall Study|Death|53|||
48908710|NCT00024167|157503016|FG001|Overall Study|Death|47|||
48908711|NCT00931944|157503017|FG000|Overall Study|Adverse Event|4|||
48908712|NCT00931944|157503017|FG000|Overall Study|W/D Consent (due to ALS progression))|19|||
48908713|NCT00931944|157503017|FG000|Overall Study|Withdrawal Consent (due to other)|2|||
48908714|NCT00931944|157503017|FG000|Overall Study|Death|28|||
48908715|NCT00931944|157503017|FG000|Overall Study|Other|2|||
48908716|NCT00239226|157503018|FG000|Overall Study|permAF during stabilization period|0|||
48908717|NCT00239226|157503019|FG001|Overall Study|permAF during stabilization period|0|||
48908718|NCT00239226|157503020|FG002|Overall Study|permAF during stabilization period|0|||
48908719|NCT00239226|157503021|FG003|Overall Study|permAF during stabilization period|3|||
48908720|NCT00239226|157503018|FG000|Overall Study|Lost to Follow-up|1|||
48908721|NCT00239226|157503019|FG001|Overall Study|Lost to Follow-up|0|||
48908722|NCT00239226|157503020|FG002|Overall Study|Lost to Follow-up|1|||
48908723|NCT00239226|157503021|FG003|Overall Study|Lost to Follow-up|0|||
48908724|NCT01109173|157503022|FG000|Overall Study|Adverse Event|15|||
48908725|NCT01109173|157503023|FG001|Overall Study|Adverse Event|17|||
48908726|NCT01109173|157503024|FG002|Overall Study|Adverse Event|9|||
48908727|NCT01109173|157503025|FG003|Overall Study|Adverse Event|6|||
48908728|NCT01109173|157503022|FG000|Overall Study|Lost to Follow-up|0|||
48908729|NCT01109173|157503023|FG001|Overall Study|Lost to Follow-up|1|||
48908730|NCT01109173|157503024|FG002|Overall Study|Lost to Follow-up|0|||
48908731|NCT01109173|157503025|FG003|Overall Study|Lost to Follow-up|0|||
48908732|NCT01109173|157503022|FG000|Overall Study|Patient Decision Unrelated to Advrs Evnt|5|||
48908733|NCT01109173|157503023|FG001|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
48908734|NCT01109173|157503024|FG002|Overall Study|Patient Decision Unrelated to Advrs Evnt|2|||
48908735|NCT01109173|157503025|FG003|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
48908736|NCT01109173|157503022|FG000|Overall Study|Noncompliance|0|||
48908737|NCT01109173|157503023|FG001|Overall Study|Noncompliance|1|||
48908738|NCT01109173|157503024|FG002|Overall Study|Noncompliance|0|||
48908739|NCT01109173|157503025|FG003|Overall Study|Noncompliance|0|||
48908740|NCT01109173|157503022|FG000|Overall Study|Treatment Failure|25|||
48908741|NCT01109173|157503023|FG001|Overall Study|Treatment Failure|32|||
48908742|NCT01109173|157503024|FG002|Overall Study|Treatment Failure|69|||
48908743|NCT01109173|157503025|FG003|Overall Study|Treatment Failure|64|||
48908744|NCT01109173|157503022|FG000|Overall Study|Protocol Violation|4|||
48908745|NCT01109173|157503023|FG001|Overall Study|Protocol Violation|5|||
48908746|NCT01109173|157503024|FG002|Overall Study|Protocol Violation|1|||
48908747|NCT01109173|157503025|FG003|Overall Study|Protocol Violation|2|||
48908748|NCT01109173|157503022|FG000|Overall Study|Patient Did Not Use Study Medication|34|||
48908749|NCT01109173|157503023|FG001|Overall Study|Patient Did Not Use Study Medication|26|||
48908750|NCT01109173|157503024|FG002|Overall Study|Patient Did Not Use Study Medication|11|||
48908751|NCT01109173|157503025|FG003|Overall Study|Patient Did Not Use Study Medication|7|||
48908752|NCT01109173|157503022|FG000|Overall Study|Not Specifiied|5|||
48908753|NCT01109173|157503023|FG001|Overall Study|Not Specifiied|4|||
48908754|NCT01109173|157503024|FG002|Overall Study|Not Specifiied|9|||
48908755|NCT01109173|157503025|FG003|Overall Study|Not Specifiied|14|||
48908756|NCT04422990|157503035|FG000|Overall Study|Withdrawal by Subject|0|||
48908757|NCT04422990|157503036|FG001|Overall Study|Withdrawal by Subject|1|||
48908758|NCT04422990|157503035|FG000|Overall Study|Travel|3|||
48908759|NCT04422990|157503036|FG001|Overall Study|Travel|0|||
48908760|NCT00117507|157503037|FG000|Overall Study|Adverse Event|4|||
48908761|NCT00117507|157503037|FG000|Overall Study|Abnormal laboratory values|3|||
48908762|NCT00117507|157503037|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
48908763|NCT00117507|157503037|FG000|Overall Study|Patient withdrew consent|4|||
48908764|NCT00117507|157503037|FG000|Overall Study|Death|3|||
48908765|NCT02375724|157503038|FG000|Overall Study|Lack of Efficacy|1|||
48908766|NCT02375724|157503039|FG001|Overall Study|Lack of Efficacy|1|||
48908767|NCT02375724|157503038|FG000|Overall Study|Withdrawal by Subject|1|||
48908768|NCT02375724|157503039|FG001|Overall Study|Withdrawal by Subject|1|||
48908769|NCT02375724|157503038|FG000|Overall Study|Lost to Follow-up|1|||
48908770|NCT02375724|157503039|FG001|Overall Study|Lost to Follow-up|0|||
48908771|NCT02375724|157503038|FG000|Overall Study|Protocol Violation|1|||
48908772|NCT02375724|157503039|FG001|Overall Study|Protocol Violation|0|||
48908773|NCT02375724|157503038|FG000|Overall Study|Adverse Event|2|||
48908774|NCT02375724|157503039|FG001|Overall Study|Adverse Event|4|||
48908775|NCT00764751|157503043|FG000|Overall Study|Adverse Event|1|||
48908776|NCT00764751|157503044|FG001|Overall Study|Adverse Event|1|||
48908777|NCT00764751|157503043|FG000|Overall Study|Psoriasis flare up on the scalp|1|||
48908778|NCT00764751|157503044|FG001|Overall Study|Psoriasis flare up on the scalp|0|||
48908779|NCT02653300|157503046|FG000|Overall Study|Withdrawal by Subject|2|||
48908780|NCT00369785|157503055|FG000|Overall Study|Physician Decision|3|||
48908781|NCT00369785|157503056|FG001|Overall Study|Physician Decision|2|||
48908782|NCT00369785|157503055|FG000|Overall Study|Death|1|||
48908783|NCT00369785|157503056|FG001|Overall Study|Death|2|||
48908784|NCT00369785|157503055|FG000|Overall Study|Withdrawal by Subject|7|||
48908785|NCT00369785|157503056|FG001|Overall Study|Withdrawal by Subject|6|||
48908786|NCT00369785|157503055|FG000|Overall Study|Toxicity|6|||
48908787|NCT00369785|157503056|FG001|Overall Study|Toxicity|4|||
48908788|NCT00369785|157503055|FG000|Overall Study|Never started|0|||
48908789|NCT00369785|157503056|FG001|Overall Study|Never started|2|||
48908790|NCT00369785|157503055|FG000|Overall Study|Progression|4|||
48908791|NCT00369785|157503056|FG001|Overall Study|Progression|4|||
48908792|NCT00369785|157503055|FG000|Overall Study|Multiple reasons|6|||
48908793|NCT00369785|157503056|FG001|Overall Study|Multiple reasons|5|||
48908794|NCT01022502|157503057|FG000|Overall Study|Adverse Event|1|||
48908795|NCT01022502|157503057|FG000|Overall Study|employment related reasons|1|||
48908796|NCT01022502|157503057|FG000|Overall Study|Withdrawal by Subject|1|||
48908797|NCT00685685|157503058|FG000|Washout Period of 7 Days|Adverse Event|2|||
48908798|NCT00685685|157503059|FG001|Washout Period of 7 Days|Adverse Event|0|||
48908799|NCT00685685|157503058|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
48908800|NCT00685685|157503059|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
48908801|NCT04029116|157503060|FG000|Overall Study|Adverse Event|0|||
48908802|NCT04029116|157503061|FG001|Overall Study|Adverse Event|2|||
48908803|NCT04029116|157503060|FG000|Overall Study|Lost to Follow-up|3|||
48908804|NCT04029116|157503061|FG001|Overall Study|Lost to Follow-up|5|||
48908805|NCT04029116|157503060|FG000|Overall Study|Physician Decision|2|||
48908806|NCT04029116|157503061|FG001|Overall Study|Physician Decision|0|||
48908807|NCT04029116|157503060|FG000|Overall Study|Pregnancy|1|||
48908808|NCT04029116|157503061|FG001|Overall Study|Pregnancy|2|||
48908809|NCT04029116|157503060|FG000|Overall Study|Withdrawal by Subject|4|||
48908810|NCT04029116|157503061|FG001|Overall Study|Withdrawal by Subject|6|||
48908811|NCT04029116|157503060|FG000|Overall Study|Other|2|||
48908812|NCT04029116|157503061|FG001|Overall Study|Other|1|||
48908813|NCT01177384|157503062|FG000|Overall Study|Adverse Event|6|||
48908814|NCT01177384|157503063|FG001|Overall Study|Adverse Event|4|||
48908815|NCT01177384|157503062|FG000|Overall Study|Lack of Efficacy|0|||
48908816|NCT01177384|157503063|FG001|Overall Study|Lack of Efficacy|1|||
48908817|NCT01177384|157503062|FG000|Overall Study|Lost to Follow-up|3|||
48908818|NCT01177384|157503063|FG001|Overall Study|Lost to Follow-up|4|||
48908819|NCT01177384|157503062|FG000|Overall Study|Physician Decision|0|||
48908820|NCT01177384|157503063|FG001|Overall Study|Physician Decision|3|||
48908821|NCT01177384|157503062|FG000|Overall Study|Protocol Violation|0|||
48908822|NCT01177384|157503063|FG001|Overall Study|Protocol Violation|2|||
48908823|NCT01177384|157503062|FG000|Overall Study|Withdrawal by Subject|5|||
48908824|NCT01177384|157503063|FG001|Overall Study|Withdrawal by Subject|12|||
48908825|NCT01221727|157503064|FG000|Overall Study|Physician Decision|2|||
48908826|NCT01221727|157503065|FG001|Overall Study|Physician Decision|0|||
48908827|NCT01221727|157503064|FG000|Overall Study|Withdrawal by Subject|1|||
48908828|NCT01221727|157503065|FG001|Overall Study|Withdrawal by Subject|1|||
48908829|NCT00590044|157503069|FG000|Overall Study|Withdrawal by Subject|2|||
48908830|NCT00590044|157503070|FG001|Overall Study|Withdrawal by Subject|2|||
48908831|NCT00590044|157503069|FG000|Overall Study|wrong insulin arm assigned|1|||
48908832|NCT00590044|157503070|FG001|Overall Study|wrong insulin arm assigned|0|||
48908833|NCT00590044|157503069|FG000|Overall Study|Protocol Violation|1|||
48908834|NCT00590044|157503070|FG001|Overall Study|Protocol Violation|0|||
48908835|NCT00773136|157503071|FG000|Overall Study|Physician Decision|2|||
48908836|NCT01514136|157503072|FG000|Test Period 1; Test A|Protocol Violation|1|||
48908837|NCT01514136|157503073|FG001|Test Period 1; Test A|Protocol Violation|0|||
48908838|NCT01514136|157503074|FG002|Test Period 1; Test A|Protocol Violation|0|||
48908839|NCT01514136|157503075|FG003|Test Period 1; Test A|Protocol Violation|0|||
48908840|NCT01514136|157503076|FG004|Test Period 1; Test A|Protocol Violation|0|||
48908841|NCT01514136|157503077|FG005|Test Period 1; Test A|Protocol Violation|0|||
48908842|NCT01514136|157503078|FG006|Test Period 1; Test A|Protocol Violation|0|||
48908843|NCT01514136|157503079|FG007|Test Period 1; Test A|Protocol Violation|0|||
48908844|NCT01514136|157503072|FG000|Test Period 1; Test A|Break from study holiday|2|||
48908845|NCT01514136|157503073|FG001|Test Period 1; Test A|Break from study holiday|0|||
48908846|NCT01514136|157503074|FG002|Test Period 1; Test A|Break from study holiday|0|||
48908847|NCT01514136|157503075|FG003|Test Period 1; Test A|Break from study holiday|0|||
48908848|NCT01514136|157503076|FG004|Test Period 1; Test A|Break from study holiday|0|||
48908849|NCT01514136|157503077|FG005|Test Period 1; Test A|Break from study holiday|0|||
48908850|NCT01514136|157503078|FG006|Test Period 1; Test A|Break from study holiday|0|||
48908851|NCT01514136|157503079|FG007|Test Period 1; Test A|Break from study holiday|0|||
48908852|NCT01514136|157503072|FG000|Test Period 1; Test B|Withdrawal by Subject|0|||
48908853|NCT01514136|157503073|FG001|Test Period 1; Test B|Withdrawal by Subject|1|||
48908854|NCT01514136|157503074|FG002|Test Period 1; Test B|Withdrawal by Subject|0|||
48908855|NCT01514136|157503075|FG003|Test Period 1; Test B|Withdrawal by Subject|0|||
48908856|NCT01514136|157503076|FG004|Test Period 1; Test B|Withdrawal by Subject|0|||
48908857|NCT01514136|157503077|FG005|Test Period 1; Test B|Withdrawal by Subject|0|||
48908858|NCT01514136|157503078|FG006|Test Period 1; Test B|Withdrawal by Subject|0|||
48908859|NCT01514136|157503079|FG007|Test Period 1; Test B|Withdrawal by Subject|0|||
48908860|NCT01514136|157503072|FG000|Test Period 1; Test D|Subject took a break due to holiday|0|||
48908861|NCT01514136|157503073|FG001|Test Period 1; Test D|Subject took a break due to holiday|0|||
48908862|NCT01514136|157503074|FG002|Test Period 1; Test D|Subject took a break due to holiday|0|||
48908863|NCT01514136|157503075|FG003|Test Period 1; Test D|Subject took a break due to holiday|2|||
48908864|NCT01514136|157503076|FG004|Test Period 1; Test D|Subject took a break due to holiday|0|||
48908865|NCT01514136|157503077|FG005|Test Period 1; Test D|Subject took a break due to holiday|0|||
48908866|NCT01514136|157503078|FG006|Test Period 1; Test D|Subject took a break due to holiday|0|||
48908867|NCT01514136|157503079|FG007|Test Period 1; Test D|Subject took a break due to holiday|0|||
48908868|NCT01514136|157503072|FG000|Test Period 2; Test A*|Adverse Event|0|||
48908869|NCT01514136|157503073|FG001|Test Period 2; Test A*|Adverse Event|0|||
48908870|NCT01514136|157503074|FG002|Test Period 2; Test A*|Adverse Event|0|||
48908871|NCT01514136|157503075|FG003|Test Period 2; Test A*|Adverse Event|0|||
48908872|NCT01514136|157503076|FG004|Test Period 2; Test A*|Adverse Event|1|||
48908873|NCT01514136|157503077|FG005|Test Period 2; Test A*|Adverse Event|0|||
48908874|NCT01514136|157503078|FG006|Test Period 2; Test A*|Adverse Event|0|||
48908875|NCT01514136|157503079|FG007|Test Period 2; Test A*|Adverse Event|0|||
48908876|NCT01514136|157503072|FG000|Test Period 2; Test A*|Holiday|0|||
48908877|NCT01514136|157503073|FG001|Test Period 2; Test A*|Holiday|0|||
48908878|NCT01514136|157503074|FG002|Test Period 2; Test A*|Holiday|0|||
48908879|NCT01514136|157503075|FG003|Test Period 2; Test A*|Holiday|0|||
48908880|NCT01514136|157503076|FG004|Test Period 2; Test A*|Holiday|1|||
48908881|NCT01514136|157503077|FG005|Test Period 2; Test A*|Holiday|0|||
48908882|NCT01514136|157503078|FG006|Test Period 2; Test A*|Holiday|0|||
48908883|NCT01514136|157503079|FG007|Test Period 2; Test A*|Holiday|0|||
48908884|NCT01514136|157503072|FG000|Test Period 2; Test B*|Withdrawal by Subject|0|||
48908885|NCT01514136|157503073|FG001|Test Period 2; Test B*|Withdrawal by Subject|0|||
48908886|NCT01514136|157503074|FG002|Test Period 2; Test B*|Withdrawal by Subject|0|||
48908887|NCT01514136|157503075|FG003|Test Period 2; Test B*|Withdrawal by Subject|0|||
48908888|NCT01514136|157503076|FG004|Test Period 2; Test B*|Withdrawal by Subject|0|||
48908889|NCT01514136|157503077|FG005|Test Period 2; Test B*|Withdrawal by Subject|2|||
48908890|NCT01514136|157503078|FG006|Test Period 2; Test B*|Withdrawal by Subject|0|||
48908891|NCT01514136|157503079|FG007|Test Period 2; Test B*|Withdrawal by Subject|0|||
48908892|NCT01514136|157503072|FG000|Test Period 2; Test C*|Withdrawal by Subject|0|||
48908893|NCT01514136|157503073|FG001|Test Period 2; Test C*|Withdrawal by Subject|0|||
48908894|NCT01514136|157503074|FG002|Test Period 2; Test C*|Withdrawal by Subject|0|||
48908895|NCT01514136|157503075|FG003|Test Period 2; Test C*|Withdrawal by Subject|0|||
48908896|NCT01514136|157503076|FG004|Test Period 2; Test C*|Withdrawal by Subject|0|||
48908897|NCT01514136|157503077|FG005|Test Period 2; Test C*|Withdrawal by Subject|0|||
48908898|NCT01514136|157503078|FG006|Test Period 2; Test C*|Withdrawal by Subject|1|||
48908899|NCT01514136|157503079|FG007|Test Period 2; Test C*|Withdrawal by Subject|0|||
48908900|NCT01514136|157503072|FG000|Test Period 2; Test C*|holiday|0|||
48908901|NCT01514136|157503073|FG001|Test Period 2; Test C*|holiday|0|||
48908902|NCT01514136|157503074|FG002|Test Period 2; Test C*|holiday|0|||
48908903|NCT01514136|157503075|FG003|Test Period 2; Test C*|holiday|0|||
48908904|NCT01514136|157503076|FG004|Test Period 2; Test C*|holiday|0|||
48908905|NCT01514136|157503077|FG005|Test Period 2; Test C*|holiday|0|||
48908906|NCT01514136|157503078|FG006|Test Period 2; Test C*|holiday|1|||
48908907|NCT01514136|157503079|FG007|Test Period 2; Test C*|holiday|0|||
48908908|NCT01514136|157503072|FG000|Test Period 2; Test C*|Protocol Violation|0|||
48908909|NCT01514136|157503073|FG001|Test Period 2; Test C*|Protocol Violation|0|||
48908910|NCT01514136|157503074|FG002|Test Period 2; Test C*|Protocol Violation|0|||
48908911|NCT01514136|157503075|FG003|Test Period 2; Test C*|Protocol Violation|0|||
48908912|NCT01514136|157503076|FG004|Test Period 2; Test C*|Protocol Violation|0|||
48908913|NCT01514136|157503077|FG005|Test Period 2; Test C*|Protocol Violation|0|||
48908914|NCT01514136|157503078|FG006|Test Period 2; Test C*|Protocol Violation|1|||
48908915|NCT01514136|157503079|FG007|Test Period 2; Test C*|Protocol Violation|0|||
48908916|NCT00757003|157503082|FG000|Overall Study|Death|33|||
48908917|NCT00757003|157503082|FG000|Overall Study|Lost to Follow-up|9|||
48908918|NCT00757003|157503082|FG000|Overall Study|Withdrawal by Subject|4|||
48908919|NCT00757003|157503082|FG000|Overall Study|Surgically explanted|2|||
48908920|NCT00757003|157503082|FG000|Overall Study|Not implanted|1|||
48908921|NCT04936841|157503083|FG000|Overall Study|Death|1|||
48908922|NCT02003014|157503084|FG000|Overall Study|Case report forms uncollected|9|||
48908923|NCT02003014|157503084|FG000|Overall Study|Treatment started after contract period|1|||
48908924|NCT02003014|157503084|FG000|Overall Study|Patient did not visit the study site|5|||
48908925|NCT02003014|157503084|FG000|Overall Study|Investigator's transfer|4|||
48908926|NCT01660451|157503085|FG000|Overall Study|Protocol Violation|0|||
48908927|NCT01660451|157503086|FG001|Overall Study|Protocol Violation|1|||
48908928|NCT01660451|157503087|FG002|Overall Study|Protocol Violation|1|||
48908929|NCT01660451|157503085|FG000|Overall Study|AE not associated with clinical disease progression|13|||
48908930|NCT01660451|157503086|FG001|Overall Study|AE not associated with clinical disease progression|10|||
48908931|NCT01660451|157503087|FG002|Overall Study|AE not associated with clinical disease progression|40|||
48908932|NCT01660451|157503085|FG000|Overall Study|AE associated with clinical disease progression|1|||
48908933|NCT01660451|157503086|FG001|Overall Study|AE associated with clinical disease progression|3|||
48908934|NCT01660451|157503087|FG002|Overall Study|AE associated with clinical disease progression|11|||
48908935|NCT01660451|157503085|FG000|Overall Study|Sponsor Decision|0|||
48908936|NCT01660451|157503086|FG001|Overall Study|Sponsor Decision|0|||
48908937|NCT01660451|157503087|FG002|Overall Study|Sponsor Decision|1|||
48908938|NCT01660451|157503085|FG000|Overall Study|Protocol Deviation|0|||
48908939|NCT01660451|157503086|FG001|Overall Study|Protocol Deviation|0|||
48908940|NCT01660451|157503087|FG002|Overall Study|Protocol Deviation|1|||
48908941|NCT01660451|157503085|FG000|Overall Study|Physician Decision|1|||
48908942|NCT01660451|157503086|FG001|Overall Study|Physician Decision|2|||
48908943|NCT01660451|157503087|FG002|Overall Study|Physician Decision|5|||
48908944|NCT01660451|157503085|FG000|Overall Study|Withdrawal by Subject|1|||
48908945|NCT01660451|157503086|FG001|Overall Study|Withdrawal by Subject|1|||
48908946|NCT01660451|157503087|FG002|Overall Study|Withdrawal by Subject|20|||
48908947|NCT01660451|157503085|FG000|Overall Study|Trial closure.|0|||
48908948|NCT01660451|157503086|FG001|Overall Study|Trial closure.|0|||
48908949|NCT01660451|157503087|FG002|Overall Study|Trial closure.|1|||
48908950|NCT01660451|157503085|FG000|Overall Study|Switching to other therapy|0|||
48908951|NCT01660451|157503086|FG001|Overall Study|Switching to other therapy|1|||
48908952|NCT01660451|157503087|FG002|Overall Study|Switching to other therapy|1|||
48908953|NCT01660451|157503085|FG000|Overall Study|Progressive disease - clinical progression|4|||
48908954|NCT01660451|157503086|FG001|Overall Study|Progressive disease - clinical progression|10|||
48908955|NCT01660451|157503087|FG002|Overall Study|Progressive disease - clinical progression|9|||
48908956|NCT01660451|157503085|FG000|Overall Study|Progressive disease - radiological progression|12|||
48908957|NCT01660451|157503086|FG001|Overall Study|Progressive disease - radiological progression|23|||
48908958|NCT01660451|157503087|FG002|Overall Study|Progressive disease - radiological progression|50|||
48908959|NCT01660451|157503085|FG000|Overall Study|Death|1|||
48908960|NCT01660451|157503086|FG001|Overall Study|Death|0|||
48908961|NCT01660451|157503087|FG002|Overall Study|Death|1|||
48908962|NCT01660451|157503085|FG000|Overall Study|Other|0|||
49116296|NCT01084538|158263088|FG000|Overall Study|Lack of effectiveness|2|||
49116297|NCT01084538|158263088|FG000|Overall Study|Patient noncompliance|2|||
49116298|NCT01084538|158263088|FG000|Overall Study|Hyperphosphatemia|2|||
48908963|NCT01660451|157503086|FG001|Overall Study|Other|0|||
48908964|NCT01660451|157503087|FG002|Overall Study|Other|1|||
48908965|NCT04695392|157503088|FG000|Overall Study|Withdrawn by parent/guardian|0|||
48908966|NCT04695392|157503089|FG001|Overall Study|Withdrawn by parent/guardian|1|||
48908967|NCT04695392|157503088|FG000|Overall Study|Withdrawn by physician|0|||
48908968|NCT04695392|157503089|FG001|Overall Study|Withdrawn by physician|1|||
48908969|NCT01034540|157503090|FG000|Overall Study|Adverse Event|0|||
48908970|NCT01034540|157503091|FG001|Overall Study|Adverse Event|1|||
48908971|NCT00932425|157503094|FG000|Overall Study|Lost to Follow-up|0|||
48908972|NCT00932425|157503095|FG001|Overall Study|Lost to Follow-up|1|||
48908973|NCT00932425|157503094|FG000|Overall Study|Withdrawal by Subject|0|||
48908974|NCT00932425|157503095|FG001|Overall Study|Withdrawal by Subject|1|||
48908975|NCT01854645|157503096|FG000|Overall Study|Protocol-Specified Criteria|13|||
48908976|NCT01854645|157503097|FG001|Overall Study|Protocol-Specified Criteria|10|||
48908977|NCT01854645|157503098|FG002|Overall Study|Protocol-Specified Criteria|8|||
48908978|NCT01854645|157503099|FG003|Overall Study|Protocol-Specified Criteria|5|||
48908979|NCT01854645|157503100|FG004|Overall Study|Protocol-Specified Criteria|7|||
48908980|NCT01854645|157503096|FG000|Overall Study|Administrative Reasons / Missing|0|||
48908981|NCT01854645|157503097|FG001|Overall Study|Administrative Reasons / Missing|0|||
48908982|NCT01854645|157503098|FG002|Overall Study|Administrative Reasons / Missing|0|||
48908983|NCT01854645|157503099|FG003|Overall Study|Administrative Reasons / Missing|1|||
48908984|NCT01854645|157503100|FG004|Overall Study|Administrative Reasons / Missing|1|||
48908985|NCT01854645|157503096|FG000|Overall Study|Protocol Violation|3|||
48908986|NCT01854645|157503097|FG001|Overall Study|Protocol Violation|0|||
48908987|NCT01854645|157503098|FG002|Overall Study|Protocol Violation|5|||
48908988|NCT01854645|157503099|FG003|Overall Study|Protocol Violation|4|||
48908989|NCT01854645|157503100|FG004|Overall Study|Protocol Violation|1|||
48908990|NCT01854645|157503096|FG000|Overall Study|Lost to Follow-up|10|||
48908991|NCT01854645|157503097|FG001|Overall Study|Lost to Follow-up|7|||
48908992|NCT01854645|157503098|FG002|Overall Study|Lost to Follow-up|8|||
48908993|NCT01854645|157503099|FG003|Overall Study|Lost to Follow-up|5|||
48908994|NCT01854645|157503100|FG004|Overall Study|Lost to Follow-up|0|||
48908995|NCT01854645|157503096|FG000|Overall Study|Physician Decision|1|||
48908996|NCT01854645|157503097|FG001|Overall Study|Physician Decision|5|||
48908997|NCT01854645|157503098|FG002|Overall Study|Physician Decision|3|||
48908998|NCT01854645|157503099|FG003|Overall Study|Physician Decision|3|||
48908999|NCT01854645|157503100|FG004|Overall Study|Physician Decision|7|||
48909000|NCT01854645|157503096|FG000|Overall Study|Withdrawal by Subject|31|||
48909001|NCT01854645|157503097|FG001|Overall Study|Withdrawal by Subject|41|||
48909002|NCT01854645|157503098|FG002|Overall Study|Withdrawal by Subject|30|||
48909003|NCT01854645|157503099|FG003|Overall Study|Withdrawal by Subject|21|||
48909004|NCT01854645|157503100|FG004|Overall Study|Withdrawal by Subject|24|||
48909005|NCT01854645|157503096|FG000|Overall Study|Lack of Efficacy|7|||
48909006|NCT01854645|157503097|FG001|Overall Study|Lack of Efficacy|12|||
48909007|NCT01854645|157503098|FG002|Overall Study|Lack of Efficacy|9|||
48909008|NCT01854645|157503099|FG003|Overall Study|Lack of Efficacy|3|||
48909009|NCT01854645|157503100|FG004|Overall Study|Lack of Efficacy|9|||
48909010|NCT01854645|157503096|FG000|Overall Study|Adverse Event|33|||
48909011|NCT01854645|157503097|FG001|Overall Study|Adverse Event|31|||
48909012|NCT01854645|157503098|FG002|Overall Study|Adverse Event|19|||
48909013|NCT01854645|157503099|FG003|Overall Study|Adverse Event|20|||
48909014|NCT01854645|157503100|FG004|Overall Study|Adverse Event|11|||
48909015|NCT00403754|157503101|FG000|Core Treatment Period 1|Withdrawal by Subject|0|||
48909016|NCT00403754|157503102|FG001|Core Treatment Period 1|Withdrawal by Subject|1|||
48909017|NCT00403754|157503103|FG002|Core Treatment Period 1|Withdrawal by Subject|0|||
48909018|NCT00403754|157503104|FG003|Core Treatment Period 1|Withdrawal by Subject|0|||
48909019|NCT00403754|157503101|FG000|Core Treatment Period 2|Lack of Efficacy|0|||
48909020|NCT00403754|157503102|FG001|Core Treatment Period 2|Lack of Efficacy|0|||
48909021|NCT00403754|157503103|FG002|Core Treatment Period 2|Lack of Efficacy|1|||
48909022|NCT00403754|157503104|FG003|Core Treatment Period 2|Lack of Efficacy|0|||
48909023|NCT02000427|157503107|FG000|Overall Study|Death|22|||
48909024|NCT00523718|157504293|FG000|Overall Study|Withdrawal by Subject|1|||
48909025|NCT00523718|157504294|FG001|Overall Study|Withdrawal by Subject|0|||
48909026|NCT00523718|157504293|FG000|Overall Study|Protocol Violation|2|||
48909027|NCT00523718|157504294|FG001|Overall Study|Protocol Violation|0|||
48909028|NCT00594516|157504295|FG000|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4|||
48909029|NCT00594516|157504296|FG001|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
48909030|NCT00594516|157504297|FG002|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
48909031|NCT00594516|157504295|FG000|Open Label (OL): Tapentadol IR|Lost to Follow-up|2|||
48909032|NCT00594516|157504296|FG001|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
48909033|NCT00594516|157504297|FG002|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
48909034|NCT00594516|157504295|FG000|Open Label (OL): Tapentadol IR|Adverse Event|16|||
48909035|NCT00594516|157504296|FG001|Open Label (OL): Tapentadol IR|Adverse Event|0|||
48909036|NCT00594516|157504297|FG002|Open Label (OL): Tapentadol IR|Adverse Event|0|||
48909037|NCT00594516|157504295|FG000|Open Label (OL): Tapentadol IR|Lack of Efficacy|1|||
48909038|NCT00594516|157504296|FG001|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
48909039|NCT00594516|157504297|FG002|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
48909040|NCT00594516|157504295|FG000|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6|||
48909041|NCT00594516|157504296|FG001|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
48909042|NCT00594516|157504297|FG002|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
48909043|NCT00594516|157504295|FG000|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0|||
48909044|NCT00594516|157504296|FG001|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
48909045|NCT00594516|157504297|FG002|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
48909046|NCT00594516|157504295|FG000|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0|||
48909047|NCT00594516|157504296|FG001|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3|||
48909048|NCT00594516|157504297|FG002|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2|||
48909049|NCT00594516|157504295|FG000|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0|||
48909050|NCT00594516|157504296|FG001|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
48909051|NCT00594516|157504297|FG002|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
48909052|NCT00594516|157504295|FG000|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
48909053|NCT00594516|157504296|FG001|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
48909054|NCT00594516|157504297|FG002|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2|||
48909055|NCT00088907|157504298|FG000|Randomized Study (Step 1)|Lack of Efficacy|55|||
48909056|NCT00088907|157504299|FG001|Randomized Study (Step 1)|Lack of Efficacy|62|||
48909057|NCT00088907|157504298|FG000|Randomized Study (Step 1)|Adverse Event|14|||
48909058|NCT00088907|157504299|FG001|Randomized Study (Step 1)|Adverse Event|19|||
48909059|NCT00088907|157504298|FG000|Randomized Study (Step 1)|Death|11|||
48909060|NCT00088907|157504299|FG001|Randomized Study (Step 1)|Death|12|||
48909061|NCT00088907|157504298|FG000|Randomized Study (Step 1)|Withdrawal by Subject|10|||
48909062|NCT00088907|157504299|FG001|Randomized Study (Step 1)|Withdrawal by Subject|15|||
48909063|NCT00088907|157504298|FG000|Randomized Study (Step 1)|complicating disease|3|||
48909064|NCT00088907|157504299|FG001|Randomized Study (Step 1)|complicating disease|1|||
48909065|NCT00088907|157504298|FG000|Randomized Study (Step 1)|unknown/not specify|24|||
48909066|NCT00088907|157504299|FG001|Randomized Study (Step 1)|unknown/not specify|13|||
48909067|NCT00088907|157504298|FG000|Randomized Study (Step 1)|ineligible or not start protocol therapy|19|||
48909068|NCT00088907|157504299|FG001|Randomized Study (Step 1)|ineligible or not start protocol therapy|12|||
48909069|NCT00088907|157504298|FG000|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16|||
48909070|NCT00088907|157504299|FG001|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0|||
48909071|NCT00088907|157504298|FG000|Single Gefitinib Treatment (Step 2)|Death|1|||
48909072|NCT00088907|157504299|FG001|Single Gefitinib Treatment (Step 2)|Death|0|||
48909073|NCT00088907|157504298|FG000|Single Gefitinib Treatment (Step 2)|unknown/not specify|2|||
48909074|NCT00088907|157504299|FG001|Single Gefitinib Treatment (Step 2)|unknown/not specify|0|||
48909075|NCT00088907|157504298|FG000|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5|||
48909076|NCT00088907|157504299|FG001|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0|||
48909077|NCT03426787|157504300|FG000|Overall Study|Withdrawal by Subject|6|||
48909078|NCT03426787|157504300|FG000|Overall Study|Lost to Follow-up|7|||
48909079|NCT03426787|157504300|FG000|Overall Study|Unrelated to intervention death|1|||
48909080|NCT03808688|157504301|FG000|Overall Study|Adverse Event|13|||
48909081|NCT03808688|157504302|FG001|Overall Study|Adverse Event|17|||
48909082|NCT03808688|157504301|FG000|Overall Study|Lack of Efficacy|2|||
48909083|NCT03808688|157504302|FG001|Overall Study|Lack of Efficacy|0|||
48909084|NCT03808688|157504301|FG000|Overall Study|Lost to Follow-up|0|||
48909085|NCT03808688|157504302|FG001|Overall Study|Lost to Follow-up|2|||
48909086|NCT03808688|157504301|FG000|Overall Study|Withdrawal by Subject|1|||
48909087|NCT03808688|157504302|FG001|Overall Study|Withdrawal by Subject|0|||
48909088|NCT03808688|157504301|FG000|Overall Study|Intolerance to Conjunctival Hyperemia|1|||
48909089|NCT03808688|157504302|FG001|Overall Study|Intolerance to Conjunctival Hyperemia|0|||
48909090|NCT03808688|157504301|FG000|Overall Study|IOP Too High|1|||
48909091|NCT03808688|157504302|FG001|Overall Study|IOP Too High|1|||
48909092|NCT03808688|157504301|FG000|Overall Study|IOP Too High, Nerve/Visual Field Changes|0|||
48909093|NCT03808688|157504302|FG001|Overall Study|IOP Too High, Nerve/Visual Field Changes|1|||
48909094|NCT03808688|157504301|FG000|Overall Study|Visit Out of Window|0|||
48909095|NCT03808688|157504302|FG001|Overall Study|Visit Out of Window|1|||
48909096|NCT03808688|157504301|FG000|Overall Study|Medication Non-Compliance|0|||
48909097|NCT03808688|157504302|FG001|Overall Study|Medication Non-Compliance|1|||
48909098|NCT02012296|157504306|FG000|Overall Study|Lack of Efficacy|0|||
48909099|NCT02012296|157504307|FG001|Overall Study|Lack of Efficacy|0|||
48909100|NCT02012296|157504308|FG002|Overall Study|Lack of Efficacy|15|||
48909101|NCT02012296|157504306|FG000|Overall Study|Adverse Event|0|||
48909102|NCT02012296|157504307|FG001|Overall Study|Adverse Event|0|||
48909103|NCT02012296|157504308|FG002|Overall Study|Adverse Event|2|||
48909104|NCT02012296|157504306|FG000|Overall Study|Early study closure|0|||
48909105|NCT02012296|157504307|FG001|Overall Study|Early study closure|0|||
48909106|NCT02012296|157504308|FG002|Overall Study|Early study closure|5|||
48909107|NCT02012296|157504306|FG000|Overall Study|Protocol Violation|0|||
48909108|NCT02012296|157504307|FG001|Overall Study|Protocol Violation|1|||
48909109|NCT02012296|157504308|FG002|Overall Study|Protocol Violation|0|||
48909110|NCT00929656|157504309|FG000|Overall Study|Lost to Follow-up|0|||
48909111|NCT00929656|157504310|FG001|Overall Study|Lost to Follow-up|1|||
48909112|NCT00607880|157504311|FG000|Overall Study|Unable to place port due to occlusion|1|||
48909113|NCT00607880|157504312|FG001|Overall Study|Unable to place port due to occlusion|0|||
48909114|NCT01170039|157504313|FG000|Overall Study|Withdrawal by Subject|5|||
48909115|NCT01170039|157504314|FG001|Overall Study|Withdrawal by Subject|3|||
48909116|NCT01170039|157504313|FG000|Overall Study|Lack of funding, drug not available|3|||
48909117|NCT01170039|157504314|FG001|Overall Study|Lack of funding, drug not available|3|||
48909118|NCT02464228|157504315|FG000|Overall Study|Termination for Symptomatic Deterioration|1|||
48695033|NCT02694744|156732150|FG000|Overall Study|Physician Decision|1|||
48695034|NCT02694744|156732151|FG001|Overall Study|Physician Decision|2|||
48695035|NCT02694744|156732150|FG000|Overall Study|Lost to Follow-up|1|||
48695036|NCT02694744|156732151|FG001|Overall Study|Lost to Follow-up|0|||
48695037|NCT02694744|156732150|FG000|Overall Study|Taking potassium supplement: exclusion 6|0|||
48695038|NCT02694744|156732151|FG001|Overall Study|Taking potassium supplement: exclusion 6|1|||
48695039|NCT00686777|156732152|FG000|Overall Study|Adverse Event|2|||
48695040|NCT00686777|156732152|FG000|Overall Study|Pregnancy|1|||
48695041|NCT00686777|156732152|FG000|Overall Study|Withdrawal by Subject|2|||
48695042|NCT00686777|156732152|FG000|Overall Study|Discontinuance Criteria (specified AEs)|4|||
48695043|NCT00686777|156732152|FG000|Overall Study|No Visit|1|||
48695044|NCT01791244|156732154|FG000|Overall Study|Adverse Event|5|||
48695045|NCT01791244|156732155|FG001|Overall Study|Adverse Event|7|||
48695046|NCT01791244|156732154|FG000|Overall Study|Insufficient clinical response|10|||
48695047|NCT01791244|156732155|FG001|Overall Study|Insufficient clinical response|10|||
48695048|NCT01791244|156732154|FG000|Overall Study|Laboratory Abnormality|0|||
48695049|NCT01791244|156732155|FG001|Overall Study|Laboratory Abnormality|1|||
48695050|NCT00739401|156732156|FG000|Overall Study|patients were not due for the 2 year follow-up|34|||
48695051|NCT00739401|156732156|FG000|Overall Study|Death|3|||
48695052|NCT00739401|156732156|FG000|Overall Study|Withdrawal by Subject|4|||
48695053|NCT04739982|156732157|FG000|Overall Study|Lost to Follow-up|176|||
48695054|NCT04739982|156732158|FG001|Overall Study|Lost to Follow-up|65|||
48695055|NCT04739982|156732157|FG000|Overall Study|Withdrawal by Subject|19|||
48695056|NCT04739982|156732158|FG001|Overall Study|Withdrawal by Subject|0|||
48695057|NCT04739982|156732157|FG000|Overall Study|Protocol Violation|0|||
48695058|NCT04739982|156732158|FG001|Overall Study|Protocol Violation|5|||
48695059|NCT02240485|156732159|FG000|3 Months Post-admission|Lost to Follow-up|1|||
48695060|NCT02240485|156732160|FG001|3 Months Post-admission|Lost to Follow-up|5|||
48695061|NCT02240485|156732159|FG000|3 Months Post-admission|Withdrawal by Subject|2|||
48695062|NCT02240485|156732160|FG001|3 Months Post-admission|Withdrawal by Subject|1|||
48695063|NCT02240485|156732159|FG000|9 Months Post-admission|Lost to Follow-up|3|||
48695064|NCT02240485|156732160|FG001|9 Months Post-admission|Lost to Follow-up|1|||
48695065|NCT02240485|156732159|FG000|9 Months Post-admission|Withdrawal by Subject|0|||
48695066|NCT02240485|156732160|FG001|9 Months Post-admission|Withdrawal by Subject|3|||
48695067|NCT02240485|156732159|FG000|18 Months Post-admission|Lost to Follow-up|1|||
48695068|NCT02240485|156732160|FG001|18 Months Post-admission|Lost to Follow-up|1|||
48695069|NCT02240485|156732159|FG000|18 Months Post-admission|Withdrawal by Subject|2|||
48695070|NCT02240485|156732160|FG001|18 Months Post-admission|Withdrawal by Subject|4|||
48695071|NCT02636699|156732161|FG000|Overall Study|Adverse Event|4|||
48695072|NCT02636699|156732162|FG001|Overall Study|Adverse Event|0|||
48695073|NCT02636699|156732161|FG000|Overall Study|Lost to Follow-up|3|||
48695074|NCT02636699|156732162|FG001|Overall Study|Lost to Follow-up|3|||
48695075|NCT02636699|156732161|FG000|Overall Study|Non-compliance with the investigational product (IP)|2|||
48695076|NCT02636699|156732162|FG001|Overall Study|Non-compliance with the investigational product (IP)|0|||
48695077|NCT02636699|156732161|FG000|Overall Study|Physician Decision|0|||
48695078|NCT02636699|156732162|FG001|Overall Study|Physician Decision|1|||
48695079|NCT02636699|156732161|FG000|Overall Study|Withdrawal by Subject|13|||
48695080|NCT02636699|156732162|FG001|Overall Study|Withdrawal by Subject|6|||
48695081|NCT02636699|156732161|FG000|Overall Study|Other|3|||
48695082|NCT02636699|156732162|FG001|Overall Study|Other|1|||
48695083|NCT00539981|156732163|FG000|Overall Study|Adverse events (AE)|3|||
48695084|NCT00539981|156732164|FG001|Overall Study|Adverse events (AE)|3|||
48695085|NCT00539981|156732163|FG000|Overall Study|Lost to Follow-up|260|||
48695086|NCT00539981|156732164|FG001|Overall Study|Lost to Follow-up|251|||
48695087|NCT00539981|156732163|FG000|Overall Study|Withdrew consent|22|||
48695088|NCT00539981|156732164|FG001|Overall Study|Withdrew consent|14|||
48695089|NCT00539981|156732163|FG000|Overall Study|Death|1|||
48695090|NCT00539981|156732164|FG001|Overall Study|Death|1|||
48695091|NCT00539981|156732163|FG000|Overall Study|Other reason-unspecified|9|||
48695092|NCT00539981|156732164|FG001|Overall Study|Other reason-unspecified|13|||
48909119|NCT02464228|157504316|FG001|Overall Study|Termination for Symptomatic Deterioration|1|||
48695093|NCT02285855|156732165|FG000|Overall Study|Withdrawal by Subject|2|||
48695094|NCT02285855|156732166|FG001|Overall Study|Withdrawal by Subject|1|||
48695095|NCT00528112|156732170|FG000|Treatment up to 3 Years|Adverse Event|313|||
48695096|NCT00528112|156732171|FG001|Treatment up to 3 Years|Adverse Event|278|||
48695097|NCT00528112|156732170|FG000|Treatment up to 3 Years|Withdrawal by Subject|26|||
48695098|NCT00528112|156732171|FG001|Treatment up to 3 Years|Withdrawal by Subject|31|||
48909120|NCT02464228|157504317|FG002|Overall Study|Termination for Symptomatic Deterioration|0|||
48909121|NCT02464228|157504318|FG003|Overall Study|Termination for Symptomatic Deterioration|0|||
48695099|NCT00528112|156732170|FG000|Treatment up to 3 Years|Protocol Violation|16|||
48695100|NCT00528112|156732171|FG001|Treatment up to 3 Years|Protocol Violation|16|||
48695101|NCT00528112|156732170|FG000|Treatment up to 3 Years|Death|0|||
48695102|NCT00528112|156732171|FG001|Treatment up to 3 Years|Death|1|||
48695103|NCT00528112|156732170|FG000|Treatment up to 3 Years|Lost to Follow-up|63|||
48695104|NCT00528112|156732171|FG001|Treatment up to 3 Years|Lost to Follow-up|61|||
48695105|NCT00528112|156732170|FG000|Treatment up to 3 Years|Pregnancy|9|||
48695106|NCT00528112|156732171|FG001|Treatment up to 3 Years|Pregnancy|10|||
48695107|NCT00528112|156732170|FG000|Treatment up to 3 Years|Other reasons|186|||
48695108|NCT00528112|156732171|FG001|Treatment up to 3 Years|Other reasons|186|||
48695109|NCT00528112|156732170|FG000|Extension Phase|Withdrawal by Subject|0|||
48695110|NCT00528112|156732171|FG001|Extension Phase|Withdrawal by Subject|3|||
48695111|NCT00528112|156732170|FG000|Extension Phase|Other reasons|0|||
48695112|NCT00528112|156732171|FG001|Extension Phase|Other reasons|100|||
48695113|NCT00528112|156732170|FG000|Extension Phase|Pregnancy|0|||
48695114|NCT00528112|156732171|FG001|Extension Phase|Pregnancy|3|||
48695115|NCT00528112|156732170|FG000|Extension Phase|Lost to Follow-up|0|||
48695116|NCT00528112|156732171|FG001|Extension Phase|Lost to Follow-up|12|||
48695117|NCT00528112|156732170|FG000|Extension Phase|Death|0|||
48695118|NCT00528112|156732171|FG001|Extension Phase|Death|1|||
48695119|NCT00528112|156732170|FG000|Extension Phase|Adverse Event|0|||
48695120|NCT00528112|156732171|FG001|Extension Phase|Adverse Event|36|||
48695121|NCT00528112|156732170|FG000|Extension Phase|Protocol Violation|0|||
48695122|NCT00528112|156732171|FG001|Extension Phase|Protocol Violation|2|||
48695123|NCT01323582|156732172|FG000|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
48695124|NCT01323582|156732173|FG001|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
48695125|NCT01323582|156732172|FG000|Weeks 5-7 (Washout)|Withdrawal by Subject|0|||
48695126|NCT01323582|156732173|FG001|Weeks 5-7 (Washout)|Withdrawal by Subject|1|||
48695127|NCT01323582|156732172|FG000|Weeks 8-11 (Period 2)|Withdrawal by Subject|0|||
48695128|NCT01323582|156732173|FG001|Weeks 8-11 (Period 2)|Withdrawal by Subject|1|||
48695129|NCT03416868|156732174|FG000|Overall Study|Withdrawal by Subject|2|||
48695130|NCT03416868|156732174|FG000|Overall Study|Lost to Follow-up|1|||
48695131|NCT02163538|156732177|FG000|Overall Study|Protocol Violation|1|||
48695132|NCT02163538|156732178|FG001|Overall Study|Protocol Violation|0|||
48695133|NCT02163538|156732177|FG000|Overall Study|Physician Decision|0|||
48695134|NCT02163538|156732178|FG001|Overall Study|Physician Decision|1|||
48695135|NCT00894803|156732179|FG000|Overall Study|Death|20|||
48695136|NCT00894803|156732180|FG001|Overall Study|Death|4|||
48695137|NCT00894803|156732179|FG000|Overall Study|Lost to Follow-up|0|||
48695138|NCT00894803|156732180|FG001|Overall Study|Lost to Follow-up|1|||
48695139|NCT02051764|156732181|FG000|Overall Study|Study terminated by sponsor|0|||
48695140|NCT02051764|156732182|FG001|Overall Study|Study terminated by sponsor|7|||
48695141|NCT00168844|156732183|FG000|Overall Study|Adverse Event|31|||
48695142|NCT00168844|156732184|FG001|Overall Study|Adverse Event|32|||
48695143|NCT00168844|156732185|FG002|Overall Study|Adverse Event|48|||
48695144|NCT00168844|156732183|FG000|Overall Study|Lost to Follow-up|4|||
48695145|NCT00168844|156732184|FG001|Overall Study|Lost to Follow-up|5|||
48695146|NCT00168844|156732185|FG002|Overall Study|Lost to Follow-up|11|||
48695147|NCT00168844|156732183|FG000|Overall Study|Withdrawal by Subject|12|||
48695148|NCT00168844|156732184|FG001|Overall Study|Withdrawal by Subject|9|||
48695149|NCT00168844|156732185|FG002|Overall Study|Withdrawal by Subject|19|||
48695150|NCT00168844|156732183|FG000|Overall Study|Protocol Violation|2|||
48695151|NCT00168844|156732184|FG001|Overall Study|Protocol Violation|2|||
48695152|NCT00168844|156732185|FG002|Overall Study|Protocol Violation|4|||
48695153|NCT00168844|156732183|FG000|Overall Study|Other|6|||
48695154|NCT00168844|156732184|FG001|Overall Study|Other|7|||
48695155|NCT00168844|156732185|FG002|Overall Study|Other|9|||
48695156|NCT00591006|156732186|FG000|Overall Study|Withdrawal by Subject|0|||
48695157|NCT00591006|156732187|FG001|Overall Study|Withdrawal by Subject|0|||
48695158|NCT00591006|156732188|FG002|Overall Study|Withdrawal by Subject|0|||
48695159|NCT00591006|156732189|FG003|Overall Study|Withdrawal by Subject|0|||
48695160|NCT00591006|156732190|FG004|Overall Study|Withdrawal by Subject|0|||
48695161|NCT00591006|156732191|FG005|Overall Study|Withdrawal by Subject|0|||
48695162|NCT00591006|156732192|FG006|Overall Study|Withdrawal by Subject|0|||
48695163|NCT00591006|156732193|FG007|Overall Study|Withdrawal by Subject|0|||
48695164|NCT00591006|156732194|FG008|Overall Study|Withdrawal by Subject|0|||
48695165|NCT00591006|156732195|FG009|Overall Study|Withdrawal by Subject|0|||
48695166|NCT00591006|156732196|FG010|Overall Study|Withdrawal by Subject|0|||
48695167|NCT00591006|156732197|FG011|Overall Study|Withdrawal by Subject|0|||
48695168|NCT00591006|156732198|FG012|Overall Study|Withdrawal by Subject|0|||
48695169|NCT00591006|156732199|FG013|Overall Study|Withdrawal by Subject|0|||
48695170|NCT00591006|156732200|FG014|Overall Study|Withdrawal by Subject|0|||
48695171|NCT00591006|156732201|FG015|Overall Study|Withdrawal by Subject|1|||
48695172|NCT00591006|156732202|FG016|Overall Study|Withdrawal by Subject|0|||
48695173|NCT00591006|156732203|FG017|Overall Study|Withdrawal by Subject|0|||
48695174|NCT00591006|156732204|FG018|Overall Study|Withdrawal by Subject|0|||
48695175|NCT00591006|156732205|FG019|Overall Study|Withdrawal by Subject|0|||
48695176|NCT00591006|156732206|FG020|Overall Study|Withdrawal by Subject|0|||
48695177|NCT00591006|156732207|FG021|Overall Study|Withdrawal by Subject|0|||
48695178|NCT00591006|156732208|FG022|Overall Study|Withdrawal by Subject|0|||
48695179|NCT00591006|156732209|FG023|Overall Study|Withdrawal by Subject|1|||
48695180|NCT00591006|156732186|FG000|Overall Study|Adverse Event|0|||
48695181|NCT00591006|156732187|FG001|Overall Study|Adverse Event|0|||
48695182|NCT00591006|156732188|FG002|Overall Study|Adverse Event|0|||
48695183|NCT00591006|156732189|FG003|Overall Study|Adverse Event|0|||
48695184|NCT00591006|156732190|FG004|Overall Study|Adverse Event|0|||
48695185|NCT00591006|156732191|FG005|Overall Study|Adverse Event|0|||
48695186|NCT00591006|156732192|FG006|Overall Study|Adverse Event|0|||
48695187|NCT00591006|156732193|FG007|Overall Study|Adverse Event|0|||
48695188|NCT00591006|156732194|FG008|Overall Study|Adverse Event|0|||
48695189|NCT00591006|156732195|FG009|Overall Study|Adverse Event|0|||
48695190|NCT00591006|156732196|FG010|Overall Study|Adverse Event|0|||
48695191|NCT00591006|156732197|FG011|Overall Study|Adverse Event|0|||
48695192|NCT00591006|156732198|FG012|Overall Study|Adverse Event|0|||
48695193|NCT00591006|156732199|FG013|Overall Study|Adverse Event|0|||
48695194|NCT00591006|156732200|FG014|Overall Study|Adverse Event|0|||
48695195|NCT00591006|156732201|FG015|Overall Study|Adverse Event|0|||
48695196|NCT00591006|156732202|FG016|Overall Study|Adverse Event|0|||
48695197|NCT00591006|156732203|FG017|Overall Study|Adverse Event|0|||
48695198|NCT00591006|156732204|FG018|Overall Study|Adverse Event|0|||
48695199|NCT00591006|156732205|FG019|Overall Study|Adverse Event|0|||
48695200|NCT00591006|156732206|FG020|Overall Study|Adverse Event|0|||
48695201|NCT00591006|156732207|FG021|Overall Study|Adverse Event|0|||
48695202|NCT00591006|156732208|FG022|Overall Study|Adverse Event|1|||
48695203|NCT00591006|156732209|FG023|Overall Study|Adverse Event|0|||
48695204|NCT00976274|156732211|FG000|Overall Study|Lost to Follow-up|5|||
48695205|NCT00976274|156732212|FG001|Overall Study|Lost to Follow-up|5|||
48695206|NCT00976274|156732211|FG000|Overall Study|Withdrawal by Subject|1|||
48695207|NCT00976274|156732212|FG001|Overall Study|Withdrawal by Subject|1|||
48695208|NCT00976274|156732211|FG000|Overall Study|Physician Decision|1|||
48695209|NCT00976274|156732212|FG001|Overall Study|Physician Decision|2|||
48695210|NCT01075243|156732213|FG000|Overall Study|Lost to Follow-up|5|||
48695211|NCT01075243|156732214|FG001|Overall Study|Lost to Follow-up|2|||
48695212|NCT01075243|156732215|FG002|Overall Study|Lost to Follow-up|0|||
48695213|NCT01075243|156732213|FG000|Overall Study|Withdrawal by Subject|1|||
48695214|NCT01075243|156732214|FG001|Overall Study|Withdrawal by Subject|1|||
48695215|NCT01075243|156732215|FG002|Overall Study|Withdrawal by Subject|0|||
48695216|NCT03050801|156732217|FG000|Experiment 1|Lost to Follow-up|0|||
48695217|NCT03050801|156732218|FG001|Experiment 1|Lost to Follow-up|1|||
48695218|NCT03050801|156732219|FG002|Experiment 1|Lost to Follow-up|0|||
48695219|NCT03050801|156732220|FG003|Experiment 1|Lost to Follow-up|0|||
48695220|NCT03050801|156732221|FG004|Experiment 1|Lost to Follow-up|0|||
48695221|NCT03050801|156732222|FG005|Experiment 1|Lost to Follow-up|0|||
48695222|NCT03050801|156732217|FG000|Experiment 1|Physician Decision|0|||
48695223|NCT03050801|156732218|FG001|Experiment 1|Physician Decision|3|||
48695224|NCT03050801|156732219|FG002|Experiment 1|Physician Decision|0|||
48695225|NCT03050801|156732220|FG003|Experiment 1|Physician Decision|0|||
48695226|NCT03050801|156732221|FG004|Experiment 1|Physician Decision|0|||
48695227|NCT03050801|156732222|FG005|Experiment 1|Physician Decision|0|||
48695228|NCT03050801|156732217|FG000|Experiment 1|Change of experimental design|0|||
48695229|NCT03050801|156732218|FG001|Experiment 1|Change of experimental design|3|||
48695230|NCT03050801|156732219|FG002|Experiment 1|Change of experimental design|0|||
48695231|NCT03050801|156732220|FG003|Experiment 1|Change of experimental design|0|||
48695232|NCT03050801|156732221|FG004|Experiment 1|Change of experimental design|0|||
48695233|NCT03050801|156732222|FG005|Experiment 1|Change of experimental design|0|||
48695234|NCT03050801|156732217|FG000|Experiment 1|Unable to obtain critical rTMS measure|0|||
48695235|NCT03050801|156732218|FG001|Experiment 1|Unable to obtain critical rTMS measure|0|||
48695236|NCT03050801|156732219|FG002|Experiment 1|Unable to obtain critical rTMS measure|2|||
48695237|NCT03050801|156732220|FG003|Experiment 1|Unable to obtain critical rTMS measure|0|||
48695238|NCT03050801|156732221|FG004|Experiment 1|Unable to obtain critical rTMS measure|0|||
48695239|NCT03050801|156732222|FG005|Experiment 1|Unable to obtain critical rTMS measure|0|||
48695240|NCT03050801|156732217|FG000|Experiment 2|Lost to Follow-up|0|||
48695241|NCT03050801|156732218|FG001|Experiment 2|Lost to Follow-up|0|||
48695242|NCT03050801|156732219|FG002|Experiment 2|Lost to Follow-up|0|||
48695243|NCT03050801|156732220|FG003|Experiment 2|Lost to Follow-up|1|||
48695244|NCT03050801|156732221|FG004|Experiment 2|Lost to Follow-up|1|||
48695245|NCT03050801|156732222|FG005|Experiment 2|Lost to Follow-up|0|||
48695246|NCT03050801|156732217|FG000|Experiment 2|Physician Decision|0|||
48695247|NCT03050801|156732218|FG001|Experiment 2|Physician Decision|0|||
48695248|NCT03050801|156732219|FG002|Experiment 2|Physician Decision|0|||
48695249|NCT03050801|156732220|FG003|Experiment 2|Physician Decision|0|||
48695250|NCT03050801|156732221|FG004|Experiment 2|Physician Decision|1|||
48695251|NCT03050801|156732222|FG005|Experiment 2|Physician Decision|0|||
48695252|NCT03050801|156732217|FG000|Experiment 2|Pregnancy|0|||
48695253|NCT03050801|156732218|FG001|Experiment 2|Pregnancy|0|||
48695254|NCT03050801|156732219|FG002|Experiment 2|Pregnancy|0|||
48695255|NCT03050801|156732220|FG003|Experiment 2|Pregnancy|0|||
48695256|NCT03050801|156732221|FG004|Experiment 2|Pregnancy|1|||
48695257|NCT03050801|156732222|FG005|Experiment 2|Pregnancy|0|||
48695258|NCT03050801|156732217|FG000|Experiment 2|Withdrawal by Subject|0|||
48695259|NCT03050801|156732218|FG001|Experiment 2|Withdrawal by Subject|0|||
48695260|NCT03050801|156732219|FG002|Experiment 2|Withdrawal by Subject|0|||
48695261|NCT03050801|156732220|FG003|Experiment 2|Withdrawal by Subject|1|||
48695262|NCT03050801|156732221|FG004|Experiment 2|Withdrawal by Subject|0|||
48695263|NCT03050801|156732222|FG005|Experiment 2|Withdrawal by Subject|0|||
48695264|NCT03050801|156732217|FG000|Experiment 2|Poor data quality|0|||
48695265|NCT03050801|156732218|FG001|Experiment 2|Poor data quality|0|||
48695266|NCT03050801|156732219|FG002|Experiment 2|Poor data quality|0|||
48695267|NCT03050801|156732220|FG003|Experiment 2|Poor data quality|4|||
48695268|NCT03050801|156732221|FG004|Experiment 2|Poor data quality|1|||
48695269|NCT03050801|156732222|FG005|Experiment 2|Poor data quality|0|||
48695270|NCT03050801|156732217|FG000|Experiment 2|Discomfort during stimulation|0|||
48695271|NCT03050801|156732218|FG001|Experiment 2|Discomfort during stimulation|0|||
48695272|NCT03050801|156732219|FG002|Experiment 2|Discomfort during stimulation|0|||
48695273|NCT03050801|156732220|FG003|Experiment 2|Discomfort during stimulation|0|||
48695274|NCT03050801|156732221|FG004|Experiment 2|Discomfort during stimulation|0|||
48695275|NCT03050801|156732222|FG005|Experiment 2|Discomfort during stimulation|2|||
48695276|NCT01844765|156732224|FG000|Overall Study|Adverse Event|6|||
48695277|NCT01844765|156732225|FG001|Overall Study|Adverse Event|8|||
48695278|NCT01844765|156732224|FG000|Overall Study|Withdrawal by Subject|2|||
48695279|NCT01844765|156732225|FG001|Overall Study|Withdrawal by Subject|3|||
48695280|NCT01844765|156732224|FG000|Overall Study|Disease progression|1|||
48695281|NCT01844765|156732225|FG001|Overall Study|Disease progression|0|||
48695282|NCT01844765|156732224|FG000|Overall Study|Administrative problems|3|||
48695283|NCT01844765|156732225|FG001|Overall Study|Administrative problems|4|||
48695284|NCT01844765|156732224|FG000|Overall Study|Protocol deviation|2|||
48695285|NCT01844765|156732225|FG001|Overall Study|Protocol deviation|0|||
48695286|NCT01844765|156732224|FG000|Overall Study|Untreated|1|||
48695287|NCT01844765|156732225|FG001|Overall Study|Untreated|0|||
48695306|NCT05496231|156732228|FG000|Overall Study|Adverse Event|1|||
48695307|NCT05496231|156732229|FG001|Overall Study|Adverse Event|1|||
48695308|NCT05496231|156732230|FG002|Overall Study|Adverse Event|0|||
48695309|NCT05496231|156732231|FG003|Overall Study|Adverse Event|4|||
48695310|NCT05496231|156732228|FG000|Overall Study|Withdrawal by Subject|5|||
48695311|NCT05496231|156732229|FG001|Overall Study|Withdrawal by Subject|5|||
48695312|NCT05496231|156732230|FG002|Overall Study|Withdrawal by Subject|4|||
48695313|NCT05496231|156732231|FG003|Overall Study|Withdrawal by Subject|11|||
48695314|NCT05496231|156732228|FG000|Overall Study|Migrated/moved from the study area|3|||
48695315|NCT05496231|156732229|FG001|Overall Study|Migrated/moved from the study area|5|||
48695316|NCT05496231|156732230|FG002|Overall Study|Migrated/moved from the study area|3|||
48695317|NCT05496231|156732231|FG003|Overall Study|Migrated/moved from the study area|3|||
48695318|NCT05496231|156732228|FG000|Overall Study|Lost to Follow-up|13|||
48695319|NCT05496231|156732229|FG001|Overall Study|Lost to Follow-up|6|||
48695320|NCT05496231|156732230|FG002|Overall Study|Lost to Follow-up|11|||
48695321|NCT05496231|156732231|FG003|Overall Study|Lost to Follow-up|6|||
48695322|NCT05496231|156732228|FG000|Overall Study|Other|9|||
48695323|NCT05496231|156732229|FG001|Overall Study|Other|7|||
48695324|NCT05496231|156732230|FG002|Overall Study|Other|7|||
48695325|NCT05496231|156732231|FG003|Overall Study|Other|8|||
48695326|NCT04228783|156732232|FG000|Overall Study|Adverse Event|1|||
48695327|NCT04228783|156732233|FG001|Overall Study|Adverse Event|0|||
48695328|NCT04228783|156732234|FG002|Overall Study|Adverse Event|2|||
48695329|NCT04228783|156732235|FG003|Overall Study|Adverse Event|0|||
48695330|NCT04228783|156732236|FG004|Overall Study|Adverse Event|0|||
48695331|NCT04228783|156732237|FG005|Overall Study|Adverse Event|1|||
48695332|NCT04228783|156732232|FG000|Overall Study|Death|0|||
48695333|NCT04228783|156732233|FG001|Overall Study|Death|0|||
48695334|NCT04228783|156732234|FG002|Overall Study|Death|0|||
48695335|NCT04228783|156732235|FG003|Overall Study|Death|0|||
48695336|NCT04228783|156732236|FG004|Overall Study|Death|1|||
48695337|NCT04228783|156732237|FG005|Overall Study|Death|0|||
48695338|NCT04228783|156732232|FG000|Overall Study|Lost to Follow-up|36|||
48695339|NCT04228783|156732233|FG001|Overall Study|Lost to Follow-up|36|||
48695340|NCT04228783|156732234|FG002|Overall Study|Lost to Follow-up|28|||
48695341|NCT04228783|156732235|FG003|Overall Study|Lost to Follow-up|6|||
48695342|NCT04228783|156732236|FG004|Overall Study|Lost to Follow-up|14|||
48695343|NCT04228783|156732237|FG005|Overall Study|Lost to Follow-up|3|||
48695344|NCT04228783|156732232|FG000|Overall Study|Physician Decision|1|||
48695345|NCT04228783|156732233|FG001|Overall Study|Physician Decision|2|||
48695346|NCT04228783|156732234|FG002|Overall Study|Physician Decision|0|||
48695347|NCT04228783|156732235|FG003|Overall Study|Physician Decision|0|||
48695348|NCT04228783|156732236|FG004|Overall Study|Physician Decision|0|||
48695349|NCT04228783|156732237|FG005|Overall Study|Physician Decision|0|||
48695350|NCT04228783|156732232|FG000|Overall Study|Protocol Violation|0|||
48695351|NCT04228783|156732233|FG001|Overall Study|Protocol Violation|0|||
48695352|NCT04228783|156732234|FG002|Overall Study|Protocol Violation|0|||
48695353|NCT04228783|156732235|FG003|Overall Study|Protocol Violation|1|||
48695354|NCT04228783|156732236|FG004|Overall Study|Protocol Violation|0|||
48695355|NCT04228783|156732237|FG005|Overall Study|Protocol Violation|0|||
48695356|NCT04228783|156732232|FG000|Overall Study|Withdrawal by Subject|6|||
48695357|NCT04228783|156732233|FG001|Overall Study|Withdrawal by Subject|10|||
48695358|NCT04228783|156732234|FG002|Overall Study|Withdrawal by Subject|19|||
48695359|NCT04228783|156732235|FG003|Overall Study|Withdrawal by Subject|1|||
48695360|NCT04228783|156732236|FG004|Overall Study|Withdrawal by Subject|2|||
48695361|NCT04228783|156732237|FG005|Overall Study|Withdrawal by Subject|0|||
48695362|NCT04228783|156732232|FG000|Overall Study|Other|4|||
48695363|NCT04228783|156732233|FG001|Overall Study|Other|3|||
48695364|NCT04228783|156732234|FG002|Overall Study|Other|2|||
48695365|NCT04228783|156732235|FG003|Overall Study|Other|1|||
48695366|NCT04228783|156732236|FG004|Overall Study|Other|0|||
48695367|NCT04228783|156732237|FG005|Overall Study|Other|0|||
48695368|NCT03253679|156732238|FG000|Overall Study|Screen Failure|1|||
48695369|NCT03341299|156732240|FG000|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
48695370|NCT03341299|156732241|FG001|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
48695371|NCT03341299|156732242|FG002|Washout (A Minimum of 21 Hours)|Adverse Event|1|||
48695372|NCT03341299|156732243|FG003|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
48695373|NCT00107653|156732244|FG000|Overall Study|Adverse Event|24|||
48695374|NCT00107653|156732245|FG001|Overall Study|Adverse Event|43|||
48695375|NCT00107653|156732244|FG000|Overall Study|Insufficient Therapeutic Response|25|||
48695376|NCT00107653|156732245|FG001|Overall Study|Insufficient Therapeutic Response|11|||
48695377|NCT00107653|156732244|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
48695378|NCT00107653|156732245|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
48695379|NCT00107653|156732244|FG000|Overall Study|Protocol Violation|1|||
48695380|NCT00107653|156732245|FG001|Overall Study|Protocol Violation|0|||
48695381|NCT00107653|156732244|FG000|Overall Study|Withdrawal by Subject|12|||
48695382|NCT00107653|156732245|FG001|Overall Study|Withdrawal by Subject|13|||
48695383|NCT00107653|156732244|FG000|Overall Study|Lost to Follow-up|13|||
48695384|NCT00107653|156732245|FG001|Overall Study|Lost to Follow-up|5|||
48695385|NCT00107653|156732244|FG000|Overall Study|Administrative Reasons|3|||
48695386|NCT00107653|156732245|FG001|Overall Study|Administrative Reasons|3|||
48695387|NCT03913442|156732247|FG000|Overall Study|Adverse Event|0|||
48695388|NCT03913442|156732248|FG001|Overall Study|Adverse Event|3|||
48695389|NCT03913442|156732247|FG000|Overall Study|Withdrawal by Subject|5|||
48695390|NCT03913442|156732248|FG001|Overall Study|Withdrawal by Subject|5|||
48695391|NCT03913442|156732247|FG000|Overall Study|Terminations|2|||
48695392|NCT03913442|156732248|FG001|Overall Study|Terminations|1|||
48695393|NCT03913442|156732247|FG000|Overall Study|Lost to Follow-up|2|||
48695394|NCT03913442|156732248|FG001|Overall Study|Lost to Follow-up|2|||
48695395|NCT00844844|156732252|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
48695396|NCT00844844|156732252|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
48695397|NCT00844844|156732252|FG000|Extension Treatment Period|Adverse Event|2|||
48695398|NCT00844844|156732252|FG000|Post Treatment Period|Withdrawal by Subject|1|||
48695399|NCT02619682|156732253|FG000|Overall Study|Withdrawal by Subject|3|||
48695400|NCT02619682|156732253|FG000|Overall Study|Lack of Efficacy|8|||
48695401|NCT02619682|156732253|FG000|Overall Study|new secondary cancer|1|||
48695402|NCT02619682|156732253|FG000|Overall Study|post surgery complications|2|||
48695403|NCT02780700|156732254|FG000|Overall Study|Progressive disease|1|||
48695404|NCT04453202|156732255|FG000|Overall Study|Adverse Event|0|||
48695405|NCT04453202|156732256|FG001|Overall Study|Adverse Event|0|||
48695406|NCT04453202|156732257|FG002|Overall Study|Adverse Event|0|||
48695407|NCT04453202|156732258|FG003|Overall Study|Adverse Event|0|||
48695408|NCT04453202|156732259|FG004|Overall Study|Adverse Event|0|||
48695409|NCT04453202|156732260|FG005|Overall Study|Adverse Event|0|||
48695410|NCT04453202|156732261|FG006|Overall Study|Adverse Event|1|||
48695411|NCT04453202|156732262|FG007|Overall Study|Adverse Event|0|||
48695412|NCT04453202|156732263|FG008|Overall Study|Adverse Event|0|||
48695413|NCT04453202|156732264|FG009|Overall Study|Adverse Event|0|||
48695414|NCT04453202|156732265|FG010|Overall Study|Adverse Event|0|||
48695415|NCT04453202|156732255|FG000|Overall Study|Death|0|||
48695416|NCT04453202|156732256|FG001|Overall Study|Death|0|||
48695417|NCT04453202|156732257|FG002|Overall Study|Death|0|||
48695418|NCT04453202|156732258|FG003|Overall Study|Death|0|||
48695419|NCT04453202|156732259|FG004|Overall Study|Death|0|||
48695420|NCT04453202|156732260|FG005|Overall Study|Death|0|||
48695421|NCT04453202|156732261|FG006|Overall Study|Death|0|||
48695422|NCT04453202|156732262|FG007|Overall Study|Death|0|||
48695423|NCT04453202|156732263|FG008|Overall Study|Death|0|||
48695424|NCT04453202|156732264|FG009|Overall Study|Death|1|||
48695425|NCT04453202|156732265|FG010|Overall Study|Death|0|||
48695426|NCT04453202|156732255|FG000|Overall Study|Lost to Follow-up|0|||
48695427|NCT04453202|156732256|FG001|Overall Study|Lost to Follow-up|1|||
48695428|NCT04453202|156732257|FG002|Overall Study|Lost to Follow-up|0|||
48695429|NCT04453202|156732258|FG003|Overall Study|Lost to Follow-up|1|||
48695430|NCT04453202|156732259|FG004|Overall Study|Lost to Follow-up|0|||
48695431|NCT04453202|156732260|FG005|Overall Study|Lost to Follow-up|0|||
48695432|NCT04453202|156732261|FG006|Overall Study|Lost to Follow-up|0|||
48695433|NCT04453202|156732262|FG007|Overall Study|Lost to Follow-up|0|||
48695434|NCT04453202|156732263|FG008|Overall Study|Lost to Follow-up|0|||
48695435|NCT04453202|156732264|FG009|Overall Study|Lost to Follow-up|1|||
48695436|NCT04453202|156732265|FG010|Overall Study|Lost to Follow-up|1|||
48695437|NCT04453202|156732255|FG000|Overall Study|Withdrawal by Subject|1|||
48695438|NCT04453202|156732256|FG001|Overall Study|Withdrawal by Subject|2|||
48695439|NCT04453202|156732257|FG002|Overall Study|Withdrawal by Subject|1|||
48695440|NCT04453202|156732258|FG003|Overall Study|Withdrawal by Subject|2|||
48695441|NCT04453202|156732259|FG004|Overall Study|Withdrawal by Subject|1|||
48695442|NCT04453202|156732260|FG005|Overall Study|Withdrawal by Subject|1|||
48695443|NCT04453202|156732261|FG006|Overall Study|Withdrawal by Subject|0|||
48695444|NCT04453202|156732262|FG007|Overall Study|Withdrawal by Subject|0|||
48695445|NCT04453202|156732263|FG008|Overall Study|Withdrawal by Subject|0|||
48695446|NCT04453202|156732264|FG009|Overall Study|Withdrawal by Subject|1|||
48695447|NCT04453202|156732265|FG010|Overall Study|Withdrawal by Subject|0|||
48695448|NCT04453202|156732255|FG000|Overall Study|Adverse Event|0|||
48695449|NCT04453202|156732256|FG001|Overall Study|Adverse Event|0|||
48695450|NCT04453202|156732257|FG002|Overall Study|Adverse Event|0|||
48695451|NCT04453202|156732258|FG003|Overall Study|Adverse Event|0|||
48695452|NCT04453202|156732259|FG004|Overall Study|Adverse Event|0|||
48695453|NCT04453202|156732260|FG005|Overall Study|Adverse Event|1|||
48695454|NCT04453202|156732261|FG006|Overall Study|Adverse Event|0|||
48695455|NCT04453202|156732262|FG007|Overall Study|Adverse Event|0|||
48695456|NCT04453202|156732263|FG008|Overall Study|Adverse Event|0|||
48695457|NCT04453202|156732264|FG009|Overall Study|Adverse Event|0|||
48695458|NCT04453202|156732265|FG010|Overall Study|Adverse Event|0|||
48695471|NCT05533190|156732271|FG000|Overall Study|Lost to Follow-up|19|||
48695472|NCT05533190|156732272|FG001|Overall Study|Lost to Follow-up|7|||
48695473|NCT05533190|156732271|FG000|Overall Study|Failed to download app|1|||
48695474|NCT05533190|156732272|FG001|Overall Study|Failed to download app|0|||
48695475|NCT05533190|156732271|FG000|Overall Study|Thought app was a scam|1|||
48695476|NCT05533190|156732272|FG001|Overall Study|Thought app was a scam|0|||
48695477|NCT05533190|156732271|FG000|Overall Study|Withdrawal by Subject|2|||
48695478|NCT05533190|156732272|FG001|Overall Study|Withdrawal by Subject|0|||
48695479|NCT02477696|156732276|FG000|Overall Study|Death|89|||
48695480|NCT02477696|156732277|FG001|Overall Study|Death|106|||
48695481|NCT02477696|156732276|FG000|Overall Study|Lost to Follow-up|7|||
48695482|NCT02477696|156732277|FG001|Overall Study|Lost to Follow-up|5|||
48695483|NCT02477696|156732276|FG000|Overall Study|Withdrawal by Subject|37|||
48695484|NCT02477696|156732277|FG001|Overall Study|Withdrawal by Subject|34|||
48695485|NCT02477696|156732276|FG000|Overall Study|Physician Decision|7|||
48695486|NCT02477696|156732277|FG001|Overall Study|Physician Decision|9|||
48695487|NCT02477696|156732276|FG000|Overall Study|Study terminated by sponsor|103|||
49116299|NCT01084538|158263088|FG000|Overall Study|Nodular hyperplasia of parathyroid gland|2|||
48695488|NCT02477696|156732277|FG001|Overall Study|Study terminated by sponsor|99|||
48695489|NCT02477696|156732276|FG000|Overall Study|Other reasons including transition to commercial drug|23|||
48695490|NCT02477696|156732277|FG001|Overall Study|Other reasons including transition to commercial drug|12|||
48695491|NCT02477696|156732276|FG000|Overall Study|Missing/Unknown|2|||
48695492|NCT02477696|156732277|FG001|Overall Study|Missing/Unknown|0|||
48695493|NCT03633396|156733689|FG000|Overall Study|Withdrawal by Subject|4|||
48695494|NCT03633396|156733690|FG001|Overall Study|Withdrawal by Subject|4|||
48695495|NCT03633396|156733689|FG000|Overall Study|Adverse Event|1|||
48695496|NCT03633396|156733690|FG001|Overall Study|Adverse Event|1|||
48695497|NCT03633396|156733689|FG000|Overall Study|Lack of Efficacy|1|||
48695498|NCT03633396|156733690|FG001|Overall Study|Lack of Efficacy|0|||
48695499|NCT03633396|156733689|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|0|||
48695500|NCT03633396|156733690|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|1|||
48695501|NCT03224130|156733691|FG000|Overall Study|consent issue|0|||
48695502|NCT03224130|156733692|FG001|Overall Study|consent issue|1|||
48695503|NCT01690052|156733693|FG000|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1|||
48695504|NCT01690052|156733694|FG001|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2|||
48695505|NCT02421172|156733695|FG000|Period 1|Adverse Event|1|||
48695506|NCT02421172|156733696|FG001|Period 1|Adverse Event|0|||
48695507|NCT02421172|156733697|FG002|Period 1|Adverse Event|0|||
48695508|NCT02421172|156733698|FG003|Period 1|Adverse Event|0|||
48695509|NCT02421172|156733699|FG004|Period 1|Adverse Event|0|||
48695510|NCT02421172|156733695|FG000|Period 1|Lost to Follow-up|3|||
48695511|NCT02421172|156733696|FG001|Period 1|Lost to Follow-up|1|||
48695512|NCT02421172|156733697|FG002|Period 1|Lost to Follow-up|0|||
48695513|NCT02421172|156733698|FG003|Period 1|Lost to Follow-up|0|||
48695514|NCT02421172|156733699|FG004|Period 1|Lost to Follow-up|0|||
48695515|NCT02421172|156733695|FG000|Period 1|Patient/guardian decision|0|||
48695516|NCT02421172|156733696|FG001|Period 1|Patient/guardian decision|1|||
48695517|NCT02421172|156733697|FG002|Period 1|Patient/guardian decision|0|||
48695518|NCT02421172|156733698|FG003|Period 1|Patient/guardian decision|0|||
48695519|NCT02421172|156733699|FG004|Period 1|Patient/guardian decision|0|||
48695520|NCT02421172|156733695|FG000|Period 2|Adverse Event|0|||
48695521|NCT02421172|156733696|FG001|Period 2|Adverse Event|0|||
48695522|NCT02421172|156733697|FG002|Period 2|Adverse Event|4|||
48695523|NCT02421172|156733698|FG003|Period 2|Adverse Event|0|||
48695524|NCT02421172|156733699|FG004|Period 2|Adverse Event|0|||
48695525|NCT02421172|156733695|FG000|Period 2|Lost to Follow-up|0|||
48695526|NCT02421172|156733696|FG001|Period 2|Lost to Follow-up|0|||
48695527|NCT02421172|156733697|FG002|Period 2|Lost to Follow-up|0|||
48695528|NCT02421172|156733698|FG003|Period 2|Lost to Follow-up|1|||
48695529|NCT02421172|156733699|FG004|Period 2|Lost to Follow-up|0|||
48695530|NCT02421172|156733695|FG000|Period 2|Patient/guardian decision|0|||
48695531|NCT02421172|156733696|FG001|Period 2|Patient/guardian decision|0|||
48695532|NCT02421172|156733697|FG002|Period 2|Patient/guardian decision|3|||
48695533|NCT02421172|156733698|FG003|Period 2|Patient/guardian decision|2|||
48695534|NCT02421172|156733699|FG004|Period 2|Patient/guardian decision|1|||
48695535|NCT00882440|156733702|FG000|Overall Study|Adverse Event|2|||
48695536|NCT00882440|156733703|FG001|Overall Study|Adverse Event|2|||
48695537|NCT00882440|156733704|FG002|Overall Study|Adverse Event|2|||
48695538|NCT00882440|156733705|FG003|Overall Study|Adverse Event|1|||
48695539|NCT00882440|156733706|FG004|Overall Study|Adverse Event|1|||
48695540|NCT00882440|156733707|FG005|Overall Study|Adverse Event|4|||
48695541|NCT00882440|156733708|FG006|Overall Study|Adverse Event|2|||
48695542|NCT00882440|156733702|FG000|Overall Study|Lack of Efficacy|3|||
48695543|NCT00882440|156733703|FG001|Overall Study|Lack of Efficacy|5|||
48695544|NCT00882440|156733704|FG002|Overall Study|Lack of Efficacy|2|||
48695545|NCT00882440|156733705|FG003|Overall Study|Lack of Efficacy|0|||
48695546|NCT00882440|156733706|FG004|Overall Study|Lack of Efficacy|0|||
48695547|NCT00882440|156733707|FG005|Overall Study|Lack of Efficacy|3|||
48695548|NCT00882440|156733708|FG006|Overall Study|Lack of Efficacy|0|||
48695549|NCT00882440|156733702|FG000|Overall Study|Lost to Follow-up|2|||
48695550|NCT00882440|156733703|FG001|Overall Study|Lost to Follow-up|0|||
48695551|NCT00882440|156733704|FG002|Overall Study|Lost to Follow-up|1|||
48695552|NCT00882440|156733705|FG003|Overall Study|Lost to Follow-up|1|||
48695553|NCT00882440|156733706|FG004|Overall Study|Lost to Follow-up|1|||
48695554|NCT00882440|156733707|FG005|Overall Study|Lost to Follow-up|0|||
48695555|NCT00882440|156733708|FG006|Overall Study|Lost to Follow-up|1|||
48695556|NCT00882440|156733702|FG000|Overall Study|Protocol Violation|0|||
48695557|NCT00882440|156733703|FG001|Overall Study|Protocol Violation|0|||
48695558|NCT00882440|156733704|FG002|Overall Study|Protocol Violation|1|||
48695559|NCT00882440|156733705|FG003|Overall Study|Protocol Violation|1|||
48695560|NCT00882440|156733706|FG004|Overall Study|Protocol Violation|1|||
48695561|NCT00882440|156733707|FG005|Overall Study|Protocol Violation|0|||
48695562|NCT00882440|156733708|FG006|Overall Study|Protocol Violation|0|||
48695563|NCT00882440|156733702|FG000|Overall Study|Withdrawal by Subject|2|||
48695564|NCT00882440|156733703|FG001|Overall Study|Withdrawal by Subject|1|||
48695565|NCT00882440|156733704|FG002|Overall Study|Withdrawal by Subject|1|||
48695566|NCT00882440|156733705|FG003|Overall Study|Withdrawal by Subject|0|||
48695567|NCT00882440|156733706|FG004|Overall Study|Withdrawal by Subject|6|||
48695568|NCT00882440|156733707|FG005|Overall Study|Withdrawal by Subject|0|||
48695569|NCT00882440|156733708|FG006|Overall Study|Withdrawal by Subject|1|||
48695570|NCT00882440|156733702|FG000|Overall Study|Patient Uncooperative|2|||
48695571|NCT00882440|156733703|FG001|Overall Study|Patient Uncooperative|0|||
48695572|NCT00882440|156733704|FG002|Overall Study|Patient Uncooperative|0|||
49010521|NCT00926289|157875639|FG000|Overall Study|Withdrawal by Subject|4|||
48695573|NCT00882440|156733705|FG003|Overall Study|Patient Uncooperative|0|||
48695574|NCT00882440|156733706|FG004|Overall Study|Patient Uncooperative|1|||
48695575|NCT00882440|156733707|FG005|Overall Study|Patient Uncooperative|0|||
48695576|NCT00882440|156733708|FG006|Overall Study|Patient Uncooperative|0|||
48695577|NCT02723773|156733717|FG000|Overall Study|Adverse Event|934|||
48695578|NCT02723773|156733718|FG001|Overall Study|Adverse Event|3|||
48695579|NCT02723773|156733719|FG002|Overall Study|Adverse Event|1|||
48695580|NCT02723773|156733720|FG003|Overall Study|Adverse Event|9|||
48695581|NCT02723773|156733717|FG000|Overall Study|Protocol Violation|1|||
48695582|NCT02723773|156733718|FG001|Overall Study|Protocol Violation|0|||
48695583|NCT02723773|156733719|FG002|Overall Study|Protocol Violation|0|||
48695584|NCT02723773|156733720|FG003|Overall Study|Protocol Violation|0|||
48695585|NCT02723773|156733717|FG000|Overall Study|Withdrawal by Subject|360|||
48695586|NCT02723773|156733718|FG001|Overall Study|Withdrawal by Subject|5|||
48695587|NCT02723773|156733719|FG002|Overall Study|Withdrawal by Subject|6|||
48695588|NCT02723773|156733720|FG003|Overall Study|Withdrawal by Subject|10|||
48695589|NCT02723773|156733717|FG000|Overall Study|Migrated/moved from study area|37|||
48695590|NCT02723773|156733718|FG001|Overall Study|Migrated/moved from study area|0|||
48695591|NCT02723773|156733719|FG002|Overall Study|Migrated/moved from study area|0|||
48695592|NCT02723773|156733720|FG003|Overall Study|Migrated/moved from study area|1|||
48695593|NCT02723773|156733717|FG000|Overall Study|Lost to Follow-up|198|||
48695594|NCT02723773|156733718|FG001|Overall Study|Lost to Follow-up|0|||
48695595|NCT02723773|156733719|FG002|Overall Study|Lost to Follow-up|0|||
48695596|NCT02723773|156733720|FG003|Overall Study|Lost to Follow-up|0|||
48695597|NCT02723773|156733717|FG000|Overall Study|Other|189|||
48695598|NCT02723773|156733718|FG001|Overall Study|Other|1|||
48695599|NCT02723773|156733719|FG002|Overall Study|Other|2|||
48695600|NCT02723773|156733720|FG003|Overall Study|Other|2|||
48695601|NCT05482308|156733724|FG000|Overall Study|Withdrawal by Subject|1|||
48695602|NCT05482308|156733725|FG001|Overall Study|Withdrawal by Subject|0|||
48695603|NCT05482308|156733724|FG000|Overall Study|No longer meets eligibility criteria|0|||
48695604|NCT05482308|156733725|FG001|Overall Study|No longer meets eligibility criteria|1|||
48695605|NCT02313766|156733727|FG000|Overall Study|surgery cancelled|1|||
48695606|NCT02313766|156733728|FG001|Overall Study|surgery cancelled|0|||
48695607|NCT02313766|156733729|FG002|Overall Study|surgery cancelled|0|||
48695608|NCT02313766|156733727|FG000|Overall Study|Lost to Follow-up|0|||
48695609|NCT02313766|156733728|FG001|Overall Study|Lost to Follow-up|2|||
48695610|NCT02313766|156733729|FG002|Overall Study|Lost to Follow-up|0|||
48695611|NCT02313766|156733727|FG000|Overall Study|Adverse Event|0|||
48695612|NCT02313766|156733728|FG001|Overall Study|Adverse Event|1|||
48695613|NCT02313766|156733729|FG002|Overall Study|Adverse Event|0|||
48695614|NCT00419393|156733730|FG000|Overall Study|Adverse Event|5|||
48695615|NCT00419393|156733730|FG000|Overall Study|Protocol Violation|5|||
48695616|NCT00419393|156733730|FG000|Overall Study|Withdrawal by Subject|7|||
48695617|NCT00419393|156733730|FG000|Overall Study|Other: Sponsor request|3|||
48695618|NCT00419393|156733730|FG000|Overall Study|Other: Subject had temporal lobectomy|1|||
48695619|NCT00419393|156733730|FG000|Overall Study|Other: Site closure|1|||
48695620|NCT00419393|156733730|FG000|Overall Study|Other: Other health problems|1|||
48695621|NCT00419393|156733730|FG000|Overall Study|Other: Investigator decision|1|||
48695622|NCT03985761|156733731|FG000|Overall Study|Withdrawal by Subject|2|||
48695623|NCT03985761|156733732|FG001|Overall Study|Withdrawal by Subject|3|||
48695624|NCT00473434|156733733|FG000|Overall Study|Physician Decision|3|||
48695625|NCT00473434|156733733|FG000|Overall Study|Withdrawal by Subject|9|||
48695626|NCT00473434|156733733|FG000|Overall Study|Compliance|3|||
48695627|NCT00473434|156733733|FG000|Overall Study|Lack of Efficacy|3|||
48695628|NCT00473434|156733733|FG000|Overall Study|Adverse Event|3|||
48695629|NCT00473434|156733733|FG000|Overall Study|Patient was selling medication to others|1|||
48695630|NCT00473434|156733733|FG000|Overall Study|Safety evaluation|1|||
48695631|NCT00473434|156733733|FG000|Overall Study|Reason not specified|6|||
48695632|NCT00473434|156733733|FG000|Overall Study|Ceased in favor of Paliperidone|1|||
48695633|NCT00473434|156733733|FG000|Overall Study|Switching to trial medication|1|||
48695634|NCT00473434|156733733|FG000|Overall Study|No longer required|1|||
48695635|NCT02182895|156733734|FG000|Overall Study|Discharged from hospital within 24 hours|2|||
48695636|NCT02182895|156733735|FG001|Overall Study|Discharged from hospital within 24 hours|4|||
48695637|NCT00642356|156733738|FG000|Overall Study|Adverse Event|1|||
48695638|NCT00642356|156733739|FG001|Overall Study|Adverse Event|0|||
48695639|NCT00642356|156733738|FG000|Overall Study|Protocol Violation|0|||
48695640|NCT00642356|156733739|FG001|Overall Study|Protocol Violation|3|||
48695641|NCT00642356|156733738|FG000|Overall Study|Lack of Efficacy|1|||
48695642|NCT00642356|156733739|FG001|Overall Study|Lack of Efficacy|0|||
48695643|NCT04551989|156733744|FG000|Overall Study|Adverse Event|4|||
48695644|NCT04551989|156733744|FG000|Overall Study|Protocol Violation|3|||
48695645|NCT04551989|156733744|FG000|Overall Study|Lost to Follow-up|1|||
49116300|NCT01084538|158263088|FG000|Overall Study|Change of residence|2|||
48695646|NCT04551989|156733744|FG000|Overall Study|Physician Decision|3|||
48695647|NCT00265564|156733745|FG000|Overall Study|Lost to Follow-up|5|||
48695648|NCT00265564|156733746|FG001|Overall Study|Lost to Follow-up|7|||
48695649|NCT00265564|156733745|FG000|Overall Study|met exclusion criteria|5|||
48695650|NCT00265564|156733746|FG001|Overall Study|met exclusion criteria|2|||
48695651|NCT04698343|156733747|FG000|Overall Study|Withdrawal by Subject|6|||
48695652|NCT04698343|156733747|FG000|Overall Study|Physician Decision|2|||
48695653|NCT04698343|156733747|FG000|Overall Study|Failed to meet the required reduction in opioid dosage due to increased RLS symptoms|4|||
48695654|NCT04698343|156733747|FG000|Overall Study|1 was discontinued based on CGI-I score exceeding 5|1|||
48695655|NCT04698343|156733747|FG000|Overall Study|Personal reasons|3|||
48695656|NCT04698343|156733747|FG000|Overall Study|1 withdrew due to non-RLS opioid withdrawal symptoms|1|||
48695657|NCT02163902|156733748|FG000|Overall Study|Subject's Request|3|||
48695658|NCT02163902|156733749|FG001|Overall Study|Subject's Request|4|||
48695659|NCT02163902|156733748|FG000|Overall Study|Lost to Follow-up|6|||
48695660|NCT02163902|156733749|FG001|Overall Study|Lost to Follow-up|7|||
48695661|NCT02163902|156733748|FG000|Overall Study|Administrative Decision|2|||
48695662|NCT02163902|156733749|FG001|Overall Study|Administrative Decision|2|||
48695663|NCT04913610|156733750|FG000|Randomized Participants|Did Not Receive Treatment|0|||
48695664|NCT04913610|156733751|FG001|Randomized Participants|Did Not Receive Treatment|0|||
48695665|NCT04913610|156733752|FG002|Randomized Participants|Did Not Receive Treatment|1|||
48695666|NCT04913610|156733753|FG003|Randomized Participants|Did Not Receive Treatment|1|||
48695667|NCT04913610|156733754|FG004|Randomized Participants|Did Not Receive Treatment|0|||
48695668|NCT04913610|156733750|FG000|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
48695669|NCT04913610|156733751|FG001|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
48695670|NCT04913610|156733752|FG002|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
48695671|NCT04913610|156733753|FG003|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
48695672|NCT04913610|156733754|FG004|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
48695673|NCT02552966|156733758|FG000|Overall Study|Lost to Follow-up|2|||
48695674|NCT02552966|156733758|FG000|Overall Study|Withdrawal by Subject|3|||
48909122|NCT02464228|157504315|FG000|Overall Study|Physician Decision|2|||
48909123|NCT02464228|157504316|FG001|Overall Study|Physician Decision|0|||
48909124|NCT02464228|157504317|FG002|Overall Study|Physician Decision|1|||
48909125|NCT02464228|157504318|FG003|Overall Study|Physician Decision|0|||
48909126|NCT02464228|157504315|FG000|Overall Study|Miscellaneous|1|||
48909127|NCT02464228|157504316|FG001|Overall Study|Miscellaneous|0|||
48909128|NCT02464228|157504317|FG002|Overall Study|Miscellaneous|1|||
48909129|NCT02464228|157504318|FG003|Overall Study|Miscellaneous|0|||
48909130|NCT02464228|157504315|FG000|Overall Study|Adverse Event|9|||
48909131|NCT02464228|157504316|FG001|Overall Study|Adverse Event|0|||
48909132|NCT02464228|157504317|FG002|Overall Study|Adverse Event|3|||
48909133|NCT02464228|157504318|FG003|Overall Study|Adverse Event|0|||
48909134|NCT02464228|157504315|FG000|Overall Study|Withdrawal by Subject|1|||
48909135|NCT02464228|157504316|FG001|Overall Study|Withdrawal by Subject|1|||
48909136|NCT02464228|157504317|FG002|Overall Study|Withdrawal by Subject|1|||
48909137|NCT02464228|157504318|FG003|Overall Study|Withdrawal by Subject|0|||
48909138|NCT02464228|157504315|FG000|Overall Study|Disease Progression|22|||
48909139|NCT02464228|157504316|FG001|Overall Study|Disease Progression|12|||
48909140|NCT02464228|157504317|FG002|Overall Study|Disease Progression|5|||
48909141|NCT02464228|157504318|FG003|Overall Study|Disease Progression|2|||
48909142|NCT00860951|157504319|FG000|Overall Study|Withdrawal by Subject|2|||
48909143|NCT00860951|157504319|FG000|Overall Study|Lost to Follow-up|5|||
48909144|NCT01650285|157504323|FG000|Overall Study|Adverse Event|1|||
48909145|NCT01794520|157504324|FG000|Overall Study|Adverse events- related to progression|0|||
48909146|NCT01794520|157504325|FG001|Overall Study|Adverse events- related to progression|0|||
48909147|NCT01794520|157504326|FG002|Overall Study|Adverse events- related to progression|1|||
48909148|NCT01794520|157504327|FG003|Overall Study|Adverse events- related to progression|2|||
48909149|NCT01794520|157504328|FG004|Overall Study|Adverse events- related to progression|0|||
48909150|NCT01794520|157504329|FG005|Overall Study|Adverse events- related to progression|1|||
48909151|NCT01794520|157504330|FG006|Overall Study|Adverse events- related to progression|0|||
48909152|NCT01794520|157504324|FG000|Overall Study|Adverse event- not related to progression|1|||
48909153|NCT01794520|157504325|FG001|Overall Study|Adverse event- not related to progression|1|||
48909154|NCT01794520|157504326|FG002|Overall Study|Adverse event- not related to progression|0|||
48909155|NCT01794520|157504327|FG003|Overall Study|Adverse event- not related to progression|0|||
48909156|NCT01794520|157504328|FG004|Overall Study|Adverse event- not related to progression|2|||
48909157|NCT01794520|157504329|FG005|Overall Study|Adverse event- not related to progression|0|||
48909158|NCT01794520|157504330|FG006|Overall Study|Adverse event- not related to progression|0|||
48909159|NCT01794520|157504324|FG000|Overall Study|Progressive disease|5|||
48909160|NCT01794520|157504325|FG001|Overall Study|Progressive disease|6|||
48909161|NCT01794520|157504326|FG002|Overall Study|Progressive disease|2|||
48695675|NCT01476722|156733759|FG000|Overall Study|Adverse Event|1|||
48695676|NCT03261336|156733760|FG000|Overall Study|Adverse Event|1|||
48909162|NCT01794520|157504327|FG003|Overall Study|Progressive disease|5|||
48909163|NCT01794520|157504328|FG004|Overall Study|Progressive disease|27|||
48909164|NCT01794520|157504329|FG005|Overall Study|Progressive disease|18|||
48695677|NCT00771914|156733763|FG000|Overall Study|Physician Decision|0|||
48695678|NCT00771914|156733764|FG001|Overall Study|Physician Decision|0|||
48695679|NCT00771914|156733765|FG002|Overall Study|Physician Decision|0|||
48909165|NCT01794520|157504330|FG006|Overall Study|Progressive disease|0|||
48909166|NCT01794520|157504324|FG000|Overall Study|Withdrew consent|0|||
48909167|NCT01794520|157504325|FG001|Overall Study|Withdrew consent|0|||
48909168|NCT01794520|157504326|FG002|Overall Study|Withdrew consent|1|||
48909169|NCT01794520|157504327|FG003|Overall Study|Withdrew consent|1|||
48909170|NCT01794520|157504328|FG004|Overall Study|Withdrew consent|0|||
48909171|NCT01794520|157504329|FG005|Overall Study|Withdrew consent|0|||
48909172|NCT01794520|157504330|FG006|Overall Study|Withdrew consent|0|||
48909173|NCT01794520|157504324|FG000|Overall Study|Lost to Follow-up|0|||
48909174|NCT01794520|157504325|FG001|Overall Study|Lost to Follow-up|0|||
48909175|NCT01794520|157504326|FG002|Overall Study|Lost to Follow-up|0|||
48909176|NCT01794520|157504327|FG003|Overall Study|Lost to Follow-up|0|||
48909177|NCT01794520|157504328|FG004|Overall Study|Lost to Follow-up|1|||
48909178|NCT01794520|157504329|FG005|Overall Study|Lost to Follow-up|0|||
48909179|NCT01794520|157504330|FG006|Overall Study|Lost to Follow-up|0|||
48909180|NCT01794520|157504324|FG000|Overall Study|Toxicity|0|||
48909181|NCT01794520|157504325|FG001|Overall Study|Toxicity|2|||
48909182|NCT01794520|157504326|FG002|Overall Study|Toxicity|0|||
48909183|NCT01794520|157504327|FG003|Overall Study|Toxicity|0|||
48909184|NCT01794520|157504328|FG004|Overall Study|Toxicity|0|||
48909185|NCT01794520|157504329|FG005|Overall Study|Toxicity|0|||
48909186|NCT01794520|157504330|FG006|Overall Study|Toxicity|0|||
48909187|NCT01794520|157504324|FG000|Overall Study|Study terminated by sponsor|0|||
48909188|NCT01794520|157504325|FG001|Overall Study|Study terminated by sponsor|0|||
48909189|NCT01794520|157504326|FG002|Overall Study|Study terminated by sponsor|1|||
48909190|NCT01794520|157504327|FG003|Overall Study|Study terminated by sponsor|0|||
48909191|NCT01794520|157504328|FG004|Overall Study|Study terminated by sponsor|1|||
48909192|NCT01794520|157504329|FG005|Overall Study|Study terminated by sponsor|0|||
48909193|NCT01794520|157504330|FG006|Overall Study|Study terminated by sponsor|7|||
48909194|NCT01794520|157504324|FG000|Overall Study|Death|0|||
48909195|NCT01794520|157504325|FG001|Overall Study|Death|0|||
48909196|NCT01794520|157504326|FG002|Overall Study|Death|0|||
48909197|NCT01794520|157504327|FG003|Overall Study|Death|0|||
48909198|NCT01794520|157504328|FG004|Overall Study|Death|1|||
48909199|NCT01794520|157504329|FG005|Overall Study|Death|0|||
48695680|NCT00771914|156733766|FG003|Overall Study|Physician Decision|1|||
48695681|NCT00771914|156733763|FG000|Overall Study|Lost to Follow-up|0|||
48695682|NCT00771914|156733764|FG001|Overall Study|Lost to Follow-up|0|||
48695683|NCT00771914|156733765|FG002|Overall Study|Lost to Follow-up|0|||
48695684|NCT00771914|156733766|FG003|Overall Study|Lost to Follow-up|1|||
48695685|NCT00918281|156733769|FG000|Overall Study|Physician Decision|29|||
48695686|NCT02978417|156733772|FG000|Overall Study|Lost to Follow-up|2|||
48695687|NCT02978417|156733773|FG001|Overall Study|Lost to Follow-up|2|||
48695688|NCT04842747|156733776|FG000|Overall Study|Withdrawal by Subject|6|||
48695689|NCT04842747|156733777|FG001|Overall Study|Withdrawal by Subject|2|||
48695690|NCT04842747|156733776|FG000|Overall Study|Lost to Follow-up|1|||
48695691|NCT04842747|156733777|FG001|Overall Study|Lost to Follow-up|2|||
48695692|NCT04842747|156733776|FG000|Overall Study|Physician Decision|1|||
48695693|NCT04842747|156733777|FG001|Overall Study|Physician Decision|0|||
48695694|NCT04842747|156733776|FG000|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|1|||
48695695|NCT04842747|156733777|FG001|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|0|||
48695696|NCT05083351|156733778|FG000|Overall Study|Adverse Event|3|||
48695697|NCT05083351|156733778|FG000|Overall Study|Did not meet data inclusion criteria|8|||
48695698|NCT05083351|156733778|FG000|Overall Study|Did not meet eligibility criteria|19|||
48695699|NCT05083351|156733778|FG000|Overall Study|Study Staff Decision|19|||
48695700|NCT01743469|156733779|FG000|Active Treatment Phase|Adverse Event|10|||
48695701|NCT01743469|156733780|FG001|Active Treatment Phase|Adverse Event|5|||
48695702|NCT01743469|156733781|FG002|Active Treatment Phase|Adverse Event|8|||
48695703|NCT01743469|156733782|FG003|Active Treatment Phase|Adverse Event|1|||
48695704|NCT01743469|156733779|FG000|Active Treatment Phase|Disease Progression|40|||
48695705|NCT01743469|156733780|FG001|Active Treatment Phase|Disease Progression|47|||
48695706|NCT01743469|156733781|FG002|Active Treatment Phase|Disease Progression|30|||
48695707|NCT01743469|156733782|FG003|Active Treatment Phase|Disease Progression|20|||
48695708|NCT01743469|156733779|FG000|Active Treatment Phase|Withdrawal by Subject|2|||
48695709|NCT01743469|156733780|FG001|Active Treatment Phase|Withdrawal by Subject|3|||
48695710|NCT01743469|156733781|FG002|Active Treatment Phase|Withdrawal by Subject|0|||
48695711|NCT01743469|156733782|FG003|Active Treatment Phase|Withdrawal by Subject|0|||
48695712|NCT01743469|156733779|FG000|Active Treatment Phase|Missing|1|||
48695713|NCT01743469|156733780|FG001|Active Treatment Phase|Missing|0|||
48695714|NCT01743469|156733781|FG002|Active Treatment Phase|Missing|0|||
48695715|NCT01743469|156733782|FG003|Active Treatment Phase|Missing|0|||
48909200|NCT01794520|157504330|FG006|Overall Study|Death|22|||
48909201|NCT01794520|157504324|FG000|Overall Study|Other, not specified|0|||
48909202|NCT01794520|157504325|FG001|Overall Study|Other, not specified|0|||
48909203|NCT01794520|157504326|FG002|Overall Study|Other, not specified|1|||
48909204|NCT01794520|157504327|FG003|Overall Study|Other, not specified|1|||
48909205|NCT01794520|157504328|FG004|Overall Study|Other, not specified|4|||
48909206|NCT01794520|157504329|FG005|Overall Study|Other, not specified|1|||
48909207|NCT01794520|157504330|FG006|Overall Study|Other, not specified|2|||
48909208|NCT01069120|157504332|FG000|Overall Study|Study prematurely terminated|27|||
48909209|NCT05111041|157504333|FG000|Overall Study|Lost to Follow-up|6|||
49116301|NCT01084538|158263088|FG000|Overall Study|Over-suppression of parathyroid gland|2|||
49116302|NCT01084538|158263088|FG000|Overall Study|Reason unknown|8|||
49116303|NCT03538691|158263092|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|24|||
49116304|NCT03538691|158263093|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
49116305|NCT03538691|158263094|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
49116306|NCT03538691|158263095|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
49116307|NCT03538691|158263092|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|82|||
49116308|NCT03538691|158263093|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
49116309|NCT03538691|158263094|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
49116310|NCT03538691|158263095|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
49116311|NCT03538691|158263092|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|54|||
49116312|NCT03538691|158263093|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
49116313|NCT03538691|158263094|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
48695716|NCT01743469|156733779|FG000|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
48695717|NCT01743469|156733780|FG001|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
48695718|NCT01743469|156733781|FG002|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
48695719|NCT01743469|156733782|FG003|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
48695720|NCT01743469|156733779|FG000|Follow-up Period - Post-Treatment|Death|43|||
48695721|NCT01743469|156733780|FG001|Follow-up Period - Post-Treatment|Death|47|||
48695722|NCT01743469|156733781|FG002|Follow-up Period - Post-Treatment|Death|22|||
48695723|NCT01743469|156733782|FG003|Follow-up Period - Post-Treatment|Death|16|||
48695724|NCT01743469|156733779|FG000|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
48695725|NCT01743469|156733780|FG001|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
48695726|NCT01743469|156733781|FG002|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
48695727|NCT01743469|156733782|FG003|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
48695728|NCT00449696|156733791|FG000|Overall Study|Other Treatment Required|6|||
48695729|NCT00449696|156733792|FG001|Overall Study|Other Treatment Required|1|||
48695730|NCT00449696|156733791|FG000|Overall Study|Withdrawal by Subject|5|||
48695731|NCT00449696|156733792|FG001|Overall Study|Withdrawal by Subject|5|||
48695732|NCT00449696|156733791|FG000|Overall Study|Lost to Follow-up|2|||
48695733|NCT00449696|156733792|FG001|Overall Study|Lost to Follow-up|3|||
48695734|NCT00449696|156733791|FG000|Overall Study|Others|7|||
48695735|NCT00449696|156733792|FG001|Overall Study|Others|0|||
48695736|NCT02343263|156733798|FG000|Overall Study|Physician Decision|5|||
48695737|NCT02343263|156733799|FG001|Overall Study|Physician Decision|3|||
48695738|NCT02343263|156733800|FG002|Overall Study|Physician Decision|1|||
48695739|NCT01446159|156733802|FG000|Overall Study|Withdrawal by Subject|1|||
48695740|NCT01446159|156733803|FG001|Overall Study|Withdrawal by Subject|0|||
48695741|NCT01446159|156733804|FG002|Overall Study|Withdrawal by Subject|14|||
48695742|NCT01446159|156733805|FG003|Overall Study|Withdrawal by Subject|11|||
48695743|NCT01446159|156733802|FG000|Overall Study|Lost to Follow-up|0|||
48695744|NCT01446159|156733803|FG001|Overall Study|Lost to Follow-up|0|||
48695745|NCT01446159|156733804|FG002|Overall Study|Lost to Follow-up|1|||
48695746|NCT01446159|156733805|FG003|Overall Study|Lost to Follow-up|2|||
48695747|NCT01446159|156733802|FG000|Overall Study|Death|2|||
48695748|NCT01446159|156733803|FG001|Overall Study|Death|3|||
48695749|NCT01446159|156733804|FG002|Overall Study|Death|43|||
48695750|NCT01446159|156733805|FG003|Overall Study|Death|36|||
48695751|NCT01446159|156733802|FG000|Overall Study|Other|0|||
48695752|NCT01446159|156733803|FG001|Overall Study|Other|0|||
48695753|NCT01446159|156733804|FG002|Overall Study|Other|13|||
48695754|NCT01446159|156733805|FG003|Overall Study|Other|13|||
48695755|NCT00468169|156733806|FG000|Overall Study|Withdrawal by Subject|1|||
48695756|NCT00468169|156733807|FG001|Overall Study|Withdrawal by Subject|0|||
48695757|NCT02060721|156733809|FG000|Overall Study|Lost to Follow-up|1|||
48695758|NCT02060721|156733809|FG000|Overall Study|Physician Decision|2|||
48695759|NCT02060721|156733809|FG000|Overall Study|Death|14|||
48695760|NCT02060721|156733809|FG000|Overall Study|Withdrawal by Subject|2|||
48695761|NCT02060721|156733809|FG000|Overall Study|Compliance with local regulation: enrolled in China|19|||
48695762|NCT05498649|156733810|FG000|Overall Study|Lost to Follow-up|1|||
48695763|NCT03597347|156733812|FG000|Overall Study|Withdrawal by Subject|1|||
48695764|NCT03597347|156733813|FG001|Overall Study|Withdrawal by Subject|1|||
48695765|NCT03597347|156733814|FG002|Overall Study|Withdrawal by Subject|0|||
48695766|NCT03597347|156733812|FG000|Overall Study|Withdrawal due to Covid-19|3|||
48695767|NCT03597347|156733813|FG001|Overall Study|Withdrawal due to Covid-19|0|||
48695768|NCT03597347|156733814|FG002|Overall Study|Withdrawal due to Covid-19|0|||
48695769|NCT03597347|156733812|FG000|Overall Study|Sponsor decision to terminate study|3|||
48695770|NCT03597347|156733813|FG001|Overall Study|Sponsor decision to terminate study|2|||
48695771|NCT03597347|156733814|FG002|Overall Study|Sponsor decision to terminate study|4|||
48695772|NCT03642873|156733815|FG000|Third Intervention (1 Day)|Screen failure|0|||
48695773|NCT03642873|156733816|FG001|Third Intervention (1 Day)|Screen failure|0|||
48695774|NCT03642873|156733817|FG002|Third Intervention (1 Day)|Screen failure|0|||
48695775|NCT03642873|156733818|FG003|Third Intervention (1 Day)|Screen failure|0|||
48695776|NCT03642873|156733819|FG004|Third Intervention (1 Day)|Screen failure|1|||
48695777|NCT03642873|156733820|FG005|Third Intervention (1 Day)|Screen failure|0|||
48695778|NCT02234843|156733821|FG000|Overall Study|Death|1|||
48695779|NCT02234843|156733822|FG001|Overall Study|Death|0|||
48695780|NCT02234843|156733823|FG002|Overall Study|Death|0|||
48695781|NCT02234843|156733824|FG003|Overall Study|Death|0|||
48695782|NCT02234843|156733825|FG004|Overall Study|Death|0|||
48695783|NCT02234843|156733826|FG005|Overall Study|Death|0|||
48695784|NCT02234843|156733827|FG006|Overall Study|Death|0|||
48695785|NCT02234843|156733828|FG007|Overall Study|Death|0|||
48695786|NCT02234843|156733829|FG008|Overall Study|Death|0|||
48695787|NCT02234843|156733830|FG009|Overall Study|Death|0|||
48695788|NCT02234843|156733821|FG000|Overall Study|Protocol Violation|1|||
48695789|NCT02234843|156733822|FG001|Overall Study|Protocol Violation|0|||
48695790|NCT02234843|156733823|FG002|Overall Study|Protocol Violation|1|||
48695791|NCT02234843|156733824|FG003|Overall Study|Protocol Violation|0|||
48695792|NCT02234843|156733825|FG004|Overall Study|Protocol Violation|0|||
48695793|NCT02234843|156733826|FG005|Overall Study|Protocol Violation|0|||
48695794|NCT02234843|156733827|FG006|Overall Study|Protocol Violation|0|||
48695795|NCT02234843|156733828|FG007|Overall Study|Protocol Violation|0|||
48695796|NCT02234843|156733829|FG008|Overall Study|Protocol Violation|0|||
48695797|NCT02234843|156733830|FG009|Overall Study|Protocol Violation|0|||
48695798|NCT02234843|156733821|FG000|Overall Study|Efficacy outcome reached|2|||
48695799|NCT02234843|156733822|FG001|Overall Study|Efficacy outcome reached|0|||
48695800|NCT02234843|156733823|FG002|Overall Study|Efficacy outcome reached|0|||
48695801|NCT02234843|156733824|FG003|Overall Study|Efficacy outcome reached|0|||
48695802|NCT02234843|156733825|FG004|Overall Study|Efficacy outcome reached|0|||
48695803|NCT02234843|156733826|FG005|Overall Study|Efficacy outcome reached|2|||
48695804|NCT02234843|156733827|FG006|Overall Study|Efficacy outcome reached|0|||
48695805|NCT02234843|156733828|FG007|Overall Study|Efficacy outcome reached|0|||
48695806|NCT02234843|156733829|FG008|Overall Study|Efficacy outcome reached|0|||
48695807|NCT02234843|156733830|FG009|Overall Study|Efficacy outcome reached|0|||
48695808|NCT02234843|156733821|FG000|Overall Study|Patient convenience|2|||
48695809|NCT02234843|156733822|FG001|Overall Study|Patient convenience|0|||
48695810|NCT02234843|156733823|FG002|Overall Study|Patient convenience|0|||
48695811|NCT02234843|156733824|FG003|Overall Study|Patient convenience|0|||
48695812|NCT02234843|156733825|FG004|Overall Study|Patient convenience|0|||
48695813|NCT02234843|156733826|FG005|Overall Study|Patient convenience|1|||
48695814|NCT02234843|156733827|FG006|Overall Study|Patient convenience|0|||
48695815|NCT02234843|156733828|FG007|Overall Study|Patient convenience|0|||
48695816|NCT02234843|156733829|FG008|Overall Study|Patient convenience|0|||
48695817|NCT02234843|156733830|FG009|Overall Study|Patient convenience|0|||
48695818|NCT02234843|156733821|FG000|Overall Study|Withdrawal by Subject|5|||
48695819|NCT02234843|156733822|FG001|Overall Study|Withdrawal by Subject|1|||
48695820|NCT02234843|156733823|FG002|Overall Study|Withdrawal by Subject|1|||
48695821|NCT02234843|156733824|FG003|Overall Study|Withdrawal by Subject|0|||
48695822|NCT02234843|156733825|FG004|Overall Study|Withdrawal by Subject|0|||
48695823|NCT02234843|156733826|FG005|Overall Study|Withdrawal by Subject|7|||
48695824|NCT02234843|156733827|FG006|Overall Study|Withdrawal by Subject|0|||
48695825|NCT02234843|156733828|FG007|Overall Study|Withdrawal by Subject|0|||
48695826|NCT02234843|156733829|FG008|Overall Study|Withdrawal by Subject|0|||
48695827|NCT02234843|156733830|FG009|Overall Study|Withdrawal by Subject|0|||
48695828|NCT02234843|156733821|FG000|Overall Study|Recovery|1|||
48695829|NCT02234843|156733822|FG001|Overall Study|Recovery|0|||
48695830|NCT02234843|156733823|FG002|Overall Study|Recovery|0|||
48695831|NCT02234843|156733824|FG003|Overall Study|Recovery|0|||
48695832|NCT02234843|156733825|FG004|Overall Study|Recovery|0|||
48695833|NCT02234843|156733826|FG005|Overall Study|Recovery|0|||
48695834|NCT02234843|156733827|FG006|Overall Study|Recovery|0|||
48695835|NCT02234843|156733828|FG007|Overall Study|Recovery|0|||
48695836|NCT02234843|156733829|FG008|Overall Study|Recovery|0|||
48695837|NCT02234843|156733830|FG009|Overall Study|Recovery|0|||
48695838|NCT02234843|156733821|FG000|Overall Study|Other|0|||
48695839|NCT02234843|156733822|FG001|Overall Study|Other|2|||
48695840|NCT02234843|156733823|FG002|Overall Study|Other|0|||
48695841|NCT02234843|156733824|FG003|Overall Study|Other|1|||
48695842|NCT02234843|156733825|FG004|Overall Study|Other|0|||
48695843|NCT02234843|156733826|FG005|Overall Study|Other|1|||
48695844|NCT02234843|156733827|FG006|Overall Study|Other|0|||
48695845|NCT02234843|156733828|FG007|Overall Study|Other|1|||
48695846|NCT02234843|156733829|FG008|Overall Study|Other|0|||
48695847|NCT02234843|156733830|FG009|Overall Study|Other|0|||
48695848|NCT02234843|156733821|FG000|Overall Study|Physician Decision|4|||
48695849|NCT02234843|156733822|FG001|Overall Study|Physician Decision|1|||
48695850|NCT02234843|156733823|FG002|Overall Study|Physician Decision|0|||
48695851|NCT02234843|156733824|FG003|Overall Study|Physician Decision|1|||
48695852|NCT02234843|156733825|FG004|Overall Study|Physician Decision|0|||
48695853|NCT02234843|156733826|FG005|Overall Study|Physician Decision|0|||
48695854|NCT02234843|156733827|FG006|Overall Study|Physician Decision|0|||
48695855|NCT02234843|156733828|FG007|Overall Study|Physician Decision|1|||
48695856|NCT02234843|156733829|FG008|Overall Study|Physician Decision|0|||
48695857|NCT02234843|156733830|FG009|Overall Study|Physician Decision|0|||
48695858|NCT02234843|156733821|FG000|Overall Study|Adverse Event|5|||
48695859|NCT02234843|156733822|FG001|Overall Study|Adverse Event|1|||
48695860|NCT02234843|156733823|FG002|Overall Study|Adverse Event|1|||
48909210|NCT05111041|157504334|FG001|Overall Study|Lost to Follow-up|7|||
48695861|NCT02234843|156733824|FG003|Overall Study|Adverse Event|3|||
48695862|NCT02234843|156733825|FG004|Overall Study|Adverse Event|2|||
48695863|NCT02234843|156733826|FG005|Overall Study|Adverse Event|1|||
48695864|NCT02234843|156733827|FG006|Overall Study|Adverse Event|0|||
48695865|NCT02234843|156733828|FG007|Overall Study|Adverse Event|0|||
48695866|NCT02234843|156733829|FG008|Overall Study|Adverse Event|1|||
48695867|NCT02234843|156733830|FG009|Overall Study|Adverse Event|0|||
48695868|NCT02234843|156733821|FG000|Overall Study|Non-compliance with study drug|1|||
48695869|NCT02234843|156733822|FG001|Overall Study|Non-compliance with study drug|0|||
48695870|NCT02234843|156733823|FG002|Overall Study|Non-compliance with study drug|0|||
48695871|NCT02234843|156733824|FG003|Overall Study|Non-compliance with study drug|0|||
48695872|NCT02234843|156733825|FG004|Overall Study|Non-compliance with study drug|0|||
48695873|NCT02234843|156733826|FG005|Overall Study|Non-compliance with study drug|1|||
48695874|NCT02234843|156733827|FG006|Overall Study|Non-compliance with study drug|1|||
48695875|NCT02234843|156733828|FG007|Overall Study|Non-compliance with study drug|0|||
48695876|NCT02234843|156733829|FG008|Overall Study|Non-compliance with study drug|0|||
48695877|NCT02234843|156733830|FG009|Overall Study|Non-compliance with study drug|0|||
48695878|NCT02234843|156733821|FG000|Overall Study|Lost to Follow-up|0|||
48695879|NCT02234843|156733822|FG001|Overall Study|Lost to Follow-up|1|||
48695880|NCT02234843|156733823|FG002|Overall Study|Lost to Follow-up|0|||
48695881|NCT02234843|156733824|FG003|Overall Study|Lost to Follow-up|0|||
48695882|NCT02234843|156733825|FG004|Overall Study|Lost to Follow-up|0|||
48695883|NCT02234843|156733826|FG005|Overall Study|Lost to Follow-up|0|||
48695884|NCT02234843|156733827|FG006|Overall Study|Lost to Follow-up|1|||
48695885|NCT02234843|156733828|FG007|Overall Study|Lost to Follow-up|0|||
48695886|NCT02234843|156733829|FG008|Overall Study|Lost to Follow-up|0|||
48695887|NCT02234843|156733830|FG009|Overall Study|Lost to Follow-up|0|||
48695888|NCT03157830|156733831|FG000|Overall Study|Lost to Follow-up|1|||
48695889|NCT03157830|156733831|FG000|Overall Study|Withdrawal by Subject|1|||
48695890|NCT02078648|156733834|FG000|Overall Study|Unequivocal Evidence of Disease Progression|36|||
48695891|NCT02078648|156733835|FG001|Overall Study|Unequivocal Evidence of Disease Progression|13|||
48695892|NCT02078648|156733834|FG000|Overall Study|Adverse Event|0|||
48695893|NCT02078648|156733835|FG001|Overall Study|Adverse Event|1|||
48695894|NCT02078648|156733834|FG000|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|1|||
48695895|NCT02078648|156733835|FG001|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|4|||
48695896|NCT02078648|156733834|FG000|Overall Study|Withdrawal by Subject|3|||
48695897|NCT02078648|156733835|FG001|Overall Study|Withdrawal by Subject|1|||
48695898|NCT02078648|156733834|FG000|Overall Study|Investigator Decision|5|||
48695899|NCT02078648|156733835|FG001|Overall Study|Investigator Decision|7|||
48909211|NCT05111041|157504333|FG000|Overall Study|Withdrawal by Subject|1|||
48909212|NCT05111041|157504334|FG001|Overall Study|Withdrawal by Subject|0|||
48909213|NCT01423812|157504336|FG000|Overall Study|Lost to Follow-up|2|||
48909214|NCT01423812|157504337|FG001|Overall Study|Lost to Follow-up|2|||
48909215|NCT01423812|157504336|FG000|Overall Study|Withdrawal by Subject|1|||
48909216|NCT01423812|157504337|FG001|Overall Study|Withdrawal by Subject|2|||
48909217|NCT03842163|157504338|FG000|Overall Study|Did not meet inclusion criteria (age less than 50 years)|2|||
48909218|NCT03842163|157504338|FG000|Overall Study|Scintigraphy was not performed|44|||
48909219|NCT01519934|157504339|FG000|Overall Study|Lost to Follow-up|3|||
49010522|NCT00926289|157875640|FG001|Overall Study|Withdrawal by Subject|4|||
49010523|NCT00926289|157875639|FG000|Overall Study|Other|1|||
49010524|NCT00926289|157875640|FG001|Overall Study|Other|3|||
48909220|NCT02445755|157504340|FG000|Overall Study|Withdrawal by Subject|2|||
48909221|NCT02445755|157504340|FG000|Overall Study|Protocol Violation|6|||
48909222|NCT02445755|157504340|FG000|Overall Study|Screen Failure|5|||
48909223|NCT00068588|157504341|FG000|Overall Study|Adverse Event|0|||
48909224|NCT00068588|157504342|FG001|Overall Study|Adverse Event|0|||
48909225|NCT00068588|157504343|FG002|Overall Study|Adverse Event|2|||
48909226|NCT00068588|157504341|FG000|Overall Study|Withdrawal by Subject|0|||
48909227|NCT00068588|157504342|FG001|Overall Study|Withdrawal by Subject|0|||
48909228|NCT00068588|157504343|FG002|Overall Study|Withdrawal by Subject|1|||
48909229|NCT00068588|157504341|FG000|Overall Study|Poor KPS|0|||
48909230|NCT00068588|157504342|FG001|Overall Study|Poor KPS|0|||
48909231|NCT00068588|157504343|FG002|Overall Study|Poor KPS|1|||
48909232|NCT03829241|157504344|FG000|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|16|||
48909233|NCT03829241|157504345|FG001|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|19|||
48909234|NCT03829241|157504344|FG000|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|5|||
48909235|NCT03829241|157504345|FG001|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|11|||
48909236|NCT03829241|157504344|FG000|Randomization Phase (Week 1 to Week 8)|Sponsor Request|0|||
48909237|NCT03829241|157504345|FG001|Randomization Phase (Week 1 to Week 8)|Sponsor Request|1|||
48909238|NCT03829241|157504344|FG000|Randomization Phase (Week 1 to Week 8)|Adverse Event|8|||
48909239|NCT03829241|157504345|FG001|Randomization Phase (Week 1 to Week 8)|Adverse Event|9|||
48909240|NCT03829241|157504344|FG000|Randomization Phase (Week 1 to Week 8)|Non compliance|2|||
48909241|NCT03829241|157504345|FG001|Randomization Phase (Week 1 to Week 8)|Non compliance|1|||
48909242|NCT03829241|157504344|FG000|Randomization Phase (Week 1 to Week 8)|Pregnancy|0|||
48909243|NCT03829241|157504345|FG001|Randomization Phase (Week 1 to Week 8)|Pregnancy|1|||
48909244|NCT03829241|157504344|FG000|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|20|||
48909245|NCT03829241|157504345|FG001|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|24|||
48909246|NCT03829241|157504344|FG000|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|9|||
48909247|NCT03829241|157504345|FG001|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|7|||
48909248|NCT03829241|157504344|FG000|Extension Phase (Week 9 up to Week 48)|Physician Decision|1|||
48909249|NCT03829241|157504345|FG001|Extension Phase (Week 9 up to Week 48)|Physician Decision|0|||
48909250|NCT03829241|157504344|FG000|Extension Phase (Week 9 up to Week 48)|Sponsor Request|117|||
48909251|NCT03829241|157504345|FG001|Extension Phase (Week 9 up to Week 48)|Sponsor Request|108|||
48909252|NCT03829241|157504344|FG000|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|0|||
48909253|NCT03829241|157504345|FG001|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|1|||
48909254|NCT03829241|157504344|FG000|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
48909255|NCT03829241|157504345|FG001|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
48909256|NCT03829241|157504344|FG000|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
48909257|NCT03829241|157504345|FG001|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
48909258|NCT03829241|157504344|FG000|Extension Phase (Week 9 up to Week 48)|Pregnancy|0|||
48909259|NCT03829241|157504345|FG001|Extension Phase (Week 9 up to Week 48)|Pregnancy|2|||
48909260|NCT04784897|157504346|FG000|Overall Study|Death|4|||
48909261|NCT04784897|157504347|FG001|Overall Study|Death|2|||
48909262|NCT04784897|157504348|FG002|Overall Study|Death|1|||
48909263|NCT04784897|157504346|FG000|Overall Study|Withdrawal by Subject|0|||
48909264|NCT04784897|157504347|FG001|Overall Study|Withdrawal by Subject|0|||
48909265|NCT04784897|157504348|FG002|Overall Study|Withdrawal by Subject|1|||
48909266|NCT00733304|157504351|FG000|Overall Study|Adverse Event|3|||
48909267|NCT00733304|157504352|FG001|Overall Study|Adverse Event|0|||
48909268|NCT00733304|157504353|FG002|Overall Study|Adverse Event|0|||
48909269|NCT00733304|157504351|FG000|Overall Study|Lack of Efficacy|0|||
48909270|NCT00733304|157504352|FG001|Overall Study|Lack of Efficacy|0|||
48909271|NCT00733304|157504353|FG002|Overall Study|Lack of Efficacy|2|||
48909272|NCT00733304|157504351|FG000|Overall Study|Lost to Follow-up|0|||
48909273|NCT00733304|157504352|FG001|Overall Study|Lost to Follow-up|1|||
48909274|NCT00733304|157504353|FG002|Overall Study|Lost to Follow-up|0|||
48909275|NCT00733304|157504351|FG000|Overall Study|Physician Decision|3|||
48909276|NCT00733304|157504352|FG001|Overall Study|Physician Decision|1|||
48909277|NCT00733304|157504353|FG002|Overall Study|Physician Decision|3|||
48909278|NCT00733304|157504351|FG000|Overall Study|Withdrawal by Subject|1|||
48909279|NCT00733304|157504352|FG001|Overall Study|Withdrawal by Subject|1|||
48695900|NCT02078648|156733834|FG000|Overall Study|Death|1|||
48695901|NCT02078648|156733835|FG001|Overall Study|Death|1|||
48695902|NCT02078648|156733834|FG000|Overall Study|Undefined|0|||
48909280|NCT00733304|157504353|FG002|Overall Study|Withdrawal by Subject|0|||
48909281|NCT03155373|157504354|FG000|Overall Study|No longer required surgery|1|||
48909282|NCT03155373|157504354|FG000|Overall Study|Protocol Violation|1|||
48909283|NCT03155373|157504354|FG000|Overall Study|Death|2|||
48695903|NCT02078648|156733835|FG001|Overall Study|Undefined|1|||
48695904|NCT00633477|156735796|FG000|Overall Study|Death|1|||
48695905|NCT00633477|156735797|FG001|Overall Study|Death|0|||
48695906|NCT00633477|156735796|FG000|Overall Study|Randomized but not treated|1|||
48695907|NCT00633477|156735797|FG001|Overall Study|Randomized but not treated|0|||
48695908|NCT04906499|156735802|FG000|Overall Study|Lack of time|1|||
48695909|NCT01908426|156735803|FG000|Overall Study|Adverse Event|98|||
48695910|NCT01908426|156735804|FG001|Overall Study|Adverse Event|11|||
48695911|NCT01908426|156735803|FG000|Overall Study|Clinical Deterioration|72|||
48695912|NCT01908426|156735804|FG001|Overall Study|Clinical Deterioration|38|||
48695913|NCT01908426|156735803|FG000|Overall Study|Lack of Efficacy|3|||
48695914|NCT01908426|156735804|FG001|Overall Study|Lack of Efficacy|0|||
48695915|NCT01908426|156735803|FG000|Overall Study|Lost to Follow-up|0|||
48695916|NCT01908426|156735804|FG001|Overall Study|Lost to Follow-up|1|||
48909284|NCT03155373|157504354|FG000|Overall Study|Withdrawal by Subject|3|||
48909285|NCT02616614|157504355|FG000|Overall Study|Withdrawal by Subject|10|||
48909286|NCT02616614|157504356|FG001|Overall Study|Withdrawal by Subject|5|||
48909287|NCT02616614|157504357|FG002|Overall Study|Withdrawal by Subject|6|||
48695917|NCT01908426|156735803|FG000|Overall Study|Physician Decision|3|||
48695918|NCT01908426|156735804|FG001|Overall Study|Physician Decision|3|||
48695919|NCT01908426|156735803|FG000|Overall Study|Withdrawal by Subject|11|||
48695920|NCT01908426|156735804|FG001|Overall Study|Withdrawal by Subject|6|||
48695921|NCT01908426|156735803|FG000|Overall Study|Progressive Disease|206|||
48909288|NCT02616614|157504355|FG000|Overall Study|Physician Decision|2|||
48909289|NCT02616614|157504356|FG001|Overall Study|Physician Decision|1|||
48909290|NCT02616614|157504357|FG002|Overall Study|Physician Decision|0|||
48909291|NCT02616614|157504355|FG000|Overall Study|Adverse Event|1|||
49116314|NCT03538691|158263095|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
48695922|NCT01908426|156735804|FG001|Overall Study|Progressive Disease|152|||
48695923|NCT01908426|156735803|FG000|Overall Study|Protocol Violation|1|||
48695924|NCT01908426|156735804|FG001|Overall Study|Protocol Violation|0|||
48695925|NCT01908426|156735803|FG000|Overall Study|No Study Treatment Given|3|||
48695926|NCT01908426|156735804|FG001|Overall Study|No Study Treatment Given|0|||
48695927|NCT00262860|156735808|FG000|Overall Study|Adverse Event|2|||
48909292|NCT02616614|157504356|FG001|Overall Study|Adverse Event|4|||
48695928|NCT02741128|156735809|FG000|Overall Study|Protocol Violation|4|||
48909293|NCT02616614|157504357|FG002|Overall Study|Adverse Event|1|||
48909294|NCT02616614|157504355|FG000|Overall Study|Protocol Violation|0|||
48695929|NCT02741128|156735810|FG001|Overall Study|Protocol Violation|1|||
48695930|NCT02741128|156735809|FG000|Overall Study|Withdrawal by Subject|2|||
48695931|NCT02741128|156735810|FG001|Overall Study|Withdrawal by Subject|0|||
48695932|NCT02741128|156735809|FG000|Overall Study|Lost to Follow-up|1|||
48695933|NCT02741128|156735810|FG001|Overall Study|Lost to Follow-up|0|||
48695934|NCT03744312|156735811|FG000|Overall Study|Withdrawal by Subject|0|||
48695935|NCT03744312|156735812|FG001|Overall Study|Withdrawal by Subject|1|||
48695936|NCT03744312|156735811|FG000|Overall Study|Screen fail|0|||
48695937|NCT03744312|156735812|FG001|Overall Study|Screen fail|1|||
48695938|NCT00445549|156735813|FG000|Overall Study|progressive disease|12|||
48695939|NCT00280917|156735823|FG000|Overall Study|Adverse Event|1|||
48695940|NCT00280917|156735824|FG001|Overall Study|Adverse Event|1|||
48695941|NCT00280917|156735825|FG002|Overall Study|Adverse Event|4|||
48695942|NCT00280917|156735826|FG003|Overall Study|Adverse Event|1|||
48695943|NCT00280917|156735823|FG000|Overall Study|Change Therapy|1|||
48695944|NCT00280917|156735824|FG001|Overall Study|Change Therapy|2|||
48695945|NCT00280917|156735825|FG002|Overall Study|Change Therapy|0|||
48695946|NCT00280917|156735826|FG003|Overall Study|Change Therapy|0|||
48695947|NCT00280917|156735823|FG000|Overall Study|Withdrawal by Subject|0|||
48695948|NCT00280917|156735824|FG001|Overall Study|Withdrawal by Subject|2|||
48695949|NCT00280917|156735825|FG002|Overall Study|Withdrawal by Subject|0|||
48695950|NCT00280917|156735826|FG003|Overall Study|Withdrawal by Subject|1|||
48695951|NCT00280917|156735823|FG000|Overall Study|Noncompliance|0|||
48695952|NCT00280917|156735824|FG001|Overall Study|Noncompliance|1|||
48695953|NCT00280917|156735825|FG002|Overall Study|Noncompliance|2|||
48695954|NCT00280917|156735826|FG003|Overall Study|Noncompliance|0|||
48695955|NCT03096834|156735827|FG000|Double-Blind Treatment Epoch|Protocol deviation|2|||
48695956|NCT03096834|156735828|FG001|Double-Blind Treatment Epoch|Protocol deviation|1|||
48695957|NCT03096834|156735829|FG002|Double-Blind Treatment Epoch|Protocol deviation|0|||
48695958|NCT03096834|156735830|FG003|Double-Blind Treatment Epoch|Protocol deviation|0|||
48695959|NCT03096834|156735827|FG000|Double-Blind Treatment Epoch|Pregnancy|0|||
48695960|NCT03096834|156735828|FG001|Double-Blind Treatment Epoch|Pregnancy|1|||
48695961|NCT03096834|156735829|FG002|Double-Blind Treatment Epoch|Pregnancy|0|||
48695962|NCT03096834|156735830|FG003|Double-Blind Treatment Epoch|Pregnancy|0|||
48695963|NCT03096834|156735827|FG000|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
48695964|NCT03096834|156735828|FG001|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
48695965|NCT03096834|156735829|FG002|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
48695966|NCT03096834|156735830|FG003|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
48695967|NCT03096834|156735827|FG000|Open-Label Treatment Epoch|Lack of Efficacy|0|||
48695968|NCT03096834|156735828|FG001|Open-Label Treatment Epoch|Lack of Efficacy|0|||
48695969|NCT03096834|156735829|FG002|Open-Label Treatment Epoch|Lack of Efficacy|15|||
48695970|NCT03096834|156735830|FG003|Open-Label Treatment Epoch|Lack of Efficacy|15|||
48695971|NCT03096834|156735827|FG000|Open-Label Treatment Epoch|Adverse Event|0|||
48695972|NCT03096834|156735828|FG001|Open-Label Treatment Epoch|Adverse Event|0|||
48695973|NCT03096834|156735829|FG002|Open-Label Treatment Epoch|Adverse Event|5|||
48695974|NCT03096834|156735830|FG003|Open-Label Treatment Epoch|Adverse Event|6|||
48695975|NCT03096834|156735827|FG000|Open-Label Treatment Epoch|New therapy for study indication|0|||
48695976|NCT03096834|156735828|FG001|Open-Label Treatment Epoch|New therapy for study indication|0|||
48695977|NCT03096834|156735829|FG002|Open-Label Treatment Epoch|New therapy for study indication|1|||
48695978|NCT03096834|156735830|FG003|Open-Label Treatment Epoch|New therapy for study indication|1|||
48695979|NCT03096834|156735827|FG000|Open-Label Treatment Epoch|Physician Decision|0|||
48695980|NCT03096834|156735828|FG001|Open-Label Treatment Epoch|Physician Decision|0|||
48695981|NCT03096834|156735829|FG002|Open-Label Treatment Epoch|Physician Decision|1|||
48695982|NCT03096834|156735830|FG003|Open-Label Treatment Epoch|Physician Decision|0|||
48695983|NCT03096834|156735827|FG000|Open-Label Treatment Epoch|Pregnancy|0|||
48695984|NCT03096834|156735828|FG001|Open-Label Treatment Epoch|Pregnancy|0|||
48695985|NCT03096834|156735829|FG002|Open-Label Treatment Epoch|Pregnancy|1|||
48695986|NCT03096834|156735830|FG003|Open-Label Treatment Epoch|Pregnancy|0|||
48695987|NCT03096834|156735827|FG000|Open-Label Treatment Epoch|Subject/guardian decision|0|||
48695988|NCT03096834|156735828|FG001|Open-Label Treatment Epoch|Subject/guardian decision|0|||
48695989|NCT03096834|156735829|FG002|Open-Label Treatment Epoch|Subject/guardian decision|9|||
48695990|NCT03096834|156735830|FG003|Open-Label Treatment Epoch|Subject/guardian decision|17|||
48695991|NCT03096834|156735827|FG000|Safety Follow-Up Epoch|New therapy for study indication|0|||
48695992|NCT03096834|156735828|FG001|Safety Follow-Up Epoch|New therapy for study indication|0|||
48695993|NCT03096834|156735829|FG002|Safety Follow-Up Epoch|New therapy for study indication|0|||
48695994|NCT03096834|156735830|FG003|Safety Follow-Up Epoch|New therapy for study indication|1|||
48695995|NCT03096834|156735827|FG000|Safety Follow-Up Epoch|Protocol deviation|0|||
48695996|NCT03096834|156735828|FG001|Safety Follow-Up Epoch|Protocol deviation|0|||
48695997|NCT03096834|156735829|FG002|Safety Follow-Up Epoch|Protocol deviation|0|||
48695998|NCT03096834|156735830|FG003|Safety Follow-Up Epoch|Protocol deviation|1|||
48695999|NCT03096834|156735827|FG000|Safety Follow-Up Epoch|Lost to Follow-up|0|||
48696000|NCT03096834|156735828|FG001|Safety Follow-Up Epoch|Lost to Follow-up|0|||
48696001|NCT03096834|156735829|FG002|Safety Follow-Up Epoch|Lost to Follow-up|1|||
48696002|NCT03096834|156735830|FG003|Safety Follow-Up Epoch|Lost to Follow-up|0|||
48696003|NCT04416204|156735835|FG000|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
48696004|NCT04416204|156735836|FG001|Washout (3-6 Weeks)|Withdrawal by Subject|0|||
48696005|NCT04416204|156735837|FG002|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
48696006|NCT04416204|156735838|FG003|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
48696007|NCT03858049|156735839|FG000|Overall Study|Adverse Event|16|||
48696008|NCT03858049|156735840|FG001|Overall Study|Adverse Event|9|||
48696009|NCT03858049|156735839|FG000|Overall Study|Other|1|||
48696010|NCT03858049|156735840|FG001|Overall Study|Other|1|||
48696011|NCT00762359|156735841|FG000|Overall Study|Adverse Event|20|||
48696012|NCT00762359|156735842|FG001|Overall Study|Adverse Event|23|||
48696013|NCT00762359|156735841|FG000|Overall Study|Protocol Violation|21|||
48696014|NCT00762359|156735842|FG001|Overall Study|Protocol Violation|13|||
48696015|NCT00762359|156735841|FG000|Overall Study|Withdrawal by Subject|13|||
48696016|NCT00762359|156735842|FG001|Overall Study|Withdrawal by Subject|10|||
48696017|NCT00762359|156735841|FG000|Overall Study|Lack of Efficacy|0|||
48696018|NCT00762359|156735842|FG001|Overall Study|Lack of Efficacy|4|||
48696019|NCT00762359|156735841|FG000|Overall Study|Institution closed|2|||
48696020|NCT00762359|156735842|FG001|Overall Study|Institution closed|3|||
48696021|NCT00762359|156735841|FG000|Overall Study|Physician Decision|2|||
48696022|NCT00762359|156735842|FG001|Overall Study|Physician Decision|3|||
48696023|NCT00762359|156735841|FG000|Overall Study|Removal|0|||
48696024|NCT00762359|156735842|FG001|Overall Study|Removal|1|||
48696025|NCT00762359|156735841|FG000|Overall Study|Withdrew consent|1|||
48696026|NCT00762359|156735842|FG001|Overall Study|Withdrew consent|0|||
48696027|NCT03629886|156735843|FG000|Overall Study|Migrated / moved from the study area|0|||
48696028|NCT03629886|156735844|FG001|Overall Study|Migrated / moved from the study area|55|||
48696029|NCT03629886|156735843|FG000|Overall Study|Consent withdrawal, not due to an AE|0|||
48696030|NCT03629886|156735844|FG001|Overall Study|Consent withdrawal, not due to an AE|50|||
48696031|NCT03629886|156735843|FG000|Overall Study|Study vaccine not administrated|0|||
48696032|NCT03629886|156735844|FG001|Overall Study|Study vaccine not administrated|3|||
48696033|NCT03629886|156735843|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|0|||
48696034|NCT03629886|156735844|FG001|Overall Study|Didn't meet inclusion/exclusion criteria|28|||
48696035|NCT03629886|156735843|FG000|Overall Study|Refused vaccination step of the study|0|||
48696036|NCT03629886|156735844|FG001|Overall Study|Refused vaccination step of the study|44|||
48696037|NCT00672555|156735847|FG000|Overall Study|Lost to Follow-up|4|||
48696038|NCT00672555|156735847|FG000|Overall Study|Did not want to answer questionnaire|2|||
48696039|NCT00979901|156735848|FG000|Overall Study|Adverse Event|1|||
48696040|NCT00979901|156735849|FG001|Overall Study|Adverse Event|3|||
48696041|NCT00979901|156735850|FG002|Overall Study|Adverse Event|9|||
48696042|NCT00979901|156735851|FG003|Overall Study|Adverse Event|2|||
48696043|NCT00979901|156735848|FG000|Overall Study|Lack of Efficacy|8|||
48696044|NCT00979901|156735849|FG001|Overall Study|Lack of Efficacy|4|||
48696045|NCT00979901|156735850|FG002|Overall Study|Lack of Efficacy|9|||
48696046|NCT00979901|156735851|FG003|Overall Study|Lack of Efficacy|0|||
48696047|NCT00979901|156735848|FG000|Overall Study|Lost to Follow-up|1|||
48696048|NCT00979901|156735849|FG001|Overall Study|Lost to Follow-up|1|||
48696049|NCT00979901|156735850|FG002|Overall Study|Lost to Follow-up|2|||
48696050|NCT00979901|156735851|FG003|Overall Study|Lost to Follow-up|0|||
48696051|NCT00979901|156735848|FG000|Overall Study|Protocol Violation|2|||
48696052|NCT00979901|156735849|FG001|Overall Study|Protocol Violation|2|||
48696053|NCT00979901|156735850|FG002|Overall Study|Protocol Violation|7|||
48909295|NCT02616614|157504356|FG001|Overall Study|Protocol Violation|3|||
48909296|NCT02616614|157504357|FG002|Overall Study|Protocol Violation|1|||
48909297|NCT02616614|157504355|FG000|Overall Study|Prohibited Medication|12|||
48909298|NCT02616614|157504356|FG001|Overall Study|Prohibited Medication|9|||
48909299|NCT02616614|157504357|FG002|Overall Study|Prohibited Medication|5|||
48909300|NCT02616614|157504355|FG000|Overall Study|More than 3 applications missed|6|||
48696054|NCT00979901|156735851|FG003|Overall Study|Protocol Violation|1|||
48696055|NCT00979901|156735848|FG000|Overall Study|Withdrawal by Subject|2|||
48696056|NCT00979901|156735849|FG001|Overall Study|Withdrawal by Subject|1|||
48696057|NCT00979901|156735850|FG002|Overall Study|Withdrawal by Subject|1|||
48696058|NCT00979901|156735851|FG003|Overall Study|Withdrawal by Subject|1|||
48696059|NCT00979901|156735848|FG000|Overall Study|Noncompliance|1|||
48696060|NCT00979901|156735849|FG001|Overall Study|Noncompliance|0|||
48696061|NCT00979901|156735850|FG002|Overall Study|Noncompliance|0|||
48696062|NCT00979901|156735851|FG003|Overall Study|Noncompliance|0|||
48696063|NCT00979901|156735848|FG000|Overall Study|out-of-state|1|||
48696064|NCT00979901|156735849|FG001|Overall Study|out-of-state|0|||
48696065|NCT00979901|156735850|FG002|Overall Study|out-of-state|0|||
48909301|NCT02616614|157504356|FG001|Overall Study|More than 3 applications missed|8|||
49010525|NCT00345683|157875641|FG000|Overall Study|Lost to Follow-up|19|||
48696066|NCT00979901|156735851|FG003|Overall Study|out-of-state|0|||
48696067|NCT00979901|156735848|FG000|Overall Study|vacation|1|||
48696068|NCT00979901|156735849|FG001|Overall Study|vacation|0|||
48696069|NCT00979901|156735850|FG002|Overall Study|vacation|0|||
48696070|NCT00979901|156735851|FG003|Overall Study|vacation|0|||
48696071|NCT00979901|156735848|FG000|Overall Study|elevated lab values pre-randomization|1|||
48696072|NCT00979901|156735849|FG001|Overall Study|elevated lab values pre-randomization|0|||
48696073|NCT00979901|156735850|FG002|Overall Study|elevated lab values pre-randomization|0|||
48696074|NCT00979901|156735851|FG003|Overall Study|elevated lab values pre-randomization|0|||
48696075|NCT00979901|156735848|FG000|Overall Study|Discontinued in Error|0|||
48696076|NCT00979901|156735849|FG001|Overall Study|Discontinued in Error|1|||
48696077|NCT00979901|156735850|FG002|Overall Study|Discontinued in Error|0|||
48696078|NCT00979901|156735851|FG003|Overall Study|Discontinued in Error|0|||
48696079|NCT00979901|156735848|FG000|Overall Study|Left Country|0|||
48696080|NCT00979901|156735849|FG001|Overall Study|Left Country|0|||
48696081|NCT00979901|156735850|FG002|Overall Study|Left Country|1|||
48696082|NCT00979901|156735851|FG003|Overall Study|Left Country|0|||
48696083|NCT00979901|156735848|FG000|Overall Study|Treatment Group Terminated by Sponsor|0|||
48696084|NCT00979901|156735849|FG001|Overall Study|Treatment Group Terminated by Sponsor|0|||
48696085|NCT00979901|156735850|FG002|Overall Study|Treatment Group Terminated by Sponsor|0|||
48696086|NCT00979901|156735851|FG003|Overall Study|Treatment Group Terminated by Sponsor|112|||
48696087|NCT03489863|156735852|FG000|Overall Study|Withdrawal by Subject|0|||
48696088|NCT03489863|156735853|FG001|Overall Study|Withdrawal by Subject|1|||
48696089|NCT00346216|156735856|FG000|Overall Study|Other|181|||
48696090|NCT00346216|156735857|FG001|Overall Study|Other|231|||
48696091|NCT00346216|156735858|FG002|Overall Study|Other|205|||
48696092|NCT00346216|156735856|FG000|Overall Study|No longer willing to participate|600|||
48696093|NCT00346216|156735857|FG001|Overall Study|No longer willing to participate|606|||
48696094|NCT00346216|156735858|FG002|Overall Study|No longer willing to participate|585|||
48696095|NCT00346216|156735856|FG000|Overall Study|Withdrawal by Subject|661|||
48696096|NCT00346216|156735857|FG001|Overall Study|Withdrawal by Subject|692|||
48696097|NCT00346216|156735858|FG002|Overall Study|Withdrawal by Subject|651|||
48696098|NCT00346216|156735856|FG000|Overall Study|Lost to Follow-up|611|||
48696099|NCT00346216|156735857|FG001|Overall Study|Lost to Follow-up|588|||
48696100|NCT00346216|156735858|FG002|Overall Study|Lost to Follow-up|542|||
48696101|NCT00346216|156735856|FG000|Overall Study|Physician Decision|80|||
48696102|NCT00346216|156735857|FG001|Overall Study|Physician Decision|76|||
48696103|NCT00346216|156735858|FG002|Overall Study|Physician Decision|59|||
48696104|NCT00346216|156735856|FG000|Overall Study|Does not meet entrance criteria|13|||
48696105|NCT00346216|156735857|FG001|Overall Study|Does not meet entrance criteria|10|||
48696106|NCT00346216|156735858|FG002|Overall Study|Does not meet entrance criteria|8|||
48696107|NCT00346216|156735856|FG000|Overall Study|Death|189|||
48696108|NCT00346216|156735857|FG001|Overall Study|Death|192|||
48696109|NCT00346216|156735858|FG002|Overall Study|Death|228|||
48696110|NCT00346216|156735856|FG000|Overall Study|Study terminated by sponsor|11|||
48696111|NCT00346216|156735857|FG001|Overall Study|Study terminated by sponsor|4|||
48696112|NCT00346216|156735858|FG002|Overall Study|Study terminated by sponsor|8|||
48696113|NCT00346216|156735856|FG000|Overall Study|Missing Subject Summary Status|62|||
48696114|NCT00346216|156735857|FG001|Overall Study|Missing Subject Summary Status|61|||
48696115|NCT00346216|156735858|FG002|Overall Study|Missing Subject Summary Status|62|||
48696116|NCT03284710|156735859|FG000|Overall Study|Withdrawal by Subject|1|||
48909302|NCT02616614|157504357|FG002|Overall Study|More than 3 applications missed|1|||
48696117|NCT03284710|156735860|FG001|Overall Study|Withdrawal by Subject|0|||
48696118|NCT03284710|156735861|FG002|Overall Study|Withdrawal by Subject|1|||
48696119|NCT03284710|156735862|FG003|Overall Study|Withdrawal by Subject|6|||
48696120|NCT03284710|156735859|FG000|Overall Study|Lost to Follow-up|3|||
48696121|NCT03284710|156735860|FG001|Overall Study|Lost to Follow-up|3|||
48696122|NCT03284710|156735861|FG002|Overall Study|Lost to Follow-up|1|||
48696123|NCT03284710|156735862|FG003|Overall Study|Lost to Follow-up|0|||
48696124|NCT03284710|156735859|FG000|Overall Study|Physician Decision|1|||
48696125|NCT03284710|156735860|FG001|Overall Study|Physician Decision|0|||
48696126|NCT03284710|156735861|FG002|Overall Study|Physician Decision|0|||
48696127|NCT03284710|156735862|FG003|Overall Study|Physician Decision|0|||
48696128|NCT03284710|156735859|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
48696129|NCT03284710|156735860|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
48696130|NCT03284710|156735861|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
48696131|NCT03284710|156735862|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
48696132|NCT03284710|156735859|FG000|Overall Study|HIV Infection|0|||
48696133|NCT03284710|156735860|FG001|Overall Study|HIV Infection|2|||
48696134|NCT03284710|156735861|FG002|Overall Study|HIV Infection|2|||
48696135|NCT03284710|156735862|FG003|Overall Study|HIV Infection|1|||
48696136|NCT00141453|156735865|FG000|Overall Study|Protocol Violation|6|||
48696137|NCT00141453|156735866|FG001|Overall Study|Protocol Violation|5|||
48696138|NCT02656017|156735868|FG000|Overall Study|Study burden|3|||
48696139|NCT02656017|156735869|FG001|Overall Study|Study burden|3|||
48696140|NCT02656017|156735868|FG000|Overall Study|Adverse Event|2|||
48696141|NCT02656017|156735869|FG001|Overall Study|Adverse Event|1|||
48696142|NCT02656017|156735868|FG000|Overall Study|Unable/unwilling to take study medication|2|||
48696143|NCT02656017|156735869|FG001|Overall Study|Unable/unwilling to take study medication|1|||
48696144|NCT02656017|156735868|FG000|Overall Study|Began Tolvaptan|1|||
48696145|NCT02656017|156735869|FG001|Overall Study|Began Tolvaptan|1|||
48696146|NCT02656017|156735868|FG000|Overall Study|Withdrawal by Subject|1|||
48696147|NCT02656017|156735869|FG001|Overall Study|Withdrawal by Subject|0|||
48696148|NCT04245111|156735873|FG000|Overall Study|Lost to Follow-up|5|||
48696149|NCT04245111|156735874|FG001|Overall Study|Lost to Follow-up|1|||
48696150|NCT04245111|156735875|FG002|Overall Study|Lost to Follow-up|1|||
48696151|NCT03661723|156735876|FG000|Overall Study|Disease Progression|4|||
48696152|NCT03661723|156735877|FG001|Overall Study|Disease Progression|24|||
48696153|NCT03661723|156735878|FG002|Overall Study|Disease Progression|4|||
48696154|NCT03661723|156735879|FG003|Overall Study|Disease Progression|19|||
48696155|NCT03661723|156735876|FG000|Overall Study|Withdrawal by Subject|1|||
48696156|NCT03661723|156735877|FG001|Overall Study|Withdrawal by Subject|0|||
48696157|NCT03661723|156735878|FG002|Overall Study|Withdrawal by Subject|2|||
48696158|NCT03661723|156735879|FG003|Overall Study|Withdrawal by Subject|4|||
48696159|NCT03661723|156735876|FG000|Overall Study|Physician Decision|1|||
48696160|NCT03661723|156735877|FG001|Overall Study|Physician Decision|0|||
48696161|NCT03661723|156735878|FG002|Overall Study|Physician Decision|0|||
48696162|NCT03661723|156735879|FG003|Overall Study|Physician Decision|0|||
48696163|NCT03661723|156735876|FG000|Overall Study|Clinical Deterioration|0|||
48696164|NCT03661723|156735877|FG001|Overall Study|Clinical Deterioration|0|||
48696165|NCT03661723|156735878|FG002|Overall Study|Clinical Deterioration|0|||
48696166|NCT03661723|156735879|FG003|Overall Study|Clinical Deterioration|1|||
48696167|NCT03760029|156735880|FG000|Overall Study|Death|1|||
48696168|NCT03760029|156735881|FG001|Overall Study|Death|0|||
48696169|NCT03760029|156735882|FG002|Overall Study|Death|0|||
48696170|NCT03760029|156735880|FG000|Overall Study|Lost to Follow-up|0|||
48696171|NCT03760029|156735881|FG001|Overall Study|Lost to Follow-up|2|||
48696172|NCT03760029|156735882|FG002|Overall Study|Lost to Follow-up|1|||
48696173|NCT03760029|156735880|FG000|Overall Study|Withdrawal by Subject|1|||
48696174|NCT03760029|156735881|FG001|Overall Study|Withdrawal by Subject|4|||
48696175|NCT03760029|156735882|FG002|Overall Study|Withdrawal by Subject|1|||
48696176|NCT03760029|156735880|FG000|Overall Study|Withdrawal by parent/guardian|4|||
48696177|NCT03760029|156735881|FG001|Overall Study|Withdrawal by parent/guardian|4|||
48696178|NCT03760029|156735882|FG002|Overall Study|Withdrawal by parent/guardian|1|||
48696179|NCT03760029|156735880|FG000|Overall Study|Other|2|||
48696180|NCT03760029|156735881|FG001|Overall Study|Other|1|||
48696181|NCT03760029|156735882|FG002|Overall Study|Other|0|||
48696182|NCT05196828|156735885|FG000|Overall Study|Withdrawal by Subject|2|||
48696183|NCT05196828|156735886|FG001|Overall Study|Withdrawal by Subject|0|||
48696184|NCT05196828|156735885|FG000|Overall Study|Lost to Follow-up|0|||
48696185|NCT05196828|156735886|FG001|Overall Study|Lost to Follow-up|4|||
48696186|NCT05196828|156735885|FG000|Overall Study|Adverse Event|1|||
48696187|NCT05196828|156735886|FG001|Overall Study|Adverse Event|0|||
48696188|NCT00713609|156735887|FG000|Overall Study|Adverse Event|2|||
48696189|NCT00713609|156735888|FG001|Overall Study|Adverse Event|0|||
48696190|NCT00713609|156735889|FG002|Overall Study|Adverse Event|2|||
48696191|NCT00713609|156735890|FG003|Overall Study|Adverse Event|2|||
48696192|NCT00713609|156735891|FG004|Overall Study|Adverse Event|3|||
48696193|NCT00713609|156735892|FG005|Overall Study|Adverse Event|1|||
48696194|NCT00713609|156735887|FG000|Overall Study|Lost to Follow-up|5|||
48696195|NCT00713609|156735888|FG001|Overall Study|Lost to Follow-up|7|||
48696196|NCT00713609|156735889|FG002|Overall Study|Lost to Follow-up|5|||
48696197|NCT00713609|156735890|FG003|Overall Study|Lost to Follow-up|5|||
48696198|NCT00713609|156735891|FG004|Overall Study|Lost to Follow-up|7|||
48696199|NCT00713609|156735892|FG005|Overall Study|Lost to Follow-up|0|||
48696200|NCT00713609|156735887|FG000|Overall Study|Lack of Efficacy|1|||
48696201|NCT00713609|156735888|FG001|Overall Study|Lack of Efficacy|3|||
48696202|NCT00713609|156735889|FG002|Overall Study|Lack of Efficacy|0|||
48696203|NCT00713609|156735890|FG003|Overall Study|Lack of Efficacy|0|||
48696204|NCT00713609|156735891|FG004|Overall Study|Lack of Efficacy|1|||
48696205|NCT00713609|156735892|FG005|Overall Study|Lack of Efficacy|0|||
48696206|NCT00713609|156735887|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
48696207|NCT00713609|156735888|FG001|Overall Study|Non-Compliance with Study Treatment|1|||
48696208|NCT00713609|156735889|FG002|Overall Study|Non-Compliance with Study Treatment|2|||
48696209|NCT00713609|156735890|FG003|Overall Study|Non-Compliance with Study Treatment|0|||
48696210|NCT00713609|156735891|FG004|Overall Study|Non-Compliance with Study Treatment|1|||
48696211|NCT00713609|156735892|FG005|Overall Study|Non-Compliance with Study Treatment|0|||
48696212|NCT00713609|156735887|FG000|Overall Study|Withdrawal by Subject|6|||
48696213|NCT00713609|156735888|FG001|Overall Study|Withdrawal by Subject|1|||
48696214|NCT00713609|156735889|FG002|Overall Study|Withdrawal by Subject|5|||
48696215|NCT00713609|156735890|FG003|Overall Study|Withdrawal by Subject|1|||
48696216|NCT00713609|156735891|FG004|Overall Study|Withdrawal by Subject|5|||
48696217|NCT00713609|156735892|FG005|Overall Study|Withdrawal by Subject|7|||
48696218|NCT00713609|156735887|FG000|Overall Study|Protocol Violation|6|||
48696219|NCT00713609|156735888|FG001|Overall Study|Protocol Violation|3|||
48909303|NCT02616614|157504355|FG000|Overall Study|Lost to Follow-up|31|||
48909304|NCT02616614|157504356|FG001|Overall Study|Lost to Follow-up|28|||
48909305|NCT02616614|157504357|FG002|Overall Study|Lost to Follow-up|13|||
48909306|NCT02616614|157504355|FG000|Overall Study|Pregnancy|2|||
48909307|NCT02616614|157504356|FG001|Overall Study|Pregnancy|0|||
48909308|NCT02616614|157504357|FG002|Overall Study|Pregnancy|1|||
48909309|NCT02616614|157504355|FG000|Overall Study|Other|1|||
48909310|NCT02616614|157504356|FG001|Overall Study|Other|2|||
48909311|NCT02616614|157504357|FG002|Overall Study|Other|1|||
48909312|NCT01233869|157504359|FG000|Initial Treatment Period (24 Months)|Death|1|||
48909313|NCT01233869|157504360|FG001|Initial Treatment Period (24 Months)|Death|0|||
48909314|NCT01233869|157504361|FG002|Initial Treatment Period (24 Months)|Death|0|||
48909315|NCT01233869|157504362|FG003|Initial Treatment Period (24 Months)|Death|0|||
48909316|NCT01233869|157504359|FG000|Initial Treatment Period (24 Months)|Adverse Event|9|||
48909317|NCT01233869|157504360|FG001|Initial Treatment Period (24 Months)|Adverse Event|17|||
48909318|NCT01233869|157504361|FG002|Initial Treatment Period (24 Months)|Adverse Event|0|||
48909319|NCT01233869|157504362|FG003|Initial Treatment Period (24 Months)|Adverse Event|3|||
48909320|NCT01233869|157504359|FG000|Initial Treatment Period (24 Months)|Not Related to Study Drug|14|||
48909321|NCT01233869|157504360|FG001|Initial Treatment Period (24 Months)|Not Related to Study Drug|11|||
48909322|NCT01233869|157504361|FG002|Initial Treatment Period (24 Months)|Not Related to Study Drug|2|||
48909323|NCT01233869|157504362|FG003|Initial Treatment Period (24 Months)|Not Related to Study Drug|19|||
48909324|NCT01233869|157504359|FG000|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
48909325|NCT01233869|157504360|FG001|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
48909326|NCT01233869|157504361|FG002|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
48909327|NCT01233869|157504362|FG003|Extended Treatment Period (46 Months)|Lost to Follow-up|1|||
48909328|NCT01233869|157504359|FG000|Extended Treatment Period (46 Months)|Withdrawal by Subject|10|||
48909329|NCT01233869|157504360|FG001|Extended Treatment Period (46 Months)|Withdrawal by Subject|3|||
48909330|NCT01233869|157504361|FG002|Extended Treatment Period (46 Months)|Withdrawal by Subject|5|||
48909331|NCT01233869|157504362|FG003|Extended Treatment Period (46 Months)|Withdrawal by Subject|11|||
48696220|NCT00713609|156735889|FG002|Overall Study|Protocol Violation|1|||
48696221|NCT00713609|156735890|FG003|Overall Study|Protocol Violation|1|||
48696222|NCT00713609|156735891|FG004|Overall Study|Protocol Violation|2|||
48909332|NCT01233869|157504359|FG000|Extended Treatment Period (46 Months)|Other|3|||
48909333|NCT01233869|157504360|FG001|Extended Treatment Period (46 Months)|Other|0|||
48909334|NCT01233869|157504361|FG002|Extended Treatment Period (46 Months)|Other|0|||
48909335|NCT01233869|157504362|FG003|Extended Treatment Period (46 Months)|Other|3|||
48909336|NCT01233869|157504359|FG000|Extended Treatment Period (46 Months)|Adverse Event|1|||
48909337|NCT01233869|157504360|FG001|Extended Treatment Period (46 Months)|Adverse Event|0|||
48909338|NCT01233869|157504361|FG002|Extended Treatment Period (46 Months)|Adverse Event|0|||
48909339|NCT01233869|157504362|FG003|Extended Treatment Period (46 Months)|Adverse Event|1|||
48909340|NCT01610687|157504366|FG000|Overall Study|Lack of Efficacy|26|||
48909341|NCT01610687|157504366|FG000|Overall Study|Adverse Event|18|||
48909342|NCT01610687|157504366|FG000|Overall Study|Moved out of area|6|||
48909343|NCT01610687|157504366|FG000|Overall Study|Withdrawal by Subject|7|||
48909344|NCT01610687|157504366|FG000|Overall Study|Lost to Follow-up|4|||
48696223|NCT00713609|156735892|FG005|Overall Study|Protocol Violation|0|||
48696224|NCT00005906|156735893|FG000|Overall Study|Lack of Efficacy|3|||
48909345|NCT01610687|157504366|FG000|Overall Study|Symptom control without study medication|2|||
48909346|NCT01610687|157504366|FG000|Overall Study|Unable to make journey|1|||
48909347|NCT01610687|157504366|FG000|Overall Study|Death|1|||
48696225|NCT03267277|156735896|FG000|Overall Study|Withdrawal by Subject|1|||
48909348|NCT01610687|157504366|FG000|Overall Study|Cannabis affecting job|1|||
48909349|NCT01610687|157504366|FG000|Overall Study|Felt more alter without study medication|1|||
48909350|NCT03123250|157504367|FG000|60 Months Follow Up|Withdrawal by Subject|2|||
48909351|NCT00132496|157504368|FG000|Overall Study|Withdrawal by Subject|1|||
48909352|NCT00132496|157504369|FG001|Overall Study|Withdrawal by Subject|2|||
48909353|NCT00132496|157504368|FG000|Overall Study|Physician Decision|1|||
48909354|NCT00132496|157504369|FG001|Overall Study|Physician Decision|0|||
48909355|NCT03986866|157504375|FG000|Overall Study|Withdrawal by Subject|0|||
48909356|NCT03986866|157504376|FG001|Overall Study|Withdrawal by Subject|3|||
48909357|NCT03986866|157504375|FG000|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
48909358|NCT03986866|157504376|FG001|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
48909359|NCT00732251|157504377|FG000|Overall Study|Lost to Follow-up|3|||
48909360|NCT00732251|157504377|FG000|Overall Study|Withdrawal by Subject|3|||
48909361|NCT00732251|157504377|FG000|Overall Study|Early Term due to Site Closure|1|||
48909362|NCT00521053|157504378|FG000|Observation Phase|Disease Progression|55|||
48909363|NCT00521053|157504378|FG000|Observation Phase|Additional PV-10 via alternate protocol|8|||
48909364|NCT00521053|157504378|FG000|Observation Phase|Death|2|||
48909365|NCT00521053|157504378|FG000|Observation Phase|Adverse Event|1|||
48909366|NCT00521053|157504378|FG000|Observation Phase|Other non-study melanoma treatment|1|||
48909367|NCT00521053|157504378|FG000|Observation Phase|Physician Decision|1|||
48909368|NCT02546765|157504383|FG000|Overall Study|Withdrawal by Subject|0|||
48909369|NCT02546765|157504384|FG001|Overall Study|Withdrawal by Subject|1|||
48909370|NCT02546765|157504385|FG002|Overall Study|Withdrawal by Subject|0|||
48909371|NCT02546765|157504386|FG003|Overall Study|Withdrawal by Subject|0|||
48909372|NCT00475722|157504387|FG000|Overall Study|Withdrawal by Subject|12|||
48909373|NCT00475722|157504388|FG001|Overall Study|Withdrawal by Subject|12|||
48909374|NCT00475722|157504387|FG000|Overall Study|Protocol Violation|3|||
48696226|NCT04038359|156735897|FG000|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|1|||
48696227|NCT04038359|156735898|FG001|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|0|||
48696228|NCT04038359|156735897|FG000|Overall Study|Death|8|||
48696229|NCT04038359|156735898|FG001|Overall Study|Death|7|||
48696230|NCT04038359|156735897|FG000|Overall Study|Lost to Follow-up|3|||
48696231|NCT04038359|156735898|FG001|Overall Study|Lost to Follow-up|0|||
48696232|NCT04038359|156735897|FG000|Overall Study|Participant Moved|1|||
48696233|NCT04038359|156735898|FG001|Overall Study|Participant Moved|0|||
48696234|NCT04038359|156735897|FG000|Overall Study|Withdrawal by Subject|4|||
48696235|NCT04038359|156735898|FG001|Overall Study|Withdrawal by Subject|3|||
48696236|NCT04038359|156735897|FG000|Overall Study|Physician Decision|3|||
48696237|NCT04038359|156735898|FG001|Overall Study|Physician Decision|2|||
48696238|NCT04038359|156735897|FG000|Overall Study|Adverse Event|0|||
48696239|NCT04038359|156735898|FG001|Overall Study|Adverse Event|2|||
48696240|NCT04038359|156735897|FG000|Overall Study|Progressive Disease|0|||
48696241|NCT04038359|156735898|FG001|Overall Study|Progressive Disease|1|||
48696242|NCT03768414|156735899|FG000|Overall Study|Adverse Event or side effects|72|||
48696243|NCT03768414|156735900|FG001|Overall Study|Adverse Event or side effects|28|||
48696244|NCT03768414|156735899|FG000|Overall Study|Refusal unrelated to adverse event|33|||
48696245|NCT03768414|156735900|FG001|Overall Study|Refusal unrelated to adverse event|33|||
48696246|NCT03768414|156735899|FG000|Overall Study|Progression/relapse|132|||
48696247|NCT03768414|156735900|FG001|Overall Study|Progression/relapse|60|||
48696248|NCT03768414|156735899|FG000|Overall Study|Death|9|||
48696249|NCT03768414|156735900|FG001|Overall Study|Death|6|||
48696250|NCT03768414|156735899|FG000|Overall Study|Other - not protocol specified|45|||
48696251|NCT03768414|156735900|FG001|Overall Study|Other - not protocol specified|18|||
48696252|NCT03768414|156735899|FG000|Overall Study|Reason under review|3|||
48696253|NCT03768414|156735900|FG001|Overall Study|Reason under review|2|||
48696254|NCT05121766|156735901|FG000|Overall Study|Covid reinfection|3|||
48696255|NCT05121766|156735902|FG001|Overall Study|Covid reinfection|0|||
48696256|NCT05121766|156735901|FG000|Overall Study|Withdrawal by Subject|3|||
48696257|NCT05121766|156735902|FG001|Overall Study|Withdrawal by Subject|1|||
48696258|NCT05121766|156735901|FG000|Overall Study|Adverse Event|2|||
48696259|NCT05121766|156735902|FG001|Overall Study|Adverse Event|4|||
48696260|NCT05121766|156735901|FG000|Overall Study|Lost to Follow-up|0|||
48696261|NCT05121766|156735902|FG001|Overall Study|Lost to Follow-up|1|||
48696262|NCT03259230|156735903|FG000|Overall Study|Excluded from the Malignancy Analysis Set|1|||
48696263|NCT03259230|156735904|FG001|Overall Study|Excluded from the Malignancy Analysis Set|0|||
48909375|NCT00475722|157504388|FG001|Overall Study|Protocol Violation|0|||
48909376|NCT02568475|157504389|FG000|Overall Study|Lost to Follow-up|40|||
48909377|NCT02568475|157504390|FG001|Overall Study|Lost to Follow-up|39|||
48696264|NCT01033240|156735905|FG000|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10|||
48696265|NCT01033240|156735906|FG001|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8|||
48696266|NCT01033240|156735907|FG002|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6|||
48696267|NCT01033240|156735905|FG000|Overall Study|Death|2|||
48696268|NCT01033240|156735906|FG001|Overall Study|Death|0|||
48696269|NCT01033240|156735907|FG002|Overall Study|Death|0|||
48696270|NCT01033240|156735905|FG000|Overall Study|Withdrew Consent|2|||
48696271|NCT01033240|156735906|FG001|Overall Study|Withdrew Consent|9|||
48696272|NCT01033240|156735907|FG002|Overall Study|Withdrew Consent|2|||
48696273|NCT01033240|156735905|FG000|Overall Study|Disease Progression|35|||
48696274|NCT01033240|156735906|FG001|Overall Study|Disease Progression|32|||
48696275|NCT01033240|156735907|FG002|Overall Study|Disease Progression|41|||
48696276|NCT01033240|156735905|FG000|Overall Study|Investigator Discretion|0|||
48696277|NCT01033240|156735906|FG001|Overall Study|Investigator Discretion|0|||
48696278|NCT01033240|156735907|FG002|Overall Study|Investigator Discretion|2|||
48696279|NCT01033240|156735905|FG000|Overall Study|Other|0|||
48696280|NCT01033240|156735906|FG001|Overall Study|Other|1|||
48696281|NCT01033240|156735907|FG002|Overall Study|Other|2|||
48696282|NCT03935126|156735908|FG000|Overall Study|Study termination by sponsor|3|||
48696283|NCT00113841|156735909|FG000|Overall Study|Disease progression|0|||
48696284|NCT00113841|156735910|FG001|Overall Study|Disease progression|2|||
48696285|NCT00113841|156735909|FG000|Overall Study|Non-compliant|1|||
48696286|NCT00113841|156735910|FG001|Overall Study|Non-compliant|0|||
48696287|NCT02520726|156735911|FG000|Overall Study|Lost to Follow-up|3|||
48696288|NCT02520726|156735912|FG001|Overall Study|Lost to Follow-up|2|||
48696289|NCT00918385|156735913|FG000|Monotherapy|Adverse Event|1|||
48696290|NCT00918385|156735914|FG001|Monotherapy|Adverse Event|6|||
48696291|NCT00918385|156735913|FG000|Monotherapy|Complicating illness|1|||
48696292|NCT00918385|156735914|FG001|Monotherapy|Complicating illness|0|||
48696293|NCT00918385|156735913|FG000|Combination Nilutamide and Dasatinib|Adverse Event|1|||
48696294|NCT00918385|156735914|FG001|Combination Nilutamide and Dasatinib|Adverse Event|1|||
48696295|NCT00918385|156735913|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
48696296|NCT00918385|156735914|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0|||
48696297|NCT00918385|156735913|FG000|Combination Nilutamide and Dasatinib|Complicating illness|1|||
48696298|NCT00918385|156735914|FG001|Combination Nilutamide and Dasatinib|Complicating illness|0|||
48696299|NCT00918385|156735913|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
48696300|NCT00918385|156735914|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7|||
48696301|NCT00377520|156735915|FG000|Overall Study|Ineligible (Prior radiation)|1|||
48696302|NCT00322881|156735917|FG000|Overall Study|Death|2|||
48696303|NCT00322881|156735917|FG000|Overall Study|Adverse Event|1|||
48696304|NCT00322881|156735917|FG000|Overall Study|Disease Progression|2|||
48696305|NCT03740048|156735918|FG000|Overall Study|Withdrawal by Subject|1|||
48696306|NCT03740048|156735919|FG001|Overall Study|Withdrawal by Subject|1|||
48696307|NCT03740048|156735918|FG000|Overall Study|Death|1|||
48696308|NCT03740048|156735919|FG001|Overall Study|Death|6|||
48696309|NCT03740048|156735918|FG000|Overall Study|Switched to thrice-weekly HD|2|||
48696310|NCT03740048|156735919|FG001|Overall Study|Switched to thrice-weekly HD|0|||
48696311|NCT03740048|156735918|FG000|Overall Study|Switched to Peritoneal Dialysis|2|||
48696312|NCT03740048|156735919|FG001|Overall Study|Switched to Peritoneal Dialysis|0|||
48696313|NCT03740048|156735918|FG000|Overall Study|Lost to Follow-up|0|||
48696314|NCT03740048|156735919|FG001|Overall Study|Lost to Follow-up|1|||
48696315|NCT03740048|156735918|FG000|Overall Study|Non-compliance with HD|0|||
48696316|NCT03740048|156735919|FG001|Overall Study|Non-compliance with HD|1|||
48696317|NCT00561652|156735921|FG000|Overall Study|Withdrawal by Subject|0|||
48696318|NCT00561652|156735922|FG001|Overall Study|Withdrawal by Subject|1|||
48696319|NCT00083889|156735923|FG000|Overall Study|Adverse Event|76|||
48696320|NCT00083889|156735924|FG001|Overall Study|Adverse Event|86|||
48696321|NCT00083889|156735923|FG000|Overall Study|Protocol Violation|2|||
48696322|NCT00083889|156735924|FG001|Overall Study|Protocol Violation|2|||
48696323|NCT00083889|156735923|FG000|Overall Study|Withdrawal by Subject|22|||
48696324|NCT00083889|156735924|FG001|Overall Study|Withdrawal by Subject|24|||
48696325|NCT00083889|156735923|FG000|Overall Study|Lack of Efficacy|240|||
48696326|NCT00083889|156735924|FG001|Overall Study|Lack of Efficacy|219|||
48696327|NCT00083889|156735923|FG000|Overall Study|Decision of sponsor|32|||
48696328|NCT00083889|156735924|FG001|Overall Study|Decision of sponsor|4|||
48696329|NCT00083889|156735923|FG000|Overall Study|Randomized: did not take study drug|0|||
48696330|NCT00083889|156735924|FG001|Overall Study|Randomized: did not take study drug|15|||
48696331|NCT00083889|156735923|FG000|Overall Study|Completed on marketed sunitinub|3|||
48696332|NCT00083889|156735924|FG001|Overall Study|Completed on marketed sunitinub|0|||
48696333|NCT00083889|156735923|FG000|Overall Study|Crossover to SU011248|0|||
48696334|NCT00083889|156735924|FG001|Overall Study|Crossover to SU011248|25|||
48696335|NCT00005780|156735928|FG000|Vaccine Administration Following EPOCH-R|Participant progressed before receiving the last vaccine.|1|||
48696336|NCT03600909|156735929|FG000|Overall Study|Not treated|0|||
48696337|NCT03600909|156735930|FG001|Overall Study|Not treated|3|||
48696338|NCT03600909|156735931|FG002|Overall Study|Not treated|0|||
48696339|NCT03309020|156735932|FG000|Overall Study|Death|1|||
48696340|NCT03309020|156735933|FG001|Overall Study|Death|0|||
48696341|NCT03309020|156735932|FG000|Overall Study|Did not undergo surgery|2|||
48696342|NCT03309020|156735933|FG001|Overall Study|Did not undergo surgery|1|||
48696343|NCT00617734|156735934|FG000|Overall Study|Withdrew Consent|2|||
48696344|NCT00617734|156735935|FG001|Overall Study|Withdrew Consent|0|||
48696345|NCT00617734|156735934|FG000|Overall Study|Adverse Event|4|||
48696346|NCT00617734|156735935|FG001|Overall Study|Adverse Event|1|||
48696347|NCT00617734|156735934|FG000|Overall Study|Protocol Violation|1|||
48696348|NCT00617734|156735935|FG001|Overall Study|Protocol Violation|0|||
48696349|NCT00617734|156735934|FG000|Overall Study|Found Ineligible After Randomization|1|||
48696350|NCT00617734|156735935|FG001|Overall Study|Found Ineligible After Randomization|4|||
48696351|NCT00617734|156735934|FG000|Overall Study|Lost to Follow-up|0|||
48696352|NCT00617734|156735935|FG001|Overall Study|Lost to Follow-up|1|||
48696353|NCT04366349|156735938|FG000|Overall Study|Withdrawal by Subject|1|||
48696354|NCT04366349|156735939|FG001|Overall Study|Withdrawal by Subject|0|||
48696355|NCT04366349|156735940|FG002|Overall Study|Withdrawal by Subject|0|||
48696356|NCT04366349|156735941|FG003|Overall Study|Withdrawal by Subject|0|||
48696357|NCT04366349|156735942|FG004|Overall Study|Withdrawal by Subject|0|||
48696358|NCT04366349|156735943|FG005|Overall Study|Withdrawal by Subject|0|||
48696359|NCT03919773|156735946|FG000|First Intervention- (12 Weeks)|Adverse Event|1|||
48696360|NCT03919773|156735947|FG001|First Intervention- (12 Weeks)|Adverse Event|1|||
48696361|NCT03919773|156735946|FG000|First Intervention- (12 Weeks)|Protocol Violation|0|||
48696362|NCT03919773|156735947|FG001|First Intervention- (12 Weeks)|Protocol Violation|1|||
48696363|NCT01352117|156737336|FG000|Overall Study|Death|15|||
48696364|NCT01352117|156737337|FG001|Overall Study|Death|16|||
48696365|NCT01352117|156737336|FG000|Overall Study|Withdrawal by Subject|1|||
48696366|NCT01352117|156737337|FG001|Overall Study|Withdrawal by Subject|0|||
48696367|NCT01352117|156737336|FG000|Overall Study|Lost to Follow-up|2|||
48696368|NCT01352117|156737337|FG001|Overall Study|Lost to Follow-up|7|||
48696369|NCT01352117|156737336|FG000|Overall Study|Non-adherent to study requirements|1|||
48696370|NCT01352117|156737337|FG001|Overall Study|Non-adherent to study requirements|1|||
48696371|NCT01352117|156737336|FG000|Overall Study|Did not initiate study treatment|1|||
48696372|NCT01352117|156737337|FG001|Overall Study|Did not initiate study treatment|0|||
48696373|NCT01352117|156737336|FG000|Overall Study|Ineligible (no KS diagnosis)|1|||
48696374|NCT01352117|156737337|FG001|Overall Study|Ineligible (no KS diagnosis)|0|||
48696375|NCT03737123|156737338|FG000|Study Treatment|Adverse Event|2|||
48696376|NCT03737123|156737339|FG001|Study Treatment|Adverse Event|0|||
48696377|NCT03737123|156737338|FG000|Study Treatment|Disease Progression|2|||
48696378|NCT03737123|156737339|FG001|Study Treatment|Disease Progression|0|||
48696379|NCT03737123|156737338|FG000|Study Treatment|Withdrawal by Subject|2|||
48696380|NCT03737123|156737339|FG001|Study Treatment|Withdrawal by Subject|0|||
48696381|NCT03737123|156737338|FG000|Follow up|Death|1|||
48696382|NCT03737123|156737339|FG001|Follow up|Death|0|||
48696383|NCT03737123|156737338|FG000|Follow up|Withdrawal by Subject|1|||
48696384|NCT03737123|156737339|FG001|Follow up|Withdrawal by Subject|0|||
48696385|NCT03737123|156737338|FG000|Follow up|Termination of study|4|||
48696386|NCT03737123|156737339|FG001|Follow up|Termination of study|0|||
48696387|NCT04233801|156737340|FG000|Overall Study|Other than listed|0|||
48696388|NCT04233801|156737341|FG001|Overall Study|Other than listed|0|||
48696389|NCT04233801|156737342|FG002|Overall Study|Other than listed|1|||
48696390|NCT04233801|156737340|FG000|Overall Study|Withdrawal by Subject|0|||
48696391|NCT04233801|156737341|FG001|Overall Study|Withdrawal by Subject|2|||
48696392|NCT04233801|156737342|FG002|Overall Study|Withdrawal by Subject|3|||
48696393|NCT00387881|156737343|FG000|Overall Study|Lost to Follow-up|23|||
48696394|NCT00387881|156737344|FG001|Overall Study|Lost to Follow-up|23|||
48696395|NCT00387881|156737343|FG000|Overall Study|Protocol Violation|2|||
48696396|NCT00387881|156737344|FG001|Overall Study|Protocol Violation|12|||
48909378|NCT02568475|157504389|FG000|Overall Study|Withdrawal by Subject|2|||
48909379|NCT02568475|157504390|FG001|Overall Study|Withdrawal by Subject|0|||
48909380|NCT02568475|157504389|FG000|Overall Study|Discharged home|4|||
48909381|NCT02568475|157504390|FG001|Overall Study|Discharged home|4|||
48909382|NCT02568475|157504389|FG000|Overall Study|Short-term: Discharge location unknown|4|||
48909383|NCT02568475|157504390|FG001|Overall Study|Short-term: Discharge location unknown|0|||
48909384|NCT02568475|157504389|FG000|Overall Study|Transferred to another facility|1|||
48909385|NCT02568475|157504390|FG001|Overall Study|Transferred to another facility|0|||
48909386|NCT00493220|157504391|FG000|Third Intervention|Withdrawal by Subject|1|||
48909387|NCT00493220|157504392|FG001|Third Intervention|Withdrawal by Subject|0|||
48909388|NCT00493220|157504393|FG002|Third Intervention|Withdrawal by Subject|0|||
48909389|NCT00493220|157504394|FG003|Third Intervention|Withdrawal by Subject|0|||
48909390|NCT00493220|157504395|FG004|Third Intervention|Withdrawal by Subject|0|||
48909391|NCT00493220|157504396|FG005|Third Intervention|Withdrawal by Subject|0|||
48909392|NCT02064920|157504397|FG000|Overall Study|Adverse Event|0|||
48696397|NCT00387881|156737343|FG000|Overall Study|Withdrawal by Subject|15|||
48696398|NCT00387881|156737344|FG001|Overall Study|Withdrawal by Subject|18|||
48696399|NCT00387881|156737343|FG000|Overall Study|Sponsor terminated Study|0|||
48696400|NCT00387881|156737344|FG001|Overall Study|Sponsor terminated Study|1|||
48696401|NCT00387881|156737343|FG000|Overall Study|Not eligible|6|||
48696402|NCT00387881|156737344|FG001|Overall Study|Not eligible|7|||
48696403|NCT00387881|156737343|FG000|Overall Study|No opportunity to treat headache|32|||
48696404|NCT00387881|156737344|FG001|Overall Study|No opportunity to treat headache|34|||
48696405|NCT00387881|156737343|FG000|Overall Study|Not otherwise specified|11|||
48696406|NCT00387881|156737344|FG001|Overall Study|Not otherwise specified|7|||
48696407|NCT03291067|156737345|FG000|Overall Study|Adverse Event|0|||
48909393|NCT02064920|157504398|FG001|Overall Study|Adverse Event|4|||
48909394|NCT02064920|157504397|FG000|Overall Study|Physician Decision|0|||
48909395|NCT02064920|157504398|FG001|Overall Study|Physician Decision|1|||
48909396|NCT02064920|157504397|FG000|Overall Study|Technical Problems|0|||
48909397|NCT02064920|157504398|FG001|Overall Study|Technical Problems|1|||
48909398|NCT02064920|157504397|FG000|Overall Study|Withdrawal by Subject|1|||
48696408|NCT03291067|156737346|FG001|Overall Study|Adverse Event|2|||
48696409|NCT03291067|156737347|FG002|Overall Study|Adverse Event|17|||
48696410|NCT03291067|156737348|FG003|Overall Study|Adverse Event|3|||
48696411|NCT03291067|156737345|FG000|Overall Study|Lost to Follow-up|2|||
48909399|NCT02064920|157504398|FG001|Overall Study|Withdrawal by Subject|3|||
48909400|NCT01130051|157504399|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
48909401|NCT01130051|157504400|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
48909402|NCT01130051|157504399|FG000|Washout Period of 14 Days|Protocol Violation|1|||
48909403|NCT01130051|157504400|FG001|Washout Period of 14 Days|Protocol Violation|1|||
48909404|NCT02383589|157504404|FG000|Treatment Period|Adverse Event|1|||
48909405|NCT02383589|157504405|FG001|Treatment Period|Adverse Event|3|||
48909406|NCT02383589|157504404|FG000|Treatment Period|Lost to Follow-up|0|||
48909407|NCT02383589|157504405|FG001|Treatment Period|Lost to Follow-up|1|||
48909408|NCT02383589|157504404|FG000|Treatment Period|Withdrawal by Subject|0|||
48909409|NCT02383589|157504405|FG001|Treatment Period|Withdrawal by Subject|5|||
48909410|NCT02383589|157504404|FG000|Treatment Period|Non-compliance with study drug|0|||
48909411|NCT02383589|157504405|FG001|Treatment Period|Non-compliance with study drug|1|||
48909412|NCT02383589|157504404|FG000|Safety Follow-up (SFU)|Lost to Follow-up|2|||
48909413|NCT02383589|157504405|FG001|Safety Follow-up (SFU)|Lost to Follow-up|4|||
48909414|NCT02383589|157504404|FG000|Safety Follow-up (SFU)|Withdrawal by Subject|5|||
48909415|NCT02383589|157504405|FG001|Safety Follow-up (SFU)|Withdrawal by Subject|0|||
48909416|NCT02383589|157504404|FG000|Safety Follow-up (SFU)|Treated by not accepted treatment|0|||
48696412|NCT03291067|156737346|FG001|Overall Study|Lost to Follow-up|1|||
48696413|NCT03291067|156737347|FG002|Overall Study|Lost to Follow-up|0|||
48909417|NCT02383589|157504405|FG001|Safety Follow-up (SFU)|Treated by not accepted treatment|1|||
48909418|NCT02906787|157504411|FG000|Overall Study|Withdrawal by Subject|12|||
48909419|NCT02906787|157504412|FG001|Overall Study|Withdrawal by Subject|10|||
48909420|NCT02906787|157504411|FG000|Overall Study|Missed|24|||
48696414|NCT03291067|156737348|FG003|Overall Study|Lost to Follow-up|1|||
48696415|NCT03291067|156737345|FG000|Overall Study|Physician Decision|0|||
48696416|NCT03291067|156737346|FG001|Overall Study|Physician Decision|0|||
48696417|NCT03291067|156737347|FG002|Overall Study|Physician Decision|1|||
48696418|NCT03291067|156737348|FG003|Overall Study|Physician Decision|0|||
48696419|NCT03291067|156737345|FG000|Overall Study|Protocol Violation|5|||
48696420|NCT03291067|156737346|FG001|Overall Study|Protocol Violation|3|||
48696421|NCT03291067|156737347|FG002|Overall Study|Protocol Violation|4|||
48696422|NCT03291067|156737348|FG003|Overall Study|Protocol Violation|2|||
48696423|NCT03291067|156737345|FG000|Overall Study|Withdrawal by Subject|3|||
48696424|NCT03291067|156737346|FG001|Overall Study|Withdrawal by Subject|4|||
48696425|NCT03291067|156737347|FG002|Overall Study|Withdrawal by Subject|7|||
48696426|NCT03291067|156737348|FG003|Overall Study|Withdrawal by Subject|5|||
48696427|NCT03291067|156737345|FG000|Overall Study|Other|0|||
48696428|NCT03291067|156737346|FG001|Overall Study|Other|4|||
48696429|NCT03291067|156737347|FG002|Overall Study|Other|4|||
48696430|NCT03291067|156737348|FG003|Overall Study|Other|6|||
48696431|NCT05473026|156737352|FG000|Overall Study|Lost to Follow-up|5|||
48696432|NCT05473026|156737353|FG001|Overall Study|Lost to Follow-up|2|||
48696433|NCT01285401|156737356|FG000|Overall Study|Prematurely withdrawn from the study|17|||
48696434|NCT01285401|156737357|FG001|Overall Study|Prematurely withdrawn from the study|29|||
48696435|NCT00524485|156737364|FG000|Overall Study|Withdrawal by Subject|5|||
48696436|NCT01089504|156737365|FG000|Overall Study|Lost to Follow-up|1|||
48696437|NCT01089504|156737366|FG001|Overall Study|Lost to Follow-up|1|||
48696438|NCT01089504|156737365|FG000|Overall Study|Withdrawal by Subject|2|||
48696439|NCT01089504|156737366|FG001|Overall Study|Withdrawal by Subject|0|||
48696440|NCT01924845|156737367|FG000|Overall Study|Adverse Event|3|||
48696441|NCT01924845|156737367|FG000|Overall Study|Withdrawal by Subject|2|||
48909421|NCT02906787|157504412|FG001|Overall Study|Missed|22|||
48909422|NCT02592018|157504413|FG000|Overall Study|Adverse Event|1|||
48909423|NCT02592018|157504413|FG000|Overall Study|Lost to Follow-up|1|||
48696442|NCT01924845|156737367|FG000|Overall Study|Protocol Violation|1|||
48696443|NCT01009060|156737368|FG000|Overall Study|Adverse Event|1|||
48696444|NCT01009060|156737369|FG001|Overall Study|Adverse Event|2|||
48696445|NCT01009060|156737368|FG000|Overall Study|Protocol Violation|0|||
48696446|NCT01009060|156737369|FG001|Overall Study|Protocol Violation|1|||
48696447|NCT01009060|156737368|FG000|Overall Study|Lost to Follow-up|1|||
48696448|NCT01009060|156737369|FG001|Overall Study|Lost to Follow-up|0|||
48909424|NCT01357577|157504417|FG000|Overall Study|Lost to Follow-up|20|||
48909425|NCT01357577|157504418|FG001|Overall Study|Lost to Follow-up|16|||
48696449|NCT01009060|156737368|FG000|Overall Study|Physician Decision|1|||
48696450|NCT01009060|156737369|FG001|Overall Study|Physician Decision|1|||
48696451|NCT01009060|156737368|FG000|Overall Study|Withdrawal by Subject|1|||
48909426|NCT01357577|157504417|FG000|Overall Study|Withdrawal by Subject|16|||
48696452|NCT01009060|156737369|FG001|Overall Study|Withdrawal by Subject|1|||
48696453|NCT02587221|156737370|FG000|Overall Study|Adverse Event|3|||
48696454|NCT02587221|156737371|FG001|Overall Study|Adverse Event|3|||
48696455|NCT02587221|156737370|FG000|Overall Study|Death|33|||
48696456|NCT02587221|156737371|FG001|Overall Study|Death|34|||
48696457|NCT02587221|156737370|FG000|Overall Study|Withdrawal by Subject|66|||
48696458|NCT02587221|156737371|FG001|Overall Study|Withdrawal by Subject|61|||
48696459|NCT02587221|156737370|FG000|Overall Study|Lost to Follow-up|21|||
48696460|NCT02587221|156737371|FG001|Overall Study|Lost to Follow-up|19|||
48696461|NCT02587221|156737370|FG000|Overall Study|Protocol Violation|6|||
48696462|NCT02587221|156737371|FG001|Overall Study|Protocol Violation|5|||
48696463|NCT02587221|156737370|FG000|Overall Study|Other Reason or Unspecified|2|||
48696464|NCT02587221|156737371|FG001|Overall Study|Other Reason or Unspecified|1|||
48696465|NCT00499486|156737372|FG000|Overall Study|Withdrawal by Subject|16|||
48696466|NCT02546609|156737373|FG000|Overall Study|Withdrawal by Subject|0|||
48696467|NCT02546609|156737374|FG001|Overall Study|Withdrawal by Subject|1|||
48696468|NCT02546609|156737375|FG002|Overall Study|Withdrawal by Subject|2|||
48696469|NCT02546609|156737373|FG000|Overall Study|Adverse Event|0|||
48696470|NCT02546609|156737374|FG001|Overall Study|Adverse Event|6|||
48696471|NCT02546609|156737375|FG002|Overall Study|Adverse Event|1|||
48696472|NCT02546609|156737373|FG000|Overall Study|Protocol Violation|0|||
48696473|NCT02546609|156737374|FG001|Overall Study|Protocol Violation|1|||
48696474|NCT02546609|156737375|FG002|Overall Study|Protocol Violation|1|||
48696475|NCT02546609|156737373|FG000|Overall Study|Lost to Follow-up|2|||
48696476|NCT02546609|156737374|FG001|Overall Study|Lost to Follow-up|3|||
48696477|NCT02546609|156737375|FG002|Overall Study|Lost to Follow-up|1|||
48696478|NCT02546609|156737373|FG000|Overall Study|travel or work schedule restriction|0|||
48696479|NCT02546609|156737374|FG001|Overall Study|travel or work schedule restriction|0|||
48696480|NCT02546609|156737375|FG002|Overall Study|travel or work schedule restriction|2|||
48696481|NCT04201431|156737378|FG000|Vaccinations and Primary CHMI|Withdrawal by Subject|6|||
48696482|NCT04201431|156737379|FG001|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
48696483|NCT04201431|156737380|FG002|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
48696484|NCT05236270|156737389|FG000|Overall Study|Lost to Follow-up|3|||
48696485|NCT05236270|156737390|FG001|Overall Study|Lost to Follow-up|2|||
48696486|NCT05236270|156737391|FG002|Overall Study|Lost to Follow-up|0|||
48696487|NCT05236270|156737392|FG003|Overall Study|Lost to Follow-up|0|||
48696488|NCT05236270|156737393|FG004|Overall Study|Lost to Follow-up|2|||
48696489|NCT05236270|156737394|FG005|Overall Study|Lost to Follow-up|0|||
48696490|NCT05236270|156737395|FG006|Overall Study|Lost to Follow-up|1|||
48696491|NCT05236270|156737396|FG007|Overall Study|Lost to Follow-up|3|||
48696492|NCT03915717|156737399|FG000|Overall Study|EchoMark Not Implanted|6|||
48696493|NCT02358473|156737400|FG000|Overall Study|Disease Progession|6|||
48696494|NCT02358473|156737400|FG000|Overall Study|Adverse Event|3|||
48696495|NCT02358473|156737400|FG000|Overall Study|Withdrawal by Subject|2|||
48696496|NCT02358473|156737400|FG000|Overall Study|Physician Decision|2|||
48696497|NCT04079296|156737401|FG000|Dose Escalation Phase (56 Days)|Progressive disease|1|||
48696498|NCT04079296|156737402|FG001|Dose Escalation Phase (56 Days)|Progressive disease|1|||
48696499|NCT04079296|156737403|FG002|Dose Escalation Phase (56 Days)|Progressive disease|1|||
48696500|NCT04079296|156737404|FG003|Dose Escalation Phase (56 Days)|Progressive disease|0|||
48696501|NCT04079296|156737405|FG004|Dose Escalation Phase (56 Days)|Progressive disease|0|||
48696502|NCT04079296|156737401|FG000|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
48696503|NCT04079296|156737402|FG001|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
48696504|NCT04079296|156737403|FG002|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
48696505|NCT04079296|156737404|FG003|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
48696506|NCT04079296|156737405|FG004|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
48909427|NCT01357577|157504418|FG001|Overall Study|Withdrawal by Subject|8|||
48909428|NCT01357577|157504417|FG000|Overall Study|look at data in database?|1|||
48909429|NCT01357577|157504418|FG001|Overall Study|look at data in database?|2|||
48909430|NCT00450216|157504420|FG000|Overall Study|Adverse Event|38|||
48909431|NCT00450216|157504421|FG001|Overall Study|Adverse Event|23|||
48909432|NCT00450216|157504420|FG000|Overall Study|Withdrawal by Subject|48|||
48909433|NCT00450216|157504421|FG001|Overall Study|Withdrawal by Subject|26|||
48909434|NCT00450216|157504420|FG000|Overall Study|Lost to Follow-up|16|||
48909435|NCT00450216|157504421|FG001|Overall Study|Lost to Follow-up|9|||
48909436|NCT00450216|157504420|FG000|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
48909437|NCT00450216|157504421|FG001|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
48909438|NCT00450216|157504420|FG000|Overall Study|misc|21|||
48696507|NCT04079296|156737401|FG000|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
48696508|NCT04079296|156737402|FG001|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
48696509|NCT04079296|156737403|FG002|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
48696510|NCT04079296|156737404|FG003|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
48696511|NCT04079296|156737405|FG004|Dose Expansion Phase (168 Days)|Miscellaneous|1|||
48696512|NCT04079296|156737401|FG000|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
48696513|NCT04079296|156737402|FG001|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
48696514|NCT04079296|156737403|FG002|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
48696515|NCT04079296|156737404|FG003|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
48696516|NCT04079296|156737405|FG004|Dose Expansion Phase (168 Days)|Withdrawal by Subject|1|||
48696517|NCT04079296|156737401|FG000|Dose Expansion Phase (168 Days)|Physician Decision|0|||
48696518|NCT04079296|156737402|FG001|Dose Expansion Phase (168 Days)|Physician Decision|0|||
48696519|NCT04079296|156737403|FG002|Dose Expansion Phase (168 Days)|Physician Decision|0|||
48696520|NCT04079296|156737404|FG003|Dose Expansion Phase (168 Days)|Physician Decision|1|||
48696521|NCT04079296|156737405|FG004|Dose Expansion Phase (168 Days)|Physician Decision|0|||
48696522|NCT04079296|156737401|FG000|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
48696523|NCT04079296|156737402|FG001|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
48696524|NCT04079296|156737403|FG002|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
48696525|NCT04079296|156737404|FG003|Dose Expansion Phase (168 Days)|Progressive Disease|6|||
48696526|NCT04079296|156737405|FG004|Dose Expansion Phase (168 Days)|Progressive Disease|5|||
48696527|NCT04079296|156737401|FG000|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
48696528|NCT04079296|156737402|FG001|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
48696529|NCT04079296|156737403|FG002|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
48696530|NCT04079296|156737404|FG003|Dose Expansion Phase (168 Days)|Lack of Efficacy|3|||
48696531|NCT04079296|156737405|FG004|Dose Expansion Phase (168 Days)|Lack of Efficacy|2|||
48696532|NCT04079296|156737401|FG000|Dose Expansion Phase (168 Days)|Death|0|||
48696533|NCT04079296|156737402|FG001|Dose Expansion Phase (168 Days)|Death|0|||
48696534|NCT04079296|156737403|FG002|Dose Expansion Phase (168 Days)|Death|0|||
48696535|NCT04079296|156737404|FG003|Dose Expansion Phase (168 Days)|Death|1|||
48696536|NCT04079296|156737405|FG004|Dose Expansion Phase (168 Days)|Death|0|||
48696537|NCT02004236|156737406|FG000|Overall Study|Lack of Efficacy|0|||
48696538|NCT02004236|156737407|FG001|Overall Study|Lack of Efficacy|0|||
48696539|NCT02004236|156737408|FG002|Overall Study|Lack of Efficacy|16|||
48696540|NCT02738801|156737410|FG000|Overall Study|Adverse Event|1|||
48696541|NCT02738801|156737411|FG001|Overall Study|Adverse Event|1|||
48696542|NCT02738801|156737410|FG000|Overall Study|Withdrawal by Subject|0|||
48696543|NCT02738801|156737411|FG001|Overall Study|Withdrawal by Subject|1|||
48696544|NCT00758771|156737415|FG000|Overall Study|Withdrawal by Subject|1|||
48696545|NCT00758771|156737416|FG001|Overall Study|Withdrawal by Subject|1|||
48696546|NCT00758771|156737415|FG000|Overall Study|Did not meet eligibility criteria|2|||
48909439|NCT00450216|157504421|FG001|Overall Study|misc|20|||
48909440|NCT01117454|157506034|FG000|Overall Study|Pregnancy|0|||
48909441|NCT01117454|157506035|FG001|Overall Study|Pregnancy|1|||
48909442|NCT01873417|157506036|FG000|Overall Study|Did Not Receive Any Study Drug|4|||
48909443|NCT01873417|157506036|FG000|Overall Study|Adverse Event|24|||
48909444|NCT01873417|157506036|FG000|Overall Study|Lost to Follow-up|2|||
48909445|NCT01873417|157506036|FG000|Overall Study|Withdrawal by Subject|2|||
48909446|NCT01873417|157506036|FG000|Overall Study|Physician Decision|3|||
48909447|NCT00419120|157506037|FG000|Long Term Follow up Period|study ongoing|10|||
48909448|NCT00388505|157506040|FG000|Overall Study|Adverse Event or Death|43|||
48696547|NCT00758771|156737416|FG001|Overall Study|Did not meet eligibility criteria|4|||
48696548|NCT03019406|156737417|FG000|ETP: Ongoing From Week 26|Ongoing|6|||
48696549|NCT03019406|156737418|FG001|ETP: Ongoing From Week 26|Ongoing|5|||
48696550|NCT03019406|156737419|FG002|ETP: Ongoing From Week 26|Ongoing|5|||
48696551|NCT03019406|156737420|FG003|ETP: Ongoing From Week 26|Ongoing|3|||
48696552|NCT02183675|156737421|FG000|Treatment Period 2 (10 Days)|Adverse Event|0|||
48909449|NCT00388505|157506041|FG001|Overall Study|Adverse Event or Death|17|||
48696553|NCT02183675|156737422|FG001|Treatment Period 2 (10 Days)|Adverse Event|0|||
48696554|NCT02183675|156737423|FG002|Treatment Period 2 (10 Days)|Adverse Event|0|||
48696555|NCT02183675|156737424|FG003|Treatment Period 2 (10 Days)|Adverse Event|0|||
48696556|NCT02183675|156737425|FG004|Treatment Period 2 (10 Days)|Adverse Event|0|||
48696557|NCT02183675|156737426|FG005|Treatment Period 2 (10 Days)|Adverse Event|2|||
48696558|NCT03337308|156737428|FG000|Overall Study|Adverse Event|2|||
48696559|NCT03337308|156737429|FG001|Overall Study|Adverse Event|3|||
48696560|NCT03337308|156737430|FG002|Overall Study|Adverse Event|3|||
48696561|NCT03337308|156737431|FG003|Overall Study|Adverse Event|1|||
48696562|NCT03337308|156737428|FG000|Overall Study|Lost to Follow-up|1|||
48696563|NCT03337308|156737429|FG001|Overall Study|Lost to Follow-up|2|||
48696564|NCT03337308|156737430|FG002|Overall Study|Lost to Follow-up|0|||
48696565|NCT03337308|156737431|FG003|Overall Study|Lost to Follow-up|0|||
48696566|NCT03337308|156737428|FG000|Overall Study|Withdrawal by Subject|2|||
48696567|NCT03337308|156737429|FG001|Overall Study|Withdrawal by Subject|1|||
48696568|NCT03337308|156737430|FG002|Overall Study|Withdrawal by Subject|2|||
48696569|NCT03337308|156737431|FG003|Overall Study|Withdrawal by Subject|1|||
48696570|NCT03337308|156737428|FG000|Overall Study|Protocol Violation|0|||
48696571|NCT03337308|156737429|FG001|Overall Study|Protocol Violation|1|||
48696572|NCT03337308|156737430|FG002|Overall Study|Protocol Violation|0|||
48696573|NCT03337308|156737431|FG003|Overall Study|Protocol Violation|0|||
48909450|NCT00388505|157506040|FG000|Overall Study|Withdrawal by Subject|24|||
48696574|NCT03043313|156737432|FG000|Overall Study|Withdrawal by Subject|5|||
48696575|NCT03043313|156737433|FG001|Overall Study|Withdrawal by Subject|1|||
48696576|NCT03043313|156737434|FG002|Overall Study|Withdrawal by Subject|1|||
48909451|NCT00388505|157506041|FG001|Overall Study|Withdrawal by Subject|9|||
48696577|NCT03043313|156737432|FG000|Overall Study|Lost to Follow-up|1|||
48696578|NCT03043313|156737433|FG001|Overall Study|Lost to Follow-up|1|||
48909452|NCT00388505|157506040|FG000|Overall Study|Lost to Follow-up|5|||
48696579|NCT03043313|156737434|FG002|Overall Study|Lost to Follow-up|0|||
48696580|NCT03043313|156737432|FG000|Overall Study|Death|28|||
48696581|NCT03043313|156737433|FG001|Overall Study|Death|26|||
48696582|NCT03043313|156737434|FG002|Overall Study|Death|17|||
48696583|NCT03043313|156737432|FG000|Overall Study|Participation terminated by sponsor|11|||
48696584|NCT03043313|156737433|FG001|Overall Study|Participation terminated by sponsor|13|||
48696585|NCT03043313|156737434|FG002|Overall Study|Participation terminated by sponsor|13|||
48696586|NCT05064735|156737438|FG000|Overall Study|Withdrawal by Subject|7|||
48696587|NCT05064735|156737439|FG001|Overall Study|Withdrawal by Subject|8|||
48696588|NCT05064735|156737438|FG000|Overall Study|Lost to Follow-up|7|||
48909453|NCT00388505|157506041|FG001|Overall Study|Lost to Follow-up|3|||
48909454|NCT00388505|157506040|FG000|Overall Study|Inappropriate Enrollment|0|||
48909455|NCT00388505|157506041|FG001|Overall Study|Inappropriate Enrollment|1|||
48909456|NCT00388505|157506040|FG000|Overall Study|Administrative Reason|1|||
48909457|NCT00388505|157506041|FG001|Overall Study|Administrative Reason|0|||
48909458|NCT00388505|157506040|FG000|Overall Study|Protocol Violation|6|||
48909459|NCT00388505|157506041|FG001|Overall Study|Protocol Violation|5|||
48909460|NCT00388505|157506040|FG000|Overall Study|Unable to classify|4|||
48909461|NCT00388505|157506041|FG001|Overall Study|Unable to classify|3|||
48909462|NCT02248259|157506044|FG000|Treatment Period 1|Adverse Event|0|||
48909463|NCT02248259|157506045|FG001|Treatment Period 1|Adverse Event|0|||
48909464|NCT02248259|157506046|FG002|Treatment Period 1|Adverse Event|1|||
48909465|NCT02248259|157506047|FG003|Treatment Period 1|Adverse Event|0|||
48909466|NCT01205438|157506048|FG000|Overall Study|Adverse Event|19|||
48909467|NCT01205438|157506049|FG001|Overall Study|Adverse Event|17|||
48909468|NCT01205438|157506050|FG002|Overall Study|Adverse Event|24|||
48909469|NCT01205438|157506048|FG000|Overall Study|Death|1|||
48909470|NCT01205438|157506049|FG001|Overall Study|Death|1|||
48909471|NCT01205438|157506050|FG002|Overall Study|Death|3|||
48909472|NCT01205438|157506048|FG000|Overall Study|Entry Criteria Not Met|16|||
48909473|NCT01205438|157506049|FG001|Overall Study|Entry Criteria Not Met|15|||
48909474|NCT01205438|157506050|FG002|Overall Study|Entry Criteria Not Met|13|||
48909475|NCT01205438|157506048|FG000|Overall Study|Lack of Efficacy|14|||
48909476|NCT01205438|157506049|FG001|Overall Study|Lack of Efficacy|11|||
48909477|NCT01205438|157506050|FG002|Overall Study|Lack of Efficacy|14|||
48909478|NCT01205438|157506048|FG000|Overall Study|Lost to Follow-up|6|||
48909479|NCT01205438|157506049|FG001|Overall Study|Lost to Follow-up|7|||
48909480|NCT01205438|157506050|FG002|Overall Study|Lost to Follow-up|8|||
48909481|NCT01205438|157506048|FG000|Overall Study|Withdrawal by Subject|19|||
48909482|NCT01205438|157506049|FG001|Overall Study|Withdrawal by Subject|25|||
48909483|NCT01205438|157506050|FG002|Overall Study|Withdrawal by Subject|19|||
48909484|NCT01205438|157506048|FG000|Overall Study|Physician Decision|0|||
48909485|NCT01205438|157506049|FG001|Overall Study|Physician Decision|3|||
48909486|NCT01205438|157506050|FG002|Overall Study|Physician Decision|2|||
48909487|NCT01205438|157506048|FG000|Overall Study|Protocol Violation|2|||
48909488|NCT01205438|157506049|FG001|Overall Study|Protocol Violation|7|||
48909489|NCT01205438|157506050|FG002|Overall Study|Protocol Violation|4|||
48909490|NCT01205438|157506048|FG000|Overall Study|Sponsor Decision|0|||
48909491|NCT01205438|157506049|FG001|Overall Study|Sponsor Decision|1|||
48909492|NCT01205438|157506050|FG002|Overall Study|Sponsor Decision|1|||
48909493|NCT01641237|157506051|FG000|Period II|Withdrawal by Subject|1|||
48909494|NCT01641237|157506052|FG001|Period II|Withdrawal by Subject|0|||
48909495|NCT01641237|157506053|FG002|Period II|Withdrawal by Subject|0|||
48909496|NCT01641237|157506054|FG003|Period II|Withdrawal by Subject|0|||
48909497|NCT01641237|157506051|FG000|Period III|Lost to Follow-up|1|||
48909498|NCT01641237|157506052|FG001|Period III|Lost to Follow-up|0|||
48909499|NCT01641237|157506053|FG002|Period III|Lost to Follow-up|0|||
48696589|NCT05064735|156737439|FG001|Overall Study|Lost to Follow-up|2|||
48696590|NCT05064735|156737438|FG000|Overall Study|Physician Decision|2|||
48696591|NCT05064735|156737439|FG001|Overall Study|Physician Decision|1|||
48909500|NCT01641237|157506054|FG003|Period III|Lost to Follow-up|0|||
48909501|NCT00915772|157506055|FG000|Overall Study|Adverse Event|12|||
48909502|NCT00915772|157506056|FG001|Overall Study|Adverse Event|13|||
48909503|NCT00915772|157506057|FG002|Overall Study|Adverse Event|11|||
48909504|NCT00915772|157506055|FG000|Overall Study|Protocol Violation|4|||
48909505|NCT00915772|157506056|FG001|Overall Study|Protocol Violation|1|||
48909506|NCT00915772|157506057|FG002|Overall Study|Protocol Violation|2|||
48909507|NCT00915772|157506055|FG000|Overall Study|Lost to Follow-up|1|||
48909508|NCT00915772|157506056|FG001|Overall Study|Lost to Follow-up|2|||
48696592|NCT05064735|156737438|FG000|Overall Study|Failing to Meet Randomization Requirements|2|||
48909509|NCT00915772|157506057|FG002|Overall Study|Lost to Follow-up|2|||
48909510|NCT00915772|157506055|FG000|Overall Study|Lack of Efficacy|9|||
48909511|NCT00915772|157506056|FG001|Overall Study|Lack of Efficacy|15|||
48909512|NCT00915772|157506057|FG002|Overall Study|Lack of Efficacy|3|||
48696593|NCT05064735|156737439|FG001|Overall Study|Failing to Meet Randomization Requirements|1|||
48909513|NCT00915772|157506055|FG000|Overall Study|Refused to continue trial medication|6|||
49010526|NCT00345683|157875642|FG001|Overall Study|Lost to Follow-up|7|||
48696594|NCT05064735|156737438|FG000|Overall Study|Site Closure|7|||
48696595|NCT05064735|156737439|FG001|Overall Study|Site Closure|2|||
48696596|NCT03804528|156737440|FG000|Overall Study|Time Commitment|18|||
48696597|NCT03804528|156737440|FG000|Overall Study|Health Reasons|5|||
48696598|NCT04050553|156737442|FG000|Period 1|Physician Decision|2|||
48696599|NCT04050553|156737443|FG001|Period 1|Physician Decision|2|||
48696600|NCT04050553|156737442|FG000|Period 1|Adverse Event|1|||
48696601|NCT04050553|156737443|FG001|Period 1|Adverse Event|1|||
48696602|NCT04050553|156737442|FG000|Period 1|Withdrawal by Subject|0|||
48696603|NCT04050553|156737443|FG001|Period 1|Withdrawal by Subject|1|||
48696604|NCT04050553|156737442|FG000|Wash-out|Adverse Event|0|||
48696605|NCT04050553|156737443|FG001|Wash-out|Adverse Event|1|||
48696606|NCT04050553|156737442|FG000|Wash-out|Withdrawal by Subject|0|||
48696607|NCT04050553|156737443|FG001|Wash-out|Withdrawal by Subject|1|||
48696608|NCT01535040|156737445|FG000|Overall Study|Physician Decision|0|||
48696609|NCT01535040|156737446|FG001|Overall Study|Physician Decision|1|||
48696610|NCT01535040|156737445|FG000|Overall Study|Withdrawal by Subject|13|||
48696611|NCT01535040|156737446|FG001|Overall Study|Withdrawal by Subject|10|||
48696612|NCT01535040|156737445|FG000|Overall Study|Never Started|9|||
48696613|NCT01535040|156737446|FG001|Overall Study|Never Started|4|||
48696614|NCT01535040|156737445|FG000|Overall Study|Toxicity|7|||
48696615|NCT01535040|156737446|FG001|Overall Study|Toxicity|5|||
48696616|NCT01535040|156737445|FG000|Overall Study|Multiple Reasons|1|||
48696617|NCT01535040|156737446|FG001|Overall Study|Multiple Reasons|1|||
48696618|NCT03724942|156737457|FG000|Overall Study|Adverse Event|20|||
48696619|NCT03724942|156737458|FG001|Overall Study|Adverse Event|14|||
48696620|NCT03724942|156737457|FG000|Overall Study|Lack of Efficacy|0|||
48696621|NCT03724942|156737458|FG001|Overall Study|Lack of Efficacy|1|||
48696622|NCT03724942|156737457|FG000|Overall Study|Physician Decision|5|||
48696623|NCT03724942|156737458|FG001|Overall Study|Physician Decision|2|||
48696624|NCT03724942|156737457|FG000|Overall Study|Protocol Violation|1|||
48696625|NCT03724942|156737458|FG001|Overall Study|Protocol Violation|0|||
48696626|NCT03724942|156737457|FG000|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|0|||
48696627|NCT03724942|156737458|FG001|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|1|||
48696628|NCT03724942|156737457|FG000|Overall Study|Withdrawal by Legal Representative|3|||
48696629|NCT03724942|156737458|FG001|Overall Study|Withdrawal by Legal Representative|0|||
48696630|NCT05472090|156737461|FG000|Overall Study|Adverse Event|2|||
48696631|NCT05472090|156737462|FG001|Overall Study|Adverse Event|3|||
48696632|NCT05472090|156737461|FG000|Overall Study|Lack of Efficacy|1|||
48696633|NCT05472090|156737462|FG001|Overall Study|Lack of Efficacy|0|||
48696634|NCT05472090|156737461|FG000|Overall Study|Physician Decision|1|||
48696635|NCT05472090|156737462|FG001|Overall Study|Physician Decision|0|||
48696636|NCT05472090|156737461|FG000|Overall Study|Withdrawal by Subject|2|||
48696637|NCT05472090|156737462|FG001|Overall Study|Withdrawal by Subject|0|||
48696638|NCT05472090|156737461|FG000|Overall Study|Lost to Follow-up|0|||
48696639|NCT05472090|156737462|FG001|Overall Study|Lost to Follow-up|3|||
48696640|NCT00948064|156739113|FG000|Phase I|No treatment received|1|||
48696641|NCT00948064|156739114|FG001|Phase I|No treatment received|0|||
48696642|NCT00948064|156739115|FG002|Phase I|No treatment received|0|||
48696643|NCT00948064|156739113|FG000|Phase II|Physician Decision|0|||
48696644|NCT00948064|156739114|FG001|Phase II|Physician Decision|0|||
48696645|NCT00948064|156739115|FG002|Phase II|Physician Decision|1|||
48696646|NCT00948064|156739113|FG000|Phase II|Withdrawal by Subject|0|||
48696647|NCT00948064|156739114|FG001|Phase II|Withdrawal by Subject|1|||
48696648|NCT00948064|156739115|FG002|Phase II|Withdrawal by Subject|0|||
48696649|NCT00179621|156739116|FG000|Double-Blind Period|Lack of Therapeutic Effect|59|||
48696650|NCT00179621|156739117|FG001|Double-Blind Period|Lack of Therapeutic Effect|35|||
48696651|NCT00179621|156739118|FG002|Double-Blind Period|Lack of Therapeutic Effect|19|||
48696652|NCT00179621|156739119|FG003|Double-Blind Period|Lack of Therapeutic Effect|0|||
48696653|NCT00179621|156739116|FG000|Double-Blind Period|Adverse Event|2|||
48696654|NCT00179621|156739117|FG001|Double-Blind Period|Adverse Event|7|||
48696655|NCT00179621|156739118|FG002|Double-Blind Period|Adverse Event|4|||
48696656|NCT00179621|156739119|FG003|Double-Blind Period|Adverse Event|0|||
48696657|NCT00179621|156739116|FG000|Double-Blind Period|Withdrawal by Subject|2|||
48696658|NCT00179621|156739117|FG001|Double-Blind Period|Withdrawal by Subject|1|||
48696659|NCT00179621|156739118|FG002|Double-Blind Period|Withdrawal by Subject|3|||
48696660|NCT00179621|156739119|FG003|Double-Blind Period|Withdrawal by Subject|0|||
48696661|NCT00179621|156739116|FG000|Double-Blind Period|Death|0|||
48696662|NCT00179621|156739117|FG001|Double-Blind Period|Death|1|||
48909514|NCT00915772|157506056|FG001|Overall Study|Refused to continue trial medication|8|||
48696663|NCT00179621|156739118|FG002|Double-Blind Period|Death|2|||
48696664|NCT00179621|156739119|FG003|Double-Blind Period|Death|0|||
48696665|NCT00179621|156739116|FG000|Double-Blind Period|Protocol Violation|1|||
48909515|NCT00915772|157506057|FG002|Overall Study|Refused to continue trial medication|4|||
48696666|NCT00179621|156739117|FG001|Double-Blind Period|Protocol Violation|0|||
48696667|NCT00179621|156739118|FG002|Double-Blind Period|Protocol Violation|0|||
48696668|NCT00179621|156739119|FG003|Double-Blind Period|Protocol Violation|0|||
48696669|NCT00179621|156739116|FG000|Double-Blind Period|Other|0|||
48696670|NCT00179621|156739117|FG001|Double-Blind Period|Other|2|||
48696671|NCT00179621|156739118|FG002|Double-Blind Period|Other|2|||
48696672|NCT00179621|156739119|FG003|Double-Blind Period|Other|0|||
48696673|NCT00179621|156739116|FG000|Open-Label Period|Lack of Therapeutic Effect|0|||
48696674|NCT00179621|156739117|FG001|Open-Label Period|Lack of Therapeutic Effect|19|||
48696675|NCT00179621|156739118|FG002|Open-Label Period|Lack of Therapeutic Effect|19|||
48696676|NCT00179621|156739119|FG003|Open-Label Period|Lack of Therapeutic Effect|31|||
48696677|NCT00179621|156739116|FG000|Open-Label Period|Adverse Event|0|||
48696678|NCT00179621|156739117|FG001|Open-Label Period|Adverse Event|6|||
48696679|NCT00179621|156739118|FG002|Open-Label Period|Adverse Event|5|||
48696680|NCT00179621|156739119|FG003|Open-Label Period|Adverse Event|6|||
48696681|NCT00179621|156739116|FG000|Open-Label Period|Withdrawal by Subject|0|||
48696682|NCT00179621|156739117|FG001|Open-Label Period|Withdrawal by Subject|2|||
48696683|NCT00179621|156739118|FG002|Open-Label Period|Withdrawal by Subject|2|||
48696684|NCT00179621|156739119|FG003|Open-Label Period|Withdrawal by Subject|2|||
48696685|NCT00179621|156739116|FG000|Open-Label Period|Death|0|||
48696686|NCT00179621|156739117|FG001|Open-Label Period|Death|0|||
48696687|NCT00179621|156739118|FG002|Open-Label Period|Death|1|||
48696688|NCT00179621|156739119|FG003|Open-Label Period|Death|2|||
48696689|NCT00179621|156739116|FG000|Open-Label Period|Other|0|||
48696690|NCT00179621|156739117|FG001|Open-Label Period|Other|1|||
48696691|NCT00179621|156739118|FG002|Open-Label Period|Other|1|||
48696692|NCT00179621|156739119|FG003|Open-Label Period|Other|2|||
48696693|NCT01777308|156739120|FG000|Overall Study|Withdrawal by Subject|5|||
48696694|NCT01777308|156739121|FG001|Overall Study|Withdrawal by Subject|1|||
48696695|NCT01777308|156739120|FG000|Overall Study|Migrated/moved from study area|1|||
48696696|NCT01777308|156739121|FG001|Overall Study|Migrated/moved from study area|0|||
48696697|NCT01777308|156739120|FG000|Overall Study|Lost to Follow-up|7|||
48696698|NCT01777308|156739121|FG001|Overall Study|Lost to Follow-up|2|||
48696699|NCT01777308|156739120|FG000|Overall Study|Blood draw refusal at Visit 3|1|||
48696700|NCT01777308|156739121|FG001|Overall Study|Blood draw refusal at Visit 3|0|||
48696701|NCT00383786|156739123|FG000|Overall Study|Protocol Violation|2|||
48696702|NCT00383786|156739124|FG001|Overall Study|Protocol Violation|6|||
48696703|NCT00383786|156739123|FG000|Overall Study|Withdrawal by Subject|2|||
48696704|NCT00383786|156739124|FG001|Overall Study|Withdrawal by Subject|5|||
48696705|NCT00383786|156739123|FG000|Overall Study|Physician Decision|0|||
48696706|NCT00383786|156739124|FG001|Overall Study|Physician Decision|1|||
48696707|NCT00644423|156739126|FG000|Overall Study|Lost to Follow-up|1|||
48696708|NCT00644423|156739127|FG001|Overall Study|Lost to Follow-up|1|||
48696709|NCT00781768|156739130|FG000|Overall Study|Not transplanted.|0|||
48696710|NCT00781768|156739131|FG001|Overall Study|Not transplanted.|2|||
48696711|NCT00984256|156739132|FG000|Overall Study|Withdrawal by Subject|0|||
48696712|NCT00984256|156739133|FG001|Overall Study|Withdrawal by Subject|1|||
48696713|NCT02426580|156739134|FG000|Overall Study|Death|2|||
48696714|NCT02426580|156739135|FG001|Overall Study|Death|2|||
48696715|NCT02426580|156739134|FG000|Overall Study|Lost to Follow-up|0|||
48696716|NCT02426580|156739135|FG001|Overall Study|Lost to Follow-up|9|||
48696717|NCT02426580|156739134|FG000|Overall Study|transfer to hemodialysis|5|||
48696718|NCT02426580|156739135|FG001|Overall Study|transfer to hemodialysis|5|||
48696719|NCT02426580|156739134|FG000|Overall Study|Kidney transplant|3|||
48696720|NCT02426580|156739135|FG001|Overall Study|Kidney transplant|0|||
48696721|NCT02426580|156739134|FG000|Overall Study|Allergic to egg white|1|||
48696722|NCT02426580|156739135|FG001|Overall Study|Allergic to egg white|0|||
48696723|NCT02647281|156739148|FG000|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
48696724|NCT02647281|156739149|FG001|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
48696725|NCT02647281|156739150|FG002|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
48696726|NCT02647281|156739151|FG003|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
48696727|NCT02647281|156739152|FG004|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
48696728|NCT02647281|156739153|FG005|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
48696729|NCT02647281|156739154|FG006|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
48696730|NCT02647281|156739155|FG007|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
48696731|NCT02647281|156739156|FG008|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1|||
48696732|NCT04235140|156739157|FG000|Overall Study|Adverse Event|2|||
48696733|NCT04235140|156739157|FG000|Overall Study|Lost to Follow-up|1|||
48696734|NCT04235140|156739157|FG000|Overall Study|Withdrawal of consent (not due to AE)|4|||
48696735|NCT04235140|156739157|FG000|Overall Study|Commercial drug is available for participants|7|||
48696736|NCT01751061|156739161|FG000|Overall Study|Death|1|||
48696737|NCT01751061|156739162|FG001|Overall Study|Death|0|||
48696738|NCT01751061|156739161|FG000|Overall Study|patient death|5|||
48696739|NCT01751061|156739162|FG001|Overall Study|patient death|0|||
48696740|NCT01751061|156739161|FG000|Overall Study|Lost to Follow-up|40|||
48696741|NCT01751061|156739162|FG001|Overall Study|Lost to Follow-up|25|||
48696742|NCT01751061|156739161|FG000|Overall Study|patient regained decisional capacity|4|||
48696743|NCT01751061|156739162|FG001|Overall Study|patient regained decisional capacity|8|||
48696744|NCT01751061|156739161|FG000|Overall Study|Withdrawal by Subject|4|||
48696745|NCT01751061|156739162|FG001|Overall Study|Withdrawal by Subject|1|||
48696746|NCT01751061|156739161|FG000|Overall Study|Physician Decision|2|||
48696747|NCT01751061|156739162|FG001|Overall Study|Physician Decision|0|||
48696748|NCT02412306|156739163|FG000|Overall Study|Lost to Follow-up|0|||
48696749|NCT02412306|156739164|FG001|Overall Study|Lost to Follow-up|1|||
48696750|NCT02412306|156739165|FG002|Overall Study|Lost to Follow-up|0|||
48696751|NCT02412306|156739166|FG003|Overall Study|Lost to Follow-up|0|||
48696752|NCT02412306|156739167|FG004|Overall Study|Lost to Follow-up|0|||
48909516|NCT00915772|157506055|FG000|Overall Study|Any other reason|4|||
48909517|NCT00915772|157506056|FG001|Overall Study|Any other reason|7|||
48909518|NCT00915772|157506057|FG002|Overall Study|Any other reason|7|||
48909519|NCT00909181|157506060|FG000|Overall Study|Lost to Follow-up|39|||
48909520|NCT00909181|157506061|FG001|Overall Study|Lost to Follow-up|18|||
48909521|NCT00909181|157506062|FG002|Overall Study|Lost to Follow-up|33|||
48909522|NCT00404066|157506065|FG000|Overall Study|Withdrawal by Subject - Pre-treatment|1|||
48909523|NCT00404066|157506065|FG000|Overall Study|Withdrawal by Subject - Adverse event|2|||
48909524|NCT01087957|157506067|FG000|Overall Study|Death|2|||
48909525|NCT01087957|157506068|FG001|Overall Study|Death|2|||
48909526|NCT01087957|157506067|FG000|Overall Study|Lost to Follow-up|3|||
48909527|NCT01087957|157506068|FG001|Overall Study|Lost to Follow-up|4|||
48909528|NCT01087957|157506067|FG000|Overall Study|Protocol Violation|13|||
48909529|NCT01087957|157506068|FG001|Overall Study|Protocol Violation|25|||
48909530|NCT01087957|157506067|FG000|Overall Study|Withdrawal by Subject|18|||
48909531|NCT01087957|157506068|FG001|Overall Study|Withdrawal by Subject|15|||
48909532|NCT01087957|157506067|FG000|Overall Study|Physician Decision|5|||
48909533|NCT01087957|157506068|FG001|Overall Study|Physician Decision|9|||
48909534|NCT00467779|157506069|FG000|Stage 1|Adverse Event|1|||
48909535|NCT00467779|157506070|FG001|Stage 1|Adverse Event|0|||
48909536|NCT00467779|157506071|FG002|Stage 1|Adverse Event|0|||
48909537|NCT00467779|157506072|FG003|Stage 1|Adverse Event|0|||
48909538|NCT00467779|157506073|FG004|Stage 1|Adverse Event|0|||
48909539|NCT00467779|157506074|FG005|Stage 1|Adverse Event|1|||
48909540|NCT00467779|157506075|FG006|Stage 1|Adverse Event|2|||
48909541|NCT00467779|157506076|FG007|Stage 1|Adverse Event|1|||
48909542|NCT00467779|157506077|FG008|Stage 1|Adverse Event|0|||
48909543|NCT00467779|157506078|FG009|Stage 1|Adverse Event|0|||
48909544|NCT00467779|157506079|FG010|Stage 1|Adverse Event|0|||
48909545|NCT00467779|157506080|FG011|Stage 1|Adverse Event|0|||
48909546|NCT00467779|157506081|FG012|Stage 1|Adverse Event|0|||
48909547|NCT00467779|157506082|FG013|Stage 1|Adverse Event|0|||
48909548|NCT00467779|157506083|FG014|Stage 1|Adverse Event|0|||
48909549|NCT00467779|157506069|FG000|Stage 1|Disease Progression|2|||
48909550|NCT00467779|157506070|FG001|Stage 1|Disease Progression|2|||
48909551|NCT00467779|157506071|FG002|Stage 1|Disease Progression|2|||
48909552|NCT00467779|157506072|FG003|Stage 1|Disease Progression|3|||
48909553|NCT00467779|157506073|FG004|Stage 1|Disease Progression|2|||
48909554|NCT00467779|157506074|FG005|Stage 1|Disease Progression|2|||
48909555|NCT00467779|157506075|FG006|Stage 1|Disease Progression|4|||
48909556|NCT00467779|157506076|FG007|Stage 1|Disease Progression|5|||
48909557|NCT00467779|157506077|FG008|Stage 1|Disease Progression|0|||
48909558|NCT00467779|157506078|FG009|Stage 1|Disease Progression|0|||
48909559|NCT00467779|157506079|FG010|Stage 1|Disease Progression|0|||
48909560|NCT00467779|157506080|FG011|Stage 1|Disease Progression|0|||
48909561|NCT00467779|157506081|FG012|Stage 1|Disease Progression|0|||
48909562|NCT00467779|157506082|FG013|Stage 1|Disease Progression|0|||
48909563|NCT00467779|157506083|FG014|Stage 1|Disease Progression|0|||
48909564|NCT00467779|157506069|FG000|Stage 1|Unspecified Reason|1|||
48909565|NCT00467779|157506070|FG001|Stage 1|Unspecified Reason|0|||
48909566|NCT00467779|157506071|FG002|Stage 1|Unspecified Reason|1|||
48909567|NCT00467779|157506072|FG003|Stage 1|Unspecified Reason|0|||
48909568|NCT00467779|157506073|FG004|Stage 1|Unspecified Reason|1|||
48909569|NCT00467779|157506074|FG005|Stage 1|Unspecified Reason|2|||
48909570|NCT00467779|157506075|FG006|Stage 1|Unspecified Reason|0|||
48909571|NCT00467779|157506076|FG007|Stage 1|Unspecified Reason|0|||
48909572|NCT00467779|157506077|FG008|Stage 1|Unspecified Reason|0|||
48909573|NCT00467779|157506078|FG009|Stage 1|Unspecified Reason|0|||
48909574|NCT00467779|157506079|FG010|Stage 1|Unspecified Reason|0|||
48909575|NCT00467779|157506080|FG011|Stage 1|Unspecified Reason|0|||
48909576|NCT00467779|157506081|FG012|Stage 1|Unspecified Reason|0|||
48909577|NCT00467779|157506082|FG013|Stage 1|Unspecified Reason|0|||
48909578|NCT00467779|157506083|FG014|Stage 1|Unspecified Reason|0|||
48909579|NCT00467779|157506069|FG000|Stage 1|Physician Decision|0|||
48909580|NCT00467779|157506070|FG001|Stage 1|Physician Decision|1|||
48909581|NCT00467779|157506071|FG002|Stage 1|Physician Decision|0|||
48909582|NCT00467779|157506072|FG003|Stage 1|Physician Decision|0|||
48909583|NCT00467779|157506073|FG004|Stage 1|Physician Decision|0|||
48909584|NCT00467779|157506074|FG005|Stage 1|Physician Decision|0|||
48909585|NCT00467779|157506075|FG006|Stage 1|Physician Decision|0|||
48909586|NCT00467779|157506076|FG007|Stage 1|Physician Decision|0|||
48909587|NCT00467779|157506077|FG008|Stage 1|Physician Decision|0|||
48909588|NCT00467779|157506078|FG009|Stage 1|Physician Decision|0|||
48909589|NCT00467779|157506079|FG010|Stage 1|Physician Decision|0|||
48909590|NCT00467779|157506080|FG011|Stage 1|Physician Decision|0|||
48909591|NCT00467779|157506081|FG012|Stage 1|Physician Decision|0|||
48909592|NCT00467779|157506082|FG013|Stage 1|Physician Decision|0|||
48909593|NCT00467779|157506083|FG014|Stage 1|Physician Decision|0|||
48909594|NCT00467779|157506069|FG000|Stage 1|Withdrawal by Subject|0|||
48909595|NCT00467779|157506070|FG001|Stage 1|Withdrawal by Subject|0|||
48909596|NCT00467779|157506071|FG002|Stage 1|Withdrawal by Subject|0|||
48909597|NCT00467779|157506072|FG003|Stage 1|Withdrawal by Subject|0|||
48909598|NCT00467779|157506073|FG004|Stage 1|Withdrawal by Subject|0|||
48909599|NCT00467779|157506074|FG005|Stage 1|Withdrawal by Subject|0|||
48909600|NCT00467779|157506075|FG006|Stage 1|Withdrawal by Subject|1|||
48909601|NCT00467779|157506076|FG007|Stage 1|Withdrawal by Subject|1|||
48909602|NCT00467779|157506077|FG008|Stage 1|Withdrawal by Subject|0|||
48909603|NCT00467779|157506078|FG009|Stage 1|Withdrawal by Subject|0|||
48909604|NCT00467779|157506079|FG010|Stage 1|Withdrawal by Subject|0|||
48909605|NCT00467779|157506080|FG011|Stage 1|Withdrawal by Subject|0|||
48909606|NCT00467779|157506081|FG012|Stage 1|Withdrawal by Subject|0|||
48909607|NCT00467779|157506082|FG013|Stage 1|Withdrawal by Subject|0|||
48909608|NCT00467779|157506083|FG014|Stage 1|Withdrawal by Subject|0|||
48909609|NCT00467779|157506069|FG000|Stage 1A|Adverse Event|0|||
48909610|NCT00467779|157506070|FG001|Stage 1A|Adverse Event|0|||
48909611|NCT00467779|157506071|FG002|Stage 1A|Adverse Event|0|||
48909612|NCT00467779|157506072|FG003|Stage 1A|Adverse Event|0|||
48909613|NCT00467779|157506073|FG004|Stage 1A|Adverse Event|0|||
48909614|NCT00467779|157506074|FG005|Stage 1A|Adverse Event|0|||
48909615|NCT00467779|157506075|FG006|Stage 1A|Adverse Event|0|||
48909616|NCT00467779|157506076|FG007|Stage 1A|Adverse Event|0|||
48909617|NCT00467779|157506077|FG008|Stage 1A|Adverse Event|0|||
48909618|NCT00467779|157506078|FG009|Stage 1A|Adverse Event|0|||
48909619|NCT00467779|157506079|FG010|Stage 1A|Adverse Event|0|||
48909620|NCT00467779|157506080|FG011|Stage 1A|Adverse Event|0|||
48909621|NCT00467779|157506081|FG012|Stage 1A|Adverse Event|1|||
48909622|NCT00467779|157506082|FG013|Stage 1A|Adverse Event|0|||
48909623|NCT00467779|157506083|FG014|Stage 1A|Adverse Event|0|||
48909624|NCT00467779|157506069|FG000|Stage 1A|Death|0|||
48909625|NCT00467779|157506070|FG001|Stage 1A|Death|0|||
48909626|NCT00467779|157506071|FG002|Stage 1A|Death|0|||
48909627|NCT00467779|157506072|FG003|Stage 1A|Death|0|||
48909628|NCT00467779|157506073|FG004|Stage 1A|Death|0|||
48909629|NCT00467779|157506074|FG005|Stage 1A|Death|0|||
48909630|NCT00467779|157506075|FG006|Stage 1A|Death|0|||
48909631|NCT00467779|157506076|FG007|Stage 1A|Death|0|||
48909632|NCT00467779|157506077|FG008|Stage 1A|Death|0|||
48909633|NCT00467779|157506078|FG009|Stage 1A|Death|0|||
48909634|NCT00467779|157506079|FG010|Stage 1A|Death|0|||
48909635|NCT00467779|157506080|FG011|Stage 1A|Death|1|||
48909636|NCT00467779|157506081|FG012|Stage 1A|Death|1|||
48909637|NCT00467779|157506082|FG013|Stage 1A|Death|0|||
48909638|NCT00467779|157506083|FG014|Stage 1A|Death|0|||
48909639|NCT00467779|157506069|FG000|Stage 1A|Disease Progression|0|||
48909640|NCT00467779|157506070|FG001|Stage 1A|Disease Progression|0|||
48909641|NCT00467779|157506071|FG002|Stage 1A|Disease Progression|0|||
48909642|NCT00467779|157506072|FG003|Stage 1A|Disease Progression|0|||
48909643|NCT00467779|157506073|FG004|Stage 1A|Disease Progression|0|||
48909644|NCT00467779|157506074|FG005|Stage 1A|Disease Progression|0|||
48909645|NCT00467779|157506075|FG006|Stage 1A|Disease Progression|0|||
48909646|NCT00467779|157506076|FG007|Stage 1A|Disease Progression|0|||
48909647|NCT00467779|157506077|FG008|Stage 1A|Disease Progression|0|||
48909648|NCT00467779|157506078|FG009|Stage 1A|Disease Progression|2|||
48909649|NCT00467779|157506079|FG010|Stage 1A|Disease Progression|2|||
48909650|NCT00467779|157506080|FG011|Stage 1A|Disease Progression|5|||
48909651|NCT00467779|157506081|FG012|Stage 1A|Disease Progression|2|||
48696753|NCT02412306|156739163|FG000|Overall Study|Withdrawal by Subject|0|||
48696754|NCT02412306|156739164|FG001|Overall Study|Withdrawal by Subject|0|||
48909652|NCT00467779|157506082|FG013|Stage 1A|Disease Progression|0|||
48909653|NCT00467779|157506083|FG014|Stage 1A|Disease Progression|0|||
48909654|NCT00467779|157506069|FG000|Stage 1A|Physician Decision|0|||
48909655|NCT00467779|157506070|FG001|Stage 1A|Physician Decision|0|||
48909656|NCT00467779|157506071|FG002|Stage 1A|Physician Decision|0|||
48909657|NCT00467779|157506072|FG003|Stage 1A|Physician Decision|0|||
48909658|NCT00467779|157506073|FG004|Stage 1A|Physician Decision|0|||
48909659|NCT00467779|157506074|FG005|Stage 1A|Physician Decision|0|||
48909660|NCT00467779|157506075|FG006|Stage 1A|Physician Decision|0|||
48909661|NCT00467779|157506076|FG007|Stage 1A|Physician Decision|0|||
48909662|NCT00467779|157506077|FG008|Stage 1A|Physician Decision|0|||
48696755|NCT02412306|156739165|FG002|Overall Study|Withdrawal by Subject|1|||
48909663|NCT00467779|157506078|FG009|Stage 1A|Physician Decision|1|||
48909664|NCT00467779|157506079|FG010|Stage 1A|Physician Decision|0|||
48909665|NCT00467779|157506080|FG011|Stage 1A|Physician Decision|0|||
48909666|NCT00467779|157506081|FG012|Stage 1A|Physician Decision|0|||
48909667|NCT00467779|157506082|FG013|Stage 1A|Physician Decision|0|||
48909668|NCT00467779|157506083|FG014|Stage 1A|Physician Decision|0|||
48909669|NCT00467779|157506069|FG000|Stage 1A|Withdrawal by Subject|0|||
48909670|NCT00467779|157506070|FG001|Stage 1A|Withdrawal by Subject|0|||
48909671|NCT00467779|157506071|FG002|Stage 1A|Withdrawal by Subject|0|||
48909672|NCT00467779|157506072|FG003|Stage 1A|Withdrawal by Subject|0|||
48909673|NCT00467779|157506073|FG004|Stage 1A|Withdrawal by Subject|0|||
48909674|NCT00467779|157506074|FG005|Stage 1A|Withdrawal by Subject|0|||
48909675|NCT00467779|157506075|FG006|Stage 1A|Withdrawal by Subject|0|||
48909676|NCT00467779|157506076|FG007|Stage 1A|Withdrawal by Subject|0|||
48909677|NCT00467779|157506077|FG008|Stage 1A|Withdrawal by Subject|0|||
48909678|NCT00467779|157506078|FG009|Stage 1A|Withdrawal by Subject|0|||
48909679|NCT00467779|157506079|FG010|Stage 1A|Withdrawal by Subject|1|||
48909680|NCT00467779|157506080|FG011|Stage 1A|Withdrawal by Subject|1|||
48909681|NCT00467779|157506081|FG012|Stage 1A|Withdrawal by Subject|1|||
48909682|NCT00467779|157506082|FG013|Stage 1A|Withdrawal by Subject|0|||
48909683|NCT00467779|157506083|FG014|Stage 1A|Withdrawal by Subject|0|||
48909684|NCT00467779|157506069|FG000|Stage 1A|Unspecified Reason|0|||
48909685|NCT00467779|157506070|FG001|Stage 1A|Unspecified Reason|0|||
48909686|NCT00467779|157506071|FG002|Stage 1A|Unspecified Reason|0|||
48696756|NCT02412306|156739166|FG003|Overall Study|Withdrawal by Subject|0|||
48696757|NCT02412306|156739167|FG004|Overall Study|Withdrawal by Subject|0|||
48696758|NCT02412306|156739163|FG000|Overall Study|Death|5|||
48696759|NCT02412306|156739164|FG001|Overall Study|Death|7|||
48696760|NCT02412306|156739165|FG002|Overall Study|Death|15|||
48696761|NCT02412306|156739166|FG003|Overall Study|Death|0|||
48909687|NCT00467779|157506072|FG003|Stage 1A|Unspecified Reason|0|||
48909688|NCT00467779|157506073|FG004|Stage 1A|Unspecified Reason|0|||
48909689|NCT00467779|157506074|FG005|Stage 1A|Unspecified Reason|0|||
48909690|NCT00467779|157506075|FG006|Stage 1A|Unspecified Reason|0|||
48909691|NCT00467779|157506076|FG007|Stage 1A|Unspecified Reason|0|||
48909692|NCT00467779|157506077|FG008|Stage 1A|Unspecified Reason|0|||
48909693|NCT00467779|157506078|FG009|Stage 1A|Unspecified Reason|0|||
48909694|NCT00467779|157506079|FG010|Stage 1A|Unspecified Reason|0|||
48909695|NCT00467779|157506080|FG011|Stage 1A|Unspecified Reason|1|||
48909696|NCT00467779|157506081|FG012|Stage 1A|Unspecified Reason|1|||
48909697|NCT00467779|157506082|FG013|Stage 1A|Unspecified Reason|0|||
48909698|NCT00467779|157506083|FG014|Stage 1A|Unspecified Reason|0|||
48909699|NCT00467779|157506069|FG000|Stage 2|Adverse Event|0|||
48909700|NCT00467779|157506070|FG001|Stage 2|Adverse Event|0|||
48909701|NCT00467779|157506071|FG002|Stage 2|Adverse Event|0|||
48909702|NCT00467779|157506072|FG003|Stage 2|Adverse Event|0|||
48909703|NCT00467779|157506073|FG004|Stage 2|Adverse Event|0|||
48909704|NCT00467779|157506074|FG005|Stage 2|Adverse Event|0|||
48909705|NCT00467779|157506075|FG006|Stage 2|Adverse Event|0|||
48909706|NCT00467779|157506076|FG007|Stage 2|Adverse Event|0|||
48909707|NCT00467779|157506077|FG008|Stage 2|Adverse Event|1|||
48909708|NCT00467779|157506078|FG009|Stage 2|Adverse Event|0|||
48909709|NCT00467779|157506079|FG010|Stage 2|Adverse Event|0|||
48909710|NCT00467779|157506080|FG011|Stage 2|Adverse Event|0|||
48909711|NCT00467779|157506081|FG012|Stage 2|Adverse Event|0|||
48909712|NCT00467779|157506082|FG013|Stage 2|Adverse Event|0|||
48909713|NCT00467779|157506083|FG014|Stage 2|Adverse Event|0|||
48696762|NCT02412306|156739167|FG004|Overall Study|Death|2|||
48696763|NCT03040999|156739168|FG000|Overall Study|Lost to Follow-up|1|||
48696764|NCT03040999|156739169|FG001|Overall Study|Lost to Follow-up|0|||
48696765|NCT03040999|156739168|FG000|Overall Study|Withdrawal by Subject|7|||
48696766|NCT03040999|156739169|FG001|Overall Study|Withdrawal by Subject|12|||
48696767|NCT03040999|156739168|FG000|Overall Study|Death|128|||
48696768|NCT03040999|156739169|FG001|Overall Study|Death|138|||
48696769|NCT03040999|156739168|FG000|Overall Study|Participants Ongoing in Trial|266|||
48696770|NCT03040999|156739169|FG001|Overall Study|Participants Ongoing in Trial|252|||
48696771|NCT05131165|156739170|FG000|Overall Study|Death|1|||
48696772|NCT05131165|156739171|FG001|Overall Study|Death|1|||
48696773|NCT05131165|156739172|FG002|Overall Study|Death|0|||
48696774|NCT05131165|156739170|FG000|Overall Study|Lost to Follow-up|2|||
48696775|NCT05131165|156739171|FG001|Overall Study|Lost to Follow-up|2|||
48696776|NCT05131165|156739172|FG002|Overall Study|Lost to Follow-up|5|||
48696777|NCT05131165|156739170|FG000|Overall Study|Transferred out of clinic|1|||
48696778|NCT05131165|156739171|FG001|Overall Study|Transferred out of clinic|0|||
48696779|NCT05131165|156739172|FG002|Overall Study|Transferred out of clinic|3|||
48696780|NCT05131165|156739170|FG000|Overall Study|Dropped out|1|||
48696781|NCT05131165|156739171|FG001|Overall Study|Dropped out|2|||
48909714|NCT00467779|157506069|FG000|Stage 2|Death|0|||
48909715|NCT00467779|157506070|FG001|Stage 2|Death|0|||
48909716|NCT00467779|157506071|FG002|Stage 2|Death|0|||
48909717|NCT00467779|157506072|FG003|Stage 2|Death|0|||
49116315|NCT03538691|158263092|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Death|1|||
48909718|NCT00467779|157506073|FG004|Stage 2|Death|0|||
48909719|NCT00467779|157506074|FG005|Stage 2|Death|0|||
48696782|NCT05131165|156739172|FG002|Overall Study|Dropped out|0|||
48696783|NCT00764699|156739173|FG000|Overall Study|PI left and study terminated|3|||
48696784|NCT00435409|156739174|FG000|Overall Study|Protocol Violation|1|||
48909720|NCT00467779|157506075|FG006|Stage 2|Death|0|||
48909721|NCT00467779|157506076|FG007|Stage 2|Death|0|||
48909722|NCT00467779|157506077|FG008|Stage 2|Death|1|||
48909723|NCT00467779|157506078|FG009|Stage 2|Death|0|||
48909724|NCT00467779|157506079|FG010|Stage 2|Death|0|||
48909725|NCT00467779|157506080|FG011|Stage 2|Death|0|||
48696785|NCT00435409|156739175|FG001|Overall Study|Protocol Violation|2|||
48696786|NCT00435409|156739176|FG002|Overall Study|Protocol Violation|0|||
48696787|NCT00435409|156739174|FG000|Overall Study|Lost to Follow-up|1|||
48696788|NCT00435409|156739175|FG001|Overall Study|Lost to Follow-up|2|||
48696789|NCT00435409|156739176|FG002|Overall Study|Lost to Follow-up|0|||
48696790|NCT00435409|156739174|FG000|Overall Study|Death|8|||
48696791|NCT00435409|156739175|FG001|Overall Study|Death|6|||
48696792|NCT00435409|156739176|FG002|Overall Study|Death|6|||
48696793|NCT00435409|156739174|FG000|Overall Study|Objective progression or relapse|158|||
48696794|NCT00435409|156739175|FG001|Overall Study|Objective progression or relapse|93|||
48696795|NCT00435409|156739176|FG002|Overall Study|Objective progression or relapse|58|||
48696796|NCT00435409|156739174|FG000|Overall Study|Global deterioration of health status|0|||
48696797|NCT00435409|156739175|FG001|Overall Study|Global deterioration of health status|0|||
48696798|NCT00435409|156739176|FG002|Overall Study|Global deterioration of health status|4|||
48696799|NCT00435409|156739174|FG000|Overall Study|Withdrawal by Subject|8|||
48696800|NCT00435409|156739175|FG001|Overall Study|Withdrawal by Subject|7|||
48696801|NCT00435409|156739176|FG002|Overall Study|Withdrawal by Subject|1|||
48696802|NCT00435409|156739174|FG000|Overall Study|Other|45|||
48696803|NCT00435409|156739175|FG001|Overall Study|Other|30|||
48696804|NCT00435409|156739176|FG002|Overall Study|Other|1|||
48696805|NCT00435409|156739174|FG000|Overall Study|Adverse Event|0|||
48696806|NCT00435409|156739175|FG001|Overall Study|Adverse Event|0|||
48696807|NCT00435409|156739176|FG002|Overall Study|Adverse Event|8|||
48696808|NCT00435409|156739174|FG000|Overall Study|Sponsor decision|0|||
48696809|NCT00435409|156739175|FG001|Overall Study|Sponsor decision|3|||
48696810|NCT00435409|156739176|FG002|Overall Study|Sponsor decision|0|||
48696811|NCT04890652|156739181|FG000|Overall Study|Withdrawal by Subject|2|||
48696812|NCT05137041|156739184|FG000|Overall Study|Lost to Follow-up|1|||
48696813|NCT05137041|156739185|FG001|Overall Study|Lost to Follow-up|1|||
48696814|NCT05137041|156739184|FG000|Overall Study|Withdrawal by Subject|0|||
48696815|NCT05137041|156739185|FG001|Overall Study|Withdrawal by Subject|2|||
48696816|NCT05137041|156739184|FG000|Overall Study|Reason not Specified|0|||
48696817|NCT05137041|156739185|FG001|Overall Study|Reason not Specified|1|||
48696818|NCT04742556|156739186|FG000|Overall Study|Withdrawal by Subject|0|||
48696819|NCT04742556|156739187|FG001|Overall Study|Withdrawal by Subject|1|||
48696820|NCT04742556|156739188|FG002|Overall Study|Withdrawal by Subject|0|||
48696821|NCT04742556|156739186|FG000|Overall Study|Adverse Event|0|||
48696822|NCT04742556|156739187|FG001|Overall Study|Adverse Event|0|||
48696823|NCT04742556|156739188|FG002|Overall Study|Adverse Event|2|||
48696824|NCT04742556|156739186|FG000|Overall Study|Clinical disease progression|0|||
48696825|NCT04742556|156739187|FG001|Overall Study|Clinical disease progression|1|||
48696826|NCT04742556|156739188|FG002|Overall Study|Clinical disease progression|2|||
48696827|NCT04742556|156739186|FG000|Overall Study|Objective disease progression|3|||
48696828|NCT04742556|156739187|FG001|Overall Study|Objective disease progression|2|||
48696829|NCT04742556|156739188|FG002|Overall Study|Objective disease progression|4|||
48696830|NCT04247347|156739189|FG000|Overall Study|Withdrawal by Subject|2|||
48696831|NCT04247347|156739190|FG001|Overall Study|Withdrawal by Subject|3|||
48696832|NCT04247347|156739191|FG002|Overall Study|Withdrawal by Subject|3|||
48696833|NCT04247347|156739189|FG000|Overall Study|Lost to Follow-up|1|||
48696834|NCT04247347|156739190|FG001|Overall Study|Lost to Follow-up|1|||
48696835|NCT04247347|156739191|FG002|Overall Study|Lost to Follow-up|1|||
48696836|NCT01383928|156739193|FG000|Overall Study|Initiation of ASCT|2|||
48696837|NCT01383928|156739194|FG001|Overall Study|Initiation of ASCT|1|||
48696838|NCT01383928|156739195|FG002|Overall Study|Initiation of ASCT|18|||
48696839|NCT01383928|156739193|FG000|Overall Study|Adverse Event|1|||
48696840|NCT01383928|156739194|FG001|Overall Study|Adverse Event|2|||
48696841|NCT01383928|156739195|FG002|Overall Study|Adverse Event|8|||
48696842|NCT01383928|156739193|FG000|Overall Study|Other|1|||
48696843|NCT01383928|156739194|FG001|Overall Study|Other|3|||
48696844|NCT01383928|156739195|FG002|Overall Study|Other|4|||
48696845|NCT01383928|156739193|FG000|Overall Study|Progressive Disease|1|||
48696846|NCT01383928|156739194|FG001|Overall Study|Progressive Disease|1|||
48696847|NCT01383928|156739195|FG002|Overall Study|Progressive Disease|5|||
48696848|NCT01383928|156739193|FG000|Overall Study|Withdrawal by Subject|0|||
48696849|NCT01383928|156739194|FG001|Overall Study|Withdrawal by Subject|0|||
48696850|NCT01383928|156739195|FG002|Overall Study|Withdrawal by Subject|4|||
48696851|NCT01383928|156739193|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
48696852|NCT01383928|156739194|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
48696853|NCT01383928|156739195|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
48696854|NCT02052778|156739199|FG000|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
48696855|NCT02052778|156739200|FG001|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
48909726|NCT00467779|157506081|FG012|Stage 2|Death|0|||
48909727|NCT00467779|157506082|FG013|Stage 2|Death|0|||
49116316|NCT03538691|158263093|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
48696856|NCT02052778|156739201|FG002|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
48696857|NCT02052778|156739202|FG003|Dose Escalation(Approximately 60 Months)|Radiographic progression|1|||
48742931|NCT00126191|156910416|FG000|Overall Study|Death|0|||
48696858|NCT02052778|156739203|FG004|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
48696859|NCT02052778|156739204|FG005|Dose Escalation(Approximately 60 Months)|Radiographic progression|3|||
48696860|NCT02052778|156739205|FG006|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
48696861|NCT02052778|156739206|FG007|Dose Escalation(Approximately 60 Months)|Radiographic progression|6|||
48696862|NCT02052778|156739207|FG008|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
48696863|NCT02052778|156739208|FG009|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
48696864|NCT02052778|156739209|FG010|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
48696865|NCT02052778|156739210|FG011|Dose Escalation(Approximately 60 Months)|Radiographic progression|11|||
48696866|NCT02052778|156739211|FG012|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
48696867|NCT02052778|156739212|FG013|Dose Escalation(Approximately 60 Months)|Radiographic progression|7|||
48696868|NCT02052778|156739213|FG014|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
48696869|NCT02052778|156739214|FG015|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
48696870|NCT02052778|156739215|FG016|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
48696871|NCT02052778|156739216|FG017|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
48696872|NCT02052778|156739217|FG018|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
48696873|NCT02052778|156739218|FG019|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
48696874|NCT02052778|156739219|FG020|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
48696875|NCT02052778|156739220|FG021|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
48696876|NCT02052778|156739221|FG022|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
48696877|NCT02052778|156739199|FG000|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
48696878|NCT02052778|156739200|FG001|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
48696879|NCT02052778|156739201|FG002|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
48696880|NCT02052778|156739202|FG003|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
48696881|NCT02052778|156739203|FG004|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
48696882|NCT02052778|156739204|FG005|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
48696883|NCT02052778|156739205|FG006|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
48696884|NCT02052778|156739206|FG007|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
48696885|NCT02052778|156739207|FG008|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
48696886|NCT02052778|156739208|FG009|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
48696887|NCT02052778|156739209|FG010|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
48696888|NCT02052778|156739210|FG011|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
48696889|NCT02052778|156739211|FG012|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
48696890|NCT02052778|156739212|FG013|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
48909728|NCT00467779|157506083|FG014|Stage 2|Death|0|||
48909729|NCT00467779|157506069|FG000|Stage 2|Disease Progression|0|||
48909730|NCT00467779|157506070|FG001|Stage 2|Disease Progression|0|||
48909731|NCT00467779|157506071|FG002|Stage 2|Disease Progression|0|||
48909732|NCT00467779|157506072|FG003|Stage 2|Disease Progression|0|||
48909733|NCT00467779|157506073|FG004|Stage 2|Disease Progression|0|||
48909734|NCT00467779|157506074|FG005|Stage 2|Disease Progression|0|||
48909735|NCT00467779|157506075|FG006|Stage 2|Disease Progression|0|||
48909736|NCT00467779|157506076|FG007|Stage 2|Disease Progression|0|||
48909737|NCT00467779|157506077|FG008|Stage 2|Disease Progression|16|||
48909738|NCT00467779|157506078|FG009|Stage 2|Disease Progression|0|||
48909739|NCT00467779|157506079|FG010|Stage 2|Disease Progression|0|||
48909740|NCT00467779|157506080|FG011|Stage 2|Disease Progression|0|||
48909741|NCT00467779|157506081|FG012|Stage 2|Disease Progression|0|||
48909742|NCT00467779|157506082|FG013|Stage 2|Disease Progression|0|||
48909743|NCT00467779|157506083|FG014|Stage 2|Disease Progression|0|||
48909744|NCT00467779|157506069|FG000|Stage 2|Unspecified Reason|0|||
48909745|NCT00467779|157506070|FG001|Stage 2|Unspecified Reason|0|||
48909746|NCT00467779|157506071|FG002|Stage 2|Unspecified Reason|0|||
48909747|NCT00467779|157506072|FG003|Stage 2|Unspecified Reason|0|||
48909748|NCT00467779|157506073|FG004|Stage 2|Unspecified Reason|0|||
48909749|NCT00467779|157506074|FG005|Stage 2|Unspecified Reason|0|||
48696891|NCT02052778|156739213|FG014|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
48696892|NCT02052778|156739214|FG015|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
48696893|NCT02052778|156739215|FG016|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
48696894|NCT02052778|156739216|FG017|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
48696895|NCT02052778|156739217|FG018|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
48742932|NCT00126191|156910417|FG001|Overall Study|Death|1|||
48909750|NCT00467779|157506075|FG006|Stage 2|Unspecified Reason|0|||
48909751|NCT00467779|157506076|FG007|Stage 2|Unspecified Reason|0|||
48909752|NCT00467779|157506077|FG008|Stage 2|Unspecified Reason|3|||
48909753|NCT00467779|157506078|FG009|Stage 2|Unspecified Reason|0|||
48909754|NCT00467779|157506079|FG010|Stage 2|Unspecified Reason|0|||
48909755|NCT00467779|157506080|FG011|Stage 2|Unspecified Reason|0|||
48696896|NCT02052778|156739218|FG019|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
48696897|NCT02052778|156739219|FG020|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
48696898|NCT02052778|156739220|FG021|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
48696899|NCT02052778|156739221|FG022|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
48696900|NCT02052778|156739199|FG000|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
48696901|NCT02052778|156739200|FG001|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
48696902|NCT02052778|156739201|FG002|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
48696903|NCT02052778|156739202|FG003|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
48696904|NCT02052778|156739203|FG004|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
48696905|NCT02052778|156739204|FG005|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
48696906|NCT02052778|156739205|FG006|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
48696907|NCT02052778|156739206|FG007|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
48696908|NCT02052778|156739207|FG008|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
48696909|NCT02052778|156739208|FG009|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
48696910|NCT02052778|156739209|FG010|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
48696911|NCT02052778|156739210|FG011|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
48696912|NCT02052778|156739211|FG012|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
48696913|NCT02052778|156739212|FG013|Dose Escalation(Approximately 60 Months)|Adverse Event|1|||
48696914|NCT02052778|156739213|FG014|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
48696915|NCT02052778|156739214|FG015|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
48696916|NCT02052778|156739215|FG016|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
48696917|NCT02052778|156739216|FG017|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
48696918|NCT02052778|156739217|FG018|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
48696919|NCT02052778|156739218|FG019|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
48696920|NCT02052778|156739219|FG020|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
48696921|NCT02052778|156739220|FG021|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
48696922|NCT02052778|156739221|FG022|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
48696923|NCT02052778|156739199|FG000|Dose Escalation(Approximately 60 Months)|Death|0|||
48696924|NCT02052778|156739200|FG001|Dose Escalation(Approximately 60 Months)|Death|0|||
48696925|NCT02052778|156739201|FG002|Dose Escalation(Approximately 60 Months)|Death|0|||
48696926|NCT02052778|156739202|FG003|Dose Escalation(Approximately 60 Months)|Death|0|||
48696927|NCT02052778|156739203|FG004|Dose Escalation(Approximately 60 Months)|Death|0|||
48696928|NCT02052778|156739204|FG005|Dose Escalation(Approximately 60 Months)|Death|0|||
48696929|NCT02052778|156739205|FG006|Dose Escalation(Approximately 60 Months)|Death|1|||
48696930|NCT02052778|156739206|FG007|Dose Escalation(Approximately 60 Months)|Death|0|||
48696931|NCT02052778|156739207|FG008|Dose Escalation(Approximately 60 Months)|Death|0|||
48696932|NCT02052778|156739208|FG009|Dose Escalation(Approximately 60 Months)|Death|0|||
48696933|NCT02052778|156739209|FG010|Dose Escalation(Approximately 60 Months)|Death|0|||
48696934|NCT02052778|156739210|FG011|Dose Escalation(Approximately 60 Months)|Death|1|||
48696935|NCT02052778|156739211|FG012|Dose Escalation(Approximately 60 Months)|Death|0|||
48696936|NCT02052778|156739212|FG013|Dose Escalation(Approximately 60 Months)|Death|0|||
48696937|NCT02052778|156739213|FG014|Dose Escalation(Approximately 60 Months)|Death|0|||
48696938|NCT02052778|156739214|FG015|Dose Escalation(Approximately 60 Months)|Death|0|||
48696939|NCT02052778|156739215|FG016|Dose Escalation(Approximately 60 Months)|Death|0|||
48696940|NCT02052778|156739216|FG017|Dose Escalation(Approximately 60 Months)|Death|0|||
48696941|NCT02052778|156739217|FG018|Dose Escalation(Approximately 60 Months)|Death|0|||
48696942|NCT02052778|156739218|FG019|Dose Escalation(Approximately 60 Months)|Death|0|||
48696943|NCT02052778|156739219|FG020|Dose Escalation(Approximately 60 Months)|Death|0|||
48696944|NCT02052778|156739220|FG021|Dose Escalation(Approximately 60 Months)|Death|0|||
48696945|NCT02052778|156739221|FG022|Dose Escalation(Approximately 60 Months)|Death|0|||
48696946|NCT02052778|156739199|FG000|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
48696947|NCT02052778|156739200|FG001|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
48696948|NCT02052778|156739201|FG002|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
48696949|NCT02052778|156739202|FG003|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
48696950|NCT02052778|156739203|FG004|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
48696951|NCT02052778|156739204|FG005|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
48696952|NCT02052778|156739205|FG006|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
48696953|NCT02052778|156739206|FG007|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
48696954|NCT02052778|156739207|FG008|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|1|||
48696955|NCT02052778|156739208|FG009|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
48696956|NCT02052778|156739209|FG010|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
48696957|NCT02052778|156739210|FG011|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
48696958|NCT02052778|156739211|FG012|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
48696959|NCT02052778|156739212|FG013|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|3|||
48742933|NCT00443261|156910418|FG000|Overall Study|Death|1|||
48696960|NCT02052778|156739213|FG014|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
48696961|NCT02052778|156739214|FG015|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
48696962|NCT02052778|156739215|FG016|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
48696963|NCT02052778|156739216|FG017|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
48696964|NCT02052778|156739217|FG018|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
48696965|NCT02052778|156739218|FG019|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
48696966|NCT02052778|156739219|FG020|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
48696967|NCT02052778|156739220|FG021|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
48696968|NCT02052778|156739221|FG022|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
48696969|NCT02052778|156739199|FG000|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
48696970|NCT02052778|156739200|FG001|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
48696971|NCT02052778|156739201|FG002|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
48696972|NCT02052778|156739202|FG003|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
48696973|NCT02052778|156739203|FG004|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
48696974|NCT02052778|156739204|FG005|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
48696975|NCT02052778|156739205|FG006|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
48696976|NCT02052778|156739206|FG007|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
48696977|NCT02052778|156739207|FG008|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
48696978|NCT02052778|156739208|FG009|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
48696979|NCT02052778|156739209|FG010|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
48696980|NCT02052778|156739210|FG011|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
48909756|NCT00467779|157506081|FG012|Stage 2|Unspecified Reason|0|||
48909757|NCT00467779|157506082|FG013|Stage 2|Unspecified Reason|0|||
48909758|NCT00467779|157506083|FG014|Stage 2|Unspecified Reason|0|||
48909759|NCT00467779|157506069|FG000|Stage 2A|Adverse Event|0|||
48909760|NCT00467779|157506070|FG001|Stage 2A|Adverse Event|0|||
48696981|NCT02052778|156739211|FG012|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
48696982|NCT02052778|156739212|FG013|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
48696983|NCT02052778|156739213|FG014|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
48696984|NCT02052778|156739214|FG015|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
48696985|NCT02052778|156739215|FG016|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
48696986|NCT02052778|156739216|FG017|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
48696987|NCT02052778|156739217|FG018|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
48696988|NCT02052778|156739218|FG019|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
48696989|NCT02052778|156739219|FG020|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
48696990|NCT02052778|156739220|FG021|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
48696991|NCT02052778|156739221|FG022|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
48696992|NCT02052778|156739199|FG000|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
48696993|NCT02052778|156739200|FG001|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
48696994|NCT02052778|156739201|FG002|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
48696995|NCT02052778|156739202|FG003|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
48696996|NCT02052778|156739203|FG004|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
48696997|NCT02052778|156739204|FG005|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
48696998|NCT02052778|156739205|FG006|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
48696999|NCT02052778|156739206|FG007|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
48697000|NCT02052778|156739207|FG008|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
48697001|NCT02052778|156739208|FG009|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
48697002|NCT02052778|156739209|FG010|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
48697003|NCT02052778|156739210|FG011|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
48697004|NCT02052778|156739211|FG012|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
48697005|NCT02052778|156739212|FG013|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
48697006|NCT02052778|156739213|FG014|Dose Expansion (Approximately 59 Months)|Radiographic progression|38|||
48697007|NCT02052778|156739214|FG015|Dose Expansion (Approximately 59 Months)|Radiographic progression|23|||
48697008|NCT02052778|156739215|FG016|Dose Expansion (Approximately 59 Months)|Radiographic progression|12|||
48697009|NCT02052778|156739216|FG017|Dose Expansion (Approximately 59 Months)|Radiographic progression|11|||
48697010|NCT02052778|156739217|FG018|Dose Expansion (Approximately 59 Months)|Radiographic progression|17|||
48697011|NCT02052778|156739218|FG019|Dose Expansion (Approximately 59 Months)|Radiographic progression|21|||
48697012|NCT02052778|156739219|FG020|Dose Expansion (Approximately 59 Months)|Radiographic progression|14|||
48697013|NCT02052778|156739220|FG021|Dose Expansion (Approximately 59 Months)|Radiographic progression|6|||
48742934|NCT01550289|156910419|FG000|Overall Study|Protocol Violation|1|||
48909761|NCT00467779|157506071|FG002|Stage 2A|Adverse Event|0|||
48909762|NCT00467779|157506072|FG003|Stage 2A|Adverse Event|0|||
48909763|NCT00467779|157506073|FG004|Stage 2A|Adverse Event|0|||
48909764|NCT00467779|157506074|FG005|Stage 2A|Adverse Event|0|||
48697014|NCT02052778|156739221|FG022|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
48697015|NCT02052778|156739199|FG000|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
48697016|NCT02052778|156739200|FG001|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
48697017|NCT02052778|156739201|FG002|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
48697018|NCT02052778|156739202|FG003|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
48697019|NCT02052778|156739203|FG004|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
48697020|NCT02052778|156739204|FG005|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
48697021|NCT02052778|156739205|FG006|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
48697022|NCT02052778|156739206|FG007|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
48697023|NCT02052778|156739207|FG008|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
48697024|NCT02052778|156739208|FG009|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
48697025|NCT02052778|156739209|FG010|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
48697026|NCT02052778|156739210|FG011|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
48697027|NCT02052778|156739211|FG012|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
48697028|NCT02052778|156739212|FG013|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
48697029|NCT02052778|156739213|FG014|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|6|||
48697030|NCT02052778|156739214|FG015|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
48697031|NCT02052778|156739215|FG016|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
48697032|NCT02052778|156739216|FG017|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|2|||
48697033|NCT02052778|156739217|FG018|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
48697034|NCT02052778|156739218|FG019|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|4|||
48697035|NCT02052778|156739219|FG020|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|5|||
48697036|NCT02052778|156739220|FG021|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|1|||
48697037|NCT02052778|156739221|FG022|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
48697038|NCT02052778|156739199|FG000|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
48697039|NCT02052778|156739200|FG001|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
48697040|NCT02052778|156739201|FG002|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
48697041|NCT02052778|156739202|FG003|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
48697042|NCT02052778|156739203|FG004|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
48697043|NCT02052778|156739204|FG005|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
48697044|NCT02052778|156739205|FG006|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
48697045|NCT02052778|156739206|FG007|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
48697046|NCT02052778|156739207|FG008|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
48697047|NCT02052778|156739208|FG009|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
48697048|NCT02052778|156739209|FG010|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
48697049|NCT02052778|156739210|FG011|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
48697050|NCT02052778|156739211|FG012|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
48697051|NCT02052778|156739212|FG013|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
48697052|NCT02052778|156739213|FG014|Dose Expansion (Approximately 59 Months)|Adverse Event|5|||
48697053|NCT02052778|156739214|FG015|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
48697054|NCT02052778|156739215|FG016|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
48697055|NCT02052778|156739216|FG017|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
48697056|NCT02052778|156739217|FG018|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
48697057|NCT02052778|156739218|FG019|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
48697058|NCT02052778|156739219|FG020|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
48697059|NCT02052778|156739220|FG021|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
48697060|NCT02052778|156739221|FG022|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
48697061|NCT02052778|156739199|FG000|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
48697062|NCT02052778|156739200|FG001|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
48697063|NCT02052778|156739201|FG002|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
48697064|NCT02052778|156739202|FG003|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
48697065|NCT02052778|156739203|FG004|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
48697066|NCT02052778|156739204|FG005|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
48697067|NCT02052778|156739205|FG006|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
48697068|NCT02052778|156739206|FG007|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
48697069|NCT02052778|156739207|FG008|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
48697070|NCT02052778|156739208|FG009|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
48697071|NCT02052778|156739209|FG010|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
48697072|NCT02052778|156739210|FG011|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
48742935|NCT01550289|156910420|FG001|Overall Study|Protocol Violation|0|||
48697073|NCT02052778|156739211|FG012|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
48697074|NCT02052778|156739212|FG013|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
48697075|NCT02052778|156739213|FG014|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|2|||
48697076|NCT02052778|156739214|FG015|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|3|||
48697077|NCT02052778|156739215|FG016|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
48697078|NCT02052778|156739216|FG017|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
48697079|NCT02052778|156739217|FG018|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
48697080|NCT02052778|156739218|FG019|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
48697081|NCT02052778|156739219|FG020|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
48697082|NCT02052778|156739220|FG021|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
48697083|NCT02052778|156739221|FG022|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
48697084|NCT02052778|156739199|FG000|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
48697085|NCT02052778|156739200|FG001|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
48697086|NCT02052778|156739201|FG002|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
48697087|NCT02052778|156739202|FG003|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
48697088|NCT02052778|156739203|FG004|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
48697089|NCT02052778|156739204|FG005|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
48697090|NCT02052778|156739205|FG006|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
48697091|NCT02052778|156739206|FG007|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
48697092|NCT02052778|156739207|FG008|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
48697093|NCT02052778|156739208|FG009|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
48697094|NCT02052778|156739209|FG010|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
48697095|NCT02052778|156739210|FG011|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
48697096|NCT02052778|156739211|FG012|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
48697097|NCT02052778|156739212|FG013|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
48697098|NCT02052778|156739213|FG014|Dose Expansion (Approximately 59 Months)|Investigator decision|5|||
48697099|NCT02052778|156739214|FG015|Dose Expansion (Approximately 59 Months)|Investigator decision|3|||
48697100|NCT02052778|156739215|FG016|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
48697101|NCT02052778|156739216|FG017|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
48697102|NCT02052778|156739217|FG018|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
48697103|NCT02052778|156739218|FG019|Dose Expansion (Approximately 59 Months)|Investigator decision|1|||
48697104|NCT02052778|156739219|FG020|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
48697105|NCT02052778|156739220|FG021|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
48697106|NCT02052778|156739221|FG022|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
48697107|NCT02052778|156739199|FG000|Dose Expansion (Approximately 59 Months)|Other|0|||
48697108|NCT02052778|156739200|FG001|Dose Expansion (Approximately 59 Months)|Other|0|||
48697109|NCT02052778|156739201|FG002|Dose Expansion (Approximately 59 Months)|Other|0|||
48697110|NCT02052778|156739202|FG003|Dose Expansion (Approximately 59 Months)|Other|0|||
48697111|NCT02052778|156739203|FG004|Dose Expansion (Approximately 59 Months)|Other|0|||
48697112|NCT02052778|156739204|FG005|Dose Expansion (Approximately 59 Months)|Other|0|||
48697113|NCT02052778|156739205|FG006|Dose Expansion (Approximately 59 Months)|Other|0|||
48697114|NCT02052778|156739206|FG007|Dose Expansion (Approximately 59 Months)|Other|0|||
48697115|NCT02052778|156739207|FG008|Dose Expansion (Approximately 59 Months)|Other|0|||
48697116|NCT02052778|156739208|FG009|Dose Expansion (Approximately 59 Months)|Other|0|||
48697117|NCT02052778|156739209|FG010|Dose Expansion (Approximately 59 Months)|Other|0|||
48697118|NCT02052778|156739210|FG011|Dose Expansion (Approximately 59 Months)|Other|0|||
48697119|NCT02052778|156739211|FG012|Dose Expansion (Approximately 59 Months)|Other|0|||
48697120|NCT02052778|156739212|FG013|Dose Expansion (Approximately 59 Months)|Other|0|||
48697121|NCT02052778|156739213|FG014|Dose Expansion (Approximately 59 Months)|Other|1|||
48697122|NCT02052778|156739214|FG015|Dose Expansion (Approximately 59 Months)|Other|1|||
48697123|NCT02052778|156739215|FG016|Dose Expansion (Approximately 59 Months)|Other|0|||
48697124|NCT02052778|156739216|FG017|Dose Expansion (Approximately 59 Months)|Other|0|||
48697125|NCT02052778|156739217|FG018|Dose Expansion (Approximately 59 Months)|Other|1|||
48697126|NCT02052778|156739218|FG019|Dose Expansion (Approximately 59 Months)|Other|0|||
48697127|NCT02052778|156739219|FG020|Dose Expansion (Approximately 59 Months)|Other|0|||
48697128|NCT02052778|156739220|FG021|Dose Expansion (Approximately 59 Months)|Other|1|||
48697129|NCT02052778|156739221|FG022|Dose Expansion (Approximately 59 Months)|Other|0|||
48697130|NCT02052778|156739199|FG000|Dose Expansion (Approximately 59 Months)|Untreated|0|||
48697131|NCT02052778|156739200|FG001|Dose Expansion (Approximately 59 Months)|Untreated|0|||
48697132|NCT02052778|156739201|FG002|Dose Expansion (Approximately 59 Months)|Untreated|0|||
48697133|NCT02052778|156739202|FG003|Dose Expansion (Approximately 59 Months)|Untreated|0|||
48697134|NCT02052778|156739203|FG004|Dose Expansion (Approximately 59 Months)|Untreated|0|||
48697135|NCT02052778|156739204|FG005|Dose Expansion (Approximately 59 Months)|Untreated|0|||
48909765|NCT00467779|157506075|FG006|Stage 2A|Adverse Event|0|||
48909766|NCT00467779|157506076|FG007|Stage 2A|Adverse Event|0|||
48697136|NCT02052778|156739205|FG006|Dose Expansion (Approximately 59 Months)|Untreated|0|||
48697137|NCT02052778|156739206|FG007|Dose Expansion (Approximately 59 Months)|Untreated|0|||
48697138|NCT02052778|156739207|FG008|Dose Expansion (Approximately 59 Months)|Untreated|0|||
48697139|NCT02052778|156739208|FG009|Dose Expansion (Approximately 59 Months)|Untreated|0|||
48697140|NCT02052778|156739209|FG010|Dose Expansion (Approximately 59 Months)|Untreated|0|||
48697141|NCT02052778|156739210|FG011|Dose Expansion (Approximately 59 Months)|Untreated|0|||
48697142|NCT02052778|156739211|FG012|Dose Expansion (Approximately 59 Months)|Untreated|0|||
48697143|NCT02052778|156739212|FG013|Dose Expansion (Approximately 59 Months)|Untreated|0|||
48697144|NCT02052778|156739213|FG014|Dose Expansion (Approximately 59 Months)|Untreated|1|||
48697145|NCT02052778|156739214|FG015|Dose Expansion (Approximately 59 Months)|Untreated|1|||
48697146|NCT02052778|156739215|FG016|Dose Expansion (Approximately 59 Months)|Untreated|1|||
48697147|NCT02052778|156739216|FG017|Dose Expansion (Approximately 59 Months)|Untreated|0|||
48697148|NCT02052778|156739217|FG018|Dose Expansion (Approximately 59 Months)|Untreated|1|||
48697149|NCT02052778|156739218|FG019|Dose Expansion (Approximately 59 Months)|Untreated|0|||
48697150|NCT02052778|156739219|FG020|Dose Expansion (Approximately 59 Months)|Untreated|0|||
48697151|NCT02052778|156739220|FG021|Dose Expansion (Approximately 59 Months)|Untreated|0|||
48697152|NCT02052778|156739221|FG022|Dose Expansion (Approximately 59 Months)|Untreated|0|||
48697153|NCT02052778|156739199|FG000|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
48697154|NCT02052778|156739200|FG001|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
48697155|NCT02052778|156739201|FG002|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
48697156|NCT02052778|156739202|FG003|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
48697157|NCT02052778|156739203|FG004|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
48697158|NCT02052778|156739204|FG005|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
48697159|NCT02052778|156739205|FG006|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
48697160|NCT02052778|156739206|FG007|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
48697161|NCT02052778|156739207|FG008|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
48697162|NCT02052778|156739208|FG009|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
48697163|NCT02052778|156739209|FG010|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
48697164|NCT02052778|156739210|FG011|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
48697165|NCT02052778|156739211|FG012|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
48697166|NCT02052778|156739212|FG013|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
48697167|NCT02052778|156739213|FG014|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
48697168|NCT02052778|156739214|FG015|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
48697169|NCT02052778|156739215|FG016|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
48697170|NCT02052778|156739216|FG017|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
48697171|NCT02052778|156739217|FG018|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
48697172|NCT02052778|156739218|FG019|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
48697173|NCT02052778|156739219|FG020|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
48697174|NCT02052778|156739220|FG021|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
48697175|NCT02052778|156739221|FG022|Phase 2 (Approximately 63 Months)|Adverse Event|7|||
48697176|NCT02052778|156739199|FG000|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
48697177|NCT02052778|156739200|FG001|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
48697178|NCT02052778|156739201|FG002|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
48697179|NCT02052778|156739202|FG003|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
48697180|NCT02052778|156739203|FG004|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
48697181|NCT02052778|156739204|FG005|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
48697182|NCT02052778|156739205|FG006|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
48697183|NCT02052778|156739206|FG007|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
48697184|NCT02052778|156739207|FG008|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
48697185|NCT02052778|156739208|FG009|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
48697186|NCT02052778|156739209|FG010|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
48697187|NCT02052778|156739210|FG011|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
48697188|NCT02052778|156739211|FG012|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
48697189|NCT02052778|156739212|FG013|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
48697190|NCT02052778|156739213|FG014|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
48697191|NCT02052778|156739214|FG015|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
48697192|NCT02052778|156739215|FG016|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
48697193|NCT02052778|156739216|FG017|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
48697194|NCT02052778|156739217|FG018|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
48697195|NCT02052778|156739218|FG019|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
48697196|NCT02052778|156739219|FG020|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
48697197|NCT02052778|156739220|FG021|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
48697198|NCT02052778|156739221|FG022|Phase 2 (Approximately 63 Months)|Radiologic Progression|78|||
48697199|NCT02052778|156739199|FG000|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
48697200|NCT02052778|156739200|FG001|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
48697201|NCT02052778|156739201|FG002|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
48697202|NCT02052778|156739202|FG003|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
48697203|NCT02052778|156739203|FG004|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
48697204|NCT02052778|156739204|FG005|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
48697205|NCT02052778|156739205|FG006|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
48697206|NCT02052778|156739206|FG007|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
48697207|NCT02052778|156739207|FG008|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
48697208|NCT02052778|156739208|FG009|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
48697209|NCT02052778|156739209|FG010|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
48697210|NCT02052778|156739210|FG011|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
48697211|NCT02052778|156739211|FG012|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
48697212|NCT02052778|156739212|FG013|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
48697213|NCT02052778|156739213|FG014|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
48697214|NCT02052778|156739214|FG015|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
48697215|NCT02052778|156739215|FG016|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
48697216|NCT02052778|156739216|FG017|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
48697217|NCT02052778|156739217|FG018|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
48697218|NCT02052778|156739218|FG019|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
48697219|NCT02052778|156739219|FG020|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
48697220|NCT02052778|156739220|FG021|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
48697221|NCT02052778|156739221|FG022|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|6|||
48697222|NCT02052778|156739199|FG000|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
48697223|NCT02052778|156739200|FG001|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
48697224|NCT02052778|156739201|FG002|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
48697225|NCT02052778|156739202|FG003|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
48697226|NCT02052778|156739203|FG004|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
48697227|NCT02052778|156739204|FG005|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
48697228|NCT02052778|156739205|FG006|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
48697229|NCT02052778|156739206|FG007|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
48697230|NCT02052778|156739207|FG008|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
48697231|NCT02052778|156739208|FG009|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
48697232|NCT02052778|156739209|FG010|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
48697233|NCT02052778|156739210|FG011|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
48697234|NCT02052778|156739211|FG012|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
48697235|NCT02052778|156739212|FG013|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
48697236|NCT02052778|156739213|FG014|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
48697237|NCT02052778|156739214|FG015|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
48697238|NCT02052778|156739215|FG016|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
48697239|NCT02052778|156739216|FG017|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
48697240|NCT02052778|156739217|FG018|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
48697241|NCT02052778|156739218|FG019|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
48697242|NCT02052778|156739219|FG020|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
48697243|NCT02052778|156739220|FG021|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
48697244|NCT02052778|156739221|FG022|Phase 2 (Approximately 63 Months)|Withdrawal by participant|2|||
48697245|NCT02052778|156739199|FG000|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
48697246|NCT02052778|156739200|FG001|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
48697247|NCT02052778|156739201|FG002|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
48697248|NCT02052778|156739202|FG003|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
48697249|NCT02052778|156739203|FG004|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
48697250|NCT02052778|156739204|FG005|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
48697251|NCT02052778|156739205|FG006|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
48697252|NCT02052778|156739206|FG007|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
48697253|NCT02052778|156739207|FG008|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
48697254|NCT02052778|156739208|FG009|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
48697255|NCT02052778|156739209|FG010|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
48697256|NCT02052778|156739210|FG011|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
48697257|NCT02052778|156739211|FG012|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
48697258|NCT02052778|156739212|FG013|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
48697259|NCT02052778|156739213|FG014|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
48697260|NCT02052778|156739214|FG015|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
48697261|NCT02052778|156739215|FG016|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
48697262|NCT02052778|156739216|FG017|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
48697263|NCT02052778|156739217|FG018|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
48697264|NCT02052778|156739218|FG019|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
48697265|NCT02052778|156739219|FG020|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
48697266|NCT02052778|156739220|FG021|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
48697267|NCT02052778|156739221|FG022|Phase 2 (Approximately 63 Months)|Investigator Decision|3|||
48697268|NCT02052778|156739199|FG000|Phase 2 (Approximately 63 Months)|Other|0|||
48697269|NCT02052778|156739200|FG001|Phase 2 (Approximately 63 Months)|Other|0|||
48697270|NCT02052778|156739201|FG002|Phase 2 (Approximately 63 Months)|Other|0|||
48697271|NCT02052778|156739202|FG003|Phase 2 (Approximately 63 Months)|Other|0|||
48697272|NCT02052778|156739203|FG004|Phase 2 (Approximately 63 Months)|Other|0|||
48697273|NCT02052778|156739204|FG005|Phase 2 (Approximately 63 Months)|Other|0|||
48697274|NCT02052778|156739205|FG006|Phase 2 (Approximately 63 Months)|Other|0|||
48697275|NCT02052778|156739206|FG007|Phase 2 (Approximately 63 Months)|Other|0|||
48697276|NCT02052778|156739207|FG008|Phase 2 (Approximately 63 Months)|Other|0|||
48697277|NCT02052778|156739208|FG009|Phase 2 (Approximately 63 Months)|Other|0|||
48697278|NCT02052778|156739209|FG010|Phase 2 (Approximately 63 Months)|Other|0|||
48697279|NCT02052778|156739210|FG011|Phase 2 (Approximately 63 Months)|Other|0|||
48697280|NCT02052778|156739211|FG012|Phase 2 (Approximately 63 Months)|Other|0|||
48697281|NCT02052778|156739212|FG013|Phase 2 (Approximately 63 Months)|Other|0|||
48697282|NCT02052778|156739213|FG014|Phase 2 (Approximately 63 Months)|Other|0|||
48697283|NCT02052778|156739214|FG015|Phase 2 (Approximately 63 Months)|Other|0|||
48697284|NCT02052778|156739215|FG016|Phase 2 (Approximately 63 Months)|Other|0|||
48697285|NCT02052778|156739216|FG017|Phase 2 (Approximately 63 Months)|Other|0|||
48697286|NCT02052778|156739217|FG018|Phase 2 (Approximately 63 Months)|Other|0|||
48697287|NCT02052778|156739218|FG019|Phase 2 (Approximately 63 Months)|Other|0|||
48697288|NCT02052778|156739219|FG020|Phase 2 (Approximately 63 Months)|Other|0|||
48697289|NCT02052778|156739220|FG021|Phase 2 (Approximately 63 Months)|Other|0|||
48697290|NCT02052778|156739221|FG022|Phase 2 (Approximately 63 Months)|Other|7|||
48697291|NCT02052778|156739199|FG000|Phase 2 (Approximately 63 Months)|Untreated|0|||
48697292|NCT02052778|156739200|FG001|Phase 2 (Approximately 63 Months)|Untreated|0|||
48697293|NCT02052778|156739201|FG002|Phase 2 (Approximately 63 Months)|Untreated|0|||
48697294|NCT02052778|156739202|FG003|Phase 2 (Approximately 63 Months)|Untreated|0|||
48697295|NCT02052778|156739203|FG004|Phase 2 (Approximately 63 Months)|Untreated|0|||
48697296|NCT02052778|156739204|FG005|Phase 2 (Approximately 63 Months)|Untreated|0|||
48697297|NCT02052778|156739205|FG006|Phase 2 (Approximately 63 Months)|Untreated|0|||
48697298|NCT02052778|156739206|FG007|Phase 2 (Approximately 63 Months)|Untreated|0|||
48697299|NCT02052778|156739207|FG008|Phase 2 (Approximately 63 Months)|Untreated|0|||
48697300|NCT02052778|156739208|FG009|Phase 2 (Approximately 63 Months)|Untreated|0|||
48697301|NCT02052778|156739209|FG010|Phase 2 (Approximately 63 Months)|Untreated|0|||
48697302|NCT02052778|156739210|FG011|Phase 2 (Approximately 63 Months)|Untreated|0|||
48697303|NCT02052778|156739211|FG012|Phase 2 (Approximately 63 Months)|Untreated|0|||
48697304|NCT02052778|156739212|FG013|Phase 2 (Approximately 63 Months)|Untreated|0|||
48697305|NCT02052778|156739213|FG014|Phase 2 (Approximately 63 Months)|Untreated|0|||
48697306|NCT02052778|156739214|FG015|Phase 2 (Approximately 63 Months)|Untreated|0|||
48697307|NCT02052778|156739215|FG016|Phase 2 (Approximately 63 Months)|Untreated|0|||
48697308|NCT02052778|156739216|FG017|Phase 2 (Approximately 63 Months)|Untreated|0|||
48697309|NCT02052778|156739217|FG018|Phase 2 (Approximately 63 Months)|Untreated|0|||
48697310|NCT02052778|156739218|FG019|Phase 2 (Approximately 63 Months)|Untreated|0|||
48697311|NCT02052778|156739219|FG020|Phase 2 (Approximately 63 Months)|Untreated|0|||
48697312|NCT02052778|156739220|FG021|Phase 2 (Approximately 63 Months)|Untreated|0|||
48697313|NCT02052778|156739221|FG022|Phase 2 (Approximately 63 Months)|Untreated|17|||
48697314|NCT01346358|156739222|FG000|Overall Study|Withdrawal by Subject|1|||
48697315|NCT01346358|156739223|FG001|Overall Study|Withdrawal by Subject|0|||
48697316|NCT01346358|156739224|FG002|Overall Study|Withdrawal by Subject|1|||
48697317|NCT01346358|156739225|FG003|Overall Study|Withdrawal by Subject|1|||
48697318|NCT01346358|156739226|FG004|Overall Study|Withdrawal by Subject|0|||
48697319|NCT01346358|156739227|FG005|Overall Study|Withdrawal by Subject|2|||
48697320|NCT01346358|156739228|FG006|Overall Study|Withdrawal by Subject|1|||
48697321|NCT01346358|156739229|FG007|Overall Study|Withdrawal by Subject|1|||
48697322|NCT01346358|156739230|FG008|Overall Study|Withdrawal by Subject|1|||
48697323|NCT01346358|156739222|FG000|Overall Study|Adverse Event|1|||
48697324|NCT01346358|156739223|FG001|Overall Study|Adverse Event|0|||
48697325|NCT01346358|156739224|FG002|Overall Study|Adverse Event|0|||
48697326|NCT01346358|156739225|FG003|Overall Study|Adverse Event|0|||
48697327|NCT01346358|156739226|FG004|Overall Study|Adverse Event|1|||
48697328|NCT01346358|156739227|FG005|Overall Study|Adverse Event|0|||
48697329|NCT01346358|156739228|FG006|Overall Study|Adverse Event|0|||
48697330|NCT01346358|156739229|FG007|Overall Study|Adverse Event|0|||
48697331|NCT01346358|156739230|FG008|Overall Study|Adverse Event|1|||
48697332|NCT01346358|156739222|FG000|Overall Study|Non-Compliance|0|||
48697333|NCT01346358|156739223|FG001|Overall Study|Non-Compliance|0|||
48697334|NCT01346358|156739224|FG002|Overall Study|Non-Compliance|0|||
48697335|NCT01346358|156739225|FG003|Overall Study|Non-Compliance|0|||
48697336|NCT01346358|156739226|FG004|Overall Study|Non-Compliance|0|||
48697337|NCT01346358|156739227|FG005|Overall Study|Non-Compliance|0|||
48697338|NCT01346358|156739228|FG006|Overall Study|Non-Compliance|0|||
48697339|NCT01346358|156739229|FG007|Overall Study|Non-Compliance|2|||
48697340|NCT01346358|156739230|FG008|Overall Study|Non-Compliance|0|||
48697341|NCT01346358|156739222|FG000|Overall Study|Physician Decision|0|||
48697342|NCT01346358|156739223|FG001|Overall Study|Physician Decision|1|||
48697343|NCT01346358|156739224|FG002|Overall Study|Physician Decision|0|||
48697344|NCT01346358|156739225|FG003|Overall Study|Physician Decision|0|||
48697345|NCT01346358|156739226|FG004|Overall Study|Physician Decision|0|||
48697346|NCT01346358|156739227|FG005|Overall Study|Physician Decision|0|||
48697347|NCT01346358|156739228|FG006|Overall Study|Physician Decision|0|||
48697348|NCT01346358|156739229|FG007|Overall Study|Physician Decision|1|||
48697349|NCT01346358|156739230|FG008|Overall Study|Physician Decision|1|||
48697350|NCT03253796|156739235|FG000|Period 1: Run-In|Adverse Event|4|||
48697351|NCT03253796|156739236|FG001|Period 1: Run-In|Adverse Event|0|||
48697352|NCT03253796|156739237|FG002|Period 1: Run-In|Adverse Event|0|||
48697353|NCT03253796|156739238|FG003|Period 1: Run-In|Adverse Event|0|||
48697354|NCT03253796|156739239|FG004|Period 1: Run-In|Adverse Event|0|||
48697355|NCT03253796|156739235|FG000|Period 1: Run-In|Lack of Efficacy|1|||
48697356|NCT03253796|156739236|FG001|Period 1: Run-In|Lack of Efficacy|0|||
48697357|NCT03253796|156739237|FG002|Period 1: Run-In|Lack of Efficacy|0|||
48697358|NCT03253796|156739238|FG003|Period 1: Run-In|Lack of Efficacy|0|||
48697359|NCT03253796|156739239|FG004|Period 1: Run-In|Lack of Efficacy|0|||
48697360|NCT03253796|156739235|FG000|Period 1: Run-In|Lack of Qualifying Event|98|||
48697361|NCT03253796|156739236|FG001|Period 1: Run-In|Lack of Qualifying Event|0|||
48697362|NCT03253796|156739237|FG002|Period 1: Run-In|Lack of Qualifying Event|0|||
48697363|NCT03253796|156739238|FG003|Period 1: Run-In|Lack of Qualifying Event|0|||
48697364|NCT03253796|156739239|FG004|Period 1: Run-In|Lack of Qualifying Event|0|||
48697365|NCT03253796|156739235|FG000|Period 1: Run-In|Protocol Violation|5|||
48697366|NCT03253796|156739236|FG001|Period 1: Run-In|Protocol Violation|0|||
48697367|NCT03253796|156739237|FG002|Period 1: Run-In|Protocol Violation|0|||
48697368|NCT03253796|156739238|FG003|Period 1: Run-In|Protocol Violation|0|||
48697369|NCT03253796|156739239|FG004|Period 1: Run-In|Protocol Violation|0|||
48697370|NCT03253796|156739235|FG000|Period 1: Run-In|Withdrawal by Subject|8|||
48697371|NCT03253796|156739236|FG001|Period 1: Run-In|Withdrawal by Subject|0|||
48697372|NCT03253796|156739237|FG002|Period 1: Run-In|Withdrawal by Subject|0|||
48697373|NCT03253796|156739238|FG003|Period 1: Run-In|Withdrawal by Subject|0|||
48697374|NCT03253796|156739239|FG004|Period 1: Run-In|Withdrawal by Subject|0|||
48697375|NCT03253796|156739235|FG000|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
48697376|NCT03253796|156739236|FG001|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
48697377|NCT03253796|156739237|FG002|Period 2: Withdrawal vs Continued Tx|Adverse Event|2|||
48697378|NCT03253796|156739238|FG003|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
48697379|NCT03253796|156739239|FG004|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
48697380|NCT03253796|156739235|FG000|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
48697381|NCT03253796|156739236|FG001|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
48697382|NCT03253796|156739237|FG002|Period 2: Withdrawal vs Continued Tx|Physician Decision|1|||
48697383|NCT03253796|156739238|FG003|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
48697384|NCT03253796|156739239|FG004|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
48697385|NCT03253796|156739235|FG000|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
48697386|NCT03253796|156739236|FG001|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
48697387|NCT03253796|156739237|FG002|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|2|||
48697388|NCT03253796|156739238|FG003|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|3|||
48697389|NCT03253796|156739239|FG004|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
48697390|NCT03253796|156739235|FG000|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
48697391|NCT03253796|156739236|FG001|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
48697392|NCT03253796|156739237|FG002|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|1|||
48697393|NCT03253796|156739238|FG003|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
48697394|NCT03253796|156739239|FG004|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
48697395|NCT03253796|156739235|FG000|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
48697396|NCT03253796|156739236|FG001|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|10|||
48697397|NCT03253796|156739237|FG002|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|15|||
48697398|NCT03253796|156739238|FG003|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|38|||
48697399|NCT03253796|156739239|FG004|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
48697400|NCT03253796|156739235|FG000|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
48697401|NCT03253796|156739236|FG001|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
48697402|NCT03253796|156739237|FG002|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
48697403|NCT03253796|156739238|FG003|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
48697404|NCT03253796|156739239|FG004|Period 2: Open-Label Retreatment|Withdrawal by Subject|5|||
48697405|NCT01451606|156739242|FG000|Overall Study|Withdrawal by Subject|4|||
48697406|NCT01451606|156739243|FG001|Overall Study|Withdrawal by Subject|3|||
48697407|NCT00388349|156739252|FG000|Phase I Dose Escalation|Dose reduction due to DLT|0|||
48697408|NCT00388349|156739253|FG001|Phase I Dose Escalation|Dose reduction due to DLT|3|||
48697409|NCT01710345|156739254|FG000|Overall Study|Adverse Event|0|||
48697410|NCT01710345|156739255|FG001|Overall Study|Adverse Event|2|||
48697411|NCT01710345|156739256|FG002|Overall Study|Adverse Event|0|||
48697412|NCT01710345|156739254|FG000|Overall Study|Lack of Efficacy|2|||
48697413|NCT01710345|156739255|FG001|Overall Study|Lack of Efficacy|3|||
48697414|NCT01710345|156739256|FG002|Overall Study|Lack of Efficacy|1|||
48697415|NCT01710345|156739254|FG000|Overall Study|Drug Dosing Error|1|||
48697416|NCT01710345|156739255|FG001|Overall Study|Drug Dosing Error|0|||
48697417|NCT01710345|156739256|FG002|Overall Study|Drug Dosing Error|0|||
48697418|NCT01667900|156739260|FG000|Part B|Death|0|||
48697419|NCT01667900|156739261|FG001|Part B|Death|0|||
48697420|NCT01667900|156739262|FG002|Part B|Death|0|||
48697421|NCT01667900|156739263|FG003|Part B|Death|0|||
48697422|NCT01667900|156739264|FG004|Part B|Death|0|||
48697423|NCT01667900|156739265|FG005|Part B|Death|0|||
48697424|NCT01667900|156739266|FG006|Part B|Death|0|||
48697425|NCT01667900|156739267|FG007|Part B|Death|0|||
48697426|NCT01667900|156739268|FG008|Part B|Death|0|||
48697427|NCT01667900|156739269|FG009|Part B|Death|0|||
48697428|NCT01667900|156739270|FG010|Part B|Death|0|||
48697429|NCT01667900|156739271|FG011|Part B|Death|0|||
48697430|NCT01667900|156739272|FG012|Part B|Death|0|||
48697431|NCT01667900|156739273|FG013|Part B|Death|0|||
48697432|NCT01667900|156739274|FG014|Part B|Death|0|||
48697433|NCT01667900|156739275|FG015|Part B|Death|0|||
48697434|NCT01667900|156739276|FG016|Part B|Death|1|||
48697435|NCT01667900|156739277|FG017|Part B|Death|0|||
48697436|NCT01667900|156739278|FG018|Part B|Death|0|||
48697437|NCT01667900|156739279|FG019|Part B|Death|0|||
48697438|NCT04011540|156739281|FG000|Overall Study|Lost to Follow-up|9|||
48697439|NCT04011540|156739282|FG001|Overall Study|Lost to Follow-up|6|||
48697440|NCT01126749|156739284|FG000|Phase 1b|Other|0|||
48697441|NCT01126749|156739285|FG001|Phase 1b|Other|1|||
48697442|NCT01126749|156739286|FG002|Phase 1b|Other|0|||
48697443|NCT01126749|156739287|FG003|Phase 1b|Other|0|||
48697444|NCT01126749|156739284|FG000|Phase 1b|Withdrawal by Subject|0|||
48697445|NCT01126749|156739285|FG001|Phase 1b|Withdrawal by Subject|1|||
48697446|NCT01126749|156739286|FG002|Phase 1b|Withdrawal by Subject|0|||
48697447|NCT01126749|156739287|FG003|Phase 1b|Withdrawal by Subject|0|||
48697448|NCT01126749|156739284|FG000|Phase 1b|Death|3|||
48697449|NCT01126749|156739285|FG001|Phase 1b|Death|4|||
48697450|NCT01126749|156739286|FG002|Phase 1b|Death|0|||
48697451|NCT01126749|156739287|FG003|Phase 1b|Death|0|||
48697452|NCT01126749|156739284|FG000|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
48697453|NCT01126749|156739285|FG001|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
48697454|NCT01126749|156739286|FG002|Phase 2|Completed 1 Year Follow-Up Per Protocol|4|||
48697455|NCT01126749|156739287|FG003|Phase 2|Completed 1 Year Follow-Up Per Protocol|7|||
48697456|NCT01126749|156739284|FG000|Phase 2|Study Termination by Sponsor|0|||
48697457|NCT01126749|156739285|FG001|Phase 2|Study Termination by Sponsor|0|||
48697458|NCT01126749|156739286|FG002|Phase 2|Study Termination by Sponsor|12|||
48697459|NCT01126749|156739287|FG003|Phase 2|Study Termination by Sponsor|6|||
48697460|NCT01126749|156739284|FG000|Phase 2|Other|0|||
48697461|NCT01126749|156739285|FG001|Phase 2|Other|0|||
48697462|NCT01126749|156739286|FG002|Phase 2|Other|4|||
48697463|NCT01126749|156739287|FG003|Phase 2|Other|2|||
48697464|NCT01126749|156739284|FG000|Phase 2|Withdrawal by Subject|0|||
48697465|NCT01126749|156739285|FG001|Phase 2|Withdrawal by Subject|0|||
48697466|NCT01126749|156739286|FG002|Phase 2|Withdrawal by Subject|0|||
48697467|NCT01126749|156739287|FG003|Phase 2|Withdrawal by Subject|2|||
48697468|NCT01126749|156739284|FG000|Phase 2|Lost to Follow-up|0|||
48697469|NCT01126749|156739285|FG001|Phase 2|Lost to Follow-up|0|||
48697470|NCT01126749|156739286|FG002|Phase 2|Lost to Follow-up|0|||
48697471|NCT01126749|156739287|FG003|Phase 2|Lost to Follow-up|1|||
48697472|NCT01126749|156739284|FG000|Phase 2|Death|0|||
48697473|NCT01126749|156739285|FG001|Phase 2|Death|0|||
48697474|NCT01126749|156739286|FG002|Phase 2|Death|22|||
48697475|NCT01126749|156739287|FG003|Phase 2|Death|22|||
48697476|NCT01126749|156739284|FG000|Phase 2|Adverse Event|0|||
48697477|NCT01126749|156739285|FG001|Phase 2|Adverse Event|0|||
48697478|NCT01126749|156739286|FG002|Phase 2|Adverse Event|0|||
48697479|NCT01126749|156739287|FG003|Phase 2|Adverse Event|1|||
48697480|NCT00537394|156739288|FG000|First Year of Follow-up|Death|7|||
48697481|NCT00537394|156739289|FG001|First Year of Follow-up|Death|0|||
48697482|NCT00537394|156739290|FG002|First Year of Follow-up|Death|0|||
48697483|NCT00537394|156739288|FG000|First Year of Follow-up|Severe debilitation|1|||
48697484|NCT00537394|156739289|FG001|First Year of Follow-up|Severe debilitation|0|||
48697485|NCT00537394|156739290|FG002|First Year of Follow-up|Severe debilitation|1|||
48697486|NCT00537394|156739288|FG000|First Year of Follow-up|Withdrawal by Subject|3|||
48697487|NCT00537394|156739289|FG001|First Year of Follow-up|Withdrawal by Subject|6|||
48697488|NCT00537394|156739290|FG002|First Year of Follow-up|Withdrawal by Subject|1|||
48697489|NCT00537394|156739288|FG000|First Year of Follow-up|Lost to Follow-up|1|||
48697490|NCT00537394|156739289|FG001|First Year of Follow-up|Lost to Follow-up|5|||
48697491|NCT00537394|156739290|FG002|First Year of Follow-up|Lost to Follow-up|1|||
48697492|NCT00537394|156739288|FG000|2nd Year of Follow-up|Death|4|||
48697493|NCT00537394|156739289|FG001|2nd Year of Follow-up|Death|1|||
48697494|NCT00537394|156739290|FG002|2nd Year of Follow-up|Death|2|||
48697495|NCT00537394|156739288|FG000|2nd Year of Follow-up|Withdrawal by Subject|0|||
48697496|NCT00537394|156739289|FG001|2nd Year of Follow-up|Withdrawal by Subject|1|||
48697497|NCT00537394|156739290|FG002|2nd Year of Follow-up|Withdrawal by Subject|2|||
48697498|NCT00537394|156739288|FG000|2nd Year of Follow-up|Lost to Follow-up|6|||
48697499|NCT00537394|156739289|FG001|2nd Year of Follow-up|Lost to Follow-up|7|||
48697500|NCT00537394|156739290|FG002|2nd Year of Follow-up|Lost to Follow-up|2|||
48697501|NCT00537394|156739288|FG000|2nd Year of Follow-up|Clinic site closure|1|||
48697502|NCT00537394|156739289|FG001|2nd Year of Follow-up|Clinic site closure|0|||
48697503|NCT00537394|156739290|FG002|2nd Year of Follow-up|Clinic site closure|0|||
48697504|NCT03668873|156739291|FG000|Overall Study|Lost to Follow-up|6|||
48697505|NCT03668873|156739292|FG001|Overall Study|Lost to Follow-up|3|||
48697506|NCT00627393|156739293|FG000|Intention-To-Treat Analysis|Adjudication indeterminate|5|||
48697507|NCT00627393|156739294|FG001|Intention-To-Treat Analysis|Adjudication indeterminate|3|||
48697508|NCT00627393|156739293|FG000|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4|||
48697509|NCT00627393|156739294|FG001|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5|||
48697510|NCT00627393|156739293|FG000|Per-Protocol Analysis|Received unstimulated/no granulocytes|6|||
48697511|NCT00627393|156739294|FG001|Per-Protocol Analysis|Received unstimulated/no granulocytes|3|||
48697512|NCT00627393|156739293|FG000|Per-Protocol Analysis|Withdrawal by patient/family/physician|4|||
48697513|NCT00627393|156739294|FG001|Per-Protocol Analysis|Withdrawal by patient/family/physician|10|||
48697514|NCT00521079|156739297|FG000|Overall Study|Adverse Event|7|||
48697515|NCT00521079|156739298|FG001|Overall Study|Adverse Event|1|||
48697516|NCT00521079|156739297|FG000|Overall Study|Lost to Follow-up|2|||
48697517|NCT00521079|156739298|FG001|Overall Study|Lost to Follow-up|1|||
48697518|NCT00521079|156739297|FG000|Overall Study|Withdrawal by Subject|5|||
48909767|NCT00467779|157506077|FG008|Stage 2A|Adverse Event|0|||
48697519|NCT00521079|156739298|FG001|Overall Study|Withdrawal by Subject|3|||
48697520|NCT00829426|156739301|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
48697521|NCT00829426|156739302|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
48697522|NCT00770653|156740595|FG000|Overall Study|Adverse Event|13|||
48697523|NCT00770653|156740596|FG001|Overall Study|Adverse Event|5|||
48697524|NCT00770653|156740595|FG000|Overall Study|Protocol Violation|8|||
48697525|NCT00770653|156740596|FG001|Overall Study|Protocol Violation|6|||
48697526|NCT00770653|156740595|FG000|Overall Study|Withdrawal by Subject|4|||
48697527|NCT00770653|156740596|FG001|Overall Study|Withdrawal by Subject|7|||
48697528|NCT00770653|156740595|FG000|Overall Study|Lack of Compliance|1|||
48697529|NCT00770653|156740596|FG001|Overall Study|Lack of Compliance|4|||
48697530|NCT00770653|156740595|FG000|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
48909768|NCT00467779|157506078|FG009|Stage 2A|Adverse Event|0|||
48909769|NCT00467779|157506079|FG010|Stage 2A|Adverse Event|0|||
48909770|NCT00467779|157506080|FG011|Stage 2A|Adverse Event|0|||
48909771|NCT00467779|157506081|FG012|Stage 2A|Adverse Event|0|||
48909772|NCT00467779|157506082|FG013|Stage 2A|Adverse Event|2|||
48909773|NCT00467779|157506083|FG014|Stage 2A|Adverse Event|0|||
48909774|NCT00467779|157506069|FG000|Stage 2A|Death|0|||
48909775|NCT00467779|157506070|FG001|Stage 2A|Death|0|||
48909776|NCT00467779|157506071|FG002|Stage 2A|Death|0|||
48909777|NCT00467779|157506072|FG003|Stage 2A|Death|0|||
48909778|NCT00467779|157506073|FG004|Stage 2A|Death|0|||
48909779|NCT00467779|157506074|FG005|Stage 2A|Death|0|||
48909780|NCT00467779|157506075|FG006|Stage 2A|Death|0|||
48909781|NCT00467779|157506076|FG007|Stage 2A|Death|0|||
48909782|NCT00467779|157506077|FG008|Stage 2A|Death|0|||
48909783|NCT00467779|157506078|FG009|Stage 2A|Death|0|||
48909784|NCT00467779|157506079|FG010|Stage 2A|Death|0|||
48909785|NCT00467779|157506080|FG011|Stage 2A|Death|0|||
48909786|NCT00467779|157506081|FG012|Stage 2A|Death|0|||
48909787|NCT00467779|157506082|FG013|Stage 2A|Death|1|||
48909788|NCT00467779|157506083|FG014|Stage 2A|Death|0|||
48909789|NCT00467779|157506069|FG000|Stage 2A|Disease Progression|0|||
48909790|NCT00467779|157506070|FG001|Stage 2A|Disease Progression|0|||
48909791|NCT00467779|157506071|FG002|Stage 2A|Disease Progression|0|||
48909792|NCT00467779|157506072|FG003|Stage 2A|Disease Progression|0|||
48697531|NCT00770653|156740596|FG001|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
48697532|NCT00770653|156740595|FG000|Overall Study|Fasting Glucose > 240 mg/dL|2|||
48909793|NCT00467779|157506073|FG004|Stage 2A|Disease Progression|0|||
48909794|NCT00467779|157506074|FG005|Stage 2A|Disease Progression|0|||
48909795|NCT00467779|157506075|FG006|Stage 2A|Disease Progression|0|||
49010527|NCT00345683|157875641|FG000|Overall Study|Other|6|||
48697533|NCT00770653|156740596|FG001|Overall Study|Fasting Glucose > 240 mg/dL|1|||
48697534|NCT00770653|156740595|FG000|Overall Study|> Three Moderate Hypoglycemic Episodes|0|||
48909796|NCT00467779|157506076|FG007|Stage 2A|Disease Progression|0|||
48909797|NCT00467779|157506077|FG008|Stage 2A|Disease Progression|0|||
48909798|NCT00467779|157506078|FG009|Stage 2A|Disease Progression|0|||
48909799|NCT00467779|157506079|FG010|Stage 2A|Disease Progression|0|||
48909800|NCT00467779|157506080|FG011|Stage 2A|Disease Progression|0|||
48909801|NCT00467779|157506081|FG012|Stage 2A|Disease Progression|0|||
48697535|NCT00770653|156740596|FG001|Overall Study|> Three Moderate Hypoglycemic Episodes|2|||
48697536|NCT00770653|156740595|FG000|Overall Study|Lost to Follow-up|1|||
48697537|NCT00770653|156740596|FG001|Overall Study|Lost to Follow-up|2|||
48697538|NCT00770653|156740595|FG000|Overall Study|Physician Decision|1|||
48697539|NCT00770653|156740596|FG001|Overall Study|Physician Decision|0|||
48697540|NCT00878501|156740607|FG000|Overall Study|Adverse Event|11|||
48697541|NCT00878501|156740608|FG001|Overall Study|Adverse Event|3|||
48697542|NCT00878501|156740609|FG002|Overall Study|Adverse Event|3|||
48697543|NCT00878501|156740607|FG000|Overall Study|Lack of Efficacy|2|||
48697544|NCT00878501|156740608|FG001|Overall Study|Lack of Efficacy|1|||
48697545|NCT00878501|156740609|FG002|Overall Study|Lack of Efficacy|0|||
48697546|NCT00878501|156740607|FG000|Overall Study|Withdrawal by Subject|2|||
48697547|NCT00878501|156740608|FG001|Overall Study|Withdrawal by Subject|1|||
48697548|NCT00878501|156740609|FG002|Overall Study|Withdrawal by Subject|2|||
48697549|NCT00878501|156740607|FG000|Overall Study|Protocol Violation|0|||
48697550|NCT00878501|156740608|FG001|Overall Study|Protocol Violation|0|||
48697551|NCT00878501|156740609|FG002|Overall Study|Protocol Violation|1|||
48697552|NCT00878501|156740607|FG000|Overall Study|Incorrect enrolment|1|||
48697553|NCT00878501|156740608|FG001|Overall Study|Incorrect enrolment|2|||
48697554|NCT00878501|156740609|FG002|Overall Study|Incorrect enrolment|0|||
48697555|NCT00878501|156740607|FG000|Overall Study|Intake of prohibited concom. medication|0|||
48697556|NCT00878501|156740608|FG001|Overall Study|Intake of prohibited concom. medication|0|||
48697557|NCT00878501|156740609|FG002|Overall Study|Intake of prohibited concom. medication|1|||
48697558|NCT00878501|156740607|FG000|Overall Study|Mis-randomisation of patient|1|||
48697559|NCT00878501|156740608|FG001|Overall Study|Mis-randomisation of patient|0|||
48697560|NCT00878501|156740609|FG002|Overall Study|Mis-randomisation of patient|0|||
48697561|NCT00878501|156740607|FG000|Overall Study|Administrative|0|||
48697562|NCT00878501|156740608|FG001|Overall Study|Administrative|0|||
48697563|NCT00878501|156740609|FG002|Overall Study|Administrative|1|||
48697564|NCT00966654|156740610|FG000|Overall Study|Study was terminated,PI left institution|12|||
48697565|NCT01584232|156740611|FG000|Overall Study|Adverse Event|3|||
48697566|NCT01584232|156740612|FG001|Overall Study|Adverse Event|1|||
48697567|NCT01584232|156740611|FG000|Overall Study|Withdrawal by Subject|2|||
48697568|NCT01584232|156740612|FG001|Overall Study|Withdrawal by Subject|1|||
48697569|NCT01584232|156740611|FG000|Overall Study|Physician Decision|2|||
48697570|NCT01584232|156740612|FG001|Overall Study|Physician Decision|1|||
48697571|NCT01584232|156740611|FG000|Overall Study|Lost to Follow-up|1|||
48697572|NCT01584232|156740612|FG001|Overall Study|Lost to Follow-up|0|||
48697573|NCT01393158|156740614|FG000|Overall Study|Adverse Event|1|||
48697574|NCT01393158|156740615|FG001|Overall Study|Adverse Event|0|||
48697575|NCT00928486|156740618|FG000|Overall Study|Adverse Event|2|||
48697576|NCT00928486|156740618|FG000|Overall Study|Disease Progression|7|||
48697577|NCT00928486|156740618|FG000|Overall Study|Withdrawal by Subject|1|||
48697578|NCT03770260|156740622|FG000|Overall Study|Disease progression|0|||
48697579|NCT03770260|156740623|FG001|Overall Study|Disease progression|1|||
48697580|NCT03770260|156740624|FG002|Overall Study|Disease progression|0|||
48697581|NCT03770260|156740625|FG003|Overall Study|Disease progression|0|||
48697582|NCT03182374|156740628|FG000|Overall Study|Lost to Follow-up|3|||
48697583|NCT03182374|156740629|FG001|Overall Study|Lost to Follow-up|2|||
48697584|NCT03182374|156740628|FG000|Overall Study|Lack of Efficacy|8|||
48697585|NCT03182374|156740629|FG001|Overall Study|Lack of Efficacy|14|||
48697586|NCT03182374|156740628|FG000|Overall Study|Withdrawal by Subject|1|||
48697587|NCT03182374|156740629|FG001|Overall Study|Withdrawal by Subject|1|||
48697588|NCT03182374|156740628|FG000|Overall Study|exit for non-compliance|1|||
48697589|NCT03182374|156740629|FG001|Overall Study|exit for non-compliance|1|||
48697590|NCT03182374|156740628|FG000|Overall Study|one subject was randomized but not treated|1|||
48697591|NCT03182374|156740629|FG001|Overall Study|one subject was randomized but not treated|0|||
48697592|NCT03182374|156740628|FG000|Overall Study|Other reasons|0|||
48697593|NCT03182374|156740629|FG001|Overall Study|Other reasons|3|||
48697594|NCT05526716|156740634|FG000|Overall Study|Death|1|||
48697595|NCT05526716|156740635|FG001|Overall Study|Death|2|||
48697596|NCT05526716|156740634|FG000|Overall Study|Lost to Follow-up|17|||
48697597|NCT05526716|156740635|FG001|Overall Study|Lost to Follow-up|15|||
48697598|NCT05526716|156740634|FG000|Overall Study|Physician Decision|0|||
48697599|NCT05526716|156740635|FG001|Overall Study|Physician Decision|1|||
48697600|NCT05526716|156740634|FG000|Overall Study|Randomized by mistake without study treatment|0|||
48697601|NCT05526716|156740635|FG001|Overall Study|Randomized by mistake without study treatment|1|||
48697602|NCT05526716|156740634|FG000|Overall Study|Withdrawal by Subject|12|||
48697603|NCT05526716|156740635|FG001|Overall Study|Withdrawal by Subject|12|||
48697604|NCT05526716|156740634|FG000|Overall Study|Not reported|0|||
48697605|NCT05526716|156740635|FG001|Overall Study|Not reported|2|||
48697606|NCT02384551|156740637|FG000|Overall Study|Lost to Follow-up|13|||
48697607|NCT02384551|156740638|FG001|Overall Study|Lost to Follow-up|14|||
48697608|NCT02384551|156740639|FG002|Overall Study|Lost to Follow-up|14|||
48697609|NCT02384551|156740640|FG003|Overall Study|Lost to Follow-up|14|||
48697610|NCT00667628|156740641|FG000|Overall Study|Lost to Follow-up|1|||
48697611|NCT00667628|156740642|FG001|Overall Study|Lost to Follow-up|0|||
48697612|NCT00667628|156740641|FG000|Overall Study|Death|6|||
48697613|NCT00667628|156740642|FG001|Overall Study|Death|6|||
48697614|NCT00667628|156740641|FG000|Overall Study|Investigator Considers in Best Interest|1|||
48697615|NCT00667628|156740642|FG001|Overall Study|Investigator Considers in Best Interest|0|||
48697616|NCT00667628|156740641|FG000|Overall Study|Sponsor Terminated Study|17|||
48697617|NCT00667628|156740642|FG001|Overall Study|Sponsor Terminated Study|21|||
48697618|NCT02927301|156740643|FG000|Overall Study|Death|39|||
48697619|NCT02927301|156740643|FG000|Overall Study|Lost to Follow-up|8|||
48697620|NCT02927301|156740643|FG000|Overall Study|Physician Decision|2|||
48697621|NCT02927301|156740643|FG000|Overall Study|Withdrawal by Subject|12|||
48697622|NCT02927301|156740643|FG000|Overall Study|Study Ended By Sponsor While in Survival Follow-Up|5|||
48697623|NCT04613362|156740644|FG000|3 Month Follow-up|Lost to Follow-up|1|||
48697624|NCT04613362|156740645|FG001|3 Month Follow-up|Lost to Follow-up|2|||
48697625|NCT04613362|156740644|FG000|6 Month Follow-up|Lost to Follow-up|0|||
48697626|NCT04613362|156740645|FG001|6 Month Follow-up|Lost to Follow-up|1|||
48697627|NCT03562195|156740648|FG000|Overall Study|Adverse Event|0|||
48697628|NCT03562195|156740649|FG001|Overall Study|Adverse Event|6|||
48697629|NCT03562195|156740648|FG000|Overall Study|Lack of Efficacy|0|||
48697630|NCT03562195|156740649|FG001|Overall Study|Lack of Efficacy|5|||
48697631|NCT03562195|156740648|FG000|Overall Study|Protocol Violation|0|||
48697632|NCT03562195|156740649|FG001|Overall Study|Protocol Violation|1|||
48697633|NCT03562195|156740648|FG000|Overall Study|Lost to Follow-up|0|||
48697634|NCT03562195|156740649|FG001|Overall Study|Lost to Follow-up|1|||
48697635|NCT03562195|156740648|FG000|Overall Study|Physician Decision|1|||
48697636|NCT03562195|156740649|FG001|Overall Study|Physician Decision|0|||
48697637|NCT03562195|156740648|FG000|Overall Study|Withdrawal by Subject|3|||
48697638|NCT03562195|156740649|FG001|Overall Study|Withdrawal by Subject|0|||
48697639|NCT02218372|156740650|FG000|Overall Study|Adverse Event|1|||
48697640|NCT02218372|156740651|FG001|Overall Study|Adverse Event|1|||
48697641|NCT02218372|156740650|FG000|Overall Study|Miscellaneous|2|||
48697642|NCT02218372|156740651|FG001|Overall Study|Miscellaneous|1|||
48697643|NCT02218372|156740650|FG000|Overall Study|Randomized but did not receive treatment|2|||
48697644|NCT02218372|156740651|FG001|Overall Study|Randomized but did not receive treatment|3|||
48697645|NCT02218372|156740650|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
48697646|NCT02218372|156740651|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
48697647|NCT01921205|156740654|FG000|Overall Study|Adverse Event|12|||
48697648|NCT01921205|156740655|FG001|Overall Study|Adverse Event|7|||
48697649|NCT01921205|156740654|FG000|Overall Study|Lack of Efficacy|1|||
48697650|NCT01921205|156740655|FG001|Overall Study|Lack of Efficacy|0|||
48697651|NCT01921205|156740654|FG000|Overall Study|Protocol Violation|1|||
48697652|NCT01921205|156740655|FG001|Overall Study|Protocol Violation|3|||
48697653|NCT01921205|156740654|FG000|Overall Study|Lost to Follow-up|1|||
48697654|NCT01921205|156740655|FG001|Overall Study|Lost to Follow-up|1|||
48697655|NCT01921205|156740654|FG000|Overall Study|Withdrawal by Subject|6|||
48697656|NCT01921205|156740655|FG001|Overall Study|Withdrawal by Subject|5|||
48697657|NCT01921205|156740654|FG000|Overall Study|Use Of Prohibited Medication|0|||
48697658|NCT01921205|156740655|FG001|Overall Study|Use Of Prohibited Medication|1|||
48697659|NCT01921205|156740654|FG000|Overall Study|The Excessive Use Of Rescue Medication|0|||
48697660|NCT01921205|156740655|FG001|Overall Study|The Excessive Use Of Rescue Medication|1|||
48697661|NCT01921205|156740654|FG000|Overall Study|Non Compliance Of The Parent|0|||
48697662|NCT01921205|156740655|FG001|Overall Study|Non Compliance Of The Parent|1|||
48697663|NCT01921205|156740654|FG000|Overall Study|Non Compliance Of Child|0|||
48697664|NCT01921205|156740655|FG001|Overall Study|Non Compliance Of Child|1|||
48697665|NCT00062439|156740656|FG000|Induction Chemotherapy + Radiotherapy|Ineligible|1|||
48697666|NCT00062439|156740656|FG000|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1|||
48697667|NCT00062439|156740656|FG000|Induction Chemotherapy + Radiotherapy|Adverse Event|3|||
48697668|NCT00062439|156740656|FG000|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3|||
48697669|NCT00062439|156740656|FG000|Post Chemoradiation Assessment|Death|1|||
48697670|NCT00062439|156740656|FG000|Post Chemoradiation Assessment|Disease progression|2|||
48697671|NCT00062439|156740656|FG000|Post Chemoradiation Assessment|Withdrawal by Subject|1|||
48697672|NCT00062439|156740656|FG000|Post Chemoradiation Assessment|Physician Decision|1|||
48697673|NCT00062439|156740656|FG000|Post Chemoradiation Assessment|Not eligible to continue to surgery|4|||
48697674|NCT00062439|156740656|FG000|Surgery|Physician Decision|4|||
48697675|NCT00062439|156740656|FG000|Surgery|Death|1|||
48697676|NCT00062439|156740656|FG000|Surgery|Adverse Event|2|||
48697677|NCT00062439|156740656|FG000|Consolidation Chemotherapy|Adverse Event|2|||
48697678|NCT01527149|156740661|FG000|Overall Study|Death|2|||
48697679|NCT00481832|156740662|FG000|Enrollment|Physician Decision|8|||
48697680|NCT00481832|156740662|FG000|Enrollment|Unable to collect enough stem cells|2|||
48697681|NCT00481832|156740662|FG000|Inter-transplant Period|Adverse Event|4|||
48697682|NCT00481832|156740662|FG000|Inter-transplant Period|Death|3|||
48697683|NCT00481832|156740662|FG000|Inter-transplant Period|Physician Decision|4|||
48697684|NCT00481832|156740662|FG000|Inter-transplant Period|Disease relapse|11|||
48697685|NCT00481832|156740662|FG000|Inter-transplant Period|Lack of allogeneic donor|5|||
48697686|NCT03379818|156740663|FG000|Overall Study|Closures due to the Covid-19 pandemic|2|||
48697687|NCT03379818|156740664|FG001|Overall Study|Closures due to the Covid-19 pandemic|2|||
48697688|NCT03379818|156740663|FG000|Overall Study|Withdrawal by Subject|2|||
48909802|NCT00467779|157506082|FG013|Stage 2A|Disease Progression|10|||
48697689|NCT03379818|156740664|FG001|Overall Study|Withdrawal by Subject|3|||
48697690|NCT03379818|156740663|FG000|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|1|||
48697691|NCT03379818|156740664|FG001|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|2|||
48697692|NCT03186209|156740674|FG000|Overall Study|Withdrawal by Subject|11|||
48697693|NCT03186209|156740675|FG001|Overall Study|Withdrawal by Subject|22|||
48697694|NCT03186209|156740674|FG000|Overall Study|Pregnancy|1|||
48697695|NCT03186209|156740675|FG001|Overall Study|Pregnancy|0|||
48697696|NCT03186209|156740674|FG000|Overall Study|Adverse Event|4|||
48697697|NCT03186209|156740675|FG001|Overall Study|Adverse Event|0|||
48697698|NCT03186209|156740674|FG000|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|1|||
48697699|NCT03186209|156740675|FG001|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|0|||
48697700|NCT03186209|156740674|FG000|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|0|||
48697701|NCT03186209|156740675|FG001|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|2|||
48697702|NCT03186209|156740674|FG000|Overall Study|Fail to meet randomization criteria|0|||
48697703|NCT03186209|156740675|FG001|Overall Study|Fail to meet randomization criteria|1|||
48697704|NCT03186209|156740674|FG000|Overall Study|Lost to Follow-up|0|||
48697705|NCT03186209|156740675|FG001|Overall Study|Lost to Follow-up|1|||
48697706|NCT04575155|156740686|FG000|2 Month|Withdrawal by Subject|1|||
48697707|NCT04575155|156740687|FG001|2 Month|Withdrawal by Subject|1|||
48697708|NCT04575155|156740686|FG000|2 Month|Lost to Follow-up|5|||
48697709|NCT04575155|156740687|FG001|2 Month|Lost to Follow-up|3|||
48697710|NCT04575155|156740686|FG000|2 Month|Ineligible|1|||
48697711|NCT04575155|156740687|FG001|2 Month|Ineligible|0|||
48697712|NCT01263769|156740688|FG000|Overall Study|Non-Compliant with treatment|1|||
48697713|NCT03748823|156740689|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
48697714|NCT03748823|156740690|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
48697715|NCT03748823|156740689|FG000|Randomized Treatment Period|Site Source Document Deviations|1|||
48697716|NCT03748823|156740690|FG001|Randomized Treatment Period|Site Source Document Deviations|6|||
48697717|NCT03748823|156740689|FG000|Extension Period|Withdrawal by Subject|9|||
48697718|NCT03748823|156740690|FG001|Extension Period|Withdrawal by Subject|12|||
48697719|NCT03748823|156740689|FG000|Extension Period|Death|2|||
48697720|NCT03748823|156740690|FG001|Extension Period|Death|2|||
48697721|NCT03748823|156740689|FG000|Extension Period|Other than Specified|0|||
48697722|NCT03748823|156740690|FG001|Extension Period|Other than Specified|1|||
48697723|NCT03748823|156740689|FG000|Extension Period|Protocol Violation|1|||
48697724|NCT03748823|156740690|FG001|Extension Period|Protocol Violation|0|||
48697725|NCT03748823|156740689|FG000|Extension Period|Lost to Follow-up|0|||
48697726|NCT03748823|156740690|FG001|Extension Period|Lost to Follow-up|1|||
48697727|NCT03748823|156740689|FG000|Extension Period|Lack of Efficacy|0|||
48697728|NCT03748823|156740690|FG001|Extension Period|Lack of Efficacy|1|||
48697729|NCT03748823|156740689|FG000|Extension Period|Physician Decision|1|||
48697730|NCT03748823|156740690|FG001|Extension Period|Physician Decision|2|||
48697731|NCT04949191|156740691|FG000|Overall Study|Non-compliance with Study Drug|1|||
48697732|NCT04949191|156740692|FG001|Overall Study|Non-compliance with Study Drug|0|||
48697733|NCT04949191|156740693|FG002|Overall Study|Non-compliance with Study Drug|0|||
48697734|NCT04949191|156740694|FG003|Overall Study|Non-compliance with Study Drug|0|||
48697735|NCT04949191|156740691|FG000|Overall Study|Progressive Disease|0|||
48697736|NCT04949191|156740692|FG001|Overall Study|Progressive Disease|1|||
48697737|NCT04949191|156740693|FG002|Overall Study|Progressive Disease|0|||
48697738|NCT04949191|156740694|FG003|Overall Study|Progressive Disease|0|||
48697739|NCT04949191|156740691|FG000|Overall Study|Transitioned to Commercial Pemigatinib|0|||
48697740|NCT04949191|156740692|FG001|Overall Study|Transitioned to Commercial Pemigatinib|1|||
48697741|NCT04949191|156740693|FG002|Overall Study|Transitioned to Commercial Pemigatinib|0|||
48697742|NCT04949191|156740694|FG003|Overall Study|Transitioned to Commercial Pemigatinib|0|||
48697743|NCT04949191|156740691|FG000|Overall Study|Sponsor Terminated Study|0|||
48697744|NCT04949191|156740692|FG001|Overall Study|Sponsor Terminated Study|0|||
48697745|NCT04949191|156740693|FG002|Overall Study|Sponsor Terminated Study|1|||
48697746|NCT04949191|156740694|FG003|Overall Study|Sponsor Terminated Study|1|||
48697747|NCT05468814|156740695|FG000|Overall Study|Lost to Follow-up|5|||
48909803|NCT00467779|157506083|FG014|Stage 2A|Disease Progression|0|||
48909804|NCT00467779|157506069|FG000|Stage 2A|Unspecified Reason|0|||
48909805|NCT00467779|157506070|FG001|Stage 2A|Unspecified Reason|0|||
48697748|NCT05468814|156740696|FG001|Overall Study|Lost to Follow-up|6|||
48697749|NCT04531176|156740697|FG000|Overall Study|Study was stopped early|24|||
48697750|NCT04531176|156740698|FG001|Overall Study|Study was stopped early|26|||
48697751|NCT04531176|156740699|FG002|Overall Study|Study was stopped early|24|||
48697752|NCT03624881|156740700|FG000|Overall Study|Screen Failure|14|||
48697753|NCT03624881|156740701|FG001|Overall Study|Screen Failure|0|||
48697754|NCT03624881|156740700|FG000|Overall Study|No Catheter Inserted|6|||
48697755|NCT03624881|156740701|FG001|Overall Study|No Catheter Inserted|1|||
48909806|NCT00467779|157506071|FG002|Stage 2A|Unspecified Reason|0|||
48697756|NCT03624881|156740700|FG000|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|2|||
48697757|NCT03624881|156740701|FG001|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|0|||
48697758|NCT03624881|156740700|FG000|Overall Study|Death|2|||
48697759|NCT03624881|156740701|FG001|Overall Study|Death|0|||
48697760|NCT03624881|156740700|FG000|Overall Study|Lost to Follow-up|10|||
48697761|NCT03624881|156740701|FG001|Overall Study|Lost to Follow-up|4|||
48697762|NCT03624881|156740700|FG000|Overall Study|Withdrawal by Subject|12|||
48697763|NCT03624881|156740701|FG001|Overall Study|Withdrawal by Subject|1|||
48697764|NCT04484961|156740702|FG000|Overall Study|Lost to Follow-up|9|||
48697765|NCT04484961|156740703|FG001|Overall Study|Lost to Follow-up|9|||
48697766|NCT01339832|156740706|FG000|Overall Study|Lost to Follow-up|3|||
48697767|NCT01339832|156740706|FG000|Overall Study|Death|11|||
48697768|NCT00774046|156740707|FG000|Screening|Not eligible|56|||
48697769|NCT00774046|156740707|FG000|Enrollment|Desired other therapy/refused|28|||
48697770|NCT00774046|156740707|FG000|Stem Cell Mobilization|Count too low (2), sudden death (1)|3|||
48697771|NCT03361137|156740716|FG000|Overall Study|Reason not specified|1|||
48697772|NCT03361137|156740717|FG001|Overall Study|Reason not specified|0|||
48697773|NCT03361137|156740718|FG002|Overall Study|Reason not specified|0|||
48697774|NCT03361137|156740719|FG003|Overall Study|Reason not specified|0|||
48697775|NCT03361137|156740720|FG004|Overall Study|Reason not specified|0|||
48697776|NCT00626106|156740723|FG000|Overall Study|Withdrawal by Subject|2|||
48697777|NCT00626106|156740724|FG001|Overall Study|Withdrawal by Subject|1|||
48697778|NCT00626106|156740723|FG000|Overall Study|Lost to Follow-up|1|||
48697779|NCT00626106|156740724|FG001|Overall Study|Lost to Follow-up|4|||
48697780|NCT00626106|156740723|FG000|Overall Study|Death|64|||
48697781|NCT00626106|156740724|FG001|Overall Study|Death|19|||
48697782|NCT03598036|156741977|FG000|Overall Study|Withdrawal by Subject|1|||
48697783|NCT03598036|156741978|FG001|Overall Study|Withdrawal by Subject|0|||
48697784|NCT04124939|156741979|FG000|Overall Study|Lost to Follow-up|1|||
48697785|NCT04124939|156741980|FG001|Overall Study|Lost to Follow-up|3|||
48697786|NCT04065048|156741982|FG000|Overall Study|Withdrawal by Subject|1|||
48697787|NCT04065048|156741983|FG001|Overall Study|Withdrawal by Subject|2|||
48697788|NCT04065048|156741984|FG002|Overall Study|Withdrawal by Subject|1|||
48697789|NCT04065048|156741985|FG003|Overall Study|Withdrawal by Subject|1|||
48697790|NCT04065048|156741982|FG000|Overall Study|Adverse Event|1|||
48697791|NCT04065048|156741983|FG001|Overall Study|Adverse Event|0|||
48697792|NCT04065048|156741984|FG002|Overall Study|Adverse Event|1|||
48697793|NCT04065048|156741985|FG003|Overall Study|Adverse Event|0|||
48697794|NCT01194830|156741986|FG000|Overall Study|Adverse Event|3|||
48697795|NCT01194830|156741987|FG001|Overall Study|Adverse Event|2|||
48697796|NCT01194830|156741986|FG000|Overall Study|Protocol Violation|5|||
48697797|NCT01194830|156741987|FG001|Overall Study|Protocol Violation|4|||
48697798|NCT01194830|156741986|FG000|Overall Study|Lost to Follow-up|9|||
48697799|NCT01194830|156741987|FG001|Overall Study|Lost to Follow-up|7|||
48697800|NCT01194830|156741986|FG000|Overall Study|Withdrawal by Subject|2|||
48697801|NCT01194830|156741987|FG001|Overall Study|Withdrawal by Subject|1|||
48697802|NCT01194830|156741986|FG000|Overall Study|Lack of Efficacy|1|||
48697803|NCT01194830|156741987|FG001|Overall Study|Lack of Efficacy|1|||
48697804|NCT01194830|156741986|FG000|Overall Study|Non-compliance issues|4|||
48697805|NCT01194830|156741987|FG001|Overall Study|Non-compliance issues|4|||
48697806|NCT01194830|156741986|FG000|Overall Study|Other Reason|12|||
48697807|NCT01194830|156741987|FG001|Overall Study|Other Reason|8|||
48697808|NCT02814916|156741990|FG000|Overall Study|Withdrawal of consent|0|||
48697809|NCT02814916|156741991|FG001|Overall Study|Withdrawal of consent|2|||
48697810|NCT02814916|156741992|FG002|Overall Study|Withdrawal of consent|0|||
48697811|NCT02814916|156741990|FG000|Overall Study|Lost to Follow-up|0|||
48697812|NCT02814916|156741991|FG001|Overall Study|Lost to Follow-up|1|||
48697813|NCT02814916|156741992|FG002|Overall Study|Lost to Follow-up|0|||
48697814|NCT02814916|156741990|FG000|Overall Study|Other, not specified|0|||
48697815|NCT02814916|156741991|FG001|Overall Study|Other, not specified|1|||
48697816|NCT02814916|156741992|FG002|Overall Study|Other, not specified|0|||
48697817|NCT05176314|156742002|FG000|Overall Study|Lost to Follow-up|2|||
48697818|NCT05176314|156742002|FG000|Overall Study|Physician Decision|1|||
48697819|NCT05176314|156742002|FG000|Overall Study|Adverse Event|1|||
48697820|NCT03547518|156742005|FG000|Overall Study|Lost to Follow-up|2|||
48697821|NCT03547518|156742006|FG001|Overall Study|Lost to Follow-up|0|||
48697822|NCT02953652|156742007|FG000|Overall Study|Adverse Event|18|||
48697823|NCT02953652|156742007|FG000|Overall Study|Withdrawal by Subject|6|||
48697824|NCT02953652|156742007|FG000|Overall Study|Protocol Violation|1|||
48697825|NCT02953652|156742007|FG000|Overall Study|Disease Progression|27|||
48697826|NCT04244253|156742010|FG000|Overall Study|Adverse Event|2|||
48697827|NCT04244253|156742011|FG001|Overall Study|Adverse Event|2|||
48697828|NCT04244253|156742012|FG002|Overall Study|Adverse Event|4|||
48697829|NCT04244253|156742010|FG000|Overall Study|Protocol Violation|1|||
48697830|NCT04244253|156742011|FG001|Overall Study|Protocol Violation|2|||
48697831|NCT04244253|156742012|FG002|Overall Study|Protocol Violation|1|||
48697832|NCT04244253|156742010|FG000|Overall Study|Withdrawal by Subject|0|||
48697833|NCT04244253|156742011|FG001|Overall Study|Withdrawal by Subject|1|||
48697834|NCT04244253|156742012|FG002|Overall Study|Withdrawal by Subject|6|||
48697835|NCT04244253|156742010|FG000|Overall Study|Non-Compliance With Study Drug|0|||
48697836|NCT04244253|156742011|FG001|Overall Study|Non-Compliance With Study Drug|0|||
48697837|NCT04244253|156742012|FG002|Overall Study|Non-Compliance With Study Drug|1|||
48697838|NCT00671658|156742017|FG000|Overall Study|Physician Decision|5|||
48697839|NCT05131204|156742020|FG000|Overall Study|Sponsor request|2|||
48697840|NCT05131204|156742021|FG001|Overall Study|Sponsor request|1|||
48697841|NCT00436332|156742022|FG000|Overall Study|Adverse Event|9|||
48697842|NCT00436332|156742022|FG000|Overall Study|Withdrawal by Subject|2|||
48697843|NCT00436332|156742022|FG000|Overall Study|Progression|59|||
48697844|NCT00436332|156742022|FG000|Overall Study|Death|2|||
48697845|NCT00436332|156742022|FG000|Overall Study|Not Protocol Specified|6|||
48697846|NCT00436332|156742022|FG000|Overall Study|Ineligible|2|||
48697847|NCT00436332|156742022|FG000|Overall Study|Never Received Treatment|3|||
48697848|NCT01903356|156742023|FG000|Overall Study|Lost to Follow-up|7|||
48697849|NCT01903356|156742023|FG000|Overall Study|Violated inclusion/exclusion criteria|5|||
48697850|NCT01903356|156742023|FG000|Overall Study|Violated the dosage and administration|3|||
48697851|NCT03041038|156742024|FG000|Overall Study|Withdrawal by Subject|4|||
48697852|NCT03041038|156742025|FG001|Overall Study|Withdrawal by Subject|0|||
48697853|NCT03041038|156742024|FG000|Overall Study|Lost to Follow-up|1|||
48697854|NCT03041038|156742025|FG001|Overall Study|Lost to Follow-up|1|||
48697855|NCT03041038|156742024|FG000|Overall Study|Protocol Violation|1|||
48697856|NCT03041038|156742025|FG001|Overall Study|Protocol Violation|1|||
48697857|NCT04529083|156742026|FG000|Overall Study|Withdrawal by Subject|3|||
48697858|NCT00360230|156742027|FG000|Overall Study|Withdrawal by Subject|1|||
48697859|NCT00360230|156742028|FG001|Overall Study|Withdrawal by Subject|1|||
48697860|NCT00360230|156742029|FG002|Overall Study|Withdrawal by Subject|0|||
48697861|NCT00360230|156742030|FG003|Overall Study|Withdrawal by Subject|1|||
48697862|NCT00360230|156742031|FG004|Overall Study|Withdrawal by Subject|1|||
48697863|NCT00360230|156742032|FG005|Overall Study|Withdrawal by Subject|1|||
48697864|NCT00360230|156742033|FG006|Overall Study|Withdrawal by Subject|0|||
48697865|NCT00360230|156742027|FG000|Overall Study|Migrated|4|||
48697866|NCT00360230|156742028|FG001|Overall Study|Migrated|1|||
48697867|NCT00360230|156742029|FG002|Overall Study|Migrated|3|||
48697868|NCT00360230|156742030|FG003|Overall Study|Migrated|1|||
48697869|NCT00360230|156742031|FG004|Overall Study|Migrated|4|||
48697870|NCT00360230|156742032|FG005|Overall Study|Migrated|1|||
48697871|NCT00360230|156742033|FG006|Overall Study|Migrated|1|||
48697872|NCT00360230|156742027|FG000|Overall Study|Other|1|||
48697873|NCT00360230|156742028|FG001|Overall Study|Other|0|||
48697874|NCT00360230|156742029|FG002|Overall Study|Other|0|||
48697875|NCT00360230|156742030|FG003|Overall Study|Other|0|||
48697876|NCT00360230|156742031|FG004|Overall Study|Other|0|||
48697877|NCT00360230|156742032|FG005|Overall Study|Other|0|||
48697878|NCT00360230|156742033|FG006|Overall Study|Other|0|||
48697879|NCT00360230|156742027|FG000|Overall Study|Protocol Violation|0|||
48697880|NCT00360230|156742028|FG001|Overall Study|Protocol Violation|0|||
48697881|NCT00360230|156742029|FG002|Overall Study|Protocol Violation|0|||
48697882|NCT00360230|156742030|FG003|Overall Study|Protocol Violation|0|||
48697883|NCT00360230|156742031|FG004|Overall Study|Protocol Violation|0|||
48697884|NCT00360230|156742032|FG005|Overall Study|Protocol Violation|1|||
48697885|NCT00360230|156742033|FG006|Overall Study|Protocol Violation|0|||
48697886|NCT00360230|156742027|FG000|Overall Study|Death|0|||
48697887|NCT00360230|156742028|FG001|Overall Study|Death|1|||
48697888|NCT00360230|156742029|FG002|Overall Study|Death|0|||
48697889|NCT00360230|156742030|FG003|Overall Study|Death|0|||
48697890|NCT00360230|156742031|FG004|Overall Study|Death|0|||
48697891|NCT00360230|156742032|FG005|Overall Study|Death|1|||
48697892|NCT00360230|156742033|FG006|Overall Study|Death|1|||
48697893|NCT04196686|156742034|FG000|First Treatment (4 Minutes)|Withdrawal by Subject|0|||
48697894|NCT04196686|156742035|FG001|First Treatment (4 Minutes)|Withdrawal by Subject|3|||
48697895|NCT02558894|156742036|FG000|Overall Study|Death; any cause, entire study duration|28|||
48697896|NCT02558894|156742037|FG001|Overall Study|Death; any cause, entire study duration|31|||
48697897|NCT02558894|156742036|FG000|Overall Study|Withdrawal by Subject|2|||
48697898|NCT02558894|156742037|FG001|Overall Study|Withdrawal by Subject|1|||
48697899|NCT02558894|156742036|FG000|Overall Study|Closure of Part A|2|||
48697900|NCT02558894|156742037|FG001|Overall Study|Closure of Part A|1|||
48697901|NCT02006472|156742038|FG000|Period 1 (Through Week 26)|Protocol Violation|1|||
48697902|NCT02006472|156742039|FG001|Period 1 (Through Week 26)|Protocol Violation|1|||
48697903|NCT02006472|156742040|FG002|Period 1 (Through Week 26)|Protocol Violation|1|||
48697904|NCT02006472|156742041|FG003|Period 1 (Through Week 26)|Protocol Violation|1|||
48697905|NCT02006472|156742042|FG004|Period 1 (Through Week 26)|Protocol Violation|0|||
48697906|NCT02006472|156742038|FG000|Period 1 (Through Week 26)|Lack of Efficacy|0|||
48697907|NCT02006472|156742039|FG001|Period 1 (Through Week 26)|Lack of Efficacy|0|||
48697908|NCT02006472|156742040|FG002|Period 1 (Through Week 26)|Lack of Efficacy|1|||
48697909|NCT02006472|156742041|FG003|Period 1 (Through Week 26)|Lack of Efficacy|0|||
48697910|NCT02006472|156742042|FG004|Period 1 (Through Week 26)|Lack of Efficacy|0|||
48697911|NCT02006472|156742038|FG000|Period 1 (Through Week 26)|Noncompliance|2|||
48697912|NCT02006472|156742039|FG001|Period 1 (Through Week 26)|Noncompliance|1|||
48697913|NCT02006472|156742040|FG002|Period 1 (Through Week 26)|Noncompliance|1|||
48697914|NCT02006472|156742041|FG003|Period 1 (Through Week 26)|Noncompliance|0|||
48697915|NCT02006472|156742042|FG004|Period 1 (Through Week 26)|Noncompliance|0|||
48697916|NCT02006472|156742038|FG000|Period 1 (Through Week 26)|Other|1|||
48697917|NCT02006472|156742039|FG001|Period 1 (Through Week 26)|Other|5|||
48697918|NCT02006472|156742040|FG002|Period 1 (Through Week 26)|Other|0|||
48697919|NCT02006472|156742041|FG003|Period 1 (Through Week 26)|Other|2|||
48697920|NCT02006472|156742042|FG004|Period 1 (Through Week 26)|Other|3|||
48697921|NCT02006472|156742038|FG000|Period 1 (Through Week 26)|Adverse Event|5|||
48697922|NCT02006472|156742039|FG001|Period 1 (Through Week 26)|Adverse Event|6|||
48697923|NCT02006472|156742040|FG002|Period 1 (Through Week 26)|Adverse Event|11|||
48697924|NCT02006472|156742041|FG003|Period 1 (Through Week 26)|Adverse Event|11|||
48697925|NCT02006472|156742042|FG004|Period 1 (Through Week 26)|Adverse Event|14|||
48697926|NCT02006472|156742038|FG000|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
48697927|NCT02006472|156742039|FG001|Period 1 (Through Week 26)|Withdrawal by Subject|9|||
48697928|NCT02006472|156742040|FG002|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
48697929|NCT02006472|156742041|FG003|Period 1 (Through Week 26)|Withdrawal by Subject|0|||
48697930|NCT02006472|156742042|FG004|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
48697931|NCT02006472|156742038|FG000|Period 2 (Through Week 52)|Lack of Efficacy|1|||
48697932|NCT02006472|156742039|FG001|Period 2 (Through Week 52)|Lack of Efficacy|0|||
48697933|NCT02006472|156742040|FG002|Period 2 (Through Week 52)|Lack of Efficacy|0|||
48697934|NCT02006472|156742041|FG003|Period 2 (Through Week 52)|Lack of Efficacy|1|||
48697935|NCT02006472|156742042|FG004|Period 2 (Through Week 52)|Lack of Efficacy|1|||
48697936|NCT02006472|156742038|FG000|Period 2 (Through Week 52)|Noncompliance|1|||
48697937|NCT02006472|156742039|FG001|Period 2 (Through Week 52)|Noncompliance|0|||
48697938|NCT02006472|156742040|FG002|Period 2 (Through Week 52)|Noncompliance|0|||
48697939|NCT02006472|156742041|FG003|Period 2 (Through Week 52)|Noncompliance|0|||
48697940|NCT02006472|156742042|FG004|Period 2 (Through Week 52)|Noncompliance|0|||
48697941|NCT02006472|156742038|FG000|Period 2 (Through Week 52)|Adverse Event|1|||
48697942|NCT02006472|156742039|FG001|Period 2 (Through Week 52)|Adverse Event|4|||
48697943|NCT02006472|156742040|FG002|Period 2 (Through Week 52)|Adverse Event|5|||
48697944|NCT02006472|156742041|FG003|Period 2 (Through Week 52)|Adverse Event|1|||
48697945|NCT02006472|156742042|FG004|Period 2 (Through Week 52)|Adverse Event|1|||
48697946|NCT02006472|156742038|FG000|Period 2 (Through Week 52)|Other|0|||
48697947|NCT02006472|156742039|FG001|Period 2 (Through Week 52)|Other|1|||
48697948|NCT02006472|156742040|FG002|Period 2 (Through Week 52)|Other|0|||
48697949|NCT02006472|156742041|FG003|Period 2 (Through Week 52)|Other|1|||
48697950|NCT02006472|156742042|FG004|Period 2 (Through Week 52)|Other|0|||
48697951|NCT02006472|156742038|FG000|Period 2 (Through Week 52)|Not treated|0|||
48697952|NCT02006472|156742039|FG001|Period 2 (Through Week 52)|Not treated|0|||
48697953|NCT02006472|156742040|FG002|Period 2 (Through Week 52)|Not treated|2|||
48697954|NCT02006472|156742041|FG003|Period 2 (Through Week 52)|Not treated|0|||
48697955|NCT02006472|156742042|FG004|Period 2 (Through Week 52)|Not treated|0|||
48697956|NCT02006472|156742038|FG000|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
48697957|NCT02006472|156742039|FG001|Period 2 (Through Week 52)|Withdrawal by Subject|1|||
48697958|NCT02006472|156742040|FG002|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
48697959|NCT02006472|156742041|FG003|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
48697960|NCT02006472|156742042|FG004|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
48697961|NCT02006472|156742038|FG000|Period 2 (Through Week 52)|Sponsor decision|0|||
48697962|NCT02006472|156742039|FG001|Period 2 (Through Week 52)|Sponsor decision|0|||
48697963|NCT02006472|156742040|FG002|Period 2 (Through Week 52)|Sponsor decision|1|||
48697964|NCT02006472|156742041|FG003|Period 2 (Through Week 52)|Sponsor decision|0|||
48697965|NCT02006472|156742042|FG004|Period 2 (Through Week 52)|Sponsor decision|0|||
48697966|NCT00784563|156742047|FG000|Years 1 & 2|Withdrawal by Subject|3|||
48697967|NCT00784563|156742048|FG001|Years 1 & 2|Withdrawal by Subject|2|||
48697968|NCT00784563|156742049|FG002|Years 1 & 2|Withdrawal by Subject|0|||
48697969|NCT00784563|156742047|FG000|Years 1 & 2|Adverse Event|0|||
48697970|NCT00784563|156742048|FG001|Years 1 & 2|Adverse Event|3|||
48697971|NCT00784563|156742049|FG002|Years 1 & 2|Adverse Event|0|||
48697972|NCT00784563|156742047|FG000|Year 3|Withdrawal by Subject|0|||
48697973|NCT00784563|156742048|FG001|Year 3|Withdrawal by Subject|0|||
48697974|NCT00784563|156742049|FG002|Year 3|Withdrawal by Subject|2|||
48697975|NCT00784563|156742047|FG000|Year 3|Adverse Event|0|||
48697976|NCT00784563|156742048|FG001|Year 3|Adverse Event|0|||
48697977|NCT00784563|156742049|FG002|Year 3|Adverse Event|1|||
48697978|NCT01614249|156742051|FG000|Overall Study|Lost to Follow-up|11|||
48697979|NCT01614249|156742052|FG001|Overall Study|Lost to Follow-up|23|||
48697980|NCT02954536|156742053|FG000|Overall Study|Adverse Event|2|||
48697981|NCT02954536|156742053|FG000|Overall Study|Death|12|||
48697982|NCT02946580|156742054|FG000|Overall Study|Withdrawal by Subject|1|||
48697983|NCT02946580|156742055|FG001|Overall Study|Withdrawal by Subject|2|||
48697984|NCT02946580|156742054|FG000|Overall Study|Adverse Event|0|||
48697985|NCT02946580|156742055|FG001|Overall Study|Adverse Event|2|||
48697986|NCT02946580|156742054|FG000|Overall Study|Did not undergo posterior spinal fusion|0|||
48697987|NCT02946580|156742055|FG001|Overall Study|Did not undergo posterior spinal fusion|1|||
48697988|NCT02521285|156742060|FG000|Overall Study|Lost to Follow-up|1|||
48697989|NCT02521285|156742061|FG001|Overall Study|Lost to Follow-up|1|||
48697990|NCT02521285|156742060|FG000|Overall Study|Withdrawal by Subject|1|||
48697991|NCT02521285|156742061|FG001|Overall Study|Withdrawal by Subject|1|||
48697992|NCT02521285|156742060|FG000|Overall Study|Adverse Event|0|||
48697993|NCT02521285|156742061|FG001|Overall Study|Adverse Event|1|||
48697994|NCT00980954|156742062|FG000|Overall Study|Protocol Violation|9|||
48697995|NCT00980954|156742063|FG001|Overall Study|Protocol Violation|15|||
48697996|NCT03104868|156742066|FG000|6 Week Follow up|Lost to Follow-up|5|||
48697997|NCT03104868|156742067|FG001|6 Week Follow up|Lost to Follow-up|8|||
48697998|NCT03104868|156742066|FG000|6 Week Follow up|Death|1|||
48697999|NCT03104868|156742067|FG001|6 Week Follow up|Death|1|||
48698000|NCT03104868|156742066|FG000|6 Week Follow up|Withdrawal by Subject|7|||
48698001|NCT03104868|156742067|FG001|6 Week Follow up|Withdrawal by Subject|6|||
48698002|NCT03104868|156742066|FG000|6 Week Follow up|Completed Later Timepoint|24|||
48698003|NCT03104868|156742067|FG001|6 Week Follow up|Completed Later Timepoint|22|||
48698004|NCT03104868|156742066|FG000|6 Month Follow up|Lost to Follow-up|2|||
48698005|NCT03104868|156742067|FG001|6 Month Follow up|Lost to Follow-up|2|||
48698006|NCT03104868|156742066|FG000|6 Month Follow up|Death|0|||
48698007|NCT03104868|156742067|FG001|6 Month Follow up|Death|1|||
48698008|NCT03104868|156742066|FG000|6 Month Follow up|Completed Later Timepoint|22|||
48698009|NCT03104868|156742067|FG001|6 Month Follow up|Completed Later Timepoint|32|||
48698010|NCT03104868|156742066|FG000|12 Month Follow up|Lost to Follow-up|1|||
48698011|NCT03104868|156742067|FG001|12 Month Follow up|Lost to Follow-up|2|||
48698012|NCT03104868|156742066|FG000|12 Month Follow up|Death|0|||
48698013|NCT03104868|156742067|FG001|12 Month Follow up|Death|1|||
48698014|NCT03104868|156742066|FG000|12 Month Follow up|Withdrawal by Subject|0|||
48698015|NCT03104868|156742067|FG001|12 Month Follow up|Withdrawal by Subject|3|||
48698016|NCT03104868|156742066|FG000|12 Month Follow up|Completed Later Timepoint|32|||
48698017|NCT03104868|156742067|FG001|12 Month Follow up|Completed Later Timepoint|29|||
48698018|NCT03104868|156742066|FG000|18 Month Follow up|Lost to Follow-up|7|||
48698019|NCT03104868|156742067|FG001|18 Month Follow up|Lost to Follow-up|11|||
48698020|NCT03104868|156742066|FG000|18 Month Follow up|Death|2|||
48698021|NCT03104868|156742067|FG001|18 Month Follow up|Death|1|||
48698022|NCT03104868|156742066|FG000|18 Month Follow up|Withdrawal by Subject|1|||
48698023|NCT03104868|156742067|FG001|18 Month Follow up|Withdrawal by Subject|2|||
48698024|NCT03104868|156742066|FG000|18 Month Follow up|Graft Loss|1|||
48698025|NCT03104868|156742067|FG001|18 Month Follow up|Graft Loss|1|||
48698026|NCT03104868|156742066|FG000|18 Month Follow up|Completed Later Timepoint|19|||
48698027|NCT03104868|156742067|FG001|18 Month Follow up|Completed Later Timepoint|20|||
48698028|NCT03104868|156742066|FG000|24 Month Follow up|Lost to Follow-up|15|||
48698029|NCT03104868|156742067|FG001|24 Month Follow up|Lost to Follow-up|16|||
48698030|NCT03104868|156742066|FG000|24 Month Follow up|Death|3|||
48698031|NCT03104868|156742067|FG001|24 Month Follow up|Death|2|||
48698032|NCT03104868|156742066|FG000|24 Month Follow up|Withdrawal by Subject|1|||
48698033|NCT03104868|156742067|FG001|24 Month Follow up|Withdrawal by Subject|0|||
48698034|NCT03104868|156742066|FG000|24 Month Follow up|Graft Loss|2|||
48698035|NCT03104868|156742067|FG001|24 Month Follow up|Graft Loss|0|||
48698036|NCT00374140|156742068|FG000|Overall Study|Lost to Follow-up|1|||
48698037|NCT00374140|156742068|FG000|Overall Study|Protocol Violation|1|||
48698038|NCT02018562|156742071|FG000|Overall Study|Withdrawal by Subject|2|||
48698039|NCT02018562|156742072|FG001|Overall Study|Withdrawal by Subject|0|||
48698040|NCT02018562|156742071|FG000|Overall Study|Discharged prior to study completion|1|||
48909807|NCT00467779|157506072|FG003|Stage 2A|Unspecified Reason|0|||
49116317|NCT03538691|158263094|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
48698041|NCT02018562|156742072|FG001|Overall Study|Discharged prior to study completion|0|||
48698042|NCT04905134|156742073|FG000|Exam With Standard Nasopharyngoscope|Study device not available|2|||
48698043|NCT04905134|156742073|FG000|Exam With Standard Nasopharyngoscope|Withdrawal by Subject|1|||
48698044|NCT03009058|156742074|FG000|Overall Study|Study terminated soon after initiation for commercial reasons|2|||
48698045|NCT03497676|156742075|FG000|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
48698046|NCT03497676|156742076|FG001|Cohort 1 Treatment Initiation to Week 16|Adverse Event|1|||
48698047|NCT03497676|156742077|FG002|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
48698048|NCT03497676|156742078|FG003|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
48698049|NCT03497676|156742075|FG000|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
48698050|NCT03497676|156742076|FG001|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
48698051|NCT03497676|156742077|FG002|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
48698052|NCT03497676|156742078|FG003|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
48698053|NCT03497676|156742075|FG000|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
48698054|NCT03497676|156742076|FG001|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
48698055|NCT03497676|156742077|FG002|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
48742936|NCT01550289|156910419|FG000|Overall Study|Lost to Follow-up|1|||
48698056|NCT03497676|156742078|FG003|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
48698057|NCT03497676|156742075|FG000|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
48698058|NCT03497676|156742076|FG001|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|1|||
48698059|NCT03497676|156742077|FG002|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
48698060|NCT03497676|156742078|FG003|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
48698061|NCT03497676|156742075|FG000|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
48698062|NCT03497676|156742076|FG001|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
48698063|NCT03497676|156742077|FG002|Cohort 2 Treatment Initiation to Week 24|Pregnancy|1|||
48698064|NCT03497676|156742078|FG003|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
48698065|NCT03497676|156742075|FG000|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
48698066|NCT03497676|156742076|FG001|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
48698067|NCT03497676|156742077|FG002|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|1|||
48909808|NCT00467779|157506073|FG004|Stage 2A|Unspecified Reason|0|||
48909809|NCT00467779|157506074|FG005|Stage 2A|Unspecified Reason|0|||
48909810|NCT00467779|157506075|FG006|Stage 2A|Unspecified Reason|0|||
48909811|NCT00467779|157506076|FG007|Stage 2A|Unspecified Reason|0|||
48909812|NCT00467779|157506077|FG008|Stage 2A|Unspecified Reason|0|||
48909813|NCT00467779|157506078|FG009|Stage 2A|Unspecified Reason|0|||
48909814|NCT00467779|157506079|FG010|Stage 2A|Unspecified Reason|0|||
48909815|NCT00467779|157506080|FG011|Stage 2A|Unspecified Reason|0|||
48909816|NCT00467779|157506081|FG012|Stage 2A|Unspecified Reason|0|||
48909817|NCT00467779|157506082|FG013|Stage 2A|Unspecified Reason|7|||
48909818|NCT00467779|157506083|FG014|Stage 2A|Unspecified Reason|0|||
48909819|NCT00467779|157506069|FG000|Stage 2A|Withdrawal by Subject|0|||
48909820|NCT00467779|157506070|FG001|Stage 2A|Withdrawal by Subject|0|||
48909821|NCT00467779|157506071|FG002|Stage 2A|Withdrawal by Subject|0|||
48909822|NCT00467779|157506072|FG003|Stage 2A|Withdrawal by Subject|0|||
48909823|NCT00467779|157506073|FG004|Stage 2A|Withdrawal by Subject|0|||
48909824|NCT00467779|157506074|FG005|Stage 2A|Withdrawal by Subject|0|||
48909825|NCT00467779|157506075|FG006|Stage 2A|Withdrawal by Subject|0|||
48909826|NCT00467779|157506076|FG007|Stage 2A|Withdrawal by Subject|0|||
48909827|NCT00467779|157506077|FG008|Stage 2A|Withdrawal by Subject|0|||
48909828|NCT00467779|157506078|FG009|Stage 2A|Withdrawal by Subject|0|||
48909829|NCT00467779|157506079|FG010|Stage 2A|Withdrawal by Subject|0|||
48909830|NCT00467779|157506080|FG011|Stage 2A|Withdrawal by Subject|0|||
48909831|NCT00467779|157506081|FG012|Stage 2A|Withdrawal by Subject|0|||
48909832|NCT00467779|157506082|FG013|Stage 2A|Withdrawal by Subject|1|||
48909833|NCT00467779|157506083|FG014|Stage 2A|Withdrawal by Subject|0|||
48909834|NCT00467779|157506069|FG000|Stage 3|Adverse Event|0|||
48909835|NCT00467779|157506070|FG001|Stage 3|Adverse Event|0|||
48909836|NCT00467779|157506071|FG002|Stage 3|Adverse Event|0|||
48909837|NCT00467779|157506072|FG003|Stage 3|Adverse Event|0|||
48909838|NCT00467779|157506073|FG004|Stage 3|Adverse Event|0|||
48909839|NCT00467779|157506074|FG005|Stage 3|Adverse Event|0|||
48909840|NCT00467779|157506075|FG006|Stage 3|Adverse Event|0|||
48909841|NCT00467779|157506076|FG007|Stage 3|Adverse Event|0|||
48909842|NCT00467779|157506077|FG008|Stage 3|Adverse Event|0|||
48909843|NCT00467779|157506078|FG009|Stage 3|Adverse Event|0|||
48909844|NCT00467779|157506079|FG010|Stage 3|Adverse Event|0|||
48909845|NCT00467779|157506080|FG011|Stage 3|Adverse Event|0|||
48698068|NCT03497676|156742078|FG003|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
48698069|NCT03497676|156742075|FG000|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
48698070|NCT03497676|156742076|FG001|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
48698071|NCT03497676|156742077|FG002|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|1|||
48698072|NCT03497676|156742078|FG003|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
48698073|NCT03497676|156742075|FG000|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
48698074|NCT03497676|156742076|FG001|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
48698075|NCT03497676|156742077|FG002|Cohort 2 Week 24 to Week 48|Lost to Follow-up|1|||
48698076|NCT03497676|156742078|FG003|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
48698077|NCT04583618|156742079|FG000|Overall Study|Adverse Event|0|||
48698078|NCT04583618|156742080|FG001|Overall Study|Adverse Event|0|||
48698079|NCT04583618|156742081|FG002|Overall Study|Adverse Event|1|||
48698080|NCT04583618|156742082|FG003|Overall Study|Adverse Event|0|||
48698081|NCT04583618|156742083|FG004|Overall Study|Adverse Event|0|||
48698082|NCT04583618|156742079|FG000|Overall Study|Protocol deviation|1|||
48698083|NCT04583618|156742080|FG001|Overall Study|Protocol deviation|1|||
48698084|NCT04583618|156742081|FG002|Overall Study|Protocol deviation|1|||
48909846|NCT00467779|157506081|FG012|Stage 3|Adverse Event|0|||
48909847|NCT00467779|157506082|FG013|Stage 3|Adverse Event|0|||
48909848|NCT00467779|157506083|FG014|Stage 3|Adverse Event|2|||
48909849|NCT00467779|157506069|FG000|Stage 3|Death|0|||
48909850|NCT00467779|157506070|FG001|Stage 3|Death|0|||
48909851|NCT00467779|157506071|FG002|Stage 3|Death|0|||
48909852|NCT00467779|157506072|FG003|Stage 3|Death|0|||
48909853|NCT00467779|157506073|FG004|Stage 3|Death|0|||
48909854|NCT00467779|157506074|FG005|Stage 3|Death|0|||
48909855|NCT00467779|157506075|FG006|Stage 3|Death|0|||
48909856|NCT00467779|157506076|FG007|Stage 3|Death|0|||
48909857|NCT00467779|157506077|FG008|Stage 3|Death|0|||
48909858|NCT00467779|157506078|FG009|Stage 3|Death|0|||
48909859|NCT00467779|157506079|FG010|Stage 3|Death|0|||
48909860|NCT00467779|157506080|FG011|Stage 3|Death|0|||
48909861|NCT00467779|157506081|FG012|Stage 3|Death|0|||
48909862|NCT00467779|157506082|FG013|Stage 3|Death|0|||
48909863|NCT00467779|157506083|FG014|Stage 3|Death|1|||
48909864|NCT00467779|157506069|FG000|Stage 3|Disease Progression|0|||
48909865|NCT00467779|157506070|FG001|Stage 3|Disease Progression|0|||
48909866|NCT00467779|157506071|FG002|Stage 3|Disease Progression|0|||
48909867|NCT00467779|157506072|FG003|Stage 3|Disease Progression|0|||
48909868|NCT00467779|157506073|FG004|Stage 3|Disease Progression|0|||
48909869|NCT00467779|157506074|FG005|Stage 3|Disease Progression|0|||
48909870|NCT00467779|157506075|FG006|Stage 3|Disease Progression|0|||
48909871|NCT00467779|157506076|FG007|Stage 3|Disease Progression|0|||
48909872|NCT00467779|157506077|FG008|Stage 3|Disease Progression|0|||
48909873|NCT00467779|157506078|FG009|Stage 3|Disease Progression|0|||
48909874|NCT00467779|157506079|FG010|Stage 3|Disease Progression|0|||
48909875|NCT00467779|157506080|FG011|Stage 3|Disease Progression|0|||
48909876|NCT00467779|157506081|FG012|Stage 3|Disease Progression|0|||
48909877|NCT00467779|157506082|FG013|Stage 3|Disease Progression|0|||
48909878|NCT00467779|157506083|FG014|Stage 3|Disease Progression|9|||
48909879|NCT00467779|157506069|FG000|Stage 3|Unspecified Reason|0|||
48909880|NCT00467779|157506070|FG001|Stage 3|Unspecified Reason|0|||
48909881|NCT00467779|157506071|FG002|Stage 3|Unspecified Reason|0|||
48909882|NCT00467779|157506072|FG003|Stage 3|Unspecified Reason|0|||
48909883|NCT00467779|157506073|FG004|Stage 3|Unspecified Reason|0|||
48909884|NCT00467779|157506074|FG005|Stage 3|Unspecified Reason|0|||
48909885|NCT00467779|157506075|FG006|Stage 3|Unspecified Reason|0|||
48909886|NCT00467779|157506076|FG007|Stage 3|Unspecified Reason|0|||
48909887|NCT00467779|157506077|FG008|Stage 3|Unspecified Reason|0|||
48909888|NCT00467779|157506078|FG009|Stage 3|Unspecified Reason|0|||
48909889|NCT00467779|157506079|FG010|Stage 3|Unspecified Reason|0|||
48909890|NCT00467779|157506080|FG011|Stage 3|Unspecified Reason|0|||
48909891|NCT00467779|157506081|FG012|Stage 3|Unspecified Reason|0|||
48909892|NCT00467779|157506082|FG013|Stage 3|Unspecified Reason|0|||
48909893|NCT00467779|157506083|FG014|Stage 3|Unspecified Reason|5|||
48909894|NCT00698204|157506084|FG000|Overall Study|Withdrawal by Subject|1|||
48909895|NCT00698204|157506085|FG001|Overall Study|Withdrawal by Subject|0|||
48909896|NCT00216203|157506086|FG000|Overall Study|Withdrawal by Subject|2|||
48909897|NCT02224599|157506087|FG000|Overall Study|Physician Decision|1|||
48909898|NCT02224599|157506087|FG000|Overall Study|Progression of Disease|1|||
48909899|NCT00314249|157506088|FG000|Overall Study|Adverse Event|73|||
48909900|NCT00314249|157506089|FG001|Overall Study|Adverse Event|94|||
48909901|NCT00314249|157506088|FG000|Overall Study|Lack of Efficacy|33|||
48909902|NCT00314249|157506089|FG001|Overall Study|Lack of Efficacy|24|||
48909903|NCT00314249|157506088|FG000|Overall Study|Withdrawal by Subject|21|||
48909904|NCT00314249|157506089|FG001|Overall Study|Withdrawal by Subject|28|||
48909905|NCT00314249|157506088|FG000|Overall Study|Lost to Follow-up|15|||
48909906|NCT00314249|157506089|FG001|Overall Study|Lost to Follow-up|9|||
48909907|NCT00314249|157506088|FG000|Overall Study|Physician Decision|1|||
48909908|NCT00314249|157506089|FG001|Overall Study|Physician Decision|1|||
48909909|NCT00314249|157506088|FG000|Overall Study|Withdrawn for other reasons|4|||
48909910|NCT00314249|157506089|FG001|Overall Study|Withdrawn for other reasons|1|||
48909911|NCT00314249|157506088|FG000|Overall Study|Non-Compliant|5|||
48909912|NCT00314249|157506089|FG001|Overall Study|Non-Compliant|6|||
48698085|NCT04583618|156742082|FG003|Overall Study|Protocol deviation|0|||
48698086|NCT04583618|156742083|FG004|Overall Study|Protocol deviation|0|||
48698087|NCT04583618|156742079|FG000|Overall Study|Withdrawal by Subject|2|||
48698088|NCT04583618|156742080|FG001|Overall Study|Withdrawal by Subject|1|||
48698089|NCT04583618|156742081|FG002|Overall Study|Withdrawal by Subject|3|||
48698090|NCT04583618|156742082|FG003|Overall Study|Withdrawal by Subject|1|||
48909913|NCT01187550|157506090|FG000|Overall Study|Protocol Violation|3|||
48909914|NCT01187550|157506091|FG001|Overall Study|Protocol Violation|1|||
48909915|NCT01187550|157506090|FG000|Overall Study|Other|3|||
48909916|NCT01187550|157506091|FG001|Overall Study|Other|0|||
48909917|NCT01187550|157506090|FG000|Overall Study|Randomized but not treated|8|||
48909918|NCT01187550|157506091|FG001|Overall Study|Randomized but not treated|0|||
48909919|NCT04060563|157506109|FG000|Overall Study|Lost to Follow-up|1|||
48698091|NCT04583618|156742083|FG004|Overall Study|Withdrawal by Subject|1|||
48909920|NCT04060563|157506110|FG001|Overall Study|Lost to Follow-up|1|||
48698092|NCT04583618|156742079|FG000|Overall Study|Lost to Follow-up|0|||
48698093|NCT04583618|156742080|FG001|Overall Study|Lost to Follow-up|1|||
48909921|NCT04060563|157506109|FG000|Overall Study|Physician Decision|0|||
48909922|NCT04060563|157506110|FG001|Overall Study|Physician Decision|1|||
48909923|NCT03838198|157506119|FG000|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
48909924|NCT03838198|157506120|FG001|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
48909925|NCT03838198|157506121|FG002|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1|||
48909926|NCT03838198|157506122|FG003|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
48909927|NCT03838198|157506119|FG000|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
48909928|NCT03838198|157506120|FG001|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
48909929|NCT03838198|157506121|FG002|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
48698094|NCT04583618|156742081|FG002|Overall Study|Lost to Follow-up|3|||
48698095|NCT04583618|156742082|FG003|Overall Study|Lost to Follow-up|1|||
48909930|NCT03838198|157506122|FG003|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
48698096|NCT04583618|156742083|FG004|Overall Study|Lost to Follow-up|1|||
48909931|NCT01379573|157506123|FG000|Overall Study|Lost to Follow-up|1|||
48909932|NCT01379573|157506123|FG000|Overall Study|Screen Failure|10|||
48909933|NCT02378220|157506124|FG000|Overall Study|Death|6|||
48909934|NCT02378220|157506125|FG001|Overall Study|Death|1|||
48909935|NCT01490814|157506126|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
48909936|NCT01490814|157506127|FG001|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
48909937|NCT01490814|157506126|FG000|Overall Study|Physician Decision|1|||
48909938|NCT01490814|157506127|FG001|Overall Study|Physician Decision|0|||
48909939|NCT01490814|157506126|FG000|Overall Study|Withdrawal by Subject|0|||
48909940|NCT01490814|157506127|FG001|Overall Study|Withdrawal by Subject|5|||
48909941|NCT01230554|157506128|FG000|Overall Study|Lost to Follow-up|2|||
48909942|NCT01230554|157506128|FG000|Overall Study|Inability to maintain visit schedule|1|||
48698097|NCT02783690|156742084|FG000|Overall Study|Withdrawal by Subject|3|||
48698098|NCT02783690|156742085|FG001|Overall Study|Withdrawal by Subject|3|||
48698099|NCT04500158|156742086|FG000|Overall Study|Physician Decision|17|||
48698100|NCT04500158|156742087|FG001|Overall Study|Physician Decision|11|||
48698101|NCT03204188|156742088|FG000|Immunotherapy Phase (1 Year)|Adverse Event|4|||
48698102|NCT03204188|156742088|FG000|Immunotherapy Phase (1 Year)|Death|1|||
48698103|NCT03204188|156742088|FG000|Follow-up Phase (Extension Study)|Progression of Disease|4|||
48698104|NCT03204188|156742088|FG000|Follow-up Phase (Extension Study)|Adverse Event|2|||
48698105|NCT04515771|156743375|FG000|Period 1: 6 Month Randomized Period|Lost to Follow-up|9|||
48698106|NCT04515771|156743376|FG001|Period 1: 6 Month Randomized Period|Lost to Follow-up|1|||
48698107|NCT04515771|156743375|FG000|Period 1: 6 Month Randomized Period|Withdrawal by Subject|3|||
48698108|NCT04515771|156743376|FG001|Period 1: 6 Month Randomized Period|Withdrawal by Subject|1|||
48698109|NCT04515771|156743375|FG000|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|0|||
48698110|NCT04515771|156743376|FG001|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|5|||
48698111|NCT01474317|156743377|FG000|Overall Study|Adverse Event|1|||
48698112|NCT01474317|156743377|FG000|Overall Study|Subject ineligible for study|1|||
48698113|NCT02891174|156743378|FG000|First Intervention (24 Hours)|Declined any study medication|1|||
48698114|NCT02891174|156743379|FG001|First Intervention (24 Hours)|Declined any study medication|5|||
48698115|NCT02891174|156743378|FG000|First Intervention (24 Hours)|Discharged prior to cross-over|0|||
48698116|NCT02891174|156743379|FG001|First Intervention (24 Hours)|Discharged prior to cross-over|2|||
48698117|NCT02891174|156743378|FG000|First Intervention (24 Hours)|Withdrew after receiving study drug|2|||
48698118|NCT02891174|156743379|FG001|First Intervention (24 Hours)|Withdrew after receiving study drug|6|||
48698119|NCT02891174|156743378|FG000|Second Intervention (24 Hours)|No blood pressure after cross-over|1|||
48698120|NCT02891174|156743379|FG001|Second Intervention (24 Hours)|No blood pressure after cross-over|0|||
48698121|NCT02891174|156743378|FG000|Second Intervention (24 Hours)|Discharged during second intervention|3|||
48698122|NCT02891174|156743379|FG001|Second Intervention (24 Hours)|Discharged during second intervention|5|||
48698123|NCT02891174|156743378|FG000|Second Intervention (24 Hours)|Withdrew after receiving study drug|2|||
48698124|NCT02891174|156743379|FG001|Second Intervention (24 Hours)|Withdrew after receiving study drug|1|||
48698125|NCT02891174|156743378|FG000|Second Intervention (24 Hours)|Protocol Violation|0|||
48698126|NCT02891174|156743379|FG001|Second Intervention (24 Hours)|Protocol Violation|1|||
48698127|NCT01838694|156743380|FG000|Overall Study|Adverse Event|0|||
48698128|NCT01838694|156743381|FG001|Overall Study|Adverse Event|1|||
48698129|NCT04516746|156743382|FG000|Overall Study|Randomized but not Treated|51|||
48698130|NCT04516746|156743383|FG001|Overall Study|Randomized but not Treated|19|||
48698131|NCT04516746|156743382|FG000|Overall Study|Adverse Event|0|||
48698132|NCT04516746|156743383|FG001|Overall Study|Adverse Event|1|||
48698133|NCT04516746|156743382|FG000|Overall Study|Death|62|||
48698134|NCT04516746|156743383|FG001|Overall Study|Death|32|||
48698135|NCT04516746|156743382|FG000|Overall Study|Lost to Follow-up|3431|||
48698136|NCT04516746|156743383|FG001|Overall Study|Lost to Follow-up|1831|||
48698137|NCT04516746|156743382|FG000|Overall Study|Withdrawal by Subject|1946|||
48698138|NCT04516746|156743383|FG001|Overall Study|Withdrawal by Subject|1696|||
48698139|NCT04516746|156743382|FG000|Overall Study|Physician Decision|10|||
48909943|NCT04195581|157506142|FG000|Comfilcon A With All in One Light|Withdrawal by Subject|4|||
48698140|NCT04516746|156743383|FG001|Overall Study|Physician Decision|8|||
48698141|NCT04516746|156743382|FG000|Overall Study|Other|35|||
48698142|NCT04516746|156743383|FG001|Overall Study|Other|16|||
48698143|NCT00248625|156743384|FG000|Overall Study|Withdrawal by Subject|0|||
48698144|NCT00248625|156743385|FG001|Overall Study|Withdrawal by Subject|2|||
48909944|NCT04195581|157506142|FG000|Comfilcon A With Hy-Care|Withdrawal by Subject|5|||
48698145|NCT02603146|156743386|FG000|Overall Study|Lost to Follow-up|5|||
48698146|NCT02603146|156743387|FG001|Overall Study|Lost to Follow-up|6|||
48698147|NCT02603146|156743386|FG000|Overall Study|Withdrawal by Subject|8|||
48698148|NCT02603146|156743387|FG001|Overall Study|Withdrawal by Subject|10|||
48698149|NCT02603146|156743386|FG000|Overall Study|Withdrawn by Investigator or NIAID|15|||
48698150|NCT02603146|156743387|FG001|Overall Study|Withdrawn by Investigator or NIAID|18|||
48698151|NCT02603146|156743386|FG000|Overall Study|Participant moved|2|||
48698152|NCT02603146|156743387|FG001|Overall Study|Participant moved|0|||
48698153|NCT02603146|156743386|FG000|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|1|||
48698154|NCT02603146|156743387|FG001|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|0|||
48698155|NCT05543265|156743390|FG000|Overall Study|Lost to Follow-up|3|||
48698156|NCT05543265|156743391|FG001|Overall Study|Lost to Follow-up|3|||
48698157|NCT05543265|156743390|FG000|Overall Study|Withdrawal by Subject|0|||
48698158|NCT05543265|156743391|FG001|Overall Study|Withdrawal by Subject|1|||
48698159|NCT01231984|156743392|FG000|Study Period 1|Withdrawal by Subject|0|||
48698160|NCT01231984|156743393|FG001|Study Period 1|Withdrawal by Subject|0|||
48698161|NCT01231984|156743394|FG002|Study Period 1|Withdrawal by Subject|0|||
48698162|NCT01231984|156743395|FG003|Study Period 1|Withdrawal by Subject|1|||
48698163|NCT01231984|156743392|FG000|Study Period 1|Lost to Follow-up|1|||
48698164|NCT01231984|156743393|FG001|Study Period 1|Lost to Follow-up|1|||
48698165|NCT01231984|156743394|FG002|Study Period 1|Lost to Follow-up|1|||
48698166|NCT01231984|156743395|FG003|Study Period 1|Lost to Follow-up|0|||
48698167|NCT01231984|156743392|FG000|Study Period 1|Did not continue to meet I/E Criteria|2|||
48698168|NCT01231984|156743393|FG001|Study Period 1|Did not continue to meet I/E Criteria|2|||
48698169|NCT01231984|156743394|FG002|Study Period 1|Did not continue to meet I/E Criteria|2|||
48698170|NCT01231984|156743395|FG003|Study Period 1|Did not continue to meet I/E Criteria|2|||
48698171|NCT01231984|156743392|FG000|Study Period 1|Screen Failure|0|||
48698172|NCT01231984|156743393|FG001|Study Period 1|Screen Failure|0|||
48698173|NCT01231984|156743394|FG002|Study Period 1|Screen Failure|0|||
48698174|NCT01231984|156743395|FG003|Study Period 1|Screen Failure|1|||
48698175|NCT01231984|156743392|FG000|Study Period 1|Non-compliance with study requirements|5|||
48698176|NCT01231984|156743393|FG001|Study Period 1|Non-compliance with study requirements|0|||
48698177|NCT01231984|156743394|FG002|Study Period 1|Non-compliance with study requirements|2|||
48698178|NCT01231984|156743395|FG003|Study Period 1|Non-compliance with study requirements|1|||
48698179|NCT01231984|156743392|FG000|Study Period 1|Protocol Violation|3|||
48698180|NCT01231984|156743393|FG001|Study Period 1|Protocol Violation|4|||
48698181|NCT01231984|156743394|FG002|Study Period 1|Protocol Violation|2|||
48698182|NCT01231984|156743395|FG003|Study Period 1|Protocol Violation|3|||
48698183|NCT01231984|156743392|FG000|Study Period 1|Adverse Event|1|||
48698184|NCT01231984|156743393|FG001|Study Period 1|Adverse Event|0|||
48698185|NCT01231984|156743394|FG002|Study Period 1|Adverse Event|0|||
48698186|NCT01231984|156743395|FG003|Study Period 1|Adverse Event|0|||
48698187|NCT01231984|156743392|FG000|Study Period 1|Other|0|||
48698188|NCT01231984|156743393|FG001|Study Period 1|Other|0|||
48698189|NCT01231984|156743394|FG002|Study Period 1|Other|0|||
48698190|NCT01231984|156743395|FG003|Study Period 1|Other|1|||
48698191|NCT01231984|156743392|FG000|Study Period 2|Withdrawal by Subject|1|||
48698192|NCT01231984|156743393|FG001|Study Period 2|Withdrawal by Subject|1|||
48698193|NCT01231984|156743394|FG002|Study Period 2|Withdrawal by Subject|0|||
48698194|NCT01231984|156743395|FG003|Study Period 2|Withdrawal by Subject|0|||
48698195|NCT01231984|156743392|FG000|Study Period 2|Lost to Follow-up|1|||
48698196|NCT01231984|156743393|FG001|Study Period 2|Lost to Follow-up|0|||
48698197|NCT01231984|156743394|FG002|Study Period 2|Lost to Follow-up|0|||
48698198|NCT01231984|156743395|FG003|Study Period 2|Lost to Follow-up|3|||
48698199|NCT01231984|156743392|FG000|Study Period 2|Did not continue to meet I/E Criteria|1|||
48698200|NCT01231984|156743393|FG001|Study Period 2|Did not continue to meet I/E Criteria|1|||
48698201|NCT01231984|156743394|FG002|Study Period 2|Did not continue to meet I/E Criteria|0|||
48698202|NCT01231984|156743395|FG003|Study Period 2|Did not continue to meet I/E Criteria|1|||
48698203|NCT04750824|156743396|FG000|Overall Study|Toxicity/intolerability|3|||
48698204|NCT04750824|156743397|FG001|Overall Study|Toxicity/intolerability|1|||
48698205|NCT04750824|156743396|FG000|Overall Study|Death|1|||
48698206|NCT04750824|156743397|FG001|Overall Study|Death|3|||
48698207|NCT04750824|156743396|FG000|Overall Study|Scheduled duration of therapy complete|1|||
48698208|NCT04750824|156743397|FG001|Overall Study|Scheduled duration of therapy complete|9|||
48698209|NCT04750824|156743396|FG000|Overall Study|Disease progression (confirmed with scan)|57|||
48698210|NCT04750824|156743397|FG001|Overall Study|Disease progression (confirmed with scan)|11|||
48698211|NCT03035032|156743404|FG000|Overall Study|Adverse Event|2|||
48698212|NCT03035032|156743404|FG000|Overall Study|Death|9|||
48698213|NCT03035032|156743404|FG000|Overall Study|Lost to Follow-up|1|||
48698214|NCT03035032|156743404|FG000|Overall Study|Progressive Disease|22|||
48698215|NCT03035032|156743404|FG000|Overall Study|Protocol Violation|2|||
48698216|NCT03035032|156743404|FG000|Overall Study|Withdrawal by Subject|2|||
48698217|NCT03035032|156743404|FG000|Overall Study|Physician Decision|5|||
48698218|NCT03466658|156743405|FG000|Overall Study|Withdrawal by Subject|3|||
48698219|NCT00837434|156743406|FG000|Overall Study|Physician Decision|3|||
48698220|NCT00837434|156743407|FG001|Overall Study|Physician Decision|0|||
48698221|NCT00837434|156743406|FG000|Overall Study|Lost to Follow-up|1|||
48698222|NCT00837434|156743407|FG001|Overall Study|Lost to Follow-up|1|||
48698223|NCT00837434|156743406|FG000|Overall Study|Withdrawn by sponsor/regulatory agency|1|||
48698224|NCT00837434|156743407|FG001|Overall Study|Withdrawn by sponsor/regulatory agency|0|||
48698225|NCT00837434|156743406|FG000|Overall Study|Noncompliant|2|||
48698226|NCT00837434|156743407|FG001|Overall Study|Noncompliant|0|||
48698227|NCT00837434|156743406|FG000|Overall Study|Baseline assessments not done in time|1|||
48698228|NCT00837434|156743407|FG001|Overall Study|Baseline assessments not done in time|0|||
48698229|NCT00837434|156743406|FG000|Overall Study|Unable to obtain study drug|1|||
48698230|NCT00837434|156743407|FG001|Overall Study|Unable to obtain study drug|0|||
48698231|NCT01349959|156743408|FG000|Overall Study|Adverse Event|7|||
48698232|NCT01680341|156743409|FG000|Overall Study|Adverse Event|3|||
48698233|NCT01680341|156743410|FG001|Overall Study|Adverse Event|2|||
48698234|NCT01680341|156743409|FG000|Overall Study|Unclassified|18|||
48698235|NCT01680341|156743410|FG001|Overall Study|Unclassified|15|||
48698236|NCT02388269|156743414|FG000|Overall Study|Adverse Event|2|||
48698237|NCT02388269|156743415|FG001|Overall Study|Adverse Event|0|||
48698238|NCT02388269|156743416|FG002|Overall Study|Adverse Event|0|||
48698239|NCT02388269|156743414|FG000|Overall Study|Withdrawal by Subject|1|||
48698240|NCT02388269|156743415|FG001|Overall Study|Withdrawal by Subject|2|||
48698241|NCT02388269|156743416|FG002|Overall Study|Withdrawal by Subject|0|||
48909945|NCT04195581|157506142|FG000|Comfilcon A With Refine One Step|Withdrawal by Subject|1|||
48909946|NCT04195581|157506142|FG000|Fanfilcon A With All in One Light|Withdrawal by Subject|1|||
48909947|NCT04195581|157506142|FG000|Fanfilcon A With Hy-Care|Withdrawal by Subject|3|||
48909948|NCT04195581|157506142|FG000|Fanfilcon A With Refine One Step|Withdrawal by Subject|2|||
48909949|NCT00935272|157506146|FG000|Overall Study|Lost to Follow-up|10|||
48909950|NCT00935272|157506147|FG001|Overall Study|Lost to Follow-up|3|||
48909951|NCT00935272|157506146|FG000|Overall Study|Withdrawal by Subject|8|||
48909952|NCT00935272|157506147|FG001|Overall Study|Withdrawal by Subject|2|||
48909953|NCT00935272|157506146|FG000|Overall Study|Physician Decision|1|||
48909954|NCT00935272|157506147|FG001|Overall Study|Physician Decision|0|||
48909955|NCT00935272|157506146|FG000|Overall Study|Protocol Violation|0|||
48909956|NCT00935272|157506147|FG001|Overall Study|Protocol Violation|1|||
48909957|NCT00736034|157506151|FG000|Overall Study|Adverse Event|2|||
48909958|NCT01910116|157506152|FG000|Overall Study|Adverse Event|0|||
48909959|NCT01910116|157506153|FG001|Overall Study|Adverse Event|3|||
48909960|NCT01910116|157506152|FG000|Overall Study|Lack of Efficacy|3|||
48909961|NCT01910116|157506153|FG001|Overall Study|Lack of Efficacy|4|||
48909962|NCT01910116|157506152|FG000|Overall Study|Lost to Follow-up|1|||
48909963|NCT01910116|157506153|FG001|Overall Study|Lost to Follow-up|0|||
48909964|NCT01910116|157506152|FG000|Overall Study|Protocol Violation|1|||
48909965|NCT01910116|157506153|FG001|Overall Study|Protocol Violation|2|||
48909966|NCT01910116|157506152|FG000|Overall Study|Withdrawal by Subject|8|||
48909967|NCT01910116|157506153|FG001|Overall Study|Withdrawal by Subject|3|||
48909968|NCT01910116|157506152|FG000|Overall Study|uncertain allocation|1|||
48909969|NCT01910116|157506153|FG001|Overall Study|uncertain allocation|3|||
48909970|NCT01910116|157506152|FG000|Overall Study|incomplete data|0|||
48909971|NCT01910116|157506153|FG001|Overall Study|incomplete data|1|||
48909972|NCT03716050|157506154|FG000|Overall Study|Lost to Follow-up|0|||
48909973|NCT03716050|157506155|FG001|Overall Study|Lost to Follow-up|0|||
48909974|NCT03716050|157506156|FG002|Overall Study|Lost to Follow-up|1|||
48909975|NCT03716050|157506157|FG003|Overall Study|Lost to Follow-up|0|||
48909976|NCT03716050|157506158|FG004|Overall Study|Lost to Follow-up|0|||
48909977|NCT03716050|157506159|FG005|Overall Study|Lost to Follow-up|0|||
48909978|NCT03716050|157506160|FG006|Overall Study|Lost to Follow-up|0|||
48909979|NCT03716050|157506161|FG007|Overall Study|Lost to Follow-up|0|||
48909980|NCT03716050|157506154|FG000|Overall Study|Physician Decision|0|||
48909981|NCT03716050|157506155|FG001|Overall Study|Physician Decision|0|||
48909982|NCT03716050|157506156|FG002|Overall Study|Physician Decision|0|||
48909983|NCT03716050|157506157|FG003|Overall Study|Physician Decision|1|||
48909984|NCT03716050|157506158|FG004|Overall Study|Physician Decision|0|||
48909985|NCT03716050|157506159|FG005|Overall Study|Physician Decision|0|||
48909986|NCT03716050|157506160|FG006|Overall Study|Physician Decision|0|||
48909987|NCT03716050|157506161|FG007|Overall Study|Physician Decision|0|||
48909988|NCT03716050|157506154|FG000|Overall Study|Protocol Violation|0|||
48909989|NCT03716050|157506155|FG001|Overall Study|Protocol Violation|0|||
48909990|NCT03716050|157506156|FG002|Overall Study|Protocol Violation|0|||
48698242|NCT02388269|156743414|FG000|Overall Study|less than 50% stimulations|1|||
48698243|NCT02388269|156743415|FG001|Overall Study|less than 50% stimulations|0|||
48698244|NCT02388269|156743416|FG002|Overall Study|less than 50% stimulations|0|||
48698245|NCT02388269|156743414|FG000|Overall Study|no diary data|3|||
48909991|NCT03716050|157506157|FG003|Overall Study|Protocol Violation|1|||
48909992|NCT03716050|157506158|FG004|Overall Study|Protocol Violation|0|||
48909993|NCT03716050|157506159|FG005|Overall Study|Protocol Violation|0|||
48698246|NCT02388269|156743415|FG001|Overall Study|no diary data|0|||
48698247|NCT02388269|156743416|FG002|Overall Study|no diary data|0|||
48698248|NCT02388269|156743414|FG000|Overall Study|Protocol Violation|2|||
48909994|NCT03716050|157506160|FG006|Overall Study|Protocol Violation|0|||
48698249|NCT02388269|156743415|FG001|Overall Study|Protocol Violation|0|||
48698250|NCT02388269|156743416|FG002|Overall Study|Protocol Violation|0|||
48698251|NCT02388269|156743414|FG000|Overall Study|Screen Failure|0|||
48698252|NCT02388269|156743415|FG001|Overall Study|Screen Failure|0|||
48698253|NCT02388269|156743416|FG002|Overall Study|Screen Failure|10|||
48698254|NCT03988400|156743418|FG000|Overall Study|Adverse Event|1|||
48698255|NCT03988400|156743419|FG001|Overall Study|Adverse Event|0|||
48698256|NCT03988400|156743418|FG000|Overall Study|Macular degeneration, unrelated to study procedures.|1|||
48698257|NCT03988400|156743419|FG001|Overall Study|Macular degeneration, unrelated to study procedures.|0|||
48698258|NCT03988400|156743418|FG000|Overall Study|Lost to Follow-up|0|||
48698259|NCT03988400|156743419|FG001|Overall Study|Lost to Follow-up|1|||
48698260|NCT02731638|156743423|FG000|Overall Study|Lost to Follow-up|6|||
48698261|NCT02731638|156743424|FG001|Overall Study|Lost to Follow-up|9|||
48698262|NCT01690143|156743425|FG000|Overall Study|Withdrawal by Subject|1|||
48698263|NCT01838395|156743431|FG000|Overall Study|Withdrawal by Subject|0|||
48698264|NCT01838395|156743432|FG001|Overall Study|Withdrawal by Subject|0|||
48698265|NCT01838395|156743433|FG002|Overall Study|Withdrawal by Subject|0|||
48698266|NCT01838395|156743434|FG003|Overall Study|Withdrawal by Subject|0|||
48698267|NCT01838395|156743435|FG004|Overall Study|Withdrawal by Subject|1|||
48698268|NCT01838395|156743436|FG005|Overall Study|Withdrawal by Subject|0|||
48698269|NCT01838395|156743431|FG000|Overall Study|Death|0|||
48698270|NCT01838395|156743432|FG001|Overall Study|Death|0|||
48698271|NCT01838395|156743433|FG002|Overall Study|Death|1|||
48698272|NCT01838395|156743434|FG003|Overall Study|Death|0|||
48698273|NCT01838395|156743435|FG004|Overall Study|Death|0|||
48698274|NCT01838395|156743436|FG005|Overall Study|Death|0|||
48698275|NCT01838395|156743431|FG000|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
48698276|NCT01838395|156743432|FG001|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|1|||
48698277|NCT01838395|156743433|FG002|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
48698278|NCT01838395|156743434|FG003|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
48698279|NCT01838395|156743435|FG004|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
48698280|NCT01838395|156743436|FG005|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
48698281|NCT03474588|156743440|FG000|Overall Study|Withdrawal by Subject|4|||
48698282|NCT03474588|156743441|FG001|Overall Study|Withdrawal by Subject|3|||
48698283|NCT03474588|156743440|FG000|Overall Study|Death|0|||
48698284|NCT03474588|156743441|FG001|Overall Study|Death|1|||
48698285|NCT05720897|156743442|FG000|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|2|||
48698286|NCT05720897|156743443|FG001|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|0|||
48698287|NCT05430854|156743445|FG000|Overall Study|Trial terminated by Sponsor|39|||
48698288|NCT05430854|156743446|FG001|Overall Study|Trial terminated by Sponsor|50|||
48698289|NCT05430854|156743447|FG002|Overall Study|Trial terminated by Sponsor|46|||
48698290|NCT05430854|156743445|FG000|Overall Study|Withdrawal by Subject|0|||
48698291|NCT05430854|156743446|FG001|Overall Study|Withdrawal by Subject|3|||
48698292|NCT05430854|156743447|FG002|Overall Study|Withdrawal by Subject|0|||
48698293|NCT05138653|156743453|FG000|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|1|||
48698294|NCT05138653|156743454|FG001|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
48698295|NCT05138653|156743455|FG002|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
48698296|NCT05138653|156743456|FG003|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
48698297|NCT05138653|156743457|FG004|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
48909995|NCT03716050|157506161|FG007|Overall Study|Protocol Violation|2|||
48909996|NCT00955279|157506162|FG000|Overall Study|Other|0|||
48909997|NCT00955279|157506163|FG001|Overall Study|Other|0|||
48909998|NCT00955279|157506164|FG002|Overall Study|Other|3|||
48909999|NCT00955279|157506162|FG000|Overall Study|Death|1|||
48910000|NCT00955279|157506163|FG001|Overall Study|Death|1|||
48910001|NCT00955279|157506164|FG002|Overall Study|Death|1|||
48910002|NCT00955279|157506162|FG000|Overall Study|Lost to Follow-up|0|||
48910003|NCT00955279|157506163|FG001|Overall Study|Lost to Follow-up|3|||
48910004|NCT00955279|157506164|FG002|Overall Study|Lost to Follow-up|1|||
48910005|NCT00955279|157506162|FG000|Overall Study|Withdrawal by Subject|2|||
48910006|NCT00955279|157506163|FG001|Overall Study|Withdrawal by Subject|0|||
48910007|NCT00955279|157506164|FG002|Overall Study|Withdrawal by Subject|3|||
48910008|NCT03044886|157506168|FG000|Overall Study|Lost to Follow-up|15|||
48910009|NCT03044886|157506169|FG001|Overall Study|Lost to Follow-up|10|||
48910010|NCT03044886|157506170|FG002|Overall Study|Lost to Follow-up|12|||
48910011|NCT02966223|157506171|FG000|Overall Study|Physician Decision|3|||
48910012|NCT02966223|157506171|FG000|Overall Study|Withdrawal by Subject|11|||
48910013|NCT02966223|157506171|FG000|Overall Study|Lost to Follow-up|1|||
48910014|NCT05093322|157506172|FG000|Overall Study|Death|6|||
48910015|NCT05093322|157506173|FG001|Overall Study|Death|2|||
48910016|NCT05093322|157506172|FG000|Overall Study|Other|4|||
48910017|NCT05093322|157506173|FG001|Overall Study|Other|1|||
48910018|NCT03715153|157506174|FG000|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
48910019|NCT03715153|157506175|FG001|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
48910020|NCT03715153|157506174|FG000|Double-blind Period (From W0 to W26)|Non medical reason|8|||
48910021|NCT03715153|157506175|FG001|Double-blind Period (From W0 to W26)|Non medical reason|2|||
48910022|NCT03715153|157506174|FG000|Double-blind Period (From W0 to W26)|Adverse Event|8|||
48910023|NCT03715153|157506175|FG001|Double-blind Period (From W0 to W26)|Adverse Event|6|||
48910024|NCT03715153|157506174|FG000|Open-label Period (From W26 to W52)|Adverse Event|8|||
48910025|NCT03715153|157506175|FG001|Open-label Period (From W26 to W52)|Adverse Event|3|||
48698298|NCT05138653|156743458|FG005|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
48698299|NCT05138653|156743459|FG006|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
48698300|NCT05138653|156743460|FG007|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
48698301|NCT05138653|156743461|FG008|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
48698302|NCT05138653|156743462|FG009|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
48698303|NCT05138653|156743463|FG010|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
48698304|NCT05138653|156743464|FG011|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
48698305|NCT05138653|156743465|FG012|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
48698306|NCT05138653|156743466|FG013|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
48698307|NCT05138653|156743467|FG014|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
48698308|NCT05138653|156743468|FG015|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
48698309|NCT05138653|156743453|FG000|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
48698310|NCT05138653|156743454|FG001|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
48698311|NCT05138653|156743455|FG002|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
48698312|NCT05138653|156743456|FG003|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
48698313|NCT05138653|156743457|FG004|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
48698314|NCT05138653|156743458|FG005|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
48698315|NCT05138653|156743459|FG006|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
48698316|NCT05138653|156743460|FG007|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
48698317|NCT05138653|156743461|FG008|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
48698318|NCT05138653|156743462|FG009|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
48698319|NCT05138653|156743463|FG010|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
48698320|NCT05138653|156743464|FG011|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
48698321|NCT05138653|156743465|FG012|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
48698322|NCT05138653|156743466|FG013|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
48698323|NCT05138653|156743467|FG014|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
48698324|NCT05138653|156743468|FG015|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
48910026|NCT03715153|157506174|FG000|Open-label Period (From W26 to W52)|Non medical reason|31|||
48698325|NCT05138653|156743453|FG000|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
48698326|NCT05138653|156743454|FG001|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
48698327|NCT05138653|156743455|FG002|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
48910027|NCT03715153|157506175|FG001|Open-label Period (From W26 to W52)|Non medical reason|38|||
48910028|NCT03715153|157506174|FG000|Open-label Period (From W26 to W52)|Protocol Violation|1|||
48910029|NCT03715153|157506175|FG001|Open-label Period (From W26 to W52)|Protocol Violation|1|||
48910030|NCT04411628|157506176|FG000|Overall Study|Withdrawal by Subject|1|||
48910031|NCT04411628|157506177|FG001|Overall Study|Withdrawal by Subject|1|||
48910032|NCT04411628|157506178|FG002|Overall Study|Withdrawal by Subject|2|||
48910033|NCT04411628|157506179|FG003|Overall Study|Withdrawal by Subject|0|||
48910034|NCT04411628|157506176|FG000|Overall Study|Lost to Follow-up|0|||
48910035|NCT04411628|157506177|FG001|Overall Study|Lost to Follow-up|1|||
48698328|NCT05138653|156743456|FG003|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
48698329|NCT05138653|156743457|FG004|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
48698330|NCT05138653|156743458|FG005|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
48698331|NCT05138653|156743459|FG006|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
48698332|NCT05138653|156743460|FG007|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
48698333|NCT05138653|156743461|FG008|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
48698334|NCT05138653|156743462|FG009|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
48698335|NCT05138653|156743463|FG010|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
48698336|NCT05138653|156743464|FG011|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
48698337|NCT05138653|156743465|FG012|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
48698338|NCT05138653|156743466|FG013|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
48698339|NCT05138653|156743467|FG014|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
48698340|NCT05138653|156743468|FG015|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
48698341|NCT05138653|156743453|FG000|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
48698342|NCT05138653|156743454|FG001|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
48698343|NCT05138653|156743455|FG002|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
48698344|NCT05138653|156743456|FG003|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
48698345|NCT05138653|156743457|FG004|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
48698346|NCT05138653|156743458|FG005|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
48698347|NCT05138653|156743459|FG006|Single Ascending Dose (Up to 13 Weeks)|Other|1|||
48698348|NCT05138653|156743460|FG007|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
48698349|NCT05138653|156743461|FG008|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
48698350|NCT05138653|156743462|FG009|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
48698351|NCT05138653|156743463|FG010|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
48698352|NCT05138653|156743464|FG011|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
48698353|NCT05138653|156743465|FG012|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
48698354|NCT05138653|156743466|FG013|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
48698355|NCT05138653|156743467|FG014|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
48698356|NCT05138653|156743468|FG015|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
48698357|NCT05138653|156743453|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
48698358|NCT05138653|156743454|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
48698359|NCT05138653|156743455|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
48698360|NCT05138653|156743456|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
48698361|NCT05138653|156743457|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
48698362|NCT05138653|156743458|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
48698363|NCT05138653|156743459|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
48698364|NCT05138653|156743460|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
48698365|NCT05138653|156743461|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
48698366|NCT05138653|156743462|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
48698367|NCT05138653|156743463|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
48698368|NCT05138653|156743464|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
48698369|NCT05138653|156743465|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
48698370|NCT05138653|156743466|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
48698371|NCT05138653|156743467|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
48698372|NCT05138653|156743468|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
48698373|NCT05138653|156743453|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
48698374|NCT05138653|156743454|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
48698375|NCT05138653|156743455|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
48698376|NCT05138653|156743456|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
48698377|NCT05138653|156743457|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
48698378|NCT05138653|156743458|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
48698379|NCT05138653|156743459|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
48698380|NCT05138653|156743460|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
48698381|NCT05138653|156743461|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
48698382|NCT05138653|156743462|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
48698383|NCT05138653|156743463|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
48698384|NCT05138653|156743464|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
48698385|NCT05138653|156743465|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
48698386|NCT05138653|156743466|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
48698387|NCT05138653|156743467|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
48698388|NCT05138653|156743468|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|1|||
48698389|NCT05138653|156743453|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
48698390|NCT05138653|156743454|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
48698391|NCT05138653|156743455|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
48742937|NCT01550289|156910420|FG001|Overall Study|Lost to Follow-up|1|||
48698392|NCT05138653|156743456|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
48698393|NCT05138653|156743457|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
48698394|NCT05138653|156743458|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
48698395|NCT05138653|156743459|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
48698396|NCT05138653|156743460|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
48698397|NCT05138653|156743461|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
48698398|NCT05138653|156743462|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
48698399|NCT05138653|156743463|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
48698400|NCT05138653|156743464|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
48698401|NCT05138653|156743465|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
48698402|NCT05138653|156743466|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|1|||
48698403|NCT05138653|156743467|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
48698404|NCT05138653|156743468|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
48698405|NCT02023086|156743469|FG000|Overall Study|Withdrawal by Subject|2|||
48698406|NCT02023086|156743470|FG001|Overall Study|Withdrawal by Subject|0|||
48698407|NCT03389477|156743471|FG000|Step 1|Withdrawal by Subject|1|||
48698408|NCT03389477|156743472|FG001|Step 1|Withdrawal by Subject|0|||
48698409|NCT03389477|156743471|FG000|Step 2|Withdrawal by Subject|1|||
48698410|NCT03389477|156743472|FG001|Step 2|Withdrawal by Subject|2|||
48698411|NCT03389477|156743471|FG000|Step 2|Disease progression|1|||
48698412|NCT03389477|156743472|FG001|Step 2|Disease progression|0|||
48698413|NCT03389477|156743471|FG000|Step 2|Death|0|||
48698414|NCT03389477|156743472|FG001|Step 2|Death|1|||
48698415|NCT03389477|156743471|FG000|Step 2|Poor performance status and nutrition|0|||
48698416|NCT03389477|156743472|FG001|Step 2|Poor performance status and nutrition|1|||
48698417|NCT03389477|156743471|FG000|Step 3|Withdrawal after 3 cycles|0|||
48698418|NCT03389477|156743472|FG001|Step 3|Withdrawal after 3 cycles|1|||
48698419|NCT03389477|156743471|FG000|Step 3|Still receiving active treatment|4|||
48698420|NCT03389477|156743472|FG001|Step 3|Still receiving active treatment|0|||
48698421|NCT03389477|156743471|FG000|Step 3|Progressive disease after 2 cycles|1|||
48698422|NCT03389477|156743472|FG001|Step 3|Progressive disease after 2 cycles|0|||
48698423|NCT04659044|156743473|FG000|Induction|Physician Decision|1|||
48698424|NCT04659044|156743473|FG000|Induction|Adverse Event|2|||
48698425|NCT04966013|156743475|FG000|Overall Study|Withdrawal by Subject|0|||
48698426|NCT04966013|156743476|FG001|Overall Study|Withdrawal by Subject|2|||
48698427|NCT04966013|156743477|FG002|Overall Study|Withdrawal by Subject|1|||
48698428|NCT04966013|156743475|FG000|Overall Study|Adverse Event|2|||
48698429|NCT04966013|156743476|FG001|Overall Study|Adverse Event|1|||
48698430|NCT04966013|156743477|FG002|Overall Study|Adverse Event|1|||
48698431|NCT04825574|156743481|FG000|Overall Study|Commercial treatment became available|1|||
48698432|NCT04825574|156743481|FG000|Overall Study|Disease progression|1|||
48698433|NCT02864394|156743487|FG000|Overall Study|Death|184|||
48698434|NCT02864394|156743488|FG001|Overall Study|Death|189|||
48698435|NCT02864394|156743487|FG000|Overall Study|Lost to Follow-up|0|||
48698436|NCT02864394|156743488|FG001|Overall Study|Lost to Follow-up|2|||
48698437|NCT02864394|156743487|FG000|Overall Study|Sponsor Decision|26|||
48698438|NCT02864394|156743488|FG001|Overall Study|Sponsor Decision|11|||
48698439|NCT02864394|156743487|FG000|Overall Study|Withdrawal by Subject|3|||
48698440|NCT02864394|156743488|FG001|Overall Study|Withdrawal by Subject|10|||
48698441|NCT03409796|156745520|FG000|Overall Study|Adverse Event|2|||
48698442|NCT03409796|156745521|FG001|Overall Study|Adverse Event|0|||
48698443|NCT03409796|156745520|FG000|Overall Study|Other|0|||
48698444|NCT03409796|156745521|FG001|Overall Study|Other|1|||
48698445|NCT00740220|156745522|FG000|Overall Study|screen failures (non-COPD patients)|9|||
48698446|NCT02458313|156745524|FG000|Overall Study|Withdrawal by Subject|6|||
48698447|NCT02458313|156745525|FG001|Overall Study|Withdrawal by Subject|8|||
48698448|NCT02458313|156745524|FG000|Overall Study|Excluded for motion during MRI|1|||
48698449|NCT02458313|156745525|FG001|Overall Study|Excluded for motion during MRI|2|||
48698450|NCT02443688|156745532|FG000|Overall Study|Adverse Event|2|||
48698451|NCT02443688|156745533|FG001|Overall Study|Adverse Event|3|||
48910036|NCT04411628|157506178|FG002|Overall Study|Lost to Follow-up|0|||
48910037|NCT04411628|157506179|FG003|Overall Study|Lost to Follow-up|0|||
48910038|NCT01846624|157506180|FG000|Overall Study|Died during induction, no midostaurin|1|||
48910039|NCT00290186|157506181|FG000|Overall Study|Adverse Event|1|||
48910040|NCT00290186|157506182|FG001|Overall Study|Adverse Event|1|||
48910041|NCT00290186|157506181|FG000|Overall Study|Lost to Follow-up|3|||
48910042|NCT00290186|157506182|FG001|Overall Study|Lost to Follow-up|2|||
48910043|NCT00290186|157506181|FG000|Overall Study|Study was terminated prior to 3-month te|1|||
48910044|NCT00290186|157506182|FG001|Overall Study|Study was terminated prior to 3-month te|1|||
48910045|NCT00290186|157506181|FG000|Overall Study|Withdrawal by Subject|0|||
48698452|NCT02443688|156745534|FG002|Overall Study|Adverse Event|2|||
48698453|NCT02443688|156745532|FG000|Overall Study|Lost to Follow-up|1|||
48698454|NCT02443688|156745533|FG001|Overall Study|Lost to Follow-up|0|||
48698455|NCT02443688|156745534|FG002|Overall Study|Lost to Follow-up|0|||
48910046|NCT00290186|157506182|FG001|Overall Study|Withdrawal by Subject|1|||
48910047|NCT01877915|157506183|FG000|Overall Study|Lost to Follow-up|10|||
48910048|NCT01877915|157506184|FG001|Overall Study|Lost to Follow-up|9|||
48910049|NCT01877915|157506183|FG000|Overall Study|Withdrawal by Subject|42|||
48910050|NCT01877915|157506184|FG001|Overall Study|Withdrawal by Subject|55|||
48910051|NCT01877915|157506183|FG000|Overall Study|Other|2|||
48910052|NCT01877915|157506184|FG001|Overall Study|Other|4|||
48910053|NCT04275297|157506185|FG000|Overall Study|Lost to Follow-up|1|||
48910054|NCT04275297|157506186|FG001|Overall Study|Lost to Follow-up|1|||
48910055|NCT04622046|157506189|FG000|Intervention Period|Adverse Event|1|||
48698456|NCT02443688|156745532|FG000|Overall Study|Physician Decision|3|||
48698457|NCT02443688|156745533|FG001|Overall Study|Physician Decision|0|||
48698458|NCT02443688|156745534|FG002|Overall Study|Physician Decision|1|||
48698459|NCT02443688|156745532|FG000|Overall Study|Pregnancy|0|||
48698460|NCT02443688|156745533|FG001|Overall Study|Pregnancy|0|||
48698461|NCT02443688|156745534|FG002|Overall Study|Pregnancy|1|||
48698462|NCT02443688|156745532|FG000|Overall Study|Withdrawal by Subject|3|||
48698463|NCT02443688|156745533|FG001|Overall Study|Withdrawal by Subject|3|||
48698464|NCT02443688|156745534|FG002|Overall Study|Withdrawal by Subject|4|||
48698465|NCT02443688|156745532|FG000|Overall Study|Non-compliance with study drug|1|||
48698466|NCT02443688|156745533|FG001|Overall Study|Non-compliance with study drug|2|||
48698467|NCT02443688|156745534|FG002|Overall Study|Non-compliance with study drug|4|||
48698468|NCT02443688|156745532|FG000|Overall Study|Sponsor Request|2|||
48698469|NCT02443688|156745533|FG001|Overall Study|Sponsor Request|1|||
48910056|NCT04622046|157506189|FG000|Intervention Period|Withdrawal by Subject|2|||
48698470|NCT02443688|156745534|FG002|Overall Study|Sponsor Request|0|||
48698471|NCT02177123|156745537|FG000|Overall Study|Lost to Follow-up|6|||
48698472|NCT02177123|156745537|FG000|Overall Study|Withdrawal by Subject|4|||
48698473|NCT02177123|156745537|FG000|Overall Study|Adverse Event|4|||
48698474|NCT02177123|156745537|FG000|Overall Study|Physician Decision|3|||
48698475|NCT02177123|156745537|FG000|Overall Study|Excluded by Sponsor - other reason|2|||
48698476|NCT02177123|156745537|FG000|Overall Study|Excluded for medical reasons|2|||
48698477|NCT02177123|156745537|FG000|Overall Study|Death|1|||
48698478|NCT02177123|156745537|FG000|Overall Study|Other|1|||
48698479|NCT02177123|156745537|FG000|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1|||
48698480|NCT05635461|156745538|FG000|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
48698481|NCT05635461|156745539|FG001|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
48698482|NCT05635461|156745540|FG002|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
48698483|NCT05635461|156745541|FG003|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
48698484|NCT05635461|156745542|FG004|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|1|||
48698485|NCT05635461|156745543|FG005|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
48698486|NCT05635461|156745538|FG000|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
48698487|NCT05635461|156745539|FG001|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|1|||
48698488|NCT05635461|156745540|FG002|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
48698489|NCT05635461|156745541|FG003|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
48698490|NCT05635461|156745542|FG004|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
48698491|NCT05635461|156745543|FG005|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
48698492|NCT05635461|156745538|FG000|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
48698493|NCT05635461|156745539|FG001|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
48698494|NCT05635461|156745540|FG002|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
48698495|NCT05635461|156745541|FG003|Period 3: Dosing 3 (Day 1)|Adverse Event|1|||
48698496|NCT05635461|156745542|FG004|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
48698497|NCT05635461|156745543|FG005|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
48698498|NCT00981656|156745550|FG000|Overall Study|Protocol Violation|1|||
48698499|NCT00981656|156745550|FG000|Overall Study|Did not start protocol treatment|2|||
48698500|NCT00772538|156745554|FG000|Overall Study|Adverse Event|6|||
48698501|NCT00772538|156745555|FG001|Overall Study|Adverse Event|6|||
48698502|NCT00772538|156745554|FG000|Overall Study|Protocol Violation|3|||
48698503|NCT00772538|156745555|FG001|Overall Study|Protocol Violation|3|||
48698504|NCT00772538|156745554|FG000|Overall Study|Lost to Follow-up|1|||
48698505|NCT00772538|156745555|FG001|Overall Study|Lost to Follow-up|1|||
48698506|NCT00772538|156745554|FG000|Overall Study|Withdrawal by Subject|3|||
48698507|NCT00772538|156745555|FG001|Overall Study|Withdrawal by Subject|8|||
48698508|NCT00772538|156745554|FG000|Overall Study|Lack of Efficacy|0|||
48698509|NCT00772538|156745555|FG001|Overall Study|Lack of Efficacy|1|||
48698510|NCT00772538|156745554|FG000|Overall Study|Other|7|||
48698511|NCT00772538|156745555|FG001|Overall Study|Other|7|||
48698512|NCT02085460|156745557|FG000|Overall Study|Adverse Event|2|||
48698513|NCT02085460|156745558|FG001|Overall Study|Adverse Event|2|||
48698514|NCT02085460|156745559|FG002|Overall Study|Adverse Event|1|||
48698515|NCT02085460|156745557|FG000|Overall Study|Physician Decision|1|||
48698516|NCT02085460|156745558|FG001|Overall Study|Physician Decision|1|||
48698517|NCT02085460|156745559|FG002|Overall Study|Physician Decision|2|||
48698518|NCT02085460|156745557|FG000|Overall Study|Withdrawal by Subject|11|||
48698519|NCT02085460|156745558|FG001|Overall Study|Withdrawal by Subject|5|||
48910057|NCT04622046|157506189|FG000|Extension Period|Ongoing in the Extension Period|21|||
48910058|NCT01086410|157507629|FG000|Overall Study|Adverse Event|1|||
48698520|NCT02085460|156745559|FG002|Overall Study|Withdrawal by Subject|7|||
48698521|NCT02230410|156745561|FG000|Overall Study|Screen Failure|3|||
48698522|NCT04629508|156745565|FG000|Overall Study|Adverse Event|1|||
48698523|NCT04629508|156745565|FG000|Overall Study|Death|2|||
48698524|NCT04629508|156745565|FG000|Overall Study|Protocol-specified withdrawal criterion met|1|||
48698525|NCT01149096|156745569|FG000|Overall Study|Lost to Follow-up|0|||
48698526|NCT01149096|156745570|FG001|Overall Study|Lost to Follow-up|1|||
48698527|NCT04914364|156745571|FG000|Overall Study|No longer eligible for study|1|||
48698528|NCT04914364|156745571|FG000|Overall Study|Lost to Follow-up|2|||
48698529|NCT02365649|156745580|FG000|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
48698530|NCT02365649|156745581|FG001|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
48698531|NCT02365649|156745582|FG002|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
48698532|NCT02365649|156745583|FG003|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|1|||
48698533|NCT02365649|156745584|FG004|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
48698534|NCT02365649|156745585|FG005|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
48698535|NCT02365649|156745586|FG006|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
48698536|NCT02365649|156745587|FG007|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
48698537|NCT02365649|156745588|FG008|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
48698538|NCT02365649|156745589|FG009|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
48698539|NCT02365649|156745580|FG000|Double-Blind Induction (Weeks 1-16)|Adverse Event|3|||
48698540|NCT02365649|156745581|FG001|Double-Blind Induction (Weeks 1-16)|Adverse Event|4|||
48698541|NCT02365649|156745582|FG002|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
48698542|NCT02365649|156745583|FG003|Double-Blind Induction (Weeks 1-16)|Adverse Event|7|||
48698543|NCT02365649|156745584|FG004|Double-Blind Induction (Weeks 1-16)|Adverse Event|1|||
48698544|NCT02365649|156745585|FG005|Double-Blind Induction (Weeks 1-16)|Adverse Event|2|||
48698545|NCT02365649|156745586|FG006|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
48698546|NCT02365649|156745587|FG007|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
48698547|NCT02365649|156745588|FG008|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
48698548|NCT02365649|156745589|FG009|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
48698549|NCT02365649|156745580|FG000|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|3|||
48698550|NCT02365649|156745581|FG001|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
48698551|NCT02365649|156745582|FG002|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
48698552|NCT02365649|156745583|FG003|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
48698553|NCT02365649|156745584|FG004|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|2|||
48698554|NCT02365649|156745585|FG005|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
48698555|NCT02365649|156745586|FG006|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
48698556|NCT02365649|156745587|FG007|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
48698557|NCT02365649|156745588|FG008|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
48698558|NCT02365649|156745589|FG009|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
48698559|NCT02365649|156745580|FG000|Double-Blind Induction (Weeks 1-16)|Other|1|||
48698560|NCT02365649|156745581|FG001|Double-Blind Induction (Weeks 1-16)|Other|0|||
48698561|NCT02365649|156745582|FG002|Double-Blind Induction (Weeks 1-16)|Other|1|||
48698562|NCT02365649|156745583|FG003|Double-Blind Induction (Weeks 1-16)|Other|0|||
48698563|NCT02365649|156745584|FG004|Double-Blind Induction (Weeks 1-16)|Other|1|||
48698564|NCT02365649|156745585|FG005|Double-Blind Induction (Weeks 1-16)|Other|1|||
48698565|NCT02365649|156745586|FG006|Double-Blind Induction (Weeks 1-16)|Other|0|||
48698566|NCT02365649|156745587|FG007|Double-Blind Induction (Weeks 1-16)|Other|0|||
48698567|NCT02365649|156745588|FG008|Double-Blind Induction (Weeks 1-16)|Other|0|||
48698568|NCT02365649|156745589|FG009|Double-Blind Induction (Weeks 1-16)|Other|0|||
48698569|NCT02365649|156745580|FG000|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
48698570|NCT02365649|156745581|FG001|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
48698571|NCT02365649|156745582|FG002|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|1|||
48698572|NCT02365649|156745583|FG003|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
48698573|NCT02365649|156745584|FG004|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
48698574|NCT02365649|156745585|FG005|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
48698575|NCT02365649|156745586|FG006|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
48698576|NCT02365649|156745587|FG007|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
48698577|NCT02365649|156745588|FG008|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
48698578|NCT02365649|156745589|FG009|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
48698579|NCT02365649|156745580|FG000|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
48698580|NCT02365649|156745581|FG001|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
48698581|NCT02365649|156745582|FG002|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
48698582|NCT02365649|156745583|FG003|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
48698583|NCT02365649|156745584|FG004|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
48698584|NCT02365649|156745585|FG005|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
48698585|NCT02365649|156745586|FG006|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
48698586|NCT02365649|156745587|FG007|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
48698587|NCT02365649|156745588|FG008|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
48910059|NCT01086410|157507630|FG001|Overall Study|Adverse Event|0|||
48910060|NCT01086410|157507631|FG002|Overall Study|Adverse Event|0|||
48910061|NCT01086410|157507632|FG003|Overall Study|Adverse Event|2|||
48910062|NCT01086410|157507629|FG000|Overall Study|Lack of Efficacy|1|||
48910063|NCT01086410|157507630|FG001|Overall Study|Lack of Efficacy|1|||
48910064|NCT01086410|157507631|FG002|Overall Study|Lack of Efficacy|0|||
48910065|NCT01086410|157507632|FG003|Overall Study|Lack of Efficacy|0|||
48910066|NCT01086410|157507629|FG000|Overall Study|Protocol Violation|1|||
48910067|NCT01086410|157507630|FG001|Overall Study|Protocol Violation|1|||
48910068|NCT01086410|157507631|FG002|Overall Study|Protocol Violation|0|||
48910069|NCT01086410|157507632|FG003|Overall Study|Protocol Violation|0|||
48910070|NCT01086410|157507629|FG000|Overall Study|Lost to Follow-up|0|||
48910071|NCT01086410|157507630|FG001|Overall Study|Lost to Follow-up|0|||
48910072|NCT01086410|157507631|FG002|Overall Study|Lost to Follow-up|1|||
48910073|NCT01086410|157507632|FG003|Overall Study|Lost to Follow-up|0|||
48910074|NCT01667081|157507633|FG000|Overall Study|Death|43|||
48910075|NCT01667081|157507634|FG001|Overall Study|Death|3|||
48910076|NCT01667081|157507633|FG000|Overall Study|Lost to Follow-up|99|||
48910077|NCT01667081|157507634|FG001|Overall Study|Lost to Follow-up|48|||
48910078|NCT01667081|157507633|FG000|Overall Study|Physician Decision|16|||
48910079|NCT01667081|157507634|FG001|Overall Study|Physician Decision|2|||
48910080|NCT01667081|157507633|FG000|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|1529|||
48910081|NCT01667081|157507634|FG001|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|269|||
48910082|NCT01667081|157507633|FG000|Overall Study|Withdrawal by Subject|90|||
48910083|NCT01667081|157507634|FG001|Overall Study|Withdrawal by Subject|35|||
48910084|NCT00295633|157507635|FG000|Overall Study|Lack of Efficacy|19|||
48910085|NCT00295633|157507636|FG001|Overall Study|Lack of Efficacy|7|||
48910086|NCT00295633|157507637|FG002|Overall Study|Lack of Efficacy|16|||
48910087|NCT00295633|157507635|FG000|Overall Study|Withdrawal of consent by subject|16|||
48910088|NCT00295633|157507636|FG001|Overall Study|Withdrawal of consent by subject|16|||
48910089|NCT00295633|157507637|FG002|Overall Study|Withdrawal of consent by subject|26|||
48910090|NCT00295633|157507635|FG000|Overall Study|Adverse Event|9|||
48910091|NCT00295633|157507636|FG001|Overall Study|Adverse Event|17|||
48910092|NCT00295633|157507637|FG002|Overall Study|Adverse Event|9|||
48910093|NCT00295633|157507635|FG000|Overall Study|Lost to Follow-up|6|||
48910094|NCT00295633|157507636|FG001|Overall Study|Lost to Follow-up|11|||
48910095|NCT00295633|157507637|FG002|Overall Study|Lost to Follow-up|7|||
48910096|NCT00295633|157507635|FG000|Overall Study|Physician Decision|9|||
48910097|NCT00295633|157507636|FG001|Overall Study|Physician Decision|10|||
48910098|NCT00295633|157507637|FG002|Overall Study|Physician Decision|8|||
48910099|NCT00295633|157507635|FG000|Overall Study|Poor/Noncompliance|2|||
48910100|NCT00295633|157507636|FG001|Overall Study|Poor/Noncompliance|2|||
48910101|NCT00295633|157507637|FG002|Overall Study|Poor/Noncompliance|6|||
48910102|NCT00295633|157507635|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
48910103|NCT00295633|157507636|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
48910104|NCT00295633|157507637|FG002|Overall Study|Subject No Longer Meets Study Criteria|3|||
48910105|NCT00295633|157507635|FG000|Overall Study|Death|1|||
48910106|NCT00295633|157507636|FG001|Overall Study|Death|1|||
48910107|NCT00295633|157507637|FG002|Overall Study|Death|0|||
48910108|NCT00295633|157507635|FG000|Overall Study|Administrative reason by sponsor|0|||
48910109|NCT00295633|157507636|FG001|Overall Study|Administrative reason by sponsor|0|||
48910110|NCT00295633|157507637|FG002|Overall Study|Administrative reason by sponsor|1|||
48910111|NCT00709111|157507638|FG000|Overall Study|Withdrawal by Subject|1|||
48910112|NCT00709111|157507638|FG000|Overall Study|Unable to attend clinic visits|1|||
48910113|NCT01524133|157507639|FG000|Treatment Phase|Withdrawal by Subject|13|||
48910114|NCT01524133|157507640|FG001|Treatment Phase|Withdrawal by Subject|28|||
48698588|NCT02365649|156745589|FG009|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
48698589|NCT02365649|156745580|FG000|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
48698590|NCT02365649|156745581|FG001|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
48698591|NCT02365649|156745582|FG002|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|1|||
48910115|NCT01524133|157507641|FG002|Treatment Phase|Withdrawal by Subject|31|||
48910116|NCT01524133|157507639|FG000|Treatment Phase|Physician Decision|6|||
48910117|NCT01524133|157507640|FG001|Treatment Phase|Physician Decision|3|||
48910118|NCT01524133|157507641|FG002|Treatment Phase|Physician Decision|3|||
48910119|NCT01524133|157507639|FG000|Treatment Phase|Lost to Follow-up|0|||
48910120|NCT01524133|157507640|FG001|Treatment Phase|Lost to Follow-up|1|||
48910121|NCT01524133|157507641|FG002|Treatment Phase|Lost to Follow-up|2|||
48910122|NCT01524133|157507639|FG000|Overall Study 52 Weeks|Withdrawal by Subject|4|||
48910123|NCT01524133|157507640|FG001|Overall Study 52 Weeks|Withdrawal by Subject|5|||
48910124|NCT01524133|157507641|FG002|Overall Study 52 Weeks|Withdrawal by Subject|10|||
48910125|NCT01524133|157507639|FG000|Overall Study 52 Weeks|Physician Decision|1|||
48910126|NCT01524133|157507640|FG001|Overall Study 52 Weeks|Physician Decision|0|||
48910127|NCT01524133|157507641|FG002|Overall Study 52 Weeks|Physician Decision|2|||
48910128|NCT01524133|157507639|FG000|Overall Study 52 Weeks|Lost to Follow-up|16|||
48910129|NCT01524133|157507640|FG001|Overall Study 52 Weeks|Lost to Follow-up|15|||
49010528|NCT00345683|157875642|FG001|Overall Study|Other|2|||
48698592|NCT02365649|156745583|FG003|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
48698593|NCT02365649|156745584|FG004|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
48698594|NCT02365649|156745585|FG005|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
48698595|NCT02365649|156745586|FG006|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
48698596|NCT02365649|156745587|FG007|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
48698597|NCT02365649|156745588|FG008|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
48698598|NCT02365649|156745589|FG009|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
48698599|NCT02365649|156745580|FG000|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
48698600|NCT02365649|156745581|FG001|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
48698601|NCT02365649|156745582|FG002|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
48698602|NCT02365649|156745583|FG003|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
48698603|NCT02365649|156745584|FG004|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
48698604|NCT02365649|156745585|FG005|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
48698605|NCT02365649|156745586|FG006|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|2|||
48698606|NCT02365649|156745587|FG007|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
48698607|NCT02365649|156745588|FG008|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
48698608|NCT02365649|156745589|FG009|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
48698609|NCT02365649|156745580|FG000|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
48698610|NCT02365649|156745581|FG001|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
48698611|NCT02365649|156745582|FG002|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
48698612|NCT02365649|156745583|FG003|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
48698613|NCT02365649|156745584|FG004|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
48698614|NCT02365649|156745585|FG005|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
48698615|NCT02365649|156745586|FG006|Double-Blind Extension (Weeks 16-52)|Adverse Event|6|||
48698616|NCT02365649|156745587|FG007|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
48698617|NCT02365649|156745588|FG008|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
48698618|NCT02365649|156745589|FG009|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
48698619|NCT02365649|156745580|FG000|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
48698620|NCT02365649|156745581|FG001|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
48698621|NCT02365649|156745582|FG002|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
48698622|NCT02365649|156745583|FG003|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
48698623|NCT02365649|156745584|FG004|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
48698624|NCT02365649|156745585|FG005|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
48698625|NCT02365649|156745586|FG006|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|7|||
48698626|NCT02365649|156745587|FG007|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|2|||
48698627|NCT02365649|156745588|FG008|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|8|||
48698628|NCT02365649|156745589|FG009|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|10|||
48698629|NCT02365649|156745580|FG000|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
48698630|NCT02365649|156745581|FG001|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
48698631|NCT02365649|156745582|FG002|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
48698632|NCT02365649|156745583|FG003|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
48698633|NCT02365649|156745584|FG004|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
48698634|NCT02365649|156745585|FG005|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
48698635|NCT02365649|156745586|FG006|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
48698636|NCT02365649|156745587|FG007|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
48698637|NCT02365649|156745588|FG008|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|2|||
48698638|NCT02365649|156745589|FG009|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
48698639|NCT02365649|156745580|FG000|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
48698640|NCT02365649|156745581|FG001|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
48698641|NCT02365649|156745582|FG002|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
48698642|NCT02365649|156745583|FG003|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
48698643|NCT02365649|156745584|FG004|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
48698644|NCT02365649|156745585|FG005|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
48698645|NCT02365649|156745586|FG006|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
48698646|NCT02365649|156745587|FG007|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
48698647|NCT02365649|156745588|FG008|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
48698648|NCT02365649|156745589|FG009|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
48698649|NCT03773978|156745591|FG000|PK/Safety and OLLI Period|Adverse Event|1|||
48698650|NCT03773978|156745592|FG001|PK/Safety and OLLI Period|Adverse Event|0|||
48698651|NCT03773978|156745591|FG000|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|39|||
48698652|NCT03773978|156745592|FG001|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|0|||
48698653|NCT03773978|156745591|FG000|PK/Safety and OLLI Period|Lost to Follow-up|1|||
48698654|NCT03773978|156745592|FG001|PK/Safety and OLLI Period|Lost to Follow-up|0|||
48698655|NCT03773978|156745591|FG000|PK/Safety and OLLI Period|Withdrawal by Subject|3|||
48698656|NCT03773978|156745592|FG001|PK/Safety and OLLI Period|Withdrawal by Subject|0|||
48698657|NCT03773978|156745591|FG000|PK/Safety and OLLI Period|Due to epidemic or pandemic|6|||
48698658|NCT03773978|156745592|FG001|PK/Safety and OLLI Period|Due to epidemic or pandemic|0|||
48698659|NCT03773978|156745591|FG000|PK/Safety and OLLI Period|unexplainable flare disease|1|||
48698660|NCT03773978|156745592|FG001|PK/Safety and OLLI Period|unexplainable flare disease|0|||
48698661|NCT03773978|156745591|FG000|PK/Safety and OLLI Period|Protocol Violation|4|||
48698662|NCT03773978|156745592|FG001|PK/Safety and OLLI Period|Protocol Violation|0|||
48698663|NCT03773978|156745591|FG000|PK/Safety and OLLI Period|Participant transitioned to JAHX|1|||
48698664|NCT03773978|156745592|FG001|PK/Safety and OLLI Period|Participant transitioned to JAHX|0|||
48698665|NCT03773978|156745591|FG000|PK/Safety and OLLI Period|Investigational product was not delivered to the site|1|||
48698666|NCT03773978|156745592|FG001|PK/Safety and OLLI Period|Investigational product was not delivered to the site|0|||
48698667|NCT03773978|156745591|FG000|DBW Period|Adverse Event|2|||
48698668|NCT03773978|156745592|FG001|DBW Period|Adverse Event|2|||
48698669|NCT03773978|156745591|FG000|DBW Period|Failure to Meet Continuation Criteria|16|||
48698670|NCT03773978|156745592|FG001|DBW Period|Failure to Meet Continuation Criteria|40|||
48698671|NCT03773978|156745591|FG000|DBW Period|Withdrawal by Subject|2|||
48698672|NCT03773978|156745592|FG001|DBW Period|Withdrawal by Subject|1|||
48698673|NCT03773978|156745591|FG000|DBW Period|Due to epidemic or pandemic|5|||
48698674|NCT03773978|156745592|FG001|DBW Period|Due to epidemic or pandemic|6|||
48698675|NCT03773978|156745591|FG000|DBW Period|Study team decision|1|||
48698676|NCT03773978|156745592|FG001|DBW Period|Study team decision|0|||
48698677|NCT01345240|156745593|FG000|Overall Study|Adverse Event|3|||
48698678|NCT01345240|156745594|FG001|Overall Study|Adverse Event|5|||
48698679|NCT01345240|156745595|FG002|Overall Study|Adverse Event|4|||
48698680|NCT01345240|156745596|FG003|Overall Study|Adverse Event|2|||
48698681|NCT01345240|156745597|FG004|Overall Study|Adverse Event|1|||
48698682|NCT01345240|156745593|FG000|Overall Study|Lost to Follow-up|8|||
48698683|NCT01345240|156745594|FG001|Overall Study|Lost to Follow-up|9|||
48698684|NCT01345240|156745595|FG002|Overall Study|Lost to Follow-up|14|||
48698685|NCT01345240|156745596|FG003|Overall Study|Lost to Follow-up|7|||
48698686|NCT01345240|156745597|FG004|Overall Study|Lost to Follow-up|9|||
48698687|NCT04298697|156745598|FG000|Overall Study|Lost to Follow-up|5|||
48698688|NCT04298697|156745599|FG001|Overall Study|Lost to Follow-up|5|||
48698689|NCT04298697|156745600|FG002|Overall Study|Lost to Follow-up|1|||
48698690|NCT04298697|156745601|FG003|Overall Study|Lost to Follow-up|0|||
48698691|NCT04298697|156745598|FG000|Overall Study|Withdrawal by Subject|0|||
48698692|NCT04298697|156745599|FG001|Overall Study|Withdrawal by Subject|3|||
48698693|NCT04298697|156745600|FG002|Overall Study|Withdrawal by Subject|2|||
48698694|NCT04298697|156745601|FG003|Overall Study|Withdrawal by Subject|3|||
48698695|NCT02246530|156745604|FG000|Overall Study|Lost to Follow-up|4|||
48698696|NCT02246530|156745605|FG001|Overall Study|Lost to Follow-up|0|||
48698697|NCT04576988|156745606|FG000|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
48698698|NCT04576988|156745607|FG001|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
48698699|NCT04576988|156745606|FG000|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|2|||
48698700|NCT04576988|156745607|FG001|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|3|||
48698701|NCT04576988|156745606|FG000|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
48698702|NCT04576988|156745607|FG001|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
48698703|NCT04576988|156745606|FG000|Double Blind Placebo Controlled (DBPC)|Death|0|||
48698704|NCT04576988|156745607|FG001|Double Blind Placebo Controlled (DBPC)|Death|5|||
48698705|NCT04576988|156745606|FG000|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|0|||
48698706|NCT04576988|156745607|FG001|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|2|||
48698707|NCT04576988|156745606|FG000|Long Term Double Blind (LTDB)|Adverse Event|2|||
48698708|NCT04576988|156745607|FG001|Long Term Double Blind (LTDB)|Adverse Event|0|||
48698709|NCT04576988|156745606|FG000|Long Term Double Blind (LTDB)|Withdrawal by Subject|0|||
48698710|NCT04576988|156745607|FG001|Long Term Double Blind (LTDB)|Withdrawal by Subject|3|||
48698711|NCT04576988|156745606|FG000|Long Term Double Blind (LTDB)|Protocol Violation|0|||
48698712|NCT04576988|156745607|FG001|Long Term Double Blind (LTDB)|Protocol Violation|1|||
48698713|NCT04576988|156745606|FG000|Long Term Double Blind (LTDB)|Death|2|||
48698714|NCT04576988|156745607|FG001|Long Term Double Blind (LTDB)|Death|1|||
48698715|NCT04576988|156745606|FG000|Long Term Double Blind (LTDB)|Sponsor decision|0|||
48698716|NCT04576988|156745607|FG001|Long Term Double Blind (LTDB)|Sponsor decision|1|||
48698717|NCT00474812|156745608|FG000|Overall Study|Withdrawal by Subject|5|||
48698718|NCT00474812|156745608|FG000|Overall Study|No Initiation of treatment|2|||
48698719|NCT01506596|156745609|FG000|Overall Study|ineligible pathology|1|||
48698720|NCT00771758|156745610|FG000|Overall Study|Adverse Event|2|||
48698721|NCT00771758|156745611|FG001|Overall Study|Adverse Event|8|||
48698722|NCT00771758|156745612|FG002|Overall Study|Adverse Event|1|||
48698723|NCT00771758|156745610|FG000|Overall Study|Lack of Efficacy|0|||
48698724|NCT00771758|156745611|FG001|Overall Study|Lack of Efficacy|2|||
48698725|NCT00771758|156745612|FG002|Overall Study|Lack of Efficacy|1|||
48698726|NCT00771758|156745610|FG000|Overall Study|Lost to Follow-up|1|||
48698727|NCT00771758|156745611|FG001|Overall Study|Lost to Follow-up|0|||
48698728|NCT00771758|156745612|FG002|Overall Study|Lost to Follow-up|0|||
48698729|NCT00771758|156745610|FG000|Overall Study|Protocol Violation|1|||
48698730|NCT00771758|156745611|FG001|Overall Study|Protocol Violation|0|||
48698731|NCT00771758|156745612|FG002|Overall Study|Protocol Violation|0|||
48698732|NCT00771758|156745610|FG000|Overall Study|Withdrawal by Subject|1|||
48698733|NCT00771758|156745611|FG001|Overall Study|Withdrawal by Subject|0|||
48698734|NCT00771758|156745612|FG002|Overall Study|Withdrawal by Subject|0|||
48698735|NCT00771758|156745610|FG000|Overall Study|Other|3|||
48698736|NCT00771758|156745611|FG001|Overall Study|Other|2|||
48698737|NCT00771758|156745612|FG002|Overall Study|Other|0|||
48698738|NCT05712460|156745615|FG000|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
48698739|NCT05712460|156745616|FG001|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
48698740|NCT05712460|156745617|FG002|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
48698741|NCT05712460|156745618|FG003|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
48698742|NCT05712460|156745619|FG004|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
48698743|NCT05712460|156745620|FG005|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
48698744|NCT05712460|156745621|FG006|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
48698745|NCT05712460|156745622|FG007|Part 1 Period 3 (4 Days)|Refused further treatment|1|||
48698746|NCT05712460|156745623|FG008|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
48698747|NCT05712460|156745624|FG009|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
48698748|NCT05712460|156745625|FG010|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
48698749|NCT05712460|156745626|FG011|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
48698750|NCT02002598|156745632|FG000|Dose Level 1|Withdrawal by Subject|1|||
48698751|NCT02002598|156745633|FG001|Dose Level 1|Withdrawal by Subject|0|||
48698752|NCT02002598|156745634|FG002|Dose Level 1|Withdrawal by Subject|0|||
48698753|NCT02002598|156745635|FG003|Dose Level 1|Withdrawal by Subject|0|||
48698754|NCT02002598|156745636|FG004|Dose Level 1|Withdrawal by Subject|0|||
48698755|NCT04672239|156745637|FG000|Week 2 Survey|Failed survey check items|1|||
48698756|NCT04672239|156745638|FG001|Week 2 Survey|Failed survey check items|2|||
48698757|NCT04672239|156745639|FG002|Week 2 Survey|Failed survey check items|3|||
48698758|NCT04672239|156745637|FG000|Week 2 Survey|Partially completed survey|7|||
48698759|NCT04672239|156745638|FG001|Week 2 Survey|Partially completed survey|1|||
48698760|NCT04672239|156745639|FG002|Week 2 Survey|Partially completed survey|4|||
48698761|NCT04672239|156745637|FG000|Week 2 Survey|Withdrawal by Subject|0|||
48698762|NCT04672239|156745638|FG001|Week 2 Survey|Withdrawal by Subject|1|||
48698763|NCT04672239|156745639|FG002|Week 2 Survey|Withdrawal by Subject|0|||
48698764|NCT04672239|156745637|FG000|Week 2 Survey|Lost to Follow-up|3|||
48698765|NCT04672239|156745638|FG001|Week 2 Survey|Lost to Follow-up|2|||
48698766|NCT04672239|156745639|FG002|Week 2 Survey|Lost to Follow-up|5|||
48698767|NCT04672239|156745637|FG000|Week 6 Survey|Failed survey check items|2|||
48698768|NCT04672239|156745638|FG001|Week 6 Survey|Failed survey check items|2|||
48698769|NCT04672239|156745639|FG002|Week 6 Survey|Failed survey check items|2|||
48698770|NCT04672239|156745637|FG000|Week 6 Survey|Partially completed survey|3|||
48698771|NCT04672239|156745638|FG001|Week 6 Survey|Partially completed survey|3|||
48698772|NCT04672239|156745639|FG002|Week 6 Survey|Partially completed survey|2|||
48698773|NCT04672239|156745637|FG000|Week 6 Survey|Withdrawal by Subject|1|||
48698774|NCT04672239|156745638|FG001|Week 6 Survey|Withdrawal by Subject|1|||
48698775|NCT04672239|156745639|FG002|Week 6 Survey|Withdrawal by Subject|1|||
48698776|NCT04672239|156745637|FG000|Week 6 Survey|Withdrawn by PI|0|||
48698777|NCT04672239|156745638|FG001|Week 6 Survey|Withdrawn by PI|1|||
48698778|NCT04672239|156745639|FG002|Week 6 Survey|Withdrawn by PI|0|||
48698779|NCT04672239|156745637|FG000|Week 6 Survey|Lost to Follow-up|12|||
48698780|NCT04672239|156745638|FG001|Week 6 Survey|Lost to Follow-up|2|||
48698781|NCT04672239|156745639|FG002|Week 6 Survey|Lost to Follow-up|5|||
48698782|NCT04672239|156745637|FG000|3-Month Follow-up Survey|Failed survey check items|2|||
48698783|NCT04672239|156745638|FG001|3-Month Follow-up Survey|Failed survey check items|3|||
48698784|NCT04672239|156745639|FG002|3-Month Follow-up Survey|Failed survey check items|2|||
48698785|NCT04672239|156745637|FG000|3-Month Follow-up Survey|Partially completed survey|3|||
48698786|NCT04672239|156745638|FG001|3-Month Follow-up Survey|Partially completed survey|1|||
48698787|NCT04672239|156745639|FG002|3-Month Follow-up Survey|Partially completed survey|3|||
48910130|NCT01524133|157507641|FG002|Overall Study 52 Weeks|Lost to Follow-up|15|||
48910131|NCT03794583|157507642|FG000|Overall Study|Death|8|||
48910132|NCT03794583|157507642|FG000|Overall Study|Study Terminated by Sponsor|24|||
48910133|NCT03794583|157507642|FG000|Overall Study|Withdrawal by Subject|9|||
48910134|NCT01754857|157507643|FG000|Overall Study|Adverse Event|7|||
48698788|NCT04672239|156745637|FG000|3-Month Follow-up Survey|Withdrawal by Subject|0|||
48698789|NCT04672239|156745638|FG001|3-Month Follow-up Survey|Withdrawal by Subject|1|||
48698790|NCT04672239|156745639|FG002|3-Month Follow-up Survey|Withdrawal by Subject|1|||
48698791|NCT04672239|156745637|FG000|3-Month Follow-up Survey|Lost to Follow-up|17|||
48698792|NCT04672239|156745638|FG001|3-Month Follow-up Survey|Lost to Follow-up|5|||
48698793|NCT04672239|156745639|FG002|3-Month Follow-up Survey|Lost to Follow-up|11|||
48910135|NCT01754857|157507643|FG000|Overall Study|Disease progression|3|||
48910136|NCT01754857|157507643|FG000|Overall Study|Physician Decision|2|||
48910137|NCT01754857|157507643|FG000|Overall Study|Withdrawal by Subject|3|||
48698794|NCT04672239|156745637|FG000|6-Month Follow-up Survey|Failed survey check items|2|||
48698795|NCT04672239|156745638|FG001|6-Month Follow-up Survey|Failed survey check items|0|||
48698796|NCT04672239|156745639|FG002|6-Month Follow-up Survey|Failed survey check items|0|||
48698797|NCT04672239|156745637|FG000|6-Month Follow-up Survey|Partially completed survey|7|||
48698798|NCT04672239|156745638|FG001|6-Month Follow-up Survey|Partially completed survey|0|||
48698799|NCT04672239|156745639|FG002|6-Month Follow-up Survey|Partially completed survey|2|||
48698800|NCT04672239|156745637|FG000|6-Month Follow-up Survey|Lost to Follow-up|13|||
48698801|NCT04672239|156745638|FG001|6-Month Follow-up Survey|Lost to Follow-up|12|||
48698802|NCT04672239|156745639|FG002|6-Month Follow-up Survey|Lost to Follow-up|9|||
48698803|NCT05194124|156745644|FG000|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
48698804|NCT05194124|156745645|FG001|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
48698805|NCT05194124|156745646|FG002|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
48698806|NCT05194124|156745647|FG003|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|1|||
48698807|NCT05194124|156745648|FG004|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
48698808|NCT05194124|156745649|FG005|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|2|||
48698809|NCT05194124|156745650|FG006|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
48698810|NCT05194124|156745651|FG007|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
48698811|NCT05194124|156745652|FG008|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
48698812|NCT05194124|156745653|FG009|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
48698813|NCT05194124|156745644|FG000|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
48698814|NCT05194124|156745645|FG001|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
48698815|NCT05194124|156745646|FG002|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
48698816|NCT05194124|156745647|FG003|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
48698817|NCT05194124|156745648|FG004|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
48698818|NCT05194124|156745649|FG005|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
48698819|NCT05194124|156745650|FG006|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
48698820|NCT05194124|156745651|FG007|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
48698821|NCT05194124|156745652|FG008|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
48698822|NCT05194124|156745653|FG009|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|1|||
48698823|NCT03221556|156745654|FG000|Allocation|post-randomization exclusion|0|||
48698824|NCT03221556|156745655|FG001|Allocation|post-randomization exclusion|1|||
48698825|NCT03221556|156745654|FG000|Follow-Up|Withdrawal by Subject|0|||
48698826|NCT03221556|156745655|FG001|Follow-Up|Withdrawal by Subject|1|||
48698827|NCT03589859|156745656|FG000|Overall Study|Withdrawal by Subject|0|||
48698828|NCT03589859|156745657|FG001|Overall Study|Withdrawal by Subject|6|||
48698829|NCT05417438|156745658|FG000|Overall Study|Withdrawal by Subject|3|||
48698830|NCT04272242|156745659|FG000|Overall Study|Withdrawal by Subject|3|||
48698831|NCT04272242|156745659|FG000|Overall Study|Lost to Follow-up|1|||
48698832|NCT04272242|156745659|FG000|Overall Study|Adverse Event|1|||
48698833|NCT02702492|156745660|FG000|Overall Study|Disease progression|3|||
48698834|NCT02702492|156745661|FG001|Overall Study|Disease progression|3|||
48698835|NCT02702492|156745662|FG002|Overall Study|Disease progression|2|||
48698836|NCT02702492|156745663|FG003|Overall Study|Disease progression|4|||
48698837|NCT02702492|156745664|FG004|Overall Study|Disease progression|4|||
48698838|NCT02702492|156745665|FG005|Overall Study|Disease progression|1|||
48698839|NCT02702492|156745666|FG006|Overall Study|Disease progression|2|||
48698840|NCT02702492|156745667|FG007|Overall Study|Disease progression|8|||
48698841|NCT02702492|156745668|FG008|Overall Study|Disease progression|5|||
48698842|NCT02702492|156745669|FG009|Overall Study|Disease progression|1|||
48698843|NCT02702492|156745670|FG010|Overall Study|Disease progression|0|||
48698844|NCT02702492|156745671|FG011|Overall Study|Disease progression|3|||
48698845|NCT02702492|156745672|FG012|Overall Study|Disease progression|2|||
48698846|NCT02702492|156745660|FG000|Overall Study|Clinical progression|0|||
48698847|NCT02702492|156745661|FG001|Overall Study|Clinical progression|0|||
48698848|NCT02702492|156745662|FG002|Overall Study|Clinical progression|2|||
48698849|NCT02702492|156745663|FG003|Overall Study|Clinical progression|1|||
48698850|NCT02702492|156745664|FG004|Overall Study|Clinical progression|0|||
48698851|NCT02702492|156745665|FG005|Overall Study|Clinical progression|2|||
48698852|NCT02702492|156745666|FG006|Overall Study|Clinical progression|1|||
48698853|NCT02702492|156745667|FG007|Overall Study|Clinical progression|4|||
48698854|NCT02702492|156745668|FG008|Overall Study|Clinical progression|0|||
48698855|NCT02702492|156745669|FG009|Overall Study|Clinical progression|0|||
49116318|NCT03538691|158263095|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
48698856|NCT02702492|156745670|FG010|Overall Study|Clinical progression|1|||
48698857|NCT02702492|156745671|FG011|Overall Study|Clinical progression|2|||
48698858|NCT02702492|156745672|FG012|Overall Study|Clinical progression|0|||
48698859|NCT02702492|156745660|FG000|Overall Study|Adverse Event|0|||
48698860|NCT02702492|156745661|FG001|Overall Study|Adverse Event|0|||
48698861|NCT02702492|156745662|FG002|Overall Study|Adverse Event|1|||
48698862|NCT02702492|156745663|FG003|Overall Study|Adverse Event|2|||
48698863|NCT02702492|156745664|FG004|Overall Study|Adverse Event|1|||
48698864|NCT02702492|156745665|FG005|Overall Study|Adverse Event|0|||
48698865|NCT02702492|156745666|FG006|Overall Study|Adverse Event|1|||
48698866|NCT02702492|156745667|FG007|Overall Study|Adverse Event|0|||
48698867|NCT02702492|156745668|FG008|Overall Study|Adverse Event|2|||
48698868|NCT02702492|156745669|FG009|Overall Study|Adverse Event|0|||
48698869|NCT02702492|156745670|FG010|Overall Study|Adverse Event|0|||
48698870|NCT02702492|156745671|FG011|Overall Study|Adverse Event|0|||
48698871|NCT02702492|156745672|FG012|Overall Study|Adverse Event|1|||
48698872|NCT02702492|156745660|FG000|Overall Study|Other|0|||
48698873|NCT02702492|156745661|FG001|Overall Study|Other|0|||
48698874|NCT02702492|156745662|FG002|Overall Study|Other|0|||
48698875|NCT02702492|156745663|FG003|Overall Study|Other|0|||
48698876|NCT02702492|156745664|FG004|Overall Study|Other|0|||
48698877|NCT02702492|156745665|FG005|Overall Study|Other|0|||
48698878|NCT02702492|156745666|FG006|Overall Study|Other|0|||
48698879|NCT02702492|156745667|FG007|Overall Study|Other|0|||
48698880|NCT02702492|156745668|FG008|Overall Study|Other|0|||
48698881|NCT02702492|156745669|FG009|Overall Study|Other|0|||
48698882|NCT02702492|156745670|FG010|Overall Study|Other|0|||
48698883|NCT02702492|156745671|FG011|Overall Study|Other|0|||
48698884|NCT02702492|156745672|FG012|Overall Study|Other|1|||
48698885|NCT01097668|156746832|FG000|Overall Study|Withdrawal by Subject|1|||
48698886|NCT01097668|156746833|FG001|Overall Study|Withdrawal by Subject|2|||
48698887|NCT01097668|156746832|FG000|Overall Study|Lost to Follow-up|1|||
48698888|NCT01097668|156746833|FG001|Overall Study|Lost to Follow-up|0|||
48698889|NCT01419236|156746836|FG000|Overall Study|Adverse Event|1|||
48698890|NCT01419236|156746837|FG001|Overall Study|Adverse Event|0|||
48698891|NCT01419236|156746836|FG000|Overall Study|Lack of Efficacy|0|||
48698892|NCT01419236|156746837|FG001|Overall Study|Lack of Efficacy|1|||
48698893|NCT01419236|156746836|FG000|Overall Study|Lost to Follow-up|1|||
48698894|NCT01419236|156746837|FG001|Overall Study|Lost to Follow-up|0|||
48698895|NCT01419236|156746836|FG000|Overall Study|Physician Decision|1|||
48698896|NCT01419236|156746837|FG001|Overall Study|Physician Decision|0|||
48698897|NCT01419236|156746836|FG000|Overall Study|Withdrawal by Subject|1|||
48698898|NCT01419236|156746837|FG001|Overall Study|Withdrawal by Subject|4|||
48698899|NCT01419236|156746836|FG000|Overall Study|Entry Criteria Not Met|1|||
48698900|NCT01419236|156746837|FG001|Overall Study|Entry Criteria Not Met|0|||
48698901|NCT04456504|156746839|FG000|Overall Study|Lost to Follow-up|2|||
48698902|NCT01131507|156746840|FG000|Overall Study|Adverse Event|1|||
48698903|NCT01131507|156746840|FG000|Overall Study|Lost to Follow-up|1|||
48698904|NCT01131507|156746840|FG000|Overall Study|Withdrawal by Subject|1|||
48698905|NCT02173769|156746849|FG000|Overall Study|Protocol Violation|4|||
48698906|NCT01775501|156746852|FG000|Overall Study|Discontinued prior to treatment|1|||
48698907|NCT05291520|156746857|FG000|Overall Study|Lost to Follow-up|0|||
48698908|NCT05291520|156746858|FG001|Overall Study|Lost to Follow-up|0|||
48698909|NCT05291520|156746859|FG002|Overall Study|Lost to Follow-up|1|||
48698910|NCT00948246|156746863|FG000|Overall Study|Lost to Follow-up|11|||
48698911|NCT00948246|156746863|FG000|Overall Study|Adverse Event|11|||
48698912|NCT00948246|156746863|FG000|Overall Study|Death|1|||
48698913|NCT00948246|156746863|FG000|Overall Study|Withdrawal by Subject|1|||
48698914|NCT04106557|156746864|FG000|Overall Study|Physician Decision|0|||
48698915|NCT04106557|156746865|FG001|Overall Study|Physician Decision|1|||
48698916|NCT04106557|156746866|FG002|Overall Study|Physician Decision|0|||
48698917|NCT04106557|156746864|FG000|Overall Study|Protocol Violation|0|||
48698918|NCT04106557|156746865|FG001|Overall Study|Protocol Violation|1|||
48698919|NCT04106557|156746866|FG002|Overall Study|Protocol Violation|0|||
48698920|NCT04607668|156746869|FG000|Overall Study|Death|49|||
48698921|NCT04607668|156746870|FG001|Overall Study|Death|26|||
48698922|NCT04607668|156746869|FG000|Overall Study|Lost to Follow-up|3|||
48698923|NCT04607668|156746870|FG001|Overall Study|Lost to Follow-up|4|||
48698924|NCT04607668|156746869|FG000|Overall Study|Study terminated by Sponsor|92|||
48698925|NCT04607668|156746870|FG001|Overall Study|Study terminated by Sponsor|114|||
48698926|NCT04607668|156746869|FG000|Overall Study|Withdrawal by Subject|12|||
48698927|NCT04607668|156746870|FG001|Overall Study|Withdrawal by Subject|11|||
48698928|NCT04607668|156746869|FG000|Overall Study|Other, unspecified|8|||
48698929|NCT04607668|156746870|FG001|Overall Study|Other, unspecified|7|||
48698930|NCT02250326|156746871|FG000|Treatment|Death|1|||
48698931|NCT02250326|156746872|FG001|Treatment|Death|13|||
48698932|NCT02250326|156746873|FG002|Treatment|Death|2|||
48698933|NCT02250326|156746871|FG000|Treatment|Adverse Event|8|||
48698934|NCT02250326|156746872|FG001|Treatment|Adverse Event|8|||
48698935|NCT02250326|156746873|FG002|Treatment|Adverse Event|9|||
48698936|NCT02250326|156746871|FG000|Treatment|Progressive Disease|42|||
48698937|NCT02250326|156746872|FG001|Treatment|Progressive Disease|40|||
48698938|NCT02250326|156746873|FG002|Treatment|Progressive Disease|47|||
48698939|NCT02250326|156746871|FG000|Treatment|Symptomatic Deterioration|9|||
48698940|NCT02250326|156746872|FG001|Treatment|Symptomatic Deterioration|4|||
48698941|NCT02250326|156746873|FG002|Treatment|Symptomatic Deterioration|10|||
48698942|NCT02250326|156746871|FG000|Treatment|Withdrawal by Subject|11|||
48698943|NCT02250326|156746872|FG001|Treatment|Withdrawal by Subject|6|||
48698944|NCT02250326|156746873|FG002|Treatment|Withdrawal by Subject|4|||
48698945|NCT02250326|156746871|FG000|Treatment|Other reasons|8|||
48698946|NCT02250326|156746872|FG001|Treatment|Other reasons|7|||
48698947|NCT02250326|156746873|FG002|Treatment|Other reasons|7|||
48698948|NCT02250326|156746871|FG000|Extension Period|Progressive Disease|0|||
48698949|NCT02250326|156746872|FG001|Extension Period|Progressive Disease|2|||
48698950|NCT02250326|156746873|FG002|Extension Period|Progressive Disease|0|||
48698951|NCT02250326|156746871|FG000|Extension Period|Withdrawal by Subject|0|||
48698952|NCT02250326|156746872|FG001|Extension Period|Withdrawal by Subject|1|||
48698953|NCT02250326|156746873|FG002|Extension Period|Withdrawal by Subject|0|||
48698954|NCT02250326|156746871|FG000|Extension Period|Withdrawal by investigator|0|||
48698955|NCT02250326|156746872|FG001|Extension Period|Withdrawal by investigator|1|||
48698956|NCT02250326|156746873|FG002|Extension Period|Withdrawal by investigator|0|||
48698957|NCT04199351|156746875|FG000|Overall Study|Decision by sponsor|0|||
48698958|NCT04199351|156746876|FG001|Overall Study|Decision by sponsor|0|||
48698959|NCT04199351|156746877|FG002|Overall Study|Decision by sponsor|0|||
48698960|NCT04199351|156746878|FG003|Overall Study|Decision by sponsor|2|||
48698961|NCT04199351|156746879|FG004|Overall Study|Decision by sponsor|0|||
48698962|NCT04199351|156746880|FG005|Overall Study|Decision by sponsor|0|||
48698963|NCT04199351|156746881|FG006|Overall Study|Decision by sponsor|0|||
48698964|NCT04199351|156746882|FG007|Overall Study|Decision by sponsor|0|||
48698965|NCT04199351|156746883|FG008|Overall Study|Decision by sponsor|0|||
48698966|NCT04199351|156746884|FG009|Overall Study|Decision by sponsor|6|||
48698967|NCT04199351|156746875|FG000|Overall Study|Lost to Follow-up|0|||
48698968|NCT04199351|156746876|FG001|Overall Study|Lost to Follow-up|0|||
48698969|NCT04199351|156746877|FG002|Overall Study|Lost to Follow-up|1|||
48698970|NCT04199351|156746878|FG003|Overall Study|Lost to Follow-up|0|||
48698971|NCT04199351|156746879|FG004|Overall Study|Lost to Follow-up|0|||
48698972|NCT04199351|156746880|FG005|Overall Study|Lost to Follow-up|1|||
48698973|NCT04199351|156746881|FG006|Overall Study|Lost to Follow-up|0|||
48698974|NCT04199351|156746882|FG007|Overall Study|Lost to Follow-up|0|||
48698975|NCT04199351|156746883|FG008|Overall Study|Lost to Follow-up|0|||
48698976|NCT04199351|156746884|FG009|Overall Study|Lost to Follow-up|0|||
48698977|NCT04199351|156746875|FG000|Overall Study|Withdrawal by Subject|0|||
48698978|NCT04199351|156746876|FG001|Overall Study|Withdrawal by Subject|1|||
48698979|NCT04199351|156746877|FG002|Overall Study|Withdrawal by Subject|0|||
48698980|NCT04199351|156746878|FG003|Overall Study|Withdrawal by Subject|0|||
48698981|NCT04199351|156746879|FG004|Overall Study|Withdrawal by Subject|1|||
48698982|NCT04199351|156746880|FG005|Overall Study|Withdrawal by Subject|4|||
48698983|NCT04199351|156746881|FG006|Overall Study|Withdrawal by Subject|2|||
48698984|NCT04199351|156746882|FG007|Overall Study|Withdrawal by Subject|0|||
48698985|NCT04199351|156746883|FG008|Overall Study|Withdrawal by Subject|3|||
48698986|NCT04199351|156746884|FG009|Overall Study|Withdrawal by Subject|0|||
48698987|NCT03459079|156746885|FG000|Overall Study|Adverse Event|4|||
48698988|NCT03459079|156746886|FG001|Overall Study|Adverse Event|2|||
48698989|NCT03459079|156746887|FG002|Overall Study|Adverse Event|0|||
48698990|NCT03459079|156746885|FG000|Overall Study|Withdrawal by Subject|2|||
48698991|NCT03459079|156746886|FG001|Overall Study|Withdrawal by Subject|2|||
48698992|NCT03459079|156746887|FG002|Overall Study|Withdrawal by Subject|0|||
48698993|NCT01251965|156746898|FG000|Overall Study|Participant/physician decision|1|||
48698994|NCT01251965|156746899|FG001|Overall Study|Participant/physician decision|2|||
48698995|NCT01251965|156746900|FG002|Overall Study|Participant/physician decision|0|||
48698996|NCT01251965|156746898|FG000|Overall Study|Death|0|||
48698997|NCT01251965|156746899|FG001|Overall Study|Death|0|||
48698998|NCT01251965|156746900|FG002|Overall Study|Death|11|||
48698999|NCT04026113|156746906|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
48699000|NCT04026113|156746907|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|2|||
48699001|NCT04026113|156746908|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
48699002|NCT04026113|156746909|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
48699003|NCT04026113|156746906|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
48699004|NCT04026113|156746907|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
48699005|NCT04026113|156746908|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
48699006|NCT04026113|156746909|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
48699007|NCT04026113|156746906|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|4|||
48699008|NCT04026113|156746907|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
48699009|NCT04026113|156746908|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
48699010|NCT04026113|156746909|FG003|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
48699011|NCT04026113|156746906|FG000|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
48699012|NCT04026113|156746907|FG001|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
48699013|NCT04026113|156746908|FG002|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
48699014|NCT04026113|156746909|FG003|Double-Blind Treatment Period (12 Weeks)|Physician Decision|0|||
48699015|NCT04026113|156746906|FG000|Double-Blind Treatment Period (12 Weeks)|Other, not specified|4|||
48910138|NCT01754857|157507643|FG000|Overall Study|other complicating disease|1|||
49010529|NCT00328783|157875643|FG000|Overall Study|Could not tolerate ABC|21|||
48699016|NCT04026113|156746907|FG001|Double-Blind Treatment Period (12 Weeks)|Other, not specified|3|||
48699017|NCT04026113|156746908|FG002|Double-Blind Treatment Period (12 Weeks)|Other, not specified|0|||
48699018|NCT04026113|156746909|FG003|Double-Blind Treatment Period (12 Weeks)|Other, not specified|1|||
48699019|NCT04026113|156746906|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
48699020|NCT04026113|156746907|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
48699021|NCT04026113|156746908|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
48699022|NCT04026113|156746909|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
48699023|NCT04026113|156746906|FG000|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
48699024|NCT04026113|156746907|FG001|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|4|||
48699025|NCT04026113|156746908|FG002|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
48699026|NCT04026113|156746909|FG003|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
48699027|NCT04026113|156746906|FG000|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
48699028|NCT04026113|156746907|FG001|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|1|||
48699029|NCT04026113|156746908|FG002|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
48699030|NCT04026113|156746909|FG003|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
48699031|NCT04026113|156746906|FG000|Post-Intervention Period (1 Week)|Other, not specified|1|||
48699032|NCT04026113|156746907|FG001|Post-Intervention Period (1 Week)|Other, not specified|0|||
48699033|NCT04026113|156746908|FG002|Post-Intervention Period (1 Week)|Other, not specified|1|||
48699034|NCT04026113|156746909|FG003|Post-Intervention Period (1 Week)|Other, not specified|0|||
48699035|NCT00886379|156746912|FG000|Overall Study|Transferred Schools|0|||
48699036|NCT00886379|156746913|FG001|Overall Study|Transferred Schools|0|||
48699037|NCT00886379|156746914|FG002|Overall Study|Transferred Schools|2|||
48699038|NCT00886379|156746915|FG003|Overall Study|Transferred Schools|1|||
48699039|NCT00886379|156746916|FG004|Overall Study|Transferred Schools|1|||
48699040|NCT00886379|156746912|FG000|Overall Study|Final blood draw not obtained|3|||
48699041|NCT00886379|156746913|FG001|Overall Study|Final blood draw not obtained|3|||
48699042|NCT00886379|156746914|FG002|Overall Study|Final blood draw not obtained|4|||
48699043|NCT00886379|156746915|FG003|Overall Study|Final blood draw not obtained|2|||
48699044|NCT00886379|156746916|FG004|Overall Study|Final blood draw not obtained|2|||
48699045|NCT03962491|156746917|FG000|Overall Study|Lost to Follow-up|4|||
48699046|NCT03962491|156746918|FG001|Overall Study|Lost to Follow-up|5|||
48699047|NCT03675126|156746922|FG000|Overall Study|Study Terminated by Sponsor|9|||
48699048|NCT03675126|156746922|FG000|Overall Study|Death|2|||
48699049|NCT03675126|156746922|FG000|Overall Study|Withdrawal by Subject|4|||
48699050|NCT02718898|156746926|FG000|Blinded Treatment Period|Adverse Event|5|||
48699051|NCT02718898|156746927|FG001|Blinded Treatment Period|Adverse Event|1|||
48699052|NCT02718898|156746928|FG002|Blinded Treatment Period|Adverse Event|0|||
48699053|NCT02718898|156746929|FG003|Blinded Treatment Period|Adverse Event|0|||
48699054|NCT02718898|156746930|FG004|Blinded Treatment Period|Adverse Event|0|||
48699055|NCT02718898|156746931|FG005|Blinded Treatment Period|Adverse Event|0|||
48699056|NCT02718898|156746932|FG006|Blinded Treatment Period|Adverse Event|0|||
48699057|NCT02718898|156746926|FG000|Blinded Treatment Period|Physician Decision|1|||
48699058|NCT02718898|156746927|FG001|Blinded Treatment Period|Physician Decision|0|||
48699059|NCT02718898|156746928|FG002|Blinded Treatment Period|Physician Decision|0|||
48699060|NCT02718898|156746929|FG003|Blinded Treatment Period|Physician Decision|0|||
48699061|NCT02718898|156746930|FG004|Blinded Treatment Period|Physician Decision|0|||
48699062|NCT02718898|156746931|FG005|Blinded Treatment Period|Physician Decision|0|||
48699063|NCT02718898|156746932|FG006|Blinded Treatment Period|Physician Decision|0|||
48699064|NCT02718898|156746926|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
48699065|NCT02718898|156746927|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
48699066|NCT02718898|156746928|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
48699067|NCT02718898|156746929|FG003|Blinded Treatment Period|Lack of Efficacy|0|||
48699068|NCT02718898|156746930|FG004|Blinded Treatment Period|Lack of Efficacy|0|||
48699069|NCT02718898|156746931|FG005|Blinded Treatment Period|Lack of Efficacy|0|||
48699070|NCT02718898|156746932|FG006|Blinded Treatment Period|Lack of Efficacy|0|||
48699071|NCT02718898|156746926|FG000|Blinded Treatment Period|Lost to Follow-up|2|||
48699072|NCT02718898|156746927|FG001|Blinded Treatment Period|Lost to Follow-up|0|||
48699073|NCT02718898|156746928|FG002|Blinded Treatment Period|Lost to Follow-up|0|||
48699074|NCT02718898|156746929|FG003|Blinded Treatment Period|Lost to Follow-up|0|||
48699075|NCT02718898|156746930|FG004|Blinded Treatment Period|Lost to Follow-up|0|||
48699076|NCT02718898|156746931|FG005|Blinded Treatment Period|Lost to Follow-up|0|||
48699077|NCT02718898|156746932|FG006|Blinded Treatment Period|Lost to Follow-up|0|||
48910139|NCT01754857|157507643|FG000|Overall Study|ineligible to continue onto maintenance|1|||
48910140|NCT01754857|157507643|FG000|Overall Study|Patient does not wish to be treated, but will continue to be followed for survival|1|||
48699078|NCT02718898|156746926|FG000|Open Label Treatment Period (OLTP)|Adverse Event|0|||
48699079|NCT02718898|156746927|FG001|Open Label Treatment Period (OLTP)|Adverse Event|0|||
48699080|NCT02718898|156746928|FG002|Open Label Treatment Period (OLTP)|Adverse Event|1|||
48699081|NCT02718898|156746929|FG003|Open Label Treatment Period (OLTP)|Adverse Event|1|||
48699082|NCT02718898|156746930|FG004|Open Label Treatment Period (OLTP)|Adverse Event|0|||
48699083|NCT02718898|156746931|FG005|Open Label Treatment Period (OLTP)|Adverse Event|0|||
48699084|NCT02718898|156746932|FG006|Open Label Treatment Period (OLTP)|Adverse Event|0|||
48699085|NCT02718898|156746926|FG000|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
48699086|NCT02718898|156746927|FG001|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
48699087|NCT02718898|156746928|FG002|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
48699088|NCT02718898|156746929|FG003|Open Label Treatment Period (OLTP)|Lost to Follow-up|2|||
48699089|NCT02718898|156746930|FG004|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
48699090|NCT02718898|156746931|FG005|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
48699091|NCT02718898|156746932|FG006|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
48699092|NCT02718898|156746926|FG000|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
48699093|NCT02718898|156746927|FG001|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
48699094|NCT02718898|156746928|FG002|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
48699095|NCT02718898|156746929|FG003|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3|||
48699096|NCT02718898|156746930|FG004|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
48699097|NCT02718898|156746931|FG005|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
48699098|NCT02718898|156746932|FG006|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
48699099|NCT02718898|156746926|FG000|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
48699100|NCT02718898|156746927|FG001|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
48699101|NCT02718898|156746928|FG002|Open Label Treatment Period (OLTP)|Lack of Efficacy|1|||
48699102|NCT02718898|156746929|FG003|Open Label Treatment Period (OLTP)|Lack of Efficacy|2|||
48699103|NCT02718898|156746930|FG004|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
48699104|NCT02718898|156746931|FG005|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
48699105|NCT02718898|156746932|FG006|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
48699106|NCT02718898|156746926|FG000|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
48699107|NCT02718898|156746927|FG001|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
48699108|NCT02718898|156746928|FG002|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
48699109|NCT02718898|156746929|FG003|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1|||
48699110|NCT02718898|156746930|FG004|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
48699111|NCT02718898|156746931|FG005|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
48699112|NCT02718898|156746932|FG006|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
48699113|NCT02718898|156746926|FG000|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
48699114|NCT02718898|156746927|FG001|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
48699115|NCT02718898|156746928|FG002|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
48699116|NCT02718898|156746929|FG003|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1|||
48699117|NCT02718898|156746930|FG004|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
48699118|NCT02718898|156746931|FG005|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
48699119|NCT02718898|156746932|FG006|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
48699120|NCT02718898|156746926|FG000|Post Treatment Follow-up Period|Adverse Event|0|||
48699121|NCT02718898|156746927|FG001|Post Treatment Follow-up Period|Adverse Event|0|||
48699122|NCT02718898|156746928|FG002|Post Treatment Follow-up Period|Adverse Event|0|||
48699123|NCT02718898|156746929|FG003|Post Treatment Follow-up Period|Adverse Event|0|||
48699124|NCT02718898|156746930|FG004|Post Treatment Follow-up Period|Adverse Event|0|||
48699125|NCT02718898|156746931|FG005|Post Treatment Follow-up Period|Adverse Event|1|||
48699126|NCT02718898|156746932|FG006|Post Treatment Follow-up Period|Adverse Event|1|||
48699127|NCT02718898|156746926|FG000|Post Treatment Follow-up Period|Lost to Follow-up|0|||
48699128|NCT02718898|156746927|FG001|Post Treatment Follow-up Period|Lost to Follow-up|0|||
48699129|NCT02718898|156746928|FG002|Post Treatment Follow-up Period|Lost to Follow-up|0|||
48699130|NCT02718898|156746929|FG003|Post Treatment Follow-up Period|Lost to Follow-up|0|||
48699131|NCT02718898|156746930|FG004|Post Treatment Follow-up Period|Lost to Follow-up|1|||
48699132|NCT02718898|156746931|FG005|Post Treatment Follow-up Period|Lost to Follow-up|5|||
48699133|NCT02718898|156746932|FG006|Post Treatment Follow-up Period|Lost to Follow-up|1|||
48699134|NCT02718898|156746926|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
48699135|NCT02718898|156746927|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
48699136|NCT02718898|156746928|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
48699137|NCT02718898|156746929|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
48699138|NCT02718898|156746930|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
48699139|NCT02718898|156746931|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|5|||
48699140|NCT02718898|156746932|FG006|Post Treatment Follow-up Period|Withdrawal by Subject|3|||
48699141|NCT00231816|156746938|FG000|Overall Study|Adverse Event|1|||
48699142|NCT00231816|156746939|FG001|Overall Study|Adverse Event|0|||
48699143|NCT00231816|156746938|FG000|Overall Study|Lost to Follow-up|8|||
48699144|NCT00231816|156746939|FG001|Overall Study|Lost to Follow-up|5|||
48699145|NCT00231816|156746938|FG000|Overall Study|Protocol Violation|2|||
48699146|NCT00231816|156746939|FG001|Overall Study|Protocol Violation|3|||
48699147|NCT00231816|156746938|FG000|Overall Study|Withdrawal by Subject|3|||
48699148|NCT00231816|156746939|FG001|Overall Study|Withdrawal by Subject|3|||
48699149|NCT00231816|156746938|FG000|Overall Study|Other|2|||
48699150|NCT00231816|156746939|FG001|Overall Study|Other|1|||
48699151|NCT01052493|156746940|FG000|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1|||
48798426|NCT02453685|157098660|FG000|Overall Study|Protocol Violation|7|||
48699152|NCT01052493|156746941|FG001|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
48699153|NCT01052493|156746942|FG002|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
48699154|NCT00004563|156746943|FG000|Overall Study|Withdrawal by Subject|20|||
48699155|NCT00004563|156746944|FG001|Overall Study|Withdrawal by Subject|16|||
48699156|NCT00004563|156746943|FG000|Overall Study|Lack of Efficacy|3|||
48910141|NCT01754857|157507643|FG000|Overall Study|Patient decided not to begin maintenance therapy|1|||
48910142|NCT01509079|157507644|FG000|Overall Study|Lack of Efficacy|0|||
48910143|NCT01509079|157507645|FG001|Overall Study|Lack of Efficacy|2|||
48910144|NCT01509079|157507644|FG000|Overall Study|started an excluded medication|0|||
48910145|NCT01509079|157507645|FG001|Overall Study|started an excluded medication|1|||
48910146|NCT00041080|157507646|FG000|Overall Study|Adverse Event|21|||
48910147|NCT00041080|157507647|FG001|Overall Study|Adverse Event|1|||
48910148|NCT00041080|157507646|FG000|Overall Study|Withdrawal by Subject|6|||
48910149|NCT00041080|157507647|FG001|Overall Study|Withdrawal by Subject|6|||
48910150|NCT00041080|157507646|FG000|Overall Study|Concommitant Illness/Other|1|||
48910151|NCT00041080|157507647|FG001|Overall Study|Concommitant Illness/Other|2|||
48910152|NCT00041080|157507646|FG000|Overall Study|Did not start therapy|1|||
48910153|NCT00041080|157507647|FG001|Overall Study|Did not start therapy|1|||
48910154|NCT00041080|157507646|FG000|Overall Study|Ineligible|1|||
48910155|NCT00041080|157507647|FG001|Overall Study|Ineligible|0|||
48910156|NCT04353596|157507648|FG000|Overall Study|Protocol Violation|4|||
48910157|NCT04353596|157507649|FG001|Overall Study|Protocol Violation|4|||
48910158|NCT04353596|157507648|FG000|Overall Study|no evidence of recent SARS-CoV-2|1|||
48910159|NCT04353596|157507649|FG001|Overall Study|no evidence of recent SARS-CoV-2|3|||
48910160|NCT01122576|157507651|FG000|Pre-Cataract Surgery|Withdrawal by Subject|0|||
48910161|NCT01122576|157507652|FG001|Pre-Cataract Surgery|Withdrawal by Subject|1|||
48910162|NCT01122576|157507653|FG002|Pre-Cataract Surgery|Withdrawal by Subject|2|||
48699157|NCT00004563|156746944|FG001|Overall Study|Lack of Efficacy|5|||
48699158|NCT00004563|156746943|FG000|Overall Study|Death|2|||
48699159|NCT00004563|156746944|FG001|Overall Study|Death|3|||
48699160|NCT00762164|156746945|FG000|Overall Study|Lost to Follow-up|1|||
48699161|NCT00762164|156746946|FG001|Overall Study|Lost to Follow-up|1|||
48699162|NCT00762164|156746945|FG000|Overall Study|Discontinued medication|2|||
48699163|NCT00762164|156746946|FG001|Overall Study|Discontinued medication|0|||
48699164|NCT00762164|156746945|FG000|Overall Study|Withdrawal by Subject|0|||
48699165|NCT00762164|156746946|FG001|Overall Study|Withdrawal by Subject|1|||
48699166|NCT03532451|156746949|FG000|Overall Study|Withdrawal by Subject|0|||
48699167|NCT03532451|156746950|FG001|Overall Study|Withdrawal by Subject|1|||
48699168|NCT03532451|156746949|FG000|Overall Study|Did not undergo surgery|1|||
48699169|NCT03532451|156746950|FG001|Overall Study|Did not undergo surgery|1|||
48699170|NCT03534804|156746957|FG000|Overall Study|Withdrawal by Subject|1|||
48699171|NCT04408989|156746958|FG000|Overall Study|Lost to Follow-up|0|||
48699172|NCT04408989|156746959|FG001|Overall Study|Lost to Follow-up|0|||
48699173|NCT04408989|156746960|FG002|Overall Study|Lost to Follow-up|1|||
48699174|NCT04408989|156746958|FG000|Overall Study|Withdrawal by Subject|0|||
48699175|NCT04408989|156746959|FG001|Overall Study|Withdrawal by Subject|0|||
48910163|NCT01122576|157507651|FG000|Post-Cataract Surgery|Central Macular Edema|0|||
48910164|NCT01122576|157507652|FG001|Post-Cataract Surgery|Central Macular Edema|0|||
48910165|NCT01122576|157507653|FG002|Post-Cataract Surgery|Central Macular Edema|1|||
48910166|NCT01122576|157507651|FG000|Post-Cataract Surgery|Fellow Eye Explanted|0|||
48910167|NCT01122576|157507652|FG001|Post-Cataract Surgery|Fellow Eye Explanted|0|||
48910168|NCT01122576|157507653|FG002|Post-Cataract Surgery|Fellow Eye Explanted|1|||
48910169|NCT03974334|157507658|FG000|Overall Study|Lost to Follow-up|1|||
48910170|NCT01132612|157507659|FG000|Overall Study|Death|0|||
48910171|NCT01132612|157507660|FG001|Overall Study|Death|0|||
48910172|NCT01132612|157507661|FG002|Overall Study|Death|1|||
48910173|NCT01132612|157507659|FG000|Overall Study|Protocol deviation|0|||
48910174|NCT01132612|157507660|FG001|Overall Study|Protocol deviation|0|||
48910175|NCT01132612|157507661|FG002|Overall Study|Protocol deviation|3|||
48910176|NCT01132612|157507659|FG000|Overall Study|Lost to Follow-up|2|||
48910177|NCT01132612|157507660|FG001|Overall Study|Lost to Follow-up|2|||
48910178|NCT01132612|157507661|FG002|Overall Study|Lost to Follow-up|7|||
48910179|NCT01132612|157507659|FG000|Overall Study|Adverse Event|5|||
48910180|NCT01132612|157507660|FG001|Overall Study|Adverse Event|2|||
48910181|NCT01132612|157507661|FG002|Overall Study|Adverse Event|15|||
48910182|NCT01132612|157507659|FG000|Overall Study|Withdrawal by Subject|5|||
48910183|NCT01132612|157507660|FG001|Overall Study|Withdrawal by Subject|8|||
48910184|NCT01132612|157507661|FG002|Overall Study|Withdrawal by Subject|19|||
48910185|NCT01132612|157507659|FG000|Overall Study|Administrative problems|5|||
48699176|NCT04408989|156746960|FG002|Overall Study|Withdrawal by Subject|2|||
48699177|NCT01285557|156746965|FG000|Overall Study|Death|173|||
48699178|NCT01285557|156746966|FG001|Overall Study|Death|90|||
48699179|NCT01285557|156746965|FG000|Overall Study|Lost to Follow-up|6|||
48699180|NCT01285557|156746966|FG001|Overall Study|Lost to Follow-up|2|||
48910186|NCT01132612|157507660|FG001|Overall Study|Administrative problems|1|||
48910187|NCT01132612|157507661|FG002|Overall Study|Administrative problems|52|||
48910188|NCT01132612|157507659|FG000|Overall Study|Lack of Efficacy|23|||
48910189|NCT01132612|157507660|FG001|Overall Study|Lack of Efficacy|22|||
48910190|NCT01132612|157507661|FG002|Overall Study|Lack of Efficacy|73|||
48910191|NCT02252536|157507665|FG000|Overall Study|Lost to Follow-up|5|||
48910192|NCT02252536|157507666|FG001|Overall Study|Lost to Follow-up|3|||
48910193|NCT02170779|157507667|FG000|Overall Study|Withdrawal by Subject|1|||
48910194|NCT02170779|157507668|FG001|Overall Study|Withdrawal by Subject|0|||
48910195|NCT02170779|157507667|FG000|Overall Study|Lost to Follow-up|0|||
48910196|NCT02170779|157507668|FG001|Overall Study|Lost to Follow-up|1|||
48910197|NCT00800683|157507669|FG000|Overall Study|Adverse Event|11|||
48910198|NCT00800683|157507670|FG001|Overall Study|Adverse Event|8|||
48910199|NCT00800683|157507669|FG000|Overall Study|Lost to Follow-up|3|||
48910200|NCT00800683|157507670|FG001|Overall Study|Lost to Follow-up|1|||
48910201|NCT00800683|157507669|FG000|Overall Study|Withdrawal by Subject|1|||
48910202|NCT00800683|157507670|FG001|Overall Study|Withdrawal by Subject|7|||
48910203|NCT00800683|157507669|FG000|Overall Study|Lack of Efficacy|1|||
48910204|NCT00800683|157507670|FG001|Overall Study|Lack of Efficacy|1|||
48910205|NCT00800683|157507669|FG000|Overall Study|Other|1|||
48910206|NCT00800683|157507670|FG001|Overall Study|Other|2|||
48910207|NCT03492554|157507671|FG000|Overall Study|Protocol Violation|0|||
48910208|NCT03492554|157507672|FG001|Overall Study|Protocol Violation|14|||
48910209|NCT01237340|157507673|FG000|Overall Study|Adverse Event|3|||
48910210|NCT01237340|157507673|FG000|Overall Study|Withdrawal by Subject|1|||
48910211|NCT01237340|157507673|FG000|Overall Study|Early termination of the trial|36|||
48910212|NCT02289352|157507674|FG000|Overall Study|Withdrawal by Subject|1|||
48910213|NCT02289352|157507675|FG001|Overall Study|Withdrawal by Subject|1|||
48910214|NCT02289352|157507676|FG002|Overall Study|Withdrawal by Subject|0|||
48910215|NCT01294150|157507679|FG000|Overall Study|Physician Decision|2|||
48910216|NCT01294150|157507680|FG001|Overall Study|Physician Decision|2|||
48910217|NCT00882310|157507685|FG000|Overall Study|Screen Failure|10|||
48910218|NCT00882310|157507685|FG000|Overall Study|Never received treatment|1|||
48910219|NCT00882310|157507685|FG000|Overall Study|Death|6|||
48910220|NCT00882310|157507685|FG000|Overall Study|Progression of disease|4|||
48910221|NCT00882310|157507685|FG000|Overall Study|Adverse Event|1|||
48910222|NCT00601705|157507686|FG000|Overall Study|Withdrawal by Subject|1|||
48910223|NCT04246801|157507700|FG000|Overall Study|Adverse Event|1|||
48910224|NCT04246801|157507701|FG001|Overall Study|Adverse Event|1|||
48910225|NCT04246801|157507700|FG000|Overall Study|Protocol Violation|1|||
48910226|NCT04246801|157507701|FG001|Overall Study|Protocol Violation|1|||
48910227|NCT04246801|157507700|FG000|Overall Study|Lack of Efficacy|0|||
48910228|NCT04246801|157507701|FG001|Overall Study|Lack of Efficacy|2|||
48910229|NCT04246801|157507700|FG000|Overall Study|Lost to Follow-up|1|||
48910230|NCT04246801|157507701|FG001|Overall Study|Lost to Follow-up|1|||
48910231|NCT04246801|157507700|FG000|Overall Study|Withdrawal by Subject|2|||
48910232|NCT04246801|157507701|FG001|Overall Study|Withdrawal by Subject|1|||
48910233|NCT03684642|157507702|FG000|Overall Study|Adverse Event|6|||
48910234|NCT03684642|157507703|FG001|Overall Study|Adverse Event|15|||
48910235|NCT03684642|157507704|FG002|Overall Study|Adverse Event|11|||
48910236|NCT03684642|157507702|FG000|Overall Study|Withdrawal by Subject|35|||
48910237|NCT03684642|157507703|FG001|Overall Study|Withdrawal by Subject|53|||
48910238|NCT03684642|157507704|FG002|Overall Study|Withdrawal by Subject|23|||
48910239|NCT03684642|157507702|FG000|Overall Study|Lack of Efficacy|0|||
48910240|NCT03684642|157507703|FG001|Overall Study|Lack of Efficacy|0|||
48699181|NCT01285557|156746965|FG000|Overall Study|Withdrew Consent|6|||
48699182|NCT01285557|156746966|FG001|Overall Study|Withdrew Consent|1|||
48699183|NCT01285557|156746965|FG000|Overall Study|Sponsor Study Termination|23|||
48699184|NCT01285557|156746966|FG001|Overall Study|Sponsor Study Termination|13|||
48699185|NCT01285557|156746965|FG000|Overall Study|Randomized but not treated|1|||
48699186|NCT01285557|156746966|FG001|Overall Study|Randomized but not treated|1|||
48910241|NCT03684642|157507704|FG002|Overall Study|Lack of Efficacy|1|||
48910242|NCT03684642|157507702|FG000|Overall Study|Poor compliance to protocol|0|||
48910243|NCT03684642|157507703|FG001|Overall Study|Poor compliance to protocol|4|||
48910244|NCT03684642|157507704|FG002|Overall Study|Poor compliance to protocol|1|||
48910245|NCT03684642|157507702|FG000|Overall Study|Other than specified|62|||
48910246|NCT03684642|157507703|FG001|Overall Study|Other than specified|60|||
48910247|NCT03684642|157507704|FG002|Overall Study|Other than specified|67|||
48910248|NCT03684642|157507702|FG000|Overall Study|Randomized and not treated|0|||
48910249|NCT03684642|157507703|FG001|Overall Study|Randomized and not treated|0|||
48910250|NCT03684642|157507704|FG002|Overall Study|Randomized and not treated|1|||
48910251|NCT03684642|157507702|FG000|Overall Study|Missing completion status but alive at last contact|0|||
48910252|NCT03684642|157507703|FG001|Overall Study|Missing completion status but alive at last contact|1|||
48910253|NCT03684642|157507704|FG002|Overall Study|Missing completion status but alive at last contact|2|||
48910254|NCT01770912|157507707|FG000|Overall Study|Lost to Follow-up|2|||
48910255|NCT01770912|157507708|FG001|Overall Study|Lost to Follow-up|0|||
48910256|NCT01708291|157507712|FG000|Overall Study|fighting|2|||
48910257|NCT01708291|157507713|FG001|Overall Study|fighting|1|||
48699187|NCT01285557|156746965|FG000|Overall Study|Study follow-up ongoing|28|||
48910258|NCT02303704|157507714|FG000|Overall Study|Protocol Violation|5|||
48910259|NCT02303704|157507715|FG001|Overall Study|Protocol Violation|9|||
48910260|NCT01458366|157507716|FG000|Period 1: 70mg/m^2|Physician Decision|2|||
48910261|NCT01458366|157507717|FG001|Period 1: 70mg/m^2|Physician Decision|0|||
48910262|NCT01458366|157507718|FG002|Period 1: 70mg/m^2|Physician Decision|0|||
48910263|NCT01458366|157507719|FG003|Period 1: 70mg/m^2|Physician Decision|0|||
48910264|NCT01458366|157507720|FG004|Period 1: 70mg/m^2|Physician Decision|0|||
48910265|NCT01458366|157507716|FG000|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
48910266|NCT01458366|157507717|FG001|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
48910267|NCT01458366|157507718|FG002|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
48910268|NCT01458366|157507719|FG003|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
48910269|NCT01458366|157507720|FG004|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1|||
48910270|NCT00805025|157507723|FG000|Overall Study|Screened but not enrolled/treated|42|||
48910271|NCT00805025|157507723|FG000|Overall Study|Adverse Event|4|||
48910272|NCT00805025|157507723|FG000|Overall Study|Withdrawal by Subject|2|||
48910273|NCT00805025|157507723|FG000|Overall Study|Physician Decision|1|||
48910274|NCT01843972|157507724|FG000|Overall Study|Withdrawal by Subject|0|||
48910275|NCT01843972|157507725|FG001|Overall Study|Withdrawal by Subject|0|||
48910276|NCT01843972|157507726|FG002|Overall Study|Withdrawal by Subject|0|||
48910277|NCT01843972|157507727|FG003|Overall Study|Withdrawal by Subject|0|||
48910278|NCT01843972|157507728|FG004|Overall Study|Withdrawal by Subject|1|||
48910279|NCT01843972|157507729|FG005|Overall Study|Withdrawal by Subject|0|||
48910280|NCT01843972|157507730|FG006|Overall Study|Withdrawal by Subject|0|||
48910281|NCT01843972|157507731|FG007|Overall Study|Withdrawal by Subject|0|||
48910282|NCT01843972|157507732|FG008|Overall Study|Withdrawal by Subject|0|||
48910283|NCT01843972|157507733|FG009|Overall Study|Withdrawal by Subject|0|||
48910284|NCT01984164|157507740|FG000|Overall Study|Withdrawal by Subject|4|||
48910285|NCT01984164|157507741|FG001|Overall Study|Withdrawal by Subject|3|||
48910286|NCT01984164|157507740|FG000|Overall Study|Adverse Event|5|||
48910287|NCT01984164|157507741|FG001|Overall Study|Adverse Event|19|||
48910288|NCT01984164|157507740|FG000|Overall Study|Lost to Follow-up|1|||
48910289|NCT01984164|157507741|FG001|Overall Study|Lost to Follow-up|3|||
48910290|NCT03710486|157507742|FG000|Overall Study|Lost to Follow-up (at least 12 months)|13|||
48910291|NCT03710486|157507743|FG001|Overall Study|Lost to Follow-up (at least 12 months)|10|||
48910292|NCT03710486|157507742|FG000|Overall Study|Missing|0|||
48910293|NCT03710486|157507743|FG001|Overall Study|Missing|2|||
48910294|NCT02811549|157507744|FG000|Overall Study|Lost to Follow-up|1|||
48910295|NCT02811549|157507744|FG000|Overall Study|Withdrawal by Subject|3|||
48910296|NCT02811549|157507744|FG000|Overall Study|Subject screen failed|4|||
48910297|NCT02811549|157507744|FG000|Overall Study|Surgery denied by subject's insurance carrier|2|||
48910298|NCT00789880|157507745|FG000|Overall Study|Adverse Event|0|||
48910299|NCT00789880|157507746|FG001|Overall Study|Adverse Event|0|||
48910300|NCT00789880|157507747|FG002|Overall Study|Adverse Event|0|||
48910301|NCT00789880|157507748|FG003|Overall Study|Adverse Event|0|||
48910302|NCT00789880|157507749|FG004|Overall Study|Adverse Event|1|||
48910303|NCT00789880|157507750|FG005|Overall Study|Adverse Event|0|||
48910304|NCT00789880|157507745|FG000|Overall Study|Protocol Violation|0|||
48910305|NCT00789880|157507746|FG001|Overall Study|Protocol Violation|1|||
48910306|NCT00789880|157507747|FG002|Overall Study|Protocol Violation|0|||
48910307|NCT00789880|157507748|FG003|Overall Study|Protocol Violation|1|||
48910308|NCT00789880|157507749|FG004|Overall Study|Protocol Violation|0|||
48910309|NCT00789880|157507750|FG005|Overall Study|Protocol Violation|0|||
48910310|NCT00789880|157507745|FG000|Overall Study|Withdrawal by Subject|1|||
48910311|NCT00789880|157507746|FG001|Overall Study|Withdrawal by Subject|0|||
48910312|NCT00789880|157507747|FG002|Overall Study|Withdrawal by Subject|0|||
48910313|NCT00789880|157507748|FG003|Overall Study|Withdrawal by Subject|0|||
48910314|NCT00789880|157507749|FG004|Overall Study|Withdrawal by Subject|2|||
48910315|NCT00789880|157507750|FG005|Overall Study|Withdrawal by Subject|0|||
48910316|NCT01279850|157507751|FG000|Overall Study|Protocol Violation|50|||
48910317|NCT01279850|157507751|FG000|Overall Study|No Drug Administration Information|7|||
48910318|NCT01279850|157507751|FG000|Overall Study|No Visit After Treatment|34|||
48910319|NCT04376060|157507753|FG000|Overall Study|Physician Decision|1|||
48910320|NCT01293968|157507754|FG000|Overall Study|non-cooperation|3|||
48910321|NCT01293968|157507755|FG001|Overall Study|non-cooperation|3|||
48910322|NCT01210690|157507756|FG000|Overall Study|Adverse Event|7|||
48910323|NCT01210690|157507756|FG000|Overall Study|Lack of Efficacy|12|||
48910324|NCT01210690|157507756|FG000|Overall Study|Lost to Follow-up|3|||
48910325|NCT01210690|157507756|FG000|Overall Study|Disease Remission|1|||
48910326|NCT01210690|157507756|FG000|Overall Study|Withdrawal by Subject|1|||
48910327|NCT01210690|157507756|FG000|Overall Study|Patient refused to swallow|1|||
48910328|NCT01210690|157507756|FG000|Overall Study|Patient could not take glucose|1|||
48910329|NCT00853749|157507757|FG000|Overall Study|Lost to Follow-up|0|||
48910330|NCT00853749|157507758|FG001|Overall Study|Lost to Follow-up|1|||
48910331|NCT00495820|157507759|FG000|Overall Study|Adverse Event|1|||
48910332|NCT00495820|157507760|FG001|Overall Study|Adverse Event|1|||
48910333|NCT00687440|157507761|FG000|Overall Study|Adverse Event|3|||
48910334|NCT00687440|157507761|FG000|Overall Study|Lost to Follow-up|3|||
48910335|NCT00687440|157507761|FG000|Overall Study|Lack of Efficacy|2|||
48910336|NCT00687440|157507761|FG000|Overall Study|Death|2|||
48910337|NCT00687440|157507761|FG000|Overall Study|Other|1|||
48910338|NCT00687440|157507761|FG000|Overall Study|Missing|1|||
48910339|NCT03337542|157507762|FG000|Overall Study|Withdrew Consent|17|||
48910340|NCT03337542|157507762|FG000|Overall Study|Allergic Adverse Event|1|||
48910341|NCT03337542|157507762|FG000|Overall Study|Chronic /Recurrent GI Adverse Event/Symptoms|1|||
48699188|NCT01285557|156746966|FG001|Overall Study|Study follow-up ongoing|14|||
48699189|NCT01285557|156746965|FG000|Overall Study|Sponsor Decision|2|||
48910342|NCT03337542|157507762|FG000|Overall Study|Lost to Follow-up|1|||
48910343|NCT03337542|157507762|FG000|Overall Study|Unable to Participate in Study Due to Relocation|1|||
48699190|NCT01285557|156746966|FG001|Overall Study|Sponsor Decision|1|||
48910344|NCT03878446|157507769|FG000|Overall Study|Withdrawn by parent or guardian|1|||
48910345|NCT03878446|157507770|FG001|Overall Study|Withdrawn by parent or guardian|0|||
48910346|NCT03878446|157507771|FG002|Overall Study|Withdrawn by parent or guardian|0|||
48910347|NCT03878446|157507772|FG003|Overall Study|Withdrawn by parent or guardian|0|||
48910348|NCT03878446|157507773|FG004|Overall Study|Withdrawn by parent or guardian|0|||
48910349|NCT04881461|157507774|FG000|Overall Study|Adverse Event|2|||
48699191|NCT05523089|156746969|FG000|Overall Study|Withdrawal by Subject|1|||
48910350|NCT04881461|157507775|FG001|Overall Study|Adverse Event|4|||
48910351|NCT04881461|157507774|FG000|Overall Study|Withdrawal by Subject|19|||
48910352|NCT04881461|157507775|FG001|Overall Study|Withdrawal by Subject|19|||
48910353|NCT04881461|157507774|FG000|Overall Study|Lost to Follow-up|4|||
48910354|NCT04881461|157507775|FG001|Overall Study|Lost to Follow-up|4|||
48910355|NCT04881461|157507774|FG000|Overall Study|Lack of Efficacy|1|||
48910356|NCT04881461|157507775|FG001|Overall Study|Lack of Efficacy|0|||
48910357|NCT04881461|157507774|FG000|Overall Study|"Reason stated as other in CRF"|1|||
48910358|NCT04881461|157507775|FG001|Overall Study|"Reason stated as other in CRF"|2|||
48910359|NCT02113579|157509223|FG000|Overall Study|Adverse Event|1|||
48910360|NCT02113579|157509224|FG001|Overall Study|Adverse Event|0|||
48910361|NCT02113579|157509223|FG000|Overall Study|Withdrawal by Subject|3|||
48910362|NCT02113579|157509224|FG001|Overall Study|Withdrawal by Subject|2|||
48910363|NCT02113579|157509223|FG000|Overall Study|Lost to Follow-up|6|||
48910364|NCT02113579|157509224|FG001|Overall Study|Lost to Follow-up|2|||
48910365|NCT00332839|157509225|FG000|Core (Months 0 - 12)|Administrative problems|1|||
48910366|NCT00332839|157509226|FG001|Core (Months 0 - 12)|Administrative problems|1|||
48910367|NCT00332839|157509225|FG000|Core (Months 0 - 12)|Withdrawal by Subject|3|||
48910368|NCT00332839|157509226|FG001|Core (Months 0 - 12)|Withdrawal by Subject|1|||
48910369|NCT00332839|157509225|FG000|Core (Months 0 - 12)|Protocol deviation|1|||
48910370|NCT00332839|157509226|FG001|Core (Months 0 - 12)|Protocol deviation|1|||
48910371|NCT00332839|157509225|FG000|Core (Months 0 - 12)|Adverse Event|5|||
48910372|NCT00332839|157509226|FG001|Core (Months 0 - 12)|Adverse Event|15|||
48910373|NCT00332839|157509225|FG000|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
48910374|NCT00332839|157509226|FG001|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
48910375|NCT00332839|157509225|FG000|Follow-up (Months 12 - 60)|Lost to Follow-up|2|||
48910376|NCT00332839|157509226|FG001|Follow-up (Months 12 - 60)|Lost to Follow-up|1|||
48910377|NCT00332839|157509225|FG000|Follow-up (Months 12 - 60)|Death|1|||
48910378|NCT00332839|157509226|FG001|Follow-up (Months 12 - 60)|Death|1|||
48910379|NCT02982239|157509240|FG000|Overall Study|Lost to Follow-up|3|||
48910380|NCT02982239|157509241|FG001|Overall Study|Lost to Follow-up|2|||
48910381|NCT00880555|157509246|FG000|Overall Study|Physician Decision|0|||
48910382|NCT00880555|157509247|FG001|Overall Study|Physician Decision|8|||
48910383|NCT00880555|157509248|FG002|Overall Study|Physician Decision|0|||
48910384|NCT00880555|157509249|FG003|Overall Study|Physician Decision|2|||
48910385|NCT00880555|157509250|FG004|Overall Study|Physician Decision|1|||
48910386|NCT00880555|157509251|FG005|Overall Study|Physician Decision|0|||
48910387|NCT00880555|157509246|FG000|Overall Study|Withdrawal by Subject|1|||
48910388|NCT00880555|157509247|FG001|Overall Study|Withdrawal by Subject|1|||
48910389|NCT00880555|157509248|FG002|Overall Study|Withdrawal by Subject|0|||
48910390|NCT00880555|157509249|FG003|Overall Study|Withdrawal by Subject|0|||
48910391|NCT00880555|157509250|FG004|Overall Study|Withdrawal by Subject|0|||
48910392|NCT00880555|157509251|FG005|Overall Study|Withdrawal by Subject|0|||
48910393|NCT00880555|157509246|FG000|Overall Study|Lack of resources (hired rater)|9|||
48910394|NCT00880555|157509247|FG001|Overall Study|Lack of resources (hired rater)|7|||
48910395|NCT00880555|157509248|FG002|Overall Study|Lack of resources (hired rater)|5|||
48910396|NCT00880555|157509249|FG003|Overall Study|Lack of resources (hired rater)|0|||
48910397|NCT00880555|157509250|FG004|Overall Study|Lack of resources (hired rater)|0|||
48910398|NCT00880555|157509251|FG005|Overall Study|Lack of resources (hired rater)|0|||
48910399|NCT00880555|157509246|FG000|Overall Study|Death|0|||
48910400|NCT00880555|157509247|FG001|Overall Study|Death|0|||
48910401|NCT00880555|157509248|FG002|Overall Study|Death|0|||
48910402|NCT00880555|157509249|FG003|Overall Study|Death|0|||
48699192|NCT05523089|156746970|FG001|Overall Study|Withdrawal by Subject|0|||
48910403|NCT00880555|157509250|FG004|Overall Study|Death|0|||
48910404|NCT00880555|157509251|FG005|Overall Study|Death|1|||
48910405|NCT00880555|157509246|FG000|Overall Study|Lost to Follow-up|0|||
48910406|NCT00880555|157509247|FG001|Overall Study|Lost to Follow-up|1|||
48910407|NCT00880555|157509248|FG002|Overall Study|Lost to Follow-up|0|||
48910408|NCT00880555|157509249|FG003|Overall Study|Lost to Follow-up|0|||
48910409|NCT00880555|157509250|FG004|Overall Study|Lost to Follow-up|0|||
48910410|NCT00880555|157509251|FG005|Overall Study|Lost to Follow-up|0|||
48910411|NCT00385203|157509252|FG000|Overall Study|Adverse Event|5|||
48910412|NCT00385203|157509253|FG001|Overall Study|Adverse Event|4|||
48910413|NCT00385203|157509252|FG000|Overall Study|Death|1|||
48910414|NCT00385203|157509253|FG001|Overall Study|Death|0|||
48910415|NCT00385203|157509252|FG000|Overall Study|Condition under investigation worsened|18|||
48910416|NCT00385203|157509253|FG001|Overall Study|Condition under investigation worsened|3|||
48910417|NCT00385203|157509252|FG000|Overall Study|Incorrect enrollment|2|||
48910418|NCT00385203|157509253|FG001|Overall Study|Incorrect enrollment|0|||
48910419|NCT03034460|157509254|FG000|Overall Study|Adverse Event|0|||
48910420|NCT03034460|157509255|FG001|Overall Study|Adverse Event|1|||
48910421|NCT03034460|157509254|FG000|Overall Study|Withdrawal by Subject|2|||
48910422|NCT03034460|157509255|FG001|Overall Study|Withdrawal by Subject|2|||
48699193|NCT05523089|156746971|FG002|Overall Study|Withdrawal by Subject|0|||
48699194|NCT05523089|156746969|FG000|Overall Study|Lost to Follow-up|1|||
48699195|NCT05523089|156746970|FG001|Overall Study|Lost to Follow-up|0|||
48699196|NCT05523089|156746971|FG002|Overall Study|Lost to Follow-up|0|||
48699197|NCT02681523|156746972|FG000|Overall Study|Adverse Event|1|||
48699198|NCT02681523|156746972|FG000|Overall Study|Patient Non-compliance|1|||
48699199|NCT00079417|156748534|FG000|Overall Study|Physician Decision|2|||
48699200|NCT00079417|156748534|FG000|Overall Study|Ineligible|7|||
48699201|NCT00992108|156748539|FG000|Overall Study|Lost to Follow-up|0|||
48699202|NCT00992108|156748540|FG001|Overall Study|Lost to Follow-up|1|||
48699203|NCT02151058|156748541|FG000|Overall Study|Withdrawal by Subject|1|||
48910423|NCT03034460|157509254|FG000|Overall Study|Personal Reasons|1|||
48910424|NCT03034460|157509255|FG001|Overall Study|Personal Reasons|0|||
48910425|NCT00312221|157509261|FG000|Open-label Run-in Period|Withdrawal by Subject|6|||
48910426|NCT00312221|157509262|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
48910427|NCT00312221|157509263|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
48910428|NCT00312221|157509264|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
48910429|NCT00312221|157509261|FG000|Open-label Run-in Period|Adverse Event|74|||
48910430|NCT00312221|157509262|FG001|Open-label Run-in Period|Adverse Event|0|||
48910431|NCT00312221|157509263|FG002|Open-label Run-in Period|Adverse Event|0|||
48910432|NCT00312221|157509264|FG003|Open-label Run-in Period|Adverse Event|0|||
48910433|NCT00312221|157509261|FG000|Open-label Run-in Period|Lost to Follow-up|5|||
48910434|NCT00312221|157509262|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
48910435|NCT00312221|157509263|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
48910436|NCT00312221|157509264|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
48910437|NCT00312221|157509261|FG000|Open-label Run-in Period|Administrative|42|||
48910438|NCT00312221|157509262|FG001|Open-label Run-in Period|Administrative|0|||
48910439|NCT00312221|157509263|FG002|Open-label Run-in Period|Administrative|0|||
48910440|NCT00312221|157509264|FG003|Open-label Run-in Period|Administrative|0|||
48910441|NCT00312221|157509261|FG000|Open-label Run-in Period|Lack of Efficacy|102|||
48910442|NCT00312221|157509262|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
48910443|NCT00312221|157509263|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
48910444|NCT00312221|157509264|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
48910445|NCT00312221|157509261|FG000|Open-label Run-in Period|Did not qualify|5|||
48910446|NCT00312221|157509262|FG001|Open-label Run-in Period|Did not qualify|0|||
48910447|NCT00312221|157509263|FG002|Open-label Run-in Period|Did not qualify|0|||
48910448|NCT00312221|157509264|FG003|Open-label Run-in Period|Did not qualify|0|||
48910449|NCT00312221|157509261|FG000|Double-blind Phase|Withdrawal by Subject|0|||
48910450|NCT00312221|157509262|FG001|Double-blind Phase|Withdrawal by Subject|6|||
48910451|NCT00312221|157509263|FG002|Double-blind Phase|Withdrawal by Subject|8|||
48910452|NCT00312221|157509264|FG003|Double-blind Phase|Withdrawal by Subject|7|||
48910453|NCT00312221|157509261|FG000|Double-blind Phase|Adverse Event|0|||
48910454|NCT00312221|157509262|FG001|Double-blind Phase|Adverse Event|10|||
49116319|NCT03538691|158263092|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|9|||
48910455|NCT00312221|157509263|FG002|Double-blind Phase|Adverse Event|19|||
48910456|NCT00312221|157509264|FG003|Double-blind Phase|Adverse Event|18|||
48910457|NCT00312221|157509261|FG000|Double-blind Phase|Lost to Follow-up|0|||
48910458|NCT00312221|157509262|FG001|Double-blind Phase|Lost to Follow-up|0|||
48910459|NCT00312221|157509263|FG002|Double-blind Phase|Lost to Follow-up|2|||
48910460|NCT00312221|157509264|FG003|Double-blind Phase|Lost to Follow-up|2|||
48910461|NCT00312221|157509261|FG000|Double-blind Phase|Administrative|0|||
48910462|NCT00312221|157509262|FG001|Double-blind Phase|Administrative|26|||
48699204|NCT02151058|156748542|FG001|Overall Study|Withdrawal by Subject|1|||
48699205|NCT02151058|156748543|FG002|Overall Study|Withdrawal by Subject|3|||
48699206|NCT02151058|156748541|FG000|Overall Study|Lost to Follow-up|1|||
48910463|NCT00312221|157509263|FG002|Double-blind Phase|Administrative|37|||
48910464|NCT00312221|157509264|FG003|Double-blind Phase|Administrative|33|||
48699207|NCT02151058|156748542|FG001|Overall Study|Lost to Follow-up|0|||
48699208|NCT02151058|156748543|FG002|Overall Study|Lost to Follow-up|2|||
48699209|NCT01280903|156748545|FG000|Overall Study|Lost to Follow-up|23|||
48699210|NCT01280903|156748546|FG001|Overall Study|Lost to Follow-up|16|||
48699211|NCT02177695|156748547|FG000|ITT Analysis|Ineligible|5|||
48699212|NCT02177695|156748548|FG001|ITT Analysis|Ineligible|5|||
48699213|NCT02177695|156748547|FG000|Primary COXEN Analysis|inadequate tissue submitted|5|||
48699214|NCT02177695|156748548|FG001|Primary COXEN Analysis|inadequate tissue submitted|6|||
48699215|NCT02177695|156748547|FG000|Primary COXEN Analysis|insufficient amount of chemotherapy received|15|||
48699216|NCT02177695|156748548|FG001|Primary COXEN Analysis|insufficient amount of chemotherapy received|8|||
48699217|NCT02177695|156748547|FG000|Primary COXEN Analysis|Pathologic response not evaluated|13|||
48699218|NCT02177695|156748548|FG001|Primary COXEN Analysis|Pathologic response not evaluated|13|||
48699219|NCT01473134|156748551|FG000|Overall Study|Lost to Follow-up|21|||
48699220|NCT01473134|156748552|FG001|Overall Study|Lost to Follow-up|13|||
48699221|NCT01473134|156748551|FG000|Overall Study|Protocol Violation|32|||
48699222|NCT01473134|156748552|FG001|Overall Study|Protocol Violation|19|||
48699223|NCT01473134|156748551|FG000|Overall Study|Withdrawal by Subject|1|||
48699224|NCT01473134|156748552|FG001|Overall Study|Withdrawal by Subject|2|||
48910465|NCT00312221|157509261|FG000|Double-blind Phase|Lack of Efficacy|0|||
48910466|NCT00312221|157509262|FG001|Double-blind Phase|Lack of Efficacy|17|||
48910467|NCT00312221|157509263|FG002|Double-blind Phase|Lack of Efficacy|6|||
48910468|NCT00312221|157509264|FG003|Double-blind Phase|Lack of Efficacy|10|||
48910469|NCT02114268|157509265|FG000|Overall Study|Lost to Follow-up|4|||
48910470|NCT02114268|157509266|FG001|Overall Study|Lost to Follow-up|1|||
48910471|NCT02114268|157509267|FG002|Overall Study|Lost to Follow-up|1|||
48910472|NCT02114268|157509268|FG003|Overall Study|Lost to Follow-up|0|||
48910473|NCT02114268|157509269|FG004|Overall Study|Lost to Follow-up|0|||
48910474|NCT02114268|157509270|FG005|Overall Study|Lost to Follow-up|2|||
48910475|NCT02114268|157509265|FG000|Overall Study|Withdrawal by Subject|1|||
48910476|NCT02114268|157509266|FG001|Overall Study|Withdrawal by Subject|0|||
48910477|NCT02114268|157509267|FG002|Overall Study|Withdrawal by Subject|0|||
48910478|NCT02114268|157509268|FG003|Overall Study|Withdrawal by Subject|0|||
48910479|NCT02114268|157509269|FG004|Overall Study|Withdrawal by Subject|0|||
48910480|NCT02114268|157509270|FG005|Overall Study|Withdrawal by Subject|1|||
48910481|NCT02114268|157509265|FG000|Overall Study|Withdrawn by site due to noncompliance|1|||
48910482|NCT02114268|157509266|FG001|Overall Study|Withdrawn by site due to noncompliance|0|||
48910483|NCT02114268|157509267|FG002|Overall Study|Withdrawn by site due to noncompliance|0|||
48910484|NCT02114268|157509268|FG003|Overall Study|Withdrawn by site due to noncompliance|0|||
48910485|NCT02114268|157509269|FG004|Overall Study|Withdrawn by site due to noncompliance|0|||
48910486|NCT02114268|157509270|FG005|Overall Study|Withdrawn by site due to noncompliance|0|||
48910487|NCT00702325|157509272|FG000|Overall Study|Adverse Event|1|||
48910488|NCT00702325|157509273|FG001|Overall Study|Adverse Event|0|||
48910489|NCT00702325|157509272|FG000|Overall Study|Withdrawal by Subject|7|||
48910490|NCT00702325|157509273|FG001|Overall Study|Withdrawal by Subject|7|||
48910491|NCT00702325|157509272|FG000|Overall Study|Lost to Follow-up|3|||
48910492|NCT00702325|157509273|FG001|Overall Study|Lost to Follow-up|4|||
48910493|NCT00702325|157509272|FG000|Overall Study|Incorrect enrollment|5|||
48910494|NCT00702325|157509273|FG001|Overall Study|Incorrect enrollment|7|||
48910495|NCT00702325|157509272|FG000|Overall Study|Developed study discontinuation criteria|18|||
48910496|NCT00702325|157509273|FG001|Overall Study|Developed study discontinuation criteria|28|||
48910497|NCT00702325|157509272|FG000|Overall Study|Severe noncompliance to protocol|3|||
48910498|NCT00702325|157509273|FG001|Overall Study|Severe noncompliance to protocol|3|||
48910499|NCT00702325|157509272|FG000|Overall Study|Termination due to lab results|1|||
48910500|NCT00702325|157509273|FG001|Overall Study|Termination due to lab results|0|||
48910501|NCT00702325|157509272|FG000|Overall Study|Didn't follow study medication dosage|0|||
48910502|NCT00702325|157509273|FG001|Overall Study|Didn't follow study medication dosage|2|||
48910503|NCT00702325|157509272|FG000|Overall Study|Withdrew consent|0|||
48910504|NCT00702325|157509273|FG001|Overall Study|Withdrew consent|1|||
48910505|NCT00702325|157509272|FG000|Overall Study|Incorrectly Discontinued|0|||
48910506|NCT00702325|157509273|FG001|Overall Study|Incorrectly Discontinued|1|||
48910507|NCT01848353|157509274|FG000|Phase 1|Withdrawal by Subject|3|||
48910508|NCT01848353|157509275|FG001|Phase 1|Withdrawal by Subject|1|||
48910509|NCT01848353|157509276|FG002|Phase 1|Withdrawal by Subject|0|||
48910510|NCT01848353|157509277|FG003|Phase 1|Withdrawal by Subject|0|||
48910511|NCT01848353|157509274|FG000|Phase 2|Withdrawal by Subject|3|||
48910512|NCT01848353|157509275|FG001|Phase 2|Withdrawal by Subject|2|||
48910513|NCT01848353|157509276|FG002|Phase 2|Withdrawal by Subject|0|||
48910514|NCT01848353|157509277|FG003|Phase 2|Withdrawal by Subject|0|||
48910515|NCT01848353|157509274|FG000|Phase 3|Withdrawal by Subject|1|||
48699225|NCT01473134|156748551|FG000|Overall Study|Death|0|||
48699226|NCT01473134|156748552|FG001|Overall Study|Death|1|||
48699227|NCT01473134|156748551|FG000|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|1|||
48699228|NCT01473134|156748552|FG001|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|0|||
48699229|NCT05316597|156748553|FG000|First Session|Withdrawal by Subject|0|||
48699230|NCT05316597|156748554|FG001|First Session|Withdrawal by Subject|1|||
48699231|NCT05316597|156748553|FG000|Washout Period|Lost to Follow-up|1|||
48699232|NCT05316597|156748554|FG001|Washout Period|Lost to Follow-up|2|||
48910516|NCT01848353|157509275|FG001|Phase 3|Withdrawal by Subject|1|||
48910517|NCT01848353|157509276|FG002|Phase 3|Withdrawal by Subject|0|||
48910518|NCT01848353|157509277|FG003|Phase 3|Withdrawal by Subject|0|||
48910519|NCT02566577|157509280|FG000|Overall Study|Withdrawal by Subject|1|||
48910520|NCT02566577|157509281|FG001|Overall Study|Withdrawal by Subject|1|||
48699233|NCT05316597|156748553|FG000|Washout Period|Physician Decision|1|||
48699234|NCT05316597|156748554|FG001|Washout Period|Physician Decision|1|||
48699235|NCT05316597|156748553|FG000|Washout Period|Excluded before second session|1|||
48699236|NCT05316597|156748554|FG001|Washout Period|Excluded before second session|1|||
48699237|NCT05316597|156748553|FG000|Washout Period|Withdrawal by Subject|0|||
48699238|NCT05316597|156748554|FG001|Washout Period|Withdrawal by Subject|4|||
48699239|NCT04385277|156748555|FG000|Overall Study|Physician Decision|2|||
48699240|NCT04385277|156748555|FG000|Overall Study|Ineligible|1|||
48699241|NCT04385277|156748555|FG000|Overall Study|Patient/Parent Refusal|2|||
48699242|NCT03363841|156748556|FG000|Overall Study|Adverse Event|1|||
48699243|NCT03363841|156748556|FG000|Overall Study|Withdrawal by Subject|1|||
48699244|NCT03363841|156748556|FG000|Overall Study|Death|7|||
48699245|NCT03363841|156748556|FG000|Overall Study|Physician Decision|1|||
48699246|NCT06271993|156748557|FG000|Overall Study|Not reactive to histamine|5|||
48699247|NCT06271993|156748558|FG001|Overall Study|Not reactive to histamine|5|||
48699248|NCT06271993|156748559|FG002|Overall Study|Not reactive to histamine|5|||
48699249|NCT00687596|156748562|FG000|Overall Study|Adverse Event (AE)|10|||
48699250|NCT00687596|156748563|FG001|Overall Study|Adverse Event (AE)|3|||
48699251|NCT00687596|156748562|FG000|Overall Study|Radiological Disease Progression|6|||
48699252|NCT00687596|156748563|FG001|Overall Study|Radiological Disease Progression|2|||
48699253|NCT00687596|156748562|FG000|Overall Study|Clinical Disease Progression|1|||
48699254|NCT00687596|156748563|FG001|Overall Study|Clinical Disease Progression|3|||
48699255|NCT00687596|156748562|FG000|Overall Study|Investigator Discretion|3|||
48699256|NCT00687596|156748563|FG001|Overall Study|Investigator Discretion|1|||
48699257|NCT00687596|156748562|FG000|Overall Study|Sponsor Terminated Study|6|||
48699258|NCT00687596|156748563|FG001|Overall Study|Sponsor Terminated Study|17|||
48699259|NCT02903771|156748565|FG000|Part A: Dose Escalation Cohort|Adverse Event|1|||
48699260|NCT02903771|156748566|FG001|Part A: Dose Escalation Cohort|Adverse Event|0|||
48699261|NCT02903771|156748567|FG002|Part A: Dose Escalation Cohort|Adverse Event|0|||
48699262|NCT02903771|156748568|FG003|Part A: Dose Escalation Cohort|Adverse Event|0|||
48699263|NCT02903771|156748569|FG004|Part A: Dose Escalation Cohort|Adverse Event|0|||
48699264|NCT02903771|156748570|FG005|Part A: Dose Escalation Cohort|Adverse Event|0|||
48699265|NCT02903771|156748571|FG006|Part A: Dose Escalation Cohort|Adverse Event|1|||
48699266|NCT02903771|156748565|FG000|Part A: Dose Escalation Cohort|Progressive disease|0|||
48699267|NCT02903771|156748566|FG001|Part A: Dose Escalation Cohort|Progressive disease|1|||
48699268|NCT02903771|156748567|FG002|Part A: Dose Escalation Cohort|Progressive disease|0|||
48699269|NCT02903771|156748568|FG003|Part A: Dose Escalation Cohort|Progressive disease|0|||
48699270|NCT02903771|156748569|FG004|Part A: Dose Escalation Cohort|Progressive disease|0|||
48699271|NCT02903771|156748570|FG005|Part A: Dose Escalation Cohort|Progressive disease|0|||
48699272|NCT02903771|156748571|FG006|Part A: Dose Escalation Cohort|Progressive disease|0|||
48699273|NCT02903771|156748565|FG000|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
48699274|NCT02903771|156748566|FG001|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
48699275|NCT02903771|156748567|FG002|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
48699276|NCT02903771|156748568|FG003|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
48699277|NCT02903771|156748569|FG004|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
48699278|NCT02903771|156748570|FG005|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
48699279|NCT02903771|156748571|FG006|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
48699280|NCT02903771|156748565|FG000|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
48699281|NCT02903771|156748566|FG001|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
48699282|NCT02903771|156748567|FG002|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
48699283|NCT02903771|156748568|FG003|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
48699284|NCT02903771|156748569|FG004|Part A: Dose Escalation Cohort|Lost to Follow-up|1|||
48699285|NCT02903771|156748570|FG005|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
48699286|NCT02903771|156748571|FG006|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
48699287|NCT02903771|156748565|FG000|Part A: Dose Escalation Cohort|Physician Decision|0|||
48699288|NCT02903771|156748566|FG001|Part A: Dose Escalation Cohort|Physician Decision|0|||
48699289|NCT02903771|156748567|FG002|Part A: Dose Escalation Cohort|Physician Decision|0|||
48699290|NCT02903771|156748568|FG003|Part A: Dose Escalation Cohort|Physician Decision|0|||
49116320|NCT03538691|158263093|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
48699291|NCT02903771|156748569|FG004|Part A: Dose Escalation Cohort|Physician Decision|0|||
48699292|NCT02903771|156748570|FG005|Part A: Dose Escalation Cohort|Physician Decision|1|||
48699293|NCT02903771|156748571|FG006|Part A: Dose Escalation Cohort|Physician Decision|0|||
48699294|NCT02903771|156748565|FG000|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
48910521|NCT02566577|157509280|FG000|Overall Study|Equipment failure|1|||
48910522|NCT02566577|157509281|FG001|Overall Study|Equipment failure|1|||
48910523|NCT02566577|157509280|FG000|Overall Study|Physical limitation|1|||
48910524|NCT02566577|157509281|FG001|Overall Study|Physical limitation|0|||
48910525|NCT02146599|157509283|FG000|Overall Study|Failed to meet inclusion criteria|5|||
48910526|NCT00916149|157509286|FG000|Overall Study|Lost to Follow-up|3|||
48910527|NCT00916149|157509287|FG001|Overall Study|Lost to Follow-up|2|||
48910528|NCT00916149|157509288|FG002|Overall Study|Lost to Follow-up|0|||
48910529|NCT00916149|157509286|FG000|Overall Study|Unable to place scalp EEG leads|1|||
48910530|NCT00916149|157509287|FG001|Overall Study|Unable to place scalp EEG leads|0|||
48910531|NCT00916149|157509288|FG002|Overall Study|Unable to place scalp EEG leads|0|||
48910532|NCT00175877|157509289|FG000|Overall Study|Adverse Event|136|||
48910533|NCT00175877|157509289|FG000|Overall Study|Withdrawal by Subject|141|||
48910534|NCT00175877|157509289|FG000|Overall Study|Lost to Follow-up|9|||
48910535|NCT00175877|157509289|FG000|Overall Study|Lack of Efficacy|26|||
48910536|NCT00175877|157509289|FG000|Overall Study|Protocol Violation|15|||
48910537|NCT00175877|157509289|FG000|Overall Study|Other Reason|20|||
48910538|NCT00175877|157509289|FG000|Overall Study|AE & Other|1|||
48910539|NCT00175877|157509289|FG000|Overall Study|Withdrawal by subject & Other|1|||
48910540|NCT00544648|157509292|FG000|Overall Study|Withdrawal by Subject|1|||
48910541|NCT00544648|157509293|FG001|Overall Study|Withdrawal by Subject|0|||
48910542|NCT00544648|157509292|FG000|Overall Study|Adverse Event|1|||
48910543|NCT00544648|157509293|FG001|Overall Study|Adverse Event|1|||
48910544|NCT00544648|157509292|FG000|Overall Study|progression of disease|1|||
48910545|NCT00544648|157509293|FG001|Overall Study|progression of disease|0|||
48910546|NCT04166383|157509294|FG000|Drug Administration|Prior to treatment (tx), had a medical emergency requiring surgery & was unable to have further tx.|1|||
48910547|NCT04166383|157509294|FG000|TAC 1 - Second Biopsy Cycle 2 Day 1|Did not complete 2nd biopsy.|2|||
48910548|NCT04166383|157509294|FG000|TAC 2 - Second Biopsy Cycle 4 Day 1|Did not complete 2nd biopsy.|1|||
48910549|NCT02876835|157509310|FG000|Treatment Period (51.1 Month)|Other|1|||
48910550|NCT02876835|157509311|FG001|Treatment Period (51.1 Month)|Other|0|||
48910551|NCT02876835|157509310|FG000|Treatment Period (51.1 Month)|Investigator Site Closed|6|||
48910552|NCT02876835|157509311|FG001|Treatment Period (51.1 Month)|Investigator Site Closed|13|||
48910553|NCT02876835|157509310|FG000|Treatment Period (51.1 Month)|Withdrawal by Subject|32|||
48910554|NCT02876835|157509311|FG001|Treatment Period (51.1 Month)|Withdrawal by Subject|23|||
48910555|NCT02876835|157509310|FG000|Treatment Period (51.1 Month)|Lost to Follow-up|25|||
48910556|NCT02876835|157509311|FG001|Treatment Period (51.1 Month)|Lost to Follow-up|29|||
48910557|NCT00504153|157509314|FG000|Overall Study|Withdrawal by Subject|1|||
48910558|NCT00504153|157509314|FG000|Overall Study|Adverse Event|4|||
48910559|NCT00504153|157509314|FG000|Overall Study|Death|1|||
48910560|NCT00074581|157509316|FG000|Overall Study|Death|15|||
48910561|NCT00074581|157509317|FG001|Overall Study|Death|16|||
48910562|NCT00074581|157509316|FG000|Overall Study|Withdrawal by Subject|50|||
48910563|NCT00074581|157509317|FG001|Overall Study|Withdrawal by Subject|49|||
48910564|NCT00074581|157509316|FG000|Overall Study|Unable to adhere to visit schedule|13|||
48910565|NCT00074581|157509317|FG001|Overall Study|Unable to adhere to visit schedule|14|||
48910566|NCT00074581|157509316|FG000|Overall Study|Relocated|14|||
48699295|NCT02903771|156748566|FG001|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
48699296|NCT02903771|156748567|FG002|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
48699297|NCT02903771|156748568|FG003|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
48699298|NCT02903771|156748569|FG004|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|2|||
48699299|NCT02903771|156748570|FG005|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
48699300|NCT02903771|156748571|FG006|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
48699301|NCT02903771|156748565|FG000|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
48699302|NCT02903771|156748566|FG001|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
48699303|NCT02903771|156748567|FG002|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
48699304|NCT02903771|156748568|FG003|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
48699305|NCT02903771|156748569|FG004|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|3|||
48699306|NCT02903771|156748570|FG005|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
48699307|NCT02903771|156748571|FG006|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
48699308|NCT02903771|156748565|FG000|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
48699309|NCT02903771|156748566|FG001|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
48699310|NCT02903771|156748567|FG002|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
48699311|NCT02903771|156748568|FG003|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
48699312|NCT02903771|156748569|FG004|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|2|||
48910567|NCT00074581|157509317|FG001|Overall Study|Relocated|9|||
48910568|NCT00074581|157509316|FG000|Overall Study|Were withdrawn by investigator|5|||
48910569|NCT00074581|157509317|FG001|Overall Study|Were withdrawn by investigator|2|||
48910570|NCT00074581|157509316|FG000|Overall Study|Lost to Follow-up|16|||
48910571|NCT00074581|157509317|FG001|Overall Study|Lost to Follow-up|11|||
48910572|NCT00074581|157509316|FG000|Overall Study|Ended relationship w. index participant|117|||
48910573|NCT00074581|157509317|FG001|Overall Study|Ended relationship w. index participant|106|||
48910574|NCT00074581|157509316|FG000|Overall Study|Other|14|||
48910575|NCT00074581|157509317|FG001|Overall Study|Other|19|||
48910576|NCT01358760|157509318|FG000|Overall Study|Adverse Event|3|||
48910577|NCT01358760|157509319|FG001|Overall Study|Adverse Event|4|||
48910578|NCT01358760|157509320|FG002|Overall Study|Adverse Event|3|||
48910579|NCT01358760|157509318|FG000|Overall Study|Lost to Follow-up|1|||
48910580|NCT01358760|157509319|FG001|Overall Study|Lost to Follow-up|1|||
48910581|NCT01358760|157509320|FG002|Overall Study|Lost to Follow-up|3|||
48910582|NCT01358760|157509318|FG000|Overall Study|Withdrawal by Subject|5|||
48910583|NCT01358760|157509319|FG001|Overall Study|Withdrawal by Subject|3|||
49116321|NCT03538691|158263094|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
49116322|NCT03538691|158263095|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
49116323|NCT03538691|158263092|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|185|||
48699313|NCT02903771|156748570|FG005|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
48699314|NCT02903771|156748571|FG006|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
48699315|NCT02903771|156748565|FG000|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
48699316|NCT02903771|156748566|FG001|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
49116324|NCT03538691|158263093|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
49116325|NCT03538691|158263094|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
49116326|NCT03538691|158263095|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
49116327|NCT03538691|158263092|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|12|||
49116328|NCT03538691|158263093|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
49116329|NCT03538691|158263094|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
49116330|NCT03538691|158263095|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
49116331|NCT03538691|158263092|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|1|||
49116332|NCT03538691|158263093|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
49116333|NCT03538691|158263094|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
49116334|NCT03538691|158263095|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
49116335|NCT03538691|158263092|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|15|||
49116336|NCT03538691|158263093|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
49116337|NCT03538691|158263094|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
49116338|NCT03538691|158263095|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
49116339|NCT03538691|158263092|FG000|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
49116340|NCT03538691|158263093|FG001|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|5|||
48910584|NCT01358760|157509320|FG002|Overall Study|Withdrawal by Subject|2|||
48910585|NCT01358760|157509318|FG000|Overall Study|Physician Decision|1|||
48910586|NCT01358760|157509319|FG001|Overall Study|Physician Decision|0|||
48699317|NCT02903771|156748567|FG002|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
48699318|NCT02903771|156748568|FG003|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
48910587|NCT01358760|157509320|FG002|Overall Study|Physician Decision|1|||
48910588|NCT01358760|157509318|FG000|Overall Study|Entry criteria not met/Non-compliance|12|||
48910589|NCT01358760|157509319|FG001|Overall Study|Entry criteria not met/Non-compliance|12|||
48910590|NCT01358760|157509320|FG002|Overall Study|Entry criteria not met/Non-compliance|16|||
48910591|NCT00482703|157509325|FG000|Overall Study|Poor compliance|1|||
48910592|NCT00482703|157509326|FG001|Overall Study|Poor compliance|0|||
48910593|NCT05715528|157509334|FG000|Overall Study|Randomized but never treated|11|||
48910594|NCT05715528|157509335|FG001|Overall Study|Randomized but never treated|13|||
48910595|NCT05715528|157509334|FG000|Overall Study|Withdrew consent|7|||
48910596|NCT05715528|157509335|FG001|Overall Study|Withdrew consent|15|||
48910597|NCT05715528|157509334|FG000|Overall Study|Lost to Follow-up|5|||
48910598|NCT05715528|157509335|FG001|Overall Study|Lost to Follow-up|13|||
48910599|NCT05715528|157509334|FG000|Overall Study|Investigator's discretion|3|||
48910600|NCT05715528|157509335|FG001|Overall Study|Investigator's discretion|1|||
48910601|NCT05715528|157509334|FG000|Overall Study|Protocol Violation|2|||
48910602|NCT05715528|157509335|FG001|Overall Study|Protocol Violation|0|||
48910603|NCT05715528|157509334|FG000|Overall Study|Non-compliance with study drug|0|||
48910604|NCT05715528|157509335|FG001|Overall Study|Non-compliance with study drug|1|||
48699319|NCT02903771|156748569|FG004|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|1|||
48699320|NCT02903771|156748570|FG005|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
48699321|NCT02903771|156748571|FG006|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
48910605|NCT02710136|157509336|FG000|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1|||
48910606|NCT02710136|157509337|FG001|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0|||
48910607|NCT00418665|157509338|FG000|Treatment Period|Ineligibility determined|1|||
48910608|NCT00418665|157509339|FG001|Treatment Period|Ineligibility determined|1|||
48910609|NCT00418665|157509340|FG002|Treatment Period|Ineligibility determined|0|||
48910610|NCT00418665|157509338|FG000|Treatment Period|Adverse Event|2|||
48910611|NCT00418665|157509339|FG001|Treatment Period|Adverse Event|2|||
48910612|NCT00418665|157509340|FG002|Treatment Period|Adverse Event|0|||
48910613|NCT00418665|157509338|FG000|Treatment Period|Withdrawal by Subject|0|||
48910614|NCT00418665|157509339|FG001|Treatment Period|Withdrawal by Subject|3|||
48910615|NCT00418665|157509340|FG002|Treatment Period|Withdrawal by Subject|1|||
48910616|NCT00418665|157509338|FG000|Treatment Period|Requirement for alternative therapy|1|||
48910617|NCT00418665|157509339|FG001|Treatment Period|Requirement for alternative therapy|0|||
48910618|NCT00418665|157509340|FG002|Treatment Period|Requirement for alternative therapy|0|||
48910619|NCT00418665|157509338|FG000|Treatment Period|Physician Decision|1|||
48910620|NCT00418665|157509339|FG001|Treatment Period|Physician Decision|0|||
48910621|NCT00418665|157509340|FG002|Treatment Period|Physician Decision|3|||
48910622|NCT00418665|157509338|FG000|Treatment Extension|Adverse Event|1|||
48910623|NCT00418665|157509339|FG001|Treatment Extension|Adverse Event|0|||
48910624|NCT00418665|157509340|FG002|Treatment Extension|Adverse Event|0|||
48910625|NCT00418665|157509338|FG000|Treatment Extension|Withdrawal by Subject|1|||
48910626|NCT00418665|157509339|FG001|Treatment Extension|Withdrawal by Subject|0|||
48910627|NCT00418665|157509340|FG002|Treatment Extension|Withdrawal by Subject|0|||
48910628|NCT00418665|157509338|FG000|Treatment Extension|Requirement for alternative therapy|2|||
48910629|NCT00418665|157509339|FG001|Treatment Extension|Requirement for alternative therapy|2|||
48910630|NCT00418665|157509340|FG002|Treatment Extension|Requirement for alternative therapy|0|||
48910631|NCT00418665|157509338|FG000|Treatment Extension|Physician Decision|2|||
48910632|NCT00418665|157509339|FG001|Treatment Extension|Physician Decision|2|||
48910633|NCT00418665|157509340|FG002|Treatment Extension|Physician Decision|1|||
48910634|NCT00418665|157509338|FG000|Treatment Extension|Death|0|||
48910635|NCT00418665|157509339|FG001|Treatment Extension|Death|0|||
48910636|NCT00418665|157509340|FG002|Treatment Extension|Death|1|||
48910637|NCT01335009|157509341|FG000|Overall Study|Too ill to travel to study sites|1|||
48910638|NCT01335009|157509342|FG001|Overall Study|Too ill to travel to study sites|0|||
48910639|NCT01335009|157509341|FG000|Overall Study|Death|28|||
48910640|NCT01335009|157509342|FG001|Overall Study|Death|32|||
48910641|NCT01335009|157509341|FG000|Overall Study|Withdrawal by Subject|1|||
48910642|NCT01335009|157509342|FG001|Overall Study|Withdrawal by Subject|1|||
48910643|NCT01335009|157509341|FG000|Overall Study|Lost to Follow-up|1|||
48910644|NCT01335009|157509342|FG001|Overall Study|Lost to Follow-up|0|||
48910645|NCT01133379|157509343|FG000|Overall Study|Withdrawal by Subject|0|||
48910646|NCT01133379|157509344|FG001|Overall Study|Withdrawal by Subject|1|||
48910647|NCT01133379|157509345|FG002|Overall Study|Withdrawal by Subject|1|||
48910648|NCT01133379|157509343|FG000|Overall Study|Lost to Follow-up|1|||
48910649|NCT01133379|157509344|FG001|Overall Study|Lost to Follow-up|1|||
48910650|NCT01133379|157509345|FG002|Overall Study|Lost to Follow-up|1|||
48910651|NCT00591214|157509346|FG000|Overall Study|Physician Decision|7|||
48910652|NCT00591214|157509346|FG000|Overall Study|Withdrawal by Subject|1|||
48910653|NCT02060383|157511047|FG000|Core Phase|Unsatisfactory therapeutic effect|1|||
48910654|NCT02060383|157511048|FG001|Core Phase|Unsatisfactory therapeutic effect|5|||
48910655|NCT02060383|157511049|FG002|Core Phase|Unsatisfactory therapeutic effect|0|||
48910656|NCT02060383|157511050|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
48910657|NCT02060383|157511051|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
48910658|NCT02060383|157511047|FG000|Core Phase|Adverse Event|2|||
48910659|NCT02060383|157511048|FG001|Core Phase|Adverse Event|0|||
48910660|NCT02060383|157511049|FG002|Core Phase|Adverse Event|0|||
48910661|NCT02060383|157511050|FG003|Core Phase|Adverse Event|2|||
48910662|NCT02060383|157511051|FG004|Core Phase|Adverse Event|6|||
48910663|NCT02060383|157511047|FG000|Core Phase|Administrative problems|0|||
48910664|NCT02060383|157511048|FG001|Core Phase|Administrative problems|1|||
48910665|NCT02060383|157511049|FG002|Core Phase|Administrative problems|0|||
48910666|NCT02060383|157511050|FG003|Core Phase|Administrative problems|0|||
48910667|NCT02060383|157511051|FG004|Core Phase|Administrative problems|0|||
48910668|NCT02060383|157511047|FG000|Core Phase|Protocol Violation|0|||
48910669|NCT02060383|157511048|FG001|Core Phase|Protocol Violation|0|||
48910670|NCT02060383|157511049|FG002|Core Phase|Protocol Violation|0|||
48910671|NCT02060383|157511050|FG003|Core Phase|Protocol Violation|1|||
48910672|NCT02060383|157511051|FG004|Core Phase|Protocol Violation|0|||
48910673|NCT02060383|157511047|FG000|Core Phase|Withdrawal by Subject|0|||
48910674|NCT02060383|157511048|FG001|Core Phase|Withdrawal by Subject|0|||
48910675|NCT02060383|157511049|FG002|Core Phase|Withdrawal by Subject|0|||
48910676|NCT02060383|157511050|FG003|Core Phase|Withdrawal by Subject|4|||
48910677|NCT02060383|157511051|FG004|Core Phase|Withdrawal by Subject|2|||
48910678|NCT02060383|157511047|FG000|Extension Phase|Unsatisfactory therapeutic effect|1|||
48910679|NCT02060383|157511048|FG001|Extension Phase|Unsatisfactory therapeutic effect|1|||
48910680|NCT02060383|157511049|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
48910681|NCT02060383|157511050|FG003|Extension Phase|Unsatisfactory therapeutic effect|2|||
48910682|NCT02060383|157511051|FG004|Extension Phase|Unsatisfactory therapeutic effect|2|||
48910683|NCT02060383|157511047|FG000|Extension Phase|Adverse Event|1|||
48910684|NCT02060383|157511048|FG001|Extension Phase|Adverse Event|1|||
48910685|NCT02060383|157511049|FG002|Extension Phase|Adverse Event|2|||
48910686|NCT02060383|157511050|FG003|Extension Phase|Adverse Event|0|||
48910687|NCT02060383|157511051|FG004|Extension Phase|Adverse Event|1|||
48910688|NCT02060383|157511047|FG000|Extension Phase|Withdrawal by Subject|0|||
48699322|NCT02903771|156748565|FG000|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
48910689|NCT02060383|157511048|FG001|Extension Phase|Withdrawal by Subject|1|||
48910690|NCT02060383|157511049|FG002|Extension Phase|Withdrawal by Subject|0|||
48910691|NCT02060383|157511050|FG003|Extension Phase|Withdrawal by Subject|0|||
48910692|NCT02060383|157511051|FG004|Extension Phase|Withdrawal by Subject|2|||
48910693|NCT02060383|157511047|FG000|Extension Phase|Administrative problems|1|||
48910694|NCT02060383|157511048|FG001|Extension Phase|Administrative problems|0|||
48910695|NCT02060383|157511049|FG002|Extension Phase|Administrative problems|0|||
48910696|NCT02060383|157511050|FG003|Extension Phase|Administrative problems|0|||
48910697|NCT02060383|157511051|FG004|Extension Phase|Administrative problems|0|||
48910698|NCT02060383|157511047|FG000|Extension Phase|Death|0|||
48910699|NCT02060383|157511048|FG001|Extension Phase|Death|0|||
48910700|NCT02060383|157511049|FG002|Extension Phase|Death|1|||
48910701|NCT02060383|157511050|FG003|Extension Phase|Death|0|||
48910702|NCT02060383|157511051|FG004|Extension Phase|Death|1|||
48910703|NCT02060383|157511047|FG000|Extension Phase|Protocol Violation|0|||
48910704|NCT02060383|157511048|FG001|Extension Phase|Protocol Violation|0|||
48910705|NCT02060383|157511049|FG002|Extension Phase|Protocol Violation|0|||
48910706|NCT02060383|157511050|FG003|Extension Phase|Protocol Violation|0|||
48910707|NCT02060383|157511051|FG004|Extension Phase|Protocol Violation|1|||
48699323|NCT02903771|156748566|FG001|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
48699324|NCT02903771|156748567|FG002|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
48699325|NCT02903771|156748568|FG003|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
48699326|NCT02903771|156748569|FG004|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|2|||
48699327|NCT02903771|156748570|FG005|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
48699328|NCT02903771|156748571|FG006|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
48699329|NCT02903771|156748565|FG000|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
48699330|NCT02903771|156748566|FG001|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
48699331|NCT02903771|156748567|FG002|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
48699332|NCT02903771|156748568|FG003|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
48699333|NCT02903771|156748569|FG004|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|2|||
48699334|NCT02903771|156748570|FG005|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
48699335|NCT02903771|156748571|FG006|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
48699336|NCT01285323|156748576|FG000|Overall Study|Adverse Event|9|||
48699337|NCT01285323|156748577|FG001|Overall Study|Adverse Event|8|||
48699338|NCT01285323|156748576|FG000|Overall Study|Lack of Efficacy|4|||
48699339|NCT01285323|156748577|FG001|Overall Study|Lack of Efficacy|2|||
48699340|NCT01285323|156748576|FG000|Overall Study|Withdrawal by Subject|15|||
48699341|NCT01285323|156748577|FG001|Overall Study|Withdrawal by Subject|11|||
48699342|NCT01285323|156748576|FG000|Overall Study|Protocol Violation|1|||
48699343|NCT01285323|156748577|FG001|Overall Study|Protocol Violation|2|||
48699344|NCT01285323|156748576|FG000|Overall Study|Non-compliance with study procedures|2|||
48699345|NCT01285323|156748577|FG001|Overall Study|Non-compliance with study procedures|3|||
48699346|NCT01285323|156748576|FG000|Overall Study|Lost to Follow-up|1|||
48699347|NCT01285323|156748577|FG001|Overall Study|Lost to Follow-up|1|||
48699348|NCT01285323|156748576|FG000|Overall Study|Other|1|||
48699349|NCT01285323|156748577|FG001|Overall Study|Other|3|||
48699350|NCT05106959|156748578|FG000|Overall Study|Lost to Follow-up|1|||
48699351|NCT00087152|156748579|FG000|Overall Study|Ineligible|6|||
48699352|NCT03199976|156748580|FG000|Overall Study|Lack of Efficacy|3|||
48699353|NCT03199976|156748581|FG001|Overall Study|Lack of Efficacy|6|||
48699354|NCT03199976|156748582|FG002|Overall Study|Lack of Efficacy|13|||
48699355|NCT03199976|156748580|FG000|Overall Study|Withdrawal by Subject|1|||
48699356|NCT03199976|156748581|FG001|Overall Study|Withdrawal by Subject|0|||
48699357|NCT03199976|156748582|FG002|Overall Study|Withdrawal by Subject|0|||
48699358|NCT03199976|156748580|FG000|Overall Study|Lost to Follow-up|0|||
48699359|NCT03199976|156748581|FG001|Overall Study|Lost to Follow-up|1|||
48699360|NCT03199976|156748582|FG002|Overall Study|Lost to Follow-up|1|||
48699361|NCT01553084|156748583|FG000|Overall Study|Withdrawal by Subject|15|||
48699362|NCT01553084|156748584|FG001|Overall Study|Withdrawal by Subject|13|||
48910708|NCT03329196|157511054|FG000|Overall Study|Adverse Event|10|||
49116341|NCT03538691|158263094|FG002|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
49116342|NCT03538691|158263095|FG003|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
49116343|NCT03538691|158263092|FG000|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
49116344|NCT03538691|158263093|FG001|Phase B: Stabilization (12 Weeks)|Adverse Event|52|||
49116345|NCT03538691|158263094|FG002|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
48910709|NCT03329196|157511055|FG001|Overall Study|Adverse Event|5|||
49116346|NCT03538691|158263095|FG003|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
48910710|NCT03329196|157511054|FG000|Overall Study|Physician Decision|2|||
48910711|NCT03329196|157511055|FG001|Overall Study|Physician Decision|2|||
48910712|NCT03329196|157511054|FG000|Overall Study|Withdrawal by Subject|11|||
48910713|NCT03329196|157511055|FG001|Overall Study|Withdrawal by Subject|3|||
48699363|NCT01553084|156748585|FG002|Overall Study|Withdrawal by Subject|35|||
48699364|NCT04227899|156748586|FG000|Overall Study|Withdrawal by Subject|6|||
48699365|NCT04227899|156748587|FG001|Overall Study|Withdrawal by Subject|3|||
48699366|NCT04227899|156748586|FG000|Overall Study|Death|12|||
48699367|NCT04227899|156748587|FG001|Overall Study|Death|6|||
48699368|NCT04227899|156748586|FG000|Overall Study|Lost to Follow-up|2|||
48699369|NCT04227899|156748587|FG001|Overall Study|Lost to Follow-up|1|||
48699370|NCT03882021|156748588|FG000|Enrollment|Procedure aborted/cancelled|2|||
48699371|NCT03882021|156748588|FG000|Enrollment|HD Grid catheter not introduced into patient|1|||
48699372|NCT03882021|156748588|FG000|Enrollment to 3-Month|Death|1|||
48699373|NCT03882021|156748588|FG000|Enrollment to 3-Month|Operator not able to achieve PVI|4|||
49116347|NCT03538691|158263092|FG000|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
48699374|NCT03882021|156748588|FG000|Enrollment to 3-Month|Missed Visit|4|||
48699375|NCT03882021|156748588|FG000|3-Month to 6-Month Visit|Missed Visit|1|||
48699376|NCT03882021|156748588|FG000|6-Month to 12-Month Visit|Death|1|||
48699377|NCT03882021|156748588|FG000|6-Month to 12-Month Visit|Missed Visit|7|||
48699378|NCT04571944|156748589|FG000|Overall Study|Death|1|||
48699379|NCT04571944|156748590|FG001|Overall Study|Death|0|||
48699380|NCT04571944|156748589|FG000|Overall Study|Withdrawal by Subject|3|||
48699381|NCT04571944|156748590|FG001|Overall Study|Withdrawal by Subject|0|||
48699382|NCT04571944|156748589|FG000|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|2|||
48699383|NCT04571944|156748590|FG001|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|0|||
48699384|NCT03119259|156748591|FG000|Overall Study|Withdrawn as no longer eligible|1|||
48699385|NCT03119259|156748592|FG001|Overall Study|Withdrawn as no longer eligible|0|||
48699386|NCT03119259|156748591|FG000|Overall Study|Withdrawal by Subject|4|||
48699387|NCT03119259|156748592|FG001|Overall Study|Withdrawal by Subject|2|||
48699388|NCT03119259|156748591|FG000|Overall Study|Lost to Follow-up|0|||
48699389|NCT03119259|156748592|FG001|Overall Study|Lost to Follow-up|1|||
48699390|NCT03486912|156748596|FG000|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
48699391|NCT03486912|156748597|FG001|Randomized (Pre-Treatment)|Withdrawal by Subject|1|||
49116348|NCT03538691|158263093|FG001|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|47|||
49116349|NCT03538691|158263094|FG002|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
49116350|NCT03538691|158263095|FG003|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
49116351|NCT03538691|158263092|FG000|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
49116352|NCT03538691|158263093|FG001|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|9|||
49116353|NCT03538691|158263094|FG002|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
48699392|NCT03486912|156748598|FG002|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
48699393|NCT03486912|156748599|FG003|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
48910714|NCT03329196|157511054|FG000|Overall Study|Hepatic function abnormalities|0|||
48699394|NCT03486912|156748596|FG000|Treatment Period|Withdrawal by Subject|3|||
48699395|NCT03486912|156748597|FG001|Treatment Period|Withdrawal by Subject|3|||
48699396|NCT03486912|156748598|FG002|Treatment Period|Withdrawal by Subject|3|||
48910715|NCT03329196|157511055|FG001|Overall Study|Hepatic function abnormalities|1|||
48910716|NCT03329196|157511054|FG000|Overall Study|Conducting rescue therapy before Week 24|2|||
48910717|NCT03329196|157511055|FG001|Overall Study|Conducting rescue therapy before Week 24|1|||
48910718|NCT03329196|157511054|FG000|Overall Study|Difficult to control Hb|2|||
48910719|NCT03329196|157511055|FG001|Overall Study|Difficult to control Hb|3|||
48910720|NCT03329196|157511054|FG000|Overall Study|Dialysis or renal transplant|13|||
48699397|NCT03486912|156748599|FG003|Treatment Period|Withdrawal by Subject|2|||
48699398|NCT03486912|156748596|FG000|Treatment Period|Other Reasons|0|||
48699399|NCT03486912|156748597|FG001|Treatment Period|Other Reasons|2|||
48699400|NCT03486912|156748598|FG002|Treatment Period|Other Reasons|1|||
48699401|NCT03486912|156748599|FG003|Treatment Period|Other Reasons|1|||
48699402|NCT03486912|156748596|FG000|Treatment Period|Adverse Event|0|||
48699403|NCT03486912|156748597|FG001|Treatment Period|Adverse Event|1|||
48699404|NCT03486912|156748598|FG002|Treatment Period|Adverse Event|1|||
48699405|NCT03486912|156748599|FG003|Treatment Period|Adverse Event|0|||
48699406|NCT03486912|156748596|FG000|Treatment Period|Lost to Follow-up|1|||
48699407|NCT03486912|156748597|FG001|Treatment Period|Lost to Follow-up|0|||
48910721|NCT03329196|157511055|FG001|Overall Study|Dialysis or renal transplant|15|||
48910722|NCT00268437|157511059|FG000|Overall Study|Ineligible|1|||
48910723|NCT04042740|157511060|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Lost to Follow-up|2|||
48910724|NCT04042740|157511060|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Withdrawal by Subject|1|||
48910725|NCT04823611|157511063|FG000|Overall Study|Adverse Event|2|||
48699408|NCT03486912|156748598|FG002|Treatment Period|Lost to Follow-up|0|||
48910726|NCT04823611|157511064|FG001|Overall Study|Adverse Event|0|||
48910727|NCT04823611|157511065|FG002|Overall Study|Adverse Event|1|||
49116354|NCT03538691|158263095|FG003|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
48699409|NCT03486912|156748599|FG003|Treatment Period|Lost to Follow-up|2|||
48699410|NCT02491684|156748600|FG000|Treatment Phase|Adverse Event|2|||
48910728|NCT04823611|157511066|FG003|Overall Study|Adverse Event|0|||
48699411|NCT02491684|156748601|FG001|Treatment Phase|Adverse Event|2|||
48699412|NCT02491684|156748600|FG000|Treatment Phase|Incorrect randomisation|1|||
48699413|NCT02491684|156748601|FG001|Treatment Phase|Incorrect randomisation|0|||
48699414|NCT02491684|156748600|FG000|Treatment Phase|Investigator and Sponsor decision|0|||
48699415|NCT02491684|156748601|FG001|Treatment Phase|Investigator and Sponsor decision|1|||
48699416|NCT00412984|156748602|FG000|Overall Study|Death|331|||
48699417|NCT00412984|156748603|FG001|Overall Study|Death|349|||
48699418|NCT00412984|156748602|FG000|Overall Study|Adverse Event|679|||
48699419|NCT00412984|156748603|FG001|Overall Study|Adverse Event|738|||
48699420|NCT00412984|156748602|FG000|Overall Study|Withdrawal by Subject|921|||
48699421|NCT00412984|156748603|FG001|Overall Study|Withdrawal by Subject|989|||
48699422|NCT00412984|156748602|FG000|Overall Study|Lost to Follow-up|51|||
48699423|NCT00412984|156748603|FG001|Overall Study|Lost to Follow-up|39|||
48699424|NCT00412984|156748602|FG000|Overall Study|Poor/Noncompliance|57|||
48699425|NCT00412984|156748603|FG001|Overall Study|Poor/Noncompliance|77|||
48699426|NCT00412984|156748602|FG000|Overall Study|Pregnancy|1|||
48699427|NCT00412984|156748603|FG001|Overall Study|Pregnancy|0|||
48699428|NCT00412984|156748602|FG000|Overall Study|Subject No Longer Meets Study Criteria|87|||
48699429|NCT00412984|156748603|FG001|Overall Study|Subject No Longer Meets Study Criteria|100|||
48699430|NCT00412984|156748602|FG000|Overall Study|Administrative Reason by Sponsor|11|||
48699431|NCT00412984|156748603|FG001|Overall Study|Administrative Reason by Sponsor|8|||
48699432|NCT00412984|156748602|FG000|Overall Study|Physician Refused to Continue Treatment|81|||
48910729|NCT04823611|157511067|FG004|Overall Study|Adverse Event|0|||
48910730|NCT04823611|157511068|FG005|Overall Study|Adverse Event|0|||
48910731|NCT04823611|157511069|FG006|Overall Study|Adverse Event|0|||
48699433|NCT00412984|156748603|FG001|Overall Study|Physician Refused to Continue Treatment|89|||
48699434|NCT00412984|156748602|FG000|Overall Study|Other Reason|80|||
48910732|NCT02615470|157511070|FG000|Overall Study|Lost to Follow-up|21|||
48910733|NCT02615470|157511071|FG001|Overall Study|Lost to Follow-up|32|||
48910734|NCT03627767|157511080|FG000|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48|||
48910735|NCT03627767|157511081|FG001|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
48910736|NCT03627767|157511082|FG002|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
48910737|NCT03627767|157511083|FG003|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
48910738|NCT03627767|157511084|FG004|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
48910739|NCT03627767|157511080|FG000|Open-label (OL) Run-in Period (12 Weeks)|Death|1|||
48910740|NCT03627767|157511081|FG001|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
48910741|NCT03627767|157511082|FG002|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
48910742|NCT03627767|157511083|FG003|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
48910743|NCT03627767|157511084|FG004|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
48910744|NCT03627767|157511080|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315|||
48910745|NCT03627767|157511081|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
48910746|NCT03627767|157511082|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
48910747|NCT03627767|157511083|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
48910748|NCT03627767|157511084|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
48910749|NCT03627767|157511080|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13|||
48910750|NCT03627767|157511081|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
48910751|NCT03627767|157511082|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
48910752|NCT03627767|157511083|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
48910753|NCT03627767|157511084|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
48910754|NCT03627767|157511080|FG000|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11|||
48910755|NCT03627767|157511081|FG001|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
48699435|NCT00412984|156748603|FG001|Overall Study|Other Reason|92|||
48699436|NCT00412984|156748602|FG000|Overall Study|Not Reported|11|||
48699437|NCT00412984|156748603|FG001|Overall Study|Not Reported|12|||
48910756|NCT03627767|157511082|FG002|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
48910757|NCT03627767|157511083|FG003|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
48910758|NCT03627767|157511084|FG004|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
48910759|NCT03627767|157511080|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40|||
48910760|NCT03627767|157511081|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
48910761|NCT03627767|157511082|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
48910762|NCT03627767|157511083|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
48910763|NCT03627767|157511084|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
48910764|NCT03627767|157511080|FG000|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1|||
48910765|NCT03627767|157511081|FG001|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
48951824|NCT00592358|157654906|FG000|Overall Study|Withdrawal by Subject|2|||
48699438|NCT00325897|156748604|FG000|Overall Study|Lost to Follow-up|12|||
48699439|NCT00325897|156748605|FG001|Overall Study|Lost to Follow-up|13|||
48699440|NCT01188343|156748606|FG000|Overall Study|Not vaccinated|0|||
48699441|NCT01188343|156748607|FG001|Overall Study|Not vaccinated|2|||
48699442|NCT01188343|156748608|FG002|Overall Study|Not vaccinated|1|||
48699443|NCT01188343|156748606|FG000|Overall Study|Withdrawal by Subject|1|||
48910766|NCT03627767|157511082|FG002|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
48910767|NCT03627767|157511083|FG003|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
48910768|NCT03627767|157511084|FG004|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
48910769|NCT03627767|157511080|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2|||
48910770|NCT03627767|157511081|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
48910771|NCT03627767|157511082|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
48910772|NCT03627767|157511083|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
48699444|NCT01188343|156748607|FG001|Overall Study|Withdrawal by Subject|24|||
48699445|NCT01188343|156748608|FG002|Overall Study|Withdrawal by Subject|0|||
48699446|NCT00107198|156748609|FG000|Overall Study|Lack of Efficacy|28|||
48699447|NCT00107198|156748609|FG000|Overall Study|Lost to Follow-up|12|||
48699448|NCT00107198|156748609|FG000|Overall Study|Protocol Violation|1|||
48699449|NCT00107198|156748609|FG000|Overall Study|Withdrawal by Subject|6|||
48699450|NCT00107198|156748609|FG000|Overall Study|Ineligible|5|||
48699451|NCT01521117|156748626|FG000|First Intervention (6 Weeks)|Adverse Event|5|||
48910773|NCT03627767|157511084|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
48910774|NCT03627767|157511080|FG000|Open-label (OL) Run-in Period (12 Weeks)|Other|4|||
48910775|NCT03627767|157511081|FG001|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
48910776|NCT03627767|157511082|FG002|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
48910777|NCT03627767|157511083|FG003|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
48910778|NCT03627767|157511084|FG004|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
48910779|NCT03627767|157511080|FG000|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2|||
48910780|NCT03627767|157511081|FG001|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
48910781|NCT03627767|157511082|FG002|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
48910782|NCT03627767|157511083|FG003|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
48910783|NCT03627767|157511084|FG004|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
48910784|NCT03627767|157511080|FG000|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
48910785|NCT03627767|157511081|FG001|Double-blind Treatment Period (40 Weeks)|Adverse Event|6|||
48910786|NCT03627767|157511082|FG002|Double-blind Treatment Period (40 Weeks)|Adverse Event|7|||
48910787|NCT03627767|157511083|FG003|Double-blind Treatment Period (40 Weeks)|Adverse Event|19|||
48910788|NCT03627767|157511084|FG004|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
48910789|NCT03627767|157511080|FG000|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
48910790|NCT03627767|157511081|FG001|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
48910791|NCT03627767|157511082|FG002|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2|||
48910792|NCT03627767|157511083|FG003|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3|||
48910793|NCT03627767|157511084|FG004|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
48910794|NCT03627767|157511080|FG000|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
48910795|NCT03627767|157511081|FG001|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1|||
48910796|NCT03627767|157511082|FG002|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5|||
48910797|NCT03627767|157511083|FG003|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2|||
48910798|NCT03627767|157511084|FG004|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
48910799|NCT03627767|157511080|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
48910800|NCT03627767|157511081|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9|||
48910801|NCT03627767|157511082|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6|||
48910802|NCT03627767|157511083|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10|||
48910803|NCT03627767|157511084|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
48910804|NCT03627767|157511080|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
48910805|NCT03627767|157511081|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
48910806|NCT03627767|157511082|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1|||
48910807|NCT03627767|157511083|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
48910808|NCT03627767|157511084|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
48910809|NCT03627767|157511080|FG000|Double-blind Treatment Period (40 Weeks)|Other|0|||
48910810|NCT03627767|157511081|FG001|Double-blind Treatment Period (40 Weeks)|Other|0|||
48910811|NCT03627767|157511082|FG002|Double-blind Treatment Period (40 Weeks)|Other|1|||
48910812|NCT03627767|157511083|FG003|Double-blind Treatment Period (40 Weeks)|Other|1|||
48910813|NCT03627767|157511084|FG004|Double-blind Treatment Period (40 Weeks)|Other|0|||
48910814|NCT03627767|157511080|FG000|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
48910815|NCT03627767|157511081|FG001|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
48910816|NCT03627767|157511082|FG002|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
48699452|NCT01521117|156748627|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
48699453|NCT01521117|156748626|FG000|First Intervention (6 Weeks)|Scheduling Issues|0|||
48699454|NCT01521117|156748627|FG001|First Intervention (6 Weeks)|Scheduling Issues|2|||
48910817|NCT03627767|157511083|FG003|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
48910818|NCT03627767|157511084|FG004|Open-label Rescue Period (12 Weeks)|Adverse Event|9|||
48910819|NCT03627767|157511080|FG000|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
48910820|NCT03627767|157511081|FG001|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
48910821|NCT03627767|157511082|FG002|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
48910822|NCT03627767|157511083|FG003|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
48910823|NCT03627767|157511084|FG004|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1|||
48910824|NCT03627767|157511080|FG000|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
48910825|NCT03627767|157511081|FG001|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
48910826|NCT03627767|157511082|FG002|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
48910827|NCT03627767|157511083|FG003|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
48910828|NCT03627767|157511084|FG004|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9|||
48910829|NCT03627767|157511080|FG000|Open-label Rescue Period (12 Weeks)|Other|0|||
48699455|NCT01521117|156748626|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
48699456|NCT01521117|156748627|FG001|Second Intervention (6 Weeks)|Adverse Event|3|||
48699457|NCT01668784|156748641|FG000|Randomized (Pre-treatment)|Disease Progression|0|||
48699458|NCT01668784|156748642|FG001|Randomized (Pre-treatment)|Disease Progression|1|||
48699459|NCT01668784|156748641|FG000|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0|||
48699460|NCT01668784|156748642|FG001|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3|||
48699461|NCT01668784|156748641|FG000|Randomized (Pre-treatment)|Withdrawal by Subject|1|||
48699462|NCT01668784|156748642|FG001|Randomized (Pre-treatment)|Withdrawal by Subject|8|||
48699463|NCT01668784|156748641|FG000|Randomized (Pre-treatment)|Poor/Non-Compliance|1|||
48699464|NCT01668784|156748642|FG001|Randomized (Pre-treatment)|Poor/Non-Compliance|0|||
48699465|NCT01668784|156748641|FG000|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2|||
48699466|NCT01668784|156748642|FG001|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1|||
48699467|NCT01668784|156748641|FG000|Randomized (Pre-treatment)|participant requested to be treated a local facility|0|||
48699468|NCT01668784|156748642|FG001|Randomized (Pre-treatment)|participant requested to be treated a local facility|1|||
48910830|NCT03627767|157511081|FG001|Open-label Rescue Period (12 Weeks)|Other|0|||
48910831|NCT03627767|157511082|FG002|Open-label Rescue Period (12 Weeks)|Other|0|||
48910832|NCT03627767|157511083|FG003|Open-label Rescue Period (12 Weeks)|Other|0|||
48910833|NCT03627767|157511084|FG004|Open-label Rescue Period (12 Weeks)|Other|1|||
48910834|NCT01717287|157511085|FG000|Overall Study|Lost to Follow-up|0|||
48910835|NCT01717287|157511086|FG001|Overall Study|Lost to Follow-up|2|||
48910836|NCT01717287|157511085|FG000|Overall Study|Protocol Violation|0|||
48910837|NCT01717287|157511086|FG001|Overall Study|Protocol Violation|1|||
48910838|NCT00283049|157511087|FG000|Overall Study|Adverse Event|6|||
48910839|NCT00283049|157511088|FG001|Overall Study|Adverse Event|1|||
48910840|NCT00283049|157511089|FG002|Overall Study|Adverse Event|4|||
48910841|NCT00283049|157511087|FG000|Overall Study|Protocol Violation|3|||
48910842|NCT00283049|157511088|FG001|Overall Study|Protocol Violation|0|||
48910843|NCT00283049|157511089|FG002|Overall Study|Protocol Violation|3|||
48910844|NCT00283049|157511087|FG000|Overall Study|Death|1|||
48910845|NCT00283049|157511088|FG001|Overall Study|Death|1|||
48910846|NCT00283049|157511089|FG002|Overall Study|Death|1|||
48910847|NCT00283049|157511087|FG000|Overall Study|Lack of Efficacy|0|||
48910848|NCT00283049|157511088|FG001|Overall Study|Lack of Efficacy|1|||
48910849|NCT00283049|157511089|FG002|Overall Study|Lack of Efficacy|1|||
49116355|NCT03538691|158263092|FG000|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
49116356|NCT03538691|158263093|FG001|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|136|||
49116357|NCT03538691|158263094|FG002|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
49116358|NCT03538691|158263095|FG003|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
49116359|NCT03538691|158263092|FG000|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
49116360|NCT03538691|158263093|FG001|Phase B: Stabilization (12 Weeks)|Pregnancy|1|||
49116361|NCT03538691|158263094|FG002|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
49116362|NCT03538691|158263095|FG003|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
49116363|NCT03538691|158263092|FG000|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
49116364|NCT03538691|158263093|FG001|Phase B: Stabilization (12 Weeks)|Protocol Deviation|9|||
49116365|NCT03538691|158263094|FG002|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
49116366|NCT03538691|158263095|FG003|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
49116367|NCT03538691|158263092|FG000|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
48699469|NCT01668784|156748641|FG000|Treatment Period|Disease Progression|316|||
48699470|NCT01668784|156748642|FG001|Treatment Period|Disease Progression|293|||
48699471|NCT01668784|156748641|FG000|Treatment Period|Study Drug Toxicity|46|||
48699472|NCT01668784|156748642|FG001|Treatment Period|Study Drug Toxicity|53|||
48910850|NCT00283049|157511087|FG000|Overall Study|Lost to Follow-up|4|||
48910851|NCT00283049|157511088|FG001|Overall Study|Lost to Follow-up|2|||
48910852|NCT00283049|157511089|FG002|Overall Study|Lost to Follow-up|5|||
48910853|NCT00283049|157511087|FG000|Overall Study|Withdrawal by Subject|26|||
48910854|NCT00283049|157511088|FG001|Overall Study|Withdrawal by Subject|24|||
48910855|NCT00283049|157511089|FG002|Overall Study|Withdrawal by Subject|19|||
48910856|NCT00283049|157511087|FG000|Overall Study|Discontinuation of Study|18|||
48910857|NCT00283049|157511088|FG001|Overall Study|Discontinuation of Study|16|||
48910858|NCT00283049|157511089|FG002|Overall Study|Discontinuation of Study|20|||
48910859|NCT00283049|157511087|FG000|Overall Study|No longer requires study treatment|0|||
48910860|NCT00283049|157511088|FG001|Overall Study|No longer requires study treatment|0|||
48910861|NCT00283049|157511089|FG002|Overall Study|No longer requires study treatment|1|||
48910862|NCT01022996|157511092|FG000|Overall Study|Adverse Event|14|||
48910863|NCT01022996|157511092|FG000|Overall Study|Withdrawal by Subject|3|||
48910864|NCT01022996|157511092|FG000|Overall Study|Lost to Follow-up|1|||
48910865|NCT01022996|157511092|FG000|Overall Study|Administrative problems|6|||
48910866|NCT01022996|157511092|FG000|Overall Study|Disease Progression|32|||
48910867|NCT01022996|157511092|FG000|Overall Study|Protocol Violation|1|||
48910868|NCT04490395|157511093|FG000|Overall Study|Lost to Follow-up|0|||
48910869|NCT04490395|157511094|FG001|Overall Study|Lost to Follow-up|1|||
48910870|NCT02767323|157511095|FG000|Overall Study|Withdrawal by Subject|17|||
48910871|NCT02767323|157511096|FG001|Overall Study|Withdrawal by Subject|5|||
48910872|NCT02767323|157511097|FG002|Overall Study|Withdrawal by Subject|13|||
48910873|NCT02767323|157511098|FG003|Overall Study|Withdrawal by Subject|0|||
48910874|NCT02767323|157511095|FG000|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
48910875|NCT02767323|157511096|FG001|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20|||
48910876|NCT02767323|157511097|FG002|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
48910877|NCT02767323|157511098|FG003|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0|||
48910878|NCT00930722|157511099|FG000|Overall Study|Lost to Follow-up|16|||
48910879|NCT00930722|157511099|FG000|Overall Study|No longer willing to participate|9|||
48910880|NCT00930722|157511099|FG000|Overall Study|Study terminated by sponsor|2|||
48910881|NCT01798992|157511101|FG000|Overall Study|Administrative withdrawal|0|||
48910882|NCT01798992|157511102|FG001|Overall Study|Administrative withdrawal|1|||
48910883|NCT01798992|157511103|FG002|Overall Study|Administrative withdrawal|0|||
48910884|NCT01798992|157511104|FG003|Overall Study|Administrative withdrawal|1|||
48910885|NCT01798992|157511101|FG000|Overall Study|Lost to Follow-up|0|||
48910886|NCT01798992|157511102|FG001|Overall Study|Lost to Follow-up|1|||
48910887|NCT01798992|157511103|FG002|Overall Study|Lost to Follow-up|1|||
48910888|NCT01798992|157511104|FG003|Overall Study|Lost to Follow-up|0|||
48910889|NCT01798992|157511101|FG000|Overall Study|Insufficient biopsy tissue|0|||
48910890|NCT01798992|157511102|FG001|Overall Study|Insufficient biopsy tissue|0|||
48910891|NCT01798992|157511103|FG002|Overall Study|Insufficient biopsy tissue|1|||
48910892|NCT01798992|157511104|FG003|Overall Study|Insufficient biopsy tissue|0|||
48910893|NCT01131351|157511105|FG000|Overall Study|Adverse Event|0|||
48910894|NCT01131351|157511106|FG001|Overall Study|Adverse Event|2|||
48910895|NCT01131351|157511105|FG000|Overall Study|Protocol Deviation|0|||
48910896|NCT01131351|157511106|FG001|Overall Study|Protocol Deviation|1|||
48910897|NCT02194062|157511107|FG000|Overall Study|Lost to Follow-up|2|||
48910898|NCT02194062|157511108|FG001|Overall Study|Lost to Follow-up|2|||
48910899|NCT02194062|157511109|FG002|Overall Study|Lost to Follow-up|5|||
48910900|NCT01942148|157511110|FG000|Overall Study|Adverse Event|4|||
48910901|NCT01942148|157511110|FG000|Overall Study|Lack of Efficacy|2|||
48910902|NCT01942148|157511110|FG000|Overall Study|Physician Decision|11|||
48910903|NCT01942148|157511110|FG000|Overall Study|Protocol Violation|1|||
48910904|NCT01942148|157511110|FG000|Overall Study|Withdrawal by Subject|8|||
48910905|NCT01942148|157511110|FG000|Overall Study|Use of the prohibition medicine|1|||
48910906|NCT01809132|157511111|FG000|Overall Study|Withdrawal by Subject|0|||
48910907|NCT01809132|157511112|FG001|Overall Study|Withdrawal by Subject|0|||
48910908|NCT01809132|157511113|FG002|Overall Study|Withdrawal by Subject|1|||
48910909|NCT03823404|157511117|FG000|Overall Study|Lost to Follow-up|1|||
48910910|NCT03823404|157511118|FG001|Overall Study|Lost to Follow-up|2|||
48910911|NCT03823404|157511119|FG002|Overall Study|Lost to Follow-up|3|||
48910912|NCT03823404|157511117|FG000|Overall Study|Protocol Violation|2|||
48910913|NCT03823404|157511118|FG001|Overall Study|Protocol Violation|0|||
48910914|NCT03823404|157511119|FG002|Overall Study|Protocol Violation|2|||
48910915|NCT03823404|157511117|FG000|Overall Study|Adverse Event|35|||
48910916|NCT03823404|157511118|FG001|Overall Study|Adverse Event|38|||
48910917|NCT03823404|157511119|FG002|Overall Study|Adverse Event|8|||
48910918|NCT03823404|157511117|FG000|Overall Study|Withdrawal by Subject|38|||
48910919|NCT03823404|157511118|FG001|Overall Study|Withdrawal by Subject|40|||
48910920|NCT03823404|157511119|FG002|Overall Study|Withdrawal by Subject|35|||
48910921|NCT03823404|157511117|FG000|Overall Study|Death|4|||
48910922|NCT03823404|157511118|FG001|Overall Study|Death|0|||
48910923|NCT03823404|157511119|FG002|Overall Study|Death|0|||
48910924|NCT03823404|157511117|FG000|Overall Study|Other: Various reasons provided|5|||
48910925|NCT03823404|157511118|FG001|Overall Study|Other: Various reasons provided|5|||
48910926|NCT03823404|157511119|FG002|Overall Study|Other: Various reasons provided|6|||
48910927|NCT00884325|157511129|FG000|Overall Study|Lost to Follow-up|1|||
48910928|NCT00884325|157511130|FG001|Overall Study|Lost to Follow-up|2|||
48910929|NCT00884325|157511129|FG000|Overall Study|Lack of Efficacy|0|||
48910930|NCT00884325|157511130|FG001|Overall Study|Lack of Efficacy|1|||
48910931|NCT00884325|157511129|FG000|Overall Study|Withdrawal by Subject|1|||
48910932|NCT00884325|157511130|FG001|Overall Study|Withdrawal by Subject|1|||
48910933|NCT00884325|157511129|FG000|Overall Study|Not provided|1|||
48910934|NCT00884325|157511130|FG001|Overall Study|Not provided|0|||
48910935|NCT02357134|157511131|FG000|Overall Study|Lost to Follow-up|1|||
48910936|NCT02357134|157511132|FG001|Overall Study|Lost to Follow-up|0|||
48910937|NCT02357134|157511133|FG002|Overall Study|Lost to Follow-up|0|||
48910938|NCT02357134|157511134|FG003|Overall Study|Lost to Follow-up|0|||
48699473|NCT01668784|156748641|FG000|Treatment Period|Death|1|||
48699474|NCT01668784|156748642|FG001|Treatment Period|Death|1|||
48910939|NCT01301456|157511146|FG000|Stage 1|Withdrawal by Subject|0|||
48910940|NCT01301456|157511147|FG001|Stage 1|Withdrawal by Subject|0|||
48910941|NCT01301456|157511148|FG002|Stage 1|Withdrawal by Subject|1|||
48910942|NCT01301456|157511149|FG003|Stage 1|Withdrawal by Subject|0|||
48910943|NCT01301456|157511150|FG004|Stage 1|Withdrawal by Subject|1|||
48910944|NCT01301456|157511151|FG005|Stage 1|Withdrawal by Subject|0|||
48910945|NCT01301456|157511152|FG006|Stage 1|Withdrawal by Subject|0|||
48910946|NCT01301456|157511153|FG007|Stage 1|Withdrawal by Subject|0|||
48910947|NCT01301456|157511154|FG008|Stage 1|Withdrawal by Subject|0|||
48910948|NCT01301456|157511155|FG009|Stage 1|Withdrawal by Subject|0|||
48910949|NCT01301456|157511156|FG010|Stage 1|Withdrawal by Subject|0|||
48910950|NCT01301456|157511157|FG011|Stage 1|Withdrawal by Subject|0|||
48910951|NCT01301456|157511146|FG000|Stage 1|Randomized but not treated|0|||
48910952|NCT01301456|157511147|FG001|Stage 1|Randomized but not treated|0|||
48910953|NCT01301456|157511148|FG002|Stage 1|Randomized but not treated|0|||
48910954|NCT01301456|157511149|FG003|Stage 1|Randomized but not treated|0|||
48910955|NCT01301456|157511150|FG004|Stage 1|Randomized but not treated|0|||
48910956|NCT01301456|157511151|FG005|Stage 1|Randomized but not treated|0|||
48910957|NCT01301456|157511152|FG006|Stage 1|Randomized but not treated|1|||
48910958|NCT01301456|157511153|FG007|Stage 1|Randomized but not treated|0|||
48910959|NCT01301456|157511154|FG008|Stage 1|Randomized but not treated|0|||
48910960|NCT01301456|157511155|FG009|Stage 1|Randomized but not treated|0|||
48910961|NCT01301456|157511156|FG010|Stage 1|Randomized but not treated|0|||
48910962|NCT01301456|157511157|FG011|Stage 1|Randomized but not treated|0|||
48910963|NCT01301456|157511146|FG000|Stage 2|Adverse Event|0|||
48910964|NCT01301456|157511147|FG001|Stage 2|Adverse Event|0|||
48910965|NCT01301456|157511148|FG002|Stage 2|Adverse Event|0|||
48910966|NCT01301456|157511149|FG003|Stage 2|Adverse Event|0|||
48910967|NCT01301456|157511150|FG004|Stage 2|Adverse Event|0|||
48910968|NCT01301456|157511151|FG005|Stage 2|Adverse Event|0|||
48910969|NCT01301456|157511152|FG006|Stage 2|Adverse Event|0|||
48699475|NCT01668784|156748641|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
48699476|NCT01668784|156748642|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
48699477|NCT01668784|156748641|FG000|Treatment Period|Request to Discontinue Study Treatment|14|||
48699478|NCT01668784|156748642|FG001|Treatment Period|Request to Discontinue Study Treatment|21|||
48699479|NCT01668784|156748641|FG000|Treatment Period|Withdrawal by Subject|5|||
48699480|NCT01668784|156748642|FG001|Treatment Period|Withdrawal by Subject|3|||
48699481|NCT01668784|156748641|FG000|Treatment Period|Maximal Clinical Benefit|3|||
48699482|NCT01668784|156748642|FG001|Treatment Period|Maximal Clinical Benefit|3|||
48699483|NCT01668784|156748641|FG000|Treatment Period|Other|2|||
48699484|NCT01668784|156748642|FG001|Treatment Period|Other|8|||
48699485|NCT01668784|156748641|FG000|Treatment Period|Administrative Reason by Sponsor|5|||
48699486|NCT01668784|156748642|FG001|Treatment Period|Administrative Reason by Sponsor|1|||
48699487|NCT02761330|156748643|FG000|Treatment Week 1|Withdrawal by Subject|0|||
48699488|NCT02761330|156748644|FG001|Treatment Week 1|Withdrawal by Subject|0|||
48699489|NCT02761330|156748645|FG002|Treatment Week 1|Withdrawal by Subject|0|||
48699490|NCT02761330|156748646|FG003|Treatment Week 1|Withdrawal by Subject|1|||
48699491|NCT02761330|156748647|FG004|Treatment Week 1|Withdrawal by Subject|0|||
48699492|NCT02761330|156748648|FG005|Treatment Week 1|Withdrawal by Subject|1|||
48699493|NCT00392327|156748655|FG000|Overall Study|Death|1|||
48699494|NCT00392327|156748656|FG001|Overall Study|Death|0|||
48699495|NCT00392327|156748657|FG002|Overall Study|Death|1|||
48699496|NCT00392327|156748658|FG003|Overall Study|Death|0|||
48699497|NCT00392327|156748659|FG004|Overall Study|Death|0|||
48699498|NCT00392327|156748660|FG005|Overall Study|Death|0|||
48699499|NCT00392327|156748661|FG006|Overall Study|Death|0|||
48910970|NCT01301456|157511153|FG007|Stage 2|Adverse Event|0|||
48910971|NCT01301456|157511154|FG008|Stage 2|Adverse Event|0|||
48910972|NCT01301456|157511155|FG009|Stage 2|Adverse Event|0|||
48910973|NCT01301456|157511156|FG010|Stage 2|Adverse Event|1|||
48699500|NCT00392327|156748662|FG007|Overall Study|Death|0|||
48910974|NCT01301456|157511157|FG011|Stage 2|Adverse Event|0|||
48910975|NCT03583450|157511158|FG000|Overall Study|hardware malfunction (battery depletion)|1|||
48910976|NCT03583450|157511159|FG001|Overall Study|hardware malfunction (battery depletion)|0|||
48699501|NCT00392327|156748655|FG000|Overall Study|Lack of Efficacy|8|||
48699502|NCT00392327|156748656|FG001|Overall Study|Lack of Efficacy|8|||
48699503|NCT00392327|156748657|FG002|Overall Study|Lack of Efficacy|9|||
48699504|NCT00392327|156748658|FG003|Overall Study|Lack of Efficacy|6|||
48699505|NCT00392327|156748659|FG004|Overall Study|Lack of Efficacy|3|||
48699506|NCT00392327|156748660|FG005|Overall Study|Lack of Efficacy|3|||
48910977|NCT01211535|157511167|FG000|Overall Study|Adverse Event|0|||
48910978|NCT01211535|157511168|FG001|Overall Study|Adverse Event|1|||
48910979|NCT00718549|157511171|FG000|Induction Phase|Disease Progression|1|||
48910980|NCT00718549|157511172|FG001|Induction Phase|Disease Progression|0|||
48910981|NCT00718549|157511173|FG002|Induction Phase|Disease Progression|0|||
48910982|NCT00718549|157511171|FG000|Induction Phase|Eligibility Criteria Violation|2|||
48910983|NCT00718549|157511172|FG001|Induction Phase|Eligibility Criteria Violation|0|||
48910984|NCT00718549|157511173|FG002|Induction Phase|Eligibility Criteria Violation|0|||
48910985|NCT00718549|157511171|FG000|Induction Phase|Early Termination - No Additional Info|59|||
48910986|NCT00718549|157511172|FG001|Induction Phase|Early Termination - No Additional Info|0|||
48910987|NCT00718549|157511173|FG002|Induction Phase|Early Termination - No Additional Info|0|||
48910988|NCT00718549|157511171|FG000|Maintenance/ Observation Phase|Early Termination - No Additional Info|0|||
48910989|NCT00718549|157511172|FG001|Maintenance/ Observation Phase|Early Termination - No Additional Info|15|||
48910990|NCT00718549|157511173|FG002|Maintenance/ Observation Phase|Early Termination - No Additional Info|8|||
48910991|NCT00718549|157511171|FG000|Maintenance/ Observation Phase|Death|0|||
48910992|NCT00718549|157511172|FG001|Maintenance/ Observation Phase|Death|1|||
48910993|NCT00718549|157511173|FG002|Maintenance/ Observation Phase|Death|2|||
48910994|NCT00718549|157511171|FG000|Maintenance/ Observation Phase|Lost to Follow-up|0|||
48910995|NCT00718549|157511172|FG001|Maintenance/ Observation Phase|Lost to Follow-up|4|||
48910996|NCT00718549|157511173|FG002|Maintenance/ Observation Phase|Lost to Follow-up|4|||
48910997|NCT00718549|157511171|FG000|Maintenance/ Observation Phase|Progression|0|||
48910998|NCT00718549|157511172|FG001|Maintenance/ Observation Phase|Progression|5|||
48910999|NCT00718549|157511173|FG002|Maintenance/ Observation Phase|Progression|14|||
48911000|NCT00718549|157511171|FG000|Maintenance/ Observation Phase|Relapse|0|||
48911001|NCT00718549|157511172|FG001|Maintenance/ Observation Phase|Relapse|3|||
48911002|NCT00718549|157511173|FG002|Maintenance/ Observation Phase|Relapse|2|||
48911003|NCT01353508|157511174|FG000|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
48911004|NCT01353508|157511175|FG001|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
48911005|NCT01353508|157511176|FG002|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
48911006|NCT01353508|157511177|FG003|Period 1 - First Intervention (7 Days)|Adverse Event|1|||
48699507|NCT00392327|156748661|FG006|Overall Study|Lack of Efficacy|3|||
48699508|NCT00392327|156748662|FG007|Overall Study|Lack of Efficacy|3|||
48699509|NCT00392327|156748655|FG000|Overall Study|Physician Decision|3|||
48699510|NCT00392327|156748656|FG001|Overall Study|Physician Decision|5|||
48699511|NCT00392327|156748657|FG002|Overall Study|Physician Decision|2|||
48699512|NCT00392327|156748658|FG003|Overall Study|Physician Decision|2|||
48699513|NCT00392327|156748659|FG004|Overall Study|Physician Decision|0|||
48699514|NCT00392327|156748660|FG005|Overall Study|Physician Decision|1|||
48699515|NCT00392327|156748661|FG006|Overall Study|Physician Decision|5|||
48699516|NCT00392327|156748662|FG007|Overall Study|Physician Decision|3|||
48699517|NCT00392327|156748655|FG000|Overall Study|Protocol Violation|0|||
48699518|NCT00392327|156748656|FG001|Overall Study|Protocol Violation|0|||
48911007|NCT01353508|157511174|FG000|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1|||
48699519|NCT00392327|156748657|FG002|Overall Study|Protocol Violation|1|||
48699520|NCT00392327|156748658|FG003|Overall Study|Protocol Violation|0|||
48699521|NCT00392327|156748659|FG004|Overall Study|Protocol Violation|0|||
48699522|NCT00392327|156748660|FG005|Overall Study|Protocol Violation|0|||
48911008|NCT01353508|157511175|FG001|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
48911009|NCT01353508|157511176|FG002|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
48911010|NCT01353508|157511177|FG003|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
48911011|NCT02459769|157511184|FG000|Overall Study|Withdrawal by Subject|7|||
48911012|NCT02459769|157511185|FG001|Overall Study|Withdrawal by Subject|4|||
48911013|NCT02459769|157511186|FG002|Overall Study|Withdrawal by Subject|8|||
48911014|NCT02459769|157511187|FG003|Overall Study|Withdrawal by Subject|5|||
48911015|NCT02459769|157511184|FG000|Overall Study|Lost to Follow-up|1|||
48911016|NCT02459769|157511185|FG001|Overall Study|Lost to Follow-up|0|||
48911017|NCT02459769|157511186|FG002|Overall Study|Lost to Follow-up|1|||
48911018|NCT02459769|157511187|FG003|Overall Study|Lost to Follow-up|0|||
48911019|NCT01010633|157511194|FG000|Overall Study|Adverse Event|1|||
48911020|NCT01010633|157511195|FG001|Overall Study|Adverse Event|1|||
48911021|NCT01010633|157511194|FG000|Overall Study|Protocol Violation|1|||
48911022|NCT01010633|157511195|FG001|Overall Study|Protocol Violation|2|||
48911023|NCT01010633|157511194|FG000|Overall Study|Withdrawal by Subject|2|||
48911024|NCT01010633|157511195|FG001|Overall Study|Withdrawal by Subject|1|||
48911025|NCT01010633|157511194|FG000|Overall Study|Investigator decision|0|||
48911026|NCT01010633|157511195|FG001|Overall Study|Investigator decision|1|||
48911027|NCT02790138|157511198|FG000|Overall Study|Adverse Event|5|||
48911028|NCT02790138|157511199|FG001|Overall Study|Adverse Event|2|||
48911029|NCT02790138|157511198|FG000|Overall Study|Significant Protocol Deviation|0|||
48911030|NCT02790138|157511199|FG001|Overall Study|Significant Protocol Deviation|1|||
48699523|NCT00392327|156748661|FG006|Overall Study|Protocol Violation|0|||
48911031|NCT02790138|157511198|FG000|Overall Study|Lost to Follow-up|1|||
48911032|NCT02790138|157511199|FG001|Overall Study|Lost to Follow-up|0|||
48699524|NCT00392327|156748662|FG007|Overall Study|Protocol Violation|0|||
48699525|NCT00392327|156748655|FG000|Overall Study|Withdrawal by Subject|3|||
48699526|NCT00392327|156748656|FG001|Overall Study|Withdrawal by Subject|2|||
48911033|NCT02790138|157511198|FG000|Overall Study|Voluntary Withdrawal|8|||
48911034|NCT02790138|157511199|FG001|Overall Study|Voluntary Withdrawal|9|||
48911035|NCT02790138|157511198|FG000|Overall Study|Lack of Efficacy|6|||
48911036|NCT02790138|157511199|FG001|Overall Study|Lack of Efficacy|7|||
48911037|NCT02790138|157511198|FG000|Overall Study|Reason not Specified|1|||
48911038|NCT02790138|157511199|FG001|Overall Study|Reason not Specified|0|||
48911039|NCT03654976|157511200|FG000|Overall Study|Withdrawal by Subject|12|||
48911040|NCT03654976|157511201|FG001|Overall Study|Withdrawal by Subject|11|||
48911041|NCT03654976|157511200|FG000|Overall Study|Reason stated as 'Other' in CRF|10|||
48911042|NCT03654976|157511201|FG001|Overall Study|Reason stated as 'Other' in CRF|6|||
48911043|NCT03654976|157511200|FG000|Overall Study|Adverse Event|5|||
48911044|NCT03654976|157511201|FG001|Overall Study|Adverse Event|0|||
48911045|NCT03654976|157511200|FG000|Overall Study|Lost to Follow-up|2|||
48911046|NCT03654976|157511201|FG001|Overall Study|Lost to Follow-up|0|||
48911047|NCT03654976|157511200|FG000|Overall Study|Lack of Efficacy|0|||
48911048|NCT03654976|157511201|FG001|Overall Study|Lack of Efficacy|1|||
48911049|NCT02632721|157511202|FG000|Overall Study|Adverse Event|0|||
48911050|NCT02632721|157511203|FG001|Overall Study|Adverse Event|0|||
48911051|NCT02632721|157511204|FG002|Overall Study|Adverse Event|2|||
48911052|NCT02632721|157511205|FG003|Overall Study|Adverse Event|5|||
48911053|NCT02632721|157511206|FG004|Overall Study|Adverse Event|3|||
48911054|NCT02632721|157511202|FG000|Overall Study|Dose limiting toxicity|0|||
48911055|NCT02632721|157511203|FG001|Overall Study|Dose limiting toxicity|0|||
48911056|NCT02632721|157511204|FG002|Overall Study|Dose limiting toxicity|0|||
48911057|NCT02632721|157511205|FG003|Overall Study|Dose limiting toxicity|1|||
48911058|NCT02632721|157511206|FG004|Overall Study|Dose limiting toxicity|0|||
48911059|NCT02632721|157511202|FG000|Overall Study|Progressive disease|3|||
48911060|NCT02632721|157511203|FG001|Overall Study|Progressive disease|0|||
48911061|NCT02632721|157511204|FG002|Overall Study|Progressive disease|4|||
48911062|NCT02632721|157511205|FG003|Overall Study|Progressive disease|6|||
48911063|NCT02632721|157511206|FG004|Overall Study|Progressive disease|5|||
48911064|NCT02632721|157511202|FG000|Overall Study|Refused to continue taking trial medication|0|||
48911065|NCT02632721|157511203|FG001|Overall Study|Refused to continue taking trial medication|1|||
48911066|NCT02632721|157511204|FG002|Overall Study|Refused to continue taking trial medication|1|||
48911067|NCT02632721|157511205|FG003|Overall Study|Refused to continue taking trial medication|1|||
48911068|NCT02632721|157511206|FG004|Overall Study|Refused to continue taking trial medication|2|||
48911069|NCT02632721|157511202|FG000|Overall Study|Inadequate clinical condition|0|||
48911070|NCT02632721|157511203|FG001|Overall Study|Inadequate clinical condition|0|||
48911071|NCT02632721|157511204|FG002|Overall Study|Inadequate clinical condition|0|||
48911072|NCT02632721|157511205|FG003|Overall Study|Inadequate clinical condition|0|||
48911073|NCT02632721|157511206|FG004|Overall Study|Inadequate clinical condition|1|||
48911074|NCT02632721|157511202|FG000|Overall Study|No meet eligibility|0|||
48911075|NCT02632721|157511203|FG001|Overall Study|No meet eligibility|0|||
48911076|NCT02632721|157511204|FG002|Overall Study|No meet eligibility|0|||
48911077|NCT02632721|157511205|FG003|Overall Study|No meet eligibility|0|||
48911078|NCT02632721|157511206|FG004|Overall Study|No meet eligibility|1|||
48911079|NCT02632721|157511202|FG000|Overall Study|Allergic reaction|0|||
48911080|NCT02632721|157511203|FG001|Overall Study|Allergic reaction|0|||
48911081|NCT02632721|157511204|FG002|Overall Study|Allergic reaction|0|||
48911082|NCT02632721|157511205|FG003|Overall Study|Allergic reaction|1|||
48911083|NCT02632721|157511206|FG004|Overall Study|Allergic reaction|0|||
48911084|NCT02632721|157511202|FG000|Overall Study|Receiving Decitabine locally|0|||
48911085|NCT02632721|157511203|FG001|Overall Study|Receiving Decitabine locally|0|||
48911086|NCT02632721|157511204|FG002|Overall Study|Receiving Decitabine locally|1|||
48911087|NCT02632721|157511205|FG003|Overall Study|Receiving Decitabine locally|0|||
48911088|NCT02632721|157511206|FG004|Overall Study|Receiving Decitabine locally|0|||
48911089|NCT02632721|157511202|FG000|Overall Study|No benefit from study treatment|1|||
48911090|NCT02632721|157511203|FG001|Overall Study|No benefit from study treatment|1|||
48911091|NCT02632721|157511204|FG002|Overall Study|No benefit from study treatment|0|||
48911092|NCT02632721|157511205|FG003|Overall Study|No benefit from study treatment|0|||
48911093|NCT02632721|157511206|FG004|Overall Study|No benefit from study treatment|1|||
48911094|NCT02632721|157511202|FG000|Overall Study|Patient wish for other treatment|0|||
48911095|NCT02632721|157511203|FG001|Overall Study|Patient wish for other treatment|1|||
48911096|NCT02632721|157511204|FG002|Overall Study|Patient wish for other treatment|0|||
48911097|NCT02632721|157511205|FG003|Overall Study|Patient wish for other treatment|0|||
48911098|NCT02632721|157511206|FG004|Overall Study|Patient wish for other treatment|0|||
48911099|NCT02632721|157511202|FG000|Overall Study|Relapsed Pneumonia|0|||
48911100|NCT02632721|157511203|FG001|Overall Study|Relapsed Pneumonia|0|||
48911101|NCT02632721|157511204|FG002|Overall Study|Relapsed Pneumonia|0|||
48911102|NCT02632721|157511205|FG003|Overall Study|Relapsed Pneumonia|0|||
48911103|NCT02632721|157511206|FG004|Overall Study|Relapsed Pneumonia|1|||
48911104|NCT02632721|157511202|FG000|Overall Study|Therapy refractory AML|0|||
48911105|NCT02632721|157511203|FG001|Overall Study|Therapy refractory AML|0|||
48911106|NCT02632721|157511204|FG002|Overall Study|Therapy refractory AML|0|||
48911107|NCT02632721|157511205|FG003|Overall Study|Therapy refractory AML|0|||
48911108|NCT02632721|157511206|FG004|Overall Study|Therapy refractory AML|1|||
48911109|NCT02632721|157511202|FG000|Overall Study|Increase of white blood cell count|0|||
48911110|NCT02632721|157511203|FG001|Overall Study|Increase of white blood cell count|0|||
48911111|NCT02632721|157511204|FG002|Overall Study|Increase of white blood cell count|0|||
48911112|NCT02632721|157511205|FG003|Overall Study|Increase of white blood cell count|0|||
48911113|NCT02632721|157511206|FG004|Overall Study|Increase of white blood cell count|1|||
48911114|NCT02632721|157511202|FG000|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
48911115|NCT02632721|157511203|FG001|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
48911116|NCT02632721|157511204|FG002|Overall Study|Allogeneic peripheral blood stem cell transplantation|1|||
48911117|NCT02632721|157511205|FG003|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
48911118|NCT02632721|157511206|FG004|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
48911119|NCT01572675|157511207|FG000|Overall Study|End of prescribed treatment|140|||
48911120|NCT01572675|157511208|FG001|Overall Study|End of prescribed treatment|118|||
48911121|NCT01572675|157511207|FG000|Overall Study|Recovery|16|||
48911122|NCT01572675|157511208|FG001|Overall Study|Recovery|23|||
48911123|NCT01572675|157511207|FG000|Overall Study|Lack of Efficacy|31|||
48911124|NCT01572675|157511208|FG001|Overall Study|Lack of Efficacy|31|||
48911125|NCT01572675|157511207|FG000|Overall Study|Intolerance|6|||
48911126|NCT01572675|157511208|FG001|Overall Study|Intolerance|5|||
48911127|NCT01572675|157511207|FG000|Overall Study|Improved symptoms|8|||
48911128|NCT01572675|157511208|FG001|Overall Study|Improved symptoms|2|||
48911129|NCT01572675|157511207|FG000|Overall Study|Surgical intervention|3|||
48911130|NCT01572675|157511208|FG001|Overall Study|Surgical intervention|6|||
48911131|NCT01572675|157511207|FG000|Overall Study|Withdrawal by Subject|5|||
48911132|NCT01572675|157511208|FG001|Overall Study|Withdrawal by Subject|1|||
48911133|NCT01572675|157511207|FG000|Overall Study|Physician Decision|2|||
48911134|NCT01572675|157511208|FG001|Overall Study|Physician Decision|2|||
48911135|NCT01572675|157511207|FG000|Overall Study|Death unrelated to coxibs|1|||
48911136|NCT01572675|157511208|FG001|Overall Study|Death unrelated to coxibs|1|||
48911137|NCT01572675|157511207|FG000|Overall Study|Other disease detected|1|||
48911138|NCT01572675|157511208|FG001|Overall Study|Other disease detected|1|||
48911139|NCT01572675|157511207|FG000|Overall Study|Unknown reason|1|||
48911140|NCT01572675|157511208|FG001|Overall Study|Unknown reason|1|||
48911141|NCT01572675|157511207|FG000|Overall Study|Rheumatologist new evaluation|0|||
48911142|NCT01572675|157511208|FG001|Overall Study|Rheumatologist new evaluation|1|||
48911143|NCT01572675|157511207|FG000|Overall Study|Missing data|1|||
48911144|NCT01572675|157511208|FG001|Overall Study|Missing data|4|||
48911145|NCT01572675|157511207|FG000|Overall Study|Lost to Follow-up|22|||
48911146|NCT01572675|157511208|FG001|Overall Study|Lost to Follow-up|27|||
48911147|NCT00430482|157511209|FG000|Completed Treatment|Insufficient Treatment|7|||
48911148|NCT00430482|157511210|FG001|Completed Treatment|Insufficient Treatment|11|||
48911149|NCT00545402|157511211|FG000|Overall Study|Discontinuation of treatment|17|||
48699527|NCT00392327|156748657|FG002|Overall Study|Withdrawal by Subject|4|||
48699528|NCT00392327|156748658|FG003|Overall Study|Withdrawal by Subject|6|||
48699529|NCT00392327|156748659|FG004|Overall Study|Withdrawal by Subject|0|||
48699530|NCT00392327|156748660|FG005|Overall Study|Withdrawal by Subject|1|||
48699531|NCT00392327|156748661|FG006|Overall Study|Withdrawal by Subject|1|||
48699532|NCT00392327|156748662|FG007|Overall Study|Withdrawal by Subject|5|||
48699533|NCT00392327|156748655|FG000|Overall Study|Ineligible|0|||
48699534|NCT00392327|156748656|FG001|Overall Study|Ineligible|4|||
48699535|NCT00392327|156748657|FG002|Overall Study|Ineligible|3|||
48699536|NCT00392327|156748658|FG003|Overall Study|Ineligible|2|||
48699537|NCT00392327|156748659|FG004|Overall Study|Ineligible|0|||
48699538|NCT00392327|156748660|FG005|Overall Study|Ineligible|0|||
48699539|NCT00392327|156748661|FG006|Overall Study|Ineligible|0|||
48699540|NCT00392327|156748662|FG007|Overall Study|Ineligible|0|||
48699541|NCT05615922|156748663|FG000|Overall Study|Lost to Follow-up|1|||
48699542|NCT01607957|156748664|FG000|Overall Study|Not treated|1|||
48699543|NCT01607957|156748665|FG001|Overall Study|Not treated|1|||
48699544|NCT01607957|156748664|FG000|Overall Study|Death|367|||
48699545|NCT01607957|156748665|FG001|Overall Study|Death|211|||
48699546|NCT01607957|156748664|FG000|Overall Study|Lost to Follow-up|3|||
48699547|NCT01607957|156748665|FG001|Overall Study|Lost to Follow-up|3|||
48911150|NCT00545402|157511212|FG001|Overall Study|Discontinuation of treatment|9|||
49116368|NCT03538691|158263093|FG001|Phase B: Stabilization (12 Weeks)|Physician Decision|6|||
48699548|NCT01607957|156748664|FG000|Overall Study|Participant refusal|1|||
48699549|NCT01607957|156748665|FG001|Overall Study|Participant refusal|0|||
48699550|NCT00400179|156748666|FG000|Overall Study|Adverse Event|2|||
48699551|NCT00400179|156748667|FG001|Overall Study|Adverse Event|2|||
48699552|NCT00400179|156748666|FG000|Overall Study|Death|1|||
48699553|NCT00400179|156748667|FG001|Overall Study|Death|2|||
48911151|NCT00545402|157511211|FG000|Overall Study|Use of unauthorized immunosuppressant|8|||
48911152|NCT00545402|157511212|FG001|Overall Study|Use of unauthorized immunosuppressant|7|||
48911153|NCT00545402|157511211|FG000|Overall Study|Death|5|||
48911154|NCT00545402|157511212|FG001|Overall Study|Death|7|||
48699554|NCT00400179|156748666|FG000|Overall Study|Withdrew Consent|1|||
48699555|NCT00400179|156748667|FG001|Overall Study|Withdrew Consent|5|||
48911155|NCT00545402|157511211|FG000|Overall Study|Graft loss|2|||
48699556|NCT00400179|156748666|FG000|Overall Study|Disease progression|1|||
48699557|NCT00400179|156748667|FG001|Overall Study|Disease progression|1|||
48699558|NCT00400179|156748666|FG000|Overall Study|Intercurrent illness|0|||
48699559|NCT00400179|156748667|FG001|Overall Study|Intercurrent illness|1|||
48699560|NCT00400179|156748666|FG000|Overall Study|Investigator judgment|0|||
48699561|NCT00400179|156748667|FG001|Overall Study|Investigator judgment|1|||
48699562|NCT00400179|156748666|FG000|Overall Study|Randomization error/patient ineligible|1|||
48699563|NCT00400179|156748667|FG001|Overall Study|Randomization error/patient ineligible|6|||
48699564|NCT02420717|156748668|FG000|Overall Study|Did not receive all study medication|2|||
48699565|NCT02420717|156748669|FG001|Overall Study|Did not receive all study medication|0|||
48699566|NCT02420717|156748670|FG002|Overall Study|Did not receive all study medication|0|||
48699567|NCT02484391|156748671|FG000|Overall Study|Lack of Efficacy|15|||
48699568|NCT02484391|156748672|FG001|Overall Study|Lack of Efficacy|14|||
48699569|NCT02484391|156748673|FG002|Overall Study|Lack of Efficacy|3|||
48699570|NCT02484391|156748671|FG000|Overall Study|Lost to Follow-up|0|||
48699571|NCT02484391|156748672|FG001|Overall Study|Lost to Follow-up|0|||
48699572|NCT02484391|156748673|FG002|Overall Study|Lost to Follow-up|2|||
48699573|NCT02484391|156748671|FG000|Overall Study|Physician Decision|1|||
48699574|NCT02484391|156748672|FG001|Overall Study|Physician Decision|3|||
48699575|NCT02484391|156748673|FG002|Overall Study|Physician Decision|0|||
48699576|NCT02484391|156748671|FG000|Overall Study|Went to Transplant|5|||
48699577|NCT02484391|156748672|FG001|Overall Study|Went to Transplant|3|||
48699578|NCT02484391|156748673|FG002|Overall Study|Went to Transplant|2|||
48699579|NCT00089297|156750464|FG000|Overall Study|Adverse Event|9|||
48699580|NCT00089297|156750464|FG000|Overall Study|Death|1|||
48699581|NCT00089297|156750464|FG000|Overall Study|Withdrawal by Subject|12|||
48699582|NCT00089297|156750464|FG000|Overall Study|Disease progression|2|||
48699583|NCT00089297|156750464|FG000|Overall Study|Ineligible|11|||
48699584|NCT00089297|156750464|FG000|Overall Study|Secondary malignancy|1|||
48699585|NCT00089297|156750464|FG000|Overall Study|IRB approval not ready|1|||
48699586|NCT00089297|156750464|FG000|Overall Study|Non-compliance|1|||
48699587|NCT03264404|156750465|FG000|Overall Study|Death|2|||
48699588|NCT03264404|156750465|FG000|Overall Study|Physician Decision|1|||
48699589|NCT03264404|156750465|FG000|Overall Study|Disease Progression|28|||
48699590|NCT03264404|156750465|FG000|Overall Study|Adverse Event|1|||
48699591|NCT03264404|156750465|FG000|Overall Study|Off study prior to treatment|2|||
48699592|NCT00904969|156750466|FG000|Overall Study|Lost to Follow-up|4|||
48699593|NCT00904969|156750466|FG000|Overall Study|Withdrawal by Subject|3|||
48699594|NCT00904969|156750466|FG000|Overall Study|Additional Treatments|11|||
48699595|NCT00904969|156750466|FG000|Overall Study|Case Aborted; Subject Exited|1|||
48699596|NCT00199381|156750467|FG000|Overall Study|Withdrawal by Subject|38|||
48699597|NCT00199381|156750467|FG000|Overall Study|Adverse Event|73|||
48699598|NCT00199381|156750467|FG000|Overall Study|Protocol Violation|6|||
48699599|NCT00199381|156750467|FG000|Overall Study|Lack of Efficacy|27|||
48699600|NCT00199381|156750467|FG000|Overall Study|Not including due to early termination|37|||
48699601|NCT00199381|156750467|FG000|Overall Study|Study termination by Sponsor|323|||
48699602|NCT00385671|156750471|FG000|Overall Study|Adverse Event|14|||
48699603|NCT00385671|156750472|FG001|Overall Study|Adverse Event|27|||
48699604|NCT00385671|156750473|FG002|Overall Study|Adverse Event|18|||
48699605|NCT00385671|156750471|FG000|Overall Study|Lack of Efficacy|5|||
48699606|NCT00385671|156750472|FG001|Overall Study|Lack of Efficacy|9|||
48699607|NCT00385671|156750473|FG002|Overall Study|Lack of Efficacy|5|||
48699608|NCT00385671|156750471|FG000|Overall Study|Lost to Follow-up|6|||
48699609|NCT00385671|156750472|FG001|Overall Study|Lost to Follow-up|6|||
48699610|NCT00385671|156750473|FG002|Overall Study|Lost to Follow-up|5|||
48699611|NCT00385671|156750471|FG000|Overall Study|Physician Decision|2|||
48699612|NCT00385671|156750472|FG001|Overall Study|Physician Decision|1|||
48699613|NCT00385671|156750473|FG002|Overall Study|Physician Decision|2|||
48699614|NCT00385671|156750471|FG000|Overall Study|Protocol Violation|5|||
48699615|NCT00385671|156750472|FG001|Overall Study|Protocol Violation|2|||
48699616|NCT00385671|156750473|FG002|Overall Study|Protocol Violation|1|||
48699617|NCT00385671|156750471|FG000|Overall Study|Sponsor Decision|2|||
48699618|NCT00385671|156750472|FG001|Overall Study|Sponsor Decision|2|||
48699619|NCT00385671|156750473|FG002|Overall Study|Sponsor Decision|1|||
48911156|NCT00545402|157511212|FG001|Overall Study|Graft loss|4|||
48699620|NCT00385671|156750471|FG000|Overall Study|Withdrawal by Subject|4|||
48699621|NCT00385671|156750472|FG001|Overall Study|Withdrawal by Subject|4|||
48699622|NCT00385671|156750473|FG002|Overall Study|Withdrawal by Subject|4|||
48699623|NCT01586364|156750474|FG000|Overall Study|Withdrawal by Subject|40|||
48699624|NCT01586364|156750474|FG000|Overall Study|Adverse Event|37|||
48699625|NCT01586364|156750474|FG000|Overall Study|Lost to Follow-up|17|||
49010530|NCT00328783|157875643|FG000|Overall Study|No heart in RT field|4|||
48699626|NCT01586364|156750474|FG000|Overall Study|Protocol Violation|16|||
48699627|NCT01586364|156750474|FG000|Overall Study|Lack of Efficacy|1|||
48699628|NCT01586364|156750474|FG000|Overall Study|Other-Did not feel better post-treatment|1|||
48699629|NCT01586364|156750474|FG000|Overall Study|Other-Subject wasn't getting much relief|1|||
48699630|NCT01586364|156750474|FG000|Overall Study|Other-Site closure due to PI illness|1|||
48699631|NCT01586364|156750474|FG000|Overall Study|Other-PI discretion, site closing|2|||
48699632|NCT01586364|156750474|FG000|Overall Study|Other-Not specified|1|||
48699633|NCT00812708|156750475|FG000|Overall Study|Device could not be implanted|2|||
48699634|NCT00812708|156750475|FG000|Overall Study|Lack of medical insurance|1|||
48699635|NCT00812708|156750475|FG000|Overall Study|Switched to another study|1|||
48699636|NCT00812708|156750475|FG000|Overall Study|Surgery cancelled due to uveitis|1|||
48699637|NCT00812708|156750475|FG000|Overall Study|Signed consent but later withdrew|3|||
48699638|NCT00303069|156750476|FG000|Overall Study|Lost to Follow-up|1|||
48699639|NCT00303069|156750477|FG001|Overall Study|Lost to Follow-up|0|||
48699640|NCT00303069|156750478|FG002|Overall Study|Lost to Follow-up|0|||
48699641|NCT00303069|156750479|FG003|Overall Study|Lost to Follow-up|2|||
48699642|NCT00303069|156750476|FG000|Overall Study|subject moved|1|||
48699643|NCT00303069|156750477|FG001|Overall Study|subject moved|0|||
48699644|NCT00303069|156750478|FG002|Overall Study|subject moved|0|||
48699645|NCT00303069|156750479|FG003|Overall Study|subject moved|0|||
48699646|NCT00303069|156750476|FG000|Overall Study|Recruitment into Army Reserves|0|||
48699647|NCT00303069|156750477|FG001|Overall Study|Recruitment into Army Reserves|0|||
48699648|NCT00303069|156750478|FG002|Overall Study|Recruitment into Army Reserves|1|||
48699649|NCT00303069|156750479|FG003|Overall Study|Recruitment into Army Reserves|0|||
48699650|NCT00092417|156750480|FG000|Overall Study|Lost to Follow-up|2|||
48699651|NCT00092417|156750481|FG001|Overall Study|Lost to Follow-up|0|||
48699652|NCT00092417|156750480|FG000|Overall Study|Withdrawal by Subject|2|||
48699653|NCT00092417|156750481|FG001|Overall Study|Withdrawal by Subject|1|||
48699654|NCT00092417|156750480|FG000|Overall Study|Other|1|||
48699655|NCT00092417|156750481|FG001|Overall Study|Other|0|||
48699656|NCT00425269|156750482|FG000|Overall Study|Pregnancy|5|||
48699657|NCT00425269|156750483|FG001|Overall Study|Pregnancy|7|||
48699658|NCT00425269|156750482|FG000|Overall Study|Lost to Follow-up|9|||
48699659|NCT00425269|156750483|FG001|Overall Study|Lost to Follow-up|9|||
48699660|NCT00425269|156750482|FG000|Overall Study|moved or medical reason|5|||
48699661|NCT00425269|156750483|FG001|Overall Study|moved or medical reason|4|||
48699662|NCT01959503|156750484|FG000|Overall Study|Death|2|||
48699663|NCT01959503|156750485|FG001|Overall Study|Death|1|||
48699664|NCT01959503|156750484|FG000|Overall Study|Randomized but not treated|1|||
48699665|NCT01959503|156750485|FG001|Overall Study|Randomized but not treated|1|||
48699666|NCT01600326|156750486|FG000|Overall Study|Lost to Follow-up|1|||
48699667|NCT01600326|156750487|FG001|Overall Study|Lost to Follow-up|1|||
48699668|NCT00751296|156750488|FG000|Overall Study|Adverse Event|2|||
48699669|NCT00394095|156750489|FG000|Overall Study|Adverse Event|1|||
48699670|NCT00394095|156750490|FG001|Overall Study|Adverse Event|0|||
48699671|NCT00474487|156750496|FG000|Overall Study|Withdrawal by Subject|6|||
48699672|NCT00474487|156750497|FG001|Overall Study|Withdrawal by Subject|0|||
48699673|NCT00474487|156750498|FG002|Overall Study|Withdrawal by Subject|0|||
48699674|NCT00474487|156750499|FG003|Overall Study|Withdrawal by Subject|0|||
48699675|NCT00474487|156750496|FG000|Overall Study|Lost to Follow-up|20|||
48699676|NCT00474487|156750497|FG001|Overall Study|Lost to Follow-up|1|||
48699677|NCT00474487|156750498|FG002|Overall Study|Lost to Follow-up|7|||
48699678|NCT00474487|156750499|FG003|Overall Study|Lost to Follow-up|0|||
48699679|NCT00474487|156750496|FG000|Overall Study|Inappropriate enrollment|4|||
48699680|NCT00474487|156750497|FG001|Overall Study|Inappropriate enrollment|0|||
48911157|NCT00545402|157511211|FG000|Overall Study|Withdrawal by Subject|0|||
48699681|NCT00474487|156750498|FG002|Overall Study|Inappropriate enrollment|7|||
48699682|NCT00474487|156750499|FG003|Overall Study|Inappropriate enrollment|0|||
48699683|NCT00474487|156750496|FG000|Overall Study|Death|0|||
48699684|NCT00474487|156750497|FG001|Overall Study|Death|1|||
48699685|NCT00474487|156750498|FG002|Overall Study|Death|0|||
48699686|NCT00474487|156750499|FG003|Overall Study|Death|0|||
48699687|NCT03085095|156750500|FG000|Overall Study|Adverse Event|23|||
48699688|NCT03085095|156750501|FG001|Overall Study|Adverse Event|8|||
48699689|NCT03085095|156750500|FG000|Overall Study|Protocol Violation|0|||
48699690|NCT03085095|156750501|FG001|Overall Study|Protocol Violation|1|||
48699691|NCT03085095|156750500|FG000|Overall Study|Lost to Follow-up|2|||
48699692|NCT03085095|156750501|FG001|Overall Study|Lost to Follow-up|1|||
48699693|NCT03085095|156750500|FG000|Overall Study|Withdrawal by Subject|17|||
48699694|NCT03085095|156750501|FG001|Overall Study|Withdrawal by Subject|6|||
48699695|NCT03085095|156750500|FG000|Overall Study|Physician Decision|9|||
48699696|NCT03085095|156750501|FG001|Overall Study|Physician Decision|3|||
48699697|NCT03085095|156750500|FG000|Overall Study|Testosterone Suppression Level Not Met|7|||
48699698|NCT03085095|156750501|FG001|Overall Study|Testosterone Suppression Level Not Met|13|||
48699699|NCT03085095|156750500|FG000|Overall Study|Did not Receive Study Drug|2|||
48699700|NCT03085095|156750501|FG001|Overall Study|Did not Receive Study Drug|2|||
48699701|NCT03085095|156750500|FG000|Overall Study|Dosing Interruption (Logistical Reason)|1|||
48699702|NCT03085095|156750501|FG001|Overall Study|Dosing Interruption (Logistical Reason)|0|||
48699703|NCT01317472|156750502|FG000|Overall Study|Withdrawal by Subject|1|||
48699704|NCT01317472|156750503|FG001|Overall Study|Withdrawal by Subject|0|||
48911158|NCT00545402|157511212|FG001|Overall Study|Withdrawal by Subject|1|||
48911159|NCT00545402|157511211|FG000|Overall Study|Protocol Violation|1|||
48911160|NCT00545402|157511212|FG001|Overall Study|Protocol Violation|0|||
48911161|NCT00545402|157511211|FG000|Overall Study|Reason not specified|1|||
48911162|NCT00545402|157511212|FG001|Overall Study|Reason not specified|1|||
48911163|NCT03519867|157511213|FG000|Overall Study|Adverse Event|1|||
48911164|NCT03519867|157511214|FG001|Overall Study|Adverse Event|1|||
48911165|NCT03519867|157511215|FG002|Overall Study|Adverse Event|0|||
48911166|NCT03519867|157511216|FG003|Overall Study|Adverse Event|0|||
48911167|NCT03519867|157511217|FG004|Overall Study|Adverse Event|0|||
48911168|NCT03519867|157511218|FG005|Overall Study|Adverse Event|0|||
48911169|NCT03519867|157511219|FG006|Overall Study|Adverse Event|0|||
48911170|NCT03519867|157511220|FG007|Overall Study|Adverse Event|0|||
48911171|NCT03519867|157511221|FG008|Overall Study|Adverse Event|0|||
48911172|NCT03519867|157511222|FG009|Overall Study|Adverse Event|0|||
48911173|NCT03519867|157511213|FG000|Overall Study|Protocol Violation|0|||
48911174|NCT03519867|157511214|FG001|Overall Study|Protocol Violation|0|||
48911175|NCT03519867|157511215|FG002|Overall Study|Protocol Violation|0|||
48911176|NCT03519867|157511216|FG003|Overall Study|Protocol Violation|0|||
48911177|NCT03519867|157511217|FG004|Overall Study|Protocol Violation|0|||
48911178|NCT03519867|157511218|FG005|Overall Study|Protocol Violation|1|||
48911179|NCT03519867|157511219|FG006|Overall Study|Protocol Violation|0|||
48911180|NCT03519867|157511220|FG007|Overall Study|Protocol Violation|0|||
48911181|NCT03519867|157511221|FG008|Overall Study|Protocol Violation|0|||
48911182|NCT03519867|157511222|FG009|Overall Study|Protocol Violation|0|||
48911183|NCT03519867|157511213|FG000|Overall Study|Admin. of relaxant other than Zemuron®|0|||
48911184|NCT03519867|157511214|FG001|Overall Study|Admin. of relaxant other than Zemuron®|0|||
48911185|NCT03519867|157511215|FG002|Overall Study|Admin. of relaxant other than Zemuron®|0|||
48911186|NCT03519867|157511216|FG003|Overall Study|Admin. of relaxant other than Zemuron®|0|||
48911187|NCT03519867|157511217|FG004|Overall Study|Admin. of relaxant other than Zemuron®|0|||
48911188|NCT03519867|157511218|FG005|Overall Study|Admin. of relaxant other than Zemuron®|0|||
48911189|NCT03519867|157511219|FG006|Overall Study|Admin. of relaxant other than Zemuron®|1|||
48911190|NCT03519867|157511220|FG007|Overall Study|Admin. of relaxant other than Zemuron®|0|||
48911191|NCT03519867|157511221|FG008|Overall Study|Admin. of relaxant other than Zemuron®|0|||
48911192|NCT03519867|157511222|FG009|Overall Study|Admin. of relaxant other than Zemuron®|0|||
48911193|NCT03519867|157511213|FG000|Overall Study|Admin. of other reversal agent|1|||
48911194|NCT03519867|157511214|FG001|Overall Study|Admin. of other reversal agent|1|||
48911195|NCT03519867|157511215|FG002|Overall Study|Admin. of other reversal agent|0|||
48911196|NCT03519867|157511216|FG003|Overall Study|Admin. of other reversal agent|0|||
48911197|NCT03519867|157511217|FG004|Overall Study|Admin. of other reversal agent|0|||
48699705|NCT01317472|156750502|FG000|Overall Study|Unrelated hospitalization|1|||
48699706|NCT01317472|156750503|FG001|Overall Study|Unrelated hospitalization|0|||
48699707|NCT04945733|156750504|FG000|Overall Study|Physician Decision|1|||
48699708|NCT04945733|156750505|FG001|Overall Study|Physician Decision|3|||
48699709|NCT04945733|156750506|FG002|Overall Study|Physician Decision|0|||
48699710|NCT04945733|156750504|FG000|Overall Study|Withdrawal by Subject|3|||
48699711|NCT04945733|156750505|FG001|Overall Study|Withdrawal by Subject|3|||
48699712|NCT04945733|156750506|FG002|Overall Study|Withdrawal by Subject|0|||
48699713|NCT00456846|156750518|FG000|Overall Study|Adverse Event|2|||
48699714|NCT00456846|156750519|FG001|Overall Study|Adverse Event|15|||
48699715|NCT00456846|156750518|FG000|Overall Study|Physician Decision|11|||
48699716|NCT00456846|156750519|FG001|Overall Study|Physician Decision|6|||
48699717|NCT00456846|156750518|FG000|Overall Study|Protocol Deviation|2|||
48699718|NCT00456846|156750519|FG001|Overall Study|Protocol Deviation|0|||
48699719|NCT00456846|156750518|FG000|Overall Study|Participant Discretion|1|||
48699720|NCT00456846|156750519|FG001|Overall Study|Participant Discretion|5|||
48699721|NCT00456846|156750518|FG000|Overall Study|Other|0|||
48699722|NCT00456846|156750519|FG001|Overall Study|Other|2|||
48699723|NCT00914849|156750522|FG000|Overall Study|Withdrawal by Subject|1|||
48699724|NCT00914849|156750523|FG001|Overall Study|Withdrawal by Subject|0|||
48699725|NCT00914849|156750522|FG000|Overall Study|Not eligible|0|||
48699726|NCT00914849|156750523|FG001|Overall Study|Not eligible|1|||
48911198|NCT03519867|157511218|FG005|Overall Study|Admin. of other reversal agent|1|||
48911199|NCT03519867|157511219|FG006|Overall Study|Admin. of other reversal agent|0|||
48911200|NCT03519867|157511220|FG007|Overall Study|Admin. of other reversal agent|0|||
48911201|NCT03519867|157511221|FG008|Overall Study|Admin. of other reversal agent|0|||
48911202|NCT03519867|157511222|FG009|Overall Study|Admin. of other reversal agent|0|||
48911203|NCT03519867|157511213|FG000|Overall Study|Reason not provided|1|||
48911204|NCT03519867|157511214|FG001|Overall Study|Reason not provided|1|||
48699727|NCT01001221|156750524|FG000|Overall Study|Adverse Event|1|||
48699728|NCT01001221|156750525|FG001|Overall Study|Adverse Event|2|||
48699729|NCT01001221|156750526|FG002|Overall Study|Adverse Event|0|||
48699730|NCT01001221|156750527|FG003|Overall Study|Adverse Event|2|||
48699731|NCT01001221|156750528|FG004|Overall Study|Adverse Event|0|||
48911205|NCT03519867|157511215|FG002|Overall Study|Reason not provided|1|||
48911206|NCT03519867|157511216|FG003|Overall Study|Reason not provided|1|||
48911207|NCT03519867|157511217|FG004|Overall Study|Reason not provided|0|||
48911208|NCT03519867|157511218|FG005|Overall Study|Reason not provided|1|||
48911209|NCT03519867|157511219|FG006|Overall Study|Reason not provided|0|||
48911210|NCT03519867|157511220|FG007|Overall Study|Reason not provided|1|||
48911211|NCT03519867|157511221|FG008|Overall Study|Reason not provided|1|||
48911212|NCT03519867|157511222|FG009|Overall Study|Reason not provided|0|||
48911213|NCT00382018|157511223|FG000|Overall Study|Progression|0|||
48911214|NCT00382018|157511224|FG001|Overall Study|Progression|136|||
48911215|NCT00382018|157511225|FG002|Overall Study|Progression|51|||
48911216|NCT00382018|157511226|FG003|Overall Study|Progression|43|||
48911217|NCT00382018|157511223|FG000|Overall Study|Death|0|||
48911218|NCT00382018|157511224|FG001|Overall Study|Death|9|||
48911219|NCT00382018|157511225|FG002|Overall Study|Death|7|||
48911220|NCT00382018|157511226|FG003|Overall Study|Death|11|||
48911221|NCT00382018|157511223|FG000|Overall Study|Withdrawal by Subject|0|||
48911222|NCT00382018|157511224|FG001|Overall Study|Withdrawal by Subject|4|||
48911223|NCT00382018|157511225|FG002|Overall Study|Withdrawal by Subject|3|||
48911224|NCT00382018|157511226|FG003|Overall Study|Withdrawal by Subject|4|||
48911225|NCT00382018|157511223|FG000|Overall Study|Other, not protocol specified|0|||
48911226|NCT00382018|157511224|FG001|Overall Study|Other, not protocol specified|16|||
48911227|NCT00382018|157511225|FG002|Overall Study|Other, not protocol specified|3|||
48911228|NCT00382018|157511226|FG003|Overall Study|Other, not protocol specified|1|||
48911229|NCT01519765|157511227|FG000|Overall Study|Adverse Event|0|||
48911230|NCT01519765|157511228|FG001|Overall Study|Adverse Event|1|||
48911231|NCT01519765|157511227|FG000|Overall Study|Lack of Efficacy|2|||
48911232|NCT01519765|157511228|FG001|Overall Study|Lack of Efficacy|0|||
48911233|NCT01519765|157511227|FG000|Overall Study|Protocol Violation|1|||
48911234|NCT01519765|157511228|FG001|Overall Study|Protocol Violation|0|||
48911235|NCT01519765|157511227|FG000|Overall Study|Withdrawal by Subject|0|||
48911236|NCT01519765|157511228|FG001|Overall Study|Withdrawal by Subject|1|||
48911237|NCT00698997|157511237|FG000|Overall Study|Lost to Follow-up|3|||
48911238|NCT00698997|157511238|FG001|Overall Study|Lost to Follow-up|0|||
48911239|NCT00698997|157511237|FG000|Overall Study|Withdrawal by Subject|7|||
48911240|NCT00698997|157511238|FG001|Overall Study|Withdrawal by Subject|27|||
48911241|NCT02109562|157511239|FG000|Overall Study|Insufficient clinical response|2|||
48911242|NCT02109562|157511240|FG001|Overall Study|Insufficient clinical response|0|||
48911243|NCT02109562|157511241|FG002|Overall Study|Insufficient clinical response|4|||
48911244|NCT02109562|157511239|FG000|Overall Study|Adverse Event|0|||
48911245|NCT02109562|157511240|FG001|Overall Study|Adverse Event|2|||
48911246|NCT02109562|157511241|FG002|Overall Study|Adverse Event|3|||
48911247|NCT02109562|157511239|FG000|Overall Study|Lost to Follow-up|1|||
48911248|NCT02109562|157511240|FG001|Overall Study|Lost to Follow-up|0|||
48911249|NCT02109562|157511241|FG002|Overall Study|Lost to Follow-up|1|||
48911250|NCT02109562|157511239|FG000|Overall Study|Protocol Violation|0|||
48911251|NCT02109562|157511240|FG001|Overall Study|Protocol Violation|3|||
48911252|NCT02109562|157511241|FG002|Overall Study|Protocol Violation|1|||
48911253|NCT02109562|157511239|FG000|Overall Study|Withdrawal by Subject|20|||
48911254|NCT02109562|157511240|FG001|Overall Study|Withdrawal by Subject|25|||
49116369|NCT03538691|158263094|FG002|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
49116370|NCT03538691|158263095|FG003|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
49116371|NCT03538691|158263092|FG000|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
49116372|NCT03538691|158263093|FG001|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|1|||
49116373|NCT03538691|158263094|FG002|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
49116374|NCT03538691|158263095|FG003|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
49116375|NCT03538691|158263092|FG000|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
49116376|NCT03538691|158263093|FG001|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|11|||
49116377|NCT03538691|158263094|FG002|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
49116378|NCT03538691|158263095|FG003|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
49116379|NCT03538691|158263092|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
48911255|NCT02109562|157511241|FG002|Overall Study|Withdrawal by Subject|21|||
48911256|NCT02109562|157511239|FG000|Overall Study|Physician Decision|3|||
48911257|NCT02109562|157511240|FG001|Overall Study|Physician Decision|4|||
48911258|NCT02109562|157511241|FG002|Overall Study|Physician Decision|5|||
48911259|NCT04498169|157512947|FG000|Study Completion|Adverse Event|1|||
48911260|NCT04498169|157512948|FG001|Study Completion|Adverse Event|1|||
48911261|NCT01195090|157512949|FG000|Overall Study|Adverse Event|1|||
48911262|NCT01195090|157512950|FG001|Overall Study|Adverse Event|2|||
48911263|NCT01195090|157512949|FG000|Overall Study|Lost to Follow-up|2|||
48911264|NCT01195090|157512950|FG001|Overall Study|Lost to Follow-up|2|||
48911265|NCT01195090|157512949|FG000|Overall Study|Protocol Violation|3|||
48911266|NCT01195090|157512950|FG001|Overall Study|Protocol Violation|4|||
48911267|NCT00791258|157512953|FG000|Overall Study|Adverse Event|87|||
48911268|NCT00791258|157512953|FG000|Overall Study|Lost to Follow-up|18|||
48911269|NCT00791258|157512953|FG000|Overall Study|Protocol Violation|109|||
48911270|NCT00791258|157512953|FG000|Overall Study|Withdrawal by Subject|40|||
48911271|NCT00791258|157512953|FG000|Overall Study|Did not take medication for >3 days|1|||
48911272|NCT00791258|157512953|FG000|Overall Study|subject left area|2|||
48911273|NCT00791258|157512953|FG000|Overall Study|non-compliance|3|||
48911274|NCT00791258|157512953|FG000|Overall Study|Subject incarcerated|1|||
48911275|NCT00791258|157512953|FG000|Overall Study|Subject required restricted medication|1|||
48911276|NCT00791258|157512953|FG000|Overall Study|Lack of Efficacy|1|||
48911277|NCT03083847|157512954|FG000|Main|Physician Decision|0|||
48911278|NCT03083847|157512955|FG001|Main|Physician Decision|0|||
48911279|NCT03083847|157512956|FG002|Main|Physician Decision|0|||
48911280|NCT03083847|157512957|FG003|Main|Physician Decision|0|||
48911281|NCT03083847|157512958|FG004|Main|Physician Decision|0|||
48911282|NCT03083847|157512959|FG005|Main|Physician Decision|1|||
49116380|NCT03538691|158263093|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
48911283|NCT03083847|157512960|FG006|Main|Physician Decision|0|||
48911284|NCT03083847|157512961|FG007|Main|Physician Decision|0|||
48911285|NCT03083847|157512962|FG008|Main|Physician Decision|0|||
48911286|NCT03083847|157512963|FG009|Main|Physician Decision|0|||
48911287|NCT03083847|157512954|FG000|Main|Pregnancy|0|||
48911288|NCT03083847|157512955|FG001|Main|Pregnancy|0|||
48911289|NCT03083847|157512956|FG002|Main|Pregnancy|0|||
48911290|NCT03083847|157512957|FG003|Main|Pregnancy|0|||
48911291|NCT03083847|157512958|FG004|Main|Pregnancy|0|||
48911292|NCT03083847|157512959|FG005|Main|Pregnancy|0|||
48911293|NCT03083847|157512960|FG006|Main|Pregnancy|0|||
48911294|NCT03083847|157512961|FG007|Main|Pregnancy|1|||
48911295|NCT03083847|157512962|FG008|Main|Pregnancy|0|||
48911296|NCT03083847|157512963|FG009|Main|Pregnancy|0|||
48911297|NCT03083847|157512954|FG000|Main|Adverse Event|0|||
48911298|NCT03083847|157512955|FG001|Main|Adverse Event|0|||
48911299|NCT03083847|157512956|FG002|Main|Adverse Event|0|||
48911300|NCT03083847|157512957|FG003|Main|Adverse Event|0|||
48911301|NCT03083847|157512958|FG004|Main|Adverse Event|0|||
48911302|NCT03083847|157512959|FG005|Main|Adverse Event|0|||
48911303|NCT03083847|157512960|FG006|Main|Adverse Event|0|||
48911304|NCT03083847|157512961|FG007|Main|Adverse Event|2|||
48911305|NCT03083847|157512962|FG008|Main|Adverse Event|0|||
48911306|NCT03083847|157512963|FG009|Main|Adverse Event|0|||
48911307|NCT03083847|157512954|FG000|Main|Withdrawal by Subject|0|||
48911308|NCT03083847|157512955|FG001|Main|Withdrawal by Subject|0|||
48911309|NCT03083847|157512956|FG002|Main|Withdrawal by Subject|0|||
48911310|NCT03083847|157512957|FG003|Main|Withdrawal by Subject|0|||
48911311|NCT03083847|157512958|FG004|Main|Withdrawal by Subject|0|||
48911312|NCT03083847|157512959|FG005|Main|Withdrawal by Subject|0|||
48911313|NCT03083847|157512960|FG006|Main|Withdrawal by Subject|1|||
48911314|NCT03083847|157512961|FG007|Main|Withdrawal by Subject|1|||
48911315|NCT03083847|157512962|FG008|Main|Withdrawal by Subject|0|||
48911316|NCT03083847|157512963|FG009|Main|Withdrawal by Subject|0|||
48911317|NCT00058552|157512966|FG000|Overall Study|Died prior to receiving treatment|4|||
48911318|NCT00058552|157512967|FG001|Overall Study|Died prior to receiving treatment|2|||
48911319|NCT00058552|157512966|FG000|Overall Study|Disease progression|52|||
48911320|NCT00058552|157512967|FG001|Overall Study|Disease progression|44|||
48911321|NCT00058552|157512966|FG000|Overall Study|Adverse Event|4|||
48911322|NCT00058552|157512967|FG001|Overall Study|Adverse Event|2|||
48911323|NCT00058552|157512966|FG000|Overall Study|Withdrawal by Subject|3|||
48911324|NCT00058552|157512967|FG001|Overall Study|Withdrawal by Subject|5|||
49116381|NCT03538691|158263094|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|16|||
48699732|NCT01001221|156750524|FG000|Overall Study|Disease progression|3|||
48911325|NCT00058552|157512966|FG000|Overall Study|Physician Decision|2|||
48911326|NCT00058552|157512967|FG001|Overall Study|Physician Decision|5|||
48911327|NCT00058552|157512966|FG000|Overall Study|Clinical disease progression|0|||
48911328|NCT00058552|157512967|FG001|Overall Study|Clinical disease progression|4|||
48911329|NCT00210184|157512968|FG000|Overall Study|The medical record was lost for these patients: no clinical data is available|2|||
48911330|NCT02319668|157512969|FG000|Overall Study|Other (Not specified)|0|||
48911331|NCT02319668|157512970|FG001|Overall Study|Other (Not specified)|2|||
48911332|NCT01054144|157512971|FG000|Overall Study|Death|2|||
48911333|NCT01555151|157512975|FG000|Overall Study|Withdrawal by Subject|6|||
48911334|NCT01555151|157512976|FG001|Overall Study|Withdrawal by Subject|2|||
48911335|NCT01555151|157512977|FG002|Overall Study|Withdrawal by Subject|0|||
48911336|NCT01555151|157512978|FG003|Overall Study|Withdrawal by Subject|2|||
48911337|NCT01555151|157512975|FG000|Overall Study|Administrative|3|||
48911338|NCT01555151|157512976|FG001|Overall Study|Administrative|1|||
48911339|NCT01555151|157512977|FG002|Overall Study|Administrative|2|||
48911340|NCT01555151|157512978|FG003|Overall Study|Administrative|0|||
48911341|NCT01555151|157512975|FG000|Overall Study|Protocol Violation|3|||
48911342|NCT01555151|157512976|FG001|Overall Study|Protocol Violation|3|||
48911343|NCT01555151|157512977|FG002|Overall Study|Protocol Violation|3|||
48911344|NCT01555151|157512978|FG003|Overall Study|Protocol Violation|5|||
48911345|NCT01555151|157512975|FG000|Overall Study|Adverse Event|1|||
48911346|NCT01555151|157512976|FG001|Overall Study|Adverse Event|2|||
48911347|NCT01555151|157512977|FG002|Overall Study|Adverse Event|1|||
48911348|NCT01555151|157512978|FG003|Overall Study|Adverse Event|2|||
48911349|NCT01555151|157512975|FG000|Overall Study|Lost to Follow-up|0|||
48911350|NCT01555151|157512976|FG001|Overall Study|Lost to Follow-up|0|||
48911351|NCT01555151|157512977|FG002|Overall Study|Lost to Follow-up|0|||
48911352|NCT01555151|157512978|FG003|Overall Study|Lost to Follow-up|1|||
49116382|NCT03538691|158263095|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|4|||
49116383|NCT03538691|158263092|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
49116384|NCT03538691|158263093|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
49116385|NCT03538691|158263094|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
49116386|NCT03538691|158263095|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
49116387|NCT03538691|158263092|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
49116388|NCT03538691|158263093|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
49116389|NCT03538691|158263094|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|6|||
49116390|NCT03538691|158263095|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|19|||
49116391|NCT03538691|158263092|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
49116392|NCT03538691|158263093|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
49116393|NCT03538691|158263094|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|1|||
49116394|NCT03538691|158263095|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|2|||
48911353|NCT03189862|157512979|FG000|Overall Study|Withdrawal by Subject|1|||
48911354|NCT03189862|157512980|FG001|Overall Study|Withdrawal by Subject|0|||
48911355|NCT03189862|157512979|FG000|Overall Study|Lost to Follow-up|54|||
48911356|NCT03189862|157512980|FG001|Overall Study|Lost to Follow-up|62|||
48911357|NCT00381563|157512981|FG000|Overall Study|Withdrawal by Subject|5|||
48911358|NCT00381563|157512982|FG001|Overall Study|Withdrawal by Subject|5|||
48911359|NCT00381563|157512981|FG000|Overall Study|Lost to Follow-up|2|||
48911360|NCT00381563|157512982|FG001|Overall Study|Lost to Follow-up|0|||
48911361|NCT00381563|157512981|FG000|Overall Study|Protocol Violation|0|||
48911362|NCT00381563|157512982|FG001|Overall Study|Protocol Violation|1|||
48911363|NCT00851682|157512983|FG000|Overall Study|screen failure|5|||
48911364|NCT00851682|157512984|FG001|Overall Study|screen failure|0|||
48911365|NCT01886313|157512988|FG000|Overall Study|Adverse Event|1|||
48911366|NCT01886313|157512989|FG001|Overall Study|Adverse Event|1|||
48911367|NCT00006392|157512991|FG000|Overall Study|Ineligible|11|||
48911368|NCT00006392|157512992|FG001|Overall Study|Ineligible|3|||
48911369|NCT00006392|157512993|FG002|Overall Study|Ineligible|5|||
48911370|NCT00006392|157512994|FG003|Overall Study|Ineligible|5|||
48911371|NCT00006392|157512991|FG000|Overall Study|Poor data/ppt mgmt, regulatory problems|156|||
48911372|NCT00006392|157512992|FG001|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
48911373|NCT00006392|157512993|FG002|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
48911374|NCT00006392|157512994|FG003|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
48911375|NCT04344301|157513001|FG000|Overall Study|Withdrawal by Subject|1|||
48911376|NCT04344301|157513002|FG001|Overall Study|Withdrawal by Subject|0|||
48911377|NCT04344301|157513001|FG000|Overall Study|Death|0|||
48911378|NCT04344301|157513002|FG001|Overall Study|Death|1|||
48911379|NCT02844920|157513003|FG000|Overall Study|Lost to Follow-up|2|||
48911380|NCT01537198|157513005|FG000|Overall Study|RSV infection|2|||
48911381|NCT01537198|157513005|FG000|Overall Study|Adverse Event|4|||
48911382|NCT01537198|157513005|FG000|Overall Study|No Further Visits to the Clinic|37|||
48911383|NCT01537198|157513005|FG000|Overall Study|Other|111|||
48911384|NCT00770770|157513006|FG000|Overall Study|Lost to Follow-up|1|||
48911385|NCT00770770|157513007|FG001|Overall Study|Lost to Follow-up|0|||
48911386|NCT00770770|157513006|FG000|Overall Study|Withdrawal by Subject|1|||
48911387|NCT00770770|157513007|FG001|Overall Study|Withdrawal by Subject|0|||
48911388|NCT00770770|157513006|FG000|Overall Study|Death|0|||
48911389|NCT00770770|157513007|FG001|Overall Study|Death|1|||
48911390|NCT00770770|157513006|FG000|Overall Study|Study Terminated|8|||
48911391|NCT00770770|157513007|FG001|Overall Study|Study Terminated|0|||
48911392|NCT04534491|157513008|FG000|Overall Study|Not completed end-of-study interview|24|||
48911393|NCT04534491|157513008|FG000|Overall Study|Non-users|70|||
48911394|NCT04534491|157513008|FG000|Overall Study|Non-verifiable users|58|||
48911395|NCT03000179|157513009|FG000|Overall Study|Lost to Follow-up|2|||
48911396|NCT00865904|157513021|FG000|Overall Study|Randomized but not Treated|2|||
48911397|NCT00865904|157513022|FG001|Overall Study|Randomized but not Treated|0|||
48911398|NCT00865904|157513023|FG002|Overall Study|Randomized but not Treated|0|||
48911399|NCT00865904|157513024|FG003|Overall Study|Randomized but not Treated|1|||
48911400|NCT00865904|157513025|FG004|Overall Study|Randomized but not Treated|1|||
48911401|NCT01543828|157513030|FG000|Treatment 2|Lost to Follow-up|1|||
48911402|NCT01543828|157513031|FG001|Treatment 2|Lost to Follow-up|0|||
48911403|NCT02463071|157513037|FG000|Overall Study|Adverse Event|3|||
48911404|NCT02463071|157513038|FG001|Overall Study|Adverse Event|5|||
48911405|NCT02463071|157513039|FG002|Overall Study|Adverse Event|1|||
48911406|NCT02463071|157513037|FG000|Overall Study|Death|1|||
48911407|NCT02463071|157513038|FG001|Overall Study|Death|0|||
48911408|NCT02463071|157513039|FG002|Overall Study|Death|0|||
48911409|NCT02463071|157513037|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
48911410|NCT02463071|157513038|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
48911411|NCT02463071|157513039|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
48911412|NCT02463071|157513037|FG000|Overall Study|Reason not specified|7|||
48911413|NCT02463071|157513038|FG001|Overall Study|Reason not specified|9|||
48911414|NCT02463071|157513039|FG002|Overall Study|Reason not specified|4|||
48699733|NCT01001221|156750525|FG001|Overall Study|Disease progression|2|||
48911415|NCT02463071|157513037|FG000|Overall Study|Protocol Violation|0|||
48911416|NCT02463071|157513038|FG001|Overall Study|Protocol Violation|2|||
48911417|NCT02463071|157513039|FG002|Overall Study|Protocol Violation|0|||
48911418|NCT02463071|157513037|FG000|Overall Study|Lost to Follow-up|0|||
48699734|NCT01001221|156750526|FG002|Overall Study|Disease progression|2|||
48699735|NCT01001221|156750527|FG003|Overall Study|Disease progression|4|||
48699736|NCT01001221|156750528|FG004|Overall Study|Disease progression|0|||
48911419|NCT02463071|157513038|FG001|Overall Study|Lost to Follow-up|0|||
48911420|NCT02463071|157513039|FG002|Overall Study|Lost to Follow-up|1|||
48911421|NCT00073528|157513040|FG000|Overall Study|Death|488|||
48911422|NCT00073528|157513041|FG001|Overall Study|Death|473|||
48911423|NCT00073528|157513040|FG000|Overall Study|Lost to Follow-up|52|||
48911424|NCT00073528|157513041|FG001|Overall Study|Lost to Follow-up|45|||
48911425|NCT00073528|157513040|FG000|Overall Study|Withdrawal by Subject|50|||
48911426|NCT00073528|157513041|FG001|Overall Study|Withdrawal by Subject|45|||
48911427|NCT00073528|157513040|FG000|Overall Study|Study terminated by Sponsor|10|||
48911428|NCT00073528|157513041|FG001|Overall Study|Study terminated by Sponsor|29|||
48911429|NCT00073528|157513040|FG000|Overall Study|Other|18|||
48911430|NCT00073528|157513041|FG001|Overall Study|Other|19|||
48911431|NCT00073528|157513040|FG000|Overall Study|Other|9|||
48911432|NCT00073528|157513041|FG001|Overall Study|Other|12|||
48911433|NCT00073528|157513040|FG000|Overall Study|Protocol Violation|3|||
48911434|NCT00073528|157513041|FG001|Overall Study|Protocol Violation|5|||
48911435|NCT03086057|157513042|FG000|Stage 1: PrEP Uptake|Incarcerated|3|||
48911436|NCT03086057|157513043|FG001|Stage 1: PrEP Uptake|Incarcerated|1|||
48911437|NCT03086057|157513044|FG002|Stage 1: PrEP Uptake|Incarcerated|0|||
48911438|NCT03086057|157513045|FG003|Stage 1: PrEP Uptake|Incarcerated|0|||
48911439|NCT03086057|157513042|FG000|Stage 1: PrEP Uptake|Withdrawal by Subject|1|||
48911440|NCT03086057|157513043|FG001|Stage 1: PrEP Uptake|Withdrawal by Subject|4|||
48911441|NCT03086057|157513044|FG002|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
48911442|NCT03086057|157513045|FG003|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
48911443|NCT03086057|157513042|FG000|Stage 1: PrEP Uptake|Lost to Follow-up|6|||
48911444|NCT03086057|157513043|FG001|Stage 1: PrEP Uptake|Lost to Follow-up|5|||
48911445|NCT03086057|157513044|FG002|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
48911446|NCT03086057|157513045|FG003|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
48911447|NCT03086057|157513042|FG000|Stage 1: PrEP Uptake|Death|1|||
48911448|NCT03086057|157513043|FG001|Stage 1: PrEP Uptake|Death|0|||
49116395|NCT03538691|158263092|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
49116396|NCT03538691|158263093|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
49116397|NCT03538691|158263094|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|32|||
49116398|NCT03538691|158263095|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|28|||
49116399|NCT03538691|158263092|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
49116400|NCT03538691|158263093|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
48911449|NCT03086057|157513044|FG002|Stage 1: PrEP Uptake|Death|0|||
48911450|NCT03086057|157513045|FG003|Stage 1: PrEP Uptake|Death|0|||
48911451|NCT03086057|157513042|FG000|Stage 2: PrEP Adherence|Incarcerated|0|||
48911452|NCT03086057|157513043|FG001|Stage 2: PrEP Adherence|Incarcerated|0|||
48699737|NCT01001221|156750524|FG000|Overall Study|Other|1|||
48699738|NCT01001221|156750525|FG001|Overall Study|Other|1|||
48699739|NCT01001221|156750526|FG002|Overall Study|Other|0|||
48699740|NCT01001221|156750527|FG003|Overall Study|Other|0|||
48911453|NCT03086057|157513044|FG002|Stage 2: PrEP Adherence|Incarcerated|2|||
48911454|NCT03086057|157513045|FG003|Stage 2: PrEP Adherence|Incarcerated|0|||
48911455|NCT03086057|157513042|FG000|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
48911456|NCT03086057|157513043|FG001|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
48911457|NCT03086057|157513044|FG002|Stage 2: PrEP Adherence|Withdrawal by Subject|1|||
48911458|NCT03086057|157513045|FG003|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
48911459|NCT03086057|157513042|FG000|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
48911460|NCT03086057|157513043|FG001|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
48911461|NCT03086057|157513044|FG002|Stage 2: PrEP Adherence|Lost to Follow-up|3|||
48911462|NCT03086057|157513045|FG003|Stage 2: PrEP Adherence|Lost to Follow-up|2|||
48911463|NCT02729740|157513046|FG000|Overall Study|Early Termination|130|||
48911464|NCT02729740|157513046|FG000|Overall Study|Other|1|||
48911465|NCT00711425|157513047|FG000|Overall Study|Protocol Violation|1|||
48911466|NCT00711425|157513047|FG000|Overall Study|Death|2|||
48911467|NCT00711425|157513047|FG000|Overall Study|Lost to Follow-up|1|||
48911468|NCT01093625|157513048|FG000|Baseline and Dispensed|Withdrawal by Subject|2|||
48911469|NCT01093625|157513049|FG001|Baseline and Dispensed|Withdrawal by Subject|0|||
48911470|NCT01093625|157513048|FG000|2-Week Visit|Withdrawal by Subject|1|||
48911471|NCT01093625|157513049|FG001|2-Week Visit|Withdrawal by Subject|0|||
48911472|NCT01093625|157513048|FG000|1-Month Visit|Lost to Follow-up|2|||
48911473|NCT01093625|157513049|FG001|1-Month Visit|Lost to Follow-up|0|||
48911474|NCT01093625|157513048|FG000|3-Month Visit|Lost to Follow-up|2|||
48911475|NCT01093625|157513049|FG001|3-Month Visit|Lost to Follow-up|0|||
48911476|NCT01093625|157513048|FG000|6-Month Visit|Withdrawal by Subject|6|||
48911477|NCT01093625|157513049|FG001|6-Month Visit|Withdrawal by Subject|7|||
48911478|NCT01093625|157513048|FG000|6-Month Visit|Lost to Follow-up|2|||
48911479|NCT01093625|157513049|FG001|6-Month Visit|Lost to Follow-up|2|||
48911480|NCT01093625|157513048|FG000|1-Year Visit|Lost to Follow-up|5|||
48911481|NCT01093625|157513049|FG001|1-Year Visit|Lost to Follow-up|3|||
48699741|NCT01001221|156750528|FG004|Overall Study|Other|0|||
48699742|NCT01001221|156750524|FG000|Overall Study|Not treated; protocol exclusion|0|||
48699743|NCT01001221|156750525|FG001|Overall Study|Not treated; protocol exclusion|0|||
48699744|NCT01001221|156750526|FG002|Overall Study|Not treated; protocol exclusion|1|||
48699745|NCT01001221|156750527|FG003|Overall Study|Not treated; protocol exclusion|0|||
48911482|NCT00307333|157513050|FG000|Overall Study|Lost to Follow-up|11|||
48911483|NCT00307333|157513051|FG001|Overall Study|Lost to Follow-up|3|||
48911484|NCT00698932|157513052|FG000|Overall Study|Adverse Event|0|||
48911485|NCT00698932|157513053|FG001|Overall Study|Adverse Event|2|||
48911486|NCT00698932|157513052|FG000|Overall Study|Incorrect enrollment|0|||
48911487|NCT00698932|157513053|FG001|Overall Study|Incorrect enrollment|2|||
48911488|NCT00698932|157513052|FG000|Overall Study|Study specific discontinuation criteria|3|||
48911489|NCT00698932|157513053|FG001|Overall Study|Study specific discontinuation criteria|4|||
48911490|NCT00698932|157513052|FG000|Overall Study|Withdrawal by Subject|11|||
48911491|NCT00698932|157513053|FG001|Overall Study|Withdrawal by Subject|23|||
48911492|NCT00698932|157513052|FG000|Overall Study|Lost to Follow-up|6|||
48911493|NCT00698932|157513053|FG001|Overall Study|Lost to Follow-up|1|||
48911494|NCT00698932|157513052|FG000|Overall Study|Severe non-compliance to protocol|1|||
48911495|NCT00698932|157513053|FG001|Overall Study|Severe non-compliance to protocol|2|||
48911496|NCT00698932|157513052|FG000|Overall Study|Safety reasons|0|||
48911497|NCT00698932|157513053|FG001|Overall Study|Safety reasons|2|||
48911498|NCT00698932|157513052|FG000|Overall Study|Death|1|||
48911499|NCT00698932|157513053|FG001|Overall Study|Death|0|||
48911500|NCT01245387|157513054|FG000|Overall Study|Lost to Follow-up|106|||
48911501|NCT01245387|157513054|FG000|Overall Study|Lack of Efficacy|195|||
48911502|NCT01245387|157513054|FG000|Overall Study|Adverse Event|9|||
48911503|NCT01245387|157513054|FG000|Overall Study|Death|3|||
49010531|NCT00328783|157875643|FG000|Overall Study|Withdrawal by Subject|1|||
49010532|NCT03558997|157875646|FG000|Overall Study|Adverse Event|0|||
49010533|NCT03558997|157875647|FG001|Overall Study|Adverse Event|2|||
49010534|NCT03558997|157875648|FG002|Overall Study|Adverse Event|5|||
49010535|NCT03558997|157875649|FG003|Overall Study|Adverse Event|1|||
48699746|NCT01001221|156750528|FG004|Overall Study|Not treated; protocol exclusion|0|||
48699747|NCT03405792|156750538|FG000|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|4|||
48699748|NCT03405792|156750539|FG001|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|0|||
48699749|NCT03405792|156750538|FG000|Overall Study|o Did not receive pembrolizumab|1|||
48699750|NCT03405792|156750539|FG001|Overall Study|o Did not receive pembrolizumab|0|||
48699751|NCT01310777|156750543|FG000|Overall Study|Adverse Event|23|||
48699752|NCT01310777|156750544|FG001|Overall Study|Adverse Event|1|||
48699753|NCT01310777|156750545|FG002|Overall Study|Adverse Event|15|||
48699754|NCT01310777|156750543|FG000|Overall Study|Lost to Follow-up|0|||
48699755|NCT01310777|156750544|FG001|Overall Study|Lost to Follow-up|4|||
48699756|NCT01310777|156750545|FG002|Overall Study|Lost to Follow-up|1|||
48699757|NCT01310777|156750543|FG000|Overall Study|Patient's Decision Unrelated to AE|1|||
48699758|NCT01310777|156750544|FG001|Overall Study|Patient's Decision Unrelated to AE|1|||
48699759|NCT01310777|156750545|FG002|Overall Study|Patient's Decision Unrelated to AE|2|||
48699760|NCT01310777|156750543|FG000|Overall Study|Inadequate Control of IOP|5|||
48699761|NCT01310777|156750544|FG001|Overall Study|Inadequate Control of IOP|7|||
48699762|NCT01310777|156750545|FG002|Overall Study|Inadequate Control of IOP|10|||
48699763|NCT01310777|156750543|FG000|Overall Study|Other|4|||
48911504|NCT01245387|157513054|FG000|Overall Study|Other|131|||
48911505|NCT01245387|157513054|FG000|Overall Study|Missing discontinuation status|369|||
48911506|NCT04233164|157513055|FG000|Overall Study|Unable to obtain specimen|0|||
48911507|NCT04233164|157513056|FG001|Overall Study|Unable to obtain specimen|1|||
48911508|NCT01423851|157513057|FG000|Whole Study|Disease progression|2|||
48911509|NCT01423851|157513058|FG001|Whole Study|Disease progression|1|||
48911510|NCT01423851|157513059|FG002|Whole Study|Disease progression|1|||
48911511|NCT01423851|157513060|FG003|Whole Study|Disease progression|4|||
48911512|NCT01423851|157513061|FG004|Whole Study|Disease progression|1|||
48911513|NCT01423851|157513062|FG005|Whole Study|Disease progression|3|||
48911514|NCT01423851|157513063|FG006|Whole Study|Disease progression|1|||
48911515|NCT01423851|157513064|FG007|Whole Study|Disease progression|4|||
48911516|NCT01423851|157513065|FG008|Whole Study|Disease progression|0|||
48911517|NCT01423851|157513066|FG009|Whole Study|Disease progression|2|||
48911518|NCT01423851|157513067|FG010|Whole Study|Disease progression|10|||
48911519|NCT01423851|157513057|FG000|Whole Study|Physician Decision|0|||
48911520|NCT01423851|157513058|FG001|Whole Study|Physician Decision|1|||
48911521|NCT01423851|157513059|FG002|Whole Study|Physician Decision|2|||
48911522|NCT01423851|157513060|FG003|Whole Study|Physician Decision|0|||
48911523|NCT01423851|157513061|FG004|Whole Study|Physician Decision|2|||
48911524|NCT01423851|157513062|FG005|Whole Study|Physician Decision|0|||
48911525|NCT01423851|157513063|FG006|Whole Study|Physician Decision|2|||
48911526|NCT01423851|157513064|FG007|Whole Study|Physician Decision|1|||
48911527|NCT01423851|157513065|FG008|Whole Study|Physician Decision|3|||
48911528|NCT01423851|157513066|FG009|Whole Study|Physician Decision|4|||
48911529|NCT01423851|157513067|FG010|Whole Study|Physician Decision|12|||
48911530|NCT01423851|157513057|FG000|Whole Study|Withdrawal by Subject|1|||
48911531|NCT01423851|157513058|FG001|Whole Study|Withdrawal by Subject|1|||
48911532|NCT01423851|157513059|FG002|Whole Study|Withdrawal by Subject|0|||
48911533|NCT01423851|157513060|FG003|Whole Study|Withdrawal by Subject|0|||
48911534|NCT01423851|157513061|FG004|Whole Study|Withdrawal by Subject|0|||
48911535|NCT01423851|157513062|FG005|Whole Study|Withdrawal by Subject|0|||
48911536|NCT01423851|157513063|FG006|Whole Study|Withdrawal by Subject|0|||
48911537|NCT01423851|157513064|FG007|Whole Study|Withdrawal by Subject|0|||
48911538|NCT01423851|157513065|FG008|Whole Study|Withdrawal by Subject|2|||
48911539|NCT01423851|157513066|FG009|Whole Study|Withdrawal by Subject|0|||
48911540|NCT01423851|157513067|FG010|Whole Study|Withdrawal by Subject|4|||
48911541|NCT01423851|157513057|FG000|Whole Study|Adverse Event|0|||
48911542|NCT01423851|157513058|FG001|Whole Study|Adverse Event|0|||
48911543|NCT01423851|157513059|FG002|Whole Study|Adverse Event|0|||
48911544|NCT01423851|157513060|FG003|Whole Study|Adverse Event|2|||
48911545|NCT01423851|157513061|FG004|Whole Study|Adverse Event|0|||
48911546|NCT01423851|157513062|FG005|Whole Study|Adverse Event|0|||
48911547|NCT01423851|157513063|FG006|Whole Study|Adverse Event|0|||
48911548|NCT01423851|157513064|FG007|Whole Study|Adverse Event|3|||
48911549|NCT01423851|157513065|FG008|Whole Study|Adverse Event|3|||
48911550|NCT01423851|157513066|FG009|Whole Study|Adverse Event|2|||
48911551|NCT01423851|157513067|FG010|Whole Study|Adverse Event|3|||
48911552|NCT02014740|157513068|FG000|Overall Study|Lost to Follow-up|4|||
48911553|NCT02014740|157513069|FG001|Overall Study|Lost to Follow-up|4|||
48911554|NCT02014740|157513068|FG000|Overall Study|Withdrawal by Subject|2|||
48911555|NCT02014740|157513069|FG001|Overall Study|Withdrawal by Subject|1|||
48911556|NCT01092143|157513070|FG000|Overall Study|Adverse Event|10|||
48911557|NCT01092143|157513071|FG001|Overall Study|Adverse Event|5|||
48911558|NCT01092143|157513072|FG002|Overall Study|Adverse Event|1|||
48911559|NCT01092143|157513073|FG003|Overall Study|Adverse Event|4|||
48911560|NCT01092143|157513074|FG004|Overall Study|Adverse Event|3|||
48911561|NCT01092143|157513070|FG000|Overall Study|Lost to Follow-up|1|||
48911562|NCT01092143|157513071|FG001|Overall Study|Lost to Follow-up|0|||
48911563|NCT01092143|157513072|FG002|Overall Study|Lost to Follow-up|1|||
48911564|NCT01092143|157513073|FG003|Overall Study|Lost to Follow-up|0|||
48911565|NCT01092143|157513074|FG004|Overall Study|Lost to Follow-up|0|||
48911566|NCT01092143|157513070|FG000|Overall Study|Consent withdrawn|2|||
48911567|NCT01092143|157513071|FG001|Overall Study|Consent withdrawn|1|||
48911568|NCT01092143|157513072|FG002|Overall Study|Consent withdrawn|0|||
48911569|NCT01092143|157513073|FG003|Overall Study|Consent withdrawn|1|||
48911570|NCT01092143|157513074|FG004|Overall Study|Consent withdrawn|3|||
48911571|NCT01092143|157513070|FG000|Overall Study|Not treated|0|||
48911572|NCT01092143|157513071|FG001|Overall Study|Not treated|0|||
49116401|NCT03538691|158263094|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|1|||
49116402|NCT03538691|158263095|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
48699764|NCT01310777|156750544|FG001|Overall Study|Other|1|||
48699765|NCT01310777|156750545|FG002|Overall Study|Other|2|||
48699766|NCT02476617|156750547|FG000|Overall Study|Adverse Event|1|||
48699767|NCT02476617|156750547|FG000|Overall Study|Lost to Follow-up|1|||
48699768|NCT03521570|156750550|FG000|Overall Study|Not eligible|11|||
48699769|NCT01210313|156750551|FG000|Overall Study|Withdrawal by Subject|3|||
48699770|NCT01210313|156750551|FG000|Overall Study|Adverse Event|2|||
48699771|NCT01210313|156750551|FG000|Overall Study|Distant recurrence|4|||
48699772|NCT01210313|156750551|FG000|Overall Study|Non-compliance|7|||
48911573|NCT01092143|157513072|FG002|Overall Study|Not treated|1|||
48911574|NCT01092143|157513073|FG003|Overall Study|Not treated|0|||
48699773|NCT03995368|156750552|FG000|Overall Study|Lost to Follow-up|1|||
48699774|NCT03995368|156750553|FG001|Overall Study|Lost to Follow-up|4|||
48699775|NCT03995368|156750554|FG002|Overall Study|Lost to Follow-up|1|||
48911575|NCT01092143|157513074|FG004|Overall Study|Not treated|0|||
48911576|NCT01092143|157513070|FG000|Overall Study|did not reversibility criteria|0|||
48911577|NCT01092143|157513071|FG001|Overall Study|did not reversibility criteria|0|||
48911578|NCT01092143|157513072|FG002|Overall Study|did not reversibility criteria|1|||
48911579|NCT01092143|157513073|FG003|Overall Study|did not reversibility criteria|0|||
48911580|NCT01092143|157513074|FG004|Overall Study|did not reversibility criteria|0|||
48911581|NCT01092143|157513070|FG000|Overall Study|Increased Albuterol use for >2 days|0|||
48911582|NCT01092143|157513071|FG001|Overall Study|Increased Albuterol use for >2 days|1|||
48911583|NCT01092143|157513072|FG002|Overall Study|Increased Albuterol use for >2 days|0|||
48911584|NCT01092143|157513073|FG003|Overall Study|Increased Albuterol use for >2 days|0|||
48911585|NCT01092143|157513074|FG004|Overall Study|Increased Albuterol use for >2 days|0|||
48911586|NCT01092143|157513070|FG000|Overall Study|Ineligible patient|1|||
48911587|NCT01092143|157513071|FG001|Overall Study|Ineligible patient|0|||
48911588|NCT01092143|157513072|FG002|Overall Study|Ineligible patient|0|||
48911589|NCT01092143|157513073|FG003|Overall Study|Ineligible patient|0|||
48911590|NCT01092143|157513074|FG004|Overall Study|Ineligible patient|0|||
48911591|NCT01092143|157513070|FG000|Overall Study|Drop in FEV1 at visit 9|1|||
48911592|NCT01092143|157513071|FG001|Overall Study|Drop in FEV1 at visit 9|0|||
48911593|NCT01092143|157513072|FG002|Overall Study|Drop in FEV1 at visit 9|0|||
48911594|NCT01092143|157513073|FG003|Overall Study|Drop in FEV1 at visit 9|0|||
48911595|NCT01092143|157513074|FG004|Overall Study|Drop in FEV1 at visit 9|0|||
48911596|NCT01092143|157513070|FG000|Overall Study|Patient travel|0|||
48911597|NCT01092143|157513071|FG001|Overall Study|Patient travel|0|||
48911598|NCT01092143|157513072|FG002|Overall Study|Patient travel|0|||
48911599|NCT01092143|157513073|FG003|Overall Study|Patient travel|0|||
48911600|NCT01092143|157513074|FG004|Overall Study|Patient travel|1|||
48911601|NCT01092143|157513070|FG000|Overall Study|Non compliance with study medication|0|||
48911602|NCT01092143|157513071|FG001|Overall Study|Non compliance with study medication|0|||
48911603|NCT01092143|157513072|FG002|Overall Study|Non compliance with study medication|0|||
48911604|NCT01092143|157513073|FG003|Overall Study|Non compliance with study medication|0|||
48911605|NCT01092143|157513074|FG004|Overall Study|Non compliance with study medication|1|||
48911606|NCT01092143|157513070|FG000|Overall Study|Randomized by mistake|0|||
48911607|NCT01092143|157513071|FG001|Overall Study|Randomized by mistake|0|||
48911608|NCT01092143|157513072|FG002|Overall Study|Randomized by mistake|0|||
48699776|NCT03995368|156750552|FG000|Overall Study|Did not meet inclusion criteria|1|||
48699777|NCT03995368|156750553|FG001|Overall Study|Did not meet inclusion criteria|6|||
48699778|NCT03995368|156750554|FG002|Overall Study|Did not meet inclusion criteria|3|||
48699779|NCT03995368|156750552|FG000|Overall Study|Withdrawal by Subject|0|||
48699780|NCT03995368|156750553|FG001|Overall Study|Withdrawal by Subject|1|||
48699781|NCT03995368|156750554|FG002|Overall Study|Withdrawal by Subject|1|||
48699782|NCT03755934|156750555|FG000|Overall Study|Adverse Event|4|||
48699783|NCT03755934|156750556|FG001|Overall Study|Adverse Event|1|||
48699784|NCT03755934|156750557|FG002|Overall Study|Adverse Event|1|||
48699785|NCT03755934|156750558|FG003|Overall Study|Adverse Event|3|||
48699786|NCT03755934|156750555|FG000|Overall Study|Physician Decision|2|||
48699787|NCT03755934|156750556|FG001|Overall Study|Physician Decision|0|||
48699788|NCT03755934|156750557|FG002|Overall Study|Physician Decision|0|||
48699789|NCT03755934|156750558|FG003|Overall Study|Physician Decision|1|||
48699790|NCT03755934|156750555|FG000|Overall Study|Withdrawal by Subject|5|||
48699791|NCT03755934|156750556|FG001|Overall Study|Withdrawal by Subject|0|||
48699792|NCT03755934|156750557|FG002|Overall Study|Withdrawal by Subject|0|||
48699793|NCT03755934|156750558|FG003|Overall Study|Withdrawal by Subject|1|||
48699794|NCT03755934|156750555|FG000|Overall Study|Other|3|||
48911609|NCT01092143|157513073|FG003|Overall Study|Randomized by mistake|1|||
48911610|NCT01092143|157513074|FG004|Overall Study|Randomized by mistake|0|||
48911611|NCT01092143|157513070|FG000|Overall Study|Pregnancy|0|||
48911612|NCT01092143|157513071|FG001|Overall Study|Pregnancy|0|||
48911613|NCT01092143|157513072|FG002|Overall Study|Pregnancy|0|||
48911614|NCT01092143|157513073|FG003|Overall Study|Pregnancy|1|||
48911615|NCT01092143|157513074|FG004|Overall Study|Pregnancy|0|||
48911616|NCT02101021|157513075|FG000|Overall Study|Death|4|||
48911617|NCT02101021|157513076|FG001|Overall Study|Death|3|||
48911618|NCT02101021|157513077|FG002|Overall Study|Death|6|||
48911619|NCT02101021|157513078|FG003|Overall Study|Death|0|||
48911620|NCT02101021|157513079|FG004|Overall Study|Death|3|||
48911621|NCT02101021|157513075|FG000|Overall Study|Withdrew Consent from study|1|||
48911622|NCT02101021|157513076|FG001|Overall Study|Withdrew Consent from study|1|||
48911623|NCT02101021|157513077|FG002|Overall Study|Withdrew Consent from study|0|||
48911624|NCT02101021|157513078|FG003|Overall Study|Withdrew Consent from study|2|||
48911625|NCT02101021|157513079|FG004|Overall Study|Withdrew Consent from study|0|||
48911626|NCT02101021|157513075|FG000|Overall Study|Lost to Follow-up|1|||
48911627|NCT02101021|157513076|FG001|Overall Study|Lost to Follow-up|0|||
48911628|NCT02101021|157513077|FG002|Overall Study|Lost to Follow-up|0|||
48911629|NCT02101021|157513078|FG003|Overall Study|Lost to Follow-up|0|||
48699795|NCT03755934|156750556|FG001|Overall Study|Other|1|||
48699796|NCT03755934|156750557|FG002|Overall Study|Other|3|||
48699797|NCT03755934|156750558|FG003|Overall Study|Other|1|||
48911630|NCT02101021|157513079|FG004|Overall Study|Lost to Follow-up|0|||
48911631|NCT02101021|157513075|FG000|Overall Study|Study Terminated by Sponsor|1|||
48911632|NCT02101021|157513076|FG001|Overall Study|Study Terminated by Sponsor|0|||
48911633|NCT02101021|157513077|FG002|Overall Study|Study Terminated by Sponsor|1|||
48911634|NCT02101021|157513078|FG003|Overall Study|Study Terminated by Sponsor|1|||
48911635|NCT02101021|157513079|FG004|Overall Study|Study Terminated by Sponsor|1|||
48699798|NCT01056822|156750559|FG000|Overall Study|Adverse Event|0|||
48699799|NCT01056822|156750560|FG001|Overall Study|Adverse Event|1|||
48699800|NCT01056822|156750559|FG000|Overall Study|Protocol Violation|6|||
48699801|NCT01056822|156750560|FG001|Overall Study|Protocol Violation|5|||
48911636|NCT01721057|157513081|FG000|Treatment Period|Withdrawal by Subject|11|||
48699802|NCT01056822|156750559|FG000|Overall Study|Withdrawal by Subject|1|||
48699803|NCT01056822|156750560|FG001|Overall Study|Withdrawal by Subject|1|||
48699804|NCT01056822|156750559|FG000|Overall Study|Lost to Follow-up|1|||
48699805|NCT01056822|156750560|FG001|Overall Study|Lost to Follow-up|0|||
48699806|NCT03558737|156750564|FG000|Overall Study|Death|1|||
48699807|NCT03558737|156750565|FG001|Overall Study|Death|1|||
48699808|NCT00453206|156750566|FG000|Overall Study|Death|1|||
48699809|NCT01394016|156750567|FG000|Overall Study|Progressive Disease|2|||
48699810|NCT01394016|156750568|FG001|Overall Study|Progressive Disease|0|||
48699811|NCT01394016|156750569|FG002|Overall Study|Progressive Disease|0|||
48699812|NCT01394016|156750570|FG003|Overall Study|Progressive Disease|0|||
48699813|NCT01394016|156750571|FG004|Overall Study|Progressive Disease|0|||
48699814|NCT01394016|156750572|FG005|Overall Study|Progressive Disease|0|||
48699815|NCT01394016|156750573|FG006|Overall Study|Progressive Disease|0|||
48699816|NCT01394016|156750574|FG007|Overall Study|Progressive Disease|0|||
48699817|NCT01394016|156750575|FG008|Overall Study|Progressive Disease|0|||
48699818|NCT01394016|156750576|FG009|Overall Study|Progressive Disease|0|||
48699819|NCT01394016|156750577|FG010|Overall Study|Progressive Disease|0|||
48699820|NCT01394016|156750578|FG011|Overall Study|Progressive Disease|0|||
48699821|NCT01394016|156750579|FG012|Overall Study|Progressive Disease|0|||
48699822|NCT01394016|156750580|FG013|Overall Study|Progressive Disease|0|||
48699823|NCT01394016|156750581|FG014|Overall Study|Progressive Disease|0|||
48699824|NCT01394016|156750582|FG015|Overall Study|Progressive Disease|0|||
48699825|NCT01394016|156750583|FG016|Overall Study|Progressive Disease|0|||
48699826|NCT01394016|156750584|FG017|Overall Study|Progressive Disease|0|||
48699827|NCT01394016|156750585|FG018|Overall Study|Progressive Disease|0|||
48699828|NCT01394016|156750567|FG000|Overall Study|Withdrawal by Subject|0|||
48699829|NCT01394016|156750568|FG001|Overall Study|Withdrawal by Subject|0|||
48699830|NCT01394016|156750569|FG002|Overall Study|Withdrawal by Subject|0|||
48699831|NCT01394016|156750570|FG003|Overall Study|Withdrawal by Subject|0|||
48699832|NCT01394016|156750571|FG004|Overall Study|Withdrawal by Subject|0|||
48699833|NCT01394016|156750572|FG005|Overall Study|Withdrawal by Subject|0|||
48699834|NCT01394016|156750573|FG006|Overall Study|Withdrawal by Subject|0|||
48699835|NCT01394016|156750574|FG007|Overall Study|Withdrawal by Subject|1|||
48699836|NCT01394016|156750575|FG008|Overall Study|Withdrawal by Subject|1|||
48699837|NCT01394016|156750576|FG009|Overall Study|Withdrawal by Subject|1|||
48699838|NCT01394016|156750577|FG010|Overall Study|Withdrawal by Subject|4|||
48699839|NCT01394016|156750578|FG011|Overall Study|Withdrawal by Subject|0|||
48699840|NCT01394016|156750579|FG012|Overall Study|Withdrawal by Subject|0|||
48699841|NCT01394016|156750580|FG013|Overall Study|Withdrawal by Subject|3|||
48699842|NCT01394016|156750581|FG014|Overall Study|Withdrawal by Subject|1|||
48699843|NCT01394016|156750582|FG015|Overall Study|Withdrawal by Subject|3|||
48699844|NCT01394016|156750583|FG016|Overall Study|Withdrawal by Subject|1|||
48699845|NCT01394016|156750584|FG017|Overall Study|Withdrawal by Subject|1|||
48699846|NCT01394016|156750585|FG018|Overall Study|Withdrawal by Subject|2|||
48911637|NCT01721057|157513082|FG001|Treatment Period|Withdrawal by Subject|5|||
48911638|NCT01721057|157513083|FG002|Treatment Period|Withdrawal by Subject|8|||
48911639|NCT01721057|157513084|FG003|Treatment Period|Withdrawal by Subject|0|||
48911640|NCT01721057|157513085|FG004|Treatment Period|Withdrawal by Subject|0|||
48911641|NCT01721057|157513086|FG005|Treatment Period|Withdrawal by Subject|0|||
48911642|NCT01721057|157513087|FG006|Treatment Period|Withdrawal by Subject|0|||
48911643|NCT01721057|157513081|FG000|Treatment Period|Adverse Event|7|||
48911644|NCT01721057|157513082|FG001|Treatment Period|Adverse Event|10|||
48911645|NCT01721057|157513083|FG002|Treatment Period|Adverse Event|12|||
48911646|NCT01721057|157513084|FG003|Treatment Period|Adverse Event|0|||
48911647|NCT01721057|157513085|FG004|Treatment Period|Adverse Event|0|||
48911648|NCT01721057|157513086|FG005|Treatment Period|Adverse Event|0|||
48911649|NCT01721057|157513087|FG006|Treatment Period|Adverse Event|0|||
48911650|NCT01721057|157513081|FG000|Treatment Period|Lack of Efficacy|7|||
48911651|NCT01721057|157513082|FG001|Treatment Period|Lack of Efficacy|3|||
48911652|NCT01721057|157513083|FG002|Treatment Period|Lack of Efficacy|0|||
48911653|NCT01721057|157513084|FG003|Treatment Period|Lack of Efficacy|0|||
48911654|NCT01721057|157513085|FG004|Treatment Period|Lack of Efficacy|0|||
49116403|NCT03538691|158263092|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
48699847|NCT01394016|156750567|FG000|Overall Study|Adverse Event|0|||
48699848|NCT01394016|156750568|FG001|Overall Study|Adverse Event|0|||
48699849|NCT01394016|156750569|FG002|Overall Study|Adverse Event|0|||
48699850|NCT01394016|156750570|FG003|Overall Study|Adverse Event|0|||
48699851|NCT01394016|156750571|FG004|Overall Study|Adverse Event|0|||
48699852|NCT01394016|156750572|FG005|Overall Study|Adverse Event|0|||
48699853|NCT01394016|156750573|FG006|Overall Study|Adverse Event|0|||
48911655|NCT01721057|157513086|FG005|Treatment Period|Lack of Efficacy|0|||
48911656|NCT01721057|157513087|FG006|Treatment Period|Lack of Efficacy|0|||
48699854|NCT01394016|156750574|FG007|Overall Study|Adverse Event|0|||
48699855|NCT01394016|156750575|FG008|Overall Study|Adverse Event|0|||
48699856|NCT01394016|156750576|FG009|Overall Study|Adverse Event|1|||
48699857|NCT01394016|156750577|FG010|Overall Study|Adverse Event|0|||
48699858|NCT01394016|156750578|FG011|Overall Study|Adverse Event|0|||
48911657|NCT01721057|157513081|FG000|Treatment Period|Lost to Follow-up|1|||
48911658|NCT01721057|157513082|FG001|Treatment Period|Lost to Follow-up|0|||
48911659|NCT01721057|157513083|FG002|Treatment Period|Lost to Follow-up|0|||
48699859|NCT01394016|156750579|FG012|Overall Study|Adverse Event|0|||
48699860|NCT01394016|156750580|FG013|Overall Study|Adverse Event|0|||
48911660|NCT01721057|157513084|FG003|Treatment Period|Lost to Follow-up|0|||
48911661|NCT01721057|157513085|FG004|Treatment Period|Lost to Follow-up|0|||
48699861|NCT01394016|156750581|FG014|Overall Study|Adverse Event|0|||
48699862|NCT01394016|156750582|FG015|Overall Study|Adverse Event|0|||
48699863|NCT01394016|156750583|FG016|Overall Study|Adverse Event|1|||
48699864|NCT01394016|156750584|FG017|Overall Study|Adverse Event|1|||
48699865|NCT01394016|156750585|FG018|Overall Study|Adverse Event|0|||
48699866|NCT01394016|156750567|FG000|Overall Study|Sponsor Decision|0|||
48699867|NCT01394016|156750568|FG001|Overall Study|Sponsor Decision|0|||
48699868|NCT01394016|156750569|FG002|Overall Study|Sponsor Decision|0|||
48699869|NCT01394016|156750570|FG003|Overall Study|Sponsor Decision|0|||
48699870|NCT01394016|156750571|FG004|Overall Study|Sponsor Decision|0|||
48699871|NCT01394016|156750572|FG005|Overall Study|Sponsor Decision|0|||
48699872|NCT01394016|156750573|FG006|Overall Study|Sponsor Decision|0|||
48699873|NCT01394016|156750574|FG007|Overall Study|Sponsor Decision|0|||
48699874|NCT01394016|156750575|FG008|Overall Study|Sponsor Decision|0|||
48699875|NCT01394016|156750576|FG009|Overall Study|Sponsor Decision|0|||
48699876|NCT01394016|156750577|FG010|Overall Study|Sponsor Decision|0|||
48699877|NCT01394016|156750578|FG011|Overall Study|Sponsor Decision|0|||
48699878|NCT01394016|156750579|FG012|Overall Study|Sponsor Decision|1|||
48699879|NCT01394016|156750580|FG013|Overall Study|Sponsor Decision|0|||
48699880|NCT01394016|156750581|FG014|Overall Study|Sponsor Decision|0|||
48699881|NCT01394016|156750582|FG015|Overall Study|Sponsor Decision|0|||
48699882|NCT01394016|156750583|FG016|Overall Study|Sponsor Decision|0|||
48699883|NCT01394016|156750584|FG017|Overall Study|Sponsor Decision|0|||
48699884|NCT01394016|156750585|FG018|Overall Study|Sponsor Decision|0|||
48699885|NCT01394016|156750567|FG000|Overall Study|Lost to Follow-up|0|||
48699886|NCT01394016|156750568|FG001|Overall Study|Lost to Follow-up|0|||
48699887|NCT01394016|156750569|FG002|Overall Study|Lost to Follow-up|0|||
48699888|NCT01394016|156750570|FG003|Overall Study|Lost to Follow-up|0|||
48699889|NCT01394016|156750571|FG004|Overall Study|Lost to Follow-up|0|||
48699890|NCT01394016|156750572|FG005|Overall Study|Lost to Follow-up|0|||
48699891|NCT01394016|156750573|FG006|Overall Study|Lost to Follow-up|0|||
48699892|NCT01394016|156750574|FG007|Overall Study|Lost to Follow-up|0|||
48699893|NCT01394016|156750575|FG008|Overall Study|Lost to Follow-up|0|||
48699894|NCT01394016|156750576|FG009|Overall Study|Lost to Follow-up|0|||
48699895|NCT01394016|156750577|FG010|Overall Study|Lost to Follow-up|0|||
48699896|NCT01394016|156750578|FG011|Overall Study|Lost to Follow-up|0|||
48699897|NCT01394016|156750579|FG012|Overall Study|Lost to Follow-up|0|||
48699898|NCT01394016|156750580|FG013|Overall Study|Lost to Follow-up|0|||
48699899|NCT01394016|156750581|FG014|Overall Study|Lost to Follow-up|0|||
48699900|NCT01394016|156750582|FG015|Overall Study|Lost to Follow-up|0|||
48699901|NCT01394016|156750583|FG016|Overall Study|Lost to Follow-up|0|||
48699902|NCT01394016|156750584|FG017|Overall Study|Lost to Follow-up|0|||
48699903|NCT01394016|156750585|FG018|Overall Study|Lost to Follow-up|1|||
48699904|NCT04123470|156750586|FG000|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|4|||
48699905|NCT04123470|156750587|FG001|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|0|||
48699906|NCT04123470|156750586|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|0|||
48699907|NCT04123470|156750587|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|1|||
48699908|NCT04123470|156750586|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|0|||
48699909|NCT04123470|156750587|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|7|||
48699910|NCT04123470|156750586|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|0|||
48699911|NCT04123470|156750587|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|1|||
48699912|NCT04825678|156750592|FG000|Overall Study|Decision by Sponsor|2|||
48911662|NCT01721057|157513086|FG005|Treatment Period|Lost to Follow-up|0|||
48911663|NCT01721057|157513087|FG006|Treatment Period|Lost to Follow-up|0|||
48911664|NCT01721057|157513081|FG000|Treatment Period|Physician Decision|0|||
48911665|NCT01721057|157513082|FG001|Treatment Period|Physician Decision|1|||
48699913|NCT04825678|156750593|FG001|Overall Study|Decision by Sponsor|3|||
48699914|NCT04825678|156750592|FG000|Overall Study|Withdrawal of Consent From Study|7|||
48699915|NCT04825678|156750593|FG001|Overall Study|Withdrawal of Consent From Study|9|||
48699916|NCT04825678|156750592|FG000|Overall Study|Lost to Follow-up|3|||
48699917|NCT04825678|156750593|FG001|Overall Study|Lost to Follow-up|4|||
48699918|NCT04825678|156750592|FG000|Overall Study|Never Received Investigational Product|1|||
48699919|NCT04825678|156750593|FG001|Overall Study|Never Received Investigational Product|1|||
48699920|NCT00651742|156750595|FG000|Overall Study|Objective Disease Progression|22|||
48699921|NCT00651742|156750595|FG000|Overall Study|Toxicity|3|||
48699922|NCT00651742|156750595|FG000|Overall Study|Investigator Judgment|1|||
48699923|NCT00651742|156750595|FG000|Overall Study|Withdrawal of Consent|1|||
48699924|NCT00651742|156750595|FG000|Overall Study|Enrolled but not treated|1|||
48951825|NCT00592358|157654906|FG000|Overall Study|Adverse Event|1|||
48699925|NCT04780061|156750600|FG000|Overall Study|Withdrawal by Subject|5|||
48699926|NCT04780061|156750601|FG001|Overall Study|Withdrawal by Subject|8|||
48699927|NCT04780061|156750600|FG000|Overall Study|Adverse Event|2|||
48699928|NCT04780061|156750601|FG001|Overall Study|Adverse Event|2|||
48699929|NCT04780061|156750600|FG000|Overall Study|Lost to Follow-up|1|||
48699930|NCT04780061|156750601|FG001|Overall Study|Lost to Follow-up|5|||
48699931|NCT00734149|156750602|FG000|Overall Study|Withdrawal by Subject|1|||
48699932|NCT04607005|156750603|FG000|Overall Study|Adverse Event|0|||
48699933|NCT04607005|156750604|FG001|Overall Study|Adverse Event|1|||
48699934|NCT04607005|156750603|FG000|Overall Study|Lack of Efficacy|1|||
48699935|NCT04607005|156750604|FG001|Overall Study|Lack of Efficacy|6|||
48699936|NCT04607005|156750603|FG000|Overall Study|Withdrawal by Subject|4|||
48699937|NCT04607005|156750604|FG001|Overall Study|Withdrawal by Subject|9|||
48699938|NCT04607005|156750603|FG000|Overall Study|Participant reached protocol-defined stopping criteria|1|||
48699939|NCT04607005|156750604|FG001|Overall Study|Participant reached protocol-defined stopping criteria|0|||
48699940|NCT03043794|156750607|FG000|Overall Study|Lost to Follow-up|1|||
48699941|NCT03173560|156750608|FG000|Overall Study|Ongoing on Treatment|38|||
48699942|NCT03173560|156750609|FG001|Overall Study|Ongoing on Treatment|50|||
48699943|NCT03173560|156750608|FG000|Overall Study|Ongoing Survival Follow-up|56|||
48699944|NCT03173560|156750609|FG001|Overall Study|Ongoing Survival Follow-up|57|||
48699945|NCT03173560|156750608|FG000|Overall Study|Lost to Follow-up|1|||
48699946|NCT03173560|156750609|FG001|Overall Study|Lost to Follow-up|4|||
48699947|NCT03173560|156750608|FG000|Overall Study|Withdrawal by Subject|10|||
48699948|NCT03173560|156750609|FG001|Overall Study|Withdrawal by Subject|5|||
48699949|NCT03173560|156750608|FG000|Overall Study|Other|0|||
48699950|NCT03173560|156750609|FG001|Overall Study|Other|1|||
48699951|NCT02807402|156750612|FG000|Overall Study|Failure to Return|1|||
48699952|NCT02807402|156750612|FG000|Overall Study|Death|3|||
48699953|NCT02807402|156750612|FG000|Overall Study|Other|2|||
48699954|NCT01972217|156751774|FG000|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
48699955|NCT01972217|156751775|FG001|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1|||
48699956|NCT01972217|156751776|FG002|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
48699957|NCT01972217|156751777|FG003|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
48699958|NCT01972217|156751774|FG000|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1|||
48699959|NCT01972217|156751775|FG001|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9|||
49010536|NCT03558997|157875646|FG000|Overall Study|Physician Decision|0|||
49010537|NCT03558997|157875647|FG001|Overall Study|Physician Decision|0|||
49010538|NCT03558997|157875648|FG002|Overall Study|Physician Decision|1|||
49010539|NCT03558997|157875649|FG003|Overall Study|Physician Decision|0|||
49010540|NCT03558997|157875646|FG000|Overall Study|Withdrawal by Subject|1|||
49010541|NCT03558997|157875647|FG001|Overall Study|Withdrawal by Subject|0|||
49010542|NCT03558997|157875648|FG002|Overall Study|Withdrawal by Subject|1|||
49010543|NCT03558997|157875649|FG003|Overall Study|Withdrawal by Subject|1|||
49010544|NCT03558997|157875646|FG000|Overall Study|Lost to Follow-up|0|||
49010545|NCT03558997|157875647|FG001|Overall Study|Lost to Follow-up|0|||
49010546|NCT03558997|157875648|FG002|Overall Study|Lost to Follow-up|1|||
49010547|NCT03558997|157875649|FG003|Overall Study|Lost to Follow-up|0|||
49010548|NCT00895583|157875650|FG000|Overall Study|Adverse Event|28|||
49010549|NCT00895583|157875651|FG001|Overall Study|Adverse Event|4|||
49010550|NCT00895583|157875650|FG000|Overall Study|Death|2|||
49010551|NCT00895583|157875651|FG001|Overall Study|Death|1|||
49010552|NCT00895583|157875650|FG000|Overall Study|Physician Decision|3|||
49010553|NCT00895583|157875651|FG001|Overall Study|Physician Decision|1|||
49010554|NCT00895583|157875650|FG000|Overall Study|Lost to Follow-up|1|||
49010555|NCT00895583|157875651|FG001|Overall Study|Lost to Follow-up|3|||
49010556|NCT00895583|157875650|FG000|Overall Study|Protocol Violation|1|||
49010557|NCT00895583|157875651|FG001|Overall Study|Protocol Violation|0|||
49010558|NCT00895583|157875650|FG000|Overall Study|Withdrawal by Subject|4|||
49010559|NCT00895583|157875651|FG001|Overall Study|Withdrawal by Subject|2|||
49010560|NCT00895583|157875650|FG000|Overall Study|Lack of Efficacy|5|||
49010561|NCT00895583|157875651|FG001|Overall Study|Lack of Efficacy|0|||
49010562|NCT00895583|157875650|FG000|Overall Study|Other|0|||
49010563|NCT00895583|157875651|FG001|Overall Study|Other|1|||
49010564|NCT00409578|157875656|FG000|Overall Study|Adverse Event|27|||
49010565|NCT00409578|157875657|FG001|Overall Study|Adverse Event|37|||
49010566|NCT00409578|157875658|FG002|Overall Study|Adverse Event|25|||
49010567|NCT00409578|157875659|FG003|Overall Study|Adverse Event|33|||
49010568|NCT00409578|157875656|FG000|Overall Study|Abnormal laboratory value(s)|2|||
49010569|NCT00409578|157875657|FG001|Overall Study|Abnormal laboratory value(s)|2|||
49010570|NCT00409578|157875658|FG002|Overall Study|Abnormal laboratory value(s)|2|||
49010571|NCT00409578|157875659|FG003|Overall Study|Abnormal laboratory value(s)|4|||
49010572|NCT00409578|157875656|FG000|Overall Study|Lack of Efficacy|0|||
49010573|NCT00409578|157875657|FG001|Overall Study|Lack of Efficacy|0|||
49010574|NCT00409578|157875658|FG002|Overall Study|Lack of Efficacy|0|||
49010575|NCT00409578|157875659|FG003|Overall Study|Lack of Efficacy|2|||
49010576|NCT00409578|157875656|FG000|Overall Study|Subject no longer requires study drug|0|||
49010577|NCT00409578|157875657|FG001|Overall Study|Subject no longer requires study drug|0|||
49116404|NCT03538691|158263093|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
49116405|NCT03538691|158263094|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|54|||
49116406|NCT03538691|158263095|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|52|||
49116407|NCT03538691|158263092|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
49116408|NCT03538691|158263093|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
49116409|NCT03538691|158263094|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
49116410|NCT03538691|158263095|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|1|||
48699960|NCT01972217|156751776|FG002|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
48699961|NCT01972217|156751777|FG003|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
48699962|NCT01972217|156751774|FG000|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
48699963|NCT01972217|156751775|FG001|Part A: Open-label Safety Run-in Period|Adverse Event|1|||
48699964|NCT01972217|156751776|FG002|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
48911666|NCT01721057|157513083|FG002|Treatment Period|Physician Decision|3|||
48911667|NCT01721057|157513084|FG003|Treatment Period|Physician Decision|0|||
48911668|NCT01721057|157513085|FG004|Treatment Period|Physician Decision|0|||
48911669|NCT01721057|157513086|FG005|Treatment Period|Physician Decision|0|||
48911670|NCT01721057|157513087|FG006|Treatment Period|Physician Decision|0|||
48911671|NCT01721057|157513081|FG000|Treatment Period|Death|2|||
48911672|NCT01721057|157513082|FG001|Treatment Period|Death|0|||
48911673|NCT01721057|157513083|FG002|Treatment Period|Death|0|||
48911674|NCT01721057|157513084|FG003|Treatment Period|Death|0|||
48911675|NCT01721057|157513085|FG004|Treatment Period|Death|0|||
48911676|NCT01721057|157513086|FG005|Treatment Period|Death|0|||
48911677|NCT01721057|157513087|FG006|Treatment Period|Death|0|||
48911678|NCT01721057|157513081|FG000|Rescue Period|Adverse Event|0|||
48911679|NCT01721057|157513082|FG001|Rescue Period|Adverse Event|0|||
48911680|NCT01721057|157513083|FG002|Rescue Period|Adverse Event|0|||
48911681|NCT01721057|157513084|FG003|Rescue Period|Adverse Event|1|||
48911682|NCT01721057|157513085|FG004|Rescue Period|Adverse Event|0|||
48911683|NCT01721057|157513086|FG005|Rescue Period|Adverse Event|0|||
48911684|NCT01721057|157513087|FG006|Rescue Period|Adverse Event|0|||
48699965|NCT01972217|156751777|FG003|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
48699966|NCT01972217|156751774|FG000|Part A: Open-label Safety Run-in Period|Death|0|||
48699967|NCT01972217|156751775|FG001|Part A: Open-label Safety Run-in Period|Death|1|||
48699968|NCT01972217|156751776|FG002|Part A: Open-label Safety Run-in Period|Death|0|||
48699969|NCT01972217|156751777|FG003|Part A: Open-label Safety Run-in Period|Death|0|||
48699970|NCT01972217|156751774|FG000|Part B Double-blind, Randomised Period|Death|0|||
48699971|NCT01972217|156751775|FG001|Part B Double-blind, Randomised Period|Death|0|||
48699972|NCT01972217|156751776|FG002|Part B Double-blind, Randomised Period|Death|43|||
48699973|NCT01972217|156751777|FG003|Part B Double-blind, Randomised Period|Death|44|||
48699974|NCT01972217|156751774|FG000|Part B Double-blind, Randomised Period|Reason not recorded|0|||
48699975|NCT01972217|156751775|FG001|Part B Double-blind, Randomised Period|Reason not recorded|0|||
48699976|NCT01972217|156751776|FG002|Part B Double-blind, Randomised Period|Reason not recorded|1|||
48699977|NCT01972217|156751777|FG003|Part B Double-blind, Randomised Period|Reason not recorded|0|||
48699978|NCT01972217|156751774|FG000|Part B Double-blind, Randomised Period|Screen failure|0|||
48699979|NCT01972217|156751775|FG001|Part B Double-blind, Randomised Period|Screen failure|0|||
48699980|NCT01972217|156751776|FG002|Part B Double-blind, Randomised Period|Screen failure|0|||
48699981|NCT01972217|156751777|FG003|Part B Double-blind, Randomised Period|Screen failure|1|||
48699982|NCT01972217|156751774|FG000|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
48699983|NCT01972217|156751775|FG001|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
48699984|NCT01972217|156751776|FG002|Part B Double-blind, Randomised Period|Lost to Follow-up|2|||
48699985|NCT01972217|156751777|FG003|Part B Double-blind, Randomised Period|Lost to Follow-up|1|||
48699986|NCT01972217|156751774|FG000|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
48699987|NCT01972217|156751775|FG001|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
48699988|NCT01972217|156751776|FG002|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
48699989|NCT01972217|156751777|FG003|Part B Double-blind, Randomised Period|Withdrawal by Subject|1|||
48699990|NCT01910298|156751778|FG000|Overall Study|Adverse Event|1|||
48699991|NCT01910298|156751779|FG001|Overall Study|Adverse Event|0|||
48699992|NCT01910298|156751778|FG000|Overall Study|Withdrawal by Subject|2|||
48699993|NCT01910298|156751779|FG001|Overall Study|Withdrawal by Subject|7|||
48699994|NCT01910298|156751778|FG000|Overall Study|Protocol Deviation|0|||
48699995|NCT01910298|156751779|FG001|Overall Study|Protocol Deviation|5|||
48699996|NCT01910298|156751778|FG000|Overall Study|Lost to Follow-up|1|||
48699997|NCT01910298|156751779|FG001|Overall Study|Lost to Follow-up|1|||
48699998|NCT01910298|156751778|FG000|Overall Study|Study Terminated by Sponsor|1|||
48699999|NCT01910298|156751779|FG001|Overall Study|Study Terminated by Sponsor|17|||
48700000|NCT01910298|156751778|FG000|Overall Study|Other Miscellaneous Reasons|0|||
48911685|NCT01721057|157513081|FG000|Rescue Period|Lack of Efficacy|0|||
48911686|NCT01721057|157513082|FG001|Rescue Period|Lack of Efficacy|0|||
48911687|NCT01721057|157513083|FG002|Rescue Period|Lack of Efficacy|0|||
48911688|NCT01721057|157513084|FG003|Rescue Period|Lack of Efficacy|2|||
48911689|NCT01721057|157513085|FG004|Rescue Period|Lack of Efficacy|0|||
48911690|NCT01721057|157513086|FG005|Rescue Period|Lack of Efficacy|0|||
48911691|NCT01721057|157513087|FG006|Rescue Period|Lack of Efficacy|0|||
48911692|NCT01177683|157513088|FG000|Study Treatment|Disease Progressions during treatment|2|||
48911693|NCT01177683|157513089|FG001|Study Treatment|Disease Progressions during treatment|0|||
48911694|NCT01177683|157513090|FG002|Study Treatment|Disease Progressions during treatment|3|||
48911695|NCT01177683|157513088|FG000|Study Treatment|Adverse Event|0|||
48911696|NCT01177683|157513089|FG001|Study Treatment|Adverse Event|1|||
49116411|NCT03538691|158263092|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
49116412|NCT03538691|158263093|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
49116413|NCT03538691|158263094|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|4|||
48700001|NCT01910298|156751779|FG001|Overall Study|Other Miscellaneous Reasons|2|||
48700002|NCT03591406|156751783|FG000|Overall Study|Adverse Event|5|||
48700003|NCT03591406|156751784|FG001|Overall Study|Adverse Event|3|||
48700004|NCT03591406|156751783|FG000|Overall Study|Protocol Violation|2|||
48700005|NCT03591406|156751784|FG001|Overall Study|Protocol Violation|1|||
48700006|NCT03591406|156751783|FG000|Overall Study|Withdrawal by Subject|0|||
48700007|NCT03591406|156751784|FG001|Overall Study|Withdrawal by Subject|5|||
48700008|NCT02536976|156751785|FG000|Overall Study|Physician Decision|0|||
48700009|NCT02536976|156751786|FG001|Overall Study|Physician Decision|1|||
48700010|NCT02992288|156751788|FG000|Overall Study|Adverse Event|8|||
48700011|NCT02992288|156751789|FG001|Overall Study|Adverse Event|2|||
48700012|NCT02992288|156751790|FG002|Overall Study|Adverse Event|2|||
48700013|NCT02992288|156751791|FG003|Overall Study|Adverse Event|2|||
48700014|NCT02992288|156751792|FG004|Overall Study|Adverse Event|2|||
48700015|NCT02992288|156751793|FG005|Overall Study|Adverse Event|7|||
48700016|NCT02992288|156751788|FG000|Overall Study|Non-compliance with study drug|0|||
48700017|NCT02992288|156751789|FG001|Overall Study|Non-compliance with study drug|1|||
48700018|NCT02992288|156751790|FG002|Overall Study|Non-compliance with study drug|1|||
48700019|NCT02992288|156751791|FG003|Overall Study|Non-compliance with study drug|0|||
48700020|NCT02992288|156751792|FG004|Overall Study|Non-compliance with study drug|1|||
48700021|NCT02992288|156751793|FG005|Overall Study|Non-compliance with study drug|0|||
48700022|NCT02992288|156751788|FG000|Overall Study|Physician Decision|3|||
48700023|NCT02992288|156751789|FG001|Overall Study|Physician Decision|0|||
48700024|NCT02992288|156751790|FG002|Overall Study|Physician Decision|1|||
48700025|NCT02992288|156751791|FG003|Overall Study|Physician Decision|0|||
48700026|NCT02992288|156751792|FG004|Overall Study|Physician Decision|0|||
48700027|NCT02992288|156751793|FG005|Overall Study|Physician Decision|1|||
48700028|NCT02992288|156751788|FG000|Overall Study|Death|2|||
48700029|NCT02992288|156751789|FG001|Overall Study|Death|0|||
48911697|NCT01177683|157513090|FG002|Study Treatment|Adverse Event|12|||
49116414|NCT03538691|158263095|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|6|||
49116415|NCT00765817|158263096|FG000|Overall Study|Adverse Event|13|||
49116416|NCT00765817|158263097|FG001|Overall Study|Adverse Event|1|||
49116417|NCT00765817|158263096|FG000|Overall Study|Death|0|||
49116418|NCT00765817|158263097|FG001|Overall Study|Death|1|||
48911698|NCT01177683|157513088|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
48911699|NCT01177683|157513089|FG001|Study Treatment|Patient Withdrawal After Therapy Start|2|||
48911700|NCT01177683|157513090|FG002|Study Treatment|Patient Withdrawal After Therapy Start|1|||
48911701|NCT01177683|157513088|FG000|Study Treatment|Alternative therapy|0|||
48911702|NCT01177683|157513089|FG001|Study Treatment|Alternative therapy|0|||
48911703|NCT01177683|157513090|FG002|Study Treatment|Alternative therapy|4|||
48911704|NCT01177683|157513088|FG000|Study Treatment|Physician Decision|1|||
48911705|NCT01177683|157513089|FG001|Study Treatment|Physician Decision|0|||
48911706|NCT01177683|157513090|FG002|Study Treatment|Physician Decision|1|||
48911707|NCT01177683|157513088|FG000|Study Treatment|Patient withdrawal before therapy start|0|||
48911708|NCT01177683|157513089|FG001|Study Treatment|Patient withdrawal before therapy start|0|||
48911709|NCT01177683|157513090|FG002|Study Treatment|Patient withdrawal before therapy start|1|||
48911710|NCT01177683|157513088|FG000|Study Treatment|Symptomatic Deterioration|0|||
48911711|NCT01177683|157513089|FG001|Study Treatment|Symptomatic Deterioration|0|||
48911712|NCT01177683|157513090|FG002|Study Treatment|Symptomatic Deterioration|1|||
48911713|NCT01177683|157513088|FG000|Study Treatment|Subject came off study without receiving any treatment.|0|||
49116419|NCT00765817|158263096|FG000|Overall Study|Entry criteria not met|2|||
49116420|NCT00765817|158263097|FG001|Overall Study|Entry criteria not met|2|||
48700030|NCT02992288|156751790|FG002|Overall Study|Death|2|||
48700031|NCT02992288|156751791|FG003|Overall Study|Death|1|||
48700032|NCT02992288|156751792|FG004|Overall Study|Death|2|||
48700033|NCT02992288|156751793|FG005|Overall Study|Death|0|||
48700034|NCT02992288|156751788|FG000|Overall Study|Lost to Follow-up|0|||
48700035|NCT02992288|156751789|FG001|Overall Study|Lost to Follow-up|0|||
48700036|NCT02992288|156751790|FG002|Overall Study|Lost to Follow-up|0|||
48700037|NCT02992288|156751791|FG003|Overall Study|Lost to Follow-up|1|||
48700038|NCT02992288|156751792|FG004|Overall Study|Lost to Follow-up|0|||
48911714|NCT01177683|157513089|FG001|Study Treatment|Subject came off study without receiving any treatment.|0|||
48911715|NCT01177683|157513090|FG002|Study Treatment|Subject came off study without receiving any treatment.|1|||
48911716|NCT01177683|157513088|FG000|Follow up|Patient lost to follow up|0|||
48911717|NCT01177683|157513089|FG001|Follow up|Patient lost to follow up|0|||
48911718|NCT01177683|157513090|FG002|Follow up|Patient lost to follow up|2|||
48911719|NCT01177683|157513088|FG000|Follow up|Death|2|||
48911720|NCT01177683|157513089|FG001|Follow up|Death|1|||
48911721|NCT01177683|157513090|FG002|Follow up|Death|7|||
48911722|NCT01177683|157513088|FG000|Follow up|Study closed by Sponsor due slow enrollment.|1|||
48911723|NCT01177683|157513089|FG001|Follow up|Study closed by Sponsor due slow enrollment.|2|||
48911724|NCT01177683|157513090|FG002|Follow up|Study closed by Sponsor due slow enrollment.|15|||
48911725|NCT03472924|157513091|FG000|Overall Study|Adverse Event|1|||
48911726|NCT03472924|157513092|FG001|Overall Study|Adverse Event|0|||
48911727|NCT05082376|157513095|FG000|Overall Study|Lost to Follow-up|2|||
48911728|NCT02228720|157513096|FG000|Open Label - Day 30|Lost to Follow-up|1|||
48911729|NCT01401842|157513097|FG000|Overall Study|Withdrawal by Subject|3|||
48911730|NCT01401842|157513098|FG001|Overall Study|Withdrawal by Subject|2|||
48911731|NCT01401842|157513097|FG000|Overall Study|academic reason|4|||
48911732|NCT01401842|157513098|FG001|Overall Study|academic reason|1|||
48911733|NCT01401842|157513097|FG000|Overall Study|changed companies|20|||
48911734|NCT01401842|157513098|FG001|Overall Study|changed companies|34|||
48911735|NCT01401842|157513097|FG000|Overall Study|discharged from US Army|3|||
48911736|NCT01401842|157513098|FG001|Overall Study|discharged from US Army|4|||
48911737|NCT01401842|157513097|FG000|Overall Study|invalid follow-up strength data|1|||
48911738|NCT01401842|157513098|FG001|Overall Study|invalid follow-up strength data|4|||
48911739|NCT01401842|157513097|FG000|Overall Study|on profile|9|||
48911740|NCT01401842|157513098|FG001|Overall Study|on profile|5|||
48911741|NCT01401842|157513097|FG000|Overall Study|other/unknown|28|||
48911742|NCT01401842|157513098|FG001|Overall Study|other/unknown|17|||
48700039|NCT02992288|156751793|FG005|Overall Study|Lost to Follow-up|0|||
48700040|NCT02992288|156751788|FG000|Overall Study|Protocol Violation|0|||
48700041|NCT02992288|156751789|FG001|Overall Study|Protocol Violation|0|||
48700042|NCT02992288|156751790|FG002|Overall Study|Protocol Violation|0|||
48700043|NCT02992288|156751791|FG003|Overall Study|Protocol Violation|0|||
48700044|NCT02992288|156751792|FG004|Overall Study|Protocol Violation|0|||
48700045|NCT02992288|156751793|FG005|Overall Study|Protocol Violation|1|||
48700046|NCT02992288|156751788|FG000|Overall Study|Withdrawal by Subject|4|||
48700047|NCT02992288|156751789|FG001|Overall Study|Withdrawal by Subject|2|||
48700048|NCT02992288|156751790|FG002|Overall Study|Withdrawal by Subject|1|||
48700049|NCT02992288|156751791|FG003|Overall Study|Withdrawal by Subject|5|||
48700050|NCT02992288|156751792|FG004|Overall Study|Withdrawal by Subject|3|||
48700051|NCT02992288|156751793|FG005|Overall Study|Withdrawal by Subject|4|||
48700052|NCT00581308|156751794|FG000|Pre Discharge|Lost to Follow-up|1|||
48700053|NCT00581308|156751794|FG000|Pre Discharge|Device Removed|1|||
48700054|NCT00581308|156751794|FG000|Month 1|Lost to Follow-up|3|||
48700055|NCT00581308|156751794|FG000|Month 1|Withdrawal by Subject|2|||
48700056|NCT00581308|156751794|FG000|Month 1|Device Removed|2|||
48700057|NCT00581308|156751794|FG000|Month 1|Uknown|1|||
48700058|NCT00581308|156751794|FG000|Month 6|Lost to Follow-up|1|||
48700059|NCT00581308|156751794|FG000|Month 6|Withdrawal by Subject|2|||
48700060|NCT00581308|156751794|FG000|Month 12|Death|1|||
48911743|NCT04869345|157513099|FG000|Overall Study|Lost to Follow-up|8|||
48911744|NCT04869345|157513100|FG001|Overall Study|Lost to Follow-up|3|||
48911745|NCT01979536|157513104|FG000|Overall Study|Physician Decision|2|||
48911746|NCT01979536|157513105|FG001|Overall Study|Physician Decision|3|||
48911747|NCT01979536|157513104|FG000|Overall Study|Withdrawal by Subject|0|||
48911748|NCT01979536|157513105|FG001|Overall Study|Withdrawal by Subject|1|||
48911749|NCT01979536|157513104|FG000|Overall Study|Refusal|0|||
48911750|NCT01979536|157513105|FG001|Overall Study|Refusal|1|||
48911751|NCT01979536|157513104|FG000|Overall Study|Relapse|0|||
48700061|NCT00581308|156751794|FG000|Month 12|Lost to Follow-up|14|||
48911752|NCT01979536|157513105|FG001|Overall Study|Relapse|1|||
48911753|NCT01979536|157513104|FG000|Overall Study|Study terminated by Sponsor|0|||
48911754|NCT01979536|157513105|FG001|Overall Study|Study terminated by Sponsor|1|||
48911755|NCT01979536|157513104|FG000|Overall Study|Did not start treatment|0|||
48700062|NCT00581308|156751794|FG000|Month 12|Withdrawal by Subject|3|||
48700063|NCT00581308|156751794|FG000|Month 12|Device Removed|1|||
48700064|NCT00581308|156751794|FG000|Month 12|Other|1|||
48700065|NCT04558125|156751796|FG000|Overall Study|Death|1|||
48700066|NCT01207414|156751798|FG000|Overall Study|Adverse Event|25|||
48700067|NCT01207414|156751799|FG001|Overall Study|Adverse Event|39|||
48700068|NCT01207414|156751798|FG000|Overall Study|Abnormal test procedure results|0|||
48700069|NCT01207414|156751799|FG001|Overall Study|Abnormal test procedure results|1|||
48700070|NCT01207414|156751798|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
48700071|NCT01207414|156751799|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
48700072|NCT01207414|156751798|FG000|Overall Study|Patient withdrew consent|14|||
48911756|NCT01979536|157513105|FG001|Overall Study|Did not start treatment|1|||
48700073|NCT01207414|156751799|FG001|Overall Study|Patient withdrew consent|11|||
48700074|NCT01207414|156751798|FG000|Overall Study|Lost to Follow-up|15|||
48700075|NCT01207414|156751799|FG001|Overall Study|Lost to Follow-up|17|||
48700076|NCT01207414|156751798|FG000|Overall Study|Administrative problems|1|||
48700077|NCT01207414|156751799|FG001|Overall Study|Administrative problems|1|||
48700078|NCT01207414|156751798|FG000|Overall Study|Protocol deviation|12|||
48700079|NCT01207414|156751799|FG001|Overall Study|Protocol deviation|9|||
48700080|NCT01207414|156751798|FG000|Overall Study|Randomized in error|1|||
48700081|NCT01207414|156751799|FG001|Overall Study|Randomized in error|0|||
48700082|NCT03448406|156751800|FG000|Overall Study|Noncompliance of scheduled visits|1|||
48700083|NCT03448406|156751801|FG001|Overall Study|Noncompliance of scheduled visits|2|||
48700084|NCT03448406|156751800|FG000|Overall Study|Withdrawal by Subject|1|||
48700085|NCT03448406|156751801|FG001|Overall Study|Withdrawal by Subject|2|||
48700086|NCT03448406|156751800|FG000|Overall Study|Protocol Violation|1|||
48700087|NCT03448406|156751801|FG001|Overall Study|Protocol Violation|0|||
48700088|NCT03448406|156751800|FG000|Overall Study|Adverse Event|8|||
48700089|NCT03448406|156751801|FG001|Overall Study|Adverse Event|9|||
48700090|NCT01292486|156751802|FG000|Overall Study|Protocol Violation|2|||
48700091|NCT01292486|156751802|FG000|Overall Study|Did not meet screening criteria|2|||
48700092|NCT01292486|156751802|FG000|Overall Study|Adverse Event|1|||
48700093|NCT01292486|156751802|FG000|Overall Study|Physician Decision|1|||
48700094|NCT04596267|156751804|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
48700095|NCT04596267|156751805|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
48700096|NCT04596267|156751804|FG000|Medication Dispense/Exposure Period 1|Physician Decision|0|||
48700097|NCT04596267|156751805|FG001|Medication Dispense/Exposure Period 1|Physician Decision|1|||
48700098|NCT02383576|156751806|FG000|Overall Study|Death|53|||
48700099|NCT02383576|156751807|FG001|Overall Study|Death|33|||
48700100|NCT02383576|156751806|FG000|Overall Study|Lost to Follow-up|7|||
48700101|NCT02383576|156751807|FG001|Overall Study|Lost to Follow-up|1|||
48700102|NCT02383576|156751806|FG000|Overall Study|Withdrew Consent|1|||
48700103|NCT02383576|156751807|FG001|Overall Study|Withdrew Consent|6|||
48700104|NCT02383576|156751806|FG000|Overall Study|Investigator's Decision|0|||
48700105|NCT02383576|156751807|FG001|Overall Study|Investigator's Decision|1|||
48700106|NCT02383576|156751806|FG000|Overall Study|Administrative/Other|2|||
48700107|NCT02383576|156751807|FG001|Overall Study|Administrative/Other|4|||
48700108|NCT04097678|156751810|FG000|Overall Study|No Radiographs Obtained During Surgery|17|||
48700109|NCT04097678|156751811|FG001|Overall Study|No Radiographs Obtained During Surgery|18|||
48700110|NCT02435212|156751812|FG000|Core Phase|Adverse Event|8|||
48700111|NCT02435212|156751813|FG001|Core Phase|Adverse Event|5|||
48700112|NCT02435212|156751812|FG000|Core Phase|Withdrawal by Subject|3|||
48700113|NCT02435212|156751813|FG001|Core Phase|Withdrawal by Subject|0|||
48700114|NCT02435212|156751812|FG000|Core Phase|Withdrawal by parent/guardian|9|||
48700115|NCT02435212|156751813|FG001|Core Phase|Withdrawal by parent/guardian|4|||
48700116|NCT02435212|156751812|FG000|Core Phase|Protocol Violation|1|||
48700117|NCT02435212|156751813|FG001|Core Phase|Protocol Violation|2|||
48700118|NCT02435212|156751812|FG000|Core Phase|Physician Decision|3|||
48700119|NCT02435212|156751813|FG001|Core Phase|Physician Decision|0|||
48700120|NCT02435212|156751812|FG000|Core Phase|Lost to Follow-up|0|||
48700121|NCT02435212|156751813|FG001|Core Phase|Lost to Follow-up|1|||
48700122|NCT02435212|156751812|FG000|Core Phase|Lack of Efficacy|0|||
48700123|NCT02435212|156751813|FG001|Core Phase|Lack of Efficacy|1|||
48700124|NCT02435212|156751812|FG000|Core Phase|Recovery|1|||
48700125|NCT02435212|156751813|FG001|Core Phase|Recovery|0|||
48700126|NCT02435212|156751812|FG000|Optional Extension Phase|Adverse Event|3|||
48700127|NCT02435212|156751813|FG001|Optional Extension Phase|Adverse Event|9|||
48911757|NCT00528021|157513106|FG000|Overall Study|Lack of Efficacy|17|||
48700128|NCT02435212|156751812|FG000|Optional Extension Phase|Physician Decision|6|||
48700129|NCT02435212|156751813|FG001|Optional Extension Phase|Physician Decision|8|||
48700130|NCT02435212|156751812|FG000|Optional Extension Phase|Withdrawal by parent/guardian|10|||
48700131|NCT02435212|156751813|FG001|Optional Extension Phase|Withdrawal by parent/guardian|7|||
48700132|NCT02435212|156751812|FG000|Optional Extension Phase|Lack of Efficacy|2|||
48700133|NCT02435212|156751813|FG001|Optional Extension Phase|Lack of Efficacy|3|||
48700134|NCT02435212|156751812|FG000|Optional Extension Phase|Withdrawal by Subject|2|||
48700135|NCT02435212|156751813|FG001|Optional Extension Phase|Withdrawal by Subject|2|||
48700136|NCT02435212|156751812|FG000|Optional Extension Phase|Protocol Violation|0|||
48700137|NCT02435212|156751813|FG001|Optional Extension Phase|Protocol Violation|1|||
48700138|NCT02435212|156751812|FG000|Optional Extension Phase|Recovery|1|||
48700139|NCT02435212|156751813|FG001|Optional Extension Phase|Recovery|1|||
48700140|NCT02435212|156751812|FG000|Optional Extension Phase|Death|1|||
48700141|NCT02435212|156751813|FG001|Optional Extension Phase|Death|0|||
48700142|NCT02435212|156751812|FG000|Optional Extension Phase|Technical problems|2|||
48700143|NCT02435212|156751813|FG001|Optional Extension Phase|Technical problems|0|||
48700144|NCT01502293|156751819|FG000|Overall Study|Progressive Disease|20|||
48700145|NCT01502293|156751820|FG001|Overall Study|Progressive Disease|12|||
48700146|NCT01502293|156751821|FG002|Overall Study|Progressive Disease|2|||
48700147|NCT01502293|156751819|FG000|Overall Study|Withdrawal by Subject|3|||
48700148|NCT01502293|156751820|FG001|Overall Study|Withdrawal by Subject|3|||
48700149|NCT01502293|156751821|FG002|Overall Study|Withdrawal by Subject|1|||
48700150|NCT01502293|156751819|FG000|Overall Study|Adverse Event|0|||
48700151|NCT01502293|156751820|FG001|Overall Study|Adverse Event|2|||
48700152|NCT01502293|156751821|FG002|Overall Study|Adverse Event|0|||
48700153|NCT01502293|156751819|FG000|Overall Study|Reason Not Specified|2|||
48700154|NCT01502293|156751820|FG001|Overall Study|Reason Not Specified|0|||
48700155|NCT01502293|156751821|FG002|Overall Study|Reason Not Specified|0|||
48700156|NCT01502293|156751819|FG000|Overall Study|Physician Decision|0|||
48700157|NCT01502293|156751820|FG001|Overall Study|Physician Decision|0|||
48700158|NCT01502293|156751821|FG002|Overall Study|Physician Decision|1|||
48700159|NCT03815929|156751822|FG000|Overall Study|Lost to Follow-up|2|||
48700160|NCT03815929|156751823|FG001|Overall Study|Lost to Follow-up|1|||
48700161|NCT03815929|156751824|FG002|Overall Study|Lost to Follow-up|0|||
48700162|NCT03815929|156751822|FG000|Overall Study|Physician Decision|2|||
48700163|NCT03815929|156751823|FG001|Overall Study|Physician Decision|2|||
48700164|NCT03815929|156751824|FG002|Overall Study|Physician Decision|0|||
48700165|NCT03815929|156751822|FG000|Overall Study|Withdrawal by Subject|0|||
48700166|NCT03815929|156751823|FG001|Overall Study|Withdrawal by Subject|0|||
48700167|NCT03815929|156751824|FG002|Overall Study|Withdrawal by Subject|1|||
48700168|NCT04973449|156751825|FG000|Overall Study|Withdrawal by Subject|3|||
48700169|NCT04973449|156751826|FG001|Overall Study|Withdrawal by Subject|3|||
48700170|NCT04973449|156751827|FG002|Overall Study|Withdrawal by Subject|2|||
48700171|NCT04973449|156751828|FG003|Overall Study|Withdrawal by Subject|5|||
48700172|NCT04973449|156751829|FG004|Overall Study|Withdrawal by Subject|5|||
48700173|NCT04973449|156751830|FG005|Overall Study|Withdrawal by Subject|4|||
48700174|NCT04973449|156751831|FG006|Overall Study|Withdrawal by Subject|7|||
48700175|NCT04973449|156751832|FG007|Overall Study|Withdrawal by Subject|5|||
48700176|NCT04973449|156751825|FG000|Overall Study|Lost to Follow-up|15|||
48700177|NCT04973449|156751826|FG001|Overall Study|Lost to Follow-up|16|||
48700178|NCT04973449|156751827|FG002|Overall Study|Lost to Follow-up|16|||
48700179|NCT04973449|156751828|FG003|Overall Study|Lost to Follow-up|13|||
48700180|NCT04973449|156751829|FG004|Overall Study|Lost to Follow-up|5|||
48700181|NCT04973449|156751830|FG005|Overall Study|Lost to Follow-up|6|||
48700182|NCT04973449|156751831|FG006|Overall Study|Lost to Follow-up|10|||
48700183|NCT04973449|156751832|FG007|Overall Study|Lost to Follow-up|6|||
48700184|NCT04973449|156751825|FG000|Overall Study|Death|1|||
48700185|NCT04973449|156751826|FG001|Overall Study|Death|0|||
48700186|NCT04973449|156751827|FG002|Overall Study|Death|0|||
48700187|NCT04973449|156751828|FG003|Overall Study|Death|0|||
48700188|NCT04973449|156751829|FG004|Overall Study|Death|0|||
48700189|NCT04973449|156751830|FG005|Overall Study|Death|1|||
48700190|NCT04973449|156751831|FG006|Overall Study|Death|0|||
48700191|NCT04973449|156751832|FG007|Overall Study|Death|0|||
48700192|NCT04973449|156751825|FG000|Overall Study|Other|1|||
48700193|NCT04973449|156751826|FG001|Overall Study|Other|1|||
48700194|NCT04973449|156751827|FG002|Overall Study|Other|2|||
48700195|NCT04973449|156751828|FG003|Overall Study|Other|1|||
48700196|NCT04973449|156751829|FG004|Overall Study|Other|4|||
48700197|NCT04973449|156751830|FG005|Overall Study|Other|0|||
48700198|NCT04973449|156751831|FG006|Overall Study|Other|2|||
48700199|NCT04973449|156751832|FG007|Overall Study|Other|2|||
48700200|NCT02205736|156751833|FG000|Overall Study|Lost to Follow-up|106|||
48700201|NCT03674411|156751834|FG000|Overall Study|Non-treatment|4|||
48700202|NCT02694185|156751838|FG000|Overall Study|Withdrawal by Subject|45|||
48700203|NCT02694185|156751839|FG001|Overall Study|Withdrawal by Subject|0|||
48700204|NCT05082857|156751840|FG000|Overall Study|participants relocated and could not continue|2|||
48700205|NCT05082857|156751841|FG001|Overall Study|participants relocated and could not continue|1|||
48700206|NCT05082857|156751840|FG000|Overall Study|Lost to Follow-up|1|||
48700207|NCT05082857|156751841|FG001|Overall Study|Lost to Follow-up|3|||
48700208|NCT04606134|156751848|FG000|Overall Study|Adverse Event|0|||
48700209|NCT04606134|156751849|FG001|Overall Study|Adverse Event|1|||
48700210|NCT03413891|156751850|FG000|Overall Study|Lost to Follow-up|2|||
48700211|NCT03413891|156751851|FG001|Overall Study|Lost to Follow-up|1|||
48700212|NCT03413891|156751850|FG000|Overall Study|Protocol Violation|0|||
48700213|NCT03413891|156751851|FG001|Overall Study|Protocol Violation|1|||
48700214|NCT03435211|156751860|FG000|Overall Study|Unable to achieve minimum desaturation level|1|||
48700215|NCT02195518|156751861|FG000|Overall Study|Adverse Event|1|||
48700216|NCT02195518|156751861|FG000|Overall Study|Protocol Violation|4|||
48700217|NCT02195518|156751861|FG000|Overall Study|Pregnancy|2|||
48700218|NCT02195518|156751861|FG000|Overall Study|Withdrawal by Subject|1|||
48700219|NCT02195518|156751861|FG000|Overall Study|Lost to Follow-up|1|||
48700220|NCT01652235|156751862|FG000|Overall Study|Death|9|||
48700221|NCT01652235|156751862|FG000|Overall Study|Lost to Follow-up|5|||
48700222|NCT01652235|156751862|FG000|Overall Study|Withdrawal by Subject|2|||
48700223|NCT01648751|156751865|FG000|Overall Study|Withdrawal by Subject|2|||
48700224|NCT01648751|156751866|FG001|Overall Study|Withdrawal by Subject|3|||
48700225|NCT02852655|156751868|FG000|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
48700226|NCT02852655|156751869|FG001|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
48911758|NCT00528021|157513107|FG001|Overall Study|Lack of Efficacy|13|||
48911759|NCT00528021|157513108|FG002|Overall Study|Lack of Efficacy|7|||
48911760|NCT00528021|157513109|FG003|Overall Study|Lack of Efficacy|9|||
48911761|NCT01704287|157514608|FG000|Initial Treatment Period|Death|139|||
48911762|NCT01704287|157514609|FG001|Initial Treatment Period|Death|129|||
48911763|NCT01704287|157514610|FG002|Initial Treatment Period|Death|71|||
48911764|NCT01704287|157514611|FG003|Initial Treatment Period|Death|0|||
48911765|NCT01704287|157514612|FG004|Initial Treatment Period|Death|0|||
48911766|NCT01704287|157514608|FG000|Initial Treatment Period|Withdrawal by Subject|3|||
48911767|NCT01704287|157514609|FG001|Initial Treatment Period|Withdrawal by Subject|2|||
48911768|NCT01704287|157514610|FG002|Initial Treatment Period|Withdrawal by Subject|4|||
48911769|NCT01704287|157514611|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
48911770|NCT01704287|157514612|FG004|Initial Treatment Period|Withdrawal by Subject|0|||
48911771|NCT01704287|157514608|FG000|Initial Treatment Period|Lost to Follow-up|5|||
48911772|NCT01704287|157514609|FG001|Initial Treatment Period|Lost to Follow-up|3|||
48911773|NCT01704287|157514610|FG002|Initial Treatment Period|Lost to Follow-up|0|||
48911774|NCT01704287|157514611|FG003|Initial Treatment Period|Lost to Follow-up|0|||
48911775|NCT01704287|157514612|FG004|Initial Treatment Period|Lost to Follow-up|0|||
48911776|NCT01704287|157514608|FG000|Initial Treatment Period|Switched to Pembrolizumab|0|||
48911777|NCT01704287|157514609|FG001|Initial Treatment Period|Switched to Pembrolizumab|0|||
48911778|NCT01704287|157514610|FG002|Initial Treatment Period|Switched to Pembrolizumab|98|||
48911779|NCT01704287|157514611|FG003|Initial Treatment Period|Switched to Pembrolizumab|0|||
48911780|NCT01704287|157514612|FG004|Initial Treatment Period|Switched to Pembrolizumab|0|||
48911781|NCT01704287|157514608|FG000|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
48911782|NCT01704287|157514609|FG001|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
48911783|NCT01704287|157514610|FG002|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
48911784|NCT01704287|157514611|FG003|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2|||
48911785|NCT01704287|157514612|FG004|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1|||
48911786|NCT01704287|157514608|FG000|Switch to Pembrolizumab Treatment Period|Death|0|||
48911787|NCT01704287|157514609|FG001|Switch to Pembrolizumab Treatment Period|Death|0|||
48911788|NCT01704287|157514610|FG002|Switch to Pembrolizumab Treatment Period|Death|0|||
48911789|NCT01704287|157514611|FG003|Switch to Pembrolizumab Treatment Period|Death|35|||
48911790|NCT01704287|157514612|FG004|Switch to Pembrolizumab Treatment Period|Death|37|||
48911791|NCT01704287|157514608|FG000|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
48911792|NCT01704287|157514609|FG001|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
48911793|NCT01704287|157514610|FG002|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
48911794|NCT01704287|157514611|FG003|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1|||
48911795|NCT01704287|157514612|FG004|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
48911796|NCT03713034|157514613|FG000|Overall Study|Withdrawn by staff for incomplete consent forms|5|||
48911797|NCT03713034|157514614|FG001|Overall Study|Withdrawn by staff for incomplete consent forms|4|||
48911798|NCT02982590|157514618|FG000|Overall Study|Lost to Follow-up|0|||
48911799|NCT02982590|157514619|FG001|Overall Study|Lost to Follow-up|1|||
48911800|NCT02982590|157514618|FG000|Overall Study|Death|4|||
48911801|NCT02982590|157514619|FG001|Overall Study|Death|0|||
48911802|NCT00785044|157514620|FG000|Overall Study|Dosed at non-participating sites|152|||
48911803|NCT00785044|157514620|FG000|Overall Study|Death|77|||
48911804|NCT00785044|157514620|FG000|Overall Study|Lost to Follow-up|266|||
48911805|NCT00785044|157514620|FG000|Overall Study|Withdrawal by Subject|1|||
48911806|NCT01168973|157514621|FG000|Overall Study|Progressive Disease|341|||
48911807|NCT01168973|157514622|FG001|Overall Study|Progressive Disease|429|||
48911808|NCT01168973|157514621|FG000|Overall Study|Adverse Event|94|||
48700227|NCT02852655|156751870|FG002|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|1|||
48700228|NCT02852655|156751868|FG000|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
48700229|NCT02852655|156751869|FG001|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
48700230|NCT02852655|156751870|FG002|Registered and Ready to Initiate Tx|Withdrawal by Subject|2|||
48700231|NCT02852655|156751868|FG000|Eligible to Initiate Adjuvant MK3475|Disease Progression|1|||
48700232|NCT02852655|156751869|FG001|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
48700233|NCT02852655|156751870|FG002|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
48700234|NCT02852655|156751868|FG000|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
48700235|NCT02852655|156751869|FG001|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|1|||
48700236|NCT02852655|156751870|FG002|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
48700237|NCT02852655|156751868|FG000|Adjuvant MK3475 Therapy|Disease Progression|13|||
48911809|NCT01168973|157514622|FG001|Overall Study|Adverse Event|55|||
48911810|NCT01168973|157514621|FG000|Overall Study|Withdrawal by Subject|90|||
48911811|NCT01168973|157514622|FG001|Overall Study|Withdrawal by Subject|53|||
48911812|NCT01168973|157514621|FG000|Overall Study|Death|42|||
48911813|NCT01168973|157514622|FG001|Overall Study|Death|45|||
48911814|NCT01168973|157514621|FG000|Overall Study|Physician Decision|37|||
48911815|NCT01168973|157514622|FG001|Overall Study|Physician Decision|19|||
48911816|NCT01168973|157514621|FG000|Overall Study|Sponsor Decision|2|||
48911817|NCT01168973|157514622|FG001|Overall Study|Sponsor Decision|1|||
48911818|NCT01168973|157514621|FG000|Overall Study|Protocol Criterion Not Met and Deviation|7|||
48911819|NCT01168973|157514622|FG001|Overall Study|Protocol Criterion Not Met and Deviation|9|||
48911820|NCT00938717|157514623|FG000|Overall Study|Adverse Event|10|||
48911821|NCT00938717|157514624|FG001|Overall Study|Adverse Event|41|||
48911822|NCT00938717|157514623|FG000|Overall Study|Protocol Violation|11|||
48911823|NCT00938717|157514624|FG001|Overall Study|Protocol Violation|8|||
48911824|NCT00938717|157514623|FG000|Overall Study|Withdrawal by Subject|26|||
48911825|NCT00938717|157514624|FG001|Overall Study|Withdrawal by Subject|24|||
48911826|NCT00938717|157514623|FG000|Overall Study|Lost to Follow-up|13|||
48911827|NCT00938717|157514624|FG001|Overall Study|Lost to Follow-up|18|||
48911828|NCT00938717|157514623|FG000|Overall Study|Lack of Efficacy|33|||
48911829|NCT00938717|157514624|FG001|Overall Study|Lack of Efficacy|15|||
48911830|NCT00938717|157514623|FG000|Overall Study|Other reason|5|||
48911831|NCT00938717|157514624|FG001|Overall Study|Other reason|2|||
48911832|NCT03523728|157514627|FG000|Stage 1 (24 Months)|Adverse Event|2|||
48911833|NCT03523728|157514628|FG001|Stage 1 (24 Months)|Adverse Event|2|||
48911834|NCT03523728|157514629|FG002|Stage 1 (24 Months)|Adverse Event|4|||
48911835|NCT03523728|157514630|FG003|Stage 1 (24 Months)|Adverse Event|0|||
48911836|NCT03523728|157514631|FG004|Stage 1 (24 Months)|Adverse Event|0|||
48911837|NCT03523728|157514627|FG000|Stage 1 (24 Months)|Progressive disease|0|||
48911838|NCT03523728|157514628|FG001|Stage 1 (24 Months)|Progressive disease|0|||
48911839|NCT03523728|157514629|FG002|Stage 1 (24 Months)|Progressive disease|1|||
48911840|NCT03523728|157514630|FG003|Stage 1 (24 Months)|Progressive disease|0|||
48911841|NCT03523728|157514631|FG004|Stage 1 (24 Months)|Progressive disease|0|||
48911842|NCT03523728|157514627|FG000|Stage 1 (24 Months)|Lack of Efficacy|2|||
48911843|NCT03523728|157514628|FG001|Stage 1 (24 Months)|Lack of Efficacy|0|||
48911844|NCT03523728|157514629|FG002|Stage 1 (24 Months)|Lack of Efficacy|0|||
48911845|NCT03523728|157514630|FG003|Stage 1 (24 Months)|Lack of Efficacy|0|||
48911846|NCT03523728|157514631|FG004|Stage 1 (24 Months)|Lack of Efficacy|0|||
48911847|NCT03523728|157514627|FG000|Stage 1 (24 Months)|Poor compliance to protocol|1|||
48911848|NCT03523728|157514628|FG001|Stage 1 (24 Months)|Poor compliance to protocol|0|||
48911849|NCT03523728|157514629|FG002|Stage 1 (24 Months)|Poor compliance to protocol|0|||
48911850|NCT03523728|157514630|FG003|Stage 1 (24 Months)|Poor compliance to protocol|0|||
48911851|NCT03523728|157514631|FG004|Stage 1 (24 Months)|Poor compliance to protocol|0|||
48911852|NCT03523728|157514627|FG000|Stage 1 (24 Months)|Withdrawal by Subject|6|||
48911853|NCT03523728|157514628|FG001|Stage 1 (24 Months)|Withdrawal by Subject|5|||
48911854|NCT03523728|157514629|FG002|Stage 1 (24 Months)|Withdrawal by Subject|7|||
48911855|NCT03523728|157514630|FG003|Stage 1 (24 Months)|Withdrawal by Subject|0|||
48911856|NCT03523728|157514631|FG004|Stage 1 (24 Months)|Withdrawal by Subject|0|||
48911857|NCT03523728|157514627|FG000|Stage 1 (24 Months)|Study terminated by sponsor|54|||
48911858|NCT03523728|157514628|FG001|Stage 1 (24 Months)|Study terminated by sponsor|59|||
48911859|NCT03523728|157514629|FG002|Stage 1 (24 Months)|Study terminated by sponsor|56|||
48911860|NCT03523728|157514630|FG003|Stage 1 (24 Months)|Study terminated by sponsor|0|||
48911861|NCT03523728|157514631|FG004|Stage 1 (24 Months)|Study terminated by sponsor|0|||
48911862|NCT03523728|157514627|FG000|Stage 1 (24 Months)|Other-Unspecified|1|||
48911863|NCT03523728|157514628|FG001|Stage 1 (24 Months)|Other-Unspecified|2|||
48911864|NCT03523728|157514629|FG002|Stage 1 (24 Months)|Other-Unspecified|0|||
49116421|NCT00765817|158263096|FG000|Overall Study|Loss of glucose control|0|||
49116422|NCT00765817|158263097|FG001|Overall Study|Loss of glucose control|2|||
48700238|NCT02852655|156751869|FG001|Adjuvant MK3475 Therapy|Disease Progression|21|||
48700239|NCT02852655|156751870|FG002|Adjuvant MK3475 Therapy|Disease Progression|12|||
48700240|NCT02852655|156751868|FG000|Adjuvant MK3475 Therapy|Adverse Event|1|||
48700241|NCT02852655|156751869|FG001|Adjuvant MK3475 Therapy|Adverse Event|0|||
48700242|NCT02852655|156751870|FG002|Adjuvant MK3475 Therapy|Adverse Event|0|||
48700243|NCT02852655|156751868|FG000|Adjuvant MK3475 Therapy|Withdrawal by Subject|0|||
48700244|NCT02852655|156751869|FG001|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
48700245|NCT02852655|156751870|FG002|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
48700246|NCT02852655|156751868|FG000|Adjuvant MK3475 Therapy|Still on Active Study Therapy|1|||
48700247|NCT02852655|156751869|FG001|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
48700248|NCT02852655|156751870|FG002|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
48700249|NCT02852655|156751868|FG000|Adjuvant MK3475 Therapy|Physician Decision|0|||
48700250|NCT02852655|156751869|FG001|Adjuvant MK3475 Therapy|Physician Decision|0|||
48700251|NCT02852655|156751870|FG002|Adjuvant MK3475 Therapy|Physician Decision|1|||
49116423|NCT00765817|158263096|FG000|Overall Study|Lost to Follow-up|1|||
48700252|NCT01967238|156751872|FG000|Overall Study|Adverse Event|1|||
48700253|NCT01967238|156751873|FG001|Overall Study|Adverse Event|1|||
48700254|NCT01967238|156751874|FG002|Overall Study|Adverse Event|0|||
48700255|NCT01967238|156751872|FG000|Overall Study|Lost to Follow-up|1|||
48911865|NCT03523728|157514630|FG003|Stage 1 (24 Months)|Other-Unspecified|0|||
48911866|NCT03523728|157514631|FG004|Stage 1 (24 Months)|Other-Unspecified|0|||
48911867|NCT03523728|157514627|FG000|Stage 2 (24 Months)|Adverse Event|0|||
48911868|NCT03523728|157514628|FG001|Stage 2 (24 Months)|Adverse Event|0|||
48911869|NCT03523728|157514629|FG002|Stage 2 (24 Months)|Adverse Event|0|||
48911870|NCT03523728|157514630|FG003|Stage 2 (24 Months)|Adverse Event|1|||
48911871|NCT03523728|157514631|FG004|Stage 2 (24 Months)|Adverse Event|2|||
48911872|NCT03523728|157514627|FG000|Stage 2 (24 Months)|Withdrawal by Subject|0|||
49116424|NCT00765817|158263097|FG001|Overall Study|Lost to Follow-up|3|||
49116425|NCT00765817|158263096|FG000|Overall Study|Physician Decision|2|||
49116426|NCT00765817|158263097|FG001|Overall Study|Physician Decision|1|||
49116427|NCT00765817|158263096|FG000|Overall Study|Protocol Violation|1|||
48911873|NCT03523728|157514628|FG001|Stage 2 (24 Months)|Withdrawal by Subject|0|||
48911874|NCT03523728|157514629|FG002|Stage 2 (24 Months)|Withdrawal by Subject|0|||
48911875|NCT03523728|157514630|FG003|Stage 2 (24 Months)|Withdrawal by Subject|0|||
48911876|NCT03523728|157514631|FG004|Stage 2 (24 Months)|Withdrawal by Subject|4|||
48911877|NCT03523728|157514627|FG000|Stage 2 (24 Months)|Study terminated by sponsor|0|||
48911878|NCT03523728|157514628|FG001|Stage 2 (24 Months)|Study terminated by sponsor|0|||
48911879|NCT03523728|157514629|FG002|Stage 2 (24 Months)|Study terminated by sponsor|0|||
48911880|NCT03523728|157514630|FG003|Stage 2 (24 Months)|Study terminated by sponsor|119|||
48911881|NCT03523728|157514631|FG004|Stage 2 (24 Months)|Study terminated by sponsor|110|||
48911882|NCT03523728|157514627|FG000|Stage 2 (24 Months)|Other-Unspecified|0|||
48911883|NCT03523728|157514628|FG001|Stage 2 (24 Months)|Other-Unspecified|0|||
48911884|NCT03523728|157514629|FG002|Stage 2 (24 Months)|Other-Unspecified|0|||
48911885|NCT03523728|157514630|FG003|Stage 2 (24 Months)|Other-Unspecified|2|||
48911886|NCT03523728|157514631|FG004|Stage 2 (24 Months)|Other-Unspecified|3|||
48911887|NCT03523728|157514627|FG000|Stage 2 (24 Months)|Randomized and not treated|0|||
48911888|NCT03523728|157514628|FG001|Stage 2 (24 Months)|Randomized and not treated|0|||
48911889|NCT03523728|157514629|FG002|Stage 2 (24 Months)|Randomized and not treated|0|||
48911890|NCT03523728|157514630|FG003|Stage 2 (24 Months)|Randomized and not treated|1|||
48911891|NCT03523728|157514631|FG004|Stage 2 (24 Months)|Randomized and not treated|0|||
48911892|NCT01007032|157514635|FG000|Overall Study|On Study Treatment at Cut-off Date|0|||
48911893|NCT01007032|157514636|FG001|Overall Study|On Study Treatment at Cut-off Date|1|||
48911894|NCT01007032|157514637|FG002|Overall Study|On Study Treatment at Cut-off Date|1|||
48911895|NCT01007032|157514638|FG003|Overall Study|On Study Treatment at Cut-off Date|0|||
48700256|NCT01967238|156751873|FG001|Overall Study|Lost to Follow-up|0|||
48911896|NCT01007032|157514635|FG000|Overall Study|Withdrawal by Subject|0|||
48911897|NCT01007032|157514636|FG001|Overall Study|Withdrawal by Subject|0|||
48911898|NCT01007032|157514637|FG002|Overall Study|Withdrawal by Subject|0|||
48911899|NCT01007032|157514638|FG003|Overall Study|Withdrawal by Subject|1|||
48911900|NCT01101438|157514640|FG000|Overall Study|Withdrawal by Subject|8|||
48911901|NCT01101438|157514641|FG001|Overall Study|Withdrawal by Subject|9|||
48911902|NCT01444742|157514642|FG000|Overall Study|Death|1|||
48911903|NCT00478933|157514643|FG000|Overall Study|Protocol Violation|22|||
48911904|NCT00478933|157514643|FG000|Overall Study|Informed consent not verified|3|||
48911905|NCT00478933|157514643|FG000|Overall Study|Inadequate data available|53|||
48911906|NCT00290290|157514644|FG000|Overall Study|Death|3|||
48911907|NCT00290290|157514645|FG001|Overall Study|Death|4|||
48911908|NCT00290290|157514644|FG000|Overall Study|Withdrawal by Subject|2|||
48911909|NCT00290290|157514645|FG001|Overall Study|Withdrawal by Subject|2|||
48911910|NCT00290290|157514644|FG000|Overall Study|Underwent clean surgical procedure|13|||
48911911|NCT00290290|157514645|FG001|Overall Study|Underwent clean surgical procedure|12|||
48911912|NCT01368536|157514654|FG000|Overall Study|Adverse Event|5|||
48911913|NCT01368536|157514655|FG001|Overall Study|Adverse Event|6|||
48911914|NCT01368536|157514656|FG002|Overall Study|Adverse Event|8|||
48911915|NCT01368536|157514654|FG000|Overall Study|Abnormal laboratory value(s)|0|||
48911916|NCT01368536|157514655|FG001|Overall Study|Abnormal laboratory value(s)|1|||
48700257|NCT01967238|156751874|FG002|Overall Study|Lost to Follow-up|1|||
48911917|NCT01368536|157514656|FG002|Overall Study|Abnormal laboratory value(s)|2|||
49116428|NCT00765817|158263097|FG001|Overall Study|Protocol Violation|1|||
49116429|NCT00765817|158263096|FG000|Overall Study|Subject decision|7|||
49116430|NCT00765817|158263097|FG001|Overall Study|Subject decision|11|||
49116431|NCT01949142|158263102|FG000|Overall Study|Withdrawal of consent|1|||
48911918|NCT01368536|157514654|FG000|Overall Study|Abnormal test procedure result(s)|0|||
48911919|NCT01368536|157514655|FG001|Overall Study|Abnormal test procedure result(s)|0|||
48911920|NCT01368536|157514656|FG002|Overall Study|Abnormal test procedure result(s)|1|||
49116432|NCT01949142|158263103|FG001|Overall Study|Withdrawal of consent|0|||
49116433|NCT01949142|158263102|FG000|Overall Study|Lost to Follow-up|1|||
48700258|NCT01967238|156751872|FG000|Overall Study|Withdrawal by Subject|0|||
49116434|NCT01949142|158263103|FG001|Overall Study|Lost to Follow-up|1|||
48911921|NCT01368536|157514654|FG000|Overall Study|Unsatisfactory therapeutic effect|7|||
48911922|NCT01368536|157514655|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
48911923|NCT01368536|157514656|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
48911924|NCT01368536|157514654|FG000|Overall Study|No longer required study medication|0|||
48911925|NCT01368536|157514655|FG001|Overall Study|No longer required study medication|0|||
48911926|NCT01368536|157514656|FG002|Overall Study|No longer required study medication|1|||
48911927|NCT01368536|157514654|FG000|Overall Study|Withdrawal by Subject|2|||
48911928|NCT01368536|157514655|FG001|Overall Study|Withdrawal by Subject|5|||
49116435|NCT01949142|158263102|FG000|Overall Study|Parent changed their mind|1|||
49116436|NCT01949142|158263103|FG001|Overall Study|Parent changed their mind|0|||
49116437|NCT00171158|158264136|FG000|Core Study|Death|27|||
48911929|NCT01368536|157514656|FG002|Overall Study|Withdrawal by Subject|4|||
48911930|NCT01368536|157514654|FG000|Overall Study|Lost to Follow-up|3|||
48911931|NCT01368536|157514655|FG001|Overall Study|Lost to Follow-up|3|||
48911932|NCT01368536|157514656|FG002|Overall Study|Lost to Follow-up|5|||
48911933|NCT01368536|157514654|FG000|Overall Study|Administrative problems|34|||
48911934|NCT01368536|157514655|FG001|Overall Study|Administrative problems|39|||
48911935|NCT01368536|157514656|FG002|Overall Study|Administrative problems|35|||
48911936|NCT01368536|157514654|FG000|Overall Study|Protocol deviation|0|||
48700259|NCT01967238|156751873|FG001|Overall Study|Withdrawal by Subject|0|||
48700260|NCT01967238|156751874|FG002|Overall Study|Withdrawal by Subject|1|||
48700261|NCT01231906|156751875|FG000|Overall Study|Lack of Efficacy|75|||
48700262|NCT01231906|156751876|FG001|Overall Study|Lack of Efficacy|68|||
48700263|NCT01231906|156751875|FG000|Overall Study|Lost to Follow-up|1|||
48700264|NCT01231906|156751876|FG001|Overall Study|Lost to Follow-up|0|||
48700265|NCT01231906|156751875|FG000|Overall Study|Physician Decision|34|||
48700266|NCT01231906|156751876|FG001|Overall Study|Physician Decision|24|||
48700267|NCT01231906|156751875|FG000|Overall Study|Withdrawal by Subject|0|||
48700268|NCT01231906|156751876|FG001|Overall Study|Withdrawal by Subject|4|||
48700269|NCT01231906|156751875|FG000|Overall Study|Ineligible|10|||
48911937|NCT01368536|157514655|FG001|Overall Study|Protocol deviation|3|||
48911938|NCT01368536|157514656|FG002|Overall Study|Protocol deviation|1|||
48911939|NCT02066311|157514657|FG000|Overall Study|Adverse Event|4|||
48911940|NCT02066311|157514657|FG000|Overall Study|Withdrawal by Subject|1|||
48911941|NCT01372150|157514658|FG000|Overall Study|Lack of Efficacy|3|||
48911942|NCT01372150|157514659|FG001|Overall Study|Lack of Efficacy|0|||
48911943|NCT01372150|157514660|FG002|Overall Study|Lack of Efficacy|1|||
48911944|NCT01372150|157514658|FG000|Overall Study|Lost to Follow-up|4|||
48911945|NCT01372150|157514659|FG001|Overall Study|Lost to Follow-up|5|||
48911946|NCT01372150|157514660|FG002|Overall Study|Lost to Follow-up|6|||
48911947|NCT01372150|157514658|FG000|Overall Study|Protocol Violation|1|||
48911948|NCT01372150|157514659|FG001|Overall Study|Protocol Violation|0|||
48911949|NCT01372150|157514660|FG002|Overall Study|Protocol Violation|3|||
49116438|NCT00171158|158264136|FG000|Core Study|Unsatisfactory therapeutic effect|163|||
49116439|NCT00171158|158264136|FG000|Core Study|Protocol Violation|4|||
49116440|NCT00171158|158264136|FG000|Core Study|Administrative problems|1|||
49116441|NCT00171158|158264136|FG000|Core Study|Adverse event, non-fatal|21|||
49116442|NCT00171158|158264136|FG000|Core Study|Consent withdrawn by subject|6|||
49116443|NCT00171158|158264136|FG000|Core Study|No longer required drug (BMT)|14|||
49116444|NCT00171158|158264136|FG000|Core Study|Abnormal Laboratory Values|2|||
49116445|NCT00171158|158264136|FG000|Core Study|Lost to Follow-up|1|||
49116446|NCT00171158|158264136|FG000|E2 Extension|Other|7|||
49116447|NCT01980628|158264138|FG000|Overall Study|Adverse Event|12|||
49116448|NCT01980628|158264138|FG000|Overall Study|Physician Decision|5|||
49116449|NCT01980628|158264138|FG000|Overall Study|Withdrawal by Subject|4|||
49116450|NCT01980628|158264138|FG000|Overall Study|PD, Subj non-Compliant,Study Terminated|42|||
49116451|NCT02849704|158264139|FG000|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1|||
49116452|NCT02849704|158264140|FG001|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0|||
49116453|NCT02849704|158264139|FG000|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1|||
49116454|NCT02849704|158264140|FG001|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0|||
49116455|NCT02849704|158264139|FG000|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1|||
49116456|NCT02849704|158264140|FG001|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0|||
49116457|NCT03536663|158264141|FG000|Endexo|Protocol Violation|1|||
49116458|NCT00734656|158264142|FG000|Lab Session 1|Withdrawal by Subject|2|||
49116459|NCT00734656|158264143|FG001|Lab Session 1|Withdrawal by Subject|0|||
49116460|NCT00734656|158264144|FG002|Lab Session 1|Withdrawal by Subject|0|||
49116461|NCT00734656|158264145|FG003|Lab Session 1|Withdrawal by Subject|0|||
49116462|NCT00734656|158264142|FG000|Washout 1|Withdrawal by Subject|1|||
49116463|NCT00734656|158264143|FG001|Washout 1|Withdrawal by Subject|5|||
49116464|NCT00734656|158264144|FG002|Washout 1|Withdrawal by Subject|2|||
49116465|NCT00734656|158264145|FG003|Washout 1|Withdrawal by Subject|3|||
48700270|NCT01231906|156751876|FG001|Overall Study|Ineligible|3|||
48700271|NCT01231906|156751875|FG000|Overall Study|No treatment|1|||
48700272|NCT01231906|156751876|FG001|Overall Study|No treatment|2|||
48700273|NCT04929249|156751877|FG000|Overall Study|Adverse Event|2|||
48911950|NCT01372150|157514658|FG000|Overall Study|Withdrawal by Subject|2|||
48700274|NCT04929249|156751878|FG001|Overall Study|Adverse Event|1|||
48700275|NCT04929249|156751877|FG000|Overall Study|Death|2|||
48911951|NCT01372150|157514659|FG001|Overall Study|Withdrawal by Subject|7|||
48911952|NCT01372150|157514660|FG002|Overall Study|Withdrawal by Subject|2|||
48911953|NCT01372150|157514658|FG000|Overall Study|Other|1|||
48911954|NCT01372150|157514659|FG001|Overall Study|Other|0|||
48911955|NCT01372150|157514660|FG002|Overall Study|Other|2|||
49116466|NCT00734656|158264142|FG000|Lab Session 2|Withdrawal by Subject|1|||
49116467|NCT00734656|158264143|FG001|Lab Session 2|Withdrawal by Subject|0|||
49116468|NCT00734656|158264144|FG002|Lab Session 2|Withdrawal by Subject|0|||
49116469|NCT00734656|158264145|FG003|Lab Session 2|Withdrawal by Subject|1|||
48700276|NCT04929249|156751878|FG001|Overall Study|Death|1|||
49116470|NCT00734656|158264142|FG000|Washout 2|Withdrawal by Subject|1|||
49116471|NCT00734656|158264143|FG001|Washout 2|Withdrawal by Subject|1|||
49116472|NCT00734656|158264144|FG002|Washout 2|Withdrawal by Subject|1|||
49116473|NCT00734656|158264145|FG003|Washout 2|Withdrawal by Subject|0|||
49116474|NCT00734656|158264142|FG000|Washout 3|Withdrawal by Subject|1|||
49116475|NCT00734656|158264143|FG001|Washout 3|Withdrawal by Subject|0|||
49116476|NCT00734656|158264144|FG002|Washout 3|Withdrawal by Subject|0|||
49116477|NCT00734656|158264145|FG003|Washout 3|Withdrawal by Subject|1|||
49116478|NCT00734656|158264142|FG000|Lab Session 4|Withdrawal by Subject|0|||
49116479|NCT00734656|158264143|FG001|Lab Session 4|Withdrawal by Subject|0|||
49116480|NCT00734656|158264144|FG002|Lab Session 4|Withdrawal by Subject|0|||
49116481|NCT00734656|158264145|FG003|Lab Session 4|Withdrawal by Subject|1|||
49116482|NCT01471444|158264146|FG000|Overall Study|Physician Decision|3|||
49116483|NCT01471444|158264147|FG001|Overall Study|Physician Decision|2|||
49116484|NCT01471444|158264146|FG000|Overall Study|Withdrawal by Subject|0|||
49116485|NCT01471444|158264147|FG001|Overall Study|Withdrawal by Subject|1|||
49116486|NCT03251482|158264149|FG000|Overall Study|Withdrawal by Subject|0|||
49116487|NCT03251482|158264150|FG001|Overall Study|Withdrawal by Subject|1|||
49116488|NCT03251482|158264151|FG002|Overall Study|Withdrawal by Subject|0|||
49116489|NCT03251482|158264152|FG003|Overall Study|Withdrawal by Subject|0|||
49116490|NCT03251482|158264153|FG004|Overall Study|Withdrawal by Subject|0|||
49116491|NCT01911793|158264154|FG000|Overall Study|Physician Decision|1|||
49116492|NCT01911793|158264155|FG001|Overall Study|Physician Decision|5|||
49116493|NCT02697916|158264156|FG000|Overall Study|Death|357|||
49116494|NCT02697916|158264157|FG001|Overall Study|Death|315|||
49116495|NCT02697916|158264156|FG000|Overall Study|Withdrawal by Subject|221|||
49116496|NCT02697916|158264157|FG001|Overall Study|Withdrawal by Subject|393|||
49116497|NCT02447328|158264160|FG000|Overall Study|Withdrawal by Subject|1|||
49116498|NCT03915626|158264161|FG000|Overall Study|study was halted due to COVID-19; once started again volunteer could no longer participate|1|||
49116499|NCT02688764|158264168|FG000|Overall Study|Adverse Event|3|||
49116500|NCT02688764|158264169|FG001|Overall Study|Adverse Event|3|||
49116501|NCT02688764|158264168|FG000|Overall Study|AE/Kidney transplant|1|||
49116502|NCT02688764|158264169|FG001|Overall Study|AE/Kidney transplant|0|||
49116503|NCT02688764|158264168|FG000|Overall Study|AE/Lack of efficacy|1|||
49116504|NCT02688764|158264169|FG001|Overall Study|AE/Lack of efficacy|0|||
49116505|NCT02688764|158264168|FG000|Overall Study|AE/Non-compl.|1|||
49116506|NCT02688764|158264169|FG001|Overall Study|AE/Non-compl.|0|||
49116507|NCT02688764|158264168|FG000|Overall Study|AE/Non-compl./Withd. parent|0|||
49116508|NCT02688764|158264169|FG001|Overall Study|AE/Non-compl./Withd. parent|1|||
48911956|NCT01372150|157514658|FG000|Overall Study|Adverse Event|2|||
48911957|NCT01372150|157514659|FG001|Overall Study|Adverse Event|1|||
48911958|NCT01372150|157514660|FG002|Overall Study|Adverse Event|2|||
48911959|NCT01372150|157514658|FG000|Overall Study|Randomized but not treated|0|||
48911960|NCT01372150|157514659|FG001|Overall Study|Randomized but not treated|1|||
48911961|NCT01372150|157514660|FG002|Overall Study|Randomized but not treated|0|||
48911962|NCT03198520|157514661|FG000|Overall Study|Physician Decision|2|||
48911963|NCT03198520|157514661|FG000|Overall Study|Protocol Violation|2|||
48911964|NCT03198520|157514661|FG000|Overall Study|Withdrawal by Subject|1|||
48911965|NCT03198520|157514661|FG000|Overall Study|Study Ended|1|||
48911966|NCT00701090|157514666|FG000|Overall Study|Adverse Event|11|||
48911967|NCT00701090|157514667|FG001|Overall Study|Adverse Event|2|||
48911968|NCT00701090|157514666|FG000|Overall Study|Death|0|||
48911969|NCT00701090|157514667|FG001|Overall Study|Death|1|||
48911970|NCT00701090|157514666|FG000|Overall Study|Lack of Efficacy|5|||
48911971|NCT00701090|157514667|FG001|Overall Study|Lack of Efficacy|4|||
48911972|NCT00701090|157514666|FG000|Overall Study|Lost to Follow-up|9|||
48911973|NCT00701090|157514667|FG001|Overall Study|Lost to Follow-up|9|||
48911974|NCT00701090|157514666|FG000|Overall Study|Physician Decision|3|||
48911975|NCT00701090|157514667|FG001|Overall Study|Physician Decision|4|||
48911976|NCT00701090|157514666|FG000|Overall Study|Protocol Violation|2|||
48911977|NCT00701090|157514667|FG001|Overall Study|Protocol Violation|3|||
48911978|NCT00701090|157514666|FG000|Overall Study|Withdrawal by Subject|11|||
48911979|NCT00701090|157514667|FG001|Overall Study|Withdrawal by Subject|16|||
48911980|NCT00701090|157514666|FG000|Overall Study|Other|7|||
48911981|NCT00701090|157514667|FG001|Overall Study|Other|12|||
48911982|NCT00873366|157514668|FG000|Overall Study|Off tamoxifen for reconstructive surgery|1|||
49116509|NCT02688764|158264168|FG000|Overall Study|AE/Other|0|||
49116510|NCT02688764|158264169|FG001|Overall Study|AE/Other|1|||
48700277|NCT04929249|156751877|FG000|Overall Study|Lost to Follow-up|3|||
48911983|NCT00873366|157514668|FG000|Overall Study|Off tamoxifen due to side effects|2|||
48911984|NCT00873366|157514668|FG000|Overall Study|Refused to continue DM-BT testing|3|||
48911985|NCT01576172|157514669|FG000|Overall Study|Ineligible|2|||
48911986|NCT01576172|157514670|FG001|Overall Study|Ineligible|1|||
49116511|NCT02688764|158264168|FG000|Overall Study|AE/Physician decision|1|||
48911987|NCT01576172|157514669|FG000|Overall Study|Withdrawal by Subject|2|||
48911988|NCT01576172|157514670|FG001|Overall Study|Withdrawal by Subject|0|||
48911989|NCT01576172|157514669|FG000|Overall Study|Insurance issue|1|||
48911990|NCT01576172|157514670|FG001|Overall Study|Insurance issue|0|||
48911991|NCT00646906|157514671|FG000|Crossover Period 1|Withdrawal by Subject|1|||
48911992|NCT00646906|157514672|FG001|Crossover Period 1|Withdrawal by Subject|0|||
48911993|NCT00646906|157514673|FG002|Crossover Period 1|Withdrawal by Subject|0|||
48911994|NCT00646906|157514674|FG003|Crossover Period 1|Withdrawal by Subject|0|||
48911995|NCT00646906|157514675|FG004|Crossover Period 1|Withdrawal by Subject|0|||
48911996|NCT00646906|157514676|FG005|Crossover Period 1|Withdrawal by Subject|1|||
48700278|NCT04929249|156751878|FG001|Overall Study|Lost to Follow-up|11|||
48700279|NCT04929249|156751877|FG000|Overall Study|Technical problems|0|||
48700280|NCT04929249|156751878|FG001|Overall Study|Technical problems|1|||
48700281|NCT04929249|156751877|FG000|Overall Study|Subject decision|6|||
48700282|NCT04929249|156751878|FG001|Overall Study|Subject decision|8|||
48700283|NCT04929249|156751877|FG000|Overall Study|Withdrew consent|0|||
48700284|NCT04929249|156751878|FG001|Overall Study|Withdrew consent|8|||
48700285|NCT04467905|156751879|FG000|Overall Study|Baseline heart rate <110 bpm|0|||
48700286|NCT04467905|156751880|FG001|Overall Study|Baseline heart rate <110 bpm|0|||
48700287|NCT04467905|156751881|FG002|Overall Study|Baseline heart rate <110 bpm|5|||
48911997|NCT00646906|157514677|FG006|Crossover Period 1|Withdrawal by Subject|0|||
48911998|NCT00646906|157514671|FG000|Crossover Period 2|Withdrawal by Subject|0|||
48911999|NCT00646906|157514672|FG001|Crossover Period 2|Withdrawal by Subject|1|||
48912000|NCT00646906|157514673|FG002|Crossover Period 2|Withdrawal by Subject|2|||
48912001|NCT00646906|157514674|FG003|Crossover Period 2|Withdrawal by Subject|1|||
48912002|NCT00646906|157514675|FG004|Crossover Period 2|Withdrawal by Subject|0|||
48912003|NCT00646906|157514676|FG005|Crossover Period 2|Withdrawal by Subject|0|||
48912004|NCT00646906|157514677|FG006|Crossover Period 2|Withdrawal by Subject|0|||
48912005|NCT00646906|157514671|FG000|Crossover Period 2|Physician Decision|0|||
48912006|NCT00646906|157514672|FG001|Crossover Period 2|Physician Decision|0|||
48912007|NCT00646906|157514673|FG002|Crossover Period 2|Physician Decision|0|||
48912008|NCT00646906|157514674|FG003|Crossover Period 2|Physician Decision|0|||
48912009|NCT00646906|157514675|FG004|Crossover Period 2|Physician Decision|0|||
48912010|NCT00646906|157514676|FG005|Crossover Period 2|Physician Decision|0|||
48912011|NCT00646906|157514677|FG006|Crossover Period 2|Physician Decision|1|||
48912012|NCT00454857|157514684|FG000|Overall Study|Withdrawal by Subject|15|||
48912013|NCT00454857|157514684|FG000|Overall Study|Lost to Follow-up|16|||
48912014|NCT00454857|157514684|FG000|Overall Study|Noncompliance|6|||
48912015|NCT00454857|157514684|FG000|Overall Study|Death|5|||
48912016|NCT00454857|157514684|FG000|Overall Study|Other|11|||
48912017|NCT00454857|157514684|FG000|Overall Study|Reason unknown|1|||
48912018|NCT04206020|157514689|FG000|Overall Study|Adverse Event|1|||
48912019|NCT04206020|157514690|FG001|Overall Study|Adverse Event|4|||
48912020|NCT04206020|157514689|FG000|Overall Study|Protocol Violation|2|||
48912021|NCT04206020|157514690|FG001|Overall Study|Protocol Violation|0|||
48912022|NCT04206020|157514689|FG000|Overall Study|Withdrawal by Subject|2|||
48912023|NCT04206020|157514690|FG001|Overall Study|Withdrawal by Subject|0|||
48912024|NCT04206020|157514689|FG000|Overall Study|Lost to Follow-up|2|||
48912025|NCT04206020|157514690|FG001|Overall Study|Lost to Follow-up|0|||
48912026|NCT04206020|157514689|FG000|Overall Study|Pregnancy|0|||
48912027|NCT04206020|157514690|FG001|Overall Study|Pregnancy|1|||
48912028|NCT04206020|157514689|FG000|Overall Study|Unable to attend visits|1|||
48912029|NCT04206020|157514690|FG001|Overall Study|Unable to attend visits|2|||
48912030|NCT01299376|157514691|FG000|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1|||
48912031|NCT01299376|157514692|FG001|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2|||
48912032|NCT01299376|157514691|FG000|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0|||
48912033|NCT01299376|157514692|FG001|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1|||
48912034|NCT01299376|157514691|FG000|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0|||
48912035|NCT01299376|157514692|FG001|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1|||
48912036|NCT01299376|157514691|FG000|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4|||
48912037|NCT01299376|157514692|FG001|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7|||
48912038|NCT01299376|157514691|FG000|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1|||
48912039|NCT01299376|157514692|FG001|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0|||
48912040|NCT01299376|157514691|FG000|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
48700288|NCT04467905|156751879|FG000|Overall Study|Conversion to SR|0|||
48700289|NCT04467905|156751880|FG001|Overall Study|Conversion to SR|0|||
48700290|NCT04467905|156751881|FG002|Overall Study|Conversion to SR|3|||
48700291|NCT04467905|156751879|FG000|Overall Study|Technical issue with Holter ECG|0|||
48700292|NCT04467905|156751880|FG001|Overall Study|Technical issue with Holter ECG|0|||
48700293|NCT04467905|156751881|FG002|Overall Study|Technical issue with Holter ECG|3|||
48700294|NCT04467905|156751879|FG000|Overall Study|Hemodynamic instability|0|||
48700295|NCT04467905|156751880|FG001|Overall Study|Hemodynamic instability|0|||
48700296|NCT04467905|156751881|FG002|Overall Study|Hemodynamic instability|1|||
48700297|NCT04467905|156751879|FG000|Overall Study|Site misinterpretation of protocol|0|||
48912041|NCT01299376|157514692|FG001|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
48912042|NCT01299376|157514691|FG000|Extension (Weeks 9 to 52)|Withdrawal by Subject|2|||
48912043|NCT01299376|157514692|FG001|Extension (Weeks 9 to 52)|Withdrawal by Subject|1|||
48798427|NCT02453685|157098661|FG001|Overall Study|Protocol Violation|4|||
48912044|NCT01299376|157514691|FG000|Extension (Weeks 9 to 52)|Adverse Event|2|||
48912045|NCT01299376|157514692|FG001|Extension (Weeks 9 to 52)|Adverse Event|3|||
48912046|NCT01299376|157514691|FG000|Extension (Weeks 9 to 52)|Lost to Follow-up|1|||
48912047|NCT01299376|157514692|FG001|Extension (Weeks 9 to 52)|Lost to Follow-up|2|||
48912048|NCT01299376|157514691|FG000|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4|||
48912049|NCT01299376|157514692|FG001|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9|||
48912050|NCT01299376|157514691|FG000|Extension (Weeks 9 to 52)|Physician Decision|1|||
48912051|NCT01299376|157514692|FG001|Extension (Weeks 9 to 52)|Physician Decision|0|||
48912052|NCT00509067|157514695|FG000|Overall Study|Lost to Follow-up|1|||
48912053|NCT00509067|157514696|FG001|Overall Study|Lost to Follow-up|1|||
48912054|NCT00509067|157514695|FG000|Overall Study|Adverse Event|3|||
48912055|NCT00509067|157514696|FG001|Overall Study|Adverse Event|1|||
48912056|NCT00509067|157514695|FG000|Overall Study|Protocol Violation|0|||
48912057|NCT00509067|157514696|FG001|Overall Study|Protocol Violation|3|||
48912058|NCT02247960|157514697|FG000|Patient Consent and Randomization|Physician Decision|2|||
48700298|NCT04467905|156751880|FG001|Overall Study|Site misinterpretation of protocol|0|||
48700299|NCT04467905|156751881|FG002|Overall Study|Site misinterpretation of protocol|1|||
48700300|NCT04944992|156753224|FG000|Overall Study|Lost to Follow-up|1|||
48700301|NCT04944992|156753225|FG001|Overall Study|Lost to Follow-up|1|||
48700302|NCT04944992|156753224|FG000|Overall Study|Physician Decision|1|||
48700303|NCT04944992|156753225|FG001|Overall Study|Physician Decision|0|||
48700304|NCT04944992|156753224|FG000|Overall Study|Withdrawal by Subject|6|||
48700305|NCT04944992|156753225|FG001|Overall Study|Withdrawal by Subject|1|||
48700306|NCT00906204|156753226|FG000|Primary Endpoint (Early Safety)|Physician Decision|1|||
48700307|NCT00906204|156753227|FG001|Primary Endpoint (Early Safety)|Physician Decision|0|||
48700308|NCT00906204|156753226|FG000|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0|||
48700309|NCT00906204|156753227|FG001|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1|||
48700310|NCT00906204|156753226|FG000|Primary Endpoint (Early Safety)|Withdrawal by Subject|1|||
48700311|NCT00906204|156753227|FG001|Primary Endpoint (Early Safety)|Withdrawal by Subject|0|||
48700312|NCT00906204|156753226|FG000|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
48700313|NCT00906204|156753227|FG001|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
48700314|NCT00906204|156753226|FG000|Secondary Endpoints (Long-term Safety)|Death|0|||
48700315|NCT00906204|156753227|FG001|Secondary Endpoints (Long-term Safety)|Death|1|||
48700316|NCT04639245|156753228|FG000|Overall Study|Death|1|||
48700317|NCT03175367|156753231|FG000|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
48700318|NCT03175367|156753232|FG001|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
48700319|NCT03175367|156753233|FG002|Double-blind Treatment Period (DBTP)|Protocol Violation|1|||
48700320|NCT03175367|156753234|FG003|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
48700321|NCT03175367|156753235|FG004|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
48700322|NCT03175367|156753236|FG005|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
48700323|NCT03175367|156753237|FG006|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
48700324|NCT03175367|156753231|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
48700325|NCT03175367|156753232|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
48700326|NCT03175367|156753233|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
48700327|NCT03175367|156753234|FG003|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
48700328|NCT03175367|156753235|FG004|Double-blind Treatment Period (DBTP)|Adverse Event|1|||
48700329|NCT03175367|156753236|FG005|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
48700330|NCT03175367|156753237|FG006|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
48912059|NCT02247960|157514698|FG001|Patient Consent and Randomization|Physician Decision|2|||
48912060|NCT02247960|157514697|FG000|Patient Consent and Randomization|Withdrawal by Subject|0|||
48912061|NCT02247960|157514698|FG001|Patient Consent and Randomization|Withdrawal by Subject|4|||
48912062|NCT02247960|157514697|FG000|Catheter Removed|Lost to Follow-up|7|||
48700331|NCT03175367|156753231|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
48912063|NCT02247960|157514698|FG001|Catheter Removed|Lost to Follow-up|10|||
48912064|NCT02361944|157514704|FG000|Overall Study|surgery cancellation|0|||
48912065|NCT02361944|157514705|FG001|Overall Study|surgery cancellation|1|||
48912066|NCT04340557|157514706|FG000|Overall Study|Transferred to ICU and/or death|1|||
48912067|NCT04340557|157514707|FG001|Overall Study|Transferred to ICU and/or death|2|||
48912068|NCT01431274|157514708|FG000|Overall Study|Adverse Event|51|||
48912069|NCT01431274|157514709|FG001|Overall Study|Adverse Event|37|||
48912070|NCT01431274|157514710|FG002|Overall Study|Adverse Event|43|||
48912071|NCT01431274|157514711|FG003|Overall Study|Adverse Event|30|||
48912072|NCT01431274|157514712|FG004|Overall Study|Adverse Event|37|||
48912073|NCT01431274|157514708|FG000|Overall Study|Consent withdrawn not due to AE|29|||
48912074|NCT01431274|157514709|FG001|Overall Study|Consent withdrawn not due to AE|20|||
48912075|NCT01431274|157514710|FG002|Overall Study|Consent withdrawn not due to AE|17|||
48700332|NCT03175367|156753232|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
48700333|NCT03175367|156753233|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
48912076|NCT01431274|157514711|FG003|Overall Study|Consent withdrawn not due to AE|20|||
48912077|NCT01431274|157514712|FG004|Overall Study|Consent withdrawn not due to AE|11|||
48912078|NCT01431274|157514708|FG000|Overall Study|Non compliant with protocol|5|||
48912079|NCT01431274|157514709|FG001|Overall Study|Non compliant with protocol|8|||
48912080|NCT01431274|157514710|FG002|Overall Study|Non compliant with protocol|4|||
48912081|NCT01431274|157514711|FG003|Overall Study|Non compliant with protocol|4|||
48912082|NCT01431274|157514712|FG004|Overall Study|Non compliant with protocol|4|||
48912083|NCT01431274|157514708|FG000|Overall Study|Lost to Follow-up|6|||
48912084|NCT01431274|157514709|FG001|Overall Study|Lost to Follow-up|7|||
48912085|NCT01431274|157514710|FG002|Overall Study|Lost to Follow-up|1|||
48912086|NCT01431274|157514711|FG003|Overall Study|Lost to Follow-up|4|||
48912087|NCT01431274|157514712|FG004|Overall Study|Lost to Follow-up|0|||
48912088|NCT01431274|157514708|FG000|Overall Study|Other reason not stated above|6|||
48912089|NCT01431274|157514709|FG001|Overall Study|Other reason not stated above|5|||
48912090|NCT01431274|157514710|FG002|Overall Study|Other reason not stated above|7|||
48912091|NCT01431274|157514711|FG003|Overall Study|Other reason not stated above|2|||
48912092|NCT01431274|157514712|FG004|Overall Study|Other reason not stated above|4|||
48912093|NCT01069172|157514716|FG000|Overall Study|Withdrawal by Subject|1|||
48912094|NCT01069172|157514717|FG001|Overall Study|Withdrawal by Subject|0|||
48912095|NCT01368042|157514719|FG000|Overall Study|Death|14|||
48912096|NCT01368042|157514719|FG000|Overall Study|Protocol Violation|11|||
48912097|NCT01368042|157514719|FG000|Overall Study|Lost to Follow-up|4|||
48912098|NCT01368042|157514719|FG000|Overall Study|Transplanted|1|||
48912099|NCT02663271|157514722|FG000|Overall Study|Withdrawal by Subject|5|||
48912100|NCT02663271|157514722|FG000|Overall Study|Lack of Efficacy|1|||
48912101|NCT01536951|157514723|FG000|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
48912102|NCT01536951|157514724|FG001|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
48912103|NCT01536951|157514725|FG002|First Intervention and Washout Period 1|Withdrawal by Subject|1|||
48912104|NCT01536951|157514726|FG003|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
48912105|NCT01536951|157514727|FG004|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
48912106|NCT01536951|157514728|FG005|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
48912107|NCT01536951|157514729|FG006|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
48912108|NCT01536951|157514730|FG007|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
48912109|NCT01536951|157514731|FG008|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
48912110|NCT01536951|157514723|FG000|Second Intervention and Washout Period 2|Adverse Event|0|||
48912111|NCT01536951|157514724|FG001|Second Intervention and Washout Period 2|Adverse Event|0|||
48912112|NCT01536951|157514725|FG002|Second Intervention and Washout Period 2|Adverse Event|0|||
48912113|NCT01536951|157514726|FG003|Second Intervention and Washout Period 2|Adverse Event|0|||
48912114|NCT01536951|157514727|FG004|Second Intervention and Washout Period 2|Adverse Event|0|||
48912115|NCT01536951|157514728|FG005|Second Intervention and Washout Period 2|Adverse Event|0|||
48912116|NCT01536951|157514729|FG006|Second Intervention and Washout Period 2|Adverse Event|0|||
48912117|NCT01536951|157514730|FG007|Second Intervention and Washout Period 2|Adverse Event|1|||
48912118|NCT01536951|157514731|FG008|Second Intervention and Washout Period 2|Adverse Event|0|||
48912119|NCT01235793|157514734|FG000|Overall Study|Death|6|||
48912120|NCT01202279|157514737|FG000|Overall Study|Adverse Event|8|||
48912121|NCT01202279|157514738|FG001|Overall Study|Adverse Event|6|||
48912122|NCT01202279|157514737|FG000|Overall Study|Withdrawal by Subject|13|||
48912123|NCT01202279|157514738|FG001|Overall Study|Withdrawal by Subject|10|||
48912124|NCT01202279|157514737|FG000|Overall Study|Physician Decision|0|||
48912125|NCT01202279|157514738|FG001|Overall Study|Physician Decision|1|||
48912126|NCT01202279|157514737|FG000|Overall Study|Lost to Follow-up|10|||
48912127|NCT01202279|157514738|FG001|Overall Study|Lost to Follow-up|7|||
48912128|NCT01202279|157514737|FG000|Overall Study|Protocol Violation|1|||
48912129|NCT01202279|157514738|FG001|Overall Study|Protocol Violation|1|||
48912130|NCT01202279|157514737|FG000|Overall Study|study compliance|5|||
48912131|NCT01202279|157514738|FG001|Overall Study|study compliance|2|||
48912132|NCT02281357|157514739|FG000|Overall Study|Adverse Event|2|||
48912133|NCT02281357|157514740|FG001|Overall Study|Adverse Event|1|||
48912134|NCT02281357|157514739|FG000|Overall Study|Lost to Follow-up|1|||
48700334|NCT03175367|156753234|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
48700335|NCT03175367|156753235|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
48700336|NCT03175367|156753236|FG005|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
48700337|NCT03175367|156753237|FG006|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
48912135|NCT02281357|157514740|FG001|Overall Study|Lost to Follow-up|0|||
48912136|NCT02281357|157514739|FG000|Overall Study|Withdrawal by Subject|4|||
48912137|NCT02281357|157514740|FG001|Overall Study|Withdrawal by Subject|3|||
48912138|NCT00228566|157514741|FG000|Overall Study|Adverse Event|31|||
48912139|NCT00228566|157514741|FG000|Overall Study|Lack of Efficacy|14|||
48912140|NCT00228566|157514741|FG000|Overall Study|Lost to Follow-up|16|||
48912141|NCT00228566|157514741|FG000|Overall Study|Physician Decision|5|||
48912142|NCT00228566|157514741|FG000|Overall Study|Withdrawal by Subject|4|||
48912143|NCT00228566|157514741|FG000|Overall Study|Miscellaneous|1|||
48912144|NCT00916279|157514742|FG000|Overall Study|Death|2|||
48912145|NCT00916279|157514742|FG000|Overall Study|Lost to Follow-up|2|||
48912146|NCT03007979|157514743|FG000|Overall Study|Deemed not eligible prior to starting palbociclib|1|||
48912147|NCT00517751|157514744|FG000|Overall Study|Death|3|||
48912148|NCT00517751|157514744|FG000|Overall Study|Withdrawal by Subject|37|||
48912149|NCT00517751|157514744|FG000|Overall Study|Lost to Follow-up|4|||
48912150|NCT00517751|157514744|FG000|Overall Study|patient not over due|6|||
48912151|NCT00517751|157514744|FG000|Overall Study|Patient not due for visit|76|||
48912152|NCT00517751|157514744|FG000|Overall Study|Missing|3|||
48912153|NCT00943579|157514745|FG000|Overall Study|Adverse Event|4|||
48912154|NCT00943579|157514746|FG001|Overall Study|Adverse Event|3|||
48912155|NCT00943579|157514745|FG000|Overall Study|Lack of Efficacy|2|||
48912156|NCT00943579|157514746|FG001|Overall Study|Lack of Efficacy|2|||
49116512|NCT02688764|158264169|FG001|Overall Study|AE/Physician decision|0|||
49116513|NCT02688764|158264168|FG000|Overall Study|AE/Withd. parent|3|||
49116514|NCT02688764|158264169|FG001|Overall Study|AE/Withd. parent|0|||
49116515|NCT02688764|158264168|FG000|Overall Study|AE/Withd. parent/Withd. subject|1|||
49116516|NCT02688764|158264169|FG001|Overall Study|AE/Withd. parent/Withd. subject|1|||
49116517|NCT02688764|158264168|FG000|Overall Study|AE/Withd. subject|1|||
49116518|NCT02688764|158264169|FG001|Overall Study|AE/Withd. subject|0|||
49116519|NCT02688764|158264168|FG000|Overall Study|Kidney transplant|10|||
49116520|NCT02688764|158264169|FG001|Overall Study|Kidney transplant|4|||
49116521|NCT02688764|158264168|FG000|Overall Study|Lack of Efficacy|3|||
49116522|NCT02688764|158264169|FG001|Overall Study|Lack of Efficacy|2|||
49116523|NCT02688764|158264168|FG000|Overall Study|Lack of efficacy/Physician decision|0|||
49116524|NCT02688764|158264169|FG001|Overall Study|Lack of efficacy/Physician decision|1|||
49116525|NCT02688764|158264168|FG000|Overall Study|Non-compliance with study drug|4|||
49116526|NCT02688764|158264169|FG001|Overall Study|Non-compliance with study drug|0|||
49116527|NCT02688764|158264168|FG000|Overall Study|Non-compl./Physician decision|2|||
49116528|NCT02688764|158264169|FG001|Overall Study|Non-compl./Physician decision|0|||
49116529|NCT02688764|158264168|FG000|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
49116530|NCT02688764|158264169|FG001|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
49116531|NCT02688764|158264168|FG000|Overall Study|Non-compl./Withd. subject|0|||
49116532|NCT02688764|158264169|FG001|Overall Study|Non-compl./Withd. subject|2|||
49116533|NCT02688764|158264168|FG000|Overall Study|Phosphorus level outside safe range|0|||
49116534|NCT02688764|158264169|FG001|Overall Study|Phosphorus level outside safe range|1|||
49116535|NCT02688764|158264168|FG000|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1|||
49116536|NCT02688764|158264169|FG001|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0|||
49116537|NCT02688764|158264168|FG000|Overall Study|Study drug taste/Withd. parent|1|||
49116538|NCT02688764|158264169|FG001|Overall Study|Study drug taste/Withd. parent|0|||
49116539|NCT02688764|158264168|FG000|Overall Study|Subject moving out|2|||
49116540|NCT02688764|158264169|FG001|Overall Study|Subject moving out|0|||
49116541|NCT02688764|158264168|FG000|Overall Study|Subject taken off dialysis|1|||
49116542|NCT02688764|158264169|FG001|Overall Study|Subject taken off dialysis|0|||
49116543|NCT02688764|158264168|FG000|Overall Study|Withdrawal by parent|3|||
49116544|NCT02688764|158264169|FG001|Overall Study|Withdrawal by parent|0|||
49116545|NCT02821416|158264172|FG000|Overall Study|Adverse Event|0|||
49116546|NCT02821416|158264173|FG001|Overall Study|Adverse Event|1|||
49116547|NCT02821416|158264172|FG000|Overall Study|Withdrawal by Subject|2|||
49116548|NCT02821416|158264173|FG001|Overall Study|Withdrawal by Subject|0|||
49116549|NCT02821416|158264172|FG000|Overall Study|Lost to Follow-up|1|||
49116550|NCT02821416|158264173|FG001|Overall Study|Lost to Follow-up|0|||
49116551|NCT04399889|158264176|FG000|Overall Study|Death|5|||
49116552|NCT04399889|158264177|FG001|Overall Study|Death|1|||
49116553|NCT04399889|158264178|FG002|Overall Study|Death|1|||
49116554|NCT01135524|158264179|FG000|Overall Study|Withdrawal by Subject|14|||
49116555|NCT01135524|158264179|FG000|Overall Study|Adverse Event|20|||
49116556|NCT01135524|158264179|FG000|Overall Study|Lost to Follow-up|3|||
49116557|NCT01135524|158264179|FG000|Overall Study|Administrative|151|||
49116558|NCT01135524|158264179|FG000|Overall Study|Lack of Efficacy|8|||
49116559|NCT03076515|158264180|FG000|Overall Study|DMC decision based on interim analysis|25|||
49116560|NCT03076515|158264181|FG001|Overall Study|DMC decision based on interim analysis|29|||
49116561|NCT02328937|158264182|FG000|Period 1|Lost to Follow-up|0|||
49116562|NCT02328937|158264183|FG001|Period 1|Lost to Follow-up|0|||
49116563|NCT02328937|158264184|FG002|Period 1|Lost to Follow-up|0|||
49116564|NCT02328937|158264185|FG003|Period 1|Lost to Follow-up|1|||
48912157|NCT02269787|157514749|FG000|Overall Study|Lost to Follow-up|20|||
48912158|NCT02269787|157514750|FG001|Overall Study|Lost to Follow-up|6|||
49116565|NCT02328937|158264186|FG004|Period 1|Lost to Follow-up|0|||
49116566|NCT02328937|158264187|FG005|Period 1|Lost to Follow-up|0|||
49116567|NCT02328937|158264182|FG000|Period 2|Adverse Event|0|||
49116568|NCT02328937|158264183|FG001|Period 2|Adverse Event|0|||
49116569|NCT02328937|158264184|FG002|Period 2|Adverse Event|1|||
48912159|NCT02269787|157514749|FG000|Overall Study|Death|2|||
48912160|NCT02269787|157514750|FG001|Overall Study|Death|3|||
48912161|NCT02269787|157514749|FG000|Overall Study|Incapacitated|0|||
49116570|NCT02328937|158264185|FG003|Period 2|Adverse Event|0|||
49116571|NCT02328937|158264186|FG004|Period 2|Adverse Event|0|||
49116572|NCT02328937|158264187|FG005|Period 2|Adverse Event|0|||
49116573|NCT02959918|158264188|FG000|Overall Study|Adverse Event|1|||
49116574|NCT02959918|158264189|FG001|Overall Study|Adverse Event|1|||
49116575|NCT02959918|158264190|FG002|Overall Study|Adverse Event|2|||
49116576|NCT02959918|158264191|FG003|Overall Study|Adverse Event|0|||
49116577|NCT02959918|158264192|FG004|Overall Study|Adverse Event|0|||
49116578|NCT02959918|158264193|FG005|Overall Study|Adverse Event|2|||
49116579|NCT02959918|158264194|FG006|Overall Study|Adverse Event|2|||
49116580|NCT02959918|158264195|FG007|Overall Study|Adverse Event|1|||
49116581|NCT02959918|158264196|FG008|Overall Study|Adverse Event|2|||
49116582|NCT02959918|158264197|FG009|Overall Study|Adverse Event|1|||
49116583|NCT02959918|158264198|FG010|Overall Study|Adverse Event|1|||
49116584|NCT02959918|158264199|FG011|Overall Study|Adverse Event|3|||
49116585|NCT02959918|158264200|FG012|Overall Study|Adverse Event|2|||
49116586|NCT02959918|158264201|FG013|Overall Study|Adverse Event|4|||
49116587|NCT02959918|158264188|FG000|Overall Study|Lost to Follow-up|0|||
49116588|NCT02959918|158264189|FG001|Overall Study|Lost to Follow-up|0|||
49116589|NCT02959918|158264190|FG002|Overall Study|Lost to Follow-up|0|||
49116590|NCT02959918|158264191|FG003|Overall Study|Lost to Follow-up|0|||
49116591|NCT02959918|158264192|FG004|Overall Study|Lost to Follow-up|0|||
49116592|NCT02959918|158264193|FG005|Overall Study|Lost to Follow-up|0|||
49116593|NCT02959918|158264194|FG006|Overall Study|Lost to Follow-up|0|||
49116594|NCT02959918|158264195|FG007|Overall Study|Lost to Follow-up|0|||
49116595|NCT02959918|158264196|FG008|Overall Study|Lost to Follow-up|0|||
49116596|NCT02959918|158264197|FG009|Overall Study|Lost to Follow-up|1|||
49116597|NCT02959918|158264198|FG010|Overall Study|Lost to Follow-up|0|||
49116598|NCT02959918|158264199|FG011|Overall Study|Lost to Follow-up|0|||
49116599|NCT02959918|158264200|FG012|Overall Study|Lost to Follow-up|1|||
49116600|NCT02959918|158264201|FG013|Overall Study|Lost to Follow-up|0|||
49116601|NCT02959918|158264188|FG000|Overall Study|Withdrawal by Subject|0|||
49116602|NCT02959918|158264189|FG001|Overall Study|Withdrawal by Subject|0|||
49116603|NCT02959918|158264190|FG002|Overall Study|Withdrawal by Subject|1|||
49116604|NCT02959918|158264191|FG003|Overall Study|Withdrawal by Subject|2|||
49116605|NCT02959918|158264192|FG004|Overall Study|Withdrawal by Subject|0|||
49116606|NCT02959918|158264193|FG005|Overall Study|Withdrawal by Subject|0|||
49116607|NCT02959918|158264194|FG006|Overall Study|Withdrawal by Subject|1|||
49116608|NCT02959918|158264195|FG007|Overall Study|Withdrawal by Subject|0|||
49116609|NCT02959918|158264196|FG008|Overall Study|Withdrawal by Subject|1|||
49116610|NCT02959918|158264197|FG009|Overall Study|Withdrawal by Subject|1|||
49116611|NCT02959918|158264198|FG010|Overall Study|Withdrawal by Subject|2|||
49116612|NCT02959918|158264199|FG011|Overall Study|Withdrawal by Subject|3|||
49116613|NCT02959918|158264200|FG012|Overall Study|Withdrawal by Subject|1|||
49116614|NCT02959918|158264201|FG013|Overall Study|Withdrawal by Subject|1|||
49116615|NCT02959918|158264188|FG000|Overall Study|Protocol Violation|0|||
48700338|NCT03175367|156753231|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
48700339|NCT03175367|156753232|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|5|||
48700340|NCT03175367|156753233|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|8|||
48700341|NCT03175367|156753234|FG003|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
48700342|NCT03175367|156753235|FG004|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
48700343|NCT03175367|156753236|FG005|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
48700344|NCT03175367|156753237|FG006|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
48700345|NCT03175367|156753231|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
48798428|NCT02453685|157098660|FG000|Overall Study|Lost to Follow-up|0|||
49116616|NCT02959918|158264189|FG001|Overall Study|Protocol Violation|0|||
49116617|NCT02959918|158264190|FG002|Overall Study|Protocol Violation|1|||
49116618|NCT02959918|158264191|FG003|Overall Study|Protocol Violation|0|||
49116619|NCT02959918|158264192|FG004|Overall Study|Protocol Violation|0|||
49116620|NCT02959918|158264193|FG005|Overall Study|Protocol Violation|1|||
49116621|NCT02959918|158264194|FG006|Overall Study|Protocol Violation|0|||
49116622|NCT02959918|158264195|FG007|Overall Study|Protocol Violation|0|||
49116623|NCT02959918|158264196|FG008|Overall Study|Protocol Violation|2|||
49116624|NCT02959918|158264197|FG009|Overall Study|Protocol Violation|1|||
49116625|NCT02959918|158264198|FG010|Overall Study|Protocol Violation|0|||
49116626|NCT02959918|158264199|FG011|Overall Study|Protocol Violation|1|||
49116627|NCT02959918|158264200|FG012|Overall Study|Protocol Violation|1|||
49116628|NCT02959918|158264201|FG013|Overall Study|Protocol Violation|0|||
49116629|NCT02959918|158264188|FG000|Overall Study|Stopping Rule Met|1|||
49116630|NCT02959918|158264189|FG001|Overall Study|Stopping Rule Met|0|||
49116631|NCT02959918|158264190|FG002|Overall Study|Stopping Rule Met|3|||
49116632|NCT02959918|158264191|FG003|Overall Study|Stopping Rule Met|4|||
49116633|NCT02959918|158264192|FG004|Overall Study|Stopping Rule Met|5|||
49116634|NCT02959918|158264193|FG005|Overall Study|Stopping Rule Met|3|||
49116635|NCT02959918|158264194|FG006|Overall Study|Stopping Rule Met|2|||
49116636|NCT02959918|158264195|FG007|Overall Study|Stopping Rule Met|4|||
49116637|NCT02959918|158264196|FG008|Overall Study|Stopping Rule Met|1|||
49116638|NCT02959918|158264197|FG009|Overall Study|Stopping Rule Met|1|||
49116639|NCT02959918|158264198|FG010|Overall Study|Stopping Rule Met|3|||
49116640|NCT02959918|158264199|FG011|Overall Study|Stopping Rule Met|5|||
49116641|NCT02959918|158264200|FG012|Overall Study|Stopping Rule Met|2|||
49116642|NCT02959918|158264201|FG013|Overall Study|Stopping Rule Met|1|||
49116643|NCT02959918|158264188|FG000|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
49116644|NCT02959918|158264189|FG001|Overall Study|Sponsor Decision, Pause in Clinical Trial|2|||
49116645|NCT02959918|158264190|FG002|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
49116646|NCT02959918|158264191|FG003|Overall Study|Sponsor Decision, Pause in Clinical Trial|3|||
49116647|NCT02959918|158264192|FG004|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
49116648|NCT02959918|158264193|FG005|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
49116649|NCT02959918|158264194|FG006|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
49116650|NCT02959918|158264195|FG007|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
49116651|NCT02959918|158264196|FG008|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
49116652|NCT02959918|158264197|FG009|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
49116653|NCT02959918|158264198|FG010|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
49116654|NCT02959918|158264199|FG011|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
49116655|NCT02959918|158264200|FG012|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
49116656|NCT02959918|158264201|FG013|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
49116657|NCT02959918|158264188|FG000|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
48700346|NCT03175367|156753232|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
49116658|NCT02959918|158264189|FG001|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
49116659|NCT02959918|158264190|FG002|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
49116660|NCT02959918|158264191|FG003|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
49116661|NCT02959918|158264192|FG004|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
49116662|NCT02959918|158264193|FG005|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
49116663|NCT02959918|158264194|FG006|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
49116664|NCT02959918|158264195|FG007|Overall Study|Subject Hospitalized, out of window for next dosing period|1|||
49116665|NCT02959918|158264196|FG008|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
49116666|NCT02959918|158264197|FG009|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
49116667|NCT02959918|158264198|FG010|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
49116668|NCT02959918|158264199|FG011|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
49116669|NCT02959918|158264200|FG012|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
49116670|NCT02959918|158264201|FG013|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
49116671|NCT02959918|158264188|FG000|Overall Study|PI Discretion due to abnormal Hgb results|0|||
49116672|NCT02959918|158264189|FG001|Overall Study|PI Discretion due to abnormal Hgb results|0|||
49116673|NCT02959918|158264190|FG002|Overall Study|PI Discretion due to abnormal Hgb results|0|||
49116674|NCT02959918|158264191|FG003|Overall Study|PI Discretion due to abnormal Hgb results|0|||
49116675|NCT02959918|158264192|FG004|Overall Study|PI Discretion due to abnormal Hgb results|0|||
49116676|NCT02959918|158264193|FG005|Overall Study|PI Discretion due to abnormal Hgb results|0|||
49116677|NCT02959918|158264194|FG006|Overall Study|PI Discretion due to abnormal Hgb results|0|||
49116678|NCT02959918|158264195|FG007|Overall Study|PI Discretion due to abnormal Hgb results|0|||
49116679|NCT02959918|158264196|FG008|Overall Study|PI Discretion due to abnormal Hgb results|1|||
49116680|NCT02959918|158264197|FG009|Overall Study|PI Discretion due to abnormal Hgb results|0|||
49116681|NCT02959918|158264198|FG010|Overall Study|PI Discretion due to abnormal Hgb results|0|||
49116682|NCT02959918|158264199|FG011|Overall Study|PI Discretion due to abnormal Hgb results|0|||
49116683|NCT02959918|158264200|FG012|Overall Study|PI Discretion due to abnormal Hgb results|0|||
49116684|NCT02959918|158264201|FG013|Overall Study|PI Discretion due to abnormal Hgb results|0|||
49116685|NCT02959918|158264188|FG000|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
49116686|NCT02959918|158264189|FG001|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
49116687|NCT02959918|158264190|FG002|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
49116688|NCT02959918|158264191|FG003|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
49116689|NCT02959918|158264192|FG004|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
49116690|NCT02959918|158264193|FG005|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
49116691|NCT02959918|158264194|FG006|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
49116692|NCT02959918|158264195|FG007|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
49116693|NCT02959918|158264196|FG008|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
49116694|NCT02959918|158264197|FG009|Overall Study|Subject under-dosed with study drug and removed by Sponsor|1|||
49116695|NCT02959918|158264198|FG010|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
49116696|NCT02959918|158264199|FG011|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
49116697|NCT02959918|158264200|FG012|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
49116698|NCT02959918|158264201|FG013|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
49116699|NCT01502033|158264204|FG000|Overall Study|1 participant had scalp discomfort|1|||
49116700|NCT01502033|158264204|FG000|Overall Study|1 participant had worsening depression|1|||
49116701|NCT01502033|158264204|FG000|Overall Study|1 participant went back to school|1|||
49116702|NCT01424241|158264205|FG000|Overall Study|Withdrawal by Subject|1|||
49116703|NCT01424241|158264205|FG000|Overall Study|Time constraints|2|||
49116704|NCT00551525|158264206|FG000|Overall Study|Protocol Violation|5|||
49116705|NCT02782377|158264212|FG000|Overall Study|Physician Decision|5|||
49116706|NCT01210222|158264214|FG000|Overall Study|Ineligible|2|||
49116707|NCT01210222|158264214|FG000|Overall Study|Never treated|1|||
49116708|NCT01737879|158264215|FG000|Overall Study|Death|1|||
49116709|NCT01737879|158264215|FG000|Overall Study|Sponsor decision|40|||
49116710|NCT02098395|158264218|FG000|Overall Study|Protocol Violation|2|||
49116711|NCT02098395|158264219|FG001|Overall Study|Protocol Violation|2|||
49116712|NCT02098395|158264220|FG002|Overall Study|Protocol Violation|0|||
49116713|NCT02098395|158264221|FG003|Overall Study|Protocol Violation|7|||
49116714|NCT02098395|158264218|FG000|Overall Study|Withdrawal by Subject|10|||
49116715|NCT02098395|158264219|FG001|Overall Study|Withdrawal by Subject|10|||
49116716|NCT02098395|158264220|FG002|Overall Study|Withdrawal by Subject|5|||
49116717|NCT02098395|158264221|FG003|Overall Study|Withdrawal by Subject|13|||
49116718|NCT02098395|158264218|FG000|Overall Study|Adverse Event|12|||
49116719|NCT02098395|158264219|FG001|Overall Study|Adverse Event|19|||
49116720|NCT02098395|158264220|FG002|Overall Study|Adverse Event|34|||
49116721|NCT02098395|158264221|FG003|Overall Study|Adverse Event|2|||
49116722|NCT02098395|158264218|FG000|Overall Study|Lost to Follow-up|2|||
49116723|NCT02098395|158264219|FG001|Overall Study|Lost to Follow-up|1|||
49116724|NCT02098395|158264220|FG002|Overall Study|Lost to Follow-up|0|||
49116725|NCT02098395|158264221|FG003|Overall Study|Lost to Follow-up|3|||
49116726|NCT02098395|158264218|FG000|Overall Study|Unclassified|0|||
49116727|NCT02098395|158264219|FG001|Overall Study|Unclassified|0|||
49116728|NCT02098395|158264220|FG002|Overall Study|Unclassified|3|||
49116729|NCT02098395|158264221|FG003|Overall Study|Unclassified|2|||
49116730|NCT01204918|158264222|FG000|Overall Study|Withdrawal by Subject|4|||
49116731|NCT01204918|158264223|FG001|Overall Study|Withdrawal by Subject|10|||
49116732|NCT01204918|158264224|FG002|Overall Study|Withdrawal by Subject|5|||
49116733|NCT00977613|158264225|FG000|Overall Study|Lost to Follow-up|16|||
49116734|NCT02559570|158264237|FG000|Overall Study|Adverse Event|0|||
49116735|NCT02559570|158264238|FG001|Overall Study|Adverse Event|2|||
49116736|NCT02559570|158264239|FG002|Overall Study|Adverse Event|0|||
49116737|NCT02559570|158264240|FG003|Overall Study|Adverse Event|1|||
49116738|NCT02559570|158264241|FG004|Overall Study|Adverse Event|0|||
49116739|NCT02559570|158264237|FG000|Overall Study|Withdrawal of Consent|0|||
49116740|NCT02559570|158264238|FG001|Overall Study|Withdrawal of Consent|0|||
49116741|NCT02559570|158264239|FG002|Overall Study|Withdrawal of Consent|1|||
49116742|NCT02559570|158264240|FG003|Overall Study|Withdrawal of Consent|2|||
49116743|NCT02559570|158264241|FG004|Overall Study|Withdrawal of Consent|1|||
49116744|NCT02559570|158264237|FG000|Overall Study|Lost to Follow-up|1|||
49116745|NCT02559570|158264238|FG001|Overall Study|Lost to Follow-up|0|||
49116746|NCT02559570|158264239|FG002|Overall Study|Lost to Follow-up|0|||
49116747|NCT02559570|158264240|FG003|Overall Study|Lost to Follow-up|0|||
49116748|NCT02559570|158264241|FG004|Overall Study|Lost to Follow-up|0|||
49116749|NCT02559570|158264237|FG000|Overall Study|Protocol Violation|1|||
49116750|NCT02559570|158264238|FG001|Overall Study|Protocol Violation|0|||
49116751|NCT02559570|158264239|FG002|Overall Study|Protocol Violation|0|||
49116752|NCT02559570|158264240|FG003|Overall Study|Protocol Violation|0|||
49116753|NCT02559570|158264241|FG004|Overall Study|Protocol Violation|1|||
49116754|NCT02559570|158264237|FG000|Overall Study|Other Miscellaneous Reasons|0|||
49116755|NCT02559570|158264238|FG001|Overall Study|Other Miscellaneous Reasons|0|||
49116756|NCT02559570|158264239|FG002|Overall Study|Other Miscellaneous Reasons|1|||
49116757|NCT02559570|158264240|FG003|Overall Study|Other Miscellaneous Reasons|0|||
49116758|NCT02559570|158264241|FG004|Overall Study|Other Miscellaneous Reasons|0|||
49116759|NCT01189461|158264244|FG000|Overall Study|Lack of Efficacy|13|||
49116760|NCT01189461|158264244|FG000|Overall Study|Lost to Follow-up|1|||
49116761|NCT01189461|158264244|FG000|Overall Study|Withdrawal by Subject|6|||
49116762|NCT01189461|158264244|FG000|Overall Study|Protocol Violation|1|||
49116763|NCT01189461|158264244|FG000|Overall Study|Adverse Event|2|||
49116764|NCT01189461|158264244|FG000|Overall Study|Did not meet entrance criteria|3|||
49116765|NCT01189461|158264244|FG000|Overall Study|Other|8|||
49116766|NCT02903420|158264254|FG000|Overall Study|Death|3|||
49116767|NCT01098162|158264255|FG000|Overall Study|Adverse Event|37|||
49116768|NCT01098162|158264255|FG000|Overall Study|Lack of Efficacy|4|||
49116769|NCT01098162|158264255|FG000|Overall Study|Wish of Patient|7|||
49116770|NCT01098162|158264255|FG000|Overall Study|Lost to Follow-up|9|||
49116771|NCT01098162|158264255|FG000|Overall Study|Lack of Efficacy & Wish of Patient|5|||
49116772|NCT01098162|158264255|FG000|Overall Study|Adverse Event & Lack of Efficacy|6|||
49116773|NCT01098162|158264255|FG000|Overall Study|Adverse Event & Wish of Patient|13|||
49116774|NCT01098162|158264255|FG000|Overall Study|Adverse Event & Lost to Follow-up|2|||
49116775|NCT01098162|158264255|FG000|Overall Study|AE & Lack of Efficacy & Wish of Patient|1|||
49116776|NCT01098162|158264255|FG000|Overall Study|Wish of Patient & Lost to Follow-up|1|||
49116777|NCT01098162|158264255|FG000|Overall Study|Other Reason|1|||
49116778|NCT01098162|158264255|FG000|Overall Study|Reason Unknown|26|||
49116779|NCT00625183|158264258|FG000|Overall Study|Disease Progression|1|||
49116780|NCT02500719|158264260|FG000|Overall Study|Lost to Follow-up|2|||
49116781|NCT02500719|158264261|FG001|Overall Study|Lost to Follow-up|3|||
49116782|NCT02500719|158264260|FG000|Overall Study|Trauma history|1|||
49116783|NCT02500719|158264261|FG001|Overall Study|Trauma history|0|||
49116784|NCT02500719|158264260|FG000|Overall Study|MRI data found to be unusable during analysis|0|||
49116785|NCT02500719|158264261|FG001|Overall Study|MRI data found to be unusable during analysis|1|||
49116786|NCT02500719|158264260|FG000|Overall Study|Did not meet criteria for PTSD|0|||
49116787|NCT02500719|158264261|FG001|Overall Study|Did not meet criteria for PTSD|1|||
49116788|NCT02500719|158264260|FG000|Overall Study|Claustrophobia|0|||
49116789|NCT02500719|158264261|FG001|Overall Study|Claustrophobia|1|||
49116790|NCT02500719|158264260|FG000|Overall Study|History of head trauma|0|||
49116791|NCT02500719|158264261|FG001|Overall Study|History of head trauma|1|||
49116792|NCT01429441|158264262|FG000|Overall Study|Adverse Event|5|||
49116793|NCT01429441|158264263|FG001|Overall Study|Adverse Event|1|||
49116794|NCT01429441|158264262|FG000|Overall Study|Death|0|||
49116795|NCT01429441|158264263|FG001|Overall Study|Death|2|||
49116796|NCT01429441|158264262|FG000|Overall Study|Lost to Follow-up|5|||
49116797|NCT01429441|158264263|FG001|Overall Study|Lost to Follow-up|2|||
49116798|NCT01429441|158264262|FG000|Overall Study|Physician Decision|1|||
49116799|NCT01429441|158264263|FG001|Overall Study|Physician Decision|0|||
49116800|NCT01429441|158264262|FG000|Overall Study|Withdrawal by Subject|27|||
49116801|NCT01429441|158264263|FG001|Overall Study|Withdrawal by Subject|18|||
49116802|NCT01605825|158264264|FG000|Overall Study|Adverse Event|4|||
49116803|NCT01605825|158264265|FG001|Overall Study|Adverse Event|2|||
49116804|NCT01605825|158264264|FG000|Overall Study|Withdrawal by Subject|0|||
49116805|NCT01605825|158264265|FG001|Overall Study|Withdrawal by Subject|1|||
49116806|NCT01605825|158264264|FG000|Overall Study|Non-Compliance -Investigational Drug|3|||
49116807|NCT01605825|158264265|FG001|Overall Study|Non-Compliance -Investigational Drug|0|||
49116808|NCT01605825|158264264|FG000|Overall Study|Non-Compliance with Protocol|3|||
49116809|NCT01605825|158264265|FG001|Overall Study|Non-Compliance with Protocol|0|||
49116810|NCT01931397|158264269|FG000|Overall Study|Physician Decision|2|||
49116811|NCT01931397|158264269|FG000|Overall Study|Withdrawal by Subject|8|||
49116812|NCT01931397|158264269|FG000|Overall Study|moved out of state|1|||
49116813|NCT00520039|158264270|FG000|Overall Study|Exclusion criteria met at first visit|7|||
49116814|NCT00520039|158264271|FG001|Overall Study|Exclusion criteria met at first visit|5|||
49116815|NCT01210482|158264275|FG000|Overall Study|Protocol Violation|1|||
49116816|NCT01210482|158264275|FG000|Overall Study|Case Report Forms were not collected|18|||
49116817|NCT01210482|158264275|FG000|Overall Study|Duplicated|2|||
48700347|NCT03175367|156753233|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
49116818|NCT01210482|158264275|FG000|Overall Study|No Drug Administration|28|||
49116819|NCT02058589|158264276|FG000|Overall Study|Serious Adverse Event|1|||
49116820|NCT02058589|158264277|FG001|Overall Study|Serious Adverse Event|1|||
49116821|NCT02058589|158264276|FG000|Overall Study|Non-Serious Adverse Event|1|||
49116822|NCT02058589|158264277|FG001|Overall Study|Non-Serious Adverse Event|0|||
49116823|NCT02058589|158264276|FG000|Overall Study|Withdrawal by Subject|0|||
49116824|NCT02058589|158264277|FG001|Overall Study|Withdrawal by Subject|1|||
49116825|NCT01859949|158265931|FG000|Overall Study|Family Matters|0|||
49116826|NCT01859949|158265932|FG001|Overall Study|Family Matters|1|||
49116827|NCT01859949|158265931|FG000|Overall Study|Physician Decision|2|||
49116828|NCT01859949|158265932|FG001|Overall Study|Physician Decision|4|||
49116829|NCT01859949|158265931|FG000|Overall Study|Withdrawal by Subject|11|||
49116830|NCT01859949|158265932|FG001|Overall Study|Withdrawal by Subject|10|||
49116831|NCT01859949|158265931|FG000|Overall Study|Protocol Violation|1|||
49116832|NCT01859949|158265932|FG001|Overall Study|Protocol Violation|1|||
49116833|NCT01859949|158265931|FG000|Overall Study|Adverse Event|0|||
49116834|NCT01859949|158265932|FG001|Overall Study|Adverse Event|1|||
49116835|NCT01890759|158265933|FG000|Overall Study|Protocol Violation|0|||
49116836|NCT01890759|158265934|FG001|Overall Study|Protocol Violation|2|||
49116837|NCT01890759|158265933|FG000|Overall Study|Lost to Follow-up|0|||
49116838|NCT01890759|158265934|FG001|Overall Study|Lost to Follow-up|2|||
49116839|NCT01890759|158265933|FG000|Overall Study|Withdrawal by Subject|2|||
49116840|NCT01890759|158265934|FG001|Overall Study|Withdrawal by Subject|8|||
49116841|NCT01344759|158265935|FG000|Overall Study|Patients failed to reach sedation level|0|||
49116842|NCT01344759|158265936|FG001|Overall Study|Patients failed to reach sedation level|2|||
49116843|NCT01153009|158265937|FG000|Overall Study|Adverse Event|4|||
49116844|NCT01153009|158265938|FG001|Overall Study|Adverse Event|14|||
49116845|NCT01153009|158265939|FG002|Overall Study|Adverse Event|14|||
49116846|NCT01153009|158265940|FG003|Overall Study|Adverse Event|10|||
49116847|NCT01153009|158265937|FG000|Overall Study|Lack of Efficacy|9|||
49116848|NCT01153009|158265938|FG001|Overall Study|Lack of Efficacy|0|||
49116849|NCT01153009|158265939|FG002|Overall Study|Lack of Efficacy|2|||
49116850|NCT01153009|158265940|FG003|Overall Study|Lack of Efficacy|1|||
49116851|NCT01153009|158265937|FG000|Overall Study|Noncompliance with Study Medication|1|||
49116852|NCT01153009|158265938|FG001|Overall Study|Noncompliance with Study Medication|3|||
49116853|NCT01153009|158265939|FG002|Overall Study|Noncompliance with Study Medication|4|||
49116854|NCT01153009|158265940|FG003|Overall Study|Noncompliance with Study Medication|1|||
49116855|NCT01153009|158265937|FG000|Overall Study|Protocol Deviations|4|||
49116856|NCT01153009|158265938|FG001|Overall Study|Protocol Deviations|3|||
49116857|NCT01153009|158265939|FG002|Overall Study|Protocol Deviations|3|||
49116858|NCT01153009|158265940|FG003|Overall Study|Protocol Deviations|2|||
49116859|NCT01153009|158265937|FG000|Overall Study|Withdrawal of Consent|5|||
49116860|NCT01153009|158265938|FG001|Overall Study|Withdrawal of Consent|5|||
49116861|NCT01153009|158265939|FG002|Overall Study|Withdrawal of Consent|4|||
49116862|NCT01153009|158265940|FG003|Overall Study|Withdrawal of Consent|6|||
49116863|NCT01153009|158265937|FG000|Overall Study|Lost to Follow-up|8|||
49116864|NCT01153009|158265938|FG001|Overall Study|Lost to Follow-up|8|||
49116865|NCT01153009|158265939|FG002|Overall Study|Lost to Follow-up|11|||
49116866|NCT01153009|158265940|FG003|Overall Study|Lost to Follow-up|15|||
49116867|NCT01153009|158265937|FG000|Overall Study|Other|1|||
49116868|NCT01153009|158265938|FG001|Overall Study|Other|1|||
49116869|NCT01153009|158265939|FG002|Overall Study|Other|3|||
49116870|NCT01153009|158265940|FG003|Overall Study|Other|2|||
49116871|NCT00401193|158265941|FG000|Overall Study|Adverse Event|1|||
49116872|NCT00401193|158265942|FG001|Overall Study|Adverse Event|3|||
49116873|NCT00401193|158265943|FG002|Overall Study|Adverse Event|1|||
49116874|NCT00401193|158265941|FG000|Overall Study|Protocol Violation|3|||
49116875|NCT00401193|158265942|FG001|Overall Study|Protocol Violation|1|||
49116876|NCT00401193|158265943|FG002|Overall Study|Protocol Violation|1|||
49116877|NCT00401193|158265941|FG000|Overall Study|Lost to Follow-up|6|||
49116878|NCT00401193|158265942|FG001|Overall Study|Lost to Follow-up|5|||
49116879|NCT00401193|158265943|FG002|Overall Study|Lost to Follow-up|1|||
49116880|NCT00401193|158265941|FG000|Overall Study|Withdrawal by Subject|2|||
49116881|NCT00401193|158265942|FG001|Overall Study|Withdrawal by Subject|0|||
49116882|NCT00401193|158265943|FG002|Overall Study|Withdrawal by Subject|1|||
49116883|NCT00401193|158265941|FG000|Overall Study|Other Event|3|||
49116884|NCT00401193|158265942|FG001|Overall Study|Other Event|2|||
49116885|NCT00401193|158265943|FG002|Overall Study|Other Event|2|||
49116886|NCT00385827|158265944|FG000|Part 1|Adverse Event|1|||
49116887|NCT00385827|158265945|FG001|Part 1|Adverse Event|0|||
49116888|NCT00385827|158265946|FG002|Part 1|Adverse Event|0|||
49116889|NCT00385827|158265944|FG000|Part 1|Death|2|||
49116890|NCT00385827|158265945|FG001|Part 1|Death|0|||
49116891|NCT00385827|158265946|FG002|Part 1|Death|0|||
49116892|NCT00385827|158265944|FG000|Part 1|Lack of Efficacy|5|||
49116893|NCT00385827|158265945|FG001|Part 1|Lack of Efficacy|0|||
49116894|NCT00385827|158265946|FG002|Part 1|Lack of Efficacy|0|||
49116895|NCT00385827|158265944|FG000|Part 1|Other|1|||
48700348|NCT03175367|156753234|FG003|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
48700349|NCT03175367|156753235|FG004|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
49116896|NCT00385827|158265945|FG001|Part 1|Other|0|||
49116897|NCT00385827|158265946|FG002|Part 1|Other|0|||
49116898|NCT00385827|158265944|FG000|Part 2|Adverse Event|0|||
49116899|NCT00385827|158265945|FG001|Part 2|Adverse Event|6|||
49116900|NCT00385827|158265946|FG002|Part 2|Adverse Event|10|||
49116901|NCT00385827|158265944|FG000|Part 2|Death|0|||
49116902|NCT00385827|158265945|FG001|Part 2|Death|0|||
49116903|NCT00385827|158265946|FG002|Part 2|Death|2|||
49116904|NCT00385827|158265944|FG000|Part 2|Lack of Efficacy|0|||
49116905|NCT00385827|158265945|FG001|Part 2|Lack of Efficacy|14|||
49116906|NCT00385827|158265946|FG002|Part 2|Lack of Efficacy|13|||
49116907|NCT00385827|158265944|FG000|Part 2|Randomized but not treated|0|||
49116908|NCT00385827|158265945|FG001|Part 2|Randomized but not treated|2|||
49116909|NCT00385827|158265946|FG002|Part 2|Randomized but not treated|2|||
48700350|NCT03175367|156753236|FG005|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
48700351|NCT03175367|156753237|FG006|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
48700352|NCT03175367|156753231|FG000|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
48700353|NCT03175367|156753232|FG001|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
48700354|NCT03175367|156753233|FG002|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
48700355|NCT03175367|156753234|FG003|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
48700356|NCT03175367|156753235|FG004|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
48700357|NCT03175367|156753236|FG005|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
48700358|NCT03175367|156753237|FG006|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|1|||
48700359|NCT03175367|156753231|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
48700360|NCT03175367|156753232|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
48700361|NCT03175367|156753233|FG002|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
48700362|NCT03175367|156753234|FG003|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
48700363|NCT03175367|156753235|FG004|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
48700364|NCT03175367|156753236|FG005|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|2|||
48700365|NCT03175367|156753237|FG006|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
48700366|NCT03453164|156753238|FG000|Overall Study|Lack of Efficacy|16|||
48700367|NCT03453164|156753238|FG000|Overall Study|3 cases did not meet the criteria for nivolumab initiation.|3|||
48700368|NCT00124943|156753239|FG000|Phase II|Adverse Event|0|||
48700369|NCT00124943|156753240|FG001|Phase II|Adverse Event|2|||
48700370|NCT00124943|156753241|FG002|Phase II|Adverse Event|0|||
48700371|NCT00124943|156753242|FG003|Phase II|Adverse Event|1|||
48700372|NCT00124943|156753239|FG000|Phase II|Protocol Violation|0|||
48700373|NCT00124943|156753240|FG001|Phase II|Protocol Violation|0|||
48700374|NCT00124943|156753241|FG002|Phase II|Protocol Violation|0|||
48700375|NCT00124943|156753242|FG003|Phase II|Protocol Violation|1|||
48700376|NCT00124943|156753239|FG000|Phase II|Lost to Follow-up|0|||
48700377|NCT00124943|156753240|FG001|Phase II|Lost to Follow-up|0|||
48700378|NCT00124943|156753241|FG002|Phase II|Lost to Follow-up|0|||
48700379|NCT00124943|156753242|FG003|Phase II|Lost to Follow-up|1|||
48700380|NCT00124943|156753239|FG000|Phase II|Withdrawal by Subject|0|||
48700381|NCT00124943|156753240|FG001|Phase II|Withdrawal by Subject|0|||
48700382|NCT00124943|156753241|FG002|Phase II|Withdrawal by Subject|0|||
48700383|NCT00124943|156753242|FG003|Phase II|Withdrawal by Subject|2|||
48700384|NCT02153086|156753243|FG000|Overall Study|Not enrolled >=28 days and <=56 days|2|||
48700385|NCT02153086|156753243|FG000|Overall Study|Other|2|||
48700386|NCT03304626|156753254|FG000|Overall Study|Adverse Event|1|||
48700387|NCT03304626|156753255|FG001|Overall Study|Adverse Event|0|||
48700388|NCT03304626|156753254|FG000|Overall Study|Lack of Efficacy|1|||
48700389|NCT03304626|156753255|FG001|Overall Study|Lack of Efficacy|1|||
48700390|NCT02113982|156753260|FG000|Stage 1: Dose Escalation|Adverse Event|0|||
48700391|NCT02113982|156753261|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
48700392|NCT02113982|156753262|FG002|Stage 1: Dose Escalation|Adverse Event|2|||
48700393|NCT02113982|156753263|FG003|Stage 1: Dose Escalation|Adverse Event|4|||
48700394|NCT02113982|156753264|FG004|Stage 1: Dose Escalation|Adverse Event|1|||
48700395|NCT02113982|156753265|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
48700396|NCT02113982|156753266|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
48700397|NCT02113982|156753267|FG007|Stage 1: Dose Escalation|Adverse Event|0|||
48700398|NCT02113982|156753268|FG008|Stage 1: Dose Escalation|Adverse Event|0|||
48700399|NCT02113982|156753269|FG009|Stage 1: Dose Escalation|Adverse Event|0|||
48700400|NCT02113982|156753270|FG010|Stage 1: Dose Escalation|Adverse Event|0|||
48700401|NCT02113982|156753271|FG011|Stage 1: Dose Escalation|Adverse Event|0|||
48700402|NCT02113982|156753272|FG012|Stage 1: Dose Escalation|Adverse Event|0|||
48700403|NCT02113982|156753273|FG013|Stage 1: Dose Escalation|Adverse Event|0|||
48700404|NCT02113982|156753260|FG000|Stage 1: Dose Escalation|Progressive Disease|3|||
48700405|NCT02113982|156753261|FG001|Stage 1: Dose Escalation|Progressive Disease|1|||
48700406|NCT02113982|156753262|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
48700407|NCT02113982|156753263|FG003|Stage 1: Dose Escalation|Progressive Disease|2|||
48700408|NCT02113982|156753264|FG004|Stage 1: Dose Escalation|Progressive Disease|2|||
48700409|NCT02113982|156753265|FG005|Stage 1: Dose Escalation|Progressive Disease|1|||
48700410|NCT02113982|156753266|FG006|Stage 1: Dose Escalation|Progressive Disease|2|||
48700411|NCT02113982|156753267|FG007|Stage 1: Dose Escalation|Progressive Disease|0|||
48700412|NCT02113982|156753268|FG008|Stage 1: Dose Escalation|Progressive Disease|0|||
48700413|NCT02113982|156753269|FG009|Stage 1: Dose Escalation|Progressive Disease|0|||
48700414|NCT02113982|156753270|FG010|Stage 1: Dose Escalation|Progressive Disease|0|||
48700415|NCT02113982|156753271|FG011|Stage 1: Dose Escalation|Progressive Disease|0|||
48700416|NCT02113982|156753272|FG012|Stage 1: Dose Escalation|Progressive Disease|0|||
48700417|NCT02113982|156753273|FG013|Stage 1: Dose Escalation|Progressive Disease|0|||
48700418|NCT02113982|156753260|FG000|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
48700419|NCT02113982|156753261|FG001|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
48700420|NCT02113982|156753262|FG002|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
48700421|NCT02113982|156753263|FG003|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
48700422|NCT02113982|156753264|FG004|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
48700423|NCT02113982|156753265|FG005|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
48700424|NCT02113982|156753266|FG006|Stage 1: Dose Escalation|Withdrawal by Subject|1|||
48700425|NCT02113982|156753267|FG007|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
48700426|NCT02113982|156753268|FG008|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
48700427|NCT02113982|156753269|FG009|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
48700428|NCT02113982|156753270|FG010|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
48700429|NCT02113982|156753271|FG011|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
48700430|NCT02113982|156753272|FG012|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
48700431|NCT02113982|156753273|FG013|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
49116910|NCT00385827|158265944|FG000|Part 2|Other|0|||
49116911|NCT00385827|158265945|FG001|Part 2|Other|11|||
49116912|NCT00385827|158265946|FG002|Part 2|Other|21|||
49116913|NCT00376532|158265947|FG000|Overall Study|Lack sufficient blood sample|6|||
49116914|NCT00376532|158265948|FG001|Overall Study|Lack sufficient blood sample|6|||
49116915|NCT01744483|158265950|FG000|Overall Study|Death|9|||
49116916|NCT01744483|158265951|FG001|Overall Study|Death|4|||
49116917|NCT01744483|158265952|FG002|Overall Study|Death|11|||
49116918|NCT01744483|158265950|FG000|Overall Study|Lost to Follow-up|8|||
49116919|NCT01744483|158265951|FG001|Overall Study|Lost to Follow-up|9|||
49116920|NCT01744483|158265952|FG002|Overall Study|Lost to Follow-up|11|||
49116921|NCT01744483|158265950|FG000|Overall Study|Protocol Violation|1|||
49116922|NCT01744483|158265951|FG001|Overall Study|Protocol Violation|2|||
49116923|NCT01744483|158265952|FG002|Overall Study|Protocol Violation|1|||
49116924|NCT01744483|158265950|FG000|Overall Study|Withdrawal by Subject|4|||
49116925|NCT01744483|158265951|FG001|Overall Study|Withdrawal by Subject|6|||
49116926|NCT01744483|158265952|FG002|Overall Study|Withdrawal by Subject|2|||
49116927|NCT01744483|158265950|FG000|Overall Study|No ICU Admit|5|||
49116928|NCT01744483|158265951|FG001|Overall Study|No ICU Admit|1|||
49116929|NCT01744483|158265952|FG002|Overall Study|No ICU Admit|2|||
49116930|NCT01744483|158265950|FG000|Overall Study|Routed to OSH|2|||
49116931|NCT01744483|158265951|FG001|Overall Study|Routed to OSH|0|||
49116932|NCT01744483|158265952|FG002|Overall Study|Routed to OSH|1|||
49116933|NCT02442206|158265953|FG000|Period 1|Adverse Event|1|||
49116934|NCT02442206|158265954|FG001|Period 1|Adverse Event|1|||
49116935|NCT02442206|158265953|FG000|Period 1|withdrew consent|0|||
49116936|NCT02442206|158265954|FG001|Period 1|withdrew consent|1|||
49116937|NCT02442206|158265953|FG000|Period 1|COPD exacerbation|0|||
49116938|NCT02442206|158265954|FG001|Period 1|COPD exacerbation|1|||
49116939|NCT02442206|158265953|FG000|Period 2|Adverse Event|1|||
49116940|NCT02442206|158265954|FG001|Period 2|Adverse Event|0|||
49116941|NCT02113007|158265955|FG000|Overall Study|Progressive disease|2|||
49116942|NCT02579382|158265956|FG000|Main Study Phase|Lost to Follow-up|0|||
49116943|NCT02579382|158265957|FG001|Main Study Phase|Lost to Follow-up|0|||
49116944|NCT02579382|158265958|FG002|Main Study Phase|Lost to Follow-up|2|||
49116945|NCT02579382|158265959|FG003|Main Study Phase|Lost to Follow-up|0|||
49116946|NCT02579382|158265956|FG000|Main Study Phase|Withdrew Consent|0|||
49116947|NCT02579382|158265957|FG001|Main Study Phase|Withdrew Consent|0|||
49116948|NCT02579382|158265958|FG002|Main Study Phase|Withdrew Consent|0|||
49116949|NCT02579382|158265959|FG003|Main Study Phase|Withdrew Consent|2|||
49116950|NCT02579382|158265956|FG000|Main Study Phase|Lack of Efficacy|0|||
49116951|NCT02579382|158265957|FG001|Main Study Phase|Lack of Efficacy|0|||
49116952|NCT02579382|158265958|FG002|Main Study Phase|Lack of Efficacy|0|||
49116953|NCT02579382|158265959|FG003|Main Study Phase|Lack of Efficacy|1|||
49116954|NCT02579382|158265956|FG000|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0|||
49116955|NCT02579382|158265957|FG001|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3|||
49116956|NCT02579382|158265958|FG002|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1|||
49116957|NCT02579382|158265959|FG003|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4|||
49116958|NCT02579382|158265956|FG000|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1|||
49116959|NCT02579382|158265957|FG001|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
49116960|NCT02579382|158265958|FG002|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2|||
49116961|NCT02579382|158265959|FG003|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
49116962|NCT02579382|158265956|FG000|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0|||
49116963|NCT02579382|158265957|FG001|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
49116964|NCT02579382|158265958|FG002|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
49116965|NCT02579382|158265959|FG003|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
49116966|NCT02579382|158265956|FG000|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
49116967|NCT02579382|158265957|FG001|Optional Treatment Extension Phase(OTEP)|Adverse Event|1|||
48700432|NCT02113982|156753260|FG000|Stage 1: Dose Escalation|Transplant|0|||
49116968|NCT02579382|158265958|FG002|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
48700433|NCT02113982|156753261|FG001|Stage 1: Dose Escalation|Transplant|1|||
49116969|NCT02579382|158265959|FG003|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
49116970|NCT02579382|158265956|FG000|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
49116971|NCT02579382|158265957|FG001|Optional Treatment Extension Phase(OTEP)|Pregnancy|1|||
49116972|NCT02579382|158265958|FG002|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
49116973|NCT02579382|158265959|FG003|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
49116974|NCT02579382|158265956|FG000|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
49116975|NCT02579382|158265957|FG001|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1|||
49116976|NCT02579382|158265958|FG002|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
49116977|NCT02579382|158265959|FG003|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
49116978|NCT01212159|158265960|FG000|Overall Study|Withdrawal by Subject|12|||
49116979|NCT01212159|158265961|FG001|Overall Study|Withdrawal by Subject|12|||
49116980|NCT01299896|158265962|FG000|Overall Study|Withdrawal by Subject|1|||
49116981|NCT01299896|158265963|FG001|Overall Study|Withdrawal by Subject|7|||
49116982|NCT01299896|158265962|FG000|Overall Study|Lost to Follow-up|0|||
49116983|NCT01299896|158265963|FG001|Overall Study|Lost to Follow-up|11|||
49116984|NCT02686814|158265964|FG000|Overall Study|Physician Decision|14|||
49116985|NCT02686814|158265964|FG000|Overall Study|Withdrawal by Subject|4|||
49116986|NCT02686814|158265964|FG000|Overall Study|Death|1|||
49116987|NCT01677182|158265970|FG000|Overall Study|Adverse Event|2|||
49116988|NCT01677182|158265971|FG001|Overall Study|Adverse Event|1|||
49116989|NCT01677182|158265972|FG002|Overall Study|Adverse Event|8|||
49116990|NCT01677182|158265970|FG000|Overall Study|Protocol Violation|5|||
49116991|NCT01677182|158265971|FG001|Overall Study|Protocol Violation|1|||
49116992|NCT01677182|158265972|FG002|Overall Study|Protocol Violation|4|||
49116993|NCT01677182|158265970|FG000|Overall Study|Lost to Follow-up|4|||
49116994|NCT01677182|158265971|FG001|Overall Study|Lost to Follow-up|0|||
49116995|NCT01677182|158265972|FG002|Overall Study|Lost to Follow-up|3|||
49116996|NCT01677182|158265970|FG000|Overall Study|Withdrawal by Subject|7|||
49116997|NCT01677182|158265971|FG001|Overall Study|Withdrawal by Subject|12|||
49116998|NCT01677182|158265972|FG002|Overall Study|Withdrawal by Subject|10|||
49116999|NCT01677182|158265970|FG000|Overall Study|Study termination|12|||
49117000|NCT01677182|158265971|FG001|Overall Study|Study termination|9|||
49117001|NCT01677182|158265972|FG002|Overall Study|Study termination|11|||
49117002|NCT01677182|158265970|FG000|Overall Study|Lack of Efficacy|3|||
49117003|NCT01677182|158265971|FG001|Overall Study|Lack of Efficacy|0|||
49117004|NCT01677182|158265972|FG002|Overall Study|Lack of Efficacy|1|||
49117005|NCT01677182|158265970|FG000|Overall Study|Other reasons|1|||
48700434|NCT02113982|156753262|FG002|Stage 1: Dose Escalation|Transplant|0|||
48700435|NCT02113982|156753263|FG003|Stage 1: Dose Escalation|Transplant|0|||
48700436|NCT02113982|156753264|FG004|Stage 1: Dose Escalation|Transplant|0|||
48700437|NCT02113982|156753265|FG005|Stage 1: Dose Escalation|Transplant|1|||
48700438|NCT02113982|156753266|FG006|Stage 1: Dose Escalation|Transplant|0|||
48798429|NCT02453685|157098661|FG001|Overall Study|Lost to Follow-up|1|||
49010578|NCT00409578|157875658|FG002|Overall Study|Subject no longer requires study drug|0|||
49010579|NCT00409578|157875659|FG003|Overall Study|Subject no longer requires study drug|1|||
49010580|NCT00409578|157875656|FG000|Overall Study|Withdrawal by Subject|8|||
49010581|NCT00409578|157875657|FG001|Overall Study|Withdrawal by Subject|15|||
49010582|NCT00409578|157875658|FG002|Overall Study|Withdrawal by Subject|16|||
49010583|NCT00409578|157875659|FG003|Overall Study|Withdrawal by Subject|17|||
49010584|NCT00409578|157875656|FG000|Overall Study|Lost to Follow-up|2|||
49010585|NCT00409578|157875657|FG001|Overall Study|Lost to Follow-up|0|||
49010586|NCT00409578|157875658|FG002|Overall Study|Lost to Follow-up|2|||
49010587|NCT00409578|157875659|FG003|Overall Study|Lost to Follow-up|2|||
49010588|NCT00409578|157875656|FG000|Overall Study|Administrative problems|8|||
49010589|NCT00409578|157875657|FG001|Overall Study|Administrative problems|9|||
49010590|NCT00409578|157875658|FG002|Overall Study|Administrative problems|2|||
49010591|NCT00409578|157875659|FG003|Overall Study|Administrative problems|4|||
49010592|NCT00409578|157875656|FG000|Overall Study|Death|2|||
49010593|NCT00409578|157875657|FG001|Overall Study|Death|4|||
49010594|NCT00409578|157875658|FG002|Overall Study|Death|4|||
49010595|NCT00409578|157875659|FG003|Overall Study|Death|2|||
49010596|NCT00409578|157875656|FG000|Overall Study|Protocol Violation|3|||
49010597|NCT00409578|157875657|FG001|Overall Study|Protocol Violation|2|||
49010598|NCT00409578|157875658|FG002|Overall Study|Protocol Violation|3|||
49010599|NCT00409578|157875659|FG003|Overall Study|Protocol Violation|1|||
49010600|NCT00409578|157875656|FG000|Overall Study|Missing|0|||
49010601|NCT00409578|157875657|FG001|Overall Study|Missing|1|||
49010602|NCT00409578|157875658|FG002|Overall Study|Missing|0|||
49010603|NCT00409578|157875659|FG003|Overall Study|Missing|1|||
49010604|NCT01200394|157875660|FG000|Overall Study|Adverse Event|0|||
49010605|NCT01200394|157875661|FG001|Overall Study|Adverse Event|14|||
49010606|NCT01200394|157875660|FG000|Overall Study|Death|1|||
49010607|NCT01200394|157875661|FG001|Overall Study|Death|0|||
49010608|NCT01200394|157875660|FG000|Overall Study|Lost to Follow-up|0|||
49010609|NCT01200394|157875661|FG001|Overall Study|Lost to Follow-up|1|||
49010610|NCT01200394|157875660|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
49117006|NCT01677182|158265971|FG001|Overall Study|Other reasons|5|||
49117007|NCT01677182|158265972|FG002|Overall Study|Other reasons|2|||
49117008|NCT01641471|158265973|FG000|Overall Study|Withdrawal by Subject|19|||
49117009|NCT01641471|158265974|FG001|Overall Study|Withdrawal by Subject|19|||
49117010|NCT01641471|158265973|FG000|Overall Study|Lost to Follow-up|2|||
49117011|NCT01641471|158265974|FG001|Overall Study|Lost to Follow-up|4|||
49117012|NCT01641471|158265973|FG000|Overall Study|Protocol Violation|2|||
49117013|NCT01641471|158265974|FG001|Overall Study|Protocol Violation|4|||
49117014|NCT00824655|158265975|FG000|Toddler Dose (12 Months of Age)|Adverse Event|1|||
49117015|NCT00824655|158265976|FG001|Toddler Dose (12 Months of Age)|Adverse Event|0|||
49117016|NCT00824655|158265975|FG000|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1|||
49117017|NCT00824655|158265976|FG001|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0|||
49117018|NCT03782571|158265977|FG000|Period 1|Withdrawal by Subject|1|||
49117019|NCT03782571|158265978|FG001|Period 1|Withdrawal by Subject|0|||
49117020|NCT03782571|158265979|FG002|Period 1|Withdrawal by Subject|0|||
49117021|NCT03782571|158265980|FG003|Period 1|Withdrawal by Subject|0|||
49117022|NCT03782571|158265977|FG000|Period 3|Subject Unable to Attend V5|1|||
49117023|NCT03782571|158265978|FG001|Period 3|Subject Unable to Attend V5|0|||
49117024|NCT03782571|158265979|FG002|Period 3|Subject Unable to Attend V5|0|||
49117025|NCT03782571|158265980|FG003|Period 3|Subject Unable to Attend V5|0|||
49117026|NCT03782571|158265977|FG000|Period 3|Adverse Event|1|||
49117027|NCT03782571|158265978|FG001|Period 3|Adverse Event|0|||
49117028|NCT03782571|158265979|FG002|Period 3|Adverse Event|0|||
49117029|NCT03782571|158265980|FG003|Period 3|Adverse Event|0|||
49117030|NCT03504189|158265981|FG000|Overall Study|Withdrawal by Subject|1|||
49117031|NCT03504189|158265981|FG000|Overall Study|Screening Failure|1|||
49117032|NCT03504189|158265981|FG000|Overall Study|Device Failure|2|||
49117033|NCT02634801|158265982|FG000|Treatment Period (Weeks 0 to 24)|Adverse Event|2|||
49117034|NCT02634801|158265983|FG001|Treatment Period (Weeks 0 to 24)|Adverse Event|20|||
49117035|NCT02634801|158265984|FG002|Treatment Period (Weeks 0 to 24)|Adverse Event|0|||
49117036|NCT02634801|158265982|FG000|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
49117037|NCT02634801|158265983|FG001|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2|||
49117038|NCT02634801|158265984|FG002|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
49117039|NCT02634801|158265982|FG000|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2|||
49117040|NCT02634801|158265983|FG001|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
49117041|NCT02634801|158265984|FG002|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
49117042|NCT02634801|158265982|FG000|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
49117043|NCT02634801|158265983|FG001|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
49117044|NCT02634801|158265984|FG002|Treatment Period (Weeks 0 to 24)|Protocol Violation|1|||
49117045|NCT02634801|158265982|FG000|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0|||
49117046|NCT02634801|158265983|FG001|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8|||
49117047|NCT02634801|158265984|FG002|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3|||
49117048|NCT02634801|158265982|FG000|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
49117049|NCT02634801|158265983|FG001|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
49117050|NCT02634801|158265984|FG002|Extension Period (Weeks 24 to 36)|Adverse Event|1|||
49117051|NCT02634801|158265982|FG000|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1|||
49117052|NCT02634801|158265983|FG001|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
49117053|NCT02634801|158265984|FG002|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
49117054|NCT02634801|158265982|FG000|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
49117055|NCT02634801|158265983|FG001|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
49117056|NCT02634801|158265984|FG002|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
49117057|NCT02634801|158265982|FG000|Extension Period (Weeks 24 to 36)|Missing|1|||
49117058|NCT02634801|158265983|FG001|Extension Period (Weeks 24 to 36)|Missing|0|||
49117059|NCT02634801|158265984|FG002|Extension Period (Weeks 24 to 36)|Missing|0|||
49117060|NCT02634801|158265982|FG000|Follow-up Period|Lost to Follow-up|3|||
49117061|NCT02634801|158265983|FG001|Follow-up Period|Lost to Follow-up|1|||
49117062|NCT02634801|158265984|FG002|Follow-up Period|Lost to Follow-up|2|||
48700439|NCT02113982|156753267|FG007|Stage 1: Dose Escalation|Transplant|0|||
48700440|NCT02113982|156753268|FG008|Stage 1: Dose Escalation|Transplant|0|||
48700441|NCT02113982|156753269|FG009|Stage 1: Dose Escalation|Transplant|0|||
48700442|NCT02113982|156753270|FG010|Stage 1: Dose Escalation|Transplant|0|||
48700443|NCT02113982|156753271|FG011|Stage 1: Dose Escalation|Transplant|0|||
48700444|NCT02113982|156753272|FG012|Stage 1: Dose Escalation|Transplant|0|||
49117063|NCT02634801|158265982|FG000|Follow-up Period|Physician Decision|0|||
49117064|NCT02634801|158265983|FG001|Follow-up Period|Physician Decision|0|||
49117065|NCT02634801|158265984|FG002|Follow-up Period|Physician Decision|1|||
49117066|NCT02634801|158265982|FG000|Follow-up Period|Withdrawal by Subject|1|||
48700445|NCT02113982|156753273|FG013|Stage 1: Dose Escalation|Transplant|0|||
49117067|NCT02634801|158265983|FG001|Follow-up Period|Withdrawal by Subject|2|||
49117068|NCT02634801|158265984|FG002|Follow-up Period|Withdrawal by Subject|5|||
49117069|NCT02634801|158265982|FG000|Follow-up Period|Adverse Event|1|||
49117070|NCT02634801|158265983|FG001|Follow-up Period|Adverse Event|5|||
49117071|NCT02634801|158265984|FG002|Follow-up Period|Adverse Event|0|||
49117072|NCT02906579|158265985|FG000|Overall Study|Adverse Event|1|||
49117073|NCT02906579|158265985|FG000|Overall Study|Physician Decision|1|||
49117074|NCT02793947|158265986|FG000|Overall Study|Death|1|||
49117075|NCT02793947|158265987|FG001|Overall Study|Death|0|||
49117076|NCT02793947|158265986|FG000|Overall Study|Physician Decision|1|||
49117077|NCT02793947|158265987|FG001|Overall Study|Physician Decision|5|||
49117078|NCT00412932|158265990|FG000|Olmesartan (Olm) 20 mg|Adverse Event|1|||
49117079|NCT00412932|158265990|FG000|Olmesartan (Olm) 20 mg|Lack of Efficacy|2|||
49117080|NCT00412932|158265990|FG000|Olmesartan (Olm) 20 mg|Protocol Violation|1|||
49117081|NCT00412932|158265990|FG000|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2|||
49117082|NCT00412932|158265990|FG000|Olmesartan (Olm) 20 mg|Other|1|||
49117083|NCT00412932|158265990|FG000|Olmesartan 40 mg|Adverse Event|4|||
49117084|NCT00412932|158265990|FG000|Olmesartan 40 mg|Lack of Efficacy|3|||
49117085|NCT00412932|158265990|FG000|Olmesartan 40 mg|Withdrawal by Subject|1|||
49117086|NCT00412932|158265990|FG000|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3|||
49117087|NCT00412932|158265990|FG000|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3|||
49117088|NCT00412932|158265990|FG000|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1|||
49117089|NCT00412932|158265990|FG000|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
49117090|NCT01516736|158265991|FG000|Overall Study|Withdrawal by Subject|10|||
49117091|NCT01516736|158265992|FG001|Overall Study|Withdrawal by Subject|4|||
49117092|NCT01516736|158265991|FG000|Overall Study|Adverse Event|4|||
49117093|NCT01516736|158265992|FG001|Overall Study|Adverse Event|5|||
49117094|NCT01516736|158265991|FG000|Overall Study|Death|3|||
49117095|NCT01516736|158265992|FG001|Overall Study|Death|1|||
49117096|NCT01516736|158265991|FG000|Overall Study|Physician Decision|2|||
49117097|NCT01516736|158265992|FG001|Overall Study|Physician Decision|1|||
49117098|NCT01516736|158265991|FG000|Overall Study|Lack of Efficacy|1|||
49117099|NCT01516736|158265992|FG001|Overall Study|Lack of Efficacy|0|||
49117100|NCT01516736|158265991|FG000|Overall Study|Protocol Violation|0|||
49117101|NCT01516736|158265992|FG001|Overall Study|Protocol Violation|1|||
49117102|NCT01516736|158265991|FG000|Overall Study|Other (not specified)|0|||
49117103|NCT01516736|158265992|FG001|Overall Study|Other (not specified)|1|||
49117104|NCT02499263|158265994|FG000|Overall Study|Lost to Follow-up|9|||
49117105|NCT02499263|158265994|FG000|Overall Study|Participant's withdrawal of consent|4|||
49117106|NCT02499263|158265994|FG000|Overall Study|Lack of Efficacy|22|||
49117107|NCT02499263|158265994|FG000|Overall Study|investigator's judgment|12|||
49117108|NCT02499263|158265994|FG000|Overall Study|Adverse Events/Serious Adverse Events|11|||
49117109|NCT02499263|158265994|FG000|Overall Study|Participant's decision|3|||
49117110|NCT02499263|158265994|FG000|Overall Study|Pregnancy|1|||
48700446|NCT02113982|156753260|FG000|Stage 1: Dose Escalation|Other Therapy|0|||
48700447|NCT02113982|156753261|FG001|Stage 1: Dose Escalation|Other Therapy|0|||
48700448|NCT02113982|156753262|FG002|Stage 1: Dose Escalation|Other Therapy|0|||
48700449|NCT02113982|156753263|FG003|Stage 1: Dose Escalation|Other Therapy|0|||
48700450|NCT02113982|156753264|FG004|Stage 1: Dose Escalation|Other Therapy|0|||
48700451|NCT02113982|156753265|FG005|Stage 1: Dose Escalation|Other Therapy|1|||
48700452|NCT02113982|156753266|FG006|Stage 1: Dose Escalation|Other Therapy|0|||
48700453|NCT02113982|156753267|FG007|Stage 1: Dose Escalation|Other Therapy|0|||
49117111|NCT02075008|158266003|FG000|Overall Study|Technical problems|1|||
49117112|NCT02075008|158266003|FG000|Overall Study|Pregnancy|1|||
49117113|NCT02075008|158266003|FG000|Overall Study|Physician Decision|1|||
48700454|NCT02113982|156753268|FG008|Stage 1: Dose Escalation|Other Therapy|0|||
48700455|NCT02113982|156753269|FG009|Stage 1: Dose Escalation|Other Therapy|0|||
48700456|NCT02113982|156753270|FG010|Stage 1: Dose Escalation|Other Therapy|0|||
48700457|NCT02113982|156753271|FG011|Stage 1: Dose Escalation|Other Therapy|0|||
48700458|NCT02113982|156753272|FG012|Stage 1: Dose Escalation|Other Therapy|0|||
48700459|NCT02113982|156753273|FG013|Stage 1: Dose Escalation|Other Therapy|0|||
48700460|NCT02113982|156753260|FG000|Stage 1: Dose Escalation|Complicating Disease|0|||
48700461|NCT02113982|156753261|FG001|Stage 1: Dose Escalation|Complicating Disease|1|||
48700462|NCT02113982|156753262|FG002|Stage 1: Dose Escalation|Complicating Disease|0|||
48700463|NCT02113982|156753263|FG003|Stage 1: Dose Escalation|Complicating Disease|0|||
48700464|NCT02113982|156753264|FG004|Stage 1: Dose Escalation|Complicating Disease|0|||
48700465|NCT02113982|156753265|FG005|Stage 1: Dose Escalation|Complicating Disease|0|||
48700466|NCT02113982|156753266|FG006|Stage 1: Dose Escalation|Complicating Disease|0|||
48700467|NCT02113982|156753267|FG007|Stage 1: Dose Escalation|Complicating Disease|0|||
48700468|NCT02113982|156753268|FG008|Stage 1: Dose Escalation|Complicating Disease|0|||
48700469|NCT02113982|156753269|FG009|Stage 1: Dose Escalation|Complicating Disease|0|||
48700470|NCT02113982|156753270|FG010|Stage 1: Dose Escalation|Complicating Disease|0|||
49117114|NCT02075008|158266003|FG000|Overall Study|Lost to Follow-up|1|||
48700471|NCT02113982|156753271|FG011|Stage 1: Dose Escalation|Complicating Disease|0|||
48700472|NCT02113982|156753272|FG012|Stage 1: Dose Escalation|Complicating Disease|0|||
48700473|NCT02113982|156753273|FG013|Stage 1: Dose Escalation|Complicating Disease|0|||
49117115|NCT02075008|158266003|FG000|Overall Study|Lack of Efficacy|1|||
49117116|NCT02075008|158266003|FG000|Overall Study|Death|1|||
49117117|NCT02075008|158266003|FG000|Overall Study|Adverse Event|5|||
49117118|NCT02075008|158266003|FG000|Overall Study|Withdrawal by Subject|6|||
49117119|NCT02075008|158266003|FG000|Overall Study|Study terminated by Sponsor|159|||
48700474|NCT02113982|156753260|FG000|Stage 2: Cohort Expansion|Adverse Event|0|||
48700475|NCT02113982|156753261|FG001|Stage 2: Cohort Expansion|Adverse Event|0|||
48700476|NCT02113982|156753262|FG002|Stage 2: Cohort Expansion|Adverse Event|0|||
48700477|NCT02113982|156753263|FG003|Stage 2: Cohort Expansion|Adverse Event|0|||
48700478|NCT02113982|156753264|FG004|Stage 2: Cohort Expansion|Adverse Event|0|||
48700479|NCT02113982|156753265|FG005|Stage 2: Cohort Expansion|Adverse Event|0|||
48700480|NCT02113982|156753266|FG006|Stage 2: Cohort Expansion|Adverse Event|0|||
48700481|NCT02113982|156753267|FG007|Stage 2: Cohort Expansion|Adverse Event|1|||
48700482|NCT02113982|156753268|FG008|Stage 2: Cohort Expansion|Adverse Event|1|||
48700483|NCT02113982|156753269|FG009|Stage 2: Cohort Expansion|Adverse Event|1|||
48700484|NCT02113982|156753270|FG010|Stage 2: Cohort Expansion|Adverse Event|0|||
48700485|NCT02113982|156753271|FG011|Stage 2: Cohort Expansion|Adverse Event|0|||
48700486|NCT02113982|156753272|FG012|Stage 2: Cohort Expansion|Adverse Event|0|||
48700487|NCT02113982|156753273|FG013|Stage 2: Cohort Expansion|Adverse Event|0|||
48700488|NCT02113982|156753260|FG000|Stage 2: Cohort Expansion|Physician Decision|0|||
48700489|NCT02113982|156753261|FG001|Stage 2: Cohort Expansion|Physician Decision|0|||
48700490|NCT02113982|156753262|FG002|Stage 2: Cohort Expansion|Physician Decision|0|||
48700491|NCT02113982|156753263|FG003|Stage 2: Cohort Expansion|Physician Decision|0|||
49117120|NCT02985021|158266008|FG000|Overall Study|Inability to comply with study procedures|1|||
49117121|NCT02232061|158266009|FG000|Overall Study|Administrative problems|1|||
48700492|NCT02113982|156753264|FG004|Stage 2: Cohort Expansion|Physician Decision|0|||
48700493|NCT02113982|156753265|FG005|Stage 2: Cohort Expansion|Physician Decision|0|||
48700494|NCT02113982|156753266|FG006|Stage 2: Cohort Expansion|Physician Decision|0|||
48700495|NCT02113982|156753267|FG007|Stage 2: Cohort Expansion|Physician Decision|7|||
48700496|NCT02113982|156753268|FG008|Stage 2: Cohort Expansion|Physician Decision|0|||
48700497|NCT02113982|156753269|FG009|Stage 2: Cohort Expansion|Physician Decision|1|||
48912162|NCT02269787|157514750|FG001|Overall Study|Incapacitated|1|||
49117122|NCT02232061|158266009|FG000|Overall Study|Withdrawal by Subject|1|||
49117123|NCT01639703|158266010|FG000|Overall Study|Withdrawal by Subject|5|||
49117124|NCT01639703|158266010|FG000|Overall Study|Other reason|7|||
49117125|NCT02087670|158266011|FG000|Overall Study|Withdrawal by Subject|3|||
49117126|NCT02087670|158266012|FG001|Overall Study|Withdrawal by Subject|2|||
49117127|NCT02496039|158266013|FG000|Overall Study|Adverse Event|3|||
49117128|NCT02496039|158266013|FG000|Overall Study|Protocol Violation|1|||
49117129|NCT00571103|158266014|FG000|Overall Study|Withdrawal by Subject|1|||
49117130|NCT00571103|158266014|FG000|Overall Study|Lost to Follow-up|1|||
49117131|NCT01308463|158266015|FG000|Overall Study|Study Discontinued|23|||
49117132|NCT01308463|158266015|FG000|Overall Study|Death|4|||
49117133|NCT01308463|158266015|FG000|Overall Study|Revision|2|||
49117134|NCT01972464|158266016|FG000|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2|||
49117135|NCT01972464|158266017|FG001|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3|||
49117136|NCT01972464|158266016|FG000|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1|||
49117137|NCT01972464|158266017|FG001|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0|||
49117138|NCT01972464|158266016|FG000|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0|||
49117139|NCT01972464|158266017|FG001|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1|||
49117140|NCT01972464|158266016|FG000|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
49117141|NCT01972464|158266017|FG001|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
49117142|NCT01042392|158266018|FG000|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6|||
49117143|NCT01042392|158266019|FG001|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
49117144|NCT01042392|158266020|FG002|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5|||
49117145|NCT01042392|158266021|FG003|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
49117146|NCT01042392|158266018|FG000|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1|||
49117147|NCT01042392|158266019|FG001|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
49117148|NCT01042392|158266020|FG002|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
49117149|NCT01042392|158266021|FG003|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
49117150|NCT01042392|158266018|FG000|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1|||
49117151|NCT01042392|158266019|FG001|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
49117152|NCT01042392|158266020|FG002|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2|||
49117153|NCT01042392|158266021|FG003|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
49117154|NCT01042392|158266018|FG000|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
49117155|NCT01042392|158266019|FG001|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
49117156|NCT01042392|158266020|FG002|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1|||
49117157|NCT01042392|158266021|FG003|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
49117158|NCT01042392|158266018|FG000|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2|||
49117159|NCT01042392|158266019|FG001|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
49117160|NCT01042392|158266020|FG002|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
48700498|NCT02113982|156753270|FG010|Stage 2: Cohort Expansion|Physician Decision|0|||
48700499|NCT02113982|156753271|FG011|Stage 2: Cohort Expansion|Physician Decision|0|||
48700500|NCT02113982|156753272|FG012|Stage 2: Cohort Expansion|Physician Decision|0|||
48912163|NCT00798135|157514751|FG000|Overall Study|Disease progression, relapse|11|||
48912164|NCT00798135|157514751|FG000|Overall Study|Disease progression, refractory|1|||
49117161|NCT01042392|158266021|FG003|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
49117162|NCT01042392|158266018|FG000|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
49117163|NCT01042392|158266019|FG001|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
49117164|NCT01042392|158266020|FG002|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1|||
49117165|NCT01042392|158266021|FG003|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
49117166|NCT01042392|158266018|FG000|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2|||
49117167|NCT01042392|158266019|FG001|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
49117168|NCT01042392|158266020|FG002|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
49117169|NCT01042392|158266021|FG003|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
49117170|NCT01042392|158266018|FG000|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
49117171|NCT01042392|158266019|FG001|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
49117172|NCT01042392|158266020|FG002|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2|||
49117173|NCT01042392|158266021|FG003|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
49117174|NCT01042392|158266018|FG000|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0|||
49117175|NCT01042392|158266019|FG001|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
49117176|NCT01042392|158266020|FG002|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
49117177|NCT01042392|158266021|FG003|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
49117178|NCT00103662|158266023|FG000|Overall Study|Entered Rescue Procedure|0|||
49117179|NCT00103662|158266024|FG001|Overall Study|Entered Rescue Procedure|7|||
49117180|NCT00103662|158266023|FG000|Overall Study|Death|7|||
49117181|NCT00103662|158266024|FG001|Overall Study|Death|7|||
49117182|NCT00103662|158266023|FG000|Overall Study|Elective Withdrawal|5|||
49117183|NCT00103662|158266024|FG001|Overall Study|Elective Withdrawal|5|||
49117184|NCT00103662|158266023|FG000|Overall Study|Lost to Follow-up|0|||
49117185|NCT00103662|158266024|FG001|Overall Study|Lost to Follow-up|1|||
49117186|NCT00103662|158266023|FG000|Overall Study|Other|6|||
49117187|NCT00103662|158266024|FG001|Overall Study|Other|9|||
49117188|NCT00103662|158266023|FG000|Overall Study|Failed mobilization|0|||
49117189|NCT00103662|158266024|FG001|Overall Study|Failed mobilization|4|||
49117190|NCT00103662|158266023|FG000|Overall Study|Intercurrent illness|1|||
49117191|NCT00103662|158266024|FG001|Overall Study|Intercurrent illness|0|||
49117192|NCT02757625|158266025|FG000|Overall Study|Investigator's discretion|0|||
49117193|NCT02757625|158266026|FG001|Overall Study|Investigator's discretion|0|||
49117194|NCT02757625|158266027|FG002|Overall Study|Investigator's discretion|1|||
49117195|NCT02757625|158266028|FG003|Overall Study|Investigator's discretion|0|||
49117196|NCT02757625|158266025|FG000|Overall Study|Adverse Event|0|||
49117197|NCT02757625|158266026|FG001|Overall Study|Adverse Event|0|||
49117198|NCT02757625|158266027|FG002|Overall Study|Adverse Event|1|||
49117199|NCT02757625|158266028|FG003|Overall Study|Adverse Event|0|||
49117200|NCT00493311|158266029|FG000|Overall Study|Need for rescue medication|2|||
49117201|NCT00493311|158266030|FG001|Overall Study|Need for rescue medication|2|||
49117202|NCT00587795|158266031|FG000|Overall Study|Withdrawal by Subject|1|||
49117203|NCT00587795|158266032|FG001|Overall Study|Withdrawal by Subject|0|||
49117204|NCT04668209|158266033|FG000|Overall Study|Withdrawal by Subject|2|||
49117205|NCT04668209|158266034|FG001|Overall Study|Withdrawal by Subject|2|||
49117206|NCT04668209|158266033|FG000|Overall Study|Lost to Follow-up|3|||
48912165|NCT00798135|157514751|FG000|Overall Study|Physician Decision|1|||
48912166|NCT00282295|157514753|FG000|Overall Study|Adverse Event|0|||
48912167|NCT00282295|157514754|FG001|Overall Study|Adverse Event|1|||
48912168|NCT00282295|157514755|FG002|Overall Study|Adverse Event|0|||
48912169|NCT00282295|157514753|FG000|Overall Study|Serious Adverse Events|0|||
48912170|NCT00282295|157514754|FG001|Overall Study|Serious Adverse Events|0|||
48912171|NCT00282295|157514755|FG002|Overall Study|Serious Adverse Events|1|||
48912172|NCT00282295|157514753|FG000|Overall Study|Protocol Violation|0|||
48912173|NCT00282295|157514754|FG001|Overall Study|Protocol Violation|2|||
48912174|NCT00282295|157514755|FG002|Overall Study|Protocol Violation|1|||
48912175|NCT00282295|157514753|FG000|Overall Study|Withdrawal by Subject|2|||
48912176|NCT00282295|157514754|FG001|Overall Study|Withdrawal by Subject|6|||
48912177|NCT00282295|157514755|FG002|Overall Study|Withdrawal by Subject|4|||
48912178|NCT00282295|157514753|FG000|Overall Study|Lost to Follow-up|1|||
48912179|NCT00282295|157514754|FG001|Overall Study|Lost to Follow-up|7|||
48912180|NCT00282295|157514755|FG002|Overall Study|Lost to Follow-up|2|||
48912181|NCT00282295|157514753|FG000|Overall Study|Other|0|||
48912182|NCT00282295|157514754|FG001|Overall Study|Other|1|||
48912183|NCT00282295|157514755|FG002|Overall Study|Other|0|||
48951826|NCT00592358|157654906|FG000|Overall Study|Lack of Efficacy|2|||
48700501|NCT02113982|156753273|FG013|Stage 2: Cohort Expansion|Physician Decision|0|||
48700502|NCT02113982|156753260|FG000|Stage 2: Cohort Expansion|Progressive Disease|0|||
48700503|NCT02113982|156753261|FG001|Stage 2: Cohort Expansion|Progressive Disease|0|||
48700504|NCT02113982|156753262|FG002|Stage 2: Cohort Expansion|Progressive Disease|0|||
48700505|NCT02113982|156753263|FG003|Stage 2: Cohort Expansion|Progressive Disease|0|||
48700506|NCT02113982|156753264|FG004|Stage 2: Cohort Expansion|Progressive Disease|0|||
48700507|NCT02113982|156753265|FG005|Stage 2: Cohort Expansion|Progressive Disease|0|||
48700508|NCT02113982|156753266|FG006|Stage 2: Cohort Expansion|Progressive Disease|0|||
48700509|NCT02113982|156753267|FG007|Stage 2: Cohort Expansion|Progressive Disease|19|||
48700510|NCT02113982|156753268|FG008|Stage 2: Cohort Expansion|Progressive Disease|0|||
48700511|NCT02113982|156753269|FG009|Stage 2: Cohort Expansion|Progressive Disease|5|||
48700512|NCT02113982|156753270|FG010|Stage 2: Cohort Expansion|Progressive Disease|7|||
48700513|NCT02113982|156753271|FG011|Stage 2: Cohort Expansion|Progressive Disease|0|||
48700514|NCT02113982|156753272|FG012|Stage 2: Cohort Expansion|Progressive Disease|0|||
48700515|NCT02113982|156753273|FG013|Stage 2: Cohort Expansion|Progressive Disease|0|||
48700516|NCT02113982|156753260|FG000|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
48700517|NCT02113982|156753261|FG001|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
48700518|NCT02113982|156753262|FG002|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
48700519|NCT02113982|156753263|FG003|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
48799474|NCT04843930|157104206|FG003|Week 6 Assessment|Adverse Event|0|||
49117207|NCT04668209|158266034|FG001|Overall Study|Lost to Follow-up|4|||
49117208|NCT04668209|158266033|FG000|Overall Study|Subject Expired|2|||
49117209|NCT04668209|158266034|FG001|Overall Study|Subject Expired|0|||
49117210|NCT04668209|158266033|FG000|Overall Study|Withdrawn from study|0|||
49117211|NCT04668209|158266034|FG001|Overall Study|Withdrawn from study|1|||
49117212|NCT04668209|158266033|FG000|Overall Study|Adverse Event|0|||
49117213|NCT04668209|158266034|FG001|Overall Study|Adverse Event|1|||
49117214|NCT01951573|158266037|FG000|Washout Period|Adverse Event|0|||
49117215|NCT01951573|158266038|FG001|Washout Period|Adverse Event|1|||
49117216|NCT00339833|158266039|FG000|Overall Study|Withdrawal by Subject|1|||
49117217|NCT00339833|158266040|FG001|Overall Study|Withdrawal by Subject|2|||
49117218|NCT00339833|158266039|FG000|Overall Study|toothache|0|||
49117219|NCT00339833|158266040|FG001|Overall Study|toothache|1|||
49117220|NCT00339833|158266039|FG000|Overall Study|indigestion|0|||
49117221|NCT00339833|158266040|FG001|Overall Study|indigestion|1|||
49117222|NCT00339833|158266039|FG000|Overall Study|Chest pain|0|||
49117223|NCT00339833|158266040|FG001|Overall Study|Chest pain|1|||
49117224|NCT00339833|158266039|FG000|Overall Study|minor infection|0|||
49117225|NCT00339833|158266040|FG001|Overall Study|minor infection|1|||
49117226|NCT00339833|158266039|FG000|Overall Study|Poor venous access|2|||
49117227|NCT00339833|158266040|FG001|Overall Study|Poor venous access|2|||
49117228|NCT00339833|158266039|FG000|Overall Study|anaemia or excess drop in glycaemia|2|||
49117229|NCT00339833|158266040|FG001|Overall Study|anaemia or excess drop in glycaemia|0|||
49117230|NCT00339833|158266039|FG000|Overall Study|Error in data records|1|||
49117231|NCT00339833|158266040|FG001|Overall Study|Error in data records|0|||
49117232|NCT00760487|158266045|FG000|Overall Study|Unilateral implantation|3|||
49117233|NCT00110357|158266048|FG000|Overall Study|Deterioration without progression|2|||
49117234|NCT00110357|158266049|FG001|Overall Study|Deterioration without progression|0|||
49117235|NCT00110357|158266048|FG000|Overall Study|Disease progression/relapse|20|||
49117236|NCT00110357|158266049|FG001|Overall Study|Disease progression/relapse|15|||
49117237|NCT00110357|158266048|FG000|Overall Study|Study Closure|1|||
49117238|NCT00110357|158266049|FG001|Overall Study|Study Closure|0|||
49117239|NCT00110357|158266048|FG000|Overall Study|Study Drug Toxicity|1|||
49117240|NCT00110357|158266049|FG001|Overall Study|Study Drug Toxicity|3|||
49117241|NCT00110357|158266048|FG000|Overall Study|Withdrawal by Subject|3|||
49117242|NCT00110357|158266049|FG001|Overall Study|Withdrawal by Subject|1|||
49117243|NCT00980655|158266073|FG000|Overall Study|Adverse Event|13|||
49117244|NCT00980655|158266074|FG001|Overall Study|Adverse Event|31|||
49117245|NCT00980655|158266073|FG000|Overall Study|Death|0|||
49117246|NCT00980655|158266074|FG001|Overall Study|Death|7|||
49117247|NCT00980655|158266073|FG000|Overall Study|Protocol Violation|2|||
49117248|NCT00980655|158266074|FG001|Overall Study|Protocol Violation|7|||
49117249|NCT00980655|158266073|FG000|Overall Study|Withdrawal by Subject|0|||
49117250|NCT00980655|158266074|FG001|Overall Study|Withdrawal by Subject|4|||
49117251|NCT00980655|158266073|FG000|Overall Study|Lost to Follow-up|0|||
49117252|NCT00980655|158266074|FG001|Overall Study|Lost to Follow-up|1|||
49117253|NCT00980655|158266073|FG000|Overall Study|Parent/legal guardian request|1|||
49117254|NCT00980655|158266074|FG001|Overall Study|Parent/legal guardian request|0|||
49117255|NCT00980655|158266073|FG000|Overall Study|Other|0|||
49117256|NCT00980655|158266074|FG001|Overall Study|Other|1|||
49117257|NCT00255164|158266075|FG000|Overall Study|Adverse Event|10|||
49117258|NCT00255164|158266076|FG001|Overall Study|Adverse Event|6|||
49117259|NCT00255164|158266077|FG002|Overall Study|Adverse Event|9|||
48700520|NCT02113982|156753264|FG004|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
48700521|NCT02113982|156753265|FG005|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
48700522|NCT02113982|156753266|FG006|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
48700523|NCT02113982|156753267|FG007|Stage 2: Cohort Expansion|Withdrawal by Subject|4|||
48700524|NCT02113982|156753268|FG008|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
48700525|NCT02113982|156753269|FG009|Stage 2: Cohort Expansion|Withdrawal by Subject|1|||
48700526|NCT02113982|156753270|FG010|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
48700527|NCT02113982|156753271|FG011|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
48700528|NCT02113982|156753272|FG012|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
48912184|NCT03441334|157516160|FG000|Overall Study|Withdrawal by Subject|1|||
48912185|NCT03441334|157516161|FG001|Overall Study|Withdrawal by Subject|0|||
48912186|NCT02217436|157516162|FG000|Overall Study|Protocol Violation|1|||
48912187|NCT02217436|157516163|FG001|Overall Study|Protocol Violation|1|||
48912188|NCT02217436|157516162|FG000|Overall Study|Incomplete data|0|||
48912189|NCT02217436|157516163|FG001|Overall Study|Incomplete data|1|||
48912190|NCT04641299|157516164|FG000|Overall Study|Adverse Event|0|||
48912191|NCT04641299|157516165|FG001|Overall Study|Adverse Event|0|||
48912192|NCT04641299|157516166|FG002|Overall Study|Adverse Event|2|||
48912193|NCT04641299|157516167|FG003|Overall Study|Adverse Event|0|||
48912194|NCT04641299|157516164|FG000|Overall Study|Lost to Follow-up|0|||
48912195|NCT04641299|157516165|FG001|Overall Study|Lost to Follow-up|1|||
48912196|NCT04641299|157516166|FG002|Overall Study|Lost to Follow-up|0|||
48912197|NCT04641299|157516167|FG003|Overall Study|Lost to Follow-up|0|||
48912198|NCT04641299|157516164|FG000|Overall Study|Withdrawal by Subject|1|||
48912199|NCT04641299|157516165|FG001|Overall Study|Withdrawal by Subject|0|||
48912200|NCT04641299|157516166|FG002|Overall Study|Withdrawal by Subject|0|||
48912201|NCT04641299|157516167|FG003|Overall Study|Withdrawal by Subject|0|||
48912202|NCT04641299|157516164|FG000|Overall Study|Reason not given|1|||
48912203|NCT04641299|157516165|FG001|Overall Study|Reason not given|0|||
48912204|NCT04641299|157516166|FG002|Overall Study|Reason not given|0|||
48912205|NCT04641299|157516167|FG003|Overall Study|Reason not given|0|||
48912206|NCT00449670|157516168|FG000|Primary Phase (Study no.109630)|Serious Adverse Event|1|||
48912207|NCT00449670|157516169|FG001|Primary Phase (Study no.109630)|Serious Adverse Event|0|||
48912208|NCT00449670|157516168|FG000|Primary Phase (Study no.109630)|Non-serious adverse event|4|||
48912209|NCT00449670|157516169|FG001|Primary Phase (Study no.109630)|Non-serious adverse event|0|||
48912210|NCT00449670|157516168|FG000|Primary Phase (Study no.109630)|Withdrawal by Subject|4|||
48912211|NCT00449670|157516169|FG001|Primary Phase (Study no.109630)|Withdrawal by Subject|1|||
48912212|NCT00449670|157516168|FG000|Primary Phase (Study no.109630)|Lost to Follow-up|5|||
48912213|NCT00449670|157516169|FG001|Primary Phase (Study no.109630)|Lost to Follow-up|1|||
48912214|NCT00449670|157516168|FG000|Booster Phase (Study no.109873)|Migrated/moved from study area|0|||
48912215|NCT00449670|157516169|FG001|Booster Phase (Study no.109873)|Migrated/moved from study area|1|||
48912216|NCT00449670|157516168|FG000|Booster Phase (Study no.109873)|Other|0|||
48912217|NCT00449670|157516169|FG001|Booster Phase (Study no.109873)|Other|2|||
48912218|NCT00525044|157516170|FG000|Overall Study|Lost to Follow-up|0|||
48912219|NCT00525044|157516171|FG001|Overall Study|Lost to Follow-up|1|||
48912220|NCT01128361|157516172|FG000|Overall Study|Lost to Follow-up|0|||
48912221|NCT01128361|157516173|FG001|Overall Study|Lost to Follow-up|1|||
48912222|NCT01128361|157516172|FG000|Overall Study|Withdrawal by Subject|5|||
48912223|NCT01128361|157516173|FG001|Overall Study|Withdrawal by Subject|2|||
48912224|NCT01830855|157516174|FG000|Overall Study|Other|7|||
48912225|NCT01830855|157516175|FG001|Overall Study|Other|1|||
48912226|NCT01830855|157516176|FG002|Overall Study|Other|4|||
48912227|NCT01830855|157516177|FG003|Overall Study|Other|4|||
48912228|NCT01830855|157516174|FG000|Overall Study|Medication error without associated AE|1|||
48912229|NCT01830855|157516175|FG001|Overall Study|Medication error without associated AE|0|||
48912230|NCT01830855|157516176|FG002|Overall Study|Medication error without associated AE|0|||
48912231|NCT01830855|157516177|FG003|Overall Study|Medication error without associated AE|1|||
48912232|NCT01830855|157516174|FG000|Overall Study|Pregnancy|3|||
48912233|NCT01830855|157516175|FG001|Overall Study|Pregnancy|1|||
48912234|NCT01830855|157516176|FG002|Overall Study|Pregnancy|2|||
48912235|NCT01830855|157516177|FG003|Overall Study|Pregnancy|1|||
48912236|NCT01830855|157516174|FG000|Overall Study|No longer meets eligibility criteria|11|||
48912237|NCT01830855|157516175|FG001|Overall Study|No longer meets eligibility criteria|2|||
48912238|NCT01830855|157516176|FG002|Overall Study|No longer meets eligibility criteria|3|||
48912239|NCT01830855|157516177|FG003|Overall Study|No longer meets eligibility criteria|5|||
48912240|NCT01830855|157516174|FG000|Overall Study|Adverse Event|11|||
48912241|NCT01830855|157516175|FG001|Overall Study|Adverse Event|5|||
48912242|NCT01830855|157516176|FG002|Overall Study|Adverse Event|6|||
48912243|NCT01830855|157516177|FG003|Overall Study|Adverse Event|3|||
48912244|NCT01830855|157516174|FG000|Overall Study|Protocol deviation|10|||
48912245|NCT01830855|157516175|FG001|Overall Study|Protocol deviation|5|||
48700529|NCT02113982|156753273|FG013|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
48700530|NCT02113982|156753260|FG000|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
48700531|NCT02113982|156753261|FG001|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
48700532|NCT02113982|156753262|FG002|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
48700533|NCT02113982|156753263|FG003|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
48700534|NCT02113982|156753264|FG004|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
48700535|NCT02113982|156753265|FG005|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
48700536|NCT02113982|156753266|FG006|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
48700537|NCT02113982|156753267|FG007|Stage 2: Cohort Expansion|Lack of Efficacy|2|||
48700538|NCT02113982|156753268|FG008|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
48700539|NCT02113982|156753269|FG009|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
48700540|NCT02113982|156753270|FG010|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
48700541|NCT02113982|156753271|FG011|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
48700542|NCT02113982|156753272|FG012|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
48700543|NCT02113982|156753273|FG013|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
48700544|NCT02113982|156753260|FG000|Stage 2: Cohort Expansion|Transplant|0|||
48700545|NCT02113982|156753261|FG001|Stage 2: Cohort Expansion|Transplant|0|||
48700546|NCT02113982|156753262|FG002|Stage 2: Cohort Expansion|Transplant|0|||
48700547|NCT02113982|156753263|FG003|Stage 2: Cohort Expansion|Transplant|0|||
48700548|NCT02113982|156753264|FG004|Stage 2: Cohort Expansion|Transplant|0|||
48700549|NCT02113982|156753265|FG005|Stage 2: Cohort Expansion|Transplant|0|||
48700550|NCT02113982|156753266|FG006|Stage 2: Cohort Expansion|Transplant|0|||
48700551|NCT02113982|156753267|FG007|Stage 2: Cohort Expansion|Transplant|0|||
48700552|NCT02113982|156753268|FG008|Stage 2: Cohort Expansion|Transplant|0|||
48700553|NCT02113982|156753269|FG009|Stage 2: Cohort Expansion|Transplant|4|||
48700554|NCT02113982|156753270|FG010|Stage 2: Cohort Expansion|Transplant|2|||
48700555|NCT02113982|156753271|FG011|Stage 2: Cohort Expansion|Transplant|0|||
48700556|NCT02113982|156753272|FG012|Stage 2: Cohort Expansion|Transplant|0|||
48700557|NCT02113982|156753273|FG013|Stage 2: Cohort Expansion|Transplant|0|||
48700558|NCT02113982|156753260|FG000|Stage 2: Cohort Expansion|Patient Preference|0|||
48700559|NCT02113982|156753261|FG001|Stage 2: Cohort Expansion|Patient Preference|0|||
48700560|NCT02113982|156753262|FG002|Stage 2: Cohort Expansion|Patient Preference|0|||
48700561|NCT02113982|156753263|FG003|Stage 2: Cohort Expansion|Patient Preference|0|||
48700562|NCT02113982|156753264|FG004|Stage 2: Cohort Expansion|Patient Preference|0|||
48700563|NCT02113982|156753265|FG005|Stage 2: Cohort Expansion|Patient Preference|0|||
48700564|NCT02113982|156753266|FG006|Stage 2: Cohort Expansion|Patient Preference|0|||
48700565|NCT02113982|156753267|FG007|Stage 2: Cohort Expansion|Patient Preference|1|||
48700566|NCT02113982|156753268|FG008|Stage 2: Cohort Expansion|Patient Preference|0|||
48700567|NCT02113982|156753269|FG009|Stage 2: Cohort Expansion|Patient Preference|0|||
48700568|NCT02113982|156753270|FG010|Stage 2: Cohort Expansion|Patient Preference|1|||
48700569|NCT02113982|156753271|FG011|Stage 2: Cohort Expansion|Patient Preference|0|||
48700570|NCT02113982|156753272|FG012|Stage 2: Cohort Expansion|Patient Preference|0|||
48700571|NCT02113982|156753273|FG013|Stage 2: Cohort Expansion|Patient Preference|0|||
48700572|NCT02113982|156753260|FG000|Stage 2: Cohort Expansion|Other Therapy|0|||
48700573|NCT02113982|156753261|FG001|Stage 2: Cohort Expansion|Other Therapy|0|||
48700574|NCT02113982|156753262|FG002|Stage 2: Cohort Expansion|Other Therapy|0|||
48700575|NCT02113982|156753263|FG003|Stage 2: Cohort Expansion|Other Therapy|0|||
48700576|NCT02113982|156753264|FG004|Stage 2: Cohort Expansion|Other Therapy|0|||
48700577|NCT02113982|156753265|FG005|Stage 2: Cohort Expansion|Other Therapy|0|||
48700578|NCT02113982|156753266|FG006|Stage 2: Cohort Expansion|Other Therapy|0|||
48700579|NCT02113982|156753267|FG007|Stage 2: Cohort Expansion|Other Therapy|0|||
48700580|NCT02113982|156753268|FG008|Stage 2: Cohort Expansion|Other Therapy|0|||
48700581|NCT02113982|156753269|FG009|Stage 2: Cohort Expansion|Other Therapy|1|||
48700582|NCT02113982|156753270|FG010|Stage 2: Cohort Expansion|Other Therapy|0|||
48700583|NCT02113982|156753271|FG011|Stage 2: Cohort Expansion|Other Therapy|0|||
48700584|NCT02113982|156753272|FG012|Stage 2: Cohort Expansion|Other Therapy|0|||
48700585|NCT02113982|156753273|FG013|Stage 2: Cohort Expansion|Other Therapy|0|||
48912246|NCT01830855|157516176|FG002|Overall Study|Protocol deviation|6|||
48700586|NCT02113982|156753260|FG000|Stage 3: Efficacy Cohort|Adverse Event|0|||
48700587|NCT02113982|156753261|FG001|Stage 3: Efficacy Cohort|Adverse Event|0|||
48700588|NCT02113982|156753262|FG002|Stage 3: Efficacy Cohort|Adverse Event|0|||
48700589|NCT02113982|156753263|FG003|Stage 3: Efficacy Cohort|Adverse Event|0|||
48700590|NCT02113982|156753264|FG004|Stage 3: Efficacy Cohort|Adverse Event|0|||
48700591|NCT02113982|156753265|FG005|Stage 3: Efficacy Cohort|Adverse Event|0|||
48700592|NCT02113982|156753266|FG006|Stage 3: Efficacy Cohort|Adverse Event|0|||
48700593|NCT02113982|156753267|FG007|Stage 3: Efficacy Cohort|Adverse Event|0|||
48700594|NCT02113982|156753268|FG008|Stage 3: Efficacy Cohort|Adverse Event|0|||
48700595|NCT02113982|156753269|FG009|Stage 3: Efficacy Cohort|Adverse Event|0|||
48700596|NCT02113982|156753270|FG010|Stage 3: Efficacy Cohort|Adverse Event|0|||
48700597|NCT02113982|156753271|FG011|Stage 3: Efficacy Cohort|Adverse Event|1|||
48700598|NCT02113982|156753272|FG012|Stage 3: Efficacy Cohort|Adverse Event|0|||
48700599|NCT02113982|156753273|FG013|Stage 3: Efficacy Cohort|Adverse Event|0|||
48700600|NCT02113982|156753260|FG000|Stage 3: Efficacy Cohort|Physician Decision|0|||
48700601|NCT02113982|156753261|FG001|Stage 3: Efficacy Cohort|Physician Decision|0|||
48700602|NCT02113982|156753262|FG002|Stage 3: Efficacy Cohort|Physician Decision|0|||
48700603|NCT02113982|156753263|FG003|Stage 3: Efficacy Cohort|Physician Decision|0|||
48700604|NCT02113982|156753264|FG004|Stage 3: Efficacy Cohort|Physician Decision|0|||
48700605|NCT02113982|156753265|FG005|Stage 3: Efficacy Cohort|Physician Decision|0|||
48700606|NCT02113982|156753266|FG006|Stage 3: Efficacy Cohort|Physician Decision|0|||
48700607|NCT02113982|156753267|FG007|Stage 3: Efficacy Cohort|Physician Decision|0|||
48700608|NCT02113982|156753268|FG008|Stage 3: Efficacy Cohort|Physician Decision|0|||
48700609|NCT02113982|156753269|FG009|Stage 3: Efficacy Cohort|Physician Decision|0|||
48700610|NCT02113982|156753270|FG010|Stage 3: Efficacy Cohort|Physician Decision|0|||
48700611|NCT02113982|156753271|FG011|Stage 3: Efficacy Cohort|Physician Decision|3|||
48700612|NCT02113982|156753272|FG012|Stage 3: Efficacy Cohort|Physician Decision|0|||
48700613|NCT02113982|156753273|FG013|Stage 3: Efficacy Cohort|Physician Decision|0|||
48700614|NCT02113982|156753260|FG000|Stage 3: Efficacy Cohort|Progressive Disease|0|||
48700615|NCT02113982|156753261|FG001|Stage 3: Efficacy Cohort|Progressive Disease|0|||
48700616|NCT02113982|156753262|FG002|Stage 3: Efficacy Cohort|Progressive Disease|0|||
48700617|NCT02113982|156753263|FG003|Stage 3: Efficacy Cohort|Progressive Disease|0|||
48700618|NCT02113982|156753264|FG004|Stage 3: Efficacy Cohort|Progressive Disease|0|||
48700619|NCT02113982|156753265|FG005|Stage 3: Efficacy Cohort|Progressive Disease|0|||
48700620|NCT02113982|156753266|FG006|Stage 3: Efficacy Cohort|Progressive Disease|0|||
48700621|NCT02113982|156753267|FG007|Stage 3: Efficacy Cohort|Progressive Disease|0|||
48700622|NCT02113982|156753268|FG008|Stage 3: Efficacy Cohort|Progressive Disease|0|||
48700623|NCT02113982|156753269|FG009|Stage 3: Efficacy Cohort|Progressive Disease|0|||
48700624|NCT02113982|156753270|FG010|Stage 3: Efficacy Cohort|Progressive Disease|0|||
48700625|NCT02113982|156753271|FG011|Stage 3: Efficacy Cohort|Progressive Disease|4|||
48700626|NCT02113982|156753272|FG012|Stage 3: Efficacy Cohort|Progressive Disease|0|||
48700627|NCT02113982|156753273|FG013|Stage 3: Efficacy Cohort|Progressive Disease|0|||
48700628|NCT02113982|156753260|FG000|Stage 3: Efficacy Cohort|Transplant|0|||
48700629|NCT02113982|156753261|FG001|Stage 3: Efficacy Cohort|Transplant|0|||
48700630|NCT02113982|156753262|FG002|Stage 3: Efficacy Cohort|Transplant|0|||
48700631|NCT02113982|156753263|FG003|Stage 3: Efficacy Cohort|Transplant|0|||
48700632|NCT02113982|156753264|FG004|Stage 3: Efficacy Cohort|Transplant|0|||
48700633|NCT02113982|156753265|FG005|Stage 3: Efficacy Cohort|Transplant|0|||
48700634|NCT02113982|156753266|FG006|Stage 3: Efficacy Cohort|Transplant|0|||
48700635|NCT02113982|156753267|FG007|Stage 3: Efficacy Cohort|Transplant|0|||
48700636|NCT02113982|156753268|FG008|Stage 3: Efficacy Cohort|Transplant|0|||
48700637|NCT02113982|156753269|FG009|Stage 3: Efficacy Cohort|Transplant|0|||
48700638|NCT02113982|156753270|FG010|Stage 3: Efficacy Cohort|Transplant|0|||
48700639|NCT02113982|156753271|FG011|Stage 3: Efficacy Cohort|Transplant|5|||
48700640|NCT02113982|156753272|FG012|Stage 3: Efficacy Cohort|Transplant|0|||
48700641|NCT02113982|156753273|FG013|Stage 3: Efficacy Cohort|Transplant|0|||
48700642|NCT02113982|156753260|FG000|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
48700643|NCT02113982|156753261|FG001|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
48700644|NCT02113982|156753262|FG002|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
48700645|NCT02113982|156753263|FG003|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
48700646|NCT02113982|156753264|FG004|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
48700647|NCT02113982|156753265|FG005|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
49117260|NCT00255164|158266075|FG000|Overall Study|Lost to Follow-up|4|||
49117261|NCT00255164|158266076|FG001|Overall Study|Lost to Follow-up|3|||
49117262|NCT00255164|158266077|FG002|Overall Study|Lost to Follow-up|4|||
49117263|NCT00255164|158266075|FG000|Overall Study|Withdrawal by Subject|18|||
49117264|NCT00255164|158266076|FG001|Overall Study|Withdrawal by Subject|17|||
49117265|NCT00255164|158266077|FG002|Overall Study|Withdrawal by Subject|8|||
49117266|NCT00255164|158266075|FG000|Overall Study|Noncompliance|0|||
49117267|NCT00255164|158266076|FG001|Overall Study|Noncompliance|1|||
49117268|NCT00255164|158266077|FG002|Overall Study|Noncompliance|2|||
49117269|NCT00255164|158266075|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
49117270|NCT00255164|158266076|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
49117271|NCT00255164|158266077|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
49117272|NCT00255164|158266075|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
49117273|NCT00255164|158266076|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
49117274|NCT00255164|158266077|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
49117275|NCT00255164|158266075|FG000|Overall Study|Possible Barrett's Esophagus|1|||
49117276|NCT00255164|158266076|FG001|Overall Study|Possible Barrett's Esophagus|3|||
49117277|NCT00255164|158266077|FG002|Overall Study|Possible Barrett's Esophagus|8|||
49117278|NCT00255164|158266075|FG000|Overall Study|Esophageal Stricture|0|||
49117279|NCT00255164|158266076|FG001|Overall Study|Esophageal Stricture|0|||
49117280|NCT00255164|158266077|FG002|Overall Study|Esophageal Stricture|1|||
49117281|NCT00255164|158266075|FG000|Overall Study|Therapeutic Failure|11|||
49117282|NCT00255164|158266076|FG001|Overall Study|Therapeutic Failure|2|||
49117283|NCT00255164|158266077|FG002|Overall Study|Therapeutic Failure|3|||
49117284|NCT03430856|158266078|FG000|Overall Study|Adverse Event|0|||
49117285|NCT03430856|158266079|FG001|Overall Study|Adverse Event|1|||
49117286|NCT03430856|158266080|FG002|Overall Study|Adverse Event|0|||
49117287|NCT03430856|158266078|FG000|Overall Study|Rescue criteria|1|||
49117288|NCT03430856|158266079|FG001|Overall Study|Rescue criteria|1|||
49117289|NCT03430856|158266080|FG002|Overall Study|Rescue criteria|0|||
49117290|NCT03430856|158266078|FG000|Overall Study|Voluntary withdrawal of consent|1|||
49117291|NCT03430856|158266079|FG001|Overall Study|Voluntary withdrawal of consent|1|||
49117292|NCT03430856|158266080|FG002|Overall Study|Voluntary withdrawal of consent|1|||
49117293|NCT04162795|158266084|FG000|Overall Study|Other|16|||
49117294|NCT04162795|158266084|FG000|Overall Study|Screen failures|10|||
49117295|NCT00565604|158266088|FG000|Overall Study|Failure to treat|2|||
49117296|NCT00565604|158266088|FG000|Overall Study|Lost to Follow-up|2|||
49117297|NCT04003623|158267631|FG000|Overall Study|Withdrawal by Subject|1|||
49117298|NCT04003623|158267632|FG001|Overall Study|Withdrawal by Subject|0|||
49117299|NCT02207400|158267635|FG000|Overall Study|Adverse Event|1|||
49117300|NCT02207400|158267636|FG001|Overall Study|Adverse Event|1|||
49117301|NCT02207400|158267635|FG000|Overall Study|Lost to Follow-up|6|||
49117302|NCT02207400|158267636|FG001|Overall Study|Lost to Follow-up|7|||
49117303|NCT02207400|158267635|FG000|Overall Study|Protocol Violation|1|||
49117304|NCT02207400|158267636|FG001|Overall Study|Protocol Violation|1|||
49117305|NCT02207400|158267635|FG000|Overall Study|Withdrawal by Subject|8|||
49117306|NCT02207400|158267636|FG001|Overall Study|Withdrawal by Subject|4|||
49117307|NCT02207400|158267635|FG000|Overall Study|Positive Urine Pregnancy Test|0|||
49117308|NCT02207400|158267636|FG001|Overall Study|Positive Urine Pregnancy Test|1|||
49117309|NCT03052920|158267641|FG000|Overall Study|Withdrawal by Subject|1|||
49117310|NCT01502956|158267642|FG000|Overall Study|Death|0|||
49117311|NCT01502956|158267643|FG001|Overall Study|Death|2|||
49117312|NCT01502956|158267642|FG000|Overall Study|Lost to Follow-up|14|||
49117313|NCT01502956|158267643|FG001|Overall Study|Lost to Follow-up|11|||
49117314|NCT01502956|158267642|FG000|Overall Study|Physician Decision|2|||
49117315|NCT01502956|158267643|FG001|Overall Study|Physician Decision|3|||
49117316|NCT01502956|158267642|FG000|Overall Study|Withdrawal by Subject|8|||
49117317|NCT01502956|158267643|FG001|Overall Study|Withdrawal by Subject|10|||
49117318|NCT02501161|158267652|FG000|Overall Study|Adverse Event|2|||
49117319|NCT02501161|158267653|FG001|Overall Study|Adverse Event|6|||
49117320|NCT02501161|158267652|FG000|Overall Study|Lost to Follow-up|7|||
49117321|NCT02501161|158267653|FG001|Overall Study|Lost to Follow-up|4|||
49117322|NCT02501161|158267652|FG000|Overall Study|Withdrawal by Subject|10|||
49117323|NCT02501161|158267653|FG001|Overall Study|Withdrawal by Subject|15|||
49117324|NCT02501161|158267652|FG000|Overall Study|Other|3|||
49117325|NCT02501161|158267653|FG001|Overall Study|Other|0|||
49117326|NCT01054222|158267654|FG000|Overall Study|Lack of Efficacy|1|||
49117327|NCT01054222|158267654|FG000|Overall Study|Lost to Follow-up|4|||
48700648|NCT02113982|156753266|FG006|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
49117328|NCT01054222|158267654|FG000|Overall Study|Withdrawal by Subject|6|||
49117329|NCT01467271|158267670|FG000|Overall Study|Death|84|||
49117330|NCT01467271|158267670|FG000|Overall Study|Lost to Follow-up|83|||
49117331|NCT01467271|158267670|FG000|Overall Study|Retraction of patient's consent|21|||
49117332|NCT01467271|158267670|FG000|Overall Study|Other reason|14|||
49117333|NCT00184002|158267675|FG000|Overall Study|Adverse Event|9|||
49117334|NCT00184002|158267675|FG000|Overall Study|Death|3|||
49117335|NCT00184002|158267675|FG000|Overall Study|Physician Decision|1|||
49117336|NCT00184002|158267675|FG000|Overall Study|Withdrawal by Subject|4|||
49117337|NCT02131233|158267681|FG000|Overall Study|Not Treated|2|||
49117338|NCT02131233|158267682|FG001|Overall Study|Not Treated|3|||
49117339|NCT02131233|158267681|FG000|Overall Study|Adverse Event|7|||
49117340|NCT02131233|158267682|FG001|Overall Study|Adverse Event|6|||
49117341|NCT02131233|158267681|FG000|Overall Study|Death|0|||
49117342|NCT02131233|158267682|FG001|Overall Study|Death|1|||
48700649|NCT02113982|156753267|FG007|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
48700650|NCT02113982|156753268|FG008|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
48700651|NCT02113982|156753269|FG009|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
48700652|NCT02113982|156753270|FG010|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
48700653|NCT02113982|156753271|FG011|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
48700654|NCT02113982|156753272|FG012|Stage 4: First-line and R/R BPDCN|Adverse Event|4|||
48700655|NCT02113982|156753273|FG013|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
48700656|NCT02113982|156753260|FG000|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
48700657|NCT02113982|156753261|FG001|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
48700658|NCT02113982|156753262|FG002|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
48700659|NCT02113982|156753263|FG003|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
48700660|NCT02113982|156753264|FG004|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
48700661|NCT02113982|156753265|FG005|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
48700662|NCT02113982|156753266|FG006|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
48700663|NCT02113982|156753267|FG007|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
48700664|NCT02113982|156753268|FG008|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
48700665|NCT02113982|156753269|FG009|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
48700666|NCT02113982|156753270|FG010|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
48700667|NCT02113982|156753271|FG011|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
48700668|NCT02113982|156753272|FG012|Stage 4: First-line and R/R BPDCN|Physician Decision|7|||
48700669|NCT02113982|156753273|FG013|Stage 4: First-line and R/R BPDCN|Physician Decision|2|||
48700670|NCT02113982|156753260|FG000|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
48700671|NCT02113982|156753261|FG001|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
48700672|NCT02113982|156753262|FG002|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
48700673|NCT02113982|156753263|FG003|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
48700674|NCT02113982|156753264|FG004|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
48700675|NCT02113982|156753265|FG005|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
48700676|NCT02113982|156753266|FG006|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
48700677|NCT02113982|156753267|FG007|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
48700678|NCT02113982|156753268|FG008|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
48700679|NCT02113982|156753269|FG009|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
48700680|NCT02113982|156753270|FG010|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
49117343|NCT02131233|158267681|FG000|Overall Study|Lack of Efficacy|6|||
48912247|NCT01830855|157516177|FG003|Overall Study|Protocol deviation|6|||
49117344|NCT02131233|158267682|FG001|Overall Study|Lack of Efficacy|3|||
49117345|NCT02131233|158267681|FG000|Overall Study|Lost to Follow-up|14|||
49117346|NCT02131233|158267682|FG001|Overall Study|Lost to Follow-up|13|||
48912248|NCT01830855|157516174|FG000|Overall Study|Withdrawal by Subject|33|||
49117347|NCT02131233|158267681|FG000|Overall Study|Non-Compliance With Study Drug|8|||
49117348|NCT02131233|158267682|FG001|Overall Study|Non-Compliance With Study Drug|5|||
49117349|NCT02131233|158267681|FG000|Overall Study|Physician Decision|7|||
49117350|NCT02131233|158267682|FG001|Overall Study|Physician Decision|0|||
49117351|NCT02131233|158267681|FG000|Overall Study|Pregnancy|4|||
48700681|NCT02113982|156753271|FG011|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
48700682|NCT02113982|156753272|FG012|Stage 4: First-line and R/R BPDCN|Progressive Disease|14|||
48700683|NCT02113982|156753273|FG013|Stage 4: First-line and R/R BPDCN|Progressive Disease|3|||
48700684|NCT02113982|156753260|FG000|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
48700685|NCT02113982|156753261|FG001|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
48700686|NCT02113982|156753262|FG002|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
48700687|NCT02113982|156753263|FG003|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
48700688|NCT02113982|156753264|FG004|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
48700689|NCT02113982|156753265|FG005|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
48700690|NCT02113982|156753266|FG006|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
48700691|NCT02113982|156753267|FG007|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
48700692|NCT02113982|156753268|FG008|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
48700693|NCT02113982|156753269|FG009|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
48700694|NCT02113982|156753270|FG010|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
48700695|NCT02113982|156753271|FG011|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
48700696|NCT02113982|156753272|FG012|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|4|||
48700697|NCT02113982|156753273|FG013|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|2|||
48700698|NCT02113982|156753260|FG000|Stage 4: First-line and R/R BPDCN|Transplant|0|||
48700699|NCT02113982|156753261|FG001|Stage 4: First-line and R/R BPDCN|Transplant|0|||
48700700|NCT02113982|156753262|FG002|Stage 4: First-line and R/R BPDCN|Transplant|0|||
48700701|NCT02113982|156753263|FG003|Stage 4: First-line and R/R BPDCN|Transplant|0|||
48700702|NCT02113982|156753264|FG004|Stage 4: First-line and R/R BPDCN|Transplant|0|||
48700703|NCT02113982|156753265|FG005|Stage 4: First-line and R/R BPDCN|Transplant|0|||
48700704|NCT02113982|156753266|FG006|Stage 4: First-line and R/R BPDCN|Transplant|0|||
48700705|NCT02113982|156753267|FG007|Stage 4: First-line and R/R BPDCN|Transplant|0|||
48912249|NCT01830855|157516175|FG001|Overall Study|Withdrawal by Subject|14|||
48912250|NCT01830855|157516176|FG002|Overall Study|Withdrawal by Subject|10|||
48912251|NCT01830855|157516177|FG003|Overall Study|Withdrawal by Subject|12|||
48912252|NCT01830855|157516174|FG000|Overall Study|No longer willing to participate|32|||
48912253|NCT01830855|157516175|FG001|Overall Study|No longer willing to participate|13|||
49117352|NCT02131233|158267682|FG001|Overall Study|Pregnancy|0|||
48700706|NCT02113982|156753268|FG008|Stage 4: First-line and R/R BPDCN|Transplant|0|||
48700707|NCT02113982|156753269|FG009|Stage 4: First-line and R/R BPDCN|Transplant|0|||
48700708|NCT02113982|156753270|FG010|Stage 4: First-line and R/R BPDCN|Transplant|0|||
48700709|NCT02113982|156753271|FG011|Stage 4: First-line and R/R BPDCN|Transplant|0|||
48700710|NCT02113982|156753272|FG012|Stage 4: First-line and R/R BPDCN|Transplant|5|||
48700711|NCT02113982|156753273|FG013|Stage 4: First-line and R/R BPDCN|Transplant|0|||
48700712|NCT02113982|156753260|FG000|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
48700713|NCT02113982|156753261|FG001|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
49117353|NCT02131233|158267681|FG000|Overall Study|Withdrawal by Subject|18|||
49117354|NCT02131233|158267682|FG001|Overall Study|Withdrawal by Subject|11|||
49117355|NCT00540644|158267684|FG000|Overall Study|Adverse Event|3|||
49117356|NCT00540644|158267685|FG001|Overall Study|Adverse Event|1|||
49117357|NCT00540644|158267684|FG000|Overall Study|Disease Progression|3|||
49117358|NCT00540644|158267685|FG001|Overall Study|Disease Progression|1|||
49117359|NCT00540644|158267684|FG000|Overall Study|Physician Decision|0|||
49117360|NCT00540644|158267685|FG001|Overall Study|Physician Decision|5|||
49117361|NCT00540644|158267684|FG000|Overall Study|Withdrawal by Subject|2|||
49117362|NCT00540644|158267685|FG001|Overall Study|Withdrawal by Subject|2|||
49117363|NCT00540644|158267684|FG000|Overall Study|Noncomplilance|1|||
49117364|NCT00540644|158267685|FG001|Overall Study|Noncomplilance|0|||
49117365|NCT02144077|158267686|FG000|Overall Study|Withdrawal by Subject|3|||
49117366|NCT02144077|158267687|FG001|Overall Study|Withdrawal by Subject|3|||
49117367|NCT02144077|158267686|FG000|Overall Study|Adverse Event|2|||
49117368|NCT02144077|158267687|FG001|Overall Study|Adverse Event|3|||
49117369|NCT02144077|158267686|FG000|Overall Study|Lost to Follow-up|2|||
49117370|NCT02144077|158267687|FG001|Overall Study|Lost to Follow-up|2|||
49117371|NCT02144077|158267686|FG000|Overall Study|Protocol Violation|1|||
49117372|NCT02144077|158267687|FG001|Overall Study|Protocol Violation|2|||
49117373|NCT02144077|158267686|FG000|Overall Study|Death|0|||
49117374|NCT02144077|158267687|FG001|Overall Study|Death|1|||
49117375|NCT02144077|158267686|FG000|Overall Study|no visits 7 & 8/no visits after visit 4|2|||
49117376|NCT02144077|158267687|FG001|Overall Study|no visits 7 & 8/no visits after visit 4|0|||
49117377|NCT00217581|158267690|FG000|Overall Study|Withdrawal by Subject|1|||
49117378|NCT01909973|158267692|FG000|Overall Study|Lost to Follow-up|1|||
49117379|NCT01909973|158267693|FG001|Overall Study|Lost to Follow-up|0|||
49117380|NCT00070564|158267694|FG000|Overall Study|Progression|2|||
48700714|NCT02113982|156753262|FG002|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
48700715|NCT02113982|156753263|FG003|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
48700716|NCT02113982|156753264|FG004|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
48700717|NCT02113982|156753265|FG005|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
48700718|NCT02113982|156753266|FG006|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
48700719|NCT02113982|156753267|FG007|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
48700720|NCT02113982|156753268|FG008|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
48700721|NCT02113982|156753269|FG009|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
48700722|NCT02113982|156753270|FG010|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
48700723|NCT02113982|156753271|FG011|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
48700724|NCT02113982|156753272|FG012|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|2|||
48700725|NCT02113982|156753273|FG013|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
48700726|NCT02113982|156753260|FG000|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
48700727|NCT02113982|156753261|FG001|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
48700728|NCT02113982|156753262|FG002|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
48700729|NCT02113982|156753263|FG003|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
48700730|NCT02113982|156753264|FG004|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
48700731|NCT02113982|156753265|FG005|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
48700732|NCT02113982|156753266|FG006|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
48700733|NCT02113982|156753267|FG007|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
48700734|NCT02113982|156753268|FG008|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
48700735|NCT02113982|156753269|FG009|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
48700736|NCT02113982|156753270|FG010|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
48700737|NCT02113982|156753271|FG011|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
48700738|NCT02113982|156753272|FG012|Stage 4: First-line and R/R BPDCN|Patient Preference|1|||
48700739|NCT02113982|156753273|FG013|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
48700740|NCT02220920|156753274|FG000|Overall Study|Adverse Event|1|||
48700741|NCT02220920|156753275|FG001|Overall Study|Adverse Event|0|||
48700742|NCT02220920|156753274|FG000|Overall Study|Lack of Efficacy|0|||
48700743|NCT02220920|156753275|FG001|Overall Study|Lack of Efficacy|1|||
48700744|NCT02220920|156753274|FG000|Overall Study|Withdrawal by Subject|1|||
48700745|NCT02220920|156753275|FG001|Overall Study|Withdrawal by Subject|0|||
48700746|NCT02220920|156753274|FG000|Overall Study|Conflict with the stopping criteria|1|||
48700747|NCT02220920|156753275|FG001|Overall Study|Conflict with the stopping criteria|2|||
48700748|NCT03198715|156753276|FG000|Overall Study|Death|0|||
48700749|NCT03198715|156753277|FG001|Overall Study|Death|0|||
48700750|NCT03198715|156753278|FG002|Overall Study|Death|1|||
48700751|NCT03198715|156753279|FG003|Overall Study|Death|0|||
48700752|NCT03198715|156753280|FG004|Overall Study|Death|2|||
49117381|NCT00070564|158267695|FG001|Overall Study|Progression|4|||
49117382|NCT00070564|158267696|FG002|Overall Study|Progression|7|||
49117383|NCT00070564|158267697|FG003|Overall Study|Progression|7|||
49117384|NCT00070564|158267698|FG004|Overall Study|Progression|1|||
49117385|NCT00070564|158267699|FG005|Overall Study|Progression|0|||
49117386|NCT00070564|158267694|FG000|Overall Study|Delinquent|1|||
49117387|NCT00070564|158267695|FG001|Overall Study|Delinquent|4|||
49117388|NCT00070564|158267696|FG002|Overall Study|Delinquent|2|||
49117389|NCT00070564|158267697|FG003|Overall Study|Delinquent|0|||
49117390|NCT00070564|158267698|FG004|Overall Study|Delinquent|0|||
49117391|NCT00070564|158267699|FG005|Overall Study|Delinquent|0|||
49117392|NCT00070564|158267694|FG000|Overall Study|Adverse Event|150|||
49117393|NCT00070564|158267695|FG001|Overall Study|Adverse Event|142|||
49117394|NCT00070564|158267696|FG002|Overall Study|Adverse Event|120|||
49117395|NCT00070564|158267697|FG003|Overall Study|Adverse Event|108|||
49117396|NCT00070564|158267698|FG004|Overall Study|Adverse Event|63|||
49117397|NCT00070564|158267699|FG005|Overall Study|Adverse Event|36|||
49117398|NCT00070564|158267694|FG000|Overall Study|Death|4|||
49117399|NCT00070564|158267695|FG001|Overall Study|Death|1|||
49117400|NCT00070564|158267696|FG002|Overall Study|Death|5|||
48700753|NCT03198715|156753276|FG000|Overall Study|Other|0|||
48700754|NCT03198715|156753277|FG001|Overall Study|Other|1|||
48700755|NCT03198715|156753278|FG002|Overall Study|Other|1|||
48700756|NCT03198715|156753279|FG003|Overall Study|Other|0|||
48700757|NCT03198715|156753280|FG004|Overall Study|Other|0|||
49117401|NCT00070564|158267697|FG003|Overall Study|Death|3|||
49117402|NCT00070564|158267698|FG004|Overall Study|Death|0|||
49117403|NCT00070564|158267699|FG005|Overall Study|Death|1|||
49117404|NCT00070564|158267694|FG000|Overall Study|Other, not protocol specified|17|||
49117405|NCT00070564|158267695|FG001|Overall Study|Other, not protocol specified|15|||
49117406|NCT00070564|158267696|FG002|Overall Study|Other, not protocol specified|14|||
49117407|NCT00070564|158267697|FG003|Overall Study|Other, not protocol specified|19|||
49117408|NCT00070564|158267698|FG004|Overall Study|Other, not protocol specified|6|||
49117409|NCT00070564|158267699|FG005|Overall Study|Other, not protocol specified|7|||
48700758|NCT00853307|156753281|FG000|Overall Study|Adverse Event|1|||
48700759|NCT00853307|156753282|FG001|Overall Study|Adverse Event|2|||
48700760|NCT00853307|156753281|FG000|Overall Study|Withdrawal by Subject|1|||
49117410|NCT00070564|158267694|FG000|Overall Study|Withdrawal by Subject|26|||
48700761|NCT00853307|156753282|FG001|Overall Study|Withdrawal by Subject|2|||
48700762|NCT00853307|156753281|FG000|Overall Study|Reason Not Specified|0|||
48700763|NCT00853307|156753282|FG001|Overall Study|Reason Not Specified|1|||
48700764|NCT00286468|156753283|FG000|Overall Study|Hyperglycemic Rescue|28|||
48700765|NCT00286468|156753284|FG001|Overall Study|Hyperglycemic Rescue|30|||
48700766|NCT00286468|156753285|FG002|Overall Study|Hyperglycemic Rescue|31|||
48700767|NCT00286468|156753283|FG000|Overall Study|Adverse Event|2|||
48700768|NCT00286468|156753284|FG001|Overall Study|Adverse Event|6|||
48700769|NCT00286468|156753285|FG002|Overall Study|Adverse Event|4|||
48700770|NCT00286468|156753283|FG000|Overall Study|Protocol Violation|0|||
48700771|NCT00286468|156753284|FG001|Overall Study|Protocol Violation|3|||
48700772|NCT00286468|156753285|FG002|Overall Study|Protocol Violation|1|||
48700773|NCT00286468|156753283|FG000|Overall Study|Lost to Follow-up|1|||
48700774|NCT00286468|156753284|FG001|Overall Study|Lost to Follow-up|1|||
48700775|NCT00286468|156753285|FG002|Overall Study|Lost to Follow-up|2|||
48700776|NCT00286468|156753283|FG000|Overall Study|Withdrawal by Subject|3|||
48700777|NCT00286468|156753284|FG001|Overall Study|Withdrawal by Subject|8|||
48700778|NCT00286468|156753285|FG002|Overall Study|Withdrawal by Subject|11|||
48700779|NCT00286468|156753283|FG000|Overall Study|Physician Decision|3|||
48700780|NCT00286468|156753284|FG001|Overall Study|Physician Decision|2|||
48700781|NCT00286468|156753285|FG002|Overall Study|Physician Decision|1|||
48700782|NCT00129402|156753307|FG000|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
48700783|NCT00129402|156753308|FG001|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
48700784|NCT00129402|156753309|FG002|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
49117411|NCT00070564|158267695|FG001|Overall Study|Withdrawal by Subject|37|||
49117412|NCT00070564|158267696|FG002|Overall Study|Withdrawal by Subject|23|||
49117413|NCT00070564|158267697|FG003|Overall Study|Withdrawal by Subject|30|||
49117414|NCT00070564|158267698|FG004|Overall Study|Withdrawal by Subject|8|||
49117415|NCT00070564|158267699|FG005|Overall Study|Withdrawal by Subject|8|||
49117416|NCT00070564|158267694|FG000|Overall Study|Not reported|0|||
49117417|NCT00070564|158267695|FG001|Overall Study|Not reported|0|||
49117418|NCT00070564|158267696|FG002|Overall Study|Not reported|0|||
49117419|NCT00070564|158267697|FG003|Overall Study|Not reported|0|||
49117420|NCT00070564|158267698|FG004|Overall Study|Not reported|1|||
49117421|NCT00070564|158267699|FG005|Overall Study|Not reported|0|||
48700785|NCT00129402|156753310|FG003|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
48700786|NCT00129402|156753311|FG004|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
48700787|NCT00129402|156753312|FG005|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
48700788|NCT00129402|156753313|FG006|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
48700789|NCT00129402|156753307|FG000|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
48700790|NCT00129402|156753308|FG001|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
48700791|NCT00129402|156753309|FG002|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
48700792|NCT00129402|156753310|FG003|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
48700793|NCT00129402|156753311|FG004|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
48700794|NCT00129402|156753312|FG005|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1|||
48700795|NCT00129402|156753313|FG006|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
48700796|NCT00129402|156753307|FG000|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
48700797|NCT00129402|156753308|FG001|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
48700798|NCT00129402|156753309|FG002|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
48700799|NCT00129402|156753310|FG003|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1|||
48700800|NCT00129402|156753311|FG004|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
48700801|NCT00129402|156753312|FG005|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
48700802|NCT00129402|156753313|FG006|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
48700803|NCT00129402|156753307|FG000|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
48700804|NCT00129402|156753308|FG001|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
48700805|NCT00129402|156753309|FG002|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
49117422|NCT03077607|158267701|FG000|Period 1 (15 Days)|Adverse Event|1|||
48700806|NCT00129402|156753310|FG003|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
48700807|NCT00129402|156753311|FG004|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
48700808|NCT00129402|156753312|FG005|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
48700809|NCT00129402|156753313|FG006|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
48700810|NCT00129402|156753307|FG000|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
48700811|NCT00129402|156753308|FG001|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
48700812|NCT00129402|156753309|FG002|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2|||
48700813|NCT00129402|156753310|FG003|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
48700814|NCT00129402|156753311|FG004|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
48700815|NCT00129402|156753312|FG005|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
48700816|NCT00129402|156753313|FG006|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
48700817|NCT00129402|156753307|FG000|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
48700818|NCT00129402|156753308|FG001|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
48700819|NCT00129402|156753309|FG002|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3|||
48700820|NCT00129402|156753310|FG003|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
48700821|NCT00129402|156753311|FG004|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
48700822|NCT00129402|156753312|FG005|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1|||
48700823|NCT00129402|156753313|FG006|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
48700824|NCT00129402|156753307|FG000|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
48700825|NCT00129402|156753308|FG001|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
48700826|NCT00129402|156753309|FG002|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1|||
48700827|NCT00129402|156753310|FG003|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
48700828|NCT00129402|156753311|FG004|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
48700829|NCT00129402|156753312|FG005|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
48700830|NCT00129402|156753313|FG006|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
48700831|NCT00129402|156753307|FG000|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
48700832|NCT00129402|156753308|FG001|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
48700833|NCT00129402|156753309|FG002|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1|||
48700834|NCT00129402|156753310|FG003|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
48700835|NCT00129402|156753311|FG004|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
48700836|NCT00129402|156753312|FG005|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3|||
48700837|NCT00129402|156753313|FG006|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
48700838|NCT00129402|156753307|FG000|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
49117423|NCT03077607|158267702|FG001|Period 1 (15 Days)|Adverse Event|0|||
49117424|NCT03077607|158267701|FG000|Period 1 (15 Days)|Death|1|||
49117425|NCT03077607|158267702|FG001|Period 1 (15 Days)|Death|0|||
49117426|NCT03077607|158267701|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1|||
49117427|NCT03077607|158267702|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0|||
49117428|NCT03077607|158267701|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
49117429|NCT03077607|158267702|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
49117430|NCT00397189|158267706|FG000|3 Weeks Period|Lost to Follow-up|5|||
49117431|NCT00397189|158267707|FG001|3 Weeks Period|Lost to Follow-up|4|||
49117432|NCT00397189|158267706|FG000|3 Weeks Period|Adverse Event|3|||
49117433|NCT00397189|158267707|FG001|3 Weeks Period|Adverse Event|2|||
49117434|NCT00397189|158267706|FG000|3 Weeks Period|Withdrawal by Subject|13|||
49117435|NCT00397189|158267707|FG001|3 Weeks Period|Withdrawal by Subject|9|||
49117436|NCT00397189|158267706|FG000|3 Weeks Period|Physician Decision|0|||
49117437|NCT00397189|158267707|FG001|3 Weeks Period|Physician Decision|2|||
49117438|NCT00397189|158267706|FG000|3 Weeks Period|Protocol Violation|0|||
49117439|NCT00397189|158267707|FG001|3 Weeks Period|Protocol Violation|3|||
49117440|NCT00397189|158267706|FG000|3 Weeks Period|Other|0|||
49117441|NCT00397189|158267707|FG001|3 Weeks Period|Other|2|||
49117442|NCT00807612|158267708|FG000|Overall Study|Death|8|||
49117443|NCT00807612|158267708|FG000|Overall Study|Study early termination|5|||
49117444|NCT00807612|158267708|FG000|Overall Study|Withdrawal by Subject|1|||
49117445|NCT04202965|158267709|FG000|Overall Study|Adverse Event|3|||
49117446|NCT04202965|158267709|FG000|Overall Study|Did not meet inclusion criteria|1|||
49117447|NCT00618826|158267710|FG000|Overall Study|Adverse Event|1|||
49117448|NCT02714036|158267713|FG000|Overall Study|Adverse Event|9|||
49117449|NCT02714036|158267714|FG001|Overall Study|Adverse Event|2|||
49117450|NCT02714036|158267713|FG000|Overall Study|Withdrawal by Subject|3|||
48700839|NCT00129402|156753308|FG001|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
48700840|NCT00129402|156753309|FG002|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
48700841|NCT00129402|156753310|FG003|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
48700842|NCT00129402|156753311|FG004|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
48856276|NCT04803734|157312807|FG000|Overall Study|Protocol Violation|0|||
48856277|NCT04803734|157312808|FG001|Overall Study|Protocol Violation|1|||
48856278|NCT01005602|157312809|FG000|Overall Study|Excluded due to unreliable clinical data|1|||
48856279|NCT01005602|157312810|FG001|Overall Study|Excluded due to unreliable clinical data|0|||
49117451|NCT02714036|158267714|FG001|Overall Study|Withdrawal by Subject|2|||
49117452|NCT01882803|158267716|FG000|Overall Study|Disease Progression|1|||
49117453|NCT01882803|158267716|FG000|Overall Study|Withdrawal by Subject|9|||
49117454|NCT01882803|158267716|FG000|Overall Study|Death|68|||
49117455|NCT01882803|158267716|FG000|Overall Study|Physician Decision|3|||
49117456|NCT01882803|158267716|FG000|Overall Study|Lost to Follow-up|3|||
49117457|NCT01882803|158267716|FG000|Overall Study|Follow-up Completed|39|||
48700843|NCT00129402|156753312|FG005|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
48700844|NCT00129402|156753313|FG006|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
48700845|NCT00129402|156753307|FG000|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
48700846|NCT00129402|156753308|FG001|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
49117458|NCT01882803|158267716|FG000|Overall Study|Study Terminated by the Sponsor|6|||
48700847|NCT00129402|156753309|FG002|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
49117459|NCT00321906|158267717|FG000|Overall Study|Adverse Event|36|||
49117460|NCT00321906|158267718|FG001|Overall Study|Adverse Event|44|||
48700848|NCT00129402|156753310|FG003|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
48700849|NCT00129402|156753311|FG004|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
48700850|NCT00129402|156753312|FG005|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
48700851|NCT00129402|156753313|FG006|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1|||
48700852|NCT00129402|156753307|FG000|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
48700853|NCT00129402|156753308|FG001|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
48700854|NCT00129402|156753309|FG002|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
48700855|NCT00129402|156753310|FG003|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
48700856|NCT00129402|156753311|FG004|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
48700857|NCT00129402|156753312|FG005|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
48700858|NCT00129402|156753313|FG006|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3|||
48700859|NCT00129402|156753307|FG000|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
48700860|NCT00129402|156753308|FG001|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
48700861|NCT00129402|156753309|FG002|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
48700862|NCT00129402|156753310|FG003|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
48700863|NCT00129402|156753311|FG004|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
48700864|NCT00129402|156753312|FG005|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
49117461|NCT00321906|158267717|FG000|Overall Study|Death|9|||
49117462|NCT00321906|158267718|FG001|Overall Study|Death|6|||
49117463|NCT00321906|158267717|FG000|Overall Study|Lost to Follow-up|1|||
49117464|NCT00321906|158267718|FG001|Overall Study|Lost to Follow-up|2|||
49117465|NCT00321906|158267717|FG000|Overall Study|Withdrawal by Subject|0|||
49117466|NCT00321906|158267718|FG001|Overall Study|Withdrawal by Subject|4|||
49117467|NCT03743025|158267721|FG000|Overall Study|Surgery was cancelled|2|||
49117468|NCT03743025|158267722|FG001|Overall Study|Surgery was cancelled|1|||
49117469|NCT00996034|158267725|FG000|Overall Study|Lost to Follow-up|2|||
49117470|NCT00996034|158267725|FG000|Overall Study|withdrawn by PI|1|||
49117471|NCT02105285|158267726|FG000|Overall Study|Adverse Event|1|||
49117472|NCT02105285|158267727|FG001|Overall Study|Adverse Event|1|||
49117473|NCT02105285|158267728|FG002|Overall Study|Adverse Event|0|||
49117474|NCT02105285|158267726|FG000|Overall Study|Protocol Violation|0|||
49117475|NCT02105285|158267727|FG001|Overall Study|Protocol Violation|1|||
49117476|NCT02105285|158267728|FG002|Overall Study|Protocol Violation|0|||
49117477|NCT02105285|158267726|FG000|Overall Study|Withdrawal by Subject|1|||
49117478|NCT02105285|158267727|FG001|Overall Study|Withdrawal by Subject|0|||
49117479|NCT02105285|158267728|FG002|Overall Study|Withdrawal by Subject|0|||
49117480|NCT00685360|158267729|FG000|Overall Study|Lost to Follow-up|0|||
49117481|NCT00685360|158267730|FG001|Overall Study|Lost to Follow-up|1|||
49117482|NCT00685360|158267731|FG002|Overall Study|Lost to Follow-up|2|||
49117483|NCT00685360|158267729|FG000|Overall Study|Adverse Event|4|||
49117484|NCT00685360|158267730|FG001|Overall Study|Adverse Event|6|||
49117485|NCT00685360|158267731|FG002|Overall Study|Adverse Event|4|||
49117486|NCT00685360|158267729|FG000|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|1|||
49117487|NCT00685360|158267730|FG001|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|0|||
49117488|NCT00685360|158267731|FG002|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|2|||
49117489|NCT00685360|158267729|FG000|Overall Study|Subject was Withdrawn From Participation by the Investigator|0|||
49117490|NCT00685360|158267730|FG001|Overall Study|Subject was Withdrawn From Participation by the Investigator|4|||
49117491|NCT00685360|158267731|FG002|Overall Study|Subject was Withdrawn From Participation by the Investigator|1|||
49117492|NCT00685360|158267729|FG000|Overall Study|Subject Withdrew Consent to Participate|13|||
49117493|NCT00685360|158267730|FG001|Overall Study|Subject Withdrew Consent to Participate|2|||
49117494|NCT00685360|158267731|FG002|Overall Study|Subject Withdrew Consent to Participate|5|||
49117495|NCT00685360|158267729|FG000|Overall Study|Protocol Deviation|0|||
49117496|NCT00685360|158267730|FG001|Overall Study|Protocol Deviation|1|||
49117497|NCT00685360|158267731|FG002|Overall Study|Protocol Deviation|1|||
49117498|NCT01223937|158267732|FG000|Overall Study|Withdrawal by Subject|3|||
49117499|NCT01223937|158267733|FG001|Overall Study|Withdrawal by Subject|2|||
49117500|NCT01223937|158267732|FG000|Overall Study|Lost to Follow-up|1|||
49117501|NCT01223937|158267733|FG001|Overall Study|Lost to Follow-up|4|||
49117502|NCT01223937|158267732|FG000|Overall Study|Adverse Event|1|||
49117503|NCT01223937|158267733|FG001|Overall Study|Adverse Event|4|||
49117504|NCT01223937|158267732|FG000|Overall Study|Protocol Violation|8|||
49117505|NCT01223937|158267733|FG001|Overall Study|Protocol Violation|7|||
49117506|NCT01223937|158267732|FG000|Overall Study|Other|4|||
49117507|NCT01223937|158267733|FG001|Overall Study|Other|1|||
49117508|NCT00547157|158267739|FG000|Overall Study|Other|1|||
49117509|NCT00547157|158267740|FG001|Overall Study|Other|0|||
49117510|NCT00547157|158267739|FG000|Overall Study|Death|38|||
49117511|NCT00547157|158267740|FG001|Overall Study|Death|18|||
49117512|NCT00547157|158267739|FG000|Overall Study|Withdrawal by Subject|3|||
49117513|NCT00547157|158267740|FG001|Overall Study|Withdrawal by Subject|1|||
49117514|NCT00547157|158267739|FG000|Overall Study|Administrative decision|3|||
49117515|NCT00547157|158267740|FG001|Overall Study|Administrative decision|2|||
49117516|NCT00547157|158267739|FG000|Overall Study|Lost to Follow-up|4|||
49117517|NCT00547157|158267740|FG001|Overall Study|Lost to Follow-up|2|||
49117518|NCT00549549|158267741|FG000|Overall Study|Adverse Event|5|||
49117519|NCT00549549|158267742|FG001|Overall Study|Adverse Event|3|||
49117520|NCT00549549|158267743|FG002|Overall Study|Adverse Event|1|||
49117521|NCT00549549|158267744|FG003|Overall Study|Adverse Event|9|||
49117522|NCT00549549|158267741|FG000|Overall Study|Lack of Efficacy|9|||
49117523|NCT00549549|158267742|FG001|Overall Study|Lack of Efficacy|6|||
49117524|NCT00549549|158267743|FG002|Overall Study|Lack of Efficacy|4|||
49117525|NCT00549549|158267744|FG003|Overall Study|Lack of Efficacy|2|||
49117526|NCT00549549|158267741|FG000|Overall Study|Lost to Follow-up|1|||
49117527|NCT00549549|158267742|FG001|Overall Study|Lost to Follow-up|0|||
49117528|NCT00549549|158267743|FG002|Overall Study|Lost to Follow-up|1|||
49117529|NCT00549549|158267744|FG003|Overall Study|Lost to Follow-up|2|||
49117530|NCT00549549|158267741|FG000|Overall Study|Withdrawal by Subject|0|||
49117531|NCT00549549|158267742|FG001|Overall Study|Withdrawal by Subject|4|||
49117532|NCT00549549|158267743|FG002|Overall Study|Withdrawal by Subject|1|||
49117533|NCT00549549|158267744|FG003|Overall Study|Withdrawal by Subject|0|||
49117534|NCT00549549|158267741|FG000|Overall Study|Other|9|||
49117535|NCT00549549|158267742|FG001|Overall Study|Other|9|||
49117536|NCT00549549|158267743|FG002|Overall Study|Other|9|||
49117537|NCT00549549|158267744|FG003|Overall Study|Other|11|||
49117538|NCT00549549|158267741|FG000|Overall Study|Randomized but not treated|0|||
49117539|NCT00549549|158267742|FG001|Overall Study|Randomized but not treated|0|||
49117540|NCT00549549|158267743|FG002|Overall Study|Randomized but not treated|1|||
49117541|NCT00549549|158267744|FG003|Overall Study|Randomized but not treated|1|||
49117542|NCT00420628|158267746|FG000|Overall Study|Withdrawn by parent or gaurdian|5|||
49117543|NCT00420628|158267747|FG001|Overall Study|Withdrawn by parent or gaurdian|2|||
49117544|NCT00420628|158267746|FG000|Overall Study|Lost to Follow-up|3|||
49117545|NCT00420628|158267747|FG001|Overall Study|Lost to Follow-up|2|||
49117546|NCT00420628|158267746|FG000|Overall Study|Adverse Event|1|||
49117547|NCT00420628|158267747|FG001|Overall Study|Adverse Event|0|||
48700865|NCT00129402|156753313|FG006|Start Period3 to End Period3(Week 34-53)|Subject moved|1|||
48700866|NCT00129402|156753307|FG000|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
48700867|NCT00129402|156753308|FG001|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
48700868|NCT00129402|156753309|FG002|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
48700869|NCT00129402|156753310|FG003|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
48700870|NCT00129402|156753311|FG004|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
48700871|NCT00129402|156753312|FG005|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
48700872|NCT00129402|156753313|FG006|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1|||
48700873|NCT03331315|156753314|FG000|Overall Study|Physician Decision|18|||
48700874|NCT03331315|156753315|FG001|Overall Study|Physician Decision|14|||
48700875|NCT01709721|156753316|FG000|Open Label Phase|Withdrawal by Subject|0|||
49117548|NCT00672633|158267757|FG000|Overall Study|Withdrawal by Subject|0|||
49117549|NCT00672633|158267758|FG001|Overall Study|Withdrawal by Subject|1|||
49117550|NCT02499120|158267759|FG000|Overall Study|Death|52|||
49117551|NCT02499120|158267760|FG001|Overall Study|Death|43|||
49117552|NCT02499120|158267759|FG000|Overall Study|Lost to Follow-up|1|||
49117553|NCT02499120|158267760|FG001|Overall Study|Lost to Follow-up|2|||
49117554|NCT02499120|158267759|FG000|Overall Study|Participant refused further follow-up|1|||
49117555|NCT02499120|158267760|FG001|Overall Study|Participant refused further follow-up|0|||
48700876|NCT01709721|156753317|FG001|Open Label Phase|Withdrawal by Subject|0|||
48700877|NCT01709721|156753318|FG002|Open Label Phase|Withdrawal by Subject|5|||
48700878|NCT01709721|156753316|FG000|Open Label Phase|Adverse Event|0|||
48700879|NCT01709721|156753317|FG001|Open Label Phase|Adverse Event|0|||
48700880|NCT01709721|156753318|FG002|Open Label Phase|Adverse Event|8|||
48700881|NCT01709721|156753316|FG000|Open Label Phase|Non-compliance With Study Drug|0|||
48700882|NCT01709721|156753317|FG001|Open Label Phase|Non-compliance With Study Drug|0|||
48700883|NCT01709721|156753318|FG002|Open Label Phase|Non-compliance With Study Drug|3|||
48700884|NCT01709721|156753316|FG000|Open Label Phase|Investigator Decision|0|||
48700885|NCT01709721|156753317|FG001|Open Label Phase|Investigator Decision|0|||
48700886|NCT01709721|156753318|FG002|Open Label Phase|Investigator Decision|1|||
48700887|NCT01709721|156753316|FG000|Open Label Phase|Sponsor Decision|0|||
48700888|NCT01709721|156753317|FG001|Open Label Phase|Sponsor Decision|0|||
48700889|NCT01709721|156753318|FG002|Open Label Phase|Sponsor Decision|2|||
49117556|NCT02499120|158267759|FG000|Overall Study|Withdrawal by Subject|2|||
49117557|NCT02499120|158267760|FG001|Overall Study|Withdrawal by Subject|5|||
49117558|NCT02499120|158267759|FG000|Overall Study|Other|9|||
49117559|NCT02499120|158267760|FG001|Overall Study|Other|10|||
49117560|NCT01429298|158267763|FG000|Overall Study|Protocol Violation|4|||
49117561|NCT01429298|158267764|FG001|Overall Study|Protocol Violation|6|||
49117562|NCT04235504|158267768|FG000|Study Phase|Withdrawal by Subject|5|||
49117563|NCT04235504|158267769|FG001|Study Phase|Withdrawal by Subject|2|||
49117564|NCT04235504|158267770|FG002|Study Phase|Withdrawal by Subject|0|||
49117565|NCT04235504|158267771|FG003|Study Phase|Withdrawal by Subject|0|||
48700890|NCT01709721|156753316|FG000|Open Label Phase|Protocol Violation|0|||
49117566|NCT04235504|158267768|FG000|Continuation Phase|Withdrawal by Subject|0|||
49117567|NCT04235504|158267769|FG001|Continuation Phase|Withdrawal by Subject|4|||
49117568|NCT04235504|158267770|FG002|Continuation Phase|Withdrawal by Subject|0|||
49117569|NCT04235504|158267771|FG003|Continuation Phase|Withdrawal by Subject|0|||
48700891|NCT01709721|156753317|FG001|Open Label Phase|Protocol Violation|0|||
48700892|NCT01709721|156753318|FG002|Open Label Phase|Protocol Violation|1|||
49117570|NCT04235504|158267768|FG000|Continuation Phase|Adverse Event|0|||
49117571|NCT04235504|158267769|FG001|Continuation Phase|Adverse Event|1|||
49117572|NCT04235504|158267770|FG002|Continuation Phase|Adverse Event|0|||
49117573|NCT04235504|158267771|FG003|Continuation Phase|Adverse Event|0|||
49117574|NCT04235504|158267768|FG000|Continuation Phase|Physician Decision|1|||
49117575|NCT04235504|158267769|FG001|Continuation Phase|Physician Decision|2|||
49117576|NCT04235504|158267770|FG002|Continuation Phase|Physician Decision|1|||
49117577|NCT04235504|158267771|FG003|Continuation Phase|Physician Decision|0|||
49117578|NCT05404711|158267772|FG000|Completed Study Visit|Withdrawal by Subject|1|||
49117579|NCT05404711|158267772|FG000|Completed 75-gram, 2-hour CGM-OGTT|Incomplete due to illness|1|||
49117580|NCT05404711|158267772|FG000|Completed 75-gram, 2-hour CGM-OGTT|CGM fell off early|3|||
49117581|NCT05404711|158267772|FG000|Valid 75-gram, 2-hour CGM-OGTT|No date/time recorded|4|||
49117582|NCT05404711|158267772|FG000|Valid 75-gram, 2-hour CGM-OGTT|Vomited after drinking glucose beverage at home|1|||
49117583|NCT05404711|158267772|FG000|Completed, Valid Lab-OGTT and CGM-OGTT|Incomplete glucose beverage for lab-OGTT|1|||
49117584|NCT01121263|158267775|FG000|Overall Study|Death|3|||
49117585|NCT01121263|158267776|FG001|Overall Study|Death|2|||
49117586|NCT01121263|158267775|FG000|Overall Study|Lost to Follow-up|22|||
49117587|NCT01121263|158267776|FG001|Overall Study|Lost to Follow-up|12|||
49117588|NCT01121263|158267775|FG000|Overall Study|Withdrawal by Subject|0|||
49117589|NCT01121263|158267776|FG001|Overall Study|Withdrawal by Subject|1|||
49117590|NCT03859648|158269420|FG000|Overall Study|Lost to Follow-up|1|||
49117591|NCT03859648|158269420|FG000|Overall Study|Adverse Event|1|||
48700893|NCT01709721|156753316|FG000|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
49117592|NCT03026283|158269421|FG000|CCTA Diagnosis|CCTA not performed as planned|9|||
49117593|NCT03026283|158269422|FG001|CCTA Diagnosis|CCTA not performed as planned|0|||
49117594|NCT03026283|158269423|FG002|CCTA Diagnosis|CCTA not performed as planned|0|||
49117595|NCT03026283|158269424|FG003|CCTA Diagnosis|CCTA not performed as planned|0|||
49117596|NCT03026283|158269425|FG004|CCTA Diagnosis|CCTA not performed as planned|0|||
49117597|NCT03026283|158269426|FG005|CCTA Diagnosis|CCTA not performed as planned|0|||
49117598|NCT03026283|158269427|FG006|CCTA Diagnosis|CCTA not performed as planned|0|||
49117599|NCT03026283|158269428|FG007|CCTA Diagnosis|CCTA not performed as planned|0|||
49117600|NCT03026283|158269421|FG000|CCTA Diagnosis|Withdrawal by Subject|5|||
49117601|NCT03026283|158269422|FG001|CCTA Diagnosis|Withdrawal by Subject|0|||
49117602|NCT03026283|158269423|FG002|CCTA Diagnosis|Withdrawal by Subject|0|||
49117603|NCT03026283|158269424|FG003|CCTA Diagnosis|Withdrawal by Subject|0|||
49117604|NCT03026283|158269425|FG004|CCTA Diagnosis|Withdrawal by Subject|0|||
49117605|NCT03026283|158269426|FG005|CCTA Diagnosis|Withdrawal by Subject|0|||
49117606|NCT03026283|158269427|FG006|CCTA Diagnosis|Withdrawal by Subject|0|||
49117607|NCT03026283|158269428|FG007|CCTA Diagnosis|Withdrawal by Subject|0|||
49117608|NCT03026283|158269421|FG000|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
49117609|NCT03026283|158269422|FG001|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3|||
49117610|NCT03026283|158269423|FG002|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
49117611|NCT03026283|158269424|FG003|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
49117612|NCT03026283|158269425|FG004|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
49117613|NCT03026283|158269426|FG005|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
49117614|NCT03026283|158269427|FG006|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
49117615|NCT03026283|158269428|FG007|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
49117616|NCT03026283|158269421|FG000|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
49117617|NCT03026283|158269422|FG001|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
49117618|NCT03026283|158269423|FG002|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15|||
49117619|NCT03026283|158269424|FG003|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
48700894|NCT01709721|156753317|FG001|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
48700895|NCT01709721|156753318|FG002|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1|||
48700896|NCT01709721|156753316|FG000|Open Label Phase|Inadequate Pain Control|0|||
48700897|NCT01709721|156753317|FG001|Open Label Phase|Inadequate Pain Control|0|||
48700898|NCT01709721|156753318|FG002|Open Label Phase|Inadequate Pain Control|37|||
48700899|NCT01709721|156753316|FG000|Open Label Phase|Other, Specify in text field in database|0|||
48700900|NCT01709721|156753317|FG001|Open Label Phase|Other, Specify in text field in database|0|||
48700901|NCT01709721|156753318|FG002|Open Label Phase|Other, Specify in text field in database|14|||
48700902|NCT01709721|156753316|FG000|Randomized Phase|Adverse Event|0|||
48700903|NCT01709721|156753317|FG001|Randomized Phase|Adverse Event|1|||
48700904|NCT01709721|156753318|FG002|Randomized Phase|Adverse Event|0|||
48700905|NCT01709721|156753316|FG000|Randomized Phase|Lost to Follow-up|1|||
48700906|NCT01709721|156753317|FG001|Randomized Phase|Lost to Follow-up|0|||
48700907|NCT01709721|156753318|FG002|Randomized Phase|Lost to Follow-up|0|||
48700908|NCT01709721|156753316|FG000|Randomized Phase|Inadequate Pain Control|1|||
48700909|NCT01709721|156753317|FG001|Randomized Phase|Inadequate Pain Control|2|||
48700910|NCT01709721|156753318|FG002|Randomized Phase|Inadequate Pain Control|0|||
48700911|NCT01709721|156753316|FG000|Randomized Phase|Other, Specify text field in database|1|||
48700912|NCT01709721|156753317|FG001|Randomized Phase|Other, Specify text field in database|3|||
48700913|NCT01709721|156753318|FG002|Randomized Phase|Other, Specify text field in database|0|||
48700914|NCT00656513|156753321|FG000|Overall Study|Protocol Violation|1|||
48700915|NCT00656513|156753322|FG001|Overall Study|Protocol Violation|0|||
48700916|NCT00656513|156753323|FG002|Overall Study|Protocol Violation|2|||
48700917|NCT00656513|156753321|FG000|Overall Study|Withdrawal by Subject|0|||
48700918|NCT00656513|156753322|FG001|Overall Study|Withdrawal by Subject|11|||
48700919|NCT00656513|156753323|FG002|Overall Study|Withdrawal by Subject|4|||
48700920|NCT00656513|156753321|FG000|Overall Study|Death|0|||
48700921|NCT00656513|156753322|FG001|Overall Study|Death|0|||
48700922|NCT00656513|156753323|FG002|Overall Study|Death|1|||
48700923|NCT00656513|156753321|FG000|Overall Study|Missing data|0|||
48700924|NCT00656513|156753322|FG001|Overall Study|Missing data|11|||
48700925|NCT00656513|156753323|FG002|Overall Study|Missing data|9|||
48700926|NCT00656513|156753321|FG000|Overall Study|Incomplete treatment|3|||
48700927|NCT00656513|156753322|FG001|Overall Study|Incomplete treatment|0|||
48700928|NCT00656513|156753323|FG002|Overall Study|Incomplete treatment|0|||
48700929|NCT00656513|156753321|FG000|Overall Study|Treatment completed outside of timeframe|0|||
48700930|NCT00656513|156753322|FG001|Overall Study|Treatment completed outside of timeframe|3|||
48700931|NCT00656513|156753323|FG002|Overall Study|Treatment completed outside of timeframe|1|||
48700932|NCT00656513|156753321|FG000|Overall Study|Missing baseline form|0|||
48700933|NCT00656513|156753322|FG001|Overall Study|Missing baseline form|5|||
48700934|NCT00656513|156753323|FG002|Overall Study|Missing baseline form|5|||
48700935|NCT03044106|156753324|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
48700936|NCT03044106|156753325|FG001|Washout (1 Week)|Withdrawal by Subject|2|||
48700937|NCT01748292|156753326|FG000|Overall Study|Adverse Event|2|||
48700938|NCT01748292|156753327|FG001|Overall Study|Adverse Event|4|||
48700939|NCT01748292|156753326|FG000|Overall Study|Lost to Follow-up|0|||
48700940|NCT01748292|156753327|FG001|Overall Study|Lost to Follow-up|3|||
48700941|NCT01748292|156753326|FG000|Overall Study|Death|0|||
48700942|NCT01748292|156753327|FG001|Overall Study|Death|3|||
48700943|NCT01748292|156753326|FG000|Overall Study|Withdrawal by Subject|0|||
48700944|NCT01748292|156753327|FG001|Overall Study|Withdrawal by Subject|2|||
48700945|NCT01527370|156753328|FG000|Overall Study|Withdrawal by Subject|4|||
48700946|NCT01527370|156753328|FG000|Overall Study|Physician Decision|1|||
48700947|NCT01527370|156753328|FG000|Overall Study|Death|1|||
48700948|NCT05058365|156753331|FG000|Overall Study|Migration|1|||
48700949|NCT05058365|156753332|FG001|Overall Study|Migration|1|||
48700950|NCT02340026|156753333|FG000|Treatment Phase|Withdrawal by Subject|2|||
48700951|NCT02340026|156753334|FG001|Treatment Phase|Withdrawal by Subject|2|||
48700952|NCT02340026|156753333|FG000|Follow-up Phase|Lost to Follow-up|1|||
48700953|NCT02340026|156753334|FG001|Follow-up Phase|Lost to Follow-up|0|||
48700954|NCT01436149|156753337|FG000|Antidepressant Lead-in Phase|Adverse Event|39|||
48700955|NCT01436149|156753338|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
48700956|NCT01436149|156753339|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
49117620|NCT03026283|158269425|FG004|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
49117621|NCT03026283|158269426|FG005|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
49117622|NCT03026283|158269427|FG006|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
49117623|NCT03026283|158269428|FG007|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
49117624|NCT03026283|158269421|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
49117625|NCT03026283|158269422|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
49117626|NCT03026283|158269423|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
49117627|NCT03026283|158269424|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8|||
48700957|NCT01436149|156753337|FG000|Antidepressant Lead-in Phase|Protocol Violation|29|||
48700958|NCT01436149|156753338|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
48700959|NCT01436149|156753339|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
48700960|NCT01436149|156753337|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|61|||
48700961|NCT01436149|156753338|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
48700962|NCT01436149|156753339|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
48700963|NCT01436149|156753337|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|96|||
48700964|NCT01436149|156753338|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
48700965|NCT01436149|156753339|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
48700966|NCT01436149|156753337|FG000|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22|||
48700967|NCT01436149|156753338|FG001|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
48700968|NCT01436149|156753339|FG002|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
48700969|NCT01436149|156753337|FG000|Antidepressant Lead-in Phase|Other|119|||
48700970|NCT01436149|156753338|FG001|Antidepressant Lead-in Phase|Other|0|||
49117628|NCT03026283|158269425|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11|||
49117629|NCT03026283|158269426|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
49117630|NCT03026283|158269427|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
49117631|NCT03026283|158269428|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
49117632|NCT03026283|158269421|FG000|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
49117633|NCT03026283|158269422|FG001|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
49117634|NCT03026283|158269423|FG002|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
49117635|NCT03026283|158269424|FG003|Optimal Care/Stress Test/ICA|Lost to Follow-up|9|||
49117636|NCT03026283|158269425|FG004|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
49117637|NCT03026283|158269426|FG005|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
49117638|NCT03026283|158269427|FG006|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
49117639|NCT03026283|158269428|FG007|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
49117640|NCT03026283|158269421|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
49117641|NCT03026283|158269422|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
49117642|NCT03026283|158269423|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
49117643|NCT03026283|158269424|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2|||
49117644|NCT03026283|158269425|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
49117645|NCT03026283|158269426|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7|||
49117646|NCT03026283|158269427|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
49117647|NCT03026283|158269428|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
49117648|NCT03026283|158269421|FG000|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
49117649|NCT03026283|158269422|FG001|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
49117650|NCT03026283|158269423|FG002|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
49117651|NCT03026283|158269424|FG003|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1|||
49117652|NCT03026283|158269425|FG004|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
49117653|NCT03026283|158269426|FG005|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
49117654|NCT03026283|158269427|FG006|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
49117655|NCT03026283|158269428|FG007|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
49117656|NCT03026283|158269421|FG000|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
49117657|NCT03026283|158269422|FG001|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
49117658|NCT03026283|158269423|FG002|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
49117659|NCT03026283|158269424|FG003|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
49117660|NCT03026283|158269425|FG004|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25|||
49117661|NCT03026283|158269426|FG005|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19|||
49117662|NCT03026283|158269427|FG006|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
49117663|NCT03026283|158269428|FG007|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
49117664|NCT00391872|158269441|FG000|Overall Study|Protocol Violation|7|||
49117665|NCT00391872|158269442|FG001|Overall Study|Protocol Violation|2|||
48700971|NCT01436149|156753339|FG002|Antidepressant Lead-in Phase|Other|0|||
48700972|NCT01436149|156753337|FG000|Randomized Phase|Adverse Event|9|||
48700973|NCT01436149|156753338|FG001|Randomized Phase|Adverse Event|10|||
48700974|NCT01436149|156753339|FG002|Randomized Phase|Adverse Event|11|||
48700975|NCT01436149|156753337|FG000|Randomized Phase|Protocol Violation|4|||
48700976|NCT01436149|156753338|FG001|Randomized Phase|Protocol Violation|5|||
48700977|NCT01436149|156753339|FG002|Randomized Phase|Protocol Violation|0|||
48700978|NCT01436149|156753337|FG000|Randomized Phase|Withdrawal by Subject|16|||
48700979|NCT01436149|156753338|FG001|Randomized Phase|Withdrawal by Subject|10|||
48700980|NCT01436149|156753339|FG002|Randomized Phase|Withdrawal by Subject|10|||
48700981|NCT01436149|156753337|FG000|Randomized Phase|Lost to Follow-up|34|||
48700982|NCT01436149|156753338|FG001|Randomized Phase|Lost to Follow-up|5|||
48700983|NCT01436149|156753339|FG002|Randomized Phase|Lost to Follow-up|6|||
48700984|NCT01436149|156753337|FG000|Randomized Phase|Lack of Efficacy|0|||
48700985|NCT01436149|156753338|FG001|Randomized Phase|Lack of Efficacy|0|||
48912254|NCT01830855|157516176|FG002|Overall Study|No longer willing to participate|12|||
49010611|NCT01200394|157875661|FG001|Overall Study|Did Not Meet Entrance Criteria|4|||
48700986|NCT01436149|156753339|FG002|Randomized Phase|Lack of Efficacy|1|||
48700987|NCT01436149|156753337|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
48700988|NCT01436149|156753338|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
48700989|NCT01436149|156753339|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
48700990|NCT01436149|156753337|FG000|Randomized Phase|Other|12|||
48700991|NCT01436149|156753338|FG001|Randomized Phase|Other|5|||
48700992|NCT01436149|156753339|FG002|Randomized Phase|Other|11|||
48700993|NCT03279081|156753354|FG000|Overall Study|Withdrawal by Subject|12|||
48700994|NCT03279081|156753355|FG001|Overall Study|Withdrawal by Subject|20|||
48700995|NCT03279081|156753354|FG000|Overall Study|Physician Decision|4|||
48912255|NCT01830855|157516177|FG003|Overall Study|No longer willing to participate|17|||
48700996|NCT03279081|156753355|FG001|Overall Study|Physician Decision|1|||
48700997|NCT03279081|156753354|FG000|Overall Study|Lost to Follow-up|8|||
48700998|NCT03279081|156753355|FG001|Overall Study|Lost to Follow-up|8|||
48700999|NCT03279081|156753354|FG000|Overall Study|Death|0|||
48912256|NCT01830855|157516174|FG000|Overall Study|Lost to Follow-up|47|||
48912257|NCT01830855|157516175|FG001|Overall Study|Lost to Follow-up|20|||
49117666|NCT00391872|158269441|FG000|Overall Study|Withdrawal by Subject|296|||
49117667|NCT00391872|158269442|FG001|Overall Study|Withdrawal by Subject|249|||
49117668|NCT00391872|158269441|FG000|Overall Study|Reason unknown|2|||
49117669|NCT00391872|158269442|FG001|Overall Study|Reason unknown|4|||
49117670|NCT00391872|158269441|FG000|Overall Study|Lost to Follow-up|2|||
49117671|NCT00391872|158269442|FG001|Overall Study|Lost to Follow-up|0|||
49117672|NCT01465230|158269447|FG000|Overall Study|Withdrawal by Subject|2|||
49117673|NCT00905567|158269448|FG000|Washout|Withdrawal by Subject|0|||
49117674|NCT00905567|158269449|FG001|Washout|Withdrawal by Subject|1|||
49117675|NCT03084302|158269453|FG000|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9|||
49117676|NCT03084302|158269453|FG000|Overall Study|No valid objective monitor data|6|||
49117677|NCT00621257|158269454|FG000|Overall Study|Lost to Follow-up|4|||
49117678|NCT00621257|158269455|FG001|Overall Study|Lost to Follow-up|0|||
49117679|NCT00621257|158269456|FG002|Overall Study|Lost to Follow-up|2|||
49117680|NCT00621257|158269457|FG003|Overall Study|Lost to Follow-up|4|||
49117681|NCT00621257|158269458|FG004|Overall Study|Lost to Follow-up|7|||
49117682|NCT00621257|158269454|FG000|Overall Study|Adverse Event|0|||
49117683|NCT00621257|158269455|FG001|Overall Study|Adverse Event|1|||
49117684|NCT00621257|158269456|FG002|Overall Study|Adverse Event|1|||
49117685|NCT00621257|158269457|FG003|Overall Study|Adverse Event|0|||
49117686|NCT00621257|158269458|FG004|Overall Study|Adverse Event|0|||
49117687|NCT00621257|158269454|FG000|Overall Study|Physician Decision|0|||
49117688|NCT00621257|158269455|FG001|Overall Study|Physician Decision|2|||
49117689|NCT00621257|158269456|FG002|Overall Study|Physician Decision|0|||
49117690|NCT00621257|158269457|FG003|Overall Study|Physician Decision|1|||
49117691|NCT00621257|158269458|FG004|Overall Study|Physician Decision|1|||
49117692|NCT00621257|158269454|FG000|Overall Study|Withdrawal by Subject|0|||
49117693|NCT00621257|158269455|FG001|Overall Study|Withdrawal by Subject|0|||
49117694|NCT00621257|158269456|FG002|Overall Study|Withdrawal by Subject|0|||
49117695|NCT00621257|158269457|FG003|Overall Study|Withdrawal by Subject|1|||
49117696|NCT00621257|158269458|FG004|Overall Study|Withdrawal by Subject|1|||
49117697|NCT03959527|158269459|FG000|Overall Study|Withdrawal by Subject|8|||
49117698|NCT03959527|158269460|FG001|Overall Study|Withdrawal by Subject|3|||
49117699|NCT03959527|158269459|FG000|Overall Study|Lost to Follow-up|31|||
49117700|NCT03959527|158269460|FG001|Overall Study|Lost to Follow-up|15|||
49117701|NCT03959527|158269459|FG000|Overall Study|Did not meet eligibility criteria|1|||
49117702|NCT03959527|158269460|FG001|Overall Study|Did not meet eligibility criteria|1|||
49117703|NCT03959527|158269459|FG000|Overall Study|Protocol Violation|10|||
49117704|NCT03959527|158269460|FG001|Overall Study|Protocol Violation|5|||
49117705|NCT02072941|158269461|FG000|Overall Study|Withdrawal by Subject|29|||
49117706|NCT02072941|158269462|FG001|Overall Study|Withdrawal by Subject|21|||
49117707|NCT02072941|158269461|FG000|Overall Study|Lost to Follow-up|4|||
49117708|NCT02072941|158269462|FG001|Overall Study|Lost to Follow-up|4|||
49117709|NCT02072941|158269461|FG000|Overall Study|Death|3|||
49117710|NCT02072941|158269462|FG001|Overall Study|Death|2|||
49117711|NCT02072941|158269461|FG000|Overall Study|Removed by Study Staff|2|||
49117712|NCT02072941|158269462|FG001|Overall Study|Removed by Study Staff|2|||
49117713|NCT01254656|158269464|FG000|Overall Study|Discontinued due to termination of study|40|||
49117714|NCT01254656|158269465|FG001|Overall Study|Discontinued due to termination of study|39|||
49117715|NCT01254656|158269466|FG002|Overall Study|Discontinued due to termination of study|13|||
49117716|NCT01254656|158269464|FG000|Overall Study|Lack of Efficacy|3|||
49117717|NCT01254656|158269465|FG001|Overall Study|Lack of Efficacy|0|||
49117718|NCT01254656|158269466|FG002|Overall Study|Lack of Efficacy|0|||
49117719|NCT01254656|158269464|FG000|Overall Study|Lost to Follow-up|1|||
49117720|NCT01254656|158269465|FG001|Overall Study|Lost to Follow-up|0|||
49117721|NCT01254656|158269466|FG002|Overall Study|Lost to Follow-up|2|||
49117722|NCT01254656|158269464|FG000|Overall Study|Withdrawal by Subject|2|||
49117723|NCT01254656|158269465|FG001|Overall Study|Withdrawal by Subject|2|||
49117724|NCT01254656|158269466|FG002|Overall Study|Withdrawal by Subject|1|||
49117725|NCT01254656|158269464|FG000|Overall Study|Pregnancy|0|||
49117726|NCT01254656|158269465|FG001|Overall Study|Pregnancy|0|||
49117727|NCT01254656|158269466|FG002|Overall Study|Pregnancy|2|||
49117728|NCT01254656|158269464|FG000|Overall Study|Adverse Event|1|||
49117729|NCT01254656|158269465|FG001|Overall Study|Adverse Event|1|||
49117730|NCT01254656|158269466|FG002|Overall Study|Adverse Event|0|||
49117731|NCT01254656|158269464|FG000|Overall Study|Death|0|||
49117732|NCT01254656|158269465|FG001|Overall Study|Death|1|||
49117733|NCT01254656|158269466|FG002|Overall Study|Death|0|||
49117734|NCT01540981|158269485|FG000|Overall Study|Withdrawal by Subject|1|||
49117735|NCT01540981|158269486|FG001|Overall Study|Withdrawal by Subject|0|||
48701000|NCT03279081|156753355|FG001|Overall Study|Death|1|||
48701001|NCT03279081|156753354|FG000|Overall Study|Adverse Event|1|||
48701002|NCT03279081|156753355|FG001|Overall Study|Adverse Event|0|||
48701003|NCT03279081|156753354|FG000|Overall Study|Reason not Specified|14|||
48701004|NCT03279081|156753355|FG001|Overall Study|Reason not Specified|4|||
48701005|NCT01283139|156753359|FG000|Overall Study|Lost to Follow-up|5|||
48701006|NCT01283139|156753360|FG001|Overall Study|Lost to Follow-up|2|||
48701007|NCT01283139|156753361|FG002|Overall Study|Lost to Follow-up|3|||
48701008|NCT01283139|156753362|FG003|Overall Study|Lost to Follow-up|1|||
48701009|NCT01283139|156753359|FG000|Overall Study|Withdrawal by Subject|8|||
48701010|NCT01283139|156753360|FG001|Overall Study|Withdrawal by Subject|8|||
48701011|NCT01283139|156753361|FG002|Overall Study|Withdrawal by Subject|6|||
48701012|NCT01283139|156753362|FG003|Overall Study|Withdrawal by Subject|8|||
48701013|NCT01283139|156753359|FG000|Overall Study|Death|2|||
48701014|NCT01283139|156753360|FG001|Overall Study|Death|0|||
48701015|NCT01283139|156753361|FG002|Overall Study|Death|2|||
48701016|NCT01283139|156753362|FG003|Overall Study|Death|2|||
48701017|NCT01283139|156753359|FG000|Overall Study|Lack of Efficacy|1|||
48701018|NCT01283139|156753360|FG001|Overall Study|Lack of Efficacy|2|||
48701019|NCT01283139|156753361|FG002|Overall Study|Lack of Efficacy|2|||
48701020|NCT01283139|156753362|FG003|Overall Study|Lack of Efficacy|1|||
48701021|NCT01283139|156753359|FG000|Overall Study|Early termination due to AE/SAE|1|||
48701022|NCT01283139|156753360|FG001|Overall Study|Early termination due to AE/SAE|1|||
48701023|NCT01283139|156753361|FG002|Overall Study|Early termination due to AE/SAE|0|||
48701024|NCT01283139|156753362|FG003|Overall Study|Early termination due to AE/SAE|0|||
48701025|NCT01283139|156753359|FG000|Overall Study|Participant's refusal to continue|0|||
48701026|NCT01283139|156753360|FG001|Overall Study|Participant's refusal to continue|3|||
48701027|NCT01283139|156753361|FG002|Overall Study|Participant's refusal to continue|1|||
48701028|NCT01283139|156753362|FG003|Overall Study|Participant's refusal to continue|1|||
48701029|NCT01283139|156753359|FG000|Overall Study|Pregnancy|0|||
48701030|NCT01283139|156753360|FG001|Overall Study|Pregnancy|1|||
48701031|NCT01283139|156753361|FG002|Overall Study|Pregnancy|1|||
48701032|NCT01283139|156753362|FG003|Overall Study|Pregnancy|0|||
48701033|NCT01283139|156753359|FG000|Overall Study|Missed follow-up visit|0|||
48701034|NCT01283139|156753360|FG001|Overall Study|Missed follow-up visit|1|||
48701035|NCT01283139|156753361|FG002|Overall Study|Missed follow-up visit|2|||
48701036|NCT01283139|156753362|FG003|Overall Study|Missed follow-up visit|2|||
48701037|NCT01283139|156753359|FG000|Overall Study|Participant randomized in error|0|||
48701038|NCT01283139|156753360|FG001|Overall Study|Participant randomized in error|0|||
48701039|NCT01283139|156753361|FG002|Overall Study|Participant randomized in error|1|||
48701040|NCT01283139|156753362|FG003|Overall Study|Participant randomized in error|0|||
48701041|NCT00307801|156753365|FG000|Overall Study|Adverse Event|12|||
48701042|NCT00307801|156753366|FG001|Overall Study|Adverse Event|4|||
48701043|NCT00307801|156753365|FG000|Overall Study|Withdrawal by Subject|9|||
48701044|NCT00307801|156753366|FG001|Overall Study|Withdrawal by Subject|4|||
48701045|NCT00307801|156753365|FG000|Overall Study|Non-compliance, not taken all tablets|1|||
48701046|NCT00307801|156753366|FG001|Overall Study|Non-compliance, not taken all tablets|2|||
48701047|NCT00307801|156753365|FG000|Overall Study|Adverse event (AE)/Withdrawal of consent|2|||
48701048|NCT00307801|156753366|FG001|Overall Study|Adverse event (AE)/Withdrawal of consent|0|||
48701049|NCT00307801|156753365|FG000|Overall Study|Decreased Libido (AE at discontinuation)|0|||
48701050|NCT00307801|156753366|FG001|Overall Study|Decreased Libido (AE at discontinuation)|1|||
48701051|NCT00307801|156753365|FG000|Overall Study|Wrong Randomization|1|||
48701052|NCT00307801|156753366|FG001|Overall Study|Wrong Randomization|0|||
48701053|NCT00307801|156753365|FG000|Overall Study|Lack of Efficacy|0|||
48701054|NCT00307801|156753366|FG001|Overall Study|Lack of Efficacy|2|||
48701055|NCT00307801|156753365|FG000|Overall Study|Lost to Follow-up, moved abroad|1|||
48701056|NCT00307801|156753366|FG001|Overall Study|Lost to Follow-up, moved abroad|1|||
48701057|NCT00307801|156753365|FG000|Overall Study|Frustration with e-diary|1|||
48701058|NCT00307801|156753366|FG001|Overall Study|Frustration with e-diary|0|||
48701059|NCT00307801|156753365|FG000|Overall Study|Protocol Violation|3|||
48701060|NCT00307801|156753366|FG001|Overall Study|Protocol Violation|2|||
48701061|NCT00307801|156753365|FG000|Overall Study|No reason specified|2|||
48701062|NCT00307801|156753366|FG001|Overall Study|No reason specified|0|||
48701063|NCT00307801|156753365|FG000|Overall Study|Pregnancy|0|||
48701064|NCT00307801|156753366|FG001|Overall Study|Pregnancy|1|||
48701065|NCT03094416|156753371|FG000|Run-in|Screening failure|8|||
48701066|NCT03094416|156753371|FG000|Run-in|Sponsor Decision To Discontinue Due To Global Covid-19 Pandemic|8|||
48701067|NCT03094416|156753371|FG000|Run-in|Withdrawal by Subject|3|||
48701068|NCT03094416|156753371|FG000|Treatment Period|Withdrawal by Subject|2|||
48701069|NCT00926237|156753373|FG000|Overall Study|Withdrawal by Subject|2|||
48701070|NCT00926237|156753374|FG001|Overall Study|Withdrawal by Subject|1|||
48701071|NCT03467750|156753375|FG000|Overall Study|Surgery canceled|1|||
48912258|NCT01830855|157516176|FG002|Overall Study|Lost to Follow-up|23|||
48701072|NCT03467750|156753376|FG001|Overall Study|Surgery canceled|0|||
48701073|NCT03467750|156753375|FG000|Overall Study|Protocol Violation|1|||
48701074|NCT03467750|156753376|FG001|Overall Study|Protocol Violation|1|||
48701075|NCT03467750|156753375|FG000|Overall Study|Withdrawal by Subject|0|||
48701076|NCT03467750|156753376|FG001|Overall Study|Withdrawal by Subject|1|||
48701077|NCT00911170|156753381|FG000|Treatment Period|Randomized in error|1|||
48701078|NCT00911170|156753382|FG001|Treatment Period|Randomized in error|1|||
48701079|NCT00911170|156753381|FG000|Treatment Period|Ineligibility determined|1|||
48701080|NCT00911170|156753382|FG001|Treatment Period|Ineligibility determined|3|||
48701081|NCT00911170|156753381|FG000|Treatment Period|Protocol deviation|1|||
48701082|NCT00911170|156753382|FG001|Treatment Period|Protocol deviation|2|||
48701083|NCT00911170|156753381|FG000|Treatment Period|Adverse Event|9|||
48701084|NCT00911170|156753382|FG001|Treatment Period|Adverse Event|10|||
48701085|NCT00911170|156753381|FG000|Treatment Period|Withdrawal by Subject|4|||
48701086|NCT00911170|156753382|FG001|Treatment Period|Withdrawal by Subject|4|||
48701087|NCT00911170|156753381|FG000|Treatment Period|Disease progression|0|||
48701088|NCT00911170|156753382|FG001|Treatment Period|Disease progression|2|||
48701089|NCT00911170|156753381|FG000|Treatment Period|Physician Decision|5|||
48701090|NCT00911170|156753382|FG001|Treatment Period|Physician Decision|5|||
48912259|NCT01830855|157516177|FG003|Overall Study|Lost to Follow-up|33|||
48912260|NCT00621751|157516180|FG000|Overall Study|Adverse Event|0|||
48912261|NCT00621751|157516181|FG001|Overall Study|Adverse Event|1|||
48912262|NCT00362414|157516182|FG000|Overall Study|Death|2|||
48701091|NCT00911170|156753381|FG000|Treatment Period|Lost to Follow-up|0|||
48701092|NCT00911170|156753382|FG001|Treatment Period|Lost to Follow-up|1|||
48701093|NCT00911170|156753381|FG000|Treatment Period|Death|6|||
48701094|NCT00911170|156753382|FG001|Treatment Period|Death|9|||
48701095|NCT00911170|156753381|FG000|Long Term Follow-Up|Continuing in study|274|||
48701096|NCT00911170|156753382|FG001|Long Term Follow-Up|Continuing in study|269|||
48701097|NCT00911170|156753381|FG000|Long Term Follow-Up|Withdrawal by Subject|20|||
48701098|NCT00911170|156753382|FG001|Long Term Follow-Up|Withdrawal by Subject|21|||
48701099|NCT00911170|156753381|FG000|Long Term Follow-Up|Physician Decision|5|||
48701100|NCT00911170|156753382|FG001|Long Term Follow-Up|Physician Decision|4|||
48701101|NCT00911170|156753381|FG000|Long Term Follow-Up|Lost to Follow-up|8|||
48701102|NCT00911170|156753382|FG001|Long Term Follow-Up|Lost to Follow-up|7|||
49117736|NCT01005901|158269488|FG000|Overall Study|Withdrawal by Subject|38|||
49117737|NCT01005901|158269489|FG001|Overall Study|Withdrawal by Subject|14|||
49117738|NCT01005901|158269488|FG000|Overall Study|Adverse Event|30|||
49117739|NCT01005901|158269489|FG001|Overall Study|Adverse Event|16|||
49117740|NCT01005901|158269488|FG000|Overall Study|Administrative problems|21|||
49117741|NCT01005901|158269489|FG001|Overall Study|Administrative problems|13|||
49117742|NCT01005901|158269488|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
49117743|NCT01005901|158269489|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
49117744|NCT01005901|158269488|FG000|Overall Study|Protocol Violation|4|||
49117745|NCT01005901|158269489|FG001|Overall Study|Protocol Violation|3|||
49117746|NCT01005901|158269488|FG000|Overall Study|Death|2|||
49117747|NCT01005901|158269489|FG001|Overall Study|Death|3|||
49117748|NCT01005901|158269488|FG000|Overall Study|Lost to Follow-up|1|||
49117749|NCT01005901|158269489|FG001|Overall Study|Lost to Follow-up|2|||
49117750|NCT01005901|158269488|FG000|Overall Study|Patient's inability to use the device|1|||
49117751|NCT01005901|158269489|FG001|Overall Study|Patient's inability to use the device|1|||
49117752|NCT01005901|158269488|FG000|Overall Study|No longer requires study drug|0|||
49117753|NCT01005901|158269489|FG001|Overall Study|No longer requires study drug|1|||
49117754|NCT01300247|158269494|FG000|Overall Study|Death|1|||
49117755|NCT01300247|158269495|FG001|Overall Study|Death|1|||
49117756|NCT01300247|158269494|FG000|Overall Study|Lost to Follow-up|2|||
49117757|NCT01300247|158269495|FG001|Overall Study|Lost to Follow-up|0|||
49117758|NCT01300247|158269494|FG000|Overall Study|Withdrawal by Subject|1|||
49117759|NCT01300247|158269495|FG001|Overall Study|Withdrawal by Subject|0|||
49117760|NCT01300247|158269494|FG000|Overall Study|Non-Compliance|0|||
49117761|NCT01300247|158269495|FG001|Overall Study|Non-Compliance|1|||
49117762|NCT02768792|158269496|FG000|Overall Study|Adverse Event|1|||
49117763|NCT03060291|158269497|FG000|3-month Follow-up|Declined to respond|8|||
49117764|NCT03060291|158269498|FG001|3-month Follow-up|Declined to respond|10|||
49117765|NCT03060291|158269499|FG002|3-month Follow-up|Declined to respond|2|||
49117766|NCT03060291|158269497|FG000|6-month Follow-up|Declined to respond|7|||
49117767|NCT03060291|158269498|FG001|6-month Follow-up|Declined to respond|13|||
49117768|NCT03060291|158269499|FG002|6-month Follow-up|Declined to respond|4|||
49117769|NCT03060291|158269497|FG000|12-month Follow-up|Declined to respond|7|||
49117770|NCT03060291|158269498|FG001|12-month Follow-up|Declined to respond|16|||
49117771|NCT03060291|158269499|FG002|12-month Follow-up|Declined to respond|6|||
49117772|NCT03173456|158269502|FG000|Baseline|Medication dispensing system malfunction'|0|||
49117773|NCT03173456|158269503|FG001|Baseline|Medication dispensing system malfunction'|1|||
49117774|NCT03173456|158269504|FG002|Baseline|Medication dispensing system malfunction'|0|||
49117775|NCT03173456|158269505|FG003|Baseline|Medication dispensing system malfunction'|0|||
49117776|NCT03173456|158269506|FG004|Baseline|Medication dispensing system malfunction'|2|||
49117777|NCT03173456|158269502|FG000|2 Hour Follow-up|Withdrawal by Subject|0|||
49117778|NCT03173456|158269503|FG001|2 Hour Follow-up|Withdrawal by Subject|1|||
49117779|NCT03173456|158269504|FG002|2 Hour Follow-up|Withdrawal by Subject|1|||
49117780|NCT03173456|158269505|FG003|2 Hour Follow-up|Withdrawal by Subject|1|||
49117781|NCT03173456|158269506|FG004|2 Hour Follow-up|Withdrawal by Subject|2|||
49117782|NCT03727841|158269512|FG000|Overall Study|Physician Decision|3|||
49117783|NCT03727841|158269513|FG001|Overall Study|Physician Decision|1|||
49117784|NCT04501952|158269519|FG000|Overall Study|Adverse Event|0|||
49117785|NCT04501952|158269520|FG001|Overall Study|Adverse Event|3|||
49117786|NCT04501952|158269519|FG000|Overall Study|Investigator's Discretion|0|||
49117787|NCT04501952|158269520|FG001|Overall Study|Investigator's Discretion|1|||
49117788|NCT04501952|158269519|FG000|Overall Study|Protocol Violation|1|||
49117789|NCT04501952|158269520|FG001|Overall Study|Protocol Violation|1|||
48701103|NCT00911170|156753381|FG000|Long Term Follow-Up|Death|116|||
48701104|NCT00911170|156753382|FG001|Long Term Follow-Up|Death|121|||
48701105|NCT02514083|156753386|FG000|Overall Study|Adverse Event|1|||
48701106|NCT00726063|156755185|FG000|Overall Study|Adverse Event|9|||
48701107|NCT00726063|156755186|FG001|Overall Study|Adverse Event|7|||
48701108|NCT03103542|156755187|FG000|Overall Study|Physician Decision|2|||
48912263|NCT00362414|157516182|FG000|Overall Study|Adverse Event|1|||
48701109|NCT03103542|156755187|FG000|Overall Study|Adverse Event|2|||
48701110|NCT03103542|156755187|FG000|Overall Study|Other|2|||
48701111|NCT03103542|156755187|FG000|Overall Study|Withdrawal by Subject|1|||
48701112|NCT00910650|156755188|FG000|Overall Study|Death|2|||
48912264|NCT02667275|157516183|FG000|Overall Study|Protocol Violation|11|||
48701113|NCT02435992|156755190|FG000|Overall Study|non compliance with protocol|2|||
48701114|NCT02435992|156755191|FG001|Overall Study|non compliance with protocol|0|||
48701115|NCT02435992|156755192|FG002|Overall Study|non compliance with protocol|1|||
48912265|NCT02667275|157516184|FG001|Overall Study|Protocol Violation|7|||
49117790|NCT04501952|158269519|FG000|Overall Study|Withdrew Consent|5|||
49117791|NCT04501952|158269520|FG001|Overall Study|Withdrew Consent|4|||
49117792|NCT04501952|158269519|FG000|Overall Study|Lost to Follow-up|7|||
49117793|NCT04501952|158269520|FG001|Overall Study|Lost to Follow-up|2|||
49117794|NCT04501952|158269519|FG000|Overall Study|Randomized and Never Treated|13|||
49117795|NCT04501952|158269520|FG001|Overall Study|Randomized and Never Treated|9|||
49117796|NCT03061188|158269521|FG000|Went on to Cycle 2 and Beyond|Adverse Event|0|||
49117797|NCT03061188|158269522|FG001|Went on to Cycle 2 and Beyond|Adverse Event|0|||
49117798|NCT03061188|158269523|FG002|Went on to Cycle 2 and Beyond|Adverse Event|1|||
49117799|NCT03061188|158269524|FG003|Went on to Cycle 2 and Beyond|Adverse Event|1|||
49117800|NCT03061188|158269521|FG000|On Follow-up for 3 Years|Death|0|||
49117801|NCT03061188|158269522|FG001|On Follow-up for 3 Years|Death|3|||
49117802|NCT03061188|158269523|FG002|On Follow-up for 3 Years|Death|5|||
49117803|NCT03061188|158269524|FG003|On Follow-up for 3 Years|Death|4|||
49117804|NCT03061188|158269521|FG000|On Follow-up for 3 Years|Withdrawal by Subject|0|||
49117805|NCT03061188|158269522|FG001|On Follow-up for 3 Years|Withdrawal by Subject|0|||
49117806|NCT03061188|158269523|FG002|On Follow-up for 3 Years|Withdrawal by Subject|0|||
49117807|NCT03061188|158269524|FG003|On Follow-up for 3 Years|Withdrawal by Subject|1|||
49117808|NCT05225389|158269530|FG000|Overall Study|Three participants were discontinued by the Investigator on day 7 due to positive COVID-19 tests.|3|||
49117809|NCT01939223|158269531|FG000|Overall Study|AE not assoc. with disease recurrence|1|||
49117810|NCT01939223|158269532|FG001|Overall Study|AE not assoc. with disease recurrence|1|||
48701116|NCT02435992|156755193|FG003|Overall Study|non compliance with protocol|0|||
48701117|NCT02435992|156755194|FG004|Overall Study|non compliance with protocol|0|||
48701118|NCT02435992|156755190|FG000|Overall Study|Adverse Event|11|||
48701119|NCT02435992|156755191|FG001|Overall Study|Adverse Event|6|||
48701120|NCT02435992|156755192|FG002|Overall Study|Adverse Event|12|||
48701121|NCT02435992|156755193|FG003|Overall Study|Adverse Event|0|||
48701122|NCT02435992|156755194|FG004|Overall Study|Adverse Event|0|||
48701123|NCT02435992|156755190|FG000|Overall Study|Lack of Efficacy|4|||
48701124|NCT02435992|156755191|FG001|Overall Study|Lack of Efficacy|10|||
48701125|NCT02435992|156755192|FG002|Overall Study|Lack of Efficacy|9|||
48701126|NCT02435992|156755193|FG003|Overall Study|Lack of Efficacy|0|||
48701127|NCT02435992|156755194|FG004|Overall Study|Lack of Efficacy|0|||
48701128|NCT02435992|156755190|FG000|Overall Study|Withdrawal by Subject|10|||
48701129|NCT02435992|156755191|FG001|Overall Study|Withdrawal by Subject|8|||
48701130|NCT02435992|156755192|FG002|Overall Study|Withdrawal by Subject|20|||
48701131|NCT02435992|156755193|FG003|Overall Study|Withdrawal by Subject|0|||
48701132|NCT02435992|156755194|FG004|Overall Study|Withdrawal by Subject|0|||
48701133|NCT02435992|156755190|FG000|Overall Study|Other Reason|1|||
48701134|NCT02435992|156755191|FG001|Overall Study|Other Reason|0|||
48701135|NCT02435992|156755192|FG002|Overall Study|Other Reason|0|||
48701136|NCT02435992|156755193|FG003|Overall Study|Other Reason|0|||
48701137|NCT02435992|156755194|FG004|Overall Study|Other Reason|0|||
48701138|NCT02435992|156755190|FG000|Overall Study|Physician Decision|0|||
48701139|NCT02435992|156755191|FG001|Overall Study|Physician Decision|0|||
48701140|NCT02435992|156755192|FG002|Overall Study|Physician Decision|1|||
48701141|NCT02435992|156755193|FG003|Overall Study|Physician Decision|0|||
48701142|NCT02435992|156755194|FG004|Overall Study|Physician Decision|0|||
48701143|NCT00423579|156755195|FG000|Overall Study|Lost to Follow-up|3|||
48701144|NCT00423579|156755196|FG001|Overall Study|Lost to Follow-up|0|||
48701145|NCT00423579|156755195|FG000|Overall Study|Protocol Violation|1|||
48701146|NCT00423579|156755196|FG001|Overall Study|Protocol Violation|3|||
48701147|NCT00423579|156755195|FG000|Overall Study|Diagnosis of diabetes|0|||
48701148|NCT00423579|156755196|FG001|Overall Study|Diagnosis of diabetes|1|||
48701149|NCT01761877|156755197|FG000|Overall Study|Adverse Event|7|||
48701150|NCT01761877|156755198|FG001|Overall Study|Adverse Event|0|||
48701151|NCT01761877|156755197|FG000|Overall Study|Withdrawal by Subject|6|||
48701152|NCT01761877|156755198|FG001|Overall Study|Withdrawal by Subject|4|||
48701153|NCT01761877|156755197|FG000|Overall Study|Stopped taking AI Aromatase Inhibitor|1|||
48701154|NCT01761877|156755198|FG001|Overall Study|Stopped taking AI Aromatase Inhibitor|5|||
48701155|NCT01761877|156755197|FG000|Overall Study|Death|0|||
48701156|NCT01761877|156755198|FG001|Overall Study|Death|1|||
48701157|NCT01761877|156755197|FG000|Overall Study|MRI intolerant|1|||
48701158|NCT01761877|156755198|FG001|Overall Study|MRI intolerant|6|||
48701159|NCT03879772|156755199|FG000|Overall Study|Adverse Event|2|||
48701160|NCT03879772|156755200|FG001|Overall Study|Adverse Event|2|||
48701161|NCT03879772|156755201|FG002|Overall Study|Adverse Event|3|||
48701162|NCT03879772|156755202|FG003|Overall Study|Adverse Event|4|||
48701163|NCT03879772|156755203|FG004|Overall Study|Adverse Event|3|||
48701164|NCT03879772|156755199|FG000|Overall Study|Treatment Failure|1|||
48701165|NCT03879772|156755200|FG001|Overall Study|Treatment Failure|0|||
48701166|NCT03879772|156755201|FG002|Overall Study|Treatment Failure|0|||
48701167|NCT03879772|156755202|FG003|Overall Study|Treatment Failure|2|||
48701168|NCT03879772|156755203|FG004|Overall Study|Treatment Failure|1|||
48701169|NCT03879772|156755199|FG000|Overall Study|Lost to Follow-up|0|||
48701170|NCT03879772|156755200|FG001|Overall Study|Lost to Follow-up|0|||
48701171|NCT03879772|156755201|FG002|Overall Study|Lost to Follow-up|0|||
48701172|NCT03879772|156755202|FG003|Overall Study|Lost to Follow-up|0|||
49117811|NCT01939223|158269531|FG000|Overall Study|Disease recurrence (radiological)|1|||
49117812|NCT01939223|158269532|FG001|Overall Study|Disease recurrence (radiological)|3|||
49117813|NCT01939223|158269531|FG000|Overall Study|Study stopped by Sponsor|5|||
49117814|NCT01939223|158269532|FG001|Overall Study|Study stopped by Sponsor|7|||
49117815|NCT01939223|158269531|FG000|Overall Study|Withdrawal by Subject|6|||
49117816|NCT01939223|158269532|FG001|Overall Study|Withdrawal by Subject|0|||
49117817|NCT02497404|158269533|FG000|Overall Study|Adverse Event|1|||
49117818|NCT01408901|158269534|FG000|6-Week Follow-Up|Lost to Follow-up|2|||
49117819|NCT01408901|158269535|FG001|6-Week Follow-Up|Lost to Follow-up|1|||
49117820|NCT01408901|158269536|FG002|6-Week Follow-Up|Lost to Follow-up|3|||
49117821|NCT01408901|158269537|FG003|6-Week Follow-Up|Lost to Follow-up|2|||
49117822|NCT01408901|158269534|FG000|6-Week Follow-Up|Death|1|||
49117823|NCT01408901|158269535|FG001|6-Week Follow-Up|Death|0|||
49117824|NCT01408901|158269536|FG002|6-Week Follow-Up|Death|0|||
49117825|NCT01408901|158269537|FG003|6-Week Follow-Up|Death|0|||
49117826|NCT01408901|158269534|FG000|6-Week Follow-Up|Cancelled visit|0|||
49117827|NCT01408901|158269535|FG001|6-Week Follow-Up|Cancelled visit|1|||
49117828|NCT01408901|158269536|FG002|6-Week Follow-Up|Cancelled visit|0|||
49117829|NCT01408901|158269537|FG003|6-Week Follow-Up|Cancelled visit|2|||
49117830|NCT01408901|158269534|FG000|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
49117831|NCT01408901|158269535|FG001|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
49117832|NCT01408901|158269536|FG002|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
49117833|NCT01408901|158269537|FG003|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2|||
49117834|NCT01408901|158269534|FG000|12-Week Follow-Up (Primary Endpoint)|Death|1|||
49117835|NCT01408901|158269535|FG001|12-Week Follow-Up (Primary Endpoint)|Death|0|||
49117836|NCT01408901|158269536|FG002|12-Week Follow-Up (Primary Endpoint)|Death|0|||
49117837|NCT01408901|158269537|FG003|12-Week Follow-Up (Primary Endpoint)|Death|0|||
49117838|NCT01408901|158269534|FG000|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
49117839|NCT01408901|158269535|FG001|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2|||
49117840|NCT01408901|158269536|FG002|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
49117841|NCT01408901|158269537|FG003|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1|||
49117842|NCT01408901|158269534|FG000|26-Week Follow-Up|Lost to Follow-up|1|||
49117843|NCT01408901|158269535|FG001|26-Week Follow-Up|Lost to Follow-up|1|||
49117844|NCT01408901|158269536|FG002|26-Week Follow-Up|Lost to Follow-up|0|||
49117845|NCT01408901|158269537|FG003|26-Week Follow-Up|Lost to Follow-up|1|||
49117846|NCT01408901|158269534|FG000|26-Week Follow-Up|Death|0|||
49117847|NCT01408901|158269535|FG001|26-Week Follow-Up|Death|1|||
49117848|NCT01408901|158269536|FG002|26-Week Follow-Up|Death|0|||
49117849|NCT01408901|158269537|FG003|26-Week Follow-Up|Death|0|||
49117850|NCT02421419|158269538|FG000|Overall Study|Physician Decision|0|||
49117851|NCT02421419|158269539|FG001|Overall Study|Physician Decision|0|||
49117852|NCT02421419|158269540|FG002|Overall Study|Physician Decision|1|||
49117853|NCT05285787|158269541|FG000|Overall Study|Withdrawal by Subject|1|||
49117854|NCT00770913|158269545|FG000|Overall Study|Adverse Event|1|||
49117855|NCT00770913|158269546|FG001|Overall Study|Adverse Event|3|||
49117856|NCT00770913|158269547|FG002|Overall Study|Adverse Event|6|||
49117857|NCT00770913|158269545|FG000|Overall Study|Refusal to continue participation|6|||
49117858|NCT00770913|158269546|FG001|Overall Study|Refusal to continue participation|4|||
49117859|NCT00770913|158269547|FG002|Overall Study|Refusal to continue participation|5|||
49117860|NCT00770913|158269545|FG000|Overall Study|Physician Decision|0|||
49117861|NCT00770913|158269546|FG001|Overall Study|Physician Decision|1|||
48701173|NCT03879772|156755203|FG004|Overall Study|Lost to Follow-up|1|||
48701174|NCT03879772|156755199|FG000|Overall Study|Withdrawal by Subject|0|||
48701175|NCT03879772|156755200|FG001|Overall Study|Withdrawal by Subject|1|||
49117862|NCT00770913|158269547|FG002|Overall Study|Physician Decision|1|||
49117863|NCT00770913|158269545|FG000|Overall Study|Protocol Violation|3|||
48701176|NCT03879772|156755201|FG002|Overall Study|Withdrawal by Subject|3|||
49117864|NCT00770913|158269546|FG001|Overall Study|Protocol Violation|0|||
49117865|NCT00770913|158269547|FG002|Overall Study|Protocol Violation|1|||
49117866|NCT00770913|158269545|FG000|Overall Study|Incorrect drug was allocated|1|||
49117867|NCT00770913|158269546|FG001|Overall Study|Incorrect drug was allocated|0|||
49117868|NCT00770913|158269547|FG002|Overall Study|Incorrect drug was allocated|0|||
49117869|NCT03382418|158269548|FG000|Overall Study|Withdrawal by Subject|1|||
48701177|NCT03879772|156755202|FG003|Overall Study|Withdrawal by Subject|1|||
48701178|NCT03879772|156755203|FG004|Overall Study|Withdrawal by Subject|1|||
48701179|NCT03879772|156755199|FG000|Overall Study|Protocol Violation|0|||
48701180|NCT03879772|156755200|FG001|Overall Study|Protocol Violation|0|||
48701181|NCT03879772|156755201|FG002|Overall Study|Protocol Violation|3|||
48701182|NCT03879772|156755202|FG003|Overall Study|Protocol Violation|1|||
48701183|NCT03879772|156755203|FG004|Overall Study|Protocol Violation|2|||
48701184|NCT03879772|156755199|FG000|Overall Study|Did Not Meet Entry Requirements|1|||
48701185|NCT03879772|156755200|FG001|Overall Study|Did Not Meet Entry Requirements|0|||
48701186|NCT03879772|156755201|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
48701187|NCT03879772|156755202|FG003|Overall Study|Did Not Meet Entry Requirements|0|||
48701188|NCT03879772|156755203|FG004|Overall Study|Did Not Meet Entry Requirements|0|||
48701189|NCT03697252|156755205|FG000|Overall Study|Adverse Event|3|||
48701190|NCT03697252|156755206|FG001|Overall Study|Adverse Event|2|||
48701191|NCT03697252|156755205|FG000|Overall Study|Withdrawal by Subject|14|||
48701192|NCT03697252|156755206|FG001|Overall Study|Withdrawal by Subject|14|||
48701193|NCT03697252|156755205|FG000|Overall Study|Lost to Follow-up|0|||
48701194|NCT03697252|156755206|FG001|Overall Study|Lost to Follow-up|1|||
48701195|NCT03697252|156755205|FG000|Overall Study|Physician Decision|1|||
48701196|NCT03697252|156755206|FG001|Overall Study|Physician Decision|1|||
48701197|NCT03697252|156755205|FG000|Overall Study|Other|0|||
48701198|NCT03697252|156755206|FG001|Overall Study|Other|1|||
48701199|NCT03125395|156755207|FG000|Overall Study|Adverse Event|2|||
48701200|NCT03125395|156755207|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
48701201|NCT03125395|156755207|FG000|Overall Study|Physician Decision|2|||
48701202|NCT03125395|156755207|FG000|Overall Study|Commercial drug is available|5|||
48701203|NCT04532528|156755208|FG000|Overall Study|Adverse Event|12|||
48912266|NCT02667275|157516183|FG000|Overall Study|Lost to Follow-up|0|||
48701204|NCT04532528|156755209|FG001|Overall Study|Adverse Event|17|||
48701205|NCT04532528|156755208|FG000|Overall Study|Withdrawal of consent|16|||
48701206|NCT04532528|156755209|FG001|Overall Study|Withdrawal of consent|17|||
48701207|NCT04532528|156755208|FG000|Overall Study|Participant stop Dabigatran during the 12-month study period|22|||
48701208|NCT04532528|156755209|FG001|Overall Study|Participant stop Dabigatran during the 12-month study period|24|||
48701209|NCT04532528|156755208|FG000|Overall Study|Lost to Follow-up|69|||
48701210|NCT04532528|156755209|FG001|Overall Study|Lost to Follow-up|68|||
48701211|NCT04532528|156755208|FG000|Overall Study|Administrative problems|12|||
48701212|NCT04532528|156755209|FG001|Overall Study|Administrative problems|14|||
48701213|NCT04532528|156755208|FG000|Overall Study|Death|3|||
48701214|NCT04532528|156755209|FG001|Overall Study|Death|3|||
48701215|NCT04532528|156755208|FG000|Overall Study|Other|38|||
48701216|NCT04532528|156755209|FG001|Overall Study|Other|46|||
48701217|NCT04030143|156755210|FG000|Overall Study|Adverse Event|5|||
48701218|NCT04030143|156755211|FG001|Overall Study|Adverse Event|10|||
48701219|NCT04030143|156755210|FG000|Overall Study|Lost to Follow-up|3|||
48701220|NCT04030143|156755211|FG001|Overall Study|Lost to Follow-up|7|||
48701221|NCT04030143|156755210|FG000|Overall Study|Protocol Deviation|2|||
48701222|NCT04030143|156755211|FG001|Overall Study|Protocol Deviation|2|||
48701223|NCT04030143|156755210|FG000|Overall Study|Withdrawal by Subject|16|||
48701224|NCT04030143|156755211|FG001|Overall Study|Withdrawal by Subject|18|||
48701225|NCT04030143|156755210|FG000|Overall Study|Physician Decision|1|||
48701226|NCT04030143|156755211|FG001|Overall Study|Physician Decision|1|||
48701227|NCT04030143|156755210|FG000|Overall Study|Due to Covid-19|2|||
48701228|NCT04030143|156755211|FG001|Overall Study|Due to Covid-19|3|||
48701229|NCT04030143|156755210|FG000|Overall Study|Not Due to Covid-19|1|||
48701230|NCT04030143|156755211|FG001|Overall Study|Not Due to Covid-19|1|||
48701231|NCT01499940|156755212|FG000|Overall Study|Study was withdrawn before completion.|9|||
48912267|NCT02667275|157516184|FG001|Overall Study|Lost to Follow-up|2|||
48912268|NCT02667275|157516183|FG000|Overall Study|Withdrawal by Subject|0|||
48912269|NCT02667275|157516184|FG001|Overall Study|Withdrawal by Subject|5|||
48701232|NCT00538902|156755213|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1|||
48701233|NCT00538902|156755214|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2|||
48701234|NCT00538902|156755215|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3|||
48701235|NCT00538902|156755213|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
48701236|NCT00538902|156755214|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
48701237|NCT00538902|156755215|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1|||
48701238|NCT00538902|156755213|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
48701239|NCT00538902|156755214|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
48701240|NCT00538902|156755215|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1|||
48701241|NCT00538902|156755213|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
48701242|NCT00538902|156755214|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
48701243|NCT00538902|156755215|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
48701244|NCT00538902|156755213|FG000|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2|||
48701245|NCT00538902|156755214|FG001|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10|||
48701246|NCT00538902|156755215|FG002|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11|||
48701247|NCT00538902|156755213|FG000|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15|||
48701248|NCT00538902|156755214|FG001|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19|||
48701249|NCT00538902|156755215|FG002|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25|||
48701250|NCT00538902|156755213|FG000|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1|||
48701251|NCT00538902|156755214|FG001|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10|||
48701252|NCT00538902|156755215|FG002|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6|||
48701253|NCT00538902|156755213|FG000|OL Wk 24 to End (Primary D/C Reasons)|Various|18|||
48701254|NCT00538902|156755214|FG001|OL Wk 24 to End (Primary D/C Reasons)|Various|25|||
48701255|NCT00538902|156755215|FG002|OL Wk 24 to End (Primary D/C Reasons)|Various|22|||
48701256|NCT04109547|156755217|FG000|Overall Study|Withdrawal by Subject|3|||
48701257|NCT04109547|156755218|FG001|Overall Study|Withdrawal by Subject|2|||
48701258|NCT04109547|156755219|FG002|Overall Study|Withdrawal by Subject|6|||
48701259|NCT04109547|156755220|FG003|Overall Study|Withdrawal by Subject|6|||
48701260|NCT04109547|156755217|FG000|Overall Study|Lost to Follow-up|0|||
48701261|NCT04109547|156755218|FG001|Overall Study|Lost to Follow-up|0|||
48701262|NCT04109547|156755219|FG002|Overall Study|Lost to Follow-up|0|||
48701263|NCT04109547|156755220|FG003|Overall Study|Lost to Follow-up|1|||
48701264|NCT04109547|156755217|FG000|Overall Study|Physician Decision|1|||
48701265|NCT04109547|156755218|FG001|Overall Study|Physician Decision|2|||
48701266|NCT04109547|156755219|FG002|Overall Study|Physician Decision|0|||
48701267|NCT04109547|156755220|FG003|Overall Study|Physician Decision|0|||
48701268|NCT04218240|156755221|FG000|Overall Study|Withdrawal by Subject|6|||
48701269|NCT04218240|156755222|FG001|Overall Study|Withdrawal by Subject|0|||
48701270|NCT04218240|156755221|FG000|Overall Study|Lack of Efficacy|24|||
48701271|NCT04218240|156755222|FG001|Overall Study|Lack of Efficacy|19|||
48701272|NCT04218240|156755221|FG000|Overall Study|Physician Decision|0|||
48701273|NCT04218240|156755222|FG001|Overall Study|Physician Decision|1|||
48701274|NCT04218240|156755221|FG000|Overall Study|Not Dosed Never met WD criteria|4|||
48701275|NCT04218240|156755222|FG001|Overall Study|Not Dosed Never met WD criteria|1|||
48701276|NCT05249582|156755227|FG000|Overall Study|Technical Problems with virtual reality prevented completion|2|||
48701277|NCT05249582|156755228|FG001|Overall Study|Technical Problems with virtual reality prevented completion|0|||
48701278|NCT05249582|156755227|FG000|Overall Study|Internet connectivity prevented completion of the condition|0|||
48701279|NCT05249582|156755228|FG001|Overall Study|Internet connectivity prevented completion of the condition|1|||
48701280|NCT05249582|156755227|FG000|Overall Study|Declined to use virtual reality headset|1|||
48701281|NCT05249582|156755228|FG001|Overall Study|Declined to use virtual reality headset|0|||
48701282|NCT01498068|156755232|FG000|Overall Study|Withdrawal by Subject|1|||
48701283|NCT01498068|156755233|FG001|Overall Study|Withdrawal by Subject|1|||
48701284|NCT00551642|156755237|FG000|Treatment Period|Protocol Deviation|6|||
48701285|NCT00551642|156755238|FG001|Treatment Period|Protocol Deviation|11|||
48701286|NCT00551642|156755237|FG000|Treatment Period|Delivery device failure|1|||
48701287|NCT00551642|156755238|FG001|Treatment Period|Delivery device failure|3|||
48701288|NCT00551642|156755237|FG000|Treatment Period|Physician Decision|0|||
48701289|NCT00551642|156755238|FG001|Treatment Period|Physician Decision|1|||
48701290|NCT00551642|156755237|FG000|Treatment Period|Death|33|||
48701291|NCT00551642|156755238|FG001|Treatment Period|Death|31|||
48701292|NCT00551642|156755237|FG000|Treatment Period|Inclusion/Exclusion criteria|4|||
48701293|NCT00551642|156755238|FG001|Treatment Period|Inclusion/Exclusion criteria|4|||
48701294|NCT00551642|156755237|FG000|Treatment Period|Adverse Event|15|||
48701295|NCT00551642|156755238|FG001|Treatment Period|Adverse Event|12|||
48701296|NCT00551642|156755237|FG000|Treatment Period|Withdrawal by Subject|2|||
48701297|NCT00551642|156755238|FG001|Treatment Period|Withdrawal by Subject|1|||
49117870|NCT03382418|158269549|FG001|Overall Study|Withdrawal by Subject|0|||
49117871|NCT03382418|158269550|FG002|Overall Study|Withdrawal by Subject|0|||
49117872|NCT03382418|158269548|FG000|Overall Study|Lost to Follow-up|2|||
49117873|NCT03382418|158269549|FG001|Overall Study|Lost to Follow-up|3|||
49117874|NCT03382418|158269550|FG002|Overall Study|Lost to Follow-up|0|||
49117875|NCT03883477|158269555|FG000|Overall Study|Death|1|||
49117876|NCT03883477|158269556|FG001|Overall Study|Death|0|||
49117877|NCT03883477|158269555|FG000|Overall Study|Protocol Violation|0|||
49117878|NCT03883477|158269556|FG001|Overall Study|Protocol Violation|1|||
49117879|NCT04186221|158269559|FG000|Overall Study|Death|1|||
49117880|NCT02401035|158269560|FG000|Overall Study|Withdrawal by Subject|1|||
49117881|NCT02401035|158269561|FG001|Overall Study|Withdrawal by Subject|0|||
49117882|NCT01134393|158269562|FG000|Overall Study|Adverse Event|18|||
49117883|NCT01134393|158269562|FG000|Overall Study|Lack of Efficacy|2|||
49117884|NCT01134393|158269562|FG000|Overall Study|Protocol Violation|12|||
49117885|NCT01134393|158269562|FG000|Overall Study|Lost to Follow-up|3|||
49117886|NCT01134393|158269562|FG000|Overall Study|Withdrawal by Subject|11|||
49117887|NCT01134393|158269562|FG000|Overall Study|Other|6|||
49117888|NCT00869128|158269563|FG000|Overall Study|lack of Compliance|6|||
49117889|NCT00869128|158269564|FG001|Overall Study|lack of Compliance|6|||
49117890|NCT00531947|158269565|FG000|Overall Study|Adverse Event|5|||
49117891|NCT00531947|158269566|FG001|Overall Study|Adverse Event|10|||
48701298|NCT01409707|156755244|FG000|Overall Study|Withdrawal by Subject|5|||
48701299|NCT01409707|156755245|FG001|Overall Study|Withdrawal by Subject|17|||
48701300|NCT01409707|156755246|FG002|Overall Study|Withdrawal by Subject|16|||
48701301|NCT00888134|156755251|FG000|Treatment With Study Drug|Withdrawal by Subject|1|||
48701302|NCT00888134|156755251|FG000|Follow-up|being followed for long-term survival|1|||
48701303|NCT02667119|156755252|FG000|Overall Study|Lost to Follow-up|3|||
48701304|NCT02667119|156755253|FG001|Overall Study|Lost to Follow-up|0|||
48701305|NCT00432172|156755254|FG000|Overall Study|Physician Decision|0|||
48701306|NCT00432172|156755255|FG001|Overall Study|Physician Decision|0|||
48701307|NCT00432172|156755256|FG002|Overall Study|Physician Decision|2|||
49117892|NCT00531947|158269565|FG000|Overall Study|Lost to Follow-up|12|||
49117893|NCT00531947|158269566|FG001|Overall Study|Lost to Follow-up|9|||
49117894|NCT00531947|158269565|FG000|Overall Study|Withdrawal by Subject|14|||
49117895|NCT00531947|158269566|FG001|Overall Study|Withdrawal by Subject|19|||
49117896|NCT00531947|158269565|FG000|Overall Study|Protocol Violation|2|||
48701308|NCT00432172|156755257|FG003|Overall Study|Physician Decision|0|||
48701309|NCT00432172|156755254|FG000|Overall Study|Adverse Event|4|||
48701310|NCT00432172|156755255|FG001|Overall Study|Adverse Event|2|||
48701311|NCT00432172|156755256|FG002|Overall Study|Adverse Event|4|||
48701312|NCT00432172|156755257|FG003|Overall Study|Adverse Event|3|||
48701313|NCT00432172|156755254|FG000|Overall Study|Disease progression|0|||
48701314|NCT00432172|156755255|FG001|Overall Study|Disease progression|2|||
48701315|NCT00432172|156755256|FG002|Overall Study|Disease progression|5|||
48701316|NCT00432172|156755257|FG003|Overall Study|Disease progression|1|||
48701317|NCT00432172|156755254|FG000|Overall Study|Withdrawal by Subject|0|||
48701318|NCT00432172|156755255|FG001|Overall Study|Withdrawal by Subject|1|||
48701319|NCT00432172|156755256|FG002|Overall Study|Withdrawal by Subject|0|||
48701320|NCT00432172|156755257|FG003|Overall Study|Withdrawal by Subject|2|||
48701321|NCT00432172|156755254|FG000|Overall Study|No treatment received|2|||
48701322|NCT00432172|156755255|FG001|Overall Study|No treatment received|2|||
48701323|NCT00432172|156755256|FG002|Overall Study|No treatment received|0|||
48701324|NCT00432172|156755257|FG003|Overall Study|No treatment received|1|||
48701325|NCT00935584|156755260|FG000|Overall Study|Withdrawal by Subject|9|||
48701326|NCT00935584|156755261|FG001|Overall Study|Withdrawal by Subject|0|||
48701327|NCT00935584|156755260|FG000|Overall Study|Death|3|||
48701328|NCT00935584|156755261|FG001|Overall Study|Death|0|||
48701329|NCT00935584|156755260|FG000|Overall Study|Lost to Follow-up|8|||
48701330|NCT00935584|156755261|FG001|Overall Study|Lost to Follow-up|0|||
48701331|NCT00935584|156755260|FG000|Overall Study|No show|9|||
48701332|NCT00935584|156755261|FG001|Overall Study|No show|0|||
48701333|NCT00935584|156755260|FG000|Overall Study|Relocated|3|||
48912270|NCT02667275|157516183|FG000|Overall Study|Discontinued early without completing|0|||
48912271|NCT02667275|157516184|FG001|Overall Study|Discontinued early without completing|1|||
48701334|NCT00935584|156755261|FG001|Overall Study|Relocated|0|||
48701335|NCT00935584|156755260|FG000|Overall Study|Patient changed provider|3|||
48701336|NCT00935584|156755261|FG001|Overall Study|Patient changed provider|0|||
48701337|NCT00935584|156755260|FG000|Overall Study|Provider dropped out of study|14|||
48701338|NCT00935584|156755261|FG001|Overall Study|Provider dropped out of study|4|||
48701339|NCT00791934|156755273|FG000|Overall Study|Withdrawal by Subject|2|||
48701340|NCT00791934|156755273|FG000|Overall Study|Did not consent for extended follow-up|13|||
48701341|NCT00541658|156755275|FG000|Overall Study|Adverse Event|28|||
48701342|NCT00541658|156755276|FG001|Overall Study|Adverse Event|37|||
48701343|NCT00541658|156755277|FG002|Overall Study|Adverse Event|25|||
48701344|NCT00541658|156755275|FG000|Overall Study|Physician Decision|0|||
48701345|NCT00541658|156755276|FG001|Overall Study|Physician Decision|0|||
48701346|NCT00541658|156755277|FG002|Overall Study|Physician Decision|4|||
48701347|NCT00541658|156755275|FG000|Overall Study|Lost to Follow-up|3|||
48701348|NCT00541658|156755276|FG001|Overall Study|Lost to Follow-up|3|||
49117897|NCT00531947|158269566|FG001|Overall Study|Protocol Violation|1|||
49117898|NCT00531947|158269565|FG000|Overall Study|Non-Compliance|4|||
49117899|NCT00531947|158269566|FG001|Overall Study|Non-Compliance|7|||
49117900|NCT00531947|158269565|FG000|Overall Study|Other (e.g., Lack of Efficacy)|5|||
49117901|NCT00531947|158269566|FG001|Overall Study|Other (e.g., Lack of Efficacy)|5|||
49117902|NCT02998996|158269567|FG000|Overall Study|Lost to Follow-up|0|||
49117903|NCT02998996|158269568|FG001|Overall Study|Lost to Follow-up|0|||
49117904|NCT02998996|158269569|FG002|Overall Study|Lost to Follow-up|1|||
49117905|NCT02998996|158269570|FG003|Overall Study|Lost to Follow-up|0|||
49117906|NCT02998996|158269571|FG004|Overall Study|Lost to Follow-up|0|||
49117907|NCT02998996|158269572|FG005|Overall Study|Lost to Follow-up|0|||
48701349|NCT00541658|156755277|FG002|Overall Study|Lost to Follow-up|6|||
48701350|NCT00541658|156755275|FG000|Overall Study|Protocol Violation|0|||
48701351|NCT00541658|156755276|FG001|Overall Study|Protocol Violation|1|||
48701352|NCT00541658|156755277|FG002|Overall Study|Protocol Violation|1|||
48701353|NCT00541658|156755275|FG000|Overall Study|Withdrawal by Subject|28|||
49117908|NCT02998996|158269567|FG000|Overall Study|Pregnancy|0|||
49117909|NCT02998996|158269568|FG001|Overall Study|Pregnancy|1|||
49117910|NCT02998996|158269569|FG002|Overall Study|Pregnancy|0|||
49117911|NCT02998996|158269570|FG003|Overall Study|Pregnancy|0|||
49117912|NCT02998996|158269571|FG004|Overall Study|Pregnancy|0|||
49117913|NCT02998996|158269572|FG005|Overall Study|Pregnancy|0|||
49117914|NCT02998996|158269567|FG000|Overall Study|Family reasons|0|||
49117915|NCT02998996|158269568|FG001|Overall Study|Family reasons|0|||
49117916|NCT02998996|158269569|FG002|Overall Study|Family reasons|0|||
49117917|NCT02998996|158269570|FG003|Overall Study|Family reasons|0|||
49117918|NCT02998996|158269571|FG004|Overall Study|Family reasons|1|||
49117919|NCT02998996|158269572|FG005|Overall Study|Family reasons|0|||
49117920|NCT00985686|158269576|FG000|Overall Study|Lost to Follow-up|1|||
48701354|NCT00541658|156755276|FG001|Overall Study|Withdrawal by Subject|32|||
48701355|NCT00541658|156755277|FG002|Overall Study|Withdrawal by Subject|32|||
48701356|NCT00541658|156755275|FG000|Overall Study|Took No Study Drug|1|||
48701357|NCT00541658|156755276|FG001|Overall Study|Took No Study Drug|0|||
48701358|NCT00541658|156755277|FG002|Overall Study|Took No Study Drug|0|||
48701359|NCT00536744|156755278|FG000|Overall Study|Adverse Event|13|||
48701360|NCT00536744|156755279|FG001|Overall Study|Adverse Event|10|||
48701361|NCT00536744|156755278|FG000|Overall Study|Death|2|||
48701362|NCT00536744|156755279|FG001|Overall Study|Death|1|||
48701363|NCT00536744|156755278|FG000|Overall Study|Physician Decision|3|||
48701364|NCT00536744|156755279|FG001|Overall Study|Physician Decision|1|||
48701365|NCT00536744|156755278|FG000|Overall Study|Lost to Follow-up|3|||
48701366|NCT00536744|156755279|FG001|Overall Study|Lost to Follow-up|5|||
48701367|NCT00536744|156755278|FG000|Overall Study|Withdrawal by Subject|7|||
48701368|NCT00536744|156755279|FG001|Overall Study|Withdrawal by Subject|8|||
48701369|NCT00536744|156755278|FG000|Overall Study|PI tried alternative treatment|1|||
48701370|NCT00536744|156755279|FG001|Overall Study|PI tried alternative treatment|3|||
48701371|NCT05408429|156755280|FG000|Overall Study|Lost to Follow-up|1|||
49117921|NCT00985686|158269577|FG001|Overall Study|Lost to Follow-up|1|||
49117922|NCT00985686|158269578|FG002|Overall Study|Lost to Follow-up|0|||
49117923|NCT00985686|158269579|FG003|Overall Study|Lost to Follow-up|2|||
49117924|NCT03134911|158269580|FG000|Overall Study|Screen failure|31|||
49117925|NCT03134911|158269580|FG000|Overall Study|Not meeting inclusion/exclusion criteria|3|||
49117926|NCT01670045|158269581|FG000|Overall Study|Withdrawal by Subject|3|||
49117927|NCT01670045|158269581|FG000|Overall Study|Adverse Event|1|||
48701372|NCT05408429|156755281|FG001|Overall Study|Lost to Follow-up|1|||
48701373|NCT05408429|156755282|FG002|Overall Study|Lost to Follow-up|0|||
48701374|NCT05408429|156755280|FG000|Overall Study|Withdrawal by Subject|5|||
48701375|NCT05408429|156755281|FG001|Overall Study|Withdrawal by Subject|0|||
48701376|NCT05408429|156755282|FG002|Overall Study|Withdrawal by Subject|1|||
48701377|NCT05530252|156755284|FG000|Overall Study|Lost to Follow-up|1|||
48701378|NCT05530252|156755285|FG001|Overall Study|Lost to Follow-up|1|||
48701379|NCT05530252|156755286|FG002|Overall Study|Lost to Follow-up|1|||
48701380|NCT03818256|156755288|FG000|Overall Study|Withdrawal by Subject|2|||
48701381|NCT03818256|156755289|FG001|Overall Study|Withdrawal by Subject|2|||
48701382|NCT03818256|156755288|FG000|Overall Study|Adverse Event|3|||
48701383|NCT03818256|156755289|FG001|Overall Study|Adverse Event|1|||
48701384|NCT03818256|156755288|FG000|Overall Study|Lost to Follow-up|0|||
48701385|NCT03818256|156755289|FG001|Overall Study|Lost to Follow-up|5|||
48701386|NCT03818256|156755288|FG000|Overall Study|Gaining weight without prohibited medication vyvanse|1|||
48701387|NCT03818256|156755289|FG001|Overall Study|Gaining weight without prohibited medication vyvanse|0|||
48701388|NCT03818256|156755288|FG000|Overall Study|Not reporting for scheduled visits|1|||
48701389|NCT03818256|156755289|FG001|Overall Study|Not reporting for scheduled visits|0|||
48701390|NCT03818256|156755288|FG000|Overall Study|Non-compliant with investigational product|1|||
48701391|NCT03818256|156755289|FG001|Overall Study|Non-compliant with investigational product|0|||
48701392|NCT01074970|156755292|FG000|Overall Study|Never Treated|0|||
48701393|NCT01074970|156755293|FG001|Overall Study|Never Treated|0|||
48701394|NCT01074970|156755294|FG002|Overall Study|Never Treated|8|||
48701395|NCT01074970|156755295|FG003|Overall Study|Never Treated|1|||
48701396|NCT01074970|156755292|FG000|Overall Study|Adverse Event|1|||
48701397|NCT01074970|156755293|FG001|Overall Study|Adverse Event|0|||
48701398|NCT01074970|156755294|FG002|Overall Study|Adverse Event|4|||
48701399|NCT01074970|156755295|FG003|Overall Study|Adverse Event|3|||
48701400|NCT01074970|156755292|FG000|Overall Study|Disease progression during treatment|3|||
48701401|NCT01074970|156755293|FG001|Overall Study|Disease progression during treatment|1|||
48701402|NCT01074970|156755294|FG002|Overall Study|Disease progression during treatment|2|||
48701403|NCT01074970|156755295|FG003|Overall Study|Disease progression during treatment|9|||
48701404|NCT01074970|156755292|FG000|Overall Study|Lost to Follow-up|0|||
48701405|NCT01074970|156755293|FG001|Overall Study|Lost to Follow-up|0|||
48701406|NCT01074970|156755294|FG002|Overall Study|Lost to Follow-up|1|||
48701407|NCT01074970|156755295|FG003|Overall Study|Lost to Follow-up|0|||
48701408|NCT01074970|156755292|FG000|Overall Study|Withdrawal by Subject|0|||
48701409|NCT01074970|156755293|FG001|Overall Study|Withdrawal by Subject|0|||
48701410|NCT01074970|156755294|FG002|Overall Study|Withdrawal by Subject|6|||
48701411|NCT01074970|156755295|FG003|Overall Study|Withdrawal by Subject|4|||
48701412|NCT04314284|156755296|FG000|Overall Study|Withdrawal by Subject|4|||
48701413|NCT04314284|156755297|FG001|Overall Study|Withdrawal by Subject|7|||
48701414|NCT04314284|156755296|FG000|Overall Study|Consented but did not complete survey|0|||
48856280|NCT05260437|157312811|FG000|Overall Study|Lost to Follow-up|5|||
48701415|NCT04314284|156755297|FG001|Overall Study|Consented but did not complete survey|6|||
48701416|NCT02991768|156755302|FG000|Overall Study|Physician Decision|4|||
49117928|NCT01670045|158269581|FG000|Overall Study|Death|1|||
49117929|NCT01670045|158269581|FG000|Overall Study|Lost to Follow-up|11|||
49117930|NCT03014206|158269582|FG000|Overall Study|Registration Violation|12|||
49117931|NCT03360019|158269588|FG000|Overall Study|Withdrawal by Subject|2|||
49117932|NCT03360019|158269589|FG001|Overall Study|Withdrawal by Subject|0|||
49117933|NCT03360019|158269590|FG002|Overall Study|Withdrawal by Subject|0|||
49117934|NCT03360019|158269588|FG000|Overall Study|Pandemic caused suspension of study activities|6|||
49117935|NCT03360019|158269589|FG001|Overall Study|Pandemic caused suspension of study activities|0|||
49117936|NCT03360019|158269590|FG002|Overall Study|Pandemic caused suspension of study activities|0|||
49117937|NCT00656175|158269591|FG000|Overall Study|Adverse Event|1|||
49117938|NCT00656175|158269592|FG001|Overall Study|Adverse Event|0|||
49117939|NCT00656175|158269591|FG000|Overall Study|Transportation issues|0|||
49117940|NCT00656175|158269592|FG001|Overall Study|Transportation issues|1|||
49117941|NCT05279131|158269593|FG000|Overall Study|Lost to Follow-up|1|||
49117942|NCT05279131|158269593|FG000|Overall Study|Death|1|||
49117943|NCT05279131|158269593|FG000|Overall Study|Physician Decision|1|||
49117944|NCT00992017|158269594|FG000|Overall Study|Lost to Follow-up|2|||
49117945|NCT00992017|158269594|FG000|Overall Study|Withdrawal by Subject|2|||
49117946|NCT00992017|158269594|FG000|Overall Study|Unable to get to clinic|5|||
49117947|NCT00992017|158269594|FG000|Overall Study|Not adhere to study requirements|1|||
49117948|NCT02149264|158269595|FG000|Overall Study|Withdrawal by Subject|9|||
49117949|NCT02149264|158269595|FG000|Overall Study|Adverse Event|7|||
49117950|NCT02149264|158269595|FG000|Overall Study|Physician Decision|3|||
49117951|NCT02149264|158269595|FG000|Overall Study|Protocol Violation|1|||
49117952|NCT04877990|158269598|FG000|Treatment|Other reasons|3|||
49117953|NCT04877990|158269599|FG001|Treatment|Other reasons|1|||
49117954|NCT04877990|158269598|FG000|Treatment|Administrative reasons by sponsor|17|||
49117955|NCT04877990|158269599|FG001|Treatment|Administrative reasons by sponsor|33|||
49117956|NCT04877990|158269598|FG000|Treatment|Withdrawal by Subject|2|||
49117957|NCT04877990|158269599|FG001|Treatment|Withdrawal by Subject|6|||
49117958|NCT04877990|158269598|FG000|Treatment|Adverse Event|2|||
48701417|NCT04163341|156755303|FG000|Overall Study|Withdrawal by Subject|2|||
48701418|NCT04163341|156755304|FG001|Overall Study|Withdrawal by Subject|0|||
48701419|NCT04163341|156755303|FG000|Overall Study|Lost to Follow-up|3|||
48701420|NCT04163341|156755304|FG001|Overall Study|Lost to Follow-up|4|||
48701421|NCT02201953|156755306|FG000|Overall Study|Randomized but Never Treated|1|||
48701422|NCT02201953|156755307|FG001|Overall Study|Randomized but Never Treated|5|||
48701423|NCT02201953|156755306|FG000|Overall Study|Lack of Efficacy|9|||
48701424|NCT02201953|156755307|FG001|Overall Study|Lack of Efficacy|30|||
48701425|NCT02201953|156755306|FG000|Overall Study|Lost to Follow-up|8|||
48701426|NCT02201953|156755307|FG001|Overall Study|Lost to Follow-up|8|||
48701427|NCT02201953|156755306|FG000|Overall Study|Withdrew Consent|2|||
48701428|NCT02201953|156755307|FG001|Overall Study|Withdrew Consent|5|||
48701429|NCT02201953|156755306|FG000|Overall Study|Adverse Event|0|||
48701430|NCT02201953|156755307|FG001|Overall Study|Adverse Event|5|||
48701431|NCT02201953|156755306|FG000|Overall Study|Death|0|||
48701432|NCT02201953|156755307|FG001|Overall Study|Death|3|||
48701433|NCT04730804|156755311|FG000|Overall Study|Physician Decision|0|||
48701434|NCT04730804|156755312|FG001|Overall Study|Physician Decision|0|||
48701435|NCT04730804|156755313|FG002|Overall Study|Physician Decision|0|||
48701436|NCT04730804|156755314|FG003|Overall Study|Physician Decision|0|||
48701437|NCT04730804|156755315|FG004|Overall Study|Physician Decision|0|||
48701438|NCT04730804|156755316|FG005|Overall Study|Physician Decision|1|||
48701439|NCT04730804|156755311|FG000|Overall Study|Withdrawal by Subject|0|||
48701440|NCT04730804|156755312|FG001|Overall Study|Withdrawal by Subject|0|||
48701441|NCT04730804|156755313|FG002|Overall Study|Withdrawal by Subject|0|||
48701442|NCT04730804|156755314|FG003|Overall Study|Withdrawal by Subject|0|||
48701443|NCT04730804|156755315|FG004|Overall Study|Withdrawal by Subject|1|||
48701444|NCT04730804|156755316|FG005|Overall Study|Withdrawal by Subject|2|||
48701445|NCT01615939|156756960|FG000|Overall Study|Lost to Follow-up|5|||
48701446|NCT01615939|156756961|FG001|Overall Study|Lost to Follow-up|0|||
48701447|NCT02121535|156756962|FG000|Period 1 (8 Trial Days)|Withdrawal by Subject|0|||
48701448|NCT02121535|156756963|FG001|Period 1 (8 Trial Days)|Withdrawal by Subject|1|||
49117959|NCT04877990|158269599|FG001|Treatment|Adverse Event|1|||
49117960|NCT03746405|158271155|FG000|Overall Study|Withdrawal by Subject|3|||
49117961|NCT03746405|158271156|FG001|Overall Study|Withdrawal by Subject|0|||
49117962|NCT03746405|158271155|FG000|Overall Study|technical difficulties|0|||
49117963|NCT03746405|158271156|FG001|Overall Study|technical difficulties|2|||
48701449|NCT02121535|156756962|FG000|Period 3 (8 Trial Days)|Withdrawal by Subject|1|||
48701450|NCT02121535|156756963|FG001|Period 3 (8 Trial Days)|Withdrawal by Subject|0|||
48701451|NCT01295814|156756964|FG000|Overall Study|Lack of Efficacy|0|||
48701452|NCT01295814|156756965|FG001|Overall Study|Lack of Efficacy|2|||
48701453|NCT01295814|156756964|FG000|Overall Study|Withdrawal by Subject|2|||
48701454|NCT01295814|156756965|FG001|Overall Study|Withdrawal by Subject|0|||
49117964|NCT03479008|158271159|FG000|Overall Study|Withdrawal by Subject|3|||
48701455|NCT01084655|156756969|FG000|Overall Study|Radiographic disease progression|3|||
48701456|NCT01084655|156756970|FG001|Overall Study|Radiographic disease progression|2|||
48701457|NCT01084655|156756971|FG002|Overall Study|Radiographic disease progression|8|||
48701458|NCT01084655|156756969|FG000|Overall Study|Withdrawal by Subject|1|||
48701459|NCT01084655|156756970|FG001|Overall Study|Withdrawal by Subject|0|||
48701460|NCT01084655|156756971|FG002|Overall Study|Withdrawal by Subject|4|||
48701461|NCT01084655|156756969|FG000|Overall Study|Adverse Event|2|||
48701462|NCT01084655|156756970|FG001|Overall Study|Adverse Event|1|||
48701463|NCT01084655|156756971|FG002|Overall Study|Adverse Event|2|||
48701464|NCT01084655|156756969|FG000|Overall Study|Other|0|||
48701465|NCT01084655|156756970|FG001|Overall Study|Other|3|||
48701466|NCT01084655|156756971|FG002|Overall Study|Other|2|||
48701467|NCT01084655|156756969|FG000|Overall Study|Symptomatic deterioration|0|||
48701468|NCT01084655|156756970|FG001|Overall Study|Symptomatic deterioration|0|||
48701469|NCT01084655|156756971|FG002|Overall Study|Symptomatic deterioration|2|||
48701470|NCT01084655|156756969|FG000|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
48701471|NCT01084655|156756970|FG001|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
48701472|NCT01084655|156756971|FG002|Overall Study|Prostate-specificAntigen(PSA)progression|1|||
48701473|NCT02083354|156756972|FG000|Overall Study|Withdrawal by Subject|9|||
48701474|NCT02083354|156756972|FG000|Overall Study|Lost to Follow-up|1|||
48701475|NCT02083354|156756972|FG000|Overall Study|Adverse Event|3|||
48701476|NCT02083354|156756972|FG000|Overall Study|Disease progression|46|||
48701477|NCT02083354|156756972|FG000|Overall Study|Study closed/terminated|5|||
48701478|NCT03312634|156756975|FG000|Overall Study|Adverse Event|11|||
48701479|NCT03312634|156756976|FG001|Overall Study|Adverse Event|0|||
48701480|NCT03312634|156756975|FG000|Overall Study|Sponsor request|2|||
48701481|NCT03312634|156756976|FG001|Overall Study|Sponsor request|0|||
48701482|NCT03312634|156756975|FG000|Overall Study|Withdrawal by Subject|31|||
48701483|NCT03312634|156756976|FG001|Overall Study|Withdrawal by Subject|9|||
48701484|NCT03312634|156756975|FG000|Overall Study|Enrolled in an interventional study|0|||
48701485|NCT03312634|156756976|FG001|Overall Study|Enrolled in an interventional study|52|||
48701486|NCT03312634|156756975|FG000|Overall Study|Enrolled in an interventional study at time of a flare-up|0|||
48701487|NCT03312634|156756976|FG001|Overall Study|Enrolled in an interventional study at time of a flare-up|9|||
48912272|NCT03677596|157516186|FG000|Overall Study|Adverse Event|0|||
49117965|NCT02781818|158271164|FG000|Overall Study|Lost to Follow-up|4|||
49117966|NCT02781818|158271165|FG001|Overall Study|Lost to Follow-up|2|||
49117967|NCT02781818|158271166|FG002|Overall Study|Lost to Follow-up|1|||
49117968|NCT02609386|158271171|FG000|Overall Study|Withdrawal by Subject|6|||
49117969|NCT02609386|158271172|FG001|Overall Study|Withdrawal by Subject|1|||
49117970|NCT02609386|158271171|FG000|Overall Study|Lost to Follow-up|3|||
49117971|NCT02609386|158271172|FG001|Overall Study|Lost to Follow-up|5|||
49117972|NCT02609386|158271171|FG000|Overall Study|Death|19|||
49117973|NCT02609386|158271172|FG001|Overall Study|Death|9|||
49117974|NCT02609386|158271171|FG000|Overall Study|Physician Decision|0|||
49117975|NCT02609386|158271172|FG001|Overall Study|Physician Decision|2|||
49117976|NCT02465437|158271173|FG000|Overall Study|Physician Decision|0|||
49117977|NCT02465437|158271174|FG001|Overall Study|Physician Decision|0|||
49117978|NCT02465437|158271175|FG002|Overall Study|Physician Decision|1|||
49117979|NCT02465437|158271176|FG003|Overall Study|Physician Decision|0|||
49117980|NCT02465437|158271173|FG000|Overall Study|Withdrawal by Subject|1|||
49117981|NCT02465437|158271174|FG001|Overall Study|Withdrawal by Subject|0|||
49117982|NCT02465437|158271175|FG002|Overall Study|Withdrawal by Subject|0|||
49117983|NCT02465437|158271176|FG003|Overall Study|Withdrawal by Subject|1|||
49117984|NCT02465437|158271173|FG000|Overall Study|Adverse Event|0|||
49117985|NCT02465437|158271174|FG001|Overall Study|Adverse Event|1|||
49117986|NCT02465437|158271175|FG002|Overall Study|Adverse Event|0|||
49117987|NCT02465437|158271176|FG003|Overall Study|Adverse Event|0|||
49117988|NCT01979523|158271180|FG000|Overall Study|Withdrawal by Subject|1|||
49117989|NCT01979523|158271181|FG001|Overall Study|Withdrawal by Subject|0|||
49117990|NCT01535443|158271183|FG000|Overall Study|Physician Decision|3|||
49117991|NCT05359952|158271186|FG000|Overall Study|Lost to Follow-up|1|||
49117992|NCT05359952|158271187|FG001|Overall Study|Lost to Follow-up|0|||
49117993|NCT02258659|158271188|FG000|Overall Study|Withdrawal by Subject|1|||
49117994|NCT00705341|158271192|FG000|Phase 2: Trial|Withdrawal by Subject|0|||
49117995|NCT00705341|158271193|FG001|Phase 2: Trial|Withdrawal by Subject|0|||
49117996|NCT00705341|158271194|FG002|Phase 2: Trial|Withdrawal by Subject|6|||
49117997|NCT00705341|158271195|FG003|Phase 2: Trial|Withdrawal by Subject|4|||
49117998|NCT00705341|158271192|FG000|Phase 2: Trial|Did not meet post-diluent threshold|0|||
49117999|NCT00705341|158271193|FG001|Phase 2: Trial|Did not meet post-diluent threshold|0|||
49118000|NCT00705341|158271194|FG002|Phase 2: Trial|Did not meet post-diluent threshold|1|||
49118001|NCT00705341|158271195|FG003|Phase 2: Trial|Did not meet post-diluent threshold|0|||
49118002|NCT01720524|158271206|FG000|Part A|Insufficient Clinical Response|2|||
48701488|NCT03312634|156756975|FG000|Overall Study|Death|0|||
48701489|NCT03312634|156756976|FG001|Overall Study|Death|1|||
48701490|NCT03312634|156756975|FG000|Overall Study|Non-compliance|0|||
48701491|NCT03312634|156756976|FG001|Overall Study|Non-compliance|2|||
48701492|NCT03312634|156756975|FG000|Overall Study|Lost to Follow-up|0|||
48701493|NCT03312634|156756976|FG001|Overall Study|Lost to Follow-up|1|||
48701494|NCT03312634|156756975|FG000|Overall Study|Enrolled into non-interventional study|0|||
48701495|NCT03312634|156756976|FG001|Overall Study|Enrolled into non-interventional study|5|||
48701496|NCT03312634|156756975|FG000|Overall Study|Worsening clinical condition|0|||
48701497|NCT03312634|156756976|FG001|Overall Study|Worsening clinical condition|1|||
48701498|NCT03312634|156756975|FG000|Overall Study|Participant did not want to travel|0|||
48701499|NCT03312634|156756976|FG001|Overall Study|Participant did not want to travel|1|||
48701500|NCT03312634|156756975|FG000|Overall Study|Physician Decision|1|||
48701501|NCT03312634|156756976|FG001|Overall Study|Physician Decision|0|||
48701502|NCT03312634|156756975|FG000|Overall Study|Other|13|||
48701503|NCT03312634|156756976|FG001|Overall Study|Other|0|||
48701504|NCT01456039|156756977|FG000|Phase 1 (First Step)|Disease Progression|1|||
48701505|NCT01456039|156756978|FG001|Phase 1 (First Step)|Disease Progression|1|||
48701506|NCT01456039|156756979|FG002|Phase 1 (First Step)|Disease Progression|0|||
48701507|NCT01456039|156756977|FG000|Phase 1 (First Step)|Withdrawal by Subject|1|||
48701508|NCT01456039|156756978|FG001|Phase 1 (First Step)|Withdrawal by Subject|2|||
48701509|NCT01456039|156756979|FG002|Phase 1 (First Step)|Withdrawal by Subject|0|||
48701510|NCT01456039|156756977|FG000|Phase 1 (First Step)|Adverse Event|0|||
48701511|NCT01456039|156756978|FG001|Phase 1 (First Step)|Adverse Event|3|||
48701512|NCT01456039|156756979|FG002|Phase 1 (First Step)|Adverse Event|0|||
48701513|NCT01456039|156756977|FG000|Phase 1 (First Step)|Other|0|||
48701514|NCT01456039|156756978|FG001|Phase 1 (First Step)|Other|1|||
48701515|NCT01456039|156756979|FG002|Phase 1 (First Step)|Other|0|||
48701516|NCT01456039|156756977|FG000|Phase 2 (Second Step)|Disease Progression|0|||
48701517|NCT01456039|156756978|FG001|Phase 2 (Second Step)|Disease Progression|0|||
48701518|NCT01456039|156756979|FG002|Phase 2 (Second Step)|Disease Progression|17|||
48701519|NCT01456039|156756977|FG000|Phase 2 (Second Step)|Adverse Event|0|||
48701520|NCT01456039|156756978|FG001|Phase 2 (Second Step)|Adverse Event|0|||
48701521|NCT01456039|156756979|FG002|Phase 2 (Second Step)|Adverse Event|10|||
48701522|NCT01456039|156756977|FG000|Phase 2 (Second Step)|Withdrawal by Subject|0|||
48701523|NCT01456039|156756978|FG001|Phase 2 (Second Step)|Withdrawal by Subject|0|||
48701524|NCT01456039|156756979|FG002|Phase 2 (Second Step)|Withdrawal by Subject|4|||
48701525|NCT01456039|156756977|FG000|Phase 2 (Second Step)|Protocol Violation|0|||
48701526|NCT01456039|156756978|FG001|Phase 2 (Second Step)|Protocol Violation|0|||
48701527|NCT01456039|156756979|FG002|Phase 2 (Second Step)|Protocol Violation|1|||
48701528|NCT01456039|156756977|FG000|Phase 2 (Second Step)|Other|0|||
48701529|NCT01456039|156756978|FG001|Phase 2 (Second Step)|Other|0|||
48701530|NCT01456039|156756979|FG002|Phase 2 (Second Step)|Other|1|||
48701531|NCT01347112|156756980|FG000|Overall Study|Withdrawal by Subject|1|||
48701532|NCT01347112|156756981|FG001|Overall Study|Withdrawal by Subject|7|||
48701533|NCT01347112|156756980|FG000|Overall Study|Lost to Follow-up|3|||
48701534|NCT01347112|156756981|FG001|Overall Study|Lost to Follow-up|5|||
48701535|NCT00696072|156756986|FG000|Overall Study|continuing active treatment|10|||
48701536|NCT00696072|156756987|FG001|Overall Study|continuing active treatment|13|||
48701537|NCT00696072|156756986|FG000|Overall Study|Adverse Event|10|||
48701538|NCT00696072|156756987|FG001|Overall Study|Adverse Event|6|||
48701539|NCT00696072|156756986|FG000|Overall Study|Patient Request|3|||
48701540|NCT00696072|156756987|FG001|Overall Study|Patient Request|7|||
48701541|NCT00696072|156756986|FG000|Overall Study|Investigator Request|1|||
48856281|NCT05260437|157312812|FG001|Overall Study|Lost to Follow-up|2|||
48701542|NCT00696072|156756987|FG001|Overall Study|Investigator Request|4|||
48701543|NCT00696072|156756986|FG000|Overall Study|Sponsor Request|0|||
48701544|NCT00696072|156756987|FG001|Overall Study|Sponsor Request|1|||
48701545|NCT00696072|156756986|FG000|Overall Study|Disease Progression|32|||
48701546|NCT00696072|156756987|FG001|Overall Study|Disease Progression|30|||
48701547|NCT00696072|156756986|FG000|Overall Study|Non-specified|1|||
48701548|NCT00696072|156756987|FG001|Overall Study|Non-specified|2|||
48701549|NCT01021020|156756988|FG000|Period I|Protocol Violation|1|||
48701550|NCT01021020|156756988|FG000|Period I|Withdrawal by Subject|1|||
48701551|NCT01021020|156756988|FG000|14 Day Washout Period A|Physician Decision|1|||
48701552|NCT01710501|156756991|FG000|Overall Study|Lost to Follow-up|2|||
48701553|NCT01710501|156756992|FG001|Overall Study|Lost to Follow-up|0|||
48701554|NCT01710501|156756993|FG002|Overall Study|Lost to Follow-up|0|||
48701555|NCT01389596|156756994|FG000|Overall Study|Protocol Violation|3|||
48701556|NCT01389596|156756995|FG001|Overall Study|Protocol Violation|4|||
48701557|NCT01389596|156756996|FG002|Overall Study|Protocol Violation|3|||
48701558|NCT01389596|156756994|FG000|Overall Study|Withdrawal by Subject|1|||
48701559|NCT01389596|156756995|FG001|Overall Study|Withdrawal by Subject|2|||
48701560|NCT01389596|156756996|FG002|Overall Study|Withdrawal by Subject|2|||
48701561|NCT01389596|156756994|FG000|Overall Study|Insufficient Clinical Response|3|||
48701562|NCT01389596|156756995|FG001|Overall Study|Insufficient Clinical Response|4|||
48701563|NCT01389596|156756996|FG002|Overall Study|Insufficient Clinical Response|5|||
48701564|NCT01389596|156756994|FG000|Overall Study|Adverse Event|1|||
49010612|NCT01200394|157875660|FG000|Overall Study|Protocol Violation|0|||
49010613|NCT01200394|157875661|FG001|Overall Study|Protocol Violation|3|||
49010614|NCT01200394|157875660|FG000|Overall Study|Withdrawal by Subject|0|||
49010615|NCT01200394|157875661|FG001|Overall Study|Withdrawal by Subject|5|||
49010616|NCT01200394|157875660|FG000|Overall Study|Other|0|||
49010617|NCT01200394|157875661|FG001|Overall Study|Other|1|||
49010618|NCT02683187|157875663|FG000|Overall Study|Failed IV access|3|||
49010619|NCT02683187|157875663|FG000|Overall Study|Withdrawal by Subject|5|||
49010620|NCT01463683|157875664|FG000|Overall Study|Adverse Event|2|||
49010621|NCT01463683|157875665|FG001|Overall Study|Adverse Event|0|||
49010622|NCT01463683|157875666|FG002|Overall Study|Adverse Event|0|||
49010623|NCT01463683|157875664|FG000|Overall Study|Lost to Follow-up|10|||
49010624|NCT01463683|157875665|FG001|Overall Study|Lost to Follow-up|9|||
49010625|NCT01463683|157875666|FG002|Overall Study|Lost to Follow-up|7|||
49010626|NCT01463683|157875664|FG000|Overall Study|Physician Decision|0|||
49010627|NCT01463683|157875665|FG001|Overall Study|Physician Decision|3|||
49010628|NCT01463683|157875666|FG002|Overall Study|Physician Decision|1|||
49010629|NCT01463683|157875664|FG000|Overall Study|Pregnancy|2|||
49010630|NCT01463683|157875665|FG001|Overall Study|Pregnancy|2|||
49010631|NCT01463683|157875666|FG002|Overall Study|Pregnancy|1|||
49010632|NCT01463683|157875664|FG000|Overall Study|Withdrawal by Subject|5|||
49010633|NCT01463683|157875665|FG001|Overall Study|Withdrawal by Subject|17|||
49010634|NCT01463683|157875666|FG002|Overall Study|Withdrawal by Subject|2|||
49010635|NCT04079842|157875667|FG000|Overall Study|Request of subject|2|||
49010636|NCT04079842|157875667|FG000|Overall Study|Unable to draw Arterial samples|1|||
49010637|NCT00095199|157875670|FG000|Overall Study|Adverse Event|40|||
49010638|NCT00095199|157875671|FG001|Overall Study|Adverse Event|22|||
49010639|NCT00095199|157875672|FG002|Overall Study|Adverse Event|26|||
49010640|NCT00095199|157875673|FG003|Overall Study|Adverse Event|11|||
49010641|NCT00095199|157875670|FG000|Overall Study|Progressive disease|213|||
49010642|NCT00095199|157875671|FG001|Overall Study|Progressive disease|179|||
49010643|NCT00095199|157875672|FG002|Overall Study|Progressive disease|105|||
49010644|NCT00095199|157875673|FG003|Overall Study|Progressive disease|98|||
48701565|NCT01389596|156756995|FG001|Overall Study|Adverse Event|4|||
48701566|NCT01389596|156756996|FG002|Overall Study|Adverse Event|0|||
48701567|NCT01389596|156756994|FG000|Overall Study|Death|0|||
48701568|NCT01389596|156756995|FG001|Overall Study|Death|1|||
48701569|NCT01389596|156756996|FG002|Overall Study|Death|0|||
48701570|NCT01389596|156756994|FG000|Overall Study|Other Unspecified|2|||
48701571|NCT01389596|156756995|FG001|Overall Study|Other Unspecified|1|||
48701572|NCT01389596|156756996|FG002|Overall Study|Other Unspecified|0|||
48701573|NCT03829228|156756998|FG000|Overall Study|Protocol Violation|1|||
48701574|NCT01458392|156756999|FG000|Overall Study|Death|2|||
48701575|NCT01458392|156757000|FG001|Overall Study|Death|11|||
48701576|NCT01458392|156757001|FG002|Overall Study|Death|22|||
48701577|NCT01458392|156756999|FG000|Overall Study|At the discretion of the sponsor|0|||
49118003|NCT01720524|158271207|FG001|Part A|Insufficient Clinical Response|4|||
49118004|NCT01720524|158271206|FG000|Part A|Adverse Event|2|||
49118005|NCT01720524|158271207|FG001|Part A|Adverse Event|2|||
49118006|NCT01720524|158271206|FG000|Part A|Death|2|||
49118007|NCT01720524|158271207|FG001|Part A|Death|1|||
49118008|NCT01720524|158271206|FG000|Part A|Lost to Follow-up|0|||
49118009|NCT01720524|158271207|FG001|Part A|Lost to Follow-up|1|||
49118010|NCT01720524|158271206|FG000|Part A|Missed 28 day follow-up visit|1|||
49118011|NCT01720524|158271207|FG001|Part A|Missed 28 day follow-up visit|1|||
49118012|NCT01720524|158271206|FG000|Part A|Withdrawal by Subject|0|||
49118013|NCT01720524|158271207|FG001|Part A|Withdrawal by Subject|1|||
49118014|NCT01720524|158271206|FG000|Part A|Other|0|||
49118015|NCT01720524|158271207|FG001|Part A|Other|1|||
49118016|NCT01720524|158271206|FG000|Part A|Lost to Follow-up|0|||
49118017|NCT01720524|158271207|FG001|Part A|Lost to Follow-up|1|||
49118018|NCT01720524|158271206|FG000|Part B|No longer willing to participate in study|1|||
49118019|NCT01720524|158271207|FG001|Part B|No longer willing to participate in study|4|||
49118020|NCT01720524|158271206|FG000|Part B|Other|2|||
49118021|NCT01720524|158271207|FG001|Part B|Other|0|||
49118022|NCT01720524|158271206|FG000|Part B|Lost to Follow-up|2|||
49118023|NCT01720524|158271207|FG001|Part B|Lost to Follow-up|3|||
49118024|NCT01720524|158271206|FG000|Part B|Death|0|||
49118025|NCT01720524|158271207|FG001|Part B|Death|2|||
49118026|NCT00158262|158271208|FG000|Overall Study|Lost to Follow-up|1|||
49118027|NCT00158262|158271209|FG001|Overall Study|Lost to Follow-up|1|||
49118028|NCT00593918|158271210|FG000|Overall Study|Withdrawal by Subject|5|||
49118029|NCT00593918|158271211|FG001|Overall Study|Withdrawal by Subject|24|||
49118030|NCT01808261|158271214|FG000|Overall Study|Physician Decision|0|||
49118031|NCT01808261|158271215|FG001|Overall Study|Physician Decision|2|||
49118032|NCT01808261|158271214|FG000|Overall Study|Study Closed/Terminated|25|||
49118033|NCT01808261|158271215|FG001|Overall Study|Study Closed/Terminated|23|||
48701578|NCT01458392|156757000|FG001|Overall Study|At the discretion of the sponsor|2|||
48701579|NCT01458392|156757001|FG002|Overall Study|At the discretion of the sponsor|7|||
48701580|NCT01458392|156756999|FG000|Overall Study|Patient unwilling to comply with protoco|0|||
48701581|NCT01458392|156757000|FG001|Overall Study|Patient unwilling to comply with protoco|0|||
48701582|NCT01458392|156757001|FG002|Overall Study|Patient unwilling to comply with protoco|2|||
49118034|NCT01808261|158271214|FG000|Overall Study|Adverse event, non-fatal|2|||
49118035|NCT01808261|158271215|FG001|Overall Study|Adverse event, non-fatal|0|||
49118036|NCT01808261|158271214|FG000|Overall Study|Consent withdrawn by subject|6|||
49118037|NCT01808261|158271215|FG001|Overall Study|Consent withdrawn by subject|7|||
49118038|NCT01808261|158271214|FG000|Overall Study|Lost to Follow-up|3|||
49118039|NCT01808261|158271215|FG001|Overall Study|Lost to Follow-up|1|||
49118040|NCT04676724|158271216|FG000|Overall Study|Adverse Event|2|||
49118041|NCT04676724|158271217|FG001|Overall Study|Adverse Event|0|||
49118042|NCT04676724|158271216|FG000|Overall Study|Lost to Follow-up|1|||
49118043|NCT04676724|158271217|FG001|Overall Study|Lost to Follow-up|0|||
49118044|NCT04676724|158271216|FG000|Overall Study|Physician Decision|0|||
49118045|NCT04676724|158271217|FG001|Overall Study|Physician Decision|1|||
49118046|NCT04676724|158271216|FG000|Overall Study|Withdrawal by Subject|3|||
49118047|NCT04676724|158271217|FG001|Overall Study|Withdrawal by Subject|2|||
49118048|NCT02585713|158271219|FG000|Overall Study|Withdrew prior to treatment|2|||
49118049|NCT02585713|158271220|FG001|Overall Study|Withdrew prior to treatment|7|||
49118050|NCT02585713|158271219|FG000|Overall Study|Other|3|||
49118051|NCT02585713|158271220|FG001|Overall Study|Other|1|||
49118052|NCT03311841|158271225|FG000|14-day Wash-out|Adverse Event|0|||
49118053|NCT03311841|158271226|FG001|14-day Wash-out|Adverse Event|1|||
49118054|NCT03311841|158271227|FG002|14-day Wash-out|Adverse Event|0|||
49118055|NCT03311841|158271228|FG003|14-day Wash-out|Adverse Event|0|||
49118056|NCT03311841|158271229|FG004|14-day Wash-out|Adverse Event|0|||
49118057|NCT03311841|158271225|FG000|14-day Wash-out|Non-Compliance With Study Drug|0|||
49118058|NCT03311841|158271226|FG001|14-day Wash-out|Non-Compliance With Study Drug|0|||
49118059|NCT03311841|158271227|FG002|14-day Wash-out|Non-Compliance With Study Drug|0|||
49118060|NCT03311841|158271228|FG003|14-day Wash-out|Non-Compliance With Study Drug|1|||
49118061|NCT03311841|158271229|FG004|14-day Wash-out|Non-Compliance With Study Drug|0|||
49118062|NCT00436826|158271230|FG000|Double Blind Period (DBP)|Adverse Event|2|||
49118063|NCT00436826|158271231|FG001|Double Blind Period (DBP)|Adverse Event|0|||
49118064|NCT00436826|158271232|FG002|Double Blind Period (DBP)|Adverse Event|0|||
49118065|NCT00436826|158271233|FG003|Double Blind Period (DBP)|Adverse Event|0|||
49118066|NCT00436826|158271234|FG004|Double Blind Period (DBP)|Adverse Event|0|||
49118067|NCT00436826|158271235|FG005|Double Blind Period (DBP)|Adverse Event|0|||
49118068|NCT00436826|158271230|FG000|Double Blind Period (DBP)|Protocol Violation|1|||
49118069|NCT00436826|158271231|FG001|Double Blind Period (DBP)|Protocol Violation|0|||
49118070|NCT00436826|158271232|FG002|Double Blind Period (DBP)|Protocol Violation|0|||
49118071|NCT00436826|158271233|FG003|Double Blind Period (DBP)|Protocol Violation|0|||
49118072|NCT00436826|158271234|FG004|Double Blind Period (DBP)|Protocol Violation|0|||
49118073|NCT00436826|158271235|FG005|Double Blind Period (DBP)|Protocol Violation|0|||
49118074|NCT00436826|158271230|FG000|Double Blind Period (DBP)|Other|10|||
49118075|NCT00436826|158271231|FG001|Double Blind Period (DBP)|Other|11|||
49118076|NCT00436826|158271232|FG002|Double Blind Period (DBP)|Other|0|||
49118077|NCT00436826|158271233|FG003|Double Blind Period (DBP)|Other|0|||
49118078|NCT00436826|158271234|FG004|Double Blind Period (DBP)|Other|0|||
49118079|NCT00436826|158271235|FG005|Double Blind Period (DBP)|Other|0|||
49118080|NCT00436826|158271230|FG000|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
49118081|NCT00436826|158271231|FG001|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
49118082|NCT00436826|158271232|FG002|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
49118083|NCT00436826|158271233|FG003|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1|||
49118084|NCT00436826|158271234|FG004|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
48701583|NCT00446849|156757004|FG000|Acute Phase|Lack of Efficacy|64|||
48701584|NCT00446849|156757004|FG000|Acute Phase|Protocol Violation|10|||
49118085|NCT00436826|158271235|FG005|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
49118086|NCT00436826|158271230|FG000|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
49118087|NCT00436826|158271231|FG001|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
49118088|NCT00436826|158271232|FG002|Ext. Period (With Cladribine Treatment)|Other un-specified|46|||
49118089|NCT00436826|158271233|FG003|Ext. Period (With Cladribine Treatment)|Other un-specified|25|||
48912273|NCT03677596|157516187|FG001|Overall Study|Adverse Event|1|||
48912274|NCT03677596|157516186|FG000|Overall Study|Death|10|||
48701585|NCT00446849|156757004|FG000|Acute Phase|Consent withdrawn|4|||
48701586|NCT00446849|156757004|FG000|Acute Phase|Lost to Follow-up|2|||
48701587|NCT00446849|156757004|FG000|Acute Phase|Physician Decision|1|||
48701588|NCT00446849|156757004|FG000|Acute Phase|noncompliance|1|||
48701589|NCT00446849|156757004|FG000|Maintenance Phase|Lack of Efficacy|40|||
48701590|NCT00446849|156757004|FG000|Maintenance Phase|Protocol Violation|7|||
49118090|NCT00436826|158271234|FG004|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
49118091|NCT00436826|158271235|FG005|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
49118092|NCT00436826|158271230|FG000|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
49118093|NCT00436826|158271231|FG001|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
49118094|NCT00436826|158271232|FG002|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
49118095|NCT00436826|158271233|FG003|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
49118096|NCT00436826|158271234|FG004|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51|||
49118097|NCT00436826|158271235|FG005|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7|||
49118098|NCT04004260|158271236|FG000|Overall Study|Withdrawal by Subject|7|||
49118099|NCT04004260|158271237|FG001|Overall Study|Withdrawal by Subject|3|||
49118100|NCT04004260|158271236|FG000|Overall Study|Lost to Follow-up|22|||
49118101|NCT04004260|158271237|FG001|Overall Study|Lost to Follow-up|12|||
49118102|NCT04004260|158271236|FG000|Overall Study|Did not engage in intervention|13|||
48701591|NCT00446849|156757004|FG000|Maintenance Phase|Adverse Event|6|||
49118103|NCT04004260|158271237|FG001|Overall Study|Did not engage in intervention|17|||
49118104|NCT05464420|158271241|FG000|Overall Study|Death|0|||
49118105|NCT05464420|158271242|FG001|Overall Study|Death|0|||
49118106|NCT05464420|158271243|FG002|Overall Study|Death|0|||
49118107|NCT05464420|158271244|FG003|Overall Study|Death|1|||
49118108|NCT05464420|158271241|FG000|Overall Study|Lost to Follow-up|16|||
49118109|NCT05464420|158271242|FG001|Overall Study|Lost to Follow-up|11|||
49118110|NCT05464420|158271243|FG002|Overall Study|Lost to Follow-up|11|||
49118111|NCT05464420|158271244|FG003|Overall Study|Lost to Follow-up|11|||
49118112|NCT05464420|158271241|FG000|Overall Study|Randomized in Error Without Study Treatment|0|||
48701592|NCT00446849|156757004|FG000|Maintenance Phase|Consent withdrawn|5|||
48701593|NCT00446849|156757004|FG000|Maintenance Phase|Lost to Follow-up|3|||
49118113|NCT05464420|158271242|FG001|Overall Study|Randomized in Error Without Study Treatment|1|||
49118114|NCT05464420|158271243|FG002|Overall Study|Randomized in Error Without Study Treatment|0|||
48701594|NCT00446849|156757004|FG000|Maintenance Phase|Pregnancy|1|||
48701595|NCT00446849|156757004|FG000|Maintenance Phase|noncompliance|2|||
48701596|NCT00446849|156757004|FG000|Maintenance Phase|prohibited medication use|2|||
48701597|NCT00446849|156757004|FG000|Maintenance Phase|antibiotic use|1|||
48701598|NCT00446849|156757004|FG000|Maintenance Phase|study closure|1|||
48701599|NCT00446849|156757004|FG000|Maintenance Phase|hydrocodone use|1|||
48701600|NCT00446849|156757004|FG000|Maintenance Phase|concomitant medication use|1|||
48701601|NCT01815918|156757005|FG000|Overall Study|Patient samples not analyzable|3|||
48701602|NCT01815918|156757006|FG001|Overall Study|Patient samples not analyzable|4|||
48701603|NCT01815918|156757005|FG000|Overall Study|Lack of Efficacy|15|||
48701604|NCT01815918|156757006|FG001|Overall Study|Lack of Efficacy|15|||
48701605|NCT02007096|156757010|FG000|Overall Study|medication not available|2|||
48701606|NCT02007096|156757011|FG001|Overall Study|medication not available|0|||
48701607|NCT02007096|156757010|FG000|Overall Study|did not inject saline|0|||
48701608|NCT02007096|156757011|FG001|Overall Study|did not inject saline|3|||
48701609|NCT02007096|156757010|FG000|Overall Study|did not follow postoperative protocol|8|||
48701610|NCT02007096|156757011|FG001|Overall Study|did not follow postoperative protocol|11|||
48701611|NCT02007096|156757010|FG000|Overall Study|converted to open surgery|1|||
48701612|NCT02007096|156757011|FG001|Overall Study|converted to open surgery|1|||
48701613|NCT02007096|156757010|FG000|Overall Study|no mesh placed|0|||
48701614|NCT02007096|156757011|FG001|Overall Study|no mesh placed|1|||
48701615|NCT01002339|156757013|FG000|Overall Study|Withdrawal by Subject|0|||
49118115|NCT05464420|158271244|FG003|Overall Study|Randomized in Error Without Study Treatment|0|||
49118116|NCT05464420|158271241|FG000|Overall Study|Withdrawal by Subject|4|||
49118117|NCT05464420|158271242|FG001|Overall Study|Withdrawal by Subject|8|||
49118118|NCT05464420|158271243|FG002|Overall Study|Withdrawal by Subject|3|||
49118119|NCT05464420|158271244|FG003|Overall Study|Withdrawal by Subject|1|||
49118120|NCT05464420|158271241|FG000|Overall Study|Protocol Violation|0|||
49118121|NCT05464420|158271242|FG001|Overall Study|Protocol Violation|0|||
49118122|NCT05464420|158271243|FG002|Overall Study|Protocol Violation|1|||
49118123|NCT05464420|158271244|FG003|Overall Study|Protocol Violation|1|||
49118124|NCT05464420|158271241|FG000|Overall Study|Unable to Adhere to Study Schedule|0|||
49118125|NCT05464420|158271242|FG001|Overall Study|Unable to Adhere to Study Schedule|0|||
49118126|NCT05464420|158271243|FG002|Overall Study|Unable to Adhere to Study Schedule|1|||
49118127|NCT05464420|158271244|FG003|Overall Study|Unable to Adhere to Study Schedule|0|||
49118128|NCT01497067|158271245|FG000|Overall Study|Lost to Follow-up|56|||
48701616|NCT01002339|156757014|FG001|Overall Study|Withdrawal by Subject|1|||
48701617|NCT01002339|156757015|FG002|Overall Study|Withdrawal by Subject|0|||
48701618|NCT01002339|156757013|FG000|Overall Study|Incorrect treatment assignment|0|||
48701619|NCT01002339|156757014|FG001|Overall Study|Incorrect treatment assignment|0|||
48701620|NCT01002339|156757015|FG002|Overall Study|Incorrect treatment assignment|1|||
48701621|NCT01002339|156757013|FG000|Overall Study|Protocol Violation|0|||
48701622|NCT01002339|156757014|FG001|Overall Study|Protocol Violation|0|||
48701623|NCT01002339|156757015|FG002|Overall Study|Protocol Violation|2|||
48701624|NCT01002339|156757013|FG000|Overall Study|Lung cancer detected before transplant|0|||
48701625|NCT01002339|156757014|FG001|Overall Study|Lung cancer detected before transplant|0|||
48701626|NCT01002339|156757015|FG002|Overall Study|Lung cancer detected before transplant|1|||
48701627|NCT01002339|156757013|FG000|Overall Study|Randomized. Not transplanted|0|||
48701628|NCT01002339|156757014|FG001|Overall Study|Randomized. Not transplanted|0|||
48701629|NCT01002339|156757015|FG002|Overall Study|Randomized. Not transplanted|1|||
48701630|NCT00807911|156757016|FG000|Overall Study|Withdrawal by Subject|12|||
48701631|NCT00807911|156757017|FG001|Overall Study|Withdrawal by Subject|10|||
48701632|NCT00807911|156757016|FG000|Overall Study|Ineligible|0|||
48701633|NCT00807911|156757017|FG001|Overall Study|Ineligible|4|||
48701634|NCT02923726|156757020|FG000|Overall Study|Death|196|||
48701635|NCT02923726|156757021|FG001|Overall Study|Death|175|||
48701636|NCT02923726|156757020|FG000|Overall Study|Withdrawal by Subject|337|||
48701637|NCT02923726|156757021|FG001|Overall Study|Withdrawal by Subject|307|||
48701638|NCT00912808|156757022|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
48701639|NCT00912808|156757023|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
48701640|NCT00912808|156757022|FG000|Washout|Withdrawal by Subject|0|||
48701641|NCT00912808|156757023|FG001|Washout|Withdrawal by Subject|1|||
48701642|NCT00912808|156757022|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
48701643|NCT00912808|156757023|FG001|Second Intervention (6 Weeks)|Adverse Event|1|||
48701644|NCT00912808|156757022|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
48701645|NCT00912808|156757023|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
48701646|NCT02531802|156757024|FG000|Received Vaccination 2|Medication interfering with study taken|0|||
49118129|NCT01497067|158271245|FG000|Overall Study|Adverse Event|3|||
49118130|NCT01497067|158271245|FG000|Overall Study|Patient decision unrel to Adverse Event|10|||
49118131|NCT01497067|158271245|FG000|Overall Study|Other|13|||
49118132|NCT02360280|158271246|FG000|Overall Study|Withdrawal by Subject|2|||
49118133|NCT02360280|158271247|FG001|Overall Study|Withdrawal by Subject|0|||
49118134|NCT02360280|158271246|FG000|Overall Study|Adverse Event|0|||
49118135|NCT02360280|158271247|FG001|Overall Study|Adverse Event|1|||
49118136|NCT02360280|158271246|FG000|Overall Study|Lost to Follow-up|1|||
49118137|NCT02360280|158271247|FG001|Overall Study|Lost to Follow-up|0|||
49118138|NCT05568797|158271258|FG000|Overall Study|Adverse Event|0|||
49118139|NCT05568797|158271259|FG001|Overall Study|Adverse Event|8|||
49118140|NCT05568797|158271258|FG000|Overall Study|Lost to Follow-up|2|||
48701647|NCT02531802|156757025|FG001|Received Vaccination 2|Medication interfering with study taken|0|||
48701648|NCT02531802|156757026|FG002|Received Vaccination 2|Medication interfering with study taken|1|||
48701649|NCT02531802|156757027|FG003|Received Vaccination 2|Medication interfering with study taken|0|||
48701650|NCT02531802|156757028|FG004|Received Vaccination 2|Medication interfering with study taken|0|||
48701651|NCT02531802|156757029|FG005|Received Vaccination 2|Medication interfering with study taken|0|||
48701652|NCT02531802|156757030|FG006|Received Vaccination 2|Medication interfering with study taken|0|||
48701653|NCT02531802|156757031|FG007|Received Vaccination 2|Medication interfering with study taken|0|||
48701654|NCT02531802|156757032|FG008|Received Vaccination 2|Medication interfering with study taken|0|||
48701655|NCT02531802|156757033|FG009|Received Vaccination 2|Medication interfering with study taken|1|||
49118141|NCT05568797|158271259|FG001|Overall Study|Lost to Follow-up|3|||
49118142|NCT05568797|158271258|FG000|Overall Study|Withdrawal by Subject|1|||
49118143|NCT05568797|158271259|FG001|Overall Study|Withdrawal by Subject|10|||
49118144|NCT05568797|158271258|FG000|Overall Study|Other|2|||
49118145|NCT05568797|158271259|FG001|Overall Study|Other|2|||
49118146|NCT03046953|158271262|FG000|Overall Study|Relapse/progressive disease|21|||
49118147|NCT03046953|158271262|FG000|Overall Study|Death|2|||
49118148|NCT03046953|158271262|FG000|Overall Study|Withdrawal by Subject|3|||
48701656|NCT02531802|156757034|FG010|Received Vaccination 2|Medication interfering with study taken|1|||
48701657|NCT02531802|156757035|FG011|Received Vaccination 2|Medication interfering with study taken|0|||
48701658|NCT02531802|156757036|FG012|Received Vaccination 2|Medication interfering with study taken|1|||
48701659|NCT02531802|156757037|FG013|Received Vaccination 2|Medication interfering with study taken|0|||
48701660|NCT02531802|156757038|FG014|Received Vaccination 2|Medication interfering with study taken|0|||
48701661|NCT02531802|156757039|FG015|Received Vaccination 2|Medication interfering with study taken|0|||
48701662|NCT02531802|156757040|FG016|Received Vaccination 2|Medication interfering with study taken|0|||
48701663|NCT02531802|156757041|FG017|Received Vaccination 2|Medication interfering with study taken|0|||
48701664|NCT02531802|156757042|FG018|Received Vaccination 2|Medication interfering with study taken|1|||
48701665|NCT02531802|156757043|FG019|Received Vaccination 2|Medication interfering with study taken|0|||
48701666|NCT02531802|156757044|FG020|Received Vaccination 2|Medication interfering with study taken|0|||
48701667|NCT02531802|156757024|FG000|Received Vaccination 2|Physician Decision|0|||
48701668|NCT02531802|156757025|FG001|Received Vaccination 2|Physician Decision|0|||
48701669|NCT02531802|156757026|FG002|Received Vaccination 2|Physician Decision|0|||
48701670|NCT02531802|156757027|FG003|Received Vaccination 2|Physician Decision|0|||
48701671|NCT02531802|156757028|FG004|Received Vaccination 2|Physician Decision|0|||
49118149|NCT02716584|158271263|FG000|Overall Study|Lost to Follow-up|8|||
49118150|NCT02716584|158271264|FG001|Overall Study|Lost to Follow-up|5|||
49118151|NCT01462110|158271265|FG000|Overall Study|Adverse Event|1|||
49118152|NCT01462110|158271266|FG001|Overall Study|Adverse Event|0|||
49118153|NCT00096538|158271267|FG000|Overall Study|Withdrawal by Subject|1|||
49118154|NCT01938846|158271268|FG000|Overall Study|Progressive disease|26|||
49118155|NCT01938846|158271269|FG001|Overall Study|Progressive disease|18|||
49118156|NCT01938846|158271270|FG002|Overall Study|Progressive disease|16|||
49118157|NCT01938846|158271268|FG000|Overall Study|Adverse Event|8|||
49118158|NCT01938846|158271269|FG001|Overall Study|Adverse Event|4|||
49118159|NCT01938846|158271270|FG002|Overall Study|Adverse Event|3|||
49118160|NCT01938846|158271268|FG000|Overall Study|Withdrawal by Subject|2|||
49118161|NCT01938846|158271269|FG001|Overall Study|Withdrawal by Subject|2|||
49118162|NCT01938846|158271270|FG002|Overall Study|Withdrawal by Subject|1|||
49118163|NCT01938846|158271268|FG000|Overall Study|Other than listed|5|||
48701672|NCT02531802|156757029|FG005|Received Vaccination 2|Physician Decision|1|||
49010645|NCT00095199|157875670|FG000|Overall Study|Death|10|||
49010646|NCT00095199|157875671|FG001|Overall Study|Death|6|||
49010647|NCT00095199|157875672|FG002|Overall Study|Death|11|||
49010648|NCT00095199|157875673|FG003|Overall Study|Death|9|||
49010649|NCT00095199|157875670|FG000|Overall Study|Withdrawal by Subject|21|||
49010650|NCT00095199|157875671|FG001|Overall Study|Withdrawal by Subject|16|||
49010651|NCT00095199|157875672|FG002|Overall Study|Withdrawal by Subject|13|||
49010652|NCT00095199|157875673|FG003|Overall Study|Withdrawal by Subject|22|||
49010653|NCT00095199|157875670|FG000|Overall Study|Protocol Violation|4|||
49010654|NCT00095199|157875671|FG001|Overall Study|Protocol Violation|4|||
49010655|NCT00095199|157875672|FG002|Overall Study|Protocol Violation|2|||
49010656|NCT00095199|157875673|FG003|Overall Study|Protocol Violation|0|||
49010657|NCT00095199|157875670|FG000|Overall Study|Liver function test results elevated|0|||
49010658|NCT00095199|157875671|FG001|Overall Study|Liver function test results elevated|0|||
49010659|NCT00095199|157875672|FG002|Overall Study|Liver function test results elevated|1|||
49010660|NCT00095199|157875673|FG003|Overall Study|Liver function test results elevated|1|||
49010661|NCT00095199|157875670|FG000|Overall Study|Surgery needed could not start in 7 days|0|||
49010662|NCT00095199|157875671|FG001|Overall Study|Surgery needed could not start in 7 days|0|||
49010663|NCT00095199|157875672|FG002|Overall Study|Surgery needed could not start in 7 days|1|||
49010664|NCT00095199|157875673|FG003|Overall Study|Surgery needed could not start in 7 days|0|||
49010665|NCT00095199|157875670|FG000|Overall Study|Physician Decision|5|||
49010666|NCT00095199|157875671|FG001|Overall Study|Physician Decision|6|||
49010667|NCT00095199|157875672|FG002|Overall Study|Physician Decision|1|||
49010668|NCT00095199|157875673|FG003|Overall Study|Physician Decision|1|||
49010669|NCT00095199|157875670|FG000|Overall Study|Not eligible|1|||
49010670|NCT00095199|157875671|FG001|Overall Study|Not eligible|7|||
49010671|NCT00095199|157875672|FG002|Overall Study|Not eligible|0|||
49010672|NCT00095199|157875673|FG003|Overall Study|Not eligible|1|||
49010673|NCT00095199|157875670|FG000|Overall Study|Started Palliative Radiotherapy|1|||
49010674|NCT00095199|157875671|FG001|Overall Study|Started Palliative Radiotherapy|0|||
49010675|NCT00095199|157875672|FG002|Overall Study|Started Palliative Radiotherapy|0|||
49010676|NCT00095199|157875673|FG003|Overall Study|Started Palliative Radiotherapy|0|||
49010677|NCT00095199|157875670|FG000|Overall Study|Started radiotherapy regimen|0|||
49010678|NCT00095199|157875671|FG001|Overall Study|Started radiotherapy regimen|1|||
49010679|NCT00095199|157875672|FG002|Overall Study|Started radiotherapy regimen|0|||
49010680|NCT00095199|157875673|FG003|Overall Study|Started radiotherapy regimen|0|||
49010681|NCT00095199|157875670|FG000|Overall Study|Primary tumor removed in other surgery|0|||
49118164|NCT01938846|158271269|FG001|Overall Study|Other than listed|1|||
49118165|NCT01938846|158271270|FG002|Overall Study|Other than listed|4|||
49118166|NCT04754542|158271276|FG000|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
49118167|NCT04754542|158271277|FG001|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
49118168|NCT02308228|158271278|FG000|Overall Study|Adverse Event|3|||
49118169|NCT02308228|158271279|FG001|Overall Study|Adverse Event|4|||
49118170|NCT02308228|158271278|FG000|Overall Study|Withdrawal by Subject|5|||
49118171|NCT02308228|158271279|FG001|Overall Study|Withdrawal by Subject|3|||
49118172|NCT02532283|158271280|FG000|Overall Study|Adverse Event|0|||
49118173|NCT02532283|158271281|FG001|Overall Study|Adverse Event|1|||
49118174|NCT02532283|158271280|FG000|Overall Study|Death|1|||
49118175|NCT02532283|158271281|FG001|Overall Study|Death|0|||
49118176|NCT02532283|158271280|FG000|Overall Study|Lost to Follow-up|0|||
49118177|NCT02532283|158271281|FG001|Overall Study|Lost to Follow-up|1|||
49118178|NCT02532283|158271280|FG000|Overall Study|Withdrawal by Subject|8|||
49118179|NCT02532283|158271281|FG001|Overall Study|Withdrawal by Subject|3|||
49118180|NCT02029274|158271286|FG000|Overall Study|Adverse Event|1|||
49118181|NCT02029274|158271287|FG001|Overall Study|Adverse Event|0|||
49118182|NCT02029274|158271288|FG002|Overall Study|Adverse Event|2|||
49118183|NCT02029274|158271289|FG003|Overall Study|Adverse Event|2|||
49118184|NCT04265261|158271293|FG000|Overall Study|Adverse Event|2|||
49118185|NCT04265261|158271294|FG001|Overall Study|Adverse Event|0|||
49118186|NCT04265261|158271295|FG002|Overall Study|Adverse Event|0|||
49118187|NCT04265261|158271293|FG000|Overall Study|Death|1|||
49118188|NCT04265261|158271294|FG001|Overall Study|Death|0|||
49118189|NCT04265261|158271295|FG002|Overall Study|Death|0|||
49118190|NCT04265261|158271293|FG000|Overall Study|Lost to Follow-up|4|||
49118191|NCT04265261|158271294|FG001|Overall Study|Lost to Follow-up|1|||
49118192|NCT04265261|158271295|FG002|Overall Study|Lost to Follow-up|3|||
49118193|NCT04265261|158271293|FG000|Overall Study|Non-Compliance with Study Drug|1|||
49118194|NCT04265261|158271294|FG001|Overall Study|Non-Compliance with Study Drug|1|||
49118195|NCT04265261|158271295|FG002|Overall Study|Non-Compliance with Study Drug|0|||
49118196|NCT04265261|158271293|FG000|Overall Study|Physician Decision|0|||
49118197|NCT04265261|158271294|FG001|Overall Study|Physician Decision|0|||
49118198|NCT04265261|158271295|FG002|Overall Study|Physician Decision|1|||
49118199|NCT04265261|158271293|FG000|Overall Study|Protocol Deviation|0|||
49118200|NCT04265261|158271294|FG001|Overall Study|Protocol Deviation|2|||
49118201|NCT04265261|158271295|FG002|Overall Study|Protocol Deviation|0|||
49118202|NCT04265261|158271293|FG000|Overall Study|Withdrawal by Subject|2|||
49118203|NCT04265261|158271294|FG001|Overall Study|Withdrawal by Subject|1|||
49118204|NCT04265261|158271295|FG002|Overall Study|Withdrawal by Subject|4|||
49118205|NCT00398216|158273079|FG000|Overall Study|Adverse Event|4|||
49118206|NCT00398216|158273080|FG001|Overall Study|Adverse Event|2|||
49118207|NCT00398216|158273081|FG002|Overall Study|Adverse Event|5|||
49118208|NCT00398216|158273082|FG003|Overall Study|Adverse Event|7|||
49118209|NCT00398216|158273083|FG004|Overall Study|Adverse Event|2|||
49118210|NCT00398216|158273079|FG000|Overall Study|Protocol Violation|2|||
49118211|NCT00398216|158273080|FG001|Overall Study|Protocol Violation|4|||
49118212|NCT00398216|158273081|FG002|Overall Study|Protocol Violation|5|||
49118213|NCT00398216|158273082|FG003|Overall Study|Protocol Violation|7|||
49118214|NCT00398216|158273083|FG004|Overall Study|Protocol Violation|5|||
49118215|NCT00398216|158273079|FG000|Overall Study|Lost to Follow-up|1|||
49118216|NCT00398216|158273080|FG001|Overall Study|Lost to Follow-up|6|||
49118217|NCT00398216|158273081|FG002|Overall Study|Lost to Follow-up|4|||
49118218|NCT00398216|158273082|FG003|Overall Study|Lost to Follow-up|4|||
49118219|NCT00398216|158273083|FG004|Overall Study|Lost to Follow-up|1|||
49118220|NCT00398216|158273079|FG000|Overall Study|Death|0|||
49118221|NCT00398216|158273080|FG001|Overall Study|Death|3|||
49118222|NCT00398216|158273081|FG002|Overall Study|Death|0|||
49118223|NCT00398216|158273082|FG003|Overall Study|Death|0|||
49118224|NCT00398216|158273083|FG004|Overall Study|Death|0|||
49118225|NCT00398216|158273079|FG000|Overall Study|Withdrawal by Subject|1|||
49118226|NCT00398216|158273080|FG001|Overall Study|Withdrawal by Subject|0|||
49118227|NCT00398216|158273081|FG002|Overall Study|Withdrawal by Subject|3|||
49118228|NCT00398216|158273082|FG003|Overall Study|Withdrawal by Subject|1|||
49118229|NCT00398216|158273083|FG004|Overall Study|Withdrawal by Subject|2|||
49118230|NCT00398216|158273079|FG000|Overall Study|administrative reasons|3|||
49118231|NCT00398216|158273080|FG001|Overall Study|administrative reasons|4|||
49118232|NCT00398216|158273081|FG002|Overall Study|administrative reasons|4|||
49118233|NCT00398216|158273082|FG003|Overall Study|administrative reasons|3|||
49118234|NCT00398216|158273083|FG004|Overall Study|administrative reasons|3|||
49118235|NCT00398216|158273079|FG000|Overall Study|entrance criteria|0|||
49118236|NCT00398216|158273080|FG001|Overall Study|entrance criteria|0|||
49118237|NCT00398216|158273081|FG002|Overall Study|entrance criteria|0|||
49118238|NCT00398216|158273082|FG003|Overall Study|entrance criteria|0|||
49118239|NCT00398216|158273083|FG004|Overall Study|entrance criteria|2|||
49118240|NCT04227405|158273086|FG000|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|26|||
49118241|NCT04227405|158273087|FG001|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|78|||
49118242|NCT04227405|158273086|FG000|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|82|||
49118243|NCT04227405|158273087|FG001|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|68|||
48701673|NCT02531802|156757030|FG006|Received Vaccination 2|Physician Decision|0|||
48701674|NCT02531802|156757031|FG007|Received Vaccination 2|Physician Decision|0|||
48701675|NCT02531802|156757032|FG008|Received Vaccination 2|Physician Decision|0|||
48701676|NCT02531802|156757033|FG009|Received Vaccination 2|Physician Decision|2|||
48701677|NCT02531802|156757034|FG010|Received Vaccination 2|Physician Decision|0|||
48912275|NCT03677596|157516187|FG001|Overall Study|Death|6|||
48912276|NCT03677596|157516186|FG000|Overall Study|Lost to Follow-up|0|||
48701678|NCT02531802|156757035|FG011|Received Vaccination 2|Physician Decision|0|||
48701679|NCT02531802|156757036|FG012|Received Vaccination 2|Physician Decision|0|||
48701680|NCT02531802|156757037|FG013|Received Vaccination 2|Physician Decision|1|||
48701681|NCT02531802|156757038|FG014|Received Vaccination 2|Physician Decision|0|||
48701682|NCT02531802|156757039|FG015|Received Vaccination 2|Physician Decision|0|||
48701683|NCT02531802|156757040|FG016|Received Vaccination 2|Physician Decision|0|||
48701684|NCT02531802|156757041|FG017|Received Vaccination 2|Physician Decision|1|||
48701685|NCT02531802|156757042|FG018|Received Vaccination 2|Physician Decision|0|||
48701686|NCT02531802|156757043|FG019|Received Vaccination 2|Physician Decision|0|||
48701687|NCT02531802|156757044|FG020|Received Vaccination 2|Physician Decision|0|||
48701688|NCT02531802|156757024|FG000|Received Vaccination 2|Adverse Event|0|||
48701689|NCT02531802|156757025|FG001|Received Vaccination 2|Adverse Event|0|||
48701690|NCT02531802|156757026|FG002|Received Vaccination 2|Adverse Event|0|||
48701691|NCT02531802|156757027|FG003|Received Vaccination 2|Adverse Event|0|||
48701692|NCT02531802|156757028|FG004|Received Vaccination 2|Adverse Event|0|||
48701693|NCT02531802|156757029|FG005|Received Vaccination 2|Adverse Event|2|||
48701694|NCT02531802|156757030|FG006|Received Vaccination 2|Adverse Event|0|||
48701695|NCT02531802|156757031|FG007|Received Vaccination 2|Adverse Event|0|||
48701696|NCT02531802|156757032|FG008|Received Vaccination 2|Adverse Event|0|||
48701697|NCT02531802|156757033|FG009|Received Vaccination 2|Adverse Event|0|||
48701698|NCT02531802|156757034|FG010|Received Vaccination 2|Adverse Event|0|||
48701699|NCT02531802|156757035|FG011|Received Vaccination 2|Adverse Event|0|||
48701700|NCT02531802|156757036|FG012|Received Vaccination 2|Adverse Event|0|||
48701701|NCT02531802|156757037|FG013|Received Vaccination 2|Adverse Event|0|||
48701702|NCT02531802|156757038|FG014|Received Vaccination 2|Adverse Event|0|||
48701703|NCT02531802|156757039|FG015|Received Vaccination 2|Adverse Event|0|||
48701704|NCT02531802|156757040|FG016|Received Vaccination 2|Adverse Event|0|||
48701705|NCT02531802|156757041|FG017|Received Vaccination 2|Adverse Event|2|||
48701706|NCT02531802|156757042|FG018|Received Vaccination 2|Adverse Event|1|||
48701707|NCT02531802|156757043|FG019|Received Vaccination 2|Adverse Event|0|||
48701708|NCT02531802|156757044|FG020|Received Vaccination 2|Adverse Event|1|||
48701709|NCT02531802|156757024|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
48701710|NCT02531802|156757025|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
48701711|NCT02531802|156757026|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
48701712|NCT02531802|156757027|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
48701713|NCT02531802|156757028|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
48701714|NCT02531802|156757029|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
48701715|NCT02531802|156757030|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
48701716|NCT02531802|156757031|FG007|Received Vaccination 2|Withdrawal by Subject|0|||
48701717|NCT02531802|156757032|FG008|Received Vaccination 2|Withdrawal by Subject|0|||
48701718|NCT02531802|156757033|FG009|Received Vaccination 2|Withdrawal by Subject|0|||
48701719|NCT02531802|156757034|FG010|Received Vaccination 2|Withdrawal by Subject|1|||
48701720|NCT02531802|156757035|FG011|Received Vaccination 2|Withdrawal by Subject|0|||
48701721|NCT02531802|156757036|FG012|Received Vaccination 2|Withdrawal by Subject|1|||
48701722|NCT02531802|156757037|FG013|Received Vaccination 2|Withdrawal by Subject|1|||
48701723|NCT02531802|156757038|FG014|Received Vaccination 2|Withdrawal by Subject|1|||
48701724|NCT02531802|156757039|FG015|Received Vaccination 2|Withdrawal by Subject|0|||
48701725|NCT02531802|156757040|FG016|Received Vaccination 2|Withdrawal by Subject|0|||
48701726|NCT02531802|156757041|FG017|Received Vaccination 2|Withdrawal by Subject|1|||
48701727|NCT02531802|156757042|FG018|Received Vaccination 2|Withdrawal by Subject|1|||
48701728|NCT02531802|156757043|FG019|Received Vaccination 2|Withdrawal by Subject|1|||
48701729|NCT02531802|156757044|FG020|Received Vaccination 2|Withdrawal by Subject|0|||
48701730|NCT04885998|156757047|FG000|Overall Study|Ongoing in study|3|||
48701731|NCT04885998|156757048|FG001|Overall Study|Ongoing in study|2|||
48701732|NCT04885998|156757049|FG002|Overall Study|Ongoing in study|2|||
48701733|NCT04885998|156757050|FG003|Overall Study|Ongoing in study|6|||
48701734|NCT04885998|156757047|FG000|Overall Study|Withdrawal by Subject|0|||
48701735|NCT04885998|156757048|FG001|Overall Study|Withdrawal by Subject|2|||
48701736|NCT04885998|156757049|FG002|Overall Study|Withdrawal by Subject|1|||
48701737|NCT04885998|156757050|FG003|Overall Study|Withdrawal by Subject|1|||
48701738|NCT04885998|156757047|FG000|Overall Study|Lost to Follow-up|1|||
48701739|NCT04885998|156757048|FG001|Overall Study|Lost to Follow-up|0|||
48701740|NCT04885998|156757049|FG002|Overall Study|Lost to Follow-up|0|||
48701741|NCT04885998|156757050|FG003|Overall Study|Lost to Follow-up|0|||
48701742|NCT04885998|156757047|FG000|Overall Study|Death|2|||
48701743|NCT04885998|156757048|FG001|Overall Study|Death|1|||
48701744|NCT04885998|156757049|FG002|Overall Study|Death|1|||
48701745|NCT04885998|156757050|FG003|Overall Study|Death|0|||
48701746|NCT03777982|156757051|FG000|Overall Study|Physician Decision|0|||
49118244|NCT04227405|158273086|FG000|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|68|||
49118245|NCT04227405|158273087|FG001|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|48|||
49118246|NCT01190189|158273088|FG000|Overall Study|Lost to Follow-up|4|||
49118247|NCT01190189|158273088|FG000|Overall Study|Withdrawal by Subject|1|||
49118248|NCT01190189|158273088|FG000|Overall Study|Migrated/moved from study area|1|||
49118249|NCT02757352|158273094|FG000|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2|||
49118250|NCT02757352|158273095|FG001|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
49118251|NCT02757352|158273096|FG002|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1|||
49118252|NCT02757352|158273097|FG003|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
49118253|NCT02757352|158273098|FG004|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
49118254|NCT02757352|158273099|FG005|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
49118255|NCT02757352|158273100|FG006|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
49118256|NCT02757352|158273101|FG007|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
48701747|NCT03777982|156757052|FG001|Overall Study|Physician Decision|1|||
48701748|NCT00870740|156757053|FG000|Overall Study|Adverse Event|2|||
48701749|NCT00870740|156757054|FG001|Overall Study|Adverse Event|1|||
48701750|NCT00870740|156757055|FG002|Overall Study|Adverse Event|3|||
48701751|NCT00870740|156757056|FG003|Overall Study|Adverse Event|2|||
48701752|NCT00870740|156757057|FG004|Overall Study|Adverse Event|1|||
48912277|NCT03677596|157516187|FG001|Overall Study|Lost to Follow-up|1|||
48701753|NCT00870740|156757058|FG005|Overall Study|Adverse Event|6|||
48701754|NCT00870740|156757053|FG000|Overall Study|Consent Withdrawn|6|||
48701755|NCT00870740|156757054|FG001|Overall Study|Consent Withdrawn|3|||
48701756|NCT00870740|156757055|FG002|Overall Study|Consent Withdrawn|4|||
48701757|NCT00870740|156757056|FG003|Overall Study|Consent Withdrawn|6|||
48701758|NCT00870740|156757057|FG004|Overall Study|Consent Withdrawn|6|||
48701759|NCT00870740|156757058|FG005|Overall Study|Consent Withdrawn|5|||
48701760|NCT00870740|156757053|FG000|Overall Study|Investigator Decision|2|||
48701761|NCT00870740|156757054|FG001|Overall Study|Investigator Decision|0|||
48701762|NCT00870740|156757055|FG002|Overall Study|Investigator Decision|1|||
48701763|NCT00870740|156757056|FG003|Overall Study|Investigator Decision|0|||
48701764|NCT00870740|156757057|FG004|Overall Study|Investigator Decision|0|||
48701765|NCT00870740|156757058|FG005|Overall Study|Investigator Decision|0|||
48701766|NCT00870740|156757053|FG000|Overall Study|Subject Non-compliance|0|||
48701767|NCT00870740|156757054|FG001|Overall Study|Subject Non-compliance|0|||
48701768|NCT00870740|156757055|FG002|Overall Study|Subject Non-compliance|0|||
48701769|NCT00870740|156757056|FG003|Overall Study|Subject Non-compliance|0|||
48701770|NCT00870740|156757057|FG004|Overall Study|Subject Non-compliance|0|||
48701771|NCT00870740|156757058|FG005|Overall Study|Subject Non-compliance|1|||
48701772|NCT00870740|156757053|FG000|Overall Study|Death|0|||
48701773|NCT00870740|156757054|FG001|Overall Study|Death|0|||
48701774|NCT00870740|156757055|FG002|Overall Study|Death|0|||
48701775|NCT00870740|156757056|FG003|Overall Study|Death|0|||
48701776|NCT00870740|156757057|FG004|Overall Study|Death|1|||
49118257|NCT02757352|158273102|FG008|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
49118258|NCT02757352|158273103|FG009|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
49118259|NCT02757352|158273094|FG000|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
49118260|NCT02757352|158273095|FG001|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
49118261|NCT02757352|158273096|FG002|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1|||
49118262|NCT02757352|158273097|FG003|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
49118263|NCT02757352|158273098|FG004|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
49118264|NCT02757352|158273099|FG005|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
49118265|NCT02757352|158273100|FG006|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
49118266|NCT02757352|158273101|FG007|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
49118267|NCT02757352|158273102|FG008|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
49118268|NCT02757352|158273103|FG009|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
49118269|NCT02757352|158273094|FG000|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6|||
49118270|NCT02757352|158273095|FG001|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1|||
49118271|NCT02757352|158273096|FG002|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2|||
49118272|NCT02757352|158273097|FG003|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
49118273|NCT02757352|158273098|FG004|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
49118274|NCT02757352|158273099|FG005|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
49118275|NCT02757352|158273100|FG006|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
49118276|NCT02757352|158273101|FG007|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
49118277|NCT02757352|158273102|FG008|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
49118278|NCT02757352|158273103|FG009|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
49118279|NCT02757352|158273094|FG000|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
49118280|NCT02757352|158273095|FG001|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1|||
49118281|NCT02757352|158273096|FG002|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
49118282|NCT02757352|158273097|FG003|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
49118283|NCT02757352|158273098|FG004|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
49118284|NCT02757352|158273099|FG005|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
49118285|NCT02757352|158273100|FG006|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
49118286|NCT02757352|158273101|FG007|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
49118287|NCT02757352|158273102|FG008|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
49118288|NCT02757352|158273103|FG009|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
49118289|NCT02757352|158273094|FG000|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
49118290|NCT02757352|158273095|FG001|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1|||
49118291|NCT02757352|158273096|FG002|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
49118292|NCT02757352|158273097|FG003|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
49118293|NCT02757352|158273098|FG004|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
49118294|NCT02757352|158273099|FG005|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
49118295|NCT02757352|158273100|FG006|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
49118296|NCT02757352|158273101|FG007|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
49118297|NCT02757352|158273102|FG008|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
49118298|NCT02757352|158273103|FG009|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
49118299|NCT02757352|158273094|FG000|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
49118300|NCT02757352|158273095|FG001|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
49118301|NCT02757352|158273096|FG002|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4|||
49118302|NCT02757352|158273097|FG003|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
49118303|NCT02757352|158273098|FG004|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
49118304|NCT02757352|158273099|FG005|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
49118305|NCT02757352|158273100|FG006|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
48701777|NCT00870740|156757058|FG005|Overall Study|Death|0|||
48701778|NCT00870740|156757053|FG000|Overall Study|Other|2|||
48701779|NCT00870740|156757054|FG001|Overall Study|Other|5|||
48701780|NCT00870740|156757055|FG002|Overall Study|Other|2|||
48701781|NCT00870740|156757056|FG003|Overall Study|Other|4|||
48701782|NCT00870740|156757057|FG004|Overall Study|Other|3|||
48701783|NCT00870740|156757058|FG005|Overall Study|Other|5|||
48701784|NCT01033019|156757059|FG000|Overall Study|Withdrawal by Subject|1|||
48701785|NCT01033019|156757060|FG001|Overall Study|Withdrawal by Subject|0|||
48701786|NCT03011099|156757064|FG000|Overall Study|Withdrawal by Subject|0|||
48701787|NCT03011099|156757065|FG001|Overall Study|Withdrawal by Subject|2|||
48701788|NCT02158442|156757069|FG000|Overall Study|Withdrawal by Subject|1|||
48701789|NCT02158442|156757070|FG001|Overall Study|Withdrawal by Subject|0|||
48701790|NCT02158442|156757069|FG000|Overall Study|Perfusion staff not available|1|||
48701791|NCT02158442|156757070|FG001|Overall Study|Perfusion staff not available|0|||
48701792|NCT01457703|156757071|FG000|Overall Study|Screen Failure|5|||
48701793|NCT01457703|156757072|FG001|Overall Study|Screen Failure|7|||
48701794|NCT01457703|156757071|FG000|Overall Study|Withdrawal by Subject|1|||
48701795|NCT01457703|156757072|FG001|Overall Study|Withdrawal by Subject|4|||
48701796|NCT00632229|156757075|FG000|Overall Study|Adverse Event|6|||
48701797|NCT00632229|156757076|FG001|Overall Study|Adverse Event|0|||
48701798|NCT00632229|156757075|FG000|Overall Study|Lost to Follow-up|0|||
48701799|NCT00632229|156757076|FG001|Overall Study|Lost to Follow-up|3|||
48701800|NCT00632229|156757075|FG000|Overall Study|Lack of Efficacy|0|||
48701801|NCT00632229|156757076|FG001|Overall Study|Lack of Efficacy|2|||
48701802|NCT00632229|156757075|FG000|Overall Study|Undisclosed reasons within the first wee|0|||
48701803|NCT00632229|156757076|FG001|Overall Study|Undisclosed reasons within the first wee|1|||
49118306|NCT02757352|158273101|FG007|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
49118307|NCT02757352|158273102|FG008|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
49118308|NCT02757352|158273103|FG009|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
49118309|NCT02757352|158273094|FG000|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62|||
49118310|NCT02757352|158273095|FG001|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40|||
49118311|NCT02757352|158273096|FG002|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42|||
49118312|NCT02757352|158273097|FG003|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
49118313|NCT02757352|158273098|FG004|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
49118314|NCT02757352|158273099|FG005|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
49118315|NCT02757352|158273100|FG006|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
48701804|NCT04322526|156757079|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
48701805|NCT04322526|156757080|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
48701806|NCT04322526|156757079|FG000|Washout (1 Week)|Lost to Follow-up|1|||
48701807|NCT04322526|156757080|FG001|Washout (1 Week)|Lost to Follow-up|2|||
48701808|NCT00888173|156757085|FG000|Overall Study|Wrong Primary|1|||
48701809|NCT00888173|156757085|FG000|Overall Study|Ineligible: required test not done|1|||
48701810|NCT00687193|156757087|FG000|Overall Study|Adverse Event|0|||
48701811|NCT00687193|156757088|FG001|Overall Study|Adverse Event|1|||
48701812|NCT00687193|156757089|FG002|Overall Study|Adverse Event|2|||
48701813|NCT00687193|156757090|FG003|Overall Study|Adverse Event|3|||
48701814|NCT00687193|156757091|FG004|Overall Study|Adverse Event|0|||
48701815|NCT00687193|156757092|FG005|Overall Study|Adverse Event|2|||
48701816|NCT00687193|156757087|FG000|Overall Study|Lack of Efficacy|1|||
48701817|NCT00687193|156757088|FG001|Overall Study|Lack of Efficacy|1|||
48701818|NCT00687193|156757089|FG002|Overall Study|Lack of Efficacy|0|||
48701819|NCT00687193|156757090|FG003|Overall Study|Lack of Efficacy|0|||
48701820|NCT00687193|156757091|FG004|Overall Study|Lack of Efficacy|0|||
48701821|NCT00687193|156757092|FG005|Overall Study|Lack of Efficacy|2|||
48701822|NCT00687193|156757087|FG000|Overall Study|Protocol Violation|1|||
48701823|NCT00687193|156757088|FG001|Overall Study|Protocol Violation|2|||
48701824|NCT00687193|156757089|FG002|Overall Study|Protocol Violation|0|||
48912278|NCT03677596|157516186|FG000|Overall Study|Progressive Disease|8|||
48701825|NCT00687193|156757090|FG003|Overall Study|Protocol Violation|1|||
48701826|NCT00687193|156757091|FG004|Overall Study|Protocol Violation|2|||
48701827|NCT00687193|156757092|FG005|Overall Study|Protocol Violation|0|||
48701828|NCT01724346|156757093|FG000|Overall Study|Death|42|||
48701829|NCT01724346|156757094|FG001|Overall Study|Death|42|||
48701830|NCT01724346|156757093|FG000|Overall Study|Lost to Follow-up|5|||
48701831|NCT01724346|156757094|FG001|Overall Study|Lost to Follow-up|1|||
48701832|NCT01724346|156757093|FG000|Overall Study|Withdrawal by Subject|27|||
48701833|NCT01724346|156757094|FG001|Overall Study|Withdrawal by Subject|19|||
48701834|NCT01724346|156757093|FG000|Overall Study|Did Not Rollover From Parent Study|5|||
49118316|NCT02757352|158273101|FG007|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
49118317|NCT02757352|158273102|FG008|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
49118318|NCT02757352|158273103|FG009|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
49118319|NCT02757352|158273094|FG000|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
49118320|NCT02757352|158273095|FG001|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
49118321|NCT02757352|158273096|FG002|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
49118322|NCT02757352|158273097|FG003|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3|||
49118323|NCT02757352|158273098|FG004|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
49118324|NCT02757352|158273099|FG005|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1|||
49118325|NCT02757352|158273100|FG006|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
49118326|NCT02757352|158273101|FG007|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
49118327|NCT02757352|158273102|FG008|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
49118328|NCT02757352|158273103|FG009|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
49118329|NCT02757352|158273094|FG000|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
49118330|NCT02757352|158273095|FG001|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
49118331|NCT02757352|158273096|FG002|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
49118332|NCT02757352|158273097|FG003|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2|||
49118333|NCT02757352|158273098|FG004|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
49118334|NCT02757352|158273099|FG005|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4|||
49118335|NCT02757352|158273100|FG006|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
49118336|NCT02757352|158273101|FG007|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
49118337|NCT02757352|158273102|FG008|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
49118338|NCT02757352|158273103|FG009|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
49118339|NCT02757352|158273094|FG000|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
49118340|NCT02757352|158273095|FG001|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
49118341|NCT02757352|158273096|FG002|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
49118342|NCT02757352|158273097|FG003|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
49118343|NCT02757352|158273098|FG004|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1|||
49118344|NCT02757352|158273099|FG005|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
49118345|NCT02757352|158273100|FG006|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
49118346|NCT02757352|158273101|FG007|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
49118347|NCT02757352|158273102|FG008|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
49118348|NCT02757352|158273103|FG009|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
49118349|NCT02757352|158273094|FG000|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
49118350|NCT02757352|158273095|FG001|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
49118351|NCT02757352|158273096|FG002|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
49118352|NCT02757352|158273097|FG003|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
49118353|NCT02757352|158273098|FG004|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
49118354|NCT02757352|158273099|FG005|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1|||
49118355|NCT02757352|158273100|FG006|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
49118356|NCT02757352|158273101|FG007|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
49118357|NCT02757352|158273102|FG008|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
49118358|NCT02757352|158273103|FG009|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
49118359|NCT02757352|158273094|FG000|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
49118360|NCT02757352|158273095|FG001|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
49118361|NCT02757352|158273096|FG002|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
49118362|NCT02757352|158273097|FG003|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2|||
49118363|NCT02757352|158273098|FG004|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
49118364|NCT02757352|158273099|FG005|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
49118365|NCT02757352|158273100|FG006|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
49118366|NCT02757352|158273101|FG007|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
49118367|NCT02757352|158273102|FG008|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
49118368|NCT02757352|158273103|FG009|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
49118369|NCT02757352|158273094|FG000|Follow-Up Period|Adverse Event|0|||
49118370|NCT02757352|158273095|FG001|Follow-Up Period|Adverse Event|0|||
49118371|NCT02757352|158273096|FG002|Follow-Up Period|Adverse Event|0|||
49118372|NCT02757352|158273097|FG003|Follow-Up Period|Adverse Event|0|||
49118373|NCT02757352|158273098|FG004|Follow-Up Period|Adverse Event|0|||
49118374|NCT02757352|158273099|FG005|Follow-Up Period|Adverse Event|0|||
49118375|NCT02757352|158273100|FG006|Follow-Up Period|Adverse Event|1|||
49118376|NCT02757352|158273101|FG007|Follow-Up Period|Adverse Event|0|||
49118377|NCT02757352|158273102|FG008|Follow-Up Period|Adverse Event|2|||
49118378|NCT02757352|158273103|FG009|Follow-Up Period|Adverse Event|0|||
49118379|NCT02757352|158273094|FG000|Follow-Up Period|Lost to Follow-up|0|||
48856282|NCT05260437|157312813|FG002|Overall Study|Lost to Follow-up|1|||
49118380|NCT02757352|158273095|FG001|Follow-Up Period|Lost to Follow-up|0|||
48701835|NCT01724346|156757094|FG001|Overall Study|Did Not Rollover From Parent Study|8|||
48701836|NCT04774094|156757102|FG000|Overall Study|Other|2|||
48701837|NCT04774094|156757102|FG000|Overall Study|Withdrawal by Subject|9|||
48701838|NCT04774094|156757102|FG000|Overall Study|Lost to Follow-up|7|||
48701839|NCT04774094|156757102|FG000|Overall Study|Lack of Efficacy|5|||
48701840|NCT04774094|156757102|FG000|Overall Study|Death|17|||
48701841|NCT04774094|156757102|FG000|Overall Study|Adverse Event|4|||
48701842|NCT02638220|156757104|FG000|Overall Study|Lost to Follow-up|6|||
48701843|NCT02638220|156757104|FG000|Overall Study|Withdrawal by Subject|3|||
48701844|NCT02638220|156757104|FG000|Overall Study|Physician Decision|1|||
48701845|NCT02638220|156757104|FG000|Overall Study|Withdrawn, sample error, non-adherence, illness|6|||
48701846|NCT05232682|156757105|FG000|Overall Study|Lost to Follow-up|2|||
48701847|NCT02318706|156758506|FG000|Double-blind Phase|Adverse Event|7|||
48701848|NCT02318706|156758507|FG001|Double-blind Phase|Adverse Event|4|||
48701849|NCT02318706|156758508|FG002|Double-blind Phase|Adverse Event|3|||
48701850|NCT02318706|156758509|FG003|Double-blind Phase|Adverse Event|10|||
48701851|NCT02318706|156758510|FG004|Double-blind Phase|Adverse Event|0|||
48701852|NCT02318706|156758506|FG000|Double-blind Phase|Lost to Follow-up|1|||
48701853|NCT02318706|156758507|FG001|Double-blind Phase|Lost to Follow-up|0|||
48701854|NCT02318706|156758508|FG002|Double-blind Phase|Lost to Follow-up|0|||
48701855|NCT02318706|156758509|FG003|Double-blind Phase|Lost to Follow-up|0|||
48701856|NCT02318706|156758510|FG004|Double-blind Phase|Lost to Follow-up|0|||
48701857|NCT02318706|156758506|FG000|Double-blind Phase|Protocol Violation|4|||
48701858|NCT02318706|156758507|FG001|Double-blind Phase|Protocol Violation|2|||
48701859|NCT02318706|156758508|FG002|Double-blind Phase|Protocol Violation|4|||
48701860|NCT02318706|156758509|FG003|Double-blind Phase|Protocol Violation|3|||
48701861|NCT02318706|156758510|FG004|Double-blind Phase|Protocol Violation|0|||
49118381|NCT02757352|158273096|FG002|Follow-Up Period|Lost to Follow-up|0|||
49118382|NCT02757352|158273097|FG003|Follow-Up Period|Lost to Follow-up|0|||
49118383|NCT02757352|158273098|FG004|Follow-Up Period|Lost to Follow-up|0|||
49118384|NCT02757352|158273099|FG005|Follow-Up Period|Lost to Follow-up|0|||
49118385|NCT02757352|158273100|FG006|Follow-Up Period|Lost to Follow-up|0|||
49118386|NCT02757352|158273101|FG007|Follow-Up Period|Lost to Follow-up|0|||
49118387|NCT02757352|158273102|FG008|Follow-Up Period|Lost to Follow-up|1|||
49118388|NCT02757352|158273103|FG009|Follow-Up Period|Lost to Follow-up|0|||
48701862|NCT02318706|156758506|FG000|Double-blind Phase|Withdrawal by Subject|9|||
48701863|NCT02318706|156758507|FG001|Double-blind Phase|Withdrawal by Subject|5|||
48701864|NCT02318706|156758508|FG002|Double-blind Phase|Withdrawal by Subject|7|||
48701865|NCT02318706|156758509|FG003|Double-blind Phase|Withdrawal by Subject|10|||
48701866|NCT02318706|156758510|FG004|Double-blind Phase|Withdrawal by Subject|0|||
49118389|NCT02757352|158273094|FG000|Follow-Up Period|Lack of Efficacy|0|||
49118390|NCT02757352|158273095|FG001|Follow-Up Period|Lack of Efficacy|0|||
48701867|NCT02318706|156758506|FG000|Double-blind Phase|Other|4|||
48701868|NCT02318706|156758507|FG001|Double-blind Phase|Other|1|||
48701869|NCT02318706|156758508|FG002|Double-blind Phase|Other|2|||
48701870|NCT02318706|156758509|FG003|Double-blind Phase|Other|1|||
48701871|NCT02318706|156758510|FG004|Double-blind Phase|Other|0|||
48701872|NCT02318706|156758506|FG000|Double-blind Phase|Death|0|||
48701873|NCT02318706|156758507|FG001|Double-blind Phase|Death|0|||
48701874|NCT02318706|156758508|FG002|Double-blind Phase|Death|2|||
48701875|NCT02318706|156758509|FG003|Double-blind Phase|Death|0|||
48701876|NCT02318706|156758510|FG004|Double-blind Phase|Death|0|||
48701877|NCT02318706|156758506|FG000|Open-label Extension Phase|Adverse Event|0|||
48701878|NCT02318706|156758507|FG001|Open-label Extension Phase|Adverse Event|0|||
48701879|NCT02318706|156758508|FG002|Open-label Extension Phase|Adverse Event|0|||
48701880|NCT02318706|156758509|FG003|Open-label Extension Phase|Adverse Event|0|||
48701881|NCT02318706|156758510|FG004|Open-label Extension Phase|Adverse Event|21|||
48701882|NCT02318706|156758506|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
48701883|NCT02318706|156758507|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
49118391|NCT02757352|158273096|FG002|Follow-Up Period|Lack of Efficacy|0|||
49118392|NCT02757352|158273097|FG003|Follow-Up Period|Lack of Efficacy|0|||
49118393|NCT02757352|158273098|FG004|Follow-Up Period|Lack of Efficacy|0|||
49118394|NCT02757352|158273099|FG005|Follow-Up Period|Lack of Efficacy|0|||
49118395|NCT02757352|158273100|FG006|Follow-Up Period|Lack of Efficacy|0|||
49118396|NCT02757352|158273101|FG007|Follow-Up Period|Lack of Efficacy|0|||
49118397|NCT02757352|158273102|FG008|Follow-Up Period|Lack of Efficacy|1|||
49118398|NCT02757352|158273103|FG009|Follow-Up Period|Lack of Efficacy|1|||
49118399|NCT02757352|158273094|FG000|Follow-Up Period|Withdrawal by Subject|0|||
49118400|NCT02757352|158273095|FG001|Follow-Up Period|Withdrawal by Subject|0|||
49118401|NCT02757352|158273096|FG002|Follow-Up Period|Withdrawal by Subject|0|||
49118402|NCT02757352|158273097|FG003|Follow-Up Period|Withdrawal by Subject|0|||
49118403|NCT02757352|158273098|FG004|Follow-Up Period|Withdrawal by Subject|0|||
49118404|NCT02757352|158273099|FG005|Follow-Up Period|Withdrawal by Subject|0|||
49118405|NCT02757352|158273100|FG006|Follow-Up Period|Withdrawal by Subject|0|||
49118406|NCT02757352|158273101|FG007|Follow-Up Period|Withdrawal by Subject|1|||
49118407|NCT02757352|158273102|FG008|Follow-Up Period|Withdrawal by Subject|6|||
49118408|NCT02757352|158273103|FG009|Follow-Up Period|Withdrawal by Subject|2|||
49118410|NCT00497146|158273105|FG000|Treatment Period|Adverse Event|6|||
49118411|NCT00497146|158273106|FG001|Treatment Period|Adverse Event|2|||
49118412|NCT00497146|158273105|FG000|Treatment Period|Withdrawal by Subject|5|||
49118413|NCT00497146|158273106|FG001|Treatment Period|Withdrawal by Subject|9|||
49118414|NCT00497146|158273105|FG000|Treatment Period|Lost to Follow-up|1|||
49118415|NCT00497146|158273106|FG001|Treatment Period|Lost to Follow-up|3|||
49118416|NCT00497146|158273105|FG000|Treatment Period|Required dialysis|4|||
49118417|NCT00497146|158273106|FG001|Treatment Period|Required dialysis|1|||
49118418|NCT00497146|158273105|FG000|Treatment Period|Change in RAAS inhibitor therapy|5|||
49118419|NCT00497146|158273106|FG001|Treatment Period|Change in RAAS inhibitor therapy|2|||
49118420|NCT00497146|158273105|FG000|Treatment Period|Unable to dose reduce per protocol|4|||
49118421|NCT00497146|158273106|FG001|Treatment Period|Unable to dose reduce per protocol|1|||
49118422|NCT00497146|158273105|FG000|Treatment Period|Other Reason|2|||
49118423|NCT00497146|158273106|FG001|Treatment Period|Other Reason|3|||
49118424|NCT00497146|158273105|FG000|Long-term Follow-up Period|Adverse Event|2|||
49118425|NCT00497146|158273106|FG001|Long-term Follow-up Period|Adverse Event|2|||
49118426|NCT00497146|158273105|FG000|Long-term Follow-up Period|Withdrawal by Subject|8|||
49118427|NCT00497146|158273106|FG001|Long-term Follow-up Period|Withdrawal by Subject|2|||
49118428|NCT00497146|158273105|FG000|Long-term Follow-up Period|Lost to Follow-up|5|||
49118429|NCT00497146|158273106|FG001|Long-term Follow-up Period|Lost to Follow-up|1|||
49118430|NCT00497146|158273105|FG000|Long-term Follow-up Period|Other|0|||
49118431|NCT00497146|158273106|FG001|Long-term Follow-up Period|Other|1|||
49118432|NCT02155309|158273109|FG000|Overall Study|Protocol Violation|0|||
49118433|NCT02155309|158273110|FG001|Overall Study|Protocol Violation|0|||
49118434|NCT02155309|158273111|FG002|Overall Study|Protocol Violation|1|||
49118435|NCT04304508|158273112|FG000|Overall Study|Subject Decision|29|||
49118436|NCT04304508|158273113|FG001|Overall Study|Subject Decision|39|||
49118437|NCT04304508|158273114|FG002|Overall Study|Subject Decision|37|||
49118438|NCT04304508|158273115|FG003|Overall Study|Subject Decision|48|||
49118439|NCT04304508|158273112|FG000|Overall Study|Death|6|||
49118440|NCT04304508|158273113|FG001|Overall Study|Death|1|||
49118441|NCT04304508|158273114|FG002|Overall Study|Death|8|||
49118442|NCT04304508|158273115|FG003|Overall Study|Death|5|||
49118443|NCT04304508|158273112|FG000|Overall Study|Non-compliance With Study Drug|3|||
49118444|NCT04304508|158273113|FG001|Overall Study|Non-compliance With Study Drug|1|||
49118445|NCT04304508|158273114|FG002|Overall Study|Non-compliance With Study Drug|2|||
49118446|NCT04304508|158273115|FG003|Overall Study|Non-compliance With Study Drug|0|||
49118447|NCT04304508|158273112|FG000|Overall Study|Switching To Other Therapy|1|||
49118448|NCT04304508|158273113|FG001|Overall Study|Switching To Other Therapy|1|||
49118449|NCT04304508|158273114|FG002|Overall Study|Switching To Other Therapy|1|||
49118450|NCT04304508|158273115|FG003|Overall Study|Switching To Other Therapy|2|||
49118451|NCT04304508|158273112|FG000|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
49118452|NCT04304508|158273113|FG001|Overall Study|Subject Decision: COVID-19 Pandemic Related|1|||
49118453|NCT04304508|158273114|FG002|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
49118454|NCT04304508|158273115|FG003|Overall Study|Subject Decision: COVID-19 Pandemic Related|2|||
49118455|NCT04304508|158273112|FG000|Overall Study|Withdrawal by Subject|7|||
49118456|NCT04304508|158273113|FG001|Overall Study|Withdrawal by Subject|5|||
49118457|NCT04304508|158273114|FG002|Overall Study|Withdrawal by Subject|11|||
49118458|NCT04304508|158273115|FG003|Overall Study|Withdrawal by Subject|6|||
49118459|NCT04304508|158273112|FG000|Overall Study|Logistical Difficulties|2|||
49118460|NCT04304508|158273113|FG001|Overall Study|Logistical Difficulties|2|||
49118461|NCT04304508|158273114|FG002|Overall Study|Logistical Difficulties|3|||
49118462|NCT04304508|158273115|FG003|Overall Study|Logistical Difficulties|2|||
48701884|NCT02318706|156758508|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
48701885|NCT02318706|156758509|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
48701886|NCT02318706|156758510|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
48701887|NCT02318706|156758506|FG000|Open-label Extension Phase|Death|0|||
48701888|NCT02318706|156758507|FG001|Open-label Extension Phase|Death|0|||
48701889|NCT02318706|156758508|FG002|Open-label Extension Phase|Death|0|||
48701890|NCT02318706|156758509|FG003|Open-label Extension Phase|Death|0|||
48701891|NCT02318706|156758510|FG004|Open-label Extension Phase|Death|1|||
48701892|NCT02318706|156758506|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
48701893|NCT02318706|156758507|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
48701894|NCT02318706|156758508|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
48701895|NCT02318706|156758509|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
48701896|NCT02318706|156758510|FG004|Open-label Extension Phase|Withdrawal by Subject|19|||
48701897|NCT01702311|156758511|FG000|Overall Study|Withdrawal by Subject|3|||
48701898|NCT01702311|156758512|FG001|Overall Study|Withdrawal by Subject|2|||
48701899|NCT01702311|156758511|FG000|Overall Study|Discharge less than 24 hours|10|||
48701900|NCT01702311|156758512|FG001|Overall Study|Discharge less than 24 hours|7|||
48701901|NCT01702311|156758511|FG000|Overall Study|Physician Decision|3|||
48701902|NCT01702311|156758512|FG001|Overall Study|Physician Decision|4|||
48701903|NCT02326155|156758513|FG000|Overall Study|Adverse Event|21|||
48701904|NCT02326155|156758514|FG001|Overall Study|Adverse Event|5|||
48701905|NCT02326155|156758513|FG000|Overall Study|Death|3|||
48701906|NCT02326155|156758514|FG001|Overall Study|Death|0|||
48701907|NCT02326155|156758513|FG000|Overall Study|Lack of Efficacy|49|||
48701908|NCT02326155|156758514|FG001|Overall Study|Lack of Efficacy|5|||
48701909|NCT02326155|156758513|FG000|Overall Study|Lost to Follow-up|14|||
48701910|NCT02326155|156758514|FG001|Overall Study|Lost to Follow-up|3|||
48701911|NCT02326155|156758513|FG000|Overall Study|Protocol Violation|2|||
48701912|NCT02326155|156758514|FG001|Overall Study|Protocol Violation|0|||
48701913|NCT02326155|156758513|FG000|Overall Study|Withdrawal by Subject|34|||
48701914|NCT02326155|156758514|FG001|Overall Study|Withdrawal by Subject|11|||
48701915|NCT02326155|156758513|FG000|Overall Study|Disease progression|37|||
48701916|NCT02326155|156758514|FG001|Overall Study|Disease progression|4|||
48701917|NCT02326155|156758513|FG000|Overall Study|Study close|188|||
48701918|NCT02326155|156758514|FG001|Overall Study|Study close|21|||
48701919|NCT02326155|156758513|FG000|Overall Study|except for study close|46|||
48701920|NCT02326155|156758514|FG001|Overall Study|except for study close|13|||
48701921|NCT01074502|156758520|FG000|Overall Study|Withdrawal by Subject|1|||
48701922|NCT04177823|156758529|FG000|Overall Study|Physician Decision|1|||
48701923|NCT04177823|156758529|FG000|Overall Study|Withdrawal by Subject|1|||
49118463|NCT04304508|158273112|FG000|Overall Study|Missing Information|1|||
48701924|NCT02351817|156758530|FG000|Period 1|Adverse Event|1|||
48701925|NCT02351817|156758531|FG001|Period 1|Adverse Event|2|||
48701926|NCT02351817|156758530|FG000|Period 1|Lack of Efficacy|0|||
49118464|NCT04304508|158273113|FG001|Overall Study|Missing Information|2|||
49118465|NCT04304508|158273114|FG002|Overall Study|Missing Information|1|||
49118466|NCT04304508|158273115|FG003|Overall Study|Missing Information|3|||
49118467|NCT04304508|158273112|FG000|Overall Study|Other|7|||
49118468|NCT04304508|158273113|FG001|Overall Study|Other|6|||
49118469|NCT04304508|158273114|FG002|Overall Study|Other|5|||
49118470|NCT04304508|158273115|FG003|Overall Study|Other|4|||
49118471|NCT04304508|158273112|FG000|Overall Study|Physician Decision: COVID-19 Pandemic Related|1|||
49118472|NCT04304508|158273113|FG001|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
49118473|NCT04304508|158273114|FG002|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
49118474|NCT04304508|158273115|FG003|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
49118475|NCT04304508|158273112|FG000|Overall Study|Physician Decision|3|||
49118476|NCT04304508|158273113|FG001|Overall Study|Physician Decision|4|||
49118477|NCT04304508|158273114|FG002|Overall Study|Physician Decision|9|||
49118478|NCT04304508|158273115|FG003|Overall Study|Physician Decision|7|||
49118479|NCT04304508|158273112|FG000|Overall Study|Study drug never administered|10|||
49118480|NCT04304508|158273113|FG001|Overall Study|Study drug never administered|4|||
49118481|NCT04304508|158273114|FG002|Overall Study|Study drug never administered|4|||
49118482|NCT04304508|158273115|FG003|Overall Study|Study drug never administered|4|||
49118483|NCT04304508|158273112|FG000|Overall Study|Adverse Event|49|||
49118484|NCT04304508|158273113|FG001|Overall Study|Adverse Event|50|||
49118485|NCT04304508|158273114|FG002|Overall Study|Adverse Event|51|||
49118486|NCT04304508|158273115|FG003|Overall Study|Adverse Event|56|||
49118487|NCT04304508|158273112|FG000|Overall Study|Lost to Follow-up|1|||
49118488|NCT04304508|158273113|FG001|Overall Study|Lost to Follow-up|5|||
49118489|NCT04304508|158273114|FG002|Overall Study|Lost to Follow-up|2|||
49118490|NCT04304508|158273115|FG003|Overall Study|Lost to Follow-up|3|||
49118491|NCT03272347|158273116|FG000|Overall Study|Death|0|||
49118492|NCT03272347|158273117|FG001|Overall Study|Death|0|||
49118493|NCT03272347|158273118|FG002|Overall Study|Death|0|||
49118494|NCT03272347|158273119|FG003|Overall Study|Death|1|||
49118495|NCT03272347|158273116|FG000|Overall Study|Lost to Follow-up|1|||
49118496|NCT03272347|158273117|FG001|Overall Study|Lost to Follow-up|3|||
48701927|NCT02351817|156758531|FG001|Period 1|Lack of Efficacy|1|||
48701928|NCT02351817|156758530|FG000|Period 2|Adverse Event|0|||
48701929|NCT02351817|156758531|FG001|Period 2|Adverse Event|2|||
48701930|NCT02351817|156758530|FG000|Period 2|Protocol Violation|1|||
48701931|NCT02351817|156758531|FG001|Period 2|Protocol Violation|0|||
49118497|NCT03272347|158273118|FG002|Overall Study|Lost to Follow-up|5|||
49118498|NCT03272347|158273119|FG003|Overall Study|Lost to Follow-up|1|||
49118499|NCT03272347|158273116|FG000|Overall Study|Physician Decision|4|||
49118500|NCT03272347|158273117|FG001|Overall Study|Physician Decision|2|||
49118501|NCT03272347|158273118|FG002|Overall Study|Physician Decision|5|||
49118502|NCT03272347|158273119|FG003|Overall Study|Physician Decision|4|||
49118503|NCT03272347|158273116|FG000|Overall Study|Screen Failure|1|||
49118504|NCT03272347|158273117|FG001|Overall Study|Screen Failure|0|||
49118505|NCT03272347|158273118|FG002|Overall Study|Screen Failure|0|||
48701932|NCT03137381|156758532|FG000|Overall Study|Adverse Event|3|||
49118506|NCT03272347|158273119|FG003|Overall Study|Screen Failure|0|||
49118507|NCT03272347|158273116|FG000|Overall Study|Withdrawal by Subject|5|||
49118508|NCT03272347|158273117|FG001|Overall Study|Withdrawal by Subject|1|||
49118509|NCT03272347|158273118|FG002|Overall Study|Withdrawal by Subject|2|||
49118510|NCT03272347|158273119|FG003|Overall Study|Withdrawal by Subject|1|||
49118511|NCT00703677|158273120|FG000|Overall Study|Dropout-withdrawal not related to drug|3|||
49118512|NCT03091738|158273121|FG000|Overall Study|Adverse Event|1|||
49118513|NCT03091738|158273121|FG000|Overall Study|Lost to Follow-up|1|||
49118514|NCT00215644|158273123|FG000|Overall Study|Disease Progression|28|||
49118515|NCT00215644|158273124|FG001|Overall Study|Disease Progression|10|||
49118516|NCT00215644|158273123|FG000|Overall Study|Adverse Event|2|||
49118517|NCT00215644|158273124|FG001|Overall Study|Adverse Event|9|||
49118518|NCT00215644|158273123|FG000|Overall Study|Death|1|||
49118519|NCT00215644|158273124|FG001|Overall Study|Death|2|||
49118520|NCT00215644|158273123|FG000|Overall Study|Withdrawal by Subject|1|||
49118521|NCT00215644|158273124|FG001|Overall Study|Withdrawal by Subject|0|||
49118522|NCT00215644|158273123|FG000|Overall Study|Other|3|||
49118523|NCT00215644|158273124|FG001|Overall Study|Other|15|||
49118524|NCT00215644|158273123|FG000|Overall Study|Randomized but Not Treated|1|||
49118525|NCT00215644|158273124|FG001|Overall Study|Randomized but Not Treated|0|||
49118526|NCT01763827|158273127|FG000|Overall Study|Withdrawal by Subject|1|||
49118527|NCT01763827|158273128|FG001|Overall Study|Withdrawal by Subject|0|||
49118528|NCT01763827|158273129|FG002|Overall Study|Withdrawal by Subject|0|||
49118529|NCT01763827|158273130|FG003|Overall Study|Withdrawal by Subject|0|||
49118530|NCT01763827|158273131|FG004|Overall Study|Withdrawal by Subject|2|||
49118531|NCT01763827|158273132|FG005|Overall Study|Withdrawal by Subject|0|||
49118532|NCT01763827|158273127|FG000|Overall Study|Decision by sponsor|2|||
49118533|NCT01763827|158273128|FG001|Overall Study|Decision by sponsor|0|||
49118534|NCT01763827|158273129|FG002|Overall Study|Decision by sponsor|3|||
49118535|NCT01763827|158273130|FG003|Overall Study|Decision by sponsor|0|||
49118536|NCT01763827|158273131|FG004|Overall Study|Decision by sponsor|2|||
49118537|NCT01763827|158273132|FG005|Overall Study|Decision by sponsor|1|||
49118538|NCT01763827|158273127|FG000|Overall Study|Lost to Follow-up|0|||
49118539|NCT01763827|158273128|FG001|Overall Study|Lost to Follow-up|1|||
49118540|NCT01763827|158273129|FG002|Overall Study|Lost to Follow-up|1|||
49118541|NCT01763827|158273130|FG003|Overall Study|Lost to Follow-up|1|||
49118542|NCT01763827|158273131|FG004|Overall Study|Lost to Follow-up|2|||
49118543|NCT01763827|158273132|FG005|Overall Study|Lost to Follow-up|1|||
49118544|NCT02753816|158273137|FG000|Overall Study|Protocol Violation|0|||
49118545|NCT02753816|158273138|FG001|Overall Study|Protocol Violation|1|||
49118546|NCT02753816|158273139|FG002|Overall Study|Protocol Violation|0|||
49118547|NCT02542397|158273140|FG000|Overall Study|Death|2|||
49118548|NCT02542397|158273140|FG000|Overall Study|Physician Decision|6|||
48701933|NCT03137381|156758533|FG001|Overall Study|Adverse Event|0|||
48701934|NCT03137381|156758534|FG002|Overall Study|Adverse Event|2|||
48701935|NCT03137381|156758535|FG003|Overall Study|Adverse Event|0|||
48701936|NCT03137381|156758532|FG000|Overall Study|Lost to Follow-up|2|||
48701937|NCT03137381|156758533|FG001|Overall Study|Lost to Follow-up|1|||
48701938|NCT03137381|156758534|FG002|Overall Study|Lost to Follow-up|1|||
48701939|NCT03137381|156758535|FG003|Overall Study|Lost to Follow-up|0|||
48701940|NCT03137381|156758532|FG000|Overall Study|Protocol deviation|1|||
48701941|NCT03137381|156758533|FG001|Overall Study|Protocol deviation|1|||
48701942|NCT03137381|156758534|FG002|Overall Study|Protocol deviation|0|||
49118549|NCT02542397|158273140|FG000|Overall Study|Withdrawal by Subject|6|||
49118550|NCT02542397|158273140|FG000|Overall Study|Lost to Follow-up|2|||
49118551|NCT01724177|158273145|FG000|Overall Study|Adverse Event|8|||
49118552|NCT01724177|158273145|FG000|Overall Study|Progressive disease or Relapsed Disease|16|||
49118553|NCT01724177|158273145|FG000|Overall Study|Nervous participant|1|||
49118554|NCT01724177|158273145|FG000|Overall Study|Serious Adverse Event Related|1|||
49118555|NCT00424593|158273148|FG000|Acute Double-Blind Period|Adverse Event|16|||
49118556|NCT00424593|158273149|FG001|Acute Double-Blind Period|Adverse Event|7|||
49118557|NCT00424593|158273148|FG000|Acute Double-Blind Period|Withdrawal by Subject|11|||
49118558|NCT00424593|158273149|FG001|Acute Double-Blind Period|Withdrawal by Subject|10|||
48701943|NCT03137381|156758535|FG003|Overall Study|Protocol deviation|1|||
48701944|NCT03137381|156758532|FG000|Overall Study|Withdrawal by Investigator|0|||
48701945|NCT03137381|156758533|FG001|Overall Study|Withdrawal by Investigator|1|||
48701946|NCT03137381|156758534|FG002|Overall Study|Withdrawal by Investigator|1|||
48701947|NCT03137381|156758535|FG003|Overall Study|Withdrawal by Investigator|0|||
48701948|NCT03137381|156758532|FG000|Overall Study|Withdrawal by Subject|3|||
48701949|NCT03137381|156758533|FG001|Overall Study|Withdrawal by Subject|4|||
48701950|NCT03137381|156758534|FG002|Overall Study|Withdrawal by Subject|3|||
48701951|NCT03137381|156758535|FG003|Overall Study|Withdrawal by Subject|0|||
48701952|NCT03137381|156758532|FG000|Overall Study|Pregnancy|0|||
48701953|NCT03137381|156758533|FG001|Overall Study|Pregnancy|0|||
48701954|NCT03137381|156758534|FG002|Overall Study|Pregnancy|1|||
48701955|NCT03137381|156758535|FG003|Overall Study|Pregnancy|0|||
48701956|NCT02488915|156758536|FG000|Overall Study|Death|21|||
48701957|NCT02488915|156758536|FG000|Overall Study|Lost to Follow-up|4|||
48701958|NCT02488915|156758536|FG000|Overall Study|Withdrawal by Subject|1|||
48701959|NCT02556177|156758537|FG000|Overall Study|Subjects did not complete all 4 visits|283|||
48701960|NCT02556177|156758538|FG001|Overall Study|Subjects did not complete all 4 visits|61|||
48701961|NCT01780506|156758539|FG000|Double-Blind Phase|Randomized but not Treated|3|||
48701962|NCT01780506|156758540|FG001|Double-Blind Phase|Randomized but not Treated|2|||
48701963|NCT01780506|156758539|FG000|Double-Blind Phase|Adverse Event|4|||
48701964|NCT01780506|156758540|FG001|Double-Blind Phase|Adverse Event|14|||
48701965|NCT01780506|156758539|FG000|Double-Blind Phase|Death|1|||
48701966|NCT01780506|156758540|FG001|Double-Blind Phase|Death|2|||
48701967|NCT01780506|156758539|FG000|Double-Blind Phase|Pregnancy|2|||
48701968|NCT01780506|156758540|FG001|Double-Blind Phase|Pregnancy|1|||
48701969|NCT01780506|156758539|FG000|Double-Blind Phase|Lack of Efficacy|1|||
48701970|NCT01780506|156758540|FG001|Double-Blind Phase|Lack of Efficacy|1|||
48701971|NCT01780506|156758539|FG000|Double-Blind Phase|Investigator's Discretion|5|||
48701972|NCT01780506|156758540|FG001|Double-Blind Phase|Investigator's Discretion|2|||
48701973|NCT01780506|156758539|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
48701974|NCT01780506|156758540|FG001|Double-Blind Phase|Non-Compliance with Study Drug|3|||
48701975|NCT01780506|156758539|FG000|Double-Blind Phase|Protocol Violation|4|||
48701976|NCT01780506|156758540|FG001|Double-Blind Phase|Protocol Violation|3|||
48701977|NCT01780506|156758539|FG000|Double-Blind Phase|Withdrew Consent|23|||
48701978|NCT01780506|156758540|FG001|Double-Blind Phase|Withdrew Consent|24|||
48701979|NCT01780506|156758539|FG000|Double-Blind Phase|Lost to Follow-up|23|||
48701980|NCT01780506|156758540|FG001|Double-Blind Phase|Lost to Follow-up|26|||
48701981|NCT01780506|156758539|FG000|Open-Label Extension Phase|Enrolled but not Treated|0|||
48701982|NCT01780506|156758540|FG001|Open-Label Extension Phase|Enrolled but not Treated|1|||
48701983|NCT01995838|156758541|FG000|Overall Study|Lost to Follow-up|0|||
48701984|NCT01995838|156758542|FG001|Overall Study|Lost to Follow-up|1|||
48701985|NCT01995838|156758543|FG002|Overall Study|Lost to Follow-up|0|||
48701986|NCT01995838|156758544|FG003|Overall Study|Lost to Follow-up|0|||
48701987|NCT01995838|156758545|FG004|Overall Study|Lost to Follow-up|0|||
48701988|NCT01995838|156758546|FG005|Overall Study|Lost to Follow-up|0|||
48701989|NCT01995838|156758547|FG006|Overall Study|Lost to Follow-up|1|||
48701990|NCT01995838|156758541|FG000|Overall Study|Participant choice|2|||
48701991|NCT01995838|156758542|FG001|Overall Study|Participant choice|0|||
48701992|NCT01995838|156758543|FG002|Overall Study|Participant choice|0|||
48701993|NCT01995838|156758544|FG003|Overall Study|Participant choice|0|||
48701994|NCT01995838|156758545|FG004|Overall Study|Participant choice|0|||
48701995|NCT01995838|156758546|FG005|Overall Study|Participant choice|1|||
48701996|NCT01995838|156758547|FG006|Overall Study|Participant choice|1|||
48701997|NCT01995838|156758541|FG000|Overall Study|Adverse Event|0|||
48701998|NCT01995838|156758542|FG001|Overall Study|Adverse Event|0|||
48701999|NCT01995838|156758543|FG002|Overall Study|Adverse Event|0|||
48702000|NCT01995838|156758544|FG003|Overall Study|Adverse Event|0|||
48702001|NCT01995838|156758545|FG004|Overall Study|Adverse Event|0|||
48702002|NCT01995838|156758546|FG005|Overall Study|Adverse Event|0|||
48702003|NCT01995838|156758547|FG006|Overall Study|Adverse Event|1|||
48702004|NCT01995838|156758541|FG000|Overall Study|Withdrawal by Subject|0|||
48702005|NCT01995838|156758542|FG001|Overall Study|Withdrawal by Subject|0|||
48702006|NCT01995838|156758543|FG002|Overall Study|Withdrawal by Subject|0|||
48702007|NCT01995838|156758544|FG003|Overall Study|Withdrawal by Subject|0|||
48702008|NCT01995838|156758545|FG004|Overall Study|Withdrawal by Subject|1|||
48702009|NCT01995838|156758546|FG005|Overall Study|Withdrawal by Subject|0|||
48702010|NCT01995838|156758547|FG006|Overall Study|Withdrawal by Subject|0|||
48702011|NCT01995838|156758541|FG000|Overall Study|Other|3|||
48702012|NCT01995838|156758542|FG001|Overall Study|Other|1|||
48702013|NCT01995838|156758543|FG002|Overall Study|Other|0|||
48702014|NCT01995838|156758544|FG003|Overall Study|Other|2|||
48702015|NCT01995838|156758545|FG004|Overall Study|Other|1|||
48702016|NCT01995838|156758546|FG005|Overall Study|Other|1|||
48702017|NCT01995838|156758547|FG006|Overall Study|Other|2|||
48702018|NCT04798196|156758548|FG000|Overall Study|Lost to Follow-up|3|||
48702019|NCT04798196|156758549|FG001|Overall Study|Lost to Follow-up|1|||
48702020|NCT04798196|156758550|FG002|Overall Study|Lost to Follow-up|3|||
48702021|NCT00728689|156758561|FG000|Washout Period (Days 4 - 10)|Death in family|1|||
48702022|NCT00728689|156758562|FG001|Washout Period (Days 4 - 10)|Death in family|0|||
48702023|NCT02461758|156758563|FG000|Overall Study|Lost to Follow-up|0|||
48702024|NCT02461758|156758564|FG001|Overall Study|Lost to Follow-up|1|||
48702025|NCT02461758|156758565|FG002|Overall Study|Lost to Follow-up|1|||
48702026|NCT02461758|156758566|FG003|Overall Study|Lost to Follow-up|0|||
48702027|NCT00887809|156758571|FG000|Overall Study|Patient Not Treated|3|||
48702028|NCT00887809|156758572|FG001|Overall Study|Patient Not Treated|0|||
48702029|NCT00887809|156758571|FG000|Overall Study|Death|1|||
48702030|NCT00887809|156758572|FG001|Overall Study|Death|0|||
48702031|NCT01782378|156758573|FG000|First Series|Lost to Follow-up|7|||
48702032|NCT01782378|156758574|FG001|First Series|Lost to Follow-up|8|||
48702033|NCT01782378|156758573|FG000|Second Series|Partial Crossover Design- no Sham 2nd|0|||
48702034|NCT01782378|156758574|FG001|Second Series|Partial Crossover Design- no Sham 2nd|25|||
48702035|NCT01782378|156758573|FG000|Second Series|Lost to Follow-up|8|||
48702036|NCT01782378|156758574|FG001|Second Series|Lost to Follow-up|7|||
48702037|NCT01782378|156758573|FG000|Second Series|Did not choose to complete S2 Optional|18|||
48702038|NCT01782378|156758574|FG001|Second Series|Did not choose to complete S2 Optional|0|||
48702039|NCT01352715|156758575|FG000|Overall Study|Death|3|||
48702040|NCT01352715|156758576|FG001|Overall Study|Death|3|||
48702041|NCT01352715|156758575|FG000|Overall Study|Lost to Follow-up|5|||
48702042|NCT01352715|156758576|FG001|Overall Study|Lost to Follow-up|7|||
48702043|NCT01352715|156758575|FG000|Overall Study|Withdrawal by Subject|4|||
48702044|NCT01352715|156758576|FG001|Overall Study|Withdrawal by Subject|8|||
48702045|NCT01352715|156758575|FG000|Overall Study|site closure|16|||
48702046|NCT01352715|156758576|FG001|Overall Study|site closure|15|||
48702047|NCT01352715|156758575|FG000|Overall Study|no final visit in closeout period|15|||
48702048|NCT01352715|156758576|FG001|Overall Study|no final visit in closeout period|12|||
48702049|NCT01352715|156758575|FG000|Overall Study|major ineligibility|2|||
48702050|NCT01352715|156758576|FG001|Overall Study|major ineligibility|1|||
48702051|NCT03023397|156758577|FG000|Run-In|Failed screening allergen challenge|1|||
48702052|NCT03023397|156758578|FG001|Run-In|Failed screening allergen challenge|0|||
48702053|NCT03023397|156758579|FG002|Run-In|Failed screening allergen challenge|0|||
48702054|NCT03023397|156758577|FG000|Run-In|Loss of funding after informed consent but before screening allergen challenge|1|||
48702055|NCT03023397|156758578|FG001|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
48702056|NCT03023397|156758579|FG002|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
48702057|NCT00999804|156758580|FG000|Overall Study|Lack of Efficacy|9|||
48702058|NCT00999804|156758581|FG001|Overall Study|Lack of Efficacy|2|||
48702059|NCT00999804|156758580|FG000|Overall Study|Adverse Event|4|||
48702060|NCT00999804|156758581|FG001|Overall Study|Adverse Event|3|||
48702061|NCT00999804|156758580|FG000|Overall Study|Withdrawal by Subject|4|||
48702062|NCT00999804|156758581|FG001|Overall Study|Withdrawal by Subject|0|||
48702063|NCT00999804|156758580|FG000|Overall Study|Death|1|||
48702064|NCT00999804|156758581|FG001|Overall Study|Death|0|||
48702065|NCT00999804|156758580|FG000|Overall Study|Ineligible|3|||
48702066|NCT00999804|156758581|FG001|Overall Study|Ineligible|0|||
48702067|NCT00071058|156758582|FG000|Overall Study|brain tumor-removed from study|1|||
48702068|NCT02000440|156758587|FG000|Overall Study|Adverse Event|3|||
48702069|NCT02000440|156758587|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
48702070|NCT01550003|156758588|FG000|Overall Study|Adverse Event|0|||
48702071|NCT01550003|156758589|FG001|Overall Study|Adverse Event|9|||
48702072|NCT01550003|156758590|FG002|Overall Study|Adverse Event|15|||
48702073|NCT01550003|156758588|FG000|Overall Study|Lack of Efficacy|4|||
48702074|NCT01550003|156758589|FG001|Overall Study|Lack of Efficacy|11|||
48702075|NCT01550003|156758590|FG002|Overall Study|Lack of Efficacy|15|||
48702076|NCT01550003|156758588|FG000|Overall Study|Protocol Violation|0|||
48702077|NCT01550003|156758589|FG001|Overall Study|Protocol Violation|3|||
48702078|NCT01550003|156758590|FG002|Overall Study|Protocol Violation|2|||
48702079|NCT01550003|156758588|FG000|Overall Study|Lost to Follow-up|1|||
48702080|NCT01550003|156758589|FG001|Overall Study|Lost to Follow-up|4|||
48702081|NCT01550003|156758590|FG002|Overall Study|Lost to Follow-up|8|||
48702082|NCT01550003|156758588|FG000|Overall Study|Consent withdrawn|2|||
48702083|NCT01550003|156758589|FG001|Overall Study|Consent withdrawn|11|||
48702084|NCT01550003|156758590|FG002|Overall Study|Consent withdrawn|23|||
48702085|NCT01550003|156758588|FG000|Overall Study|Missing|1|||
48912279|NCT03677596|157516187|FG001|Overall Study|Progressive Disease|8|||
48912280|NCT03677596|157516186|FG000|Overall Study|Withdrawal by Subject|3|||
48702086|NCT01550003|156758589|FG001|Overall Study|Missing|0|||
48702087|NCT01550003|156758590|FG002|Overall Study|Missing|2|||
48702088|NCT01550003|156758588|FG000|Overall Study|Study closure as announced by sponsor|7|||
48702089|NCT01550003|156758589|FG001|Overall Study|Study closure as announced by sponsor|6|||
48702090|NCT01550003|156758590|FG002|Overall Study|Study closure as announced by sponsor|24|||
48702091|NCT01550003|156758588|FG000|Overall Study|Protocol Noncompliance|1|||
48702092|NCT01550003|156758589|FG001|Overall Study|Protocol Noncompliance|0|||
48702093|NCT01550003|156758590|FG002|Overall Study|Protocol Noncompliance|0|||
48702094|NCT01550003|156758588|FG000|Overall Study|Study closure|0|||
48702095|NCT01550003|156758589|FG001|Overall Study|Study closure|1|||
48702096|NCT01550003|156758590|FG002|Overall Study|Study closure|1|||
48702097|NCT01550003|156758588|FG000|Overall Study|Patient reached adulthood|0|||
48702098|NCT01550003|156758589|FG001|Overall Study|Patient reached adulthood|1|||
48702099|NCT01550003|156758590|FG002|Overall Study|Patient reached adulthood|0|||
48702100|NCT01550003|156758588|FG000|Overall Study|Early discontinuation at request of sponsor|0|||
48702101|NCT01550003|156758589|FG001|Overall Study|Early discontinuation at request of sponsor|2|||
48702102|NCT01550003|156758590|FG002|Overall Study|Early discontinuation at request of sponsor|4|||
48702103|NCT01550003|156758588|FG000|Overall Study|Sponsor's order|0|||
48702104|NCT01550003|156758589|FG001|Overall Study|Sponsor's order|3|||
48702105|NCT01550003|156758590|FG002|Overall Study|Sponsor's order|3|||
48702106|NCT01550003|156758588|FG000|Overall Study|Sponsor's decision|1|||
48702107|NCT01550003|156758589|FG001|Overall Study|Sponsor's decision|5|||
48702108|NCT01550003|156758590|FG002|Overall Study|Sponsor's decision|4|||
48702109|NCT01550003|156758588|FG000|Overall Study|Subject mother passed away|0|||
48702110|NCT01550003|156758589|FG001|Overall Study|Subject mother passed away|1|||
48702111|NCT01550003|156758590|FG002|Overall Study|Subject mother passed away|0|||
48702112|NCT01550003|156758588|FG000|Overall Study|Discontinuation|0|||
48702113|NCT01550003|156758589|FG001|Overall Study|Discontinuation|1|||
48702114|NCT01550003|156758590|FG002|Overall Study|Discontinuation|0|||
48702115|NCT01550003|156758588|FG000|Overall Study|Subject moved to rheumatology and out of study|0|||
48702116|NCT01550003|156758589|FG001|Overall Study|Subject moved to rheumatology and out of study|1|||
48702117|NCT01550003|156758590|FG002|Overall Study|Subject moved to rheumatology and out of study|1|||
48702118|NCT01550003|156758588|FG000|Overall Study|Site closure|0|||
48702119|NCT01550003|156758589|FG001|Overall Study|Site closure|2|||
48702120|NCT01550003|156758590|FG002|Overall Study|Site closure|0|||
48702121|NCT01550003|156758588|FG000|Overall Study|Pregnancy|0|||
48702122|NCT01550003|156758589|FG001|Overall Study|Pregnancy|1|||
48702123|NCT01550003|156758590|FG002|Overall Study|Pregnancy|0|||
48702124|NCT01550003|156758588|FG000|Overall Study|By medical decision and approved by the sponsor|0|||
48702125|NCT01550003|156758589|FG001|Overall Study|By medical decision and approved by the sponsor|0|||
48702126|NCT01550003|156758590|FG002|Overall Study|By medical decision and approved by the sponsor|1|||
48702127|NCT01550003|156758588|FG000|Overall Study|Subject is in college/unable to come to visits|0|||
48702128|NCT01550003|156758589|FG001|Overall Study|Subject is in college/unable to come to visits|0|||
48702129|NCT01550003|156758590|FG002|Overall Study|Subject is in college/unable to come to visits|1|||
48702130|NCT01550003|156758588|FG000|Overall Study|Switching to adult rheumatologist|0|||
48702131|NCT01550003|156758589|FG001|Overall Study|Switching to adult rheumatologist|0|||
48702132|NCT01550003|156758590|FG002|Overall Study|Switching to adult rheumatologist|1|||
48702133|NCT01550003|156758588|FG000|Overall Study|Patient transition to adult care|0|||
48702134|NCT01550003|156758589|FG001|Overall Study|Patient transition to adult care|0|||
48702135|NCT01550003|156758590|FG002|Overall Study|Patient transition to adult care|1|||
48702136|NCT01550003|156758588|FG000|Overall Study|Subject was able to obtain commercial cimzia|0|||
48702137|NCT01550003|156758589|FG001|Overall Study|Subject was able to obtain commercial cimzia|0|||
48702138|NCT01550003|156758590|FG002|Overall Study|Subject was able to obtain commercial cimzia|1|||
48702139|NCT01550003|156758588|FG000|Overall Study|Treatment or 12 week follow up visit completed|0|||
48702140|NCT01550003|156758589|FG001|Overall Study|Treatment or 12 week follow up visit completed|0|||
48702141|NCT01550003|156758590|FG002|Overall Study|Treatment or 12 week follow up visit completed|1|||
48702142|NCT01550003|156758588|FG000|Overall Study|Per Sponsor request|1|||
48702143|NCT01550003|156758589|FG001|Overall Study|Per Sponsor request|0|||
48702144|NCT01550003|156758590|FG002|Overall Study|Per Sponsor request|1|||
48702145|NCT01550003|156758588|FG000|Overall Study|Patient not compliance|0|||
48702146|NCT01550003|156758589|FG001|Overall Study|Patient not compliance|0|||
48702147|NCT01550003|156758590|FG002|Overall Study|Patient not compliance|1|||
48702148|NCT01550003|156758588|FG000|Overall Study|Non-compliance|0|||
48702149|NCT01550003|156758589|FG001|Overall Study|Non-compliance|0|||
48702150|NCT01550003|156758590|FG002|Overall Study|Non-compliance|1|||
48702151|NCT01550003|156758588|FG000|Overall Study|Study closed|0|||
48702152|NCT01550003|156758589|FG001|Overall Study|Study closed|1|||
48702153|NCT01550003|156758590|FG002|Overall Study|Study closed|0|||
48702154|NCT01550003|156758588|FG000|Overall Study|Transitioned to adult rheumatology|0|||
48702155|NCT01550003|156758589|FG001|Overall Study|Transitioned to adult rheumatology|0|||
48702156|NCT01550003|156758590|FG002|Overall Study|Transitioned to adult rheumatology|1|||
48702157|NCT00871975|156758591|FG000|Overall Study|Technical difficulty w155-1ith equipment|3|||
48702158|NCT00871975|156758591|FG000|Overall Study|Catheters could not be inserted|1|||
48702159|NCT00871975|156758591|FG000|Overall Study|Patient unable to void/insufficient vol|13|||
48702160|NCT00871975|156758591|FG000|Overall Study|Motion artifact, tracing uninterpretable|5|||
48702161|NCT04102098|156758594|FG000|Main Study Period|Ongoing in study|302|||
48702162|NCT04102098|156758595|FG001|Main Study Period|Ongoing in study|291|||
48702163|NCT04102098|156758594|FG000|Main Study Period|Death|20|||
48702164|NCT04102098|156758595|FG001|Main Study Period|Death|27|||
48702165|NCT04102098|156758594|FG000|Main Study Period|Lost to Follow-up|1|||
48702166|NCT04102098|156758595|FG001|Main Study Period|Lost to Follow-up|1|||
48702167|NCT04102098|156758594|FG000|Main Study Period|Physician Decision|0|||
48702168|NCT04102098|156758595|FG001|Main Study Period|Physician Decision|1|||
48702169|NCT04102098|156758594|FG000|Main Study Period|Withdrawal by Subject|11|||
48702170|NCT04102098|156758595|FG001|Main Study Period|Withdrawal by Subject|14|||
48702171|NCT04102098|156758594|FG000|Crossover: AS Who Crossed Over|Withdrawal by Subject|1|||
48702172|NCT04102098|156758595|FG001|Crossover: AS Who Crossed Over|Withdrawal by Subject|0|||
48702173|NCT04102098|156758594|FG000|Crossover: AS Who Crossed Over|Death|11|||
48702174|NCT04102098|156758595|FG001|Crossover: AS Who Crossed Over|Death|0|||
48702175|NCT04102098|156758594|FG000|Crossover: AS Who Crossed Over|Ongoing in study|69|||
48702176|NCT04102098|156758595|FG001|Crossover: AS Who Crossed Over|Ongoing in study|0|||
48702177|NCT03592186|156758596|FG000|Overall Study|Withdrawal by Subject|1|||
48702178|NCT03592186|156758597|FG001|Overall Study|Withdrawal by Subject|0|||
48702179|NCT03592186|156758596|FG000|Overall Study|Lost to Follow-up|16|||
48702180|NCT03592186|156758597|FG001|Overall Study|Lost to Follow-up|11|||
48702181|NCT00283296|156758603|FG000|Overall Study|in-home trial not completed|5|||
48702182|NCT02072668|156758604|FG000|Second Intervention|Lost to Follow-up|1|||
48702183|NCT02072668|156758605|FG001|Second Intervention|Lost to Follow-up|0|||
48702184|NCT01353898|156758606|FG000|Overall Study|Study site terminated|0|||
48702185|NCT01353898|156758607|FG001|Overall Study|Study site terminated|0|||
48702186|NCT01353898|156758608|FG002|Overall Study|Study site terminated|0|||
48702187|NCT01353898|156758609|FG003|Overall Study|Study site terminated|0|||
48702188|NCT01353898|156758610|FG004|Overall Study|Study site terminated|0|||
48702189|NCT01353898|156758611|FG005|Overall Study|Study site terminated|1|||
48702190|NCT02589938|156758612|FG000|Overall Study|Withdrawal by Subject|11|||
48702191|NCT02589938|156758613|FG001|Overall Study|Withdrawal by Subject|5|||
48702192|NCT02589938|156758614|FG002|Overall Study|Withdrawal by Subject|6|||
48702193|NCT02589938|156758612|FG000|Overall Study|Lost to Follow-up|3|||
48702194|NCT02589938|156758613|FG001|Overall Study|Lost to Follow-up|3|||
48702195|NCT02589938|156758614|FG002|Overall Study|Lost to Follow-up|3|||
48702196|NCT02589938|156758612|FG000|Overall Study|Death|1|||
48702197|NCT02589938|156758613|FG001|Overall Study|Death|0|||
48702198|NCT02589938|156758614|FG002|Overall Study|Death|1|||
48702199|NCT02589938|156758612|FG000|Overall Study|Protocol Violation|6|||
48702200|NCT02589938|156758613|FG001|Overall Study|Protocol Violation|2|||
48702201|NCT02589938|156758614|FG002|Overall Study|Protocol Violation|3|||
48702202|NCT02589938|156758612|FG000|Overall Study|Physician Decision|1|||
48702203|NCT02589938|156758613|FG001|Overall Study|Physician Decision|0|||
48702204|NCT02589938|156758614|FG002|Overall Study|Physician Decision|0|||
48702205|NCT02589938|156758612|FG000|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|2|||
48702206|NCT02589938|156758613|FG001|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|3|||
48702207|NCT02589938|156758614|FG002|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|4|||
48702208|NCT01294553|156758615|FG000|Overall Study|Duplicated Participants|1|||
48702209|NCT01294553|156758615|FG000|Overall Study|Protocol Violation|268|||
48702210|NCT03133793|156758616|FG000|Overall Study|Withdrawal by Subject|0|||
48702211|NCT03133793|156758617|FG001|Overall Study|Withdrawal by Subject|4|||
48702212|NCT03133793|156758618|FG002|Overall Study|Withdrawal by Subject|2|||
48702213|NCT03133793|156758619|FG003|Overall Study|Withdrawal by Subject|4|||
48702214|NCT03133793|156758616|FG000|Overall Study|Lost to Follow-up|1|||
48702215|NCT03133793|156758617|FG001|Overall Study|Lost to Follow-up|0|||
48702216|NCT03133793|156758618|FG002|Overall Study|Lost to Follow-up|2|||
48702217|NCT03133793|156758619|FG003|Overall Study|Lost to Follow-up|0|||
48702218|NCT03133793|156758616|FG000|Overall Study|Death|0|||
48702219|NCT03133793|156758617|FG001|Overall Study|Death|0|||
48702220|NCT03133793|156758618|FG002|Overall Study|Death|0|||
48702221|NCT03133793|156758619|FG003|Overall Study|Death|1|||
48702222|NCT02651675|156758621|FG000|Overall Study|Death|0|||
48702223|NCT02651675|156758622|FG001|Overall Study|Death|0|||
48702224|NCT02651675|156758623|FG002|Overall Study|Death|1|||
48702225|NCT03955146|156758624|FG000|DB Period (48 Weeks)|Study terminated by sponsor|0|||
48702226|NCT03955146|156758625|FG001|DB Period (48 Weeks)|Study terminated by sponsor|0|||
48702227|NCT03955146|156758626|FG002|DB Period (48 Weeks)|Study terminated by sponsor|1|||
48702228|NCT03955146|156758627|FG003|DB Period (48 Weeks)|Study terminated by sponsor|4|||
48702229|NCT03955146|156758624|FG000|DB Period (48 Weeks)|Adverse Event|2|||
48702230|NCT03955146|156758625|FG001|DB Period (48 Weeks)|Adverse Event|5|||
48702231|NCT03955146|156758626|FG002|DB Period (48 Weeks)|Adverse Event|1|||
48702232|NCT03955146|156758627|FG003|DB Period (48 Weeks)|Adverse Event|2|||
48702233|NCT03955146|156758624|FG000|DB Period (48 Weeks)|Death|13|||
48702234|NCT03955146|156758625|FG001|DB Period (48 Weeks)|Death|17|||
48702235|NCT03955146|156758626|FG002|DB Period (48 Weeks)|Death|1|||
48702236|NCT03955146|156758627|FG003|DB Period (48 Weeks)|Death|0|||
48702237|NCT03955146|156758624|FG000|DB Period (48 Weeks)|Investigator Decision|2|||
48702238|NCT03955146|156758625|FG001|DB Period (48 Weeks)|Investigator Decision|2|||
48702239|NCT03955146|156758626|FG002|DB Period (48 Weeks)|Investigator Decision|0|||
48702240|NCT03955146|156758627|FG003|DB Period (48 Weeks)|Investigator Decision|0|||
48702241|NCT03955146|156758624|FG000|DB Period (48 Weeks)|Disease Progression|2|||
48702242|NCT03955146|156758625|FG001|DB Period (48 Weeks)|Disease Progression|0|||
48702243|NCT03955146|156758626|FG002|DB Period (48 Weeks)|Disease Progression|0|||
48702244|NCT03955146|156758627|FG003|DB Period (48 Weeks)|Disease Progression|0|||
48702245|NCT03955146|156758624|FG000|DB Period (48 Weeks)|Withdrawal by Subject|6|||
48702246|NCT03955146|156758625|FG001|DB Period (48 Weeks)|Withdrawal by Subject|3|||
48702247|NCT03955146|156758626|FG002|DB Period (48 Weeks)|Withdrawal by Subject|0|||
48702248|NCT03955146|156758627|FG003|DB Period (48 Weeks)|Withdrawal by Subject|1|||
48702249|NCT03955146|156758624|FG000|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
48702250|NCT03955146|156758625|FG001|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
48702251|NCT03955146|156758626|FG002|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
48702252|NCT03955146|156758627|FG003|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
48702253|NCT03955146|156758624|FG000|DB Period (48 Weeks)|Lung Transplant|0|||
48702254|NCT03955146|156758625|FG001|DB Period (48 Weeks)|Lung Transplant|1|||
48702255|NCT03955146|156758626|FG002|DB Period (48 Weeks)|Lung Transplant|0|||
48702256|NCT03955146|156758627|FG003|DB Period (48 Weeks)|Lung Transplant|0|||
48702257|NCT03955146|156758624|FG000|DB Period (48 Weeks)|Participant Decision|9|||
48702258|NCT03955146|156758625|FG001|DB Period (48 Weeks)|Participant Decision|12|||
48702259|NCT03955146|156758626|FG002|DB Period (48 Weeks)|Participant Decision|1|||
48702260|NCT03955146|156758627|FG003|DB Period (48 Weeks)|Participant Decision|1|||
48702261|NCT03955146|156758624|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|7|||
48702262|NCT03955146|156758625|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|1|||
48702263|NCT03955146|156758626|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
48702264|NCT03955146|156758627|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
48702265|NCT03955146|156758624|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
48702266|NCT03955146|156758625|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
48702267|NCT03955146|156758626|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
48702268|NCT03955146|156758627|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
48702269|NCT03955146|156758624|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
48702270|NCT03955146|156758625|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|1|||
48702271|NCT03955146|156758626|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
48702272|NCT03955146|156758627|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
48702273|NCT03955146|156758624|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
48702274|NCT03955146|156758625|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
48702275|NCT03955146|156758626|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
48702276|NCT03955146|156758627|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
48702277|NCT03955146|156758624|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|84|||
48702278|NCT03955146|156758625|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|88|||
48702279|NCT03955146|156758626|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
48702280|NCT03955146|156758627|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
48702281|NCT03955146|156758624|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|1|||
48702282|NCT03955146|156758625|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
48702283|NCT03955146|156758626|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
48702284|NCT03955146|156758627|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
48702285|NCT03955146|156758624|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|7|||
48702286|NCT03955146|156758625|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|5|||
48702287|NCT03955146|156758626|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
48702288|NCT03955146|156758627|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
48702289|NCT03955146|156758624|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|2|||
48702290|NCT03955146|156758625|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|1|||
48702291|NCT03955146|156758626|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
48702292|NCT03955146|156758627|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
48702293|NCT03955146|156758624|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|1|||
48702294|NCT03955146|156758625|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
48702295|NCT03955146|156758626|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
48702296|NCT03955146|156758627|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
48702297|NCT03955146|156758624|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|12|||
48702298|NCT03955146|156758625|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|13|||
48702299|NCT03955146|156758626|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
48702300|NCT03955146|156758627|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
48702301|NCT03955146|156758624|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|1|||
48702302|NCT03955146|156758625|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
48702303|NCT03955146|156758626|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
48702304|NCT03955146|156758627|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
48702305|NCT00630838|156758628|FG000|Overall Study|Death|0|||
48702306|NCT00630838|156758629|FG001|Overall Study|Death|1|||
48702307|NCT00630838|156758628|FG000|Overall Study|Lost to Follow-up|0|||
48702308|NCT00630838|156758629|FG001|Overall Study|Lost to Follow-up|1|||
48702309|NCT01099267|156758630|FG000|MDS-003 Study|Adverse Event|37|||
48702310|NCT01099267|156758630|FG000|MDS-003 Study|Lack of Efficacy|52|||
48702311|NCT01099267|156758630|FG000|MDS-003 Study|Withdrawal by Subject|8|||
48702312|NCT01099267|156758630|FG000|MDS-003 Study|Lost to Follow-up|1|||
48702313|NCT01099267|156758630|FG000|MDS-003 Study|Death|11|||
48702314|NCT01099267|156758630|FG000|MDS-003 Study|Study Closed by Sponsor|2|||
48702315|NCT01099267|156758630|FG000|MDS-003 Study|Disease Progression|7|||
48702316|NCT01099267|156758630|FG000|MDS-003 Study|Investigator Decision|2|||
48702317|NCT01099267|156758630|FG000|MDS-003 Study|Non-Compliance|2|||
48702318|NCT01099267|156758630|FG000|MDS-003 Study|Loss of Response|1|||
48702319|NCT01099267|156758630|FG000|MDS-003 Study|Secondary Malign Disease|1|||
48702320|NCT00174187|156758634|FG000|Period 1 (up to 3 Years)|Serious adverse event|0|||
48702321|NCT00174187|156758635|FG001|Period 1 (up to 3 Years)|Serious adverse event|1|||
48702322|NCT00174187|156758636|FG002|Period 1 (up to 3 Years)|Serious adverse event|0|||
48702323|NCT00174187|156758634|FG000|Period 1 (up to 3 Years)|Non compliance|0|||
48702324|NCT00174187|156758635|FG001|Period 1 (up to 3 Years)|Non compliance|1|||
48702325|NCT00174187|156758636|FG002|Period 1 (up to 3 Years)|Non compliance|0|||
48702326|NCT00174187|156758634|FG000|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
48702327|NCT00174187|156758635|FG001|Period 1 (up to 3 Years)|Withdrawal by Subject|1|||
48702328|NCT00174187|156758636|FG002|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
48702329|NCT00174187|156758634|FG000|Period 1 (up to 3 Years)|Other|0|||
48702330|NCT00174187|156758635|FG001|Period 1 (up to 3 Years)|Other|1|||
48702331|NCT00174187|156758636|FG002|Period 1 (up to 3 Years)|Other|0|||
48702332|NCT00174187|156758634|FG000|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
48702333|NCT00174187|156758635|FG001|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
48702334|NCT00174187|156758636|FG002|Between Period 1 and Period 2|Did not consent to continue treatment|2|||
48702335|NCT00174187|156758634|FG000|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
48702336|NCT00174187|156758635|FG001|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
48702337|NCT00174187|156758636|FG002|Between Period 1 and Period 2|Consented, not assigned to treatment|3|||
48702338|NCT00174187|156758634|FG000|Period 2 (After 3 Years)|Lost to Follow-up|0|||
48702339|NCT00174187|156758635|FG001|Period 2 (After 3 Years)|Lost to Follow-up|0|||
48702340|NCT00174187|156758636|FG002|Period 2 (After 3 Years)|Lost to Follow-up|2|||
48702341|NCT00174187|156758634|FG000|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
48702342|NCT00174187|156758635|FG001|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
48702343|NCT00174187|156758636|FG002|Period 2 (After 3 Years)|Withdrawal by Subject|1|||
48702344|NCT00174187|156758634|FG000|Period 2 (After 3 Years)|Other|0|||
48702345|NCT00174187|156758635|FG001|Period 2 (After 3 Years)|Other|0|||
48702346|NCT00174187|156758636|FG002|Period 2 (After 3 Years)|Other|5|||
48702347|NCT03205423|156758643|FG000|Overall Study|Personal|1|||
48702348|NCT03205423|156758644|FG001|Overall Study|Personal|1|||
48702349|NCT03205423|156758643|FG000|Overall Study|Physician Decision|0|||
48702350|NCT03205423|156758644|FG001|Overall Study|Physician Decision|2|||
48702351|NCT04434937|156758647|FG000|Overall Study|Death|4|||
48702352|NCT04434937|156758647|FG000|Overall Study|Withdrawal by Subject|1|||
48702353|NCT04434937|156758647|FG000|Overall Study|Transitioned to Rollover Study|19|||
48702354|NCT04434937|156758647|FG000|Overall Study|Progressive Disease|18|||
48702355|NCT05767749|156758648|FG000|Overall Study|Withdrawal by Subject|0|||
48702356|NCT05767749|156758649|FG001|Overall Study|Withdrawal by Subject|0|||
48702357|NCT05767749|156758650|FG002|Overall Study|Withdrawal by Subject|2|||
48702358|NCT05767749|156758651|FG003|Overall Study|Withdrawal by Subject|2|||
48702359|NCT05767749|156758652|FG004|Overall Study|Withdrawal by Subject|2|||
48702360|NCT05767749|156758653|FG005|Overall Study|Withdrawal by Subject|2|||
48702361|NCT04949490|156758654|FG000|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
48702362|NCT04949490|156758655|FG001|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
48702363|NCT04949490|156758656|FG002|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
48702364|NCT04949490|156758657|FG003|Group A and Group B|Non-study SARS-COV-2 vaccination|2|||
48702365|NCT04949490|156758658|FG004|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
48702366|NCT04949490|156758659|FG005|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
48702367|NCT04949490|156758654|FG000|Group A and Group B|Withdrawal by Subject|0|||
48702368|NCT04949490|156758655|FG001|Group A and Group B|Withdrawal by Subject|0|||
48702369|NCT04949490|156758656|FG002|Group A and Group B|Withdrawal by Subject|1|||
48702370|NCT04949490|156758657|FG003|Group A and Group B|Withdrawal by Subject|0|||
48702371|NCT04949490|156758658|FG004|Group A and Group B|Withdrawal by Subject|0|||
48702372|NCT04949490|156758659|FG005|Group A and Group B|Withdrawal by Subject|0|||
48702373|NCT04949490|156758654|FG000|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
48702374|NCT04949490|156758655|FG001|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
48702375|NCT04949490|156758656|FG002|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
48702376|NCT04949490|156758657|FG003|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
48702377|NCT04949490|156758658|FG004|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
48702378|NCT04949490|156758659|FG005|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|2|||
48702379|NCT04949490|156758654|FG000|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
48702380|NCT04949490|156758655|FG001|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
48702381|NCT04949490|156758656|FG002|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
48702382|NCT04949490|156758657|FG003|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
48702383|NCT04949490|156758658|FG004|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|1|||
48912281|NCT03677596|157516187|FG001|Overall Study|Withdrawal by Subject|0|||
48702384|NCT04949490|156758659|FG005|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
48702385|NCT03278249|156758660|FG000|Overall Study|Withdrawal by Subject|2|||
48702386|NCT03278249|156758660|FG000|Overall Study|Lost to Follow-up|1|||
48702387|NCT03299166|156758661|FG000|Overall Study|Adverse Event|9|||
48702388|NCT03299166|156758662|FG001|Overall Study|Adverse Event|4|||
48702389|NCT03299166|156758661|FG000|Overall Study|Withdrawal by Subject|6|||
48702390|NCT03299166|156758662|FG001|Overall Study|Withdrawal by Subject|5|||
48702391|NCT03299166|156758661|FG000|Overall Study|Physician Decision|1|||
48912282|NCT03677596|157516186|FG000|Overall Study|Disease Relapse|2|||
48702392|NCT03299166|156758662|FG001|Overall Study|Physician Decision|1|||
48702393|NCT03299166|156758661|FG000|Overall Study|Sponsor Decision|3|||
48702394|NCT03299166|156758662|FG001|Overall Study|Sponsor Decision|0|||
48702395|NCT03299166|156758661|FG000|Overall Study|Lost to Follow-up|2|||
48702396|NCT03299166|156758662|FG001|Overall Study|Lost to Follow-up|4|||
48702397|NCT03299166|156758661|FG000|Overall Study|Randomization Error|0|||
48702398|NCT03299166|156758662|FG001|Overall Study|Randomization Error|1|||
48702399|NCT03299166|156758661|FG000|Overall Study|Subject unable to return due to COVID|1|||
48702400|NCT03299166|156758662|FG001|Overall Study|Subject unable to return due to COVID|0|||
48702401|NCT03299166|156758661|FG000|Overall Study|Unable to complete Week 12 visit at site|1|||
48702402|NCT03299166|156758662|FG001|Overall Study|Unable to complete Week 12 visit at site|0|||
48702403|NCT02374450|156758663|FG000|Overall Study|Protocol Violation|0|||
48702404|NCT02374450|156758664|FG001|Overall Study|Protocol Violation|1|||
48702405|NCT02374450|156758665|FG002|Overall Study|Protocol Violation|0|||
48702406|NCT02374450|156758663|FG000|Overall Study|Withdrawal by Subject|91|||
48702407|NCT02374450|156758664|FG001|Overall Study|Withdrawal by Subject|110|||
48702408|NCT02374450|156758665|FG002|Overall Study|Withdrawal by Subject|4|||
48702409|NCT02374450|156758663|FG000|Overall Study|Lost to Follow-up|168|||
48702410|NCT02374450|156758664|FG001|Overall Study|Lost to Follow-up|194|||
48912283|NCT03677596|157516187|FG001|Overall Study|Disease Relapse|2|||
48702411|NCT02374450|156758665|FG002|Overall Study|Lost to Follow-up|138|||
48702412|NCT02374450|156758663|FG000|Overall Study|Death|173|||
48702413|NCT02374450|156758664|FG001|Overall Study|Death|185|||
48702414|NCT02374450|156758665|FG002|Overall Study|Death|81|||
48702415|NCT02374450|156758663|FG000|Overall Study|Migrated from the study area|538|||
48702416|NCT02374450|156758664|FG001|Overall Study|Migrated from the study area|648|||
48702417|NCT02374450|156758665|FG002|Overall Study|Migrated from the study area|181|||
48702418|NCT02374450|156758663|FG000|Overall Study|Enrollment in NCT03855995 study|0|||
48702419|NCT02374450|156758664|FG001|Overall Study|Enrollment in NCT03855995 study|1|||
48702420|NCT02374450|156758665|FG002|Overall Study|Enrollment in NCT03855995 study|0|||
48702421|NCT02374450|156758663|FG000|Overall Study|Vaccination with RTS,S/AS01E vaccine|2|||
48702422|NCT02374450|156758664|FG001|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
48702423|NCT02374450|156758665|FG002|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
48702424|NCT02374450|156758663|FG000|Overall Study|Other|0|||
48702425|NCT02374450|156758664|FG001|Overall Study|Other|21|||
48702426|NCT02374450|156758665|FG002|Overall Study|Other|79|||
48702427|NCT02892344|156760606|FG000|Overall Study|Protocol deviation|3|||
48702428|NCT02892344|156760607|FG001|Overall Study|Protocol deviation|4|||
48702429|NCT02892344|156760606|FG000|Overall Study|Adverse Event|1|||
48702430|NCT02892344|156760607|FG001|Overall Study|Adverse Event|8|||
48702431|NCT02892344|156760606|FG000|Overall Study|Lost to Follow-up|0|||
48702432|NCT02892344|156760607|FG001|Overall Study|Lost to Follow-up|1|||
48702433|NCT02892344|156760606|FG000|Overall Study|Non-compliance with study treatment|0|||
48702434|NCT02892344|156760607|FG001|Overall Study|Non-compliance with study treatment|1|||
48702435|NCT02892344|156760606|FG000|Overall Study|Physician Decision|0|||
48702436|NCT02892344|156760607|FG001|Overall Study|Physician Decision|2|||
48702437|NCT02892344|156760606|FG000|Overall Study|Subject/guardian decision|0|||
48702438|NCT02892344|156760607|FG001|Overall Study|Subject/guardian decision|4|||
48702439|NCT02892344|156760606|FG000|Overall Study|Technical problems|0|||
48702440|NCT02892344|156760607|FG001|Overall Study|Technical problems|1|||
48702441|NCT03780244|156760608|FG000|Overall Study|Lost to Follow-up|1|||
48702442|NCT03780244|156760609|FG001|Overall Study|Lost to Follow-up|0|||
48702443|NCT02066181|156760610|FG000|Overall Study|Withdrawal by Subject|1|||
48702444|NCT02066181|156760611|FG001|Overall Study|Withdrawal by Subject|1|||
48702445|NCT02851615|156760612|FG000|Overall Study|Cognitive Issue|1|||
48702446|NCT02851615|156760613|FG001|Overall Study|Cognitive Issue|0|||
49118559|NCT00424593|158273148|FG000|Acute Double-Blind Period|Protocol Violation|2|||
49118560|NCT00424593|158273149|FG001|Acute Double-Blind Period|Protocol Violation|2|||
49118561|NCT00424593|158273148|FG000|Acute Double-Blind Period|Physician Decision|1|||
49118562|NCT00424593|158273149|FG001|Acute Double-Blind Period|Physician Decision|2|||
49118563|NCT00424593|158273148|FG000|Acute Double-Blind Period|Lost to Follow-up|1|||
49118564|NCT00424593|158273149|FG001|Acute Double-Blind Period|Lost to Follow-up|1|||
49118565|NCT00424593|158273148|FG000|Acute Double-Blind Period|Lack of Efficacy|0|||
49118566|NCT00424593|158273149|FG001|Acute Double-Blind Period|Lack of Efficacy|1|||
48702447|NCT02851615|156760612|FG000|Overall Study|Lost to Follow-up|0|||
48702448|NCT02851615|156760613|FG001|Overall Study|Lost to Follow-up|4|||
48702449|NCT00313014|156760614|FG000|Overall Study|Withdrawal by Subject|11|||
49118567|NCT00424593|158273148|FG000|Dose-Blind Extension Period|Withdrawal by Subject|19|||
49118568|NCT00424593|158273149|FG001|Dose-Blind Extension Period|Withdrawal by Subject|0|||
49118569|NCT00424593|158273148|FG000|Dose-Blind Extension Period|Adverse Event|18|||
49118570|NCT00424593|158273149|FG001|Dose-Blind Extension Period|Adverse Event|0|||
49118571|NCT00424593|158273148|FG000|Dose-Blind Extension Period|Lack of Efficacy|9|||
49118572|NCT00424593|158273149|FG001|Dose-Blind Extension Period|Lack of Efficacy|0|||
49118573|NCT00424593|158273148|FG000|Dose-Blind Extension Period|Protocol Violation|9|||
49118574|NCT00424593|158273149|FG001|Dose-Blind Extension Period|Protocol Violation|0|||
49118575|NCT00424593|158273148|FG000|Dose-Blind Extension Period|Lost to Follow-up|6|||
49118576|NCT00424593|158273149|FG001|Dose-Blind Extension Period|Lost to Follow-up|0|||
49118577|NCT00424593|158273148|FG000|Dose-Blind Extension Period|Physician Decision|3|||
49118578|NCT00424593|158273149|FG001|Dose-Blind Extension Period|Physician Decision|0|||
49118579|NCT00632125|158273150|FG000|Overall Study|Death|82|||
49118580|NCT00632125|158273150|FG000|Overall Study|Withdrawal by Subject|44|||
49118581|NCT00632125|158273150|FG000|Overall Study|Adverse Event|36|||
49118582|NCT00632125|158273150|FG000|Overall Study|Renal transplantation|17|||
49118583|NCT00632125|158273150|FG000|Overall Study|Need for systemic immunosuppressive medi|8|||
48702450|NCT00313014|156760615|FG001|Overall Study|Withdrawal by Subject|7|||
48702451|NCT00313014|156760616|FG002|Overall Study|Withdrawal by Subject|5|||
48702452|NCT00313014|156760614|FG000|Overall Study|Adverse Event|14|||
48702453|NCT00313014|156760615|FG001|Overall Study|Adverse Event|29|||
48702454|NCT00313014|156760616|FG002|Overall Study|Adverse Event|16|||
48702455|NCT00313014|156760614|FG000|Overall Study|Lost to Follow-up|7|||
48702456|NCT00313014|156760615|FG001|Overall Study|Lost to Follow-up|6|||
48702457|NCT00313014|156760616|FG002|Overall Study|Lost to Follow-up|10|||
48702458|NCT00313014|156760614|FG000|Overall Study|Administrative|9|||
48702459|NCT00313014|156760615|FG001|Overall Study|Administrative|6|||
48702460|NCT00313014|156760616|FG002|Overall Study|Administrative|14|||
48702461|NCT00313014|156760614|FG000|Overall Study|Lack of Efficacy|52|||
48702462|NCT00313014|156760615|FG001|Overall Study|Lack of Efficacy|25|||
48702463|NCT00313014|156760616|FG002|Overall Study|Lack of Efficacy|16|||
48702464|NCT00371150|156760619|FG000|Overall Study|Lost to Follow-up|3|||
48702465|NCT00371150|156760620|FG001|Overall Study|Lost to Follow-up|2|||
48702466|NCT02141295|156760621|FG000|Overall Study|Adverse Event|1|||
48702467|NCT02141295|156760622|FG001|Overall Study|Adverse Event|18|||
48702468|NCT02141295|156760623|FG002|Overall Study|Adverse Event|11|||
48702469|NCT02141295|156760621|FG000|Overall Study|Physician Decision|2|||
48912284|NCT03677596|157516186|FG000|Overall Study|Other|0|||
48702470|NCT02141295|156760622|FG001|Overall Study|Physician Decision|19|||
48702471|NCT02141295|156760623|FG002|Overall Study|Physician Decision|14|||
48702472|NCT02141295|156760621|FG000|Overall Study|Study terminated by sponsor|0|||
48702473|NCT02141295|156760622|FG001|Overall Study|Study terminated by sponsor|6|||
48702474|NCT02141295|156760623|FG002|Overall Study|Study terminated by sponsor|6|||
48702475|NCT02141295|156760621|FG000|Overall Study|Non-compliance|0|||
48702476|NCT02141295|156760622|FG001|Overall Study|Non-compliance|1|||
48702477|NCT02141295|156760623|FG002|Overall Study|Non-compliance|0|||
48702478|NCT02141295|156760621|FG000|Overall Study|Progressive disease|3|||
48702479|NCT02141295|156760622|FG001|Overall Study|Progressive disease|32|||
48702480|NCT02141295|156760623|FG002|Overall Study|Progressive disease|50|||
48702481|NCT02141295|156760621|FG000|Overall Study|Reason not specified|0|||
48702482|NCT02141295|156760622|FG001|Overall Study|Reason not specified|9|||
48702483|NCT02141295|156760623|FG002|Overall Study|Reason not specified|10|||
48702484|NCT02141295|156760621|FG000|Overall Study|Withdrawal by Subject|0|||
48702485|NCT02141295|156760622|FG001|Overall Study|Withdrawal by Subject|9|||
48702486|NCT02141295|156760623|FG002|Overall Study|Withdrawal by Subject|4|||
48702487|NCT05050318|156760625|FG000|Overall Study|Protocol Deviation|1|||
48702488|NCT05050318|156760626|FG001|Overall Study|Protocol Deviation|0|||
48702489|NCT05050318|156760627|FG002|Overall Study|Protocol Deviation|0|||
48702490|NCT02345070|156760628|FG000|Overall Study|Adverse Event|12|||
48702491|NCT02345070|156760629|FG001|Overall Study|Adverse Event|8|||
48702492|NCT02345070|156760630|FG002|Overall Study|Adverse Event|16|||
48702493|NCT02345070|156760628|FG000|Overall Study|Poor compliance to protocol|2|||
48702494|NCT02345070|156760629|FG001|Overall Study|Poor compliance to protocol|0|||
48702495|NCT02345070|156760630|FG002|Overall Study|Poor compliance to protocol|0|||
48702496|NCT02345070|156760628|FG000|Overall Study|Other than specified above|6|||
48702497|NCT02345070|156760629|FG001|Overall Study|Other than specified above|3|||
48702498|NCT02345070|156760630|FG002|Overall Study|Other than specified above|7|||
48702499|NCT01942837|156760634|FG000|Overall Study|Death|1|||
48702500|NCT01942837|156760634|FG000|Overall Study|Symptomatic or radiographic progression|49|||
48702501|NCT01942837|156760634|FG000|Overall Study|Adverse Event|6|||
48702502|NCT01942837|156760634|FG000|Overall Study|Physician Decision|3|||
48702503|NCT01942837|156760634|FG000|Overall Study|Withdrawal by Subject|2|||
48702504|NCT01942837|156760634|FG000|Overall Study|Intercurrent Illness|1|||
48702505|NCT01942837|156760634|FG000|Overall Study|On treatment|3|||
48702506|NCT01942837|156760634|FG000|Overall Study|Never initiate the treatment|2|||
48702507|NCT00321620|156760635|FG000|Overall Study|Death|269|||
48702508|NCT00321620|156760636|FG001|Overall Study|Death|294|||
48702509|NCT00321620|156760635|FG000|Overall Study|Withdrawal by Subject|164|||
48702510|NCT00321620|156760636|FG001|Overall Study|Withdrawal by Subject|147|||
48702511|NCT00321620|156760635|FG000|Overall Study|Disease progression|113|||
48702512|NCT00321620|156760636|FG001|Overall Study|Disease progression|117|||
48702513|NCT00321620|156760635|FG000|Overall Study|Adverse Event|43|||
48702514|NCT00321620|156760636|FG001|Overall Study|Adverse Event|56|||
48702515|NCT00321620|156760635|FG000|Overall Study|Lost to Follow-up|13|||
48702516|NCT00321620|156760636|FG001|Overall Study|Lost to Follow-up|9|||
48702517|NCT00321620|156760635|FG000|Overall Study|Physician Decision|4|||
48702518|NCT00321620|156760636|FG001|Overall Study|Physician Decision|1|||
48702519|NCT00321620|156760635|FG000|Overall Study|Noncompliance|14|||
48702520|NCT00321620|156760636|FG001|Overall Study|Noncompliance|7|||
48702521|NCT00321620|156760635|FG000|Overall Study|Protocol deviation|4|||
48702522|NCT00321620|156760636|FG001|Overall Study|Protocol deviation|3|||
48702523|NCT00321620|156760635|FG000|Overall Study|Ineligibility determined|2|||
48702524|NCT00321620|156760636|FG001|Overall Study|Ineligibility determined|3|||
48702525|NCT00321620|156760635|FG000|Overall Study|Participant request|75|||
48702526|NCT00321620|156760636|FG001|Overall Study|Participant request|52|||
48702527|NCT00321620|156760635|FG000|Overall Study|Other|42|||
48702528|NCT00321620|156760636|FG001|Overall Study|Other|33|||
48702529|NCT01198795|156760639|FG000|Overall Study|Did not meet InclusionExclusion criteria|30|||
48702530|NCT01198795|156760639|FG000|Overall Study|Withdrawal by Subject|17|||
48702531|NCT01198795|156760639|FG000|Overall Study|Lost to Follow-up|15|||
48702532|NCT01198795|156760639|FG000|Overall Study|Adverse Event|9|||
48702533|NCT01198795|156760639|FG000|Overall Study|Lack of Efficacy|5|||
48702534|NCT01198795|156760639|FG000|Overall Study|Protocol Violation|2|||
48702535|NCT01198795|156760639|FG000|Overall Study|Other Reason|4|||
48702536|NCT03038100|156760640|FG000|Overall Study|Death|289|||
48702537|NCT03038100|156760641|FG001|Overall Study|Death|272|||
48702538|NCT03038100|156760640|FG000|Overall Study|Lost to Follow-up|9|||
48702539|NCT03038100|156760641|FG001|Overall Study|Lost to Follow-up|10|||
48702540|NCT03038100|156760640|FG000|Overall Study|Protocol Deviation|1|||
48702541|NCT03038100|156760641|FG001|Overall Study|Protocol Deviation|4|||
48702542|NCT03038100|156760640|FG000|Overall Study|Withdrawal by Subject|45|||
48702543|NCT03038100|156760641|FG001|Overall Study|Withdrawal by Subject|51|||
48702544|NCT03038100|156760640|FG000|Overall Study|Study Terminated By Sponsor|305|||
48702545|NCT03038100|156760641|FG001|Overall Study|Study Terminated By Sponsor|311|||
48702546|NCT03038100|156760640|FG000|Overall Study|Physician Decision|1|||
48702547|NCT03038100|156760641|FG001|Overall Study|Physician Decision|3|||
48702548|NCT00918255|156760642|FG000|Overall Study|Adverse Event|1|||
48702549|NCT00918255|156760643|FG001|Overall Study|Adverse Event|0|||
48702550|NCT00918255|156760644|FG002|Overall Study|Adverse Event|0|||
48702551|NCT00918255|156760642|FG000|Overall Study|Withdrawal by Subject|1|||
48702552|NCT00918255|156760643|FG001|Overall Study|Withdrawal by Subject|0|||
48702553|NCT00918255|156760644|FG002|Overall Study|Withdrawal by Subject|2|||
48702554|NCT00918255|156760642|FG000|Overall Study|Lack of Efficacy|1|||
48702555|NCT00918255|156760643|FG001|Overall Study|Lack of Efficacy|0|||
48702556|NCT00918255|156760644|FG002|Overall Study|Lack of Efficacy|0|||
48702557|NCT00918255|156760642|FG000|Overall Study|Lost to Follow-up|1|||
48702558|NCT00918255|156760643|FG001|Overall Study|Lost to Follow-up|0|||
48702559|NCT00918255|156760644|FG002|Overall Study|Lost to Follow-up|2|||
48702560|NCT00918255|156760642|FG000|Overall Study|Exceeded allowed number of interventions|0|||
48702561|NCT00918255|156760643|FG001|Overall Study|Exceeded allowed number of interventions|0|||
48702562|NCT00918255|156760644|FG002|Overall Study|Exceeded allowed number of interventions|1|||
48702563|NCT00918255|156760642|FG000|Overall Study|Non-compliance|1|||
48702564|NCT00918255|156760643|FG001|Overall Study|Non-compliance|0|||
48702565|NCT00918255|156760644|FG002|Overall Study|Non-compliance|0|||
48702566|NCT00918255|156760642|FG000|Overall Study|Investigator discretion|1|||
48702567|NCT00918255|156760643|FG001|Overall Study|Investigator discretion|0|||
48702568|NCT00918255|156760644|FG002|Overall Study|Investigator discretion|0|||
48702569|NCT00408317|156760646|FG000|First Intervention Period|Adverse Event|0|||
48702570|NCT00408317|156760647|FG001|First Intervention Period|Adverse Event|1|||
48702571|NCT00408317|156760646|FG000|Second Intervention Period|Adverse Event|2|||
48702572|NCT00408317|156760647|FG001|Second Intervention Period|Adverse Event|0|||
48702573|NCT00408317|156760646|FG000|Second Intervention Period|Protocol Violation|0|||
48702574|NCT00408317|156760647|FG001|Second Intervention Period|Protocol Violation|1|||
48702575|NCT00408317|156760646|FG000|Second Intervention Period|Withdrawal of consent|0|||
48702576|NCT00408317|156760647|FG001|Second Intervention Period|Withdrawal of consent|1|||
48702577|NCT02703597|156760648|FG000|Assignment to Baseline|Lost to Follow-up|17|||
48702578|NCT02703597|156760649|FG001|Assignment to Baseline|Lost to Follow-up|16|||
48702579|NCT02703597|156760648|FG000|Baseline to First Post-test|Lost to Follow-up|61|||
48702580|NCT02703597|156760649|FG001|Baseline to First Post-test|Lost to Follow-up|92|||
48702581|NCT02703597|156760648|FG000|First Post-test to First Follow-up|Lost to Follow-up|5|||
48702582|NCT02703597|156760649|FG001|First Post-test to First Follow-up|Lost to Follow-up|3|||
48702583|NCT02703597|156760648|FG000|First Post-test to First Follow-up|Site drop out|0|||
48702584|NCT02703597|156760649|FG001|First Post-test to First Follow-up|Site drop out|58|||
48702585|NCT02703597|156760648|FG000|Recruitment Period for Assessment 5|Withdrawal by Site|16|||
48702586|NCT02703597|156760649|FG001|Recruitment Period for Assessment 5|Withdrawal by Site|0|||
48702587|NCT02703597|156760648|FG000|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|0|||
48702588|NCT02703597|156760649|FG001|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|71|||
48702589|NCT02703597|156760648|FG000|Assessment 5 to Second Post-test|Lost to Follow-up|27|||
48702590|NCT02703597|156760649|FG001|Assessment 5 to Second Post-test|Lost to Follow-up|0|||
48702591|NCT00459316|156760651|FG000|Steps 1 & 2|Other eligibility failure|1|||
48702592|NCT00459316|156760652|FG001|Steps 1 & 2|Other eligibility failure|1|||
48702593|NCT00459316|156760653|FG002|Steps 1 & 2|Other eligibility failure|0|||
48702594|NCT00459316|156760651|FG000|Steps 1 & 2|Death|1|||
48702595|NCT00459316|156760652|FG001|Steps 1 & 2|Death|1|||
48702596|NCT00459316|156760653|FG002|Steps 1 & 2|Death|0|||
48702597|NCT00459316|156760651|FG000|Steps 1 & 2|Not able to get to clinic|7|||
48702598|NCT00459316|156760652|FG001|Steps 1 & 2|Not able to get to clinic|4|||
48702599|NCT00459316|156760653|FG002|Steps 1 & 2|Not able to get to clinic|0|||
48702600|NCT00459316|156760651|FG000|Steps 1 & 2|Withdrawal by Subject|6|||
48702601|NCT00459316|156760652|FG001|Steps 1 & 2|Withdrawal by Subject|1|||
48702602|NCT00459316|156760653|FG002|Steps 1 & 2|Withdrawal by Subject|0|||
48702603|NCT00459316|156760651|FG000|Steps 1 & 2|Not willing to adhere to regulations|1|||
48702604|NCT00459316|156760652|FG001|Steps 1 & 2|Not willing to adhere to regulations|0|||
48912285|NCT03677596|157516187|FG001|Overall Study|Other|1|||
48702605|NCT00459316|156760653|FG002|Steps 1 & 2|Not willing to adhere to regulations|0|||
48702606|NCT00459316|156760651|FG000|Steps 1 & 2|Lost to Follow-up|5|||
48702607|NCT00459316|156760652|FG001|Steps 1 & 2|Lost to Follow-up|0|||
48702608|NCT00459316|156760653|FG002|Steps 1 & 2|Lost to Follow-up|2|||
48702609|NCT00459316|156760651|FG000|Step 3|Withdrawal by Subject|3|||
48702610|NCT00459316|156760652|FG001|Step 3|Withdrawal by Subject|0|||
48702611|NCT00459316|156760653|FG002|Step 3|Withdrawal by Subject|1|||
48702612|NCT01393821|156760654|FG000|Overall Study|Cancel|1|||
48702613|NCT01393821|156760655|FG001|Overall Study|Cancel|1|||
48702614|NCT01393821|156760654|FG000|Overall Study|not evaluable for primary endpoint|4|||
48702615|NCT01393821|156760655|FG001|Overall Study|not evaluable for primary endpoint|2|||
48702616|NCT01435382|156760661|FG000|Overall Study|Lost to Follow-up|1|||
48702617|NCT01435382|156760662|FG001|Overall Study|Lost to Follow-up|0|||
48702618|NCT01435382|156760663|FG002|Overall Study|Lost to Follow-up|1|||
48702619|NCT01435382|156760664|FG003|Overall Study|Lost to Follow-up|0|||
48702620|NCT01435382|156760661|FG000|Overall Study|Withdrawal by Subject|0|||
48702621|NCT01435382|156760662|FG001|Overall Study|Withdrawal by Subject|2|||
48702622|NCT01435382|156760663|FG002|Overall Study|Withdrawal by Subject|0|||
48702623|NCT01435382|156760664|FG003|Overall Study|Withdrawal by Subject|1|||
48702624|NCT01046396|156760667|FG000|Overall Study|Withdrawal by Subject|5|||
48702625|NCT03367793|156760668|FG000|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
48702626|NCT03367793|156760669|FG001|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
48702627|NCT03367793|156760670|FG002|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1|||
48702628|NCT03367793|156760671|FG003|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
48702629|NCT03367793|156760672|FG004|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
48702630|NCT03367793|156760673|FG005|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
48702631|NCT00907335|156760674|FG000|Overall Study|Withdrawal by Subject|2|||
48702632|NCT00907335|156760675|FG001|Overall Study|Withdrawal by Subject|0|||
48702633|NCT00907335|156760674|FG000|Overall Study|Adverse Event|4|||
48702634|NCT00907335|156760675|FG001|Overall Study|Adverse Event|1|||
48702635|NCT00907335|156760674|FG000|Overall Study|Lost to Follow-up|2|||
48702636|NCT00907335|156760675|FG001|Overall Study|Lost to Follow-up|0|||
48702637|NCT00260533|156760678|FG000|Overall Study|Other|3|||
48702638|NCT00260533|156760679|FG001|Overall Study|Other|3|||
48702639|NCT02161016|156760680|FG000|Overall Study|withdrawn by IRB|1|||
48702640|NCT03873116|156760681|FG000|Part 1|Study drug discontinuation due to rash|0|||
48702641|NCT03873116|156760682|FG001|Part 1|Study drug discontinuation due to rash|0|||
48702642|NCT03873116|156760683|FG002|Part 1|Study drug discontinuation due to rash|0|||
48702643|NCT03873116|156760684|FG003|Part 1|Study drug discontinuation due to rash|0|||
48702644|NCT03873116|156760685|FG004|Part 1|Study drug discontinuation due to rash|0|||
48702645|NCT03873116|156760686|FG005|Part 1|Study drug discontinuation due to rash|1|||
48702646|NCT03873116|156760681|FG000|Part 2|Withdrawal by Subject|0|||
48702647|NCT03873116|156760682|FG001|Part 2|Withdrawal by Subject|0|||
48702648|NCT03873116|156760683|FG002|Part 2|Withdrawal by Subject|1|||
48702649|NCT03873116|156760684|FG003|Part 2|Withdrawal by Subject|0|||
48702650|NCT03873116|156760685|FG004|Part 2|Withdrawal by Subject|0|||
48702651|NCT03873116|156760686|FG005|Part 2|Withdrawal by Subject|0|||
48702652|NCT03873116|156760681|FG000|Part 2|Lab abnormality or AE|0|||
48702653|NCT03873116|156760682|FG001|Part 2|Lab abnormality or AE|0|||
48702654|NCT03873116|156760683|FG002|Part 2|Lab abnormality or AE|0|||
48702655|NCT03873116|156760684|FG003|Part 2|Lab abnormality or AE|0|||
48702656|NCT03873116|156760685|FG004|Part 2|Lab abnormality or AE|1|||
48702657|NCT03873116|156760686|FG005|Part 2|Lab abnormality or AE|0|||
48702658|NCT03873116|156760681|FG000|Part 3|Withdrawal by Subject|0|||
48702659|NCT03873116|156760682|FG001|Part 3|Withdrawal by Subject|0|||
48702660|NCT03873116|156760683|FG002|Part 3|Withdrawal by Subject|0|||
48702661|NCT03873116|156760684|FG003|Part 3|Withdrawal by Subject|0|||
48702662|NCT03873116|156760685|FG004|Part 3|Withdrawal by Subject|1|||
48702663|NCT03873116|156760686|FG005|Part 3|Withdrawal by Subject|0|||
48702664|NCT00003475|156760687|FG000|Overall Study|Not evaluable|13|||
48702665|NCT00702221|156760688|FG000|Overall Study|Adverse Event|4|||
48702666|NCT00702221|156760689|FG001|Overall Study|Adverse Event|3|||
48702667|NCT02558296|156760690|FG000|Completed the Study Through Week 24|Adverse Event|9|||
48702668|NCT02558296|156760691|FG001|Completed the Study Through Week 24|Adverse Event|3|||
48702669|NCT02558296|156760690|FG000|Completed the Study Through Week 24|Death|7|||
48702670|NCT02558296|156760691|FG001|Completed the Study Through Week 24|Death|7|||
48702671|NCT02558296|156760690|FG000|Completed the Study Through Week 24|Lost to Follow-up|8|||
48702672|NCT02558296|156760691|FG001|Completed the Study Through Week 24|Lost to Follow-up|1|||
48702673|NCT02558296|156760690|FG000|Completed the Study Through Week 24|Physician Decision|1|||
49118584|NCT00632125|158273150|FG000|Overall Study|Non-compliance|8|||
49118585|NCT00632125|158273150|FG000|Overall Study|Development of uncontrolled hypertension|5|||
49118586|NCT00632125|158273150|FG000|Overall Study|Moved to other dialysis unit, etc.|102|||
49118587|NCT00572455|158273151|FG000|Stage I (14 Days)|Adverse Event|0|||
49118588|NCT00572455|158273152|FG001|Stage I (14 Days)|Adverse Event|0|||
49118589|NCT00572455|158273153|FG002|Stage I (14 Days)|Adverse Event|0|||
49118590|NCT00572455|158273154|FG003|Stage I (14 Days)|Adverse Event|0|||
49118591|NCT00572455|158273155|FG004|Stage I (14 Days)|Adverse Event|0|||
49118592|NCT00572455|158273156|FG005|Stage I (14 Days)|Adverse Event|3|||
49118593|NCT00572455|158273157|FG006|Stage I (14 Days)|Adverse Event|0|||
49118594|NCT00572455|158273158|FG007|Stage I (14 Days)|Adverse Event|0|||
49118595|NCT00572455|158273159|FG008|Stage I (14 Days)|Adverse Event|0|||
49118596|NCT00572455|158273160|FG009|Stage I (14 Days)|Adverse Event|0|||
49118597|NCT00572455|158273161|FG010|Stage I (14 Days)|Adverse Event|0|||
48702674|NCT02558296|156760691|FG001|Completed the Study Through Week 24|Physician Decision|0|||
48702675|NCT02558296|156760690|FG000|Completed the Study Through Week 24|Protocol Violation|1|||
48702676|NCT02558296|156760691|FG001|Completed the Study Through Week 24|Protocol Violation|1|||
48702677|NCT02558296|156760690|FG000|Completed the Study Through Week 24|Withdrawal by Subject|17|||
48702678|NCT02558296|156760691|FG001|Completed the Study Through Week 24|Withdrawal by Subject|13|||
48702679|NCT02558296|156760690|FG000|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1|||
48702680|NCT02558296|156760691|FG001|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0|||
48702681|NCT02558296|156760690|FG000|Completed the Study|Adverse Event|14|||
48702682|NCT02558296|156760691|FG001|Completed the Study|Adverse Event|5|||
48702683|NCT02558296|156760690|FG000|Completed the Study|Death|39|||
49118598|NCT00572455|158273162|FG011|Stage I (14 Days)|Adverse Event|0|||
49118599|NCT00572455|158273163|FG012|Stage I (14 Days)|Adverse Event|0|||
48702684|NCT02558296|156760691|FG001|Completed the Study|Death|25|||
48702685|NCT02558296|156760690|FG000|Completed the Study|Lost to Follow-up|31|||
48702686|NCT02558296|156760691|FG001|Completed the Study|Lost to Follow-up|23|||
48702687|NCT02558296|156760690|FG000|Completed the Study|Physician Decision|6|||
48702688|NCT02558296|156760691|FG001|Completed the Study|Physician Decision|0|||
48702689|NCT02558296|156760690|FG000|Completed the Study|Protocol Violation|2|||
49118600|NCT00572455|158273164|FG013|Stage I (14 Days)|Adverse Event|0|||
48912286|NCT01735279|157516188|FG000|Overall Study|Lost to Follow-up|11|||
49118601|NCT00572455|158273151|FG000|Stage I (14 Days)|Other|0|||
49118602|NCT00572455|158273152|FG001|Stage I (14 Days)|Other|0|||
48702690|NCT02558296|156760691|FG001|Completed the Study|Protocol Violation|1|||
48702691|NCT02558296|156760690|FG000|Completed the Study|Withdrawal by Subject|53|||
48702692|NCT02558296|156760691|FG001|Completed the Study|Withdrawal by Subject|31|||
48702693|NCT02558296|156760690|FG000|Completed the Study|The subject was randomized, but did not take any investigational product|1|||
48702694|NCT02558296|156760691|FG001|Completed the Study|The subject was randomized, but did not take any investigational product|0|||
48702695|NCT00389610|156760692|FG000|Overall Study|Disease Progression|0|||
48702696|NCT00389610|156760693|FG001|Overall Study|Disease Progression|19|||
48702697|NCT00389610|156760692|FG000|Overall Study|Death|0|||
48702698|NCT00389610|156760693|FG001|Overall Study|Death|1|||
48702699|NCT00389610|156760692|FG000|Overall Study|Physician Decision|0|||
48702700|NCT00389610|156760693|FG001|Overall Study|Physician Decision|1|||
48702701|NCT00389610|156760692|FG000|Overall Study|Withdrawal by Subject|0|||
48702702|NCT00389610|156760693|FG001|Overall Study|Withdrawal by Subject|1|||
48702703|NCT00904982|156760699|FG000|Overall Study|Withdrawal by Subject|2|||
49118603|NCT00572455|158273153|FG002|Stage I (14 Days)|Other|0|||
49118604|NCT00572455|158273154|FG003|Stage I (14 Days)|Other|0|||
49118605|NCT00572455|158273155|FG004|Stage I (14 Days)|Other|1|||
49118606|NCT00572455|158273156|FG005|Stage I (14 Days)|Other|0|||
49118607|NCT00572455|158273157|FG006|Stage I (14 Days)|Other|0|||
49118608|NCT00572455|158273158|FG007|Stage I (14 Days)|Other|0|||
49118609|NCT00572455|158273159|FG008|Stage I (14 Days)|Other|0|||
49118610|NCT00572455|158273160|FG009|Stage I (14 Days)|Other|0|||
49118611|NCT00572455|158273161|FG010|Stage I (14 Days)|Other|0|||
49118612|NCT00572455|158273162|FG011|Stage I (14 Days)|Other|0|||
49118613|NCT00572455|158273163|FG012|Stage I (14 Days)|Other|0|||
49118614|NCT00572455|158273164|FG013|Stage I (14 Days)|Other|0|||
49118615|NCT00572455|158273151|FG000|Stage II (28 Days)|Adverse Event|0|||
49118616|NCT00572455|158273152|FG001|Stage II (28 Days)|Adverse Event|0|||
49118617|NCT00572455|158273153|FG002|Stage II (28 Days)|Adverse Event|0|||
49118618|NCT00572455|158273154|FG003|Stage II (28 Days)|Adverse Event|0|||
49118619|NCT00572455|158273155|FG004|Stage II (28 Days)|Adverse Event|0|||
49118620|NCT00572455|158273156|FG005|Stage II (28 Days)|Adverse Event|0|||
49118621|NCT00572455|158273157|FG006|Stage II (28 Days)|Adverse Event|0|||
49118622|NCT00572455|158273158|FG007|Stage II (28 Days)|Adverse Event|0|||
49118623|NCT00572455|158273159|FG008|Stage II (28 Days)|Adverse Event|1|||
49118624|NCT00572455|158273160|FG009|Stage II (28 Days)|Adverse Event|3|||
49118625|NCT00572455|158273161|FG010|Stage II (28 Days)|Adverse Event|3|||
49118626|NCT00572455|158273162|FG011|Stage II (28 Days)|Adverse Event|4|||
49118627|NCT00572455|158273163|FG012|Stage II (28 Days)|Adverse Event|5|||
49118628|NCT00572455|158273164|FG013|Stage II (28 Days)|Adverse Event|1|||
49118629|NCT00572455|158273151|FG000|Stage II (28 Days)|Death|0|||
49118630|NCT00572455|158273152|FG001|Stage II (28 Days)|Death|0|||
49118631|NCT00572455|158273153|FG002|Stage II (28 Days)|Death|0|||
49118632|NCT00572455|158273154|FG003|Stage II (28 Days)|Death|0|||
49118633|NCT00572455|158273155|FG004|Stage II (28 Days)|Death|0|||
49118634|NCT00572455|158273156|FG005|Stage II (28 Days)|Death|0|||
49118635|NCT00572455|158273157|FG006|Stage II (28 Days)|Death|0|||
49118636|NCT00572455|158273158|FG007|Stage II (28 Days)|Death|0|||
49118637|NCT00572455|158273159|FG008|Stage II (28 Days)|Death|1|||
49118638|NCT00572455|158273160|FG009|Stage II (28 Days)|Death|0|||
49118639|NCT00572455|158273161|FG010|Stage II (28 Days)|Death|0|||
49118640|NCT00572455|158273162|FG011|Stage II (28 Days)|Death|0|||
49118641|NCT00572455|158273163|FG012|Stage II (28 Days)|Death|0|||
49118642|NCT00572455|158273164|FG013|Stage II (28 Days)|Death|0|||
49118643|NCT00572455|158273151|FG000|Stage II (28 Days)|Withdrawal by Subject|0|||
49118644|NCT00572455|158273152|FG001|Stage II (28 Days)|Withdrawal by Subject|0|||
49118645|NCT00572455|158273153|FG002|Stage II (28 Days)|Withdrawal by Subject|0|||
49118646|NCT00572455|158273154|FG003|Stage II (28 Days)|Withdrawal by Subject|0|||
49118647|NCT00572455|158273155|FG004|Stage II (28 Days)|Withdrawal by Subject|0|||
49118648|NCT00572455|158273156|FG005|Stage II (28 Days)|Withdrawal by Subject|0|||
49118649|NCT00572455|158273157|FG006|Stage II (28 Days)|Withdrawal by Subject|0|||
49118650|NCT00572455|158273158|FG007|Stage II (28 Days)|Withdrawal by Subject|1|||
49118651|NCT00572455|158273159|FG008|Stage II (28 Days)|Withdrawal by Subject|0|||
48702704|NCT00904982|156760700|FG001|Overall Study|Withdrawal by Subject|0|||
48702705|NCT00904982|156760701|FG002|Overall Study|Withdrawal by Subject|0|||
49118652|NCT00572455|158273160|FG009|Stage II (28 Days)|Withdrawal by Subject|0|||
49118653|NCT00572455|158273161|FG010|Stage II (28 Days)|Withdrawal by Subject|2|||
49118654|NCT00572455|158273162|FG011|Stage II (28 Days)|Withdrawal by Subject|0|||
49118655|NCT00572455|158273163|FG012|Stage II (28 Days)|Withdrawal by Subject|0|||
49118656|NCT00572455|158273164|FG013|Stage II (28 Days)|Withdrawal by Subject|0|||
48702706|NCT00904982|156760702|FG003|Overall Study|Withdrawal by Subject|0|||
48702707|NCT02420821|156760703|FG000|Overall Study|Lost to Follow-up|6|||
48702708|NCT02420821|156760704|FG001|Overall Study|Lost to Follow-up|6|||
48702709|NCT02420821|156760703|FG000|Overall Study|Non-compliance|0|||
48702710|NCT02420821|156760704|FG001|Overall Study|Non-compliance|2|||
48702711|NCT02420821|156760703|FG000|Overall Study|Physician Decision|6|||
48702712|NCT02420821|156760704|FG001|Overall Study|Physician Decision|2|||
48702713|NCT02420821|156760703|FG000|Overall Study|Withdrawal by Subject|32|||
48702714|NCT02420821|156760704|FG001|Overall Study|Withdrawal by Subject|25|||
48702715|NCT02420821|156760703|FG000|Overall Study|Death|270|||
48702716|NCT02420821|156760704|FG001|Overall Study|Death|263|||
48702717|NCT02420821|156760703|FG000|Overall Study|Study Terminated By Sponsor|145|||
48702718|NCT02420821|156760704|FG001|Overall Study|Study Terminated By Sponsor|149|||
48702719|NCT02420821|156760703|FG000|Overall Study|Patient refused end of treatment visit due to Covid-19|0|||
48702720|NCT02420821|156760704|FG001|Overall Study|Patient refused end of treatment visit due to Covid-19|1|||
48702721|NCT02420821|156760703|FG000|Overall Study|Adverse Event|0|||
48702722|NCT02420821|156760704|FG001|Overall Study|Adverse Event|1|||
48702723|NCT02420821|156760703|FG000|Overall Study|Protinuria|0|||
48702724|NCT02420821|156760704|FG001|Overall Study|Protinuria|1|||
48702725|NCT02420821|156760703|FG000|Overall Study|Progressive Disease|1|||
48702726|NCT02420821|156760704|FG001|Overall Study|Progressive Disease|1|||
48702727|NCT02420821|156760703|FG000|Overall Study|Disease Progression|0|||
48702728|NCT02420821|156760704|FG001|Overall Study|Disease Progression|1|||
48702729|NCT02420821|156760703|FG000|Overall Study|Patient missing record of discontinuation from Atezo.|0|||
48702730|NCT02420821|156760704|FG001|Overall Study|Patient missing record of discontinuation from Atezo.|1|||
48702731|NCT01217229|156760706|FG000|Overall Study|Adverse Event|1|||
48702732|NCT01217229|156760706|FG000|Overall Study|Disease progression, deterioration|2|||
48702733|NCT01217229|156760706|FG000|Overall Study|Disease progression, Cheson criteria|14|||
48702734|NCT01217229|156760706|FG000|Overall Study|Protocol Violation|1|||
48702735|NCT01217229|156760706|FG000|Overall Study|Disease progression not confirmed|2|||
48702736|NCT01318915|156760707|FG000|Overall Study|Lost to Follow-up|1|||
48702737|NCT03058146|156760708|FG000|Overall Study|Withdrawal by Subject|4|||
48702738|NCT03058146|156760709|FG001|Overall Study|Withdrawal by Subject|1|||
48702739|NCT03058146|156760708|FG000|Overall Study|Coronavirus (COVID)-19 shutdown|0|||
48702740|NCT03058146|156760709|FG001|Overall Study|Coronavirus (COVID)-19 shutdown|1|||
48702741|NCT01599637|156760714|FG000|Overall Study|administrative problems|0|||
48702742|NCT01599637|156760715|FG001|Overall Study|administrative problems|2|||
48702743|NCT01599637|156760716|FG002|Overall Study|administrative problems|0|||
48702744|NCT01599637|156760714|FG000|Overall Study|Adverse Event|1|||
48702745|NCT01599637|156760715|FG001|Overall Study|Adverse Event|0|||
48702746|NCT01599637|156760716|FG002|Overall Study|Adverse Event|0|||
48702747|NCT04139018|156760717|FG000|Overall Study|Screen fail|1|||
48702748|NCT04139018|156760718|FG001|Overall Study|Screen fail|0|||
48702749|NCT04139018|156760717|FG000|Overall Study|Withdrawal by Subject|2|||
48702750|NCT04139018|156760718|FG001|Overall Study|Withdrawal by Subject|0|||
48702751|NCT04139018|156760717|FG000|Overall Study|Lost to Follow-up|0|||
48702752|NCT04139018|156760718|FG001|Overall Study|Lost to Follow-up|1|||
48702753|NCT00577889|156760719|FG000|Overall Study|Withdrawal by Subject|1|||
48702754|NCT00577889|156760720|FG001|Overall Study|Withdrawal by Subject|0|||
48702755|NCT00577889|156760721|FG002|Overall Study|Withdrawal by Subject|0|||
48702756|NCT03486834|156760722|FG000|Overall Study|Withdrawal by Subject|46|||
48702757|NCT03486834|156760723|FG001|Overall Study|Withdrawal by Subject|46|||
48702758|NCT03486834|156760724|FG002|Overall Study|Withdrawal by Subject|52|||
48702759|NCT03486834|156760722|FG000|Overall Study|Adverse Event|8|||
48702760|NCT03486834|156760723|FG001|Overall Study|Adverse Event|7|||
48702761|NCT03486834|156760724|FG002|Overall Study|Adverse Event|0|||
48702762|NCT03486834|156760722|FG000|Overall Study|Lost to Follow-up|41|||
48702763|NCT03486834|156760723|FG001|Overall Study|Lost to Follow-up|24|||
48702764|NCT03486834|156760724|FG002|Overall Study|Lost to Follow-up|39|||
48702765|NCT03486834|156760722|FG000|Overall Study|Non-compliance with Study Drug|2|||
48702766|NCT03486834|156760723|FG001|Overall Study|Non-compliance with Study Drug|2|||
48702767|NCT03486834|156760724|FG002|Overall Study|Non-compliance with Study Drug|0|||
48702768|NCT03486834|156760722|FG000|Overall Study|Physician Decision|5|||
48702769|NCT03486834|156760723|FG001|Overall Study|Physician Decision|2|||
48702770|NCT03486834|156760724|FG002|Overall Study|Physician Decision|3|||
48702771|NCT03486834|156760722|FG000|Overall Study|Pregnancy|10|||
48702772|NCT03486834|156760723|FG001|Overall Study|Pregnancy|12|||
48702773|NCT03486834|156760724|FG002|Overall Study|Pregnancy|12|||
48702774|NCT03486834|156760722|FG000|Overall Study|Protocol Deviation|2|||
48702775|NCT03486834|156760723|FG001|Overall Study|Protocol Deviation|3|||
48702776|NCT03486834|156760724|FG002|Overall Study|Protocol Deviation|3|||
48702777|NCT03486834|156760722|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
48702778|NCT03486834|156760723|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
48702779|NCT03486834|156760724|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
48702780|NCT03486834|156760722|FG000|Overall Study|Randomized but not treated|4|||
48702781|NCT03486834|156760723|FG001|Overall Study|Randomized but not treated|4|||
48702782|NCT03486834|156760724|FG002|Overall Study|Randomized but not treated|1|||
48702783|NCT03041181|156760727|FG000|Overall Study|Disease Progression|1|||
48912287|NCT01735279|157516189|FG001|Overall Study|Lost to Follow-up|8|||
48912288|NCT03945591|157516192|FG000|Overall Study|Participant not transplanted|1|||
48912289|NCT03945591|157516192|FG000|Overall Study|Change in treatment plan|3|||
48912290|NCT03945591|157516192|FG000|Overall Study|Adverse Event|1|||
48912291|NCT00359021|157516193|FG000|Overall Study|Adverse Event|26|||
48912292|NCT00359021|157516194|FG001|Overall Study|Adverse Event|8|||
48912293|NCT00359021|157516193|FG000|Overall Study|Subject Non-Compliant|1|||
48912294|NCT00359021|157516194|FG001|Overall Study|Subject Non-Compliant|2|||
48912295|NCT00359021|157516193|FG000|Overall Study|Subject Ineligible To Continue The Trial|1|||
48912296|NCT00359021|157516194|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
48912297|NCT00359021|157516193|FG000|Overall Study|Subject Reached A Virologic Endpoint|45|||
48912298|NCT00359021|157516194|FG001|Overall Study|Subject Reached A Virologic Endpoint|32|||
48702784|NCT03041181|156760728|FG001|Overall Study|Disease Progression|2|||
48702785|NCT00960999|156760729|FG000|Overall Study|Withdrawal by Subject|1|||
48702786|NCT00960999|156760730|FG001|Overall Study|Withdrawal by Subject|0|||
48702787|NCT00960999|156760729|FG000|Overall Study|Protocol Violation|5|||
48702788|NCT00960999|156760730|FG001|Overall Study|Protocol Violation|2|||
48702789|NCT00960999|156760729|FG000|Overall Study|RT dose constraints not met|2|||
48702790|NCT00960999|156760730|FG001|Overall Study|RT dose constraints not met|0|||
48702791|NCT03067077|156760731|FG000|Overall Study|Did not receive surgery|4|||
48702792|NCT03067077|156760732|FG001|Overall Study|Did not receive surgery|5|||
48702793|NCT03067077|156760731|FG000|Overall Study|Lost to Follow-up|3|||
48702794|NCT03067077|156760732|FG001|Overall Study|Lost to Follow-up|2|||
48702795|NCT04201262|156760739|FG000|Overall Study|Adverse Event|1|||
48702796|NCT04201262|156760740|FG001|Overall Study|Adverse Event|2|||
48702797|NCT04201262|156760739|FG000|Overall Study|Continuing in the study|57|||
48702798|NCT04201262|156760740|FG001|Overall Study|Continuing in the study|0|||
48702799|NCT04201262|156760739|FG000|Overall Study|Withdrawal by Subject|0|||
48702800|NCT04201262|156760740|FG001|Overall Study|Withdrawal by Subject|1|||
48702801|NCT03312231|156760746|FG000|Overall Study|Lost to Follow-up|2|||
48702802|NCT03312231|156760747|FG001|Overall Study|Lost to Follow-up|6|||
48702803|NCT03312231|156760748|FG002|Overall Study|Lost to Follow-up|1|||
48702804|NCT03312231|156760749|FG003|Overall Study|Lost to Follow-up|3|||
48702805|NCT03312231|156760750|FG004|Overall Study|Lost to Follow-up|1|||
48702806|NCT03312231|156760746|FG000|Overall Study|Withdrawal by Subject|0|||
48702807|NCT03312231|156760747|FG001|Overall Study|Withdrawal by Subject|3|||
49118657|NCT00572455|158273151|FG000|Stage II (28 Days)|Other|0|||
48702808|NCT03312231|156760748|FG002|Overall Study|Withdrawal by Subject|1|||
48702809|NCT03312231|156760749|FG003|Overall Study|Withdrawal by Subject|0|||
48702810|NCT03312231|156760750|FG004|Overall Study|Withdrawal by Subject|0|||
48702811|NCT03312231|156760746|FG000|Overall Study|Death|0|||
48702812|NCT03312231|156760747|FG001|Overall Study|Death|1|||
48912299|NCT00359021|157516193|FG000|Overall Study|Withdrawal by Subject|2|||
48702813|NCT03312231|156760748|FG002|Overall Study|Death|1|||
48702814|NCT03312231|156760749|FG003|Overall Study|Death|0|||
48702815|NCT03312231|156760750|FG004|Overall Study|Death|0|||
48702816|NCT03312231|156760746|FG000|Overall Study|Study Vaccination not Received|1|||
48702817|NCT03312231|156760747|FG001|Overall Study|Study Vaccination not Received|1|||
48702818|NCT03312231|156760748|FG002|Overall Study|Study Vaccination not Received|1|||
48702819|NCT03312231|156760749|FG003|Overall Study|Study Vaccination not Received|0|||
48702820|NCT03312231|156760750|FG004|Overall Study|Study Vaccination not Received|0|||
48702821|NCT03694353|156760753|FG000|Overall Study|Withdrawal by Subject|1|||
48702822|NCT03694353|156760753|FG000|Overall Study|Subject received <= 40 mg/day for > 32 weeks|1|||
48702823|NCT01198977|156760754|FG000|Overall Study|Lost to Follow-up|1|||
48702824|NCT01198977|156760755|FG001|Overall Study|Lost to Follow-up|0|||
48702825|NCT05786651|156760760|FG000|Overall Study|fire alarm during testing session, incomplete testing|1|||
48702826|NCT03472885|156760761|FG000|24-Week Treatment Period|Adverse Event|1|||
48702827|NCT03493464|156760762|FG000|Overall Study|Surgery not performed|1|||
48702828|NCT02017405|156760765|FG000|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
48702829|NCT02017405|156760766|FG001|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
48702830|NCT02017405|156760767|FG002|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
48702831|NCT02017405|156760768|FG003|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
48702832|NCT02017405|156760769|FG004|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
48702833|NCT02017405|156760770|FG005|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|1|||
48702834|NCT02017405|156760765|FG000|Open-label Phase|Adverse Event|1|||
48702835|NCT02017405|156760766|FG001|Open-label Phase|Adverse Event|1|||
48702836|NCT02017405|156760767|FG002|Open-label Phase|Adverse Event|0|||
48702837|NCT02017405|156760768|FG003|Open-label Phase|Adverse Event|0|||
48702838|NCT02017405|156760769|FG004|Open-label Phase|Adverse Event|0|||
48702839|NCT02017405|156760770|FG005|Open-label Phase|Adverse Event|0|||
48702840|NCT04323124|156760771|FG000|Overall Study|Adverse Event|0|||
48702841|NCT04323124|156760772|FG001|Overall Study|Adverse Event|0|||
48702842|NCT04323124|156760773|FG002|Overall Study|Adverse Event|0|||
48702843|NCT04323124|156760774|FG003|Overall Study|Adverse Event|0|||
48702844|NCT04323124|156760775|FG004|Overall Study|Adverse Event|0|||
48702845|NCT04323124|156760776|FG005|Overall Study|Adverse Event|1|||
48912300|NCT00359021|157516194|FG001|Overall Study|Withdrawal by Subject|9|||
48702846|NCT04323124|156760777|FG006|Overall Study|Adverse Event|0|||
48702847|NCT04323124|156760778|FG007|Overall Study|Adverse Event|1|||
48702848|NCT04323124|156760779|FG008|Overall Study|Adverse Event|1|||
48702849|NCT04323124|156760780|FG009|Overall Study|Adverse Event|0|||
48702850|NCT04323124|156760781|FG010|Overall Study|Adverse Event|0|||
48702851|NCT04323124|156760782|FG011|Overall Study|Adverse Event|0|||
48702852|NCT04323124|156760783|FG012|Overall Study|Adverse Event|0|||
48702853|NCT04323124|156760784|FG013|Overall Study|Adverse Event|0|||
48702854|NCT04323124|156760785|FG014|Overall Study|Adverse Event|0|||
48702855|NCT04323124|156760771|FG000|Overall Study|Other|0|||
48702856|NCT04323124|156760772|FG001|Overall Study|Other|0|||
48702857|NCT04323124|156760773|FG002|Overall Study|Other|0|||
48702858|NCT04323124|156760774|FG003|Overall Study|Other|0|||
48702859|NCT04323124|156760775|FG004|Overall Study|Other|1|||
48702860|NCT04323124|156760776|FG005|Overall Study|Other|0|||
48702861|NCT04323124|156760777|FG006|Overall Study|Other|0|||
48912301|NCT00359021|157516193|FG000|Overall Study|Lost to Follow-up|1|||
48702862|NCT04323124|156760778|FG007|Overall Study|Other|0|||
48702863|NCT04323124|156760779|FG008|Overall Study|Other|1|||
48702864|NCT04323124|156760780|FG009|Overall Study|Other|0|||
48702865|NCT04323124|156760781|FG010|Overall Study|Other|0|||
48702866|NCT04323124|156760782|FG011|Overall Study|Other|0|||
48702867|NCT04323124|156760783|FG012|Overall Study|Other|0|||
48702868|NCT04323124|156760784|FG013|Overall Study|Other|0|||
48702869|NCT04323124|156760785|FG014|Overall Study|Other|0|||
48702870|NCT04323124|156760771|FG000|Overall Study|Coming from a red zone (COVID)|0|||
48702871|NCT04323124|156760772|FG001|Overall Study|Coming from a red zone (COVID)|0|||
48702872|NCT04323124|156760773|FG002|Overall Study|Coming from a red zone (COVID)|0|||
48702873|NCT04323124|156760774|FG003|Overall Study|Coming from a red zone (COVID)|0|||
48702874|NCT04323124|156760775|FG004|Overall Study|Coming from a red zone (COVID)|1|||
48702875|NCT04323124|156760776|FG005|Overall Study|Coming from a red zone (COVID)|1|||
48702876|NCT04323124|156760777|FG006|Overall Study|Coming from a red zone (COVID)|0|||
48702877|NCT04323124|156760778|FG007|Overall Study|Coming from a red zone (COVID)|0|||
48702878|NCT04323124|156760779|FG008|Overall Study|Coming from a red zone (COVID)|0|||
48702879|NCT04323124|156760780|FG009|Overall Study|Coming from a red zone (COVID)|0|||
48702880|NCT04323124|156760781|FG010|Overall Study|Coming from a red zone (COVID)|0|||
48702881|NCT04323124|156760782|FG011|Overall Study|Coming from a red zone (COVID)|0|||
48702882|NCT04323124|156760783|FG012|Overall Study|Coming from a red zone (COVID)|0|||
48702883|NCT04323124|156760784|FG013|Overall Study|Coming from a red zone (COVID)|0|||
48702884|NCT04323124|156760785|FG014|Overall Study|Coming from a red zone (COVID)|0|||
48702885|NCT04323124|156760771|FG000|Overall Study|No longer meets eligibility criteria|0|||
48702886|NCT04323124|156760772|FG001|Overall Study|No longer meets eligibility criteria|0|||
48702887|NCT04323124|156760773|FG002|Overall Study|No longer meets eligibility criteria|0|||
48702888|NCT04323124|156760774|FG003|Overall Study|No longer meets eligibility criteria|0|||
48702889|NCT04323124|156760775|FG004|Overall Study|No longer meets eligibility criteria|0|||
48702890|NCT04323124|156760776|FG005|Overall Study|No longer meets eligibility criteria|0|||
48702891|NCT04323124|156760777|FG006|Overall Study|No longer meets eligibility criteria|0|||
48702892|NCT04323124|156760778|FG007|Overall Study|No longer meets eligibility criteria|1|||
48702893|NCT04323124|156760779|FG008|Overall Study|No longer meets eligibility criteria|0|||
48702894|NCT04323124|156760780|FG009|Overall Study|No longer meets eligibility criteria|0|||
48702895|NCT04323124|156760781|FG010|Overall Study|No longer meets eligibility criteria|0|||
48702896|NCT04323124|156760782|FG011|Overall Study|No longer meets eligibility criteria|0|||
48702897|NCT04323124|156760783|FG012|Overall Study|No longer meets eligibility criteria|0|||
48702898|NCT04323124|156760784|FG013|Overall Study|No longer meets eligibility criteria|1|||
48702899|NCT04323124|156760785|FG014|Overall Study|No longer meets eligibility criteria|1|||
48702900|NCT04323124|156760771|FG000|Overall Study|Study terminated by sponsor|0|||
48702901|NCT04323124|156760772|FG001|Overall Study|Study terminated by sponsor|0|||
48702902|NCT04323124|156760773|FG002|Overall Study|Study terminated by sponsor|0|||
48702903|NCT04323124|156760774|FG003|Overall Study|Study terminated by sponsor|0|||
48702904|NCT04323124|156760775|FG004|Overall Study|Study terminated by sponsor|0|||
48702905|NCT04323124|156760776|FG005|Overall Study|Study terminated by sponsor|0|||
48702906|NCT04323124|156760777|FG006|Overall Study|Study terminated by sponsor|0|||
48702907|NCT04323124|156760778|FG007|Overall Study|Study terminated by sponsor|0|||
48702908|NCT04323124|156760779|FG008|Overall Study|Study terminated by sponsor|0|||
48702909|NCT04323124|156760780|FG009|Overall Study|Study terminated by sponsor|0|||
48702910|NCT04323124|156760781|FG010|Overall Study|Study terminated by sponsor|0|||
48702911|NCT04323124|156760782|FG011|Overall Study|Study terminated by sponsor|2|||
48702912|NCT04323124|156760783|FG012|Overall Study|Study terminated by sponsor|1|||
48702913|NCT04323124|156760784|FG013|Overall Study|Study terminated by sponsor|0|||
48702914|NCT04323124|156760785|FG014|Overall Study|Study terminated by sponsor|0|||
48702915|NCT00905164|156760786|FG000|Period 1|Protocol Violation|0|||
48702916|NCT00905164|156760787|FG001|Period 1|Protocol Violation|1|||
48702917|NCT03525678|156760788|FG000|Overall Study|Withdrawal by Subject|8|||
48702918|NCT03525678|156760789|FG001|Overall Study|Withdrawal by Subject|2|||
48702919|NCT03525678|156760790|FG002|Overall Study|Withdrawal by Subject|2|||
48702920|NCT03525678|156760788|FG000|Overall Study|Physician Decision|2|||
48702921|NCT03525678|156760789|FG001|Overall Study|Physician Decision|4|||
48702922|NCT03525678|156760790|FG002|Overall Study|Physician Decision|0|||
48702923|NCT03525678|156760788|FG000|Overall Study|Lost to Follow-up|2|||
48702924|NCT03525678|156760789|FG001|Overall Study|Lost to Follow-up|1|||
48702925|NCT03525678|156760790|FG002|Overall Study|Lost to Follow-up|2|||
48702926|NCT03525678|156760788|FG000|Overall Study|Death|70|||
48702927|NCT03525678|156760789|FG001|Overall Study|Death|80|||
48702928|NCT03525678|156760790|FG002|Overall Study|Death|16|||
48702929|NCT03525678|156760788|FG000|Overall Study|other reasons|14|||
48912302|NCT00359021|157516194|FG001|Overall Study|Lost to Follow-up|0|||
49118658|NCT00572455|158273152|FG001|Stage II (28 Days)|Other|0|||
49118659|NCT00572455|158273153|FG002|Stage II (28 Days)|Other|0|||
49118660|NCT00572455|158273154|FG003|Stage II (28 Days)|Other|0|||
48702930|NCT03525678|156760789|FG001|Overall Study|other reasons|10|||
48702931|NCT03525678|156760790|FG002|Overall Study|other reasons|5|||
48702932|NCT03525678|156760788|FG000|Overall Study|ongoing at the time of analysis|1|||
48702933|NCT03525678|156760789|FG001|Overall Study|ongoing at the time of analysis|2|||
48702934|NCT03525678|156760790|FG002|Overall Study|ongoing at the time of analysis|0|||
48702935|NCT02081677|156762809|FG000|Overall Study|Adverse Event|0|||
48702936|NCT02081677|156762810|FG001|Overall Study|Adverse Event|0|||
49118661|NCT00572455|158273155|FG004|Stage II (28 Days)|Other|0|||
49118662|NCT00572455|158273156|FG005|Stage II (28 Days)|Other|0|||
48702937|NCT02081677|156762811|FG002|Overall Study|Adverse Event|1|||
48702938|NCT02081677|156762812|FG003|Overall Study|Adverse Event|0|||
48702939|NCT02081677|156762809|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
48702940|NCT02081677|156762810|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
48702941|NCT02081677|156762811|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
48702942|NCT02081677|156762812|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
48702943|NCT02081677|156762809|FG000|Overall Study|Not comfortable with lens care system|1|||
48702944|NCT02081677|156762810|FG001|Overall Study|Not comfortable with lens care system|0|||
48702945|NCT02081677|156762811|FG002|Overall Study|Not comfortable with lens care system|0|||
48702946|NCT02081677|156762812|FG003|Overall Study|Not comfortable with lens care system|0|||
48702947|NCT02081677|156762809|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
48702948|NCT02081677|156762810|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
48702949|NCT02081677|156762811|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
48702950|NCT02081677|156762812|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
48702951|NCT00091949|156762822|FG000|Overall Study|Withdrawal by Subject|117|||
48702952|NCT00091949|156762823|FG001|Overall Study|Withdrawal by Subject|110|||
48702953|NCT00091949|156762822|FG000|Overall Study|Lost to Follow-up|58|||
48702954|NCT00091949|156762823|FG001|Overall Study|Lost to Follow-up|41|||
48702955|NCT01520506|156762824|FG000|Overall Study|Missed Visit|4|||
48702956|NCT01520506|156762824|FG000|Overall Study|Lost to Follow-up|1|||
48702957|NCT01520506|156762824|FG000|Overall Study|Withdrawal by Subject|1|||
48702958|NCT04226742|156762833|FG000|Overall Study|Lost to Follow-up|16|||
48702959|NCT04226742|156762834|FG001|Overall Study|Lost to Follow-up|13|||
48702960|NCT04226742|156762833|FG000|Overall Study|Withdrawal by Subject|5|||
48702961|NCT04226742|156762834|FG001|Overall Study|Withdrawal by Subject|3|||
48702962|NCT01774721|156762835|FG000|Overall Study|Death|133|||
48702963|NCT01774721|156762836|FG001|Overall Study|Death|152|||
48702964|NCT01774721|156762835|FG000|Overall Study|Withdrawal by Subject|20|||
48702965|NCT01774721|156762836|FG001|Overall Study|Withdrawal by Subject|14|||
48702966|NCT01774721|156762835|FG000|Overall Study|Lost to Follow-up|6|||
48702967|NCT01774721|156762836|FG001|Overall Study|Lost to Follow-up|7|||
48702968|NCT01774721|156762835|FG000|Overall Study|Did not meet eligibility criteria|0|||
48702969|NCT01774721|156762836|FG001|Overall Study|Did not meet eligibility criteria|3|||
48702970|NCT01774721|156762835|FG000|Overall Study|Other reasons and patients who completed the 48-month follow-up period|58|||
48702971|NCT01774721|156762836|FG001|Overall Study|Other reasons and patients who completed the 48-month follow-up period|49|||
48702972|NCT01774721|156762835|FG000|Overall Study|Study terminated by sponsor|5|||
48702973|NCT01774721|156762836|FG001|Overall Study|Study terminated by sponsor|0|||
48702974|NCT01774721|156762835|FG000|Overall Study|Disease progression|5|||
48702975|NCT01774721|156762836|FG001|Overall Study|Disease progression|0|||
48702976|NCT01112917|156762838|FG000|Overall Study|Death|2|||
48702977|NCT01112917|156762839|FG001|Overall Study|Death|11|||
48702978|NCT01112917|156762838|FG000|Overall Study|Lost to Follow-up|1|||
48702979|NCT01112917|156762839|FG001|Overall Study|Lost to Follow-up|1|||
48702980|NCT01112917|156762838|FG000|Overall Study|Withdrawal by Subject|1|||
48702981|NCT01112917|156762839|FG001|Overall Study|Withdrawal by Subject|3|||
48702982|NCT01112917|156762838|FG000|Overall Study|Unable to Convert Filter|3|||
48702983|NCT01112917|156762839|FG001|Overall Study|Unable to Convert Filter|0|||
48702984|NCT05101122|156762840|FG000|Atomoxetine Only|Withdrawal by Subject|1|||
48702985|NCT05101122|156762840|FG000|AD313 40/2.5|Withdrawal by Subject|2|||
48702986|NCT05101122|156762840|FG000|AD313 80/5|Withdrawal by Subject|1|||
48702987|NCT05101122|156762840|FG000|AD313 80/10|Physician Decision|1|||
48702988|NCT03131219|156762841|FG000|Initial Evaluation Period|Adverse Event|2|||
48702989|NCT03131219|156762842|FG001|Initial Evaluation Period|Adverse Event|0|||
48702990|NCT03131219|156762841|FG000|Initial Evaluation Period|Protocol Violation|1|||
48702991|NCT03131219|156762842|FG001|Initial Evaluation Period|Protocol Violation|0|||
48702992|NCT03131219|156762841|FG000|Initial Evaluation Period|Deemed Ineligible Post Treatment|3|||
48702993|NCT03131219|156762842|FG001|Initial Evaluation Period|Deemed Ineligible Post Treatment|0|||
48702994|NCT03131219|156762841|FG000|Initial Evaluation Period|Physician Decision|1|||
48702995|NCT03131219|156762842|FG001|Initial Evaluation Period|Physician Decision|0|||
48702996|NCT03131219|156762841|FG000|Extension Period|Physician Decision|1|||
48702997|NCT03131219|156762842|FG001|Extension Period|Physician Decision|0|||
48702998|NCT03938259|156762845|FG000|Overall Study|unable to establish baseline for ventilation|1|||
48702999|NCT03938259|156762846|FG001|Overall Study|unable to establish baseline for ventilation|1|||
48703000|NCT00836693|156762847|FG000|Overall Study|Adverse Event|4|||
48703001|NCT00836693|156762848|FG001|Overall Study|Adverse Event|1|||
48703002|NCT00836693|156762847|FG000|Overall Study|Sponsor Decision|0|||
48703003|NCT00836693|156762848|FG001|Overall Study|Sponsor Decision|1|||
48703004|NCT00836693|156762847|FG000|Overall Study|Physician Decision|2|||
48703005|NCT00836693|156762848|FG001|Overall Study|Physician Decision|0|||
48703006|NCT00836693|156762847|FG000|Overall Study|Withdrawal by Subject|9|||
48703007|NCT00836693|156762848|FG001|Overall Study|Withdrawal by Subject|4|||
48703008|NCT00836693|156762847|FG000|Overall Study|Protocol Violation|1|||
48703009|NCT00836693|156762848|FG001|Overall Study|Protocol Violation|0|||
48703010|NCT00836693|156762847|FG000|Overall Study|Lost to Follow-up|1|||
48703011|NCT00836693|156762848|FG001|Overall Study|Lost to Follow-up|0|||
48703012|NCT02612779|156762849|FG000|Overall Study|Administrative reason by sponsor|4|||
48703013|NCT02612779|156762850|FG001|Overall Study|Administrative reason by sponsor|1|||
48703014|NCT02612779|156762849|FG000|Overall Study|No longer meet study criteria|0|||
48703015|NCT02612779|156762850|FG001|Overall Study|No longer meet study criteria|1|||
48703016|NCT02612779|156762849|FG000|Overall Study|Disease progression|29|||
48703017|NCT02612779|156762850|FG001|Overall Study|Disease progression|2|||
48703018|NCT02612779|156762849|FG000|Overall Study|Study drug toxicity|10|||
48703019|NCT02612779|156762850|FG001|Overall Study|Study drug toxicity|1|||
48703020|NCT02612779|156762849|FG000|Overall Study|Death|1|||
48703021|NCT02612779|156762850|FG001|Overall Study|Death|0|||
48703022|NCT02612779|156762849|FG000|Overall Study|Adverse event unrelated to study drug|5|||
48703023|NCT02612779|156762850|FG001|Overall Study|Adverse event unrelated to study drug|0|||
48703024|NCT02612779|156762849|FG000|Overall Study|Participant withdrew consent|4|||
48703025|NCT02612779|156762850|FG001|Overall Study|Participant withdrew consent|0|||
48703026|NCT02612779|156762849|FG000|Overall Study|Lost to Follow-up|1|||
48703027|NCT02612779|156762850|FG001|Overall Study|Lost to Follow-up|0|||
48703028|NCT02612779|156762849|FG000|Overall Study|Maximum clinical benefit|10|||
48703029|NCT02612779|156762850|FG001|Overall Study|Maximum clinical benefit|1|||
48703030|NCT02612779|156762849|FG000|Overall Study|Other reasons|4|||
48703031|NCT02612779|156762850|FG001|Overall Study|Other reasons|0|||
48703032|NCT02118584|156762851|FG000|Part 1: Open Label Extension Period|Adverse Event|79|||
48703033|NCT02118584|156762852|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
48703034|NCT02118584|156762853|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
48703035|NCT02118584|156762851|FG000|Part 1: Open Label Extension Period|Death|9|||
48703036|NCT02118584|156762852|FG001|Part 1: Open Label Extension Period|Death|0|||
48703037|NCT02118584|156762853|FG002|Part 1: Open Label Extension Period|Death|0|||
48703038|NCT02118584|156762851|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|53|||
48703039|NCT02118584|156762852|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
48703040|NCT02118584|156762853|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
48703041|NCT02118584|156762851|FG000|Part 1: Open Label Extension Period|Non-compliance|12|||
48703042|NCT02118584|156762852|FG001|Part 1: Open Label Extension Period|Non-compliance|0|||
48703043|NCT02118584|156762853|FG002|Part 1: Open Label Extension Period|Non-compliance|0|||
48703044|NCT02118584|156762851|FG000|Part 1: Open Label Extension Period|Other|135|||
48703045|NCT02118584|156762852|FG001|Part 1: Open Label Extension Period|Other|0|||
48703046|NCT02118584|156762853|FG002|Part 1: Open Label Extension Period|Other|0|||
48703047|NCT02118584|156762851|FG000|Part 1: Open Label Extension Period|Physician Decision|128|||
48703048|NCT02118584|156762852|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
48703049|NCT02118584|156762853|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
48703050|NCT02118584|156762851|FG000|Part 1: Open Label Extension Period|Protocol Violation|1|||
48703051|NCT02118584|156762852|FG001|Part 1: Open Label Extension Period|Protocol Violation|0|||
48703052|NCT02118584|156762853|FG002|Part 1: Open Label Extension Period|Protocol Violation|0|||
48703053|NCT02118584|156762851|FG000|Part 1: Open Label Extension Period|Study Terminated by Sponsor|29|||
48703054|NCT02118584|156762852|FG001|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
48703055|NCT02118584|156762853|FG002|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
48703056|NCT02118584|156762851|FG000|Part 1: Open Label Extension Period|Other|3|||
48703057|NCT02118584|156762852|FG001|Part 1: Open Label Extension Period|Other|0|||
48912303|NCT00359021|157516193|FG000|Overall Study|Other|4|||
48703058|NCT02118584|156762853|FG002|Part 1: Open Label Extension Period|Other|0|||
48703059|NCT02118584|156762851|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|568|||
48703060|NCT02118584|156762852|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
48703061|NCT02118584|156762853|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
48703062|NCT02118584|156762851|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
48703063|NCT02118584|156762852|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|5|||
48703064|NCT02118584|156762853|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
48703065|NCT02118584|156762851|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
48703066|NCT02118584|156762852|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
48703067|NCT02118584|156762853|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
48703068|NCT02118584|156762851|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
48703069|NCT02118584|156762852|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|22|||
48703070|NCT02118584|156762853|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
48703071|NCT02118584|156762851|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
48703072|NCT02118584|156762852|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
48703073|NCT02118584|156762853|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
48703074|NCT02118584|156762851|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
48703075|NCT02118584|156762852|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
48703076|NCT02118584|156762853|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
48703077|NCT02118584|156762851|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
48703078|NCT02118584|156762852|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|10|||
48703079|NCT02118584|156762853|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|1|||
48703080|NCT02118584|156762851|FG000|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
48703081|NCT02118584|156762852|FG001|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|354|||
48703082|NCT02118584|156762853|FG002|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
48703083|NCT02118584|156762851|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
48703084|NCT02118584|156762852|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|32|||
48703085|NCT02118584|156762853|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|1|||
48703086|NCT01744977|156762854|FG000|Overall Study|Withdrawal by Subject|1|||
48703087|NCT01744977|156762855|FG001|Overall Study|Withdrawal by Subject|2|||
48703088|NCT01744977|156762854|FG000|Overall Study|Death|2|||
48703089|NCT01744977|156762855|FG001|Overall Study|Death|3|||
48703090|NCT01744977|156762854|FG000|Overall Study|Lost to Follow-up|2|||
48703091|NCT01744977|156762855|FG001|Overall Study|Lost to Follow-up|0|||
48703092|NCT01744977|156762854|FG000|Overall Study|No longer meets inclusion|6|||
48703093|NCT01744977|156762855|FG001|Overall Study|No longer meets inclusion|0|||
48703094|NCT02636595|156762856|FG000|Overall Study|Lost to Follow-up|1|||
48703095|NCT02636595|156762856|FG000|Overall Study|Other|1|||
48703096|NCT02156076|156762857|FG000|Treatment Period|no longer meets study criteria|0|||
48703097|NCT02156076|156762858|FG001|Treatment Period|no longer meets study criteria|0|||
48703098|NCT02156076|156762859|FG002|Treatment Period|no longer meets study criteria|1|||
48703099|NCT02156076|156762860|FG003|Treatment Period|no longer meets study criteria|0|||
48703100|NCT02156076|156762857|FG000|Treatment Period|Poor/non-compliance|0|||
48703101|NCT02156076|156762858|FG001|Treatment Period|Poor/non-compliance|1|||
48703102|NCT02156076|156762859|FG002|Treatment Period|Poor/non-compliance|0|||
48703103|NCT02156076|156762860|FG003|Treatment Period|Poor/non-compliance|0|||
48703104|NCT02156076|156762857|FG000|Treatment Period|Lost to Follow-up|0|||
48703105|NCT02156076|156762858|FG001|Treatment Period|Lost to Follow-up|0|||
48703106|NCT02156076|156762859|FG002|Treatment Period|Lost to Follow-up|0|||
48703107|NCT02156076|156762860|FG003|Treatment Period|Lost to Follow-up|1|||
48703108|NCT02156076|156762857|FG000|Treatment Period|Withdrawal by Subject|0|||
48703109|NCT02156076|156762858|FG001|Treatment Period|Withdrawal by Subject|0|||
48703110|NCT02156076|156762859|FG002|Treatment Period|Withdrawal by Subject|1|||
48703111|NCT02156076|156762860|FG003|Treatment Period|Withdrawal by Subject|0|||
48703112|NCT02156076|156762857|FG000|Treatment Period|Subject request to discontinue treatment|0|||
48703113|NCT02156076|156762858|FG001|Treatment Period|Subject request to discontinue treatment|1|||
48703114|NCT02156076|156762859|FG002|Treatment Period|Subject request to discontinue treatment|0|||
48703115|NCT02156076|156762860|FG003|Treatment Period|Subject request to discontinue treatment|0|||
48703116|NCT02156076|156762857|FG000|Treatment Period|Adverse Event|0|||
48703117|NCT02156076|156762858|FG001|Treatment Period|Adverse Event|0|||
48703118|NCT02156076|156762859|FG002|Treatment Period|Adverse Event|0|||
48703119|NCT02156076|156762860|FG003|Treatment Period|Adverse Event|1|||
48703120|NCT02156076|156762857|FG000|Follow-up Period|Withdrawal by Subject|1|||
48703121|NCT02156076|156762858|FG001|Follow-up Period|Withdrawal by Subject|0|||
48703122|NCT02156076|156762859|FG002|Follow-up Period|Withdrawal by Subject|0|||
48703123|NCT02156076|156762860|FG003|Follow-up Period|Withdrawal by Subject|0|||
48703124|NCT02766023|156762861|FG000|Overall Study|Lost to Follow-up|23|||
48703125|NCT02766023|156762862|FG001|Overall Study|Lost to Follow-up|11|||
48703126|NCT02766023|156762861|FG000|Overall Study|Pregnancy|1|||
48703127|NCT02766023|156762862|FG001|Overall Study|Pregnancy|0|||
48703128|NCT02766023|156762861|FG000|Overall Study|Adverse Event|1|||
48703129|NCT02766023|156762862|FG001|Overall Study|Adverse Event|0|||
48703130|NCT02766023|156762861|FG000|Overall Study|Withdrawal by Subject|4|||
48703131|NCT02766023|156762862|FG001|Overall Study|Withdrawal by Subject|5|||
48703132|NCT02766023|156762861|FG000|Overall Study|Physician Decision|1|||
48703133|NCT02766023|156762862|FG001|Overall Study|Physician Decision|0|||
48703134|NCT02766023|156762861|FG000|Overall Study|Not Eligible at Enrollment|0|||
48703135|NCT02766023|156762862|FG001|Overall Study|Not Eligible at Enrollment|1|||
48703136|NCT02939287|156762867|FG000|Overall Study|met exclusion criteria|1|||
48703137|NCT02939287|156762868|FG001|Overall Study|met exclusion criteria|1|||
48703138|NCT02939287|156762869|FG002|Overall Study|met exclusion criteria|1|||
48703139|NCT02939287|156762867|FG000|Overall Study|Did not complete survey|2|||
48703140|NCT02939287|156762868|FG001|Overall Study|Did not complete survey|2|||
48703141|NCT02939287|156762869|FG002|Overall Study|Did not complete survey|0|||
48703142|NCT02939287|156762867|FG000|Overall Study|Withdrawal by Subject|1|||
48703143|NCT02939287|156762868|FG001|Overall Study|Withdrawal by Subject|1|||
48703144|NCT02939287|156762869|FG002|Overall Study|Withdrawal by Subject|0|||
48703145|NCT04225897|156762870|FG000|Part A (Screening Visit to Day 7)|Adverse Event|0|||
48703146|NCT04225897|156762871|FG001|Part A (Screening Visit to Day 7)|Adverse Event|1|||
48703147|NCT04225897|156762872|FG002|Part A (Screening Visit to Day 7)|Adverse Event|0|||
48703148|NCT04225897|156762873|FG003|Part A (Screening Visit to Day 7)|Adverse Event|0|||
48703149|NCT04225897|156762874|FG004|Part A (Screening Visit to Day 7)|Adverse Event|0|||
48703150|NCT04225897|156762875|FG005|Part A (Screening Visit to Day 7)|Adverse Event|0|||
48703151|NCT04225897|156762876|FG006|Part A (Screening Visit to Day 7)|Adverse Event|0|||
48703152|NCT04225897|156762877|FG007|Part A (Screening Visit to Day 7)|Adverse Event|0|||
48703153|NCT04225897|156762878|FG008|Part A (Screening Visit to Day 7)|Adverse Event|0|||
48703154|NCT04225897|156762879|FG009|Part A (Screening Visit to Day 7)|Adverse Event|0|||
48703155|NCT04225897|156762880|FG010|Part A (Screening Visit to Day 7)|Adverse Event|0|||
48703156|NCT04225897|156762881|FG011|Part A (Screening Visit to Day 7)|Adverse Event|0|||
48703157|NCT04225897|156762870|FG000|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
48703158|NCT04225897|156762871|FG001|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
48703159|NCT04225897|156762872|FG002|Part A (Screening Visit to Day 7)|Lost to Follow-up|1|||
48703160|NCT04225897|156762873|FG003|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
48703161|NCT04225897|156762874|FG004|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
48703162|NCT04225897|156762875|FG005|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
48703163|NCT04225897|156762876|FG006|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
48703164|NCT04225897|156762877|FG007|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
48703165|NCT04225897|156762878|FG008|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
48703166|NCT04225897|156762879|FG009|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
48703167|NCT04225897|156762880|FG010|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
48703168|NCT04225897|156762881|FG011|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
48703169|NCT04225897|156762870|FG000|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
48912304|NCT00359021|157516194|FG001|Overall Study|Other|1|||
48703170|NCT04225897|156762871|FG001|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
48703171|NCT04225897|156762872|FG002|Part A (Screening Visit to Day 7)|Parent/legal guardian request|1|||
48703172|NCT04225897|156762873|FG003|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
48703173|NCT04225897|156762874|FG004|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
48703174|NCT04225897|156762875|FG005|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
48703175|NCT04225897|156762876|FG006|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
48703176|NCT04225897|156762877|FG007|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
48703177|NCT04225897|156762878|FG008|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
48703178|NCT04225897|156762879|FG009|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
48703179|NCT04225897|156762880|FG010|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
48703180|NCT04225897|156762881|FG011|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
48703181|NCT04225897|156762870|FG000|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
48703182|NCT04225897|156762871|FG001|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
48703183|NCT04225897|156762872|FG002|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
48703184|NCT04225897|156762873|FG003|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
48703185|NCT04225897|156762874|FG004|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
48703186|NCT04225897|156762875|FG005|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
48703187|NCT04225897|156762876|FG006|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
48703188|NCT04225897|156762877|FG007|Part B (Screening Visit to Day 12)|Parent/legal guardian request|1|||
48703189|NCT04225897|156762878|FG008|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
48703190|NCT04225897|156762879|FG009|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
48703191|NCT04225897|156762880|FG010|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
48703192|NCT04225897|156762881|FG011|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
48703193|NCT03126591|156762882|FG000|Overall Study|Death|6|||
48703194|NCT03126591|156762883|FG001|Overall Study|Death|3|||
48703195|NCT03126591|156762884|FG002|Overall Study|Death|17|||
48703196|NCT03126591|156762882|FG000|Overall Study|Progressive Disease|0|||
48703197|NCT03126591|156762883|FG001|Overall Study|Progressive Disease|1|||
48703198|NCT03126591|156762884|FG002|Overall Study|Progressive Disease|2|||
48703199|NCT03126591|156762882|FG000|Overall Study|Terminated by Sponsor|0|||
48703200|NCT03126591|156762883|FG001|Overall Study|Terminated by Sponsor|1|||
48703201|NCT03126591|156762884|FG002|Overall Study|Terminated by Sponsor|4|||
48703202|NCT03126591|156762882|FG000|Overall Study|Withdrawal by Subject|1|||
48703203|NCT03126591|156762883|FG001|Overall Study|Withdrawal by Subject|1|||
48703204|NCT03126591|156762884|FG002|Overall Study|Withdrawal by Subject|4|||
48703205|NCT01614886|156762885|FG000|Overall Study|Adverse Event|15|||
48703206|NCT01614886|156762886|FG001|Overall Study|Adverse Event|20|||
48703207|NCT01614886|156762885|FG000|Overall Study|Withdrawal by Subject|4|||
48703208|NCT01614886|156762886|FG001|Overall Study|Withdrawal by Subject|4|||
48703209|NCT01614886|156762885|FG000|Overall Study|Death|1|||
48703210|NCT01614886|156762886|FG001|Overall Study|Death|0|||
48703211|NCT01614886|156762885|FG000|Overall Study|Protocol deviation|0|||
48703212|NCT01614886|156762886|FG001|Overall Study|Protocol deviation|2|||
48703213|NCT02177032|156762889|FG000|Overall Study|ADMINISTRATIVE REASON|2|||
48703214|NCT02177032|156762890|FG001|Overall Study|ADMINISTRATIVE REASON|0|||
48703215|NCT02177032|156762891|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
48703216|NCT02177032|156762892|FG003|Overall Study|ADMINISTRATIVE REASON|0|||
48703217|NCT02177032|156762889|FG000|Overall Study|Lost to Follow-up|0|||
48703218|NCT02177032|156762890|FG001|Overall Study|Lost to Follow-up|2|||
48703219|NCT02177032|156762891|FG002|Overall Study|Lost to Follow-up|0|||
48703220|NCT02177032|156762892|FG003|Overall Study|Lost to Follow-up|0|||
48703221|NCT02177032|156762889|FG000|Overall Study|OTHER|2|||
48703222|NCT02177032|156762890|FG001|Overall Study|OTHER|0|||
48703223|NCT02177032|156762891|FG002|Overall Study|OTHER|1|||
48703224|NCT02177032|156762892|FG003|Overall Study|OTHER|0|||
48703225|NCT02177032|156762889|FG000|Overall Study|Withdrawal by Subject|1|||
48703226|NCT02177032|156762890|FG001|Overall Study|Withdrawal by Subject|0|||
48703227|NCT02177032|156762891|FG002|Overall Study|Withdrawal by Subject|1|||
48703228|NCT02177032|156762892|FG003|Overall Study|Withdrawal by Subject|0|||
48703229|NCT00665652|156762893|FG000|Overall Study|Adverse Event|4|||
48703230|NCT00665652|156762893|FG000|Overall Study|Death|1|||
48703231|NCT00665652|156762893|FG000|Overall Study|No longer met inclusion criteria.|1|||
48703232|NCT03096288|156762894|FG000|Overall Study|Withdrawal by Subject|0|||
48703233|NCT03096288|156762895|FG001|Overall Study|Withdrawal by Subject|1|||
48703234|NCT03096288|156762896|FG002|Overall Study|Withdrawal by Subject|0|||
48703235|NCT03096288|156762897|FG003|Overall Study|Withdrawal by Subject|1|||
48703236|NCT01967940|156762900|FG000|Part 2|Enrolled in Part 2 and Never Treated|0|||
48703237|NCT01967940|156762901|FG001|Part 2|Enrolled in Part 2 and Never Treated|0|||
48703238|NCT01967940|156762902|FG002|Part 2|Enrolled in Part 2 and Never Treated|0|||
48703239|NCT01967940|156762903|FG003|Part 2|Enrolled in Part 2 and Never Treated|1|||
48703240|NCT01967940|156762900|FG000|Part 2|Adverse Event|0|||
48703241|NCT01967940|156762901|FG001|Part 2|Adverse Event|0|||
48703242|NCT01967940|156762902|FG002|Part 2|Adverse Event|0|||
48703243|NCT01967940|156762903|FG003|Part 2|Adverse Event|1|||
48703244|NCT01967940|156762900|FG000|Part 2|Unknown Reason|0|||
48703245|NCT01967940|156762901|FG001|Part 2|Unknown Reason|0|||
48703246|NCT01967940|156762902|FG002|Part 2|Unknown Reason|0|||
48703247|NCT01967940|156762903|FG003|Part 2|Unknown Reason|1|||
48703248|NCT03944577|156762904|FG000|Overall Study|Adverse Event|3|||
48703249|NCT01654302|156762905|FG000|Second Intervention (Day 7)|Lost to Follow-up|1|||
48703250|NCT01654302|156762906|FG001|Second Intervention (Day 7)|Lost to Follow-up|1|||
48703251|NCT01352793|156762907|FG000|Overall Study|Lost to Follow-up|289|||
48912305|NCT00359021|157516193|FG000|Overall Study|Pregnancy|1|||
48912306|NCT00359021|157516194|FG001|Overall Study|Pregnancy|0|||
48912307|NCT01161043|157516195|FG000|Overall Study|Withdrawal by Subject|3|||
48703252|NCT01352793|156762908|FG001|Overall Study|Lost to Follow-up|125|||
48703253|NCT01352793|156762907|FG000|Overall Study|Withdrawal by Subject|120|||
48703254|NCT01352793|156762908|FG001|Overall Study|Withdrawal by Subject|55|||
48703255|NCT01352793|156762907|FG000|Overall Study|Protocol Violation|44|||
48703256|NCT01352793|156762908|FG001|Overall Study|Protocol Violation|23|||
48703257|NCT01352793|156762907|FG000|Overall Study|Adverse Event|44|||
48703258|NCT01352793|156762908|FG001|Overall Study|Adverse Event|10|||
48703259|NCT01352793|156762907|FG000|Overall Study|Physician Decision|1|||
48703260|NCT01352793|156762908|FG001|Overall Study|Physician Decision|0|||
48703261|NCT01352793|156762907|FG000|Overall Study|Pregnancy|26|||
48703262|NCT01352793|156762908|FG001|Overall Study|Pregnancy|8|||
48703263|NCT01352793|156762907|FG000|Overall Study|Other|25|||
48703264|NCT01352793|156762908|FG001|Overall Study|Other|7|||
48703265|NCT01352793|156762907|FG000|Overall Study|Medication error|2|||
48703266|NCT01352793|156762908|FG001|Overall Study|Medication error|2|||
48703267|NCT01352793|156762907|FG000|Overall Study|Death|1|||
48703268|NCT01352793|156762908|FG001|Overall Study|Death|0|||
48703269|NCT01352793|156762907|FG000|Overall Study|Randomized but not vaccinated|8|||
48703270|NCT01352793|156762908|FG001|Overall Study|Randomized but not vaccinated|0|||
48703271|NCT01352793|156762907|FG000|Overall Study|No longer meets eligibility criteria|25|||
48703272|NCT01352793|156762908|FG001|Overall Study|No longer meets eligibility criteria|15|||
48703273|NCT04476797|156762912|FG000|Overall Study|Withdrawal by Subject|1|||
48703274|NCT04476797|156762913|FG001|Overall Study|Withdrawal by Subject|0|||
48703275|NCT04476797|156762914|FG002|Overall Study|Withdrawal by Subject|0|||
48703276|NCT04476797|156762912|FG000|Overall Study|Death|0|||
48703277|NCT04476797|156762913|FG001|Overall Study|Death|1|||
48912308|NCT01621542|157516198|FG000|Overall Study|Adverse Event|0|||
48912309|NCT01621542|157516199|FG001|Overall Study|Adverse Event|0|||
48703278|NCT04476797|156762914|FG002|Overall Study|Death|2|||
48703279|NCT04476797|156762912|FG000|Overall Study|Sponsor Terminated Study|0|||
48703280|NCT04476797|156762913|FG001|Overall Study|Sponsor Terminated Study|18|||
48703281|NCT04476797|156762914|FG002|Overall Study|Sponsor Terminated Study|17|||
48703282|NCT01716234|156762915|FG000|Overall Study|Protocol Violation|0|||
48703283|NCT01716234|156762916|FG001|Overall Study|Protocol Violation|0|||
48703284|NCT01716234|156762917|FG002|Overall Study|Protocol Violation|0|||
48703285|NCT01716234|156762918|FG003|Overall Study|Protocol Violation|1|||
48703286|NCT01716234|156762919|FG004|Overall Study|Protocol Violation|1|||
48703287|NCT01716234|156762920|FG005|Overall Study|Protocol Violation|1|||
48703288|NCT01716234|156762921|FG006|Overall Study|Protocol Violation|0|||
48703289|NCT01716234|156762915|FG000|Overall Study|Lack of Efficacy|0|||
48703290|NCT01716234|156762916|FG001|Overall Study|Lack of Efficacy|0|||
48703291|NCT01716234|156762917|FG002|Overall Study|Lack of Efficacy|0|||
48703292|NCT01716234|156762918|FG003|Overall Study|Lack of Efficacy|1|||
48703293|NCT01716234|156762919|FG004|Overall Study|Lack of Efficacy|0|||
48703294|NCT01716234|156762920|FG005|Overall Study|Lack of Efficacy|0|||
48703295|NCT01716234|156762921|FG006|Overall Study|Lack of Efficacy|0|||
48703296|NCT01716234|156762915|FG000|Overall Study|Did not meet protocol eligibility|0|||
48703297|NCT01716234|156762916|FG001|Overall Study|Did not meet protocol eligibility|0|||
48703298|NCT01716234|156762917|FG002|Overall Study|Did not meet protocol eligibility|1|||
48703299|NCT01716234|156762918|FG003|Overall Study|Did not meet protocol eligibility|0|||
48703300|NCT01716234|156762919|FG004|Overall Study|Did not meet protocol eligibility|0|||
48703301|NCT01716234|156762920|FG005|Overall Study|Did not meet protocol eligibility|4|||
48703302|NCT01716234|156762921|FG006|Overall Study|Did not meet protocol eligibility|0|||
48703303|NCT01716234|156762915|FG000|Overall Study|Adverse Event|7|||
48703304|NCT01716234|156762916|FG001|Overall Study|Adverse Event|10|||
48703305|NCT01716234|156762917|FG002|Overall Study|Adverse Event|2|||
48703306|NCT01716234|156762918|FG003|Overall Study|Adverse Event|8|||
48703307|NCT01716234|156762919|FG004|Overall Study|Adverse Event|3|||
48703308|NCT01716234|156762920|FG005|Overall Study|Adverse Event|6|||
48703309|NCT01716234|156762921|FG006|Overall Study|Adverse Event|0|||
48703310|NCT01716234|156762915|FG000|Overall Study|Withdrawal by Subject|3|||
48703311|NCT01716234|156762916|FG001|Overall Study|Withdrawal by Subject|0|||
48703312|NCT01716234|156762917|FG002|Overall Study|Withdrawal by Subject|2|||
48703313|NCT01716234|156762918|FG003|Overall Study|Withdrawal by Subject|2|||
48703314|NCT01716234|156762919|FG004|Overall Study|Withdrawal by Subject|1|||
48703315|NCT01716234|156762920|FG005|Overall Study|Withdrawal by Subject|3|||
48703316|NCT01716234|156762921|FG006|Overall Study|Withdrawal by Subject|0|||
48703317|NCT02059278|156762922|FG000|Overall Study|Adverse Event|1|||
48703318|NCT02059278|156762923|FG001|Overall Study|Adverse Event|1|||
48703319|NCT02059278|156762922|FG000|Overall Study|Lost to Follow-up|1|||
48703320|NCT02059278|156762923|FG001|Overall Study|Lost to Follow-up|0|||
48703321|NCT02059278|156762922|FG000|Overall Study|Withdrawal by Subject|0|||
48703322|NCT02059278|156762923|FG001|Overall Study|Withdrawal by Subject|3|||
48703323|NCT02059278|156762922|FG000|Overall Study|Ran out of IP and decided to discontinue|1|||
48703324|NCT02059278|156762923|FG001|Overall Study|Ran out of IP and decided to discontinue|0|||
48703325|NCT01488890|156762924|FG000|Overall Study|Serious adverse event|2|||
48703326|NCT01488890|156762925|FG001|Overall Study|Serious adverse event|0|||
48703327|NCT01488890|156762926|FG002|Overall Study|Serious adverse event|0|||
48703328|NCT01488890|156762927|FG003|Overall Study|Serious adverse event|0|||
48703329|NCT01488890|156762924|FG000|Overall Study|Protocol Violation|3|||
48703330|NCT01488890|156762925|FG001|Overall Study|Protocol Violation|0|||
48703331|NCT01488890|156762926|FG002|Overall Study|Protocol Violation|4|||
48703332|NCT01488890|156762927|FG003|Overall Study|Protocol Violation|0|||
48703333|NCT01488890|156762924|FG000|Overall Study|Lost to Follow-up|13|||
48703334|NCT01488890|156762925|FG001|Overall Study|Lost to Follow-up|10|||
48703335|NCT01488890|156762926|FG002|Overall Study|Lost to Follow-up|20|||
48703336|NCT01488890|156762927|FG003|Overall Study|Lost to Follow-up|3|||
48703337|NCT01488890|156762924|FG000|Overall Study|Withdrawal by Subject|14|||
48703338|NCT01488890|156762925|FG001|Overall Study|Withdrawal by Subject|10|||
48703339|NCT01488890|156762926|FG002|Overall Study|Withdrawal by Subject|11|||
48703340|NCT01488890|156762927|FG003|Overall Study|Withdrawal by Subject|2|||
48703341|NCT03848728|156762928|FG000|Overall Study|Death|16|||
48703342|NCT03848728|156762929|FG001|Overall Study|Death|13|||
48703343|NCT03848728|156762928|FG000|Overall Study|Outmigrated to non-study community|98|||
48703344|NCT03848728|156762929|FG001|Overall Study|Outmigrated to non-study community|106|||
48703345|NCT03848728|156762928|FG000|Overall Study|Transfered to non-study clinic|32|||
48703346|NCT03848728|156762929|FG001|Overall Study|Transfered to non-study clinic|48|||
48703347|NCT03848728|156762928|FG000|Overall Study|Withdrawal by Subject|1|||
48703348|NCT03848728|156762929|FG001|Overall Study|Withdrawal by Subject|0|||
48703349|NCT05135767|156762930|FG000|Baseline|Lost to Follow-up|1|||
48703350|NCT05135767|156762931|FG001|Baseline|Lost to Follow-up|1|||
48703351|NCT05135767|156762930|FG000|Baseline|Withdrawal by Subject|0|||
48703352|NCT05135767|156762931|FG001|Baseline|Withdrawal by Subject|2|||
48703353|NCT05135767|156762930|FG000|Active Study Phase|Lost to Follow-up|2|||
48703354|NCT05135767|156762931|FG001|Active Study Phase|Lost to Follow-up|0|||
48703355|NCT04498832|156762932|FG000|Overall Study|Adverse Event|1|||
48703356|NCT04498832|156762933|FG001|Overall Study|Adverse Event|3|||
48703357|NCT04498832|156762932|FG000|Overall Study|Withdrawal by Subject|0|||
48703358|NCT04498832|156762933|FG001|Overall Study|Withdrawal by Subject|1|||
48703359|NCT02581410|156762936|FG000|Vaccination Phase|Adverse Event|2|||
48703360|NCT02581410|156762937|FG001|Vaccination Phase|Adverse Event|1|||
48703361|NCT02581410|156762936|FG000|Vaccination Phase|Withdrawal by Subject|0|||
48703362|NCT02581410|156762937|FG001|Vaccination Phase|Withdrawal by Subject|1|||
48703363|NCT02581410|156762936|FG000|Vaccination Phase|Migrated/moved from study area|0|||
48703364|NCT02581410|156762937|FG001|Vaccination Phase|Migrated/moved from study area|1|||
48703365|NCT02581410|156762936|FG000|End of Study Phase|Adverse Event|4|||
48703366|NCT02581410|156762937|FG001|End of Study Phase|Adverse Event|3|||
48703367|NCT02581410|156762936|FG000|End of Study Phase|Withdrawal by Subject|1|||
48703368|NCT02581410|156762937|FG001|End of Study Phase|Withdrawal by Subject|2|||
48703369|NCT02581410|156762936|FG000|End of Study Phase|Migrated/moved from study area|0|||
48703370|NCT02581410|156762937|FG001|End of Study Phase|Migrated/moved from study area|3|||
48703371|NCT02581410|156762936|FG000|End of Study Phase|Lost to Follow-up|0|||
48912310|NCT01621542|157516200|FG002|Overall Study|Adverse Event|1|||
48912311|NCT01621542|157516201|FG003|Overall Study|Adverse Event|3|||
48703372|NCT02581410|156762937|FG001|End of Study Phase|Lost to Follow-up|2|||
48703373|NCT02581410|156762936|FG000|End of Study Phase|Other-transfer of subject not completed|0|||
48703374|NCT02581410|156762937|FG001|End of Study Phase|Other-transfer of subject not completed|1|||
48703375|NCT01063751|156762939|FG000|Overall Study|Site terminated|45|||
48703376|NCT01063751|156762939|FG000|Overall Study|Lost to Follow-up|28|||
48703377|NCT01063751|156762939|FG000|Overall Study|Withdrawal by Subject|25|||
48703378|NCT01063751|156762939|FG000|Overall Study|Revision|6|||
48703379|NCT01063751|156762939|FG000|Overall Study|Death|12|||
48912312|NCT01621542|157516202|FG004|Overall Study|Adverse Event|0|||
48703380|NCT01063751|156762939|FG000|Overall Study|Physician Decision|4|||
48703381|NCT01063751|156762939|FG000|Overall Study|Active|91|||
48703382|NCT03863080|156762940|FG000|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
48703383|NCT03863080|156762941|FG001|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
48703384|NCT03863080|156762942|FG002|Double-Blind Treatment Period (6 Weeks)|Adverse Event|1|||
48703385|NCT03863080|156762943|FG003|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
48703386|NCT03863080|156762940|FG000|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
48703387|NCT03863080|156762941|FG001|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
48703388|NCT03863080|156762942|FG002|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
48703389|NCT03863080|156762943|FG003|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|3|||
48703390|NCT03863080|156762940|FG000|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
48703391|NCT03863080|156762941|FG001|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
48703392|NCT03863080|156762942|FG002|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
48703393|NCT03863080|156762943|FG003|Open Label Extension Period (12 Weeks)|Adverse Event|3|||
48703394|NCT04081103|156762946|FG000|Overall Study|Adverse Event|1|||
48703395|NCT04081103|156762947|FG001|Overall Study|Adverse Event|1|||
48703396|NCT04081103|156762948|FG002|Overall Study|Adverse Event|1|||
48703397|NCT04081103|156762946|FG000|Overall Study|Physician Decision|0|||
48703398|NCT04081103|156762947|FG001|Overall Study|Physician Decision|0|||
48703399|NCT04081103|156762948|FG002|Overall Study|Physician Decision|1|||
48703400|NCT03173248|156762949|FG000|Overall Study|Death|28|||
48703401|NCT03173248|156762950|FG001|Overall Study|Death|46|||
48703402|NCT03173248|156762949|FG000|Overall Study|Lost to Follow-up|0|||
48703403|NCT03173248|156762950|FG001|Overall Study|Lost to Follow-up|1|||
48703404|NCT03173248|156762949|FG000|Overall Study|Withdrawal by Subject|6|||
48703405|NCT03173248|156762950|FG001|Overall Study|Withdrawal by Subject|4|||
48703406|NCT03173248|156762949|FG000|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|38|||
48703407|NCT03173248|156762950|FG001|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|23|||
48703408|NCT04163016|156762962|FG000|Enrollment|Adverse Event|1|||
48703409|NCT04163016|156762963|FG001|Enrollment|Adverse Event|0|||
48703410|NCT04163016|156762964|FG002|Enrollment|Adverse Event|0|||
48703411|NCT04163016|156762965|FG003|Enrollment|Adverse Event|0|||
48703412|NCT04163016|156762962|FG000|Treatment|Adverse Event|0|||
48703413|NCT04163016|156762963|FG001|Treatment|Adverse Event|1|||
48703414|NCT04163016|156762964|FG002|Treatment|Adverse Event|0|||
48703415|NCT04163016|156762965|FG003|Treatment|Adverse Event|0|||
48703416|NCT04163016|156762962|FG000|Treatment|Withdrawal by Subject|0|||
48703417|NCT04163016|156762963|FG001|Treatment|Withdrawal by Subject|2|||
48703418|NCT04163016|156762964|FG002|Treatment|Withdrawal by Subject|0|||
48703419|NCT04163016|156762965|FG003|Treatment|Withdrawal by Subject|0|||
48703420|NCT04163016|156762962|FG000|Treatment|Indeterminate TB-test|0|||
48703421|NCT04163016|156762963|FG001|Treatment|Indeterminate TB-test|0|||
48703422|NCT04163016|156762964|FG002|Treatment|Indeterminate TB-test|0|||
48703423|NCT04163016|156762965|FG003|Treatment|Indeterminate TB-test|1|||
48703424|NCT04163016|156762962|FG000|Treatment|Participant did not want to continue in study|0|||
48703425|NCT04163016|156762963|FG001|Treatment|Participant did not want to continue in study|0|||
48703426|NCT04163016|156762964|FG002|Treatment|Participant did not want to continue in study|0|||
48703427|NCT04163016|156762965|FG003|Treatment|Participant did not want to continue in study|1|||
48703428|NCT02594124|156762966|FG000|Overall Study|Adverse Event|0|||
48703429|NCT02594124|156762967|FG001|Overall Study|Adverse Event|5|||
48703430|NCT02594124|156762968|FG002|Overall Study|Adverse Event|8|||
48703431|NCT02594124|156762969|FG003|Overall Study|Adverse Event|1|||
48703432|NCT02594124|156762970|FG004|Overall Study|Adverse Event|0|||
48703433|NCT02594124|156762971|FG005|Overall Study|Adverse Event|0|||
48703434|NCT02594124|156762972|FG006|Overall Study|Adverse Event|2|||
48703435|NCT02594124|156762973|FG007|Overall Study|Adverse Event|2|||
48703436|NCT02594124|156762974|FG008|Overall Study|Adverse Event|0|||
48703437|NCT02594124|156762966|FG000|Overall Study|Withdrawal by Subject|2|||
48703438|NCT02594124|156762967|FG001|Overall Study|Withdrawal by Subject|3|||
48703439|NCT02594124|156762968|FG002|Overall Study|Withdrawal by Subject|5|||
48703440|NCT02594124|156762969|FG003|Overall Study|Withdrawal by Subject|1|||
48703441|NCT02594124|156762970|FG004|Overall Study|Withdrawal by Subject|8|||
48703442|NCT02594124|156762971|FG005|Overall Study|Withdrawal by Subject|4|||
48912313|NCT01621542|157516203|FG005|Overall Study|Adverse Event|0|||
49118663|NCT00572455|158273157|FG006|Stage II (28 Days)|Other|0|||
49118664|NCT00572455|158273158|FG007|Stage II (28 Days)|Other|0|||
49118665|NCT00572455|158273159|FG008|Stage II (28 Days)|Other|1|||
48703443|NCT02594124|156762972|FG006|Overall Study|Withdrawal by Subject|13|||
48703444|NCT02594124|156762973|FG007|Overall Study|Withdrawal by Subject|19|||
48703445|NCT02594124|156762974|FG008|Overall Study|Withdrawal by Subject|0|||
48703446|NCT02594124|156762966|FG000|Overall Study|Physician Decision|0|||
48703447|NCT02594124|156762967|FG001|Overall Study|Physician Decision|2|||
48912314|NCT01621542|157516198|FG000|Overall Study|Death|0|||
48703448|NCT02594124|156762968|FG002|Overall Study|Physician Decision|0|||
48703449|NCT02594124|156762969|FG003|Overall Study|Physician Decision|0|||
48703450|NCT02594124|156762970|FG004|Overall Study|Physician Decision|0|||
48703451|NCT02594124|156762971|FG005|Overall Study|Physician Decision|0|||
48703452|NCT02594124|156762972|FG006|Overall Study|Physician Decision|0|||
49118666|NCT00572455|158273160|FG009|Stage II (28 Days)|Other|0|||
48703453|NCT02594124|156762973|FG007|Overall Study|Physician Decision|1|||
48703454|NCT02594124|156762974|FG008|Overall Study|Physician Decision|0|||
48703455|NCT02594124|156762966|FG000|Overall Study|Commercial drug|0|||
48703456|NCT02594124|156762967|FG001|Overall Study|Commercial drug|1|||
48703457|NCT02594124|156762968|FG002|Overall Study|Commercial drug|6|||
48703458|NCT02594124|156762969|FG003|Overall Study|Commercial drug|3|||
48703459|NCT02594124|156762970|FG004|Overall Study|Commercial drug|0|||
48703460|NCT02594124|156762971|FG005|Overall Study|Commercial drug|0|||
48703461|NCT02594124|156762972|FG006|Overall Study|Commercial drug|7|||
48703462|NCT02594124|156762973|FG007|Overall Study|Commercial drug|11|||
48703463|NCT02594124|156762974|FG008|Overall Study|Commercial drug|2|||
48703464|NCT02594124|156762966|FG000|Overall Study|Reason Not Specified|1|||
48703465|NCT02594124|156762967|FG001|Overall Study|Reason Not Specified|3|||
48703466|NCT02594124|156762968|FG002|Overall Study|Reason Not Specified|4|||
48703467|NCT02594124|156762969|FG003|Overall Study|Reason Not Specified|0|||
48703468|NCT02594124|156762970|FG004|Overall Study|Reason Not Specified|0|||
48703469|NCT02594124|156762971|FG005|Overall Study|Reason Not Specified|1|||
48703470|NCT02594124|156762972|FG006|Overall Study|Reason Not Specified|1|||
48703471|NCT02594124|156762973|FG007|Overall Study|Reason Not Specified|6|||
48703472|NCT02594124|156762974|FG008|Overall Study|Reason Not Specified|1|||
48703473|NCT01256788|156764345|FG000|Overall Study|Lost to Follow-up|5|||
48703474|NCT01256788|156764346|FG001|Overall Study|Lost to Follow-up|8|||
48703475|NCT01256788|156764347|FG002|Overall Study|Lost to Follow-up|3|||
48703476|NCT02144610|156764356|FG000|Overall Study|Physician Decision|1|||
48703477|NCT02144610|156764357|FG001|Overall Study|Physician Decision|0|||
48703478|NCT02144610|156764356|FG000|Overall Study|Withdrawal by Subject|1|||
48703479|NCT02144610|156764357|FG001|Overall Study|Withdrawal by Subject|5|||
48703480|NCT02144610|156764356|FG000|Overall Study|Death|2|||
48703481|NCT02144610|156764357|FG001|Overall Study|Death|2|||
48703482|NCT02144610|156764356|FG000|Overall Study|Study Discontinuation by Sponsor|19|||
48703483|NCT02144610|156764357|FG001|Overall Study|Study Discontinuation by Sponsor|14|||
48703484|NCT02144610|156764356|FG000|Overall Study|Other|0|||
48703485|NCT02144610|156764357|FG001|Overall Study|Other|1|||
48703486|NCT01298648|156764358|FG000|Overall Study|Withdrawal by Subject|2|||
48703487|NCT01298648|156764358|FG000|Overall Study|Lost to Follow-up|21|||
48703488|NCT01281124|156764359|FG000|Overall Study|Death|1|||
48703489|NCT01600716|156764363|FG000|Overall Study|Other Reasons|3|||
48703490|NCT01600716|156764364|FG001|Overall Study|Other Reasons|1|||
48703491|NCT01600716|156764363|FG000|Overall Study|Personal Reasons|0|||
48703492|NCT01600716|156764364|FG001|Overall Study|Personal Reasons|2|||
48703493|NCT01600716|156764363|FG000|Overall Study|Lost to Follow-up|0|||
48703494|NCT01600716|156764364|FG001|Overall Study|Lost to Follow-up|2|||
48703495|NCT01600716|156764363|FG000|Overall Study|Pregnancy|1|||
48703496|NCT01600716|156764364|FG001|Overall Study|Pregnancy|0|||
48703497|NCT01600716|156764363|FG000|Overall Study|Lack of Efficacy|2|||
48703498|NCT01600716|156764364|FG001|Overall Study|Lack of Efficacy|1|||
48703499|NCT01600716|156764363|FG000|Overall Study|Adverse Event|1|||
48703500|NCT01600716|156764364|FG001|Overall Study|Adverse Event|1|||
48703501|NCT03557034|156764366|FG000|Overall Study|Withdrawal by Subject|1|||
48703502|NCT03557034|156764367|FG001|Overall Study|Withdrawal by Subject|0|||
48703503|NCT00674817|156764368|FG000|Period 1|Withdrawal by Subject|2|||
48703504|NCT00674817|156764368|FG000|Period 1|Protocol Violation|1|||
48703505|NCT00674817|156764368|FG000|Period 3|Adverse Event|1|||
48703506|NCT00674817|156764368|FG000|Period 3|Protocol Violation|1|||
48703507|NCT00674817|156764368|FG000|Period 4|Adverse Event|1|||
48703508|NCT00473564|156764369|FG000|Overall Study|robot surgery aborted in OR|23|||
48703509|NCT01907854|156764371|FG000|Overall Study|Protocol Violation|1|||
48703510|NCT01907854|156764372|FG001|Overall Study|Protocol Violation|1|||
48703511|NCT01907854|156764371|FG000|Overall Study|Withdrawal by Subject|9|||
48703512|NCT01907854|156764372|FG001|Overall Study|Withdrawal by Subject|7|||
48703513|NCT01907854|156764371|FG000|Overall Study|Lost to Follow-up|2|||
48703514|NCT01907854|156764372|FG001|Overall Study|Lost to Follow-up|2|||
48703515|NCT01907854|156764371|FG000|Overall Study|Unclassified|4|||
48703516|NCT01907854|156764372|FG001|Overall Study|Unclassified|3|||
48703517|NCT03910244|156764373|FG000|Overall Study|Adverse Event|14|||
48703518|NCT03910244|156764374|FG001|Overall Study|Adverse Event|0|||
48703519|NCT03910244|156764373|FG000|Overall Study|Death|1|||
48703520|NCT03910244|156764374|FG001|Overall Study|Death|0|||
48703521|NCT03910244|156764373|FG000|Overall Study|Lost to Follow-up|0|||
48703522|NCT03910244|156764374|FG001|Overall Study|Lost to Follow-up|2|||
48703523|NCT03910244|156764373|FG000|Overall Study|Joint withdrawal decision|1|||
48703524|NCT03910244|156764374|FG001|Overall Study|Joint withdrawal decision|0|||
48703525|NCT03910244|156764373|FG000|Overall Study|Study Terminated by Sponsor|7|||
48703526|NCT03910244|156764374|FG001|Overall Study|Study Terminated by Sponsor|4|||
48703527|NCT03910244|156764373|FG000|Overall Study|Physician Decision|1|||
49010682|NCT00095199|157875671|FG001|Overall Study|Primary tumor removed in other surgery|1|||
48703528|NCT03910244|156764374|FG001|Overall Study|Physician Decision|0|||
48703529|NCT03910244|156764373|FG000|Overall Study|Protocol Violation|1|||
48703530|NCT03910244|156764374|FG001|Overall Study|Protocol Violation|0|||
48703531|NCT03910244|156764373|FG000|Overall Study|Withdrawal by Subject|7|||
48703532|NCT03910244|156764374|FG001|Overall Study|Withdrawal by Subject|2|||
48703533|NCT00763035|156764375|FG000|First Intervention|Did not meeting inclusion/exclusion|1|||
48703534|NCT00763035|156764376|FG001|First Intervention|Did not meeting inclusion/exclusion|0|||
48703535|NCT00763035|156764375|FG000|First Intervention|Adverse Event|0|||
48703536|NCT00763035|156764376|FG001|First Intervention|Adverse Event|1|||
48703537|NCT00763035|156764375|FG000|Second Intervention|Adverse Event|1|||
48703538|NCT00763035|156764376|FG001|Second Intervention|Adverse Event|0|||
48703539|NCT00763035|156764375|FG000|Second Intervention|Physician Decision|2|||
48703540|NCT00763035|156764376|FG001|Second Intervention|Physician Decision|0|||
48703541|NCT02606643|156764377|FG000|Overall Study|did not meet inclusion criteria|1|||
48703542|NCT02606643|156764378|FG001|Overall Study|did not meet inclusion criteria|3|||
48703543|NCT03219723|156764380|FG000|Overall Study|Case Report Forms Uncollected|6|||
48703544|NCT03219723|156764380|FG000|Overall Study|Protocol Deviation|4|||
48703545|NCT02796170|156764381|FG000|Overall Study|Lost to Follow-up|3|||
48703546|NCT02796170|156764382|FG001|Overall Study|Lost to Follow-up|0|||
48703547|NCT01980017|156764383|FG000|Overall Study|Lost to Follow-up|30|||
48703548|NCT01980017|156764384|FG001|Overall Study|Lost to Follow-up|21|||
48703549|NCT01980017|156764383|FG000|Overall Study|Death|0|||
48703550|NCT01980017|156764384|FG001|Overall Study|Death|1|||
48703551|NCT00561925|156764385|FG000|14 Day Lead-In Period|Adverse Event|38|||
48703552|NCT00561925|156764386|FG001|14 Day Lead-In Period|Adverse Event|0|||
48703553|NCT00561925|156764387|FG002|14 Day Lead-In Period|Adverse Event|0|||
48703554|NCT00561925|156764388|FG003|14 Day Lead-In Period|Adverse Event|0|||
48703555|NCT00561925|156764389|FG004|14 Day Lead-In Period|Adverse Event|0|||
48703556|NCT00561925|156764385|FG000|14 Day Lead-In Period|In/Exclusion criteria|4|||
48703557|NCT00561925|156764386|FG001|14 Day Lead-In Period|In/Exclusion criteria|0|||
48703558|NCT00561925|156764387|FG002|14 Day Lead-In Period|In/Exclusion criteria|0|||
48703559|NCT00561925|156764388|FG003|14 Day Lead-In Period|In/Exclusion criteria|0|||
48703560|NCT00561925|156764389|FG004|14 Day Lead-In Period|In/Exclusion criteria|0|||
48703561|NCT00561925|156764385|FG000|14 Day Lead-In Period|Lost to Follow-up|4|||
48703562|NCT00561925|156764386|FG001|14 Day Lead-In Period|Lost to Follow-up|0|||
48703563|NCT00561925|156764387|FG002|14 Day Lead-In Period|Lost to Follow-up|0|||
48703564|NCT00561925|156764388|FG003|14 Day Lead-In Period|Lost to Follow-up|0|||
48703565|NCT00561925|156764389|FG004|14 Day Lead-In Period|Lost to Follow-up|0|||
48703566|NCT00561925|156764385|FG000|14 Day Lead-In Period|Withdrawal by Subject|4|||
48703567|NCT00561925|156764386|FG001|14 Day Lead-In Period|Withdrawal by Subject|0|||
48703568|NCT00561925|156764387|FG002|14 Day Lead-In Period|Withdrawal by Subject|0|||
48703569|NCT00561925|156764388|FG003|14 Day Lead-In Period|Withdrawal by Subject|0|||
48912315|NCT01621542|157516199|FG001|Overall Study|Death|1|||
48912316|NCT01621542|157516200|FG002|Overall Study|Death|0|||
48912317|NCT01621542|157516201|FG003|Overall Study|Death|0|||
48703570|NCT00561925|156764389|FG004|14 Day Lead-In Period|Withdrawal by Subject|0|||
48703571|NCT00561925|156764385|FG000|14 Day Lead-In Period|Other|5|||
48703572|NCT00561925|156764386|FG001|14 Day Lead-In Period|Other|0|||
48703573|NCT00561925|156764387|FG002|14 Day Lead-In Period|Other|0|||
48703574|NCT00561925|156764388|FG003|14 Day Lead-In Period|Other|0|||
48703575|NCT00561925|156764389|FG004|14 Day Lead-In Period|Other|0|||
48703576|NCT00561925|156764385|FG000|144-week Double-blind, Double-dummy|Adverse Event|0|||
48703577|NCT00561925|156764386|FG001|144-week Double-blind, Double-dummy|Adverse Event|48|||
48703578|NCT00561925|156764387|FG002|144-week Double-blind, Double-dummy|Adverse Event|43|||
48703579|NCT00561925|156764388|FG003|144-week Double-blind, Double-dummy|Adverse Event|0|||
48703580|NCT00561925|156764389|FG004|144-week Double-blind, Double-dummy|Adverse Event|0|||
48703581|NCT00561925|156764385|FG000|144-week Double-blind, Double-dummy|Protocol Violation|0|||
48912318|NCT01621542|157516202|FG004|Overall Study|Death|0|||
48912319|NCT01621542|157516203|FG005|Overall Study|Death|0|||
48912320|NCT01621542|157516198|FG000|Overall Study|Physician Decision|1|||
48912321|NCT01621542|157516199|FG001|Overall Study|Physician Decision|0|||
48912322|NCT01621542|157516200|FG002|Overall Study|Physician Decision|1|||
48912323|NCT01621542|157516201|FG003|Overall Study|Physician Decision|13|||
48912324|NCT01621542|157516202|FG004|Overall Study|Physician Decision|3|||
48912325|NCT01621542|157516203|FG005|Overall Study|Physician Decision|1|||
48912326|NCT01621542|157516198|FG000|Overall Study|Withdrawal by Subject|2|||
48912327|NCT01621542|157516199|FG001|Overall Study|Withdrawal by Subject|0|||
48912328|NCT01621542|157516200|FG002|Overall Study|Withdrawal by Subject|1|||
48912329|NCT01621542|157516201|FG003|Overall Study|Withdrawal by Subject|3|||
48703582|NCT00561925|156764386|FG001|144-week Double-blind, Double-dummy|Protocol Violation|15|||
48703583|NCT00561925|156764387|FG002|144-week Double-blind, Double-dummy|Protocol Violation|9|||
48703584|NCT00561925|156764388|FG003|144-week Double-blind, Double-dummy|Protocol Violation|0|||
48912330|NCT01621542|157516202|FG004|Overall Study|Withdrawal by Subject|3|||
48912331|NCT01621542|157516203|FG005|Overall Study|Withdrawal by Subject|3|||
48912332|NCT01621542|157516198|FG000|Overall Study|progression/treatment failure|2|||
48912333|NCT01621542|157516199|FG001|Overall Study|progression/treatment failure|4|||
48912334|NCT01621542|157516200|FG002|Overall Study|progression/treatment failure|3|||
48912335|NCT01621542|157516201|FG003|Overall Study|progression/treatment failure|7|||
48912336|NCT01621542|157516202|FG004|Overall Study|progression/treatment failure|3|||
48912337|NCT01621542|157516203|FG005|Overall Study|progression/treatment failure|5|||
48912338|NCT01621542|157516198|FG000|Overall Study|Protocol Violation|0|||
48912339|NCT01621542|157516199|FG001|Overall Study|Protocol Violation|0|||
48703585|NCT00561925|156764389|FG004|144-week Double-blind, Double-dummy|Protocol Violation|0|||
48703586|NCT00561925|156764385|FG000|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
48703587|NCT00561925|156764386|FG001|144-week Double-blind, Double-dummy|Lost to Follow-up|15|||
48703588|NCT00561925|156764387|FG002|144-week Double-blind, Double-dummy|Lost to Follow-up|12|||
48703589|NCT00561925|156764388|FG003|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
48703590|NCT00561925|156764389|FG004|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
48703591|NCT00561925|156764385|FG000|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
48703592|NCT00561925|156764386|FG001|144-week Double-blind, Double-dummy|Withdrawal by Subject|19|||
48703593|NCT00561925|156764387|FG002|144-week Double-blind, Double-dummy|Withdrawal by Subject|7|||
48703594|NCT00561925|156764388|FG003|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
48703595|NCT00561925|156764389|FG004|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
48703596|NCT00561925|156764385|FG000|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
48703597|NCT00561925|156764386|FG001|144-week Double-blind, Double-dummy|Lack of Efficacy|36|||
48703598|NCT00561925|156764387|FG002|144-week Double-blind, Double-dummy|Lack of Efficacy|33|||
48703599|NCT00561925|156764388|FG003|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
48703600|NCT00561925|156764389|FG004|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
48703601|NCT00561925|156764385|FG000|144-week Double-blind, Double-dummy|Pregnancy|0|||
48703602|NCT00561925|156764386|FG001|144-week Double-blind, Double-dummy|Pregnancy|1|||
48703603|NCT00561925|156764387|FG002|144-week Double-blind, Double-dummy|Pregnancy|9|||
48703604|NCT00561925|156764388|FG003|144-week Double-blind, Double-dummy|Pregnancy|0|||
48703605|NCT00561925|156764389|FG004|144-week Double-blind, Double-dummy|Pregnancy|0|||
48703606|NCT00561925|156764385|FG000|144-week Double-blind, Double-dummy|Death|0|||
48703607|NCT00561925|156764386|FG001|144-week Double-blind, Double-dummy|Death|6|||
48703608|NCT00561925|156764387|FG002|144-week Double-blind, Double-dummy|Death|3|||
48703609|NCT00561925|156764388|FG003|144-week Double-blind, Double-dummy|Death|0|||
48703610|NCT00561925|156764389|FG004|144-week Double-blind, Double-dummy|Death|0|||
48912340|NCT01621542|157516200|FG002|Overall Study|Protocol Violation|0|||
48912341|NCT01621542|157516201|FG003|Overall Study|Protocol Violation|1|||
48703611|NCT00561925|156764385|FG000|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
48703612|NCT00561925|156764386|FG001|144-week Double-blind, Double-dummy|Not treated with study drug|2|||
48703613|NCT00561925|156764387|FG002|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
48912342|NCT01621542|157516202|FG004|Overall Study|Protocol Violation|0|||
48912343|NCT01621542|157516203|FG005|Overall Study|Protocol Violation|0|||
48912344|NCT01621542|157516198|FG000|Overall Study|study stopped by sponsor|0|||
48912345|NCT01621542|157516199|FG001|Overall Study|study stopped by sponsor|0|||
48703614|NCT00561925|156764388|FG003|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
48703615|NCT00561925|156764389|FG004|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
48703616|NCT00561925|156764385|FG000|144-week Double-blind, Double-dummy|Other|0|||
48703617|NCT00561925|156764386|FG001|144-week Double-blind, Double-dummy|Other|8|||
48703618|NCT00561925|156764387|FG002|144-week Double-blind, Double-dummy|Other|11|||
48703619|NCT00561925|156764388|FG003|144-week Double-blind, Double-dummy|Other|0|||
48703620|NCT00561925|156764389|FG004|144-week Double-blind, Double-dummy|Other|0|||
48703621|NCT00561925|156764385|FG000|Open-Label Extension Period|Declined entry into extension period|0|||
48912346|NCT01621542|157516200|FG002|Overall Study|study stopped by sponsor|0|||
48912347|NCT01621542|157516201|FG003|Overall Study|study stopped by sponsor|1|||
48912348|NCT01621542|157516202|FG004|Overall Study|study stopped by sponsor|0|||
48912349|NCT01621542|157516203|FG005|Overall Study|study stopped by sponsor|0|||
48912350|NCT02973087|157516204|FG000|Overall Study|Withdrawal by Subject|2|||
48912351|NCT02973087|157516205|FG001|Overall Study|Withdrawal by Subject|1|||
48912352|NCT02973087|157516204|FG000|Overall Study|Adverse Event|1|||
48912353|NCT02973087|157516205|FG001|Overall Study|Adverse Event|0|||
48912354|NCT02973087|157516204|FG000|Overall Study|other|1|||
48912355|NCT02973087|157516205|FG001|Overall Study|other|1|||
48912356|NCT01817751|157516207|FG000|Overall Study|Physician Decision|1|||
48912357|NCT01721876|157516210|FG000|Overall Study|Not treated|1|||
48912358|NCT01721876|157516211|FG001|Overall Study|Not treated|4|||
48912359|NCT01721876|157516210|FG000|Overall Study|Disease progression / relapse|123|||
48703622|NCT00561925|156764386|FG001|Open-Label Extension Period|Declined entry into extension period|0|||
48912360|NCT01721876|157516211|FG001|Overall Study|Disease progression / relapse|156|||
48912361|NCT01721876|157516210|FG000|Overall Study|Death|6|||
48912362|NCT01721876|157516211|FG001|Overall Study|Death|13|||
48912363|NCT01721876|157516210|FG000|Overall Study|Adverse Event|41|||
48912364|NCT01721876|157516211|FG001|Overall Study|Adverse Event|165|||
48912365|NCT01721876|157516210|FG000|Overall Study|Protocol Violation|2|||
48912366|NCT01721876|157516211|FG001|Overall Study|Protocol Violation|1|||
48912367|NCT01721876|157516210|FG000|Overall Study|Withdrawal by Subject|15|||
48912368|NCT01721876|157516211|FG001|Overall Study|Withdrawal by Subject|38|||
48912369|NCT01721876|157516210|FG000|Overall Study|Reason not listed|34|||
48912370|NCT01721876|157516211|FG001|Overall Study|Reason not listed|63|||
48912371|NCT01721876|157516210|FG000|Overall Study|Sponsor terminated trial|0|||
48912372|NCT01721876|157516211|FG001|Overall Study|Sponsor terminated trial|4|||
48912373|NCT00078325|157516212|FG000|Overall Study|Adverse Event|15|||
48912374|NCT00078325|157516213|FG001|Overall Study|Adverse Event|10|||
48912375|NCT00078325|157516214|FG002|Overall Study|Adverse Event|5|||
48912376|NCT00078325|157516212|FG000|Overall Study|Protocol Violation|2|||
48912377|NCT00078325|157516213|FG001|Overall Study|Protocol Violation|2|||
48912378|NCT00078325|157516214|FG002|Overall Study|Protocol Violation|0|||
48912379|NCT00078325|157516212|FG000|Overall Study|Withdrawal by Subject|1|||
48912380|NCT00078325|157516213|FG001|Overall Study|Withdrawal by Subject|5|||
48703623|NCT00561925|156764387|FG002|Open-Label Extension Period|Declined entry into extension period|0|||
48703624|NCT00561925|156764388|FG003|Open-Label Extension Period|Declined entry into extension period|43|||
48703625|NCT00561925|156764389|FG004|Open-Label Extension Period|Declined entry into extension period|50|||
48703626|NCT04313244|156764390|FG000|Overall Study|Withdrawal of Consent|3|||
48703627|NCT04313244|156764391|FG001|Overall Study|Withdrawal of Consent|3|||
48703628|NCT04313244|156764390|FG000|Overall Study|Met Exclusion Criteria|1|||
48703629|NCT04313244|156764391|FG001|Overall Study|Met Exclusion Criteria|0|||
48703630|NCT04313244|156764390|FG000|Overall Study|Invalid Informed Consent Form (ICF)|1|||
48912381|NCT00078325|157516214|FG002|Overall Study|Withdrawal by Subject|3|||
48912382|NCT00078325|157516212|FG000|Overall Study|Lost to Follow-up|0|||
48912383|NCT00078325|157516213|FG001|Overall Study|Lost to Follow-up|1|||
48912384|NCT00078325|157516214|FG002|Overall Study|Lost to Follow-up|1|||
48912385|NCT00078325|157516212|FG000|Overall Study|Physician Decision|2|||
48912386|NCT00078325|157516213|FG001|Overall Study|Physician Decision|0|||
48912387|NCT00078325|157516214|FG002|Overall Study|Physician Decision|1|||
48912388|NCT00078325|157516212|FG000|Overall Study|Miscellaneous|1|||
48912389|NCT00078325|157516213|FG001|Overall Study|Miscellaneous|1|||
48703631|NCT04313244|156764391|FG001|Overall Study|Invalid Informed Consent Form (ICF)|0|||
48703632|NCT00684021|156764392|FG000|Overall Study|MRI Contraindicated|1|||
48912390|NCT00078325|157516214|FG002|Overall Study|Miscellaneous|1|||
48912391|NCT01473563|157516215|FG000|Overall Study|Lost to FU post tx discontinuation|1|||
48912392|NCT00786565|157516219|FG000|Enrollment Prior to Surgery|Site Closed|3|||
48912393|NCT00786565|157516219|FG000|Enrollment Prior to Surgery|Protocol Violation|3|||
48912394|NCT00786565|157516219|FG000|Post Surgery|Abnormal macular pucker|1|||
48912395|NCT00786565|157516219|FG000|Post Surgery|Adapt AO implanted posterior side up|1|||
48912396|NCT00578136|157516220|FG000|Overall Study|Not given intervention|1|||
48912397|NCT00578136|157516221|FG001|Overall Study|Not given intervention|1|||
48912398|NCT02047253|157516224|FG000|Overall Study|Lost to Follow-up|8|||
48912399|NCT03805750|157516225|FG000|Second Intervention - 4 Weeks|Adverse Event|0|||
48912400|NCT03805750|157516226|FG001|Second Intervention - 4 Weeks|Adverse Event|2|||
48912401|NCT02437864|157516229|FG000|Overall Study|Protocol Violation|4|||
48912402|NCT02437864|157516230|FG001|Overall Study|Protocol Violation|0|||
48912403|NCT03302975|157516231|FG000|Overall Study|Lost to Follow-up|4|||
48912404|NCT01436084|157516232|FG000|Overall Study|Disease Progression|2|||
48912405|NCT01436084|157516232|FG000|Overall Study|Withdrawal by Subject|1|||
48912406|NCT01436084|157516232|FG000|Overall Study|Early Closure of Study|1|||
48912407|NCT00310804|157516233|FG000|Overall Study|Lost to Follow-up|2|||
48912408|NCT00310804|157516234|FG001|Overall Study|Lost to Follow-up|0|||
49118667|NCT00572455|158273161|FG010|Stage II (28 Days)|Other|0|||
48703633|NCT00684021|156764393|FG001|Overall Study|MRI Contraindicated|1|||
48703634|NCT00684021|156764394|FG002|Overall Study|MRI Contraindicated|1|||
48703635|NCT00684021|156764395|FG003|Overall Study|MRI Contraindicated|0|||
48703636|NCT00684021|156764392|FG000|Overall Study|MRI not performed|0|||
48703637|NCT00684021|156764393|FG001|Overall Study|MRI not performed|1|||
48703638|NCT00684021|156764394|FG002|Overall Study|MRI not performed|1|||
48703639|NCT00684021|156764395|FG003|Overall Study|MRI not performed|2|||
48703640|NCT00684021|156764392|FG000|Overall Study|Death|1|||
48703641|NCT00684021|156764393|FG001|Overall Study|Death|0|||
48703642|NCT00684021|156764394|FG002|Overall Study|Death|0|||
48703643|NCT00684021|156764395|FG003|Overall Study|Death|0|||
48703644|NCT00891904|156764396|FG000|Overall Study|Death|1|||
48703645|NCT00891904|156764396|FG000|Overall Study|Adverse Event|1|||
48703646|NCT02976038|156764399|FG000|Overall Study|Physician Decision|22|||
48703647|NCT02976038|156764399|FG000|Overall Study|Withdrawal by Subject|3|||
48703648|NCT02976038|156764399|FG000|Overall Study|Lost to Follow-up|2|||
48703649|NCT02976038|156764399|FG000|Overall Study|Adverse Event|1|||
48703650|NCT01598532|156764402|FG000|Overall Study|Lost to Follow-up|3|||
48703651|NCT01598532|156764402|FG000|Overall Study|Did not meet inclusion criteria|8|||
48703652|NCT02691507|156764408|FG000|Overall Study|Missed Visit 3|0|||
48703653|NCT02691507|156764409|FG001|Overall Study|Missed Visit 3|1|||
48703654|NCT05567783|156764412|FG000|Overall Study|Death|2|||
48703655|NCT05567783|156764413|FG001|Overall Study|Death|3|||
48703656|NCT05567783|156764414|FG002|Overall Study|Death|0|||
48703657|NCT05567783|156764412|FG000|Overall Study|Lost to Follow-up|25|||
48703658|NCT05567783|156764413|FG001|Overall Study|Lost to Follow-up|19|||
48703659|NCT05567783|156764414|FG002|Overall Study|Lost to Follow-up|17|||
48703660|NCT05567783|156764412|FG000|Overall Study|Physician Decision|10|||
48703661|NCT05567783|156764413|FG001|Overall Study|Physician Decision|7|||
48703662|NCT05567783|156764414|FG002|Overall Study|Physician Decision|9|||
48703663|NCT05567783|156764412|FG000|Overall Study|Study Terminated by Sponsor|924|||
48703664|NCT05567783|156764413|FG001|Overall Study|Study Terminated by Sponsor|937|||
48703665|NCT05567783|156764414|FG002|Overall Study|Study Terminated by Sponsor|941|||
48912409|NCT00310804|157516233|FG000|Overall Study|Withdrawal by Subject|3|||
49118668|NCT00572455|158273162|FG011|Stage II (28 Days)|Other|0|||
49118669|NCT00572455|158273163|FG012|Stage II (28 Days)|Other|0|||
49118670|NCT00572455|158273164|FG013|Stage II (28 Days)|Other|0|||
49118671|NCT00572455|158273151|FG000|Stage II (28 Days)|Randomized, but not treated|0|||
49118672|NCT00572455|158273152|FG001|Stage II (28 Days)|Randomized, but not treated|0|||
49118673|NCT00572455|158273153|FG002|Stage II (28 Days)|Randomized, but not treated|0|||
49118674|NCT00572455|158273154|FG003|Stage II (28 Days)|Randomized, but not treated|0|||
49118675|NCT00572455|158273155|FG004|Stage II (28 Days)|Randomized, but not treated|0|||
49118676|NCT00572455|158273156|FG005|Stage II (28 Days)|Randomized, but not treated|0|||
49118677|NCT00572455|158273157|FG006|Stage II (28 Days)|Randomized, but not treated|0|||
49118678|NCT00572455|158273158|FG007|Stage II (28 Days)|Randomized, but not treated|0|||
49118679|NCT00572455|158273159|FG008|Stage II (28 Days)|Randomized, but not treated|0|||
48703666|NCT05567783|156764412|FG000|Overall Study|Withdrawal by Subject|23|||
48703667|NCT05567783|156764413|FG001|Overall Study|Withdrawal by Subject|27|||
48703668|NCT05567783|156764414|FG002|Overall Study|Withdrawal by Subject|24|||
48703669|NCT05567783|156764412|FG000|Overall Study|Incarcerated|1|||
48703670|NCT05567783|156764413|FG001|Overall Study|Incarcerated|0|||
48703671|NCT05567783|156764414|FG002|Overall Study|Incarcerated|0|||
48703672|NCT05567783|156764412|FG000|Overall Study|Participant randomized in error|4|||
48703673|NCT05567783|156764413|FG001|Overall Study|Participant randomized in error|2|||
48703674|NCT05567783|156764414|FG002|Overall Study|Participant randomized in error|2|||
48703675|NCT02839200|156764421|FG000|Overall Study|Withdrawal by Subject|2|||
48912410|NCT00310804|157516234|FG001|Overall Study|Withdrawal by Subject|0|||
48912411|NCT00688155|157516240|FG000|Overall Study|Withdrawal by Subject|2|||
48912412|NCT00688155|157516241|FG001|Overall Study|Withdrawal by Subject|2|||
48912413|NCT00688155|157516242|FG002|Overall Study|Withdrawal by Subject|1|||
48912414|NCT00688155|157516243|FG003|Overall Study|Withdrawal by Subject|1|||
48912415|NCT04425720|157516244|FG000|Overall Study|Withdrawal by Subject|0|||
48912416|NCT04425720|157516245|FG001|Overall Study|Withdrawal by Subject|20|||
48912417|NCT00445224|157516246|FG000|Specific Exercises|Withdrawal by Subject|3|||
48912418|NCT00445224|157516247|FG001|Specific Exercises|Withdrawal by Subject|3|||
48912419|NCT00445224|157516246|FG000|Specific Exercises|Withdrawal by Subject|1|||
48912420|NCT00445224|157516247|FG001|Specific Exercises|Withdrawal by Subject|0|||
48912421|NCT02046096|157516249|FG000|Overall Study|Death|28|||
48912422|NCT02046096|157516250|FG001|Overall Study|Death|45|||
48912423|NCT02046096|157516249|FG000|Overall Study|Lost to Follow-up|9|||
48912424|NCT02046096|157516250|FG001|Overall Study|Lost to Follow-up|20|||
48912425|NCT02046096|157516249|FG000|Overall Study|Withdrawal by Subject|5|||
48912426|NCT02046096|157516250|FG001|Overall Study|Withdrawal by Subject|17|||
48912427|NCT02046096|157516249|FG000|Overall Study|Other endpoint|2|||
48912428|NCT02046096|157516250|FG001|Overall Study|Other endpoint|19|||
48912429|NCT03520959|157516251|FG000|Overall Study|Study terminated by Sponsor|0|||
48912430|NCT03520959|157516252|FG001|Overall Study|Study terminated by Sponsor|1|||
48912431|NCT02090413|157516253|FG000|Overall Study|Adverse Event|11|||
48912432|NCT02090413|157516254|FG001|Overall Study|Adverse Event|15|||
48912433|NCT02090413|157516255|FG002|Overall Study|Adverse Event|20|||
48912434|NCT02090413|157516253|FG000|Overall Study|Flushing event|2|||
48912435|NCT02090413|157516254|FG001|Overall Study|Flushing event|0|||
48912436|NCT02090413|157516255|FG002|Overall Study|Flushing event|1|||
48912437|NCT02090413|157516253|FG000|Overall Study|Withdrawal by Subject|2|||
48912438|NCT02090413|157516254|FG001|Overall Study|Withdrawal by Subject|2|||
48912439|NCT02090413|157516255|FG002|Overall Study|Withdrawal by Subject|2|||
48912440|NCT02090413|157516253|FG000|Overall Study|Investigator Decision|1|||
48912441|NCT02090413|157516254|FG001|Overall Study|Investigator Decision|1|||
48912442|NCT02090413|157516255|FG002|Overall Study|Investigator Decision|0|||
48912443|NCT02090413|157516253|FG000|Overall Study|Other|2|||
48912444|NCT02090413|157516254|FG001|Overall Study|Other|1|||
48912445|NCT02090413|157516255|FG002|Overall Study|Other|0|||
48912446|NCT02090413|157516253|FG000|Overall Study|Lost to Follow-up|1|||
48912447|NCT02090413|157516254|FG001|Overall Study|Lost to Follow-up|1|||
48912448|NCT02090413|157516255|FG002|Overall Study|Lost to Follow-up|0|||
48912449|NCT02321930|157516258|FG000|Overall Study|Lost to Follow-up|1|||
48912450|NCT01484977|157516261|FG000|Overall Study|Adverse Event|8|||
48912451|NCT01484977|157516261|FG000|Overall Study|Lack of Efficacy|4|||
49118680|NCT00572455|158273160|FG009|Stage II (28 Days)|Randomized, but not treated|0|||
48912452|NCT01484977|157516261|FG000|Overall Study|Protocol Violation|6|||
48912453|NCT01484977|157516261|FG000|Overall Study|Lost to Follow-up|1|||
48912454|NCT01484977|157516261|FG000|Overall Study|Withdrawal by Subject|4|||
48912455|NCT01484977|157516261|FG000|Overall Study|Subject Protocol Non-compliant|1|||
48912456|NCT01484977|157516261|FG000|Overall Study|Moving Overseas|1|||
48912457|NCT01484977|157516261|FG000|Overall Study|Low White Blood Cell Count|1|||
49118681|NCT00572455|158273161|FG010|Stage II (28 Days)|Randomized, but not treated|0|||
49118682|NCT00572455|158273162|FG011|Stage II (28 Days)|Randomized, but not treated|0|||
49118683|NCT00572455|158273163|FG012|Stage II (28 Days)|Randomized, but not treated|0|||
49118684|NCT00572455|158273164|FG013|Stage II (28 Days)|Randomized, but not treated|1|||
49118685|NCT02384538|158273165|FG000|Overall Study|Adverse Event|1|||
49118686|NCT02384538|158273166|FG001|Overall Study|Adverse Event|4|||
49118687|NCT02384538|158273165|FG000|Overall Study|Lack of Efficacy|4|||
49118688|NCT02384538|158273166|FG001|Overall Study|Lack of Efficacy|4|||
49118689|NCT02384538|158273165|FG000|Overall Study|Withdrew Consent|0|||
49118690|NCT02384538|158273166|FG001|Overall Study|Withdrew Consent|4|||
49118691|NCT02384538|158273165|FG000|Overall Study|Other|1|||
49118692|NCT02384538|158273166|FG001|Overall Study|Other|3|||
49118693|NCT02256917|158273169|FG000|Prophylactic Treatment Phase I|Lost to Follow-up|1|||
49118694|NCT02256917|158273169|FG000|Prophylactic Treatment Phase II|Lost to Follow-up|1|||
49118695|NCT02256917|158273169|FG000|Prophylactic Treatment Phase II|Withdrawn Consent|1|||
49118696|NCT02256917|158273169|FG000|Prophylactic Treatment Phase II|Did not attend completion visit|1|||
49118697|NCT02256917|158273169|FG000|Prophylactic Treatment Phase II|Discontinued medication|1|||
49118698|NCT04152083|158273170|FG000|Overall Study|Lost to Follow-up|2|||
49118699|NCT04152083|158273171|FG001|Overall Study|Lost to Follow-up|1|||
49118700|NCT04152083|158273170|FG000|Overall Study|Adverse Event|1|||
49118701|NCT04152083|158273171|FG001|Overall Study|Adverse Event|0|||
49118702|NCT04152083|158273170|FG000|Overall Study|Randomized but not treated|3|||
49118703|NCT04152083|158273171|FG001|Overall Study|Randomized but not treated|2|||
48912458|NCT01484977|157516261|FG000|Overall Study|Lack of Compliance|1|||
48912459|NCT00470054|157516264|FG000|Overall Study|Ineligible|1|||
49118704|NCT02095197|158273178|FG000|Overall Study|Lost to Follow-up|0|||
49118705|NCT02095197|158273179|FG001|Overall Study|Lost to Follow-up|3|||
49118706|NCT03076996|158273180|FG000|Overall Study|Withdrawal by Subject|2|||
49118707|NCT03076996|158273180|FG000|Overall Study|Lost to Follow-up|3|||
48912460|NCT00820950|157516265|FG000|Overall Study|Scheduling Conflict|0|||
48912461|NCT00820950|157516266|FG001|Overall Study|Scheduling Conflict|0|||
48912462|NCT00820950|157516267|FG002|Overall Study|Scheduling Conflict|0|||
48912463|NCT00820950|157516268|FG003|Overall Study|Scheduling Conflict|0|||
48912464|NCT00820950|157516269|FG004|Overall Study|Scheduling Conflict|0|||
48912465|NCT00820950|157516270|FG005|Overall Study|Scheduling Conflict|0|||
48912466|NCT00820950|157516271|FG006|Overall Study|Scheduling Conflict|1|||
48912467|NCT00820950|157516272|FG007|Overall Study|Scheduling Conflict|1|||
48912468|NCT00820950|157516273|FG008|Overall Study|Scheduling Conflict|0|||
48912469|NCT00820950|157516274|FG009|Overall Study|Scheduling Conflict|0|||
48912470|NCT00820950|157516265|FG000|Overall Study|Protocol Violation|1|||
48912471|NCT00820950|157516266|FG001|Overall Study|Protocol Violation|1|||
48912472|NCT00820950|157516267|FG002|Overall Study|Protocol Violation|0|||
48912473|NCT00820950|157516268|FG003|Overall Study|Protocol Violation|0|||
48912474|NCT00820950|157516269|FG004|Overall Study|Protocol Violation|0|||
48912475|NCT00820950|157516270|FG005|Overall Study|Protocol Violation|0|||
48912476|NCT00820950|157516271|FG006|Overall Study|Protocol Violation|0|||
48912477|NCT00820950|157516272|FG007|Overall Study|Protocol Violation|0|||
48912478|NCT00820950|157516273|FG008|Overall Study|Protocol Violation|0|||
48912479|NCT00820950|157516274|FG009|Overall Study|Protocol Violation|0|||
48912480|NCT01129921|157516275|FG000|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2|||
48912481|NCT01129921|157516276|FG001|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1|||
48912482|NCT01129921|157516275|FG000|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0|||
48912483|NCT01129921|157516276|FG001|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1|||
48912484|NCT01129921|157516275|FG000|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0|||
48912485|NCT01129921|157516276|FG001|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4|||
48912486|NCT01129921|157516275|FG000|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0|||
48912487|NCT01129921|157516276|FG001|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1|||
48912488|NCT01624259|157516277|FG000|Overall Study|Adverse Event|18|||
48912489|NCT01624259|157516278|FG001|Overall Study|Adverse Event|18|||
48912490|NCT01624259|157516277|FG000|Overall Study|Protocol Violation|1|||
48912491|NCT01624259|157516278|FG001|Overall Study|Protocol Violation|2|||
48912492|NCT01624259|157516277|FG000|Overall Study|Withdrawal by Subject|5|||
48912493|NCT01624259|157516278|FG001|Overall Study|Withdrawal by Subject|7|||
48912494|NCT01624259|157516277|FG000|Overall Study|Physician Decision|1|||
48912495|NCT01624259|157516278|FG001|Overall Study|Physician Decision|1|||
48912496|NCT01624259|157516277|FG000|Overall Study|Lost to Follow-up|2|||
48912497|NCT01624259|157516278|FG001|Overall Study|Lost to Follow-up|3|||
48912498|NCT01624259|157516277|FG000|Overall Study|Abnormal laboratory measure|3|||
48912499|NCT01624259|157516278|FG001|Overall Study|Abnormal laboratory measure|0|||
48912500|NCT00121108|157516284|FG000|Overall Study|Lost to Follow-up|10|||
48912501|NCT00121108|157516285|FG001|Overall Study|Lost to Follow-up|22|||
48912502|NCT00121108|157516284|FG000|Overall Study|Withdrawal by Subject|106|||
48912503|NCT00121108|157516285|FG001|Overall Study|Withdrawal by Subject|195|||
48912504|NCT00121108|157516284|FG000|Overall Study|Death|5|||
48912505|NCT00121108|157516285|FG001|Overall Study|Death|8|||
48912506|NCT00102960|157516289|FG000|Overall Study|Death|23|||
48912507|NCT00102960|157516290|FG001|Overall Study|Death|11|||
48912508|NCT00102960|157516291|FG002|Overall Study|Death|11|||
48912509|NCT00102960|157516289|FG000|Overall Study|Lost to Follow-up|6|||
48912510|NCT00102960|157516290|FG001|Overall Study|Lost to Follow-up|12|||
48912511|NCT00102960|157516291|FG002|Overall Study|Lost to Follow-up|16|||
48912512|NCT00102960|157516289|FG000|Overall Study|Withdrawal by Subject|1|||
48912513|NCT00102960|157516290|FG001|Overall Study|Withdrawal by Subject|0|||
48912514|NCT00102960|157516291|FG002|Overall Study|Withdrawal by Subject|1|||
48912515|NCT00823823|157517512|FG000|Overall Study|Lost to Follow-up|3|||
48912516|NCT00823823|157517513|FG001|Overall Study|Lost to Follow-up|1|||
48912517|NCT00823823|157517512|FG000|Overall Study|Protocol Violation|5|||
48912518|NCT00823823|157517513|FG001|Overall Study|Protocol Violation|5|||
48912519|NCT00424749|157517514|FG000|Overall Study|Withdrawal by Subject|1|||
48912520|NCT01732796|157517516|FG000|Overall Study|Adverse Event|16|||
48912521|NCT01732796|157517517|FG001|Overall Study|Adverse Event|16|||
48912522|NCT01732796|157517518|FG002|Overall Study|Adverse Event|4|||
48912523|NCT01732796|157517516|FG000|Overall Study|Lack of Efficacy|21|||
48912524|NCT01732796|157517517|FG001|Overall Study|Lack of Efficacy|18|||
48912525|NCT01732796|157517518|FG002|Overall Study|Lack of Efficacy|5|||
48912526|NCT01732796|157517516|FG000|Overall Study|Lost to Follow-up|2|||
48912527|NCT01732796|157517517|FG001|Overall Study|Lost to Follow-up|0|||
48912528|NCT01732796|157517518|FG002|Overall Study|Lost to Follow-up|0|||
48912529|NCT01732796|157517516|FG000|Overall Study|Withdrawal by Subject|6|||
48912530|NCT01732796|157517517|FG001|Overall Study|Withdrawal by Subject|8|||
48912531|NCT01732796|157517518|FG002|Overall Study|Withdrawal by Subject|2|||
48912532|NCT01732796|157517516|FG000|Overall Study|Other reason not defined above|1|||
48912533|NCT01732796|157517517|FG001|Overall Study|Other reason not defined above|0|||
48912534|NCT01732796|157517518|FG002|Overall Study|Other reason not defined above|2|||
48912535|NCT00766090|157517523|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48912536|NCT00766090|157517524|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48912537|NCT00766090|157517525|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48912538|NCT00766090|157517526|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48912539|NCT00766090|157517527|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48912540|NCT00766090|157517528|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48912541|NCT00766090|157517529|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48912542|NCT00766090|157517530|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48912543|NCT00766090|157517531|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
48912544|NCT00766090|157517532|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48912545|NCT00766090|157517533|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48912546|NCT00766090|157517534|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48912547|NCT00766090|157517523|FG000|Treatment Period 1 (28 Days)|Lack of Efficacy|2|||
48912548|NCT00766090|157517524|FG001|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
48912549|NCT00766090|157517525|FG002|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
48912550|NCT00766090|157517526|FG003|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
48912551|NCT00766090|157517527|FG004|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
48912552|NCT00766090|157517528|FG005|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
48912553|NCT00766090|157517529|FG006|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
48912554|NCT00766090|157517530|FG007|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
48912555|NCT00766090|157517531|FG008|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
48912556|NCT00766090|157517532|FG009|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
48703676|NCT02839200|156764422|FG001|Overall Study|Withdrawal by Subject|0|||
48703677|NCT02839200|156764423|FG002|Overall Study|Withdrawal by Subject|1|||
48703678|NCT02839200|156764424|FG003|Overall Study|Withdrawal by Subject|0|||
48703679|NCT02839200|156764425|FG004|Overall Study|Withdrawal by Subject|0|||
48703680|NCT02839200|156764426|FG005|Overall Study|Withdrawal by Subject|1|||
48703681|NCT02839200|156764421|FG000|Overall Study|Lost to Follow-up|2|||
48703682|NCT02839200|156764422|FG001|Overall Study|Lost to Follow-up|0|||
48703683|NCT02839200|156764423|FG002|Overall Study|Lost to Follow-up|0|||
48703684|NCT02839200|156764424|FG003|Overall Study|Lost to Follow-up|0|||
48703685|NCT02839200|156764425|FG004|Overall Study|Lost to Follow-up|1|||
48703686|NCT02839200|156764426|FG005|Overall Study|Lost to Follow-up|0|||
48703687|NCT02839200|156764421|FG000|Overall Study|Adverse Event|0|||
48703688|NCT02839200|156764422|FG001|Overall Study|Adverse Event|0|||
48703689|NCT02839200|156764423|FG002|Overall Study|Adverse Event|0|||
48703690|NCT02839200|156764424|FG003|Overall Study|Adverse Event|0|||
48703691|NCT02839200|156764425|FG004|Overall Study|Adverse Event|1|||
48703692|NCT02839200|156764426|FG005|Overall Study|Adverse Event|0|||
48703693|NCT02839200|156764421|FG000|Overall Study|Randomized in error|0|||
48703694|NCT02839200|156764422|FG001|Overall Study|Randomized in error|1|||
48912557|NCT00766090|157517533|FG010|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
48912558|NCT00766090|157517534|FG011|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
48912559|NCT00766090|157517523|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
48703695|NCT02839200|156764423|FG002|Overall Study|Randomized in error|0|||
48703696|NCT02839200|156764424|FG003|Overall Study|Randomized in error|0|||
48703697|NCT02839200|156764425|FG004|Overall Study|Randomized in error|0|||
48703698|NCT02839200|156764426|FG005|Overall Study|Randomized in error|0|||
48703699|NCT01958164|156764448|FG000|Overall Study|Adverse Event|0|||
48912560|NCT00766090|157517524|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
48703700|NCT01958164|156764449|FG001|Overall Study|Adverse Event|2|||
48703701|NCT01958164|156764448|FG000|Overall Study|Lost to Follow-up|2|||
48703702|NCT01958164|156764449|FG001|Overall Study|Lost to Follow-up|3|||
48703703|NCT01780974|156764450|FG000|Overall Study|Death|1|||
48703704|NCT01780974|156764451|FG001|Overall Study|Death|0|||
48703705|NCT01780974|156764450|FG000|Overall Study|Adverse Event|1|||
48703706|NCT01780974|156764451|FG001|Overall Study|Adverse Event|3|||
48703707|NCT00525161|156764454|FG000|Overall Study|Adverse Event|1|||
48703708|NCT00750438|156764456|FG000|Overall Study|Protocol Violation|4|||
48703709|NCT00750438|156764457|FG001|Overall Study|Protocol Violation|1|||
48703710|NCT00750438|156764456|FG000|Overall Study|Physician Decision|2|||
48703711|NCT00750438|156764457|FG001|Overall Study|Physician Decision|2|||
48703712|NCT00750438|156764456|FG000|Overall Study|Withdrawal by Subject|1|||
48703713|NCT00750438|156764457|FG001|Overall Study|Withdrawal by Subject|1|||
48703714|NCT01108185|156764461|FG000|Overall Study|Non-compliance|15|||
48703715|NCT01108185|156764461|FG000|Overall Study|Lost to Follow-up|12|||
48703716|NCT00759941|156764462|FG000|Overall Study|Use of medication|1|||
48703717|NCT00759941|156764463|FG001|Overall Study|Use of medication|0|||
48703718|NCT00759941|156764462|FG000|Overall Study|Adverse Event|1|||
48703719|NCT00759941|156764463|FG001|Overall Study|Adverse Event|0|||
48703720|NCT00759941|156764462|FG000|Overall Study|Exited in error by site|1|||
48703721|NCT00759941|156764463|FG001|Overall Study|Exited in error by site|1|||
48703722|NCT02749422|156764471|FG000|Overall Study|Lost to Follow-up|0|||
48703723|NCT02749422|156764472|FG001|Overall Study|Lost to Follow-up|2|||
48703724|NCT02749422|156764471|FG000|Overall Study|Ineligible|0|||
48703725|NCT02749422|156764472|FG001|Overall Study|Ineligible|1|||
48703726|NCT02855125|156764475|FG000|Overall Study|Withdrawal by Subject|2|||
48703727|NCT02855125|156764476|FG001|Overall Study|Withdrawal by Subject|2|||
48703728|NCT02855125|156764475|FG000|Overall Study|Clinical Disease Progression|5|||
48703729|NCT02855125|156764476|FG001|Overall Study|Clinical Disease Progression|4|||
48703730|NCT02855125|156764475|FG000|Overall Study|Radiologic Disease Progression|36|||
48703731|NCT02855125|156764476|FG001|Overall Study|Radiologic Disease Progression|39|||
48703732|NCT02855125|156764475|FG000|Overall Study|Adverse Event|11|||
48703733|NCT02855125|156764476|FG001|Overall Study|Adverse Event|7|||
48703734|NCT02855125|156764475|FG000|Overall Study|Physician Decision|1|||
48703735|NCT02855125|156764476|FG001|Overall Study|Physician Decision|0|||
48703736|NCT02855125|156764475|FG000|Overall Study|On Treatment|9|||
48703737|NCT02855125|156764476|FG001|Overall Study|On Treatment|11|||
48703738|NCT02855125|156764475|FG000|Overall Study|Randomized but not treated|0|||
48703739|NCT02855125|156764476|FG001|Overall Study|Randomized but not treated|1|||
48703740|NCT03414983|156765811|FG000|Pre-Treatment|Other reasons|1|||
48703741|NCT03414983|156765812|FG001|Pre-Treatment|Other reasons|0|||
48703742|NCT03414983|156765811|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
48703743|NCT03414983|156765812|FG001|Pre-Treatment|Participant no longer meets study criteria|3|||
48703744|NCT03414983|156765811|FG000|Pre-Treatment|Participant withdrew consent|1|||
48703745|NCT03414983|156765812|FG001|Pre-Treatment|Participant withdrew consent|3|||
48703746|NCT03414983|156765811|FG000|Treatment|Participant withdrew consent|4|||
48703747|NCT03414983|156765812|FG001|Treatment|Participant withdrew consent|3|||
48703748|NCT03414983|156765811|FG000|Treatment|Participant request to discontinue study treatment|8|||
48703749|NCT03414983|156765812|FG001|Treatment|Participant request to discontinue study treatment|10|||
48703750|NCT03414983|156765811|FG000|Treatment|Adverse Event Unrelated to Study Drug|5|||
48703751|NCT03414983|156765812|FG001|Treatment|Adverse Event Unrelated to Study Drug|2|||
48703752|NCT03414983|156765811|FG000|Treatment|Death|0|||
48703753|NCT03414983|156765812|FG001|Treatment|Death|1|||
48703754|NCT03414983|156765811|FG000|Treatment|Study Drug Toxicity|10|||
48703755|NCT03414983|156765812|FG001|Treatment|Study Drug Toxicity|5|||
48703756|NCT03414983|156765811|FG000|Treatment|Disease Progression|75|||
49118708|NCT03076996|158273180|FG000|Overall Study|Literacy precluded participation|1|||
48703757|NCT03414983|156765812|FG001|Treatment|Disease Progression|29|||
48703758|NCT03414983|156765811|FG000|Treatment|Not reported|1|||
48703759|NCT03414983|156765812|FG001|Treatment|Not reported|0|||
48703760|NCT03414983|156765811|FG000|Treatment|Other reasons|3|||
48703761|NCT03414983|156765812|FG001|Treatment|Other reasons|2|||
48703762|NCT03414983|156765811|FG000|Treatment|Poor/non-compliance|2|||
48703763|NCT03414983|156765812|FG001|Treatment|Poor/non-compliance|0|||
48703764|NCT03414983|156765811|FG000|Treatment|Maximum clinical benefit|5|||
48703765|NCT03414983|156765812|FG001|Treatment|Maximum clinical benefit|9|||
48703766|NCT03414983|156765811|FG000|Treatment|Lost to Follow-up|0|||
48703767|NCT03414983|156765812|FG001|Treatment|Lost to Follow-up|1|||
48703768|NCT03414983|156765811|FG000|Treatment|Administrative reasons by sponsor|1|||
48703769|NCT03414983|156765812|FG001|Treatment|Administrative reasons by sponsor|0|||
48703770|NCT00535496|156765833|FG000|Overall Study|Lost to Follow-up|0|||
48703771|NCT00535496|156765834|FG001|Overall Study|Lost to Follow-up|1|||
48703772|NCT00535496|156765835|FG002|Overall Study|Lost to Follow-up|0|||
48703773|NCT00535496|156765836|FG003|Overall Study|Lost to Follow-up|0|||
48703774|NCT00535496|156765833|FG000|Overall Study|Not treated with sugammadex|0|||
48703775|NCT00535496|156765834|FG001|Overall Study|Not treated with sugammadex|1|||
48703776|NCT00535496|156765835|FG002|Overall Study|Not treated with sugammadex|0|||
48703777|NCT00535496|156765836|FG003|Overall Study|Not treated with sugammadex|0|||
48703778|NCT01709084|156765838|FG000|Overall Study|Lost to Follow-up|4|||
48703779|NCT01709084|156765839|FG001|Overall Study|Lost to Follow-up|7|||
48703780|NCT01709084|156765838|FG000|Overall Study|Withdrawal by Subject|2|||
48703781|NCT01709084|156765839|FG001|Overall Study|Withdrawal by Subject|2|||
48912561|NCT00766090|157517525|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
48912562|NCT00766090|157517526|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
48912563|NCT00766090|157517527|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
48912564|NCT00766090|157517528|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
48912565|NCT00766090|157517529|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
48912566|NCT00766090|157517530|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
48912567|NCT00766090|157517531|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
48703782|NCT01709084|156765838|FG000|Overall Study|Adverse Event|5|||
48703783|NCT01709084|156765839|FG001|Overall Study|Adverse Event|0|||
48703784|NCT01709084|156765838|FG000|Overall Study|Other|5|||
48703785|NCT01709084|156765839|FG001|Overall Study|Other|3|||
48703786|NCT01709084|156765838|FG000|Overall Study|Participant Reached a Virologic Endpoint|0|||
48703787|NCT01709084|156765839|FG001|Overall Study|Participant Reached a Virologic Endpoint|1|||
48703788|NCT01709084|156765838|FG000|Overall Study|Not Treated|0|||
48703789|NCT01709084|156765839|FG001|Overall Study|Not Treated|2|||
48912568|NCT00766090|157517532|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
48912569|NCT00766090|157517533|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
48703790|NCT03337477|156765848|FG000|Overall Study|not categorized into the listed ones|11|||
48703791|NCT03337477|156765849|FG001|Overall Study|not categorized into the listed ones|9|||
48703792|NCT03337477|156765848|FG000|Overall Study|Withdrawal by Subject|0|||
48703793|NCT03337477|156765849|FG001|Overall Study|Withdrawal by Subject|1|||
48703794|NCT03337477|156765848|FG000|Overall Study|Death|0|||
48703795|NCT03337477|156765849|FG001|Overall Study|Death|1|||
48703796|NCT03337477|156765848|FG000|Overall Study|Lost to Follow-up|0|||
48912570|NCT00766090|157517534|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
48912571|NCT00766090|157517523|FG000|Washout Period 1 (14 Days)|Protocol Violation|0|||
48912572|NCT00766090|157517524|FG001|Washout Period 1 (14 Days)|Protocol Violation|0|||
49118709|NCT01831427|158273185|FG000|Overall Study|Adverse Event|0|||
49118710|NCT01831427|158273186|FG001|Overall Study|Adverse Event|1|||
49118711|NCT01831427|158273187|FG002|Overall Study|Adverse Event|0|||
49118712|NCT01831427|158273188|FG003|Overall Study|Adverse Event|0|||
49118713|NCT01831427|158273189|FG004|Overall Study|Adverse Event|0|||
49118714|NCT01831427|158273190|FG005|Overall Study|Adverse Event|1|||
49118715|NCT01831427|158273191|FG006|Overall Study|Adverse Event|0|||
49118716|NCT01831427|158273192|FG007|Overall Study|Adverse Event|1|||
49118717|NCT01831427|158273193|FG008|Overall Study|Adverse Event|0|||
49118718|NCT01831427|158273194|FG009|Overall Study|Adverse Event|0|||
49118719|NCT01831427|158273195|FG010|Overall Study|Adverse Event|2|||
49118720|NCT01831427|158273185|FG000|Overall Study|Investigator's Discretion|0|||
48703797|NCT03337477|156765849|FG001|Overall Study|Lost to Follow-up|2|||
48703798|NCT03181932|156765850|FG000|Period 1 (Double-blind Period)|Adverse Event|5|||
48703799|NCT03181932|156765851|FG001|Period 1 (Double-blind Period)|Adverse Event|1|||
48703800|NCT03181932|156765850|FG000|Period 1 (Double-blind Period)|Lost to Follow-up|0|||
48703801|NCT03181932|156765851|FG001|Period 1 (Double-blind Period)|Lost to Follow-up|1|||
48703802|NCT03181932|156765850|FG000|Period 1 (Double-blind Period)|Protocol Violation|1|||
48703803|NCT03181932|156765851|FG001|Period 1 (Double-blind Period)|Protocol Violation|2|||
48912573|NCT00766090|157517525|FG002|Washout Period 1 (14 Days)|Protocol Violation|1|||
48912574|NCT00766090|157517526|FG003|Washout Period 1 (14 Days)|Protocol Violation|0|||
48912575|NCT00766090|157517527|FG004|Washout Period 1 (14 Days)|Protocol Violation|0|||
48912576|NCT00766090|157517528|FG005|Washout Period 1 (14 Days)|Protocol Violation|0|||
48912577|NCT00766090|157517529|FG006|Washout Period 1 (14 Days)|Protocol Violation|0|||
48912578|NCT00766090|157517530|FG007|Washout Period 1 (14 Days)|Protocol Violation|0|||
48912579|NCT00766090|157517531|FG008|Washout Period 1 (14 Days)|Protocol Violation|0|||
48912580|NCT00766090|157517532|FG009|Washout Period 1 (14 Days)|Protocol Violation|0|||
48912581|NCT00766090|157517533|FG010|Washout Period 1 (14 Days)|Protocol Violation|0|||
48912582|NCT00766090|157517534|FG011|Washout Period 1 (14 Days)|Protocol Violation|0|||
48912583|NCT00766090|157517523|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
48912584|NCT00766090|157517524|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
48912585|NCT00766090|157517525|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
48912586|NCT00766090|157517526|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
48912587|NCT00766090|157517527|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|2|||
48912588|NCT00766090|157517528|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
48912589|NCT00766090|157517529|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
48912590|NCT00766090|157517530|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
48912591|NCT00766090|157517531|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
48912592|NCT00766090|157517532|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
48912593|NCT00766090|157517533|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
48703804|NCT03181932|156765850|FG000|Period 1 (Double-blind Period)|Withdrawal by Subject|5|||
48703805|NCT03181932|156765851|FG001|Period 1 (Double-blind Period)|Withdrawal by Subject|9|||
48703806|NCT03181932|156765850|FG000|Period 2 (Open-label Period)|Adverse Event|1|||
48703807|NCT03181932|156765851|FG001|Period 2 (Open-label Period)|Adverse Event|6|||
48703808|NCT03181932|156765850|FG000|Period 2 (Open-label Period)|Lost to Follow-up|0|||
48703809|NCT03181932|156765851|FG001|Period 2 (Open-label Period)|Lost to Follow-up|1|||
48703810|NCT03181932|156765850|FG000|Period 2 (Open-label Period)|Protocol Violation|3|||
48703811|NCT03181932|156765851|FG001|Period 2 (Open-label Period)|Protocol Violation|1|||
48703812|NCT03181932|156765850|FG000|Period 2 (Open-label Period)|Withdrawal by Subject|2|||
48703813|NCT03181932|156765851|FG001|Period 2 (Open-label Period)|Withdrawal by Subject|5|||
48703814|NCT03181932|156765850|FG000|Period 2 (Open-label Period)|Reason missing|2|||
48703815|NCT03181932|156765851|FG001|Period 2 (Open-label Period)|Reason missing|0|||
48703816|NCT00744497|156765852|FG000|Overall Study|Withdrawal by Subject|21|||
48703817|NCT00744497|156765853|FG001|Overall Study|Withdrawal by Subject|18|||
48703818|NCT00744497|156765852|FG000|Overall Study|Death|11|||
48703819|NCT00744497|156765853|FG001|Overall Study|Death|9|||
48703820|NCT00744497|156765852|FG000|Overall Study|Lost to Follow-up|4|||
48703821|NCT00744497|156765853|FG001|Overall Study|Lost to Follow-up|2|||
48703822|NCT00744497|156765852|FG000|Overall Study|Poor compliance/noncompliance|9|||
48703823|NCT00744497|156765853|FG001|Overall Study|Poor compliance/noncompliance|5|||
48703824|NCT00744497|156765852|FG000|Overall Study|No longer meets study criteria|7|||
48703825|NCT00744497|156765853|FG001|Overall Study|No longer meets study criteria|3|||
48703826|NCT00744497|156765852|FG000|Overall Study|Administrative Reason By Sponsor|25|||
48703827|NCT00744497|156765853|FG001|Overall Study|Administrative Reason By Sponsor|8|||
48703828|NCT00744497|156765852|FG000|Overall Study|Disease progression|312|||
48703829|NCT00744497|156765853|FG001|Overall Study|Disease progression|219|||
48703830|NCT00744497|156765852|FG000|Overall Study|Study drug toxicity|68|||
48703831|NCT00744497|156765853|FG001|Overall Study|Study drug toxicity|141|||
48703832|NCT00744497|156765852|FG000|Overall Study|Adverse event unrelated to study drug|78|||
48703833|NCT00744497|156765853|FG001|Overall Study|Adverse event unrelated to study drug|122|||
48703834|NCT00744497|156765852|FG000|Overall Study|Patient requested to stop study drug|65|||
48703835|NCT00744497|156765853|FG001|Overall Study|Patient requested to stop study drug|80|||
48703836|NCT00744497|156765852|FG000|Overall Study|Maximum clinical benefit|141|||
48703837|NCT00744497|156765853|FG001|Overall Study|Maximum clinical benefit|142|||
48703838|NCT00744497|156765852|FG000|Overall Study|Not defined|19|||
48703839|NCT00744497|156765853|FG001|Overall Study|Not defined|13|||
48703840|NCT02379728|156765859|FG000|Overall Study|Lost to Follow-up|1|||
48912594|NCT00766090|157517534|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
48912595|NCT00766090|157517523|FG000|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
48912596|NCT00766090|157517524|FG001|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
48912597|NCT00766090|157517525|FG002|Treatment Period 2 (28 Days)|Lack of Efficacy|1|||
48912598|NCT00766090|157517526|FG003|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
48912599|NCT00766090|157517527|FG004|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
48703841|NCT02379728|156765860|FG001|Overall Study|Lost to Follow-up|0|||
48703842|NCT02379728|156765861|FG002|Overall Study|Lost to Follow-up|3|||
48703843|NCT02379728|156765862|FG003|Overall Study|Lost to Follow-up|0|||
48703844|NCT02379728|156765859|FG000|Overall Study|Withdrawal by Subject|5|||
48703845|NCT02379728|156765860|FG001|Overall Study|Withdrawal by Subject|0|||
48703846|NCT02379728|156765861|FG002|Overall Study|Withdrawal by Subject|5|||
48703847|NCT02379728|156765862|FG003|Overall Study|Withdrawal by Subject|3|||
48703848|NCT02379728|156765859|FG000|Overall Study|Protocol Violation|0|||
48703849|NCT02379728|156765860|FG001|Overall Study|Protocol Violation|0|||
48703850|NCT02379728|156765861|FG002|Overall Study|Protocol Violation|2|||
48703851|NCT02379728|156765862|FG003|Overall Study|Protocol Violation|0|||
48703852|NCT00628108|156765863|FG000|Overall Study|Adverse Event|0|||
48703853|NCT00628108|156765864|FG001|Overall Study|Adverse Event|3|||
48703854|NCT00628108|156765863|FG000|Overall Study|Withdrawal by Subject|1|||
48703855|NCT00628108|156765864|FG001|Overall Study|Withdrawal by Subject|0|||
48703856|NCT00815659|156765867|FG000|Overall Study|Adverse Event|9|||
48703857|NCT00815659|156765867|FG000|Overall Study|Withdrawal by Subject|9|||
48703858|NCT00815659|156765867|FG000|Overall Study|Lost to Follow-up|4|||
48703859|NCT00815659|156765867|FG000|Overall Study|Protocol Violation|1|||
48703860|NCT00616759|156765868|FG000|Overall Study|Physician Decision|2|||
48703861|NCT00616759|156765869|FG001|Overall Study|Physician Decision|0|||
48703862|NCT00616759|156765868|FG000|Overall Study|Withdrawal by Subject|1|||
48703863|NCT00616759|156765869|FG001|Overall Study|Withdrawal by Subject|2|||
48703864|NCT01383356|156765870|FG000|Period 1|Adverse Event|5|||
48703865|NCT01383356|156765871|FG001|Period 1|Adverse Event|3|||
48703866|NCT01383356|156765870|FG000|Period 1|Non-compliance|3|||
48703867|NCT01383356|156765871|FG001|Period 1|Non-compliance|0|||
48703868|NCT01383356|156765870|FG000|Period 1|Out of Range Mid-study-Test|0|||
48703869|NCT01383356|156765871|FG001|Period 1|Out of Range Mid-study-Test|1|||
48703870|NCT01383356|156765870|FG000|Period 1|Personal|0|||
48703871|NCT01383356|156765871|FG001|Period 1|Personal|2|||
48703872|NCT02015637|156765876|FG000|Overall Study|Lost to Follow-up|3|||
48703873|NCT02015637|156765877|FG001|Overall Study|Lost to Follow-up|5|||
48703874|NCT02015637|156765876|FG000|Overall Study|Adverse Event|3|||
48703875|NCT02015637|156765877|FG001|Overall Study|Adverse Event|0|||
48703876|NCT02015637|156765876|FG000|Overall Study|Did not take study drug|2|||
48703877|NCT02015637|156765877|FG001|Overall Study|Did not take study drug|0|||
48703878|NCT03722238|156765878|FG000|Overall Study|Protocol Violation|1|||
48703879|NCT03722238|156765879|FG001|Overall Study|Protocol Violation|0|||
48703880|NCT03722238|156765878|FG000|Overall Study|Physician Decision|1|||
48703881|NCT03722238|156765879|FG001|Overall Study|Physician Decision|0|||
48703882|NCT03722238|156765878|FG000|Overall Study|Death|1|||
48703883|NCT03722238|156765879|FG001|Overall Study|Death|0|||
48703884|NCT03722238|156765878|FG000|Overall Study|Lost to Follow-up|6|||
48703885|NCT03722238|156765879|FG001|Overall Study|Lost to Follow-up|0|||
48703886|NCT03722238|156765878|FG000|Overall Study|Partial missing data|44|||
48703887|NCT03722238|156765879|FG001|Overall Study|Partial missing data|1|||
48703888|NCT03722238|156765878|FG000|Overall Study|Withdrawal by Subject|2|||
48703889|NCT03722238|156765879|FG001|Overall Study|Withdrawal by Subject|0|||
48703890|NCT03722238|156765878|FG000|Overall Study|Other|4|||
48703891|NCT03722238|156765879|FG001|Overall Study|Other|0|||
48703892|NCT03722238|156765878|FG000|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2|||
48703893|NCT03722238|156765879|FG001|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0|||
48703894|NCT03722238|156765878|FG000|Overall Study|Did not meet risk classification group criteria|90|||
48703895|NCT03722238|156765879|FG001|Overall Study|Did not meet risk classification group criteria|0|||
48703896|NCT03722238|156765878|FG000|Overall Study|Did not sign consent|17|||
48703897|NCT03722238|156765879|FG001|Overall Study|Did not sign consent|0|||
48703898|NCT03722238|156765878|FG000|Overall Study|Other eligibility criteria not met pre-consent|22|||
48703899|NCT03722238|156765879|FG001|Overall Study|Other eligibility criteria not met pre-consent|0|||
48703900|NCT03722238|156765878|FG000|Overall Study|Not willing to purchase study medication|142|||
48703901|NCT03722238|156765879|FG001|Overall Study|Not willing to purchase study medication|0|||
48703902|NCT03722238|156765878|FG000|Overall Study|Did not qualify at re-screening and medical conditions|133|||
48703903|NCT03722238|156765879|FG001|Overall Study|Did not qualify at re-screening and medical conditions|0|||
48703904|NCT04682366|156765886|FG000|Overall Study|Lost to Follow-up|1|||
48703905|NCT04682366|156765887|FG001|Overall Study|Lost to Follow-up|1|||
48703906|NCT01189032|156765890|FG000|Overall Study|Adverse Event|1|||
48703907|NCT01189032|156765891|FG001|Overall Study|Adverse Event|3|||
48703908|NCT01189032|156765892|FG002|Overall Study|Adverse Event|4|||
48703909|NCT01189032|156765890|FG000|Overall Study|Lack of Efficacy|2|||
48703910|NCT01189032|156765891|FG001|Overall Study|Lack of Efficacy|3|||
48703911|NCT01189032|156765892|FG002|Overall Study|Lack of Efficacy|0|||
48703912|NCT01189032|156765890|FG000|Overall Study|Withdrawal by Subject|1|||
48703913|NCT01189032|156765891|FG001|Overall Study|Withdrawal by Subject|0|||
48703914|NCT01189032|156765892|FG002|Overall Study|Withdrawal by Subject|1|||
48703915|NCT01189032|156765890|FG000|Overall Study|Protocol Violation|1|||
48703916|NCT01189032|156765891|FG001|Overall Study|Protocol Violation|1|||
48703917|NCT01189032|156765892|FG002|Overall Study|Protocol Violation|1|||
48703918|NCT00106704|156765893|FG000|Overall Study|Adverse Event|10|||
48703919|NCT00106704|156765894|FG001|Overall Study|Adverse Event|7|||
48703920|NCT00106704|156765893|FG000|Overall Study|Death|2|||
48703921|NCT00106704|156765894|FG001|Overall Study|Death|1|||
48703922|NCT00106704|156765893|FG000|Overall Study|Lack of Efficacy|67|||
48703923|NCT00106704|156765894|FG001|Overall Study|Lack of Efficacy|69|||
48703924|NCT00106704|156765893|FG000|Overall Study|Lost to Follow-up|7|||
48703925|NCT00106704|156765894|FG001|Overall Study|Lost to Follow-up|3|||
48703926|NCT00106704|156765893|FG000|Overall Study|Pregnancy|1|||
48703927|NCT00106704|156765894|FG001|Overall Study|Pregnancy|0|||
48703928|NCT00106704|156765893|FG000|Overall Study|Protocol Violation|4|||
48703929|NCT00106704|156765894|FG001|Overall Study|Protocol Violation|7|||
48703930|NCT00106704|156765893|FG000|Overall Study|Withdrawal by Subject|14|||
48703931|NCT00106704|156765894|FG001|Overall Study|Withdrawal by Subject|21|||
48703932|NCT00106704|156765893|FG000|Overall Study|Patient moved|1|||
48703933|NCT00106704|156765894|FG001|Overall Study|Patient moved|0|||
48703934|NCT00106704|156765893|FG000|Overall Study|Site terminated|0|||
48703935|NCT00106704|156765894|FG001|Overall Study|Site terminated|1|||
48703936|NCT00106704|156765893|FG000|Overall Study|Planned major surgery|1|||
48703937|NCT00106704|156765894|FG001|Overall Study|Planned major surgery|0|||
48703938|NCT00106704|156765893|FG000|Overall Study|Patient Received Glycemic Medication|22|||
48703939|NCT00106704|156765894|FG001|Overall Study|Patient Received Glycemic Medication|41|||
48703940|NCT00106704|156765893|FG000|Overall Study|Unable to re-enter US|1|||
48703941|NCT00106704|156765894|FG001|Overall Study|Unable to re-enter US|0|||
48703942|NCT00106704|156765893|FG000|Overall Study|Laboratory test|1|||
48703943|NCT00106704|156765894|FG001|Overall Study|Laboratory test|1|||
48703944|NCT01249261|156765895|FG000|Overall Study|Withdrawal by Subject|1|||
48703945|NCT01249261|156765896|FG001|Overall Study|Withdrawal by Subject|0|||
48703946|NCT01327482|156765897|FG000|Overall Study|Adverse Event|1|||
48703947|NCT00391586|156765900|FG000|Overall Study|Progressive disease|13|||
48703948|NCT00391586|156765900|FG000|Overall Study|Adverse Event|5|||
48703949|NCT00391586|156765900|FG000|Overall Study|Physician Decision|2|||
48703950|NCT00391586|156765900|FG000|Overall Study|Death|4|||
48703951|NCT00198822|156765901|FG000|Overall Study|Lost to Follow-up|14|||
48703952|NCT00198822|156765902|FG001|Overall Study|Lost to Follow-up|20|||
48703953|NCT00198822|156765903|FG002|Overall Study|Lost to Follow-up|21|||
48703954|NCT01658436|156765908|FG000|Overall Study|Adverse Event|6|||
48703955|NCT01658436|156765909|FG001|Overall Study|Adverse Event|5|||
48703956|NCT01658436|156765908|FG000|Overall Study|Physician Decision|1|||
48703957|NCT01658436|156765909|FG001|Overall Study|Physician Decision|0|||
48703958|NCT01658436|156765908|FG000|Overall Study|Progressive disease|12|||
48703959|NCT01658436|156765909|FG001|Overall Study|Progressive disease|4|||
48703960|NCT01658436|156765908|FG000|Overall Study|Study terminated by sponsor|0|||
48703961|NCT01658436|156765909|FG001|Overall Study|Study terminated by sponsor|1|||
48703962|NCT01658436|156765908|FG000|Overall Study|Subject/guardian decision|0|||
48703963|NCT01658436|156765909|FG001|Overall Study|Subject/guardian decision|1|||
48703964|NCT01658436|156765908|FG000|Overall Study|Death|1|||
48703965|NCT01658436|156765909|FG001|Overall Study|Death|0|||
48703966|NCT00686712|156765910|FG000|Overall Study|Protocol Violation|8|||
48703967|NCT00686712|156765911|FG001|Overall Study|Protocol Violation|8|||
48703968|NCT00686712|156765912|FG002|Overall Study|Protocol Violation|10|||
48703969|NCT00686712|156765910|FG000|Overall Study|Lost to Follow-up|1|||
48703970|NCT00686712|156765911|FG001|Overall Study|Lost to Follow-up|2|||
48703971|NCT00686712|156765912|FG002|Overall Study|Lost to Follow-up|3|||
48703972|NCT00686712|156765910|FG000|Overall Study|Adverse Event|1|||
48703973|NCT00686712|156765911|FG001|Overall Study|Adverse Event|1|||
48703974|NCT00686712|156765912|FG002|Overall Study|Adverse Event|0|||
48703975|NCT00949702|156765913|FG000|Overall Study|Death|40|||
48703976|NCT00949702|156765913|FG000|Overall Study|Disease progression|7|||
48912600|NCT00766090|157517528|FG005|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
48912601|NCT00766090|157517529|FG006|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
48912602|NCT00766090|157517530|FG007|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
48703977|NCT00949702|156765913|FG000|Overall Study|Withdrawal of consent|1|||
48703978|NCT04119414|156765914|FG000|Overall Study|300 couples did not have a male child, and 4 clinics were only observed|300|||
48703979|NCT02170077|156765920|FG000|Overall Study|Withdrawal by Subject|3|||
48703980|NCT02170077|156765921|FG001|Overall Study|Withdrawal by Subject|4|||
48703981|NCT02170077|156765922|FG002|Overall Study|Withdrawal by Subject|2|||
48703982|NCT02170077|156765920|FG000|Overall Study|Adverse Event|4|||
48703983|NCT02170077|156765921|FG001|Overall Study|Adverse Event|4|||
48703984|NCT02170077|156765922|FG002|Overall Study|Adverse Event|4|||
48703985|NCT02170077|156765920|FG000|Overall Study|Lost to Follow-up|0|||
48703986|NCT02170077|156765921|FG001|Overall Study|Lost to Follow-up|1|||
48703987|NCT02170077|156765922|FG002|Overall Study|Lost to Follow-up|0|||
48703988|NCT02170077|156765920|FG000|Overall Study|Exclusion criteria|2|||
48912603|NCT00766090|157517531|FG008|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
48912604|NCT00766090|157517532|FG009|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
48912605|NCT00766090|157517533|FG010|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
49010683|NCT00095199|157875672|FG002|Overall Study|Primary tumor removed in other surgery|0|||
48703989|NCT02170077|156765921|FG001|Overall Study|Exclusion criteria|2|||
48703990|NCT02170077|156765922|FG002|Overall Study|Exclusion criteria|5|||
48703991|NCT02170077|156765920|FG000|Overall Study|Exacerbation of seizures|0|||
48703992|NCT02170077|156765921|FG001|Overall Study|Exacerbation of seizures|2|||
48703993|NCT02170077|156765922|FG002|Overall Study|Exacerbation of seizures|1|||
48703994|NCT02963506|156765928|FG000|Double-Blind Period|Adverse Event|0|||
48703995|NCT02963506|156765929|FG001|Double-Blind Period|Adverse Event|0|||
48703996|NCT02963506|156765930|FG002|Double-Blind Period|Adverse Event|1|||
48703997|NCT02963506|156765931|FG003|Double-Blind Period|Adverse Event|0|||
48703998|NCT02963506|156765932|FG004|Double-Blind Period|Adverse Event|0|||
48703999|NCT02963506|156765933|FG005|Double-Blind Period|Adverse Event|0|||
48704000|NCT02963506|156765934|FG006|Double-Blind Period|Adverse Event|0|||
48704001|NCT02963506|156765935|FG007|Double-Blind Period|Adverse Event|0|||
48704002|NCT02963506|156765936|FG008|Double-Blind Period|Adverse Event|0|||
48704003|NCT02963506|156765937|FG009|Double-Blind Period|Adverse Event|0|||
48704004|NCT02963506|156765938|FG010|Double-Blind Period|Adverse Event|0|||
48704005|NCT02963506|156765939|FG011|Double-Blind Period|Adverse Event|0|||
48704006|NCT02963506|156765940|FG012|Double-Blind Period|Adverse Event|0|||
48704007|NCT02963506|156765928|FG000|Double-Blind Period|Death|0|||
48704008|NCT02963506|156765929|FG001|Double-Blind Period|Death|0|||
48704009|NCT02963506|156765930|FG002|Double-Blind Period|Death|0|||
48704010|NCT02963506|156765931|FG003|Double-Blind Period|Death|1|||
48704011|NCT02963506|156765932|FG004|Double-Blind Period|Death|0|||
48704012|NCT02963506|156765933|FG005|Double-Blind Period|Death|0|||
48704013|NCT02963506|156765934|FG006|Double-Blind Period|Death|0|||
48704014|NCT02963506|156765935|FG007|Double-Blind Period|Death|0|||
48704015|NCT02963506|156765936|FG008|Double-Blind Period|Death|0|||
48704016|NCT02963506|156765937|FG009|Double-Blind Period|Death|0|||
48704017|NCT02963506|156765938|FG010|Double-Blind Period|Death|0|||
48704018|NCT02963506|156765939|FG011|Double-Blind Period|Death|0|||
48704019|NCT02963506|156765940|FG012|Double-Blind Period|Death|0|||
48704020|NCT02963506|156765928|FG000|Double-Blind Period|Lost to Follow-up|0|||
48704021|NCT02963506|156765929|FG001|Double-Blind Period|Lost to Follow-up|1|||
48704022|NCT02963506|156765930|FG002|Double-Blind Period|Lost to Follow-up|0|||
48704023|NCT02963506|156765931|FG003|Double-Blind Period|Lost to Follow-up|0|||
48704024|NCT02963506|156765932|FG004|Double-Blind Period|Lost to Follow-up|0|||
48704025|NCT02963506|156765933|FG005|Double-Blind Period|Lost to Follow-up|0|||
48704026|NCT02963506|156765934|FG006|Double-Blind Period|Lost to Follow-up|0|||
48704027|NCT02963506|156765935|FG007|Double-Blind Period|Lost to Follow-up|0|||
48704028|NCT02963506|156765936|FG008|Double-Blind Period|Lost to Follow-up|0|||
48704029|NCT02963506|156765937|FG009|Double-Blind Period|Lost to Follow-up|0|||
48704030|NCT02963506|156765938|FG010|Double-Blind Period|Lost to Follow-up|0|||
48704031|NCT02963506|156765939|FG011|Double-Blind Period|Lost to Follow-up|0|||
48704032|NCT02963506|156765940|FG012|Double-Blind Period|Lost to Follow-up|0|||
48704033|NCT02963506|156765928|FG000|Double-Blind Period|Withdrawal by Subject|0|||
48704034|NCT02963506|156765929|FG001|Double-Blind Period|Withdrawal by Subject|0|||
48704035|NCT02963506|156765930|FG002|Double-Blind Period|Withdrawal by Subject|1|||
48704036|NCT02963506|156765931|FG003|Double-Blind Period|Withdrawal by Subject|1|||
48704037|NCT02963506|156765932|FG004|Double-Blind Period|Withdrawal by Subject|0|||
48704038|NCT02963506|156765933|FG005|Double-Blind Period|Withdrawal by Subject|0|||
48704039|NCT02963506|156765934|FG006|Double-Blind Period|Withdrawal by Subject|0|||
48704040|NCT02963506|156765935|FG007|Double-Blind Period|Withdrawal by Subject|0|||
48704041|NCT02963506|156765936|FG008|Double-Blind Period|Withdrawal by Subject|0|||
48704042|NCT02963506|156765937|FG009|Double-Blind Period|Withdrawal by Subject|0|||
48704043|NCT02963506|156765938|FG010|Double-Blind Period|Withdrawal by Subject|0|||
48704044|NCT02963506|156765939|FG011|Double-Blind Period|Withdrawal by Subject|0|||
48704045|NCT02963506|156765940|FG012|Double-Blind Period|Withdrawal by Subject|0|||
48704046|NCT02963506|156765928|FG000|Double-Blind Period|No compliance|0|||
48704047|NCT02963506|156765929|FG001|Double-Blind Period|No compliance|1|||
48704048|NCT02963506|156765930|FG002|Double-Blind Period|No compliance|0|||
48704049|NCT02963506|156765931|FG003|Double-Blind Period|No compliance|0|||
48704050|NCT02963506|156765932|FG004|Double-Blind Period|No compliance|0|||
48704051|NCT02963506|156765933|FG005|Double-Blind Period|No compliance|0|||
48704052|NCT02963506|156765934|FG006|Double-Blind Period|No compliance|0|||
48704053|NCT02963506|156765935|FG007|Double-Blind Period|No compliance|0|||
48704054|NCT02963506|156765936|FG008|Double-Blind Period|No compliance|0|||
48704055|NCT02963506|156765937|FG009|Double-Blind Period|No compliance|0|||
48912606|NCT00766090|157517534|FG011|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
48912607|NCT00766090|157517523|FG000|Washout Period 2 (14 Days)|Physician Decision|0|||
49118721|NCT01831427|158273186|FG001|Overall Study|Investigator's Discretion|0|||
49118722|NCT01831427|158273187|FG002|Overall Study|Investigator's Discretion|0|||
49118723|NCT01831427|158273188|FG003|Overall Study|Investigator's Discretion|1|||
49118724|NCT01831427|158273189|FG004|Overall Study|Investigator's Discretion|0|||
49118725|NCT01831427|158273190|FG005|Overall Study|Investigator's Discretion|0|||
48704056|NCT02963506|156765938|FG010|Double-Blind Period|No compliance|0|||
48704057|NCT02963506|156765939|FG011|Double-Blind Period|No compliance|0|||
48704058|NCT02963506|156765940|FG012|Double-Blind Period|No compliance|0|||
48704059|NCT02963506|156765928|FG000|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
48704060|NCT02963506|156765929|FG001|Double-Blind Period|Adverse event, non fatal after Wk12|1|||
48704061|NCT02963506|156765930|FG002|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
48704062|NCT02963506|156765931|FG003|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
48704063|NCT02963506|156765932|FG004|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
48704064|NCT02963506|156765933|FG005|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
48704065|NCT02963506|156765934|FG006|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
48704066|NCT02963506|156765935|FG007|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
48704067|NCT02963506|156765936|FG008|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
48704068|NCT02963506|156765937|FG009|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
48704069|NCT02963506|156765938|FG010|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
48704070|NCT02963506|156765939|FG011|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
48704071|NCT02963506|156765940|FG012|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
48704072|NCT02963506|156765928|FG000|Dose-Blind Period|Adverse Event|0|||
48704073|NCT02963506|156765929|FG001|Dose-Blind Period|Adverse Event|0|||
48704074|NCT02963506|156765930|FG002|Dose-Blind Period|Adverse Event|0|||
48704075|NCT02963506|156765931|FG003|Dose-Blind Period|Adverse Event|0|||
48704076|NCT02963506|156765932|FG004|Dose-Blind Period|Adverse Event|0|||
48704077|NCT02963506|156765933|FG005|Dose-Blind Period|Adverse Event|1|||
48704078|NCT02963506|156765934|FG006|Dose-Blind Period|Adverse Event|3|||
48704079|NCT02963506|156765935|FG007|Dose-Blind Period|Adverse Event|2|||
48704080|NCT02963506|156765936|FG008|Dose-Blind Period|Adverse Event|2|||
48704081|NCT02963506|156765937|FG009|Dose-Blind Period|Adverse Event|2|||
48704082|NCT02963506|156765938|FG010|Dose-Blind Period|Adverse Event|1|||
48704083|NCT02963506|156765939|FG011|Dose-Blind Period|Adverse Event|1|||
48704084|NCT02963506|156765940|FG012|Dose-Blind Period|Adverse Event|6|||
48704085|NCT02963506|156765928|FG000|Dose-Blind Period|Lack of Efficacy|0|||
48704086|NCT02963506|156765929|FG001|Dose-Blind Period|Lack of Efficacy|0|||
48704087|NCT02963506|156765930|FG002|Dose-Blind Period|Lack of Efficacy|0|||
48704088|NCT02963506|156765931|FG003|Dose-Blind Period|Lack of Efficacy|0|||
48704089|NCT02963506|156765932|FG004|Dose-Blind Period|Lack of Efficacy|0|||
48704090|NCT02963506|156765933|FG005|Dose-Blind Period|Lack of Efficacy|0|||
48704091|NCT02963506|156765934|FG006|Dose-Blind Period|Lack of Efficacy|0|||
49118726|NCT01831427|158273191|FG006|Overall Study|Investigator's Discretion|0|||
49118727|NCT01831427|158273192|FG007|Overall Study|Investigator's Discretion|0|||
48704092|NCT02963506|156765935|FG007|Dose-Blind Period|Lack of Efficacy|1|||
48704093|NCT02963506|156765936|FG008|Dose-Blind Period|Lack of Efficacy|0|||
48704094|NCT02963506|156765937|FG009|Dose-Blind Period|Lack of Efficacy|1|||
48704095|NCT02963506|156765938|FG010|Dose-Blind Period|Lack of Efficacy|0|||
48704096|NCT02963506|156765939|FG011|Dose-Blind Period|Lack of Efficacy|0|||
48704097|NCT02963506|156765940|FG012|Dose-Blind Period|Lack of Efficacy|0|||
48704098|NCT02963506|156765928|FG000|Dose-Blind Period|Lost to Follow-up|0|||
48704099|NCT02963506|156765929|FG001|Dose-Blind Period|Lost to Follow-up|0|||
48704100|NCT02963506|156765930|FG002|Dose-Blind Period|Lost to Follow-up|0|||
48704101|NCT02963506|156765931|FG003|Dose-Blind Period|Lost to Follow-up|0|||
48704102|NCT02963506|156765932|FG004|Dose-Blind Period|Lost to Follow-up|0|||
48704103|NCT02963506|156765933|FG005|Dose-Blind Period|Lost to Follow-up|1|||
48704104|NCT02963506|156765934|FG006|Dose-Blind Period|Lost to Follow-up|0|||
48704105|NCT02963506|156765935|FG007|Dose-Blind Period|Lost to Follow-up|0|||
48704106|NCT02963506|156765936|FG008|Dose-Blind Period|Lost to Follow-up|1|||
48704107|NCT02963506|156765937|FG009|Dose-Blind Period|Lost to Follow-up|0|||
48704108|NCT02963506|156765938|FG010|Dose-Blind Period|Lost to Follow-up|0|||
48704109|NCT02963506|156765939|FG011|Dose-Blind Period|Lost to Follow-up|1|||
48704110|NCT02963506|156765940|FG012|Dose-Blind Period|Lost to Follow-up|0|||
48704111|NCT02963506|156765928|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
48704112|NCT02963506|156765929|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
48704113|NCT02963506|156765930|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
48704114|NCT02963506|156765931|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
48704115|NCT02963506|156765932|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
48704116|NCT02963506|156765933|FG005|Dose-Blind Period|Withdrawal by Subject|1|||
48704117|NCT02963506|156765934|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
48704118|NCT02963506|156765935|FG007|Dose-Blind Period|Withdrawal by Subject|2|||
48704119|NCT02963506|156765936|FG008|Dose-Blind Period|Withdrawal by Subject|0|||
48704120|NCT02963506|156765937|FG009|Dose-Blind Period|Withdrawal by Subject|1|||
48704121|NCT02963506|156765938|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
48704122|NCT02963506|156765939|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
48704123|NCT02963506|156765940|FG012|Dose-Blind Period|Withdrawal by Subject|0|||
48704124|NCT02963506|156765928|FG000|Dose-Blind Period|Sponsor decision|0|||
48704125|NCT02963506|156765929|FG001|Dose-Blind Period|Sponsor decision|0|||
48704126|NCT02963506|156765930|FG002|Dose-Blind Period|Sponsor decision|0|||
48704127|NCT02963506|156765931|FG003|Dose-Blind Period|Sponsor decision|0|||
48704128|NCT02963506|156765932|FG004|Dose-Blind Period|Sponsor decision|0|||
48704129|NCT02963506|156765933|FG005|Dose-Blind Period|Sponsor decision|1|||
48704130|NCT02963506|156765934|FG006|Dose-Blind Period|Sponsor decision|0|||
48704131|NCT02963506|156765935|FG007|Dose-Blind Period|Sponsor decision|0|||
48704132|NCT02963506|156765936|FG008|Dose-Blind Period|Sponsor decision|0|||
48704133|NCT02963506|156765937|FG009|Dose-Blind Period|Sponsor decision|0|||
48704134|NCT02963506|156765938|FG010|Dose-Blind Period|Sponsor decision|0|||
48704135|NCT02963506|156765939|FG011|Dose-Blind Period|Sponsor decision|0|||
48704136|NCT02963506|156765940|FG012|Dose-Blind Period|Sponsor decision|0|||
48704137|NCT02963506|156765928|FG000|Dose-Blind Period|Meeting exclusion criteria 9|0|||
48704138|NCT02963506|156765929|FG001|Dose-Blind Period|Meeting exclusion criteria 9|0|||
48704139|NCT02963506|156765930|FG002|Dose-Blind Period|Meeting exclusion criteria 9|0|||
48704140|NCT02963506|156765931|FG003|Dose-Blind Period|Meeting exclusion criteria 9|0|||
48704141|NCT02963506|156765932|FG004|Dose-Blind Period|Meeting exclusion criteria 9|0|||
48704142|NCT02963506|156765933|FG005|Dose-Blind Period|Meeting exclusion criteria 9|0|||
48704143|NCT02963506|156765934|FG006|Dose-Blind Period|Meeting exclusion criteria 9|0|||
48704144|NCT02963506|156765935|FG007|Dose-Blind Period|Meeting exclusion criteria 9|0|||
48704145|NCT02963506|156765936|FG008|Dose-Blind Period|Meeting exclusion criteria 9|0|||
48704146|NCT02963506|156765937|FG009|Dose-Blind Period|Meeting exclusion criteria 9|0|||
48704147|NCT02963506|156765938|FG010|Dose-Blind Period|Meeting exclusion criteria 9|0|||
48704148|NCT02963506|156765939|FG011|Dose-Blind Period|Meeting exclusion criteria 9|0|||
48704149|NCT02963506|156765940|FG012|Dose-Blind Period|Meeting exclusion criteria 9|1|||
48704150|NCT02129699|156765941|FG000|Overall Study|Did not start treatment|3|||
48704151|NCT02129699|156765942|FG001|Overall Study|Did not start treatment|2|||
48704152|NCT01076361|156765943|FG000|Overall Study|22 leads were excluded from analysis|21|||
48704153|NCT00928408|156765944|FG000|Overall Study|Other|2|||
48704154|NCT00928408|156765944|FG000|Overall Study|Withdrawal by Subject|4|||
48704155|NCT00928408|156765944|FG000|Overall Study|Death|5|||
48704156|NCT00928408|156765944|FG000|Overall Study|Lost to Follow-up|12|||
48704157|NCT04393454|156765945|FG000|Overall Study|Death|1|||
48704158|NCT04393454|156765945|FG000|Overall Study|Lost to Follow-up|1|||
48704159|NCT00472030|156765946|FG000|Overall Study|Physician Decision|1|||
48704160|NCT00472030|156765947|FG001|Overall Study|Physician Decision|0|||
48704161|NCT00256997|156765948|FG000|Overall Study|Protocol Violation|1|||
48704162|NCT00256997|156765949|FG001|Overall Study|Protocol Violation|4|||
48704163|NCT00256997|156765948|FG000|Overall Study|Lack of Efficacy|1|||
48704164|NCT00256997|156765949|FG001|Overall Study|Lack of Efficacy|4|||
48704165|NCT00256997|156765948|FG000|Overall Study|Death|2|||
48704166|NCT00256997|156765949|FG001|Overall Study|Death|0|||
48704167|NCT00256997|156765948|FG000|Overall Study|Adverse Event|4|||
48704168|NCT00256997|156765949|FG001|Overall Study|Adverse Event|0|||
48704169|NCT00256997|156765948|FG000|Overall Study|Lost to Follow-up|3|||
48704170|NCT00256997|156765949|FG001|Overall Study|Lost to Follow-up|5|||
48704171|NCT00256997|156765948|FG000|Overall Study|Withdrawal by Subject|13|||
48704172|NCT00256997|156765949|FG001|Overall Study|Withdrawal by Subject|3|||
48704173|NCT00256997|156765948|FG000|Overall Study|Started but not treated|2|||
48704174|NCT00256997|156765949|FG001|Overall Study|Started but not treated|0|||
48704175|NCT00256997|156765948|FG000|Overall Study|Other|5|||
48704176|NCT00256997|156765949|FG001|Overall Study|Other|8|||
48704177|NCT00256997|156765948|FG000|Overall Study|End of Study (As Per Sponsor)|12|||
48704178|NCT00256997|156765949|FG001|Overall Study|End of Study (As Per Sponsor)|24|||
48704179|NCT00256997|156765948|FG000|Overall Study|Participant Non-compliant|3|||
48704180|NCT00256997|156765949|FG001|Overall Study|Participant Non-compliant|6|||
48704181|NCT00256997|156765948|FG000|Overall Study|Investigator Withdrew Participant|2|||
48704182|NCT00256997|156765949|FG001|Overall Study|Investigator Withdrew Participant|1|||
48704183|NCT01868997|156765950|FG000|Overall Study|Adverse Event|2|||
48704184|NCT01868997|156765951|FG001|Overall Study|Adverse Event|5|||
48704185|NCT01868997|156765950|FG000|Overall Study|Lack of Efficacy|2|||
48704186|NCT01868997|156765951|FG001|Overall Study|Lack of Efficacy|0|||
48704187|NCT01868997|156765950|FG000|Overall Study|Other|3|||
48704188|NCT01868997|156765951|FG001|Overall Study|Other|1|||
48704189|NCT00494676|156765952|FG000|Allocation|Withdrawal by Subject|2|||
48704190|NCT00494676|156765953|FG001|Allocation|Withdrawal by Subject|4|||
48704191|NCT00494676|156765952|FG000|First Intervention|Withdrawal by Subject|1|||
48704192|NCT00494676|156765953|FG001|First Intervention|Withdrawal by Subject|3|||
48704193|NCT00494676|156765952|FG000|Second Intervention|Withdrawal by Subject|1|||
48704194|NCT00494676|156765953|FG001|Second Intervention|Withdrawal by Subject|1|||
48704195|NCT02392624|156767222|FG000|Overall Study|Withdrawal by Subject|15|||
48704196|NCT02392624|156767223|FG001|Overall Study|Withdrawal by Subject|12|||
48704197|NCT02392624|156767224|FG002|Overall Study|Withdrawal by Subject|9|||
48704198|NCT02392624|156767222|FG000|Overall Study|Adverse Event|4|||
48704199|NCT02392624|156767223|FG001|Overall Study|Adverse Event|1|||
48704200|NCT02392624|156767224|FG002|Overall Study|Adverse Event|2|||
48704201|NCT02392624|156767222|FG000|Overall Study|Pregnancy|1|||
48704202|NCT02392624|156767223|FG001|Overall Study|Pregnancy|0|||
48704203|NCT02392624|156767224|FG002|Overall Study|Pregnancy|0|||
48704204|NCT02392624|156767222|FG000|Overall Study|Protocol Violation|0|||
48704205|NCT02392624|156767223|FG001|Overall Study|Protocol Violation|0|||
48704206|NCT02392624|156767224|FG002|Overall Study|Protocol Violation|1|||
48704207|NCT02392624|156767222|FG000|Overall Study|Sponsor/Investigator Decision|2|||
48704208|NCT02392624|156767223|FG001|Overall Study|Sponsor/Investigator Decision|1|||
48704209|NCT02392624|156767224|FG002|Overall Study|Sponsor/Investigator Decision|0|||
48704210|NCT02392624|156767222|FG000|Overall Study|Other|49|||
48704211|NCT02392624|156767223|FG001|Overall Study|Other|1|||
48704212|NCT02392624|156767224|FG002|Overall Study|Other|1|||
48704213|NCT00936715|156767225|FG000|Overall Study|Investigators Discretion|1|||
48704214|NCT00936715|156767225|FG000|Overall Study|Protocol Violation|1|||
48704215|NCT00936715|156767225|FG000|Overall Study|Safety or Tolerability Reasons|4|||
48704216|NCT00753506|156767226|FG000|Overall Study|Withdrawal by Subject|4|||
48704217|NCT00753506|156767227|FG001|Overall Study|Withdrawal by Subject|1|||
48704218|NCT00753506|156767226|FG000|Overall Study|Lost to Follow-up|2|||
48704219|NCT00753506|156767227|FG001|Overall Study|Lost to Follow-up|0|||
48704220|NCT00753506|156767226|FG000|Overall Study|Other reason|1|||
48704221|NCT00753506|156767227|FG001|Overall Study|Other reason|1|||
48704222|NCT01193244|156767232|FG000|Overall Study|Withdrawal by Subject|79|||
48704223|NCT01193244|156767233|FG001|Overall Study|Withdrawal by Subject|97|||
48704224|NCT01193244|156767232|FG000|Overall Study|Other|303|||
48704225|NCT01193244|156767233|FG001|Overall Study|Other|278|||
48704226|NCT01193244|156767232|FG000|Overall Study|Lost to Follow-up|6|||
48704227|NCT01193244|156767233|FG001|Overall Study|Lost to Follow-up|15|||
48704228|NCT01337960|156767234|FG000|Overall Study|Lost to Follow-up|1|||
48704229|NCT01337960|156767235|FG001|Overall Study|Lost to Follow-up|0|||
48704230|NCT01337960|156767236|FG002|Overall Study|Lost to Follow-up|0|||
48704231|NCT01337960|156767234|FG000|Overall Study|Withdrawal by Subject|1|||
48704232|NCT01337960|156767235|FG001|Overall Study|Withdrawal by Subject|0|||
48704233|NCT01337960|156767236|FG002|Overall Study|Withdrawal by Subject|0|||
48704234|NCT03877510|156767237|FG000|Overall Study|Death|6|||
48704235|NCT03877510|156767237|FG000|Overall Study|Lost to Follow-up|2|||
48704236|NCT03877510|156767237|FG000|Overall Study|Non-compliance with study drug|2|||
48704237|NCT03877510|156767237|FG000|Overall Study|Lack of Efficacy|14|||
48704238|NCT03877510|156767237|FG000|Overall Study|Adverse Event|20|||
48704239|NCT03877510|156767237|FG000|Overall Study|Withdrawal by Subject|22|||
48704240|NCT03877510|156767237|FG000|Overall Study|Miscellaneous|1|||
48704241|NCT00716417|156767240|FG000|Overall Study|Adverse Event|0|||
48704242|NCT00716417|156767241|FG001|Overall Study|Adverse Event|0|||
48704243|NCT00716417|156767242|FG002|Overall Study|Adverse Event|2|||
48704244|NCT00716417|156767243|FG003|Overall Study|Adverse Event|1|||
48704245|NCT00716417|156767244|FG004|Overall Study|Adverse Event|0|||
48704246|NCT00716417|156767245|FG005|Overall Study|Adverse Event|0|||
48704247|NCT00716417|156767246|FG006|Overall Study|Adverse Event|3|||
48704248|NCT00716417|156767247|FG007|Overall Study|Adverse Event|1|||
48704249|NCT00716417|156767248|FG008|Overall Study|Adverse Event|0|||
48704250|NCT00716417|156767249|FG009|Overall Study|Adverse Event|3|||
48704251|NCT00716417|156767240|FG000|Overall Study|Withdrawal by Subject|0|||
48704252|NCT00716417|156767241|FG001|Overall Study|Withdrawal by Subject|1|||
48704253|NCT00716417|156767242|FG002|Overall Study|Withdrawal by Subject|0|||
48704254|NCT00716417|156767243|FG003|Overall Study|Withdrawal by Subject|2|||
48704255|NCT00716417|156767244|FG004|Overall Study|Withdrawal by Subject|0|||
48704256|NCT00716417|156767245|FG005|Overall Study|Withdrawal by Subject|0|||
48912608|NCT00766090|157517524|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
48912609|NCT00766090|157517525|FG002|Washout Period 2 (14 Days)|Physician Decision|1|||
48704257|NCT00716417|156767246|FG006|Overall Study|Withdrawal by Subject|1|||
48704258|NCT00716417|156767247|FG007|Overall Study|Withdrawal by Subject|0|||
48704259|NCT00716417|156767248|FG008|Overall Study|Withdrawal by Subject|0|||
48704260|NCT00716417|156767249|FG009|Overall Study|Withdrawal by Subject|0|||
48704261|NCT00716417|156767240|FG000|Overall Study|Progressive disease|3|||
48704262|NCT00716417|156767241|FG001|Overall Study|Progressive disease|5|||
48704263|NCT00716417|156767242|FG002|Overall Study|Progressive disease|3|||
48704264|NCT00716417|156767243|FG003|Overall Study|Progressive disease|8|||
48704265|NCT00716417|156767244|FG004|Overall Study|Progressive disease|0|||
48912610|NCT00766090|157517526|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
49118728|NCT01831427|158273193|FG008|Overall Study|Investigator's Discretion|0|||
48704266|NCT00716417|156767245|FG005|Overall Study|Progressive disease|3|||
48704267|NCT00716417|156767246|FG006|Overall Study|Progressive disease|3|||
48704268|NCT00716417|156767247|FG007|Overall Study|Progressive disease|1|||
48704269|NCT00716417|156767248|FG008|Overall Study|Progressive disease|5|||
48704270|NCT00716417|156767249|FG009|Overall Study|Progressive disease|0|||
48704271|NCT00716417|156767240|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
48704272|NCT00716417|156767241|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
48704273|NCT00716417|156767242|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
48704274|NCT00716417|156767243|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
48704275|NCT00716417|156767244|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
49118729|NCT01831427|158273194|FG009|Overall Study|Investigator's Discretion|0|||
48704276|NCT00716417|156767245|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
49118730|NCT01831427|158273195|FG010|Overall Study|Investigator's Discretion|0|||
49118731|NCT01831427|158273185|FG000|Overall Study|Withdrew Consent|0|||
49118732|NCT01831427|158273186|FG001|Overall Study|Withdrew Consent|0|||
48704277|NCT00716417|156767246|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
48704278|NCT00716417|156767247|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
48704279|NCT00716417|156767248|FG008|Overall Study|Dose limiting toxicity (DLT)|0|||
48704280|NCT00716417|156767249|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
48704281|NCT00716417|156767240|FG000|Overall Study|On patient request due to toxicities|0|||
48704282|NCT00716417|156767241|FG001|Overall Study|On patient request due to toxicities|0|||
48704283|NCT00716417|156767242|FG002|Overall Study|On patient request due to toxicities|0|||
48704284|NCT00716417|156767243|FG003|Overall Study|On patient request due to toxicities|0|||
48704285|NCT00716417|156767244|FG004|Overall Study|On patient request due to toxicities|0|||
48704286|NCT00716417|156767245|FG005|Overall Study|On patient request due to toxicities|0|||
48704287|NCT00716417|156767246|FG006|Overall Study|On patient request due to toxicities|0|||
48704288|NCT00716417|156767247|FG007|Overall Study|On patient request due to toxicities|1|||
48704289|NCT00716417|156767248|FG008|Overall Study|On patient request due to toxicities|0|||
48704290|NCT00716417|156767249|FG009|Overall Study|On patient request due to toxicities|0|||
48704291|NCT00118417|156767252|FG000|Phase I (Weeks 0 to 6)|Remission|8|||
48704292|NCT00118417|156767253|FG001|Phase I (Weeks 0 to 6)|Remission|0|||
48704293|NCT00118417|156767252|FG000|Phase I (Weeks 0 to 6)|Lost to Follow-up|6|||
48704294|NCT00118417|156767253|FG001|Phase I (Weeks 0 to 6)|Lost to Follow-up|0|||
48704295|NCT00118417|156767252|FG000|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4|||
48704296|NCT00118417|156767253|FG001|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0|||
48704297|NCT00118417|156767252|FG000|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
48704298|NCT00118417|156767253|FG001|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
48704299|NCT00118417|156767252|FG000|Phase II (Weeks 6 to 12)|Remission|1|||
48704300|NCT00118417|156767253|FG001|Phase II (Weeks 6 to 12)|Remission|2|||
48704301|NCT00785785|156767254|FG000|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3|||
48704302|NCT00785785|156767255|FG001|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4|||
48704303|NCT00785785|156767254|FG000|Core Phase up to 36 Months|Adverse Event|31|||
48704304|NCT00785785|156767255|FG001|Core Phase up to 36 Months|Adverse Event|21|||
48704305|NCT00785785|156767254|FG000|Core Phase up to 36 Months|Abnormal laboratory value|1|||
48704306|NCT00785785|156767255|FG001|Core Phase up to 36 Months|Abnormal laboratory value|0|||
48704307|NCT00785785|156767254|FG000|Core Phase up to 36 Months|Abnormal test procedure result|2|||
48704308|NCT00785785|156767255|FG001|Core Phase up to 36 Months|Abnormal test procedure result|2|||
48704309|NCT00785785|156767254|FG000|Core Phase up to 36 Months|Withdrawal by Subject|16|||
48704310|NCT00785785|156767255|FG001|Core Phase up to 36 Months|Withdrawal by Subject|17|||
48704311|NCT00785785|156767254|FG000|Core Phase up to 36 Months|Lost to Follow-up|3|||
48704312|NCT00785785|156767255|FG001|Core Phase up to 36 Months|Lost to Follow-up|7|||
48704313|NCT00785785|156767254|FG000|Core Phase up to 36 Months|Administrative problems|3|||
48704314|NCT00785785|156767255|FG001|Core Phase up to 36 Months|Administrative problems|3|||
48704315|NCT00785785|156767254|FG000|Core Phase up to 36 Months|Death|5|||
48704316|NCT00785785|156767255|FG001|Core Phase up to 36 Months|Death|8|||
48704317|NCT00785785|156767254|FG000|Core Phase up to 36 Months|Disease progression|139|||
48704318|NCT00785785|156767255|FG001|Core Phase up to 36 Months|Disease progression|119|||
48704319|NCT00785785|156767254|FG000|Core Phase up to 36 Months|Protocol deviation|5|||
48704320|NCT00785785|156767255|FG001|Core Phase up to 36 Months|Protocol deviation|6|||
48704321|NCT00785785|156767254|FG000|Core Phase up to 36 Months|Study terminated by sponsor|116|||
48704322|NCT00785785|156767255|FG001|Core Phase up to 36 Months|Study terminated by sponsor|133|||
48704323|NCT00785785|156767254|FG000|Optional Extension Phase|Adverse Event|4|||
48704324|NCT00785785|156767255|FG001|Optional Extension Phase|Adverse Event|5|||
48704325|NCT00785785|156767254|FG000|Optional Extension Phase|Withdrawal by Subject|6|||
48704326|NCT00785785|156767255|FG001|Optional Extension Phase|Withdrawal by Subject|6|||
48704327|NCT00785785|156767254|FG000|Optional Extension Phase|Lost to Follow-up|1|||
48704328|NCT00785785|156767255|FG001|Optional Extension Phase|Lost to Follow-up|0|||
48704329|NCT00785785|156767254|FG000|Optional Extension Phase|Administrative problems|2|||
48704330|NCT00785785|156767255|FG001|Optional Extension Phase|Administrative problems|0|||
48704331|NCT00785785|156767254|FG000|Optional Extension Phase|Death|1|||
48704332|NCT00785785|156767255|FG001|Optional Extension Phase|Death|5|||
48704333|NCT00785785|156767254|FG000|Optional Extension Phase|Disease progression|22|||
48704334|NCT00785785|156767255|FG001|Optional Extension Phase|Disease progression|70|||
48704335|NCT00785785|156767254|FG000|Optional Extension Phase|Protocol deviation|0|||
48704336|NCT00785785|156767255|FG001|Optional Extension Phase|Protocol deviation|2|||
48704337|NCT00785785|156767254|FG000|Optional Extension Phase|Study terminated by sponsor|3|||
48704338|NCT00785785|156767255|FG001|Optional Extension Phase|Study terminated by sponsor|37|||
48704339|NCT01391546|156767259|FG000|Overall Study|History of Herpes Zoster (HZ)|1|||
48704340|NCT01391546|156767260|FG001|Overall Study|History of Herpes Zoster (HZ)|0|||
48704341|NCT05660577|156767261|FG000|Overall Study|Discontinued|9|||
48704342|NCT02118961|156767262|FG000|Overall Study|Withdrawal by Subject|1|||
48704343|NCT02118961|156767263|FG001|Overall Study|Withdrawal by Subject|0|||
48704344|NCT01213472|156767264|FG000|Overall Study|Recurrence/Progressive disease|25|||
48704345|NCT01213472|156767264|FG000|Overall Study|Withdrawal by Subject|1|||
48704346|NCT01213472|156767264|FG000|Overall Study|Physician Decision|1|||
48704347|NCT03774576|156767268|FG000|Period 2|Adverse Event|1|||
48704348|NCT03771664|156767271|FG000|Overall Study|Adverse Event|1|||
48704349|NCT03771664|156767272|FG001|Overall Study|Adverse Event|0|||
48704350|NCT03771664|156767271|FG000|Overall Study|Lost to Follow-up|1|||
48704351|NCT03771664|156767272|FG001|Overall Study|Lost to Follow-up|0|||
48704352|NCT03771664|156767271|FG000|Overall Study|Withdrawal by Participant|1|||
48704353|NCT03771664|156767272|FG001|Overall Study|Withdrawal by Participant|4|||
48704354|NCT03771664|156767271|FG000|Overall Study|Randomized but not Treated|0|||
48704355|NCT03771664|156767272|FG001|Overall Study|Randomized but not Treated|1|||
48704356|NCT00831181|156767274|FG000|Overall Study|Adverse Event|12|||
48704357|NCT02004093|156767277|FG000|Overall Study|Death|2|||
48704358|NCT02004093|156767278|FG001|Overall Study|Death|1|||
48704359|NCT02004093|156767277|FG000|Overall Study|Lack of Efficacy|66|||
48704360|NCT02004093|156767278|FG001|Overall Study|Lack of Efficacy|62|||
48704361|NCT02004093|156767277|FG000|Overall Study|Protocol Violation|0|||
48704362|NCT02004093|156767278|FG001|Overall Study|Protocol Violation|1|||
48704363|NCT02004093|156767277|FG000|Overall Study|Lost to Follow-up|0|||
48704364|NCT02004093|156767278|FG001|Overall Study|Lost to Follow-up|1|||
48704365|NCT02004093|156767277|FG000|Overall Study|Withdrawal by Subject|3|||
48704366|NCT02004093|156767278|FG001|Overall Study|Withdrawal by Subject|7|||
48704367|NCT02004093|156767277|FG000|Overall Study|Other|3|||
48704368|NCT02004093|156767278|FG001|Overall Study|Other|1|||
48704369|NCT00930046|156767279|FG000|Overall Study|Wound catheter malfunctioned|1|||
48704370|NCT00930046|156767280|FG001|Overall Study|Wound catheter malfunctioned|2|||
48704371|NCT03345784|156767287|FG000|Overall Study|Withdrawal by Subject|2|||
48704372|NCT03345784|156767288|FG001|Overall Study|Withdrawal by Subject|1|||
48704373|NCT03216226|156767293|FG000|Overall Study|Adverse Event|3|||
48704374|NCT03216226|156767294|FG001|Overall Study|Adverse Event|0|||
48704375|NCT03216226|156767293|FG000|Overall Study|Protocol Violation|1|||
48704376|NCT03216226|156767294|FG001|Overall Study|Protocol Violation|3|||
48704377|NCT03216226|156767293|FG000|Overall Study|Patient unable to take time off work to come in for the third injection|1|||
48704378|NCT03216226|156767294|FG001|Overall Study|Patient unable to take time off work to come in for the third injection|0|||
48704379|NCT03216226|156767293|FG000|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0|||
48704380|NCT03216226|156767294|FG001|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1|||
48704381|NCT03216226|156767293|FG000|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0|||
48704382|NCT03216226|156767294|FG001|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1|||
48704383|NCT03131570|156767297|FG000|Overall Study|Adverse Event|1|||
48704384|NCT03131570|156767298|FG001|Overall Study|Adverse Event|0|||
48704385|NCT00830440|156767299|FG000|Overall Study|Protocol Violation|1|||
48704386|NCT00830440|156767300|FG001|Overall Study|Protocol Violation|0|||
48704387|NCT00830440|156767299|FG000|Overall Study|Withdrawal by Subject|1|||
48704388|NCT00830440|156767300|FG001|Overall Study|Withdrawal by Subject|0|||
48704389|NCT00830440|156767299|FG000|Overall Study|unsuccessful procedure|4|||
48704390|NCT00830440|156767300|FG001|Overall Study|unsuccessful procedure|0|||
48704391|NCT00830440|156767299|FG000|Overall Study|Adverse Event|2|||
48704392|NCT00830440|156767300|FG001|Overall Study|Adverse Event|0|||
48704393|NCT02592798|156767301|FG000|Double-Blind Period 1 (DB1)|Pregnancy|1|||
48704394|NCT02592798|156767302|FG001|Double-Blind Period 1 (DB1)|Pregnancy|0|||
48704395|NCT02592798|156767301|FG000|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0|||
48704396|NCT02592798|156767302|FG001|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1|||
48704397|NCT02592798|156767301|FG000|Double-Blind Period 1 (DB1)|Lack of Efficacy|1|||
48704398|NCT02592798|156767302|FG001|Double-Blind Period 1 (DB1)|Lack of Efficacy|3|||
48704399|NCT02592798|156767301|FG000|Double-Blind Period 1 (DB1)|Adverse Event|1|||
48704400|NCT02592798|156767302|FG001|Double-Blind Period 1 (DB1)|Adverse Event|2|||
48704401|NCT02592798|156767301|FG000|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3|||
48704402|NCT02592798|156767302|FG001|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2|||
48704403|NCT02592798|156767301|FG000|Double-Blind Period 2 (DB2)|Other reasons|1|||
48704404|NCT02592798|156767302|FG001|Double-Blind Period 2 (DB2)|Other reasons|0|||
48704405|NCT02592798|156767301|FG000|Double-Blind Period 2 (DB2)|Participant request to discontinue|1|||
48704406|NCT02592798|156767302|FG001|Double-Blind Period 2 (DB2)|Participant request to discontinue|0|||
48704407|NCT02592798|156767301|FG000|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1|||
48704408|NCT02592798|156767302|FG001|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0|||
48704409|NCT02592798|156767301|FG000|Double-Blind Period 2 (DB2)|Lack of Efficacy|1|||
48704410|NCT02592798|156767302|FG001|Double-Blind Period 2 (DB2)|Lack of Efficacy|2|||
48704411|NCT02592798|156767301|FG000|Double-Blind Period 2 (DB2)|Adverse Event|1|||
48704412|NCT02592798|156767302|FG001|Double-Blind Period 2 (DB2)|Adverse Event|0|||
48704413|NCT02592798|156767301|FG000|Transition From DB2 to OLE|Other reasons|1|||
48704414|NCT02592798|156767302|FG001|Transition From DB2 to OLE|Other reasons|0|||
48704415|NCT02592798|156767301|FG000|Open Label Period (OLE)|Other reasons|0|||
48704416|NCT02592798|156767302|FG001|Open Label Period (OLE)|Other reasons|2|||
48704417|NCT02592798|156767301|FG000|Open Label Period (OLE)|Participant request to discontinue|1|||
48704418|NCT02592798|156767302|FG001|Open Label Period (OLE)|Participant request to discontinue|0|||
48704419|NCT02592798|156767301|FG000|Open Label Period (OLE)|Lost to Follow-up|0|||
48704420|NCT02592798|156767302|FG001|Open Label Period (OLE)|Lost to Follow-up|1|||
48704421|NCT02592798|156767301|FG000|Open Label Period (OLE)|Lack of Efficacy|3|||
48704422|NCT02592798|156767302|FG001|Open Label Period (OLE)|Lack of Efficacy|5|||
48704423|NCT02592798|156767301|FG000|Open Label Period (OLE)|Adverse Event|0|||
48704424|NCT02592798|156767302|FG001|Open Label Period (OLE)|Adverse Event|1|||
48704425|NCT01519921|156767303|FG000|Overall Study|Adverse Event|10|||
49010684|NCT00095199|157875673|FG003|Overall Study|Primary tumor removed in other surgery|0|||
48704426|NCT01519921|156767304|FG001|Overall Study|Adverse Event|9|||
48704427|NCT01519921|156767303|FG000|Overall Study|Lack of Efficacy|4|||
48704428|NCT01519921|156767304|FG001|Overall Study|Lack of Efficacy|3|||
48704429|NCT01519921|156767303|FG000|Overall Study|Withdrawal by Subject|3|||
48704430|NCT01519921|156767304|FG001|Overall Study|Withdrawal by Subject|0|||
48704431|NCT01519921|156767303|FG000|Overall Study|Lost to Follow-up|2|||
48704432|NCT01519921|156767304|FG001|Overall Study|Lost to Follow-up|1|||
48704433|NCT01519921|156767303|FG000|Overall Study|Treatment refusal|2|||
48704434|NCT01519921|156767304|FG001|Overall Study|Treatment refusal|1|||
48704435|NCT01519921|156767303|FG000|Overall Study|High alanine aminotransferase (ALT)|0|||
48704436|NCT01519921|156767304|FG001|Overall Study|High alanine aminotransferase (ALT)|1|||
48704437|NCT00705016|156767305|FG000|Overall Study|Adverse Event|6|||
48704438|NCT00705016|156767306|FG001|Overall Study|Adverse Event|11|||
48704439|NCT00705016|156767307|FG002|Overall Study|Adverse Event|10|||
48704440|NCT00705016|156767305|FG000|Overall Study|Death|5|||
48704441|NCT00705016|156767306|FG001|Overall Study|Death|7|||
48704442|NCT00705016|156767307|FG002|Overall Study|Death|5|||
48704443|NCT00705016|156767305|FG000|Overall Study|Protocol Violation|0|||
48704444|NCT00705016|156767306|FG001|Overall Study|Protocol Violation|1|||
48704445|NCT00705016|156767307|FG002|Overall Study|Protocol Violation|1|||
48704446|NCT00705016|156767305|FG000|Overall Study|Withdrawal by Subject|4|||
48704447|NCT00705016|156767306|FG001|Overall Study|Withdrawal by Subject|3|||
48704448|NCT00705016|156767307|FG002|Overall Study|Withdrawal by Subject|2|||
48704449|NCT00705016|156767305|FG000|Overall Study|Progressive Disease|33|||
48704450|NCT00705016|156767306|FG001|Overall Study|Progressive Disease|29|||
48704451|NCT00705016|156767307|FG002|Overall Study|Progressive Disease|33|||
48704452|NCT00705016|156767305|FG000|Overall Study|Symptomatic Deterioration|3|||
48704453|NCT00705016|156767306|FG001|Overall Study|Symptomatic Deterioration|1|||
48704454|NCT00705016|156767307|FG002|Overall Study|Symptomatic Deterioration|1|||
48704455|NCT00705016|156767305|FG000|Overall Study|Other|9|||
48704456|NCT00705016|156767306|FG001|Overall Study|Other|6|||
48704457|NCT00705016|156767307|FG002|Overall Study|Other|6|||
48704458|NCT00942604|156767311|FG000|Overall Study|Protocol Violation|1|||
48704459|NCT00942604|156767312|FG001|Overall Study|Protocol Violation|1|||
48704460|NCT00942604|156767311|FG000|Overall Study|Adverse Event|0|||
48704461|NCT00942604|156767312|FG001|Overall Study|Adverse Event|1|||
48704462|NCT00942604|156767311|FG000|Overall Study|Withdrawal by Subject|0|||
48704463|NCT00942604|156767312|FG001|Overall Study|Withdrawal by Subject|1|||
48704464|NCT00942604|156767311|FG000|Overall Study|Patient relocation|1|||
48704465|NCT00942604|156767312|FG001|Overall Study|Patient relocation|1|||
48704466|NCT01143246|156767313|FG000|Overall Study|Adverse Event|24|||
48704467|NCT01143246|156767314|FG001|Overall Study|Adverse Event|28|||
48704468|NCT01143246|156767313|FG000|Overall Study|Participant Withdrew Informed Consent|2|||
48704469|NCT01143246|156767314|FG001|Overall Study|Participant Withdrew Informed Consent|2|||
48704470|NCT01143246|156767313|FG000|Overall Study|Lost to Follow-up|0|||
48704471|NCT01143246|156767314|FG001|Overall Study|Lost to Follow-up|1|||
48704472|NCT01143246|156767313|FG000|Overall Study|Death|16|||
48704473|NCT01143246|156767314|FG001|Overall Study|Death|15|||
48704474|NCT01143246|156767313|FG000|Overall Study|Reason not Specified|3|||
48704475|NCT01143246|156767314|FG001|Overall Study|Reason not Specified|5|||
48704476|NCT04139798|156767317|FG000|Overall Study|Withdrawal by Subject|6|||
48704477|NCT04139798|156767318|FG001|Overall Study|Withdrawal by Subject|5|||
48704478|NCT04139798|156767317|FG000|Overall Study|Lost to Follow-up|2|||
48704479|NCT04139798|156767318|FG001|Overall Study|Lost to Follow-up|5|||
48704480|NCT04139798|156767317|FG000|Overall Study|Discontinued|4|||
48704481|NCT04139798|156767318|FG001|Overall Study|Discontinued|2|||
48704482|NCT04139798|156767317|FG000|Overall Study|Adverse Event|1|||
48704483|NCT04139798|156767318|FG001|Overall Study|Adverse Event|3|||
48704484|NCT04139798|156767317|FG000|Overall Study|Protocol Violation|1|||
48704485|NCT04139798|156767318|FG001|Overall Study|Protocol Violation|0|||
48704486|NCT00361296|156767321|FG000|Overall Study|Physician Decision|1|||
48704487|NCT00361296|156767321|FG000|Overall Study|Lack of Efficacy|2|||
48704488|NCT03155841|156767324|FG000|Overall Study|Protocol Violation|3|||
48704489|NCT03155841|156767325|FG001|Overall Study|Protocol Violation|4|||
48704490|NCT01499355|156767326|FG000|Run-In Period|Study Termination|15|||
48704491|NCT01499355|156767327|FG001|Run-In Period|Study Termination|0|||
48704492|NCT01499355|156767328|FG002|Run-In Period|Study Termination|0|||
48704493|NCT01499355|156767329|FG003|Run-In Period|Study Termination|0|||
48704494|NCT01499355|156767326|FG000|Run-In Period|Other|3|||
48704495|NCT01499355|156767327|FG001|Run-In Period|Other|0|||
48704496|NCT01499355|156767328|FG002|Run-In Period|Other|0|||
48704497|NCT01499355|156767329|FG003|Run-In Period|Other|0|||
49010685|NCT00095199|157875670|FG000|Overall Study|Data inadvertently lost by site|1|||
48704498|NCT01499355|156767326|FG000|Run-In Period|Death|2|||
48704499|NCT01499355|156767327|FG001|Run-In Period|Death|0|||
48704500|NCT01499355|156767328|FG002|Run-In Period|Death|0|||
48704501|NCT01499355|156767329|FG003|Run-In Period|Death|0|||
48704502|NCT01499355|156767326|FG000|Run-In Period|Investigator Decision|2|||
48704503|NCT01499355|156767327|FG001|Run-In Period|Investigator Decision|0|||
48704504|NCT01499355|156767328|FG002|Run-In Period|Investigator Decision|0|||
48704505|NCT01499355|156767329|FG003|Run-In Period|Investigator Decision|0|||
48704506|NCT01499355|156767326|FG000|Run-In Period|Consent Withdrawn|1|||
48704507|NCT01499355|156767327|FG001|Run-In Period|Consent Withdrawn|0|||
48704508|NCT01499355|156767328|FG002|Run-In Period|Consent Withdrawn|0|||
48704509|NCT01499355|156767329|FG003|Run-In Period|Consent Withdrawn|0|||
48704510|NCT01499355|156767326|FG000|Run-In Period|Adverse Event|8|||
48704511|NCT01499355|156767327|FG001|Run-In Period|Adverse Event|0|||
48704512|NCT01499355|156767328|FG002|Run-In Period|Adverse Event|0|||
48704513|NCT01499355|156767329|FG003|Run-In Period|Adverse Event|0|||
48704514|NCT01499355|156767326|FG000|Double-Blind Period|Adverse Event|0|||
48704515|NCT01499355|156767327|FG001|Double-Blind Period|Adverse Event|2|||
48704516|NCT01499355|156767328|FG002|Double-Blind Period|Adverse Event|3|||
48704517|NCT01499355|156767329|FG003|Double-Blind Period|Adverse Event|2|||
48704518|NCT01499355|156767326|FG000|Double-Blind Period|Study Termination|0|||
48704519|NCT01499355|156767327|FG001|Double-Blind Period|Study Termination|18|||
48704520|NCT01499355|156767328|FG002|Double-Blind Period|Study Termination|16|||
48704521|NCT01499355|156767329|FG003|Double-Blind Period|Study Termination|14|||
48704522|NCT01499355|156767326|FG000|Double-Blind Period|Other|0|||
48704523|NCT01499355|156767327|FG001|Double-Blind Period|Other|1|||
48704524|NCT01499355|156767328|FG002|Double-Blind Period|Other|2|||
48704525|NCT01499355|156767329|FG003|Double-Blind Period|Other|2|||
48704526|NCT01499355|156767326|FG000|Double-Blind Period|Death|0|||
48704527|NCT01499355|156767327|FG001|Double-Blind Period|Death|1|||
48704528|NCT01499355|156767328|FG002|Double-Blind Period|Death|0|||
48704529|NCT01499355|156767329|FG003|Double-Blind Period|Death|0|||
48704530|NCT01499355|156767326|FG000|Double-Blind Period|Investigator Decision|0|||
48704531|NCT01499355|156767327|FG001|Double-Blind Period|Investigator Decision|0|||
48704532|NCT01499355|156767328|FG002|Double-Blind Period|Investigator Decision|3|||
48704533|NCT01499355|156767329|FG003|Double-Blind Period|Investigator Decision|3|||
48704534|NCT01499355|156767326|FG000|Double-Blind Period|Consent Withdrawn|0|||
48704535|NCT01499355|156767327|FG001|Double-Blind Period|Consent Withdrawn|0|||
48704536|NCT01499355|156767328|FG002|Double-Blind Period|Consent Withdrawn|1|||
48704537|NCT01499355|156767329|FG003|Double-Blind Period|Consent Withdrawn|2|||
48704538|NCT01499355|156767326|FG000|Double-Blind Period|Lost to Follow-up|0|||
48704539|NCT01499355|156767327|FG001|Double-Blind Period|Lost to Follow-up|1|||
48704540|NCT01499355|156767328|FG002|Double-Blind Period|Lost to Follow-up|0|||
48704541|NCT01499355|156767329|FG003|Double-Blind Period|Lost to Follow-up|0|||
48704542|NCT02952820|156767336|FG000|Placebo-Controlled Treatment (6 Months)|Adverse Event|8|||
48704543|NCT02952820|156767337|FG001|Placebo-Controlled Treatment (6 Months)|Adverse Event|9|||
48704544|NCT02952820|156767338|FG002|Placebo-Controlled Treatment (6 Months)|Adverse Event|16|||
48704545|NCT02952820|156767336|FG000|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
48704546|NCT02952820|156767337|FG001|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
48704547|NCT02952820|156767338|FG002|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6|||
48704548|NCT02952820|156767336|FG000|Placebo-Controlled Treatment (6 Months)|Subject choice|15|||
48704549|NCT02952820|156767337|FG001|Placebo-Controlled Treatment (6 Months)|Subject choice|12|||
48704550|NCT02952820|156767338|FG002|Placebo-Controlled Treatment (6 Months)|Subject choice|17|||
48704551|NCT02952820|156767336|FG000|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17|||
48704552|NCT02952820|156767337|FG001|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12|||
48704553|NCT02952820|156767338|FG002|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11|||
48704554|NCT02952820|156767336|FG000|Placebo-Controlled Treatment (6 Months)|Other than specified|0|||
48704555|NCT02952820|156767337|FG001|Placebo-Controlled Treatment (6 Months)|Other than specified|14|||
48704556|NCT02952820|156767338|FG002|Placebo-Controlled Treatment (6 Months)|Other than specified|13|||
48704557|NCT02952820|156767336|FG000|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13|||
48704558|NCT02952820|156767337|FG001|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11|||
48704559|NCT02952820|156767338|FG002|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21|||
48704560|NCT02952820|156767336|FG000|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
48704561|NCT02952820|156767337|FG001|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
48704562|NCT02952820|156767338|FG002|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
48704563|NCT02952820|156767336|FG000|Active Treatment Period (6 Months)|Adverse Event|0|||
48704564|NCT02952820|156767337|FG001|Active Treatment Period (6 Months)|Adverse Event|6|||
48704565|NCT02952820|156767338|FG002|Active Treatment Period (6 Months)|Adverse Event|5|||
48704566|NCT02952820|156767336|FG000|Active Treatment Period (6 Months)|Lost to Follow-up|0|||
48704567|NCT02952820|156767337|FG001|Active Treatment Period (6 Months)|Lost to Follow-up|4|||
48704568|NCT02952820|156767338|FG002|Active Treatment Period (6 Months)|Lost to Follow-up|6|||
48704569|NCT02952820|156767336|FG000|Active Treatment Period (6 Months)|Subject choice|0|||
48704570|NCT02952820|156767337|FG001|Active Treatment Period (6 Months)|Subject choice|10|||
48704571|NCT02952820|156767338|FG002|Active Treatment Period (6 Months)|Subject choice|7|||
48704572|NCT02952820|156767336|FG000|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0|||
48704573|NCT02952820|156767337|FG001|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6|||
48704574|NCT02952820|156767338|FG002|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2|||
48704575|NCT02952820|156767336|FG000|Active Treatment Period (6 Months)|Withdrawal of consent|0|||
48704576|NCT02952820|156767337|FG001|Active Treatment Period (6 Months)|Withdrawal of consent|6|||
48704577|NCT02952820|156767338|FG002|Active Treatment Period (6 Months)|Withdrawal of consent|8|||
48912611|NCT00766090|157517527|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
48912612|NCT00766090|157517528|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
48912613|NCT00766090|157517529|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
48912614|NCT00766090|157517530|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
48912615|NCT00766090|157517531|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
48912616|NCT00766090|157517532|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
48912617|NCT00766090|157517533|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
48912618|NCT00766090|157517534|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
48912619|NCT00766090|157517523|FG000|Treatment Period 3 (28 Days)|Protocol Violation|0|||
48912620|NCT00766090|157517524|FG001|Treatment Period 3 (28 Days)|Protocol Violation|0|||
48912621|NCT00766090|157517525|FG002|Treatment Period 3 (28 Days)|Protocol Violation|0|||
48912622|NCT00766090|157517526|FG003|Treatment Period 3 (28 Days)|Protocol Violation|0|||
48704578|NCT02952820|156767336|FG000|Active Treatment Period (6 Months)|Other than specified|0|||
48704579|NCT02952820|156767337|FG001|Active Treatment Period (6 Months)|Other than specified|6|||
48704580|NCT02952820|156767338|FG002|Active Treatment Period (6 Months)|Other than specified|2|||
48704581|NCT02952820|156767336|FG000|Active Treatment Period (6 Months)|Not treated|0|||
48704582|NCT02952820|156767337|FG001|Active Treatment Period (6 Months)|Not treated|0|||
48704583|NCT02952820|156767338|FG002|Active Treatment Period (6 Months)|Not treated|1|||
48704584|NCT01929317|156767339|FG000|Dose Increase Effect Verification Phase|Adverse Event|5|||
48704585|NCT01929317|156767340|FG001|Dose Increase Effect Verification Phase|Adverse Event|1|||
48704586|NCT01929317|156767339|FG000|Dose Increase Effect Verification Phase|Physician Decision|1|||
48704587|NCT01929317|156767340|FG001|Dose Increase Effect Verification Phase|Physician Decision|0|||
48704588|NCT01929317|156767339|FG000|Dose Increase Effect Verification Phase|Withdrawal by Subject|3|||
48704589|NCT01929317|156767340|FG001|Dose Increase Effect Verification Phase|Withdrawal by Subject|0|||
48704590|NCT01929317|156767339|FG000|Long-term Phase|Adverse Event|5|||
48704591|NCT01929317|156767340|FG001|Long-term Phase|Adverse Event|1|||
48704592|NCT01929317|156767339|FG000|Long-term Phase|Physician Decision|3|||
48704593|NCT01929317|156767340|FG001|Long-term Phase|Physician Decision|0|||
48704594|NCT01929317|156767339|FG000|Long-term Phase|Withdrawal by Subject|4|||
48704595|NCT01929317|156767340|FG001|Long-term Phase|Withdrawal by Subject|0|||
48704596|NCT01929317|156767339|FG000|Long-term Phase|Protocol Violation|1|||
48704597|NCT01929317|156767340|FG001|Long-term Phase|Protocol Violation|0|||
48704598|NCT01929317|156767339|FG000|Long-term Phase|Protocol-defined Stopping Criteria|1|||
48704599|NCT01929317|156767340|FG001|Long-term Phase|Protocol-defined Stopping Criteria|0|||
48704600|NCT01929317|156767339|FG000|Long-term Phase|Study Closed/Terminated|5|||
48704601|NCT01929317|156767340|FG001|Long-term Phase|Study Closed/Terminated|3|||
48704602|NCT02395081|156767341|FG000|Overall Study|Withdrawal by Subject|1|||
48704603|NCT02395081|156767342|FG001|Overall Study|Withdrawal by Subject|1|||
48704604|NCT02395081|156767343|FG002|Overall Study|Withdrawal by Subject|0|||
48704605|NCT02395081|156767341|FG000|Overall Study|Moved where blood couldn't be collected|4|||
48704606|NCT02395081|156767342|FG001|Overall Study|Moved where blood couldn't be collected|1|||
48704607|NCT02395081|156767343|FG002|Overall Study|Moved where blood couldn't be collected|3|||
48704608|NCT02395081|156767341|FG000|Overall Study|Fetal Loss|2|||
48704609|NCT02395081|156767342|FG001|Overall Study|Fetal Loss|3|||
48704610|NCT02395081|156767343|FG002|Overall Study|Fetal Loss|1|||
48704611|NCT02157883|156767344|FG000|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1|||
48704612|NCT02157883|156767344|FG000|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3|||
48704613|NCT02157883|156767344|FG000|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15|||
48704614|NCT02157883|156767344|FG000|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1|||
48704615|NCT02157883|156767344|FG000|Part B: Day 19 to End Part B (AZD9291)|Death|3|||
48704616|NCT01523756|156767345|FG000|Baseline Period|Adverse Event|0|||
48704617|NCT01523756|156767346|FG001|Baseline Period|Adverse Event|1|||
48704618|NCT01523756|156767345|FG000|Test Period 1|Adverse Event|1|||
48704619|NCT01523756|156767346|FG001|Test Period 1|Adverse Event|0|||
48704620|NCT01523756|156767345|FG000|Test Period 2|Withdrawal by Subject|0|||
48704621|NCT01523756|156767346|FG001|Test Period 2|Withdrawal by Subject|1|||
48704622|NCT01578486|156767347|FG000|Overall Study|Physician Decision|3|||
48704623|NCT01578486|156767347|FG000|Overall Study|Withdrawal by Subject|2|||
48704624|NCT02536963|156767348|FG000|Overall Study|Withdrawal by Subject|18|||
48704625|NCT04292899|156767349|FG000|Overall Study|Death|21|||
48704626|NCT04292899|156767350|FG001|Overall Study|Death|28|||
48704627|NCT04292899|156767351|FG002|Overall Study|Death|188|||
48704628|NCT04292899|156767352|FG003|Overall Study|Death|371|||
48704629|NCT04292899|156767349|FG000|Overall Study|Lost to Follow-up|8|||
48704630|NCT04292899|156767350|FG001|Overall Study|Lost to Follow-up|4|||
48704631|NCT04292899|156767351|FG002|Overall Study|Lost to Follow-up|22|||
48704632|NCT04292899|156767352|FG003|Overall Study|Lost to Follow-up|235|||
48704633|NCT04292899|156767349|FG000|Overall Study|Withdrew consent|1|||
48704634|NCT04292899|156767350|FG001|Overall Study|Withdrew consent|0|||
48704635|NCT04292899|156767351|FG002|Overall Study|Withdrew consent|11|||
48704636|NCT04292899|156767352|FG003|Overall Study|Withdrew consent|32|||
48912623|NCT00766090|157517527|FG004|Treatment Period 3 (28 Days)|Protocol Violation|0|||
48912624|NCT00766090|157517528|FG005|Treatment Period 3 (28 Days)|Protocol Violation|1|||
48704637|NCT04292899|156767349|FG000|Overall Study|Adverse Event|2|||
48704638|NCT04292899|156767350|FG001|Overall Study|Adverse Event|1|||
48704639|NCT04292899|156767351|FG002|Overall Study|Adverse Event|2|||
48704640|NCT04292899|156767352|FG003|Overall Study|Adverse Event|2|||
48704641|NCT04292899|156767349|FG000|Overall Study|Investigator's Discretion|0|||
48704642|NCT04292899|156767350|FG001|Overall Study|Investigator's Discretion|0|||
48704643|NCT04292899|156767351|FG002|Overall Study|Investigator's Discretion|0|||
48704644|NCT04292899|156767352|FG003|Overall Study|Investigator's Discretion|3|||
48704645|NCT04292899|156767349|FG000|Overall Study|Non-compliance With Study Drug|0|||
48704646|NCT04292899|156767350|FG001|Overall Study|Non-compliance With Study Drug|0|||
48704647|NCT04292899|156767351|FG002|Overall Study|Non-compliance With Study Drug|0|||
48704648|NCT04292899|156767352|FG003|Overall Study|Non-compliance With Study Drug|1|||
48704649|NCT04292899|156767349|FG000|Overall Study|Protocol Violation|0|||
48704650|NCT04292899|156767350|FG001|Overall Study|Protocol Violation|0|||
48704651|NCT04292899|156767351|FG002|Overall Study|Protocol Violation|0|||
48704652|NCT04292899|156767352|FG003|Overall Study|Protocol Violation|1|||
48704653|NCT00068419|156767354|FG000|Overall Study|Adverse Event|3|||
48704654|NCT00068419|156767354|FG000|Overall Study|Lack of Efficacy|24|||
48704655|NCT00068419|156767354|FG000|Overall Study|Lost to Follow-up|1|||
48704656|NCT00068419|156767354|FG000|Overall Study|Physician Decision|7|||
48704657|NCT00068419|156767354|FG000|Overall Study|Withdrawal by Subject|14|||
48704658|NCT00068419|156767354|FG000|Overall Study|Ineligible|11|||
48704659|NCT02628873|156767355|FG000|Break (1 Hour)|Withdrawal by Subject|0|||
48704660|NCT02628873|156767356|FG001|Break (1 Hour)|Withdrawal by Subject|1|||
48704661|NCT02628873|156767355|FG000|Second Test (1 Hour)|Physician Decision|1|||
48704662|NCT02628873|156767356|FG001|Second Test (1 Hour)|Physician Decision|0|||
48704663|NCT04237116|156767358|FG000|Overall Study|Adverse Event|0|||
48704664|NCT04237116|156767359|FG001|Overall Study|Adverse Event|1|||
48704665|NCT04237116|156767358|FG000|Overall Study|Study terminated by Sponsor|4|||
48704666|NCT04237116|156767359|FG001|Overall Study|Study terminated by Sponsor|1|||
48704667|NCT00755183|156769256|FG000|Overall Study|Adverse Event|5|||
48704668|NCT00755183|156769257|FG001|Overall Study|Adverse Event|2|||
48704669|NCT00755183|156769256|FG000|Overall Study|Protocol Violation|0|||
48704670|NCT00755183|156769257|FG001|Overall Study|Protocol Violation|1|||
48704671|NCT00755183|156769256|FG000|Overall Study|Withdrawal by Subject|0|||
48704672|NCT00755183|156769257|FG001|Overall Study|Withdrawal by Subject|2|||
48704673|NCT00755183|156769256|FG000|Overall Study|Administrative|2|||
48704674|NCT00755183|156769257|FG001|Overall Study|Administrative|1|||
48856283|NCT05260437|157312814|FG003|Overall Study|Lost to Follow-up|2|||
48856284|NCT05260437|157312815|FG004|Overall Study|Lost to Follow-up|2|||
48856285|NCT05260437|157312811|FG000|Overall Study|Withdrawal by Subject|3|||
48856286|NCT05260437|157312812|FG001|Overall Study|Withdrawal by Subject|0|||
48856287|NCT05260437|157312813|FG002|Overall Study|Withdrawal by Subject|4|||
48856288|NCT05260437|157312814|FG003|Overall Study|Withdrawal by Subject|5|||
48856289|NCT05260437|157312815|FG004|Overall Study|Withdrawal by Subject|0|||
48856290|NCT05260437|157312811|FG000|Overall Study|Vaccine Not Administered|0|||
48856291|NCT05260437|157312812|FG001|Overall Study|Vaccine Not Administered|1|||
48856292|NCT05260437|157312813|FG002|Overall Study|Vaccine Not Administered|0|||
48856293|NCT05260437|157312814|FG003|Overall Study|Vaccine Not Administered|0|||
48856294|NCT05260437|157312815|FG004|Overall Study|Vaccine Not Administered|0|||
48856295|NCT01029704|157312816|FG000|Overall Study|Adverse Event|0|||
48856296|NCT01029704|157312817|FG001|Overall Study|Adverse Event|0|||
48856297|NCT01029704|157312818|FG002|Overall Study|Adverse Event|0|||
48856298|NCT01029704|157312819|FG003|Overall Study|Adverse Event|0|||
48856299|NCT01029704|157312820|FG004|Overall Study|Adverse Event|0|||
48856300|NCT01029704|157312821|FG005|Overall Study|Adverse Event|0|||
48856301|NCT01029704|157312822|FG006|Overall Study|Adverse Event|1|||
48856302|NCT01029704|157312823|FG007|Overall Study|Adverse Event|1|||
48856303|NCT01029704|157312824|FG008|Overall Study|Adverse Event|0|||
48856304|NCT01029704|157312816|FG000|Overall Study|Withdrawal by Subject|0|||
48856305|NCT01029704|157312817|FG001|Overall Study|Withdrawal by Subject|0|||
48856306|NCT01029704|157312818|FG002|Overall Study|Withdrawal by Subject|0|||
48856307|NCT01029704|157312819|FG003|Overall Study|Withdrawal by Subject|0|||
48856308|NCT01029704|157312820|FG004|Overall Study|Withdrawal by Subject|2|||
48856309|NCT01029704|157312821|FG005|Overall Study|Withdrawal by Subject|1|||
48856310|NCT01029704|157312822|FG006|Overall Study|Withdrawal by Subject|1|||
48856311|NCT01029704|157312823|FG007|Overall Study|Withdrawal by Subject|1|||
48856312|NCT01029704|157312824|FG008|Overall Study|Withdrawal by Subject|0|||
48856313|NCT01029704|157312816|FG000|Overall Study|Lost to Follow-up|0|||
48856314|NCT01029704|157312817|FG001|Overall Study|Lost to Follow-up|0|||
48856315|NCT01029704|157312818|FG002|Overall Study|Lost to Follow-up|0|||
48856316|NCT01029704|157312819|FG003|Overall Study|Lost to Follow-up|0|||
48856317|NCT01029704|157312820|FG004|Overall Study|Lost to Follow-up|0|||
48856318|NCT01029704|157312821|FG005|Overall Study|Lost to Follow-up|0|||
48856319|NCT01029704|157312822|FG006|Overall Study|Lost to Follow-up|1|||
48856320|NCT01029704|157312823|FG007|Overall Study|Lost to Follow-up|1|||
48856321|NCT01029704|157312824|FG008|Overall Study|Lost to Follow-up|1|||
48912625|NCT00766090|157517529|FG006|Treatment Period 3 (28 Days)|Protocol Violation|0|||
48912626|NCT00766090|157517530|FG007|Treatment Period 3 (28 Days)|Protocol Violation|0|||
48912627|NCT00766090|157517531|FG008|Treatment Period 3 (28 Days)|Protocol Violation|0|||
48912628|NCT00766090|157517532|FG009|Treatment Period 3 (28 Days)|Protocol Violation|0|||
48912629|NCT00766090|157517533|FG010|Treatment Period 3 (28 Days)|Protocol Violation|0|||
48912630|NCT00766090|157517534|FG011|Treatment Period 3 (28 Days)|Protocol Violation|0|||
48912631|NCT00766090|157517523|FG000|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
48912632|NCT00766090|157517524|FG001|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
48912633|NCT00766090|157517525|FG002|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
48912634|NCT00766090|157517526|FG003|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
48912635|NCT00766090|157517527|FG004|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
48912636|NCT00766090|157517528|FG005|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
48912637|NCT00766090|157517529|FG006|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
48912638|NCT00766090|157517530|FG007|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
48912639|NCT00766090|157517531|FG008|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
48912640|NCT00766090|157517532|FG009|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
48912641|NCT00766090|157517533|FG010|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
48912642|NCT00766090|157517534|FG011|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
48912643|NCT00766090|157517523|FG000|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
48912644|NCT00766090|157517524|FG001|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
48912645|NCT00766090|157517525|FG002|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
48912646|NCT00766090|157517526|FG003|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
48912647|NCT00766090|157517527|FG004|Treatment Period 3 (28 Days)|Lost to Follow-up|1|||
48912648|NCT00766090|157517528|FG005|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
48912649|NCT00766090|157517529|FG006|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
48912650|NCT00766090|157517530|FG007|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
48912651|NCT00766090|157517531|FG008|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
48912652|NCT00766090|157517532|FG009|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
48912653|NCT00766090|157517533|FG010|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
48912654|NCT00766090|157517534|FG011|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
48912655|NCT00113074|157517535|FG000|Overall Study|Lost to Follow-up|10|||
48912656|NCT00113074|157517536|FG001|Overall Study|Lost to Follow-up|10|||
48912657|NCT00113074|157517537|FG002|Overall Study|Lost to Follow-up|14|||
48912658|NCT00574288|157517546|FG000|Overall Study|Adverse Event|2|||
48912659|NCT00574288|157517547|FG001|Overall Study|Adverse Event|0|||
48912660|NCT00574288|157517548|FG002|Overall Study|Adverse Event|0|||
48912661|NCT00574288|157517549|FG003|Overall Study|Adverse Event|0|||
48912662|NCT00574288|157517550|FG004|Overall Study|Adverse Event|1|||
48912663|NCT00574288|157517551|FG005|Overall Study|Adverse Event|0|||
48912664|NCT00574288|157517552|FG006|Overall Study|Adverse Event|0|||
48912665|NCT00574288|157517546|FG000|Overall Study|Death|0|||
48912666|NCT00574288|157517547|FG001|Overall Study|Death|0|||
48912667|NCT00574288|157517548|FG002|Overall Study|Death|0|||
48912668|NCT00574288|157517549|FG003|Overall Study|Death|0|||
48912669|NCT00574288|157517550|FG004|Overall Study|Death|0|||
48912670|NCT00574288|157517551|FG005|Overall Study|Death|25|||
48912671|NCT00574288|157517552|FG006|Overall Study|Death|21|||
48912672|NCT00574288|157517546|FG000|Overall Study|Lost to Follow-up|0|||
48912673|NCT00574288|157517547|FG001|Overall Study|Lost to Follow-up|0|||
48912674|NCT00574288|157517548|FG002|Overall Study|Lost to Follow-up|0|||
48912675|NCT00574288|157517549|FG003|Overall Study|Lost to Follow-up|0|||
48912676|NCT00574288|157517550|FG004|Overall Study|Lost to Follow-up|0|||
48912677|NCT00574288|157517551|FG005|Overall Study|Lost to Follow-up|1|||
48912678|NCT00574288|157517552|FG006|Overall Study|Lost to Follow-up|2|||
48912679|NCT00574288|157517546|FG000|Overall Study|Study Terminated By Sponsor|0|||
48912680|NCT00574288|157517547|FG001|Overall Study|Study Terminated By Sponsor|0|||
48912681|NCT00574288|157517548|FG002|Overall Study|Study Terminated By Sponsor|0|||
48912682|NCT00574288|157517549|FG003|Overall Study|Study Terminated By Sponsor|0|||
48912683|NCT00574288|157517550|FG004|Overall Study|Study Terminated By Sponsor|0|||
48912684|NCT00574288|157517551|FG005|Overall Study|Study Terminated By Sponsor|0|||
48912685|NCT00574288|157517552|FG006|Overall Study|Study Terminated By Sponsor|5|||
48912686|NCT00574288|157517546|FG000|Overall Study|Progressive Disease|17|||
48912687|NCT00574288|157517547|FG001|Overall Study|Progressive Disease|2|||
48912688|NCT00574288|157517548|FG002|Overall Study|Progressive Disease|3|||
48912689|NCT00574288|157517549|FG003|Overall Study|Progressive Disease|2|||
48912690|NCT00574288|157517550|FG004|Overall Study|Progressive Disease|1|||
48912691|NCT00574288|157517551|FG005|Overall Study|Progressive Disease|0|||
48912692|NCT00574288|157517552|FG006|Overall Study|Progressive Disease|0|||
48912693|NCT00574288|157517546|FG000|Overall Study|Other|1|||
48912694|NCT00574288|157517547|FG001|Overall Study|Other|1|||
48912695|NCT00574288|157517548|FG002|Overall Study|Other|0|||
48912696|NCT00574288|157517549|FG003|Overall Study|Other|0|||
48912697|NCT00574288|157517550|FG004|Overall Study|Other|0|||
48912698|NCT00574288|157517551|FG005|Overall Study|Other|0|||
48912699|NCT00574288|157517552|FG006|Overall Study|Other|0|||
48912700|NCT00356889|157517553|FG000|Overall Study|Protocol Violation|2|||
48912701|NCT00356889|157517553|FG000|Overall Study|Adverse Event|1|||
48912702|NCT02409290|157517555|FG000|Overall Study|Protocol Violation|3|||
48912703|NCT02409290|157517556|FG001|Overall Study|Protocol Violation|6|||
48912704|NCT02409290|157517557|FG002|Overall Study|Protocol Violation|9|||
48704675|NCT00148317|156769258|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8|||
48704676|NCT00148317|156769258|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2|||
48704677|NCT00148317|156769258|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1|||
48704678|NCT00335777|156769260|FG000|Enrolled and Dispensed Study Medication|Lost to Follow-up|5|||
48704679|NCT00335777|156769260|FG000|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6|||
48704680|NCT00335777|156769260|FG000|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18|||
48704681|NCT00335777|156769260|FG000|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1|||
48704682|NCT00335777|156769260|FG000|Treated 2 Headaches Per Protocol|Treated out of protocol for early and late|12|||
48704683|NCT02419001|156769263|FG000|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1|||
48704684|NCT02419001|156769264|FG001|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0|||
48704685|NCT01524796|156769269|FG000|Overall Study|Adverse Event|13|||
48704686|NCT01524796|156769269|FG000|Overall Study|Lack of Efficacy|3|||
48704687|NCT01524796|156769269|FG000|Overall Study|Lost to Follow-up|1|||
48704688|NCT01524796|156769269|FG000|Overall Study|The price|1|||
48704689|NCT01524796|156769269|FG000|Overall Study|Withdrawal by Subject|4|||
48704690|NCT01524796|156769269|FG000|Overall Study|Move|1|||
48704691|NCT01524796|156769269|FG000|Overall Study|Deterioration of pains|1|||
48704692|NCT01524796|156769269|FG000|Overall Study|Gall stone surgery|1|||
48704693|NCT01524796|156769269|FG000|Overall Study|Nervous about confidentiality|1|||
48704694|NCT01524796|156769269|FG000|Overall Study|Switch to carbamazapine|1|||
48704695|NCT01524796|156769269|FG000|Overall Study|Adverse Event and Lack of Efficacy|1|||
48704696|NCT00943618|156769270|FG000|Overall Study|Lost to Follow-up|38|||
48704697|NCT00943618|156769271|FG001|Overall Study|Lost to Follow-up|48|||
48704698|NCT00943618|156769272|FG002|Overall Study|Lost to Follow-up|20|||
48704699|NCT00943618|156769270|FG000|Overall Study|Discontinued Medication|17|||
48704700|NCT00943618|156769271|FG001|Overall Study|Discontinued Medication|29|||
48704701|NCT00943618|156769272|FG002|Overall Study|Discontinued Medication|11|||
48704702|NCT01532986|156769273|FG000|Overall Study|Death|9|||
48704703|NCT01532986|156769274|FG001|Overall Study|Death|9|||
48704704|NCT01532986|156769273|FG000|Overall Study|Withdrawal by Subject|7|||
48704705|NCT01532986|156769274|FG001|Overall Study|Withdrawal by Subject|10|||
48704706|NCT01532986|156769273|FG000|Overall Study|Physician Decision|7|||
48704707|NCT01532986|156769274|FG001|Overall Study|Physician Decision|5|||
48704708|NCT02120898|156769277|FG000|Overall Study|Withdrawal by Subject|4|||
48704709|NCT02120898|156769278|FG001|Overall Study|Withdrawal by Subject|2|||
48704710|NCT02120898|156769279|FG002|Overall Study|Withdrawal by Subject|2|||
48704711|NCT02120898|156769277|FG000|Overall Study|Non-compliance with study drug|3|||
48704712|NCT02120898|156769278|FG001|Overall Study|Non-compliance with study drug|0|||
48704713|NCT02120898|156769279|FG002|Overall Study|Non-compliance with study drug|0|||
48704714|NCT02120898|156769277|FG000|Overall Study|Adverse Event|1|||
48704715|NCT02120898|156769278|FG001|Overall Study|Adverse Event|2|||
48704716|NCT02120898|156769279|FG002|Overall Study|Adverse Event|1|||
48704717|NCT02120898|156769277|FG000|Overall Study|Protocol Violation|1|||
48704718|NCT02120898|156769278|FG001|Overall Study|Protocol Violation|2|||
48704719|NCT02120898|156769279|FG002|Overall Study|Protocol Violation|0|||
48704720|NCT02120898|156769277|FG000|Overall Study|Lost to Follow-up|0|||
48704721|NCT02120898|156769278|FG001|Overall Study|Lost to Follow-up|0|||
48704722|NCT02120898|156769279|FG002|Overall Study|Lost to Follow-up|1|||
48704723|NCT01472289|156769280|FG000|Overall Study|Death|2|||
48704724|NCT02863419|156769281|FG000|Overall Study|Lost to Follow-up|0|||
48704725|NCT02863419|156769282|FG001|Overall Study|Lost to Follow-up|1|||
48704726|NCT02863419|156769283|FG002|Overall Study|Lost to Follow-up|4|||
48704727|NCT02863419|156769281|FG000|Overall Study|Withdrawal by Subject|5|||
48704728|NCT02863419|156769282|FG001|Overall Study|Withdrawal by Subject|5|||
48704729|NCT02863419|156769283|FG002|Overall Study|Withdrawal by Subject|3|||
48704730|NCT02863419|156769281|FG000|Overall Study|Died|3|||
48912705|NCT02409290|157517558|FG003|Overall Study|Protocol Violation|4|||
48912706|NCT02409290|157517555|FG000|Overall Study|No positive culture/no baseline sample|3|||
48912707|NCT02409290|157517556|FG001|Overall Study|No positive culture/no baseline sample|9|||
48704731|NCT02863419|156769282|FG001|Overall Study|Died|4|||
48704732|NCT02863419|156769283|FG002|Overall Study|Died|1|||
48912708|NCT02409290|157517557|FG002|Overall Study|No positive culture/no baseline sample|6|||
48912709|NCT02409290|157517558|FG003|Overall Study|No positive culture/no baseline sample|5|||
48704733|NCT05021978|156769286|FG000|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|1|||
48704734|NCT05021978|156769287|FG001|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
48912710|NCT02409290|157517555|FG000|Overall Study|Completed but not analysed as recruitment stopped to this arm|26|||
48912711|NCT02409290|157517556|FG001|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
48912712|NCT02409290|157517557|FG002|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
48704735|NCT05021978|156769288|FG002|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
48704736|NCT05021978|156769289|FG003|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
48704737|NCT05021978|156769286|FG000|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
48704738|NCT05021978|156769287|FG001|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|6|||
48704739|NCT05021978|156769288|FG002|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
48704740|NCT05021978|156769289|FG003|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
48704741|NCT04004988|156769290|FG000|Period 1|Physician Decision|2|||
48704742|NCT04004988|156769291|FG001|Period 1|Physician Decision|0|||
48704743|NCT04004988|156769290|FG000|Period 1|Withdrawal by Subject|0|||
48704744|NCT04004988|156769291|FG001|Period 1|Withdrawal by Subject|1|||
48704745|NCT04004988|156769290|FG000|Period 1|Adverse Event|1|||
48704746|NCT04004988|156769291|FG001|Period 1|Adverse Event|2|||
48704747|NCT00414596|156769294|FG000|Overall Study|Protocol Violation|2|||
48704748|NCT00658359|156769296|FG000|Overall Study|Death|3|||
48704749|NCT00658359|156769297|FG001|Overall Study|Death|1|||
48704750|NCT00658359|156769298|FG002|Overall Study|Death|2|||
48704751|NCT00658359|156769296|FG000|Overall Study|Adverse Event|13|||
48704752|NCT00658359|156769297|FG001|Overall Study|Adverse Event|6|||
48704753|NCT00658359|156769298|FG002|Overall Study|Adverse Event|9|||
48704754|NCT00658359|156769296|FG000|Overall Study|Protocol Violation|1|||
48704755|NCT00658359|156769297|FG001|Overall Study|Protocol Violation|0|||
48704756|NCT00658359|156769298|FG002|Overall Study|Protocol Violation|0|||
48704757|NCT00658359|156769296|FG000|Overall Study|Includes protocol Amendments 3 and 4|2|||
48704758|NCT00658359|156769297|FG001|Overall Study|Includes protocol Amendments 3 and 4|31|||
48704759|NCT00658359|156769298|FG002|Overall Study|Includes protocol Amendments 3 and 4|29|||
48704760|NCT00658359|156769296|FG000|Overall Study|Withdrawal by Subject|7|||
48704761|NCT00658359|156769297|FG001|Overall Study|Withdrawal by Subject|4|||
48704762|NCT00658359|156769298|FG002|Overall Study|Withdrawal by Subject|2|||
48704763|NCT00658359|156769296|FG000|Overall Study|Lost to Follow-up|2|||
48704764|NCT00658359|156769297|FG001|Overall Study|Lost to Follow-up|2|||
48704765|NCT00658359|156769298|FG002|Overall Study|Lost to Follow-up|4|||
48704766|NCT00658359|156769296|FG000|Overall Study|Lack of Efficacy|0|||
48704767|NCT00658359|156769297|FG001|Overall Study|Lack of Efficacy|1|||
48704768|NCT00658359|156769298|FG002|Overall Study|Lack of Efficacy|0|||
48704769|NCT02919995|156769299|FG000|Overall Study|Adverse Event|0|||
48704770|NCT02919995|156769300|FG001|Overall Study|Adverse Event|0|||
48704771|NCT02919995|156769301|FG002|Overall Study|Adverse Event|0|||
48704772|NCT02919995|156769302|FG003|Overall Study|Adverse Event|0|||
48704773|NCT02919995|156769303|FG004|Overall Study|Adverse Event|0|||
48704774|NCT02919995|156769304|FG005|Overall Study|Adverse Event|1|||
48704775|NCT00297258|156769306|FG000|Overall Study|Disease Progression, Relapse, Death|120|||
48704776|NCT00297258|156769306|FG000|Overall Study|Toxicity (or Toxic Death)|10|||
48704777|NCT00297258|156769306|FG000|Overall Study|Patient Refusal: Not Related to Toxicity|2|||
48704778|NCT00297258|156769306|FG000|Overall Study|Intercurrent Illness|3|||
48704779|NCT00297258|156769306|FG000|Overall Study|Intercurrent Death|2|||
48704780|NCT00297258|156769306|FG000|Overall Study|Deteriorization of General Condition|1|||
48704781|NCT00297258|156769306|FG000|Overall Study|Radiotherapy to Destroy Last Lesion|1|||
48704782|NCT00297258|156769306|FG000|Overall Study|Surgery Performed on Target Lesion|1|||
48704783|NCT00297258|156769306|FG000|Overall Study|Switch to Commercial Treatment|1|||
48704784|NCT00297258|156769306|FG000|Overall Study|Interruption: Cold/Flu-like Symptoms|1|||
48704785|NCT01263197|156769307|FG000|First Intervention (Period 1)|Adverse Event|0|||
48704786|NCT01263197|156769308|FG001|First Intervention (Period 1)|Adverse Event|0|||
48704787|NCT01263197|156769309|FG002|First Intervention (Period 1)|Adverse Event|0|||
48704788|NCT01263197|156769310|FG003|First Intervention (Period 1)|Adverse Event|0|||
48704789|NCT01263197|156769311|FG004|First Intervention (Period 1)|Adverse Event|0|||
48704790|NCT01263197|156769312|FG005|First Intervention (Period 1)|Adverse Event|1|||
48704791|NCT01263197|156769307|FG000|Washout Period 1|Protocol Violation|0|||
48704792|NCT01263197|156769308|FG001|Washout Period 1|Protocol Violation|0|||
48704793|NCT01263197|156769309|FG002|Washout Period 1|Protocol Violation|0|||
48704794|NCT01263197|156769310|FG003|Washout Period 1|Protocol Violation|0|||
48704795|NCT01263197|156769311|FG004|Washout Period 1|Protocol Violation|1|||
48704796|NCT01263197|156769312|FG005|Washout Period 1|Protocol Violation|0|||
48704797|NCT01263197|156769307|FG000|Washout Period 2|Physician Decision|0|||
48704798|NCT01263197|156769308|FG001|Washout Period 2|Physician Decision|0|||
48704799|NCT01263197|156769309|FG002|Washout Period 2|Physician Decision|0|||
48704800|NCT01263197|156769310|FG003|Washout Period 2|Physician Decision|0|||
48704801|NCT01263197|156769311|FG004|Washout Period 2|Physician Decision|0|||
48704802|NCT01263197|156769312|FG005|Washout Period 2|Physician Decision|1|||
48704803|NCT01263197|156769307|FG000|Washout Period 2|Protocol Violation|0|||
48704804|NCT01263197|156769308|FG001|Washout Period 2|Protocol Violation|0|||
48704805|NCT01263197|156769309|FG002|Washout Period 2|Protocol Violation|0|||
48704806|NCT01263197|156769310|FG003|Washout Period 2|Protocol Violation|1|||
48704807|NCT01263197|156769311|FG004|Washout Period 2|Protocol Violation|0|||
48704808|NCT01263197|156769312|FG005|Washout Period 2|Protocol Violation|0|||
48704809|NCT01263197|156769307|FG000|Third Intervention (Period 3)|Adverse Event|0|||
48704810|NCT01263197|156769308|FG001|Third Intervention (Period 3)|Adverse Event|1|||
48704811|NCT01263197|156769309|FG002|Third Intervention (Period 3)|Adverse Event|0|||
48704812|NCT01263197|156769310|FG003|Third Intervention (Period 3)|Adverse Event|0|||
48704813|NCT01263197|156769311|FG004|Third Intervention (Period 3)|Adverse Event|0|||
48704814|NCT01263197|156769312|FG005|Third Intervention (Period 3)|Adverse Event|0|||
48704815|NCT01055197|156769313|FG000|Overall Study|Protocol Violation|7|||
48704816|NCT01055197|156769314|FG001|Overall Study|Protocol Violation|2|||
48704817|NCT01055197|156769313|FG000|Overall Study|Withdrawal by Subject|2|||
48704818|NCT01055197|156769314|FG001|Overall Study|Withdrawal by Subject|0|||
48704819|NCT03818321|156769315|FG000|Overall Study|Withdrawal by Subject|1|||
48704820|NCT03818321|156769316|FG001|Overall Study|Withdrawal by Subject|2|||
48704821|NCT01470326|156769317|FG000|Overall Study|Protocol Violation|32|||
48704822|NCT01470326|156769317|FG000|Overall Study|No Drug Administration Information|2|||
48704823|NCT01470326|156769317|FG000|Overall Study|No Visit After 1st Day of Treatment|119|||
48704824|NCT01166282|156769318|FG000|Open-label Period|Adverse Event|0|||
48704825|NCT01166282|156769319|FG001|Open-label Period|Adverse Event|0|||
48704826|NCT01166282|156769320|FG002|Open-label Period|Adverse Event|6|||
48704827|NCT01166282|156769318|FG000|Open-label Period|Withdrawal by Subject|0|||
48704828|NCT01166282|156769319|FG001|Open-label Period|Withdrawal by Subject|0|||
48704829|NCT01166282|156769320|FG002|Open-label Period|Withdrawal by Subject|4|||
48704830|NCT01166282|156769318|FG000|Open-label Period|Lack of Efficacy|0|||
48704831|NCT01166282|156769319|FG001|Open-label Period|Lack of Efficacy|0|||
48704832|NCT01166282|156769320|FG002|Open-label Period|Lack of Efficacy|2|||
48704833|NCT01166282|156769318|FG000|Open-label Period|Remission|0|||
48704834|NCT01166282|156769319|FG001|Open-label Period|Remission|0|||
48704835|NCT01166282|156769320|FG002|Open-label Period|Remission|4|||
48704836|NCT01166282|156769318|FG000|Open-label Period|Irregular Compliance|0|||
48704837|NCT01166282|156769319|FG001|Open-label Period|Irregular Compliance|0|||
48704838|NCT01166282|156769320|FG002|Open-label Period|Irregular Compliance|1|||
48704839|NCT00811018|156769323|FG000|Overall Study|Additional Chronic Treatment|31|||
48704840|NCT00811018|156769323|FG000|Overall Study|Adverse Event|79|||
48704841|NCT00811018|156769323|FG000|Overall Study|Death|147|||
48704842|NCT00811018|156769323|FG000|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4|||
48704843|NCT00811018|156769323|FG000|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70|||
48704844|NCT00811018|156769323|FG000|Overall Study|Investigator Decision|57|||
48704845|NCT00811018|156769323|FG000|Overall Study|Lost to Follow-up|19|||
48704846|NCT00811018|156769323|FG000|Overall Study|Pregnancy|6|||
48704847|NCT00811018|156769323|FG000|Overall Study|Sponsor Decision|450|||
48704848|NCT00811018|156769323|FG000|Overall Study|Withdrawal by Subject|70|||
48704849|NCT00811018|156769323|FG000|Overall Study|WHO FC deterioration and 6MWD decrease|9|||
48704850|NCT00811018|156769323|FG000|Overall Study|Other|26|||
48704851|NCT00345358|156769331|FG000|Primary Vaccination Phase|Other|0|||
48704852|NCT00345358|156769332|FG001|Primary Vaccination Phase|Other|1|||
48704853|NCT00345358|156769333|FG002|Primary Vaccination Phase|Other|1|||
48704854|NCT00345358|156769334|FG003|Primary Vaccination Phase|Other|0|||
48704855|NCT00345358|156769331|FG000|Primary Vaccination Phase|Adverse event, non-fatal|3|||
48704856|NCT00345358|156769332|FG001|Primary Vaccination Phase|Adverse event, non-fatal|1|||
48704857|NCT00345358|156769333|FG002|Primary Vaccination Phase|Adverse event, non-fatal|1|||
48704858|NCT00345358|156769334|FG003|Primary Vaccination Phase|Adverse event, non-fatal|0|||
48704859|NCT00345358|156769331|FG000|Primary Vaccination Phase|Withdrawal by Subject|1|||
48704860|NCT00345358|156769332|FG001|Primary Vaccination Phase|Withdrawal by Subject|2|||
48704861|NCT00345358|156769333|FG002|Primary Vaccination Phase|Withdrawal by Subject|4|||
48704862|NCT00345358|156769334|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
48704863|NCT00345358|156769331|FG000|Primary Vaccination Phase|Lost to Follow-up|1|||
48704864|NCT00345358|156769332|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
48704865|NCT00345358|156769333|FG002|Primary Vaccination Phase|Lost to Follow-up|2|||
48704866|NCT00345358|156769334|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
48704867|NCT00345358|156769331|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
48704868|NCT00345358|156769332|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
48704869|NCT00345358|156769333|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
48704870|NCT00345358|156769334|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
48704871|NCT00345358|156769331|FG000|Booster Vaccination Phase|Lost to Follow-up|3|||
48704872|NCT00345358|156769332|FG001|Booster Vaccination Phase|Lost to Follow-up|0|||
48704873|NCT00345358|156769333|FG002|Booster Vaccination Phase|Lost to Follow-up|0|||
48704874|NCT00345358|156769334|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
48704875|NCT02892448|156769336|FG000|Overall Study|Screening failure|2|||
48704876|NCT02892448|156769337|FG001|Overall Study|Screening failure|2|||
48704877|NCT02892448|156769338|FG002|Overall Study|Screening failure|1|||
48704878|NCT01012440|156769341|FG000|Overall Study|Withdrawal by Subject|2|||
48704879|NCT01867671|156769342|FG000|Overall Study|Adverse Event|5|||
48704880|NCT01867671|156769343|FG001|Overall Study|Adverse Event|3|||
48704881|NCT01867671|156769342|FG000|Overall Study|Anaphylaxis|0|||
48704882|NCT01867671|156769343|FG001|Overall Study|Anaphylaxis|1|||
48704883|NCT01867671|156769342|FG000|Overall Study|Inability to reach 3 mg peanut/placebo|2|||
48704884|NCT01867671|156769343|FG001|Overall Study|Inability to reach 3 mg peanut/placebo|0|||
48704885|NCT01867671|156769342|FG000|Overall Study|Lost to Follow-up|0|||
48704886|NCT01867671|156769343|FG001|Overall Study|Lost to Follow-up|1|||
48704887|NCT01867671|156769342|FG000|Overall Study|Non-compliance with Study Drug|1|||
48704888|NCT01867671|156769343|FG001|Overall Study|Non-compliance with Study Drug|2|||
48704889|NCT01867671|156769342|FG000|Overall Study|Withdrawal by Subject|21|||
48704890|NCT01867671|156769343|FG001|Overall Study|Withdrawal by Subject|21|||
48704891|NCT03599089|156769344|FG000|Overall Study|Lost to Follow-up|1|||
48704892|NCT03599089|156769345|FG001|Overall Study|Lost to Follow-up|0|||
48704893|NCT03599089|156769346|FG002|Overall Study|Lost to Follow-up|0|||
48704894|NCT03599089|156769347|FG003|Overall Study|Lost to Follow-up|0|||
48704895|NCT03599089|156769344|FG000|Overall Study|Withdrawal by Subject|2|||
48704896|NCT03599089|156769345|FG001|Overall Study|Withdrawal by Subject|1|||
48704897|NCT03599089|156769346|FG002|Overall Study|Withdrawal by Subject|0|||
48704898|NCT03599089|156769347|FG003|Overall Study|Withdrawal by Subject|0|||
48704899|NCT03599089|156769344|FG000|Overall Study|Lack of Efficacy|0|||
48704900|NCT03599089|156769345|FG001|Overall Study|Lack of Efficacy|0|||
48704901|NCT03599089|156769346|FG002|Overall Study|Lack of Efficacy|1|||
48704902|NCT03599089|156769347|FG003|Overall Study|Lack of Efficacy|2|||
48704903|NCT01523366|156769348|FG000|Treatment Period 1|Withdrawal by Subject|1|||
48704904|NCT01523366|156769349|FG001|Treatment Period 1|Withdrawal by Subject|0|||
48704905|NCT01523366|156769348|FG000|Treatment Period 2|Not completed at least 7 days treatment|1|||
48704906|NCT01523366|156769349|FG001|Treatment Period 2|Not completed at least 7 days treatment|0|||
48704907|NCT00131248|156769350|FG000|Intervention 1 (3-day Course)|Withdrawal by Subject|1|||
48704908|NCT00131248|156769351|FG001|Intervention 1 (3-day Course)|Withdrawal by Subject|0|||
48704909|NCT02504151|156769354|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
48704910|NCT02504151|156769355|FG001|First Intervention (4 Weeks)|Physician Decision|1|||
48704911|NCT02504151|156769354|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
48704912|NCT02504151|156769355|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
48704913|NCT02504151|156769354|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
48704914|NCT02504151|156769355|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
48704915|NCT02504151|156769354|FG000|Second Intervention (4 Weeks)|Physician Decision|2|||
48704916|NCT02504151|156769355|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
48704917|NCT00318643|156769356|FG000|Overall Study|Adverse Event|0|||
48704918|NCT00318643|156769357|FG001|Overall Study|Adverse Event|0|||
48704919|NCT00318643|156769358|FG002|Overall Study|Adverse Event|0|||
48704920|NCT00318643|156769359|FG003|Overall Study|Adverse Event|0|||
48704921|NCT00318643|156769360|FG004|Overall Study|Adverse Event|1|||
48704922|NCT00318643|156769356|FG000|Overall Study|Participant's Decision|0|||
48704923|NCT00318643|156769357|FG001|Overall Study|Participant's Decision|0|||
48704924|NCT00318643|156769358|FG002|Overall Study|Participant's Decision|0|||
48704925|NCT00318643|156769359|FG003|Overall Study|Participant's Decision|0|||
48704926|NCT00318643|156769360|FG004|Overall Study|Participant's Decision|1|||
48704927|NCT00318643|156769356|FG000|Overall Study|Investigator's Decision|0|||
48704928|NCT00318643|156769357|FG001|Overall Study|Investigator's Decision|0|||
48704929|NCT00318643|156769358|FG002|Overall Study|Investigator's Decision|0|||
48704930|NCT00318643|156769359|FG003|Overall Study|Investigator's Decision|0|||
48704931|NCT00318643|156769360|FG004|Overall Study|Investigator's Decision|1|||
48704932|NCT03051178|156769361|FG000|Overall Study|Withdrawal by Subject|5|||
48704933|NCT01454102|156769362|FG000|Overall Study|Continuing in the treatment period|0|||
48704934|NCT01454102|156769363|FG001|Overall Study|Continuing in the treatment period|0|||
48704935|NCT01454102|156769364|FG002|Overall Study|Continuing in the treatment period|0|||
48704936|NCT01454102|156769365|FG003|Overall Study|Continuing in the treatment period|0|||
48704937|NCT01454102|156769366|FG004|Overall Study|Continuing in the treatment period|3|||
48704938|NCT01454102|156769367|FG005|Overall Study|Continuing in the treatment period|3|||
48704939|NCT01454102|156769368|FG006|Overall Study|Continuing in the treatment period|2|||
48704940|NCT01454102|156769369|FG007|Overall Study|Continuing in the treatment period|0|||
48704941|NCT01454102|156769370|FG008|Overall Study|Continuing in the treatment period|1|||
48704942|NCT01454102|156769371|FG009|Overall Study|Continuing in the treatment period|0|||
48704943|NCT01454102|156769372|FG010|Overall Study|Continuing in the treatment period|0|||
48704944|NCT01454102|156769373|FG011|Overall Study|Continuing in the treatment period|4|||
48704945|NCT01454102|156769374|FG012|Overall Study|Continuing in the treatment period|7|||
48704946|NCT01454102|156769375|FG013|Overall Study|Continuing in the treatment period|4|||
48704947|NCT01454102|156769376|FG014|Overall Study|Continuing in the treatment period|3|||
48704948|NCT01454102|156769377|FG015|Overall Study|Continuing in the treatment period|1|||
48704949|NCT00760617|156769381|FG000|Overall Study|Adverse Event|5|||
48704950|NCT00760617|156769382|FG001|Overall Study|Adverse Event|2|||
48704951|NCT00760617|156769383|FG002|Overall Study|Adverse Event|0|||
48704952|NCT00760617|156769381|FG000|Overall Study|Lost to Follow-up|0|||
48704953|NCT00760617|156769382|FG001|Overall Study|Lost to Follow-up|0|||
48704954|NCT00760617|156769383|FG002|Overall Study|Lost to Follow-up|5|||
48704955|NCT01094119|156769385|FG000|Overall Study|Lack of Efficacy|2|||
48704956|NCT01094119|156769386|FG001|Overall Study|Lack of Efficacy|4|||
48704957|NCT01286480|156769388|FG000|Overall Study|Withdrawal by Subject|5|||
48704958|NCT01286480|156769389|FG001|Overall Study|Withdrawal by Subject|3|||
48704959|NCT00993967|156769390|FG000|Overall Study|Adverse Event|8|||
48704960|NCT00993967|156769390|FG000|Overall Study|Death|1|||
48704961|NCT00993967|156769390|FG000|Overall Study|Lost to Follow-up|14|||
48704962|NCT00993967|156769390|FG000|Overall Study|Withdrawal by Subject|36|||
48704963|NCT00993967|156769390|FG000|Overall Study|Protocol Violation|2|||
48704964|NCT00888940|156769391|FG000|Overall Study|Adverse Event|12|||
48704965|NCT00888940|156769392|FG001|Overall Study|Adverse Event|3|||
48704966|NCT00888940|156769391|FG000|Overall Study|Lost to Follow-up|5|||
48704967|NCT00888940|156769392|FG001|Overall Study|Lost to Follow-up|5|||
48704968|NCT00888940|156769391|FG000|Overall Study|Randomized Not Treated|11|||
48704969|NCT00888940|156769392|FG001|Overall Study|Randomized Not Treated|13|||
48704970|NCT02141204|156769395|FG000|Overall Study|Lost to Follow-up|2|||
48704971|NCT02141204|156769396|FG001|Overall Study|Lost to Follow-up|1|||
48704972|NCT02141204|156769395|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1|||
48912713|NCT02409290|157517558|FG003|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
48912714|NCT03625687|157517559|FG000|Overall Study|Death|1|||
48912715|NCT00888381|157517562|FG000|Overall Study|Lost to Follow-up|0|||
48912716|NCT00888381|157517563|FG001|Overall Study|Lost to Follow-up|1|||
48912717|NCT00097773|157517564|FG000|Overall Study|Lost to Follow-up|2|||
48912718|NCT00097773|157517565|FG001|Overall Study|Lost to Follow-up|2|||
48912719|NCT00097773|157517566|FG002|Overall Study|Lost to Follow-up|0|||
48912720|NCT00097773|157517567|FG003|Overall Study|Lost to Follow-up|1|||
48912721|NCT00097773|157517564|FG000|Overall Study|Physician Decision|2|||
48912722|NCT00097773|157517565|FG001|Overall Study|Physician Decision|2|||
48912723|NCT00097773|157517566|FG002|Overall Study|Physician Decision|3|||
48912724|NCT00097773|157517567|FG003|Overall Study|Physician Decision|1|||
48912725|NCT00097773|157517564|FG000|Overall Study|Withdrawal by Subject|3|||
48912726|NCT00097773|157517565|FG001|Overall Study|Withdrawal by Subject|3|||
48912727|NCT00097773|157517566|FG002|Overall Study|Withdrawal by Subject|3|||
48912728|NCT00097773|157517567|FG003|Overall Study|Withdrawal by Subject|1|||
48912729|NCT00097773|157517564|FG000|Overall Study|Adverse Event|0|||
48912730|NCT00097773|157517565|FG001|Overall Study|Adverse Event|1|||
48912731|NCT00097773|157517566|FG002|Overall Study|Adverse Event|0|||
48912732|NCT00097773|157517567|FG003|Overall Study|Adverse Event|0|||
48912733|NCT00097773|157517564|FG000|Overall Study|Other|1|||
48912734|NCT00097773|157517565|FG001|Overall Study|Other|0|||
48912735|NCT00097773|157517566|FG002|Overall Study|Other|2|||
48912736|NCT00097773|157517567|FG003|Overall Study|Other|0|||
49118733|NCT01831427|158273187|FG002|Overall Study|Withdrew Consent|0|||
48704973|NCT02141204|156769396|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2|||
48704974|NCT02141204|156769395|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
48704975|NCT02141204|156769396|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5|||
48704976|NCT02141204|156769395|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9|||
48704977|NCT02141204|156769396|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7|||
48704978|NCT03224819|156769397|FG000|Overall Study|Withdrawal by Subject|0|||
48704979|NCT03224819|156769398|FG001|Overall Study|Withdrawal by Subject|0|||
48704980|NCT03224819|156769399|FG002|Overall Study|Withdrawal by Subject|0|||
48704981|NCT03224819|156769400|FG003|Overall Study|Withdrawal by Subject|0|||
48704982|NCT03224819|156769401|FG004|Overall Study|Withdrawal by Subject|0|||
48704983|NCT03224819|156769402|FG005|Overall Study|Withdrawal by Subject|0|||
48704984|NCT03224819|156769403|FG006|Overall Study|Withdrawal by Subject|0|||
48704985|NCT03224819|156769404|FG007|Overall Study|Withdrawal by Subject|0|||
48704986|NCT03224819|156769405|FG008|Overall Study|Withdrawal by Subject|0|||
48704987|NCT03224819|156769406|FG009|Overall Study|Withdrawal by Subject|0|||
48704988|NCT03224819|156769407|FG010|Overall Study|Withdrawal by Subject|0|||
48704989|NCT03224819|156769408|FG011|Overall Study|Withdrawal by Subject|0|||
48704990|NCT03224819|156769409|FG012|Overall Study|Withdrawal by Subject|1|||
48704991|NCT03224819|156769410|FG013|Overall Study|Withdrawal by Subject|0|||
48704992|NCT03224819|156769397|FG000|Overall Study|Sponsor Decision|0|||
48704993|NCT03224819|156769398|FG001|Overall Study|Sponsor Decision|0|||
48704994|NCT03224819|156769399|FG002|Overall Study|Sponsor Decision|0|||
48704995|NCT03224819|156769400|FG003|Overall Study|Sponsor Decision|1|||
48912737|NCT00003702|157517568|FG000|Overall Study|Ineligible cell types|2|||
48912738|NCT00003702|157517569|FG001|Overall Study|Ineligible cell types|2|||
48704996|NCT03224819|156769401|FG004|Overall Study|Sponsor Decision|1|||
48704997|NCT03224819|156769402|FG005|Overall Study|Sponsor Decision|2|||
48912739|NCT00003702|157517568|FG000|Overall Study|Did not meet criteria for persistence|8|||
48912740|NCT00003702|157517569|FG001|Overall Study|Did not meet criteria for persistence|5|||
48704998|NCT03224819|156769403|FG006|Overall Study|Sponsor Decision|1|||
48704999|NCT03224819|156769404|FG007|Overall Study|Sponsor Decision|1|||
48705000|NCT03224819|156769405|FG008|Overall Study|Sponsor Decision|1|||
48912741|NCT00003702|157517568|FG000|Overall Study|WHO score > 6|2|||
48705001|NCT03224819|156769406|FG009|Overall Study|Sponsor Decision|2|||
48705002|NCT03224819|156769407|FG010|Overall Study|Sponsor Decision|1|||
48705003|NCT03224819|156769408|FG011|Overall Study|Sponsor Decision|1|||
48705004|NCT03224819|156769409|FG012|Overall Study|Sponsor Decision|1|||
48705005|NCT03224819|156769410|FG013|Overall Study|Sponsor Decision|0|||
48705006|NCT03224819|156769397|FG000|Overall Study|Lost to Follow-up|0|||
48705007|NCT03224819|156769398|FG001|Overall Study|Lost to Follow-up|0|||
48705008|NCT03224819|156769399|FG002|Overall Study|Lost to Follow-up|0|||
48705009|NCT03224819|156769400|FG003|Overall Study|Lost to Follow-up|0|||
48705010|NCT03224819|156769401|FG004|Overall Study|Lost to Follow-up|0|||
48705011|NCT03224819|156769402|FG005|Overall Study|Lost to Follow-up|0|||
48705012|NCT03224819|156769403|FG006|Overall Study|Lost to Follow-up|0|||
48705013|NCT03224819|156769404|FG007|Overall Study|Lost to Follow-up|0|||
48705014|NCT03224819|156769405|FG008|Overall Study|Lost to Follow-up|1|||
48705015|NCT03224819|156769406|FG009|Overall Study|Lost to Follow-up|0|||
48705016|NCT03224819|156769407|FG010|Overall Study|Lost to Follow-up|0|||
48705017|NCT03224819|156769408|FG011|Overall Study|Lost to Follow-up|0|||
48705018|NCT03224819|156769409|FG012|Overall Study|Lost to Follow-up|0|||
48705019|NCT03224819|156769410|FG013|Overall Study|Lost to Follow-up|0|||
48705020|NCT03224819|156769397|FG000|Overall Study|Death|0|||
48705021|NCT03224819|156769398|FG001|Overall Study|Death|1|||
48705022|NCT03224819|156769399|FG002|Overall Study|Death|0|||
48705023|NCT03224819|156769400|FG003|Overall Study|Death|0|||
48705024|NCT03224819|156769401|FG004|Overall Study|Death|0|||
48705025|NCT03224819|156769402|FG005|Overall Study|Death|0|||
48705026|NCT03224819|156769403|FG006|Overall Study|Death|0|||
48705027|NCT03224819|156769404|FG007|Overall Study|Death|1|||
48705028|NCT03224819|156769405|FG008|Overall Study|Death|0|||
48705029|NCT03224819|156769406|FG009|Overall Study|Death|0|||
48705030|NCT03224819|156769407|FG010|Overall Study|Death|0|||
48705031|NCT03224819|156769408|FG011|Overall Study|Death|1|||
48705032|NCT03224819|156769409|FG012|Overall Study|Death|0|||
48705033|NCT03224819|156769410|FG013|Overall Study|Death|0|||
48705034|NCT02506244|156769413|FG000|Overall Study|Did not undergo active monitoring|458|||
48705035|NCT02506244|156769414|FG001|Overall Study|Did not undergo active monitoring|459|||
48705036|NCT02506244|156769415|FG002|Overall Study|Did not undergo active monitoring|0|||
48705037|NCT04986904|156769429|FG000|Overall Study|Lost to Follow-up|11|||
48705038|NCT04986904|156769429|FG000|Overall Study|Withdrawal by Subject|1|||
48705039|NCT04161157|156769430|FG000|Overall Study|Lost to Follow-up|4|||
48705040|NCT04161157|156769430|FG000|Overall Study|Death|3|||
48705041|NCT04161157|156769430|FG000|Overall Study|Ineligible|2|||
48705042|NCT04161157|156769430|FG000|Overall Study|Withdrawal by Subject|4|||
48705043|NCT00670748|156769440|FG000|Overall Study|Death during treatment|1|||
48705044|NCT00670748|156769441|FG001|Overall Study|Death during treatment|1|||
48705045|NCT00670748|156769442|FG002|Overall Study|Death during treatment|1|||
48705046|NCT00670748|156769443|FG003|Overall Study|Death during treatment|0|||
48705047|NCT00670748|156769440|FG000|Overall Study|Not off study|2|||
48705048|NCT00670748|156769441|FG001|Overall Study|Not off study|1|||
48705049|NCT00670748|156769442|FG002|Overall Study|Not off study|1|||
48705050|NCT00670748|156769443|FG003|Overall Study|Not off study|1|||
48705051|NCT01342211|156769445|FG000|Overall Study|Lost to Follow-up|0|||
48705052|NCT01342211|156769446|FG001|Overall Study|Lost to Follow-up|0|||
48705053|NCT01342211|156769447|FG002|Overall Study|Lost to Follow-up|0|||
48705054|NCT01342211|156769448|FG003|Overall Study|Lost to Follow-up|1|||
48705055|NCT01342211|156769449|FG004|Overall Study|Lost to Follow-up|0|||
48705056|NCT01342211|156769445|FG000|Overall Study|Adverse Event|0|||
48705057|NCT01342211|156769446|FG001|Overall Study|Adverse Event|0|||
48705058|NCT01342211|156769447|FG002|Overall Study|Adverse Event|0|||
48705059|NCT01342211|156769448|FG003|Overall Study|Adverse Event|0|||
48705060|NCT01342211|156769449|FG004|Overall Study|Adverse Event|1|||
48705061|NCT01342211|156769445|FG000|Overall Study|Withdrawal by Subject|0|||
48705062|NCT01342211|156769446|FG001|Overall Study|Withdrawal by Subject|0|||
48705063|NCT01342211|156769447|FG002|Overall Study|Withdrawal by Subject|0|||
48705064|NCT01342211|156769448|FG003|Overall Study|Withdrawal by Subject|1|||
48705065|NCT01342211|156769449|FG004|Overall Study|Withdrawal by Subject|0|||
48705066|NCT01342211|156769445|FG000|Overall Study|Randomized, but not Treated|0|||
48705067|NCT01342211|156769446|FG001|Overall Study|Randomized, but not Treated|2|||
48705068|NCT01342211|156769447|FG002|Overall Study|Randomized, but not Treated|0|||
48705069|NCT01342211|156769448|FG003|Overall Study|Randomized, but not Treated|0|||
48705070|NCT01342211|156769449|FG004|Overall Study|Randomized, but not Treated|1|||
48705071|NCT00912197|156769454|FG000|Overall Study|Withdrawal by Subject|3|||
48705072|NCT00912197|156769455|FG001|Overall Study|Withdrawal by Subject|3|||
48705073|NCT01287741|156769456|FG000|Overall Study|Withdrawal by Subject|35|||
48705074|NCT01287741|156769457|FG001|Overall Study|Withdrawal by Subject|38|||
48705075|NCT01287741|156769456|FG000|Overall Study|Protocol Violation|2|||
48705076|NCT01287741|156769457|FG001|Overall Study|Protocol Violation|0|||
48705077|NCT01287741|156769456|FG000|Overall Study|Physician Decision|15|||
48705078|NCT01287741|156769457|FG001|Overall Study|Physician Decision|23|||
48705079|NCT01287741|156769456|FG000|Overall Study|Non-compliance|8|||
48705080|NCT01287741|156769457|FG001|Overall Study|Non-compliance|6|||
48705081|NCT01287741|156769456|FG000|Overall Study|Lost to Follow-up|10|||
48705082|NCT01287741|156769457|FG001|Overall Study|Lost to Follow-up|8|||
48705083|NCT01287741|156769456|FG000|Overall Study|Death|32|||
48705084|NCT01287741|156769457|FG001|Overall Study|Death|44|||
48705085|NCT01287741|156769456|FG000|Overall Study|Adverse Event|4|||
48705086|NCT01287741|156769457|FG001|Overall Study|Adverse Event|6|||
48705087|NCT01287741|156769456|FG000|Overall Study|Study terminated by Sponsor|307|||
48705088|NCT01287741|156769457|FG001|Overall Study|Study terminated by Sponsor|315|||
48705089|NCT01287741|156769456|FG000|Overall Study|Progressive disease|190|||
48705090|NCT01287741|156769457|FG001|Overall Study|Progressive disease|166|||
48705091|NCT01287741|156769456|FG000|Overall Study|Reason not specified|23|||
48705092|NCT01287741|156769457|FG001|Overall Study|Reason not specified|9|||
48705093|NCT02608684|156771400|FG000|Overall Study|Physician Decision|2|||
48705094|NCT02608684|156771400|FG000|Overall Study|Withdrawal by Subject|1|||
48705095|NCT02202759|156771403|FG000|Overall Study|Study Terminated by Sponsor|3|||
48705096|NCT02202759|156771404|FG001|Overall Study|Study Terminated by Sponsor|3|||
48705097|NCT02202759|156771405|FG002|Overall Study|Study Terminated by Sponsor|3|||
48705098|NCT02202759|156771403|FG000|Overall Study|Withdrawal by Subject|2|||
48705099|NCT02202759|156771404|FG001|Overall Study|Withdrawal by Subject|1|||
48705100|NCT02202759|156771405|FG002|Overall Study|Withdrawal by Subject|1|||
48705101|NCT02202759|156771403|FG000|Overall Study|Reason not Specified|4|||
48705102|NCT02202759|156771404|FG001|Overall Study|Reason not Specified|11|||
48705103|NCT02202759|156771405|FG002|Overall Study|Reason not Specified|10|||
48705104|NCT01083771|156771406|FG000|Overall Study|non-compliant|2|||
48705105|NCT01083771|156771406|FG000|Overall Study|Withdrawal by Subject|3|||
48705106|NCT03841604|156771409|FG000|Overall Study|Withdrawal by Subject|3|||
48705107|NCT03841604|156771410|FG001|Overall Study|Withdrawal by Subject|1|||
48705108|NCT03841604|156771409|FG000|Overall Study|Adverse Event|4|||
48705109|NCT03841604|156771410|FG001|Overall Study|Adverse Event|2|||
48705110|NCT03841604|156771409|FG000|Overall Study|Physician Decision|1|||
48705111|NCT03841604|156771410|FG001|Overall Study|Physician Decision|0|||
48705112|NCT02492763|156771411|FG000|Overall Study|Withdrawal by Subject|0|||
48705113|NCT02492763|156771412|FG001|Overall Study|Withdrawal by Subject|2|||
48705114|NCT02492763|156771413|FG002|Overall Study|Withdrawal by Subject|1|||
48705115|NCT02492763|156771414|FG003|Overall Study|Withdrawal by Subject|0|||
48705116|NCT02492763|156771411|FG000|Overall Study|Adverse Event|3|||
48705117|NCT02492763|156771412|FG001|Overall Study|Adverse Event|1|||
48705118|NCT02492763|156771413|FG002|Overall Study|Adverse Event|1|||
48705119|NCT02492763|156771414|FG003|Overall Study|Adverse Event|2|||
48705120|NCT02492763|156771411|FG000|Overall Study|Death|0|||
48705121|NCT02492763|156771412|FG001|Overall Study|Death|0|||
48705122|NCT02492763|156771413|FG002|Overall Study|Death|1|||
48705123|NCT02492763|156771414|FG003|Overall Study|Death|0|||
48705124|NCT02492763|156771411|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
48705125|NCT02492763|156771412|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|1|||
48705126|NCT02492763|156771413|FG002|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
48705127|NCT02492763|156771414|FG003|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
48705128|NCT02492763|156771411|FG000|Overall Study|Lost to Follow-up|0|||
48705129|NCT02492763|156771412|FG001|Overall Study|Lost to Follow-up|0|||
48705130|NCT02492763|156771413|FG002|Overall Study|Lost to Follow-up|1|||
48705131|NCT02492763|156771414|FG003|Overall Study|Lost to Follow-up|0|||
48705132|NCT02492763|156771411|FG000|Overall Study|Non-Compliance With Study Drug|0|||
48705133|NCT02492763|156771412|FG001|Overall Study|Non-Compliance With Study Drug|1|||
48705134|NCT02492763|156771413|FG002|Overall Study|Non-Compliance With Study Drug|0|||
48705135|NCT02492763|156771414|FG003|Overall Study|Non-Compliance With Study Drug|0|||
48705136|NCT02492763|156771411|FG000|Overall Study|Screen Failure|0|||
48705137|NCT02492763|156771412|FG001|Overall Study|Screen Failure|0|||
48705138|NCT02492763|156771413|FG002|Overall Study|Screen Failure|0|||
48705139|NCT02492763|156771414|FG003|Overall Study|Screen Failure|1|||
48705140|NCT02492763|156771411|FG000|Overall Study|Study Terminated by Sponsor|13|||
48705141|NCT02492763|156771412|FG001|Overall Study|Study Terminated by Sponsor|10|||
48705142|NCT02492763|156771413|FG002|Overall Study|Study Terminated by Sponsor|6|||
48705143|NCT02492763|156771414|FG003|Overall Study|Study Terminated by Sponsor|10|||
48705144|NCT03848832|156771415|FG000|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
48705145|NCT03848832|156771416|FG001|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
48705146|NCT03848832|156771417|FG002|Overall Study|Withdrawal of Consent Due To Covid-19|1|||
48705147|NCT03848832|156771415|FG000|Overall Study|Withdrawal by Subject|0|||
48705148|NCT03848832|156771416|FG001|Overall Study|Withdrawal by Subject|0|||
48705149|NCT03848832|156771417|FG002|Overall Study|Withdrawal by Subject|1|||
48912742|NCT00003702|157517569|FG001|Overall Study|WHO score > 6|1|||
48705150|NCT03848832|156771415|FG000|Overall Study|Withdrawal (Covid-19)|0|||
48705151|NCT03848832|156771416|FG001|Overall Study|Withdrawal (Covid-19)|2|||
48705152|NCT03848832|156771417|FG002|Overall Study|Withdrawal (Covid-19)|0|||
48705153|NCT03848832|156771415|FG000|Overall Study|Physician Decision|2|||
48705154|NCT03848832|156771416|FG001|Overall Study|Physician Decision|1|||
48705155|NCT03848832|156771417|FG002|Overall Study|Physician Decision|3|||
48705156|NCT03848832|156771415|FG000|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
48705157|NCT03848832|156771416|FG001|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
48705158|NCT03848832|156771417|FG002|Overall Study|Sponsor Decision - Covid-19 Precaution|1|||
48705159|NCT03848832|156771415|FG000|Overall Study|Adverse Event|1|||
48705160|NCT03848832|156771416|FG001|Overall Study|Adverse Event|0|||
48705161|NCT03848832|156771417|FG002|Overall Study|Adverse Event|0|||
48705162|NCT02453321|156771418|FG000|Overall Study|Weakness|1|||
48705163|NCT02453321|156771419|FG001|Overall Study|Weakness|1|||
48705164|NCT02453321|156771420|FG002|Overall Study|Weakness|2|||
48705165|NCT02453321|156771418|FG000|Overall Study|Deep Venous Thrombosis|0|||
48705166|NCT02453321|156771419|FG001|Overall Study|Deep Venous Thrombosis|1|||
48705167|NCT02453321|156771420|FG002|Overall Study|Deep Venous Thrombosis|0|||
48705168|NCT00882557|156771422|FG000|Overall Study|Withdrawal by Subject|1|||
48705169|NCT00882557|156771423|FG001|Overall Study|Withdrawal by Subject|0|||
48705170|NCT00882557|156771422|FG000|Overall Study|Trouble with Vein Access|1|||
48705171|NCT00882557|156771423|FG001|Overall Study|Trouble with Vein Access|0|||
48705172|NCT00882557|156771422|FG000|Overall Study|Randomized Not Treated|0|||
48705173|NCT00882557|156771423|FG001|Overall Study|Randomized Not Treated|1|||
48705174|NCT02633306|156771426|FG000|Overall Study|Withdrawal by Subject|3|||
48705175|NCT00998296|156771427|FG000|Overall Study|Progressive disease|0|||
48705176|NCT00998296|156771428|FG001|Overall Study|Progressive disease|1|||
48705177|NCT00998296|156771429|FG002|Overall Study|Progressive disease|0|||
48705178|NCT00998296|156771430|FG003|Overall Study|Progressive disease|0|||
48705179|NCT00998296|156771431|FG004|Overall Study|Progressive disease|0|||
48705180|NCT00998296|156771432|FG005|Overall Study|Progressive disease|0|||
48705181|NCT00998296|156771433|FG006|Overall Study|Progressive disease|1|||
48705182|NCT00998296|156771434|FG007|Overall Study|Progressive disease|0|||
48705183|NCT00998296|156771435|FG008|Overall Study|Progressive disease|0|||
48705184|NCT00998296|156771436|FG009|Overall Study|Progressive disease|14|||
48705185|NCT00998296|156771437|FG010|Overall Study|Progressive disease|5|||
48705186|NCT00998296|156771427|FG000|Overall Study|Dose limiting or dose reducing toxicity|0|||
48705187|NCT00998296|156771428|FG001|Overall Study|Dose limiting or dose reducing toxicity|0|||
48705188|NCT00998296|156771429|FG002|Overall Study|Dose limiting or dose reducing toxicity|0|||
48705189|NCT00998296|156771430|FG003|Overall Study|Dose limiting or dose reducing toxicity|0|||
48705190|NCT00998296|156771431|FG004|Overall Study|Dose limiting or dose reducing toxicity|1|||
48705191|NCT00998296|156771432|FG005|Overall Study|Dose limiting or dose reducing toxicity|0|||
48705192|NCT00998296|156771433|FG006|Overall Study|Dose limiting or dose reducing toxicity|0|||
48912743|NCT00003702|157517568|FG000|Overall Study|Inadequate documentation of disease|1|||
48912744|NCT00003702|157517569|FG001|Overall Study|Inadequate documentation of disease|3|||
48912745|NCT00733954|157517570|FG000|Overall Study|Lost to Follow-up|5|||
48912746|NCT00733954|157517571|FG001|Overall Study|Lost to Follow-up|2|||
48912747|NCT00733954|157517570|FG000|Overall Study|Protocol Violation|1|||
48912748|NCT00733954|157517571|FG001|Overall Study|Protocol Violation|0|||
48912749|NCT00733954|157517570|FG000|Overall Study|Withdrawal by Subject|2|||
48912750|NCT00733954|157517571|FG001|Overall Study|Withdrawal by Subject|0|||
48912751|NCT00843518|157517572|FG000|Period 2 (Double-blind Treatment)|Adverse Event|5|||
48912752|NCT00843518|157517573|FG001|Period 2 (Double-blind Treatment)|Adverse Event|3|||
48912753|NCT00843518|157517572|FG000|Period 2 (Double-blind Treatment)|Death|0|||
48912754|NCT00843518|157517573|FG001|Period 2 (Double-blind Treatment)|Death|1|||
48912755|NCT00843518|157517572|FG000|Period 2 (Double-blind Treatment)|Lost to Follow-up|2|||
48912756|NCT00843518|157517573|FG001|Period 2 (Double-blind Treatment)|Lost to Follow-up|3|||
48912757|NCT00843518|157517572|FG000|Period 2 (Double-blind Treatment)|Physician Decision|2|||
48912758|NCT00843518|157517573|FG001|Period 2 (Double-blind Treatment)|Physician Decision|1|||
48912759|NCT00843518|157517572|FG000|Period 2 (Double-blind Treatment)|Protocol Violation|2|||
48912760|NCT00843518|157517573|FG001|Period 2 (Double-blind Treatment)|Protocol Violation|5|||
48912761|NCT00843518|157517572|FG000|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2|||
48912762|NCT00843518|157517573|FG001|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0|||
48912763|NCT00843518|157517572|FG000|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
48912764|NCT00843518|157517573|FG001|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
48912765|NCT01226459|157517578|FG000|Overall Study|Adverse Event|2|||
48912766|NCT01226459|157517579|FG001|Overall Study|Adverse Event|8|||
48912767|NCT01226459|157517578|FG000|Overall Study|Protocol Violation|4|||
48912768|NCT01226459|157517579|FG001|Overall Study|Protocol Violation|3|||
48912769|NCT01226459|157517578|FG000|Overall Study|Withdrawal by Subject|10|||
48912770|NCT01226459|157517579|FG001|Overall Study|Withdrawal by Subject|13|||
48912771|NCT01226459|157517578|FG000|Overall Study|Lost to Follow-up|4|||
48912772|NCT01226459|157517579|FG001|Overall Study|Lost to Follow-up|8|||
48912773|NCT01226459|157517578|FG000|Overall Study|Pregnancy|1|||
48912774|NCT01226459|157517579|FG001|Overall Study|Pregnancy|0|||
48912775|NCT00804570|157517585|FG000|Overall Study|Adverse Event|14|||
49118734|NCT01831427|158273188|FG003|Overall Study|Withdrew Consent|0|||
49118735|NCT01831427|158273189|FG004|Overall Study|Withdrew Consent|0|||
49118736|NCT01831427|158273190|FG005|Overall Study|Withdrew Consent|0|||
48705193|NCT00998296|156771434|FG007|Overall Study|Dose limiting or dose reducing toxicity|2|||
48705194|NCT00998296|156771435|FG008|Overall Study|Dose limiting or dose reducing toxicity|2|||
48705195|NCT00998296|156771436|FG009|Overall Study|Dose limiting or dose reducing toxicity|0|||
48705196|NCT00998296|156771437|FG010|Overall Study|Dose limiting or dose reducing toxicity|0|||
48705197|NCT00998296|156771427|FG000|Overall Study|Other adverse event|0|||
48912776|NCT00804570|157517586|FG001|Overall Study|Adverse Event|7|||
48912777|NCT00804570|157517585|FG000|Overall Study|Lack of Efficacy|0|||
48912778|NCT00804570|157517586|FG001|Overall Study|Lack of Efficacy|1|||
48912779|NCT00804570|157517585|FG000|Overall Study|Lost to Follow-up|18|||
48912780|NCT00804570|157517586|FG001|Overall Study|Lost to Follow-up|21|||
48912781|NCT00804570|157517585|FG000|Overall Study|Entry criteria not met|5|||
48912782|NCT00804570|157517586|FG001|Overall Study|Entry criteria not met|5|||
48912783|NCT00804570|157517585|FG000|Overall Study|Protocol Violation|12|||
48912784|NCT00804570|157517586|FG001|Overall Study|Protocol Violation|16|||
48912785|NCT00804570|157517585|FG000|Overall Study|Physician Decision|1|||
48912786|NCT00804570|157517586|FG001|Overall Study|Physician Decision|2|||
48912787|NCT00804570|157517585|FG000|Overall Study|Sponsor decision|1|||
48912788|NCT00804570|157517586|FG001|Overall Study|Sponsor decision|4|||
48912789|NCT00804570|157517585|FG000|Overall Study|Withdrawal by Subject|21|||
48912790|NCT00804570|157517586|FG001|Overall Study|Withdrawal by Subject|38|||
48912791|NCT00199836|157517597|FG000|Overall Study|Progressive Disease|5|||
48912792|NCT00199836|157517597|FG000|Overall Study|Death|1|||
48912793|NCT03061175|157517600|FG000|Baseline|Participant was deemed ineligible|1|||
48912794|NCT03061175|157517601|FG001|Baseline|Participant was deemed ineligible|0|||
48912795|NCT03061175|157517600|FG000|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6|||
48912796|NCT03061175|157517601|FG001|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2|||
48912797|NCT03061175|157517600|FG000|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0|||
48912798|NCT03061175|157517601|FG001|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1|||
48912799|NCT03061175|157517600|FG000|Followup 2 at 6 Months|Lost to Follow-up|4|||
48912800|NCT03061175|157517601|FG001|Followup 2 at 6 Months|Lost to Follow-up|7|||
48912801|NCT03451084|157517604|FG000|Overall Study|Withdrawal by Subject|2|||
48912802|NCT03451084|157517605|FG001|Overall Study|Withdrawal by Subject|1|||
48912803|NCT03451084|157517606|FG002|Overall Study|Withdrawal by Subject|2|||
48912804|NCT03451084|157517607|FG003|Overall Study|Withdrawal by Subject|1|||
48912805|NCT03451084|157517604|FG000|Overall Study|Disease recurrence|0|||
48912806|NCT03451084|157517605|FG001|Overall Study|Disease recurrence|2|||
48912807|NCT03451084|157517606|FG002|Overall Study|Disease recurrence|0|||
48705198|NCT00998296|156771428|FG001|Overall Study|Other adverse event|0|||
48705199|NCT00998296|156771429|FG002|Overall Study|Other adverse event|0|||
48705200|NCT00998296|156771430|FG003|Overall Study|Other adverse event|0|||
48705201|NCT00998296|156771431|FG004|Overall Study|Other adverse event|1|||
48705202|NCT00998296|156771432|FG005|Overall Study|Other adverse event|0|||
48705203|NCT00998296|156771433|FG006|Overall Study|Other adverse event|0|||
48705204|NCT00998296|156771434|FG007|Overall Study|Other adverse event|0|||
48705205|NCT00998296|156771435|FG008|Overall Study|Other adverse event|0|||
48705206|NCT00998296|156771436|FG009|Overall Study|Other adverse event|1|||
48705207|NCT00998296|156771437|FG010|Overall Study|Other adverse event|2|||
48705208|NCT00998296|156771427|FG000|Overall Study|Refused to continue taking trial med.|0|||
48705209|NCT00998296|156771428|FG001|Overall Study|Refused to continue taking trial med.|0|||
48705210|NCT00998296|156771429|FG002|Overall Study|Refused to continue taking trial med.|0|||
48705211|NCT00998296|156771430|FG003|Overall Study|Refused to continue taking trial med.|0|||
48705212|NCT00998296|156771431|FG004|Overall Study|Refused to continue taking trial med.|0|||
48705213|NCT00998296|156771432|FG005|Overall Study|Refused to continue taking trial med.|0|||
48705214|NCT00998296|156771433|FG006|Overall Study|Refused to continue taking trial med.|0|||
48705215|NCT00998296|156771434|FG007|Overall Study|Refused to continue taking trial med.|0|||
48705216|NCT00998296|156771435|FG008|Overall Study|Refused to continue taking trial med.|0|||
48705217|NCT00998296|156771436|FG009|Overall Study|Refused to continue taking trial med.|2|||
48705218|NCT00998296|156771437|FG010|Overall Study|Refused to continue taking trial med.|0|||
48705219|NCT00998296|156771427|FG000|Overall Study|Reason other than those specified above|0|||
48705220|NCT00998296|156771428|FG001|Overall Study|Reason other than those specified above|0|||
48705221|NCT00998296|156771429|FG002|Overall Study|Reason other than those specified above|0|||
48705222|NCT00998296|156771430|FG003|Overall Study|Reason other than those specified above|0|||
48912808|NCT03451084|157517607|FG003|Overall Study|Disease recurrence|0|||
48912809|NCT03451084|157517604|FG000|Overall Study|Lack of Efficacy|0|||
48912810|NCT03451084|157517605|FG001|Overall Study|Lack of Efficacy|3|||
48912811|NCT03451084|157517606|FG002|Overall Study|Lack of Efficacy|0|||
48912812|NCT03451084|157517607|FG003|Overall Study|Lack of Efficacy|1|||
48912813|NCT03451084|157517604|FG000|Overall Study|Death|1|||
48912814|NCT03451084|157517605|FG001|Overall Study|Death|0|||
48912815|NCT03451084|157517606|FG002|Overall Study|Death|2|||
48912816|NCT03451084|157517607|FG003|Overall Study|Death|0|||
48912817|NCT03451084|157517604|FG000|Overall Study|Physician Decision|0|||
49118737|NCT01831427|158273191|FG006|Overall Study|Withdrew Consent|2|||
48912818|NCT03451084|157517605|FG001|Overall Study|Physician Decision|0|||
48705223|NCT00998296|156771431|FG004|Overall Study|Reason other than those specified above|0|||
48912819|NCT03451084|157517606|FG002|Overall Study|Physician Decision|2|||
48912820|NCT03451084|157517607|FG003|Overall Study|Physician Decision|2|||
48912821|NCT03451084|157517604|FG000|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3|||
48705224|NCT00998296|156771432|FG005|Overall Study|Reason other than those specified above|0|||
48705225|NCT00998296|156771433|FG006|Overall Study|Reason other than those specified above|0|||
48705226|NCT00998296|156771434|FG007|Overall Study|Reason other than those specified above|0|||
48705227|NCT00998296|156771435|FG008|Overall Study|Reason other than those specified above|0|||
48705228|NCT00998296|156771436|FG009|Overall Study|Reason other than those specified above|1|||
48705229|NCT00998296|156771437|FG010|Overall Study|Reason other than those specified above|0|||
48705230|NCT01746901|156771438|FG000|Naloxone Challenge Phase|Adverse Event|2|||
48705231|NCT01746901|156771439|FG001|Naloxone Challenge Phase|Adverse Event|0|||
48705232|NCT01746901|156771440|FG002|Naloxone Challenge Phase|Adverse Event|0|||
48705233|NCT01746901|156771441|FG003|Naloxone Challenge Phase|Adverse Event|0|||
48705234|NCT01746901|156771442|FG004|Naloxone Challenge Phase|Adverse Event|0|||
48705235|NCT01746901|156771443|FG005|Naloxone Challenge Phase|Adverse Event|0|||
48705236|NCT01746901|156771444|FG006|Naloxone Challenge Phase|Adverse Event|0|||
48705237|NCT01746901|156771445|FG007|Naloxone Challenge Phase|Adverse Event|0|||
48705238|NCT01746901|156771446|FG008|Naloxone Challenge Phase|Adverse Event|0|||
48705239|NCT01746901|156771438|FG000|Naloxone Challenge Phase|Did not meet entrance criteria|1|||
48705240|NCT01746901|156771439|FG001|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
48705241|NCT01746901|156771440|FG002|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
48705242|NCT01746901|156771441|FG003|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
48705243|NCT01746901|156771442|FG004|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
48705244|NCT01746901|156771443|FG005|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
48705245|NCT01746901|156771444|FG006|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
48705246|NCT01746901|156771445|FG007|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
48705247|NCT01746901|156771446|FG008|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
48705248|NCT01746901|156771438|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
48705249|NCT01746901|156771439|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
48705250|NCT01746901|156771440|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
48705251|NCT01746901|156771441|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
48705252|NCT01746901|156771442|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
48705253|NCT01746901|156771443|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
48705254|NCT01746901|156771444|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
48705255|NCT01746901|156771445|FG007|Drug Discrimination Phase: Day 1|Adverse Event|0|||
48705256|NCT01746901|156771446|FG008|Drug Discrimination Phase: Day 1|Adverse Event|0|||
48705257|NCT01746901|156771438|FG000|Drug Discrimination Phase: Day 2|Adverse Event|0|||
48705258|NCT01746901|156771439|FG001|Drug Discrimination Phase: Day 2|Adverse Event|2|||
48705259|NCT01746901|156771440|FG002|Drug Discrimination Phase: Day 2|Adverse Event|1|||
48705260|NCT01746901|156771441|FG003|Drug Discrimination Phase: Day 2|Adverse Event|0|||
48705261|NCT01746901|156771442|FG004|Drug Discrimination Phase: Day 2|Adverse Event|0|||
48705262|NCT01746901|156771443|FG005|Drug Discrimination Phase: Day 2|Adverse Event|0|||
48705263|NCT01746901|156771444|FG006|Drug Discrimination Phase: Day 2|Adverse Event|0|||
48705264|NCT01746901|156771445|FG007|Drug Discrimination Phase: Day 2|Adverse Event|0|||
48705265|NCT01746901|156771446|FG008|Drug Discrimination Phase: Day 2|Adverse Event|0|||
48705266|NCT01746901|156771438|FG000|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
48705267|NCT01746901|156771439|FG001|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9|||
48705268|NCT01746901|156771440|FG002|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10|||
48705269|NCT01746901|156771441|FG003|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
48705270|NCT01746901|156771442|FG004|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
48705271|NCT01746901|156771443|FG005|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
48705272|NCT01746901|156771444|FG006|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
48705273|NCT01746901|156771445|FG007|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
48705274|NCT01746901|156771446|FG008|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
48705275|NCT01746901|156771438|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
48705276|NCT01746901|156771439|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
48705277|NCT01746901|156771440|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
48705278|NCT01746901|156771441|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
48705279|NCT01746901|156771442|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
48705280|NCT01746901|156771443|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
48705281|NCT01746901|156771444|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
48705282|NCT01746901|156771445|FG007|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
48705283|NCT01746901|156771446|FG008|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
48705284|NCT01746901|156771438|FG000|Treatment Phase: First Intervention|Protocol Violation|0|||
48705285|NCT01746901|156771439|FG001|Treatment Phase: First Intervention|Protocol Violation|0|||
48705286|NCT01746901|156771440|FG002|Treatment Phase: First Intervention|Protocol Violation|0|||
48705287|NCT01746901|156771441|FG003|Treatment Phase: First Intervention|Protocol Violation|0|||
48705288|NCT01746901|156771442|FG004|Treatment Phase: First Intervention|Protocol Violation|0|||
48705289|NCT01746901|156771443|FG005|Treatment Phase: First Intervention|Protocol Violation|0|||
48705290|NCT01746901|156771444|FG006|Treatment Phase: First Intervention|Protocol Violation|1|||
48705291|NCT01746901|156771445|FG007|Treatment Phase: First Intervention|Protocol Violation|0|||
48705292|NCT01746901|156771446|FG008|Treatment Phase: First Intervention|Protocol Violation|0|||
48912822|NCT03451084|157517605|FG001|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
48912823|NCT03451084|157517606|FG002|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
48912824|NCT03451084|157517607|FG003|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2|||
48912825|NCT01301950|157517614|FG000|Overall Study|Surgery was cancelled by patient|0|||
48912826|NCT01301950|157517615|FG001|Overall Study|Surgery was cancelled by patient|1|||
48912827|NCT02016820|157517616|FG000|Overall Study|Lost to Follow-up|2|||
48912828|NCT02016820|157517617|FG001|Overall Study|Lost to Follow-up|4|||
48912829|NCT01940471|157517618|FG000|Period 1: Double-blind Phase|Withdrew Consent|31|||
48912830|NCT01940471|157517619|FG001|Period 1: Double-blind Phase|Withdrew Consent|18|||
48705293|NCT01746901|156771438|FG000|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
48705294|NCT01746901|156771439|FG001|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
48912831|NCT01940471|157517620|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
48912832|NCT01940471|157517621|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
48912833|NCT01940471|157517618|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
48912834|NCT01940471|157517619|FG001|Period 1: Double-blind Phase|Lost to Follow-up|6|||
48912835|NCT01940471|157517620|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
48912836|NCT01940471|157517621|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
48912837|NCT01940471|157517618|FG000|Period 1: Double-blind Phase|Investigator's Discretion|8|||
48912838|NCT01940471|157517619|FG001|Period 1: Double-blind Phase|Investigator's Discretion|5|||
48705295|NCT01746901|156771440|FG002|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
48705296|NCT01746901|156771441|FG003|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
48705297|NCT01746901|156771442|FG004|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
48705298|NCT01746901|156771443|FG005|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
48705299|NCT01746901|156771444|FG006|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
48705300|NCT01746901|156771445|FG007|Treatment Phase: Second Intervention|Withdrawal by Subject|1|||
48705301|NCT01746901|156771446|FG008|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
48705302|NCT01746901|156771438|FG000|Treatment Phase: Third Intervention|Protocol Violation|0|||
48705303|NCT01746901|156771439|FG001|Treatment Phase: Third Intervention|Protocol Violation|0|||
48705304|NCT01746901|156771440|FG002|Treatment Phase: Third Intervention|Protocol Violation|0|||
48705305|NCT01746901|156771441|FG003|Treatment Phase: Third Intervention|Protocol Violation|0|||
48705306|NCT01746901|156771442|FG004|Treatment Phase: Third Intervention|Protocol Violation|0|||
48705307|NCT01746901|156771443|FG005|Treatment Phase: Third Intervention|Protocol Violation|1|||
48705308|NCT01746901|156771444|FG006|Treatment Phase: Third Intervention|Protocol Violation|1|||
48705309|NCT01746901|156771445|FG007|Treatment Phase: Third Intervention|Protocol Violation|0|||
48705310|NCT01746901|156771446|FG008|Treatment Phase: Third Intervention|Protocol Violation|0|||
48705311|NCT01746901|156771438|FG000|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
48705312|NCT01746901|156771439|FG001|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
48705313|NCT01746901|156771440|FG002|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
48705314|NCT01746901|156771441|FG003|Treatment Phase: Fourth Intervention|Lost to Follow-up|1|||
48705315|NCT01746901|156771442|FG004|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
48705316|NCT01746901|156771443|FG005|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
48705317|NCT01746901|156771444|FG006|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
48705318|NCT01746901|156771445|FG007|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
48705319|NCT01746901|156771446|FG008|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
48705320|NCT01746901|156771438|FG000|Treatment Phase: Fourth Intervention|Adverse Event|0|||
48705321|NCT01746901|156771439|FG001|Treatment Phase: Fourth Intervention|Adverse Event|0|||
48705322|NCT01746901|156771440|FG002|Treatment Phase: Fourth Intervention|Adverse Event|0|||
48705323|NCT01746901|156771441|FG003|Treatment Phase: Fourth Intervention|Adverse Event|0|||
48705324|NCT01746901|156771442|FG004|Treatment Phase: Fourth Intervention|Adverse Event|0|||
48705325|NCT01746901|156771443|FG005|Treatment Phase: Fourth Intervention|Adverse Event|1|||
48912839|NCT01940471|157517620|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
48705326|NCT01746901|156771444|FG006|Treatment Phase: Fourth Intervention|Adverse Event|0|||
48705327|NCT01746901|156771445|FG007|Treatment Phase: Fourth Intervention|Adverse Event|0|||
48705328|NCT01746901|156771446|FG008|Treatment Phase: Fourth Intervention|Adverse Event|1|||
48705329|NCT01746901|156771438|FG000|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
48705330|NCT01746901|156771439|FG001|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
48705331|NCT01746901|156771440|FG002|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
48705332|NCT01746901|156771441|FG003|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
48705333|NCT01746901|156771442|FG004|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
48705334|NCT01746901|156771443|FG005|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
48705335|NCT01746901|156771444|FG006|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
48705336|NCT01746901|156771445|FG007|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
48705337|NCT01746901|156771446|FG008|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
48912840|NCT01940471|157517621|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
48912841|NCT01940471|157517618|FG000|Period 1: Double-blind Phase|Pregnancy|9|||
48912842|NCT01940471|157517619|FG001|Period 1: Double-blind Phase|Pregnancy|2|||
48705338|NCT02106390|156771447|FG000|Overall Study|Withdrawal by Subject|15|||
48705339|NCT02106390|156771448|FG001|Overall Study|Withdrawal by Subject|16|||
48705340|NCT02106390|156771449|FG002|Overall Study|Withdrawal by Subject|15|||
48705341|NCT02106390|156771447|FG000|Overall Study|Lost to Follow-up|25|||
48705342|NCT02106390|156771448|FG001|Overall Study|Lost to Follow-up|20|||
48705343|NCT02106390|156771449|FG002|Overall Study|Lost to Follow-up|13|||
48705344|NCT02106390|156771447|FG000|Overall Study|Other: Administrative Reason|8|||
48705345|NCT02106390|156771448|FG001|Overall Study|Other: Administrative Reason|5|||
48705346|NCT02106390|156771449|FG002|Overall Study|Other: Administrative Reason|12|||
48705347|NCT02106390|156771447|FG000|Overall Study|Other: Unspecified|1|||
48705348|NCT02106390|156771448|FG001|Overall Study|Other: Unspecified|4|||
48705349|NCT02106390|156771449|FG002|Overall Study|Other: Unspecified|2|||
48705350|NCT02106390|156771447|FG000|Overall Study|Adverse Event|0|||
48705351|NCT02106390|156771448|FG001|Overall Study|Adverse Event|2|||
48705352|NCT02106390|156771449|FG002|Overall Study|Adverse Event|1|||
48705353|NCT02106390|156771447|FG000|Overall Study|Protocol Violation|0|||
48705354|NCT02106390|156771448|FG001|Overall Study|Protocol Violation|1|||
48705355|NCT02106390|156771449|FG002|Overall Study|Protocol Violation|0|||
48705356|NCT03809104|156771450|FG000|Overall Study|Withdrawal by Subject|3|||
48705357|NCT00790842|156771451|FG000|Dose Level 1|Adverse Event|1|||
48705358|NCT00790842|156771452|FG001|Dose Level 1|Adverse Event|0|||
48705359|NCT00790842|156771453|FG002|Dose Level 1|Adverse Event|0|||
48705360|NCT00790842|156771454|FG003|Dose Level 1|Adverse Event|2|||
48705361|NCT00790842|156771455|FG004|Dose Level 1|Adverse Event|0|||
48705362|NCT00790842|156771456|FG005|Dose Level 1|Adverse Event|0|||
48705363|NCT00790842|156771457|FG006|Dose Level 1|Adverse Event|0|||
48705364|NCT00790842|156771458|FG007|Dose Level 1|Adverse Event|1|||
48705365|NCT00790842|156771459|FG008|Dose Level 1|Adverse Event|0|||
48705366|NCT00790842|156771460|FG009|Dose Level 1|Adverse Event|0|||
48705367|NCT00790842|156771461|FG010|Dose Level 1|Adverse Event|0|||
48705368|NCT00790842|156771451|FG000|Dose Level 1|Physician Decision|1|||
48705369|NCT00790842|156771452|FG001|Dose Level 1|Physician Decision|0|||
48705370|NCT00790842|156771453|FG002|Dose Level 1|Physician Decision|0|||
48705371|NCT00790842|156771454|FG003|Dose Level 1|Physician Decision|0|||
48705372|NCT00790842|156771455|FG004|Dose Level 1|Physician Decision|0|||
48705373|NCT00790842|156771456|FG005|Dose Level 1|Physician Decision|0|||
48705374|NCT00790842|156771457|FG006|Dose Level 1|Physician Decision|0|||
48705375|NCT00790842|156771458|FG007|Dose Level 1|Physician Decision|1|||
48705376|NCT00790842|156771459|FG008|Dose Level 1|Physician Decision|0|||
48912843|NCT01940471|157517620|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
48912844|NCT01940471|157517621|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
48912845|NCT01940471|157517618|FG000|Period 1: Double-blind Phase|Non-Compliance with Study Drug|3|||
48912846|NCT01940471|157517619|FG001|Period 1: Double-blind Phase|Non-Compliance with Study Drug|2|||
48912847|NCT01940471|157517620|FG002|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
48912848|NCT01940471|157517621|FG003|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
48912849|NCT01940471|157517618|FG000|Period 1: Double-blind Phase|Adverse Event|2|||
48912850|NCT01940471|157517619|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
48912851|NCT01940471|157517620|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
48912852|NCT01940471|157517621|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
48912853|NCT01940471|157517618|FG000|Period 1: Double-blind Phase|Death|2|||
48912854|NCT01940471|157517619|FG001|Period 1: Double-blind Phase|Death|1|||
48912855|NCT01940471|157517620|FG002|Period 1: Double-blind Phase|Death|0|||
48912856|NCT01940471|157517621|FG003|Period 1: Double-blind Phase|Death|0|||
48912857|NCT01940471|157517618|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
48912858|NCT01940471|157517619|FG001|Period 1: Double-blind Phase|Lack of Efficacy|1|||
48912859|NCT01940471|157517620|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
48912860|NCT01940471|157517621|FG003|Period 1: Double-blind Phase|Lack of Efficacy|0|||
48912861|NCT01940471|157517618|FG000|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
48912862|NCT01940471|157517619|FG001|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
48912863|NCT01940471|157517620|FG002|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
48912864|NCT01940471|157517621|FG003|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
48912865|NCT01940471|157517618|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
48912866|NCT01940471|157517619|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
49010686|NCT00095199|157875671|FG001|Overall Study|Data inadvertently lost by site|0|||
48705377|NCT00790842|156771460|FG009|Dose Level 1|Physician Decision|0|||
48705378|NCT00790842|156771461|FG010|Dose Level 1|Physician Decision|0|||
48705379|NCT00790842|156771451|FG000|Dose Level 1|Withdrawal by Subject|1|||
48705380|NCT00790842|156771452|FG001|Dose Level 1|Withdrawal by Subject|0|||
48705381|NCT00790842|156771453|FG002|Dose Level 1|Withdrawal by Subject|0|||
48705382|NCT00790842|156771454|FG003|Dose Level 1|Withdrawal by Subject|0|||
48705383|NCT00790842|156771455|FG004|Dose Level 1|Withdrawal by Subject|0|||
48705384|NCT00790842|156771456|FG005|Dose Level 1|Withdrawal by Subject|0|||
48705385|NCT00790842|156771457|FG006|Dose Level 1|Withdrawal by Subject|0|||
48705386|NCT00790842|156771458|FG007|Dose Level 1|Withdrawal by Subject|0|||
48912867|NCT01940471|157517620|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
48912868|NCT01940471|157517621|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
48912869|NCT01940471|157517618|FG000|Period 1: Double-blind Phase|HbsAg Seroconversion|1|||
48912870|NCT01940471|157517619|FG001|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
48912871|NCT01940471|157517620|FG002|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
48912872|NCT01940471|157517621|FG003|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
48912873|NCT01940471|157517618|FG000|Period 1: Double-blind Phase|Protocol Violation|0|||
48912874|NCT01940471|157517619|FG001|Period 1: Double-blind Phase|Protocol Violation|1|||
48912875|NCT01940471|157517620|FG002|Period 1: Double-blind Phase|Protocol Violation|0|||
48912876|NCT01940471|157517621|FG003|Period 1: Double-blind Phase|Protocol Violation|0|||
48912877|NCT01940471|157517618|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
48912878|NCT01940471|157517619|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
48912879|NCT01940471|157517620|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|48|||
48912880|NCT01940471|157517621|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|22|||
48912881|NCT01940471|157517618|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
48912882|NCT01940471|157517619|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
48912883|NCT01940471|157517620|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|13|||
48912884|NCT01940471|157517621|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|8|||
48912885|NCT01940471|157517618|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
48912886|NCT01940471|157517619|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
48912887|NCT01940471|157517620|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|9|||
48912888|NCT01940471|157517621|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
48912889|NCT01940471|157517618|FG000|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
48912890|NCT01940471|157517619|FG001|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
48912891|NCT01940471|157517620|FG002|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|5|||
48912892|NCT01940471|157517621|FG003|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|4|||
48912893|NCT01940471|157517618|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
48912894|NCT01940471|157517619|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
48912895|NCT01940471|157517620|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|5|||
48705387|NCT00790842|156771459|FG008|Dose Level 1|Withdrawal by Subject|0|||
48912896|NCT01940471|157517621|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|1|||
48912897|NCT01940471|157517618|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
48705388|NCT00790842|156771460|FG009|Dose Level 1|Withdrawal by Subject|0|||
48705389|NCT00790842|156771461|FG010|Dose Level 1|Withdrawal by Subject|0|||
48705390|NCT00790842|156771451|FG000|Dose Level 2|Death|0|||
48705391|NCT00790842|156771452|FG001|Dose Level 2|Death|1|||
48705392|NCT00790842|156771453|FG002|Dose Level 2|Death|0|||
48705393|NCT00790842|156771454|FG003|Dose Level 2|Death|0|||
48705394|NCT00790842|156771455|FG004|Dose Level 2|Death|1|||
48705395|NCT00790842|156771456|FG005|Dose Level 2|Death|0|||
48705396|NCT00790842|156771457|FG006|Dose Level 2|Death|0|||
48705397|NCT00790842|156771458|FG007|Dose Level 2|Death|0|||
48705398|NCT00790842|156771459|FG008|Dose Level 2|Death|0|||
48705399|NCT00790842|156771460|FG009|Dose Level 2|Death|0|||
48705400|NCT00790842|156771461|FG010|Dose Level 2|Death|0|||
48705401|NCT00790842|156771451|FG000|Dose Level 2|Physician Decision|0|||
48705402|NCT00790842|156771452|FG001|Dose Level 2|Physician Decision|1|||
48705403|NCT00790842|156771453|FG002|Dose Level 2|Physician Decision|0|||
48705404|NCT00790842|156771454|FG003|Dose Level 2|Physician Decision|0|||
48705405|NCT00790842|156771455|FG004|Dose Level 2|Physician Decision|0|||
48705406|NCT00790842|156771456|FG005|Dose Level 2|Physician Decision|0|||
48705407|NCT00790842|156771457|FG006|Dose Level 2|Physician Decision|0|||
48705408|NCT00790842|156771458|FG007|Dose Level 2|Physician Decision|0|||
48705409|NCT00790842|156771459|FG008|Dose Level 2|Physician Decision|0|||
48705410|NCT00790842|156771460|FG009|Dose Level 2|Physician Decision|0|||
48705411|NCT00790842|156771461|FG010|Dose Level 2|Physician Decision|0|||
48705412|NCT00790842|156771451|FG000|Dose Level 2|Withdrawal by Subject|0|||
48705413|NCT00790842|156771452|FG001|Dose Level 2|Withdrawal by Subject|1|||
48705414|NCT00790842|156771453|FG002|Dose Level 2|Withdrawal by Subject|0|||
48705415|NCT00790842|156771454|FG003|Dose Level 2|Withdrawal by Subject|0|||
48912898|NCT01940471|157517619|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
48912899|NCT01940471|157517620|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|4|||
48912900|NCT01940471|157517621|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
48912901|NCT01940471|157517618|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
48705416|NCT00790842|156771455|FG004|Dose Level 2|Withdrawal by Subject|0|||
48705417|NCT00790842|156771456|FG005|Dose Level 2|Withdrawal by Subject|0|||
48705418|NCT00790842|156771457|FG006|Dose Level 2|Withdrawal by Subject|0|||
48705419|NCT00790842|156771458|FG007|Dose Level 2|Withdrawal by Subject|0|||
48705420|NCT00790842|156771459|FG008|Dose Level 2|Withdrawal by Subject|0|||
48705421|NCT00790842|156771460|FG009|Dose Level 2|Withdrawal by Subject|0|||
48912902|NCT01940471|157517619|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
48912903|NCT01940471|157517620|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|5|||
48912904|NCT01940471|157517621|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
48912905|NCT01940471|157517618|FG000|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
48912906|NCT01940471|157517619|FG001|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
48705422|NCT00790842|156771461|FG010|Dose Level 2|Withdrawal by Subject|0|||
48705423|NCT00790842|156771451|FG000|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
48705424|NCT00790842|156771452|FG001|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
48705425|NCT00790842|156771453|FG002|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
48705426|NCT00790842|156771454|FG003|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
48705427|NCT00790842|156771455|FG004|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
48705428|NCT00790842|156771456|FG005|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
48705429|NCT00790842|156771457|FG006|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
48705430|NCT00790842|156771458|FG007|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
48705431|NCT00790842|156771459|FG008|Dose Level 2|Intercurrent Illness/Other Treatment|2|||
48705432|NCT00790842|156771460|FG009|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
48705433|NCT00790842|156771461|FG010|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
48705434|NCT00790842|156771451|FG000|Dose Level 3|Adverse Event|0|||
48705435|NCT00790842|156771452|FG001|Dose Level 3|Adverse Event|0|||
48705436|NCT00790842|156771453|FG002|Dose Level 3|Adverse Event|1|||
48705437|NCT00790842|156771454|FG003|Dose Level 3|Adverse Event|0|||
48705438|NCT00790842|156771455|FG004|Dose Level 3|Adverse Event|0|||
48705439|NCT00790842|156771456|FG005|Dose Level 3|Adverse Event|0|||
48705440|NCT00790842|156771457|FG006|Dose Level 3|Adverse Event|0|||
48705441|NCT00790842|156771458|FG007|Dose Level 3|Adverse Event|0|||
48705442|NCT00790842|156771459|FG008|Dose Level 3|Adverse Event|0|||
48705443|NCT00790842|156771460|FG009|Dose Level 3|Adverse Event|0|||
48705444|NCT00790842|156771461|FG010|Dose Level 3|Adverse Event|0|||
48705445|NCT00790842|156771451|FG000|Dose Level 3|Withdrawal by Subject|0|||
48705446|NCT00790842|156771452|FG001|Dose Level 3|Withdrawal by Subject|0|||
48705447|NCT00790842|156771453|FG002|Dose Level 3|Withdrawal by Subject|3|||
48705448|NCT00790842|156771454|FG003|Dose Level 3|Withdrawal by Subject|0|||
48705449|NCT00790842|156771455|FG004|Dose Level 3|Withdrawal by Subject|0|||
48705450|NCT00790842|156771456|FG005|Dose Level 3|Withdrawal by Subject|0|||
48705451|NCT00790842|156771457|FG006|Dose Level 3|Withdrawal by Subject|0|||
48705452|NCT00790842|156771458|FG007|Dose Level 3|Withdrawal by Subject|0|||
48705453|NCT00790842|156771459|FG008|Dose Level 3|Withdrawal by Subject|0|||
48705454|NCT00790842|156771460|FG009|Dose Level 3|Withdrawal by Subject|2|||
48705455|NCT00790842|156771461|FG010|Dose Level 3|Withdrawal by Subject|0|||
48912907|NCT01940471|157517620|FG002|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|2|||
48912908|NCT01940471|157517621|FG003|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
48912909|NCT01940471|157517618|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
48912910|NCT01940471|157517619|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
48912911|NCT01940471|157517620|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
48912912|NCT01940471|157517621|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
48912913|NCT01378104|157517624|FG000|Overall Study|Adverse Event|8|||
48912914|NCT01378104|157517625|FG001|Overall Study|Adverse Event|8|||
48912915|NCT01378104|157517624|FG000|Overall Study|Lack of Efficacy|7|||
48705456|NCT00790842|156771451|FG000|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
48705457|NCT00790842|156771452|FG001|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
48705458|NCT00790842|156771453|FG002|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
48705459|NCT00790842|156771454|FG003|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
48705460|NCT00790842|156771455|FG004|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
48705461|NCT00790842|156771456|FG005|Dose Level 3|Intercurrent Illness/Alternative Therapy|1|||
48705462|NCT00790842|156771457|FG006|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
48705463|NCT00790842|156771458|FG007|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
48705464|NCT00790842|156771459|FG008|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
48705465|NCT00790842|156771460|FG009|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
48705466|NCT00790842|156771461|FG010|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
48912916|NCT01378104|157517625|FG001|Overall Study|Lack of Efficacy|5|||
48912917|NCT01378104|157517624|FG000|Overall Study|Withdrawal by Subject|12|||
48912918|NCT01378104|157517625|FG001|Overall Study|Withdrawal by Subject|13|||
48705467|NCT00790842|156771451|FG000|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
48705468|NCT00790842|156771452|FG001|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
48705469|NCT00790842|156771453|FG002|Dose Level 3|Ineligible/Withdrew before Treatment|1|||
48705470|NCT00790842|156771454|FG003|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
48705471|NCT00790842|156771455|FG004|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
48705472|NCT00790842|156771456|FG005|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
48705473|NCT00790842|156771457|FG006|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
48705474|NCT00790842|156771458|FG007|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
48705475|NCT00790842|156771459|FG008|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
48912919|NCT00455013|157517626|FG000|Short Term Period|Adverse Event|2|||
48705476|NCT00790842|156771460|FG009|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
48705477|NCT00790842|156771461|FG010|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
48705478|NCT00790842|156771451|FG000|Dose Level 4|Adverse Event|0|||
48705479|NCT00790842|156771452|FG001|Dose Level 4|Adverse Event|0|||
48705480|NCT00790842|156771453|FG002|Dose Level 4|Adverse Event|0|||
48705481|NCT00790842|156771454|FG003|Dose Level 4|Adverse Event|0|||
48705482|NCT00790842|156771455|FG004|Dose Level 4|Adverse Event|0|||
48705483|NCT00790842|156771456|FG005|Dose Level 4|Adverse Event|0|||
48705484|NCT00790842|156771457|FG006|Dose Level 4|Adverse Event|1|||
48705485|NCT00790842|156771458|FG007|Dose Level 4|Adverse Event|0|||
48705486|NCT00790842|156771459|FG008|Dose Level 4|Adverse Event|0|||
48705487|NCT00790842|156771460|FG009|Dose Level 4|Adverse Event|0|||
48705488|NCT00790842|156771461|FG010|Dose Level 4|Adverse Event|0|||
48705489|NCT00790842|156771451|FG000|Dose Level 4|Physician Decision|0|||
48705490|NCT00790842|156771452|FG001|Dose Level 4|Physician Decision|0|||
48705491|NCT00790842|156771453|FG002|Dose Level 4|Physician Decision|0|||
48705492|NCT00790842|156771454|FG003|Dose Level 4|Physician Decision|0|||
48705493|NCT00790842|156771455|FG004|Dose Level 4|Physician Decision|0|||
48705494|NCT00790842|156771456|FG005|Dose Level 4|Physician Decision|0|||
48705495|NCT00790842|156771457|FG006|Dose Level 4|Physician Decision|1|||
48705496|NCT00790842|156771458|FG007|Dose Level 4|Physician Decision|0|||
48705497|NCT00790842|156771459|FG008|Dose Level 4|Physician Decision|0|||
48705498|NCT00790842|156771460|FG009|Dose Level 4|Physician Decision|0|||
48705499|NCT00790842|156771461|FG010|Dose Level 4|Physician Decision|1|||
48705500|NCT00790842|156771451|FG000|Dose Level 4|Withdrawal by Subject|0|||
48705501|NCT00790842|156771452|FG001|Dose Level 4|Withdrawal by Subject|0|||
48705502|NCT00790842|156771453|FG002|Dose Level 4|Withdrawal by Subject|0|||
48705503|NCT00790842|156771454|FG003|Dose Level 4|Withdrawal by Subject|0|||
48705504|NCT00790842|156771455|FG004|Dose Level 4|Withdrawal by Subject|0|||
48705505|NCT00790842|156771456|FG005|Dose Level 4|Withdrawal by Subject|0|||
48705506|NCT00790842|156771457|FG006|Dose Level 4|Withdrawal by Subject|0|||
48705507|NCT00790842|156771458|FG007|Dose Level 4|Withdrawal by Subject|0|||
48705508|NCT00790842|156771459|FG008|Dose Level 4|Withdrawal by Subject|0|||
48705509|NCT00790842|156771460|FG009|Dose Level 4|Withdrawal by Subject|0|||
48705510|NCT00790842|156771461|FG010|Dose Level 4|Withdrawal by Subject|1|||
48705511|NCT00790842|156771451|FG000|Expansion Cohort|Adverse Event|0|||
48705512|NCT00790842|156771452|FG001|Expansion Cohort|Adverse Event|0|||
48705513|NCT00790842|156771453|FG002|Expansion Cohort|Adverse Event|0|||
48705514|NCT00790842|156771454|FG003|Expansion Cohort|Adverse Event|0|||
48705515|NCT00790842|156771455|FG004|Expansion Cohort|Adverse Event|0|||
48705516|NCT00790842|156771456|FG005|Expansion Cohort|Adverse Event|0|||
48705517|NCT00790842|156771457|FG006|Expansion Cohort|Adverse Event|1|||
48705518|NCT00790842|156771458|FG007|Expansion Cohort|Adverse Event|0|||
48705519|NCT00790842|156771459|FG008|Expansion Cohort|Adverse Event|0|||
48705520|NCT00790842|156771460|FG009|Expansion Cohort|Adverse Event|0|||
48705521|NCT00790842|156771461|FG010|Expansion Cohort|Adverse Event|0|||
48705522|NCT00790842|156771451|FG000|Expansion Cohort|Death|0|||
48705523|NCT00790842|156771452|FG001|Expansion Cohort|Death|0|||
48705524|NCT00790842|156771453|FG002|Expansion Cohort|Death|2|||
48705525|NCT00790842|156771454|FG003|Expansion Cohort|Death|0|||
48705526|NCT00790842|156771455|FG004|Expansion Cohort|Death|0|||
48705527|NCT00790842|156771456|FG005|Expansion Cohort|Death|0|||
48705528|NCT00790842|156771457|FG006|Expansion Cohort|Death|0|||
48705529|NCT00790842|156771458|FG007|Expansion Cohort|Death|0|||
48705530|NCT00790842|156771459|FG008|Expansion Cohort|Death|0|||
48705531|NCT00790842|156771460|FG009|Expansion Cohort|Death|0|||
48705532|NCT00790842|156771461|FG010|Expansion Cohort|Death|0|||
48705533|NCT00790842|156771451|FG000|Expansion Cohort|Physician Decision|0|||
48705534|NCT00790842|156771452|FG001|Expansion Cohort|Physician Decision|0|||
48705535|NCT00790842|156771453|FG002|Expansion Cohort|Physician Decision|1|||
48912920|NCT00455013|157517627|FG001|Short Term Period|Adverse Event|5|||
48912921|NCT00455013|157517628|FG002|Short Term Period|Adverse Event|0|||
48705536|NCT00790842|156771454|FG003|Expansion Cohort|Physician Decision|0|||
48705537|NCT00790842|156771455|FG004|Expansion Cohort|Physician Decision|0|||
48705538|NCT00790842|156771456|FG005|Expansion Cohort|Physician Decision|0|||
48705539|NCT00790842|156771457|FG006|Expansion Cohort|Physician Decision|0|||
48705540|NCT00790842|156771458|FG007|Expansion Cohort|Physician Decision|0|||
48705541|NCT00790842|156771459|FG008|Expansion Cohort|Physician Decision|0|||
48912922|NCT00455013|157517626|FG000|Short Term Period|Withdrawal by Subject|0|||
48705542|NCT00790842|156771460|FG009|Expansion Cohort|Physician Decision|0|||
48705543|NCT00790842|156771461|FG010|Expansion Cohort|Physician Decision|0|||
48705544|NCT00790842|156771451|FG000|Expansion Cohort|Withdrawal by Subject|0|||
48705545|NCT00790842|156771452|FG001|Expansion Cohort|Withdrawal by Subject|0|||
48705546|NCT00790842|156771453|FG002|Expansion Cohort|Withdrawal by Subject|3|||
48705547|NCT00790842|156771454|FG003|Expansion Cohort|Withdrawal by Subject|0|||
48705548|NCT00790842|156771455|FG004|Expansion Cohort|Withdrawal by Subject|0|||
48705549|NCT00790842|156771456|FG005|Expansion Cohort|Withdrawal by Subject|0|||
48705550|NCT00790842|156771457|FG006|Expansion Cohort|Withdrawal by Subject|0|||
48912923|NCT00455013|157517627|FG001|Short Term Period|Withdrawal by Subject|0|||
48912924|NCT00455013|157517628|FG002|Short Term Period|Withdrawal by Subject|1|||
48912925|NCT00455013|157517626|FG000|Short Term Period|Lack of Efficacy|4|||
48912926|NCT00455013|157517627|FG001|Short Term Period|Lack of Efficacy|0|||
48912927|NCT00455013|157517628|FG002|Short Term Period|Lack of Efficacy|0|||
48912928|NCT00455013|157517626|FG000|Short Term Period|Other|0|||
48912929|NCT00455013|157517627|FG001|Short Term Period|Other|0|||
48912930|NCT00455013|157517628|FG002|Short Term Period|Other|1|||
48912931|NCT00455013|157517626|FG000|Long Term Extension (LTE)|Adverse Event|0|||
48705551|NCT00790842|156771458|FG007|Expansion Cohort|Withdrawal by Subject|0|||
48705552|NCT00790842|156771459|FG008|Expansion Cohort|Withdrawal by Subject|0|||
48705553|NCT00790842|156771460|FG009|Expansion Cohort|Withdrawal by Subject|0|||
48705554|NCT00790842|156771461|FG010|Expansion Cohort|Withdrawal by Subject|0|||
48705555|NCT00790842|156771451|FG000|Expansion Cohort|Study Closure|0|||
48705556|NCT00790842|156771452|FG001|Expansion Cohort|Study Closure|0|||
48705557|NCT00790842|156771453|FG002|Expansion Cohort|Study Closure|1|||
48705558|NCT00790842|156771454|FG003|Expansion Cohort|Study Closure|0|||
48705559|NCT00790842|156771455|FG004|Expansion Cohort|Study Closure|0|||
48705560|NCT00790842|156771456|FG005|Expansion Cohort|Study Closure|0|||
48705561|NCT00790842|156771457|FG006|Expansion Cohort|Study Closure|0|||
48705562|NCT00790842|156771458|FG007|Expansion Cohort|Study Closure|0|||
48705563|NCT00790842|156771459|FG008|Expansion Cohort|Study Closure|0|||
48705564|NCT00790842|156771460|FG009|Expansion Cohort|Study Closure|0|||
48705565|NCT00790842|156771461|FG010|Expansion Cohort|Study Closure|0|||
48705566|NCT02131259|156771462|FG000|Overall Study|Progressive disease|751|||
48705567|NCT02131259|156771462|FG000|Overall Study|Adverse Event|341|||
48705568|NCT02131259|156771462|FG000|Overall Study|Lost to Follow-up|7|||
48705569|NCT02131259|156771462|FG000|Overall Study|Relocation|32|||
48705570|NCT02131259|156771462|FG000|Overall Study|Other|63|||
48705571|NCT02131259|156771462|FG000|Overall Study|Progressive disease/Adverse Event (AE)|22|||
48705572|NCT02131259|156771462|FG000|Overall Study|Progressive disease/relocation|1|||
48705573|NCT02131259|156771462|FG000|Overall Study|Progressive disease/other|2|||
48705574|NCT02131259|156771462|FG000|Overall Study|AE/lost to follow-up|1|||
48705575|NCT02131259|156771462|FG000|Overall Study|AE/other|1|||
48705576|NCT02131259|156771462|FG000|Overall Study|Progressive disease/AE/other|1|||
48705577|NCT02131259|156771462|FG000|Overall Study|Missing|3|||
48705578|NCT02158546|156771469|FG000|Overall Study|Physician Decision|0|||
48705579|NCT02158546|156771470|FG001|Overall Study|Physician Decision|1|||
48705580|NCT02158546|156771471|FG002|Overall Study|Physician Decision|0|||
48705581|NCT02158546|156771472|FG003|Overall Study|Physician Decision|0|||
48705582|NCT02158546|156771469|FG000|Overall Study|Non-compliance|0|||
48705583|NCT02158546|156771470|FG001|Overall Study|Non-compliance|1|||
48705584|NCT02158546|156771471|FG002|Overall Study|Non-compliance|0|||
48705585|NCT02158546|156771472|FG003|Overall Study|Non-compliance|1|||
48705586|NCT02158546|156771469|FG000|Overall Study|Failure to meet eligibility criteria|0|||
48705587|NCT02158546|156771470|FG001|Overall Study|Failure to meet eligibility criteria|1|||
48705588|NCT02158546|156771471|FG002|Overall Study|Failure to meet eligibility criteria|0|||
48705589|NCT02158546|156771472|FG003|Overall Study|Failure to meet eligibility criteria|0|||
48705590|NCT02158546|156771469|FG000|Overall Study|Lack of Efficacy|1|||
48705591|NCT02158546|156771470|FG001|Overall Study|Lack of Efficacy|1|||
48705592|NCT02158546|156771471|FG002|Overall Study|Lack of Efficacy|0|||
48705593|NCT02158546|156771472|FG003|Overall Study|Lack of Efficacy|0|||
48705594|NCT02158546|156771469|FG000|Overall Study|Adverse Event|2|||
48705595|NCT02158546|156771470|FG001|Overall Study|Adverse Event|2|||
48705596|NCT02158546|156771471|FG002|Overall Study|Adverse Event|0|||
48705597|NCT02158546|156771472|FG003|Overall Study|Adverse Event|0|||
48705598|NCT02158546|156771469|FG000|Overall Study|Withdrawal by Subject|6|||
48705599|NCT02158546|156771470|FG001|Overall Study|Withdrawal by Subject|2|||
48705600|NCT02158546|156771471|FG002|Overall Study|Withdrawal by Subject|1|||
48705601|NCT02158546|156771472|FG003|Overall Study|Withdrawal by Subject|0|||
48705602|NCT02158546|156771469|FG000|Overall Study|Lost to Follow-up|5|||
48705603|NCT02158546|156771470|FG001|Overall Study|Lost to Follow-up|4|||
48705604|NCT02158546|156771471|FG002|Overall Study|Lost to Follow-up|0|||
48705605|NCT02158546|156771472|FG003|Overall Study|Lost to Follow-up|1|||
48705606|NCT02158546|156771469|FG000|Overall Study|Site Excluded|5|||
48705607|NCT02158546|156771470|FG001|Overall Study|Site Excluded|5|||
48705608|NCT02158546|156771471|FG002|Overall Study|Site Excluded|3|||
48705609|NCT02158546|156771472|FG003|Overall Study|Site Excluded|4|||
48705610|NCT00803569|156771473|FG000|Overall Study|Progressive Disease|3|||
48705611|NCT00803569|156771473|FG000|Overall Study|Noncompliance|1|||
48705612|NCT02057250|156771476|FG000|AID Assessment Phase|Adverse Event|3|||
48705613|NCT02057250|156771477|FG001|AID Assessment Phase|Adverse Event|2|||
48705614|NCT02057250|156771478|FG002|AID Assessment Phase|Adverse Event|6|||
48705615|NCT02057250|156771479|FG003|AID Assessment Phase|Adverse Event|1|||
48912932|NCT00455013|157517627|FG001|Long Term Extension (LTE)|Adverse Event|1|||
48705616|NCT02057250|156771480|FG004|AID Assessment Phase|Adverse Event|0|||
48705617|NCT02057250|156771476|FG000|AID Assessment Phase|Other than specified above|1|||
48912933|NCT00455013|157517628|FG002|Long Term Extension (LTE)|Adverse Event|1|||
48912934|NCT00455013|157517626|FG000|Long Term Extension (LTE)|Withdrawal by Subject|1|||
48912935|NCT00455013|157517627|FG001|Long Term Extension (LTE)|Withdrawal by Subject|0|||
48912936|NCT00455013|157517628|FG002|Long Term Extension (LTE)|Withdrawal by Subject|1|||
48705618|NCT02057250|156771477|FG001|AID Assessment Phase|Other than specified above|1|||
48705619|NCT02057250|156771478|FG002|AID Assessment Phase|Other than specified above|1|||
48705620|NCT02057250|156771479|FG003|AID Assessment Phase|Other than specified above|1|||
48705621|NCT02057250|156771480|FG004|AID Assessment Phase|Other than specified above|0|||
48705622|NCT02057250|156771476|FG000|Extension Phase|Adverse Event|0|||
48705623|NCT02057250|156771477|FG001|Extension Phase|Adverse Event|0|||
48705624|NCT02057250|156771478|FG002|Extension Phase|Adverse Event|0|||
48705625|NCT02057250|156771479|FG003|Extension Phase|Adverse Event|0|||
48705626|NCT02057250|156771480|FG004|Extension Phase|Adverse Event|15|||
48705627|NCT02057250|156771476|FG000|Extension Phase|Lack of Efficacy|0|||
48705628|NCT02057250|156771477|FG001|Extension Phase|Lack of Efficacy|0|||
48705629|NCT02057250|156771478|FG002|Extension Phase|Lack of Efficacy|0|||
48705630|NCT02057250|156771479|FG003|Extension Phase|Lack of Efficacy|0|||
48705631|NCT02057250|156771480|FG004|Extension Phase|Lack of Efficacy|10|||
48705632|NCT02057250|156771476|FG000|Extension Phase|Entered in this period but not treated|0|||
48705633|NCT02057250|156771477|FG001|Extension Phase|Entered in this period but not treated|0|||
48705634|NCT02057250|156771478|FG002|Extension Phase|Entered in this period but not treated|0|||
48705635|NCT02057250|156771479|FG003|Extension Phase|Entered in this period but not treated|0|||
48705636|NCT02057250|156771480|FG004|Extension Phase|Entered in this period but not treated|4|||
48705637|NCT02057250|156771476|FG000|Extension Phase|Other than specified above|0|||
48705638|NCT02057250|156771477|FG001|Extension Phase|Other than specified above|0|||
48705639|NCT02057250|156771478|FG002|Extension Phase|Other than specified above|0|||
48705640|NCT02057250|156771479|FG003|Extension Phase|Other than specified above|0|||
48705641|NCT02057250|156771480|FG004|Extension Phase|Other than specified above|7|||
48705642|NCT01662102|156771484|FG000|Overall Study|Sponsor's decision|1|||
48705643|NCT01662102|156771485|FG001|Overall Study|Sponsor's decision|0|||
48705644|NCT00927953|156771486|FG000|Overall Study|Death|2|||
48705645|NCT00927953|156771487|FG001|Overall Study|Death|1|||
48705646|NCT00724698|156771488|FG000|Overall Study|Adverse Event|9|||
48705647|NCT00724698|156771488|FG000|Overall Study|Failure of Therapy|4|||
48705648|NCT00724698|156771488|FG000|Overall Study|Poor Compliance|16|||
48705649|NCT00724698|156771488|FG000|Overall Study|Lost to Follow-up|36|||
48705650|NCT00724698|156771488|FG000|Overall Study|No Info|25|||
48705651|NCT00043979|156771489|FG000|Period 1|recipient with progressive disease|7|||
48705652|NCT00043979|156771490|FG001|Period 1|recipient with progressive disease|4|||
48705653|NCT00043979|156771491|FG002|Period 1|recipient with progressive disease|3|||
48705654|NCT01491607|156771493|FG000|Overall Study|Lost to Follow-up|7|||
48705655|NCT01491607|156771493|FG000|Overall Study|Withdrawal by Subject|3|||
48705656|NCT01635153|156771499|FG000|Overall Study|Lost to Follow-up|40|||
48705657|NCT01635153|156771500|FG001|Overall Study|Lost to Follow-up|43|||
48705658|NCT02819804|156771503|FG000|Complete Cycle 1 (28 Days)|Progressive disease/no response|1|||
48705659|NCT00482053|156771507|FG000|Inter-treatment Period|Disease progression|1|||
48705660|NCT01821118|156771508|FG000|Overall Study|Death|0|||
48705661|NCT01821118|156771509|FG001|Overall Study|Death|1|||
48705662|NCT02224560|156771510|FG000|Overall Study|Protocol Deviation|1|||
48705663|NCT02224560|156771511|FG001|Overall Study|Protocol Deviation|0|||
48705664|NCT02224560|156771512|FG002|Overall Study|Protocol Deviation|0|||
48705665|NCT02224560|156771510|FG000|Overall Study|Withdrawal by Subject|2|||
48705666|NCT02224560|156771511|FG001|Overall Study|Withdrawal by Subject|0|||
48705667|NCT02224560|156771512|FG002|Overall Study|Withdrawal by Subject|1|||
48705668|NCT02224560|156771510|FG000|Overall Study|Met Withdrawal Criteria|1|||
48705669|NCT02224560|156771511|FG001|Overall Study|Met Withdrawal Criteria|0|||
48705670|NCT02224560|156771512|FG002|Overall Study|Met Withdrawal Criteria|0|||
48705671|NCT02224560|156771510|FG000|Overall Study|Adverse Event|4|||
48705672|NCT02224560|156771511|FG001|Overall Study|Adverse Event|1|||
48705673|NCT02224560|156771512|FG002|Overall Study|Adverse Event|1|||
48705674|NCT02224560|156771510|FG000|Overall Study|Withdrawn by Investigator|1|||
48705675|NCT02224560|156771511|FG001|Overall Study|Withdrawn by Investigator|1|||
48705676|NCT02224560|156771512|FG002|Overall Study|Withdrawn by Investigator|0|||
48705677|NCT02304367|156771513|FG000|Overall Study|Lack of Response to Bruosumab|1|||
48705678|NCT02304367|156771513|FG000|Overall Study|Sponsor Decision|3|||
48705679|NCT02304367|156771513|FG000|Overall Study|Death|2|||
48705680|NCT02304367|156771513|FG000|Overall Study|Physician Decision|1|||
48705681|NCT02304367|156771513|FG000|Overall Study|Unable to Return Due to Corona Virus Pandemic|1|||
48705682|NCT04154189|156771514|FG000|Overall Study|Withdrawal by Subject|4|||
48705683|NCT04154189|156771515|FG001|Overall Study|Withdrawal by Subject|6|||
48705684|NCT04154189|156771514|FG000|Overall Study|Survival follow-up discontinued by sponsor|8|||
48705685|NCT04154189|156771515|FG001|Overall Study|Survival follow-up discontinued by sponsor|10|||
48705686|NCT04154189|156771514|FG000|Overall Study|Participants transitioned to patient access program (PAP)|1|||
48705687|NCT04154189|156771515|FG001|Overall Study|Participants transitioned to patient access program (PAP)|0|||
48705688|NCT04154189|156771514|FG000|Overall Study|Participants transitioned to managed access program (MAP)|2|||
48705689|NCT04154189|156771515|FG001|Overall Study|Participants transitioned to managed access program (MAP)|0|||
48705690|NCT04154189|156771514|FG000|Overall Study|Death|25|||
48705691|NCT04154189|156771515|FG001|Overall Study|Death|25|||
48705692|NCT00929695|156771516|FG000|Overall Study|Death|2|||
48705693|NCT00929695|156771517|FG001|Overall Study|Death|1|||
48705694|NCT00929695|156771516|FG000|Overall Study|Withdrawal by Subject|0|||
48705695|NCT00929695|156771517|FG001|Overall Study|Withdrawal by Subject|2|||
48705696|NCT00929695|156771516|FG000|Overall Study|discharge home|4|||
48705697|NCT00929695|156771517|FG001|Overall Study|discharge home|3|||
48705698|NCT00929695|156771516|FG000|Overall Study|incorrect stratification|2|||
48705699|NCT00929695|156771517|FG001|Overall Study|incorrect stratification|0|||
48705700|NCT01812252|156771518|FG000|Overall Study|Persistent Disease|1|||
48705701|NCT01812252|156771519|FG001|Overall Study|Persistent Disease|0|||
48705702|NCT01812252|156771518|FG000|Overall Study|Not transplanted|11|||
48705703|NCT01812252|156771519|FG001|Overall Study|Not transplanted|11|||
48705704|NCT01812252|156771518|FG000|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|5|||
48705705|NCT01812252|156771519|FG001|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|3|||
48705706|NCT01812252|156771518|FG000|Overall Study|Withdrawal by Subject|1|||
48705707|NCT01812252|156771519|FG001|Overall Study|Withdrawal by Subject|1|||
48705708|NCT01812252|156771518|FG000|Overall Study|Screen Failure|1|||
48705709|NCT01812252|156771519|FG001|Overall Study|Screen Failure|0|||
48705710|NCT02557139|156771520|FG000|Overall Study|Significant liver elevation|1|||
48705711|NCT02557139|156771521|FG001|Overall Study|Significant liver elevation|0|||
48705712|NCT02557139|156771522|FG002|Overall Study|Significant liver elevation|1|||
48705713|NCT02557139|156771520|FG000|Overall Study|Withdrawal by Subject|1|||
48705714|NCT02557139|156771521|FG001|Overall Study|Withdrawal by Subject|0|||
48705715|NCT02557139|156771522|FG002|Overall Study|Withdrawal by Subject|0|||
48705716|NCT02557139|156771520|FG000|Overall Study|Illness of prohibited medication|0|||
48705717|NCT02557139|156771521|FG001|Overall Study|Illness of prohibited medication|0|||
48705718|NCT02557139|156771522|FG002|Overall Study|Illness of prohibited medication|1|||
48856322|NCT01029704|157312816|FG000|Overall Study|Lack of Efficacy|0|||
48856323|NCT01029704|157312817|FG001|Overall Study|Lack of Efficacy|0|||
48856324|NCT01029704|157312818|FG002|Overall Study|Lack of Efficacy|0|||
48856325|NCT01029704|157312819|FG003|Overall Study|Lack of Efficacy|0|||
48856326|NCT01029704|157312820|FG004|Overall Study|Lack of Efficacy|2|||
48856327|NCT01029704|157312821|FG005|Overall Study|Lack of Efficacy|3|||
48856328|NCT01029704|157312822|FG006|Overall Study|Lack of Efficacy|1|||
48856329|NCT01029704|157312823|FG007|Overall Study|Lack of Efficacy|2|||
48856330|NCT01029704|157312824|FG008|Overall Study|Lack of Efficacy|0|||
48856331|NCT01029704|157312816|FG000|Overall Study|Withdrawn due to major protocol violation|0|||
48856332|NCT01029704|157312817|FG001|Overall Study|Withdrawn due to major protocol violation|0|||
48856333|NCT01029704|157312818|FG002|Overall Study|Withdrawn due to major protocol violation|0|||
48856334|NCT01029704|157312819|FG003|Overall Study|Withdrawn due to major protocol violation|0|||
48856335|NCT01029704|157312820|FG004|Overall Study|Withdrawn due to major protocol violation|1|||
48856336|NCT01029704|157312821|FG005|Overall Study|Withdrawn due to major protocol violation|0|||
48856337|NCT01029704|157312822|FG006|Overall Study|Withdrawn due to major protocol violation|0|||
48856338|NCT01029704|157312823|FG007|Overall Study|Withdrawn due to major protocol violation|1|||
48856339|NCT01029704|157312824|FG008|Overall Study|Withdrawn due to major protocol violation|0|||
48856340|NCT03695185|157312825|FG000|Induction Period (Week 0 to Week 12)|Adverse Event|1|||
48856341|NCT03695185|157312825|FG000|Induction Period (Week 0 to Week 12)|Withdrew consent|2|||
48856342|NCT03695185|157312825|FG000|Induction Period (Week 0 to Week 12)|Lack of Efficacy|10|||
48856343|NCT03695185|157312825|FG000|Maintenance Period (Week 12 to Week 102)|Withdrew consent|3|||
48856344|NCT03695185|157312825|FG000|Maintenance Period (Week 12 to Week 102)|Lack of Efficacy|2|||
48856345|NCT03695185|157312825|FG000|Maintenance Period (Week 12 to Week 102)|Reason not specified|23|||
48856346|NCT03390166|157312826|FG000|Overall Study|Death|0|||
48856347|NCT03390166|157312827|FG001|Overall Study|Death|1|||
48856348|NCT03390166|157312826|FG000|Overall Study|Lost to Follow-up|6|||
48856349|NCT03390166|157312827|FG001|Overall Study|Lost to Follow-up|4|||
48856350|NCT03390166|157312826|FG000|Overall Study|Physician Decision|2|||
48856351|NCT03390166|157312827|FG001|Overall Study|Physician Decision|1|||
48856352|NCT03390166|157312826|FG000|Overall Study|Move from study area|3|||
48856353|NCT03390166|157312827|FG001|Overall Study|Move from study area|2|||
48856354|NCT03390166|157312826|FG000|Overall Study|To militarycamp for conscript|1|||
48856355|NCT03390166|157312827|FG001|Overall Study|To militarycamp for conscript|0|||
48912937|NCT00455013|157517626|FG000|Long Term Extension (LTE)|Death|1|||
48912938|NCT00455013|157517627|FG001|Long Term Extension (LTE)|Death|1|||
48912939|NCT00455013|157517628|FG002|Long Term Extension (LTE)|Death|0|||
48912940|NCT00455013|157517626|FG000|Long Term Extension (LTE)|No longer met criteria|0|||
48912941|NCT00455013|157517627|FG001|Long Term Extension (LTE)|No longer met criteria|0|||
48912942|NCT00455013|157517628|FG002|Long Term Extension (LTE)|No longer met criteria|1|||
48912943|NCT00455013|157517626|FG000|Long Term Extension (LTE)|Subject Request or refused|0|||
48912944|NCT00455013|157517627|FG001|Long Term Extension (LTE)|Subject Request or refused|0|||
48912945|NCT00455013|157517628|FG002|Long Term Extension (LTE)|Subject Request or refused|3|||
48912946|NCT00455013|157517626|FG000|Long Term Extension (LTE)|Poor non-compliance|0|||
48912947|NCT00455013|157517627|FG001|Long Term Extension (LTE)|Poor non-compliance|1|||
48912948|NCT00455013|157517628|FG002|Long Term Extension (LTE)|Poor non-compliance|0|||
48912949|NCT00455013|157517626|FG000|Long Term Extension (LTE)|non-specified|0|||
48912950|NCT00455013|157517627|FG001|Long Term Extension (LTE)|non-specified|0|||
48912951|NCT00455013|157517628|FG002|Long Term Extension (LTE)|non-specified|1|||
48912952|NCT01506960|157517629|FG000|Overall Study|Did not meet angiographic criteria|47|||
48912953|NCT00555477|157517630|FG000|Overall Study|Adverse Event|0|||
48912954|NCT00555477|157517631|FG001|Overall Study|Adverse Event|9|||
48912955|NCT00555477|157517630|FG000|Overall Study|Withdrawal by Subject|1|||
48912956|NCT00555477|157517631|FG001|Overall Study|Withdrawal by Subject|2|||
48912957|NCT00555477|157517630|FG000|Overall Study|Physician Decision|1|||
48705719|NCT02500797|156771523|FG000|Overall Study|Cancel (rapid disease progression)|0|||
48705720|NCT02500797|156771524|FG001|Overall Study|Cancel (rapid disease progression)|0|||
48705721|NCT02500797|156771525|FG002|Overall Study|Cancel (rapid disease progression)|0|||
48705722|NCT02500797|156771526|FG003|Overall Study|Cancel (rapid disease progression)|0|||
48705723|NCT02500797|156771527|FG004|Overall Study|Cancel (rapid disease progression)|1|||
48705724|NCT02500797|156771528|FG005|Overall Study|Cancel (rapid disease progression)|1|||
48705725|NCT02500797|156771529|FG006|Overall Study|Cancel (rapid disease progression)|0|||
48705726|NCT02500797|156771530|FG007|Overall Study|Cancel (rapid disease progression)|0|||
48705727|NCT02500797|156771523|FG000|Overall Study|Withdrawal by Subject|1|||
48705728|NCT02500797|156771524|FG001|Overall Study|Withdrawal by Subject|0|||
48705729|NCT02500797|156771525|FG002|Overall Study|Withdrawal by Subject|0|||
48705730|NCT02500797|156771526|FG003|Overall Study|Withdrawal by Subject|0|||
48705731|NCT02500797|156771527|FG004|Overall Study|Withdrawal by Subject|0|||
48705732|NCT02500797|156771528|FG005|Overall Study|Withdrawal by Subject|0|||
48705733|NCT02500797|156771529|FG006|Overall Study|Withdrawal by Subject|0|||
48705734|NCT02500797|156771530|FG007|Overall Study|Withdrawal by Subject|0|||
48705735|NCT00369265|156771536|FG000|Overall Study|Study terminated|4|||
48705736|NCT00369265|156771537|FG001|Overall Study|Study terminated|7|||
48705737|NCT03895840|156771538|FG000|Overall Study|Withdrawal by Subject|21|||
48705738|NCT03857867|156771539|FG000|Overall Study|Physician Decision|1|||
48705739|NCT01869764|156771540|FG000|Overall Study|Withdrawal by Subject|0|||
48705740|NCT01869764|156771541|FG001|Overall Study|Withdrawal by Subject|2|||
48705741|NCT00834093|156771542|FG000|Overall Study|Progressive Disease|3|||
48705742|NCT00834093|156771542|FG000|Overall Study|Withdrawal by subject or MD Decision|5|||
48705743|NCT02745119|156771543|FG000|Overall Study|Adverse Event|1|||
48705744|NCT02745119|156771544|FG001|Overall Study|Adverse Event|0|||
48705745|NCT02745119|156771545|FG002|Overall Study|Adverse Event|1|||
48705746|NCT02745119|156771546|FG003|Overall Study|Adverse Event|3|||
48705747|NCT02745119|156771543|FG000|Overall Study|Death|3|||
48705748|NCT02745119|156771544|FG001|Overall Study|Death|3|||
48705749|NCT02745119|156771545|FG002|Overall Study|Death|0|||
48705750|NCT02745119|156771546|FG003|Overall Study|Death|4|||
48705751|NCT02745119|156771543|FG000|Overall Study|Lost to Follow-up|0|||
48705752|NCT02745119|156771544|FG001|Overall Study|Lost to Follow-up|0|||
48705753|NCT02745119|156771545|FG002|Overall Study|Lost to Follow-up|0|||
48705754|NCT02745119|156771546|FG003|Overall Study|Lost to Follow-up|1|||
48705755|NCT02745119|156771543|FG000|Overall Study|Protocol Deviation|0|||
48912958|NCT00555477|157517631|FG001|Overall Study|Physician Decision|2|||
48912959|NCT00397033|157517632|FG000|Overall Study|Adverse Event|7|||
48912960|NCT00397033|157517633|FG001|Overall Study|Adverse Event|10|||
48705756|NCT02745119|156771544|FG001|Overall Study|Protocol Deviation|0|||
48705757|NCT02745119|156771545|FG002|Overall Study|Protocol Deviation|0|||
48705758|NCT02745119|156771546|FG003|Overall Study|Protocol Deviation|1|||
48705759|NCT02745119|156771543|FG000|Overall Study|Withdrawal by Subject|7|||
48705760|NCT02745119|156771544|FG001|Overall Study|Withdrawal by Subject|15|||
48705761|NCT02745119|156771545|FG002|Overall Study|Withdrawal by Subject|8|||
48705762|NCT02745119|156771546|FG003|Overall Study|Withdrawal by Subject|14|||
48705763|NCT02745119|156771543|FG000|Overall Study|Study Terminated by Sponsor|134|||
48705764|NCT02745119|156771544|FG001|Overall Study|Study Terminated by Sponsor|252|||
48705765|NCT02745119|156771545|FG002|Overall Study|Study Terminated by Sponsor|135|||
48705766|NCT02745119|156771546|FG003|Overall Study|Study Terminated by Sponsor|251|||
48705767|NCT02745119|156771543|FG000|Overall Study|Physician Decision|0|||
48705768|NCT02745119|156771544|FG001|Overall Study|Physician Decision|2|||
48705769|NCT02745119|156771545|FG002|Overall Study|Physician Decision|2|||
48705770|NCT02745119|156771546|FG003|Overall Study|Physician Decision|2|||
48705771|NCT02745119|156771543|FG000|Overall Study|Reason Not Specified|0|||
48705772|NCT02745119|156771544|FG001|Overall Study|Reason Not Specified|2|||
48705773|NCT02745119|156771545|FG002|Overall Study|Reason Not Specified|0|||
48705774|NCT02745119|156771546|FG003|Overall Study|Reason Not Specified|1|||
48705775|NCT00515619|156771547|FG000|Overall Study|Adverse Event|34|||
48705776|NCT00515619|156771547|FG000|Overall Study|Lack of Efficacy|92|||
48705777|NCT00515619|156771547|FG000|Overall Study|Withdrawal by Subject|66|||
48705778|NCT00515619|156771547|FG000|Overall Study|Protocol Violation|3|||
48705779|NCT00515619|156771547|FG000|Overall Study|Lost to Follow-up|4|||
48705780|NCT00515619|156771547|FG000|Overall Study|Unsatisfactory compliance|6|||
48705781|NCT00515619|156771547|FG000|Overall Study|Other: Site discontinuing trials|2|||
48705782|NCT00515619|156771547|FG000|Overall Study|Other: Subject cannot attend visits|2|||
48705783|NCT00515619|156771547|FG000|Overall Study|Other: Subject required surgery|1|||
48705784|NCT00515619|156771547|FG000|Overall Study|Other: Subject moved to another country|1|||
48705785|NCT00515619|156771547|FG000|Overall Study|Other: Investigator decision|1|||
48705786|NCT00515619|156771547|FG000|Overall Study|Other: Subject became pregnant|1|||
48705787|NCT00515619|156771547|FG000|Overall Study|Other: Request from sponsor|1|||
48705788|NCT00515619|156771547|FG000|Overall Study|Other: Drug available on license|1|||
48705789|NCT00515619|156771547|FG000|Overall Study|Other: Subject interested in other AED|1|||
48705790|NCT03313037|156771548|FG000|Overall Study|Protocol Violation|4|||
48705791|NCT03313037|156771549|FG001|Overall Study|Protocol Violation|1|||
48705792|NCT03313037|156771548|FG000|Overall Study|Other|1|||
48705793|NCT03313037|156771549|FG001|Overall Study|Other|1|||
48705794|NCT03313037|156771548|FG000|Overall Study|Withdrawal by Subject|4|||
48705795|NCT03313037|156771549|FG001|Overall Study|Withdrawal by Subject|3|||
48705796|NCT03313037|156771548|FG000|Overall Study|No longer meets eligibility criteria|1|||
48705797|NCT03313037|156771549|FG001|Overall Study|No longer meets eligibility criteria|7|||
48705798|NCT03313037|156771548|FG000|Overall Study|Lost to Follow-up|9|||
48705799|NCT03313037|156771549|FG001|Overall Study|Lost to Follow-up|8|||
48705800|NCT03313037|156771548|FG000|Overall Study|Randomized but not treated|1|||
48705801|NCT03313037|156771549|FG001|Overall Study|Randomized but not treated|0|||
48705802|NCT01918306|156771553|FG000|Overall Study|progresive disease|4|||
48705803|NCT01918306|156771554|FG001|Overall Study|progresive disease|0|||
48705804|NCT01918306|156771555|FG002|Overall Study|progresive disease|1|||
48705805|NCT01918306|156771556|FG003|Overall Study|progresive disease|1|||
48705806|NCT01918306|156771553|FG000|Overall Study|Withdrawal by Subject|0|||
48705807|NCT01918306|156771554|FG001|Overall Study|Withdrawal by Subject|0|||
48705808|NCT01918306|156771555|FG002|Overall Study|Withdrawal by Subject|0|||
48705809|NCT01918306|156771556|FG003|Overall Study|Withdrawal by Subject|2|||
48705810|NCT01918306|156771553|FG000|Overall Study|neutropenia|1|||
48705811|NCT01918306|156771554|FG001|Overall Study|neutropenia|0|||
48705812|NCT01918306|156771555|FG002|Overall Study|neutropenia|0|||
48799475|NCT04843930|157104203|FG000|Week 6 Assessment|Withdrawal by Subject|2|||
48799476|NCT04843930|157104204|FG001|Week 6 Assessment|Withdrawal by Subject|1|||
48799477|NCT04843930|157104205|FG002|Week 6 Assessment|Withdrawal by Subject|0|||
48912961|NCT00397033|157517634|FG002|Overall Study|Adverse Event|4|||
48912962|NCT00397033|157517632|FG000|Overall Study|Lack of Efficacy|22|||
48799478|NCT04843930|157104206|FG003|Week 6 Assessment|Withdrawal by Subject|0|||
48799479|NCT04843930|157104203|FG000|Week 16 Follow-Up|Lost to Follow-up|0|||
48799480|NCT04843930|157104204|FG001|Week 16 Follow-Up|Lost to Follow-up|0|||
48799481|NCT04843930|157104205|FG002|Week 16 Follow-Up|Lost to Follow-up|2|||
48799482|NCT04843930|157104206|FG003|Week 16 Follow-Up|Lost to Follow-up|0|||
48799483|NCT02220894|157104208|FG000|Overall Study|Adverse Event|127|||
48799484|NCT02220894|157104209|FG001|Overall Study|Adverse Event|74|||
48799485|NCT02220894|157104208|FG000|Overall Study|Death|418|||
48799486|NCT02220894|157104209|FG001|Overall Study|Death|508|||
48799487|NCT02220894|157104208|FG000|Overall Study|Lost to Follow-up|0|||
48799488|NCT02220894|157104209|FG001|Overall Study|Lost to Follow-up|4|||
48912963|NCT00397033|157517633|FG001|Overall Study|Lack of Efficacy|12|||
48799489|NCT02220894|157104208|FG000|Overall Study|Site Terminated by Sponsor|2|||
48799490|NCT02220894|157104209|FG001|Overall Study|Site Terminated by Sponsor|0|||
48799491|NCT02220894|157104208|FG000|Overall Study|Participation in Study Terminated by Sponsor|80|||
48799492|NCT02220894|157104209|FG001|Overall Study|Participation in Study Terminated by Sponsor|41|||
48799493|NCT02220894|157104208|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
48799494|NCT02220894|157104209|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
48912964|NCT00397033|157517634|FG002|Overall Study|Lack of Efficacy|9|||
48799495|NCT02220894|157104208|FG000|Overall Study|Withdrawal by Subject|10|||
48799496|NCT02220894|157104209|FG001|Overall Study|Withdrawal by Subject|9|||
49118738|NCT01831427|158273192|FG007|Overall Study|Withdrew Consent|0|||
48705813|NCT01918306|156771556|FG003|Overall Study|neutropenia|0|||
49118739|NCT01831427|158273193|FG008|Overall Study|Withdrew Consent|0|||
48705814|NCT01918306|156771553|FG000|Overall Study|Lack of Efficacy|1|||
48705815|NCT01918306|156771554|FG001|Overall Study|Lack of Efficacy|0|||
48705816|NCT01918306|156771555|FG002|Overall Study|Lack of Efficacy|0|||
48705817|NCT01918306|156771556|FG003|Overall Study|Lack of Efficacy|0|||
48705818|NCT01918306|156771553|FG000|Overall Study|progress disease, crossover|0|||
48705819|NCT01918306|156771554|FG001|Overall Study|progress disease, crossover|0|||
48705820|NCT01918306|156771555|FG002|Overall Study|progress disease, crossover|1|||
48705821|NCT01918306|156771556|FG003|Overall Study|progress disease, crossover|0|||
48705822|NCT02379091|156771557|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
48705823|NCT02379091|156771558|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
48705824|NCT02379091|156771559|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
48705825|NCT02379091|156771560|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
48705826|NCT02379091|156771557|FG000|Overall Study|Principal Investigator Discretion|0|||
48705827|NCT02379091|156771558|FG001|Overall Study|Principal Investigator Discretion|1|||
48705828|NCT02379091|156771559|FG002|Overall Study|Principal Investigator Discretion|0|||
48705829|NCT02379091|156771560|FG003|Overall Study|Principal Investigator Discretion|0|||
48705830|NCT02379091|156771557|FG000|Overall Study|Lost to Follow-up|0|||
48705831|NCT02379091|156771558|FG001|Overall Study|Lost to Follow-up|0|||
48705832|NCT02379091|156771559|FG002|Overall Study|Lost to Follow-up|0|||
48705833|NCT02379091|156771560|FG003|Overall Study|Lost to Follow-up|1|||
48705834|NCT02379091|156771557|FG000|Overall Study|Voluntary Withdrawal|2|||
48705835|NCT02379091|156771558|FG001|Overall Study|Voluntary Withdrawal|5|||
48705836|NCT02379091|156771559|FG002|Overall Study|Voluntary Withdrawal|2|||
48705837|NCT02379091|156771560|FG003|Overall Study|Voluntary Withdrawal|4|||
48705838|NCT02379091|156771557|FG000|Overall Study|Study Termination|7|||
48705839|NCT02379091|156771558|FG001|Overall Study|Study Termination|2|||
48705840|NCT02379091|156771559|FG002|Overall Study|Study Termination|5|||
48705841|NCT02379091|156771560|FG003|Overall Study|Study Termination|8|||
48705842|NCT02379091|156771557|FG000|Overall Study|Lack of Efficacy|3|||
48705843|NCT02379091|156771558|FG001|Overall Study|Lack of Efficacy|0|||
48705844|NCT02379091|156771559|FG002|Overall Study|Lack of Efficacy|0|||
48705845|NCT02379091|156771560|FG003|Overall Study|Lack of Efficacy|0|||
48705846|NCT01467960|156771563|FG000|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
48705847|NCT01467960|156771564|FG001|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
48705848|NCT01467960|156771565|FG002|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
48705849|NCT01467960|156771566|FG003|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
48705850|NCT01467960|156771567|FG004|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
48705851|NCT01467960|156771568|FG005|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
48705852|NCT00737672|156771569|FG000|Overall Study|Graft Abandonment|48|||
48705853|NCT00737672|156771570|FG001|Overall Study|Graft Abandonment|56|||
48705854|NCT00737672|156771569|FG000|Overall Study|Death|23|||
48705855|NCT00737672|156771570|FG001|Overall Study|Death|22|||
48705856|NCT00737672|156771569|FG000|Overall Study|Withdrawal by Subject|1|||
48705857|NCT00737672|156771570|FG001|Overall Study|Withdrawal by Subject|2|||
48705858|NCT00737672|156771569|FG000|Overall Study|Lost to Follow-up|1|||
48705859|NCT00737672|156771570|FG001|Overall Study|Lost to Follow-up|0|||
48705860|NCT00737672|156771569|FG000|Overall Study|Miscellaneous|7|||
48705861|NCT00737672|156771570|FG001|Overall Study|Miscellaneous|1|||
48705862|NCT00737672|156771569|FG000|Overall Study|Physician Decision|0|||
48705863|NCT00737672|156771570|FG001|Overall Study|Physician Decision|2|||
48705864|NCT02447003|156771571|FG000|Overall Study|Other|0|||
48705865|NCT02447003|156771572|FG001|Overall Study|Other|4|||
48705866|NCT02447003|156771571|FG000|Overall Study|Site discontinued|0|||
48705867|NCT02447003|156771572|FG001|Overall Study|Site discontinued|2|||
48705868|NCT02447003|156771571|FG000|Overall Study|Physician Decision|0|||
48705869|NCT02447003|156771572|FG001|Overall Study|Physician Decision|1|||
48705870|NCT02447003|156771571|FG000|Overall Study|Withdrawal by Subject|4|||
48705871|NCT02447003|156771572|FG001|Overall Study|Withdrawal by Subject|3|||
48705872|NCT02447003|156771571|FG000|Overall Study|Sponsor Decision|6|||
48705873|NCT02447003|156771572|FG001|Overall Study|Sponsor Decision|11|||
48705874|NCT02447003|156771571|FG000|Overall Study|Progressive Disease|1|||
48705875|NCT02447003|156771572|FG001|Overall Study|Progressive Disease|0|||
48705876|NCT02447003|156771571|FG000|Overall Study|Lost to Follow-up|5|||
48705877|NCT02447003|156771572|FG001|Overall Study|Lost to Follow-up|0|||
48705878|NCT02447003|156771571|FG000|Overall Study|Death|154|||
48705879|NCT02447003|156771572|FG001|Overall Study|Death|63|||
48705880|NCT00787644|156771573|FG000|Overall Study|Lost to Follow-up|1|||
48705881|NCT00787644|156771574|FG001|Overall Study|Lost to Follow-up|1|||
48705882|NCT00787644|156771573|FG000|Overall Study|Withdrawal by Subject|1|||
48705883|NCT00787644|156771574|FG001|Overall Study|Withdrawal by Subject|1|||
48705884|NCT02930018|156771580|FG000|Overall Study|Lost to Follow-up|1|||
48705885|NCT02930018|156771581|FG001|Overall Study|Lost to Follow-up|1|||
48705886|NCT02930018|156771580|FG000|Overall Study|Withdrawal by Subject|5|||
48705887|NCT02930018|156771581|FG001|Overall Study|Withdrawal by Subject|2|||
48705888|NCT00807001|156773453|FG000|Overall Study|Non-compliance|0|||
48705889|NCT00807001|156773454|FG001|Overall Study|Non-compliance|1|||
48705890|NCT00807001|156773455|FG002|Overall Study|Non-compliance|0|||
48705891|NCT00807001|156773456|FG003|Overall Study|Non-compliance|0|||
48705892|NCT00807001|156773457|FG004|Overall Study|Non-compliance|0|||
48705893|NCT01803607|156773458|FG000|Overall Study|Adverse Event|5|||
48705894|NCT01803607|156773459|FG001|Overall Study|Adverse Event|3|||
48705895|NCT01803607|156773458|FG000|Overall Study|Lack of Efficacy|0|||
48705896|NCT01803607|156773459|FG001|Overall Study|Lack of Efficacy|1|||
48705897|NCT01803607|156773458|FG000|Overall Study|Protocol Violation|3|||
48705898|NCT01803607|156773459|FG001|Overall Study|Protocol Violation|2|||
48705899|NCT01803607|156773458|FG000|Overall Study|Study terminated by sponsor|54|||
48705900|NCT01803607|156773459|FG001|Overall Study|Study terminated by sponsor|56|||
48705901|NCT01803607|156773458|FG000|Overall Study|Withdrawal by Subject|6|||
48705902|NCT01803607|156773459|FG001|Overall Study|Withdrawal by Subject|5|||
48705903|NCT02266888|156773466|FG000|Overall Study|Death|2|||
48705904|NCT02266888|156773467|FG001|Overall Study|Death|2|||
48705905|NCT02266888|156773468|FG002|Overall Study|Death|4|||
48705906|NCT02266888|156773469|FG003|Overall Study|Death|2|||
48705907|NCT02266888|156773466|FG000|Overall Study|Physician Decision|0|||
48705908|NCT02266888|156773467|FG001|Overall Study|Physician Decision|1|||
48705909|NCT02266888|156773468|FG002|Overall Study|Physician Decision|2|||
48705910|NCT02266888|156773469|FG003|Overall Study|Physician Decision|2|||
48705911|NCT02266888|156773466|FG000|Overall Study|Study Terminated|5|||
48705912|NCT02266888|156773467|FG001|Overall Study|Study Terminated|1|||
48705913|NCT02266888|156773468|FG002|Overall Study|Study Terminated|0|||
48705914|NCT02266888|156773469|FG003|Overall Study|Study Terminated|0|||
48705915|NCT02266888|156773466|FG000|Overall Study|No Longer Eligible|0|||
48705916|NCT02266888|156773467|FG001|Overall Study|No Longer Eligible|0|||
48705917|NCT02266888|156773468|FG002|Overall Study|No Longer Eligible|0|||
48705918|NCT02266888|156773469|FG003|Overall Study|No Longer Eligible|2|||
48705919|NCT02266888|156773466|FG000|Overall Study|Randomization Closed|0|||
48705920|NCT02266888|156773467|FG001|Overall Study|Randomization Closed|0|||
48705921|NCT02266888|156773468|FG002|Overall Study|Randomization Closed|4|||
48705922|NCT02266888|156773469|FG003|Overall Study|Randomization Closed|0|||
48705923|NCT02266888|156773466|FG000|Overall Study|Personnel unavailable at transplant|0|||
48705924|NCT02266888|156773467|FG001|Overall Study|Personnel unavailable at transplant|0|||
48705925|NCT02266888|156773468|FG002|Overall Study|Personnel unavailable at transplant|0|||
48705926|NCT02266888|156773469|FG003|Overall Study|Personnel unavailable at transplant|1|||
48705927|NCT02266888|156773466|FG000|Overall Study|Transfer of care|0|||
48705928|NCT02266888|156773467|FG001|Overall Study|Transfer of care|0|||
48705929|NCT02266888|156773468|FG002|Overall Study|Transfer of care|1|||
48705930|NCT02266888|156773469|FG003|Overall Study|Transfer of care|0|||
48705931|NCT02038933|156773472|FG000|Overall Study|Disease progression|104|||
48705932|NCT02038933|156773472|FG000|Overall Study|Study drug toxicity|6|||
48705933|NCT02038933|156773472|FG000|Overall Study|Adverse event unrelated to study drug|6|||
48705934|NCT02038933|156773472|FG000|Overall Study|Participant request to discontinue treatment|2|||
48705935|NCT02038933|156773472|FG000|Overall Study|Lost to Follow-up|1|||
48705936|NCT02038933|156773472|FG000|Overall Study|Other reasons|2|||
48705937|NCT04154904|156773473|FG000|At Home Period (28 Days)|Withdrawal by Subject|0|||
48705938|NCT04154904|156773474|FG001|At Home Period (28 Days)|Withdrawal by Subject|0|||
48705939|NCT04154904|156773475|FG002|At Home Period (28 Days)|Withdrawal by Subject|1|||
48705940|NCT00706238|156773476|FG000|Overall Study|Disease progression|4|||
48705941|NCT00706238|156773476|FG000|Overall Study|Other|1|||
48705942|NCT03819114|156773478|FG000|Overall Study|Protocol Violation|0|||
48705943|NCT03819114|156773479|FG001|Overall Study|Protocol Violation|1|||
48705944|NCT03819114|156773480|FG002|Overall Study|Protocol Violation|1|||
48705945|NCT03819114|156773481|FG003|Overall Study|Protocol Violation|0|||
48705946|NCT03819114|156773478|FG000|Overall Study|Lost to Follow-up|0|||
48705947|NCT03819114|156773479|FG001|Overall Study|Lost to Follow-up|0|||
48705948|NCT03819114|156773480|FG002|Overall Study|Lost to Follow-up|1|||
48705949|NCT03819114|156773481|FG003|Overall Study|Lost to Follow-up|0|||
48705950|NCT01462370|156773482|FG000|Overall Study|Lack of Qualifying Event|1|||
49118740|NCT01831427|158273194|FG009|Overall Study|Withdrew Consent|1|||
49118741|NCT01831427|158273195|FG010|Overall Study|Withdrew Consent|1|||
48705951|NCT01462370|156773483|FG001|Overall Study|Lack of Qualifying Event|1|||
48705952|NCT01462370|156773482|FG000|Overall Study|Physician Decision|0|||
48705953|NCT01462370|156773483|FG001|Overall Study|Physician Decision|1|||
49118742|NCT03442088|158273196|FG000|Overall Study|Adverse Event|1|||
49118743|NCT03442088|158273196|FG000|Overall Study|Lack of Efficacy|2|||
48705954|NCT01462370|156773482|FG000|Overall Study|Withdrawal by Subject|0|||
48705955|NCT01462370|156773483|FG001|Overall Study|Withdrawal by Subject|3|||
48705956|NCT02085161|156773484|FG000|Overall Study|Not Treated|1|||
48705957|NCT02085161|156773485|FG001|Overall Study|Not Treated|0|||
48705958|NCT02085161|156773486|FG002|Overall Study|Not Treated|0|||
48705959|NCT02085161|156773487|FG003|Overall Study|Not Treated|0|||
48705960|NCT02085161|156773484|FG000|Overall Study|Adverse Event|8|||
48705961|NCT02085161|156773485|FG001|Overall Study|Adverse Event|5|||
48705962|NCT02085161|156773486|FG002|Overall Study|Adverse Event|4|||
48705963|NCT02085161|156773487|FG003|Overall Study|Adverse Event|5|||
48705964|NCT02085161|156773484|FG000|Overall Study|Protocol Violation|0|||
48705965|NCT02085161|156773485|FG001|Overall Study|Protocol Violation|1|||
48705966|NCT02085161|156773486|FG002|Overall Study|Protocol Violation|0|||
48705967|NCT02085161|156773487|FG003|Overall Study|Protocol Violation|1|||
48705968|NCT02085161|156773484|FG000|Overall Study|Withdrawal by Subject|2|||
48705969|NCT02085161|156773485|FG001|Overall Study|Withdrawal by Subject|4|||
48705970|NCT02085161|156773486|FG002|Overall Study|Withdrawal by Subject|0|||
48705971|NCT02085161|156773487|FG003|Overall Study|Withdrawal by Subject|3|||
48705972|NCT02085161|156773484|FG000|Overall Study|Other Reason|1|||
48705973|NCT02085161|156773485|FG001|Overall Study|Other Reason|0|||
48705974|NCT02085161|156773486|FG002|Overall Study|Other Reason|1|||
48705975|NCT02085161|156773487|FG003|Overall Study|Other Reason|1|||
48705976|NCT03763877|156773499|FG000|Overall Study|Withdrawal by Subject|3|||
48705977|NCT03763877|156773500|FG001|Overall Study|Withdrawal by Subject|1|||
48705978|NCT03763877|156773501|FG002|Overall Study|Withdrawal by Subject|3|||
48705979|NCT03763877|156773502|FG003|Overall Study|Withdrawal by Subject|4|||
48705980|NCT03763877|156773499|FG000|Overall Study|Adverse Event|1|||
48705981|NCT03763877|156773500|FG001|Overall Study|Adverse Event|1|||
48705982|NCT03763877|156773501|FG002|Overall Study|Adverse Event|3|||
48705983|NCT03763877|156773502|FG003|Overall Study|Adverse Event|1|||
48705984|NCT03763877|156773499|FG000|Overall Study|Protocol Violation|1|||
48705985|NCT03763877|156773500|FG001|Overall Study|Protocol Violation|1|||
48705986|NCT03763877|156773501|FG002|Overall Study|Protocol Violation|0|||
48705987|NCT03763877|156773502|FG003|Overall Study|Protocol Violation|0|||
48705988|NCT03763877|156773499|FG000|Overall Study|Lost to Follow-up|0|||
48705989|NCT03763877|156773500|FG001|Overall Study|Lost to Follow-up|1|||
48705990|NCT03763877|156773501|FG002|Overall Study|Lost to Follow-up|1|||
48705991|NCT03763877|156773502|FG003|Overall Study|Lost to Follow-up|0|||
48705992|NCT03040336|156773503|FG000|Overall Study|Death|1|||
48705993|NCT03040336|156773504|FG001|Overall Study|Death|0|||
48705994|NCT03040336|156773503|FG000|Overall Study|Withdrawal by Subject|2|||
48705995|NCT03040336|156773504|FG001|Overall Study|Withdrawal by Subject|3|||
48705996|NCT01747876|156773505|FG000|Overall Study|Adverse Event|1|||
48705997|NCT01747876|156773506|FG001|Overall Study|Adverse Event|0|||
48705998|NCT01747876|156773507|FG002|Overall Study|Adverse Event|2|||
48705999|NCT01747876|156773505|FG000|Overall Study|Withdrawal by Subject|0|||
48706000|NCT01747876|156773506|FG001|Overall Study|Withdrawal by Subject|1|||
48706001|NCT01747876|156773507|FG002|Overall Study|Withdrawal by Subject|1|||
48706002|NCT01747876|156773505|FG000|Overall Study|Disease progression|4|||
48706003|NCT01747876|156773506|FG001|Overall Study|Disease progression|13|||
48706004|NCT01747876|156773507|FG002|Overall Study|Disease progression|8|||
48706005|NCT01747876|156773505|FG000|Overall Study|Trtment duration compl. as per protocol|0|||
48706006|NCT01747876|156773506|FG001|Overall Study|Trtment duration compl. as per protocol|1|||
48706007|NCT01747876|156773507|FG002|Overall Study|Trtment duration compl. as per protocol|1|||
48706008|NCT03822117|156773508|FG000|Overall Study|Death|18|||
48706009|NCT03822117|156773509|FG001|Overall Study|Death|17|||
48706010|NCT03822117|156773510|FG002|Overall Study|Death|12|||
48706011|NCT03822117|156773511|FG003|Overall Study|Death|4|||
48706012|NCT03822117|156773508|FG000|Overall Study|Lost to Follow-up|1|||
48706013|NCT03822117|156773509|FG001|Overall Study|Lost to Follow-up|2|||
48706014|NCT03822117|156773510|FG002|Overall Study|Lost to Follow-up|3|||
48706015|NCT03822117|156773511|FG003|Overall Study|Lost to Follow-up|0|||
48706016|NCT03822117|156773508|FG000|Overall Study|Study Terminated by Sponsor|25|||
48706017|NCT03822117|156773509|FG001|Overall Study|Study Terminated by Sponsor|11|||
48706018|NCT03822117|156773510|FG002|Overall Study|Study Terminated by Sponsor|6|||
48706019|NCT03822117|156773511|FG003|Overall Study|Study Terminated by Sponsor|0|||
48706020|NCT03822117|156773508|FG000|Overall Study|Withdrawal by Subject|4|||
48706021|NCT03822117|156773509|FG001|Overall Study|Withdrawal by Subject|0|||
48706022|NCT03822117|156773510|FG002|Overall Study|Withdrawal by Subject|3|||
48706023|NCT03822117|156773511|FG003|Overall Study|Withdrawal by Subject|0|||
48706024|NCT03822117|156773508|FG000|Overall Study|Disease Progression|1|||
48706025|NCT03822117|156773509|FG001|Overall Study|Disease Progression|2|||
48912965|NCT00397033|157517632|FG000|Overall Study|Lost to Follow-up|3|||
48706026|NCT03822117|156773510|FG002|Overall Study|Disease Progression|1|||
48706027|NCT03822117|156773511|FG003|Overall Study|Disease Progression|0|||
48706028|NCT03822117|156773508|FG000|Overall Study|Never Returned to Hospital|0|||
48706029|NCT03822117|156773509|FG001|Overall Study|Never Returned to Hospital|0|||
48706030|NCT03822117|156773510|FG002|Overall Study|Never Returned to Hospital|1|||
48706031|NCT03822117|156773511|FG003|Overall Study|Never Returned to Hospital|0|||
48706032|NCT00068692|156773516|FG000|Step 1: Registration|Disese progression/relapse|5|||
48706033|NCT00068692|156773517|FG001|Step 1: Registration|Disese progression/relapse|0|||
48706034|NCT00068692|156773518|FG002|Step 1: Registration|Disese progression/relapse|0|||
48706035|NCT00068692|156773519|FG003|Step 1: Registration|Disese progression/relapse|0|||
48706036|NCT00068692|156773520|FG004|Step 1: Registration|Disese progression/relapse|0|||
48912966|NCT00397033|157517633|FG001|Overall Study|Lost to Follow-up|3|||
48706037|NCT00068692|156773521|FG005|Step 1: Registration|Disese progression/relapse|0|||
48706038|NCT00068692|156773522|FG006|Step 1: Registration|Disese progression/relapse|0|||
48706039|NCT00068692|156773523|FG007|Step 1: Registration|Disese progression/relapse|0|||
48706040|NCT00068692|156773516|FG000|Step 1: Registration|Adverse Event|7|||
48706041|NCT00068692|156773517|FG001|Step 1: Registration|Adverse Event|0|||
48706042|NCT00068692|156773518|FG002|Step 1: Registration|Adverse Event|0|||
48706043|NCT00068692|156773519|FG003|Step 1: Registration|Adverse Event|0|||
48706044|NCT00068692|156773520|FG004|Step 1: Registration|Adverse Event|0|||
48706045|NCT00068692|156773521|FG005|Step 1: Registration|Adverse Event|0|||
48706046|NCT00068692|156773522|FG006|Step 1: Registration|Adverse Event|0|||
48706047|NCT00068692|156773523|FG007|Step 1: Registration|Adverse Event|0|||
48706048|NCT00068692|156773516|FG000|Step 1: Registration|Death|1|||
48706049|NCT00068692|156773517|FG001|Step 1: Registration|Death|0|||
48706050|NCT00068692|156773518|FG002|Step 1: Registration|Death|0|||
48706051|NCT00068692|156773519|FG003|Step 1: Registration|Death|0|||
48706052|NCT00068692|156773520|FG004|Step 1: Registration|Death|0|||
48706053|NCT00068692|156773521|FG005|Step 1: Registration|Death|0|||
48706054|NCT00068692|156773522|FG006|Step 1: Registration|Death|0|||
48706055|NCT00068692|156773523|FG007|Step 1: Registration|Death|0|||
48706056|NCT00068692|156773516|FG000|Step 1: Registration|Withdrawal by Subject|11|||
48706057|NCT00068692|156773517|FG001|Step 1: Registration|Withdrawal by Subject|0|||
48706058|NCT00068692|156773518|FG002|Step 1: Registration|Withdrawal by Subject|0|||
48706059|NCT00068692|156773519|FG003|Step 1: Registration|Withdrawal by Subject|0|||
48706060|NCT00068692|156773520|FG004|Step 1: Registration|Withdrawal by Subject|0|||
48706061|NCT00068692|156773521|FG005|Step 1: Registration|Withdrawal by Subject|0|||
48706062|NCT00068692|156773522|FG006|Step 1: Registration|Withdrawal by Subject|0|||
48706063|NCT00068692|156773523|FG007|Step 1: Registration|Withdrawal by Subject|0|||
48706064|NCT00068692|156773516|FG000|Step 1: Registration|Alternative therapy|2|||
48706065|NCT00068692|156773517|FG001|Step 1: Registration|Alternative therapy|0|||
48706066|NCT00068692|156773518|FG002|Step 1: Registration|Alternative therapy|0|||
48706067|NCT00068692|156773519|FG003|Step 1: Registration|Alternative therapy|0|||
48706068|NCT00068692|156773520|FG004|Step 1: Registration|Alternative therapy|0|||
48706069|NCT00068692|156773521|FG005|Step 1: Registration|Alternative therapy|0|||
48706070|NCT00068692|156773522|FG006|Step 1: Registration|Alternative therapy|0|||
48706071|NCT00068692|156773523|FG007|Step 1: Registration|Alternative therapy|0|||
48706072|NCT00068692|156773516|FG000|Step 1: Registration|Complicating disease|2|||
48706073|NCT00068692|156773517|FG001|Step 1: Registration|Complicating disease|0|||
48706074|NCT00068692|156773518|FG002|Step 1: Registration|Complicating disease|0|||
48706075|NCT00068692|156773519|FG003|Step 1: Registration|Complicating disease|0|||
48706076|NCT00068692|156773520|FG004|Step 1: Registration|Complicating disease|0|||
48706077|NCT00068692|156773521|FG005|Step 1: Registration|Complicating disease|0|||
48706078|NCT00068692|156773522|FG006|Step 1: Registration|Complicating disease|0|||
48706079|NCT00068692|156773523|FG007|Step 1: Registration|Complicating disease|0|||
48706080|NCT00068692|156773516|FG000|Step 1: Registration|Protocol Violation|1|||
48706081|NCT00068692|156773517|FG001|Step 1: Registration|Protocol Violation|0|||
48706082|NCT00068692|156773518|FG002|Step 1: Registration|Protocol Violation|0|||
48706083|NCT00068692|156773519|FG003|Step 1: Registration|Protocol Violation|0|||
48706084|NCT00068692|156773520|FG004|Step 1: Registration|Protocol Violation|0|||
48706085|NCT00068692|156773521|FG005|Step 1: Registration|Protocol Violation|0|||
48706086|NCT00068692|156773522|FG006|Step 1: Registration|Protocol Violation|0|||
48706087|NCT00068692|156773523|FG007|Step 1: Registration|Protocol Violation|0|||
48706088|NCT00068692|156773516|FG000|Step 1: Registration|Not eligible|6|||
48706089|NCT00068692|156773517|FG001|Step 1: Registration|Not eligible|0|||
48706090|NCT00068692|156773518|FG002|Step 1: Registration|Not eligible|0|||
48706091|NCT00068692|156773519|FG003|Step 1: Registration|Not eligible|0|||
48706092|NCT00068692|156773520|FG004|Step 1: Registration|Not eligible|0|||
48706093|NCT00068692|156773521|FG005|Step 1: Registration|Not eligible|0|||
48706094|NCT00068692|156773522|FG006|Step 1: Registration|Not eligible|0|||
48706095|NCT00068692|156773523|FG007|Step 1: Registration|Not eligible|0|||
48706096|NCT00068692|156773516|FG000|Step 1: Registration|Other|2|||
48706097|NCT00068692|156773517|FG001|Step 1: Registration|Other|0|||
48706098|NCT00068692|156773518|FG002|Step 1: Registration|Other|0|||
48706099|NCT00068692|156773519|FG003|Step 1: Registration|Other|0|||
48706100|NCT00068692|156773520|FG004|Step 1: Registration|Other|0|||
48706101|NCT00068692|156773521|FG005|Step 1: Registration|Other|0|||
48706102|NCT00068692|156773522|FG006|Step 1: Registration|Other|0|||
48706103|NCT00068692|156773523|FG007|Step 1: Registration|Other|0|||
48912967|NCT00397033|157517634|FG002|Overall Study|Lost to Follow-up|3|||
48912968|NCT00397033|157517632|FG000|Overall Study|Withdrawal by Subject|12|||
48912969|NCT00397033|157517633|FG001|Overall Study|Withdrawal by Subject|7|||
48706104|NCT00068692|156773516|FG000|Step 1: Registration|Not start protocol therapy|3|||
48706105|NCT00068692|156773517|FG001|Step 1: Registration|Not start protocol therapy|0|||
48706106|NCT00068692|156773518|FG002|Step 1: Registration|Not start protocol therapy|0|||
48706107|NCT00068692|156773519|FG003|Step 1: Registration|Not start protocol therapy|0|||
48706108|NCT00068692|156773520|FG004|Step 1: Registration|Not start protocol therapy|0|||
48912970|NCT00397033|157517634|FG002|Overall Study|Withdrawal by Subject|5|||
48912971|NCT00397033|157517632|FG000|Overall Study|Other|0|||
48706109|NCT00068692|156773521|FG005|Step 1: Registration|Not start protocol therapy|0|||
48706110|NCT00068692|156773522|FG006|Step 1: Registration|Not start protocol therapy|0|||
48706111|NCT00068692|156773523|FG007|Step 1: Registration|Not start protocol therapy|0|||
48706112|NCT00068692|156773516|FG000|Step 1: Registration|Registered but not randomized|0|||
48706113|NCT00068692|156773517|FG001|Step 1: Registration|Registered but not randomized|1|||
48706114|NCT00068692|156773518|FG002|Step 1: Registration|Registered but not randomized|0|||
48706115|NCT00068692|156773519|FG003|Step 1: Registration|Registered but not randomized|0|||
48706116|NCT00068692|156773520|FG004|Step 1: Registration|Registered but not randomized|0|||
48706117|NCT00068692|156773521|FG005|Step 1: Registration|Registered but not randomized|0|||
48706118|NCT00068692|156773522|FG006|Step 1: Registration|Registered but not randomized|0|||
48706119|NCT00068692|156773523|FG007|Step 1: Registration|Registered but not randomized|0|||
48706120|NCT00068692|156773516|FG000|Step 2: Randomization|Disesae progression/replase|0|||
48706121|NCT00068692|156773517|FG001|Step 2: Randomization|Disesae progression/replase|0|||
48706122|NCT00068692|156773518|FG002|Step 2: Randomization|Disesae progression/replase|1|||
48706123|NCT00068692|156773519|FG003|Step 2: Randomization|Disesae progression/replase|1|||
48706124|NCT00068692|156773520|FG004|Step 2: Randomization|Disesae progression/replase|0|||
48706125|NCT00068692|156773521|FG005|Step 2: Randomization|Disesae progression/replase|0|||
48706126|NCT00068692|156773522|FG006|Step 2: Randomization|Disesae progression/replase|0|||
48706127|NCT00068692|156773523|FG007|Step 2: Randomization|Disesae progression/replase|0|||
48706128|NCT00068692|156773516|FG000|Step 2: Randomization|Adverse Event|0|||
48706129|NCT00068692|156773517|FG001|Step 2: Randomization|Adverse Event|0|||
48706130|NCT00068692|156773518|FG002|Step 2: Randomization|Adverse Event|4|||
48706131|NCT00068692|156773519|FG003|Step 2: Randomization|Adverse Event|2|||
48706132|NCT00068692|156773520|FG004|Step 2: Randomization|Adverse Event|2|||
48706133|NCT00068692|156773521|FG005|Step 2: Randomization|Adverse Event|3|||
48706134|NCT00068692|156773522|FG006|Step 2: Randomization|Adverse Event|4|||
48706135|NCT00068692|156773523|FG007|Step 2: Randomization|Adverse Event|4|||
48706136|NCT00068692|156773516|FG000|Step 2: Randomization|Death|0|||
48706137|NCT00068692|156773517|FG001|Step 2: Randomization|Death|0|||
48706138|NCT00068692|156773518|FG002|Step 2: Randomization|Death|0|||
48706139|NCT00068692|156773519|FG003|Step 2: Randomization|Death|0|||
48706140|NCT00068692|156773520|FG004|Step 2: Randomization|Death|1|||
48706141|NCT00068692|156773521|FG005|Step 2: Randomization|Death|0|||
48706142|NCT00068692|156773522|FG006|Step 2: Randomization|Death|0|||
48706143|NCT00068692|156773523|FG007|Step 2: Randomization|Death|1|||
48706144|NCT00068692|156773516|FG000|Step 2: Randomization|Withdrawal by Subject|0|||
48706145|NCT00068692|156773517|FG001|Step 2: Randomization|Withdrawal by Subject|0|||
48706146|NCT00068692|156773518|FG002|Step 2: Randomization|Withdrawal by Subject|4|||
48706147|NCT00068692|156773519|FG003|Step 2: Randomization|Withdrawal by Subject|6|||
48706148|NCT00068692|156773520|FG004|Step 2: Randomization|Withdrawal by Subject|3|||
48706149|NCT00068692|156773521|FG005|Step 2: Randomization|Withdrawal by Subject|2|||
48706150|NCT00068692|156773522|FG006|Step 2: Randomization|Withdrawal by Subject|0|||
48706151|NCT00068692|156773523|FG007|Step 2: Randomization|Withdrawal by Subject|3|||
48706152|NCT00068692|156773516|FG000|Step 2: Randomization|alternative therapy|0|||
48706153|NCT00068692|156773517|FG001|Step 2: Randomization|alternative therapy|0|||
48706154|NCT00068692|156773518|FG002|Step 2: Randomization|alternative therapy|0|||
48706155|NCT00068692|156773519|FG003|Step 2: Randomization|alternative therapy|1|||
48706156|NCT00068692|156773520|FG004|Step 2: Randomization|alternative therapy|1|||
48706157|NCT00068692|156773521|FG005|Step 2: Randomization|alternative therapy|0|||
48706158|NCT00068692|156773522|FG006|Step 2: Randomization|alternative therapy|0|||
48706159|NCT00068692|156773523|FG007|Step 2: Randomization|alternative therapy|0|||
48706160|NCT00068692|156773516|FG000|Step 2: Randomization|Physician Decision|0|||
48706161|NCT00068692|156773517|FG001|Step 2: Randomization|Physician Decision|0|||
48706162|NCT00068692|156773518|FG002|Step 2: Randomization|Physician Decision|0|||
48706163|NCT00068692|156773519|FG003|Step 2: Randomization|Physician Decision|1|||
48706164|NCT00068692|156773520|FG004|Step 2: Randomization|Physician Decision|1|||
48706165|NCT00068692|156773521|FG005|Step 2: Randomization|Physician Decision|0|||
48706166|NCT00068692|156773522|FG006|Step 2: Randomization|Physician Decision|0|||
48706167|NCT00068692|156773523|FG007|Step 2: Randomization|Physician Decision|0|||
48706168|NCT00068692|156773516|FG000|Step 2: Randomization|Other|0|||
48706169|NCT00068692|156773517|FG001|Step 2: Randomization|Other|0|||
48706170|NCT00068692|156773518|FG002|Step 2: Randomization|Other|0|||
48706171|NCT00068692|156773519|FG003|Step 2: Randomization|Other|1|||
48912972|NCT00397033|157517633|FG001|Overall Study|Other|5|||
48912973|NCT00397033|157517634|FG002|Overall Study|Other|2|||
48706172|NCT00068692|156773520|FG004|Step 2: Randomization|Other|0|||
48706173|NCT00068692|156773521|FG005|Step 2: Randomization|Other|1|||
48706174|NCT00068692|156773522|FG006|Step 2: Randomization|Other|0|||
48706175|NCT00068692|156773523|FG007|Step 2: Randomization|Other|0|||
48706176|NCT00068692|156773516|FG000|Step 2: Randomization|never start protocol therapy|0|||
48706177|NCT00068692|156773517|FG001|Step 2: Randomization|never start protocol therapy|0|||
48706178|NCT00068692|156773518|FG002|Step 2: Randomization|never start protocol therapy|1|||
48706179|NCT00068692|156773519|FG003|Step 2: Randomization|never start protocol therapy|0|||
48706180|NCT00068692|156773520|FG004|Step 2: Randomization|never start protocol therapy|1|||
48912974|NCT05513625|157517635|FG000|Overall Study|Withdrawal by Subject|1|||
48912975|NCT03574753|157517636|FG000|Overall Study|Adverse Event|3|||
48912976|NCT03574753|157517636|FG000|Overall Study|Progression/relapse|19|||
48912977|NCT03574753|157517636|FG000|Overall Study|Death|1|||
48912978|NCT01987960|157517637|FG000|Period 1|Adverse Event|24|||
48912979|NCT01987960|157517638|FG001|Period 1|Adverse Event|0|||
48706181|NCT00068692|156773521|FG005|Step 2: Randomization|never start protocol therapy|0|||
48706182|NCT00068692|156773522|FG006|Step 2: Randomization|never start protocol therapy|0|||
48706183|NCT00068692|156773523|FG007|Step 2: Randomization|never start protocol therapy|0|||
48706184|NCT00248040|156773524|FG000|Overall Study|transplantectomy|2|||
48706185|NCT00248040|156773525|FG001|Overall Study|transplantectomy|1|||
48706186|NCT00248040|156773526|FG002|Overall Study|transplantectomy|3|||
48706187|NCT00248040|156773524|FG000|Overall Study|transplant cancelled post treat start|1|||
48706188|NCT00248040|156773525|FG001|Overall Study|transplant cancelled post treat start|0|||
48706189|NCT00248040|156773526|FG002|Overall Study|transplant cancelled post treat start|0|||
48706190|NCT00248040|156773524|FG000|Overall Study|Death|0|||
48706191|NCT00248040|156773525|FG001|Overall Study|Death|0|||
48706192|NCT00248040|156773526|FG002|Overall Study|Death|1|||
48706193|NCT03387085|156773529|FG000|Overall Study|Reason for Treatment Discontinuation|7|||
48706194|NCT00914316|156773532|FG000|Phase 1|Physician Decision|4|||
48706195|NCT00914316|156773533|FG001|Phase 1|Physician Decision|0|||
48706196|NCT00914316|156773534|FG002|Phase 1|Physician Decision|1|||
48706197|NCT00914316|156773535|FG003|Phase 1|Physician Decision|2|||
48706198|NCT00914316|156773532|FG000|Phase 1|Withdrawal by Subject|0|||
48706199|NCT00914316|156773533|FG001|Phase 1|Withdrawal by Subject|2|||
48706200|NCT00914316|156773534|FG002|Phase 1|Withdrawal by Subject|4|||
48706201|NCT00914316|156773535|FG003|Phase 1|Withdrawal by Subject|0|||
48706202|NCT00914316|156773532|FG000|Phase 1|Adverse Event|1|||
48706203|NCT00914316|156773533|FG001|Phase 1|Adverse Event|0|||
48706204|NCT00914316|156773534|FG002|Phase 1|Adverse Event|0|||
48706205|NCT00914316|156773535|FG003|Phase 1|Adverse Event|0|||
48706206|NCT00914316|156773532|FG000|Phase 2|Withdrawal by Subject|1|||
48706207|NCT00914316|156773533|FG001|Phase 2|Withdrawal by Subject|0|||
48706208|NCT00914316|156773534|FG002|Phase 2|Withdrawal by Subject|1|||
48706209|NCT00914316|156773535|FG003|Phase 2|Withdrawal by Subject|0|||
48706210|NCT03349034|156773538|FG000|Overall Study|catheters dislodged during transport|2|||
48706211|NCT03349034|156773539|FG001|Overall Study|catheters dislodged during transport|0|||
48706212|NCT03349034|156773538|FG000|Overall Study|intubated for >48 hrs following surgery|1|||
48706213|NCT03349034|156773539|FG001|Overall Study|intubated for >48 hrs following surgery|1|||
48706214|NCT03349034|156773538|FG000|Overall Study|soft tissue flap used|1|||
48706215|NCT03349034|156773539|FG001|Overall Study|soft tissue flap used|0|||
48706216|NCT03349034|156773538|FG000|Overall Study|Other|0|||
48706217|NCT03349034|156773539|FG001|Overall Study|Other|1|||
48706218|NCT01759446|156773542|FG000|Overall Study|Protocol Violation|1|||
48706219|NCT01759446|156773543|FG001|Overall Study|Protocol Violation|0|||
48706220|NCT01759446|156773544|FG002|Overall Study|Protocol Violation|1|||
48706221|NCT01759446|156773545|FG003|Overall Study|Protocol Violation|0|||
48706222|NCT01759446|156773546|FG004|Overall Study|Protocol Violation|0|||
48706223|NCT01759446|156773542|FG000|Overall Study|Withdrawal by Subject|0|||
48706224|NCT01759446|156773543|FG001|Overall Study|Withdrawal by Subject|1|||
48706225|NCT01759446|156773544|FG002|Overall Study|Withdrawal by Subject|0|||
48706226|NCT01759446|156773545|FG003|Overall Study|Withdrawal by Subject|1|||
48706227|NCT01759446|156773546|FG004|Overall Study|Withdrawal by Subject|0|||
48706228|NCT02395471|156773548|FG000|Overall Study|Lost to Follow-up|2|||
48706229|NCT02395471|156773549|FG001|Overall Study|Lost to Follow-up|0|||
48706230|NCT02395471|156773548|FG000|Overall Study|Withdrawal by Subject|2|||
48706231|NCT02395471|156773549|FG001|Overall Study|Withdrawal by Subject|1|||
48912980|NCT01987960|157517639|FG002|Period 1|Adverse Event|0|||
48706232|NCT02395471|156773548|FG000|Overall Study|Physician Decision|1|||
48706233|NCT02395471|156773549|FG001|Overall Study|Physician Decision|0|||
48706234|NCT02395471|156773548|FG000|Overall Study|Protocol Violation|0|||
48706235|NCT02395471|156773549|FG001|Overall Study|Protocol Violation|1|||
48706236|NCT02395471|156773548|FG000|Overall Study|Failure to swollow sponge twice|1|||
48706237|NCT02395471|156773549|FG001|Overall Study|Failure to swollow sponge twice|0|||
48706238|NCT02395471|156773548|FG000|Overall Study|Patient did not return for procedure|0|||
48706239|NCT02395471|156773549|FG001|Overall Study|Patient did not return for procedure|1|||
48706240|NCT02395471|156773548|FG000|Overall Study|Subject not eligible|1|||
48706241|NCT02395471|156773549|FG001|Overall Study|Subject not eligible|0|||
48706242|NCT01413204|156773550|FG000|Overall Study|Adverse Event|1|||
48706243|NCT01413204|156773551|FG001|Overall Study|Adverse Event|2|||
48706244|NCT01413204|156773552|FG002|Overall Study|Adverse Event|2|||
48706245|NCT01413204|156773550|FG000|Overall Study|Physician Decision|3|||
48706246|NCT01413204|156773551|FG001|Overall Study|Physician Decision|0|||
48706247|NCT01413204|156773552|FG002|Overall Study|Physician Decision|2|||
48706248|NCT01413204|156773550|FG000|Overall Study|Withdrawal by Subject|1|||
48912981|NCT01987960|157517640|FG003|Period 1|Adverse Event|0|||
48912982|NCT01987960|157517637|FG000|Period 1|Lack of Efficacy|4|||
48706249|NCT01413204|156773551|FG001|Overall Study|Withdrawal by Subject|4|||
48706250|NCT01413204|156773552|FG002|Overall Study|Withdrawal by Subject|4|||
48912983|NCT01987960|157517638|FG001|Period 1|Lack of Efficacy|0|||
48706251|NCT01413204|156773550|FG000|Overall Study|Clearly not eligible for the study|0|||
48706252|NCT01413204|156773551|FG001|Overall Study|Clearly not eligible for the study|0|||
48706253|NCT01413204|156773552|FG002|Overall Study|Clearly not eligible for the study|1|||
48706254|NCT01413204|156773550|FG000|Overall Study|Fasting plasma glucose level increased|1|||
48706255|NCT01413204|156773551|FG001|Overall Study|Fasting plasma glucose level increased|0|||
48706256|NCT01413204|156773552|FG002|Overall Study|Fasting plasma glucose level increased|10|||
48706257|NCT00354432|156773553|FG000|Overall Study|Adverse Event|3|||
48706258|NCT00354432|156773554|FG001|Overall Study|Adverse Event|1|||
48706259|NCT00354432|156773555|FG002|Overall Study|Adverse Event|5|||
48706260|NCT00354432|156773556|FG003|Overall Study|Adverse Event|5|||
48706261|NCT00354432|156773553|FG000|Overall Study|Off/Toxicity|3|||
48706262|NCT00354432|156773554|FG001|Overall Study|Off/Toxicity|7|||
48706263|NCT00354432|156773555|FG002|Overall Study|Off/Toxicity|5|||
48706264|NCT00354432|156773556|FG003|Overall Study|Off/Toxicity|5|||
48706265|NCT01244893|156773557|FG000|Baseline|Protocol Violation|0|||
48706266|NCT01244893|156773558|FG001|Baseline|Protocol Violation|1|||
48706267|NCT01244893|156773557|FG000|1-Week Follow Up|Lost to Follow-up|1|||
48706268|NCT01244893|156773558|FG001|1-Week Follow Up|Lost to Follow-up|0|||
48706269|NCT00521404|156773559|FG000|Overall Study|Adverse Event|13|||
48706270|NCT00521404|156773559|FG000|Overall Study|Disease Progression|33|||
48706271|NCT00521404|156773559|FG000|Overall Study|Investigator decision|5|||
48706272|NCT00521404|156773559|FG000|Overall Study|Withdrawal of consent|3|||
48706273|NCT00521404|156773559|FG000|Overall Study|Noncompliance or lack of cooperation|1|||
48706274|NCT00521404|156773559|FG000|Overall Study|Other|7|||
48706275|NCT03584789|156773562|FG000|Overall Study|refused EHR permission|19|||
48706276|NCT03584789|156773563|FG001|Overall Study|refused EHR permission|28|||
48706277|NCT03584789|156773564|FG002|Overall Study|refused EHR permission|23|||
48706278|NCT03584789|156773562|FG000|Overall Study|patients tied to a provider who retired|0|||
48706279|NCT03584789|156773563|FG001|Overall Study|patients tied to a provider who retired|0|||
48706280|NCT03584789|156773564|FG002|Overall Study|patients tied to a provider who retired|3|||
48706281|NCT03038880|156773565|FG000|Overall Study|Death|1|||
48706282|NCT03038880|156773566|FG001|Overall Study|Death|2|||
48706283|NCT03038880|156773567|FG002|Overall Study|Death|0|||
48706284|NCT03038880|156773565|FG000|Overall Study|Physician Decision|2|||
48706285|NCT03038880|156773566|FG001|Overall Study|Physician Decision|1|||
48706286|NCT03038880|156773567|FG002|Overall Study|Physician Decision|0|||
48706287|NCT01106690|156773573|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
48706288|NCT01106690|156773574|FG001|Core Period: Baseline to Week 26|Adverse Event|1|||
48706289|NCT01106690|156773575|FG002|Core Period: Baseline to Week 26|Adverse Event|4|||
48706290|NCT01106690|156773573|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
48706291|NCT01106690|156773574|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
48706292|NCT01106690|156773575|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
48706293|NCT01106690|156773573|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
48706294|NCT01106690|156773574|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
48706295|NCT01106690|156773575|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
48706296|NCT01106690|156773573|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
48706297|NCT01106690|156773574|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
48706298|NCT01106690|156773575|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|0|||
48706299|NCT01106690|156773573|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0|||
48706300|NCT01106690|156773574|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
48706301|NCT01106690|156773575|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
48706302|NCT01106690|156773573|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
48706303|NCT01106690|156773574|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
48706304|NCT01106690|156773575|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
48706305|NCT01106690|156773573|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
48706306|NCT01106690|156773574|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
48706307|NCT01106690|156773575|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
48706308|NCT01106690|156773573|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
48706309|NCT01106690|156773574|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
48706310|NCT01106690|156773575|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
48706311|NCT01106690|156773573|FG000|Core Period: Baseline to Week 26|Other|10|||
48706312|NCT01106690|156773574|FG001|Core Period: Baseline to Week 26|Other|2|||
48706313|NCT01106690|156773575|FG002|Core Period: Baseline to Week 26|Other|6|||
48706314|NCT01106690|156773573|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
48706315|NCT01106690|156773574|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
48706316|NCT01106690|156773575|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
48706317|NCT01106690|156773573|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
48706318|NCT01106690|156773574|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
48799497|NCT02238379|157104214|FG000|Overall Study|Lost to Follow-up|1|||
48912984|NCT01987960|157517639|FG002|Period 1|Lack of Efficacy|0|||
48912985|NCT01987960|157517640|FG003|Period 1|Lack of Efficacy|0|||
48912986|NCT01987960|157517637|FG000|Period 1|Non-compliance with IMP|6|||
48912987|NCT01987960|157517638|FG001|Period 1|Non-compliance with IMP|0|||
48706319|NCT01106690|156773575|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
48706320|NCT01106690|156773573|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
48706321|NCT01106690|156773574|FG001|Extension Period: Week 26 to Week 52|Physician Decision|2|||
48706322|NCT01106690|156773575|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
48706323|NCT01106690|156773573|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
48706324|NCT01106690|156773574|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
48706325|NCT01106690|156773575|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
48706326|NCT01106690|156773573|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
48706327|NCT01106690|156773574|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
48706328|NCT01106690|156773575|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
48706329|NCT01106690|156773573|FG000|Extension Period: Week 26 to Week 52|Other|8|||
48706330|NCT01106690|156773574|FG001|Extension Period: Week 26 to Week 52|Other|3|||
48706331|NCT01106690|156773575|FG002|Extension Period: Week 26 to Week 52|Other|4|||
48706332|NCT01106690|156773573|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
48706333|NCT01106690|156773574|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
48706334|NCT01106690|156773575|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
48706335|NCT01208207|156773576|FG000|Part I|Adverse Event|19|||
48706336|NCT01208207|156773577|FG001|Part I|Adverse Event|2|||
48706337|NCT01208207|156773578|FG002|Part I|Adverse Event|6|||
48706338|NCT01208207|156773579|FG003|Part I|Adverse Event|0|||
48706339|NCT01208207|156773580|FG004|Part I|Adverse Event|0|||
48706340|NCT01208207|156773581|FG005|Part I|Adverse Event|0|||
48706341|NCT01208207|156773582|FG006|Part I|Adverse Event|0|||
48706342|NCT01208207|156773576|FG000|Part I|Lack of Efficacy|21|||
48706343|NCT01208207|156773577|FG001|Part I|Lack of Efficacy|3|||
48706344|NCT01208207|156773578|FG002|Part I|Lack of Efficacy|2|||
48706345|NCT01208207|156773579|FG003|Part I|Lack of Efficacy|0|||
48706346|NCT01208207|156773580|FG004|Part I|Lack of Efficacy|0|||
48706347|NCT01208207|156773581|FG005|Part I|Lack of Efficacy|0|||
48706348|NCT01208207|156773582|FG006|Part I|Lack of Efficacy|0|||
48706349|NCT01208207|156773576|FG000|Part I|Lost to Follow-up|6|||
48706350|NCT01208207|156773577|FG001|Part I|Lost to Follow-up|1|||
48706351|NCT01208207|156773578|FG002|Part I|Lost to Follow-up|0|||
48706352|NCT01208207|156773579|FG003|Part I|Lost to Follow-up|0|||
48706353|NCT01208207|156773580|FG004|Part I|Lost to Follow-up|0|||
48706354|NCT01208207|156773581|FG005|Part I|Lost to Follow-up|0|||
48706355|NCT01208207|156773582|FG006|Part I|Lost to Follow-up|0|||
48706356|NCT01208207|156773576|FG000|Part I|Non-Compliance With Study Drug|1|||
48706357|NCT01208207|156773577|FG001|Part I|Non-Compliance With Study Drug|0|||
48706358|NCT01208207|156773578|FG002|Part I|Non-Compliance With Study Drug|1|||
48706359|NCT01208207|156773579|FG003|Part I|Non-Compliance With Study Drug|0|||
48706360|NCT01208207|156773580|FG004|Part I|Non-Compliance With Study Drug|0|||
48706361|NCT01208207|156773581|FG005|Part I|Non-Compliance With Study Drug|0|||
48706362|NCT01208207|156773582|FG006|Part I|Non-Compliance With Study Drug|0|||
48706363|NCT01208207|156773576|FG000|Part I|Physician Decision|0|||
48706364|NCT01208207|156773577|FG001|Part I|Physician Decision|1|||
48706365|NCT01208207|156773578|FG002|Part I|Physician Decision|0|||
48706366|NCT01208207|156773579|FG003|Part I|Physician Decision|0|||
48706367|NCT01208207|156773580|FG004|Part I|Physician Decision|0|||
48706368|NCT01208207|156773581|FG005|Part I|Physician Decision|0|||
48706369|NCT01208207|156773582|FG006|Part I|Physician Decision|0|||
48706370|NCT01208207|156773576|FG000|Part I|Progressive Disease|1|||
48706371|NCT01208207|156773577|FG001|Part I|Progressive Disease|0|||
48706372|NCT01208207|156773578|FG002|Part I|Progressive Disease|0|||
48706373|NCT01208207|156773579|FG003|Part I|Progressive Disease|0|||
48706374|NCT01208207|156773580|FG004|Part I|Progressive Disease|0|||
48706375|NCT01208207|156773581|FG005|Part I|Progressive Disease|0|||
48706376|NCT01208207|156773582|FG006|Part I|Progressive Disease|0|||
48706377|NCT01208207|156773576|FG000|Part I|Protocol Violation|8|||
48706378|NCT01208207|156773577|FG001|Part I|Protocol Violation|0|||
48706379|NCT01208207|156773578|FG002|Part I|Protocol Violation|2|||
48706380|NCT01208207|156773579|FG003|Part I|Protocol Violation|0|||
48706381|NCT01208207|156773580|FG004|Part I|Protocol Violation|0|||
48706382|NCT01208207|156773581|FG005|Part I|Protocol Violation|0|||
48706383|NCT01208207|156773582|FG006|Part I|Protocol Violation|0|||
48706384|NCT01208207|156773576|FG000|Part I|Withdrawal by Subject|14|||
48706385|NCT01208207|156773577|FG001|Part I|Withdrawal by Subject|4|||
48706386|NCT01208207|156773578|FG002|Part I|Withdrawal by Subject|4|||
48706387|NCT01208207|156773579|FG003|Part I|Withdrawal by Subject|0|||
48706388|NCT01208207|156773580|FG004|Part I|Withdrawal by Subject|0|||
48706389|NCT01208207|156773581|FG005|Part I|Withdrawal by Subject|0|||
48706390|NCT01208207|156773582|FG006|Part I|Withdrawal by Subject|0|||
48706391|NCT01208207|156773576|FG000|Part II|Withdrawal by Subject|0|||
48706392|NCT01208207|156773577|FG001|Part II|Withdrawal by Subject|0|||
48706393|NCT01208207|156773578|FG002|Part II|Withdrawal by Subject|0|||
48706394|NCT01208207|156773579|FG003|Part II|Withdrawal by Subject|10|||
48706395|NCT01208207|156773580|FG004|Part II|Withdrawal by Subject|9|||
48706396|NCT01208207|156773581|FG005|Part II|Withdrawal by Subject|3|||
48706397|NCT01208207|156773582|FG006|Part II|Withdrawal by Subject|5|||
48706398|NCT01208207|156773576|FG000|Part II|Adverse Event|0|||
48706399|NCT01208207|156773577|FG001|Part II|Adverse Event|0|||
48706400|NCT01208207|156773578|FG002|Part II|Adverse Event|0|||
48706401|NCT01208207|156773579|FG003|Part II|Adverse Event|5|||
48706402|NCT01208207|156773580|FG004|Part II|Adverse Event|9|||
48706403|NCT01208207|156773581|FG005|Part II|Adverse Event|4|||
48706404|NCT01208207|156773582|FG006|Part II|Adverse Event|2|||
48706405|NCT01208207|156773576|FG000|Part II|Lack of Efficacy|0|||
48706406|NCT01208207|156773577|FG001|Part II|Lack of Efficacy|0|||
48706407|NCT01208207|156773578|FG002|Part II|Lack of Efficacy|0|||
48706408|NCT01208207|156773579|FG003|Part II|Lack of Efficacy|6|||
48706409|NCT01208207|156773580|FG004|Part II|Lack of Efficacy|4|||
48706410|NCT01208207|156773581|FG005|Part II|Lack of Efficacy|3|||
48706411|NCT01208207|156773582|FG006|Part II|Lack of Efficacy|3|||
48706412|NCT01208207|156773576|FG000|Part II|Lost to Follow-up|0|||
48706413|NCT01208207|156773577|FG001|Part II|Lost to Follow-up|0|||
48706414|NCT01208207|156773578|FG002|Part II|Lost to Follow-up|0|||
48706415|NCT01208207|156773579|FG003|Part II|Lost to Follow-up|4|||
48706416|NCT01208207|156773580|FG004|Part II|Lost to Follow-up|0|||
48706417|NCT01208207|156773581|FG005|Part II|Lost to Follow-up|2|||
48706418|NCT01208207|156773582|FG006|Part II|Lost to Follow-up|1|||
48706419|NCT01208207|156773576|FG000|Part II|Non-Compliance With Study Drug|0|||
48706420|NCT01208207|156773577|FG001|Part II|Non-Compliance With Study Drug|0|||
48706421|NCT01208207|156773578|FG002|Part II|Non-Compliance With Study Drug|0|||
48706422|NCT01208207|156773579|FG003|Part II|Non-Compliance With Study Drug|4|||
48706423|NCT01208207|156773580|FG004|Part II|Non-Compliance With Study Drug|1|||
48706424|NCT01208207|156773581|FG005|Part II|Non-Compliance With Study Drug|1|||
48706425|NCT01208207|156773582|FG006|Part II|Non-Compliance With Study Drug|0|||
48706426|NCT01208207|156773576|FG000|Part II|Physician Decision|0|||
48706427|NCT01208207|156773577|FG001|Part II|Physician Decision|0|||
48706428|NCT01208207|156773578|FG002|Part II|Physician Decision|0|||
48706429|NCT01208207|156773579|FG003|Part II|Physician Decision|1|||
48706430|NCT01208207|156773580|FG004|Part II|Physician Decision|0|||
48706431|NCT01208207|156773581|FG005|Part II|Physician Decision|2|||
48706432|NCT01208207|156773582|FG006|Part II|Physician Decision|0|||
48706433|NCT01208207|156773576|FG000|Part II|Protocol Violation|0|||
48706434|NCT01208207|156773577|FG001|Part II|Protocol Violation|0|||
48706435|NCT01208207|156773578|FG002|Part II|Protocol Violation|0|||
48706436|NCT01208207|156773579|FG003|Part II|Protocol Violation|1|||
48912988|NCT01987960|157517639|FG002|Period 1|Non-compliance with IMP|0|||
48912989|NCT01987960|157517640|FG003|Period 1|Non-compliance with IMP|0|||
48912990|NCT01987960|157517637|FG000|Period 1|Protocol Violation|12|||
48912991|NCT01987960|157517638|FG001|Period 1|Protocol Violation|0|||
49118744|NCT03442088|158273196|FG000|Overall Study|Lost to Follow-up|2|||
48706437|NCT01208207|156773580|FG004|Part II|Protocol Violation|0|||
48706438|NCT01208207|156773581|FG005|Part II|Protocol Violation|0|||
48706439|NCT01208207|156773582|FG006|Part II|Protocol Violation|0|||
48706440|NCT01208207|156773576|FG000|Part II|Technical Problems|0|||
48706441|NCT01208207|156773577|FG001|Part II|Technical Problems|0|||
48706442|NCT01208207|156773578|FG002|Part II|Technical Problems|0|||
48706443|NCT01208207|156773579|FG003|Part II|Technical Problems|1|||
48706444|NCT01208207|156773580|FG004|Part II|Technical Problems|0|||
48706445|NCT01208207|156773581|FG005|Part II|Technical Problems|1|||
48706446|NCT01208207|156773582|FG006|Part II|Technical Problems|0|||
49118745|NCT01001520|158273197|FG000|Medication Period 1|Withdrawal by Subject|2|||
48706447|NCT03112603|156773583|FG000|End of Randomization Period|Lost to Follow-up|3|||
48706448|NCT03112603|156773584|FG001|End of Randomization Period|Lost to Follow-up|0|||
48706449|NCT03112603|156773585|FG002|End of Randomization Period|Lost to Follow-up|0|||
48706450|NCT03112603|156773583|FG000|End of Randomization Period|Participant/Guardian Decision|7|||
48706451|NCT03112603|156773584|FG001|End of Randomization Period|Participant/Guardian Decision|14|||
48706452|NCT03112603|156773585|FG002|End of Randomization Period|Participant/Guardian Decision|0|||
48706453|NCT03112603|156773583|FG000|End of Randomization Period|Physician Decision|43|||
48706454|NCT03112603|156773584|FG001|End of Randomization Period|Physician Decision|18|||
48706455|NCT03112603|156773585|FG002|End of Randomization Period|Physician Decision|0|||
48706456|NCT03112603|156773583|FG000|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|4|||
48706457|NCT03112603|156773584|FG001|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|5|||
48706458|NCT03112603|156773585|FG002|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|0|||
48706459|NCT03112603|156773583|FG000|End of Randomization Period|Death|10|||
48706460|NCT03112603|156773584|FG001|End of Randomization Period|Death|7|||
48706461|NCT03112603|156773585|FG002|End of Randomization Period|Death|0|||
48706462|NCT03112603|156773583|FG000|End of Randomization Period|Disease Relapse|12|||
48706463|NCT03112603|156773584|FG001|End of Randomization Period|Disease Relapse|7|||
48706464|NCT03112603|156773585|FG002|End of Randomization Period|Disease Relapse|0|||
48799498|NCT02238379|157104215|FG001|Overall Study|Lost to Follow-up|0|||
48912992|NCT01987960|157517639|FG002|Period 1|Protocol Violation|0|||
48706465|NCT03112603|156773583|FG000|End of Randomization Period|Lack of Efficacy|25|||
48706466|NCT03112603|156773584|FG001|End of Randomization Period|Lack of Efficacy|77|||
48706467|NCT03112603|156773585|FG002|End of Randomization Period|Lack of Efficacy|0|||
48706468|NCT03112603|156773583|FG000|End of Randomization Period|Adverse Event|32|||
48706469|NCT03112603|156773584|FG001|End of Randomization Period|Adverse Event|12|||
48706470|NCT03112603|156773585|FG002|End of Randomization Period|Adverse Event|0|||
48706471|NCT03112603|156773583|FG000|End of Cross Over Period|Death|0|||
48706472|NCT03112603|156773584|FG001|End of Cross Over Period|Death|0|||
48706473|NCT03112603|156773585|FG002|End of Cross Over Period|Death|2|||
48706474|NCT03112603|156773583|FG000|End of Cross Over Period|Participant/Guardian Decision|0|||
48706475|NCT03112603|156773584|FG001|End of Cross Over Period|Participant/Guardian Decision|0|||
48706476|NCT03112603|156773585|FG002|End of Cross Over Period|Participant/Guardian Decision|7|||
48706477|NCT03112603|156773583|FG000|End of Cross Over Period|Physician Decision|0|||
48706478|NCT03112603|156773584|FG001|End of Cross Over Period|Physician Decision|0|||
48706479|NCT03112603|156773585|FG002|End of Cross Over Period|Physician Decision|29|||
48706480|NCT03112603|156773583|FG000|End of Cross Over Period|Lack of Efficacy|0|||
48706481|NCT03112603|156773584|FG001|End of Cross Over Period|Lack of Efficacy|0|||
48706482|NCT03112603|156773585|FG002|End of Cross Over Period|Lack of Efficacy|8|||
48706483|NCT03112603|156773583|FG000|End of Cross Over Period|Adverse Event|0|||
48706484|NCT03112603|156773584|FG001|End of Cross Over Period|Adverse Event|0|||
48706485|NCT03112603|156773585|FG002|End of Cross Over Period|Adverse Event|6|||
48706486|NCT03112603|156773583|FG000|End of Cross Over Period|Disease Relapse|0|||
48706487|NCT03112603|156773584|FG001|End of Cross Over Period|Disease Relapse|0|||
48706488|NCT03112603|156773585|FG002|End of Cross Over Period|Disease Relapse|2|||
48706489|NCT02754440|156773588|FG000|Overall Study|Protocol Violation|3|||
48706490|NCT02754440|156773589|FG001|Overall Study|Protocol Violation|2|||
48706491|NCT02754440|156773590|FG002|Overall Study|Protocol Violation|2|||
48706492|NCT02754440|156773591|FG003|Overall Study|Protocol Violation|6|||
48706493|NCT02754440|156773588|FG000|Overall Study|Adverse Event|3|||
48706494|NCT02754440|156773589|FG001|Overall Study|Adverse Event|1|||
48706495|NCT02754440|156773590|FG002|Overall Study|Adverse Event|0|||
48706496|NCT02754440|156773591|FG003|Overall Study|Adverse Event|9|||
48706497|NCT02754440|156773588|FG000|Overall Study|Withdrawal by Subject|0|||
48706498|NCT02754440|156773589|FG001|Overall Study|Withdrawal by Subject|0|||
48706499|NCT02754440|156773590|FG002|Overall Study|Withdrawal by Subject|0|||
48706500|NCT02754440|156773591|FG003|Overall Study|Withdrawal by Subject|1|||
48706501|NCT02754440|156773588|FG000|Overall Study|Equipment failure|0|||
48706502|NCT02754440|156773589|FG001|Overall Study|Equipment failure|5|||
48706503|NCT02754440|156773590|FG002|Overall Study|Equipment failure|5|||
48706504|NCT02754440|156773591|FG003|Overall Study|Equipment failure|7|||
48706505|NCT02754440|156773588|FG000|Overall Study|Subject issues not resulting in AE|0|||
48706506|NCT02754440|156773589|FG001|Overall Study|Subject issues not resulting in AE|0|||
48706507|NCT02754440|156773590|FG002|Overall Study|Subject issues not resulting in AE|0|||
48706508|NCT02754440|156773591|FG003|Overall Study|Subject issues not resulting in AE|12|||
48706509|NCT02900378|156773594|FG000|Randomization (Visit 2)|Adverse Event|14|||
48706510|NCT02900378|156773595|FG001|Randomization (Visit 2)|Adverse Event|11|||
48706511|NCT02900378|156773594|FG000|Randomization (Visit 2)|Death|1|||
48706512|NCT02900378|156773595|FG001|Randomization (Visit 2)|Death|4|||
48706513|NCT02900378|156773594|FG000|Randomization (Visit 2)|Lost to Follow-up|1|||
48706514|NCT02900378|156773595|FG001|Randomization (Visit 2)|Lost to Follow-up|0|||
48706515|NCT02900378|156773594|FG000|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
48706516|NCT02900378|156773595|FG001|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
48706517|NCT02900378|156773594|FG000|Randomization (Visit 2)|Protocol Deviation|1|||
48706518|NCT02900378|156773595|FG001|Randomization (Visit 2)|Protocol Deviation|7|||
48706519|NCT02900378|156773594|FG000|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5|||
48706520|NCT02900378|156773595|FG001|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3|||
48706521|NCT02900378|156773594|FG000|Randomization (Visit 2)|Withdrawal of Informed Consent|0|||
48706522|NCT02900378|156773595|FG001|Randomization (Visit 2)|Withdrawal of Informed Consent|2|||
48706523|NCT04960202|156773596|FG000|Overall Study|Other|12|||
48706524|NCT04960202|156773597|FG001|Overall Study|Other|10|||
48706525|NCT04960202|156773596|FG000|Overall Study|Withdrawal by Subject|43|||
48706526|NCT04960202|156773597|FG001|Overall Study|Withdrawal by Subject|45|||
48706527|NCT04960202|156773596|FG000|Overall Study|Lost to Follow-up|20|||
48912993|NCT01987960|157517640|FG003|Period 1|Protocol Violation|0|||
48706528|NCT04960202|156773597|FG001|Overall Study|Lost to Follow-up|17|||
48706529|NCT04960202|156773596|FG000|Overall Study|Death|0|||
48706530|NCT04960202|156773597|FG001|Overall Study|Death|15|||
48706531|NCT00439517|156773600|FG000|Overall Study|Subject on treatment|1|||
48706532|NCT00439517|156773601|FG001|Overall Study|Subject on treatment|0|||
48912994|NCT01987960|157517637|FG000|Period 1|Withdrawal by Subject|21|||
48706533|NCT00439517|156773600|FG000|Overall Study|Subject in survival follow-up|1|||
48706534|NCT00439517|156773601|FG001|Overall Study|Subject in survival follow-up|0|||
48706535|NCT00477386|156773611|FG000|Overall Study|Adverse Event|4|||
48706536|NCT00477386|156773612|FG001|Overall Study|Adverse Event|8|||
48706537|NCT00477386|156773611|FG000|Overall Study|Disease progression, relapse|3|||
48706538|NCT00477386|156773612|FG001|Overall Study|Disease progression, relapse|4|||
48706539|NCT00477386|156773611|FG000|Overall Study|Disease progression, refractory|1|||
48706540|NCT00477386|156773612|FG001|Overall Study|Disease progression, refractory|3|||
48706541|NCT00477386|156773611|FG000|Overall Study|Other|1|||
48706542|NCT00477386|156773612|FG001|Overall Study|Other|2|||
48706543|NCT00477386|156773611|FG000|Overall Study|Physician Decision|1|||
48706544|NCT00477386|156773612|FG001|Overall Study|Physician Decision|0|||
48706545|NCT00477386|156773611|FG000|Overall Study|Withdrawal by Subject|1|||
48706546|NCT00477386|156773612|FG001|Overall Study|Withdrawal by Subject|0|||
48706547|NCT00643162|156773614|FG000|Overall Study|Withdrawal by Subject|1|||
48706548|NCT00643162|156773615|FG001|Overall Study|Withdrawal by Subject|1|||
48706549|NCT00734539|156773618|FG000|Main Study|Death|33|||
48706550|NCT00734539|156773619|FG001|Main Study|Death|32|||
48706551|NCT00734539|156773618|FG000|Main Study|Physician Decision|2|||
48706552|NCT00734539|156773619|FG001|Main Study|Physician Decision|0|||
48706553|NCT00734539|156773618|FG000|Main Study|Withdrawal by Subject|1|||
48706554|NCT00734539|156773619|FG001|Main Study|Withdrawal by Subject|3|||
48706555|NCT00734539|156773618|FG000|Main Study|Enrolled in error; ineligible|1|||
48706556|NCT00734539|156773619|FG001|Main Study|Enrolled in error; ineligible|0|||
48706557|NCT00357006|156773620|FG000|Overall Study|Lost to Follow-up|1|||
48706558|NCT00357006|156773621|FG001|Overall Study|Lost to Follow-up|2|||
48706559|NCT00357006|156773622|FG002|Overall Study|Lost to Follow-up|1|||
48706560|NCT00357006|156773620|FG000|Overall Study|Withdrawal by Subject|1|||
48706561|NCT00357006|156773621|FG001|Overall Study|Withdrawal by Subject|3|||
48706562|NCT00357006|156773622|FG002|Overall Study|Withdrawal by Subject|2|||
48706563|NCT01656408|156773623|FG000|Overall Study|Adverse Event|0|||
48706564|NCT01656408|156773624|FG001|Overall Study|Adverse Event|0|||
48706565|NCT01656408|156773625|FG002|Overall Study|Adverse Event|1|||
48706566|NCT01656408|156773626|FG003|Overall Study|Adverse Event|0|||
48706567|NCT01656408|156773627|FG004|Overall Study|Adverse Event|0|||
48706568|NCT01656408|156773628|FG005|Overall Study|Adverse Event|1|||
48706569|NCT01656408|156773629|FG006|Overall Study|Adverse Event|1|||
48706570|NCT01656408|156773630|FG007|Overall Study|Adverse Event|0|||
48706571|NCT01656408|156773631|FG008|Overall Study|Adverse Event|1|||
48706572|NCT01656408|156773632|FG009|Overall Study|Adverse Event|0|||
48706573|NCT01656408|156773623|FG000|Overall Study|Physician Decision|1|||
48706574|NCT01656408|156773624|FG001|Overall Study|Physician Decision|0|||
48706575|NCT01656408|156773625|FG002|Overall Study|Physician Decision|1|||
48706576|NCT01656408|156773626|FG003|Overall Study|Physician Decision|0|||
48706577|NCT01656408|156773627|FG004|Overall Study|Physician Decision|1|||
48706578|NCT01656408|156773628|FG005|Overall Study|Physician Decision|1|||
48706579|NCT01656408|156773629|FG006|Overall Study|Physician Decision|0|||
48706580|NCT01656408|156773630|FG007|Overall Study|Physician Decision|1|||
48706581|NCT01656408|156773631|FG008|Overall Study|Physician Decision|1|||
48706582|NCT01656408|156773632|FG009|Overall Study|Physician Decision|3|||
48706583|NCT04308291|156773633|FG000|Run-In Phase|Withdrawal by Subject|4|||
48706584|NCT04308291|156773633|FG000|Study Phase 6-M|Withdrawal by Subject|13|||
48706585|NCT04308291|156773633|FG000|Study Phase 6-M|Physician Decision|2|||
48706586|NCT04308291|156773633|FG000|Study Phase 6-M|Carelink uploading issues (Linux user)|1|||
48706587|NCT04308291|156773633|FG000|Study Phase 12-M|Withdrawal by Subject|11|||
48706588|NCT04308291|156773633|FG000|Study Phase 12-M|Physician Decision|2|||
48706589|NCT04308291|156773633|FG000|Study Phase 12-M|Hospitalization for cause not related to the study (Pancytopenia)|1|||
48706590|NCT03610269|156773634|FG000|Overall Study|Physician Decision|10|||
48706591|NCT03610269|156773634|FG000|Overall Study|Protocol Violation|1|||
48706592|NCT03610269|156773634|FG000|Overall Study|Unable to draw blood|1|||
48706593|NCT03610269|156773634|FG000|Overall Study|Screen fail|4|||
48706594|NCT02668653|156773635|FG000|Overall Study|Refractory disease|41|||
48706595|NCT02668653|156773636|FG001|Overall Study|Refractory disease|70|||
48706596|NCT02668653|156773635|FG000|Overall Study|Relapse|44|||
48706597|NCT02668653|156773636|FG001|Overall Study|Relapse|65|||
48706598|NCT02668653|156773635|FG000|Overall Study|Adverse Event|58|||
48706599|NCT02668653|156773636|FG001|Overall Study|Adverse Event|23|||
48706600|NCT02668653|156773635|FG000|Overall Study|Subject decision to stop study drug|25|||
48799499|NCT04241094|157104222|FG000|Overall Study|Dropped out of treatment|4|||
48706601|NCT02668653|156773636|FG001|Overall Study|Subject decision to stop study drug|23|||
48706602|NCT02668653|156773635|FG000|Overall Study|Other reasons not specified|16|||
48706603|NCT02668653|156773636|FG001|Overall Study|Other reasons not specified|11|||
48706604|NCT02668653|156773635|FG000|Overall Study|Non-protocol-specified AML therapy|12|||
48706605|NCT02668653|156773636|FG001|Overall Study|Non-protocol-specified AML therapy|6|||
48706606|NCT02668653|156773635|FG000|Overall Study|Investigator decision|10|||
48706607|NCT02668653|156773636|FG001|Overall Study|Investigator decision|7|||
48706608|NCT02668653|156773635|FG000|Overall Study|Failure to meet continuation criteria|5|||
48706609|NCT02668653|156773636|FG001|Overall Study|Failure to meet continuation criteria|12|||
48706610|NCT02668653|156773635|FG000|Overall Study|Lost to Follow-up|1|||
48706611|NCT02668653|156773636|FG001|Overall Study|Lost to Follow-up|0|||
48706612|NCT02668653|156773635|FG000|Overall Study|Pregnancy|0|||
48706613|NCT02668653|156773636|FG001|Overall Study|Pregnancy|1|||
48706614|NCT02668653|156773635|FG000|Overall Study|Death|0|||
48706615|NCT02668653|156773636|FG001|Overall Study|Death|1|||
48706616|NCT00067002|156773637|FG000|Overall Study|Early Death|1|||
48706617|NCT00067002|156773638|FG001|Overall Study|Early Death|2|||
48706618|NCT00067002|156773637|FG000|Overall Study|Delayed|1|||
48706619|NCT00067002|156773638|FG001|Overall Study|Delayed|1|||
48706620|NCT00067002|156773637|FG000|Overall Study|Graft Failure|5|||
48706621|NCT00067002|156773638|FG001|Overall Study|Graft Failure|6|||
48706622|NCT03399552|156773640|FG000|Overall Study|No evidence of disease|1|||
48706623|NCT03399552|156773640|FG000|Overall Study|Unevaluable|1|||
48706624|NCT02377817|156773641|FG000|Overall Study|Transportation/childcare barriers.|2|||
48706625|NCT02377817|156773642|FG001|Overall Study|Transportation/childcare barriers.|0|||
48706626|NCT02377817|156773641|FG000|Overall Study|Unrelated injury prevented lateral sleep|1|||
48706627|NCT02377817|156773642|FG001|Overall Study|Unrelated injury prevented lateral sleep|0|||
48706628|NCT01931566|156773643|FG000|Overall Study|Randomized But Not Treated|6|||
48706629|NCT01931566|156773644|FG001|Overall Study|Randomized But Not Treated|9|||
48706630|NCT01931566|156773645|FG002|Overall Study|Randomized But Not Treated|14|||
48706631|NCT01931566|156773643|FG000|Overall Study|Adverse Event|37|||
48799500|NCT04241094|157104222|FG000|Overall Study|Ineligible after clinical assessment|2|||
48799501|NCT04241094|157104222|FG000|Overall Study|Lost to Follow-up|2|||
48799502|NCT02432105|157104225|FG000|Overall Study|Lost to Follow-up|1|||
48799503|NCT02432105|157104226|FG001|Overall Study|Lost to Follow-up|1|||
48799504|NCT02432105|157104227|FG002|Overall Study|Lost to Follow-up|0|||
48799505|NCT02432105|157104225|FG000|Overall Study|Withdrawal by Subject|1|||
48799506|NCT02432105|157104226|FG001|Overall Study|Withdrawal by Subject|0|||
48799507|NCT02432105|157104227|FG002|Overall Study|Withdrawal by Subject|1|||
48799508|NCT02432105|157104225|FG000|Overall Study|Culture positive for yeast|0|||
48799509|NCT02432105|157104226|FG001|Overall Study|Culture positive for yeast|1|||
48799510|NCT02432105|157104227|FG002|Overall Study|Culture positive for yeast|0|||
48799511|NCT02432105|157104225|FG000|Overall Study|Randomized in error|0|||
48799512|NCT02432105|157104226|FG001|Overall Study|Randomized in error|0|||
48799513|NCT02432105|157104227|FG002|Overall Study|Randomized in error|2|||
48799514|NCT00538590|157104228|FG000|Overall Study|Death|1|||
48799515|NCT00538590|157104229|FG001|Overall Study|Death|0|||
48799516|NCT01256567|157104230|FG000|Overall Study|Withdrawal by Subject|1|||
48799517|NCT00279201|157104234|FG000|Initiation|Death|1|||
48799518|NCT00279201|157104235|FG001|Initiation|Death|5|||
48799519|NCT00279201|157104236|FG002|Initiation|Death|0|||
48799520|NCT00279201|157104237|FG003|Initiation|Death|0|||
48799521|NCT00279201|157104238|FG004|Initiation|Death|0|||
48799522|NCT00279201|157104239|FG005|Initiation|Death|0|||
48799523|NCT00279201|157104234|FG000|Initiation|Adverse Event|6|||
48799524|NCT00279201|157104235|FG001|Initiation|Adverse Event|15|||
48799525|NCT00279201|157104236|FG002|Initiation|Adverse Event|0|||
48799526|NCT00279201|157104237|FG003|Initiation|Adverse Event|0|||
48799527|NCT00279201|157104238|FG004|Initiation|Adverse Event|0|||
48799528|NCT00279201|157104239|FG005|Initiation|Adverse Event|0|||
48799529|NCT00279201|157104234|FG000|Initiation|Lost to Follow-up|42|||
48799530|NCT00279201|157104235|FG001|Initiation|Lost to Follow-up|41|||
48799531|NCT00279201|157104236|FG002|Initiation|Lost to Follow-up|0|||
48799532|NCT00279201|157104237|FG003|Initiation|Lost to Follow-up|0|||
48799533|NCT00279201|157104238|FG004|Initiation|Lost to Follow-up|0|||
48799534|NCT00279201|157104239|FG005|Initiation|Lost to Follow-up|0|||
48799535|NCT00279201|157104234|FG000|Initiation|Entry Criteria Exclusion|7|||
48799536|NCT00279201|157104235|FG001|Initiation|Entry Criteria Exclusion|9|||
48912995|NCT01987960|157517638|FG001|Period 1|Withdrawal by Subject|0|||
48912996|NCT01987960|157517639|FG002|Period 1|Withdrawal by Subject|0|||
48912997|NCT01987960|157517640|FG003|Period 1|Withdrawal by Subject|0|||
48912998|NCT01987960|157517637|FG000|Period 1|Lost to Follow-up|40|||
48799537|NCT00279201|157104236|FG002|Initiation|Entry Criteria Exclusion|0|||
48912999|NCT01987960|157517638|FG001|Period 1|Lost to Follow-up|0|||
48913000|NCT01987960|157517639|FG002|Period 1|Lost to Follow-up|0|||
48913001|NCT01987960|157517640|FG003|Period 1|Lost to Follow-up|0|||
48913002|NCT01987960|157517637|FG000|Period 1|administrative or other reason|75|||
48913003|NCT01987960|157517638|FG001|Period 1|administrative or other reason|0|||
48913004|NCT01987960|157517639|FG002|Period 1|administrative or other reason|0|||
48706632|NCT01931566|156773644|FG001|Overall Study|Adverse Event|167|||
48799538|NCT00279201|157104237|FG003|Initiation|Entry Criteria Exclusion|0|||
48799539|NCT00279201|157104238|FG004|Initiation|Entry Criteria Exclusion|0|||
48799540|NCT00279201|157104239|FG005|Initiation|Entry Criteria Exclusion|0|||
48799541|NCT00279201|157104234|FG000|Initiation|Protocol Violation|9|||
48799542|NCT00279201|157104235|FG001|Initiation|Protocol Violation|10|||
48799543|NCT00279201|157104236|FG002|Initiation|Protocol Violation|0|||
48799544|NCT00279201|157104237|FG003|Initiation|Protocol Violation|0|||
48799545|NCT00279201|157104238|FG004|Initiation|Protocol Violation|0|||
48799546|NCT00279201|157104239|FG005|Initiation|Protocol Violation|0|||
48799547|NCT00279201|157104234|FG000|Initiation|Withdrawal by Subject|35|||
48799548|NCT00279201|157104235|FG001|Initiation|Withdrawal by Subject|41|||
48799549|NCT00279201|157104236|FG002|Initiation|Withdrawal by Subject|0|||
48799550|NCT00279201|157104237|FG003|Initiation|Withdrawal by Subject|0|||
48799551|NCT00279201|157104238|FG004|Initiation|Withdrawal by Subject|0|||
48913005|NCT01987960|157517640|FG003|Period 1|administrative or other reason|0|||
48799552|NCT00279201|157104239|FG005|Initiation|Withdrawal by Subject|0|||
48799553|NCT00279201|157104234|FG000|Initiation|Physician Decision|15|||
48799554|NCT00279201|157104235|FG001|Initiation|Physician Decision|18|||
48799555|NCT00279201|157104236|FG002|Initiation|Physician Decision|0|||
48799556|NCT00279201|157104237|FG003|Initiation|Physician Decision|0|||
48799557|NCT00279201|157104238|FG004|Initiation|Physician Decision|0|||
48799558|NCT00279201|157104239|FG005|Initiation|Physician Decision|0|||
48799559|NCT00279201|157104234|FG000|Initiation|Sponsor Decision|13|||
48799560|NCT00279201|157104235|FG001|Initiation|Sponsor Decision|5|||
48799561|NCT00279201|157104236|FG002|Initiation|Sponsor Decision|0|||
48799562|NCT00279201|157104237|FG003|Initiation|Sponsor Decision|0|||
48799563|NCT00279201|157104238|FG004|Initiation|Sponsor Decision|0|||
48799564|NCT00279201|157104239|FG005|Initiation|Sponsor Decision|0|||
48799565|NCT00279201|157104234|FG000|Initiation|Discontinuation Oral Antihyperglycemics|0|||
48799566|NCT00279201|157104235|FG001|Initiation|Discontinuation Oral Antihyperglycemics|1|||
48799567|NCT00279201|157104236|FG002|Initiation|Discontinuation Oral Antihyperglycemics|0|||
48799568|NCT00279201|157104237|FG003|Initiation|Discontinuation Oral Antihyperglycemics|0|||
48799569|NCT00279201|157104238|FG004|Initiation|Discontinuation Oral Antihyperglycemics|0|||
48799570|NCT00279201|157104239|FG005|Initiation|Discontinuation Oral Antihyperglycemics|0|||
48799571|NCT00279201|157104234|FG000|Maintenance|Lack of Efficacy|32|||
48799572|NCT00279201|157104235|FG001|Maintenance|Lack of Efficacy|30|||
48799573|NCT00279201|157104236|FG002|Maintenance|Lack of Efficacy|0|||
48799574|NCT00279201|157104237|FG003|Maintenance|Lack of Efficacy|0|||
48799575|NCT00279201|157104238|FG004|Maintenance|Lack of Efficacy|0|||
48799576|NCT00279201|157104239|FG005|Maintenance|Lack of Efficacy|0|||
48799577|NCT00279201|157104234|FG000|Maintenance|Discontinuation Antihyperglycemic Drugs|3|||
48799578|NCT00279201|157104235|FG001|Maintenance|Discontinuation Antihyperglycemic Drugs|2|||
48799579|NCT00279201|157104236|FG002|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
48799580|NCT00279201|157104237|FG003|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
48799581|NCT00279201|157104238|FG004|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
48799582|NCT00279201|157104239|FG005|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
48799583|NCT00279201|157104234|FG000|Maintenance|Adverse Event|4|||
48799584|NCT00279201|157104235|FG001|Maintenance|Adverse Event|4|||
48799585|NCT00279201|157104236|FG002|Maintenance|Adverse Event|0|||
48799586|NCT00279201|157104237|FG003|Maintenance|Adverse Event|0|||
48799587|NCT00279201|157104238|FG004|Maintenance|Adverse Event|0|||
48799588|NCT00279201|157104239|FG005|Maintenance|Adverse Event|0|||
48799589|NCT00279201|157104234|FG000|Maintenance|Death|4|||
48799590|NCT00279201|157104235|FG001|Maintenance|Death|4|||
48799591|NCT00279201|157104236|FG002|Maintenance|Death|0|||
48799592|NCT00279201|157104237|FG003|Maintenance|Death|0|||
48799593|NCT00279201|157104238|FG004|Maintenance|Death|0|||
48799594|NCT00279201|157104239|FG005|Maintenance|Death|0|||
48799595|NCT00279201|157104234|FG000|Maintenance|Lost to Follow-up|17|||
48799596|NCT00279201|157104235|FG001|Maintenance|Lost to Follow-up|13|||
48799597|NCT00279201|157104236|FG002|Maintenance|Lost to Follow-up|0|||
49118746|NCT01001520|158273198|FG001|Medication Period 1|Withdrawal by Subject|2|||
49118747|NCT01001520|158273197|FG000|Medication Period 1|Ineligible: Positive Urine Drug Screen|0|||
49118748|NCT01001520|158273198|FG001|Medication Period 1|Ineligible: Positive Urine Drug Screen|3|||
49118749|NCT01001520|158273197|FG000|Medication Period 1|Ineligible: fMRI contraindicated metal|0|||
49118750|NCT01001520|158273198|FG001|Medication Period 1|Ineligible: fMRI contraindicated metal|2|||
49118751|NCT01001520|158273197|FG000|Medication Period 1|Ineligible: Claustrophobia in fMRI|2|||
49118752|NCT01001520|158273198|FG001|Medication Period 1|Ineligible: Claustrophobia in fMRI|0|||
49118753|NCT01001520|158273197|FG000|Washout Period|Withdrawal by Subject|2|||
49118754|NCT01001520|158273198|FG001|Washout Period|Withdrawal by Subject|1|||
49118755|NCT01001520|158273197|FG000|Medication Period 2|Withdrawal by Subject|0|||
49118756|NCT01001520|158273198|FG001|Medication Period 2|Withdrawal by Subject|3|||
49118757|NCT00536510|158273199|FG000|Overall Study|Adverse Event|27|||
49118758|NCT00536510|158273200|FG001|Overall Study|Adverse Event|4|||
49118759|NCT00536510|158273199|FG000|Overall Study|Lost to Follow-up|11|||
49118760|NCT00536510|158273200|FG001|Overall Study|Lost to Follow-up|8|||
48799598|NCT00279201|157104237|FG003|Maintenance|Lost to Follow-up|0|||
48799599|NCT00279201|157104238|FG004|Maintenance|Lost to Follow-up|0|||
48799600|NCT00279201|157104239|FG005|Maintenance|Lost to Follow-up|0|||
48799601|NCT00279201|157104234|FG000|Maintenance|Entry Criteria Exclusion|1|||
48799602|NCT00279201|157104235|FG001|Maintenance|Entry Criteria Exclusion|4|||
48913006|NCT01987960|157517637|FG000|Period 1|Withdrawal of consent before treatment|4|||
48913007|NCT01987960|157517638|FG001|Period 1|Withdrawal of consent before treatment|0|||
48799603|NCT00279201|157104236|FG002|Maintenance|Entry Criteria Exclusion|0|||
48799604|NCT00279201|157104237|FG003|Maintenance|Entry Criteria Exclusion|0|||
48799605|NCT00279201|157104238|FG004|Maintenance|Entry Criteria Exclusion|0|||
48799606|NCT00279201|157104239|FG005|Maintenance|Entry Criteria Exclusion|0|||
48799607|NCT00279201|157104234|FG000|Maintenance|Protocol Violation|16|||
48799608|NCT00279201|157104235|FG001|Maintenance|Protocol Violation|24|||
48799609|NCT00279201|157104236|FG002|Maintenance|Protocol Violation|0|||
48799610|NCT00279201|157104237|FG003|Maintenance|Protocol Violation|0|||
48799611|NCT00279201|157104238|FG004|Maintenance|Protocol Violation|0|||
48913008|NCT01987960|157517639|FG002|Period 1|Withdrawal of consent before treatment|0|||
48799612|NCT00279201|157104239|FG005|Maintenance|Protocol Violation|0|||
48799613|NCT00279201|157104234|FG000|Maintenance|Withdrawal by Subject|18|||
48799614|NCT00279201|157104235|FG001|Maintenance|Withdrawal by Subject|18|||
48799615|NCT00279201|157104236|FG002|Maintenance|Withdrawal by Subject|0|||
48799616|NCT00279201|157104237|FG003|Maintenance|Withdrawal by Subject|0|||
48799617|NCT00279201|157104238|FG004|Maintenance|Withdrawal by Subject|0|||
48799618|NCT00279201|157104239|FG005|Maintenance|Withdrawal by Subject|0|||
48799619|NCT00279201|157104234|FG000|Maintenance|Physician Decision|9|||
48799620|NCT00279201|157104235|FG001|Maintenance|Physician Decision|9|||
48799621|NCT00279201|157104236|FG002|Maintenance|Physician Decision|0|||
48799622|NCT00279201|157104237|FG003|Maintenance|Physician Decision|0|||
48799623|NCT00279201|157104238|FG004|Maintenance|Physician Decision|0|||
48799624|NCT00279201|157104239|FG005|Maintenance|Physician Decision|0|||
48799625|NCT00279201|157104234|FG000|Maintenance|Sponsor Decision|4|||
48799626|NCT00279201|157104235|FG001|Maintenance|Sponsor Decision|0|||
48799627|NCT00279201|157104236|FG002|Maintenance|Sponsor Decision|0|||
48799628|NCT00279201|157104237|FG003|Maintenance|Sponsor Decision|0|||
48799629|NCT00279201|157104238|FG004|Maintenance|Sponsor Decision|0|||
48799630|NCT00279201|157104239|FG005|Maintenance|Sponsor Decision|0|||
48799631|NCT00279201|157104234|FG000|Maintenance|HbA1c>7.5%|123|||
48799632|NCT00279201|157104235|FG001|Maintenance|HbA1c>7.5%|126|||
48799633|NCT00279201|157104236|FG002|Maintenance|HbA1c>7.5%|0|||
48799634|NCT00279201|157104237|FG003|Maintenance|HbA1c>7.5%|0|||
48799635|NCT00279201|157104238|FG004|Maintenance|HbA1c>7.5%|0|||
48799636|NCT00279201|157104239|FG005|Maintenance|HbA1c>7.5%|0|||
48799637|NCT00279201|157104234|FG000|Intensification Addendum|Withdrawal by Subject|0|||
48799638|NCT00279201|157104235|FG001|Intensification Addendum|Withdrawal by Subject|0|||
48799639|NCT00279201|157104236|FG002|Intensification Addendum|Withdrawal by Subject|12|||
48799640|NCT00279201|157104237|FG003|Intensification Addendum|Withdrawal by Subject|14|||
48799641|NCT00279201|157104238|FG004|Intensification Addendum|Withdrawal by Subject|9|||
48799642|NCT00279201|157104239|FG005|Intensification Addendum|Withdrawal by Subject|18|||
48799643|NCT00279201|157104234|FG000|Intensification Addendum|Lost to Follow-up|0|||
48799644|NCT00279201|157104235|FG001|Intensification Addendum|Lost to Follow-up|0|||
48799645|NCT00279201|157104236|FG002|Intensification Addendum|Lost to Follow-up|4|||
48799646|NCT00279201|157104237|FG003|Intensification Addendum|Lost to Follow-up|6|||
48799647|NCT00279201|157104238|FG004|Intensification Addendum|Lost to Follow-up|7|||
48799648|NCT00279201|157104239|FG005|Intensification Addendum|Lost to Follow-up|7|||
48799649|NCT00279201|157104234|FG000|Intensification Addendum|Protocol Violation|0|||
48799650|NCT00279201|157104235|FG001|Intensification Addendum|Protocol Violation|0|||
48799651|NCT00279201|157104236|FG002|Intensification Addendum|Protocol Violation|2|||
48799652|NCT00279201|157104237|FG003|Intensification Addendum|Protocol Violation|2|||
48799653|NCT00279201|157104238|FG004|Intensification Addendum|Protocol Violation|6|||
48799654|NCT00279201|157104239|FG005|Intensification Addendum|Protocol Violation|6|||
48799655|NCT00279201|157104234|FG000|Intensification Addendum|Adverse Event|0|||
48799656|NCT00279201|157104235|FG001|Intensification Addendum|Adverse Event|0|||
48799657|NCT00279201|157104236|FG002|Intensification Addendum|Adverse Event|0|||
48799658|NCT00279201|157104237|FG003|Intensification Addendum|Adverse Event|4|||
48799659|NCT00279201|157104238|FG004|Intensification Addendum|Adverse Event|1|||
48799660|NCT00279201|157104239|FG005|Intensification Addendum|Adverse Event|3|||
48799661|NCT00279201|157104234|FG000|Intensification Addendum|Physician Decision|0|||
48799662|NCT00279201|157104235|FG001|Intensification Addendum|Physician Decision|0|||
48799663|NCT00279201|157104236|FG002|Intensification Addendum|Physician Decision|4|||
48799664|NCT00279201|157104237|FG003|Intensification Addendum|Physician Decision|1|||
48799665|NCT00279201|157104238|FG004|Intensification Addendum|Physician Decision|3|||
48799666|NCT00279201|157104239|FG005|Intensification Addendum|Physician Decision|2|||
48799667|NCT00279201|157104234|FG000|Intensification Addendum|Sponsor Decision|0|||
48913009|NCT01987960|157517640|FG003|Period 1|Withdrawal of consent before treatment|0|||
48913010|NCT01987960|157517637|FG000|Period 2|Adverse Event|0|||
48913011|NCT01987960|157517638|FG001|Period 2|Adverse Event|0|||
48799668|NCT00279201|157104235|FG001|Intensification Addendum|Sponsor Decision|0|||
48799669|NCT00279201|157104236|FG002|Intensification Addendum|Sponsor Decision|0|||
48799670|NCT00279201|157104237|FG003|Intensification Addendum|Sponsor Decision|0|||
48799671|NCT00279201|157104238|FG004|Intensification Addendum|Sponsor Decision|1|||
48913012|NCT01987960|157517639|FG002|Period 2|Adverse Event|1|||
48913013|NCT01987960|157517640|FG003|Period 2|Adverse Event|0|||
48799672|NCT00279201|157104239|FG005|Intensification Addendum|Sponsor Decision|1|||
48799673|NCT00279201|157104234|FG000|Intensification Addendum|Entry Criteria Exclusion|0|||
48913014|NCT01987960|157517637|FG000|Period 2|Withdrawal by Subject|0|||
48913015|NCT01987960|157517638|FG001|Period 2|Withdrawal by Subject|0|||
49118761|NCT00536510|158273199|FG000|Overall Study|Protocol Violation|4|||
48799674|NCT00279201|157104235|FG001|Intensification Addendum|Entry Criteria Exclusion|0|||
48799675|NCT00279201|157104236|FG002|Intensification Addendum|Entry Criteria Exclusion|1|||
48799676|NCT00279201|157104237|FG003|Intensification Addendum|Entry Criteria Exclusion|0|||
48799677|NCT00279201|157104238|FG004|Intensification Addendum|Entry Criteria Exclusion|0|||
48913016|NCT01987960|157517639|FG002|Period 2|Withdrawal by Subject|1|||
48799678|NCT00279201|157104239|FG005|Intensification Addendum|Entry Criteria Exclusion|0|||
48799679|NCT00279201|157104234|FG000|Intensification Addendum|Lack of Efficacy|0|||
48799680|NCT00279201|157104235|FG001|Intensification Addendum|Lack of Efficacy|0|||
48799681|NCT00279201|157104236|FG002|Intensification Addendum|Lack of Efficacy|0|||
48799682|NCT00279201|157104237|FG003|Intensification Addendum|Lack of Efficacy|1|||
48799683|NCT00279201|157104238|FG004|Intensification Addendum|Lack of Efficacy|1|||
48799684|NCT00279201|157104239|FG005|Intensification Addendum|Lack of Efficacy|0|||
48799685|NCT00279201|157104234|FG000|Intensification Addendum|Death|0|||
48799686|NCT00279201|157104235|FG001|Intensification Addendum|Death|0|||
48799687|NCT00279201|157104236|FG002|Intensification Addendum|Death|0|||
48799688|NCT00279201|157104237|FG003|Intensification Addendum|Death|0|||
48799689|NCT00279201|157104238|FG004|Intensification Addendum|Death|1|||
48799690|NCT00279201|157104239|FG005|Intensification Addendum|Death|0|||
48799691|NCT04512066|157104240|FG000|Double-blind Treatment Period|Adverse Event|6|||
48799692|NCT04512066|157104241|FG001|Double-blind Treatment Period|Adverse Event|4|||
48799693|NCT04512066|157104242|FG002|Double-blind Treatment Period|Adverse Event|5|||
48799694|NCT04512066|157104243|FG003|Double-blind Treatment Period|Adverse Event|1|||
48799695|NCT04512066|157104244|FG004|Double-blind Treatment Period|Adverse Event|0|||
48799696|NCT04512066|157104245|FG005|Double-blind Treatment Period|Adverse Event|0|||
48799697|NCT04512066|157104240|FG000|Double-blind Treatment Period|Lack of Efficacy|3|||
48799698|NCT04512066|157104241|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
48799699|NCT04512066|157104242|FG002|Double-blind Treatment Period|Lack of Efficacy|5|||
48799700|NCT04512066|157104243|FG003|Double-blind Treatment Period|Lack of Efficacy|1|||
48799701|NCT04512066|157104244|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
48799702|NCT04512066|157104245|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
48799703|NCT04512066|157104240|FG000|Double-blind Treatment Period|Physician Decision|1|||
48799704|NCT04512066|157104241|FG001|Double-blind Treatment Period|Physician Decision|0|||
48799705|NCT04512066|157104242|FG002|Double-blind Treatment Period|Physician Decision|1|||
48799706|NCT04512066|157104243|FG003|Double-blind Treatment Period|Physician Decision|0|||
48799707|NCT04512066|157104244|FG004|Double-blind Treatment Period|Physician Decision|0|||
48799708|NCT04512066|157104245|FG005|Double-blind Treatment Period|Physician Decision|0|||
48799709|NCT04512066|157104240|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
48799710|NCT04512066|157104241|FG001|Double-blind Treatment Period|Withdrawal by Subject|9|||
48799711|NCT04512066|157104242|FG002|Double-blind Treatment Period|Withdrawal by Subject|5|||
48799712|NCT04512066|157104243|FG003|Double-blind Treatment Period|Withdrawal by Subject|12|||
48799713|NCT04512066|157104244|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
48799714|NCT04512066|157104245|FG005|Double-blind Treatment Period|Withdrawal by Subject|0|||
48799715|NCT04512066|157104240|FG000|Extension Period|Adverse Event|0|||
48799716|NCT04512066|157104241|FG001|Extension Period|Adverse Event|1|||
48799717|NCT04512066|157104242|FG002|Extension Period|Adverse Event|4|||
48799718|NCT04512066|157104243|FG003|Extension Period|Adverse Event|3|||
48799719|NCT04512066|157104244|FG004|Extension Period|Adverse Event|1|||
48799720|NCT04512066|157104245|FG005|Extension Period|Adverse Event|3|||
48799721|NCT04512066|157104240|FG000|Extension Period|Death|0|||
48799722|NCT04512066|157104241|FG001|Extension Period|Death|0|||
48799723|NCT04512066|157104242|FG002|Extension Period|Death|0|||
48799724|NCT04512066|157104243|FG003|Extension Period|Death|0|||
48799725|NCT04512066|157104244|FG004|Extension Period|Death|0|||
48799726|NCT04512066|157104245|FG005|Extension Period|Death|1|||
48799727|NCT04512066|157104240|FG000|Extension Period|Lack of Efficacy|0|||
48799728|NCT04512066|157104241|FG001|Extension Period|Lack of Efficacy|4|||
48799729|NCT04512066|157104242|FG002|Extension Period|Lack of Efficacy|4|||
48799730|NCT04512066|157104243|FG003|Extension Period|Lack of Efficacy|1|||
48799731|NCT04512066|157104244|FG004|Extension Period|Lack of Efficacy|3|||
48799732|NCT04512066|157104245|FG005|Extension Period|Lack of Efficacy|3|||
48799733|NCT04512066|157104240|FG000|Extension Period|Lost to Follow-up|0|||
48799734|NCT04512066|157104241|FG001|Extension Period|Lost to Follow-up|1|||
48799735|NCT04512066|157104242|FG002|Extension Period|Lost to Follow-up|5|||
48799736|NCT04512066|157104243|FG003|Extension Period|Lost to Follow-up|2|||
48799737|NCT04512066|157104244|FG004|Extension Period|Lost to Follow-up|3|||
48799738|NCT04512066|157104245|FG005|Extension Period|Lost to Follow-up|2|||
48799739|NCT04512066|157104240|FG000|Extension Period|Non-compliance with study drug|0|||
48799740|NCT04512066|157104241|FG001|Extension Period|Non-compliance with study drug|1|||
48799741|NCT04512066|157104242|FG002|Extension Period|Non-compliance with study drug|0|||
48799742|NCT04512066|157104243|FG003|Extension Period|Non-compliance with study drug|0|||
48799743|NCT04512066|157104244|FG004|Extension Period|Non-compliance with study drug|0|||
48799744|NCT04512066|157104245|FG005|Extension Period|Non-compliance with study drug|1|||
48799745|NCT04512066|157104240|FG000|Extension Period|Other|0|||
48799746|NCT04512066|157104241|FG001|Extension Period|Other|2|||
48799747|NCT04512066|157104242|FG002|Extension Period|Other|0|||
48799748|NCT04512066|157104243|FG003|Extension Period|Other|0|||
49118762|NCT00536510|158273200|FG001|Overall Study|Protocol Violation|5|||
48799749|NCT04512066|157104244|FG004|Extension Period|Other|0|||
48913017|NCT01987960|157517640|FG003|Period 2|Withdrawal by Subject|0|||
49118763|NCT00536510|158273199|FG000|Overall Study|Withdrawal by Subject|16|||
48799750|NCT04512066|157104245|FG005|Extension Period|Other|0|||
48799751|NCT04512066|157104240|FG000|Extension Period|Physician Decision|0|||
48799752|NCT04512066|157104241|FG001|Extension Period|Physician Decision|2|||
48706633|NCT01931566|156773645|FG002|Overall Study|Adverse Event|132|||
48706634|NCT01931566|156773643|FG000|Overall Study|Major Protocol Deviation|5|||
48799753|NCT04512066|157104242|FG002|Extension Period|Physician Decision|0|||
48799754|NCT04512066|157104243|FG003|Extension Period|Physician Decision|1|||
48799755|NCT04512066|157104244|FG004|Extension Period|Physician Decision|1|||
48799756|NCT04512066|157104245|FG005|Extension Period|Physician Decision|0|||
48799757|NCT04512066|157104240|FG000|Extension Period|Withdrawal by Subject|0|||
48799758|NCT04512066|157104241|FG001|Extension Period|Withdrawal by Subject|3|||
48799759|NCT04512066|157104242|FG002|Extension Period|Withdrawal by Subject|7|||
48799760|NCT04512066|157104243|FG003|Extension Period|Withdrawal by Subject|11|||
48799761|NCT04512066|157104244|FG004|Extension Period|Withdrawal by Subject|8|||
48706635|NCT01931566|156773644|FG001|Overall Study|Major Protocol Deviation|14|||
48706636|NCT01931566|156773645|FG002|Overall Study|Major Protocol Deviation|21|||
48706637|NCT01931566|156773643|FG000|Overall Study|Lost to Follow-up|3|||
48706638|NCT01931566|156773644|FG001|Overall Study|Lost to Follow-up|26|||
48706639|NCT01931566|156773645|FG002|Overall Study|Lost to Follow-up|23|||
48706640|NCT01931566|156773643|FG000|Overall Study|Voluntary Withdrawal|78|||
48706641|NCT01931566|156773644|FG001|Overall Study|Voluntary Withdrawal|245|||
48706642|NCT01931566|156773645|FG002|Overall Study|Voluntary Withdrawal|225|||
48706643|NCT01931566|156773643|FG000|Overall Study|Study Termination|289|||
48706644|NCT01931566|156773644|FG001|Overall Study|Study Termination|968|||
48706645|NCT01931566|156773645|FG002|Overall Study|Study Termination|1037|||
48706646|NCT01931566|156773643|FG000|Overall Study|Reason Not Specified|11|||
48706647|NCT01931566|156773644|FG001|Overall Study|Reason Not Specified|47|||
48706648|NCT01931566|156773645|FG002|Overall Study|Reason Not Specified|53|||
48706649|NCT01931566|156773643|FG000|Overall Study|Missing|0|||
48706650|NCT01931566|156773644|FG001|Overall Study|Missing|0|||
48706651|NCT01931566|156773645|FG002|Overall Study|Missing|1|||
48706652|NCT01147874|156773647|FG000|Overall Study|Adverse Event|5|||
48706653|NCT01147874|156773647|FG000|Overall Study|Investigator's Request|1|||
48706654|NCT01147874|156773647|FG000|Overall Study|Lost to Follow-up|25|||
48706655|NCT01147874|156773647|FG000|Overall Study|Other|5|||
48706656|NCT01147874|156773647|FG000|Overall Study|Protocol Violation|5|||
48706657|NCT01147874|156773647|FG000|Overall Study|Sponsor's Decision|2|||
48706658|NCT01147874|156773647|FG000|Overall Study|Withdrawal by Subject|24|||
48706659|NCT01696188|156773651|FG000|Overall Study|Protocol Violation|1|||
48706660|NCT01696188|156773652|FG001|Overall Study|Protocol Violation|1|||
48706661|NCT01987453|156775849|FG000|Overall Study|Death|0|||
48706662|NCT01987453|156775850|FG001|Overall Study|Death|0|||
48706663|NCT01987453|156775851|FG002|Overall Study|Death|1|||
48706664|NCT01987453|156775849|FG000|Overall Study|Lack of Efficacy|1|||
48706665|NCT01987453|156775850|FG001|Overall Study|Lack of Efficacy|12|||
48706666|NCT01987453|156775851|FG002|Overall Study|Lack of Efficacy|0|||
48706667|NCT05366738|156775852|FG000|Overall Study|Adverse Event|0|||
48799762|NCT04512066|157104245|FG005|Extension Period|Withdrawal by Subject|4|||
48799763|NCT02883062|157104246|FG000|Overall Study|Withdrawal by Subject|6|||
48799764|NCT02883062|157104247|FG001|Overall Study|Withdrawal by Subject|0|||
48799765|NCT00316173|157104250|FG000|Run-in Phase|Adverse Event|1|||
48799766|NCT00316173|157104251|FG001|Run-in Phase|Adverse Event|0|||
48799767|NCT00316173|157104250|FG000|Run-in Phase|Protocol Violation|1|||
48799768|NCT00316173|157104251|FG001|Run-in Phase|Protocol Violation|0|||
48799769|NCT00316173|157104250|FG000|Run-in Phase|Study Follow-up Stopped|5|||
48799770|NCT00316173|157104251|FG001|Run-in Phase|Study Follow-up Stopped|0|||
48799771|NCT00316173|157104250|FG000|Treatment Phase|Adverse Event|0|||
48799772|NCT00316173|157104251|FG001|Treatment Phase|Adverse Event|1|||
48799773|NCT00316173|157104250|FG000|Treatment Phase|Lack of Efficacy|0|||
48799774|NCT00316173|157104251|FG001|Treatment Phase|Lack of Efficacy|3|||
48706668|NCT05366738|156775853|FG001|Overall Study|Adverse Event|1|||
48706669|NCT05366738|156775854|FG002|Overall Study|Adverse Event|0|||
48706670|NCT02079246|156775856|FG000|OLEX|Withdrawal before treatment|1|||
48706671|NCT02079246|156775857|FG001|OLEX|Withdrawal before treatment|0|||
48706672|NCT02079246|156775856|FG000|OLEX|Death|11|||
48706673|NCT02079246|156775857|FG001|OLEX|Death|0|||
48706674|NCT02079246|156775856|FG000|OLEX|Adverse Event|66|||
48706675|NCT02079246|156775857|FG001|OLEX|Adverse Event|0|||
48706676|NCT02079246|156775856|FG000|OLEX|Withdrawal by Subject|60|||
48706677|NCT02079246|156775857|FG001|OLEX|Withdrawal by Subject|0|||
48706678|NCT02079246|156775856|FG000|OLEX|Lost to Follow-up|6|||
48706679|NCT02079246|156775857|FG001|OLEX|Lost to Follow-up|0|||
48706680|NCT02079246|156775856|FG000|OLEX|Protocol Violation|6|||
48706681|NCT02079246|156775857|FG001|OLEX|Protocol Violation|0|||
48706682|NCT02079246|156775856|FG000|OLEX|Lack of Efficacy|3|||
48706683|NCT02079246|156775857|FG001|OLEX|Lack of Efficacy|0|||
48706684|NCT02079246|156775856|FG000|OLEX|Results of the lead-in studies|58|||
48706685|NCT02079246|156775857|FG001|OLEX|Results of the lead-in studies|0|||
48706686|NCT02079246|156775856|FG000|OLEX|Other: Disallowed medication|8|||
48706687|NCT02079246|156775857|FG001|OLEX|Other: Disallowed medication|0|||
48706688|NCT02079246|156775856|FG000|OLEX|Other: Insufficient compliance|2|||
49118764|NCT00536510|158273200|FG001|Overall Study|Withdrawal by Subject|9|||
49118765|NCT00536510|158273199|FG000|Overall Study|Flushing with Product|20|||
49118766|NCT00536510|158273200|FG001|Overall Study|Flushing with Product|0|||
49118767|NCT00536510|158273199|FG000|Overall Study|Laboratory Adverse Event|2|||
49118768|NCT00536510|158273200|FG001|Overall Study|Laboratory Adverse Event|1|||
49118769|NCT00536510|158273199|FG000|Overall Study|Patient Discontinued for Other Reasons|2|||
49118770|NCT00536510|158273200|FG001|Overall Study|Patient Discontinued for Other Reasons|2|||
49118771|NCT00943397|158273208|FG000|Overall Study|Adverse Event|0|||
49118772|NCT00943397|158273209|FG001|Overall Study|Adverse Event|6|||
49118773|NCT00943397|158273208|FG000|Overall Study|Lost to Follow-up|0|||
48706689|NCT02079246|156775857|FG001|OLEX|Other: Insufficient compliance|0|||
48706690|NCT02079246|156775856|FG000|OLEX|Other: Caregiver unavailable|3|||
48706691|NCT02079246|156775857|FG001|OLEX|Other: Caregiver unavailable|0|||
49118774|NCT00943397|158273209|FG001|Overall Study|Lost to Follow-up|4|||
48706692|NCT02079246|156775856|FG000|OLEX|Other: Coordinator decision|1|||
48706693|NCT02079246|156775857|FG001|OLEX|Other: Coordinator decision|0|||
48706694|NCT02079246|156775856|FG000|OLEX|Other: Worsening of condition|1|||
48706695|NCT02079246|156775857|FG001|OLEX|Other: Worsening of condition|0|||
48706696|NCT02079246|156775856|FG000|OLEX|Other: Moved to nursing home|1|||
48706697|NCT02079246|156775857|FG001|OLEX|Other: Moved to nursing home|0|||
48706698|NCT02079246|156775856|FG000|OLEX|Other: Withdrawal of caregiver consent|1|||
48706699|NCT02079246|156775857|FG001|OLEX|Other: Withdrawal of caregiver consent|0|||
48706700|NCT02079246|156775856|FG000|OLEX-MEM|Adverse Event|0|||
48706701|NCT02079246|156775857|FG001|OLEX-MEM|Adverse Event|6|||
48706702|NCT02079246|156775856|FG000|OLEX-MEM|Withdrawal by Subject|0|||
48706703|NCT02079246|156775857|FG001|OLEX-MEM|Withdrawal by Subject|7|||
48706704|NCT02079246|156775856|FG000|OLEX-MEM|Protocol Violation|0|||
48706705|NCT02079246|156775857|FG001|OLEX-MEM|Protocol Violation|2|||
48706706|NCT02079246|156775856|FG000|OLEX-MEM|Lost to Follow-up|0|||
48706707|NCT02079246|156775857|FG001|OLEX-MEM|Lost to Follow-up|1|||
48706708|NCT02079246|156775856|FG000|OLEX-MEM|Other: Moved to nursing home|0|||
48706709|NCT02079246|156775857|FG001|OLEX-MEM|Other: Moved to nursing home|3|||
48706710|NCT05024032|156775859|FG000|Overall Study|Withdrawal by Subject|0|||
48706711|NCT05024032|156775860|FG001|Overall Study|Withdrawal by Subject|3|||
48706712|NCT05024032|156775861|FG002|Overall Study|Withdrawal by Subject|4|||
48706713|NCT05024032|156775859|FG000|Overall Study|Adverse Event|0|||
48706714|NCT05024032|156775860|FG001|Overall Study|Adverse Event|1|||
48706715|NCT05024032|156775861|FG002|Overall Study|Adverse Event|0|||
48706716|NCT05024032|156775859|FG000|Overall Study|Protocol Deviation|1|||
48706717|NCT05024032|156775860|FG001|Overall Study|Protocol Deviation|0|||
48706718|NCT05024032|156775861|FG002|Overall Study|Protocol Deviation|0|||
48706719|NCT01209689|156775862|FG000|Overall Study|Insufficient Therapeutic Response|7|||
48706720|NCT01209689|156775863|FG001|Overall Study|Insufficient Therapeutic Response|2|||
48706721|NCT01209689|156775862|FG000|Overall Study|Refused Treatment|8|||
48706722|NCT01209689|156775863|FG001|Overall Study|Refused Treatment|3|||
48706723|NCT01209689|156775862|FG000|Overall Study|Adverse Event|4|||
48706724|NCT01209689|156775863|FG001|Overall Study|Adverse Event|0|||
48706725|NCT01209689|156775862|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
48706726|NCT01209689|156775863|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
48706727|NCT01209689|156775862|FG000|Overall Study|Failure to Return|3|||
48706728|NCT01209689|156775863|FG001|Overall Study|Failure to Return|0|||
48706729|NCT01209689|156775862|FG000|Overall Study|Sponsor's Decision to Stop the Study|68|||
48706730|NCT01209689|156775863|FG001|Overall Study|Sponsor's Decision to Stop the Study|17|||
49118775|NCT00943397|158273208|FG000|Overall Study|Protocol Violation|2|||
49118776|NCT00943397|158273209|FG001|Overall Study|Protocol Violation|5|||
49118777|NCT00943397|158273208|FG000|Overall Study|Withdrawal by Subject|1|||
49118778|NCT00943397|158273209|FG001|Overall Study|Withdrawal by Subject|1|||
48706731|NCT00775190|156775866|FG000|Overall Study|Lost to Follow-up|2|||
48706732|NCT00775190|156775867|FG001|Overall Study|Lost to Follow-up|3|||
48706733|NCT00775190|156775866|FG000|Overall Study|Withdrawal by Subject|1|||
48706734|NCT00775190|156775867|FG001|Overall Study|Withdrawal by Subject|2|||
48706735|NCT00775190|156775866|FG000|Overall Study|Protocol Violation|1|||
48706736|NCT00775190|156775867|FG001|Overall Study|Protocol Violation|0|||
48706737|NCT03714672|156775868|FG000|Overall Study|Adverse Event|0|||
48706738|NCT03714672|156775869|FG001|Overall Study|Adverse Event|0|||
48706739|NCT03714672|156775870|FG002|Overall Study|Adverse Event|3|||
48706740|NCT03714672|156775871|FG003|Overall Study|Adverse Event|0|||
48799775|NCT00316173|157104250|FG000|Treatment Phase|Lost to Follow-up|0|||
48799776|NCT00316173|157104251|FG001|Treatment Phase|Lost to Follow-up|3|||
48799777|NCT00316173|157104250|FG000|Treatment Phase|Withdrawal by Subject|0|||
48799778|NCT00316173|157104251|FG001|Treatment Phase|Withdrawal by Subject|1|||
48799779|NCT00316173|157104250|FG000|Treatment Phase|Study Follow-up Stopped|0|||
48799780|NCT00316173|157104251|FG001|Treatment Phase|Study Follow-up Stopped|34|||
48799781|NCT02390531|157104252|FG000|Overall Study|Death|0|||
48706741|NCT03714672|156775868|FG000|Overall Study|Physician Decision|0|||
48706742|NCT03714672|156775869|FG001|Overall Study|Physician Decision|1|||
48706743|NCT03714672|156775870|FG002|Overall Study|Physician Decision|0|||
48706744|NCT03714672|156775871|FG003|Overall Study|Physician Decision|0|||
48799782|NCT02390531|157104253|FG001|Overall Study|Death|2|||
48799783|NCT02390531|157104254|FG002|Overall Study|Death|0|||
48799784|NCT02390531|157104255|FG003|Overall Study|Death|1|||
48799785|NCT02390531|157104256|FG004|Overall Study|Death|0|||
48799786|NCT02390531|157104257|FG005|Overall Study|Death|0|||
48799787|NCT02390531|157104258|FG006|Overall Study|Death|0|||
48799788|NCT02390531|157104259|FG007|Overall Study|Death|1|||
48799789|NCT02390531|157104252|FG000|Overall Study|Protocol Violation|0|||
48799790|NCT02390531|157104253|FG001|Overall Study|Protocol Violation|0|||
48799791|NCT02390531|157104254|FG002|Overall Study|Protocol Violation|0|||
48799792|NCT02390531|157104255|FG003|Overall Study|Protocol Violation|0|||
48799793|NCT02390531|157104256|FG004|Overall Study|Protocol Violation|1|||
48799794|NCT02390531|157104257|FG005|Overall Study|Protocol Violation|0|||
48799795|NCT02390531|157104258|FG006|Overall Study|Protocol Violation|2|||
48799796|NCT02390531|157104259|FG007|Overall Study|Protocol Violation|0|||
48799797|NCT03260868|157104260|FG000|Overall Study|Poor Compliance to Protocol|0|||
48799798|NCT03260868|157104261|FG001|Overall Study|Poor Compliance to Protocol|2|||
48799799|NCT03260868|157104260|FG000|Overall Study|Study Terminated By Sponsor|2|||
48799800|NCT03260868|157104261|FG001|Overall Study|Study Terminated By Sponsor|1|||
48799801|NCT03260868|157104260|FG000|Overall Study|Other than specified above|1|||
48799802|NCT03260868|157104261|FG001|Overall Study|Other than specified above|0|||
48799803|NCT00511875|157104262|FG000|Overall Study|Lost to Follow-up|4|||
48799804|NCT00511875|157104263|FG001|Overall Study|Lost to Follow-up|0|||
48799805|NCT00511875|157104262|FG000|Overall Study|Missing variables|1|||
48799806|NCT00511875|157104263|FG001|Overall Study|Missing variables|0|||
48799807|NCT01169675|157104264|FG000|Overall Study|Progressive disease|13|||
48799808|NCT01169675|157104265|FG001|Overall Study|Progressive disease|2|||
48799809|NCT01169675|157104266|FG002|Overall Study|Progressive disease|5|||
48799810|NCT01169675|157104267|FG003|Overall Study|Progressive disease|15|||
48799811|NCT01169675|157104268|FG004|Overall Study|Progressive disease|1|||
48799812|NCT01169675|157104264|FG000|Overall Study|Dose Limiting Toxicity (DLT)|1|||
48799813|NCT01169675|157104265|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
48799814|NCT01169675|157104266|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
48799815|NCT01169675|157104267|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
48799816|NCT01169675|157104268|FG004|Overall Study|Dose Limiting Toxicity (DLT)|2|||
48799817|NCT01169675|157104264|FG000|Overall Study|Adverse Event|5|||
48799818|NCT01169675|157104265|FG001|Overall Study|Adverse Event|1|||
48799819|NCT01169675|157104266|FG002|Overall Study|Adverse Event|2|||
48799820|NCT01169675|157104267|FG003|Overall Study|Adverse Event|0|||
48799821|NCT01169675|157104268|FG004|Overall Study|Adverse Event|0|||
48799822|NCT01169675|157104264|FG000|Overall Study|Withdrawal by Subject|1|||
48913018|NCT01987960|157517637|FG000|Period 2|Administrative or other reason|0|||
48913019|NCT01987960|157517638|FG001|Period 2|Administrative or other reason|5|||
48706745|NCT03714672|156775868|FG000|Overall Study|Other Reason|1|||
48706746|NCT03714672|156775869|FG001|Overall Study|Other Reason|2|||
48706747|NCT03714672|156775870|FG002|Overall Study|Other Reason|1|||
48706748|NCT03714672|156775871|FG003|Overall Study|Other Reason|1|||
48706749|NCT03714672|156775868|FG000|Overall Study|Lost to Follow-up|1|||
48706750|NCT03714672|156775869|FG001|Overall Study|Lost to Follow-up|1|||
48706751|NCT03714672|156775870|FG002|Overall Study|Lost to Follow-up|0|||
48799823|NCT01169675|157104265|FG001|Overall Study|Withdrawal by Subject|0|||
48799824|NCT01169675|157104266|FG002|Overall Study|Withdrawal by Subject|0|||
48799825|NCT01169675|157104267|FG003|Overall Study|Withdrawal by Subject|1|||
48799826|NCT01169675|157104268|FG004|Overall Study|Withdrawal by Subject|2|||
48799827|NCT01169675|157104264|FG000|Overall Study|Other Reason Not Defined Above|0|||
48799828|NCT01169675|157104265|FG001|Overall Study|Other Reason Not Defined Above|0|||
48799829|NCT01169675|157104266|FG002|Overall Study|Other Reason Not Defined Above|0|||
48799830|NCT01169675|157104267|FG003|Overall Study|Other Reason Not Defined Above|1|||
48799831|NCT01169675|157104268|FG004|Overall Study|Other Reason Not Defined Above|1|||
48799832|NCT00445679|157104269|FG000|Overall Study|Adverse Event|22|||
48913020|NCT01987960|157517639|FG002|Period 2|Administrative or other reason|7|||
48913021|NCT01987960|157517640|FG003|Period 2|Administrative or other reason|0|||
49118779|NCT00943397|158273208|FG000|Overall Study|Site terminated and other|12|||
49118780|NCT00943397|158273209|FG001|Overall Study|Site terminated and other|56|||
49118781|NCT00460239|158273210|FG000|Overall Study|Physician Decision|0|||
49118782|NCT00460239|158273211|FG001|Overall Study|Physician Decision|1|||
49118783|NCT00460239|158273212|FG002|Overall Study|Physician Decision|0|||
49118784|NCT00460239|158273213|FG003|Overall Study|Physician Decision|0|||
49118785|NCT00460239|158273214|FG004|Overall Study|Physician Decision|0|||
49118786|NCT00460239|158273215|FG005|Overall Study|Physician Decision|2|||
48706752|NCT03714672|156775871|FG003|Overall Study|Lost to Follow-up|0|||
49118787|NCT00460239|158273216|FG006|Overall Study|Physician Decision|0|||
48799833|NCT00445679|157104270|FG001|Overall Study|Adverse Event|12|||
48799834|NCT00445679|157104271|FG002|Overall Study|Adverse Event|30|||
48799835|NCT00445679|157104272|FG003|Overall Study|Adverse Event|19|||
48799836|NCT00445679|157104269|FG000|Overall Study|Failed to return|1|||
48706753|NCT01054885|156775872|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246|||
48799837|NCT00445679|157104270|FG001|Overall Study|Failed to return|3|||
48913022|NCT01987960|157517637|FG000|Period 3|Adverse Event|0|||
48913023|NCT01987960|157517638|FG001|Period 3|Adverse Event|0|||
48913024|NCT01987960|157517639|FG002|Period 3|Adverse Event|0|||
48913025|NCT01987960|157517640|FG003|Period 3|Adverse Event|7|||
48706754|NCT01054885|156775873|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
48706755|NCT01054885|156775874|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
48706756|NCT01054885|156775875|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
48706757|NCT01054885|156775876|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
48706758|NCT01054885|156775877|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
48706759|NCT01054885|156775878|FG006|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
48706760|NCT01054885|156775872|FG000|2-week, Single-blind Run-In Period|Physician Decision|6|||
48706761|NCT01054885|156775873|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
48706762|NCT01054885|156775874|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
48706763|NCT01054885|156775875|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
48706764|NCT01054885|156775876|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
48706765|NCT01054885|156775877|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
48706766|NCT01054885|156775878|FG006|2-week, Single-blind Run-In Period|Physician Decision|0|||
48706767|NCT01054885|156775872|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|23|||
48706768|NCT01054885|156775873|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
48706769|NCT01054885|156775874|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
48706770|NCT01054885|156775875|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
48706771|NCT01054885|156775876|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
48706772|NCT01054885|156775877|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
48706773|NCT01054885|156775878|FG006|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
48706774|NCT01054885|156775872|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
48706775|NCT01054885|156775873|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
48706776|NCT01054885|156775874|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
48706777|NCT01054885|156775875|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
48706778|NCT01054885|156775876|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
48706779|NCT01054885|156775877|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
48706780|NCT01054885|156775878|FG006|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
48706781|NCT01054885|156775872|FG000|2-week, Single-blind Run-In Period|Adverse Event|7|||
48706782|NCT01054885|156775873|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
48706783|NCT01054885|156775874|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
48706784|NCT01054885|156775875|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
48706785|NCT01054885|156775876|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
48706786|NCT01054885|156775877|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
48706787|NCT01054885|156775878|FG006|2-week, Single-blind Run-In Period|Adverse Event|0|||
48706788|NCT01054885|156775872|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|68|||
48706789|NCT01054885|156775873|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
48706790|NCT01054885|156775874|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
48706791|NCT01054885|156775875|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
48706792|NCT01054885|156775876|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
48706793|NCT01054885|156775877|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
48706794|NCT01054885|156775878|FG006|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
48706795|NCT01054885|156775872|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
48706796|NCT01054885|156775873|FG001|24-week, Double-blind Treatment Period|Adverse Event|18|||
48706797|NCT01054885|156775874|FG002|24-week, Double-blind Treatment Period|Adverse Event|12|||
48706798|NCT01054885|156775875|FG003|24-week, Double-blind Treatment Period|Adverse Event|15|||
48706799|NCT01054885|156775876|FG004|24-week, Double-blind Treatment Period|Adverse Event|15|||
48706800|NCT01054885|156775877|FG005|24-week, Double-blind Treatment Period|Adverse Event|17|||
48706801|NCT01054885|156775878|FG006|24-week, Double-blind Treatment Period|Adverse Event|19|||
48706802|NCT01054885|156775872|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
48706803|NCT01054885|156775873|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
48706804|NCT01054885|156775874|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
48706805|NCT01054885|156775875|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
48913026|NCT01987960|157517637|FG000|Period 3|Non-compliance with IMP|0|||
48913027|NCT01987960|157517638|FG001|Period 3|Non-compliance with IMP|0|||
48913028|NCT01987960|157517639|FG002|Period 3|Non-compliance with IMP|0|||
48913029|NCT01987960|157517640|FG003|Period 3|Non-compliance with IMP|1|||
48913030|NCT01987960|157517637|FG000|Period 3|Protocol Violation|0|||
48913031|NCT01987960|157517638|FG001|Period 3|Protocol Violation|0|||
48706806|NCT01054885|156775876|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
48799838|NCT00445679|157104271|FG002|Overall Study|Failed to return|2|||
48913032|NCT01987960|157517639|FG002|Period 3|Protocol Violation|0|||
49010687|NCT00095199|157875672|FG002|Overall Study|Data inadvertently lost by site|0|||
48913033|NCT01987960|157517640|FG003|Period 3|Protocol Violation|6|||
48799839|NCT00445679|157104272|FG003|Overall Study|Failed to return|2|||
48799840|NCT00445679|157104269|FG000|Overall Study|Physician Decision|0|||
48799841|NCT00445679|157104270|FG001|Overall Study|Physician Decision|0|||
48799842|NCT00445679|157104271|FG002|Overall Study|Physician Decision|1|||
48799843|NCT00445679|157104272|FG003|Overall Study|Physician Decision|0|||
48799844|NCT00445679|157104269|FG000|Overall Study|Lost to Follow-up|10|||
48799845|NCT00445679|157104270|FG001|Overall Study|Lost to Follow-up|6|||
48799846|NCT00445679|157104271|FG002|Overall Study|Lost to Follow-up|6|||
48799847|NCT00445679|157104272|FG003|Overall Study|Lost to Follow-up|5|||
48799848|NCT00445679|157104269|FG000|Overall Study|Compliance|3|||
48799849|NCT00445679|157104270|FG001|Overall Study|Compliance|2|||
48799850|NCT00445679|157104271|FG002|Overall Study|Compliance|1|||
48799851|NCT00445679|157104272|FG003|Overall Study|Compliance|2|||
48799852|NCT00445679|157104269|FG000|Overall Study|Withdrawal of Informed Consent|0|||
48799853|NCT00445679|157104270|FG001|Overall Study|Withdrawal of Informed Consent|0|||
48799854|NCT00445679|157104271|FG002|Overall Study|Withdrawal of Informed Consent|1|||
48799855|NCT00445679|157104272|FG003|Overall Study|Withdrawal of Informed Consent|0|||
48799856|NCT00445679|157104269|FG000|Overall Study|Protocol Violation|2|||
48799857|NCT00445679|157104270|FG001|Overall Study|Protocol Violation|3|||
48799858|NCT00445679|157104271|FG002|Overall Study|Protocol Violation|3|||
48799859|NCT00445679|157104272|FG003|Overall Study|Protocol Violation|1|||
48799860|NCT00445679|157104269|FG000|Overall Study|Withdrawal by Subject|8|||
48799861|NCT00445679|157104270|FG001|Overall Study|Withdrawal by Subject|14|||
48799862|NCT00445679|157104271|FG002|Overall Study|Withdrawal by Subject|20|||
48799863|NCT00445679|157104272|FG003|Overall Study|Withdrawal by Subject|18|||
48799864|NCT00445679|157104269|FG000|Overall Study|Lack of Efficacy|2|||
48799865|NCT00445679|157104270|FG001|Overall Study|Lack of Efficacy|6|||
48799866|NCT00445679|157104271|FG002|Overall Study|Lack of Efficacy|2|||
48799867|NCT00445679|157104272|FG003|Overall Study|Lack of Efficacy|0|||
48799868|NCT04102579|157104277|FG000|Overall Study|Withdrawal by Subject|3|||
48799869|NCT04102579|157104278|FG001|Overall Study|Withdrawal by Subject|4|||
48799870|NCT04102579|157104277|FG000|Overall Study|Lost to Follow-up|0|||
48799871|NCT04102579|157104278|FG001|Overall Study|Lost to Follow-up|1|||
48799872|NCT04102579|157104277|FG000|Overall Study|Discontinued Due to COVID-19-related Study Pause|3|||
48799873|NCT04102579|157104278|FG001|Overall Study|Discontinued Due to COVID-19-related Study Pause|4|||
48799874|NCT04102579|157104277|FG000|Overall Study|Other than Specified|1|||
48799875|NCT04102579|157104278|FG001|Overall Study|Other than Specified|0|||
48799876|NCT04102579|157104277|FG000|Overall Study|Not Dosed with Study Drug|0|||
48799877|NCT04102579|157104278|FG001|Overall Study|Not Dosed with Study Drug|1|||
48799878|NCT00542880|157104279|FG000|Period 1|Eligibility criteria not fulfilled|2|||
48799879|NCT00542880|157104280|FG001|Period 1|Eligibility criteria not fulfilled|6|||
48799880|NCT00542880|157104279|FG000|Period 1|Adverse Event|2|||
48799881|NCT00542880|157104280|FG001|Period 1|Adverse Event|2|||
48799882|NCT00542880|157104279|FG000|Period 1|Development of study-specific criteria|1|||
48799883|NCT00542880|157104280|FG001|Period 1|Development of study-specific criteria|2|||
48799884|NCT00542880|157104279|FG000|Period 1|Withdrawal by Subject|1|||
48799885|NCT00542880|157104280|FG001|Period 1|Withdrawal by Subject|1|||
48799886|NCT00542880|157104279|FG000|Period 1|Protocol Violation|0|||
48799887|NCT00542880|157104280|FG001|Period 1|Protocol Violation|1|||
48799888|NCT00542880|157104279|FG000|Period 2|Adverse Event|5|||
48799889|NCT00542880|157104280|FG001|Period 2|Adverse Event|7|||
48799890|NCT00542880|157104279|FG000|Period 2|Eligibility not fulfilled|0|||
48799891|NCT00542880|157104280|FG001|Period 2|Eligibility not fulfilled|1|||
48799892|NCT00542880|157104279|FG000|Period 2|Discontinuation criteria|2|||
48799893|NCT00542880|157104280|FG001|Period 2|Discontinuation criteria|0|||
48799894|NCT00542880|157104279|FG000|Period 2|Severe non-compliance|0|||
48799895|NCT00542880|157104280|FG001|Period 2|Severe non-compliance|1|||
48799896|NCT00542880|157104279|FG000|Period 2|Other|0|||
48799897|NCT00542880|157104280|FG001|Period 2|Other|1|||
48799898|NCT00542880|157104279|FG000|Period 3|Adverse Event|0|||
48799899|NCT00542880|157104280|FG001|Period 3|Adverse Event|2|||
48799900|NCT05899686|157104281|FG000|Overall Study|Protocol Violation|1|||
48799901|NCT00558064|157104282|FG000|Overall Study|Adverse Event|3|||
48799902|NCT00558064|157104283|FG001|Overall Study|Adverse Event|2|||
48799903|NCT00558064|157104282|FG000|Overall Study|Lack of Efficacy|0|||
48799904|NCT00558064|157104283|FG001|Overall Study|Lack of Efficacy|1|||
48799905|NCT00558064|157104282|FG000|Overall Study|Protocol Violation|1|||
48799906|NCT00558064|157104283|FG001|Overall Study|Protocol Violation|0|||
48799907|NCT00558064|157104282|FG000|Overall Study|Lost to Follow-up|0|||
48913034|NCT01987960|157517637|FG000|Period 3|Withdrawal by Subject|0|||
48799908|NCT00558064|157104283|FG001|Overall Study|Lost to Follow-up|1|||
48913035|NCT01987960|157517638|FG001|Period 3|Withdrawal by Subject|0|||
48799909|NCT00558064|157104282|FG000|Overall Study|Withdrawal by Subject|0|||
48799910|NCT00558064|157104283|FG001|Overall Study|Withdrawal by Subject|1|||
48799911|NCT00558064|157104282|FG000|Overall Study|No visit within allowance period|1|||
48799912|NCT00558064|157104283|FG001|Overall Study|No visit within allowance period|0|||
48799913|NCT03419364|157104284|FG000|Overall Study|Delivery due to maternal condition|2|||
48799914|NCT03419364|157104285|FG001|Overall Study|Delivery due to maternal condition|0|||
48913036|NCT01987960|157517639|FG002|Period 3|Withdrawal by Subject|0|||
48799915|NCT03419364|157104286|FG002|Overall Study|Delivery due to maternal condition|0|||
48799916|NCT01525602|157104287|FG000|Overall Study|Adverse Event|1|||
48799917|NCT01525602|157104288|FG001|Overall Study|Adverse Event|0|||
48799918|NCT01525602|157104289|FG002|Overall Study|Adverse Event|1|||
48799919|NCT01525602|157104290|FG003|Overall Study|Adverse Event|1|||
48799920|NCT01525602|157104291|FG004|Overall Study|Adverse Event|3|||
48799921|NCT01525602|157104292|FG005|Overall Study|Adverse Event|3|||
48799922|NCT01525602|157104293|FG006|Overall Study|Adverse Event|0|||
48799923|NCT01525602|157104294|FG007|Overall Study|Adverse Event|1|||
48799924|NCT01525602|157104287|FG000|Overall Study|Disease progression|6|||
48799925|NCT01525602|157104288|FG001|Overall Study|Disease progression|3|||
48799926|NCT01525602|157104289|FG002|Overall Study|Disease progression|2|||
48799927|NCT01525602|157104290|FG003|Overall Study|Disease progression|5|||
48799928|NCT01525602|157104291|FG004|Overall Study|Disease progression|22|||
48799929|NCT01525602|157104292|FG005|Overall Study|Disease progression|2|||
48799930|NCT01525602|157104293|FG006|Overall Study|Disease progression|3|||
48799931|NCT01525602|157104294|FG007|Overall Study|Disease progression|3|||
48799932|NCT01525602|157104287|FG000|Overall Study|Clinical progression|2|||
48799933|NCT01525602|157104288|FG001|Overall Study|Clinical progression|0|||
48799934|NCT01525602|157104289|FG002|Overall Study|Clinical progression|0|||
48799935|NCT01525602|157104290|FG003|Overall Study|Clinical progression|0|||
48799936|NCT01525602|157104291|FG004|Overall Study|Clinical progression|0|||
48799937|NCT01525602|157104292|FG005|Overall Study|Clinical progression|0|||
48799938|NCT01525602|157104293|FG006|Overall Study|Clinical progression|1|||
48799939|NCT01525602|157104294|FG007|Overall Study|Clinical progression|1|||
48799940|NCT01525602|157104287|FG000|Overall Study|Non-compliance|0|||
48799941|NCT01525602|157104288|FG001|Overall Study|Non-compliance|0|||
48799942|NCT01525602|157104289|FG002|Overall Study|Non-compliance|0|||
48799943|NCT01525602|157104290|FG003|Overall Study|Non-compliance|0|||
48799944|NCT01525602|157104291|FG004|Overall Study|Non-compliance|1|||
48799945|NCT01525602|157104292|FG005|Overall Study|Non-compliance|0|||
48799946|NCT01525602|157104293|FG006|Overall Study|Non-compliance|0|||
48799947|NCT01525602|157104294|FG007|Overall Study|Non-compliance|0|||
48799948|NCT01525602|157104287|FG000|Overall Study|Withdrawal by Subject|0|||
48799949|NCT01525602|157104288|FG001|Overall Study|Withdrawal by Subject|0|||
48799950|NCT01525602|157104289|FG002|Overall Study|Withdrawal by Subject|0|||
48913037|NCT01987960|157517640|FG003|Period 3|Withdrawal by Subject|9|||
48913038|NCT01987960|157517637|FG000|Period 3|Lost to Follow-up|0|||
48913039|NCT01987960|157517638|FG001|Period 3|Lost to Follow-up|0|||
48913040|NCT01987960|157517639|FG002|Period 3|Lost to Follow-up|0|||
48799951|NCT01525602|157104290|FG003|Overall Study|Withdrawal by Subject|0|||
48799952|NCT01525602|157104291|FG004|Overall Study|Withdrawal by Subject|3|||
48799953|NCT01525602|157104292|FG005|Overall Study|Withdrawal by Subject|1|||
48799954|NCT01525602|157104293|FG006|Overall Study|Withdrawal by Subject|0|||
48913041|NCT01987960|157517640|FG003|Period 3|Lost to Follow-up|5|||
48913042|NCT01987960|157517637|FG000|Period 3|Administrative or other reason|0|||
48913043|NCT01987960|157517638|FG001|Period 3|Administrative or other reason|0|||
48913044|NCT01987960|157517639|FG002|Period 3|Administrative or other reason|0|||
48913045|NCT01987960|157517640|FG003|Period 3|Administrative or other reason|43|||
48913046|NCT01131520|157517643|FG000|Overall Study|Computer problem|1|||
48913047|NCT01131520|157517644|FG001|Overall Study|Computer problem|0|||
48913048|NCT01131520|157517643|FG000|Overall Study|Counselor not available|0|||
48913049|NCT01131520|157517644|FG001|Overall Study|Counselor not available|3|||
48913050|NCT01131520|157517643|FG000|Overall Study|Subject changed history after enrollment|0|||
48913051|NCT01131520|157517644|FG001|Overall Study|Subject changed history after enrollment|1|||
48913052|NCT00932360|157517645|FG000|Washout (One Week)|Withdrawal by Subject|0|||
48913053|NCT00932360|157517646|FG001|Washout (One Week)|Withdrawal by Subject|0|||
48913054|NCT00932360|157517647|FG002|Washout (One Week)|Withdrawal by Subject|0|||
48913055|NCT00932360|157517648|FG003|Washout (One Week)|Withdrawal by Subject|0|||
48913056|NCT00932360|157517649|FG004|Washout (One Week)|Withdrawal by Subject|2|||
48913057|NCT00932360|157517650|FG005|Washout (One Week)|Withdrawal by Subject|0|||
48913058|NCT01073267|157517651|FG000|Overall Study|Disease Progression|3|||
48913059|NCT02536313|157517657|FG000|Overall Study|Lack of Efficacy|0|||
48913060|NCT02536313|157517658|FG001|Overall Study|Lack of Efficacy|1|||
48913061|NCT01977820|157517660|FG000|Overall Study|Sponsor terminated the study|1|||
48913062|NCT01977820|157517661|FG001|Overall Study|Sponsor terminated the study|1|||
48913063|NCT01045798|157517664|FG000|Overall Study|Changed to Open-Label Caspofungin|1|||
48913064|NCT01045798|157517665|FG001|Overall Study|Changed to Open-Label Caspofungin|0|||
48799955|NCT01525602|157104294|FG007|Overall Study|Withdrawal by Subject|1|||
48799956|NCT01525602|157104287|FG000|Overall Study|Physician Decision|0|||
48799957|NCT01525602|157104288|FG001|Overall Study|Physician Decision|0|||
49118788|NCT00460239|158273217|FG007|Overall Study|Physician Decision|0|||
48799958|NCT01525602|157104289|FG002|Overall Study|Physician Decision|0|||
48799959|NCT01525602|157104290|FG003|Overall Study|Physician Decision|0|||
48799960|NCT01525602|157104291|FG004|Overall Study|Physician Decision|3|||
48799961|NCT01525602|157104292|FG005|Overall Study|Physician Decision|0|||
48799962|NCT01525602|157104293|FG006|Overall Study|Physician Decision|1|||
48799963|NCT01525602|157104294|FG007|Overall Study|Physician Decision|0|||
48799964|NCT01525602|157104287|FG000|Overall Study|Death|0|||
48799965|NCT01525602|157104288|FG001|Overall Study|Death|0|||
48799966|NCT01525602|157104289|FG002|Overall Study|Death|0|||
48799967|NCT01525602|157104290|FG003|Overall Study|Death|0|||
48799968|NCT01525602|157104291|FG004|Overall Study|Death|1|||
48799969|NCT01525602|157104292|FG005|Overall Study|Death|1|||
48799970|NCT01525602|157104293|FG006|Overall Study|Death|0|||
48799971|NCT01525602|157104294|FG007|Overall Study|Death|0|||
48799972|NCT01525602|157104287|FG000|Overall Study|Unqualified based on biopsy; not dosed|0|||
48799973|NCT01525602|157104288|FG001|Overall Study|Unqualified based on biopsy; not dosed|0|||
48799974|NCT01525602|157104289|FG002|Overall Study|Unqualified based on biopsy; not dosed|0|||
48799975|NCT01525602|157104290|FG003|Overall Study|Unqualified based on biopsy; not dosed|0|||
48799976|NCT01525602|157104291|FG004|Overall Study|Unqualified based on biopsy; not dosed|0|||
48799977|NCT01525602|157104292|FG005|Overall Study|Unqualified based on biopsy; not dosed|0|||
48799978|NCT01525602|157104293|FG006|Overall Study|Unqualified based on biopsy; not dosed|1|||
48799979|NCT01525602|157104294|FG007|Overall Study|Unqualified based on biopsy; not dosed|1|||
48799980|NCT02543658|157106277|FG000|Overall Study|Lack of Efficacy|0|||
48799981|NCT02543658|157106278|FG001|Overall Study|Lack of Efficacy|4|||
48799982|NCT00593567|157106279|FG000|Overall Study|Adverse Event|2|||
48799983|NCT00593567|157106280|FG001|Overall Study|Adverse Event|0|||
48799984|NCT00593567|157106279|FG000|Overall Study|Physician Decision|2|||
48799985|NCT00593567|157106280|FG001|Overall Study|Physician Decision|0|||
48799986|NCT00593567|157106279|FG000|Overall Study|Protocol Violation|13|||
48799987|NCT00593567|157106280|FG001|Overall Study|Protocol Violation|7|||
48799988|NCT00593567|157106279|FG000|Overall Study|Lack of Efficacy|2|||
48799989|NCT00593567|157106280|FG001|Overall Study|Lack of Efficacy|1|||
48799990|NCT00593567|157106279|FG000|Overall Study|Withdrawal by Subject|1|||
48799991|NCT00593567|157106280|FG001|Overall Study|Withdrawal by Subject|2|||
48799992|NCT00789815|157106281|FG000|Overall Study|Protocol Violation|6|||
48799993|NCT00789815|157106282|FG001|Overall Study|Protocol Violation|1|||
48799994|NCT00789815|157106281|FG000|Overall Study|Intubation due to massive bleeding|1|||
48799995|NCT00789815|157106282|FG001|Overall Study|Intubation due to massive bleeding|0|||
48799996|NCT03576768|157106284|FG000|Overall Study|Lost to Follow-up|3|||
48913065|NCT01045798|157517664|FG000|Overall Study|Invasive Fungal Infection at Baseline|0|||
48913066|NCT01045798|157517665|FG001|Overall Study|Invasive Fungal Infection at Baseline|1|||
48913067|NCT01045798|157517664|FG000|Overall Study|Changed to Other Antifungal Therapy|1|||
48913068|NCT01045798|157517665|FG001|Overall Study|Changed to Other Antifungal Therapy|2|||
48913069|NCT01045798|157517664|FG000|Overall Study|Received Systemic Antifungal Prestudy|0|||
48913070|NCT01045798|157517665|FG001|Overall Study|Received Systemic Antifungal Prestudy|1|||
48913071|NCT03021499|157517668|FG000|Overall Study|Adverse Event|1|||
48799997|NCT03576768|157106285|FG001|Overall Study|Lost to Follow-up|3|||
48913072|NCT03021499|157517669|FG001|Overall Study|Adverse Event|0|||
48913073|NCT03021499|157517668|FG000|Overall Study|Death|1|||
48913074|NCT03021499|157517669|FG001|Overall Study|Death|5|||
48913075|NCT03021499|157517668|FG000|Overall Study|Lack of Efficacy|0|||
48913076|NCT03021499|157517669|FG001|Overall Study|Lack of Efficacy|1|||
48913077|NCT03021499|157517668|FG000|Overall Study|Lost to Follow-up|1|||
48913078|NCT03021499|157517669|FG001|Overall Study|Lost to Follow-up|3|||
48913079|NCT03021499|157517668|FG000|Overall Study|Physician Decision|2|||
48913080|NCT03021499|157517669|FG001|Overall Study|Physician Decision|3|||
48913081|NCT03021499|157517668|FG000|Overall Study|Pregnancy|1|||
48913082|NCT03021499|157517669|FG001|Overall Study|Pregnancy|0|||
48913083|NCT03021499|157517668|FG000|Overall Study|Withdrawal by Subject|7|||
48913084|NCT03021499|157517669|FG001|Overall Study|Withdrawal by Subject|14|||
48913085|NCT03021499|157517668|FG000|Overall Study|Prohibited medication required|1|||
48913086|NCT03021499|157517669|FG001|Overall Study|Prohibited medication required|0|||
48913087|NCT03021499|157517668|FG000|Overall Study|Protocol non-compliance|1|||
48799998|NCT03576768|157106286|FG002|Overall Study|Lost to Follow-up|0|||
48799999|NCT03576768|157106287|FG003|Overall Study|Lost to Follow-up|0|||
48800000|NCT00590902|157106288|FG000|Overall Study|Death|1|||
48800001|NCT00785291|157106289|FG000|Overall Study|Never began treatment|8|||
48800002|NCT00785291|157106290|FG001|Overall Study|Never began treatment|4|||
48800003|NCT00785291|157106291|FG002|Overall Study|Never began treatment|4|||
48800004|NCT00785291|157106289|FG000|Overall Study|Adverse Event|39|||
48800005|NCT00785291|157106290|FG001|Overall Study|Adverse Event|70|||
48913088|NCT03021499|157517669|FG001|Overall Study|Protocol non-compliance|1|||
48913089|NCT03021499|157517668|FG000|Overall Study|None of the above|0|||
48800006|NCT00785291|157106291|FG002|Overall Study|Adverse Event|56|||
48800007|NCT00785291|157106289|FG000|Overall Study|Death|7|||
48800008|NCT00785291|157106290|FG001|Overall Study|Death|4|||
48800009|NCT00785291|157106291|FG002|Overall Study|Death|3|||
48800010|NCT00785291|157106289|FG000|Overall Study|Withdrawal by Subject|35|||
48913090|NCT03021499|157517669|FG001|Overall Study|None of the above|4|||
48800011|NCT00785291|157106290|FG001|Overall Study|Withdrawal by Subject|36|||
48800012|NCT00785291|157106291|FG002|Overall Study|Withdrawal by Subject|17|||
48800013|NCT00785291|157106289|FG000|Overall Study|Alternative Therapy|12|||
48800014|NCT00785291|157106290|FG001|Overall Study|Alternative Therapy|6|||
48800015|NCT00785291|157106291|FG002|Overall Study|Alternative Therapy|7|||
48800016|NCT00785291|157106289|FG000|Overall Study|Complicating illness|6|||
48800017|NCT00785291|157106290|FG001|Overall Study|Complicating illness|4|||
48913091|NCT03021499|157517668|FG000|Overall Study|Adverse Event (AE) Prior to First Dose|1|||
48913092|NCT03021499|157517669|FG001|Overall Study|Adverse Event (AE) Prior to First Dose|0|||
48800018|NCT00785291|157106291|FG002|Overall Study|Complicating illness|4|||
48800019|NCT00785291|157106289|FG000|Overall Study|Other Medical Reasons|29|||
48800020|NCT00785291|157106290|FG001|Overall Study|Other Medical Reasons|25|||
48800021|NCT00785291|157106291|FG002|Overall Study|Other Medical Reasons|15|||
48800022|NCT01111123|157106292|FG000|Open- Label Phase|Failed to be clear or almost cleared|14|||
48913093|NCT04857996|157517672|FG000|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|4|||
48913094|NCT04857996|157517673|FG001|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|5|||
48706807|NCT01054885|156775877|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
48706808|NCT01054885|156775878|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
48706809|NCT01054885|156775872|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
48706810|NCT01054885|156775873|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
48706811|NCT01054885|156775874|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2|||
48706812|NCT01054885|156775875|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5|||
48706813|NCT01054885|156775876|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11|||
48706814|NCT01054885|156775877|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
48706815|NCT01054885|156775878|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
48706816|NCT01054885|156775872|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
48706817|NCT01054885|156775873|FG001|24-week, Double-blind Treatment Period|Protocol Violation|7|||
48706818|NCT01054885|156775874|FG002|24-week, Double-blind Treatment Period|Protocol Violation|7|||
48706819|NCT01054885|156775875|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
48706820|NCT01054885|156775876|FG004|24-week, Double-blind Treatment Period|Protocol Violation|3|||
48706821|NCT01054885|156775877|FG005|24-week, Double-blind Treatment Period|Protocol Violation|8|||
48706822|NCT01054885|156775878|FG006|24-week, Double-blind Treatment Period|Protocol Violation|4|||
48706823|NCT01054885|156775872|FG000|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0|||
48913095|NCT04857996|157517672|FG000|Overall Study|Lost to Follow-up|1|||
48913096|NCT04857996|157517673|FG001|Overall Study|Lost to Follow-up|3|||
48913097|NCT04857996|157517672|FG000|Overall Study|Site Closure|1|||
48913098|NCT04857996|157517673|FG001|Overall Study|Site Closure|0|||
48913099|NCT04857996|157517672|FG000|Overall Study|Withdrawal by Subject|1|||
48913100|NCT04857996|157517673|FG001|Overall Study|Withdrawal by Subject|0|||
48913101|NCT03996876|157517674|FG000|Overall Study|Incomplete Data|2|||
48913102|NCT03996876|157517675|FG001|Overall Study|Incomplete Data|4|||
48913103|NCT00729378|157519055|FG000|Baseline|Did not complete study measurements|72|||
48913104|NCT00729378|157519056|FG001|Baseline|Did not complete study measurements|33|||
48913105|NCT00729378|157519055|FG000|Baseline|Withdrawal by Subject|66|||
48913106|NCT00729378|157519056|FG001|Baseline|Withdrawal by Subject|59|||
48913107|NCT00729378|157519055|FG000|12-months|Lost to Follow-up|100|||
48913108|NCT00729378|157519056|FG001|12-months|Lost to Follow-up|65|||
48913109|NCT00729378|157519055|FG000|24-months|Lost to Follow-up|72|||
48913110|NCT00729378|157519056|FG001|24-months|Lost to Follow-up|51|||
48913111|NCT00729378|157519055|FG000|36-months|Lost to Follow-up|15|||
48913112|NCT00729378|157519056|FG001|36-months|Lost to Follow-up|6|||
48913113|NCT00395863|157519060|FG000|Overall Study|Patients did not complete both exams|2|||
48913114|NCT00395863|157519061|FG001|Overall Study|Patients did not complete both exams|3|||
48913115|NCT00382720|157519066|FG000|Overall Study|Adverse Event|21|||
48913116|NCT00382720|157519067|FG001|Overall Study|Adverse Event|23|||
48913117|NCT00382720|157519068|FG002|Overall Study|Adverse Event|15|||
48913118|NCT00382720|157519066|FG000|Overall Study|Protocol Violation|2|||
48913119|NCT00382720|157519067|FG001|Overall Study|Protocol Violation|5|||
48913120|NCT00382720|157519068|FG002|Overall Study|Protocol Violation|1|||
48913121|NCT00382720|157519066|FG000|Overall Study|Death|0|||
48913122|NCT00382720|157519067|FG001|Overall Study|Death|1|||
48706824|NCT01054885|156775873|FG001|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
48706825|NCT01054885|156775874|FG002|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
48800023|NCT01111123|157106293|FG001|Open- Label Phase|Failed to be clear or almost cleared|0|||
48800024|NCT01111123|157106292|FG000|Maintenance Phase|Lost to Follow-up|0|||
48913123|NCT00382720|157519068|FG002|Overall Study|Death|2|||
48913124|NCT00382720|157519066|FG000|Overall Study|Progressive disease|37|||
48913125|NCT00382720|157519067|FG001|Overall Study|Progressive disease|28|||
48913126|NCT00382720|157519068|FG002|Overall Study|Progressive disease|38|||
48913127|NCT00382720|157519066|FG000|Overall Study|Withdrew consent|1|||
48913128|NCT00382720|157519067|FG001|Overall Study|Withdrew consent|1|||
48913129|NCT00382720|157519068|FG002|Overall Study|Withdrew consent|2|||
48800025|NCT01111123|157106293|FG001|Maintenance Phase|Lost to Follow-up|2|||
48800026|NCT00119405|157106294|FG000|Overall Study|Withdrawal by Subject|1|||
48800027|NCT00570674|157106295|FG000|Overall Study|Withdrawal by Subject|0|||
48800028|NCT00570674|157106296|FG001|Overall Study|Withdrawal by Subject|0|||
48800029|NCT00570674|157106297|FG002|Overall Study|Withdrawal by Subject|1|||
48800030|NCT00570674|157106298|FG003|Overall Study|Withdrawal by Subject|0|||
48800031|NCT00570674|157106299|FG004|Overall Study|Withdrawal by Subject|0|||
48800032|NCT00570674|157106300|FG005|Overall Study|Withdrawal by Subject|0|||
48800033|NCT00570674|157106301|FG006|Overall Study|Withdrawal by Subject|0|||
48800034|NCT01735201|157106303|FG000|Overall Study|Adverse Event|1|||
48800035|NCT01735201|157106304|FG001|Overall Study|Adverse Event|1|||
48800036|NCT01735201|157106305|FG002|Overall Study|Adverse Event|0|||
48800037|NCT01735201|157106306|FG003|Overall Study|Adverse Event|1|||
48800038|NCT01735201|157106307|FG004|Overall Study|Adverse Event|1|||
48800039|NCT01735201|157106308|FG005|Overall Study|Adverse Event|3|||
48800040|NCT01735201|157106309|FG006|Overall Study|Adverse Event|2|||
48800041|NCT01735201|157106310|FG007|Overall Study|Adverse Event|1|||
48800042|NCT01735201|157106303|FG000|Overall Study|Personal Reasons|1|||
48800043|NCT01735201|157106304|FG001|Overall Study|Personal Reasons|0|||
48800044|NCT01735201|157106305|FG002|Overall Study|Personal Reasons|0|||
48800045|NCT01735201|157106306|FG003|Overall Study|Personal Reasons|0|||
48800046|NCT01735201|157106307|FG004|Overall Study|Personal Reasons|0|||
48800047|NCT01735201|157106308|FG005|Overall Study|Personal Reasons|0|||
48800048|NCT01735201|157106309|FG006|Overall Study|Personal Reasons|0|||
48800049|NCT01735201|157106310|FG007|Overall Study|Personal Reasons|0|||
48800050|NCT01735201|157106303|FG000|Overall Study|Protocol Violation|1|||
48800051|NCT01735201|157106304|FG001|Overall Study|Protocol Violation|0|||
48800052|NCT01735201|157106305|FG002|Overall Study|Protocol Violation|0|||
48800053|NCT01735201|157106306|FG003|Overall Study|Protocol Violation|0|||
48800054|NCT01735201|157106307|FG004|Overall Study|Protocol Violation|0|||
48800055|NCT01735201|157106308|FG005|Overall Study|Protocol Violation|0|||
48800056|NCT01735201|157106309|FG006|Overall Study|Protocol Violation|0|||
48800057|NCT01735201|157106310|FG007|Overall Study|Protocol Violation|0|||
48800058|NCT01735201|157106303|FG000|Overall Study|Other Miscellaneous Reasons|0|||
48800059|NCT01735201|157106304|FG001|Overall Study|Other Miscellaneous Reasons|0|||
48800060|NCT01735201|157106305|FG002|Overall Study|Other Miscellaneous Reasons|0|||
48800061|NCT01735201|157106306|FG003|Overall Study|Other Miscellaneous Reasons|1|||
48800062|NCT01735201|157106307|FG004|Overall Study|Other Miscellaneous Reasons|0|||
48913130|NCT00382720|157519066|FG000|Overall Study|Withdrawal by Subject|11|||
48913131|NCT00382720|157519067|FG001|Overall Study|Withdrawal by Subject|20|||
48913132|NCT00382720|157519068|FG002|Overall Study|Withdrawal by Subject|12|||
48913133|NCT00382720|157519066|FG000|Overall Study|Surgery|1|||
48913134|NCT00382720|157519067|FG001|Overall Study|Surgery|1|||
48913135|NCT00382720|157519068|FG002|Overall Study|Surgery|4|||
48913136|NCT00382720|157519066|FG000|Overall Study|Patient did not receive study medication|1|||
48913137|NCT00382720|157519067|FG001|Overall Study|Patient did not receive study medication|1|||
48913138|NCT00382720|157519068|FG002|Overall Study|Patient did not receive study medication|4|||
48913139|NCT00382720|157519066|FG000|Overall Study|Clinically progressive disease|0|||
48913140|NCT00382720|157519067|FG001|Overall Study|Clinically progressive disease|1|||
48913141|NCT00382720|157519068|FG002|Overall Study|Clinically progressive disease|0|||
48913142|NCT00382720|157519066|FG000|Overall Study|Good prognosis|0|||
48913143|NCT00382720|157519067|FG001|Overall Study|Good prognosis|1|||
48913144|NCT00382720|157519068|FG002|Overall Study|Good prognosis|0|||
48913145|NCT00382720|157519066|FG000|Overall Study|Investigator/Clinical decision|5|||
48913146|NCT00382720|157519067|FG001|Overall Study|Investigator/Clinical decision|6|||
48913147|NCT00382720|157519068|FG002|Overall Study|Investigator/Clinical decision|6|||
48913148|NCT00382720|157519066|FG000|Overall Study|Discontinued at end of study|0|||
48913149|NCT00382720|157519067|FG001|Overall Study|Discontinued at end of study|1|||
48913150|NCT00382720|157519068|FG002|Overall Study|Discontinued at end of study|2|||
48913151|NCT00682448|157519069|FG000|Overall Study|Adverse Event|1|||
48913152|NCT00682448|157519070|FG001|Overall Study|Adverse Event|2|||
48800063|NCT01735201|157106308|FG005|Overall Study|Other Miscellaneous Reasons|2|||
48800064|NCT01735201|157106309|FG006|Overall Study|Other Miscellaneous Reasons|1|||
48913153|NCT00682448|157519069|FG000|Overall Study|Lack of Efficacy|1|||
48800065|NCT01735201|157106310|FG007|Overall Study|Other Miscellaneous Reasons|1|||
48913154|NCT00682448|157519070|FG001|Overall Study|Lack of Efficacy|0|||
48800066|NCT00289887|157106311|FG000|Overall Study|Adverse Event|3|||
48800067|NCT00289887|157106312|FG001|Overall Study|Adverse Event|3|||
48800068|NCT00289887|157106311|FG000|Overall Study|Lack of Efficacy|3|||
48800069|NCT00289887|157106312|FG001|Overall Study|Lack of Efficacy|11|||
48800070|NCT00289887|157106311|FG000|Overall Study|Lost to Follow-up|3|||
48913155|NCT00682448|157519069|FG000|Overall Study|Lost to Follow-up|1|||
48800071|NCT00289887|157106312|FG001|Overall Study|Lost to Follow-up|3|||
48800072|NCT00289887|157106311|FG000|Overall Study|Protocol Violation|3|||
48800073|NCT00289887|157106312|FG001|Overall Study|Protocol Violation|1|||
48800074|NCT00289887|157106311|FG000|Overall Study|Withdrawal by Subject|3|||
48913156|NCT00682448|157519070|FG001|Overall Study|Lost to Follow-up|3|||
48913157|NCT00682448|157519069|FG000|Overall Study|Pregnancy|0|||
48913158|NCT00682448|157519070|FG001|Overall Study|Pregnancy|1|||
48913159|NCT00682448|157519069|FG000|Overall Study|Withdrawal by Subject|2|||
48913160|NCT00682448|157519070|FG001|Overall Study|Withdrawal by Subject|0|||
48913161|NCT02737852|157519077|FG000|Overall Study|Withdrawal by Subject|2|||
48913162|NCT03511053|157519080|FG000|Overall Study|Withdrawal by Subject|1|||
48913163|NCT01876251|157519081|FG000|Overall Study|Clinical progression|1|||
48913164|NCT01876251|157519082|FG001|Overall Study|Clinical progression|0|||
48913165|NCT01876251|157519083|FG002|Overall Study|Clinical progression|0|||
48913166|NCT01876251|157519081|FG000|Overall Study|Death|2|||
48913167|NCT01876251|157519082|FG001|Overall Study|Death|0|||
48913168|NCT01876251|157519083|FG002|Overall Study|Death|1|||
48913169|NCT01876251|157519081|FG000|Overall Study|Participant started new treatment|1|||
48913170|NCT01876251|157519082|FG001|Overall Study|Participant started new treatment|0|||
48913171|NCT01876251|157519083|FG002|Overall Study|Participant started new treatment|1|||
48913172|NCT01876251|157519081|FG000|Overall Study|Participant refused further follow-up|0|||
48913173|NCT01876251|157519082|FG001|Overall Study|Participant refused further follow-up|0|||
48913174|NCT01876251|157519083|FG002|Overall Study|Participant refused further follow-up|1|||
48913175|NCT01876251|157519081|FG000|Overall Study|Study terminated|1|||
48913176|NCT01876251|157519082|FG001|Overall Study|Study terminated|0|||
48913177|NCT01876251|157519083|FG002|Overall Study|Study terminated|0|||
48913178|NCT01876251|157519081|FG000|Overall Study|Objective progression or relapse|10|||
48913179|NCT01876251|157519082|FG001|Overall Study|Objective progression or relapse|3|||
48913180|NCT01876251|157519083|FG002|Overall Study|Objective progression or relapse|8|||
48913181|NCT05162027|157519084|FG000|Overall Study|Adverse Event|1|||
48913182|NCT05162027|157519085|FG001|Overall Study|Adverse Event|0|||
48913183|NCT03335163|157519086|FG000|Overall Study|Not eligible due to laboratory criteria|3|||
48913184|NCT03335163|157519086|FG000|Overall Study|Withdrawal by Subject|18|||
48913185|NCT02230254|157519087|FG000|Overall Study|Lost to Follow-up|3|||
48913186|NCT00516048|157519091|FG000|Overall Study|Death|0|||
48913187|NCT00516048|157519092|FG001|Overall Study|Death|0|||
48913188|NCT00516048|157519093|FG002|Overall Study|Death|1|||
48913189|NCT00516048|157519091|FG000|Overall Study|Subject Decision|0|||
48913190|NCT00516048|157519092|FG001|Overall Study|Subject Decision|2|||
48913191|NCT00516048|157519093|FG002|Overall Study|Subject Decision|0|||
48913192|NCT02163187|157519096|FG000|Overall Study|Device removed|1|||
48913193|NCT02163187|157519097|FG001|Overall Study|Device removed|0|||
48913194|NCT02163187|157519096|FG000|Overall Study|Progressive disease|1|||
48913195|NCT02163187|157519097|FG001|Overall Study|Progressive disease|0|||
48913196|NCT02716675|157519105|FG000|Overall Study|Death|2|||
48913197|NCT02716675|157519106|FG001|Overall Study|Death|3|||
48913198|NCT02716675|157519107|FG002|Overall Study|Death|0|||
48913199|NCT02716675|157519105|FG000|Overall Study|Physician Decision|2|||
48913200|NCT02716675|157519106|FG001|Overall Study|Physician Decision|1|||
48913201|NCT02716675|157519107|FG002|Overall Study|Physician Decision|1|||
48913202|NCT02716675|157519105|FG000|Overall Study|Lost to Follow-up|100|||
48913203|NCT02716675|157519106|FG001|Overall Study|Lost to Follow-up|87|||
48913204|NCT02716675|157519107|FG002|Overall Study|Lost to Follow-up|99|||
48913205|NCT02716675|157519105|FG000|Overall Study|Withdrawal by Subject|22|||
48913206|NCT02716675|157519106|FG001|Overall Study|Withdrawal by Subject|25|||
48913207|NCT02716675|157519107|FG002|Overall Study|Withdrawal by Subject|20|||
48913208|NCT02716675|157519105|FG000|Overall Study|Protocol Violation|0|||
48913209|NCT02716675|157519106|FG001|Overall Study|Protocol Violation|3|||
48913210|NCT02716675|157519107|FG002|Overall Study|Protocol Violation|1|||
48913211|NCT02716675|157519105|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|36|||
48913212|NCT02716675|157519106|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|31|||
48913213|NCT02716675|157519107|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|42|||
48913214|NCT02716675|157519105|FG000|Overall Study|Other|38|||
48913215|NCT02716675|157519106|FG001|Overall Study|Other|47|||
48913216|NCT02716675|157519107|FG002|Overall Study|Other|48|||
48913217|NCT02865018|157519108|FG000|Overall Study|Withdrawal by Subject|1|||
48913218|NCT01360554|157519115|FG000|Overall Study|Death|359|||
48913219|NCT01360554|157519116|FG001|Overall Study|Death|371|||
48913220|NCT01360554|157519115|FG000|Overall Study|Lost to Follow-up|4|||
48913221|NCT01360554|157519116|FG001|Overall Study|Lost to Follow-up|4|||
48913222|NCT01360554|157519115|FG000|Overall Study|Withdrawal by Subject|23|||
48913223|NCT01360554|157519116|FG001|Overall Study|Withdrawal by Subject|24|||
48706826|NCT01054885|156775875|FG003|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
48706827|NCT01054885|156775876|FG004|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
48706828|NCT01054885|156775877|FG005|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15|||
48913224|NCT01360554|157519115|FG000|Overall Study|Study terminated by sponsor|49|||
48913225|NCT01360554|157519116|FG001|Overall Study|Study terminated by sponsor|37|||
48913226|NCT01360554|157519115|FG000|Overall Study|Other, not specified|1|||
48913227|NCT01360554|157519116|FG001|Overall Study|Other, not specified|0|||
48913228|NCT01360554|157519115|FG000|Overall Study|Randomized but not treated.|3|||
48913229|NCT01360554|157519116|FG001|Overall Study|Randomized but not treated.|3|||
48913230|NCT00187096|157519117|FG000|Overall Study|unacceptable toxicity|0|||
48913231|NCT00187096|157519118|FG001|Overall Study|unacceptable toxicity|0|||
48913232|NCT00187096|157519119|FG002|Overall Study|unacceptable toxicity|1|||
48706829|NCT01054885|156775878|FG006|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
48800075|NCT00289887|157106312|FG001|Overall Study|Withdrawal by Subject|8|||
48800076|NCT00289887|157106311|FG000|Overall Study|Other|7|||
48800077|NCT00289887|157106312|FG001|Overall Study|Other|3|||
48800078|NCT04517864|157106318|FG000|Placebo-Controlled Phase|Adverse Event|1|||
48800079|NCT04517864|157106319|FG001|Placebo-Controlled Phase|Adverse Event|0|||
48800080|NCT04517864|157106318|FG000|Placebo-Controlled Phase|Lost to Follow-up|1|||
48800081|NCT04517864|157106319|FG001|Placebo-Controlled Phase|Lost to Follow-up|1|||
48800082|NCT04517864|157106318|FG000|Placebo-Controlled Phase|Protocol Violation|1|||
48800083|NCT04517864|157106319|FG001|Placebo-Controlled Phase|Protocol Violation|0|||
48800084|NCT04517864|157106318|FG000|Placebo-Controlled Phase|Withdrawal by Subject|1|||
48800085|NCT04517864|157106319|FG001|Placebo-Controlled Phase|Withdrawal by Subject|1|||
48800086|NCT04517864|157106318|FG000|Active Therapy Extension Phase|Adverse Event|1|||
48800087|NCT04517864|157106319|FG001|Active Therapy Extension Phase|Adverse Event|0|||
48800088|NCT04517864|157106318|FG000|Active Therapy Extension Phase|Lack of Efficacy|1|||
48800089|NCT04517864|157106319|FG001|Active Therapy Extension Phase|Lack of Efficacy|0|||
48800090|NCT04517864|157106318|FG000|Active Therapy Extension Phase|Lost to Follow-up|0|||
48800091|NCT04517864|157106319|FG001|Active Therapy Extension Phase|Lost to Follow-up|1|||
48800092|NCT04517864|157106318|FG000|Active Therapy Extension Phase|Physician Decision|1|||
48800093|NCT04517864|157106319|FG001|Active Therapy Extension Phase|Physician Decision|0|||
48800094|NCT04517864|157106318|FG000|Active Therapy Extension Phase|Withdrawal by Subject|8|||
48800095|NCT04517864|157106319|FG001|Active Therapy Extension Phase|Withdrawal by Subject|8|||
48800096|NCT04517864|157106318|FG000|Active Therapy Extension Phase|44 participants in this row remained ongoing in the Active Therapy Extension Phase|20|||
48800097|NCT04517864|157106319|FG001|Active Therapy Extension Phase|44 participants in this row remained ongoing in the Active Therapy Extension Phase|24|||
48800098|NCT00512148|157106320|FG000|Primay Study Period|Withdrawal by Subject|1|||
48800099|NCT03315143|157106325|FG000|Overall Study|Death|240|||
48800100|NCT03315143|157106326|FG001|Overall Study|Death|246|||
48800101|NCT03315143|157106325|FG000|Overall Study|Withdrawal by Subject|57|||
48800102|NCT03315143|157106326|FG001|Overall Study|Withdrawal by Subject|68|||
48800103|NCT03315143|157106325|FG000|Overall Study|Site Terminated by Sponsor|256|||
48800104|NCT03315143|157106326|FG001|Overall Study|Site Terminated by Sponsor|282|||
48800105|NCT03315143|157106325|FG000|Overall Study|Study Terminated by Sponsor|4723|||
48800106|NCT03315143|157106326|FG001|Overall Study|Study Terminated by Sponsor|4664|||
48800107|NCT03315143|157106325|FG000|Overall Study|Reason not Specified|16|||
48800108|NCT03315143|157106326|FG001|Overall Study|Reason not Specified|32|||
48800109|NCT00526630|157106331|FG000|First Intervention Period - 12 Weeks|Withdrawn|0|||
48800110|NCT00526630|157106332|FG001|First Intervention Period - 12 Weeks|Withdrawn|3|||
48800111|NCT00526630|157106331|FG000|Second Intervention Period - 12 Weeks|Withdrawn|2|||
48800112|NCT00526630|157106332|FG001|Second Intervention Period - 12 Weeks|Withdrawn|1|||
48800113|NCT02606279|157106335|FG000|Overall Study|Lost to Follow-up|0|||
48913233|NCT01205230|157519126|FG000|Overall Study|Adverse Event|4|||
48706830|NCT01054885|156775872|FG000|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
48706831|NCT01054885|156775873|FG001|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
48706832|NCT01054885|156775874|FG002|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
48706833|NCT01054885|156775875|FG003|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
48706834|NCT01054885|156775876|FG004|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
48706835|NCT01054885|156775877|FG005|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
48706836|NCT01054885|156775878|FG006|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
48706837|NCT01054885|156775872|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
48706838|NCT01054885|156775873|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
48706839|NCT01054885|156775874|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
48706840|NCT01054885|156775875|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
48706841|NCT01054885|156775876|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
48706842|NCT01054885|156775877|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
48706843|NCT01054885|156775878|FG006|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
48706844|NCT01054885|156775872|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
48706845|NCT01054885|156775873|FG001|24-week, Double-blind Treatment Period|Physician Decision|4|||
48706846|NCT01054885|156775874|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
48706847|NCT01054885|156775875|FG003|24-week, Double-blind Treatment Period|Physician Decision|6|||
48706848|NCT01054885|156775876|FG004|24-week, Double-blind Treatment Period|Physician Decision|3|||
48800114|NCT02606279|157106336|FG001|Overall Study|Lost to Follow-up|1|||
48800115|NCT00335452|157106337|FG000|Overall Study|Death|156|||
48800116|NCT00335452|157106338|FG001|Overall Study|Death|144|||
48800117|NCT00335452|157106339|FG002|Overall Study|Death|158|||
48913234|NCT01205230|157519127|FG001|Overall Study|Adverse Event|0|||
48913235|NCT01205230|157519126|FG000|Overall Study|Physician Decision|1|||
48706849|NCT01054885|156775877|FG005|24-week, Double-blind Treatment Period|Physician Decision|1|||
48800118|NCT00335452|157106340|FG003|Overall Study|Death|129|||
48800119|NCT00335452|157106337|FG000|Overall Study|Lost to Follow-up|2|||
48800120|NCT00335452|157106338|FG001|Overall Study|Lost to Follow-up|3|||
48800121|NCT00335452|157106339|FG002|Overall Study|Lost to Follow-up|1|||
48800122|NCT00335452|157106340|FG003|Overall Study|Lost to Follow-up|2|||
48800123|NCT01843192|157106345|FG000|Overall Study|Intra-operative exclusions per protocol|2|||
48800124|NCT01843192|157106346|FG001|Overall Study|Intra-operative exclusions per protocol|6|||
48800125|NCT01843192|157106347|FG002|Overall Study|Intra-operative exclusions per protocol|2|||
48800126|NCT02052310|157106350|FG000|Overall Study|Death|64|||
48800127|NCT02052310|157106351|FG001|Overall Study|Death|54|||
48800128|NCT02052310|157106350|FG000|Overall Study|Withdrawal by Subject|37|||
48800129|NCT02052310|157106351|FG001|Overall Study|Withdrawal by Subject|49|||
48800130|NCT02052310|157106350|FG000|Overall Study|Other than specified|32|||
48800131|NCT02052310|157106351|FG001|Overall Study|Other than specified|29|||
48800132|NCT02052310|157106350|FG000|Overall Study|Adverse Event|29|||
48800133|NCT02052310|157106351|FG001|Overall Study|Adverse Event|22|||
48800134|NCT02052310|157106350|FG000|Overall Study|Kidney Transplant|23|||
48800135|NCT02052310|157106351|FG001|Overall Study|Kidney Transplant|29|||
48800136|NCT02052310|157106350|FG000|Overall Study|Physician Decision|14|||
48800137|NCT02052310|157106351|FG001|Overall Study|Physician Decision|7|||
48800138|NCT02052310|157106350|FG000|Overall Study|Lack of Efficacy|6|||
48800139|NCT02052310|157106351|FG001|Overall Study|Lack of Efficacy|1|||
48800140|NCT02052310|157106350|FG000|Overall Study|Site Terminated by Sponsor|5|||
48800141|NCT02052310|157106351|FG001|Overall Study|Site Terminated by Sponsor|13|||
48800142|NCT02052310|157106350|FG000|Overall Study|Lost to Follow-up|4|||
48800143|NCT02052310|157106351|FG001|Overall Study|Lost to Follow-up|2|||
48800144|NCT02052310|157106350|FG000|Overall Study|Protocol Violation|1|||
48800145|NCT02052310|157106351|FG001|Overall Study|Protocol Violation|6|||
48800146|NCT01682213|157106356|FG000|Overall Study|Withdrawal by Subject|2|||
48800147|NCT04605978|157106357|FG000|Overall Study|Adverse Event|2|||
48800148|NCT04605978|157106358|FG001|Overall Study|Adverse Event|1|||
48800149|NCT04605978|157106357|FG000|Overall Study|Withdrawal nonmedical reason|1|||
48800150|NCT04605978|157106358|FG001|Overall Study|Withdrawal nonmedical reason|1|||
48800151|NCT02583425|157106359|FG000|Screening|Did not meet entry criteria|12|||
48800152|NCT02583425|157106359|FG000|Baseline|Did not meet continued criteria|5|||
48800153|NCT02583425|157106359|FG000|Treatment Period|Adverse Event|1|||
48800154|NCT04638998|157106360|FG000|Overall Study|Withdrawal by Subject|1|||
48800155|NCT04638998|157106361|FG001|Overall Study|Withdrawal by Subject|3|||
48800156|NCT01559454|157106364|FG000|Overall Study|Lost to Follow-up|3|||
48800157|NCT01559454|157106365|FG001|Overall Study|Lost to Follow-up|2|||
48800158|NCT01559454|157106364|FG000|Overall Study|Withdrawal by Subject|0|||
48800159|NCT01559454|157106365|FG001|Overall Study|Withdrawal by Subject|1|||
48800160|NCT01559454|157106364|FG000|Overall Study|Physician Decision|0|||
48800161|NCT01559454|157106365|FG001|Overall Study|Physician Decision|1|||
48800162|NCT01559454|157106364|FG000|Overall Study|Protocol Violation|0|||
48800163|NCT01559454|157106365|FG001|Overall Study|Protocol Violation|1|||
48800164|NCT01559454|157106364|FG000|Overall Study|Lack of Efficacy|0|||
48800165|NCT01559454|157106365|FG001|Overall Study|Lack of Efficacy|1|||
48800166|NCT04493931|157106368|FG000|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|1|||
48800167|NCT04493931|157106369|FG001|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
48800168|NCT04493931|157106370|FG002|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
48800169|NCT04493931|157106371|FG003|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
48800170|NCT04493931|157106372|FG004|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
48800171|NCT04493931|157106373|FG005|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
48800172|NCT04493931|157106374|FG006|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
48800173|NCT04493931|157106368|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
48800174|NCT04493931|157106369|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|2|||
48800175|NCT04493931|157106370|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
48800176|NCT04493931|157106371|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
48800177|NCT04493931|157106372|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
48800178|NCT04493931|157106373|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
48800179|NCT04493931|157106374|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
48800180|NCT04493931|157106368|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
48800181|NCT04493931|157106369|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|1|||
48800182|NCT04493931|157106370|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
48800183|NCT04493931|157106371|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
48800184|NCT04493931|157106372|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
48800185|NCT04493931|157106373|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
48800186|NCT04493931|157106374|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
48800187|NCT04493931|157106368|FG000|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
48913236|NCT01205230|157519127|FG001|Overall Study|Physician Decision|0|||
48913237|NCT02689284|157519129|FG000|Overall Study|Adverse Event|1|||
48800188|NCT04493931|157106369|FG001|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
48800189|NCT04493931|157106370|FG002|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|1|||
48800190|NCT04493931|157106371|FG003|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
48800191|NCT04493931|157106372|FG004|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
48800192|NCT04493931|157106373|FG005|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
48800193|NCT04493931|157106374|FG006|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
48800194|NCT01949870|157106382|FG000|Overall Study|Lack of Efficacy|2|||
48800195|NCT01949870|157106382|FG000|Overall Study|Adverse Event|1|||
48800196|NCT01949870|157106382|FG000|Overall Study|Study termination|1|||
48800197|NCT01949870|157106382|FG000|Overall Study|Eligibility requirements not fulfilled|2|||
49118789|NCT00460239|158273218|FG008|Overall Study|Physician Decision|0|||
49118790|NCT00460239|158273210|FG000|Overall Study|Withdrawal by Subject|0|||
49118791|NCT00460239|158273211|FG001|Overall Study|Withdrawal by Subject|0|||
49118792|NCT00460239|158273212|FG002|Overall Study|Withdrawal by Subject|0|||
49118793|NCT00460239|158273213|FG003|Overall Study|Withdrawal by Subject|0|||
48706850|NCT01054885|156775878|FG006|24-week, Double-blind Treatment Period|Physician Decision|1|||
48706851|NCT01054885|156775872|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
48706852|NCT01054885|156775873|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|8|||
48706853|NCT01054885|156775874|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
48706854|NCT01054885|156775875|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
48706855|NCT01054885|156775876|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
48706856|NCT01054885|156775877|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
48706857|NCT01054885|156775878|FG006|24-week, Double-blind Treatment Period|Withdrawal by Subject|2|||
48706858|NCT00804908|156775879|FG000|Overall Study|Other|115|||
48706859|NCT00804908|156775880|FG001|Overall Study|Other|116|||
48706860|NCT00804908|156775881|FG002|Overall Study|Other|114|||
48706861|NCT01177397|156775884|FG000|Overall Study|Protocol Violation|0|||
48706862|NCT01177397|156775885|FG001|Overall Study|Protocol Violation|0|||
48706863|NCT01177397|156775886|FG002|Overall Study|Protocol Violation|0|||
48706864|NCT01177397|156775887|FG003|Overall Study|Protocol Violation|0|||
48706865|NCT01177397|156775888|FG004|Overall Study|Protocol Violation|0|||
48706866|NCT01177397|156775889|FG005|Overall Study|Protocol Violation|1|||
48706867|NCT01177397|156775890|FG006|Overall Study|Protocol Violation|0|||
48706868|NCT01177397|156775891|FG007|Overall Study|Protocol Violation|0|||
48706869|NCT01177397|156775892|FG008|Overall Study|Protocol Violation|0|||
48706870|NCT01177397|156775893|FG009|Overall Study|Protocol Violation|0|||
48706871|NCT01177397|156775894|FG010|Overall Study|Protocol Violation|0|||
48800198|NCT01123382|157106383|FG000|Overall Study|Withdrawal by Subject|1|||
48800199|NCT01123382|157106384|FG001|Overall Study|Withdrawal by Subject|4|||
48800200|NCT01123382|157106383|FG000|Overall Study|Lost to Follow-up|1|||
48800201|NCT01123382|157106384|FG001|Overall Study|Lost to Follow-up|2|||
48800202|NCT00330174|157106388|FG000|Overall Study|Withdrawal by Subject|7|||
48800203|NCT00330174|157106389|FG001|Overall Study|Withdrawal by Subject|7|||
48800204|NCT00330174|157106388|FG000|Overall Study|Lost to Follow-up|4|||
49118794|NCT00460239|158273214|FG004|Overall Study|Withdrawal by Subject|0|||
48706872|NCT01177397|156775895|FG011|Overall Study|Protocol Violation|0|||
48706873|NCT01177397|156775884|FG000|Overall Study|Lost to Follow-up|0|||
48706874|NCT01177397|156775885|FG001|Overall Study|Lost to Follow-up|0|||
48706875|NCT01177397|156775886|FG002|Overall Study|Lost to Follow-up|0|||
48706876|NCT01177397|156775887|FG003|Overall Study|Lost to Follow-up|0|||
48706877|NCT01177397|156775888|FG004|Overall Study|Lost to Follow-up|1|||
48706878|NCT01177397|156775889|FG005|Overall Study|Lost to Follow-up|0|||
48706879|NCT01177397|156775890|FG006|Overall Study|Lost to Follow-up|0|||
48706880|NCT01177397|156775891|FG007|Overall Study|Lost to Follow-up|2|||
48706881|NCT01177397|156775892|FG008|Overall Study|Lost to Follow-up|0|||
48706882|NCT01177397|156775893|FG009|Overall Study|Lost to Follow-up|0|||
48706883|NCT01177397|156775894|FG010|Overall Study|Lost to Follow-up|0|||
48706884|NCT01177397|156775895|FG011|Overall Study|Lost to Follow-up|0|||
48706885|NCT01177397|156775884|FG000|Overall Study|Death|0|||
48706886|NCT01177397|156775885|FG001|Overall Study|Death|0|||
48706887|NCT01177397|156775886|FG002|Overall Study|Death|1|||
48706888|NCT01177397|156775887|FG003|Overall Study|Death|1|||
48706889|NCT01177397|156775888|FG004|Overall Study|Death|0|||
48706890|NCT01177397|156775889|FG005|Overall Study|Death|0|||
48706891|NCT01177397|156775890|FG006|Overall Study|Death|0|||
48706892|NCT01177397|156775891|FG007|Overall Study|Death|5|||
48706893|NCT01177397|156775892|FG008|Overall Study|Death|2|||
48706894|NCT01177397|156775893|FG009|Overall Study|Death|1|||
48706895|NCT01177397|156775894|FG010|Overall Study|Death|0|||
48706896|NCT01177397|156775895|FG011|Overall Study|Death|0|||
48800205|NCT00330174|157106389|FG001|Overall Study|Lost to Follow-up|1|||
48913238|NCT02689284|157519130|FG001|Overall Study|Adverse Event|8|||
49118795|NCT00460239|158273215|FG005|Overall Study|Withdrawal by Subject|1|||
49118796|NCT00460239|158273216|FG006|Overall Study|Withdrawal by Subject|0|||
49118797|NCT00460239|158273217|FG007|Overall Study|Withdrawal by Subject|0|||
48706897|NCT01177397|156775884|FG000|Overall Study|Withdrawal by Subject|0|||
48913239|NCT02689284|157519129|FG000|Overall Study|Death|0|||
48913240|NCT02689284|157519130|FG001|Overall Study|Death|1|||
48913241|NCT02689284|157519129|FG000|Overall Study|Physician Decision|1|||
48913242|NCT02689284|157519130|FG001|Overall Study|Physician Decision|2|||
48913243|NCT02689284|157519129|FG000|Overall Study|Withdrawal by Subject|0|||
48913244|NCT02689284|157519130|FG001|Overall Study|Withdrawal by Subject|1|||
48913245|NCT02689284|157519129|FG000|Overall Study|progression of cancer|1|||
48913246|NCT02689284|157519130|FG001|Overall Study|progression of cancer|72|||
48913247|NCT02689284|157519129|FG000|Overall Study|decreased heart function|0|||
48913248|NCT02689284|157519130|FG001|Overall Study|decreased heart function|1|||
48913249|NCT02689284|157519129|FG000|Overall Study|concern for anemia|0|||
48913250|NCT02689284|157519130|FG001|Overall Study|concern for anemia|1|||
48913251|NCT02689284|157519129|FG000|Overall Study|no measurable cancer for evaluation|0|||
48913252|NCT02689284|157519130|FG001|Overall Study|no measurable cancer for evaluation|1|||
48913253|NCT01011439|157519131|FG000|Overall Study|Death|37|||
48913254|NCT01011439|157519131|FG000|Overall Study|Lost to Follow-up|4|||
48913255|NCT01011439|157519131|FG000|Overall Study|Withdrawal by Subject|1|||
48913256|NCT01011439|157519131|FG000|Overall Study|Sponsor's decision|15|||
48913257|NCT02428855|157519132|FG000|Overall Study|Withdrawal by Subject|2|||
48913258|NCT03179891|157519133|FG000|First Intervention|Withdrawal by Subject|1|||
48913259|NCT03179891|157519134|FG001|First Intervention|Withdrawal by Subject|1|||
48913260|NCT03179891|157519133|FG000|First Intervention|Unspecified reason|1|||
48913261|NCT03179891|157519134|FG001|First Intervention|Unspecified reason|0|||
48913262|NCT03179891|157519133|FG000|First Intervention|Protocol Violation|0|||
48913263|NCT03179891|157519134|FG001|First Intervention|Protocol Violation|1|||
48913264|NCT01670539|157519135|FG000|Overall Study|Death|3|||
48913265|NCT01670539|157519136|FG001|Overall Study|Death|5|||
48913266|NCT01670539|157519135|FG000|Overall Study|Withdrawal by Subject|3|||
48913267|NCT01670539|157519136|FG001|Overall Study|Withdrawal by Subject|0|||
48913268|NCT05418673|157519137|FG000|Overall Study|Study Terminated by Sponsor|2|||
48913269|NCT05418673|157519138|FG001|Overall Study|Study Terminated by Sponsor|4|||
48913270|NCT05418673|157519137|FG000|Overall Study|Lost to Follow-up|1|||
48913271|NCT05418673|157519138|FG001|Overall Study|Lost to Follow-up|0|||
48913272|NCT02665052|157519139|FG000|Overall Study|Lost to Follow-up|1|||
48913273|NCT02665052|157519140|FG001|Overall Study|Lost to Follow-up|0|||
48913274|NCT02665052|157519141|FG002|Overall Study|Lost to Follow-up|0|||
48913275|NCT02665052|157519142|FG003|Overall Study|Lost to Follow-up|0|||
48913276|NCT02665052|157519139|FG000|Overall Study|Withdrawal by Subject|1|||
48913277|NCT02665052|157519140|FG001|Overall Study|Withdrawal by Subject|1|||
48913278|NCT02665052|157519141|FG002|Overall Study|Withdrawal by Subject|0|||
48913279|NCT02665052|157519142|FG003|Overall Study|Withdrawal by Subject|5|||
48913280|NCT02665052|157519139|FG000|Overall Study|Adverse Event|1|||
48913281|NCT02665052|157519140|FG001|Overall Study|Adverse Event|1|||
48913282|NCT02665052|157519141|FG002|Overall Study|Adverse Event|0|||
48913283|NCT02665052|157519142|FG003|Overall Study|Adverse Event|0|||
48913284|NCT02161575|157519143|FG000|Overall Study|Protocol Violation|8|||
48913285|NCT02161575|157519143|FG000|Overall Study|Lack of Efficacy|1|||
48913286|NCT02161575|157519143|FG000|Overall Study|Adverse Event|2|||
48913287|NCT01186796|157519144|FG000|Overall Study|Adverse Event|3|||
48913288|NCT01186796|157519145|FG001|Overall Study|Adverse Event|0|||
48913289|NCT01186796|157519144|FG000|Overall Study|Withdrawal by Subject|1|||
48913290|NCT01186796|157519145|FG001|Overall Study|Withdrawal by Subject|1|||
48913291|NCT01186796|157519144|FG000|Overall Study|Protocol Violation|0|||
48913292|NCT01186796|157519145|FG001|Overall Study|Protocol Violation|1|||
48913293|NCT02576444|157519146|FG000|Overall Study|Death|1|||
48913294|NCT02576444|157519147|FG001|Overall Study|Death|1|||
48913295|NCT02576444|157519148|FG002|Overall Study|Death|0|||
48913296|NCT02576444|157519149|FG003|Overall Study|Death|0|||
48913297|NCT02576444|157519146|FG000|Overall Study|Withdrawal by Subject|0|||
48913298|NCT02576444|157519147|FG001|Overall Study|Withdrawal by Subject|0|||
48913299|NCT02576444|157519148|FG002|Overall Study|Withdrawal by Subject|2|||
48913300|NCT02576444|157519149|FG003|Overall Study|Withdrawal by Subject|0|||
48913301|NCT02576444|157519146|FG000|Overall Study|Adverse Event|0|||
48913302|NCT02576444|157519147|FG001|Overall Study|Adverse Event|0|||
48706898|NCT01177397|156775885|FG001|Overall Study|Withdrawal by Subject|0|||
48706899|NCT01177397|156775886|FG002|Overall Study|Withdrawal by Subject|1|||
48913303|NCT02576444|157519148|FG002|Overall Study|Adverse Event|1|||
48913304|NCT02576444|157519149|FG003|Overall Study|Adverse Event|0|||
48913305|NCT02576444|157519146|FG000|Overall Study|Physician Decision|0|||
48913306|NCT02576444|157519147|FG001|Overall Study|Physician Decision|0|||
48913307|NCT02576444|157519148|FG002|Overall Study|Physician Decision|1|||
48913308|NCT02576444|157519149|FG003|Overall Study|Physician Decision|0|||
48913309|NCT02613884|157519153|FG000|Overall Study|Death|1|||
48913310|NCT02613884|157519153|FG000|Overall Study|Lost to Follow-up|1|||
48913311|NCT02700412|157519157|FG000|Overall Study|Adverse Event|6|||
48913312|NCT02700412|157519157|FG000|Overall Study|Death|1|||
48913313|NCT02700412|157519157|FG000|Overall Study|Lack of Efficacy|19|||
48913314|NCT02700412|157519157|FG000|Overall Study|Protocol Violation|5|||
48913315|NCT02700412|157519157|FG000|Overall Study|Withdrawal by Subject|2|||
48800206|NCT00330174|157106388|FG000|Overall Study|Clinical deterioration|1|||
48913316|NCT01231659|157519158|FG000|Overall Study|Adverse Event|9|||
48913317|NCT01231659|157519158|FG000|Overall Study|Disease Progression|48|||
48913318|NCT01231659|157519158|FG000|Overall Study|Death|2|||
48913319|NCT01231659|157519158|FG000|Overall Study|Patient refused to complete study visit|1|||
48913320|NCT01231659|157519158|FG000|Overall Study|Other protocol defined criteria|12|||
48913321|NCT04305275|157519159|FG000|Overall Study|Adverse Event|4|||
48913322|NCT04305275|157519160|FG001|Overall Study|Adverse Event|0|||
48913323|NCT04305275|157519159|FG000|Overall Study|Lost to Follow-up|1|||
48800207|NCT00330174|157106389|FG001|Overall Study|Clinical deterioration|2|||
48800208|NCT00330174|157106388|FG000|Overall Study|Excessive missed visits|3|||
48800209|NCT00330174|157106389|FG001|Overall Study|Excessive missed visits|8|||
48800210|NCT00330174|157106388|FG000|Overall Study|Miscellaneous reasons|7|||
48800211|NCT00330174|157106389|FG001|Overall Study|Miscellaneous reasons|1|||
48800212|NCT01059630|157106396|FG000|Overall Study|Death|100|||
48800213|NCT01059630|157106397|FG001|Overall Study|Death|84|||
48800214|NCT01059630|157106396|FG000|Overall Study|Lost to Follow-up|4|||
48800215|NCT01059630|157106397|FG001|Overall Study|Lost to Follow-up|1|||
48800216|NCT01059630|157106396|FG000|Overall Study|Physician Decision|2|||
48800217|NCT01059630|157106397|FG001|Overall Study|Physician Decision|4|||
48800218|NCT01059630|157106396|FG000|Overall Study|Withdrawal by Subject|21|||
48800219|NCT01059630|157106397|FG001|Overall Study|Withdrawal by Subject|14|||
48800220|NCT02403180|157106398|FG000|Pre-Treatment Period|Withdrawal by subject prior to treatment|0|||
48800221|NCT02403180|157106399|FG001|Pre-Treatment Period|Withdrawal by subject prior to treatment|1|||
48800222|NCT02403180|157106398|FG000|Period 2 (5 Days)|Withdrawal by Subject|0|||
48800223|NCT02403180|157106399|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
48800224|NCT01445652|157106400|FG000|Overall Study|Not comfortable in lenses|5|||
48800225|NCT01445652|157106401|FG001|Overall Study|Not comfortable in lenses|0|||
48800226|NCT01445652|157106400|FG000|Overall Study|Failed to attend scheduled visit|2|||
48800227|NCT01445652|157106401|FG001|Overall Study|Failed to attend scheduled visit|3|||
48800228|NCT01445652|157106400|FG000|Overall Study|Failed teach session|2|||
48800229|NCT01445652|157106401|FG001|Overall Study|Failed teach session|0|||
48800230|NCT01445652|157106400|FG000|Overall Study|Adverse Event|1|||
48800231|NCT01445652|157106401|FG001|Overall Study|Adverse Event|0|||
48800232|NCT01089374|157106407|FG000|Overall Study|Lost to Follow-up|3|||
48800233|NCT01089374|157106408|FG001|Overall Study|Lost to Follow-up|0|||
48800234|NCT01089374|157106407|FG000|Overall Study|Withdrawal by Subject|1|||
48800235|NCT01089374|157106408|FG001|Overall Study|Withdrawal by Subject|0|||
48913324|NCT04305275|157519160|FG001|Overall Study|Lost to Follow-up|1|||
48913325|NCT04305275|157519159|FG000|Overall Study|Withdrawal by Participant|8|||
48913326|NCT04305275|157519160|FG001|Overall Study|Withdrawal by Participant|1|||
48913327|NCT03418129|157519167|FG000|Overall Study|Lost to Follow-up|11|||
48913328|NCT03418129|157519168|FG001|Overall Study|Lost to Follow-up|20|||
48913329|NCT03418129|157519169|FG002|Overall Study|Lost to Follow-up|15|||
48913330|NCT03418129|157519167|FG000|Overall Study|Withdrawal by Subject|3|||
48913331|NCT03418129|157519168|FG001|Overall Study|Withdrawal by Subject|6|||
48913332|NCT03418129|157519169|FG002|Overall Study|Withdrawal by Subject|4|||
48913333|NCT01553188|157519170|FG000|Overall Study|Patient choice|1|||
48913334|NCT01553188|157519171|FG001|Overall Study|Patient choice|0|||
48913335|NCT01553188|157519172|FG002|Overall Study|Patient choice|0|||
48913336|NCT01553188|157519173|FG003|Overall Study|Patient choice|0|||
48913337|NCT01553188|157519170|FG000|Overall Study|Intercurrent illness and adverse event|0|||
48913338|NCT01553188|157519171|FG001|Overall Study|Intercurrent illness and adverse event|1|||
48913339|NCT01553188|157519172|FG002|Overall Study|Intercurrent illness and adverse event|2|||
48913340|NCT01553188|157519173|FG003|Overall Study|Intercurrent illness and adverse event|0|||
48913341|NCT05376215|157519177|FG000|Overall Study|Withdrawal by Subject|2|||
48913342|NCT05376215|157519178|FG001|Overall Study|Withdrawal by Subject|1|||
48913343|NCT05376215|157519177|FG000|Overall Study|Lost to Follow-up|0|||
48913344|NCT05376215|157519178|FG001|Overall Study|Lost to Follow-up|1|||
48913345|NCT00942175|157519179|FG000|Overall Study|Adverse Event|2|||
48913346|NCT00942175|157519180|FG001|Overall Study|Adverse Event|1|||
48800236|NCT01089374|157106407|FG000|Overall Study|Study closed early - low accrual|6|||
48800237|NCT01089374|157106408|FG001|Overall Study|Study closed early - low accrual|0|||
48800238|NCT00117676|157106409|FG000|Double-blind Period Through Week 48|Randomized but Not Treated|4|||
48800239|NCT00117676|157106410|FG001|Double-blind Period Through Week 48|Randomized but Not Treated|3|||
48800240|NCT00117676|157106409|FG000|Double-blind Period Through Week 48|Lost to Follow-up|1|||
48800241|NCT00117676|157106410|FG001|Double-blind Period Through Week 48|Lost to Follow-up|0|||
48913347|NCT00942175|157519181|FG002|Overall Study|Adverse Event|0|||
48913348|NCT00942175|157519182|FG003|Overall Study|Adverse Event|0|||
48913349|NCT00942175|157519179|FG000|Overall Study|Protocol Violation|0|||
48913350|NCT00942175|157519180|FG001|Overall Study|Protocol Violation|1|||
48913351|NCT00942175|157519181|FG002|Overall Study|Protocol Violation|2|||
48913352|NCT00942175|157519182|FG003|Overall Study|Protocol Violation|0|||
48913353|NCT00942175|157519179|FG000|Overall Study|Pregnancy|0|||
48913354|NCT00942175|157519180|FG001|Overall Study|Pregnancy|0|||
48913355|NCT00942175|157519181|FG002|Overall Study|Pregnancy|0|||
48913356|NCT00942175|157519182|FG003|Overall Study|Pregnancy|1|||
48913357|NCT00942175|157519179|FG000|Overall Study|Elevated Alanine Amino Transferase|0|||
48913358|NCT00942175|157519180|FG001|Overall Study|Elevated Alanine Amino Transferase|0|||
48913359|NCT00942175|157519181|FG002|Overall Study|Elevated Alanine Amino Transferase|0|||
48913360|NCT00942175|157519182|FG003|Overall Study|Elevated Alanine Amino Transferase|1|||
48913361|NCT00942175|157519179|FG000|Overall Study|Low Platelet Count|0|||
48913362|NCT00942175|157519180|FG001|Overall Study|Low Platelet Count|2|||
48913363|NCT00942175|157519181|FG002|Overall Study|Low Platelet Count|0|||
48913364|NCT00942175|157519182|FG003|Overall Study|Low Platelet Count|0|||
48913365|NCT01066585|157519183|FG000|Overall Study|Protocol Violation|1|||
48913366|NCT01066585|157519184|FG001|Overall Study|Protocol Violation|0|||
48800242|NCT00117676|157106409|FG000|Double-blind Period Through Week 48|Protocol Violation|0|||
48800243|NCT00117676|157106410|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
48800244|NCT00117676|157106409|FG000|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5|||
48800245|NCT00117676|157106410|FG001|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2|||
48800246|NCT00117676|157106409|FG000|Double-blind Period Through Week 48|Withdrew Consent|0|||
48800247|NCT00117676|157106410|FG001|Double-blind Period Through Week 48|Withdrew Consent|1|||
48800248|NCT00117676|157106409|FG000|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2|||
48800249|NCT00117676|157106410|FG001|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0|||
48800250|NCT00117676|157106409|FG000|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3|||
48800251|NCT00117676|157106410|FG001|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
48913367|NCT01066585|157519183|FG000|Overall Study|Withdrawal by Subject|0|||
48913368|NCT01066585|157519184|FG001|Overall Study|Withdrawal by Subject|3|||
48913369|NCT00427349|157519191|FG000|Overall Study|Lack of Efficacy|23|||
48913370|NCT00427349|157519191|FG000|Overall Study|Adverse Event|14|||
48913371|NCT00427349|157519191|FG000|Overall Study|Death|1|||
48913372|NCT00427349|157519191|FG000|Overall Study|Withdrawal by Subject|3|||
48913373|NCT00427349|157519191|FG000|Overall Study|Alternative therapy|1|||
48913374|NCT00427349|157519191|FG000|Overall Study|Other|2|||
48913375|NCT00427349|157519191|FG000|Overall Study|Ineligible|1|||
48913376|NCT00427349|157519191|FG000|Overall Study|Never started therapy|1|||
48913377|NCT01357655|157519195|FG000|Overall Study|Administrative Reason by Sponsor|45|||
48913378|NCT01357655|157519196|FG001|Overall Study|Administrative Reason by Sponsor|0|||
48913379|NCT01357655|157519195|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
48913380|NCT01357655|157519196|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
48913381|NCT01357655|157519195|FG000|Overall Study|Disease Progression|1|||
48913382|NCT01357655|157519196|FG001|Overall Study|Disease Progression|0|||
48913383|NCT01357655|157519195|FG000|Overall Study|Lost to Follow-up|2|||
48913384|NCT01357655|157519196|FG001|Overall Study|Lost to Follow-up|0|||
48913385|NCT01357655|157519195|FG000|Overall Study|Maximum Clinical Benefit|2|||
48913386|NCT01357655|157519196|FG001|Overall Study|Maximum Clinical Benefit|0|||
48913387|NCT01357655|157519195|FG000|Overall Study|Reason Unspecified|1|||
48913388|NCT01357655|157519196|FG001|Overall Study|Reason Unspecified|0|||
48913389|NCT01357655|157519195|FG000|Overall Study|Study Drug Toxicity|11|||
48913390|NCT01357655|157519196|FG001|Overall Study|Study Drug Toxicity|0|||
48913391|NCT01357655|157519195|FG000|Overall Study|Subject Withdrew Consent|1|||
48800252|NCT00117676|157106409|FG000|Open-label Period: Weeks 49 - 96|Withdrew Consent|5|||
48913392|NCT01357655|157519196|FG001|Overall Study|Subject Withdrew Consent|0|||
48913393|NCT05003622|157519197|FG000|Overall Study|Progressive disease|2|||
48913394|NCT05003622|157519197|FG000|Overall Study|Withdrawal by Subject|1|||
48913395|NCT01538628|157519204|FG000|Overall Study|Withdrawal by Subject|1|||
48800253|NCT00117676|157106410|FG001|Open-label Period: Weeks 49 - 96|Withdrew Consent|1|||
48800254|NCT00117676|157106409|FG000|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4|||
48800255|NCT00117676|157106410|FG001|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1|||
48800256|NCT00117676|157106409|FG000|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1|||
48800257|NCT00117676|157106410|FG001|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0|||
48800258|NCT00117676|157106409|FG000|Open-label Period: Weeks 97 - 144|Withdrew Consent|1|||
48800259|NCT00117676|157106410|FG001|Open-label Period: Weeks 97 - 144|Withdrew Consent|0|||
48800260|NCT00117676|157106409|FG000|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2|||
48913396|NCT01538628|157519205|FG001|Overall Study|Withdrawal by Subject|1|||
48913397|NCT01538628|157519204|FG000|Overall Study|Lost to Follow-up|0|||
48913398|NCT01538628|157519205|FG001|Overall Study|Lost to Follow-up|1|||
48913399|NCT00574145|157521107|FG000|Overall Study|Withdrawal by Subject|2|||
48913400|NCT00574145|157521108|FG001|Overall Study|Withdrawal by Subject|1|||
48913401|NCT01524198|157521109|FG000|Overall Study|Protocol Violation|8|||
48913402|NCT01524198|157521110|FG001|Overall Study|Protocol Violation|6|||
48913403|NCT01524198|157521109|FG000|Overall Study|Withdrawal by Subject|15|||
48913404|NCT01524198|157521110|FG001|Overall Study|Withdrawal by Subject|10|||
48913405|NCT02142738|157521111|FG000|Overall Study|Adverse Event|13|||
48913406|NCT02142738|157521112|FG001|Overall Study|Adverse Event|9|||
48913407|NCT02142738|157521111|FG000|Overall Study|Death|92|||
48913408|NCT02142738|157521112|FG001|Overall Study|Death|112|||
48913409|NCT02142738|157521111|FG000|Overall Study|Lost to Follow-up|0|||
48800261|NCT00117676|157106410|FG001|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0|||
48800262|NCT00117676|157106409|FG000|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3|||
48800263|NCT00117676|157106410|FG001|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1|||
48800264|NCT00117676|157106409|FG000|Open-label Period: Weeks 145 - 192|Withdrew Consent|5|||
48800265|NCT00117676|157106410|FG001|Open-label Period: Weeks 145 - 192|Withdrew Consent|2|||
48800266|NCT00117676|157106409|FG000|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
48800267|NCT00117676|157106410|FG001|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
48800268|NCT00117676|157106409|FG000|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0|||
48800269|NCT00117676|157106410|FG001|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1|||
48800270|NCT00117676|157106409|FG000|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
48800271|NCT00117676|157106410|FG001|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0|||
48800272|NCT00117676|157106409|FG000|Open-label Period: Weeks 193 - 240|Withdrew Consent|4|||
48800273|NCT00117676|157106410|FG001|Open-label Period: Weeks 193 - 240|Withdrew Consent|1|||
48800274|NCT00117676|157106409|FG000|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0|||
48800275|NCT00117676|157106410|FG001|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1|||
48800276|NCT00117676|157106409|FG000|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2|||
48800277|NCT00117676|157106410|FG001|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1|||
48800278|NCT00117676|157106409|FG000|Open-label Period: Weeks 241 - 288|Protocol Violation|2|||
48800279|NCT00117676|157106410|FG001|Open-label Period: Weeks 241 - 288|Protocol Violation|0|||
48800280|NCT00117676|157106409|FG000|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1|||
48800281|NCT00117676|157106410|FG001|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
48800282|NCT00117676|157106409|FG000|Open-label Period: Weeks 241 - 288|Withdrew Consent|5|||
48800283|NCT00117676|157106410|FG001|Open-label Period: Weeks 241 - 288|Withdrew Consent|1|||
48800284|NCT00117676|157106409|FG000|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7|||
48800285|NCT00117676|157106410|FG001|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4|||
48800286|NCT00117676|157106409|FG000|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
48800287|NCT00117676|157106410|FG001|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
48800288|NCT00117676|157106409|FG000|Open-label Period: Weeks 289 - 336|Withdrew Consent|0|||
48800289|NCT00117676|157106410|FG001|Open-label Period: Weeks 289 - 336|Withdrew Consent|1|||
48800290|NCT00117676|157106409|FG000|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
48800291|NCT00117676|157106410|FG001|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
48800292|NCT00117676|157106409|FG000|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3|||
48800293|NCT00117676|157106410|FG001|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1|||
48800294|NCT00117676|157106409|FG000|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1|||
48800295|NCT00117676|157106410|FG001|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0|||
48800296|NCT00117676|157106409|FG000|Open-label Period: Weeks 337 - 384|Withdrew Consent|2|||
48800297|NCT00117676|157106410|FG001|Open-label Period: Weeks 337 - 384|Withdrew Consent|1|||
48800298|NCT00117676|157106409|FG000|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0|||
48800299|NCT00117676|157106410|FG001|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1|||
48800300|NCT00117676|157106409|FG000|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0|||
48800301|NCT00117676|157106410|FG001|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1|||
48800302|NCT00117676|157106409|FG000|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1|||
48800303|NCT00117676|157106410|FG001|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0|||
48800304|NCT00117676|157106409|FG000|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
48800305|NCT00117676|157106410|FG001|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
48800306|NCT00117676|157106409|FG000|Open-label Period: Weeks 433 - 480|Withdrew Consent|0|||
48800307|NCT00117676|157106410|FG001|Open-label Period: Weeks 433 - 480|Withdrew Consent|1|||
48800308|NCT02063828|157106413|FG000|Overall Study|Withdrawal by Subject|4|||
48800309|NCT02063828|157106414|FG001|Overall Study|Withdrawal by Subject|6|||
48800310|NCT02063828|157106415|FG002|Overall Study|Withdrawal by Subject|3|||
48800311|NCT02063828|157106413|FG000|Overall Study|Death|0|||
48800312|NCT02063828|157106414|FG001|Overall Study|Death|0|||
48800313|NCT02063828|157106415|FG002|Overall Study|Death|1|||
48800314|NCT00031486|157106423|FG000|Overall Study|Adverse Event|1|||
48800315|NCT00031486|157106424|FG001|Overall Study|Adverse Event|0|||
48800316|NCT00031486|157106423|FG000|Overall Study|Lost to Follow-up|0|||
48800317|NCT00031486|157106424|FG001|Overall Study|Lost to Follow-up|1|||
48800318|NCT00031486|157106423|FG000|Overall Study|Withdrawal by Subject|3|||
48800319|NCT00031486|157106424|FG001|Overall Study|Withdrawal by Subject|2|||
48800320|NCT00031486|157106423|FG000|Overall Study|Death|0|||
48800321|NCT00031486|157106424|FG001|Overall Study|Death|3|||
48800322|NCT00031486|157106423|FG000|Overall Study|Non-compliant|0|||
48800323|NCT00031486|157106424|FG001|Overall Study|Non-compliant|4|||
48800324|NCT00031486|157106423|FG000|Overall Study|Did not meet eligibility requirement|2|||
48800325|NCT00031486|157106424|FG001|Overall Study|Did not meet eligibility requirement|1|||
48800326|NCT00031486|157106423|FG000|Overall Study|Other|1|||
48800327|NCT00031486|157106424|FG001|Overall Study|Other|1|||
48800328|NCT00441090|157106429|FG000|Overall Study|Adverse Event|0|||
48800329|NCT00441090|157106430|FG001|Overall Study|Adverse Event|1|||
48800330|NCT00441090|157106431|FG002|Overall Study|Adverse Event|1|||
48800331|NCT00441090|157106432|FG003|Overall Study|Adverse Event|0|||
48800332|NCT00441090|157106433|FG004|Overall Study|Adverse Event|0|||
48800333|NCT00441090|157106429|FG000|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
48800334|NCT00441090|157106430|FG001|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
48800335|NCT00441090|157106431|FG002|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
48800336|NCT00441090|157106432|FG003|Overall Study|Platelet increase;more than 500,000 mm^3|2|||
48800337|NCT00441090|157106433|FG004|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
48800338|NCT00441090|157106429|FG000|Overall Study|Withdrawal by Subject|1|||
48800339|NCT00441090|157106430|FG001|Overall Study|Withdrawal by Subject|0|||
48800340|NCT00441090|157106431|FG002|Overall Study|Withdrawal by Subject|1|||
48800341|NCT00441090|157106432|FG003|Overall Study|Withdrawal by Subject|0|||
48800342|NCT00441090|157106433|FG004|Overall Study|Withdrawal by Subject|0|||
48800343|NCT00441090|157106429|FG000|Overall Study|Lack of Efficacy|1|||
48800344|NCT00441090|157106430|FG001|Overall Study|Lack of Efficacy|0|||
48800345|NCT00441090|157106431|FG002|Overall Study|Lack of Efficacy|0|||
48800346|NCT00441090|157106432|FG003|Overall Study|Lack of Efficacy|0|||
48800347|NCT00441090|157106433|FG004|Overall Study|Lack of Efficacy|0|||
48800348|NCT01648348|157106437|FG000|Overall Study|Cancel|1|||
48800349|NCT01648348|157106438|FG001|Overall Study|Cancel|0|||
48800350|NCT01648348|157106439|FG002|Overall Study|Cancel|0|||
48800351|NCT01648348|157106440|FG003|Overall Study|Cancel|0|||
48800352|NCT01648348|157106441|FG004|Overall Study|Cancel|3|||
48800353|NCT01648348|157106442|FG005|Overall Study|Cancel|6|||
48800354|NCT01648348|157106437|FG000|Overall Study|Replaced for MTD analysis|1|||
48800355|NCT01648348|157106438|FG001|Overall Study|Replaced for MTD analysis|0|||
48800356|NCT01648348|157106439|FG002|Overall Study|Replaced for MTD analysis|1|||
48706900|NCT01177397|156775887|FG003|Overall Study|Withdrawal by Subject|1|||
48706901|NCT01177397|156775888|FG004|Overall Study|Withdrawal by Subject|1|||
48800357|NCT01648348|157106440|FG003|Overall Study|Replaced for MTD analysis|0|||
48800358|NCT01648348|157106441|FG004|Overall Study|Replaced for MTD analysis|0|||
48913410|NCT02142738|157521112|FG001|Overall Study|Lost to Follow-up|3|||
48913411|NCT02142738|157521111|FG000|Overall Study|Withdrawal by Subject|6|||
48913412|NCT02142738|157521112|FG001|Overall Study|Withdrawal by Subject|7|||
48913413|NCT02142738|157521111|FG000|Overall Study|Follow up ended by sponsor|43|||
48913414|NCT02142738|157521112|FG001|Overall Study|Follow up ended by sponsor|20|||
48913415|NCT02553265|157521113|FG000|Enrollment|Death|0|||
48913416|NCT02553265|157521114|FG001|Enrollment|Death|0|||
48913417|NCT02553265|157521115|FG002|Enrollment|Death|1|||
48913418|NCT02553265|157521113|FG000|First Intervention (28 Days)|Adverse Event|1|||
48913419|NCT02553265|157521114|FG001|First Intervention (28 Days)|Adverse Event|0|||
48913420|NCT02553265|157521115|FG002|First Intervention (28 Days)|Adverse Event|0|||
48913421|NCT02553265|157521113|FG000|First Intervention (28 Days)|Withdrawal by Subject|0|||
48913422|NCT02553265|157521114|FG001|First Intervention (28 Days)|Withdrawal by Subject|0|||
48913423|NCT02553265|157521115|FG002|First Intervention (28 Days)|Withdrawal by Subject|1|||
48913424|NCT02553265|157521113|FG000|Second Intervention (28 Days)|Adverse Event|1|||
48913425|NCT02553265|157521114|FG001|Second Intervention (28 Days)|Adverse Event|0|||
48913426|NCT02553265|157521115|FG002|Second Intervention (28 Days)|Adverse Event|0|||
48913427|NCT02553265|157521113|FG000|Third Intervention (28 Days)|Adverse Event|1|||
48913428|NCT02553265|157521114|FG001|Third Intervention (28 Days)|Adverse Event|0|||
48913429|NCT02553265|157521115|FG002|Third Intervention (28 Days)|Adverse Event|0|||
48706902|NCT01177397|156775889|FG005|Overall Study|Withdrawal by Subject|2|||
48706903|NCT01177397|156775890|FG006|Overall Study|Withdrawal by Subject|0|||
48706904|NCT01177397|156775891|FG007|Overall Study|Withdrawal by Subject|5|||
48706905|NCT01177397|156775892|FG008|Overall Study|Withdrawal by Subject|9|||
48706906|NCT01177397|156775893|FG009|Overall Study|Withdrawal by Subject|1|||
48706907|NCT01177397|156775894|FG010|Overall Study|Withdrawal by Subject|1|||
48706908|NCT01177397|156775895|FG011|Overall Study|Withdrawal by Subject|0|||
48706909|NCT01177397|156775884|FG000|Overall Study|Adverse Event|0|||
48706910|NCT01177397|156775885|FG001|Overall Study|Adverse Event|0|||
48706911|NCT01177397|156775886|FG002|Overall Study|Adverse Event|1|||
48706912|NCT01177397|156775887|FG003|Overall Study|Adverse Event|2|||
48800359|NCT01648348|157106442|FG005|Overall Study|Replaced for MTD analysis|0|||
48913430|NCT02553265|157521113|FG000|Third Intervention (28 Days)|Lost to Follow-up|0|||
48913431|NCT02553265|157521114|FG001|Third Intervention (28 Days)|Lost to Follow-up|0|||
48913432|NCT02553265|157521115|FG002|Third Intervention (28 Days)|Lost to Follow-up|1|||
48800360|NCT00453986|157106449|FG000|Overall Study|Lost to Follow-up|6|||
48913433|NCT01628107|157521116|FG000|Overall Study|Withdrawal by Subject|17|||
48800361|NCT00453986|157106450|FG001|Overall Study|Lost to Follow-up|5|||
48800362|NCT00453986|157106451|FG002|Overall Study|Lost to Follow-up|6|||
48800363|NCT00453986|157106452|FG003|Overall Study|Lost to Follow-up|2|||
48800364|NCT00453986|157106453|FG004|Overall Study|Lost to Follow-up|0|||
48800365|NCT00522626|157106454|FG000|Overall Study|Lost to Follow-up|7|||
48800366|NCT02151266|157106455|FG000|Overall Study|Lost to Follow-up|1|||
48800367|NCT02151266|157106456|FG001|Overall Study|Lost to Follow-up|4|||
48800368|NCT02151266|157106457|FG002|Overall Study|Lost to Follow-up|1|||
48800369|NCT02151266|157106455|FG000|Overall Study|Did NOT receive intervention|3|||
48800370|NCT02151266|157106456|FG001|Overall Study|Did NOT receive intervention|6|||
48800371|NCT02151266|157106457|FG002|Overall Study|Did NOT receive intervention|2|||
48800372|NCT02151266|157106455|FG000|Overall Study|Not able to exercise|4|||
48800373|NCT02151266|157106456|FG001|Overall Study|Not able to exercise|5|||
48800374|NCT02151266|157106457|FG002|Overall Study|Not able to exercise|4|||
48800375|NCT02618616|157106458|FG000|Overall Study|Lack of Efficacy|4|||
48800376|NCT02618616|157106459|FG001|Overall Study|Lack of Efficacy|0|||
48800377|NCT02618616|157106458|FG000|Overall Study|Pregnancy|0|||
48800378|NCT02618616|157106459|FG001|Overall Study|Pregnancy|1|||
48800379|NCT02618616|157106458|FG000|Overall Study|Adverse Event|8|||
48800380|NCT02618616|157106459|FG001|Overall Study|Adverse Event|0|||
48800381|NCT02618616|157106458|FG000|Overall Study|Failure to comply with dosing/evaluation|1|||
48800382|NCT02618616|157106459|FG001|Overall Study|Failure to comply with dosing/evaluation|0|||
48800383|NCT02618616|157106458|FG000|Overall Study|Consent withdrawn by subject|8|||
48800384|NCT02618616|157106459|FG001|Overall Study|Consent withdrawn by subject|5|||
48800385|NCT02618616|157106458|FG000|Overall Study|Lost to Follow-up|0|||
48800386|NCT02618616|157106459|FG001|Overall Study|Lost to Follow-up|1|||
48800387|NCT02170025|157106462|FG000|Overall Study|Adverse Event|2|||
48800388|NCT02170025|157106463|FG001|Overall Study|Adverse Event|0|||
48800389|NCT00118898|157106464|FG000|Overall Study|Death|6|||
48800390|NCT00118898|157106465|FG001|Overall Study|Death|11|||
48800391|NCT00118898|157106466|FG002|Overall Study|Death|6|||
48800392|NCT00118898|157106467|FG003|Overall Study|Death|8|||
48800393|NCT00118898|157106464|FG000|Overall Study|Lost to Follow-up|26|||
48800394|NCT00118898|157106465|FG001|Overall Study|Lost to Follow-up|34|||
48800395|NCT00118898|157106466|FG002|Overall Study|Lost to Follow-up|33|||
48800396|NCT00118898|157106467|FG003|Overall Study|Lost to Follow-up|33|||
48800397|NCT00118898|157106464|FG000|Overall Study|Withdrawal by Subject|10|||
48800398|NCT00118898|157106465|FG001|Overall Study|Withdrawal by Subject|5|||
48800399|NCT00118898|157106466|FG002|Overall Study|Withdrawal by Subject|8|||
48800400|NCT00118898|157106467|FG003|Overall Study|Withdrawal by Subject|8|||
48800401|NCT00118898|157106464|FG000|Overall Study|Site Closure|33|||
48800402|NCT00118898|157106465|FG001|Overall Study|Site Closure|31|||
48800403|NCT00118898|157106466|FG002|Overall Study|Site Closure|28|||
48800404|NCT00118898|157106467|FG003|Overall Study|Site Closure|37|||
48800405|NCT00118898|157106464|FG000|Overall Study|Severe debilitation|1|||
48800406|NCT00118898|157106465|FG001|Overall Study|Severe debilitation|4|||
48800407|NCT00118898|157106466|FG002|Overall Study|Severe debilitation|6|||
48800408|NCT00118898|157106467|FG003|Overall Study|Severe debilitation|4|||
48800409|NCT00118898|157106464|FG000|Overall Study|Not compliant with requirements|11|||
48800410|NCT00118898|157106465|FG001|Overall Study|Not compliant with requirements|13|||
48800411|NCT00118898|157106466|FG002|Overall Study|Not compliant with requirements|11|||
48800412|NCT00118898|157106467|FG003|Overall Study|Not compliant with requirements|11|||
48800413|NCT00118898|157106464|FG000|Overall Study|Not able to get to clinic|34|||
48800414|NCT00118898|157106465|FG001|Overall Study|Not able to get to clinic|43|||
48800415|NCT00118898|157106466|FG002|Overall Study|Not able to get to clinic|31|||
48800416|NCT00118898|157106467|FG003|Overall Study|Not able to get to clinic|40|||
48800417|NCT02160314|157108269|FG000|Overall Study|Adverse Event|0|||
48800418|NCT02160314|157108270|FG001|Overall Study|Adverse Event|6|||
48800419|NCT02160314|157108269|FG000|Overall Study|Protocol Violation|0|||
48800420|NCT02160314|157108270|FG001|Overall Study|Protocol Violation|4|||
48800421|NCT02160314|157108269|FG000|Overall Study|Withdrawal by Subject|1|||
48800422|NCT02160314|157108270|FG001|Overall Study|Withdrawal by Subject|2|||
48800423|NCT02160314|157108269|FG000|Overall Study|Lost to Follow-up|0|||
48800424|NCT02160314|157108270|FG001|Overall Study|Lost to Follow-up|1|||
48800425|NCT00939484|157108273|FG000|Overall Study|Progression/Relapse|8|||
48800426|NCT00939484|157108274|FG001|Overall Study|Progression/Relapse|20|||
48800427|NCT00939484|157108275|FG002|Overall Study|Progression/Relapse|3|||
48800428|NCT01216176|157108279|FG000|Overall Study|Adverse Event|0|||
48800429|NCT01216176|157108280|FG001|Overall Study|Adverse Event|8|||
48800430|NCT01216176|157108281|FG002|Overall Study|Adverse Event|0|||
48800431|NCT01216176|157108279|FG000|Overall Study|Physician Decision|0|||
48800432|NCT01216176|157108280|FG001|Overall Study|Physician Decision|0|||
48800433|NCT01216176|157108281|FG002|Overall Study|Physician Decision|1|||
48800434|NCT02243280|157108282|FG000|Treated|Adverse Event|1|||
48800435|NCT02243280|157108283|FG001|Treated|Adverse Event|0|||
48800436|NCT02243280|157108284|FG002|Treated|Adverse Event|0|||
48800437|NCT02243280|157108285|FG003|Treated|Adverse Event|0|||
48800438|NCT02243280|157108286|FG004|Treated|Adverse Event|0|||
48800439|NCT02243280|157108287|FG005|Treated|Adverse Event|0|||
48800440|NCT02243280|157108288|FG006|Treated|Adverse Event|0|||
48800441|NCT02243280|157108289|FG007|Treated|Adverse Event|0|||
48800442|NCT02243280|157108290|FG008|Treated|Adverse Event|0|||
48800443|NCT02243280|157108291|FG009|Treated|Adverse Event|0|||
48800444|NCT02243280|157108292|FG010|Treated|Adverse Event|1|||
48800445|NCT02243280|157108282|FG000|Treated|Lost to Follow-up|0|||
48800446|NCT02243280|157108283|FG001|Treated|Lost to Follow-up|0|||
48800447|NCT02243280|157108284|FG002|Treated|Lost to Follow-up|0|||
48800448|NCT02243280|157108285|FG003|Treated|Lost to Follow-up|0|||
48800449|NCT02243280|157108286|FG004|Treated|Lost to Follow-up|0|||
48800450|NCT02243280|157108287|FG005|Treated|Lost to Follow-up|0|||
48913434|NCT01628107|157521116|FG000|Overall Study|Lost to Follow-up|4|||
48913435|NCT01628107|157521116|FG000|Overall Study|Adverse Event|33|||
48913436|NCT01628107|157521116|FG000|Overall Study|Physician Decision|2|||
48913437|NCT01628107|157521116|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|1|||
48913438|NCT01628107|157521116|FG000|Overall Study|Non-compliant with Study Procedures|10|||
48913439|NCT01628107|157521116|FG000|Overall Study|Not Treated|8|||
48913440|NCT01628107|157521116|FG000|Overall Study|Sponsor Decision|11|||
48913441|NCT01628107|157521116|FG000|Overall Study|Missed Study Drug More than 2 Weeks|7|||
48913442|NCT01628107|157521116|FG000|Overall Study|Relocated|8|||
48913443|NCT01628107|157521116|FG000|Overall Study|Kidney Transplant|9|||
48913444|NCT01628107|157521116|FG000|Overall Study|Use of Standard of Care|9|||
48913445|NCT02023242|157521117|FG000|Overall Study|Lost to Follow-up|3|||
48706913|NCT01177397|156775888|FG004|Overall Study|Adverse Event|0|||
48706914|NCT01177397|156775889|FG005|Overall Study|Adverse Event|12|||
48706915|NCT01177397|156775890|FG006|Overall Study|Adverse Event|1|||
48706916|NCT01177397|156775891|FG007|Overall Study|Adverse Event|14|||
48706917|NCT01177397|156775892|FG008|Overall Study|Adverse Event|8|||
48706918|NCT01177397|156775893|FG009|Overall Study|Adverse Event|6|||
48706919|NCT01177397|156775894|FG010|Overall Study|Adverse Event|3|||
48706920|NCT01177397|156775895|FG011|Overall Study|Adverse Event|7|||
48706921|NCT01177397|156775884|FG000|Overall Study|Disease progression|1|||
48706922|NCT01177397|156775885|FG001|Overall Study|Disease progression|2|||
48706923|NCT01177397|156775886|FG002|Overall Study|Disease progression|5|||
48706924|NCT01177397|156775887|FG003|Overall Study|Disease progression|5|||
48706925|NCT01177397|156775888|FG004|Overall Study|Disease progression|4|||
48706926|NCT01177397|156775889|FG005|Overall Study|Disease progression|10|||
48706927|NCT01177397|156775890|FG006|Overall Study|Disease progression|10|||
48706928|NCT01177397|156775891|FG007|Overall Study|Disease progression|21|||
48706929|NCT01177397|156775892|FG008|Overall Study|Disease progression|18|||
48706930|NCT01177397|156775893|FG009|Overall Study|Disease progression|12|||
48706931|NCT01177397|156775894|FG010|Overall Study|Disease progression|10|||
48706932|NCT01177397|156775895|FG011|Overall Study|Disease progression|8|||
48706933|NCT01177397|156775884|FG000|Overall Study|Other reasons|0|||
48706934|NCT01177397|156775885|FG001|Overall Study|Other reasons|0|||
48706935|NCT01177397|156775886|FG002|Overall Study|Other reasons|1|||
48706936|NCT01177397|156775887|FG003|Overall Study|Other reasons|0|||
48706937|NCT01177397|156775888|FG004|Overall Study|Other reasons|1|||
48706938|NCT01177397|156775889|FG005|Overall Study|Other reasons|1|||
48706939|NCT01177397|156775890|FG006|Overall Study|Other reasons|2|||
48706940|NCT01177397|156775891|FG007|Overall Study|Other reasons|6|||
48706941|NCT01177397|156775892|FG008|Overall Study|Other reasons|10|||
48706942|NCT01177397|156775893|FG009|Overall Study|Other reasons|8|||
48706943|NCT01177397|156775894|FG010|Overall Study|Other reasons|0|||
48800451|NCT02243280|157108288|FG006|Treated|Lost to Follow-up|0|||
48706944|NCT01177397|156775895|FG011|Overall Study|Other reasons|2|||
48800452|NCT02243280|157108289|FG007|Treated|Lost to Follow-up|0|||
48800453|NCT02243280|157108290|FG008|Treated|Lost to Follow-up|1|||
48800454|NCT02243280|157108291|FG009|Treated|Lost to Follow-up|0|||
48800455|NCT02243280|157108292|FG010|Treated|Lost to Follow-up|2|||
48913446|NCT02023242|157521118|FG001|Overall Study|Lost to Follow-up|1|||
48913447|NCT02023242|157521117|FG000|Overall Study|Death|0|||
48706945|NCT01760733|156775896|FG000|Waiting List|Death|18|||
48706946|NCT01760733|156775896|FG000|Waiting List|Removed from waiting list|41|||
48800456|NCT01783418|157108297|FG000|Overall Study|Withdrawal by Subject|1|||
48800457|NCT01783418|157108298|FG001|Overall Study|Withdrawal by Subject|0|||
48800458|NCT04279314|157108300|FG000|Overall Study|Adverse Event|55|||
48800459|NCT04279314|157108300|FG000|Overall Study|Withdrawal by Subject|5|||
48800460|NCT04279314|157108300|FG000|Overall Study|Lack of Efficacy|5|||
48800461|NCT04279314|157108300|FG000|Overall Study|Protocol Violation|3|||
48800462|NCT04279314|157108300|FG000|Overall Study|Other (not COVID-19 related)|2|||
48800463|NCT00415610|157108301|FG000|Overall Study|Death|3|||
48800464|NCT00415610|157108302|FG001|Overall Study|Death|2|||
48800465|NCT00415610|157108303|FG002|Overall Study|Death|5|||
48800466|NCT02459262|157108304|FG000|Overall Study|Withdrawal by Subject|0|||
48800467|NCT02459262|157108305|FG001|Overall Study|Withdrawal by Subject|0|||
48800468|NCT02459262|157108306|FG002|Overall Study|Withdrawal by Subject|0|||
48800469|NCT02459262|157108307|FG003|Overall Study|Withdrawal by Subject|0|||
48800470|NCT02459262|157108308|FG004|Overall Study|Withdrawal by Subject|0|||
48800471|NCT02459262|157108309|FG005|Overall Study|Withdrawal by Subject|0|||
48800472|NCT02459262|157108310|FG006|Overall Study|Withdrawal by Subject|0|||
48800473|NCT02459262|157108311|FG007|Overall Study|Withdrawal by Subject|0|||
48800474|NCT02459262|157108312|FG008|Overall Study|Withdrawal by Subject|0|||
48800475|NCT02459262|157108313|FG009|Overall Study|Withdrawal by Subject|1|||
48800476|NCT02459262|157108314|FG010|Overall Study|Withdrawal by Subject|0|||
48800477|NCT05168579|157108315|FG000|Overall Study|Lack of Consent|1|||
48800478|NCT05168579|157108316|FG001|Overall Study|Lack of Consent|0|||
48800479|NCT05168579|157108315|FG000|Overall Study|Conflicts with time|2|||
48800480|NCT05168579|157108316|FG001|Overall Study|Conflicts with time|0|||
48800481|NCT05168579|157108315|FG000|Overall Study|Time slots were full|3|||
48800482|NCT05168579|157108316|FG001|Overall Study|Time slots were full|0|||
48800483|NCT05168579|157108315|FG000|Overall Study|Lost to Follow-up|0|||
48800484|NCT05168579|157108316|FG001|Overall Study|Lost to Follow-up|15|||
48800485|NCT02691182|157108320|FG000|Overall Study|Withdrawal by Subject|4|||
48800486|NCT02691182|157108321|FG001|Overall Study|Withdrawal by Subject|7|||
48800487|NCT02691182|157108322|FG002|Overall Study|Withdrawal by Subject|6|||
48800488|NCT02691182|157108323|FG003|Overall Study|Withdrawal by Subject|8|||
48800489|NCT02691182|157108320|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
48800490|NCT02691182|157108321|FG001|Overall Study|Withdrawal by Parent/Guardian|47|||
48800491|NCT02691182|157108322|FG002|Overall Study|Withdrawal by Parent/Guardian|33|||
48800492|NCT02691182|157108323|FG003|Overall Study|Withdrawal by Parent/Guardian|38|||
48800493|NCT02691182|157108320|FG000|Overall Study|Lost to Follow-up|8|||
48800494|NCT02691182|157108321|FG001|Overall Study|Lost to Follow-up|33|||
48800495|NCT02691182|157108322|FG002|Overall Study|Lost to Follow-up|19|||
48800496|NCT02691182|157108323|FG003|Overall Study|Lost to Follow-up|22|||
48800497|NCT02691182|157108320|FG000|Overall Study|Adverse Event|3|||
48800498|NCT02691182|157108321|FG001|Overall Study|Adverse Event|10|||
48800499|NCT02691182|157108322|FG002|Overall Study|Adverse Event|10|||
48800500|NCT02691182|157108323|FG003|Overall Study|Adverse Event|11|||
48800501|NCT02691182|157108320|FG000|Overall Study|Physician Decision|3|||
48800502|NCT02691182|157108321|FG001|Overall Study|Physician Decision|7|||
48800503|NCT02691182|157108322|FG002|Overall Study|Physician Decision|14|||
48800504|NCT02691182|157108323|FG003|Overall Study|Physician Decision|8|||
48800505|NCT02691182|157108320|FG000|Overall Study|Lack of Efficacy|0|||
48800506|NCT02691182|157108321|FG001|Overall Study|Lack of Efficacy|0|||
48800507|NCT02691182|157108322|FG002|Overall Study|Lack of Efficacy|0|||
48800508|NCT02691182|157108323|FG003|Overall Study|Lack of Efficacy|4|||
48800509|NCT02691182|157108320|FG000|Overall Study|Protocol Violation|2|||
48800510|NCT02691182|157108321|FG001|Overall Study|Protocol Violation|6|||
48800511|NCT02691182|157108322|FG002|Overall Study|Protocol Violation|6|||
48800512|NCT02691182|157108323|FG003|Overall Study|Protocol Violation|8|||
48800513|NCT02691182|157108320|FG000|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|9|||
48800514|NCT02691182|157108321|FG001|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|43|||
48800515|NCT02691182|157108322|FG002|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|40|||
48800516|NCT02691182|157108323|FG003|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|58|||
48800517|NCT02691182|157108320|FG000|Overall Study|Missing|0|||
48800518|NCT02691182|157108321|FG001|Overall Study|Missing|5|||
48800519|NCT02691182|157108322|FG002|Overall Study|Missing|1|||
48800520|NCT02691182|157108323|FG003|Overall Study|Missing|5|||
48800521|NCT01114204|157108324|FG000|Overall Study|Adverse Event|3|||
48800522|NCT01114204|157108325|FG001|Overall Study|Adverse Event|2|||
48800523|NCT01114204|157108324|FG000|Overall Study|Lost to Follow-up|1|||
48800524|NCT01114204|157108325|FG001|Overall Study|Lost to Follow-up|0|||
48800525|NCT01114204|157108324|FG000|Overall Study|Withdrawal by Subject|10|||
48800526|NCT01114204|157108325|FG001|Overall Study|Withdrawal by Subject|6|||
48800527|NCT01114204|157108324|FG000|Overall Study|Death|1|||
48800528|NCT01114204|157108325|FG001|Overall Study|Death|0|||
48800529|NCT01114204|157108324|FG000|Overall Study|Other-Personal reasons|2|||
48800530|NCT01114204|157108325|FG001|Overall Study|Other-Personal reasons|0|||
48800531|NCT01114204|157108324|FG000|Overall Study|Other-Medical monitor request|1|||
48800532|NCT01114204|157108325|FG001|Overall Study|Other-Medical monitor request|0|||
48800533|NCT01114204|157108324|FG000|Overall Study|Other-Participant request|2|||
48913448|NCT02023242|157521118|FG001|Overall Study|Death|1|||
48913449|NCT05092919|157521119|FG000|Overall Study|Lost to Follow-up|7|||
48913450|NCT05092919|157521119|FG000|Overall Study|Withdrawal by Subject|2|||
48913451|NCT00710879|157521120|FG000|Overall Study|Lost to Follow-up|2|||
48706947|NCT01760733|156775896|FG000|Waiting List|Not received a transplant yet|13|||
48706948|NCT01760733|156775896|FG000|Transplanted|Not reached 10 years post transplant|184|||
48706949|NCT01760733|156775896|FG000|Transplanted|Death|26|||
48706950|NCT01760733|156775896|FG000|Transplanted|Graft loss|7|||
48706951|NCT00865566|156775897|FG000|Overall Study|Death|1|||
48706952|NCT00865566|156775898|FG001|Overall Study|Death|11|||
48706953|NCT00865566|156775897|FG000|Overall Study|Lost to Follow-up|314|||
48706954|NCT00865566|156775898|FG001|Overall Study|Lost to Follow-up|315|||
48706955|NCT00865566|156775897|FG000|Overall Study|Withdrawal by Subject|45|||
48706956|NCT00865566|156775898|FG001|Overall Study|Withdrawal by Subject|65|||
48706957|NCT00865566|156775897|FG000|Overall Study|Physician Decision|0|||
48706958|NCT00865566|156775898|FG001|Overall Study|Physician Decision|1|||
48706959|NCT00865566|156775897|FG000|Overall Study|Participant relocated|78|||
48706960|NCT00865566|156775898|FG001|Overall Study|Participant relocated|107|||
48706961|NCT00865566|156775897|FG000|Overall Study|Participant unable to adhere|27|||
48706962|NCT00865566|156775898|FG001|Overall Study|Participant unable to adhere|42|||
48706963|NCT00865566|156775897|FG000|Overall Study|Other; N=245 due to early study closure|154|||
48706964|NCT00865566|156775898|FG001|Overall Study|Other; N=245 due to early study closure|139|||
48706965|NCT00865566|156775897|FG000|Overall Study|HIV infection|5|||
48706966|NCT00865566|156775898|FG001|Overall Study|HIV infection|7|||
48706967|NCT03847896|156775901|FG000|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
48706968|NCT03847896|156775902|FG001|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
48706969|NCT03847896|156775903|FG002|Overall Study|Randomized in error and did not receive randomized study treatment|1|||
48706970|NCT03847896|156775904|FG003|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
48706971|NCT03847896|156775905|FG004|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
48706972|NCT03847896|156775901|FG000|Overall Study|Withdrawal by Subject|2|||
48706973|NCT03847896|156775902|FG001|Overall Study|Withdrawal by Subject|10|||
48706974|NCT03847896|156775903|FG002|Overall Study|Withdrawal by Subject|5|||
48706975|NCT03847896|156775904|FG003|Overall Study|Withdrawal by Subject|9|||
48706976|NCT03847896|156775905|FG004|Overall Study|Withdrawal by Subject|8|||
48706977|NCT03847896|156775901|FG000|Overall Study|Withdrawal by parent/guardian|0|||
48706978|NCT03847896|156775902|FG001|Overall Study|Withdrawal by parent/guardian|0|||
48706979|NCT03847896|156775903|FG002|Overall Study|Withdrawal by parent/guardian|1|||
48706980|NCT03847896|156775904|FG003|Overall Study|Withdrawal by parent/guardian|0|||
48706981|NCT03847896|156775905|FG004|Overall Study|Withdrawal by parent/guardian|0|||
48706982|NCT03847896|156775901|FG000|Overall Study|Adverse Event|2|||
48706983|NCT03847896|156775902|FG001|Overall Study|Adverse Event|1|||
48706984|NCT03847896|156775903|FG002|Overall Study|Adverse Event|3|||
48706985|NCT03847896|156775904|FG003|Overall Study|Adverse Event|2|||
48706986|NCT03847896|156775905|FG004|Overall Study|Adverse Event|4|||
48706987|NCT03847896|156775901|FG000|Overall Study|A severe exacerbation event|0|||
48706988|NCT03847896|156775902|FG001|Overall Study|A severe exacerbation event|0|||
48706989|NCT03847896|156775903|FG002|Overall Study|A severe exacerbation event|0|||
48706990|NCT03847896|156775904|FG003|Overall Study|A severe exacerbation event|0|||
48706991|NCT03847896|156775905|FG004|Overall Study|A severe exacerbation event|3|||
48706992|NCT03847896|156775901|FG000|Overall Study|Protocol Violation|0|||
48706993|NCT03847896|156775902|FG001|Overall Study|Protocol Violation|2|||
48706994|NCT03847896|156775903|FG002|Overall Study|Protocol Violation|1|||
48706995|NCT03847896|156775904|FG003|Overall Study|Protocol Violation|0|||
48706996|NCT03847896|156775905|FG004|Overall Study|Protocol Violation|2|||
48706997|NCT03847896|156775901|FG000|Overall Study|Lost to Follow-up|0|||
48706998|NCT03847896|156775902|FG001|Overall Study|Lost to Follow-up|0|||
48706999|NCT03847896|156775903|FG002|Overall Study|Lost to Follow-up|0|||
48707000|NCT03847896|156775904|FG003|Overall Study|Lost to Follow-up|1|||
48707001|NCT03847896|156775905|FG004|Overall Study|Lost to Follow-up|0|||
48707002|NCT03847896|156775901|FG000|Overall Study|Condition under investigation worsened|0|||
48707003|NCT03847896|156775902|FG001|Overall Study|Condition under investigation worsened|0|||
48707004|NCT03847896|156775903|FG002|Overall Study|Condition under investigation worsened|0|||
48707005|NCT03847896|156775904|FG003|Overall Study|Condition under investigation worsened|1|||
48707006|NCT03847896|156775905|FG004|Overall Study|Condition under investigation worsened|1|||
48707007|NCT03847896|156775901|FG000|Overall Study|Lack of Efficacy|0|||
48707008|NCT03847896|156775902|FG001|Overall Study|Lack of Efficacy|0|||
48707009|NCT03847896|156775903|FG002|Overall Study|Lack of Efficacy|0|||
48707010|NCT03847896|156775904|FG003|Overall Study|Lack of Efficacy|2|||
48707011|NCT03847896|156775905|FG004|Overall Study|Lack of Efficacy|2|||
48707012|NCT03847896|156775901|FG000|Overall Study|Other reasons|3|||
48913452|NCT00710879|157521121|FG001|Overall Study|Lost to Follow-up|1|||
49010688|NCT00095199|157875673|FG003|Overall Study|Data inadvertently lost by site|0|||
48707013|NCT03847896|156775902|FG001|Overall Study|Other reasons|3|||
48707014|NCT03847896|156775903|FG002|Overall Study|Other reasons|1|||
48707015|NCT03847896|156775904|FG003|Overall Study|Other reasons|2|||
49118798|NCT00460239|158273218|FG008|Overall Study|Withdrawal by Subject|0|||
49118799|NCT02028507|158273221|FG000|Overall Study|Progressive Disease|122|||
48707016|NCT03847896|156775905|FG004|Overall Study|Other reasons|1|||
48707017|NCT00753649|156775906|FG000|Overall Study|Migrated/moved from study area|1|||
48707018|NCT00753649|156775907|FG001|Overall Study|Migrated/moved from study area|0|||
48707019|NCT00753649|156775906|FG000|Overall Study|Lost to follow-up-incomplete vaccination|3|||
48707020|NCT00753649|156775907|FG001|Overall Study|Lost to follow-up-incomplete vaccination|0|||
48707021|NCT00753649|156775906|FG000|Overall Study|Lost to follow-up-complete vaccination|1|||
48707022|NCT00753649|156775907|FG001|Overall Study|Lost to follow-up-complete vaccination|0|||
48707023|NCT00753649|156775906|FG000|Overall Study|Protocol Violation|2|||
48707024|NCT00753649|156775907|FG001|Overall Study|Protocol Violation|0|||
48707025|NCT01255436|156775910|FG000|Overall Study|Lost to Follow-up|178|||
48707026|NCT01255436|156775911|FG001|Overall Study|Lost to Follow-up|191|||
48707027|NCT01255436|156775910|FG000|Overall Study|Death, stroke, or MI|4|||
48707028|NCT01255436|156775911|FG001|Overall Study|Death, stroke, or MI|3|||
48707029|NCT00602472|156775912|FG000|Overall Study|Adverse Event|5|||
48707030|NCT00602472|156775913|FG001|Overall Study|Adverse Event|23|||
48707031|NCT00602472|156775912|FG000|Overall Study|Protocol Violation|4|||
48707032|NCT00602472|156775913|FG001|Overall Study|Protocol Violation|19|||
48707033|NCT00602472|156775912|FG000|Overall Study|Withdrawal by Subject|8|||
48707034|NCT00602472|156775913|FG001|Overall Study|Withdrawal by Subject|14|||
48707035|NCT00602472|156775912|FG000|Overall Study|Other incl. lack of efficacy|4|||
48707036|NCT00602472|156775913|FG001|Overall Study|Other incl. lack of efficacy|2|||
48707037|NCT02803580|156775916|FG000|Overall Study|Death|13|||
48707038|NCT02803580|156775916|FG000|Overall Study|Lost to Follow-up|19|||
48707039|NCT02803580|156775916|FG000|Overall Study|Withdrawal by Subject|3|||
48707040|NCT02803580|156775916|FG000|Overall Study|Inclusion in clinical trial|1|||
48707041|NCT01554241|156775917|FG000|Overall Study|Death|3|||
48707042|NCT01554241|156775918|FG001|Overall Study|Death|1|||
48707043|NCT01554241|156775919|FG002|Overall Study|Death|1|||
48707044|NCT01554241|156775920|FG003|Overall Study|Death|0|||
48707045|NCT01554241|156775917|FG000|Overall Study|protocol specified renal stone|0|||
48707046|NCT01554241|156775918|FG001|Overall Study|protocol specified renal stone|0|||
48707047|NCT01554241|156775919|FG002|Overall Study|protocol specified renal stone|0|||
48707048|NCT01554241|156775920|FG003|Overall Study|protocol specified renal stone|1|||
48707049|NCT01554241|156775917|FG000|Overall Study|protocol specified change in eGFR|0|||
48707050|NCT01554241|156775918|FG001|Overall Study|protocol specified change in eGFR|0|||
48707051|NCT01554241|156775919|FG002|Overall Study|protocol specified change in eGFR|1|||
48707052|NCT01554241|156775920|FG003|Overall Study|protocol specified change in eGFR|0|||
48707053|NCT01554241|156775917|FG000|Overall Study|Withdrawal by Subject|0|||
48707054|NCT01554241|156775918|FG001|Overall Study|Withdrawal by Subject|0|||
48707055|NCT01554241|156775919|FG002|Overall Study|Withdrawal by Subject|2|||
48707056|NCT01554241|156775920|FG003|Overall Study|Withdrawal by Subject|0|||
48707057|NCT02215252|156775921|FG000|Overall Study|Adverse Event|1|||
48707058|NCT02215252|156775922|FG001|Overall Study|Adverse Event|5|||
48707059|NCT02215252|156775923|FG002|Overall Study|Adverse Event|2|||
48707060|NCT02215252|156775921|FG000|Overall Study|Lost to Follow-up|0|||
48707061|NCT02215252|156775922|FG001|Overall Study|Lost to Follow-up|0|||
48707062|NCT02215252|156775923|FG002|Overall Study|Lost to Follow-up|1|||
48707063|NCT02215252|156775921|FG000|Overall Study|Does not Meet Entrance Criteria|0|||
48707064|NCT02215252|156775922|FG001|Overall Study|Does not Meet Entrance Criteria|1|||
48707065|NCT02215252|156775923|FG002|Overall Study|Does not Meet Entrance Criteria|0|||
48707066|NCT02215252|156775921|FG000|Overall Study|Protocol Violation|0|||
48707067|NCT02215252|156775922|FG001|Overall Study|Protocol Violation|1|||
48707068|NCT02215252|156775923|FG002|Overall Study|Protocol Violation|0|||
48707069|NCT02215252|156775921|FG000|Overall Study|Withdrawal by Subject|1|||
48707070|NCT02215252|156775922|FG001|Overall Study|Withdrawal by Subject|0|||
48707071|NCT02215252|156775923|FG002|Overall Study|Withdrawal by Subject|0|||
48707072|NCT02215252|156775921|FG000|Overall Study|Other|0|||
48707073|NCT02215252|156775922|FG001|Overall Study|Other|1|||
48707074|NCT02215252|156775923|FG002|Overall Study|Other|1|||
48707075|NCT00892099|156775924|FG000|Overall Study|Death|1|||
48707076|NCT00892099|156775925|FG001|Overall Study|Death|0|||
48707077|NCT00892099|156775926|FG002|Overall Study|Death|1|||
48707078|NCT00892099|156775924|FG000|Overall Study|Adverse Event|1|||
48707079|NCT00892099|156775925|FG001|Overall Study|Adverse Event|0|||
48707080|NCT00892099|156775926|FG002|Overall Study|Adverse Event|0|||
48707081|NCT00892099|156775924|FG000|Overall Study|replocated|1|||
48707082|NCT00892099|156775925|FG001|Overall Study|replocated|0|||
48707083|NCT00892099|156775926|FG002|Overall Study|replocated|2|||
48707084|NCT00892099|156775924|FG000|Overall Study|Prolonged hospitalization|1|||
48707085|NCT00892099|156775925|FG001|Overall Study|Prolonged hospitalization|0|||
48707086|NCT00892099|156775926|FG002|Overall Study|Prolonged hospitalization|1|||
48707087|NCT00892099|156775924|FG000|Overall Study|no further details|1|||
48707088|NCT00892099|156775925|FG001|Overall Study|no further details|0|||
48707089|NCT00892099|156775926|FG002|Overall Study|no further details|1|||
48800534|NCT01114204|157108325|FG001|Overall Study|Other-Participant request|0|||
48800535|NCT01114204|157108324|FG000|Overall Study|Other-Protocol Violation|1|||
48800536|NCT01114204|157108325|FG001|Overall Study|Other-Protocol Violation|0|||
48800537|NCT00863655|157108328|FG000|Overall Study|Protocol Violation|4|||
48800538|NCT00863655|157108329|FG001|Overall Study|Protocol Violation|0|||
48800539|NCT00863655|157108328|FG000|Overall Study|Adverse Event|52|||
48800540|NCT00863655|157108329|FG001|Overall Study|Adverse Event|8|||
48800541|NCT00863655|157108328|FG000|Overall Study|Withdrawal by Subject|47|||
48800542|NCT00863655|157108329|FG001|Overall Study|Withdrawal by Subject|7|||
48800543|NCT00863655|157108328|FG000|Overall Study|Administrative problems|1|||
48800544|NCT00863655|157108329|FG001|Overall Study|Administrative problems|0|||
48707090|NCT00892099|156775924|FG000|Overall Study|kidney function recovered|0|||
48707091|NCT00892099|156775925|FG001|Overall Study|kidney function recovered|1|||
48707092|NCT00892099|156775926|FG002|Overall Study|kidney function recovered|0|||
48707093|NCT00892099|156775924|FG000|Overall Study|investigator decision|0|||
48707094|NCT00892099|156775925|FG001|Overall Study|investigator decision|0|||
48707095|NCT00892099|156775926|FG002|Overall Study|investigator decision|1|||
48707096|NCT00892099|156775924|FG000|Overall Study|Lost to Follow-up|0|||
48707097|NCT00892099|156775925|FG001|Overall Study|Lost to Follow-up|0|||
48707098|NCT00892099|156775926|FG002|Overall Study|Lost to Follow-up|1|||
48707099|NCT02346721|156775927|FG000|Overall Study|Withdrew Consent|3|||
48707100|NCT02346721|156775927|FG000|Overall Study|Lack of Efficacy|1|||
48707101|NCT04543279|156775932|FG000|Overall Study|Withdrawal by Subject|1|||
48707102|NCT04543279|156775933|FG001|Overall Study|Withdrawal by Subject|0|||
48707103|NCT04543279|156775932|FG000|Overall Study|Adverse Event|1|||
48707104|NCT04543279|156775933|FG001|Overall Study|Adverse Event|0|||
48707105|NCT04543279|156775932|FG000|Overall Study|Physician Decision|1|||
48707106|NCT04543279|156775933|FG001|Overall Study|Physician Decision|0|||
48707107|NCT05038982|156775936|FG000|Overall Study|Withdrawal by Subject|0|||
48707108|NCT05038982|156775937|FG001|Overall Study|Withdrawal by Subject|2|||
48707109|NCT04411667|156775943|FG000|Overall Study|Physician Decision|1|||
48707110|NCT04411667|156775944|FG001|Overall Study|Physician Decision|0|||
48707111|NCT02699749|156775951|FG000|Overall Study|Other|0|||
48707112|NCT02699749|156775952|FG001|Overall Study|Other|0|||
48707113|NCT02699749|156775953|FG002|Overall Study|Other|2|||
48707114|NCT02699749|156775954|FG003|Overall Study|Other|0|||
48707115|NCT02699749|156775955|FG004|Overall Study|Other|0|||
48707116|NCT02699749|156775956|FG005|Overall Study|Other|1|||
48707117|NCT02699749|156775957|FG006|Overall Study|Other|1|||
48707118|NCT02699749|156775958|FG007|Overall Study|Other|0|||
48707119|NCT02699749|156775959|FG008|Overall Study|Other|0|||
48707120|NCT02699749|156775960|FG009|Overall Study|Other|0|||
48707121|NCT02699749|156775961|FG010|Overall Study|Other|1|||
48707122|NCT02699749|156775962|FG011|Overall Study|Other|0|||
48707123|NCT02699749|156775963|FG012|Overall Study|Other|0|||
48707124|NCT02699749|156775964|FG013|Overall Study|Other|0|||
48707125|NCT02699749|156775951|FG000|Overall Study|Progressive Disease|3|||
48707126|NCT02699749|156775952|FG001|Overall Study|Progressive Disease|3|||
48707127|NCT02699749|156775953|FG002|Overall Study|Progressive Disease|14|||
48707128|NCT02699749|156775954|FG003|Overall Study|Progressive Disease|3|||
48707129|NCT02699749|156775955|FG004|Overall Study|Progressive Disease|3|||
48707130|NCT02699749|156775956|FG005|Overall Study|Progressive Disease|7|||
48707131|NCT02699749|156775957|FG006|Overall Study|Progressive Disease|5|||
48707132|NCT02699749|156775958|FG007|Overall Study|Progressive Disease|5|||
48707133|NCT02699749|156775959|FG008|Overall Study|Progressive Disease|6|||
48707134|NCT02699749|156775960|FG009|Overall Study|Progressive Disease|6|||
48707135|NCT02699749|156775961|FG010|Overall Study|Progressive Disease|5|||
48707136|NCT02699749|156775962|FG011|Overall Study|Progressive Disease|4|||
48707137|NCT02699749|156775963|FG012|Overall Study|Progressive Disease|3|||
48707138|NCT02699749|156775964|FG013|Overall Study|Progressive Disease|5|||
48707139|NCT02699749|156775951|FG000|Overall Study|Death|0|||
48707140|NCT02699749|156775952|FG001|Overall Study|Death|0|||
48707141|NCT02699749|156775953|FG002|Overall Study|Death|0|||
48707142|NCT02699749|156775954|FG003|Overall Study|Death|0|||
48800545|NCT00863655|157108328|FG000|Overall Study|Death|7|||
48800546|NCT00863655|157108329|FG001|Overall Study|Death|1|||
48800547|NCT00863655|157108328|FG000|Overall Study|New cancer therapy|5|||
48707143|NCT02699749|156775955|FG004|Overall Study|Death|0|||
48707144|NCT02699749|156775956|FG005|Overall Study|Death|0|||
48707145|NCT02699749|156775957|FG006|Overall Study|Death|0|||
48707146|NCT02699749|156775958|FG007|Overall Study|Death|0|||
48707147|NCT02699749|156775959|FG008|Overall Study|Death|0|||
48707148|NCT02699749|156775960|FG009|Overall Study|Death|0|||
48707149|NCT02699749|156775961|FG010|Overall Study|Death|0|||
48707150|NCT02699749|156775962|FG011|Overall Study|Death|0|||
48707151|NCT02699749|156775963|FG012|Overall Study|Death|0|||
48707152|NCT02699749|156775964|FG013|Overall Study|Death|1|||
48707153|NCT02699749|156775951|FG000|Overall Study|Lost to Follow-up|0|||
48707154|NCT02699749|156775952|FG001|Overall Study|Lost to Follow-up|0|||
48707155|NCT02699749|156775953|FG002|Overall Study|Lost to Follow-up|0|||
48707156|NCT02699749|156775954|FG003|Overall Study|Lost to Follow-up|0|||
48707157|NCT02699749|156775955|FG004|Overall Study|Lost to Follow-up|0|||
48800548|NCT00863655|157108329|FG001|Overall Study|New cancer therapy|1|||
48800549|NCT00863655|157108328|FG000|Overall Study|Disease progression|364|||
48800550|NCT00863655|157108329|FG001|Overall Study|Disease progression|221|||
48800551|NCT00863655|157108328|FG000|Overall Study|Treatment completed as per protocol|5|||
48800552|NCT00863655|157108329|FG001|Overall Study|Treatment completed as per protocol|1|||
48800553|NCT01197508|157108330|FG000|Overall Study|Withdrawal by Subject|8|||
48800554|NCT01197508|157108331|FG001|Overall Study|Withdrawal by Subject|7|||
48800555|NCT01197508|157108332|FG002|Overall Study|Withdrawal by Subject|15|||
49118800|NCT02028507|158273222|FG001|Overall Study|Progressive Disease|90|||
49118801|NCT02028507|158273223|FG002|Overall Study|Progressive Disease|102|||
49118802|NCT02028507|158273224|FG003|Overall Study|Progressive Disease|89|||
49118803|NCT02028507|158273221|FG000|Overall Study|Adverse Event|8|||
49118804|NCT02028507|158273222|FG001|Overall Study|Adverse Event|25|||
48707158|NCT02699749|156775956|FG005|Overall Study|Lost to Follow-up|1|||
48707159|NCT02699749|156775957|FG006|Overall Study|Lost to Follow-up|0|||
48707160|NCT02699749|156775958|FG007|Overall Study|Lost to Follow-up|1|||
48707161|NCT02699749|156775959|FG008|Overall Study|Lost to Follow-up|0|||
48707162|NCT02699749|156775960|FG009|Overall Study|Lost to Follow-up|0|||
48707163|NCT02699749|156775961|FG010|Overall Study|Lost to Follow-up|0|||
48707164|NCT02699749|156775962|FG011|Overall Study|Lost to Follow-up|0|||
48707165|NCT02699749|156775963|FG012|Overall Study|Lost to Follow-up|0|||
48707166|NCT02699749|156775964|FG013|Overall Study|Lost to Follow-up|0|||
48707167|NCT02357368|156775965|FG000|Overall Study|Lost to Follow-up|0|||
48707168|NCT02357368|156775966|FG001|Overall Study|Lost to Follow-up|0|||
48707169|NCT02357368|156775967|FG002|Overall Study|Lost to Follow-up|0|||
48707170|NCT02357368|156775968|FG003|Overall Study|Lost to Follow-up|1|||
48707171|NCT02357368|156775965|FG000|Overall Study|Pregnancy|3|||
49118805|NCT02028507|158273223|FG002|Overall Study|Adverse Event|3|||
49118806|NCT02028507|158273224|FG003|Overall Study|Adverse Event|16|||
49118807|NCT02028507|158273221|FG000|Overall Study|Withdrawal by Subject|6|||
49118808|NCT02028507|158273222|FG001|Overall Study|Withdrawal by Subject|8|||
48707172|NCT02357368|156775966|FG001|Overall Study|Pregnancy|2|||
48800556|NCT01197508|157108333|FG003|Overall Study|Withdrawal by Subject|4|||
48800557|NCT01197508|157108330|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
48800558|NCT01197508|157108331|FG001|Overall Study|Eligiblity criteria not fulfilled|0|||
48800559|NCT01197508|157108332|FG002|Overall Study|Eligiblity criteria not fulfilled|2|||
48800560|NCT01197508|157108333|FG003|Overall Study|Eligiblity criteria not fulfilled|0|||
48800561|NCT01197508|157108330|FG000|Overall Study|Adverse Event|10|||
48800562|NCT01197508|157108331|FG001|Overall Study|Adverse Event|13|||
49118809|NCT02028507|158273223|FG002|Overall Study|Withdrawal by Subject|5|||
48707173|NCT02357368|156775967|FG002|Overall Study|Pregnancy|0|||
48707174|NCT02357368|156775968|FG003|Overall Study|Pregnancy|0|||
48707175|NCT02357368|156775965|FG000|Overall Study|Withdrawal by Subject|3|||
48707176|NCT02357368|156775966|FG001|Overall Study|Withdrawal by Subject|1|||
48800563|NCT01197508|157108332|FG002|Overall Study|Adverse Event|23|||
48800564|NCT01197508|157108333|FG003|Overall Study|Adverse Event|3|||
48800565|NCT01197508|157108330|FG000|Overall Study|Severe non-compliance to protocol|0|||
48800566|NCT01197508|157108331|FG001|Overall Study|Severe non-compliance to protocol|3|||
48800567|NCT01197508|157108332|FG002|Overall Study|Severe non-compliance to protocol|1|||
48800568|NCT01197508|157108333|FG003|Overall Study|Severe non-compliance to protocol|3|||
48800569|NCT01197508|157108330|FG000|Overall Study|Condition under investigation worsened|1|||
48800570|NCT01197508|157108331|FG001|Overall Study|Condition under investigation worsened|1|||
48800571|NCT01197508|157108332|FG002|Overall Study|Condition under investigation worsened|1|||
48800572|NCT01197508|157108333|FG003|Overall Study|Condition under investigation worsened|1|||
48800573|NCT01197508|157108330|FG000|Overall Study|Lack of Efficacy|1|||
48800574|NCT01197508|157108331|FG001|Overall Study|Lack of Efficacy|2|||
48800575|NCT01197508|157108332|FG002|Overall Study|Lack of Efficacy|2|||
48800576|NCT01197508|157108333|FG003|Overall Study|Lack of Efficacy|1|||
48800577|NCT01197508|157108330|FG000|Overall Study|Study-specific withdrawal criteria|0|||
48800578|NCT01197508|157108331|FG001|Overall Study|Study-specific withdrawal criteria|0|||
48800579|NCT01197508|157108332|FG002|Overall Study|Study-specific withdrawal criteria|1|||
48800580|NCT01197508|157108333|FG003|Overall Study|Study-specific withdrawal criteria|2|||
48800581|NCT01197508|157108330|FG000|Overall Study|Lost to Follow-up|1|||
48800582|NCT01197508|157108331|FG001|Overall Study|Lost to Follow-up|1|||
48800583|NCT01197508|157108332|FG002|Overall Study|Lost to Follow-up|2|||
48800584|NCT01197508|157108333|FG003|Overall Study|Lost to Follow-up|0|||
48800585|NCT01197508|157108330|FG000|Overall Study|Other|2|||
48800586|NCT01197508|157108331|FG001|Overall Study|Other|3|||
48800587|NCT01197508|157108332|FG002|Overall Study|Other|2|||
48800588|NCT01197508|157108333|FG003|Overall Study|Other|2|||
48800589|NCT03295318|157108334|FG000|Overall Study|Withdrawal by Subject prior to initial vaccination|1|||
48800590|NCT03295318|157108335|FG001|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
48800591|NCT03295318|157108336|FG002|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
48800592|NCT03295318|157108334|FG000|Overall Study|Death|1|||
48800593|NCT03295318|157108335|FG001|Overall Study|Death|1|||
48800594|NCT03295318|157108336|FG002|Overall Study|Death|1|||
48800595|NCT03295318|157108334|FG000|Overall Study|Protocol Violation|4|||
48800596|NCT03295318|157108335|FG001|Overall Study|Protocol Violation|3|||
48800597|NCT03295318|157108336|FG002|Overall Study|Protocol Violation|3|||
48800598|NCT03295318|157108334|FG000|Overall Study|Withdrawal by Subject|0|||
48800599|NCT03295318|157108335|FG001|Overall Study|Withdrawal by Subject|0|||
48800600|NCT03295318|157108336|FG002|Overall Study|Withdrawal by Subject|1|||
48800601|NCT03295318|157108334|FG000|Overall Study|Subject discontinued due to travel|0|||
48800602|NCT03295318|157108335|FG001|Overall Study|Subject discontinued due to travel|1|||
48800603|NCT03295318|157108336|FG002|Overall Study|Subject discontinued due to travel|0|||
48800604|NCT00266825|157108337|FG000|Completed Follow-Up|Lost to Follow-up|14|||
48800605|NCT00266825|157108338|FG001|Completed Follow-Up|Lost to Follow-up|19|||
48800606|NCT00266825|157108337|FG000|Completed Follow-Up|Withdrawal by Subject|11|||
48800607|NCT00266825|157108338|FG001|Completed Follow-Up|Withdrawal by Subject|5|||
48800608|NCT01078155|157108339|FG000|Overall Study|Adverse Event|7|||
48800609|NCT01078155|157108339|FG000|Overall Study|Lack of Efficacy|16|||
48913453|NCT00710879|157521120|FG000|Overall Study|Protocol Violation|0|||
48913454|NCT00710879|157521121|FG001|Overall Study|Protocol Violation|3|||
48913455|NCT03104075|157521124|FG000|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|1|||
48913456|NCT03104075|157521125|FG001|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|0|||
48913457|NCT03281668|157521127|FG000|Overall Study|Physician Decision|1|||
48800610|NCT01078155|157108339|FG000|Overall Study|Participant's Decision|6|||
48800611|NCT01078155|157108339|FG000|Overall Study|Lost to Follow-up|15|||
48800612|NCT01127646|157108342|FG000|Overall Study|Entry Criteria Not Met|1|||
48800613|NCT01127646|157108343|FG001|Overall Study|Entry Criteria Not Met|0|||
48800614|NCT01127646|157108342|FG000|Overall Study|Protocol Violation|0|||
48800615|NCT01127646|157108343|FG001|Overall Study|Protocol Violation|1|||
48800616|NCT01966003|157108347|FG000|Overall Study|Death|43|||
48913458|NCT03281668|157521127|FG000|Overall Study|scheduling conflict, family circumstance|2|||
49118810|NCT02028507|158273224|FG003|Overall Study|Withdrawal by Subject|9|||
48800617|NCT01966003|157108348|FG001|Overall Study|Death|36|||
48800618|NCT01966003|157108347|FG000|Overall Study|Protocol Violation|6|||
48800619|NCT01966003|157108348|FG001|Overall Study|Protocol Violation|4|||
48800620|NCT01966003|157108347|FG000|Overall Study|Lost to Follow-up|4|||
48800621|NCT01966003|157108348|FG001|Overall Study|Lost to Follow-up|3|||
48800622|NCT01966003|157108347|FG000|Overall Study|Physician Decision|12|||
48800623|NCT01966003|157108348|FG001|Overall Study|Physician Decision|13|||
48800624|NCT01966003|157108347|FG000|Overall Study|Withdrawal by Subject|29|||
48800625|NCT01966003|157108348|FG001|Overall Study|Withdrawal by Subject|19|||
48800626|NCT01966003|157108347|FG000|Overall Study|Plan to Receive Other Anticancer Therapy|131|||
48800627|NCT01966003|157108348|FG001|Overall Study|Plan to Receive Other Anticancer Therapy|127|||
48800628|NCT01966003|157108347|FG000|Overall Study|Plan to Receive Commercial Bevacizumab|44|||
48800629|NCT01966003|157108348|FG001|Overall Study|Plan to Receive Commercial Bevacizumab|67|||
48800630|NCT01966003|157108347|FG000|Overall Study|Other|1|||
48913459|NCT03281668|157521127|FG000|Overall Study|Withdrawal by Subject|4|||
48913460|NCT03281668|157521127|FG000|Overall Study|Lost to Follow-up|1|||
48913461|NCT01469182|157521128|FG000|Overall Study|Adverse Event|21|||
48913462|NCT01469182|157521129|FG001|Overall Study|Adverse Event|3|||
48913463|NCT01469182|157521128|FG000|Overall Study|Lost to Follow-up|3|||
48913464|NCT01469182|157521129|FG001|Overall Study|Lost to Follow-up|0|||
48913465|NCT01469182|157521128|FG000|Overall Study|Withdrawal by Subject|4|||
48913466|NCT01469182|157521129|FG001|Overall Study|Withdrawal by Subject|1|||
48913467|NCT01469182|157521128|FG000|Overall Study|Protocol Violation|4|||
48800631|NCT01966003|157108348|FG001|Overall Study|Other|1|||
48800632|NCT03466086|157108351|FG000|Period 1|Sponsor decision due to study timeline|1|||
48800633|NCT03466086|157108352|FG001|Period 1|Sponsor decision due to study timeline|0|||
48800634|NCT03466086|157108351|FG000|Period 1|Withdrawal by Subject|1|||
48913468|NCT01469182|157521129|FG001|Overall Study|Protocol Violation|2|||
48913469|NCT01469182|157521128|FG000|Overall Study|Did not meet Protocol Eligibility|3|||
48800635|NCT03466086|157108352|FG001|Period 1|Withdrawal by Subject|0|||
48800636|NCT01477853|157108353|FG000|Phase A|Adverse Event|1|||
48800637|NCT01477853|157108354|FG001|Phase A|Adverse Event|2|||
48800638|NCT01477853|157108355|FG002|Phase A|Adverse Event|2|||
48800639|NCT01477853|157108353|FG000|Phase A|Lost to Follow-up|4|||
48913470|NCT01469182|157521129|FG001|Overall Study|Did not meet Protocol Eligibility|0|||
48913471|NCT01516970|157521130|FG000|Overall Study|Lost to Follow-up|7|||
48913472|NCT01516970|157521131|FG001|Overall Study|Lost to Follow-up|8|||
48913473|NCT01516970|157521130|FG000|Overall Study|Adverse Event|1|||
48913474|NCT01516970|157521131|FG001|Overall Study|Adverse Event|5|||
49118811|NCT02028507|158273221|FG000|Overall Study|Protocol Violation|2|||
49118812|NCT02028507|158273222|FG001|Overall Study|Protocol Violation|4|||
48707177|NCT02357368|156775967|FG002|Overall Study|Withdrawal by Subject|1|||
48707178|NCT02357368|156775968|FG003|Overall Study|Withdrawal by Subject|2|||
48707179|NCT02565108|156775969|FG000|Overall Study|Adverse Event|1|||
48707180|NCT02565108|156775970|FG001|Overall Study|Adverse Event|0|||
48707181|NCT02565108|156775969|FG000|Overall Study|Withdrew Consent|1|||
48707182|NCT02565108|156775970|FG001|Overall Study|Withdrew Consent|0|||
48707183|NCT00048074|156775971|FG000|Overall Study|Adverse Event|46|||
48707184|NCT00048074|156775972|FG001|Overall Study|Adverse Event|41|||
48707185|NCT00048074|156775973|FG002|Overall Study|Adverse Event|53|||
48707186|NCT00048074|156775971|FG000|Overall Study|Death|3|||
48707187|NCT00048074|156775972|FG001|Overall Study|Death|3|||
48707188|NCT00048074|156775973|FG002|Overall Study|Death|2|||
48707189|NCT00048074|156775971|FG000|Overall Study|Lost to Follow-up|2|||
48707190|NCT00048074|156775972|FG001|Overall Study|Lost to Follow-up|6|||
48707191|NCT00048074|156775973|FG002|Overall Study|Lost to Follow-up|6|||
48707192|NCT00048074|156775971|FG000|Overall Study|Withdrawal by Subject|28|||
48707193|NCT00048074|156775972|FG001|Overall Study|Withdrawal by Subject|30|||
48707194|NCT00048074|156775973|FG002|Overall Study|Withdrawal by Subject|35|||
48707195|NCT00048074|156775971|FG000|Overall Study|Protocol Violation|1|||
48707196|NCT00048074|156775972|FG001|Overall Study|Protocol Violation|3|||
48707197|NCT00048074|156775973|FG002|Overall Study|Protocol Violation|0|||
48707198|NCT00048074|156775971|FG000|Overall Study|Study participation was terminated|0|||
48707199|NCT00048074|156775972|FG001|Overall Study|Study participation was terminated|1|||
48707200|NCT00048074|156775973|FG002|Overall Study|Study participation was terminated|0|||
48707201|NCT00048074|156775971|FG000|Overall Study|Husband ill|0|||
48707202|NCT00048074|156775972|FG001|Overall Study|Husband ill|1|||
48707203|NCT00048074|156775973|FG002|Overall Study|Husband ill|0|||
48707204|NCT00048074|156775971|FG000|Overall Study|Poor compliance|0|||
48707205|NCT00048074|156775972|FG001|Overall Study|Poor compliance|1|||
48707206|NCT00048074|156775973|FG002|Overall Study|Poor compliance|0|||
48707207|NCT00048074|156775971|FG000|Overall Study|Out of station|0|||
48707208|NCT00048074|156775972|FG001|Overall Study|Out of station|1|||
48707209|NCT00048074|156775973|FG002|Overall Study|Out of station|1|||
48707210|NCT00048074|156775971|FG000|Overall Study|Social reasons|1|||
48707211|NCT00048074|156775972|FG001|Overall Study|Social reasons|0|||
48707212|NCT00048074|156775973|FG002|Overall Study|Social reasons|0|||
48707213|NCT02873377|156775974|FG000|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
48707214|NCT02873377|156775975|FG001|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
48800640|NCT01477853|157108354|FG001|Phase A|Lost to Follow-up|3|||
48800641|NCT01477853|157108355|FG002|Phase A|Lost to Follow-up|2|||
48707215|NCT02873377|156775974|FG000|Period Title 3: 6 Months Follow up|Lost to Follow-up|15|||
48707216|NCT02873377|156775975|FG001|Period Title 3: 6 Months Follow up|Lost to Follow-up|23|||
48707217|NCT01587924|156775976|FG000|Overall Study|Adverse Event|0|||
48707218|NCT01587924|156775977|FG001|Overall Study|Adverse Event|2|||
48707219|NCT01587924|156775978|FG002|Overall Study|Adverse Event|0|||
48707220|NCT01587924|156775979|FG003|Overall Study|Adverse Event|0|||
48707221|NCT01587924|156775976|FG000|Overall Study|Protocol Violation|2|||
48707222|NCT01587924|156775977|FG001|Overall Study|Protocol Violation|1|||
48913475|NCT01516970|157521130|FG000|Overall Study|Withdrawal by Subject|1|||
48913476|NCT01516970|157521131|FG001|Overall Study|Withdrawal by Subject|1|||
48913477|NCT01516970|157521130|FG000|Overall Study|Other|9|||
48913478|NCT01516970|157521131|FG001|Overall Study|Other|7|||
48800642|NCT01477853|157108353|FG000|Phase A|Physician Decision|1|||
48800643|NCT01477853|157108354|FG001|Phase A|Physician Decision|0|||
48800644|NCT01477853|157108355|FG002|Phase A|Physician Decision|1|||
48800645|NCT01477853|157108353|FG000|Phase A|Study terminated by sponsor|37|||
48800646|NCT01477853|157108354|FG001|Phase A|Study terminated by sponsor|40|||
48800647|NCT01477853|157108355|FG002|Phase A|Study terminated by sponsor|39|||
48800648|NCT01477853|157108353|FG000|Phase B|Lost to Follow-up|0|||
48800649|NCT01477853|157108354|FG001|Phase B|Lost to Follow-up|1|||
48800650|NCT01477853|157108355|FG002|Phase B|Lost to Follow-up|0|||
48800651|NCT01477853|157108353|FG000|Phase B|Study terminated by sponsor|12|||
48800652|NCT01477853|157108354|FG001|Phase B|Study terminated by sponsor|10|||
48800653|NCT01477853|157108355|FG002|Phase B|Study terminated by sponsor|11|||
48800654|NCT03086330|157108356|FG000|Overall Study|Withdrawal by Subject|3|||
48800655|NCT03086330|157108357|FG001|Overall Study|Withdrawal by Subject|2|||
48800656|NCT03086330|157108356|FG000|Overall Study|Lost to Follow-up|1|||
48800657|NCT03086330|157108357|FG001|Overall Study|Lost to Follow-up|2|||
48800658|NCT01814748|157108366|FG000|Overall Study|Lost to Follow-up|1|||
48800659|NCT01814748|157108367|FG001|Overall Study|Lost to Follow-up|2|||
48800660|NCT01814748|157108366|FG000|Overall Study|Study site terminated by sponsor|1|||
48800661|NCT01814748|157108367|FG001|Overall Study|Study site terminated by sponsor|1|||
48800662|NCT01814748|157108366|FG000|Overall Study|Withdrawal by Subject|6|||
48800663|NCT01814748|157108367|FG001|Overall Study|Withdrawal by Subject|4|||
48800664|NCT01591382|157108368|FG000|Overall Study|Discharged Prior to Study Completion|2|||
48800665|NCT01591382|157108369|FG001|Overall Study|Discharged Prior to Study Completion|1|||
48800666|NCT01591382|157108368|FG000|Overall Study|Participant Opted for Morphine PCA|1|||
48800667|NCT01591382|157108369|FG001|Overall Study|Participant Opted for Morphine PCA|1|||
48800668|NCT02274857|157108370|FG000|Overall Study|Adverse Event|1|||
48800669|NCT02274857|157108371|FG001|Overall Study|Adverse Event|0|||
48800670|NCT02274857|157108370|FG000|Overall Study|Death|1|||
48800671|NCT02274857|157108371|FG001|Overall Study|Death|2|||
48800672|NCT02274857|157108370|FG000|Overall Study|Lost to Follow-up|3|||
48800673|NCT02274857|157108371|FG001|Overall Study|Lost to Follow-up|0|||
48800674|NCT02274857|157108370|FG000|Overall Study|Physician Decision|2|||
48800675|NCT02274857|157108371|FG001|Overall Study|Physician Decision|0|||
48800676|NCT02274857|157108370|FG000|Overall Study|Trial screen failure|0|||
48800677|NCT02274857|157108371|FG001|Overall Study|Trial screen failure|2|||
48800678|NCT02274857|157108370|FG000|Overall Study|Withdrawal by Subject|11|||
48800679|NCT02274857|157108371|FG001|Overall Study|Withdrawal by Subject|2|||
48800680|NCT02274857|157108370|FG000|Overall Study|Other|2|||
48800681|NCT02274857|157108371|FG001|Overall Study|Other|0|||
48800682|NCT00716092|157108372|FG000|Overall Study|Other incl. Lack of Efficacy|2|||
48800683|NCT00716092|157108373|FG001|Overall Study|Other incl. Lack of Efficacy|1|||
48800684|NCT00716092|157108374|FG002|Overall Study|Other incl. Lack of Efficacy|0|||
48800685|NCT02316769|157108376|FG000|Overall Study|Physician Decision|1|||
48800686|NCT02316769|157108377|FG001|Overall Study|Physician Decision|0|||
48800687|NCT02316769|157108376|FG000|Overall Study|Withdrawal by Subject|1|||
48800688|NCT02316769|157108377|FG001|Overall Study|Withdrawal by Subject|0|||
48800689|NCT02054806|157108378|FG000|Overall Study|Sponsor Decision|31|||
48800690|NCT02054806|157108378|FG000|Overall Study|Withdrawal by Subject|43|||
48800691|NCT02054806|157108378|FG000|Overall Study|Protocol Violation|2|||
48800692|NCT02054806|157108378|FG000|Overall Study|Lost to Follow-up|10|||
48800693|NCT02054806|157108378|FG000|Overall Study|Death|391|||
48800694|NCT00855062|157108381|FG000|Step1|Early Study Closure|5|||
48800695|NCT00855062|157108382|FG001|Step1|Early Study Closure|7|||
48800696|NCT00855062|157108381|FG000|Step1|Adverse Event|1|||
48800697|NCT00855062|157108382|FG001|Step1|Adverse Event|1|||
48800698|NCT00855062|157108381|FG000|Step1|Protocol Violation|1|||
48800699|NCT00855062|157108382|FG001|Step1|Protocol Violation|0|||
49118813|NCT02028507|158273223|FG002|Overall Study|Protocol Violation|1|||
49118814|NCT02028507|158273224|FG003|Overall Study|Protocol Violation|3|||
49118815|NCT02028507|158273221|FG000|Overall Study|Physician Decision|0|||
49118816|NCT02028507|158273222|FG001|Overall Study|Physician Decision|4|||
49118817|NCT02028507|158273223|FG002|Overall Study|Physician Decision|0|||
49118818|NCT02028507|158273224|FG003|Overall Study|Physician Decision|0|||
48800700|NCT00855062|157108381|FG000|Step1|Pregnancy|1|||
48800701|NCT00855062|157108382|FG001|Step1|Pregnancy|0|||
48800702|NCT00855062|157108381|FG000|Step1|Withdrawal by Subject|2|||
48800703|NCT00855062|157108382|FG001|Step1|Withdrawal by Subject|3|||
48800704|NCT00855062|157108381|FG000|Step2|Early Study Closure|6|||
48800705|NCT00855062|157108382|FG001|Step2|Early Study Closure|2|||
48800706|NCT00855062|157108381|FG000|Step2|Adverse Event|0|||
48800707|NCT00855062|157108382|FG001|Step2|Adverse Event|3|||
48800708|NCT00855062|157108381|FG000|Step2|Initiation of antiretroviral therapy/ART|0|||
48800709|NCT00855062|157108382|FG001|Step2|Initiation of antiretroviral therapy/ART|1|||
48800710|NCT02007434|157108383|FG000|Overall Study|Lost to Follow-up|0|||
48800711|NCT02007434|157108384|FG001|Overall Study|Lost to Follow-up|1|||
48800712|NCT02007434|157108385|FG002|Overall Study|Lost to Follow-up|0|||
48800713|NCT02007434|157108386|FG003|Overall Study|Lost to Follow-up|0|||
48800714|NCT02007434|157108387|FG004|Overall Study|Lost to Follow-up|0|||
48800715|NCT02007434|157108388|FG005|Overall Study|Lost to Follow-up|0|||
48913479|NCT00636675|157521132|FG000|Overall Study|Lost to Follow-up|121|||
48913480|NCT00636675|157521133|FG001|Overall Study|Lost to Follow-up|31|||
48913481|NCT00636675|157521132|FG000|Overall Study|Withdrawal by Subject|19|||
48800716|NCT02007434|157108389|FG006|Overall Study|Lost to Follow-up|0|||
48913482|NCT00636675|157521133|FG001|Overall Study|Withdrawal by Subject|10|||
48913483|NCT00096785|157521136|FG000|Overall Study|Lost to Follow-up|1|||
48913484|NCT00096785|157521137|FG001|Overall Study|Lost to Follow-up|0|||
48913485|NCT00096785|157521136|FG000|Overall Study|Withdrawal by Subject|0|||
48913486|NCT00096785|157521137|FG001|Overall Study|Withdrawal by Subject|1|||
48913487|NCT00096785|157521136|FG000|Overall Study|Relocated|1|||
48913488|NCT00096785|157521137|FG001|Overall Study|Relocated|0|||
48913489|NCT00257725|157521138|FG000|Overall Study|Adverse Event|3|||
48913490|NCT02573870|157521139|FG000|Overall Study|Adverse Event|0|||
48913491|NCT02573870|157521140|FG001|Overall Study|Adverse Event|2|||
48800717|NCT02007434|157108390|FG007|Overall Study|Lost to Follow-up|0|||
48800718|NCT02007434|157108383|FG000|Overall Study|Non-compliance|1|||
48800719|NCT02007434|157108384|FG001|Overall Study|Non-compliance|0|||
48800720|NCT02007434|157108385|FG002|Overall Study|Non-compliance|1|||
48800721|NCT02007434|157108386|FG003|Overall Study|Non-compliance|0|||
48800722|NCT02007434|157108387|FG004|Overall Study|Non-compliance|0|||
48800723|NCT02007434|157108388|FG005|Overall Study|Non-compliance|0|||
48800724|NCT02007434|157108389|FG006|Overall Study|Non-compliance|0|||
48800725|NCT02007434|157108390|FG007|Overall Study|Non-compliance|0|||
48800726|NCT03002610|157108391|FG000|Overall Study|Withdrawal by Subject|6|||
48800727|NCT03002610|157108392|FG001|Overall Study|Withdrawal by Subject|25|||
48800728|NCT03002610|157108393|FG002|Overall Study|Withdrawal by Subject|13|||
48800729|NCT02192970|157108394|FG000|Overall Study|Lost to Follow-up|6|||
48800730|NCT02192970|157108395|FG001|Overall Study|Lost to Follow-up|0|||
48800731|NCT00929162|157108397|FG000|Overall Study|Adverse Event|8|||
48800732|NCT00929162|157108398|FG001|Overall Study|Adverse Event|5|||
48800733|NCT00929162|157108397|FG000|Overall Study|Withdrawal by Subject|3|||
48800734|NCT00929162|157108398|FG001|Overall Study|Withdrawal by Subject|1|||
48800735|NCT00929162|157108397|FG000|Overall Study|Protocol Violation|32|||
48913492|NCT02573870|157521139|FG000|Overall Study|Lack of Efficacy|0|||
48913493|NCT02573870|157521140|FG001|Overall Study|Lack of Efficacy|1|||
48913494|NCT02573870|157521139|FG000|Overall Study|Other: Reached defined stopping criteria|0|||
48913495|NCT02573870|157521140|FG001|Overall Study|Other: Reached defined stopping criteria|1|||
48913496|NCT02573870|157521139|FG000|Overall Study|Lost to Follow-up|0|||
48913497|NCT02573870|157521140|FG001|Overall Study|Lost to Follow-up|1|||
48913498|NCT02573870|157521139|FG000|Overall Study|Other: Fail to Meet Visit|0|||
48913499|NCT02573870|157521140|FG001|Overall Study|Other: Fail to Meet Visit|2|||
49118819|NCT02028507|158273221|FG000|Overall Study|Death|1|||
48800736|NCT00929162|157108398|FG001|Overall Study|Protocol Violation|30|||
48800737|NCT00929162|157108397|FG000|Overall Study|Other termination reason|5|||
48800738|NCT00929162|157108398|FG001|Overall Study|Other termination reason|6|||
48800739|NCT01822587|157108400|FG000|Overall Study|Lost to Follow-up|7|||
48800740|NCT01822587|157108401|FG001|Overall Study|Lost to Follow-up|9|||
48800741|NCT01822587|157108402|FG002|Overall Study|Lost to Follow-up|12|||
48800742|NCT01822587|157108400|FG000|Overall Study|Physician Decision|9|||
48800743|NCT01822587|157108401|FG001|Overall Study|Physician Decision|6|||
48800744|NCT01822587|157108402|FG002|Overall Study|Physician Decision|6|||
48800745|NCT01281202|157108403|FG000|Overall Study|Adverse Event|2|||
48800746|NCT01281202|157108404|FG001|Overall Study|Adverse Event|0|||
48800747|NCT01281202|157108403|FG000|Overall Study|Withdrawal by Subject|2|||
48800748|NCT01281202|157108404|FG001|Overall Study|Withdrawal by Subject|2|||
48800749|NCT01281202|157108403|FG000|Overall Study|Protocol Violation|11|||
48800750|NCT01281202|157108404|FG001|Overall Study|Protocol Violation|10|||
48800751|NCT01281202|157108403|FG000|Overall Study|Administrative|2|||
48800752|NCT01281202|157108404|FG001|Overall Study|Administrative|8|||
49118820|NCT02028507|158273222|FG001|Overall Study|Death|0|||
49118821|NCT02028507|158273223|FG002|Overall Study|Death|1|||
49118822|NCT02028507|158273224|FG003|Overall Study|Death|3|||
49118823|NCT02028507|158273221|FG000|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
48800753|NCT01281202|157108403|FG000|Overall Study|Lost to Follow-up|11|||
48800754|NCT01281202|157108404|FG001|Overall Study|Lost to Follow-up|13|||
48800755|NCT01281202|157108403|FG000|Overall Study|Incarceration|0|||
48800756|NCT01281202|157108404|FG001|Overall Study|Incarceration|3|||
48800757|NCT03172702|157108405|FG000|Overall Study|Adverse Event|9|||
48800758|NCT03172702|157108405|FG000|Overall Study|Death|2|||
48800759|NCT03172702|157108405|FG000|Overall Study|Study-specific Withdrawal Criteria|10|||
48800760|NCT03172702|157108405|FG000|Overall Study|Withdrawal by Subject|5|||
48800761|NCT03172702|157108405|FG000|Overall Study|Other|2|||
48800762|NCT02835339|157108406|FG000|Overall Study|Did not receive allocated intervention|13|||
48800763|NCT02835339|157108407|FG001|Overall Study|Did not receive allocated intervention|16|||
48913500|NCT01858532|157521141|FG000|Overall Study|Adverse Event|58|||
48913501|NCT01858532|157521142|FG001|Overall Study|Adverse Event|50|||
48913502|NCT01858532|157521143|FG002|Overall Study|Adverse Event|23|||
48913503|NCT01858532|157521144|FG003|Overall Study|Adverse Event|28|||
48913504|NCT01858532|157521141|FG000|Overall Study|Withdrew consent|71|||
48800764|NCT01077544|157108408|FG000|Overall Study|New Cancer Therapy|3|||
48800765|NCT01077544|157108409|FG001|Overall Study|New Cancer Therapy|3|||
48800766|NCT01077544|157108408|FG000|Overall Study|Adverse Event|0|||
48800767|NCT01077544|157108409|FG001|Overall Study|Adverse Event|1|||
48800768|NCT01077544|157108408|FG000|Overall Study|Disease Progression|0|||
48800769|NCT01077544|157108409|FG001|Overall Study|Disease Progression|1|||
48800770|NCT03707951|157108410|FG000|Overall Study|Lost to Follow-up|8|||
48800771|NCT03707951|157108411|FG001|Overall Study|Lost to Follow-up|17|||
48800772|NCT03707951|157108410|FG000|Overall Study|Withdrawal by Subject|6|||
48800773|NCT03707951|157108411|FG001|Overall Study|Withdrawal by Subject|6|||
48800774|NCT02753595|157108412|FG000|Overall Study|Sponsor termination|2|||
48800775|NCT02753595|157108413|FG001|Overall Study|Sponsor termination|2|||
48800776|NCT03804710|157108414|FG000|Overall Study|Adverse Event|0|||
48800777|NCT03804710|157108415|FG001|Overall Study|Adverse Event|3|||
48800778|NCT03804710|157108414|FG000|Overall Study|Withdrawal by Subject|2|||
48800779|NCT03804710|157108415|FG001|Overall Study|Withdrawal by Subject|1|||
48800780|NCT03804710|157108414|FG000|Overall Study|Other|0|||
48800781|NCT03804710|157108415|FG001|Overall Study|Other|1|||
48800782|NCT04987762|157108418|FG000|Overall Study|Study was Terminated by Sponsor|103|||
48800783|NCT02953938|157108419|FG000|Overall Study|Adverse Event|0|||
48800784|NCT02953938|157108420|FG001|Overall Study|Adverse Event|1|||
48800785|NCT02953938|157108419|FG000|Overall Study|Withdrawal by Subject|1|||
48800786|NCT02953938|157108420|FG001|Overall Study|Withdrawal by Subject|1|||
48800787|NCT02342886|157108421|FG000|Overall Study|Treatment non-compliance|1|||
48800788|NCT02342886|157108422|FG001|Overall Study|Treatment non-compliance|0|||
48800789|NCT02342886|157108423|FG002|Overall Study|Treatment non-compliance|0|||
48800790|NCT02342886|157108424|FG003|Overall Study|Treatment non-compliance|1|||
48800791|NCT02342886|157108425|FG004|Overall Study|Treatment non-compliance|0|||
48800792|NCT02342886|157108421|FG000|Overall Study|Late exclusion: rifampicin resistance|1|||
48800793|NCT02342886|157108422|FG001|Overall Study|Late exclusion: rifampicin resistance|0|||
48800794|NCT02342886|157108423|FG002|Overall Study|Late exclusion: rifampicin resistance|0|||
48800795|NCT02342886|157108424|FG003|Overall Study|Late exclusion: rifampicin resistance|0|||
48800796|NCT02342886|157108425|FG004|Overall Study|Late exclusion: rifampicin resistance|0|||
48800797|NCT02342886|157108421|FG000|Overall Study|Adverse event/specific toxicity|4|||
48800798|NCT02342886|157108422|FG001|Overall Study|Adverse event/specific toxicity|3|||
48800799|NCT02342886|157108423|FG002|Overall Study|Adverse event/specific toxicity|11|||
48800800|NCT02342886|157108424|FG003|Overall Study|Adverse event/specific toxicity|2|||
48800801|NCT02342886|157108425|FG004|Overall Study|Adverse event/specific toxicity|1|||
48800802|NCT02342886|157108421|FG000|Overall Study|Lost to Follow-up|1|||
48800803|NCT02342886|157108422|FG001|Overall Study|Lost to Follow-up|0|||
48800804|NCT02342886|157108423|FG002|Overall Study|Lost to Follow-up|0|||
48800805|NCT02342886|157108424|FG003|Overall Study|Lost to Follow-up|0|||
48800806|NCT02342886|157108425|FG004|Overall Study|Lost to Follow-up|0|||
48800807|NCT02342886|157108421|FG000|Overall Study|Death|1|||
48800808|NCT02342886|157108422|FG001|Overall Study|Death|2|||
48800809|NCT02342886|157108423|FG002|Overall Study|Death|1|||
48800810|NCT02342886|157108424|FG003|Overall Study|Death|0|||
48800811|NCT02342886|157108425|FG004|Overall Study|Death|1|||
48800812|NCT02342886|157108421|FG000|Overall Study|Withdrawal by Subject|0|||
48800813|NCT02342886|157108422|FG001|Overall Study|Withdrawal by Subject|1|||
48800814|NCT02342886|157108423|FG002|Overall Study|Withdrawal by Subject|0|||
48800815|NCT02342886|157108424|FG003|Overall Study|Withdrawal by Subject|1|||
48800816|NCT02342886|157108425|FG004|Overall Study|Withdrawal by Subject|0|||
48800817|NCT02342886|157108421|FG000|Overall Study|Investigator/sponsor decision|0|||
48800818|NCT02342886|157108422|FG001|Overall Study|Investigator/sponsor decision|2|||
48800819|NCT02342886|157108423|FG002|Overall Study|Investigator/sponsor decision|0|||
48800820|NCT02342886|157108424|FG003|Overall Study|Investigator/sponsor decision|3|||
48800821|NCT02342886|157108425|FG004|Overall Study|Investigator/sponsor decision|1|||
48800822|NCT02342886|157108421|FG000|Overall Study|Pregnancy|0|||
48800823|NCT02342886|157108422|FG001|Overall Study|Pregnancy|0|||
48800824|NCT02342886|157108423|FG002|Overall Study|Pregnancy|2|||
48800825|NCT02342886|157108424|FG003|Overall Study|Pregnancy|0|||
48800826|NCT02342886|157108425|FG004|Overall Study|Pregnancy|0|||
48800827|NCT02342886|157108421|FG000|Overall Study|Late exclusion: pyrazinamide resistance|0|||
48800828|NCT02342886|157108422|FG001|Overall Study|Late exclusion: pyrazinamide resistance|0|||
48800829|NCT02342886|157108423|FG002|Overall Study|Late exclusion: pyrazinamide resistance|1|||
48800830|NCT02342886|157108424|FG003|Overall Study|Late exclusion: pyrazinamide resistance|0|||
48800831|NCT02342886|157108425|FG004|Overall Study|Late exclusion: pyrazinamide resistance|0|||
48800832|NCT02342886|157108421|FG000|Overall Study|Protocol Violation|0|||
48800833|NCT02342886|157108422|FG001|Overall Study|Protocol Violation|0|||
48800834|NCT02342886|157108423|FG002|Overall Study|Protocol Violation|0|||
48800835|NCT02342886|157108424|FG003|Overall Study|Protocol Violation|2|||
48800836|NCT02342886|157108425|FG004|Overall Study|Protocol Violation|0|||
48800837|NCT01064297|157108426|FG000|Overall Study|Lost to Follow-up|791|||
48800838|NCT01064297|157108427|FG001|Overall Study|Lost to Follow-up|48|||
48800839|NCT01064297|157108428|FG002|Overall Study|Lost to Follow-up|133|||
48800840|NCT00045305|157108429|FG000|Overall Study|Lack of Efficacy|6|||
48800841|NCT00045305|157108429|FG000|Overall Study|Adverse Event|3|||
48800842|NCT00045305|157108429|FG000|Overall Study|Death|3|||
48800843|NCT00045305|157108429|FG000|Overall Study|site error|2|||
48800844|NCT02158884|157108430|FG000|Baseline Assessment|Missed performance assessment|3|||
48800845|NCT02158884|157108430|FG000|Baseline Assessment|Missed SMFA|1|||
48800846|NCT02158884|157108430|FG000|Intervention: IDEO and PT Program|Did not complete PT intervention|6|||
48800847|NCT02158884|157108430|FG000|Post Intervention (~4 Weeks)|Did not complete performance assessment|10|||
48800848|NCT02158884|157108430|FG000|6 Month Assessment|Missed SMFA|20|||
48800849|NCT02158884|157108430|FG000|12 Month Assessment|Missed SMFA|17|||
48800850|NCT02124265|157108432|FG000|Overall Study|Adverse Event|1|||
48800851|NCT01685138|157108433|FG000|Overall Study|Lost to Follow-up|1|||
48800852|NCT01685138|157108433|FG000|Overall Study|Protocol Violation|1|||
48800853|NCT01685138|157108433|FG000|Overall Study|No longer requires treatment|1|||
48800854|NCT01685138|157108433|FG000|Overall Study|Subject/guardian decision|2|||
48800855|NCT01685138|157108433|FG000|Overall Study|Physician Decision|6|||
48800856|NCT01685138|157108433|FG000|Overall Study|Death|10|||
48913505|NCT01858532|157521142|FG001|Overall Study|Withdrew consent|93|||
48913506|NCT01858532|157521143|FG002|Overall Study|Withdrew consent|46|||
48800857|NCT01685138|157108433|FG000|Overall Study|Adverse Event|18|||
48800858|NCT01685138|157108433|FG000|Overall Study|Progressive disease|53|||
48800859|NCT01313286|157108434|FG000|Period 1|Withdrawal by Subject|2|||
48800860|NCT01313286|157108435|FG001|Period 1|Withdrawal by Subject|0|||
48800861|NCT02070484|157108438|FG000|Overall Study|Withdrawal by Subject|1|||
48800862|NCT02070484|157108439|FG001|Overall Study|Withdrawal by Subject|0|||
48800863|NCT01669798|157108444|FG000|Overall Study|Physician Decision|5|||
48800864|NCT01489189|157108446|FG000|Overall Study|Withdrawal by Subject|20|||
48800865|NCT01489189|157108447|FG001|Overall Study|Withdrawal by Subject|23|||
48800866|NCT01489189|157108446|FG000|Overall Study|Death|10|||
48800867|NCT01489189|157108447|FG001|Overall Study|Death|8|||
48800868|NCT01489189|157108446|FG000|Overall Study|Missed Visit|1|||
48800869|NCT01489189|157108447|FG001|Overall Study|Missed Visit|4|||
48800870|NCT04225988|157108448|FG000|Overall Study|Withdrawal by Subject|2|||
48800871|NCT04225988|157108449|FG001|Overall Study|Withdrawal by Subject|0|||
49118824|NCT02028507|158273222|FG001|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
48800872|NCT00404495|157108450|FG000|Overall Study|Death|37|||
48800873|NCT00404495|157108451|FG001|Overall Study|Death|11|||
48913507|NCT01858532|157521144|FG003|Overall Study|Withdrew consent|27|||
48913508|NCT01858532|157521141|FG000|Overall Study|Lost to Follow-up|17|||
48913509|NCT01858532|157521142|FG001|Overall Study|Lost to Follow-up|26|||
48913510|NCT01858532|157521143|FG002|Overall Study|Lost to Follow-up|11|||
48913511|NCT01858532|157521144|FG003|Overall Study|Lost to Follow-up|14|||
48913512|NCT01858532|157521141|FG000|Overall Study|Deterioration of medical status|3|||
48913513|NCT01858532|157521142|FG001|Overall Study|Deterioration of medical status|4|||
48913514|NCT01858532|157521143|FG002|Overall Study|Deterioration of medical status|3|||
48913515|NCT01858532|157521144|FG003|Overall Study|Deterioration of medical status|7|||
48913516|NCT01858532|157521141|FG000|Overall Study|Investigator request|3|||
48913517|NCT01858532|157521142|FG001|Overall Study|Investigator request|4|||
48913518|NCT01858532|157521143|FG002|Overall Study|Investigator request|2|||
48913519|NCT01858532|157521144|FG003|Overall Study|Investigator request|6|||
48913520|NCT01858532|157521141|FG000|Overall Study|Other, not specified|29|||
48913521|NCT01858532|157521142|FG001|Overall Study|Other, not specified|15|||
48800874|NCT00404495|157108450|FG000|Overall Study|Lost to Follow-up|5|||
48800875|NCT00404495|157108451|FG001|Overall Study|Lost to Follow-up|0|||
48800876|NCT00404495|157108450|FG000|Overall Study|Other|1|||
48800877|NCT00404495|157108451|FG001|Overall Study|Other|0|||
48800878|NCT00404495|157108450|FG000|Overall Study|Withdrawal by Subject|1|||
48800879|NCT00404495|157108451|FG001|Overall Study|Withdrawal by Subject|0|||
48800880|NCT03017079|157108452|FG000|Overall Study|Physician Decision|1|||
48800881|NCT03017079|157108453|FG001|Overall Study|Physician Decision|1|||
48800882|NCT03017079|157108452|FG000|Overall Study|Death|3|||
48800883|NCT03017079|157108453|FG001|Overall Study|Death|2|||
48800884|NCT03017079|157108452|FG000|Overall Study|Lack of Efficacy|2|||
48800885|NCT03017079|157108453|FG001|Overall Study|Lack of Efficacy|2|||
48800886|NCT03017079|157108452|FG000|Overall Study|Protocol Violation|0|||
48800887|NCT03017079|157108453|FG001|Overall Study|Protocol Violation|1|||
48800888|NCT01984697|157110230|FG000|Overall Study|Adverse Event|0|||
48800889|NCT01984697|157110231|FG001|Overall Study|Adverse Event|0|||
48800890|NCT01984697|157110232|FG002|Overall Study|Adverse Event|2|||
48800891|NCT01984697|157110233|FG003|Overall Study|Adverse Event|0|||
48800892|NCT01984697|157110234|FG004|Overall Study|Adverse Event|0|||
48800893|NCT01984697|157110230|FG000|Overall Study|Lost to Follow-up|14|||
48800894|NCT01984697|157110231|FG001|Overall Study|Lost to Follow-up|5|||
48800895|NCT01984697|157110232|FG002|Overall Study|Lost to Follow-up|10|||
48800896|NCT01984697|157110233|FG003|Overall Study|Lost to Follow-up|6|||
48800897|NCT01984697|157110234|FG004|Overall Study|Lost to Follow-up|21|||
48800898|NCT01984697|157110230|FG000|Overall Study|Physician Decision|3|||
48800899|NCT01984697|157110231|FG001|Overall Study|Physician Decision|0|||
48800900|NCT01984697|157110232|FG002|Overall Study|Physician Decision|0|||
48800901|NCT01984697|157110233|FG003|Overall Study|Physician Decision|1|||
48800902|NCT01984697|157110234|FG004|Overall Study|Physician Decision|0|||
48800903|NCT01984697|157110230|FG000|Overall Study|Protocol Violation|8|||
48800904|NCT01984697|157110231|FG001|Overall Study|Protocol Violation|5|||
48800905|NCT01984697|157110232|FG002|Overall Study|Protocol Violation|3|||
48800906|NCT01984697|157110233|FG003|Overall Study|Protocol Violation|2|||
48800907|NCT01984697|157110234|FG004|Overall Study|Protocol Violation|0|||
48800908|NCT01984697|157110230|FG000|Overall Study|Withdrawal by Subject|15|||
48800909|NCT01984697|157110231|FG001|Overall Study|Withdrawal by Subject|21|||
48800910|NCT01984697|157110232|FG002|Overall Study|Withdrawal by Subject|13|||
48800911|NCT01984697|157110233|FG003|Overall Study|Withdrawal by Subject|11|||
48800912|NCT01984697|157110234|FG004|Overall Study|Withdrawal by Subject|13|||
48800913|NCT01984697|157110230|FG000|Overall Study|Missed last follow-up visit|1|||
48800914|NCT01984697|157110231|FG001|Overall Study|Missed last follow-up visit|0|||
48800915|NCT01984697|157110232|FG002|Overall Study|Missed last follow-up visit|0|||
48800916|NCT01984697|157110233|FG003|Overall Study|Missed last follow-up visit|0|||
48800917|NCT01984697|157110234|FG004|Overall Study|Missed last follow-up visit|0|||
48800918|NCT01984697|157110230|FG000|Overall Study|Death|0|||
48800919|NCT01984697|157110231|FG001|Overall Study|Death|0|||
48800920|NCT01984697|157110232|FG002|Overall Study|Death|0|||
48800921|NCT01984697|157110233|FG003|Overall Study|Death|1|||
48800922|NCT01984697|157110234|FG004|Overall Study|Death|0|||
48800923|NCT01984697|157110230|FG000|Overall Study|Pregnancy|2|||
48800924|NCT01984697|157110231|FG001|Overall Study|Pregnancy|0|||
48800925|NCT01984697|157110232|FG002|Overall Study|Pregnancy|1|||
48800926|NCT01984697|157110233|FG003|Overall Study|Pregnancy|0|||
48800927|NCT01984697|157110234|FG004|Overall Study|Pregnancy|1|||
48800928|NCT02044848|157110237|FG000|Overall Study|Administrative Problems|2|||
48800929|NCT02044848|157110238|FG001|Overall Study|Administrative Problems|3|||
48800930|NCT02979639|157110241|FG000|Overall Study|Withdrawal based on medical judgement|1|||
48800931|NCT02979639|157110241|FG000|Overall Study|Lost to Follow-up|8|||
48800932|NCT02979639|157110241|FG000|Overall Study|Withdrawal by Subject|3|||
48800933|NCT02979639|157110241|FG000|Overall Study|Adverse Event|2|||
48800934|NCT04539821|157110242|FG000|Overall Study|Withdrawal by Subject|2|||
48800935|NCT04539821|157110242|FG000|Overall Study|continued care with their physician|20|||
48800936|NCT04539821|157110242|FG000|Overall Study|treatment needs outside scope of VCPM|3|||
48800937|NCT01235546|157110244|FG000|Overall Study|Staff error, medication not administered|1|||
48800938|NCT01235546|157110245|FG001|Overall Study|Staff error, medication not administered|0|||
48800939|NCT01235546|157110244|FG000|Overall Study|Protocol Violation|1|||
48800940|NCT01235546|157110245|FG001|Overall Study|Protocol Violation|1|||
48800941|NCT00677235|157110253|FG000|Overall Study|Withdrawal by Subject|1|||
48800942|NCT00677235|157110254|FG001|Overall Study|Withdrawal by Subject|1|||
48800943|NCT00677235|157110253|FG000|Overall Study|Lost to Follow-up|2|||
48800944|NCT00677235|157110254|FG001|Overall Study|Lost to Follow-up|1|||
48800945|NCT00677235|157110253|FG000|Overall Study|Death|37|||
48800946|NCT00677235|157110254|FG001|Overall Study|Death|36|||
48800947|NCT00677235|157110253|FG000|Overall Study|Adverse Experience|1|||
48800948|NCT00677235|157110254|FG001|Overall Study|Adverse Experience|0|||
48800949|NCT03595332|157110270|FG000|Overall Study|Lost to Follow-up|16|||
48800950|NCT03595332|157110271|FG001|Overall Study|Lost to Follow-up|22|||
48800951|NCT03595332|157110270|FG000|Overall Study|Unable to retrieve ID from school|0|||
48800952|NCT03595332|157110271|FG001|Overall Study|Unable to retrieve ID from school|2|||
48800953|NCT02227875|157110272|FG000|Overall Study|Protocol Violation|10|||
48800954|NCT02227875|157110273|FG001|Overall Study|Protocol Violation|7|||
48800955|NCT02227875|157110272|FG000|Overall Study|Other|1|||
48800956|NCT02227875|157110273|FG001|Overall Study|Other|3|||
48800957|NCT02227875|157110272|FG000|Overall Study|Physician Decision|1|||
48800958|NCT02227875|157110273|FG001|Overall Study|Physician Decision|0|||
48800959|NCT02227875|157110272|FG000|Overall Study|Adverse Event|3|||
48800960|NCT02227875|157110273|FG001|Overall Study|Adverse Event|0|||
48800961|NCT02227875|157110272|FG000|Overall Study|Withdrawal by Subject|12|||
48800962|NCT02227875|157110273|FG001|Overall Study|Withdrawal by Subject|13|||
48800963|NCT02227875|157110272|FG000|Overall Study|Lost to Follow-up|10|||
48800964|NCT02227875|157110273|FG001|Overall Study|Lost to Follow-up|10|||
48800965|NCT01058304|157110289|FG000|Overall Study|Withdrawal by Subject|8|||
48800966|NCT01058304|157110290|FG001|Overall Study|Withdrawal by Subject|5|||
48800967|NCT01058304|157110289|FG000|Overall Study|Lost to Follow-up|13|||
48800968|NCT01058304|157110290|FG001|Overall Study|Lost to Follow-up|16|||
48800969|NCT01058304|157110289|FG000|Overall Study|Developed exclusion criterion|6|||
48800970|NCT01058304|157110290|FG001|Overall Study|Developed exclusion criterion|12|||
48800971|NCT01820559|157110291|FG000|Overall Study|Adverse Event|4|||
48800972|NCT01820559|157110292|FG001|Overall Study|Adverse Event|6|||
48800973|NCT01820559|157110293|FG002|Overall Study|Adverse Event|13|||
48800974|NCT01820559|157110291|FG000|Overall Study|Withdrawal by Subject|1|||
48800975|NCT01820559|157110292|FG001|Overall Study|Withdrawal by Subject|2|||
48800976|NCT01820559|157110293|FG002|Overall Study|Withdrawal by Subject|5|||
48800977|NCT01820559|157110291|FG000|Overall Study|Protocol Violation|2|||
48800978|NCT01820559|157110292|FG001|Overall Study|Protocol Violation|1|||
48800979|NCT01820559|157110293|FG002|Overall Study|Protocol Violation|3|||
48800980|NCT01820559|157110291|FG000|Overall Study|Subject's non-compliance|1|||
48800981|NCT01820559|157110292|FG001|Overall Study|Subject's non-compliance|0|||
48800982|NCT01820559|157110293|FG002|Overall Study|Subject's non-compliance|2|||
48800983|NCT01820559|157110291|FG000|Overall Study|Lost to Follow-up|3|||
48913522|NCT01858532|157521143|FG002|Overall Study|Other, not specified|13|||
48913523|NCT01858532|157521144|FG003|Overall Study|Other, not specified|11|||
48913524|NCT00434421|157521145|FG000|Overall Study|Withdrawal by Subject|1|||
48913525|NCT00434421|157521145|FG000|Overall Study|Non-compliance with study treatment|1|||
49010689|NCT03016078|157875674|FG000|Overall Study|Protocol Violation|1|||
48707223|NCT01587924|156775978|FG002|Overall Study|Protocol Violation|2|||
48707224|NCT01587924|156775979|FG003|Overall Study|Protocol Violation|1|||
48707225|NCT01587924|156775976|FG000|Overall Study|Met Hemoglobin stopping criteria|2|||
48707226|NCT01587924|156775977|FG001|Overall Study|Met Hemoglobin stopping criteria|0|||
48707227|NCT01587924|156775978|FG002|Overall Study|Met Hemoglobin stopping criteria|1|||
48707228|NCT01587924|156775979|FG003|Overall Study|Met Hemoglobin stopping criteria|0|||
48707229|NCT01587924|156775976|FG000|Overall Study|Withdrawal by Subject|0|||
48707230|NCT01587924|156775977|FG001|Overall Study|Withdrawal by Subject|1|||
48707231|NCT01587924|156775978|FG002|Overall Study|Withdrawal by Subject|1|||
48707232|NCT01587924|156775979|FG003|Overall Study|Withdrawal by Subject|0|||
48707233|NCT01106248|156775980|FG000|Overall Study|Adverse Event|1|||
48707234|NCT01106248|156775980|FG000|Overall Study|Administrative|2|||
48707235|NCT01668589|156775981|FG000|Overall Study|Lost to Follow-up|29|||
48707236|NCT01668589|156775982|FG001|Overall Study|Lost to Follow-up|37|||
48707237|NCT01668589|156775983|FG002|Overall Study|Lost to Follow-up|15|||
48707238|NCT01668589|156775984|FG003|Overall Study|Lost to Follow-up|5|||
48707239|NCT01668589|156775981|FG000|Overall Study|Full Consent/Agreement Withdrawn|54|||
48707240|NCT01668589|156775982|FG001|Overall Study|Full Consent/Agreement Withdrawn|8|||
48707241|NCT01668589|156775983|FG002|Overall Study|Full Consent/Agreement Withdrawn|11|||
48707242|NCT01668589|156775984|FG003|Overall Study|Full Consent/Agreement Withdrawn|4|||
48707243|NCT01668589|156775981|FG000|Overall Study|Death|12|||
48707244|NCT01668589|156775982|FG001|Overall Study|Death|3|||
48707245|NCT01668589|156775983|FG002|Overall Study|Death|2|||
48707246|NCT01668589|156775984|FG003|Overall Study|Death|11|||
48707247|NCT01668589|156775981|FG000|Overall Study|Other|44|||
48707248|NCT01668589|156775982|FG001|Overall Study|Other|10|||
48707249|NCT01668589|156775983|FG002|Overall Study|Other|7|||
48707250|NCT01668589|156775984|FG003|Overall Study|Other|15|||
48707251|NCT00828204|156775987|FG000|Main Study: Prior to Study Suspension|Adverse Event|1|||
48707252|NCT00828204|156775988|FG001|Main Study: Prior to Study Suspension|Adverse Event|0|||
48707253|NCT00828204|156775987|FG000|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2|||
48707254|NCT00828204|156775988|FG001|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0|||
48707255|NCT00828204|156775987|FG000|Main Study: Prior to Study Suspension|Study Suspension|11|||
48707256|NCT00828204|156775988|FG001|Main Study: Prior to Study Suspension|Study Suspension|0|||
48707257|NCT00828204|156775987|FG000|Main Study: After Study Restart|Adverse Event|0|||
48707258|NCT00828204|156775988|FG001|Main Study: After Study Restart|Adverse Event|2|||
48707259|NCT00828204|156775987|FG000|Main Study: After Study Restart|Noncompliance|0|||
48707260|NCT00828204|156775988|FG001|Main Study: After Study Restart|Noncompliance|1|||
48707261|NCT00828204|156775987|FG000|Extension Study|Lost to Follow-up|0|||
48707262|NCT00828204|156775988|FG001|Extension Study|Lost to Follow-up|1|||
48707263|NCT00828204|156775987|FG000|Extension Study|Physician Decision|0|||
48707264|NCT00828204|156775988|FG001|Extension Study|Physician Decision|2|||
48707265|NCT01642589|156775994|FG000|Overall Study|Withdrawal by Subject|1|||
48707266|NCT01642589|156775995|FG001|Overall Study|Withdrawal by Subject|1|||
48913526|NCT01756040|157521149|FG000|IP in Preterm Infants: Cohort 1|Death|1|||
48913527|NCT01756040|157521149|FG000|IP in Preterm Infants: Cohort 2|Death|1|||
48913528|NCT01756040|157521149|FG000|IP in Preterm Infants: Cohort 2|did not receive sugar probe dose|8|||
48913529|NCT01274715|157521150|FG000|Overall Study|Lost to Follow-up|1|||
48913530|NCT01274715|157521150|FG000|Overall Study|After consent, met exclusion criteria.|1|||
48913531|NCT01274715|157521150|FG000|Overall Study|After consent, met exclusion criteria.|1|||
48913532|NCT01274715|157521150|FG000|Overall Study|After consent, met exclusion criteria.|1|||
49118825|NCT02028507|158273223|FG002|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
49118826|NCT02028507|158273224|FG003|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
49118827|NCT02028507|158273221|FG000|Overall Study|Second Invasive Primary Malignancy|1|||
49118828|NCT02028507|158273222|FG001|Overall Study|Second Invasive Primary Malignancy|0|||
49118829|NCT02028507|158273223|FG002|Overall Study|Second Invasive Primary Malignancy|0|||
49118830|NCT02028507|158273224|FG003|Overall Study|Second Invasive Primary Malignancy|1|||
49118831|NCT02028507|158273221|FG000|Overall Study|Randomized But Not Treated|3|||
49118832|NCT02028507|158273222|FG001|Overall Study|Randomized But Not Treated|6|||
49118833|NCT02028507|158273223|FG002|Overall Study|Randomized But Not Treated|0|||
49118834|NCT02028507|158273224|FG003|Overall Study|Randomized But Not Treated|4|||
49118835|NCT02028507|158273221|FG000|Overall Study|Enzyme defect|0|||
49118836|NCT02028507|158273222|FG001|Overall Study|Enzyme defect|0|||
49118837|NCT02028507|158273223|FG002|Overall Study|Enzyme defect|0|||
49118838|NCT02028507|158273224|FG003|Overall Study|Enzyme defect|1|||
49118839|NCT02028507|158273221|FG000|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
49118840|NCT02028507|158273222|FG001|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
49118841|NCT02028507|158273223|FG002|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
49118842|NCT02028507|158273224|FG003|Overall Study|Patient was not able to take whole dose of capecitabine|1|||
49118843|NCT02028507|158273221|FG000|Overall Study|Ongoing at date of cut-off 30-May-2019|10|||
49118844|NCT02028507|158273222|FG001|Overall Study|Ongoing at date of cut-off 30-May-2019|5|||
49118845|NCT02028507|158273223|FG002|Overall Study|Ongoing at date of cut-off 30-May-2019|37|||
49118846|NCT02028507|158273224|FG003|Overall Study|Ongoing at date of cut-off 30-May-2019|28|||
49118847|NCT02091414|158273225|FG000|Overall Study|Withdrawal by Subject|2|||
49118848|NCT02091414|158273225|FG000|Overall Study|Death|2|||
49118849|NCT01383018|158273233|FG000|Overall Study|Adverse Event|14|||
49118850|NCT01383018|158273233|FG000|Overall Study|Death|10|||
49118851|NCT01383018|158273233|FG000|Overall Study|Lost to Follow-up|5|||
49118852|NCT01383018|158273233|FG000|Overall Study|Physician Decision|5|||
49118853|NCT01383018|158273233|FG000|Overall Study|Withdrawal by Subject|9|||
49118854|NCT01383018|158273233|FG000|Overall Study|Subject not implanted|76|||
49118855|NCT01383018|158273233|FG000|Overall Study|Missed Visit|247|||
49118856|NCT01383018|158273233|FG000|Overall Study|Site closed early-not compliance related|7|||
49118857|NCT01383018|158273233|FG000|Overall Study|Patient moved away from site|1|||
49118858|NCT01383018|158273233|FG000|Overall Study|Subject Incarcerated|1|||
49118859|NCT02472886|158273234|FG000|Overall Study|Lack of Efficacy|0|||
49118860|NCT02472886|158273235|FG001|Overall Study|Lack of Efficacy|2|||
49118861|NCT02472886|158273236|FG002|Overall Study|Lack of Efficacy|1|||
49118862|NCT01051817|158273238|FG000|Overall Study|Adverse Event|0|||
49118863|NCT01051817|158273239|FG001|Overall Study|Adverse Event|2|||
49118864|NCT01051817|158273238|FG000|Overall Study|Abnormal Test Proceedure reults|0|||
49118865|NCT01051817|158273239|FG001|Overall Study|Abnormal Test Proceedure reults|1|||
49118866|NCT01051817|158273238|FG000|Overall Study|Withdrawal by Subject|3|||
49118867|NCT01051817|158273239|FG001|Overall Study|Withdrawal by Subject|5|||
49118868|NCT01051817|158273238|FG000|Overall Study|Protocol Violation|0|||
49118869|NCT01051817|158273239|FG001|Overall Study|Protocol Violation|1|||
49118870|NCT00320788|158273242|FG000|Overall Study|Adverse Event|0|||
49118871|NCT00320788|158273243|FG001|Overall Study|Adverse Event|0|||
49118872|NCT00320788|158273244|FG002|Overall Study|Adverse Event|0|||
49118873|NCT00320788|158273245|FG003|Overall Study|Adverse Event|1|||
49118874|NCT00320788|158273246|FG004|Overall Study|Adverse Event|0|||
48707267|NCT01120964|156775996|FG000|Overall Study|Did not receive full treatment|1|||
48707268|NCT01120964|156775997|FG001|Overall Study|Did not receive full treatment|0|||
48707269|NCT01704599|156776000|FG000|Overall Study|Adverse Event|1|||
48707270|NCT02840461|156776004|FG000|Overall Study|Adverse Event|1|||
48707271|NCT02840461|156776005|FG001|Overall Study|Adverse Event|5|||
49118875|NCT00320788|158273242|FG000|Overall Study|Death|0|||
49118876|NCT00320788|158273243|FG001|Overall Study|Death|0|||
49118877|NCT00320788|158273244|FG002|Overall Study|Death|1|||
49118878|NCT00320788|158273245|FG003|Overall Study|Death|0|||
49118879|NCT00320788|158273246|FG004|Overall Study|Death|1|||
48707272|NCT02840461|156776006|FG002|Overall Study|Adverse Event|3|||
48707273|NCT02840461|156776004|FG000|Overall Study|Lost to Follow-up|10|||
49118880|NCT00320788|158273242|FG000|Overall Study|Lost to Follow-up|0|||
49118881|NCT00320788|158273243|FG001|Overall Study|Lost to Follow-up|2|||
49118882|NCT00320788|158273244|FG002|Overall Study|Lost to Follow-up|1|||
49118883|NCT00320788|158273245|FG003|Overall Study|Lost to Follow-up|0|||
48800984|NCT01820559|157110292|FG001|Overall Study|Lost to Follow-up|2|||
48800985|NCT01820559|157110293|FG002|Overall Study|Lost to Follow-up|2|||
48800986|NCT01820559|157110291|FG000|Overall Study|At sponsor request|0|||
48800987|NCT01820559|157110292|FG001|Overall Study|At sponsor request|0|||
48800988|NCT01820559|157110293|FG002|Overall Study|At sponsor request|1|||
48800989|NCT01820559|157110291|FG000|Overall Study|Lack of Efficacy|3|||
48800990|NCT01820559|157110292|FG001|Overall Study|Lack of Efficacy|2|||
48800991|NCT01820559|157110293|FG002|Overall Study|Lack of Efficacy|3|||
48800992|NCT03205371|157110294|FG000|Overall Study|Withdrawal by Subject|4|||
48800993|NCT03205371|157110295|FG001|Overall Study|Withdrawal by Subject|1|||
48800994|NCT03205371|157110296|FG002|Overall Study|Withdrawal by Subject|0|||
48800995|NCT03205371|157110297|FG003|Overall Study|Withdrawal by Subject|0|||
48800996|NCT03205371|157110298|FG004|Overall Study|Withdrawal by Subject|0|||
48800997|NCT03205371|157110299|FG005|Overall Study|Withdrawal by Subject|0|||
48800998|NCT03205371|157110300|FG006|Overall Study|Withdrawal by Subject|4|||
48800999|NCT03205371|157110301|FG007|Overall Study|Withdrawal by Subject|0|||
48801000|NCT03205371|157110302|FG008|Overall Study|Withdrawal by Subject|2|||
48801001|NCT03205371|157110303|FG009|Overall Study|Withdrawal by Subject|0|||
48801002|NCT03205371|157110304|FG010|Overall Study|Withdrawal by Subject|0|||
48801003|NCT03205371|157110305|FG011|Overall Study|Withdrawal by Subject|1|||
48801004|NCT03205371|157110294|FG000|Overall Study|Lost to Follow-up|0|||
48801005|NCT03205371|157110295|FG001|Overall Study|Lost to Follow-up|0|||
48801006|NCT03205371|157110296|FG002|Overall Study|Lost to Follow-up|0|||
48801007|NCT03205371|157110297|FG003|Overall Study|Lost to Follow-up|0|||
48801008|NCT03205371|157110298|FG004|Overall Study|Lost to Follow-up|0|||
48801009|NCT03205371|157110299|FG005|Overall Study|Lost to Follow-up|0|||
48801010|NCT03205371|157110300|FG006|Overall Study|Lost to Follow-up|5|||
48801011|NCT03205371|157110301|FG007|Overall Study|Lost to Follow-up|2|||
48801012|NCT03205371|157110302|FG008|Overall Study|Lost to Follow-up|3|||
48801013|NCT03205371|157110303|FG009|Overall Study|Lost to Follow-up|0|||
48801014|NCT03205371|157110304|FG010|Overall Study|Lost to Follow-up|0|||
48801015|NCT03205371|157110305|FG011|Overall Study|Lost to Follow-up|0|||
48801016|NCT03205371|157110294|FG000|Overall Study|Protocol Violation|0|||
48801017|NCT03205371|157110295|FG001|Overall Study|Protocol Violation|0|||
48801018|NCT03205371|157110296|FG002|Overall Study|Protocol Violation|0|||
48801019|NCT03205371|157110297|FG003|Overall Study|Protocol Violation|0|||
48801020|NCT03205371|157110298|FG004|Overall Study|Protocol Violation|0|||
48801021|NCT03205371|157110299|FG005|Overall Study|Protocol Violation|0|||
48913533|NCT02495844|157521153|FG000|Overall Study|Lack of Efficacy|1|||
48913534|NCT02495844|157521154|FG001|Overall Study|Lack of Efficacy|2|||
48913535|NCT02495844|157521153|FG000|Overall Study|AE, non-fatal|0|||
48913536|NCT02495844|157521154|FG001|Overall Study|AE, non-fatal|1|||
48913537|NCT02495844|157521153|FG000|Overall Study|Hepatitis Positivity|0|||
48913538|NCT02495844|157521154|FG001|Overall Study|Hepatitis Positivity|1|||
48913539|NCT02285920|157521155|FG000|Overall Study|Kidney transplantation|2|||
48913540|NCT02285920|157521156|FG001|Overall Study|Kidney transplantation|2|||
48913541|NCT02285920|157521157|FG002|Overall Study|Kidney transplantation|2|||
48913542|NCT02285920|157521158|FG003|Overall Study|Kidney transplantation|0|||
48913543|NCT02285920|157521155|FG000|Overall Study|Change to peritoneal dialysis|0|||
48913544|NCT02285920|157521156|FG001|Overall Study|Change to peritoneal dialysis|0|||
48913545|NCT02285920|157521157|FG002|Overall Study|Change to peritoneal dialysis|1|||
48913546|NCT02285920|157521158|FG003|Overall Study|Change to peritoneal dialysis|0|||
48913547|NCT02285920|157521155|FG000|Overall Study|Transfer to non-participating unit|0|||
48913548|NCT02285920|157521156|FG001|Overall Study|Transfer to non-participating unit|1|||
48913549|NCT02285920|157521157|FG002|Overall Study|Transfer to non-participating unit|0|||
48913550|NCT02285920|157521158|FG003|Overall Study|Transfer to non-participating unit|0|||
48913551|NCT02285920|157521155|FG000|Overall Study|Dialysis discontinuation|0|||
48913552|NCT02285920|157521156|FG001|Overall Study|Dialysis discontinuation|1|||
48913553|NCT02285920|157521157|FG002|Overall Study|Dialysis discontinuation|0|||
48913554|NCT02285920|157521158|FG003|Overall Study|Dialysis discontinuation|0|||
48913555|NCT02285920|157521155|FG000|Overall Study|Death|2|||
48913556|NCT02285920|157521156|FG001|Overall Study|Death|0|||
48913557|NCT02285920|157521157|FG002|Overall Study|Death|2|||
48913558|NCT02285920|157521158|FG003|Overall Study|Death|1|||
48913559|NCT03593850|157521163|FG000|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|2|||
48913560|NCT03593850|157521164|FG001|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|3|||
48913561|NCT01380730|157521165|FG000|Overall Study|Death|0|||
48801022|NCT03205371|157110300|FG006|Overall Study|Protocol Violation|1|||
48801023|NCT03205371|157110301|FG007|Overall Study|Protocol Violation|0|||
48913562|NCT01380730|157521166|FG001|Overall Study|Death|0|||
48913563|NCT01380730|157521167|FG002|Overall Study|Death|0|||
48913564|NCT01380730|157521168|FG003|Overall Study|Death|0|||
48913565|NCT01380730|157521169|FG004|Overall Study|Death|1|||
48913566|NCT01380730|157521170|FG005|Overall Study|Death|0|||
48801024|NCT03205371|157110302|FG008|Overall Study|Protocol Violation|0|||
48913567|NCT01380730|157521171|FG006|Overall Study|Death|0|||
48913568|NCT01380730|157521172|FG007|Overall Study|Death|0|||
48913569|NCT00806195|157521173|FG000|Overall Study|Death|6|||
48913570|NCT00806195|157521174|FG001|Overall Study|Death|0|||
48913571|NCT00806195|157521175|FG002|Overall Study|Death|1|||
48913572|NCT00806195|157521176|FG003|Overall Study|Death|0|||
48913573|NCT00806195|157521173|FG000|Overall Study|Adverse Event|25|||
48913574|NCT00806195|157521174|FG001|Overall Study|Adverse Event|5|||
48913575|NCT00806195|157521175|FG002|Overall Study|Adverse Event|11|||
48913576|NCT00806195|157521176|FG003|Overall Study|Adverse Event|2|||
48913577|NCT00806195|157521173|FG000|Overall Study|Withdrawal by Subject|119|||
48913578|NCT00806195|157521174|FG001|Overall Study|Withdrawal by Subject|31|||
48913579|NCT00806195|157521175|FG002|Overall Study|Withdrawal by Subject|76|||
48913580|NCT00806195|157521176|FG003|Overall Study|Withdrawal by Subject|35|||
48913581|NCT00806195|157521173|FG000|Overall Study|Lost to Follow-up|217|||
48913582|NCT00806195|157521174|FG001|Overall Study|Lost to Follow-up|66|||
48913583|NCT00806195|157521175|FG002|Overall Study|Lost to Follow-up|90|||
48913584|NCT00806195|157521176|FG003|Overall Study|Lost to Follow-up|34|||
48913585|NCT00806195|157521173|FG000|Overall Study|Inappropriate Enrollment|0|||
48913586|NCT00806195|157521174|FG001|Overall Study|Inappropriate Enrollment|1|||
48913587|NCT00806195|157521175|FG002|Overall Study|Inappropriate Enrollment|0|||
48913588|NCT00806195|157521176|FG003|Overall Study|Inappropriate Enrollment|0|||
48913589|NCT00806195|157521173|FG000|Overall Study|Administrative Reason|113|||
48913590|NCT00806195|157521174|FG001|Overall Study|Administrative Reason|35|||
48913591|NCT00806195|157521175|FG002|Overall Study|Administrative Reason|66|||
48913592|NCT00806195|157521176|FG003|Overall Study|Administrative Reason|26|||
48913593|NCT00806195|157521173|FG000|Overall Study|Protocol Violation|34|||
48913594|NCT00806195|157521174|FG001|Overall Study|Protocol Violation|24|||
48913595|NCT00806195|157521175|FG002|Overall Study|Protocol Violation|26|||
48913596|NCT00806195|157521176|FG003|Overall Study|Protocol Violation|9|||
48913597|NCT04912245|157521177|FG000|Overall Study|Withdrawal by Subject|21|||
48913598|NCT04912245|157521178|FG001|Overall Study|Withdrawal by Subject|4|||
48913599|NCT04912245|157521177|FG000|Overall Study|Lost to Follow-up|5|||
48913600|NCT04912245|157521178|FG001|Overall Study|Lost to Follow-up|11|||
48707274|NCT02840461|156776005|FG001|Overall Study|Lost to Follow-up|7|||
48707275|NCT02840461|156776006|FG002|Overall Study|Lost to Follow-up|6|||
48707276|NCT02840461|156776004|FG000|Overall Study|Non-Comliance with Dosing Requirements|0|||
48707277|NCT02840461|156776005|FG001|Overall Study|Non-Comliance with Dosing Requirements|1|||
48707278|NCT02840461|156776006|FG002|Overall Study|Non-Comliance with Dosing Requirements|0|||
48707279|NCT02840461|156776004|FG000|Overall Study|Protocol Violation|2|||
48707280|NCT02840461|156776005|FG001|Overall Study|Protocol Violation|3|||
48707281|NCT02840461|156776006|FG002|Overall Study|Protocol Violation|1|||
48707282|NCT02840461|156776004|FG000|Overall Study|Withdrawal by Subject|10|||
48707283|NCT02840461|156776005|FG001|Overall Study|Withdrawal by Subject|6|||
48707284|NCT02840461|156776006|FG002|Overall Study|Withdrawal by Subject|2|||
48707285|NCT02840461|156776004|FG000|Overall Study|Worsening of Symptom & Kit Error|0|||
48707286|NCT02840461|156776005|FG001|Overall Study|Worsening of Symptom & Kit Error|0|||
48707287|NCT02840461|156776006|FG002|Overall Study|Worsening of Symptom & Kit Error|2|||
48707288|NCT00721968|156776009|FG000|Overall Study|Lost to Follow-up|2|||
48707289|NCT00721968|156776010|FG001|Overall Study|Lost to Follow-up|0|||
48707290|NCT02970942|156776011|FG000|Overall Study|Death|0|||
48707291|NCT02970942|156776012|FG001|Overall Study|Death|1|||
48707292|NCT02970942|156776013|FG002|Overall Study|Death|0|||
48707293|NCT02970942|156776014|FG003|Overall Study|Death|0|||
48707294|NCT02970942|156776011|FG000|Overall Study|Lost to Follow-up|1|||
48707295|NCT02970942|156776012|FG001|Overall Study|Lost to Follow-up|0|||
48707296|NCT02970942|156776013|FG002|Overall Study|Lost to Follow-up|2|||
48707297|NCT02970942|156776014|FG003|Overall Study|Lost to Follow-up|1|||
48707298|NCT02970942|156776011|FG000|Overall Study|Withdrawal by Subject|3|||
48707299|NCT02970942|156776012|FG001|Overall Study|Withdrawal by Subject|5|||
48707300|NCT02970942|156776013|FG002|Overall Study|Withdrawal by Subject|3|||
48707301|NCT02970942|156776014|FG003|Overall Study|Withdrawal by Subject|2|||
48707302|NCT04328077|156777482|FG000|Overall Study|Lost to Follow-up|0|||
48707303|NCT04328077|156777483|FG001|Overall Study|Lost to Follow-up|1|||
48707304|NCT04328077|156777484|FG002|Overall Study|Lost to Follow-up|0|||
48707305|NCT04328077|156777485|FG003|Overall Study|Lost to Follow-up|0|||
48707306|NCT04328077|156777482|FG000|Overall Study|Withdrawal by Subject|0|||
48913601|NCT01911442|157521179|FG000|Overall Study|Adverse Event|2|||
48913602|NCT01911442|157521180|FG001|Overall Study|Adverse Event|2|||
48707307|NCT04328077|156777483|FG001|Overall Study|Withdrawal by Subject|1|||
48707308|NCT04328077|156777484|FG002|Overall Study|Withdrawal by Subject|1|||
48913603|NCT01911442|157521181|FG002|Overall Study|Adverse Event|4|||
48913604|NCT01911442|157521179|FG000|Overall Study|Lack of Efficacy|1|||
48913605|NCT01911442|157521180|FG001|Overall Study|Lack of Efficacy|1|||
48707309|NCT04328077|156777485|FG003|Overall Study|Withdrawal by Subject|3|||
48707310|NCT01597596|156777486|FG000|Overall Study|Study terminated by sponsor|1|||
49118884|NCT00320788|158273246|FG004|Overall Study|Lost to Follow-up|0|||
48707311|NCT01597596|156777487|FG001|Overall Study|Study terminated by sponsor|0|||
48707312|NCT01597596|156777486|FG000|Overall Study|Physician Decision|0|||
48707313|NCT01597596|156777487|FG001|Overall Study|Physician Decision|1|||
48707314|NCT00939393|156777488|FG000|Overall Study|Withdrawal by Subject|1|||
48707315|NCT00939393|156777489|FG001|Overall Study|Withdrawal by Subject|0|||
48707316|NCT00939393|156777488|FG000|Overall Study|Lost to Follow-up|3|||
48707317|NCT00939393|156777489|FG001|Overall Study|Lost to Follow-up|0|||
48707318|NCT01399372|156777492|FG000|Overall Study|Protocol Violation|3|||
48707319|NCT01399372|156777493|FG001|Overall Study|Protocol Violation|1|||
48707320|NCT01376804|156777494|FG000|Treatment Period|Withdrawal by Subject|1|||
48707321|NCT01376804|156777494|FG000|Treatment Period|Adverse Event|6|||
48707322|NCT01376804|156777494|FG000|Treatment Period|Patient did not receive study drug|1|||
48707323|NCT00463567|156777497|FG000|Overall Study|Adverse Event|29|||
48707324|NCT00463567|156777498|FG001|Overall Study|Adverse Event|26|||
48707325|NCT00463567|156777499|FG002|Overall Study|Adverse Event|17|||
48707326|NCT00463567|156777500|FG003|Overall Study|Adverse Event|46|||
48707327|NCT00463567|156777501|FG004|Overall Study|Adverse Event|10|||
48707328|NCT00463567|156777502|FG005|Overall Study|Adverse Event|10|||
48707329|NCT00463567|156777503|FG006|Overall Study|Adverse Event|4|||
48707330|NCT00463567|156777497|FG000|Overall Study|Withdrawal by Subject|29|||
48707331|NCT00463567|156777498|FG001|Overall Study|Withdrawal by Subject|22|||
48707332|NCT00463567|156777499|FG002|Overall Study|Withdrawal by Subject|20|||
48707333|NCT00463567|156777500|FG003|Overall Study|Withdrawal by Subject|37|||
48707334|NCT00463567|156777501|FG004|Overall Study|Withdrawal by Subject|6|||
48707335|NCT00463567|156777502|FG005|Overall Study|Withdrawal by Subject|5|||
48707336|NCT00463567|156777503|FG006|Overall Study|Withdrawal by Subject|1|||
48707337|NCT00463567|156777497|FG000|Overall Study|Protocol Deviation|13|||
48707338|NCT00463567|156777498|FG001|Overall Study|Protocol Deviation|9|||
48707339|NCT00463567|156777499|FG002|Overall Study|Protocol Deviation|14|||
48707340|NCT00463567|156777500|FG003|Overall Study|Protocol Deviation|11|||
48707341|NCT00463567|156777501|FG004|Overall Study|Protocol Deviation|1|||
48707342|NCT00463567|156777502|FG005|Overall Study|Protocol Deviation|1|||
48707343|NCT00463567|156777503|FG006|Overall Study|Protocol Deviation|2|||
48707344|NCT00463567|156777497|FG000|Overall Study|Lost to Follow-up|12|||
48707345|NCT00463567|156777498|FG001|Overall Study|Lost to Follow-up|6|||
48707346|NCT00463567|156777499|FG002|Overall Study|Lost to Follow-up|13|||
48707347|NCT00463567|156777500|FG003|Overall Study|Lost to Follow-up|8|||
48707348|NCT00463567|156777501|FG004|Overall Study|Lost to Follow-up|1|||
48707349|NCT00463567|156777502|FG005|Overall Study|Lost to Follow-up|1|||
48707350|NCT00463567|156777503|FG006|Overall Study|Lost to Follow-up|1|||
48707351|NCT00463567|156777497|FG000|Overall Study|Administrative problems|5|||
48707352|NCT00463567|156777498|FG001|Overall Study|Administrative problems|3|||
48707353|NCT00463567|156777499|FG002|Overall Study|Administrative problems|6|||
48707354|NCT00463567|156777500|FG003|Overall Study|Administrative problems|9|||
48707355|NCT00463567|156777501|FG004|Overall Study|Administrative problems|3|||
48707356|NCT00463567|156777502|FG005|Overall Study|Administrative problems|2|||
48707357|NCT00463567|156777503|FG006|Overall Study|Administrative problems|2|||
48707358|NCT00463567|156777497|FG000|Overall Study|Lack of Efficacy|4|||
48707359|NCT00463567|156777498|FG001|Overall Study|Lack of Efficacy|9|||
48707360|NCT00463567|156777499|FG002|Overall Study|Lack of Efficacy|9|||
48707361|NCT00463567|156777500|FG003|Overall Study|Lack of Efficacy|17|||
48707362|NCT00463567|156777501|FG004|Overall Study|Lack of Efficacy|1|||
48707363|NCT00463567|156777502|FG005|Overall Study|Lack of Efficacy|0|||
48707364|NCT00463567|156777503|FG006|Overall Study|Lack of Efficacy|1|||
48707365|NCT00463567|156777497|FG000|Overall Study|Abnormal lab value(s)|1|||
48707366|NCT00463567|156777498|FG001|Overall Study|Abnormal lab value(s)|1|||
48707367|NCT00463567|156777499|FG002|Overall Study|Abnormal lab value(s)|2|||
48707368|NCT00463567|156777500|FG003|Overall Study|Abnormal lab value(s)|1|||
48707369|NCT00463567|156777501|FG004|Overall Study|Abnormal lab value(s)|1|||
48707370|NCT00463567|156777502|FG005|Overall Study|Abnormal lab value(s)|0|||
48707371|NCT00463567|156777503|FG006|Overall Study|Abnormal lab value(s)|0|||
48707372|NCT00463567|156777497|FG000|Overall Study|Abnormal test procedure result(s)|1|||
48707373|NCT00463567|156777498|FG001|Overall Study|Abnormal test procedure result(s)|1|||
48707374|NCT00463567|156777499|FG002|Overall Study|Abnormal test procedure result(s)|6|||
48707375|NCT00463567|156777500|FG003|Overall Study|Abnormal test procedure result(s)|2|||
48707376|NCT00463567|156777501|FG004|Overall Study|Abnormal test procedure result(s)|0|||
48707377|NCT00463567|156777502|FG005|Overall Study|Abnormal test procedure result(s)|2|||
48707378|NCT00463567|156777503|FG006|Overall Study|Abnormal test procedure result(s)|0|||
48707379|NCT00463567|156777497|FG000|Overall Study|Death|1|||
48707380|NCT00463567|156777498|FG001|Overall Study|Death|0|||
48707381|NCT00463567|156777499|FG002|Overall Study|Death|2|||
48707382|NCT00463567|156777500|FG003|Overall Study|Death|0|||
48707383|NCT00463567|156777501|FG004|Overall Study|Death|0|||
48707384|NCT00463567|156777502|FG005|Overall Study|Death|0|||
48707385|NCT00463567|156777503|FG006|Overall Study|Death|0|||
48707386|NCT01432730|156777504|FG000|Period 1|Adverse Event|2|||
48801025|NCT03205371|157110303|FG009|Overall Study|Protocol Violation|0|||
48801026|NCT03205371|157110304|FG010|Overall Study|Protocol Violation|0|||
48801027|NCT03205371|157110305|FG011|Overall Study|Protocol Violation|0|||
48801028|NCT03205371|157110294|FG000|Overall Study|Adverse Event|0|||
48801029|NCT03205371|157110295|FG001|Overall Study|Adverse Event|0|||
48801030|NCT03205371|157110296|FG002|Overall Study|Adverse Event|0|||
48801031|NCT03205371|157110297|FG003|Overall Study|Adverse Event|0|||
48801032|NCT03205371|157110298|FG004|Overall Study|Adverse Event|0|||
48801033|NCT03205371|157110299|FG005|Overall Study|Adverse Event|0|||
48801034|NCT03205371|157110300|FG006|Overall Study|Adverse Event|0|||
48801035|NCT03205371|157110301|FG007|Overall Study|Adverse Event|1|||
48801036|NCT03205371|157110302|FG008|Overall Study|Adverse Event|0|||
48801037|NCT03205371|157110303|FG009|Overall Study|Adverse Event|0|||
48801038|NCT03205371|157110304|FG010|Overall Study|Adverse Event|0|||
48801039|NCT03205371|157110305|FG011|Overall Study|Adverse Event|0|||
48801040|NCT03574597|157110312|FG000|Overall Study|Withdrawal by Subject|67|||
48801041|NCT03574597|157110313|FG001|Overall Study|Withdrawal by Subject|96|||
48801042|NCT03574597|157110312|FG000|Overall Study|Lost to Follow-up|192|||
48801043|NCT03574597|157110313|FG001|Overall Study|Lost to Follow-up|188|||
48801044|NCT02355743|157110314|FG000|Overall Study|Withdrawal by Subject|1|||
48801045|NCT02355743|157110314|FG000|Overall Study|Lost to Follow-up|1|||
48801046|NCT04247282|157110315|FG000|Overall Study|Participant declined to participate before treatment started.|0|||
48801047|NCT04247282|157110316|FG001|Overall Study|Participant declined to participate before treatment started.|0|||
48801048|NCT04247282|157110317|FG002|Overall Study|Participant declined to participate before treatment started.|0|||
48801049|NCT04247282|157110318|FG003|Overall Study|Participant declined to participate before treatment started.|1|||
48801050|NCT04247282|157110315|FG000|Overall Study|Refused further treatment|0|||
48801051|NCT04247282|157110316|FG001|Overall Study|Refused further treatment|1|||
48801052|NCT04247282|157110317|FG002|Overall Study|Refused further treatment|0|||
48801053|NCT04247282|157110318|FG003|Overall Study|Refused further treatment|0|||
48801054|NCT00386022|157110322|FG000|Plus Estrogen|Lost to Follow-up|2|||
48801055|NCT00386022|157110323|FG001|Plus Estrogen|Lost to Follow-up|0|||
48801056|NCT00386022|157110322|FG000|Plus Estrogen|Adverse Event|0|||
48801057|NCT00386022|157110323|FG001|Plus Estrogen|Adverse Event|1|||
48801058|NCT00724152|157110324|FG000|Two-arm Study Period|Withdrawal by Subject|3|||
48801059|NCT00724152|157110325|FG001|Two-arm Study Period|Withdrawal by Subject|2|||
48801060|NCT00724152|157110326|FG002|Two-arm Study Period|Withdrawal by Subject|0|||
48801061|NCT00724152|157110324|FG000|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
48801062|NCT00724152|157110325|FG001|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2|||
48801063|NCT00724152|157110326|FG002|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
48801064|NCT00295022|157110327|FG000|Overall Study|Adverse Event|1|||
48801065|NCT00295022|157110328|FG001|Overall Study|Adverse Event|1|||
48801066|NCT00295022|157110329|FG002|Overall Study|Adverse Event|2|||
48801067|NCT00295022|157110327|FG000|Overall Study|Lost to Follow-up|0|||
48801068|NCT00295022|157110328|FG001|Overall Study|Lost to Follow-up|0|||
48707387|NCT01432730|156777505|FG001|Period 1|Adverse Event|0|||
48707388|NCT01432730|156777504|FG000|Period 2|Adverse Event|0|||
48707389|NCT01432730|156777505|FG001|Period 2|Adverse Event|4|||
48707390|NCT00641667|156777508|FG000|Overall Study|Withdrawal by Subject|1|||
48707391|NCT00641667|156777508|FG000|Overall Study|Adverse Event|1|||
48707392|NCT00641667|156777508|FG000|Overall Study|Physician Decision|1|||
48707393|NCT00641667|156777508|FG000|Overall Study|Worsening of underlying disease|3|||
48707394|NCT01421719|156777509|FG000|Overall Study|Withdrawal by Subject|4|||
48707395|NCT03077412|156777518|FG000|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|1|||
48707396|NCT03077412|156777519|FG001|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|5|||
48707397|NCT03077412|156777520|FG002|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|3|||
48707398|NCT03077412|156777518|FG000|Overall Study|Protocol-Specified Disease Worsening|1|||
48707399|NCT03077412|156777519|FG001|Overall Study|Protocol-Specified Disease Worsening|3|||
48801069|NCT00295022|157110329|FG002|Overall Study|Lost to Follow-up|1|||
48801070|NCT00295022|157110327|FG000|Overall Study|Withdrawal by Subject|0|||
48801071|NCT00295022|157110328|FG001|Overall Study|Withdrawal by Subject|0|||
48801072|NCT00295022|157110329|FG002|Overall Study|Withdrawal by Subject|2|||
48801073|NCT02068495|157110332|FG000|Overall Study|Case Report Forms Uncollected|60|||
48801074|NCT02068495|157110332|FG000|Overall Study|Protocol Deviation|49|||
48801075|NCT00654901|157110335|FG000|Overall Study|Lost to Follow-up|1|||
48801076|NCT00654901|157110336|FG001|Overall Study|Lost to Follow-up|0|||
48801077|NCT00654901|157110337|FG002|Overall Study|Lost to Follow-up|1|||
49118885|NCT00320788|158273242|FG000|Overall Study|Decision by the Sponsor|1|||
49118886|NCT00320788|158273243|FG001|Overall Study|Decision by the Sponsor|1|||
49118887|NCT00320788|158273244|FG002|Overall Study|Decision by the Sponsor|0|||
49118888|NCT00320788|158273245|FG003|Overall Study|Decision by the Sponsor|0|||
49118889|NCT00320788|158273246|FG004|Overall Study|Decision by the Sponsor|1|||
49118890|NCT00320788|158273242|FG000|Overall Study|Other|1|||
48801078|NCT00654901|157110338|FG003|Overall Study|Lost to Follow-up|0|||
49118891|NCT00320788|158273243|FG001|Overall Study|Other|2|||
48801079|NCT00654901|157110335|FG000|Overall Study|Withdrawal by Subject|3|||
48801080|NCT00654901|157110336|FG001|Overall Study|Withdrawal by Subject|0|||
48801081|NCT00654901|157110337|FG002|Overall Study|Withdrawal by Subject|1|||
48801082|NCT00654901|157110338|FG003|Overall Study|Withdrawal by Subject|0|||
48801083|NCT00779779|157110339|FG000|Overall Study|Adverse Event|1|||
48801084|NCT00779779|157110339|FG000|Overall Study|Protocol Violation|14|||
48801085|NCT00779779|157110339|FG000|Overall Study|Withdrawal by Subject|4|||
48801086|NCT00779779|157110339|FG000|Overall Study|Lost to Follow-up|5|||
48801087|NCT01412801|157110343|FG000|Overall Study|Death|0|||
48801088|NCT01412801|157110344|FG001|Overall Study|Death|1|||
48801089|NCT01412801|157110345|FG002|Overall Study|Death|0|||
48801090|NCT01412801|157110346|FG003|Overall Study|Death|4|||
48801091|NCT01412801|157110347|FG004|Overall Study|Death|2|||
48801092|NCT01412801|157110348|FG005|Overall Study|Death|2|||
48801093|NCT01412801|157110343|FG000|Overall Study|Lost to Follow-up|1|||
48801094|NCT01412801|157110344|FG001|Overall Study|Lost to Follow-up|2|||
48801095|NCT01412801|157110345|FG002|Overall Study|Lost to Follow-up|4|||
48801096|NCT01412801|157110346|FG003|Overall Study|Lost to Follow-up|0|||
48801097|NCT01412801|157110347|FG004|Overall Study|Lost to Follow-up|1|||
48801098|NCT01412801|157110348|FG005|Overall Study|Lost to Follow-up|1|||
48801099|NCT01412801|157110343|FG000|Overall Study|Withdrawal by Subject|3|||
48801100|NCT01412801|157110344|FG001|Overall Study|Withdrawal by Subject|2|||
48801101|NCT01412801|157110345|FG002|Overall Study|Withdrawal by Subject|1|||
48801102|NCT01412801|157110346|FG003|Overall Study|Withdrawal by Subject|0|||
48801103|NCT01412801|157110347|FG004|Overall Study|Withdrawal by Subject|0|||
48801104|NCT01412801|157110348|FG005|Overall Study|Withdrawal by Subject|0|||
48801105|NCT01412801|157110343|FG000|Overall Study|Relocated to another area|0|||
48801106|NCT01412801|157110344|FG001|Overall Study|Relocated to another area|0|||
48801107|NCT01412801|157110345|FG002|Overall Study|Relocated to another area|2|||
48801108|NCT01412801|157110346|FG003|Overall Study|Relocated to another area|0|||
48801109|NCT01412801|157110347|FG004|Overall Study|Relocated to another area|0|||
48801110|NCT01412801|157110348|FG005|Overall Study|Relocated to another area|0|||
48801111|NCT02296190|157110349|FG000|Overall Study|Lost to Follow-up|0|||
48801112|NCT02296190|157110350|FG001|Overall Study|Lost to Follow-up|0|||
48801113|NCT02296190|157110351|FG002|Overall Study|Lost to Follow-up|0|||
48801114|NCT02296190|157110352|FG003|Overall Study|Lost to Follow-up|0|||
48801115|NCT02296190|157110353|FG004|Overall Study|Lost to Follow-up|1|||
48801116|NCT02296190|157110354|FG005|Overall Study|Lost to Follow-up|0|||
48801117|NCT02296190|157110349|FG000|Overall Study|Failure to induce PSVT|6|||
48801118|NCT02296190|157110350|FG001|Overall Study|Failure to induce PSVT|10|||
48801119|NCT02296190|157110351|FG002|Overall Study|Failure to induce PSVT|5|||
48801120|NCT02296190|157110352|FG003|Overall Study|Failure to induce PSVT|13|||
48801121|NCT02296190|157110353|FG004|Overall Study|Failure to induce PSVT|8|||
48801122|NCT02296190|157110354|FG005|Overall Study|Failure to induce PSVT|0|||
48801123|NCT02296190|157110349|FG000|Overall Study|Physician Decision|1|||
48801124|NCT02296190|157110350|FG001|Overall Study|Physician Decision|1|||
48801125|NCT02296190|157110351|FG002|Overall Study|Physician Decision|0|||
48801126|NCT02296190|157110352|FG003|Overall Study|Physician Decision|1|||
48801127|NCT02296190|157110353|FG004|Overall Study|Physician Decision|2|||
48801128|NCT02296190|157110354|FG005|Overall Study|Physician Decision|0|||
48801129|NCT02296190|157110349|FG000|Overall Study|Withdrawal by Subject|0|||
48801130|NCT02296190|157110350|FG001|Overall Study|Withdrawal by Subject|1|||
48801131|NCT02296190|157110351|FG002|Overall Study|Withdrawal by Subject|0|||
48801132|NCT02296190|157110352|FG003|Overall Study|Withdrawal by Subject|0|||
48801133|NCT02296190|157110353|FG004|Overall Study|Withdrawal by Subject|0|||
48801134|NCT02296190|157110354|FG005|Overall Study|Withdrawal by Subject|0|||
48801135|NCT02296190|157110349|FG000|Overall Study|PSVT < 5 minutes|5|||
48801136|NCT02296190|157110350|FG001|Overall Study|PSVT < 5 minutes|6|||
48801137|NCT02296190|157110351|FG002|Overall Study|PSVT < 5 minutes|6|||
48801138|NCT02296190|157110352|FG003|Overall Study|PSVT < 5 minutes|6|||
48801139|NCT02296190|157110353|FG004|Overall Study|PSVT < 5 minutes|5|||
48801140|NCT02296190|157110354|FG005|Overall Study|PSVT < 5 minutes|0|||
48801141|NCT02296190|157110349|FG000|Overall Study|Patient was given Propofol|0|||
48801142|NCT02296190|157110350|FG001|Overall Study|Patient was given Propofol|1|||
48801143|NCT02296190|157110351|FG002|Overall Study|Patient was given Propofol|0|||
48801144|NCT02296190|157110352|FG003|Overall Study|Patient was given Propofol|1|||
48801145|NCT02296190|157110353|FG004|Overall Study|Patient was given Propofol|0|||
48801146|NCT02296190|157110354|FG005|Overall Study|Patient was given Propofol|0|||
48801147|NCT02296190|157110349|FG000|Overall Study|Patient with Atrial Tachycardia|0|||
48801148|NCT02296190|157110350|FG001|Overall Study|Patient with Atrial Tachycardia|0|||
48801149|NCT02296190|157110351|FG002|Overall Study|Patient with Atrial Tachycardia|0|||
48801150|NCT02296190|157110352|FG003|Overall Study|Patient with Atrial Tachycardia|1|||
48801151|NCT02296190|157110353|FG004|Overall Study|Patient with Atrial Tachycardia|0|||
48801152|NCT02296190|157110354|FG005|Overall Study|Patient with Atrial Tachycardia|0|||
48801153|NCT02296190|157110349|FG000|Overall Study|Blood pressure <100 after sedation|0|||
48801154|NCT02296190|157110350|FG001|Overall Study|Blood pressure <100 after sedation|0|||
48801155|NCT02296190|157110351|FG002|Overall Study|Blood pressure <100 after sedation|0|||
48801156|NCT02296190|157110352|FG003|Overall Study|Blood pressure <100 after sedation|1|||
48801157|NCT02296190|157110353|FG004|Overall Study|Blood pressure <100 after sedation|0|||
48801158|NCT02296190|157110354|FG005|Overall Study|Blood pressure <100 after sedation|0|||
48801159|NCT02296190|157110349|FG000|Overall Study|Atrial Tachycardia induced not PSVT|0|||
48801160|NCT02296190|157110350|FG001|Overall Study|Atrial Tachycardia induced not PSVT|1|||
48801161|NCT02296190|157110351|FG002|Overall Study|Atrial Tachycardia induced not PSVT|1|||
48801162|NCT02296190|157110352|FG003|Overall Study|Atrial Tachycardia induced not PSVT|0|||
48801163|NCT02296190|157110353|FG004|Overall Study|Atrial Tachycardia induced not PSVT|0|||
48801164|NCT02296190|157110354|FG005|Overall Study|Atrial Tachycardia induced not PSVT|0|||
48801165|NCT02296190|157110349|FG000|Overall Study|Patient on antiarrhythmic medication|1|||
48801166|NCT02296190|157110350|FG001|Overall Study|Patient on antiarrhythmic medication|0|||
48801167|NCT02296190|157110351|FG002|Overall Study|Patient on antiarrhythmic medication|0|||
48801168|NCT02296190|157110352|FG003|Overall Study|Patient on antiarrhythmic medication|0|||
48801169|NCT02296190|157110353|FG004|Overall Study|Patient on antiarrhythmic medication|0|||
48801170|NCT02296190|157110354|FG005|Overall Study|Patient on antiarrhythmic medication|0|||
48801171|NCT02296190|157110349|FG000|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
48801172|NCT02296190|157110350|FG001|Overall Study|Failed PSVT with mechanism of AVNRT|1|||
48801173|NCT02296190|157110351|FG002|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
48801174|NCT02296190|157110352|FG003|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
48801175|NCT02296190|157110353|FG004|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
48801176|NCT02296190|157110354|FG005|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
48801177|NCT02296190|157110349|FG000|Overall Study|Lab result not available in time|1|||
48801178|NCT02296190|157110350|FG001|Overall Study|Lab result not available in time|0|||
48801179|NCT02296190|157110351|FG002|Overall Study|Lab result not available in time|0|||
48801180|NCT02296190|157110352|FG003|Overall Study|Lab result not available in time|0|||
48801181|NCT02296190|157110353|FG004|Overall Study|Lab result not available in time|0|||
48801182|NCT02296190|157110354|FG005|Overall Study|Lab result not available in time|0|||
48801183|NCT02178566|157110355|FG000|Overall Study|patient did not complete due to noncompliance|0|||
48801184|NCT02178566|157110356|FG001|Overall Study|patient did not complete due to noncompliance|1|||
48801185|NCT02658630|157110359|FG000|Overall Study|Withdrawal by Subject|4|||
48801186|NCT00085202|157110360|FG000|Overall Study|Still on therapy|2|||
48801187|NCT00085202|157110361|FG001|Overall Study|Still on therapy|0|||
48801188|NCT00085202|157110360|FG000|Overall Study|Bone involvement confirmed by bone scan|0|||
48801189|NCT00085202|157110361|FG001|Overall Study|Bone involvement confirmed by bone scan|1|||
48801190|NCT00085202|157110360|FG000|Overall Study|Excessive toxicity|6|||
48801191|NCT00085202|157110361|FG001|Overall Study|Excessive toxicity|5|||
48801192|NCT00085202|157110360|FG000|Overall Study|Non-specified|3|||
48801193|NCT00085202|157110361|FG001|Overall Study|Non-specified|5|||
48801194|NCT00085202|157110360|FG000|Overall Study|Withdrawal by Subject|2|||
48801195|NCT00085202|157110361|FG001|Overall Study|Withdrawal by Subject|1|||
48801196|NCT00085202|157110360|FG000|Overall Study|Physician Decision|4|||
48801197|NCT00085202|157110361|FG001|Overall Study|Physician Decision|1|||
48801198|NCT00085202|157110360|FG000|Overall Study|Progressive disease|1|||
48801199|NCT00085202|157110361|FG001|Overall Study|Progressive disease|11|||
48801200|NCT00394355|157110362|FG000|Overall Study|Adverse Event|10|||
48801201|NCT00394355|157110363|FG001|Overall Study|Adverse Event|6|||
48801202|NCT00394355|157110364|FG002|Overall Study|Adverse Event|7|||
48801203|NCT00394355|157110365|FG003|Overall Study|Adverse Event|8|||
48801204|NCT00394355|157110362|FG000|Overall Study|Did not meet protocol eligibility|1|||
48801205|NCT00394355|157110363|FG001|Overall Study|Did not meet protocol eligibility|5|||
48801206|NCT00394355|157110364|FG002|Overall Study|Did not meet protocol eligibility|4|||
48801207|NCT00394355|157110365|FG003|Overall Study|Did not meet protocol eligibility|2|||
48801208|NCT00394355|157110362|FG000|Overall Study|Subject withdrawal - unrelated to drug|12|||
48801209|NCT00394355|157110363|FG001|Overall Study|Subject withdrawal - unrelated to drug|14|||
48801210|NCT00394355|157110364|FG002|Overall Study|Subject withdrawal - unrelated to drug|10|||
48801211|NCT00394355|157110365|FG003|Overall Study|Subject withdrawal - unrelated to drug|6|||
48801212|NCT00394355|157110362|FG000|Overall Study|Subject withdrawal - related to drug|1|||
48801213|NCT00394355|157110363|FG001|Overall Study|Subject withdrawal - related to drug|0|||
48801214|NCT00394355|157110364|FG002|Overall Study|Subject withdrawal - related to drug|0|||
48801215|NCT00394355|157110365|FG003|Overall Study|Subject withdrawal - related to drug|0|||
48801216|NCT00394355|157110362|FG000|Overall Study|Lost to Follow-up|7|||
48801217|NCT00394355|157110363|FG001|Overall Study|Lost to Follow-up|5|||
48801218|NCT00394355|157110364|FG002|Overall Study|Lost to Follow-up|4|||
48801219|NCT00394355|157110365|FG003|Overall Study|Lost to Follow-up|3|||
48801220|NCT00394355|157110362|FG000|Overall Study|Noncompliance with protocol|4|||
48801221|NCT00394355|157110363|FG001|Overall Study|Noncompliance with protocol|3|||
48801222|NCT00394355|157110364|FG002|Overall Study|Noncompliance with protocol|10|||
48801223|NCT00394355|157110365|FG003|Overall Study|Noncompliance with protocol|8|||
48801224|NCT00394355|157110362|FG000|Overall Study|Administrative|0|||
48801225|NCT00394355|157110363|FG001|Overall Study|Administrative|1|||
48801226|NCT00394355|157110364|FG002|Overall Study|Administrative|1|||
48801227|NCT00394355|157110365|FG003|Overall Study|Administrative|1|||
48801228|NCT00394355|157110362|FG000|Overall Study|Lack of Efficacy|0|||
48801229|NCT00394355|157110363|FG001|Overall Study|Lack of Efficacy|0|||
48913606|NCT01911442|157521181|FG002|Overall Study|Lack of Efficacy|1|||
48913607|NCT01911442|157521179|FG000|Overall Study|Lost to Follow-up|2|||
48913608|NCT01911442|157521180|FG001|Overall Study|Lost to Follow-up|0|||
48913609|NCT01911442|157521181|FG002|Overall Study|Lost to Follow-up|1|||
48913610|NCT01911442|157521179|FG000|Overall Study|Withdrawal by Subject|1|||
48913611|NCT01911442|157521180|FG001|Overall Study|Withdrawal by Subject|0|||
48707400|NCT03077412|156777520|FG002|Overall Study|Protocol-Specified Disease Worsening|3|||
48707401|NCT03077412|156777518|FG000|Overall Study|Adverse Event|1|||
48707402|NCT03077412|156777519|FG001|Overall Study|Adverse Event|2|||
48707403|NCT03077412|156777520|FG002|Overall Study|Adverse Event|2|||
48707404|NCT03077412|156777518|FG000|Overall Study|Investigator's Discretion|0|||
48707405|NCT03077412|156777519|FG001|Overall Study|Investigator's Discretion|1|||
48707406|NCT03077412|156777520|FG002|Overall Study|Investigator's Discretion|1|||
48707407|NCT03077412|156777518|FG000|Overall Study|Withdrew Consent|0|||
48707408|NCT03077412|156777519|FG001|Overall Study|Withdrew Consent|2|||
48707409|NCT03077412|156777520|FG002|Overall Study|Withdrew Consent|0|||
48707410|NCT03436082|156777525|FG000|Overall Study|Did not undergo procedure|1|||
48707411|NCT03436082|156777526|FG001|Overall Study|Did not undergo procedure|0|||
48707412|NCT04646044|156777529|FG000|Overall Study|Lost to Follow-up|0|||
48707413|NCT04646044|156777530|FG001|Overall Study|Lost to Follow-up|0|||
48707414|NCT04646044|156777531|FG002|Overall Study|Lost to Follow-up|1|||
48707415|NCT04646044|156777532|FG003|Overall Study|Lost to Follow-up|0|||
48707416|NCT04646044|156777529|FG000|Overall Study|Withdrawal by Subject|0|||
48707417|NCT04646044|156777530|FG001|Overall Study|Withdrawal by Subject|1|||
48707418|NCT04646044|156777531|FG002|Overall Study|Withdrawal by Subject|0|||
48707419|NCT04646044|156777532|FG003|Overall Study|Withdrawal by Subject|0|||
48707420|NCT01938716|156777533|FG000|Overall Study|Physician Decision|2|||
48707421|NCT01938716|156777533|FG000|Overall Study|Withdrawal by Subject|2|||
48707422|NCT01657019|156777534|FG000|Overall Study|Withdrawal by Subject|65|||
48707423|NCT01657019|156777534|FG000|Overall Study|Adverse Event|55|||
48707424|NCT01657019|156777534|FG000|Overall Study|Lost to Follow-up|48|||
48707425|NCT01657019|156777534|FG000|Overall Study|Protocol Violation|6|||
48707426|NCT01657019|156777534|FG000|Overall Study|Lack of Efficacy|3|||
48707427|NCT01657019|156777534|FG000|Overall Study|Other|58|||
48707428|NCT01750229|156777535|FG000|Randomized Crossover Phase|Adverse Event|1|||
48707429|NCT01750229|156777535|FG000|Randomized Crossover Phase|Withdrawal by Subject|1|||
48707430|NCT01750229|156777535|FG000|Long-term Follow-up Phase|Adverse Event|2|||
48707431|NCT01750229|156777535|FG000|Long-term Follow-up Phase|Withdrawal by Subject|1|||
48707432|NCT01092546|156777536|FG000|Overall Study|Subjects withdrawn prior to dosing|4|||
48707433|NCT02578706|156777539|FG000|Overall Study|Withdrawal by Subject|1|||
48707434|NCT02578706|156777540|FG001|Overall Study|Withdrawal by Subject|0|||
48707435|NCT02578706|156777541|FG002|Overall Study|Withdrawal by Subject|0|||
48707436|NCT02578706|156777539|FG000|Overall Study|Lost to Follow-up|0|||
48707437|NCT02578706|156777540|FG001|Overall Study|Lost to Follow-up|4|||
48707438|NCT02578706|156777541|FG002|Overall Study|Lost to Follow-up|0|||
48707439|NCT02578706|156777539|FG000|Overall Study|Physician Decision|0|||
48707440|NCT02578706|156777540|FG001|Overall Study|Physician Decision|1|||
48707441|NCT02578706|156777541|FG002|Overall Study|Physician Decision|0|||
48707442|NCT04396639|156777542|FG000|Overall Study|Withdrawal by Subject|1|||
48707443|NCT04396639|156777542|FG000|Overall Study|Other|1|||
48707444|NCT00885170|156777543|FG000|Overall Study|Adverse Event|12|||
48707445|NCT00885170|156777544|FG001|Overall Study|Adverse Event|4|||
48707446|NCT00885170|156777543|FG000|Overall Study|Excessive bone loss|6|||
48707447|NCT00885170|156777544|FG001|Overall Study|Excessive bone loss|3|||
48707448|NCT00885170|156777543|FG000|Overall Study|Lost to Follow-up|2|||
48801230|NCT00394355|157110364|FG002|Overall Study|Lack of Efficacy|2|||
48801231|NCT00394355|157110365|FG003|Overall Study|Lack of Efficacy|3|||
48801232|NCT02686034|157110370|FG000|Run-In Period 1|Eligibility|12|||
48801233|NCT02686034|157110371|FG001|Run-In Period 1|Eligibility|10|||
48801234|NCT02686034|157110370|FG000|Run-In Period 1|Withdrawal by Subject|4|||
48913612|NCT01911442|157521181|FG002|Overall Study|Withdrawal by Subject|6|||
48913613|NCT01911442|157521179|FG000|Overall Study|Mother's Work Schedule|0|||
48913614|NCT01911442|157521180|FG001|Overall Study|Mother's Work Schedule|1|||
48707449|NCT00885170|156777544|FG001|Overall Study|Lost to Follow-up|1|||
48707450|NCT00885170|156777543|FG000|Overall Study|Physician Decision|2|||
48707451|NCT00885170|156777544|FG001|Overall Study|Physician Decision|1|||
48707452|NCT00885170|156777543|FG000|Overall Study|Protocol Violation|3|||
48707453|NCT00885170|156777544|FG001|Overall Study|Protocol Violation|1|||
48707454|NCT00885170|156777543|FG000|Overall Study|Withdrawal by Subject|13|||
48707455|NCT00885170|156777544|FG001|Overall Study|Withdrawal by Subject|13|||
48913615|NCT01911442|157521181|FG002|Overall Study|Mother's Work Schedule|0|||
48707456|NCT02454517|156777545|FG000|Overall Study|Withdrawal by Subject|3|||
48707457|NCT02454517|156777546|FG001|Overall Study|Withdrawal by Subject|0|||
48707458|NCT02454517|156777545|FG000|Overall Study|Lost to Follow-up|4|||
48707459|NCT02454517|156777546|FG001|Overall Study|Lost to Follow-up|7|||
48801235|NCT02686034|157110371|FG001|Run-In Period 1|Withdrawal by Subject|3|||
48913616|NCT00122681|157521182|FG000|Overall Study|Adverse Event|20|||
48913617|NCT00122681|157521183|FG001|Overall Study|Adverse Event|16|||
48913618|NCT00122681|157521182|FG000|Overall Study|Lost to Follow-up|1080|||
48913619|NCT00122681|157521183|FG001|Overall Study|Lost to Follow-up|1097|||
48913620|NCT00122681|157521182|FG000|Overall Study|Protocol Violation|7|||
48913621|NCT00122681|157521183|FG001|Overall Study|Protocol Violation|10|||
48913622|NCT00122681|157521182|FG000|Overall Study|Withdrawal by Subject|257|||
48913623|NCT00122681|157521183|FG001|Overall Study|Withdrawal by Subject|251|||
48913624|NCT00122681|157521182|FG000|Overall Study|Personal reasons|150|||
48913625|NCT00122681|157521183|FG001|Overall Study|Personal reasons|147|||
48913626|NCT00922480|157521185|FG000|Main Study|Protocol Violation|3|||
48913627|NCT00922480|157521186|FG001|Main Study|Protocol Violation|6|||
48913628|NCT00922480|157521185|FG000|Main Study|Adverse Event|6|||
48707460|NCT02454517|156777545|FG000|Overall Study|Discontinued Active surveillance and underwent treatment|1|||
48707461|NCT02454517|156777546|FG001|Overall Study|Discontinued Active surveillance and underwent treatment|2|||
48707462|NCT01254422|156777549|FG000|Overall Study|Protocol Violation|1|||
48707463|NCT01254422|156777550|FG001|Overall Study|Protocol Violation|0|||
48707464|NCT01254422|156777549|FG000|Overall Study|Adverse Event|1|||
48707465|NCT01254422|156777550|FG001|Overall Study|Adverse Event|0|||
48707466|NCT01254422|156777549|FG000|Overall Study|Serious adverse event|0|||
48707467|NCT01254422|156777550|FG001|Overall Study|Serious adverse event|1|||
48707468|NCT01254422|156777549|FG000|Overall Study|Lost to Follow-up|1|||
48707469|NCT01254422|156777550|FG001|Overall Study|Lost to Follow-up|0|||
48707470|NCT00953056|156777553|FG000|Overall Study|Withdrew Consent|0|||
48707471|NCT00953056|156777554|FG001|Overall Study|Withdrew Consent|0|||
48707472|NCT00953056|156777555|FG002|Overall Study|Withdrew Consent|0|||
48707473|NCT00953056|156777556|FG003|Overall Study|Withdrew Consent|0|||
48707474|NCT00953056|156777557|FG004|Overall Study|Withdrew Consent|2|||
48707475|NCT00953056|156777558|FG005|Overall Study|Withdrew Consent|3|||
48707476|NCT00953056|156777553|FG000|Overall Study|Serious Adverse Event|0|||
48707477|NCT00953056|156777554|FG001|Overall Study|Serious Adverse Event|0|||
48707478|NCT00953056|156777555|FG002|Overall Study|Serious Adverse Event|0|||
48707479|NCT00953056|156777556|FG003|Overall Study|Serious Adverse Event|0|||
48707480|NCT00953056|156777557|FG004|Overall Study|Serious Adverse Event|0|||
48707481|NCT00953056|156777558|FG005|Overall Study|Serious Adverse Event|1|||
48707482|NCT01598506|156777559|FG000|Overall Study|Withdrawal by Subject|2|||
48707483|NCT03739203|156777560|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
48707484|NCT03739203|156777561|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|9|||
48707485|NCT03739203|156777562|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|13|||
48707486|NCT03739203|156777560|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
48707487|NCT03739203|156777561|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
48707488|NCT03739203|156777562|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
48707489|NCT03739203|156777560|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
48707490|NCT03739203|156777561|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
48707491|NCT03739203|156777562|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
48707492|NCT03739203|156777560|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
48707493|NCT03739203|156777561|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
48707494|NCT03739203|156777562|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|6|||
48707495|NCT03739203|156777560|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
48707496|NCT03739203|156777561|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
48707497|NCT03739203|156777562|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
48707498|NCT03739203|156777560|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
48707499|NCT03739203|156777561|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|3|||
48801236|NCT02686034|157110370|FG000|Run-In Period 1|Lost to Follow-up|4|||
48913629|NCT00922480|157521186|FG001|Main Study|Adverse Event|7|||
49010690|NCT03016078|157875674|FG000|Overall Study|Protocol Violation|1|||
48707500|NCT03739203|156777562|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
48707501|NCT03739203|156777560|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
48707502|NCT03739203|156777561|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
48707503|NCT03739203|156777562|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
48707504|NCT03739203|156777560|FG000|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|1|||
48707505|NCT03739203|156777561|FG001|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|2|||
48707506|NCT03739203|156777562|FG002|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|0|||
48707507|NCT03739203|156777560|FG000|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
48707508|NCT03739203|156777561|FG001|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
48707509|NCT03739203|156777562|FG002|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|2|||
48707510|NCT03739203|156777560|FG000|Safety Follow-Up Period (4 Weeks)|Death|1|||
48707511|NCT03739203|156777561|FG001|Safety Follow-Up Period (4 Weeks)|Death|0|||
48707512|NCT03739203|156777562|FG002|Safety Follow-Up Period (4 Weeks)|Death|0|||
48707513|NCT03739203|156777560|FG000|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
48707514|NCT03739203|156777561|FG001|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
48707515|NCT03739203|156777562|FG002|Safety Follow-Up Period (4 Weeks)|Reason not Specified|2|||
48707516|NCT01077076|156777565|FG000|First Intervention|Withdrawal by Subject|1|||
48707517|NCT01077076|156777566|FG001|First Intervention|Withdrawal by Subject|0|||
48707518|NCT01077076|156777567|FG002|First Intervention|Withdrawal by Subject|0|||
48707519|NCT01077076|156777568|FG003|First Intervention|Withdrawal by Subject|0|||
48707520|NCT01077076|156777569|FG004|First Intervention|Withdrawal by Subject|0|||
48707521|NCT01077076|156777570|FG005|First Intervention|Withdrawal by Subject|0|||
48707522|NCT01077076|156777565|FG000|Third Intervention|Death in the participant's family|0|||
48707523|NCT01077076|156777566|FG001|Third Intervention|Death in the participant's family|0|||
48707524|NCT01077076|156777567|FG002|Third Intervention|Death in the participant's family|0|||
48707525|NCT01077076|156777568|FG003|Third Intervention|Death in the participant's family|0|||
48707526|NCT01077076|156777569|FG004|Third Intervention|Death in the participant's family|0|||
48707527|NCT01077076|156777570|FG005|Third Intervention|Death in the participant's family|1|||
48707528|NCT03710161|156777575|FG000|Overall Study|Study halted due to COVID pandemic|3|||
48707529|NCT03710161|156777576|FG001|Overall Study|Study halted due to COVID pandemic|2|||
48707530|NCT00363480|156777578|FG000|Overall Study|Criteria for treatment period not fulfil|1|||
48707531|NCT00363480|156777578|FG000|Overall Study|Adverse Event|4|||
48707532|NCT00363480|156777578|FG000|Overall Study|Lost to Follow-up|5|||
48707533|NCT00363480|156777578|FG000|Overall Study|Withdrawal by Subject|5|||
48707534|NCT00363480|156777578|FG000|Overall Study|Non-compliance of subject|1|||
48707535|NCT00363480|156777578|FG000|Overall Study|Participant discontinued on its own|1|||
48707536|NCT01301027|156777579|FG000|Overall Study|Physician Decision|2|||
48707537|NCT01301027|156777580|FG001|Overall Study|Physician Decision|0|||
48707538|NCT01301027|156777579|FG000|Overall Study|Withdrawal by Subject|2|||
48707539|NCT01301027|156777580|FG001|Overall Study|Withdrawal by Subject|3|||
48707540|NCT01301027|156777579|FG000|Overall Study|Adverse Event|0|||
48707541|NCT01301027|156777580|FG001|Overall Study|Adverse Event|2|||
48707542|NCT01301027|156777579|FG000|Overall Study|Fracture|1|||
48707543|NCT01301027|156777580|FG001|Overall Study|Fracture|3|||
48707544|NCT01301027|156777579|FG000|Overall Study|Transplant|0|||
48707545|NCT01301027|156777580|FG001|Overall Study|Transplant|2|||
48707546|NCT01301027|156777579|FG000|Overall Study|Volume Overload|3|||
48913630|NCT00922480|157521185|FG000|Main Study|Lack of Efficacy|3|||
48913631|NCT00922480|157521186|FG001|Main Study|Lack of Efficacy|0|||
48913632|NCT00922480|157521185|FG000|Main Study|Withdrawal by Subject|20|||
48707547|NCT01301027|156777580|FG001|Overall Study|Volume Overload|0|||
48707548|NCT00541385|156777581|FG000|Overall Study|Adverse Event|6|||
48707549|NCT00541385|156777582|FG001|Overall Study|Adverse Event|3|||
48707550|NCT00541385|156777581|FG000|Overall Study|Withdrawal by Subject|2|||
48707551|NCT00541385|156777582|FG001|Overall Study|Withdrawal by Subject|2|||
48913633|NCT00922480|157521186|FG001|Main Study|Withdrawal by Subject|15|||
48801237|NCT02686034|157110371|FG001|Run-In Period 1|Lost to Follow-up|4|||
48801238|NCT02686034|157110370|FG000|Randomized Controlled Period 2|Lost to Follow-up|1|||
48801239|NCT02686034|157110371|FG001|Randomized Controlled Period 2|Lost to Follow-up|2|||
48801240|NCT02686034|157110370|FG000|Randomized Controlled Period 2|Withdrawal by Subject|3|||
48801241|NCT02686034|157110371|FG001|Randomized Controlled Period 2|Withdrawal by Subject|0|||
48801242|NCT02686034|157110370|FG000|Randomized Controlled Period 2|Adverse Event|0|||
48801243|NCT02686034|157110371|FG001|Randomized Controlled Period 2|Adverse Event|2|||
48801244|NCT02686034|157110370|FG000|Randomized Controlled Period 2|Spontaneous reduction in migraines|1|||
48801245|NCT02686034|157110371|FG001|Randomized Controlled Period 2|Spontaneous reduction in migraines|0|||
48801246|NCT02686034|157110370|FG000|Open Label Period 3|Lost to Follow-up|0|||
48801247|NCT02686034|157110371|FG001|Open Label Period 3|Lost to Follow-up|1|||
48801248|NCT02636270|157110372|FG000|Overall Study|Adverse Event|1|||
48801249|NCT02636270|157110373|FG001|Overall Study|Adverse Event|0|||
48801250|NCT02636270|157110374|FG002|Overall Study|Adverse Event|0|||
48801251|NCT02636270|157110372|FG000|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|1|||
48801252|NCT02636270|157110373|FG001|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
48801253|NCT02636270|157110374|FG002|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
48801254|NCT01678131|157110375|FG000|Overall Study|Adverse Event|0|||
48801255|NCT01678131|157110376|FG001|Overall Study|Adverse Event|1|||
48801256|NCT01678131|157110377|FG002|Overall Study|Adverse Event|0|||
48801257|NCT01678131|157110375|FG000|Overall Study|Withdrawal by Subject|0|||
48801258|NCT01678131|157110376|FG001|Overall Study|Withdrawal by Subject|0|||
48801259|NCT01678131|157110377|FG002|Overall Study|Withdrawal by Subject|2|||
48801260|NCT00982930|157110382|FG000|Overall Study|Adverse Event|1|||
48801261|NCT00982930|157110382|FG000|Overall Study|Withdrawal by Subject|1|||
48801262|NCT00982930|157110382|FG000|Overall Study|Administrative Problems|2|||
48801263|NCT00552084|157110383|FG000|Overall Study|Adverse Event|2|||
48801264|NCT00552084|157110384|FG001|Overall Study|Adverse Event|3|||
48801265|NCT00552084|157110383|FG000|Overall Study|Withdrawal by Subject|4|||
48801266|NCT00552084|157110384|FG001|Overall Study|Withdrawal by Subject|5|||
48801267|NCT00552084|157110383|FG000|Overall Study|Protocol Violation|1|||
48801268|NCT00552084|157110384|FG001|Overall Study|Protocol Violation|0|||
48801269|NCT00552084|157110383|FG000|Overall Study|change in anti-arrythmic drug|1|||
48801270|NCT00552084|157110384|FG001|Overall Study|change in anti-arrythmic drug|1|||
48801271|NCT02946918|157110385|FG000|Overall Study|Patient unblinded himself|1|||
48801272|NCT02946918|157110386|FG001|Overall Study|Patient unblinded himself|0|||
48801273|NCT02946918|157110385|FG000|Overall Study|Physician Decision|0|||
48801274|NCT02946918|157110386|FG001|Overall Study|Physician Decision|2|||
48801275|NCT02946918|157110385|FG000|Overall Study|Ran out of study medication|0|||
48801276|NCT02946918|157110386|FG001|Overall Study|Ran out of study medication|1|||
48801277|NCT02969525|157110387|FG000|Double-Blind Period|Adverse Event|0|||
48801278|NCT02969525|157110388|FG001|Double-Blind Period|Adverse Event|0|||
48801279|NCT02969525|157110389|FG002|Double-Blind Period|Adverse Event|1|||
48801280|NCT02969525|157110390|FG003|Double-Blind Period|Adverse Event|1|||
48801281|NCT02969525|157110391|FG004|Double-Blind Period|Adverse Event|0|||
48801282|NCT02969525|157110392|FG005|Double-Blind Period|Adverse Event|0|||
48801283|NCT02969525|157110393|FG006|Double-Blind Period|Adverse Event|0|||
48801284|NCT02969525|157110394|FG007|Double-Blind Period|Adverse Event|0|||
48801285|NCT02969525|157110395|FG008|Double-Blind Period|Adverse Event|0|||
48801286|NCT02969525|157110396|FG009|Double-Blind Period|Adverse Event|0|||
48801287|NCT02969525|157110397|FG010|Double-Blind Period|Adverse Event|0|||
48801288|NCT02969525|157110398|FG011|Double-Blind Period|Adverse Event|0|||
48801289|NCT02969525|157110387|FG000|Double-Blind Period|LOW EGFR|0|||
48801290|NCT02969525|157110388|FG001|Double-Blind Period|LOW EGFR|0|||
48801291|NCT02969525|157110389|FG002|Double-Blind Period|LOW EGFR|0|||
48801292|NCT02969525|157110390|FG003|Double-Blind Period|LOW EGFR|1|||
48801293|NCT02969525|157110391|FG004|Double-Blind Period|LOW EGFR|0|||
48801294|NCT02969525|157110392|FG005|Double-Blind Period|LOW EGFR|0|||
48801295|NCT02969525|157110393|FG006|Double-Blind Period|LOW EGFR|0|||
48801296|NCT02969525|157110394|FG007|Double-Blind Period|LOW EGFR|0|||
48801297|NCT02969525|157110395|FG008|Double-Blind Period|LOW EGFR|0|||
48801298|NCT02969525|157110396|FG009|Double-Blind Period|LOW EGFR|0|||
48801299|NCT02969525|157110397|FG010|Double-Blind Period|LOW EGFR|0|||
48801300|NCT02969525|157110398|FG011|Double-Blind Period|LOW EGFR|0|||
48801301|NCT02969525|157110387|FG000|Double-Blind Period|Study medication discontinued prior Wk12|2|||
48801302|NCT02969525|157110388|FG001|Double-Blind Period|Study medication discontinued prior Wk12|0|||
48801303|NCT02969525|157110389|FG002|Double-Blind Period|Study medication discontinued prior Wk12|0|||
48801304|NCT02969525|157110390|FG003|Double-Blind Period|Study medication discontinued prior Wk12|2|||
48801305|NCT02969525|157110391|FG004|Double-Blind Period|Study medication discontinued prior Wk12|0|||
48801306|NCT02969525|157110392|FG005|Double-Blind Period|Study medication discontinued prior Wk12|0|||
48801307|NCT02969525|157110393|FG006|Double-Blind Period|Study medication discontinued prior Wk12|0|||
48801308|NCT02969525|157110394|FG007|Double-Blind Period|Study medication discontinued prior Wk12|0|||
48801309|NCT02969525|157110395|FG008|Double-Blind Period|Study medication discontinued prior Wk12|0|||
48801310|NCT02969525|157110396|FG009|Double-Blind Period|Study medication discontinued prior Wk12|0|||
48801311|NCT02969525|157110397|FG010|Double-Blind Period|Study medication discontinued prior Wk12|0|||
48801312|NCT02969525|157110398|FG011|Double-Blind Period|Study medication discontinued prior Wk12|0|||
48801313|NCT02969525|157110387|FG000|Dose-Blind Period|Adverse Event|0|||
48801314|NCT02969525|157110388|FG001|Dose-Blind Period|Adverse Event|0|||
48801315|NCT02969525|157110389|FG002|Dose-Blind Period|Adverse Event|0|||
48801316|NCT02969525|157110390|FG003|Dose-Blind Period|Adverse Event|0|||
48801317|NCT02969525|157110391|FG004|Dose-Blind Period|Adverse Event|0|||
48801318|NCT02969525|157110392|FG005|Dose-Blind Period|Adverse Event|0|||
48801319|NCT02969525|157110393|FG006|Dose-Blind Period|Adverse Event|0|||
48801320|NCT02969525|157110394|FG007|Dose-Blind Period|Adverse Event|0|||
48801321|NCT02969525|157110395|FG008|Dose-Blind Period|Adverse Event|0|||
48801322|NCT02969525|157110396|FG009|Dose-Blind Period|Adverse Event|1|||
48801323|NCT02969525|157110397|FG010|Dose-Blind Period|Adverse Event|1|||
48801324|NCT02969525|157110398|FG011|Dose-Blind Period|Adverse Event|1|||
48801325|NCT02969525|157110387|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
48801326|NCT02969525|157110388|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
48801327|NCT02969525|157110389|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
48801328|NCT02969525|157110390|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
48801329|NCT02969525|157110391|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
48801330|NCT02969525|157110392|FG005|Dose-Blind Period|Withdrawal by Subject|0|||
48801331|NCT02969525|157110393|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
48801332|NCT02969525|157110394|FG007|Dose-Blind Period|Withdrawal by Subject|0|||
48801333|NCT02969525|157110395|FG008|Dose-Blind Period|Withdrawal by Subject|1|||
48801334|NCT02969525|157110396|FG009|Dose-Blind Period|Withdrawal by Subject|2|||
48801335|NCT02969525|157110397|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
48913634|NCT00922480|157521185|FG000|Main Study|Lost to Follow-up|5|||
48913635|NCT00922480|157521186|FG001|Main Study|Lost to Follow-up|0|||
48913636|NCT00922480|157521185|FG000|Main Study|Physician Decision|0|||
48913637|NCT00922480|157521186|FG001|Main Study|Physician Decision|1|||
48913638|NCT00922480|157521185|FG000|Extension Study|Protocol Violation|3|||
48913639|NCT00922480|157521186|FG001|Extension Study|Protocol Violation|0|||
48913640|NCT00922480|157521185|FG000|Extension Study|Adverse Event|1|||
48913641|NCT00922480|157521186|FG001|Extension Study|Adverse Event|1|||
48913642|NCT00922480|157521185|FG000|Extension Study|Withdrawal by Subject|1|||
48913643|NCT00922480|157521186|FG001|Extension Study|Withdrawal by Subject|1|||
48913644|NCT00922480|157521185|FG000|Extension Study|Others|0|||
48913645|NCT00922480|157521186|FG001|Extension Study|Others|1|||
48913646|NCT01994382|157521187|FG000|Overall Study|Informed consent withdrawn|0|||
48913647|NCT01994382|157521188|FG001|Overall Study|Informed consent withdrawn|0|||
48913648|NCT01994382|157521189|FG002|Overall Study|Informed consent withdrawn|0|||
48913649|NCT01994382|157521190|FG003|Overall Study|Informed consent withdrawn|0|||
48913650|NCT01994382|157521191|FG004|Overall Study|Informed consent withdrawn|0|||
48913651|NCT01994382|157521192|FG005|Overall Study|Informed consent withdrawn|0|||
48913652|NCT01994382|157521193|FG006|Overall Study|Informed consent withdrawn|1|||
48913653|NCT01994382|157521194|FG007|Overall Study|Informed consent withdrawn|0|||
48913654|NCT01994382|157521195|FG008|Overall Study|Informed consent withdrawn|0|||
48913655|NCT01994382|157521196|FG009|Overall Study|Informed consent withdrawn|0|||
48707552|NCT00541385|156777581|FG000|Overall Study|Lost to Follow-up|6|||
48707553|NCT00541385|156777582|FG001|Overall Study|Lost to Follow-up|1|||
48707554|NCT00541385|156777581|FG000|Overall Study|Parasite reappearance/malaria|67|||
48707555|NCT00541385|156777582|FG001|Overall Study|Parasite reappearance/malaria|32|||
48707556|NCT01469377|156777583|FG000|Overall Study|Protocol Deviation|7|||
48707557|NCT01469377|156777584|FG001|Overall Study|Protocol Deviation|10|||
48707558|NCT01469377|156777585|FG002|Overall Study|Protocol Deviation|10|||
48707559|NCT01469377|156777583|FG000|Overall Study|Lost to Follow-up|3|||
48707560|NCT01469377|156777584|FG001|Overall Study|Lost to Follow-up|2|||
48707561|NCT01469377|156777585|FG002|Overall Study|Lost to Follow-up|5|||
48707562|NCT01469377|156777583|FG000|Overall Study|Withdrawal of Consent|12|||
48707563|NCT01469377|156777584|FG001|Overall Study|Withdrawal of Consent|14|||
48707564|NCT01469377|156777585|FG002|Overall Study|Withdrawal of Consent|15|||
48707565|NCT01469377|156777583|FG000|Overall Study|Adverse Event|8|||
48801336|NCT02969525|157110398|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
48801337|NCT02969525|157110387|FG000|Dose-Blind Period|Non-cooperating patient|0|||
48707566|NCT01469377|156777584|FG001|Overall Study|Adverse Event|18|||
48707567|NCT01469377|156777585|FG002|Overall Study|Adverse Event|36|||
48707568|NCT01469377|156777583|FG000|Overall Study|Insufficient Therapeutic Response|3|||
48801338|NCT02969525|157110388|FG001|Dose-Blind Period|Non-cooperating patient|0|||
48913656|NCT01994382|157521197|FG010|Overall Study|Informed consent withdrawn|0|||
48707569|NCT01469377|156777584|FG001|Overall Study|Insufficient Therapeutic Response|4|||
48707570|NCT01469377|156777585|FG002|Overall Study|Insufficient Therapeutic Response|0|||
48801339|NCT02969525|157110389|FG002|Dose-Blind Period|Non-cooperating patient|0|||
48801340|NCT02969525|157110390|FG003|Dose-Blind Period|Non-cooperating patient|0|||
48801341|NCT02969525|157110391|FG004|Dose-Blind Period|Non-cooperating patient|0|||
48913657|NCT01994382|157521198|FG011|Overall Study|Informed consent withdrawn|0|||
48913658|NCT01994382|157521199|FG012|Overall Study|Informed consent withdrawn|0|||
48913659|NCT01994382|157521200|FG013|Overall Study|Informed consent withdrawn|0|||
48707571|NCT01469377|156777583|FG000|Overall Study|Other Miscellaneous Reasons|2|||
48801342|NCT02969525|157110392|FG005|Dose-Blind Period|Non-cooperating patient|0|||
48801343|NCT02969525|157110393|FG006|Dose-Blind Period|Non-cooperating patient|0|||
48801344|NCT02969525|157110394|FG007|Dose-Blind Period|Non-cooperating patient|0|||
48801345|NCT02969525|157110395|FG008|Dose-Blind Period|Non-cooperating patient|0|||
48801346|NCT02969525|157110396|FG009|Dose-Blind Period|Non-cooperating patient|0|||
48801347|NCT02969525|157110397|FG010|Dose-Blind Period|Non-cooperating patient|0|||
48801348|NCT02969525|157110398|FG011|Dose-Blind Period|Non-cooperating patient|1|||
48801349|NCT02969525|157110387|FG000|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
48801350|NCT02969525|157110388|FG001|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
48801351|NCT02969525|157110389|FG002|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
48801352|NCT02969525|157110390|FG003|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
48801353|NCT02969525|157110391|FG004|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
48801354|NCT02969525|157110392|FG005|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
48801355|NCT02969525|157110393|FG006|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
48801356|NCT02969525|157110394|FG007|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
48801357|NCT02969525|157110395|FG008|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
48913660|NCT01994382|157521201|FG014|Overall Study|Informed consent withdrawn|0|||
48913661|NCT01994382|157521202|FG015|Overall Study|Informed consent withdrawn|0|||
48913662|NCT01994382|157521203|FG016|Overall Study|Informed consent withdrawn|0|||
48913663|NCT01994382|157521187|FG000|Overall Study|Progressive disease|3|||
48913664|NCT01994382|157521188|FG001|Overall Study|Progressive disease|4|||
48913665|NCT01994382|157521189|FG002|Overall Study|Progressive disease|4|||
48913666|NCT01994382|157521190|FG003|Overall Study|Progressive disease|3|||
48913667|NCT01994382|157521191|FG004|Overall Study|Progressive disease|2|||
48913668|NCT01994382|157521192|FG005|Overall Study|Progressive disease|3|||
48913669|NCT01994382|157521193|FG006|Overall Study|Progressive disease|3|||
48913670|NCT01994382|157521194|FG007|Overall Study|Progressive disease|6|||
48913671|NCT01994382|157521195|FG008|Overall Study|Progressive disease|2|||
48913672|NCT01994382|157521196|FG009|Overall Study|Progressive disease|2|||
48913673|NCT01994382|157521197|FG010|Overall Study|Progressive disease|13|||
48913674|NCT01994382|157521198|FG011|Overall Study|Progressive disease|8|||
48913675|NCT01994382|157521199|FG012|Overall Study|Progressive disease|7|||
48913676|NCT01994382|157521200|FG013|Overall Study|Progressive disease|3|||
48913677|NCT01994382|157521201|FG014|Overall Study|Progressive disease|6|||
48913678|NCT01994382|157521202|FG015|Overall Study|Progressive disease|44|||
48913679|NCT01994382|157521203|FG016|Overall Study|Progressive disease|28|||
48913680|NCT01994382|157521187|FG000|Overall Study|Physician Decision|0|||
48913681|NCT01994382|157521188|FG001|Overall Study|Physician Decision|1|||
48913682|NCT01994382|157521189|FG002|Overall Study|Physician Decision|0|||
48913683|NCT01994382|157521190|FG003|Overall Study|Physician Decision|0|||
48913684|NCT01994382|157521191|FG004|Overall Study|Physician Decision|0|||
48913685|NCT01994382|157521192|FG005|Overall Study|Physician Decision|0|||
48913686|NCT01994382|157521193|FG006|Overall Study|Physician Decision|0|||
48913687|NCT01994382|157521194|FG007|Overall Study|Physician Decision|0|||
48913688|NCT01994382|157521195|FG008|Overall Study|Physician Decision|0|||
48913689|NCT01994382|157521196|FG009|Overall Study|Physician Decision|0|||
48801358|NCT02969525|157110396|FG009|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
48801359|NCT02969525|157110397|FG010|Dose-Blind Period|Withdrew before Safety Follow-up visit|1|||
48801360|NCT02969525|157110398|FG011|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
48801361|NCT03445065|157110399|FG000|Overall Study|Withdrawal by Subject|3|||
48801362|NCT03445065|157110400|FG001|Overall Study|Withdrawal by Subject|6|||
48801363|NCT03445065|157110401|FG002|Overall Study|Withdrawal by Subject|2|||
48801364|NCT03445065|157110402|FG003|Overall Study|Withdrawal by Subject|2|||
48801365|NCT03445065|157110399|FG000|Overall Study|Other|4|||
48801366|NCT03445065|157110400|FG001|Overall Study|Other|3|||
48801367|NCT03445065|157110401|FG002|Overall Study|Other|3|||
48801368|NCT03445065|157110402|FG003|Overall Study|Other|1|||
48801369|NCT04349280|157110403|FG000|Main Study (Up to Approx. 95 Weeks)|Ongoing|1|||
48801370|NCT04349280|157110404|FG001|Main Study (Up to Approx. 95 Weeks)|Ongoing|0|||
48801371|NCT04349280|157110403|FG000|Main Study (Up to Approx. 95 Weeks)|Death|12|||
48801372|NCT04349280|157110404|FG001|Main Study (Up to Approx. 95 Weeks)|Death|0|||
48801373|NCT04349280|157110403|FG000|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|0|||
48801374|NCT04349280|157110404|FG001|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|1|||
48913690|NCT01994382|157521197|FG010|Overall Study|Physician Decision|3|||
49118892|NCT00320788|158273244|FG002|Overall Study|Other|1|||
48801375|NCT02172625|157110405|FG000|Overall Study|Adverse Event|0|||
48801376|NCT02172625|157110406|FG001|Overall Study|Adverse Event|1|||
48913691|NCT01994382|157521198|FG011|Overall Study|Physician Decision|1|||
48913692|NCT01994382|157521199|FG012|Overall Study|Physician Decision|1|||
49118893|NCT00320788|158273245|FG003|Overall Study|Other|1|||
49118894|NCT00320788|158273246|FG004|Overall Study|Other|1|||
48913693|NCT01994382|157521200|FG013|Overall Study|Physician Decision|0|||
48913694|NCT01994382|157521201|FG014|Overall Study|Physician Decision|1|||
48913695|NCT01994382|157521202|FG015|Overall Study|Physician Decision|4|||
48913696|NCT01994382|157521203|FG016|Overall Study|Physician Decision|2|||
48913697|NCT01994382|157521187|FG000|Overall Study|Death|0|||
49118895|NCT00320788|158273242|FG000|Overall Study|Physician Decision|1|||
48801377|NCT02172625|157110405|FG000|Overall Study|Pregnancy|0|||
48801378|NCT02172625|157110406|FG001|Overall Study|Pregnancy|1|||
48801379|NCT02172625|157110405|FG000|Overall Study|car accident|0|||
48801380|NCT02172625|157110406|FG001|Overall Study|car accident|1|||
48801381|NCT02089230|157110415|FG000|Overall Study|Death|0|||
48801382|NCT02089230|157110416|FG001|Overall Study|Death|0|||
48801383|NCT02089230|157110417|FG002|Overall Study|Death|2|||
48801384|NCT02089230|157110415|FG000|Overall Study|Seeking Alternative Therapy|0|||
48913698|NCT01994382|157521188|FG001|Overall Study|Death|0|||
48913699|NCT01994382|157521189|FG002|Overall Study|Death|0|||
48913700|NCT01994382|157521190|FG003|Overall Study|Death|0|||
48913701|NCT01994382|157521191|FG004|Overall Study|Death|1|||
48913702|NCT01994382|157521192|FG005|Overall Study|Death|0|||
48913703|NCT01994382|157521193|FG006|Overall Study|Death|0|||
48913704|NCT01994382|157521194|FG007|Overall Study|Death|0|||
48913705|NCT01994382|157521195|FG008|Overall Study|Death|1|||
48913706|NCT01994382|157521196|FG009|Overall Study|Death|1|||
48913707|NCT01994382|157521197|FG010|Overall Study|Death|0|||
48913708|NCT01994382|157521198|FG011|Overall Study|Death|0|||
48913709|NCT01994382|157521199|FG012|Overall Study|Death|0|||
48913710|NCT01994382|157521200|FG013|Overall Study|Death|0|||
48913711|NCT01994382|157521201|FG014|Overall Study|Death|0|||
48913712|NCT01994382|157521202|FG015|Overall Study|Death|1|||
48913713|NCT01994382|157521203|FG016|Overall Study|Death|0|||
48913714|NCT01994382|157521187|FG000|Overall Study|Adverse Event|0|||
48913715|NCT01994382|157521188|FG001|Overall Study|Adverse Event|1|||
48913716|NCT01994382|157521189|FG002|Overall Study|Adverse Event|2|||
48913717|NCT01994382|157521190|FG003|Overall Study|Adverse Event|0|||
48913718|NCT01994382|157521191|FG004|Overall Study|Adverse Event|0|||
48913719|NCT01994382|157521192|FG005|Overall Study|Adverse Event|0|||
48913720|NCT01994382|157521193|FG006|Overall Study|Adverse Event|0|||
48913721|NCT01994382|157521194|FG007|Overall Study|Adverse Event|0|||
48707572|NCT01469377|156777584|FG001|Overall Study|Other Miscellaneous Reasons|0|||
48707573|NCT01469377|156777585|FG002|Overall Study|Other Miscellaneous Reasons|0|||
48707574|NCT01721044|156777586|FG000|Treatment Period|Adverse Event|7|||
48707575|NCT01721044|156777587|FG001|Treatment Period|Adverse Event|7|||
48707576|NCT01721044|156777588|FG002|Treatment Period|Adverse Event|10|||
48707577|NCT01721044|156777586|FG000|Treatment Period|Death|0|||
48707578|NCT01721044|156777587|FG001|Treatment Period|Death|0|||
48707579|NCT01721044|156777588|FG002|Treatment Period|Death|1|||
48707580|NCT01721044|156777586|FG000|Treatment Period|Lack of Efficacy|16|||
48707581|NCT01721044|156777587|FG001|Treatment Period|Lack of Efficacy|4|||
48707582|NCT01721044|156777588|FG002|Treatment Period|Lack of Efficacy|4|||
48707583|NCT01721044|156777586|FG000|Treatment Period|Lost to Follow-up|0|||
48707584|NCT01721044|156777587|FG001|Treatment Period|Lost to Follow-up|0|||
48707585|NCT01721044|156777588|FG002|Treatment Period|Lost to Follow-up|1|||
48707586|NCT01721044|156777586|FG000|Treatment Period|Physician Decision|1|||
48707587|NCT01721044|156777587|FG001|Treatment Period|Physician Decision|0|||
48707588|NCT01721044|156777588|FG002|Treatment Period|Physician Decision|2|||
48707589|NCT01721044|156777586|FG000|Treatment Period|Protocol Violation|1|||
48707590|NCT01721044|156777587|FG001|Treatment Period|Protocol Violation|0|||
48707591|NCT01721044|156777588|FG002|Treatment Period|Protocol Violation|0|||
48707592|NCT01721044|156777586|FG000|Treatment Period|Withdrawal by Subject|7|||
48707593|NCT01721044|156777587|FG001|Treatment Period|Withdrawal by Subject|6|||
48707594|NCT01721044|156777588|FG002|Treatment Period|Withdrawal by Subject|1|||
48707595|NCT04634253|156777589|FG000|Overall Study|Adverse Event|1|||
48707596|NCT04634253|156777590|FG001|Overall Study|Adverse Event|1|||
48707597|NCT04634253|156777591|FG002|Overall Study|Adverse Event|0|||
48707598|NCT04634253|156777589|FG000|Overall Study|Physician Decision|0|||
48707599|NCT04634253|156777590|FG001|Overall Study|Physician Decision|1|||
48707600|NCT04634253|156777591|FG002|Overall Study|Physician Decision|0|||
48801385|NCT02089230|157110416|FG001|Overall Study|Seeking Alternative Therapy|0|||
48913722|NCT01994382|157521195|FG008|Overall Study|Adverse Event|0|||
48913723|NCT01994382|157521196|FG009|Overall Study|Adverse Event|0|||
49118896|NCT00320788|158273243|FG001|Overall Study|Physician Decision|1|||
49118897|NCT00320788|158273244|FG002|Overall Study|Physician Decision|0|||
48707601|NCT04634253|156777589|FG000|Overall Study|Withdrawal by Subject|1|||
48707602|NCT04634253|156777590|FG001|Overall Study|Withdrawal by Subject|0|||
48707603|NCT04634253|156777591|FG002|Overall Study|Withdrawal by Subject|3|||
48707604|NCT01526733|156777592|FG000|Phase 1|Protocol Violation|1|||
48707605|NCT01526733|156777593|FG001|Phase 1|Protocol Violation|0|||
48801386|NCT02089230|157110417|FG002|Overall Study|Seeking Alternative Therapy|4|||
48801387|NCT03308825|157111522|FG000|Overall Study|Lost to Follow-up|2|||
48913724|NCT01994382|157521197|FG010|Overall Study|Adverse Event|15|||
48913725|NCT01994382|157521198|FG011|Overall Study|Adverse Event|2|||
48913726|NCT01994382|157521199|FG012|Overall Study|Adverse Event|7|||
48913727|NCT01994382|157521200|FG013|Overall Study|Adverse Event|3|||
48913728|NCT01994382|157521201|FG014|Overall Study|Adverse Event|17|||
48913729|NCT01994382|157521202|FG015|Overall Study|Adverse Event|6|||
48913730|NCT01994382|157521203|FG016|Overall Study|Adverse Event|3|||
49118898|NCT00320788|158273245|FG003|Overall Study|Physician Decision|0|||
48913731|NCT01994382|157521187|FG000|Overall Study|Other than specified|0|||
48913732|NCT01994382|157521188|FG001|Overall Study|Other than specified|0|||
48913733|NCT01994382|157521189|FG002|Overall Study|Other than specified|0|||
48913734|NCT01994382|157521190|FG003|Overall Study|Other than specified|0|||
48913735|NCT01994382|157521191|FG004|Overall Study|Other than specified|0|||
48913736|NCT01994382|157521192|FG005|Overall Study|Other than specified|0|||
48913737|NCT01994382|157521193|FG006|Overall Study|Other than specified|0|||
48913738|NCT01994382|157521194|FG007|Overall Study|Other than specified|0|||
48913739|NCT01994382|157521195|FG008|Overall Study|Other than specified|0|||
48913740|NCT01994382|157521196|FG009|Overall Study|Other than specified|0|||
48913741|NCT01994382|157521197|FG010|Overall Study|Other than specified|2|||
48913742|NCT01994382|157521198|FG011|Overall Study|Other than specified|0|||
48913743|NCT01994382|157521199|FG012|Overall Study|Other than specified|2|||
48913744|NCT01994382|157521200|FG013|Overall Study|Other than specified|0|||
48913745|NCT01994382|157521201|FG014|Overall Study|Other than specified|0|||
48913746|NCT01994382|157521202|FG015|Overall Study|Other than specified|4|||
48913747|NCT01994382|157521203|FG016|Overall Study|Other than specified|4|||
48913748|NCT01994382|157521187|FG000|Overall Study|Withdrawal by Subject|0|||
48913749|NCT01994382|157521188|FG001|Overall Study|Withdrawal by Subject|0|||
48913750|NCT01994382|157521189|FG002|Overall Study|Withdrawal by Subject|0|||
48913751|NCT01994382|157521190|FG003|Overall Study|Withdrawal by Subject|0|||
48913752|NCT01994382|157521191|FG004|Overall Study|Withdrawal by Subject|0|||
48913753|NCT01994382|157521192|FG005|Overall Study|Withdrawal by Subject|0|||
48913754|NCT01994382|157521193|FG006|Overall Study|Withdrawal by Subject|0|||
48913755|NCT01994382|157521194|FG007|Overall Study|Withdrawal by Subject|0|||
48913756|NCT01994382|157521195|FG008|Overall Study|Withdrawal by Subject|0|||
48913757|NCT01994382|157521196|FG009|Overall Study|Withdrawal by Subject|0|||
48913758|NCT01994382|157521197|FG010|Overall Study|Withdrawal by Subject|6|||
48913759|NCT01994382|157521198|FG011|Overall Study|Withdrawal by Subject|0|||
48913760|NCT01994382|157521199|FG012|Overall Study|Withdrawal by Subject|2|||
48913761|NCT01994382|157521200|FG013|Overall Study|Withdrawal by Subject|0|||
48707606|NCT01526733|156777592|FG000|Phase 1|Withdrawal by Subject|1|||
48707607|NCT01526733|156777593|FG001|Phase 1|Withdrawal by Subject|1|||
48707608|NCT04032093|156777594|FG000|Overall Study|Lost to Follow-up|7|||
48913762|NCT01994382|157521201|FG014|Overall Study|Withdrawal by Subject|4|||
48707609|NCT04032093|156777595|FG001|Overall Study|Lost to Follow-up|7|||
48707610|NCT04032093|156777596|FG002|Overall Study|Lost to Follow-up|6|||
48707611|NCT04032093|156777597|FG003|Overall Study|Lost to Follow-up|10|||
48707612|NCT04032093|156777598|FG004|Overall Study|Lost to Follow-up|13|||
48707613|NCT04032093|156777599|FG005|Overall Study|Lost to Follow-up|7|||
48707614|NCT04032093|156777600|FG006|Overall Study|Lost to Follow-up|7|||
48707615|NCT04032093|156777601|FG007|Overall Study|Lost to Follow-up|5|||
48707616|NCT04032093|156777602|FG008|Overall Study|Lost to Follow-up|9|||
48707617|NCT04032093|156777603|FG009|Overall Study|Lost to Follow-up|12|||
48707618|NCT04032093|156777594|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
48707619|NCT04032093|156777595|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
48707620|NCT04032093|156777596|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
48707621|NCT04032093|156777597|FG003|Overall Study|No Longer Meets Eligibility Criteria|2|||
48707622|NCT04032093|156777598|FG004|Overall Study|No Longer Meets Eligibility Criteria|1|||
48707623|NCT04032093|156777599|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
48707624|NCT04032093|156777600|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
48707625|NCT04032093|156777601|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
48707626|NCT04032093|156777602|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
48707627|NCT04032093|156777603|FG009|Overall Study|No Longer Meets Eligibility Criteria|1|||
48707628|NCT04032093|156777594|FG000|Overall Study|Other|1|||
48707629|NCT04032093|156777595|FG001|Overall Study|Other|0|||
48707630|NCT04032093|156777596|FG002|Overall Study|Other|0|||
48707631|NCT04032093|156777597|FG003|Overall Study|Other|1|||
48707632|NCT04032093|156777598|FG004|Overall Study|Other|1|||
48707633|NCT04032093|156777599|FG005|Overall Study|Other|0|||
48707634|NCT04032093|156777600|FG006|Overall Study|Other|0|||
49118899|NCT00320788|158273246|FG004|Overall Study|Physician Decision|0|||
49118900|NCT00320788|158273242|FG000|Overall Study|Protocol Violation|0|||
49118901|NCT00320788|158273243|FG001|Overall Study|Protocol Violation|0|||
49118902|NCT00320788|158273244|FG002|Overall Study|Protocol Violation|0|||
49118903|NCT00320788|158273245|FG003|Overall Study|Protocol Violation|0|||
48707635|NCT04032093|156777601|FG007|Overall Study|Other|0|||
48707636|NCT04032093|156777602|FG008|Overall Study|Other|0|||
48707637|NCT04032093|156777603|FG009|Overall Study|Other|1|||
48913763|NCT01994382|157521202|FG015|Overall Study|Withdrawal by Subject|3|||
48913764|NCT01994382|157521203|FG016|Overall Study|Withdrawal by Subject|0|||
48913765|NCT01994382|157521187|FG000|Overall Study|Lost to Follow-up|0|||
48913766|NCT01994382|157521188|FG001|Overall Study|Lost to Follow-up|0|||
48913767|NCT01994382|157521189|FG002|Overall Study|Lost to Follow-up|0|||
49118904|NCT00320788|158273246|FG004|Overall Study|Protocol Violation|1|||
49118905|NCT00320788|158273242|FG000|Overall Study|Withdrawal by Subject|3|||
48707638|NCT04032093|156777594|FG000|Overall Study|Withdrawal by Subject|1|||
48801388|NCT03308825|157111523|FG001|Overall Study|Lost to Follow-up|2|||
48801389|NCT03308825|157111524|FG002|Overall Study|Lost to Follow-up|1|||
48801390|NCT03308825|157111525|FG003|Overall Study|Lost to Follow-up|0|||
48801391|NCT03308825|157111522|FG000|Overall Study|Protocol Violation|0|||
48801392|NCT03308825|157111523|FG001|Overall Study|Protocol Violation|2|||
48801393|NCT03308825|157111524|FG002|Overall Study|Protocol Violation|0|||
48801394|NCT03308825|157111525|FG003|Overall Study|Protocol Violation|0|||
48801395|NCT00844857|157111527|FG000|Overall Study|Adverse Event|24|||
48801396|NCT00844857|157111528|FG001|Overall Study|Adverse Event|5|||
48801397|NCT00844857|157111527|FG000|Overall Study|Sponsor Decision|1|||
48801398|NCT00844857|157111528|FG001|Overall Study|Sponsor Decision|1|||
48801399|NCT00844857|157111527|FG000|Overall Study|Physician Decision|2|||
48801400|NCT00844857|157111528|FG001|Overall Study|Physician Decision|0|||
48801401|NCT00844857|157111527|FG000|Overall Study|Parent/Caregiver Decision|6|||
48801402|NCT00844857|157111528|FG001|Overall Study|Parent/Caregiver Decision|2|||
48801403|NCT00844857|157111527|FG000|Overall Study|Withdrawal by Subject|8|||
48801404|NCT00844857|157111528|FG001|Overall Study|Withdrawal by Subject|7|||
48801405|NCT00844857|157111527|FG000|Overall Study|Protocol Violation|6|||
48801406|NCT00844857|157111528|FG001|Overall Study|Protocol Violation|0|||
48801407|NCT00844857|157111527|FG000|Overall Study|Lack of Efficacy|5|||
48801408|NCT00844857|157111528|FG001|Overall Study|Lack of Efficacy|5|||
48801409|NCT00844857|157111527|FG000|Overall Study|Clinical Relapse|0|||
48801410|NCT00844857|157111528|FG001|Overall Study|Clinical Relapse|1|||
48801411|NCT00844857|157111527|FG000|Overall Study|Entry Criteria Not Met|0|||
48801412|NCT00844857|157111528|FG001|Overall Study|Entry Criteria Not Met|1|||
48801413|NCT00844857|157111527|FG000|Overall Study|Lost to Follow-up|2|||
48801414|NCT00844857|157111528|FG001|Overall Study|Lost to Follow-up|3|||
48801415|NCT00844857|157111527|FG000|Overall Study|Did Not Take Study Drug|3|||
48801416|NCT00844857|157111528|FG001|Overall Study|Did Not Take Study Drug|1|||
48801417|NCT00844857|157111527|FG000|Overall Study|Good Clinical Practice Violations|21|||
48801418|NCT00844857|157111528|FG001|Overall Study|Good Clinical Practice Violations|11|||
48801419|NCT01553318|157111533|FG000|Overall Study|Protocol Violation|3|||
48801420|NCT01553318|157111534|FG001|Overall Study|Protocol Violation|2|||
48801421|NCT00685945|157111539|FG000|L-NMMA + Bradykinin|Physician Decision|1|||
48801422|NCT02178059|157111542|FG000|Washout|Physician Decision|1|||
48801423|NCT02178059|157111543|FG001|Washout|Physician Decision|0|||
48801424|NCT00662857|157111546|FG000|Washout 1 (3 - 14 Days)|Physician Decision|0|||
48801425|NCT00662857|157111547|FG001|Washout 1 (3 - 14 Days)|Physician Decision|1|||
48801426|NCT00662857|157111546|FG000|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0|||
48801427|NCT00662857|157111547|FG001|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1|||
48801428|NCT00662857|157111546|FG000|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1|||
48801429|NCT00662857|157111547|FG001|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0|||
48801430|NCT00989092|157111548|FG000|Overall Study|Physician Decision|9|||
48801431|NCT00989092|157111549|FG001|Overall Study|Physician Decision|6|||
48801432|NCT00989092|157111548|FG000|Overall Study|Adverse Event|20|||
48801433|NCT00989092|157111549|FG001|Overall Study|Adverse Event|1|||
48801434|NCT00989092|157111548|FG000|Overall Study|Chemotherapy initiated|12|||
48801435|NCT00989092|157111549|FG001|Overall Study|Chemotherapy initiated|4|||
48801436|NCT00989092|157111548|FG000|Overall Study|Withdrawal by Subject|17|||
48801437|NCT00989092|157111549|FG001|Overall Study|Withdrawal by Subject|9|||
48801438|NCT00989092|157111548|FG000|Overall Study|Death|14|||
48801439|NCT00989092|157111549|FG001|Overall Study|Death|2|||
48801440|NCT00989092|157111548|FG000|Overall Study|Ineligibility determined|3|||
48801441|NCT00989092|157111549|FG001|Overall Study|Ineligibility determined|3|||
48801442|NCT00989092|157111548|FG000|Overall Study|Lost to Follow-up|6|||
48801443|NCT00989092|157111549|FG001|Overall Study|Lost to Follow-up|2|||
48801444|NCT00989092|157111548|FG000|Overall Study|Other|3|||
48801445|NCT00989092|157111549|FG001|Overall Study|Other|1|||
48801446|NCT00989092|157111548|FG000|Overall Study|Protocol deviation|2|||
48801447|NCT00989092|157111549|FG001|Overall Study|Protocol deviation|0|||
48801448|NCT00989092|157111548|FG000|Overall Study|Erythropoietin therapy initiated|2|||
48801449|NCT00989092|157111549|FG001|Overall Study|Erythropoietin therapy initiated|0|||
48801450|NCT00989092|157111548|FG000|Overall Study|Did not receive study drug|2|||
48801451|NCT00989092|157111549|FG001|Overall Study|Did not receive study drug|0|||
48801452|NCT01061333|157111550|FG000|Period 4: 20-day Washout|Discontinued by Study Team|0|||
48801453|NCT01061333|157111551|FG001|Period 4: 20-day Washout|Discontinued by Study Team|1|||
48801454|NCT00089141|157111554|FG000|Overall Study|Termination of trial|18|||
48801455|NCT00089141|157111555|FG001|Overall Study|Termination of trial|24|||
48801456|NCT00337272|157111571|FG000|Screening Period (Pre-randomization)|Withdrawal by Subject|2|||
48801457|NCT00337272|157111572|FG001|Screening Period (Pre-randomization)|Withdrawal by Subject|0|||
48913768|NCT01994382|157521190|FG003|Overall Study|Lost to Follow-up|0|||
48913769|NCT01994382|157521191|FG004|Overall Study|Lost to Follow-up|0|||
48913770|NCT01994382|157521192|FG005|Overall Study|Lost to Follow-up|0|||
48913771|NCT01994382|157521193|FG006|Overall Study|Lost to Follow-up|0|||
48913772|NCT01994382|157521194|FG007|Overall Study|Lost to Follow-up|0|||
48913773|NCT01994382|157521195|FG008|Overall Study|Lost to Follow-up|0|||
48913774|NCT01994382|157521196|FG009|Overall Study|Lost to Follow-up|0|||
48913775|NCT01994382|157521197|FG010|Overall Study|Lost to Follow-up|1|||
48913776|NCT01994382|157521198|FG011|Overall Study|Lost to Follow-up|0|||
48913777|NCT01994382|157521199|FG012|Overall Study|Lost to Follow-up|0|||
48913778|NCT01994382|157521200|FG013|Overall Study|Lost to Follow-up|0|||
48913779|NCT01994382|157521201|FG014|Overall Study|Lost to Follow-up|0|||
48913780|NCT01994382|157521202|FG015|Overall Study|Lost to Follow-up|0|||
48913781|NCT01994382|157521203|FG016|Overall Study|Lost to Follow-up|0|||
48913782|NCT01994382|157521187|FG000|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
48913783|NCT01994382|157521188|FG001|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
48913784|NCT01994382|157521189|FG002|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
48707639|NCT04032093|156777595|FG001|Overall Study|Withdrawal by Subject|3|||
48707640|NCT04032093|156777596|FG002|Overall Study|Withdrawal by Subject|2|||
48707641|NCT04032093|156777597|FG003|Overall Study|Withdrawal by Subject|2|||
48707642|NCT04032093|156777598|FG004|Overall Study|Withdrawal by Subject|3|||
48707643|NCT04032093|156777599|FG005|Overall Study|Withdrawal by Subject|0|||
48707644|NCT04032093|156777600|FG006|Overall Study|Withdrawal by Subject|0|||
48707645|NCT04032093|156777601|FG007|Overall Study|Withdrawal by Subject|0|||
48707646|NCT04032093|156777602|FG008|Overall Study|Withdrawal by Subject|0|||
48707647|NCT04032093|156777603|FG009|Overall Study|Withdrawal by Subject|0|||
48707648|NCT04032093|156777594|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
48707649|NCT04032093|156777595|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
48707650|NCT04032093|156777596|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
48707651|NCT04032093|156777597|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
48707652|NCT04032093|156777598|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
48707653|NCT04032093|156777599|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
48707654|NCT04032093|156777600|FG006|Overall Study|Withdrawal by Parent/Guardian|3|||
48707655|NCT04032093|156777601|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
48707656|NCT04032093|156777602|FG008|Overall Study|Withdrawal by Parent/Guardian|2|||
48707657|NCT04032093|156777603|FG009|Overall Study|Withdrawal by Parent/Guardian|3|||
48707658|NCT04032093|156777594|FG000|Overall Study|Adverse Event|0|||
48707659|NCT04032093|156777595|FG001|Overall Study|Adverse Event|0|||
48707660|NCT04032093|156777596|FG002|Overall Study|Adverse Event|0|||
48707661|NCT04032093|156777597|FG003|Overall Study|Adverse Event|0|||
48707662|NCT04032093|156777598|FG004|Overall Study|Adverse Event|0|||
48707663|NCT04032093|156777599|FG005|Overall Study|Adverse Event|0|||
48707664|NCT04032093|156777600|FG006|Overall Study|Adverse Event|0|||
48707665|NCT04032093|156777601|FG007|Overall Study|Adverse Event|0|||
48707666|NCT04032093|156777602|FG008|Overall Study|Adverse Event|0|||
48707667|NCT04032093|156777603|FG009|Overall Study|Adverse Event|1|||
48707668|NCT04032093|156777594|FG000|Overall Study|Physician Decision|0|||
48707669|NCT04032093|156777595|FG001|Overall Study|Physician Decision|0|||
48707670|NCT04032093|156777596|FG002|Overall Study|Physician Decision|0|||
48707671|NCT04032093|156777597|FG003|Overall Study|Physician Decision|0|||
48707672|NCT04032093|156777598|FG004|Overall Study|Physician Decision|0|||
48707673|NCT04032093|156777599|FG005|Overall Study|Physician Decision|1|||
48707674|NCT04032093|156777600|FG006|Overall Study|Physician Decision|0|||
48707675|NCT04032093|156777601|FG007|Overall Study|Physician Decision|0|||
48707676|NCT04032093|156777602|FG008|Overall Study|Physician Decision|0|||
48707677|NCT04032093|156777603|FG009|Overall Study|Physician Decision|0|||
48707678|NCT03350672|156777604|FG000|Overall Study|Withdrawal by Subject|7|||
48707679|NCT03350672|156777605|FG001|Overall Study|Withdrawal by Subject|0|||
48707680|NCT03350672|156777606|FG002|Overall Study|Withdrawal by Subject|0|||
48707681|NCT01354314|156777609|FG000|Overall Study|Lost to Follow-up|1|||
48707682|NCT01354314|156777610|FG001|Overall Study|Lost to Follow-up|0|||
48707683|NCT01354314|156777611|FG002|Overall Study|Lost to Follow-up|1|||
48707684|NCT01354314|156777612|FG003|Overall Study|Lost to Follow-up|1|||
48707685|NCT01354314|156777609|FG000|Overall Study|Withdrawal by Subject|0|||
48707686|NCT01354314|156777610|FG001|Overall Study|Withdrawal by Subject|0|||
48707687|NCT01354314|156777611|FG002|Overall Study|Withdrawal by Subject|1|||
48707688|NCT01354314|156777612|FG003|Overall Study|Withdrawal by Subject|0|||
48707689|NCT01354314|156777609|FG000|Overall Study|Adverse Event|0|||
48707690|NCT01354314|156777610|FG001|Overall Study|Adverse Event|0|||
48707691|NCT01354314|156777611|FG002|Overall Study|Adverse Event|0|||
48707692|NCT01354314|156777612|FG003|Overall Study|Adverse Event|1|||
48707693|NCT01354314|156777609|FG000|Overall Study|Protocol Violation|1|||
48707694|NCT01354314|156777610|FG001|Overall Study|Protocol Violation|1|||
48707695|NCT01354314|156777611|FG002|Overall Study|Protocol Violation|0|||
48707696|NCT01354314|156777612|FG003|Overall Study|Protocol Violation|0|||
48707697|NCT01354314|156777609|FG000|Overall Study|Less than 90% Adherence|4|||
48707698|NCT01354314|156777610|FG001|Overall Study|Less than 90% Adherence|2|||
48913785|NCT01994382|157521190|FG003|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
48913786|NCT01994382|157521191|FG004|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
48913787|NCT01994382|157521192|FG005|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
48913788|NCT01994382|157521193|FG006|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
48913789|NCT01994382|157521194|FG007|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
48913790|NCT01994382|157521195|FG008|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
48913791|NCT01994382|157521196|FG009|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
48913792|NCT01994382|157521197|FG010|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
48913793|NCT01994382|157521198|FG011|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
48913794|NCT01994382|157521199|FG012|Overall Study|Participants rolled over into expanded access program (NCT04757259)|7|||
48913795|NCT01994382|157521200|FG013|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
48913796|NCT01994382|157521201|FG014|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
48913797|NCT01994382|157521202|FG015|Overall Study|Participants rolled over into expanded access program (NCT04757259)|3|||
48913798|NCT01994382|157521203|FG016|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
48913799|NCT01994382|157521187|FG000|Overall Study|Protocol violation/noncompliance|0|||
48801458|NCT00337272|157111571|FG000|Screening Period (Pre-randomization)|Non-compliance|1|||
48801459|NCT00337272|157111572|FG001|Screening Period (Pre-randomization)|Non-compliance|0|||
48801460|NCT00337272|157111571|FG000|Screening Period (Pre-randomization)|Screen failure|3|||
48801461|NCT00337272|157111572|FG001|Screening Period (Pre-randomization)|Screen failure|0|||
48801462|NCT00337272|157111571|FG000|Treatment Period|Non-compliance|1|||
48801463|NCT00337272|157111572|FG001|Treatment Period|Non-compliance|1|||
48801464|NCT00337272|157111571|FG000|Treatment Period|Withdrawal by Subject|0|||
48801465|NCT00337272|157111572|FG001|Treatment Period|Withdrawal by Subject|1|||
48801466|NCT00337272|157111571|FG000|Withdrawal Period|Non-compliance|0|||
48801467|NCT00337272|157111572|FG001|Withdrawal Period|Non-compliance|1|||
48801468|NCT00742079|157111575|FG000|Overall Study|Lost to Follow-up|0|||
48801469|NCT00742079|157111576|FG001|Overall Study|Lost to Follow-up|1|||
48801470|NCT01181726|157111577|FG000|First Intervention|Adverse Event|1|||
48801471|NCT01181726|157111578|FG001|First Intervention|Adverse Event|0|||
48801472|NCT01964326|157111579|FG000|Overall Study|Adverse Event|48|||
48801473|NCT01964326|157111579|FG000|Overall Study|Death|2|||
48801474|NCT01964326|157111579|FG000|Overall Study|Protocol Violation|4|||
48801475|NCT01964326|157111579|FG000|Overall Study|Lost to Follow-up|88|||
48801476|NCT01964326|157111579|FG000|Overall Study|Withdrawal by Subject|87|||
48801477|NCT01964326|157111579|FG000|Overall Study|Pregnancy|1|||
48801478|NCT01964326|157111579|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
48801479|NCT01964326|157111579|FG000|Overall Study|Physician Decision|55|||
48801480|NCT01964326|157111579|FG000|Overall Study|Investigator Discretion|1|||
48801481|NCT01964326|157111579|FG000|Overall Study|Other|9|||
48801482|NCT01964326|157111579|FG000|Overall Study|Did not meet eligibility criteria|1|||
48801483|NCT01644734|157111580|FG000|Overall Study|Adverse Event|4|||
48801484|NCT01644734|157111580|FG000|Overall Study|Lost to Follow-up|17|||
48801485|NCT01644734|157111580|FG000|Overall Study|Reasons other than stated above|7|||
48801486|NCT01644734|157111580|FG000|Overall Study|Missing documentation|238|||
48801487|NCT01424930|157111581|FG000|Overall Study|Adverse Event|0|||
48913800|NCT01994382|157521188|FG001|Overall Study|Protocol violation/noncompliance|0|||
48913801|NCT01994382|157521189|FG002|Overall Study|Protocol violation/noncompliance|0|||
48913802|NCT01994382|157521190|FG003|Overall Study|Protocol violation/noncompliance|0|||
48913803|NCT01994382|157521191|FG004|Overall Study|Protocol violation/noncompliance|0|||
48913804|NCT01994382|157521192|FG005|Overall Study|Protocol violation/noncompliance|0|||
48913805|NCT01994382|157521193|FG006|Overall Study|Protocol violation/noncompliance|0|||
48913806|NCT01994382|157521194|FG007|Overall Study|Protocol violation/noncompliance|0|||
48913807|NCT01994382|157521195|FG008|Overall Study|Protocol violation/noncompliance|0|||
48913808|NCT01994382|157521196|FG009|Overall Study|Protocol violation/noncompliance|0|||
48913809|NCT01994382|157521197|FG010|Overall Study|Protocol violation/noncompliance|0|||
48913810|NCT01994382|157521198|FG011|Overall Study|Protocol violation/noncompliance|1|||
48913811|NCT01994382|157521199|FG012|Overall Study|Protocol violation/noncompliance|0|||
48913812|NCT01994382|157521200|FG013|Overall Study|Protocol violation/noncompliance|0|||
48913813|NCT01994382|157521201|FG014|Overall Study|Protocol violation/noncompliance|0|||
48913814|NCT01994382|157521202|FG015|Overall Study|Protocol violation/noncompliance|0|||
48913815|NCT01994382|157521203|FG016|Overall Study|Protocol violation/noncompliance|2|||
48913816|NCT01994382|157521187|FG000|Overall Study|Rolled over to Phase 2a|0|||
48913817|NCT01994382|157521188|FG001|Overall Study|Rolled over to Phase 2a|0|||
48913818|NCT01994382|157521189|FG002|Overall Study|Rolled over to Phase 2a|1|||
48913819|NCT01994382|157521190|FG003|Overall Study|Rolled over to Phase 2a|0|||
48913820|NCT01994382|157521191|FG004|Overall Study|Rolled over to Phase 2a|0|||
48801488|NCT01424930|157111582|FG001|Overall Study|Adverse Event|1|||
48801489|NCT01424930|157111581|FG000|Overall Study|Death|1|||
48801490|NCT01424930|157111582|FG001|Overall Study|Death|0|||
48801491|NCT01424930|157111581|FG000|Overall Study|Progressive Disease|3|||
48801492|NCT01424930|157111582|FG001|Overall Study|Progressive Disease|6|||
48801493|NCT01424930|157111581|FG000|Overall Study|Screen Failure|0|||
48801494|NCT01424930|157111582|FG001|Overall Study|Screen Failure|1|||
48801495|NCT01424930|157111581|FG000|Overall Study|Reason not specified|0|||
48801496|NCT01424930|157111582|FG001|Overall Study|Reason not specified|6|||
48801497|NCT00002558|157111583|FG000|Overall Study|Withdrawal by Subject|0|||
48801498|NCT00002558|157111584|FG001|Overall Study|Withdrawal by Subject|1|||
48801499|NCT01538472|157111586|FG000|Overall Study|Disease Progression|3|||
48801500|NCT01538472|157111586|FG000|Overall Study|Death|1|||
48913821|NCT01994382|157521192|FG005|Overall Study|Rolled over to Phase 2a|0|||
48913822|NCT01994382|157521193|FG006|Overall Study|Rolled over to Phase 2a|0|||
48913823|NCT01994382|157521194|FG007|Overall Study|Rolled over to Phase 2a|0|||
48913824|NCT01994382|157521195|FG008|Overall Study|Rolled over to Phase 2a|0|||
48913825|NCT01994382|157521196|FG009|Overall Study|Rolled over to Phase 2a|2|||
48707699|NCT01354314|156777611|FG002|Overall Study|Less than 90% Adherence|6|||
48707700|NCT01354314|156777612|FG003|Overall Study|Less than 90% Adherence|4|||
48707701|NCT00478023|156777613|FG000|Overall Study|Adverse Event|11|||
48707702|NCT00478023|156777614|FG001|Overall Study|Adverse Event|7|||
48707703|NCT00478023|156777615|FG002|Overall Study|Adverse Event|8|||
48707704|NCT00478023|156777616|FG003|Overall Study|Adverse Event|14|||
48707705|NCT00478023|156777617|FG004|Overall Study|Adverse Event|6|||
48707706|NCT00478023|156777613|FG000|Overall Study|Death|1|||
48707707|NCT00478023|156777614|FG001|Overall Study|Death|0|||
48707708|NCT00478023|156777615|FG002|Overall Study|Death|0|||
48707709|NCT00478023|156777616|FG003|Overall Study|Death|0|||
48707710|NCT00478023|156777617|FG004|Overall Study|Death|0|||
48707711|NCT00478023|156777613|FG000|Overall Study|Lack of Efficacy|11|||
48707712|NCT00478023|156777614|FG001|Overall Study|Lack of Efficacy|10|||
48707713|NCT00478023|156777615|FG002|Overall Study|Lack of Efficacy|4|||
48707714|NCT00478023|156777616|FG003|Overall Study|Lack of Efficacy|5|||
48707715|NCT00478023|156777617|FG004|Overall Study|Lack of Efficacy|41|||
48707716|NCT00478023|156777613|FG000|Overall Study|Lost to Follow-up|3|||
48707717|NCT00478023|156777614|FG001|Overall Study|Lost to Follow-up|1|||
48707718|NCT00478023|156777615|FG002|Overall Study|Lost to Follow-up|1|||
48707719|NCT00478023|156777616|FG003|Overall Study|Lost to Follow-up|1|||
48707720|NCT00478023|156777617|FG004|Overall Study|Lost to Follow-up|0|||
48707721|NCT00478023|156777613|FG000|Overall Study|Withdrawal by Subject|2|||
48707722|NCT00478023|156777614|FG001|Overall Study|Withdrawal by Subject|3|||
48707723|NCT00478023|156777615|FG002|Overall Study|Withdrawal by Subject|2|||
48707724|NCT00478023|156777616|FG003|Overall Study|Withdrawal by Subject|4|||
48707725|NCT00478023|156777617|FG004|Overall Study|Withdrawal by Subject|5|||
48801501|NCT02740049|157111587|FG000|Overall Study|Isolated cells did not grow sufficiently|1|||
48913826|NCT01994382|157521197|FG010|Overall Study|Rolled over to Phase 2a|0|||
48913827|NCT01994382|157521198|FG011|Overall Study|Rolled over to Phase 2a|0|||
48913828|NCT01994382|157521199|FG012|Overall Study|Rolled over to Phase 2a|0|||
48913829|NCT01994382|157521200|FG013|Overall Study|Rolled over to Phase 2a|0|||
48913830|NCT01994382|157521201|FG014|Overall Study|Rolled over to Phase 2a|0|||
48913831|NCT01994382|157521202|FG015|Overall Study|Rolled over to Phase 2a|0|||
48913832|NCT01994382|157521203|FG016|Overall Study|Rolled over to Phase 2a|0|||
48913833|NCT04667377|157521204|FG000|Dose Escalation Period|Other not specified below|3|||
48913834|NCT04667377|157521205|FG001|Dose Escalation Period|Other not specified below|3|||
48913835|NCT04667377|157521206|FG002|Dose Escalation Period|Other not specified below|2|||
48913836|NCT04667377|157521207|FG003|Dose Escalation Period|Other not specified below|1|||
48913837|NCT04667377|157521208|FG004|Dose Escalation Period|Other not specified below|3|||
48913838|NCT04667377|157521204|FG000|Dose Escalation Period|Protocol Violation|2|||
48913839|NCT04667377|157521205|FG001|Dose Escalation Period|Protocol Violation|2|||
48913840|NCT04667377|157521206|FG002|Dose Escalation Period|Protocol Violation|0|||
48913841|NCT04667377|157521207|FG003|Dose Escalation Period|Protocol Violation|2|||
48913842|NCT04667377|157521208|FG004|Dose Escalation Period|Protocol Violation|1|||
48913843|NCT04667377|157521204|FG000|Dose Escalation Period|Burden of study procedures|2|||
48913844|NCT04667377|157521205|FG001|Dose Escalation Period|Burden of study procedures|1|||
48913845|NCT04667377|157521206|FG002|Dose Escalation Period|Burden of study procedures|1|||
48913846|NCT04667377|157521207|FG003|Dose Escalation Period|Burden of study procedures|1|||
48707726|NCT00478023|156777613|FG000|Overall Study|Lack of pain, Technical difficulties|7|||
48707727|NCT00478023|156777614|FG001|Overall Study|Lack of pain, Technical difficulties|3|||
48707728|NCT00478023|156777615|FG002|Overall Study|Lack of pain, Technical difficulties|5|||
48913847|NCT04667377|157521208|FG004|Dose Escalation Period|Burden of study procedures|5|||
48913848|NCT04667377|157521204|FG000|Dose Escalation Period|Change of residence|0|||
48913849|NCT04667377|157521205|FG001|Dose Escalation Period|Change of residence|0|||
48707729|NCT00478023|156777616|FG003|Overall Study|Lack of pain, Technical difficulties|6|||
48707730|NCT00478023|156777617|FG004|Overall Study|Lack of pain, Technical difficulties|3|||
48707731|NCT00714870|156777621|FG000|Overall Study|Lost to Follow-up|22|||
48707732|NCT00714870|156777622|FG001|Overall Study|Lost to Follow-up|5|||
48801502|NCT00454571|157111588|FG000|Overall Study|Adverse Event|2|||
48801503|NCT00454571|157111589|FG001|Overall Study|Adverse Event|0|||
48801504|NCT00454571|157111588|FG000|Overall Study|Physician Decision|0|||
48801505|NCT00454571|157111589|FG001|Overall Study|Physician Decision|1|||
48801506|NCT00454571|157111588|FG000|Overall Study|Protocol Violation|1|||
48801507|NCT00454571|157111589|FG001|Overall Study|Protocol Violation|0|||
48801508|NCT00454571|157111588|FG000|Overall Study|Withdrawal by Subject|10|||
48801509|NCT00454571|157111589|FG001|Overall Study|Withdrawal by Subject|5|||
48801510|NCT02436811|157111600|FG000|Overall Study|Lost to Follow-up|2|||
48801511|NCT02436811|157111601|FG001|Overall Study|Lost to Follow-up|9|||
48801512|NCT02436811|157111602|FG002|Overall Study|Lost to Follow-up|7|||
48801513|NCT04209725|157111605|FG000|Overall Study|Adverse Event|1|||
48801514|NCT02856113|157111606|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
48801515|NCT02856113|157111607|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
48801516|NCT02856113|157111606|FG000|Overall Study|Significant Protocol Deviation|1|||
48801517|NCT02856113|157111607|FG001|Overall Study|Significant Protocol Deviation|0|||
48801518|NCT02856113|157111606|FG000|Overall Study|Lost to Follow-up|3|||
48801519|NCT02856113|157111607|FG001|Overall Study|Lost to Follow-up|5|||
48913850|NCT04667377|157521206|FG002|Dose Escalation Period|Change of residence|1|||
48913851|NCT04667377|157521207|FG003|Dose Escalation Period|Change of residence|0|||
48913852|NCT04667377|157521208|FG004|Dose Escalation Period|Change of residence|0|||
48913853|NCT04667377|157521204|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
48913854|NCT04667377|157521205|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
48801520|NCT02856113|157111606|FG000|Overall Study|Voluntary Withdrawal|3|||
48801521|NCT02856113|157111607|FG001|Overall Study|Voluntary Withdrawal|5|||
48801522|NCT02856113|157111606|FG000|Overall Study|Pregnancy|0|||
48801523|NCT02856113|157111607|FG001|Overall Study|Pregnancy|1|||
48801524|NCT02856113|157111606|FG000|Overall Study|Principal Investigator Discretion|2|||
48801525|NCT02856113|157111607|FG001|Overall Study|Principal Investigator Discretion|1|||
48801526|NCT02856113|157111606|FG000|Overall Study|Randomized but not Treated|1|||
48801527|NCT02856113|157111607|FG001|Overall Study|Randomized but not Treated|0|||
48801528|NCT02856113|157111606|FG000|Overall Study|Did not Complete Study but Contacted at Week 52|0|||
48913855|NCT04667377|157521206|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
48913856|NCT04667377|157521207|FG003|Dose Escalation Period|Perceived lack of efficacy|0|||
48913857|NCT04667377|157521208|FG004|Dose Escalation Period|Perceived lack of efficacy|6|||
48913858|NCT04667377|157521204|FG000|Dose Escalation Period|Adverse Event|9|||
48913859|NCT04667377|157521205|FG001|Dose Escalation Period|Adverse Event|10|||
48913860|NCT04667377|157521206|FG002|Dose Escalation Period|Adverse Event|12|||
48913861|NCT04667377|157521207|FG003|Dose Escalation Period|Adverse Event|17|||
48913862|NCT04667377|157521208|FG004|Dose Escalation Period|Adverse Event|3|||
48913863|NCT04667377|157521204|FG000|Dose Escalation Period|Adverse event: COVID-infection|4|||
48707733|NCT00714870|156777621|FG000|Overall Study|patient unable to come b/c back pain|1|||
48707734|NCT00714870|156777622|FG001|Overall Study|patient unable to come b/c back pain|0|||
48707735|NCT00714870|156777621|FG000|Overall Study|did not attend minimum of 4 sessions|4|||
48707736|NCT00714870|156777622|FG001|Overall Study|did not attend minimum of 4 sessions|0|||
48707737|NCT01064947|156777624|FG000|Overall Study|negative culture|41|||
48707738|NCT00560352|156777625|FG000|Overall Study|Adverse event unrelated to study drug|2|||
48707739|NCT00560352|156777626|FG001|Overall Study|Adverse event unrelated to study drug|1|||
48707740|NCT00560352|156777627|FG002|Overall Study|Adverse event unrelated to study drug|1|||
48707741|NCT00560352|156777625|FG000|Overall Study|Study drug toxicity|3|||
48707742|NCT00560352|156777626|FG001|Overall Study|Study drug toxicity|0|||
48707743|NCT00560352|156777627|FG002|Overall Study|Study drug toxicity|1|||
48707744|NCT00560352|156777625|FG000|Overall Study|Disease progression|0|||
48707745|NCT00560352|156777626|FG001|Overall Study|Disease progression|1|||
48707746|NCT00560352|156777627|FG002|Overall Study|Disease progression|1|||
48707747|NCT00560352|156777625|FG000|Overall Study|Withdrawal by Subject|1|||
48707748|NCT00560352|156777626|FG001|Overall Study|Withdrawal by Subject|1|||
48707749|NCT00560352|156777627|FG002|Overall Study|Withdrawal by Subject|1|||
48707750|NCT00560352|156777625|FG000|Overall Study|Maximum clinical benefit|1|||
48707751|NCT00560352|156777626|FG001|Overall Study|Maximum clinical benefit|0|||
48707752|NCT00560352|156777627|FG002|Overall Study|Maximum clinical benefit|0|||
48707753|NCT02904954|156778999|FG000|Neoadjuvant (Preoperative) to Surgery|Death|1|||
48707754|NCT02904954|156779000|FG001|Neoadjuvant (Preoperative) to Surgery|Death|1|||
48707755|NCT02904954|156778999|FG000|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1|||
48707756|NCT02904954|156779000|FG001|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0|||
48707757|NCT02904954|156778999|FG000|Neoadjuvant (Preoperative) to Surgery|Disease progression|2|||
48707758|NCT02904954|156779000|FG001|Neoadjuvant (Preoperative) to Surgery|Disease progression|3|||
48707759|NCT02904954|156778999|FG000|Adjuvant Durvalumab|Recurrence|2|||
48707760|NCT02904954|156779000|FG001|Adjuvant Durvalumab|Recurrence|0|||
48707761|NCT02904954|156778999|FG000|Adjuvant Durvalumab|Adverse Event|2|||
48707762|NCT02904954|156779000|FG001|Adjuvant Durvalumab|Adverse Event|6|||
48801529|NCT02856113|157111607|FG001|Overall Study|Did not Complete Study but Contacted at Week 52|3|||
48801530|NCT00658567|157111609|FG000|Overall Study|Adverse Event|5|||
48801531|NCT00658567|157111610|FG001|Overall Study|Adverse Event|2|||
48801532|NCT00658567|157111611|FG002|Overall Study|Adverse Event|3|||
48801533|NCT00658567|157111609|FG000|Overall Study|Voluntary Withdrawal of Consent|2|||
48801534|NCT00658567|157111610|FG001|Overall Study|Voluntary Withdrawal of Consent|0|||
48801535|NCT00658567|157111611|FG002|Overall Study|Voluntary Withdrawal of Consent|2|||
48801536|NCT00658567|157111609|FG000|Overall Study|Physician Decision|0|||
48801537|NCT00658567|157111610|FG001|Overall Study|Physician Decision|1|||
48801538|NCT00658567|157111611|FG002|Overall Study|Physician Decision|0|||
48801539|NCT00658567|157111609|FG000|Overall Study|At Discretion of Sponsor|1|||
48801540|NCT00658567|157111610|FG001|Overall Study|At Discretion of Sponsor|1|||
48801541|NCT00658567|157111611|FG002|Overall Study|At Discretion of Sponsor|1|||
48801542|NCT00691938|157111615|FG000|Overall Study|QTc prolongation|1|||
48801543|NCT00691938|157111616|FG001|Overall Study|QTc prolongation|0|||
48801544|NCT00691938|157111617|FG002|Overall Study|QTc prolongation|0|||
48801545|NCT00691938|157111618|FG003|Overall Study|QTc prolongation|0|||
48913864|NCT04667377|157521205|FG001|Dose Escalation Period|Adverse event: COVID-infection|1|||
48913865|NCT04667377|157521206|FG002|Dose Escalation Period|Adverse event: COVID-infection|2|||
48913866|NCT04667377|157521207|FG003|Dose Escalation Period|Adverse event: COVID-infection|1|||
48913867|NCT04667377|157521208|FG004|Dose Escalation Period|Adverse event: COVID-infection|0|||
48913868|NCT04667377|157521204|FG000|Dose Escalation Period|Not treated|1|||
48801546|NCT00691938|157111619|FG004|Overall Study|QTc prolongation|0|||
48801547|NCT00691938|157111620|FG005|Overall Study|QTc prolongation|0|||
48801548|NCT00691938|157111621|FG006|Overall Study|QTc prolongation|0|||
48801549|NCT04860518|157111622|FG000|Overall Study|Screen Failure, patient was not dosed|1|||
48801550|NCT04860518|157111623|FG001|Overall Study|Screen Failure, patient was not dosed|1|||
48801551|NCT02831257|157111629|FG000|Overall Study|Lack of Efficacy|3|||
48801552|NCT02831257|157111629|FG000|Overall Study|Adverse Event|2|||
48801553|NCT02831257|157111629|FG000|Overall Study|Physician Decision|1|||
48801554|NCT02831257|157111629|FG000|Overall Study|Withdrawal by Subject|6|||
48801555|NCT02755597|157111630|FG000|Overall Study|Withdrew consent|27|||
48801556|NCT02755597|157111631|FG001|Overall Study|Withdrew consent|11|||
48801557|NCT02755597|157111630|FG000|Overall Study|Lost to Follow-up|1|||
48801558|NCT02755597|157111631|FG001|Overall Study|Lost to Follow-up|0|||
48801559|NCT02755597|157111630|FG000|Overall Study|Death|78|||
48801560|NCT02755597|157111631|FG001|Overall Study|Death|36|||
48801561|NCT02755597|157111630|FG000|Overall Study|Study terminated by Sponsor|67|||
48801562|NCT02755597|157111631|FG001|Overall Study|Study terminated by Sponsor|47|||
48801563|NCT02755597|157111630|FG000|Overall Study|Other, not specified|20|||
48801564|NCT02755597|157111631|FG001|Overall Study|Other, not specified|3|||
48801565|NCT02755597|157111630|FG000|Overall Study|Participant missing reason for study discontinuation|1|||
48801566|NCT02755597|157111631|FG001|Overall Study|Participant missing reason for study discontinuation|0|||
48801567|NCT02889133|157111637|FG000|Completed Primary Outcome|Lost to Follow-up|1|||
48801568|NCT02889133|157111638|FG001|Completed Primary Outcome|Lost to Follow-up|1|||
48801569|NCT02889133|157111637|FG000|Completed Primary Outcome|Manufacturing error|3|||
48801570|NCT02889133|157111638|FG001|Completed Primary Outcome|Manufacturing error|8|||
48801571|NCT02889133|157111637|FG000|Completed Primary Outcome|Chromium labeling failure|1|||
48801572|NCT02889133|157111638|FG001|Completed Primary Outcome|Chromium labeling failure|0|||
48801573|NCT02889133|157111637|FG000|Completed Primary Outcome|COVID-19/Illness|4|||
48801574|NCT02889133|157111638|FG001|Completed Primary Outcome|COVID-19/Illness|2|||
48801575|NCT02889133|157111637|FG000|Completed Primary Outcome|Protocol Violation|1|||
48801576|NCT02889133|157111638|FG001|Completed Primary Outcome|Protocol Violation|0|||
48801577|NCT02889133|157111637|FG000|Completed Primary Outcome|Subject did not meet donor criteria|0|||
48801578|NCT02889133|157111638|FG001|Completed Primary Outcome|Subject did not meet donor criteria|1|||
48801579|NCT02889133|157111637|FG000|Completed Secondary Outcomes|Lost to Follow-up|1|||
48913869|NCT04667377|157521205|FG001|Dose Escalation Period|Not treated|0|||
48913870|NCT04667377|157521206|FG002|Dose Escalation Period|Not treated|0|||
48913871|NCT04667377|157521207|FG003|Dose Escalation Period|Not treated|0|||
48913872|NCT04667377|157521208|FG004|Dose Escalation Period|Not treated|0|||
48913873|NCT04667377|157521204|FG000|Dose Escalation Period|Withdrawal by Subject|2|||
48913874|NCT04667377|157521205|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
48913875|NCT04667377|157521206|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
48913876|NCT04667377|157521207|FG003|Dose Escalation Period|Withdrawal by Subject|0|||
48913877|NCT04667377|157521208|FG004|Dose Escalation Period|Withdrawal by Subject|2|||
48913878|NCT04667377|157521204|FG000|Dose Escalation Period|Lost to Follow-up|0|||
48913879|NCT04667377|157521205|FG001|Dose Escalation Period|Lost to Follow-up|1|||
48913880|NCT04667377|157521206|FG002|Dose Escalation Period|Lost to Follow-up|0|||
48913881|NCT04667377|157521207|FG003|Dose Escalation Period|Lost to Follow-up|0|||
48913882|NCT04667377|157521208|FG004|Dose Escalation Period|Lost to Follow-up|0|||
48801580|NCT02889133|157111638|FG001|Completed Secondary Outcomes|Lost to Follow-up|1|||
48801581|NCT02889133|157111637|FG000|Completed Secondary Outcomes|COVID-19/illness|4|||
48801582|NCT02889133|157111638|FG001|Completed Secondary Outcomes|COVID-19/illness|2|||
49118906|NCT00320788|158273243|FG001|Overall Study|Withdrawal by Subject|0|||
49118907|NCT00320788|158273244|FG002|Overall Study|Withdrawal by Subject|0|||
49118908|NCT00320788|158273245|FG003|Overall Study|Withdrawal by Subject|3|||
49118909|NCT00320788|158273246|FG004|Overall Study|Withdrawal by Subject|1|||
49118910|NCT01765569|158273247|FG000|Period B|Withdrawal by Subject|1|||
49118911|NCT01765569|158273247|FG000|Period C|Death|1|||
49118912|NCT00805129|158273248|FG000|Overall Study|Not treated|1|||
49118913|NCT01676012|158273253|FG000|Overall Study|Adverse Event|2|||
49118914|NCT01676012|158273253|FG000|Overall Study|incomplete set of videos|1|||
49118915|NCT01827592|158273254|FG000|Overall Study|Adverse Event|11|||
49118916|NCT01827592|158273255|FG001|Overall Study|Adverse Event|9|||
49118917|NCT01827592|158273256|FG002|Overall Study|Adverse Event|2|||
49118918|NCT01827592|158273254|FG000|Overall Study|Physician Decision|0|||
48707763|NCT02904954|156778999|FG000|Adjuvant Durvalumab|Participant wishes|12|||
48707764|NCT02904954|156779000|FG001|Adjuvant Durvalumab|Participant wishes|7|||
48707765|NCT02904954|156778999|FG000|Adjuvant Durvalumab|Physician Decision|2|||
48707766|NCT02904954|156779000|FG001|Adjuvant Durvalumab|Physician Decision|1|||
48707767|NCT02904954|156778999|FG000|Adjuvant Durvalumab|Slow recovery after chemotherapy|1|||
48707768|NCT02904954|156779000|FG001|Adjuvant Durvalumab|Slow recovery after chemotherapy|0|||
48707769|NCT02904954|156778999|FG000|Adjuvant Durvalumab|Death|0|||
48707770|NCT02904954|156779000|FG001|Adjuvant Durvalumab|Death|1|||
48707771|NCT02904954|156778999|FG000|Adjuvant Durvalumab|Prostate cancer|1|||
48707772|NCT02904954|156779000|FG001|Adjuvant Durvalumab|Prostate cancer|0|||
48707773|NCT05097963|156779001|FG000|Overall Study|Protocol Violation|13|||
48707774|NCT05097963|156779001|FG000|Overall Study|Withdrawal by Subject|21|||
48707775|NCT01772316|156779004|FG000|Overall Study|Serious adverse event|1|||
48707776|NCT01772316|156779004|FG000|Overall Study|Inform consent withdrawn|1|||
48707777|NCT01772316|156779004|FG000|Overall Study|Withdrawn by sponsor decision|5|||
48707778|NCT01936870|156779007|FG000|Overall Study|No Visit After Treatment|176|||
48707779|NCT01936870|156779007|FG000|Overall Study|Protocol Violation|12|||
48707780|NCT01936870|156779007|FG000|Overall Study|No Drug Administration|1|||
48707781|NCT01039519|156779013|FG000|Treatment|Progressive disease|20|||
48707782|NCT01039519|156779013|FG000|Treatment|Treatment failure|2|||
48707783|NCT01039519|156779013|FG000|Treatment|Adverse Event|3|||
48707784|NCT01039519|156779013|FG000|Treatment|Physician Decision|2|||
49118919|NCT01827592|158273255|FG001|Overall Study|Physician Decision|2|||
48707785|NCT01039519|156779013|FG000|Survival Follow-up|Death|23|||
48707786|NCT01039519|156779013|FG000|Survival Follow-up|Sponsor decision|4|||
48707787|NCT01229267|156779014|FG000|Overall Study|Adverse Event|4|||
48707788|NCT01229267|156779015|FG001|Overall Study|Adverse Event|6|||
48707789|NCT01229267|156779016|FG002|Overall Study|Adverse Event|3|||
48707790|NCT01229267|156779017|FG003|Overall Study|Adverse Event|2|||
48707791|NCT01229267|156779018|FG004|Overall Study|Adverse Event|10|||
48707792|NCT01229267|156779014|FG000|Overall Study|Death|40|||
48707793|NCT01229267|156779015|FG001|Overall Study|Death|37|||
48707794|NCT01229267|156779016|FG002|Overall Study|Death|35|||
48707795|NCT01229267|156779017|FG003|Overall Study|Death|13|||
48707796|NCT01229267|156779018|FG004|Overall Study|Death|103|||
48707797|NCT01229267|156779014|FG000|Overall Study|Withdrawal by Subject|23|||
48707798|NCT01229267|156779015|FG001|Overall Study|Withdrawal by Subject|22|||
48707799|NCT01229267|156779016|FG002|Overall Study|Withdrawal by Subject|32|||
48707800|NCT01229267|156779017|FG003|Overall Study|Withdrawal by Subject|14|||
48707801|NCT01229267|156779018|FG004|Overall Study|Withdrawal by Subject|59|||
49118920|NCT01827592|158273256|FG002|Overall Study|Physician Decision|1|||
49118921|NCT01827592|158273254|FG000|Overall Study|Protocol Violation|2|||
49118922|NCT01827592|158273255|FG001|Overall Study|Protocol Violation|1|||
49118923|NCT01827592|158273256|FG002|Overall Study|Protocol Violation|0|||
49118924|NCT01827592|158273254|FG000|Overall Study|Lost to Follow-up|1|||
49118925|NCT01827592|158273255|FG001|Overall Study|Lost to Follow-up|2|||
49118926|NCT01827592|158273256|FG002|Overall Study|Lost to Follow-up|2|||
49118927|NCT01827592|158273254|FG000|Overall Study|Withdrawal by Subject|12|||
49118928|NCT01827592|158273255|FG001|Overall Study|Withdrawal by Subject|11|||
49118929|NCT01827592|158273256|FG002|Overall Study|Withdrawal by Subject|11|||
49118930|NCT01827592|158273254|FG000|Overall Study|Patient's substantial non-compliance|1|||
49118931|NCT01827592|158273255|FG001|Overall Study|Patient's substantial non-compliance|1|||
49118932|NCT01827592|158273256|FG002|Overall Study|Patient's substantial non-compliance|6|||
49118933|NCT01827592|158273254|FG000|Overall Study|Trial terminated by Sponsor|47|||
49118934|NCT01827592|158273255|FG001|Overall Study|Trial terminated by Sponsor|53|||
49118935|NCT01827592|158273256|FG002|Overall Study|Trial terminated by Sponsor|51|||
49118936|NCT01827592|158273254|FG000|Overall Study|Others|0|||
49118937|NCT01827592|158273255|FG001|Overall Study|Others|1|||
49118938|NCT01827592|158273256|FG002|Overall Study|Others|3|||
49118939|NCT02324361|158273259|FG000|Overall Study|Lost to Follow-up|5|||
49118940|NCT02324361|158273260|FG001|Overall Study|Lost to Follow-up|2|||
49118941|NCT03518086|158273272|FG000|Overall Study|Adverse Event|23|||
48707802|NCT01229267|156779014|FG000|Overall Study|Protocol Violation|0|||
49118942|NCT03518086|158273273|FG001|Overall Study|Adverse Event|15|||
49118943|NCT03518086|158273274|FG002|Overall Study|Adverse Event|0|||
49118944|NCT03518086|158273275|FG003|Overall Study|Adverse Event|0|||
48913883|NCT04667377|157521204|FG000|Maintenance Period|Perceived lack of efficacy|0|||
48913884|NCT04667377|157521205|FG001|Maintenance Period|Perceived lack of efficacy|2|||
48913885|NCT04667377|157521206|FG002|Maintenance Period|Perceived lack of efficacy|1|||
48913886|NCT04667377|157521207|FG003|Maintenance Period|Perceived lack of efficacy|0|||
48913887|NCT04667377|157521208|FG004|Maintenance Period|Perceived lack of efficacy|1|||
48913888|NCT04667377|157521204|FG000|Maintenance Period|Adverse Event|2|||
48913889|NCT04667377|157521205|FG001|Maintenance Period|Adverse Event|8|||
48913890|NCT04667377|157521206|FG002|Maintenance Period|Adverse Event|5|||
48913891|NCT04667377|157521207|FG003|Maintenance Period|Adverse Event|4|||
48913892|NCT04667377|157521208|FG004|Maintenance Period|Adverse Event|1|||
48913893|NCT04667377|157521204|FG000|Maintenance Period|Adverse event: COVID infection|0|||
48913894|NCT04667377|157521205|FG001|Maintenance Period|Adverse event: COVID infection|1|||
48913895|NCT04667377|157521206|FG002|Maintenance Period|Adverse event: COVID infection|0|||
48913896|NCT04667377|157521207|FG003|Maintenance Period|Adverse event: COVID infection|0|||
48913897|NCT04667377|157521208|FG004|Maintenance Period|Adverse event: COVID infection|0|||
48913898|NCT04667377|157521204|FG000|Maintenance Period|COVID-related|0|||
48913899|NCT04667377|157521205|FG001|Maintenance Period|COVID-related|0|||
48913900|NCT04667377|157521206|FG002|Maintenance Period|COVID-related|1|||
48913901|NCT04667377|157521207|FG003|Maintenance Period|COVID-related|1|||
48913902|NCT04667377|157521208|FG004|Maintenance Period|COVID-related|0|||
48801583|NCT02889133|157111637|FG000|Completed Secondary Outcomes|Subject could not donate blood after randomization|0|||
48801584|NCT02889133|157111638|FG001|Completed Secondary Outcomes|Subject could not donate blood after randomization|2|||
48801585|NCT02889133|157111637|FG000|Completed Secondary Outcomes|Protocol Violation|1|||
48801586|NCT02889133|157111638|FG001|Completed Secondary Outcomes|Protocol Violation|0|||
48801587|NCT01060553|157111639|FG000|Overall Study|Lost to Follow-up|3|||
48801588|NCT01060553|157111640|FG001|Overall Study|Lost to Follow-up|5|||
48801589|NCT01060553|157111639|FG000|Overall Study|Withdrawal by Subject|5|||
48801590|NCT01060553|157111640|FG001|Overall Study|Withdrawal by Subject|5|||
48801591|NCT01060553|157111639|FG000|Overall Study|Lack of Efficacy|1|||
48801592|NCT01060553|157111640|FG001|Overall Study|Lack of Efficacy|0|||
48801593|NCT02719990|157111643|FG000|Overall Study|Physician Decision|2|||
48801594|NCT02719990|157111643|FG000|Overall Study|Withdrawal by Subject|2|||
48801595|NCT02719990|157111643|FG000|Overall Study|Study Terminated By Sponsor|32|||
48801596|NCT00766675|157113907|FG000|Overall Study|Adverse Event|16|||
48801597|NCT00766675|157113907|FG000|Overall Study|Lost to Follow-up|2|||
48801598|NCT00766675|157113907|FG000|Overall Study|Withdrawal by Subject|11|||
48801599|NCT00766675|157113907|FG000|Overall Study|Protocol Violation|8|||
48801600|NCT00766675|157113907|FG000|Overall Study|Participant took prohibited medication|1|||
48801601|NCT00766675|157113907|FG000|Overall Study|Receive other anti-neoplastic treatment|1|||
48801602|NCT00766675|157113907|FG000|Overall Study|Insufficient therapy|1|||
48801603|NCT01337674|157113913|FG000|Treatment Period 1|Adverse Event|0|||
48801604|NCT01337674|157113914|FG001|Treatment Period 1|Adverse Event|1|||
48801605|NCT01337674|157113915|FG002|Treatment Period 1|Adverse Event|0|||
48801606|NCT01337674|157113916|FG003|Treatment Period 1|Adverse Event|0|||
48801607|NCT01337674|157113913|FG000|Treatment Period 1|Discontinued due to blood draws|0|||
48801608|NCT01337674|157113914|FG001|Treatment Period 1|Discontinued due to blood draws|0|||
48801609|NCT01337674|157113915|FG002|Treatment Period 1|Discontinued due to blood draws|0|||
48801610|NCT01337674|157113916|FG003|Treatment Period 1|Discontinued due to blood draws|1|||
48801611|NCT01337674|157113913|FG000|Treatment Period 2|Withdrawal by Subject|0|||
48801612|NCT01337674|157113914|FG001|Treatment Period 2|Withdrawal by Subject|0|||
48801613|NCT01337674|157113915|FG002|Treatment Period 2|Withdrawal by Subject|1|||
48801614|NCT01337674|157113916|FG003|Treatment Period 2|Withdrawal by Subject|0|||
48801615|NCT00437645|157113917|FG000|Overall Study|Adverse Event|15|||
48801616|NCT00437645|157113918|FG001|Overall Study|Adverse Event|84|||
48801617|NCT00437645|157113917|FG000|Overall Study|Withdrawal by Subject|10|||
48801618|NCT00437645|157113918|FG001|Overall Study|Withdrawal by Subject|22|||
48801619|NCT00437645|157113917|FG000|Overall Study|Protocol Violation|3|||
48801620|NCT00437645|157113918|FG001|Overall Study|Protocol Violation|3|||
48801621|NCT00437645|157113917|FG000|Overall Study|Lost to Follow-up|2|||
48801622|NCT00437645|157113918|FG001|Overall Study|Lost to Follow-up|3|||
48913903|NCT04667377|157521204|FG000|Maintenance Period|Protocol Violation|1|||
48913904|NCT04667377|157521205|FG001|Maintenance Period|Protocol Violation|0|||
48913905|NCT04667377|157521206|FG002|Maintenance Period|Protocol Violation|0|||
48913906|NCT04667377|157521207|FG003|Maintenance Period|Protocol Violation|0|||
48913907|NCT04667377|157521208|FG004|Maintenance Period|Protocol Violation|1|||
48801623|NCT00437645|157113917|FG000|Overall Study|Administrative problems|2|||
48801624|NCT00437645|157113918|FG001|Overall Study|Administrative problems|1|||
48801625|NCT00437645|157113917|FG000|Overall Study|Lack of Efficacy|2|||
48801626|NCT00437645|157113918|FG001|Overall Study|Lack of Efficacy|1|||
48801627|NCT00437645|157113917|FG000|Overall Study|Condition no longer requires study drug|1|||
48801628|NCT00437645|157113918|FG001|Overall Study|Condition no longer requires study drug|1|||
48801629|NCT02710292|157113919|FG000|Period 1, First 10 Days of Wear|Adverse Event|0|||
48801630|NCT02710292|157113920|FG001|Period 1, First 10 Days of Wear|Adverse Event|1|||
48913908|NCT04667377|157521204|FG000|Maintenance Period|Burden of study procedures|1|||
48913909|NCT04667377|157521205|FG001|Maintenance Period|Burden of study procedures|2|||
48913910|NCT04667377|157521206|FG002|Maintenance Period|Burden of study procedures|0|||
48913911|NCT04667377|157521207|FG003|Maintenance Period|Burden of study procedures|1|||
48913912|NCT04667377|157521208|FG004|Maintenance Period|Burden of study procedures|0|||
48913913|NCT04667377|157521204|FG000|Maintenance Period|Change of residence|0|||
48913914|NCT04667377|157521205|FG001|Maintenance Period|Change of residence|1|||
48913915|NCT04667377|157521206|FG002|Maintenance Period|Change of residence|0|||
48707803|NCT01229267|156779015|FG001|Overall Study|Protocol Violation|1|||
48707804|NCT01229267|156779016|FG002|Overall Study|Protocol Violation|0|||
48707805|NCT01229267|156779017|FG003|Overall Study|Protocol Violation|0|||
48707806|NCT01229267|156779018|FG004|Overall Study|Protocol Violation|0|||
48707807|NCT01229267|156779014|FG000|Overall Study|Progressive disease|0|||
48707808|NCT01229267|156779015|FG001|Overall Study|Progressive disease|0|||
48707809|NCT01229267|156779016|FG002|Overall Study|Progressive disease|0|||
48707810|NCT01229267|156779017|FG003|Overall Study|Progressive disease|0|||
48707811|NCT01229267|156779018|FG004|Overall Study|Progressive disease|1|||
48707812|NCT01229267|156779014|FG000|Overall Study|Physician Decision|8|||
48707813|NCT01229267|156779015|FG001|Overall Study|Physician Decision|11|||
48707814|NCT01229267|156779016|FG002|Overall Study|Physician Decision|8|||
48707815|NCT01229267|156779017|FG003|Overall Study|Physician Decision|3|||
48707816|NCT01229267|156779018|FG004|Overall Study|Physician Decision|25|||
48707817|NCT01229267|156779014|FG000|Overall Study|Lost to Follow-up|6|||
48707818|NCT01229267|156779015|FG001|Overall Study|Lost to Follow-up|5|||
48707819|NCT01229267|156779016|FG002|Overall Study|Lost to Follow-up|8|||
48707820|NCT01229267|156779017|FG003|Overall Study|Lost to Follow-up|3|||
48707821|NCT01229267|156779018|FG004|Overall Study|Lost to Follow-up|22|||
48707822|NCT00711191|156779021|FG000|Overall Study|Adverse Event|1|||
48707823|NCT00711191|156779022|FG001|Overall Study|Adverse Event|1|||
48707824|NCT00711191|156779023|FG002|Overall Study|Adverse Event|2|||
48707825|NCT00711191|156779021|FG000|Overall Study|Objective progression or relapse|2|||
48707826|NCT00711191|156779022|FG001|Overall Study|Objective progression or relapse|3|||
48707827|NCT00711191|156779023|FG002|Overall Study|Objective progression or relapse|7|||
48707828|NCT00711191|156779021|FG000|Overall Study|Withdrawal by Subject|0|||
48707829|NCT00711191|156779022|FG001|Overall Study|Withdrawal by Subject|1|||
48707830|NCT00711191|156779023|FG002|Overall Study|Withdrawal by Subject|3|||
48707831|NCT02035267|156779024|FG000|Overall Study|Withdrawal consent-subject convenience|0|||
48707832|NCT02035267|156779025|FG001|Overall Study|Withdrawal consent-subject convenience|0|||
48707833|NCT02035267|156779026|FG002|Overall Study|Withdrawal consent-subject convenience|1|||
48707834|NCT02035267|156779027|FG003|Overall Study|Withdrawal consent-subject convenience|0|||
48707835|NCT02035267|156779024|FG000|Overall Study|Adverse Event|0|||
48707836|NCT02035267|156779025|FG001|Overall Study|Adverse Event|0|||
48707837|NCT02035267|156779026|FG002|Overall Study|Adverse Event|1|||
48707838|NCT02035267|156779027|FG003|Overall Study|Adverse Event|0|||
48707839|NCT02035267|156779024|FG000|Overall Study|Lost to Follow-up|0|||
48707840|NCT02035267|156779025|FG001|Overall Study|Lost to Follow-up|0|||
48707841|NCT02035267|156779026|FG002|Overall Study|Lost to Follow-up|0|||
48707842|NCT02035267|156779027|FG003|Overall Study|Lost to Follow-up|1|||
48707843|NCT02035267|156779024|FG000|Overall Study|Other unspecified|0|||
48707844|NCT02035267|156779025|FG001|Overall Study|Other unspecified|1|||
48707845|NCT02035267|156779026|FG002|Overall Study|Other unspecified|0|||
48707846|NCT02035267|156779027|FG003|Overall Study|Other unspecified|0|||
48707847|NCT04294680|156779033|FG000|Overall Study|Withdrawal by Subject|2|||
48707848|NCT04294680|156779034|FG001|Overall Study|Withdrawal by Subject|1|||
48707849|NCT04294680|156779033|FG000|Overall Study|Follow-up visits completed outside of window|1|||
48707850|NCT04294680|156779034|FG001|Overall Study|Follow-up visits completed outside of window|0|||
48707851|NCT02858362|156779039|FG000|Overall Study|Protocol Violation|0|||
48707852|NCT02858362|156779040|FG001|Overall Study|Protocol Violation|1|||
48707853|NCT02858362|156779041|FG002|Overall Study|Protocol Violation|0|||
48707854|NCT02858362|156779039|FG000|Overall Study|Withdrawal by Subject|1|||
48707855|NCT02858362|156779040|FG001|Overall Study|Withdrawal by Subject|0|||
48707856|NCT02858362|156779041|FG002|Overall Study|Withdrawal by Subject|0|||
48707857|NCT02858362|156779039|FG000|Overall Study|Early Study Termination|0|||
48707858|NCT02858362|156779040|FG001|Overall Study|Early Study Termination|0|||
48707859|NCT02858362|156779041|FG002|Overall Study|Early Study Termination|3|||
48707860|NCT02858362|156779039|FG000|Overall Study|Lost to Follow-up|1|||
48707861|NCT02858362|156779040|FG001|Overall Study|Lost to Follow-up|0|||
48707862|NCT02858362|156779041|FG002|Overall Study|Lost to Follow-up|0|||
48707863|NCT03967444|156779042|FG000|Overall Study|Lost to Follow-up|1|||
48707864|NCT03967444|156779043|FG001|Overall Study|Lost to Follow-up|2|||
48913916|NCT04667377|157521207|FG003|Maintenance Period|Change of residence|0|||
48707865|NCT01605799|156779050|FG000|Overall Study|Withdrawal by Subject|2|||
48707866|NCT01605799|156779051|FG001|Overall Study|Withdrawal by Subject|1|||
48707867|NCT03527732|156779053|FG000|Overall Study|Lost to Follow-up|21|||
48707868|NCT03527732|156779054|FG001|Overall Study|Lost to Follow-up|23|||
48707869|NCT03527732|156779055|FG002|Overall Study|Lost to Follow-up|80|||
48707870|NCT03527732|156779056|FG003|Overall Study|Lost to Follow-up|62|||
48801631|NCT02710292|157113919|FG000|Period 1, First 10 Days of Wear|Withdrawal by Subject|1|||
48801632|NCT02710292|157113920|FG001|Period 1, First 10 Days of Wear|Withdrawal by Subject|2|||
48801633|NCT00514943|157113926|FG000|Stage 1|Progressive disease|4|||
48801634|NCT00514943|157113927|FG001|Stage 1|Progressive disease|8|||
48801635|NCT00514943|157113926|FG000|Stage 1|Other Adverse Event|16|||
48801636|NCT00514943|157113927|FG001|Stage 1|Other Adverse Event|6|||
48801637|NCT00514943|157113926|FG000|Stage 1|Not treated|1|||
48801638|NCT00514943|157113927|FG001|Stage 1|Not treated|2|||
48801639|NCT00514943|157113926|FG000|Stage 1|Patient refused to continue study meds|8|||
48801640|NCT00514943|157113927|FG001|Stage 1|Patient refused to continue study meds|3|||
48801641|NCT00514943|157113926|FG000|Stage 1|Other than stated above|1|||
48801642|NCT00514943|157113927|FG001|Stage 1|Other than stated above|7|||
48801643|NCT00514943|157113926|FG000|Stage 2|Progressive disease|27|||
48801644|NCT00514943|157113927|FG001|Stage 2|Progressive disease|24|||
48801645|NCT00514943|157113926|FG000|Stage 2|Other Adverse Event|3|||
48801646|NCT00514943|157113927|FG001|Stage 2|Other Adverse Event|10|||
48801647|NCT00514943|157113926|FG000|Stage 2|Patient refused to continue study meds|2|||
48801648|NCT00514943|157113927|FG001|Stage 2|Patient refused to continue study meds|0|||
48801649|NCT00514943|157113926|FG000|Stage 2|Other than stated above|0|||
48801650|NCT00514943|157113927|FG001|Stage 2|Other than stated above|2|||
48801651|NCT01370525|157113936|FG000|Overall Study|Voluntary Discontinuation by Subject|2|||
48801652|NCT01370525|157113937|FG001|Overall Study|Voluntary Discontinuation by Subject|3|||
48801653|NCT01370525|157113936|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
48801654|NCT01370525|157113937|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
48801655|NCT01370525|157113936|FG000|Overall Study|Adverse Event|0|||
48801656|NCT01370525|157113937|FG001|Overall Study|Adverse Event|1|||
48801657|NCT01370525|157113936|FG000|Overall Study|Protocol Violation|2|||
48801658|NCT01370525|157113937|FG001|Overall Study|Protocol Violation|1|||
48801659|NCT01370525|157113936|FG000|Overall Study|Lost to follow up|2|||
48801660|NCT01370525|157113937|FG001|Overall Study|Lost to follow up|6|||
48801661|NCT01756352|157113941|FG000|Overall Study|moved away and lost to followup|1|||
48801662|NCT00514683|157113945|FG000|Overall Study|Not treated|2|||
48801663|NCT00514683|157113946|FG001|Overall Study|Not treated|1|||
48801664|NCT00514683|157113947|FG002|Overall Study|Not treated|0|||
48801665|NCT00514683|157113948|FG003|Overall Study|Not treated|0|||
48801666|NCT00514683|157113949|FG004|Overall Study|Not treated|1|||
48801667|NCT00514683|157113945|FG000|Overall Study|Adverse Event|21|||
48801668|NCT00514683|157113946|FG001|Overall Study|Adverse Event|20|||
48801669|NCT00514683|157113947|FG002|Overall Study|Adverse Event|15|||
48801670|NCT00514683|157113948|FG003|Overall Study|Adverse Event|13|||
48801671|NCT00514683|157113949|FG004|Overall Study|Adverse Event|27|||
48801672|NCT00514683|157113945|FG000|Overall Study|Protocol Violation|1|||
48801673|NCT00514683|157113946|FG001|Overall Study|Protocol Violation|1|||
48801674|NCT00514683|157113947|FG002|Overall Study|Protocol Violation|0|||
48801675|NCT00514683|157113948|FG003|Overall Study|Protocol Violation|1|||
48801676|NCT00514683|157113949|FG004|Overall Study|Protocol Violation|0|||
48801677|NCT00514683|157113945|FG000|Overall Study|Withdrawal by Subject|2|||
48801678|NCT00514683|157113946|FG001|Overall Study|Withdrawal by Subject|2|||
48801679|NCT00514683|157113947|FG002|Overall Study|Withdrawal by Subject|1|||
48801680|NCT00514683|157113948|FG003|Overall Study|Withdrawal by Subject|0|||
48801681|NCT00514683|157113949|FG004|Overall Study|Withdrawal by Subject|4|||
48801682|NCT00514683|157113945|FG000|Overall Study|Reason other than listed above|0|||
48801683|NCT00514683|157113946|FG001|Overall Study|Reason other than listed above|1|||
48801684|NCT00514683|157113947|FG002|Overall Study|Reason other than listed above|2|||
48801685|NCT00514683|157113948|FG003|Overall Study|Reason other than listed above|0|||
48801686|NCT00514683|157113949|FG004|Overall Study|Reason other than listed above|1|||
48801687|NCT00840801|157113950|FG000|Part A: Screening- Day 28 Postdose 2|Screen failure|1|||
48801688|NCT00840801|157113951|FG001|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
48801689|NCT00840801|157113952|FG002|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
48801690|NCT00840801|157113950|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
48801691|NCT00840801|157113951|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
48801692|NCT00840801|157113952|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|1|||
48801693|NCT00840801|157113950|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
48801694|NCT00840801|157113951|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
48801695|NCT00840801|157113952|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|1|||
48801696|NCT00840801|157113950|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
48801697|NCT00840801|157113951|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
48801698|NCT00840801|157113952|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|2|||
48801699|NCT01242748|157113953|FG000|Overall Study|Adverse Event|10|||
48801700|NCT01242748|157113954|FG001|Overall Study|Adverse Event|5|||
48801701|NCT01242748|157113953|FG000|Overall Study|Lost to Follow-up|6|||
48801702|NCT01242748|157113954|FG001|Overall Study|Lost to Follow-up|2|||
48801703|NCT01242748|157113953|FG000|Overall Study|Physician Decision|3|||
48801704|NCT01242748|157113954|FG001|Overall Study|Physician Decision|2|||
48801705|NCT01242748|157113953|FG000|Overall Study|Protocol Violation|1|||
48801706|NCT01242748|157113954|FG001|Overall Study|Protocol Violation|0|||
48801707|NCT01242748|157113953|FG000|Overall Study|Withdrawal by Subject|10|||
48801708|NCT01242748|157113954|FG001|Overall Study|Withdrawal by Subject|2|||
48801709|NCT01242748|157113953|FG000|Overall Study|Miscellaneous reasons|8|||
48801710|NCT01242748|157113954|FG001|Overall Study|Miscellaneous reasons|3|||
48801711|NCT05056870|157113957|FG000|Period 1|Site COVID-19 Related|3|||
48801712|NCT05056870|157113958|FG001|Period 1|Site COVID-19 Related|3|||
48801713|NCT05056870|157113957|FG000|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
48801714|NCT05056870|157113958|FG001|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
48801715|NCT05056870|157113957|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
48801716|NCT05056870|157113958|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
48801717|NCT05056870|157113957|FG000|Period 2|COVID-19 Related|1|||
48801718|NCT05056870|157113958|FG001|Period 2|COVID-19 Related|0|||
48801719|NCT05056870|157113957|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
48801720|NCT05056870|157113958|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
48801721|NCT04082884|157113959|FG000|Overall Study|Withdrawal by Subject|1|||
48801722|NCT00331344|157113962|FG000|Phase I|Adverse Event|0|||
48801723|NCT00331344|157113963|FG001|Phase I|Adverse Event|0|||
48801724|NCT00331344|157113964|FG002|Phase I|Adverse Event|0|||
48801725|NCT00331344|157113965|FG003|Phase I|Adverse Event|1|||
48801726|NCT00331344|157113966|FG004|Phase I|Adverse Event|2|||
48801727|NCT00331344|157113967|FG005|Phase I|Adverse Event|2|||
48801728|NCT00331344|157113968|FG006|Phase I|Adverse Event|0|||
48801729|NCT00331344|157113969|FG007|Phase I|Adverse Event|1|||
48801730|NCT00331344|157113970|FG008|Phase I|Adverse Event|0|||
48801731|NCT00331344|157113962|FG000|Phase II|Death|0|||
48801732|NCT00331344|157113963|FG001|Phase II|Death|0|||
48801733|NCT00331344|157113964|FG002|Phase II|Death|0|||
48801734|NCT00331344|157113965|FG003|Phase II|Death|0|||
48801735|NCT00331344|157113966|FG004|Phase II|Death|0|||
48801736|NCT00331344|157113967|FG005|Phase II|Death|0|||
48801737|NCT00331344|157113968|FG006|Phase II|Death|0|||
48801738|NCT00331344|157113969|FG007|Phase II|Death|0|||
48801739|NCT00331344|157113970|FG008|Phase II|Death|4|||
48801740|NCT01373931|157113971|FG000|Lead-in Period|Adverse Event|2|||
48801741|NCT01373931|157113972|FG001|Lead-in Period|Adverse Event|0|||
48801742|NCT01373931|157113971|FG000|Period 1|Adverse Event|2|||
48801743|NCT01373931|157113972|FG001|Period 1|Adverse Event|0|||
48801744|NCT01373931|157113971|FG000|Period 1|Withdrawal by Subject|0|||
48801745|NCT01373931|157113972|FG001|Period 1|Withdrawal by Subject|2|||
48801746|NCT02940574|157113973|FG000|From Study Start to 1-month Follow-up|Withdrawal by Subject|1|||
48801747|NCT02940574|157113974|FG001|From Study Start to 1-month Follow-up|Withdrawal by Subject|0|||
48801748|NCT02940574|157113973|FG000|1-year Follow-up|Lost to Follow-up|3|||
48801749|NCT02940574|157113974|FG001|1-year Follow-up|Lost to Follow-up|4|||
48801750|NCT00387894|157113975|FG000|Overall Study|Withdrawal by Subject|1|||
48801751|NCT00659490|157113976|FG000|Overall Study|Lost to Follow-up|2|||
48913917|NCT04667377|157521208|FG004|Maintenance Period|Change of residence|1|||
48801752|NCT00659490|157113977|FG001|Overall Study|Lost to Follow-up|0|||
48801753|NCT00659490|157113978|FG002|Overall Study|Lost to Follow-up|1|||
48801754|NCT02347657|157113983|FG000|Overall Study|Physician Decision|0|||
48801755|NCT02347657|157113984|FG001|Overall Study|Physician Decision|1|||
48801756|NCT02347657|157113983|FG000|Overall Study|Adverse Event|8|||
48801757|NCT02347657|157113984|FG001|Overall Study|Adverse Event|4|||
48801758|NCT02347657|157113983|FG000|Overall Study|Withdrawal by Subject|6|||
48801759|NCT02347657|157113984|FG001|Overall Study|Withdrawal by Subject|7|||
48801760|NCT02347657|157113983|FG000|Overall Study|Randomized but not treated|1|||
48801761|NCT02347657|157113984|FG001|Overall Study|Randomized but not treated|0|||
48801762|NCT02347657|157113983|FG000|Overall Study|Other|3|||
48801763|NCT02347657|157113984|FG001|Overall Study|Other|3|||
48801764|NCT01757665|157113985|FG000|Overall Study|Still on Study - Visit Completed|240|||
48801765|NCT01757665|157113986|FG001|Overall Study|Still on Study - Visit Completed|30|||
48801766|NCT01757665|157113985|FG000|Overall Study|Still on Study - Visit Pending|398|||
48801767|NCT01757665|157113986|FG001|Overall Study|Still on Study - Visit Pending|40|||
48801768|NCT01757665|157113985|FG000|Overall Study|Still on Study - Missed Visit|14|||
48913918|NCT04667377|157521204|FG000|Maintenance Period|Missing|1|||
48801769|NCT01757665|157113986|FG001|Overall Study|Still on Study - Missed Visit|1|||
48801770|NCT01757665|157113985|FG000|Overall Study|Death|25|||
48801771|NCT01757665|157113986|FG001|Overall Study|Death|8|||
48801772|NCT01757665|157113985|FG000|Overall Study|Explant|1|||
48913919|NCT04667377|157521205|FG001|Maintenance Period|Missing|0|||
48913920|NCT04667377|157521206|FG002|Maintenance Period|Missing|0|||
48801773|NCT01757665|157113986|FG001|Overall Study|Explant|2|||
48801774|NCT01757665|157113985|FG000|Overall Study|Withdrawal by Subject|10|||
48801775|NCT01757665|157113986|FG001|Overall Study|Withdrawal by Subject|0|||
48801776|NCT01757665|157113985|FG000|Overall Study|Lost to Follow-up|1|||
48801777|NCT01757665|157113986|FG001|Overall Study|Lost to Follow-up|1|||
48801778|NCT01757665|157113985|FG000|Overall Study|Not Implanted with Device|5|||
48801779|NCT01757665|157113986|FG001|Overall Study|Not Implanted with Device|1|||
48801780|NCT02428296|157113991|FG000|Overall Study|Adverse Event|7|||
48801781|NCT02428296|157113991|FG000|Overall Study|Withdrawal by Subject|2|||
48801782|NCT01505387|157113992|FG000|Overall Study|Protocol Violation|1|||
48801783|NCT01505387|157113993|FG001|Overall Study|Protocol Violation|0|||
48913921|NCT04667377|157521207|FG003|Maintenance Period|Missing|0|||
48913922|NCT04667377|157521208|FG004|Maintenance Period|Missing|0|||
48913923|NCT04667377|157521204|FG000|Maintenance Period|Other than listed above|2|||
48913924|NCT04667377|157521205|FG001|Maintenance Period|Other than listed above|0|||
48913925|NCT04667377|157521206|FG002|Maintenance Period|Other than listed above|3|||
48913926|NCT04667377|157521207|FG003|Maintenance Period|Other than listed above|2|||
49118945|NCT03518086|158273272|FG000|Overall Study|Withdrawal by Subject|8|||
48801784|NCT01505387|157113992|FG000|Overall Study|Withdrawal by Subject|1|||
48801785|NCT01505387|157113993|FG001|Overall Study|Withdrawal by Subject|1|||
48801786|NCT00620750|157113994|FG000|Overall Study|Lost to Follow-up|25|||
48801787|NCT04477187|157113995|FG000|Overall Study|Lost to Follow-up|2|||
48801788|NCT03420781|157113999|FG000|Treatment Period (40 Weeks)|Adverse Event|1|||
48801789|NCT03420781|157114000|FG001|Treatment Period (40 Weeks)|Adverse Event|6|||
48801790|NCT03420781|157114001|FG002|Treatment Period (40 Weeks)|Adverse Event|0|||
48801791|NCT03420781|157114002|FG003|Treatment Period (40 Weeks)|Adverse Event|0|||
48801792|NCT03420781|157114003|FG004|Treatment Period (40 Weeks)|Adverse Event|0|||
48801793|NCT03420781|157113999|FG000|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
48801794|NCT03420781|157114000|FG001|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
48801795|NCT03420781|157114001|FG002|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
48801796|NCT03420781|157114002|FG003|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
48801797|NCT03420781|157114003|FG004|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
48801798|NCT03420781|157113999|FG000|Treatment Period (40 Weeks)|Withdrawal by Subject|22|||
48801799|NCT03420781|157114000|FG001|Treatment Period (40 Weeks)|Withdrawal by Subject|16|||
48801800|NCT03420781|157114001|FG002|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
48801801|NCT03420781|157114002|FG003|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
48801802|NCT03420781|157114003|FG004|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
48801803|NCT03420781|157113999|FG000|Treatment Period (40 Weeks)|Lost to Follow-up|10|||
48801804|NCT03420781|157114000|FG001|Treatment Period (40 Weeks)|Lost to Follow-up|6|||
48801805|NCT03420781|157114001|FG002|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
48801806|NCT03420781|157114002|FG003|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
48801807|NCT03420781|157114003|FG004|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
48801808|NCT03420781|157113999|FG000|Treatment Period (40 Weeks)|Death|2|||
48801809|NCT03420781|157114000|FG001|Treatment Period (40 Weeks)|Death|2|||
48801810|NCT03420781|157114001|FG002|Treatment Period (40 Weeks)|Death|0|||
48801811|NCT03420781|157114002|FG003|Treatment Period (40 Weeks)|Death|0|||
48801812|NCT03420781|157114003|FG004|Treatment Period (40 Weeks)|Death|0|||
48801813|NCT03420781|157113999|FG000|Treatment Period (40 Weeks)|Physician Decision|3|||
48801814|NCT03420781|157114000|FG001|Treatment Period (40 Weeks)|Physician Decision|4|||
48801815|NCT03420781|157114001|FG002|Treatment Period (40 Weeks)|Physician Decision|0|||
48801816|NCT03420781|157114002|FG003|Treatment Period (40 Weeks)|Physician Decision|0|||
48801817|NCT03420781|157114003|FG004|Treatment Period (40 Weeks)|Physician Decision|0|||
48801818|NCT03420781|157113999|FG000|Treatment Period (40 Weeks)|Protocol Deviation|0|||
48801819|NCT03420781|157114000|FG001|Treatment Period (40 Weeks)|Protocol Deviation|2|||
48801820|NCT03420781|157114001|FG002|Treatment Period (40 Weeks)|Protocol Deviation|0|||
48801821|NCT03420781|157114002|FG003|Treatment Period (40 Weeks)|Protocol Deviation|0|||
48801822|NCT03420781|157114003|FG004|Treatment Period (40 Weeks)|Protocol Deviation|0|||
48801823|NCT03420781|157113999|FG000|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|101|||
48801824|NCT03420781|157114000|FG001|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|89|||
48801825|NCT03420781|157114001|FG002|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
48801826|NCT03420781|157114002|FG003|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
48801827|NCT03420781|157114003|FG004|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
48801828|NCT03420781|157113999|FG000|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|1|||
48801829|NCT03420781|157114000|FG001|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
48801830|NCT03420781|157114001|FG002|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
48801831|NCT03420781|157114002|FG003|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
48801832|NCT03420781|157114003|FG004|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
48801833|NCT03420781|157113999|FG000|Treatment Period (40 Weeks)|Reason Not Specified|3|||
48801834|NCT03420781|157114000|FG001|Treatment Period (40 Weeks)|Reason Not Specified|0|||
48801835|NCT03420781|157114001|FG002|Treatment Period (40 Weeks)|Reason Not Specified|0|||
48801836|NCT03420781|157114002|FG003|Treatment Period (40 Weeks)|Reason Not Specified|0|||
48801837|NCT03420781|157114003|FG004|Treatment Period (40 Weeks)|Reason Not Specified|0|||
48913927|NCT04667377|157521208|FG004|Maintenance Period|Other than listed above|6|||
48801838|NCT03420781|157113999|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
48801839|NCT03420781|157114000|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
48801840|NCT03420781|157114001|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
48801841|NCT03420781|157114002|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|2|||
48913928|NCT04667377|157521204|FG000|Maintenance Period|Withdrawal by Subject|0|||
49118946|NCT03518086|158273273|FG001|Overall Study|Withdrawal by Subject|5|||
48913929|NCT04667377|157521205|FG001|Maintenance Period|Withdrawal by Subject|1|||
48913930|NCT04667377|157521206|FG002|Maintenance Period|Withdrawal by Subject|0|||
48913931|NCT04667377|157521207|FG003|Maintenance Period|Withdrawal by Subject|0|||
48913932|NCT04667377|157521208|FG004|Maintenance Period|Withdrawal by Subject|0|||
48913933|NCT04667377|157521204|FG000|Maintenance Period|Lost to Follow-up|1|||
48913934|NCT04667377|157521205|FG001|Maintenance Period|Lost to Follow-up|0|||
48913935|NCT04667377|157521206|FG002|Maintenance Period|Lost to Follow-up|1|||
48913936|NCT04667377|157521207|FG003|Maintenance Period|Lost to Follow-up|0|||
48913937|NCT04667377|157521208|FG004|Maintenance Period|Lost to Follow-up|1|||
48913938|NCT02819635|157521209|FG000|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
49118947|NCT03518086|158273274|FG002|Overall Study|Withdrawal by Subject|0|||
49118948|NCT03518086|158273275|FG003|Overall Study|Withdrawal by Subject|0|||
49118949|NCT03518086|158273272|FG000|Overall Study|Lack of Efficacy|5|||
49118950|NCT03518086|158273273|FG001|Overall Study|Lack of Efficacy|5|||
49118951|NCT03518086|158273274|FG002|Overall Study|Lack of Efficacy|0|||
49118952|NCT03518086|158273275|FG003|Overall Study|Lack of Efficacy|0|||
49118953|NCT03518086|158273272|FG000|Overall Study|Protocol Violation|1|||
49118954|NCT03518086|158273273|FG001|Overall Study|Protocol Violation|5|||
49118955|NCT03518086|158273274|FG002|Overall Study|Protocol Violation|0|||
49118956|NCT03518086|158273275|FG003|Overall Study|Protocol Violation|0|||
49118957|NCT03518086|158273272|FG000|Overall Study|Lost to Follow-up|0|||
49118958|NCT03518086|158273273|FG001|Overall Study|Lost to Follow-up|3|||
49118959|NCT03518086|158273274|FG002|Overall Study|Lost to Follow-up|0|||
48707871|NCT03527732|156779057|FG004|Overall Study|Lost to Follow-up|12|||
48707872|NCT03527732|156779058|FG005|Overall Study|Lost to Follow-up|20|||
48707873|NCT02207088|156779063|FG000|Overall Study|Adverse Event|2|||
48707874|NCT00060840|156779066|FG000|Overall Study|Change in surgical plan|2|||
48707875|NCT00060840|156779067|FG001|Overall Study|Change in surgical plan|6|||
48913939|NCT02819635|157521210|FG001|Substudy 1 and Substudy 2, Part 1|Adverse Event|1|||
48913940|NCT02819635|157521211|FG002|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
48913941|NCT02819635|157521212|FG003|Substudy 1 and Substudy 2, Part 1|Adverse Event|5|||
48913942|NCT02819635|157521213|FG004|Substudy 1 and Substudy 2, Part 1|Adverse Event|4|||
48913943|NCT02819635|157521214|FG005|Substudy 1 and Substudy 2, Part 1|Adverse Event|9|||
48913944|NCT02819635|157521215|FG006|Substudy 1 and Substudy 2, Part 1|Adverse Event|6|||
48913945|NCT02819635|157521216|FG007|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
48913946|NCT02819635|157521217|FG008|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
48913947|NCT02819635|157521218|FG009|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
48913948|NCT02819635|157521219|FG010|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
48913949|NCT02819635|157521220|FG011|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
48913950|NCT02819635|157521209|FG000|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
48913951|NCT02819635|157521210|FG001|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
48913952|NCT02819635|157521211|FG002|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
48913953|NCT02819635|157521212|FG003|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
48913954|NCT02819635|157521213|FG004|Substudy 1 and Substudy 2, Part 1|Withdrew consent|1|||
48913955|NCT02819635|157521214|FG005|Substudy 1 and Substudy 2, Part 1|Withdrew consent|3|||
48913956|NCT02819635|157521215|FG006|Substudy 1 and Substudy 2, Part 1|Withdrew consent|2|||
48913957|NCT02819635|157521216|FG007|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
48913958|NCT02819635|157521217|FG008|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
48913959|NCT02819635|157521218|FG009|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
48913960|NCT02819635|157521219|FG010|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
48913961|NCT02819635|157521220|FG011|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
49118960|NCT03518086|158273275|FG003|Overall Study|Lost to Follow-up|0|||
49118961|NCT03518086|158273272|FG000|Overall Study|Insufficient Diary Data|0|||
48707876|NCT00060840|156779066|FG000|Overall Study|Death|0|||
48707877|NCT00060840|156779067|FG001|Overall Study|Death|1|||
48707878|NCT00060840|156779066|FG000|Overall Study|Withdrawal by Subject|0|||
48707879|NCT00060840|156779067|FG001|Overall Study|Withdrawal by Subject|1|||
48707880|NCT00060840|156779066|FG000|Overall Study|Subinvestigator unavailable|0|||
48707881|NCT00060840|156779067|FG001|Overall Study|Subinvestigator unavailable|1|||
48913962|NCT02819635|157521209|FG000|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
48913963|NCT02819635|157521210|FG001|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
48913964|NCT02819635|157521211|FG002|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
48913965|NCT02819635|157521212|FG003|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
48913966|NCT02819635|157521213|FG004|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
48913967|NCT02819635|157521214|FG005|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
48913968|NCT02819635|157521215|FG006|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
48913969|NCT02819635|157521216|FG007|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
48913970|NCT02819635|157521217|FG008|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
48913971|NCT02819635|157521218|FG009|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
48913972|NCT02819635|157521219|FG010|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
49118962|NCT03518086|158273273|FG001|Overall Study|Insufficient Diary Data|2|||
48707882|NCT00060840|156779066|FG000|Overall Study|Physician Decision|1|||
48801842|NCT03420781|157114003|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
48801843|NCT03420781|157113999|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
48801844|NCT03420781|157114000|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
48801845|NCT03420781|157114001|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
48801846|NCT03420781|157114002|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
48801847|NCT03420781|157114003|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|2|||
48801848|NCT03420781|157113999|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
48801849|NCT03420781|157114000|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
48801850|NCT03420781|157114001|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|6|||
48801851|NCT03420781|157114002|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
48801852|NCT03420781|157114003|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
48801853|NCT00420199|157114004|FG000|Overall Study|Participant no longer met study criteria|1|||
48801854|NCT00420199|157114005|FG001|Overall Study|Participant no longer met study criteria|0|||
48801855|NCT03286751|157114006|FG000|Washout Period 1|Withdrawal by Subject|0|||
48801856|NCT03286751|157114007|FG001|Washout Period 1|Withdrawal by Subject|0|||
48801857|NCT03286751|157114008|FG002|Washout Period 1|Withdrawal by Subject|0|||
48801858|NCT03286751|157114009|FG003|Washout Period 1|Withdrawal by Subject|0|||
48801859|NCT03286751|157114010|FG004|Washout Period 1|Withdrawal by Subject|1|||
48801860|NCT03286751|157114011|FG005|Washout Period 1|Withdrawal by Subject|0|||
48801861|NCT03286751|157114006|FG000|Washout Period 2|Personal Reasons|0|||
48801862|NCT03286751|157114007|FG001|Washout Period 2|Personal Reasons|1|||
48801863|NCT03286751|157114008|FG002|Washout Period 2|Personal Reasons|0|||
48801864|NCT03286751|157114009|FG003|Washout Period 2|Personal Reasons|0|||
48801865|NCT03286751|157114010|FG004|Washout Period 2|Personal Reasons|0|||
48801866|NCT03286751|157114011|FG005|Washout Period 2|Personal Reasons|0|||
48801867|NCT03286751|157114006|FG000|Washout Period 5|Adverse Event|0|||
48801868|NCT03286751|157114007|FG001|Washout Period 5|Adverse Event|0|||
48801869|NCT03286751|157114008|FG002|Washout Period 5|Adverse Event|0|||
48801870|NCT03286751|157114009|FG003|Washout Period 5|Adverse Event|0|||
48801871|NCT03286751|157114010|FG004|Washout Period 5|Adverse Event|1|||
48801872|NCT03286751|157114011|FG005|Washout Period 5|Adverse Event|0|||
48801873|NCT02923739|157114016|FG000|Overall Study|Withdrawal by Subject|2|||
48801874|NCT02923739|157114017|FG001|Overall Study|Withdrawal by Subject|0|||
48801875|NCT02923739|157114018|FG002|Overall Study|Withdrawal by Subject|0|||
48801876|NCT02923739|157114019|FG003|Overall Study|Withdrawal by Subject|0|||
48801877|NCT02923739|157114016|FG000|Overall Study|Failed Screening|3|||
48801878|NCT02923739|157114017|FG001|Overall Study|Failed Screening|0|||
48801879|NCT02923739|157114018|FG002|Overall Study|Failed Screening|0|||
48801880|NCT02923739|157114019|FG003|Overall Study|Failed Screening|0|||
48801881|NCT01376323|157114027|FG000|Overall Study|Adverse Event|1|||
48801882|NCT01376323|157114028|FG001|Overall Study|Adverse Event|0|||
48801883|NCT01376323|157114029|FG002|Overall Study|Adverse Event|0|||
48913973|NCT02819635|157521220|FG011|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
48913974|NCT02819635|157521209|FG000|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
49010691|NCT02557672|157875675|FG000|Overall Study|Withdrawal by Subject|4|||
48707883|NCT00060840|156779067|FG001|Overall Study|Physician Decision|0|||
48707884|NCT00060840|156779066|FG000|Overall Study|Other|1|||
48707885|NCT00060840|156779067|FG001|Overall Study|Other|0|||
48707886|NCT01388335|156779068|FG000|Period 1|Progressive Disease|1|||
48707887|NCT01388335|156779068|FG000|Period 2|Progressive Disease|2|||
48707888|NCT01388335|156779068|FG000|Period 2|Sponsor Decision|1|||
48707889|NCT01388335|156779068|FG000|Safety Extension|Progressive Disease|7|||
48707890|NCT00976560|156779070|FG000|Overall Study|Adverse Event|5|||
48707891|NCT00976560|156779071|FG001|Overall Study|Adverse Event|5|||
48707892|NCT00976560|156779070|FG000|Overall Study|Lack of Efficacy|3|||
48707893|NCT00976560|156779071|FG001|Overall Study|Lack of Efficacy|5|||
48707894|NCT00976560|156779070|FG000|Overall Study|Protocol Violation|1|||
48707895|NCT00976560|156779071|FG001|Overall Study|Protocol Violation|0|||
48707896|NCT00976560|156779070|FG000|Overall Study|Lost to Follow-up|1|||
48707897|NCT00976560|156779071|FG001|Overall Study|Lost to Follow-up|0|||
48707898|NCT00976560|156779070|FG000|Overall Study|Physician Decision|2|||
48707899|NCT00976560|156779071|FG001|Overall Study|Physician Decision|0|||
48707900|NCT00976560|156779070|FG000|Overall Study|Withdrawal by Subject|2|||
48707901|NCT00976560|156779071|FG001|Overall Study|Withdrawal by Subject|3|||
48707902|NCT01216189|156779072|FG000|Overall Study|Lost to Follow-up|21|||
48707903|NCT01216189|156779073|FG001|Overall Study|Lost to Follow-up|3|||
48707904|NCT01216189|156779072|FG000|Overall Study|Death|4|||
48707905|NCT01216189|156779073|FG001|Overall Study|Death|2|||
48707906|NCT00670306|156779074|FG000|Overall Study|Adverse Event|8|||
48707907|NCT00670306|156779074|FG000|Overall Study|Lack of Efficacy|10|||
48801884|NCT01376323|157114030|FG003|Overall Study|Adverse Event|2|||
48801885|NCT01376323|157114031|FG004|Overall Study|Adverse Event|0|||
49010692|NCT02557672|157875676|FG001|Overall Study|Withdrawal by Subject|2|||
49010693|NCT02378506|157875677|FG000|Overall Study|Lack of Efficacy|3|||
49010694|NCT02378506|157875677|FG000|Overall Study|Withdrawal by Subject|4|||
48801886|NCT01376323|157114027|FG000|Overall Study|Lost to Follow-up|0|||
48801887|NCT01376323|157114028|FG001|Overall Study|Lost to Follow-up|0|||
48801888|NCT01376323|157114029|FG002|Overall Study|Lost to Follow-up|0|||
48801889|NCT01376323|157114030|FG003|Overall Study|Lost to Follow-up|2|||
48801890|NCT01376323|157114031|FG004|Overall Study|Lost to Follow-up|0|||
48801891|NCT01376323|157114027|FG000|Overall Study|Physician Decision|1|||
48801892|NCT01376323|157114028|FG001|Overall Study|Physician Decision|0|||
48801893|NCT01376323|157114029|FG002|Overall Study|Physician Decision|2|||
48801894|NCT01376323|157114030|FG003|Overall Study|Physician Decision|1|||
48801895|NCT01376323|157114031|FG004|Overall Study|Physician Decision|1|||
48801896|NCT01376323|157114027|FG000|Overall Study|Withdrawal by Subject|0|||
48801897|NCT01376323|157114028|FG001|Overall Study|Withdrawal by Subject|1|||
48801898|NCT01376323|157114029|FG002|Overall Study|Withdrawal by Subject|1|||
48801899|NCT01376323|157114030|FG003|Overall Study|Withdrawal by Subject|0|||
48801900|NCT01376323|157114031|FG004|Overall Study|Withdrawal by Subject|0|||
48801901|NCT04806594|157114040|FG000|Overall Study|Withdrawal by Subject|2|||
48801902|NCT04806594|157114040|FG000|Overall Study|Did never apply the study product and did not attend following visits.|1|||
48801903|NCT02467270|157114041|FG000|Overall Study|Participants Never Treated|0|||
48801904|NCT02467270|157114042|FG001|Overall Study|Participants Never Treated|1|||
48801905|NCT02467270|157114043|FG002|Overall Study|Participants Never Treated|0|||
48801906|NCT02467270|157114041|FG000|Overall Study|Ongoing|50|||
48801907|NCT02467270|157114042|FG001|Overall Study|Ongoing|41|||
48801908|NCT02467270|157114043|FG002|Overall Study|Ongoing|43|||
48801909|NCT02467270|157114041|FG000|Overall Study|Adverse Event|16|||
48801910|NCT02467270|157114042|FG001|Overall Study|Adverse Event|15|||
48801911|NCT02467270|157114043|FG002|Overall Study|Adverse Event|14|||
48801912|NCT02467270|157114041|FG000|Overall Study|Progressive Disease|7|||
48801913|NCT02467270|157114042|FG001|Overall Study|Progressive Disease|7|||
48801914|NCT02467270|157114043|FG002|Overall Study|Progressive Disease|4|||
48801915|NCT02467270|157114041|FG000|Overall Study|Death|2|||
48801916|NCT02467270|157114042|FG001|Overall Study|Death|0|||
48801917|NCT02467270|157114043|FG002|Overall Study|Death|2|||
48801918|NCT02467270|157114041|FG000|Overall Study|Lack of Efficacy|12|||
48801919|NCT02467270|157114042|FG001|Overall Study|Lack of Efficacy|18|||
48801920|NCT02467270|157114043|FG002|Overall Study|Lack of Efficacy|23|||
48801921|NCT02467270|157114041|FG000|Overall Study|Non-compliance With Study Drug|0|||
48801922|NCT02467270|157114042|FG001|Overall Study|Non-compliance With Study Drug|2|||
48801923|NCT02467270|157114043|FG002|Overall Study|Non-compliance With Study Drug|1|||
48801924|NCT02467270|157114041|FG000|Overall Study|Lost to Follow-up|2|||
48801925|NCT02467270|157114042|FG001|Overall Study|Lost to Follow-up|1|||
48801926|NCT02467270|157114043|FG002|Overall Study|Lost to Follow-up|0|||
48801927|NCT02467270|157114041|FG000|Overall Study|Pregnancy|0|||
48801928|NCT02467270|157114042|FG001|Overall Study|Pregnancy|1|||
48801929|NCT02467270|157114043|FG002|Overall Study|Pregnancy|0|||
48801930|NCT02467270|157114041|FG000|Overall Study|Physician Decision|0|||
48801931|NCT02467270|157114042|FG001|Overall Study|Physician Decision|4|||
48801932|NCT02467270|157114043|FG002|Overall Study|Physician Decision|1|||
48801933|NCT02467270|157114041|FG000|Overall Study|Withdrawal by Subject|4|||
48801934|NCT02467270|157114042|FG001|Overall Study|Withdrawal by Subject|3|||
48801935|NCT02467270|157114043|FG002|Overall Study|Withdrawal by Subject|5|||
48801936|NCT02467270|157114041|FG000|Overall Study|Reason not Specified|1|||
48801937|NCT02467270|157114042|FG001|Overall Study|Reason not Specified|2|||
48801938|NCT02467270|157114043|FG002|Overall Study|Reason not Specified|1|||
48801939|NCT04632992|157114044|FG000|Overall Study|Adverse Event|0|||
48801940|NCT04632992|157114045|FG001|Overall Study|Adverse Event|0|||
48801941|NCT04632992|157114046|FG002|Overall Study|Adverse Event|0|||
48801942|NCT04632992|157114047|FG003|Overall Study|Adverse Event|0|||
48801943|NCT04632992|157114048|FG004|Overall Study|Adverse Event|0|||
48801944|NCT04632992|157114049|FG005|Overall Study|Adverse Event|0|||
48801945|NCT04632992|157114050|FG006|Overall Study|Adverse Event|0|||
48801946|NCT04632992|157114051|FG007|Overall Study|Adverse Event|0|||
48801947|NCT04632992|157114052|FG008|Overall Study|Adverse Event|0|||
48801948|NCT04632992|157114053|FG009|Overall Study|Adverse Event|0|||
48801949|NCT04632992|157114054|FG010|Overall Study|Adverse Event|0|||
48801950|NCT04632992|157114055|FG011|Overall Study|Adverse Event|0|||
48801951|NCT04632992|157114056|FG012|Overall Study|Adverse Event|1|||
48801952|NCT04632992|157114057|FG013|Overall Study|Adverse Event|0|||
48801953|NCT04632992|157114044|FG000|Overall Study|Death|17|||
48801954|NCT04632992|157114045|FG001|Overall Study|Death|1|||
48801955|NCT04632992|157114046|FG002|Overall Study|Death|14|||
48801956|NCT04632992|157114047|FG003|Overall Study|Death|14|||
48801957|NCT04632992|157114048|FG004|Overall Study|Death|13|||
48801958|NCT04632992|157114049|FG005|Overall Study|Death|6|||
48801959|NCT04632992|157114050|FG006|Overall Study|Death|7|||
48801960|NCT04632992|157114051|FG007|Overall Study|Death|12|||
48801961|NCT04632992|157114052|FG008|Overall Study|Death|15|||
48801962|NCT04632992|157114053|FG009|Overall Study|Death|20|||
48801963|NCT04632992|157114054|FG010|Overall Study|Death|8|||
48801964|NCT04632992|157114055|FG011|Overall Study|Death|2|||
48801965|NCT04632992|157114056|FG012|Overall Study|Death|10|||
48801966|NCT04632992|157114057|FG013|Overall Study|Death|1|||
48801967|NCT04632992|157114044|FG000|Overall Study|Lost to Follow-up|1|||
48801968|NCT04632992|157114045|FG001|Overall Study|Lost to Follow-up|0|||
48801969|NCT04632992|157114046|FG002|Overall Study|Lost to Follow-up|1|||
48801970|NCT04632992|157114047|FG003|Overall Study|Lost to Follow-up|0|||
48801971|NCT04632992|157114048|FG004|Overall Study|Lost to Follow-up|2|||
48801972|NCT04632992|157114049|FG005|Overall Study|Lost to Follow-up|0|||
48801973|NCT04632992|157114050|FG006|Overall Study|Lost to Follow-up|1|||
48801974|NCT04632992|157114051|FG007|Overall Study|Lost to Follow-up|1|||
48801975|NCT04632992|157114052|FG008|Overall Study|Lost to Follow-up|1|||
48801976|NCT04632992|157114053|FG009|Overall Study|Lost to Follow-up|1|||
48801977|NCT04632992|157114054|FG010|Overall Study|Lost to Follow-up|2|||
48801978|NCT04632992|157114055|FG011|Overall Study|Lost to Follow-up|0|||
48801979|NCT04632992|157114056|FG012|Overall Study|Lost to Follow-up|0|||
48801980|NCT04632992|157114057|FG013|Overall Study|Lost to Follow-up|0|||
48801981|NCT04632992|157114044|FG000|Overall Study|Reason not Specified|2|||
48801982|NCT04632992|157114045|FG001|Overall Study|Reason not Specified|0|||
48801983|NCT04632992|157114046|FG002|Overall Study|Reason not Specified|1|||
48801984|NCT04632992|157114047|FG003|Overall Study|Reason not Specified|1|||
48801985|NCT04632992|157114048|FG004|Overall Study|Reason not Specified|0|||
48801986|NCT04632992|157114049|FG005|Overall Study|Reason not Specified|0|||
48801987|NCT04632992|157114050|FG006|Overall Study|Reason not Specified|0|||
48801988|NCT04632992|157114051|FG007|Overall Study|Reason not Specified|0|||
48801989|NCT04632992|157114052|FG008|Overall Study|Reason not Specified|0|||
48801990|NCT04632992|157114053|FG009|Overall Study|Reason not Specified|0|||
48801991|NCT04632992|157114054|FG010|Overall Study|Reason not Specified|1|||
48801992|NCT04632992|157114055|FG011|Overall Study|Reason not Specified|0|||
48801993|NCT04632992|157114056|FG012|Overall Study|Reason not Specified|0|||
48801994|NCT04632992|157114057|FG013|Overall Study|Reason not Specified|0|||
48801995|NCT04632992|157114044|FG000|Overall Study|Physician Decision|0|||
48801996|NCT04632992|157114045|FG001|Overall Study|Physician Decision|0|||
48801997|NCT04632992|157114046|FG002|Overall Study|Physician Decision|0|||
48801998|NCT04632992|157114047|FG003|Overall Study|Physician Decision|2|||
48801999|NCT04632992|157114048|FG004|Overall Study|Physician Decision|1|||
48802000|NCT04632992|157114049|FG005|Overall Study|Physician Decision|0|||
48802001|NCT04632992|157114050|FG006|Overall Study|Physician Decision|0|||
48802002|NCT04632992|157114051|FG007|Overall Study|Physician Decision|0|||
48802003|NCT04632992|157114052|FG008|Overall Study|Physician Decision|0|||
48802004|NCT04632992|157114053|FG009|Overall Study|Physician Decision|0|||
48802005|NCT04632992|157114054|FG010|Overall Study|Physician Decision|0|||
48802006|NCT04632992|157114055|FG011|Overall Study|Physician Decision|0|||
48802007|NCT04632992|157114056|FG012|Overall Study|Physician Decision|3|||
48802008|NCT04632992|157114057|FG013|Overall Study|Physician Decision|0|||
48802009|NCT04632992|157114044|FG000|Overall Study|Progressive Disease|0|||
48802010|NCT04632992|157114045|FG001|Overall Study|Progressive Disease|0|||
48802011|NCT04632992|157114046|FG002|Overall Study|Progressive Disease|0|||
48802012|NCT04632992|157114047|FG003|Overall Study|Progressive Disease|0|||
48802013|NCT04632992|157114048|FG004|Overall Study|Progressive Disease|1|||
48802014|NCT04632992|157114049|FG005|Overall Study|Progressive Disease|0|||
48802015|NCT04632992|157114050|FG006|Overall Study|Progressive Disease|0|||
48913975|NCT02819635|157521210|FG001|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
48913976|NCT02819635|157521211|FG002|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
48913977|NCT02819635|157521212|FG003|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
48913978|NCT02819635|157521213|FG004|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
48913979|NCT02819635|157521214|FG005|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
48913980|NCT02819635|157521215|FG006|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|1|||
48913981|NCT02819635|157521216|FG007|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
48913982|NCT02819635|157521217|FG008|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
48913983|NCT02819635|157521218|FG009|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
48913984|NCT02819635|157521219|FG010|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
48913985|NCT02819635|157521220|FG011|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
48913986|NCT02819635|157521209|FG000|Substudy 1 and Substudy 2, Part 1|Other, not specified|2|||
48913987|NCT02819635|157521210|FG001|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
48913988|NCT02819635|157521211|FG002|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
48913989|NCT02819635|157521212|FG003|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
48913990|NCT02819635|157521213|FG004|Substudy 1 and Substudy 2, Part 1|Other, not specified|5|||
48802016|NCT04632992|157114051|FG007|Overall Study|Progressive Disease|0|||
48802017|NCT04632992|157114052|FG008|Overall Study|Progressive Disease|0|||
48802018|NCT04632992|157114053|FG009|Overall Study|Progressive Disease|1|||
48802019|NCT04632992|157114054|FG010|Overall Study|Progressive Disease|1|||
48802020|NCT04632992|157114055|FG011|Overall Study|Progressive Disease|0|||
48802021|NCT04632992|157114056|FG012|Overall Study|Progressive Disease|2|||
48802022|NCT04632992|157114057|FG013|Overall Study|Progressive Disease|0|||
48802023|NCT04632992|157114044|FG000|Overall Study|Withdrawal by Subject|4|||
48802024|NCT04632992|157114045|FG001|Overall Study|Withdrawal by Subject|1|||
48802025|NCT04632992|157114046|FG002|Overall Study|Withdrawal by Subject|5|||
48802026|NCT04632992|157114047|FG003|Overall Study|Withdrawal by Subject|4|||
48802027|NCT04632992|157114048|FG004|Overall Study|Withdrawal by Subject|3|||
48802028|NCT04632992|157114049|FG005|Overall Study|Withdrawal by Subject|3|||
48802029|NCT04632992|157114050|FG006|Overall Study|Withdrawal by Subject|0|||
48802030|NCT04632992|157114051|FG007|Overall Study|Withdrawal by Subject|5|||
48802031|NCT04632992|157114052|FG008|Overall Study|Withdrawal by Subject|0|||
48802032|NCT04632992|157114053|FG009|Overall Study|Withdrawal by Subject|2|||
48802033|NCT04632992|157114054|FG010|Overall Study|Withdrawal by Subject|8|||
48802034|NCT04632992|157114055|FG011|Overall Study|Withdrawal by Subject|0|||
48802035|NCT04632992|157114056|FG012|Overall Study|Withdrawal by Subject|1|||
48802036|NCT04632992|157114057|FG013|Overall Study|Withdrawal by Subject|1|||
48802037|NCT00733499|157114067|FG000|Pre-operative|Protocol Violation|0|||
48913991|NCT02819635|157521214|FG005|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
48913992|NCT02819635|157521215|FG006|Substudy 1 and Substudy 2, Part 1|Other, not specified|3|||
48913993|NCT02819635|157521216|FG007|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
48913994|NCT02819635|157521217|FG008|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
48913995|NCT02819635|157521218|FG009|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
48913996|NCT02819635|157521219|FG010|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
48913997|NCT02819635|157521220|FG011|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
48913998|NCT02819635|157521209|FG000|Substudy 2, Part 2|Adverse Event|0|||
48913999|NCT02819635|157521210|FG001|Substudy 2, Part 2|Adverse Event|0|||
48914000|NCT02819635|157521211|FG002|Substudy 2, Part 2|Adverse Event|0|||
48914001|NCT02819635|157521212|FG003|Substudy 2, Part 2|Adverse Event|0|||
48914002|NCT02819635|157521213|FG004|Substudy 2, Part 2|Adverse Event|0|||
48914003|NCT02819635|157521214|FG005|Substudy 2, Part 2|Adverse Event|4|||
48914004|NCT02819635|157521215|FG006|Substudy 2, Part 2|Adverse Event|0|||
48914005|NCT02819635|157521216|FG007|Substudy 2, Part 2|Adverse Event|0|||
48914006|NCT02819635|157521217|FG008|Substudy 2, Part 2|Adverse Event|0|||
48914007|NCT02819635|157521218|FG009|Substudy 2, Part 2|Adverse Event|0|||
48914008|NCT02819635|157521219|FG010|Substudy 2, Part 2|Adverse Event|0|||
48914009|NCT02819635|157521220|FG011|Substudy 2, Part 2|Adverse Event|0|||
48914010|NCT02819635|157521209|FG000|Substudy 2, Part 2|Withdrew consent|0|||
48914011|NCT02819635|157521210|FG001|Substudy 2, Part 2|Withdrew consent|0|||
48914012|NCT02819635|157521211|FG002|Substudy 2, Part 2|Withdrew consent|0|||
48914013|NCT02819635|157521212|FG003|Substudy 2, Part 2|Withdrew consent|0|||
48914014|NCT02819635|157521213|FG004|Substudy 2, Part 2|Withdrew consent|0|||
48914015|NCT02819635|157521214|FG005|Substudy 2, Part 2|Withdrew consent|3|||
48914016|NCT02819635|157521215|FG006|Substudy 2, Part 2|Withdrew consent|1|||
48914017|NCT02819635|157521216|FG007|Substudy 2, Part 2|Withdrew consent|0|||
48914018|NCT02819635|157521217|FG008|Substudy 2, Part 2|Withdrew consent|0|||
48914019|NCT02819635|157521218|FG009|Substudy 2, Part 2|Withdrew consent|0|||
48914020|NCT02819635|157521219|FG010|Substudy 2, Part 2|Withdrew consent|0|||
48914021|NCT02819635|157521220|FG011|Substudy 2, Part 2|Withdrew consent|0|||
48914022|NCT02819635|157521209|FG000|Substudy 2, Part 2|Lost to Follow-up|0|||
48914023|NCT02819635|157521210|FG001|Substudy 2, Part 2|Lost to Follow-up|0|||
48914024|NCT02819635|157521211|FG002|Substudy 2, Part 2|Lost to Follow-up|0|||
48914025|NCT02819635|157521212|FG003|Substudy 2, Part 2|Lost to Follow-up|0|||
48914026|NCT02819635|157521213|FG004|Substudy 2, Part 2|Lost to Follow-up|0|||
48914027|NCT02819635|157521214|FG005|Substudy 2, Part 2|Lost to Follow-up|0|||
48914028|NCT02819635|157521215|FG006|Substudy 2, Part 2|Lost to Follow-up|1|||
48914029|NCT02819635|157521216|FG007|Substudy 2, Part 2|Lost to Follow-up|0|||
48914030|NCT02819635|157521217|FG008|Substudy 2, Part 2|Lost to Follow-up|0|||
48914031|NCT02819635|157521218|FG009|Substudy 2, Part 2|Lost to Follow-up|0|||
48914032|NCT02819635|157521219|FG010|Substudy 2, Part 2|Lost to Follow-up|0|||
48914033|NCT02819635|157521220|FG011|Substudy 2, Part 2|Lost to Follow-up|0|||
48914034|NCT02819635|157521209|FG000|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
48914035|NCT02819635|157521210|FG001|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
48914036|NCT02819635|157521211|FG002|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
48914037|NCT02819635|157521212|FG003|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
48914038|NCT02819635|157521213|FG004|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
48914039|NCT02819635|157521214|FG005|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
48914040|NCT02819635|157521215|FG006|Substudy 2, Part 2|COVID-19 Logistical Restrictions|2|||
48914041|NCT02819635|157521216|FG007|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
48802038|NCT00733499|157114068|FG001|Pre-operative|Protocol Violation|1|||
48802039|NCT00733499|157114067|FG000|3 Months Follow-up|Death|1|||
48914042|NCT02819635|157521217|FG008|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
48914043|NCT02819635|157521218|FG009|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
48914044|NCT02819635|157521219|FG010|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
48914045|NCT02819635|157521220|FG011|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
48914046|NCT02819635|157521209|FG000|Substudy 2, Part 2|Other, not specified|0|||
48914047|NCT02819635|157521210|FG001|Substudy 2, Part 2|Other, not specified|0|||
48914048|NCT02819635|157521211|FG002|Substudy 2, Part 2|Other, not specified|0|||
48914049|NCT02819635|157521212|FG003|Substudy 2, Part 2|Other, not specified|0|||
48802040|NCT00733499|157114068|FG001|3 Months Follow-up|Death|2|||
48802041|NCT00733499|157114067|FG000|6 Months Follow-up|Death|0|||
48802042|NCT00733499|157114068|FG001|6 Months Follow-up|Death|2|||
48802043|NCT00733499|157114067|FG000|6 Months Follow-up|Adverse Event|0|||
48802044|NCT00733499|157114068|FG001|6 Months Follow-up|Adverse Event|1|||
48802045|NCT00733499|157114067|FG000|12 Months Follow-up|Death|2|||
48802046|NCT00733499|157114068|FG001|12 Months Follow-up|Death|1|||
48802047|NCT00733499|157114067|FG000|24 Months Follow-up|Death|0|||
48802048|NCT00733499|157114068|FG001|24 Months Follow-up|Death|1|||
48802049|NCT00733499|157114067|FG000|5 Year Followup|Adverse Event|2|||
48802050|NCT00733499|157114068|FG001|5 Year Followup|Adverse Event|2|||
48802051|NCT00733499|157114067|FG000|5 Year Followup|Non device related AE|0|||
48802052|NCT00733499|157114068|FG001|5 Year Followup|Non device related AE|1|||
48802053|NCT00733499|157114067|FG000|5 Year Followup|Revision of Study Implant|0|||
48802054|NCT00733499|157114068|FG001|5 Year Followup|Revision of Study Implant|1|||
48802055|NCT00733499|157114067|FG000|5 Year Followup|Lost to Follow-up|2|||
48802056|NCT00733499|157114068|FG001|5 Year Followup|Lost to Follow-up|0|||
48802057|NCT00733499|157114067|FG000|5 Year Followup|Death|13|||
48802058|NCT00733499|157114068|FG001|5 Year Followup|Death|19|||
48802059|NCT00733499|157114067|FG000|5 Year Followup|missing, unable to locate|0|||
48802060|NCT00733499|157114068|FG001|5 Year Followup|missing, unable to locate|1|||
48802061|NCT00733499|157114067|FG000|5 Year Followup|Withdrawal by Subject|4|||
48802062|NCT00733499|157114068|FG001|5 Year Followup|Withdrawal by Subject|1|||
48802063|NCT00733499|157114067|FG000|10 Year Followup|Death|9|||
48802064|NCT00733499|157114068|FG001|10 Year Followup|Death|7|||
48802065|NCT00733499|157114067|FG000|10 Year Followup|Adverse Event|3|||
48802066|NCT00733499|157114068|FG001|10 Year Followup|Adverse Event|3|||
48802067|NCT00733499|157114067|FG000|10 Year Followup|Lost to Follow-up|3|||
48802068|NCT00733499|157114068|FG001|10 Year Followup|Lost to Follow-up|2|||
48802069|NCT00733499|157114067|FG000|10 Year Followup|Withdrawal by Subject|5|||
48802070|NCT00733499|157114068|FG001|10 Year Followup|Withdrawal by Subject|5|||
48802071|NCT00733499|157114067|FG000|10 Year Followup|missing, unable to locate|0|||
48802072|NCT00733499|157114068|FG001|10 Year Followup|missing, unable to locate|2|||
48802073|NCT05158296|157114069|FG000|Overall Study|Sponsor Decision|2|||
48802074|NCT05158296|157114070|FG001|Overall Study|Sponsor Decision|3|||
48802075|NCT05158296|157114071|FG002|Overall Study|Sponsor Decision|2|||
48802076|NCT03078816|157114072|FG000|Overall Study|Withdrawal by Subject|1|||
48802077|NCT01778556|157114073|FG000|Intervention 1 (5 Days)|Protocol Violation|0|||
48802078|NCT01778556|157114074|FG001|Intervention 1 (5 Days)|Protocol Violation|1|||
48802079|NCT01778556|157114073|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
48802080|NCT01778556|157114074|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|1|||
48802081|NCT01778556|157114073|FG000|Intervention 2 (14 Days)|Protocol Violation|1|||
48802082|NCT01778556|157114074|FG001|Intervention 2 (14 Days)|Protocol Violation|0|||
48802083|NCT01778556|157114073|FG000|Long-term Follow-up|noncompliance with metreleptin|1|||
48802084|NCT01778556|157114074|FG001|Long-term Follow-up|noncompliance with metreleptin|0|||
48802085|NCT03188120|157114075|FG000|Overall Study|Adverse Event|4|||
48802086|NCT03188120|157114075|FG000|Overall Study|Insufficient Effectiveness|8|||
48802087|NCT03188120|157114075|FG000|Overall Study|Improved|12|||
48802088|NCT03188120|157114075|FG000|Overall Study|Lost to Follow-up|7|||
48802089|NCT03188120|157114075|FG000|Overall Study|Other than specified|3|||
48802090|NCT03188120|157114075|FG000|Overall Study|No visit after the first visit|13|||
48802091|NCT03764072|157114081|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
48802092|NCT03764072|157114082|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
48802093|NCT03764072|157114083|FG002|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
48802094|NCT03764072|157114084|FG003|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
48802095|NCT03764072|157114085|FG004|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
48802096|NCT03764072|157114086|FG005|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
48802097|NCT03764072|157114081|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
48802098|NCT03764072|157114082|FG001|Overall Study|Withdrawal of consent (for other reason)|0|||
48802099|NCT03764072|157114083|FG002|Overall Study|Withdrawal of consent (for other reason)|0|||
48802100|NCT03764072|157114084|FG003|Overall Study|Withdrawal of consent (for other reason)|0|||
48802101|NCT03764072|157114085|FG004|Overall Study|Withdrawal of consent (for other reason)|0|||
48802102|NCT03764072|157114086|FG005|Overall Study|Withdrawal of consent (for other reason)|1|||
48802103|NCT03764072|157114081|FG000|Overall Study|Lost to Follow-up|0|||
48802104|NCT03764072|157114082|FG001|Overall Study|Lost to Follow-up|0|||
48802105|NCT03764072|157114083|FG002|Overall Study|Lost to Follow-up|0|||
48802106|NCT03764072|157114084|FG003|Overall Study|Lost to Follow-up|0|||
48802107|NCT03764072|157114085|FG004|Overall Study|Lost to Follow-up|1|||
48802108|NCT03764072|157114086|FG005|Overall Study|Lost to Follow-up|0|||
48802109|NCT02355028|157114087|FG000|Overall Study|Adverse Event|2|||
48802110|NCT02355028|157114088|FG001|Overall Study|Adverse Event|0|||
48802111|NCT02355028|157114087|FG000|Overall Study|Withdrawal by Subject|1|||
48802112|NCT02355028|157114088|FG001|Overall Study|Withdrawal by Subject|1|||
48802113|NCT02355028|157114087|FG000|Overall Study|Deemed ineligible after randomization|8|||
48802114|NCT02355028|157114088|FG001|Overall Study|Deemed ineligible after randomization|4|||
48802115|NCT00459342|157114089|FG000|Overall Study|Not eligible|1|||
48802116|NCT01833143|157114090|FG000|Overall Study|Not Treated|1|||
48802117|NCT00116844|157114100|FG000|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
48802118|NCT00116844|157114101|FG001|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
48802119|NCT00116844|157114100|FG000|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0|||
48802120|NCT00116844|157114101|FG001|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1|||
48802121|NCT00116844|157114100|FG000|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5|||
48802122|NCT00116844|157114101|FG001|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0|||
48802123|NCT00116844|157114100|FG000|Period 1: Treatment Period 1 (60 Days)|Other|1|||
48802124|NCT00116844|157114101|FG001|Period 1: Treatment Period 1 (60 Days)|Other|1|||
48802125|NCT00116844|157114100|FG000|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1|||
48802126|NCT00116844|157114101|FG001|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0|||
48802127|NCT00116844|157114100|FG000|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2|||
48802128|NCT00116844|157114101|FG001|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1|||
48802129|NCT00116844|157114100|FG000|Period 1: Treatment Period 2 (60 Days)|Other|0|||
48802130|NCT00116844|157114101|FG001|Period 1: Treatment Period 2 (60 Days)|Other|2|||
48802131|NCT00116844|157114100|FG000|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0|||
48802132|NCT00116844|157114101|FG001|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1|||
48802133|NCT00116844|157114100|FG000|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
48802134|NCT00116844|157114101|FG001|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
48802135|NCT00847405|157116148|FG000|First Intervention|Adverse Event|0|||
48802136|NCT00847405|157116149|FG001|First Intervention|Adverse Event|1|||
48802137|NCT00847405|157116148|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
48802138|NCT00847405|157116149|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
48802139|NCT03928028|157116153|FG000|Overall Study|Physician Decision|9|||
48802140|NCT03928028|157116154|FG001|Overall Study|Physician Decision|6|||
48802141|NCT03928028|157116155|FG002|Overall Study|Physician Decision|3|||
48802142|NCT03928028|157116153|FG000|Overall Study|Withdrawal by Subject|12|||
48802143|NCT03928028|157116154|FG001|Overall Study|Withdrawal by Subject|3|||
48802144|NCT03928028|157116155|FG002|Overall Study|Withdrawal by Subject|3|||
48802145|NCT03025789|157116159|FG000|Overall Study|Lack of Efficacy|6|||
48802146|NCT03025789|157116160|FG001|Overall Study|Lack of Efficacy|1|||
48802147|NCT03025789|157116159|FG000|Overall Study|Death|1|||
48802148|NCT03025789|157116160|FG001|Overall Study|Death|0|||
48802149|NCT03025789|157116159|FG000|Overall Study|Withdrawal by Subject|0|||
48802150|NCT03025789|157116160|FG001|Overall Study|Withdrawal by Subject|2|||
48802151|NCT00800202|157116161|FG000|Overall Study|Adverse Event|7|||
48802152|NCT00800202|157116162|FG001|Overall Study|Adverse Event|6|||
48802153|NCT00800202|157116161|FG000|Overall Study|Death|1|||
48802154|NCT00800202|157116162|FG001|Overall Study|Death|0|||
48802155|NCT00800202|157116161|FG000|Overall Study|Other|5|||
48802156|NCT00800202|157116162|FG001|Overall Study|Other|0|||
48802157|NCT00800202|157116161|FG000|Overall Study|Disease Progression|54|||
48802158|NCT00800202|157116162|FG001|Overall Study|Disease Progression|18|||
48802159|NCT04440176|157116166|FG000|Overall Study|Withdrawal by Subject|5|||
48802160|NCT04440176|157116167|FG001|Overall Study|Withdrawal by Subject|3|||
48802161|NCT04440176|157116166|FG000|Overall Study|Withdrawal by parent/guardian|4|||
48802162|NCT04440176|157116167|FG001|Overall Study|Withdrawal by parent/guardian|5|||
48802163|NCT04440176|157116166|FG000|Overall Study|Adverse Event|2|||
48802164|NCT04440176|157116167|FG001|Overall Study|Adverse Event|6|||
48802165|NCT04440176|157116166|FG000|Overall Study|Lost to Follow-up|22|||
48802166|NCT04440176|157116167|FG001|Overall Study|Lost to Follow-up|23|||
48802167|NCT04440176|157116166|FG000|Overall Study|Medication error without associated adverse event|0|||
48802168|NCT04440176|157116167|FG001|Overall Study|Medication error without associated adverse event|1|||
48802169|NCT04440176|157116166|FG000|Overall Study|No longer met eligibility criteria|7|||
48802170|NCT04440176|157116167|FG001|Overall Study|No longer met eligibility criteria|1|||
48914050|NCT02819635|157521213|FG004|Substudy 2, Part 2|Other, not specified|0|||
48914051|NCT02819635|157521214|FG005|Substudy 2, Part 2|Other, not specified|4|||
48802171|NCT04440176|157116166|FG000|Overall Study|Other|1|||
48802172|NCT04440176|157116167|FG001|Overall Study|Other|2|||
48802173|NCT04440176|157116166|FG000|Overall Study|Protocol deviation|6|||
48802174|NCT04440176|157116167|FG001|Overall Study|Protocol deviation|8|||
48914052|NCT02819635|157521215|FG006|Substudy 2, Part 2|Other, not specified|8|||
48802175|NCT04440176|157116166|FG000|Overall Study|Randomized but not vaccinated|6|||
48802176|NCT04440176|157116167|FG001|Overall Study|Randomized but not vaccinated|3|||
48802177|NCT00985725|157116168|FG000|Overall Study|Adverse Event|4|||
48914053|NCT02819635|157521216|FG007|Substudy 2, Part 2|Other, not specified|0|||
48802178|NCT00985725|157116169|FG001|Overall Study|Adverse Event|1|||
48914054|NCT02819635|157521217|FG008|Substudy 2, Part 2|Other, not specified|0|||
48914055|NCT02819635|157521218|FG009|Substudy 2, Part 2|Other, not specified|0|||
48802179|NCT00985725|157116168|FG000|Overall Study|Protocol Violation|1|||
48802180|NCT00985725|157116169|FG001|Overall Study|Protocol Violation|3|||
48802181|NCT00985725|157116168|FG000|Overall Study|Withdrawal by Subject|4|||
48802182|NCT00985725|157116169|FG001|Overall Study|Withdrawal by Subject|4|||
48802183|NCT00985725|157116168|FG000|Overall Study|Lost to Follow-up|1|||
48802184|NCT00985725|157116169|FG001|Overall Study|Lost to Follow-up|1|||
48802185|NCT00985725|157116168|FG000|Overall Study|Lack of Efficacy|0|||
48802186|NCT00985725|157116169|FG001|Overall Study|Lack of Efficacy|1|||
48802187|NCT00985725|157116168|FG000|Overall Study|Non-compliance|1|||
48802188|NCT00985725|157116169|FG001|Overall Study|Non-compliance|2|||
48802189|NCT00985725|157116168|FG000|Overall Study|Out-of-window visits|0|||
48802190|NCT00985725|157116169|FG001|Overall Study|Out-of-window visits|1|||
48802191|NCT00261495|157116172|FG000|Titration Phase (Weeks 0 to 4)|Adverse Event|28|||
48802192|NCT00261495|157116173|FG001|Titration Phase (Weeks 0 to 4)|Adverse Event|36|||
48802193|NCT00261495|157116172|FG000|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6|||
48802194|NCT00261495|157116173|FG001|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11|||
48802195|NCT00261495|157116172|FG000|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
48802196|NCT00261495|157116173|FG001|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
48802197|NCT00261495|157116172|FG000|Titration Phase (Weeks 0 to 4)|Physician Decision|3|||
48802198|NCT00261495|157116173|FG001|Titration Phase (Weeks 0 to 4)|Physician Decision|1|||
48802199|NCT00261495|157116172|FG000|Titration Phase (Weeks 0 to 4)|Non-compliance|2|||
48802200|NCT00261495|157116173|FG001|Titration Phase (Weeks 0 to 4)|Non-compliance|5|||
48802201|NCT00261495|157116172|FG000|Titration Phase (Weeks 0 to 4)|Protocol Violation|1|||
48802202|NCT00261495|157116173|FG001|Titration Phase (Weeks 0 to 4)|Protocol Violation|4|||
48802203|NCT00261495|157116172|FG000|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29|||
48802204|NCT00261495|157116173|FG001|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20|||
48802205|NCT00261495|157116172|FG000|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14|||
48802206|NCT00261495|157116173|FG001|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10|||
48802207|NCT00261495|157116172|FG000|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6|||
48802208|NCT00261495|157116173|FG001|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5|||
48802209|NCT00261495|157116172|FG000|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1|||
48802210|NCT00261495|157116173|FG001|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5|||
48802211|NCT00261495|157116172|FG000|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5|||
48802212|NCT00261495|157116173|FG001|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2|||
48802213|NCT00261495|157116172|FG000|Maintenance Phase (Weeks 4 to 24)|Other|6|||
48802214|NCT00261495|157116173|FG001|Maintenance Phase (Weeks 4 to 24)|Other|5|||
48802215|NCT00261495|157116172|FG000|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
48802216|NCT00261495|157116173|FG001|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
48802217|NCT00261495|157116172|FG000|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2|||
48802218|NCT00261495|157116173|FG001|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0|||
48802219|NCT00261495|157116172|FG000|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2|||
48802220|NCT00261495|157116173|FG001|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0|||
48802221|NCT00261495|157116172|FG000|Extension Phase (Weeks 24 to 52)|Other|4|||
48802222|NCT00261495|157116173|FG001|Extension Phase (Weeks 24 to 52)|Other|2|||
48802223|NCT00261495|157116172|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|4|||
48802224|NCT00261495|157116173|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
48802225|NCT00261495|157116172|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
48802226|NCT00261495|157116173|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
48802227|NCT00261495|157116172|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
48802228|NCT00261495|157116173|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
48802229|NCT00261495|157116172|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance|1|||
48802230|NCT00261495|157116173|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance|0|||
48802231|NCT00261495|157116172|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
48802232|NCT00261495|157116173|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
48802233|NCT00429663|157116176|FG000|Overall Study|Lost to Follow-up|24|||
48802234|NCT00429663|157116177|FG001|Overall Study|Lost to Follow-up|31|||
48802235|NCT00429663|157116176|FG000|Overall Study|Physician Decision|6|||
48802236|NCT00429663|157116177|FG001|Overall Study|Physician Decision|3|||
48802237|NCT00429663|157116176|FG000|Overall Study|Withdrawal by Subject|2|||
48802238|NCT00429663|157116177|FG001|Overall Study|Withdrawal by Subject|5|||
48802239|NCT00429663|157116176|FG000|Overall Study|Death|4|||
48802240|NCT00429663|157116177|FG001|Overall Study|Death|0|||
48802241|NCT01690130|157116182|FG000|Overall Study|Subject have cancelled visit.|1|||
48914056|NCT02819635|157521219|FG010|Substudy 2, Part 2|Other, not specified|0|||
48914057|NCT02819635|157521220|FG011|Substudy 2, Part 2|Other, not specified|0|||
48802242|NCT01690130|157116183|FG001|Overall Study|Subject have cancelled visit.|0|||
48802243|NCT00152464|157116184|FG000|Overall Study|Adverse Event|3|||
48802244|NCT00152464|157116185|FG001|Overall Study|Adverse Event|6|||
48802245|NCT00152464|157116184|FG000|Overall Study|Lost to Follow-up|8|||
48802246|NCT00152464|157116185|FG001|Overall Study|Lost to Follow-up|4|||
48802247|NCT00152464|157116184|FG000|Overall Study|Protocol Violation|3|||
48802248|NCT00152464|157116185|FG001|Overall Study|Protocol Violation|1|||
48802249|NCT00152464|157116184|FG000|Overall Study|Withdrawal by Subject|21|||
48802250|NCT00152464|157116185|FG001|Overall Study|Withdrawal by Subject|22|||
48802251|NCT00152464|157116184|FG000|Overall Study|Atopic dermatitis poorly controlled|0|||
48802252|NCT00152464|157116185|FG001|Overall Study|Atopic dermatitis poorly controlled|1|||
48802253|NCT00152464|157116184|FG000|Overall Study|Eczema deterioration|0|||
48802254|NCT00152464|157116185|FG001|Overall Study|Eczema deterioration|1|||
48802255|NCT00152464|157116184|FG000|Overall Study|Parent decision|1|||
48802256|NCT00152464|157116185|FG001|Overall Study|Parent decision|1|||
48802257|NCT00152464|157116184|FG000|Overall Study|Investigator decision|1|||
48802258|NCT00152464|157116185|FG001|Overall Study|Investigator decision|0|||
48802259|NCT00152464|157116184|FG000|Overall Study|Lack of Efficacy|1|||
48802260|NCT00152464|157116185|FG001|Overall Study|Lack of Efficacy|0|||
48802261|NCT00152464|157116184|FG000|Overall Study|Eczema poorly controlled|1|||
48802262|NCT00152464|157116185|FG001|Overall Study|Eczema poorly controlled|0|||
48802263|NCT00152464|157116184|FG000|Overall Study|Patient relocated|1|||
48802264|NCT00152464|157116185|FG001|Overall Study|Patient relocated|0|||
48802265|NCT01330316|157116196|FG000|Overall Study|Adverse Event|2|||
48802266|NCT01330316|157116197|FG001|Overall Study|Adverse Event|2|||
48802267|NCT01330316|157116196|FG000|Overall Study|Lack of Efficacy|0|||
48802268|NCT01330316|157116197|FG001|Overall Study|Lack of Efficacy|10|||
48802269|NCT01330316|157116196|FG000|Overall Study|Lost to Follow-up|0|||
48802270|NCT01330316|157116197|FG001|Overall Study|Lost to Follow-up|1|||
48802271|NCT01330316|157116196|FG000|Overall Study|Withdrawal by Subject|0|||
48802272|NCT01330316|157116197|FG001|Overall Study|Withdrawal by Subject|1|||
48802273|NCT01330316|157116196|FG000|Overall Study|other than above|0|||
48802274|NCT01330316|157116197|FG001|Overall Study|other than above|1|||
48802275|NCT04176939|157116198|FG000|Overall Study|Adverse Event|7|||
48802276|NCT04176939|157116198|FG000|Overall Study|Unspecified reason|2|||
48802277|NCT04176939|157116198|FG000|Overall Study|Migrated/Moved from the study area|1|||
48802278|NCT04176939|157116198|FG000|Overall Study|Withdrawal by Subject|4|||
48802279|NCT04176939|157116198|FG000|Overall Study|In follow-up|54|||
48802280|NCT00595504|157116199|FG000|Overall Study|Withdrawal by Subject|1|||
48802281|NCT00595504|157116200|FG001|Overall Study|Withdrawal by Subject|3|||
48802282|NCT00595504|157116199|FG000|Overall Study|Physician Decision|1|||
48802283|NCT00595504|157116200|FG001|Overall Study|Physician Decision|0|||
48802284|NCT01662063|157116201|FG000|Overall Study|Adverse Event or Intercurrent Illness|1|||
48802285|NCT01662063|157116202|FG001|Overall Study|Adverse Event or Intercurrent Illness|12|||
48802286|NCT01662063|157116203|FG002|Overall Study|Adverse Event or Intercurrent Illness|0|||
48802287|NCT01662063|157116201|FG000|Overall Study|Lack of Efficacy|1|||
48802288|NCT01662063|157116202|FG001|Overall Study|Lack of Efficacy|6|||
48802289|NCT01662063|157116203|FG002|Overall Study|Lack of Efficacy|0|||
48802290|NCT01662063|157116201|FG000|Overall Study|Lost to Follow-up|0|||
48802291|NCT01662063|157116202|FG001|Overall Study|Lost to Follow-up|4|||
48802292|NCT01662063|157116203|FG002|Overall Study|Lost to Follow-up|0|||
48802293|NCT01662063|157116201|FG000|Overall Study|Protocol Violation|1|||
48802294|NCT01662063|157116202|FG001|Overall Study|Protocol Violation|0|||
48802295|NCT01662063|157116203|FG002|Overall Study|Protocol Violation|0|||
48802296|NCT01662063|157116201|FG000|Overall Study|Withdrawal by Subject|2|||
48802297|NCT01662063|157116202|FG001|Overall Study|Withdrawal by Subject|4|||
48802298|NCT01662063|157116203|FG002|Overall Study|Withdrawal by Subject|1|||
48802299|NCT01662063|157116201|FG000|Overall Study|Physician Decision|0|||
48802300|NCT01662063|157116202|FG001|Overall Study|Physician Decision|2|||
48802301|NCT01662063|157116203|FG002|Overall Study|Physician Decision|0|||
48802302|NCT01662063|157116201|FG000|Overall Study|Other|0|||
48802303|NCT01662063|157116202|FG001|Overall Study|Other|1|||
48802304|NCT01662063|157116203|FG002|Overall Study|Other|0|||
48802305|NCT00615264|157116204|FG000|Overall Study|Withdrawal by Subject|17|||
48802306|NCT00615264|157116205|FG001|Overall Study|Withdrawal by Subject|19|||
48802307|NCT00615264|157116204|FG000|Overall Study|Lost to Follow-up|6|||
48802308|NCT00615264|157116205|FG001|Overall Study|Lost to Follow-up|13|||
48802309|NCT00615264|157116204|FG000|Overall Study|Adverse Event|8|||
48802310|NCT00615264|157116205|FG001|Overall Study|Adverse Event|5|||
48802311|NCT00615264|157116204|FG000|Overall Study|Death|1|||
48802312|NCT00615264|157116205|FG001|Overall Study|Death|1|||
48802313|NCT00615264|157116204|FG000|Overall Study|Protocol Violation|11|||
48802314|NCT00615264|157116205|FG001|Overall Study|Protocol Violation|7|||
48802315|NCT00615264|157116204|FG000|Overall Study|Not defined|7|||
48802316|NCT00615264|157116205|FG001|Overall Study|Not defined|4|||
48802317|NCT00615264|157116204|FG000|Overall Study|Dermal Hypersensitivity|0|||
48802318|NCT00615264|157116205|FG001|Overall Study|Dermal Hypersensitivity|3|||
48802319|NCT01520402|157116206|FG000|Overall Study|Withdrawal by Subject|2|||
48802320|NCT01520402|157116206|FG000|Overall Study|Physician Decision|3|||
48802321|NCT02313909|157116208|FG000|Overall Study|Consent withdrawn by participant|33|||
48802322|NCT02313909|157116209|FG001|Overall Study|Consent withdrawn by participant|33|||
48802323|NCT02313909|157116208|FG000|Overall Study|Lost to Follow-up|24|||
48802324|NCT02313909|157116209|FG001|Overall Study|Lost to Follow-up|17|||
48802325|NCT01982435|157116218|FG000|Overall Study|Adverse Event|1|||
48802326|NCT01982435|157116219|FG001|Overall Study|Adverse Event|0|||
48802327|NCT00638235|157116223|FG000|Overall Study|Lost to Follow-up|31|||
48802328|NCT00638235|157116224|FG001|Overall Study|Lost to Follow-up|3|||
48802329|NCT00638235|157116225|FG002|Overall Study|Lost to Follow-up|18|||
48802330|NCT00638235|157116226|FG003|Overall Study|Lost to Follow-up|10|||
48802331|NCT00638235|157116227|FG004|Overall Study|Lost to Follow-up|13|||
48802332|NCT00638235|157116228|FG005|Overall Study|Lost to Follow-up|26|||
48802333|NCT00638235|157116229|FG006|Overall Study|Lost to Follow-up|0|||
48802334|NCT00638235|157116230|FG007|Overall Study|Lost to Follow-up|1|||
48802335|NCT00638235|157116231|FG008|Overall Study|Lost to Follow-up|18|||
48802336|NCT04026165|157116237|FG000|Run-in Placebo Period|Enrollment Error|13|||
48802337|NCT04026165|157116238|FG001|Run-in Placebo Period|Enrollment Error|0|||
48802338|NCT04026165|157116239|FG002|Run-in Placebo Period|Enrollment Error|0|||
48802339|NCT04026165|157116240|FG003|Run-in Placebo Period|Enrollment Error|0|||
48802340|NCT04026165|157116237|FG000|Run-in Placebo Period|Run-in Failure|4|||
48802341|NCT04026165|157116238|FG001|Run-in Placebo Period|Run-in Failure|0|||
48802342|NCT04026165|157116239|FG002|Run-in Placebo Period|Run-in Failure|0|||
48802343|NCT04026165|157116240|FG003|Run-in Placebo Period|Run-in Failure|0|||
48802344|NCT04026165|157116237|FG000|Run-in Placebo Period|Protocol Violation|2|||
48802345|NCT04026165|157116238|FG001|Run-in Placebo Period|Protocol Violation|0|||
48802346|NCT04026165|157116239|FG002|Run-in Placebo Period|Protocol Violation|0|||
48802347|NCT04026165|157116240|FG003|Run-in Placebo Period|Protocol Violation|0|||
48802348|NCT04026165|157116237|FG000|Run-in Placebo Period|Withdrew Consent|2|||
48802349|NCT04026165|157116238|FG001|Run-in Placebo Period|Withdrew Consent|0|||
48802350|NCT04026165|157116239|FG002|Run-in Placebo Period|Withdrew Consent|0|||
48802351|NCT04026165|157116240|FG003|Run-in Placebo Period|Withdrew Consent|0|||
48802352|NCT04026165|157116237|FG000|Run-in Placebo Period|Significant Non-Compliance with Study Drug|1|||
48802353|NCT04026165|157116238|FG001|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
48802354|NCT04026165|157116239|FG002|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
48802355|NCT04026165|157116240|FG003|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
48802356|NCT04026165|157116237|FG000|Run-in SEL Period|Run-in Failure|0|||
48802357|NCT04026165|157116238|FG001|Run-in SEL Period|Run-in Failure|26|||
48802358|NCT04026165|157116239|FG002|Run-in SEL Period|Run-in Failure|0|||
48802359|NCT04026165|157116240|FG003|Run-in SEL Period|Run-in Failure|0|||
48802360|NCT04026165|157116237|FG000|Run-in SEL Period|Withdrew Consent|0|||
48802361|NCT04026165|157116238|FG001|Run-in SEL Period|Withdrew Consent|10|||
48802362|NCT04026165|157116239|FG002|Run-in SEL Period|Withdrew Consent|0|||
48802363|NCT04026165|157116240|FG003|Run-in SEL Period|Withdrew Consent|0|||
48802364|NCT04026165|157116237|FG000|Run-in SEL Period|Enrollment Error|0|||
48802365|NCT04026165|157116238|FG001|Run-in SEL Period|Enrollment Error|4|||
48802366|NCT04026165|157116239|FG002|Run-in SEL Period|Enrollment Error|0|||
48802367|NCT04026165|157116240|FG003|Run-in SEL Period|Enrollment Error|0|||
48802368|NCT04026165|157116237|FG000|Run-in SEL Period|Protocol Violation|0|||
48802369|NCT04026165|157116238|FG001|Run-in SEL Period|Protocol Violation|3|||
48802370|NCT04026165|157116239|FG002|Run-in SEL Period|Protocol Violation|0|||
48802371|NCT04026165|157116240|FG003|Run-in SEL Period|Protocol Violation|0|||
48802372|NCT04026165|157116237|FG000|Run-in SEL Period|Investigator's Discretion|0|||
48802373|NCT04026165|157116238|FG001|Run-in SEL Period|Investigator's Discretion|2|||
48802374|NCT04026165|157116239|FG002|Run-in SEL Period|Investigator's Discretion|0|||
48914058|NCT02819635|157521209|FG000|Substudy 3|Adverse Event|0|||
48914059|NCT02819635|157521210|FG001|Substudy 3|Adverse Event|0|||
48914060|NCT02819635|157521211|FG002|Substudy 3|Adverse Event|0|||
48914061|NCT02819635|157521212|FG003|Substudy 3|Adverse Event|0|||
48914062|NCT02819635|157521213|FG004|Substudy 3|Adverse Event|0|||
48914063|NCT02819635|157521214|FG005|Substudy 3|Adverse Event|0|||
48914064|NCT02819635|157521215|FG006|Substudy 3|Adverse Event|0|||
48914065|NCT02819635|157521216|FG007|Substudy 3|Adverse Event|0|||
48707908|NCT00670306|156779074|FG000|Overall Study|Withdrawal by Subject|9|||
48707909|NCT00670306|156779074|FG000|Overall Study|Physician Decision|1|||
48707910|NCT00670306|156779074|FG000|Overall Study|Lost to Follow-up|8|||
48707911|NCT00670306|156779074|FG000|Overall Study|incl/excl criterias did not meet|19|||
48707912|NCT01663103|156779078|FG000|Overall Study|Withdrawal by Subject|1|||
48707913|NCT01663103|156779079|FG001|Overall Study|Withdrawal by Subject|2|||
48707914|NCT01663103|156779078|FG000|Overall Study|Adverse Event|1|||
48707915|NCT01663103|156779079|FG001|Overall Study|Adverse Event|0|||
48707916|NCT01663103|156779078|FG000|Overall Study|dog bite|1|||
48707917|NCT01663103|156779079|FG001|Overall Study|dog bite|0|||
48707918|NCT05375760|156779080|FG000|Overall Study|Adverse Event|1|||
48707919|NCT05375760|156779081|FG001|Overall Study|Adverse Event|0|||
48707920|NCT05375760|156779080|FG000|Overall Study|Death|0|||
48707921|NCT05375760|156779081|FG001|Overall Study|Death|1|||
48707922|NCT05375760|156779080|FG000|Overall Study|Lost to Follow-up|6|||
48707923|NCT05375760|156779081|FG001|Overall Study|Lost to Follow-up|6|||
48802375|NCT04026165|157116240|FG003|Run-in SEL Period|Investigator's Discretion|0|||
48802376|NCT04026165|157116237|FG000|Run-in SEL Period|Death|0|||
48914066|NCT02819635|157521217|FG008|Substudy 3|Adverse Event|32|||
48914067|NCT02819635|157521218|FG009|Substudy 3|Adverse Event|3|||
48802377|NCT04026165|157116238|FG001|Run-in SEL Period|Death|1|||
48802378|NCT04026165|157116239|FG002|Run-in SEL Period|Death|0|||
48802379|NCT04026165|157116240|FG003|Run-in SEL Period|Death|0|||
48802380|NCT04026165|157116237|FG000|Randomized Period|Withdrew Consent|0|||
48802381|NCT04026165|157116238|FG001|Randomized Period|Withdrew Consent|0|||
48802382|NCT04026165|157116239|FG002|Randomized Period|Withdrew Consent|5|||
48802383|NCT04026165|157116240|FG003|Randomized Period|Withdrew Consent|8|||
48802384|NCT04026165|157116237|FG000|Randomized Period|Death|0|||
48802385|NCT04026165|157116238|FG001|Randomized Period|Death|0|||
48802386|NCT04026165|157116239|FG002|Randomized Period|Death|5|||
48802387|NCT04026165|157116240|FG003|Randomized Period|Death|7|||
48802388|NCT04026165|157116237|FG000|Randomized Period|Investigator's Discretion|0|||
48802389|NCT04026165|157116238|FG001|Randomized Period|Investigator's Discretion|0|||
48802390|NCT04026165|157116239|FG002|Randomized Period|Investigator's Discretion|2|||
48802391|NCT04026165|157116240|FG003|Randomized Period|Investigator's Discretion|2|||
48802392|NCT04026165|157116237|FG000|Randomized Period|Lost to Follow-up|0|||
48802393|NCT04026165|157116238|FG001|Randomized Period|Lost to Follow-up|0|||
48802394|NCT04026165|157116239|FG002|Randomized Period|Lost to Follow-up|2|||
48802395|NCT04026165|157116240|FG003|Randomized Period|Lost to Follow-up|2|||
48802396|NCT02992925|157116241|FG000|Cohort 2|Physician Decision|0|||
48802397|NCT02992925|157116242|FG001|Cohort 2|Physician Decision|0|||
48802398|NCT02992925|157116243|FG002|Cohort 2|Physician Decision|1|||
48802399|NCT02992925|157116244|FG003|Cohort 2|Physician Decision|0|||
48802400|NCT02992925|157116241|FG000|Cohort 2|Withdrawal by parent/guardian|0|||
48802401|NCT02992925|157116242|FG001|Cohort 2|Withdrawal by parent/guardian|0|||
48802402|NCT02992925|157116243|FG002|Cohort 2|Withdrawal by parent/guardian|0|||
48802403|NCT02992925|157116244|FG003|Cohort 2|Withdrawal by parent/guardian|2|||
48802404|NCT00948974|157116249|FG000|Overall Study|Lost to Follow-up|23|||
48802405|NCT00948974|157116250|FG001|Overall Study|Lost to Follow-up|20|||
48802406|NCT02487810|157116251|FG000|Overall Study|Withdrawal by Subject|1|||
48802407|NCT02487810|157116252|FG001|Overall Study|Withdrawal by Subject|0|||
48802408|NCT02569437|157116253|FG000|Overall Study|Lost to Follow-up|12|||
48802409|NCT02569437|157116254|FG001|Overall Study|Lost to Follow-up|14|||
48802410|NCT04650269|157116261|FG000|Overall Study|Death|3|||
48802411|NCT04650269|157116261|FG000|Overall Study|Lost to Follow-up|6|||
48802412|NCT00946296|157116262|FG000|Overall Study|Physician Decision|3|||
48802413|NCT00946296|157116263|FG001|Overall Study|Physician Decision|0|||
48802414|NCT03252847|157116264|FG000|Overall Study|Withdrawal by Subject|0|||
48802415|NCT03252847|157116265|FG001|Overall Study|Withdrawal by Subject|0|||
48802416|NCT03252847|157116266|FG002|Overall Study|Withdrawal by Subject|1|||
48802417|NCT03252847|157116267|FG003|Overall Study|Withdrawal by Subject|0|||
48802418|NCT03252847|157116268|FG004|Overall Study|Withdrawal by Subject|0|||
48802419|NCT03252847|157116269|FG005|Overall Study|Withdrawal by Subject|0|||
48802420|NCT03252847|157116270|FG006|Overall Study|Withdrawal by Subject|0|||
48802421|NCT03252847|157116264|FG000|Overall Study|Other: Patient decision|0|||
48802422|NCT03252847|157116265|FG001|Overall Study|Other: Patient decision|0|||
48802423|NCT03252847|157116266|FG002|Overall Study|Other: Patient decision|0|||
48802424|NCT03252847|157116267|FG003|Overall Study|Other: Patient decision|0|||
48802425|NCT03252847|157116268|FG004|Overall Study|Other: Patient decision|1|||
48802426|NCT03252847|157116269|FG005|Overall Study|Other: Patient decision|0|||
48802427|NCT03252847|157116270|FG006|Overall Study|Other: Patient decision|0|||
48802428|NCT02010632|157116292|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
48802429|NCT02010632|157116293|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
48802430|NCT02612064|157116297|FG000|Overall Study|Withdrawal by Subject|1|||
48802431|NCT02612064|157116298|FG001|Overall Study|Withdrawal by Subject|1|||
48802432|NCT02612064|157116297|FG000|Overall Study|Other|0|||
48707924|NCT05375760|156779080|FG000|Overall Study|Withdrawal by Subject|17|||
48707925|NCT05375760|156779081|FG001|Overall Study|Withdrawal by Subject|19|||
48707926|NCT05375760|156779080|FG000|Overall Study|Dosing halted by FDA|96|||
48707927|NCT05375760|156779081|FG001|Overall Study|Dosing halted by FDA|100|||
48707928|NCT05375760|156779080|FG000|Overall Study|Not compliant with study visit|2|||
48707929|NCT05375760|156779081|FG001|Overall Study|Not compliant with study visit|0|||
48707930|NCT05375760|156779080|FG000|Overall Study|Physician Decision|1|||
48707931|NCT05375760|156779081|FG001|Overall Study|Physician Decision|0|||
48707932|NCT05375760|156779080|FG000|Overall Study|Signed ICF addendum, however refused procedures|1|||
48707933|NCT05375760|156779081|FG001|Overall Study|Signed ICF addendum, however refused procedures|0|||
48707934|NCT05375760|156779080|FG000|Overall Study|Participant moved|1|||
48707935|NCT05375760|156779081|FG001|Overall Study|Participant moved|0|||
48707936|NCT03636893|156779082|FG000|Overall Study|Death|0|||
48707937|NCT03636893|156779083|FG001|Overall Study|Death|1|||
48707938|NCT03636893|156779082|FG000|Overall Study|Protocol Violation|0|||
48802433|NCT02612064|157116298|FG001|Overall Study|Other|2|||
48802434|NCT01651403|157116299|FG000|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
48856356|NCT03390166|157312826|FG000|Overall Study|To drug therapy course|0|||
48856357|NCT03390166|157312827|FG001|Overall Study|To drug therapy course|1|||
48856358|NCT03390166|157312826|FG000|Overall Study|Move to work oversea|0|||
48856359|NCT03390166|157312827|FG001|Overall Study|Move to work oversea|1|||
48802435|NCT01651403|157116300|FG001|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
48802436|NCT01651403|157116299|FG000|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
48802437|NCT01651403|157116300|FG001|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
48802438|NCT01651403|157116299|FG000|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0|||
48802439|NCT01651403|157116300|FG001|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1|||
48802440|NCT01651403|157116299|FG000|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13|||
48802441|NCT01651403|157116300|FG001|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9|||
48802442|NCT01651403|157116299|FG000|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2|||
48802443|NCT01651403|157116300|FG001|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1|||
48802444|NCT01651403|157116299|FG000|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6|||
48802445|NCT01651403|157116300|FG001|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4|||
48802446|NCT01120249|157116301|FG000|Overall Study|No protocol treatment received|21|||
48802447|NCT01120249|157116302|FG001|Overall Study|No protocol treatment received|15|||
48802448|NCT01120249|157116301|FG000|Overall Study|Disease recurrence|107|||
48802449|NCT01120249|157116302|FG001|Overall Study|Disease recurrence|57|||
48802450|NCT01120249|157116301|FG000|Overall Study|Death|1|||
48802451|NCT01120249|157116302|FG001|Overall Study|Death|0|||
48802452|NCT01120249|157116301|FG000|Overall Study|Adverse Event|40|||
48802453|NCT01120249|157116302|FG001|Overall Study|Adverse Event|276|||
48802454|NCT01120249|157116301|FG000|Overall Study|Participant refusal|34|||
48802455|NCT01120249|157116302|FG001|Overall Study|Participant refusal|42|||
48802456|NCT01120249|157116301|FG000|Overall Study|Other reasons, not protocol specified|29|||
48802457|NCT01120249|157116302|FG001|Overall Study|Other reasons, not protocol specified|22|||
48802458|NCT04689256|157116303|FG000|Overall Study|Participants declined to participate in the interventions per protocol|2|||
48802459|NCT04689256|157116304|FG001|Overall Study|Participants declined to participate in the interventions per protocol|0|||
48802460|NCT04741776|157116305|FG000|Overall Study|Withdrawal by Subject|7|||
48802461|NCT04741776|157116306|FG001|Overall Study|Withdrawal by Subject|10|||
48802462|NCT04741776|157116307|FG002|Overall Study|Withdrawal by Subject|10|||
48802463|NCT04741776|157116308|FG003|Overall Study|Withdrawal by Subject|17|||
48802464|NCT04741776|157116305|FG000|Overall Study|Death|0|||
48802465|NCT04741776|157116306|FG001|Overall Study|Death|0|||
48802466|NCT04741776|157116307|FG002|Overall Study|Death|1|||
48802467|NCT04741776|157116308|FG003|Overall Study|Death|0|||
48802468|NCT03520400|157116309|FG000|Overall Study|Physician Decision|15|||
48802469|NCT03520400|157116310|FG001|Overall Study|Physician Decision|7|||
48802470|NCT01654601|157116313|FG000|1st Administration|Withdrawal by Subject|2|||
48802471|NCT01654601|157116314|FG001|1st Administration|Withdrawal by Subject|0|||
48802472|NCT01654601|157116313|FG000|1st Administration|Protocol Violation|0|||
48802473|NCT01654601|157116314|FG001|1st Administration|Protocol Violation|2|||
48802474|NCT01654601|157116313|FG000|2nd Administration|Adverse Event|1|||
48802475|NCT01654601|157116314|FG001|2nd Administration|Adverse Event|0|||
48802476|NCT01654601|157116313|FG000|2nd Administration|Protocol Violation|0|||
48802477|NCT01654601|157116314|FG001|2nd Administration|Protocol Violation|1|||
48802478|NCT01119898|157116315|FG000|Overall Study|Adverse Event|4|||
48802479|NCT01119898|157116316|FG001|Overall Study|Adverse Event|5|||
48802480|NCT01119898|157116315|FG000|Overall Study|Withdrawal by Subject|1|||
48802481|NCT01119898|157116316|FG001|Overall Study|Withdrawal by Subject|4|||
48802482|NCT01119898|157116315|FG000|Overall Study|Lack of Efficacy|0|||
48802483|NCT01119898|157116316|FG001|Overall Study|Lack of Efficacy|2|||
48802484|NCT01119898|157116315|FG000|Overall Study|Protocol Violation|1|||
48802485|NCT01119898|157116316|FG001|Overall Study|Protocol Violation|1|||
48802486|NCT01119898|157116315|FG000|Overall Study|Medical procedure|1|||
48802487|NCT01119898|157116316|FG001|Overall Study|Medical procedure|0|||
48802488|NCT01119898|157116315|FG000|Overall Study|Randomized in error did not participate|1|||
48802489|NCT01119898|157116316|FG001|Overall Study|Randomized in error did not participate|0|||
48802490|NCT01122381|157116317|FG000|Overall Study|study terminated early|0|||
48802491|NCT01122381|157116318|FG001|Overall Study|study terminated early|1|||
48802492|NCT04108000|157116319|FG000|Overall Study|Death of patient|1|||
48802493|NCT04108000|157116320|FG001|Overall Study|Death of patient|0|||
48802494|NCT04108000|157116321|FG002|Overall Study|Death of patient|1|||
48802495|NCT04108000|157116322|FG003|Overall Study|Death of patient|0|||
48802496|NCT04108000|157116319|FG000|Overall Study|Withdrawal by Subject|2|||
48802497|NCT04108000|157116320|FG001|Overall Study|Withdrawal by Subject|2|||
48802498|NCT04108000|157116321|FG002|Overall Study|Withdrawal by Subject|0|||
48802499|NCT04108000|157116322|FG003|Overall Study|Withdrawal by Subject|0|||
48802500|NCT04108000|157116319|FG000|Overall Study|Death of surrogate partner|0|||
48802501|NCT04108000|157116320|FG001|Overall Study|Death of surrogate partner|1|||
48802502|NCT04108000|157116321|FG002|Overall Study|Death of surrogate partner|0|||
48802503|NCT04108000|157116322|FG003|Overall Study|Death of surrogate partner|1|||
48802504|NCT02272725|157116326|FG000|Overall Study|equipment malfunction|2|||
48802505|NCT02272725|157116327|FG001|Overall Study|equipment malfunction|0|||
48802506|NCT02323646|157117786|FG000|Treatment Course 1|Adverse Event|1|||
48802507|NCT02323646|157117787|FG001|Treatment Course 1|Adverse Event|0|||
48802508|NCT02323646|157117788|FG002|Treatment Course 1|Adverse Event|1|||
48914068|NCT02819635|157521219|FG010|Substudy 3|Adverse Event|12|||
48914069|NCT02819635|157521220|FG011|Substudy 3|Adverse Event|18|||
48914070|NCT02819635|157521209|FG000|Substudy 3|Withdrew consent|0|||
48914071|NCT02819635|157521210|FG001|Substudy 3|Withdrew consent|0|||
48914072|NCT02819635|157521211|FG002|Substudy 3|Withdrew consent|0|||
48914073|NCT02819635|157521212|FG003|Substudy 3|Withdrew consent|0|||
48914074|NCT02819635|157521213|FG004|Substudy 3|Withdrew consent|0|||
48914075|NCT02819635|157521214|FG005|Substudy 3|Withdrew consent|0|||
48914076|NCT02819635|157521215|FG006|Substudy 3|Withdrew consent|0|||
48914077|NCT02819635|157521216|FG007|Substudy 3|Withdrew consent|0|||
48914078|NCT02819635|157521217|FG008|Substudy 3|Withdrew consent|11|||
48707939|NCT03636893|156779083|FG001|Overall Study|Protocol Violation|3|||
48707940|NCT03636893|156779082|FG000|Overall Study|Withdrawal by Subject|1|||
48707941|NCT03636893|156779083|FG001|Overall Study|Withdrawal by Subject|2|||
48707942|NCT03636893|156779082|FG000|Overall Study|Refusal to surgery|4|||
48707943|NCT03636893|156779083|FG001|Overall Study|Refusal to surgery|3|||
48707944|NCT03636893|156779082|FG000|Overall Study|Early surgery (for acute bleeding)|3|||
48707945|NCT03636893|156779083|FG001|Overall Study|Early surgery (for acute bleeding)|0|||
48707946|NCT03636893|156779082|FG000|Overall Study|Adverse Event|1|||
48707947|NCT03636893|156779083|FG001|Overall Study|Adverse Event|1|||
48707948|NCT00996333|156779084|FG000|Overall Study|Screen failure|1|||
48707949|NCT00996333|156779084|FG000|Overall Study|Withdrawal by Subject|1|||
48707950|NCT00996333|156779084|FG000|Overall Study|Death|4|||
48707951|NCT00996333|156779084|FG000|Overall Study|Adverse Event|1|||
48707952|NCT00996333|156779084|FG000|Overall Study|Physician Decision|1|||
48707953|NCT00996333|156779084|FG000|Overall Study|Other|5|||
48707954|NCT00611026|156779089|FG000|Randomized to Double-blind Treatment|Not treated|2|||
48707955|NCT00611026|156779090|FG001|Randomized to Double-blind Treatment|Not treated|1|||
48707956|NCT00611026|156779091|FG002|Randomized to Double-blind Treatment|Not treated|3|||
48707957|NCT00611026|156779089|FG000|Double-blind Treatment Period|Death|1|||
48707958|NCT00611026|156779090|FG001|Double-blind Treatment Period|Death|0|||
48707959|NCT00611026|156779091|FG002|Double-blind Treatment Period|Death|0|||
48707960|NCT00611026|156779089|FG000|Double-blind Treatment Period|Adverse Event|9|||
48707961|NCT00611026|156779090|FG001|Double-blind Treatment Period|Adverse Event|28|||
48707962|NCT00611026|156779091|FG002|Double-blind Treatment Period|Adverse Event|46|||
48707963|NCT00611026|156779089|FG000|Double-blind Treatment Period|Lack of Efficacy|11|||
48707964|NCT00611026|156779090|FG001|Double-blind Treatment Period|Lack of Efficacy|10|||
48707965|NCT00611026|156779091|FG002|Double-blind Treatment Period|Lack of Efficacy|4|||
48707966|NCT00611026|156779089|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
48707967|NCT00611026|156779090|FG001|Double-blind Treatment Period|Lost to Follow-up|11|||
48707968|NCT00611026|156779091|FG002|Double-blind Treatment Period|Lost to Follow-up|14|||
48707969|NCT00611026|156779089|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
48707970|NCT00611026|156779090|FG001|Double-blind Treatment Period|Withdrawal by Subject|19|||
48707971|NCT00611026|156779091|FG002|Double-blind Treatment Period|Withdrawal by Subject|16|||
48707972|NCT00611026|156779089|FG000|Double-blind Treatment Period|Other|13|||
48707973|NCT00611026|156779090|FG001|Double-blind Treatment Period|Other|20|||
48707974|NCT00611026|156779091|FG002|Double-blind Treatment Period|Other|18|||
48707975|NCT01310075|156779092|FG000|Overall Study|Lost to Follow-up|1|||
48707976|NCT01310075|156779093|FG001|Overall Study|Lost to Follow-up|0|||
48707977|NCT01310075|156779092|FG000|Overall Study|Physician Decision|10|||
48707978|NCT01310075|156779093|FG001|Overall Study|Physician Decision|7|||
48707979|NCT01310075|156779092|FG000|Overall Study|Protocol Violation|2|||
48707980|NCT01310075|156779093|FG001|Overall Study|Protocol Violation|2|||
48707981|NCT01310075|156779092|FG000|Overall Study|Withdrawal by Subject|1|||
48707982|NCT01310075|156779093|FG001|Overall Study|Withdrawal by Subject|1|||
48707983|NCT03614156|156779094|FG000|Open-Label Treatment Period|Protocol-specified withdrawal met|6|||
48707984|NCT03614156|156779095|FG001|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
48707985|NCT03614156|156779096|FG002|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
48707986|NCT03614156|156779097|FG003|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
48707987|NCT03614156|156779094|FG000|Open-Label Treatment Period|Adverse Event|7|||
48707988|NCT03614156|156779095|FG001|Open-Label Treatment Period|Adverse Event|0|||
48707989|NCT03614156|156779096|FG002|Open-Label Treatment Period|Adverse Event|0|||
48707990|NCT03614156|156779097|FG003|Open-Label Treatment Period|Adverse Event|0|||
48707991|NCT03614156|156779094|FG000|Open-Label Treatment Period|Lack of Efficacy|18|||
48707992|NCT03614156|156779095|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
48707993|NCT03614156|156779096|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
48707994|NCT03614156|156779097|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
48707995|NCT03614156|156779094|FG000|Open-Label Treatment Period|Withdrawal by Subject|36|||
48707996|NCT03614156|156779095|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
48707997|NCT03614156|156779096|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
48707998|NCT03614156|156779097|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
48707999|NCT03614156|156779094|FG000|Open-Label Treatment Period|Lost to Follow-up|10|||
48708000|NCT03614156|156779095|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
48914079|NCT02819635|157521218|FG009|Substudy 3|Withdrew consent|1|||
48708001|NCT03614156|156779096|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
48802509|NCT02323646|157117786|FG000|Treatment Course 1|Heavy Bleeding|1|||
48802510|NCT02323646|157117787|FG001|Treatment Course 1|Heavy Bleeding|1|||
48802511|NCT02323646|157117788|FG002|Treatment Course 1|Heavy Bleeding|0|||
48802512|NCT02323646|157117786|FG000|Treatment Course 1|Lost to Follow-up|1|||
48802513|NCT02323646|157117787|FG001|Treatment Course 1|Lost to Follow-up|0|||
48802514|NCT02323646|157117788|FG002|Treatment Course 1|Lost to Follow-up|2|||
48914080|NCT02819635|157521219|FG010|Substudy 3|Withdrew consent|4|||
48914081|NCT02819635|157521220|FG011|Substudy 3|Withdrew consent|9|||
48914082|NCT02819635|157521209|FG000|Substudy 3|Lost to Follow-up|0|||
48914083|NCT02819635|157521210|FG001|Substudy 3|Lost to Follow-up|0|||
48914084|NCT02819635|157521211|FG002|Substudy 3|Lost to Follow-up|0|||
48914085|NCT02819635|157521212|FG003|Substudy 3|Lost to Follow-up|0|||
48708002|NCT03614156|156779097|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
48708003|NCT03614156|156779094|FG000|Open-Label Treatment Period|Protocol Violation|2|||
48708004|NCT03614156|156779095|FG001|Open-Label Treatment Period|Protocol Violation|0|||
48708005|NCT03614156|156779096|FG002|Open-Label Treatment Period|Protocol Violation|0|||
48708006|NCT03614156|156779097|FG003|Open-Label Treatment Period|Protocol Violation|0|||
48708007|NCT03614156|156779094|FG000|Open-Label Treatment Period|Non-compliance with study drug|1|||
48708008|NCT03614156|156779095|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
48708009|NCT03614156|156779096|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
48708010|NCT03614156|156779097|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
48708011|NCT03614156|156779094|FG000|Open-Label Treatment Period|Study terminated by sponsor|74|||
48708012|NCT03614156|156779095|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
48708013|NCT03614156|156779096|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
48708014|NCT03614156|156779097|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
48708015|NCT03614156|156779094|FG000|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
48708016|NCT03614156|156779095|FG001|Double-Blind Treatment Period (DBTP)|Adverse Event|2|||
48708017|NCT03614156|156779096|FG002|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
48708018|NCT03614156|156779097|FG003|Double-Blind Treatment Period (DBTP)|Adverse Event|1|||
48708019|NCT03614156|156779094|FG000|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
48708020|NCT03614156|156779095|FG001|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4|||
48708021|NCT03614156|156779096|FG002|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
48708022|NCT03614156|156779097|FG003|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
48708023|NCT03614156|156779094|FG000|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
48708024|NCT03614156|156779095|FG001|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
48708025|NCT03614156|156779096|FG002|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3|||
48708026|NCT03614156|156779097|FG003|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4|||
48708027|NCT03614156|156779094|FG000|Double-Blind Treatment Period (DBTP)|Protocol Violation|0|||
48708028|NCT03614156|156779095|FG001|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
48708029|NCT03614156|156779096|FG002|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
48708030|NCT03614156|156779097|FG003|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
48708031|NCT03614156|156779094|FG000|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0|||
48708032|NCT03614156|156779095|FG001|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22|||
48708033|NCT03614156|156779096|FG002|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26|||
48708034|NCT03614156|156779097|FG003|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38|||
48708035|NCT03614156|156779094|FG000|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
48708036|NCT03614156|156779095|FG001|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1|||
48708037|NCT03614156|156779096|FG002|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
48708038|NCT03614156|156779097|FG003|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
48708039|NCT03614156|156779094|FG000|Safety Follow-Up Period|Miscellaneous Reasons|2|||
48708040|NCT03614156|156779095|FG001|Safety Follow-Up Period|Miscellaneous Reasons|0|||
48708041|NCT03614156|156779096|FG002|Safety Follow-Up Period|Miscellaneous Reasons|0|||
48708042|NCT03614156|156779097|FG003|Safety Follow-Up Period|Miscellaneous Reasons|0|||
48708043|NCT03614156|156779094|FG000|Safety Follow-Up Period|Withdrawal by Subject|0|||
48708044|NCT03614156|156779095|FG001|Safety Follow-Up Period|Withdrawal by Subject|0|||
48708045|NCT03614156|156779096|FG002|Safety Follow-Up Period|Withdrawal by Subject|1|||
48708046|NCT03614156|156779097|FG003|Safety Follow-Up Period|Withdrawal by Subject|0|||
48708047|NCT03614156|156779094|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
48708048|NCT03614156|156779095|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
48708049|NCT03614156|156779096|FG002|Safety Follow-Up Period|Lost to Follow-up|0|||
48708050|NCT03614156|156779097|FG003|Safety Follow-Up Period|Lost to Follow-up|1|||
48708051|NCT02991040|156779101|FG000|Overall Study|Withdrawal by Subject|2|||
48708052|NCT02991040|156779101|FG000|Overall Study|Lost to Follow-up|2|||
48708053|NCT04287517|156779103|FG000|Overall Study|Withdrawal by Subject|1|||
48802515|NCT02323646|157117786|FG000|Treatment Course 1|Withdrawal by Subject|0|||
48802516|NCT02323646|157117787|FG001|Treatment Course 1|Withdrawal by Subject|2|||
48914086|NCT02819635|157521213|FG004|Substudy 3|Lost to Follow-up|0|||
48914087|NCT02819635|157521214|FG005|Substudy 3|Lost to Follow-up|0|||
48802517|NCT02323646|157117788|FG002|Treatment Course 1|Withdrawal by Subject|0|||
48802518|NCT02323646|157117786|FG000|Treatment Course 2|Adverse Event|1|||
48802519|NCT02323646|157117787|FG001|Treatment Course 2|Adverse Event|0|||
48802520|NCT02323646|157117788|FG002|Treatment Course 2|Adverse Event|1|||
48802521|NCT02323646|157117786|FG000|Treatment Course 2|Lost to Follow-up|0|||
48802522|NCT02323646|157117787|FG001|Treatment Course 2|Lost to Follow-up|0|||
48802523|NCT02323646|157117788|FG002|Treatment Course 2|Lost to Follow-up|1|||
48802524|NCT02323646|157117786|FG000|Treatment Course 2|Non-compliance|0|||
48802525|NCT02323646|157117787|FG001|Treatment Course 2|Non-compliance|1|||
48802526|NCT02323646|157117788|FG002|Treatment Course 2|Non-compliance|1|||
48802527|NCT00508261|157117789|FG000|Overall Study|Other|0|||
48802528|NCT00508261|157117790|FG001|Overall Study|Other|1|||
48802529|NCT00508261|157117791|FG002|Overall Study|Other|1|||
48802530|NCT00508261|157117792|FG003|Overall Study|Other|0|||
48802531|NCT00508261|157117789|FG000|Overall Study|Serious Adverse Event|0|||
48802532|NCT00508261|157117790|FG001|Overall Study|Serious Adverse Event|1|||
48802533|NCT00508261|157117791|FG002|Overall Study|Serious Adverse Event|0|||
48802534|NCT00508261|157117792|FG003|Overall Study|Serious Adverse Event|0|||
48802535|NCT00508261|157117789|FG000|Overall Study|Withdrawal by Subject|3|||
48802536|NCT00508261|157117790|FG001|Overall Study|Withdrawal by Subject|4|||
48802537|NCT00508261|157117791|FG002|Overall Study|Withdrawal by Subject|4|||
48802538|NCT00508261|157117792|FG003|Overall Study|Withdrawal by Subject|0|||
48802539|NCT00508261|157117789|FG000|Overall Study|Migrated/ moved from study area|0|||
48802540|NCT00508261|157117790|FG001|Overall Study|Migrated/ moved from study area|1|||
48802541|NCT00508261|157117791|FG002|Overall Study|Migrated/ moved from study area|0|||
48802542|NCT00508261|157117792|FG003|Overall Study|Migrated/ moved from study area|0|||
48802543|NCT00508261|157117789|FG000|Overall Study|Lost to Follow-up|0|||
48802544|NCT00508261|157117790|FG001|Overall Study|Lost to Follow-up|1|||
48802545|NCT00508261|157117791|FG002|Overall Study|Lost to Follow-up|1|||
48802546|NCT00508261|157117792|FG003|Overall Study|Lost to Follow-up|1|||
48802547|NCT03517553|157117795|FG000|Overall Study|Withdrawal by Subject|2|||
48802548|NCT02736825|157117798|FG000|Overall Study|Lost to Follow-up|10|||
48802549|NCT02736825|157117799|FG001|Overall Study|Lost to Follow-up|11|||
48802550|NCT02736825|157117798|FG000|Overall Study|Early Termination|0|||
48802551|NCT02736825|157117799|FG001|Overall Study|Early Termination|1|||
48802552|NCT00790452|157117800|FG000|Overall Study|Drug supply issue|1|||
48802553|NCT00790452|157117801|FG001|Overall Study|Drug supply issue|0|||
48802554|NCT01564368|157117802|FG000|Overall Study|Ineligible|18|||
48802555|NCT01564368|157117802|FG000|Overall Study|Not Randomized in Parent study|116|||
48802556|NCT01564368|157117802|FG000|Overall Study|Baseline Imaging failed QC requirements|9|||
48802557|NCT01564368|157117802|FG000|Overall Study|No Acceptable post-baseline imaging|21|||
48802558|NCT03320018|157117808|FG000|Treatment Period|Withdrawal by Subject|1|||
48802559|NCT03320018|157117809|FG001|Treatment Period|Withdrawal by Subject|0|||
48802560|NCT03320018|157117808|FG000|Day 90 Follow up|Death|0|||
48802561|NCT03320018|157117809|FG001|Day 90 Follow up|Death|1|||
48802562|NCT01699022|157117810|FG000|Overall Study|Early discontinuation from the study|3|||
48802563|NCT00827541|157117811|FG000|Overall Study|Exitus|1|||
48802564|NCT00827541|157117812|FG001|Overall Study|Exitus|8|||
48802565|NCT00827541|157117811|FG000|Overall Study|Other|1|||
48802566|NCT00827541|157117812|FG001|Overall Study|Other|3|||
48802567|NCT00827541|157117811|FG000|Overall Study|Pathogen not susceptible|1|||
48802568|NCT00827541|157117812|FG001|Overall Study|Pathogen not susceptible|0|||
48802569|NCT00827541|157117811|FG000|Overall Study|Lack of effectiveness|1|||
48802570|NCT00827541|157117812|FG001|Overall Study|Lack of effectiveness|0|||
48802571|NCT01750879|157117813|FG000|Overall Study|Adverse Event|8|||
48802572|NCT01750879|157117814|FG001|Overall Study|Adverse Event|0|||
48802573|NCT01750879|157117813|FG000|Overall Study|Lack of Efficacy|1|||
48802574|NCT01750879|157117814|FG001|Overall Study|Lack of Efficacy|0|||
48802575|NCT01750879|157117813|FG000|Overall Study|Withdrawal by Subject|1|||
48802576|NCT01750879|157117814|FG001|Overall Study|Withdrawal by Subject|0|||
48802577|NCT01750879|157117813|FG000|Overall Study|Did not complete per protocol|0|||
48802578|NCT01750879|157117814|FG001|Overall Study|Did not complete per protocol|3|||
48802579|NCT01995539|157117815|FG000|Overall Study|Screening Failure|1|||
48802580|NCT01995539|157117815|FG000|Overall Study|Withdrawal by Investigator|15|||
48802581|NCT01995539|157117815|FG000|Overall Study|Withdrawal by Subject|11|||
48914088|NCT02819635|157521215|FG006|Substudy 3|Lost to Follow-up|0|||
48802582|NCT01995539|157117815|FG000|Overall Study|Lost to Follow-up|5|||
48802583|NCT01995539|157117815|FG000|Overall Study|Subject missed visit 3,4, came in for V5|1|||
48802584|NCT01287611|157117816|FG000|Overall Study|Lost to Follow-up|29|||
48802585|NCT01287611|157117817|FG001|Overall Study|Lost to Follow-up|16|||
48802586|NCT01287611|157117816|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
48802587|NCT01287611|157117817|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
48802588|NCT03476187|157117824|FG000|Overall Study|Protocol Violation|7|||
48802589|NCT03476187|157117824|FG000|Overall Study|Physician Decision|5|||
48802590|NCT03879408|157117825|FG000|Overall Study|Lost to Follow-up|0|||
48802591|NCT03879408|157117826|FG001|Overall Study|Lost to Follow-up|3|||
48802592|NCT03879408|157117827|FG002|Overall Study|Lost to Follow-up|2|||
48914089|NCT02819635|157521216|FG007|Substudy 3|Lost to Follow-up|0|||
48802593|NCT03879408|157117828|FG003|Overall Study|Lost to Follow-up|1|||
48802594|NCT03879408|157117829|FG004|Overall Study|Lost to Follow-up|0|||
48802595|NCT03879408|157117825|FG000|Overall Study|Withdrawal by Subject|2|||
48802596|NCT03879408|157117826|FG001|Overall Study|Withdrawal by Subject|1|||
48802597|NCT03879408|157117827|FG002|Overall Study|Withdrawal by Subject|1|||
48802598|NCT03879408|157117828|FG003|Overall Study|Withdrawal by Subject|0|||
48802599|NCT03879408|157117829|FG004|Overall Study|Withdrawal by Subject|1|||
48802600|NCT05239455|157117834|FG000|Overall Study|Adverse Event|1|||
48802601|NCT05239455|157117834|FG000|Overall Study|Sponsor Decision|5|||
48802602|NCT05239455|157117834|FG000|Overall Study|Incomplete Blood Collection|1|||
48802603|NCT02277743|157117841|FG000|Overall Study|Protocol Violation|1|||
48802604|NCT02277743|157117842|FG001|Overall Study|Protocol Violation|1|||
48802605|NCT02277743|157117843|FG002|Overall Study|Protocol Violation|1|||
48802606|NCT02277743|157117841|FG000|Overall Study|Adverse Event|10|||
48802607|NCT02277743|157117842|FG001|Overall Study|Adverse Event|6|||
48802608|NCT02277743|157117843|FG002|Overall Study|Adverse Event|6|||
48802609|NCT02277743|157117841|FG000|Overall Study|Lack of Efficacy|11|||
48802610|NCT02277743|157117842|FG001|Overall Study|Lack of Efficacy|4|||
48802611|NCT02277743|157117843|FG002|Overall Study|Lack of Efficacy|3|||
48802612|NCT02277743|157117841|FG000|Overall Study|Other than specified above|18|||
48802613|NCT02277743|157117842|FG001|Overall Study|Other than specified above|5|||
48802614|NCT02277743|157117843|FG002|Overall Study|Other than specified above|16|||
48802615|NCT00782496|157117846|FG000|Overall Study|Lost to Follow-up|14|||
48802616|NCT00782496|157117847|FG001|Overall Study|Lost to Follow-up|15|||
48802617|NCT01987817|157117848|FG000|Overall Study|Adverse Event|4|||
48802618|NCT01987817|157117849|FG001|Overall Study|Adverse Event|0|||
48802619|NCT01987817|157117848|FG000|Overall Study|Withdrawal by Subject|1|||
48802620|NCT01987817|157117849|FG001|Overall Study|Withdrawal by Subject|1|||
48802621|NCT01987817|157117848|FG000|Overall Study|Physician Decision|1|||
48708054|NCT04287517|156779104|FG001|Overall Study|Withdrawal by Subject|1|||
48708055|NCT02721966|156779105|FG000|Overall Study|Protocol Violation|1|||
48708056|NCT02721966|156779106|FG001|Overall Study|Protocol Violation|0|||
48708057|NCT02721966|156779107|FG002|Overall Study|Protocol Violation|0|||
48708058|NCT02721966|156779108|FG003|Overall Study|Protocol Violation|0|||
48708059|NCT02721966|156779109|FG004|Overall Study|Protocol Violation|0|||
48708060|NCT02721966|156779105|FG000|Overall Study|Withdrawal by Subject|9|||
48708061|NCT02721966|156779106|FG001|Overall Study|Withdrawal by Subject|2|||
48708062|NCT02721966|156779107|FG002|Overall Study|Withdrawal by Subject|3|||
48708063|NCT02721966|156779108|FG003|Overall Study|Withdrawal by Subject|7|||
48708064|NCT02721966|156779109|FG004|Overall Study|Withdrawal by Subject|0|||
48708065|NCT02721966|156779105|FG000|Overall Study|Adverse Event|4|||
48708066|NCT02721966|156779106|FG001|Overall Study|Adverse Event|4|||
48708067|NCT02721966|156779107|FG002|Overall Study|Adverse Event|3|||
48708068|NCT02721966|156779108|FG003|Overall Study|Adverse Event|0|||
48708069|NCT02721966|156779109|FG004|Overall Study|Adverse Event|0|||
48708070|NCT02721966|156779105|FG000|Overall Study|Death|1|||
48708071|NCT02721966|156779106|FG001|Overall Study|Death|0|||
48708072|NCT02721966|156779107|FG002|Overall Study|Death|0|||
48708073|NCT02721966|156779108|FG003|Overall Study|Death|0|||
48708074|NCT02721966|156779109|FG004|Overall Study|Death|0|||
48708075|NCT02721966|156779105|FG000|Overall Study|Lack of Efficacy|7|||
48708076|NCT02721966|156779106|FG001|Overall Study|Lack of Efficacy|4|||
48708077|NCT02721966|156779107|FG002|Overall Study|Lack of Efficacy|0|||
48708078|NCT02721966|156779108|FG003|Overall Study|Lack of Efficacy|0|||
48708079|NCT02721966|156779109|FG004|Overall Study|Lack of Efficacy|0|||
48708080|NCT02721966|156779105|FG000|Overall Study|Lost to Follow-up|0|||
48708081|NCT02721966|156779106|FG001|Overall Study|Lost to Follow-up|0|||
48708082|NCT02721966|156779107|FG002|Overall Study|Lost to Follow-up|3|||
48708083|NCT02721966|156779108|FG003|Overall Study|Lost to Follow-up|0|||
48708084|NCT02721966|156779109|FG004|Overall Study|Lost to Follow-up|0|||
48708085|NCT02721966|156779105|FG000|Overall Study|Physician Decision|1|||
48708086|NCT02721966|156779106|FG001|Overall Study|Physician Decision|1|||
48708087|NCT02721966|156779107|FG002|Overall Study|Physician Decision|0|||
48708088|NCT02721966|156779108|FG003|Overall Study|Physician Decision|0|||
48708089|NCT02721966|156779109|FG004|Overall Study|Physician Decision|0|||
48708090|NCT02721966|156779105|FG000|Overall Study|Pregnancy|1|||
48708091|NCT02721966|156779106|FG001|Overall Study|Pregnancy|0|||
48708092|NCT02721966|156779107|FG002|Overall Study|Pregnancy|0|||
48708093|NCT02721966|156779108|FG003|Overall Study|Pregnancy|0|||
48708094|NCT02721966|156779109|FG004|Overall Study|Pregnancy|0|||
48708095|NCT02721966|156779105|FG000|Overall Study|Did not continue to period 2|5|||
48708096|NCT02721966|156779106|FG001|Overall Study|Did not continue to period 2|12|||
48708097|NCT02721966|156779107|FG002|Overall Study|Did not continue to period 2|0|||
48802622|NCT01987817|157117849|FG001|Overall Study|Physician Decision|0|||
48802623|NCT02130284|157117850|FG000|Overall Study|Withdrawal by Subject|3|||
48802624|NCT02130284|157117850|FG000|Overall Study|Subject Withdrew Consent|1|||
48802625|NCT02130284|157117850|FG000|Overall Study|Subject's sensor failed at Visit 2, Day|1|||
48802626|NCT02130284|157117850|FG000|Overall Study|Subject was screened as backup for study|3|||
48802627|NCT02130284|157117850|FG000|Overall Study|Screen Failure|1|||
48802628|NCT00682643|157117851|FG000|Overall Study|Adverse Event|12|||
48802629|NCT00682643|157117852|FG001|Overall Study|Adverse Event|23|||
48802630|NCT00682643|157117851|FG000|Overall Study|Lack of Efficacy|2|||
48802631|NCT00682643|157117852|FG001|Overall Study|Lack of Efficacy|0|||
48802632|NCT00682643|157117851|FG000|Overall Study|Protocol Violation|38|||
48802633|NCT00682643|157117852|FG001|Overall Study|Protocol Violation|76|||
48802634|NCT00682643|157117851|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
48914090|NCT02819635|157521217|FG008|Substudy 3|Lost to Follow-up|1|||
48914091|NCT02819635|157521218|FG009|Substudy 3|Lost to Follow-up|0|||
48914092|NCT02819635|157521219|FG010|Substudy 3|Lost to Follow-up|1|||
48914093|NCT02819635|157521220|FG011|Substudy 3|Lost to Follow-up|1|||
48914094|NCT02819635|157521209|FG000|Substudy 3|COVID-19 Logistical Restrictions|0|||
48914095|NCT02819635|157521210|FG001|Substudy 3|COVID-19 Logistical Restrictions|0|||
48914096|NCT02819635|157521211|FG002|Substudy 3|COVID-19 Logistical Restrictions|0|||
48914097|NCT02819635|157521212|FG003|Substudy 3|COVID-19 Logistical Restrictions|0|||
48914098|NCT02819635|157521213|FG004|Substudy 3|COVID-19 Logistical Restrictions|0|||
48914099|NCT02819635|157521214|FG005|Substudy 3|COVID-19 Logistical Restrictions|0|||
48914100|NCT02819635|157521215|FG006|Substudy 3|COVID-19 Logistical Restrictions|0|||
48914101|NCT02819635|157521216|FG007|Substudy 3|COVID-19 Logistical Restrictions|0|||
48914102|NCT02819635|157521217|FG008|Substudy 3|COVID-19 Logistical Restrictions|0|||
48914103|NCT02819635|157521218|FG009|Substudy 3|COVID-19 Logistical Restrictions|0|||
48914104|NCT02819635|157521219|FG010|Substudy 3|COVID-19 Logistical Restrictions|0|||
48914105|NCT02819635|157521220|FG011|Substudy 3|COVID-19 Logistical Restrictions|1|||
48914106|NCT02819635|157521209|FG000|Substudy 3|Other, not specified|0|||
48914107|NCT02819635|157521210|FG001|Substudy 3|Other, not specified|0|||
48914108|NCT02819635|157521211|FG002|Substudy 3|Other, not specified|0|||
48914109|NCT02819635|157521212|FG003|Substudy 3|Other, not specified|0|||
48914110|NCT02819635|157521213|FG004|Substudy 3|Other, not specified|0|||
48914111|NCT02819635|157521214|FG005|Substudy 3|Other, not specified|0|||
48914112|NCT02819635|157521215|FG006|Substudy 3|Other, not specified|0|||
48914113|NCT02819635|157521216|FG007|Substudy 3|Other, not specified|0|||
48914114|NCT02819635|157521217|FG008|Substudy 3|Other, not specified|202|||
48914115|NCT02819635|157521218|FG009|Substudy 3|Other, not specified|5|||
48914116|NCT02819635|157521219|FG010|Substudy 3|Other, not specified|89|||
48914117|NCT02819635|157521220|FG011|Substudy 3|Other, not specified|39|||
48914118|NCT03861936|157521223|FG000|Overall Study|Withdrawal by Subject|4|||
48914119|NCT03861936|157521224|FG001|Overall Study|Withdrawal by Subject|1|||
48914120|NCT03861936|157521225|FG002|Overall Study|Withdrawal by Subject|3|||
48708098|NCT02721966|156779108|FG003|Overall Study|Did not continue to period 2|0|||
48914121|NCT03861936|157521223|FG000|Overall Study|Lost to Follow-up|5|||
48914122|NCT03861936|157521224|FG001|Overall Study|Lost to Follow-up|3|||
48914123|NCT03861936|157521225|FG002|Overall Study|Lost to Follow-up|3|||
48914124|NCT03861936|157521223|FG000|Overall Study|Physician Decision|0|||
48914125|NCT03861936|157521224|FG001|Overall Study|Physician Decision|1|||
48914126|NCT03861936|157521225|FG002|Overall Study|Physician Decision|0|||
48914127|NCT03861936|157521223|FG000|Overall Study|Protocol Deviation|0|||
48914128|NCT03861936|157521224|FG001|Overall Study|Protocol Deviation|0|||
48914129|NCT03861936|157521225|FG002|Overall Study|Protocol Deviation|1|||
48914130|NCT03861936|157521223|FG000|Overall Study|Reason not Specified|5|||
48914131|NCT03861936|157521224|FG001|Overall Study|Reason not Specified|5|||
48914132|NCT03861936|157521225|FG002|Overall Study|Reason not Specified|3|||
48914133|NCT01265615|157521241|FG000|Overall Study|Protocol Violation|2|||
48914134|NCT01265615|157521242|FG001|Overall Study|Protocol Violation|2|||
48708099|NCT02721966|156779109|FG004|Overall Study|Did not continue to period 2|5|||
48708100|NCT01192191|156779110|FG000|Overall Study|Adverse Event|7|||
48708101|NCT01192191|156779111|FG001|Overall Study|Adverse Event|12|||
48708102|NCT01192191|156779110|FG000|Overall Study|Participants Reached Stopping Criteria|3|||
48708103|NCT01192191|156779111|FG001|Overall Study|Participants Reached Stopping Criteria|2|||
48708104|NCT01192191|156779110|FG000|Overall Study|Lost to Follow-up|0|||
48708105|NCT01192191|156779111|FG001|Overall Study|Lost to Follow-up|1|||
48708106|NCT01192191|156779110|FG000|Overall Study|Withdrawal by Subject|1|||
48708107|NCT01192191|156779111|FG001|Overall Study|Withdrawal by Subject|6|||
48708108|NCT03070964|156779112|FG000|Overall Study|Progressive disease|8|||
48708109|NCT03070964|156779112|FG000|Overall Study|Treatment-unrelated adverse event|2|||
48708110|NCT03070964|156779112|FG000|Overall Study|Never treated|1|||
48708111|NCT03070964|156779112|FG000|Overall Study|Physician Decision|1|||
48802635|NCT00682643|157117852|FG001|Overall Study|Met Protocol-defined Stopping Criteria|4|||
48802636|NCT00682643|157117851|FG000|Overall Study|Lost to Follow-up|1|||
48802637|NCT00682643|157117852|FG001|Overall Study|Lost to Follow-up|6|||
48802638|NCT00682643|157117851|FG000|Overall Study|Physician Decision|2|||
48802639|NCT00682643|157117852|FG001|Overall Study|Physician Decision|6|||
48914135|NCT01265615|157521243|FG002|Overall Study|Protocol Violation|4|||
48914136|NCT01265615|157521244|FG003|Overall Study|Protocol Violation|3|||
48914137|NCT02486653|157521245|FG000|Overall Study|Withdrawal by Subject|1|||
48914138|NCT02486653|157521246|FG001|Overall Study|Withdrawal by Subject|3|||
48914139|NCT02486653|157521245|FG000|Overall Study|Protocol Violation|1|||
48802640|NCT00682643|157117851|FG000|Overall Study|Withdrawal by Subject|19|||
48914140|NCT02486653|157521246|FG001|Overall Study|Protocol Violation|0|||
48914141|NCT02486653|157521245|FG000|Overall Study|surgery cancelled|4|||
48914142|NCT02486653|157521246|FG001|Overall Study|surgery cancelled|1|||
48914143|NCT03044249|157521247|FG000|Overall Study|Adverse Event|4|||
48914144|NCT03044249|157521248|FG001|Overall Study|Adverse Event|9|||
48914145|NCT03044249|157521247|FG000|Overall Study|Lost to Follow-up|1|||
48914146|NCT03044249|157521248|FG001|Overall Study|Lost to Follow-up|0|||
48914147|NCT03044249|157521247|FG000|Overall Study|Non-compliance with Study Drug|1|||
48914148|NCT03044249|157521248|FG001|Overall Study|Non-compliance with Study Drug|0|||
48914149|NCT03044249|157521247|FG000|Overall Study|Study Terminated by Sponsor|2|||
48914150|NCT03044249|157521248|FG001|Overall Study|Study Terminated by Sponsor|0|||
48914151|NCT03044249|157521247|FG000|Overall Study|Withdrawal by Subject|2|||
48802641|NCT00682643|157117852|FG001|Overall Study|Withdrawal by Subject|53|||
48802642|NCT00682643|157117851|FG000|Overall Study|Did Not Receive Study Drug|1|||
48802643|NCT00682643|157117852|FG001|Overall Study|Did Not Receive Study Drug|1|||
48802644|NCT01875185|157117853|FG000|Overall Study|study was terminated|52|||
48802645|NCT01875185|157117854|FG001|Overall Study|study was terminated|48|||
48802646|NCT03403426|157117858|FG000|Overall Study|Death|1|||
48802647|NCT03403426|157117858|FG000|Overall Study|Lost to Follow-up|2|||
48802648|NCT00736489|157117860|FG000|Period 1|Lost to Follow-up|1|||
48914152|NCT03044249|157521248|FG001|Overall Study|Withdrawal by Subject|5|||
48914153|NCT01793142|157521249|FG000|Overall Study|Randomized not treated|7|||
48914154|NCT01378858|157521256|FG000|Overall Study|Withdrawal by Subject|4|||
48914155|NCT01378858|157521257|FG001|Overall Study|Withdrawal by Subject|4|||
48914156|NCT02554903|157521258|FG000|Overall Study|Death|1|||
48914157|NCT02554903|157521259|FG001|Overall Study|Death|1|||
48914158|NCT02554903|157521258|FG000|Overall Study|Physician Decision|2|||
48914159|NCT02554903|157521259|FG001|Overall Study|Physician Decision|2|||
48914160|NCT02554903|157521258|FG000|Overall Study|Heart Transplant|1|||
48914161|NCT02554903|157521259|FG001|Overall Study|Heart Transplant|2|||
48914162|NCT02700997|157521260|FG000|Overall Study|Did not undergo CT imaging|1|||
48914163|NCT02700997|157521260|FG000|Overall Study|No CT measurement - pelvic calcification|1|||
48914164|NCT04126083|157521261|FG000|Overall Study|Withdrawal by Subject|1|||
48914165|NCT01015768|157521262|FG000|Overall Study|Some subject data unuseable|4|||
48914166|NCT01015768|157521263|FG001|Overall Study|Some subject data unuseable|4|||
48914167|NCT00754793|157521264|FG000|Overall Study|voluntary withdrawn from study|0|||
48914168|NCT00754793|157521265|FG001|Overall Study|voluntary withdrawn from study|1|||
48914169|NCT01225731|157521266|FG000|Part 1|Did not meet eligibility criteria|1|||
48914170|NCT01225731|157521267|FG001|Part 1|Did not meet eligibility criteria|0|||
48914171|NCT01225731|157521268|FG002|Part 1|Did not meet eligibility criteria|0|||
48914172|NCT01225731|157521269|FG003|Part 1|Did not meet eligibility criteria|0|||
48914173|NCT01225731|157521270|FG004|Part 1|Did not meet eligibility criteria|1|||
48914174|NCT01225731|157521271|FG005|Part 1|Did not meet eligibility criteria|0|||
48914175|NCT01225731|157521272|FG006|Part 1|Did not meet eligibility criteria|0|||
48914176|NCT01225731|157521273|FG007|Part 1|Did not meet eligibility criteria|0|||
48914177|NCT01225731|157521274|FG008|Part 1|Did not meet eligibility criteria|0|||
48914178|NCT01225731|157521275|FG009|Part 1|Did not meet eligibility criteria|0|||
48914179|NCT01225731|157521276|FG010|Part 1|Did not meet eligibility criteria|0|||
48914180|NCT01225731|157521277|FG011|Part 1|Did not meet eligibility criteria|0|||
48914181|NCT01225731|157521278|FG012|Part 1|Did not meet eligibility criteria|0|||
48914182|NCT01225731|157521266|FG000|Part 1|Adverse Event|1|||
48914183|NCT01225731|157521267|FG001|Part 1|Adverse Event|2|||
48914184|NCT01225731|157521268|FG002|Part 1|Adverse Event|1|||
48914185|NCT01225731|157521269|FG003|Part 1|Adverse Event|1|||
48914186|NCT01225731|157521270|FG004|Part 1|Adverse Event|1|||
48914187|NCT01225731|157521271|FG005|Part 1|Adverse Event|0|||
48914188|NCT01225731|157521272|FG006|Part 1|Adverse Event|0|||
48802649|NCT00736489|157117861|FG001|Period 1|Lost to Follow-up|0|||
48802650|NCT00736489|157117862|FG002|Period 1|Lost to Follow-up|0|||
48802651|NCT00736489|157117863|FG003|Period 1|Lost to Follow-up|0|||
48802652|NCT00736489|157117864|FG004|Period 1|Lost to Follow-up|0|||
48802653|NCT00736489|157117865|FG005|Period 1|Lost to Follow-up|0|||
48802654|NCT00736489|157117860|FG000|Period 1|Withdrawal by Subject|0|||
48802655|NCT00736489|157117861|FG001|Period 1|Withdrawal by Subject|0|||
48802656|NCT00736489|157117862|FG002|Period 1|Withdrawal by Subject|0|||
48802657|NCT00736489|157117863|FG003|Period 1|Withdrawal by Subject|0|||
48802658|NCT00736489|157117864|FG004|Period 1|Withdrawal by Subject|0|||
48802659|NCT00736489|157117865|FG005|Period 1|Withdrawal by Subject|1|||
48914189|NCT01225731|157521273|FG007|Part 1|Adverse Event|0|||
48914190|NCT01225731|157521274|FG008|Part 1|Adverse Event|0|||
48914191|NCT01225731|157521275|FG009|Part 1|Adverse Event|0|||
48914192|NCT01225731|157521276|FG010|Part 1|Adverse Event|0|||
48914193|NCT01225731|157521277|FG011|Part 1|Adverse Event|0|||
48914194|NCT01225731|157521278|FG012|Part 1|Adverse Event|0|||
48802660|NCT03995784|157117866|FG000|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1|||
48802661|NCT00941798|157117867|FG000|Overall Study|Withdrawal by Subject|72|||
48802662|NCT00941798|157117868|FG001|Overall Study|Withdrawal by Subject|74|||
48802663|NCT00941798|157117867|FG000|Overall Study|Adverse Event|43|||
48914195|NCT01225731|157521266|FG000|Part 1|Withdrawal by Subject|0|||
48914196|NCT01225731|157521267|FG001|Part 1|Withdrawal by Subject|3|||
48914197|NCT01225731|157521268|FG002|Part 1|Withdrawal by Subject|0|||
48914198|NCT01225731|157521269|FG003|Part 1|Withdrawal by Subject|0|||
48914199|NCT01225731|157521270|FG004|Part 1|Withdrawal by Subject|4|||
48914200|NCT01225731|157521271|FG005|Part 1|Withdrawal by Subject|0|||
48914201|NCT01225731|157521272|FG006|Part 1|Withdrawal by Subject|0|||
48914202|NCT01225731|157521273|FG007|Part 1|Withdrawal by Subject|0|||
48914203|NCT01225731|157521274|FG008|Part 1|Withdrawal by Subject|0|||
48914204|NCT01225731|157521275|FG009|Part 1|Withdrawal by Subject|0|||
48914205|NCT01225731|157521276|FG010|Part 1|Withdrawal by Subject|0|||
48914206|NCT01225731|157521277|FG011|Part 1|Withdrawal by Subject|0|||
48914207|NCT01225731|157521278|FG012|Part 1|Withdrawal by Subject|0|||
48914208|NCT01225731|157521266|FG000|Part 1|Protocol Violation|0|||
48914209|NCT01225731|157521267|FG001|Part 1|Protocol Violation|0|||
48914210|NCT01225731|157521268|FG002|Part 1|Protocol Violation|0|||
48914211|NCT01225731|157521269|FG003|Part 1|Protocol Violation|1|||
48914212|NCT01225731|157521270|FG004|Part 1|Protocol Violation|0|||
48914213|NCT01225731|157521271|FG005|Part 1|Protocol Violation|0|||
48914214|NCT01225731|157521272|FG006|Part 1|Protocol Violation|0|||
48914215|NCT01225731|157521273|FG007|Part 1|Protocol Violation|0|||
48914216|NCT01225731|157521274|FG008|Part 1|Protocol Violation|0|||
48914217|NCT01225731|157521275|FG009|Part 1|Protocol Violation|0|||
48914218|NCT01225731|157521276|FG010|Part 1|Protocol Violation|0|||
48914219|NCT01225731|157521277|FG011|Part 1|Protocol Violation|0|||
48914220|NCT01225731|157521278|FG012|Part 1|Protocol Violation|0|||
48914221|NCT01225731|157521266|FG000|Part 2|Protocol Violation|0|||
48914222|NCT01225731|157521267|FG001|Part 2|Protocol Violation|0|||
48914223|NCT01225731|157521268|FG002|Part 2|Protocol Violation|0|||
48914224|NCT01225731|157521269|FG003|Part 2|Protocol Violation|0|||
48914225|NCT01225731|157521270|FG004|Part 2|Protocol Violation|0|||
48914226|NCT01225731|157521271|FG005|Part 2|Protocol Violation|1|||
48914227|NCT01225731|157521272|FG006|Part 2|Protocol Violation|0|||
48914228|NCT01225731|157521273|FG007|Part 2|Protocol Violation|0|||
48914229|NCT01225731|157521274|FG008|Part 2|Protocol Violation|1|||
48914230|NCT01225731|157521275|FG009|Part 2|Protocol Violation|0|||
48914231|NCT01225731|157521276|FG010|Part 2|Protocol Violation|0|||
48914232|NCT01225731|157521277|FG011|Part 2|Protocol Violation|0|||
48914233|NCT01225731|157521278|FG012|Part 2|Protocol Violation|0|||
48914234|NCT01225731|157521266|FG000|Part 2|Adverse Event|0|||
48914235|NCT01225731|157521267|FG001|Part 2|Adverse Event|0|||
48914236|NCT01225731|157521268|FG002|Part 2|Adverse Event|0|||
48914237|NCT01225731|157521269|FG003|Part 2|Adverse Event|0|||
48914238|NCT01225731|157521270|FG004|Part 2|Adverse Event|0|||
48914239|NCT01225731|157521271|FG005|Part 2|Adverse Event|0|||
48914240|NCT01225731|157521272|FG006|Part 2|Adverse Event|4|||
48914241|NCT01225731|157521273|FG007|Part 2|Adverse Event|4|||
48914242|NCT01225731|157521274|FG008|Part 2|Adverse Event|2|||
48914243|NCT01225731|157521275|FG009|Part 2|Adverse Event|0|||
48914244|NCT01225731|157521276|FG010|Part 2|Adverse Event|0|||
48914245|NCT01225731|157521277|FG011|Part 2|Adverse Event|0|||
48914246|NCT01225731|157521278|FG012|Part 2|Adverse Event|0|||
48914247|NCT01225731|157521266|FG000|Part 2|Lack of Efficacy|0|||
48914248|NCT01225731|157521267|FG001|Part 2|Lack of Efficacy|0|||
48914249|NCT01225731|157521268|FG002|Part 2|Lack of Efficacy|0|||
48914250|NCT01225731|157521269|FG003|Part 2|Lack of Efficacy|0|||
48914251|NCT01225731|157521270|FG004|Part 2|Lack of Efficacy|0|||
48802664|NCT00941798|157117868|FG001|Overall Study|Adverse Event|23|||
48914252|NCT01225731|157521271|FG005|Part 2|Lack of Efficacy|1|||
48914253|NCT01225731|157521272|FG006|Part 2|Lack of Efficacy|0|||
48914254|NCT01225731|157521273|FG007|Part 2|Lack of Efficacy|12|||
48914255|NCT01225731|157521274|FG008|Part 2|Lack of Efficacy|3|||
48914256|NCT01225731|157521275|FG009|Part 2|Lack of Efficacy|0|||
48914257|NCT01225731|157521276|FG010|Part 2|Lack of Efficacy|0|||
48914258|NCT01225731|157521277|FG011|Part 2|Lack of Efficacy|0|||
48914259|NCT01225731|157521278|FG012|Part 2|Lack of Efficacy|0|||
48914260|NCT01225731|157521266|FG000|Part 2|Pregnancy|0|||
48914261|NCT01225731|157521267|FG001|Part 2|Pregnancy|0|||
48914262|NCT01225731|157521268|FG002|Part 2|Pregnancy|0|||
48914263|NCT01225731|157521269|FG003|Part 2|Pregnancy|0|||
48914264|NCT01225731|157521270|FG004|Part 2|Pregnancy|0|||
48914265|NCT01225731|157521271|FG005|Part 2|Pregnancy|0|||
48914266|NCT01225731|157521272|FG006|Part 2|Pregnancy|1|||
48914267|NCT01225731|157521273|FG007|Part 2|Pregnancy|0|||
48914268|NCT01225731|157521274|FG008|Part 2|Pregnancy|1|||
48802665|NCT00941798|157117867|FG000|Overall Study|Lost to Follow-up|29|||
48802666|NCT00941798|157117868|FG001|Overall Study|Lost to Follow-up|23|||
48914269|NCT01225731|157521275|FG009|Part 2|Pregnancy|0|||
48914270|NCT01225731|157521276|FG010|Part 2|Pregnancy|0|||
48914271|NCT01225731|157521277|FG011|Part 2|Pregnancy|0|||
48914272|NCT01225731|157521278|FG012|Part 2|Pregnancy|0|||
48914273|NCT01225731|157521266|FG000|Part 2|Lost to Follow-up|0|||
48914274|NCT01225731|157521267|FG001|Part 2|Lost to Follow-up|0|||
48914275|NCT01225731|157521268|FG002|Part 2|Lost to Follow-up|0|||
48914276|NCT01225731|157521269|FG003|Part 2|Lost to Follow-up|0|||
48914277|NCT01225731|157521270|FG004|Part 2|Lost to Follow-up|0|||
48914278|NCT01225731|157521271|FG005|Part 2|Lost to Follow-up|0|||
48914279|NCT01225731|157521272|FG006|Part 2|Lost to Follow-up|0|||
48708112|NCT03070964|156779112|FG000|Overall Study|Withdrawal by Subject|1|||
48708113|NCT03070964|156779112|FG000|Overall Study|Adverse Event|1|||
48708114|NCT00467753|156779115|FG000|Overall Study|Lost to Follow-up|1|||
48708115|NCT00467753|156779116|FG001|Overall Study|Lost to Follow-up|2|||
48708116|NCT00467753|156779115|FG000|Overall Study|Adverse Event|2|||
48708117|NCT00467753|156779116|FG001|Overall Study|Adverse Event|0|||
48708118|NCT03530124|156779117|FG000|Overall Study|Withdrawal by Subject|0|||
48708119|NCT03530124|156779118|FG001|Overall Study|Withdrawal by Subject|1|||
48708120|NCT03530124|156779117|FG000|Overall Study|Protocol Violation|1|||
48708121|NCT03530124|156779118|FG001|Overall Study|Protocol Violation|0|||
48708122|NCT03530124|156779117|FG000|Overall Study|Discharged prior to study completion|1|||
48708123|NCT03530124|156779118|FG001|Overall Study|Discharged prior to study completion|0|||
48708124|NCT02175030|156779119|FG000|Overall Study|Failed screen after consent|7|||
48708125|NCT02175030|156779120|FG001|Overall Study|Failed screen after consent|6|||
48708126|NCT02175030|156779119|FG000|Overall Study|Failed IUD Insertion|20|||
48708127|NCT02175030|156779120|FG001|Overall Study|Failed IUD Insertion|21|||
48708128|NCT02175030|156779119|FG000|Overall Study|Physician Decision|1|||
48708129|NCT02175030|156779120|FG001|Overall Study|Physician Decision|1|||
48708130|NCT02175030|156779119|FG000|Overall Study|Lost to Follow-up|6|||
48708131|NCT02175030|156779120|FG001|Overall Study|Lost to Follow-up|6|||
48708132|NCT02175030|156779119|FG000|Overall Study|Withdrawal by Subject|1|||
48708133|NCT02175030|156779120|FG001|Overall Study|Withdrawal by Subject|4|||
48802667|NCT00941798|157117867|FG000|Overall Study|Protocol Violation|17|||
48802668|NCT00941798|157117868|FG001|Overall Study|Protocol Violation|20|||
48802669|NCT00941798|157117867|FG000|Overall Study|Administrative problems|13|||
48802670|NCT00941798|157117868|FG001|Overall Study|Administrative problems|23|||
48802671|NCT00941798|157117867|FG000|Overall Study|Lack of Efficacy|10|||
48802672|NCT00941798|157117868|FG001|Overall Study|Lack of Efficacy|17|||
48802673|NCT00941798|157117867|FG000|Overall Study|Patient's inability to use device|6|||
48802674|NCT00941798|157117868|FG001|Overall Study|Patient's inability to use device|1|||
48802675|NCT00941798|157117867|FG000|Overall Study|Abnormal test procedure results|3|||
48802676|NCT00941798|157117868|FG001|Overall Study|Abnormal test procedure results|1|||
48802677|NCT00941798|157117867|FG000|Overall Study|Abnormal laboratory values|1|||
48802678|NCT00941798|157117868|FG001|Overall Study|Abnormal laboratory values|2|||
48802679|NCT00941798|157117867|FG000|Overall Study|Death|0|||
48802680|NCT00941798|157117868|FG001|Overall Study|Death|1|||
48802681|NCT02395133|157117869|FG000|Overall Study|Adverse Event|4|||
48802682|NCT02395133|157117870|FG001|Overall Study|Adverse Event|1|||
48802683|NCT02395133|157117871|FG002|Overall Study|Adverse Event|3|||
48802684|NCT02395133|157117872|FG003|Overall Study|Adverse Event|0|||
48802685|NCT02395133|157117869|FG000|Overall Study|Lack of Efficacy|1|||
48802686|NCT02395133|157117870|FG001|Overall Study|Lack of Efficacy|0|||
48802687|NCT02395133|157117871|FG002|Overall Study|Lack of Efficacy|1|||
48802688|NCT02395133|157117872|FG003|Overall Study|Lack of Efficacy|1|||
48802689|NCT02395133|157117869|FG000|Overall Study|Protocol Violation|1|||
48802690|NCT02395133|157117870|FG001|Overall Study|Protocol Violation|1|||
48802691|NCT02395133|157117871|FG002|Overall Study|Protocol Violation|0|||
48802692|NCT02395133|157117872|FG003|Overall Study|Protocol Violation|3|||
48802693|NCT02395133|157117869|FG000|Overall Study|Lost to Follow-up|0|||
48802694|NCT02395133|157117870|FG001|Overall Study|Lost to Follow-up|1|||
48802695|NCT02395133|157117871|FG002|Overall Study|Lost to Follow-up|1|||
48802696|NCT02395133|157117872|FG003|Overall Study|Lost to Follow-up|0|||
48802697|NCT02395133|157117869|FG000|Overall Study|Pregnancy|0|||
48802698|NCT02395133|157117870|FG001|Overall Study|Pregnancy|0|||
48802699|NCT02395133|157117871|FG002|Overall Study|Pregnancy|3|||
48802700|NCT02395133|157117872|FG003|Overall Study|Pregnancy|0|||
48802701|NCT02395133|157117869|FG000|Overall Study|Consent withdrawn with no reason given|1|||
48802702|NCT02395133|157117870|FG001|Overall Study|Consent withdrawn with no reason given|3|||
48802703|NCT02395133|157117871|FG002|Overall Study|Consent withdrawn with no reason given|0|||
48802704|NCT02395133|157117872|FG003|Overall Study|Consent withdrawn with no reason given|2|||
48802705|NCT02395133|157117869|FG000|Overall Study|Consent withdrawn with personal reason|0|||
48802706|NCT02395133|157117870|FG001|Overall Study|Consent withdrawn with personal reason|1|||
48914280|NCT01225731|157521273|FG007|Part 2|Lost to Follow-up|3|||
48914281|NCT01225731|157521274|FG008|Part 2|Lost to Follow-up|1|||
48708134|NCT01583296|156779121|FG000|Overall Study|Withdrawal by Subject|11|||
48708135|NCT01583296|156779122|FG001|Overall Study|Withdrawal by Subject|10|||
48802707|NCT02395133|157117871|FG002|Overall Study|Consent withdrawn with personal reason|0|||
48802708|NCT02395133|157117872|FG003|Overall Study|Consent withdrawn with personal reason|3|||
48802709|NCT02395133|157117869|FG000|Overall Study|Sponsor decision|2|||
48802710|NCT02395133|157117870|FG001|Overall Study|Sponsor decision|0|||
48802711|NCT02395133|157117871|FG002|Overall Study|Sponsor decision|0|||
48802712|NCT02395133|157117872|FG003|Overall Study|Sponsor decision|1|||
48802713|NCT02395133|157117869|FG000|Overall Study|Other than specified above|5|||
48802714|NCT02395133|157117870|FG001|Overall Study|Other than specified above|2|||
48802715|NCT02395133|157117871|FG002|Overall Study|Other than specified above|2|||
48802716|NCT02395133|157117872|FG003|Overall Study|Other than specified above|4|||
48802717|NCT00539279|157117882|FG000|Treatment|Withdrawal by Subject|10|||
48914282|NCT01225731|157521275|FG009|Part 2|Lost to Follow-up|0|||
48914283|NCT01225731|157521276|FG010|Part 2|Lost to Follow-up|0|||
48914284|NCT01225731|157521277|FG011|Part 2|Lost to Follow-up|0|||
48914285|NCT01225731|157521278|FG012|Part 2|Lost to Follow-up|0|||
48914286|NCT01225731|157521266|FG000|Part 2|Physician Decision|0|||
48914287|NCT01225731|157521267|FG001|Part 2|Physician Decision|0|||
48914288|NCT01225731|157521268|FG002|Part 2|Physician Decision|0|||
48914289|NCT01225731|157521269|FG003|Part 2|Physician Decision|0|||
48914290|NCT01225731|157521270|FG004|Part 2|Physician Decision|0|||
48914291|NCT01225731|157521271|FG005|Part 2|Physician Decision|0|||
48914292|NCT01225731|157521272|FG006|Part 2|Physician Decision|0|||
48914293|NCT01225731|157521273|FG007|Part 2|Physician Decision|2|||
48914294|NCT01225731|157521274|FG008|Part 2|Physician Decision|2|||
48914295|NCT01225731|157521275|FG009|Part 2|Physician Decision|0|||
48914296|NCT01225731|157521276|FG010|Part 2|Physician Decision|0|||
48914297|NCT01225731|157521277|FG011|Part 2|Physician Decision|0|||
48914298|NCT01225731|157521278|FG012|Part 2|Physician Decision|0|||
48914299|NCT01225731|157521266|FG000|Part 2|Withdrawal by Subject|0|||
48914300|NCT01225731|157521267|FG001|Part 2|Withdrawal by Subject|0|||
48914301|NCT01225731|157521268|FG002|Part 2|Withdrawal by Subject|0|||
48914302|NCT01225731|157521269|FG003|Part 2|Withdrawal by Subject|0|||
48914303|NCT01225731|157521270|FG004|Part 2|Withdrawal by Subject|0|||
48914304|NCT01225731|157521271|FG005|Part 2|Withdrawal by Subject|1|||
48914305|NCT01225731|157521272|FG006|Part 2|Withdrawal by Subject|3|||
48914306|NCT01225731|157521273|FG007|Part 2|Withdrawal by Subject|4|||
48914307|NCT01225731|157521274|FG008|Part 2|Withdrawal by Subject|1|||
48914308|NCT01225731|157521275|FG009|Part 2|Withdrawal by Subject|0|||
48914309|NCT01225731|157521276|FG010|Part 2|Withdrawal by Subject|0|||
48914310|NCT01225731|157521277|FG011|Part 2|Withdrawal by Subject|0|||
48914311|NCT01225731|157521278|FG012|Part 2|Withdrawal by Subject|0|||
48914312|NCT01225731|157521266|FG000|Part 3|Adverse Event|0|||
48914313|NCT01225731|157521267|FG001|Part 3|Adverse Event|0|||
48914314|NCT01225731|157521268|FG002|Part 3|Adverse Event|0|||
48914315|NCT01225731|157521269|FG003|Part 3|Adverse Event|0|||
48914316|NCT01225731|157521270|FG004|Part 3|Adverse Event|0|||
48914317|NCT01225731|157521271|FG005|Part 3|Adverse Event|0|||
48914318|NCT01225731|157521272|FG006|Part 3|Adverse Event|0|||
48914319|NCT01225731|157521273|FG007|Part 3|Adverse Event|0|||
48914320|NCT01225731|157521274|FG008|Part 3|Adverse Event|0|||
48914321|NCT01225731|157521275|FG009|Part 3|Adverse Event|0|||
48914322|NCT01225731|157521276|FG010|Part 3|Adverse Event|1|||
48914323|NCT01225731|157521277|FG011|Part 3|Adverse Event|1|||
48914324|NCT01225731|157521278|FG012|Part 3|Adverse Event|0|||
48914325|NCT01225731|157521266|FG000|Part 3|Lost to Follow-up|0|||
48914326|NCT01225731|157521267|FG001|Part 3|Lost to Follow-up|0|||
48914327|NCT01225731|157521268|FG002|Part 3|Lost to Follow-up|0|||
48914328|NCT01225731|157521269|FG003|Part 3|Lost to Follow-up|0|||
48914329|NCT01225731|157521270|FG004|Part 3|Lost to Follow-up|0|||
48914330|NCT01225731|157521271|FG005|Part 3|Lost to Follow-up|0|||
48914331|NCT01225731|157521272|FG006|Part 3|Lost to Follow-up|0|||
49118963|NCT03518086|158273274|FG002|Overall Study|Insufficient Diary Data|0|||
49118964|NCT03518086|158273275|FG003|Overall Study|Insufficient Diary Data|0|||
49118965|NCT03518086|158273272|FG000|Overall Study|Non- compliance to Protocol|0|||
49118966|NCT03518086|158273273|FG001|Overall Study|Non- compliance to Protocol|1|||
49118967|NCT03518086|158273274|FG002|Overall Study|Non- compliance to Protocol|0|||
49118968|NCT03518086|158273275|FG003|Overall Study|Non- compliance to Protocol|0|||
49118969|NCT03518086|158273272|FG000|Overall Study|COVID-19 Related Study Disruption|0|||
49118970|NCT03518086|158273273|FG001|Overall Study|COVID-19 Related Study Disruption|2|||
49118971|NCT03518086|158273274|FG002|Overall Study|COVID-19 Related Study Disruption|0|||
49118972|NCT03518086|158273275|FG003|Overall Study|COVID-19 Related Study Disruption|0|||
49118973|NCT03518086|158273272|FG000|Overall Study|Site Terminated by Sponsor|0|||
49118974|NCT03518086|158273273|FG001|Overall Study|Site Terminated by Sponsor|1|||
49118975|NCT03518086|158273274|FG002|Overall Study|Site Terminated by Sponsor|0|||
49118976|NCT03518086|158273275|FG003|Overall Study|Site Terminated by Sponsor|0|||
48914332|NCT01225731|157521273|FG007|Part 3|Lost to Follow-up|0|||
48914333|NCT01225731|157521274|FG008|Part 3|Lost to Follow-up|0|||
48914334|NCT01225731|157521275|FG009|Part 3|Lost to Follow-up|0|||
48914335|NCT01225731|157521276|FG010|Part 3|Lost to Follow-up|1|||
48914336|NCT01225731|157521277|FG011|Part 3|Lost to Follow-up|2|||
48914337|NCT01225731|157521278|FG012|Part 3|Lost to Follow-up|1|||
48914338|NCT01225731|157521266|FG000|Part 3|Physician Decision|0|||
49118977|NCT03560869|158273276|FG000|Overall Study|Withdrawal by Subject|3|||
49118978|NCT03560869|158273277|FG001|Overall Study|Withdrawal by Subject|4|||
48914339|NCT01225731|157521267|FG001|Part 3|Physician Decision|0|||
48914340|NCT01225731|157521268|FG002|Part 3|Physician Decision|0|||
48914341|NCT01225731|157521269|FG003|Part 3|Physician Decision|0|||
48914342|NCT01225731|157521270|FG004|Part 3|Physician Decision|0|||
48914343|NCT01225731|157521271|FG005|Part 3|Physician Decision|0|||
48914344|NCT01225731|157521272|FG006|Part 3|Physician Decision|0|||
48914345|NCT01225731|157521273|FG007|Part 3|Physician Decision|0|||
48914346|NCT01225731|157521274|FG008|Part 3|Physician Decision|0|||
48914347|NCT01225731|157521275|FG009|Part 3|Physician Decision|0|||
48914348|NCT01225731|157521276|FG010|Part 3|Physician Decision|0|||
48914349|NCT01225731|157521277|FG011|Part 3|Physician Decision|1|||
48802718|NCT00539279|157117883|FG001|Treatment|Withdrawal by Subject|8|||
48802719|NCT00539279|157117882|FG000|Treatment|Death|1|||
48802720|NCT00539279|157117883|FG001|Treatment|Death|0|||
48802721|NCT00539279|157117882|FG000|Post-Treatment Assessment|Lost to Follow-up|12|||
48802722|NCT00539279|157117883|FG001|Post-Treatment Assessment|Lost to Follow-up|9|||
48802723|NCT00539279|157117882|FG000|6-Month Follow-Up Assessment|Lost to Follow-up|1|||
48802724|NCT00539279|157117883|FG001|6-Month Follow-Up Assessment|Lost to Follow-up|7|||
48802725|NCT03315130|157117884|FG000|Main Portion (12 Weeks)|Subject withdrew consent|0|||
48802726|NCT03315130|157117885|FG001|Main Portion (12 Weeks)|Subject withdrew consent|1|||
48802727|NCT03315130|157117886|FG002|Main Portion (12 Weeks)|Subject withdrew consent|0|||
48802728|NCT03315130|157117887|FG003|Main Portion (12 Weeks)|Subject withdrew consent|0|||
48802729|NCT03315130|157117884|FG000|Main Portion (12 Weeks)|Lost to Follow-up|0|||
48802730|NCT03315130|157117885|FG001|Main Portion (12 Weeks)|Lost to Follow-up|1|||
48802731|NCT03315130|157117886|FG002|Main Portion (12 Weeks)|Lost to Follow-up|0|||
48802732|NCT03315130|157117887|FG003|Main Portion (12 Weeks)|Lost to Follow-up|0|||
48802733|NCT03315130|157117884|FG000|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|1|||
48802734|NCT03315130|157117885|FG001|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
48802735|NCT03315130|157117886|FG002|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
48802736|NCT03315130|157117887|FG003|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
48802737|NCT03315130|157117884|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
48802738|NCT03315130|157117885|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|1|||
48802739|NCT03315130|157117886|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
48802740|NCT03315130|157117887|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
48802741|NCT03315130|157117884|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
48802742|NCT03315130|157117885|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|1|||
48802743|NCT03315130|157117886|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
48802744|NCT03315130|157117887|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
48802745|NCT03315130|157117884|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
48802746|NCT03315130|157117885|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|2|||
48802747|NCT03315130|157117886|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
48802748|NCT03315130|157117887|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|1|||
48802749|NCT02532179|157119799|FG000|Overall Study|Lost to Follow-up|1|||
48802750|NCT02532179|157119799|FG000|Overall Study|Pregnancy|1|||
49118979|NCT03560869|158273276|FG000|Overall Study|Screening failure|4|||
49118980|NCT03560869|158273277|FG001|Overall Study|Screening failure|4|||
48708136|NCT03179319|156779123|FG000|Overall Study|Lost to Follow-up|6|||
48708137|NCT03179319|156779124|FG001|Overall Study|Lost to Follow-up|0|||
48708138|NCT00885534|156779130|FG000|Overall Study|Patient deemed ineligible|1|||
48708139|NCT02817464|156779131|FG000|Overall Study|Lost to Follow-up|1|||
48708140|NCT02817464|156779132|FG001|Overall Study|Lost to Follow-up|0|||
48802751|NCT02532179|157119799|FG000|Overall Study|Subject received depot steroid injection|1|||
48802752|NCT01712009|157119800|FG000|Overall Study|Withdrawal by Subject|24|||
48802753|NCT01712009|157119801|FG001|Overall Study|Withdrawal by Subject|15|||
48802754|NCT01712009|157119802|FG002|Overall Study|Withdrawal by Subject|8|||
48914350|NCT01225731|157521278|FG012|Part 3|Physician Decision|2|||
48708141|NCT02817464|156779131|FG000|Overall Study|Discontinued early due to personal decision|1|||
48708142|NCT02817464|156779132|FG001|Overall Study|Discontinued early due to personal decision|1|||
48708143|NCT00357903|156779134|FG000|Overall Study|Adverse Event|87|||
48708144|NCT00357903|156779135|FG001|Overall Study|Adverse Event|4|||
48708145|NCT00357903|156779134|FG000|Overall Study|Death|33|||
48708146|NCT00357903|156779135|FG001|Overall Study|Death|0|||
48708147|NCT00357903|156779134|FG000|Overall Study|Lost to Follow-up|23|||
48708148|NCT00357903|156779135|FG001|Overall Study|Lost to Follow-up|4|||
48708149|NCT00357903|156779134|FG000|Overall Study|Physician Decision|39|||
48708150|NCT00357903|156779135|FG001|Overall Study|Physician Decision|5|||
48708151|NCT00357903|156779134|FG000|Overall Study|Withdrawal by Subject|57|||
48708152|NCT00357903|156779135|FG001|Overall Study|Withdrawal by Subject|7|||
48708153|NCT00357903|156779134|FG000|Overall Study|Completed month 12 only|0|||
48708154|NCT00357903|156779135|FG001|Overall Study|Completed month 12 only|1|||
48708155|NCT00357903|156779134|FG000|Overall Study|Protocol issues|14|||
48708156|NCT00357903|156779135|FG001|Overall Study|Protocol issues|3|||
48708157|NCT00357903|156779134|FG000|Overall Study|Response status|61|||
48708158|NCT00357903|156779135|FG001|Overall Study|Response status|9|||
48708159|NCT00357903|156779134|FG000|Overall Study|Other|49|||
48708160|NCT00357903|156779135|FG001|Overall Study|Other|10|||
48708161|NCT00606593|156779136|FG000|Overall Study|Adverse Event|0|||
48708162|NCT00606593|156779137|FG001|Overall Study|Adverse Event|0|||
48802755|NCT01712009|157119800|FG000|Overall Study|Lost to Follow-up|2|||
48802756|NCT01712009|157119801|FG001|Overall Study|Lost to Follow-up|0|||
48802757|NCT01712009|157119802|FG002|Overall Study|Lost to Follow-up|1|||
48802758|NCT01712009|157119800|FG000|Overall Study|Decision by Sponsor|12|||
48802759|NCT01712009|157119801|FG001|Overall Study|Decision by Sponsor|14|||
48802760|NCT01712009|157119802|FG002|Overall Study|Decision by Sponsor|12|||
48802761|NCT02240108|157119803|FG000|Overall Study|Other than specified|8|||
48914351|NCT01225731|157521266|FG000|Part 3|Withdrawal by Subject|0|||
48914352|NCT01225731|157521267|FG001|Part 3|Withdrawal by Subject|0|||
48914353|NCT01225731|157521268|FG002|Part 3|Withdrawal by Subject|0|||
48914354|NCT01225731|157521269|FG003|Part 3|Withdrawal by Subject|0|||
48914355|NCT01225731|157521270|FG004|Part 3|Withdrawal by Subject|0|||
48914356|NCT01225731|157521271|FG005|Part 3|Withdrawal by Subject|0|||
48914357|NCT01225731|157521272|FG006|Part 3|Withdrawal by Subject|0|||
48914358|NCT01225731|157521273|FG007|Part 3|Withdrawal by Subject|0|||
48914359|NCT01225731|157521274|FG008|Part 3|Withdrawal by Subject|0|||
48914360|NCT01225731|157521275|FG009|Part 3|Withdrawal by Subject|0|||
48914361|NCT01225731|157521276|FG010|Part 3|Withdrawal by Subject|4|||
48914362|NCT01225731|157521277|FG011|Part 3|Withdrawal by Subject|6|||
49118981|NCT03560869|158273276|FG000|Overall Study|Withdrawal by PI|0|||
49118982|NCT03560869|158273277|FG001|Overall Study|Withdrawal by PI|1|||
48914363|NCT01225731|157521278|FG012|Part 3|Withdrawal by Subject|4|||
48914364|NCT01147744|157521279|FG000|Overall Study|Protocol Violation|1|||
48914365|NCT01147744|157521280|FG001|Overall Study|Protocol Violation|0|||
48914366|NCT01147744|157521281|FG002|Overall Study|Protocol Violation|1|||
48914367|NCT01147744|157521282|FG003|Overall Study|Protocol Violation|0|||
48914368|NCT01147744|157521283|FG004|Overall Study|Protocol Violation|1|||
48914369|NCT01147744|157521284|FG005|Overall Study|Protocol Violation|3|||
48914370|NCT01147744|157521285|FG006|Overall Study|Protocol Violation|1|||
48914371|NCT01147744|157521279|FG000|Overall Study|Physician Decision|0|||
48914372|NCT01147744|157521280|FG001|Overall Study|Physician Decision|1|||
48914373|NCT01147744|157521281|FG002|Overall Study|Physician Decision|1|||
48914374|NCT01147744|157521282|FG003|Overall Study|Physician Decision|0|||
48914375|NCT01147744|157521283|FG004|Overall Study|Physician Decision|0|||
48914376|NCT01147744|157521284|FG005|Overall Study|Physician Decision|0|||
48914377|NCT01147744|157521285|FG006|Overall Study|Physician Decision|1|||
48914378|NCT01147744|157521279|FG000|Overall Study|Lack of Efficacy|11|||
49118983|NCT01395810|158273280|FG000|Overall Study|Adverse Event|0|||
48708163|NCT00606593|156779138|FG002|Overall Study|Adverse Event|0|||
48708164|NCT00606593|156779139|FG003|Overall Study|Adverse Event|1|||
48708165|NCT00606593|156779140|FG004|Overall Study|Adverse Event|1|||
48708166|NCT00606593|156779141|FG005|Overall Study|Adverse Event|0|||
48708167|NCT00606593|156779142|FG006|Overall Study|Adverse Event|1|||
48708168|NCT00606593|156779143|FG007|Overall Study|Adverse Event|2|||
48708169|NCT00606593|156779144|FG008|Overall Study|Adverse Event|1|||
48708170|NCT00606593|156779145|FG009|Overall Study|Adverse Event|0|||
48708171|NCT00606593|156779136|FG000|Overall Study|Withdrawal of consent|1|||
48708172|NCT00606593|156779137|FG001|Overall Study|Withdrawal of consent|0|||
48708173|NCT00606593|156779138|FG002|Overall Study|Withdrawal of consent|1|||
48708174|NCT00606593|156779139|FG003|Overall Study|Withdrawal of consent|0|||
48708175|NCT00606593|156779140|FG004|Overall Study|Withdrawal of consent|0|||
48708176|NCT00606593|156779141|FG005|Overall Study|Withdrawal of consent|0|||
48708177|NCT00606593|156779142|FG006|Overall Study|Withdrawal of consent|0|||
48708178|NCT00606593|156779143|FG007|Overall Study|Withdrawal of consent|0|||
48708179|NCT00606593|156779144|FG008|Overall Study|Withdrawal of consent|0|||
48708180|NCT00606593|156779145|FG009|Overall Study|Withdrawal of consent|0|||
48708181|NCT00606593|156779136|FG000|Overall Study|Administrative/Other|0|||
48708182|NCT00606593|156779137|FG001|Overall Study|Administrative/Other|0|||
48708183|NCT00606593|156779138|FG002|Overall Study|Administrative/Other|1|||
48708184|NCT00606593|156779139|FG003|Overall Study|Administrative/Other|0|||
48708185|NCT00606593|156779140|FG004|Overall Study|Administrative/Other|0|||
48708186|NCT00606593|156779141|FG005|Overall Study|Administrative/Other|0|||
48708187|NCT00606593|156779142|FG006|Overall Study|Administrative/Other|0|||
48708188|NCT00606593|156779143|FG007|Overall Study|Administrative/Other|0|||
48708189|NCT00606593|156779144|FG008|Overall Study|Administrative/Other|0|||
48708190|NCT00606593|156779145|FG009|Overall Study|Administrative/Other|0|||
48708191|NCT03695367|156779148|FG000|Overall Study|Missed the Day 28 visit.|1|||
48708192|NCT03695367|156779149|FG001|Overall Study|Missed the Day 28 visit.|0|||
48708193|NCT03695367|156779148|FG000|Overall Study|Lost to Follow-up|0|||
48708194|NCT03695367|156779149|FG001|Overall Study|Lost to Follow-up|1|||
48708195|NCT03695367|156779148|FG000|Overall Study|Withdrawal by Subject|0|||
48708196|NCT03695367|156779149|FG001|Overall Study|Withdrawal by Subject|1|||
48708197|NCT03695367|156779148|FG000|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0|||
48708198|NCT03695367|156779149|FG001|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2|||
48708199|NCT00829504|156779150|FG000|First Intervention|Adverse Event|1|||
48708200|NCT00829504|156779151|FG001|First Intervention|Adverse Event|0|||
48708201|NCT00829504|156779150|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
48708202|NCT00829504|156779151|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
48708203|NCT00829504|156779150|FG000|Second Intervention|Physician Decision|1|||
48708204|NCT00829504|156779151|FG001|Second Intervention|Physician Decision|0|||
48708205|NCT00599339|156779152|FG000|Overall Study|Adverse Event|79|||
48708206|NCT00599339|156779152|FG000|Overall Study|Withdrawal by Subject|137|||
48708207|NCT00599339|156779152|FG000|Overall Study|Other Reason|179|||
48802762|NCT02240108|157119804|FG001|Overall Study|Other than specified|6|||
48802763|NCT02240108|157119803|FG000|Overall Study|Adverse Event|1|||
48802764|NCT02240108|157119804|FG001|Overall Study|Adverse Event|9|||
48802765|NCT02240108|157119803|FG000|Overall Study|Pregnancy|1|||
48802766|NCT02240108|157119804|FG001|Overall Study|Pregnancy|0|||
48802767|NCT02240108|157119803|FG000|Overall Study|Withdrawal by Subject|4|||
48802768|NCT02240108|157119804|FG001|Overall Study|Withdrawal by Subject|9|||
48802769|NCT02240108|157119803|FG000|Overall Study|StudyTerminated by Sponsor|0|||
48802770|NCT02240108|157119804|FG001|Overall Study|StudyTerminated by Sponsor|1|||
48914379|NCT01147744|157521280|FG001|Overall Study|Lack of Efficacy|11|||
48914380|NCT01147744|157521281|FG002|Overall Study|Lack of Efficacy|9|||
48802771|NCT01377480|157119805|FG000|Overall Study|Protocol Violation|0|||
48802772|NCT01377480|157119806|FG001|Overall Study|Protocol Violation|0|||
48802773|NCT01377480|157119807|FG002|Overall Study|Protocol Violation|0|||
48802774|NCT01377480|157119808|FG003|Overall Study|Protocol Violation|4|||
48802775|NCT01377480|157119805|FG000|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
48802776|NCT01377480|157119806|FG001|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
48802777|NCT01377480|157119807|FG002|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
48802778|NCT01377480|157119808|FG003|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
48802779|NCT01377480|157119805|FG000|Overall Study|Withdrawal by Subject|0|||
48802780|NCT01377480|157119806|FG001|Overall Study|Withdrawal by Subject|0|||
48802781|NCT01377480|157119807|FG002|Overall Study|Withdrawal by Subject|1|||
48802782|NCT01377480|157119808|FG003|Overall Study|Withdrawal by Subject|0|||
48802783|NCT01377480|157119805|FG000|Overall Study|Serious adverse event|0|||
48802784|NCT01377480|157119806|FG001|Overall Study|Serious adverse event|0|||
48802785|NCT01377480|157119807|FG002|Overall Study|Serious adverse event|1|||
48802786|NCT01377480|157119808|FG003|Overall Study|Serious adverse event|1|||
48802787|NCT01377480|157119805|FG000|Overall Study|Other|0|||
48802788|NCT01377480|157119806|FG001|Overall Study|Other|0|||
48802789|NCT01377480|157119807|FG002|Overall Study|Other|7|||
48802790|NCT01377480|157119808|FG003|Overall Study|Other|6|||
48802791|NCT00045708|157119809|FG000|Phase 1|early progressive disease|0|||
48802792|NCT00045708|157119810|FG001|Phase 1|early progressive disease|1|||
48802793|NCT00045708|157119811|FG002|Phase 1|early progressive disease|0|||
48802794|NCT01986881|157119820|FG000|Overall Study|Death|228|||
48802795|NCT01986881|157119821|FG001|Overall Study|Death|233|||
48802796|NCT01986881|157119822|FG002|Overall Study|Death|247|||
48802797|NCT01986881|157119820|FG000|Overall Study|Lost to Follow-up|51|||
48802798|NCT01986881|157119821|FG001|Overall Study|Lost to Follow-up|44|||
48802799|NCT01986881|157119822|FG002|Overall Study|Lost to Follow-up|55|||
48802800|NCT01986881|157119820|FG000|Overall Study|Physician Decision|7|||
48802801|NCT01986881|157119821|FG001|Overall Study|Physician Decision|4|||
48802802|NCT01986881|157119822|FG002|Overall Study|Physician Decision|6|||
48914381|NCT01147744|157521282|FG003|Overall Study|Lack of Efficacy|11|||
48802803|NCT01986881|157119820|FG000|Overall Study|Study Site Terminated by Sponsor|2|||
48802804|NCT01986881|157119821|FG001|Overall Study|Study Site Terminated by Sponsor|2|||
48802805|NCT01986881|157119822|FG002|Overall Study|Study Site Terminated by Sponsor|3|||
48802806|NCT01986881|157119820|FG000|Overall Study|Withdrawal by Subject|41|||
48802807|NCT01986881|157119821|FG001|Overall Study|Withdrawal by Subject|60|||
48802808|NCT01986881|157119822|FG002|Overall Study|Withdrawal by Subject|45|||
48802809|NCT01986881|157119820|FG000|Overall Study|Subject Moved|0|||
48914382|NCT01147744|157521283|FG004|Overall Study|Lack of Efficacy|13|||
48914383|NCT01147744|157521284|FG005|Overall Study|Lack of Efficacy|8|||
48914384|NCT01147744|157521285|FG006|Overall Study|Lack of Efficacy|7|||
48914385|NCT01147744|157521279|FG000|Overall Study|Adverse Event|1|||
48914386|NCT01147744|157521280|FG001|Overall Study|Adverse Event|2|||
48914387|NCT01147744|157521281|FG002|Overall Study|Adverse Event|3|||
48914388|NCT01147744|157521282|FG003|Overall Study|Adverse Event|0|||
48914389|NCT01147744|157521283|FG004|Overall Study|Adverse Event|2|||
48914390|NCT01147744|157521284|FG005|Overall Study|Adverse Event|1|||
48914391|NCT01147744|157521285|FG006|Overall Study|Adverse Event|2|||
48914392|NCT01147744|157521279|FG000|Overall Study|Withdrawal by Subject|8|||
48914393|NCT01147744|157521280|FG001|Overall Study|Withdrawal by Subject|4|||
48914394|NCT01147744|157521281|FG002|Overall Study|Withdrawal by Subject|2|||
48914395|NCT01147744|157521282|FG003|Overall Study|Withdrawal by Subject|2|||
48914396|NCT01147744|157521283|FG004|Overall Study|Withdrawal by Subject|2|||
48914397|NCT01147744|157521284|FG005|Overall Study|Withdrawal by Subject|5|||
48802810|NCT01986881|157119821|FG001|Overall Study|Subject Moved|1|||
48802811|NCT01986881|157119822|FG002|Overall Study|Subject Moved|0|||
48802812|NCT01986881|157119820|FG000|Overall Study|Other|1|||
48802813|NCT01986881|157119821|FG001|Overall Study|Other|2|||
48802814|NCT01986881|157119822|FG002|Overall Study|Other|2|||
48802815|NCT04128293|157119824|FG000|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
48802816|NCT04128293|157119825|FG001|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
48802817|NCT04128293|157119826|FG002|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
48802818|NCT04128293|157119827|FG003|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
48802819|NCT02259517|157119828|FG000|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
48914398|NCT01147744|157521285|FG006|Overall Study|Withdrawal by Subject|2|||
49118984|NCT01395810|158273281|FG001|Overall Study|Adverse Event|1|||
49118985|NCT01395810|158273282|FG002|Overall Study|Adverse Event|0|||
48914399|NCT01147744|157521279|FG000|Overall Study|Lost to Follow-up|0|||
48914400|NCT01147744|157521280|FG001|Overall Study|Lost to Follow-up|1|||
48802820|NCT02259517|157119829|FG001|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
48802821|NCT02259517|157119830|FG002|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|6|||
48802822|NCT02259517|157119828|FG000|Overall Study|Withdrawal by Subject|0|||
48802823|NCT02259517|157119829|FG001|Overall Study|Withdrawal by Subject|0|||
48802824|NCT02259517|157119830|FG002|Overall Study|Withdrawal by Subject|3|||
48802825|NCT00838682|157119835|FG000|Overall Study|Lost to Follow-up|21|||
48802826|NCT00838682|157119836|FG001|Overall Study|Lost to Follow-up|14|||
48802827|NCT00838682|157119835|FG000|Overall Study|detection of exclusion criteria|4|||
48802828|NCT00838682|157119836|FG001|Overall Study|detection of exclusion criteria|3|||
48802829|NCT00838682|157119835|FG000|Overall Study|Protocol Violation|0|||
48802830|NCT00838682|157119836|FG001|Overall Study|Protocol Violation|1|||
48802831|NCT00838682|157119835|FG000|Overall Study|Withdrawal by Subject|0|||
48802832|NCT00838682|157119836|FG001|Overall Study|Withdrawal by Subject|1|||
48802833|NCT00710606|157119837|FG000|Overall Study|Adverse Event|0|||
48802834|NCT00710606|157119838|FG001|Overall Study|Adverse Event|2|||
48802835|NCT03243422|157119853|FG000|Overall Study|Death|20|||
48802836|NCT03243422|157119854|FG001|Overall Study|Death|21|||
48802837|NCT03243422|157119853|FG000|Overall Study|Lost to Follow-up|9|||
48802838|NCT03243422|157119854|FG001|Overall Study|Lost to Follow-up|21|||
48802839|NCT03243422|157119853|FG000|Overall Study|Withdrawal by Subject|22|||
48802840|NCT03243422|157119854|FG001|Overall Study|Withdrawal by Subject|8|||
48802841|NCT00508404|157119855|FG000|Overall Study|Ongoing at Data Cut-off|12|||
48802842|NCT00508404|157119855|FG000|Overall Study|Adverse Event|2|||
48802843|NCT00508404|157119855|FG000|Overall Study|Death|16|||
48802844|NCT00508404|157119855|FG000|Overall Study|Physician Decision|2|||
48802845|NCT00508404|157119855|FG000|Overall Study|Withdrawal by Subject|3|||
48802846|NCT00508404|157119855|FG000|Overall Study|Protocol-specified Criteria|2|||
48802847|NCT00508404|157119855|FG000|Overall Study|Lost to Follow-up|2|||
48802848|NCT00508404|157119855|FG000|Overall Study|Other - Not Specified|3|||
48802849|NCT02799784|157119862|FG000|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
48802850|NCT02799784|157119863|FG001|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
48802851|NCT02799784|157119862|FG000|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5|||
48802852|NCT02799784|157119863|FG001|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0|||
48802853|NCT02799784|157119862|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0|||
48802854|NCT02799784|157119863|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1|||
48802855|NCT02799784|157119862|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1|||
48802856|NCT02799784|157119863|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0|||
48802857|NCT02799784|157119862|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0|||
48802858|NCT02799784|157119863|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1|||
48802859|NCT02799784|157119862|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0|||
48802860|NCT02799784|157119863|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1|||
48802861|NCT03988634|157119864|FG000|Double-Blind|Adverse Event|4|||
48802862|NCT03988634|157119865|FG001|Double-Blind|Adverse Event|0|||
48802863|NCT03988634|157119866|FG002|Double-Blind|Adverse Event|0|||
48802864|NCT03988634|157119864|FG000|Double-Blind|Death|18|||
48802865|NCT03988634|157119865|FG001|Double-Blind|Death|26|||
48802866|NCT03988634|157119866|FG002|Double-Blind|Death|0|||
48802867|NCT03988634|157119864|FG000|Double-Blind|Lost to Follow-up|6|||
48802868|NCT03988634|157119865|FG001|Double-Blind|Lost to Follow-up|7|||
48802869|NCT03988634|157119866|FG002|Double-Blind|Lost to Follow-up|0|||
48802870|NCT03988634|157119864|FG000|Double-Blind|Physician Decision|9|||
48802871|NCT03988634|157119865|FG001|Double-Blind|Physician Decision|5|||
48802872|NCT03988634|157119866|FG002|Double-Blind|Physician Decision|0|||
48802873|NCT03988634|157119864|FG000|Double-Blind|Subject decision|24|||
48802874|NCT03988634|157119865|FG001|Double-Blind|Subject decision|13|||
48802875|NCT03988634|157119866|FG002|Double-Blind|Subject decision|0|||
48802876|NCT03988634|157119864|FG000|Open-Label|Adverse Event|0|||
48802877|NCT03988634|157119865|FG001|Open-Label|Adverse Event|0|||
48802878|NCT03988634|157119866|FG002|Open-Label|Adverse Event|7|||
48802879|NCT03988634|157119864|FG000|Open-Label|Physician Decision|0|||
48802880|NCT03988634|157119865|FG001|Open-Label|Physician Decision|0|||
48802881|NCT03988634|157119866|FG002|Open-Label|Physician Decision|1|||
48802882|NCT03988634|157119864|FG000|Open-Label|Technical problems|0|||
49118986|NCT01395810|158273283|FG003|Overall Study|Adverse Event|0|||
48802883|NCT03988634|157119865|FG001|Open-Label|Technical problems|0|||
48802884|NCT03988634|157119866|FG002|Open-Label|Technical problems|1|||
48802885|NCT01226511|157119867|FG000|Acute Treatment Period|Adverse Event|7|||
48802886|NCT01226511|157119868|FG001|Acute Treatment Period|Adverse Event|6|||
48802887|NCT01226511|157119867|FG000|Acute Treatment Period|Lack of Efficacy|2|||
48802888|NCT01226511|157119868|FG001|Acute Treatment Period|Lack of Efficacy|1|||
48802889|NCT01226511|157119867|FG000|Acute Treatment Period|Lost to Follow-up|3|||
48802890|NCT01226511|157119868|FG001|Acute Treatment Period|Lost to Follow-up|6|||
49118987|NCT01395810|158273280|FG000|Overall Study|Lack of Efficacy|0|||
48914401|NCT01147744|157521281|FG002|Overall Study|Lost to Follow-up|0|||
48914402|NCT01147744|157521282|FG003|Overall Study|Lost to Follow-up|0|||
48914403|NCT01147744|157521283|FG004|Overall Study|Lost to Follow-up|0|||
48914404|NCT01147744|157521284|FG005|Overall Study|Lost to Follow-up|0|||
48914405|NCT01147744|157521285|FG006|Overall Study|Lost to Follow-up|0|||
48914406|NCT01147744|157521279|FG000|Overall Study|Sponsor decision to amend protocol|7|||
48914407|NCT01147744|157521280|FG001|Overall Study|Sponsor decision to amend protocol|4|||
48914408|NCT01147744|157521281|FG002|Overall Study|Sponsor decision to amend protocol|2|||
48914409|NCT01147744|157521282|FG003|Overall Study|Sponsor decision to amend protocol|5|||
48914410|NCT01147744|157521283|FG004|Overall Study|Sponsor decision to amend protocol|7|||
48914411|NCT01147744|157521284|FG005|Overall Study|Sponsor decision to amend protocol|2|||
48914412|NCT01147744|157521285|FG006|Overall Study|Sponsor decision to amend protocol|6|||
48914413|NCT01147744|157521279|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
48914414|NCT01147744|157521280|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
48914415|NCT01147744|157521281|FG002|Overall Study|Met Protocol-defined Stopping Criteria|0|||
48914416|NCT01147744|157521282|FG003|Overall Study|Met Protocol-defined Stopping Criteria|0|||
48914417|NCT01147744|157521283|FG004|Overall Study|Met Protocol-defined Stopping Criteria|0|||
48914418|NCT01147744|157521284|FG005|Overall Study|Met Protocol-defined Stopping Criteria|1|||
48914419|NCT01147744|157521285|FG006|Overall Study|Met Protocol-defined Stopping Criteria|0|||
48914420|NCT01342484|157521288|FG000|Overall Study|Other Reasons|1|||
48914421|NCT01342484|157521289|FG001|Overall Study|Other Reasons|0|||
48914422|NCT01342484|157521290|FG002|Overall Study|Other Reasons|0|||
48914423|NCT01342484|157521288|FG000|Overall Study|Protocol Violation|0|||
48914424|NCT01342484|157521289|FG001|Overall Study|Protocol Violation|0|||
48914425|NCT01342484|157521290|FG002|Overall Study|Protocol Violation|1|||
48914426|NCT01342484|157521288|FG000|Overall Study|Withdrawal by Subject|1|||
48914427|NCT01342484|157521289|FG001|Overall Study|Withdrawal by Subject|0|||
48914428|NCT01342484|157521290|FG002|Overall Study|Withdrawal by Subject|0|||
48914429|NCT01892163|157521292|FG000|Overall Study|Death|1|||
48802891|NCT01226511|157119867|FG000|Acute Treatment Period|Parent/caregiver decision|5|||
48802892|NCT01226511|157119868|FG001|Acute Treatment Period|Parent/caregiver decision|7|||
48802893|NCT01226511|157119867|FG000|Acute Treatment Period|Protocol Violation|5|||
48802894|NCT01226511|157119868|FG001|Acute Treatment Period|Protocol Violation|5|||
48802895|NCT01226511|157119867|FG000|Acute Treatment Period|Withdrawal by Subject|10|||
48802896|NCT01226511|157119868|FG001|Acute Treatment Period|Withdrawal by Subject|6|||
48802897|NCT01226511|157119867|FG000|Extension Treatment Period|Adverse Event|8|||
48802898|NCT01226511|157119868|FG001|Extension Treatment Period|Adverse Event|8|||
48802899|NCT01226511|157119867|FG000|Extension Treatment Period|Lack of Efficacy|3|||
48802900|NCT01226511|157119868|FG001|Extension Treatment Period|Lack of Efficacy|2|||
48802901|NCT01226511|157119867|FG000|Extension Treatment Period|Lost to Follow-up|4|||
48802902|NCT01226511|157119868|FG001|Extension Treatment Period|Lost to Follow-up|3|||
48802903|NCT01226511|157119867|FG000|Extension Treatment Period|Protocol Violation|2|||
48802904|NCT01226511|157119868|FG001|Extension Treatment Period|Protocol Violation|2|||
48802905|NCT01226511|157119867|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
48802906|NCT01226511|157119868|FG001|Extension Treatment Period|Withdrawal by Subject|3|||
48802907|NCT01226511|157119867|FG000|Extension Treatment Period|Parent/Caregiver Decision|8|||
48802908|NCT01226511|157119868|FG001|Extension Treatment Period|Parent/Caregiver Decision|8|||
48802909|NCT01226511|157119867|FG000|Extension Treatment Period|Sponsor Decision|1|||
48802910|NCT01226511|157119868|FG001|Extension Treatment Period|Sponsor Decision|1|||
48802911|NCT01226511|157119867|FG000|Taper Period|Adverse Event|1|||
48914430|NCT01892163|157521293|FG001|Overall Study|Death|1|||
48914431|NCT01892163|157521292|FG000|Overall Study|Lost to Follow-up|1|||
48914432|NCT01892163|157521293|FG001|Overall Study|Lost to Follow-up|0|||
48914433|NCT03697720|157522935|FG000|Overall Study|Lost to Follow-up|7|||
48914434|NCT02187172|157522942|FG000|Overall Study|Lost to Follow-up|1|||
48914435|NCT02187172|157522943|FG001|Overall Study|Lost to Follow-up|2|||
48914436|NCT02187172|157522942|FG000|Overall Study|Lack of Efficacy|1|||
48914437|NCT02187172|157522943|FG001|Overall Study|Lack of Efficacy|2|||
48914438|NCT02187172|157522942|FG000|Overall Study|Adverse Event|0|||
48802912|NCT01226511|157119868|FG001|Taper Period|Adverse Event|0|||
48802913|NCT01226511|157119867|FG000|Taper Period|Lost to Follow-up|2|||
48802914|NCT01226511|157119868|FG001|Taper Period|Lost to Follow-up|2|||
48914439|NCT02187172|157522943|FG001|Overall Study|Adverse Event|1|||
48914440|NCT02187172|157522942|FG000|Overall Study|Physician Decision|1|||
48802915|NCT01226511|157119867|FG000|Taper Period|Protocol Violation|1|||
48802916|NCT01226511|157119868|FG001|Taper Period|Protocol Violation|0|||
48914441|NCT02187172|157522943|FG001|Overall Study|Physician Decision|1|||
48914442|NCT02181816|157522944|FG000|Overall Study|Case Report Forms Uncollected|38|||
48914443|NCT02181816|157522944|FG000|Overall Study|Protocol Deviation|21|||
48802917|NCT01226511|157119867|FG000|Taper Period|Parent/Caregiver Decision|1|||
48802918|NCT01226511|157119868|FG001|Taper Period|Parent/Caregiver Decision|1|||
48802919|NCT01337986|157119869|FG000|Overall Study|Adverse Event|2|||
48802920|NCT01337986|157119870|FG001|Overall Study|Adverse Event|2|||
48914444|NCT02535715|157522945|FG000|Overall Study|Withdrawal by Subject|0|||
48914445|NCT02535715|157522946|FG001|Overall Study|Withdrawal by Subject|0|||
48802921|NCT01337986|157119869|FG000|Overall Study|Lost to Follow-up|1|||
48802922|NCT01337986|157119870|FG001|Overall Study|Lost to Follow-up|0|||
48802923|NCT01337986|157119869|FG000|Overall Study|Protocol Violation|0|||
48802924|NCT01337986|157119870|FG001|Overall Study|Protocol Violation|3|||
48802925|NCT00058422|157119871|FG000|Overall Study|Not treated|2|||
48802926|NCT02287584|157119872|FG000|the Double-blind Phase|Adverse Event|17|||
48802927|NCT02287584|157119873|FG001|the Double-blind Phase|Adverse Event|17|||
48802928|NCT02287584|157119874|FG002|the Double-blind Phase|Adverse Event|12|||
48802929|NCT02287584|157119875|FG003|the Double-blind Phase|Adverse Event|0|||
48802930|NCT02287584|157119876|FG004|the Double-blind Phase|Adverse Event|0|||
48802931|NCT02287584|157119877|FG005|the Double-blind Phase|Adverse Event|0|||
48802932|NCT02287584|157119872|FG000|the Double-blind Phase|Lack of Efficacy|18|||
48802933|NCT02287584|157119873|FG001|the Double-blind Phase|Lack of Efficacy|8|||
48802934|NCT02287584|157119874|FG002|the Double-blind Phase|Lack of Efficacy|8|||
48802935|NCT02287584|157119875|FG003|the Double-blind Phase|Lack of Efficacy|0|||
48802936|NCT02287584|157119876|FG004|the Double-blind Phase|Lack of Efficacy|0|||
48802937|NCT02287584|157119877|FG005|the Double-blind Phase|Lack of Efficacy|0|||
48802938|NCT02287584|157119872|FG000|the Double-blind Phase|Lost to Follow-up|0|||
48802939|NCT02287584|157119873|FG001|the Double-blind Phase|Lost to Follow-up|1|||
48802940|NCT02287584|157119874|FG002|the Double-blind Phase|Lost to Follow-up|1|||
48802941|NCT02287584|157119875|FG003|the Double-blind Phase|Lost to Follow-up|0|||
48802942|NCT02287584|157119876|FG004|the Double-blind Phase|Lost to Follow-up|0|||
48802943|NCT02287584|157119877|FG005|the Double-blind Phase|Lost to Follow-up|0|||
48802944|NCT02287584|157119872|FG000|the Double-blind Phase|Withdrawal by Subject|17|||
48802945|NCT02287584|157119873|FG001|the Double-blind Phase|Withdrawal by Subject|17|||
48802946|NCT02287584|157119874|FG002|the Double-blind Phase|Withdrawal by Subject|11|||
48802947|NCT02287584|157119875|FG003|the Double-blind Phase|Withdrawal by Subject|0|||
48802948|NCT02287584|157119876|FG004|the Double-blind Phase|Withdrawal by Subject|0|||
48802949|NCT02287584|157119877|FG005|the Double-blind Phase|Withdrawal by Subject|0|||
48802950|NCT02287584|157119872|FG000|the Double-blind Phase|Pregnancy|0|||
48802951|NCT02287584|157119873|FG001|the Double-blind Phase|Pregnancy|1|||
48802952|NCT02287584|157119874|FG002|the Double-blind Phase|Pregnancy|0|||
48802953|NCT02287584|157119875|FG003|the Double-blind Phase|Pregnancy|0|||
48802954|NCT02287584|157119876|FG004|the Double-blind Phase|Pregnancy|0|||
48802955|NCT02287584|157119877|FG005|the Double-blind Phase|Pregnancy|0|||
48802956|NCT02287584|157119872|FG000|the Double-blind Phase|Protocol Violation|0|||
48802957|NCT02287584|157119873|FG001|the Double-blind Phase|Protocol Violation|3|||
48802958|NCT02287584|157119874|FG002|the Double-blind Phase|Protocol Violation|0|||
48802959|NCT02287584|157119875|FG003|the Double-blind Phase|Protocol Violation|0|||
48802960|NCT02287584|157119876|FG004|the Double-blind Phase|Protocol Violation|0|||
48802961|NCT02287584|157119877|FG005|the Double-blind Phase|Protocol Violation|0|||
48802962|NCT02287584|157119872|FG000|the Double-blind Phase|other reasons|0|||
48802963|NCT02287584|157119873|FG001|the Double-blind Phase|other reasons|0|||
48802964|NCT02287584|157119874|FG002|the Double-blind Phase|other reasons|1|||
48802965|NCT02287584|157119875|FG003|the Double-blind Phase|other reasons|0|||
48802966|NCT02287584|157119876|FG004|the Double-blind Phase|other reasons|0|||
48802967|NCT02287584|157119877|FG005|the Double-blind Phase|other reasons|0|||
48802968|NCT02287584|157119872|FG000|the Open-label Phase|Did not receive drug|0|||
48802969|NCT02287584|157119873|FG001|the Open-label Phase|Did not receive drug|0|||
48802970|NCT02287584|157119874|FG002|the Open-label Phase|Did not receive drug|0|||
48802971|NCT02287584|157119875|FG003|the Open-label Phase|Did not receive drug|7|||
48802972|NCT02287584|157119876|FG004|the Open-label Phase|Did not receive drug|6|||
48802973|NCT02287584|157119877|FG005|the Open-label Phase|Did not receive drug|4|||
48802974|NCT02287584|157119872|FG000|the Open-label Phase|Adverse Event|0|||
48802975|NCT02287584|157119873|FG001|the Open-label Phase|Adverse Event|0|||
48914446|NCT02535715|157522947|FG002|Overall Study|Withdrawal by Subject|1|||
48914447|NCT04353284|157522948|FG000|Overall Study|Adverse Event|1|||
48802976|NCT02287584|157119874|FG002|the Open-label Phase|Adverse Event|0|||
48802977|NCT02287584|157119875|FG003|the Open-label Phase|Adverse Event|15|||
48802978|NCT02287584|157119876|FG004|the Open-label Phase|Adverse Event|12|||
48802979|NCT02287584|157119877|FG005|the Open-label Phase|Adverse Event|16|||
48914448|NCT04353284|157522949|FG001|Overall Study|Adverse Event|1|||
48914449|NCT04353284|157522948|FG000|Overall Study|Lost to Follow-up|1|||
48914450|NCT04353284|157522949|FG001|Overall Study|Lost to Follow-up|0|||
48802980|NCT02287584|157119872|FG000|the Open-label Phase|Lack of Efficacy|0|||
48802981|NCT02287584|157119873|FG001|the Open-label Phase|Lack of Efficacy|0|||
48802982|NCT02287584|157119874|FG002|the Open-label Phase|Lack of Efficacy|0|||
48802983|NCT02287584|157119875|FG003|the Open-label Phase|Lack of Efficacy|8|||
48802984|NCT02287584|157119876|FG004|the Open-label Phase|Lack of Efficacy|3|||
48802985|NCT02287584|157119877|FG005|the Open-label Phase|Lack of Efficacy|7|||
48802986|NCT02287584|157119872|FG000|the Open-label Phase|Lost to Follow-up|0|||
48802987|NCT02287584|157119873|FG001|the Open-label Phase|Lost to Follow-up|0|||
48802988|NCT02287584|157119874|FG002|the Open-label Phase|Lost to Follow-up|0|||
48802989|NCT02287584|157119875|FG003|the Open-label Phase|Lost to Follow-up|4|||
48802990|NCT02287584|157119876|FG004|the Open-label Phase|Lost to Follow-up|1|||
48802991|NCT02287584|157119877|FG005|the Open-label Phase|Lost to Follow-up|2|||
48802992|NCT02287584|157119872|FG000|the Open-label Phase|Withdrawal by Subject|0|||
48802993|NCT02287584|157119873|FG001|the Open-label Phase|Withdrawal by Subject|0|||
48802994|NCT02287584|157119874|FG002|the Open-label Phase|Withdrawal by Subject|0|||
48802995|NCT02287584|157119875|FG003|the Open-label Phase|Withdrawal by Subject|18|||
48802996|NCT02287584|157119876|FG004|the Open-label Phase|Withdrawal by Subject|29|||
48802997|NCT02287584|157119877|FG005|the Open-label Phase|Withdrawal by Subject|21|||
48802998|NCT02287584|157119872|FG000|the Open-label Phase|non-compliance|0|||
48914451|NCT00549939|157522950|FG000|12-week Double Blind Treatment Period|Adverse Event|1|||
48914452|NCT00549939|157522951|FG001|12-week Double Blind Treatment Period|Adverse Event|1|||
48914453|NCT00549939|157522952|FG002|12-week Double Blind Treatment Period|Adverse Event|2|||
48914454|NCT00549939|157522950|FG000|12-week Double Blind Treatment Period|Too many blood draws|0|||
48914455|NCT00549939|157522951|FG001|12-week Double Blind Treatment Period|Too many blood draws|1|||
48914456|NCT00549939|157522952|FG002|12-week Double Blind Treatment Period|Too many blood draws|0|||
48914457|NCT00549939|157522950|FG000|40-week Open Label Treatment Period|Adverse Event|0|||
48914458|NCT00549939|157522951|FG001|40-week Open Label Treatment Period|Adverse Event|2|||
48914459|NCT00549939|157522952|FG002|40-week Open Label Treatment Period|Adverse Event|1|||
48914460|NCT00549939|157522950|FG000|40-week Open Label Treatment Period|Lack of Efficacy|0|||
48914461|NCT00549939|157522951|FG001|40-week Open Label Treatment Period|Lack of Efficacy|1|||
48914462|NCT00549939|157522952|FG002|40-week Open Label Treatment Period|Lack of Efficacy|0|||
48914463|NCT00549939|157522950|FG000|40-week Open Label Treatment Period|Protocol Violation|0|||
48914464|NCT00549939|157522951|FG001|40-week Open Label Treatment Period|Protocol Violation|1|||
48914465|NCT00549939|157522952|FG002|40-week Open Label Treatment Period|Protocol Violation|0|||
48914466|NCT00549939|157522950|FG000|40-week Open Label Treatment Period|Other|0|||
48914467|NCT00549939|157522951|FG001|40-week Open Label Treatment Period|Other|1|||
48914468|NCT00549939|157522952|FG002|40-week Open Label Treatment Period|Other|4|||
48914469|NCT00003895|157522953|FG000|Overall Study|Adverse Event|4|||
48914470|NCT00003895|157522954|FG001|Overall Study|Adverse Event|0|||
48914471|NCT00003895|157522953|FG000|Overall Study|Lack of Efficacy|1|||
48914472|NCT00003895|157522954|FG001|Overall Study|Lack of Efficacy|1|||
48914473|NCT00003895|157522953|FG000|Overall Study|Patient Vacation|2|||
48914474|NCT00003895|157522954|FG001|Overall Study|Patient Vacation|0|||
48914475|NCT00003895|157522953|FG000|Overall Study|Withdrawal by Subject|0|||
48914476|NCT00003895|157522954|FG001|Overall Study|Withdrawal by Subject|3|||
48914477|NCT02490475|157522955|FG000|Period 1: First 6 Cycles|Adverse Event|2|||
48914478|NCT02490475|157522956|FG001|Period 1: First 6 Cycles|Adverse Event|1|||
48914479|NCT02490475|157522957|FG002|Period 1: First 6 Cycles|Adverse Event|0|||
48914480|NCT02490475|157522958|FG003|Period 1: First 6 Cycles|Adverse Event|1|||
48914481|NCT02490475|157522955|FG000|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
48914482|NCT02490475|157522956|FG001|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0|||
48914483|NCT02490475|157522957|FG002|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
48914484|NCT02490475|157522958|FG003|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
48914485|NCT02490475|157522955|FG000|Period 1: First 6 Cycles|Refused Treatment|1|||
48914486|NCT02490475|157522956|FG001|Period 1: First 6 Cycles|Refused Treatment|0|||
48914487|NCT02490475|157522957|FG002|Period 1: First 6 Cycles|Refused Treatment|0|||
48914488|NCT02490475|157522958|FG003|Period 1: First 6 Cycles|Refused Treatment|0|||
48914489|NCT02490475|157522955|FG000|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
48914490|NCT02490475|157522956|FG001|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
48914491|NCT02490475|157522957|FG002|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4|||
48914492|NCT02490475|157522958|FG003|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2|||
48914493|NCT02490475|157522955|FG000|Period 2: Extension Phase|Insufficient Therapeutic Response|1|||
48914494|NCT02490475|157522956|FG001|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
48802999|NCT02287584|157119873|FG001|the Open-label Phase|non-compliance|0|||
48803000|NCT02287584|157119874|FG002|the Open-label Phase|non-compliance|0|||
48803001|NCT02287584|157119875|FG003|the Open-label Phase|non-compliance|2|||
48803002|NCT02287584|157119876|FG004|the Open-label Phase|non-compliance|5|||
48803003|NCT02287584|157119877|FG005|the Open-label Phase|non-compliance|1|||
48914495|NCT02490475|157522957|FG002|Period 2: Extension Phase|Insufficient Therapeutic Response|2|||
48914496|NCT02490475|157522958|FG003|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
48914497|NCT02490475|157522955|FG000|Period 2: Extension Phase|Refused Treatment|0|||
48914498|NCT02490475|157522956|FG001|Period 2: Extension Phase|Refused Treatment|0|||
48914499|NCT02490475|157522957|FG002|Period 2: Extension Phase|Refused Treatment|0|||
48803004|NCT02287584|157119872|FG000|the Open-label Phase|other reasons|0|||
48914500|NCT02490475|157522958|FG003|Period 2: Extension Phase|Refused Treatment|1|||
48914501|NCT02490475|157522955|FG000|Period 2: Extension Phase|Adverse Event|0|||
48914502|NCT02490475|157522956|FG001|Period 2: Extension Phase|Adverse Event|0|||
48914503|NCT02490475|157522957|FG002|Period 2: Extension Phase|Adverse Event|1|||
49118988|NCT01395810|158273281|FG001|Overall Study|Lack of Efficacy|1|||
48803005|NCT02287584|157119873|FG001|the Open-label Phase|other reasons|0|||
48803006|NCT02287584|157119874|FG002|the Open-label Phase|other reasons|0|||
49118989|NCT01395810|158273282|FG002|Overall Study|Lack of Efficacy|0|||
48914504|NCT02490475|157522958|FG003|Period 2: Extension Phase|Adverse Event|0|||
48914505|NCT01349465|157522959|FG000|Overall Study|Adverse Event|1|||
48914506|NCT01349465|157522960|FG001|Overall Study|Adverse Event|0|||
48914507|NCT01349465|157522959|FG000|Overall Study|Death|3|||
48914508|NCT01349465|157522960|FG001|Overall Study|Death|0|||
48914509|NCT01349465|157522959|FG000|Overall Study|Lost to Follow-up|10|||
48914510|NCT01349465|157522960|FG001|Overall Study|Lost to Follow-up|1|||
48914511|NCT01349465|157522959|FG000|Overall Study|Withdrawal by Subject|4|||
48914512|NCT01349465|157522960|FG001|Overall Study|Withdrawal by Subject|2|||
48914513|NCT01349465|157522959|FG000|Overall Study|Subject Ineligible To Continue The Trial|0|||
48914514|NCT01349465|157522960|FG001|Overall Study|Subject Ineligible To Continue The Trial|19|||
48914515|NCT00383084|157522961|FG000|Overall Study|Withdrawal by Subject|12|||
48914516|NCT00383084|157522962|FG001|Overall Study|Withdrawal by Subject|10|||
48914517|NCT01877187|157522963|FG000|Overall Study|Death|2|||
48914518|NCT01877187|157522963|FG000|Overall Study|Withdrawal by Subject|4|||
48914519|NCT01877187|157522963|FG000|Overall Study|Lost to Follow-up|3|||
48914520|NCT01877187|157522963|FG000|Overall Study|Declining clinical status|11|||
48803007|NCT02287584|157119875|FG003|the Open-label Phase|other reasons|3|||
48803008|NCT02287584|157119876|FG004|the Open-label Phase|other reasons|6|||
48803009|NCT02287584|157119877|FG005|the Open-label Phase|other reasons|6|||
48803010|NCT00106184|157119878|FG000|Overall Study|Withdrawal by Subject|3|||
48803011|NCT00106184|157119879|FG001|Overall Study|Withdrawal by Subject|2|||
48803012|NCT01572389|157119881|FG000|Overall Study|Death|1|||
48914521|NCT01877187|157522963|FG000|Overall Study|Liver transplant|2|||
48914522|NCT01648790|157522968|FG000|Treatment 3|Withdrawal by Subject|0|||
48914523|NCT01648790|157522969|FG001|Treatment 3|Withdrawal by Subject|0|||
48914524|NCT01648790|157522970|FG002|Treatment 3|Withdrawal by Subject|0|||
48914525|NCT01648790|157522971|FG003|Treatment 3|Withdrawal by Subject|1|||
48914526|NCT01648790|157522972|FG004|Treatment 3|Withdrawal by Subject|0|||
48914527|NCT02164929|157522973|FG000|Overall Study|Converted to open procedure|1|||
48914528|NCT02164929|157522974|FG001|Overall Study|Converted to open procedure|0|||
48914529|NCT02164929|157522975|FG002|Overall Study|Converted to open procedure|0|||
48914530|NCT02164929|157522976|FG003|Overall Study|Converted to open procedure|2|||
48914531|NCT02164929|157522973|FG000|Overall Study|Failed regional block|0|||
48914532|NCT02164929|157522974|FG001|Overall Study|Failed regional block|0|||
48914533|NCT02164929|157522975|FG002|Overall Study|Failed regional block|1|||
48914534|NCT02164929|157522976|FG003|Overall Study|Failed regional block|0|||
48914535|NCT02969187|157522977|FG000|Overall Study|Physician Decision|12|||
48914536|NCT02969187|157522978|FG001|Overall Study|Physician Decision|13|||
48914537|NCT01986920|157522979|FG000|A- 101 25%|Withdrawal by Subject|1|||
48914538|NCT01986920|157522980|FG001|A- 101 25%|Withdrawal by Subject|0|||
48914539|NCT01986920|157522981|FG002|A- 101 25%|Withdrawal by Subject|0|||
48914540|NCT01986920|157522982|FG003|A- 101 25%|Withdrawal by Subject|0|||
48914541|NCT01986920|157522979|FG000|A-101 32.5%|Withdrawal by Subject|0|||
48914542|NCT01986920|157522980|FG001|A-101 32.5%|Withdrawal by Subject|1|||
48914543|NCT01986920|157522981|FG002|A-101 32.5%|Withdrawal by Subject|0|||
48914544|NCT01986920|157522982|FG003|A-101 32.5%|Withdrawal by Subject|0|||
48914545|NCT01986920|157522979|FG000|A-101 40%|Withdrawal by Subject|0|||
48914546|NCT01986920|157522980|FG001|A-101 40%|Withdrawal by Subject|0|||
48914547|NCT01986920|157522981|FG002|A-101 40%|Withdrawal by Subject|1|||
48914548|NCT01986920|157522982|FG003|A-101 40%|Withdrawal by Subject|0|||
48914549|NCT01986920|157522979|FG000|Placebo|Withdrawal by Subject|0|||
48914550|NCT01986920|157522980|FG001|Placebo|Withdrawal by Subject|0|||
48914551|NCT01986920|157522981|FG002|Placebo|Withdrawal by Subject|0|||
48914552|NCT01986920|157522982|FG003|Placebo|Withdrawal by Subject|1|||
48914553|NCT01471015|157522993|FG000|Overall Study|Death|0|||
48914554|NCT01471015|157522994|FG001|Overall Study|Death|1|||
48914555|NCT01471015|157522995|FG002|Overall Study|Death|1|||
48914556|NCT01376778|157522997|FG000|Overall Study|Lost to Follow-up|3|||
48914557|NCT01376778|157522998|FG001|Overall Study|Lost to Follow-up|2|||
48914558|NCT02285777|157523003|FG000|Overall Study|Withdrawal by Subject|1|||
48803013|NCT01572389|157119882|FG001|Overall Study|Death|3|||
48914559|NCT02285777|157523004|FG001|Overall Study|Withdrawal by Subject|1|||
48914560|NCT02285777|157523003|FG000|Overall Study|Lost to Follow-up|4|||
48914561|NCT02285777|157523004|FG001|Overall Study|Lost to Follow-up|2|||
49118990|NCT01395810|158273283|FG003|Overall Study|Lack of Efficacy|0|||
48803014|NCT01572389|157119881|FG000|Overall Study|Withdrawal by Subject|14|||
48914562|NCT04607148|157523005|FG000|Overall Study|Withdrawal by Subject|0|||
48914563|NCT04607148|157523006|FG001|Overall Study|Withdrawal by Subject|4|||
48914564|NCT04607148|157523007|FG002|Overall Study|Withdrawal by Subject|2|||
48914565|NCT04607148|157523008|FG003|Overall Study|Withdrawal by Subject|8|||
48914566|NCT04607148|157523005|FG000|Overall Study|Study Terminated by Sponsor|14|||
48914567|NCT04607148|157523006|FG001|Overall Study|Study Terminated by Sponsor|59|||
49118991|NCT01395810|158273280|FG000|Overall Study|Withdrawal criteria|0|||
48803015|NCT01572389|157119882|FG001|Overall Study|Withdrawal by Subject|2|||
48914568|NCT04607148|157523007|FG002|Overall Study|Study Terminated by Sponsor|9|||
48914569|NCT04607148|157523008|FG003|Overall Study|Study Terminated by Sponsor|39|||
48914570|NCT04607148|157523005|FG000|Overall Study|Sponsor Decision|0|||
48914571|NCT04607148|157523006|FG001|Overall Study|Sponsor Decision|0|||
48914572|NCT04607148|157523007|FG002|Overall Study|Sponsor Decision|1|||
48914573|NCT04607148|157523008|FG003|Overall Study|Sponsor Decision|0|||
48914574|NCT04607148|157523005|FG000|Overall Study|Non-Compliance With Study Drug|0|||
48914575|NCT04607148|157523006|FG001|Overall Study|Non-Compliance With Study Drug|1|||
48914576|NCT04607148|157523007|FG002|Overall Study|Non-Compliance With Study Drug|0|||
48914577|NCT04607148|157523008|FG003|Overall Study|Non-Compliance With Study Drug|0|||
48914578|NCT04607148|157523005|FG000|Overall Study|Lost to Follow-up|0|||
48914579|NCT04607148|157523006|FG001|Overall Study|Lost to Follow-up|2|||
48914580|NCT04607148|157523007|FG002|Overall Study|Lost to Follow-up|0|||
48914581|NCT04607148|157523008|FG003|Overall Study|Lost to Follow-up|0|||
48914582|NCT04607148|157523005|FG000|Overall Study|Death|0|||
48914583|NCT04607148|157523006|FG001|Overall Study|Death|3|||
48914584|NCT04607148|157523007|FG002|Overall Study|Death|0|||
48914585|NCT04607148|157523008|FG003|Overall Study|Death|1|||
48914586|NCT04607148|157523005|FG000|Overall Study|Adverse Event|0|||
48914587|NCT04607148|157523006|FG001|Overall Study|Adverse Event|1|||
48914588|NCT04607148|157523007|FG002|Overall Study|Adverse Event|0|||
48914589|NCT04607148|157523008|FG003|Overall Study|Adverse Event|0|||
48914590|NCT02285998|157523009|FG000|Overall Study|Adverse Event|9|||
48914591|NCT02285998|157523010|FG001|Overall Study|Adverse Event|8|||
48914592|NCT02285998|157523009|FG000|Overall Study|Physician Decision|1|||
48914593|NCT02285998|157523010|FG001|Overall Study|Physician Decision|2|||
48914594|NCT02285998|157523009|FG000|Overall Study|Lost to Follow-up|176|||
48914595|NCT02285998|157523010|FG001|Overall Study|Lost to Follow-up|172|||
48914596|NCT02285998|157523009|FG000|Overall Study|Withdrawal by Subject|53|||
48914597|NCT02285998|157523010|FG001|Overall Study|Withdrawal by Subject|61|||
48914598|NCT02285998|157523009|FG000|Overall Study|Other Reasons|7|||
48914599|NCT02285998|157523010|FG001|Overall Study|Other Reasons|10|||
48914600|NCT01820364|157523011|FG000|Part I: LGX818|Death|1|||
48914601|NCT01820364|157523012|FG001|Part I: LGX818|Death|0|||
48914602|NCT01820364|157523011|FG000|Part I: LGX818|Administrative Problems|3|||
49118992|NCT01395810|158273281|FG001|Overall Study|Withdrawal criteria|2|||
49118993|NCT01395810|158273282|FG002|Overall Study|Withdrawal criteria|0|||
49118994|NCT01395810|158273283|FG003|Overall Study|Withdrawal criteria|0|||
49118995|NCT01395810|158273280|FG000|Overall Study|Unclassified|2|||
49118996|NCT01395810|158273281|FG001|Overall Study|Unclassified|0|||
49118997|NCT01395810|158273282|FG002|Overall Study|Unclassified|0|||
49118998|NCT01395810|158273283|FG003|Overall Study|Unclassified|0|||
49118999|NCT05027815|158273284|FG000|Overall Study|Death|2|||
49119000|NCT05027815|158273285|FG001|Overall Study|Death|1|||
49119001|NCT00490919|158273286|FG000|Open-label Run-in Period|Adverse Event|239|||
49119002|NCT00490919|158273287|FG001|Open-label Run-in Period|Adverse Event|0|||
49119003|NCT00490919|158273288|FG002|Open-label Run-in Period|Adverse Event|0|||
49119004|NCT00490919|158273286|FG000|Open-label Run-in Period|Withdrawal by Subject|37|||
49119005|NCT00490919|158273287|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
49119006|NCT00490919|158273288|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
49119007|NCT00490919|158273286|FG000|Open-label Run-in Period|Lost to Follow-up|21|||
49119008|NCT00490919|158273287|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
49119009|NCT00490919|158273288|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
49119010|NCT00490919|158273286|FG000|Open-label Run-in Period|Lack of Efficacy|143|||
49119011|NCT00490919|158273287|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
49119012|NCT00490919|158273288|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
49119013|NCT00490919|158273286|FG000|Open-label Run-in Period|Administrative|40|||
49119014|NCT00490919|158273287|FG001|Open-label Run-in Period|Administrative|0|||
49119015|NCT00490919|158273288|FG002|Open-label Run-in Period|Administrative|0|||
49119016|NCT00490919|158273286|FG000|Open-label Run-in Period|Confirmed or suspected diversion|3|||
49119017|NCT00490919|158273287|FG001|Open-label Run-in Period|Confirmed or suspected diversion|0|||
49119018|NCT00490919|158273288|FG002|Open-label Run-in Period|Confirmed or suspected diversion|0|||
48914603|NCT01820364|157523012|FG001|Part I: LGX818|Administrative Problems|0|||
49119019|NCT00490919|158273286|FG000|Double-blind Phase|Adverse Event|0|||
49119020|NCT00490919|158273287|FG001|Double-blind Phase|Adverse Event|40|||
49119021|NCT00490919|158273288|FG002|Double-blind Phase|Adverse Event|20|||
48708208|NCT00599339|156779152|FG000|Overall Study|Lost to Follow-up|221|||
48914604|NCT01820364|157523011|FG000|Part I: LGX818|Adverse Event|6|||
48914605|NCT01820364|157523012|FG001|Part I: LGX818|Adverse Event|0|||
48914606|NCT01820364|157523011|FG000|Part I: LGX818|Disease Progression|4|||
48914607|NCT01820364|157523012|FG001|Part I: LGX818|Disease Progression|0|||
48914608|NCT01820364|157523011|FG000|Part II: LGX818 + MEK162|Study Termination|0|||
48914609|NCT01820364|157523012|FG001|Part II: LGX818 + MEK162|Study Termination|1|||
49119022|NCT00490919|158273286|FG000|Double-blind Phase|Withdrawal by Subject|0|||
49119023|NCT00490919|158273287|FG001|Double-blind Phase|Withdrawal by Subject|10|||
49119024|NCT00490919|158273288|FG002|Double-blind Phase|Withdrawal by Subject|11|||
49119025|NCT00490919|158273286|FG000|Double-blind Phase|Lost to Follow-up|0|||
48708209|NCT00599339|156779152|FG000|Overall Study|No valid data consent|36|||
49119026|NCT00490919|158273287|FG001|Double-blind Phase|Lost to Follow-up|8|||
48914610|NCT01617070|157523018|FG000|BH4 and LNAA (4 Weeks)|started medication interfere with study|1|||
48914611|NCT02230384|157523020|FG000|Phase 1|Lost to Follow-up|1|||
49119027|NCT00490919|158273288|FG002|Double-blind Phase|Lost to Follow-up|11|||
49119028|NCT00490919|158273286|FG000|Double-blind Phase|Lack of Efficacy|0|||
48914612|NCT02230384|157523021|FG001|Phase 1|Lost to Follow-up|0|||
48914613|NCT02230384|157523020|FG000|Phase 1|Physician Decision|0|||
48914614|NCT02230384|157523021|FG001|Phase 1|Physician Decision|1|||
48914615|NCT02230384|157523020|FG000|Phase 2 - Switch|Withdrawal by Subject|0|||
48914616|NCT02230384|157523021|FG001|Phase 2 - Switch|Withdrawal by Subject|1|||
49119029|NCT00490919|158273287|FG001|Double-blind Phase|Lack of Efficacy|22|||
49119030|NCT00490919|158273288|FG002|Double-blind Phase|Lack of Efficacy|36|||
48708210|NCT00599339|156779152|FG000|Overall Study|Study Termination Status Unknown|12|||
48708211|NCT04421027|156779153|FG000|Treatment Period|Adverse Event|5|||
48708212|NCT04421027|156779154|FG001|Treatment Period|Adverse Event|3|||
48708213|NCT04421027|156779155|FG002|Treatment Period|Adverse Event|0|||
48708214|NCT04421027|156779156|FG003|Treatment Period|Adverse Event|0|||
48708215|NCT04421027|156779153|FG000|Treatment Period|Death|98|||
49119031|NCT00490919|158273286|FG000|Double-blind Phase|Administrative|0|||
48708216|NCT04421027|156779154|FG001|Treatment Period|Death|61|||
48708217|NCT04421027|156779155|FG002|Treatment Period|Death|0|||
48708218|NCT04421027|156779156|FG003|Treatment Period|Death|0|||
48708219|NCT04421027|156779153|FG000|Treatment Period|Lost to Follow-up|22|||
48708220|NCT04421027|156779154|FG001|Treatment Period|Lost to Follow-up|20|||
48708221|NCT04421027|156779155|FG002|Treatment Period|Lost to Follow-up|0|||
48708222|NCT04421027|156779156|FG003|Treatment Period|Lost to Follow-up|0|||
48708223|NCT04421027|156779153|FG000|Treatment Period|Other-Unknown|15|||
48708224|NCT04421027|156779154|FG001|Treatment Period|Other-Unknown|9|||
48708225|NCT04421027|156779155|FG002|Treatment Period|Other-Unknown|0|||
48708226|NCT04421027|156779156|FG003|Treatment Period|Other-Unknown|0|||
48708227|NCT04421027|156779153|FG000|Treatment Period|Physician Decision|1|||
48708228|NCT04421027|156779154|FG001|Treatment Period|Physician Decision|1|||
48708229|NCT04421027|156779155|FG002|Treatment Period|Physician Decision|0|||
48708230|NCT04421027|156779156|FG003|Treatment Period|Physician Decision|0|||
48708231|NCT04421027|156779153|FG000|Treatment Period|Withdrawal by Subject|7|||
48708232|NCT04421027|156779154|FG001|Treatment Period|Withdrawal by Subject|12|||
48708233|NCT04421027|156779155|FG002|Treatment Period|Withdrawal by Subject|0|||
48708234|NCT04421027|156779156|FG003|Treatment Period|Withdrawal by Subject|0|||
48708235|NCT04421027|156779153|FG000|Treatment Period|Randomized Not Dosed|9|||
48708236|NCT04421027|156779154|FG001|Treatment Period|Randomized Not Dosed|14|||
48708237|NCT04421027|156779155|FG002|Treatment Period|Randomized Not Dosed|0|||
48708238|NCT04421027|156779156|FG003|Treatment Period|Randomized Not Dosed|0|||
48708239|NCT04421027|156779153|FG000|Follow-Up Period|Adverse Event|0|||
48708240|NCT04421027|156779154|FG001|Follow-Up Period|Adverse Event|0|||
48708241|NCT04421027|156779155|FG002|Follow-Up Period|Adverse Event|0|||
48708242|NCT04421027|156779156|FG003|Follow-Up Period|Adverse Event|3|||
48708243|NCT04421027|156779153|FG000|Follow-Up Period|Death|0|||
48708244|NCT04421027|156779154|FG001|Follow-Up Period|Death|0|||
48708245|NCT04421027|156779155|FG002|Follow-Up Period|Death|16|||
48708246|NCT04421027|156779156|FG003|Follow-Up Period|Death|17|||
48708247|NCT04421027|156779153|FG000|Follow-Up Period|Lost to Follow-up|0|||
48708248|NCT04421027|156779154|FG001|Follow-Up Period|Lost to Follow-up|0|||
48708249|NCT04421027|156779155|FG002|Follow-Up Period|Lost to Follow-up|7|||
48708250|NCT04421027|156779156|FG003|Follow-Up Period|Lost to Follow-up|7|||
48708251|NCT04421027|156779153|FG000|Follow-Up Period|Protocol Deviation|0|||
48708252|NCT04421027|156779154|FG001|Follow-Up Period|Protocol Deviation|0|||
48708253|NCT04421027|156779155|FG002|Follow-Up Period|Protocol Deviation|1|||
48708254|NCT04421027|156779156|FG003|Follow-Up Period|Protocol Deviation|0|||
48708255|NCT04421027|156779153|FG000|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
48708256|NCT04421027|156779154|FG001|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
48708257|NCT04421027|156779155|FG002|Follow-Up Period|Still in hospital on ventilator at end of study|1|||
48708258|NCT04421027|156779156|FG003|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
48708259|NCT04421027|156779153|FG000|Follow-Up Period|Left message, participant did not call back|0|||
48708260|NCT04421027|156779154|FG001|Follow-Up Period|Left message, participant did not call back|0|||
48708261|NCT04421027|156779155|FG002|Follow-Up Period|Left message, participant did not call back|0|||
48708262|NCT04421027|156779156|FG003|Follow-Up Period|Left message, participant did not call back|1|||
48708263|NCT04421027|156779153|FG000|Follow-Up Period|Participant died|0|||
48708264|NCT04421027|156779154|FG001|Follow-Up Period|Participant died|0|||
48708265|NCT04421027|156779155|FG002|Follow-Up Period|Participant died|0|||
48708266|NCT04421027|156779156|FG003|Follow-Up Period|Participant died|1|||
49119032|NCT00490919|158273287|FG001|Double-blind Phase|Administrative|6|||
49119033|NCT00490919|158273288|FG002|Double-blind Phase|Administrative|6|||
49119034|NCT02526160|158274595|FG000|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0|||
49119035|NCT02526160|158274596|FG001|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1|||
48708267|NCT04421027|156779153|FG000|Follow-Up Period|Participant was alive but did not respond to calls|0|||
48708268|NCT04421027|156779154|FG001|Follow-Up Period|Participant was alive but did not respond to calls|0|||
48708269|NCT04421027|156779155|FG002|Follow-Up Period|Participant was alive but did not respond to calls|0|||
48742938|NCT01550289|156910419|FG000|Overall Study|Withdrawal by Subject|11|||
48803016|NCT01572389|157119881|FG000|Overall Study|Lost to Follow-up|25|||
48803017|NCT01572389|157119882|FG001|Overall Study|Lost to Follow-up|14|||
48803018|NCT01572389|157119881|FG000|Overall Study|Only A1C or Assessment was Collected|6|||
48803019|NCT01572389|157119882|FG001|Overall Study|Only A1C or Assessment was Collected|2|||
48803020|NCT01111838|157119885|FG000|Overall Study|Patient Ineligible|2|||
48803021|NCT01111838|157119885|FG000|Overall Study|Not Treated|3|||
48803022|NCT01111838|157119885|FG000|Overall Study|Clinical deterioration|1|||
48803023|NCT01111838|157119885|FG000|Overall Study|Other Complicating Disease|1|||
48803024|NCT01780935|157119888|FG000|Overall Study|Admin problems due to early termination|321|||
48803025|NCT01780935|157119889|FG001|Overall Study|Admin problems due to early termination|309|||
48803026|NCT01780935|157119888|FG000|Overall Study|Adverse Event|2|||
48803027|NCT01780935|157119889|FG001|Overall Study|Adverse Event|4|||
48803028|NCT01780935|157119888|FG000|Overall Study|Death|1|||
48803029|NCT01780935|157119889|FG001|Overall Study|Death|6|||
48803030|NCT01780935|157119888|FG000|Overall Study|Lost to Follow-up|2|||
48803031|NCT01780935|157119889|FG001|Overall Study|Lost to Follow-up|6|||
48803032|NCT01780935|157119888|FG000|Overall Study|Physician Decision|1|||
48803033|NCT01780935|157119889|FG001|Overall Study|Physician Decision|1|||
48803034|NCT01780935|157119888|FG000|Overall Study|Protocol deviation|0|||
48803035|NCT01780935|157119889|FG001|Overall Study|Protocol deviation|1|||
48803036|NCT01780935|157119888|FG000|Overall Study|Patient withdrew consent|8|||
48803037|NCT01780935|157119889|FG001|Overall Study|Patient withdrew consent|9|||
48803038|NCT01480596|157119890|FG000|Overall Study|Adverse Event|3|||
48803039|NCT01480596|157119891|FG001|Overall Study|Adverse Event|0|||
48803040|NCT01480596|157119890|FG000|Overall Study|MG exacerbation or change in medication|2|||
48803041|NCT01480596|157119891|FG001|Overall Study|MG exacerbation or change in medication|2|||
48803042|NCT02277990|157119895|FG000|Overall Study|Death|170|||
48803043|NCT02277990|157119896|FG001|Overall Study|Death|188|||
48803044|NCT02277990|157119895|FG000|Overall Study|Withdrawal by Subject|64|||
48803045|NCT02277990|157119896|FG001|Overall Study|Withdrawal by Subject|53|||
48803046|NCT02277990|157119895|FG000|Overall Study|Physician Decision|40|||
48803047|NCT02277990|157119896|FG001|Overall Study|Physician Decision|34|||
48803048|NCT02277990|157119895|FG000|Overall Study|Lost to Follow-up|66|||
48803049|NCT02277990|157119896|FG001|Overall Study|Lost to Follow-up|69|||
48803050|NCT02277990|157119895|FG000|Overall Study|Had other reason|26|||
48803051|NCT02277990|157119896|FG001|Overall Study|Had other reason|32|||
48803052|NCT04359771|157119897|FG000|Overall Study|Lack of Efficacy|2|||
48803053|NCT04359771|157119898|FG001|Overall Study|Lack of Efficacy|2|||
48803054|NCT01498822|157119899|FG000|Overall Study|Protocol Violation|8|||
48803055|NCT01498822|157119900|FG001|Overall Study|Protocol Violation|4|||
48803056|NCT01498822|157119899|FG000|Overall Study|Other Reason|5|||
48803057|NCT01498822|157119900|FG001|Overall Study|Other Reason|2|||
48803058|NCT01498822|157119899|FG000|Overall Study|Lack of Efficacy|7|||
48803059|NCT01498822|157119900|FG001|Overall Study|Lack of Efficacy|2|||
48803060|NCT01498822|157119899|FG000|Overall Study|AE, non-serious non-fatal|8|||
48803061|NCT01498822|157119900|FG001|Overall Study|AE, non-serious non-fatal|17|||
48803062|NCT01498822|157119899|FG000|Overall Study|SAE, non-fatal|2|||
48803063|NCT01498822|157119900|FG001|Overall Study|SAE, non-fatal|2|||
48803064|NCT01498822|157119899|FG000|Overall Study|Adverse Event, serious fatal|1|||
48803065|NCT01498822|157119900|FG001|Overall Study|Adverse Event, serious fatal|1|||
48803066|NCT01498822|157119899|FG000|Overall Study|Withdrawal by Subject|15|||
48803067|NCT01498822|157119900|FG001|Overall Study|Withdrawal by Subject|25|||
48803068|NCT01498822|157119899|FG000|Overall Study|Lost to Follow-up|8|||
48803069|NCT01498822|157119900|FG001|Overall Study|Lost to Follow-up|3|||
48803070|NCT03131960|157119901|FG000|Overall Study|Adverse Event|0|||
48803071|NCT03131960|157119902|FG001|Overall Study|Adverse Event|1|||
48803072|NCT01566695|157119903|FG000|Overall Study|Lack of Efficacy|1|||
48803073|NCT01566695|157119904|FG001|Overall Study|Lack of Efficacy|0|||
48803074|NCT01566695|157119903|FG000|Overall Study|Adverse Event|3|||
48803075|NCT01566695|157119904|FG001|Overall Study|Adverse Event|0|||
48803076|NCT01566695|157119903|FG000|Overall Study|Death|79|||
48803077|NCT01566695|157119904|FG001|Overall Study|Death|86|||
48803078|NCT01566695|157119903|FG000|Overall Study|Withdrawal by Subject|13|||
48803079|NCT01566695|157119904|FG001|Overall Study|Withdrawal by Subject|12|||
48803080|NCT01566695|157119903|FG000|Overall Study|Lost to Follow-up|0|||
48803081|NCT01566695|157119904|FG001|Overall Study|Lost to Follow-up|3|||
48803082|NCT01566695|157119903|FG000|Overall Study|Other reasons|11|||
48803083|NCT01566695|157119904|FG001|Overall Study|Other reasons|8|||
48803084|NCT04111536|157119916|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
48803085|NCT04111536|157119917|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
48803086|NCT04111536|157119916|FG000|First Intervention (8 Weeks)|Adverse Event|0|||
48803087|NCT04111536|157119917|FG001|First Intervention (8 Weeks)|Adverse Event|1|||
48803088|NCT04111536|157119916|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
48803089|NCT04111536|157119917|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
48803090|NCT04111536|157119916|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
48803091|NCT04111536|157119917|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
48803092|NCT06037369|157119918|FG000|Overall Study|Lost to Follow-up|0|||
48803093|NCT06037369|157119919|FG001|Overall Study|Lost to Follow-up|1|||
48708270|NCT04421027|156779156|FG003|Follow-Up Period|Participant was alive but did not respond to calls|1|||
48708271|NCT04198714|156779157|FG000|Overall Study|Physician Decision|0|||
48708272|NCT04198714|156779158|FG001|Overall Study|Physician Decision|1|||
48708273|NCT01104311|156779159|FG000|Overall Study|Withdrawal by Subject|6|||
48708274|NCT01104311|156779160|FG001|Overall Study|Withdrawal by Subject|6|||
48708275|NCT01104311|156779159|FG000|Overall Study|Protocol Violation|0|||
48708276|NCT01104311|156779160|FG001|Overall Study|Protocol Violation|1|||
48708277|NCT01104311|156779159|FG000|Overall Study|Physician Decision|2|||
48708278|NCT01104311|156779160|FG001|Overall Study|Physician Decision|2|||
48708279|NCT01104311|156779159|FG000|Overall Study|low compliance|1|||
48708280|NCT01104311|156779160|FG001|Overall Study|low compliance|1|||
48708281|NCT01104311|156779159|FG000|Overall Study|Adverse Event|1|||
48708282|NCT01104311|156779160|FG001|Overall Study|Adverse Event|2|||
48708283|NCT00214201|156780882|FG000|Overall Study|Withdrawal by Subject|2|||
48708284|NCT00214201|156780883|FG001|Overall Study|Withdrawal by Subject|0|||
48708285|NCT00214201|156780882|FG000|Overall Study|Death|0|||
48708286|NCT00214201|156780883|FG001|Overall Study|Death|2|||
48708287|NCT02351856|156780885|FG000|Overall Study|Adverse Event|2|||
48708288|NCT02351856|156780885|FG000|Overall Study|Physician Decision|5|||
48708289|NCT02351856|156780885|FG000|Overall Study|Study terminated by sponsor|1|||
48708290|NCT01039376|156780886|FG000|Overall Study|Lost to Follow-up|5|||
48708291|NCT01039376|156780887|FG001|Overall Study|Lost to Follow-up|12|||
48708292|NCT01039376|156780886|FG000|Overall Study|Physician Decision|15|||
48708293|NCT01039376|156780887|FG001|Overall Study|Physician Decision|10|||
48708294|NCT01039376|156780886|FG000|Overall Study|Withdrawal by Subject|20|||
48708295|NCT01039376|156780887|FG001|Overall Study|Withdrawal by Subject|32|||
48708296|NCT01039376|156780886|FG000|Overall Study|Study terminated by Sponsor|90|||
48708297|NCT01039376|156780887|FG001|Overall Study|Study terminated by Sponsor|72|||
48708298|NCT00114517|156780888|FG000|Overall Study|Adverse Event|6|||
48708299|NCT00114517|156780889|FG001|Overall Study|Adverse Event|1|||
48708300|NCT00114517|156780890|FG002|Overall Study|Adverse Event|6|||
48708301|NCT00114517|156780891|FG003|Overall Study|Adverse Event|3|||
48708302|NCT00114517|156780888|FG000|Overall Study|Lost to Follow-up|2|||
48708303|NCT00114517|156780889|FG001|Overall Study|Lost to Follow-up|2|||
48708304|NCT00114517|156780890|FG002|Overall Study|Lost to Follow-up|2|||
48708305|NCT00114517|156780891|FG003|Overall Study|Lost to Follow-up|1|||
48708306|NCT00114517|156780888|FG000|Overall Study|Too busy|3|||
48708307|NCT00114517|156780889|FG001|Overall Study|Too busy|1|||
48708308|NCT00114517|156780890|FG002|Overall Study|Too busy|1|||
48708309|NCT00114517|156780891|FG003|Overall Study|Too busy|2|||
48708310|NCT00114517|156780888|FG000|Overall Study|Moved from area|0|||
48708311|NCT00114517|156780889|FG001|Overall Study|Moved from area|3|||
48708312|NCT00114517|156780890|FG002|Overall Study|Moved from area|2|||
48708313|NCT00114517|156780891|FG003|Overall Study|Moved from area|1|||
48708314|NCT00114517|156780888|FG000|Overall Study|Did not want estradiol|1|||
48708315|NCT00114517|156780889|FG001|Overall Study|Did not want estradiol|1|||
48708316|NCT00114517|156780890|FG002|Overall Study|Did not want estradiol|0|||
48708317|NCT00114517|156780891|FG003|Overall Study|Did not want estradiol|0|||
48708318|NCT00114517|156780888|FG000|Overall Study|Armed-services duty|0|||
48708319|NCT00114517|156780889|FG001|Overall Study|Armed-services duty|1|||
48708320|NCT00114517|156780890|FG002|Overall Study|Armed-services duty|0|||
48708321|NCT00114517|156780891|FG003|Overall Study|Armed-services duty|1|||
48708322|NCT00114517|156780888|FG000|Overall Study|Competing family issue|0|||
48708323|NCT00114517|156780889|FG001|Overall Study|Competing family issue|1|||
48708324|NCT00114517|156780890|FG002|Overall Study|Competing family issue|0|||
48708325|NCT00114517|156780891|FG003|Overall Study|Competing family issue|1|||
48708326|NCT00114517|156780888|FG000|Overall Study|Physician Decision|0|||
48708327|NCT00114517|156780889|FG001|Overall Study|Physician Decision|1|||
48708328|NCT00114517|156780890|FG002|Overall Study|Physician Decision|0|||
48708329|NCT00114517|156780891|FG003|Overall Study|Physician Decision|0|||
48708330|NCT00114517|156780888|FG000|Overall Study|Lost interest|0|||
48708331|NCT00114517|156780889|FG001|Overall Study|Lost interest|0|||
48708332|NCT00114517|156780890|FG002|Overall Study|Lost interest|1|||
48708333|NCT00114517|156780891|FG003|Overall Study|Lost interest|0|||
48708334|NCT00114517|156780888|FG000|Overall Study|Weight increase|0|||
48803094|NCT04181762|157119920|FG000|Overall Study|Adverse Event|1|||
48803095|NCT04181762|157119921|FG001|Overall Study|Adverse Event|3|||
48803096|NCT04181762|157119920|FG000|Overall Study|Lost to Follow-up|1|||
48803097|NCT04181762|157119921|FG001|Overall Study|Lost to Follow-up|1|||
48803098|NCT04181762|157119920|FG000|Overall Study|Physician Decision|1|||
48803099|NCT04181762|157119921|FG001|Overall Study|Physician Decision|3|||
48803100|NCT04181762|157119920|FG000|Overall Study|Pregnancy|0|||
48803101|NCT04181762|157119921|FG001|Overall Study|Pregnancy|1|||
48803102|NCT04181762|157119920|FG000|Overall Study|Lack of Efficacy|2|||
48803103|NCT04181762|157119921|FG001|Overall Study|Lack of Efficacy|2|||
48803104|NCT04181762|157119920|FG000|Overall Study|Study terminated by sponsor|95|||
48803105|NCT04181762|157119921|FG001|Overall Study|Study terminated by sponsor|97|||
48708335|NCT00114517|156780889|FG001|Overall Study|Weight increase|0|||
48708336|NCT00114517|156780890|FG002|Overall Study|Weight increase|1|||
48914617|NCT02230384|157523020|FG000|Phase 2 - Switch|Lost to Follow-up|1|||
48914618|NCT02230384|157523021|FG001|Phase 2 - Switch|Lost to Follow-up|0|||
48914619|NCT02230384|157523020|FG000|Phase 2 - Switch|Adverse Event|2|||
48914620|NCT02230384|157523021|FG001|Phase 2 - Switch|Adverse Event|0|||
48914621|NCT00808236|157523022|FG000|Overall Study|Was not resuscitated|50|||
48914622|NCT00808236|157523023|FG001|Overall Study|Was not resuscitated|56|||
48914623|NCT00808236|157523022|FG000|Overall Study|Pre-defined exclusion|13|||
48914624|NCT00808236|157523023|FG001|Overall Study|Pre-defined exclusion|3|||
48914625|NCT00808236|157523022|FG000|Overall Study|Lost to Follow-up|1|||
48914626|NCT00808236|157523023|FG001|Overall Study|Lost to Follow-up|1|||
48914627|NCT00808236|157523022|FG000|Overall Study|Physician Decision|0|||
48914628|NCT00808236|157523023|FG001|Overall Study|Physician Decision|1|||
48914629|NCT00808236|157523022|FG000|Overall Study|Death|18|||
48914630|NCT00808236|157523023|FG001|Overall Study|Death|30|||
48708337|NCT00114517|156780891|FG003|Overall Study|Weight increase|0|||
48708338|NCT00114517|156780888|FG000|Overall Study|Concern about blood clots|0|||
48708339|NCT00114517|156780889|FG001|Overall Study|Concern about blood clots|0|||
48708340|NCT00114517|156780890|FG002|Overall Study|Concern about blood clots|1|||
48708341|NCT00114517|156780891|FG003|Overall Study|Concern about blood clots|0|||
48708342|NCT00114517|156780888|FG000|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
48708343|NCT00114517|156780889|FG001|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
48708344|NCT00114517|156780890|FG002|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
48708345|NCT00114517|156780891|FG003|Overall Study|Breast cancer diagnosis on baseline mammogram|1|||
48708346|NCT03252925|156780892|FG000|Overall Study|Withdrawal by Subject|1|||
48708347|NCT03252925|156780893|FG001|Overall Study|Withdrawal by Subject|0|||
48708348|NCT03252925|156780892|FG000|Overall Study|Protocol Violation|6|||
48708349|NCT03252925|156780893|FG001|Overall Study|Protocol Violation|0|||
48708350|NCT03252925|156780892|FG000|Overall Study|Adverse Event|1|||
48708351|NCT03252925|156780893|FG001|Overall Study|Adverse Event|0|||
48708352|NCT03252925|156780892|FG000|Overall Study|Lost to Follow-up|6|||
48708353|NCT03252925|156780893|FG001|Overall Study|Lost to Follow-up|6|||
48708354|NCT00357552|156780894|FG000|Screening|Did not meet eligibility criteria|84|||
48708355|NCT00357552|156780894|FG000|Weeks 0 to 24|Death|1|||
48708356|NCT00357552|156780894|FG000|Weeks 24 to 104|Death|3|||
48708357|NCT00357552|156780894|FG000|Weeks 24 to 104|Not able to get to clinic|2|||
48708358|NCT01908803|156780909|FG000|Overall Study|Adverse Event|1|||
48708359|NCT01908803|156780910|FG001|Overall Study|Adverse Event|0|||
48708360|NCT01908803|156780909|FG000|Overall Study|Physician Decision|0|||
48708361|NCT01908803|156780910|FG001|Overall Study|Physician Decision|1|||
48708362|NCT01908803|156780909|FG000|Overall Study|Withdrawal by Subject|1|||
48708363|NCT01908803|156780910|FG001|Overall Study|Withdrawal by Subject|0|||
48708364|NCT01908803|156780909|FG000|Overall Study|Randomization Error|1|||
48708365|NCT01908803|156780910|FG001|Overall Study|Randomization Error|0|||
48708366|NCT01908803|156780909|FG000|Overall Study|Adverse Event (pre-treatment)|1|||
48708367|NCT01908803|156780910|FG001|Overall Study|Adverse Event (pre-treatment)|0|||
48708368|NCT00867815|156780911|FG000|Overall Study|Lost to Follow-up|1|||
48708369|NCT02404025|156780912|FG000|Overall Study|Adverse Event|1|||
48708370|NCT02404025|156780912|FG000|Overall Study|Lack of Efficacy|3|||
48708371|NCT00098813|156780913|FG000|Overall Study|Death|8|||
48708372|NCT00098813|156780913|FG000|Overall Study|Protocol Violation|1|||
48708373|NCT00098813|156780913|FG000|Overall Study|Withdrawal by Subject|7|||
48708374|NCT00098813|156780913|FG000|Overall Study|Progression of Disease|1|||
48708375|NCT00098813|156780913|FG000|Overall Study|Other complicating disease|1|||
48803106|NCT04181762|157119920|FG000|Overall Study|Subject decision|11|||
48803107|NCT04181762|157119921|FG001|Overall Study|Subject decision|4|||
48914631|NCT02664272|157523028|FG000|Overall Study|Fluoroscopic images not made available|2|||
48914632|NCT03073980|157523034|FG000|Overall Study|Lost to Follow-up|10|||
49010695|NCT02378506|157875677|FG000|Overall Study|Protocol Violation|2|||
48803108|NCT04181762|157119920|FG000|Overall Study|Death|1|||
48803109|NCT04181762|157119921|FG001|Overall Study|Death|1|||
49010696|NCT02378506|157875677|FG000|Overall Study|Death|1|||
49010697|NCT02378506|157875677|FG000|Overall Study|Adverse Event|14|||
49010698|NCT02378506|157875677|FG000|Overall Study|Randomized But Not Treated|1|||
48914633|NCT03073980|157523035|FG001|Overall Study|Lost to Follow-up|2|||
48914634|NCT03073980|157523036|FG002|Overall Study|Lost to Follow-up|9|||
48914635|NCT03073980|157523034|FG000|Overall Study|No post-procedure data|0|||
48914636|NCT03073980|157523035|FG001|Overall Study|No post-procedure data|0|||
48914637|NCT03073980|157523036|FG002|Overall Study|No post-procedure data|2|||
48914638|NCT00545064|157523041|FG000|Overall Study|Lost to Follow-up|3|||
48914639|NCT00545064|157523041|FG000|Overall Study|Withdrawal by Subject|2|||
48914640|NCT00545064|157523041|FG000|Overall Study|did not complete course of treatment|1|||
48914641|NCT00545064|157523041|FG000|Overall Study|cancel all appointments, no rebooking|1|||
48914642|NCT00545064|157523041|FG000|Overall Study|inclement weather|1|||
48914643|NCT02739620|157523046|FG000|Overall Study|Lost to Follow-up|3|||
48914644|NCT02739620|157523047|FG001|Overall Study|Lost to Follow-up|1|||
48914645|NCT02739620|157523046|FG000|Overall Study|Adverse Event|0|||
48914646|NCT02739620|157523047|FG001|Overall Study|Adverse Event|1|||
48914647|NCT02873936|157523048|FG000|Overall Study|Withdrew Consent|4|||
48914648|NCT02873936|157523049|FG001|Overall Study|Withdrew Consent|11|||
48914649|NCT02873936|157523050|FG002|Overall Study|Withdrew Consent|20|||
48914650|NCT02873936|157523048|FG000|Overall Study|Investigator's Discretion|3|||
48914651|NCT02873936|157523049|FG001|Overall Study|Investigator's Discretion|5|||
48914652|NCT02873936|157523050|FG002|Overall Study|Investigator's Discretion|4|||
48914653|NCT02873936|157523048|FG000|Overall Study|Adverse Event|3|||
48914654|NCT02873936|157523049|FG001|Overall Study|Adverse Event|5|||
48914655|NCT02873936|157523050|FG002|Overall Study|Adverse Event|3|||
48914656|NCT02873936|157523048|FG000|Overall Study|Protocol Violation|0|||
48914657|NCT02873936|157523049|FG001|Overall Study|Protocol Violation|1|||
48914658|NCT02873936|157523050|FG002|Overall Study|Protocol Violation|3|||
48914659|NCT02873936|157523048|FG000|Overall Study|Lost to Follow-up|1|||
48914660|NCT02873936|157523049|FG001|Overall Study|Lost to Follow-up|1|||
48914661|NCT02873936|157523050|FG002|Overall Study|Lost to Follow-up|1|||
48914662|NCT02873936|157523048|FG000|Overall Study|Non-compliance With Study Drug|1|||
48914663|NCT02873936|157523049|FG001|Overall Study|Non-compliance With Study Drug|0|||
48914664|NCT02873936|157523050|FG002|Overall Study|Non-compliance With Study Drug|1|||
48914665|NCT02873936|157523048|FG000|Overall Study|Randomized but not Dosed|1|||
48914666|NCT02873936|157523049|FG001|Overall Study|Randomized but not Dosed|0|||
48914667|NCT02873936|157523050|FG002|Overall Study|Randomized but not Dosed|0|||
48914668|NCT01585272|157523051|FG000|Overall Study|Adverse Event|22|||
48914669|NCT01585272|157523051|FG000|Overall Study|Protocol Violation|7|||
48914670|NCT01585272|157523051|FG000|Overall Study|Withdrawal by Subject|10|||
48914671|NCT00219284|157523056|FG000|Treatment Phase - 16 Weeks|Adverse Event|26|||
48914672|NCT00219284|157523057|FG001|Treatment Phase - 16 Weeks|Adverse Event|24|||
48914673|NCT00219284|157523056|FG000|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0|||
48914674|NCT00219284|157523057|FG001|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1|||
48914675|NCT00219284|157523056|FG000|Treatment Phase - 16 Weeks|Lack of Efficacy|3|||
49119036|NCT02526160|158274595|FG000|Open-label Treatment Continuation Period|Withdrawal by Subject|0|||
49119037|NCT02526160|158274596|FG001|Open-label Treatment Continuation Period|Withdrawal by Subject|1|||
48708376|NCT00098813|156780913|FG000|Overall Study|Reversal of RAI resistance|1|||
48708377|NCT01716052|156780914|FG000|Overall Study|Withdrawal of funding|1|||
48708378|NCT01716052|156780915|FG001|Overall Study|Withdrawal of funding|1|||
48708379|NCT00372593|156780916|FG000|Overall Study|Adverse Event|43|||
48708380|NCT00372593|156780917|FG001|Overall Study|Adverse Event|45|||
48708381|NCT00372593|156780918|FG002|Overall Study|Adverse Event|0|||
48914676|NCT00219284|157523057|FG001|Treatment Phase - 16 Weeks|Lack of Efficacy|10|||
48914677|NCT00219284|157523056|FG000|Treatment Phase - 16 Weeks|Protocol Violation|9|||
48914678|NCT00219284|157523057|FG001|Treatment Phase - 16 Weeks|Protocol Violation|5|||
48914679|NCT00219284|157523056|FG000|Treatment Phase - 16 Weeks|Withdrawal by Subject|5|||
48914680|NCT00219284|157523057|FG001|Treatment Phase - 16 Weeks|Withdrawal by Subject|9|||
48914681|NCT00219284|157523056|FG000|Treatment Phase - 16 Weeks|Lost to Follow-up|1|||
48914682|NCT00219284|157523057|FG001|Treatment Phase - 16 Weeks|Lost to Follow-up|2|||
48914683|NCT00219284|157523056|FG000|Extension Phase - 8 Weeks|Adverse Event|2|||
48914684|NCT00219284|157523057|FG001|Extension Phase - 8 Weeks|Adverse Event|3|||
48914685|NCT00219284|157523056|FG000|Extension Phase - 8 Weeks|Withdrawal by Subject|0|||
48914686|NCT00219284|157523057|FG001|Extension Phase - 8 Weeks|Withdrawal by Subject|2|||
48914687|NCT00219284|157523056|FG000|Extension Phase - 8 Weeks|Lost to Follow-up|0|||
48914688|NCT00219284|157523057|FG001|Extension Phase - 8 Weeks|Lost to Follow-up|2|||
48914689|NCT03028870|157523058|FG000|Overall Study|Adverse Event|7|||
48914690|NCT03028870|157523059|FG001|Overall Study|Adverse Event|4|||
48914691|NCT03028870|157523060|FG002|Overall Study|Adverse Event|3|||
48914692|NCT03028870|157523061|FG003|Overall Study|Adverse Event|3|||
48914693|NCT03028870|157523058|FG000|Overall Study|Withdrawal by Subject|1|||
48914694|NCT03028870|157523059|FG001|Overall Study|Withdrawal by Subject|1|||
48914695|NCT03028870|157523060|FG002|Overall Study|Withdrawal by Subject|1|||
48914696|NCT03028870|157523061|FG003|Overall Study|Withdrawal by Subject|2|||
48914697|NCT03028870|157523058|FG000|Overall Study|Lost to Follow-up|1|||
48914698|NCT03028870|157523059|FG001|Overall Study|Lost to Follow-up|0|||
48708382|NCT00372593|156780916|FG000|Overall Study|Death|16|||
48803110|NCT04181762|157119920|FG000|Overall Study|Protocol deviation|1|||
48803111|NCT04181762|157119921|FG001|Overall Study|Protocol deviation|0|||
48803112|NCT04181762|157119920|FG000|Overall Study|Withdrawal of informed consent|1|||
48803113|NCT04181762|157119921|FG001|Overall Study|Withdrawal of informed consent|3|||
48803114|NCT01368900|157119922|FG000|Overall Study|Lost to Follow-up|7|||
48803115|NCT04027348|157119923|FG000|Overall Study|Adverse Event|2|||
48803116|NCT02487472|157119924|FG000|Overall Study|Did not complete telephonic interviews|9|||
48803117|NCT02487472|157119924|FG000|Overall Study|Other|2|||
48803118|NCT01224158|157119925|FG000|Overall Study|Withdrawal by Subject|1|||
48803119|NCT01224158|157119926|FG001|Overall Study|Withdrawal by Subject|0|||
48803120|NCT02055157|157119927|FG000|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
48803121|NCT02055157|157119928|FG001|Initial 6 Months|Subject discontinued due to NeedlePhobia|1|||
48803122|NCT02055157|157119929|FG002|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
48803123|NCT02055157|157119930|FG003|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
48803124|NCT02055157|157119927|FG000|Initial 6 Months|Adverse Event|0|||
48803125|NCT02055157|157119928|FG001|Initial 6 Months|Adverse Event|0|||
48803126|NCT02055157|157119929|FG002|Initial 6 Months|Adverse Event|0|||
48803127|NCT02055157|157119930|FG003|Initial 6 Months|Adverse Event|1|||
48803128|NCT02055157|157119927|FG000|Initial 6 Months|Consent withdrawn by subject|1|||
48803129|NCT02055157|157119928|FG001|Initial 6 Months|Consent withdrawn by subject|0|||
48803130|NCT02055157|157119929|FG002|Initial 6 Months|Consent withdrawn by subject|0|||
48803131|NCT02055157|157119930|FG003|Initial 6 Months|Consent withdrawn by subject|0|||
48803132|NCT02055157|157119927|FG000|18-month Extension|Investigator decision|0|||
48803133|NCT02055157|157119928|FG001|18-month Extension|Investigator decision|1|||
48803134|NCT02055157|157119929|FG002|18-month Extension|Investigator decision|0|||
48803135|NCT02055157|157119930|FG003|18-month Extension|Investigator decision|0|||
48803136|NCT02055157|157119927|FG000|18-month Extension|Subject discontinued due to NeedlePhobia|1|||
48803137|NCT02055157|157119928|FG001|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
48803138|NCT02055157|157119929|FG002|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
48803139|NCT02055157|157119930|FG003|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
48803140|NCT03988166|157119931|FG000|Overall Study|Lost to Follow-up|2|||
48803141|NCT03988166|157119931|FG000|Overall Study|Death|1|||
48803142|NCT01807650|157119934|FG000|Overall Study|Lack of Full Wound Closure at Day 28|13|||
48803143|NCT01807650|157119934|FG000|Overall Study|Adverse Event|5|||
48803144|NCT01807650|157119934|FG000|Overall Study|Other|2|||
48803145|NCT02090634|157119937|FG000|Overall Study|Lost to Follow-up|0|||
48803146|NCT02090634|157119938|FG001|Overall Study|Lost to Follow-up|1|||
48803147|NCT02090634|157119937|FG000|Overall Study|Death|0|||
48803148|NCT02090634|157119938|FG001|Overall Study|Death|1|||
48803149|NCT02090634|157119937|FG000|Overall Study|Protocol Violation|3|||
48803150|NCT02090634|157119938|FG001|Overall Study|Protocol Violation|1|||
48803151|NCT02090634|157119937|FG000|Overall Study|Adverse Event|2|||
48803152|NCT02090634|157119938|FG001|Overall Study|Adverse Event|0|||
48803153|NCT00895622|157119939|FG000|Overall Study|Protocol Violation|5|||
48803154|NCT00895622|157119940|FG001|Overall Study|Protocol Violation|4|||
48803155|NCT00895622|157119941|FG002|Overall Study|Protocol Violation|4|||
48803156|NCT00695786|157121724|FG000|Overall Study|Adverse Event|0|||
48803157|NCT00695786|157121725|FG001|Overall Study|Adverse Event|3|||
48803158|NCT00695786|157121726|FG002|Overall Study|Adverse Event|4|||
48803159|NCT00695786|157121727|FG003|Overall Study|Adverse Event|2|||
48803160|NCT00695786|157121724|FG000|Overall Study|Lost to Follow-up|0|||
48803161|NCT00695786|157121725|FG001|Overall Study|Lost to Follow-up|5|||
48803162|NCT00695786|157121726|FG002|Overall Study|Lost to Follow-up|1|||
48803163|NCT00695786|157121727|FG003|Overall Study|Lost to Follow-up|1|||
48803164|NCT00695786|157121724|FG000|Overall Study|Withdrawal by Subject|0|||
48803165|NCT00695786|157121725|FG001|Overall Study|Withdrawal by Subject|4|||
48803166|NCT00695786|157121726|FG002|Overall Study|Withdrawal by Subject|3|||
48803167|NCT00695786|157121727|FG003|Overall Study|Withdrawal by Subject|1|||
48803168|NCT00695786|157121724|FG000|Overall Study|Deemed Ineligible|1|||
48914699|NCT03028870|157523060|FG002|Overall Study|Lost to Follow-up|0|||
48914700|NCT03028870|157523061|FG003|Overall Study|Lost to Follow-up|0|||
48914701|NCT03028870|157523058|FG000|Overall Study|Lack of Efficacy|3|||
48914702|NCT03028870|157523059|FG001|Overall Study|Lack of Efficacy|0|||
48914703|NCT03028870|157523060|FG002|Overall Study|Lack of Efficacy|0|||
48914704|NCT03028870|157523061|FG003|Overall Study|Lack of Efficacy|0|||
48914705|NCT03028870|157523058|FG000|Overall Study|Administrative|5|||
48914706|NCT03028870|157523059|FG001|Overall Study|Administrative|5|||
48803169|NCT00695786|157121725|FG001|Overall Study|Deemed Ineligible|0|||
48803170|NCT00695786|157121726|FG002|Overall Study|Deemed Ineligible|0|||
48803171|NCT00695786|157121727|FG003|Overall Study|Deemed Ineligible|0|||
48803172|NCT00695786|157121724|FG000|Overall Study|Lack of Efficacy|0|||
48803173|NCT00695786|157121725|FG001|Overall Study|Lack of Efficacy|0|||
48803174|NCT00695786|157121726|FG002|Overall Study|Lack of Efficacy|0|||
48803175|NCT00695786|157121727|FG003|Overall Study|Lack of Efficacy|4|||
48803176|NCT03092375|157121732|FG000|Overall Study|Lack of Efficacy|0|||
48803177|NCT03092375|157121733|FG001|Overall Study|Lack of Efficacy|1|||
48803178|NCT03092375|157121734|FG002|Overall Study|Lack of Efficacy|1|||
48914707|NCT03028870|157523060|FG002|Overall Study|Administrative|12|||
48914708|NCT03028870|157523061|FG003|Overall Study|Administrative|4|||
48914709|NCT03184077|157523062|FG000|Overall Study|Lost to Follow-up|21|||
48914710|NCT03184077|157523063|FG001|Overall Study|Lost to Follow-up|21|||
48914711|NCT00708123|157523064|FG000|Period 1|Protocol Violation|0|||
48914712|NCT00708123|157523065|FG001|Period 1|Protocol Violation|1|||
48914713|NCT00708123|157523066|FG002|Period 1|Protocol Violation|0|||
48914714|NCT00708123|157523067|FG003|Period 1|Protocol Violation|1|||
48914715|NCT00708123|157523068|FG004|Period 1|Protocol Violation|0|||
48914716|NCT00708123|157523064|FG000|Period 1|Adverse Event|0|||
48914717|NCT00708123|157523065|FG001|Period 1|Adverse Event|0|||
48914718|NCT00708123|157523066|FG002|Period 1|Adverse Event|1|||
48914719|NCT00708123|157523067|FG003|Period 1|Adverse Event|0|||
48914720|NCT00708123|157523068|FG004|Period 1|Adverse Event|0|||
48803179|NCT03092375|157121735|FG003|Overall Study|Lack of Efficacy|0|||
48803180|NCT04098406|157121738|FG000|Overall Study|Adverse Event|2|||
48803181|NCT04098406|157121739|FG001|Overall Study|Adverse Event|1|||
48803182|NCT04098406|157121738|FG000|Overall Study|Withdrawal by Subject|1|||
48803183|NCT04098406|157121739|FG001|Overall Study|Withdrawal by Subject|0|||
48803184|NCT02832622|157121740|FG000|Overall Study|MPP not programmed|1259|||
48803185|NCT02832622|157121740|FG000|Overall Study|Withdrawal by Subject|123|||
48803186|NCT02832622|157121740|FG000|Overall Study|Death|119|||
48803187|NCT02832622|157121740|FG000|Overall Study|Unsuccessful CRT implant|93|||
48803188|NCT02832622|157121740|FG000|Overall Study|Lost to Follow-up|45|||
48803189|NCT02832622|157121740|FG000|Overall Study|Patient non-compliance|42|||
48803190|NCT02832622|157121740|FG000|Overall Study|Withdrawal by other reasons|25|||
48803191|NCT02832622|157121740|FG000|Overall Study|System explant|24|||
48803192|NCT02832622|157121740|FG000|Overall Study|Physician Decision|6|||
48803193|NCT02472652|157121743|FG000|Overall Study|Lost to Follow-up|1|||
48803194|NCT00998400|157121744|FG000|Overall Study|Lack of interest/motivation|1|||
48803195|NCT00998400|157121745|FG001|Overall Study|Lack of interest/motivation|2|||
48803196|NCT00998400|157121744|FG000|Overall Study|Logistical problems|1|||
48803197|NCT00998400|157121745|FG001|Overall Study|Logistical problems|0|||
48803198|NCT03122119|157121746|FG000|Overall Study|Did not meet eligibility critria|1|||
48803199|NCT02127372|157121747|FG000|Overall Study|Withdrawal by Subject|1|||
48803200|NCT02127372|157121748|FG001|Overall Study|Withdrawal by Subject|0|||
48803201|NCT01191840|157121749|FG000|Overall Study|withdrew consent|2|||
48803202|NCT01191840|157121750|FG001|Overall Study|withdrew consent|1|||
48803203|NCT01191840|157121749|FG000|Overall Study|Subject discontinued treatment|1|||
48803204|NCT01191840|157121750|FG001|Overall Study|Subject discontinued treatment|2|||
48803205|NCT01191840|157121749|FG000|Overall Study|Lost to Follow-up|4|||
48803206|NCT01191840|157121750|FG001|Overall Study|Lost to Follow-up|6|||
48803207|NCT01191840|157121749|FG000|Overall Study|Non Staph Infection|4|||
48803208|NCT01191840|157121750|FG001|Overall Study|Non Staph Infection|3|||
48803209|NCT01191840|157121749|FG000|Overall Study|ineligible at enrollment|1|||
48803210|NCT01191840|157121750|FG001|Overall Study|ineligible at enrollment|0|||
48803211|NCT01191840|157121749|FG000|Overall Study|IRB approval lapse|0|||
48803212|NCT01191840|157121750|FG001|Overall Study|IRB approval lapse|2|||
48803213|NCT01191840|157121749|FG000|Overall Study|lab error speciation - non Staph infecti|0|||
48803214|NCT01191840|157121750|FG001|Overall Study|lab error speciation - non Staph infecti|1|||
48803215|NCT01191840|157121749|FG000|Overall Study|Withdrawal by Subject|2|||
48803216|NCT01191840|157121750|FG001|Overall Study|Withdrawal by Subject|0|||
48803217|NCT01392300|157121751|FG000|Main Period (MP)|Predefined discontinuation criteria|2|||
48803218|NCT01392300|157121752|FG001|Main Period (MP)|Predefined discontinuation criteria|3|||
48803219|NCT01392300|157121753|FG002|Main Period (MP)|Predefined discontinuation criteria|0|||
48803220|NCT01392300|157121751|FG000|Main Period (MP)|Withdrawal by Subject|5|||
48803221|NCT01392300|157121752|FG001|Main Period (MP)|Withdrawal by Subject|1|||
48803222|NCT01392300|157121753|FG002|Main Period (MP)|Withdrawal by Subject|0|||
48914721|NCT00708123|157523064|FG000|Period 2|Protocol Violation|0|||
48914722|NCT00708123|157523065|FG001|Period 2|Protocol Violation|0|||
48914723|NCT00708123|157523066|FG002|Period 2|Protocol Violation|0|||
48914724|NCT00708123|157523067|FG003|Period 2|Protocol Violation|1|||
48914725|NCT00708123|157523068|FG004|Period 2|Protocol Violation|0|||
48914726|NCT00708123|157523064|FG000|Period 2|Other Reason|1|||
48803223|NCT01392300|157121751|FG000|Main Period (MP)|Lost to Follow-up|3|||
48803224|NCT01392300|157121752|FG001|Main Period (MP)|Lost to Follow-up|3|||
48803225|NCT01392300|157121753|FG002|Main Period (MP)|Lost to Follow-up|0|||
48803226|NCT01392300|157121751|FG000|Main Period (MP)|Non-compliance|1|||
48803227|NCT01392300|157121752|FG001|Main Period (MP)|Non-compliance|0|||
48803228|NCT01392300|157121753|FG002|Main Period (MP)|Non-compliance|0|||
48803229|NCT01392300|157121751|FG000|Open Label Extension (OLEX) Period|Protocol Violation|0|||
48914727|NCT00708123|157523065|FG001|Period 2|Other Reason|0|||
48914728|NCT00708123|157523066|FG002|Period 2|Other Reason|0|||
48914729|NCT00708123|157523067|FG003|Period 2|Other Reason|0|||
48914730|NCT00708123|157523068|FG004|Period 2|Other Reason|0|||
48914731|NCT00708123|157523064|FG000|Period 3|Lost to Follow-up|0|||
48803230|NCT01392300|157121752|FG001|Open Label Extension (OLEX) Period|Protocol Violation|0|||
48914732|NCT00708123|157523065|FG001|Period 3|Lost to Follow-up|0|||
48914733|NCT00708123|157523066|FG002|Period 3|Lost to Follow-up|1|||
48914734|NCT00708123|157523067|FG003|Period 3|Lost to Follow-up|1|||
48914735|NCT00708123|157523068|FG004|Period 3|Lost to Follow-up|0|||
48914736|NCT00708123|157523064|FG000|Period 4|Protocol Violation|0|||
48914737|NCT00708123|157523065|FG001|Period 4|Protocol Violation|1|||
48914738|NCT00708123|157523066|FG002|Period 4|Protocol Violation|0|||
48914739|NCT00708123|157523067|FG003|Period 4|Protocol Violation|0|||
48914740|NCT00708123|157523068|FG004|Period 4|Protocol Violation|0|||
48914741|NCT04013529|157523069|FG000|Overall Study|Withdrawal by Subject|1|||
48914742|NCT04013529|157523070|FG001|Overall Study|Withdrawal by Subject|1|||
48914743|NCT00254501|157523071|FG000|Overall Study|Lost to Follow-up|1|||
48914744|NCT00254501|157523072|FG001|Overall Study|Lost to Follow-up|1|||
48914745|NCT00262522|157523073|FG000|Study Start Through 8 Weeks|Adverse Event|1|||
48914746|NCT00262522|157523074|FG001|Study Start Through 8 Weeks|Adverse Event|2|||
48914747|NCT00262522|157523075|FG002|Study Start Through 8 Weeks|Adverse Event|3|||
49119038|NCT02526160|158274595|FG000|Open-label Treatment Continuation Period|Other, Not Specified|3|||
49119039|NCT02526160|158274596|FG001|Open-label Treatment Continuation Period|Other, Not Specified|3|||
49119040|NCT02526160|158274595|FG000|Open-Label Treatment Extension Period I|Death|0|||
48914748|NCT00262522|157523076|FG003|Study Start Through 8 Weeks|Adverse Event|1|||
48708383|NCT00372593|156780917|FG001|Overall Study|Death|20|||
48914749|NCT00262522|157523073|FG000|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
48914750|NCT00262522|157523074|FG001|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
48914751|NCT00262522|157523075|FG002|Study Start Through 8 Weeks|Withdrawal by Subject|3|||
48914752|NCT00262522|157523076|FG003|Study Start Through 8 Weeks|Withdrawal by Subject|0|||
48914753|NCT00262522|157523073|FG000|Study Start Through 8 Weeks|Lost to Follow-up|1|||
48914754|NCT00262522|157523074|FG001|Study Start Through 8 Weeks|Lost to Follow-up|2|||
48914755|NCT00262522|157523075|FG002|Study Start Through 8 Weeks|Lost to Follow-up|3|||
48914756|NCT00262522|157523076|FG003|Study Start Through 8 Weeks|Lost to Follow-up|2|||
48914757|NCT00262522|157523073|FG000|Study Start Through 8 Weeks|Noncompliance|0|||
48914758|NCT00262522|157523074|FG001|Study Start Through 8 Weeks|Noncompliance|0|||
48914759|NCT00262522|157523075|FG002|Study Start Through 8 Weeks|Noncompliance|2|||
48914760|NCT00262522|157523076|FG003|Study Start Through 8 Weeks|Noncompliance|2|||
48914761|NCT00262522|157523073|FG000|Study Start Through 8 Weeks|Death|1|||
48914762|NCT00262522|157523074|FG001|Study Start Through 8 Weeks|Death|0|||
49119041|NCT02526160|158274596|FG001|Open-Label Treatment Extension Period I|Death|1|||
49119042|NCT02526160|158274595|FG000|Open-Label Treatment Extension Period I|Other, Not Specified|3|||
49119043|NCT02526160|158274596|FG001|Open-Label Treatment Extension Period I|Other, Not Specified|1|||
49119044|NCT02526160|158274595|FG000|Open-Label Treatment Extension Period I|Withdrawal by Subject|0|||
49119045|NCT02526160|158274596|FG001|Open-Label Treatment Extension Period I|Withdrawal by Subject|1|||
49119046|NCT02526160|158274595|FG000|Open-Label Treatment Extension Period I|Lost to Follow-up|0|||
49119047|NCT02526160|158274596|FG001|Open-Label Treatment Extension Period I|Lost to Follow-up|1|||
49119048|NCT02526160|158274595|FG000|Open-Label Treatment Extension Period II|Other, Not Specified|1|||
49119049|NCT02526160|158274596|FG001|Open-Label Treatment Extension Period II|Other, Not Specified|0|||
49119050|NCT00410072|158274598|FG000|Day 1 to Week 48|Adverse Event|1|||
49119051|NCT00410072|158274599|FG001|Day 1 to Week 48|Adverse Event|2|||
48708384|NCT00372593|156780918|FG002|Overall Study|Death|1|||
48708385|NCT00372593|156780916|FG000|Overall Study|Lack of Efficacy|82|||
48708386|NCT00372593|156780917|FG001|Overall Study|Lack of Efficacy|71|||
48708387|NCT00372593|156780918|FG002|Overall Study|Lack of Efficacy|2|||
48708388|NCT00372593|156780916|FG000|Overall Study|Lost to Follow-up|1|||
48708389|NCT00372593|156780917|FG001|Overall Study|Lost to Follow-up|0|||
48708390|NCT00372593|156780918|FG002|Overall Study|Lost to Follow-up|0|||
48708391|NCT00372593|156780916|FG000|Overall Study|Physician Decision|42|||
48708392|NCT00372593|156780917|FG001|Overall Study|Physician Decision|41|||
48708393|NCT00372593|156780918|FG002|Overall Study|Physician Decision|0|||
48708394|NCT00372593|156780916|FG000|Overall Study|Ineligible|20|||
48708395|NCT00372593|156780917|FG001|Overall Study|Ineligible|21|||
48708396|NCT00372593|156780918|FG002|Overall Study|Ineligible|1|||
48708397|NCT02779556|156780924|FG000|Baseline|Partial baseline interview completed|1|||
48708398|NCT02779556|156780925|FG001|Baseline|Partial baseline interview completed|0|||
48708399|NCT02779556|156780924|FG000|3 Months|Lost to Follow-up|40|||
48708400|NCT02779556|156780925|FG001|3 Months|Lost to Follow-up|29|||
48708401|NCT02779556|156780924|FG000|3 Months|Missed 3 month clinic visit|27|||
48708402|NCT02779556|156780925|FG001|3 Months|Missed 3 month clinic visit|19|||
48708403|NCT02779556|156780924|FG000|6 Month|Lost to Follow-up|33|||
48708404|NCT02779556|156780925|FG001|6 Month|Lost to Follow-up|39|||
48708405|NCT02779556|156780924|FG000|6 Month HbA1c|No value collected during window|69|||
48708406|NCT02779556|156780925|FG001|6 Month HbA1c|No value collected during window|50|||
48708407|NCT02779556|156780924|FG000|12 Month HbA1c|No value collected during window|138|||
48708408|NCT02779556|156780925|FG001|12 Month HbA1c|No value collected during window|102|||
48708409|NCT01544335|156780926|FG000|Overall Study|Lost to Follow-up|27|||
48708410|NCT01544335|156780926|FG000|Overall Study|Death|4|||
48708411|NCT01544335|156780926|FG000|Overall Study|Disease progression|3|||
48914763|NCT00262522|157523075|FG002|Study Start Through 8 Weeks|Death|0|||
49119052|NCT00410072|158274598|FG000|Day 1 to Week 48|Lost to Follow-up|5|||
49119053|NCT00410072|158274599|FG001|Day 1 to Week 48|Lost to Follow-up|2|||
49119054|NCT00410072|158274598|FG000|Day 1 to Week 48|Other|0|||
49119055|NCT00410072|158274599|FG001|Day 1 to Week 48|Other|1|||
49119056|NCT00410072|158274598|FG000|Day 1 to Week 48|poor compliance/noncompliance|0|||
49119057|NCT00410072|158274599|FG001|Day 1 to Week 48|poor compliance/noncompliance|3|||
49119058|NCT00410072|158274598|FG000|Day 1 to Week 48|Pregnancy|0|||
49119059|NCT00410072|158274599|FG001|Day 1 to Week 48|Pregnancy|2|||
49119060|NCT00410072|158274598|FG000|Day 1 to Week 48|Withdrawal by Subject|0|||
49119061|NCT00410072|158274599|FG001|Day 1 to Week 48|Withdrawal by Subject|2|||
49119062|NCT00410072|158274598|FG000|After Week 48 to Week 96|Adverse Event|1|||
49119063|NCT00410072|158274599|FG001|After Week 48 to Week 96|Adverse Event|2|||
49119064|NCT00410072|158274598|FG000|After Week 48 to Week 96|Death|0|||
49119065|NCT00410072|158274599|FG001|After Week 48 to Week 96|Death|1|||
49119066|NCT00410072|158274598|FG000|After Week 48 to Week 96|Lack of Efficacy|1|||
49119067|NCT00410072|158274599|FG001|After Week 48 to Week 96|Lack of Efficacy|0|||
49119068|NCT00410072|158274598|FG000|After Week 48 to Week 96|Lost to Follow-up|2|||
49119069|NCT00410072|158274599|FG001|After Week 48 to Week 96|Lost to Follow-up|4|||
49119070|NCT00410072|158274598|FG000|After Week 48 to Week 96|Other|2|||
49119071|NCT00410072|158274599|FG001|After Week 48 to Week 96|Other|0|||
49119072|NCT00410072|158274598|FG000|After Week 48 to Week 96|Poor compliance/noncompliance|0|||
49119073|NCT00410072|158274599|FG001|After Week 48 to Week 96|Poor compliance/noncompliance|1|||
49119074|NCT00410072|158274598|FG000|After Week 48 to Week 96|Pregnancy|0|||
49119075|NCT00410072|158274599|FG001|After Week 48 to Week 96|Pregnancy|2|||
48914764|NCT00262522|157523076|FG003|Study Start Through 8 Weeks|Death|0|||
48914765|NCT00262522|157523073|FG000|Study Start Through 48 Weeks|Adverse Event|16|||
48914766|NCT00262522|157523074|FG001|Study Start Through 48 Weeks|Adverse Event|0|||
48914767|NCT00262522|157523075|FG002|Study Start Through 48 Weeks|Adverse Event|10|||
48914768|NCT00262522|157523076|FG003|Study Start Through 48 Weeks|Adverse Event|0|||
48914769|NCT00262522|157523073|FG000|Study Start Through 48 Weeks|Withdrawal by Subject|10|||
48914770|NCT00262522|157523074|FG001|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
48914771|NCT00262522|157523075|FG002|Study Start Through 48 Weeks|Withdrawal by Subject|11|||
48914772|NCT00262522|157523076|FG003|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
48914773|NCT00262522|157523073|FG000|Study Start Through 48 Weeks|Lost to Follow-up|8|||
48914774|NCT00262522|157523074|FG001|Study Start Through 48 Weeks|Lost to Follow-up|0|||
48914775|NCT00262522|157523075|FG002|Study Start Through 48 Weeks|Lost to Follow-up|14|||
48914776|NCT00262522|157523076|FG003|Study Start Through 48 Weeks|Lost to Follow-up|0|||
48914777|NCT00262522|157523073|FG000|Study Start Through 48 Weeks|Noncompliance|3|||
48914778|NCT00262522|157523074|FG001|Study Start Through 48 Weeks|Noncompliance|0|||
48914779|NCT00262522|157523075|FG002|Study Start Through 48 Weeks|Noncompliance|8|||
48914780|NCT00262522|157523076|FG003|Study Start Through 48 Weeks|Noncompliance|0|||
48914781|NCT00262522|157523073|FG000|Study Start Through 48 Weeks|Death|2|||
48914782|NCT00262522|157523074|FG001|Study Start Through 48 Weeks|Death|0|||
48914783|NCT00262522|157523075|FG002|Study Start Through 48 Weeks|Death|1|||
49119076|NCT00410072|158274598|FG000|After Week 48 to Week 96|Withdrawal by Subject|0|||
49119077|NCT00410072|158274599|FG001|After Week 48 to Week 96|Withdrawal by Subject|1|||
49119078|NCT01962948|158274600|FG000|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
49119079|NCT01962948|158274601|FG001|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
49119080|NCT01962948|158274602|FG002|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|6|||
48914784|NCT00262522|157523076|FG003|Study Start Through 48 Weeks|Death|0|||
48914785|NCT00262522|157523073|FG000|Study Start Through 48 Weeks|Virologic failure|2|||
48914786|NCT00262522|157523074|FG001|Study Start Through 48 Weeks|Virologic failure|0|||
48914787|NCT00262522|157523075|FG002|Study Start Through 48 Weeks|Virologic failure|4|||
48914788|NCT00262522|157523076|FG003|Study Start Through 48 Weeks|Virologic failure|0|||
48914789|NCT00262522|157523073|FG000|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8|||
48914790|NCT00262522|157523074|FG001|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
48914791|NCT00262522|157523075|FG002|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7|||
48914792|NCT00262522|157523076|FG003|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
48914793|NCT00262522|157523073|FG000|Study Start Through 96 Weeks|Adverse Event|20|||
48914794|NCT00262522|157523074|FG001|Study Start Through 96 Weeks|Adverse Event|0|||
48914795|NCT00262522|157523075|FG002|Study Start Through 96 Weeks|Adverse Event|16|||
48914796|NCT00262522|157523076|FG003|Study Start Through 96 Weeks|Adverse Event|0|||
48914797|NCT00262522|157523073|FG000|Study Start Through 96 Weeks|Withdrawal by Subject|15|||
48914798|NCT00262522|157523074|FG001|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
48914799|NCT00262522|157523075|FG002|Study Start Through 96 Weeks|Withdrawal by Subject|13|||
48914800|NCT00262522|157523076|FG003|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
48914801|NCT00262522|157523073|FG000|Study Start Through 96 Weeks|Lost to Follow-up|19|||
48914802|NCT00262522|157523074|FG001|Study Start Through 96 Weeks|Lost to Follow-up|0|||
48914803|NCT00262522|157523075|FG002|Study Start Through 96 Weeks|Lost to Follow-up|18|||
48914804|NCT00262522|157523076|FG003|Study Start Through 96 Weeks|Lost to Follow-up|0|||
48914805|NCT00262522|157523073|FG000|Study Start Through 96 Weeks|Noncompliance|6|||
48914806|NCT00262522|157523074|FG001|Study Start Through 96 Weeks|Noncompliance|0|||
48914807|NCT00262522|157523075|FG002|Study Start Through 96 Weeks|Noncompliance|11|||
48914808|NCT00262522|157523076|FG003|Study Start Through 96 Weeks|Noncompliance|0|||
48914809|NCT00262522|157523073|FG000|Study Start Through 96 Weeks|Death|2|||
48914810|NCT00262522|157523074|FG001|Study Start Through 96 Weeks|Death|0|||
48914811|NCT00262522|157523075|FG002|Study Start Through 96 Weeks|Death|2|||
48914812|NCT00262522|157523076|FG003|Study Start Through 96 Weeks|Death|0|||
49119081|NCT01962948|158274603|FG003|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|0|||
49119082|NCT01133704|158274604|FG000|Overall Study|Death|44|||
49119083|NCT01133704|158274605|FG001|Overall Study|Death|26|||
49119084|NCT01133704|158274604|FG000|Overall Study|Patient refused to continue|4|||
49119085|NCT01133704|158274605|FG001|Overall Study|Patient refused to continue|0|||
49119086|NCT01133704|158274604|FG000|Overall Study|Study Closure|1|||
49119087|NCT01133704|158274605|FG001|Overall Study|Study Closure|0|||
49119088|NCT01990573|158274606|FG000|Overall Study|Physician Decision|0|||
49119089|NCT01990573|158274607|FG001|Overall Study|Physician Decision|0|||
49119090|NCT01990573|158274608|FG002|Overall Study|Physician Decision|1|||
48914813|NCT00262522|157523073|FG000|Study Start Through 96 Weeks|Virologic failure|5|||
48914814|NCT00262522|157523074|FG001|Study Start Through 96 Weeks|Virologic failure|0|||
48914815|NCT00262522|157523075|FG002|Study Start Through 96 Weeks|Virologic failure|8|||
48914816|NCT00262522|157523076|FG003|Study Start Through 96 Weeks|Virologic failure|0|||
48914817|NCT00262522|157523073|FG000|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10|||
48914818|NCT00262522|157523074|FG001|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
48914819|NCT00262522|157523075|FG002|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9|||
48914820|NCT00262522|157523076|FG003|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
48914821|NCT01553136|157523081|FG000|Overall Study|Adverse Event|3|||
48914822|NCT01553136|157523082|FG001|Overall Study|Adverse Event|2|||
48914823|NCT01553136|157523081|FG000|Overall Study|Withdrawal by Subject|2|||
48914824|NCT01553136|157523082|FG001|Overall Study|Withdrawal by Subject|3|||
48914825|NCT01553136|157523081|FG000|Overall Study|Lost to Follow-up|4|||
48708412|NCT01544335|156780926|FG000|Overall Study|Baseline Measurements not Available|19|||
48708413|NCT00622440|156780927|FG000|Baseline - Week 12 (Treatment)|Received cream but did not return|4|||
48708414|NCT00622440|156780928|FG001|Baseline - Week 12 (Treatment)|Received cream but did not return|1|||
48708415|NCT00622440|156780927|FG000|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3|||
48708416|NCT00622440|156780928|FG001|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5|||
48708417|NCT00622440|156780927|FG000|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0|||
48708418|NCT00622440|156780928|FG001|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1|||
48914826|NCT01553136|157523082|FG001|Overall Study|Lost to Follow-up|10|||
48914827|NCT01553136|157523081|FG000|Overall Study|Physician Decision|2|||
48914828|NCT01553136|157523082|FG001|Overall Study|Physician Decision|3|||
48914829|NCT01553136|157523081|FG000|Overall Study|Scheduling Difficulties|5|||
48914830|NCT01553136|157523082|FG001|Overall Study|Scheduling Difficulties|4|||
48914831|NCT03069352|157523083|FG000|Overall Study|Ongoing|12|||
48914832|NCT03069352|157523084|FG001|Overall Study|Ongoing|40|||
49119091|NCT00758498|158274613|FG000|Overall Study|Adverse Event|2|||
49119092|NCT00758498|158274614|FG001|Overall Study|Adverse Event|2|||
49119093|NCT00758498|158274615|FG002|Overall Study|Adverse Event|3|||
49119094|NCT00758498|158274613|FG000|Overall Study|Subject legally detained out of state|1|||
49119095|NCT00758498|158274614|FG001|Overall Study|Subject legally detained out of state|0|||
49119096|NCT00758498|158274615|FG002|Overall Study|Subject legally detained out of state|0|||
49119097|NCT00758498|158274613|FG000|Overall Study|Withdrawal by Subject|0|||
49119098|NCT00758498|158274614|FG001|Overall Study|Withdrawal by Subject|0|||
48803231|NCT01392300|157121753|FG002|Open Label Extension (OLEX) Period|Protocol Violation|13|||
48803232|NCT01392300|157121751|FG000|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
48803233|NCT01392300|157121752|FG001|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
48803234|NCT01392300|157121753|FG002|Open Label Extension (OLEX) Period|Lack of Efficacy|3|||
48803235|NCT01392300|157121751|FG000|Open Label Extension (OLEX) Period|Non-compliance|0|||
48803236|NCT01392300|157121752|FG001|Open Label Extension (OLEX) Period|Non-compliance|0|||
48803237|NCT01392300|157121753|FG002|Open Label Extension (OLEX) Period|Non-compliance|1|||
48803238|NCT01392300|157121751|FG000|Open Label Extension (OLEX) Period|Death|0|||
48803239|NCT01392300|157121752|FG001|Open Label Extension (OLEX) Period|Death|0|||
48803240|NCT01392300|157121753|FG002|Open Label Extension (OLEX) Period|Death|4|||
48803241|NCT01392300|157121751|FG000|Open Label Extension (OLEX) Period|Adverse Event|0|||
48803242|NCT01392300|157121752|FG001|Open Label Extension (OLEX) Period|Adverse Event|0|||
48803243|NCT01392300|157121753|FG002|Open Label Extension (OLEX) Period|Adverse Event|7|||
48803244|NCT01392300|157121751|FG000|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
48803245|NCT01392300|157121752|FG001|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
48803246|NCT01392300|157121753|FG002|Open Label Extension (OLEX) Period|Withdrawal by Subject|17|||
48803247|NCT01392300|157121751|FG000|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
48803248|NCT01392300|157121752|FG001|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
48803249|NCT01392300|157121753|FG002|Open Label Extension (OLEX) Period|Lost to Follow-up|6|||
48803250|NCT00521144|157121756|FG000|Overall Study|Not Treated|0|||
48803251|NCT00521144|157121757|FG001|Overall Study|Not Treated|0|||
48803252|NCT00521144|157121758|FG002|Overall Study|Not Treated|0|||
48803253|NCT00521144|157121759|FG003|Overall Study|Not Treated|1|||
48803254|NCT00521144|157121760|FG004|Overall Study|Not Treated|0|||
48803255|NCT00521144|157121756|FG000|Overall Study|Adverse Event|0|||
48803256|NCT00521144|157121757|FG001|Overall Study|Adverse Event|1|||
48803257|NCT00521144|157121758|FG002|Overall Study|Adverse Event|0|||
48803258|NCT00521144|157121759|FG003|Overall Study|Adverse Event|0|||
48803259|NCT00521144|157121760|FG004|Overall Study|Adverse Event|1|||
48803260|NCT00521144|157121756|FG000|Overall Study|Progressive Disease|4|||
48803261|NCT00521144|157121757|FG001|Overall Study|Progressive Disease|2|||
48803262|NCT00521144|157121758|FG002|Overall Study|Progressive Disease|2|||
48803263|NCT00521144|157121759|FG003|Overall Study|Progressive Disease|0|||
48803264|NCT00521144|157121760|FG004|Overall Study|Progressive Disease|6|||
48803265|NCT00180479|157121762|FG000|Overall Study|Death|4|||
48803266|NCT00180479|157121763|FG001|Overall Study|Death|2|||
48803267|NCT00180479|157121762|FG000|Overall Study|Lost to Follow-up|9|||
48803268|NCT00180479|157121763|FG001|Overall Study|Lost to Follow-up|7|||
48803269|NCT00180479|157121762|FG000|Overall Study|Withdrawal by Subject|3|||
48803270|NCT00180479|157121763|FG001|Overall Study|Withdrawal by Subject|3|||
48803271|NCT00180479|157121762|FG000|Overall Study|Informed consent not signed|0|||
48803272|NCT00180479|157121763|FG001|Overall Study|Informed consent not signed|1|||
48914833|NCT04202679|157523088|FG000|Overall Study|Adverse Event|2|||
48914834|NCT04202679|157523089|FG001|Overall Study|Adverse Event|0|||
48914835|NCT04202679|157523088|FG000|Overall Study|Poor compliance to protocol|1|||
48914836|NCT04202679|157523089|FG001|Overall Study|Poor compliance to protocol|0|||
48914837|NCT04202679|157523088|FG000|Overall Study|Withdrawal by Subject|23|||
48914838|NCT04202679|157523089|FG001|Overall Study|Withdrawal by Subject|6|||
48914839|NCT02246582|157524694|FG000|Overall Study|Withdrawal by Subject|3|||
48914840|NCT02246582|157524695|FG001|Overall Study|Withdrawal by Subject|4|||
48914841|NCT03496012|157524696|FG000|Overall Study|Withdrawal by Subject|2|||
48914842|NCT03496012|157524697|FG001|Overall Study|Withdrawal by Subject|0|||
48914843|NCT03496012|157524698|FG002|Overall Study|Withdrawal by Subject|2|||
48914844|NCT03496012|157524696|FG000|Overall Study|Adverse Event|0|||
48914845|NCT03496012|157524697|FG001|Overall Study|Adverse Event|0|||
48914846|NCT03496012|157524698|FG002|Overall Study|Adverse Event|1|||
48914847|NCT03496012|157524696|FG000|Overall Study|Reason Not Specified|2|||
48914848|NCT03496012|157524697|FG001|Overall Study|Reason Not Specified|0|||
48914849|NCT03496012|157524698|FG002|Overall Study|Reason Not Specified|1|||
48914850|NCT02592551|157524701|FG000|Overall Study|Not evaluable|1|||
48914851|NCT02592551|157524702|FG001|Overall Study|Not evaluable|3|||
48914852|NCT02592551|157524703|FG002|Overall Study|Not evaluable|0|||
48914853|NCT00847145|157524705|FG000|Overall Study|AE or Death|0|||
48803273|NCT02991482|157121764|FG000|Overall Study|Disease progression|56|||
48803274|NCT02991482|157121765|FG001|Overall Study|Disease progression|47|||
48803275|NCT02991482|157121764|FG000|Overall Study|Death|4|||
49119099|NCT00758498|158274615|FG002|Overall Study|Withdrawal by Subject|1|||
48803276|NCT02991482|157121765|FG001|Overall Study|Death|4|||
48914854|NCT00847145|157524706|FG001|Overall Study|AE or Death|1|||
48914855|NCT00847145|157524707|FG002|Overall Study|AE or Death|1|||
48914856|NCT00847145|157524708|FG003|Overall Study|AE or Death|0|||
48914857|NCT00847145|157524709|FG004|Overall Study|AE or Death|0|||
48914858|NCT00847145|157524710|FG005|Overall Study|AE or Death|0|||
48914859|NCT00847145|157524711|FG006|Overall Study|AE or Death|0|||
48914860|NCT00847145|157524712|FG007|Overall Study|AE or Death|0|||
48914861|NCT00847145|157524705|FG000|Overall Study|Withdrawal by Subject|3|||
48914862|NCT00847145|157524706|FG001|Overall Study|Withdrawal by Subject|4|||
48914863|NCT00847145|157524707|FG002|Overall Study|Withdrawal by Subject|6|||
48914864|NCT00847145|157524708|FG003|Overall Study|Withdrawal by Subject|1|||
48914865|NCT00847145|157524709|FG004|Overall Study|Withdrawal by Subject|0|||
48914866|NCT00847145|157524710|FG005|Overall Study|Withdrawal by Subject|0|||
48914867|NCT00847145|157524711|FG006|Overall Study|Withdrawal by Subject|1|||
48914868|NCT00847145|157524712|FG007|Overall Study|Withdrawal by Subject|1|||
48914869|NCT00847145|157524705|FG000|Overall Study|Lost to Follow-up|3|||
48914870|NCT00847145|157524706|FG001|Overall Study|Lost to Follow-up|1|||
48914871|NCT00847145|157524707|FG002|Overall Study|Lost to Follow-up|1|||
48914872|NCT00847145|157524708|FG003|Overall Study|Lost to Follow-up|0|||
48914873|NCT00847145|157524709|FG004|Overall Study|Lost to Follow-up|4|||
48914874|NCT00847145|157524710|FG005|Overall Study|Lost to Follow-up|4|||
48914875|NCT00847145|157524711|FG006|Overall Study|Lost to Follow-up|8|||
48914876|NCT00847145|157524712|FG007|Overall Study|Lost to Follow-up|2|||
48914877|NCT00847145|157524705|FG000|Overall Study|Inappropriate enrollment|0|||
48914878|NCT00847145|157524706|FG001|Overall Study|Inappropriate enrollment|0|||
48914879|NCT00847145|157524707|FG002|Overall Study|Inappropriate enrollment|0|||
48914880|NCT00847145|157524708|FG003|Overall Study|Inappropriate enrollment|0|||
49119100|NCT00758498|158274613|FG000|Overall Study|Noncompliance to study procedures|0|||
49119101|NCT00758498|158274614|FG001|Overall Study|Noncompliance to study procedures|0|||
49119102|NCT00758498|158274615|FG002|Overall Study|Noncompliance to study procedures|1|||
49119103|NCT01310127|158274616|FG000|Overall Study|Protocol Violation|1|||
49119104|NCT01310127|158274617|FG001|Overall Study|Protocol Violation|1|||
49119105|NCT01310127|158274616|FG000|Overall Study|advanced psc cataract outlier|1|||
49119106|NCT01310127|158274617|FG001|Overall Study|advanced psc cataract outlier|0|||
48708419|NCT00622440|156780927|FG000|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0|||
48708420|NCT00622440|156780928|FG001|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1|||
48708421|NCT04455815|156780929|FG000|Randomisation Phase|Adverse Event|1|||
48708422|NCT04455815|156780930|FG001|Randomisation Phase|Adverse Event|0|||
48708423|NCT04455815|156780929|FG000|Treatment Phase|Adverse Event|0|||
48708424|NCT04455815|156780930|FG001|Treatment Phase|Adverse Event|1|||
48708425|NCT04455815|156780929|FG000|Treatment Phase|Hospital admission and treatment stopped in hospital|1|||
48708426|NCT04455815|156780930|FG001|Treatment Phase|Hospital admission and treatment stopped in hospital|0|||
48708427|NCT04455815|156780929|FG000|Treatment Phase|Withdrawal by Subject|1|||
48708428|NCT04455815|156780930|FG001|Treatment Phase|Withdrawal by Subject|1|||
48708429|NCT03682770|156780939|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
48708430|NCT03682770|156780940|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|1|||
48708431|NCT03682770|156780941|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
48708432|NCT03682770|156780942|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
48708433|NCT03682770|156780943|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
48708434|NCT03682770|156780944|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
48708435|NCT03682770|156780945|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
48708436|NCT03682770|156780939|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
48708437|NCT03682770|156780940|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
48708438|NCT03682770|156780941|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
48708439|NCT03682770|156780942|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
48708440|NCT03682770|156780943|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
48708441|NCT03682770|156780944|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
48708442|NCT03682770|156780945|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
48708443|NCT03682770|156780939|FG000|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
48708444|NCT03682770|156780940|FG001|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
48708445|NCT03682770|156780941|FG002|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|7|||
48708446|NCT03682770|156780942|FG003|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|3|||
48914881|NCT00847145|157524709|FG004|Overall Study|Inappropriate enrollment|1|||
48914882|NCT00847145|157524710|FG005|Overall Study|Inappropriate enrollment|0|||
48914883|NCT00847145|157524711|FG006|Overall Study|Inappropriate enrollment|0|||
48914884|NCT00847145|157524712|FG007|Overall Study|Inappropriate enrollment|0|||
48914885|NCT00847145|157524705|FG000|Overall Study|Protocol Violation|0|||
48914886|NCT00847145|157524706|FG001|Overall Study|Protocol Violation|0|||
48914887|NCT00847145|157524707|FG002|Overall Study|Protocol Violation|3|||
48708447|NCT03682770|156780943|FG004|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
48914888|NCT00847145|157524708|FG003|Overall Study|Protocol Violation|0|||
48914889|NCT00847145|157524709|FG004|Overall Study|Protocol Violation|1|||
49119107|NCT04147247|158274618|FG000|Overall Study|Progressive disease|3|||
48803277|NCT02991482|157121764|FG000|Overall Study|Adverse Event|1|||
48803278|NCT02991482|157121765|FG001|Overall Study|Adverse Event|6|||
48803279|NCT02991482|157121764|FG000|Overall Study|Patient decision|1|||
48803280|NCT02991482|157121765|FG001|Overall Study|Patient decision|1|||
48803281|NCT02991482|157121764|FG000|Overall Study|Physician Decision|0|||
48803282|NCT02991482|157121765|FG001|Overall Study|Physician Decision|6|||
48803283|NCT02991482|157121764|FG000|Overall Study|Clinical deterioration|1|||
48803284|NCT02991482|157121765|FG001|Overall Study|Clinical deterioration|0|||
48803285|NCT02991482|157121764|FG000|Overall Study|Patient feeling too unwell|1|||
48914890|NCT00847145|157524710|FG005|Overall Study|Protocol Violation|0|||
48914891|NCT00847145|157524711|FG006|Overall Study|Protocol Violation|0|||
48914892|NCT00847145|157524712|FG007|Overall Study|Protocol Violation|1|||
48803286|NCT02991482|157121765|FG001|Overall Study|Patient feeling too unwell|0|||
48803287|NCT02991482|157121764|FG000|Overall Study|Worsening of performance status|0|||
48803288|NCT02991482|157121765|FG001|Overall Study|Worsening of performance status|1|||
48803289|NCT02991482|157121764|FG000|Overall Study|Death prior to study drug initiation|1|||
48803290|NCT02991482|157121765|FG001|Overall Study|Death prior to study drug initiation|0|||
48803291|NCT02991482|157121764|FG000|Overall Study|Consent withdrawal prior to study drug initiation|0|||
48803292|NCT02991482|157121765|FG001|Overall Study|Consent withdrawal prior to study drug initiation|1|||
48803293|NCT02901626|157121766|FG000|Overall Study|Lost to Follow-up|1|||
48803294|NCT02901626|157121767|FG001|Overall Study|Lost to Follow-up|1|||
48803295|NCT04810221|157121768|FG000|Overall Study|Physician Decision|3|||
48803296|NCT00105235|157121769|FG000|Overall Study|Death|4|||
48803297|NCT00105235|157121769|FG000|Overall Study|Physician Decision|1|||
48803298|NCT00105235|157121769|FG000|Overall Study|Withdrawal by Subject|2|||
48803299|NCT00991341|157121770|FG000|Overall Study|no surgery w/in 30 days of randomization|11|||
48803300|NCT00991341|157121771|FG001|Overall Study|no surgery w/in 30 days of randomization|18|||
48803301|NCT00991341|157121770|FG000|Overall Study|Death|3|||
48803302|NCT00991341|157121771|FG001|Overall Study|Death|0|||
48803303|NCT00991341|157121770|FG000|Overall Study|no RBCs received 96hrs after randomized|186|||
48803304|NCT00991341|157121771|FG001|Overall Study|no RBCs received 96hrs after randomized|155|||
48803305|NCT00991341|157121770|FG000|Overall Study|Physician Decision|1|||
48803306|NCT00991341|157121771|FG001|Overall Study|Physician Decision|2|||
48803307|NCT00991341|157121770|FG000|Overall Study|Withdrawal by Subject|3|||
48803308|NCT00991341|157121771|FG001|Overall Study|Withdrawal by Subject|4|||
48803309|NCT02207725|157121772|FG000|Overall Study|Did Not Receive Treatment|0|||
48803310|NCT02207725|157121773|FG001|Overall Study|Did Not Receive Treatment|1|||
48803311|NCT02207725|157121774|FG002|Overall Study|Did Not Receive Treatment|1|||
48803312|NCT02207725|157121775|FG003|Overall Study|Did Not Receive Treatment|1|||
48803313|NCT01621880|157121782|FG000|Overall Study|Adverse Event|5|||
48803314|NCT01621880|157121783|FG001|Overall Study|Adverse Event|1|||
48803315|NCT01621880|157121782|FG000|Overall Study|Withdrawal by Subject|5|||
48803316|NCT01621880|157121783|FG001|Overall Study|Withdrawal by Subject|4|||
48803317|NCT00674570|157121784|FG000|Overall Study|Withdrawal by Subject|0|||
48803318|NCT00674570|157121785|FG001|Overall Study|Withdrawal by Subject|2|||
48803319|NCT00674570|157121786|FG002|Overall Study|Withdrawal by Subject|0|||
48803320|NCT03633929|157121787|FG000|Overall Study|Lost to Follow-up|1|||
48803321|NCT03633929|157121787|FG000|Overall Study|Did not login to software. Did not participate|3|||
48803322|NCT05292534|157121788|FG000|Overall Study|Protocol Violation|3|||
48803323|NCT05292534|157121789|FG001|Overall Study|Protocol Violation|4|||
48803324|NCT05292534|157121788|FG000|Overall Study|Withdrawal by Subject|0|||
48914893|NCT04419610|157524713|FG000|Overall Study|Withdrawal by Subject|3|||
48914894|NCT04419610|157524714|FG001|Overall Study|Withdrawal by Subject|1|||
48914895|NCT04419610|157524713|FG000|Overall Study|Adverse Event|1|||
48914896|NCT04419610|157524714|FG001|Overall Study|Adverse Event|0|||
48914897|NCT04419610|157524713|FG000|Overall Study|discharged early|1|||
48914898|NCT04419610|157524714|FG001|Overall Study|discharged early|1|||
48914899|NCT01490450|157524715|FG000|Period 1|Lack of Efficacy|2|||
48914900|NCT01490450|157524716|FG001|Period 1|Lack of Efficacy|0|||
48914901|NCT01490450|157524717|FG002|Period 1|Lack of Efficacy|3|||
48914902|NCT01490450|157524718|FG003|Period 1|Lack of Efficacy|0|||
48914903|NCT01490450|157524715|FG000|Period 1|Adverse Event|0|||
48914904|NCT01490450|157524716|FG001|Period 1|Adverse Event|0|||
48914905|NCT01490450|157524717|FG002|Period 1|Adverse Event|0|||
48914906|NCT01490450|157524718|FG003|Period 1|Adverse Event|5|||
48914907|NCT01490450|157524715|FG000|Period 1|Request to discontinue treatment|1|||
48914908|NCT01490450|157524716|FG001|Period 1|Request to discontinue treatment|0|||
48914909|NCT01490450|157524717|FG002|Period 1|Request to discontinue treatment|0|||
48803325|NCT05292534|157121789|FG001|Overall Study|Withdrawal by Subject|1|||
48803326|NCT01889186|157121790|FG000|Overall Study|Adverse event- not related to progression|18|||
48803327|NCT01889186|157121791|FG001|Overall Study|Adverse event- not related to progression|5|||
48803328|NCT01889186|157121790|FG000|Overall Study|Adverse event- related to progression|7|||
49119108|NCT04147247|158274619|FG001|Overall Study|Progressive disease|3|||
49119109|NCT04147247|158274620|FG002|Overall Study|Progressive disease|4|||
48803329|NCT01889186|157121791|FG001|Overall Study|Adverse event- related to progression|2|||
48803330|NCT01889186|157121790|FG000|Overall Study|COVID-19 logistical restrictions|1|||
48914910|NCT01490450|157524718|FG003|Period 1|Request to discontinue treatment|0|||
48914911|NCT01490450|157524715|FG000|Period 1|Withdrawal by Subject|0|||
48914912|NCT01490450|157524716|FG001|Period 1|Withdrawal by Subject|0|||
48914913|NCT01490450|157524717|FG002|Period 1|Withdrawal by Subject|0|||
48914914|NCT01490450|157524718|FG003|Period 1|Withdrawal by Subject|3|||
48914915|NCT01490450|157524715|FG000|Period 1|No longer met study criteria|0|||
48914916|NCT01490450|157524716|FG001|Period 1|No longer met study criteria|1|||
48914917|NCT01490450|157524717|FG002|Period 1|No longer met study criteria|1|||
48914918|NCT01490450|157524718|FG003|Period 1|No longer met study criteria|0|||
48914919|NCT01490450|157524715|FG000|Period 2|Lack of Efficacy|0|||
48914920|NCT01490450|157524716|FG001|Period 2|Lack of Efficacy|0|||
48914921|NCT01490450|157524717|FG002|Period 2|Lack of Efficacy|0|||
48914922|NCT01490450|157524718|FG003|Period 2|Lack of Efficacy|1|||
48914923|NCT01490450|157524715|FG000|Period 2|Adverse Event|1|||
48914924|NCT01490450|157524716|FG001|Period 2|Adverse Event|1|||
48914925|NCT01490450|157524717|FG002|Period 2|Adverse Event|0|||
48914926|NCT01490450|157524718|FG003|Period 2|Adverse Event|1|||
48914927|NCT01490450|157524715|FG000|Period 2|Withdrawal by Subject|1|||
48914928|NCT01490450|157524716|FG001|Period 2|Withdrawal by Subject|0|||
48914929|NCT01490450|157524717|FG002|Period 2|Withdrawal by Subject|0|||
48914930|NCT01490450|157524718|FG003|Period 2|Withdrawal by Subject|0|||
48914931|NCT01490450|157524715|FG000|Period 2|Lost to Follow-up|0|||
48914932|NCT01490450|157524716|FG001|Period 2|Lost to Follow-up|0|||
48914933|NCT01490450|157524717|FG002|Period 2|Lost to Follow-up|0|||
48914934|NCT01490450|157524718|FG003|Period 2|Lost to Follow-up|2|||
48914935|NCT00404820|157524719|FG000|Overall Study|Adverse Event|4|||
48914936|NCT00404820|157524720|FG001|Overall Study|Adverse Event|16|||
48914937|NCT00404820|157524719|FG000|Overall Study|Withdrawal by Subject|5|||
48708448|NCT03682770|156780944|FG005|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
48708449|NCT03682770|156780945|FG006|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
48708450|NCT03682770|156780939|FG000|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
48708451|NCT03682770|156780940|FG001|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
48708452|NCT03682770|156780941|FG002|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
48708453|NCT03682770|156780942|FG003|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|1|||
48708454|NCT03682770|156780943|FG004|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
48708455|NCT03682770|156780944|FG005|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
48708456|NCT03682770|156780945|FG006|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
48708457|NCT03682770|156780939|FG000|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
48708458|NCT03682770|156780940|FG001|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
48708459|NCT03682770|156780941|FG002|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|1|||
48708460|NCT03682770|156780942|FG003|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|2|||
48708461|NCT03682770|156780943|FG004|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
48708462|NCT03682770|156780944|FG005|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
48914938|NCT00404820|157524720|FG001|Overall Study|Withdrawal by Subject|3|||
48914939|NCT00404820|157524719|FG000|Overall Study|Lost to Follow-up|7|||
48914940|NCT00404820|157524720|FG001|Overall Study|Lost to Follow-up|3|||
49119110|NCT04147247|158274621|FG003|Overall Study|Progressive disease|4|||
49119111|NCT04147247|158274622|FG004|Overall Study|Progressive disease|3|||
49119112|NCT04147247|158274618|FG000|Overall Study|Physician Decision|0|||
49119113|NCT04147247|158274619|FG001|Overall Study|Physician Decision|1|||
48803331|NCT01889186|157121791|FG001|Overall Study|COVID-19 logistical restrictions|0|||
48803332|NCT01889186|157121790|FG000|Overall Study|Investigator request|1|||
48803333|NCT01889186|157121791|FG001|Overall Study|Investigator request|1|||
48803334|NCT01889186|157121790|FG000|Overall Study|Progressive disease- Richter's|12|||
48803335|NCT01889186|157121791|FG001|Overall Study|Progressive disease- Richter's|7|||
48803336|NCT01889186|157121790|FG000|Overall Study|Progressive disease per protocol|46|||
48803337|NCT01889186|157121791|FG001|Overall Study|Progressive disease per protocol|17|||
48803338|NCT01889186|157121790|FG000|Overall Study|Stem cell transplant|2|||
48803339|NCT01889186|157121791|FG001|Overall Study|Stem cell transplant|1|||
48803340|NCT01889186|157121790|FG000|Overall Study|Withdrew consent|2|||
48803341|NCT01889186|157121791|FG001|Overall Study|Withdrew consent|3|||
48803342|NCT01889186|157121790|FG000|Overall Study|Other, not specified|18|||
48803343|NCT01889186|157121791|FG001|Overall Study|Other, not specified|15|||
48803344|NCT02768662|157121794|FG000|Overall Study|Adverse Event|1|||
48803345|NCT02768662|157121794|FG000|Overall Study|Lost to Follow-up|4|||
48803346|NCT02768662|157121794|FG000|Overall Study|Withdrawal by Subject|3|||
48803347|NCT02768662|157121794|FG000|Overall Study|Study terminated by Sponsor|78|||
48803348|NCT01755702|157121795|FG000|Wash Out Period I|Other Reason|3|||
48803349|NCT01755702|157121795|FG000|Washout Period II|Other Reason|5|||
48803350|NCT00571701|157121796|FG000|First Intervention 12 Months|Withdrawal by Subject|2|||
48803351|NCT00571701|157121797|FG001|First Intervention 12 Months|Withdrawal by Subject|1|||
48803352|NCT00571701|157121796|FG000|First Intervention 12 Months|Death|1|||
48803353|NCT00571701|157121797|FG001|First Intervention 12 Months|Death|0|||
48803354|NCT00571701|157121796|FG000|Second Intervention 12 Months|Adverse Event|0|||
48803355|NCT00571701|157121797|FG001|Second Intervention 12 Months|Adverse Event|1|||
48803356|NCT00571701|157121796|FG000|Second Intervention 12 Months|Withdrawal by Subject|3|||
48803357|NCT00571701|157121797|FG001|Second Intervention 12 Months|Withdrawal by Subject|0|||
48803358|NCT00758459|157121799|FG000|Overall Study|Adverse Event|3|||
48803359|NCT00758459|157121800|FG001|Overall Study|Adverse Event|2|||
48803360|NCT00758459|157121799|FG000|Overall Study|Protocol Violation|0|||
48803361|NCT00758459|157121800|FG001|Overall Study|Protocol Violation|1|||
48803362|NCT00758459|157121799|FG000|Overall Study|Withdrawal by Subject|0|||
48803363|NCT00758459|157121800|FG001|Overall Study|Withdrawal by Subject|1|||
48803364|NCT00691132|157121801|FG000|Overall Study|Adverse Event|2|||
48803365|NCT00691132|157121802|FG001|Overall Study|Adverse Event|3|||
48803366|NCT00691132|157121801|FG000|Overall Study|Withdrawal by Subject|10|||
48803367|NCT00691132|157121802|FG001|Overall Study|Withdrawal by Subject|10|||
48803368|NCT02036645|157121804|FG000|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
48803369|NCT02036645|157121805|FG001|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
48803370|NCT02036645|157121806|FG002|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
48803371|NCT02036645|157121807|FG003|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
48803372|NCT02036645|157121808|FG004|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
48803373|NCT02036645|157121809|FG005|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
48803374|NCT02036645|157121810|FG006|SAD Cohorts : Study Part 1|Lost to Follow-up|1|||
48803375|NCT02036645|157121811|FG007|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
48803376|NCT02036645|157121812|FG008|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
48803377|NCT02036645|157121813|FG009|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
48803378|NCT02036645|157121814|FG010|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
48803379|NCT02036645|157121815|FG011|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
48803380|NCT02036645|157121804|FG000|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
48803381|NCT02036645|157121805|FG001|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
48803382|NCT02036645|157121806|FG002|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
48803383|NCT02036645|157121807|FG003|SAD Cohorts : Study Part 1|Withdrawal by Subject|1|||
48803384|NCT02036645|157121808|FG004|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
48803385|NCT02036645|157121809|FG005|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
48803386|NCT02036645|157121810|FG006|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
48803387|NCT02036645|157121811|FG007|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
48803388|NCT02036645|157121812|FG008|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
48803389|NCT02036645|157121813|FG009|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
48803390|NCT02036645|157121814|FG010|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
48803391|NCT02036645|157121815|FG011|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
48803392|NCT00652938|157121816|FG000|Overall Study|Adverse Event|1|||
48803393|NCT00652938|157121817|FG001|Overall Study|Adverse Event|0|||
48803394|NCT00652938|157121818|FG002|Overall Study|Adverse Event|2|||
49119114|NCT04147247|158274620|FG002|Overall Study|Physician Decision|0|||
48803395|NCT00652938|157121816|FG000|Overall Study|Withdrawal by Subject|0|||
48803396|NCT00652938|157121817|FG001|Overall Study|Withdrawal by Subject|6|||
48803397|NCT00652938|157121818|FG002|Overall Study|Withdrawal by Subject|1|||
48803398|NCT00652938|157121816|FG000|Overall Study|Lost to Follow-up|0|||
48803399|NCT00652938|157121817|FG001|Overall Study|Lost to Follow-up|0|||
48803400|NCT00652938|157121818|FG002|Overall Study|Lost to Follow-up|2|||
48803401|NCT00652938|157121816|FG000|Overall Study|fear of blood sampling|0|||
48803402|NCT00652938|157121817|FG001|Overall Study|fear of blood sampling|1|||
48803403|NCT00652938|157121818|FG002|Overall Study|fear of blood sampling|0|||
48803404|NCT02978443|157121819|FG000|Overall Study|Withdrawal by Subject|1|||
48803405|NCT02978443|157121819|FG000|Overall Study|Adverse Event|3|||
48803406|NCT02978443|157121819|FG000|Overall Study|Disease Progression on study|6|||
48803407|NCT02978443|157121819|FG000|Overall Study|Death|1|||
48803408|NCT02978443|157121819|FG000|Overall Study|Physician Decision|1|||
48803409|NCT02978443|157121819|FG000|Overall Study|Switch to alternative therapy|1|||
48803410|NCT02978443|157121819|FG000|Overall Study|Refused further treatment|1|||
48803411|NCT00117156|157121820|FG000|Overall Study|Adverse Event|9|||
48803412|NCT00117156|157121820|FG000|Overall Study|Physician Decision|1|||
48803413|NCT00117156|157121820|FG000|Overall Study|Trt for Pre-Exist Second Primary|1|||
48803414|NCT04066205|157121821|FG000|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|5|||
48803415|NCT04066205|157121822|FG001|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|3|||
48803416|NCT04066205|157121821|FG000|T2 Immediate Post-Intervention|did not respond|5|||
48803417|NCT04066205|157121822|FG001|T2 Immediate Post-Intervention|did not respond|3|||
48803418|NCT01436201|157121830|FG000|Overall Study|Adverse Event|2|||
48803419|NCT01436201|157121830|FG000|Overall Study|Withdrawal by Subject|1|||
48803420|NCT01436201|157121830|FG000|Overall Study|Protocol Violation|1|||
48803421|NCT01435655|157121831|FG000|Overall Study|Death|2|||
48803422|NCT01435655|157121831|FG000|Overall Study|Other|1|||
48803423|NCT00110890|157121832|FG000|Overall Study|Adverse Event|30|||
48803424|NCT00110890|157121833|FG001|Overall Study|Adverse Event|7|||
48803425|NCT00110890|157121832|FG000|Overall Study|Death|16|||
48803426|NCT00110890|157121833|FG001|Overall Study|Death|9|||
48803427|NCT00110890|157121832|FG000|Overall Study|Lost to Follow-up|3|||
48803428|NCT00110890|157121833|FG001|Overall Study|Lost to Follow-up|1|||
48803429|NCT00110890|157121832|FG000|Overall Study|Physician Decision|4|||
48803430|NCT00110890|157121833|FG001|Overall Study|Physician Decision|5|||
48803431|NCT00110890|157121832|FG000|Overall Study|Withdrawal by Subject|17|||
48803432|NCT00110890|157121833|FG001|Overall Study|Withdrawal by Subject|5|||
48803433|NCT00110890|157121832|FG000|Overall Study|Protocol Deviation|1|||
48803434|NCT00110890|157121833|FG001|Overall Study|Protocol Deviation|0|||
48803435|NCT00110890|157121832|FG000|Overall Study|Noncompliance|10|||
48803436|NCT00110890|157121833|FG001|Overall Study|Noncompliance|0|||
48803437|NCT00110890|157121832|FG000|Overall Study|Kidney Transplant|16|||
48803438|NCT00110890|157121833|FG001|Overall Study|Kidney Transplant|12|||
48803439|NCT00110890|157121832|FG000|Overall Study|Invest. Product Commercially Available|217|||
48803440|NCT00110890|157121833|FG001|Overall Study|Invest. Product Commercially Available|110|||
48803441|NCT00110890|157121832|FG000|Overall Study|Other|34|||
48803442|NCT00110890|157121833|FG001|Overall Study|Other|23|||
48803443|NCT00110890|157121832|FG000|Overall Study|Ineligibility determined|3|||
48803444|NCT00110890|157121833|FG001|Overall Study|Ineligibility determined|0|||
48803445|NCT00110890|157121832|FG000|Overall Study|Requirement for alternative therapy|0|||
48803446|NCT00110890|157121833|FG001|Overall Study|Requirement for alternative therapy|1|||
48803447|NCT00110890|157121832|FG000|Overall Study|Disease progression|0|||
48803448|NCT00110890|157121833|FG001|Overall Study|Disease progression|1|||
48803449|NCT00110890|157121832|FG000|Overall Study|Parathyroidectomy|0|||
48803450|NCT00110890|157121833|FG001|Overall Study|Parathyroidectomy|1|||
48803451|NCT00110890|157121832|FG000|Overall Study|Did not enter follow-up phase|10|||
48914941|NCT00404820|157524719|FG000|Overall Study|Administrative problems|2|||
48914942|NCT00404820|157524720|FG001|Overall Study|Administrative problems|0|||
48914943|NCT00404820|157524719|FG000|Overall Study|Death|1|||
48914944|NCT00404820|157524720|FG001|Overall Study|Death|0|||
48803452|NCT00110890|157121833|FG001|Overall Study|Did not enter follow-up phase|4|||
48914945|NCT00404820|157524719|FG000|Overall Study|Other|0|||
48803453|NCT02839343|157121834|FG000|Overall Study|Withdrawal by Subject|3|||
48803454|NCT02839343|157121835|FG001|Overall Study|Withdrawal by Subject|1|||
48803455|NCT02839343|157121834|FG000|Overall Study|Disease Progression Prior to Treatment|1|||
48803456|NCT02839343|157121835|FG001|Overall Study|Disease Progression Prior to Treatment|0|||
48803457|NCT02839343|157121834|FG000|Overall Study|Adverse Event|1|||
48803458|NCT02839343|157121835|FG001|Overall Study|Adverse Event|0|||
48803459|NCT00622180|157121838|FG000|Overall Study|Lost to Follow-up|1|||
48803460|NCT00622180|157121839|FG001|Overall Study|Lost to Follow-up|2|||
48803461|NCT03916744|157121840|FG000|Overall Study|Withdrawal by Subject|0|||
48803462|NCT03916744|157121841|FG001|Overall Study|Withdrawal by Subject|1|||
48803463|NCT03916744|157121842|FG002|Overall Study|Withdrawal by Subject|2|||
48803464|NCT00661661|157121845|FG000|Overall Study|Adverse Event|99|||
48803465|NCT00661661|157121846|FG001|Overall Study|Adverse Event|24|||
48914946|NCT00404820|157524720|FG001|Overall Study|Other|2|||
48914947|NCT00054704|157524727|FG000|Overall Study|Lack of Efficacy|2|||
48803466|NCT00661661|157121845|FG000|Overall Study|Lack of Efficacy|3|||
48803467|NCT00661661|157121846|FG001|Overall Study|Lack of Efficacy|2|||
48803468|NCT00661661|157121845|FG000|Overall Study|Lost to Follow-up|0|||
48803469|NCT00661661|157121846|FG001|Overall Study|Lost to Follow-up|1|||
48803470|NCT00661661|157121845|FG000|Overall Study|Withdrawal by Subject|15|||
48803471|NCT00661661|157121846|FG001|Overall Study|Withdrawal by Subject|5|||
48803472|NCT00661661|157121845|FG000|Overall Study|Other|22|||
48803473|NCT00661661|157121846|FG001|Overall Study|Other|7|||
48803474|NCT00661661|157121845|FG000|Overall Study|Not assigned treatment|1|||
48803475|NCT00661661|157121846|FG001|Overall Study|Not assigned treatment|0|||
48803476|NCT02569710|157121847|FG000|Overall Study|Adverse Event|1|||
48803477|NCT02569710|157121848|FG001|Overall Study|Adverse Event|0|||
48803478|NCT02569710|157121849|FG002|Overall Study|Adverse Event|0|||
48803479|NCT02569710|157121850|FG003|Overall Study|Adverse Event|0|||
48803480|NCT02569710|157121851|FG004|Overall Study|Adverse Event|0|||
49119115|NCT04147247|158274621|FG003|Overall Study|Physician Decision|0|||
48803481|NCT02569710|157121852|FG005|Overall Study|Adverse Event|0|||
48803482|NCT02569710|157121853|FG006|Overall Study|Adverse Event|0|||
48803483|NCT02569710|157121854|FG007|Overall Study|Adverse Event|0|||
48803484|NCT02569710|157121855|FG008|Overall Study|Adverse Event|0|||
48803485|NCT02569710|157121856|FG009|Overall Study|Adverse Event|0|||
48803486|NCT02569710|157121847|FG000|Overall Study|Lost to Follow-up|0|||
48803487|NCT02569710|157121848|FG001|Overall Study|Lost to Follow-up|0|||
48803488|NCT02569710|157121849|FG002|Overall Study|Lost to Follow-up|0|||
48803489|NCT02569710|157121850|FG003|Overall Study|Lost to Follow-up|0|||
48803490|NCT02569710|157121851|FG004|Overall Study|Lost to Follow-up|0|||
48803491|NCT02569710|157121852|FG005|Overall Study|Lost to Follow-up|0|||
48803492|NCT02569710|157121853|FG006|Overall Study|Lost to Follow-up|1|||
48803493|NCT02569710|157121854|FG007|Overall Study|Lost to Follow-up|0|||
48803494|NCT02569710|157121855|FG008|Overall Study|Lost to Follow-up|1|||
48803495|NCT02569710|157121856|FG009|Overall Study|Lost to Follow-up|0|||
48803496|NCT02569710|157121847|FG000|Overall Study|Virologic failure|0|||
48803497|NCT02569710|157121848|FG001|Overall Study|Virologic failure|0|||
48803498|NCT02569710|157121849|FG002|Overall Study|Virologic failure|0|||
48803499|NCT02569710|157121850|FG003|Overall Study|Virologic failure|0|||
48803500|NCT02569710|157121851|FG004|Overall Study|Virologic failure|1|||
48803501|NCT02569710|157121852|FG005|Overall Study|Virologic failure|0|||
48803502|NCT02569710|157121853|FG006|Overall Study|Virologic failure|1|||
48803503|NCT02569710|157121854|FG007|Overall Study|Virologic failure|0|||
48803504|NCT02569710|157121855|FG008|Overall Study|Virologic failure|0|||
48803505|NCT02569710|157121856|FG009|Overall Study|Virologic failure|0|||
48803506|NCT02569710|157121847|FG000|Overall Study|Withdrawal by Subject|0|||
48803507|NCT02569710|157121848|FG001|Overall Study|Withdrawal by Subject|0|||
48803508|NCT02569710|157121849|FG002|Overall Study|Withdrawal by Subject|0|||
48803509|NCT02569710|157121850|FG003|Overall Study|Withdrawal by Subject|0|||
48803510|NCT02569710|157121851|FG004|Overall Study|Withdrawal by Subject|0|||
48803511|NCT02569710|157121852|FG005|Overall Study|Withdrawal by Subject|1|||
48803512|NCT02569710|157121853|FG006|Overall Study|Withdrawal by Subject|0|||
48803513|NCT02569710|157121854|FG007|Overall Study|Withdrawal by Subject|0|||
48803514|NCT02569710|157121855|FG008|Overall Study|Withdrawal by Subject|0|||
48803515|NCT02569710|157121856|FG009|Overall Study|Withdrawal by Subject|0|||
48803516|NCT05597722|157121859|FG000|Overall Study|Study was terminated|6|||
48803517|NCT05597722|157121860|FG001|Overall Study|Study was terminated|1|||
48803518|NCT01965938|157121868|FG000|Overall Study|Withdrawal by Subject|1|||
48803519|NCT01965938|157121869|FG001|Overall Study|Withdrawal by Subject|0|||
48803520|NCT03021486|157122939|FG000|Overall Study|Withdrawal by Subject|1|||
48803521|NCT03021486|157122940|FG001|Overall Study|Withdrawal by Subject|1|||
48803522|NCT03021486|157122941|FG002|Overall Study|Withdrawal by Subject|3|||
48803523|NCT03021486|157122939|FG000|Overall Study|Did not develop an RASS score of at least >= 1|7|||
48803524|NCT03021486|157122940|FG001|Overall Study|Did not develop an RASS score of at least >= 1|5|||
48803525|NCT03021486|157122941|FG002|Overall Study|Did not develop an RASS score of at least >= 1|6|||
48803526|NCT01693120|157122942|FG000|Enrollment|Lost to Follow-up|1|||
48803527|NCT01693120|157122942|FG000|Enrollment|Withdrawal by Subject|10|||
48803528|NCT01693120|157122942|FG000|Enrollment|Protocol Violation|46|||
48803529|NCT01693120|157122942|FG000|Enrollment|Physician Decision|3|||
48803530|NCT01693120|157122942|FG000|Enrollment|Adverse Event|1|||
48803531|NCT01693120|157122942|FG000|Enrollment|Study closed|8|||
48803532|NCT01693120|157122942|FG000|Enrollment|Other|1|||
48803533|NCT01693120|157122942|FG000|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1|||
48803534|NCT01693120|157122942|FG000|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5|||
48803535|NCT01693120|157122942|FG000|Phased RF Study Procedure and Follow-up|Physician Decision|3|||
48803536|NCT01693120|157122942|FG000|Phased RF Study Procedure and Follow-up|Protocol Violation|1|||
48803537|NCT01693120|157122942|FG000|Phased RF Study Procedure and Follow-up|Other reasons|7|||
48803538|NCT00676130|157122945|FG000|Overall Study|Lost to Follow-up|0|||
48803539|NCT00676130|157122946|FG001|Overall Study|Lost to Follow-up|1|||
48803540|NCT00676130|157122945|FG000|Overall Study|Found ineligible|3|||
48803541|NCT00676130|157122946|FG001|Overall Study|Found ineligible|2|||
48803542|NCT00676130|157122945|FG000|Overall Study|Withdrawal by Subject|0|||
49119116|NCT04147247|158274622|FG004|Overall Study|Physician Decision|0|||
49119117|NCT04147247|158274618|FG000|Overall Study|Clinical Disease Progression|0|||
48803543|NCT00676130|157122946|FG001|Overall Study|Withdrawal by Subject|1|||
48803544|NCT03642938|157122948|FG000|Overall Study|Withdrawal by Subject|0|||
48803545|NCT03642938|157122949|FG001|Overall Study|Withdrawal by Subject|0|||
48803546|NCT03642938|157122950|FG002|Overall Study|Withdrawal by Subject|0|||
48803547|NCT03642938|157122951|FG003|Overall Study|Withdrawal by Subject|1|||
48914948|NCT00054704|157524728|FG001|Overall Study|Lack of Efficacy|3|||
48914949|NCT00054704|157524727|FG000|Overall Study|Adverse Event|3|||
48914950|NCT00054704|157524728|FG001|Overall Study|Adverse Event|1|||
48914951|NCT00054704|157524727|FG000|Overall Study|Lost to Follow-up|0|||
48914952|NCT00054704|157524728|FG001|Overall Study|Lost to Follow-up|1|||
48914953|NCT03349775|157524729|FG000|Overall Study|Side Effects|1|||
48914954|NCT03349775|157524730|FG001|Overall Study|Side Effects|2|||
48803548|NCT02243202|157122952|FG000|Overall Study|Adverse Event|5|||
48803549|NCT02243202|157122953|FG001|Overall Study|Adverse Event|6|||
48803550|NCT02243202|157122954|FG002|Overall Study|Adverse Event|10|||
48803551|NCT02243202|157122955|FG003|Overall Study|Adverse Event|4|||
48803552|NCT02243202|157122952|FG000|Overall Study|Lost to Follow-up|9|||
48803553|NCT02243202|157122953|FG001|Overall Study|Lost to Follow-up|9|||
48803554|NCT02243202|157122954|FG002|Overall Study|Lost to Follow-up|14|||
48803555|NCT02243202|157122955|FG003|Overall Study|Lost to Follow-up|11|||
48803556|NCT02243202|157122952|FG000|Overall Study|Protocol Violation|3|||
48803557|NCT02243202|157122953|FG001|Overall Study|Protocol Violation|1|||
48803558|NCT02243202|157122954|FG002|Overall Study|Protocol Violation|2|||
48803559|NCT02243202|157122955|FG003|Overall Study|Protocol Violation|1|||
48803560|NCT02243202|157122952|FG000|Overall Study|Withdrawal by Subject|7|||
48803561|NCT02243202|157122953|FG001|Overall Study|Withdrawal by Subject|6|||
48803562|NCT02243202|157122954|FG002|Overall Study|Withdrawal by Subject|4|||
48803563|NCT02243202|157122955|FG003|Overall Study|Withdrawal by Subject|4|||
48803564|NCT02243202|157122952|FG000|Overall Study|Other|1|||
48803565|NCT02243202|157122953|FG001|Overall Study|Other|3|||
48803566|NCT02243202|157122954|FG002|Overall Study|Other|1|||
48803567|NCT02243202|157122955|FG003|Overall Study|Other|2|||
48803568|NCT02243202|157122952|FG000|Overall Study|Randomized but not received treatment|0|||
48803569|NCT02243202|157122953|FG001|Overall Study|Randomized but not received treatment|0|||
48803570|NCT02243202|157122954|FG002|Overall Study|Randomized but not received treatment|0|||
48803571|NCT02243202|157122955|FG003|Overall Study|Randomized but not received treatment|1|||
48803572|NCT00642902|157122960|FG000|Overall Study|Adverse Event|0|||
48803573|NCT00642902|157122961|FG001|Overall Study|Adverse Event|1|||
48803574|NCT00642902|157122962|FG002|Overall Study|Adverse Event|3|||
48803575|NCT00642902|157122963|FG003|Overall Study|Adverse Event|1|||
48803576|NCT00642902|157122960|FG000|Overall Study|Lost to Follow-up|1|||
48803577|NCT00642902|157122961|FG001|Overall Study|Lost to Follow-up|1|||
48803578|NCT00642902|157122962|FG002|Overall Study|Lost to Follow-up|0|||
48803579|NCT00642902|157122963|FG003|Overall Study|Lost to Follow-up|0|||
48803580|NCT00642902|157122960|FG000|Overall Study|Lack of Efficacy|0|||
48803581|NCT00642902|157122961|FG001|Overall Study|Lack of Efficacy|3|||
48803582|NCT00642902|157122962|FG002|Overall Study|Lack of Efficacy|3|||
48803583|NCT00642902|157122963|FG003|Overall Study|Lack of Efficacy|0|||
48803584|NCT00642902|157122960|FG000|Overall Study|Death|1|||
48803585|NCT00642902|157122961|FG001|Overall Study|Death|0|||
48803586|NCT00642902|157122962|FG002|Overall Study|Death|0|||
48803587|NCT00642902|157122963|FG003|Overall Study|Death|0|||
48803588|NCT00642902|157122960|FG000|Overall Study|Premature termination of clinical trial|37|||
48914955|NCT03349775|157524729|FG000|Overall Study|Withdrawal by Subject|1|||
48914956|NCT03349775|157524730|FG001|Overall Study|Withdrawal by Subject|1|||
48914957|NCT03349775|157524729|FG000|Overall Study|No primary outcome measurements|0|||
48914958|NCT03349775|157524730|FG001|Overall Study|No primary outcome measurements|1|||
48914959|NCT02234479|157524731|FG000|Overall Study|Withdrawal by Subject|1|||
48914960|NCT02234479|157524732|FG001|Overall Study|Withdrawal by Subject|3|||
48914961|NCT01848288|157524733|FG000|Overall Study|Death|1|||
48914962|NCT01848288|157524733|FG000|Overall Study|Protocol Violation|1|||
48914963|NCT01848288|157524733|FG000|Overall Study|Withdrawal by Subject|1|||
48914964|NCT00365456|157524738|FG000|Trial Period I (12 Months)|Adverse Event|84|||
48803589|NCT00642902|157122961|FG001|Overall Study|Premature termination of clinical trial|32|||
48803590|NCT00642902|157122962|FG002|Overall Study|Premature termination of clinical trial|35|||
48914965|NCT00365456|157524739|FG001|Trial Period I (12 Months)|Adverse Event|0|||
48914966|NCT00365456|157524738|FG000|Trial Period I (12 Months)|Non-compliance|3|||
48803591|NCT00642902|157122963|FG003|Overall Study|Premature termination of clinical trial|35|||
48803592|NCT00642902|157122960|FG000|Overall Study|Randomized, but not treated|0|||
48803593|NCT00642902|157122961|FG001|Overall Study|Randomized, but not treated|0|||
48803594|NCT00642902|157122962|FG002|Overall Study|Randomized, but not treated|1|||
48803595|NCT00642902|157122963|FG003|Overall Study|Randomized, but not treated|0|||
48803596|NCT00642902|157122960|FG000|Overall Study|Other|1|||
48914967|NCT00365456|157524739|FG001|Trial Period I (12 Months)|Non-compliance|0|||
48914968|NCT00365456|157524738|FG000|Trial Period I (12 Months)|Withdrawal by Subject|27|||
48914969|NCT00365456|157524739|FG001|Trial Period I (12 Months)|Withdrawal by Subject|0|||
48914970|NCT00365456|157524738|FG000|Trial Period I (12 Months)|Other|11|||
48803597|NCT00642902|157122961|FG001|Overall Study|Other|5|||
48803598|NCT00642902|157122962|FG002|Overall Study|Other|1|||
48803599|NCT00642902|157122963|FG003|Overall Study|Other|4|||
48803600|NCT04538417|157122964|FG000|Overall Study|Withdrawal by Subject|2|||
48803601|NCT02173054|157122965|FG000|Overall Study|lack of compliance|1|||
48803602|NCT02173054|157122966|FG001|Overall Study|lack of compliance|0|||
48803603|NCT02173054|157122967|FG002|Overall Study|lack of compliance|0|||
48803604|NCT02173054|157122965|FG000|Overall Study|Withdrawal by Subject|0|||
48803605|NCT02173054|157122966|FG001|Overall Study|Withdrawal by Subject|0|||
48803606|NCT02173054|157122967|FG002|Overall Study|Withdrawal by Subject|1|||
48803607|NCT04074590|157122977|FG000|Overall Study|Adverse Event|1|||
48803608|NCT04074590|157122978|FG001|Overall Study|Adverse Event|0|||
48803609|NCT04074590|157122977|FG000|Overall Study|Physician Decision|1|||
48803610|NCT04074590|157122978|FG001|Overall Study|Physician Decision|0|||
48803611|NCT04074590|157122977|FG000|Overall Study|Withdrawal by Subject|2|||
48803612|NCT04074590|157122978|FG001|Overall Study|Withdrawal by Subject|0|||
48803613|NCT03299686|157122979|FG000|Treatment Epoch|Subject/Guardian Decision|2|||
48803614|NCT03299686|157122980|FG001|Treatment Epoch|Subject/Guardian Decision|0|||
48803615|NCT03299686|157122979|FG000|Treatment Epoch|Physician Decision|1|||
48803616|NCT03299686|157122980|FG001|Treatment Epoch|Physician Decision|0|||
48803617|NCT03299686|157122979|FG000|Treatment Epoch|Adverse Event|8|||
48803618|NCT03299686|157122980|FG001|Treatment Epoch|Adverse Event|4|||
48803619|NCT03299686|157122979|FG000|Follow-up Epoch|Subject/Guardian Decision|0|||
48803620|NCT03299686|157122980|FG001|Follow-up Epoch|Subject/Guardian Decision|1|||
48803621|NCT01201811|157122982|FG000|Overall Study|Adverse Event|6|||
48803622|NCT01201811|157122982|FG000|Overall Study|Disease progression|3|||
48803623|NCT01201811|157122982|FG000|Overall Study|Withdrawal by Subject|3|||
48803624|NCT01201811|157122982|FG000|Overall Study|Death|4|||
48803625|NCT01201811|157122982|FG000|Overall Study|Treatment Failure|2|||
48803626|NCT01201811|157122982|FG000|Overall Study|Physician Decision|1|||
48803627|NCT02857426|157122983|FG000|Overall Study|Disease progression|34|||
48803628|NCT02857426|157122984|FG001|Overall Study|Disease progression|13|||
48803629|NCT02857426|157122983|FG000|Overall Study|Study drug toxicity|4|||
48803630|NCT02857426|157122984|FG001|Overall Study|Study drug toxicity|1|||
48803631|NCT02857426|157122983|FG000|Overall Study|Death|1|||
48803632|NCT02857426|157122984|FG001|Overall Study|Death|0|||
48803633|NCT02857426|157122983|FG000|Overall Study|Adverse event unrelated to study drug|6|||
48803634|NCT02857426|157122984|FG001|Overall Study|Adverse event unrelated to study drug|2|||
48803635|NCT02857426|157122983|FG000|Overall Study|Participant withdrew consent|1|||
48803636|NCT02857426|157122984|FG001|Overall Study|Participant withdrew consent|1|||
48803637|NCT02857426|157122983|FG000|Overall Study|Maximum clinical benefit|1|||
48803638|NCT02857426|157122984|FG001|Overall Study|Maximum clinical benefit|0|||
48803639|NCT02857426|157122983|FG000|Overall Study|Completed treatment|0|||
48803640|NCT02857426|157122984|FG001|Overall Study|Completed treatment|2|||
48803641|NCT01960725|157122985|FG000|Overall Study|Lost to Follow-up|4|||
48803642|NCT01960725|157122986|FG001|Overall Study|Lost to Follow-up|3|||
48803643|NCT01960725|157122985|FG000|Overall Study|Withdrawal by Subject|1|||
48803644|NCT01960725|157122986|FG001|Overall Study|Withdrawal by Subject|0|||
48803645|NCT01960725|157122985|FG000|Overall Study|unable to obtain blood sample|1|||
48803646|NCT01960725|157122986|FG001|Overall Study|unable to obtain blood sample|2|||
48803647|NCT03587142|157122987|FG000|Overall Study|Lost to Follow-up|5|||
48803648|NCT03587142|157122988|FG001|Overall Study|Lost to Follow-up|3|||
48803649|NCT03587142|157122987|FG000|Overall Study|Did not complete the f4 visit|3|||
48803650|NCT03587142|157122988|FG001|Overall Study|Did not complete the f4 visit|7|||
48803651|NCT04766086|157122989|FG000|Overall Study|Lost to Follow-up|3|||
48803652|NCT04766086|157122990|FG001|Overall Study|Lost to Follow-up|5|||
48803653|NCT04766086|157122991|FG002|Overall Study|Lost to Follow-up|3|||
48803654|NCT04766086|157122989|FG000|Overall Study|Withdrawal by Subject|1|||
48803655|NCT04766086|157122990|FG001|Overall Study|Withdrawal by Subject|1|||
48803656|NCT04766086|157122991|FG002|Overall Study|Withdrawal by Subject|2|||
48803657|NCT04766086|157122989|FG000|Overall Study|Other|0|||
48914971|NCT00365456|157524739|FG001|Trial Period I (12 Months)|Other|0|||
48803658|NCT04766086|157122990|FG001|Overall Study|Other|0|||
48914972|NCT00365456|157524738|FG000|Trial Period II (12 Months)|Adverse Event|0|||
48914973|NCT00365456|157524739|FG001|Trial Period II (12 Months)|Adverse Event|6|||
48914974|NCT00365456|157524738|FG000|Trial Period II (12 Months)|Non-compliance|0|||
48914975|NCT00365456|157524739|FG001|Trial Period II (12 Months)|Non-compliance|2|||
48914976|NCT00365456|157524738|FG000|Trial Period II (12 Months)|Withdrawal by Subject|0|||
48914977|NCT00365456|157524739|FG001|Trial Period II (12 Months)|Withdrawal by Subject|5|||
48914978|NCT00365456|157524738|FG000|Trial Period II (12 Months)|Other|0|||
48914979|NCT00365456|157524739|FG001|Trial Period II (12 Months)|Other|1|||
48803659|NCT04766086|157122991|FG002|Overall Study|Other|1|||
48803660|NCT03072238|157123000|FG000|Overall Study|Withdrawal by Subject|30|||
48803661|NCT03072238|157123001|FG001|Overall Study|Withdrawal by Subject|51|||
48914980|NCT00365456|157524738|FG000|Trial Period III (12 Months)|Adverse Event|13|||
48914981|NCT00365456|157524739|FG001|Trial Period III (12 Months)|Adverse Event|3|||
48803662|NCT03072238|157123000|FG000|Overall Study|Lost to Follow-up|7|||
48803663|NCT03072238|157123001|FG001|Overall Study|Lost to Follow-up|4|||
48803664|NCT03072238|157123000|FG000|Overall Study|Physician Decision|1|||
48803665|NCT03072238|157123001|FG001|Overall Study|Physician Decision|3|||
48803666|NCT03072238|157123000|FG000|Overall Study|Death|139|||
48803667|NCT03072238|157123001|FG001|Overall Study|Death|121|||
48803668|NCT03072238|157123000|FG000|Overall Study|Other|0|||
48803669|NCT03072238|157123001|FG001|Overall Study|Other|1|||
48803670|NCT03072238|157123000|FG000|Overall Study|Ongoing on study|377|||
48803671|NCT03072238|157123001|FG001|Overall Study|Ongoing on study|367|||
48803672|NCT03502616|157123002|FG000|Up to Week 16|Withdrawal by Subject|1|||
48803673|NCT03502616|157123003|FG001|Up to Week 16|Withdrawal by Subject|2|||
48803674|NCT03502616|157123002|FG000|Up to Week 16|Lost to Follow-up|0|||
48803675|NCT03502616|157123003|FG001|Up to Week 16|Lost to Follow-up|1|||
48803676|NCT03502616|157123002|FG000|Up to Week 16|Randomized, but not treated|1|||
48803677|NCT03502616|157123003|FG001|Up to Week 16|Randomized, but not treated|0|||
48803678|NCT03502616|157123002|FG000|Week 16 to Week 48|Withdrawal by Subject|6|||
48803679|NCT03502616|157123003|FG001|Week 16 to Week 48|Withdrawal by Subject|6|||
48803680|NCT03502616|157123002|FG000|Week 16 to Week 48|Lost to Follow-up|1|||
48914982|NCT00365456|157524738|FG000|Trial Period III (12 Months)|Withdrawal by Subject|4|||
48914983|NCT00365456|157524739|FG001|Trial Period III (12 Months)|Withdrawal by Subject|1|||
48914984|NCT00365456|157524738|FG000|Trial Period III (12 Months)|Other|1|||
48914985|NCT00365456|157524739|FG001|Trial Period III (12 Months)|Other|1|||
48914986|NCT01438489|157524742|FG000|Overall Study|Lost to Follow-up|4|||
48914987|NCT01438489|157524743|FG001|Overall Study|Lost to Follow-up|2|||
48914988|NCT01438489|157524744|FG002|Overall Study|Lost to Follow-up|2|||
48914989|NCT01438489|157524742|FG000|Overall Study|Withdrawal by Subject|11|||
48914990|NCT01438489|157524743|FG001|Overall Study|Withdrawal by Subject|3|||
48914991|NCT01438489|157524744|FG002|Overall Study|Withdrawal by Subject|8|||
48914992|NCT01438489|157524742|FG000|Overall Study|Death|0|||
48914993|NCT01438489|157524743|FG001|Overall Study|Death|0|||
48914994|NCT01438489|157524744|FG002|Overall Study|Death|1|||
48914995|NCT01438489|157524742|FG000|Overall Study|Sponsor decision|4|||
48914996|NCT01438489|157524743|FG001|Overall Study|Sponsor decision|1|||
48914997|NCT01438489|157524744|FG002|Overall Study|Sponsor decision|4|||
48914998|NCT01438489|157524742|FG000|Overall Study|Subject choice/Subject moved|2|||
48914999|NCT01438489|157524743|FG001|Overall Study|Subject choice/Subject moved|1|||
48915000|NCT01438489|157524744|FG002|Overall Study|Subject choice/Subject moved|1|||
48915001|NCT01438489|157524742|FG000|Overall Study|Investigator decision|0|||
48915002|NCT01438489|157524743|FG001|Overall Study|Investigator decision|1|||
48915003|NCT01438489|157524744|FG002|Overall Study|Investigator decision|0|||
48915004|NCT01438489|157524742|FG000|Overall Study|AE/SAEs|2|||
48915005|NCT01438489|157524743|FG001|Overall Study|AE/SAEs|1|||
48915006|NCT01438489|157524744|FG002|Overall Study|AE/SAEs|1|||
48915007|NCT01438489|157524742|FG000|Overall Study|Received prohibited medication|1|||
48915008|NCT01438489|157524743|FG001|Overall Study|Received prohibited medication|0|||
48915009|NCT01438489|157524744|FG002|Overall Study|Received prohibited medication|0|||
48915010|NCT01438489|157524742|FG000|Overall Study|Did not complete all 3 follow-up visits|2|||
48915011|NCT01438489|157524743|FG001|Overall Study|Did not complete all 3 follow-up visits|5|||
48915012|NCT01438489|157524744|FG002|Overall Study|Did not complete all 3 follow-up visits|2|||
48915013|NCT01438489|157524742|FG000|Overall Study|Inadequate venous access|0|||
48915014|NCT01438489|157524743|FG001|Overall Study|Inadequate venous access|2|||
48915015|NCT01438489|157524744|FG002|Overall Study|Inadequate venous access|0|||
48915016|NCT03680911|157524745|FG000|At Home Treatment|Study Termination|3|||
48915017|NCT03680911|157524746|FG001|At Home Treatment|Study Termination|0|||
48915018|NCT03680911|157524745|FG000|At Home Treatment|Lost to Follow-up|0|||
48915019|NCT03680911|157524746|FG001|At Home Treatment|Lost to Follow-up|1|||
48915020|NCT03680911|157524745|FG000|At Home Treatment|Withdrawal by Subject|0|||
48915021|NCT03680911|157524746|FG001|At Home Treatment|Withdrawal by Subject|2|||
48915022|NCT03680911|157524745|FG000|Visit 3 (4 Month Follow up)|Study Termination|0|||
48915023|NCT03680911|157524746|FG001|Visit 3 (4 Month Follow up)|Study Termination|1|||
48915024|NCT01075412|157524749|FG000|Overall Study|Withdrawal by Subject|0|||
48915025|NCT01075412|157524750|FG001|Overall Study|Withdrawal by Subject|1|||
48915026|NCT03962738|157524751|FG000|Overall Study|Protocol Deviation|3|||
48915027|NCT03962738|157524752|FG001|Overall Study|Protocol Deviation|0|||
48803681|NCT03502616|157123003|FG001|Week 16 to Week 48|Lost to Follow-up|0|||
48803682|NCT00312702|157123004|FG000|Immunization Phase|Lost to Follow-up|0|||
48803683|NCT00312702|157123005|FG001|Immunization Phase|Lost to Follow-up|1|||
48915028|NCT03962738|157524753|FG002|Overall Study|Protocol Deviation|1|||
48915029|NCT03962738|157524754|FG003|Overall Study|Protocol Deviation|1|||
48915030|NCT03962738|157524751|FG000|Overall Study|Withdrawal by Subject|4|||
48915031|NCT03962738|157524752|FG001|Overall Study|Withdrawal by Subject|0|||
48915032|NCT03962738|157524753|FG002|Overall Study|Withdrawal by Subject|0|||
48915033|NCT03962738|157524754|FG003|Overall Study|Withdrawal by Subject|0|||
48915034|NCT03962738|157524751|FG000|Overall Study|Lost to Follow-up|0|||
48915035|NCT03962738|157524752|FG001|Overall Study|Lost to Follow-up|0|||
48915036|NCT03962738|157524753|FG002|Overall Study|Lost to Follow-up|1|||
48803684|NCT00312702|157123006|FG002|Immunization Phase|Lost to Follow-up|0|||
48915037|NCT03962738|157524754|FG003|Overall Study|Lost to Follow-up|0|||
48803685|NCT01859793|157123011|FG000|First Intervention (8 Weeks)|Protocol Violation|2|||
48915038|NCT02614859|157524755|FG000|Overall Study|Physician Decision|0|||
48915039|NCT02614859|157524756|FG001|Overall Study|Physician Decision|1|||
48915040|NCT00131469|157524757|FG000|Overall Study|Withdrawal by Subject|3|||
48915041|NCT00131469|157524758|FG001|Overall Study|Withdrawal by Subject|4|||
48915042|NCT00131469|157524757|FG000|Overall Study|Protocol Violation|3|||
48915043|NCT00131469|157524758|FG001|Overall Study|Protocol Violation|1|||
48803686|NCT01859793|157123012|FG001|First Intervention (8 Weeks)|Protocol Violation|0|||
48803687|NCT01859793|157123011|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
48915044|NCT00131469|157524757|FG000|Overall Study|Death|0|||
48803688|NCT01859793|157123012|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
48803689|NCT01859793|157123011|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
48803690|NCT01859793|157123012|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
48803691|NCT01859793|157123011|FG000|Washout Period (4 Weeks)|Lost to Follow-up|1|||
48803692|NCT01859793|157123012|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
48803693|NCT04552223|157123014|FG000|Overall Study|Withdrawal by Subject|1|||
48803694|NCT04332926|157123015|FG000|Overall Study|Withdrawal by Subject|6|||
48803695|NCT04332926|157123015|FG000|Overall Study|Physician Decision|6|||
48803696|NCT04662931|157123019|FG000|Overall Study|Withdrawal by Subject|17|||
48803697|NCT04662931|157123019|FG000|Overall Study|Death|3|||
48803698|NCT04662931|157123019|FG000|Overall Study|Lost to Follow-up|3|||
48803699|NCT04662931|157123019|FG000|Overall Study|Guardian Decision|1|||
48803700|NCT04899245|157123022|FG000|Overall Study|Withdrawal by Subject|3|||
48803701|NCT04899245|157123023|FG001|Overall Study|Withdrawal by Subject|5|||
48803702|NCT04899245|157123024|FG002|Overall Study|Withdrawal by Subject|2|||
48803703|NCT04899245|157123022|FG000|Overall Study|No longer eligible - Left staff position|0|||
48803704|NCT04899245|157123023|FG001|Overall Study|No longer eligible - Left staff position|0|||
48803705|NCT04899245|157123024|FG002|Overall Study|No longer eligible - Left staff position|1|||
48803706|NCT04899245|157123022|FG000|Overall Study|No longer eligible - Child graduated from school program|19|||
48803707|NCT04899245|157123023|FG001|Overall Study|No longer eligible - Child graduated from school program|21|||
48803708|NCT04899245|157123024|FG002|Overall Study|No longer eligible - Child graduated from school program|0|||
48803709|NCT04899245|157123022|FG000|Overall Study|No longer eligible - Moved away from area|2|||
48803710|NCT04899245|157123023|FG001|Overall Study|No longer eligible - Moved away from area|2|||
48803711|NCT04899245|157123024|FG002|Overall Study|No longer eligible - Moved away from area|0|||
48803712|NCT01456949|157123025|FG000|Enrollment|PI death- incomplete data|6|||
48803713|NCT01456949|157123025|FG000|Enrollment|Death|1|||
48803714|NCT01456949|157123025|FG000|Enrollment|I/E criteria not met prior to procedure|13|||
48803715|NCT01456949|157123025|FG000|Enrollment|Physician Decision|10|||
48803716|NCT01456949|157123025|FG000|Enrollment|Withdrawal by Subject|7|||
48803717|NCT01456949|157123025|FG000|Study Cryoablation Procedure & Follow-up|Death|5|||
48803718|NCT01456949|157123025|FG000|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23|||
48803719|NCT01456949|157123025|FG000|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11|||
48803720|NCT01456949|157123025|FG000|Study Cryoablation Procedure & Follow-up|Physician Decision|1|||
48803721|NCT01456949|157123025|FG000|Study Cryoablation Procedure & Follow-up|Subject Relocation|10|||
48915045|NCT00131469|157524758|FG001|Overall Study|Death|1|||
48915046|NCT00131469|157524757|FG000|Overall Study|Lost to Follow-up|0|||
48915047|NCT00131469|157524758|FG001|Overall Study|Lost to Follow-up|1|||
48915048|NCT00131469|157524757|FG000|Overall Study|scan not analyzable|3|||
48915049|NCT00131469|157524758|FG001|Overall Study|scan not analyzable|6|||
48915050|NCT02871778|157524759|FG000|Part A: Treatment Period 1|Adverse Event|1|||
48915051|NCT02871778|157524760|FG001|Part A: Treatment Period 1|Adverse Event|1|||
48915052|NCT02871778|157524761|FG002|Part A: Treatment Period 1|Adverse Event|1|||
48915053|NCT02871778|157524762|FG003|Part A: Treatment Period 1|Adverse Event|0|||
48915054|NCT02871778|157524763|FG004|Part A: Treatment Period 1|Adverse Event|0|||
48915055|NCT02871778|157524764|FG005|Part A: Treatment Period 1|Adverse Event|0|||
48915056|NCT02871778|157524765|FG006|Part A: Treatment Period 1|Adverse Event|0|||
48915057|NCT02871778|157524766|FG007|Part A: Treatment Period 1|Adverse Event|0|||
48915058|NCT02871778|157524759|FG000|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
48915059|NCT02871778|157524760|FG001|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
48915060|NCT02871778|157524761|FG002|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
48915061|NCT02871778|157524762|FG003|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
48915062|NCT02871778|157524763|FG004|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
48915063|NCT02871778|157524764|FG005|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
48915064|NCT02871778|157524765|FG006|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
48915065|NCT02871778|157524766|FG007|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
48803722|NCT01456949|157123025|FG000|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2|||
48803723|NCT01456949|157123025|FG000|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6|||
48915066|NCT02871778|157524759|FG000|Part A: Treatment Period 1|Noncompliant with study drug|0|||
48915067|NCT02871778|157524760|FG001|Part A: Treatment Period 1|Noncompliant with study drug|0|||
48915068|NCT02871778|157524761|FG002|Part A: Treatment Period 1|Noncompliant with study drug|1|||
48803724|NCT01456949|157123025|FG000|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4|||
48803725|NCT03976466|157123029|FG000|Overall Study|Lost to Follow-up|1|||
48803726|NCT03976466|157123030|FG001|Overall Study|Lost to Follow-up|3|||
48803727|NCT00943306|157123033|FG000|Overall Study|Physician Decision|1|||
48803728|NCT00943306|157123033|FG000|Overall Study|Death|1|||
48803729|NCT00943306|157123033|FG000|Overall Study|Sponsor decision due to non-compliance|1|||
48803730|NCT01395823|157123035|FG000|Overall Study|Death|4|||
48803731|NCT01395823|157123036|FG001|Overall Study|Death|4|||
48803732|NCT01395823|157123035|FG000|Overall Study|Physician Decision|3|||
48803733|NCT01395823|157123036|FG001|Overall Study|Physician Decision|1|||
48803734|NCT01395823|157123035|FG000|Overall Study|Lost to Follow-up|1|||
48803735|NCT01395823|157123036|FG001|Overall Study|Lost to Follow-up|0|||
48803736|NCT01395823|157123035|FG000|Overall Study|Transplant|1|||
48803737|NCT01395823|157123036|FG001|Overall Study|Transplant|0|||
48803738|NCT01395823|157123035|FG000|Overall Study|GI symptoms|1|||
48803739|NCT01395823|157123036|FG001|Overall Study|GI symptoms|0|||
48803740|NCT01395823|157123035|FG000|Overall Study|Withdrawal by Subject|5|||
48803741|NCT01395823|157123036|FG001|Overall Study|Withdrawal by Subject|4|||
48803742|NCT00717314|157123037|FG000|Overall Study|Adverse Event|3|||
48803743|NCT00717314|157123038|FG001|Overall Study|Adverse Event|2|||
48803744|NCT00717314|157123037|FG000|Overall Study|Protocol Violation|1|||
48803745|NCT00717314|157123038|FG001|Overall Study|Protocol Violation|0|||
48803746|NCT00717314|157123037|FG000|Overall Study|Lost to Follow-up|1|||
48803747|NCT00717314|157123038|FG001|Overall Study|Lost to Follow-up|5|||
48803748|NCT00717314|157123037|FG000|Overall Study|Withdrawal by Subject|1|||
48803749|NCT00717314|157123038|FG001|Overall Study|Withdrawal by Subject|3|||
48803750|NCT02613221|157123039|FG000|Overall Study|Lack of efficacy (exacerbation)|50|||
48803751|NCT02613221|157123039|FG000|Overall Study|Adverse Event|2|||
48803752|NCT02613221|157123039|FG000|Overall Study|Voluntary Discontinuation|1|||
48803753|NCT02613221|157123039|FG000|Overall Study|Delayed Treatment|1|||
48803754|NCT02613221|157123039|FG000|Overall Study|Enrolled but Not Treated|1|||
48803755|NCT04095039|157123040|FG000|Overall Study|Withdrawal by Subject|2|||
48803756|NCT04095039|157123041|FG001|Overall Study|Withdrawal by Subject|16|||
48803757|NCT04095039|157123040|FG000|Overall Study|Transplanted|21|||
48803758|NCT04095039|157123041|FG001|Overall Study|Transplanted|24|||
48803759|NCT04095039|157123040|FG000|Overall Study|Transferred to Non-study Facility|47|||
48803760|NCT04095039|157123041|FG001|Overall Study|Transferred to Non-study Facility|44|||
48803761|NCT04095039|157123040|FG000|Overall Study|Withdrawal from internvention target|0|||
48803762|NCT04095039|157123041|FG001|Overall Study|Withdrawal from internvention target|2|||
48803763|NCT04095039|157123040|FG000|Overall Study|Switch to peritoneal dialysis or home hemodialysis|2|||
48803764|NCT04095039|157123041|FG001|Overall Study|Switch to peritoneal dialysis or home hemodialysis|4|||
48803765|NCT04095039|157123040|FG000|Overall Study|Cacliphylaxis|0|||
48803766|NCT04095039|157123041|FG001|Overall Study|Cacliphylaxis|1|||
48803767|NCT04095039|157123040|FG000|Overall Study|Pregnancy|1|||
48803768|NCT04095039|157123041|FG001|Overall Study|Pregnancy|0|||
48803769|NCT00886639|157123044|FG000|Overall Study|acute exacerbation|14|||
48803770|NCT00886639|157123044|FG000|Overall Study|non-compliance|2|||
48803771|NCT01396317|157123045|FG000|Overall Study|Adverse Event|1|||
48803772|NCT01396317|157123046|FG001|Overall Study|Adverse Event|0|||
48803773|NCT03156465|157123047|FG000|Overall Study|Withdrawal by Subject|2|||
48803774|NCT01786330|157123048|FG000|Overall Study|Withdrawal by Subject|0|||
48803775|NCT01786330|157123049|FG001|Overall Study|Withdrawal by Subject|1|||
48803776|NCT01786330|157123048|FG000|Overall Study|Lost to Follow-up|0|||
48803777|NCT01786330|157123049|FG001|Overall Study|Lost to Follow-up|1|||
48803778|NCT01786330|157123048|FG000|Overall Study|Excluded intraoperatively|0|||
48803779|NCT01786330|157123049|FG001|Overall Study|Excluded intraoperatively|1|||
48803780|NCT01786330|157123048|FG000|Overall Study|Protocol Violation|1|||
48915069|NCT02871778|157524762|FG003|Part A: Treatment Period 1|Noncompliant with study drug|0|||
49119118|NCT04147247|158274619|FG001|Overall Study|Clinical Disease Progression|0|||
49119119|NCT04147247|158274620|FG002|Overall Study|Clinical Disease Progression|0|||
49119120|NCT04147247|158274621|FG003|Overall Study|Clinical Disease Progression|0|||
49119121|NCT04147247|158274622|FG004|Overall Study|Clinical Disease Progression|1|||
49119122|NCT04147247|158274618|FG000|Overall Study|Adverse Event|0|||
49119123|NCT04147247|158274619|FG001|Overall Study|Adverse Event|0|||
48803781|NCT01786330|157123049|FG001|Overall Study|Protocol Violation|0|||
48803782|NCT03012841|157124104|FG000|Overall Study|Protocol Violation|0|||
48803783|NCT03012841|157124105|FG001|Overall Study|Protocol Violation|10|||
48803784|NCT03012841|157124104|FG000|Overall Study|Lost to Follow-up|6|||
48803785|NCT03012841|157124105|FG001|Overall Study|Lost to Follow-up|1|||
48803786|NCT03012841|157124104|FG000|Overall Study|Withdrawal by Subject|6|||
48803787|NCT03012841|157124105|FG001|Overall Study|Withdrawal by Subject|0|||
48803788|NCT03012841|157124104|FG000|Overall Study|Unable to complete 12 month visit|6|||
48803789|NCT03012841|157124105|FG001|Overall Study|Unable to complete 12 month visit|0|||
48803790|NCT03012841|157124104|FG000|Overall Study|Subject relocation|1|||
48803791|NCT03012841|157124105|FG001|Overall Study|Subject relocation|0|||
48803792|NCT03012841|157124104|FG000|Overall Study|Seasonal winter travel|1|||
48803793|NCT03012841|157124105|FG001|Overall Study|Seasonal winter travel|0|||
48803794|NCT03012841|157124104|FG000|Overall Study|Physician Decision|0|||
48803795|NCT03012841|157124105|FG001|Overall Study|Physician Decision|2|||
48803796|NCT03012841|157124104|FG000|Overall Study|No ablation performed|0|||
48803797|NCT03012841|157124105|FG001|Overall Study|No ablation performed|2|||
48803798|NCT03012841|157124104|FG000|Overall Study|Study reached n=165 treated subject cap|0|||
48803799|NCT03012841|157124105|FG001|Overall Study|Study reached n=165 treated subject cap|5|||
48803800|NCT03012841|157124104|FG000|Overall Study|Insurance change|0|||
48803801|NCT03012841|157124105|FG001|Overall Study|Insurance change|1|||
48803802|NCT01493687|157124111|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|2|||
48803803|NCT01493687|157124112|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
48803804|NCT01493687|157124111|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
48803805|NCT01493687|157124112|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
48803806|NCT01493687|157124111|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|7|||
48803807|NCT01493687|157124112|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
48803808|NCT01493687|157124111|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18|||
48803809|NCT01493687|157124112|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7|||
48803810|NCT01493687|157124111|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|2|||
48803811|NCT01493687|157124112|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|1|||
48803812|NCT01493687|157124111|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7|||
48803813|NCT01493687|157124112|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
48803814|NCT01493687|157124111|FG000|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
48803815|NCT01493687|157124112|FG001|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
48803816|NCT01493687|157124111|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|5|||
48803817|NCT01493687|157124112|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|1|||
48803818|NCT01493687|157124111|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2|||
48803819|NCT01493687|157124112|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
48803820|NCT01493687|157124111|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
48803821|NCT01493687|157124112|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|4|||
48803822|NCT01493687|157124111|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27|||
48803823|NCT01493687|157124112|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16|||
48803824|NCT01493687|157124111|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|1|||
48803825|NCT01493687|157124112|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|0|||
48803826|NCT01493687|157124111|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16|||
48803827|NCT01493687|157124112|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
48803828|NCT01493687|157124111|FG000|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5|||
48803829|NCT01493687|157124112|FG001|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1|||
48803830|NCT01493687|157124111|FG000|Part C Safety Follow up (4 Weeks)|Adverse Event|0|||
48803831|NCT01493687|157124112|FG001|Part C Safety Follow up (4 Weeks)|Adverse Event|1|||
48803832|NCT02739347|157124113|FG000|Overall Study|Adverse Event|3|||
48803833|NCT02739347|157124114|FG001|Overall Study|Adverse Event|0|||
48803834|NCT02739347|157124113|FG000|Overall Study|Protocol Violation|0|||
48803835|NCT02739347|157124114|FG001|Overall Study|Protocol Violation|1|||
48803836|NCT02739347|157124113|FG000|Overall Study|Lost to Follow-up|0|||
48803837|NCT02739347|157124114|FG001|Overall Study|Lost to Follow-up|2|||
48803838|NCT04836858|157124115|FG000|Overall Study|Adverse Event|0|||
48803839|NCT04836858|157124116|FG001|Overall Study|Adverse Event|0|||
48803840|NCT04836858|157124117|FG002|Overall Study|Adverse Event|0|||
48803841|NCT04836858|157124118|FG003|Overall Study|Adverse Event|1|||
48803842|NCT04836858|157124115|FG000|Overall Study|Lost to Follow-up|1|||
48803843|NCT04836858|157124116|FG001|Overall Study|Lost to Follow-up|0|||
48803844|NCT04836858|157124117|FG002|Overall Study|Lost to Follow-up|0|||
48803845|NCT04836858|157124118|FG003|Overall Study|Lost to Follow-up|0|||
48803846|NCT04836858|157124115|FG000|Overall Study|Subject/Guardian decision|3|||
48803847|NCT04836858|157124116|FG001|Overall Study|Subject/Guardian decision|0|||
48803848|NCT04836858|157124117|FG002|Overall Study|Subject/Guardian decision|0|||
48803849|NCT04836858|157124118|FG003|Overall Study|Subject/Guardian decision|1|||
48803850|NCT04836858|157124115|FG000|Overall Study|Randomized but not treated|4|||
48803851|NCT04836858|157124116|FG001|Overall Study|Randomized but not treated|0|||
48803852|NCT04836858|157124117|FG002|Overall Study|Randomized but not treated|0|||
48803853|NCT04836858|157124118|FG003|Overall Study|Randomized but not treated|0|||
48803854|NCT03124199|157124119|FG000|Overall Study|Lost to Follow-up|4|||
48803855|NCT01782872|157124120|FG000|Overall Study|Protocol Violation|0|||
48803856|NCT01782872|157124121|FG001|Overall Study|Protocol Violation|0|||
48803857|NCT01782872|157124122|FG002|Overall Study|Protocol Violation|0|||
48803858|NCT01782872|157124123|FG003|Overall Study|Protocol Violation|1|||
48803859|NCT01782872|157124120|FG000|Overall Study|Withdrawal by Subject|0|||
48803860|NCT01782872|157124121|FG001|Overall Study|Withdrawal by Subject|1|||
48803861|NCT01782872|157124122|FG002|Overall Study|Withdrawal by Subject|0|||
48803862|NCT01782872|157124123|FG003|Overall Study|Withdrawal by Subject|0|||
48803863|NCT02228395|157124124|FG000|First Intervention Period|No longer willing to participate|1|||
48803864|NCT02228395|157124125|FG001|First Intervention Period|No longer willing to participate|0|||
49119124|NCT04147247|158274620|FG002|Overall Study|Adverse Event|1|||
48803865|NCT02228395|157124126|FG002|First Intervention Period|No longer willing to participate|0|||
48803866|NCT02228395|157124124|FG000|First Intervention Period|Unable to comply with study dates|0|||
48803867|NCT02228395|157124125|FG001|First Intervention Period|Unable to comply with study dates|1|||
48803868|NCT02228395|157124126|FG002|First Intervention Period|Unable to comply with study dates|1|||
48803869|NCT02724878|157124127|FG000|Overall Study|Still on Active Therapy|15|||
48803870|NCT02724878|157124127|FG000|Overall Study|Disease Progression|31|||
48803871|NCT02724878|157124127|FG000|Overall Study|Toxicity|5|||
48803872|NCT02724878|157124127|FG000|Overall Study|Death|1|||
48803873|NCT02724878|157124127|FG000|Overall Study|Withdrawal by Subject|4|||
48803874|NCT02724878|157124127|FG000|Overall Study|Lost to Follow-up|2|||
48803875|NCT02724878|157124127|FG000|Overall Study|Protocol Violation|1|||
48803876|NCT02724878|157124127|FG000|Overall Study|Ineligible for Study Drug|5|||
48803877|NCT02724878|157124127|FG000|Overall Study|not started|1|||
48803878|NCT04710927|157124128|FG000|Overall Study|Lost to Follow-up|7|||
48803879|NCT04710927|157124129|FG001|Overall Study|Lost to Follow-up|6|||
48803880|NCT04710927|157124130|FG002|Overall Study|Lost to Follow-up|5|||
48803881|NCT02634788|157124132|FG000|Overall Study|Adverse Event|0|||
48803882|NCT02634788|157124133|FG001|Overall Study|Adverse Event|8|||
48803883|NCT02634788|157124134|FG002|Overall Study|Adverse Event|3|||
48803884|NCT02634788|157124135|FG003|Overall Study|Adverse Event|1|||
48803885|NCT02634788|157124132|FG000|Overall Study|Lack of Efficacy|4|||
48803886|NCT02634788|157124133|FG001|Overall Study|Lack of Efficacy|0|||
48803887|NCT02634788|157124134|FG002|Overall Study|Lack of Efficacy|1|||
48803888|NCT02634788|157124135|FG003|Overall Study|Lack of Efficacy|4|||
48803889|NCT02634788|157124132|FG000|Overall Study|Lost to Follow-up|0|||
48803890|NCT02634788|157124133|FG001|Overall Study|Lost to Follow-up|1|||
48803891|NCT02634788|157124134|FG002|Overall Study|Lost to Follow-up|0|||
48803892|NCT02634788|157124135|FG003|Overall Study|Lost to Follow-up|0|||
48803893|NCT02634788|157124132|FG000|Overall Study|Withdrawal by Subject|0|||
48803894|NCT02634788|157124133|FG001|Overall Study|Withdrawal by Subject|1|||
48708463|NCT03682770|156780945|FG006|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
48708464|NCT03682770|156780939|FG000|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
48708465|NCT03682770|156780940|FG001|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
48708466|NCT03682770|156780941|FG002|AR101 Up-dosing Period (Week 28-40)|Adverse Event|1|||
48708467|NCT03682770|156780942|FG003|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
48708468|NCT03682770|156780943|FG004|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
48708469|NCT03682770|156780944|FG005|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
48708470|NCT03682770|156780945|FG006|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
48708471|NCT03682770|156780939|FG000|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
48708472|NCT03682770|156780940|FG001|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
48708473|NCT03682770|156780941|FG002|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|1|||
48708474|NCT03682770|156780942|FG003|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
48708475|NCT03682770|156780943|FG004|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
48708476|NCT03682770|156780944|FG005|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
48708477|NCT03682770|156780945|FG006|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
48708478|NCT03682770|156780939|FG000|AR101 Up-dosing Period (Week 28-40)|Other|0|||
48708479|NCT03682770|156780940|FG001|AR101 Up-dosing Period (Week 28-40)|Other|0|||
48708480|NCT03682770|156780941|FG002|AR101 Up-dosing Period (Week 28-40)|Other|0|||
48708481|NCT03682770|156780942|FG003|AR101 Up-dosing Period (Week 28-40)|Other|2|||
48708482|NCT03682770|156780943|FG004|AR101 Up-dosing Period (Week 28-40)|Other|0|||
48708483|NCT03682770|156780944|FG005|AR101 Up-dosing Period (Week 28-40)|Other|0|||
48708484|NCT03682770|156780945|FG006|AR101 Up-dosing Period (Week 28-40)|Other|0|||
48708485|NCT03682770|156780939|FG000|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
48708486|NCT03682770|156780940|FG001|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
48708487|NCT03682770|156780941|FG002|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
48708488|NCT03682770|156780942|FG003|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
48708489|NCT03682770|156780943|FG004|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|3|||
48708490|NCT03682770|156780944|FG005|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
48708491|NCT03682770|156780945|FG006|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
48708492|NCT03682770|156780939|FG000|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
48803895|NCT02634788|157124134|FG002|Overall Study|Withdrawal by Subject|1|||
48803896|NCT02634788|157124135|FG003|Overall Study|Withdrawal by Subject|0|||
48803897|NCT01959347|157124139|FG000|Overall Study|Protocol Violation|9|||
48803898|NCT01959347|157124140|FG001|Overall Study|Protocol Violation|7|||
48803899|NCT01691521|157124143|FG000|Overall Study|Adverse Event|4|||
48803900|NCT01691521|157124144|FG001|Overall Study|Adverse Event|0|||
48803901|NCT01691521|157124145|FG002|Overall Study|Adverse Event|1|||
48803902|NCT01691521|157124143|FG000|Overall Study|Lack of Efficacy|1|||
48803903|NCT01691521|157124144|FG001|Overall Study|Lack of Efficacy|1|||
48803904|NCT01691521|157124145|FG002|Overall Study|Lack of Efficacy|2|||
48803905|NCT01691521|157124143|FG000|Overall Study|Protocol Violation|0|||
48803906|NCT01691521|157124144|FG001|Overall Study|Protocol Violation|3|||
48915070|NCT02871778|157524763|FG004|Part A: Treatment Period 1|Noncompliant with study drug|0|||
48915071|NCT02871778|157524764|FG005|Part A: Treatment Period 1|Noncompliant with study drug|0|||
48915072|NCT02871778|157524765|FG006|Part A: Treatment Period 1|Noncompliant with study drug|0|||
48915073|NCT02871778|157524766|FG007|Part A: Treatment Period 1|Noncompliant with study drug|0|||
48915074|NCT02871778|157524759|FG000|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
48708493|NCT03682770|156780940|FG001|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
48708494|NCT03682770|156780941|FG002|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
48708495|NCT03682770|156780942|FG003|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
48708496|NCT03682770|156780943|FG004|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|1|||
48708497|NCT03682770|156780944|FG005|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
48708498|NCT03682770|156780945|FG006|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
48708499|NCT03682770|156780939|FG000|AR101 Maintenance Period: (Week 52-64)|Other|0|||
48708500|NCT03682770|156780940|FG001|AR101 Maintenance Period: (Week 52-64)|Other|0|||
48708501|NCT03682770|156780941|FG002|AR101 Maintenance Period: (Week 52-64)|Other|0|||
48708502|NCT03682770|156780942|FG003|AR101 Maintenance Period: (Week 52-64)|Other|0|||
48708503|NCT03682770|156780943|FG004|AR101 Maintenance Period: (Week 52-64)|Other|0|||
48708504|NCT03682770|156780944|FG005|AR101 Maintenance Period: (Week 52-64)|Other|1|||
48708505|NCT03682770|156780945|FG006|AR101 Maintenance Period: (Week 52-64)|Other|0|||
48708506|NCT03682770|156780939|FG000|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
48708507|NCT03682770|156780940|FG001|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
48708508|NCT03682770|156780941|FG002|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
48708509|NCT03682770|156780942|FG003|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
48708510|NCT03682770|156780943|FG004|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
48708511|NCT03682770|156780944|FG005|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|1|||
48708512|NCT03682770|156780945|FG006|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|2|||
48708513|NCT00196313|156780946|FG000|Overall Study|Protocol Violation|2|||
48708514|NCT00196313|156780947|FG001|Overall Study|Protocol Violation|3|||
48708515|NCT00196313|156780946|FG000|Overall Study|Withdrawal by Subject|3|||
48708516|NCT00196313|156780947|FG001|Overall Study|Withdrawal by Subject|1|||
48708517|NCT00196313|156780946|FG000|Overall Study|Adverse Event|3|||
48708518|NCT00196313|156780947|FG001|Overall Study|Adverse Event|1|||
48708519|NCT00196313|156780946|FG000|Overall Study|Subject Pregnant|1|||
48708520|NCT00196313|156780947|FG001|Overall Study|Subject Pregnant|1|||
48708521|NCT00196313|156780946|FG000|Overall Study|Lost to Follow-up|2|||
48708522|NCT00196313|156780947|FG001|Overall Study|Lost to Follow-up|2|||
48708523|NCT02362282|156780948|FG000|Overall Study|Withdrawal by Subject|1|||
48708524|NCT02362282|156780949|FG001|Overall Study|Withdrawal by Subject|0|||
48708525|NCT04085289|156780950|FG000|Overall Study|Withdrawal by Subject|0|||
48708526|NCT04085289|156780951|FG001|Overall Study|Withdrawal by Subject|0|||
48708527|NCT04085289|156780952|FG002|Overall Study|Withdrawal by Subject|1|||
48708528|NCT04639258|156780953|FG000|Overall Study|Screen failure|5|||
48708529|NCT04639258|156780953|FG000|Overall Study|Physician Decision|2|||
48708530|NCT04639258|156780953|FG000|Overall Study|Early study termination|3|||
48708531|NCT04639258|156780953|FG000|Overall Study|Withdrawal by Subject|1|||
48708532|NCT01941186|156780955|FG000|Follow-up|Lost to Follow-up|1|||
48708533|NCT01941186|156780956|FG001|Follow-up|Lost to Follow-up|0|||
48708534|NCT02560558|156780958|FG000|Overall Study|Adverse Event|1|||
48708535|NCT02560558|156780959|FG001|Overall Study|Adverse Event|0|||
48708536|NCT02560558|156780958|FG000|Overall Study|Death|0|||
48708537|NCT02560558|156780959|FG001|Overall Study|Death|2|||
48708538|NCT02560558|156780958|FG000|Overall Study|Lost to Follow-up|0|||
48708539|NCT02560558|156780959|FG001|Overall Study|Lost to Follow-up|4|||
48708540|NCT02560558|156780958|FG000|Overall Study|Protocol Violation|3|||
48708541|NCT02560558|156780959|FG001|Overall Study|Protocol Violation|0|||
48708542|NCT02560558|156780958|FG000|Overall Study|Withdrawal by Subject|3|||
48708543|NCT02560558|156780959|FG001|Overall Study|Withdrawal by Subject|0|||
48708544|NCT02999672|156780972|FG000|Overall Study|Death|0|||
48708545|NCT02999672|156780973|FG001|Overall Study|Death|1|||
48708546|NCT02999672|156780972|FG000|Overall Study|Study Terminated by Sponsor|0|||
48708547|NCT02999672|156780973|FG001|Overall Study|Study Terminated by Sponsor|1|||
48708548|NCT02999672|156780972|FG000|Overall Study|Progressive Disease|9|||
48708549|NCT02999672|156780973|FG001|Overall Study|Progressive Disease|5|||
48708550|NCT02999672|156780972|FG000|Overall Study|Adverse Event|4|||
48708551|NCT02999672|156780973|FG001|Overall Study|Adverse Event|0|||
48708552|NCT02577718|156780974|FG000|Overall Study|Death|6|||
48708553|NCT02577718|156780974|FG000|Overall Study|Withdrawal by Subject|2|||
48708554|NCT00275509|156780975|FG000|Overall Study|graft thrombosis, post-operative day #8|0|||
48708555|NCT00275509|156780976|FG001|Overall Study|graft thrombosis, post-operative day #8|1|||
48708556|NCT01967576|156780977|FG000|Overall Study|Withdrawal by Subject|3|||
48708557|NCT01967576|156780977|FG000|Overall Study|Progressed/Removed from treatment|1|||
48708558|NCT01967576|156780977|FG000|Overall Study|Study closing at site|1|||
48708559|NCT01967576|156780977|FG000|Overall Study|Adverse Event|1|||
48803907|NCT01691521|157124145|FG002|Overall Study|Protocol Violation|0|||
48803908|NCT01691521|157124143|FG000|Overall Study|Lost to Follow-up|0|||
48803909|NCT01691521|157124144|FG001|Overall Study|Lost to Follow-up|2|||
48803910|NCT01691521|157124145|FG002|Overall Study|Lost to Follow-up|2|||
48803911|NCT01691521|157124143|FG000|Overall Study|Physician Decision|2|||
48803912|NCT01691521|157124144|FG001|Overall Study|Physician Decision|1|||
48803913|NCT01691521|157124145|FG002|Overall Study|Physician Decision|0|||
48803914|NCT01691521|157124143|FG000|Overall Study|Withdrawal by Subject|5|||
48803915|NCT01691521|157124144|FG001|Overall Study|Withdrawal by Subject|9|||
48803916|NCT01691521|157124145|FG002|Overall Study|Withdrawal by Subject|4|||
48803925|NCT03453619|157124147|FG000|Core Study (Part A)|Physician Decision|0|||
48803926|NCT03453619|157124148|FG001|Core Study (Part A)|Physician Decision|0|||
48803927|NCT03453619|157124149|FG002|Core Study (Part A)|Physician Decision|2|||
48803928|NCT03453619|157124150|FG003|Core Study (Part A)|Physician Decision|0|||
48803929|NCT03453619|157124147|FG000|Core Study (Part A)|Withdrawal by Subject|2|||
48803930|NCT03453619|157124148|FG001|Core Study (Part A)|Withdrawal by Subject|0|||
49119125|NCT04147247|158274621|FG003|Overall Study|Adverse Event|0|||
49119126|NCT04147247|158274622|FG004|Overall Study|Adverse Event|1|||
49119127|NCT00105989|158274623|FG000|Acute - Open Label: Week 0-10|Adverse Event|33|||
49119128|NCT00105989|158274624|FG001|Acute - Open Label: Week 0-10|Adverse Event|0|||
49119129|NCT00105989|158274623|FG000|Acute - Open Label: Week 0-10|Withdrawal by Subject|24|||
49119130|NCT00105989|158274624|FG001|Acute - Open Label: Week 0-10|Withdrawal by Subject|0|||
49119131|NCT00105989|158274623|FG000|Acute - Open Label: Week 0-10|Lack of Efficacy|17|||
49119132|NCT00105989|158274624|FG001|Acute - Open Label: Week 0-10|Lack of Efficacy|0|||
49119133|NCT00105989|158274623|FG000|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14|||
49119134|NCT00105989|158274624|FG001|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0|||
48708560|NCT01967576|156780977|FG000|Overall Study|Refused further treatment|1|||
48708561|NCT03388164|156780981|FG000|Overall Study|Withdrawal by Subject|3|||
48708562|NCT03388164|156780982|FG001|Overall Study|Withdrawal by Subject|1|||
48708563|NCT02561832|156780984|FG000|Overall Study|Withdrawal by Subject|1|||
48708564|NCT02561832|156780985|FG001|Overall Study|Withdrawal by Subject|1|||
48708565|NCT02561832|156780984|FG000|Overall Study|Adverse Event|3|||
48708566|NCT02561832|156780985|FG001|Overall Study|Adverse Event|0|||
48708567|NCT02561832|156780984|FG000|Overall Study|Disease progression|3|||
48708568|NCT02561832|156780985|FG001|Overall Study|Disease progression|3|||
48708569|NCT00346697|156780986|FG000|Overall Study|Lost to Follow-up|0|||
48708570|NCT00346697|156780987|FG001|Overall Study|Lost to Follow-up|1|||
48708571|NCT00686686|156780988|FG000|Overall Study|Non-compliance|1|||
48708572|NCT00686686|156780988|FG000|Overall Study|Adverse Event|2|||
48708573|NCT00686686|156780988|FG000|Overall Study|Lost to Follow-up|3|||
48708574|NCT02367833|156780990|FG000|Overall Study|Withdrawal by Subject|1|||
48708575|NCT02367833|156780991|FG001|Overall Study|Withdrawal by Subject|1|||
48708576|NCT02367833|156780992|FG002|Overall Study|Withdrawal by Subject|0|||
48708577|NCT01459497|156780993|FG000|Overall Study|Inability to meet trial constraints.|1|||
48708578|NCT01459497|156780994|FG001|Overall Study|Inability to meet trial constraints.|0|||
48708579|NCT01459497|156780993|FG000|Overall Study|Physician Decision|1|||
48708580|NCT01459497|156780994|FG001|Overall Study|Physician Decision|1|||
48708581|NCT01459497|156780993|FG000|Overall Study|Hospitalization.|0|||
48708582|NCT01459497|156780994|FG001|Overall Study|Hospitalization.|3|||
48708583|NCT01459497|156780993|FG000|Overall Study|Disease progression.|0|||
48708584|NCT01459497|156780994|FG001|Overall Study|Disease progression.|1|||
48708585|NCT02447302|156781006|FG000|Overall Study|Physician Decision|1|||
48708586|NCT02447302|156781007|FG001|Overall Study|Physician Decision|0|||
48708587|NCT02447302|156781008|FG002|Overall Study|Physician Decision|0|||
48708588|NCT02447302|156781006|FG000|Overall Study|Adverse Event|4|||
48708589|NCT02447302|156781007|FG001|Overall Study|Adverse Event|3|||
48708590|NCT02447302|156781008|FG002|Overall Study|Adverse Event|0|||
48708591|NCT02447302|156781006|FG000|Overall Study|Withdrawal by Subject|0|||
48708592|NCT02447302|156781007|FG001|Overall Study|Withdrawal by Subject|1|||
48708593|NCT02447302|156781008|FG002|Overall Study|Withdrawal by Subject|5|||
48708594|NCT02447302|156781006|FG000|Overall Study|Sponsor Decision|0|||
48708595|NCT02447302|156781007|FG001|Overall Study|Sponsor Decision|0|||
48708596|NCT02447302|156781008|FG002|Overall Study|Sponsor Decision|1|||
48803931|NCT03453619|157124149|FG002|Core Study (Part A)|Withdrawal by Subject|2|||
48708597|NCT05334212|156781009|FG000|Overall Study|Study terminated prematurely|7|||
48708598|NCT00396253|156781015|FG000|Overall Study|Protocol Violation|1|||
48708599|NCT00396253|156781015|FG000|Overall Study|Withdrawal by Subject|7|||
48708600|NCT00396253|156781015|FG000|Overall Study|Death|3|||
48803932|NCT03453619|157124150|FG003|Core Study (Part A)|Withdrawal by Subject|1|||
48803933|NCT03453619|157124147|FG000|Core Study (Part A)|Other|0|||
48803934|NCT03453619|157124148|FG001|Core Study (Part A)|Other|1|||
48803935|NCT03453619|157124149|FG002|Core Study (Part A)|Other|0|||
48803936|NCT03453619|157124150|FG003|Core Study (Part A)|Other|0|||
48803937|NCT03453619|157124147|FG000|Long-Term Extension (Part B)|Adverse Event|1|||
48803938|NCT03453619|157124148|FG001|Long-Term Extension (Part B)|Adverse Event|0|||
48803939|NCT03453619|157124149|FG002|Long-Term Extension (Part B)|Adverse Event|0|||
48803940|NCT03453619|157124150|FG003|Long-Term Extension (Part B)|Adverse Event|0|||
48803941|NCT03453619|157124147|FG000|Long-Term Extension (Part B)|Lost to Follow-up|1|||
48803942|NCT03453619|157124148|FG001|Long-Term Extension (Part B)|Lost to Follow-up|0|||
48803943|NCT03453619|157124149|FG002|Long-Term Extension (Part B)|Lost to Follow-up|0|||
48803944|NCT03453619|157124150|FG003|Long-Term Extension (Part B)|Lost to Follow-up|1|||
48803945|NCT03453619|157124147|FG000|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
48803946|NCT03453619|157124148|FG001|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
48803947|NCT03453619|157124149|FG002|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
48803948|NCT03453619|157124150|FG003|Long-Term Extension (Part B)|Non-compliance with study drug|1|||
48803949|NCT03453619|157124147|FG000|Long-Term Extension (Part B)|Physician Decision|0|||
48803950|NCT03453619|157124148|FG001|Long-Term Extension (Part B)|Physician Decision|1|||
48803951|NCT03453619|157124149|FG002|Long-Term Extension (Part B)|Physician Decision|0|||
48803952|NCT03453619|157124150|FG003|Long-Term Extension (Part B)|Physician Decision|0|||
48708601|NCT00396253|156781015|FG000|Overall Study|Physician Decision|1|||
48708602|NCT00396253|156781015|FG000|Overall Study|Change in eligibility status|1|||
48708603|NCT00557856|156781020|FG000|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
48708604|NCT00557856|156781021|FG001|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
48708605|NCT00557856|156781022|FG002|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
48708606|NCT00557856|156781023|FG003|Part 1: Dose Escalation Phase|objective progression or relapse|1|||
48708607|NCT00557856|156781024|FG004|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
48708608|NCT00557856|156781025|FG005|Part 1: Dose Escalation Phase|objective progression or relapse|2|||
48708609|NCT00557856|156781026|FG006|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
48708610|NCT00557856|156781027|FG007|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
48708611|NCT00557856|156781028|FG008|Part 1: Dose Escalation Phase|objective progression or relapse|0|||
48708612|NCT00557856|156781020|FG000|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
48708613|NCT00557856|156781021|FG001|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
48708614|NCT00557856|156781022|FG002|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
48708615|NCT00557856|156781023|FG003|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
48708616|NCT00557856|156781024|FG004|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
48708617|NCT00557856|156781025|FG005|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
48708618|NCT00557856|156781026|FG006|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
48708619|NCT00557856|156781027|FG007|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
48708620|NCT00557856|156781028|FG008|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
48708621|NCT00557856|156781020|FG000|Part 1: Dose Escalation Phase|Adverse Event|1|||
48708622|NCT00557856|156781021|FG001|Part 1: Dose Escalation Phase|Adverse Event|0|||
48708623|NCT00557856|156781022|FG002|Part 1: Dose Escalation Phase|Adverse Event|1|||
48708624|NCT00557856|156781023|FG003|Part 1: Dose Escalation Phase|Adverse Event|1|||
48708625|NCT00557856|156781024|FG004|Part 1: Dose Escalation Phase|Adverse Event|1|||
48708626|NCT00557856|156781025|FG005|Part 1: Dose Escalation Phase|Adverse Event|3|||
48708627|NCT00557856|156781026|FG006|Part 1: Dose Escalation Phase|Adverse Event|1|||
48708628|NCT00557856|156781027|FG007|Part 1: Dose Escalation Phase|Adverse Event|2|||
48708629|NCT00557856|156781028|FG008|Part 1: Dose Escalation Phase|Adverse Event|0|||
48708630|NCT00557856|156781020|FG000|Part 1: Dose Escalation Phase|Other|0|||
48708631|NCT00557856|156781021|FG001|Part 1: Dose Escalation Phase|Other|0|||
48708632|NCT00557856|156781022|FG002|Part 1: Dose Escalation Phase|Other|1|||
48708633|NCT00557856|156781023|FG003|Part 1: Dose Escalation Phase|Other|1|||
48708634|NCT00557856|156781024|FG004|Part 1: Dose Escalation Phase|Other|0|||
48708635|NCT00557856|156781025|FG005|Part 1: Dose Escalation Phase|Other|0|||
48708636|NCT00557856|156781026|FG006|Part 1: Dose Escalation Phase|Other|0|||
48708637|NCT00557856|156781027|FG007|Part 1: Dose Escalation Phase|Other|1|||
48708638|NCT00557856|156781028|FG008|Part 1: Dose Escalation Phase|Other|0|||
48708639|NCT00557856|156781020|FG000|Part 1: Dose Escalation Phase|Death|0|||
48708640|NCT00557856|156781021|FG001|Part 1: Dose Escalation Phase|Death|0|||
48708641|NCT00557856|156781022|FG002|Part 1: Dose Escalation Phase|Death|0|||
48708642|NCT00557856|156781023|FG003|Part 1: Dose Escalation Phase|Death|0|||
48708643|NCT00557856|156781024|FG004|Part 1: Dose Escalation Phase|Death|0|||
48708644|NCT00557856|156781025|FG005|Part 1: Dose Escalation Phase|Death|1|||
48708645|NCT00557856|156781026|FG006|Part 1: Dose Escalation Phase|Death|0|||
48708646|NCT00557856|156781027|FG007|Part 1: Dose Escalation Phase|Death|0|||
48708647|NCT00557856|156781028|FG008|Part 1: Dose Escalation Phase|Death|0|||
48708648|NCT00557856|156781020|FG000|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
48708649|NCT00557856|156781021|FG001|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
48803953|NCT01148862|157124154|FG000|Second Intervention|Withdrawal by Subject|0|||
48803954|NCT01148862|157124155|FG001|Second Intervention|Withdrawal by Subject|2|||
48803955|NCT05520190|157124156|FG000|Overall Study|Lost to Follow-up|7|||
48803956|NCT05520190|157124156|FG000|Overall Study|Withdrawal by Subject|2|||
48803957|NCT03138733|157124157|FG000|Overall Study|Death|17|||
48803958|NCT03138733|157124158|FG001|Overall Study|Death|18|||
48915075|NCT02871778|157524760|FG001|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
48915076|NCT02871778|157524761|FG002|Part A: Treatment Period 1|Other withdrawal criteria met|1|||
48915077|NCT02871778|157524762|FG003|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
48915078|NCT02871778|157524763|FG004|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
48803959|NCT03138733|157124157|FG000|Overall Study|Withdrawal by Subject|11|||
48803960|NCT03138733|157124158|FG001|Overall Study|Withdrawal by Subject|6|||
48803961|NCT03138733|157124157|FG000|Overall Study|Lost to Follow-up|3|||
48803962|NCT03138733|157124158|FG001|Overall Study|Lost to Follow-up|2|||
48803963|NCT03138733|157124157|FG000|Overall Study|Adverse Event|1|||
48803964|NCT03138733|157124158|FG001|Overall Study|Adverse Event|0|||
48803965|NCT03138733|157124157|FG000|Overall Study|Protocol Violation|1|||
48803966|NCT03138733|157124158|FG001|Overall Study|Protocol Violation|3|||
48803967|NCT03138733|157124157|FG000|Overall Study|Administrative or logistical reason|1|||
48803968|NCT03138733|157124158|FG001|Overall Study|Administrative or logistical reason|0|||
48803969|NCT03138733|157124157|FG000|Overall Study|The patient was transferred to another hospital|1|||
48803970|NCT03138733|157124158|FG001|Overall Study|The patient was transferred to another hospital|0|||
48803971|NCT03338933|157124159|FG000|Screening Visit|Lost to Follow-up|1|||
48803972|NCT03338933|157124160|FG001|Screening Visit|Lost to Follow-up|3|||
48803973|NCT03338933|157124161|FG002|Screening Visit|Lost to Follow-up|1|||
48803974|NCT03338933|157124162|FG003|Screening Visit|Lost to Follow-up|4|||
48803975|NCT03338933|157124159|FG000|Screening Visit|Screen fail after consent|2|||
48803976|NCT03338933|157124160|FG001|Screening Visit|Screen fail after consent|7|||
48803977|NCT03338933|157124161|FG002|Screening Visit|Screen fail after consent|1|||
48803978|NCT03338933|157124162|FG003|Screening Visit|Screen fail after consent|4|||
48803979|NCT03338933|157124159|FG000|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
48803980|NCT03338933|157124160|FG001|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
48803981|NCT03338933|157124161|FG002|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|2|||
48803982|NCT03338933|157124162|FG003|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|9|||
48803983|NCT03338933|157124159|FG000|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
48803984|NCT03338933|157124160|FG001|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
48803985|NCT03338933|157124161|FG002|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
48803986|NCT03338933|157124162|FG003|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
48803987|NCT03338933|157124159|FG000|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
48803988|NCT03338933|157124160|FG001|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
48803989|NCT03338933|157124161|FG002|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|1|||
48803990|NCT03338933|157124162|FG003|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|2|||
48803991|NCT01415882|157124165|FG000|Overall Study|Ineligible|1|||
48803992|NCT01415882|157124166|FG001|Overall Study|Ineligible|0|||
48803993|NCT01415882|157124167|FG002|Overall Study|Ineligible|0|||
48803994|NCT01415882|157124168|FG003|Overall Study|Ineligible|3|||
48803995|NCT01415882|157124169|FG004|Overall Study|Ineligible|0|||
48803996|NCT01415882|157124165|FG000|Overall Study|Withdrawal by Subject|0|||
48803997|NCT01415882|157124166|FG001|Overall Study|Withdrawal by Subject|1|||
48803998|NCT01415882|157124167|FG002|Overall Study|Withdrawal by Subject|0|||
48803999|NCT01415882|157124168|FG003|Overall Study|Withdrawal by Subject|1|||
48804000|NCT01415882|157124169|FG004|Overall Study|Withdrawal by Subject|0|||
48804001|NCT05200845|157124172|FG000|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
48804002|NCT05200845|157124173|FG001|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
48804003|NCT05200845|157124174|FG002|Overall Study|stopped collecting pilot data for metabolic chamber|2|||
48804004|NCT05200845|157124175|FG003|Overall Study|stopped collecting pilot data for metabolic chamber|0|||
48804005|NCT05200845|157124172|FG000|Overall Study|Withdrawal by Subject|0|||
48804006|NCT05200845|157124173|FG001|Overall Study|Withdrawal by Subject|1|||
48804007|NCT05200845|157124174|FG002|Overall Study|Withdrawal by Subject|1|||
48804008|NCT05200845|157124175|FG003|Overall Study|Withdrawal by Subject|0|||
48915079|NCT02871778|157524764|FG005|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
48915080|NCT02871778|157524765|FG006|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
48804009|NCT02552238|157124179|FG000|Overall Study|Withdrawal by Subject|2|||
48804010|NCT02552238|157124179|FG000|Overall Study|Adverse Event|2|||
48804011|NCT00263328|157124181|FG000|Overall Study|Death|0|||
48915081|NCT02871778|157524766|FG007|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
48804012|NCT00263328|157124182|FG001|Overall Study|Death|0|||
48804013|NCT00263328|157124183|FG002|Overall Study|Death|1|||
48915082|NCT02871778|157524759|FG000|Part A: Treatment Period 1|Wrong drug shipment|0|||
48915083|NCT02871778|157524760|FG001|Part A: Treatment Period 1|Wrong drug shipment|1|||
48915084|NCT02871778|157524761|FG002|Part A: Treatment Period 1|Wrong drug shipment|0|||
48915085|NCT02871778|157524762|FG003|Part A: Treatment Period 1|Wrong drug shipment|0|||
48915086|NCT02871778|157524763|FG004|Part A: Treatment Period 1|Wrong drug shipment|0|||
48915087|NCT02871778|157524764|FG005|Part A: Treatment Period 1|Wrong drug shipment|0|||
48915088|NCT02871778|157524765|FG006|Part A: Treatment Period 1|Wrong drug shipment|0|||
48915089|NCT02871778|157524766|FG007|Part A: Treatment Period 1|Wrong drug shipment|0|||
48915090|NCT02871778|157524759|FG000|Part A: Treatment Period 2|Adverse Event|2|||
48915091|NCT02871778|157524760|FG001|Part A: Treatment Period 2|Adverse Event|2|||
48915092|NCT02871778|157524761|FG002|Part A: Treatment Period 2|Adverse Event|0|||
48915093|NCT02871778|157524762|FG003|Part A: Treatment Period 2|Adverse Event|0|||
48915094|NCT02871778|157524763|FG004|Part A: Treatment Period 2|Adverse Event|0|||
48915095|NCT02871778|157524764|FG005|Part A: Treatment Period 2|Adverse Event|0|||
48915096|NCT02871778|157524765|FG006|Part A: Treatment Period 2|Adverse Event|0|||
48915097|NCT02871778|157524766|FG007|Part A: Treatment Period 2|Adverse Event|0|||
48915098|NCT02871778|157524759|FG000|Part A: Treatment Period 2|Lost to Follow-up|0|||
48915099|NCT02871778|157524760|FG001|Part A: Treatment Period 2|Lost to Follow-up|0|||
48915100|NCT02871778|157524761|FG002|Part A: Treatment Period 2|Lost to Follow-up|0|||
48915101|NCT02871778|157524762|FG003|Part A: Treatment Period 2|Lost to Follow-up|1|||
48915102|NCT02871778|157524763|FG004|Part A: Treatment Period 2|Lost to Follow-up|0|||
48915103|NCT02871778|157524764|FG005|Part A: Treatment Period 2|Lost to Follow-up|0|||
48915104|NCT02871778|157524765|FG006|Part A: Treatment Period 2|Lost to Follow-up|0|||
48804014|NCT00263328|157124181|FG000|Overall Study|Lost to Follow-up|1|||
48804015|NCT00263328|157124182|FG001|Overall Study|Lost to Follow-up|1|||
48804016|NCT00263328|157124183|FG002|Overall Study|Lost to Follow-up|0|||
48804017|NCT00263328|157124181|FG000|Overall Study|Withdrawal by Subject|3|||
48804018|NCT00263328|157124182|FG001|Overall Study|Withdrawal by Subject|0|||
48804019|NCT00263328|157124183|FG002|Overall Study|Withdrawal by Subject|1|||
48804020|NCT00263328|157124181|FG000|Overall Study|Other|3|||
48804021|NCT00263328|157124182|FG001|Overall Study|Other|0|||
48804022|NCT00263328|157124183|FG002|Overall Study|Other|1|||
48804023|NCT00263328|157124181|FG000|Overall Study|Adverse Event|1|||
48804024|NCT00263328|157124182|FG001|Overall Study|Adverse Event|1|||
48804025|NCT00263328|157124183|FG002|Overall Study|Adverse Event|4|||
48804026|NCT01065350|157124187|FG000|Overall Study|Received incorrect drug allocation|0|||
48804027|NCT01065350|157124188|FG001|Overall Study|Received incorrect drug allocation|1|||
48804028|NCT03477175|157124194|FG000|Overall Study|Unable to travel due to COVID-19|0|||
48804029|NCT03477175|157124195|FG001|Overall Study|Unable to travel due to COVID-19|1|||
48804030|NCT03477175|157124194|FG000|Overall Study|Physician Decision|1|||
48804031|NCT03477175|157124195|FG001|Overall Study|Physician Decision|0|||
48804032|NCT03477175|157124194|FG000|Overall Study|Transitioned to commercial drug|6|||
48804033|NCT03477175|157124195|FG001|Overall Study|Transitioned to commercial drug|6|||
48804034|NCT03477175|157124194|FG000|Overall Study|Lost to Follow-up|1|||
48804035|NCT03477175|157124195|FG001|Overall Study|Lost to Follow-up|1|||
48804036|NCT03477175|157124194|FG000|Overall Study|Withdrawal by Subject|3|||
48804037|NCT03477175|157124195|FG001|Overall Study|Withdrawal by Subject|1|||
48804038|NCT03477175|157124194|FG000|Overall Study|Adverse Event|1|||
48804039|NCT03477175|157124195|FG001|Overall Study|Adverse Event|5|||
48804040|NCT03477175|157124194|FG000|Overall Study|Disease Progression|7|||
48804041|NCT03477175|157124195|FG001|Overall Study|Disease Progression|7|||
48804042|NCT02073097|157124196|FG000|Overall Study|Adverse Event|0|||
48804043|NCT02073097|157124197|FG001|Overall Study|Adverse Event|0|||
48804044|NCT02073097|157124198|FG002|Overall Study|Adverse Event|0|||
48804045|NCT02073097|157124199|FG003|Overall Study|Adverse Event|0|||
48915105|NCT02871778|157524766|FG007|Part A: Treatment Period 2|Lost to Follow-up|0|||
48915106|NCT02871778|157524759|FG000|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
48915107|NCT02871778|157524760|FG001|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
48915108|NCT02871778|157524761|FG002|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
48915109|NCT02871778|157524762|FG003|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
48915110|NCT02871778|157524763|FG004|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
48915111|NCT02871778|157524764|FG005|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
48915112|NCT02871778|157524765|FG006|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
48915113|NCT02871778|157524766|FG007|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
48915114|NCT02871778|157524759|FG000|Part B: Treatment Period 3|Adverse Event|0|||
48915115|NCT02871778|157524760|FG001|Part B: Treatment Period 3|Adverse Event|0|||
48915116|NCT02871778|157524761|FG002|Part B: Treatment Period 3|Adverse Event|0|||
48915117|NCT02871778|157524762|FG003|Part B: Treatment Period 3|Adverse Event|0|||
48915118|NCT02871778|157524763|FG004|Part B: Treatment Period 3|Adverse Event|1|||
48915119|NCT02871778|157524764|FG005|Part B: Treatment Period 3|Adverse Event|1|||
48915120|NCT02871778|157524765|FG006|Part B: Treatment Period 3|Adverse Event|1|||
48915121|NCT02871778|157524766|FG007|Part B: Treatment Period 3|Adverse Event|0|||
48915122|NCT01390272|157524767|FG000|Overall Study|Death|3|||
48915123|NCT01390272|157524768|FG001|Overall Study|Death|2|||
48915124|NCT01390272|157524767|FG000|Overall Study|Withdrawal by Subject|9|||
48915125|NCT01390272|157524768|FG001|Overall Study|Withdrawal by Subject|5|||
48915126|NCT01390272|157524767|FG000|Overall Study|Patient moved, no longer eligible|5|||
48915127|NCT01390272|157524768|FG001|Overall Study|Patient moved, no longer eligible|8|||
48915128|NCT04206605|157524772|FG000|Overall Study|Adverse Event|0|||
48915129|NCT04206605|157524773|FG001|Overall Study|Adverse Event|1|||
48915130|NCT04206605|157524772|FG000|Overall Study|Withdrawal by Subject|1|||
48915131|NCT04206605|157524773|FG001|Overall Study|Withdrawal by Subject|0|||
48915132|NCT03631784|157524776|FG000|Overall Study|Death|48|||
48804046|NCT02073097|157124200|FG004|Overall Study|Adverse Event|0|||
48804047|NCT02073097|157124201|FG005|Overall Study|Adverse Event|0|||
48804048|NCT02073097|157124202|FG006|Overall Study|Adverse Event|0|||
48915133|NCT03631784|157524777|FG001|Overall Study|Death|28|||
48915134|NCT03631784|157524776|FG000|Overall Study|Lost to Follow-up|1|||
48915135|NCT03631784|157524777|FG001|Overall Study|Lost to Follow-up|0|||
48915136|NCT03631784|157524776|FG000|Overall Study|Withdrawal by Subject|0|||
48804049|NCT02073097|157124203|FG007|Overall Study|Adverse Event|2|||
48804050|NCT02073097|157124196|FG000|Overall Study|Withdrawal by Subject|0|||
48804051|NCT02073097|157124197|FG001|Overall Study|Withdrawal by Subject|0|||
48804052|NCT02073097|157124198|FG002|Overall Study|Withdrawal by Subject|0|||
48804053|NCT02073097|157124199|FG003|Overall Study|Withdrawal by Subject|0|||
48804054|NCT02073097|157124200|FG004|Overall Study|Withdrawal by Subject|0|||
48804055|NCT02073097|157124201|FG005|Overall Study|Withdrawal by Subject|0|||
48804056|NCT02073097|157124202|FG006|Overall Study|Withdrawal by Subject|0|||
48915137|NCT03631784|157524777|FG001|Overall Study|Withdrawal by Subject|3|||
48915138|NCT03631784|157524776|FG000|Overall Study|Participants Ongoing|63|||
48915139|NCT03631784|157524777|FG001|Overall Study|Participants Ongoing|71|||
48915140|NCT00618410|157524784|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
48915141|NCT00618410|157524785|FG001|Washout Period (2 Weeks)|Physician Decision|1|||
48915142|NCT00474708|157524788|FG000|Overall Study|Lack of Efficacy|11|||
48915143|NCT00474708|157524789|FG001|Overall Study|Lack of Efficacy|5|||
48915144|NCT00474708|157524788|FG000|Overall Study|Suicide ideation/behavior|0|||
48915145|NCT00474708|157524789|FG001|Overall Study|Suicide ideation/behavior|1|||
48915146|NCT00474708|157524788|FG000|Overall Study|Withdrawal by Subject|7|||
48915147|NCT00474708|157524789|FG001|Overall Study|Withdrawal by Subject|0|||
48915148|NCT00474708|157524788|FG000|Overall Study|Lack of compliance|12|||
48915149|NCT00474708|157524789|FG001|Overall Study|Lack of compliance|4|||
48915150|NCT00474708|157524788|FG000|Overall Study|Lost to Follow-up|18|||
48915151|NCT00474708|157524789|FG001|Overall Study|Lost to Follow-up|9|||
48915152|NCT00474708|157524788|FG000|Overall Study|Physician Decision|9|||
48915153|NCT00474708|157524789|FG001|Overall Study|Physician Decision|6|||
48915154|NCT03700320|157524790|FG000|Overall Study|Adverse Event|5|||
48915155|NCT03700320|157524791|FG001|Overall Study|Adverse Event|31|||
48915156|NCT03700320|157524790|FG000|Overall Study|Lack of Efficacy|2|||
48915157|NCT03700320|157524791|FG001|Overall Study|Lack of Efficacy|5|||
48915158|NCT03700320|157524790|FG000|Overall Study|Withdrawal by Subject|29|||
48915159|NCT03700320|157524791|FG001|Overall Study|Withdrawal by Subject|75|||
48804057|NCT02073097|157124203|FG007|Overall Study|Withdrawal by Subject|2|||
48804058|NCT02073097|157124196|FG000|Overall Study|Death|0|||
48804059|NCT02073097|157124197|FG001|Overall Study|Death|0|||
48804060|NCT02073097|157124198|FG002|Overall Study|Death|0|||
48804061|NCT02073097|157124199|FG003|Overall Study|Death|0|||
48804062|NCT02073097|157124200|FG004|Overall Study|Death|0|||
48804063|NCT02073097|157124201|FG005|Overall Study|Death|0|||
48804064|NCT02073097|157124202|FG006|Overall Study|Death|0|||
48804065|NCT02073097|157124203|FG007|Overall Study|Death|1|||
48804066|NCT02073097|157124196|FG000|Overall Study|Physician Decision|0|||
48804067|NCT02073097|157124197|FG001|Overall Study|Physician Decision|0|||
48804068|NCT02073097|157124198|FG002|Overall Study|Physician Decision|0|||
48804069|NCT02073097|157124199|FG003|Overall Study|Physician Decision|0|||
48804070|NCT02073097|157124200|FG004|Overall Study|Physician Decision|0|||
48804071|NCT02073097|157124201|FG005|Overall Study|Physician Decision|0|||
48804072|NCT02073097|157124202|FG006|Overall Study|Physician Decision|0|||
48804073|NCT02073097|157124203|FG007|Overall Study|Physician Decision|1|||
48804074|NCT01728792|157125384|FG000|Overall Study|Withdrawal of Consent|1|||
48804075|NCT01728792|157125385|FG001|Overall Study|Withdrawal of Consent|1|||
48804076|NCT01728792|157125386|FG002|Overall Study|Withdrawal of Consent|0|||
48804077|NCT01728792|157125387|FG003|Overall Study|Withdrawal of Consent|1|||
48804078|NCT01728792|157125388|FG004|Overall Study|Withdrawal of Consent|0|||
48804079|NCT01728792|157125384|FG000|Overall Study|Lost to Follow-up|2|||
48804080|NCT01728792|157125385|FG001|Overall Study|Lost to Follow-up|1|||
48804081|NCT01728792|157125386|FG002|Overall Study|Lost to Follow-up|4|||
48804082|NCT01728792|157125387|FG003|Overall Study|Lost to Follow-up|2|||
48804083|NCT01728792|157125388|FG004|Overall Study|Lost to Follow-up|0|||
48804084|NCT01224925|157125389|FG000|Overall Study|Lost to Follow-up|3|||
48804085|NCT01224925|157125390|FG001|Overall Study|Lost to Follow-up|2|||
48804086|NCT01203930|157125393|FG000|Overall Study|Disease Progression|0|||
48915160|NCT03700320|157524790|FG000|Overall Study|Lost to Follow-up|16|||
48915161|NCT03700320|157524791|FG001|Overall Study|Lost to Follow-up|23|||
48915162|NCT03700320|157524790|FG000|Overall Study|Pregnancy|2|||
48915163|NCT03700320|157524791|FG001|Overall Study|Pregnancy|4|||
48915164|NCT03700320|157524790|FG000|Overall Study|Protocol Deviation|7|||
48915165|NCT03700320|157524791|FG001|Overall Study|Protocol Deviation|31|||
48915166|NCT03700320|157524790|FG000|Overall Study|Non-compliance with Study Drug|1|||
48915167|NCT03700320|157524791|FG001|Overall Study|Non-compliance with Study Drug|3|||
48804087|NCT01203930|157125394|FG001|Overall Study|Disease Progression|4|||
48804088|NCT01203930|157125393|FG000|Overall Study|Death|3|||
48804089|NCT01203930|157125394|FG001|Overall Study|Death|1|||
48804090|NCT01203930|157125393|FG000|Overall Study|Withdrew Consent|1|||
48804091|NCT01203930|157125394|FG001|Overall Study|Withdrew Consent|10|||
48804092|NCT01203930|157125393|FG000|Overall Study|Investigator Request|0|||
48804093|NCT01203930|157125394|FG001|Overall Study|Investigator Request|8|||
48804094|NCT01203930|157125393|FG000|Overall Study|Study Terminated by Sponsor|0|||
48804095|NCT01203930|157125394|FG001|Overall Study|Study Terminated by Sponsor|12|||
48804096|NCT01203930|157125393|FG000|Overall Study|Poor tolerance of study drug|0|||
48915168|NCT03700320|157524790|FG000|Overall Study|Reason not Specified|0|||
48804097|NCT01203930|157125394|FG001|Overall Study|Poor tolerance of study drug|1|||
48804098|NCT01203930|157125393|FG000|Overall Study|Adverse Event|17|||
48804099|NCT01203930|157125394|FG001|Overall Study|Adverse Event|5|||
48804100|NCT00245102|157125395|FG000|Overall Study|Not Treated|1|||
48804101|NCT00245102|157125396|FG001|Overall Study|Not Treated|0|||
48804102|NCT00245102|157125397|FG002|Overall Study|Not Treated|1|||
48804103|NCT00245102|157125398|FG003|Overall Study|Not Treated|0|||
48804104|NCT00245102|157125399|FG004|Overall Study|Not Treated|0|||
48804105|NCT00245102|157125400|FG005|Overall Study|Not Treated|0|||
48804106|NCT00245102|157125395|FG000|Overall Study|Protocol Violation|1|||
48804107|NCT00245102|157125396|FG001|Overall Study|Protocol Violation|0|||
48804108|NCT00245102|157125397|FG002|Overall Study|Protocol Violation|0|||
48804109|NCT00245102|157125398|FG003|Overall Study|Protocol Violation|0|||
48804110|NCT00245102|157125399|FG004|Overall Study|Protocol Violation|0|||
48804111|NCT00245102|157125400|FG005|Overall Study|Protocol Violation|0|||
48804112|NCT00245102|157125395|FG000|Overall Study|Death|0|||
48804113|NCT00245102|157125396|FG001|Overall Study|Death|0|||
48804114|NCT00245102|157125397|FG002|Overall Study|Death|0|||
48804115|NCT00245102|157125398|FG003|Overall Study|Death|1|||
48804116|NCT00245102|157125399|FG004|Overall Study|Death|0|||
48804117|NCT00245102|157125400|FG005|Overall Study|Death|0|||
48804118|NCT00245102|157125395|FG000|Overall Study|Adverse Event|4|||
48804119|NCT00245102|157125396|FG001|Overall Study|Adverse Event|2|||
48804120|NCT00245102|157125397|FG002|Overall Study|Adverse Event|5|||
48804121|NCT00245102|157125398|FG003|Overall Study|Adverse Event|1|||
48804122|NCT00245102|157125399|FG004|Overall Study|Adverse Event|0|||
48804123|NCT00245102|157125400|FG005|Overall Study|Adverse Event|2|||
48804124|NCT00245102|157125395|FG000|Overall Study|Decline in performance|0|||
48804125|NCT00245102|157125396|FG001|Overall Study|Decline in performance|2|||
48804126|NCT00245102|157125397|FG002|Overall Study|Decline in performance|0|||
48804127|NCT00245102|157125398|FG003|Overall Study|Decline in performance|1|||
48804128|NCT00245102|157125399|FG004|Overall Study|Decline in performance|0|||
48804129|NCT00245102|157125400|FG005|Overall Study|Decline in performance|2|||
48804130|NCT00245102|157125395|FG000|Overall Study|Participant needed surgery|0|||
48804131|NCT00245102|157125396|FG001|Overall Study|Participant needed surgery|0|||
48804132|NCT00245102|157125397|FG002|Overall Study|Participant needed surgery|1|||
48804133|NCT00245102|157125398|FG003|Overall Study|Participant needed surgery|0|||
48804134|NCT00245102|157125399|FG004|Overall Study|Participant needed surgery|0|||
48804135|NCT00245102|157125400|FG005|Overall Study|Participant needed surgery|0|||
48804136|NCT00245102|157125395|FG000|Overall Study|Clinical progression|1|||
48804137|NCT00245102|157125396|FG001|Overall Study|Clinical progression|0|||
48804138|NCT00245102|157125397|FG002|Overall Study|Clinical progression|0|||
48804139|NCT00245102|157125398|FG003|Overall Study|Clinical progression|0|||
48804140|NCT00245102|157125399|FG004|Overall Study|Clinical progression|0|||
48804141|NCT00245102|157125400|FG005|Overall Study|Clinical progression|0|||
48804142|NCT04858802|157125404|FG000|Overall Study|Lost to Follow-up|1|||
48804143|NCT04858802|157125405|FG001|Overall Study|Lost to Follow-up|1|||
48804144|NCT04858802|157125404|FG000|Overall Study|Withdrawal by Subject|1|||
48804145|NCT04858802|157125405|FG001|Overall Study|Withdrawal by Subject|1|||
48804146|NCT03391765|157125406|FG000|Overall Study|Adverse Event|2|||
48804147|NCT03391765|157125407|FG001|Overall Study|Adverse Event|0|||
48804148|NCT03391765|157125408|FG002|Overall Study|Adverse Event|0|||
48804149|NCT03391765|157125409|FG003|Overall Study|Adverse Event|2|||
48804150|NCT03391765|157125406|FG000|Overall Study|Withdrew consent|5|||
48804151|NCT03391765|157125407|FG001|Overall Study|Withdrew consent|7|||
48804152|NCT03391765|157125408|FG002|Overall Study|Withdrew consent|2|||
48804153|NCT03391765|157125409|FG003|Overall Study|Withdrew consent|5|||
48804154|NCT03391765|157125406|FG000|Overall Study|Other, not specified|44|||
48804155|NCT03391765|157125407|FG001|Overall Study|Other, not specified|38|||
48804156|NCT03391765|157125408|FG002|Overall Study|Other, not specified|21|||
48804157|NCT03391765|157125409|FG003|Overall Study|Other, not specified|16|||
48804158|NCT03966053|157125410|FG000|Overall Study|Withdrawal by subject prior to starting study drug.|1|||
48804159|NCT04425902|157125415|FG000|Treatment Period 2 (Days 11 to 20)|Adverse Event|1|||
48804160|NCT04607044|157125421|FG000|Overall Study|Study Early Termination by Sponsor.|40|||
48804161|NCT04607044|157125421|FG000|Overall Study|Adverse Event|1|||
48804162|NCT04607044|157125421|FG000|Overall Study|Did not receive study device|3|||
48804163|NCT04607044|157125421|FG000|Overall Study|Death|1|||
48804164|NCT04152200|157125422|FG000|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|6|||
48804165|NCT04152200|157125423|FG001|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|15|||
48804166|NCT03585296|157125430|FG000|Overall Study|Adverse Event|1|||
48804167|NCT03585296|157125430|FG000|Overall Study|Lost to Follow-up|2|||
48804168|NCT03585296|157125430|FG000|Overall Study|Withdrawal by Subject|2|||
48804169|NCT01059643|157125431|FG000|Overall Study|Adverse Event|3|||
48804170|NCT01059643|157125431|FG000|Overall Study|Withdrawal by Subject|2|||
48804171|NCT01059643|157125431|FG000|Overall Study|Physician Decision|1|||
48804172|NCT00185640|157125432|FG000|Overall Study|Not Eligible|4|||
48804173|NCT00185640|157125432|FG000|Overall Study|Withdrawal by Subject|3|||
48804174|NCT00185640|157125432|FG000|Overall Study|Death|138|||
48804175|NCT00708435|157125434|FG000|Overall Study|Death / Serious Adverse Event|10|||
48804176|NCT00708435|157125435|FG001|Overall Study|Death / Serious Adverse Event|5|||
48804177|NCT00708435|157125434|FG000|Overall Study|Lost to Follow-up|9|||
48804178|NCT00708435|157125435|FG001|Overall Study|Lost to Follow-up|4|||
48804179|NCT00708435|157125434|FG000|Overall Study|Withdrawal by Subject|3|||
48804180|NCT00708435|157125435|FG001|Overall Study|Withdrawal by Subject|7|||
48804181|NCT00708435|157125434|FG000|Overall Study|Adverse Event|1|||
48804182|NCT00708435|157125435|FG001|Overall Study|Adverse Event|0|||
48804183|NCT00708435|157125434|FG000|Overall Study|Protocol Violation|0|||
48804184|NCT00708435|157125435|FG001|Overall Study|Protocol Violation|1|||
48804185|NCT00708435|157125434|FG000|Overall Study|Intervention by primary care physician|1|||
48804186|NCT00708435|157125435|FG001|Overall Study|Intervention by primary care physician|0|||
48804187|NCT00708435|157125434|FG000|Overall Study|Refused hospitalization|1|||
48804188|NCT00708435|157125435|FG001|Overall Study|Refused hospitalization|0|||
48804189|NCT02437318|157125436|FG000|Overall Study|Progressive disease|207|||
48804190|NCT02437318|157125437|FG001|Overall Study|Progressive disease|240|||
48804191|NCT02437318|157125436|FG000|Overall Study|Subject/guardian decision|24|||
48804192|NCT02437318|157125437|FG001|Overall Study|Subject/guardian decision|11|||
48804193|NCT02437318|157125436|FG000|Overall Study|Physician Decision|29|||
48804194|NCT02437318|157125437|FG001|Overall Study|Physician Decision|22|||
48804195|NCT02437318|157125436|FG000|Overall Study|Adverse Event|14|||
48804196|NCT02437318|157125437|FG001|Overall Study|Adverse Event|4|||
48804197|NCT02437318|157125436|FG000|Overall Study|Death|4|||
48804198|NCT02437318|157125437|FG001|Overall Study|Death|4|||
48804199|NCT02437318|157125436|FG000|Overall Study|Protocol deviation|5|||
48804200|NCT02437318|157125437|FG001|Overall Study|Protocol deviation|7|||
48804201|NCT02437318|157125436|FG000|Overall Study|Sponsor decision|1|||
48804202|NCT02437318|157125437|FG001|Overall Study|Sponsor decision|0|||
48804203|NCT01446796|157125438|FG000|Overall Study|Withdrawal by Subject|1|||
49119135|NCT00105989|158274623|FG000|Acute - Open Label: Week 0-10|Protocol Violation|8|||
49119136|NCT00105989|158274624|FG001|Acute - Open Label: Week 0-10|Protocol Violation|0|||
49119137|NCT00105989|158274623|FG000|Acute - Open Label: Week 0-10|Lost to Follow-up|4|||
49119138|NCT00105989|158274624|FG001|Acute - Open Label: Week 0-10|Lost to Follow-up|0|||
48804204|NCT01446796|157125439|FG001|Overall Study|Withdrawal by Subject|0|||
48804205|NCT01426425|157125440|FG000|Overall Study|Exited prior to EP study|22|||
48804206|NCT01426425|157125440|FG000|Overall Study|Inclusion/exclusion criteria not met|151|||
48804207|NCT01426425|157125440|FG000|Overall Study|Met inclusion/exclusion, not treated|2|||
48804208|NCT00909480|157125441|FG000|Overall Study|Adverse Event|5|||
48804209|NCT00909480|157125442|FG001|Overall Study|Adverse Event|3|||
48804210|NCT00909480|157125441|FG000|Overall Study|Protocol Violation|6|||
48804211|NCT00909480|157125442|FG001|Overall Study|Protocol Violation|8|||
48804212|NCT00909480|157125441|FG000|Overall Study|Withdrawal criteria|9|||
48804213|NCT00909480|157125442|FG001|Overall Study|Withdrawal criteria|11|||
48804214|NCT00909480|157125441|FG000|Overall Study|Unclassified|18|||
48804215|NCT00909480|157125442|FG001|Overall Study|Unclassified|19|||
48804216|NCT01999075|157125447|FG000|Overall Study|Lost to Follow-up|0|||
48804217|NCT01999075|157125448|FG001|Overall Study|Lost to Follow-up|2|||
48804218|NCT01999075|157125447|FG000|Overall Study|Withdrawal by Subject|2|||
48804219|NCT01999075|157125448|FG001|Overall Study|Withdrawal by Subject|7|||
48804220|NCT01999075|157125447|FG000|Overall Study|Enrolled in drug trial|3|||
48804221|NCT01999075|157125448|FG001|Overall Study|Enrolled in drug trial|1|||
48804222|NCT01999075|157125447|FG000|Overall Study|Became ineligible|0|||
48804223|NCT01999075|157125448|FG001|Overall Study|Became ineligible|2|||
48804224|NCT04995419|157125449|FG000|Overall Study|Withdrawal by Subject|3|||
48804225|NCT04995419|157125449|FG000|Overall Study|Progressive Disease|19|||
48804226|NCT04995419|157125449|FG000|Overall Study|Adverse Event|2|||
48804227|NCT04995419|157125449|FG000|Overall Study|Ongoing|16|||
48804228|NCT04096040|157125454|FG000|Overall Study|Protocol Violation|12|||
48804229|NCT04096040|157125454|FG000|Overall Study|Non-compliant site|4|||
48804230|NCT04524598|157125455|FG000|Phase I - Feasibility|Lost to Follow-up|2|||
48804231|NCT04524598|157125456|FG001|Phase I - Feasibility|Lost to Follow-up|4|||
48804232|NCT04524598|157125457|FG002|Phase I - Feasibility|Lost to Follow-up|0|||
48804233|NCT04524598|157125458|FG003|Phase I - Feasibility|Lost to Follow-up|0|||
48804234|NCT04524598|157125459|FG004|Phase I - Feasibility|Lost to Follow-up|0|||
48804235|NCT04524598|157125455|FG000|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|2|||
48804236|NCT04524598|157125456|FG001|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|1|||
48804237|NCT04524598|157125457|FG002|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
48804238|NCT04524598|157125458|FG003|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
48804239|NCT04524598|157125459|FG004|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
48804240|NCT04524598|157125455|FG000|Phase II - Outcomes|Lost to Follow-up|0|||
48804241|NCT04524598|157125456|FG001|Phase II - Outcomes|Lost to Follow-up|0|||
48804242|NCT04524598|157125457|FG002|Phase II - Outcomes|Lost to Follow-up|16|||
48915169|NCT03700320|157524791|FG001|Overall Study|Reason not Specified|1|||
48804243|NCT04524598|157125458|FG003|Phase II - Outcomes|Lost to Follow-up|8|||
48804244|NCT04524598|157125459|FG004|Phase II - Outcomes|Lost to Follow-up|0|||
48804245|NCT04524598|157125455|FG000|Phase II - Outcomes|Withdrawal by Subject|0|||
48804246|NCT04524598|157125456|FG001|Phase II - Outcomes|Withdrawal by Subject|0|||
48804247|NCT04524598|157125457|FG002|Phase II - Outcomes|Withdrawal by Subject|2|||
48804248|NCT04524598|157125458|FG003|Phase II - Outcomes|Withdrawal by Subject|0|||
48804249|NCT04524598|157125459|FG004|Phase II - Outcomes|Withdrawal by Subject|0|||
48804250|NCT04524598|157125455|FG000|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
48804251|NCT04524598|157125456|FG001|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
48804252|NCT04524598|157125457|FG002|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|8|||
48804253|NCT04524598|157125458|FG003|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|5|||
48804254|NCT04524598|157125459|FG004|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
48804255|NCT04524598|157125455|FG000|Phase II - Control Extension|Lost to Follow-up|0|||
48804256|NCT04524598|157125456|FG001|Phase II - Control Extension|Lost to Follow-up|0|||
48804257|NCT04524598|157125457|FG002|Phase II - Control Extension|Lost to Follow-up|0|||
48804258|NCT04524598|157125458|FG003|Phase II - Control Extension|Lost to Follow-up|0|||
48804259|NCT04524598|157125459|FG004|Phase II - Control Extension|Lost to Follow-up|6|||
48804260|NCT04524598|157125455|FG000|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
48804261|NCT04524598|157125456|FG001|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
48804262|NCT04524598|157125457|FG002|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
48804263|NCT04524598|157125458|FG003|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
48804264|NCT04524598|157125459|FG004|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|6|||
48804265|NCT02668016|157125460|FG000|Month 2|Withdrew due to other health condition preventing continuation with the protocol|1|||
48804266|NCT02668016|157125460|FG000|Month 2|Withdrew due to repeated failure to provide treatment scores|1|||
48804267|NCT02668016|157125460|FG000|Month 2|Not applicable - stopped trial medication for rest of month but continued in the trial|4|||
48804268|NCT02668016|157125460|FG000|Month 4|Withdrawal due to severe symptoms|1|||
48804269|NCT02668016|157125460|FG000|Month 4|Withdrawal due to non-compliance with trial protocol|1|||
48804270|NCT02668016|157125460|FG000|Month 4|Not applicable - stopped trial medication for rest of month but continued in the trial|3|||
48804271|NCT02668016|157125460|FG000|Month 6|Withdrawal as decided side effects non longer statin mediated|1|||
48804272|NCT02668016|157125460|FG000|Month 6|Withdrawal due to severe symptoms|2|||
48804273|NCT02668016|157125460|FG000|Month 6|Withdrawal due to other health issues preventing continuation with the protocol|1|||
48804274|NCT02668016|157125460|FG000|Month 6|Not applicable - stopped trial medication for rest of month but continued in the trial|2|||
48804275|NCT02668016|157125460|FG000|Month 8|Withdrawal due to severe symptoms|1|||
48804276|NCT02668016|157125460|FG000|Month 8|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
48804277|NCT02668016|157125460|FG000|Month 10|Withdrawal due to intercurrent social stresses|1|||
48804278|NCT02668016|157125460|FG000|Month 10|Withdrawal due to severe symptoms|1|||
48804279|NCT02668016|157125460|FG000|Month 10|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
48804280|NCT00962247|157125461|FG000|25% Reduction of Sedentary Activity|Protocol Violation|4|||
48804281|NCT00962247|157125461|FG000|25% Reduction of Sedentary Activity|Withdrawal by Subject|1|||
48804282|NCT03474549|157125462|FG000|Overall Study|Death|31|||
48804283|NCT03474549|157125462|FG000|Overall Study|Lost to Follow-up|4|||
48804284|NCT03474549|157125462|FG000|Overall Study|Withdrawal by Subject|2|||
48804285|NCT04109066|157125468|FG000|Pre-treatment|Participant withdrew consent|2|||
48804286|NCT04109066|157125469|FG001|Pre-treatment|Participant withdrew consent|0|||
48804287|NCT04109066|157125468|FG000|Pre-treatment|Participant no longer meets study criteria|1|||
48804288|NCT04109066|157125469|FG001|Pre-treatment|Participant no longer meets study criteria|1|||
48804289|NCT04109066|157125468|FG000|Treatment|Lack of Efficacy|2|||
48804290|NCT04109066|157125469|FG001|Treatment|Lack of Efficacy|4|||
48804291|NCT04109066|157125468|FG000|Treatment|Adverse Event|23|||
48804292|NCT04109066|157125469|FG001|Treatment|Adverse Event|7|||
48804293|NCT04109066|157125468|FG000|Treatment|Participant request to discontinue Study treatment|15|||
48804294|NCT04109066|157125469|FG001|Treatment|Participant request to discontinue Study treatment|14|||
48804295|NCT04109066|157125468|FG000|Treatment|Withdrawal by Subject|8|||
48804296|NCT04109066|157125469|FG001|Treatment|Withdrawal by Subject|8|||
48804297|NCT04109066|157125468|FG000|Treatment|Death|3|||
48804298|NCT04109066|157125469|FG001|Treatment|Death|0|||
48804299|NCT04109066|157125468|FG000|Treatment|Participant no longer meets study criteria|2|||
48804300|NCT04109066|157125469|FG001|Treatment|Participant no longer meets study criteria|2|||
48804301|NCT04109066|157125468|FG000|Treatment|Administrative reasons by sponsor|2|||
48804302|NCT04109066|157125469|FG001|Treatment|Administrative reasons by sponsor|3|||
48804303|NCT04109066|157125468|FG000|Treatment|Other reasons|17|||
48804304|NCT04109066|157125469|FG001|Treatment|Other reasons|23|||
48804305|NCT04109066|157125468|FG000|Treatment|Disease Progression|4|||
48804306|NCT04109066|157125469|FG001|Treatment|Disease Progression|7|||
48804307|NCT04109066|157125468|FG000|Treatment|Study drug toxicity|12|||
48804308|NCT04109066|157125469|FG001|Treatment|Study drug toxicity|5|||
48915170|NCT04251910|157524792|FG000|Overall Study|Covid 19 lockdown|0|||
48915171|NCT04251910|157524793|FG001|Overall Study|Covid 19 lockdown|5|||
48804309|NCT04109066|157125468|FG000|Treatment|Adverse Event unrelated to Study drug|1|||
48804310|NCT04109066|157125469|FG001|Treatment|Adverse Event unrelated to Study drug|0|||
48804311|NCT04109066|157125468|FG000|Treatment|Disease Recurrence|0|||
48804312|NCT04109066|157125469|FG001|Treatment|Disease Recurrence|2|||
48804313|NCT04109066|157125468|FG000|Treatment|Not reported|4|||
48804314|NCT04109066|157125469|FG001|Treatment|Not reported|8|||
48804315|NCT03386032|157126467|FG000|Overall Study|Lack of Efficacy|6|||
48804316|NCT03386032|157126468|FG001|Overall Study|Lack of Efficacy|2|||
48804317|NCT03386032|157126469|FG002|Overall Study|Lack of Efficacy|0|||
48804318|NCT03386032|157126467|FG000|Overall Study|Adverse Event|2|||
48804319|NCT03386032|157126468|FG001|Overall Study|Adverse Event|2|||
48804320|NCT03386032|157126469|FG002|Overall Study|Adverse Event|0|||
48804321|NCT03386032|157126467|FG000|Overall Study|Withdrawal by Subject|1|||
48804322|NCT03386032|157126468|FG001|Overall Study|Withdrawal by Subject|0|||
48804323|NCT03386032|157126469|FG002|Overall Study|Withdrawal by Subject|0|||
48804324|NCT03386032|157126467|FG000|Overall Study|Lost to Follow-up|9|||
48804325|NCT03386032|157126468|FG001|Overall Study|Lost to Follow-up|3|||
48804326|NCT03386032|157126469|FG002|Overall Study|Lost to Follow-up|0|||
48804327|NCT04907474|157126474|FG000|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|1|||
48804328|NCT04907474|157126475|FG001|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|0|||
48804329|NCT02364180|157126476|FG000|Overall Study|Screen Fail|1|||
48804330|NCT02487498|157126481|FG000|Period: Period 1|Adverse Event|2|||
48804331|NCT02487498|157126482|FG001|Period: Period 1|Adverse Event|4|||
48804332|NCT02487498|157126481|FG000|Period: Period 1|Subject/guardian decision|2|||
48804333|NCT02487498|157126482|FG001|Period: Period 1|Subject/guardian decision|4|||
48804334|NCT02487498|157126481|FG000|Period: Period 1|Lost to Follow-up|0|||
48804335|NCT02487498|157126482|FG001|Period: Period 1|Lost to Follow-up|2|||
48804336|NCT02487498|157126481|FG000|Period: Period 1|Lack of Efficacy|1|||
48804337|NCT02487498|157126482|FG001|Period: Period 1|Lack of Efficacy|0|||
48804338|NCT02487498|157126481|FG000|Period: Period 1|Physician Decision|0|||
48804339|NCT02487498|157126482|FG001|Period: Period 1|Physician Decision|1|||
48804340|NCT02487498|157126481|FG000|Period: Period 1|Protocol deviation|1|||
48804341|NCT02487498|157126482|FG001|Period: Period 1|Protocol deviation|0|||
48804342|NCT02487498|157126481|FG000|Period: Washout|Subject/guardian decision|0|||
48804343|NCT02487498|157126482|FG001|Period: Washout|Subject/guardian decision|5|||
48804344|NCT02487498|157126481|FG000|Period: Washout|Lack of Efficacy|1|||
48804345|NCT02487498|157126482|FG001|Period: Washout|Lack of Efficacy|1|||
48804346|NCT02487498|157126481|FG000|Period: Washout|Physician Decision|1|||
48804347|NCT02487498|157126482|FG001|Period: Washout|Physician Decision|0|||
48804348|NCT02487498|157126481|FG000|Period: Washout|Non-compliance with study treatment|0|||
48804349|NCT02487498|157126482|FG001|Period: Washout|Non-compliance with study treatment|1|||
48804350|NCT02487498|157126481|FG000|Period: Period 2|Adverse Event|2|||
48804351|NCT02487498|157126482|FG001|Period: Period 2|Adverse Event|2|||
48804352|NCT02487498|157126481|FG000|Period: Period 2|Subject/guardian decision|2|||
48804353|NCT02487498|157126482|FG001|Period: Period 2|Subject/guardian decision|1|||
48804354|NCT02487498|157126481|FG000|Period: Period 2|Lost to Follow-up|1|||
48804355|NCT02487498|157126482|FG001|Period: Period 2|Lost to Follow-up|1|||
48804356|NCT02487498|157126481|FG000|Period: Period 2|Death|0|||
48804357|NCT02487498|157126482|FG001|Period: Period 2|Death|1|||
48804358|NCT02487498|157126481|FG000|Period: Period 2|Physician Decision|1|||
48804359|NCT02487498|157126482|FG001|Period: Period 2|Physician Decision|0|||
48804360|NCT04934722|157126483|FG000|Overall Study|Death|4|||
48804361|NCT04934722|157126484|FG001|Overall Study|Death|3|||
48804362|NCT04934722|157126483|FG000|Overall Study|Participants Ongoing|88|||
48804363|NCT04934722|157126484|FG001|Overall Study|Participants Ongoing|91|||
48804364|NCT02513563|157126485|FG000|Overall Study|Death|4|||
48804365|NCT02513563|157126485|FG000|Overall Study|Withdrawal by Subject|4|||
48804366|NCT02513563|157126485|FG000|Overall Study|Physician Decision|1|||
48804367|NCT04908397|157126486|FG000|Overall Study|Withdrawal by Subject|2|||
48804368|NCT02231164|157126488|FG000|Overall Study|Adverse Event|1|||
48804369|NCT02231164|157126489|FG001|Overall Study|Adverse Event|1|||
48804370|NCT02231164|157126488|FG000|Overall Study|Lack of Efficacy|4|||
48915172|NCT04251910|157524794|FG002|Overall Study|Covid 19 lockdown|0|||
48804371|NCT02231164|157126489|FG001|Overall Study|Lack of Efficacy|3|||
48804372|NCT02231164|157126488|FG000|Overall Study|Withdrawal by Subject|1|||
48804373|NCT02231164|157126489|FG001|Overall Study|Withdrawal by Subject|2|||
48804374|NCT04765384|157126490|FG000|Post-baseline: Adults|Lost to Follow-up|0|||
48804375|NCT04765384|157126491|FG001|Post-baseline: Adults|Lost to Follow-up|1|||
48804376|NCT04765384|157126492|FG002|Post-baseline: Adults|Lost to Follow-up|3|||
48804377|NCT04765384|157126493|FG003|Post-baseline: Adults|Lost to Follow-up|0|||
48804378|NCT04765384|157126494|FG004|Post-baseline: Adults|Lost to Follow-up|0|||
48804379|NCT04765384|157126495|FG005|Post-baseline: Adults|Lost to Follow-up|0|||
48804380|NCT04765384|157126490|FG000|Post-baseline: Adults|Withdrawal by Subject|2|||
48804381|NCT04765384|157126491|FG001|Post-baseline: Adults|Withdrawal by Subject|1|||
48804382|NCT04765384|157126492|FG002|Post-baseline: Adults|Withdrawal by Subject|3|||
48804383|NCT04765384|157126493|FG003|Post-baseline: Adults|Withdrawal by Subject|0|||
48804384|NCT04765384|157126494|FG004|Post-baseline: Adults|Withdrawal by Subject|0|||
48804385|NCT04765384|157126495|FG005|Post-baseline: Adults|Withdrawal by Subject|0|||
48804386|NCT04765384|157126490|FG000|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
48804387|NCT04765384|157126491|FG001|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
48804388|NCT04765384|157126492|FG002|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
48804389|NCT04765384|157126493|FG003|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
48804390|NCT04765384|157126494|FG004|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
48804391|NCT04765384|157126495|FG005|Post-natal: Neonates and Infants|Lost to Follow-up|5|||
48804392|NCT04765384|157126490|FG000|Post-natal: Neonates and Infants|Death|0|||
48804393|NCT04765384|157126491|FG001|Post-natal: Neonates and Infants|Death|0|||
48804394|NCT04765384|157126492|FG002|Post-natal: Neonates and Infants|Death|0|||
48804395|NCT04765384|157126493|FG003|Post-natal: Neonates and Infants|Death|1|||
48804396|NCT04765384|157126494|FG004|Post-natal: Neonates and Infants|Death|0|||
48804397|NCT04765384|157126495|FG005|Post-natal: Neonates and Infants|Death|0|||
48804398|NCT04765384|157126490|FG000|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
48804399|NCT04765384|157126491|FG001|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
48804400|NCT04765384|157126492|FG002|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
48804401|NCT04765384|157126493|FG003|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
48804402|NCT04765384|157126494|FG004|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
48804403|NCT04765384|157126495|FG005|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|3|||
48804404|NCT04568486|157126496|FG000|Overall Study|Withdrawal by Subject|26|||
48804405|NCT04568486|157126496|FG000|Overall Study|Lost to Follow-up|7|||
48804406|NCT04517253|157126497|FG000|Overall Study|Adverse Event|1|||
48804407|NCT04517253|157126498|FG001|Overall Study|Adverse Event|0|||
48804408|NCT04517253|157126499|FG002|Overall Study|Adverse Event|0|||
48804409|NCT04517253|157126497|FG000|Overall Study|Death|0|||
48804410|NCT04517253|157126498|FG001|Overall Study|Death|1|||
48804411|NCT04517253|157126499|FG002|Overall Study|Death|0|||
48804412|NCT04830800|157126501|FG000|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|2|||
48804413|NCT04830800|157126502|FG001|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
48804414|NCT04830800|157126503|FG002|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
48804415|NCT04830800|157126504|FG003|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
48804416|NCT04830800|157126505|FG004|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
48804417|NCT01036022|157126509|FG000|Overall Study|Adverse Event|1|||
48804418|NCT01036022|157126510|FG001|Overall Study|Adverse Event|3|||
48804419|NCT01036022|157126511|FG002|Overall Study|Adverse Event|2|||
48804420|NCT01036022|157126512|FG003|Overall Study|Adverse Event|1|||
48804421|NCT01036022|157126513|FG004|Overall Study|Adverse Event|0|||
48804422|NCT01036022|157126514|FG005|Overall Study|Adverse Event|2|||
48804423|NCT01036022|157126509|FG000|Overall Study|Lack of Efficacy|1|||
48804424|NCT01036022|157126510|FG001|Overall Study|Lack of Efficacy|1|||
48804425|NCT01036022|157126511|FG002|Overall Study|Lack of Efficacy|1|||
48804426|NCT01036022|157126512|FG003|Overall Study|Lack of Efficacy|0|||
48804427|NCT01036022|157126513|FG004|Overall Study|Lack of Efficacy|1|||
48804428|NCT01036022|157126514|FG005|Overall Study|Lack of Efficacy|1|||
48804429|NCT01036022|157126509|FG000|Overall Study|Physician Decision|0|||
48804430|NCT01036022|157126510|FG001|Overall Study|Physician Decision|0|||
48804431|NCT01036022|157126511|FG002|Overall Study|Physician Decision|1|||
48804432|NCT01036022|157126512|FG003|Overall Study|Physician Decision|0|||
48804433|NCT01036022|157126513|FG004|Overall Study|Physician Decision|0|||
48804434|NCT01036022|157126514|FG005|Overall Study|Physician Decision|0|||
48915173|NCT04251910|157524795|FG003|Overall Study|Covid 19 lockdown|4|||
48915174|NCT04251910|157524796|FG004|Overall Study|Covid 19 lockdown|0|||
48804435|NCT01036022|157126509|FG000|Overall Study|Withdrawal by Subject|0|||
48915175|NCT04251910|157524797|FG005|Overall Study|Covid 19 lockdown|0|||
48915176|NCT04251910|157524792|FG000|Overall Study|Assisted living facility was closed|0|||
48915177|NCT04251910|157524793|FG001|Overall Study|Assisted living facility was closed|0|||
48804436|NCT01036022|157126510|FG001|Overall Study|Withdrawal by Subject|0|||
48804437|NCT01036022|157126511|FG002|Overall Study|Withdrawal by Subject|0|||
48804438|NCT01036022|157126512|FG003|Overall Study|Withdrawal by Subject|1|||
48804439|NCT01036022|157126513|FG004|Overall Study|Withdrawal by Subject|2|||
48804440|NCT01036022|157126514|FG005|Overall Study|Withdrawal by Subject|0|||
48804441|NCT01483937|157126517|FG000|Overall Study|Withdrawal by Subject|4|||
48804442|NCT01483937|157126518|FG001|Overall Study|Withdrawal by Subject|3|||
48804443|NCT01919970|157126519|FG000|Overall Study|Withdrawal by Subject|3|||
48804444|NCT01919970|157126520|FG001|Overall Study|Withdrawal by Subject|0|||
48804445|NCT03334630|157126521|FG000|Overall Study|Withdrawal by Subject|7|||
48804446|NCT03334630|157126522|FG001|Overall Study|Withdrawal by Subject|7|||
48804447|NCT03334630|157126521|FG000|Overall Study|Lost to Follow-up|3|||
48804448|NCT03334630|157126522|FG001|Overall Study|Lost to Follow-up|1|||
48804449|NCT03334630|157126521|FG000|Overall Study|Adverse Event|0|||
48804450|NCT03334630|157126522|FG001|Overall Study|Adverse Event|1|||
48804451|NCT03334630|157126521|FG000|Overall Study|Physician Decision|1|||
48804452|NCT03334630|157126522|FG001|Overall Study|Physician Decision|1|||
48804453|NCT03334630|157126521|FG000|Overall Study|Enrollment closed|2|||
48804454|NCT03334630|157126522|FG001|Overall Study|Enrollment closed|1|||
48804455|NCT03334630|157126521|FG000|Overall Study|Subject not treated with study ablation due to technical difficulties|0|||
48804456|NCT03334630|157126522|FG001|Overall Study|Subject not treated with study ablation due to technical difficulties|1|||
48804457|NCT03334630|157126521|FG000|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
48804458|NCT03334630|157126522|FG001|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
48804459|NCT03389802|157126523|FG000|Overall Study|Lack of Efficacy|3|||
48804460|NCT03389802|157126524|FG001|Overall Study|Lack of Efficacy|3|||
48804461|NCT03389802|157126525|FG002|Overall Study|Lack of Efficacy|13|||
48804462|NCT03389802|157126526|FG003|Overall Study|Lack of Efficacy|6|||
48804463|NCT03389802|157126527|FG004|Overall Study|Lack of Efficacy|1|||
48804464|NCT03389802|157126523|FG000|Overall Study|Adverse Event|0|||
48804465|NCT03389802|157126524|FG001|Overall Study|Adverse Event|0|||
48804466|NCT03389802|157126525|FG002|Overall Study|Adverse Event|1|||
48804467|NCT03389802|157126526|FG003|Overall Study|Adverse Event|0|||
48804468|NCT03389802|157126527|FG004|Overall Study|Adverse Event|4|||
48804469|NCT03389802|157126523|FG000|Overall Study|Subject deemed ineligible after enrollment|0|||
48804470|NCT03389802|157126524|FG001|Overall Study|Subject deemed ineligible after enrollment|0|||
48804471|NCT03389802|157126525|FG002|Overall Study|Subject deemed ineligible after enrollment|1|||
48804472|NCT03389802|157126526|FG003|Overall Study|Subject deemed ineligible after enrollment|0|||
48804473|NCT03389802|157126527|FG004|Overall Study|Subject deemed ineligible after enrollment|0|||
48804474|NCT05218096|157126534|FG000|Primary Evaluation|Withdrawal by Subject|0|||
48804475|NCT05218096|157126535|FG001|Primary Evaluation|Withdrawal by Subject|0|||
48804476|NCT05218096|157126536|FG002|Primary Evaluation|Withdrawal by Subject|2|||
48804477|NCT05218096|157126537|FG003|Primary Evaluation|Withdrawal by Subject|0|||
48804478|NCT05218096|157126538|FG004|Primary Evaluation|Withdrawal by Subject|0|||
48804479|NCT05218096|157126534|FG000|Primary Evaluation|Physician Decision|1|||
48804480|NCT05218096|157126535|FG001|Primary Evaluation|Physician Decision|0|||
48804481|NCT05218096|157126536|FG002|Primary Evaluation|Physician Decision|0|||
48804482|NCT05218096|157126537|FG003|Primary Evaluation|Physician Decision|0|||
48804483|NCT05218096|157126538|FG004|Primary Evaluation|Physician Decision|0|||
48804484|NCT05218096|157126534|FG000|Extended Treatment|Clinical Deterioration|1|||
48804485|NCT05218096|157126535|FG001|Extended Treatment|Clinical Deterioration|1|||
48804486|NCT05218096|157126536|FG002|Extended Treatment|Clinical Deterioration|0|||
48804487|NCT05218096|157126537|FG003|Extended Treatment|Clinical Deterioration|0|||
48804488|NCT05218096|157126538|FG004|Extended Treatment|Clinical Deterioration|0|||
48804489|NCT05218096|157126534|FG000|Extended Treatment|Study Terminated by Sponsor|6|||
48804490|NCT05218096|157126535|FG001|Extended Treatment|Study Terminated by Sponsor|3|||
48804491|NCT05218096|157126536|FG002|Extended Treatment|Study Terminated by Sponsor|0|||
48804492|NCT05218096|157126537|FG003|Extended Treatment|Study Terminated by Sponsor|3|||
48804493|NCT05218096|157126538|FG004|Extended Treatment|Study Terminated by Sponsor|2|||
48804494|NCT05218096|157126534|FG000|Extended Treatment|Withdrawal by Subject|1|||
48804495|NCT05218096|157126535|FG001|Extended Treatment|Withdrawal by Subject|3|||
48804496|NCT05218096|157126536|FG002|Extended Treatment|Withdrawal by Subject|0|||
48804497|NCT05218096|157126537|FG003|Extended Treatment|Withdrawal by Subject|2|||
48804498|NCT05218096|157126538|FG004|Extended Treatment|Withdrawal by Subject|2|||
48804499|NCT05218096|157126534|FG000|Extended Treatment|Lack of Efficacy|3|||
48804500|NCT05218096|157126535|FG001|Extended Treatment|Lack of Efficacy|0|||
48804501|NCT05218096|157126536|FG002|Extended Treatment|Lack of Efficacy|0|||
48804502|NCT05218096|157126537|FG003|Extended Treatment|Lack of Efficacy|0|||
48804503|NCT05218096|157126538|FG004|Extended Treatment|Lack of Efficacy|0|||
48804504|NCT05218096|157126534|FG000|Extended Treatment|Physician Decision|0|||
48915178|NCT04251910|157524794|FG002|Overall Study|Assisted living facility was closed|0|||
48804505|NCT05218096|157126535|FG001|Extended Treatment|Physician Decision|1|||
48804506|NCT05218096|157126536|FG002|Extended Treatment|Physician Decision|0|||
48804507|NCT05218096|157126537|FG003|Extended Treatment|Physician Decision|0|||
48804508|NCT05218096|157126538|FG004|Extended Treatment|Physician Decision|0|||
48804509|NCT05218096|157126534|FG000|Open-label Extension|Adverse Event|1|||
48804510|NCT05218096|157126535|FG001|Open-label Extension|Adverse Event|0|||
48804511|NCT05218096|157126536|FG002|Open-label Extension|Adverse Event|0|||
48804512|NCT05218096|157126537|FG003|Open-label Extension|Adverse Event|0|||
48804513|NCT05218096|157126538|FG004|Open-label Extension|Adverse Event|1|||
48804514|NCT05218096|157126534|FG000|Open-label Extension|Pregnancy|0|||
48804515|NCT05218096|157126535|FG001|Open-label Extension|Pregnancy|0|||
48804516|NCT05218096|157126536|FG002|Open-label Extension|Pregnancy|0|||
48804517|NCT05218096|157126537|FG003|Open-label Extension|Pregnancy|0|||
48804518|NCT05218096|157126538|FG004|Open-label Extension|Pregnancy|1|||
48804519|NCT05218096|157126534|FG000|Open-label Extension|Lack of Efficacy|1|||
48804520|NCT05218096|157126535|FG001|Open-label Extension|Lack of Efficacy|2|||
48804521|NCT05218096|157126536|FG002|Open-label Extension|Lack of Efficacy|0|||
48804522|NCT05218096|157126537|FG003|Open-label Extension|Lack of Efficacy|0|||
48708650|NCT00557856|156781022|FG002|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
48708651|NCT00557856|156781023|FG003|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
48708652|NCT00557856|156781024|FG004|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
48708653|NCT00557856|156781025|FG005|Part 1: Dose Escalation Phase|global deterioration of health status|2|||
48804523|NCT05218096|157126538|FG004|Open-label Extension|Lack of Efficacy|0|||
48804524|NCT05218096|157126534|FG000|Open-label Extension|Lost to Follow-up|1|||
48804525|NCT05218096|157126535|FG001|Open-label Extension|Lost to Follow-up|0|||
48804526|NCT05218096|157126536|FG002|Open-label Extension|Lost to Follow-up|0|||
48804527|NCT05218096|157126537|FG003|Open-label Extension|Lost to Follow-up|0|||
48804528|NCT05218096|157126538|FG004|Open-label Extension|Lost to Follow-up|0|||
48804529|NCT05218096|157126534|FG000|Open-label Extension|Death|0|||
48804530|NCT05218096|157126535|FG001|Open-label Extension|Death|0|||
48804531|NCT05218096|157126536|FG002|Open-label Extension|Death|0|||
48804532|NCT05218096|157126537|FG003|Open-label Extension|Death|1|||
48804533|NCT05218096|157126538|FG004|Open-label Extension|Death|0|||
48804534|NCT05218096|157126534|FG000|Open-label Extension|Study Terminated by Sponsor|13|||
48804535|NCT05218096|157126535|FG001|Open-label Extension|Study Terminated by Sponsor|4|||
48804536|NCT05218096|157126536|FG002|Open-label Extension|Study Terminated by Sponsor|0|||
48804537|NCT05218096|157126537|FG003|Open-label Extension|Study Terminated by Sponsor|7|||
48804538|NCT05218096|157126538|FG004|Open-label Extension|Study Terminated by Sponsor|7|||
48804539|NCT03362476|157126539|FG000|Overall Study|Withdrawal by Subject|0|||
48804540|NCT03362476|157126540|FG001|Overall Study|Withdrawal by Subject|1|||
48804541|NCT03108157|157126541|FG000|Overall Study|Protocol Violation|15|||
48804542|NCT03108157|157126542|FG001|Overall Study|Protocol Violation|4|||
48804543|NCT03287414|157126543|FG000|Treatment Epoch|Adverse Event|0|||
48804544|NCT03287414|157126544|FG001|Treatment Epoch|Adverse Event|1|||
48804545|NCT03287414|157126543|FG000|Treatment Epoch|Study terminated by sponsor|2|||
48804546|NCT03287414|157126544|FG001|Treatment Epoch|Study terminated by sponsor|2|||
49119139|NCT00105989|158274623|FG000|Acute - Open Label: Week 0-10|Physician Decision|0|||
49119140|NCT00105989|158274624|FG001|Acute - Open Label: Week 0-10|Physician Decision|0|||
49119141|NCT00105989|158274623|FG000|Acute - Open Label: Week 0-10|Death|1|||
49119142|NCT00105989|158274624|FG001|Acute - Open Label: Week 0-10|Death|0|||
49119143|NCT00105989|158274623|FG000|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
49119144|NCT00105989|158274624|FG001|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
49119145|NCT00105989|158274623|FG000|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
49119146|NCT00105989|158274624|FG001|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
49119147|NCT00105989|158274623|FG000|Continuation - Open Label:Week 10-34|Adverse Event|25|||
48708654|NCT00557856|156781026|FG006|Part 1: Dose Escalation Phase|global deterioration of health status|1|||
48708655|NCT00557856|156781027|FG007|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
48708656|NCT00557856|156781028|FG008|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
48708657|NCT00557856|156781020|FG000|Part 1: Dose Escalation Phase|randomized but not treated|2|||
48804547|NCT03287414|157126543|FG000|Treatment Epoch|Subject/Guardian decision|4|||
48804548|NCT03287414|157126544|FG001|Treatment Epoch|Subject/Guardian decision|0|||
48804549|NCT03287414|157126543|FG000|Treatment Epoch|"Discontinued early with reason other selected"|1|||
48804550|NCT03287414|157126544|FG001|Treatment Epoch|"Discontinued early with reason other selected"|1|||
48804551|NCT03287414|157126543|FG000|Treatment Epoch|Withdrawal by Subject|1|||
48804552|NCT03287414|157126544|FG001|Treatment Epoch|Withdrawal by Subject|0|||
49119148|NCT00105989|158274624|FG001|Continuation - Open Label:Week 10-34|Adverse Event|0|||
49119149|NCT00105989|158274623|FG000|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50|||
48708658|NCT00557856|156781021|FG001|Part 1: Dose Escalation Phase|randomized but not treated|0|||
48708659|NCT00557856|156781022|FG002|Part 1: Dose Escalation Phase|randomized but not treated|0|||
48708660|NCT00557856|156781023|FG003|Part 1: Dose Escalation Phase|randomized but not treated|0|||
48708661|NCT00557856|156781024|FG004|Part 1: Dose Escalation Phase|randomized but not treated|0|||
48708662|NCT00557856|156781025|FG005|Part 1: Dose Escalation Phase|randomized but not treated|0|||
48708663|NCT00557856|156781026|FG006|Part 1: Dose Escalation Phase|randomized but not treated|0|||
48708664|NCT00557856|156781027|FG007|Part 1: Dose Escalation Phase|randomized but not treated|0|||
48708665|NCT00557856|156781028|FG008|Part 1: Dose Escalation Phase|randomized but not treated|0|||
48708666|NCT00557856|156781020|FG000|Part 2: Exploratory Phase|objective progression or relapse|0|||
48708667|NCT00557856|156781021|FG001|Part 2: Exploratory Phase|objective progression or relapse|0|||
48915179|NCT04251910|157524795|FG003|Overall Study|Assisted living facility was closed|0|||
48915180|NCT04251910|157524796|FG004|Overall Study|Assisted living facility was closed|1|||
48915181|NCT04251910|157524797|FG005|Overall Study|Assisted living facility was closed|0|||
48915182|NCT00243386|157524798|FG000|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1|||
48915183|NCT00243386|157524799|FG001|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
48915184|NCT00243386|157524800|FG002|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
48915185|NCT00243386|157524798|FG000|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1|||
48915186|NCT00243386|157524799|FG001|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
48804553|NCT03287414|157126543|FG000|PD/Safety Follow-up Epoch|Lost to Follow-up|1|||
48804554|NCT03287414|157126544|FG001|PD/Safety Follow-up Epoch|Lost to Follow-up|0|||
48804555|NCT03287414|157126543|FG000|PD/Safety Follow-up Epoch|Subject/Guardian decision|1|||
48915187|NCT00243386|157524800|FG002|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
48915188|NCT00243386|157524798|FG000|On-Demand Regimen (Study Part 1)|Screen Failures|2|||
48915189|NCT00243386|157524799|FG001|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
48708668|NCT00557856|156781022|FG002|Part 2: Exploratory Phase|objective progression or relapse|0|||
48804556|NCT03287414|157126544|FG001|PD/Safety Follow-up Epoch|Subject/Guardian decision|0|||
48804557|NCT01301274|157126547|FG000|Overall Study|Physician Decision|2|||
48804558|NCT01301274|157126548|FG001|Overall Study|Physician Decision|1|||
48804559|NCT01314105|157126550|FG000|Overall Study|Progressive Disease|6|||
48804560|NCT01314105|157126551|FG001|Overall Study|Progressive Disease|10|||
48804561|NCT01314105|157126550|FG000|Overall Study|Refused to continue taking medication|0|||
48804562|NCT01314105|157126551|FG001|Overall Study|Refused to continue taking medication|1|||
48804563|NCT01314105|157126550|FG000|Overall Study|Other Adverse Event|1|||
48804564|NCT01314105|157126551|FG001|Overall Study|Other Adverse Event|1|||
48804565|NCT00112580|157126554|FG000|Overall Study|Adverse Event|1|||
48804566|NCT00112580|157126555|FG001|Overall Study|Adverse Event|2|||
48804567|NCT00112580|157126554|FG000|Overall Study|Disease progression|5|||
48804568|NCT00112580|157126555|FG001|Overall Study|Disease progression|16|||
48804569|NCT00112580|157126554|FG000|Overall Study|Participant withdrew consent|2|||
49119150|NCT00105989|158274624|FG001|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0|||
49119151|NCT00105989|158274623|FG000|Continuation - Open Label:Week 10-34|Lack of Efficacy|15|||
48804570|NCT00112580|157126555|FG001|Overall Study|Participant withdrew consent|1|||
48915190|NCT00243386|157524800|FG002|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
49119152|NCT00105989|158274624|FG001|Continuation - Open Label:Week 10-34|Lack of Efficacy|0|||
49119153|NCT00105989|158274623|FG000|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16|||
49119154|NCT00105989|158274624|FG001|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0|||
49119155|NCT00105989|158274623|FG000|Continuation - Open Label:Week 10-34|Protocol Violation|5|||
49119156|NCT00105989|158274624|FG001|Continuation - Open Label:Week 10-34|Protocol Violation|0|||
49119157|NCT00105989|158274623|FG000|Continuation - Open Label:Week 10-34|Lost to Follow-up|9|||
49119158|NCT00105989|158274624|FG001|Continuation - Open Label:Week 10-34|Lost to Follow-up|0|||
49119159|NCT00105989|158274623|FG000|Continuation - Open Label:Week 10-34|Physician Decision|3|||
49119160|NCT00105989|158274624|FG001|Continuation - Open Label:Week 10-34|Physician Decision|0|||
49119161|NCT00105989|158274623|FG000|Continuation - Open Label:Week 10-34|Death|0|||
49119162|NCT00105989|158274624|FG001|Continuation - Open Label:Week 10-34|Death|0|||
49119163|NCT00105989|158274623|FG000|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2|||
48915191|NCT00243386|157524798|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1|||
48915192|NCT00243386|157524799|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
48915193|NCT00243386|157524800|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
48915194|NCT00243386|157524798|FG000|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1|||
48915195|NCT00243386|157524799|FG001|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
48915196|NCT00243386|157524800|FG002|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
48915197|NCT00243386|157524798|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1|||
48915198|NCT00243386|157524799|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
48708669|NCT00557856|156781023|FG003|Part 2: Exploratory Phase|objective progression or relapse|0|||
48708670|NCT00557856|156781024|FG004|Part 2: Exploratory Phase|objective progression or relapse|0|||
48708671|NCT00557856|156781025|FG005|Part 2: Exploratory Phase|objective progression or relapse|0|||
48708672|NCT00557856|156781026|FG006|Part 2: Exploratory Phase|objective progression or relapse|0|||
48708673|NCT00557856|156781027|FG007|Part 2: Exploratory Phase|objective progression or relapse|0|||
48708674|NCT00557856|156781028|FG008|Part 2: Exploratory Phase|objective progression or relapse|15|||
48708675|NCT00557856|156781020|FG000|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
48708676|NCT00557856|156781021|FG001|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
48708677|NCT00557856|156781022|FG002|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
48708678|NCT00557856|156781023|FG003|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
48708679|NCT00557856|156781024|FG004|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
48708680|NCT00557856|156781025|FG005|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
48708681|NCT00557856|156781026|FG006|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
48708682|NCT00557856|156781027|FG007|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
48708683|NCT00557856|156781028|FG008|Part 2: Exploratory Phase|Withdrawal by Subject|1|||
48708684|NCT00557856|156781020|FG000|Part 2: Exploratory Phase|Adverse Event|0|||
48708685|NCT00557856|156781021|FG001|Part 2: Exploratory Phase|Adverse Event|0|||
48708686|NCT00557856|156781022|FG002|Part 2: Exploratory Phase|Adverse Event|0|||
48708687|NCT00557856|156781023|FG003|Part 2: Exploratory Phase|Adverse Event|0|||
48708688|NCT00557856|156781024|FG004|Part 2: Exploratory Phase|Adverse Event|0|||
48708689|NCT00557856|156781025|FG005|Part 2: Exploratory Phase|Adverse Event|0|||
48708690|NCT00557856|156781026|FG006|Part 2: Exploratory Phase|Adverse Event|0|||
48915199|NCT00243386|157524800|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
48804571|NCT03118518|157126558|FG000|Overall Study|Early Exit after treatment|2|||
48804572|NCT03118518|157126559|FG001|Overall Study|Early Exit after treatment|8|||
48804573|NCT03118518|157126558|FG000|Overall Study|Early Exit after randomization but prior to treatment|4|||
48804574|NCT03118518|157126559|FG001|Overall Study|Early Exit after randomization but prior to treatment|3|||
48804575|NCT03812614|157126560|FG000|Intervention|Withdrawal by Subject|7|||
48804576|NCT03812614|157126561|FG001|Intervention|Withdrawal by Subject|2|||
48804577|NCT03812614|157126562|FG002|Intervention|Withdrawal by Subject|7|||
48804578|NCT03812614|157126563|FG003|Intervention|Withdrawal by Subject|2|||
48804579|NCT03812614|157126560|FG000|Intervention|Patient declined to participate in the introductory session intervention|1|||
48804580|NCT03812614|157126561|FG001|Intervention|Patient declined to participate in the introductory session intervention|5|||
48804581|NCT03812614|157126562|FG002|Intervention|Patient declined to participate in the introductory session intervention|11|||
49119164|NCT00105989|158274624|FG001|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0|||
49119165|NCT00105989|158274623|FG000|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
49119166|NCT00105989|158274624|FG001|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
49119167|NCT00105989|158274623|FG000|Maintenance - Double-Blind:Week 34-86|Adverse Event|6|||
49119168|NCT00105989|158274624|FG001|Maintenance - Double-Blind:Week 34-86|Adverse Event|3|||
49119169|NCT00105989|158274623|FG000|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17|||
49119170|NCT00105989|158274624|FG001|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18|||
49119171|NCT00105989|158274623|FG000|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
49119172|NCT00105989|158274624|FG001|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
49119173|NCT00105989|158274623|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
49119174|NCT00105989|158274624|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
49119175|NCT00105989|158274623|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5|||
49119176|NCT00105989|158274624|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4|||
49119177|NCT00105989|158274623|FG000|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4|||
49119178|NCT00105989|158274624|FG001|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0|||
49119179|NCT00105989|158274623|FG000|Maintenance - Double-Blind:Week 34-86|Physician Decision|4|||
49119180|NCT00105989|158274624|FG001|Maintenance - Double-Blind:Week 34-86|Physician Decision|1|||
48804582|NCT03812614|157126563|FG003|Intervention|Patient declined to participate in the introductory session intervention|86|||
48804583|NCT03812614|157126560|FG000|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|23|||
48804584|NCT03812614|157126561|FG001|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|20|||
48804585|NCT03812614|157126562|FG002|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
48804586|NCT03812614|157126563|FG003|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
48804587|NCT03812614|157126560|FG000|6-month Follow-up|Lost to Follow-up|0|||
48804588|NCT03812614|157126561|FG001|6-month Follow-up|Lost to Follow-up|0|||
48804589|NCT03812614|157126562|FG002|6-month Follow-up|Lost to Follow-up|12|||
48804590|NCT03812614|157126563|FG003|6-month Follow-up|Lost to Follow-up|8|||
48804591|NCT03812614|157126560|FG000|12-month Follow-up|Lost to Follow-up|18|||
48804592|NCT03812614|157126561|FG001|12-month Follow-up|Lost to Follow-up|17|||
48804593|NCT03812614|157126562|FG002|12-month Follow-up|Lost to Follow-up|5|||
48804594|NCT03812614|157126563|FG003|12-month Follow-up|Lost to Follow-up|2|||
48804595|NCT03459846|157126564|FG000|Overall Study|Death|52|||
48804596|NCT03459846|157126565|FG001|Overall Study|Death|46|||
48804597|NCT03459846|157126564|FG000|Overall Study|Study terminated by sponsor|24|||
48804598|NCT03459846|157126565|FG001|Overall Study|Study terminated by sponsor|28|||
48804599|NCT03459846|157126564|FG000|Overall Study|Withdrawal by Subject|2|||
48804600|NCT03459846|157126565|FG001|Overall Study|Withdrawal by Subject|2|||
48804601|NCT02228967|157127861|FG000|Overall Study|Lost to Follow-up|146|||
48804602|NCT02228967|157127862|FG001|Overall Study|Lost to Follow-up|142|||
48804603|NCT02228967|157127861|FG000|Overall Study|Withdrawal by Subject|13|||
48804604|NCT02228967|157127862|FG001|Overall Study|Withdrawal by Subject|18|||
48804605|NCT03625882|157127863|FG000|Overall Study|Protocol Violation|3|||
48804606|NCT01264380|157127866|FG000|Period C|Disease Progression|0|||
48804607|NCT01264380|157127867|FG001|Period C|Disease Progression|0|||
48804608|NCT01264380|157127868|FG002|Period C|Disease Progression|4|||
48804609|NCT01264380|157127866|FG000|Period C|Death|0|||
48804610|NCT01264380|157127867|FG001|Period C|Death|0|||
48804611|NCT01264380|157127868|FG002|Period C|Death|2|||
48804612|NCT01264380|157127866|FG000|Period C|Follow-up for survival status|0|||
48804613|NCT01264380|157127867|FG001|Period C|Follow-up for survival status|0|||
48804614|NCT01264380|157127868|FG002|Period C|Follow-up for survival status|6|||
48804615|NCT01264380|157127866|FG000|Period C|Withdrawal by Subject|0|||
49119181|NCT00105989|158274623|FG000|Maintenance - Double-Blind:Week 34-86|Death|0|||
49119182|NCT00105989|158274624|FG001|Maintenance - Double-Blind:Week 34-86|Death|0|||
49119183|NCT00105989|158274623|FG000|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14|||
48804616|NCT01264380|157127867|FG001|Period C|Withdrawal by Subject|0|||
48804617|NCT01264380|157127868|FG002|Period C|Withdrawal by Subject|1|||
48915200|NCT00243386|157524798|FG000|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
48915201|NCT00243386|157524799|FG001|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2|||
48915202|NCT00243386|157524800|FG002|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
48915203|NCT00243386|157524798|FG000|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
48915204|NCT00243386|157524799|FG001|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1|||
48915205|NCT00243386|157524800|FG002|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
48915206|NCT04037748|157524801|FG000|Treatment Period 1|Withdrawal by Subject|3|||
48915207|NCT04037748|157524802|FG001|Treatment Period 1|Withdrawal by Subject|0|||
48915208|NCT04037748|157524801|FG000|Treatment Period 1|Adverse Event|1|||
48915209|NCT04037748|157524802|FG001|Treatment Period 1|Adverse Event|1|||
48915210|NCT04037748|157524801|FG000|Treatment Period 1|Protocol Violation|4|||
48915211|NCT04037748|157524802|FG001|Treatment Period 1|Protocol Violation|5|||
48915212|NCT04037748|157524801|FG000|Treatment Period 2|Adverse Event|0|||
48915213|NCT04037748|157524802|FG001|Treatment Period 2|Adverse Event|1|||
48915214|NCT04037748|157524801|FG000|Treatment Period 2|Protocol Violation|2|||
48915215|NCT04037748|157524802|FG001|Treatment Period 2|Protocol Violation|0|||
48915216|NCT02663453|157524803|FG000|Overall Study|Death|4|||
48915217|NCT02663453|157524804|FG001|Overall Study|Death|4|||
48915218|NCT02663453|157524803|FG000|Overall Study|Withdrawal by Subject|1|||
49119184|NCT00105989|158274624|FG001|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43|||
49119185|NCT00105989|158274623|FG000|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
49119186|NCT00105989|158274624|FG001|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
49119187|NCT00613366|158274625|FG000|Overall Study|Withdrawal by Subject|3|||
49119188|NCT00613366|158274626|FG001|Overall Study|Withdrawal by Subject|2|||
49119189|NCT01673984|158274627|FG000|Overall Study|Adverse Event|1|||
49119190|NCT01673984|158274628|FG001|Overall Study|Adverse Event|0|||
49119191|NCT01673984|158274627|FG000|Overall Study|Study termination|9|||
49119192|NCT01673984|158274628|FG001|Overall Study|Study termination|6|||
49119193|NCT00943592|158274629|FG000|Overall Study|Death|3|||
49119194|NCT00878800|158274630|FG000|Overall Study|Adverse Event|0|||
49119195|NCT00878800|158274631|FG001|Overall Study|Adverse Event|0|||
49119196|NCT00878800|158274632|FG002|Overall Study|Adverse Event|2|||
49119197|NCT00878800|158274633|FG003|Overall Study|Adverse Event|0|||
49119198|NCT00878800|158274634|FG004|Overall Study|Adverse Event|1|||
49119199|NCT00878800|158274630|FG000|Overall Study|Progressive disease|1|||
49119200|NCT00878800|158274631|FG001|Overall Study|Progressive disease|5|||
49119201|NCT00878800|158274632|FG002|Overall Study|Progressive disease|6|||
49119202|NCT00878800|158274633|FG003|Overall Study|Progressive disease|5|||
49119203|NCT00878800|158274634|FG004|Overall Study|Progressive disease|13|||
49119204|NCT00878800|158274630|FG000|Overall Study|Withdrew consent|1|||
49119205|NCT00878800|158274631|FG001|Overall Study|Withdrew consent|1|||
49119206|NCT00878800|158274632|FG002|Overall Study|Withdrew consent|0|||
49119207|NCT00878800|158274633|FG003|Overall Study|Withdrew consent|1|||
49119208|NCT00878800|158274634|FG004|Overall Study|Withdrew consent|1|||
49119209|NCT00878800|158274630|FG000|Overall Study|Death|0|||
49119210|NCT00878800|158274631|FG001|Overall Study|Death|0|||
49119211|NCT00878800|158274632|FG002|Overall Study|Death|1|||
49119212|NCT00878800|158274633|FG003|Overall Study|Death|0|||
49119213|NCT00878800|158274634|FG004|Overall Study|Death|0|||
49119214|NCT00878800|158274630|FG000|Overall Study|Other|1|||
49119215|NCT00878800|158274631|FG001|Overall Study|Other|1|||
49119216|NCT00878800|158274632|FG002|Overall Study|Other|0|||
49119217|NCT00878800|158274633|FG003|Overall Study|Other|0|||
49119218|NCT00878800|158274634|FG004|Overall Study|Other|1|||
49119219|NCT01152996|158274635|FG000|Overall Study|Withdrawal by Subject|142|||
49119220|NCT01152996|158274635|FG000|Overall Study|Adverse Event|115|||
49119221|NCT01152996|158274635|FG000|Overall Study|Lost to Follow-up|112|||
48708691|NCT00557856|156781027|FG007|Part 2: Exploratory Phase|Adverse Event|0|||
49119222|NCT01152996|158274635|FG000|Overall Study|Lack of Efficacy|68|||
49119223|NCT01152996|158274635|FG000|Overall Study|Noncompliance|41|||
49119224|NCT01152996|158274635|FG000|Overall Study|Other|36|||
49119225|NCT01152996|158274635|FG000|Overall Study|Protocol Violation|22|||
49119226|NCT01152996|158274635|FG000|Overall Study|Elevated liver enzymes|1|||
49119227|NCT01768559|158274636|FG000|Overall Study|Randomized but not treated|0|||
49119228|NCT01768559|158274637|FG001|Overall Study|Randomized but not treated|0|||
49119229|NCT01768559|158274638|FG002|Overall Study|Randomized but not treated|1|||
49119230|NCT01768559|158274636|FG000|Overall Study|Adverse Event|15|||
48915219|NCT02663453|157524804|FG001|Overall Study|Withdrawal by Subject|0|||
48915220|NCT01087775|157524807|FG000|Overall Study|failed inclusion criteria|2|||
48915221|NCT05289570|157524813|FG000|Overall Study|Physician Decision|1|||
49119231|NCT01768559|158274637|FG001|Overall Study|Adverse Event|2|||
49119232|NCT01768559|158274638|FG002|Overall Study|Adverse Event|5|||
49119233|NCT01768559|158274636|FG000|Overall Study|Lack of Efficacy|6|||
49119234|NCT01768559|158274637|FG001|Overall Study|Lack of Efficacy|4|||
49119235|NCT01768559|158274638|FG002|Overall Study|Lack of Efficacy|0|||
49119236|NCT01768559|158274636|FG000|Overall Study|Poor compliance to protocol|0|||
49119237|NCT01768559|158274637|FG001|Overall Study|Poor compliance to protocol|3|||
49119238|NCT01768559|158274638|FG002|Overall Study|Poor compliance to protocol|2|||
48708692|NCT00557856|156781028|FG008|Part 2: Exploratory Phase|Adverse Event|4|||
48708693|NCT00557856|156781020|FG000|Part 2: Exploratory Phase|Other|0|||
48708694|NCT00557856|156781021|FG001|Part 2: Exploratory Phase|Other|0|||
48708695|NCT00557856|156781022|FG002|Part 2: Exploratory Phase|Other|0|||
48804618|NCT01264380|157127866|FG000|Period C|Adverse Event|0|||
48804619|NCT01264380|157127867|FG001|Period C|Adverse Event|0|||
48804620|NCT01264380|157127868|FG002|Period C|Adverse Event|1|||
48708696|NCT00557856|156781023|FG003|Part 2: Exploratory Phase|Other|0|||
48708697|NCT00557856|156781024|FG004|Part 2: Exploratory Phase|Other|0|||
48708698|NCT00557856|156781025|FG005|Part 2: Exploratory Phase|Other|0|||
48708699|NCT00557856|156781026|FG006|Part 2: Exploratory Phase|Other|0|||
48708700|NCT00557856|156781027|FG007|Part 2: Exploratory Phase|Other|0|||
48708701|NCT00557856|156781028|FG008|Part 2: Exploratory Phase|Other|1|||
48708702|NCT00557856|156781020|FG000|Part 2: Exploratory Phase|Death|0|||
48708703|NCT00557856|156781021|FG001|Part 2: Exploratory Phase|Death|0|||
48708704|NCT00557856|156781022|FG002|Part 2: Exploratory Phase|Death|0|||
48915222|NCT04544475|157524814|FG000|Overall Study|Withdrawal by Subject|1|||
48708705|NCT00557856|156781023|FG003|Part 2: Exploratory Phase|Death|0|||
48708706|NCT00557856|156781024|FG004|Part 2: Exploratory Phase|Death|0|||
49010699|NCT02123459|157875678|FG000|Washout Period (1 Day)|Adverse Event|1|||
48708707|NCT00557856|156781025|FG005|Part 2: Exploratory Phase|Death|0|||
48708708|NCT00557856|156781026|FG006|Part 2: Exploratory Phase|Death|0|||
48708709|NCT00557856|156781027|FG007|Part 2: Exploratory Phase|Death|0|||
48708710|NCT00557856|156781028|FG008|Part 2: Exploratory Phase|Death|2|||
48708711|NCT00557856|156781020|FG000|Part 2: Exploratory Phase|global deterioration of health status|0|||
48804621|NCT02563002|157127869|FG000|Overall Study|Death|72|||
48708712|NCT00557856|156781021|FG001|Part 2: Exploratory Phase|global deterioration of health status|0|||
48708713|NCT00557856|156781022|FG002|Part 2: Exploratory Phase|global deterioration of health status|0|||
48708714|NCT00557856|156781023|FG003|Part 2: Exploratory Phase|global deterioration of health status|0|||
48708715|NCT00557856|156781024|FG004|Part 2: Exploratory Phase|global deterioration of health status|0|||
48708716|NCT00557856|156781025|FG005|Part 2: Exploratory Phase|global deterioration of health status|0|||
48708717|NCT00557856|156781026|FG006|Part 2: Exploratory Phase|global deterioration of health status|0|||
48708718|NCT00557856|156781027|FG007|Part 2: Exploratory Phase|global deterioration of health status|0|||
48708719|NCT00557856|156781028|FG008|Part 2: Exploratory Phase|global deterioration of health status|1|||
48708720|NCT00802945|156781029|FG000|Overall Study|Death|27|||
48708721|NCT00802945|156781030|FG001|Overall Study|Death|23|||
48708722|NCT00802945|156781029|FG000|Overall Study|Terminated by sponsor|8|||
48708723|NCT00802945|156781030|FG001|Overall Study|Terminated by sponsor|12|||
48708724|NCT01442103|156782182|FG000|Overall Study|Lost to Follow-up|2|||
48708725|NCT01671319|156782184|FG000|Overall Study|Withdrawal by Subject|1|||
48708726|NCT01677377|156782189|FG000|Overall Study|Protocol Violation|1|||
48708727|NCT01677377|156782190|FG001|Overall Study|Protocol Violation|0|||
48708728|NCT01677377|156782191|FG002|Overall Study|Protocol Violation|0|||
49119239|NCT01768559|158274636|FG000|Overall Study|Other than specified|9|||
49119240|NCT01768559|158274637|FG001|Overall Study|Other than specified|8|||
49119241|NCT01768559|158274638|FG002|Overall Study|Other than specified|5|||
49119242|NCT03146741|158274644|FG000|Overall Study|Txp with non-HCV+ heart|4|||
49119243|NCT03146741|158274644|FG000|Overall Study|Listeted for MOT|2|||
49119244|NCT03146741|158274644|FG000|Overall Study|Physician Decision|2|||
49119245|NCT03146741|158274644|FG000|Overall Study|Awaiting txp|2|||
48708729|NCT01677377|156782189|FG000|Overall Study|Lost to Follow-up|0|||
48708730|NCT01677377|156782190|FG001|Overall Study|Lost to Follow-up|1|||
48708731|NCT01677377|156782191|FG002|Overall Study|Lost to Follow-up|1|||
48708732|NCT01677377|156782189|FG000|Overall Study|Withdrawal by Subject|0|||
48708733|NCT01677377|156782190|FG001|Overall Study|Withdrawal by Subject|0|||
48708734|NCT01677377|156782191|FG002|Overall Study|Withdrawal by Subject|3|||
49119246|NCT01421641|158274645|FG000|Overall Study|Protocol Violation|2|||
49119247|NCT01421641|158274646|FG001|Overall Study|Protocol Violation|2|||
49119248|NCT02420119|158274650|FG000|Overall Study|insufficient laboratory data|5|||
48915223|NCT04544475|157524815|FG001|Overall Study|Withdrawal by Subject|3|||
48915224|NCT00501007|157524819|FG000|Overall Study|Inclusion criteria not met.|29|||
48915225|NCT00501007|157524820|FG001|Overall Study|Inclusion criteria not met.|25|||
48915226|NCT00450723|157524825|FG000|Overall Study|Physician Decision|5|||
48915227|NCT03610724|157524826|FG000|Overall Study|Death|17|||
48915228|NCT03610724|157524826|FG000|Overall Study|Lost to Follow-up|1|||
48915229|NCT03610724|157524826|FG000|Overall Study|Physician Decision|1|||
48915230|NCT03610724|157524826|FG000|Overall Study|Died prior to infusion|1|||
48915231|NCT01840579|157524834|FG000|Overall Study|Status not recorded|0|||
48915232|NCT01840579|157524835|FG001|Overall Study|Status not recorded|0|||
48915233|NCT01840579|157524836|FG002|Overall Study|Status not recorded|2|||
48915234|NCT01840579|157524837|FG003|Overall Study|Status not recorded|3|||
48915235|NCT01840579|157524838|FG004|Overall Study|Status not recorded|4|||
48915236|NCT01840579|157524839|FG005|Overall Study|Status not recorded|3|||
48915237|NCT01840579|157524840|FG006|Overall Study|Status not recorded|0|||
48915238|NCT01840579|157524841|FG007|Overall Study|Status not recorded|3|||
48915239|NCT01840579|157524842|FG008|Overall Study|Status not recorded|3|||
48915240|NCT01840579|157524843|FG009|Overall Study|Status not recorded|3|||
48915241|NCT01840579|157524834|FG000|Overall Study|Progressive disease|3|||
48915242|NCT01840579|157524835|FG001|Overall Study|Progressive disease|5|||
48915243|NCT01840579|157524836|FG002|Overall Study|Progressive disease|0|||
48915244|NCT01840579|157524837|FG003|Overall Study|Progressive disease|0|||
48915245|NCT01840579|157524838|FG004|Overall Study|Progressive disease|0|||
48708735|NCT01677377|156782189|FG000|Overall Study|Lack of Efficacy|0|||
48708736|NCT01677377|156782190|FG001|Overall Study|Lack of Efficacy|0|||
48708737|NCT01677377|156782191|FG002|Overall Study|Lack of Efficacy|1|||
48708738|NCT01677377|156782189|FG000|Overall Study|Pregnancy|0|||
48708739|NCT01677377|156782190|FG001|Overall Study|Pregnancy|0|||
48708740|NCT01677377|156782191|FG002|Overall Study|Pregnancy|1|||
48708741|NCT01712399|156782196|FG000|Overall Study|Lost to Follow-up|1|||
48708742|NCT01712399|156782196|FG000|Overall Study|Withdrawal by Subject|39|||
48708743|NCT01712399|156782196|FG000|Overall Study|Death|1|||
48708744|NCT01712399|156782196|FG000|Overall Study|Adverse Event|11|||
48708745|NCT01712399|156782196|FG000|Overall Study|Study closure|345|||
48708746|NCT01227018|156782197|FG000|Overall Study|Disease progression|9|||
48708747|NCT01227018|156782197|FG000|Overall Study|Toxicity|2|||
48708748|NCT01227018|156782197|FG000|Overall Study|Withdrew after beginning treatment|4|||
48708749|NCT02136069|156782209|FG000|Overall Study|UC flare-up|1|||
48708750|NCT02136069|156782210|FG001|Overall Study|UC flare-up|0|||
48708751|NCT02136069|156782209|FG000|Overall Study|Adverse Event|6|||
48708752|NCT02136069|156782210|FG001|Overall Study|Adverse Event|8|||
48708753|NCT02136069|156782209|FG000|Overall Study|Death|0|||
48708754|NCT02136069|156782210|FG001|Overall Study|Death|1|||
48708755|NCT02136069|156782209|FG000|Overall Study|Lack of Efficacy|10|||
48708756|NCT02136069|156782210|FG001|Overall Study|Lack of Efficacy|4|||
48708757|NCT02136069|156782209|FG000|Overall Study|Lost to Follow-up|1|||
48708758|NCT02136069|156782210|FG001|Overall Study|Lost to Follow-up|0|||
48708759|NCT02136069|156782209|FG000|Overall Study|Non-Compliance|1|||
48708760|NCT02136069|156782210|FG001|Overall Study|Non-Compliance|0|||
48708761|NCT02136069|156782209|FG000|Overall Study|Physician Decision|5|||
48708762|NCT02136069|156782210|FG001|Overall Study|Physician Decision|4|||
48708763|NCT02136069|156782209|FG000|Overall Study|Withdrawal by Subject|10|||
48708764|NCT02136069|156782210|FG001|Overall Study|Withdrawal by Subject|11|||
48708765|NCT04041414|156782211|FG000|Overall Study|Lost to Follow-up|1|||
48708766|NCT04041414|156782212|FG001|Overall Study|Lost to Follow-up|2|||
48708767|NCT00774566|156782213|FG000|Overall Study|Protocol Violation|18|||
48708768|NCT00774566|156782214|FG001|Overall Study|Protocol Violation|15|||
48708769|NCT00499083|156782215|FG000|Overall Study|Not evaluable|3|||
48708770|NCT00594815|156782218|FG000|Overall Study|Never Treated|3|||
48708771|NCT00594815|156782218|FG000|Overall Study|Withdrawal by Subject|2|||
48708772|NCT00594815|156782218|FG000|Overall Study|Toxicity|4|||
48708773|NCT03214666|156782219|FG000|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
48708774|NCT03214666|156782220|FG001|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
48708775|NCT03214666|156782221|FG002|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
48708776|NCT03214666|156782222|FG003|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
48708777|NCT03214666|156782223|FG004|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|1|||
48708778|NCT03214666|156782224|FG005|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
48708779|NCT00526071|156782225|FG000|Overall Study|Adverse Event|1|||
48708780|NCT00526071|156782225|FG000|Overall Study|Withdrawal by Subject|1|||
48708781|NCT00526071|156782225|FG000|Overall Study|Lack of Response to Study Drug|4|||
48915246|NCT01840579|157524839|FG005|Overall Study|Progressive disease|0|||
48915247|NCT01840579|157524840|FG006|Overall Study|Progressive disease|0|||
48915248|NCT01840579|157524841|FG007|Overall Study|Progressive disease|0|||
48915249|NCT01840579|157524842|FG008|Overall Study|Progressive disease|0|||
48708782|NCT05300763|156782228|FG000|Overall Study|Adverse Event|0|||
48708783|NCT05300763|156782229|FG001|Overall Study|Adverse Event|1|||
48708784|NCT05300763|156782228|FG000|Overall Study|Major Protocol Deviation|1|||
48708785|NCT05300763|156782229|FG001|Overall Study|Major Protocol Deviation|0|||
48708786|NCT05300763|156782228|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
48708787|NCT05300763|156782229|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
48708788|NCT00975780|156782232|FG000|Follow Up|Death|88|||
48708789|NCT00975780|156782233|FG001|Follow Up|Death|122|||
48708790|NCT00975780|156782232|FG000|Follow Up|Facility Withdrawal|7|||
48708791|NCT00975780|156782233|FG001|Follow Up|Facility Withdrawal|23|||
48708792|NCT00975780|156782232|FG000|Follow Up|Discharged from Facility|7|||
48708793|NCT00975780|156782233|FG001|Follow Up|Discharged from Facility|12|||
48708794|NCT02625909|156782234|FG000|Overall Study|Death|2|||
48708795|NCT02625909|156782235|FG001|Overall Study|Death|0|||
48804622|NCT02563002|157127870|FG001|Overall Study|Death|87|||
48708796|NCT02625909|156782234|FG000|Overall Study|Lost to Follow-up|3|||
48708797|NCT02625909|156782235|FG001|Overall Study|Lost to Follow-up|5|||
48708798|NCT02625909|156782234|FG000|Overall Study|Lack of Efficacy|9|||
48708799|NCT02625909|156782235|FG001|Overall Study|Lack of Efficacy|2|||
48708800|NCT02625909|156782234|FG000|Overall Study|Reinfection|3|||
48915250|NCT01840579|157524843|FG009|Overall Study|Progressive disease|0|||
48708801|NCT02625909|156782235|FG001|Overall Study|Reinfection|2|||
48708802|NCT00889720|156782240|FG000|Overall Study|Withdrawal by Subject|4|||
48708803|NCT00889720|156782240|FG000|Overall Study|Other|4|||
48708804|NCT01339052|156782241|FG000|Overall Study|Disease progression|13|||
48708805|NCT01339052|156782242|FG001|Overall Study|Disease progression|46|||
48708806|NCT01339052|156782241|FG000|Overall Study|Adverse Event|1|||
48708807|NCT01339052|156782242|FG001|Overall Study|Adverse Event|1|||
48708808|NCT01339052|156782241|FG000|Overall Study|Withdrawal by Subject|0|||
48708809|NCT01339052|156782242|FG001|Overall Study|Withdrawal by Subject|3|||
48708810|NCT01339052|156782241|FG000|Overall Study|Physician Decision|1|||
48708811|NCT01339052|156782242|FG001|Overall Study|Physician Decision|0|||
48708812|NCT03566485|156782244|FG000|Overall Study|Disease progression|5|||
48708813|NCT03566485|156782245|FG001|Overall Study|Disease progression|4|||
48708814|NCT03566485|156782244|FG000|Overall Study|Clinical progression|0|||
48708815|NCT03566485|156782245|FG001|Overall Study|Clinical progression|1|||
48708816|NCT03566485|156782244|FG000|Overall Study|Toxicity|0|||
48708817|NCT03566485|156782245|FG001|Overall Study|Toxicity|2|||
48708818|NCT03241368|156782246|FG000|Overall Study|MRE Stricture or Patency Capsule Failure|25|||
48708819|NCT03241368|156782246|FG000|Overall Study|Lost to Follow-up|1|||
48708820|NCT03241368|156782246|FG000|Overall Study|Physician Decision|6|||
48708821|NCT03241368|156782246|FG000|Overall Study|Withdrawal by Subject|6|||
48708822|NCT03241368|156782246|FG000|Overall Study|Protocol Violation|1|||
48708823|NCT00787267|156782248|FG000|Overall Study|Screen failure/Ineligible|10|||
48708824|NCT00787267|156782248|FG000|Overall Study|No Reason Provided|1|||
48708825|NCT00787267|156782248|FG000|Overall Study|Withdrawal by Subject|1|||
48708826|NCT00981058|156782249|FG000|Overall Study|Adverse Event|1|||
48915251|NCT01840579|157524834|FG000|Overall Study|Ongoing in study|0|||
48915252|NCT01840579|157524835|FG001|Overall Study|Ongoing in study|1|||
48915253|NCT01840579|157524836|FG002|Overall Study|Ongoing in study|0|||
48915254|NCT01840579|157524837|FG003|Overall Study|Ongoing in study|0|||
48915255|NCT01840579|157524838|FG004|Overall Study|Ongoing in study|0|||
48915256|NCT01840579|157524839|FG005|Overall Study|Ongoing in study|0|||
48915257|NCT01840579|157524840|FG006|Overall Study|Ongoing in study|0|||
48915258|NCT01840579|157524841|FG007|Overall Study|Ongoing in study|0|||
48915259|NCT01840579|157524842|FG008|Overall Study|Ongoing in study|0|||
48915260|NCT01840579|157524843|FG009|Overall Study|Ongoing in study|0|||
49010700|NCT02123459|157875679|FG001|Washout Period (1 Day)|Adverse Event|0|||
48708827|NCT00981058|156782250|FG001|Overall Study|Adverse Event|1|||
48708828|NCT00981058|156782249|FG000|Overall Study|Progressive Disease|61|||
48708829|NCT00981058|156782250|FG001|Overall Study|Progressive Disease|49|||
48708830|NCT00981058|156782249|FG000|Overall Study|Lost to Follow-up|16|||
48708831|NCT00981058|156782250|FG001|Overall Study|Lost to Follow-up|15|||
48708832|NCT00981058|156782249|FG000|Overall Study|New Anticancer Therapy|6|||
48915261|NCT01840579|157524834|FG000|Overall Study|Death|0|||
48915262|NCT01840579|157524835|FG001|Overall Study|Death|0|||
48915263|NCT01840579|157524836|FG002|Overall Study|Death|0|||
48804623|NCT02563002|157127869|FG000|Overall Study|Lost to Follow-up|5|||
48804624|NCT02563002|157127870|FG001|Overall Study|Lost to Follow-up|0|||
48804625|NCT02563002|157127869|FG000|Overall Study|Physician Decision|0|||
48804626|NCT02563002|157127870|FG001|Overall Study|Physician Decision|2|||
48804627|NCT02563002|157127869|FG000|Overall Study|Withdrawal by Subject|2|||
48804628|NCT02563002|157127870|FG001|Overall Study|Withdrawal by Subject|10|||
48804629|NCT02563002|157127869|FG000|Overall Study|Sponsor decision|74|||
48804630|NCT02563002|157127870|FG001|Overall Study|Sponsor decision|55|||
48804631|NCT02013388|157127871|FG000|Overall Study|work emergency|1|||
48804632|NCT02013388|157127872|FG001|Overall Study|work emergency|0|||
48804633|NCT02013388|157127873|FG002|Overall Study|work emergency|0|||
48804634|NCT02013388|157127874|FG003|Overall Study|work emergency|0|||
48804635|NCT02013388|157127875|FG004|Overall Study|work emergency|1|||
48804636|NCT02013388|157127876|FG005|Overall Study|work emergency|0|||
48804637|NCT02013388|157127877|FG006|Overall Study|work emergency|0|||
48804638|NCT02013388|157127878|FG007|Overall Study|work emergency|0|||
48804639|NCT04207840|157127879|FG000|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
48804640|NCT04207840|157127880|FG001|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
48804641|NCT04207840|157127881|FG002|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1|||
48804642|NCT04207840|157127879|FG000|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
48804643|NCT04207840|157127880|FG001|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
48804644|NCT04207840|157127881|FG002|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1|||
48804645|NCT05382936|157127884|FG000|Overall Study|Progressive Disease|3|||
48804646|NCT05382936|157127885|FG001|Overall Study|Progressive Disease|5|||
48804647|NCT05382936|157127886|FG002|Overall Study|Progressive Disease|2|||
48804648|NCT05382936|157127887|FG003|Overall Study|Progressive Disease|5|||
48804649|NCT05382936|157127884|FG000|Overall Study|Adverse Event|0|||
48804650|NCT05382936|157127885|FG001|Overall Study|Adverse Event|1|||
48804651|NCT05382936|157127886|FG002|Overall Study|Adverse Event|1|||
48804652|NCT05382936|157127887|FG003|Overall Study|Adverse Event|0|||
48804653|NCT05382936|157127884|FG000|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
48804654|NCT05382936|157127885|FG001|Overall Study|Deteriorated Performance Status. Unlikely Benefit|1|||
48804655|NCT05382936|157127886|FG002|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
48804656|NCT05382936|157127887|FG003|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
48804657|NCT05382936|157127884|FG000|Overall Study|Withdrawal by Subject|0|||
48804658|NCT05382936|157127885|FG001|Overall Study|Withdrawal by Subject|0|||
48804659|NCT05382936|157127886|FG002|Overall Study|Withdrawal by Subject|1|||
48804660|NCT05382936|157127887|FG003|Overall Study|Withdrawal by Subject|1|||
48804661|NCT00215540|157127898|FG000|Overall Study|Withdrew from study medication|1|||
48804662|NCT00215540|157127899|FG001|Overall Study|Withdrew from study medication|0|||
48804663|NCT00215540|157127900|FG002|Overall Study|Withdrew from study medication|0|||
48804664|NCT03145766|157127901|FG000|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
48804665|NCT03145766|157127902|FG001|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
48804666|NCT03145766|157127903|FG002|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0|||
48804667|NCT03145766|157127904|FG003|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
48804668|NCT03145766|157127905|FG004|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2|||
48804669|NCT03145766|157127901|FG000|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
48804670|NCT03145766|157127902|FG001|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
48804671|NCT03145766|157127903|FG002|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
48804672|NCT03145766|157127904|FG003|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2|||
48804673|NCT03145766|157127905|FG004|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
48804674|NCT03145766|157127901|FG000|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
48915264|NCT01840579|157524837|FG003|Overall Study|Death|0|||
48915265|NCT01840579|157524838|FG004|Overall Study|Death|0|||
48915266|NCT01840579|157524839|FG005|Overall Study|Death|1|||
48915267|NCT01840579|157524840|FG006|Overall Study|Death|0|||
48915268|NCT01840579|157524841|FG007|Overall Study|Death|0|||
49119249|NCT00837967|158274651|FG000|Washout Period of 7 - 14 Days|Adverse Event|2|||
48804675|NCT03145766|157127902|FG001|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
48804676|NCT03145766|157127903|FG002|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
48804677|NCT03145766|157127904|FG003|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3|||
48804678|NCT03145766|157127905|FG004|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
48915269|NCT01840579|157524842|FG008|Overall Study|Death|0|||
48915270|NCT01840579|157524843|FG009|Overall Study|Death|0|||
48915271|NCT01840579|157524834|FG000|Overall Study|Adverse Event|0|||
48804679|NCT03145766|157127901|FG000|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4|||
48915272|NCT01840579|157524835|FG001|Overall Study|Adverse Event|1|||
48804680|NCT03145766|157127902|FG001|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
48915273|NCT01840579|157524836|FG002|Overall Study|Adverse Event|0|||
48915274|NCT01840579|157524837|FG003|Overall Study|Adverse Event|0|||
49119250|NCT00837967|158274652|FG001|Washout Period of 7 - 14 Days|Adverse Event|0|||
49119251|NCT02658669|158274655|FG000|Overall Study|Lost to Follow-up|7|||
49119252|NCT02658669|158274656|FG001|Overall Study|Lost to Follow-up|5|||
48804681|NCT03145766|157127903|FG002|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
48804682|NCT03145766|157127904|FG003|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
48804683|NCT03145766|157127905|FG004|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0|||
48804684|NCT03145766|157127901|FG000|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2|||
48804685|NCT03145766|157127902|FG001|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
48804686|NCT03145766|157127903|FG002|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
48804687|NCT03145766|157127904|FG003|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1|||
48804688|NCT03145766|157127905|FG004|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
48804689|NCT03145766|157127901|FG000|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
48804690|NCT03145766|157127902|FG001|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1|||
48804691|NCT03145766|157127903|FG002|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
48804692|NCT03145766|157127904|FG003|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2|||
48804693|NCT03145766|157127905|FG004|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3|||
48804694|NCT03145766|157127901|FG000|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
48804695|NCT03145766|157127902|FG001|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
48804696|NCT03145766|157127903|FG002|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
48804697|NCT03145766|157127904|FG003|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
48804698|NCT03145766|157127905|FG004|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
48804699|NCT00246337|157127906|FG000|Overall Study|Lost to Follow-up|3|||
48804700|NCT00246337|157127907|FG001|Overall Study|Lost to Follow-up|0|||
48804701|NCT00246337|157127908|FG002|Overall Study|Lost to Follow-up|0|||
48804702|NCT00246337|157127909|FG003|Overall Study|Lost to Follow-up|0|||
48804703|NCT00246337|157127910|FG004|Overall Study|Lost to Follow-up|2|||
48804704|NCT00246337|157127911|FG005|Overall Study|Lost to Follow-up|2|||
48804705|NCT00246337|157127912|FG006|Overall Study|Lost to Follow-up|1|||
48804706|NCT00246337|157127913|FG007|Overall Study|Lost to Follow-up|2|||
48804707|NCT00246337|157127914|FG008|Overall Study|Lost to Follow-up|0|||
48804708|NCT00246337|157127906|FG000|Overall Study|Protocol Violation|1|||
48804709|NCT00246337|157127907|FG001|Overall Study|Protocol Violation|0|||
48804710|NCT00246337|157127908|FG002|Overall Study|Protocol Violation|0|||
48804711|NCT00246337|157127909|FG003|Overall Study|Protocol Violation|0|||
48804712|NCT00246337|157127910|FG004|Overall Study|Protocol Violation|1|||
48804713|NCT00246337|157127911|FG005|Overall Study|Protocol Violation|0|||
48804714|NCT00246337|157127912|FG006|Overall Study|Protocol Violation|1|||
48804715|NCT00246337|157127913|FG007|Overall Study|Protocol Violation|1|||
48804716|NCT00246337|157127914|FG008|Overall Study|Protocol Violation|0|||
48804717|NCT00246337|157127906|FG000|Overall Study|Withdrawal by Subject|2|||
48804718|NCT00246337|157127907|FG001|Overall Study|Withdrawal by Subject|0|||
48804719|NCT00246337|157127908|FG002|Overall Study|Withdrawal by Subject|0|||
48915275|NCT01840579|157524838|FG004|Overall Study|Adverse Event|0|||
48915276|NCT01840579|157524839|FG005|Overall Study|Adverse Event|0|||
48915277|NCT01840579|157524840|FG006|Overall Study|Adverse Event|0|||
48915278|NCT01840579|157524841|FG007|Overall Study|Adverse Event|0|||
48915279|NCT01840579|157524842|FG008|Overall Study|Adverse Event|0|||
48915280|NCT01840579|157524843|FG009|Overall Study|Adverse Event|0|||
48915281|NCT01840579|157524834|FG000|Overall Study|Follow-up ended by Sponsor|0|||
48915282|NCT01840579|157524835|FG001|Overall Study|Follow-up ended by Sponsor|0|||
48915283|NCT01840579|157524836|FG002|Overall Study|Follow-up ended by Sponsor|0|||
48915284|NCT01840579|157524837|FG003|Overall Study|Follow-up ended by Sponsor|0|||
48915285|NCT01840579|157524838|FG004|Overall Study|Follow-up ended by Sponsor|0|||
48915286|NCT01840579|157524839|FG005|Overall Study|Follow-up ended by Sponsor|0|||
48915287|NCT01840579|157524840|FG006|Overall Study|Follow-up ended by Sponsor|2|||
48915288|NCT01840579|157524841|FG007|Overall Study|Follow-up ended by Sponsor|0|||
48915289|NCT01840579|157524842|FG008|Overall Study|Follow-up ended by Sponsor|0|||
48915290|NCT01840579|157524843|FG009|Overall Study|Follow-up ended by Sponsor|0|||
48915291|NCT02625233|157524844|FG000|Overall Study|Adverse Event|2|||
48915292|NCT02625233|157524845|FG001|Overall Study|Adverse Event|0|||
48915293|NCT01924182|157524848|FG000|Overall Study|Withdrawal by Subject|1|||
48915294|NCT01924182|157524849|FG001|Overall Study|Withdrawal by Subject|0|||
48915295|NCT00609986|157524852|FG000|Overall Study|Did not receive transplant or treatment|8|||
48915296|NCT00609986|157524853|FG001|Overall Study|Did not receive transplant or treatment|3|||
48915297|NCT02374099|157524854|FG000|Overall Study|Adverse Event|1|||
48915298|NCT02374099|157524855|FG001|Overall Study|Adverse Event|0|||
48915299|NCT02374099|157524854|FG000|Overall Study|Progressive Disease|35|||
48915300|NCT02374099|157524855|FG001|Overall Study|Progressive Disease|40|||
48915301|NCT02374099|157524854|FG000|Overall Study|Withdrawal by Subject|5|||
48915302|NCT02374099|157524855|FG001|Overall Study|Withdrawal by Subject|1|||
48915303|NCT02374099|157524854|FG000|Overall Study|Miscellaneous|2|||
48804720|NCT00246337|157127909|FG003|Overall Study|Withdrawal by Subject|0|||
48804721|NCT00246337|157127910|FG004|Overall Study|Withdrawal by Subject|0|||
48804722|NCT00246337|157127911|FG005|Overall Study|Withdrawal by Subject|0|||
48804723|NCT00246337|157127912|FG006|Overall Study|Withdrawal by Subject|1|||
48915304|NCT02374099|157524855|FG001|Overall Study|Miscellaneous|3|||
48804724|NCT00246337|157127913|FG007|Overall Study|Withdrawal by Subject|1|||
48804725|NCT00246337|157127914|FG008|Overall Study|Withdrawal by Subject|0|||
48804726|NCT00246337|157127906|FG000|Overall Study|Lack of Qualifying Event|8|||
48804727|NCT00246337|157127907|FG001|Overall Study|Lack of Qualifying Event|2|||
48804728|NCT00246337|157127908|FG002|Overall Study|Lack of Qualifying Event|1|||
48804729|NCT00246337|157127909|FG003|Overall Study|Lack of Qualifying Event|1|||
48804730|NCT00246337|157127910|FG004|Overall Study|Lack of Qualifying Event|1|||
48804731|NCT00246337|157127911|FG005|Overall Study|Lack of Qualifying Event|3|||
48804732|NCT00246337|157127912|FG006|Overall Study|Lack of Qualifying Event|3|||
48804733|NCT00246337|157127913|FG007|Overall Study|Lack of Qualifying Event|2|||
48804734|NCT00246337|157127914|FG008|Overall Study|Lack of Qualifying Event|5|||
48915305|NCT02374099|157524854|FG000|Overall Study|Randomized, but not treated|2|||
48915306|NCT02374099|157524855|FG001|Overall Study|Randomized, but not treated|1|||
48915307|NCT02374099|157524854|FG000|Overall Study|Study Terminated by Sponsor|3|||
48915308|NCT02374099|157524855|FG001|Overall Study|Study Terminated by Sponsor|4|||
48915309|NCT03349099|157524856|FG000|Overall Study|Physician Decision|3|||
48915310|NCT03349099|157524857|FG001|Overall Study|Physician Decision|4|||
48915311|NCT03349099|157524856|FG000|Overall Study|Stone migrated from the kidney|1|||
48915312|NCT03349099|157524857|FG001|Overall Study|Stone migrated from the kidney|0|||
48915313|NCT01380379|157524865|FG000|Overall Study|Pregnancy|1|||
48915314|NCT04050670|157526531|FG000|Period 3|Physician Decision|0|||
48804735|NCT00246337|157127906|FG000|Overall Study|Site Terminated|10|||
48804736|NCT00246337|157127907|FG001|Overall Study|Site Terminated|0|||
48804737|NCT00246337|157127908|FG002|Overall Study|Site Terminated|0|||
48804738|NCT00246337|157127909|FG003|Overall Study|Site Terminated|0|||
48804739|NCT00246337|157127910|FG004|Overall Study|Site Terminated|0|||
48804740|NCT00246337|157127911|FG005|Overall Study|Site Terminated|7|||
48804741|NCT00246337|157127912|FG006|Overall Study|Site Terminated|1|||
48804742|NCT00246337|157127913|FG007|Overall Study|Site Terminated|6|||
48804743|NCT00246337|157127914|FG008|Overall Study|Site Terminated|2|||
48804744|NCT00246337|157127906|FG000|Overall Study|Abnormal baseline lab values|7|||
48804745|NCT00246337|157127907|FG001|Overall Study|Abnormal baseline lab values|0|||
48804746|NCT00246337|157127908|FG002|Overall Study|Abnormal baseline lab values|2|||
48804747|NCT00246337|157127909|FG003|Overall Study|Abnormal baseline lab values|0|||
48804748|NCT00246337|157127910|FG004|Overall Study|Abnormal baseline lab values|0|||
48804749|NCT00246337|157127911|FG005|Overall Study|Abnormal baseline lab values|2|||
48804750|NCT00246337|157127912|FG006|Overall Study|Abnormal baseline lab values|2|||
48804751|NCT00246337|157127913|FG007|Overall Study|Abnormal baseline lab values|0|||
48804752|NCT00246337|157127914|FG008|Overall Study|Abnormal baseline lab values|4|||
48804753|NCT00246337|157127906|FG000|Overall Study|Overwhelmed|0|||
48804754|NCT00246337|157127907|FG001|Overall Study|Overwhelmed|0|||
48804755|NCT00246337|157127908|FG002|Overall Study|Overwhelmed|0|||
48804756|NCT00246337|157127909|FG003|Overall Study|Overwhelmed|0|||
48804757|NCT00246337|157127910|FG004|Overall Study|Overwhelmed|0|||
48804758|NCT00246337|157127911|FG005|Overall Study|Overwhelmed|1|||
48804759|NCT00246337|157127912|FG006|Overall Study|Overwhelmed|0|||
48915315|NCT04050670|157526532|FG001|Period 3|Physician Decision|1|||
48915316|NCT04050670|157526533|FG002|Period 3|Physician Decision|0|||
48915317|NCT00761306|157526534|FG000|Overall Study|Adverse Event|5|||
48915318|NCT00761306|157526534|FG000|Overall Study|Lack of Efficacy|4|||
48915319|NCT00761306|157526534|FG000|Overall Study|Protocol Violation|2|||
48915320|NCT00761306|157526534|FG000|Overall Study|Withdrawal of Consent|3|||
48915321|NCT00761306|157526534|FG000|Overall Study|Lost to Follow-up|1|||
48915322|NCT00761306|157526534|FG000|Overall Study|Administrative or Other Reasons|5|||
48915323|NCT03688880|157526541|FG000|Overall Study|Withdrawal by Subject|0|||
48915324|NCT03688880|157526542|FG001|Overall Study|Withdrawal by Subject|2|||
48915325|NCT03688880|157526541|FG000|Overall Study|Use of non-permitted concurrent therapy|0|||
48915326|NCT03688880|157526542|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
48915327|NCT03688880|157526541|FG000|Overall Study|Lost to Follow-up|4|||
48804760|NCT00246337|157127913|FG007|Overall Study|Overwhelmed|0|||
48915328|NCT03688880|157526542|FG001|Overall Study|Lost to Follow-up|7|||
48915329|NCT03688880|157526541|FG000|Overall Study|Adverse Event|0|||
48915330|NCT03688880|157526542|FG001|Overall Study|Adverse Event|2|||
48915331|NCT03688880|157526541|FG000|Overall Study|Device deficiencies|0|||
48915332|NCT03688880|157526542|FG001|Overall Study|Device deficiencies|2|||
48915333|NCT03688880|157526541|FG000|Overall Study|Other|10|||
48915334|NCT03688880|157526542|FG001|Overall Study|Other|16|||
48915335|NCT00885703|157526543|FG000|Overall Study|Death|9|||
48804761|NCT00246337|157127914|FG008|Overall Study|Overwhelmed|0|||
48804762|NCT00246337|157127906|FG000|Overall Study|Protocol Violator|1|||
48804763|NCT00246337|157127907|FG001|Overall Study|Protocol Violator|0|||
48915336|NCT00885703|157526544|FG001|Overall Study|Death|7|||
48915337|NCT00885703|157526545|FG002|Overall Study|Death|8|||
48804764|NCT00246337|157127908|FG002|Overall Study|Protocol Violator|0|||
48804765|NCT00246337|157127909|FG003|Overall Study|Protocol Violator|0|||
48804766|NCT00246337|157127910|FG004|Overall Study|Protocol Violator|0|||
48804767|NCT00246337|157127911|FG005|Overall Study|Protocol Violator|0|||
48915338|NCT00885703|157526546|FG003|Overall Study|Death|7|||
48915339|NCT00885703|157526547|FG004|Overall Study|Death|7|||
48708833|NCT00981058|156782250|FG001|Overall Study|New Anticancer Therapy|6|||
48708834|NCT00981058|156782249|FG000|Overall Study|Noncompliance|1|||
48708835|NCT00981058|156782250|FG001|Overall Study|Noncompliance|0|||
48708836|NCT00981058|156782249|FG000|Overall Study|Radiologist Error|0|||
48708837|NCT00981058|156782250|FG001|Overall Study|Radiologist Error|1|||
48708838|NCT00981058|156782249|FG000|Overall Study|Randomization Error|1|||
48804768|NCT00246337|157127912|FG006|Overall Study|Protocol Violator|0|||
48804769|NCT00246337|157127913|FG007|Overall Study|Protocol Violator|0|||
48804770|NCT00246337|157127914|FG008|Overall Study|Protocol Violator|0|||
48804771|NCT00246337|157127906|FG000|Overall Study|Reported as completing trial in error|0|||
48708839|NCT00981058|156782250|FG001|Overall Study|Randomization Error|2|||
48804772|NCT00246337|157127907|FG001|Overall Study|Reported as completing trial in error|0|||
48804773|NCT00246337|157127908|FG002|Overall Study|Reported as completing trial in error|0|||
48708840|NCT00981058|156782249|FG000|Overall Study|Withdrawal by Subject|25|||
48708841|NCT00981058|156782250|FG001|Overall Study|Withdrawal by Subject|23|||
48708842|NCT00981058|156782249|FG000|Overall Study|On study treatment at conclusion|9|||
48708843|NCT00981058|156782250|FG001|Overall Study|On study treatment at conclusion|0|||
48708844|NCT00635999|156782251|FG000|Overall Study|Withdrawal by Subject|4|||
48708845|NCT00635999|156782252|FG001|Overall Study|Withdrawal by Subject|2|||
48708846|NCT00635999|156782253|FG002|Overall Study|Withdrawal by Subject|1|||
48708847|NCT01561313|156782255|FG000|Overall Study|Withdrawal by Subject|1|||
48708848|NCT01561313|156782256|FG001|Overall Study|Withdrawal by Subject|0|||
48708849|NCT01561313|156782255|FG000|Overall Study|Adverse event and withdrawal by subject|1|||
48804774|NCT00246337|157127909|FG003|Overall Study|Reported as completing trial in error|0|||
48804775|NCT00246337|157127910|FG004|Overall Study|Reported as completing trial in error|0|||
48804776|NCT00246337|157127911|FG005|Overall Study|Reported as completing trial in error|0|||
48804777|NCT00246337|157127912|FG006|Overall Study|Reported as completing trial in error|0|||
48804778|NCT00246337|157127913|FG007|Overall Study|Reported as completing trial in error|1|||
48804779|NCT00246337|157127914|FG008|Overall Study|Reported as completing trial in error|0|||
48804780|NCT02801669|157127915|FG000|Overall Study|Death|66|||
48804781|NCT02801669|157127916|FG001|Overall Study|Death|69|||
48804782|NCT02801669|157127915|FG000|Overall Study|Withdrawal by Subject|81|||
48804783|NCT02801669|157127916|FG001|Overall Study|Withdrawal by Subject|77|||
48804784|NCT02801669|157127915|FG000|Overall Study|Other|4|||
48804785|NCT02801669|157127916|FG001|Overall Study|Other|6|||
48915340|NCT00885703|157526548|FG005|Overall Study|Death|8|||
48915341|NCT00885703|157526549|FG006|Overall Study|Death|4|||
48915342|NCT00885703|157526543|FG000|Overall Study|Lost to Follow-up|0|||
48915343|NCT00885703|157526544|FG001|Overall Study|Lost to Follow-up|0|||
48915344|NCT00885703|157526545|FG002|Overall Study|Lost to Follow-up|1|||
48915345|NCT00885703|157526546|FG003|Overall Study|Lost to Follow-up|0|||
48915346|NCT00885703|157526547|FG004|Overall Study|Lost to Follow-up|0|||
48915347|NCT00885703|157526548|FG005|Overall Study|Lost to Follow-up|1|||
48915348|NCT00885703|157526549|FG006|Overall Study|Lost to Follow-up|0|||
48915349|NCT00885703|157526543|FG000|Overall Study|Withdrawal by Subject|0|||
48915350|NCT00885703|157526544|FG001|Overall Study|Withdrawal by Subject|0|||
48915351|NCT00885703|157526545|FG002|Overall Study|Withdrawal by Subject|0|||
48915352|NCT00885703|157526546|FG003|Overall Study|Withdrawal by Subject|1|||
48915353|NCT00885703|157526547|FG004|Overall Study|Withdrawal by Subject|3|||
48915354|NCT00885703|157526548|FG005|Overall Study|Withdrawal by Subject|1|||
48915355|NCT00885703|157526549|FG006|Overall Study|Withdrawal by Subject|1|||
48915356|NCT00885703|157526543|FG000|Overall Study|Ineligible (no CM)|1|||
48915357|NCT00885703|157526544|FG001|Overall Study|Ineligible (no CM)|3|||
48915358|NCT00885703|157526545|FG002|Overall Study|Ineligible (no CM)|2|||
48915359|NCT00885703|157526546|FG003|Overall Study|Ineligible (no CM)|1|||
48915360|NCT00885703|157526547|FG004|Overall Study|Ineligible (no CM)|2|||
48915361|NCT00885703|157526548|FG005|Overall Study|Ineligible (no CM)|3|||
48915362|NCT00885703|157526549|FG006|Overall Study|Ineligible (no CM)|1|||
48915363|NCT03723707|157526550|FG000|Overall Study|Death|32|||
48915364|NCT03723707|157526551|FG001|Overall Study|Death|32|||
48915365|NCT03723707|157526550|FG000|Overall Study|Admitted to long term care|12|||
48915366|NCT03723707|157526551|FG001|Overall Study|Admitted to long term care|12|||
48915367|NCT03723707|157526550|FG000|Overall Study|No longer receiving care at NYU Langone Health|15|||
48915368|NCT03723707|157526551|FG001|Overall Study|No longer receiving care at NYU Langone Health|8|||
48915369|NCT03723707|157526550|FG000|Overall Study|Lost to Follow-up|40|||
48915370|NCT03723707|157526551|FG001|Overall Study|Lost to Follow-up|22|||
48915371|NCT03723707|157526550|FG000|Overall Study|Discontinued after study closure|24|||
48804786|NCT00643123|157127917|FG000|Overall Study|Lost to Follow-up|4|||
48804787|NCT00643123|157127918|FG001|Overall Study|Lost to Follow-up|0|||
48804788|NCT00643123|157127917|FG000|Overall Study|Withdrawal by Subject|1|||
48915372|NCT03723707|157526551|FG001|Overall Study|Discontinued after study closure|12|||
48915373|NCT05121480|157526552|FG000|Overall Study|Lack of Efficacy|2|||
48708850|NCT01561313|156782256|FG001|Overall Study|Adverse event and withdrawal by subject|0|||
48804789|NCT00643123|157127918|FG001|Overall Study|Withdrawal by Subject|1|||
48915374|NCT05121480|157526553|FG001|Overall Study|Lack of Efficacy|2|||
48915375|NCT05121480|157526554|FG002|Overall Study|Lack of Efficacy|1|||
48915376|NCT05121480|157526555|FG003|Overall Study|Lack of Efficacy|4|||
48915377|NCT05121480|157526556|FG004|Overall Study|Lack of Efficacy|0|||
48915378|NCT05121480|157526557|FG005|Overall Study|Lack of Efficacy|1|||
48915379|NCT05121480|157526558|FG006|Overall Study|Lack of Efficacy|0|||
48915380|NCT05121480|157526559|FG007|Overall Study|Lack of Efficacy|2|||
48915381|NCT05121480|157526552|FG000|Overall Study|Treatment Failure|0|||
48915382|NCT05121480|157526553|FG001|Overall Study|Treatment Failure|2|||
48915383|NCT05121480|157526554|FG002|Overall Study|Treatment Failure|0|||
48915384|NCT05121480|157526555|FG003|Overall Study|Treatment Failure|1|||
48915385|NCT05121480|157526556|FG004|Overall Study|Treatment Failure|0|||
48915386|NCT05121480|157526557|FG005|Overall Study|Treatment Failure|0|||
48915387|NCT05121480|157526558|FG006|Overall Study|Treatment Failure|0|||
48915388|NCT05121480|157526559|FG007|Overall Study|Treatment Failure|0|||
48915389|NCT05121480|157526552|FG000|Overall Study|Adverse Event|0|||
48915390|NCT05121480|157526553|FG001|Overall Study|Adverse Event|1|||
48915391|NCT05121480|157526554|FG002|Overall Study|Adverse Event|0|||
48915392|NCT05121480|157526555|FG003|Overall Study|Adverse Event|5|||
48915393|NCT05121480|157526556|FG004|Overall Study|Adverse Event|3|||
48915394|NCT05121480|157526557|FG005|Overall Study|Adverse Event|2|||
48915395|NCT05121480|157526558|FG006|Overall Study|Adverse Event|0|||
48915396|NCT05121480|157526559|FG007|Overall Study|Adverse Event|4|||
48915397|NCT05121480|157526552|FG000|Overall Study|Withdrawal by Subject|4|||
48915398|NCT05121480|157526553|FG001|Overall Study|Withdrawal by Subject|9|||
48915399|NCT05121480|157526554|FG002|Overall Study|Withdrawal by Subject|1|||
48915400|NCT05121480|157526555|FG003|Overall Study|Withdrawal by Subject|8|||
48915401|NCT05121480|157526556|FG004|Overall Study|Withdrawal by Subject|0|||
48915402|NCT05121480|157526557|FG005|Overall Study|Withdrawal by Subject|9|||
48915403|NCT05121480|157526558|FG006|Overall Study|Withdrawal by Subject|0|||
48915404|NCT05121480|157526559|FG007|Overall Study|Withdrawal by Subject|4|||
48915405|NCT05121480|157526552|FG000|Overall Study|Non-compliance with the protocol|0|||
48915406|NCT05121480|157526553|FG001|Overall Study|Non-compliance with the protocol|0|||
48915407|NCT05121480|157526554|FG002|Overall Study|Non-compliance with the protocol|0|||
48915408|NCT05121480|157526555|FG003|Overall Study|Non-compliance with the protocol|0|||
48915409|NCT05121480|157526556|FG004|Overall Study|Non-compliance with the protocol|1|||
48915410|NCT05121480|157526557|FG005|Overall Study|Non-compliance with the protocol|6|||
48915411|NCT05121480|157526558|FG006|Overall Study|Non-compliance with the protocol|0|||
48915412|NCT05121480|157526559|FG007|Overall Study|Non-compliance with the protocol|1|||
48915413|NCT05121480|157526552|FG000|Overall Study|Lost to Follow-up|0|||
48915414|NCT05121480|157526553|FG001|Overall Study|Lost to Follow-up|4|||
48915415|NCT05121480|157526554|FG002|Overall Study|Lost to Follow-up|1|||
48915416|NCT05121480|157526555|FG003|Overall Study|Lost to Follow-up|3|||
48915417|NCT05121480|157526556|FG004|Overall Study|Lost to Follow-up|1|||
48708851|NCT02695420|156782257|FG000|Overall Study|Death|0|||
48708852|NCT02695420|156782258|FG001|Overall Study|Death|1|||
48708853|NCT02695420|156782259|FG002|Overall Study|Death|0|||
48708854|NCT02695420|156782260|FG003|Overall Study|Death|0|||
48708855|NCT00092443|156782262|FG000|Overall Study|Adverse Event|9|||
48708856|NCT00092443|156782263|FG001|Overall Study|Adverse Event|13|||
48708857|NCT00092443|156782262|FG000|Overall Study|Lost to Follow-up|7|||
48708858|NCT00092443|156782263|FG001|Overall Study|Lost to Follow-up|3|||
48708859|NCT00092443|156782262|FG000|Overall Study|Protocol Violation|11|||
48708860|NCT00092443|156782263|FG001|Overall Study|Protocol Violation|9|||
48708861|NCT00092443|156782262|FG000|Overall Study|Withdrawal by Subject|9|||
48708862|NCT00092443|156782263|FG001|Overall Study|Withdrawal by Subject|11|||
48708863|NCT00092443|156782262|FG000|Overall Study|Moved|5|||
48708864|NCT00092443|156782263|FG001|Overall Study|Moved|5|||
48708865|NCT00092443|156782262|FG000|Overall Study|Other|17|||
48708866|NCT00092443|156782263|FG001|Overall Study|Other|13|||
48708867|NCT00314795|156782266|FG000|Overall Study|Adverse Event|8|||
48708868|NCT00314795|156782266|FG000|Overall Study|Death|4|||
48708869|NCT00314795|156782266|FG000|Overall Study|Reason not Specified|3|||
48708870|NCT00314795|156782266|FG000|Overall Study|Renal Transplant|3|||
48708871|NCT00314795|156782266|FG000|Overall Study|Participants Withdrew Consent|2|||
48708872|NCT03500224|156782268|FG000|Overall Study|Withdrawal by Subject|2|||
48708873|NCT01500720|156782269|FG000|Overall Study|Randomized But Not Treated|1|||
48708874|NCT01500720|156782270|FG001|Overall Study|Randomized But Not Treated|1|||
48708875|NCT01500720|156782269|FG000|Overall Study|Other|4|||
48915418|NCT05121480|157526557|FG005|Overall Study|Lost to Follow-up|1|||
48915419|NCT05121480|157526558|FG006|Overall Study|Lost to Follow-up|1|||
48915420|NCT05121480|157526559|FG007|Overall Study|Lost to Follow-up|4|||
48915421|NCT05121480|157526552|FG000|Overall Study|Physician Decision|0|||
48915422|NCT05121480|157526553|FG001|Overall Study|Physician Decision|0|||
48915423|NCT05121480|157526554|FG002|Overall Study|Physician Decision|0|||
48708876|NCT01500720|156782270|FG001|Overall Study|Other|8|||
48708877|NCT02633020|156782272|FG000|Overall Study|Adverse Event|1|||
48708878|NCT02633020|156782273|FG001|Overall Study|Adverse Event|0|||
48915424|NCT05121480|157526555|FG003|Overall Study|Physician Decision|0|||
48915425|NCT05121480|157526556|FG004|Overall Study|Physician Decision|0|||
48915426|NCT05121480|157526557|FG005|Overall Study|Physician Decision|1|||
48915427|NCT05121480|157526558|FG006|Overall Study|Physician Decision|0|||
48804790|NCT00509236|157127923|FG000|Overall Study|Adverse Event|7|||
48804791|NCT00509236|157127924|FG001|Overall Study|Adverse Event|9|||
48804792|NCT00509236|157127923|FG000|Overall Study|Withdrawal by Subject|5|||
48804793|NCT00509236|157127924|FG001|Overall Study|Withdrawal by Subject|10|||
48804794|NCT00509236|157127923|FG000|Overall Study|Protocol Violation|3|||
48804795|NCT00509236|157127924|FG001|Overall Study|Protocol Violation|0|||
48804796|NCT00509236|157127923|FG000|Overall Study|Excluded Medication|1|||
48804797|NCT00509236|157127924|FG001|Overall Study|Excluded Medication|1|||
48804798|NCT00509236|157127923|FG000|Overall Study|Scheduled Kidney Transplant|1|||
48804799|NCT00509236|157127924|FG001|Overall Study|Scheduled Kidney Transplant|0|||
48804800|NCT03745222|157127925|FG000|Overall Study|Withdrawal by Subject|0|||
48804801|NCT03745222|157127926|FG001|Overall Study|Withdrawal by Subject|1|||
48804802|NCT03745222|157127927|FG002|Overall Study|Withdrawal by Subject|0|||
49119253|NCT00186485|158274657|FG000|Overall Study|Lost to Follow-up|3|||
49119254|NCT01733121|158274658|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|2|||
49119255|NCT01733121|158274659|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
49119256|NCT01733121|158274658|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
49119257|NCT01733121|158274659|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
49119258|NCT01733121|158274658|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
48804803|NCT02535364|157127928|FG000|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22|||
48804804|NCT02535364|157127928|FG000|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2|||
48804805|NCT02535364|157127928|FG000|Part A Screening Through Leukapheresis|Disease progression|1|||
48804806|NCT02535364|157127928|FG000|Part B Screening|Study placed on clinical hold by FDA|7|||
48804807|NCT02535364|157127928|FG000|Part B Screening|Unable to manufacture JCAR015|3|||
48804808|NCT02535364|157127928|FG000|Part B Screening|Death|2|||
48804809|NCT02535364|157127928|FG000|Part B Screening|Physician Decision|1|||
48804810|NCT02535364|157127928|FG000|Part B Screening|Withdrawal by Subject|1|||
48804811|NCT02535364|157127928|FG000|Part B Screening|Adverse Event|1|||
48804812|NCT02535364|157127928|FG000|Part B Screening|Change in diagnosis, no longer eligible|2|||
48804813|NCT02535364|157127928|FG000|Study Treatment|Death|1|||
48804814|NCT02535364|157127928|FG000|Study Treatment|Study placed on clinical hold by FDA|1|||
48804815|NCT02535364|157127928|FG000|12-Month Follow-up Period|Disease progression|22|||
48915428|NCT05121480|157526559|FG007|Overall Study|Physician Decision|1|||
48915429|NCT05121480|157526552|FG000|Overall Study|Other Reason|0|||
48915430|NCT05121480|157526553|FG001|Overall Study|Other Reason|0|||
48915431|NCT05121480|157526554|FG002|Overall Study|Other Reason|0|||
48915432|NCT05121480|157526555|FG003|Overall Study|Other Reason|0|||
48915433|NCT05121480|157526556|FG004|Overall Study|Other Reason|0|||
48915434|NCT05121480|157526557|FG005|Overall Study|Other Reason|1|||
48915435|NCT05121480|157526558|FG006|Overall Study|Other Reason|1|||
48915436|NCT05121480|157526559|FG007|Overall Study|Other Reason|1|||
48915437|NCT01429584|157526561|FG000|Overall Study|Withdrawal by Subject|1|||
48915438|NCT01429584|157526562|FG001|Overall Study|Withdrawal by Subject|0|||
48915439|NCT01429584|157526561|FG000|Overall Study|Protocol Violation|0|||
48915440|NCT01429584|157526562|FG001|Overall Study|Protocol Violation|1|||
48915441|NCT02953639|157526566|FG000|Overall Study|Adverse Event|2|||
48915442|NCT02953639|157526567|FG001|Overall Study|Adverse Event|0|||
48915443|NCT02953639|157526568|FG002|Overall Study|Adverse Event|1|||
48915444|NCT02953639|157526566|FG000|Overall Study|Lost to Follow-up|8|||
48915445|NCT02953639|157526567|FG001|Overall Study|Lost to Follow-up|4|||
48915446|NCT02953639|157526568|FG002|Overall Study|Lost to Follow-up|3|||
48915447|NCT02953639|157526566|FG000|Overall Study|Non-Compliance With Study Drug|0|||
48915448|NCT02953639|157526567|FG001|Overall Study|Non-Compliance With Study Drug|2|||
49119259|NCT01733121|158274659|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3|||
49119260|NCT01733121|158274658|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
49119261|NCT01733121|158274659|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
49119262|NCT03126786|158274666|FG000|Overall Study|Adverse Event|3|||
49119263|NCT03126786|158274667|FG001|Overall Study|Adverse Event|0|||
48804816|NCT02535364|157127928|FG000|12-Month Follow-up Period|Death|5|||
48804817|NCT02535364|157127928|FG000|12-Month Follow-up Period|Underwent stem cell transplant|5|||
48804818|NCT02535364|157127928|FG000|12-Month Follow-up Period|Subject received alternative therapy|2|||
48804819|NCT02535364|157127928|FG000|12-Month Follow-up Period|Subject transferred to hospice|1|||
48804820|NCT00499863|157127929|FG000|Overall Study|Lack of Efficacy|21|||
48804821|NCT00499863|157127930|FG001|Overall Study|Lack of Efficacy|27|||
48804822|NCT00499863|157127929|FG000|Overall Study|Protocol Violation|12|||
48804823|NCT00499863|157127930|FG001|Overall Study|Protocol Violation|7|||
48915449|NCT02953639|157526568|FG002|Overall Study|Non-Compliance With Study Drug|1|||
48915450|NCT02953639|157526566|FG000|Overall Study|Multiple Reasons|1|||
48915451|NCT02953639|157526567|FG001|Overall Study|Multiple Reasons|0|||
48915452|NCT02953639|157526568|FG002|Overall Study|Multiple Reasons|1|||
48915453|NCT02953639|157526566|FG000|Overall Study|Physician Decision|1|||
48915454|NCT02953639|157526567|FG001|Overall Study|Physician Decision|0|||
48915455|NCT02953639|157526568|FG002|Overall Study|Physician Decision|0|||
48915456|NCT02953639|157526566|FG000|Overall Study|Withdrawal by Subject|7|||
48915457|NCT02953639|157526567|FG001|Overall Study|Withdrawal by Subject|8|||
48915458|NCT02953639|157526568|FG002|Overall Study|Withdrawal by Subject|10|||
48915459|NCT02953639|157526566|FG000|Overall Study|Completed or Discontinued information is missing|1|||
48915460|NCT02953639|157526567|FG001|Overall Study|Completed or Discontinued information is missing|0|||
48915461|NCT02953639|157526568|FG002|Overall Study|Completed or Discontinued information is missing|0|||
48915462|NCT00747643|157526570|FG000|Overall Study|Withdrawal by Subject|36|||
48915463|NCT00747643|157526571|FG001|Overall Study|Withdrawal by Subject|27|||
48915464|NCT00750698|157526572|FG000|Overall Study|Withdrawal by Subject|1|||
48915465|NCT00750698|157526573|FG001|Overall Study|Withdrawal by Subject|0|||
48915466|NCT00750698|157526572|FG000|Overall Study|Progressive disease|5|||
48915467|NCT00750698|157526573|FG001|Overall Study|Progressive disease|2|||
48915468|NCT01462435|157526574|FG000|Overall Study|Lack of Efficacy|1|||
48915469|NCT01462435|157526575|FG001|Overall Study|Lack of Efficacy|0|||
48915470|NCT01462435|157526576|FG002|Overall Study|Lack of Efficacy|0|||
48915471|NCT01462435|157526577|FG003|Overall Study|Lack of Efficacy|3|||
48915472|NCT01462435|157526574|FG000|Overall Study|Physician Decision|0|||
48915473|NCT01462435|157526575|FG001|Overall Study|Physician Decision|0|||
48915474|NCT01462435|157526576|FG002|Overall Study|Physician Decision|1|||
48915475|NCT01462435|157526577|FG003|Overall Study|Physician Decision|0|||
48915476|NCT01462435|157526574|FG000|Overall Study|Withdrawal by Subject|0|||
49119264|NCT03126786|158274666|FG000|Overall Study|Lost to Follow-up|0|||
49119265|NCT03126786|158274667|FG001|Overall Study|Lost to Follow-up|1|||
49119266|NCT03126786|158274666|FG000|Overall Study|Withdrawal by Subject|3|||
49119267|NCT03126786|158274667|FG001|Overall Study|Withdrawal by Subject|1|||
49119268|NCT01601496|158274668|FG000|Overall Study|Physician Decision|1|||
49119269|NCT01601496|158274668|FG000|Overall Study|Withdrawal by Subject|1|||
49119270|NCT01601496|158274668|FG000|Overall Study|Lost to Follow-up|6|||
49119271|NCT01601496|158274668|FG000|Overall Study|Death|4|||
49119272|NCT01601496|158274668|FG000|Overall Study|Other: patient refusal to continue|3|||
49119273|NCT03243305|158274669|FG000|Overall Study|Lost to Follow-up|250|||
48804824|NCT00499863|157127929|FG000|Overall Study|Withdrawal by Subject|6|||
48804825|NCT00499863|157127930|FG001|Overall Study|Withdrawal by Subject|4|||
48804826|NCT00499863|157127929|FG000|Overall Study|Adverse Event|8|||
49119274|NCT03243305|158274669|FG000|Overall Study|Withdrawal by Subject|170|||
48804827|NCT00499863|157127930|FG001|Overall Study|Adverse Event|2|||
48804828|NCT00499863|157127929|FG000|Overall Study|Sponsor decision|2|||
48804829|NCT00499863|157127930|FG001|Overall Study|Sponsor decision|2|||
48804830|NCT00499863|157127929|FG000|Overall Study|Lost to Follow-up|1|||
48804831|NCT00499863|157127930|FG001|Overall Study|Lost to Follow-up|1|||
48804832|NCT01800201|157127931|FG000|Overall Study|Withdrawal by Subject|2|||
48804833|NCT01800201|157127932|FG001|Overall Study|Withdrawal by Subject|0|||
48804834|NCT01800201|157127931|FG000|Overall Study|patient privacy concerns|1|||
48804835|NCT01800201|157127932|FG001|Overall Study|patient privacy concerns|1|||
48804836|NCT01800201|157127931|FG000|Overall Study|did not want to use device|0|||
48804837|NCT01800201|157127932|FG001|Overall Study|did not want to use device|1|||
48804838|NCT01800201|157127931|FG000|Overall Study|PI withdrawal, cognitive concerns|0|||
48804839|NCT01800201|157127932|FG001|Overall Study|PI withdrawal, cognitive concerns|1|||
48804840|NCT04704154|157127935|FG000|Overall Study|Adverse Event|2|||
48804841|NCT04704154|157127936|FG001|Overall Study|Adverse Event|1|||
48804842|NCT04704154|157127937|FG002|Overall Study|Adverse Event|3|||
48804843|NCT04704154|157127938|FG003|Overall Study|Adverse Event|2|||
48804844|NCT04704154|157127939|FG004|Overall Study|Adverse Event|3|||
48804845|NCT04704154|157127940|FG005|Overall Study|Adverse Event|0|||
48804846|NCT04704154|157127935|FG000|Overall Study|Death|3|||
48804847|NCT04704154|157127936|FG001|Overall Study|Death|0|||
48804848|NCT04704154|157127937|FG002|Overall Study|Death|0|||
48804849|NCT04704154|157127938|FG003|Overall Study|Death|0|||
48804850|NCT04704154|157127939|FG004|Overall Study|Death|3|||
48804851|NCT04704154|157127940|FG005|Overall Study|Death|0|||
48804852|NCT04704154|157127935|FG000|Overall Study|Physician Decision|1|||
48804853|NCT04704154|157127936|FG001|Overall Study|Physician Decision|0|||
48804854|NCT04704154|157127937|FG002|Overall Study|Physician Decision|0|||
48804855|NCT04704154|157127938|FG003|Overall Study|Physician Decision|0|||
48804856|NCT04704154|157127939|FG004|Overall Study|Physician Decision|1|||
48804857|NCT04704154|157127940|FG005|Overall Study|Physician Decision|0|||
48804858|NCT04704154|157127935|FG000|Overall Study|Participant Decision|1|||
48804859|NCT04704154|157127936|FG001|Overall Study|Participant Decision|1|||
48804860|NCT04704154|157127937|FG002|Overall Study|Participant Decision|0|||
48804861|NCT04704154|157127938|FG003|Overall Study|Participant Decision|0|||
48804862|NCT04704154|157127939|FG004|Overall Study|Participant Decision|0|||
48915477|NCT01462435|157526575|FG001|Overall Study|Withdrawal by Subject|0|||
48915478|NCT01462435|157526576|FG002|Overall Study|Withdrawal by Subject|0|||
48915479|NCT01462435|157526577|FG003|Overall Study|Withdrawal by Subject|1|||
48915480|NCT01462435|157526574|FG000|Overall Study|Lost to Follow-up|0|||
48915481|NCT01462435|157526575|FG001|Overall Study|Lost to Follow-up|0|||
48915482|NCT01462435|157526576|FG002|Overall Study|Lost to Follow-up|0|||
48915483|NCT01462435|157526577|FG003|Overall Study|Lost to Follow-up|1|||
48915484|NCT01417195|157526582|FG000|Overall Study|Stimulation failure|1|||
48915485|NCT01417195|157526583|FG001|Overall Study|Stimulation failure|0|||
48915486|NCT01417195|157526582|FG000|Overall Study|No embryos for transfer|0|||
48915487|NCT01417195|157526583|FG001|Overall Study|No embryos for transfer|1|||
48915488|NCT01417195|157526582|FG000|Overall Study|No transfer due to risk of OHSS|1|||
48915489|NCT01417195|157526583|FG001|Overall Study|No transfer due to risk of OHSS|0|||
48915490|NCT01417195|157526582|FG000|Overall Study|No transfer due to elevated progesterone|1|||
48915491|NCT01417195|157526583|FG001|Overall Study|No transfer due to elevated progesterone|0|||
48915492|NCT00677820|157526584|FG000|Overall Study|Lost to Follow-up|1|||
48915493|NCT00677820|157526585|FG001|Overall Study|Lost to Follow-up|0|||
48915494|NCT02713542|157526586|FG000|Overall Study|Use of prohibited medication|14|||
48915495|NCT02713542|157526587|FG001|Overall Study|Use of prohibited medication|5|||
48915496|NCT02713542|157526586|FG000|Overall Study|Withdrawal by Subject|4|||
48915497|NCT02713542|157526587|FG001|Overall Study|Withdrawal by Subject|1|||
48915498|NCT01365039|157526589|FG000|Overall Study|Study related symptoms and complaints|1|||
48915499|NCT01365039|157526590|FG001|Overall Study|Study related symptoms and complaints|0|||
48915500|NCT03807349|157526591|FG000|Overall Study|Early Study Termination|9|||
48915501|NCT00129766|157526592|FG000|Overall Study|Death|3|||
48915502|NCT00129766|157526593|FG001|Overall Study|Death|8|||
48915503|NCT00129766|157526592|FG000|Overall Study|Withdrawal of consent|31|||
48915504|NCT00129766|157526593|FG001|Overall Study|Withdrawal of consent|30|||
48915505|NCT00129766|157526592|FG000|Overall Study|Lost to Follow-up|26|||
48915506|NCT00129766|157526593|FG001|Overall Study|Lost to Follow-up|21|||
48915507|NCT00111800|157526594|FG000|Period 1: Main Phase (12 Weeks)|Adverse Event|5|||
48915508|NCT00111800|157526595|FG001|Period 1: Main Phase (12 Weeks)|Adverse Event|4|||
48915509|NCT00111800|157526596|FG002|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
49119275|NCT03243305|158274669|FG000|Overall Study|Pregnancy|104|||
48708879|NCT04200352|156782289|FG000|Overall Study|Death|1|||
48708880|NCT04200352|156782289|FG000|Overall Study|Adverse Event|6|||
48708881|NCT04200352|156782289|FG000|Overall Study|Withdrawal by parent/guardian|6|||
48708882|NCT04200352|156782289|FG000|Overall Study|Lack of Efficacy|1|||
48708883|NCT04200352|156782289|FG000|Overall Study|Other than specified|6|||
48708884|NCT00806819|156782292|FG000|Overall Study|progressive disease (modified RECIST )|217|||
48708885|NCT00806819|156782293|FG001|Overall Study|progressive disease (modified RECIST )|216|||
48708886|NCT00806819|156782292|FG000|Overall Study|Worsening or AE of underlying disease|18|||
48708887|NCT00806819|156782293|FG001|Overall Study|Worsening or AE of underlying disease|25|||
48708888|NCT00806819|156782292|FG000|Overall Study|Other AE|38|||
48708889|NCT00806819|156782293|FG001|Overall Study|Other AE|40|||
48708890|NCT00806819|156782292|FG000|Overall Study|Protocol Violation|9|||
48708891|NCT00806819|156782293|FG001|Overall Study|Protocol Violation|4|||
48708892|NCT00806819|156782292|FG000|Overall Study|Lost to Follow-up|1|||
48708893|NCT00806819|156782293|FG001|Overall Study|Lost to Follow-up|0|||
48708894|NCT00806819|156782292|FG000|Overall Study|Withdrawal by Subject|32|||
48708895|NCT00806819|156782293|FG001|Overall Study|Withdrawal by Subject|29|||
48708896|NCT00806819|156782292|FG000|Overall Study|Not treated|6|||
48708897|NCT00806819|156782293|FG001|Overall Study|Not treated|3|||
48708898|NCT00806819|156782292|FG000|Overall Study|Reasons other than stated above|25|||
48708899|NCT00806819|156782293|FG001|Overall Study|Reasons other than stated above|41|||
48708900|NCT00233064|156782296|FG000|Overall Study|Lost to Follow-up|7|||
48708901|NCT00233064|156782297|FG001|Overall Study|Lost to Follow-up|7|||
48708902|NCT00233064|156782296|FG000|Overall Study|Withdrawal by Subject|5|||
48708903|NCT00233064|156782297|FG001|Overall Study|Withdrawal by Subject|3|||
48708904|NCT00233064|156782296|FG000|Overall Study|Death|0|||
48708905|NCT00233064|156782297|FG001|Overall Study|Death|1|||
48708906|NCT00233064|156782296|FG000|Overall Study|Relocation|0|||
48708907|NCT00233064|156782297|FG001|Overall Study|Relocation|1|||
48708908|NCT00233064|156782296|FG000|Overall Study|Protocol Violation|1|||
48708909|NCT00233064|156782297|FG001|Overall Study|Protocol Violation|0|||
48708910|NCT00233064|156782296|FG000|Overall Study|Moved to Dom. Republic|1|||
48708911|NCT00233064|156782297|FG001|Overall Study|Moved to Dom. Republic|0|||
48708912|NCT02302339|156782298|FG000|Overall Study|Lost to Follow-up|1|||
48708913|NCT02302339|156782299|FG001|Overall Study|Lost to Follow-up|0|||
48708914|NCT02302339|156782300|FG002|Overall Study|Lost to Follow-up|0|||
48708915|NCT02302339|156782301|FG003|Overall Study|Lost to Follow-up|0|||
48708916|NCT02302339|156782298|FG000|Overall Study|Withdrawal by Subject|0|||
48708917|NCT02302339|156782299|FG001|Overall Study|Withdrawal by Subject|2|||
48708918|NCT02302339|156782300|FG002|Overall Study|Withdrawal by Subject|1|||
48708919|NCT02302339|156782301|FG003|Overall Study|Withdrawal by Subject|0|||
48708920|NCT03212144|156782302|FG000|First Sequence (4 Weeks)|Lost to Follow-up|1|||
48708921|NCT03212144|156782303|FG001|First Sequence (4 Weeks)|Lost to Follow-up|0|||
48708922|NCT03212144|156782302|FG000|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
48708923|NCT03212144|156782303|FG001|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
48708924|NCT01185080|156782304|FG000|Overall Study|Adverse Event|1|||
48708925|NCT01185080|156782305|FG001|Overall Study|Adverse Event|1|||
48708926|NCT01185080|156782306|FG002|Overall Study|Adverse Event|0|||
48915510|NCT00111800|157526597|FG003|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
48804863|NCT04704154|157127940|FG005|Overall Study|Participant Decision|0|||
48804864|NCT04704154|157127935|FG000|Overall Study|Progressive Disease|16|||
48804865|NCT04704154|157127936|FG001|Overall Study|Progressive Disease|17|||
48804866|NCT04704154|157127937|FG002|Overall Study|Progressive Disease|20|||
48804867|NCT04704154|157127938|FG003|Overall Study|Progressive Disease|18|||
48804868|NCT04704154|157127939|FG004|Overall Study|Progressive Disease|36|||
48804869|NCT04704154|157127940|FG005|Overall Study|Progressive Disease|30|||
48804870|NCT04704154|157127935|FG000|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
48804871|NCT04704154|157127936|FG001|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
48804872|NCT04704154|157127937|FG002|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
48804873|NCT04704154|157127938|FG003|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
48804874|NCT04704154|157127939|FG004|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
48804875|NCT04704154|157127940|FG005|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
48804876|NCT00855595|157127943|FG000|Overall Study|Withdrawal by Subject|1|||
48915511|NCT00111800|157526598|FG004|Period 1: Main Phase (12 Weeks)|Adverse Event|1|||
48915512|NCT00111800|157526599|FG005|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
48915513|NCT00111800|157526594|FG000|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1|||
48915514|NCT00111800|157526595|FG001|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
48915515|NCT00111800|157526596|FG002|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
48915516|NCT00111800|157526597|FG003|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
48915517|NCT00111800|157526598|FG004|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
48915518|NCT00111800|157526599|FG005|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
48915519|NCT00111800|157526594|FG000|Period 1: Main Phase (12 Weeks)|Protocol Violation|0|||
48915520|NCT00111800|157526595|FG001|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
48915521|NCT00111800|157526596|FG002|Period 1: Main Phase (12 Weeks)|Protocol Violation|4|||
48915522|NCT00111800|157526597|FG003|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
48915523|NCT00111800|157526598|FG004|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
48915524|NCT00111800|157526599|FG005|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
48915525|NCT00111800|157526594|FG000|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
48915526|NCT00111800|157526595|FG001|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
48915527|NCT00111800|157526596|FG002|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3|||
48915528|NCT00111800|157526597|FG003|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
48915529|NCT00111800|157526598|FG004|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
48915530|NCT00111800|157526599|FG005|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1|||
48915531|NCT00111800|157526594|FG000|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3|||
48915532|NCT00111800|157526595|FG001|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
48915533|NCT00111800|157526596|FG002|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
48915534|NCT00111800|157526597|FG003|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1|||
48915535|NCT00111800|157526598|FG004|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
48915536|NCT00111800|157526599|FG005|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
48915537|NCT00111800|157526594|FG000|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
48915538|NCT00111800|157526595|FG001|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
48915539|NCT00111800|157526596|FG002|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
48915540|NCT00111800|157526597|FG003|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
48915541|NCT00111800|157526598|FG004|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
48915542|NCT00111800|157526599|FG005|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
48915543|NCT00111800|157526594|FG000|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
48915544|NCT00111800|157526595|FG001|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
48915545|NCT00111800|157526596|FG002|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
48915546|NCT00111800|157526597|FG003|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
48915547|NCT00111800|157526598|FG004|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
48915548|NCT00111800|157526599|FG005|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
48915549|NCT00111800|157526594|FG000|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
48915550|NCT00111800|157526595|FG001|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
48915551|NCT00111800|157526596|FG002|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
48915552|NCT00111800|157526597|FG003|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
48915553|NCT00111800|157526598|FG004|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
48915554|NCT00111800|157526599|FG005|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
48915555|NCT00111800|157526594|FG000|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1|||
48915556|NCT00111800|157526595|FG001|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
48804877|NCT00855595|157127944|FG001|Overall Study|Withdrawal by Subject|2|||
48804878|NCT00855595|157127943|FG000|Overall Study|Lost to Follow-up|3|||
48804879|NCT00855595|157127944|FG001|Overall Study|Lost to Follow-up|3|||
48804880|NCT00855595|157127943|FG000|Overall Study|Adverse Event|1|||
48804881|NCT00855595|157127944|FG001|Overall Study|Adverse Event|1|||
48804882|NCT00855595|157127943|FG000|Overall Study|patient moved out of state|1|||
48804883|NCT00855595|157127944|FG001|Overall Study|patient moved out of state|0|||
48804884|NCT00855595|157127943|FG000|Overall Study|patient left country|0|||
48804885|NCT00855595|157127944|FG001|Overall Study|patient left country|1|||
48804886|NCT04555096|157127945|FG000|Overall Study|Death|4|||
48804887|NCT04555096|157127946|FG001|Overall Study|Death|4|||
48804888|NCT04555096|157127945|FG000|Overall Study|Withdrawal by Subject|1|||
48804889|NCT04555096|157127946|FG001|Overall Study|Withdrawal by Subject|0|||
48804890|NCT04555096|157127945|FG000|Overall Study|Other|0|||
48804891|NCT04555096|157127946|FG001|Overall Study|Other|1|||
48804892|NCT02343003|157127949|FG000|Overall Study|Withdrawal by Subject|9|||
48804893|NCT02343003|157127950|FG001|Overall Study|Withdrawal by Subject|4|||
48804894|NCT02343003|157127949|FG000|Overall Study|Lost to Follow-up|5|||
48804895|NCT02343003|157127950|FG001|Overall Study|Lost to Follow-up|1|||
48804896|NCT02343003|157127949|FG000|Overall Study|Protocol Violation|1|||
48804897|NCT02343003|157127950|FG001|Overall Study|Protocol Violation|0|||
48804898|NCT02343003|157127949|FG000|Overall Study|Death|0|||
48804899|NCT02343003|157127950|FG001|Overall Study|Death|1|||
48804900|NCT02343003|157127949|FG000|Overall Study|exclusion criteria met|1|||
48804901|NCT02343003|157127950|FG001|Overall Study|exclusion criteria met|1|||
48804902|NCT02343003|157127949|FG000|Overall Study|terminated by sponsor|2|||
48804903|NCT02343003|157127950|FG001|Overall Study|terminated by sponsor|0|||
48804904|NCT03954743|157127951|FG000|Overall Study|Adverse Event|1|||
48804905|NCT03954743|157127952|FG001|Overall Study|Adverse Event|0|||
48804906|NCT03954743|157127951|FG000|Overall Study|Lost to Follow-up|6|||
48804907|NCT03954743|157127952|FG001|Overall Study|Lost to Follow-up|4|||
48804908|NCT03954743|157127951|FG000|Overall Study|Protocol Violation|1|||
48804909|NCT03954743|157127952|FG001|Overall Study|Protocol Violation|0|||
48804910|NCT03954743|157127951|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13|||
48804911|NCT03954743|157127952|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12|||
48804912|NCT03954743|157127951|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
48804913|NCT03954743|157127952|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
48804914|NCT02496767|157127955|FG000|Open-label Lead-in Phase|Adverse Event|176|||
48804915|NCT02496767|157127956|FG001|Open-label Lead-in Phase|Adverse Event|0|||
48804916|NCT02496767|157127957|FG002|Open-label Lead-in Phase|Adverse Event|0|||
48804917|NCT02496767|157127958|FG003|Open-label Lead-in Phase|Adverse Event|0|||
48804918|NCT02496767|157127959|FG004|Open-label Lead-in Phase|Adverse Event|0|||
48804919|NCT02496767|157127960|FG005|Open-label Lead-in Phase|Adverse Event|0|||
48804920|NCT02496767|157127961|FG006|Open-label Lead-in Phase|Adverse Event|0|||
48804921|NCT02496767|157127962|FG007|Open-label Lead-in Phase|Adverse Event|0|||
48804922|NCT02496767|157127955|FG000|Open-label Lead-in Phase|Protocol Violation|2|||
48804923|NCT02496767|157127956|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
48804924|NCT02496767|157127957|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
48804925|NCT02496767|157127958|FG003|Open-label Lead-in Phase|Protocol Violation|0|||
48804926|NCT02496767|157127959|FG004|Open-label Lead-in Phase|Protocol Violation|0|||
48804927|NCT02496767|157127960|FG005|Open-label Lead-in Phase|Protocol Violation|0|||
48804928|NCT02496767|157127961|FG006|Open-label Lead-in Phase|Protocol Violation|0|||
48804929|NCT02496767|157127962|FG007|Open-label Lead-in Phase|Protocol Violation|0|||
48804930|NCT02496767|157127955|FG000|Open-label Lead-in Phase|Lost to Follow-up|1|||
48804931|NCT02496767|157127956|FG001|Open-label Lead-in Phase|Lost to Follow-up|0|||
48804932|NCT02496767|157127957|FG002|Open-label Lead-in Phase|Lost to Follow-up|0|||
48804933|NCT02496767|157127958|FG003|Open-label Lead-in Phase|Lost to Follow-up|0|||
48804934|NCT02496767|157127959|FG004|Open-label Lead-in Phase|Lost to Follow-up|0|||
48804935|NCT02496767|157127960|FG005|Open-label Lead-in Phase|Lost to Follow-up|0|||
48804936|NCT02496767|157127961|FG006|Open-label Lead-in Phase|Lost to Follow-up|0|||
48804937|NCT02496767|157127962|FG007|Open-label Lead-in Phase|Lost to Follow-up|0|||
48804938|NCT02496767|157127955|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
48804939|NCT02496767|157127956|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|13|||
48804940|NCT02496767|157127957|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|23|||
48804941|NCT02496767|157127958|FG003|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
48804942|NCT02496767|157127959|FG004|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
48804943|NCT02496767|157127960|FG005|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
48804944|NCT02496767|157127961|FG006|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
48804945|NCT02496767|157127962|FG007|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
48951827|NCT00592358|157654906|FG000|Overall Study|Inability to swallow pills|1|||
48804946|NCT02496767|157127955|FG000|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
48804947|NCT02496767|157127956|FG001|Double-blind, Placebo-controlled Phase|Progressive disease|13|||
48915557|NCT00111800|157526596|FG002|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
48915558|NCT00111800|157526597|FG003|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
48915559|NCT00111800|157526598|FG004|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
48915560|NCT00111800|157526599|FG005|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
48915561|NCT00111800|157526594|FG000|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
48915562|NCT00111800|157526595|FG001|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1|||
48915563|NCT00111800|157526596|FG002|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
48915564|NCT00111800|157526597|FG003|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
49119276|NCT03243305|158274669|FG000|Overall Study|Non-Compliance with Study Drug|38|||
49119277|NCT03243305|158274669|FG000|Overall Study|Adverse Event|23|||
49119278|NCT03243305|158274669|FG000|Overall Study|No sexually active|26|||
49119279|NCT03243305|158274669|FG000|Overall Study|Physician Decision|22|||
49119280|NCT03243305|158274669|FG000|Overall Study|Protocol Violation|22|||
49119281|NCT03243305|158274669|FG000|Overall Study|Study method no longer primary method|12|||
49119282|NCT03243305|158274669|FG000|Overall Study|Study Terminated by Sponsor|1|||
49119283|NCT03243305|158274669|FG000|Overall Study|Early terminations|267|||
49119284|NCT02521792|158274670|FG000|Overall Study|Study Terminated|6|||
49119285|NCT02504320|158274671|FG000|Treatment Period 1|Positive Drug Screen|0|||
49119286|NCT02504320|158274672|FG001|Treatment Period 1|Positive Drug Screen|0|||
49119287|NCT02504320|158274673|FG002|Treatment Period 1|Positive Drug Screen|1|||
49119288|NCT02504320|158274674|FG003|Treatment Period 1|Positive Drug Screen|0|||
49119289|NCT02504320|158274671|FG000|Treatment Period 2|Positive Drug Screen|0|||
49119290|NCT02504320|158274672|FG001|Treatment Period 2|Positive Drug Screen|1|||
48708927|NCT01185080|156782304|FG000|Overall Study|Personal reasons|0|||
48708928|NCT01185080|156782305|FG001|Overall Study|Personal reasons|0|||
48708929|NCT01185080|156782306|FG002|Overall Study|Personal reasons|1|||
48708930|NCT03894813|156784151|FG000|Overall Study|Adverse Event|1|||
48708931|NCT03894813|156784152|FG001|Overall Study|Adverse Event|1|||
48708932|NCT03894813|156784151|FG000|Overall Study|Lack of Efficacy|3|||
48708933|NCT03894813|156784152|FG001|Overall Study|Lack of Efficacy|3|||
48708934|NCT03894813|156784151|FG000|Overall Study|Lost to Follow-up|1|||
48708935|NCT03894813|156784152|FG001|Overall Study|Lost to Follow-up|0|||
48708936|NCT03894813|156784151|FG000|Overall Study|Pregnancy|2|||
48708937|NCT03894813|156784152|FG001|Overall Study|Pregnancy|1|||
48708938|NCT03894813|156784151|FG000|Overall Study|Protocol Violation|3|||
48708939|NCT03894813|156784152|FG001|Overall Study|Protocol Violation|7|||
48708940|NCT03894813|156784151|FG000|Overall Study|Withdrawal by Subject|1|||
48708941|NCT03894813|156784152|FG001|Overall Study|Withdrawal by Subject|3|||
48708942|NCT03894813|156784151|FG000|Overall Study|Complain of the research staff and refused to continue the trial|0|||
48708943|NCT03894813|156784152|FG001|Overall Study|Complain of the research staff and refused to continue the trial|1|||
48708944|NCT03083873|156784153|FG000|Overall Study|Death|6|||
48708945|NCT03083873|156784154|FG001|Overall Study|Death|15|||
48708946|NCT03083873|156784155|FG002|Overall Study|Death|13|||
48708947|NCT03083873|156784156|FG003|Overall Study|Death|9|||
48708948|NCT03083873|156784157|FG004|Overall Study|Death|0|||
48708949|NCT03083873|156784153|FG000|Overall Study|Sponsor Terminated Study|0|||
48708950|NCT03083873|156784154|FG001|Overall Study|Sponsor Terminated Study|1|||
48708951|NCT03083873|156784155|FG002|Overall Study|Sponsor Terminated Study|2|||
48708952|NCT03083873|156784156|FG003|Overall Study|Sponsor Terminated Study|3|||
48708953|NCT03083873|156784157|FG004|Overall Study|Sponsor Terminated Study|0|||
48708954|NCT03083873|156784153|FG000|Overall Study|Lost to Follow-up|0|||
48708955|NCT03083873|156784154|FG001|Overall Study|Lost to Follow-up|1|||
48708956|NCT03083873|156784155|FG002|Overall Study|Lost to Follow-up|1|||
48708957|NCT03083873|156784156|FG003|Overall Study|Lost to Follow-up|0|||
48708958|NCT03083873|156784157|FG004|Overall Study|Lost to Follow-up|0|||
48708959|NCT03083873|156784153|FG000|Overall Study|Withdrawal by Subject|2|||
48708960|NCT03083873|156784154|FG001|Overall Study|Withdrawal by Subject|0|||
48708961|NCT03083873|156784155|FG002|Overall Study|Withdrawal by Subject|0|||
48708962|NCT03083873|156784156|FG003|Overall Study|Withdrawal by Subject|0|||
48708963|NCT03083873|156784157|FG004|Overall Study|Withdrawal by Subject|0|||
48708964|NCT03083873|156784153|FG000|Overall Study|Did Not Receive TIL|2|||
48708965|NCT03083873|156784154|FG001|Overall Study|Did Not Receive TIL|5|||
48708966|NCT03083873|156784155|FG002|Overall Study|Did Not Receive TIL|3|||
48708967|NCT03083873|156784156|FG003|Overall Study|Did Not Receive TIL|1|||
48708968|NCT03083873|156784157|FG004|Overall Study|Did Not Receive TIL|0|||
48708969|NCT03983317|156784158|FG000|Overall Study|Physician Decision|5|||
48708970|NCT01069900|156784165|FG000|Overall Study|Technical problems|0|||
48804948|NCT02496767|157127957|FG002|Double-blind, Placebo-controlled Phase|Progressive disease|9|||
48804949|NCT02496767|157127958|FG003|Double-blind, Placebo-controlled Phase|Progressive disease|8|||
48804950|NCT02496767|157127959|FG004|Double-blind, Placebo-controlled Phase|Progressive disease|14|||
48804951|NCT02496767|157127960|FG005|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
48804952|NCT02496767|157127961|FG006|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
48804953|NCT02496767|157127962|FG007|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
48804954|NCT02496767|157127955|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
48804955|NCT02496767|157127956|FG001|Double-blind, Placebo-controlled Phase|Death|10|||
48804956|NCT02496767|157127957|FG002|Double-blind, Placebo-controlled Phase|Death|6|||
48804957|NCT02496767|157127958|FG003|Double-blind, Placebo-controlled Phase|Death|2|||
48804958|NCT02496767|157127959|FG004|Double-blind, Placebo-controlled Phase|Death|4|||
48804959|NCT02496767|157127960|FG005|Double-blind, Placebo-controlled Phase|Death|0|||
48804960|NCT02496767|157127961|FG006|Double-blind, Placebo-controlled Phase|Death|0|||
48804961|NCT02496767|157127962|FG007|Double-blind, Placebo-controlled Phase|Death|0|||
48804962|NCT02496767|157127955|FG000|Double-blind, Placebo-controlled Phase|Various|0|||
48804963|NCT02496767|157127956|FG001|Double-blind, Placebo-controlled Phase|Various|9|||
48804964|NCT02496767|157127957|FG002|Double-blind, Placebo-controlled Phase|Various|4|||
48804965|NCT02496767|157127958|FG003|Double-blind, Placebo-controlled Phase|Various|5|||
48804966|NCT02496767|157127959|FG004|Double-blind, Placebo-controlled Phase|Various|2|||
48804967|NCT02496767|157127960|FG005|Double-blind, Placebo-controlled Phase|Various|0|||
48804968|NCT02496767|157127961|FG006|Double-blind, Placebo-controlled Phase|Various|0|||
48804969|NCT02496767|157127962|FG007|Double-blind, Placebo-controlled Phase|Various|0|||
48804970|NCT02496767|157127955|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
48804971|NCT02496767|157127956|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4|||
48804972|NCT02496767|157127957|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3|||
48804973|NCT02496767|157127958|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1|||
48804974|NCT02496767|157127959|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2|||
48804975|NCT02496767|157127960|FG005|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
48804976|NCT02496767|157127961|FG006|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
48804977|NCT02496767|157127962|FG007|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
48804978|NCT02496767|157127955|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
48804979|NCT02496767|157127956|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|4|||
48804980|NCT02496767|157127957|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|1|||
48804981|NCT02496767|157127958|FG003|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
48804982|NCT02496767|157127959|FG004|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
48804983|NCT02496767|157127960|FG005|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
48804984|NCT02496767|157127961|FG006|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
48804985|NCT02496767|157127962|FG007|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
48804986|NCT02496767|157127955|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
48804987|NCT02496767|157127956|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
48804988|NCT02496767|157127957|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
48804989|NCT02496767|157127958|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
48804990|NCT02496767|157127959|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1|||
48804991|NCT02496767|157127960|FG005|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
48804992|NCT02496767|157127961|FG006|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
48804993|NCT02496767|157127962|FG007|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
48804994|NCT02496767|157127955|FG000|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
48804995|NCT02496767|157127956|FG001|Double-blind, Placebo-controlled Phase|Protocol Violation|1|||
48804996|NCT02496767|157127957|FG002|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
48804997|NCT02496767|157127958|FG003|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
48804998|NCT02496767|157127959|FG004|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
48804999|NCT02496767|157127960|FG005|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
48805000|NCT02496767|157127961|FG006|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
48805001|NCT02496767|157127962|FG007|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
48805002|NCT02496767|157127955|FG000|Double-blind, Withdrawal Phase|Progressive disease|0|||
48805003|NCT02496767|157127956|FG001|Double-blind, Withdrawal Phase|Progressive disease|0|||
48805004|NCT02496767|157127957|FG002|Double-blind, Withdrawal Phase|Progressive disease|0|||
48805005|NCT02496767|157127958|FG003|Double-blind, Withdrawal Phase|Progressive disease|0|||
48805006|NCT02496767|157127959|FG004|Double-blind, Withdrawal Phase|Progressive disease|0|||
48805007|NCT02496767|157127960|FG005|Double-blind, Withdrawal Phase|Progressive disease|4|||
48805008|NCT02496767|157127961|FG006|Double-blind, Withdrawal Phase|Progressive disease|0|||
48805009|NCT02496767|157127962|FG007|Double-blind, Withdrawal Phase|Progressive disease|1|||
48805010|NCT02496767|157127955|FG000|Double-blind, Withdrawal Phase|Adverse Event|0|||
49119291|NCT02504320|158274673|FG002|Treatment Period 2|Positive Drug Screen|0|||
49119292|NCT02504320|158274674|FG003|Treatment Period 2|Positive Drug Screen|0|||
49119293|NCT02504320|158274671|FG000|Treatment Period 3|Positive Drug Screen|0|||
48805011|NCT02496767|157127956|FG001|Double-blind, Withdrawal Phase|Adverse Event|0|||
49119294|NCT02504320|158274672|FG001|Treatment Period 3|Positive Drug Screen|0|||
49119295|NCT02504320|158274673|FG002|Treatment Period 3|Positive Drug Screen|0|||
49119296|NCT02504320|158274674|FG003|Treatment Period 3|Positive Drug Screen|1|||
49119297|NCT02504320|158274671|FG000|Treatment Period 3|Adverse Event|0|||
48805012|NCT02496767|157127957|FG002|Double-blind, Withdrawal Phase|Adverse Event|0|||
48805013|NCT02496767|157127958|FG003|Double-blind, Withdrawal Phase|Adverse Event|0|||
48805014|NCT02496767|157127959|FG004|Double-blind, Withdrawal Phase|Adverse Event|0|||
48805015|NCT02496767|157127960|FG005|Double-blind, Withdrawal Phase|Adverse Event|1|||
48805016|NCT02496767|157127961|FG006|Double-blind, Withdrawal Phase|Adverse Event|2|||
48805017|NCT02496767|157127962|FG007|Double-blind, Withdrawal Phase|Adverse Event|1|||
48805018|NCT02496767|157127955|FG000|Double-blind, Withdrawal Phase|Death|0|||
48805019|NCT02496767|157127956|FG001|Double-blind, Withdrawal Phase|Death|0|||
48805020|NCT02496767|157127957|FG002|Double-blind, Withdrawal Phase|Death|0|||
48805021|NCT02496767|157127958|FG003|Double-blind, Withdrawal Phase|Death|0|||
48805022|NCT02496767|157127959|FG004|Double-blind, Withdrawal Phase|Death|0|||
48805023|NCT02496767|157127960|FG005|Double-blind, Withdrawal Phase|Death|0|||
48805024|NCT02496767|157127961|FG006|Double-blind, Withdrawal Phase|Death|1|||
48805025|NCT02496767|157127962|FG007|Double-blind, Withdrawal Phase|Death|2|||
48805026|NCT02496767|157127955|FG000|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
48805027|NCT02496767|157127956|FG001|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
48805028|NCT02496767|157127957|FG002|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
48805029|NCT02496767|157127958|FG003|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
48805030|NCT02496767|157127959|FG004|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
48805031|NCT02496767|157127960|FG005|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
48805032|NCT02496767|157127961|FG006|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
48805033|NCT02496767|157127962|FG007|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
48805034|NCT05687916|157127964|FG000|Overall Study|Adverse Event|1|||
48805035|NCT05687916|157127965|FG001|Overall Study|Adverse Event|2|||
48805036|NCT05687916|157127966|FG002|Overall Study|Adverse Event|0|||
48805037|NCT05687916|157127964|FG000|Overall Study|Withdrawal by Subject|1|||
48805038|NCT05687916|157127965|FG001|Overall Study|Withdrawal by Subject|0|||
48805039|NCT05687916|157127966|FG002|Overall Study|Withdrawal by Subject|1|||
48805040|NCT05687916|157127964|FG000|Overall Study|Protocol Violation|0|||
48805041|NCT05687916|157127965|FG001|Overall Study|Protocol Violation|2|||
48805042|NCT05687916|157127966|FG002|Overall Study|Protocol Violation|1|||
48805043|NCT05687916|157127964|FG000|Overall Study|Reason not Specified|1|||
48805044|NCT05687916|157127965|FG001|Overall Study|Reason not Specified|0|||
48805045|NCT05687916|157127966|FG002|Overall Study|Reason not Specified|0|||
48805046|NCT01490125|157127967|FG000|Period I|Adverse Event|4|||
48805047|NCT01490125|157127968|FG001|Period I|Adverse Event|1|||
48805048|NCT01490125|157127969|FG002|Period I|Adverse Event|1|||
48805049|NCT01490125|157127970|FG003|Period I|Adverse Event|3|||
48805050|NCT01490125|157127971|FG004|Period I|Adverse Event|2|||
48805051|NCT01490125|157127972|FG005|Period I|Adverse Event|4|||
48805052|NCT01490125|157127967|FG000|Period I|Protocol Violation|1|||
48805053|NCT01490125|157127968|FG001|Period I|Protocol Violation|1|||
48805054|NCT01490125|157127969|FG002|Period I|Protocol Violation|1|||
48805055|NCT01490125|157127970|FG003|Period I|Protocol Violation|1|||
48805056|NCT01490125|157127971|FG004|Period I|Protocol Violation|0|||
48805057|NCT01490125|157127972|FG005|Period I|Protocol Violation|0|||
48805058|NCT01490125|157127967|FG000|Period I|Withdrawal by Subject|1|||
48805059|NCT01490125|157127968|FG001|Period I|Withdrawal by Subject|3|||
48805060|NCT01490125|157127969|FG002|Period I|Withdrawal by Subject|2|||
48805061|NCT01490125|157127970|FG003|Period I|Withdrawal by Subject|1|||
48805062|NCT01490125|157127971|FG004|Period I|Withdrawal by Subject|2|||
48805063|NCT01490125|157127972|FG005|Period I|Withdrawal by Subject|1|||
49119298|NCT02504320|158274672|FG001|Treatment Period 3|Adverse Event|0|||
49119299|NCT02504320|158274673|FG002|Treatment Period 3|Adverse Event|1|||
49119300|NCT02504320|158274674|FG003|Treatment Period 3|Adverse Event|0|||
49119301|NCT00905424|158274675|FG000|Overall Study|Lost to Follow-up|3|||
48805064|NCT01490125|157127967|FG000|Period II|Adverse Event|2|||
48805065|NCT01490125|157127968|FG001|Period II|Adverse Event|3|||
49119302|NCT00905424|158274676|FG001|Overall Study|Lost to Follow-up|3|||
49119303|NCT00905424|158274675|FG000|Overall Study|Withdrawal by Subject|1|||
48805066|NCT01490125|157127969|FG002|Period II|Adverse Event|2|||
48805067|NCT01490125|157127970|FG003|Period II|Adverse Event|2|||
49119304|NCT00905424|158274676|FG001|Overall Study|Withdrawal by Subject|2|||
49119305|NCT00905424|158274675|FG000|Overall Study|Adverse Event|4|||
49119306|NCT00905424|158274676|FG001|Overall Study|Adverse Event|2|||
48805068|NCT01490125|157127971|FG004|Period II|Adverse Event|4|||
49119307|NCT00905424|158274675|FG000|Overall Study|Non-compliance with study medication|2|||
48805069|NCT01490125|157127972|FG005|Period II|Adverse Event|2|||
49119308|NCT00905424|158274676|FG001|Overall Study|Non-compliance with study medication|0|||
49119309|NCT00905424|158274675|FG000|Overall Study|Sponsor decision|1|||
49119310|NCT00905424|158274676|FG001|Overall Study|Sponsor decision|0|||
49119311|NCT00905424|158274675|FG000|Overall Study|Positive urine drug screen|0|||
49119312|NCT00905424|158274676|FG001|Overall Study|Positive urine drug screen|1|||
49119313|NCT00905424|158274675|FG000|Overall Study|Non-adherence to visit schedule|0|||
49119314|NCT00905424|158274676|FG001|Overall Study|Non-adherence to visit schedule|1|||
49119315|NCT01211145|158274678|FG000|Overall Study|Reason not specified|3|||
49119316|NCT01211145|158274679|FG001|Overall Study|Reason not specified|2|||
49119317|NCT01211145|158274680|FG002|Overall Study|Reason not specified|2|||
48805070|NCT01490125|157127967|FG000|Period II|Protocol Violation|0|||
48805071|NCT01490125|157127968|FG001|Period II|Protocol Violation|0|||
48805072|NCT01490125|157127969|FG002|Period II|Protocol Violation|1|||
48805073|NCT01490125|157127970|FG003|Period II|Protocol Violation|1|||
48805074|NCT01490125|157127971|FG004|Period II|Protocol Violation|0|||
48805075|NCT01490125|157127972|FG005|Period II|Protocol Violation|0|||
48805076|NCT01490125|157127967|FG000|Period II|Lost to Follow-up|0|||
48805077|NCT01490125|157127968|FG001|Period II|Lost to Follow-up|1|||
48805078|NCT01490125|157127969|FG002|Period II|Lost to Follow-up|0|||
48805079|NCT01490125|157127970|FG003|Period II|Lost to Follow-up|0|||
48805080|NCT01490125|157127971|FG004|Period II|Lost to Follow-up|0|||
48805081|NCT01490125|157127972|FG005|Period II|Lost to Follow-up|0|||
48805082|NCT01490125|157127967|FG000|Period II|Withdrawal by Subject|1|||
48805083|NCT01490125|157127968|FG001|Period II|Withdrawal by Subject|0|||
48805084|NCT01490125|157127969|FG002|Period II|Withdrawal by Subject|0|||
48805085|NCT01490125|157127970|FG003|Period II|Withdrawal by Subject|0|||
48805086|NCT01490125|157127971|FG004|Period II|Withdrawal by Subject|0|||
48805087|NCT01490125|157127972|FG005|Period II|Withdrawal by Subject|0|||
48805088|NCT01490125|157127967|FG000|Period III|Adverse Event|3|||
48805089|NCT01490125|157127968|FG001|Period III|Adverse Event|1|||
48805090|NCT01490125|157127969|FG002|Period III|Adverse Event|0|||
48805091|NCT01490125|157127970|FG003|Period III|Adverse Event|1|||
48805092|NCT01490125|157127971|FG004|Period III|Adverse Event|0|||
48805093|NCT01490125|157127972|FG005|Period III|Adverse Event|0|||
48805094|NCT01490125|157127967|FG000|Period III|Death|0|||
48805095|NCT01490125|157127968|FG001|Period III|Death|0|||
48805096|NCT01490125|157127969|FG002|Period III|Death|0|||
48805097|NCT01490125|157127970|FG003|Period III|Death|1|||
48805098|NCT01490125|157127971|FG004|Period III|Death|0|||
48805099|NCT01490125|157127972|FG005|Period III|Death|0|||
48805100|NCT01490125|157127967|FG000|Period III|Lack of Efficacy|0|||
49119318|NCT01211145|158274681|FG003|Overall Study|Reason not specified|1|||
49119319|NCT01211145|158274678|FG000|Overall Study|Lost to Follow-up|3|||
49119320|NCT01211145|158274679|FG001|Overall Study|Lost to Follow-up|2|||
48805101|NCT01490125|157127968|FG001|Period III|Lack of Efficacy|0|||
48805102|NCT01490125|157127969|FG002|Period III|Lack of Efficacy|0|||
48805103|NCT01490125|157127970|FG003|Period III|Lack of Efficacy|0|||
48805104|NCT01490125|157127971|FG004|Period III|Lack of Efficacy|1|||
48805105|NCT01490125|157127972|FG005|Period III|Lack of Efficacy|0|||
48805106|NCT02237508|157127973|FG000|Overall Study|Withdrawal by Subject|0|||
48805107|NCT02237508|157127974|FG001|Overall Study|Withdrawal by Subject|2|||
48805108|NCT02237508|157127975|FG002|Overall Study|Withdrawal by Subject|0|||
48805109|NCT02237508|157127976|FG003|Overall Study|Withdrawal by Subject|1|||
48805110|NCT02237508|157127977|FG004|Overall Study|Withdrawal by Subject|0|||
48805111|NCT02237508|157127978|FG005|Overall Study|Withdrawal by Subject|1|||
48805112|NCT02237508|157127979|FG006|Overall Study|Withdrawal by Subject|1|||
48805113|NCT02237508|157127980|FG007|Overall Study|Withdrawal by Subject|0|||
48805114|NCT02237508|157127981|FG008|Overall Study|Withdrawal by Subject|1|||
48805115|NCT02237508|157127982|FG009|Overall Study|Withdrawal by Subject|0|||
48805116|NCT02237508|157127973|FG000|Overall Study|Physician Decision|0|||
48805117|NCT02237508|157127974|FG001|Overall Study|Physician Decision|1|||
48805118|NCT02237508|157127975|FG002|Overall Study|Physician Decision|0|||
48805119|NCT02237508|157127976|FG003|Overall Study|Physician Decision|0|||
48805120|NCT02237508|157127977|FG004|Overall Study|Physician Decision|0|||
48805121|NCT02237508|157127978|FG005|Overall Study|Physician Decision|0|||
48805122|NCT02237508|157127979|FG006|Overall Study|Physician Decision|0|||
48805123|NCT02237508|157127980|FG007|Overall Study|Physician Decision|0|||
48805124|NCT02237508|157127981|FG008|Overall Study|Physician Decision|0|||
48805125|NCT02237508|157127982|FG009|Overall Study|Physician Decision|0|||
48805126|NCT02237508|157127973|FG000|Overall Study|Protocol Violation|0|||
48805127|NCT02237508|157127974|FG001|Overall Study|Protocol Violation|0|||
48805128|NCT02237508|157127975|FG002|Overall Study|Protocol Violation|1|||
48805129|NCT02237508|157127976|FG003|Overall Study|Protocol Violation|0|||
48805130|NCT02237508|157127977|FG004|Overall Study|Protocol Violation|0|||
48805131|NCT02237508|157127978|FG005|Overall Study|Protocol Violation|0|||
48805132|NCT02237508|157127979|FG006|Overall Study|Protocol Violation|0|||
48805133|NCT02237508|157127980|FG007|Overall Study|Protocol Violation|0|||
48805134|NCT02237508|157127981|FG008|Overall Study|Protocol Violation|0|||
48805135|NCT02237508|157127982|FG009|Overall Study|Protocol Violation|0|||
49119321|NCT01211145|158274680|FG002|Overall Study|Lost to Follow-up|1|||
48805136|NCT01931735|157127985|FG000|Randomized Phase|Lost to Follow-up|2|||
48805137|NCT01931735|157127986|FG001|Randomized Phase|Lost to Follow-up|2|||
48805138|NCT01931735|157127987|FG002|Randomized Phase|Lost to Follow-up|5|||
48805139|NCT01931735|157127988|FG003|Randomized Phase|Lost to Follow-up|0|||
48805140|NCT01931735|157127985|FG000|Observational Non-Randomized Phase|Adverse Event|0|||
48805141|NCT01931735|157127986|FG001|Observational Non-Randomized Phase|Adverse Event|0|||
48805142|NCT01931735|157127987|FG002|Observational Non-Randomized Phase|Adverse Event|0|||
48805143|NCT01931735|157127988|FG003|Observational Non-Randomized Phase|Adverse Event|1|||
48805144|NCT01931735|157127985|FG000|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
48805145|NCT01931735|157127986|FG001|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
48805146|NCT01931735|157127987|FG002|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
48805147|NCT01931735|157127988|FG003|Observational Non-Randomized Phase|Withdrawal by Subject|1|||
48805148|NCT00990340|157127991|FG000|First 14-day Treatment|Not Compliant|2|||
48805149|NCT00990340|157127992|FG001|First 14-day Treatment|Not Compliant|1|||
48805150|NCT00990340|157127991|FG000|First 14-day Treatment|Lost to Follow-up|2|||
48805151|NCT00990340|157127992|FG001|First 14-day Treatment|Lost to Follow-up|1|||
48805152|NCT00990340|157127991|FG000|First 14-day Treatment|Protocol Violation|2|||
48805153|NCT00990340|157127992|FG001|First 14-day Treatment|Protocol Violation|2|||
48805154|NCT04209855|157127994|FG000|Overall Study|Adverse Event|20|||
48805155|NCT04209855|157127995|FG001|Overall Study|Adverse Event|28|||
48805156|NCT04209855|157127994|FG000|Overall Study|Death|3|||
48805157|NCT04209855|157127995|FG001|Overall Study|Death|1|||
48805158|NCT04209855|157127994|FG000|Overall Study|Principal Investigator (PI) Discretion|4|||
48805159|NCT04209855|157127995|FG001|Overall Study|Principal Investigator (PI) Discretion|9|||
48805160|NCT04209855|157127994|FG000|Overall Study|Participant Withdrew Consent to Treatment|4|||
48805161|NCT04209855|157127995|FG001|Overall Study|Participant Withdrew Consent to Treatment|11|||
48805162|NCT04209855|157127994|FG000|Overall Study|Participant Withdrew Consent to Treatment and Follow-Up|4|||
48805163|NCT04209855|157127995|FG001|Overall Study|Participant Withdrew Consent to Treatment and Follow-Up|15|||
48805164|NCT04209855|157127994|FG000|Overall Study|Progressive Disease|154|||
48805165|NCT04209855|157127995|FG001|Overall Study|Progressive Disease|145|||
48805166|NCT04209855|157127994|FG000|Overall Study|Protocol Deviation|1|||
48805167|NCT04209855|157127995|FG001|Overall Study|Protocol Deviation|1|||
48805168|NCT04209855|157127994|FG000|Overall Study|Other Than Specified|5|||
48805169|NCT04209855|157127995|FG001|Overall Study|Other Than Specified|10|||
48805170|NCT01933880|157127996|FG000|Overall Study|Withdrawal by Subject|5|||
48805171|NCT01933880|157127997|FG001|Overall Study|Withdrawal by Subject|0|||
48805172|NCT01933880|157127996|FG000|Overall Study|Lack of Efficacy|1|||
48805173|NCT01933880|157127997|FG001|Overall Study|Lack of Efficacy|0|||
48805174|NCT01933880|157127996|FG000|Overall Study|Concomitant medication Interference|0|||
48805175|NCT01933880|157127997|FG001|Overall Study|Concomitant medication Interference|1|||
48805176|NCT01933880|157127996|FG000|Overall Study|Followup exceeded 4 days to visit window|19|||
48805177|NCT01933880|157127997|FG001|Overall Study|Followup exceeded 4 days to visit window|0|||
48805178|NCT01933880|157127996|FG000|Overall Study|Other|4|||
48805179|NCT01933880|157127997|FG001|Overall Study|Other|0|||
48805180|NCT01933880|157127996|FG000|Overall Study|Protocol Violation|1|||
48805181|NCT01933880|157127997|FG001|Overall Study|Protocol Violation|0|||
48805182|NCT00118092|157127998|FG000|Overall Study|Withdrawal by Subject|1|||
48805183|NCT00118092|157127998|FG000|Overall Study|Protocol Violation|1|||
48805184|NCT03091192|157128005|FG000|Overall Study|Study terminated by sponsor|21|||
48805185|NCT03091192|157128006|FG001|Overall Study|Study terminated by sponsor|14|||
48805186|NCT03091192|157128005|FG000|Overall Study|Death|9|||
48805187|NCT03091192|157128006|FG001|Overall Study|Death|13|||
48805188|NCT03091192|157128005|FG000|Overall Study|Withdrawal by Subject|2|||
48805189|NCT03091192|157128006|FG001|Overall Study|Withdrawal by Subject|0|||
48805190|NCT03091192|157128005|FG000|Overall Study|Lost to Follow-up|1|||
48805191|NCT03091192|157128006|FG001|Overall Study|Lost to Follow-up|0|||
48805192|NCT03183388|157129300|FG000|Overall Study|Lost to Follow-up|3|||
48805193|NCT03183388|157129301|FG001|Overall Study|Lost to Follow-up|5|||
48805194|NCT03183388|157129300|FG000|Overall Study|Physician Decision|1|||
48805195|NCT03183388|157129301|FG001|Overall Study|Physician Decision|4|||
48805196|NCT03183388|157129300|FG000|Overall Study|Withdrawal by Subject|4|||
48805197|NCT03183388|157129301|FG001|Overall Study|Withdrawal by Subject|1|||
48805198|NCT03183388|157129300|FG000|Overall Study|Moved|1|||
48805199|NCT03183388|157129301|FG001|Overall Study|Moved|0|||
48805200|NCT03183388|157129300|FG000|Overall Study|Met Exclusion Criteria|2|||
48805201|NCT03183388|157129301|FG001|Overall Study|Met Exclusion Criteria|2|||
48805202|NCT03183388|157129300|FG000|Overall Study|COVID Pandemic Related|2|||
48805203|NCT03183388|157129301|FG001|Overall Study|COVID Pandemic Related|4|||
48805204|NCT02799472|157129303|FG000|Overall Study|Withdrawal by Subject|2|||
48805205|NCT02799472|157129304|FG001|Overall Study|Withdrawal by Subject|4|||
48805206|NCT02799472|157129303|FG000|Overall Study|Lack of Efficacy|2|||
49010701|NCT03387059|157875681|FG000|Overall Study|Study termination|5|||
48805207|NCT02799472|157129304|FG001|Overall Study|Lack of Efficacy|0|||
48805208|NCT02799472|157129303|FG000|Overall Study|Lost to Follow-up|0|||
48805209|NCT02799472|157129304|FG001|Overall Study|Lost to Follow-up|1|||
48805210|NCT02696564|157129305|FG000|Overall Study|Death|1|||
48805211|NCT02696564|157129306|FG001|Overall Study|Death|2|||
48805212|NCT02696564|157129305|FG000|Overall Study|Withdrawal by Subject|3|||
48805213|NCT02696564|157129306|FG001|Overall Study|Withdrawal by Subject|2|||
48805214|NCT02696564|157129305|FG000|Overall Study|Lost to Follow-up|3|||
48805215|NCT02696564|157129306|FG001|Overall Study|Lost to Follow-up|3|||
48805216|NCT02696564|157129305|FG000|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|3|||
48805217|NCT02696564|157129306|FG001|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|1|||
48805218|NCT02696564|157129305|FG000|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
48805219|NCT02696564|157129306|FG001|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
48915565|NCT00111800|157526598|FG004|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
48915566|NCT00111800|157526599|FG005|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
48915567|NCT00111800|157526594|FG000|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
48915568|NCT00111800|157526595|FG001|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1|||
48915569|NCT00111800|157526596|FG002|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
48915570|NCT00111800|157526597|FG003|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
48915571|NCT00111800|157526598|FG004|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
48915572|NCT00111800|157526599|FG005|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
48915573|NCT00111800|157526594|FG000|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
48915574|NCT00111800|157526595|FG001|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1|||
48915575|NCT00111800|157526596|FG002|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
48915576|NCT00111800|157526597|FG003|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
48915577|NCT00111800|157526598|FG004|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
48915578|NCT00111800|157526599|FG005|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
48915579|NCT00111800|157526594|FG000|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
48915580|NCT00111800|157526595|FG001|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1|||
48915581|NCT00111800|157526596|FG002|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
48915582|NCT00111800|157526597|FG003|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
48915583|NCT00111800|157526598|FG004|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
48915584|NCT00111800|157526599|FG005|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
48915585|NCT00111800|157526594|FG000|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
48915586|NCT00111800|157526595|FG001|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
48915587|NCT00111800|157526596|FG002|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
48915588|NCT00111800|157526597|FG003|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1|||
48915589|NCT00111800|157526598|FG004|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
48915590|NCT00111800|157526599|FG005|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
48915591|NCT00111800|157526594|FG000|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
48915592|NCT00111800|157526595|FG001|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
48915593|NCT00111800|157526596|FG002|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
48915594|NCT00111800|157526597|FG003|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1|||
48915595|NCT00111800|157526598|FG004|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
48915596|NCT00111800|157526599|FG005|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
48915597|NCT00111800|157526594|FG000|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
48915598|NCT00111800|157526595|FG001|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
48915599|NCT00111800|157526596|FG002|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
48915600|NCT00111800|157526597|FG003|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
48915601|NCT00111800|157526598|FG004|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1|||
48915602|NCT00111800|157526599|FG005|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
48915603|NCT00111800|157526594|FG000|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
48915604|NCT00111800|157526595|FG001|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
48915605|NCT00111800|157526596|FG002|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
48915606|NCT00111800|157526597|FG003|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
48915607|NCT00111800|157526598|FG004|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1|||
48915608|NCT00111800|157526599|FG005|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
48915609|NCT00111800|157526594|FG000|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
48915610|NCT00111800|157526595|FG001|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
48915611|NCT00111800|157526596|FG002|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
48915612|NCT00111800|157526597|FG003|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
48915613|NCT00111800|157526598|FG004|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
48915614|NCT00111800|157526599|FG005|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1|||
48915615|NCT00111800|157526594|FG000|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
48915616|NCT00111800|157526595|FG001|Period 2: Extension Phase (12 Weeks)|Adverse Event|2|||
48915617|NCT00111800|157526596|FG002|Period 2: Extension Phase (12 Weeks)|Adverse Event|1|||
48915618|NCT00111800|157526597|FG003|Period 2: Extension Phase (12 Weeks)|Adverse Event|3|||
48915619|NCT00111800|157526598|FG004|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
48915620|NCT00111800|157526599|FG005|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
48915621|NCT00111800|157526594|FG000|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
48915622|NCT00111800|157526595|FG001|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
48915623|NCT00111800|157526596|FG002|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
48915624|NCT00111800|157526597|FG003|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
48915625|NCT00111800|157526598|FG004|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
48915626|NCT00111800|157526599|FG005|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
48915627|NCT00111800|157526594|FG000|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
48915628|NCT00111800|157526595|FG001|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
48915629|NCT00111800|157526596|FG002|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
48915630|NCT00111800|157526597|FG003|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
48915631|NCT00111800|157526598|FG004|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3|||
48915632|NCT00111800|157526599|FG005|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
48915633|NCT00111800|157526594|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
48915634|NCT00111800|157526595|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
48915635|NCT00111800|157526596|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
48915636|NCT00111800|157526597|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
48915637|NCT00111800|157526598|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
48915638|NCT00111800|157526599|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
48915639|NCT00111800|157526594|FG000|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
48915640|NCT00111800|157526595|FG001|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
48915641|NCT00111800|157526596|FG002|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0|||
48915642|NCT00111800|157526597|FG003|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
48915643|NCT00111800|157526598|FG004|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
48915644|NCT00111800|157526599|FG005|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
48915645|NCT00111800|157526594|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
48915646|NCT00111800|157526595|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1|||
48915647|NCT00111800|157526596|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
48915648|NCT00111800|157526597|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
48915649|NCT00111800|157526598|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
48915650|NCT00111800|157526599|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
48915651|NCT00111800|157526594|FG000|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
48915652|NCT00111800|157526595|FG001|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
48915653|NCT00111800|157526596|FG002|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1|||
48915654|NCT00111800|157526597|FG003|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
48915655|NCT00111800|157526598|FG004|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
48915656|NCT00111800|157526599|FG005|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
48915657|NCT00111800|157526594|FG000|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
48915658|NCT00111800|157526595|FG001|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
48915659|NCT00111800|157526596|FG002|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1|||
48915660|NCT00111800|157526597|FG003|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
48915661|NCT00111800|157526598|FG004|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
48915662|NCT00111800|157526599|FG005|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
48915663|NCT00914927|157526600|FG000|Overall Study|Adverse Event|0|||
48915664|NCT00914927|157526601|FG001|Overall Study|Adverse Event|0|||
48915665|NCT00914927|157526602|FG002|Overall Study|Adverse Event|0|||
48915666|NCT00914927|157526603|FG003|Overall Study|Adverse Event|0|||
48915667|NCT00914927|157526604|FG004|Overall Study|Adverse Event|1|||
48915668|NCT00914927|157526605|FG005|Overall Study|Adverse Event|0|||
48915669|NCT00914927|157526606|FG006|Overall Study|Adverse Event|0|||
48915670|NCT00914927|157526600|FG000|Overall Study|Withdrawal by Subject|0|||
48915671|NCT00914927|157526601|FG001|Overall Study|Withdrawal by Subject|1|||
48915672|NCT00914927|157526602|FG002|Overall Study|Withdrawal by Subject|0|||
48915673|NCT00914927|157526603|FG003|Overall Study|Withdrawal by Subject|1|||
48915674|NCT00914927|157526604|FG004|Overall Study|Withdrawal by Subject|0|||
48915675|NCT00914927|157526605|FG005|Overall Study|Withdrawal by Subject|0|||
48915676|NCT00914927|157526606|FG006|Overall Study|Withdrawal by Subject|0|||
48915677|NCT00914927|157526600|FG000|Overall Study|Lost to Follow-up|0|||
48915678|NCT00914927|157526601|FG001|Overall Study|Lost to Follow-up|0|||
48915679|NCT00914927|157526602|FG002|Overall Study|Lost to Follow-up|0|||
48915680|NCT00914927|157526603|FG003|Overall Study|Lost to Follow-up|1|||
48915681|NCT00914927|157526604|FG004|Overall Study|Lost to Follow-up|0|||
48915682|NCT00914927|157526605|FG005|Overall Study|Lost to Follow-up|0|||
48915683|NCT00914927|157526606|FG006|Overall Study|Lost to Follow-up|0|||
48915684|NCT00914927|157526600|FG000|Overall Study|Administrative/Other|2|||
48915685|NCT00914927|157526601|FG001|Overall Study|Administrative/Other|1|||
48915686|NCT00914927|157526602|FG002|Overall Study|Administrative/Other|0|||
48915687|NCT00914927|157526603|FG003|Overall Study|Administrative/Other|0|||
48915688|NCT00914927|157526604|FG004|Overall Study|Administrative/Other|1|||
48915689|NCT00914927|157526605|FG005|Overall Study|Administrative/Other|0|||
48915690|NCT00914927|157526606|FG006|Overall Study|Administrative/Other|0|||
48915691|NCT00253643|157526607|FG000|Overall Study|Withdrawal by Subject|0|||
48915692|NCT00253643|157526608|FG001|Overall Study|Withdrawal by Subject|0|||
48915693|NCT00253643|157526609|FG002|Overall Study|Withdrawal by Subject|1|||
48915694|NCT00253643|157526610|FG003|Overall Study|Withdrawal by Subject|1|||
48915695|NCT00253643|157526607|FG000|Overall Study|Non-Compliance|0|||
48915696|NCT00253643|157526608|FG001|Overall Study|Non-Compliance|0|||
48915697|NCT00253643|157526609|FG002|Overall Study|Non-Compliance|0|||
48915698|NCT00253643|157526610|FG003|Overall Study|Non-Compliance|2|||
48915699|NCT02256540|157526611|FG000|Overall Study|Withdrawal by Subject|0|||
48915700|NCT02256540|157526612|FG001|Overall Study|Withdrawal by Subject|1|||
48708971|NCT01069900|156784166|FG001|Overall Study|Technical problems|1|||
48708972|NCT01069900|156784165|FG000|Overall Study|Lost to Follow-up|7|||
48708973|NCT01069900|156784166|FG001|Overall Study|Lost to Follow-up|1|||
48708974|NCT01069900|156784165|FG000|Overall Study|Withdrawal by Subject|6|||
48708975|NCT01069900|156784166|FG001|Overall Study|Withdrawal by Subject|1|||
48708976|NCT01069900|156784165|FG000|Overall Study|Protocol Violation|4|||
48708977|NCT01069900|156784166|FG001|Overall Study|Protocol Violation|1|||
48708978|NCT01069900|156784165|FG000|Overall Study|Insufficient Therapeutic effect|1|||
48708979|NCT01069900|156784166|FG001|Overall Study|Insufficient Therapeutic effect|0|||
48915701|NCT02256540|157526613|FG002|Overall Study|Withdrawal by Subject|1|||
48708980|NCT01417377|156784168|FG000|Overall Study|Lost to Follow-up|12|||
48708981|NCT01417377|156784168|FG000|Overall Study|Enrolled, but not treated|1|||
48708982|NCT01621802|156784169|FG000|Overall Study|Protocol Violation|0|||
48708983|NCT01621802|156784170|FG001|Overall Study|Protocol Violation|0|||
48708984|NCT01621802|156784171|FG002|Overall Study|Protocol Violation|0|||
48708985|NCT01621802|156784172|FG003|Overall Study|Protocol Violation|0|||
48915702|NCT02256540|157526611|FG000|Overall Study|Back pain preventing exercise|0|||
48915703|NCT02256540|157526612|FG001|Overall Study|Back pain preventing exercise|0|||
48915704|NCT02256540|157526613|FG002|Overall Study|Back pain preventing exercise|1|||
48915705|NCT01236573|157526614|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
48915706|NCT01236573|157526615|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
49119322|NCT01211145|158274681|FG003|Overall Study|Lost to Follow-up|2|||
48708986|NCT01621802|156784173|FG004|Overall Study|Protocol Violation|0|||
48708987|NCT01621802|156784174|FG005|Overall Study|Protocol Violation|1|||
48915707|NCT01236573|157526616|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
48915708|NCT01236573|157526617|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
48915709|NCT01236573|157526618|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
48915710|NCT01236573|157526619|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
48915711|NCT01236573|157526620|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
48915712|NCT01236573|157526621|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
49119323|NCT01211145|158274678|FG000|Overall Study|Study-specific withdrawal criteria|1|||
49119324|NCT01211145|158274679|FG001|Overall Study|Study-specific withdrawal criteria|0|||
49119325|NCT01211145|158274680|FG002|Overall Study|Study-specific withdrawal criteria|0|||
49119326|NCT01211145|158274681|FG003|Overall Study|Study-specific withdrawal criteria|0|||
49119327|NCT01211145|158274678|FG000|Overall Study|Severe noncompliance to protocol|1|||
49119328|NCT01211145|158274679|FG001|Overall Study|Severe noncompliance to protocol|0|||
49119329|NCT01211145|158274680|FG002|Overall Study|Severe noncompliance to protocol|0|||
49119330|NCT01211145|158274681|FG003|Overall Study|Severe noncompliance to protocol|0|||
48708988|NCT01621802|156784169|FG000|Overall Study|Withdrawal by Subject|8|||
48915713|NCT01236573|157526622|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
48805220|NCT02696564|157129305|FG000|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
48915714|NCT01236573|157526623|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
48915715|NCT01236573|157526624|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
48915716|NCT01236573|157526614|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
48915717|NCT01236573|157526615|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
48915718|NCT01236573|157526616|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
48915719|NCT01236573|157526617|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
48915720|NCT01236573|157526618|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
48915721|NCT01236573|157526619|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
48915722|NCT01236573|157526620|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
48915723|NCT01236573|157526621|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
48915724|NCT01236573|157526622|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1|||
48915725|NCT01236573|157526623|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
48915726|NCT01236573|157526624|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
48915727|NCT01236573|157526614|FG000|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
48915728|NCT01236573|157526615|FG001|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
48915729|NCT01236573|157526616|FG002|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
48915730|NCT01236573|157526617|FG003|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
48915731|NCT01236573|157526618|FG004|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
48915732|NCT01236573|157526619|FG005|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
48915733|NCT01236573|157526620|FG006|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
48915734|NCT01236573|157526621|FG007|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
48915735|NCT01236573|157526622|FG008|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
48915736|NCT01236573|157526623|FG009|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
48805221|NCT02696564|157129306|FG001|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
48805222|NCT02696564|157129305|FG000|Overall Study|Participant diagnosed with lung cancer|1|||
48805223|NCT02696564|157129306|FG001|Overall Study|Participant diagnosed with lung cancer|0|||
48805224|NCT02696564|157129305|FG000|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|0|||
48805225|NCT02696564|157129306|FG001|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|2|||
48805226|NCT04067401|157129307|FG000|Overall Study|Withdrawal by Subject|7|||
48805227|NCT04067401|157129308|FG001|Overall Study|Withdrawal by Subject|0|||
48805228|NCT04067401|157129307|FG000|Overall Study|no data provided|1|||
48805229|NCT04067401|157129308|FG001|Overall Study|no data provided|0|||
48805230|NCT01722162|157129317|FG000|Overall Study|Withdrawal by Subject|1|||
48805231|NCT01722162|157129318|FG001|Overall Study|Withdrawal by Subject|1|||
48805232|NCT01722162|157129317|FG000|Overall Study|Found ineligible|1|||
48805233|NCT01722162|157129318|FG001|Overall Study|Found ineligible|0|||
48805234|NCT01722162|157129317|FG000|Overall Study|Unrelated to study adverse event|2|||
48805235|NCT01722162|157129318|FG001|Overall Study|Unrelated to study adverse event|2|||
48805236|NCT01722162|157129317|FG000|Overall Study|Adverse Event|1|||
48805237|NCT01722162|157129318|FG001|Overall Study|Adverse Event|1|||
48805238|NCT01722162|157129317|FG000|Overall Study|Insurance denial post enrollment|0|||
48805239|NCT01722162|157129318|FG001|Overall Study|Insurance denial post enrollment|1|||
48805240|NCT01722162|157129317|FG000|Overall Study|Noncompliance|0|||
48805241|NCT01722162|157129318|FG001|Overall Study|Noncompliance|1|||
48805242|NCT02312856|157129320|FG000|Overall Study|Death|1|||
48805243|NCT02312856|157129320|FG000|Overall Study|Lost to Follow-up|3|||
48805244|NCT02309112|157129321|FG000|Overall Study|Withdrawal by Subject|1|||
48805245|NCT02309112|157129322|FG001|Overall Study|Withdrawal by Subject|0|||
48805246|NCT02309112|157129323|FG002|Overall Study|Withdrawal by Subject|1|||
48805247|NCT02309112|157129321|FG000|Overall Study|Lost to Follow-up|0|||
48805248|NCT02309112|157129322|FG001|Overall Study|Lost to Follow-up|1|||
48805249|NCT02309112|157129323|FG002|Overall Study|Lost to Follow-up|0|||
48805250|NCT01892345|157129324|FG000|Overall Study|Adverse Event|0|||
48805251|NCT01892345|157129325|FG001|Overall Study|Adverse Event|2|||
48805252|NCT01892345|157129324|FG000|Overall Study|Death|1|||
48805253|NCT01892345|157129325|FG001|Overall Study|Death|0|||
48805254|NCT01892345|157129324|FG000|Overall Study|Lost to Follow-up|3|||
48805255|NCT01892345|157129325|FG001|Overall Study|Lost to Follow-up|0|||
48805256|NCT01892345|157129324|FG000|Overall Study|Withdrawal by Subject|12|||
48805257|NCT01892345|157129325|FG001|Overall Study|Withdrawal by Subject|1|||
48805258|NCT04673929|157129328|FG000|Overall Study|Death|73|||
48805259|NCT04673929|157129328|FG000|Overall Study|Did not reach the 2 year follow up point (observational study)|43|||
48805260|NCT00985985|157129331|FG000|Overall Study|Adverse Event|4|||
48805261|NCT00985985|157129332|FG001|Overall Study|Adverse Event|2|||
48805262|NCT00985985|157129333|FG002|Overall Study|Adverse Event|2|||
48805263|NCT00985985|157129334|FG003|Overall Study|Adverse Event|2|||
48805264|NCT00985985|157129331|FG000|Overall Study|Lost to Follow-up|4|||
48915737|NCT01236573|157526624|FG010|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1|||
48805265|NCT00985985|157129332|FG001|Overall Study|Lost to Follow-up|11|||
48805266|NCT00985985|157129333|FG002|Overall Study|Lost to Follow-up|2|||
48805267|NCT00985985|157129334|FG003|Overall Study|Lost to Follow-up|3|||
48805268|NCT00985985|157129331|FG000|Overall Study|Protocol Violation|1|||
48805269|NCT00985985|157129332|FG001|Overall Study|Protocol Violation|2|||
48805270|NCT00985985|157129333|FG002|Overall Study|Protocol Violation|0|||
48805271|NCT00985985|157129334|FG003|Overall Study|Protocol Violation|1|||
48805272|NCT00985985|157129331|FG000|Overall Study|Lack of Efficacy|5|||
48805273|NCT00985985|157129332|FG001|Overall Study|Lack of Efficacy|6|||
48805274|NCT00985985|157129333|FG002|Overall Study|Lack of Efficacy|1|||
48805275|NCT00985985|157129334|FG003|Overall Study|Lack of Efficacy|3|||
48805276|NCT00985985|157129331|FG000|Overall Study|Withdrawal by Subject|4|||
48915738|NCT03668600|157526625|FG000|Overall Study|Study Terminated by the Sponsor|157|||
48915739|NCT03668600|157526625|FG000|Overall Study|Protocol Violation|1|||
48805277|NCT00985985|157129332|FG001|Overall Study|Withdrawal by Subject|2|||
48805278|NCT00985985|157129333|FG002|Overall Study|Withdrawal by Subject|2|||
48805279|NCT00985985|157129334|FG003|Overall Study|Withdrawal by Subject|2|||
48805280|NCT00985985|157129331|FG000|Overall Study|Other Reason|6|||
48805281|NCT00985985|157129332|FG001|Overall Study|Other Reason|1|||
48805282|NCT00985985|157129333|FG002|Overall Study|Other Reason|4|||
48805283|NCT00985985|157129334|FG003|Overall Study|Other Reason|2|||
48805284|NCT01364597|157129337|FG000|Overall Study|Adverse Event|4|||
48805285|NCT01364597|157129338|FG001|Overall Study|Adverse Event|5|||
48805286|NCT01364597|157129339|FG002|Overall Study|Adverse Event|16|||
48805287|NCT01364597|157129340|FG003|Overall Study|Adverse Event|7|||
48805288|NCT01364597|157129337|FG000|Overall Study|Lack of Efficacy|4|||
48805289|NCT01364597|157129338|FG001|Overall Study|Lack of Efficacy|4|||
48805290|NCT01364597|157129339|FG002|Overall Study|Lack of Efficacy|23|||
48805291|NCT01364597|157129340|FG003|Overall Study|Lack of Efficacy|8|||
48805292|NCT01364597|157129337|FG000|Overall Study|Protocol Violation|0|||
48805293|NCT01364597|157129338|FG001|Overall Study|Protocol Violation|0|||
48805294|NCT01364597|157129339|FG002|Overall Study|Protocol Violation|2|||
48805295|NCT01364597|157129340|FG003|Overall Study|Protocol Violation|0|||
48805296|NCT01364597|157129337|FG000|Overall Study|Lost to Follow-up|0|||
48805297|NCT01364597|157129338|FG001|Overall Study|Lost to Follow-up|0|||
48805298|NCT01364597|157129339|FG002|Overall Study|Lost to Follow-up|5|||
48805299|NCT01364597|157129340|FG003|Overall Study|Lost to Follow-up|3|||
48805300|NCT01364597|157129337|FG000|Overall Study|Withdrawal by Subject|4|||
48805301|NCT01364597|157129338|FG001|Overall Study|Withdrawal by Subject|1|||
48805302|NCT01364597|157129339|FG002|Overall Study|Withdrawal by Subject|18|||
48805303|NCT01364597|157129340|FG003|Overall Study|Withdrawal by Subject|6|||
48805304|NCT01364597|157129337|FG000|Overall Study|Non compliance|1|||
48805305|NCT01364597|157129338|FG001|Overall Study|Non compliance|0|||
48805306|NCT01364597|157129339|FG002|Overall Study|Non compliance|1|||
48805307|NCT01364597|157129340|FG003|Overall Study|Non compliance|0|||
48805308|NCT01364597|157129337|FG000|Overall Study|Lack of compliance|1|||
48805309|NCT01364597|157129338|FG001|Overall Study|Lack of compliance|0|||
48805310|NCT01364597|157129339|FG002|Overall Study|Lack of compliance|0|||
48805311|NCT01364597|157129340|FG003|Overall Study|Lack of compliance|0|||
48805312|NCT01364597|157129337|FG000|Overall Study|End of treatment epilepsy|1|||
48805313|NCT01364597|157129338|FG001|Overall Study|End of treatment epilepsy|0|||
48805314|NCT01364597|157129339|FG002|Overall Study|End of treatment epilepsy|0|||
48805315|NCT01364597|157129340|FG003|Overall Study|End of treatment epilepsy|0|||
48805316|NCT01364597|157129337|FG000|Overall Study|No Seizures|1|||
48805317|NCT01364597|157129338|FG001|Overall Study|No Seizures|0|||
48805318|NCT01364597|157129339|FG002|Overall Study|No Seizures|0|||
48805319|NCT01364597|157129340|FG003|Overall Study|No Seizures|0|||
48805320|NCT01364597|157129337|FG000|Overall Study|Lack of reliability from the subject's caregiver|1|||
48805321|NCT01364597|157129338|FG001|Overall Study|Lack of reliability from the subject's caregiver|0|||
48805322|NCT01364597|157129339|FG002|Overall Study|Lack of reliability from the subject's caregiver|0|||
48805323|NCT01364597|157129340|FG003|Overall Study|Lack of reliability from the subject's caregiver|0|||
48805324|NCT01364597|157129337|FG000|Overall Study|Cure|1|||
48805325|NCT01364597|157129338|FG001|Overall Study|Cure|0|||
48805326|NCT01364597|157129339|FG002|Overall Study|Cure|0|||
48805327|NCT01364597|157129340|FG003|Overall Study|Cure|0|||
48805328|NCT01364597|157129337|FG000|Overall Study|Patient was moving|0|||
48805329|NCT01364597|157129338|FG001|Overall Study|Patient was moving|1|||
48915740|NCT03668600|157526625|FG000|Overall Study|Pregnancy|1|||
48915741|NCT03668600|157526625|FG000|Overall Study|Lost to Follow-up|7|||
48915742|NCT03668600|157526625|FG000|Overall Study|Withdrawal by Subject|56|||
48805330|NCT01364597|157129339|FG002|Overall Study|Patient was moving|0|||
48805331|NCT01364597|157129340|FG003|Overall Study|Patient was moving|0|||
48805332|NCT01364597|157129337|FG000|Overall Study|Seizures resolved|0|||
49119331|NCT01211145|158274678|FG000|Overall Study|Eligibility criteria not fulfilled|16|||
48805333|NCT01364597|157129338|FG001|Overall Study|Seizures resolved|0|||
48805334|NCT01364597|157129339|FG002|Overall Study|Seizures resolved|1|||
48805335|NCT01364597|157129340|FG003|Overall Study|Seizures resolved|0|||
49119332|NCT01211145|158274679|FG001|Overall Study|Eligibility criteria not fulfilled|12|||
48805336|NCT01364597|157129337|FG000|Overall Study|Patient became seizure-free after surgery|0|||
48915743|NCT03668600|157526625|FG000|Overall Study|Lack of Efficacy|7|||
48915744|NCT03668600|157526625|FG000|Overall Study|Adverse Event|1|||
48805337|NCT01364597|157129338|FG001|Overall Study|Patient became seizure-free after surgery|0|||
48805338|NCT01364597|157129339|FG002|Overall Study|Patient became seizure-free after surgery|1|||
48805339|NCT01364597|157129340|FG003|Overall Study|Patient became seizure-free after surgery|0|||
48805340|NCT01364597|157129337|FG000|Overall Study|5 year without seizures. Treatment is finish|0|||
48708989|NCT01621802|156784170|FG001|Overall Study|Withdrawal by Subject|4|||
48708990|NCT01621802|156784171|FG002|Overall Study|Withdrawal by Subject|4|||
48805341|NCT01364597|157129338|FG001|Overall Study|5 year without seizures. Treatment is finish|0|||
48805342|NCT01364597|157129339|FG002|Overall Study|5 year without seizures. Treatment is finish|1|||
48805343|NCT01364597|157129340|FG003|Overall Study|5 year without seizures. Treatment is finish|0|||
48805344|NCT01364597|157129337|FG000|Overall Study|Patient cured from Epilepsy|0|||
48805345|NCT01364597|157129338|FG001|Overall Study|Patient cured from Epilepsy|0|||
48805346|NCT01364597|157129339|FG002|Overall Study|Patient cured from Epilepsy|1|||
48805347|NCT01364597|157129340|FG003|Overall Study|Patient cured from Epilepsy|0|||
48805348|NCT01364597|157129337|FG000|Overall Study|Investigator decision|0|||
48805349|NCT01364597|157129338|FG001|Overall Study|Investigator decision|0|||
48805350|NCT01364597|157129339|FG002|Overall Study|Investigator decision|1|||
48805351|NCT01364597|157129340|FG003|Overall Study|Investigator decision|0|||
48805352|NCT01364597|157129337|FG000|Overall Study|Sponsor recommended discontinuation|0|||
48805353|NCT01364597|157129338|FG001|Overall Study|Sponsor recommended discontinuation|0|||
48805354|NCT01364597|157129339|FG002|Overall Study|Sponsor recommended discontinuation|0|||
48805355|NCT01364597|157129340|FG003|Overall Study|Sponsor recommended discontinuation|1|||
48805356|NCT01364597|157129337|FG000|Overall Study|Parents went abroad with the patient|0|||
48805357|NCT01364597|157129338|FG001|Overall Study|Parents went abroad with the patient|0|||
48805358|NCT01364597|157129339|FG002|Overall Study|Parents went abroad with the patient|1|||
48805359|NCT01364597|157129340|FG003|Overall Study|Parents went abroad with the patient|0|||
48805360|NCT01364597|157129337|FG000|Overall Study|BRV discontinued as no seizures during 2 years|0|||
48805361|NCT01364597|157129338|FG001|Overall Study|BRV discontinued as no seizures during 2 years|0|||
48805362|NCT01364597|157129339|FG002|Overall Study|BRV discontinued as no seizures during 2 years|1|||
48915745|NCT01835015|157526626|FG000|Overall Study|Adverse Event|0|||
48915746|NCT01835015|157526627|FG001|Overall Study|Adverse Event|0|||
48915747|NCT01835015|157526628|FG002|Overall Study|Adverse Event|1|||
48915748|NCT01835015|157526629|FG003|Overall Study|Adverse Event|0|||
48915749|NCT01835015|157526630|FG004|Overall Study|Adverse Event|0|||
48915750|NCT00441974|157526631|FG000|Overall Study|Adverse Event|6|||
48915751|NCT00441974|157526631|FG000|Overall Study|Consent Withdrawn|35|||
48915752|NCT00441974|157526631|FG000|Overall Study|Lost to Follow-up|80|||
48708991|NCT01621802|156784172|FG003|Overall Study|Withdrawal by Subject|2|||
48708992|NCT01621802|156784173|FG004|Overall Study|Withdrawal by Subject|2|||
48708993|NCT01621802|156784174|FG005|Overall Study|Withdrawal by Subject|0|||
48708994|NCT01621802|156784169|FG000|Overall Study|Migrated/moved from study area|0|||
48708995|NCT01621802|156784170|FG001|Overall Study|Migrated/moved from study area|0|||
48708996|NCT01621802|156784171|FG002|Overall Study|Migrated/moved from study area|2|||
48708997|NCT01621802|156784172|FG003|Overall Study|Migrated/moved from study area|0|||
48708998|NCT01621802|156784173|FG004|Overall Study|Migrated/moved from study area|1|||
48708999|NCT01621802|156784174|FG005|Overall Study|Migrated/moved from study area|0|||
48709000|NCT01621802|156784169|FG000|Overall Study|Others|3|||
48709001|NCT01621802|156784170|FG001|Overall Study|Others|3|||
48709002|NCT01621802|156784171|FG002|Overall Study|Others|3|||
48709003|NCT01621802|156784172|FG003|Overall Study|Others|2|||
48709004|NCT01621802|156784173|FG004|Overall Study|Others|1|||
48709005|NCT01621802|156784174|FG005|Overall Study|Others|0|||
48709006|NCT01621802|156784169|FG000|Overall Study|Lost to Follow-up|36|||
48709007|NCT01621802|156784170|FG001|Overall Study|Lost to Follow-up|16|||
48709008|NCT01621802|156784171|FG002|Overall Study|Lost to Follow-up|24|||
48709009|NCT01621802|156784172|FG003|Overall Study|Lost to Follow-up|7|||
48709010|NCT01621802|156784173|FG004|Overall Study|Lost to Follow-up|31|||
48709011|NCT01621802|156784174|FG005|Overall Study|Lost to Follow-up|11|||
48709012|NCT02948634|156784175|FG000|Overall Study|Lack of efficacy and study suspended|10|||
48709013|NCT02948634|156784176|FG001|Overall Study|Lack of efficacy and study suspended|2|||
48709014|NCT00719472|156784177|FG000|Enrolled in Study|Physician decision to withdraw patient|1|||
48709015|NCT00719472|156784177|FG000|Enrolled in Study|Subject decision to withdraw|8|||
48709016|NCT00719472|156784177|FG000|Enrolled in Study|Various Reasons|17|||
48709017|NCT00719472|156784177|FG000|Received Cycle 1 Treatment|Adverse Event|8|||
48709018|NCT00719472|156784177|FG000|Received Cycle 1 Treatment|Death|5|||
48709019|NCT00719472|156784177|FG000|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11|||
48709020|NCT00719472|156784177|FG000|Received Cycle 1 Treatment|Physician decision to withdraw patient|7|||
48709021|NCT00719472|156784177|FG000|Received Cycle 1 Treatment|Subject decision to withdraw|9|||
48709022|NCT00719472|156784177|FG000|Received Cycle 1 Treatment|Various Reasons|13|||
48709023|NCT00719472|156784177|FG000|Received Cycle 2 Treatment|Adverse Event|12|||
48709024|NCT00719472|156784177|FG000|Received Cycle 2 Treatment|Death|6|||
48915753|NCT00441974|157526631|FG000|Overall Study|Protocol Violation|7|||
48709025|NCT00719472|156784177|FG000|Received Cycle 2 Treatment|Disease progression|3|||
48709026|NCT00719472|156784177|FG000|Received Cycle 2 Treatment|Lost to Follow-up|3|||
48709027|NCT00719472|156784177|FG000|Received Cycle 2 Treatment|Physician decision to withdraw patient|13|||
48709028|NCT00719472|156784177|FG000|Received Cycle 2 Treatment|Subject decision to withdraw|6|||
48709029|NCT00719472|156784177|FG000|Received Cycle 2 Treatment|Various Reasons|25|||
48709030|NCT01149148|156784180|FG000|Overall Study|Lost to Follow-up|1|||
48915754|NCT01816061|157526632|FG000|Overall Study|Lost to Follow-up|13|||
48915755|NCT01816061|157526633|FG001|Overall Study|Lost to Follow-up|24|||
48915756|NCT03370120|157526634|FG000|Overall Study|Adverse event, non-fatal|24|||
48915757|NCT03370120|157526634|FG000|Overall Study|Withdrawal by Subject|6|||
48915758|NCT03370120|157526634|FG000|Overall Study|Lost to Follow-up|1|||
48915759|NCT03370120|157526634|FG000|Overall Study|Lack of Efficacy|37|||
48915760|NCT03370120|157526634|FG000|Overall Study|Per sponsor's instructions|1|||
48915761|NCT03370120|157526634|FG000|Overall Study|Study was terminated by parent company UCB|2|||
48915762|NCT03370120|157526634|FG000|Overall Study|The study was ended by the promoter|3|||
48915763|NCT03370120|157526634|FG000|Overall Study|Discontinuation of drug development|3|||
48915764|NCT03370120|157526634|FG000|Overall Study|End of project|2|||
48915765|NCT03370120|157526634|FG000|Overall Study|Premature study closure|2|||
48915766|NCT03370120|157526634|FG000|Overall Study|Premature program termination|1|||
48915767|NCT03370120|157526634|FG000|Overall Study|Premature study termination|7|||
48915768|NCT03370120|157526634|FG000|Overall Study|Trial terminated by sponsor|2|||
48915769|NCT03370120|157526634|FG000|Overall Study|Trial discontinued by sponsor|2|||
48915770|NCT03370120|157526634|FG000|Overall Study|Study ended|15|||
48915771|NCT03370120|157526634|FG000|Overall Study|Clinical trial has been cancelled|1|||
49119333|NCT01211145|158274680|FG002|Overall Study|Eligibility criteria not fulfilled|10|||
48709031|NCT01149148|156784181|FG001|Overall Study|Lost to Follow-up|2|||
48709032|NCT01149148|156784180|FG000|Overall Study|Death|1|||
48709033|NCT01149148|156784181|FG001|Overall Study|Death|0|||
48709034|NCT00123422|156784184|FG000|Overall Study|Physician Decision|2|||
48709035|NCT00123422|156784185|FG001|Overall Study|Physician Decision|2|||
48709036|NCT00123422|156784186|FG002|Overall Study|Physician Decision|6|||
48709037|NCT00123422|156784184|FG000|Overall Study|Withdrawal by Subject|1|||
48709038|NCT00123422|156784185|FG001|Overall Study|Withdrawal by Subject|2|||
48709039|NCT00123422|156784186|FG002|Overall Study|Withdrawal by Subject|2|||
48709040|NCT00123422|156784184|FG000|Overall Study|Lost to Follow-up|1|||
48709041|NCT00123422|156784185|FG001|Overall Study|Lost to Follow-up|2|||
48709042|NCT00123422|156784186|FG002|Overall Study|Lost to Follow-up|2|||
48709043|NCT04555616|156784187|FG000|Overall Study|Death|1|||
48709044|NCT04555616|156784188|FG001|Overall Study|Death|0|||
48709045|NCT04555616|156784189|FG002|Overall Study|Death|1|||
48709046|NCT04555616|156784187|FG000|Overall Study|Withdrawal by Subject|2|||
48709047|NCT04555616|156784188|FG001|Overall Study|Withdrawal by Subject|1|||
48709048|NCT04555616|156784189|FG002|Overall Study|Withdrawal by Subject|0|||
48709049|NCT03544333|156784190|FG000|Overall Study|Withdrawal by Subject|1|||
48709050|NCT03544333|156784191|FG001|Overall Study|Withdrawal by Subject|0|||
48709051|NCT04816669|156784192|FG000|Part 1|Adverse Event|1|||
48709052|NCT04816669|156784193|FG001|Part 1|Adverse Event|1|||
48709053|NCT04816669|156784194|FG002|Part 1|Adverse Event|0|||
48709054|NCT04816669|156784195|FG003|Part 1|Adverse Event|0|||
48709055|NCT04816669|156784192|FG000|Part 1|Lost to Follow-up|2|||
48709056|NCT04816669|156784193|FG001|Part 1|Lost to Follow-up|2|||
48709057|NCT04816669|156784194|FG002|Part 1|Lost to Follow-up|0|||
48709058|NCT04816669|156784195|FG003|Part 1|Lost to Follow-up|0|||
48709059|NCT04816669|156784192|FG000|Part 1|Protocol Violation|0|||
48709060|NCT04816669|156784193|FG001|Part 1|Protocol Violation|1|||
48709061|NCT04816669|156784194|FG002|Part 1|Protocol Violation|0|||
48709062|NCT04816669|156784195|FG003|Part 1|Protocol Violation|0|||
48709063|NCT04816669|156784192|FG000|Part 1|Withdrawal by Subject|1|||
48709064|NCT04816669|156784193|FG001|Part 1|Withdrawal by Subject|2|||
48709065|NCT04816669|156784194|FG002|Part 1|Withdrawal by Subject|0|||
48709066|NCT04816669|156784195|FG003|Part 1|Withdrawal by Subject|0|||
48709067|NCT04816669|156784192|FG000|Part 2|Other|0|||
48709068|NCT04816669|156784193|FG001|Part 2|Other|0|||
48709069|NCT04816669|156784194|FG002|Part 2|Other|1|||
48709070|NCT04816669|156784195|FG003|Part 2|Other|0|||
48709071|NCT04816669|156784192|FG000|Part 2|Withdrawal by Subject|0|||
48805363|NCT01364597|157129340|FG003|Overall Study|BRV discontinued as no seizures during 2 years|0|||
48915772|NCT03370120|157526634|FG000|Overall Study|End of study per sponsor decision|2|||
49119334|NCT01211145|158274681|FG003|Overall Study|Eligibility criteria not fulfilled|15|||
49119335|NCT01211145|158274678|FG000|Overall Study|Patient decision|2|||
49119336|NCT01211145|158274679|FG001|Overall Study|Patient decision|1|||
49119337|NCT01211145|158274680|FG002|Overall Study|Patient decision|0|||
49119338|NCT01211145|158274681|FG003|Overall Study|Patient decision|2|||
49119339|NCT00426764|158274682|FG000|Overall Study|Protocol Violation|1|||
48915773|NCT03370120|157526634|FG000|Overall Study|Promoter's decision|2|||
49119340|NCT00426764|158274682|FG000|Overall Study|Withdrawal by Subject|4|||
48709072|NCT04816669|156784193|FG001|Part 2|Withdrawal by Subject|0|||
48709073|NCT04816669|156784194|FG002|Part 2|Withdrawal by Subject|0|||
48709074|NCT04816669|156784195|FG003|Part 2|Withdrawal by Subject|1|||
48709075|NCT04816669|156784192|FG000|Part 2|Lost to Follow-up|0|||
48709076|NCT04816669|156784193|FG001|Part 2|Lost to Follow-up|0|||
48709077|NCT04816669|156784194|FG002|Part 2|Lost to Follow-up|1|||
48709078|NCT04816669|156784195|FG003|Part 2|Lost to Follow-up|0|||
48709079|NCT01528969|156784196|FG000|Overall Study|absent from the school at baseline|2|||
48709080|NCT01528969|156784197|FG001|Overall Study|absent from the school at baseline|0|||
48709081|NCT02282605|156784198|FG000|Overall Study|negative SA result on Day -1|3|||
48709082|NCT02282605|156784199|FG001|Overall Study|negative SA result on Day -1|0|||
48709083|NCT02282605|156784200|FG002|Overall Study|negative SA result on Day -1|0|||
48709084|NCT02399163|156784201|FG000|Overall Study|Adverse Event|2|||
48709085|NCT02399163|156784201|FG000|Overall Study|Protocol Deviation|2|||
48709086|NCT02399163|156784201|FG000|Overall Study|Withdrawal by Participant|5|||
48709087|NCT00808080|156784203|FG000|Overall Study|Patients Became Ineligible for infusion|6|||
48709088|NCT00387790|156784206|FG000|Overall Study|Adverse Event|5|||
48709089|NCT00387790|156784206|FG000|Overall Study|Lack of Efficacy|2|||
48709090|NCT00387790|156784206|FG000|Overall Study|Physician Decision|2|||
48709091|NCT00387790|156784206|FG000|Overall Study|Withdrawal by Subject|3|||
48709092|NCT00387790|156784206|FG000|Overall Study|Ineligible for study|2|||
48709093|NCT03085797|156784207|FG000|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1|||
48709094|NCT03085797|156784208|FG001|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0|||
48709095|NCT03085797|156784207|FG000|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16|||
48709096|NCT03085797|156784208|FG001|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17|||
48709097|NCT03085797|156784207|FG000|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0|||
48709098|NCT03085797|156784208|FG001|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1|||
48709099|NCT02974543|156784211|FG000|Overall Study|Withdrawal by Subject|1|||
48709100|NCT02974543|156784212|FG001|Overall Study|Withdrawal by Subject|0|||
48709101|NCT02597478|156784213|FG000|Overall Study|Withdrawal by Subject|2|||
48709102|NCT02597478|156784214|FG001|Overall Study|Withdrawal by Subject|0|||
48709103|NCT02597478|156784213|FG000|Overall Study|Change of opioid dose|1|||
48709104|NCT02597478|156784214|FG001|Overall Study|Change of opioid dose|0|||
48709105|NCT02597478|156784213|FG000|Overall Study|Insufficient exertional dyspnea|0|||
48709106|NCT02597478|156784214|FG001|Overall Study|Insufficient exertional dyspnea|1|||
48709107|NCT03110770|156784217|FG000|Overall Study|Death|1|||
48709108|NCT03110770|156784218|FG001|Overall Study|Death|0|||
48709109|NCT03110770|156784219|FG002|Overall Study|Death|0|||
48709110|NCT03110770|156784220|FG003|Overall Study|Death|1|||
48709111|NCT03110770|156784221|FG004|Overall Study|Death|0|||
48709112|NCT03110770|156784217|FG000|Overall Study|Enrolled but did not receive product|0|||
48915774|NCT03370120|157526634|FG000|Overall Study|The trial has been suspended|3|||
48915775|NCT03370120|157526634|FG000|Overall Study|Sponsor stopped PSL development based on data|3|||
48915776|NCT03370120|157526634|FG000|Overall Study|Early termination by order of sponsor|2|||
48915777|NCT03370120|157526634|FG000|Overall Study|Discontinuation of the study|5|||
48709113|NCT03110770|156784218|FG001|Overall Study|Enrolled but did not receive product|0|||
48709114|NCT03110770|156784219|FG002|Overall Study|Enrolled but did not receive product|0|||
48709115|NCT03110770|156784220|FG003|Overall Study|Enrolled but did not receive product|8|||
48709116|NCT03110770|156784221|FG004|Overall Study|Enrolled but did not receive product|7|||
48709117|NCT03110770|156784217|FG000|Overall Study|Lost to Follow-up|0|||
48709118|NCT03110770|156784218|FG001|Overall Study|Lost to Follow-up|0|||
48709119|NCT03110770|156784219|FG002|Overall Study|Lost to Follow-up|0|||
48709120|NCT03110770|156784220|FG003|Overall Study|Lost to Follow-up|53|||
48709121|NCT03110770|156784221|FG004|Overall Study|Lost to Follow-up|45|||
48709122|NCT03110770|156784217|FG000|Overall Study|Investigator Decision|0|||
48915778|NCT03370120|157526634|FG000|Overall Study|End of clinical trial discontinuation|1|||
48915779|NCT03370120|157526634|FG000|Overall Study|Because the clinical trial ended halfway|4|||
48915780|NCT03370120|157526634|FG000|Overall Study|Development discontinued|5|||
48915781|NCT03370120|157526634|FG000|Overall Study|Padsenovil program closed|3|||
48915782|NCT03370120|157526634|FG000|Overall Study|End of project|2|||
48915783|NCT03370120|157526634|FG000|Overall Study|Termination of project|1|||
48915784|NCT03370120|157526634|FG000|Overall Study|The study was interrupted by sponsor|4|||
48915785|NCT03370120|157526634|FG000|Overall Study|The protocol was interrupted by sponsor|1|||
48915786|NCT03370120|157526634|FG000|Overall Study|End of sponsor decision|1|||
48915787|NCT03370120|157526634|FG000|Overall Study|The study was terminated prematurely by study lead|1|||
48915788|NCT03370120|157526634|FG000|Overall Study|Early termination of studies|5|||
48915789|NCT03370120|157526634|FG000|Overall Study|This study is ended early|1|||
48915790|NCT03370120|157526634|FG000|Overall Study|End of padsevonil program|2|||
48915791|NCT03370120|157526634|FG000|Overall Study|Decision of sponsor|6|||
48709123|NCT03110770|156784218|FG001|Overall Study|Investigator Decision|0|||
48709124|NCT03110770|156784219|FG002|Overall Study|Investigator Decision|0|||
48709125|NCT03110770|156784220|FG003|Overall Study|Investigator Decision|5|||
48709126|NCT03110770|156784221|FG004|Overall Study|Investigator Decision|3|||
48709127|NCT03110770|156784217|FG000|Overall Study|Withdrawal by Subject|0|||
48709128|NCT03110770|156784218|FG001|Overall Study|Withdrawal by Subject|0|||
48709129|NCT03110770|156784219|FG002|Overall Study|Withdrawal by Subject|0|||
48709130|NCT03110770|156784220|FG003|Overall Study|Withdrawal by Subject|24|||
48709131|NCT03110770|156784221|FG004|Overall Study|Withdrawal by Subject|24|||
48709132|NCT03110770|156784217|FG000|Overall Study|Moved from area|5|||
48915792|NCT03370120|157526634|FG000|Overall Study|Asked by the sponsor|3|||
48915793|NCT03370120|157526634|FG000|Overall Study|Sponsor decision to stop the protocol|1|||
48915794|NCT03370120|157526634|FG000|Overall Study|PI decision poor compliance from participant|1|||
48915795|NCT03370120|157526634|FG000|Overall Study|Promoter ended the study|3|||
48915796|NCT03370120|157526634|FG000|Overall Study|Premature study close by sponsor's decision|4|||
48915797|NCT03370120|157526634|FG000|Overall Study|Study terminated by sponsor|33|||
48915798|NCT03370120|157526634|FG000|Overall Study|Sponsor prematurely terminated this study|2|||
48915799|NCT03370120|157526634|FG000|Overall Study|Sponsor decision to terminate study|63|||
48709133|NCT03110770|156784218|FG001|Overall Study|Moved from area|0|||
48709134|NCT03110770|156784219|FG002|Overall Study|Moved from area|2|||
48805364|NCT01364597|157129337|FG000|Overall Study|BRV administration dropout|0|||
48805365|NCT01364597|157129338|FG001|Overall Study|BRV administration dropout|0|||
48915800|NCT03370120|157526634|FG000|Overall Study|Program closure|3|||
48709135|NCT03110770|156784220|FG003|Overall Study|Moved from area|42|||
48709136|NCT03110770|156784221|FG004|Overall Study|Moved from area|43|||
48709137|NCT03110770|156784217|FG000|Overall Study|Illness/Injury unrelated to product|0|||
48709138|NCT03110770|156784218|FG001|Overall Study|Illness/Injury unrelated to product|0|||
48709139|NCT03110770|156784219|FG002|Overall Study|Illness/Injury unrelated to product|0|||
48709140|NCT03110770|156784220|FG003|Overall Study|Illness/Injury unrelated to product|0|||
48709141|NCT03110770|156784221|FG004|Overall Study|Illness/Injury unrelated to product|1|||
48709142|NCT03198507|156784222|FG000|Overall Study|Withdrawal by Subject|1|||
48709143|NCT03198507|156784223|FG001|Overall Study|Withdrawal by Subject|0|||
48805366|NCT01364597|157129339|FG002|Overall Study|BRV administration dropout|1|||
48805367|NCT01364597|157129340|FG003|Overall Study|BRV administration dropout|0|||
48709144|NCT02888119|156784224|FG000|Overall Study|Lost to Follow-up|5|||
48709145|NCT02888119|156784225|FG001|Overall Study|Lost to Follow-up|4|||
48709146|NCT02888119|156784226|FG002|Overall Study|Lost to Follow-up|0|||
48709147|NCT00241839|156784227|FG000|Overall Study|Withdrawal by Subject|18|||
48709148|NCT00241839|156784228|FG001|Overall Study|Withdrawal by Subject|17|||
48709149|NCT00241839|156784227|FG000|Overall Study|Adverse Event|1|||
48709150|NCT00241839|156784228|FG001|Overall Study|Adverse Event|1|||
48709151|NCT00419952|156784229|FG000|Overall Study|Adverse Event|8|||
48709152|NCT00419952|156784230|FG001|Overall Study|Adverse Event|10|||
48709153|NCT00419952|156784229|FG000|Overall Study|Withdrawal by Subject|44|||
48709154|NCT00419952|156784230|FG001|Overall Study|Withdrawal by Subject|43|||
48709155|NCT00419952|156784229|FG000|Overall Study|Lost to Follow-up|43|||
48805368|NCT01364597|157129337|FG000|Overall Study|Dropout|0|||
48805369|NCT01364597|157129338|FG001|Overall Study|Dropout|0|||
48805370|NCT01364597|157129339|FG002|Overall Study|Dropout|3|||
48915801|NCT03370120|157526634|FG000|Overall Study|Study ended prematurely|1|||
48915802|NCT03370120|157526634|FG000|Overall Study|Study stopped by sponsor|2|||
48805371|NCT01364597|157129340|FG003|Overall Study|Dropout|1|||
48915803|NCT03370120|157526634|FG000|Overall Study|Program termination|55|||
48915804|NCT03370120|157526634|FG000|Overall Study|Sponsor decision|62|||
48915805|NCT03370120|157526634|FG000|Overall Study|Sponsor study closure|10|||
48709156|NCT00419952|156784230|FG001|Overall Study|Lost to Follow-up|34|||
48709157|NCT00419952|156784229|FG000|Overall Study|Protocol Violation|32|||
48805372|NCT01364597|157129337|FG000|Overall Study|Unreliable subject|0|||
48709158|NCT00419952|156784230|FG001|Overall Study|Protocol Violation|24|||
48709159|NCT00419952|156784229|FG000|Overall Study|Pregnancy|4|||
48709160|NCT00419952|156784230|FG001|Overall Study|Pregnancy|2|||
48805373|NCT01364597|157129338|FG001|Overall Study|Unreliable subject|0|||
48915806|NCT00829179|157526635|FG000|Overall Study|Withdrawal by Subject|1|||
48805374|NCT01364597|157129339|FG002|Overall Study|Unreliable subject|0|||
48805375|NCT01364597|157129340|FG003|Overall Study|Unreliable subject|1|||
48805376|NCT01364597|157129337|FG000|Overall Study|Other|0|||
48805377|NCT01364597|157129338|FG001|Overall Study|Other|0|||
48805378|NCT01364597|157129339|FG002|Overall Study|Other|0|||
48805379|NCT01364597|157129340|FG003|Overall Study|Other|1|||
48805380|NCT05436262|157129343|FG000|Pre-Randomization|Withdrawal by Subject|1|||
48805381|NCT05436262|157129344|FG001|Pre-Randomization|Withdrawal by Subject|0|||
48805382|NCT05436262|157129345|FG002|Pre-Randomization|Withdrawal by Subject|0|||
48805383|NCT05436262|157129343|FG000|Randomization|Withdrawal by Subject|0|||
48805384|NCT05436262|157129344|FG001|Randomization|Withdrawal by Subject|1|||
48805385|NCT05436262|157129345|FG002|Randomization|Withdrawal by Subject|0|||
48805386|NCT03324880|157129348|FG000|Overall Study|Adverse Event|0|||
48805387|NCT03324880|157129349|FG001|Overall Study|Adverse Event|2|||
48805388|NCT03324880|157129348|FG000|Overall Study|Withdrawal by Subject|2|||
48805389|NCT03324880|157129349|FG001|Overall Study|Withdrawal by Subject|2|||
48805390|NCT03324880|157129348|FG000|Overall Study|Lost to Follow-up|0|||
48805391|NCT03324880|157129349|FG001|Overall Study|Lost to Follow-up|1|||
48915807|NCT00596947|157526636|FG000|Overall Study|study halted due to low enrollment|5|||
48915808|NCT00596947|157526637|FG001|Overall Study|study halted due to low enrollment|3|||
48915809|NCT00596947|157526636|FG000|Overall Study|Lost to Follow-up|1|||
48915810|NCT00596947|157526637|FG001|Overall Study|Lost to Follow-up|0|||
48915811|NCT04416555|157526639|FG000|Overall Study|Withdrawal by Subject|0|||
48915812|NCT04416555|157526640|FG001|Overall Study|Withdrawal by Subject|3|||
48915813|NCT00800436|157526643|FG000|Overall Study|Withdrawal by Subject|0|||
48915814|NCT00800436|157526644|FG001|Overall Study|Withdrawal by Subject|0|||
48915815|NCT00800436|157526645|FG002|Overall Study|Withdrawal by Subject|1|||
48915816|NCT00800436|157526646|FG003|Overall Study|Withdrawal by Subject|1|||
48915817|NCT00800436|157526647|FG004|Overall Study|Withdrawal by Subject|0|||
48915818|NCT00800436|157526648|FG005|Overall Study|Withdrawal by Subject|0|||
48915819|NCT00800436|157526649|FG006|Overall Study|Withdrawal by Subject|0|||
48709161|NCT00419952|156784229|FG000|Overall Study|Physician Decision|1|||
48709162|NCT00419952|156784230|FG001|Overall Study|Physician Decision|3|||
48709163|NCT00419952|156784229|FG000|Overall Study|Incorrectly enrolled|10|||
48709164|NCT00419952|156784230|FG001|Overall Study|Incorrectly enrolled|3|||
48709165|NCT00419952|156784229|FG000|Overall Study|Intake of prohibited medication|2|||
48709166|NCT00419952|156784230|FG001|Overall Study|Intake of prohibited medication|2|||
48709167|NCT00419952|156784229|FG000|Overall Study|Occurence of 2 or more exacerbations|2|||
48709168|NCT00419952|156784230|FG001|Overall Study|Occurence of 2 or more exacerbations|0|||
48709169|NCT00419952|156784229|FG000|Overall Study|Diary or medication non-compliance|2|||
48709170|NCT00419952|156784230|FG001|Overall Study|Diary or medication non-compliance|4|||
48709171|NCT00419952|156784229|FG000|Overall Study|Abnormal ECG|1|||
48709172|NCT00419952|156784230|FG001|Overall Study|Abnormal ECG|0|||
48709173|NCT02675634|156784231|FG000|Test Period 1|Adverse Event|0|||
48709174|NCT02675634|156784232|FG001|Test Period 1|Adverse Event|1|||
48709175|NCT02675634|156784233|FG002|Test Period 1|Adverse Event|0|||
48709176|NCT02675634|156784234|FG003|Test Period 1|Adverse Event|1|||
48709177|NCT02675634|156784235|FG004|Test Period 1|Adverse Event|0|||
48709178|NCT02675634|156784236|FG005|Test Period 1|Adverse Event|0|||
48709179|NCT02675634|156784231|FG000|Test Period 1|Device deficiency that did not lead to A|0|||
48709180|NCT02675634|156784232|FG001|Test Period 1|Device deficiency that did not lead to A|0|||
48709181|NCT02675634|156784233|FG002|Test Period 1|Device deficiency that did not lead to A|1|||
48709182|NCT02675634|156784234|FG003|Test Period 1|Device deficiency that did not lead to A|0|||
48709183|NCT02675634|156784235|FG004|Test Period 1|Device deficiency that did not lead to A|0|||
48709184|NCT02675634|156784236|FG005|Test Period 1|Device deficiency that did not lead to A|0|||
48709185|NCT02675634|156784231|FG000|Test Period 2|Lack of Efficacy|1|||
48709186|NCT02675634|156784232|FG001|Test Period 2|Lack of Efficacy|0|||
48709187|NCT02675634|156784233|FG002|Test Period 2|Lack of Efficacy|0|||
48709188|NCT02675634|156784234|FG003|Test Period 2|Lack of Efficacy|0|||
48709189|NCT02675634|156784235|FG004|Test Period 2|Lack of Efficacy|0|||
48709190|NCT02675634|156784236|FG005|Test Period 2|Lack of Efficacy|0|||
48709191|NCT02675634|156784231|FG000|Test Period 2|Adverse Event|0|||
48805392|NCT03324880|157129348|FG000|Overall Study|Product Recall|0|||
48805393|NCT03324880|157129349|FG001|Overall Study|Product Recall|1|||
48805394|NCT00116272|157129350|FG000|Overall Study|Lost to Follow-up|11|||
48915820|NCT01967628|157526650|FG000|Overall Study|Withdrawal by Subject|2|||
48915821|NCT01967628|157526651|FG001|Overall Study|Withdrawal by Subject|0|||
48915822|NCT01967628|157526650|FG000|Overall Study|Unable to complete bronchoscopy|4|||
48709192|NCT02675634|156784232|FG001|Test Period 2|Adverse Event|0|||
48709193|NCT02675634|156784233|FG002|Test Period 2|Adverse Event|0|||
48709194|NCT02675634|156784234|FG003|Test Period 2|Adverse Event|0|||
48709195|NCT02675634|156784235|FG004|Test Period 2|Adverse Event|0|||
48709196|NCT02675634|156784236|FG005|Test Period 2|Adverse Event|1|||
48709197|NCT01652534|156784237|FG000|Overall Study|Lack of Efficacy|1|||
48805395|NCT00116272|157129351|FG001|Overall Study|Lost to Follow-up|6|||
48805396|NCT00405639|157129354|FG000|Overall Study|Withdrawal by Subject|1|||
48915823|NCT01967628|157526651|FG001|Overall Study|Unable to complete bronchoscopy|6|||
49119341|NCT00426764|158274682|FG000|Overall Study|Physician Decision|6|||
49119342|NCT00426764|158274682|FG000|Overall Study|Compassionate Use|1|||
49119343|NCT00426764|158274682|FG000|Overall Study|Progressive Disease|83|||
49119344|NCT00426764|158274682|FG000|Overall Study|Adverse Event|24|||
48915824|NCT01967628|157526650|FG000|Overall Study|Lost to Follow-up|1|||
48915825|NCT01967628|157526651|FG001|Overall Study|Lost to Follow-up|0|||
48915826|NCT01967628|157526650|FG000|Overall Study|Low protein concentration in sample|20|||
48915827|NCT01967628|157526651|FG001|Overall Study|Low protein concentration in sample|25|||
48915828|NCT01328951|157526652|FG000|Overall Study|Disease Progression|17|||
48915829|NCT01328951|157526653|FG001|Overall Study|Disease Progression|14|||
48915830|NCT01328951|157526652|FG000|Overall Study|Adverse Event|2|||
48915831|NCT01328951|157526653|FG001|Overall Study|Adverse Event|0|||
48915832|NCT01328951|157526652|FG000|Overall Study|Death|243|||
48915833|NCT01328951|157526653|FG001|Overall Study|Death|258|||
48915834|NCT01328951|157526652|FG000|Overall Study|Lost to Follow-up|6|||
48915835|NCT01328951|157526653|FG001|Overall Study|Lost to Follow-up|7|||
48915836|NCT01328951|157526652|FG000|Overall Study|Withdrawal by Subject|6|||
48915837|NCT01328951|157526653|FG001|Overall Study|Withdrawal by Subject|6|||
48915838|NCT01328951|157526652|FG000|Overall Study|Study Closed by the Sponsor|36|||
48915839|NCT01328951|157526653|FG001|Overall Study|Study Closed by the Sponsor|31|||
48915840|NCT01328951|157526652|FG000|Overall Study|Other|11|||
48915841|NCT01328951|157526653|FG001|Overall Study|Other|6|||
48915842|NCT01517893|157526658|FG000|Overall Study|Withdrawal by Subject|3|||
48915843|NCT01517893|157526659|FG001|Overall Study|Withdrawal by Subject|0|||
48915844|NCT03200366|157526660|FG000|Patient Navigation Intervention Given|Death|0|||
49119345|NCT00426764|158274682|FG000|Overall Study|Other|1|||
49119346|NCT00426764|158274682|FG000|Overall Study|Death|1|||
48709198|NCT01652534|156784238|FG001|Overall Study|Lack of Efficacy|0|||
48709199|NCT01411891|156784239|FG000|Overall Study|Catheter dislodgement or loss to follow-|3|||
48709200|NCT01411891|156784240|FG001|Overall Study|Catheter dislodgement or loss to follow-|2|||
48709201|NCT03860259|156784248|FG000|Overall Study|Lost to Follow-up|5|||
48709202|NCT03860259|156784249|FG001|Overall Study|Lost to Follow-up|5|||
48709203|NCT03860259|156784248|FG000|Overall Study|Protocol Violation|1|||
48709204|NCT03860259|156784249|FG001|Overall Study|Protocol Violation|0|||
48709205|NCT00392769|156784254|FG000|Overall Study|Clinical Deterioration|9|||
48709206|NCT00392769|156784254|FG000|Overall Study|Adverse Event|1|||
48709207|NCT02280408|156784255|FG000|Overall Study|Lost to Follow-up|0|||
48709208|NCT02280408|156784256|FG001|Overall Study|Lost to Follow-up|2|||
48709209|NCT02280408|156784257|FG002|Overall Study|Lost to Follow-up|0|||
48709210|NCT02280408|156784258|FG003|Overall Study|Lost to Follow-up|0|||
48709211|NCT00470275|156784259|FG000|Overall Study|Death|1|||
48709212|NCT00470275|156784259|FG000|Overall Study|Lack of Efficacy|7|||
48709213|NCT00470275|156784259|FG000|Overall Study|Withdrawal by Subject|2|||
48709214|NCT02474069|156784260|FG000|Selection Phase (SP)|Adverse Event|8|||
48709215|NCT02474069|156784261|FG001|Selection Phase (SP)|Adverse Event|0|||
48709216|NCT02474069|156784262|FG002|Selection Phase (SP)|Adverse Event|0|||
48709217|NCT02474069|156784260|FG000|Selection Phase (SP)|Lack of Efficacy|1|||
48709218|NCT02474069|156784261|FG001|Selection Phase (SP)|Lack of Efficacy|0|||
48709219|NCT02474069|156784262|FG002|Selection Phase (SP)|Lack of Efficacy|0|||
48709220|NCT02474069|156784260|FG000|Selection Phase (SP)|Lost to Follow-up|4|||
48709221|NCT02474069|156784261|FG001|Selection Phase (SP)|Lost to Follow-up|0|||
48709222|NCT02474069|156784262|FG002|Selection Phase (SP)|Lost to Follow-up|0|||
48709223|NCT02474069|156784260|FG000|Selection Phase (SP)|Physician Decision|1|||
48709224|NCT02474069|156784261|FG001|Selection Phase (SP)|Physician Decision|0|||
48709225|NCT02474069|156784262|FG002|Selection Phase (SP)|Physician Decision|0|||
48709226|NCT02474069|156784260|FG000|Selection Phase (SP)|Protocol Violation|1|||
48709227|NCT02474069|156784261|FG001|Selection Phase (SP)|Protocol Violation|0|||
48709228|NCT02474069|156784262|FG002|Selection Phase (SP)|Protocol Violation|0|||
48709229|NCT02474069|156784260|FG000|Selection Phase (SP)|No longer requires treatment|1|||
48709230|NCT02474069|156784261|FG001|Selection Phase (SP)|No longer requires treatment|0|||
48709231|NCT02474069|156784262|FG002|Selection Phase (SP)|No longer requires treatment|0|||
48709232|NCT02474069|156784260|FG000|Selection Phase (SP)|Technical Problem|1|||
48709233|NCT02474069|156784261|FG001|Selection Phase (SP)|Technical Problem|0|||
48709234|NCT02474069|156784262|FG002|Selection Phase (SP)|Technical Problem|0|||
48709235|NCT02474069|156784260|FG000|Selection Phase (SP)|Withdrawal by Subject|3|||
48709236|NCT02474069|156784261|FG001|Selection Phase (SP)|Withdrawal by Subject|0|||
48709237|NCT02474069|156784262|FG002|Selection Phase (SP)|Withdrawal by Subject|0|||
48709238|NCT02474069|156784260|FG000|Selection Phase (SP)|Withdrawal of Informed Consent|3|||
48709239|NCT02474069|156784261|FG001|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
48709240|NCT02474069|156784262|FG002|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
48709241|NCT02474069|156784260|FG000|Comparative Dosing Phase (CDP)|Adverse Event|0|||
48709242|NCT02474069|156784261|FG001|Comparative Dosing Phase (CDP)|Adverse Event|3|||
48709243|NCT02474069|156784262|FG002|Comparative Dosing Phase (CDP)|Adverse Event|2|||
48709244|NCT02474069|156784260|FG000|Comparative Dosing Phase (CDP)|Lost to Follow-up|0|||
48915845|NCT03200366|157526661|FG001|Patient Navigation Intervention Given|Death|2|||
48915846|NCT03200366|157526662|FG002|Patient Navigation Intervention Given|Death|0|||
48915847|NCT03200366|157526660|FG000|Patient Navigation Intervention Given|Lost to Follow-up|0|||
48709245|NCT02474069|156784261|FG001|Comparative Dosing Phase (CDP)|Lost to Follow-up|4|||
48709246|NCT02474069|156784262|FG002|Comparative Dosing Phase (CDP)|Lost to Follow-up|1|||
48709247|NCT02474069|156784260|FG000|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
48709248|NCT02474069|156784261|FG001|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
48709249|NCT02474069|156784262|FG002|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1|||
48709250|NCT02474069|156784260|FG000|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0|||
48709251|NCT02474069|156784261|FG001|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
48709252|NCT02474069|156784262|FG002|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
48709253|NCT00035932|156784268|FG000|Overall Study|Adverse Event|10|||
48709254|NCT00035932|156784269|FG001|Overall Study|Adverse Event|9|||
48709255|NCT00035932|156784270|FG002|Overall Study|Adverse Event|9|||
48709256|NCT00035932|156784268|FG000|Overall Study|Death|0|||
48709257|NCT00035932|156784269|FG001|Overall Study|Death|0|||
48709258|NCT00035932|156784270|FG002|Overall Study|Death|1|||
48709259|NCT00035932|156784268|FG000|Overall Study|Disease Progression / Relapse|1|||
48709260|NCT00035932|156784269|FG001|Overall Study|Disease Progression / Relapse|1|||
48709261|NCT00035932|156784270|FG002|Overall Study|Disease Progression / Relapse|0|||
48709262|NCT00035932|156784268|FG000|Overall Study|Lost to Follow-up|4|||
48709263|NCT00035932|156784269|FG001|Overall Study|Lost to Follow-up|4|||
48709264|NCT00035932|156784270|FG002|Overall Study|Lost to Follow-up|3|||
48709265|NCT00035932|156784268|FG000|Overall Study|Noncompliance|6|||
48709266|NCT00035932|156784269|FG001|Overall Study|Noncompliance|7|||
48709267|NCT00035932|156784270|FG002|Overall Study|Noncompliance|6|||
48709268|NCT00035932|156784268|FG000|Overall Study|Protocol Violation While on Study|0|||
48709269|NCT00035932|156784269|FG001|Overall Study|Protocol Violation While on Study|1|||
48709270|NCT00035932|156784270|FG002|Overall Study|Protocol Violation While on Study|2|||
48709271|NCT00035932|156784268|FG000|Overall Study|Withdrawal by Subject|1|||
48709272|NCT00035932|156784269|FG001|Overall Study|Withdrawal by Subject|5|||
48709273|NCT00035932|156784270|FG002|Overall Study|Withdrawal by Subject|0|||
48709274|NCT00035932|156784268|FG000|Overall Study|Study Termination by Sponsor|1|||
48709275|NCT00035932|156784269|FG001|Overall Study|Study Termination by Sponsor|0|||
48709276|NCT00035932|156784270|FG002|Overall Study|Study Termination by Sponsor|0|||
48709277|NCT00035932|156784268|FG000|Overall Study|Lack of Efficacy|33|||
48709278|NCT00035932|156784269|FG001|Overall Study|Lack of Efficacy|33|||
48709279|NCT00035932|156784270|FG002|Overall Study|Lack of Efficacy|28|||
48709280|NCT02284243|156784271|FG000|Overall Study|Lack of Efficacy|3|||
48709281|NCT02284243|156784272|FG001|Overall Study|Lack of Efficacy|3|||
48915848|NCT03200366|157526661|FG001|Patient Navigation Intervention Given|Lost to Follow-up|25|||
48915849|NCT03200366|157526662|FG002|Patient Navigation Intervention Given|Lost to Follow-up|0|||
48915850|NCT03200366|157526660|FG000|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
48915851|NCT03200366|157526661|FG001|Patient Navigation Intervention Given|Not attempted/missed by nurse|1|||
48915852|NCT03200366|157526662|FG002|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
48915853|NCT03200366|157526660|FG000|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
48915854|NCT03200366|157526661|FG001|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2|||
48915855|NCT03200366|157526662|FG002|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
48915856|NCT03200366|157526660|FG000|Patient Navigation Intervention Given|Declined navigation intervention|0|||
48915857|NCT03200366|157526661|FG001|Patient Navigation Intervention Given|Declined navigation intervention|1|||
48915858|NCT03200366|157526662|FG002|Patient Navigation Intervention Given|Declined navigation intervention|0|||
48915859|NCT03200366|157526660|FG000|6 Month Post-Baseline Interview|Death|1|||
48915860|NCT03200366|157526661|FG001|6 Month Post-Baseline Interview|Death|1|||
48915861|NCT03200366|157526662|FG002|6 Month Post-Baseline Interview|Death|1|||
48915862|NCT03200366|157526660|FG000|6 Month Post-Baseline Interview|Lost to Follow-up|27|||
48915863|NCT03200366|157526661|FG001|6 Month Post-Baseline Interview|Lost to Follow-up|21|||
48709282|NCT02284243|156784271|FG000|Overall Study|Adverse Event|1|||
48709283|NCT02284243|156784272|FG001|Overall Study|Adverse Event|0|||
48709284|NCT00125164|156784273|FG000|Overall Study|Adverse Event|0|||
48709285|NCT00125164|156784274|FG001|Overall Study|Adverse Event|0|||
48709286|NCT00125164|156784275|FG002|Overall Study|Adverse Event|2|||
48709287|NCT00125164|156784276|FG003|Overall Study|Adverse Event|4|||
48709288|NCT00125164|156784273|FG000|Overall Study|Lost to Follow-up|0|||
48709289|NCT00125164|156784274|FG001|Overall Study|Lost to Follow-up|0|||
48709290|NCT00125164|156784275|FG002|Overall Study|Lost to Follow-up|1|||
48709291|NCT00125164|156784276|FG003|Overall Study|Lost to Follow-up|1|||
48709292|NCT00125164|156784273|FG000|Overall Study|Withdrawal by Subject|2|||
48709293|NCT00125164|156784274|FG001|Overall Study|Withdrawal by Subject|0|||
48709294|NCT00125164|156784275|FG002|Overall Study|Withdrawal by Subject|1|||
48709295|NCT00125164|156784276|FG003|Overall Study|Withdrawal by Subject|1|||
48709296|NCT04080167|156784277|FG000|Overall Study|Lost to Follow-up-Patients|7|||
48709297|NCT04080167|156784278|FG001|Overall Study|Lost to Follow-up-Patients|14|||
48709298|NCT04080167|156784279|FG002|Overall Study|Lost to Follow-up-Patients|0|||
48709299|NCT04080167|156784277|FG000|Overall Study|Lost to Follow-up-Providers|2|||
48805397|NCT00405639|157129355|FG001|Overall Study|Withdrawal by Subject|0|||
48805398|NCT00405639|157129354|FG000|Overall Study|Adverse Event|1|||
48805399|NCT00405639|157129355|FG001|Overall Study|Adverse Event|0|||
48805400|NCT00405639|157129354|FG000|Overall Study|Seizure prior to receiving BNP|1|||
48805401|NCT00405639|157129355|FG001|Overall Study|Seizure prior to receiving BNP|0|||
48805402|NCT05076149|157129356|FG000|Overall Study|Adverse Event|3|||
48805403|NCT05076149|157129357|FG001|Overall Study|Adverse Event|9|||
48805404|NCT05076149|157129356|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
48805405|NCT05076149|157129357|FG001|Overall Study|Withdrawal of consent (not due to AE)|3|||
48805406|NCT05076149|157129356|FG000|Overall Study|Lost to Follow-up|0|||
48805407|NCT05076149|157129357|FG001|Overall Study|Lost to Follow-up|1|||
48805408|NCT05076149|157129356|FG000|Overall Study|Commercial drug is available for participant|0|||
48805409|NCT05076149|157129357|FG001|Overall Study|Commercial drug is available for participant|1|||
48805410|NCT05076149|157129356|FG000|Overall Study|Other non compliance|1|||
48805411|NCT05076149|157129357|FG001|Overall Study|Other non compliance|1|||
48805412|NCT05076149|157129356|FG000|Overall Study|Physician Decision|0|||
48805413|NCT05076149|157129357|FG001|Overall Study|Physician Decision|1|||
48805414|NCT05076149|157129356|FG000|Overall Study|Other|5|||
48805415|NCT05076149|157129357|FG001|Overall Study|Other|4|||
48805416|NCT05096208|157129358|FG000|Overall Study|Lost to Follow-up|3|||
48805417|NCT05096208|157129359|FG001|Overall Study|Lost to Follow-up|5|||
48805418|NCT05096208|157129360|FG002|Overall Study|Lost to Follow-up|5|||
48805419|NCT05096208|157129361|FG003|Overall Study|Lost to Follow-up|2|||
48805420|NCT05096208|157129358|FG000|Overall Study|Withdrawal by Subject|0|||
48805421|NCT05096208|157129359|FG001|Overall Study|Withdrawal by Subject|1|||
48805422|NCT05096208|157129360|FG002|Overall Study|Withdrawal by Subject|2|||
48805423|NCT05096208|157129361|FG003|Overall Study|Withdrawal by Subject|3|||
48805424|NCT05096208|157129358|FG000|Overall Study|No longer met eligibility criteria|1|||
48805425|NCT05096208|157129359|FG001|Overall Study|No longer met eligibility criteria|0|||
48915864|NCT03200366|157526662|FG002|6 Month Post-Baseline Interview|Lost to Follow-up|17|||
48915865|NCT03200366|157526660|FG000|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
48915866|NCT03200366|157526661|FG001|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
48915867|NCT03200366|157526662|FG002|6 Month Post-Baseline Interview|Withdrawal by Subject|0|||
48915868|NCT03200366|157526660|FG000|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1|||
48915869|NCT03200366|157526661|FG001|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
48915870|NCT03200366|157526662|FG002|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
48915871|NCT03200366|157526660|FG000|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
48915872|NCT03200366|157526661|FG001|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
48915873|NCT03200366|157526662|FG002|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1|||
48915874|NCT03200366|157526660|FG000|9 Month Post-Baseline Interview|Death|1|||
48915875|NCT03200366|157526661|FG001|9 Month Post-Baseline Interview|Death|1|||
48915876|NCT03200366|157526662|FG002|9 Month Post-Baseline Interview|Death|1|||
48915877|NCT03200366|157526660|FG000|9 Month Post-Baseline Interview|Lost to Follow-up|23|||
48915878|NCT03200366|157526661|FG001|9 Month Post-Baseline Interview|Lost to Follow-up|18|||
48915879|NCT03200366|157526662|FG002|9 Month Post-Baseline Interview|Lost to Follow-up|9|||
48915880|NCT03200366|157526660|FG000|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
48915881|NCT03200366|157526661|FG001|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
48915882|NCT03200366|157526662|FG002|9 Month Post-Baseline Interview|Withdrawal by PI|1|||
48915883|NCT03200366|157526660|FG000|9 Month Post-Baseline Interview|Refused interview|0|||
48915884|NCT03200366|157526661|FG001|9 Month Post-Baseline Interview|Refused interview|2|||
48915885|NCT03200366|157526662|FG002|9 Month Post-Baseline Interview|Refused interview|0|||
48915886|NCT00715026|157526671|FG000|Overall Study|Withdrawal by Subject|5|||
48915887|NCT00715026|157526671|FG000|Overall Study|Lost to Follow-up|3|||
48915888|NCT00715026|157526671|FG000|Overall Study|Protocol Violation|1|||
48709300|NCT04080167|156784278|FG001|Overall Study|Lost to Follow-up-Providers|2|||
48709301|NCT04080167|156784279|FG002|Overall Study|Lost to Follow-up-Providers|0|||
48709302|NCT04080167|156784277|FG000|Overall Study|Withdrawal by Subject|1|||
48915889|NCT00715026|157526671|FG000|Overall Study|Surgery done on non-study consented hip|1|||
48709303|NCT04080167|156784278|FG001|Overall Study|Withdrawal by Subject|2|||
48709304|NCT04080167|156784279|FG002|Overall Study|Withdrawal by Subject|0|||
48709305|NCT04080167|156784277|FG000|Overall Study|Withdrawal by Provider|0|||
48709306|NCT04080167|156784278|FG001|Overall Study|Withdrawal by Provider|0|||
48709307|NCT04080167|156784279|FG002|Overall Study|Withdrawal by Provider|4|||
48709308|NCT04080167|156784277|FG000|Overall Study|Death-Patient|2|||
48709309|NCT04080167|156784278|FG001|Overall Study|Death-Patient|1|||
48709310|NCT04080167|156784279|FG002|Overall Study|Death-Patient|0|||
48709311|NCT04080167|156784277|FG000|Overall Study|Hydroxyurea New Starts|0|||
48805426|NCT05096208|157129360|FG002|Overall Study|No longer met eligibility criteria|0|||
48805427|NCT05096208|157129361|FG003|Overall Study|No longer met eligibility criteria|0|||
48805428|NCT05096208|157129358|FG000|Overall Study|Other|0|||
48805429|NCT05096208|157129359|FG001|Overall Study|Other|0|||
48805430|NCT05096208|157129360|FG002|Overall Study|Other|1|||
48915890|NCT00552175|157526672|FG000|Overall Study|Lack of Efficacy|2|||
48805431|NCT05096208|157129361|FG003|Overall Study|Other|0|||
48805432|NCT00612534|157129362|FG000|Overall Study|Adverse Event|0|||
48805433|NCT00612534|157129363|FG001|Overall Study|Adverse Event|4|||
48805434|NCT00612534|157129364|FG002|Overall Study|Adverse Event|2|||
48805435|NCT00612534|157129365|FG003|Overall Study|Adverse Event|1|||
48805436|NCT00612534|157129362|FG000|Overall Study|Lack of Efficacy|13|||
48805437|NCT00612534|157129363|FG001|Overall Study|Lack of Efficacy|12|||
48805438|NCT00612534|157129364|FG002|Overall Study|Lack of Efficacy|5|||
48805439|NCT00612534|157129365|FG003|Overall Study|Lack of Efficacy|16|||
48805440|NCT00612534|157129362|FG000|Overall Study|Other Reason|0|||
48805441|NCT00612534|157129363|FG001|Overall Study|Other Reason|1|||
48805442|NCT00612534|157129364|FG002|Overall Study|Other Reason|0|||
48805443|NCT00612534|157129365|FG003|Overall Study|Other Reason|0|||
48805444|NCT04043962|157129366|FG000|Post-Treatment|Declined due to lack of time/interest or could not be reached|3|||
48805445|NCT04043962|157129366|FG000|Post-Treatment|Withdrawal by Subject|5|||
48805446|NCT04043962|157129366|FG000|Follow-up|Declined due to lack of time/interest or could not be reached|7|||
48805447|NCT01521884|157129369|FG000|Overall Study|Non Responders|10|||
48805448|NCT01521884|157129369|FG000|Overall Study|Adverse Event|5|||
48805449|NCT01521884|157129369|FG000|Overall Study|Pregnancy|1|||
48915891|NCT00552175|157526673|FG001|Overall Study|Lack of Efficacy|0|||
48915892|NCT00552175|157526674|FG002|Overall Study|Lack of Efficacy|1|||
48915893|NCT00552175|157526672|FG000|Overall Study|Adverse Event|9|||
49119347|NCT00426764|158274682|FG000|Overall Study|Other Reasons (Miscellaneous)|10|||
49119348|NCT02306850|158274683|FG000|Overall Study|Lack of Efficacy|2|||
48805450|NCT01521884|157129369|FG000|Overall Study|Withdrawal by Subject|1|||
48805451|NCT01521884|157129369|FG000|Overall Study|Physician Decision|2|||
48805452|NCT01521884|157129369|FG000|Overall Study|Protocol Violation|3|||
48805453|NCT01521884|157129369|FG000|Overall Study|Participant non-eligible|1|||
48805454|NCT01521884|157129369|FG000|Overall Study|Lost to Follow-up|4|||
48805455|NCT05170841|157129370|FG000|Single Dose Phase|Adverse Event|1|||
48805456|NCT05170841|157129371|FG001|Single Dose Phase|Adverse Event|2|||
48805457|NCT05170841|157129372|FG002|Single Dose Phase|Adverse Event|0|||
48915894|NCT00552175|157526673|FG001|Overall Study|Adverse Event|9|||
48915895|NCT00552175|157526674|FG002|Overall Study|Adverse Event|10|||
48915896|NCT00552175|157526672|FG000|Overall Study|Withdrawal by Subject|2|||
48915897|NCT00552175|157526673|FG001|Overall Study|Withdrawal by Subject|2|||
49119349|NCT01922258|158274684|FG000|Overall Study|Lost to Follow-up|1|||
49119350|NCT01922258|158274685|FG001|Overall Study|Lost to Follow-up|1|||
49119351|NCT01922258|158274684|FG000|Overall Study|Adverse Event|9|||
49119352|NCT01922258|158274685|FG001|Overall Study|Adverse Event|2|||
49119353|NCT01922258|158274684|FG000|Overall Study|Met Withdrawal Criteria|0|||
49119354|NCT01922258|158274685|FG001|Overall Study|Met Withdrawal Criteria|4|||
49119355|NCT01922258|158274684|FG000|Overall Study|Withdrawn by the Investigator|1|||
49119356|NCT01922258|158274685|FG001|Overall Study|Withdrawn by the Investigator|4|||
49119357|NCT01922258|158274684|FG000|Overall Study|Withdrawal by participant|5|||
49119358|NCT01922258|158274685|FG001|Overall Study|Withdrawal by participant|5|||
49119359|NCT00673257|158274686|FG000|Overall Study|Withdrawal by Subject|4|||
49119360|NCT00673257|158274686|FG000|Overall Study|Unable to obtain specimen|1|||
48805458|NCT05170841|157129373|FG003|Single Dose Phase|Adverse Event|2|||
48805459|NCT05170841|157129370|FG000|Multiple Dose Phase|Adverse Event|1|||
48915898|NCT00552175|157526674|FG002|Overall Study|Withdrawal by Subject|1|||
49119361|NCT01188668|158274687|FG000|Period 1: ARIP Alone|Protocol Violation|2|||
49119362|NCT01188668|158274687|FG000|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2|||
48805460|NCT05170841|157129371|FG001|Multiple Dose Phase|Adverse Event|2|||
48805461|NCT05170841|157129372|FG002|Multiple Dose Phase|Adverse Event|1|||
48805462|NCT05170841|157129373|FG003|Multiple Dose Phase|Adverse Event|4|||
48915899|NCT00552175|157526672|FG000|Overall Study|Lost to Follow-up|0|||
49119363|NCT01188668|158274687|FG000|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1|||
49119364|NCT01585246|158274688|FG000|Overall Study|Lost to Follow-up|0|||
48915900|NCT00552175|157526673|FG001|Overall Study|Lost to Follow-up|0|||
48915901|NCT00552175|157526674|FG002|Overall Study|Lost to Follow-up|1|||
49119365|NCT01585246|158274689|FG001|Overall Study|Lost to Follow-up|0|||
48805463|NCT05170841|157129370|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
48805464|NCT05170841|157129371|FG001|Multiple Dose Phase|Withdrawal by Subject|1|||
48805465|NCT05170841|157129372|FG002|Multiple Dose Phase|Withdrawal by Subject|0|||
48805466|NCT05170841|157129373|FG003|Multiple Dose Phase|Withdrawal by Subject|0|||
48805467|NCT00903786|157129376|FG000|Overall Study|Physician Decision|6|||
48805468|NCT00903786|157129376|FG000|Overall Study|Lack of Efficacy|5|||
48805469|NCT00903786|157129376|FG000|Overall Study|Reason other than lack of efficacy|4|||
48805470|NCT00746096|157129377|FG000|Overall Study|Adverse Event|1|||
48805471|NCT00746096|157129378|FG001|Overall Study|Adverse Event|0|||
48805472|NCT00746096|157129377|FG000|Overall Study|Withdrawal by Subject|5|||
48805473|NCT00746096|157129378|FG001|Overall Study|Withdrawal by Subject|1|||
48805474|NCT00746096|157129377|FG000|Overall Study|Lost to Follow-up|2|||
48805475|NCT00746096|157129378|FG001|Overall Study|Lost to Follow-up|1|||
48805476|NCT00746096|157129377|FG000|Overall Study|Protocol Violation|1|||
48805477|NCT00746096|157129378|FG001|Overall Study|Protocol Violation|0|||
48805478|NCT00746096|157129377|FG000|Overall Study|No study drug treatment|1|||
48805479|NCT00746096|157129378|FG001|Overall Study|No study drug treatment|1|||
48805480|NCT01852058|157129379|FG000|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1|||
48805481|NCT01852058|157129380|FG001|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
48805482|NCT01852058|157129381|FG002|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
48805483|NCT01852058|157129382|FG003|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
48805484|NCT01852058|157129383|FG004|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
48805485|NCT01852058|157129384|FG005|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
48805486|NCT01852058|157129385|FG006|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
48805487|NCT01852058|157129386|FG007|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
48805488|NCT01852058|157129387|FG008|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
48805489|NCT01852058|157129388|FG009|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
48805490|NCT01852058|157129389|FG010|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
48805491|NCT01852058|157129390|FG011|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
48805492|NCT01852058|157129379|FG000|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
48805493|NCT01852058|157129380|FG001|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
48805494|NCT01852058|157129381|FG002|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
49119366|NCT01585246|158274690|FG002|Overall Study|Lost to Follow-up|2|||
48805495|NCT01852058|157129382|FG003|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
48805496|NCT01852058|157129383|FG004|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1|||
48805497|NCT01852058|157129384|FG005|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
48805498|NCT01852058|157129385|FG006|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
48805499|NCT01852058|157129386|FG007|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
48805500|NCT01852058|157129387|FG008|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
48805501|NCT01852058|157129388|FG009|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
48805502|NCT01852058|157129389|FG010|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
48805503|NCT01852058|157129390|FG011|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
48805504|NCT01852058|157129379|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
48805505|NCT01852058|157129380|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
48805506|NCT01852058|157129381|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
49119367|NCT01585246|158274691|FG003|Overall Study|Lost to Follow-up|1|||
49119368|NCT01585246|158274692|FG004|Overall Study|Lost to Follow-up|0|||
49119369|NCT01585246|158274688|FG000|Overall Study|Protocol Violation|0|||
49119370|NCT01585246|158274689|FG001|Overall Study|Protocol Violation|0|||
49119371|NCT01585246|158274690|FG002|Overall Study|Protocol Violation|0|||
49119372|NCT01585246|158274691|FG003|Overall Study|Protocol Violation|0|||
49119373|NCT01585246|158274692|FG004|Overall Study|Protocol Violation|1|||
49119374|NCT01585246|158274688|FG000|Overall Study|Withdrawal by Subject|0|||
48805507|NCT01852058|157129382|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
48805508|NCT01852058|157129383|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
48915902|NCT00552175|157526672|FG000|Overall Study|Entry Criteria Not Met|1|||
48915903|NCT00552175|157526673|FG001|Overall Study|Entry Criteria Not Met|1|||
48915904|NCT00552175|157526674|FG002|Overall Study|Entry Criteria Not Met|0|||
48915905|NCT00552175|157526672|FG000|Overall Study|Reason Not Specified|3|||
49119375|NCT01585246|158274689|FG001|Overall Study|Withdrawal by Subject|0|||
49119376|NCT01585246|158274690|FG002|Overall Study|Withdrawal by Subject|1|||
49119377|NCT01585246|158274691|FG003|Overall Study|Withdrawal by Subject|2|||
49119378|NCT01585246|158274692|FG004|Overall Study|Withdrawal by Subject|1|||
49119379|NCT01585246|158274688|FG000|Overall Study|Other|0|||
49119380|NCT01585246|158274689|FG001|Overall Study|Other|1|||
48915906|NCT00552175|157526673|FG001|Overall Study|Reason Not Specified|1|||
48915907|NCT00552175|157526674|FG002|Overall Study|Reason Not Specified|1|||
48915908|NCT00631020|157526677|FG000|Overall Study|Lost to Follow-up|7|||
48915909|NCT00631020|157526677|FG000|Overall Study|Incarcerated|1|||
48915910|NCT03221751|157526678|FG000|Overall Study|lumbar puncture not performed at early termination.|1|||
48915911|NCT03221751|157526679|FG001|Overall Study|lumbar puncture not performed at early termination.|0|||
48915912|NCT04677959|157526681|FG000|Overall Study|Adverse Event|1|||
48915913|NCT04677959|157526682|FG001|Overall Study|Adverse Event|9|||
48915914|NCT04677959|157526681|FG000|Overall Study|Withdrawal by Subject|2|||
48915915|NCT04677959|157526682|FG001|Overall Study|Withdrawal by Subject|15|||
48915916|NCT04677959|157526681|FG000|Overall Study|Withdrawal by parent/guardian|0|||
48915917|NCT04677959|157526682|FG001|Overall Study|Withdrawal by parent/guardian|1|||
48915918|NCT04677959|157526681|FG000|Overall Study|Non-compliance with study drug|0|||
48915919|NCT04677959|157526682|FG001|Overall Study|Non-compliance with study drug|2|||
48915920|NCT04677959|157526681|FG000|Overall Study|Protocol deviation|0|||
48915921|NCT04677959|157526682|FG001|Overall Study|Protocol deviation|11|||
48915922|NCT04677959|157526681|FG000|Overall Study|Lost to Follow-up|9|||
48915923|NCT04677959|157526682|FG001|Overall Study|Lost to Follow-up|13|||
48915924|NCT04677959|157526681|FG000|Overall Study|Other than specified|0|||
48915925|NCT04677959|157526682|FG001|Overall Study|Other than specified|8|||
48915926|NCT00577642|157526689|FG000|Overall Study|Clinical Disease Progression|1|||
48915927|NCT00807742|157526696|FG000|Overall Study|Death|9|||
48915928|NCT00807742|157526697|FG001|Overall Study|Death|2|||
48915929|NCT00807742|157526696|FG000|Overall Study|Withdrawal by Subject|2|||
48915930|NCT00807742|157526697|FG001|Overall Study|Withdrawal by Subject|1|||
48915931|NCT00807742|157526696|FG000|Overall Study|Lost to Follow-up|35|||
48915932|NCT00807742|157526697|FG001|Overall Study|Lost to Follow-up|51|||
48915933|NCT00788372|157526700|FG000|Period 1 (up to 4 Weeks)|Adverse Event|18|||
48915934|NCT00788372|157526700|FG000|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9|||
48915935|NCT00788372|157526700|FG000|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4|||
49119381|NCT01585246|158274690|FG002|Overall Study|Other|1|||
49119382|NCT01585246|158274691|FG003|Overall Study|Other|1|||
49119383|NCT01585246|158274692|FG004|Overall Study|Other|0|||
49119384|NCT00237692|158274693|FG000|Overall Study|Lost to Follow-up|9|||
49119385|NCT00237692|158274694|FG001|Overall Study|Lost to Follow-up|3|||
49119386|NCT00237692|158274695|FG002|Overall Study|Lost to Follow-up|5|||
49119387|NCT00237692|158274696|FG003|Overall Study|Lost to Follow-up|3|||
49119388|NCT00237692|158274693|FG000|Overall Study|Death|1|||
49119389|NCT00237692|158274694|FG001|Overall Study|Death|2|||
49119390|NCT00237692|158274695|FG002|Overall Study|Death|2|||
49119391|NCT00237692|158274696|FG003|Overall Study|Death|3|||
49119392|NCT00237692|158274693|FG000|Overall Study|Excluded - did not meet criteria|4|||
49119393|NCT00237692|158274694|FG001|Overall Study|Excluded - did not meet criteria|3|||
49119394|NCT00237692|158274695|FG002|Overall Study|Excluded - did not meet criteria|5|||
49119395|NCT00237692|158274696|FG003|Overall Study|Excluded - did not meet criteria|9|||
49119396|NCT00237692|158274693|FG000|Overall Study|Withdrawal by Subject|4|||
49119397|NCT00237692|158274694|FG001|Overall Study|Withdrawal by Subject|6|||
49119398|NCT00237692|158274695|FG002|Overall Study|Withdrawal by Subject|10|||
48709312|NCT04080167|156784278|FG001|Overall Study|Hydroxyurea New Starts|0|||
48709313|NCT04080167|156784279|FG002|Overall Study|Hydroxyurea New Starts|1|||
48709314|NCT04080167|156784277|FG000|Overall Study|Did not complete the baseline survey/activities|0|||
48709315|NCT04080167|156784278|FG001|Overall Study|Did not complete the baseline survey/activities|4|||
48709316|NCT04080167|156784279|FG002|Overall Study|Did not complete the baseline survey/activities|0|||
48709317|NCT03339219|156784280|FG000|Overall Study|Death|12|||
48709318|NCT03339219|156784280|FG000|Overall Study|Site Terminated by Sponsor|22|||
48709319|NCT03339219|156784280|FG000|Overall Study|Withdrawal by Subject|1|||
48709320|NCT02167139|156784281|FG000|Randomised, Double-blind|Withdrawal by Subject|11|||
48709321|NCT02167139|156784282|FG001|Randomised, Double-blind|Withdrawal by Subject|8|||
48709322|NCT02167139|156784283|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
48709323|NCT02167139|156784284|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
48709324|NCT02167139|156784281|FG000|Randomised, Double-blind|Adverse Event|2|||
48709325|NCT02167139|156784282|FG001|Randomised, Double-blind|Adverse Event|9|||
48709326|NCT02167139|156784283|FG002|Randomised, Double-blind|Adverse Event|0|||
48709327|NCT02167139|156784284|FG003|Randomised, Double-blind|Adverse Event|0|||
48709328|NCT02167139|156784281|FG000|Randomised, Double-blind|Lack of Efficacy|1|||
48709329|NCT02167139|156784282|FG001|Randomised, Double-blind|Lack of Efficacy|2|||
48709330|NCT02167139|156784283|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
48915936|NCT00788372|157526700|FG000|Period 2 (Week 4 to Week 52)|Adverse Event|13|||
48915937|NCT00788372|157526700|FG000|Period 2 (Week 4 to Week 52)|Physician Decision|9|||
48915938|NCT00788372|157526700|FG000|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9|||
48915939|NCT00788372|157526700|FG000|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1|||
49119399|NCT00237692|158274696|FG003|Overall Study|Withdrawal by Subject|4|||
49119400|NCT02420262|158274697|FG000|Overall Study|Adverse Event|1|||
49119401|NCT02420262|158274698|FG001|Overall Study|Adverse Event|0|||
49119402|NCT02420262|158274697|FG000|Overall Study|Withdrawal by Subject|1|||
48915940|NCT04066491|157526702|FG000|Overall Study|Randomized, not treated|0|||
48915941|NCT04066491|157526703|FG001|Overall Study|Randomized, not treated|0|||
48915942|NCT04066491|157526704|FG002|Overall Study|Randomized, not treated|2|||
48915943|NCT02043548|157526705|FG000|Overall Study|Lack of Efficacy|1|||
48915944|NCT02043548|157526706|FG001|Overall Study|Lack of Efficacy|0|||
48915945|NCT02043548|157526705|FG000|Overall Study|Adverse Event|0|||
48915946|NCT02043548|157526706|FG001|Overall Study|Adverse Event|1|||
48915947|NCT03227471|157528392|FG000|Overall Study|Withdrawal by Subject|0|||
48709331|NCT02167139|156784284|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
48709332|NCT02167139|156784281|FG000|Randomised, Double-blind|Other|3|||
48709333|NCT02167139|156784282|FG001|Randomised, Double-blind|Other|0|||
48915948|NCT03227471|157528393|FG001|Overall Study|Withdrawal by Subject|0|||
48915949|NCT03227471|157528394|FG002|Overall Study|Withdrawal by Subject|0|||
49119403|NCT02420262|158274698|FG001|Overall Study|Withdrawal by Subject|4|||
49119404|NCT02420262|158274697|FG000|Overall Study|Unclassified|0|||
49119405|NCT02420262|158274698|FG001|Overall Study|Unclassified|1|||
48709334|NCT02167139|156784283|FG002|Randomised, Double-blind|Other|0|||
48709335|NCT02167139|156784284|FG003|Randomised, Double-blind|Other|0|||
48709336|NCT02167139|156784281|FG000|Transition-extension|Adverse Event|2|||
48709337|NCT02167139|156784282|FG001|Transition-extension|Adverse Event|0|||
48709338|NCT02167139|156784283|FG002|Transition-extension|Adverse Event|2|||
48709339|NCT02167139|156784284|FG003|Transition-extension|Adverse Event|3|||
48709340|NCT02167139|156784281|FG000|Transition-extension|Withdrawal by Subject|2|||
48709341|NCT02167139|156784282|FG001|Transition-extension|Withdrawal by Subject|0|||
48709342|NCT02167139|156784283|FG002|Transition-extension|Withdrawal by Subject|4|||
48709343|NCT02167139|156784284|FG003|Transition-extension|Withdrawal by Subject|1|||
48709344|NCT02167139|156784281|FG000|Transition-extension|Lack of Efficacy|0|||
48805509|NCT01852058|157129384|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
48805510|NCT01852058|157129385|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
48805511|NCT01852058|157129386|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
48805512|NCT01852058|157129387|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
48805513|NCT01852058|157129388|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
48805514|NCT01852058|157129389|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
48805515|NCT01852058|157129390|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
48805516|NCT01852058|157129379|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
48805517|NCT01852058|157129380|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
48805518|NCT01852058|157129381|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
48805519|NCT01852058|157129382|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
48805520|NCT01852058|157129383|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1|||
48805521|NCT01852058|157129384|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
48805522|NCT01852058|157129385|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
48805523|NCT01852058|157129386|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
48805524|NCT01852058|157129387|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
48805525|NCT01852058|157129388|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
48805526|NCT01852058|157129389|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
48915950|NCT03227471|157528395|FG003|Overall Study|Withdrawal by Subject|0|||
48915951|NCT03227471|157528396|FG004|Overall Study|Withdrawal by Subject|1|||
48915952|NCT03227471|157528397|FG005|Overall Study|Withdrawal by Subject|0|||
48915953|NCT03227471|157528398|FG006|Overall Study|Withdrawal by Subject|0|||
48915954|NCT03227471|157528399|FG007|Overall Study|Withdrawal by Subject|0|||
48915955|NCT03227471|157528400|FG008|Overall Study|Withdrawal by Subject|0|||
48915956|NCT03227471|157528401|FG009|Overall Study|Withdrawal by Subject|0|||
48915957|NCT03227471|157528402|FG010|Overall Study|Withdrawal by Subject|0|||
48915958|NCT03227471|157528403|FG011|Overall Study|Withdrawal by Subject|0|||
48915959|NCT03227471|157528404|FG012|Overall Study|Withdrawal by Subject|1|||
48915960|NCT03227471|157528405|FG013|Overall Study|Withdrawal by Subject|0|||
48915961|NCT03227471|157528406|FG014|Overall Study|Withdrawal by Subject|0|||
48915962|NCT03227471|157528392|FG000|Overall Study|Randomized, Never Dosed|0|||
48915963|NCT03227471|157528393|FG001|Overall Study|Randomized, Never Dosed|0|||
49119406|NCT02716779|158274699|FG000|Monotherapy|Adverse Event|0|||
49119407|NCT02716779|158274700|FG001|Monotherapy|Adverse Event|1|||
49119408|NCT02716779|158274701|FG002|Monotherapy|Adverse Event|1|||
49119409|NCT02716779|158274699|FG000|Combination Therapy|Adverse Event|0|||
49119410|NCT02716779|158274700|FG001|Combination Therapy|Adverse Event|2|||
49119411|NCT02716779|158274701|FG002|Combination Therapy|Adverse Event|1|||
49119412|NCT02600923|158274702|FG000|Overall Study|Death|10|||
49119413|NCT02600923|158274702|FG000|Overall Study|Adverse Event|3|||
48915964|NCT03227471|157528394|FG002|Overall Study|Randomized, Never Dosed|0|||
48915965|NCT03227471|157528395|FG003|Overall Study|Randomized, Never Dosed|0|||
49119414|NCT02600923|158274702|FG000|Overall Study|Global deterioration of health status|2|||
48709345|NCT02167139|156784282|FG001|Transition-extension|Lack of Efficacy|0|||
48709346|NCT02167139|156784283|FG002|Transition-extension|Lack of Efficacy|1|||
48709347|NCT02167139|156784284|FG003|Transition-extension|Lack of Efficacy|1|||
48805527|NCT01852058|157129390|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
48805528|NCT01852058|157129379|FG000|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
48805529|NCT01852058|157129380|FG001|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
48805530|NCT01852058|157129381|FG002|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
48805531|NCT01852058|157129382|FG003|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
48805532|NCT01852058|157129383|FG004|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3|||
48805533|NCT01852058|157129384|FG005|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1|||
48805534|NCT01852058|157129385|FG006|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
48805535|NCT01852058|157129386|FG007|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
48805536|NCT01852058|157129387|FG008|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
48805537|NCT01852058|157129388|FG009|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
48805538|NCT01852058|157129389|FG010|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
48805539|NCT01852058|157129390|FG011|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
48805540|NCT01852058|157129379|FG000|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
48805541|NCT01852058|157129380|FG001|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
48805542|NCT01852058|157129381|FG002|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
48805543|NCT01852058|157129382|FG003|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1|||
48805544|NCT01852058|157129383|FG004|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
48805545|NCT01852058|157129384|FG005|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
48805546|NCT01852058|157129385|FG006|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
48805547|NCT01852058|157129386|FG007|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
48805548|NCT01852058|157129387|FG008|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
48805549|NCT01852058|157129388|FG009|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
48805550|NCT01852058|157129389|FG010|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
48805551|NCT01852058|157129390|FG011|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
48805552|NCT01852058|157129379|FG000|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
48805553|NCT01852058|157129380|FG001|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
48805554|NCT01852058|157129381|FG002|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
48709348|NCT02167139|156784281|FG000|Transition-extension|Other|1|||
48709349|NCT02167139|156784282|FG001|Transition-extension|Other|0|||
48709350|NCT02167139|156784283|FG002|Transition-extension|Other|1|||
48709351|NCT02167139|156784284|FG003|Transition-extension|Other|0|||
48709352|NCT02167139|156784281|FG000|Transition-extension|Lost to Follow-up|1|||
48709353|NCT02167139|156784282|FG001|Transition-extension|Lost to Follow-up|0|||
48709354|NCT02167139|156784283|FG002|Transition-extension|Lost to Follow-up|0|||
48709355|NCT02167139|156784284|FG003|Transition-extension|Lost to Follow-up|0|||
48709356|NCT01146795|156784285|FG000|Overall Study|Withdrawal by Subject|4|||
48709357|NCT01146795|156784285|FG000|Overall Study|Adverse Event|6|||
48709358|NCT01146795|156784285|FG000|Overall Study|Still in treatment at study closure|10|||
48709359|NCT00845897|156784288|FG000|Overall Study|Lost to Follow-up|1|||
48709360|NCT00845897|156784289|FG001|Overall Study|Lost to Follow-up|1|||
48709361|NCT00845897|156784290|FG002|Overall Study|Lost to Follow-up|0|||
48709362|NCT00845897|156784288|FG000|Overall Study|Withdrawal by Subject|0|||
48709363|NCT00845897|156784289|FG001|Overall Study|Withdrawal by Subject|3|||
48709364|NCT00845897|156784290|FG002|Overall Study|Withdrawal by Subject|2|||
48709365|NCT00845897|156784288|FG000|Overall Study|Ulcer did not heal|1|||
48709366|NCT00845897|156784289|FG001|Overall Study|Ulcer did not heal|0|||
48709367|NCT00845897|156784290|FG002|Overall Study|Ulcer did not heal|1|||
48709368|NCT00845897|156784288|FG000|Overall Study|Too ill to participate|0|||
48709369|NCT00845897|156784289|FG001|Overall Study|Too ill to participate|1|||
48709370|NCT00845897|156784290|FG002|Overall Study|Too ill to participate|0|||
48709371|NCT00074490|156784291|FG000|Overall Study|Progressive malignancy|0|||
48709372|NCT00074490|156784292|FG001|Overall Study|Progressive malignancy|7|||
48709373|NCT00074490|156784293|FG002|Overall Study|Progressive malignancy|0|||
48709374|NCT00074490|156784294|FG003|Overall Study|Progressive malignancy|0|||
48709375|NCT00074490|156784295|FG004|Overall Study|Progressive malignancy|3|||
48709376|NCT00074490|156784296|FG005|Overall Study|Progressive malignancy|0|||
48709377|NCT00566696|156784297|FG000|Overall Study|Met Exclusion Criteria|2|||
48805555|NCT01852058|157129382|FG003|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
48805556|NCT01852058|157129383|FG004|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1|||
48805557|NCT01852058|157129384|FG005|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7|||
48709378|NCT00566696|156784297|FG000|Overall Study|Muromonab not available|1|||
48709379|NCT00566696|156784297|FG000|Overall Study|Health Status Change|1|||
48709380|NCT00566696|156784297|FG000|Overall Study|Physician Decision|1|||
48709381|NCT00566696|156784297|FG000|Overall Study|Non-Patient Donors|37|||
48709382|NCT01276054|156784303|FG000|Overall Study|No one to oversee trial after P.I. left|2|||
48709383|NCT01276054|156784304|FG001|Overall Study|No one to oversee trial after P.I. left|2|||
48709384|NCT01626872|156784305|FG000|Overall Study|Physician Decision|13|||
48805558|NCT01852058|157129385|FG006|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
48805559|NCT01852058|157129386|FG007|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
48805560|NCT01852058|157129387|FG008|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
48805561|NCT01852058|157129388|FG009|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
48805562|NCT01852058|157129389|FG010|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
48805563|NCT01852058|157129390|FG011|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
48805564|NCT01852058|157129379|FG000|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
48805565|NCT01852058|157129380|FG001|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
48805566|NCT01852058|157129381|FG002|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
48805567|NCT01852058|157129382|FG003|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
48805568|NCT01852058|157129383|FG004|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
48805569|NCT01852058|157129384|FG005|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
48805570|NCT01852058|157129385|FG006|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
48805571|NCT01852058|157129386|FG007|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1|||
48805572|NCT01852058|157129387|FG008|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
48805573|NCT01852058|157129388|FG009|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
48805574|NCT01852058|157129389|FG010|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
48805575|NCT01852058|157129390|FG011|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
48805576|NCT01852058|157129379|FG000|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
48805577|NCT01852058|157129380|FG001|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
48805578|NCT01852058|157129381|FG002|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
48805579|NCT01852058|157129382|FG003|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
48805580|NCT01852058|157129383|FG004|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
48805581|NCT01852058|157129384|FG005|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
48805582|NCT01852058|157129385|FG006|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
48805583|NCT01852058|157129386|FG007|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
48805584|NCT01852058|157129387|FG008|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1|||
48805585|NCT01852058|157129388|FG009|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
48805586|NCT01852058|157129389|FG010|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
48805587|NCT01852058|157129390|FG011|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
48805588|NCT01279343|157129391|FG000|Overall Study|Did not receive treatment|2|||
48805589|NCT01279343|157129392|FG001|Overall Study|Did not receive treatment|6|||
48805590|NCT02759185|157129393|FG000|Stage 1|Adverse Event|0|||
48805591|NCT02759185|157129394|FG001|Stage 1|Adverse Event|1|||
48805592|NCT02759185|157129395|FG002|Stage 1|Adverse Event|3|||
48805593|NCT02759185|157129396|FG003|Stage 1|Adverse Event|0|||
48805594|NCT02759185|157129397|FG004|Stage 1|Adverse Event|0|||
48805595|NCT02759185|157129398|FG005|Stage 1|Adverse Event|0|||
49119415|NCT02600923|158274702|FG000|Overall Study|Insufficient clinical response|6|||
49119416|NCT02600923|158274702|FG000|Overall Study|Lost to Follow-up|1|||
49119417|NCT02600923|158274702|FG000|Overall Study|Withdrawal by Subject|5|||
49119418|NCT02600923|158274702|FG000|Overall Study|Objective progression or relapse|50|||
49119419|NCT02600923|158274702|FG000|Overall Study|Study terminated by Sponsor|53|||
49119420|NCT02600923|158274702|FG000|Overall Study|Not treated|1|||
49119421|NCT00181883|158274712|FG000|Overall Study|Lack of Efficacy|2|||
49119422|NCT00181883|158274712|FG000|Overall Study|Treatment Limiting AEs|3|||
49119423|NCT00181883|158274712|FG000|Overall Study|Withdrawal by Subject|4|||
49119424|NCT00181883|158274712|FG000|Overall Study|Lost to Follow-up|1|||
49119425|NCT02895295|158274713|FG000|Overall Study|Survey Non-response|71|||
49119426|NCT02895295|158274714|FG001|Overall Study|Survey Non-response|94|||
49119427|NCT02895295|158274715|FG002|Overall Study|Survey Non-response|92|||
49119428|NCT05176717|158274717|FG000|Overall Study|Sponsor Decision|1|||
49119429|NCT05176717|158274718|FG001|Overall Study|Sponsor Decision|2|||
49119430|NCT05176717|158274719|FG002|Overall Study|Sponsor Decision|2|||
49119431|NCT02143024|158274720|FG000|Overall Study|Lost to Follow-up|1|||
49119432|NCT02143024|158274721|FG001|Overall Study|Lost to Follow-up|1|||
49119433|NCT02143024|158274720|FG000|Overall Study|Withdrawal by Subject|1|||
49119434|NCT02143024|158274721|FG001|Overall Study|Withdrawal by Subject|0|||
49119435|NCT04888494|158274728|FG000|Overall Study|Lost to Follow-up|2|||
49119436|NCT04888494|158274729|FG001|Overall Study|Lost to Follow-up|3|||
49119437|NCT04888494|158274728|FG000|Overall Study|We dropped the participant due to safety concerns for the staff.|1|||
48915966|NCT03227471|157528396|FG004|Overall Study|Randomized, Never Dosed|0|||
49119438|NCT04888494|158274729|FG001|Overall Study|We dropped the participant due to safety concerns for the staff.|0|||
49119439|NCT03677869|158274730|FG000|Overall Study|Withdrawal by Subject|1|||
49119440|NCT03630705|158277129|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
49119441|NCT03630705|158277130|FG001|Overall Study|Withdrawal by Parent/Guardian|6|||
49119442|NCT03630705|158277131|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
49119443|NCT03630705|158277132|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
49119444|NCT03630705|158277129|FG000|Overall Study|Lost to Follow-up|1|||
48915967|NCT03227471|157528397|FG005|Overall Study|Randomized, Never Dosed|0|||
48915968|NCT03227471|157528398|FG006|Overall Study|Randomized, Never Dosed|0|||
48915969|NCT03227471|157528399|FG007|Overall Study|Randomized, Never Dosed|0|||
48915970|NCT03227471|157528400|FG008|Overall Study|Randomized, Never Dosed|0|||
48915971|NCT03227471|157528401|FG009|Overall Study|Randomized, Never Dosed|0|||
48915972|NCT03227471|157528402|FG010|Overall Study|Randomized, Never Dosed|0|||
48915973|NCT03227471|157528403|FG011|Overall Study|Randomized, Never Dosed|0|||
48915974|NCT03227471|157528404|FG012|Overall Study|Randomized, Never Dosed|0|||
48915975|NCT03227471|157528405|FG013|Overall Study|Randomized, Never Dosed|0|||
48915976|NCT03227471|157528406|FG014|Overall Study|Randomized, Never Dosed|1|||
48915977|NCT00257166|157528407|FG000|Overall Study|Adverse Event|18|||
48915978|NCT00257166|157528408|FG001|Overall Study|Adverse Event|13|||
48915979|NCT00257166|157528407|FG000|Overall Study|Laboratory abnormality|1|||
48915980|NCT00257166|157528408|FG001|Overall Study|Laboratory abnormality|0|||
48915981|NCT00257166|157528407|FG000|Overall Study|Lost to Follow-up|8|||
48915982|NCT00257166|157528408|FG001|Overall Study|Lost to Follow-up|1|||
48915983|NCT00257166|157528407|FG000|Overall Study|Withdrawal by Subject|9|||
48915984|NCT00257166|157528408|FG001|Overall Study|Withdrawal by Subject|2|||
48805596|NCT02759185|157129399|FG006|Stage 1|Adverse Event|0|||
48805597|NCT02759185|157129393|FG000|Stage 1|Withdrawal by Subject|1|||
48805598|NCT02759185|157129394|FG001|Stage 1|Withdrawal by Subject|0|||
48805599|NCT02759185|157129395|FG002|Stage 1|Withdrawal by Subject|0|||
48805600|NCT02759185|157129396|FG003|Stage 1|Withdrawal by Subject|0|||
48805601|NCT02759185|157129397|FG004|Stage 1|Withdrawal by Subject|0|||
48805602|NCT02759185|157129398|FG005|Stage 1|Withdrawal by Subject|0|||
48805603|NCT02759185|157129399|FG006|Stage 1|Withdrawal by Subject|0|||
48805604|NCT02759185|157129393|FG000|Stage 2|Adverse Event|0|||
48805605|NCT02759185|157129394|FG001|Stage 2|Adverse Event|0|||
48805606|NCT02759185|157129395|FG002|Stage 2|Adverse Event|0|||
48805607|NCT02759185|157129396|FG003|Stage 2|Adverse Event|0|||
48805608|NCT02759185|157129397|FG004|Stage 2|Adverse Event|1|||
48805609|NCT02759185|157129398|FG005|Stage 2|Adverse Event|2|||
48805610|NCT02759185|157129399|FG006|Stage 2|Adverse Event|0|||
48805611|NCT02759185|157129393|FG000|Stage 2|Withdrawal by Subject|0|||
48805612|NCT02759185|157129394|FG001|Stage 2|Withdrawal by Subject|0|||
48805613|NCT02759185|157129395|FG002|Stage 2|Withdrawal by Subject|0|||
48805614|NCT02759185|157129396|FG003|Stage 2|Withdrawal by Subject|0|||
48805615|NCT02759185|157129397|FG004|Stage 2|Withdrawal by Subject|1|||
48805616|NCT02759185|157129398|FG005|Stage 2|Withdrawal by Subject|1|||
48805617|NCT02759185|157129399|FG006|Stage 2|Withdrawal by Subject|1|||
48805618|NCT01806584|157129400|FG000|Overall Study|Adverse Event|2|||
48805619|NCT01806584|157129401|FG001|Overall Study|Adverse Event|1|||
48805620|NCT01806584|157129400|FG000|Overall Study|Death|1|||
48805621|NCT01806584|157129401|FG001|Overall Study|Death|0|||
48805622|NCT01806584|157129400|FG000|Overall Study|Lost to Follow-up|0|||
48805623|NCT01806584|157129401|FG001|Overall Study|Lost to Follow-up|2|||
48805624|NCT01806584|157129400|FG000|Overall Study|Study terminated by sponsor|9|||
48805625|NCT01806584|157129401|FG001|Overall Study|Study terminated by sponsor|14|||
48805626|NCT01806584|157129400|FG000|Overall Study|Withdrawal by Subject|1|||
48805627|NCT01806584|157129401|FG001|Overall Study|Withdrawal by Subject|1|||
48805628|NCT01806584|157129400|FG000|Overall Study|Other unspecified|1|||
48805629|NCT01806584|157129401|FG001|Overall Study|Other unspecified|0|||
48805630|NCT03021668|157129402|FG000|Overall Study|Physician Decision|0|||
48805631|NCT03021668|157129403|FG001|Overall Study|Physician Decision|1|||
48805632|NCT02234063|157129412|FG000|Overall Study|Lost to Follow-up|235|||
48805633|NCT02234063|157129413|FG001|Overall Study|Lost to Follow-up|42|||
48805634|NCT02234063|157129412|FG000|Overall Study|Withdrawal by Subject|20|||
48805635|NCT02234063|157129413|FG001|Overall Study|Withdrawal by Subject|1|||
48805636|NCT00069784|157129414|FG000|Overall Study|Adverse Event|105|||
48805637|NCT00069784|157129415|FG001|Overall Study|Adverse Event|0|||
48805638|NCT00069784|157129414|FG000|Overall Study|Withdrawal by Subject|1090|||
48805639|NCT00069784|157129415|FG001|Overall Study|Withdrawal by Subject|0|||
48805640|NCT00069784|157129414|FG000|Overall Study|Other|17|||
48805641|NCT00069784|157129415|FG001|Overall Study|Other|0|||
48805642|NCT03573908|157129416|FG000|Treatment Period|Adverse Event|4|||
48805643|NCT03573908|157129417|FG001|Treatment Period|Adverse Event|9|||
48805644|NCT03573908|157129418|FG002|Treatment Period|Adverse Event|0|||
48805645|NCT03573908|157129419|FG003|Treatment Period|Adverse Event|0|||
48915985|NCT00257166|157528407|FG000|Overall Study|Other|16|||
48915986|NCT00257166|157528408|FG001|Overall Study|Other|21|||
48915987|NCT00257166|157528407|FG000|Overall Study|Randomized, but not treated|1|||
48915988|NCT00257166|157528408|FG001|Overall Study|Randomized, but not treated|0|||
48915989|NCT01543152|157528415|FG000|Overall Study|Withdrawal by Subject|0|||
48915990|NCT01543152|157528416|FG001|Overall Study|Withdrawal by Subject|2|||
48915991|NCT01543152|157528417|FG002|Overall Study|Withdrawal by Subject|0|||
48915992|NCT01543152|157528418|FG003|Overall Study|Withdrawal by Subject|0|||
48915993|NCT01543152|157528419|FG004|Overall Study|Withdrawal by Subject|0|||
48915994|NCT01999465|157528420|FG000|Overall Study|Lost to Follow-up|0|||
48915995|NCT01999465|157528421|FG001|Overall Study|Lost to Follow-up|2|||
48915996|NCT01999465|157528420|FG000|Overall Study|Protocol Violation|0|||
48915997|NCT01999465|157528421|FG001|Overall Study|Protocol Violation|1|||
48805646|NCT03573908|157129420|FG004|Treatment Period|Adverse Event|0|||
48805647|NCT03573908|157129416|FG000|Treatment Period|Protocol Violation|1|||
48805648|NCT03573908|157129417|FG001|Treatment Period|Protocol Violation|0|||
48805649|NCT03573908|157129418|FG002|Treatment Period|Protocol Violation|0|||
48805650|NCT03573908|157129419|FG003|Treatment Period|Protocol Violation|0|||
48805651|NCT03573908|157129420|FG004|Treatment Period|Protocol Violation|0|||
48805652|NCT03573908|157129416|FG000|Treatment Period|Withdrawal by Subject|7|||
48805653|NCT03573908|157129417|FG001|Treatment Period|Withdrawal by Subject|5|||
48805654|NCT03573908|157129418|FG002|Treatment Period|Withdrawal by Subject|0|||
48805655|NCT03573908|157129419|FG003|Treatment Period|Withdrawal by Subject|0|||
48805656|NCT03573908|157129420|FG004|Treatment Period|Withdrawal by Subject|0|||
48915998|NCT02687542|157528422|FG000|Overall Study|Medication error without associated AEs|0|||
49010702|NCT03387059|157875682|FG001|Overall Study|Study termination|4|||
48805657|NCT03573908|157129416|FG000|Treatment Period|Lost to Follow-up|7|||
48805658|NCT03573908|157129417|FG001|Treatment Period|Lost to Follow-up|6|||
48805659|NCT03573908|157129418|FG002|Treatment Period|Lost to Follow-up|0|||
48805660|NCT03573908|157129419|FG003|Treatment Period|Lost to Follow-up|0|||
48805661|NCT03573908|157129420|FG004|Treatment Period|Lost to Follow-up|0|||
48805662|NCT03573908|157129416|FG000|Treatment Period|Pregnancy|1|||
48805663|NCT03573908|157129417|FG001|Treatment Period|Pregnancy|0|||
48805664|NCT03573908|157129418|FG002|Treatment Period|Pregnancy|0|||
48805665|NCT03573908|157129419|FG003|Treatment Period|Pregnancy|0|||
48805666|NCT03573908|157129420|FG004|Treatment Period|Pregnancy|0|||
48805667|NCT03573908|157129416|FG000|Treatment Period|Other, Not Specified|4|||
48805668|NCT03573908|157129417|FG001|Treatment Period|Other, Not Specified|6|||
48805669|NCT03573908|157129418|FG002|Treatment Period|Other, Not Specified|0|||
48805670|NCT03573908|157129419|FG003|Treatment Period|Other, Not Specified|0|||
48805671|NCT03573908|157129420|FG004|Treatment Period|Other, Not Specified|0|||
48805672|NCT03573908|157129416|FG000|Randomized Withdrawal Period|Adverse Event|0|||
48805673|NCT03573908|157129417|FG001|Randomized Withdrawal Period|Adverse Event|0|||
48915999|NCT02687542|157528423|FG001|Overall Study|Medication error without associated AEs|0|||
48916000|NCT02687542|157528424|FG002|Overall Study|Medication error without associated AEs|0|||
48916001|NCT02687542|157528425|FG003|Overall Study|Medication error without associated AEs|0|||
48916002|NCT02687542|157528426|FG004|Overall Study|Medication error without associated AEs|1|||
48916003|NCT02687542|157528422|FG000|Overall Study|Lost to Follow-up|0|||
48916004|NCT02687542|157528423|FG001|Overall Study|Lost to Follow-up|0|||
49119445|NCT03630705|158277130|FG001|Overall Study|Lost to Follow-up|2|||
49119446|NCT03630705|158277131|FG002|Overall Study|Lost to Follow-up|0|||
49119447|NCT03630705|158277132|FG003|Overall Study|Lost to Follow-up|0|||
49119448|NCT02576977|158277133|FG000|Overall Study|Adverse Event|13|||
49119449|NCT02576977|158277134|FG001|Overall Study|Adverse Event|2|||
48916005|NCT02687542|157528424|FG002|Overall Study|Lost to Follow-up|0|||
48916006|NCT02687542|157528425|FG003|Overall Study|Lost to Follow-up|0|||
49119450|NCT02576977|158277133|FG000|Overall Study|Death|73|||
49119451|NCT02576977|158277134|FG001|Overall Study|Death|60|||
49119452|NCT02576977|158277133|FG000|Overall Study|Screen failure|1|||
49119453|NCT02576977|158277134|FG001|Overall Study|Screen failure|0|||
49119454|NCT02576977|158277133|FG000|Overall Study|Study Terminated at Selected Sites|27|||
49119455|NCT02576977|158277134|FG001|Overall Study|Study Terminated at Selected Sites|50|||
49119456|NCT02576977|158277133|FG000|Overall Study|Withdrawal by Subject|11|||
49119457|NCT02576977|158277134|FG001|Overall Study|Withdrawal by Subject|11|||
48709385|NCT01626872|156784306|FG001|Overall Study|Physician Decision|9|||
48709386|NCT01626872|156784307|FG002|Overall Study|Physician Decision|6|||
48709387|NCT01626872|156784305|FG000|Overall Study|Withdrawal by Subject|19|||
48709388|NCT01626872|156784306|FG001|Overall Study|Withdrawal by Subject|27|||
48709389|NCT01626872|156784307|FG002|Overall Study|Withdrawal by Subject|8|||
48709390|NCT01626872|156784305|FG000|Overall Study|Adverse Event (including Death)|20|||
48709391|NCT01626872|156784306|FG001|Overall Study|Adverse Event (including Death)|28|||
48709392|NCT01626872|156784307|FG002|Overall Study|Adverse Event (including Death)|8|||
48709393|NCT01626872|156784305|FG000|Overall Study|Protocol Violation (including Pregnancy)|0|||
48709394|NCT01626872|156784306|FG001|Overall Study|Protocol Violation (including Pregnancy)|2|||
48709395|NCT01626872|156784307|FG002|Overall Study|Protocol Violation (including Pregnancy)|2|||
48709396|NCT02998268|156784308|FG000|Overall Study|Adverse Event|0|||
48709397|NCT02998268|156784309|FG001|Overall Study|Adverse Event|2|||
48709398|NCT02998268|156784308|FG000|Overall Study|Withdrawal by Subject|0|||
48709399|NCT02998268|156784309|FG001|Overall Study|Withdrawal by Subject|1|||
48709400|NCT01273519|156784310|FG000|Overall Study|Adverse Event|3|||
48709401|NCT01273519|156784311|FG001|Overall Study|Adverse Event|0|||
48709402|NCT01273519|156784312|FG002|Overall Study|Adverse Event|0|||
48709403|NCT01273519|156784310|FG000|Overall Study|Lost to Follow-up|2|||
48709404|NCT01273519|156784311|FG001|Overall Study|Lost to Follow-up|1|||
48709405|NCT01273519|156784312|FG002|Overall Study|Lost to Follow-up|3|||
48709406|NCT01273519|156784310|FG000|Overall Study|Lack of Efficacy|8|||
48709407|NCT01273519|156784311|FG001|Overall Study|Lack of Efficacy|3|||
48709408|NCT01273519|156784312|FG002|Overall Study|Lack of Efficacy|4|||
48709409|NCT01273519|156784310|FG000|Overall Study|Other|6|||
48709410|NCT01273519|156784311|FG001|Overall Study|Other|1|||
48709411|NCT01273519|156784312|FG002|Overall Study|Other|1|||
48709412|NCT02425943|156784320|FG000|Overall Study|Adverse Event|3|||
48805674|NCT03573908|157129418|FG002|Randomized Withdrawal Period|Adverse Event|3|||
48805675|NCT03573908|157129419|FG003|Randomized Withdrawal Period|Adverse Event|0|||
48805676|NCT03573908|157129420|FG004|Randomized Withdrawal Period|Adverse Event|0|||
48805677|NCT03573908|157129416|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
48805678|NCT03573908|157129417|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
48805679|NCT03573908|157129418|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
48805680|NCT03573908|157129419|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
48916007|NCT02687542|157528426|FG004|Overall Study|Lost to Follow-up|1|||
48916008|NCT02687542|157528422|FG000|Overall Study|Protocol Violation|0|||
48709413|NCT02425943|156784321|FG001|Overall Study|Adverse Event|1|||
49119458|NCT02576977|158277133|FG000|Overall Study|Final Disposition Unknown|0|||
48709414|NCT02425943|156784320|FG000|Overall Study|Lost to Follow-up|59|||
48709415|NCT02425943|156784321|FG001|Overall Study|Lost to Follow-up|37|||
48805681|NCT03573908|157129420|FG004|Randomized Withdrawal Period|Withdrawal by Subject|2|||
48805682|NCT03573908|157129416|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
48805683|NCT03573908|157129417|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
48805684|NCT03573908|157129418|FG002|Randomized Withdrawal Period|Lost to Follow-up|1|||
48805685|NCT03573908|157129419|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
48805686|NCT03573908|157129420|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
48805687|NCT03573908|157129416|FG000|Randomized Withdrawal Period|Other, Not Specified|0|||
48805688|NCT03573908|157129417|FG001|Randomized Withdrawal Period|Other, Not Specified|0|||
48805689|NCT03573908|157129418|FG002|Randomized Withdrawal Period|Other, Not Specified|4|||
48805690|NCT03573908|157129419|FG003|Randomized Withdrawal Period|Other, Not Specified|2|||
48805691|NCT03573908|157129420|FG004|Randomized Withdrawal Period|Other, Not Specified|0|||
48805692|NCT02669095|157129421|FG000|Overall Study|Adverse Event|1|||
48805693|NCT02669095|157129422|FG001|Overall Study|Adverse Event|0|||
48805694|NCT02669095|157129421|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
48805695|NCT02669095|157129422|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
48805696|NCT02669095|157129421|FG000|Overall Study|Torn Lens|0|||
48805697|NCT02669095|157129422|FG001|Overall Study|Torn Lens|1|||
48805698|NCT02669095|157129421|FG000|Overall Study|Visit 5 assessments not completed|0|||
48805699|NCT02669095|157129422|FG001|Overall Study|Visit 5 assessments not completed|1|||
48805700|NCT00738101|157129423|FG000|Overall Study|Physician Decision|5|||
48805701|NCT00738101|157129423|FG000|Overall Study|Death|1|||
48805702|NCT00738101|157129423|FG000|Overall Study|Repeat enrollment|1|||
48805703|NCT01555164|157129424|FG000|Overall Study|Adverse Event|5|||
48805704|NCT01555164|157129425|FG001|Overall Study|Adverse Event|7|||
48805705|NCT01555164|157129424|FG000|Overall Study|Hyperglycemia|0|||
48805706|NCT01555164|157129425|FG001|Overall Study|Hyperglycemia|1|||
48805707|NCT01555164|157129424|FG000|Overall Study|Investigator's Discretion|2|||
48916009|NCT02687542|157528423|FG001|Overall Study|Protocol Violation|1|||
48916010|NCT02687542|157528424|FG002|Overall Study|Protocol Violation|0|||
48916011|NCT02687542|157528425|FG003|Overall Study|Protocol Violation|0|||
48916012|NCT02687542|157528426|FG004|Overall Study|Protocol Violation|0|||
48916013|NCT02687542|157528422|FG000|Overall Study|Other|5|||
48916014|NCT02687542|157528423|FG001|Overall Study|Other|9|||
48916015|NCT02687542|157528424|FG002|Overall Study|Other|10|||
48916016|NCT02687542|157528425|FG003|Overall Study|Other|6|||
48916017|NCT02687542|157528426|FG004|Overall Study|Other|5|||
49119459|NCT02576977|158277134|FG001|Overall Study|Final Disposition Unknown|1|||
48805708|NCT01555164|157129425|FG001|Overall Study|Investigator's Discretion|2|||
48805709|NCT01555164|157129424|FG000|Overall Study|Lost to Follow-up|4|||
48805710|NCT01555164|157129425|FG001|Overall Study|Lost to Follow-up|3|||
49119460|NCT02576977|158277133|FG000|Overall Study|Lost to Follow-up|1|||
49119461|NCT02576977|158277134|FG001|Overall Study|Lost to Follow-up|0|||
49119462|NCT02576977|158277133|FG000|Overall Study|Progressive Disease|0|||
49119463|NCT02576977|158277134|FG001|Overall Study|Progressive Disease|1|||
48709416|NCT02425943|156784320|FG000|Overall Study|Protocol Violation|4|||
48709417|NCT02425943|156784321|FG001|Overall Study|Protocol Violation|1|||
48709418|NCT02425943|156784320|FG000|Overall Study|Withdrawal by Subject|64|||
48709419|NCT02425943|156784321|FG001|Overall Study|Withdrawal by Subject|31|||
48709420|NCT02425943|156784320|FG000|Overall Study|Other|6|||
48709421|NCT02425943|156784321|FG001|Overall Study|Other|0|||
48709422|NCT02668393|156784322|FG000|Overall Study|Progressive disease|6|||
48709423|NCT02668393|156784323|FG001|Overall Study|Progressive disease|3|||
48709424|NCT02668393|156784322|FG000|Overall Study|Adverse Event|0|||
48709425|NCT02668393|156784323|FG001|Overall Study|Adverse Event|2|||
48709426|NCT02668393|156784322|FG000|Overall Study|Withdrawal from the trial|0|||
48709427|NCT02668393|156784323|FG001|Overall Study|Withdrawal from the trial|1|||
48709428|NCT02668393|156784322|FG000|Overall Study|Lack of benefit and side effects|1|||
48709429|NCT02668393|156784323|FG001|Overall Study|Lack of benefit and side effects|0|||
48709430|NCT00607373|156784327|FG000|Treatment Period|Adverse Event|0|||
48709431|NCT00607373|156784328|FG001|Treatment Period|Adverse Event|4|||
48805711|NCT01555164|157129424|FG000|Overall Study|Protocol Violation|9|||
48805712|NCT01555164|157129425|FG001|Overall Study|Protocol Violation|5|||
48805713|NCT01555164|157129424|FG000|Overall Study|Subject Non-compliance|14|||
48805714|NCT01555164|157129425|FG001|Overall Study|Subject Non-compliance|6|||
48805715|NCT01555164|157129424|FG000|Overall Study|Subject Withdrew Consent|6|||
48916018|NCT02687542|157528422|FG000|Overall Study|Adverse Event|3|||
48916019|NCT02687542|157528423|FG001|Overall Study|Adverse Event|1|||
48916020|NCT02687542|157528424|FG002|Overall Study|Adverse Event|3|||
48916021|NCT02687542|157528425|FG003|Overall Study|Adverse Event|2|||
48916022|NCT02687542|157528426|FG004|Overall Study|Adverse Event|9|||
49119464|NCT00762034|158277135|FG000|Induction Period|Protocol Violation|1|||
48709432|NCT00607373|156784327|FG000|Treatment Period|Physician Decision|0|||
48709433|NCT00607373|156784328|FG001|Treatment Period|Physician Decision|1|||
48709434|NCT00607373|156784327|FG000|Treatment Period|Withdrawal by Subject|0|||
48805716|NCT01555164|157129425|FG001|Overall Study|Subject Withdrew Consent|11|||
48805717|NCT01518946|157129439|FG000|Open-label Phase|Other|4|||
48916023|NCT02687542|157528422|FG000|Overall Study|Withdrawal by Subject|0|||
49119465|NCT00762034|158277136|FG001|Induction Period|Protocol Violation|2|||
48805718|NCT01518946|157129440|FG001|Open-label Phase|Other|0|||
48805719|NCT01518946|157129441|FG002|Open-label Phase|Other|0|||
48805720|NCT01518946|157129439|FG000|Randomized Phase (First Intervention)|Other|0|||
48805721|NCT01518946|157129440|FG001|Randomized Phase (First Intervention)|Other|1|||
48805722|NCT01518946|157129441|FG002|Randomized Phase (First Intervention)|Other|0|||
48805723|NCT05718687|157129442|FG000|Overall Study|Withdrawal by Subject|3|||
48805724|NCT05134337|157130902|FG000|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|3|||
48805725|NCT05134337|157130903|FG001|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|0|||
48805726|NCT04244396|157130907|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|1|||
48805727|NCT04244396|157130907|FG000|Overall Study|Withdrawal by Subject|2|||
48805728|NCT04244396|157130907|FG000|Overall Study|Study termination|37|||
48805729|NCT03237858|157130908|FG000|Overall Study|Death|19|||
48805730|NCT03237858|157130908|FG000|Overall Study|Withdrawal by Subject|37|||
48805731|NCT01787097|157130909|FG000|Overall Study|Withdrawal by Subject|1|||
48805732|NCT01787097|157130910|FG001|Overall Study|Withdrawal by Subject|0|||
48805733|NCT01787097|157130911|FG002|Overall Study|Withdrawal by Subject|0|||
48805734|NCT01787097|157130912|FG003|Overall Study|Withdrawal by Subject|0|||
48805735|NCT03749447|157130913|FG000|Overall Study|Adverse Event|11|||
48805736|NCT03749447|157130914|FG001|Overall Study|Adverse Event|3|||
48805737|NCT03749447|157130913|FG000|Overall Study|Death|1|||
48805738|NCT03749447|157130914|FG001|Overall Study|Death|1|||
48805739|NCT03749447|157130913|FG000|Overall Study|Lost to Follow-up|2|||
48805740|NCT03749447|157130914|FG001|Overall Study|Lost to Follow-up|2|||
48805741|NCT03749447|157130913|FG000|Overall Study|Reason Not Specified|0|||
48805742|NCT03749447|157130914|FG001|Overall Study|Reason Not Specified|3|||
48805743|NCT03749447|157130913|FG000|Overall Study|Physician Decision|4|||
48805744|NCT03749447|157130914|FG001|Overall Study|Physician Decision|3|||
48805745|NCT03749447|157130913|FG000|Overall Study|Protocol-Specified Withdrawal Criteria Met|1|||
48805746|NCT03749447|157130914|FG001|Overall Study|Protocol-Specified Withdrawal Criteria Met|3|||
48805747|NCT03749447|157130913|FG000|Overall Study|Study Terminated By Sponsor|112|||
48805748|NCT03749447|157130914|FG001|Overall Study|Study Terminated By Sponsor|105|||
48805749|NCT03749447|157130913|FG000|Overall Study|Withdrawal by Subject|12|||
48805750|NCT03749447|157130914|FG001|Overall Study|Withdrawal by Subject|6|||
48805751|NCT03749447|157130913|FG000|Overall Study|Non-compliance With Study Drug|0|||
48805752|NCT03749447|157130914|FG001|Overall Study|Non-compliance With Study Drug|1|||
48805753|NCT05178121|157130915|FG000|Overall Study|Other|4|||
48805754|NCT05178121|157130915|FG000|Overall Study|Data collection ended before participant reached 6 months|1|||
48805755|NCT01782742|157130916|FG000|Double-blind Treatment Phase|Adverse Event|1|||
48805756|NCT01782742|157130917|FG001|Double-blind Treatment Phase|Adverse Event|0|||
48805757|NCT01953003|157130924|FG000|Overall Study|Not treated|0|||
49119466|NCT00762034|158277135|FG000|Induction Period|Entry Criterion Not Met|12|||
48709435|NCT00607373|156784328|FG001|Treatment Period|Withdrawal by Subject|1|||
48709436|NCT00607373|156784327|FG000|Follow-up Period|Other|0|||
48709437|NCT00607373|156784328|FG001|Follow-up Period|Other|1|||
48709438|NCT00607373|156784327|FG000|Follow-up Period|Protocol Violation|0|||
48709439|NCT00607373|156784328|FG001|Follow-up Period|Protocol Violation|1|||
48709440|NCT00607373|156784327|FG000|Follow-up Period|Withdrawal by Subject|1|||
48709441|NCT00607373|156784328|FG001|Follow-up Period|Withdrawal by Subject|3|||
48709442|NCT01396070|156784329|FG000|Overall Study|Withdrawal by Subject|2|||
48709443|NCT01396070|156784329|FG000|Overall Study|Death|2|||
48709444|NCT01396070|156784329|FG000|Overall Study|Adverse Event|8|||
48709445|NCT01396070|156784329|FG000|Overall Study|Physician Decision|3|||
48709446|NCT01396070|156784329|FG000|Overall Study|Lack of Efficacy|4|||
48709447|NCT01742286|156784335|FG000|Escalation Phase|Administrative problems|1|||
48709448|NCT01742286|156784336|FG001|Escalation Phase|Administrative problems|1|||
48709449|NCT01742286|156784337|FG002|Escalation Phase|Administrative problems|0|||
48709450|NCT01742286|156784338|FG003|Escalation Phase|Administrative problems|0|||
48709451|NCT01742286|156784339|FG004|Escalation Phase|Administrative problems|0|||
48709452|NCT01742286|156784340|FG005|Escalation Phase|Administrative problems|0|||
48709453|NCT01742286|156784341|FG006|Escalation Phase|Administrative problems|2|||
48805758|NCT01953003|157130925|FG001|Overall Study|Not treated|1|||
49119467|NCT00762034|158277136|FG001|Induction Period|Entry Criterion Not Met|11|||
48805759|NCT01953003|157130924|FG000|Overall Study|Progressive disease|35|||
48805760|NCT01953003|157130925|FG001|Overall Study|Progressive disease|45|||
48805761|NCT01953003|157130924|FG000|Overall Study|Related Adverse events|7|||
48805762|NCT01953003|157130925|FG001|Overall Study|Related Adverse events|2|||
48805763|NCT01953003|157130924|FG000|Overall Study|Non-related adverse events|0|||
48805764|NCT01953003|157130925|FG001|Overall Study|Non-related adverse events|2|||
48805765|NCT01953003|157130924|FG000|Overall Study|Protocol Violation|0|||
48805766|NCT01953003|157130925|FG001|Overall Study|Protocol Violation|1|||
48805767|NCT01953003|157130924|FG000|Overall Study|Withdrawal by Subject|14|||
48805768|NCT01953003|157130925|FG001|Overall Study|Withdrawal by Subject|4|||
48805769|NCT04737109|157130926|FG000|Study Treatment|Disease Progression|5|||
48709454|NCT01742286|156784335|FG000|Escalation Phase|Adverse Event|0|||
48709455|NCT01742286|156784336|FG001|Escalation Phase|Adverse Event|1|||
48709456|NCT01742286|156784337|FG002|Escalation Phase|Adverse Event|2|||
48805770|NCT04737109|157130927|FG001|Study Treatment|Disease Progression|0|||
48805771|NCT04737109|157130928|FG002|Study Treatment|Disease Progression|0|||
48805772|NCT04737109|157130929|FG003|Study Treatment|Disease Progression|0|||
48805773|NCT04737109|157130926|FG000|Study Treatment|Death on study|1|||
48805774|NCT04737109|157130927|FG001|Study Treatment|Death on study|0|||
48805775|NCT04737109|157130928|FG002|Study Treatment|Death on study|0|||
48805776|NCT04737109|157130929|FG003|Study Treatment|Death on study|0|||
48805777|NCT01529008|157130931|FG000|Bone Marrow Harvesting|Physician Decision|1|||
48805778|NCT01529008|157130932|FG001|Bone Marrow Harvesting|Physician Decision|1|||
48805779|NCT01529008|157130931|FG000|Bone Marrow Harvesting|Withdrawal by Subject|0|||
48805780|NCT01529008|157130932|FG001|Bone Marrow Harvesting|Withdrawal by Subject|2|||
48805781|NCT01529008|157130931|FG000|Treatment|Adverse Event|6|||
48805782|NCT01529008|157130932|FG001|Treatment|Adverse Event|0|||
48805783|NCT01529008|157130931|FG000|Treatment|Other|3|||
48805784|NCT01529008|157130932|FG001|Treatment|Other|1|||
48805785|NCT01529008|157130931|FG000|Efficacy Analysis|Protocol Violation|2|||
48805786|NCT01529008|157130932|FG001|Efficacy Analysis|Protocol Violation|0|||
48805787|NCT01529008|157130931|FG000|Efficacy Analysis|Physician Decision|0|||
48805788|NCT01529008|157130932|FG001|Efficacy Analysis|Physician Decision|1|||
48805789|NCT01529008|157130931|FG000|Efficacy Analysis|Withdrawal by Subject|0|||
48805790|NCT01529008|157130932|FG001|Efficacy Analysis|Withdrawal by Subject|2|||
48805791|NCT00224770|157130933|FG000|Overall Study|Lost to Follow-up|4|||
48805792|NCT00224770|157130934|FG001|Overall Study|Lost to Follow-up|2|||
48805793|NCT00224770|157130935|FG002|Overall Study|Lost to Follow-up|0|||
48805794|NCT01255592|157130936|FG000|Overall Study|Adverse Event|5|||
48805795|NCT01255592|157130937|FG001|Overall Study|Adverse Event|0|||
48805796|NCT01255592|157130936|FG000|Overall Study|Withdrawal by Subject|1|||
48805797|NCT01255592|157130937|FG001|Overall Study|Withdrawal by Subject|0|||
48805798|NCT01255592|157130936|FG000|Overall Study|Other|0|||
48805799|NCT01255592|157130937|FG001|Overall Study|Other|1|||
48805800|NCT03346538|157130938|FG000|Overall Study|Physician Decision|0|||
48805801|NCT03346538|157130939|FG001|Overall Study|Physician Decision|1|||
48805802|NCT03346538|157130940|FG002|Overall Study|Physician Decision|0|||
48805803|NCT03346538|157130938|FG000|Overall Study|Withdrawal by Subject|3|||
48805804|NCT03346538|157130939|FG001|Overall Study|Withdrawal by Subject|2|||
48805805|NCT03346538|157130940|FG002|Overall Study|Withdrawal by Subject|0|||
48805806|NCT03346538|157130938|FG000|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
48805807|NCT03346538|157130939|FG001|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
48805808|NCT03346538|157130940|FG002|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|1|||
48805809|NCT05687903|157130941|FG000|Overall Study|Protocol Deviation|1|||
48805810|NCT05687903|157130942|FG001|Overall Study|Protocol Deviation|1|||
48805811|NCT05687903|157130943|FG002|Overall Study|Protocol Deviation|0|||
48805812|NCT05687903|157130944|FG003|Overall Study|Protocol Deviation|1|||
48805813|NCT05687903|157130945|FG004|Overall Study|Protocol Deviation|0|||
48805814|NCT05044325|157130946|FG000|Part A:Treatment Period 1|Adverse Event|0|||
48805815|NCT05044325|157130947|FG001|Part A:Treatment Period 1|Adverse Event|0|||
48805816|NCT05044325|157130948|FG002|Part A:Treatment Period 1|Adverse Event|0|||
48805817|NCT05044325|157130949|FG003|Part A:Treatment Period 1|Adverse Event|0|||
48805818|NCT05044325|157130950|FG004|Part A:Treatment Period 1|Adverse Event|0|||
48805819|NCT05044325|157130951|FG005|Part A:Treatment Period 1|Adverse Event|1|||
48916024|NCT02687542|157528423|FG001|Overall Study|Withdrawal by Subject|1|||
48916025|NCT02687542|157528424|FG002|Overall Study|Withdrawal by Subject|1|||
48916026|NCT02687542|157528425|FG003|Overall Study|Withdrawal by Subject|2|||
49119468|NCT00762034|158277135|FG000|Induction Period|Adverse Event|27|||
49119469|NCT00762034|158277136|FG001|Induction Period|Adverse Event|38|||
48805820|NCT05044325|157130952|FG006|Part A:Treatment Period 1|Adverse Event|0|||
48805821|NCT05044325|157130953|FG007|Part A:Treatment Period 1|Adverse Event|1|||
48805822|NCT05044325|157130954|FG008|Part A:Treatment Period 1|Adverse Event|0|||
48805823|NCT05044325|157130955|FG009|Part A:Treatment Period 1|Adverse Event|0|||
48805824|NCT05044325|157130946|FG000|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
48916027|NCT02687542|157528426|FG004|Overall Study|Withdrawal by Subject|4|||
48805825|NCT05044325|157130947|FG001|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
48805826|NCT05044325|157130948|FG002|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
48805827|NCT05044325|157130949|FG003|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
48805828|NCT05044325|157130950|FG004|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
48916028|NCT01838616|157528427|FG000|Titration Period|Adverse Event|18|||
48805829|NCT05044325|157130951|FG005|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
48805830|NCT05044325|157130952|FG006|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
48805831|NCT05044325|157130953|FG007|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
48805832|NCT05044325|157130954|FG008|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
48805833|NCT05044325|157130955|FG009|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
48805834|NCT05044325|157130946|FG000|Part A:Treatment Period 1|Physician Decision|0|||
48916029|NCT01838616|157528428|FG001|Titration Period|Adverse Event|48|||
48916030|NCT01838616|157528427|FG000|Titration Period|Lack of Efficacy|5|||
48916031|NCT01838616|157528428|FG001|Titration Period|Lack of Efficacy|12|||
48805835|NCT05044325|157130947|FG001|Part A:Treatment Period 1|Physician Decision|0|||
48805836|NCT05044325|157130948|FG002|Part A:Treatment Period 1|Physician Decision|0|||
48805837|NCT05044325|157130949|FG003|Part A:Treatment Period 1|Physician Decision|0|||
48805838|NCT05044325|157130950|FG004|Part A:Treatment Period 1|Physician Decision|0|||
48916032|NCT01838616|157528427|FG000|Titration Period|Withdrawal by Subject|5|||
48916033|NCT01838616|157528428|FG001|Titration Period|Withdrawal by Subject|5|||
48916034|NCT01838616|157528427|FG000|Titration Period|Technical problems|1|||
48916035|NCT01838616|157528428|FG001|Titration Period|Technical problems|0|||
48916036|NCT01838616|157528427|FG000|Titration Period|Other|1|||
48916037|NCT01838616|157528428|FG001|Titration Period|Other|0|||
48916038|NCT01838616|157528427|FG000|Titration Period|Protocol Violation|0|||
48916039|NCT01838616|157528428|FG001|Titration Period|Protocol Violation|1|||
48916040|NCT01838616|157528427|FG000|Continuation Period|Lack of Efficacy|3|||
48916041|NCT01838616|157528428|FG001|Continuation Period|Lack of Efficacy|5|||
48916042|NCT01838616|157528427|FG000|Continuation Period|Adverse Event|8|||
48916043|NCT01838616|157528428|FG001|Continuation Period|Adverse Event|4|||
48916044|NCT01838616|157528427|FG000|Continuation Period|Protocol Violation|2|||
48805839|NCT05044325|157130951|FG005|Part A:Treatment Period 1|Physician Decision|0|||
48805840|NCT05044325|157130952|FG006|Part A:Treatment Period 1|Physician Decision|1|||
48805841|NCT05044325|157130953|FG007|Part A:Treatment Period 1|Physician Decision|0|||
48805842|NCT05044325|157130954|FG008|Part A:Treatment Period 1|Physician Decision|0|||
48805843|NCT05044325|157130955|FG009|Part A:Treatment Period 1|Physician Decision|0|||
48805844|NCT05044325|157130946|FG000|Part A:Treatment Period 1|Withdrawal by Subject|0|||
48805845|NCT05044325|157130947|FG001|Part A:Treatment Period 1|Withdrawal by Subject|0|||
48805846|NCT05044325|157130948|FG002|Part A:Treatment Period 1|Withdrawal by Subject|1|||
48805847|NCT05044325|157130949|FG003|Part A:Treatment Period 1|Withdrawal by Subject|0|||
48805848|NCT05044325|157130950|FG004|Part A:Treatment Period 1|Withdrawal by Subject|0|||
48805849|NCT05044325|157130951|FG005|Part A:Treatment Period 1|Withdrawal by Subject|0|||
48805850|NCT05044325|157130952|FG006|Part A:Treatment Period 1|Withdrawal by Subject|0|||
48805851|NCT05044325|157130953|FG007|Part A:Treatment Period 1|Withdrawal by Subject|0|||
48805852|NCT05044325|157130954|FG008|Part A:Treatment Period 1|Withdrawal by Subject|0|||
48805853|NCT05044325|157130955|FG009|Part A:Treatment Period 1|Withdrawal by Subject|0|||
48805854|NCT05044325|157130946|FG000|Part A:Treatment Period 2|Adverse Event|0|||
48805855|NCT05044325|157130947|FG001|Part A:Treatment Period 2|Adverse Event|1|||
48805856|NCT05044325|157130948|FG002|Part A:Treatment Period 2|Adverse Event|0|||
48805857|NCT05044325|157130949|FG003|Part A:Treatment Period 2|Adverse Event|0|||
48805858|NCT05044325|157130950|FG004|Part A:Treatment Period 2|Adverse Event|1|||
48805859|NCT05044325|157130951|FG005|Part A:Treatment Period 2|Adverse Event|1|||
48805860|NCT05044325|157130952|FG006|Part A:Treatment Period 2|Adverse Event|0|||
48805861|NCT05044325|157130953|FG007|Part A:Treatment Period 2|Adverse Event|0|||
48805862|NCT05044325|157130954|FG008|Part A:Treatment Period 2|Adverse Event|0|||
48805863|NCT05044325|157130955|FG009|Part A:Treatment Period 2|Adverse Event|0|||
48805864|NCT05044325|157130946|FG000|Part A:Treatment Period 2|Physician Decision|0|||
48805865|NCT05044325|157130947|FG001|Part A:Treatment Period 2|Physician Decision|0|||
48805866|NCT05044325|157130948|FG002|Part A:Treatment Period 2|Physician Decision|0|||
48805867|NCT05044325|157130949|FG003|Part A:Treatment Period 2|Physician Decision|0|||
48805868|NCT05044325|157130950|FG004|Part A:Treatment Period 2|Physician Decision|0|||
48805869|NCT05044325|157130951|FG005|Part A:Treatment Period 2|Physician Decision|1|||
48805870|NCT05044325|157130952|FG006|Part A:Treatment Period 2|Physician Decision|0|||
48805871|NCT05044325|157130953|FG007|Part A:Treatment Period 2|Physician Decision|0|||
48805872|NCT05044325|157130954|FG008|Part A:Treatment Period 2|Physician Decision|0|||
48805873|NCT05044325|157130955|FG009|Part A:Treatment Period 2|Physician Decision|0|||
48805874|NCT05044325|157130946|FG000|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
48805875|NCT05044325|157130947|FG001|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
48805876|NCT05044325|157130948|FG002|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
48805877|NCT05044325|157130949|FG003|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
48805878|NCT05044325|157130950|FG004|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
48805879|NCT05044325|157130951|FG005|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
48916045|NCT01838616|157528428|FG001|Continuation Period|Protocol Violation|0|||
48916046|NCT01838616|157528427|FG000|Continuation Period|Lost to Follow-up|1|||
48805880|NCT05044325|157130952|FG006|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
48805881|NCT05044325|157130953|FG007|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
48805882|NCT05044325|157130954|FG008|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
48805883|NCT05044325|157130955|FG009|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
48805884|NCT04382924|157130958|FG000|Overall Study|Death|2|||
48805885|NCT04382924|157130959|FG001|Overall Study|Death|5|||
48805886|NCT04382924|157130960|FG002|Overall Study|Death|4|||
48805887|NCT04382924|157130958|FG000|Overall Study|Protocol Violation|0|||
48916047|NCT01838616|157528428|FG001|Continuation Period|Lost to Follow-up|0|||
48916048|NCT01838616|157528427|FG000|Continuation Period|Withdrawal by Subject|0|||
49119470|NCT00762034|158277135|FG000|Induction Period|Lost to Follow-up|1|||
49119471|NCT00762034|158277136|FG001|Induction Period|Lost to Follow-up|1|||
49119472|NCT00762034|158277135|FG000|Induction Period|Progressive Disease|73|||
49119473|NCT00762034|158277136|FG001|Induction Period|Progressive Disease|55|||
49119474|NCT00762034|158277135|FG000|Induction Period|Physician Decision|21|||
49119475|NCT00762034|158277136|FG001|Induction Period|Physician Decision|20|||
49119476|NCT00762034|158277135|FG000|Induction Period|Withdrawal by Subject|15|||
49119477|NCT00762034|158277136|FG001|Induction Period|Withdrawal by Subject|19|||
49119478|NCT00762034|158277135|FG000|Induction Period|Deaths Not Due to Study Disease|19|||
49119479|NCT00762034|158277136|FG001|Induction Period|Deaths Not Due to Study Disease|14|||
49119480|NCT00762034|158277135|FG000|Induction Period|Deaths Due to Study Disease|9|||
49119481|NCT00762034|158277136|FG001|Induction Period|Deaths Due to Study Disease|9|||
48916049|NCT01838616|157528428|FG001|Continuation Period|Withdrawal by Subject|4|||
48916050|NCT01838616|157528427|FG000|Continuation Period|Technical problems|0|||
48916051|NCT01838616|157528428|FG001|Continuation Period|Technical problems|1|||
48916052|NCT01838616|157528427|FG000|Pick-up Arm|Lack of Efficacy|4|||
48916053|NCT01838616|157528428|FG001|Pick-up Arm|Lack of Efficacy|0|||
48916054|NCT01838616|157528427|FG000|Pick-up Arm|Adverse Event|9|||
48916055|NCT01838616|157528428|FG001|Pick-up Arm|Adverse Event|0|||
48916056|NCT01838616|157528427|FG000|Pick-up Arm|Withdrawal by Subject|1|||
48916057|NCT01838616|157528428|FG001|Pick-up Arm|Withdrawal by Subject|0|||
48916058|NCT01838616|157528427|FG000|Pick-up Arm|Technical problems|1|||
48916059|NCT01838616|157528428|FG001|Pick-up Arm|Technical problems|0|||
48916060|NCT00514514|157528430|FG000|Pre-phase|Death|10|||
48916061|NCT00514514|157528431|FG001|Pre-phase|Death|0|||
48916062|NCT00514514|157528432|FG002|Pre-phase|Death|0|||
48916063|NCT00514514|157528430|FG000|Pre-phase|administrative problems|2|||
49119482|NCT00762034|158277135|FG000|Maintenance Period|Protocol Violation|1|||
49119483|NCT00762034|158277136|FG001|Maintenance Period|Protocol Violation|3|||
49119484|NCT00762034|158277135|FG000|Maintenance Period|Entry Criterion Not Met|0|||
49119485|NCT00762034|158277136|FG001|Maintenance Period|Entry Criterion Not Met|2|||
49119486|NCT00762034|158277135|FG000|Maintenance Period|Adverse Event|42|||
49119487|NCT00762034|158277136|FG001|Maintenance Period|Adverse Event|26|||
49119488|NCT00762034|158277135|FG000|Maintenance Period|Progressive Disease|186|||
49119489|NCT00762034|158277136|FG001|Maintenance Period|Progressive Disease|224|||
49119490|NCT00762034|158277135|FG000|Maintenance Period|Physician Decision|25|||
49119491|NCT00762034|158277136|FG001|Maintenance Period|Physician Decision|20|||
49119492|NCT00762034|158277135|FG000|Maintenance Period|Withdrawal by Subject|34|||
49119493|NCT00762034|158277136|FG001|Maintenance Period|Withdrawal by Subject|14|||
49119494|NCT00762034|158277135|FG000|Maintenance Period|Death not due to study disease|2|||
49119495|NCT00762034|158277136|FG001|Maintenance Period|Death not due to study disease|5|||
49119496|NCT00762034|158277135|FG000|Maintenance Period|Death due to study disease|3|||
48709457|NCT01742286|156784338|FG003|Escalation Phase|Adverse Event|0|||
48709458|NCT01742286|156784339|FG004|Escalation Phase|Adverse Event|0|||
48709459|NCT01742286|156784340|FG005|Escalation Phase|Adverse Event|1|||
48709460|NCT01742286|156784341|FG006|Escalation Phase|Adverse Event|0|||
48709461|NCT01742286|156784335|FG000|Escalation Phase|Disease progression|3|||
48916064|NCT00514514|157528431|FG001|Pre-phase|administrative problems|0|||
48916065|NCT00514514|157528432|FG002|Pre-phase|administrative problems|0|||
48916066|NCT00514514|157528430|FG000|Pre-phase|Protocol Violation|6|||
48916067|NCT00514514|157528431|FG001|Pre-phase|Protocol Violation|0|||
48916068|NCT00514514|157528432|FG002|Pre-phase|Protocol Violation|0|||
48709462|NCT01742286|156784336|FG001|Escalation Phase|Disease progression|7|||
48709463|NCT01742286|156784337|FG002|Escalation Phase|Disease progression|4|||
48709464|NCT01742286|156784338|FG003|Escalation Phase|Disease progression|1|||
48709465|NCT01742286|156784339|FG004|Escalation Phase|Disease progression|4|||
48709466|NCT01742286|156784340|FG005|Escalation Phase|Disease progression|3|||
48709467|NCT01742286|156784341|FG006|Escalation Phase|Disease progression|2|||
48709468|NCT01742286|156784335|FG000|Escalation Phase|Death|0|||
48709469|NCT01742286|156784336|FG001|Escalation Phase|Death|0|||
48709470|NCT01742286|156784337|FG002|Escalation Phase|Death|0|||
48709471|NCT01742286|156784338|FG003|Escalation Phase|Death|0|||
48709472|NCT01742286|156784339|FG004|Escalation Phase|Death|0|||
48709473|NCT01742286|156784340|FG005|Escalation Phase|Death|1|||
48709474|NCT01742286|156784341|FG006|Escalation Phase|Death|0|||
48916069|NCT00514514|157528430|FG000|Pre-phase|condition no longer requires study drug|7|||
48916070|NCT00514514|157528431|FG001|Pre-phase|condition no longer requires study drug|0|||
48916071|NCT00514514|157528432|FG002|Pre-phase|condition no longer requires study drug|0|||
48916072|NCT00514514|157528430|FG000|Pre-phase|abnormal test procedure results|15|||
49119497|NCT00762034|158277136|FG001|Maintenance Period|Death due to study disease|3|||
49119498|NCT00762034|158277135|FG000|Maintenance Period|Other|1|||
49119499|NCT00762034|158277136|FG001|Maintenance Period|Other|1|||
49119500|NCT03214679|158277137|FG000|Overall Study|Lost to Follow-up|12|||
49119501|NCT03214679|158277138|FG001|Overall Study|Lost to Follow-up|14|||
49119502|NCT03214679|158277137|FG000|Overall Study|not eligible|2|||
49119503|NCT03214679|158277138|FG001|Overall Study|not eligible|0|||
48709475|NCT01742286|156784335|FG000|Escalation Phase|Physician Decision|0|||
48709476|NCT01742286|156784336|FG001|Escalation Phase|Physician Decision|3|||
48805888|NCT04382924|157130959|FG001|Overall Study|Protocol Violation|1|||
48805889|NCT04382924|157130960|FG002|Overall Study|Protocol Violation|1|||
48805890|NCT04382924|157130958|FG000|Overall Study|Transferred to other hospital/declined in person visits|0|||
48805891|NCT04382924|157130959|FG001|Overall Study|Transferred to other hospital/declined in person visits|1|||
48805892|NCT04382924|157130960|FG002|Overall Study|Transferred to other hospital/declined in person visits|1|||
48805893|NCT04382924|157130958|FG000|Overall Study|Withdrawal by Subject|6|||
48805894|NCT04382924|157130959|FG001|Overall Study|Withdrawal by Subject|3|||
48805895|NCT04382924|157130960|FG002|Overall Study|Withdrawal by Subject|6|||
48805896|NCT03518125|157130961|FG000|Overall Study|Lost to Follow-up|0|||
48805897|NCT03518125|157130962|FG001|Overall Study|Lost to Follow-up|2|||
48805898|NCT03518125|157130963|FG002|Overall Study|Lost to Follow-up|0|||
48805899|NCT03518125|157130964|FG003|Overall Study|Lost to Follow-up|0|||
48805900|NCT03518125|157130965|FG004|Overall Study|Lost to Follow-up|3|||
48805901|NCT03518125|157130966|FG005|Overall Study|Lost to Follow-up|5|||
48805902|NCT03518125|157130961|FG000|Overall Study|Physician Decision|0|||
48805903|NCT03518125|157130962|FG001|Overall Study|Physician Decision|1|||
48805904|NCT03518125|157130963|FG002|Overall Study|Physician Decision|0|||
48805905|NCT03518125|157130964|FG003|Overall Study|Physician Decision|0|||
48805906|NCT03518125|157130965|FG004|Overall Study|Physician Decision|0|||
48805907|NCT03518125|157130966|FG005|Overall Study|Physician Decision|0|||
48805908|NCT03518125|157130961|FG000|Overall Study|Withdrawal by Subject|1|||
48805909|NCT03518125|157130962|FG001|Overall Study|Withdrawal by Subject|1|||
49119504|NCT04530838|158277140|FG000|Overall Study|Other|2|||
48805910|NCT03518125|157130963|FG002|Overall Study|Withdrawal by Subject|0|||
48805911|NCT03518125|157130964|FG003|Overall Study|Withdrawal by Subject|1|||
48805912|NCT03518125|157130965|FG004|Overall Study|Withdrawal by Subject|1|||
48805913|NCT03518125|157130966|FG005|Overall Study|Withdrawal by Subject|3|||
48805914|NCT03518125|157130961|FG000|Overall Study|Missed Day 394 Visit|1|||
48805915|NCT03518125|157130962|FG001|Overall Study|Missed Day 394 Visit|0|||
48805916|NCT03518125|157130963|FG002|Overall Study|Missed Day 394 Visit|0|||
48805917|NCT03518125|157130964|FG003|Overall Study|Missed Day 394 Visit|0|||
48805918|NCT03518125|157130965|FG004|Overall Study|Missed Day 394 Visit|0|||
48805919|NCT03518125|157130966|FG005|Overall Study|Missed Day 394 Visit|0|||
48805920|NCT02066402|157130968|FG000|Overall Study|Adverse Event|1|||
48805921|NCT02066402|157130969|FG001|Overall Study|Adverse Event|2|||
48805922|NCT02066402|157130968|FG000|Overall Study|Lost to Follow-up|11|||
48805923|NCT02066402|157130969|FG001|Overall Study|Lost to Follow-up|8|||
48805924|NCT02066402|157130968|FG000|Overall Study|Withdrawal by Subject|14|||
48805925|NCT02066402|157130969|FG001|Overall Study|Withdrawal by Subject|11|||
48805926|NCT02066402|157130968|FG000|Overall Study|Progressive disease-clinical progression|0|||
48805927|NCT02066402|157130969|FG001|Overall Study|Progressive disease-clinical progression|1|||
48805928|NCT02066402|157130968|FG000|Overall Study|Protocol driven decision point|0|||
48805929|NCT02066402|157130969|FG001|Overall Study|Protocol driven decision point|1|||
48805930|NCT03303469|157130975|FG000|Overall Study|Lost to Follow-up|2|||
48805931|NCT05061537|157130976|FG000|Treatment Phase|Progressive disease|0|||
48805932|NCT05061537|157130977|FG001|Treatment Phase|Progressive disease|1|||
48805933|NCT05061537|157130978|FG002|Treatment Phase|Progressive disease|2|||
48805934|NCT05061537|157130979|FG003|Treatment Phase|Progressive disease|0|||
48805935|NCT05061537|157130980|FG004|Treatment Phase|Progressive disease|0|||
48805936|NCT05061537|157130976|FG000|Treatment Phase|Adverse Event|0|||
48805937|NCT05061537|157130977|FG001|Treatment Phase|Adverse Event|0|||
48709477|NCT01742286|156784337|FG002|Escalation Phase|Physician Decision|0|||
48709478|NCT01742286|156784338|FG003|Escalation Phase|Physician Decision|1|||
48709479|NCT01742286|156784339|FG004|Escalation Phase|Physician Decision|0|||
48709480|NCT01742286|156784340|FG005|Escalation Phase|Physician Decision|0|||
48709481|NCT01742286|156784341|FG006|Escalation Phase|Physician Decision|2|||
48709482|NCT01742286|156784335|FG000|Escalation Phase|Subject/guardian decision|1|||
48709483|NCT01742286|156784336|FG001|Escalation Phase|Subject/guardian decision|0|||
48709484|NCT01742286|156784337|FG002|Escalation Phase|Subject/guardian decision|0|||
48709485|NCT01742286|156784338|FG003|Escalation Phase|Subject/guardian decision|0|||
48709486|NCT01742286|156784339|FG004|Escalation Phase|Subject/guardian decision|0|||
48709487|NCT01742286|156784340|FG005|Escalation Phase|Subject/guardian decision|0|||
48709488|NCT01742286|156784341|FG006|Escalation Phase|Subject/guardian decision|0|||
48709489|NCT01742286|156784335|FG000|Expansion Phase|Administrative problems|0|||
48709490|NCT01742286|156784336|FG001|Expansion Phase|Administrative problems|0|||
48709491|NCT01742286|156784337|FG002|Expansion Phase|Administrative problems|0|||
48805938|NCT05061537|157130978|FG002|Treatment Phase|Adverse Event|2|||
48805939|NCT05061537|157130979|FG003|Treatment Phase|Adverse Event|0|||
48805940|NCT05061537|157130980|FG004|Treatment Phase|Adverse Event|0|||
48805941|NCT05061537|157130976|FG000|Treatment Phase|Global deterioration of health status|0|||
48805942|NCT05061537|157130977|FG001|Treatment Phase|Global deterioration of health status|1|||
48709492|NCT01742286|156784338|FG003|Expansion Phase|Administrative problems|0|||
48709493|NCT01742286|156784339|FG004|Expansion Phase|Administrative problems|0|||
48805943|NCT05061537|157130978|FG002|Treatment Phase|Global deterioration of health status|0|||
49010703|NCT03705169|157875683|FG000|Overall Study|Lost to Follow-up|0|||
48916073|NCT00514514|157528431|FG001|Pre-phase|abnormal test procedure results|0|||
48916074|NCT00514514|157528432|FG002|Pre-phase|abnormal test procedure results|0|||
48916075|NCT00514514|157528430|FG000|Pre-phase|Lost to Follow-up|2|||
48916076|NCT00514514|157528431|FG001|Pre-phase|Lost to Follow-up|0|||
48916077|NCT00514514|157528432|FG002|Pre-phase|Lost to Follow-up|0|||
48916078|NCT00514514|157528430|FG000|Pre-phase|abnormal lab values|23|||
48916079|NCT00514514|157528431|FG001|Pre-phase|abnormal lab values|0|||
48916080|NCT00514514|157528432|FG002|Pre-phase|abnormal lab values|0|||
48916081|NCT00514514|157528430|FG000|Pre-phase|Lack of Efficacy|35|||
48916082|NCT00514514|157528431|FG001|Pre-phase|Lack of Efficacy|0|||
48916083|NCT00514514|157528432|FG002|Pre-phase|Lack of Efficacy|0|||
48916084|NCT00514514|157528430|FG000|Pre-phase|Adverse Event|137|||
48916085|NCT00514514|157528431|FG001|Pre-phase|Adverse Event|0|||
48916086|NCT00514514|157528432|FG002|Pre-phase|Adverse Event|0|||
48916087|NCT00514514|157528430|FG000|Pre-phase|Withdrawal by Subject|66|||
48916088|NCT00514514|157528431|FG001|Pre-phase|Withdrawal by Subject|0|||
48916089|NCT00514514|157528432|FG002|Pre-phase|Withdrawal by Subject|0|||
48916090|NCT00514514|157528430|FG000|Randomized - 9 Month|Death|3|||
48916091|NCT00514514|157528431|FG001|Randomized - 9 Month|Death|2|||
48916092|NCT00514514|157528432|FG002|Randomized - 9 Month|Death|2|||
48916093|NCT00514514|157528430|FG000|Randomized - 9 Month|Administrative problems|1|||
48916094|NCT00514514|157528431|FG001|Randomized - 9 Month|Administrative problems|1|||
48916095|NCT00514514|157528432|FG002|Randomized - 9 Month|Administrative problems|2|||
48916096|NCT00514514|157528430|FG000|Randomized - 9 Month|Withdrawal by Subject|7|||
48916097|NCT00514514|157528431|FG001|Randomized - 9 Month|Withdrawal by Subject|7|||
48916098|NCT00514514|157528432|FG002|Randomized - 9 Month|Withdrawal by Subject|5|||
48916099|NCT00514514|157528430|FG000|Randomized - 9 Month|Protocol Violation|1|||
48916100|NCT00514514|157528431|FG001|Randomized - 9 Month|Protocol Violation|1|||
48916101|NCT00514514|157528432|FG002|Randomized - 9 Month|Protocol Violation|0|||
48916102|NCT00514514|157528430|FG000|Randomized - 9 Month|Lack of Efficacy|2|||
48916103|NCT00514514|157528431|FG001|Randomized - 9 Month|Lack of Efficacy|3|||
48916104|NCT00514514|157528432|FG002|Randomized - 9 Month|Lack of Efficacy|1|||
48916105|NCT00514514|157528430|FG000|Randomized - 9 Month|Abnormal laboratory values|0|||
48916106|NCT00514514|157528431|FG001|Randomized - 9 Month|Abnormal laboratory values|3|||
48916107|NCT00514514|157528432|FG002|Randomized - 9 Month|Abnormal laboratory values|1|||
48916108|NCT00514514|157528430|FG000|Randomized - 9 Month|Adverse Event|25|||
48916109|NCT00514514|157528431|FG001|Randomized - 9 Month|Adverse Event|44|||
48916110|NCT00514514|157528432|FG002|Randomized - 9 Month|Adverse Event|27|||
48916111|NCT00514514|157528430|FG000|Extension - 4 Years|Withdrawal by Subject|5|||
48916112|NCT00514514|157528431|FG001|Extension - 4 Years|Withdrawal by Subject|2|||
48916113|NCT00514514|157528432|FG002|Extension - 4 Years|Withdrawal by Subject|2|||
48916114|NCT00514514|157528430|FG000|Extension - 4 Years|Lost to Follow-up|12|||
48916115|NCT00514514|157528431|FG001|Extension - 4 Years|Lost to Follow-up|10|||
48916116|NCT00514514|157528432|FG002|Extension - 4 Years|Lost to Follow-up|9|||
48916117|NCT00514514|157528430|FG000|Extension - 4 Years|Administrative problems|3|||
48916118|NCT00514514|157528431|FG001|Extension - 4 Years|Administrative problems|1|||
48916119|NCT00514514|157528432|FG002|Extension - 4 Years|Administrative problems|1|||
48916120|NCT00514514|157528430|FG000|Extension - 4 Years|Death|8|||
48916121|NCT00514514|157528431|FG001|Extension - 4 Years|Death|3|||
48916122|NCT00514514|157528432|FG002|Extension - 4 Years|Death|6|||
48916123|NCT00514514|157528430|FG000|Extension - 4 Years|Adverse Event|9|||
48916124|NCT00514514|157528431|FG001|Extension - 4 Years|Adverse Event|6|||
48916125|NCT00514514|157528432|FG002|Extension - 4 Years|Adverse Event|3|||
48916126|NCT00840086|157528436|FG000|Overall Study|Adverse Event|1|||
48916127|NCT00840086|157528436|FG000|Overall Study|Protocol Violation|2|||
48916128|NCT00840086|157528436|FG000|Overall Study|Lost to Follow-up|1|||
48916129|NCT03332498|157528437|FG000|Overall Study|Severe illness prior to Day 1 of treatment|0|||
49119505|NCT04530838|158277141|FG001|Overall Study|Other|1|||
49119506|NCT04530838|158277142|FG002|Overall Study|Other|0|||
49119507|NCT04530838|158277140|FG000|Overall Study|Physician Decision|0|||
49119508|NCT04530838|158277141|FG001|Overall Study|Physician Decision|0|||
49119509|NCT04530838|158277142|FG002|Overall Study|Physician Decision|1|||
49119510|NCT04530838|158277140|FG000|Overall Study|Death|0|||
49119511|NCT04530838|158277141|FG001|Overall Study|Death|0|||
49119512|NCT04530838|158277142|FG002|Overall Study|Death|1|||
48916130|NCT03332498|157528438|FG001|Overall Study|Severe illness prior to Day 1 of treatment|0|||
48916131|NCT03332498|157528439|FG002|Overall Study|Severe illness prior to Day 1 of treatment|2|||
48916132|NCT02554019|157528440|FG000|Overall Study|Withdrawal by Subject|1|||
48916133|NCT02554019|157528441|FG001|Overall Study|Withdrawal by Subject|0|||
48916134|NCT02554019|157528442|FG002|Overall Study|Withdrawal by Subject|2|||
48916135|NCT02554019|157528440|FG000|Overall Study|Adverse Event|1|||
49119513|NCT04530838|158277140|FG000|Overall Study|Adverse Event|0|||
48916136|NCT02554019|157528441|FG001|Overall Study|Adverse Event|0|||
48916137|NCT02554019|157528442|FG002|Overall Study|Adverse Event|0|||
48916138|NCT00833053|157528443|FG000|Overall Study|Adverse Event|4|||
49119514|NCT04530838|158277141|FG001|Overall Study|Adverse Event|1|||
49119515|NCT04530838|158277142|FG002|Overall Study|Adverse Event|0|||
49119516|NCT04530838|158277140|FG000|Overall Study|No longer meets eligibility criteria|1|||
48805944|NCT05061537|157130979|FG003|Treatment Phase|Global deterioration of health status|0|||
48805945|NCT05061537|157130980|FG004|Treatment Phase|Global deterioration of health status|0|||
48805946|NCT05061537|157130976|FG000|Follow up|Other|2|||
48805947|NCT05061537|157130977|FG001|Follow up|Other|0|||
48805948|NCT05061537|157130978|FG002|Follow up|Other|2|||
48805949|NCT05061537|157130979|FG003|Follow up|Other|0|||
48805950|NCT05061537|157130980|FG004|Follow up|Other|0|||
48805951|NCT05061537|157130976|FG000|Follow up|Study terminated by sponsor|0|||
48805952|NCT05061537|157130977|FG001|Follow up|Study terminated by sponsor|0|||
48805953|NCT05061537|157130978|FG002|Follow up|Study terminated by sponsor|2|||
48805954|NCT05061537|157130979|FG003|Follow up|Study terminated by sponsor|0|||
48805955|NCT05061537|157130980|FG004|Follow up|Study terminated by sponsor|0|||
48805956|NCT05061537|157130976|FG000|Long-term Follow-up|Study terminated by sponsor|2|||
48805957|NCT05061537|157130977|FG001|Long-term Follow-up|Study terminated by sponsor|2|||
48805958|NCT05061537|157130978|FG002|Long-term Follow-up|Study terminated by sponsor|2|||
48805959|NCT05061537|157130979|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
48805960|NCT05061537|157130980|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
48805961|NCT05061537|157130976|FG000|Long-term Follow-up|Death|0|||
48805962|NCT05061537|157130977|FG001|Long-term Follow-up|Death|1|||
48805963|NCT05061537|157130978|FG002|Long-term Follow-up|Death|0|||
48805964|NCT05061537|157130979|FG003|Long-term Follow-up|Death|0|||
48805965|NCT05061537|157130980|FG004|Long-term Follow-up|Death|0|||
48805966|NCT01576367|157130981|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
48805967|NCT01576367|157130981|FG000|Overall Study|Moved to commercial use after 6 months|1|||
48805968|NCT03496168|157130991|FG000|Overall Study|Other Reasons|1|||
48805969|NCT03496168|157130991|FG000|Overall Study|Adverse Event|1|||
48805970|NCT03663569|157130992|FG000|Overall Study|Discontinuation of study|11|||
48805971|NCT03663569|157130992|FG000|Overall Study|Never taken Spiolto® Respimat®|1|||
48805972|NCT03663569|157130992|FG000|Overall Study|Deceased patient|6|||
48805973|NCT03663569|157130992|FG000|Overall Study|Lost to Follow-up|18|||
48805974|NCT03663569|157130992|FG000|Overall Study|Withdrawal of consent|5|||
48805975|NCT03663569|157130992|FG000|Overall Study|Patient's request|11|||
48805976|NCT03663569|157130992|FG000|Overall Study|Adverse Event|4|||
48805977|NCT03663569|157130992|FG000|Overall Study|Not come to second visit|3|||
48805978|NCT03663569|157130992|FG000|Overall Study|Not meet inclusion / exclusion criterion|3|||
48805979|NCT03663569|157130992|FG000|Overall Study|Serious adverse event|1|||
48805982|NCT01693692|157131011|FG000|Overall Study|Withdrawal by Subject|12|||
48805983|NCT01693692|157131012|FG001|Overall Study|Withdrawal by Subject|10|||
48805984|NCT01693692|157131013|FG002|Overall Study|Withdrawal by Subject|11|||
48805985|NCT01693692|157131011|FG000|Overall Study|Adverse Event|7|||
48805986|NCT01693692|157131012|FG001|Overall Study|Adverse Event|14|||
48805987|NCT01693692|157131013|FG002|Overall Study|Adverse Event|9|||
48805988|NCT01693692|157131011|FG000|Overall Study|Physician Decision|0|||
48805989|NCT01693692|157131012|FG001|Overall Study|Physician Decision|0|||
48805990|NCT01693692|157131013|FG002|Overall Study|Physician Decision|1|||
48805991|NCT01693692|157131011|FG000|Overall Study|Protocol Violation|5|||
48805992|NCT01693692|157131012|FG001|Overall Study|Protocol Violation|4|||
48805993|NCT01693692|157131013|FG002|Overall Study|Protocol Violation|6|||
48805994|NCT01693692|157131011|FG000|Overall Study|Lost to Follow-up|2|||
48805995|NCT01693692|157131012|FG001|Overall Study|Lost to Follow-up|2|||
48805996|NCT01693692|157131013|FG002|Overall Study|Lost to Follow-up|3|||
48805997|NCT01693692|157131011|FG000|Overall Study|Other|4|||
48805998|NCT01693692|157131012|FG001|Overall Study|Other|4|||
48805999|NCT01693692|157131013|FG002|Overall Study|Other|6|||
48806000|NCT02404389|157131014|FG000|Overall Study|Adverse Event|1|||
48806001|NCT02404389|157131015|FG001|Overall Study|Adverse Event|0|||
48806002|NCT02404389|157131016|FG002|Overall Study|Adverse Event|1|||
48806003|NCT02404389|157131017|FG003|Overall Study|Adverse Event|0|||
48806004|NCT02404389|157131018|FG004|Overall Study|Adverse Event|2|||
48806005|NCT02404389|157131014|FG000|Overall Study|Subject/guardian decision|1|||
48806006|NCT02404389|157131015|FG001|Overall Study|Subject/guardian decision|0|||
48806007|NCT02404389|157131016|FG002|Overall Study|Subject/guardian decision|0|||
48806008|NCT02404389|157131017|FG003|Overall Study|Subject/guardian decision|1|||
48806009|NCT02404389|157131018|FG004|Overall Study|Subject/guardian decision|1|||
48806010|NCT03300570|157131019|FG000|Overall Study|Adverse Event|0|||
48806011|NCT03300570|157131020|FG001|Overall Study|Adverse Event|1|||
48806012|NCT03300570|157131019|FG000|Overall Study|Withdrawal by Subject|1|||
48806013|NCT03300570|157131020|FG001|Overall Study|Withdrawal by Subject|0|||
48806014|NCT03300570|157131019|FG000|Overall Study|Inadequate bowel prep|1|||
48806015|NCT03300570|157131020|FG001|Overall Study|Inadequate bowel prep|0|||
48806016|NCT00384059|157131023|FG000|Infant Series|Not consented|2|||
48806017|NCT00384059|157131024|FG001|Infant Series|Not consented|6|||
48806018|NCT00384059|157131023|FG000|Infant Series|Withdrawal by Subject|2|||
48806019|NCT00384059|157131024|FG001|Infant Series|Withdrawal by Subject|2|||
48806020|NCT00384059|157131023|FG000|Infant Series|Adverse Event|1|||
48806021|NCT00384059|157131024|FG001|Infant Series|Adverse Event|2|||
48806022|NCT00384059|157131023|FG000|Infant Series|Protocol Violation|1|||
48916139|NCT00833053|157528444|FG001|Overall Study|Adverse Event|0|||
49119517|NCT04530838|158277141|FG001|Overall Study|No longer meets eligibility criteria|0|||
49119518|NCT04530838|158277142|FG002|Overall Study|No longer meets eligibility criteria|2|||
49119519|NCT04530838|158277140|FG000|Overall Study|Withdrawal by parent/guardian|5|||
49119520|NCT04530838|158277141|FG001|Overall Study|Withdrawal by parent/guardian|2|||
48806023|NCT00384059|157131024|FG001|Infant Series|Protocol Violation|2|||
48806024|NCT00384059|157131023|FG000|Infant Series|Lost to Follow-up|0|||
48806025|NCT00384059|157131024|FG001|Infant Series|Lost to Follow-up|1|||
48806026|NCT00384059|157131023|FG000|After Infant Series|Protocol Violation|2|||
48806027|NCT00384059|157131024|FG001|After Infant Series|Protocol Violation|3|||
49119521|NCT04530838|158277142|FG002|Overall Study|Withdrawal by parent/guardian|2|||
49119522|NCT01073163|158277144|FG000|Overall Study|Adverse Event|1|||
49119523|NCT01073163|158277144|FG000|Overall Study|Disease Progression|1|||
49119524|NCT01073163|158277144|FG000|Overall Study|Early termination|1|||
49119525|NCT01775787|158277145|FG000|First 7-10 Days|Adverse Event|0|||
49119526|NCT01775787|158277146|FG001|First 7-10 Days|Adverse Event|1|||
49119527|NCT01775787|158277145|FG000|First 7-10 Days|family emergency|0|||
49119528|NCT01775787|158277146|FG001|First 7-10 Days|family emergency|1|||
49119529|NCT01775787|158277145|FG000|First 7-10 Days|time commitment|0|||
49119530|NCT01775787|158277146|FG001|First 7-10 Days|time commitment|2|||
49119531|NCT01775787|158277145|FG000|First 7-10 Days|concerns with using IV|1|||
49119532|NCT01775787|158277146|FG001|First 7-10 Days|concerns with using IV|2|||
49119533|NCT01775787|158277145|FG000|Second 7-10 Days|time commitment|0|||
49119534|NCT01775787|158277146|FG001|Second 7-10 Days|time commitment|1|||
49119535|NCT01775787|158277145|FG000|Second 7-10 Days|concerns with using IV|0|||
49119536|NCT01775787|158277146|FG001|Second 7-10 Days|concerns with using IV|1|||
49119537|NCT03252145|158277148|FG000|Overall Study|Withdrawal by Subject|1|||
49119538|NCT03252145|158277149|FG001|Overall Study|Withdrawal by Subject|0|||
49119539|NCT03252145|158277148|FG000|Overall Study|Complicating Disease|1|||
49119540|NCT03252145|158277149|FG001|Overall Study|Complicating Disease|2|||
49119541|NCT02748057|158277150|FG000|Overall Study|Adverse Event|1|||
49119542|NCT02748057|158277151|FG001|Overall Study|Adverse Event|0|||
49119543|NCT02748057|158277150|FG000|Overall Study|Physician Decision|0|||
49119544|NCT02748057|158277151|FG001|Overall Study|Physician Decision|1|||
49119545|NCT02748057|158277150|FG000|Overall Study|Protocol Violation|2|||
49119546|NCT02748057|158277151|FG001|Overall Study|Protocol Violation|1|||
49119547|NCT02748057|158277150|FG000|Overall Study|Participant Moved|1|||
49119548|NCT02748057|158277151|FG001|Overall Study|Participant Moved|0|||
49119549|NCT02748057|158277150|FG000|Overall Study|Withdrawal by Subject|1|||
49119550|NCT02748057|158277151|FG001|Overall Study|Withdrawal by Subject|0|||
49119551|NCT00905632|158277152|FG000|Overall Study|Adverse Event|0|||
49119552|NCT00905632|158277153|FG001|Overall Study|Adverse Event|0|||
49119553|NCT00905632|158277154|FG002|Overall Study|Adverse Event|0|||
49119554|NCT00905632|158277155|FG003|Overall Study|Adverse Event|0|||
49119555|NCT00905632|158277156|FG004|Overall Study|Adverse Event|0|||
49119556|NCT00905632|158277157|FG005|Overall Study|Adverse Event|1|||
49119557|NCT00905632|158277158|FG006|Overall Study|Adverse Event|4|||
49119558|NCT01845597|158277159|FG000|Overall Study|Death|8|||
48806028|NCT00384059|157131023|FG000|After Infant Series|Withdrawal by Subject|2|||
48806029|NCT00384059|157131024|FG001|After Infant Series|Withdrawal by Subject|2|||
48806030|NCT00384059|157131023|FG000|After Infant Series|Failed to Return|0|||
48806031|NCT00384059|157131024|FG001|After Infant Series|Failed to Return|2|||
48806032|NCT00384059|157131023|FG000|After Infant Series|Adverse Event|0|||
48806033|NCT00384059|157131024|FG001|After Infant Series|Adverse Event|1|||
48806034|NCT00384059|157131023|FG000|After Infant Series|Physician Decision|0|||
48916140|NCT00833053|157528443|FG000|Overall Study|Treatment Failure|3|||
49119559|NCT01845597|158277159|FG000|Overall Study|Lost to Follow-up|22|||
49119560|NCT02581488|158277168|FG000|Overall Study|Adverse Event|6|||
49119561|NCT02581488|158277169|FG001|Overall Study|Adverse Event|7|||
49119562|NCT02581488|158277168|FG000|Overall Study|Lost to Follow-up|1|||
49119563|NCT02581488|158277169|FG001|Overall Study|Lost to Follow-up|0|||
49119564|NCT02581488|158277168|FG000|Overall Study|Withdrawal by Subject|1|||
49119565|NCT02581488|158277169|FG001|Overall Study|Withdrawal by Subject|0|||
49119566|NCT02581488|158277168|FG000|Overall Study|Non-Compliance|1|||
49119567|NCT02581488|158277169|FG001|Overall Study|Non-Compliance|0|||
49119568|NCT02581488|158277168|FG000|Overall Study|Protocol Violation|0|||
48806035|NCT00384059|157131024|FG001|After Infant Series|Physician Decision|1|||
48806036|NCT00384059|157131023|FG000|After Infant Series|Lost to Follow-up|0|||
48806037|NCT00384059|157131024|FG001|After Infant Series|Lost to Follow-up|1|||
48806038|NCT00384059|157131023|FG000|Toddler Dose|Lost to Follow-up|1|||
48806039|NCT00384059|157131024|FG001|Toddler Dose|Lost to Follow-up|1|||
48806040|NCT00384059|157131023|FG000|Toddler Dose|Failed to return|0|||
48806041|NCT00384059|157131024|FG001|Toddler Dose|Failed to return|1|||
48806042|NCT01396395|157131025|FG000|Overall Study|Withdrawal by Subject|10|||
48806043|NCT01396395|157131026|FG001|Overall Study|Withdrawal by Subject|12|||
48806044|NCT01396395|157131025|FG000|Overall Study|Protocol Violation|3|||
48806045|NCT01396395|157131026|FG001|Overall Study|Protocol Violation|1|||
48806046|NCT01396395|157131025|FG000|Overall Study|Adverse Event|10|||
48806047|NCT01396395|157131026|FG001|Overall Study|Adverse Event|2|||
48806048|NCT01396395|157131025|FG000|Overall Study|Lost to Follow-up|17|||
48806049|NCT01396395|157131026|FG001|Overall Study|Lost to Follow-up|11|||
49119569|NCT02581488|158277169|FG001|Overall Study|Protocol Violation|4|||
49119570|NCT01877668|158277170|FG000|Overall Study|Death|0|||
49119571|NCT01877668|158277171|FG001|Overall Study|Death|0|||
49119572|NCT01877668|158277172|FG002|Overall Study|Death|0|||
49119573|NCT01877668|158277173|FG003|Overall Study|Death|1|||
49119574|NCT01877668|158277174|FG004|Overall Study|Death|0|||
49119575|NCT01877668|158277170|FG000|Overall Study|No longer met study criteria|1|||
49119576|NCT01877668|158277171|FG001|Overall Study|No longer met study criteria|0|||
49119577|NCT01877668|158277172|FG002|Overall Study|No longer met study criteria|1|||
49119578|NCT01877668|158277173|FG003|Overall Study|No longer met study criteria|0|||
49119579|NCT01877668|158277174|FG004|Overall Study|No longer met study criteria|0|||
49119580|NCT01877668|158277170|FG000|Overall Study|Insufficient clinical response|0|||
49119581|NCT01877668|158277171|FG001|Overall Study|Insufficient clinical response|1|||
49119582|NCT01877668|158277172|FG002|Overall Study|Insufficient clinical response|2|||
49119583|NCT01877668|158277173|FG003|Overall Study|Insufficient clinical response|2|||
49119584|NCT01877668|158277174|FG004|Overall Study|Insufficient clinical response|0|||
49119585|NCT01877668|158277170|FG000|Overall Study|Lost to Follow-up|0|||
49119586|NCT01877668|158277171|FG001|Overall Study|Lost to Follow-up|2|||
49119587|NCT01877668|158277172|FG002|Overall Study|Lost to Follow-up|1|||
49119588|NCT01877668|158277173|FG003|Overall Study|Lost to Follow-up|0|||
49119589|NCT01877668|158277174|FG004|Overall Study|Lost to Follow-up|0|||
49119590|NCT01877668|158277170|FG000|Overall Study|Withdrawal by Subject|2|||
49119591|NCT01877668|158277171|FG001|Overall Study|Withdrawal by Subject|0|||
49119592|NCT01877668|158277172|FG002|Overall Study|Withdrawal by Subject|3|||
49119593|NCT01877668|158277173|FG003|Overall Study|Withdrawal by Subject|2|||
49119594|NCT01877668|158277174|FG004|Overall Study|Withdrawal by Subject|2|||
48806050|NCT01396395|157131025|FG000|Overall Study|Other|0|||
48806051|NCT01396395|157131026|FG001|Overall Study|Other|1|||
48806052|NCT03682705|157131027|FG000|Overall Study|Adverse Event|1|||
48806053|NCT03682705|157131028|FG001|Overall Study|Adverse Event|1|||
48806054|NCT03682705|157131029|FG002|Overall Study|Adverse Event|1|||
48806055|NCT03682705|157131030|FG003|Overall Study|Adverse Event|0|||
48806056|NCT03682705|157131031|FG004|Overall Study|Adverse Event|1|||
48806057|NCT03682705|157131032|FG005|Overall Study|Adverse Event|1|||
48806058|NCT03682705|157131027|FG000|Overall Study|Withdrawal by Subject|1|||
49119595|NCT01877668|158277170|FG000|Overall Study|Other|1|||
48806059|NCT03682705|157131028|FG001|Overall Study|Withdrawal by Subject|3|||
49119596|NCT01877668|158277171|FG001|Overall Study|Other|1|||
49119597|NCT01877668|158277172|FG002|Overall Study|Other|1|||
48806060|NCT03682705|157131029|FG002|Overall Study|Withdrawal by Subject|2|||
48806061|NCT03682705|157131030|FG003|Overall Study|Withdrawal by Subject|4|||
49119598|NCT01877668|158277173|FG003|Overall Study|Other|1|||
49119599|NCT01877668|158277174|FG004|Overall Study|Other|3|||
49119600|NCT01877668|158277170|FG000|Overall Study|Protocol Violation|1|||
48806062|NCT03682705|157131031|FG004|Overall Study|Withdrawal by Subject|0|||
48806063|NCT03682705|157131032|FG005|Overall Study|Withdrawal by Subject|1|||
48806064|NCT03682705|157131027|FG000|Overall Study|Other, not specified|0|||
48806065|NCT03682705|157131028|FG001|Overall Study|Other, not specified|0|||
48806066|NCT03682705|157131029|FG002|Overall Study|Other, not specified|0|||
48806067|NCT03682705|157131030|FG003|Overall Study|Other, not specified|1|||
48709494|NCT01742286|156784340|FG005|Expansion Phase|Administrative problems|0|||
48806068|NCT03682705|157131031|FG004|Overall Study|Other, not specified|2|||
48806069|NCT03682705|157131032|FG005|Overall Study|Other, not specified|0|||
48806070|NCT03682705|157131027|FG000|Overall Study|Lost to Follow-up|0|||
48806071|NCT03682705|157131028|FG001|Overall Study|Lost to Follow-up|0|||
48806072|NCT03682705|157131029|FG002|Overall Study|Lost to Follow-up|0|||
48806073|NCT03682705|157131030|FG003|Overall Study|Lost to Follow-up|0|||
48806074|NCT03682705|157131031|FG004|Overall Study|Lost to Follow-up|3|||
48806075|NCT03682705|157131032|FG005|Overall Study|Lost to Follow-up|0|||
48806076|NCT00709059|157131036|FG000|Overall Study|Lost to Follow-up|34|||
48806077|NCT00709059|157131036|FG000|Overall Study|Withdrawal by Subject|19|||
48806078|NCT00709059|157131036|FG000|Overall Study|Physician Decision|7|||
48806079|NCT00709059|157131036|FG000|Overall Study|Disease complication|3|||
48806080|NCT00709059|157131036|FG000|Overall Study|Side effects|20|||
48806081|NCT00709059|157131036|FG000|Overall Study|Serious side effects|11|||
48806082|NCT00524030|157131037|FG000|Overall Study|Lack of Efficacy|10|||
48806083|NCT00524030|157131038|FG001|Overall Study|Lack of Efficacy|24|||
48806084|NCT00524030|157131037|FG000|Overall Study|Lost to Follow-up|0|||
48806085|NCT00524030|157131038|FG001|Overall Study|Lost to Follow-up|2|||
48806086|NCT00524030|157131037|FG000|Overall Study|Withdrawal by Subject|3|||
48806087|NCT00524030|157131038|FG001|Overall Study|Withdrawal by Subject|8|||
48806088|NCT00524030|157131037|FG000|Overall Study|Noncompliance/Investigator discretion|0|||
48806089|NCT00524030|157131038|FG001|Overall Study|Noncompliance/Investigator discretion|2|||
48806090|NCT00524030|157131037|FG000|Overall Study|Protocol Violation|0|||
48806091|NCT00524030|157131038|FG001|Overall Study|Protocol Violation|1|||
48806092|NCT00524030|157131037|FG000|Overall Study|Pregnancy|1|||
48806093|NCT00524030|157131038|FG001|Overall Study|Pregnancy|0|||
48806094|NCT00524030|157131037|FG000|Overall Study|Adverse Event|3|||
48806095|NCT00524030|157131038|FG001|Overall Study|Adverse Event|21|||
48806096|NCT00524030|157131037|FG000|Overall Study|Death|0|||
48806097|NCT00524030|157131038|FG001|Overall Study|Death|1|||
48806098|NCT04247802|157131039|FG000|Overall Study|Withdrawal by Subject|1|||
48806099|NCT04247802|157131040|FG001|Overall Study|Withdrawal by Subject|3|||
48806100|NCT04247802|157131039|FG000|Overall Study|LTFU COVID lockdown restrictions|10|||
48806101|NCT04247802|157131040|FG001|Overall Study|LTFU COVID lockdown restrictions|7|||
48806102|NCT03704584|157132451|FG000|Overall Study|Withdrawal by Subject|1|||
48806103|NCT03704584|157132452|FG001|Overall Study|Withdrawal by Subject|0|||
48806104|NCT03439189|157132455|FG000|Overall Study|Protocol Violation|19|||
48806105|NCT03439189|157132455|FG000|Overall Study|Lack of Efficacy|63|||
48709495|NCT01742286|156784341|FG006|Expansion Phase|Administrative problems|5|||
48709496|NCT01742286|156784335|FG000|Expansion Phase|Physician Decision|0|||
48709497|NCT01742286|156784336|FG001|Expansion Phase|Physician Decision|0|||
48709498|NCT01742286|156784337|FG002|Expansion Phase|Physician Decision|4|||
48709499|NCT01742286|156784338|FG003|Expansion Phase|Physician Decision|0|||
48709500|NCT01742286|156784339|FG004|Expansion Phase|Physician Decision|0|||
48709501|NCT01742286|156784340|FG005|Expansion Phase|Physician Decision|0|||
48709502|NCT01742286|156784341|FG006|Expansion Phase|Physician Decision|9|||
48709503|NCT01742286|156784335|FG000|Expansion Phase|Adverse Event|0|||
48709504|NCT01742286|156784336|FG001|Expansion Phase|Adverse Event|0|||
48709505|NCT01742286|156784337|FG002|Expansion Phase|Adverse Event|0|||
48709506|NCT01742286|156784338|FG003|Expansion Phase|Adverse Event|0|||
48709507|NCT01742286|156784339|FG004|Expansion Phase|Adverse Event|0|||
48709508|NCT01742286|156784340|FG005|Expansion Phase|Adverse Event|0|||
48709509|NCT01742286|156784341|FG006|Expansion Phase|Adverse Event|6|||
48709510|NCT01742286|156784335|FG000|Expansion Phase|Disease progression|0|||
48709511|NCT01742286|156784336|FG001|Expansion Phase|Disease progression|0|||
48709512|NCT01742286|156784337|FG002|Expansion Phase|Disease progression|3|||
48709513|NCT01742286|156784338|FG003|Expansion Phase|Disease progression|0|||
48806106|NCT01807156|157132456|FG000|Overall Study|Physician Decision|1|||
48709514|NCT01742286|156784339|FG004|Expansion Phase|Disease progression|0|||
48709515|NCT01742286|156784340|FG005|Expansion Phase|Disease progression|0|||
48806107|NCT00659984|157132460|FG000|Overall Study|Adverse Event|1|||
48806108|NCT00792103|157132469|FG000|Overall Study|Enrolled, not treated|15|||
48709516|NCT01742286|156784341|FG006|Expansion Phase|Disease progression|15|||
48709517|NCT01742286|156784335|FG000|Expansion Phase|Withdrawal by Subject|0|||
48709518|NCT01742286|156784336|FG001|Expansion Phase|Withdrawal by Subject|0|||
48709519|NCT01742286|156784337|FG002|Expansion Phase|Withdrawal by Subject|0|||
48806109|NCT00792103|157132469|FG000|Overall Study|Lost to Follow-up|17|||
48806110|NCT00792103|157132469|FG000|Overall Study|Adverse Event|25|||
48806111|NCT00792103|157132469|FG000|Overall Study|Withdrawal by Subject|52|||
49119601|NCT01877668|158277171|FG001|Overall Study|Protocol Violation|1|||
49119602|NCT01877668|158277172|FG002|Overall Study|Protocol Violation|0|||
49119603|NCT01877668|158277173|FG003|Overall Study|Protocol Violation|0|||
49119604|NCT01877668|158277174|FG004|Overall Study|Protocol Violation|3|||
49119605|NCT01877668|158277170|FG000|Overall Study|Adverse event related to study drug|2|||
49119606|NCT01877668|158277171|FG001|Overall Study|Adverse event related to study drug|2|||
49119607|NCT01877668|158277172|FG002|Overall Study|Adverse event related to study drug|2|||
49119608|NCT01877668|158277173|FG003|Overall Study|Adverse event related to study drug|2|||
49119609|NCT01877668|158277174|FG004|Overall Study|Adverse event related to study drug|1|||
49119610|NCT01877668|158277170|FG000|Overall Study|Adverse event unrelated to study drug|4|||
49119611|NCT01877668|158277171|FG001|Overall Study|Adverse event unrelated to study drug|1|||
49119612|NCT01877668|158277172|FG002|Overall Study|Adverse event unrelated to study drug|2|||
49119613|NCT01877668|158277173|FG003|Overall Study|Adverse event unrelated to study drug|0|||
49119614|NCT01877668|158277174|FG004|Overall Study|Adverse event unrelated to study drug|1|||
49119615|NCT01302418|158277175|FG000|Overall Study|Protocol Violation|9|||
49119616|NCT01302418|158277175|FG000|Overall Study|Non-evaluable|9|||
49119617|NCT01957579|158277177|FG000|Overall Study|Withdrawal of concent|0|||
49119618|NCT01957579|158277178|FG001|Overall Study|Withdrawal of concent|1|||
49119619|NCT01957579|158277179|FG002|Overall Study|Withdrawal of concent|0|||
49119620|NCT01957579|158277180|FG003|Overall Study|Withdrawal of concent|0|||
49119621|NCT01957579|158277177|FG000|Overall Study|Death|0|||
48916141|NCT00833053|157528444|FG001|Overall Study|Treatment Failure|1|||
49119622|NCT01957579|158277178|FG001|Overall Study|Death|0|||
49119623|NCT01957579|158277179|FG002|Overall Study|Death|2|||
49119624|NCT01957579|158277180|FG003|Overall Study|Death|0|||
48916142|NCT00833053|157528443|FG000|Overall Study|Withdrawal by Subject|0|||
48916143|NCT00833053|157528444|FG001|Overall Study|Withdrawal by Subject|1|||
48916144|NCT00833053|157528443|FG000|Overall Study|Protocol Violation|2|||
48916145|NCT00833053|157528444|FG001|Overall Study|Protocol Violation|1|||
48916146|NCT01785160|157528445|FG000|Treatment Period 1: Raltegravir|Not treated|1|||
48916147|NCT01785160|157528445|FG000|Washout Period of at Least 7 Days|Consent withdrawn|1|||
48916148|NCT00957528|157528447|FG000|Overall Study|Protocol Violation|0|||
48916149|NCT00957528|157528448|FG001|Overall Study|Protocol Violation|1|||
48916150|NCT00957528|157528449|FG002|Overall Study|Protocol Violation|0|||
48916151|NCT00957528|157528447|FG000|Overall Study|Withdrawal by Subject|0|||
48916152|NCT00957528|157528448|FG001|Overall Study|Withdrawal by Subject|0|||
48916153|NCT00957528|157528449|FG002|Overall Study|Withdrawal by Subject|1|||
48916154|NCT01961349|157528451|FG000|Overall Study|Withdrawal by Subject|1|||
48916155|NCT01961349|157528452|FG001|Overall Study|Withdrawal by Subject|4|||
48916156|NCT01961349|157528453|FG002|Overall Study|Withdrawal by Subject|0|||
48916157|NCT01961349|157528451|FG000|Overall Study|Adverse Event|0|||
48916158|NCT01961349|157528452|FG001|Overall Study|Adverse Event|0|||
48916159|NCT01961349|157528453|FG002|Overall Study|Adverse Event|1|||
49119625|NCT01639144|158277183|FG000|Overall Study|Withdrawal by Subject|4|||
48916160|NCT01961349|157528451|FG000|Overall Study|registration error, personal reason etc|2|||
48916161|NCT01961349|157528452|FG001|Overall Study|registration error, personal reason etc|2|||
48916162|NCT01961349|157528453|FG002|Overall Study|registration error, personal reason etc|1|||
48916163|NCT00496730|157528464|FG000|Overall Study|Lost to Follow-up|4|||
49119626|NCT01639144|158277184|FG001|Overall Study|Withdrawal by Subject|2|||
49119627|NCT01639144|158277183|FG000|Overall Study|Physician Decision|2|||
49119628|NCT01639144|158277184|FG001|Overall Study|Physician Decision|0|||
49119629|NCT01639144|158277183|FG000|Overall Study|Met postoperative exclusion criteria|4|||
49119630|NCT01639144|158277184|FG001|Overall Study|Met postoperative exclusion criteria|3|||
49119631|NCT02019550|158277185|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
49119632|NCT02019550|158277186|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
49119633|NCT03365934|158277187|FG000|Overall Study|Adverse Event|1|||
49119634|NCT03365934|158277187|FG000|Overall Study|Withdrawal by Subject|1|||
49119635|NCT01307891|158277188|FG000|Overall Study|Progressive Disease|3|||
49119636|NCT01307891|158277189|FG001|Overall Study|Progressive Disease|1|||
49119637|NCT02937740|158277190|FG000|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3|||
49119638|NCT02937740|158277191|FG001|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14|||
49119639|NCT02937740|158277190|FG000|BID for 90 Days, 22 mg/Day|Adverse Event|0|||
49119640|NCT02937740|158277191|FG001|BID for 90 Days, 22 mg/Day|Adverse Event|10|||
49119641|NCT02937740|158277190|FG000|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2|||
49119642|NCT02937740|158277191|FG001|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7|||
49119643|NCT02937740|158277190|FG000|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1|||
49119644|NCT02937740|158277191|FG001|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0|||
49119645|NCT02937740|158277190|FG000|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0|||
49119646|NCT02937740|158277191|FG001|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1|||
49119647|NCT02937740|158277190|FG000|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0|||
49119648|NCT02937740|158277191|FG001|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1|||
49119649|NCT01473940|158277192|FG000|Induction Therapy|Death|0|||
49119650|NCT01473940|158277193|FG001|Induction Therapy|Death|0|||
49119651|NCT01473940|158277194|FG002|Induction Therapy|Death|1|||
49119652|NCT01473940|158277195|FG003|Induction Therapy|Death|1|||
49119653|NCT01473940|158277192|FG000|Induction Therapy|Progressive Disease|0|||
49119654|NCT01473940|158277193|FG001|Induction Therapy|Progressive Disease|1|||
49119655|NCT01473940|158277194|FG002|Induction Therapy|Progressive Disease|1|||
49119656|NCT01473940|158277195|FG003|Induction Therapy|Progressive Disease|0|||
49119657|NCT01473940|158277192|FG000|Maintenance Therapy|Progressive Disease|1|||
49119658|NCT01473940|158277193|FG001|Maintenance Therapy|Progressive Disease|2|||
49119659|NCT01473940|158277194|FG002|Maintenance Therapy|Progressive Disease|1|||
49119660|NCT01473940|158277195|FG003|Maintenance Therapy|Progressive Disease|4|||
49119661|NCT00547248|158277196|FG000|Overall Study|Protocol Violation|0|||
49119662|NCT00547248|158277197|FG001|Overall Study|Protocol Violation|0|||
49119663|NCT00547248|158277198|FG002|Overall Study|Protocol Violation|1|||
49119664|NCT00547248|158277199|FG003|Overall Study|Protocol Violation|1|||
49119665|NCT00547248|158277196|FG000|Overall Study|Migrated/moved from study area|0|||
48709520|NCT01742286|156784338|FG003|Expansion Phase|Withdrawal by Subject|0|||
48709521|NCT01742286|156784339|FG004|Expansion Phase|Withdrawal by Subject|0|||
48709522|NCT01742286|156784340|FG005|Expansion Phase|Withdrawal by Subject|0|||
48709523|NCT01742286|156784341|FG006|Expansion Phase|Withdrawal by Subject|1|||
48709524|NCT01010867|156784343|FG000|Overall Study|< 50% adherence to probiotic|1|||
48709525|NCT00993148|156784344|FG000|Overall Study|Lost to Follow-up|2|||
48709526|NCT00993148|156784344|FG000|Overall Study|never initiated treatment|1|||
48709527|NCT01077050|156786464|FG000|Overall Study|Subjects signed ICF could not be located|1|||
48709528|NCT01077050|156786464|FG000|Overall Study|Screen failure|8|||
48709529|NCT04953728|156786475|FG000|Overall Study|Withdrawal by Subject|3|||
48709530|NCT04953728|156786475|FG000|Overall Study|Physician Decision|1|||
48709531|NCT01148979|156786476|FG000|Overall Study|Lost to Follow-up|0|||
48709532|NCT01148979|156786477|FG001|Overall Study|Lost to Follow-up|1|||
48709533|NCT01646125|156786480|FG000|Overall Study|Untreated|2|||
48709534|NCT01646125|156786481|FG001|Overall Study|Untreated|5|||
48709535|NCT01646125|156786480|FG000|Overall Study|Adverse Event|2|||
48709536|NCT01646125|156786481|FG001|Overall Study|Adverse Event|1|||
48709537|NCT01646125|156786480|FG000|Overall Study|Death|1|||
48709538|NCT01646125|156786481|FG001|Overall Study|Death|1|||
48709539|NCT01646125|156786480|FG000|Overall Study|Physician Decision|1|||
48709540|NCT01646125|156786481|FG001|Overall Study|Physician Decision|3|||
48709541|NCT01646125|156786480|FG000|Overall Study|Progressive disease|22|||
48709542|NCT01646125|156786481|FG001|Overall Study|Progressive disease|16|||
48709543|NCT01646125|156786480|FG000|Overall Study|Study terminated by sponsor|2|||
48709544|NCT01646125|156786481|FG001|Overall Study|Study terminated by sponsor|1|||
48806112|NCT00792103|157132469|FG000|Overall Study|Protocol Violation|10|||
48916164|NCT00496730|157528465|FG001|Overall Study|Lost to Follow-up|3|||
48916165|NCT00496730|157528464|FG000|Overall Study|Withdrawal by Subject|2|||
49119666|NCT00547248|158277197|FG001|Overall Study|Migrated/moved from study area|0|||
49119667|NCT00547248|158277198|FG002|Overall Study|Migrated/moved from study area|2|||
49119668|NCT00547248|158277199|FG003|Overall Study|Migrated/moved from study area|0|||
49119669|NCT00547248|158277196|FG000|Overall Study|Withdrawal by Subject|0|||
48709545|NCT01646125|156786480|FG000|Overall Study|Subject/Guardian decision|1|||
48709546|NCT01646125|156786481|FG001|Overall Study|Subject/Guardian decision|1|||
48709547|NCT00990704|156786484|FG000|Overall Study|Adverse Event|1|||
48709548|NCT00990704|156786485|FG001|Overall Study|Adverse Event|1|||
48709549|NCT00990704|156786484|FG000|Overall Study|Physician Decision|0|||
48709550|NCT00990704|156786485|FG001|Overall Study|Physician Decision|1|||
48916166|NCT00496730|157528465|FG001|Overall Study|Withdrawal by Subject|2|||
48916167|NCT01197521|157528466|FG000|Overall Study|Not reported|24|||
48709551|NCT04040933|156786486|FG000|Overall Study|Protocol Violation|1|||
48709552|NCT04040933|156786486|FG000|Overall Study|Withdrawal by Subject|2|||
48709553|NCT02656693|156786500|FG000|Overall Study|Pregnancy|1|||
48709554|NCT02656693|156786501|FG001|Overall Study|Pregnancy|1|||
48709555|NCT02656693|156786502|FG002|Overall Study|Pregnancy|1|||
48709556|NCT02656693|156786500|FG000|Overall Study|Bariatric surgery|0|||
48709557|NCT02656693|156786501|FG001|Overall Study|Bariatric surgery|1|||
48709558|NCT02656693|156786502|FG002|Overall Study|Bariatric surgery|2|||
48709559|NCT01124006|156786506|FG000|Overall Study|Withdrawal by Subject|2|||
48709560|NCT01124006|156786507|FG001|Overall Study|Withdrawal by Subject|2|||
48709561|NCT01124006|156786508|FG002|Overall Study|Withdrawal by Subject|0|||
48709562|NCT01124006|156786506|FG000|Overall Study|Lost to Follow-up|1|||
48709563|NCT01124006|156786507|FG001|Overall Study|Lost to Follow-up|0|||
48709564|NCT01124006|156786508|FG002|Overall Study|Lost to Follow-up|1|||
48709565|NCT01124006|156786506|FG000|Overall Study|Other|0|||
48709566|NCT01124006|156786507|FG001|Overall Study|Other|0|||
48709567|NCT01124006|156786508|FG002|Overall Study|Other|1|||
48709568|NCT00796419|156786509|FG000|Overall Study|Death|0|||
48709569|NCT00796419|156786510|FG001|Overall Study|Death|1|||
48709570|NCT02840799|156786511|FG000|Phase 1|Physician Decision|1|||
48709571|NCT02840799|156786512|FG001|Phase 1|Physician Decision|3|||
48709572|NCT02840799|156786511|FG000|Phase 1|Withdrawal by Subject|4|||
48709573|NCT02840799|156786512|FG001|Phase 1|Withdrawal by Subject|0|||
48709574|NCT02840799|156786511|FG000|Phase 2 (Crossover)|Adverse Event|0|||
48709575|NCT02840799|156786512|FG001|Phase 2 (Crossover)|Adverse Event|1|||
48709576|NCT02840799|156786511|FG000|Phase 2 (Crossover)|Withdrawal by Subject|0|||
48709577|NCT02840799|156786512|FG001|Phase 2 (Crossover)|Withdrawal by Subject|1|||
48709578|NCT02736578|156786516|FG000|Overall Study|Adverse Event|1|||
48709579|NCT02736578|156786517|FG001|Overall Study|Adverse Event|0|||
48709580|NCT01837823|156786528|FG000|Overall Study|Lost to Follow-up|6|||
48709581|NCT02054104|156786529|FG000|Overall Study|Did not want to continue due to college classes|1|||
48709582|NCT02054104|156786530|FG001|Overall Study|Did not want to continue due to college classes|0|||
48709583|NCT02054104|156786529|FG000|Overall Study|Biopsy positive for malignancy, appears to be new primary|1|||
48709584|NCT02054104|156786530|FG001|Overall Study|Biopsy positive for malignancy, appears to be new primary|0|||
48709585|NCT02054104|156786529|FG000|Overall Study|No evidence of immunologic response|2|||
48709586|NCT02054104|156786530|FG001|Overall Study|No evidence of immunologic response|2|||
48709587|NCT02054104|156786529|FG000|Overall Study|Disease Progression On Study|4|||
48709588|NCT02054104|156786530|FG001|Overall Study|Disease Progression On Study|5|||
48709589|NCT02054104|156786529|FG000|Overall Study|Diagnosis of lymphoma|0|||
48709590|NCT02054104|156786530|FG001|Overall Study|Diagnosis of lymphoma|1|||
48709591|NCT02054104|156786529|FG000|Overall Study|Inconclusive response|0|||
48709592|NCT02054104|156786530|FG001|Overall Study|Inconclusive response|1|||
48709593|NCT00823615|156786531|FG000|Period 2|Lost to Follow-up|2|||
48709594|NCT00823615|156786532|FG001|Period 2|Lost to Follow-up|0|||
48709595|NCT00823615|156786531|FG000|Period 2|Time/Job Conflict|1|||
48709596|NCT00823615|156786532|FG001|Period 2|Time/Job Conflict|2|||
48709597|NCT01864603|156786537|FG000|Stage 2|DSMB design modification|86056|||
48709598|NCT01864603|156786538|FG001|Stage 2|DSMB design modification|92558|||
48709599|NCT00485134|156786540|FG000|Overall Study|Lost to Follow-up|1|||
48709600|NCT00485134|156786541|FG001|Overall Study|Lost to Follow-up|0|||
48709601|NCT00485134|156786542|FG002|Overall Study|Lost to Follow-up|0|||
48709602|NCT00485134|156786543|FG003|Overall Study|Lost to Follow-up|0|||
48709603|NCT00485134|156786544|FG004|Overall Study|Lost to Follow-up|0|||
48709604|NCT00485134|156786545|FG005|Overall Study|Lost to Follow-up|0|||
48709605|NCT00485134|156786546|FG006|Overall Study|Lost to Follow-up|0|||
48709606|NCT00485134|156786547|FG007|Overall Study|Lost to Follow-up|0|||
48709607|NCT00485134|156786540|FG000|Overall Study|Withdrawal by Subject|0|||
48709608|NCT00485134|156786541|FG001|Overall Study|Withdrawal by Subject|1|||
48709609|NCT00485134|156786542|FG002|Overall Study|Withdrawal by Subject|0|||
48709610|NCT00485134|156786543|FG003|Overall Study|Withdrawal by Subject|0|||
48709611|NCT00485134|156786544|FG004|Overall Study|Withdrawal by Subject|0|||
48709612|NCT00485134|156786545|FG005|Overall Study|Withdrawal by Subject|0|||
48709613|NCT00485134|156786546|FG006|Overall Study|Withdrawal by Subject|0|||
48709614|NCT00485134|156786547|FG007|Overall Study|Withdrawal by Subject|0|||
48709615|NCT00485134|156786540|FG000|Overall Study|Change in health status|0|||
48709616|NCT00485134|156786541|FG001|Overall Study|Change in health status|1|||
48709617|NCT00485134|156786542|FG002|Overall Study|Change in health status|2|||
48709618|NCT00485134|156786543|FG003|Overall Study|Change in health status|1|||
48709619|NCT00485134|156786544|FG004|Overall Study|Change in health status|0|||
48709620|NCT00485134|156786545|FG005|Overall Study|Change in health status|1|||
48709621|NCT00485134|156786546|FG006|Overall Study|Change in health status|0|||
48709622|NCT00485134|156786547|FG007|Overall Study|Change in health status|0|||
48709623|NCT00485134|156786540|FG000|Overall Study|Withdrew for adverse event|0|||
48709624|NCT00485134|156786541|FG001|Overall Study|Withdrew for adverse event|0|||
48709625|NCT00485134|156786542|FG002|Overall Study|Withdrew for adverse event|1|||
48709626|NCT00485134|156786543|FG003|Overall Study|Withdrew for adverse event|0|||
48709627|NCT00485134|156786544|FG004|Overall Study|Withdrew for adverse event|0|||
48709628|NCT00485134|156786545|FG005|Overall Study|Withdrew for adverse event|0|||
48709629|NCT00485134|156786546|FG006|Overall Study|Withdrew for adverse event|0|||
48709630|NCT00485134|156786547|FG007|Overall Study|Withdrew for adverse event|0|||
48709631|NCT00485134|156786540|FG000|Overall Study|Positive drug test|0|||
48709632|NCT00485134|156786541|FG001|Overall Study|Positive drug test|0|||
48709633|NCT00485134|156786542|FG002|Overall Study|Positive drug test|0|||
48709634|NCT00485134|156786543|FG003|Overall Study|Positive drug test|0|||
48709635|NCT00485134|156786544|FG004|Overall Study|Positive drug test|2|||
48709636|NCT00485134|156786545|FG005|Overall Study|Positive drug test|1|||
48709637|NCT00485134|156786546|FG006|Overall Study|Positive drug test|0|||
48709638|NCT00485134|156786547|FG007|Overall Study|Positive drug test|0|||
48806113|NCT00792103|157132469|FG000|Overall Study|Did not apply 6 patches in 1st 3 mths|14|||
48806114|NCT03673462|157132470|FG000|Overall Study|Adverse Event|11|||
48806115|NCT03673462|157132471|FG001|Overall Study|Adverse Event|1|||
48806116|NCT03673462|157132470|FG000|Overall Study|Protocol Violation|25|||
48806117|NCT03673462|157132471|FG001|Overall Study|Protocol Violation|11|||
48806118|NCT03673462|157132470|FG000|Overall Study|Withdrawal by Parent/Guardian|162|||
48806119|NCT03673462|157132471|FG001|Overall Study|Withdrawal by Parent/Guardian|56|||
48806120|NCT03673462|157132470|FG000|Overall Study|Lost to Follow-up|102|||
48806121|NCT03673462|157132471|FG001|Overall Study|Lost to Follow-up|19|||
48806122|NCT00113360|157132475|FG000|Overall Study|Adverse Event|3|||
48806123|NCT00113360|157132475|FG000|Overall Study|Subject required surgery|1|||
48806124|NCT00113360|157132475|FG000|Overall Study|Did not meet eligibility criteria|3|||
48806125|NCT03002038|157132482|FG000|Overall Study|Adverse Event|3|||
48806126|NCT03002038|157132483|FG001|Overall Study|Adverse Event|1|||
48806127|NCT03002038|157132482|FG000|Overall Study|Withdrawal by Subject|8|||
48806128|NCT03002038|157132483|FG001|Overall Study|Withdrawal by Subject|4|||
48806129|NCT03002038|157132482|FG000|Overall Study|Immigration to another region|0|||
48806130|NCT03002038|157132483|FG001|Overall Study|Immigration to another region|2|||
48806131|NCT03351738|157132486|FG000|Overall Study|Withdrawal by Subject|0|||
48806132|NCT03351738|157132487|FG001|Overall Study|Withdrawal by Subject|1|||
48806133|NCT03351738|157132488|FG002|Overall Study|Withdrawal by Subject|0|||
48806134|NCT03351738|157132489|FG003|Overall Study|Withdrawal by Subject|1|||
48806135|NCT03351738|157132490|FG004|Overall Study|Withdrawal by Subject|0|||
48806136|NCT03351738|157132491|FG005|Overall Study|Withdrawal by Subject|0|||
48806137|NCT02243709|157132496|FG000|Phase 1|Lost to Follow-up|0|||
48916168|NCT01197521|157528467|FG001|Overall Study|Not reported|25|||
48709639|NCT00485134|156786540|FG000|Overall Study|Non-compliance|0|||
48709640|NCT00485134|156786541|FG001|Overall Study|Non-compliance|0|||
48709641|NCT00485134|156786542|FG002|Overall Study|Non-compliance|0|||
48709642|NCT00485134|156786543|FG003|Overall Study|Non-compliance|0|||
48709643|NCT00485134|156786544|FG004|Overall Study|Non-compliance|1|||
48709644|NCT00485134|156786545|FG005|Overall Study|Non-compliance|2|||
48709645|NCT00485134|156786546|FG006|Overall Study|Non-compliance|2|||
48709646|NCT00485134|156786547|FG007|Overall Study|Non-compliance|0|||
48709647|NCT00485134|156786540|FG000|Overall Study|Unable to comply with study schedule|0|||
48709648|NCT00485134|156786541|FG001|Overall Study|Unable to comply with study schedule|0|||
48709649|NCT00485134|156786542|FG002|Overall Study|Unable to comply with study schedule|0|||
48709650|NCT00485134|156786543|FG003|Overall Study|Unable to comply with study schedule|0|||
48709651|NCT00485134|156786544|FG004|Overall Study|Unable to comply with study schedule|0|||
48709652|NCT00485134|156786545|FG005|Overall Study|Unable to comply with study schedule|0|||
48709653|NCT00485134|156786546|FG006|Overall Study|Unable to comply with study schedule|0|||
48709654|NCT00485134|156786547|FG007|Overall Study|Unable to comply with study schedule|1|||
48709655|NCT00485134|156786540|FG000|Overall Study|Pregnancy|0|||
48709656|NCT00485134|156786541|FG001|Overall Study|Pregnancy|0|||
48709657|NCT00485134|156786542|FG002|Overall Study|Pregnancy|0|||
48709658|NCT00485134|156786543|FG003|Overall Study|Pregnancy|0|||
48709659|NCT00485134|156786544|FG004|Overall Study|Pregnancy|0|||
48709660|NCT00485134|156786545|FG005|Overall Study|Pregnancy|0|||
48709661|NCT00485134|156786546|FG006|Overall Study|Pregnancy|1|||
48709662|NCT00485134|156786547|FG007|Overall Study|Pregnancy|0|||
48709663|NCT00001213|156786550|FG000|Overall Study|Death|18|||
48709664|NCT00975689|156786554|FG000|Overall Study|Adverse Event|0|||
48709665|NCT00975689|156786555|FG001|Overall Study|Adverse Event|3|||
48709666|NCT00975689|156786554|FG000|Overall Study|Withdrawal by Subject|1|||
48709667|NCT00975689|156786555|FG001|Overall Study|Withdrawal by Subject|0|||
48709668|NCT00975689|156786554|FG000|Overall Study|Physician Decision|1|||
48709669|NCT00975689|156786555|FG001|Overall Study|Physician Decision|0|||
48709670|NCT04335136|156786556|FG000|Overall Study|Death|8|||
48709671|NCT04335136|156786557|FG001|Overall Study|Death|4|||
48709672|NCT04335136|156786556|FG000|Overall Study|Lost to Follow-up|2|||
48709673|NCT04335136|156786557|FG001|Overall Study|Lost to Follow-up|0|||
48709674|NCT04335136|156786556|FG000|Overall Study|Protocol Violation|1|||
48709675|NCT04335136|156786557|FG001|Overall Study|Protocol Violation|0|||
48709676|NCT04335136|156786556|FG000|Overall Study|Withdrawal by Subject|1|||
48709677|NCT04335136|156786557|FG001|Overall Study|Withdrawal by Subject|1|||
48709678|NCT04335136|156786556|FG000|Overall Study|Health-threatening condition|0|||
48709679|NCT04335136|156786557|FG001|Overall Study|Health-threatening condition|1|||
48709680|NCT04335136|156786556|FG000|Overall Study|Adverse Event|0|||
48709681|NCT04335136|156786557|FG001|Overall Study|Adverse Event|1|||
48709682|NCT04335136|156786556|FG000|Overall Study|Erroneously randomized|2|||
48709683|NCT04335136|156786557|FG001|Overall Study|Erroneously randomized|0|||
48709684|NCT00433004|156786558|FG000|Overall Study|Lost to Follow-up|5|||
48709685|NCT00433004|156786559|FG001|Overall Study|Lost to Follow-up|7|||
48709686|NCT00742235|156786560|FG000|Overall Study|Lost to Follow-up|0|||
48709687|NCT00742235|156786561|FG001|Overall Study|Lost to Follow-up|31|||
48709688|NCT03534180|156786562|FG000|Overall Study|Withdrawal by Subject|1|||
48806138|NCT02243709|157132497|FG001|Phase 1|Lost to Follow-up|1|||
48806139|NCT02243709|157132496|FG000|Phase 1|Withdrawal by Subject|1|||
48709689|NCT00330967|156786563|FG000|Overall Study|Withdrawal by Subject|0|||
48709690|NCT00330967|156786564|FG001|Overall Study|Withdrawal by Subject|5|||
48709691|NCT00330967|156786563|FG000|Overall Study|Physician Decision|0|||
48709692|NCT00330967|156786564|FG001|Overall Study|Physician Decision|9|||
48709693|NCT00473382|156786567|FG000|Core Study|Adverse Event|3|||
48709694|NCT00473382|156786568|FG001|Core Study|Adverse Event|1|||
48709695|NCT00473382|156786569|FG002|Core Study|Adverse Event|1|||
48709696|NCT00473382|156786567|FG000|Core Study|Death|3|||
48709697|NCT00473382|156786568|FG001|Core Study|Death|5|||
48709698|NCT00473382|156786569|FG002|Core Study|Death|10|||
48709699|NCT00473382|156786567|FG000|Core Study|Lost to Follow-up|3|||
48806140|NCT02243709|157132497|FG001|Phase 1|Withdrawal by Subject|0|||
48806141|NCT02243709|157132496|FG000|Phase 1|Protocol Violation|0|||
48806142|NCT02243709|157132497|FG001|Phase 1|Protocol Violation|1|||
48806143|NCT02243709|157132496|FG000|Phase 1|Adverse Event|0|||
48806144|NCT02243709|157132497|FG001|Phase 1|Adverse Event|1|||
48806145|NCT01013792|157132501|FG000|Overall Study|Study suspended|2|||
48806146|NCT01013792|157132502|FG001|Overall Study|Study suspended|1|||
48709700|NCT00473382|156786568|FG001|Core Study|Lost to Follow-up|3|||
48709701|NCT00473382|156786569|FG002|Core Study|Lost to Follow-up|3|||
48709702|NCT00473382|156786567|FG000|Core Study|Physician Decision|1|||
48709703|NCT00473382|156786568|FG001|Core Study|Physician Decision|2|||
48709704|NCT00473382|156786569|FG002|Core Study|Physician Decision|2|||
48709705|NCT00473382|156786567|FG000|Core Study|Subject non-compliance|5|||
48709706|NCT00473382|156786568|FG001|Core Study|Subject non-compliance|2|||
48709707|NCT00473382|156786569|FG002|Core Study|Subject non-compliance|1|||
48709708|NCT00473382|156786567|FG000|Core Study|Subject needed other treatment|1|||
48709709|NCT00473382|156786568|FG001|Core Study|Subject needed other treatment|3|||
48709710|NCT00473382|156786569|FG002|Core Study|Subject needed other treatment|2|||
48709711|NCT00473382|156786567|FG000|Core Study|Subject's decision|12|||
48709712|NCT00473382|156786568|FG001|Core Study|Subject's decision|11|||
48709713|NCT00473382|156786569|FG002|Core Study|Subject's decision|10|||
48709714|NCT00473382|156786567|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
48709715|NCT00473382|156786568|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
48709716|NCT00473382|156786569|FG002|Open-label Extension Through Month 48|Adverse Event|1|||
48709717|NCT00473382|156786567|FG000|Open-label Extension Through Month 48|Death|1|||
48709718|NCT00473382|156786568|FG001|Open-label Extension Through Month 48|Death|3|||
48709719|NCT00473382|156786569|FG002|Open-label Extension Through Month 48|Death|3|||
48709720|NCT00473382|156786567|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
48709721|NCT00473382|156786568|FG001|Open-label Extension Through Month 48|Lost to Follow-up|2|||
48709722|NCT00473382|156786569|FG002|Open-label Extension Through Month 48|Lost to Follow-up|1|||
48709723|NCT00473382|156786567|FG000|Open-label Extension Through Month 48|Subject's Decision|5|||
48709724|NCT00473382|156786568|FG001|Open-label Extension Through Month 48|Subject's Decision|1|||
48709725|NCT00473382|156786569|FG002|Open-label Extension Through Month 48|Subject's Decision|6|||
48806147|NCT01013792|157132501|FG000|Overall Study|Adverse Event|0|||
48806148|NCT01013792|157132502|FG001|Overall Study|Adverse Event|3|||
48806149|NCT01013792|157132501|FG000|Overall Study|Lost to Follow-up|0|||
49119670|NCT00547248|158277197|FG001|Overall Study|Withdrawal by Subject|0|||
49119671|NCT00547248|158277198|FG002|Overall Study|Withdrawal by Subject|7|||
48709726|NCT00473382|156786567|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41|||
49119672|NCT00547248|158277199|FG003|Overall Study|Withdrawal by Subject|1|||
48709727|NCT00473382|156786568|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34|||
48709728|NCT00473382|156786569|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36|||
48709729|NCT00473382|156786567|FG000|Open-label Extension Through Month 48|Subject Required Other Intervention|2|||
48709730|NCT00473382|156786568|FG001|Open-label Extension Through Month 48|Subject Required Other Intervention|1|||
48709731|NCT00473382|156786569|FG002|Open-label Extension Through Month 48|Subject Required Other Intervention|0|||
49119673|NCT00534248|158277200|FG000|Overall Study|Adverse Event|19|||
49119674|NCT00534248|158277201|FG001|Overall Study|Adverse Event|29|||
49119675|NCT00534248|158277200|FG000|Overall Study|Lost to Follow-up|353|||
49119676|NCT00534248|158277201|FG001|Overall Study|Lost to Follow-up|375|||
49119677|NCT00534248|158277200|FG000|Overall Study|Other protocol specified criteria|13|||
49119678|NCT00534248|158277201|FG001|Overall Study|Other protocol specified criteria|3|||
49119679|NCT00534248|158277200|FG000|Overall Study|Physician Decision|10|||
48709732|NCT00473382|156786567|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
48709733|NCT00473382|156786568|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
48709734|NCT00473382|156786569|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
48806150|NCT01013792|157132502|FG001|Overall Study|Lost to Follow-up|1|||
48806151|NCT05375955|157132505|FG000|Treatment (12 Weeks)|Lost to Follow-up|0|||
48806152|NCT05375955|157132506|FG001|Treatment (12 Weeks)|Lost to Follow-up|2|||
48806153|NCT05375955|157132507|FG002|Treatment (12 Weeks)|Lost to Follow-up|2|||
48806154|NCT05375955|157132508|FG003|Treatment (12 Weeks)|Lost to Follow-up|1|||
48806155|NCT05375955|157132509|FG004|Treatment (12 Weeks)|Lost to Follow-up|1|||
48806156|NCT05375955|157132510|FG005|Treatment (12 Weeks)|Lost to Follow-up|1|||
49119680|NCT00534248|158277201|FG001|Overall Study|Physician Decision|7|||
49119681|NCT00534248|158277200|FG000|Overall Study|Protocol Violation|3|||
49119682|NCT00534248|158277201|FG001|Overall Study|Protocol Violation|4|||
49119683|NCT00534248|158277200|FG000|Overall Study|Withdrawal by Subject|263|||
49119684|NCT00534248|158277201|FG001|Overall Study|Withdrawal by Subject|255|||
49119685|NCT02532257|158277202|FG000|Overall Study|Adverse Event|2|||
49119686|NCT02532257|158277202|FG000|Overall Study|Physician Decision|4|||
49119687|NCT02532257|158277202|FG000|Overall Study|Withdrawal by Subject|3|||
49119688|NCT02532257|158277202|FG000|Overall Study|Progressive Disease|10|||
49119689|NCT00697593|158277206|FG000|Overall Study|Adverse Event|3|||
49119690|NCT00697593|158277206|FG000|Overall Study|Protocol Violation|1|||
49119691|NCT00697593|158277206|FG000|Overall Study|Lack of Efficacy|3|||
49119692|NCT00697593|158277206|FG000|Overall Study|Suspension of the study by sponsor|12|||
49119693|NCT02964338|158277207|FG000|Overall Study|Sponsor terminated study for futility|12|||
49119694|NCT02964338|158277208|FG001|Overall Study|Sponsor terminated study for futility|15|||
49119695|NCT02964338|158277209|FG002|Overall Study|Sponsor terminated study for futility|14|||
49119696|NCT02964338|158277207|FG000|Overall Study|Lack of Efficacy|0|||
48806157|NCT05375955|157132511|FG006|Treatment (12 Weeks)|Lost to Follow-up|0|||
48806158|NCT05375955|157132505|FG000|Treatment (12 Weeks)|Physician Decision|4|||
48806159|NCT05375955|157132506|FG001|Treatment (12 Weeks)|Physician Decision|1|||
48806160|NCT05375955|157132507|FG002|Treatment (12 Weeks)|Physician Decision|3|||
48806161|NCT05375955|157132508|FG003|Treatment (12 Weeks)|Physician Decision|0|||
48806162|NCT05375955|157132509|FG004|Treatment (12 Weeks)|Physician Decision|0|||
48806163|NCT05375955|157132510|FG005|Treatment (12 Weeks)|Physician Decision|1|||
48806164|NCT05375955|157132511|FG006|Treatment (12 Weeks)|Physician Decision|0|||
48806165|NCT05375955|157132505|FG000|Treatment (12 Weeks)|Other|0|||
48916169|NCT01197521|157528468|FG002|Overall Study|Not reported|21|||
48916170|NCT01197521|157528466|FG000|Overall Study|Enrolment in long term extension|42|||
48916171|NCT01197521|157528467|FG001|Overall Study|Enrolment in long term extension|36|||
49119697|NCT02964338|158277208|FG001|Overall Study|Lack of Efficacy|3|||
48806166|NCT05375955|157132506|FG001|Treatment (12 Weeks)|Other|1|||
48806167|NCT05375955|157132507|FG002|Treatment (12 Weeks)|Other|0|||
48806168|NCT05375955|157132508|FG003|Treatment (12 Weeks)|Other|0|||
48806169|NCT05375955|157132509|FG004|Treatment (12 Weeks)|Other|0|||
49119698|NCT02964338|158277209|FG002|Overall Study|Lack of Efficacy|0|||
48806170|NCT05375955|157132510|FG005|Treatment (12 Weeks)|Other|0|||
48806171|NCT05375955|157132511|FG006|Treatment (12 Weeks)|Other|0|||
49119699|NCT02964338|158277207|FG000|Overall Study|Lost to Follow-up|1|||
49119700|NCT02964338|158277208|FG001|Overall Study|Lost to Follow-up|0|||
49119701|NCT02964338|158277209|FG002|Overall Study|Lost to Follow-up|3|||
48806172|NCT05375955|157132505|FG000|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
48806173|NCT05375955|157132506|FG001|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
48806174|NCT05375955|157132507|FG002|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
48806175|NCT05375955|157132508|FG003|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
48806176|NCT05375955|157132509|FG004|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
48806177|NCT05375955|157132510|FG005|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
48806178|NCT05375955|157132511|FG006|Treatment (12 Weeks)|Withdrawal by parent/guardian|1|||
48806179|NCT05375955|157132505|FG000|Treatment (12 Weeks)|Withdrawal by Subject|8|||
48806180|NCT05375955|157132506|FG001|Treatment (12 Weeks)|Withdrawal by Subject|4|||
48806181|NCT05375955|157132507|FG002|Treatment (12 Weeks)|Withdrawal by Subject|7|||
48806182|NCT05375955|157132508|FG003|Treatment (12 Weeks)|Withdrawal by Subject|8|||
48806183|NCT05375955|157132509|FG004|Treatment (12 Weeks)|Withdrawal by Subject|4|||
48806184|NCT05375955|157132510|FG005|Treatment (12 Weeks)|Withdrawal by Subject|3|||
48806185|NCT05375955|157132511|FG006|Treatment (12 Weeks)|Withdrawal by Subject|3|||
48806186|NCT05375955|157132505|FG000|Treatment (12 Weeks)|Pregnancy|0|||
48806187|NCT05375955|157132506|FG001|Treatment (12 Weeks)|Pregnancy|0|||
48806188|NCT05375955|157132507|FG002|Treatment (12 Weeks)|Pregnancy|1|||
48806189|NCT05375955|157132508|FG003|Treatment (12 Weeks)|Pregnancy|0|||
48806190|NCT05375955|157132509|FG004|Treatment (12 Weeks)|Pregnancy|0|||
48806191|NCT05375955|157132510|FG005|Treatment (12 Weeks)|Pregnancy|0|||
48806192|NCT05375955|157132511|FG006|Treatment (12 Weeks)|Pregnancy|0|||
48806193|NCT05375955|157132505|FG000|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
48916172|NCT01197521|157528468|FG002|Overall Study|Enrolment in long term extension|87|||
48916173|NCT01197521|157528466|FG000|Overall Study|Severe non-compliance to protocol|1|||
48916174|NCT01197521|157528467|FG001|Overall Study|Severe non-compliance to protocol|3|||
48916175|NCT01197521|157528468|FG002|Overall Study|Severe non-compliance to protocol|3|||
48916176|NCT01197521|157528466|FG000|Overall Study|Lack of therapeutic response|2|||
48916177|NCT01197521|157528467|FG001|Overall Study|Lack of therapeutic response|3|||
48916178|NCT01197521|157528468|FG002|Overall Study|Lack of therapeutic response|4|||
48916179|NCT01197521|157528466|FG000|Overall Study|Dev. of study specific discont. criteria|6|||
48916180|NCT01197521|157528467|FG001|Overall Study|Dev. of study specific discont. criteria|16|||
48916181|NCT01197521|157528468|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
48916182|NCT01197521|157528466|FG000|Overall Study|Lost to Follow-up|3|||
48806194|NCT05375955|157132506|FG001|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
48806195|NCT05375955|157132507|FG002|Follow-up (up to 5 Weeks)|Protocol Violation|1|||
48806196|NCT05375955|157132508|FG003|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
48806197|NCT05375955|157132509|FG004|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
48806198|NCT05375955|157132510|FG005|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
48806199|NCT05375955|157132511|FG006|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
48806200|NCT05375955|157132505|FG000|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
48806201|NCT05375955|157132506|FG001|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
48806202|NCT05375955|157132507|FG002|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
48806203|NCT05375955|157132508|FG003|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
48806204|NCT05375955|157132509|FG004|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
48806205|NCT05375955|157132510|FG005|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
48806206|NCT05375955|157132511|FG006|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
48806207|NCT05375955|157132505|FG000|Follow-up (up to 5 Weeks)|Other|0|||
48806208|NCT05375955|157132506|FG001|Follow-up (up to 5 Weeks)|Other|1|||
48806209|NCT05375955|157132507|FG002|Follow-up (up to 5 Weeks)|Other|0|||
48806210|NCT05375955|157132508|FG003|Follow-up (up to 5 Weeks)|Other|0|||
48806211|NCT05375955|157132509|FG004|Follow-up (up to 5 Weeks)|Other|0|||
48916183|NCT01197521|157528467|FG001|Overall Study|Lost to Follow-up|2|||
48916184|NCT01197521|157528468|FG002|Overall Study|Lost to Follow-up|2|||
49119702|NCT02964338|158277207|FG000|Overall Study|Protocol Violation|0|||
49119703|NCT02964338|158277208|FG001|Overall Study|Protocol Violation|1|||
48806212|NCT05375955|157132510|FG005|Follow-up (up to 5 Weeks)|Other|0|||
48806213|NCT05375955|157132511|FG006|Follow-up (up to 5 Weeks)|Other|0|||
48806214|NCT05375955|157132505|FG000|Follow-up (up to 5 Weeks)|Physician's decision|2|||
48806215|NCT05375955|157132506|FG001|Follow-up (up to 5 Weeks)|Physician's decision|0|||
48806216|NCT05375955|157132507|FG002|Follow-up (up to 5 Weeks)|Physician's decision|2|||
48806217|NCT05375955|157132508|FG003|Follow-up (up to 5 Weeks)|Physician's decision|0|||
48806218|NCT05375955|157132509|FG004|Follow-up (up to 5 Weeks)|Physician's decision|0|||
48806219|NCT05375955|157132510|FG005|Follow-up (up to 5 Weeks)|Physician's decision|0|||
48806220|NCT05375955|157132511|FG006|Follow-up (up to 5 Weeks)|Physician's decision|0|||
48806221|NCT05375955|157132505|FG000|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
48806222|NCT05375955|157132506|FG001|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
48806223|NCT05375955|157132507|FG002|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
48806224|NCT05375955|157132508|FG003|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
48806225|NCT05375955|157132509|FG004|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
49119704|NCT02964338|158277209|FG002|Overall Study|Protocol Violation|0|||
49119705|NCT02964338|158277207|FG000|Overall Study|Withdrawal by Subject|1|||
49119706|NCT02964338|158277208|FG001|Overall Study|Withdrawal by Subject|3|||
48806226|NCT05375955|157132510|FG005|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
48806227|NCT05375955|157132511|FG006|Follow-up (up to 5 Weeks)|Lost to Follow-up|2|||
48806228|NCT02485938|157132515|FG000|Overall Study|Withdrawal of consent|2|||
48806229|NCT02485938|157132516|FG001|Overall Study|Withdrawal of consent|0|||
48806230|NCT04195698|157132517|FG000|Overall Study|Adverse Event|4|||
48806231|NCT04195698|157132518|FG001|Overall Study|Adverse Event|11|||
48806232|NCT04195698|157132517|FG000|Overall Study|Withdrawal by Subject|9|||
48806233|NCT04195698|157132518|FG001|Overall Study|Withdrawal by Subject|10|||
48806234|NCT04195698|157132517|FG000|Overall Study|Lost to Follow-up|5|||
48806235|NCT04195698|157132518|FG001|Overall Study|Lost to Follow-up|4|||
48806236|NCT04195698|157132517|FG000|Overall Study|Lack of Efficacy|2|||
48806237|NCT04195698|157132518|FG001|Overall Study|Lack of Efficacy|10|||
48806238|NCT04195698|157132517|FG000|Overall Study|Other|5|||
48806239|NCT04195698|157132518|FG001|Overall Study|Other|4|||
48806240|NCT04282148|157132519|FG000|Overall Study|Death|7|||
48916185|NCT01197521|157528466|FG000|Overall Study|Adverse Event|25|||
48916186|NCT01197521|157528467|FG001|Overall Study|Adverse Event|28|||
48916187|NCT01197521|157528468|FG002|Overall Study|Adverse Event|24|||
48916188|NCT01560780|157528469|FG000|Overall Study|Death|2|||
48916189|NCT01560780|157528470|FG001|Overall Study|Death|1|||
48916190|NCT01560780|157528469|FG000|Overall Study|Patient Preference|11|||
48916191|NCT01560780|157528470|FG001|Overall Study|Patient Preference|11|||
48916192|NCT03975920|157528477|FG000|Overall Study|Lost to Follow-up|1|||
48916193|NCT03975920|157528478|FG001|Overall Study|Lost to Follow-up|2|||
48916194|NCT03975920|157528477|FG000|Overall Study|Protocol Violation|1|||
48916195|NCT03975920|157528478|FG001|Overall Study|Protocol Violation|1|||
48916196|NCT03975920|157528477|FG000|Overall Study|Did not complete survey|2|||
48916197|NCT03975920|157528478|FG001|Overall Study|Did not complete survey|1|||
48916198|NCT03199040|157528479|FG000|Overall Study|Lack of Efficacy|2|||
48916199|NCT03199040|157528480|FG001|Overall Study|Lack of Efficacy|0|||
48916200|NCT03199040|157528479|FG000|Overall Study|Withdrawal by Subject|2|||
48916201|NCT03199040|157528480|FG001|Overall Study|Withdrawal by Subject|0|||
48916202|NCT03199040|157528479|FG000|Overall Study|Adverse Event|0|||
48916203|NCT03199040|157528480|FG001|Overall Study|Adverse Event|1|||
48916204|NCT03199040|157528479|FG000|Overall Study|Only completed 5 out of 6 vaccines|0|||
48916205|NCT03199040|157528480|FG001|Overall Study|Only completed 5 out of 6 vaccines|1|||
48916206|NCT01786603|157528481|FG000|Overall Study|Death|5|||
48916207|NCT01786603|157528482|FG001|Overall Study|Death|1|||
48916208|NCT01786603|157528481|FG000|Overall Study|Adverse Event|6|||
48916209|NCT01786603|157528482|FG001|Overall Study|Adverse Event|2|||
48916210|NCT01786603|157528481|FG000|Overall Study|Physician decision to withdraw|6|||
48916211|NCT01786603|157528482|FG001|Overall Study|Physician decision to withdraw|7|||
48916212|NCT01786603|157528481|FG000|Overall Study|Lost to Follow-up|1|||
48916213|NCT01786603|157528482|FG001|Overall Study|Lost to Follow-up|2|||
48916214|NCT00827606|157528484|FG000|Overall Study|Protocol Violation|4|||
48916215|NCT00827606|157528485|FG001|Overall Study|Protocol Violation|3|||
48916216|NCT00827606|157528484|FG000|Overall Study|Lost to Follow-up|3|||
48916217|NCT00827606|157528485|FG001|Overall Study|Lost to Follow-up|1|||
48916218|NCT00827606|157528484|FG000|Overall Study|Withdrawal by Subject|7|||
48916219|NCT00827606|157528485|FG001|Overall Study|Withdrawal by Subject|6|||
48916220|NCT00827606|157528484|FG000|Overall Study|Pregnancy|0|||
48916221|NCT00827606|157528485|FG001|Overall Study|Pregnancy|1|||
48916222|NCT00827606|157528484|FG000|Overall Study|Other|5|||
48916223|NCT00827606|157528485|FG001|Overall Study|Other|13|||
48916224|NCT00827606|157528484|FG000|Overall Study|LDL below 2.59 mmol/L|4|||
48916225|NCT00827606|157528485|FG001|Overall Study|LDL below 2.59 mmol/L|12|||
48806241|NCT04282148|157132519|FG000|Overall Study|Withdrawal by Subject|1|||
48806242|NCT04282148|157132519|FG000|Overall Study|Physician Decision|1|||
48806243|NCT01547299|157132520|FG000|Overall Study|Withdrawal by Subject|2|||
48806244|NCT01547299|157132521|FG001|Overall Study|Withdrawal by Subject|2|||
48806245|NCT02087501|157132522|FG000|Overall Study|Death|7|||
48806246|NCT02087501|157132522|FG000|Overall Study|Open repair of aneurysm|1|||
48806247|NCT02087501|157132522|FG000|Overall Study|Lost to Follow-up|2|||
48806248|NCT00265330|157132523|FG000|Overall Study|Adverse Event|41|||
48806249|NCT00265330|157132523|FG000|Overall Study|Lost to Follow-up|8|||
48806250|NCT00265330|157132523|FG000|Overall Study|Withdrawal by Subject|34|||
48806251|NCT00265330|157132523|FG000|Overall Study|Patient Wanted to Start Psychotherapy|1|||
48806252|NCT00265330|157132523|FG000|Overall Study|Lack of Efficacy|4|||
48916226|NCT00827606|157528484|FG000|Overall Study|Adverse Event|4|||
48916227|NCT00827606|157528485|FG001|Overall Study|Adverse Event|2|||
48916228|NCT02184195|157528488|FG000|Overall Study|Patient decision|5|||
48916229|NCT02184195|157528489|FG001|Overall Study|Patient decision|2|||
48916230|NCT02184195|157528488|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
48916231|NCT02184195|157528489|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
48916232|NCT02184195|157528488|FG000|Overall Study|Death|67|||
48916233|NCT02184195|157528489|FG001|Overall Study|Death|44|||
49010704|NCT03705169|157875684|FG001|Overall Study|Lost to Follow-up|0|||
48806253|NCT00265330|157132523|FG000|Overall Study|Family Scheduling Conflicts|1|||
48916234|NCT02184195|157528488|FG000|Overall Study|Lost to Follow-up|1|||
48916235|NCT02184195|157528489|FG001|Overall Study|Lost to Follow-up|5|||
48916236|NCT02184195|157528488|FG000|Overall Study|Other|0|||
48916237|NCT02184195|157528489|FG001|Overall Study|Other|3|||
48916238|NCT00290342|157528490|FG000|Overall Study|Other|0|||
48916239|NCT00290342|157528491|FG001|Overall Study|Other|1|||
48916240|NCT00290342|157528490|FG000|Overall Study|Withdrawal by Subject|6|||
48916241|NCT00290342|157528491|FG001|Overall Study|Withdrawal by Subject|4|||
48916242|NCT00290342|157528490|FG000|Overall Study|Lost to Follow-up|1|||
48916243|NCT00290342|157528491|FG001|Overall Study|Lost to Follow-up|0|||
48916244|NCT01056510|157528496|FG000|Overall Study|Dropout Before Start of Treatment|1|||
48916245|NCT01056510|157528497|FG001|Overall Study|Dropout Before Start of Treatment|1|||
48916246|NCT01056510|157528496|FG000|Overall Study|Withdrawal by Subject|4|||
48916247|NCT01056510|157528497|FG001|Overall Study|Withdrawal by Subject|2|||
48916248|NCT01056510|157528496|FG000|Overall Study|Death|29|||
48916249|NCT01056510|157528497|FG001|Overall Study|Death|34|||
48916250|NCT01056510|157528496|FG000|Overall Study|Noncompliance|1|||
48916251|NCT01056510|157528497|FG001|Overall Study|Noncompliance|3|||
48916252|NCT01056510|157528496|FG000|Overall Study|Physician Decision|4|||
48916253|NCT01056510|157528497|FG001|Overall Study|Physician Decision|5|||
48806254|NCT00265330|157132523|FG000|Overall Study|Began Taking Formulary Geodon|1|||
48806255|NCT00265330|157132523|FG000|Overall Study|Discharged from Unit for Long Term Care|1|||
48806256|NCT00265330|157132523|FG000|Overall Study|Site Closed by Sponsor|1|||
48806257|NCT00265330|157132523|FG000|Overall Study|Principal Investigators Request|1|||
48806258|NCT00265330|157132523|FG000|Overall Study|Withdrew Consent|1|||
48806259|NCT00265330|157132523|FG000|Overall Study|Protocol Violation|1|||
48806260|NCT01336621|157132526|FG000|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11|||
48806261|NCT01336621|157132526|FG000|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2|||
48806262|NCT01336621|157132526|FG000|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12|||
48806263|NCT01336621|157132526|FG000|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27|||
48806264|NCT01336621|157132526|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11|||
48806265|NCT01336621|157132526|FG000|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2|||
48806266|NCT01336621|157132526|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22|||
48806267|NCT01336621|157132526|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2|||
48806268|NCT01336621|157132526|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9|||
48806269|NCT01336621|157132526|FG000|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1|||
48806270|NCT01336621|157132526|FG000|SFUCP (up to 2.6 Years)|Adverse Event|1|||
48806271|NCT01336621|157132526|FG000|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3|||
48806272|NCT01336621|157132526|FG000|SFUCP (up to 2.6 Years)|Physician Decision|1|||
48806273|NCT01336621|157132526|FG000|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3|||
48806274|NCT01874145|157132527|FG000|Core Period|Non-compliance|1|||
48806275|NCT01874145|157132528|FG001|Core Period|Non-compliance|0|||
48806276|NCT01874145|157132527|FG000|Core Period|Protocol Violation|1|||
48806277|NCT01874145|157132528|FG001|Core Period|Protocol Violation|1|||
48806278|NCT01874145|157132527|FG000|Core Period|Physician Decision|1|||
48806279|NCT01874145|157132528|FG001|Core Period|Physician Decision|1|||
48806280|NCT01874145|157132527|FG000|Core Period|Adverse Event|0|||
48806281|NCT01874145|157132528|FG001|Core Period|Adverse Event|1|||
48806282|NCT01874145|157132527|FG000|Core Period|Withdrawal by Subject|0|||
48806283|NCT01874145|157132528|FG001|Core Period|Withdrawal by Subject|4|||
48806284|NCT01874145|157132527|FG000|Extension Period|Adverse Event|3|||
48806285|NCT01874145|157132528|FG001|Extension Period|Adverse Event|2|||
48806286|NCT01874145|157132527|FG000|Extension Period|Withdrawal by Subject|2|||
48806287|NCT01874145|157132528|FG001|Extension Period|Withdrawal by Subject|1|||
49119707|NCT02964338|158277209|FG002|Overall Study|Withdrawal by Subject|1|||
49119708|NCT02964338|158277207|FG000|Overall Study|Adverse Event|2|||
49119709|NCT02964338|158277208|FG001|Overall Study|Adverse Event|1|||
49119710|NCT02964338|158277209|FG002|Overall Study|Adverse Event|1|||
49119711|NCT02964338|158277207|FG000|Overall Study|Non-compliant with e-diary|0|||
48806288|NCT01874145|157132527|FG000|Extension Period|Lost to Follow-up|1|||
48806289|NCT01874145|157132528|FG001|Extension Period|Lost to Follow-up|1|||
48806290|NCT01960452|157132529|FG000|Overall Study|Withdrawal by Subject|2|||
49119712|NCT02964338|158277208|FG001|Overall Study|Non-compliant with e-diary|1|||
49119713|NCT02964338|158277209|FG002|Overall Study|Non-compliant with e-diary|0|||
49119714|NCT02964338|158277207|FG000|Overall Study|Did not meet criteria|1|||
49119715|NCT02964338|158277208|FG001|Overall Study|Did not meet criteria|0|||
49119716|NCT02964338|158277209|FG002|Overall Study|Did not meet criteria|0|||
48916254|NCT01056510|157528496|FG000|Overall Study|Lost to Follow-up|5|||
48916255|NCT01056510|157528497|FG001|Overall Study|Lost to Follow-up|6|||
49119717|NCT01214668|158277218|FG000|Overall Study|Adverse Event|0|||
48916256|NCT01056510|157528496|FG000|Overall Study|Other|10|||
48916257|NCT01056510|157528497|FG001|Overall Study|Other|12|||
48916258|NCT01056510|157528496|FG000|Overall Study|Missing|0|||
48916259|NCT01056510|157528497|FG001|Overall Study|Missing|1|||
49119718|NCT01214668|158277219|FG001|Overall Study|Adverse Event|1|||
49119719|NCT01214668|158277220|FG002|Overall Study|Adverse Event|0|||
49119720|NCT01214668|158277221|FG003|Overall Study|Adverse Event|2|||
49119721|NCT01214668|158277222|FG004|Overall Study|Adverse Event|1|||
49119722|NCT01214668|158277223|FG005|Overall Study|Adverse Event|1|||
49119723|NCT01214668|158277218|FG000|Overall Study|Death|0|||
49119724|NCT01214668|158277219|FG001|Overall Study|Death|0|||
49119725|NCT01214668|158277220|FG002|Overall Study|Death|1|||
49119726|NCT01214668|158277221|FG003|Overall Study|Death|0|||
49119727|NCT01214668|158277222|FG004|Overall Study|Death|0|||
49119728|NCT01214668|158277223|FG005|Overall Study|Death|0|||
49119729|NCT01214668|158277218|FG000|Overall Study|Progressive Disease|4|||
48806291|NCT01960452|157132530|FG001|Overall Study|Withdrawal by Subject|1|||
48806292|NCT01960452|157132529|FG000|Overall Study|Sleep apnea in Night 1|1|||
48806293|NCT01960452|157132530|FG001|Overall Study|Sleep apnea in Night 1|0|||
48806294|NCT01960452|157132529|FG000|Overall Study|Poor Sleep in Night 1|0|||
48806295|NCT01960452|157132530|FG001|Overall Study|Poor Sleep in Night 1|2|||
48806296|NCT01960452|157132529|FG000|Overall Study|No Sex/Age Match Night 1|1|||
48806297|NCT01960452|157132530|FG001|Overall Study|No Sex/Age Match Night 1|0|||
48806298|NCT01960452|157132529|FG000|Overall Study|No Sex/Age Match Night 2|0|||
48806299|NCT01960452|157132530|FG001|Overall Study|No Sex/Age Match Night 2|2|||
48806300|NCT01960452|157132529|FG000|Overall Study|Technical Difficulties Night 2|2|||
48806301|NCT01960452|157132530|FG001|Overall Study|Technical Difficulties Night 2|0|||
48806302|NCT03565068|157132533|FG000|Overall Study|Protocol Violation|0|||
48806303|NCT03565068|157132534|FG001|Overall Study|Protocol Violation|0|||
48806304|NCT03565068|157132535|FG002|Overall Study|Protocol Violation|0|||
48806305|NCT03565068|157132536|FG003|Overall Study|Protocol Violation|0|||
48806306|NCT03565068|157132537|FG004|Overall Study|Protocol Violation|1|||
48806307|NCT03565068|157132538|FG005|Overall Study|Protocol Violation|0|||
48806308|NCT03565068|157132539|FG006|Overall Study|Protocol Violation|0|||
48806309|NCT03565068|157132540|FG007|Overall Study|Protocol Violation|1|||
48806310|NCT03565068|157132541|FG008|Overall Study|Protocol Violation|0|||
48806311|NCT03565068|157132533|FG000|Overall Study|Sponsor decision|0|||
48806312|NCT03565068|157132534|FG001|Overall Study|Sponsor decision|0|||
48806313|NCT03565068|157132535|FG002|Overall Study|Sponsor decision|0|||
48806314|NCT03565068|157132536|FG003|Overall Study|Sponsor decision|0|||
48806315|NCT03565068|157132537|FG004|Overall Study|Sponsor decision|1|||
48806316|NCT03565068|157132538|FG005|Overall Study|Sponsor decision|1|||
48806317|NCT03565068|157132539|FG006|Overall Study|Sponsor decision|0|||
48806318|NCT03565068|157132540|FG007|Overall Study|Sponsor decision|0|||
48806319|NCT03565068|157132541|FG008|Overall Study|Sponsor decision|0|||
48806320|NCT03565068|157132533|FG000|Overall Study|Withdrawal by Subject|0|||
48806321|NCT03565068|157132534|FG001|Overall Study|Withdrawal by Subject|0|||
48806322|NCT03565068|157132535|FG002|Overall Study|Withdrawal by Subject|1|||
48806323|NCT03565068|157132536|FG003|Overall Study|Withdrawal by Subject|0|||
49119730|NCT01214668|158277219|FG001|Overall Study|Progressive Disease|2|||
49119731|NCT01214668|158277220|FG002|Overall Study|Progressive Disease|5|||
49119732|NCT01214668|158277221|FG003|Overall Study|Progressive Disease|4|||
49119733|NCT01214668|158277222|FG004|Overall Study|Progressive Disease|4|||
49119734|NCT01214668|158277223|FG005|Overall Study|Progressive Disease|5|||
49119735|NCT01214668|158277218|FG000|Overall Study|Withdrawal by Subject|0|||
49119736|NCT01214668|158277219|FG001|Overall Study|Withdrawal by Subject|0|||
49119737|NCT01214668|158277220|FG002|Overall Study|Withdrawal by Subject|0|||
49119738|NCT01214668|158277221|FG003|Overall Study|Withdrawal by Subject|0|||
49119739|NCT01214668|158277222|FG004|Overall Study|Withdrawal by Subject|1|||
49119740|NCT01214668|158277223|FG005|Overall Study|Withdrawal by Subject|0|||
48806324|NCT03565068|157132537|FG004|Overall Study|Withdrawal by Subject|2|||
48806325|NCT03565068|157132538|FG005|Overall Study|Withdrawal by Subject|0|||
48806326|NCT03565068|157132539|FG006|Overall Study|Withdrawal by Subject|1|||
48806327|NCT03565068|157132540|FG007|Overall Study|Withdrawal by Subject|5|||
48806328|NCT03565068|157132541|FG008|Overall Study|Withdrawal by Subject|1|||
48806329|NCT03565068|157132533|FG000|Overall Study|Physician Decision|0|||
48806330|NCT03565068|157132534|FG001|Overall Study|Physician Decision|0|||
49119741|NCT01964989|158277224|FG000|Overall Study|Protocol Violation|3|||
49119742|NCT01964989|158277225|FG001|Overall Study|Protocol Violation|4|||
48806331|NCT03565068|157132535|FG002|Overall Study|Physician Decision|0|||
48806332|NCT03565068|157132536|FG003|Overall Study|Physician Decision|0|||
49119743|NCT01964989|158277224|FG000|Overall Study|Administrative Reason|103|||
49119744|NCT01964989|158277225|FG001|Overall Study|Administrative Reason|95|||
49119745|NCT01964989|158277224|FG000|Overall Study|Adverse Event|0|||
49119746|NCT01964989|158277225|FG001|Overall Study|Adverse Event|1|||
49119747|NCT01964989|158277224|FG000|Overall Study|Death|1|||
48806333|NCT03565068|157132537|FG004|Overall Study|Physician Decision|0|||
48806334|NCT03565068|157132538|FG005|Overall Study|Physician Decision|0|||
48806335|NCT03565068|157132539|FG006|Overall Study|Physician Decision|0|||
48806336|NCT03565068|157132540|FG007|Overall Study|Physician Decision|1|||
48806337|NCT03565068|157132541|FG008|Overall Study|Physician Decision|0|||
48806338|NCT03565068|157132533|FG000|Overall Study|Lost to Follow-up|0|||
48806339|NCT03565068|157132534|FG001|Overall Study|Lost to Follow-up|0|||
49119748|NCT01964989|158277225|FG001|Overall Study|Death|3|||
49119749|NCT01964989|158277224|FG000|Overall Study|Withdrawal by Subject|156|||
49119750|NCT01964989|158277225|FG001|Overall Study|Withdrawal by Subject|160|||
49119751|NCT01964989|158277224|FG000|Overall Study|Lost to Follow-up|254|||
49119752|NCT01964989|158277225|FG001|Overall Study|Lost to Follow-up|232|||
49119753|NCT01964989|158277224|FG000|Overall Study|Other|267|||
49119754|NCT01964989|158277225|FG001|Overall Study|Other|252|||
48709735|NCT00473382|156786567|FG000|Open-label Extension Through Month 60|Death|1|||
48709736|NCT00473382|156786568|FG001|Open-label Extension Through Month 60|Death|7|||
48709737|NCT00473382|156786569|FG002|Open-label Extension Through Month 60|Death|4|||
48709738|NCT00473382|156786567|FG000|Open-label Extension Through Month 60|Lost to Follow-up|1|||
48806340|NCT03565068|157132535|FG002|Overall Study|Lost to Follow-up|0|||
48806341|NCT03565068|157132536|FG003|Overall Study|Lost to Follow-up|0|||
48806342|NCT03565068|157132537|FG004|Overall Study|Lost to Follow-up|0|||
48806343|NCT03565068|157132538|FG005|Overall Study|Lost to Follow-up|0|||
48806344|NCT03565068|157132539|FG006|Overall Study|Lost to Follow-up|0|||
48806345|NCT03565068|157132540|FG007|Overall Study|Lost to Follow-up|1|||
48806346|NCT03565068|157132541|FG008|Overall Study|Lost to Follow-up|0|||
48806347|NCT01893827|157132550|FG000|Overall Study|Lost to Follow-up|19|||
48806348|NCT01893827|157132551|FG001|Overall Study|Lost to Follow-up|26|||
49119755|NCT02061813|158277226|FG000|Overall Study|Withdrawal by Subject|1|||
48806349|NCT02217280|157132554|FG000|Overall Study|Withdrawal by Subject|2|||
48806350|NCT02217280|157132554|FG000|Overall Study|Post-consent sceen fail|2|||
48806351|NCT02293395|157133599|FG000|Overall Study|Lost to Follow-up|1|||
48806352|NCT02293395|157133600|FG001|Overall Study|Lost to Follow-up|0|||
48806353|NCT02293395|157133599|FG000|Overall Study|Withdrawal by Subject|8|||
48806354|NCT02293395|157133600|FG001|Overall Study|Withdrawal by Subject|7|||
48806355|NCT00755222|157133601|FG000|Overall Study|Withdrawal by Subject|4|||
48806356|NCT00755222|157133602|FG001|Overall Study|Withdrawal by Subject|2|||
48806357|NCT00755222|157133601|FG000|Overall Study|Adverse Event|2|||
48806358|NCT00755222|157133602|FG001|Overall Study|Adverse Event|0|||
48806359|NCT00755222|157133601|FG000|Overall Study|Protocol Violation|2|||
48806360|NCT00755222|157133602|FG001|Overall Study|Protocol Violation|0|||
48806361|NCT01802437|157133603|FG000|Overall Study|Lost to Follow-up|1|||
48806362|NCT01802437|157133604|FG001|Overall Study|Lost to Follow-up|0|||
48806363|NCT01802437|157133603|FG000|Overall Study|Withdrawal by Subject|3|||
48806364|NCT01802437|157133604|FG001|Overall Study|Withdrawal by Subject|4|||
48806365|NCT04242446|157133605|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
48806366|NCT04242446|157133606|FG001|Initial Treatment Period: Week 0-16|Adverse Event|5|||
48806367|NCT04242446|157133607|FG002|Initial Treatment Period: Week 0-16|Adverse Event|7|||
48806368|NCT04242446|157133608|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
48806369|NCT04242446|157133609|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
48806370|NCT04242446|157133610|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
48806371|NCT04242446|157133611|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
48806372|NCT04242446|157133605|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
48806373|NCT04242446|157133606|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
48806374|NCT04242446|157133607|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
48806375|NCT04242446|157133608|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
48806376|NCT04242446|157133609|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
49119756|NCT02061813|158277226|FG000|Overall Study|Protocol Violation|2|||
48709739|NCT00473382|156786568|FG001|Open-label Extension Through Month 60|Lost to Follow-up|3|||
48709740|NCT00473382|156786569|FG002|Open-label Extension Through Month 60|Lost to Follow-up|1|||
48709741|NCT00473382|156786567|FG000|Open-label Extension Through Month 60|Subject's Decision|7|||
48709742|NCT00473382|156786568|FG001|Open-label Extension Through Month 60|Subject's Decision|1|||
48709743|NCT00473382|156786569|FG002|Open-label Extension Through Month 60|Subject's Decision|6|||
48709744|NCT00473382|156786567|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75|||
48709745|NCT00473382|156786568|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70|||
48709746|NCT00473382|156786569|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69|||
48709747|NCT00473382|156786567|FG000|Open-label Extension Through Month 60|Subject Required Other Intervention|2|||
48709748|NCT00473382|156786568|FG001|Open-label Extension Through Month 60|Subject Required Other Intervention|1|||
48709749|NCT00473382|156786569|FG002|Open-label Extension Through Month 60|Subject Required Other Intervention|0|||
48709750|NCT01134055|156786570|FG000|Overall Study|Adverse Event|5|||
48709751|NCT01134055|156786571|FG001|Overall Study|Adverse Event|2|||
48709752|NCT01134055|156786572|FG002|Overall Study|Adverse Event|2|||
48709753|NCT01134055|156786573|FG003|Overall Study|Adverse Event|2|||
48709754|NCT01134055|156786574|FG004|Overall Study|Adverse Event|5|||
48709755|NCT01134055|156786575|FG005|Overall Study|Adverse Event|7|||
48709756|NCT01134055|156786576|FG006|Overall Study|Adverse Event|2|||
48806377|NCT04242446|157133610|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
48806378|NCT04242446|157133611|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
48806379|NCT04242446|157133605|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
49119757|NCT02299388|158277232|FG000|Overall Study|Withdrawal by Subject|0|||
48806380|NCT04242446|157133606|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
48916260|NCT00589420|157528500|FG000|Overall Study|screen failure|1|||
48916261|NCT00841568|157528501|FG000|Overall Study|Adverse Event|1|||
48916262|NCT00841568|157528501|FG000|Overall Study|Death|1|||
48916263|NCT00841568|157528501|FG000|Overall Study|Withdrawal by Subject|2|||
48916264|NCT00841568|157528501|FG000|Overall Study|Creatinine over the withdrawal criteria|1|||
48916265|NCT00545298|157528504|FG000|Overall Study|Issues with Standard of Care|2|||
48916266|NCT00545298|157528505|FG001|Overall Study|Issues with Standard of Care|0|||
48916267|NCT00545298|157528506|FG002|Overall Study|Issues with Standard of Care|1|||
48916268|NCT04995055|157528507|FG000|Period 1|COVID-19 Related|1|||
48916269|NCT04995055|157528508|FG001|Period 1|COVID-19 Related|0|||
48916270|NCT04995055|157528507|FG000|Period 1|Withdrawal by Subject|0|||
48806381|NCT04242446|157133607|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|2|||
48806382|NCT04242446|157133608|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
48806383|NCT04242446|157133609|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
48916271|NCT04995055|157528508|FG001|Period 1|Withdrawal by Subject|1|||
48916272|NCT04995055|157528507|FG000|Period 1|Subject discontinued due to timing|4|||
48916273|NCT04995055|157528508|FG001|Period 1|Subject discontinued due to timing|4|||
48916274|NCT01422915|157528515|FG000|Overall Study|Adverse Event|1|||
48806384|NCT04242446|157133610|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
48806385|NCT04242446|157133611|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
48806386|NCT04242446|157133605|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|4|||
48806387|NCT04242446|157133606|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|6|||
48806388|NCT04242446|157133607|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|14|||
48806389|NCT04242446|157133608|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
48916275|NCT01265797|157528516|FG000|Run-in Month|Withdrawal by Subject|0|||
48916276|NCT01265797|157528517|FG001|Run-in Month|Withdrawal by Subject|4|||
48916277|NCT01265797|157528516|FG000|Run-in Month|1st seizure during run-in month|0|||
48916278|NCT01265797|157528517|FG001|Run-in Month|1st seizure during run-in month|1|||
48916279|NCT01265797|157528516|FG000|Blinded Month|Lack of Efficacy|5|||
48916280|NCT01265797|157528517|FG001|Blinded Month|Lack of Efficacy|0|||
49119758|NCT02299388|158277233|FG001|Overall Study|Withdrawal by Subject|1|||
49119759|NCT00941304|158277236|FG000|Overall Study|Lost to Follow-up|1|||
49119760|NCT00941304|158277237|FG001|Overall Study|Lost to Follow-up|0|||
49119761|NCT00941304|158277238|FG002|Overall Study|Lost to Follow-up|0|||
49119762|NCT00941304|158277239|FG003|Overall Study|Lost to Follow-up|0|||
49119763|NCT00941304|158277240|FG004|Overall Study|Lost to Follow-up|0|||
49119764|NCT02256839|158277241|FG000|Overall Study|Did not meet Eligibility Criteria|2|||
49119765|NCT02256839|158277242|FG001|Overall Study|Did not meet Eligibility Criteria|3|||
49119766|NCT01843803|158277243|FG000|Overall Study|not a Veteran, did not see provider|1|||
49119767|NCT01843803|158277244|FG001|Overall Study|not a Veteran, did not see provider|3|||
49119768|NCT04633226|158277253|FG000|Overall Study|Withdrawal by parent/guardian|4|||
49119769|NCT04633226|158277253|FG000|Overall Study|Randomized by mistake without study treatment|1|||
49119770|NCT02155699|158277255|FG000|Overall Study|Withdrawal by Subject|0|||
49119771|NCT02155699|158277256|FG001|Overall Study|Withdrawal by Subject|3|||
49119772|NCT02155699|158277257|FG002|Overall Study|Withdrawal by Subject|6|||
49119773|NCT02155699|158277258|FG003|Overall Study|Withdrawal by Subject|1|||
49119774|NCT02155699|158277255|FG000|Overall Study|Lost to Follow-up|0|||
49119775|NCT02155699|158277256|FG001|Overall Study|Lost to Follow-up|0|||
49119776|NCT02155699|158277257|FG002|Overall Study|Lost to Follow-up|0|||
49119777|NCT02155699|158277258|FG003|Overall Study|Lost to Follow-up|3|||
49119778|NCT02155699|158277255|FG000|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
48916281|NCT01265797|157528516|FG000|Blinded Month|Lost to Follow-up|1|||
48916282|NCT01265797|157528517|FG001|Blinded Month|Lost to Follow-up|0|||
48916283|NCT01265797|157528516|FG000|Blinded Month|Protocol Violation|2|||
48916284|NCT01265797|157528517|FG001|Blinded Month|Protocol Violation|1|||
48916285|NCT01265797|157528516|FG000|Blinded Month|Adverse Event|2|||
48806390|NCT04242446|157133609|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
48806391|NCT04242446|157133610|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
49119779|NCT02155699|158277256|FG001|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
49119780|NCT02155699|158277257|FG002|Overall Study|Emergence of Psychosis or Substance disorder during protocol|2|||
49119781|NCT02155699|158277258|FG003|Overall Study|Emergence of Psychosis or Substance disorder during protocol|1|||
49119782|NCT02227784|158277262|FG000|Double-Blind Phase|Adverse Event|3|||
49119783|NCT02227784|158277263|FG001|Double-Blind Phase|Adverse Event|2|||
49119784|NCT02227784|158277264|FG002|Double-Blind Phase|Adverse Event|1|||
49119785|NCT02227784|158277265|FG003|Double-Blind Phase|Adverse Event|3|||
49119786|NCT02227784|158277266|FG004|Double-Blind Phase|Adverse Event|0|||
49119787|NCT02227784|158277262|FG000|Double-Blind Phase|Physician Decision|1|||
49119788|NCT02227784|158277263|FG001|Double-Blind Phase|Physician Decision|0|||
49119789|NCT02227784|158277264|FG002|Double-Blind Phase|Physician Decision|0|||
49119790|NCT02227784|158277265|FG003|Double-Blind Phase|Physician Decision|1|||
49119791|NCT02227784|158277266|FG004|Double-Blind Phase|Physician Decision|0|||
49119792|NCT02227784|158277262|FG000|Double-Blind Phase|Protocol Violation|0|||
49119793|NCT02227784|158277263|FG001|Double-Blind Phase|Protocol Violation|0|||
49119794|NCT02227784|158277264|FG002|Double-Blind Phase|Protocol Violation|1|||
49119795|NCT02227784|158277265|FG003|Double-Blind Phase|Protocol Violation|1|||
49119796|NCT02227784|158277266|FG004|Double-Blind Phase|Protocol Violation|0|||
49119797|NCT02227784|158277262|FG000|Double-Blind Phase|Sponsor Decision|34|||
49119798|NCT02227784|158277263|FG001|Double-Blind Phase|Sponsor Decision|15|||
49119799|NCT02227784|158277264|FG002|Double-Blind Phase|Sponsor Decision|14|||
49119800|NCT02227784|158277265|FG003|Double-Blind Phase|Sponsor Decision|32|||
49119801|NCT02227784|158277266|FG004|Double-Blind Phase|Sponsor Decision|0|||
49119802|NCT02227784|158277262|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
49119803|NCT02227784|158277263|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
49119804|NCT02227784|158277264|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
49119805|NCT02227784|158277265|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
49119806|NCT02227784|158277266|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
49119807|NCT02227784|158277262|FG000|Open-Label Extension Phase (OLE)|Adverse Event|0|||
49119808|NCT02227784|158277263|FG001|Open-Label Extension Phase (OLE)|Adverse Event|0|||
49119809|NCT02227784|158277264|FG002|Open-Label Extension Phase (OLE)|Adverse Event|0|||
49119810|NCT02227784|158277265|FG003|Open-Label Extension Phase (OLE)|Adverse Event|0|||
48806392|NCT04242446|157133611|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
48806393|NCT04242446|157133605|FG000|Initial Treatment Period: Week 0-16|Country Relocation|1|||
48806394|NCT04242446|157133606|FG001|Initial Treatment Period: Week 0-16|Country Relocation|0|||
48806395|NCT04242446|157133607|FG002|Initial Treatment Period: Week 0-16|Country Relocation|0|||
48806396|NCT04242446|157133608|FG003|Initial Treatment Period: Week 0-16|Country Relocation|0|||
48806397|NCT04242446|157133609|FG004|Initial Treatment Period: Week 0-16|Country Relocation|0|||
48806398|NCT04242446|157133610|FG005|Initial Treatment Period: Week 0-16|Country Relocation|0|||
48806399|NCT04242446|157133611|FG006|Initial Treatment Period: Week 0-16|Country Relocation|0|||
48806400|NCT04242446|157133605|FG000|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
49119811|NCT02227784|158277266|FG004|Open-Label Extension Phase (OLE)|Adverse Event|1|||
48916286|NCT01265797|157528517|FG001|Blinded Month|Adverse Event|0|||
48709757|NCT01134055|156786570|FG000|Overall Study|Lost to Follow-up|0|||
48709758|NCT01134055|156786571|FG001|Overall Study|Lost to Follow-up|1|||
48916287|NCT01265797|157528516|FG000|Blinded Month|Diary data incomplete|0|||
48709759|NCT01134055|156786572|FG002|Overall Study|Lost to Follow-up|0|||
48709760|NCT01134055|156786573|FG003|Overall Study|Lost to Follow-up|1|||
48709761|NCT01134055|156786574|FG004|Overall Study|Lost to Follow-up|0|||
48709762|NCT01134055|156786575|FG005|Overall Study|Lost to Follow-up|0|||
48709763|NCT01134055|156786576|FG006|Overall Study|Lost to Follow-up|0|||
48709764|NCT01134055|156786570|FG000|Overall Study|Withdrawal by Subject|3|||
48709765|NCT01134055|156786571|FG001|Overall Study|Withdrawal by Subject|3|||
48709766|NCT01134055|156786572|FG002|Overall Study|Withdrawal by Subject|1|||
48709767|NCT01134055|156786573|FG003|Overall Study|Withdrawal by Subject|2|||
48709768|NCT01134055|156786574|FG004|Overall Study|Withdrawal by Subject|0|||
48709769|NCT01134055|156786575|FG005|Overall Study|Withdrawal by Subject|0|||
48709770|NCT01134055|156786576|FG006|Overall Study|Withdrawal by Subject|8|||
48709771|NCT01134055|156786570|FG000|Overall Study|Protocol Violation|0|||
48709772|NCT01134055|156786571|FG001|Overall Study|Protocol Violation|0|||
48709773|NCT01134055|156786572|FG002|Overall Study|Protocol Violation|0|||
48709774|NCT01134055|156786573|FG003|Overall Study|Protocol Violation|1|||
48709775|NCT01134055|156786574|FG004|Overall Study|Protocol Violation|1|||
48709776|NCT01134055|156786575|FG005|Overall Study|Protocol Violation|0|||
48709777|NCT01134055|156786576|FG006|Overall Study|Protocol Violation|0|||
48709778|NCT01134055|156786570|FG000|Overall Study|Physician Decision|0|||
48709779|NCT01134055|156786571|FG001|Overall Study|Physician Decision|0|||
48709780|NCT01134055|156786572|FG002|Overall Study|Physician Decision|0|||
48709781|NCT01134055|156786573|FG003|Overall Study|Physician Decision|0|||
48709782|NCT01134055|156786574|FG004|Overall Study|Physician Decision|0|||
48709783|NCT01134055|156786575|FG005|Overall Study|Physician Decision|0|||
48709784|NCT01134055|156786576|FG006|Overall Study|Physician Decision|1|||
48709785|NCT01075685|156786577|FG000|Overall Study|Protocol Violation|9|||
48709786|NCT01075685|156786578|FG001|Overall Study|Protocol Violation|1|||
48709787|NCT01075685|156786577|FG000|Overall Study|Withdrawal by Subject|20|||
48709788|NCT01075685|156786578|FG001|Overall Study|Withdrawal by Subject|5|||
48709789|NCT01075685|156786577|FG000|Overall Study|Lost to Follow-up|563|||
48709790|NCT01075685|156786578|FG001|Overall Study|Lost to Follow-up|220|||
48916288|NCT01265797|157528517|FG001|Blinded Month|Diary data incomplete|1|||
48916289|NCT01265797|157528516|FG000|Open Label Month|Lost to Follow-up|0|||
48916290|NCT01265797|157528517|FG001|Open Label Month|Lost to Follow-up|1|||
48916291|NCT00825162|157528521|FG000|Overall Study|Withdrawal by Subject|11|||
48916292|NCT00825162|157528522|FG001|Overall Study|Withdrawal by Subject|13|||
48916293|NCT00825162|157528523|FG002|Overall Study|Withdrawal by Subject|3|||
48916294|NCT00825162|157528521|FG000|Overall Study|Lost to Follow-up|9|||
48916295|NCT00825162|157528522|FG001|Overall Study|Lost to Follow-up|6|||
48916296|NCT00825162|157528523|FG002|Overall Study|Lost to Follow-up|3|||
48916297|NCT00825162|157528521|FG000|Overall Study|Physician Decision|2|||
48916298|NCT00825162|157528522|FG001|Overall Study|Physician Decision|0|||
48916299|NCT00825162|157528523|FG002|Overall Study|Physician Decision|0|||
48916300|NCT00825162|157528521|FG000|Overall Study|Move away from the study area|1|||
48916301|NCT00825162|157528522|FG001|Overall Study|Move away from the study area|0|||
48916302|NCT00825162|157528523|FG002|Overall Study|Move away from the study area|0|||
48916303|NCT00825162|157528521|FG000|Overall Study|Unable to attend the study visit|5|||
48916304|NCT00825162|157528522|FG001|Overall Study|Unable to attend the study visit|2|||
48916305|NCT00825162|157528523|FG002|Overall Study|Unable to attend the study visit|0|||
48916306|NCT00964743|157528527|FG000|Overall Study|Neither patient completed 8 weeks of tre|2|||
48916307|NCT00939783|157528529|FG000|Overall Study|Death|6|||
48916308|NCT00939783|157528529|FG000|Overall Study|Adverse Event|39|||
48916309|NCT00939783|157528529|FG000|Overall Study|Study Terminated by Sponsor|498|||
48916310|NCT00939783|157528529|FG000|Overall Study|Withdrawal by Subject|78|||
48916311|NCT00939783|157528529|FG000|Overall Study|Other|16|||
48916312|NCT00939783|157528529|FG000|Overall Study|Lost to Follow-up|8|||
48916313|NCT00939783|157528529|FG000|Overall Study|Protocol Violation|3|||
48916314|NCT00939783|157528529|FG000|Overall Study|Enrolled but not treated|1|||
48916315|NCT02255409|157528530|FG000|Overall Study|Administrative Reason|3|||
48916316|NCT02255409|157528531|FG001|Overall Study|Administrative Reason|7|||
48916317|NCT02255409|157528530|FG000|Overall Study|Withdrawal by Subject|1|||
48916318|NCT02255409|157528531|FG001|Overall Study|Withdrawal by Subject|5|||
48916319|NCT02255409|157528530|FG000|Overall Study|Lost to Follow-up|10|||
49010705|NCT03705169|157875685|FG002|Overall Study|Lost to Follow-up|0|||
49010706|NCT03705169|157875686|FG003|Overall Study|Lost to Follow-up|2|||
49010707|NCT03705169|157875687|FG004|Overall Study|Lost to Follow-up|0|||
49010708|NCT03705169|157875688|FG005|Overall Study|Lost to Follow-up|2|||
49010709|NCT03705169|157875689|FG006|Overall Study|Lost to Follow-up|1|||
49010710|NCT03705169|157875690|FG007|Overall Study|Lost to Follow-up|0|||
49010711|NCT03705169|157875691|FG008|Overall Study|Lost to Follow-up|0|||
49010712|NCT03705169|157875692|FG009|Overall Study|Lost to Follow-up|1|||
49010713|NCT03705169|157875683|FG000|Overall Study|Adverse Event|0|||
49010714|NCT03705169|157875684|FG001|Overall Study|Adverse Event|0|||
48916320|NCT02255409|157528531|FG001|Overall Study|Lost to Follow-up|19|||
48916321|NCT04247061|157528533|FG000|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6|||
48916322|NCT04247061|157528533|FG000|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2|||
48916323|NCT04247061|157528533|FG000|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1|||
48806401|NCT04242446|157133606|FG001|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
48806402|NCT04242446|157133607|FG002|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|1|||
48806403|NCT04242446|157133608|FG003|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
48806404|NCT04242446|157133609|FG004|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
48916324|NCT04688775|157528534|FG000|Placebo-controlled Period|Randomized, not treated|1|||
48916325|NCT04688775|157528535|FG001|Placebo-controlled Period|Randomized, not treated|1|||
48916326|NCT04688775|157528536|FG002|Placebo-controlled Period|Randomized, not treated|0|||
48916327|NCT04688775|157528537|FG003|Placebo-controlled Period|Randomized, not treated|0|||
48916328|NCT04688775|157528534|FG000|Placebo-controlled Period|Adverse Event|2|||
48916329|NCT04688775|157528535|FG001|Placebo-controlled Period|Adverse Event|0|||
48806405|NCT04242446|157133610|FG005|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
48806406|NCT04242446|157133611|FG006|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
48806407|NCT04242446|157133605|FG000|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
48916330|NCT04688775|157528536|FG002|Placebo-controlled Period|Adverse Event|0|||
48916331|NCT04688775|157528537|FG003|Placebo-controlled Period|Adverse Event|0|||
48916332|NCT04688775|157528534|FG000|Placebo-controlled Period|Lack of Efficacy|1|||
48916333|NCT04688775|157528535|FG001|Placebo-controlled Period|Lack of Efficacy|2|||
48916334|NCT04688775|157528536|FG002|Placebo-controlled Period|Lack of Efficacy|0|||
48916335|NCT04688775|157528537|FG003|Placebo-controlled Period|Lack of Efficacy|0|||
48916336|NCT04688775|157528534|FG000|Placebo-controlled Period|Protocol Violation|0|||
48916337|NCT04688775|157528535|FG001|Placebo-controlled Period|Protocol Violation|1|||
48916338|NCT04688775|157528536|FG002|Placebo-controlled Period|Protocol Violation|0|||
48916339|NCT04688775|157528537|FG003|Placebo-controlled Period|Protocol Violation|0|||
48916340|NCT04688775|157528534|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
48916341|NCT04688775|157528535|FG001|Placebo-controlled Period|Withdrawal by Subject|6|||
48916342|NCT04688775|157528536|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
48916343|NCT04688775|157528537|FG003|Placebo-controlled Period|Withdrawal by Subject|0|||
48916344|NCT04688775|157528534|FG000|Placebo-controlled Period|Other reasons|0|||
48916345|NCT04688775|157528535|FG001|Placebo-controlled Period|Other reasons|1|||
48916346|NCT04688775|157528536|FG002|Placebo-controlled Period|Other reasons|0|||
48916347|NCT04688775|157528537|FG003|Placebo-controlled Period|Other reasons|0|||
48916348|NCT04688775|157528534|FG000|Delayed Start Period|Adverse Event|0|||
48916349|NCT04688775|157528535|FG001|Delayed Start Period|Adverse Event|0|||
48916350|NCT04688775|157528536|FG002|Delayed Start Period|Adverse Event|1|||
48916351|NCT04688775|157528537|FG003|Delayed Start Period|Adverse Event|0|||
48916352|NCT04688775|157528534|FG000|Delayed Start Period|Lack of Efficacy|0|||
48916353|NCT04688775|157528535|FG001|Delayed Start Period|Lack of Efficacy|0|||
48916354|NCT04688775|157528536|FG002|Delayed Start Period|Lack of Efficacy|0|||
48916355|NCT04688775|157528537|FG003|Delayed Start Period|Lack of Efficacy|3|||
48916356|NCT04688775|157528534|FG000|Delayed Start Period|Withdrawal by Subject|0|||
48916357|NCT04688775|157528535|FG001|Delayed Start Period|Withdrawal by Subject|0|||
48916358|NCT04688775|157528536|FG002|Delayed Start Period|Withdrawal by Subject|2|||
48916359|NCT04688775|157528537|FG003|Delayed Start Period|Withdrawal by Subject|4|||
48916360|NCT04688775|157528534|FG000|Delayed Start Period|Lost to Follow-up|0|||
48806408|NCT04242446|157133606|FG001|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
48916361|NCT04688775|157528535|FG001|Delayed Start Period|Lost to Follow-up|0|||
48916362|NCT04688775|157528536|FG002|Delayed Start Period|Lost to Follow-up|2|||
48916363|NCT04688775|157528537|FG003|Delayed Start Period|Lost to Follow-up|1|||
48806409|NCT04242446|157133607|FG002|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|1|||
48916364|NCT04688775|157528534|FG000|Delayed Start Period|other reasons|0|||
48916365|NCT04688775|157528535|FG001|Delayed Start Period|other reasons|0|||
48916366|NCT04688775|157528536|FG002|Delayed Start Period|other reasons|1|||
48916367|NCT04688775|157528537|FG003|Delayed Start Period|other reasons|0|||
48916368|NCT02354222|157528538|FG000|Overall Study|Adverse Event|0|||
48916369|NCT02354222|157528539|FG001|Overall Study|Adverse Event|3|||
48916370|NCT02354222|157528538|FG000|Overall Study|Physician Decision|1|||
48916371|NCT02354222|157528539|FG001|Overall Study|Physician Decision|1|||
48916372|NCT02354222|157528538|FG000|Overall Study|Pregnancy|1|||
48916373|NCT02354222|157528539|FG001|Overall Study|Pregnancy|0|||
48916374|NCT02354222|157528538|FG000|Overall Study|Withdrawal by Subject|2|||
48916375|NCT02354222|157528539|FG001|Overall Study|Withdrawal by Subject|3|||
48916376|NCT02354222|157528538|FG000|Overall Study|Conflict with the stopping criteria|0|||
48916377|NCT02354222|157528539|FG001|Overall Study|Conflict with the stopping criteria|4|||
48916378|NCT02943564|157528540|FG000|Overall Study|Miscellaneous Reasons|0|||
48916379|NCT02943564|157528541|FG001|Overall Study|Miscellaneous Reasons|0|||
48709791|NCT00934362|156786583|FG000|Overall Study|Adverse Event|1|||
48709792|NCT00934362|156786584|FG001|Overall Study|Adverse Event|0|||
48709793|NCT00202878|156786585|FG000|Overall Study|Death|964|||
48709794|NCT00202878|156786586|FG001|Overall Study|Death|968|||
48709795|NCT00202878|156786585|FG000|Overall Study|Only Vital Status Known|357|||
48709796|NCT00202878|156786586|FG001|Overall Study|Only Vital Status Known|356|||
48709797|NCT00202878|156786585|FG000|Overall Study|Lost to Follow-up|44|||
48709798|NCT00202878|156786586|FG001|Overall Study|Lost to Follow-up|49|||
48709799|NCT00202878|156786585|FG000|Overall Study|Site Closure|39|||
48709800|NCT00202878|156786586|FG001|Overall Study|Site Closure|36|||
48709801|NCT00202878|156786585|FG000|Overall Study|Withdrawal by Subject|795|||
48709802|NCT00202878|156786586|FG001|Overall Study|Withdrawal by Subject|808|||
48806410|NCT04242446|157133608|FG003|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
48806411|NCT04242446|157133609|FG004|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
48806412|NCT04242446|157133610|FG005|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
48709803|NCT01587014|156786587|FG000|Overall Study|Death|2|||
48709804|NCT03962504|156786590|FG000|Overall Study|Other|11|||
48709805|NCT03962504|156786591|FG001|Overall Study|Other|32|||
48709806|NCT02637037|156786594|FG000|Overall Study|Positive drug screen at admission|1|||
48709807|NCT02637037|156786595|FG001|Overall Study|Positive drug screen at admission|0|||
48709808|NCT02637037|156786594|FG000|Overall Study|Withdrawal by Subject|2|||
48709809|NCT02637037|156786595|FG001|Overall Study|Withdrawal by Subject|1|||
48806413|NCT04242446|157133611|FG006|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
48806414|NCT04242446|157133605|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
48806415|NCT04242446|157133606|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
48806416|NCT04242446|157133607|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|3|||
48806417|NCT04242446|157133608|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
48806418|NCT04242446|157133609|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
48806419|NCT04242446|157133610|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
48806420|NCT04242446|157133611|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
48806421|NCT04242446|157133605|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
48806422|NCT04242446|157133606|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
48806423|NCT04242446|157133607|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
48806424|NCT04242446|157133608|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|9|||
48806425|NCT04242446|157133609|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
48806426|NCT04242446|157133610|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|5|||
48806427|NCT04242446|157133611|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
48806428|NCT04242446|157133605|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
48806429|NCT04242446|157133606|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
48806430|NCT04242446|157133607|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
48806431|NCT04242446|157133608|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|1|||
48806432|NCT04242446|157133609|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|7|||
48806433|NCT04242446|157133610|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
48806434|NCT04242446|157133611|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
49010715|NCT03705169|157875685|FG002|Overall Study|Adverse Event|0|||
49010716|NCT03705169|157875686|FG003|Overall Study|Adverse Event|1|||
49010717|NCT03705169|157875687|FG004|Overall Study|Adverse Event|0|||
49010718|NCT03705169|157875688|FG005|Overall Study|Adverse Event|0|||
49010719|NCT03705169|157875689|FG006|Overall Study|Adverse Event|0|||
49010720|NCT03705169|157875690|FG007|Overall Study|Adverse Event|0|||
49010721|NCT03705169|157875691|FG008|Overall Study|Adverse Event|0|||
49010722|NCT03705169|157875692|FG009|Overall Study|Adverse Event|0|||
49010723|NCT03705169|157875683|FG000|Overall Study|Site Closure|0|||
49010724|NCT03705169|157875684|FG001|Overall Study|Site Closure|0|||
49010725|NCT03705169|157875685|FG002|Overall Study|Site Closure|0|||
49010726|NCT03705169|157875686|FG003|Overall Study|Site Closure|1|||
49010727|NCT03705169|157875687|FG004|Overall Study|Site Closure|0|||
49010728|NCT03705169|157875688|FG005|Overall Study|Site Closure|0|||
49010729|NCT03705169|157875689|FG006|Overall Study|Site Closure|0|||
49010730|NCT03705169|157875690|FG007|Overall Study|Site Closure|0|||
49010731|NCT03705169|157875691|FG008|Overall Study|Site Closure|0|||
49010732|NCT03705169|157875692|FG009|Overall Study|Site Closure|0|||
49010733|NCT03705169|157875683|FG000|Overall Study|Did not receive study treatment|0|||
49010734|NCT03705169|157875684|FG001|Overall Study|Did not receive study treatment|0|||
49010735|NCT03705169|157875685|FG002|Overall Study|Did not receive study treatment|0|||
49010736|NCT03705169|157875686|FG003|Overall Study|Did not receive study treatment|1|||
49010737|NCT03705169|157875687|FG004|Overall Study|Did not receive study treatment|0|||
49010738|NCT03705169|157875688|FG005|Overall Study|Did not receive study treatment|0|||
49010739|NCT03705169|157875689|FG006|Overall Study|Did not receive study treatment|0|||
49010740|NCT03705169|157875690|FG007|Overall Study|Did not receive study treatment|0|||
49010741|NCT03705169|157875691|FG008|Overall Study|Did not receive study treatment|0|||
49010742|NCT03705169|157875692|FG009|Overall Study|Did not receive study treatment|0|||
48806435|NCT04242446|157133605|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
48806436|NCT04242446|157133606|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
48806437|NCT04242446|157133607|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
48806438|NCT04242446|157133608|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
48806439|NCT04242446|157133609|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
48806440|NCT04242446|157133610|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
48806441|NCT04242446|157133611|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
48806442|NCT04242446|157133605|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
48806443|NCT04242446|157133606|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
48806444|NCT04242446|157133607|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
48806445|NCT04242446|157133608|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
48806446|NCT04242446|157133609|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|5|||
48806447|NCT04242446|157133610|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
48806448|NCT04242446|157133611|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
48806449|NCT04242446|157133605|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
48806450|NCT04242446|157133606|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
48806451|NCT04242446|157133607|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
48806452|NCT04242446|157133608|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|7|||
48806453|NCT04242446|157133609|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|12|||
49010743|NCT03705169|157875683|FG000|Overall Study|Concerns about study visit compliance|0|||
48806454|NCT04242446|157133610|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
48806455|NCT04242446|157133611|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|14|||
48806456|NCT04242446|157133605|FG000|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
48806457|NCT04242446|157133606|FG001|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
48806458|NCT04242446|157133607|FG002|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
48806459|NCT04242446|157133608|FG003|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|1|||
48806460|NCT04242446|157133609|FG004|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
48806461|NCT04242446|157133610|FG005|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
48806462|NCT04242446|157133611|FG006|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
48806463|NCT04242446|157133605|FG000|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
48806464|NCT04242446|157133606|FG001|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
48806465|NCT04242446|157133607|FG002|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
48806466|NCT04242446|157133608|FG003|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
48806467|NCT04242446|157133609|FG004|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|1|||
48806468|NCT04242446|157133610|FG005|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
48806469|NCT04242446|157133611|FG006|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
48806470|NCT04242446|157133605|FG000|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
48806471|NCT04242446|157133606|FG001|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
48806472|NCT04242446|157133607|FG002|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
48806473|NCT04242446|157133608|FG003|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
48806474|NCT04242446|157133609|FG004|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|1|||
48806475|NCT04242446|157133610|FG005|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
48856360|NCT00659373|157312828|FG000|Overall Study|Withdrawal by Subject|3|||
48856361|NCT00659373|157312829|FG001|Overall Study|Withdrawal by Subject|5|||
48856362|NCT00659373|157312828|FG000|Overall Study|Assessment Missed|2|||
48856363|NCT00659373|157312829|FG001|Overall Study|Assessment Missed|2|||
48856364|NCT02382640|157312832|FG000|Intervention Period 4 (3 Days)|Laboratory Abnormality|1|||
48856365|NCT02382640|157312833|FG001|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
48856366|NCT02382640|157312834|FG002|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
48709810|NCT02637037|156786594|FG000|Overall Study|Adverse Event|1|||
48709811|NCT02637037|156786595|FG001|Overall Study|Adverse Event|0|||
48709812|NCT04413617|156786596|FG000|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
48709813|NCT04413617|156786597|FG001|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
48709814|NCT04413617|156786598|FG002|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
48709815|NCT04413617|156786599|FG003|Overall Study|Refused to come for FU visit and was contacted by phone|1|||
48709816|NCT04413617|156786600|FG004|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
48856367|NCT02382640|157312835|FG003|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
48856368|NCT01052272|157312836|FG000|Overall Study|Death|0|||
48806476|NCT04242446|157133611|FG006|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
48806477|NCT04242446|157133605|FG000|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
48806478|NCT04242446|157133606|FG001|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
48806479|NCT04242446|157133607|FG002|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
48806480|NCT04242446|157133608|FG003|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
48806481|NCT04242446|157133609|FG004|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|1|||
48806482|NCT04242446|157133610|FG005|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
48806483|NCT04242446|157133611|FG006|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
48806484|NCT04242446|157133605|FG000|Maintenance Treatment Period: Week 16-48|Relocation|0|||
48806485|NCT04242446|157133606|FG001|Maintenance Treatment Period: Week 16-48|Relocation|0|||
48806486|NCT04242446|157133607|FG002|Maintenance Treatment Period: Week 16-48|Relocation|0|||
48806487|NCT04242446|157133608|FG003|Maintenance Treatment Period: Week 16-48|Relocation|0|||
48806488|NCT04242446|157133609|FG004|Maintenance Treatment Period: Week 16-48|Relocation|1|||
48806489|NCT04242446|157133610|FG005|Maintenance Treatment Period: Week 16-48|Relocation|0|||
48806490|NCT04242446|157133611|FG006|Maintenance Treatment Period: Week 16-48|Relocation|0|||
48806491|NCT04242446|157133605|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
48806492|NCT04242446|157133606|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
48806493|NCT04242446|157133607|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
48806494|NCT04242446|157133608|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
48806495|NCT04242446|157133609|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|1|||
48806496|NCT04242446|157133610|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
48806497|NCT04242446|157133611|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
48806498|NCT04242446|157133605|FG000|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
48806499|NCT04242446|157133606|FG001|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
48806500|NCT04242446|157133607|FG002|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
48806501|NCT04242446|157133608|FG003|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
48806502|NCT04242446|157133609|FG004|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
49119812|NCT02227784|158277262|FG000|Open-Label Extension Phase (OLE)|Death|0|||
49119813|NCT02227784|158277263|FG001|Open-Label Extension Phase (OLE)|Death|0|||
49119814|NCT02227784|158277264|FG002|Open-Label Extension Phase (OLE)|Death|0|||
49119815|NCT02227784|158277265|FG003|Open-Label Extension Phase (OLE)|Death|0|||
48806503|NCT04242446|157133610|FG005|Maintenance Treatment Period: Week 16-48|Patient Move Away|1|||
48806504|NCT04242446|157133611|FG006|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
48806505|NCT04242446|157133605|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
48806506|NCT04242446|157133606|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
48806507|NCT04242446|157133607|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
48806508|NCT04242446|157133608|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
48806509|NCT04242446|157133609|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
48806510|NCT04242446|157133610|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|1|||
48806511|NCT04242446|157133611|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
48806512|NCT04242446|157133605|FG000|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
48806513|NCT04242446|157133606|FG001|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
48806514|NCT04242446|157133607|FG002|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
48806515|NCT04242446|157133608|FG003|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
48806516|NCT04242446|157133609|FG004|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
48806517|NCT04242446|157133610|FG005|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
49119816|NCT02227784|158277266|FG004|Open-Label Extension Phase (OLE)|Death|1|||
49119817|NCT02227784|158277262|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
49119818|NCT02227784|158277263|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
48709817|NCT04413617|156786596|FG000|Overall Study|Protocol Violation|0|||
48709818|NCT04413617|156786597|FG001|Overall Study|Protocol Violation|1|||
48709819|NCT04413617|156786598|FG002|Overall Study|Protocol Violation|0|||
48709820|NCT04413617|156786599|FG003|Overall Study|Protocol Violation|0|||
48709821|NCT04413617|156786600|FG004|Overall Study|Protocol Violation|1|||
48709822|NCT04413617|156786596|FG000|Overall Study|Lack of Efficacy|2|||
48709823|NCT04413617|156786597|FG001|Overall Study|Lack of Efficacy|0|||
48709824|NCT04413617|156786598|FG002|Overall Study|Lack of Efficacy|2|||
48709825|NCT04413617|156786599|FG003|Overall Study|Lack of Efficacy|1|||
48709826|NCT04413617|156786600|FG004|Overall Study|Lack of Efficacy|0|||
48709827|NCT04413617|156786596|FG000|Overall Study|Withdrawal by Subject|3|||
48709828|NCT04413617|156786597|FG001|Overall Study|Withdrawal by Subject|4|||
48709829|NCT04413617|156786598|FG002|Overall Study|Withdrawal by Subject|2|||
48709830|NCT04413617|156786599|FG003|Overall Study|Withdrawal by Subject|5|||
48709831|NCT04413617|156786600|FG004|Overall Study|Withdrawal by Subject|3|||
48709832|NCT04413617|156786596|FG000|Overall Study|Death|1|||
48709833|NCT04413617|156786597|FG001|Overall Study|Death|0|||
48709834|NCT04413617|156786598|FG002|Overall Study|Death|0|||
48709835|NCT04413617|156786599|FG003|Overall Study|Death|0|||
48709836|NCT04413617|156786600|FG004|Overall Study|Death|0|||
48709837|NCT04413617|156786596|FG000|Overall Study|Adverse Event|1|||
48709838|NCT04413617|156786597|FG001|Overall Study|Adverse Event|0|||
48709839|NCT04413617|156786598|FG002|Overall Study|Adverse Event|0|||
48709840|NCT04413617|156786599|FG003|Overall Study|Adverse Event|1|||
48709841|NCT04413617|156786600|FG004|Overall Study|Adverse Event|1|||
48709842|NCT04413617|156786596|FG000|Overall Study|COVID-19|0|||
48709843|NCT04413617|156786597|FG001|Overall Study|COVID-19|1|||
48709844|NCT04413617|156786598|FG002|Overall Study|COVID-19|0|||
48709845|NCT04413617|156786599|FG003|Overall Study|COVID-19|0|||
48709846|NCT04413617|156786600|FG004|Overall Study|COVID-19|0|||
48709847|NCT02533453|156786605|FG000|Overall Study|Adverse Event|6|||
48709848|NCT02533453|156786605|FG000|Overall Study|Protocol Violation|1|||
48806518|NCT04242446|157133611|FG006|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|1|||
48806519|NCT04242446|157133605|FG000|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
48806520|NCT04242446|157133606|FG001|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
48806521|NCT04242446|157133607|FG002|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
48806522|NCT04242446|157133608|FG003|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
48806523|NCT04242446|157133609|FG004|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
48806524|NCT04242446|157133610|FG005|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
48806525|NCT04242446|157133611|FG006|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|1|||
48806526|NCT04242446|157133605|FG000|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
48806527|NCT04242446|157133606|FG001|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
48806528|NCT04242446|157133607|FG002|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
48806529|NCT04242446|157133608|FG003|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
48806530|NCT04242446|157133609|FG004|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
48806531|NCT04242446|157133610|FG005|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
48806532|NCT04242446|157133611|FG006|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|1|||
48806533|NCT05674890|157133612|FG000|Overall Study|5 eyes were excluded due to poor reliability indices|2|||
48806534|NCT05674890|157133613|FG001|Overall Study|5 eyes were excluded due to poor reliability indices|3|||
48806535|NCT05674890|157133612|FG000|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
48806536|NCT05674890|157133613|FG001|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
48806537|NCT05674890|157133612|FG000|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|3|||
48806538|NCT05674890|157133613|FG001|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|5|||
48806539|NCT02421666|157133614|FG000|6-month Follow-up|Lost to Follow-up|8|||
48806540|NCT02421666|157133615|FG001|6-month Follow-up|Lost to Follow-up|7|||
48806541|NCT02421666|157133614|FG000|6-month Follow-up|Withdrawal by Subject|5|||
48806542|NCT02421666|157133615|FG001|6-month Follow-up|Withdrawal by Subject|6|||
48806543|NCT02421666|157133614|FG000|12-month Follow-up|Lost to Follow-up|5|||
48806544|NCT02421666|157133615|FG001|12-month Follow-up|Lost to Follow-up|5|||
48806545|NCT02421666|157133614|FG000|12-month Follow-up|Withdrawal by Subject|6|||
48806546|NCT02421666|157133615|FG001|12-month Follow-up|Withdrawal by Subject|11|||
48806547|NCT00255346|157133616|FG000|Overall Study|Adverse Event|1|||
48806548|NCT00255346|157133617|FG001|Overall Study|Adverse Event|0|||
48806549|NCT00255346|157133618|FG002|Overall Study|Adverse Event|0|||
48806550|NCT00255346|157133619|FG003|Overall Study|Adverse Event|0|||
48806551|NCT00255346|157133620|FG004|Overall Study|Adverse Event|0|||
48806552|NCT00768430|157133621|FG000|7 Day Endpoint|Withdrawal by Subject|2|||
48806553|NCT00768430|157133622|FG001|7 Day Endpoint|Withdrawal by Subject|3|||
48806554|NCT02093663|157133623|FG000|Double Blind Acute Phase (8 Weeks)|Adverse Event|1|||
48806555|NCT02093663|157133624|FG001|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
48806556|NCT02093663|157133625|FG002|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
48806557|NCT02093663|157133626|FG003|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
48806558|NCT02093663|157133627|FG004|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
48806559|NCT02093663|157133623|FG000|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5|||
48709849|NCT02533453|156786605|FG000|Overall Study|Withdrawal by Subject|2|||
48709850|NCT02453711|156786608|FG000|Overall Study|Withdrawal by Subject|5|||
48709851|NCT02453711|156786609|FG001|Overall Study|Withdrawal by Subject|4|||
48709852|NCT02453711|156786610|FG002|Overall Study|Withdrawal by Subject|6|||
48709853|NCT02453711|156786611|FG003|Overall Study|Withdrawal by Subject|4|||
48916380|NCT02943564|157528542|FG002|Overall Study|Miscellaneous Reasons|3|||
48916381|NCT02943564|157528540|FG000|Overall Study|Site terminated by sponsor|0|||
48916382|NCT02943564|157528541|FG001|Overall Study|Site terminated by sponsor|1|||
48916383|NCT02943564|157528542|FG002|Overall Study|Site terminated by sponsor|0|||
48916384|NCT02943564|157528540|FG000|Overall Study|Non-compliance with study drug|0|||
48916385|NCT02943564|157528541|FG001|Overall Study|Non-compliance with study drug|1|||
48916386|NCT02943564|157528542|FG002|Overall Study|Non-compliance with study drug|0|||
48916387|NCT02943564|157528540|FG000|Overall Study|Pregnancy|0|||
48916388|NCT02943564|157528541|FG001|Overall Study|Pregnancy|1|||
48916389|NCT02943564|157528542|FG002|Overall Study|Pregnancy|1|||
48916390|NCT02943564|157528540|FG000|Overall Study|Protocol Violation|2|||
48916391|NCT02943564|157528541|FG001|Overall Study|Protocol Violation|2|||
48916392|NCT02943564|157528542|FG002|Overall Study|Protocol Violation|2|||
48916393|NCT02943564|157528540|FG000|Overall Study|Lost to Follow-up|1|||
48916394|NCT02943564|157528541|FG001|Overall Study|Lost to Follow-up|0|||
48916395|NCT02943564|157528542|FG002|Overall Study|Lost to Follow-up|0|||
48916396|NCT02943564|157528540|FG000|Overall Study|Withdrawal by Subject|6|||
48916397|NCT02943564|157528541|FG001|Overall Study|Withdrawal by Subject|5|||
48916398|NCT02943564|157528542|FG002|Overall Study|Withdrawal by Subject|2|||
48916399|NCT02943564|157528540|FG000|Overall Study|Adverse Event|1|||
48916400|NCT02943564|157528541|FG001|Overall Study|Adverse Event|2|||
48916401|NCT02943564|157528542|FG002|Overall Study|Adverse Event|1|||
48916402|NCT02943564|157528540|FG000|Overall Study|Lack of Efficacy|0|||
48916403|NCT02943564|157528541|FG001|Overall Study|Lack of Efficacy|1|||
49119819|NCT02227784|158277264|FG002|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
49119820|NCT02227784|158277265|FG003|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
49119821|NCT02227784|158277266|FG004|Open-Label Extension Phase (OLE)|Sponsor Decision|243|||
49119822|NCT02227784|158277262|FG000|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
49119823|NCT02227784|158277263|FG001|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
49119824|NCT02227784|158277264|FG002|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
49119825|NCT02227784|158277265|FG003|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
49119826|NCT02227784|158277266|FG004|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3|||
49119827|NCT05415462|158277267|FG000|Overall Study|Death|18|||
49119828|NCT05415462|158277268|FG001|Overall Study|Death|10|||
49119829|NCT05415462|158277267|FG000|Overall Study|Lost to Follow-up|72|||
49119830|NCT05415462|158277268|FG001|Overall Study|Lost to Follow-up|64|||
49119831|NCT05415462|158277267|FG000|Overall Study|Physician Decision|5|||
49119832|NCT05415462|158277268|FG001|Overall Study|Physician Decision|5|||
49119833|NCT05415462|158277267|FG000|Overall Study|Protocol Deviation|1|||
49119834|NCT05415462|158277268|FG001|Overall Study|Protocol Deviation|0|||
49119835|NCT05415462|158277267|FG000|Overall Study|Withdrawal by Subject|129|||
49119836|NCT05415462|158277268|FG001|Overall Study|Withdrawal by Subject|101|||
49119837|NCT05415462|158277267|FG000|Overall Study|Other Than Specified|8|||
49119838|NCT05415462|158277268|FG001|Overall Study|Other Than Specified|8|||
49119839|NCT04391842|158277271|FG000|Overall Study|Withdrawal by Subject|2|||
49119840|NCT04039204|158277272|FG000|Overall Study|Withdrawal by Subject|0|||
49119841|NCT04039204|158277273|FG001|Overall Study|Withdrawal by Subject|2|||
49119842|NCT00972283|158277279|FG000|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31|||
49119843|NCT00972283|158277280|FG001|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9|||
49119844|NCT00972283|158277279|FG000|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3|||
49119845|NCT00972283|158277280|FG001|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0|||
49119846|NCT00972283|158277279|FG000|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23|||
49119847|NCT00972283|158277280|FG001|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12|||
48709854|NCT02453711|156786612|FG004|Overall Study|Withdrawal by Subject|1|||
48709855|NCT02453711|156786613|FG005|Overall Study|Withdrawal by Subject|1|||
48709856|NCT02453711|156786614|FG006|Overall Study|Withdrawal by Subject|0|||
48916404|NCT02943564|157528542|FG002|Overall Study|Lack of Efficacy|0|||
48916405|NCT04770389|157528543|FG000|Overall Study|Adverse Event|1|||
48709857|NCT02453711|156786615|FG007|Overall Study|Withdrawal by Subject|1|||
48709858|NCT02453711|156786616|FG008|Overall Study|Withdrawal by Subject|7|||
48709859|NCT02453711|156786608|FG000|Overall Study|Lost to Follow-up|5|||
48709860|NCT02453711|156786609|FG001|Overall Study|Lost to Follow-up|3|||
48709861|NCT02453711|156786610|FG002|Overall Study|Lost to Follow-up|2|||
48709862|NCT02453711|156786611|FG003|Overall Study|Lost to Follow-up|3|||
48709863|NCT02453711|156786612|FG004|Overall Study|Lost to Follow-up|1|||
48709864|NCT02453711|156786613|FG005|Overall Study|Lost to Follow-up|5|||
48709865|NCT02453711|156786614|FG006|Overall Study|Lost to Follow-up|2|||
48709866|NCT02453711|156786615|FG007|Overall Study|Lost to Follow-up|6|||
48916406|NCT04770389|157528544|FG001|Overall Study|Adverse Event|2|||
48916407|NCT04770389|157528545|FG002|Overall Study|Adverse Event|0|||
48916408|NCT04770389|157528546|FG003|Overall Study|Adverse Event|1|||
48916409|NCT04770389|157528543|FG000|Overall Study|Withdrawal by Subject|0|||
48916410|NCT04770389|157528544|FG001|Overall Study|Withdrawal by Subject|2|||
48916411|NCT04770389|157528545|FG002|Overall Study|Withdrawal by Subject|1|||
49119848|NCT00972283|158277279|FG000|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8|||
49119849|NCT00972283|158277280|FG001|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2|||
48916412|NCT04770389|157528546|FG003|Overall Study|Withdrawal by Subject|0|||
48916413|NCT04770389|157528543|FG000|Overall Study|Failed attempt to draw blood|1|||
48916414|NCT04770389|157528544|FG001|Overall Study|Failed attempt to draw blood|0|||
48916415|NCT04770389|157528545|FG002|Overall Study|Failed attempt to draw blood|0|||
48916416|NCT04770389|157528546|FG003|Overall Study|Failed attempt to draw blood|0|||
48916417|NCT04770389|157528543|FG000|Overall Study|Left the country|0|||
48806560|NCT02093663|157133624|FG001|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
48806561|NCT02093663|157133625|FG002|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
48916418|NCT04770389|157528544|FG001|Overall Study|Left the country|0|||
48709867|NCT02453711|156786616|FG008|Overall Study|Lost to Follow-up|6|||
48709868|NCT02453711|156786608|FG000|Overall Study|Death|0|||
48709869|NCT02453711|156786609|FG001|Overall Study|Death|0|||
48709870|NCT02453711|156786610|FG002|Overall Study|Death|0|||
48709871|NCT02453711|156786611|FG003|Overall Study|Death|0|||
48709872|NCT02453711|156786612|FG004|Overall Study|Death|0|||
48709873|NCT02453711|156786613|FG005|Overall Study|Death|0|||
48806562|NCT02093663|157133626|FG003|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
48806563|NCT02093663|157133627|FG004|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
48806564|NCT02093663|157133623|FG000|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2|||
48806565|NCT02093663|157133624|FG001|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4|||
48806566|NCT02093663|157133625|FG002|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
48806567|NCT02093663|157133626|FG003|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
48806568|NCT02093663|157133627|FG004|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
48916419|NCT04770389|157528545|FG002|Overall Study|Left the country|1|||
48916420|NCT04770389|157528546|FG003|Overall Study|Left the country|2|||
48916421|NCT04770389|157528543|FG000|Overall Study|Randomized in error and did not receive study drug|0|||
48916422|NCT04770389|157528544|FG001|Overall Study|Randomized in error and did not receive study drug|0|||
48916423|NCT04770389|157528545|FG002|Overall Study|Randomized in error and did not receive study drug|0|||
48806569|NCT02093663|157133623|FG000|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
48806570|NCT02093663|157133624|FG001|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
48806571|NCT02093663|157133625|FG002|Open Label Acute Phase (8 Weeks)|Adverse Event|1|||
48806572|NCT02093663|157133626|FG003|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
48806573|NCT02093663|157133627|FG004|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
48806574|NCT02093663|157133623|FG000|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
48806575|NCT02093663|157133624|FG001|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
48806576|NCT02093663|157133625|FG002|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5|||
48806577|NCT02093663|157133626|FG003|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
48806578|NCT02093663|157133627|FG004|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
48916424|NCT04770389|157528546|FG003|Overall Study|Randomized in error and did not receive study drug|1|||
48916425|NCT04770389|157528543|FG000|Overall Study|Lost to Follow-up|0|||
48916426|NCT04770389|157528544|FG001|Overall Study|Lost to Follow-up|0|||
48916427|NCT04770389|157528545|FG002|Overall Study|Lost to Follow-up|0|||
48916428|NCT04770389|157528546|FG003|Overall Study|Lost to Follow-up|1|||
48916429|NCT04770389|157528543|FG000|Overall Study|Moved away from study site|0|||
48916430|NCT04770389|157528544|FG001|Overall Study|Moved away from study site|1|||
48916431|NCT04770389|157528545|FG002|Overall Study|Moved away from study site|0|||
48916432|NCT04770389|157528546|FG003|Overall Study|Moved away from study site|0|||
48916433|NCT03127384|157528547|FG000|Overall Study|Lost to Follow-up|4|||
48916434|NCT03127384|157528547|FG000|Overall Study|Subject request|2|||
48916435|NCT04143009|157528548|FG000|Pilot Trial|Lost to Follow-up|0|||
48916436|NCT04143009|157528549|FG001|Pilot Trial|Lost to Follow-up|1|||
49119850|NCT00972283|158277279|FG000|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72|||
49119851|NCT00972283|158277280|FG001|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17|||
49119852|NCT00972283|158277279|FG000|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4|||
49119853|NCT00972283|158277280|FG001|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0|||
49119854|NCT00972283|158277279|FG000|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
49119855|NCT00972283|158277280|FG001|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
48916437|NCT04143009|157528550|FG002|Pilot Trial|Lost to Follow-up|1|||
49119856|NCT00972283|158277279|FG000|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5|||
49119857|NCT00972283|158277280|FG001|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0|||
48709874|NCT02453711|156786614|FG006|Overall Study|Death|1|||
48709875|NCT02453711|156786615|FG007|Overall Study|Death|0|||
48709876|NCT02453711|156786616|FG008|Overall Study|Death|0|||
48709877|NCT02453711|156786608|FG000|Overall Study|Unclassified|1|||
48806579|NCT02093663|157133623|FG000|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
48916438|NCT02322125|157530023|FG000|Overall Study|Withdrawal by Subject|2|||
48916439|NCT00388973|157530026|FG000|Overall Study|Adverse Event|16|||
48916440|NCT00388973|157530027|FG001|Overall Study|Adverse Event|6|||
48916441|NCT00388973|157530026|FG000|Overall Study|Lack of Efficacy|1|||
48709878|NCT02453711|156786609|FG001|Overall Study|Unclassified|0|||
48709879|NCT02453711|156786610|FG002|Overall Study|Unclassified|1|||
48709880|NCT02453711|156786611|FG003|Overall Study|Unclassified|0|||
48806580|NCT02093663|157133624|FG001|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
48806581|NCT02093663|157133625|FG002|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
48806582|NCT02093663|157133626|FG003|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3|||
48806583|NCT02093663|157133627|FG004|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2|||
48806584|NCT02093663|157133623|FG000|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
48806585|NCT02093663|157133624|FG001|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
48806586|NCT02093663|157133625|FG002|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
48806587|NCT02093663|157133626|FG003|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6|||
48806588|NCT02093663|157133627|FG004|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7|||
48806589|NCT02093663|157133623|FG000|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
48806590|NCT02093663|157133624|FG001|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
48806591|NCT02093663|157133625|FG002|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
48806592|NCT02093663|157133626|FG003|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
48709881|NCT02453711|156786612|FG004|Overall Study|Unclassified|0|||
48709882|NCT02453711|156786613|FG005|Overall Study|Unclassified|0|||
48709883|NCT02453711|156786614|FG006|Overall Study|Unclassified|0|||
48709884|NCT02453711|156786615|FG007|Overall Study|Unclassified|0|||
48709885|NCT02453711|156786616|FG008|Overall Study|Unclassified|0|||
48709886|NCT02504216|156786617|FG000|Overall Study|Lost to Follow-up|3|||
48709887|NCT02504216|156786618|FG001|Overall Study|Lost to Follow-up|3|||
48709888|NCT02504216|156786617|FG000|Overall Study|Withdrawal by Subject|8|||
48709889|NCT02504216|156786618|FG001|Overall Study|Withdrawal by Subject|12|||
48709890|NCT00862082|156786619|FG000|Overall Study|Sponsor decision to terminate the study|5|||
48709891|NCT00862082|156786620|FG001|Overall Study|Sponsor decision to terminate the study|0|||
48709892|NCT00862082|156786619|FG000|Overall Study|Withdrawal by Subject|0|||
48709893|NCT00862082|156786620|FG001|Overall Study|Withdrawal by Subject|1|||
48709894|NCT02598583|156786621|FG000|Extension Period|Withdrawal by Subject|1|||
48709895|NCT02598583|156786622|FG001|Extension Period|Withdrawal by Subject|0|||
48709896|NCT02792829|156786623|FG000|Treatment Period 2|Non compliance with alcohol prohibition|0|||
48709897|NCT02792829|156786624|FG001|Treatment Period 2|Non compliance with alcohol prohibition|1|||
48709898|NCT02792829|156786625|FG002|Treatment Period 2|Non compliance with alcohol prohibition|0|||
48709899|NCT02792829|156786626|FG003|Treatment Period 2|Non compliance with alcohol prohibition|0|||
48709900|NCT02792829|156786627|FG004|Treatment Period 2|Non compliance with alcohol prohibition|0|||
48709901|NCT02792829|156786628|FG005|Treatment Period 2|Non compliance with alcohol prohibition|0|||
48709902|NCT02792829|156786629|FG006|Treatment Period 2|Non compliance with alcohol prohibition|0|||
48709903|NCT02792829|156786630|FG007|Treatment Period 2|Non compliance with alcohol prohibition|0|||
48709904|NCT02792829|156786623|FG000|Treatment Period 2|Adverse Event|0|||
48709905|NCT02792829|156786624|FG001|Treatment Period 2|Adverse Event|0|||
48709906|NCT02792829|156786625|FG002|Treatment Period 2|Adverse Event|0|||
48709907|NCT02792829|156786626|FG003|Treatment Period 2|Adverse Event|0|||
48709908|NCT02792829|156786627|FG004|Treatment Period 2|Adverse Event|1|||
48709909|NCT02792829|156786628|FG005|Treatment Period 2|Adverse Event|0|||
48709910|NCT02792829|156786629|FG006|Treatment Period 2|Adverse Event|1|||
48709911|NCT02792829|156786630|FG007|Treatment Period 2|Adverse Event|1|||
48709912|NCT02792829|156786623|FG000|Treatment Period 2|Use of proscribed medications|0|||
48709913|NCT02792829|156786624|FG001|Treatment Period 2|Use of proscribed medications|0|||
48709914|NCT02792829|156786625|FG002|Treatment Period 2|Use of proscribed medications|0|||
48709915|NCT02792829|156786626|FG003|Treatment Period 2|Use of proscribed medications|0|||
48709916|NCT02792829|156786627|FG004|Treatment Period 2|Use of proscribed medications|0|||
48806593|NCT02093663|157133627|FG004|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
48856369|NCT01052272|157312837|FG001|Overall Study|Death|0|||
48856370|NCT01052272|157312838|FG002|Overall Study|Death|1|||
48856371|NCT01052272|157312839|FG003|Overall Study|Death|1|||
48856372|NCT01052272|157312836|FG000|Overall Study|Physician Decision|0|||
48856373|NCT01052272|157312837|FG001|Overall Study|Physician Decision|1|||
48856374|NCT01052272|157312838|FG002|Overall Study|Physician Decision|0|||
48856375|NCT01052272|157312839|FG003|Overall Study|Physician Decision|0|||
48856376|NCT01052272|157312836|FG000|Overall Study|patient refuses follow-up|5|||
48856377|NCT01052272|157312837|FG001|Overall Study|patient refuses follow-up|4|||
48856378|NCT01052272|157312838|FG002|Overall Study|patient refuses follow-up|2|||
48856379|NCT01052272|157312839|FG003|Overall Study|patient refuses follow-up|4|||
48856380|NCT01052272|157312836|FG000|Overall Study|Withdrawal by Subject|0|||
48856381|NCT01052272|157312837|FG001|Overall Study|Withdrawal by Subject|2|||
48856382|NCT01052272|157312838|FG002|Overall Study|Withdrawal by Subject|3|||
48856383|NCT01052272|157312839|FG003|Overall Study|Withdrawal by Subject|2|||
48856384|NCT01052272|157312836|FG000|Overall Study|placed in long-term care|0|||
48856385|NCT01052272|157312837|FG001|Overall Study|placed in long-term care|0|||
48856386|NCT01052272|157312838|FG002|Overall Study|placed in long-term care|1|||
48856387|NCT01052272|157312839|FG003|Overall Study|placed in long-term care|0|||
48856388|NCT01052272|157312836|FG000|Overall Study|decline in health|0|||
48856389|NCT01052272|157312837|FG001|Overall Study|decline in health|0|||
48806594|NCT02093663|157133623|FG000|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
48806595|NCT02093663|157133624|FG001|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
48806596|NCT02093663|157133625|FG002|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
48806597|NCT02093663|157133626|FG003|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
48806598|NCT02093663|157133627|FG004|Double Blind Maintenance Phase(26 Weeks)|Missing|1|||
49119858|NCT00972283|158277279|FG000|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6|||
49119859|NCT00972283|158277280|FG001|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2|||
49119860|NCT00972283|158277279|FG000|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11|||
49119861|NCT00972283|158277280|FG001|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5|||
49119862|NCT04577794|158277281|FG000|Overall Study|Adverse Event|1|||
49119863|NCT04577794|158277282|FG001|Overall Study|Adverse Event|1|||
49119864|NCT00447902|158277283|FG000|Overall Study|Adverse Event|0|||
49119865|NCT00447902|158277284|FG001|Overall Study|Adverse Event|3|||
48709917|NCT02792829|156786628|FG005|Treatment Period 2|Use of proscribed medications|0|||
48709918|NCT02792829|156786629|FG006|Treatment Period 2|Use of proscribed medications|0|||
48709919|NCT02792829|156786630|FG007|Treatment Period 2|Use of proscribed medications|1|||
48709920|NCT00947882|156786634|FG000|Overall Study|Adverse Event|0|||
48709921|NCT00947882|156786635|FG001|Overall Study|Adverse Event|1|||
48709922|NCT00947882|156786636|FG002|Overall Study|Adverse Event|4|||
48709923|NCT00947882|156786637|FG003|Overall Study|Adverse Event|4|||
48709924|NCT00947882|156786634|FG000|Overall Study|Withdrawal by Subject|2|||
48709925|NCT00947882|156786635|FG001|Overall Study|Withdrawal by Subject|0|||
48709926|NCT00947882|156786636|FG002|Overall Study|Withdrawal by Subject|8|||
48709927|NCT00947882|156786637|FG003|Overall Study|Withdrawal by Subject|2|||
48709928|NCT00947882|156786634|FG000|Overall Study|Protocol Violation|0|||
48709929|NCT00947882|156786635|FG001|Overall Study|Protocol Violation|0|||
48709930|NCT00947882|156786636|FG002|Overall Study|Protocol Violation|1|||
48709931|NCT00947882|156786637|FG003|Overall Study|Protocol Violation|0|||
48709932|NCT00947882|156786634|FG000|Overall Study|Lost to Follow-up|0|||
48709933|NCT00947882|156786635|FG001|Overall Study|Lost to Follow-up|2|||
48709934|NCT00947882|156786636|FG002|Overall Study|Lost to Follow-up|1|||
48709935|NCT00947882|156786637|FG003|Overall Study|Lost to Follow-up|0|||
48709936|NCT00947882|156786634|FG000|Overall Study|Other/Unknown|10|||
48709937|NCT00947882|156786635|FG001|Overall Study|Other/Unknown|13|||
48709938|NCT00947882|156786636|FG002|Overall Study|Other/Unknown|3|||
48709939|NCT00947882|156786637|FG003|Overall Study|Other/Unknown|6|||
48709940|NCT00947882|156786634|FG000|Overall Study|Trial Terminated by Sponsor|62|||
48709941|NCT00947882|156786635|FG001|Overall Study|Trial Terminated by Sponsor|61|||
48709942|NCT00947882|156786636|FG002|Overall Study|Trial Terminated by Sponsor|62|||
48709943|NCT00947882|156786637|FG003|Overall Study|Trial Terminated by Sponsor|70|||
48709944|NCT01026324|156786638|FG000|Follow up/Survival|Withdrawal by Subject|1|||
48806599|NCT03010462|157133628|FG000|Overall Study|Withdrawal by Subject|3|||
48806600|NCT03010462|157133629|FG001|Overall Study|Withdrawal by Subject|1|||
49119866|NCT00447902|158277283|FG000|Overall Study|Protocol Violation|1|||
49119867|NCT00447902|158277284|FG001|Overall Study|Protocol Violation|0|||
49119868|NCT00447902|158277283|FG000|Overall Study|Withdrawal by Subject|0|||
49119869|NCT00447902|158277284|FG001|Overall Study|Withdrawal by Subject|1|||
49119870|NCT00447902|158277283|FG000|Overall Study|included patients who discontinued|1|||
48709945|NCT01026324|156786639|FG001|Follow up/Survival|Withdrawal by Subject|0|||
48709946|NCT01026324|156786640|FG002|Follow up/Survival|Withdrawal by Subject|0|||
48709947|NCT01209325|156786644|FG000|Overall Study|Lost to Follow-up|24|||
48709948|NCT01209325|156786644|FG000|Overall Study|Adverse Event|1|||
48709949|NCT01209325|156786644|FG000|Overall Study|Relocated|3|||
48709950|NCT01209325|156786644|FG000|Overall Study|Refusal after starting therapy|8|||
48709951|NCT01209325|156786644|FG000|Overall Study|Protocol Violation|4|||
48709952|NCT01209325|156786644|FG000|Overall Study|Refusal prior to therapy|1|||
48709953|NCT01209325|156786644|FG000|Overall Study|Incarceration|2|||
48709954|NCT02876601|156786645|FG000|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
48806601|NCT01492686|157133631|FG000|Double-blind Phase|Adverse Event|0|||
48806602|NCT01492686|157133632|FG001|Double-blind Phase|Adverse Event|2|||
48806603|NCT01492686|157133631|FG000|Double-blind Phase|Physician Decision|0|||
48806604|NCT01492686|157133632|FG001|Double-blind Phase|Physician Decision|1|||
48806605|NCT01492686|157133631|FG000|Double-blind Phase|Withdrawal by Subject|0|||
48806606|NCT01492686|157133632|FG001|Double-blind Phase|Withdrawal by Subject|2|||
48806607|NCT01492686|157133631|FG000|Double-blind Phase|Due to a discontinuation criterion|2|||
48806608|NCT01492686|157133632|FG001|Double-blind Phase|Due to a discontinuation criterion|3|||
48806609|NCT01492686|157133631|FG000|Open-label Phase|Adverse Event|1|||
48806610|NCT01492686|157133632|FG001|Open-label Phase|Adverse Event|2|||
48806611|NCT01492686|157133631|FG000|Open-label Phase|Physician Decision|1|||
48806612|NCT01492686|157133632|FG001|Open-label Phase|Physician Decision|0|||
48806613|NCT01492686|157133631|FG000|Open-label Phase|Withdrawal by Subject|6|||
48806614|NCT01492686|157133632|FG001|Open-label Phase|Withdrawal by Subject|7|||
48806615|NCT01492686|157133631|FG000|Open-label Phase|Due to a discontinuation criterion|4|||
48806616|NCT01492686|157133632|FG001|Open-label Phase|Due to a discontinuation criterion|9|||
48806617|NCT03086018|157133634|FG000|Final Testing for End of Trial|Adverse Event|1|||
48806618|NCT03086018|157133634|FG000|Final Testing for End of Trial|Withdrawal by Subject|1|||
48806619|NCT01785563|157133635|FG000|Overall Study|Physician Decision|10|||
48806620|NCT01785563|157133635|FG000|Overall Study|Withdrawal by Subject|1|||
48806621|NCT01785563|157133635|FG000|Overall Study|Protocol Violation|2|||
48806622|NCT01282801|157133636|FG000|Second Intervention|Emesis During Critical Breakfast|0|||
48806623|NCT01282801|157133637|FG001|Second Intervention|Emesis During Critical Breakfast|1|||
48916442|NCT00388973|157530027|FG001|Overall Study|Lack of Efficacy|12|||
48916443|NCT00388973|157530026|FG000|Overall Study|Protocol Violation|3|||
48916444|NCT00388973|157530027|FG001|Overall Study|Protocol Violation|0|||
48916445|NCT00388973|157530026|FG000|Overall Study|Withdrawal by Subject|14|||
48916446|NCT00388973|157530027|FG001|Overall Study|Withdrawal by Subject|17|||
48916447|NCT00388973|157530026|FG000|Overall Study|Study specific Discontinuation Criteria|0|||
48916448|NCT00388973|157530027|FG001|Overall Study|Study specific Discontinuation Criteria|1|||
48916449|NCT00388973|157530026|FG000|Overall Study|Did not complete 61 days of treatment|5|||
48916450|NCT00388973|157530027|FG001|Overall Study|Did not complete 61 days of treatment|4|||
48916451|NCT00388973|157530026|FG000|Overall Study|Left region|0|||
48916452|NCT00388973|157530027|FG001|Overall Study|Left region|1|||
48916453|NCT00388973|157530026|FG000|Overall Study|Did not complete 2-week follow-up visit|17|||
48916454|NCT00388973|157530027|FG001|Overall Study|Did not complete 2-week follow-up visit|17|||
48916455|NCT03703882|157530032|FG000|Overall Study|Adverse Event|1|||
49119871|NCT00447902|158277284|FG001|Overall Study|included patients who discontinued|1|||
49119872|NCT00447902|158277283|FG000|Overall Study|Lack of Efficacy|2|||
48806624|NCT01453348|157133638|FG000|Overall Study|Death|0|||
48806625|NCT01453348|157133639|FG001|Overall Study|Death|0|||
48806626|NCT01453348|157133640|FG002|Overall Study|Death|1|||
49119873|NCT00447902|158277284|FG001|Overall Study|Lack of Efficacy|1|||
49119874|NCT02849080|158277287|FG000|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7|||
49119875|NCT02849080|158277288|FG001|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4|||
49119876|NCT02849080|158277289|FG002|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
49119877|NCT02849080|158277290|FG003|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
49119878|NCT02849080|158277287|FG000|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5|||
49119879|NCT02849080|158277288|FG001|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1|||
49119880|NCT02849080|158277289|FG002|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
49119881|NCT02849080|158277290|FG003|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
49119882|NCT02849080|158277287|FG000|Main Phase: 0 - 52 Weeks|Death|0|||
49119883|NCT02849080|158277288|FG001|Main Phase: 0 - 52 Weeks|Death|2|||
49119884|NCT02849080|158277289|FG002|Main Phase: 0 - 52 Weeks|Death|0|||
49119885|NCT02849080|158277290|FG003|Main Phase: 0 - 52 Weeks|Death|0|||
49119886|NCT02849080|158277287|FG000|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2|||
49119887|NCT02849080|158277288|FG001|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
49119888|NCT02849080|158277289|FG002|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
49119889|NCT02849080|158277290|FG003|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
49119890|NCT02849080|158277287|FG000|Extension Phase: 53 - 104 Weeks|Other|0|||
49119891|NCT02849080|158277288|FG001|Extension Phase: 53 - 104 Weeks|Other|0|||
49119892|NCT02849080|158277289|FG002|Extension Phase: 53 - 104 Weeks|Other|1|||
49119893|NCT02849080|158277290|FG003|Extension Phase: 53 - 104 Weeks|Other|0|||
49119894|NCT02849080|158277287|FG000|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1|||
49119895|NCT02849080|158277288|FG001|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
49119896|NCT02849080|158277289|FG002|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
49119897|NCT02849080|158277290|FG003|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
49119898|NCT02155985|158277291|FG000|Overall Study|Withdrawal by Subject|0|||
49119899|NCT02155985|158277292|FG001|Overall Study|Withdrawal by Subject|0|||
49119900|NCT02155985|158277293|FG002|Overall Study|Withdrawal by Subject|1|||
49119901|NCT02155985|158277291|FG000|Overall Study|Lost to Follow-up|1|||
49119902|NCT02155985|158277292|FG001|Overall Study|Lost to Follow-up|0|||
49119903|NCT02155985|158277293|FG002|Overall Study|Lost to Follow-up|0|||
49119904|NCT02998151|158277294|FG000|Overall Study|Withdrawal by Subject|3|||
49119905|NCT02998151|158277294|FG000|Overall Study|Participant declined to re-enroll for baclofen|8|||
49119906|NCT02998151|158277294|FG000|Overall Study|Participant was not offered acamprosate; acamprosate was discontinued and replaced with baclofen|13|||
49119907|NCT00751140|158277295|FG000|Overall Study|benign angioma excluded from analysis|1|||
49119908|NCT03654729|158278795|FG000|Overall Study|Death|9|||
49119909|NCT03654729|158278796|FG001|Overall Study|Death|9|||
49119910|NCT03654729|158278797|FG002|Overall Study|Death|16|||
49119911|NCT03654729|158278795|FG000|Overall Study|Withdrawal by Subject|8|||
49119912|NCT03654729|158278796|FG001|Overall Study|Withdrawal by Subject|6|||
49119913|NCT03654729|158278797|FG002|Overall Study|Withdrawal by Subject|4|||
48806627|NCT01453348|157133638|FG000|Overall Study|Withdrawal by Subject|0|||
48916456|NCT03703882|157530033|FG001|Overall Study|Adverse Event|0|||
48916457|NCT03703882|157530032|FG000|Overall Study|Lost to Follow-up|0|||
48916458|NCT03703882|157530033|FG001|Overall Study|Lost to Follow-up|2|||
49119914|NCT03654729|158278795|FG000|Overall Study|Study terminated by Sponsor|3|||
49119915|NCT03654729|158278796|FG001|Overall Study|Study terminated by Sponsor|5|||
48806628|NCT01453348|157133639|FG001|Overall Study|Withdrawal by Subject|1|||
48806629|NCT01453348|157133640|FG002|Overall Study|Withdrawal by Subject|0|||
48806630|NCT01453348|157133638|FG000|Overall Study|Protocol Violation|1|||
48806631|NCT01453348|157133639|FG001|Overall Study|Protocol Violation|0|||
48806632|NCT01453348|157133640|FG002|Overall Study|Protocol Violation|0|||
48806633|NCT03579290|157133641|FG000|Overall Study|Lost to Follow-up|9|||
48806634|NCT04707196|157133642|FG000|Overall Study|Withdrawal by Subject|9|||
48806635|NCT04707196|157133643|FG001|Overall Study|Withdrawal by Subject|6|||
48806636|NCT04707196|157133642|FG000|Overall Study|Lost to Follow-up|1|||
48806637|NCT04707196|157133643|FG001|Overall Study|Lost to Follow-up|0|||
48806638|NCT04707196|157133642|FG000|Overall Study|Protocol Violation|4|||
48806639|NCT04707196|157133643|FG001|Overall Study|Protocol Violation|1|||
48806640|NCT04707196|157133642|FG000|Overall Study|Adverse Event|2|||
48806641|NCT04707196|157133643|FG001|Overall Study|Adverse Event|2|||
48806642|NCT04707196|157133642|FG000|Overall Study|Death|3|||
48806643|NCT04707196|157133643|FG001|Overall Study|Death|1|||
48806644|NCT04707196|157133642|FG000|Overall Study|Non-compliance with study drug|1|||
48806645|NCT04707196|157133643|FG001|Overall Study|Non-compliance with study drug|0|||
48806646|NCT04707196|157133642|FG000|Overall Study|Progressive disease|9|||
48806647|NCT04707196|157133643|FG001|Overall Study|Progressive disease|10|||
48806648|NCT00622713|157133644|FG000|Overall Study|Adverse Event|35|||
48806649|NCT00622713|157133644|FG000|Overall Study|Administrative problems|4|||
48806650|NCT00622713|157133644|FG000|Overall Study|Withdrawal by Subject|11|||
48806651|NCT00622713|157133644|FG000|Overall Study|Lost to Follow-up|5|||
48806652|NCT00622713|157133644|FG000|Overall Study|Death|2|||
48806653|NCT00622713|157133644|FG000|Overall Study|Subject no longer required study drug|1|||
48806654|NCT00622713|157133644|FG000|Overall Study|Did not meet eligibility criteria|1|||
48806655|NCT04404478|157133647|FG000|Overall Study|Withdrawal by Subject|1|||
48806656|NCT04404478|157133648|FG001|Overall Study|Withdrawal by Subject|3|||
48806657|NCT03485911|157133649|FG000|Part 1|Perceived lack of efficacy|1|||
48806658|NCT03485911|157133650|FG001|Part 1|Perceived lack of efficacy|1|||
48806659|NCT03485911|157133651|FG002|Part 1|Perceived lack of efficacy|2|||
48806660|NCT03485911|157133652|FG003|Part 1|Perceived lack of efficacy|0|||
48806661|NCT03485911|157133649|FG000|Part 1|Subject withdrew consent|0|||
48806662|NCT03485911|157133650|FG001|Part 1|Subject withdrew consent|1|||
48806663|NCT03485911|157133651|FG002|Part 1|Subject withdrew consent|0|||
48806664|NCT03485911|157133652|FG003|Part 1|Subject withdrew consent|1|||
48806665|NCT03485911|157133649|FG000|Part 1|Lab abnormalities/AEs|3|||
48806666|NCT03485911|157133650|FG001|Part 1|Lab abnormalities/AEs|1|||
48806667|NCT03485911|157133651|FG002|Part 1|Lab abnormalities/AEs|1|||
48806668|NCT03485911|157133652|FG003|Part 1|Lab abnormalities/AEs|0|||
48806669|NCT03485911|157133649|FG000|Part 1|Withdrew Consent prior to dosing|0|||
48806670|NCT03485911|157133650|FG001|Part 1|Withdrew Consent prior to dosing|0|||
48806671|NCT03485911|157133651|FG002|Part 1|Withdrew Consent prior to dosing|0|||
48709955|NCT02876601|156786646|FG001|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
48709956|NCT02876601|156786647|FG002|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1|||
48709957|NCT02876601|156786648|FG003|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
48709958|NCT02873702|156788721|FG000|Healing Period (up to Week 8)|Adverse Event|1|||
48709959|NCT02873702|156788722|FG001|Healing Period (up to Week 8)|Adverse Event|0|||
48709960|NCT02873702|156788723|FG002|Healing Period (up to Week 8)|Adverse Event|0|||
48709961|NCT02873702|156788724|FG003|Healing Period (up to Week 8)|Adverse Event|0|||
48709962|NCT02873702|156788721|FG000|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
48709963|NCT02873702|156788722|FG001|Healing Period (up to Week 8)|Withdrawal by Subject|1|||
48709964|NCT02873702|156788723|FG002|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
48709965|NCT02873702|156788724|FG003|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
48709966|NCT02873702|156788721|FG000|Maintenance Period (up to Month 6)|Adverse Event|0|||
48709967|NCT02873702|156788722|FG001|Maintenance Period (up to Month 6)|Adverse Event|0|||
48709968|NCT02873702|156788723|FG002|Maintenance Period (up to Month 6)|Adverse Event|1|||
48806672|NCT03485911|157133652|FG003|Part 1|Withdrew Consent prior to dosing|1|||
48709969|NCT02873702|156788724|FG003|Maintenance Period (up to Month 6)|Adverse Event|0|||
48709970|NCT02873702|156788721|FG000|Maintenance Period (up to Month 6)|Relapse of EE|0|||
48709971|NCT02873702|156788722|FG001|Maintenance Period (up to Month 6)|Relapse of EE|0|||
48709972|NCT02873702|156788723|FG002|Maintenance Period (up to Month 6)|Relapse of EE|4|||
48709973|NCT02873702|156788724|FG003|Maintenance Period (up to Month 6)|Relapse of EE|1|||
48806673|NCT03485911|157133649|FG000|Part 1|Other NOS|0|||
48806674|NCT03485911|157133650|FG001|Part 1|Other NOS|0|||
48806675|NCT03485911|157133651|FG002|Part 1|Other NOS|0|||
48806676|NCT03485911|157133652|FG003|Part 1|Other NOS|1|||
48806677|NCT03485911|157133649|FG000|Part 2|Perceived lack of efficacy|5|||
48806678|NCT03485911|157133650|FG001|Part 2|Perceived lack of efficacy|3|||
48806679|NCT03485911|157133651|FG002|Part 2|Perceived lack of efficacy|0|||
48806680|NCT03485911|157133652|FG003|Part 2|Perceived lack of efficacy|2|||
48806681|NCT03485911|157133649|FG000|Part 2|Subject withdrew consent|1|||
48806682|NCT03485911|157133650|FG001|Part 2|Subject withdrew consent|0|||
48916459|NCT03703882|157530032|FG000|Overall Study|Non-compliance with study drug|0|||
48916460|NCT03703882|157530033|FG001|Overall Study|Non-compliance with study drug|1|||
48806683|NCT03485911|157133651|FG002|Part 2|Subject withdrew consent|2|||
48806684|NCT03485911|157133652|FG003|Part 2|Subject withdrew consent|1|||
48806685|NCT03485911|157133649|FG000|Part 2|Lab abnormalities/AEs|1|||
48806686|NCT03485911|157133650|FG001|Part 2|Lab abnormalities/AEs|2|||
48806687|NCT03485911|157133651|FG002|Part 2|Lab abnormalities/AEs|0|||
48806688|NCT03485911|157133652|FG003|Part 2|Lab abnormalities/AEs|0|||
48806689|NCT03485911|157133649|FG000|Part 2|Other NOS|0|||
48806690|NCT03485911|157133650|FG001|Part 2|Other NOS|1|||
48806691|NCT03485911|157133651|FG002|Part 2|Other NOS|0|||
48806692|NCT03485911|157133652|FG003|Part 2|Other NOS|0|||
48806693|NCT03485911|157133649|FG000|Part 2|Intercurrent illness/new medical condition|1|||
48806694|NCT03485911|157133650|FG001|Part 2|Intercurrent illness/new medical condition|0|||
48806695|NCT03485911|157133651|FG002|Part 2|Intercurrent illness/new medical condition|0|||
48806696|NCT03485911|157133652|FG003|Part 2|Intercurrent illness/new medical condition|0|||
48806697|NCT03485911|157133649|FG000|Part 2|Investigator judgement|1|||
48806698|NCT03485911|157133650|FG001|Part 2|Investigator judgement|0|||
48806699|NCT03485911|157133651|FG002|Part 2|Investigator judgement|0|||
48806700|NCT03485911|157133652|FG003|Part 2|Investigator judgement|0|||
48806701|NCT03485911|157133649|FG000|Part 3|Perceived lack of efficacy|2|||
48806702|NCT03485911|157133650|FG001|Part 3|Perceived lack of efficacy|2|||
48806703|NCT03485911|157133651|FG002|Part 3|Perceived lack of efficacy|2|||
48806704|NCT03485911|157133652|FG003|Part 3|Perceived lack of efficacy|0|||
48806705|NCT03485911|157133649|FG000|Part 3|Subject withdrew consent|1|||
48806706|NCT03485911|157133650|FG001|Part 3|Subject withdrew consent|4|||
48806707|NCT03485911|157133651|FG002|Part 3|Subject withdrew consent|0|||
48806708|NCT03485911|157133652|FG003|Part 3|Subject withdrew consent|1|||
48806709|NCT03485911|157133649|FG000|Part 3|Lab abnormalities/AEs|1|||
48806710|NCT03485911|157133650|FG001|Part 3|Lab abnormalities/AEs|1|||
48806711|NCT03485911|157133651|FG002|Part 3|Lab abnormalities/AEs|0|||
48806712|NCT03485911|157133652|FG003|Part 3|Lab abnormalities/AEs|2|||
48806713|NCT03485911|157133649|FG000|Part 3|Other NOS|1|||
48806714|NCT03485911|157133650|FG001|Part 3|Other NOS|1|||
48806715|NCT03485911|157133651|FG002|Part 3|Other NOS|0|||
48806716|NCT03485911|157133652|FG003|Part 3|Other NOS|0|||
48806717|NCT03485911|157133649|FG000|Part 3|Intercurrent illness/new medical condition|0|||
48806718|NCT03485911|157133650|FG001|Part 3|Intercurrent illness/new medical condition|1|||
48806719|NCT03485911|157133651|FG002|Part 3|Intercurrent illness/new medical condition|1|||
48806720|NCT03485911|157133652|FG003|Part 3|Intercurrent illness/new medical condition|0|||
48806721|NCT03485911|157133649|FG000|Part 3|Sponsor discontinuation|1|||
48806722|NCT03485911|157133650|FG001|Part 3|Sponsor discontinuation|0|||
48806723|NCT03485911|157133651|FG002|Part 3|Sponsor discontinuation|0|||
48806724|NCT03485911|157133652|FG003|Part 3|Sponsor discontinuation|0|||
48806725|NCT03485911|157133649|FG000|Part 3|Berotralstat provided by alternative means|13|||
48806726|NCT03485911|157133650|FG001|Part 3|Berotralstat provided by alternative means|13|||
48806727|NCT03485911|157133651|FG002|Part 3|Berotralstat provided by alternative means|7|||
48806728|NCT03485911|157133652|FG003|Part 3|Berotralstat provided by alternative means|7|||
48806729|NCT01350505|157133654|FG000|Overall Study|Lost to Follow-up|4|||
48806730|NCT03528174|157133655|FG000|Overall Study|Adverse Event|1|||
48806731|NCT03528174|157133655|FG000|Overall Study|sensors dislodged|1|||
48806732|NCT01725386|157133658|FG000|Overall Study|Death|84|||
48806733|NCT01725386|157133659|FG001|Overall Study|Death|40|||
48806734|NCT01725386|157133658|FG000|Overall Study|Lost to Follow-up|81|||
48806735|NCT01725386|157133659|FG001|Overall Study|Lost to Follow-up|6|||
48806736|NCT01725386|157133658|FG000|Overall Study|Withdrawal by Subject|10|||
48806737|NCT01725386|157133659|FG001|Overall Study|Withdrawal by Subject|0|||
48806738|NCT00393523|157133661|FG000|Overall Study|Lost to Follow-up|0|||
48806739|NCT00393523|157133662|FG001|Overall Study|Lost to Follow-up|0|||
48806740|NCT00393523|157133663|FG002|Overall Study|Lost to Follow-up|0|||
48806741|NCT00393523|157133664|FG003|Overall Study|Lost to Follow-up|2|||
48806742|NCT00393523|157133665|FG004|Overall Study|Lost to Follow-up|1|||
48806743|NCT00393523|157133661|FG000|Overall Study|Protocol Violation|6|||
48806744|NCT00393523|157133662|FG001|Overall Study|Protocol Violation|2|||
48806745|NCT00393523|157133663|FG002|Overall Study|Protocol Violation|0|||
48806746|NCT00393523|157133664|FG003|Overall Study|Protocol Violation|1|||
48806747|NCT00393523|157133665|FG004|Overall Study|Protocol Violation|0|||
48806748|NCT00393523|157133661|FG000|Overall Study|Withdrawal by Subject|6|||
48806749|NCT00393523|157133662|FG001|Overall Study|Withdrawal by Subject|7|||
48806750|NCT00393523|157133663|FG002|Overall Study|Withdrawal by Subject|2|||
48806751|NCT00393523|157133664|FG003|Overall Study|Withdrawal by Subject|3|||
48806752|NCT00393523|157133665|FG004|Overall Study|Withdrawal by Subject|0|||
48806753|NCT00393523|157133661|FG000|Overall Study|Difficulties in specimen collection|0|||
48806754|NCT00393523|157133662|FG001|Overall Study|Difficulties in specimen collection|0|||
48806755|NCT00393523|157133663|FG002|Overall Study|Difficulties in specimen collection|1|||
48806756|NCT00393523|157133664|FG003|Overall Study|Difficulties in specimen collection|0|||
48806757|NCT00393523|157133665|FG004|Overall Study|Difficulties in specimen collection|0|||
48806758|NCT00393523|157133661|FG000|Overall Study|Vaccine supply issue|0|||
48856390|NCT01052272|157312838|FG002|Overall Study|decline in health|1|||
48806759|NCT00393523|157133662|FG001|Overall Study|Vaccine supply issue|0|||
48806760|NCT00393523|157133663|FG002|Overall Study|Vaccine supply issue|1|||
48806761|NCT00393523|157133664|FG003|Overall Study|Vaccine supply issue|0|||
48806762|NCT00393523|157133665|FG004|Overall Study|Vaccine supply issue|0|||
48806763|NCT02002182|157133666|FG000|Overall Study|Withdraw from study|3|||
48806764|NCT02002182|157133667|FG001|Overall Study|Withdraw from study|1|||
48806765|NCT02002182|157133666|FG000|Overall Study|Health Reasons|1|||
48806766|NCT02002182|157133667|FG001|Overall Study|Health Reasons|0|||
48806767|NCT02002182|157133666|FG000|Overall Study|Death|1|||
48806768|NCT02002182|157133667|FG001|Overall Study|Death|0|||
48806769|NCT00744263|157133668|FG000|Overall Study|Death|3006|||
48806770|NCT00744263|157133669|FG001|Overall Study|Death|3005|||
48806771|NCT00744263|157133668|FG000|Overall Study|Lost to Follow-up|2038|||
48806772|NCT00744263|157133669|FG001|Overall Study|Lost to Follow-up|2135|||
48806773|NCT00744263|157133668|FG000|Overall Study|Withdrawal by Subject|166|||
48806774|NCT00744263|157133669|FG001|Overall Study|Withdrawal by Subject|150|||
48806775|NCT00744263|157133668|FG000|Overall Study|Physician Decision|20|||
48806776|NCT00744263|157133669|FG001|Overall Study|Physician Decision|23|||
48806777|NCT00744263|157133668|FG000|Overall Study|Protocol Violation|3|||
48806778|NCT00744263|157133669|FG001|Overall Study|Protocol Violation|5|||
48806779|NCT00744263|157133668|FG000|Overall Study|Adverse Event|1|||
48806780|NCT00744263|157133669|FG001|Overall Study|Adverse Event|0|||
48806781|NCT00744263|157133668|FG000|Overall Study|Other|2|||
48806782|NCT00744263|157133669|FG001|Overall Study|Other|2|||
48806783|NCT03891667|157133671|FG000|Overall Study|Physician Decision|1|||
48806784|NCT03891667|157133672|FG001|Overall Study|Physician Decision|1|||
48806785|NCT03891667|157133671|FG000|Overall Study|COVID related pause|1|||
48806786|NCT03891667|157133672|FG001|Overall Study|COVID related pause|0|||
48806787|NCT03891667|157133671|FG000|Overall Study|Withdrawal by Subject|0|||
48806788|NCT03891667|157133672|FG001|Overall Study|Withdrawal by Subject|1|||
48806789|NCT03891667|157133671|FG000|Overall Study|Adverse Event|0|||
48806790|NCT03891667|157133672|FG001|Overall Study|Adverse Event|1|||
48806791|NCT02276885|157133678|FG000|Overall Study|Withdrawal by Subject|2|||
48806792|NCT02276885|157133679|FG001|Overall Study|Withdrawal by Subject|0|||
48806793|NCT02276885|157133678|FG000|Overall Study|Lost to Follow-up|5|||
48806794|NCT02276885|157133679|FG001|Overall Study|Lost to Follow-up|2|||
48806795|NCT05783102|157133680|FG000|Overall Study|Lost to Follow-up|1|||
48806796|NCT05783102|157133680|FG000|Overall Study|Withdrawal by Subject|2|||
48806797|NCT05008835|157133681|FG000|Overall Study|Adverse Event|5|||
48806798|NCT05008835|157133682|FG001|Overall Study|Adverse Event|2|||
48806799|NCT05008835|157133683|FG002|Overall Study|Adverse Event|1|||
48806800|NCT05008835|157133681|FG000|Overall Study|Lack of Efficacy|0|||
48806801|NCT05008835|157133682|FG001|Overall Study|Lack of Efficacy|0|||
49119916|NCT03654729|158278797|FG002|Overall Study|Study terminated by Sponsor|4|||
49119917|NCT03654729|158278795|FG000|Overall Study|Not reported|2|||
49119918|NCT03654729|158278796|FG001|Overall Study|Not reported|4|||
49119919|NCT03654729|158278797|FG002|Overall Study|Not reported|5|||
49119920|NCT03654729|158278795|FG000|Overall Study|Progressive disease|3|||
49119921|NCT03654729|158278796|FG001|Overall Study|Progressive disease|0|||
49119922|NCT03654729|158278797|FG002|Overall Study|Progressive disease|0|||
49119923|NCT03654729|158278795|FG000|Overall Study|Lost to Follow-up|2|||
48806802|NCT05008835|157133683|FG002|Overall Study|Lack of Efficacy|1|||
48806803|NCT05008835|157133681|FG000|Overall Study|Study terminated by sponsor|0|||
48806804|NCT05008835|157133682|FG001|Overall Study|Study terminated by sponsor|0|||
48806805|NCT05008835|157133683|FG002|Overall Study|Study terminated by sponsor|1|||
48806806|NCT05008835|157133681|FG000|Overall Study|Not further specified|3|||
48806807|NCT05008835|157133682|FG001|Overall Study|Not further specified|2|||
48806808|NCT05008835|157133683|FG002|Overall Study|Not further specified|1|||
48806809|NCT02721732|157133685|FG000|Overall Study|Adverse Event|2|||
48806810|NCT02721732|157133686|FG001|Overall Study|Adverse Event|0|||
48806811|NCT02721732|157133687|FG002|Overall Study|Adverse Event|2|||
48806812|NCT02721732|157133688|FG003|Overall Study|Adverse Event|0|||
49119924|NCT03654729|158278796|FG001|Overall Study|Lost to Follow-up|0|||
49119925|NCT03654729|158278797|FG002|Overall Study|Lost to Follow-up|0|||
49119926|NCT03654729|158278795|FG000|Overall Study|Physician Decision|2|||
48806813|NCT02721732|157133689|FG004|Overall Study|Adverse Event|1|||
48806814|NCT02721732|157133690|FG005|Overall Study|Adverse Event|0|||
48806815|NCT02721732|157133691|FG006|Overall Study|Adverse Event|1|||
48806816|NCT02721732|157133692|FG007|Overall Study|Adverse Event|0|||
48806817|NCT02721732|157133693|FG008|Overall Study|Adverse Event|1|||
48916461|NCT03703882|157530032|FG000|Overall Study|Physician Decision|0|||
49119927|NCT03654729|158278796|FG001|Overall Study|Physician Decision|0|||
49119928|NCT03654729|158278797|FG002|Overall Study|Physician Decision|0|||
48806818|NCT02721732|157133694|FG009|Overall Study|Adverse Event|1|||
48806819|NCT02721732|157133685|FG000|Overall Study|Death|0|||
48806820|NCT02721732|157133686|FG001|Overall Study|Death|0|||
48806821|NCT02721732|157133687|FG002|Overall Study|Death|0|||
48806822|NCT02721732|157133688|FG003|Overall Study|Death|0|||
48806823|NCT02721732|157133689|FG004|Overall Study|Death|1|||
48806824|NCT02721732|157133690|FG005|Overall Study|Death|0|||
49119929|NCT03654729|158278795|FG000|Overall Study|Protocol Violation|1|||
48806825|NCT02721732|157133691|FG006|Overall Study|Death|1|||
48806826|NCT02721732|157133692|FG007|Overall Study|Death|0|||
48806827|NCT02721732|157133693|FG008|Overall Study|Death|0|||
48806828|NCT02721732|157133694|FG009|Overall Study|Death|1|||
48806829|NCT02721732|157133685|FG000|Overall Study|Lack of Efficacy|12|||
48806830|NCT02721732|157133686|FG001|Overall Study|Lack of Efficacy|11|||
48806831|NCT02721732|157133687|FG002|Overall Study|Lack of Efficacy|18|||
48806832|NCT02721732|157133688|FG003|Overall Study|Lack of Efficacy|5|||
48806833|NCT02721732|157133689|FG004|Overall Study|Lack of Efficacy|21|||
48806834|NCT02721732|157133690|FG005|Overall Study|Lack of Efficacy|2|||
48806835|NCT02721732|157133691|FG006|Overall Study|Lack of Efficacy|8|||
48806836|NCT02721732|157133692|FG007|Overall Study|Lack of Efficacy|11|||
48806837|NCT02721732|157133693|FG008|Overall Study|Lack of Efficacy|10|||
48806838|NCT02721732|157133694|FG009|Overall Study|Lack of Efficacy|20|||
48806839|NCT02721732|157133685|FG000|Overall Study|Physician Decision|0|||
48806840|NCT02721732|157133686|FG001|Overall Study|Physician Decision|0|||
48806841|NCT02721732|157133687|FG002|Overall Study|Physician Decision|1|||
48806842|NCT02721732|157133688|FG003|Overall Study|Physician Decision|0|||
48806843|NCT02721732|157133689|FG004|Overall Study|Physician Decision|0|||
48806844|NCT02721732|157133690|FG005|Overall Study|Physician Decision|0|||
48806845|NCT02721732|157133691|FG006|Overall Study|Physician Decision|0|||
48806846|NCT02721732|157133692|FG007|Overall Study|Physician Decision|0|||
48806847|NCT02721732|157133693|FG008|Overall Study|Physician Decision|0|||
48806848|NCT02721732|157133694|FG009|Overall Study|Physician Decision|0|||
48806849|NCT02721732|157133685|FG000|Overall Study|Withdrawal by Subject|1|||
48806850|NCT02721732|157133686|FG001|Overall Study|Withdrawal by Subject|0|||
48806851|NCT02721732|157133687|FG002|Overall Study|Withdrawal by Subject|0|||
48806852|NCT02721732|157133688|FG003|Overall Study|Withdrawal by Subject|0|||
48806853|NCT02721732|157133689|FG004|Overall Study|Withdrawal by Subject|3|||
48806854|NCT02721732|157133690|FG005|Overall Study|Withdrawal by Subject|0|||
48806855|NCT02721732|157133691|FG006|Overall Study|Withdrawal by Subject|1|||
48806856|NCT02721732|157133692|FG007|Overall Study|Withdrawal by Subject|1|||
48806857|NCT02721732|157133693|FG008|Overall Study|Withdrawal by Subject|0|||
48806858|NCT02721732|157133694|FG009|Overall Study|Withdrawal by Subject|1|||
48806859|NCT02721732|157133685|FG000|Overall Study|Participant Choice|1|||
48806860|NCT02721732|157133686|FG001|Overall Study|Participant Choice|0|||
48806861|NCT02721732|157133687|FG002|Overall Study|Participant Choice|0|||
49119930|NCT03654729|158278796|FG001|Overall Study|Protocol Violation|1|||
49119931|NCT03654729|158278797|FG002|Overall Study|Protocol Violation|0|||
49119932|NCT03654729|158278795|FG000|Overall Study|Non-compliance with study drug|0|||
48806862|NCT02721732|157133688|FG003|Overall Study|Participant Choice|0|||
48806863|NCT02721732|157133689|FG004|Overall Study|Participant Choice|0|||
48806864|NCT02721732|157133690|FG005|Overall Study|Participant Choice|0|||
48806865|NCT02721732|157133691|FG006|Overall Study|Participant Choice|0|||
48806866|NCT02721732|157133692|FG007|Overall Study|Participant Choice|0|||
48806867|NCT02721732|157133693|FG008|Overall Study|Participant Choice|0|||
48806868|NCT02721732|157133694|FG009|Overall Study|Participant Choice|1|||
49119933|NCT03654729|158278796|FG001|Overall Study|Non-compliance with study drug|1|||
49119934|NCT03654729|158278797|FG002|Overall Study|Non-compliance with study drug|0|||
49119935|NCT03654729|158278795|FG000|Overall Study|Site terminated by Sponsor|1|||
49119936|NCT03654729|158278796|FG001|Overall Study|Site terminated by Sponsor|0|||
49119937|NCT03654729|158278797|FG002|Overall Study|Site terminated by Sponsor|0|||
49119938|NCT00588146|158278802|FG000|First Intervention (Baseline to 6 mo)|Adverse Event|4|||
48806869|NCT02721732|157133685|FG000|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
48806870|NCT02721732|157133686|FG001|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
48806871|NCT02721732|157133687|FG002|Overall Study|Progression and Exclusion from study due to changed diagnosis|1|||
48806872|NCT02721732|157133688|FG003|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
48806873|NCT02721732|157133689|FG004|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
48806874|NCT02721732|157133690|FG005|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
48806875|NCT02721732|157133691|FG006|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
48806876|NCT02721732|157133692|FG007|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
48856391|NCT01052272|157312839|FG003|Overall Study|decline in health|0|||
48856392|NCT01328756|157312840|FG000|Overall Study|Protocol Violation|4|||
48856393|NCT01328756|157312840|FG000|Overall Study|Adverse Event|39|||
48856394|NCT01328756|157312840|FG000|Overall Study|Lack of Efficacy|5|||
48856395|NCT01328756|157312840|FG000|Overall Study|Withdrawal by Subject|41|||
48856396|NCT01328756|157312840|FG000|Overall Study|Lost to Follow-up|5|||
48856397|NCT01328756|157312840|FG000|Overall Study|Other|29|||
48856398|NCT01560429|157312845|FG000|Overall Study|Protocol Violation|3|||
48856399|NCT01560429|157312846|FG001|Overall Study|Protocol Violation|6|||
48856400|NCT01365546|157312847|FG000|Overall Study|Withdrawal by Subject|1|||
48856401|NCT01365546|157312847|FG000|Overall Study|Screen failure|9|||
48856402|NCT01365546|157312847|FG000|Overall Study|Study termination|1|||
48856403|NCT02066636|157312850|FG000|Overall Study|Disease progression|51|||
48856404|NCT02066636|157312851|FG001|Overall Study|Disease progression|60|||
48916462|NCT03703882|157530033|FG001|Overall Study|Physician Decision|1|||
49119939|NCT00588146|158278803|FG001|First Intervention (Baseline to 6 mo)|Adverse Event|3|||
49119940|NCT00463801|158278808|FG000|Overall Study|Protocol Violation|1|||
49119941|NCT00463801|158278808|FG000|Overall Study|Lack of Efficacy|2|||
49119942|NCT00463801|158278808|FG000|Overall Study|Adverse Event|4|||
49119943|NCT00463801|158278808|FG000|Overall Study|Lost to Follow-up|5|||
49119944|NCT00463801|158278808|FG000|Overall Study|No longer require therapy|1|||
48916463|NCT03703882|157530032|FG000|Overall Study|Progressive disease|1|||
48916464|NCT03703882|157530033|FG001|Overall Study|Progressive disease|0|||
48916465|NCT03703882|157530032|FG000|Overall Study|Withdrawal by parent/guardian|1|||
49119945|NCT00940888|158278809|FG000|Overall Study|Unsuccessful Implant|4|||
49119946|NCT00940888|158278809|FG000|Overall Study|Death|461|||
49119947|NCT00940888|158278809|FG000|Overall Study|Withdrawn - Non-Death|364|||
49119948|NCT00940888|158278809|FG000|Overall Study|Lost to Follow-up|6|||
49119949|NCT04441788|158278812|FG000|Overall Study|Voluntary Withdrawl|0|||
49119950|NCT04441788|158278813|FG001|Overall Study|Voluntary Withdrawl|1|||
49119951|NCT04441788|158278814|FG002|Overall Study|Voluntary Withdrawl|0|||
49119952|NCT04441788|158278812|FG000|Overall Study|Ineligibility|1|||
49119953|NCT04441788|158278813|FG001|Overall Study|Ineligibility|0|||
49119954|NCT04441788|158278814|FG002|Overall Study|Ineligibility|0|||
49119955|NCT04441788|158278812|FG000|Overall Study|Adverse Event|0|||
49119956|NCT04441788|158278813|FG001|Overall Study|Adverse Event|0|||
49119957|NCT04441788|158278814|FG002|Overall Study|Adverse Event|4|||
49119958|NCT04441788|158278812|FG000|Overall Study|Study Terminated by Sponsor|16|||
49119959|NCT04441788|158278813|FG001|Overall Study|Study Terminated by Sponsor|16|||
49119960|NCT04441788|158278814|FG002|Overall Study|Study Terminated by Sponsor|12|||
49119961|NCT00667992|158278817|FG000|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
49119962|NCT00667992|158278818|FG001|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
48916466|NCT03703882|157530033|FG001|Overall Study|Withdrawal by parent/guardian|0|||
48916467|NCT03703882|157530032|FG000|Overall Study|Starting another treatment|0|||
48916468|NCT03703882|157530033|FG001|Overall Study|Starting another treatment|1|||
48916469|NCT03703882|157530032|FG000|Overall Study|noncompliance with study procedures|0|||
48916470|NCT03703882|157530033|FG001|Overall Study|noncompliance with study procedures|1|||
48916471|NCT04179734|157530034|FG000|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|4|||
48916472|NCT04179734|157530035|FG001|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|3|||
48916473|NCT04179734|157530034|FG000|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|0|||
48916474|NCT04179734|157530035|FG001|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|2|||
48916475|NCT02369848|157530036|FG000|Overall Study|Death|1|||
48916476|NCT02369848|157530036|FG000|Overall Study|Withdrawal by Subject|2|||
48916477|NCT02369848|157530036|FG000|Overall Study|Lost to Follow-up|1|||
48916478|NCT00402649|157530037|FG000|Overall Study|Lost to Follow-up|1|||
49119963|NCT00667992|158278817|FG000|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2|||
49119964|NCT00667992|158278818|FG001|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
48916479|NCT00402649|157530037|FG000|Overall Study|Withdrawal by Subject|1|||
48916480|NCT02053168|157530038|FG000|Overall Study|Withdrawal by Subject|1|||
49119965|NCT00667992|158278817|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
48916481|NCT02053168|157530038|FG000|Overall Study|Physician Decision|1|||
48916482|NCT02053168|157530038|FG000|Overall Study|Lost to Follow-up|1|||
48916483|NCT04053868|157530039|FG000|Overall Study|Withdrawal by Subject|1|||
48916484|NCT04053868|157530040|FG001|Overall Study|Withdrawal by Subject|0|||
48916485|NCT03785925|157530042|FG000|Overall Study|Withdrawal by Subject|15|||
49119966|NCT00667992|158278818|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
49119967|NCT00667992|158278817|FG000|First Intervention 100 Mcg Twice Daily|Pregnancy|1|||
48806877|NCT02721732|157133693|FG008|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
48806878|NCT02721732|157133694|FG009|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
48806879|NCT02721732|157133685|FG000|Overall Study|Progression and withdrew consent|1|||
48806880|NCT02721732|157133686|FG001|Overall Study|Progression and withdrew consent|1|||
48806881|NCT02721732|157133687|FG002|Overall Study|Progression and withdrew consent|0|||
48806882|NCT02721732|157133688|FG003|Overall Study|Progression and withdrew consent|0|||
48806883|NCT02721732|157133689|FG004|Overall Study|Progression and withdrew consent|0|||
48806884|NCT02721732|157133690|FG005|Overall Study|Progression and withdrew consent|0|||
48806885|NCT02721732|157133691|FG006|Overall Study|Progression and withdrew consent|0|||
48806886|NCT02721732|157133692|FG007|Overall Study|Progression and withdrew consent|0|||
48806887|NCT02721732|157133693|FG008|Overall Study|Progression and withdrew consent|0|||
48806888|NCT02721732|157133694|FG009|Overall Study|Progression and withdrew consent|1|||
48806889|NCT02721732|157133685|FG000|Overall Study|No evidence of tumor following radical surgery|0|||
48806890|NCT02721732|157133686|FG001|Overall Study|No evidence of tumor following radical surgery|0|||
48806891|NCT02721732|157133687|FG002|Overall Study|No evidence of tumor following radical surgery|0|||
48806892|NCT02721732|157133688|FG003|Overall Study|No evidence of tumor following radical surgery|0|||
48806893|NCT02721732|157133689|FG004|Overall Study|No evidence of tumor following radical surgery|0|||
48806894|NCT02721732|157133690|FG005|Overall Study|No evidence of tumor following radical surgery|1|||
48806895|NCT02721732|157133691|FG006|Overall Study|No evidence of tumor following radical surgery|0|||
48916486|NCT03785925|157530042|FG000|Overall Study|Lost to Follow-up|1|||
48916487|NCT02463409|157530043|FG000|Overall Study|Withdrawal by Subject|1|||
48916488|NCT02463409|157530043|FG000|Overall Study|Screen failure|1|||
48916489|NCT03357731|157530044|FG000|Overall Study|Withdrew consent due to personal reasons|0|||
48916490|NCT03357731|157530045|FG001|Overall Study|Withdrew consent due to personal reasons|0|||
48916491|NCT03357731|157530046|FG002|Overall Study|Withdrew consent due to personal reasons|0|||
48916492|NCT03357731|157530047|FG003|Overall Study|Withdrew consent due to personal reasons|0|||
48916493|NCT03357731|157530048|FG004|Overall Study|Withdrew consent due to personal reasons|1|||
48916494|NCT03357731|157530049|FG005|Overall Study|Withdrew consent due to personal reasons|0|||
48916495|NCT03357731|157530044|FG000|Overall Study|Acute bradycardia and hypotension|0|||
48916496|NCT03357731|157530045|FG001|Overall Study|Acute bradycardia and hypotension|0|||
48916497|NCT03357731|157530046|FG002|Overall Study|Acute bradycardia and hypotension|0|||
48916498|NCT03357731|157530047|FG003|Overall Study|Acute bradycardia and hypotension|1|||
48916499|NCT03357731|157530048|FG004|Overall Study|Acute bradycardia and hypotension|0|||
48916500|NCT03357731|157530049|FG005|Overall Study|Acute bradycardia and hypotension|0|||
49119968|NCT00667992|158278818|FG001|First Intervention 100 Mcg Twice Daily|Pregnancy|0|||
49119969|NCT00667992|158278817|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
49119970|NCT00667992|158278818|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
49119971|NCT00667992|158278817|FG000|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1|||
49119972|NCT00667992|158278818|FG001|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0|||
49119973|NCT00667992|158278817|FG000|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
49119974|NCT00667992|158278818|FG001|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
49119975|NCT00667992|158278817|FG000|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0|||
49119976|NCT00667992|158278818|FG001|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1|||
49119977|NCT00667992|158278817|FG000|Wash-out|Not within one doubling dilution|4|||
49119978|NCT00667992|158278818|FG001|Wash-out|Not within one doubling dilution|3|||
49119979|NCT00667992|158278817|FG000|Wash-out|Failure to wash-out|2|||
49119980|NCT00667992|158278818|FG001|Wash-out|Failure to wash-out|2|||
49119981|NCT00667992|158278817|FG000|Wash-out|Withdrawal by Subject|1|||
49119982|NCT00667992|158278818|FG001|Wash-out|Withdrawal by Subject|0|||
49119983|NCT00667992|158278817|FG000|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1|||
49119984|NCT00667992|158278818|FG001|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
49119985|NCT00667992|158278817|FG000|Third Intervention 100 Mcg Twice Daily|Adverse Event|0|||
49119986|NCT00667992|158278818|FG001|Third Intervention 100 Mcg Twice Daily|Adverse Event|1|||
49119987|NCT01409915|158278826|FG000|Overall Study|Adverse Event|0|||
49119988|NCT01409915|158278827|FG001|Overall Study|Adverse Event|2|||
48916501|NCT03357731|157530044|FG000|Overall Study|Adverse Event|0|||
49119989|NCT01409915|158278826|FG000|Overall Study|Withdrawal by Subject|0|||
49119990|NCT01409915|158278827|FG001|Overall Study|Withdrawal by Subject|1|||
48806896|NCT02721732|157133692|FG007|Overall Study|No evidence of tumor following radical surgery|0|||
48806897|NCT02721732|157133693|FG008|Overall Study|No evidence of tumor following radical surgery|0|||
48806898|NCT02721732|157133694|FG009|Overall Study|No evidence of tumor following radical surgery|0|||
48806899|NCT01845974|157133703|FG000|Overall Study|screen failure|1|||
48806900|NCT01845974|157133704|FG001|Overall Study|screen failure|0|||
48806901|NCT04954586|157133705|FG000|Overall Study|Withdrawal by Subject|5|||
48806902|NCT03489057|157133706|FG000|Overall Study|Lost to Follow-up|16|||
48916502|NCT03357731|157530045|FG001|Overall Study|Adverse Event|0|||
48916503|NCT03357731|157530046|FG002|Overall Study|Adverse Event|0|||
48806903|NCT03489057|157133707|FG001|Overall Study|Lost to Follow-up|16|||
48806904|NCT03489057|157133708|FG002|Overall Study|Lost to Follow-up|14|||
48806905|NCT03489057|157133709|FG003|Overall Study|Lost to Follow-up|14|||
48916504|NCT03357731|157530047|FG003|Overall Study|Adverse Event|0|||
48916505|NCT03357731|157530048|FG004|Overall Study|Adverse Event|0|||
48916506|NCT03357731|157530049|FG005|Overall Study|Adverse Event|1|||
48916507|NCT03357731|157530044|FG000|Overall Study|Hypotension|0|||
48916508|NCT03357731|157530045|FG001|Overall Study|Hypotension|0|||
48916509|NCT03357731|157530046|FG002|Overall Study|Hypotension|1|||
48916510|NCT03357731|157530047|FG003|Overall Study|Hypotension|1|||
48916511|NCT03357731|157530048|FG004|Overall Study|Hypotension|0|||
48916512|NCT03357731|157530049|FG005|Overall Study|Hypotension|0|||
48916513|NCT03357731|157530044|FG000|Overall Study|Lost to Follow-up|0|||
48916514|NCT03357731|157530045|FG001|Overall Study|Lost to Follow-up|0|||
48916515|NCT03357731|157530046|FG002|Overall Study|Lost to Follow-up|0|||
48916516|NCT03357731|157530047|FG003|Overall Study|Lost to Follow-up|1|||
48916517|NCT03357731|157530048|FG004|Overall Study|Lost to Follow-up|0|||
48916518|NCT03357731|157530049|FG005|Overall Study|Lost to Follow-up|0|||
48916519|NCT01239342|157530051|FG000|Overall Study|Adverse Event|1|||
48916520|NCT01239342|157530052|FG001|Overall Study|Adverse Event|0|||
49119991|NCT01409915|158278826|FG000|Overall Study|Protocol Violation|1|||
48916521|NCT01239342|157530051|FG000|Overall Study|Withdrawal by Subject|1|||
48916522|NCT01239342|157530052|FG001|Overall Study|Withdrawal by Subject|5|||
48916523|NCT01239342|157530051|FG000|Overall Study|Reason Unknown|1|||
48916524|NCT01239342|157530052|FG001|Overall Study|Reason Unknown|1|||
48916525|NCT02318667|157530055|FG000|Overall Study|Adverse Event|1|||
49119992|NCT01409915|158278827|FG001|Overall Study|Protocol Violation|0|||
49119993|NCT04826484|158278828|FG000|Overall Study|Lost to Follow-up|2|||
49119994|NCT04826484|158278829|FG001|Overall Study|Lost to Follow-up|0|||
49119995|NCT04727528|158278830|FG000|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|1|||
49119996|NCT04727528|158278831|FG001|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|0|||
49119997|NCT04727528|158278830|FG000|Open-label Period|Randomized who did not receive treatment|1|||
49119998|NCT04727528|158278831|FG001|Open-label Period|Randomized who did not receive treatment|0|||
49119999|NCT04727528|158278830|FG000|Double-blind Treatment Phase|Adverse Event|0|||
49120000|NCT04727528|158278831|FG001|Double-blind Treatment Phase|Adverse Event|1|||
49120001|NCT04727528|158278830|FG000|Double-blind Treatment Phase|Death|0|||
49120002|NCT04727528|158278831|FG001|Double-blind Treatment Phase|Death|1|||
49120003|NCT04727528|158278830|FG000|Double-blind Treatment Phase|Missed doses whilst in hospital|0|||
48806906|NCT03489057|157133706|FG000|Overall Study|Withdrawal by Subject|12|||
48806907|NCT03489057|157133707|FG001|Overall Study|Withdrawal by Subject|12|||
48806908|NCT03489057|157133708|FG002|Overall Study|Withdrawal by Subject|8|||
48806909|NCT03489057|157133709|FG003|Overall Study|Withdrawal by Subject|8|||
48806910|NCT03489057|157133706|FG000|Overall Study|Protocol Violation|7|||
48806911|NCT03489057|157133707|FG001|Overall Study|Protocol Violation|7|||
48806912|NCT03489057|157133708|FG002|Overall Study|Protocol Violation|2|||
48806913|NCT03489057|157133709|FG003|Overall Study|Protocol Violation|2|||
48806914|NCT03599661|157133710|FG000|Overall Study|Lost to Follow-up|9|||
48806915|NCT03635489|157133711|FG000|Overall Study|Death|19|||
48806916|NCT03635489|157133712|FG001|Overall Study|Death|13|||
48806917|NCT03635489|157133711|FG000|Overall Study|Lost to Follow-up|1|||
48806918|NCT03635489|157133712|FG001|Overall Study|Lost to Follow-up|2|||
48806919|NCT03635489|157133711|FG000|Overall Study|Withdrawal by Subject|1|||
48806920|NCT03635489|157133712|FG001|Overall Study|Withdrawal by Subject|2|||
48806921|NCT03635489|157133711|FG000|Overall Study|Study Ended by Sponsor|28|||
48806922|NCT03635489|157133712|FG001|Overall Study|Study Ended by Sponsor|34|||
48806923|NCT03929562|157133713|FG000|From Baseline to 1 Month Follow Up|Lost to Follow-up|2|||
48806924|NCT03929562|157133714|FG001|From Baseline to 1 Month Follow Up|Lost to Follow-up|1|||
48806925|NCT03929562|157133713|FG000|From Baseline to 1 Month Follow Up|Withdrawal by Subject|2|||
48806926|NCT03929562|157133714|FG001|From Baseline to 1 Month Follow Up|Withdrawal by Subject|0|||
48806927|NCT03929562|157133713|FG000|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|2|||
48806928|NCT03929562|157133714|FG001|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|0|||
48806929|NCT00576732|157133719|FG000|DOUBLE BLIND|Adverse Event|0|||
48806930|NCT00576732|157133720|FG001|DOUBLE BLIND|Adverse Event|0|||
48806931|NCT00576732|157133721|FG002|DOUBLE BLIND|Adverse Event|1|||
48806932|NCT00576732|157133722|FG003|DOUBLE BLIND|Adverse Event|0|||
48806933|NCT00576732|157133723|FG004|DOUBLE BLIND|Adverse Event|0|||
48806934|NCT00576732|157133724|FG005|DOUBLE BLIND|Adverse Event|0|||
48916526|NCT02318667|157530055|FG000|Overall Study|Lack of Efficacy|6|||
48806935|NCT00576732|157133719|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
48806936|NCT00576732|157133720|FG001|DOUBLE BLIND|Lost to Follow-up|1|||
48916527|NCT02318667|157530055|FG000|Overall Study|Protocol Violation|2|||
48916528|NCT02257372|157530056|FG000|Overall Study|Adverse Event|3|||
48806937|NCT00576732|157133721|FG002|DOUBLE BLIND|Lost to Follow-up|1|||
48806938|NCT00576732|157133722|FG003|DOUBLE BLIND|Lost to Follow-up|0|||
48806939|NCT00576732|157133723|FG004|DOUBLE BLIND|Lost to Follow-up|0|||
48806940|NCT00576732|157133724|FG005|DOUBLE BLIND|Lost to Follow-up|0|||
48916529|NCT02257372|157530057|FG001|Overall Study|Adverse Event|7|||
48806941|NCT00576732|157133719|FG000|DOUBLE BLIND|Withdrawal by Subject|1|||
48806942|NCT00576732|157133720|FG001|DOUBLE BLIND|Withdrawal by Subject|1|||
48806943|NCT00576732|157133721|FG002|DOUBLE BLIND|Withdrawal by Subject|3|||
48806944|NCT00576732|157133722|FG003|DOUBLE BLIND|Withdrawal by Subject|0|||
48806945|NCT00576732|157133723|FG004|DOUBLE BLIND|Withdrawal by Subject|0|||
48806946|NCT00576732|157133724|FG005|DOUBLE BLIND|Withdrawal by Subject|0|||
48806947|NCT00576732|157133719|FG000|DOUBLE BLIND|OTHER|0|||
48806948|NCT00576732|157133720|FG001|DOUBLE BLIND|OTHER|2|||
48806949|NCT00576732|157133721|FG002|DOUBLE BLIND|OTHER|1|||
48806950|NCT00576732|157133722|FG003|DOUBLE BLIND|OTHER|0|||
48806951|NCT00576732|157133723|FG004|DOUBLE BLIND|OTHER|0|||
48806952|NCT00576732|157133724|FG005|DOUBLE BLIND|OTHER|0|||
48806953|NCT00576732|157133719|FG000|DOUBLE BLIND|Lack of Efficacy|6|||
48806954|NCT00576732|157133720|FG001|DOUBLE BLIND|Lack of Efficacy|1|||
48806955|NCT00576732|157133721|FG002|DOUBLE BLIND|Lack of Efficacy|0|||
48806956|NCT00576732|157133722|FG003|DOUBLE BLIND|Lack of Efficacy|0|||
48806957|NCT00576732|157133723|FG004|DOUBLE BLIND|Lack of Efficacy|0|||
48806958|NCT00576732|157133724|FG005|DOUBLE BLIND|Lack of Efficacy|0|||
48806959|NCT00576732|157133719|FG000|DOUBLE BLIND|Protocol Violation|1|||
48806960|NCT00576732|157133720|FG001|DOUBLE BLIND|Protocol Violation|0|||
48806961|NCT00576732|157133721|FG002|DOUBLE BLIND|Protocol Violation|0|||
48806962|NCT00576732|157133722|FG003|DOUBLE BLIND|Protocol Violation|0|||
48806963|NCT00576732|157133723|FG004|DOUBLE BLIND|Protocol Violation|0|||
48806964|NCT00576732|157133724|FG005|DOUBLE BLIND|Protocol Violation|0|||
48806965|NCT00576732|157133719|FG000|OPEN LABEL|Adverse Event|0|||
48806966|NCT00576732|157133720|FG001|OPEN LABEL|Adverse Event|0|||
48806967|NCT00576732|157133721|FG002|OPEN LABEL|Adverse Event|0|||
48806968|NCT00576732|157133722|FG003|OPEN LABEL|Adverse Event|4|||
48806969|NCT00576732|157133723|FG004|OPEN LABEL|Adverse Event|0|||
48916530|NCT02257372|157530056|FG000|Overall Study|Lack of Efficacy|2|||
48916531|NCT02257372|157530057|FG001|Overall Study|Lack of Efficacy|1|||
48916532|NCT02257372|157530056|FG000|Overall Study|Protocol Violation|1|||
48916533|NCT02257372|157530057|FG001|Overall Study|Protocol Violation|1|||
48806970|NCT00576732|157133724|FG005|OPEN LABEL|Adverse Event|1|||
48806971|NCT00576732|157133719|FG000|OPEN LABEL|Lost to Follow-up|0|||
48806972|NCT00576732|157133720|FG001|OPEN LABEL|Lost to Follow-up|0|||
48806973|NCT00576732|157133721|FG002|OPEN LABEL|Lost to Follow-up|0|||
48916534|NCT02257372|157530056|FG000|Overall Study|Lost to Follow-up|0|||
48916535|NCT02257372|157530057|FG001|Overall Study|Lost to Follow-up|1|||
48916536|NCT02257372|157530056|FG000|Overall Study|Withdrew consent|1|||
48916537|NCT02257372|157530057|FG001|Overall Study|Withdrew consent|0|||
48916538|NCT02634151|157530058|FG000|Overall Study|Withdrawal by Subject|1|||
48916539|NCT02634151|157530059|FG001|Overall Study|Withdrawal by Subject|0|||
48916540|NCT02634151|157530058|FG000|Overall Study|Non-Compliance|0|||
48916541|NCT02634151|157530059|FG001|Overall Study|Non-Compliance|1|||
48916542|NCT02634151|157530058|FG000|Overall Study|Other|0|||
48916543|NCT02634151|157530059|FG001|Overall Study|Other|1|||
48916544|NCT00003535|157530060|FG000|Overall Study|Not evaluable|5|||
48916545|NCT02289742|157530061|FG000|First Wear Period|Adverse event prior to treatment|0|||
48916546|NCT02289742|157530062|FG001|First Wear Period|Adverse event prior to treatment|1|||
48806974|NCT00576732|157133722|FG003|OPEN LABEL|Lost to Follow-up|2|||
48806975|NCT00576732|157133723|FG004|OPEN LABEL|Lost to Follow-up|1|||
48806976|NCT00576732|157133724|FG005|OPEN LABEL|Lost to Follow-up|1|||
48806977|NCT00576732|157133719|FG000|OPEN LABEL|Withdrawal by Subject|0|||
48806978|NCT00576732|157133720|FG001|OPEN LABEL|Withdrawal by Subject|0|||
48916547|NCT02289742|157530063|FG002|First Wear Period|Adverse event prior to treatment|0|||
48916548|NCT02289742|157530064|FG003|First Wear Period|Adverse event prior to treatment|0|||
48916549|NCT02289742|157530061|FG000|First Wear Period|Adverse Event|0|||
48806979|NCT00576732|157133721|FG002|OPEN LABEL|Withdrawal by Subject|0|||
48806980|NCT00576732|157133722|FG003|OPEN LABEL|Withdrawal by Subject|1|||
48806981|NCT00576732|157133723|FG004|OPEN LABEL|Withdrawal by Subject|0|||
48806982|NCT00576732|157133724|FG005|OPEN LABEL|Withdrawal by Subject|1|||
48806983|NCT00576732|157133719|FG000|OPEN LABEL|OTHER|0|||
48806984|NCT00576732|157133720|FG001|OPEN LABEL|OTHER|0|||
48916550|NCT02289742|157530062|FG001|First Wear Period|Adverse Event|0|||
48916551|NCT02289742|157530063|FG002|First Wear Period|Adverse Event|1|||
48806985|NCT00576732|157133721|FG002|OPEN LABEL|OTHER|0|||
48806986|NCT00576732|157133722|FG003|OPEN LABEL|OTHER|0|||
48806987|NCT00576732|157133723|FG004|OPEN LABEL|OTHER|0|||
48806988|NCT00576732|157133724|FG005|OPEN LABEL|OTHER|2|||
48806989|NCT00576732|157133719|FG000|OPEN LABEL|Lack of Efficacy|0|||
48806990|NCT00576732|157133720|FG001|OPEN LABEL|Lack of Efficacy|0|||
48806991|NCT00576732|157133721|FG002|OPEN LABEL|Lack of Efficacy|0|||
48806992|NCT00576732|157133722|FG003|OPEN LABEL|Lack of Efficacy|2|||
48806993|NCT00576732|157133723|FG004|OPEN LABEL|Lack of Efficacy|2|||
48916552|NCT02289742|157530064|FG003|First Wear Period|Adverse Event|0|||
48806994|NCT00576732|157133724|FG005|OPEN LABEL|Lack of Efficacy|3|||
48806995|NCT00576732|157133719|FG000|OPEN LABEL|Protocol Violation|0|||
48806996|NCT00576732|157133720|FG001|OPEN LABEL|Protocol Violation|0|||
48806997|NCT00576732|157133721|FG002|OPEN LABEL|Protocol Violation|0|||
48806998|NCT00576732|157133722|FG003|OPEN LABEL|Protocol Violation|2|||
48806999|NCT00576732|157133723|FG004|OPEN LABEL|Protocol Violation|1|||
48807000|NCT00576732|157133724|FG005|OPEN LABEL|Protocol Violation|0|||
48807001|NCT00094328|157133725|FG000|Overall Study|Lost to Follow-up|1|||
48807002|NCT04737330|157133730|FG000|Treatment Period (Baseline to Week 16)|Lost to Follow-up|1|||
48807003|NCT04737330|157133731|FG001|Treatment Period (Baseline to Week 16)|Lost to Follow-up|0|||
48807004|NCT04737330|157133730|FG000|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|1|||
48807005|NCT04737330|157133731|FG001|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|2|||
48807006|NCT04737330|157133730|FG000|Follow-up Period (Week 16 to Week 108)|Not satisfied|1|||
48807007|NCT04737330|157133731|FG001|Follow-up Period (Week 16 to Week 108)|Not satisfied|0|||
48807008|NCT04737330|157133730|FG000|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|3|||
48807009|NCT04737330|157133731|FG001|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|1|||
48807010|NCT04737330|157133730|FG000|Follow-up Period (Week 16 to Week 108)|No benefit IMP|0|||
48807011|NCT04737330|157133731|FG001|Follow-up Period (Week 16 to Week 108)|No benefit IMP|1|||
48807012|NCT04737330|157133730|FG000|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|0|||
48807013|NCT04737330|157133731|FG001|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|1|||
48807014|NCT00949884|157134869|FG000|Overall Study|Adverse Event|14|||
48916553|NCT02289742|157530061|FG000|First Wear Period|Other prior to treatment|0|||
48916554|NCT02289742|157530062|FG001|First Wear Period|Other prior to treatment|0|||
48916555|NCT02289742|157530063|FG002|First Wear Period|Other prior to treatment|0|||
48916556|NCT02289742|157530064|FG003|First Wear Period|Other prior to treatment|1|||
48916557|NCT02289742|157530061|FG000|Third Wear Period|Adverse Event|0|||
48916558|NCT02289742|157530062|FG001|Third Wear Period|Adverse Event|1|||
48916559|NCT02289742|157530063|FG002|Third Wear Period|Adverse Event|0|||
48916560|NCT02289742|157530064|FG003|Third Wear Period|Adverse Event|0|||
48916561|NCT02289742|157530061|FG000|Third Wear Period|Reason not given|0|||
48916562|NCT02289742|157530062|FG001|Third Wear Period|Reason not given|0|||
48916563|NCT02289742|157530063|FG002|Third Wear Period|Reason not given|0|||
48916564|NCT02289742|157530064|FG003|Third Wear Period|Reason not given|1|||
48916565|NCT00880399|157530068|FG000|Overall Study|Adverse Event|4|||
48916566|NCT00880399|157530069|FG001|Overall Study|Adverse Event|6|||
48916567|NCT00880399|157530070|FG002|Overall Study|Adverse Event|5|||
48916568|NCT00880399|157530068|FG000|Overall Study|Lack of Efficacy|1|||
48916569|NCT00880399|157530069|FG001|Overall Study|Lack of Efficacy|4|||
48916570|NCT00880399|157530070|FG002|Overall Study|Lack of Efficacy|2|||
48916571|NCT00880399|157530068|FG000|Overall Study|Protocol Violation|4|||
48916572|NCT00880399|157530069|FG001|Overall Study|Protocol Violation|4|||
48916573|NCT00880399|157530070|FG002|Overall Study|Protocol Violation|6|||
48916574|NCT00880399|157530068|FG000|Overall Study|Study closed/terminated|3|||
48916575|NCT00880399|157530069|FG001|Overall Study|Study closed/terminated|7|||
48916576|NCT00880399|157530070|FG002|Overall Study|Study closed/terminated|4|||
48916577|NCT00880399|157530068|FG000|Overall Study|Lost to Follow-up|8|||
48916578|NCT00880399|157530069|FG001|Overall Study|Lost to Follow-up|5|||
49120004|NCT04727528|158278831|FG001|Double-blind Treatment Phase|Missed doses whilst in hospital|1|||
49120005|NCT04727528|158278830|FG000|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|0|||
49120006|NCT04727528|158278831|FG001|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|1|||
49120007|NCT04727528|158278830|FG000|Double-blind Treatment Phase|Physician Decision|0|||
49120008|NCT04727528|158278831|FG001|Double-blind Treatment Phase|Physician Decision|1|||
49120009|NCT04727528|158278830|FG000|Double-blind Treatment Phase|Withdrawal by Subject|1|||
49120010|NCT04727528|158278831|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
48709974|NCT02873702|156788721|FG000|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
48709975|NCT02873702|156788722|FG001|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
48709976|NCT02873702|156788723|FG002|Maintenance Period (up to Month 6)|Withdrawal by Subject|2|||
48709977|NCT02873702|156788724|FG003|Maintenance Period (up to Month 6)|Withdrawal by Subject|1|||
48709978|NCT02978781|156788725|FG000|Part A|Adverse Event|1|||
48709979|NCT02978781|156788726|FG001|Part A|Adverse Event|1|||
48709980|NCT02978781|156788727|FG002|Part A|Adverse Event|0|||
48709981|NCT02978781|156788728|FG003|Part A|Adverse Event|0|||
48709982|NCT02978781|156788729|FG004|Part A|Adverse Event|0|||
48709983|NCT02978781|156788725|FG000|Part A|Withdrawal by Subject|0|||
48709984|NCT02978781|156788726|FG001|Part A|Withdrawal by Subject|1|||
48807015|NCT00949884|157134870|FG001|Overall Study|Adverse Event|3|||
48807016|NCT00949884|157134871|FG002|Overall Study|Adverse Event|12|||
48807017|NCT00949884|157134869|FG000|Overall Study|Did not meet inclusion/exclusion|2|||
48916579|NCT00880399|157530070|FG002|Overall Study|Lost to Follow-up|3|||
48709985|NCT02978781|156788727|FG002|Part A|Withdrawal by Subject|0|||
48709986|NCT02978781|156788728|FG003|Part A|Withdrawal by Subject|0|||
48709987|NCT02978781|156788729|FG004|Part A|Withdrawal by Subject|0|||
48916580|NCT00880399|157530068|FG000|Overall Study|Physician Decision|5|||
48916581|NCT00880399|157530069|FG001|Overall Study|Physician Decision|0|||
48916582|NCT00880399|157530070|FG002|Overall Study|Physician Decision|3|||
48916583|NCT00880399|157530068|FG000|Overall Study|Withdrawal by Subject|6|||
48916584|NCT00880399|157530069|FG001|Overall Study|Withdrawal by Subject|3|||
48916585|NCT00880399|157530070|FG002|Overall Study|Withdrawal by Subject|3|||
48807018|NCT00949884|157134870|FG001|Overall Study|Did not meet inclusion/exclusion|1|||
48807019|NCT00949884|157134871|FG002|Overall Study|Did not meet inclusion/exclusion|3|||
48807020|NCT00949884|157134869|FG000|Overall Study|Lost to Follow-up|7|||
48807021|NCT00949884|157134870|FG001|Overall Study|Lost to Follow-up|5|||
48807022|NCT00949884|157134871|FG002|Overall Study|Lost to Follow-up|5|||
48807023|NCT00949884|157134869|FG000|Overall Study|Physician Decision|5|||
48807024|NCT00949884|157134870|FG001|Overall Study|Physician Decision|0|||
48807025|NCT00949884|157134871|FG002|Overall Study|Physician Decision|6|||
48807026|NCT00949884|157134869|FG000|Overall Study|Treatment non-compliance|5|||
48807027|NCT00949884|157134870|FG001|Overall Study|Treatment non-compliance|0|||
48807028|NCT00949884|157134871|FG002|Overall Study|Treatment non-compliance|8|||
48807029|NCT00949884|157134869|FG000|Overall Study|Withdrawal by Subject|13|||
48807030|NCT00949884|157134870|FG001|Overall Study|Withdrawal by Subject|4|||
48807031|NCT00949884|157134871|FG002|Overall Study|Withdrawal by Subject|16|||
48807032|NCT00949884|157134869|FG000|Overall Study|Lack of Efficacy|4|||
48807033|NCT00949884|157134870|FG001|Overall Study|Lack of Efficacy|2|||
48807034|NCT00949884|157134871|FG002|Overall Study|Lack of Efficacy|7|||
48807035|NCT00949884|157134869|FG000|Overall Study|Study terminated by sponsor|0|||
48807036|NCT00949884|157134870|FG001|Overall Study|Study terminated by sponsor|0|||
48807037|NCT00949884|157134871|FG002|Overall Study|Study terminated by sponsor|1|||
48807038|NCT00949715|157134877|FG000|Overall Study|Physician Decision|1|||
48807039|NCT00949715|157134878|FG001|Overall Study|Physician Decision|0|||
48807040|NCT00949715|157134877|FG000|Overall Study|Lost to Follow-up|1|||
48807041|NCT00949715|157134878|FG001|Overall Study|Lost to Follow-up|0|||
48807042|NCT00949715|157134877|FG000|Overall Study|Missing 24 month LVEF measurement|2|||
48807043|NCT00949715|157134878|FG001|Overall Study|Missing 24 month LVEF measurement|0|||
48807044|NCT02026232|157134879|FG000|Overall Study|incomplete visit/missing data|3|||
48807045|NCT02026232|157134880|FG001|Overall Study|incomplete visit/missing data|2|||
48807046|NCT04170686|157134888|FG000|Screening|Physician Decision|12|||
48807047|NCT04170686|157134889|FG001|Screening|Physician Decision|13|||
48807048|NCT04170686|157134888|FG000|Randomization and Treatment|Lost to Follow-up|26|||
48807049|NCT04170686|157134889|FG001|Randomization and Treatment|Lost to Follow-up|15|||
48807050|NCT00861614|157134890|FG000|Overall Study|Disease Progression|182|||
48807051|NCT00861614|157134891|FG001|Overall Study|Disease Progression|263|||
48807052|NCT00861614|157134890|FG000|Overall Study|Study Drug Toxicity|79|||
48807053|NCT00861614|157134891|FG001|Overall Study|Study Drug Toxicity|6|||
48807054|NCT00861614|157134890|FG000|Overall Study|Death|32|||
48807055|NCT00861614|157134891|FG001|Overall Study|Death|19|||
48807056|NCT00861614|157134890|FG000|Overall Study|Adverse Event|27|||
48807057|NCT00861614|157134891|FG001|Overall Study|Adverse Event|23|||
48807058|NCT00861614|157134890|FG000|Overall Study|Withdrawal by Subject|34|||
48807059|NCT00861614|157134891|FG001|Overall Study|Withdrawal by Subject|35|||
48807060|NCT00861614|157134890|FG000|Overall Study|Other|17|||
48807061|NCT00861614|157134891|FG001|Overall Study|Other|22|||
48807062|NCT05050578|157134896|FG000|Period 1, 30 Days|Lost to Follow-up|1|||
48807063|NCT05050578|157134897|FG001|Period 1, 30 Days|Lost to Follow-up|1|||
48807064|NCT05050578|157134896|FG000|Period 1, 30 Days|Withdrawal by Subject|1|||
48807065|NCT05050578|157134897|FG001|Period 1, 30 Days|Withdrawal by Subject|0|||
48807066|NCT05050578|157134896|FG000|Period 2, 30 Days|Protocol Violation|0|||
48807067|NCT05050578|157134897|FG001|Period 2, 30 Days|Protocol Violation|1|||
48807068|NCT04525547|157134900|FG000|Overall Study|Not treated with Ofev|2|||
48807069|NCT04525547|157134900|FG000|Overall Study|Off-label use|2|||
48916586|NCT01040351|157530075|FG000|Overall Study|poor ovarian response|1|||
48916587|NCT01040351|157530076|FG001|Overall Study|poor ovarian response|2|||
48916588|NCT02316340|157530077|FG000|First Progression|Clinical progression|2|||
48916589|NCT02316340|157530078|FG001|First Progression|Clinical progression|1|||
48916590|NCT02316340|157530077|FG000|First Progression|Withdrawal by Subject|1|||
48916591|NCT02316340|157530078|FG001|First Progression|Withdrawal by Subject|0|||
48916592|NCT02159729|157530079|FG000|Overall Study|Adverse Event|0|||
49120011|NCT01826981|158278832|FG000|Overall Study|Lack of Efficacy|0|||
48807070|NCT04525547|157134900|FG000|Overall Study|Lost to Follow-up|1|||
48807071|NCT00787319|157134906|FG000|Overall Study|Lost to Follow-up|2|||
48807072|NCT00787319|157134906|FG000|Overall Study|Withdrawal by Subject|15|||
48807073|NCT00787319|157134906|FG000|Overall Study|Adverse Event|3|||
48807074|NCT00787319|157134906|FG000|Overall Study|Objective progression or relapse|30|||
48807075|NCT00787319|157134906|FG000|Overall Study|Lack of Efficacy|1|||
48807076|NCT00787319|157134906|FG000|Overall Study|Budget exhausted/exceeded|1|||
48807077|NCT00787319|157134906|FG000|Overall Study|Unresponsiveness to visit invitation|1|||
48807078|NCT00787319|157134906|FG000|Overall Study|No health insurance reimbursement|2|||
48807079|NCT00787319|157134906|FG000|Overall Study|Stabilized disease findings|3|||
48807080|NCT00787319|157134906|FG000|Overall Study|Inactive disease|5|||
48807081|NCT03214081|157134907|FG000|Overall Study|Case Report Forms Uncollected|9|||
48807082|NCT03214081|157134907|FG000|Overall Study|Protocol Deviation|54|||
48807083|NCT01054573|157134908|FG000|Overall Study|Adverse Event|1|||
48807084|NCT01054573|157134909|FG001|Overall Study|Adverse Event|0|||
48807085|NCT01054573|157134910|FG002|Overall Study|Adverse Event|1|||
48807086|NCT01054573|157134911|FG003|Overall Study|Adverse Event|1|||
49120012|NCT01826981|158278833|FG001|Overall Study|Lack of Efficacy|1|||
49120013|NCT01826981|158278834|FG002|Overall Study|Lack of Efficacy|0|||
49120014|NCT01826981|158278835|FG003|Overall Study|Lack of Efficacy|0|||
49120015|NCT01826981|158278836|FG004|Overall Study|Lack of Efficacy|5|||
49120016|NCT01826981|158278837|FG005|Overall Study|Lack of Efficacy|0|||
49120017|NCT01826981|158278838|FG006|Overall Study|Lack of Efficacy|0|||
49120018|NCT01826981|158278839|FG007|Overall Study|Lack of Efficacy|8|||
48709988|NCT02978781|156788725|FG000|Part B|Withdrawal by Subject|0|||
48709989|NCT02978781|156788726|FG001|Part B|Withdrawal by Subject|0|||
48709990|NCT02978781|156788727|FG002|Part B|Withdrawal by Subject|0|||
48709991|NCT02978781|156788728|FG003|Part B|Withdrawal by Subject|1|||
48709992|NCT02978781|156788729|FG004|Part B|Withdrawal by Subject|0|||
48709993|NCT02978781|156788725|FG000|Part C|Adverse Event|0|||
48709994|NCT02978781|156788726|FG001|Part C|Adverse Event|0|||
48709995|NCT02978781|156788727|FG002|Part C|Adverse Event|0|||
48709996|NCT02978781|156788728|FG003|Part C|Adverse Event|0|||
48709997|NCT02978781|156788729|FG004|Part C|Adverse Event|2|||
48709998|NCT02978781|156788725|FG000|Part C|Withdrawal by Subject|0|||
48709999|NCT02978781|156788726|FG001|Part C|Withdrawal by Subject|0|||
48710000|NCT02978781|156788727|FG002|Part C|Withdrawal by Subject|0|||
48807087|NCT01054573|157134908|FG000|Overall Study|Lost to Follow-up|0|||
48807088|NCT01054573|157134909|FG001|Overall Study|Lost to Follow-up|2|||
48807089|NCT01054573|157134910|FG002|Overall Study|Lost to Follow-up|0|||
48807090|NCT01054573|157134911|FG003|Overall Study|Lost to Follow-up|0|||
48807091|NCT01054573|157134908|FG000|Overall Study|Withdrawal by Subject|0|||
48807092|NCT01054573|157134909|FG001|Overall Study|Withdrawal by Subject|2|||
48807093|NCT01054573|157134910|FG002|Overall Study|Withdrawal by Subject|2|||
48807094|NCT01054573|157134911|FG003|Overall Study|Withdrawal by Subject|1|||
48807095|NCT01216163|157134913|FG000|Overall Study|Withdrawal by Subject|1|||
48916593|NCT02159729|157530080|FG001|Overall Study|Adverse Event|1|||
48916594|NCT02159729|157530079|FG000|Overall Study|Subject's Request|13|||
48916595|NCT02159729|157530080|FG001|Overall Study|Subject's Request|10|||
48916596|NCT02159729|157530079|FG000|Overall Study|Lost to Follow-up|24|||
48916597|NCT02159729|157530080|FG001|Overall Study|Lost to Follow-up|9|||
48916598|NCT02159729|157530079|FG000|Overall Study|Non compliance|2|||
48916599|NCT02159729|157530080|FG001|Overall Study|Non compliance|0|||
48916600|NCT02159729|157530079|FG000|Overall Study|Other Unspecified|3|||
48916601|NCT02159729|157530080|FG001|Overall Study|Other Unspecified|1|||
48916602|NCT01476475|157530081|FG000|Overall Study|Adverse Event|6|||
48916603|NCT01476475|157530082|FG001|Overall Study|Adverse Event|0|||
48916604|NCT01476475|157530081|FG000|Overall Study|Poor compliance to protocol|1|||
48916605|NCT01476475|157530082|FG001|Overall Study|Poor compliance to protocol|1|||
48916606|NCT01476475|157530081|FG000|Overall Study|Other reasons|4|||
48916607|NCT01476475|157530082|FG001|Overall Study|Other reasons|2|||
48916608|NCT00326209|157530083|FG000|Overall Study|Adverse Event|28|||
48916609|NCT00326209|157530083|FG000|Overall Study|Withdrawal by Subject|22|||
48916610|NCT00326209|157530083|FG000|Overall Study|Lack of Efficacy|31|||
48916611|NCT00326209|157530083|FG000|Overall Study|Lost to Follow-up|18|||
48916612|NCT00326209|157530083|FG000|Overall Study|Participant non-compliant|6|||
48916613|NCT00326209|157530083|FG000|Overall Study|Sponsor closed study|173|||
48916614|NCT00326209|157530083|FG000|Overall Study|Prohibited medication use|1|||
48916615|NCT00326209|157530083|FG000|Overall Study|Violation of entry criteria|1|||
48916616|NCT00326209|157530083|FG000|Overall Study|Withdrawn in error|1|||
48916617|NCT00326209|157530083|FG000|Overall Study|Pregnancy|1|||
48916618|NCT02037295|157530084|FG000|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
48916619|NCT02037295|157530085|FG001|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
48916620|NCT02037295|157530086|FG002|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
48916621|NCT02037295|157530087|FG003|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
48916622|NCT01278745|157530088|FG000|Overall Study|Death|2|||
48916623|NCT01278745|157530089|FG001|Overall Study|Death|5|||
48916624|NCT01278745|157530090|FG002|Overall Study|Death|7|||
48916625|NCT01278745|157530091|FG003|Overall Study|Death|0|||
48916626|NCT01278745|157530088|FG000|Overall Study|Physician Decision|1|||
48916627|NCT01278745|157530089|FG001|Overall Study|Physician Decision|0|||
48916628|NCT01278745|157530090|FG002|Overall Study|Physician Decision|0|||
48916629|NCT01278745|157530091|FG003|Overall Study|Physician Decision|9|||
48916630|NCT01278745|157530088|FG000|Overall Study|Withdrawal by Subject|1|||
48916631|NCT01278745|157530089|FG001|Overall Study|Withdrawal by Subject|1|||
48916632|NCT01278745|157530090|FG002|Overall Study|Withdrawal by Subject|5|||
48916633|NCT01278745|157530091|FG003|Overall Study|Withdrawal by Subject|1|||
48916634|NCT01278745|157530088|FG000|Overall Study|Sponsor Decision|1|||
48710001|NCT02978781|156788728|FG003|Part C|Withdrawal by Subject|0|||
48710002|NCT02978781|156788729|FG004|Part C|Withdrawal by Subject|1|||
48807096|NCT01216163|157134914|FG001|Overall Study|Withdrawal by Subject|1|||
48807097|NCT01216163|157134915|FG002|Overall Study|Withdrawal by Subject|0|||
48807098|NCT00152009|157134916|FG000|Overall Study|Adverse Event|9|||
48710003|NCT02978781|156788725|FG000|Part C|Tremor not improved due to Topamax discontinuation|0|||
49120019|NCT01826981|158278840|FG008|Overall Study|Lack of Efficacy|7|||
49120020|NCT01826981|158278841|FG009|Overall Study|Lack of Efficacy|0|||
48916635|NCT01278745|157530089|FG001|Overall Study|Sponsor Decision|0|||
48916636|NCT01278745|157530090|FG002|Overall Study|Sponsor Decision|62|||
48916637|NCT01278745|157530091|FG003|Overall Study|Sponsor Decision|6|||
48916638|NCT01278745|157530088|FG000|Overall Study|Ineligible|0|||
48916639|NCT01278745|157530089|FG001|Overall Study|Ineligible|0|||
48916640|NCT01278745|157530090|FG002|Overall Study|Ineligible|42|||
48916641|NCT01278745|157530091|FG003|Overall Study|Ineligible|61|||
48916642|NCT01278745|157530088|FG000|Overall Study|Moves,enrollment in mx studies, et al.|0|||
48916643|NCT01278745|157530089|FG001|Overall Study|Moves,enrollment in mx studies, et al.|0|||
48916644|NCT01278745|157530090|FG002|Overall Study|Moves,enrollment in mx studies, et al.|5|||
48916645|NCT01278745|157530091|FG003|Overall Study|Moves,enrollment in mx studies, et al.|1|||
48916646|NCT00960661|157530092|FG000|Basal Insulin Optimization Phase (BIO)|Adverse Event|6|||
48916647|NCT00960661|157530093|FG001|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
48916648|NCT00960661|157530094|FG002|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
48916649|NCT00960661|157530092|FG000|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4|||
48916650|NCT00960661|157530093|FG001|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
48916651|NCT00960661|157530094|FG002|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
48916652|NCT00960661|157530092|FG000|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331|||
48916653|NCT00960661|157530093|FG001|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
48916654|NCT00960661|157530094|FG002|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
48916655|NCT00960661|157530092|FG000|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47|||
48916656|NCT00960661|157530093|FG001|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
48916657|NCT00960661|157530094|FG002|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
48916658|NCT00960661|157530092|FG000|Basal Insulin Optimization Phase (BIO)|Physician Decision|8|||
48916659|NCT00960661|157530093|FG001|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
48916660|NCT00960661|157530094|FG002|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
48916661|NCT00960661|157530092|FG000|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3|||
48916662|NCT00960661|157530093|FG001|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
48916663|NCT00960661|157530094|FG002|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
48916664|NCT00960661|157530092|FG000|Interventional Phase|Adverse Event|0|||
48916665|NCT00960661|157530093|FG001|Interventional Phase|Adverse Event|17|||
48916666|NCT00960661|157530094|FG002|Interventional Phase|Adverse Event|8|||
48916667|NCT00960661|157530092|FG000|Interventional Phase|Death|0|||
48916668|NCT00960661|157530093|FG001|Interventional Phase|Death|1|||
48916669|NCT00960661|157530094|FG002|Interventional Phase|Death|0|||
48916670|NCT00960661|157530092|FG000|Interventional Phase|Lost to Follow-up|0|||
48916671|NCT00960661|157530093|FG001|Interventional Phase|Lost to Follow-up|0|||
48916672|NCT00960661|157530094|FG002|Interventional Phase|Lost to Follow-up|2|||
48916673|NCT00960661|157530092|FG000|Interventional Phase|entry criteria not met|0|||
48916674|NCT00960661|157530093|FG001|Interventional Phase|entry criteria not met|3|||
48916675|NCT00960661|157530094|FG002|Interventional Phase|entry criteria not met|0|||
48916676|NCT00960661|157530092|FG000|Interventional Phase|Protocol Violation|0|||
48916677|NCT00960661|157530093|FG001|Interventional Phase|Protocol Violation|7|||
48916678|NCT00960661|157530094|FG002|Interventional Phase|Protocol Violation|2|||
48916679|NCT00960661|157530092|FG000|Interventional Phase|Withdrawal by Subject|0|||
48916680|NCT00960661|157530093|FG001|Interventional Phase|Withdrawal by Subject|18|||
48916681|NCT00960661|157530094|FG002|Interventional Phase|Withdrawal by Subject|29|||
48916682|NCT00960661|157530092|FG000|Interventional Phase|Physician Decision|0|||
48916683|NCT00960661|157530093|FG001|Interventional Phase|Physician Decision|3|||
48916684|NCT00960661|157530094|FG002|Interventional Phase|Physician Decision|5|||
48916685|NCT00960661|157530092|FG000|Interventional Phase|sponsor decision|0|||
48916686|NCT00960661|157530093|FG001|Interventional Phase|sponsor decision|1|||
48916687|NCT00960661|157530094|FG002|Interventional Phase|sponsor decision|0|||
48916688|NCT00960661|157530092|FG000|Interventional Phase|Lack of Efficacy|0|||
48916689|NCT00960661|157530093|FG001|Interventional Phase|Lack of Efficacy|2|||
48916690|NCT00960661|157530094|FG002|Interventional Phase|Lack of Efficacy|0|||
48916691|NCT03134599|157530100|FG000|Week 1|Lost to Follow-up|0|||
48916692|NCT03134599|157530101|FG001|Week 1|Lost to Follow-up|0|||
48916693|NCT03134599|157530102|FG002|Week 1|Lost to Follow-up|0|||
48916694|NCT03134599|157530103|FG003|Week 1|Lost to Follow-up|0|||
48916695|NCT03134599|157530104|FG004|Week 1|Lost to Follow-up|1|||
48916696|NCT03134599|157530105|FG005|Week 1|Lost to Follow-up|0|||
48916697|NCT03134599|157530100|FG000|Week 2|Lost to Follow-up|1|||
49120021|NCT01826981|158278842|FG010|Overall Study|Lack of Efficacy|1|||
49120022|NCT01826981|158278843|FG011|Overall Study|Lack of Efficacy|0|||
48710004|NCT02978781|156788726|FG001|Part C|Tremor not improved due to Topamax discontinuation|0|||
48710005|NCT02978781|156788727|FG002|Part C|Tremor not improved due to Topamax discontinuation|0|||
48916698|NCT03134599|157530101|FG001|Week 2|Lost to Follow-up|0|||
48916699|NCT03134599|157530102|FG002|Week 2|Lost to Follow-up|0|||
48916700|NCT03134599|157530103|FG003|Week 2|Lost to Follow-up|1|||
48916701|NCT03134599|157530104|FG004|Week 2|Lost to Follow-up|1|||
48916702|NCT03134599|157530105|FG005|Week 2|Lost to Follow-up|0|||
48916703|NCT03134599|157530100|FG000|Week 3|Lost to Follow-up|0|||
48916704|NCT03134599|157530101|FG001|Week 3|Lost to Follow-up|0|||
49120023|NCT01826981|158278844|FG012|Overall Study|Lack of Efficacy|0|||
49120024|NCT01826981|158278845|FG013|Overall Study|Lack of Efficacy|3|||
49120025|NCT01826981|158278846|FG014|Overall Study|Lack of Efficacy|0|||
49120026|NCT01826981|158278832|FG000|Overall Study|Lost to Follow-up|0|||
49120027|NCT01826981|158278833|FG001|Overall Study|Lost to Follow-up|0|||
49120028|NCT01826981|158278834|FG002|Overall Study|Lost to Follow-up|0|||
49120029|NCT01826981|158278835|FG003|Overall Study|Lost to Follow-up|0|||
48916705|NCT03134599|157530102|FG002|Week 3|Lost to Follow-up|0|||
49120030|NCT01826981|158278836|FG004|Overall Study|Lost to Follow-up|1|||
49120031|NCT01826981|158278837|FG005|Overall Study|Lost to Follow-up|1|||
49120032|NCT01826981|158278838|FG006|Overall Study|Lost to Follow-up|0|||
49120033|NCT01826981|158278839|FG007|Overall Study|Lost to Follow-up|1|||
49120034|NCT01826981|158278840|FG008|Overall Study|Lost to Follow-up|0|||
49120035|NCT01826981|158278841|FG009|Overall Study|Lost to Follow-up|1|||
49120036|NCT01826981|158278842|FG010|Overall Study|Lost to Follow-up|1|||
49120037|NCT01826981|158278843|FG011|Overall Study|Lost to Follow-up|1|||
49120038|NCT01826981|158278844|FG012|Overall Study|Lost to Follow-up|1|||
49120039|NCT01826981|158278845|FG013|Overall Study|Lost to Follow-up|0|||
49120040|NCT01826981|158278846|FG014|Overall Study|Lost to Follow-up|0|||
49120041|NCT01826981|158278832|FG000|Overall Study|Withdrew Consent|0|||
49120042|NCT01826981|158278833|FG001|Overall Study|Withdrew Consent|0|||
49120043|NCT01826981|158278834|FG002|Overall Study|Withdrew Consent|0|||
49120044|NCT01826981|158278835|FG003|Overall Study|Withdrew Consent|0|||
48916706|NCT03134599|157530103|FG003|Week 3|Lost to Follow-up|1|||
48916707|NCT03134599|157530104|FG004|Week 3|Lost to Follow-up|0|||
48916708|NCT03134599|157530105|FG005|Week 3|Lost to Follow-up|1|||
48916709|NCT01033825|157530126|FG000|Overall Study|Withdrawal by Subject|2|||
48916710|NCT01033825|157530127|FG001|Overall Study|Withdrawal by Subject|3|||
48916711|NCT01033825|157530128|FG002|Overall Study|Withdrawal by Subject|2|||
48916712|NCT01033825|157530129|FG003|Overall Study|Withdrawal by Subject|1|||
48916713|NCT01033825|157530130|FG004|Overall Study|Withdrawal by Subject|1|||
48916714|NCT01033825|157530131|FG005|Overall Study|Withdrawal by Subject|0|||
48916715|NCT01033825|157530132|FG006|Overall Study|Withdrawal by Subject|0|||
48916716|NCT01033825|157530126|FG000|Overall Study|Adverse Event|0|||
48916717|NCT01033825|157530127|FG001|Overall Study|Adverse Event|0|||
48916718|NCT01033825|157530128|FG002|Overall Study|Adverse Event|0|||
48916719|NCT01033825|157530129|FG003|Overall Study|Adverse Event|1|||
48916720|NCT01033825|157530130|FG004|Overall Study|Adverse Event|0|||
48916721|NCT01033825|157530131|FG005|Overall Study|Adverse Event|0|||
48916722|NCT01033825|157530132|FG006|Overall Study|Adverse Event|0|||
48916723|NCT01033825|157530126|FG000|Overall Study|Protocol Violation|1|||
48916724|NCT01033825|157530127|FG001|Overall Study|Protocol Violation|0|||
48916725|NCT01033825|157530128|FG002|Overall Study|Protocol Violation|0|||
49120045|NCT01826981|158278836|FG004|Overall Study|Withdrew Consent|0|||
48710006|NCT02978781|156788728|FG003|Part C|Tremor not improved due to Topamax discontinuation|0|||
48916726|NCT01033825|157530129|FG003|Overall Study|Protocol Violation|0|||
48916727|NCT01033825|157530130|FG004|Overall Study|Protocol Violation|0|||
48916728|NCT01033825|157530131|FG005|Overall Study|Protocol Violation|0|||
48916729|NCT01033825|157530132|FG006|Overall Study|Protocol Violation|0|||
48916730|NCT01033825|157530126|FG000|Overall Study|Other|0|||
48916731|NCT01033825|157530127|FG001|Overall Study|Other|0|||
48916732|NCT01033825|157530128|FG002|Overall Study|Other|0|||
48916733|NCT01033825|157530129|FG003|Overall Study|Other|0|||
48916734|NCT01033825|157530130|FG004|Overall Study|Other|1|||
48916735|NCT01033825|157530131|FG005|Overall Study|Other|0|||
48916736|NCT01033825|157530132|FG006|Overall Study|Other|0|||
48916737|NCT00923130|157530135|FG000|Overall Study|Stopped treatment due to progression|17|||
48916738|NCT00923130|157530135|FG000|Overall Study|Death|1|||
48916739|NCT00923130|157530135|FG000|Overall Study|Discontinued treatment due to toxicities|3|||
48916740|NCT00923130|157530135|FG000|Overall Study|Switched to alternative treatment|2|||
48916741|NCT00923130|157530135|FG000|Overall Study|Refused further treatment|2|||
48916742|NCT03159091|157530136|FG000|Overall Study|Incorrect inclusion ineligible patient|5|||
49120046|NCT01826981|158278837|FG005|Overall Study|Withdrew Consent|0|||
49120047|NCT01826981|158278838|FG006|Overall Study|Withdrew Consent|1|||
49120048|NCT01826981|158278839|FG007|Overall Study|Withdrew Consent|1|||
49120049|NCT01826981|158278840|FG008|Overall Study|Withdrew Consent|0|||
49120050|NCT01826981|158278841|FG009|Overall Study|Withdrew Consent|0|||
48710007|NCT02978781|156788729|FG004|Part C|Tremor not improved due to Topamax discontinuation|1|||
48916743|NCT03159091|157530137|FG001|Overall Study|Incorrect inclusion ineligible patient|3|||
48916744|NCT03159091|157530136|FG000|Overall Study|Patient has taken no dose of study drug|0|||
48916745|NCT03159091|157530137|FG001|Overall Study|Patient has taken no dose of study drug|1|||
48916746|NCT03693625|157530138|FG000|Overall Study|Adverse Event|2|||
48916747|NCT03693625|157530139|FG001|Overall Study|Adverse Event|0|||
48916748|NCT03693625|157530138|FG000|Overall Study|Study Terminated By Sponsor|20|||
48916749|NCT03693625|157530139|FG001|Overall Study|Study Terminated By Sponsor|7|||
48916750|NCT03693625|157530138|FG000|Overall Study|Withdrawal by Subject|1|||
48916751|NCT03693625|157530139|FG001|Overall Study|Withdrawal by Subject|1|||
48916752|NCT00761514|157530142|FG000|Overall Study|Adverse Event|1|||
48916753|NCT00761514|157530142|FG000|Overall Study|Withdrawal by Subject|2|||
48916754|NCT00761514|157530142|FG000|Overall Study|Lost to Follow-up|1|||
48916755|NCT00761514|157530142|FG000|Overall Study|Health insurance didn't cover study drug|1|||
48916756|NCT00761514|157530142|FG000|Overall Study|Problem complying with study visit|1|||
48916757|NCT00761514|157530142|FG000|Overall Study|Unable to pay for medications|1|||
48916758|NCT01003210|157530143|FG000|Overall Study|Lost to Follow-up|1|||
48916759|NCT01003210|157530144|FG001|Overall Study|Lost to Follow-up|3|||
49120051|NCT01826981|158278842|FG010|Overall Study|Withdrew Consent|0|||
49120052|NCT01826981|158278843|FG011|Overall Study|Withdrew Consent|1|||
49120053|NCT01826981|158278844|FG012|Overall Study|Withdrew Consent|0|||
49120054|NCT01826981|158278845|FG013|Overall Study|Withdrew Consent|1|||
49120055|NCT01826981|158278846|FG014|Overall Study|Withdrew Consent|0|||
49120056|NCT01826981|158278832|FG000|Overall Study|Adverse Event|0|||
49120057|NCT01826981|158278833|FG001|Overall Study|Adverse Event|0|||
49120058|NCT01826981|158278834|FG002|Overall Study|Adverse Event|0|||
48916760|NCT03077685|157530147|FG000|Overall Study|Lost to Follow-up|0|||
48916761|NCT03077685|157530148|FG001|Overall Study|Lost to Follow-up|0|||
49120059|NCT01826981|158278835|FG003|Overall Study|Adverse Event|0|||
49120060|NCT01826981|158278836|FG004|Overall Study|Adverse Event|1|||
49120061|NCT01826981|158278837|FG005|Overall Study|Adverse Event|0|||
48916762|NCT03077685|157530149|FG002|Overall Study|Lost to Follow-up|0|||
48916763|NCT03077685|157530150|FG003|Overall Study|Lost to Follow-up|0|||
48916764|NCT03077685|157530151|FG004|Overall Study|Lost to Follow-up|1|||
48916765|NCT03077685|157530147|FG000|Overall Study|Death|0|||
48916766|NCT03077685|157530148|FG001|Overall Study|Death|0|||
48916767|NCT03077685|157530149|FG002|Overall Study|Death|1|||
48916768|NCT03077685|157530150|FG003|Overall Study|Death|1|||
48916769|NCT03077685|157530151|FG004|Overall Study|Death|3|||
48916770|NCT03077685|157530147|FG000|Overall Study|Withdrawal by Subject|0|||
48916771|NCT03077685|157530148|FG001|Overall Study|Withdrawal by Subject|0|||
48916772|NCT03077685|157530149|FG002|Overall Study|Withdrawal by Subject|0|||
48916773|NCT03077685|157530150|FG003|Overall Study|Withdrawal by Subject|2|||
48916774|NCT03077685|157530151|FG004|Overall Study|Withdrawal by Subject|1|||
48916775|NCT03077685|157530147|FG000|Overall Study|Physician Decision|0|||
48916776|NCT03077685|157530148|FG001|Overall Study|Physician Decision|0|||
48916777|NCT03077685|157530149|FG002|Overall Study|Physician Decision|1|||
48916778|NCT03077685|157530150|FG003|Overall Study|Physician Decision|0|||
49120062|NCT01826981|158278838|FG006|Overall Study|Adverse Event|0|||
49120063|NCT01826981|158278839|FG007|Overall Study|Adverse Event|0|||
48710008|NCT02563067|156788730|FG000|Overall Study|Subject/guardian decision|14|||
48710009|NCT02563067|156788731|FG001|Overall Study|Subject/guardian decision|20|||
48916779|NCT03077685|157530151|FG004|Overall Study|Physician Decision|3|||
48916780|NCT03077685|157530147|FG000|Overall Study|Disease Progression|1|||
48916781|NCT03077685|157530148|FG001|Overall Study|Disease Progression|0|||
49120064|NCT01826981|158278840|FG008|Overall Study|Adverse Event|0|||
48710010|NCT02563067|156788732|FG002|Overall Study|Subject/guardian decision|16|||
48710011|NCT02563067|156788730|FG000|Overall Study|Physician Decision|0|||
48710012|NCT02563067|156788731|FG001|Overall Study|Physician Decision|1|||
48710013|NCT02563067|156788732|FG002|Overall Study|Physician Decision|3|||
48710014|NCT02563067|156788730|FG000|Overall Study|Lost to Follow-up|1|||
48710015|NCT02563067|156788731|FG001|Overall Study|Lost to Follow-up|2|||
48916782|NCT03077685|157530149|FG002|Overall Study|Disease Progression|0|||
48916783|NCT03077685|157530150|FG003|Overall Study|Disease Progression|2|||
48916784|NCT03077685|157530151|FG004|Overall Study|Disease Progression|1|||
48916785|NCT03077685|157530147|FG000|Overall Study|Withdrawn to proceed to surgery|0|||
48916786|NCT03077685|157530148|FG001|Overall Study|Withdrawn to proceed to surgery|0|||
48916787|NCT03077685|157530149|FG002|Overall Study|Withdrawn to proceed to surgery|0|||
48916788|NCT03077685|157530150|FG003|Overall Study|Withdrawn to proceed to surgery|1|||
49120065|NCT01826981|158278841|FG009|Overall Study|Adverse Event|0|||
49120066|NCT01826981|158278842|FG010|Overall Study|Adverse Event|0|||
49120067|NCT01826981|158278843|FG011|Overall Study|Adverse Event|0|||
49120068|NCT01826981|158278844|FG012|Overall Study|Adverse Event|0|||
48916789|NCT03077685|157530151|FG004|Overall Study|Withdrawn to proceed to surgery|1|||
48916790|NCT03077685|157530147|FG000|Overall Study|Subject entered hospice care|0|||
49120069|NCT01826981|158278845|FG013|Overall Study|Adverse Event|0|||
49120070|NCT01826981|158278846|FG014|Overall Study|Adverse Event|0|||
48916791|NCT03077685|157530148|FG001|Overall Study|Subject entered hospice care|0|||
48916792|NCT03077685|157530149|FG002|Overall Study|Subject entered hospice care|0|||
48916793|NCT03077685|157530150|FG003|Overall Study|Subject entered hospice care|0|||
48916794|NCT03077685|157530151|FG004|Overall Study|Subject entered hospice care|1|||
48916795|NCT02116777|157530155|FG000|Overall Study|Adverse Event|0|||
48916796|NCT02116777|157530156|FG001|Overall Study|Adverse Event|0|||
48916797|NCT02116777|157530157|FG002|Overall Study|Adverse Event|0|||
48916798|NCT02116777|157530158|FG003|Overall Study|Adverse Event|0|||
48916799|NCT02116777|157530159|FG004|Overall Study|Adverse Event|2|||
48916800|NCT02116777|157530160|FG005|Overall Study|Adverse Event|2|||
48916801|NCT02116777|157530161|FG006|Overall Study|Adverse Event|0|||
48916802|NCT02116777|157530155|FG000|Overall Study|Death|0|||
48916803|NCT02116777|157530156|FG001|Overall Study|Death|0|||
48916804|NCT02116777|157530157|FG002|Overall Study|Death|0|||
48916805|NCT02116777|157530158|FG003|Overall Study|Death|1|||
48916806|NCT02116777|157530159|FG004|Overall Study|Death|0|||
48916807|NCT02116777|157530160|FG005|Overall Study|Death|0|||
48916808|NCT02116777|157530161|FG006|Overall Study|Death|0|||
48916809|NCT02116777|157530155|FG000|Overall Study|Lack of Efficacy|3|||
48916810|NCT02116777|157530156|FG001|Overall Study|Lack of Efficacy|3|||
48916811|NCT02116777|157530157|FG002|Overall Study|Lack of Efficacy|3|||
48916812|NCT02116777|157530158|FG003|Overall Study|Lack of Efficacy|8|||
48916813|NCT02116777|157530159|FG004|Overall Study|Lack of Efficacy|4|||
48916814|NCT02116777|157530160|FG005|Overall Study|Lack of Efficacy|1|||
48916815|NCT02116777|157530161|FG006|Overall Study|Lack of Efficacy|9|||
48916816|NCT02116777|157530155|FG000|Overall Study|Physician Decision|0|||
48916817|NCT02116777|157530156|FG001|Overall Study|Physician Decision|0|||
48916818|NCT02116777|157530157|FG002|Overall Study|Physician Decision|0|||
48916819|NCT02116777|157530158|FG003|Overall Study|Physician Decision|2|||
48916820|NCT02116777|157530159|FG004|Overall Study|Physician Decision|0|||
48916821|NCT02116777|157530160|FG005|Overall Study|Physician Decision|0|||
48916822|NCT02116777|157530161|FG006|Overall Study|Physician Decision|0|||
48916823|NCT02116777|157530155|FG000|Overall Study|Protocol Violation|0|||
48916824|NCT02116777|157530156|FG001|Overall Study|Protocol Violation|0|||
48916825|NCT02116777|157530157|FG002|Overall Study|Protocol Violation|0|||
48916826|NCT02116777|157530158|FG003|Overall Study|Protocol Violation|1|||
48916827|NCT02116777|157530159|FG004|Overall Study|Protocol Violation|0|||
48916828|NCT02116777|157530160|FG005|Overall Study|Protocol Violation|0|||
48916829|NCT02116777|157530161|FG006|Overall Study|Protocol Violation|0|||
48916830|NCT02116777|157530155|FG000|Overall Study|Withdrawal by Subject|0|||
48916831|NCT02116777|157530156|FG001|Overall Study|Withdrawal by Subject|0|||
48916832|NCT02116777|157530157|FG002|Overall Study|Withdrawal by Subject|0|||
48916833|NCT02116777|157530158|FG003|Overall Study|Withdrawal by Subject|1|||
48916834|NCT02116777|157530159|FG004|Overall Study|Withdrawal by Subject|0|||
48916835|NCT02116777|157530160|FG005|Overall Study|Withdrawal by Subject|0|||
48916836|NCT02116777|157530161|FG006|Overall Study|Withdrawal by Subject|0|||
48916837|NCT05038020|157530162|FG000|Overall Study|Early Termination|3|||
48916838|NCT05038020|157530163|FG001|Overall Study|Early Termination|0|||
48916839|NCT03581786|157532150|FG000|Overall Study|Death|17|||
48916840|NCT03581786|157532151|FG001|Overall Study|Death|12|||
48916841|NCT03581786|157532150|FG000|Overall Study|Withdrawal by Subject|2|||
48916842|NCT03581786|157532151|FG001|Overall Study|Withdrawal by Subject|4|||
49120071|NCT01826981|158278832|FG000|Overall Study|Upper G-I Haemorrhage|0|||
49120072|NCT01826981|158278833|FG001|Overall Study|Upper G-I Haemorrhage|0|||
49120073|NCT01826981|158278834|FG002|Overall Study|Upper G-I Haemorrhage|0|||
49120074|NCT01826981|158278835|FG003|Overall Study|Upper G-I Haemorrhage|0|||
49120075|NCT01826981|158278836|FG004|Overall Study|Upper G-I Haemorrhage|0|||
49120076|NCT01826981|158278837|FG005|Overall Study|Upper G-I Haemorrhage|0|||
49120077|NCT01826981|158278838|FG006|Overall Study|Upper G-I Haemorrhage|0|||
48916843|NCT03581786|157532150|FG000|Overall Study|Lost to Follow-up|1|||
48916844|NCT03581786|157532151|FG001|Overall Study|Lost to Follow-up|0|||
48916845|NCT03581786|157532150|FG000|Overall Study|reason other than specified above|0|||
48916846|NCT03581786|157532151|FG001|Overall Study|reason other than specified above|1|||
48916847|NCT03581786|157532150|FG000|Overall Study|Ongoing in the study|123|||
48916848|NCT03581786|157532151|FG001|Overall Study|Ongoing in the study|129|||
49120078|NCT01826981|158278839|FG007|Overall Study|Upper G-I Haemorrhage|0|||
48916849|NCT01251653|157532152|FG000|Overall Study|Progressive Disease|1|||
48710016|NCT02563067|156788732|FG002|Overall Study|Lost to Follow-up|0|||
48916850|NCT01251653|157532153|FG001|Overall Study|Progressive Disease|7|||
48916851|NCT01251653|157532154|FG002|Overall Study|Progressive Disease|16|||
48916852|NCT01251653|157532155|FG003|Overall Study|Progressive Disease|4|||
48916853|NCT01251653|157532156|FG004|Overall Study|Progressive Disease|0|||
48916854|NCT01251653|157532157|FG005|Overall Study|Progressive Disease|17|||
48916855|NCT01251653|157532158|FG006|Overall Study|Progressive Disease|14|||
49120079|NCT01826981|158278840|FG008|Overall Study|Upper G-I Haemorrhage|0|||
49120080|NCT01826981|158278841|FG009|Overall Study|Upper G-I Haemorrhage|0|||
49120081|NCT01826981|158278842|FG010|Overall Study|Upper G-I Haemorrhage|0|||
49120082|NCT01826981|158278843|FG011|Overall Study|Upper G-I Haemorrhage|0|||
49120083|NCT01826981|158278844|FG012|Overall Study|Upper G-I Haemorrhage|0|||
49120084|NCT01826981|158278845|FG013|Overall Study|Upper G-I Haemorrhage|1|||
49120085|NCT01826981|158278846|FG014|Overall Study|Upper G-I Haemorrhage|0|||
49120086|NCT01826981|158278832|FG000|Overall Study|Enrolled/Randomized but Not Treated|0|||
49120087|NCT01826981|158278833|FG001|Overall Study|Enrolled/Randomized but Not Treated|0|||
49120088|NCT01826981|158278834|FG002|Overall Study|Enrolled/Randomized but Not Treated|0|||
49120089|NCT01826981|158278835|FG003|Overall Study|Enrolled/Randomized but Not Treated|0|||
49120090|NCT01826981|158278836|FG004|Overall Study|Enrolled/Randomized but Not Treated|0|||
49120091|NCT01826981|158278837|FG005|Overall Study|Enrolled/Randomized but Not Treated|0|||
49120092|NCT01826981|158278838|FG006|Overall Study|Enrolled/Randomized but Not Treated|0|||
49120093|NCT01826981|158278839|FG007|Overall Study|Enrolled/Randomized but Not Treated|1|||
49120094|NCT01826981|158278840|FG008|Overall Study|Enrolled/Randomized but Not Treated|0|||
48710017|NCT02563067|156788730|FG000|Overall Study|Technical problems|0|||
48710018|NCT02563067|156788731|FG001|Overall Study|Technical problems|1|||
48710019|NCT02563067|156788732|FG002|Overall Study|Technical problems|0|||
48710020|NCT02563067|156788730|FG000|Overall Study|Lack of Efficacy|1|||
48710021|NCT02563067|156788731|FG001|Overall Study|Lack of Efficacy|0|||
48710022|NCT02563067|156788732|FG002|Overall Study|Lack of Efficacy|0|||
48710023|NCT02563067|156788730|FG000|Overall Study|Death|0|||
48710024|NCT02563067|156788731|FG001|Overall Study|Death|1|||
48710025|NCT02563067|156788732|FG002|Overall Study|Death|1|||
48710026|NCT02563067|156788730|FG000|Overall Study|Adverse Event|2|||
48710027|NCT02563067|156788731|FG001|Overall Study|Adverse Event|1|||
48710028|NCT02563067|156788732|FG002|Overall Study|Adverse Event|0|||
48710029|NCT02563067|156788730|FG000|Overall Study|Death post Treatment/safety period|1|||
48710030|NCT02563067|156788731|FG001|Overall Study|Death post Treatment/safety period|0|||
48710031|NCT02563067|156788732|FG002|Overall Study|Death post Treatment/safety period|0|||
48710032|NCT03583385|156788740|FG000|Treatment Period 1|Withdrawal by Subject|1|||
49120095|NCT01826981|158278841|FG009|Overall Study|Enrolled/Randomized but Not Treated|0|||
48710033|NCT03583385|156788741|FG001|Treatment Period 1|Withdrawal by Subject|1|||
48710034|NCT03583385|156788740|FG000|Treatment Period 2|Adverse Event|1|||
48710035|NCT03583385|156788741|FG001|Treatment Period 2|Adverse Event|0|||
48710036|NCT00423917|156788742|FG000|Overall Study|Cancel|2|||
48710037|NCT00423917|156788742|FG000|Overall Study|Ineligible|1|||
48710038|NCT00220636|156788746|FG000|Overall Study|Withdrawal by Subject|4|||
48710039|NCT01092117|156788753|FG000|Index Procedure to 1 Month|Death|1|||
48710040|NCT01092117|156788753|FG000|1 Month|Death|1|||
48710041|NCT01092117|156788753|FG000|1 Month|Withdrawal by Subject|1|||
48710042|NCT01092117|156788753|FG000|1 Month|Lost to Follow-up|1|||
48710043|NCT01092117|156788753|FG000|6 Months|Death|2|||
48710044|NCT01092117|156788753|FG000|6 Months|Withdrawal by Subject|3|||
48710045|NCT01092117|156788753|FG000|12 Month|Death|11|||
48710046|NCT01092117|156788753|FG000|12 Month|Withdrawal by Subject|2|||
48710047|NCT01092117|156788753|FG000|12 Month|Lost to Follow-up|1|||
48807099|NCT00152009|157134917|FG001|Overall Study|Adverse Event|13|||
48807100|NCT00152009|157134918|FG002|Overall Study|Adverse Event|20|||
48807101|NCT00152009|157134919|FG003|Overall Study|Adverse Event|1|||
48807102|NCT00152009|157134916|FG000|Overall Study|Protocol Violation|3|||
48807103|NCT00152009|157134917|FG001|Overall Study|Protocol Violation|0|||
48807104|NCT00152009|157134918|FG002|Overall Study|Protocol Violation|0|||
48807105|NCT00152009|157134919|FG003|Overall Study|Protocol Violation|1|||
48807106|NCT00152009|157134916|FG000|Overall Study|Withdrawal by Subject|2|||
48807107|NCT00152009|157134917|FG001|Overall Study|Withdrawal by Subject|3|||
48807108|NCT00152009|157134918|FG002|Overall Study|Withdrawal by Subject|4|||
48807109|NCT00152009|157134919|FG003|Overall Study|Withdrawal by Subject|9|||
48807110|NCT00152009|157134916|FG000|Overall Study|Lost to Follow-up|2|||
48807111|NCT00152009|157134917|FG001|Overall Study|Lost to Follow-up|4|||
48807112|NCT00152009|157134918|FG002|Overall Study|Lost to Follow-up|3|||
48807113|NCT00152009|157134919|FG003|Overall Study|Lost to Follow-up|3|||
48807114|NCT00152009|157134916|FG000|Overall Study|Lack of Efficacy|8|||
48710048|NCT01092117|156788753|FG000|Year 2|Death|5|||
48710049|NCT01092117|156788753|FG000|Year 2|Withdrawal by Subject|4|||
48710050|NCT01092117|156788753|FG000|Year 2|Lost to Follow-up|1|||
48807115|NCT00152009|157134917|FG001|Overall Study|Lack of Efficacy|6|||
48807116|NCT00152009|157134918|FG002|Overall Study|Lack of Efficacy|7|||
48710051|NCT01092117|156788753|FG000|Year 3|Death|7|||
48807117|NCT00152009|157134919|FG003|Overall Study|Lack of Efficacy|15|||
48807118|NCT00152009|157134916|FG000|Overall Study|ECG abnormalities|2|||
48807119|NCT00152009|157134917|FG001|Overall Study|ECG abnormalities|2|||
48710052|NCT01092117|156788753|FG000|Year 3|Withdrawal by Subject|9|||
48710053|NCT01092117|156788753|FG000|Year 3|Lost to Follow-up|3|||
48710054|NCT01092117|156788753|FG000|Year 4|Death|8|||
48710055|NCT01092117|156788753|FG000|Year 4|Withdrawal by Subject|4|||
48710056|NCT01092117|156788753|FG000|Year 4|Lost to Follow-up|4|||
48710057|NCT01623050|156788754|FG000|Overall Study|Lost to Follow-up|9|||
49120096|NCT01826981|158278842|FG010|Overall Study|Enrolled/Randomized but Not Treated|0|||
48916856|NCT01251653|157532159|FG007|Overall Study|Progressive Disease|7|||
48916857|NCT01251653|157532160|FG008|Overall Study|Progressive Disease|5|||
48916858|NCT01251653|157532152|FG000|Overall Study|Dose-limiting toxicity|0|||
48916859|NCT01251653|157532153|FG001|Overall Study|Dose-limiting toxicity|1|||
48916860|NCT01251653|157532154|FG002|Overall Study|Dose-limiting toxicity|1|||
48916861|NCT01251653|157532155|FG003|Overall Study|Dose-limiting toxicity|1|||
48916862|NCT01251653|157532156|FG004|Overall Study|Dose-limiting toxicity|0|||
48916863|NCT01251653|157532157|FG005|Overall Study|Dose-limiting toxicity|0|||
48916864|NCT01251653|157532158|FG006|Overall Study|Dose-limiting toxicity|2|||
48916865|NCT01251653|157532159|FG007|Overall Study|Dose-limiting toxicity|0|||
48710058|NCT03048578|156788755|FG000|Overall Study|Withdrawal by Subject|5|||
48710059|NCT03048578|156788756|FG001|Overall Study|Withdrawal by Subject|6|||
48710060|NCT03048578|156788755|FG000|Overall Study|Lost to Follow-up|22|||
48710061|NCT03048578|156788756|FG001|Overall Study|Lost to Follow-up|10|||
48710062|NCT03048578|156788755|FG000|Overall Study|Adverse Event|1|||
48710063|NCT03048578|156788756|FG001|Overall Study|Adverse Event|2|||
48710064|NCT03048578|156788755|FG000|Overall Study|Terminated|3|||
48710065|NCT03048578|156788756|FG001|Overall Study|Terminated|2|||
48710066|NCT03710083|156788757|FG000|Overall Study|Withdrawal by Subject|2|||
48710067|NCT03710083|156788757|FG000|Overall Study|Unsuccessful Procedure|1|||
48710068|NCT02283762|156788758|FG000|Main Treatment Phase (MT)|Adverse Event|9|||
48710069|NCT02283762|156788759|FG001|Main Treatment Phase (MT)|Adverse Event|9|||
48710070|NCT02283762|156788758|FG000|Main Treatment Phase (MT)|Lack of Efficacy|1|||
48710071|NCT02283762|156788759|FG001|Main Treatment Phase (MT)|Lack of Efficacy|0|||
48710072|NCT02283762|156788758|FG000|Main Treatment Phase (MT)|Physician Decision|1|||
48710073|NCT02283762|156788759|FG001|Main Treatment Phase (MT)|Physician Decision|1|||
48710074|NCT02283762|156788758|FG000|Main Treatment Phase (MT)|Pregnancy|0|||
48710075|NCT02283762|156788759|FG001|Main Treatment Phase (MT)|Pregnancy|1|||
48710076|NCT02283762|156788758|FG000|Main Treatment Phase (MT)|Withdrawal by Subject|7|||
48710077|NCT02283762|156788759|FG001|Main Treatment Phase (MT)|Withdrawal by Subject|4|||
48710078|NCT02283762|156788758|FG000|Long-term Extension Phase (LTE)|Adverse Event|2|||
48710079|NCT02283762|156788759|FG001|Long-term Extension Phase (LTE)|Adverse Event|6|||
48710080|NCT02283762|156788758|FG000|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
48710081|NCT02283762|156788759|FG001|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
48710082|NCT02283762|156788758|FG000|Long-term Extension Phase (LTE)|Study terminated at site|1|||
48710083|NCT02283762|156788759|FG001|Long-term Extension Phase (LTE)|Study terminated at site|0|||
48710084|NCT02283762|156788758|FG000|Long-term Extension Phase (LTE)|Withdrawal by Subject|4|||
48710085|NCT02283762|156788759|FG001|Long-term Extension Phase (LTE)|Withdrawal by Subject|3|||
48710086|NCT02283762|156788758|FG000|Long-term Extension Phase (LTE)|Protocol Violation|1|||
48710087|NCT02283762|156788759|FG001|Long-term Extension Phase (LTE)|Protocol Violation|1|||
48710088|NCT02283762|156788758|FG000|Long-term Extension Phase (LTE)|Lost to Follow-up|0|||
48710089|NCT02283762|156788759|FG001|Long-term Extension Phase (LTE)|Lost to Follow-up|1|||
48710090|NCT02283762|156788758|FG000|Long-term Extension Phase (LTE)|Physician Decision|1|||
48710091|NCT02283762|156788759|FG001|Long-term Extension Phase (LTE)|Physician Decision|2|||
48710092|NCT01137604|156788760|FG000|Overall Study|Adverse Event|3|||
48710093|NCT01137604|156788761|FG001|Overall Study|Adverse Event|6|||
48710094|NCT01137604|156788762|FG002|Overall Study|Adverse Event|9|||
48710095|NCT01137604|156788763|FG003|Overall Study|Adverse Event|9|||
48710096|NCT01137604|156788760|FG000|Overall Study|Participant Choice|0|||
48710097|NCT01137604|156788761|FG001|Overall Study|Participant Choice|2|||
48710098|NCT01137604|156788762|FG002|Overall Study|Participant Choice|2|||
48710099|NCT01137604|156788763|FG003|Overall Study|Participant Choice|0|||
48710100|NCT01137604|156788760|FG000|Overall Study|Withdrawal of consent|0|||
48710101|NCT01137604|156788761|FG001|Overall Study|Withdrawal of consent|0|||
48710102|NCT01137604|156788762|FG002|Overall Study|Withdrawal of consent|0|||
48710103|NCT01137604|156788763|FG003|Overall Study|Withdrawal of consent|2|||
48710104|NCT01137604|156788760|FG000|Overall Study|Clinical progression/deterioration|1|||
48710105|NCT01137604|156788761|FG001|Overall Study|Clinical progression/deterioration|2|||
48710106|NCT01137604|156788762|FG002|Overall Study|Clinical progression/deterioration|2|||
48710107|NCT01137604|156788763|FG003|Overall Study|Clinical progression/deterioration|0|||
48916866|NCT01251653|157532160|FG008|Overall Study|Dose-limiting toxicity|0|||
49120097|NCT01826981|158278843|FG011|Overall Study|Enrolled/Randomized but Not Treated|0|||
49120098|NCT01826981|158278844|FG012|Overall Study|Enrolled/Randomized but Not Treated|0|||
48710108|NCT01409811|156788764|FG000|Overall Study|Insurance denial|1|||
48710109|NCT00838513|156788765|FG000|Screening Period|Screen Failure|3|||
48710110|NCT00838513|156788765|FG000|Extension Treatment Period|Death|1|||
48710111|NCT00838513|156788765|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
48710112|NCT00312195|156788770|FG000|Overall Study|Adverse Event|4|||
48710113|NCT00312195|156788771|FG001|Overall Study|Adverse Event|6|||
48710114|NCT00312195|156788770|FG000|Overall Study|Lost to Follow-up|1|||
48710115|NCT00312195|156788771|FG001|Overall Study|Lost to Follow-up|0|||
48916867|NCT01251653|157532152|FG000|Overall Study|Adverse Event|1|||
49120099|NCT01826981|158278845|FG013|Overall Study|Enrolled/Randomized but Not Treated|0|||
48710116|NCT00312195|156788770|FG000|Overall Study|Protocol Violation|1|||
48710117|NCT00312195|156788771|FG001|Overall Study|Protocol Violation|0|||
48710118|NCT02023697|156788772|FG000|Treatment Period|Radiological progression|13|||
48710119|NCT02023697|156788773|FG001|Treatment Period|Radiological progression|17|||
48710120|NCT02023697|156788774|FG002|Treatment Period|Radiological progression|26|||
48710121|NCT02023697|156788772|FG000|Treatment Period|Never Treated|5|||
48710122|NCT02023697|156788773|FG001|Treatment Period|Never Treated|6|||
48710123|NCT02023697|156788774|FG002|Treatment Period|Never Treated|10|||
48710124|NCT02023697|156788772|FG000|Treatment Period|Adverse Event|13|||
48710125|NCT02023697|156788773|FG001|Treatment Period|Adverse Event|25|||
48710126|NCT02023697|156788774|FG002|Treatment Period|Adverse Event|23|||
48710127|NCT02023697|156788772|FG000|Treatment Period|Logistical difficulties|1|||
48710128|NCT02023697|156788773|FG001|Treatment Period|Logistical difficulties|1|||
48710129|NCT02023697|156788774|FG002|Treatment Period|Logistical difficulties|1|||
48710130|NCT02023697|156788772|FG000|Treatment Period|Clinical progression|10|||
48916868|NCT01251653|157532153|FG001|Overall Study|Adverse Event|0|||
48710131|NCT02023697|156788773|FG001|Treatment Period|Clinical progression|8|||
48710132|NCT02023697|156788774|FG002|Treatment Period|Clinical progression|28|||
48710133|NCT02023697|156788772|FG000|Treatment Period|Withdrawal by Subject|4|||
48807120|NCT00152009|157134918|FG002|Overall Study|ECG abnormalities|2|||
48916869|NCT01251653|157532154|FG002|Overall Study|Adverse Event|2|||
48916870|NCT01251653|157532155|FG003|Overall Study|Adverse Event|1|||
48916871|NCT01251653|157532156|FG004|Overall Study|Adverse Event|1|||
48916872|NCT01251653|157532157|FG005|Overall Study|Adverse Event|0|||
48916873|NCT01251653|157532158|FG006|Overall Study|Adverse Event|2|||
48916874|NCT01251653|157532159|FG007|Overall Study|Adverse Event|2|||
48916875|NCT01251653|157532160|FG008|Overall Study|Adverse Event|1|||
48916876|NCT01251653|157532152|FG000|Overall Study|Withdrawal by Subject|1|||
48916877|NCT01251653|157532153|FG001|Overall Study|Withdrawal by Subject|0|||
48916878|NCT01251653|157532154|FG002|Overall Study|Withdrawal by Subject|1|||
48916879|NCT01251653|157532155|FG003|Overall Study|Withdrawal by Subject|0|||
48916880|NCT01251653|157532156|FG004|Overall Study|Withdrawal by Subject|1|||
48916881|NCT01251653|157532157|FG005|Overall Study|Withdrawal by Subject|1|||
48916882|NCT01251653|157532158|FG006|Overall Study|Withdrawal by Subject|0|||
48916883|NCT01251653|157532159|FG007|Overall Study|Withdrawal by Subject|1|||
49120100|NCT01826981|158278846|FG014|Overall Study|Enrolled/Randomized but Not Treated|0|||
49120101|NCT02030119|158278849|FG000|Overall Study|Withdrawal by Subject|3|||
49120102|NCT02030119|158278850|FG001|Overall Study|Withdrawal by Subject|1|||
49120103|NCT02030119|158278851|FG002|Overall Study|Withdrawal by Subject|5|||
49120104|NCT02030119|158278852|FG003|Overall Study|Withdrawal by Subject|3|||
49120105|NCT02030119|158278849|FG000|Overall Study|Ineligible (see Pre-assignment Details)|0|||
49120106|NCT02030119|158278850|FG001|Overall Study|Ineligible (see Pre-assignment Details)|1|||
49120107|NCT02030119|158278851|FG002|Overall Study|Ineligible (see Pre-assignment Details)|1|||
49120108|NCT02030119|158278852|FG003|Overall Study|Ineligible (see Pre-assignment Details)|0|||
49120109|NCT02861664|158278853|FG000|Overall Study|Withdrawal of Consent|0|||
49120110|NCT02861664|158278854|FG001|Overall Study|Withdrawal of Consent|1|||
49120111|NCT02213380|158278858|FG000|Underwent Randomization|Withdrawal by Subject|2|||
49120112|NCT02213380|158278859|FG001|Underwent Randomization|Withdrawal by Subject|0|||
49120113|NCT02213380|158278858|FG000|Underwent Randomization|Not treated|3|||
49120114|NCT02213380|158278859|FG001|Underwent Randomization|Not treated|3|||
49120115|NCT02213380|158278858|FG000|Per-protocol Analysis|Protocol Violation|32|||
49120116|NCT02213380|158278859|FG001|Per-protocol Analysis|Protocol Violation|36|||
49120117|NCT00707057|158278861|FG000|Overall Study|Withdrawal by Subject|8|||
49120118|NCT00707057|158278862|FG001|Overall Study|Withdrawal by Subject|3|||
49120119|NCT00707057|158278861|FG000|Overall Study|Dosed incorrectly|0|||
49120120|NCT00707057|158278862|FG001|Overall Study|Dosed incorrectly|1|||
49120121|NCT01025284|158278863|FG000|Overall Study|Investigator Decision|0|||
49120122|NCT01025284|158278864|FG001|Overall Study|Investigator Decision|1|||
49120123|NCT01025284|158278865|FG002|Overall Study|Investigator Decision|0|||
49120124|NCT01025284|158278863|FG000|Overall Study|Withdrawal by Subject|0|||
49120125|NCT01025284|158278864|FG001|Overall Study|Withdrawal by Subject|1|||
49120126|NCT01025284|158278865|FG002|Overall Study|Withdrawal by Subject|0|||
49120127|NCT01000974|158278866|FG000|Primary Vaccination Phase|Withdrawal by Subject|109|||
49120128|NCT01000974|158278867|FG001|Primary Vaccination Phase|Withdrawal by Subject|17|||
49120129|NCT01000974|158278868|FG002|Primary Vaccination Phase|Withdrawal by Subject|21|||
49120130|NCT01000974|158278866|FG000|Primary Vaccination Phase|Lost to Follow-up|171|||
49120131|NCT01000974|158278867|FG001|Primary Vaccination Phase|Lost to Follow-up|19|||
49120132|NCT01000974|158278868|FG002|Primary Vaccination Phase|Lost to Follow-up|26|||
49120133|NCT01000974|158278866|FG000|Primary Vaccination Phase|Protocol Violation|40|||
49120134|NCT01000974|158278867|FG001|Primary Vaccination Phase|Protocol Violation|3|||
49120135|NCT01000974|158278868|FG002|Primary Vaccination Phase|Protocol Violation|2|||
49120136|NCT01000974|158278866|FG000|Primary Vaccination Phase|Adverse Event|14|||
49120137|NCT01000974|158278867|FG001|Primary Vaccination Phase|Adverse Event|2|||
49120138|NCT01000974|158278868|FG002|Primary Vaccination Phase|Adverse Event|2|||
49120139|NCT01000974|158278866|FG000|Primary Vaccination Phase|Other|4|||
48916884|NCT01251653|157532160|FG008|Overall Study|Withdrawal by Subject|0|||
48916885|NCT01251653|157532152|FG000|Overall Study|Other reason not mentioned above|0|||
48710134|NCT02023697|156788773|FG001|Treatment Period|Withdrawal by Subject|5|||
48710135|NCT02023697|156788774|FG002|Treatment Period|Withdrawal by Subject|13|||
48710136|NCT02023697|156788772|FG000|Treatment Period|Safety outcome reached|0|||
48710137|NCT02023697|156788773|FG001|Treatment Period|Safety outcome reached|1|||
48710138|NCT02023697|156788774|FG002|Treatment Period|Safety outcome reached|0|||
48710139|NCT02023697|156788772|FG000|Treatment Period|Physician Decision|0|||
48710140|NCT02023697|156788773|FG001|Treatment Period|Physician Decision|0|||
48710141|NCT02023697|156788774|FG002|Treatment Period|Physician Decision|1|||
48807121|NCT00152009|157134919|FG003|Overall Study|ECG abnormalities|1|||
48807122|NCT00152009|157134916|FG000|Overall Study|Sponsor's decision|3|||
48807123|NCT00152009|157134917|FG001|Overall Study|Sponsor's decision|3|||
48807124|NCT00152009|157134918|FG002|Overall Study|Sponsor's decision|1|||
48807125|NCT00152009|157134919|FG003|Overall Study|Sponsor's decision|3|||
48807126|NCT02914314|157134920|FG000|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
48807127|NCT02914314|157134921|FG001|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
48807128|NCT02914314|157134922|FG002|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
48807129|NCT02914314|157134923|FG003|Core Phase (Up to 20 Weeks)|Lost to Follow-up|1|||
48807130|NCT02914314|157134920|FG000|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
48807131|NCT02914314|157134921|FG001|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
48807132|NCT02914314|157134922|FG002|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
48807133|NCT02914314|157134923|FG003|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|1|||
48807134|NCT02914314|157134920|FG000|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
48807135|NCT02914314|157134921|FG001|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
48807136|NCT02914314|157134922|FG002|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|1|||
48807137|NCT02914314|157134923|FG003|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
48807138|NCT02914314|157134920|FG000|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
48807139|NCT02914314|157134921|FG001|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
48807140|NCT02914314|157134922|FG002|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|1|||
48807141|NCT02914314|157134923|FG003|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
48807142|NCT02914314|157134920|FG000|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
48807143|NCT02914314|157134921|FG001|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
48807144|NCT02914314|157134922|FG002|Extension Phase (Up to 36 Weeks)|Participant choice|1|||
48807145|NCT02914314|157134923|FG003|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
48807146|NCT05256706|157134928|FG000|Overall Study|Lost to Follow-up|9|||
48807147|NCT05256706|157134929|FG001|Overall Study|Lost to Follow-up|3|||
48807148|NCT05256706|157134928|FG000|Overall Study|Withdrawal by Subject|7|||
48807149|NCT05256706|157134929|FG001|Overall Study|Withdrawal by Subject|11|||
48807150|NCT05256706|157134928|FG000|Overall Study|Screen Failures|3|||
48807151|NCT05256706|157134929|FG001|Overall Study|Screen Failures|0|||
48807152|NCT02285114|157134930|FG000|Overall Study|Investigator's Discretion|0|||
48807153|NCT02285114|157134931|FG001|Overall Study|Investigator's Discretion|2|||
48807154|NCT02285114|157134932|FG002|Overall Study|Investigator's Discretion|0|||
48807155|NCT02285114|157134930|FG000|Overall Study|Withdrew Consent|0|||
48807156|NCT02285114|157134931|FG001|Overall Study|Withdrew Consent|0|||
48807157|NCT02285114|157134932|FG002|Overall Study|Withdrew Consent|1|||
48807158|NCT02285114|157134930|FG000|Overall Study|Enrolled but not treated|1|||
48807159|NCT02285114|157134931|FG001|Overall Study|Enrolled but not treated|0|||
48807160|NCT02285114|157134932|FG002|Overall Study|Enrolled but not treated|0|||
48807161|NCT02285114|157134930|FG000|Overall Study|Still on study|21|||
48916886|NCT01251653|157532153|FG001|Overall Study|Other reason not mentioned above|0|||
48916887|NCT01251653|157532154|FG002|Overall Study|Other reason not mentioned above|0|||
48916888|NCT01251653|157532155|FG003|Overall Study|Other reason not mentioned above|0|||
48916889|NCT01251653|157532156|FG004|Overall Study|Other reason not mentioned above|0|||
48916890|NCT01251653|157532157|FG005|Overall Study|Other reason not mentioned above|0|||
48916891|NCT01251653|157532158|FG006|Overall Study|Other reason not mentioned above|0|||
48916892|NCT01251653|157532159|FG007|Overall Study|Other reason not mentioned above|2|||
48916893|NCT01251653|157532160|FG008|Overall Study|Other reason not mentioned above|0|||
48916894|NCT01439282|157532161|FG000|Overall Study|Adverse Event|5|||
48916895|NCT01439282|157532162|FG001|Overall Study|Adverse Event|0|||
48916896|NCT01439282|157532161|FG000|Overall Study|Withdrawal by Subject|2|||
48916897|NCT01439282|157532162|FG001|Overall Study|Withdrawal by Subject|0|||
49120140|NCT01000974|158278867|FG001|Primary Vaccination Phase|Other|9|||
49120141|NCT01000974|158278868|FG002|Primary Vaccination Phase|Other|12|||
49120142|NCT01000974|158278866|FG000|Booster Vaccination Phase|Protocol Violation|0|||
48916898|NCT01439282|157532161|FG000|Overall Study|Other|1|||
48916899|NCT01439282|157532162|FG001|Overall Study|Other|1|||
49120143|NCT01000974|158278867|FG001|Booster Vaccination Phase|Protocol Violation|0|||
48710142|NCT02023697|156788772|FG000|Active Follow-up Period|Withdrawal by Subject|5|||
48807162|NCT02285114|157134931|FG001|Overall Study|Still on study|5|||
48807163|NCT02285114|157134932|FG002|Overall Study|Still on study|2|||
48807164|NCT01125722|157134940|FG000|Overall Study|Withdrawal by Subject|2|||
48807165|NCT01125722|157134941|FG001|Overall Study|Withdrawal by Subject|1|||
48807166|NCT01125722|157134940|FG000|Overall Study|Lost to Follow-up|1|||
48807167|NCT01125722|157134941|FG001|Overall Study|Lost to Follow-up|0|||
48807168|NCT00621296|157134950|FG000|Overall Study|Adverse Event|2|||
48807169|NCT00621296|157134950|FG000|Overall Study|Lack of Efficacy|1|||
48807170|NCT00621296|157134950|FG000|Overall Study|Physician Decision|7|||
48807171|NCT00621296|157134950|FG000|Overall Study|Unmatch Criteria|1|||
48807172|NCT00621296|157134950|FG000|Overall Study|Stopping Criteria|3|||
48807173|NCT02944656|157134954|FG000|Overall Study|No longer eligible|3|||
48807174|NCT02944656|157134955|FG001|Overall Study|No longer eligible|0|||
48807175|NCT02944656|157134954|FG000|Overall Study|Lost to Follow-up|7|||
48807176|NCT02944656|157134955|FG001|Overall Study|Lost to Follow-up|10|||
48807177|NCT04158739|157134956|FG000|Overall Study|Adverse Event|1|||
48807178|NCT04158739|157134957|FG001|Overall Study|Adverse Event|0|||
48807179|NCT04158739|157134956|FG000|Overall Study|Death|0|||
48807180|NCT04158739|157134957|FG001|Overall Study|Death|1|||
48807181|NCT04158739|157134956|FG000|Overall Study|Lack of Efficacy|3|||
49120144|NCT01000974|158278868|FG002|Booster Vaccination Phase|Protocol Violation|2|||
49120145|NCT01000974|158278866|FG000|Booster Vaccination Phase|Withdrawal by Subject|3|||
49120146|NCT01000974|158278867|FG001|Booster Vaccination Phase|Withdrawal by Subject|1|||
49120147|NCT01000974|158278868|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
48807182|NCT04158739|157134957|FG001|Overall Study|Lack of Efficacy|7|||
48807183|NCT04158739|157134956|FG000|Overall Study|Physician Decision|0|||
48807184|NCT04158739|157134957|FG001|Overall Study|Physician Decision|1|||
48807185|NCT04158739|157134956|FG000|Overall Study|Withdrawal by Subject|3|||
48807186|NCT04158739|157134957|FG001|Overall Study|Withdrawal by Subject|0|||
48807187|NCT02601937|157134960|FG000|Period 1: Dose Escalation Phase|Adverse Event|0|||
48807188|NCT02601937|157134961|FG001|Period 1: Dose Escalation Phase|Adverse Event|0|||
48807189|NCT02601937|157134962|FG002|Period 1: Dose Escalation Phase|Adverse Event|0|||
48807190|NCT02601937|157134963|FG003|Period 1: Dose Escalation Phase|Adverse Event|0|||
48807191|NCT02601937|157134964|FG004|Period 1: Dose Escalation Phase|Adverse Event|0|||
48807192|NCT02601937|157134965|FG005|Period 1: Dose Escalation Phase|Adverse Event|1|||
48807193|NCT02601937|157134966|FG006|Period 1: Dose Escalation Phase|Adverse Event|0|||
48807194|NCT02601937|157134967|FG007|Period 1: Dose Escalation Phase|Adverse Event|0|||
48807195|NCT02601937|157134968|FG008|Period 1: Dose Escalation Phase|Adverse Event|0|||
48807196|NCT02601937|157134969|FG009|Period 1: Dose Escalation Phase|Adverse Event|0|||
48807197|NCT02601937|157134970|FG010|Period 1: Dose Escalation Phase|Adverse Event|0|||
48807198|NCT02601937|157134960|FG000|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
48807199|NCT02601937|157134961|FG001|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
48807200|NCT02601937|157134962|FG002|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
48807201|NCT02601937|157134963|FG003|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
48807202|NCT02601937|157134964|FG004|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
48807203|NCT02601937|157134965|FG005|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
48807204|NCT02601937|157134966|FG006|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
48856405|NCT02066636|157312852|FG002|Overall Study|Disease progression|700|||
48856406|NCT02066636|157312850|FG000|Overall Study|Study drug toxicity|13|||
48856407|NCT02066636|157312851|FG001|Overall Study|Study drug toxicity|2|||
48856408|NCT02066636|157312852|FG002|Overall Study|Study drug toxicity|58|||
48856409|NCT02066636|157312850|FG000|Overall Study|Death|4|||
48856410|NCT02066636|157312851|FG001|Overall Study|Death|2|||
48856411|NCT02066636|157312852|FG002|Overall Study|Death|158|||
48856412|NCT02066636|157312850|FG000|Overall Study|Adverse event unrelated to study drug|6|||
48856413|NCT02066636|157312851|FG001|Overall Study|Adverse event unrelated to study drug|4|||
48856414|NCT02066636|157312852|FG002|Overall Study|Adverse event unrelated to study drug|45|||
48856415|NCT02066636|157312850|FG000|Overall Study|Participant request to discontinue treatment|12|||
48856416|NCT02066636|157312851|FG001|Overall Study|Participant request to discontinue treatment|12|||
48856417|NCT02066636|157312852|FG002|Overall Study|Participant request to discontinue treatment|70|||
48856418|NCT02066636|157312850|FG000|Overall Study|Participant withdrew consent|10|||
48856419|NCT02066636|157312851|FG001|Overall Study|Participant withdrew consent|18|||
48856420|NCT02066636|157312852|FG002|Overall Study|Participant withdrew consent|61|||
48856421|NCT02066636|157312850|FG000|Overall Study|Lost to Follow-up|0|||
48856422|NCT02066636|157312851|FG001|Overall Study|Lost to Follow-up|2|||
48856423|NCT02066636|157312852|FG002|Overall Study|Lost to Follow-up|2|||
48856424|NCT02066636|157312850|FG000|Overall Study|Maximum clinical benefit|2|||
48856425|NCT02066636|157312851|FG001|Overall Study|Maximum clinical benefit|2|||
48856426|NCT02066636|157312852|FG002|Overall Study|Maximum clinical benefit|3|||
48856427|NCT02066636|157312850|FG000|Overall Study|Poor/non-compliance|2|||
48856428|NCT02066636|157312851|FG001|Overall Study|Poor/non-compliance|1|||
48856429|NCT02066636|157312852|FG002|Overall Study|Poor/non-compliance|1|||
48856430|NCT02066636|157312850|FG000|Overall Study|Participant no loner meets study criteria|3|||
48856431|NCT02066636|157312851|FG001|Overall Study|Participant no loner meets study criteria|2|||
48856432|NCT02066636|157312852|FG002|Overall Study|Participant no loner meets study criteria|28|||
48856433|NCT02066636|157312850|FG000|Overall Study|Administrative reasons by sponsor|8|||
48856434|NCT02066636|157312851|FG001|Overall Study|Administrative reasons by sponsor|5|||
48807205|NCT02601937|157134967|FG007|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
48807206|NCT02601937|157134968|FG008|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
48807207|NCT02601937|157134969|FG009|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
48807208|NCT02601937|157134970|FG010|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
48807209|NCT02601937|157134960|FG000|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
48807210|NCT02601937|157134961|FG001|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
48807211|NCT02601937|157134962|FG002|Period 1: Dose Escalation Phase|Unacceptable toxicity|1|||
48807212|NCT02601937|157134963|FG003|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
48807213|NCT02601937|157134964|FG004|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
48807214|NCT02601937|157134965|FG005|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
48807215|NCT02601937|157134966|FG006|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
48807216|NCT02601937|157134967|FG007|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
48807217|NCT02601937|157134968|FG008|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
48807218|NCT02601937|157134969|FG009|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
48807219|NCT02601937|157134970|FG010|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
48807220|NCT02601937|157134960|FG000|Period 1: Dose Escalation Phase|Progressive disease|7|||
48807221|NCT02601937|157134961|FG001|Period 1: Dose Escalation Phase|Progressive disease|6|||
48807222|NCT02601937|157134962|FG002|Period 1: Dose Escalation Phase|Progressive disease|5|||
48807223|NCT02601937|157134963|FG003|Period 1: Dose Escalation Phase|Progressive disease|6|||
48807224|NCT02601937|157134964|FG004|Period 1: Dose Escalation Phase|Progressive disease|6|||
48807225|NCT02601937|157134965|FG005|Period 1: Dose Escalation Phase|Progressive disease|4|||
48807226|NCT02601937|157134966|FG006|Period 1: Dose Escalation Phase|Progressive disease|6|||
48807227|NCT02601937|157134967|FG007|Period 1: Dose Escalation Phase|Progressive disease|0|||
48807228|NCT02601937|157134968|FG008|Period 1: Dose Escalation Phase|Progressive disease|0|||
48807229|NCT02601937|157134969|FG009|Period 1: Dose Escalation Phase|Progressive disease|0|||
48807230|NCT02601937|157134970|FG010|Period 1: Dose Escalation Phase|Progressive disease|0|||
48807231|NCT02601937|157134960|FG000|Period 2: Dose Expansion Cohort|Adverse Event|0|||
48807232|NCT02601937|157134961|FG001|Period 2: Dose Expansion Cohort|Adverse Event|0|||
48807233|NCT02601937|157134962|FG002|Period 2: Dose Expansion Cohort|Adverse Event|0|||
48807234|NCT02601937|157134963|FG003|Period 2: Dose Expansion Cohort|Adverse Event|0|||
48807235|NCT02601937|157134964|FG004|Period 2: Dose Expansion Cohort|Adverse Event|0|||
48807236|NCT02601937|157134965|FG005|Period 2: Dose Expansion Cohort|Adverse Event|0|||
48807237|NCT02601937|157134966|FG006|Period 2: Dose Expansion Cohort|Adverse Event|0|||
48807238|NCT02601937|157134967|FG007|Period 2: Dose Expansion Cohort|Adverse Event|0|||
48807239|NCT02601937|157134968|FG008|Period 2: Dose Expansion Cohort|Adverse Event|0|||
48807240|NCT02601937|157134969|FG009|Period 2: Dose Expansion Cohort|Adverse Event|1|||
48916900|NCT01502709|157532163|FG000|Overall Study|Lost to Follow-up|4|||
48916901|NCT01502709|157532164|FG001|Overall Study|Lost to Follow-up|0|||
48916902|NCT02966509|157532169|FG000|Baseline Satisfaction Survey|Withdrawal by Subject|2|||
48916903|NCT02966509|157532170|FG001|Baseline Satisfaction Survey|Withdrawal by Subject|3|||
48916904|NCT02966509|157532169|FG000|Baseline Satisfaction Survey|Death|0|||
48916905|NCT02966509|157532170|FG001|Baseline Satisfaction Survey|Death|1|||
48916906|NCT02966509|157532169|FG000|Baseline Satisfaction Survey|Lost to Follow-up|1|||
48916907|NCT02966509|157532170|FG001|Baseline Satisfaction Survey|Lost to Follow-up|1|||
48916908|NCT02966509|157532169|FG000|Baseline Satisfaction Survey|Refused to Answer|1|||
48916909|NCT02966509|157532170|FG001|Baseline Satisfaction Survey|Refused to Answer|2|||
48916910|NCT02966509|157532169|FG000|6 Month Satisfaction Decision Survey|Death|22|||
48916911|NCT02966509|157532170|FG001|6 Month Satisfaction Decision Survey|Death|25|||
48807241|NCT02601937|157134970|FG010|Period 2: Dose Expansion Cohort|Adverse Event|0|||
48916912|NCT02966509|157532169|FG000|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2|||
48807242|NCT02601937|157134960|FG000|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
48807243|NCT02601937|157134961|FG001|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
48807244|NCT02601937|157134962|FG002|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
48807245|NCT02601937|157134963|FG003|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
48807246|NCT02601937|157134964|FG004|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
48807247|NCT02601937|157134965|FG005|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
48807248|NCT02601937|157134966|FG006|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
48807249|NCT02601937|157134967|FG007|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|2|||
48807250|NCT02601937|157134968|FG008|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
48807251|NCT02601937|157134969|FG009|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
48807252|NCT02601937|157134970|FG010|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
48807253|NCT02601937|157134960|FG000|Period 2: Dose Expansion Cohort|Physician Decision|0|||
48807254|NCT02601937|157134961|FG001|Period 2: Dose Expansion Cohort|Physician Decision|0|||
48807255|NCT02601937|157134962|FG002|Period 2: Dose Expansion Cohort|Physician Decision|0|||
48807256|NCT02601937|157134963|FG003|Period 2: Dose Expansion Cohort|Physician Decision|0|||
48807257|NCT02601937|157134964|FG004|Period 2: Dose Expansion Cohort|Physician Decision|0|||
48807258|NCT02601937|157134965|FG005|Period 2: Dose Expansion Cohort|Physician Decision|0|||
48807259|NCT02601937|157134966|FG006|Period 2: Dose Expansion Cohort|Physician Decision|0|||
48807260|NCT02601937|157134967|FG007|Period 2: Dose Expansion Cohort|Physician Decision|0|||
48807261|NCT02601937|157134968|FG008|Period 2: Dose Expansion Cohort|Physician Decision|0|||
48807262|NCT02601937|157134969|FG009|Period 2: Dose Expansion Cohort|Physician Decision|1|||
48807263|NCT02601937|157134970|FG010|Period 2: Dose Expansion Cohort|Physician Decision|1|||
48807264|NCT02601937|157134960|FG000|Period 2: Dose Expansion Cohort|Progressive disease|0|||
48807265|NCT02601937|157134961|FG001|Period 2: Dose Expansion Cohort|Progressive disease|0|||
48807266|NCT02601937|157134962|FG002|Period 2: Dose Expansion Cohort|Progressive disease|0|||
48807267|NCT02601937|157134963|FG003|Period 2: Dose Expansion Cohort|Progressive disease|0|||
48807268|NCT02601937|157134964|FG004|Period 2: Dose Expansion Cohort|Progressive disease|0|||
48807269|NCT02601937|157134965|FG005|Period 2: Dose Expansion Cohort|Progressive disease|0|||
48807270|NCT02601937|157134966|FG006|Period 2: Dose Expansion Cohort|Progressive disease|0|||
48807271|NCT02601937|157134967|FG007|Period 2: Dose Expansion Cohort|Progressive disease|16|||
48807272|NCT02601937|157134968|FG008|Period 2: Dose Expansion Cohort|Progressive disease|17|||
48807273|NCT02601937|157134969|FG009|Period 2: Dose Expansion Cohort|Progressive disease|14|||
48807274|NCT02601937|157134970|FG010|Period 2: Dose Expansion Cohort|Progressive disease|4|||
48807275|NCT02601937|157134960|FG000|Period 2: Dose Expansion Cohort|Other|0|||
48807276|NCT02601937|157134961|FG001|Period 2: Dose Expansion Cohort|Other|0|||
48807277|NCT02601937|157134962|FG002|Period 2: Dose Expansion Cohort|Other|0|||
48807278|NCT02601937|157134963|FG003|Period 2: Dose Expansion Cohort|Other|0|||
48807279|NCT02601937|157134964|FG004|Period 2: Dose Expansion Cohort|Other|0|||
48807280|NCT02601937|157134965|FG005|Period 2: Dose Expansion Cohort|Other|0|||
48807281|NCT02601937|157134966|FG006|Period 2: Dose Expansion Cohort|Other|0|||
48807282|NCT02601937|157134967|FG007|Period 2: Dose Expansion Cohort|Other|0|||
48807283|NCT02601937|157134968|FG008|Period 2: Dose Expansion Cohort|Other|2|||
48807284|NCT02601937|157134969|FG009|Period 2: Dose Expansion Cohort|Other|2|||
48807285|NCT02601937|157134970|FG010|Period 2: Dose Expansion Cohort|Other|0|||
48807286|NCT02601937|157134960|FG000|Period 2: Dose Expansion Cohort|Death|0|||
48807287|NCT02601937|157134961|FG001|Period 2: Dose Expansion Cohort|Death|0|||
48807288|NCT02601937|157134962|FG002|Period 2: Dose Expansion Cohort|Death|0|||
48807289|NCT02601937|157134963|FG003|Period 2: Dose Expansion Cohort|Death|0|||
48807290|NCT02601937|157134964|FG004|Period 2: Dose Expansion Cohort|Death|0|||
48807291|NCT02601937|157134965|FG005|Period 2: Dose Expansion Cohort|Death|0|||
48807292|NCT02601937|157134966|FG006|Period 2: Dose Expansion Cohort|Death|0|||
48807293|NCT02601937|157134967|FG007|Period 2: Dose Expansion Cohort|Death|0|||
48807294|NCT02601937|157134968|FG008|Period 2: Dose Expansion Cohort|Death|1|||
48807295|NCT02601937|157134969|FG009|Period 2: Dose Expansion Cohort|Death|0|||
48807296|NCT02601937|157134970|FG010|Period 2: Dose Expansion Cohort|Death|0|||
48807297|NCT00284141|157136540|FG000|Overall Study|Disease Progression / Lack of efficacy|51|||
48807298|NCT00284141|157136540|FG000|Overall Study|Adverse Event|19|||
48807299|NCT00284141|157136540|FG000|Overall Study|Participant's request|9|||
48807300|NCT00284141|157136540|FG000|Overall Study|Symptomatic / Clinical Progression|11|||
48807301|NCT00284141|157136540|FG000|Overall Study|Clinical deterioration / death|2|||
48807302|NCT00284141|157136540|FG000|Overall Study|General decline|1|||
48807303|NCT00284141|157136540|FG000|Overall Study|Pneumonia|1|||
48807304|NCT00284141|157136540|FG000|Overall Study|Did not take study medication|2|||
48807305|NCT00284141|157136540|FG000|Overall Study|Ongoing treatment|2|||
48807306|NCT01090310|157136541|FG000|Core Study|Adverse Event|2|||
48807307|NCT01090310|157136542|FG001|Core Study|Adverse Event|2|||
48807308|NCT01090310|157136543|FG002|Core Study|Adverse Event|1|||
48807309|NCT01090310|157136544|FG003|Core Study|Adverse Event|1|||
48807310|NCT01090310|157136541|FG000|Core Study|Subject withdrew consent|0|||
48807311|NCT01090310|157136542|FG001|Core Study|Subject withdrew consent|3|||
48807312|NCT01090310|157136543|FG002|Core Study|Subject withdrew consent|1|||
48807313|NCT01090310|157136544|FG003|Core Study|Subject withdrew consent|1|||
48807314|NCT01090310|157136541|FG000|Core Study|Abnormal test procedure result|0|||
48807315|NCT01090310|157136542|FG001|Core Study|Abnormal test procedure result|0|||
48807316|NCT01090310|157136543|FG002|Core Study|Abnormal test procedure result|1|||
48807317|NCT01090310|157136544|FG003|Core Study|Abnormal test procedure result|0|||
48807318|NCT01090310|157136541|FG000|Core Study|Administrative reasons|5|||
48807319|NCT01090310|157136542|FG001|Core Study|Administrative reasons|6|||
48807320|NCT01090310|157136543|FG002|Core Study|Administrative reasons|4|||
48807321|NCT01090310|157136544|FG003|Core Study|Administrative reasons|4|||
48807322|NCT01090310|157136541|FG000|Core Study|Protocol deviation|1|||
48807323|NCT01090310|157136542|FG001|Core Study|Protocol deviation|0|||
48807324|NCT01090310|157136543|FG002|Core Study|Protocol deviation|0|||
48807325|NCT01090310|157136544|FG003|Core Study|Protocol deviation|1|||
48807326|NCT01090310|157136541|FG000|Extension Study|Aministrative problems|13|||
48807327|NCT01090310|157136542|FG001|Extension Study|Aministrative problems|15|||
48807328|NCT01090310|157136543|FG002|Extension Study|Aministrative problems|14|||
48807329|NCT01090310|157136544|FG003|Extension Study|Aministrative problems|18|||
48807330|NCT01090310|157136541|FG000|Extension Study|Adverse Event|0|||
48807331|NCT01090310|157136542|FG001|Extension Study|Adverse Event|0|||
48807332|NCT01090310|157136543|FG002|Extension Study|Adverse Event|0|||
48807333|NCT01090310|157136544|FG003|Extension Study|Adverse Event|1|||
48807334|NCT01090310|157136541|FG000|Extension Study|Unsatisfactory therapeutic effect|1|||
48807335|NCT01090310|157136542|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
48807336|NCT01090310|157136543|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
48807337|NCT01090310|157136544|FG003|Extension Study|Unsatisfactory therapeutic effect|1|||
48807338|NCT01090310|157136541|FG000|Extension Study|Subject withdrew consent|0|||
48807339|NCT01090310|157136542|FG001|Extension Study|Subject withdrew consent|1|||
48807340|NCT01090310|157136543|FG002|Extension Study|Subject withdrew consent|0|||
48807341|NCT01090310|157136544|FG003|Extension Study|Subject withdrew consent|0|||
48807342|NCT02202434|157136545|FG000|Overall Study|Death|70|||
48807343|NCT02202434|157136546|FG001|Overall Study|Death|39|||
48807344|NCT02202434|157136547|FG002|Overall Study|Death|13|||
48807345|NCT02202434|157136548|FG003|Overall Study|Death|27|||
48807346|NCT02202434|157136545|FG000|Overall Study|Lost to Follow-up|1|||
48807347|NCT02202434|157136546|FG001|Overall Study|Lost to Follow-up|1|||
48807348|NCT02202434|157136547|FG002|Overall Study|Lost to Follow-up|1|||
48807349|NCT02202434|157136548|FG003|Overall Study|Lost to Follow-up|0|||
48807350|NCT02202434|157136545|FG000|Overall Study|Physician Decision|2|||
48807351|NCT02202434|157136546|FG001|Overall Study|Physician Decision|3|||
48807352|NCT02202434|157136547|FG002|Overall Study|Physician Decision|0|||
48807353|NCT02202434|157136548|FG003|Overall Study|Physician Decision|0|||
48807354|NCT02202434|157136545|FG000|Overall Study|Withdrawal by Subject|13|||
48807355|NCT02202434|157136546|FG001|Overall Study|Withdrawal by Subject|14|||
48807356|NCT02202434|157136547|FG002|Overall Study|Withdrawal by Subject|1|||
48807357|NCT02202434|157136548|FG003|Overall Study|Withdrawal by Subject|4|||
48807358|NCT02202434|157136545|FG000|Overall Study|Completed Study|1|||
48807359|NCT02202434|157136546|FG001|Overall Study|Completed Study|0|||
48807360|NCT02202434|157136547|FG002|Overall Study|Completed Study|0|||
48807361|NCT02202434|157136548|FG003|Overall Study|Completed Study|0|||
48807362|NCT02202434|157136545|FG000|Overall Study|Visit Missed|21|||
48807363|NCT02202434|157136546|FG001|Overall Study|Visit Missed|12|||
48807364|NCT02202434|157136547|FG002|Overall Study|Visit Missed|0|||
48807365|NCT02202434|157136548|FG003|Overall Study|Visit Missed|5|||
48807366|NCT02202434|157136545|FG000|Overall Study|Other|1|||
48916913|NCT02966509|157532170|FG001|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3|||
48807367|NCT02202434|157136546|FG001|Overall Study|Other|0|||
48807368|NCT02202434|157136547|FG002|Overall Study|Other|0|||
48807369|NCT02202434|157136548|FG003|Overall Study|Other|1|||
48807370|NCT01160484|157136551|FG000|Overall Study|Lack of Efficacy|9|||
48807371|NCT01160484|157136551|FG000|Overall Study|Adverse Event|6|||
48807372|NCT01160484|157136551|FG000|Overall Study|Withdrawal by Subject|2|||
48807373|NCT01160484|157136551|FG000|Overall Study|inclusion/exclusion criteria failure|1|||
48807374|NCT00553501|157136554|FG000|Overall Study|Adverse Event|2|||
48807375|NCT00553501|157136554|FG000|Overall Study|Death|1|||
48807376|NCT00553501|157136554|FG000|Overall Study|Progression|1|||
48807377|NCT02035332|157136555|FG000|Overall Study|Procedure Aborted due to Uterine Width|1|||
48807378|NCT01352585|157136556|FG000|Overall Study|Adverse Event|2|||
48807379|NCT01352585|157136557|FG001|Overall Study|Adverse Event|1|||
48807380|NCT01352585|157136556|FG000|Overall Study|Lost to Follow-up|1|||
48916914|NCT02966509|157532169|FG000|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
48807381|NCT01352585|157136557|FG001|Overall Study|Lost to Follow-up|0|||
48807382|NCT01352585|157136556|FG000|Overall Study|Other|5|||
48807383|NCT01352585|157136557|FG001|Overall Study|Other|2|||
48807384|NCT03185832|157136558|FG000|Overall Study|Death|9|||
48807385|NCT03185832|157136559|FG001|Overall Study|Death|14|||
48807386|NCT03185832|157136560|FG002|Overall Study|Death|9|||
48807387|NCT03185832|157136561|FG003|Overall Study|Death|7|||
48807388|NCT03185832|157136558|FG000|Overall Study|Withdrawn - vital status available|0|||
48807389|NCT03185832|157136559|FG001|Overall Study|Withdrawn - vital status available|1|||
48807390|NCT03185832|157136560|FG002|Overall Study|Withdrawn - vital status available|1|||
49120148|NCT01000974|158278866|FG000|Booster Vaccination Phase|Lost to Follow-up|40|||
49120149|NCT01000974|158278867|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
49120150|NCT01000974|158278868|FG002|Booster Vaccination Phase|Lost to Follow-up|7|||
49120151|NCT01000974|158278866|FG000|Booster Vaccination Phase|Other|24|||
49120152|NCT01000974|158278867|FG001|Booster Vaccination Phase|Other|6|||
49120153|NCT01000974|158278868|FG002|Booster Vaccination Phase|Other|4|||
49120154|NCT01738919|158278870|FG000|Overall Study|Lost to Follow-up|1|||
49120155|NCT01738919|158278871|FG001|Overall Study|Lost to Follow-up|0|||
49120156|NCT01738919|158278870|FG000|Overall Study|Immigrated|0|||
49120157|NCT01738919|158278871|FG001|Overall Study|Immigrated|1|||
49120158|NCT01738919|158278870|FG000|Overall Study|Withdrawal by Subject|0|||
49120159|NCT01738919|158278871|FG001|Overall Study|Withdrawal by Subject|1|||
49120160|NCT01738919|158278870|FG000|Overall Study|Not treated in accordance to guidelines|0|||
49120161|NCT01738919|158278871|FG001|Overall Study|Not treated in accordance to guidelines|1|||
49120162|NCT04131712|158278878|FG000|Overall Study|COVID related|0|||
49120163|NCT04131712|158278879|FG001|Overall Study|COVID related|0|||
49120164|NCT04131712|158278880|FG002|Overall Study|COVID related|2|||
49120165|NCT04131712|158278881|FG003|Overall Study|COVID related|0|||
49120166|NCT04131712|158278878|FG000|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
49120167|NCT04131712|158278879|FG001|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
49120168|NCT04131712|158278880|FG002|Overall Study|PI withdrawal, subject could not follow study schedule|1|||
49120169|NCT04131712|158278881|FG003|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
49120170|NCT02090283|158278882|FG000|Overall Study|Withdrawal by Subject|6|||
49120171|NCT02090283|158278883|FG001|Overall Study|Withdrawal by Subject|6|||
49120172|NCT02090283|158278884|FG002|Overall Study|Withdrawal by Subject|6|||
48807391|NCT03185832|157136561|FG003|Overall Study|Withdrawn - vital status available|4|||
48807392|NCT01083641|157136562|FG000|Overall Study|Withdrawal by Subject|2|||
49120173|NCT02090283|158278882|FG000|Overall Study|Sponsor Terminated Study|6|||
49120174|NCT02090283|158278883|FG001|Overall Study|Sponsor Terminated Study|6|||
49120175|NCT02090283|158278884|FG002|Overall Study|Sponsor Terminated Study|1|||
49120176|NCT02090283|158278882|FG000|Overall Study|Lost to Follow-up|2|||
49120177|NCT02090283|158278883|FG001|Overall Study|Lost to Follow-up|2|||
49120178|NCT02090283|158278884|FG002|Overall Study|Lost to Follow-up|3|||
49120179|NCT02090283|158278882|FG000|Overall Study|Adverse Event|1|||
49120180|NCT02090283|158278883|FG001|Overall Study|Adverse Event|1|||
49120181|NCT02090283|158278884|FG002|Overall Study|Adverse Event|0|||
49120182|NCT02090283|158278882|FG000|Overall Study|Protocol Violation|2|||
48916915|NCT02966509|157532170|FG001|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
48916916|NCT02966509|157532169|FG000|6 Month Satisfaction Decision Survey|Refused to Answer|0|||
48916917|NCT02966509|157532170|FG001|6 Month Satisfaction Decision Survey|Refused to Answer|2|||
48916918|NCT02966509|157532169|FG000|6 Month Satisfaction Survey|Death|36|||
48916919|NCT02966509|157532170|FG001|6 Month Satisfaction Survey|Death|33|||
48916920|NCT02966509|157532169|FG000|6 Month Satisfaction Survey|Withdrawal by Subject|2|||
48916921|NCT02966509|157532170|FG001|6 Month Satisfaction Survey|Withdrawal by Subject|3|||
48916922|NCT02966509|157532169|FG000|6 Month Satisfaction Survey|Lost to Follow-up|1|||
48916923|NCT02966509|157532170|FG001|6 Month Satisfaction Survey|Lost to Follow-up|1|||
48916924|NCT02966509|157532169|FG000|6 Month Satisfaction Survey|Refused to Answer|8|||
48916925|NCT02966509|157532170|FG001|6 Month Satisfaction Survey|Refused to Answer|11|||
48916926|NCT02966509|157532169|FG000|End of Life Utilization and Cost 6 Month|Patient Still Alive|69|||
48916927|NCT02966509|157532170|FG001|End of Life Utilization and Cost 6 Month|Patient Still Alive|75|||
48916928|NCT02966509|157532169|FG000|End of Life Utilization and Cost 15month|Patient Still Alive|45|||
48916929|NCT02966509|157532170|FG001|End of Life Utilization and Cost 15month|Patient Still Alive|48|||
48916930|NCT04854434|157532171|FG000|Overall Study|Death|1|||
48916931|NCT04854434|157532172|FG001|Overall Study|Death|3|||
48916932|NCT04854434|157532173|FG002|Overall Study|Death|4|||
48916933|NCT04854434|157532171|FG000|Overall Study|Study Terminated by Sponsor|2|||
48916934|NCT04854434|157532172|FG001|Overall Study|Study Terminated by Sponsor|0|||
48916935|NCT04854434|157532173|FG002|Overall Study|Study Terminated by Sponsor|0|||
48916936|NCT04854434|157532171|FG000|Overall Study|Other|1|||
48916937|NCT04854434|157532172|FG001|Overall Study|Other|1|||
48916938|NCT04854434|157532173|FG002|Overall Study|Other|0|||
49120183|NCT02090283|158278883|FG001|Overall Study|Protocol Violation|0|||
49120184|NCT02090283|158278884|FG002|Overall Study|Protocol Violation|0|||
49120185|NCT02259400|158278885|FG000|Overall Study|Death|0|||
48807393|NCT01777321|157136563|FG000|Overall Study|Withdrawal by Subject|0|||
48807394|NCT01777321|157136564|FG001|Overall Study|Withdrawal by Subject|1|||
49120186|NCT02259400|158278886|FG001|Overall Study|Death|2|||
49120187|NCT00206427|158278887|FG000|Overall Study|Adverse Event|2|||
49120188|NCT03872843|158278888|FG000|Overall Study|Lost to Follow-up|5|||
49120189|NCT03872843|158278889|FG001|Overall Study|Lost to Follow-up|7|||
49120190|NCT02824224|158278890|FG000|Overall Study|Discontinued, IUS expulsion|0|||
49120191|NCT02824224|158278891|FG001|Overall Study|Discontinued, IUS expulsion|1|||
48807395|NCT01119768|157136566|FG000|Treatment Period|Lack of Efficacy|18|||
48807396|NCT01119768|157136567|FG001|Treatment Period|Lack of Efficacy|25|||
48807397|NCT04461795|157136568|FG000|Overall Study|Lost to Follow-up|2|||
48807398|NCT04461795|157136568|FG000|Overall Study|Withdrawal by Subject|2|||
48807399|NCT04461795|157136568|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|1|||
48807400|NCT01641926|157136570|FG000|Overall Study|Adverse Event|5|||
48807401|NCT01641926|157136571|FG001|Overall Study|Adverse Event|2|||
48807402|NCT01641926|157136572|FG002|Overall Study|Adverse Event|3|||
48807403|NCT01641926|157136573|FG003|Overall Study|Adverse Event|1|||
48807404|NCT01641926|157136570|FG000|Overall Study|Lost to Follow-up|2|||
48807405|NCT01641926|157136571|FG001|Overall Study|Lost to Follow-up|2|||
48807406|NCT01641926|157136572|FG002|Overall Study|Lost to Follow-up|1|||
48807407|NCT01641926|157136573|FG003|Overall Study|Lost to Follow-up|0|||
48807408|NCT01641926|157136570|FG000|Overall Study|Physician Decision|6|||
48807409|NCT01641926|157136571|FG001|Overall Study|Physician Decision|5|||
48807410|NCT01641926|157136572|FG002|Overall Study|Physician Decision|0|||
48807411|NCT01641926|157136573|FG003|Overall Study|Physician Decision|1|||
48807412|NCT01641926|157136570|FG000|Overall Study|Protocol Violation|1|||
48807413|NCT01641926|157136571|FG001|Overall Study|Protocol Violation|0|||
48807414|NCT01641926|157136572|FG002|Overall Study|Protocol Violation|0|||
49120192|NCT02824224|158278890|FG000|Overall Study|Did not show up for allocation visit|2|||
49120193|NCT02824224|158278891|FG001|Overall Study|Did not show up for allocation visit|0|||
49120194|NCT02683239|158278892|FG000|Overall Study|Protocol Violation|35|||
49120195|NCT02683239|158278893|FG001|Overall Study|Protocol Violation|23|||
49120196|NCT02683239|158278894|FG002|Overall Study|Protocol Violation|26|||
48807415|NCT01641926|157136573|FG003|Overall Study|Protocol Violation|1|||
48807416|NCT01641926|157136570|FG000|Overall Study|Withdrawal by Subject|13|||
48807417|NCT01641926|157136571|FG001|Overall Study|Withdrawal by Subject|5|||
48807418|NCT01641926|157136572|FG002|Overall Study|Withdrawal by Subject|6|||
48807419|NCT01641926|157136573|FG003|Overall Study|Withdrawal by Subject|1|||
48807420|NCT01641926|157136570|FG000|Overall Study|Not Treated|1|||
48807421|NCT01641926|157136571|FG001|Overall Study|Not Treated|1|||
48807422|NCT01641926|157136572|FG002|Overall Study|Not Treated|1|||
48807423|NCT01641926|157136573|FG003|Overall Study|Not Treated|0|||
48807424|NCT01287520|157136574|FG000|Overall Study|Adverse Event|2|||
48807425|NCT01287520|157136575|FG001|Overall Study|Adverse Event|2|||
48807426|NCT01287520|157136576|FG002|Overall Study|Adverse Event|2|||
48807427|NCT01287520|157136577|FG003|Overall Study|Adverse Event|1|||
48807428|NCT01287520|157136578|FG004|Overall Study|Adverse Event|1|||
48807429|NCT01287520|157136579|FG005|Overall Study|Adverse Event|2|||
48807430|NCT01287520|157136580|FG006|Overall Study|Adverse Event|0|||
48807431|NCT01287520|157136581|FG007|Overall Study|Adverse Event|2|||
48807432|NCT01287520|157136582|FG008|Overall Study|Adverse Event|0|||
48807433|NCT01287520|157136574|FG000|Overall Study|Physician Decision|1|||
49120197|NCT02683239|158278895|FG003|Overall Study|Protocol Violation|4|||
48807434|NCT01287520|157136575|FG001|Overall Study|Physician Decision|1|||
48807435|NCT01287520|157136576|FG002|Overall Study|Physician Decision|2|||
48807436|NCT01287520|157136577|FG003|Overall Study|Physician Decision|0|||
48807437|NCT01287520|157136578|FG004|Overall Study|Physician Decision|1|||
48807438|NCT01287520|157136579|FG005|Overall Study|Physician Decision|1|||
48807439|NCT01287520|157136580|FG006|Overall Study|Physician Decision|0|||
48807440|NCT01287520|157136581|FG007|Overall Study|Physician Decision|1|||
48807441|NCT01287520|157136582|FG008|Overall Study|Physician Decision|0|||
48807442|NCT01287520|157136574|FG000|Overall Study|Progressive disease|0|||
48807443|NCT01287520|157136575|FG001|Overall Study|Progressive disease|4|||
48807444|NCT01287520|157136576|FG002|Overall Study|Progressive disease|1|||
49120198|NCT02683239|158278896|FG004|Overall Study|Protocol Violation|35|||
48807445|NCT01287520|157136577|FG003|Overall Study|Progressive disease|6|||
49120199|NCT02683239|158278897|FG005|Overall Study|Protocol Violation|4|||
49120200|NCT02683239|158278898|FG006|Overall Study|Protocol Violation|5|||
49120201|NCT02683239|158278892|FG000|Overall Study|Adverse Event|64|||
49120202|NCT02683239|158278893|FG001|Overall Study|Adverse Event|39|||
49120203|NCT02683239|158278894|FG002|Overall Study|Adverse Event|42|||
48807446|NCT01287520|157136578|FG004|Overall Study|Progressive disease|1|||
48807447|NCT01287520|157136579|FG005|Overall Study|Progressive disease|0|||
48807448|NCT01287520|157136580|FG006|Overall Study|Progressive disease|2|||
48807449|NCT01287520|157136581|FG007|Overall Study|Progressive disease|2|||
48807450|NCT01287520|157136582|FG008|Overall Study|Progressive disease|4|||
48807451|NCT01287520|157136574|FG000|Overall Study|Withdrawal by Subject|0|||
48807452|NCT01287520|157136575|FG001|Overall Study|Withdrawal by Subject|0|||
48807453|NCT01287520|157136576|FG002|Overall Study|Withdrawal by Subject|0|||
48807454|NCT01287520|157136577|FG003|Overall Study|Withdrawal by Subject|0|||
48807455|NCT01287520|157136578|FG004|Overall Study|Withdrawal by Subject|0|||
48807456|NCT01287520|157136579|FG005|Overall Study|Withdrawal by Subject|1|||
48807457|NCT01287520|157136580|FG006|Overall Study|Withdrawal by Subject|0|||
48807458|NCT01287520|157136581|FG007|Overall Study|Withdrawal by Subject|0|||
48807459|NCT01287520|157136582|FG008|Overall Study|Withdrawal by Subject|1|||
48807460|NCT04035200|157136584|FG000|Overall Study|Lost to Follow-up|0|||
48807461|NCT04035200|157136585|FG001|Overall Study|Lost to Follow-up|1|||
48807462|NCT04035200|157136586|FG002|Overall Study|Lost to Follow-up|0|||
48807463|NCT04035200|157136584|FG000|Overall Study|Withdrawal by Subject|1|||
48807464|NCT04035200|157136585|FG001|Overall Study|Withdrawal by Subject|4|||
48807465|NCT04035200|157136586|FG002|Overall Study|Withdrawal by Subject|4|||
48807466|NCT04035200|157136584|FG000|Overall Study|COVID-19|1|||
48807467|NCT04035200|157136585|FG001|Overall Study|COVID-19|0|||
48807468|NCT04035200|157136586|FG002|Overall Study|COVID-19|0|||
48807469|NCT04035200|157136584|FG000|Overall Study|Early Termination|0|||
48807470|NCT04035200|157136585|FG001|Overall Study|Early Termination|1|||
48807471|NCT04035200|157136586|FG002|Overall Study|Early Termination|0|||
48916939|NCT00139776|157532174|FG000|Period I|Did not enter Period II|575|||
48916940|NCT00139776|157532175|FG001|Period I|Did not enter Period II|0|||
48916941|NCT00139776|157532176|FG002|Period I|Did not enter Period II|0|||
48916942|NCT00139776|157532177|FG003|Period I|Did not enter Period II|0|||
48916943|NCT00139776|157532174|FG000|Period II|Not Randomized into Period III|0|||
48916944|NCT00139776|157532175|FG001|Period II|Not Randomized into Period III|322|||
48916945|NCT00139776|157532176|FG002|Period II|Not Randomized into Period III|0|||
48916946|NCT00139776|157532177|FG003|Period II|Not Randomized into Period III|0|||
48916947|NCT00139776|157532174|FG000|Period III|Adverse Event|0|||
48916948|NCT00139776|157532175|FG001|Period III|Adverse Event|0|||
48916949|NCT00139776|157532176|FG002|Period III|Adverse Event|22|||
48916950|NCT00139776|157532177|FG003|Period III|Adverse Event|23|||
48916951|NCT00139776|157532174|FG000|Period III|Other|0|||
48916952|NCT00139776|157532175|FG001|Period III|Other|0|||
48916953|NCT00139776|157532176|FG002|Period III|Other|23|||
48916954|NCT00139776|157532177|FG003|Period III|Other|34|||
48916955|NCT00139776|157532174|FG000|Period III|Lack of Efficacy|0|||
48916956|NCT00139776|157532175|FG001|Period III|Lack of Efficacy|0|||
48916957|NCT00139776|157532176|FG002|Period III|Lack of Efficacy|10|||
48916958|NCT00139776|157532177|FG003|Period III|Lack of Efficacy|24|||
48916959|NCT00139776|157532174|FG000|Period III|Lost to Follow-up|0|||
48916960|NCT00139776|157532175|FG001|Period III|Lost to Follow-up|0|||
48916961|NCT00139776|157532176|FG002|Period III|Lost to Follow-up|5|||
48916962|NCT00139776|157532177|FG003|Period III|Lost to Follow-up|4|||
48916963|NCT00139776|157532174|FG000|Period III|Withdrawal by Subject|0|||
48916964|NCT00139776|157532175|FG001|Period III|Withdrawal by Subject|0|||
48916965|NCT00139776|157532176|FG002|Period III|Withdrawal by Subject|16|||
48916966|NCT00139776|157532177|FG003|Period III|Withdrawal by Subject|21|||
48916967|NCT02349048|157532183|FG000|Overall Study|Withdrawal by Subject|4|||
48916968|NCT02349048|157532184|FG001|Overall Study|Withdrawal by Subject|0|||
48916969|NCT02349048|157532183|FG000|Overall Study|Lost to Follow-up|1|||
48916970|NCT02349048|157532184|FG001|Overall Study|Lost to Follow-up|0|||
48916971|NCT01549275|157532185|FG000|Overall Study|Lost to Follow-up|1|||
48916972|NCT01549275|157532186|FG001|Overall Study|Lost to Follow-up|0|||
48916973|NCT02113436|157532188|FG000|Period 1: 8 Weeks|Adverse Event|1|||
48916974|NCT02113436|157532189|FG001|Period 1: 8 Weeks|Adverse Event|0|||
48916975|NCT02113436|157532190|FG002|Period 1: 8 Weeks|Adverse Event|0|||
48916976|NCT02113436|157532191|FG003|Period 1: 8 Weeks|Adverse Event|0|||
48916977|NCT02113436|157532188|FG000|Period 1: 8 Weeks|Protocol Violation|1|||
48916978|NCT02113436|157532189|FG001|Period 1: 8 Weeks|Protocol Violation|0|||
48916979|NCT02113436|157532190|FG002|Period 1: 8 Weeks|Protocol Violation|0|||
48916980|NCT02113436|157532191|FG003|Period 1: 8 Weeks|Protocol Violation|0|||
48916981|NCT02113436|157532188|FG000|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5|||
48916982|NCT02113436|157532189|FG001|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2|||
48807472|NCT04035200|157136584|FG000|Overall Study|Non-compliance|0|||
48807473|NCT04035200|157136585|FG001|Overall Study|Non-compliance|1|||
48916983|NCT02113436|157532190|FG002|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
48916984|NCT02113436|157532191|FG003|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
48916985|NCT02113436|157532188|FG000|Period 1: 8 Weeks|Withdrawal by Subject|1|||
48916986|NCT02113436|157532189|FG001|Period 1: 8 Weeks|Withdrawal by Subject|0|||
48807474|NCT04035200|157136586|FG002|Overall Study|Non-compliance|0|||
48916987|NCT02113436|157532190|FG002|Period 1: 8 Weeks|Withdrawal by Subject|0|||
48916988|NCT02113436|157532191|FG003|Period 1: 8 Weeks|Withdrawal by Subject|0|||
48916989|NCT02113436|157532188|FG000|Period 2: 16 Weeks|Adverse Event|0|||
48916990|NCT02113436|157532189|FG001|Period 2: 16 Weeks|Adverse Event|0|||
48916991|NCT02113436|157532190|FG002|Period 2: 16 Weeks|Adverse Event|4|||
49010744|NCT03705169|157875684|FG001|Overall Study|Concerns about study visit compliance|0|||
48807475|NCT04399356|157136587|FG000|Overall Study|Lost to Follow-up|1|||
48916992|NCT02113436|157532191|FG003|Period 2: 16 Weeks|Adverse Event|5|||
48916993|NCT02113436|157532188|FG000|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
48916994|NCT02113436|157532189|FG001|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
49120204|NCT02683239|158278895|FG003|Overall Study|Adverse Event|16|||
48710143|NCT02023697|156788773|FG001|Active Follow-up Period|Withdrawal by Subject|13|||
49120205|NCT02683239|158278896|FG004|Overall Study|Adverse Event|189|||
49120206|NCT02683239|158278897|FG005|Overall Study|Adverse Event|9|||
48710144|NCT02023697|156788774|FG002|Active Follow-up Period|Withdrawal by Subject|7|||
48710145|NCT02023697|156788772|FG000|Active Follow-up Period|Lost to Follow-up|1|||
48710146|NCT02023697|156788773|FG001|Active Follow-up Period|Lost to Follow-up|1|||
48710147|NCT02023697|156788774|FG002|Active Follow-up Period|Lost to Follow-up|1|||
48710148|NCT02023697|156788772|FG000|Active Follow-up Period|Deterioration of general condition|1|||
48710149|NCT02023697|156788773|FG001|Active Follow-up Period|Deterioration of general condition|1|||
48710150|NCT02023697|156788774|FG002|Active Follow-up Period|Deterioration of general condition|1|||
48710151|NCT02023697|156788772|FG000|Active Follow-up Period|Other unspecified|2|||
48710152|NCT02023697|156788773|FG001|Active Follow-up Period|Other unspecified|0|||
48710153|NCT02023697|156788774|FG002|Active Follow-up Period|Other unspecified|1|||
48710154|NCT02023697|156788772|FG000|Active Follow-up Period|Clinical progression|0|||
48710155|NCT02023697|156788773|FG001|Active Follow-up Period|Clinical progression|2|||
48710156|NCT02023697|156788774|FG002|Active Follow-up Period|Clinical progression|1|||
48710157|NCT02023697|156788772|FG000|Active Follow-up Period|Radiological progression|0|||
48710158|NCT02023697|156788773|FG001|Active Follow-up Period|Radiological progression|0|||
48710159|NCT02023697|156788774|FG002|Active Follow-up Period|Radiological progression|1|||
48710160|NCT02023697|156788772|FG000|Active Follow-up Period|Death|83|||
48710161|NCT02023697|156788773|FG001|Active Follow-up Period|Death|82|||
48710162|NCT02023697|156788774|FG002|Active Follow-up Period|Death|87|||
48710163|NCT02023697|156788772|FG000|Long-term Follow-up Period|Death|9|||
48710164|NCT02023697|156788773|FG001|Long-term Follow-up Period|Death|6|||
48710165|NCT02023697|156788774|FG002|Long-term Follow-up Period|Death|4|||
48710166|NCT02023697|156788772|FG000|Long-term Follow-up Period|Withdrawal by Subject|6|||
48710167|NCT02023697|156788773|FG001|Long-term Follow-up Period|Withdrawal by Subject|3|||
48710168|NCT02023697|156788774|FG002|Long-term Follow-up Period|Withdrawal by Subject|0|||
48710169|NCT02023697|156788772|FG000|Long-term Follow-up Period|Lost to Follow-up|1|||
48710170|NCT02023697|156788773|FG001|Long-term Follow-up Period|Lost to Follow-up|0|||
48710171|NCT02023697|156788774|FG002|Long-term Follow-up Period|Lost to Follow-up|1|||
48710172|NCT02023697|156788772|FG000|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
48710173|NCT02023697|156788773|FG001|Long-term Follow-up Period|Entered the long-term follow-up study|9|||
48710174|NCT02023697|156788774|FG002|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
48710175|NCT02023697|156788772|FG000|Long-term Follow-up Period|Technical problems|0|||
48710176|NCT02023697|156788773|FG001|Long-term Follow-up Period|Technical problems|0|||
48710177|NCT02023697|156788774|FG002|Long-term Follow-up Period|Technical problems|1|||
48710178|NCT02023697|156788772|FG000|Long-term Follow-up Period|Other unspecified|6|||
48710179|NCT02023697|156788773|FG001|Long-term Follow-up Period|Other unspecified|3|||
48710180|NCT02023697|156788774|FG002|Long-term Follow-up Period|Other unspecified|5|||
48710181|NCT01733680|156788775|FG000|Overall Study|Withdrawal by Subject|0|||
48710182|NCT01733680|156788776|FG001|Overall Study|Withdrawal by Subject|1|||
48710183|NCT00476229|156788777|FG000|Overall Study|Progressive shortness of breath|1|||
48710184|NCT02164461|156788778|FG000|Overall Study|Adverse Event|0|||
48710185|NCT02164461|156788779|FG001|Overall Study|Adverse Event|0|||
48710186|NCT02164461|156788780|FG002|Overall Study|Adverse Event|1|||
48807476|NCT04399356|157136588|FG001|Overall Study|Lost to Follow-up|1|||
48807477|NCT04399356|157136587|FG000|Overall Study|Discontinued Niclosamide/ Placebo|1|||
48807478|NCT04399356|157136588|FG001|Overall Study|Discontinued Niclosamide/ Placebo|2|||
48807479|NCT04399356|157136587|FG000|Overall Study|Withdrawal by Subject|1|||
48807480|NCT04399356|157136588|FG001|Overall Study|Withdrawal by Subject|0|||
48807481|NCT01121484|157136592|FG000|Overall Study|Adverse Event|12|||
48807482|NCT01121484|157136593|FG001|Overall Study|Adverse Event|5|||
48807483|NCT01121484|157136592|FG000|Overall Study|Lack of Efficacy|3|||
48807484|NCT01121484|157136593|FG001|Overall Study|Lack of Efficacy|11|||
48807485|NCT01121484|157136592|FG000|Overall Study|Lost to Follow-up|5|||
48807486|NCT01121484|157136593|FG001|Overall Study|Lost to Follow-up|9|||
48807487|NCT01121484|157136592|FG000|Overall Study|Physician Decision|0|||
48807488|NCT01121484|157136593|FG001|Overall Study|Physician Decision|3|||
48807489|NCT01121484|157136592|FG000|Overall Study|Protocol Violation|1|||
48807490|NCT01121484|157136593|FG001|Overall Study|Protocol Violation|0|||
48807491|NCT01121484|157136592|FG000|Overall Study|Withdrawal by Subject|8|||
48710187|NCT02164461|156788778|FG000|Overall Study|Disease Progression|1|||
48710188|NCT02164461|156788779|FG001|Overall Study|Disease Progression|3|||
48710189|NCT02164461|156788780|FG002|Overall Study|Disease Progression|4|||
48710190|NCT02164461|156788778|FG000|Overall Study|Withdrawal by Subject|0|||
48710191|NCT02164461|156788779|FG001|Overall Study|Withdrawal by Subject|3|||
48710192|NCT02164461|156788780|FG002|Overall Study|Withdrawal by Subject|0|||
48710193|NCT04145219|156788783|FG000|Overall Study|Adverse Event|18|||
48807492|NCT01121484|157136593|FG001|Overall Study|Withdrawal by Subject|7|||
48807493|NCT01121484|157136592|FG000|Overall Study|Discontinuation of study by sponsor|0|||
48807494|NCT01121484|157136593|FG001|Overall Study|Discontinuation of study by sponsor|1|||
48807495|NCT01121484|157136592|FG000|Overall Study|Other|3|||
48916995|NCT02113436|157532190|FG002|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2|||
48916996|NCT02113436|157532191|FG003|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5|||
48916997|NCT02113436|157532188|FG000|Period 2: 16 Weeks|Physician Decision|0|||
48916998|NCT02113436|157532189|FG001|Period 2: 16 Weeks|Physician Decision|0|||
48916999|NCT02113436|157532190|FG002|Period 2: 16 Weeks|Physician Decision|2|||
48917000|NCT02113436|157532191|FG003|Period 2: 16 Weeks|Physician Decision|0|||
48917001|NCT02113436|157532188|FG000|Period 2: 16 Weeks|Withdrawal by Subject|0|||
48917002|NCT02113436|157532189|FG001|Period 2: 16 Weeks|Withdrawal by Subject|0|||
48917003|NCT02113436|157532190|FG002|Period 2: 16 Weeks|Withdrawal by Subject|1|||
48917004|NCT02113436|157532191|FG003|Period 2: 16 Weeks|Withdrawal by Subject|1|||
48917005|NCT00971178|157532194|FG000|Overall Study|Lost to Follow-up|2|||
48917006|NCT00971178|157532195|FG001|Overall Study|Lost to Follow-up|2|||
48917007|NCT00971178|157532196|FG002|Overall Study|Lost to Follow-up|2|||
48917008|NCT03719690|157532198|FG000|Overall Study|Withdrawal by Subject|5|||
48917009|NCT03719690|157532199|FG001|Overall Study|Withdrawal by Subject|10|||
48917010|NCT03719690|157532198|FG000|Overall Study|Death|40|||
48917011|NCT03719690|157532199|FG001|Overall Study|Death|149|||
48917012|NCT03719690|157532198|FG000|Overall Study|Miscellaneous|12|||
48917013|NCT03719690|157532199|FG001|Overall Study|Miscellaneous|56|||
48917014|NCT03719690|157532198|FG000|Overall Study|Lost to Follow-up|2|||
48917015|NCT03719690|157532199|FG001|Overall Study|Lost to Follow-up|18|||
48917016|NCT03719690|157532198|FG000|Overall Study|Unwilling or unable to comply with study requirements|0|||
48917017|NCT03719690|157532199|FG001|Overall Study|Unwilling or unable to comply with study requirements|4|||
48917018|NCT01131676|157532200|FG000|Discontinuation From Treatment|Study drug stopped, reason missing|5|||
48917019|NCT01131676|157532201|FG001|Discontinuation From Treatment|Study drug stopped, reason missing|3|||
48917020|NCT01131676|157532202|FG002|Discontinuation From Treatment|Study drug stopped, reason missing|4|||
48917021|NCT01131676|157532200|FG000|Discontinuation From Treatment|Not treated|4|||
48917022|NCT01131676|157532201|FG001|Discontinuation From Treatment|Not treated|2|||
48917023|NCT01131676|157532202|FG002|Discontinuation From Treatment|Not treated|2|||
48917024|NCT01131676|157532200|FG000|Discontinuation From Treatment|Lack of Efficacy|11|||
48917025|NCT01131676|157532201|FG001|Discontinuation From Treatment|Lack of Efficacy|1|||
48917026|NCT01131676|157532202|FG002|Discontinuation From Treatment|Lack of Efficacy|0|||
48917027|NCT01131676|157532200|FG000|Discontinuation From Treatment|Non compliant with protocol|15|||
48917028|NCT01131676|157532201|FG001|Discontinuation From Treatment|Non compliant with protocol|15|||
48917029|NCT01131676|157532202|FG002|Discontinuation From Treatment|Non compliant with protocol|12|||
48917030|NCT01131676|157532200|FG000|Discontinuation From Treatment|Lost to Follow-up|15|||
48917031|NCT01131676|157532201|FG001|Discontinuation From Treatment|Lost to Follow-up|9|||
48917032|NCT01131676|157532202|FG002|Discontinuation From Treatment|Lost to Follow-up|6|||
48917033|NCT01131676|157532200|FG000|Discontinuation From Treatment|Refusal to continue, not due to AE|172|||
48917034|NCT01131676|157532201|FG001|Discontinuation From Treatment|Refusal to continue, not due to AE|118|||
48917035|NCT01131676|157532202|FG002|Discontinuation From Treatment|Refusal to continue, not due to AE|122|||
48917036|NCT01131676|157532200|FG000|Discontinuation From Treatment|Other than those specified|162|||
48917037|NCT01131676|157532201|FG001|Discontinuation From Treatment|Other than those specified|142|||
48917038|NCT01131676|157532202|FG002|Discontinuation From Treatment|Other than those specified|125|||
48917039|NCT01131676|157532200|FG000|Discontinuation From Treatment|Adverse Event|303|||
48917040|NCT01131676|157532201|FG001|Discontinuation From Treatment|Adverse Event|267|||
48917041|NCT01131676|157532202|FG002|Discontinuation From Treatment|Adverse Event|273|||
48917042|NCT01131676|157532200|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23|||
48917043|NCT01131676|157532201|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35|||
48917044|NCT01131676|157532202|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25|||
48917045|NCT01131676|157532200|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8|||
48917046|NCT01131676|157532201|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6|||
48917047|NCT01131676|157532202|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5|||
48917048|NCT01131676|157532200|FG000|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20|||
48917049|NCT01131676|157532201|FG001|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21|||
48917050|NCT01131676|157532202|FG002|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19|||
48917051|NCT01131676|157532200|FG000|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5|||
48917052|NCT01131676|157532201|FG001|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9|||
48917053|NCT01131676|157532202|FG002|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7|||
48917054|NCT01131676|157532200|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7|||
48917055|NCT01131676|157532201|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6|||
48917056|NCT01131676|157532202|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5|||
48917057|NCT01131676|157532200|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
48917058|NCT01131676|157532201|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
48917059|NCT01131676|157532202|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2|||
48917060|NCT00393887|157532203|FG000|Overall Study|Physician Decision|5|||
48917061|NCT00393887|157532204|FG001|Overall Study|Physician Decision|0|||
48917062|NCT00393887|157532203|FG000|Overall Study|Lost to Follow-up|11|||
48917063|NCT00393887|157532204|FG001|Overall Study|Lost to Follow-up|9|||
48917064|NCT01111851|157532205|FG000|Overall Study|All planned PET scans were not obtained.|2|||
48917065|NCT01111851|157532206|FG001|Overall Study|All planned PET scans were not obtained.|0|||
48917066|NCT02343159|157532207|FG000|Overall Study|Early Study Termination|16|||
48917067|NCT02343159|157532208|FG001|Overall Study|Early Study Termination|19|||
48917068|NCT02343159|157532209|FG002|Overall Study|Early Study Termination|23|||
48917069|NCT02343159|157532207|FG000|Overall Study|Physician Decision|2|||
48917070|NCT02343159|157532208|FG001|Overall Study|Physician Decision|0|||
48917071|NCT02343159|157532209|FG002|Overall Study|Physician Decision|1|||
48917072|NCT02343159|157532207|FG000|Overall Study|Withdrawal by Subject|3|||
48917073|NCT02343159|157532208|FG001|Overall Study|Withdrawal by Subject|0|||
48917074|NCT02343159|157532209|FG002|Overall Study|Withdrawal by Subject|2|||
48917075|NCT02343159|157532207|FG000|Overall Study|Lost to Follow-up|0|||
48917076|NCT02343159|157532208|FG001|Overall Study|Lost to Follow-up|2|||
48917077|NCT02343159|157532209|FG002|Overall Study|Lost to Follow-up|2|||
48917078|NCT02343159|157532207|FG000|Overall Study|Adverse Event|4|||
48917079|NCT02343159|157532208|FG001|Overall Study|Adverse Event|4|||
48917080|NCT02343159|157532209|FG002|Overall Study|Adverse Event|2|||
48917081|NCT02343159|157532207|FG000|Overall Study|Sponsor Decision|0|||
48917082|NCT02343159|157532208|FG001|Overall Study|Sponsor Decision|1|||
48917083|NCT02343159|157532209|FG002|Overall Study|Sponsor Decision|0|||
48917084|NCT02343159|157532207|FG000|Overall Study|Enrollment Error|1|||
48917085|NCT02343159|157532208|FG001|Overall Study|Enrollment Error|0|||
48917086|NCT02343159|157532209|FG002|Overall Study|Enrollment Error|0|||
48917087|NCT01923285|157532210|FG000|Overall Study|Withdrawal by Subject|7|||
48917088|NCT01923285|157532211|FG001|Overall Study|Withdrawal by Subject|6|||
48917089|NCT03374189|157532213|FG000|Overall Study|Lost to Follow-up|1|||
48917090|NCT03374189|157532214|FG001|Overall Study|Lost to Follow-up|0|||
48917091|NCT02311153|157532215|FG000|Overall Study|Lost to Follow-up|5|||
48917092|NCT02311153|157532216|FG001|Overall Study|Lost to Follow-up|7|||
48917093|NCT04712110|157532217|FG000|Overall Study|Lost to Follow-up|0|||
48917094|NCT04712110|157532218|FG001|Overall Study|Lost to Follow-up|1|||
48917095|NCT04712110|157532217|FG000|Overall Study|Withdrawal by Subject|0|||
48917096|NCT04712110|157532218|FG001|Overall Study|Withdrawal by Subject|4|||
48917097|NCT04712110|157532217|FG000|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|46|||
48917098|NCT04712110|157532218|FG001|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|14|||
48917099|NCT03024970|157532221|FG000|First Intervention|Adverse Event|1|||
48917100|NCT03024970|157532222|FG001|First Intervention|Adverse Event|0|||
48807496|NCT01121484|157136593|FG001|Overall Study|Other|3|||
48807497|NCT01121484|157136592|FG000|Overall Study|Randomized, not treated|1|||
48807498|NCT01121484|157136593|FG001|Overall Study|Randomized, not treated|4|||
48807499|NCT01834222|157136597|FG000|Overall Study|Not meet inclusion/exclusion criteria|1|||
48807500|NCT01375205|157136598|FG000|Overall Study|Lost to Follow-up|15|||
48917101|NCT03024970|157532221|FG000|Second Intervention|Lost to Follow-up|1|||
48917102|NCT03024970|157532222|FG001|Second Intervention|Lost to Follow-up|0|||
48917103|NCT03462576|157532223|FG000|Overall Study|Protocol Violation|5|||
49120207|NCT02683239|158278898|FG006|Overall Study|Adverse Event|9|||
49120208|NCT02683239|158278892|FG000|Overall Study|Physician Decision|38|||
49120209|NCT02683239|158278893|FG001|Overall Study|Physician Decision|19|||
49120210|NCT02683239|158278894|FG002|Overall Study|Physician Decision|14|||
49120211|NCT02683239|158278895|FG003|Overall Study|Physician Decision|73|||
49120212|NCT02683239|158278896|FG004|Overall Study|Physician Decision|143|||
48917104|NCT03462576|157532224|FG001|Overall Study|Protocol Violation|11|||
48710194|NCT04145219|156788784|FG001|Overall Study|Adverse Event|6|||
48710195|NCT04145219|156788783|FG000|Overall Study|Lost to Follow-up|2|||
48710196|NCT04145219|156788784|FG001|Overall Study|Lost to Follow-up|3|||
48710197|NCT04145219|156788783|FG000|Overall Study|Physician Decision|0|||
48710198|NCT04145219|156788784|FG001|Overall Study|Physician Decision|2|||
48710199|NCT04145219|156788783|FG000|Overall Study|Withdrawal by Subject|12|||
48710200|NCT04145219|156788784|FG001|Overall Study|Withdrawal by Subject|8|||
48710201|NCT04145219|156788783|FG000|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
48710202|NCT04145219|156788784|FG001|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
48710203|NCT02722499|156788785|FG000|Overall Study|Lost to Follow-up|2|||
48710204|NCT02722499|156788786|FG001|Overall Study|Lost to Follow-up|0|||
48710205|NCT02722499|156788787|FG002|Overall Study|Lost to Follow-up|1|||
48710206|NCT01047553|156788801|FG000|Overall Study|Adverse Event|10|||
48710207|NCT01047553|156788802|FG001|Overall Study|Adverse Event|5|||
48710208|NCT01047553|156788801|FG000|Overall Study|Withdrawal by Subject|4|||
48710209|NCT01047553|156788802|FG001|Overall Study|Withdrawal by Subject|2|||
48917105|NCT03462576|157532225|FG002|Overall Study|Protocol Violation|7|||
48917106|NCT03462576|157532223|FG000|Overall Study|Device Malfunction|0|||
48807501|NCT01375205|157136599|FG001|Overall Study|Lost to Follow-up|12|||
48917107|NCT03462576|157532224|FG001|Overall Study|Device Malfunction|0|||
48917108|NCT03462576|157532225|FG002|Overall Study|Device Malfunction|1|||
48917109|NCT03363321|157532226|FG000|Overall Study|Withdrawal by Subject|0|||
48917110|NCT03363321|157532227|FG001|Overall Study|Withdrawal by Subject|1|||
48917111|NCT03363321|157532228|FG002|Overall Study|Withdrawal by Subject|0|||
48917112|NCT03363321|157532229|FG003|Overall Study|Withdrawal by Subject|1|||
48917113|NCT03363321|157532230|FG004|Overall Study|Withdrawal by Subject|0|||
48917114|NCT00781911|157532240|FG000|Overall Study|Adverse Event|4|||
48917115|NCT00781911|157532241|FG001|Overall Study|Adverse Event|4|||
48710210|NCT01047553|156788801|FG000|Overall Study|Development of Study-Specific Withdrawal|1|||
48710211|NCT01047553|156788802|FG001|Overall Study|Development of Study-Specific Withdrawal|1|||
48710212|NCT01047553|156788801|FG000|Overall Study|Lost to Follow-up|1|||
48710213|NCT01047553|156788802|FG001|Overall Study|Lost to Follow-up|0|||
48710214|NCT01047553|156788801|FG000|Overall Study|Sever Non-Compliance to Protocol|1|||
48710215|NCT01047553|156788802|FG001|Overall Study|Sever Non-Compliance to Protocol|0|||
48710216|NCT01047553|156788801|FG000|Overall Study|PI's decision|0|||
48807502|NCT01375205|157136598|FG000|Overall Study|Withdrawal by Subject|6|||
48807503|NCT01375205|157136599|FG001|Overall Study|Withdrawal by Subject|1|||
48807504|NCT01674621|157136603|FG000|Overall Study|Adverse Event|3|||
48807505|NCT01674621|157136604|FG001|Overall Study|Adverse Event|2|||
48807506|NCT01674621|157136605|FG002|Overall Study|Adverse Event|5|||
48807507|NCT01674621|157136606|FG003|Overall Study|Adverse Event|5|||
48807508|NCT01674621|157136607|FG004|Overall Study|Adverse Event|1|||
48807509|NCT01674621|157136603|FG000|Overall Study|Inability to Complete Study Procedures|0|||
48807510|NCT01674621|157136604|FG001|Overall Study|Inability to Complete Study Procedures|0|||
48807511|NCT01674621|157136605|FG002|Overall Study|Inability to Complete Study Procedures|0|||
48807512|NCT01674621|157136606|FG003|Overall Study|Inability to Complete Study Procedures|0|||
48807513|NCT01674621|157136607|FG004|Overall Study|Inability to Complete Study Procedures|2|||
48807514|NCT01674621|157136603|FG000|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
48917116|NCT00781911|157532240|FG000|Overall Study|Withdrawal by Subject|1|||
48917117|NCT00781911|157532241|FG001|Overall Study|Withdrawal by Subject|2|||
48807515|NCT01674621|157136604|FG001|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
48917118|NCT00781911|157532240|FG000|Overall Study|Physician Decision|0|||
49120213|NCT02683239|158278897|FG005|Overall Study|Physician Decision|14|||
48917119|NCT00781911|157532241|FG001|Overall Study|Physician Decision|2|||
49120214|NCT02683239|158278898|FG006|Overall Study|Physician Decision|15|||
49120215|NCT02683239|158278892|FG000|Overall Study|Withdrawal by Subject|187|||
49120216|NCT02683239|158278893|FG001|Overall Study|Withdrawal by Subject|99|||
49120217|NCT02683239|158278894|FG002|Overall Study|Withdrawal by Subject|91|||
49120218|NCT02683239|158278895|FG003|Overall Study|Withdrawal by Subject|18|||
49120219|NCT02683239|158278896|FG004|Overall Study|Withdrawal by Subject|248|||
49120220|NCT02683239|158278897|FG005|Overall Study|Withdrawal by Subject|22|||
49120221|NCT02683239|158278898|FG006|Overall Study|Withdrawal by Subject|28|||
49120222|NCT02683239|158278892|FG000|Overall Study|Lost to Follow-up|77|||
49120223|NCT02683239|158278893|FG001|Overall Study|Lost to Follow-up|24|||
49120224|NCT02683239|158278894|FG002|Overall Study|Lost to Follow-up|25|||
49120225|NCT02683239|158278895|FG003|Overall Study|Lost to Follow-up|7|||
49120226|NCT02683239|158278896|FG004|Overall Study|Lost to Follow-up|88|||
49120227|NCT02683239|158278897|FG005|Overall Study|Lost to Follow-up|8|||
49120228|NCT02683239|158278898|FG006|Overall Study|Lost to Follow-up|11|||
49120229|NCT02683239|158278892|FG000|Overall Study|Death|9|||
49120230|NCT02683239|158278893|FG001|Overall Study|Death|5|||
49120231|NCT02683239|158278894|FG002|Overall Study|Death|8|||
49120232|NCT02683239|158278895|FG003|Overall Study|Death|0|||
49120233|NCT02683239|158278896|FG004|Overall Study|Death|12|||
49120234|NCT02683239|158278897|FG005|Overall Study|Death|1|||
49120235|NCT02683239|158278898|FG006|Overall Study|Death|0|||
49120236|NCT02683239|158278892|FG000|Overall Study|Lack of Efficacy|50|||
49120237|NCT02683239|158278893|FG001|Overall Study|Lack of Efficacy|23|||
49120238|NCT02683239|158278894|FG002|Overall Study|Lack of Efficacy|12|||
49120239|NCT02683239|158278895|FG003|Overall Study|Lack of Efficacy|2|||
49120240|NCT02683239|158278896|FG004|Overall Study|Lack of Efficacy|29|||
49120241|NCT02683239|158278897|FG005|Overall Study|Lack of Efficacy|2|||
49120242|NCT02683239|158278898|FG006|Overall Study|Lack of Efficacy|3|||
49120243|NCT02683239|158278892|FG000|Overall Study|Missing data|0|||
49120244|NCT02683239|158278893|FG001|Overall Study|Missing data|1|||
49120245|NCT02683239|158278894|FG002|Overall Study|Missing data|1|||
49120246|NCT02683239|158278895|FG003|Overall Study|Missing data|0|||
49120247|NCT02683239|158278896|FG004|Overall Study|Missing data|1|||
49120248|NCT02683239|158278897|FG005|Overall Study|Missing data|0|||
49120249|NCT02683239|158278898|FG006|Overall Study|Missing data|0|||
49120250|NCT00856999|158278899|FG000|Overall Study|Withdrawal by Subject|5|||
49120251|NCT04547140|158278900|FG000|Overall Study|Adverse Event|0|||
49120252|NCT04547140|158278901|FG001|Overall Study|Adverse Event|1|||
49120253|NCT04547140|158278900|FG000|Overall Study|Withdrawal by Subject|0|||
49120254|NCT04547140|158278901|FG001|Overall Study|Withdrawal by Subject|1|||
48710217|NCT01047553|156788802|FG001|Overall Study|PI's decision|1|||
48710218|NCT05343624|156788803|FG000|Overall Study|Chart review not completed|1|||
48710219|NCT01262820|156788804|FG000|Overall Study|Adverse Event|5|||
48710220|NCT01262820|156788804|FG000|Overall Study|Lack of Efficacy|9|||
48710221|NCT01262820|156788804|FG000|Overall Study|Drug held for 21+ days|1|||
48710222|NCT03181529|156788805|FG000|Overall Study|Withdrawal by Subject|1|||
48710223|NCT03181529|156788806|FG001|Overall Study|Withdrawal by Subject|1|||
48710224|NCT03181529|156788805|FG000|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|1|||
48710225|NCT03181529|156788806|FG001|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|0|||
48710226|NCT00104520|156788808|FG000|Overall Study|Unrelated adverse event|34|||
48710227|NCT00104520|156788809|FG001|Overall Study|Unrelated adverse event|47|||
48710228|NCT00104520|156788808|FG000|Overall Study|Study drug intolerance|0|||
48710229|NCT00104520|156788809|FG001|Overall Study|Study drug intolerance|1|||
48710230|NCT00104520|156788808|FG000|Overall Study|Related adverse event|13|||
48710231|NCT00104520|156788809|FG001|Overall Study|Related adverse event|15|||
48710232|NCT00104520|156788808|FG000|Overall Study|Lost to Follow-up|1|||
48710233|NCT00104520|156788809|FG001|Overall Study|Lost to Follow-up|0|||
48710234|NCT00104520|156788808|FG000|Overall Study|Noncompliance|0|||
48710235|NCT00104520|156788809|FG001|Overall Study|Noncompliance|2|||
48710236|NCT00104520|156788808|FG000|Overall Study|Personal/administrative|1|||
48710237|NCT00104520|156788809|FG001|Overall Study|Personal/administrative|1|||
48710238|NCT00104520|156788808|FG000|Overall Study|Other|1|||
48710239|NCT00104520|156788809|FG001|Overall Study|Other|5|||
48710240|NCT02379637|156788819|FG000|Overall Study|Protocol Violation|0|||
48710241|NCT02379637|156788820|FG001|Overall Study|Protocol Violation|1|||
48710242|NCT02379637|156788819|FG000|Overall Study|Adverse Event|1|||
48710243|NCT02379637|156788820|FG001|Overall Study|Adverse Event|0|||
48710244|NCT02379637|156788819|FG000|Overall Study|Withdrawal by Subject|1|||
48710245|NCT02379637|156788820|FG001|Overall Study|Withdrawal by Subject|0|||
48710246|NCT00706342|156788825|FG000|Overall Study|Adverse Event|3|||
48710247|NCT00706342|156788825|FG000|Overall Study|Not responding to treatment|2|||
48710248|NCT00706342|156788825|FG000|Overall Study|Withdrawn due to failure to respond|1|||
48710249|NCT00706342|156788825|FG000|Overall Study|Death|1|||
48710250|NCT00706342|156788825|FG000|Overall Study|Withdrew from the study on his own.|1|||
48710251|NCT00706342|156788825|FG000|Overall Study|Investigator discretion|2|||
48710252|NCT00706342|156788825|FG000|Overall Study|Non-responder Week 12|1|||
48710253|NCT00706342|156788825|FG000|Overall Study|Ongoing|6|||
48710254|NCT00706342|156788825|FG000|Overall Study|WIthdrawal of consent|1|||
48710255|NCT01781299|156788827|FG000|Overall Study|Withdrawal by Subject|0|||
48710256|NCT01781299|156788828|FG001|Overall Study|Withdrawal by Subject|1|||
48710257|NCT01798849|156788829|FG000|Overall Study|Physician Decision|0|||
48710258|NCT01798849|156788830|FG001|Overall Study|Physician Decision|0|||
48710259|NCT01798849|156788831|FG002|Overall Study|Physician Decision|1|||
48710260|NCT04254913|156788832|FG000|Overall Study|Adverse Event|1|||
48710261|NCT04535453|156788833|FG000|Overall Study|Death|0|||
48710262|NCT04535453|156788834|FG001|Overall Study|Death|1|||
48710263|NCT04535453|156788835|FG002|Overall Study|Death|0|||
48710264|NCT04535453|156788836|FG003|Overall Study|Death|0|||
48710265|NCT04535453|156788837|FG004|Overall Study|Death|0|||
48710266|NCT04535453|156788838|FG005|Overall Study|Death|0|||
48710267|NCT04535453|156788839|FG006|Overall Study|Death|0|||
48710268|NCT04535453|156788840|FG007|Overall Study|Death|0|||
48710269|NCT04535453|156788841|FG008|Overall Study|Death|0|||
48710270|NCT04535453|156788842|FG009|Overall Study|Death|0|||
48710271|NCT04535453|156788843|FG010|Overall Study|Death|0|||
48710272|NCT04535453|156788844|FG011|Overall Study|Death|0|||
48710273|NCT04535453|156788833|FG000|Overall Study|Lost to Follow-up|1|||
48710274|NCT04535453|156788834|FG001|Overall Study|Lost to Follow-up|1|||
48710275|NCT04535453|156788835|FG002|Overall Study|Lost to Follow-up|1|||
48710276|NCT04535453|156788836|FG003|Overall Study|Lost to Follow-up|0|||
48710277|NCT04535453|156788837|FG004|Overall Study|Lost to Follow-up|3|||
48710278|NCT04535453|156788838|FG005|Overall Study|Lost to Follow-up|1|||
48710279|NCT04535453|156788839|FG006|Overall Study|Lost to Follow-up|0|||
48917120|NCT00781911|157532240|FG000|Overall Study|Sponsor Decision|1|||
48917121|NCT00781911|157532241|FG001|Overall Study|Sponsor Decision|0|||
48917122|NCT03317795|157532244|FG000|Overall Study|IUD Expulsion|1|||
48710280|NCT04535453|156788840|FG007|Overall Study|Lost to Follow-up|0|||
48710281|NCT04535453|156788841|FG008|Overall Study|Lost to Follow-up|1|||
48710282|NCT04535453|156788842|FG009|Overall Study|Lost to Follow-up|1|||
48710283|NCT04535453|156788843|FG010|Overall Study|Lost to Follow-up|0|||
48710284|NCT04535453|156788844|FG011|Overall Study|Lost to Follow-up|0|||
48710285|NCT04535453|156788833|FG000|Overall Study|Physician Decision|0|||
48710286|NCT04535453|156788834|FG001|Overall Study|Physician Decision|0|||
48710287|NCT04535453|156788835|FG002|Overall Study|Physician Decision|0|||
48710288|NCT04535453|156788836|FG003|Overall Study|Physician Decision|1|||
48917123|NCT03317795|157532245|FG001|Overall Study|IUD Expulsion|0|||
48710289|NCT04535453|156788837|FG004|Overall Study|Physician Decision|0|||
48710290|NCT04535453|156788838|FG005|Overall Study|Physician Decision|0|||
48710291|NCT04535453|156788839|FG006|Overall Study|Physician Decision|0|||
48710292|NCT04535453|156788840|FG007|Overall Study|Physician Decision|0|||
48710293|NCT04535453|156788841|FG008|Overall Study|Physician Decision|0|||
48710294|NCT04535453|156788842|FG009|Overall Study|Physician Decision|0|||
48710295|NCT04535453|156788843|FG010|Overall Study|Physician Decision|0|||
48710296|NCT04535453|156788844|FG011|Overall Study|Physician Decision|0|||
48710297|NCT04535453|156788833|FG000|Overall Study|Withdrawal by Subject|3|||
48710298|NCT04535453|156788834|FG001|Overall Study|Withdrawal by Subject|6|||
48710299|NCT04535453|156788835|FG002|Overall Study|Withdrawal by Subject|3|||
48710300|NCT04535453|156788836|FG003|Overall Study|Withdrawal by Subject|3|||
48710301|NCT04535453|156788837|FG004|Overall Study|Withdrawal by Subject|2|||
48710302|NCT04535453|156788838|FG005|Overall Study|Withdrawal by Subject|1|||
48710303|NCT04535453|156788839|FG006|Overall Study|Withdrawal by Subject|1|||
48710304|NCT04535453|156788840|FG007|Overall Study|Withdrawal by Subject|1|||
48710305|NCT04535453|156788841|FG008|Overall Study|Withdrawal by Subject|1|||
48710306|NCT04535453|156788842|FG009|Overall Study|Withdrawal by Subject|1|||
48710307|NCT04535453|156788843|FG010|Overall Study|Withdrawal by Subject|0|||
48710308|NCT04535453|156788844|FG011|Overall Study|Withdrawal by Subject|1|||
48710309|NCT04535453|156788833|FG000|Overall Study|Other|0|||
48710310|NCT04535453|156788834|FG001|Overall Study|Other|0|||
48710311|NCT04535453|156788835|FG002|Overall Study|Other|1|||
48710312|NCT04535453|156788836|FG003|Overall Study|Other|0|||
48710313|NCT04535453|156788837|FG004|Overall Study|Other|1|||
48710314|NCT04535453|156788838|FG005|Overall Study|Other|0|||
48710315|NCT04535453|156788839|FG006|Overall Study|Other|1|||
48710316|NCT04535453|156788840|FG007|Overall Study|Other|1|||
48710317|NCT04535453|156788841|FG008|Overall Study|Other|1|||
48710318|NCT04535453|156788842|FG009|Overall Study|Other|0|||
48710319|NCT04535453|156788843|FG010|Overall Study|Other|0|||
48710320|NCT04535453|156788844|FG011|Overall Study|Other|0|||
48710321|NCT00916929|156788845|FG000|Overall Study|Lost to Follow-up|1|||
48710322|NCT00916929|156788846|FG001|Overall Study|Lost to Follow-up|3|||
48710323|NCT00916929|156788845|FG000|Overall Study|Death|5|||
48710324|NCT00916929|156788846|FG001|Overall Study|Death|10|||
48710325|NCT00916929|156788845|FG000|Overall Study|Withdrawal by Subject|1|||
48710326|NCT00916929|156788846|FG001|Overall Study|Withdrawal by Subject|5|||
48710327|NCT00916929|156788845|FG000|Overall Study|Left ventricular epicardial lead|1|||
48710328|NCT00916929|156788846|FG001|Overall Study|Left ventricular epicardial lead|2|||
48710329|NCT00916929|156788845|FG000|Overall Study|Transferred to hospice care|1|||
48710330|NCT00916929|156788846|FG001|Overall Study|Transferred to hospice care|1|||
48710331|NCT00916929|156788845|FG000|Overall Study|System explant|1|||
48710332|NCT00916929|156788846|FG001|Overall Study|System explant|0|||
48710333|NCT00916929|156788845|FG000|Overall Study|Moved to another state|0|||
48710334|NCT00916929|156788846|FG001|Overall Study|Moved to another state|1|||
48710335|NCT00916929|156788845|FG000|Overall Study|Device unable to process impedance data|0|||
48917124|NCT03317795|157532244|FG000|Overall Study|Lost to Follow-up|1|||
48917125|NCT03317795|157532245|FG001|Overall Study|Lost to Follow-up|3|||
48917126|NCT03317795|157532244|FG000|Overall Study|Treatment change|0|||
48917127|NCT03317795|157532245|FG001|Overall Study|Treatment change|3|||
48917128|NCT03317795|157532244|FG000|Overall Study|Intolerance of medication|0|||
48917129|NCT03317795|157532245|FG001|Overall Study|Intolerance of medication|1|||
48917130|NCT00432042|157532249|FG000|Overall Study|Protocol Violation|2|||
48917131|NCT00432042|157532250|FG001|Overall Study|Protocol Violation|0|||
48917132|NCT00432042|157532251|FG002|Overall Study|Protocol Violation|0|||
48917133|NCT00432042|157532249|FG000|Overall Study|Withdrawal by Subject|0|||
48917134|NCT00432042|157532250|FG001|Overall Study|Withdrawal by Subject|0|||
48917135|NCT00432042|157532251|FG002|Overall Study|Withdrawal by Subject|2|||
48917136|NCT00432042|157532249|FG000|Overall Study|Lost to Follow-up|5|||
48917137|NCT00432042|157532250|FG001|Overall Study|Lost to Follow-up|1|||
48917138|NCT00432042|157532251|FG002|Overall Study|Lost to Follow-up|0|||
48917139|NCT00993265|157532266|FG000|Overall Study|Adverse Event|1|||
49120255|NCT04547140|158278900|FG000|Overall Study|Lost to Follow-up|3|||
48917140|NCT00993265|157532267|FG001|Overall Study|Adverse Event|0|||
48917141|NCT00993265|157532266|FG000|Overall Study|Changed dose of concomitant drug|2|||
49120256|NCT04547140|158278901|FG001|Overall Study|Lost to Follow-up|1|||
49120257|NCT04547140|158278900|FG000|Overall Study|Death|2|||
49120258|NCT04547140|158278901|FG001|Overall Study|Death|1|||
49120259|NCT04547140|158278900|FG000|Overall Study|Physician Decision (Does not Include Adverse Events)|0|||
49120260|NCT04547140|158278901|FG001|Overall Study|Physician Decision (Does not Include Adverse Events)|1|||
49120261|NCT04547140|158278900|FG000|Overall Study|Pregnancy|1|||
48710336|NCT00916929|156788846|FG001|Overall Study|Device unable to process impedance data|7|||
48710337|NCT02929407|156788847|FG000|Overall Study|Adverse Event|1|||
48710338|NCT01160822|156788850|FG000|Overall Study|Adverse Event|0|||
48710339|NCT01160822|156788851|FG001|Overall Study|Adverse Event|0|||
48917142|NCT00993265|157532267|FG001|Overall Study|Changed dose of concomitant drug|0|||
48917143|NCT00993265|157532266|FG000|Overall Study|Non-compliant with study medication|1|||
49120262|NCT04547140|158278901|FG001|Overall Study|Pregnancy|0|||
48710340|NCT01160822|156788852|FG002|Overall Study|Adverse Event|0|||
48710341|NCT01160822|156788853|FG003|Overall Study|Adverse Event|0|||
49120263|NCT04547140|158278900|FG000|Overall Study|Reason Not Specified|4|||
48917144|NCT00993265|157532267|FG001|Overall Study|Non-compliant with study medication|0|||
48917145|NCT00960843|157532268|FG000|Overall Study|Lost to Follow-up|2|||
48917146|NCT00960843|157532269|FG001|Overall Study|Lost to Follow-up|0|||
48917147|NCT00960843|157532268|FG000|Overall Study|Protocol Violation|0|||
48917148|NCT00960843|157532269|FG001|Overall Study|Protocol Violation|4|||
48917149|NCT00960843|157532268|FG000|Overall Study|Repeated needle dislodgment|0|||
48917150|NCT00960843|157532269|FG001|Overall Study|Repeated needle dislodgment|1|||
48710342|NCT01160822|156788854|FG004|Overall Study|Adverse Event|1|||
48710343|NCT01160822|156788855|FG005|Overall Study|Adverse Event|2|||
48710344|NCT01160822|156788856|FG006|Overall Study|Adverse Event|5|||
48710345|NCT01160822|156788850|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
48710346|NCT01160822|156788851|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
48710347|NCT01160822|156788852|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
48710348|NCT01160822|156788853|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
48710349|NCT01160822|156788854|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
48710350|NCT01160822|156788855|FG005|Overall Study|Unsatisfactory therapeutic effect|5|||
48710351|NCT01160822|156788856|FG006|Overall Study|Unsatisfactory therapeutic effect|3|||
48710352|NCT01160822|156788850|FG000|Overall Study|Withdrawal by Subject|0|||
48710353|NCT01160822|156788851|FG001|Overall Study|Withdrawal by Subject|0|||
48710354|NCT01160822|156788852|FG002|Overall Study|Withdrawal by Subject|0|||
48710355|NCT01160822|156788853|FG003|Overall Study|Withdrawal by Subject|0|||
48710356|NCT01160822|156788854|FG004|Overall Study|Withdrawal by Subject|0|||
48710357|NCT01160822|156788855|FG005|Overall Study|Withdrawal by Subject|0|||
48807516|NCT01674621|157136605|FG002|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
48807517|NCT01674621|157136606|FG003|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1|||
48807518|NCT01674621|157136607|FG004|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
48807519|NCT01674621|157136603|FG000|Overall Study|Withdrawal by Subject|2|||
48807520|NCT01674621|157136604|FG001|Overall Study|Withdrawal by Subject|5|||
48807521|NCT01674621|157136605|FG002|Overall Study|Withdrawal by Subject|2|||
48807522|NCT01674621|157136606|FG003|Overall Study|Withdrawal by Subject|0|||
48807523|NCT01674621|157136607|FG004|Overall Study|Withdrawal by Subject|1|||
48807524|NCT01674621|157136603|FG000|Overall Study|Other than specified|0|||
48807525|NCT01674621|157136604|FG001|Overall Study|Other than specified|1|||
48807526|NCT01674621|157136605|FG002|Overall Study|Other than specified|0|||
48807527|NCT01674621|157136606|FG003|Overall Study|Other than specified|0|||
48807528|NCT01674621|157136607|FG004|Overall Study|Other than specified|2|||
48807529|NCT04772053|157136620|FG000|Overall Study|Physician Decision|2|||
48807530|NCT04772053|157136620|FG000|Overall Study|Withdrawal by Subject|3|||
48807531|NCT04772053|157136620|FG000|Overall Study|Study Terminated by Sponsor|1|||
48807532|NCT04146896|157136621|FG000|Overall Study|Adverse Event|5|||
48807533|NCT04146896|157136622|FG001|Overall Study|Adverse Event|8|||
48807534|NCT04146896|157136621|FG000|Overall Study|Lack of Efficacy|3|||
48807535|NCT04146896|157136622|FG001|Overall Study|Lack of Efficacy|2|||
48807536|NCT04146896|157136621|FG000|Overall Study|Lost to Follow-up|0|||
48807537|NCT04146896|157136622|FG001|Overall Study|Lost to Follow-up|1|||
48807538|NCT04146896|157136621|FG000|Overall Study|Non-compliance|5|||
48807539|NCT04146896|157136622|FG001|Overall Study|Non-compliance|4|||
48807540|NCT04146896|157136621|FG000|Overall Study|Withdrawal by Subject|3|||
48807541|NCT04146896|157136622|FG001|Overall Study|Withdrawal by Subject|5|||
48807542|NCT04146896|157136621|FG000|Overall Study|Randomized in error|1|||
48807543|NCT04146896|157136622|FG001|Overall Study|Randomized in error|2|||
48807544|NCT02118337|157136623|FG000|Overall Study|Other|1|||
48807545|NCT02118337|157136624|FG001|Overall Study|Other|0|||
48807546|NCT02118337|157136625|FG002|Overall Study|Other|0|||
48807547|NCT02118337|157136626|FG003|Overall Study|Other|0|||
48807548|NCT02118337|157136627|FG004|Overall Study|Other|2|||
48807549|NCT02118337|157136628|FG005|Overall Study|Other|3|||
48807550|NCT02118337|157136629|FG006|Overall Study|Other|1|||
48710358|NCT01160822|156788856|FG006|Overall Study|Withdrawal by Subject|1|||
48710359|NCT01160822|156788850|FG000|Overall Study|Lost to Follow-up|0|||
48710360|NCT01160822|156788851|FG001|Overall Study|Lost to Follow-up|0|||
48710361|NCT01160822|156788852|FG002|Overall Study|Lost to Follow-up|0|||
48710362|NCT01160822|156788853|FG003|Overall Study|Lost to Follow-up|0|||
48917151|NCT01744665|157532270|FG000|Monitoring Phase|Adverse Event|4|||
48917152|NCT01744665|157532270|FG000|Monitoring Phase|Abnormal laboratory value(s)|1|||
48917153|NCT01744665|157532270|FG000|Monitoring Phase|Unsatisfactory therapeutic effect|7|||
48917154|NCT01744665|157532270|FG000|Monitoring Phase|Withdrawal by Subject|5|||
48710363|NCT01160822|156788854|FG004|Overall Study|Lost to Follow-up|1|||
48710364|NCT01160822|156788855|FG005|Overall Study|Lost to Follow-up|0|||
48710365|NCT01160822|156788856|FG006|Overall Study|Lost to Follow-up|0|||
48710366|NCT01160822|156788850|FG000|Overall Study|Administrative problems|0|||
48807551|NCT02118337|157136630|FG007|Overall Study|Other|28|||
48807552|NCT02118337|157136631|FG008|Overall Study|Other|15|||
48807553|NCT02118337|157136623|FG000|Overall Study|Lost to Follow-up|0|||
48807554|NCT02118337|157136624|FG001|Overall Study|Lost to Follow-up|0|||
48807555|NCT02118337|157136625|FG002|Overall Study|Lost to Follow-up|0|||
48807556|NCT02118337|157136626|FG003|Overall Study|Lost to Follow-up|0|||
48917155|NCT01744665|157532270|FG000|Monitoring Phase|Did not achieve MR4.5|1|||
48917156|NCT01744665|157532270|FG000|Consolidation Phase|Adverse Event|2|||
48917157|NCT01744665|157532270|FG000|Consolidation Phase|Unsatisfactory therapeutic effect|4|||
48917158|NCT01744665|157532270|FG000|Consolidation Phase|Withdrawal by Subject|4|||
48917159|NCT01744665|157532270|FG000|Consolidation Phase|Administrative problems|9|||
48710367|NCT01160822|156788851|FG001|Overall Study|Administrative problems|0|||
48710368|NCT01160822|156788852|FG002|Overall Study|Administrative problems|0|||
48710369|NCT01160822|156788853|FG003|Overall Study|Administrative problems|0|||
48710370|NCT01160822|156788854|FG004|Overall Study|Administrative problems|1|||
48710371|NCT01160822|156788855|FG005|Overall Study|Administrative problems|0|||
48710372|NCT01160822|156788856|FG006|Overall Study|Administrative problems|0|||
48710373|NCT01160822|156788850|FG000|Overall Study|Protocol deviation|0|||
48710374|NCT01160822|156788851|FG001|Overall Study|Protocol deviation|0|||
48710375|NCT01160822|156788852|FG002|Overall Study|Protocol deviation|0|||
48710376|NCT01160822|156788853|FG003|Overall Study|Protocol deviation|0|||
48710377|NCT01160822|156788854|FG004|Overall Study|Protocol deviation|2|||
48710378|NCT01160822|156788855|FG005|Overall Study|Protocol deviation|0|||
48710379|NCT01160822|156788856|FG006|Overall Study|Protocol deviation|0|||
48710380|NCT03037580|156788857|FG000|Overall Study|Withdrawal by Subject|3|||
48710381|NCT03037580|156788858|FG001|Overall Study|Withdrawal by Subject|0|||
48710382|NCT03037580|156788857|FG000|Overall Study|Adverse Event|1|||
48710383|NCT03037580|156788858|FG001|Overall Study|Adverse Event|0|||
48710384|NCT03037580|156788857|FG000|Overall Study|Study Terminated by Sponsor|12|||
48710385|NCT03037580|156788858|FG001|Overall Study|Study Terminated by Sponsor|15|||
48710386|NCT03037580|156788857|FG000|Overall Study|Death|0|||
48710387|NCT03037580|156788858|FG001|Overall Study|Death|1|||
48710388|NCT02442804|156788859|FG000|Overall Study|Withdrawal by Subject|0|||
48710389|NCT02442804|156788860|FG001|Overall Study|Withdrawal by Subject|1|||
48710390|NCT02442804|156788859|FG000|Overall Study|Adverse Event|1|||
48710391|NCT02442804|156788860|FG001|Overall Study|Adverse Event|0|||
48710392|NCT02036853|156788861|FG000|Overall Study|Adverse Event|0|||
48710393|NCT02036853|156788862|FG001|Overall Study|Adverse Event|2|||
48710394|NCT02036853|156788861|FG000|Overall Study|Lack of Efficacy|0|||
48710395|NCT02036853|156788862|FG001|Overall Study|Lack of Efficacy|2|||
48710396|NCT02036853|156788861|FG000|Overall Study|Physician Decision|0|||
48710397|NCT02036853|156788862|FG001|Overall Study|Physician Decision|1|||
48710398|NCT02036853|156788861|FG000|Overall Study|Withdrawal by Subject|0|||
48710399|NCT02036853|156788862|FG001|Overall Study|Withdrawal by Subject|1|||
48710400|NCT02039843|156788865|FG000|Randomization and Observation Period|Adverse Event|2|||
48710401|NCT02039843|156788866|FG001|Randomization and Observation Period|Adverse Event|0|||
48710402|NCT02039843|156788865|FG000|Randomization and Observation Period|Death|1|||
48710403|NCT02039843|156788866|FG001|Randomization and Observation Period|Death|0|||
48710404|NCT02039843|156788865|FG000|Randomization and Observation Period|Lost to Follow-up|2|||
48710405|NCT02039843|156788866|FG001|Randomization and Observation Period|Lost to Follow-up|3|||
48710406|NCT02039843|156788865|FG000|Randomization and Observation Period|Withdrawal by Subject|2|||
48710407|NCT02039843|156788866|FG001|Randomization and Observation Period|Withdrawal by Subject|3|||
48710408|NCT02039843|156788865|FG000|Randomization and Observation Period|Other reasons not paired with a study dog|22|||
48710409|NCT02039843|156788866|FG001|Randomization and Observation Period|Other reasons not paired with a study dog|11|||
48710410|NCT02039843|156788865|FG000|Pairing With a Study Dog|Death|1|||
48710411|NCT02039843|156788866|FG001|Pairing With a Study Dog|Death|0|||
48710412|NCT02039843|156788865|FG000|Pairing With a Study Dog|Lost to Follow-up|1|||
48710413|NCT02039843|156788866|FG001|Pairing With a Study Dog|Lost to Follow-up|4|||
48710414|NCT02039843|156788865|FG000|Pairing With a Study Dog|Withdrawal by Subject|4|||
48710415|NCT02039843|156788866|FG001|Pairing With a Study Dog|Withdrawal by Subject|1|||
48710416|NCT02039843|156788865|FG000|Pairing With a Study Dog|Other reasons for not completing study|13|||
48710417|NCT02039843|156788866|FG001|Pairing With a Study Dog|Other reasons for not completing study|4|||
48710418|NCT00884741|156788867|FG000|Step 1 Registration: Tissue Screening|Protocol Violation|157|||
48710419|NCT00884741|156788868|FG001|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
48710420|NCT00884741|156788869|FG002|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
48710421|NCT00884741|156788870|FG003|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
48807557|NCT02118337|157136627|FG004|Overall Study|Lost to Follow-up|0|||
48807558|NCT02118337|157136628|FG005|Overall Study|Lost to Follow-up|0|||
48807559|NCT02118337|157136629|FG006|Overall Study|Lost to Follow-up|0|||
48807560|NCT02118337|157136630|FG007|Overall Study|Lost to Follow-up|1|||
48807561|NCT02118337|157136631|FG008|Overall Study|Lost to Follow-up|0|||
48807562|NCT02118337|157136623|FG000|Overall Study|Withdrawal by Subject|1|||
48807563|NCT02118337|157136624|FG001|Overall Study|Withdrawal by Subject|3|||
48807564|NCT02118337|157136625|FG002|Overall Study|Withdrawal by Subject|2|||
48807565|NCT02118337|157136626|FG003|Overall Study|Withdrawal by Subject|1|||
49120264|NCT04547140|158278901|FG001|Overall Study|Reason Not Specified|1|||
48807566|NCT02118337|157136627|FG004|Overall Study|Withdrawal by Subject|2|||
48807567|NCT02118337|157136628|FG005|Overall Study|Withdrawal by Subject|2|||
48807568|NCT02118337|157136629|FG006|Overall Study|Withdrawal by Subject|1|||
48807569|NCT02118337|157136630|FG007|Overall Study|Withdrawal by Subject|4|||
48807570|NCT02118337|157136631|FG008|Overall Study|Withdrawal by Subject|2|||
48807571|NCT02118337|157136623|FG000|Overall Study|Death|2|||
48807572|NCT02118337|157136624|FG001|Overall Study|Death|2|||
48807573|NCT02118337|157136625|FG002|Overall Study|Death|1|||
48807574|NCT02118337|157136626|FG003|Overall Study|Death|2|||
48807575|NCT02118337|157136627|FG004|Overall Study|Death|5|||
48807576|NCT02118337|157136628|FG005|Overall Study|Death|1|||
48807577|NCT02118337|157136629|FG006|Overall Study|Death|2|||
48807578|NCT02118337|157136630|FG007|Overall Study|Death|9|||
48807579|NCT02118337|157136631|FG008|Overall Study|Death|4|||
48807580|NCT03107377|157136632|FG000|Overall Study|Adverse Event|3|||
48807581|NCT03107377|157136633|FG001|Overall Study|Adverse Event|3|||
48807582|NCT03107377|157136632|FG000|Overall Study|Protocol Violation|9|||
48807583|NCT03107377|157136633|FG001|Overall Study|Protocol Violation|12|||
48807584|NCT03107377|157136632|FG000|Overall Study|Physician Decision|3|||
48807585|NCT03107377|157136633|FG001|Overall Study|Physician Decision|6|||
48807586|NCT03107377|157136632|FG000|Overall Study|Pregnancy|7|||
48917160|NCT01744665|157532270|FG000|Re-initiation Phase|Administrative problems|10|||
48917161|NCT01744665|157532270|FG000|Re-initiation Phase|Adverse Event|1|||
48917162|NCT01744665|157532270|FG000|Re-initiation Phase|No longer required treatment|1|||
48917163|NCT01744665|157532270|FG000|Re-initiation Phase|Withdrawal by Subject|1|||
48917164|NCT00652366|157532271|FG000|Overall Study|Adverse Event|8|||
48917165|NCT00652366|157532272|FG001|Overall Study|Adverse Event|4|||
48917166|NCT00652366|157532273|FG002|Overall Study|Adverse Event|7|||
49120265|NCT01093586|158278902|FG000|Overall Study|Failed to engraft|3|||
49120266|NCT01711983|158278903|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|32|||
49120267|NCT01711983|158278903|FG000|6-Month Closure Evaluation|Technical Failure (No Test Device)|26|||
49120268|NCT01711983|158278903|FG000|36-Month Closure Evaluation|Test Device Removal|2|||
48807587|NCT03107377|157136633|FG001|Overall Study|Pregnancy|7|||
48807588|NCT03107377|157136632|FG000|Overall Study|Withdrawal by Subject|16|||
48807589|NCT03107377|157136633|FG001|Overall Study|Withdrawal by Subject|22|||
48917167|NCT00652366|157532274|FG003|Overall Study|Adverse Event|17|||
48917168|NCT00652366|157532275|FG004|Overall Study|Adverse Event|13|||
48917169|NCT00652366|157532271|FG000|Overall Study|Death|5|||
48917170|NCT00652366|157532272|FG001|Overall Study|Death|4|||
48917171|NCT00652366|157532273|FG002|Overall Study|Death|1|||
48917172|NCT00652366|157532274|FG003|Overall Study|Death|8|||
48917173|NCT00652366|157532275|FG004|Overall Study|Death|5|||
48917174|NCT00652366|157532271|FG000|Overall Study|Lack of Efficacy|84|||
48917175|NCT00652366|157532272|FG001|Overall Study|Lack of Efficacy|58|||
48917176|NCT00652366|157532273|FG002|Overall Study|Lack of Efficacy|53|||
48917177|NCT00652366|157532274|FG003|Overall Study|Lack of Efficacy|133|||
48917178|NCT00652366|157532275|FG004|Overall Study|Lack of Efficacy|13|||
48917179|NCT00652366|157532271|FG000|Overall Study|Violation of Selection Criteria|0|||
49120269|NCT01711983|158278903|FG000|36-Month Closure Evaluation|Missed Echocardiograph|62|||
49120270|NCT02438280|158278904|FG000|Overall Study|Physician Decision|1|||
48807590|NCT03107377|157136632|FG000|Overall Study|Lost to Follow-up|37|||
48807591|NCT03107377|157136633|FG001|Overall Study|Lost to Follow-up|34|||
48807592|NCT03107377|157136632|FG000|Overall Study|Other reason not specified|16|||
48807593|NCT03107377|157136633|FG001|Overall Study|Other reason not specified|15|||
48807594|NCT01515189|157136634|FG000|Induction|Disease Progression|109|||
48917180|NCT00652366|157532272|FG001|Overall Study|Violation of Selection Criteria|0|||
48917181|NCT00652366|157532273|FG002|Overall Study|Violation of Selection Criteria|1|||
48917182|NCT00652366|157532274|FG003|Overall Study|Violation of Selection Criteria|0|||
48917183|NCT00652366|157532275|FG004|Overall Study|Violation of Selection Criteria|0|||
48917184|NCT00652366|157532271|FG000|Overall Study|Protocol Violation|1|||
48917185|NCT00652366|157532272|FG001|Overall Study|Protocol Violation|0|||
48917186|NCT00652366|157532273|FG002|Overall Study|Protocol Violation|0|||
49120271|NCT02438280|158278905|FG001|Overall Study|Physician Decision|0|||
49120272|NCT02620787|158278906|FG000|Overall Study|Adverse Event|1|||
48807595|NCT01515189|157136635|FG001|Induction|Disease Progression|155|||
48807596|NCT01515189|157136634|FG000|Induction|Study drug toxicity|86|||
48917187|NCT00652366|157532274|FG003|Overall Study|Protocol Violation|0|||
48917188|NCT00652366|157532275|FG004|Overall Study|Protocol Violation|0|||
48917189|NCT00652366|157532271|FG000|Overall Study|Refused treatment|3|||
48917190|NCT00652366|157532272|FG001|Overall Study|Refused treatment|7|||
48917191|NCT00652366|157532273|FG002|Overall Study|Refused treatment|6|||
48917192|NCT00652366|157532274|FG003|Overall Study|Refused treatment|17|||
48917193|NCT00652366|157532275|FG004|Overall Study|Refused treatment|5|||
48917194|NCT00652366|157532271|FG000|Overall Study|Other|5|||
48917195|NCT00652366|157532272|FG001|Overall Study|Other|2|||
48917196|NCT00652366|157532273|FG002|Overall Study|Other|3|||
48917197|NCT00652366|157532274|FG003|Overall Study|Other|4|||
48917198|NCT00652366|157532275|FG004|Overall Study|Other|0|||
48917199|NCT02577146|157532279|FG000|Overall Study|Lost to Follow-up|8|||
48917200|NCT02577146|157532279|FG000|Overall Study|Physician Decision|3|||
48917201|NCT02577146|157532279|FG000|Overall Study|Screen Failure|17|||
48917202|NCT01970501|157532280|FG000|Overall Study|Discontinuation of study by sponsor|16|||
48917203|NCT01970501|157532281|FG001|Overall Study|Discontinuation of study by sponsor|14|||
48917204|NCT01970501|157532280|FG000|Overall Study|Withdrawal by Subject|6|||
48917205|NCT01970501|157532281|FG001|Overall Study|Withdrawal by Subject|7|||
48917206|NCT01970501|157532280|FG000|Overall Study|Adverse Event|2|||
48917207|NCT01970501|157532281|FG001|Overall Study|Adverse Event|4|||
48917208|NCT01970501|157532280|FG000|Overall Study|Death|1|||
48917209|NCT01970501|157532281|FG001|Overall Study|Death|3|||
48917210|NCT01970501|157532280|FG000|Overall Study|Physician Decision|2|||
48917211|NCT01970501|157532281|FG001|Overall Study|Physician Decision|0|||
48917212|NCT00794157|157532282|FG000|Overall Study|Adverse Event|4|||
48917213|NCT00794157|157532283|FG001|Overall Study|Adverse Event|1|||
48917214|NCT00794157|157532284|FG002|Overall Study|Adverse Event|8|||
48917215|NCT00794157|157532282|FG000|Overall Study|Subject withdrew consent|2|||
48917216|NCT00794157|157532283|FG001|Overall Study|Subject withdrew consent|0|||
48917217|NCT00794157|157532284|FG002|Overall Study|Subject withdrew consent|3|||
48917218|NCT00794157|157532282|FG000|Overall Study|Lost to Follow-up|2|||
48917219|NCT00794157|157532283|FG001|Overall Study|Lost to Follow-up|0|||
48917220|NCT00794157|157532284|FG002|Overall Study|Lost to Follow-up|1|||
48917221|NCT00794157|157532282|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
48917222|NCT00794157|157532283|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
48917223|NCT00794157|157532284|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
48917224|NCT00794157|157532282|FG000|Overall Study|Administrative problems|1|||
48917225|NCT00794157|157532283|FG001|Overall Study|Administrative problems|7|||
48917226|NCT00794157|157532284|FG002|Overall Study|Administrative problems|4|||
48917227|NCT00794157|157532282|FG000|Overall Study|Abnormal test procedure result(s)|0|||
48917228|NCT00794157|157532283|FG001|Overall Study|Abnormal test procedure result(s)|1|||
48917229|NCT00794157|157532284|FG002|Overall Study|Abnormal test procedure result(s)|0|||
48917230|NCT00794157|157532282|FG000|Overall Study|Protocol deviation|0|||
48917231|NCT00794157|157532283|FG001|Overall Study|Protocol deviation|1|||
48917232|NCT00794157|157532284|FG002|Overall Study|Protocol deviation|1|||
48917233|NCT00814892|157532285|FG000|Overall Study|Disease Progression|1|||
48917234|NCT00814892|157532285|FG000|Overall Study|Study Termination|1|||
48917235|NCT00550680|157532290|FG000|Overall Study|Administrative Reasons|1|||
48917236|NCT00550680|157532290|FG000|Overall Study|Adverse Event|5|||
48917237|NCT00550680|157532290|FG000|Overall Study|Death|3|||
48917238|NCT00550680|157532290|FG000|Overall Study|Early Improvement|1|||
48917239|NCT00550680|157532290|FG000|Overall Study|Lost to Follow-up|3|||
48917240|NCT00550680|157532290|FG000|Overall Study|Lack of Efficacy|1|||
48917241|NCT00550680|157532290|FG000|Overall Study|Other|10|||
48917242|NCT00550680|157532290|FG000|Overall Study|Protocol Violation|7|||
48917243|NCT00550680|157532290|FG000|Overall Study|Refused Treatment|19|||
48917244|NCT00550680|157532290|FG000|Overall Study|Screen Failure|6|||
48917245|NCT02258451|157532291|FG000|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|90|||
48917246|NCT02258451|157532292|FG001|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|101|||
48917247|NCT02258451|157532291|FG000|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
48917248|NCT02258451|157532292|FG001|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
48917249|NCT02258451|157532291|FG000|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|8|||
48917250|NCT02258451|157532292|FG001|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|1|||
48917251|NCT02258451|157532291|FG000|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|8|||
48917252|NCT02258451|157532292|FG001|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|6|||
48917253|NCT02258451|157532291|FG000|Overall Study|Discontinuation all treatment due to death|4|||
48917254|NCT02258451|157532292|FG001|Overall Study|Discontinuation all treatment due to death|3|||
48917255|NCT02258451|157532291|FG000|Overall Study|Discontinuation all treatment due to withdrawal by participant|21|||
48917256|NCT02258451|157532292|FG001|Overall Study|Discontinuation all treatment due to withdrawal by participant|13|||
48917257|NCT02258451|157532291|FG000|Overall Study|Discontinuation all treatment due to end point reached|1|||
48917258|NCT02258451|157532292|FG001|Overall Study|Discontinuation all treatment due to end point reached|1|||
48917259|NCT02258451|157532291|FG000|Overall Study|Discontinuation all treatment due to physician decision|0|||
48917260|NCT02258451|157532292|FG001|Overall Study|Discontinuation all treatment due to physician decision|2|||
48917261|NCT02258451|157532291|FG000|Overall Study|Discontinuation all treatment due to study terminated by sponsor|0|||
48917262|NCT02258451|157532292|FG001|Overall Study|Discontinuation all treatment due to study terminated by sponsor|3|||
48710422|NCT00884741|156788867|FG000|Step 1 Registration: Tissue Screening|Death|3|||
48710423|NCT00884741|156788868|FG001|Step 1 Registration: Tissue Screening|Death|0|||
48710424|NCT00884741|156788869|FG002|Step 1 Registration: Tissue Screening|Death|0|||
48710425|NCT00884741|156788870|FG003|Step 1 Registration: Tissue Screening|Death|0|||
48710426|NCT00884741|156788867|FG000|Step 1 Registration: Tissue Screening|Physician Decision|3|||
48710427|NCT00884741|156788868|FG001|Step 1 Registration: Tissue Screening|Physician Decision|0|||
48710428|NCT00884741|156788869|FG002|Step 1 Registration: Tissue Screening|Physician Decision|0|||
48710429|NCT00884741|156788870|FG003|Step 1 Registration: Tissue Screening|Physician Decision|0|||
48807597|NCT01515189|157136635|FG001|Induction|Study drug toxicity|36|||
48917263|NCT02258451|157532291|FG000|Overall Study|Other reason|1|||
48917264|NCT02258451|157532292|FG001|Overall Study|Other reason|1|||
48917265|NCT02258451|157532291|FG000|Overall Study|Never treated|2|||
48917266|NCT02258451|157532292|FG001|Overall Study|Never treated|3|||
48917267|NCT01449461|157532293|FG000|Overall Study|Adverse Event|0|||
48917268|NCT01449461|157532294|FG001|Overall Study|Adverse Event|3|||
48917269|NCT01449461|157532295|FG002|Overall Study|Adverse Event|2|||
49120273|NCT02620787|158278907|FG001|Overall Study|Adverse Event|0|||
49120274|NCT02620787|158278906|FG000|Overall Study|Eligibility Criteria Not Met|1|||
48710430|NCT00884741|156788867|FG000|Step 1 Registration: Tissue Screening|Insufficient tissue|105|||
48710431|NCT00884741|156788868|FG001|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
48807598|NCT01515189|157136634|FG000|Induction|Death|24|||
48807599|NCT01515189|157136635|FG001|Induction|Death|17|||
48807600|NCT01515189|157136634|FG000|Induction|Adverse Event|14|||
48807601|NCT01515189|157136635|FG001|Induction|Adverse Event|9|||
49120275|NCT02620787|158278907|FG001|Overall Study|Eligibility Criteria Not Met|0|||
49120276|NCT02864407|158278913|FG000|Overall Study|Protocol Violation|3|||
49120277|NCT02864407|158278913|FG000|Overall Study|Lost to Follow-up|115|||
49120278|NCT02864407|158278913|FG000|Overall Study|Not treated with Vahelva® Respimat®|1|||
49120279|NCT02864407|158278913|FG000|Overall Study|Were administered Vahelva® Respimat® prior to the consent date|3|||
49120280|NCT02864407|158278913|FG000|Overall Study|Consent prior to the contract date|1|||
49120281|NCT03283930|158278914|FG000|Overall Study|Scheduling conflict|8|||
49120282|NCT03283930|158278915|FG001|Overall Study|Scheduling conflict|10|||
49120283|NCT03283930|158278914|FG000|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
49120284|NCT03283930|158278915|FG001|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
49120285|NCT03283930|158278914|FG000|Overall Study|Technical software issue|2|||
49120286|NCT03283930|158278915|FG001|Overall Study|Technical software issue|2|||
49120287|NCT02824627|158278916|FG000|Overall Study|Adverse Event|1|||
49120288|NCT02824627|158278917|FG001|Overall Study|Adverse Event|2|||
49120289|NCT02824627|158278916|FG000|Overall Study|Lost to Follow-up|2|||
48807602|NCT01515189|157136634|FG000|Induction|Withdrawal by Subject|3|||
49120290|NCT02824627|158278917|FG001|Overall Study|Lost to Follow-up|1|||
49120291|NCT05502302|158278918|FG000|Overall Study|Lost to Follow-up|6|||
49120292|NCT05502302|158278918|FG000|Overall Study|Death|2|||
49120293|NCT02710084|158278919|FG000|First Phase - 12 Weeks|Withdrawal by Subject|3|||
49120294|NCT02710084|158278920|FG001|First Phase - 12 Weeks|Withdrawal by Subject|1|||
49120295|NCT03839394|158278921|FG000|Overall Study|Lost to Follow-up|6|||
49120296|NCT03839394|158278922|FG001|Overall Study|Lost to Follow-up|8|||
49120297|NCT03839394|158278921|FG000|Overall Study|Withdrawal by Subject|0|||
49120298|NCT03839394|158278922|FG001|Overall Study|Withdrawal by Subject|2|||
48710432|NCT00884741|156788869|FG002|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
48710433|NCT00884741|156788870|FG003|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
48710434|NCT00884741|156788867|FG000|Step 1 Registration: Tissue Screening|Disease progression|12|||
48710435|NCT00884741|156788868|FG001|Step 1 Registration: Tissue Screening|Disease progression|0|||
48807603|NCT01515189|157136635|FG001|Induction|Withdrawal by Subject|9|||
48807604|NCT01515189|157136634|FG000|Induction|No longer meets study criteria|0|||
48807605|NCT01515189|157136635|FG001|Induction|No longer meets study criteria|2|||
48807606|NCT01515189|157136634|FG000|Induction|Lost to Follow-up|1|||
48807607|NCT01515189|157136635|FG001|Induction|Lost to Follow-up|0|||
48807608|NCT01515189|157136634|FG000|Induction|Other|0|||
48807609|NCT01515189|157136635|FG001|Induction|Other|4|||
48807610|NCT01515189|157136634|FG000|First Re-Induction Phase|Disease progression|6|||
48807611|NCT01515189|157136635|FG001|First Re-Induction Phase|Disease progression|14|||
48807612|NCT01515189|157136634|FG000|First Re-Induction Phase|Study drug toxicity|5|||
48807613|NCT01515189|157136635|FG001|First Re-Induction Phase|Study drug toxicity|0|||
48807614|NCT01515189|157136634|FG000|First Re-Induction Phase|Withdrawal by Subject|1|||
48807615|NCT01515189|157136635|FG001|First Re-Induction Phase|Withdrawal by Subject|1|||
48807616|NCT01515189|157136634|FG000|First Re-Induction Phase|No longer meets study criteria|1|||
49120299|NCT00101868|158278923|FG000|Overall Study|Death|10|||
49120300|NCT00101868|158278924|FG001|Overall Study|Death|10|||
49120301|NCT00101868|158278923|FG000|Overall Study|Withdrawal by Subject|8|||
49120302|NCT00101868|158278924|FG001|Overall Study|Withdrawal by Subject|9|||
49120303|NCT00101868|158278923|FG000|Overall Study|Protocol Violation|3|||
48807617|NCT01515189|157136635|FG001|First Re-Induction Phase|No longer meets study criteria|0|||
48807618|NCT01515189|157136634|FG000|First Re-Induction Phase|Other|1|||
48807619|NCT01515189|157136635|FG001|First Re-Induction Phase|Other|0|||
48807620|NCT04064164|157136636|FG000|Overall Study|Withdrawal by Subject|8|||
48807621|NCT04064164|157136637|FG001|Overall Study|Withdrawal by Subject|8|||
48807622|NCT06190691|157136638|FG000|Overall Study|Adverse Event|2|||
48807623|NCT06190691|157136639|FG001|Overall Study|Adverse Event|0|||
48807624|NCT06190691|157136640|FG002|Overall Study|Adverse Event|0|||
48807625|NCT06190691|157136641|FG003|Overall Study|Adverse Event|0|||
48807626|NCT01320943|157136642|FG000|Overall Study|Lost to Follow-up|1|||
48807627|NCT01320943|157136643|FG001|Overall Study|Lost to Follow-up|0|||
48807628|NCT01320943|157136642|FG000|Overall Study|Physician Decision|0|||
48807629|NCT01320943|157136643|FG001|Overall Study|Physician Decision|1|||
48807630|NCT01320943|157136642|FG000|Overall Study|Randomized but not Treated|0|||
48807631|NCT01320943|157136643|FG001|Overall Study|Randomized but not Treated|1|||
48807632|NCT04000594|157136644|FG000|Overall Study|Withdrawal by Subject|1|||
48807633|NCT04000594|157136645|FG001|Overall Study|Withdrawal by Subject|0|||
48807634|NCT04000594|157136646|FG002|Overall Study|Withdrawal by Subject|0|||
48807635|NCT01407354|157136650|FG000|First Intervention|Withdrawal by Subject|0|||
48807636|NCT01407354|157136651|FG001|First Intervention|Withdrawal by Subject|2|||
48807637|NCT01407354|157136650|FG000|First Intervention|Adverse Event|1|||
48807638|NCT01407354|157136651|FG001|First Intervention|Adverse Event|0|||
48807639|NCT01407354|157136650|FG000|First Intervention|Physician Decision|1|||
48807640|NCT01407354|157136651|FG001|First Intervention|Physician Decision|0|||
48807641|NCT02204579|157136652|FG000|Overall Study|Screen failures|2|||
48807642|NCT04615182|157136655|FG000|Overall Study|Re-transplanted|2|||
48807643|NCT04615182|157136655|FG000|Overall Study|Protocol Violation|6|||
48807644|NCT04615182|157136655|FG000|Overall Study|Death|6|||
48807645|NCT04615182|157136655|FG000|Overall Study|Death and protocol violation|1|||
48807646|NCT01370005|157136656|FG000|Overall Study|Not treated|1|||
48807647|NCT01370005|157136657|FG001|Overall Study|Not treated|0|||
48807648|NCT01370005|157136658|FG002|Overall Study|Not treated|0|||
48807649|NCT01370005|157136656|FG000|Overall Study|Adverse Event|5|||
48807650|NCT01370005|157136657|FG001|Overall Study|Adverse Event|5|||
48917270|NCT01449461|157532296|FG003|Overall Study|Adverse Event|3|||
48917271|NCT01449461|157532297|FG004|Overall Study|Adverse Event|4|||
48917272|NCT01449461|157532298|FG005|Overall Study|Adverse Event|4|||
48917273|NCT01449461|157532293|FG000|Overall Study|Death|0|||
48917274|NCT01449461|157532294|FG001|Overall Study|Death|2|||
48917275|NCT01449461|157532295|FG002|Overall Study|Death|0|||
48917276|NCT01449461|157532296|FG003|Overall Study|Death|0|||
48917277|NCT01449461|157532297|FG004|Overall Study|Death|7|||
48917278|NCT01449461|157532298|FG005|Overall Study|Death|1|||
48917279|NCT01449461|157532293|FG000|Overall Study|Physician Decision|0|||
48917280|NCT01449461|157532294|FG001|Overall Study|Physician Decision|1|||
48917281|NCT01449461|157532295|FG002|Overall Study|Physician Decision|0|||
48917282|NCT01449461|157532296|FG003|Overall Study|Physician Decision|4|||
48917283|NCT01449461|157532297|FG004|Overall Study|Physician Decision|1|||
48917284|NCT01449461|157532298|FG005|Overall Study|Physician Decision|0|||
48917285|NCT01449461|157532293|FG000|Overall Study|Documented Progressive Disease|4|||
48917286|NCT01449461|157532294|FG001|Overall Study|Documented Progressive Disease|7|||
48917287|NCT01449461|157532295|FG002|Overall Study|Documented Progressive Disease|14|||
48807651|NCT01370005|157136658|FG002|Overall Study|Adverse Event|6|||
48807652|NCT01370005|157136656|FG000|Overall Study|Lack of Efficacy|1|||
48807653|NCT01370005|157136657|FG001|Overall Study|Lack of Efficacy|0|||
48917288|NCT01449461|157532296|FG003|Overall Study|Documented Progressive Disease|15|||
48917289|NCT01449461|157532297|FG004|Overall Study|Documented Progressive Disease|24|||
48917290|NCT01449461|157532298|FG005|Overall Study|Documented Progressive Disease|5|||
48917291|NCT01449461|157532293|FG000|Overall Study|Clinical Progressive Disease|2|||
48917292|NCT01449461|157532294|FG001|Overall Study|Clinical Progressive Disease|2|||
48917293|NCT01449461|157532295|FG002|Overall Study|Clinical Progressive Disease|0|||
48917294|NCT01449461|157532296|FG003|Overall Study|Clinical Progressive Disease|3|||
48807654|NCT01370005|157136658|FG002|Overall Study|Lack of Efficacy|0|||
48807655|NCT01370005|157136656|FG000|Overall Study|Non compliant with protocol|0|||
48917295|NCT01449461|157532297|FG004|Overall Study|Clinical Progressive Disease|4|||
48917296|NCT01449461|157532298|FG005|Overall Study|Clinical Progressive Disease|2|||
48917297|NCT01449461|157532293|FG000|Overall Study|Protocol Violation|0|||
48807656|NCT01370005|157136657|FG001|Overall Study|Non compliant with protocol|1|||
48807657|NCT01370005|157136658|FG002|Overall Study|Non compliant with protocol|2|||
48917298|NCT01449461|157532294|FG001|Overall Study|Protocol Violation|0|||
48917299|NCT01449461|157532295|FG002|Overall Study|Protocol Violation|0|||
48917300|NCT01449461|157532296|FG003|Overall Study|Protocol Violation|1|||
48917301|NCT01449461|157532297|FG004|Overall Study|Protocol Violation|0|||
48917302|NCT01449461|157532298|FG005|Overall Study|Protocol Violation|0|||
48917303|NCT01449461|157532293|FG000|Overall Study|Site Terminated by Sponsor|0|||
48917304|NCT01449461|157532294|FG001|Overall Study|Site Terminated by Sponsor|1|||
48917305|NCT01449461|157532295|FG002|Overall Study|Site Terminated by Sponsor|2|||
48917306|NCT01449461|157532296|FG003|Overall Study|Site Terminated by Sponsor|3|||
48917307|NCT01449461|157532297|FG004|Overall Study|Site Terminated by Sponsor|4|||
48917308|NCT01449461|157532298|FG005|Overall Study|Site Terminated by Sponsor|1|||
48917309|NCT01449461|157532293|FG000|Overall Study|Withdrawal by Subject|0|||
48710436|NCT00884741|156788869|FG002|Step 1 Registration: Tissue Screening|Disease progression|0|||
48710437|NCT00884741|156788870|FG003|Step 1 Registration: Tissue Screening|Disease progression|0|||
48917310|NCT01449461|157532294|FG001|Overall Study|Withdrawal by Subject|1|||
48917311|NCT01449461|157532295|FG002|Overall Study|Withdrawal by Subject|0|||
48917312|NCT01449461|157532296|FG003|Overall Study|Withdrawal by Subject|0|||
48917313|NCT01449461|157532297|FG004|Overall Study|Withdrawal by Subject|2|||
48917314|NCT01449461|157532298|FG005|Overall Study|Withdrawal by Subject|1|||
48917315|NCT01449461|157532293|FG000|Overall Study|Reason not Specified|0|||
48917316|NCT01449461|157532294|FG001|Overall Study|Reason not Specified|1|||
48917317|NCT01449461|157532295|FG002|Overall Study|Reason not Specified|0|||
48917318|NCT01449461|157532296|FG003|Overall Study|Reason not Specified|3|||
48917319|NCT01449461|157532297|FG004|Overall Study|Reason not Specified|2|||
48917320|NCT01449461|157532298|FG005|Overall Study|Reason not Specified|1|||
48917321|NCT04518462|157532301|FG000|Overall Study|Withdrawal by Subject|0|||
48917322|NCT04518462|157532302|FG001|Overall Study|Withdrawal by Subject|0|||
48917323|NCT04518462|157532303|FG002|Overall Study|Withdrawal by Subject|1|||
48917324|NCT04518462|157532301|FG000|Overall Study|Physician Decision|1|||
48917325|NCT04518462|157532302|FG001|Overall Study|Physician Decision|1|||
48917326|NCT04518462|157532303|FG002|Overall Study|Physician Decision|0|||
48917327|NCT01392677|157532306|FG000|Overall Study|Adverse Event|3|||
48917328|NCT01392677|157532307|FG001|Overall Study|Adverse Event|1|||
48917329|NCT01392677|157532306|FG000|Overall Study|Withdrawal by Subject|0|||
48917330|NCT01392677|157532307|FG001|Overall Study|Withdrawal by Subject|2|||
48917331|NCT01392677|157532306|FG000|Overall Study|Incorrect enrollment|2|||
48917332|NCT01392677|157532307|FG001|Overall Study|Incorrect enrollment|3|||
48917333|NCT01392677|157532306|FG000|Overall Study|Other reason|3|||
48917334|NCT01392677|157532307|FG001|Overall Study|Other reason|2|||
48917335|NCT01430455|157532308|FG000|Overall Study|Withdrawal by Subject|1|||
48917336|NCT01430455|157532308|FG000|Overall Study|Switched to follow-up phase|1|||
48917337|NCT03921424|157532313|FG000|Overall Study|Lost to Follow-up|0|||
48917338|NCT03921424|157532314|FG001|Overall Study|Lost to Follow-up|1|||
48917339|NCT03921424|157532313|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
48917340|NCT03921424|157532314|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
48917341|NCT02581202|157532320|FG000|Overall Study|Lack of Efficacy|2|||
48917342|NCT02581202|157532320|FG000|Overall Study|Withdrawal by Subject|4|||
48917343|NCT02581202|157532320|FG000|Overall Study|Lost to Follow-up|5|||
48917344|NCT02581202|157532320|FG000|Overall Study|Pregnancy|3|||
48917345|NCT04050982|157532321|FG000|Overall Study|Did not meet eligibility criteria|0|||
48917346|NCT04050982|157532322|FG001|Overall Study|Did not meet eligibility criteria|1|||
48917347|NCT04050982|157532323|FG002|Overall Study|Did not meet eligibility criteria|0|||
48917348|NCT04050982|157532321|FG000|Overall Study|Withdrawal by Subject|1|||
48917349|NCT04050982|157532322|FG001|Overall Study|Withdrawal by Subject|0|||
48917350|NCT04050982|157532323|FG002|Overall Study|Withdrawal by Subject|0|||
48917351|NCT04050982|157532321|FG000|Overall Study|Unable to enroll on platform|1|||
49120304|NCT00101868|158278924|FG001|Overall Study|Protocol Violation|0|||
48710438|NCT00884741|156788867|FG000|Step 1 Registration: Tissue Screening|Patient refusal|32|||
48710439|NCT00884741|156788868|FG001|Step 1 Registration: Tissue Screening|Patient refusal|0|||
48710440|NCT00884741|156788869|FG002|Step 1 Registration: Tissue Screening|Patient refusal|0|||
48710441|NCT00884741|156788870|FG003|Step 1 Registration: Tissue Screening|Patient refusal|0|||
48710442|NCT00884741|156788867|FG000|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
48710443|NCT00884741|156788868|FG001|Step 2 Registration: Tissue Analysis|Protocol Violation|15|||
48710444|NCT00884741|156788869|FG002|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
48710445|NCT00884741|156788870|FG003|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
48710446|NCT00884741|156788867|FG000|Step 2 Registration: Tissue Analysis|Death|0|||
48917352|NCT04050982|157532322|FG001|Overall Study|Unable to enroll on platform|0|||
49120305|NCT00101868|158278923|FG000|Overall Study|Lost to Follow-up|8|||
48710447|NCT00884741|156788868|FG001|Step 2 Registration: Tissue Analysis|Death|1|||
48710448|NCT00884741|156788869|FG002|Step 2 Registration: Tissue Analysis|Death|0|||
48917353|NCT04050982|157532323|FG002|Overall Study|Unable to enroll on platform|0|||
48917354|NCT01246583|157532324|FG000|Overall Study|Lost to Follow-up|0|||
48917355|NCT01246583|157532325|FG001|Overall Study|Lost to Follow-up|0|||
49120306|NCT00101868|158278924|FG001|Overall Study|Lost to Follow-up|13|||
49120307|NCT01619878|158278925|FG000|6 Week Follow-up Phase|Adverse Event|1|||
48917356|NCT01246583|157532326|FG002|Overall Study|Lost to Follow-up|0|||
48917357|NCT01246583|157532327|FG003|Overall Study|Lost to Follow-up|1|||
48917358|NCT01246583|157532324|FG000|Overall Study|Protocol Violation|0|||
48917359|NCT01246583|157532325|FG001|Overall Study|Protocol Violation|0|||
48917360|NCT01246583|157532326|FG002|Overall Study|Protocol Violation|1|||
48917361|NCT01246583|157532327|FG003|Overall Study|Protocol Violation|0|||
48917362|NCT01246583|157532324|FG000|Overall Study|Withdrawal by Subject|1|||
48917363|NCT01246583|157532325|FG001|Overall Study|Withdrawal by Subject|0|||
48917364|NCT01246583|157532326|FG002|Overall Study|Withdrawal by Subject|0|||
48917365|NCT01246583|157532327|FG003|Overall Study|Withdrawal by Subject|0|||
48917366|NCT00075400|157533997|FG000|Overall Study|Ineligible: wrong primary|1|||
48917367|NCT00075400|157533997|FG000|Overall Study|Never treated|2|||
48917368|NCT00346073|157533998|FG000|Overall Study|Serious Adverse Event|2|||
48917369|NCT00346073|157533999|FG001|Overall Study|Serious Adverse Event|0|||
48917370|NCT00346073|157533998|FG000|Overall Study|Lost to Follow-up|39|||
48917371|NCT00346073|157533999|FG001|Overall Study|Lost to Follow-up|24|||
48917372|NCT04342871|157534000|FG000|Overall Study|Death|4|||
48917373|NCT04342871|157534000|FG000|Overall Study|Clinical deterioration/illness progression|2|||
48710449|NCT00884741|156788870|FG003|Step 2 Registration: Tissue Analysis|Death|0|||
48917374|NCT04342871|157534000|FG000|Overall Study|Did not complete baseline assessments|5|||
49120308|NCT01619878|158278925|FG000|Follow-up at 12 Months of Age|Lost to Follow-up|1|||
49120309|NCT01619878|158278925|FG000|Follow-up at 12 Months of Age|Death|2|||
48710450|NCT00884741|156788867|FG000|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
48710451|NCT00884741|156788868|FG001|Step 2 Registration: Tissue Analysis|Adverse Event|2|||
48710452|NCT00884741|156788869|FG002|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
48710453|NCT00884741|156788870|FG003|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
48710454|NCT00884741|156788867|FG000|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
48710455|NCT00884741|156788868|FG001|Step 2 Registration: Tissue Analysis|Patient refusal|7|||
48710456|NCT00884741|156788869|FG002|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
48710457|NCT00884741|156788870|FG003|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
48710458|NCT00884741|156788867|FG000|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
48917375|NCT04342871|157534000|FG000|Overall Study|Lost to Follow-up|13|||
49120310|NCT02106351|158278926|FG000|Treatment Cycle 1|Adverse Event|2|||
49120311|NCT02106351|158278927|FG001|Treatment Cycle 1|Adverse Event|0|||
49120312|NCT02106351|158278928|FG002|Treatment Cycle 1|Adverse Event|0|||
49120313|NCT02106351|158278926|FG000|Treatment Cycle 1|Consent withdrawn|1|||
49120314|NCT02106351|158278927|FG001|Treatment Cycle 1|Consent withdrawn|0|||
49120315|NCT02106351|158278928|FG002|Treatment Cycle 1|Consent withdrawn|2|||
49120316|NCT02106351|158278926|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
49120317|NCT02106351|158278927|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
49120318|NCT02106351|158278928|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
49120319|NCT02106351|158278926|FG000|Treatment Cycle 1|Other|0|||
49120320|NCT02106351|158278927|FG001|Treatment Cycle 1|Other|3|||
49120321|NCT02106351|158278928|FG002|Treatment Cycle 1|Other|1|||
49120322|NCT02106351|158278926|FG000|Treatment Cycle 1|Randomised but not treated|1|||
49120323|NCT02106351|158278927|FG001|Treatment Cycle 1|Randomised but not treated|0|||
49120324|NCT02106351|158278928|FG002|Treatment Cycle 1|Randomised but not treated|1|||
49120325|NCT02106351|158278926|FG000|Treatment Cycle 2|Adverse Event|0|||
49120326|NCT02106351|158278927|FG001|Treatment Cycle 2|Adverse Event|2|||
49120327|NCT02106351|158278928|FG002|Treatment Cycle 2|Adverse Event|0|||
49120328|NCT02106351|158278926|FG000|Treatment Cycle 2|Consent withdrawn|0|||
49120329|NCT02106351|158278927|FG001|Treatment Cycle 2|Consent withdrawn|1|||
49120330|NCT02106351|158278928|FG002|Treatment Cycle 2|Consent withdrawn|1|||
49120331|NCT02106351|158278926|FG000|Treatment Cycle 2|Other|0|||
49120332|NCT02106351|158278927|FG001|Treatment Cycle 2|Other|2|||
49120333|NCT02106351|158278928|FG002|Treatment Cycle 2|Other|2|||
49120334|NCT02106351|158278926|FG000|Treatment Cycle 3|Adverse Event|0|||
49120335|NCT02106351|158278927|FG001|Treatment Cycle 3|Adverse Event|1|||
49120336|NCT02106351|158278928|FG002|Treatment Cycle 3|Adverse Event|0|||
49120337|NCT02106351|158278926|FG000|Treatment Cycle 3|Consent withdrawn|0|||
49120338|NCT02106351|158278927|FG001|Treatment Cycle 3|Consent withdrawn|0|||
49120339|NCT02106351|158278928|FG002|Treatment Cycle 3|Consent withdrawn|2|||
49120340|NCT02106351|158278926|FG000|Treatment Cycle 3|Lost to Follow-up|0|||
49120341|NCT02106351|158278927|FG001|Treatment Cycle 3|Lost to Follow-up|1|||
49120342|NCT02106351|158278928|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
49120343|NCT02106351|158278926|FG000|Treatment Cycle 3|Other|0|||
49120344|NCT02106351|158278927|FG001|Treatment Cycle 3|Other|2|||
49120345|NCT02106351|158278928|FG002|Treatment Cycle 3|Other|3|||
49120346|NCT02106351|158278926|FG000|Treatment Cycle 4|Consent withdrawn|0|||
48917376|NCT01199042|157534002|FG000|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2|||
48917377|NCT01199042|157534002|FG000|At Home (3 Months)|Lost to Follow-up|1|||
48917378|NCT01230307|157534013|FG000|Overall Study|LVAD Placement|0|||
49120347|NCT02106351|158278927|FG001|Treatment Cycle 4|Consent withdrawn|0|||
49120348|NCT02106351|158278928|FG002|Treatment Cycle 4|Consent withdrawn|2|||
49120349|NCT02106351|158278926|FG000|Treatment Cycle 4|Other|0|||
49120350|NCT02106351|158278927|FG001|Treatment Cycle 4|Other|1|||
48710459|NCT00884741|156788868|FG001|Step 2 Registration: Tissue Analysis|Disease Progression|4|||
48710460|NCT00884741|156788869|FG002|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
48710461|NCT00884741|156788870|FG003|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
48710462|NCT00884741|156788867|FG000|Randomization|Protocol Violation|0|||
48710463|NCT00884741|156788868|FG001|Randomization|Protocol Violation|0|||
48710464|NCT00884741|156788869|FG002|Randomization|Protocol Violation|8|||
48710465|NCT00884741|156788870|FG003|Randomization|Protocol Violation|8|||
48710466|NCT00530816|156788872|FG000|Overall Study|Progressive Disease|16|||
48710467|NCT00530816|156788873|FG001|Overall Study|Progressive Disease|24|||
48710468|NCT00530816|156788874|FG002|Overall Study|Progressive Disease|24|||
48710469|NCT00530816|156788872|FG000|Overall Study|Adverse Event|6|||
48710470|NCT00530816|156788873|FG001|Overall Study|Adverse Event|13|||
48710471|NCT00530816|156788874|FG002|Overall Study|Adverse Event|7|||
48710472|NCT00530816|156788872|FG000|Overall Study|Other|3|||
48710473|NCT00530816|156788873|FG001|Overall Study|Other|3|||
48710474|NCT00530816|156788874|FG002|Overall Study|Other|4|||
48710475|NCT00530816|156788872|FG000|Overall Study|Withdrawal by Subject|1|||
48710476|NCT00530816|156788873|FG001|Overall Study|Withdrawal by Subject|2|||
48710477|NCT00530816|156788874|FG002|Overall Study|Withdrawal by Subject|6|||
48710478|NCT02116205|156788875|FG000|Overall Study|Withdrawal by Subject|2|||
48710479|NCT02116205|156788876|FG001|Overall Study|Withdrawal by Subject|4|||
48710480|NCT02116205|156788877|FG002|Overall Study|Withdrawal by Subject|1|||
48710481|NCT02116205|156788878|FG003|Overall Study|Withdrawal by Subject|3|||
48710482|NCT02116205|156788875|FG000|Overall Study|Lost to Follow-up|0|||
48710483|NCT02116205|156788876|FG001|Overall Study|Lost to Follow-up|2|||
48710484|NCT02116205|156788877|FG002|Overall Study|Lost to Follow-up|1|||
48710485|NCT02116205|156788878|FG003|Overall Study|Lost to Follow-up|2|||
48710486|NCT02116205|156788875|FG000|Overall Study|Physician Decision|0|||
48710487|NCT02116205|156788876|FG001|Overall Study|Physician Decision|1|||
48710488|NCT02116205|156788877|FG002|Overall Study|Physician Decision|1|||
48710489|NCT02116205|156788878|FG003|Overall Study|Physician Decision|1|||
48710490|NCT02116205|156788875|FG000|Overall Study|Exclusion criteria|0|||
48710491|NCT02116205|156788876|FG001|Overall Study|Exclusion criteria|0|||
48710492|NCT02116205|156788877|FG002|Overall Study|Exclusion criteria|1|||
48710493|NCT02116205|156788878|FG003|Overall Study|Exclusion criteria|0|||
48710494|NCT02954172|156788879|FG000|Overall Study|Protocol Violation|3|||
48710495|NCT02954172|156788880|FG001|Overall Study|Protocol Violation|0|||
48710496|NCT02954172|156788879|FG000|Overall Study|allergic reaction|2|||
48710497|NCT02954172|156788880|FG001|Overall Study|allergic reaction|1|||
48710498|NCT02954172|156788879|FG000|Overall Study|non-measurable lesions at baseline|1|||
48710499|NCT02954172|156788880|FG001|Overall Study|non-measurable lesions at baseline|2|||
48710500|NCT00853567|156788883|FG000|Overall Study|Study prematurely terminated|71|||
48710501|NCT02055118|156788884|FG000|Overall Study|Withdrawal by Subject|0|||
48710502|NCT02055118|156788885|FG001|Overall Study|Withdrawal by Subject|2|||
48710503|NCT02055118|156788886|FG002|Overall Study|Withdrawal by Subject|0|||
48710504|NCT02281383|156788895|FG000|Overall Study|Progressive Disease|1|||
48710505|NCT02281383|156788895|FG000|Overall Study|Withdrawal by Subject|6|||
48710506|NCT02281383|156788895|FG000|Overall Study|Protocol Violation|2|||
48710507|NCT02281383|156788895|FG000|Overall Study|Death|1|||
48710508|NCT02281383|156788895|FG000|Overall Study|Adverse Event|2|||
48710509|NCT01215097|156788896|FG000|Overall Study|Adverse Event|1|||
48710510|NCT01215097|156788897|FG001|Overall Study|Adverse Event|3|||
48710511|NCT01215097|156788896|FG000|Overall Study|Protocol Violation|0|||
48710512|NCT01215097|156788897|FG001|Overall Study|Protocol Violation|2|||
48710513|NCT01215097|156788896|FG000|Overall Study|Lost to Follow-up|2|||
48710514|NCT01215097|156788897|FG001|Overall Study|Lost to Follow-up|0|||
48710515|NCT01215097|156788896|FG000|Overall Study|Withdrawal by Subject|6|||
48710516|NCT01215097|156788897|FG001|Overall Study|Withdrawal by Subject|3|||
48710517|NCT01215097|156788896|FG000|Overall Study|Lack of Efficacy|0|||
48710518|NCT01215097|156788897|FG001|Overall Study|Lack of Efficacy|3|||
48807658|NCT01370005|157136656|FG000|Overall Study|Lost to Follow-up|1|||
48807659|NCT01370005|157136657|FG001|Overall Study|Lost to Follow-up|1|||
48710519|NCT01215097|156788896|FG000|Overall Study|patient's refusal to come|2|||
48710520|NCT01215097|156788897|FG001|Overall Study|patient's refusal to come|2|||
48710521|NCT01215097|156788896|FG000|Overall Study|patient's private reason|1|||
48710522|NCT01215097|156788897|FG001|Overall Study|patient's private reason|1|||
48710523|NCT01711216|156788898|FG000|Overall Study|Adverse Event|4|||
48710524|NCT01711216|156788898|FG000|Overall Study|Pregnancy|56|||
48710525|NCT01711216|156788898|FG000|Overall Study|Withdrawal by Subject|6|||
48710526|NCT01711216|156788898|FG000|Overall Study|Lost to Follow-up|46|||
48710527|NCT01711216|156788898|FG000|Overall Study|variety of other minor reasons|83|||
48710528|NCT01711216|156788898|FG000|Overall Study|no reason specified|22|||
48710529|NCT02541604|156788899|FG000|Overall Study|Death|6|||
48710530|NCT02541604|156788900|FG001|Overall Study|Death|5|||
48710531|NCT02541604|156788901|FG002|Overall Study|Death|7|||
48710532|NCT02541604|156788902|FG003|Overall Study|Death|2|||
48710533|NCT02541604|156788903|FG004|Overall Study|Death|9|||
48710534|NCT02541604|156788904|FG005|Overall Study|Death|8|||
48807660|NCT01370005|157136658|FG002|Overall Study|Lost to Follow-up|1|||
48710535|NCT02541604|156788905|FG006|Overall Study|Death|9|||
48710536|NCT02541604|156788906|FG007|Overall Study|Death|9|||
48710537|NCT02541604|156788907|FG008|Overall Study|Death|3|||
48710538|NCT02541604|156788908|FG009|Overall Study|Death|4|||
48710539|NCT02541604|156788909|FG010|Overall Study|Death|2|||
48710540|NCT02541604|156788910|FG011|Overall Study|Death|3|||
48710541|NCT02541604|156788899|FG000|Overall Study|Lost to Follow-up|2|||
48710542|NCT02541604|156788900|FG001|Overall Study|Lost to Follow-up|0|||
48710543|NCT02541604|156788901|FG002|Overall Study|Lost to Follow-up|1|||
48710544|NCT02541604|156788902|FG003|Overall Study|Lost to Follow-up|0|||
48710545|NCT02541604|156788903|FG004|Overall Study|Lost to Follow-up|0|||
48710546|NCT02541604|156788904|FG005|Overall Study|Lost to Follow-up|1|||
48710547|NCT02541604|156788905|FG006|Overall Study|Lost to Follow-up|1|||
48710548|NCT02541604|156788906|FG007|Overall Study|Lost to Follow-up|0|||
48710549|NCT02541604|156788907|FG008|Overall Study|Lost to Follow-up|0|||
48710550|NCT02541604|156788908|FG009|Overall Study|Lost to Follow-up|0|||
48710551|NCT02541604|156788909|FG010|Overall Study|Lost to Follow-up|0|||
48710552|NCT02541604|156788910|FG011|Overall Study|Lost to Follow-up|0|||
48710553|NCT02541604|156788899|FG000|Overall Study|Withdrawal by Subject|2|||
48710554|NCT02541604|156788900|FG001|Overall Study|Withdrawal by Subject|0|||
48710555|NCT02541604|156788901|FG002|Overall Study|Withdrawal by Subject|1|||
48807661|NCT01370005|157136656|FG000|Overall Study|Patient refusal to continue,not due toAE|5|||
48807662|NCT01370005|157136657|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
48807663|NCT01370005|157136658|FG002|Overall Study|Patient refusal to continue,not due toAE|0|||
48807664|NCT01370005|157136656|FG000|Overall Study|Other reason not defined above|3|||
48807665|NCT01370005|157136657|FG001|Overall Study|Other reason not defined above|0|||
48807666|NCT01370005|157136658|FG002|Overall Study|Other reason not defined above|2|||
48807667|NCT04631705|157136659|FG000|Overall Study|Withdrawal by Subject|0|||
48807668|NCT04631705|157136660|FG001|Overall Study|Withdrawal by Subject|0|||
48807669|NCT04631705|157136661|FG002|Overall Study|Withdrawal by Subject|0|||
48807670|NCT04631705|157136662|FG003|Overall Study|Withdrawal by Subject|0|||
48807671|NCT04631705|157136663|FG004|Overall Study|Withdrawal by Subject|0|||
48807672|NCT04631705|157136664|FG005|Overall Study|Withdrawal by Subject|0|||
48807673|NCT04631705|157136665|FG006|Overall Study|Withdrawal by Subject|1|||
48807674|NCT04631705|157136666|FG007|Overall Study|Withdrawal by Subject|0|||
48807675|NCT04631705|157136667|FG008|Overall Study|Withdrawal by Subject|0|||
48807676|NCT01686581|157136670|FG000|Overall Study|Side-effects or Health Problems|15|||
48710556|NCT02541604|156788902|FG003|Overall Study|Withdrawal by Subject|0|||
48710557|NCT02541604|156788903|FG004|Overall Study|Withdrawal by Subject|1|||
48807677|NCT01686581|157136670|FG000|Overall Study|Lack of Efficacy|90|||
48807678|NCT01686581|157136670|FG000|Overall Study|Participant Concerned about Risks|6|||
48807679|NCT01686581|157136670|FG000|Overall Study|Thinks Injections Too Painful|8|||
48710558|NCT02541604|156788904|FG005|Overall Study|Withdrawal by Subject|1|||
48710559|NCT02541604|156788905|FG006|Overall Study|Withdrawal by Subject|0|||
48710560|NCT02541604|156788906|FG007|Overall Study|Withdrawal by Subject|0|||
48710561|NCT02541604|156788907|FG008|Overall Study|Withdrawal by Subject|1|||
48807680|NCT01686581|157136670|FG000|Overall Study|Thinks Injections Take Too Much Time|2|||
48807681|NCT01686581|157136670|FG000|Overall Study|Trying to get Pregnant or Nursing|2|||
48710562|NCT02541604|156788908|FG009|Overall Study|Withdrawal by Subject|0|||
48710563|NCT02541604|156788909|FG010|Overall Study|Withdrawal by Subject|0|||
48710564|NCT02541604|156788910|FG011|Overall Study|Withdrawal by Subject|0|||
48710565|NCT02541604|156788899|FG000|Overall Study|Study Terminated by Sponsor|1|||
48710566|NCT02541604|156788900|FG001|Overall Study|Study Terminated by Sponsor|4|||
48710567|NCT02541604|156788901|FG002|Overall Study|Study Terminated by Sponsor|2|||
48710568|NCT02541604|156788902|FG003|Overall Study|Study Terminated by Sponsor|1|||
48710569|NCT02541604|156788903|FG004|Overall Study|Study Terminated by Sponsor|0|||
48710570|NCT02541604|156788904|FG005|Overall Study|Study Terminated by Sponsor|0|||
48917379|NCT01230307|157534014|FG001|Overall Study|LVAD Placement|2|||
48917380|NCT01372384|157534019|FG000|Overall Study|Progression of disease|3|||
48917381|NCT02770547|157534020|FG000|Overall Study|Patient non-compliant|1|||
48917382|NCT02770547|157534021|FG001|Overall Study|Patient non-compliant|0|||
48917383|NCT02770547|157534020|FG000|Overall Study|Adverse Event|0|||
48917384|NCT02770547|157534021|FG001|Overall Study|Adverse Event|1|||
48917385|NCT01843842|157534029|FG000|Overall Study|Do not meet inclusion criteria|1|||
48917386|NCT01843842|157534030|FG001|Overall Study|Do not meet inclusion criteria|1|||
48710571|NCT02541604|156788905|FG006|Overall Study|Study Terminated by Sponsor|0|||
48710572|NCT02541604|156788906|FG007|Overall Study|Study Terminated by Sponsor|0|||
48807682|NCT01686581|157136670|FG000|Overall Study|Thinks it is Inconvenient|17|||
48710573|NCT02541604|156788907|FG008|Overall Study|Study Terminated by Sponsor|0|||
48710574|NCT02541604|156788908|FG009|Overall Study|Study Terminated by Sponsor|0|||
48807683|NCT01686581|157136670|FG000|Overall Study|Other Miscellaneous Reasons|36|||
48807684|NCT01686581|157136670|FG000|Overall Study|Reason Missing|1|||
48807685|NCT04534114|157136671|FG000|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
48807686|NCT04534114|157136672|FG001|Main Treatment Period|COVID-19 pandemic: Participant decision|1|||
48807687|NCT04534114|157136673|FG002|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
48807688|NCT04534114|157136674|FG003|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
48807689|NCT04534114|157136671|FG000|Main Treatment Period|COVID-19 pandemic: Death|0|||
48807690|NCT04534114|157136672|FG001|Main Treatment Period|COVID-19 pandemic: Death|1|||
48807691|NCT04534114|157136673|FG002|Main Treatment Period|COVID-19 pandemic: Death|0|||
48710575|NCT02541604|156788909|FG010|Overall Study|Study Terminated by Sponsor|0|||
48710576|NCT02541604|156788910|FG011|Overall Study|Study Terminated by Sponsor|0|||
48710577|NCT02541604|156788899|FG000|Overall Study|Medical condition may jeopardize safety|0|||
48710578|NCT02541604|156788900|FG001|Overall Study|Medical condition may jeopardize safety|0|||
48710579|NCT02541604|156788901|FG002|Overall Study|Medical condition may jeopardize safety|0|||
48710580|NCT02541604|156788902|FG003|Overall Study|Medical condition may jeopardize safety|0|||
48710581|NCT02541604|156788903|FG004|Overall Study|Medical condition may jeopardize safety|0|||
48710582|NCT02541604|156788904|FG005|Overall Study|Medical condition may jeopardize safety|0|||
48710583|NCT02541604|156788905|FG006|Overall Study|Medical condition may jeopardize safety|0|||
48710584|NCT02541604|156788906|FG007|Overall Study|Medical condition may jeopardize safety|1|||
48710585|NCT02541604|156788907|FG008|Overall Study|Medical condition may jeopardize safety|0|||
48710586|NCT02541604|156788908|FG009|Overall Study|Medical condition may jeopardize safety|0|||
48710587|NCT02541604|156788909|FG010|Overall Study|Medical condition may jeopardize safety|0|||
48710588|NCT02541604|156788910|FG011|Overall Study|Medical condition may jeopardize safety|0|||
48710589|NCT01033448|156788911|FG000|Overall Study|Withdrawal by Subject|4|||
48710590|NCT01033448|156788911|FG000|Overall Study|Positive HCV-RNA at week 48|1|||
48710591|NCT01033448|156788911|FG000|Overall Study|Lost to Follow-up|3|||
48710592|NCT01033448|156788911|FG000|Overall Study|Withdrew due to other reasons|3|||
48710593|NCT01033448|156788911|FG000|Overall Study|Unknown disposition|1|||
48710594|NCT00554216|156791308|FG000|Overall Study|Lost to Follow-up|92|||
48710595|NCT00554216|156791309|FG001|Overall Study|Lost to Follow-up|31|||
48710596|NCT00554216|156791310|FG002|Overall Study|Lost to Follow-up|63|||
48710597|NCT00554216|156791308|FG000|Overall Study|Adverse Event|16|||
48710598|NCT00554216|156791309|FG001|Overall Study|Adverse Event|16|||
48710599|NCT00554216|156791310|FG002|Overall Study|Adverse Event|36|||
48710600|NCT00554216|156791308|FG000|Overall Study|Withdrawal by Subject|92|||
48710601|NCT00554216|156791309|FG001|Overall Study|Withdrawal by Subject|31|||
48710602|NCT00554216|156791310|FG002|Overall Study|Withdrawal by Subject|43|||
48710603|NCT00554216|156791308|FG000|Overall Study|Non compliance|10|||
48710604|NCT00554216|156791309|FG001|Overall Study|Non compliance|4|||
48710605|NCT00554216|156791310|FG002|Overall Study|Non compliance|5|||
48710606|NCT00554216|156791308|FG000|Overall Study|Pregnancy|2|||
48710607|NCT00554216|156791309|FG001|Overall Study|Pregnancy|1|||
48710608|NCT00554216|156791310|FG002|Overall Study|Pregnancy|14|||
48807692|NCT04534114|157136674|FG003|Main Treatment Period|COVID-19 pandemic: Death|2|||
48807693|NCT04534114|157136671|FG000|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
48917387|NCT01671111|157534031|FG000|Overall Study|Adverse Event|2|||
48710609|NCT00554216|156791308|FG000|Overall Study|Restricted med|3|||
48710610|NCT00554216|156791309|FG001|Overall Study|Restricted med|1|||
48710611|NCT00554216|156791310|FG002|Overall Study|Restricted med|1|||
48710612|NCT00554216|156791308|FG000|Overall Study|Other|12|||
48710613|NCT00554216|156791309|FG001|Overall Study|Other|7|||
48807694|NCT04534114|157136672|FG001|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
48917388|NCT01671111|157534031|FG000|Overall Study|Lack of Efficacy|1|||
48917389|NCT01671111|157534031|FG000|Overall Study|Withdrawal by Subject|2|||
48710614|NCT00554216|156791310|FG002|Overall Study|Other|10|||
48710615|NCT00554216|156791308|FG000|Overall Study|Lack of Efficacy|15|||
48710616|NCT00554216|156791309|FG001|Overall Study|Lack of Efficacy|3|||
48710617|NCT00554216|156791310|FG002|Overall Study|Lack of Efficacy|0|||
48710618|NCT01071798|156791321|FG000|Participants Who Received One Cycle|Lack of Efficacy|18|||
48710619|NCT01071798|156791321|FG000|Participants Who Received One Cycle|Lack of tolerability|14|||
48710620|NCT01071798|156791321|FG000|Participants Who Received One Cycle|Patient requirement|20|||
48710621|NCT01071798|156791321|FG000|Participants Who Received One Cycle|Death|5|||
48710622|NCT01071798|156791321|FG000|Participants Who Received One Cycle|Change of therapy|6|||
48710623|NCT01071798|156791321|FG000|Participants Who Received One Cycle|Severe concomitant disease|2|||
48710624|NCT01071798|156791321|FG000|Subpopulation Who Received Two Cycles|Remission|1|||
48710625|NCT01071798|156791321|FG000|Subpopulation Who Received Two Cycles|Lack of Efficacy|3|||
48710626|NCT01071798|156791321|FG000|Subpopulation Who Received Two Cycles|Lack of Tolerability|4|||
48710627|NCT01071798|156791321|FG000|Subpopulation Who Received Two Cycles|Patient Requirement|7|||
48710628|NCT01330108|156791329|FG000|Overall Study|Withdrawal by Subject|4|||
48710629|NCT02446899|156791330|FG000|Overall Study|Adverse Event|4|||
48710630|NCT02446899|156791331|FG001|Overall Study|Adverse Event|7|||
48710631|NCT02446899|156791330|FG000|Overall Study|Condition Under Investigation Worsened|1|||
48710632|NCT02446899|156791331|FG001|Overall Study|Condition Under Investigation Worsened|4|||
48710633|NCT02446899|156791330|FG000|Overall Study|Study Specific Withdrawal Criteria|1|||
48710634|NCT02446899|156791331|FG001|Overall Study|Study Specific Withdrawal Criteria|0|||
48710635|NCT02446899|156791330|FG000|Overall Study|Lack of Efficacy|2|||
48710636|NCT02446899|156791331|FG001|Overall Study|Lack of Efficacy|8|||
48710637|NCT02446899|156791330|FG000|Overall Study|Lost to Follow-up|1|||
48710638|NCT02446899|156791331|FG001|Overall Study|Lost to Follow-up|3|||
48710639|NCT02446899|156791330|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
48710640|NCT02446899|156791331|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
48710641|NCT02446899|156791330|FG000|Overall Study|Withdrawal by Subject|11|||
48710642|NCT02446899|156791331|FG001|Overall Study|Withdrawal by Subject|19|||
48710643|NCT02446899|156791330|FG000|Overall Study|Miscellaneous|5|||
48710644|NCT02446899|156791331|FG001|Overall Study|Miscellaneous|4|||
48710645|NCT02446899|156791330|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
48710646|NCT02446899|156791331|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
48710647|NCT00373113|156791332|FG000|Overall Study|Death|1|||
48710648|NCT00373113|156791333|FG001|Overall Study|Death|7|||
48710649|NCT00373113|156791332|FG000|Overall Study|Adverse Event|38|||
48807695|NCT04534114|157136673|FG002|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
48807696|NCT04534114|157136674|FG003|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
48807697|NCT04534114|157136671|FG000|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
48807698|NCT04534114|157136672|FG001|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
48807699|NCT04534114|157136673|FG002|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
48807700|NCT04534114|157136674|FG003|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
48807701|NCT04534114|157136671|FG000|Main Treatment Period|Physician Decision|0|||
48807702|NCT04534114|157136672|FG001|Main Treatment Period|Physician Decision|0|||
48807703|NCT04534114|157136673|FG002|Main Treatment Period|Physician Decision|0|||
48807704|NCT04534114|157136674|FG003|Main Treatment Period|Physician Decision|1|||
48807705|NCT04534114|157136671|FG000|Main Treatment Period|Death|1|||
48807706|NCT04534114|157136672|FG001|Main Treatment Period|Death|0|||
48807707|NCT04534114|157136673|FG002|Main Treatment Period|Death|0|||
48807708|NCT04534114|157136674|FG003|Main Treatment Period|Death|1|||
48807709|NCT04534114|157136671|FG000|Main Treatment Period|Other reason|1|||
48807710|NCT04534114|157136672|FG001|Main Treatment Period|Other reason|1|||
48807711|NCT04534114|157136673|FG002|Main Treatment Period|Other reason|0|||
48807712|NCT04534114|157136674|FG003|Main Treatment Period|Other reason|0|||
48807713|NCT04534114|157136671|FG000|Main Treatment Period|Participant decision|1|||
48807714|NCT04534114|157136672|FG001|Main Treatment Period|Participant decision|3|||
48807715|NCT04534114|157136673|FG002|Main Treatment Period|Participant decision|3|||
48807716|NCT04534114|157136674|FG003|Main Treatment Period|Participant decision|1|||
48807717|NCT04534114|157136671|FG000|Main Treatment Period|Protocol-specified withdrawal criterion met|2|||
48807718|NCT04534114|157136672|FG001|Main Treatment Period|Protocol-specified withdrawal criterion met|1|||
48807719|NCT04534114|157136673|FG002|Main Treatment Period|Protocol-specified withdrawal criterion met|4|||
48807720|NCT04534114|157136674|FG003|Main Treatment Period|Protocol-specified withdrawal criterion met|6|||
48807721|NCT04534114|157136671|FG000|Main Treatment Period|Adverse Event|4|||
48807722|NCT04534114|157136672|FG001|Main Treatment Period|Adverse Event|2|||
48807723|NCT04534114|157136673|FG002|Main Treatment Period|Adverse Event|1|||
48807724|NCT04534114|157136674|FG003|Main Treatment Period|Adverse Event|2|||
48807725|NCT04534114|157136671|FG000|Extension Treatment Period|COVID-19 pandemic: Death|0|||
48807726|NCT04534114|157136672|FG001|Extension Treatment Period|COVID-19 pandemic: Death|0|||
48807727|NCT04534114|157136673|FG002|Extension Treatment Period|COVID-19 pandemic: Death|0|||
48807728|NCT04534114|157136674|FG003|Extension Treatment Period|COVID-19 pandemic: Death|1|||
48807729|NCT04534114|157136671|FG000|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
48807730|NCT04534114|157136672|FG001|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
48917390|NCT01671111|157534031|FG000|Overall Study|Physician Decision|1|||
48917391|NCT01671111|157534031|FG000|Overall Study|Other|24|||
48710650|NCT00373113|156791333|FG001|Overall Study|Adverse Event|24|||
48710651|NCT00373113|156791332|FG000|Overall Study|Study terminated by sponsor|9|||
48710652|NCT00373113|156791333|FG001|Overall Study|Study terminated by sponsor|1|||
48917392|NCT02953340|157534032|FG000|Overall Study|Death|0|||
48917393|NCT02953340|157534033|FG001|Overall Study|Death|1|||
48917394|NCT02953340|157534032|FG000|Overall Study|Investigator Decision|3|||
48710653|NCT00373113|156791332|FG000|Overall Study|Global deterioration of health status|10|||
48710654|NCT00373113|156791333|FG001|Overall Study|Global deterioration of health status|7|||
48710655|NCT00373113|156791332|FG000|Overall Study|Lost to Follow-up|1|||
48710656|NCT00373113|156791333|FG001|Overall Study|Lost to Follow-up|3|||
48917395|NCT02953340|157534033|FG001|Overall Study|Investigator Decision|3|||
48807731|NCT04534114|157136673|FG002|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
48807732|NCT04534114|157136674|FG003|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
48807733|NCT04534114|157136671|FG000|Extension Treatment Period|Other reason|0|||
48807734|NCT04534114|157136672|FG001|Extension Treatment Period|Other reason|1|||
48807735|NCT04534114|157136673|FG002|Extension Treatment Period|Other reason|0|||
48807736|NCT04534114|157136674|FG003|Extension Treatment Period|Other reason|0|||
48807737|NCT04534114|157136671|FG000|Extension Treatment Period|Death|0|||
48807738|NCT04534114|157136672|FG001|Extension Treatment Period|Death|0|||
48807739|NCT04534114|157136673|FG002|Extension Treatment Period|Death|1|||
48807740|NCT04534114|157136674|FG003|Extension Treatment Period|Death|2|||
48807741|NCT04534114|157136671|FG000|Extension Treatment Period|Adverse Event|0|||
48807742|NCT04534114|157136672|FG001|Extension Treatment Period|Adverse Event|1|||
48807743|NCT04534114|157136673|FG002|Extension Treatment Period|Adverse Event|0|||
48807744|NCT04534114|157136674|FG003|Extension Treatment Period|Adverse Event|1|||
48807745|NCT04534114|157136671|FG000|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
48807746|NCT04534114|157136672|FG001|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
48807747|NCT04534114|157136673|FG002|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|0|||
48807748|NCT04534114|157136674|FG003|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|1|||
48807749|NCT02301156|157136675|FG000|Overall Study|Adverse Event|13|||
48807750|NCT02301156|157136676|FG001|Overall Study|Adverse Event|14|||
48807751|NCT02301156|157136675|FG000|Overall Study|Death|1|||
48807752|NCT02301156|157136676|FG001|Overall Study|Death|5|||
48807753|NCT02301156|157136675|FG000|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
48807754|NCT02301156|157136676|FG001|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
48807755|NCT02301156|157136675|FG000|Overall Study|Site Terminated by Sponsor at the End of Study|27|||
48807756|NCT02301156|157136676|FG001|Overall Study|Site Terminated by Sponsor at the End of Study|16|||
48807757|NCT02301156|157136675|FG000|Overall Study|Withdrawal of Consent by Subject|4|||
48807758|NCT02301156|157136676|FG001|Overall Study|Withdrawal of Consent by Subject|12|||
48807759|NCT02301156|157136675|FG000|Overall Study|Reason not Specified|6|||
48807760|NCT02301156|157136676|FG001|Overall Study|Reason not Specified|3|||
48807761|NCT00785707|157136677|FG000|Overall Study|Lost to Follow-up|7|||
48807762|NCT04035486|157136680|FG000|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|7|||
48807763|NCT04035486|157136681|FG001|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|10|||
49120351|NCT02106351|158278928|FG002|Treatment Cycle 4|Other|0|||
49120352|NCT01801111|158278929|FG000|Overall Study|Adverse Event|12|||
49120353|NCT01801111|158278929|FG000|Overall Study|Death|8|||
49120354|NCT01801111|158278929|FG000|Overall Study|Physician Decision|5|||
49120355|NCT01801111|158278929|FG000|Overall Study|Other|1|||
49120356|NCT01801111|158278929|FG000|Overall Study|Withdrawal by Subject|4|||
49120357|NCT01801111|158278929|FG000|Overall Study|Study Terminated by Sponsor|27|||
49120358|NCT01801111|158278929|FG000|Overall Study|Progressive Disease|81|||
49120359|NCT03284853|158278930|FG000|Overall Study|Adverse Event|40|||
49120360|NCT03284853|158278931|FG001|Overall Study|Adverse Event|4|||
49120361|NCT03284853|158278930|FG000|Overall Study|Withdrawal by Subject|5|||
49120362|NCT03284853|158278931|FG001|Overall Study|Withdrawal by Subject|1|||
49120363|NCT03284853|158278930|FG000|Overall Study|Lost to Follow-up|1|||
49120364|NCT03284853|158278931|FG001|Overall Study|Lost to Follow-up|0|||
49120365|NCT03284853|158278930|FG000|Overall Study|Lack of Efficacy|1|||
49120366|NCT03284853|158278931|FG001|Overall Study|Lack of Efficacy|0|||
49120367|NCT03284853|158278930|FG000|Overall Study|Disallowed Concurrent Medication|1|||
49120368|NCT03284853|158278931|FG001|Overall Study|Disallowed Concurrent Medication|1|||
49120369|NCT03284853|158278930|FG000|Overall Study|Protocol Violation|3|||
49120370|NCT03284853|158278931|FG001|Overall Study|Protocol Violation|3|||
49120371|NCT03284853|158278930|FG000|Overall Study|Death|0|||
49120372|NCT03284853|158278931|FG001|Overall Study|Death|1|||
49120373|NCT03284853|158278930|FG000|Overall Study|Other - Reason not reported in CSR|4|||
49120374|NCT03284853|158278931|FG001|Overall Study|Other - Reason not reported in CSR|3|||
49120375|NCT01419535|158278932|FG000|Overall Study|could not maintain iv line|1|||
49120376|NCT01419535|158278933|FG001|Overall Study|could not maintain iv line|1|||
49120377|NCT01419535|158278932|FG000|Overall Study|Withdrawal by Subject|0|||
49120378|NCT01419535|158278933|FG001|Overall Study|Withdrawal by Subject|1|||
49120379|NCT02489448|158280455|FG000|Overall Study|Death|3|||
49120380|NCT02489448|158280455|FG000|Overall Study|Withdrawal by Subject|2|||
49120381|NCT03335813|158280461|FG000|Overall Study|Withdrawal by Subject|1|||
49120382|NCT02750332|158280468|FG000|Treatment Period 1|Withdrawal by Subject|0|||
49120383|NCT02750332|158280469|FG001|Treatment Period 1|Withdrawal by Subject|1|||
49120384|NCT03498313|158280477|FG000|Experimental Period 1|Adverse Event|1|||
49120385|NCT03498313|158280478|FG001|Experimental Period 1|Adverse Event|0|||
49120386|NCT03498313|158280479|FG002|Experimental Period 1|Adverse Event|0|||
49120387|NCT03498313|158280480|FG003|Experimental Period 1|Adverse Event|1|||
49120388|NCT03498313|158280481|FG004|Experimental Period 1|Adverse Event|0|||
49120389|NCT03498313|158280482|FG005|Experimental Period 1|Adverse Event|0|||
48917396|NCT02953340|157534032|FG000|Overall Study|Initiated Non-Protocol Therapy|5|||
48917397|NCT02953340|157534033|FG001|Overall Study|Initiated Non-Protocol Therapy|14|||
48917398|NCT02953340|157534032|FG000|Overall Study|Myeloid Growth Factors Treatment|0|||
48917399|NCT02953340|157534033|FG001|Overall Study|Myeloid Growth Factors Treatment|1|||
48917400|NCT02953340|157534032|FG000|Overall Study|Withdrawal by Subject|9|||
48917401|NCT02953340|157534033|FG001|Overall Study|Withdrawal by Subject|9|||
48917402|NCT02953340|157534032|FG000|Overall Study|Sponsor decision|0|||
48917403|NCT02953340|157534033|FG001|Overall Study|Sponsor decision|2|||
48917404|NCT02953340|157534032|FG000|Overall Study|Lost to Follow-up|3|||
48917405|NCT02953340|157534033|FG001|Overall Study|Lost to Follow-up|2|||
48917406|NCT02953340|157534032|FG000|Overall Study|Reason not specified|2|||
48917407|NCT02953340|157534033|FG001|Overall Study|Reason not specified|2|||
48917408|NCT00433914|157534034|FG000|Overall Study|Withdrawal by Subject|0|||
48917409|NCT00433914|157534035|FG001|Overall Study|Withdrawal by Subject|2|||
48917410|NCT00433914|157534034|FG000|Overall Study|Lost to Follow-up|0|||
48917411|NCT00433914|157534035|FG001|Overall Study|Lost to Follow-up|1|||
49120390|NCT03498313|158280477|FG000|Experimental Period 1|Withdrawal by Subject|0|||
49120391|NCT03498313|158280478|FG001|Experimental Period 1|Withdrawal by Subject|1|||
49120392|NCT03498313|158280479|FG002|Experimental Period 1|Withdrawal by Subject|0|||
49120393|NCT03498313|158280480|FG003|Experimental Period 1|Withdrawal by Subject|0|||
48710657|NCT00373113|156791332|FG000|Overall Study|Objective progression or relapse|150|||
48710658|NCT00373113|156791333|FG001|Overall Study|Objective progression or relapse|169|||
48710659|NCT00373113|156791332|FG000|Overall Study|Other|14|||
48710660|NCT00373113|156791333|FG001|Overall Study|Other|17|||
48710661|NCT00373113|156791332|FG000|Overall Study|Protocol Violation|5|||
48710662|NCT00373113|156791333|FG001|Overall Study|Protocol Violation|1|||
48710663|NCT00373113|156791332|FG000|Overall Study|Withdrawal by Subject|10|||
48710664|NCT00373113|156791333|FG001|Overall Study|Withdrawal by Subject|15|||
49120394|NCT03498313|158280481|FG004|Experimental Period 1|Withdrawal by Subject|0|||
49120395|NCT03498313|158280482|FG005|Experimental Period 1|Withdrawal by Subject|0|||
48710665|NCT03275350|156791334|FG000|Overall Study|Lost to Follow-up|4|||
48710666|NCT03275350|156791335|FG001|Overall Study|Lost to Follow-up|6|||
48710667|NCT03275350|156791334|FG000|Overall Study|Death|2|||
48710668|NCT03275350|156791335|FG001|Overall Study|Death|1|||
48710669|NCT03275350|156791334|FG000|Overall Study|Physician Decision|1|||
48710670|NCT03275350|156791335|FG001|Overall Study|Physician Decision|0|||
48710671|NCT03275350|156791334|FG000|Overall Study|Incarcerated|1|||
48710672|NCT03275350|156791335|FG001|Overall Study|Incarcerated|1|||
48710673|NCT01402102|156791336|FG000|Overall Study|Protocol Violation|1|||
49120396|NCT03498313|158280477|FG000|Washout Period 1|Anovulation|1|||
49120397|NCT03498313|158280478|FG001|Washout Period 1|Anovulation|0|||
48710674|NCT01402102|156791337|FG001|Overall Study|Protocol Violation|0|||
48710675|NCT01402102|156791336|FG000|Overall Study|Insufficiency of compliance|1|||
49120398|NCT03498313|158280479|FG002|Washout Period 1|Anovulation|0|||
49120399|NCT03498313|158280480|FG003|Washout Period 1|Anovulation|0|||
49120400|NCT03498313|158280481|FG004|Washout Period 1|Anovulation|0|||
49120401|NCT03498313|158280482|FG005|Washout Period 1|Anovulation|0|||
49120402|NCT03498313|158280477|FG000|Washout Period 1|Withdrawal by Subject|0|||
49120403|NCT03498313|158280478|FG001|Washout Period 1|Withdrawal by Subject|3|||
49120404|NCT03498313|158280479|FG002|Washout Period 1|Withdrawal by Subject|0|||
49120405|NCT03498313|158280480|FG003|Washout Period 1|Withdrawal by Subject|1|||
49120406|NCT03498313|158280481|FG004|Washout Period 1|Withdrawal by Subject|0|||
49120407|NCT03498313|158280482|FG005|Washout Period 1|Withdrawal by Subject|1|||
49120408|NCT03498313|158280477|FG000|Experimental Period 2|Adverse Event|0|||
49120409|NCT03498313|158280478|FG001|Experimental Period 2|Adverse Event|0|||
49120410|NCT03498313|158280479|FG002|Experimental Period 2|Adverse Event|0|||
49120411|NCT03498313|158280480|FG003|Experimental Period 2|Adverse Event|0|||
49120412|NCT03498313|158280481|FG004|Experimental Period 2|Adverse Event|1|||
49120413|NCT03498313|158280482|FG005|Experimental Period 2|Adverse Event|2|||
49120414|NCT03498313|158280477|FG000|Washout Period 2|Physician Decision|1|||
49120415|NCT03498313|158280478|FG001|Washout Period 2|Physician Decision|0|||
49120416|NCT03498313|158280479|FG002|Washout Period 2|Physician Decision|0|||
49120417|NCT03498313|158280480|FG003|Washout Period 2|Physician Decision|1|||
49120418|NCT03498313|158280481|FG004|Washout Period 2|Physician Decision|0|||
49120419|NCT03498313|158280482|FG005|Washout Period 2|Physician Decision|1|||
49120420|NCT03498313|158280477|FG000|Washout Period 2|Withdrawal by Subject|3|||
49120421|NCT03498313|158280478|FG001|Washout Period 2|Withdrawal by Subject|2|||
48710676|NCT01402102|156791337|FG001|Overall Study|Insufficiency of compliance|1|||
48710677|NCT01402102|156791336|FG000|Overall Study|Withdrawal by Subject|0|||
48710678|NCT01402102|156791337|FG001|Overall Study|Withdrawal by Subject|2|||
48710679|NCT02813577|156791341|FG000|Overall Study|Study terminated|4|||
48710680|NCT01976741|156791342|FG000|Overall Study|Withdrawal by Subject|1|||
48710681|NCT01976741|156791343|FG001|Overall Study|Withdrawal by Subject|0|||
48917412|NCT00928889|157534037|FG000|Overall Study|Lost to Follow-up|3|||
48917413|NCT00928889|157534038|FG001|Overall Study|Lost to Follow-up|1|||
48917414|NCT00928889|157534037|FG000|Overall Study|Protocol Violation|0|||
48710682|NCT01976741|156791344|FG002|Overall Study|Withdrawal by Subject|1|||
48710683|NCT01976741|156791345|FG003|Overall Study|Withdrawal by Subject|1|||
48710684|NCT01976741|156791346|FG004|Overall Study|Withdrawal by Subject|0|||
48710685|NCT01976741|156791347|FG005|Overall Study|Withdrawal by Subject|0|||
48710686|NCT01976741|156791348|FG006|Overall Study|Withdrawal by Subject|1|||
48710687|NCT01976741|156791349|FG007|Overall Study|Withdrawal by Subject|4|||
48710688|NCT01976741|156791350|FG008|Overall Study|Withdrawal by Subject|0|||
48710689|NCT01976741|156791351|FG009|Overall Study|Withdrawal by Subject|0|||
48710690|NCT01976741|156791342|FG000|Overall Study|Adverse Event|0|||
48710691|NCT01976741|156791343|FG001|Overall Study|Adverse Event|0|||
48710692|NCT01976741|156791344|FG002|Overall Study|Adverse Event|2|||
48710693|NCT01976741|156791345|FG003|Overall Study|Adverse Event|0|||
48710694|NCT01976741|156791346|FG004|Overall Study|Adverse Event|0|||
48710695|NCT01976741|156791347|FG005|Overall Study|Adverse Event|0|||
48710696|NCT01976741|156791348|FG006|Overall Study|Adverse Event|3|||
48710697|NCT01976741|156791349|FG007|Overall Study|Adverse Event|8|||
48710698|NCT01976741|156791350|FG008|Overall Study|Adverse Event|1|||
48710699|NCT01976741|156791351|FG009|Overall Study|Adverse Event|4|||
48710700|NCT03052426|156791352|FG000|Overall Study|Withdrawal by Subject|0|||
48710701|NCT03052426|156791353|FG001|Overall Study|Withdrawal by Subject|1|||
48710702|NCT03052426|156791354|FG002|Overall Study|Withdrawal by Subject|0|||
48710703|NCT03052426|156791352|FG000|Overall Study|Lost to Follow-up|2|||
48710704|NCT03052426|156791353|FG001|Overall Study|Lost to Follow-up|0|||
48710705|NCT03052426|156791354|FG002|Overall Study|Lost to Follow-up|1|||
48710706|NCT00775593|156791357|FG000|Overall Study|Unmet eligibility criteria|6|||
48710707|NCT00775593|156791357|FG000|Overall Study|Death|1|||
48710708|NCT02067676|156791358|FG000|Overall Study|Withdrawal by Subject|1|||
48710709|NCT02067676|156791359|FG001|Overall Study|Withdrawal by Subject|0|||
48710710|NCT02067676|156791360|FG002|Overall Study|Withdrawal by Subject|0|||
48710711|NCT02067676|156791361|FG003|Overall Study|Withdrawal by Subject|0|||
48710712|NCT02067676|156791362|FG004|Overall Study|Withdrawal by Subject|0|||
48710713|NCT02067676|156791363|FG005|Overall Study|Withdrawal by Subject|0|||
48710714|NCT02100696|156791365|FG000|Induction Phase|Adverse Event|0|||
48710715|NCT02100696|156791366|FG001|Induction Phase|Adverse Event|0|||
48710716|NCT02100696|156791367|FG002|Induction Phase|Adverse Event|1|||
48710717|NCT02100696|156791368|FG003|Induction Phase|Adverse Event|0|||
48710718|NCT02100696|156791369|FG004|Induction Phase|Adverse Event|0|||
48710719|NCT02100696|156791370|FG005|Induction Phase|Adverse Event|0|||
48710720|NCT02100696|156791365|FG000|Induction Phase|Lost to Follow-up|1|||
48710721|NCT02100696|156791366|FG001|Induction Phase|Lost to Follow-up|0|||
48710722|NCT02100696|156791367|FG002|Induction Phase|Lost to Follow-up|1|||
48710723|NCT02100696|156791368|FG003|Induction Phase|Lost to Follow-up|0|||
48710724|NCT02100696|156791369|FG004|Induction Phase|Lost to Follow-up|0|||
48710725|NCT02100696|156791370|FG005|Induction Phase|Lost to Follow-up|0|||
48710726|NCT02100696|156791365|FG000|Induction Phase|Protocol Violation|0|||
48710727|NCT02100696|156791366|FG001|Induction Phase|Protocol Violation|1|||
48710728|NCT02100696|156791367|FG002|Induction Phase|Protocol Violation|1|||
48710729|NCT02100696|156791368|FG003|Induction Phase|Protocol Violation|0|||
48710730|NCT02100696|156791369|FG004|Induction Phase|Protocol Violation|0|||
48710731|NCT02100696|156791370|FG005|Induction Phase|Protocol Violation|0|||
48710732|NCT02100696|156791365|FG000|Induction Phase|Withdrawal by Subject|8|||
48710733|NCT02100696|156791366|FG001|Induction Phase|Withdrawal by Subject|2|||
48710734|NCT02100696|156791367|FG002|Induction Phase|Withdrawal by Subject|13|||
48710735|NCT02100696|156791368|FG003|Induction Phase|Withdrawal by Subject|0|||
48710736|NCT02100696|156791369|FG004|Induction Phase|Withdrawal by Subject|0|||
48710737|NCT02100696|156791370|FG005|Induction Phase|Withdrawal by Subject|0|||
48710738|NCT02100696|156791365|FG000|Induction Phase|Physician Decision|1|||
48710739|NCT02100696|156791366|FG001|Induction Phase|Physician Decision|0|||
48710740|NCT02100696|156791367|FG002|Induction Phase|Physician Decision|2|||
48710741|NCT02100696|156791368|FG003|Induction Phase|Physician Decision|0|||
48710742|NCT02100696|156791369|FG004|Induction Phase|Physician Decision|0|||
48710743|NCT02100696|156791370|FG005|Induction Phase|Physician Decision|0|||
48710744|NCT02100696|156791365|FG000|Induction Phase|Multiple Reasons|5|||
48710745|NCT02100696|156791366|FG001|Induction Phase|Multiple Reasons|2|||
48710746|NCT02100696|156791367|FG002|Induction Phase|Multiple Reasons|8|||
48710747|NCT02100696|156791368|FG003|Induction Phase|Multiple Reasons|0|||
48710748|NCT02100696|156791369|FG004|Induction Phase|Multiple Reasons|0|||
48710749|NCT02100696|156791370|FG005|Induction Phase|Multiple Reasons|0|||
48710750|NCT02100696|156791365|FG000|Maintenance Phase|Adverse Event|0|||
48710751|NCT02100696|156791366|FG001|Maintenance Phase|Adverse Event|0|||
48710752|NCT02100696|156791367|FG002|Maintenance Phase|Adverse Event|0|||
48710753|NCT02100696|156791368|FG003|Maintenance Phase|Adverse Event|0|||
48710754|NCT02100696|156791369|FG004|Maintenance Phase|Adverse Event|0|||
48710755|NCT02100696|156791370|FG005|Maintenance Phase|Adverse Event|2|||
48710756|NCT02100696|156791365|FG000|Maintenance Phase|Lost to Follow-up|0|||
48710757|NCT02100696|156791366|FG001|Maintenance Phase|Lost to Follow-up|0|||
48710758|NCT02100696|156791367|FG002|Maintenance Phase|Lost to Follow-up|0|||
48710759|NCT02100696|156791368|FG003|Maintenance Phase|Lost to Follow-up|0|||
48710760|NCT02100696|156791369|FG004|Maintenance Phase|Lost to Follow-up|1|||
48807764|NCT04035486|157136682|FG002|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|197|||
48807765|NCT04035486|157136683|FG003|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|191|||
48807766|NCT04035486|157136680|FG000|Overall Study|Death|6|||
48807767|NCT04035486|157136681|FG001|Overall Study|Death|3|||
48807768|NCT04035486|157136682|FG002|Overall Study|Death|70|||
48807769|NCT04035486|157136683|FG003|Overall Study|Death|77|||
48807770|NCT04035486|157136680|FG000|Overall Study|Screen Failure|0|||
48807771|NCT04035486|157136681|FG001|Overall Study|Screen Failure|0|||
48807772|NCT04035486|157136682|FG002|Overall Study|Screen Failure|1|||
49120422|NCT03498313|158280479|FG002|Washout Period 2|Withdrawal by Subject|0|||
49120423|NCT03498313|158280480|FG003|Washout Period 2|Withdrawal by Subject|0|||
49120424|NCT03498313|158280481|FG004|Washout Period 2|Withdrawal by Subject|2|||
48710761|NCT02100696|156791370|FG005|Maintenance Phase|Lost to Follow-up|0|||
48710762|NCT02100696|156791365|FG000|Maintenance Phase|Protocol Violation|0|||
48710763|NCT02100696|156791366|FG001|Maintenance Phase|Protocol Violation|0|||
48710764|NCT02100696|156791367|FG002|Maintenance Phase|Protocol Violation|0|||
48710765|NCT02100696|156791368|FG003|Maintenance Phase|Protocol Violation|0|||
48710766|NCT02100696|156791369|FG004|Maintenance Phase|Protocol Violation|1|||
48710767|NCT02100696|156791370|FG005|Maintenance Phase|Protocol Violation|0|||
48710768|NCT02100696|156791365|FG000|Maintenance Phase|Withdrawal by Subject|0|||
48710769|NCT02100696|156791366|FG001|Maintenance Phase|Withdrawal by Subject|0|||
48710770|NCT02100696|156791367|FG002|Maintenance Phase|Withdrawal by Subject|0|||
48807773|NCT04035486|157136683|FG003|Overall Study|Screen Failure|1|||
48807774|NCT04035486|157136680|FG000|Overall Study|Withdrawal by Subject|1|||
48807775|NCT04035486|157136681|FG001|Overall Study|Withdrawal by Subject|1|||
48807776|NCT04035486|157136682|FG002|Overall Study|Withdrawal by Subject|11|||
48807777|NCT04035486|157136683|FG003|Overall Study|Withdrawal by Subject|9|||
48807778|NCT04006925|157136684|FG000|Overall Study|Side effects|2|||
48807779|NCT04006925|157136685|FG001|Overall Study|Side effects|0|||
48917415|NCT00928889|157534038|FG001|Overall Study|Protocol Violation|1|||
48917416|NCT00928889|157534037|FG000|Overall Study|Adverse Event|1|||
48917417|NCT00928889|157534038|FG001|Overall Study|Adverse Event|0|||
48917418|NCT00928889|157534037|FG000|Overall Study|Other|1|||
48917419|NCT00928889|157534038|FG001|Overall Study|Other|0|||
48917420|NCT00632099|157534039|FG000|Overall Study|Lost to Follow-up|3|||
48917421|NCT00632099|157534040|FG001|Overall Study|Lost to Follow-up|3|||
48917422|NCT00530270|157534041|FG000|Overall Study|Protocol Violation|1|||
48917423|NCT00530270|157534042|FG001|Overall Study|Protocol Violation|0|||
48917424|NCT02004262|157534046|FG000|Overall Study|Death|67|||
48917425|NCT02004262|157534047|FG001|Overall Study|Death|64|||
48917426|NCT02004262|157534048|FG002|Overall Study|Death|66|||
48917427|NCT02004262|157534049|FG003|Overall Study|Death|28|||
49120425|NCT03498313|158280482|FG005|Washout Period 2|Withdrawal by Subject|0|||
49120426|NCT03498313|158280477|FG000|Washout Period 2|Anovulation|0|||
49120427|NCT03498313|158280478|FG001|Washout Period 2|Anovulation|0|||
49120428|NCT03498313|158280479|FG002|Washout Period 2|Anovulation|0|||
49120429|NCT03498313|158280480|FG003|Washout Period 2|Anovulation|0|||
49120430|NCT03498313|158280481|FG004|Washout Period 2|Anovulation|0|||
49120431|NCT03498313|158280482|FG005|Washout Period 2|Anovulation|1|||
49120432|NCT00522548|158280486|FG000|Overall Study|Adverse Event|2|||
49120433|NCT00522548|158280487|FG001|Overall Study|Adverse Event|2|||
49120434|NCT00522548|158280486|FG000|Overall Study|Withdrawal by Subject|0|||
49120435|NCT00522548|158280487|FG001|Overall Study|Withdrawal by Subject|2|||
49120436|NCT02035553|158280492|FG000|Overall Study|Death (See All-Cause Mortality Table)|0|||
49120437|NCT02035553|158280493|FG001|Overall Study|Death (See All-Cause Mortality Table)|1|||
49120438|NCT02035553|158280492|FG000|Overall Study|Adverse Event|10|||
49120439|NCT02035553|158280493|FG001|Overall Study|Adverse Event|6|||
49120440|NCT02035553|158280492|FG000|Overall Study|Physician Decision|3|||
49120441|NCT02035553|158280493|FG001|Overall Study|Physician Decision|2|||
49120442|NCT02035553|158280492|FG000|Overall Study|Lack of Efficacy|1|||
49120443|NCT02035553|158280493|FG001|Overall Study|Lack of Efficacy|1|||
49120444|NCT02035553|158280492|FG000|Overall Study|Withdrawal by Subject|4|||
49120445|NCT02035553|158280493|FG001|Overall Study|Withdrawal by Subject|7|||
49120446|NCT02035553|158280492|FG000|Overall Study|Non-compliance with Study Drug|0|||
49120447|NCT02035553|158280493|FG001|Overall Study|Non-compliance with Study Drug|1|||
48807780|NCT01598298|157136690|FG000|Overall Study|Not eligible|5|||
48807781|NCT01598298|157136691|FG001|Overall Study|Not eligible|5|||
48807782|NCT01598298|157136690|FG000|Overall Study|Adverse Event|21|||
49120448|NCT02035553|158280492|FG000|Overall Study|Lost to Follow-up|0|||
49120449|NCT02035553|158280493|FG001|Overall Study|Lost to Follow-up|1|||
49120450|NCT02035553|158280492|FG000|Overall Study|Other Reason|0|||
49120451|NCT02035553|158280493|FG001|Overall Study|Other Reason|4|||
48710771|NCT02100696|156791368|FG003|Maintenance Phase|Withdrawal by Subject|1|||
48917428|NCT02004262|157534050|FG004|Overall Study|Death|29|||
48917429|NCT02004262|157534051|FG005|Overall Study|Death|22|||
48807783|NCT01598298|157136691|FG001|Overall Study|Adverse Event|19|||
48917430|NCT02004262|157534046|FG000|Overall Study|Withdrawal by Subject|1|||
49120452|NCT00169104|158280494|FG000|Overall Study|Withdrawal by Subject|2|||
48807784|NCT01598298|157136690|FG000|Overall Study|Progression/relapse|0|||
48807785|NCT01598298|157136691|FG001|Overall Study|Progression/relapse|2|||
48807786|NCT01598298|157136690|FG000|Overall Study|Withdrawal by Subject|10|||
48807787|NCT01598298|157136691|FG001|Overall Study|Withdrawal by Subject|15|||
48917431|NCT02004262|157534047|FG001|Overall Study|Withdrawal by Subject|0|||
48917432|NCT02004262|157534048|FG002|Overall Study|Withdrawal by Subject|4|||
48917433|NCT02004262|157534049|FG003|Overall Study|Withdrawal by Subject|0|||
48917434|NCT02004262|157534050|FG004|Overall Study|Withdrawal by Subject|1|||
48917435|NCT02004262|157534051|FG005|Overall Study|Withdrawal by Subject|3|||
48917436|NCT02004262|157534046|FG000|Overall Study|Lost to Follow-up|1|||
48917437|NCT02004262|157534047|FG001|Overall Study|Lost to Follow-up|1|||
48917438|NCT02004262|157534048|FG002|Overall Study|Lost to Follow-up|0|||
48917439|NCT02004262|157534049|FG003|Overall Study|Lost to Follow-up|0|||
48917440|NCT02004262|157534050|FG004|Overall Study|Lost to Follow-up|0|||
48917441|NCT02004262|157534051|FG005|Overall Study|Lost to Follow-up|0|||
48917442|NCT02004262|157534046|FG000|Overall Study|Study Terminated by Sponsor|4|||
48917443|NCT02004262|157534047|FG001|Overall Study|Study Terminated by Sponsor|3|||
48917444|NCT02004262|157534048|FG002|Overall Study|Study Terminated by Sponsor|2|||
48917445|NCT02004262|157534049|FG003|Overall Study|Study Terminated by Sponsor|1|||
48917446|NCT02004262|157534050|FG004|Overall Study|Study Terminated by Sponsor|1|||
48917447|NCT02004262|157534051|FG005|Overall Study|Study Terminated by Sponsor|5|||
48917448|NCT03703102|157534052|FG000|Overall Study|Adverse Event|4|||
48807788|NCT01598298|157136690|FG000|Overall Study|Other reason (not protocol specified)|4|||
48807789|NCT01598298|157136691|FG001|Overall Study|Other reason (not protocol specified)|0|||
48807790|NCT00803101|157138112|FG000|Overall Study|Death / Serious Adverse Event|4|||
48807791|NCT00803101|157138113|FG001|Overall Study|Death / Serious Adverse Event|6|||
48807792|NCT00803101|157138112|FG000|Overall Study|Withdrawal by Subject|6|||
48807793|NCT00803101|157138113|FG001|Overall Study|Withdrawal by Subject|4|||
48807794|NCT00803101|157138112|FG000|Overall Study|Lost to Follow-up|2|||
48807795|NCT00803101|157138113|FG001|Overall Study|Lost to Follow-up|2|||
48807796|NCT00803101|157138112|FG000|Overall Study|Protocol Violation|1|||
48807797|NCT00803101|157138113|FG001|Overall Study|Protocol Violation|7|||
48807798|NCT00803101|157138112|FG000|Overall Study|Surgery finished outside protocol window|1|||
48807799|NCT00803101|157138113|FG001|Overall Study|Surgery finished outside protocol window|1|||
48807800|NCT00803101|157138112|FG000|Overall Study|Patient died outside SAE report period|1|||
48917449|NCT03703102|157534053|FG001|Overall Study|Adverse Event|3|||
48917450|NCT03703102|157534054|FG002|Overall Study|Adverse Event|7|||
48917451|NCT03703102|157534055|FG003|Overall Study|Adverse Event|3|||
49120453|NCT00169104|158280495|FG001|Overall Study|Withdrawal by Subject|0|||
49120454|NCT00169104|158280494|FG000|Overall Study|Protocol Violation|0|||
48710772|NCT02100696|156791369|FG004|Maintenance Phase|Withdrawal by Subject|4|||
49120455|NCT00169104|158280495|FG001|Overall Study|Protocol Violation|1|||
49120456|NCT00169104|158280494|FG000|Overall Study|Physician Decision|0|||
48710773|NCT02100696|156791370|FG005|Maintenance Phase|Withdrawal by Subject|2|||
48710774|NCT02100696|156791365|FG000|Maintenance Phase|Physician Decision|0|||
48710775|NCT02100696|156791366|FG001|Maintenance Phase|Physician Decision|0|||
48710776|NCT02100696|156791367|FG002|Maintenance Phase|Physician Decision|0|||
48710777|NCT02100696|156791368|FG003|Maintenance Phase|Physician Decision|0|||
48710778|NCT02100696|156791369|FG004|Maintenance Phase|Physician Decision|1|||
48710779|NCT02100696|156791370|FG005|Maintenance Phase|Physician Decision|0|||
48710780|NCT02100696|156791365|FG000|Maintenance Phase|Multiple Reasons|0|||
48710781|NCT02100696|156791366|FG001|Maintenance Phase|Multiple Reasons|0|||
48710782|NCT02100696|156791367|FG002|Maintenance Phase|Multiple Reasons|0|||
48710783|NCT02100696|156791368|FG003|Maintenance Phase|Multiple Reasons|0|||
48710784|NCT02100696|156791369|FG004|Maintenance Phase|Multiple Reasons|2|||
48710785|NCT02100696|156791370|FG005|Maintenance Phase|Multiple Reasons|1|||
48710786|NCT03865381|156791371|FG000|Overall Study|Protocol Violation/Non-Compliance|3|||
48710787|NCT03865381|156791371|FG000|Overall Study|Withdrawal by Subject|2|||
48710788|NCT02424578|156791372|FG000|Overall Study|Withdrawal by Subject|0|||
48807801|NCT00803101|157138113|FG001|Overall Study|Patient died outside SAE report period|0|||
48807802|NCT00803101|157138112|FG000|Overall Study|Patient did not attend scheduled visit|2|||
48807803|NCT00803101|157138113|FG001|Overall Study|Patient did not attend scheduled visit|1|||
48807804|NCT00803101|157138112|FG000|Overall Study|Patient did not have surgery|1|||
48807805|NCT00803101|157138113|FG001|Overall Study|Patient did not have surgery|1|||
48807806|NCT01106430|157138118|FG000|Overall Study|Adverse Event|8|||
48917452|NCT03703102|157534056|FG004|Overall Study|Adverse Event|13|||
48917453|NCT03703102|157534052|FG000|Overall Study|Lack of Efficacy|4|||
48917454|NCT03703102|157534053|FG001|Overall Study|Lack of Efficacy|0|||
48917455|NCT03703102|157534054|FG002|Overall Study|Lack of Efficacy|1|||
48917456|NCT03703102|157534055|FG003|Overall Study|Lack of Efficacy|4|||
48917457|NCT03703102|157534056|FG004|Overall Study|Lack of Efficacy|1|||
48710789|NCT02424578|156791373|FG001|Overall Study|Withdrawal by Subject|1|||
48917458|NCT03703102|157534052|FG000|Overall Study|Lost to Follow-up|0|||
48917459|NCT03703102|157534053|FG001|Overall Study|Lost to Follow-up|0|||
49120457|NCT00169104|158280495|FG001|Overall Study|Physician Decision|1|||
48710790|NCT01063283|156791377|FG000|Cycle 1|Adverse Event|2|||
48917460|NCT03703102|157534054|FG002|Overall Study|Lost to Follow-up|1|||
48917461|NCT03703102|157534055|FG003|Overall Study|Lost to Follow-up|2|||
48917462|NCT03703102|157534056|FG004|Overall Study|Lost to Follow-up|2|||
48917463|NCT03703102|157534052|FG000|Overall Study|Physician Decision|2|||
48917464|NCT03703102|157534053|FG001|Overall Study|Physician Decision|2|||
48917465|NCT03703102|157534054|FG002|Overall Study|Physician Decision|2|||
48917466|NCT03703102|157534055|FG003|Overall Study|Physician Decision|2|||
48917467|NCT03703102|157534056|FG004|Overall Study|Physician Decision|4|||
48917468|NCT03703102|157534052|FG000|Overall Study|Withdrawal by Subject|7|||
48917469|NCT03703102|157534053|FG001|Overall Study|Withdrawal by Subject|5|||
48917470|NCT03703102|157534054|FG002|Overall Study|Withdrawal by Subject|5|||
48917471|NCT03703102|157534055|FG003|Overall Study|Withdrawal by Subject|5|||
48917472|NCT03703102|157534056|FG004|Overall Study|Withdrawal by Subject|9|||
48917473|NCT03703102|157534052|FG000|Overall Study|Ineligibility|0|||
48917474|NCT03703102|157534053|FG001|Overall Study|Ineligibility|0|||
48917475|NCT03703102|157534054|FG002|Overall Study|Ineligibility|1|||
48917476|NCT03703102|157534055|FG003|Overall Study|Ineligibility|0|||
48917477|NCT03703102|157534056|FG004|Overall Study|Ineligibility|0|||
48917478|NCT03703102|157534052|FG000|Overall Study|Protocol Deviation|4|||
48917479|NCT03703102|157534053|FG001|Overall Study|Protocol Deviation|4|||
48917480|NCT03703102|157534054|FG002|Overall Study|Protocol Deviation|3|||
48917481|NCT03703102|157534055|FG003|Overall Study|Protocol Deviation|0|||
48917482|NCT03703102|157534056|FG004|Overall Study|Protocol Deviation|0|||
48917483|NCT03703102|157534052|FG000|Overall Study|Non-Compliance with Study Drug|1|||
48917484|NCT03703102|157534053|FG001|Overall Study|Non-Compliance with Study Drug|1|||
48917485|NCT03703102|157534054|FG002|Overall Study|Non-Compliance with Study Drug|2|||
48917486|NCT03703102|157534055|FG003|Overall Study|Non-Compliance with Study Drug|1|||
48917487|NCT03703102|157534056|FG004|Overall Study|Non-Compliance with Study Drug|4|||
48917488|NCT01356407|157534057|FG000|Overall Study|Lost to Follow-up|2|||
48917489|NCT01356407|157534058|FG001|Overall Study|Lost to Follow-up|0|||
48917490|NCT01356407|157534057|FG000|Overall Study|Patient Withdrew Consent|2|||
48917491|NCT01356407|157534058|FG001|Overall Study|Patient Withdrew Consent|1|||
48917492|NCT01356407|157534057|FG000|Overall Study|Could not afford IMP administration|0|||
48917493|NCT01356407|157534058|FG001|Overall Study|Could not afford IMP administration|1|||
48917494|NCT01356407|157534057|FG000|Overall Study|Not complete Endoscopy|2|||
48917495|NCT01356407|157534058|FG001|Overall Study|Not complete Endoscopy|2|||
48710791|NCT01063283|156791378|FG001|Cycle 1|Adverse Event|0|||
48710792|NCT01063283|156791379|FG002|Cycle 1|Adverse Event|0|||
48710793|NCT01063283|156791377|FG000|Cycle 1|Technical failure in data collection|1|||
48710794|NCT01063283|156791378|FG001|Cycle 1|Technical failure in data collection|0|||
48710795|NCT01063283|156791379|FG002|Cycle 1|Technical failure in data collection|0|||
48710796|NCT01120717|156791380|FG000|Overall Study|Withdrawal by Subject|11|||
48710797|NCT01120717|156791381|FG001|Overall Study|Withdrawal by Subject|6|||
48710798|NCT01120717|156791380|FG000|Overall Study|Adverse Event|10|||
48710799|NCT01120717|156791381|FG001|Overall Study|Adverse Event|6|||
48710800|NCT01120717|156791380|FG000|Overall Study|Protocol Deviation|2|||
48710801|NCT01120717|156791381|FG001|Overall Study|Protocol Deviation|5|||
48710802|NCT01120717|156791380|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
48710803|NCT01120717|156791381|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
48710804|NCT01120717|156791380|FG000|Overall Study|Lost to Follow-up|2|||
48710805|NCT01120717|156791381|FG001|Overall Study|Lost to Follow-up|3|||
48710806|NCT01120717|156791380|FG000|Overall Study|Death|3|||
48710807|NCT01120717|156791381|FG001|Overall Study|Death|1|||
48710808|NCT01120717|156791380|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
48710809|NCT01120717|156791381|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
48710810|NCT00865280|156791382|FG000|Overall Study|Withdrawal by Subject|4|||
48710811|NCT00865280|156791383|FG001|Overall Study|Withdrawal by Subject|1|||
48710812|NCT00865280|156791382|FG000|Overall Study|End of Treatment/Lost to Follow-up|0|||
48710813|NCT00865280|156791383|FG001|Overall Study|End of Treatment/Lost to Follow-up|1|||
48710814|NCT00865280|156791382|FG000|Overall Study|Adverse Event/Lost to Follow-up|1|||
48710815|NCT00865280|156791383|FG001|Overall Study|Adverse Event/Lost to Follow-up|0|||
48710816|NCT00865280|156791382|FG000|Overall Study|Exclusion Condition|1|||
48710817|NCT00865280|156791383|FG001|Overall Study|Exclusion Condition|0|||
48710818|NCT00865280|156791382|FG000|Overall Study|Adverse Event|0|||
48710819|NCT00865280|156791383|FG001|Overall Study|Adverse Event|1|||
48710820|NCT00948441|156791384|FG000|Overall Study|no longer meet inclusion criteria|1|||
48710821|NCT00948441|156791385|FG001|Overall Study|no longer meet inclusion criteria|4|||
48710822|NCT01134705|156791392|FG000|Overall Study|Adverse Event|1|||
48710823|NCT01134705|156791393|FG001|Overall Study|Adverse Event|7|||
48710824|NCT01134705|156791392|FG000|Overall Study|Withdrawal by Subject|6|||
48710825|NCT01134705|156791393|FG001|Overall Study|Withdrawal by Subject|6|||
48710826|NCT01134705|156791392|FG000|Overall Study|Pregnancy|1|||
48917496|NCT03201458|157534065|FG000|Overall Study|No longer eligible|2|||
48710827|NCT01134705|156791393|FG001|Overall Study|Pregnancy|0|||
48710828|NCT01134705|156791392|FG000|Overall Study|Lost to Follow-up|5|||
48710829|NCT01134705|156791393|FG001|Overall Study|Lost to Follow-up|2|||
48917497|NCT03201458|157534066|FG001|Overall Study|No longer eligible|5|||
48917498|NCT03201458|157534065|FG000|Overall Study|Health event before starting|1|||
48917499|NCT03201458|157534066|FG001|Overall Study|Health event before starting|0|||
48917500|NCT03201458|157534065|FG000|Overall Study|Physician Decision|1|||
48917501|NCT03201458|157534066|FG001|Overall Study|Physician Decision|0|||
48917502|NCT03962101|157534071|FG000|Overall Study|Adverse Event|1|||
48917503|NCT03962101|157534071|FG000|Overall Study|Physician Decision|2|||
48917504|NCT03962101|157534071|FG000|Overall Study|Not related to medical events|1|||
49120458|NCT01854697|158280496|FG000|Overall Study|Adverse Event|1|||
49120459|NCT01854697|158280497|FG001|Overall Study|Adverse Event|0|||
49120460|NCT01854697|158280498|FG002|Overall Study|Adverse Event|0|||
49120461|NCT01854697|158280499|FG003|Overall Study|Adverse Event|0|||
49120462|NCT01854697|158280500|FG004|Overall Study|Adverse Event|1|||
49120463|NCT01854697|158280496|FG000|Overall Study|Lost to Follow-up|4|||
49120464|NCT01854697|158280497|FG001|Overall Study|Lost to Follow-up|1|||
49120465|NCT01854697|158280498|FG002|Overall Study|Lost to Follow-up|1|||
49120466|NCT01854697|158280499|FG003|Overall Study|Lost to Follow-up|2|||
49120467|NCT01854697|158280500|FG004|Overall Study|Lost to Follow-up|0|||
49120468|NCT01854697|158280496|FG000|Overall Study|To enter another AbbVie study|1|||
49120469|NCT01854697|158280497|FG001|Overall Study|To enter another AbbVie study|0|||
49120470|NCT01854697|158280498|FG002|Overall Study|To enter another AbbVie study|0|||
49120471|NCT01854697|158280499|FG003|Overall Study|To enter another AbbVie study|0|||
49120472|NCT01854697|158280500|FG004|Overall Study|To enter another AbbVie study|1|||
49120473|NCT01854697|158280496|FG000|Overall Study|Withdrew Consent|0|||
49120474|NCT01854697|158280497|FG001|Overall Study|Withdrew Consent|1|||
49120475|NCT01854697|158280498|FG002|Overall Study|Withdrew Consent|0|||
49120476|NCT01854697|158280499|FG003|Overall Study|Withdrew Consent|1|||
49120477|NCT01854697|158280500|FG004|Overall Study|Withdrew Consent|0|||
49120478|NCT01854697|158280496|FG000|Overall Study|Other|0|||
48710830|NCT01134705|156791392|FG000|Overall Study|Protocol Violation|1|||
48710831|NCT01134705|156791393|FG001|Overall Study|Protocol Violation|1|||
48710832|NCT01134705|156791392|FG000|Overall Study|Other|1|||
49120479|NCT01854697|158280497|FG001|Overall Study|Other|1|||
49120480|NCT01854697|158280498|FG002|Overall Study|Other|1|||
49120481|NCT01854697|158280499|FG003|Overall Study|Other|0|||
48710833|NCT01134705|156791393|FG001|Overall Study|Other|6|||
48710834|NCT01324401|156791396|FG000|Overall Study|Withdrawn before any treatment|0|||
48710835|NCT01324401|156791397|FG001|Overall Study|Withdrawn before any treatment|3|||
48710836|NCT01324401|156791396|FG000|Overall Study|Adverse Event|1|||
48710837|NCT01324401|156791397|FG001|Overall Study|Adverse Event|3|||
48710838|NCT01708902|156791398|FG000|Overall Study|Adverse Event|3|||
48710839|NCT01708902|156791399|FG001|Overall Study|Adverse Event|4|||
48710840|NCT01708902|156791400|FG002|Overall Study|Adverse Event|9|||
48710841|NCT01708902|156791401|FG003|Overall Study|Adverse Event|2|||
48710842|NCT01708902|156791402|FG004|Overall Study|Adverse Event|7|||
48710843|NCT01708902|156791403|FG005|Overall Study|Adverse Event|3|||
48710844|NCT01708902|156791404|FG006|Overall Study|Adverse Event|5|||
48710845|NCT01708902|156791398|FG000|Overall Study|Lack of Efficacy|3|||
48917505|NCT00930761|157534072|FG000|Overall Study|3 newborns died; 1 mother quit the study|4|||
49120482|NCT01854697|158280500|FG004|Overall Study|Other|0|||
49120483|NCT01178125|158280504|FG000|Overall Study|Lost to Follow-up|397|||
48710846|NCT01708902|156791399|FG001|Overall Study|Lack of Efficacy|1|||
48917506|NCT00930761|157534073|FG001|Overall Study|3 newborns died; 1 mother quit the study|0|||
48917507|NCT00930761|157534072|FG000|Overall Study|less than 3 music therapy sessions|0|||
48917508|NCT00930761|157534073|FG001|Overall Study|less than 3 music therapy sessions|3|||
48917509|NCT00271596|157534077|FG000|Overall Study|Protocol Violation|1|||
48917510|NCT00271596|157534078|FG001|Overall Study|Protocol Violation|0|||
48917511|NCT00271596|157534077|FG000|Overall Study|Withdrawal by Subject|0|||
48807807|NCT01106430|157138119|FG001|Overall Study|Adverse Event|10|||
48807808|NCT01106430|157138118|FG000|Overall Study|Lack of Efficacy|2|||
48807809|NCT01106430|157138119|FG001|Overall Study|Lack of Efficacy|13|||
48807810|NCT01106430|157138118|FG000|Overall Study|Lost to Follow-up|5|||
48917512|NCT00271596|157534078|FG001|Overall Study|Withdrawal by Subject|1|||
48917513|NCT00794677|157534084|FG000|First Intervention|Withdrawal by Subject|2|||
48807811|NCT01106430|157138119|FG001|Overall Study|Lost to Follow-up|1|||
48807812|NCT01106430|157138118|FG000|Overall Study|Early Termination Requested By Sponsor|1|||
48807813|NCT01106430|157138119|FG001|Overall Study|Early Termination Requested By Sponsor|0|||
48917514|NCT00794677|157534085|FG001|First Intervention|Withdrawal by Subject|0|||
48917515|NCT02290873|157534086|FG000|Overall Study|Withdrawal by Subject|0|||
48917516|NCT02290873|157534087|FG001|Overall Study|Withdrawal by Subject|1|||
48917517|NCT02290873|157534088|FG002|Overall Study|Withdrawal by Subject|1|||
48917518|NCT02290873|157534086|FG000|Overall Study|Nellcor device error|1|||
48917519|NCT02290873|157534087|FG001|Overall Study|Nellcor device error|0|||
48917520|NCT02290873|157534088|FG002|Overall Study|Nellcor device error|0|||
48917521|NCT02290873|157534086|FG000|Overall Study|Esophagogastroduodenoscopy was added|1|||
48917522|NCT02290873|157534087|FG001|Overall Study|Esophagogastroduodenoscopy was added|0|||
48917523|NCT02290873|157534088|FG002|Overall Study|Esophagogastroduodenoscopy was added|0|||
48917524|NCT02290873|157534086|FG000|Overall Study|Protocol Violation|0|||
48917525|NCT02290873|157534087|FG001|Overall Study|Protocol Violation|0|||
48917526|NCT02290873|157534088|FG002|Overall Study|Protocol Violation|1|||
48917527|NCT01136655|157534089|FG000|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1|||
48917528|NCT01136655|157534089|FG000|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1|||
48917529|NCT01136655|157534089|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1|||
48917530|NCT01136655|157534089|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1|||
48917531|NCT02937818|157534090|FG000|Overall Study|Participants decision|2|||
48917532|NCT02937818|157534091|FG001|Overall Study|Participants decision|1|||
48917533|NCT02937818|157534092|FG002|Overall Study|Participants decision|1|||
48917534|NCT02937818|157534093|FG003|Overall Study|Participants decision|1|||
49120484|NCT01178125|158280504|FG000|Overall Study|Adverse Event|244|||
49120485|NCT01178125|158280504|FG000|Overall Study|Withdrawal by Subject|209|||
49120486|NCT01178125|158280504|FG000|Overall Study|Noncompliance|184|||
49120487|NCT01178125|158280504|FG000|Overall Study|Pregnancy|55|||
49120488|NCT01178125|158280504|FG000|Overall Study|Other Reason|39|||
49120489|NCT01178125|158280504|FG000|Overall Study|Sponsor Decision|28|||
49120490|NCT01178125|158280504|FG000|Overall Study|Protocol Violation|17|||
49120491|NCT01178125|158280504|FG000|Overall Study|Investigator Decision|5|||
48807814|NCT01106430|157138118|FG000|Overall Study|Moved Out Of State|0|||
48807815|NCT01106430|157138119|FG001|Overall Study|Moved Out Of State|1|||
48917535|NCT02937818|157534090|FG000|Overall Study|Adverse Event|2|||
48917536|NCT02937818|157534091|FG001|Overall Study|Adverse Event|4|||
48917537|NCT02937818|157534092|FG002|Overall Study|Adverse Event|1|||
48917538|NCT02937818|157534093|FG003|Overall Study|Adverse Event|1|||
48917539|NCT02937818|157534090|FG000|Overall Study|Disease progression|17|||
48917540|NCT02937818|157534091|FG001|Overall Study|Disease progression|15|||
48917541|NCT02937818|157534092|FG002|Overall Study|Disease progression|7|||
48917542|NCT02937818|157534093|FG003|Overall Study|Disease progression|19|||
48917543|NCT02937818|157534090|FG000|Overall Study|Condition under investigation worsened|0|||
48917544|NCT02937818|157534091|FG001|Overall Study|Condition under investigation worsened|0|||
48917545|NCT02937818|157534092|FG002|Overall Study|Condition under investigation worsened|1|||
49120492|NCT00715299|158280505|FG000|Overall Study|Withdrawal by Subject|1|||
48807816|NCT01106430|157138118|FG000|Overall Study|Refused To Take Medication|0|||
48807817|NCT01106430|157138119|FG001|Overall Study|Refused To Take Medication|1|||
48807818|NCT01106430|157138118|FG000|Overall Study|Noncompliance|0|||
48807819|NCT01106430|157138119|FG001|Overall Study|Noncompliance|1|||
48807820|NCT01106430|157138118|FG000|Overall Study|Hard Time Swallowing The Pills|1|||
48807821|NCT01106430|157138119|FG001|Overall Study|Hard Time Swallowing The Pills|0|||
48807822|NCT01106430|157138118|FG000|Overall Study|Previous Use Of Marijuana|1|||
48807823|NCT01106430|157138119|FG001|Overall Study|Previous Use Of Marijuana|0|||
48807824|NCT01106430|157138118|FG000|Overall Study|Protocol Violation|7|||
48807825|NCT01106430|157138119|FG001|Overall Study|Protocol Violation|2|||
48807826|NCT01106430|157138118|FG000|Overall Study|Withdrawal by Subject|8|||
48807827|NCT01106430|157138119|FG001|Overall Study|Withdrawal by Subject|4|||
48807828|NCT01289418|157138120|FG000|Day 8 Survey|email address invalid|283|||
48807829|NCT01289418|157138120|FG000|Day 8 Survey|participants did not complete the survey|1935|||
48807830|NCT01289418|157138120|FG000|Day 29 Survey|email address invalid|283|||
48807831|NCT01289418|157138120|FG000|Day 29 Survey|participants did not complete the survey|2185|||
48807832|NCT02276066|157138123|FG000|Overall Study|Lost to Follow-up|21|||
48807833|NCT02276066|157138124|FG001|Overall Study|Lost to Follow-up|11|||
48807834|NCT02567825|157138132|FG000|Overall Study|No follow-up post-randomization|5|||
48807835|NCT02567825|157138133|FG001|Overall Study|No follow-up post-randomization|1|||
48917546|NCT02937818|157534093|FG003|Overall Study|Condition under investigation worsened|0|||
48807836|NCT02567825|157138132|FG000|Overall Study|Follow-up less than 23 months|16|||
48807837|NCT02567825|157138133|FG001|Overall Study|Follow-up less than 23 months|20|||
48807838|NCT02424591|157138153|FG000|Overall Study|Protocol Violation|2|||
48807839|NCT02424591|157138154|FG001|Overall Study|Protocol Violation|3|||
48807840|NCT00954733|157138159|FG000|Overall Study|blood gas machine did not work|1|||
48807841|NCT01781390|157138160|FG000|Overall Study|Withdrawal of Consent|0|||
48807842|NCT01781390|157138161|FG001|Overall Study|Withdrawal of Consent|3|||
48807843|NCT01781390|157138162|FG002|Overall Study|Withdrawal of Consent|1|||
48807844|NCT01781390|157138160|FG000|Overall Study|Lost to Follow-up|1|||
48807845|NCT01781390|157138161|FG001|Overall Study|Lost to Follow-up|1|||
48807846|NCT01781390|157138162|FG002|Overall Study|Lost to Follow-up|1|||
48807847|NCT01781390|157138160|FG000|Overall Study|Adverse Event|1|||
48807848|NCT01781390|157138161|FG001|Overall Study|Adverse Event|2|||
48807849|NCT01781390|157138162|FG002|Overall Study|Adverse Event|1|||
48807850|NCT01781390|157138160|FG000|Overall Study|Participants who were Randomized and Not Treated|1|||
48807851|NCT01781390|157138161|FG001|Overall Study|Participants who were Randomized and Not Treated|1|||
48807852|NCT01781390|157138162|FG002|Overall Study|Participants who were Randomized and Not Treated|1|||
48807853|NCT01862796|157138165|FG000|Overall Study|Prohibited medications|0|||
49120493|NCT00715299|158280505|FG000|Overall Study|Adverse Event|3|||
48807854|NCT01862796|157138166|FG001|Overall Study|Prohibited medications|0|||
48807855|NCT01862796|157138167|FG002|Overall Study|Prohibited medications|1|||
48807856|NCT01462162|157138168|FG000|Overall Study|Adverse Event|5|||
48807857|NCT01462162|157138168|FG000|Overall Study|Lack of Efficacy|4|||
48807858|NCT01462162|157138168|FG000|Overall Study|Abnormal laboratory parameters|1|||
48807859|NCT01462162|157138168|FG000|Overall Study|Other|2|||
48807860|NCT02712398|157138198|FG000|Overall Study|Withdrawal by Subject|6|||
48807861|NCT02712398|157138198|FG000|Overall Study|Lost to Follow-up|6|||
48807862|NCT02712398|157138198|FG000|Overall Study|Sponsor Decision|1|||
48807863|NCT02712398|157138198|FG000|Overall Study|Physician Decision|1|||
48807864|NCT02712398|157138198|FG000|Overall Study|Death|2|||
48807865|NCT02712398|157138198|FG000|Overall Study|Re-operation|21|||
48917547|NCT02287623|157534096|FG000|Overall Study|Protocol Violation|0|||
48917548|NCT02287623|157534097|FG001|Overall Study|Protocol Violation|1|||
48917549|NCT02039375|157534104|FG000|Overall Study|Lost to Follow-up|2|||
48917550|NCT00917150|157534105|FG000|Overall Study|Adverse Event|12|||
49120494|NCT00715299|158280505|FG000|Overall Study|failed the pre-screen exercise test|2|||
49120495|NCT01004978|158280506|FG000|Overall Study|Disease progression|31|||
49120496|NCT01004978|158280507|FG001|Overall Study|Disease progression|48|||
49120497|NCT01004978|158280506|FG000|Overall Study|Adverse Event|42|||
49120498|NCT01004978|158280507|FG001|Overall Study|Adverse Event|22|||
49120499|NCT01004978|158280506|FG000|Overall Study|Death|3|||
48917551|NCT00917150|157534106|FG001|Overall Study|Adverse Event|7|||
49120500|NCT01004978|158280507|FG001|Overall Study|Death|2|||
49120501|NCT01004978|158280506|FG000|Overall Study|Withdrawal by Subject|16|||
49120502|NCT01004978|158280507|FG001|Overall Study|Withdrawal by Subject|16|||
49120503|NCT01004978|158280506|FG000|Overall Study|Alternative therapy|4|||
49120504|NCT01004978|158280507|FG001|Overall Study|Alternative therapy|8|||
49120505|NCT01004978|158280506|FG000|Overall Study|Physician Decision|6|||
49120506|NCT01004978|158280507|FG001|Overall Study|Physician Decision|3|||
48807866|NCT01735396|157138199|FG000|Overall Study|not evaluable|1|||
48807867|NCT03724396|157138200|FG000|Overall Study|Lost to Follow-up|1|||
48807868|NCT03724396|157138201|FG001|Overall Study|Lost to Follow-up|1|||
48807869|NCT03724396|157138200|FG000|Overall Study|Withdrawal by Subject|1|||
48807870|NCT03724396|157138201|FG001|Overall Study|Withdrawal by Subject|0|||
48917552|NCT00917150|157534107|FG002|Overall Study|Adverse Event|12|||
49120507|NCT01004978|158280506|FG000|Overall Study|Other complicating disease|2|||
49120508|NCT01004978|158280507|FG001|Overall Study|Other complicating disease|2|||
49120509|NCT01004978|158280506|FG000|Overall Study|Protocol Violation|2|||
49120510|NCT01004978|158280507|FG001|Overall Study|Protocol Violation|3|||
49120511|NCT01004978|158280506|FG000|Overall Study|Non-compliance|3|||
49120512|NCT01004978|158280507|FG001|Overall Study|Non-compliance|2|||
49120513|NCT01004978|158280506|FG000|Overall Study|Ineligible|1|||
49120514|NCT01004978|158280507|FG001|Overall Study|Ineligible|0|||
49120515|NCT01004978|158280506|FG000|Overall Study|Unblinded|0|||
49120516|NCT01004978|158280507|FG001|Overall Study|Unblinded|1|||
48710847|NCT01708902|156791400|FG002|Overall Study|Lack of Efficacy|0|||
48710848|NCT01708902|156791401|FG003|Overall Study|Lack of Efficacy|0|||
48710849|NCT01708902|156791402|FG004|Overall Study|Lack of Efficacy|0|||
48710850|NCT01708902|156791403|FG005|Overall Study|Lack of Efficacy|1|||
49120517|NCT01004978|158280506|FG000|Overall Study|Performance status worsening|0|||
49120518|NCT01004978|158280507|FG001|Overall Study|Performance status worsening|1|||
49120519|NCT01004978|158280506|FG000|Overall Study|Never started treatment|8|||
48710851|NCT01708902|156791404|FG006|Overall Study|Lack of Efficacy|0|||
48710852|NCT01708902|156791398|FG000|Overall Study|Non compliance with protocol|0|||
48710853|NCT01708902|156791399|FG001|Overall Study|Non compliance with protocol|2|||
48710854|NCT01708902|156791400|FG002|Overall Study|Non compliance with protocol|1|||
48710855|NCT01708902|156791401|FG003|Overall Study|Non compliance with protocol|3|||
48710856|NCT01708902|156791402|FG004|Overall Study|Non compliance with protocol|0|||
48710857|NCT01708902|156791403|FG005|Overall Study|Non compliance with protocol|0|||
48710858|NCT01708902|156791404|FG006|Overall Study|Non compliance with protocol|0|||
48710859|NCT01708902|156791398|FG000|Overall Study|Lost to Follow-up|2|||
48710860|NCT01708902|156791399|FG001|Overall Study|Lost to Follow-up|1|||
48710861|NCT01708902|156791400|FG002|Overall Study|Lost to Follow-up|2|||
48710862|NCT01708902|156791401|FG003|Overall Study|Lost to Follow-up|2|||
48710863|NCT01708902|156791402|FG004|Overall Study|Lost to Follow-up|0|||
48710864|NCT01708902|156791403|FG005|Overall Study|Lost to Follow-up|0|||
48710865|NCT01708902|156791404|FG006|Overall Study|Lost to Follow-up|1|||
48710866|NCT01708902|156791398|FG000|Overall Study|Refused to continue trial medication|8|||
48710867|NCT01708902|156791399|FG001|Overall Study|Refused to continue trial medication|0|||
48710868|NCT01708902|156791400|FG002|Overall Study|Refused to continue trial medication|4|||
48710869|NCT01708902|156791401|FG003|Overall Study|Refused to continue trial medication|2|||
48710870|NCT01708902|156791402|FG004|Overall Study|Refused to continue trial medication|8|||
48710871|NCT01708902|156791403|FG005|Overall Study|Refused to continue trial medication|1|||
48710872|NCT01708902|156791404|FG006|Overall Study|Refused to continue trial medication|1|||
48710873|NCT01708902|156791398|FG000|Overall Study|Other Reason|1|||
48710874|NCT01708902|156791399|FG001|Overall Study|Other Reason|0|||
48710875|NCT01708902|156791400|FG002|Overall Study|Other Reason|1|||
48710876|NCT01708902|156791401|FG003|Overall Study|Other Reason|1|||
48710877|NCT01708902|156791402|FG004|Overall Study|Other Reason|1|||
48710878|NCT01708902|156791403|FG005|Overall Study|Other Reason|2|||
48710879|NCT01708902|156791404|FG006|Overall Study|Other Reason|0|||
48710880|NCT00499590|156791405|FG000|Overall Study|Study Terminated|112|||
48710881|NCT00499590|156791406|FG001|Overall Study|Study Terminated|112|||
48710882|NCT00499590|156791407|FG002|Overall Study|Study Terminated|112|||
48710883|NCT00499590|156791405|FG000|Overall Study|Not treated|1|||
48710884|NCT00499590|156791406|FG001|Overall Study|Not treated|0|||
48710885|NCT00499590|156791407|FG002|Overall Study|Not treated|1|||
48710886|NCT02624986|156791408|FG000|Overall Study|Death|0|||
48710887|NCT02624986|156791409|FG001|Overall Study|Death|1|||
48710888|NCT02624986|156791410|FG002|Overall Study|Death|2|||
48710889|NCT02624986|156791411|FG003|Overall Study|Death|2|||
48710890|NCT02624986|156791412|FG004|Overall Study|Death|2|||
48710891|NCT02624986|156791413|FG005|Overall Study|Death|0|||
48710892|NCT02624986|156791414|FG006|Overall Study|Death|0|||
48710893|NCT02624986|156791415|FG007|Overall Study|Death|1|||
48710894|NCT02624986|156791408|FG000|Overall Study|Study Terminated by Sponsor|1|||
48710895|NCT02624986|156791409|FG001|Overall Study|Study Terminated by Sponsor|1|||
48710896|NCT02624986|156791410|FG002|Overall Study|Study Terminated by Sponsor|0|||
48710897|NCT02624986|156791411|FG003|Overall Study|Study Terminated by Sponsor|1|||
48917553|NCT00917150|157534108|FG003|Overall Study|Adverse Event|11|||
48710898|NCT02624986|156791412|FG004|Overall Study|Study Terminated by Sponsor|2|||
48710899|NCT02624986|156791413|FG005|Overall Study|Study Terminated by Sponsor|2|||
48710900|NCT02624986|156791414|FG006|Overall Study|Study Terminated by Sponsor|4|||
48710901|NCT02624986|156791415|FG007|Overall Study|Study Terminated by Sponsor|3|||
48710902|NCT02624986|156791408|FG000|Overall Study|Progressive Disease|0|||
48710903|NCT02624986|156791409|FG001|Overall Study|Progressive Disease|1|||
48807871|NCT00728962|157138205|FG000|Implant Placement Surgery|Adverse Event|8|||
48807872|NCT00728962|157138205|FG000|Implant Placement Surgery|Lost to Follow-up|1|||
48807873|NCT00728962|157138205|FG000|Implant Placement Surgery|Protocol Violation|1|||
48807874|NCT00728962|157138205|FG000|Permanent Prosthesis Placement|Adverse Event|3|||
48807875|NCT00728962|157138205|FG000|Two Year Post Placement Follow-up|Lost to Follow-up|3|||
48807876|NCT01576718|157138208|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49|||
48807877|NCT01576718|157138209|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
48807878|NCT01576718|157138210|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
48807879|NCT01576718|157138211|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
48807880|NCT01576718|157138212|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
48917554|NCT00917150|157534105|FG000|Overall Study|Death|1|||
48917555|NCT00917150|157534106|FG001|Overall Study|Death|4|||
48917556|NCT00917150|157534107|FG002|Overall Study|Death|3|||
49120520|NCT01004978|158280507|FG001|Overall Study|Never started treatment|9|||
49120521|NCT02326272|158280508|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
49120522|NCT02326272|158280509|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|3|||
49120523|NCT02326272|158280510|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
49120524|NCT02326272|158280511|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
49120525|NCT02326272|158280512|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
49120526|NCT02326272|158280513|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
49120527|NCT02326272|158280514|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
48710904|NCT02624986|156791410|FG002|Overall Study|Progressive Disease|0|||
48710905|NCT02624986|156791411|FG003|Overall Study|Progressive Disease|0|||
48710906|NCT02624986|156791412|FG004|Overall Study|Progressive Disease|0|||
48710907|NCT02624986|156791413|FG005|Overall Study|Progressive Disease|0|||
48917557|NCT00917150|157534108|FG003|Overall Study|Death|2|||
48710908|NCT02624986|156791414|FG006|Overall Study|Progressive Disease|0|||
48917558|NCT00917150|157534105|FG000|Overall Study|Lost to Follow-up|1|||
48710909|NCT02624986|156791415|FG007|Overall Study|Progressive Disease|0|||
48807881|NCT01576718|157138213|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
48807882|NCT01576718|157138214|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
48807883|NCT01576718|157138208|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17|||
48807884|NCT01576718|157138209|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
48807885|NCT01576718|157138210|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
48807886|NCT01576718|157138211|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
48807887|NCT01576718|157138212|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
48807888|NCT01576718|157138213|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
48807889|NCT01576718|157138214|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
48807890|NCT01576718|157138208|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166|||
48807891|NCT01576718|157138209|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
48807892|NCT01576718|157138210|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
48807893|NCT01576718|157138211|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
48807894|NCT01576718|157138212|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
48807895|NCT01576718|157138213|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
48807896|NCT01576718|157138214|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
48710910|NCT02624986|156791408|FG000|Overall Study|Protocol Violation|1|||
48710911|NCT02624986|156791409|FG001|Overall Study|Protocol Violation|0|||
48710912|NCT02624986|156791410|FG002|Overall Study|Protocol Violation|0|||
48710913|NCT02624986|156791411|FG003|Overall Study|Protocol Violation|0|||
48710914|NCT02624986|156791412|FG004|Overall Study|Protocol Violation|0|||
48710915|NCT02624986|156791413|FG005|Overall Study|Protocol Violation|0|||
48710916|NCT02624986|156791414|FG006|Overall Study|Protocol Violation|0|||
48710917|NCT02624986|156791415|FG007|Overall Study|Protocol Violation|0|||
48710918|NCT02624986|156791408|FG000|Overall Study|Withdrawal by Subject|0|||
48710919|NCT02624986|156791409|FG001|Overall Study|Withdrawal by Subject|0|||
48710920|NCT02624986|156791410|FG002|Overall Study|Withdrawal by Subject|0|||
48807897|NCT01576718|157138208|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2|||
48807898|NCT01576718|157138209|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
48807899|NCT01576718|157138210|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
48807900|NCT01576718|157138211|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
48807901|NCT01576718|157138212|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
48807902|NCT01576718|157138213|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
48807903|NCT01576718|157138214|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
48807904|NCT01576718|157138208|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
48807905|NCT01576718|157138209|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
48807906|NCT01576718|157138210|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
48807907|NCT01576718|157138211|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
48807908|NCT01576718|157138212|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
48807909|NCT01576718|157138213|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
48807910|NCT01576718|157138214|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
48807911|NCT01576718|157138208|FG000|Treatment Period|Adverse Event|0|||
48807912|NCT01576718|157138209|FG001|Treatment Period|Adverse Event|1|||
48807913|NCT01576718|157138210|FG002|Treatment Period|Adverse Event|1|||
48807914|NCT01576718|157138211|FG003|Treatment Period|Adverse Event|1|||
48807915|NCT01576718|157138212|FG004|Treatment Period|Adverse Event|1|||
48807916|NCT01576718|157138213|FG005|Treatment Period|Adverse Event|1|||
48710921|NCT02624986|156791411|FG003|Overall Study|Withdrawal by Subject|0|||
48710922|NCT02624986|156791412|FG004|Overall Study|Withdrawal by Subject|0|||
48710923|NCT02624986|156791413|FG005|Overall Study|Withdrawal by Subject|0|||
48710924|NCT02624986|156791414|FG006|Overall Study|Withdrawal by Subject|0|||
48710925|NCT02624986|156791415|FG007|Overall Study|Withdrawal by Subject|1|||
48710926|NCT00740857|156791416|FG000|Overall Study|Withdrawal by Subject|1|||
48807917|NCT01576718|157138214|FG006|Treatment Period|Adverse Event|0|||
48807918|NCT01576718|157138208|FG000|Treatment Period|Withdrawal by Subject|0|||
48807919|NCT01576718|157138209|FG001|Treatment Period|Withdrawal by Subject|1|||
48710927|NCT00740857|156791417|FG001|Overall Study|Withdrawal by Subject|0|||
48710928|NCT00740857|156791418|FG002|Overall Study|Withdrawal by Subject|0|||
48807920|NCT01576718|157138210|FG002|Treatment Period|Withdrawal by Subject|1|||
48807921|NCT01576718|157138211|FG003|Treatment Period|Withdrawal by Subject|0|||
48807922|NCT01576718|157138212|FG004|Treatment Period|Withdrawal by Subject|2|||
48807923|NCT01576718|157138213|FG005|Treatment Period|Withdrawal by Subject|4|||
48807924|NCT01576718|157138214|FG006|Treatment Period|Withdrawal by Subject|2|||
48807925|NCT01576718|157138208|FG000|Treatment Period|Physician Decision|0|||
48807926|NCT01576718|157138209|FG001|Treatment Period|Physician Decision|1|||
48807927|NCT01576718|157138210|FG002|Treatment Period|Physician Decision|1|||
48807928|NCT01576718|157138211|FG003|Treatment Period|Physician Decision|1|||
48807929|NCT01576718|157138212|FG004|Treatment Period|Physician Decision|1|||
48807930|NCT01576718|157138213|FG005|Treatment Period|Physician Decision|0|||
48807931|NCT01576718|157138214|FG006|Treatment Period|Physician Decision|0|||
48807932|NCT01576718|157138208|FG000|Treatment Period|Protocol Violation|0|||
48807933|NCT01576718|157138209|FG001|Treatment Period|Protocol Violation|5|||
48807934|NCT01576718|157138210|FG002|Treatment Period|Protocol Violation|4|||
48807935|NCT01576718|157138211|FG003|Treatment Period|Protocol Violation|10|||
48807936|NCT01576718|157138212|FG004|Treatment Period|Protocol Violation|6|||
48807937|NCT01576718|157138213|FG005|Treatment Period|Protocol Violation|8|||
48807938|NCT01576718|157138214|FG006|Treatment Period|Protocol Violation|12|||
48807939|NCT01576718|157138208|FG000|Treatment Period|Sponsor request|0|||
48807940|NCT01576718|157138209|FG001|Treatment Period|Sponsor request|1|||
48807941|NCT01576718|157138210|FG002|Treatment Period|Sponsor request|0|||
48807942|NCT01576718|157138211|FG003|Treatment Period|Sponsor request|0|||
48807943|NCT01576718|157138212|FG004|Treatment Period|Sponsor request|0|||
48807944|NCT01576718|157138213|FG005|Treatment Period|Sponsor request|1|||
48807945|NCT01576718|157138214|FG006|Treatment Period|Sponsor request|0|||
48807946|NCT01576718|157138208|FG000|Treatment Period|Met stopping criteria|0|||
48807947|NCT01576718|157138209|FG001|Treatment Period|Met stopping criteria|16|||
48807948|NCT01576718|157138210|FG002|Treatment Period|Met stopping criteria|13|||
48807949|NCT01576718|157138211|FG003|Treatment Period|Met stopping criteria|19|||
48807950|NCT01576718|157138212|FG004|Treatment Period|Met stopping criteria|16|||
48807951|NCT01576718|157138213|FG005|Treatment Period|Met stopping criteria|33|||
48807952|NCT01576718|157138214|FG006|Treatment Period|Met stopping criteria|15|||
48807953|NCT01576718|157138208|FG000|Treatment Period|Lost to Follow-up|0|||
48807954|NCT01576718|157138209|FG001|Treatment Period|Lost to Follow-up|0|||
48807955|NCT01576718|157138210|FG002|Treatment Period|Lost to Follow-up|0|||
48807956|NCT01576718|157138211|FG003|Treatment Period|Lost to Follow-up|0|||
48710929|NCT02152956|156791419|FG000|Overall Study|Adverse Event|0|||
48710930|NCT02152956|156791420|FG001|Overall Study|Adverse Event|0|||
48807957|NCT01576718|157138212|FG004|Treatment Period|Lost to Follow-up|1|||
48807958|NCT01576718|157138213|FG005|Treatment Period|Lost to Follow-up|0|||
48807959|NCT01576718|157138214|FG006|Treatment Period|Lost to Follow-up|0|||
48807960|NCT01576718|157138208|FG000|Treatment Period|Noncompliance to study medication|0|||
48807961|NCT01576718|157138209|FG001|Treatment Period|Noncompliance to study medication|0|||
48807962|NCT01576718|157138210|FG002|Treatment Period|Noncompliance to study medication|0|||
48807963|NCT01576718|157138211|FG003|Treatment Period|Noncompliance to study medication|0|||
48807964|NCT01576718|157138212|FG004|Treatment Period|Noncompliance to study medication|0|||
48807965|NCT01576718|157138213|FG005|Treatment Period|Noncompliance to study medication|1|||
48807966|NCT01576718|157138214|FG006|Treatment Period|Noncompliance to study medication|1|||
48807967|NCT01126060|157138215|FG000|Overall Study|Protocol Violation|0|||
48807968|NCT01126060|157138216|FG001|Overall Study|Protocol Violation|2|||
48807969|NCT02821819|157138221|FG000|Overall Study|Protocol Violation|1|||
48807970|NCT00856661|157138222|FG000|Overall Study|Death|15|||
48807971|NCT00856661|157138223|FG001|Overall Study|Death|18|||
48807972|NCT00856661|157138222|FG000|Overall Study|Protocol Violation|2|||
48710931|NCT02152956|156791421|FG002|Overall Study|Adverse Event|0|||
48710932|NCT02152956|156791422|FG003|Overall Study|Adverse Event|0|||
48710933|NCT02152956|156791423|FG004|Overall Study|Adverse Event|0|||
48710934|NCT02152956|156791424|FG005|Overall Study|Adverse Event|0|||
48710935|NCT02152956|156791425|FG006|Overall Study|Adverse Event|0|||
48710936|NCT02152956|156791426|FG007|Overall Study|Adverse Event|0|||
48710937|NCT02152956|156791427|FG008|Overall Study|Adverse Event|0|||
48710938|NCT02152956|156791428|FG009|Overall Study|Adverse Event|0|||
48710939|NCT02152956|156791429|FG010|Overall Study|Adverse Event|0|||
48710940|NCT02152956|156791430|FG011|Overall Study|Adverse Event|4|||
48710941|NCT02152956|156791431|FG012|Overall Study|Adverse Event|0|||
48710942|NCT02152956|156791419|FG000|Overall Study|Death|0|||
48710943|NCT02152956|156791420|FG001|Overall Study|Death|3|||
48710944|NCT02152956|156791421|FG002|Overall Study|Death|3|||
48710945|NCT02152956|156791422|FG003|Overall Study|Death|4|||
48710946|NCT02152956|156791423|FG004|Overall Study|Death|1|||
48710947|NCT02152956|156791424|FG005|Overall Study|Death|2|||
48807973|NCT00856661|157138223|FG001|Overall Study|Protocol Violation|1|||
48807974|NCT00856661|157138222|FG000|Overall Study|Withdrawal by Subject|1|||
48710948|NCT02152956|156791425|FG006|Overall Study|Death|6|||
48710949|NCT02152956|156791426|FG007|Overall Study|Death|6|||
48807975|NCT00856661|157138223|FG001|Overall Study|Withdrawal by Subject|2|||
48807976|NCT00856661|157138222|FG000|Overall Study|Lost to Follow-up|1|||
48917559|NCT00917150|157534106|FG001|Overall Study|Lost to Follow-up|0|||
48917560|NCT00917150|157534107|FG002|Overall Study|Lost to Follow-up|4|||
48917561|NCT00917150|157534108|FG003|Overall Study|Lost to Follow-up|2|||
48807977|NCT00856661|157138223|FG001|Overall Study|Lost to Follow-up|3|||
48807978|NCT00856661|157138222|FG000|Overall Study|Physician Judgement|8|||
48807979|NCT00856661|157138223|FG001|Overall Study|Physician Judgement|5|||
48807980|NCT04395183|157138225|FG000|Overall Study|Withdrawal by Subject|1|||
48807981|NCT04395183|157138226|FG001|Overall Study|Withdrawal by Subject|0|||
48807982|NCT04395183|157138227|FG002|Overall Study|Withdrawal by Subject|2|||
48807983|NCT04395183|157138228|FG003|Overall Study|Withdrawal by Subject|2|||
48807984|NCT01008475|157138229|FG000|Overall Study|Ongoing treatment at data cut-off date|0|||
48807985|NCT01008475|157138230|FG001|Overall Study|Ongoing treatment at data cut-off date|0|||
48807986|NCT01008475|157138231|FG002|Overall Study|Ongoing treatment at data cut-off date|0|||
48807987|NCT01008475|157138232|FG003|Overall Study|Ongoing treatment at data cut-off date|0|||
48807988|NCT01008475|157138233|FG004|Overall Study|Ongoing treatment at data cut-off date|5|||
48807989|NCT01008475|157138234|FG005|Overall Study|Ongoing treatment at data cut-off date|6|||
48807990|NCT01008475|157138235|FG006|Overall Study|Ongoing treatment at data cut-off date|4|||
48807991|NCT02306122|157138237|FG000|Initial Physician Randomization|Physician Decision|0|||
48807992|NCT02306122|157138238|FG001|Initial Physician Randomization|Physician Decision|0|||
48917562|NCT00917150|157534105|FG000|Overall Study|Physician Decision|0|||
48917563|NCT00917150|157534106|FG001|Overall Study|Physician Decision|2|||
48917564|NCT00917150|157534107|FG002|Overall Study|Physician Decision|0|||
48917565|NCT00917150|157534108|FG003|Overall Study|Physician Decision|1|||
48917566|NCT00917150|157534105|FG000|Overall Study|Protocol Violation|5|||
48807993|NCT02306122|157138239|FG002|Initial Physician Randomization|Physician Decision|0|||
48807994|NCT02306122|157138240|FG003|Initial Physician Randomization|Physician Decision|0|||
48807995|NCT02306122|157138241|FG004|Initial Physician Randomization|Physician Decision|0|||
48807996|NCT02306122|157138242|FG005|Initial Physician Randomization|Physician Decision|0|||
48807997|NCT02306122|157138243|FG006|Initial Physician Randomization|Physician Decision|0|||
48807998|NCT02306122|157138244|FG007|Initial Physician Randomization|Physician Decision|0|||
48807999|NCT02306122|157138245|FG008|Initial Physician Randomization|Physician Decision|1|||
48808000|NCT02306122|157138246|FG009|Initial Physician Randomization|Physician Decision|0|||
48808001|NCT02306122|157138247|FG010|Initial Physician Randomization|Physician Decision|0|||
48808002|NCT00399763|157138248|FG000|Overall Study|Lost to Follow-up|2|||
48808003|NCT00399763|157138249|FG001|Overall Study|Lost to Follow-up|3|||
48808004|NCT02638623|157138251|FG000|Overall Study|Surgery timing|5|||
48808005|NCT02638623|157138252|FG001|Overall Study|Surgery timing|6|||
48808006|NCT02638623|157138251|FG000|Overall Study|Not given intervention|2|||
48808007|NCT02638623|157138252|FG001|Overall Study|Not given intervention|0|||
48808008|NCT01657266|157138253|FG000|Overall Study|Lost to Follow-up|2|||
48808009|NCT01657266|157138254|FG001|Overall Study|Lost to Follow-up|2|||
48917567|NCT00917150|157534106|FG001|Overall Study|Protocol Violation|5|||
48917568|NCT00917150|157534107|FG002|Overall Study|Protocol Violation|3|||
48917569|NCT00917150|157534108|FG003|Overall Study|Protocol Violation|5|||
48917570|NCT00917150|157534105|FG000|Overall Study|Withdrawal by Subject|15|||
48917571|NCT00917150|157534106|FG001|Overall Study|Withdrawal by Subject|16|||
49120528|NCT02326272|158280515|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
49120529|NCT02326272|158280516|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
49120530|NCT02326272|158280517|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
49120531|NCT02326272|158280518|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
49120532|NCT02326272|158280519|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
49120533|NCT02326272|158280520|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
49120534|NCT02326272|158280521|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
49120535|NCT02326272|158280522|FG014|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
49120536|NCT02326272|158280508|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
49120537|NCT02326272|158280509|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2|||
49120538|NCT02326272|158280510|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
49120539|NCT02326272|158280511|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
48808010|NCT01657266|157138253|FG000|Overall Study|Adverse Event|2|||
48808011|NCT01657266|157138254|FG001|Overall Study|Adverse Event|3|||
48808012|NCT00909428|157138258|FG000|Overall Study|Lost to Follow-up|13|||
48808013|NCT00909428|157138259|FG001|Overall Study|Lost to Follow-up|10|||
48808014|NCT00909428|157138260|FG002|Overall Study|Lost to Follow-up|9|||
48808015|NCT00457639|157138261|FG000|Intervention 1 (6 Months)|Lost to Follow-up|3|||
48917572|NCT00917150|157534107|FG002|Overall Study|Withdrawal by Subject|18|||
49120540|NCT02326272|158280512|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
48917573|NCT00917150|157534108|FG003|Overall Study|Withdrawal by Subject|11|||
48917574|NCT00917150|157534105|FG000|Overall Study|Other than specified|3|||
48917575|NCT00917150|157534106|FG001|Overall Study|Other than specified|3|||
49120541|NCT02326272|158280513|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
49120542|NCT02326272|158280514|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
49120543|NCT02326272|158280515|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
49120544|NCT02326272|158280516|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
49120545|NCT02326272|158280517|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
49120546|NCT02326272|158280518|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
49120547|NCT02326272|158280519|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
49120548|NCT02326272|158280520|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
49120549|NCT02326272|158280521|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
49120550|NCT02326272|158280522|FG014|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
49120551|NCT02326272|158280508|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
49120552|NCT02326272|158280509|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
49120553|NCT02326272|158280510|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
49120554|NCT02326272|158280511|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
49120555|NCT02326272|158280512|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
49120556|NCT02326272|158280513|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
49120557|NCT02326272|158280514|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
49120558|NCT02326272|158280515|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
49120559|NCT02326272|158280516|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
49120560|NCT02326272|158280517|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
49120561|NCT02326272|158280518|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
49120562|NCT02326272|158280519|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
49120563|NCT02326272|158280520|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
49120564|NCT02326272|158280521|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
49120565|NCT02326272|158280522|FG014|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
49120566|NCT02326272|158280508|FG000|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
49120567|NCT02326272|158280509|FG001|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
49120568|NCT02326272|158280510|FG002|Initial Period (Week 0 to Week 16)|Moved from the study area|1|||
49120569|NCT02326272|158280511|FG003|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
49120570|NCT02326272|158280512|FG004|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
49120571|NCT02326272|158280513|FG005|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
49120572|NCT02326272|158280514|FG006|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
49120573|NCT02326272|158280515|FG007|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
49120574|NCT02326272|158280516|FG008|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
49120575|NCT02326272|158280517|FG009|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
49120576|NCT02326272|158280518|FG010|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
49120577|NCT02326272|158280519|FG011|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
49120578|NCT02326272|158280520|FG012|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
49120579|NCT02326272|158280521|FG013|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
49120580|NCT02326272|158280522|FG014|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
49120581|NCT02326272|158280508|FG000|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
49120582|NCT02326272|158280509|FG001|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
49120583|NCT02326272|158280510|FG002|Initial Period (Week 0 to Week 16)|Missed two doses|1|||
49120584|NCT02326272|158280511|FG003|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
49120585|NCT02326272|158280512|FG004|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
49120586|NCT02326272|158280513|FG005|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
49120587|NCT02326272|158280514|FG006|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
49120588|NCT02326272|158280515|FG007|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
49120589|NCT02326272|158280516|FG008|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
49120590|NCT02326272|158280517|FG009|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
49120591|NCT02326272|158280518|FG010|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
49120592|NCT02326272|158280519|FG011|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
49120593|NCT02326272|158280520|FG012|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
49120594|NCT02326272|158280521|FG013|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
49120595|NCT02326272|158280522|FG014|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
49120596|NCT02326272|158280508|FG000|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
48710950|NCT02152956|156791427|FG008|Overall Study|Death|4|||
48710951|NCT02152956|156791428|FG009|Overall Study|Death|5|||
48710952|NCT02152956|156791429|FG010|Overall Study|Death|3|||
48710953|NCT02152956|156791430|FG011|Overall Study|Death|143|||
48710954|NCT02152956|156791431|FG012|Overall Study|Death|12|||
48710955|NCT02152956|156791419|FG000|Overall Study|Lost to Follow-up|0|||
48710956|NCT02152956|156791420|FG001|Overall Study|Lost to Follow-up|1|||
48808016|NCT00457639|157138262|FG001|Intervention 1 (6 Months)|Lost to Follow-up|0|||
48710957|NCT02152956|156791421|FG002|Overall Study|Lost to Follow-up|0|||
48710958|NCT02152956|156791422|FG003|Overall Study|Lost to Follow-up|0|||
48710959|NCT02152956|156791423|FG004|Overall Study|Lost to Follow-up|0|||
48710960|NCT02152956|156791424|FG005|Overall Study|Lost to Follow-up|0|||
48710961|NCT02152956|156791425|FG006|Overall Study|Lost to Follow-up|0|||
48710962|NCT02152956|156791426|FG007|Overall Study|Lost to Follow-up|0|||
48710963|NCT02152956|156791427|FG008|Overall Study|Lost to Follow-up|0|||
48710964|NCT02152956|156791428|FG009|Overall Study|Lost to Follow-up|0|||
48710965|NCT02152956|156791429|FG010|Overall Study|Lost to Follow-up|0|||
48710966|NCT02152956|156791430|FG011|Overall Study|Lost to Follow-up|3|||
48808017|NCT00457639|157138261|FG000|Intervention 1 (6 Months)|unrelated illness|0|||
48808018|NCT00457639|157138262|FG001|Intervention 1 (6 Months)|unrelated illness|2|||
48808019|NCT00457639|157138261|FG000|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0|||
48808020|NCT00457639|157138262|FG001|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1|||
48808021|NCT02322814|157138265|FG000|Overall Study|Death|7|||
48808022|NCT02322814|157138266|FG001|Overall Study|Death|29|||
48808023|NCT02322814|157138267|FG002|Overall Study|Death|32|||
48710967|NCT02152956|156791431|FG012|Overall Study|Lost to Follow-up|0|||
48710968|NCT02152956|156791419|FG000|Overall Study|Withdrawal by Subject|1|||
48808024|NCT02322814|157138268|FG003|Overall Study|Death|23|||
48808025|NCT02322814|157138269|FG004|Overall Study|Death|14|||
48808026|NCT02322814|157138265|FG000|Overall Study|Lost to Follow-up|1|||
48808027|NCT02322814|157138266|FG001|Overall Study|Lost to Follow-up|3|||
48808028|NCT02322814|157138267|FG002|Overall Study|Lost to Follow-up|3|||
48808029|NCT02322814|157138268|FG003|Overall Study|Lost to Follow-up|1|||
48808030|NCT02322814|157138269|FG004|Overall Study|Lost to Follow-up|0|||
48808031|NCT02322814|157138265|FG000|Overall Study|Various Reasons|2|||
48808032|NCT02322814|157138266|FG001|Overall Study|Various Reasons|0|||
48808033|NCT02322814|157138267|FG002|Overall Study|Various Reasons|1|||
48808034|NCT02322814|157138268|FG003|Overall Study|Various Reasons|1|||
48808035|NCT02322814|157138269|FG004|Overall Study|Various Reasons|0|||
48808036|NCT02322814|157138265|FG000|Overall Study|Progressive Disease|0|||
48808037|NCT02322814|157138266|FG001|Overall Study|Progressive Disease|0|||
48808038|NCT02322814|157138267|FG002|Overall Study|Progressive Disease|0|||
48808039|NCT02322814|157138268|FG003|Overall Study|Progressive Disease|1|||
48808040|NCT02322814|157138269|FG004|Overall Study|Progressive Disease|1|||
48808041|NCT02322814|157138265|FG000|Overall Study|Protocol Violation|1|||
48808042|NCT02322814|157138266|FG001|Overall Study|Protocol Violation|0|||
48808043|NCT02322814|157138267|FG002|Overall Study|Protocol Violation|0|||
48808044|NCT02322814|157138268|FG003|Overall Study|Protocol Violation|0|||
48808045|NCT02322814|157138269|FG004|Overall Study|Protocol Violation|0|||
48808046|NCT02322814|157138265|FG000|Overall Study|Study Terminated by Sponsor|0|||
48808047|NCT02322814|157138266|FG001|Overall Study|Study Terminated by Sponsor|7|||
48808048|NCT02322814|157138267|FG002|Overall Study|Study Terminated by Sponsor|9|||
48808049|NCT02322814|157138268|FG003|Overall Study|Study Terminated by Sponsor|5|||
48808050|NCT02322814|157138269|FG004|Overall Study|Study Terminated by Sponsor|13|||
48808051|NCT02322814|157138265|FG000|Overall Study|Withdrawal by Subject|5|||
48808052|NCT02322814|157138266|FG001|Overall Study|Withdrawal by Subject|4|||
48808053|NCT02322814|157138267|FG002|Overall Study|Withdrawal by Subject|2|||
48808054|NCT02322814|157138268|FG003|Overall Study|Withdrawal by Subject|1|||
48808055|NCT02322814|157138269|FG004|Overall Study|Withdrawal by Subject|3|||
48808056|NCT01861522|157138270|FG000|Overall Study|Adverse Event|1|||
48808057|NCT01861522|157138271|FG001|Overall Study|Adverse Event|0|||
48808058|NCT01861522|157138270|FG000|Overall Study|Withdrawal by Subject|2|||
48808059|NCT01861522|157138271|FG001|Overall Study|Withdrawal by Subject|0|||
48808060|NCT00550550|157138272|FG000|Overall Study|Adverse Event|13|||
48808061|NCT00550550|157138273|FG001|Overall Study|Adverse Event|5|||
48808062|NCT00550550|157138272|FG000|Overall Study|Treatment Failure|0|||
48808063|NCT00550550|157138273|FG001|Overall Study|Treatment Failure|1|||
48808064|NCT00550550|157138272|FG000|Overall Study|Lost to Follow-up|4|||
48808065|NCT00550550|157138273|FG001|Overall Study|Lost to Follow-up|0|||
48808066|NCT00550550|157138272|FG000|Overall Study|Withdrawal by Subject|10|||
48808067|NCT00550550|157138273|FG001|Overall Study|Withdrawal by Subject|8|||
48808068|NCT00550550|157138272|FG000|Overall Study|Protocol Violation|5|||
48808069|NCT00550550|157138273|FG001|Overall Study|Protocol Violation|14|||
48808070|NCT00550550|157138272|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
48808071|NCT00550550|157138273|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
48808072|NCT00550550|157138272|FG000|Overall Study|Randomized But Not Treated|1|||
48808073|NCT00550550|157138273|FG001|Overall Study|Randomized But Not Treated|0|||
48808074|NCT01164228|157138274|FG000|Overall Study|Progression|24|||
48808075|NCT01164228|157138275|FG001|Overall Study|Progression|25|||
48808076|NCT01164228|157138274|FG000|Overall Study|Adverse Event|13|||
48808077|NCT01164228|157138275|FG001|Overall Study|Adverse Event|7|||
48808078|NCT01164228|157138274|FG000|Overall Study|Death|1|||
48808079|NCT01164228|157138275|FG001|Overall Study|Death|1|||
48808080|NCT01164228|157138274|FG000|Overall Study|Withdrawal by Subject|2|||
48808081|NCT01164228|157138275|FG001|Overall Study|Withdrawal by Subject|0|||
48808082|NCT01164228|157138274|FG000|Overall Study|Physician Decision|1|||
48808083|NCT01164228|157138275|FG001|Overall Study|Physician Decision|2|||
48808084|NCT01164228|157138274|FG000|Overall Study|Symptomatic deterioration|1|||
48808085|NCT01164228|157138275|FG001|Overall Study|Symptomatic deterioration|0|||
48808086|NCT01164228|157138274|FG000|Overall Study|Never started treatment|1|||
48808087|NCT01164228|157138275|FG001|Overall Study|Never started treatment|3|||
48808088|NCT01164228|157138274|FG000|Overall Study|Ineligible|1|||
48808089|NCT01164228|157138275|FG001|Overall Study|Ineligible|0|||
48808090|NCT03757234|157138276|FG000|Overall Study|Adverse Event|0|||
48808091|NCT03757234|157138277|FG001|Overall Study|Adverse Event|0|||
48808092|NCT03757234|157138278|FG002|Overall Study|Adverse Event|0|||
48808093|NCT03757234|157138279|FG003|Overall Study|Adverse Event|0|||
48808094|NCT03757234|157138280|FG004|Overall Study|Adverse Event|1|||
48808095|NCT03757234|157138276|FG000|Overall Study|Lost to Follow-up|1|||
48917576|NCT00917150|157534107|FG002|Overall Study|Other than specified|2|||
48917577|NCT00917150|157534108|FG003|Overall Study|Other than specified|2|||
48808096|NCT03757234|157138277|FG001|Overall Study|Lost to Follow-up|0|||
48808097|NCT03757234|157138278|FG002|Overall Study|Lost to Follow-up|0|||
48808098|NCT03757234|157138279|FG003|Overall Study|Lost to Follow-up|0|||
48808099|NCT03757234|157138280|FG004|Overall Study|Lost to Follow-up|1|||
48808100|NCT03757234|157138276|FG000|Overall Study|Withdrawal by Subject|1|||
48808101|NCT03757234|157138277|FG001|Overall Study|Withdrawal by Subject|1|||
48808102|NCT03757234|157138278|FG002|Overall Study|Withdrawal by Subject|0|||
48808103|NCT03757234|157138279|FG003|Overall Study|Withdrawal by Subject|1|||
48808104|NCT03757234|157138280|FG004|Overall Study|Withdrawal by Subject|2|||
48808105|NCT03757234|157138276|FG000|Overall Study|Other|1|||
48808106|NCT03757234|157138277|FG001|Overall Study|Other|1|||
48808107|NCT03757234|157138278|FG002|Overall Study|Other|0|||
48917578|NCT03765138|157534111|FG000|Overall Study|Lost to Follow-up|1|||
48808108|NCT03757234|157138279|FG003|Overall Study|Other|0|||
48808109|NCT03757234|157138280|FG004|Overall Study|Other|0|||
48808110|NCT03311230|157138283|FG000|Overall Study|Withdrawal by Subject|1|||
48808111|NCT03311230|157138284|FG001|Overall Study|Withdrawal by Subject|4|||
48808112|NCT03311230|157138285|FG002|Overall Study|Withdrawal by Subject|2|||
48808113|NCT03311230|157138286|FG003|Overall Study|Withdrawal by Subject|7|||
48808114|NCT03311230|157138283|FG000|Overall Study|Unrelated injury|0|||
48808115|NCT03311230|157138284|FG001|Overall Study|Unrelated injury|1|||
48808116|NCT03311230|157138285|FG002|Overall Study|Unrelated injury|0|||
48808117|NCT03311230|157138286|FG003|Overall Study|Unrelated injury|0|||
48808118|NCT02041923|157138288|FG000|Overall Study|Lost to Follow-up|26|||
48808119|NCT02041923|157138289|FG001|Overall Study|Lost to Follow-up|30|||
48808120|NCT00876460|157138290|FG000|Combination Therapy Phase|Progressive disease|2|||
48808121|NCT00876460|157138291|FG001|Combination Therapy Phase|Progressive disease|3|||
48808122|NCT00876460|157138292|FG002|Combination Therapy Phase|Progressive disease|3|||
48808123|NCT00876460|157138293|FG003|Combination Therapy Phase|Progressive disease|3|||
48808124|NCT00876460|157138294|FG004|Combination Therapy Phase|Progressive disease|3|||
48808125|NCT00876460|157138295|FG005|Combination Therapy Phase|Progressive disease|1|||
48808126|NCT00876460|157138296|FG006|Combination Therapy Phase|Progressive disease|1|||
48808127|NCT00876460|157138297|FG007|Combination Therapy Phase|Progressive disease|1|||
48808128|NCT00876460|157138290|FG000|Combination Therapy Phase|Dose limiting toxicity|0|||
48808129|NCT00876460|157138291|FG001|Combination Therapy Phase|Dose limiting toxicity|1|||
48808130|NCT00876460|157138292|FG002|Combination Therapy Phase|Dose limiting toxicity|0|||
48808131|NCT00876460|157138293|FG003|Combination Therapy Phase|Dose limiting toxicity|1|||
48808132|NCT00876460|157138294|FG004|Combination Therapy Phase|Dose limiting toxicity|1|||
48808133|NCT00876460|157138295|FG005|Combination Therapy Phase|Dose limiting toxicity|2|||
48808134|NCT00876460|157138296|FG006|Combination Therapy Phase|Dose limiting toxicity|2|||
48808135|NCT00876460|157138297|FG007|Combination Therapy Phase|Dose limiting toxicity|1|||
48808136|NCT00876460|157138290|FG000|Combination Therapy Phase|Adverse Event|0|||
48808137|NCT00876460|157138291|FG001|Combination Therapy Phase|Adverse Event|2|||
48808138|NCT00876460|157138292|FG002|Combination Therapy Phase|Adverse Event|0|||
48808139|NCT00876460|157138293|FG003|Combination Therapy Phase|Adverse Event|2|||
48808140|NCT00876460|157138294|FG004|Combination Therapy Phase|Adverse Event|2|||
48808141|NCT00876460|157138295|FG005|Combination Therapy Phase|Adverse Event|0|||
48808142|NCT00876460|157138296|FG006|Combination Therapy Phase|Adverse Event|3|||
48808143|NCT00876460|157138297|FG007|Combination Therapy Phase|Adverse Event|2|||
48808144|NCT00876460|157138290|FG000|Combination Therapy Phase|Withdrawal by Subject|1|||
48808145|NCT00876460|157138291|FG001|Combination Therapy Phase|Withdrawal by Subject|1|||
48808146|NCT00876460|157138292|FG002|Combination Therapy Phase|Withdrawal by Subject|0|||
48808147|NCT00876460|157138293|FG003|Combination Therapy Phase|Withdrawal by Subject|0|||
48808148|NCT00876460|157138294|FG004|Combination Therapy Phase|Withdrawal by Subject|1|||
48808149|NCT00876460|157138295|FG005|Combination Therapy Phase|Withdrawal by Subject|0|||
48808150|NCT00876460|157138296|FG006|Combination Therapy Phase|Withdrawal by Subject|0|||
48808151|NCT00876460|157138297|FG007|Combination Therapy Phase|Withdrawal by Subject|0|||
48808152|NCT00876460|157138290|FG000|Combination Therapy Phase|Other reason not defined above|0|||
48808153|NCT00876460|157138291|FG001|Combination Therapy Phase|Other reason not defined above|0|||
48808154|NCT00876460|157138292|FG002|Combination Therapy Phase|Other reason not defined above|0|||
48808155|NCT00876460|157138293|FG003|Combination Therapy Phase|Other reason not defined above|0|||
48808156|NCT00876460|157138294|FG004|Combination Therapy Phase|Other reason not defined above|0|||
48808157|NCT00876460|157138295|FG005|Combination Therapy Phase|Other reason not defined above|0|||
48808158|NCT00876460|157138296|FG006|Combination Therapy Phase|Other reason not defined above|1|||
48808159|NCT00876460|157138297|FG007|Combination Therapy Phase|Other reason not defined above|2|||
48808160|NCT00876460|157138290|FG000|Combination Therapy Phase|Not treated|0|||
48808161|NCT00876460|157138291|FG001|Combination Therapy Phase|Not treated|0|||
48808162|NCT00876460|157138292|FG002|Combination Therapy Phase|Not treated|0|||
48808163|NCT00876460|157138293|FG003|Combination Therapy Phase|Not treated|0|||
48808164|NCT00876460|157138294|FG004|Combination Therapy Phase|Not treated|0|||
48808165|NCT00876460|157138295|FG005|Combination Therapy Phase|Not treated|0|||
48808166|NCT00876460|157138296|FG006|Combination Therapy Phase|Not treated|1|||
48808167|NCT00876460|157138297|FG007|Combination Therapy Phase|Not treated|0|||
48808168|NCT00876460|157138290|FG000|Mono Therapy Phase|Progressive disease|0|||
48808169|NCT00876460|157138291|FG001|Mono Therapy Phase|Progressive disease|0|||
48808170|NCT00876460|157138292|FG002|Mono Therapy Phase|Progressive disease|0|||
48808171|NCT00876460|157138293|FG003|Mono Therapy Phase|Progressive disease|0|||
48808172|NCT00876460|157138294|FG004|Mono Therapy Phase|Progressive disease|2|||
48808173|NCT00876460|157138295|FG005|Mono Therapy Phase|Progressive disease|0|||
48808174|NCT00876460|157138296|FG006|Mono Therapy Phase|Progressive disease|1|||
49010745|NCT03705169|157875685|FG002|Overall Study|Concerns about study visit compliance|0|||
49010746|NCT03705169|157875686|FG003|Overall Study|Concerns about study visit compliance|1|||
49010747|NCT03705169|157875687|FG004|Overall Study|Concerns about study visit compliance|0|||
49010748|NCT03705169|157875688|FG005|Overall Study|Concerns about study visit compliance|0|||
49010749|NCT03705169|157875689|FG006|Overall Study|Concerns about study visit compliance|0|||
49010750|NCT03705169|157875690|FG007|Overall Study|Concerns about study visit compliance|0|||
49010751|NCT03705169|157875691|FG008|Overall Study|Concerns about study visit compliance|0|||
48808175|NCT00876460|157138297|FG007|Mono Therapy Phase|Progressive disease|3|||
48808176|NCT00876460|157138290|FG000|Mono Therapy Phase|Withdrawal by Subject|0|||
48808177|NCT00876460|157138291|FG001|Mono Therapy Phase|Withdrawal by Subject|1|||
48808178|NCT00876460|157138292|FG002|Mono Therapy Phase|Withdrawal by Subject|0|||
48808179|NCT00876460|157138293|FG003|Mono Therapy Phase|Withdrawal by Subject|0|||
48808180|NCT00876460|157138294|FG004|Mono Therapy Phase|Withdrawal by Subject|0|||
48808181|NCT00876460|157138295|FG005|Mono Therapy Phase|Withdrawal by Subject|0|||
48808182|NCT00876460|157138296|FG006|Mono Therapy Phase|Withdrawal by Subject|0|||
48808183|NCT00876460|157138297|FG007|Mono Therapy Phase|Withdrawal by Subject|0|||
48808184|NCT00876460|157138290|FG000|Mono Therapy Phase|Adverse Event|0|||
48808185|NCT00876460|157138291|FG001|Mono Therapy Phase|Adverse Event|0|||
48808186|NCT00876460|157138292|FG002|Mono Therapy Phase|Adverse Event|0|||
48808187|NCT00876460|157138293|FG003|Mono Therapy Phase|Adverse Event|1|||
48808188|NCT00876460|157138294|FG004|Mono Therapy Phase|Adverse Event|0|||
48808189|NCT00876460|157138295|FG005|Mono Therapy Phase|Adverse Event|0|||
48808190|NCT00876460|157138296|FG006|Mono Therapy Phase|Adverse Event|0|||
48808191|NCT00876460|157138297|FG007|Mono Therapy Phase|Adverse Event|0|||
48808192|NCT03443713|157138302|FG000|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
48808193|NCT03443713|157138303|FG001|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
48808194|NCT03443713|157138304|FG002|First at Home Period (9-14 Days)|Withdrawal by Subject|1|||
48808195|NCT03713021|157138306|FG000|Overall Study|Did not have CT sim scan available|6|||
48808196|NCT03713021|157138306|FG000|Overall Study|Not eligible|4|||
48808197|NCT03713021|157138306|FG000|Overall Study|Issues with TraceIT markers|5|||
48808198|NCT01672853|157138307|FG000|Overall Study|Protocol Specified Criteria for Withdraw|0|||
48808199|NCT01672853|157138308|FG001|Overall Study|Protocol Specified Criteria for Withdraw|4|||
48808200|NCT01672853|157138309|FG002|Overall Study|Protocol Specified Criteria for Withdraw|0|||
48808201|NCT01672853|157138307|FG000|Overall Study|Pregnancy|0|||
48808202|NCT01672853|157138308|FG001|Overall Study|Pregnancy|1|||
48808203|NCT01672853|157138309|FG002|Overall Study|Pregnancy|0|||
48808204|NCT01672853|157138307|FG000|Overall Study|Investigator's Discretion|1|||
48808205|NCT01672853|157138308|FG001|Overall Study|Investigator's Discretion|0|||
48808206|NCT01672853|157138309|FG002|Overall Study|Investigator's Discretion|0|||
48808207|NCT01672853|157138307|FG000|Overall Study|Withdrew Consent|5|||
48808208|NCT01672853|157138308|FG001|Overall Study|Withdrew Consent|5|||
48808209|NCT01672853|157138309|FG002|Overall Study|Withdrew Consent|5|||
48808210|NCT01672853|157138307|FG000|Overall Study|Adverse Event|4|||
48808211|NCT01672853|157138308|FG001|Overall Study|Adverse Event|6|||
48808212|NCT01672853|157138309|FG002|Overall Study|Adverse Event|8|||
48808213|NCT01672853|157138307|FG000|Overall Study|Lost to Follow-up|0|||
48808214|NCT01672853|157138308|FG001|Overall Study|Lost to Follow-up|1|||
48808215|NCT01672853|157138309|FG002|Overall Study|Lost to Follow-up|0|||
48808216|NCT01672853|157138307|FG000|Overall Study|Randomized but Never Treated|0|||
48808217|NCT01672853|157138308|FG001|Overall Study|Randomized but Never Treated|0|||
48808218|NCT01672853|157138309|FG002|Overall Study|Randomized but Never Treated|1|||
48808219|NCT05660434|157138310|FG000|Overall Study|Never obtained study materials|2|||
48808220|NCT05660434|157138311|FG001|Overall Study|Never obtained study materials|1|||
48808221|NCT03880955|157138312|FG000|Overall Study|Adverse Event|1|||
48808222|NCT03880955|157138312|FG000|Overall Study|Death|1|||
48808223|NCT03880955|157138312|FG000|Overall Study|Lost to Follow-up|12|||
48808224|NCT03880955|157138312|FG000|Overall Study|Withdrawal by Subject|4|||
48808225|NCT03880955|157138312|FG000|Overall Study|Missing- Study Site Closed|27|||
48808226|NCT04159519|157138313|FG000|Overall Study|Adverse Event|1|||
48808227|NCT04159519|157138314|FG001|Overall Study|Adverse Event|1|||
48808228|NCT04159519|157138313|FG000|Overall Study|Lack of Efficacy|1|||
48808229|NCT04159519|157138314|FG001|Overall Study|Lack of Efficacy|0|||
48808230|NCT04159519|157138313|FG000|Overall Study|Discontinued from study|1|||
48808231|NCT04159519|157138314|FG001|Overall Study|Discontinued from study|0|||
48808232|NCT04159519|157138313|FG000|Overall Study|Protocol Violation|1|||
48917579|NCT00889265|157534112|FG000|Overall Study|Adverse Event|1|||
48917580|NCT00889265|157534112|FG000|Overall Study|Lost to Follow-up|5|||
48917581|NCT00889265|157534112|FG000|Overall Study|Protocol Violation|1|||
48917582|NCT00845650|157534113|FG000|Overall Study|Withdrawal by Subject|0|||
48808233|NCT04159519|157138314|FG001|Overall Study|Protocol Violation|1|||
48917583|NCT00845650|157534114|FG001|Overall Study|Withdrawal by Subject|0|||
48808234|NCT04159519|157138313|FG000|Overall Study|Withdrawal by Subject|4|||
48808235|NCT04159519|157138314|FG001|Overall Study|Withdrawal by Subject|4|||
48808236|NCT03391960|157138315|FG000|Overall Study|Protocol Violation|0|||
48808237|NCT03391960|157138316|FG001|Overall Study|Protocol Violation|0|||
48808238|NCT01364922|157140160|FG000|Open-label (OL) Period|Adverse Event|7|||
48808239|NCT01364922|157140161|FG001|Open-label (OL) Period|Adverse Event|0|||
48917584|NCT00845650|157534115|FG002|Overall Study|Withdrawal by Subject|0|||
48808240|NCT01364922|157140162|FG002|Open-label (OL) Period|Adverse Event|0|||
48808241|NCT01364922|157140160|FG000|Open-label (OL) Period|Did Not Meet Randomization Criteria|6|||
48808242|NCT01364922|157140161|FG001|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
48917585|NCT00845650|157534116|FG003|Overall Study|Withdrawal by Subject|0|||
48808243|NCT01364922|157140162|FG002|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
48808244|NCT01364922|157140160|FG000|Open-label (OL) Period|Withdrawal by Subject|4|||
48808245|NCT01364922|157140161|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
48808246|NCT01364922|157140162|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
48808247|NCT01364922|157140160|FG000|Open-label (OL) Period|Lack of Efficacy|3|||
48808248|NCT01364922|157140161|FG001|Open-label (OL) Period|Lack of Efficacy|0|||
48808249|NCT01364922|157140162|FG002|Open-label (OL) Period|Lack of Efficacy|0|||
48808250|NCT01364922|157140160|FG000|Open-label (OL) Period|Lost to Follow-up|1|||
48808251|NCT01364922|157140161|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
48808252|NCT01364922|157140162|FG002|Open-label (OL) Period|Lost to Follow-up|0|||
48808253|NCT01364922|157140160|FG000|Open-label (OL) Period|Other, Unspecified|1|||
48808254|NCT01364922|157140161|FG001|Open-label (OL) Period|Other, Unspecified|0|||
48808255|NCT01364922|157140162|FG002|Open-label (OL) Period|Other, Unspecified|0|||
48808256|NCT01364922|157140160|FG000|Double-Blind (DB) Period|Lack of Efficacy|0|||
48808257|NCT01364922|157140161|FG001|Double-Blind (DB) Period|Lack of Efficacy|3|||
48808258|NCT01364922|157140162|FG002|Double-Blind (DB) Period|Lack of Efficacy|4|||
48808259|NCT01364922|157140160|FG000|Double-Blind (DB) Period|Subject Noncompliant|0|||
48808260|NCT01364922|157140161|FG001|Double-Blind (DB) Period|Subject Noncompliant|1|||
48808261|NCT01364922|157140162|FG002|Double-Blind (DB) Period|Subject Noncompliant|0|||
48808262|NCT01364922|157140160|FG000|Double-Blind (DB) Period|Adverse Event|0|||
48808263|NCT01364922|157140161|FG001|Double-Blind (DB) Period|Adverse Event|0|||
48808264|NCT01364922|157140162|FG002|Double-Blind (DB) Period|Adverse Event|1|||
48808265|NCT01364922|157140160|FG000|Double-Blind (DB) Period|Other, Unspecified|0|||
48808266|NCT01364922|157140161|FG001|Double-Blind (DB) Period|Other, Unspecified|1|||
48808267|NCT01364922|157140162|FG002|Double-Blind (DB) Period|Other, Unspecified|0|||
48808268|NCT03559218|157140163|FG000|Overall Study|Withdrawal by Subject|1|||
48808269|NCT03559218|157140164|FG001|Overall Study|Withdrawal by Subject|0|||
48808270|NCT04277455|157140167|FG000|Overall Study|Lost to Follow-up|1|||
48808271|NCT01659658|157140170|FG000|Overall Study|Withdrawal by Patient|18|||
48808272|NCT01659658|157140171|FG001|Overall Study|Withdrawal by Patient|4|||
48808273|NCT01659658|157140172|FG002|Overall Study|Withdrawal by Patient|2|||
48808274|NCT01659658|157140173|FG003|Overall Study|Withdrawal by Patient|0|||
48808275|NCT01659658|157140174|FG004|Overall Study|Withdrawal by Patient|11|||
48808276|NCT01659658|157140170|FG000|Overall Study|Study Terminated by Sponsor|9|||
48808277|NCT01659658|157140171|FG001|Overall Study|Study Terminated by Sponsor|7|||
48808278|NCT01659658|157140172|FG002|Overall Study|Study Terminated by Sponsor|0|||
48808279|NCT01659658|157140173|FG003|Overall Study|Study Terminated by Sponsor|1|||
48808280|NCT01659658|157140174|FG004|Overall Study|Study Terminated by Sponsor|4|||
48808281|NCT01659658|157140170|FG000|Overall Study|Reason not Specified|61|||
48808282|NCT01659658|157140171|FG001|Overall Study|Reason not Specified|15|||
48808283|NCT01659658|157140172|FG002|Overall Study|Reason not Specified|8|||
48808284|NCT01659658|157140173|FG003|Overall Study|Reason not Specified|1|||
48808285|NCT01659658|157140174|FG004|Overall Study|Reason not Specified|34|||
48808286|NCT01659658|157140170|FG000|Overall Study|Lost to Follow-up|2|||
48808287|NCT01659658|157140171|FG001|Overall Study|Lost to Follow-up|0|||
48808288|NCT01659658|157140172|FG002|Overall Study|Lost to Follow-up|0|||
48808289|NCT01659658|157140173|FG003|Overall Study|Lost to Follow-up|0|||
48808290|NCT01659658|157140174|FG004|Overall Study|Lost to Follow-up|0|||
48808291|NCT01679301|157140175|FG000|Screening Period|screen failure|3|||
48808292|NCT01679301|157140176|FG001|Screening Period|screen failure|0|||
48808293|NCT01679301|157140177|FG002|Screening Period|screen failure|0|||
48808294|NCT01582789|157140182|FG000|Second Intervention (14 Days)|Withdrawal by Subject|1|||
48808295|NCT01582789|157140183|FG001|Second Intervention (14 Days)|Withdrawal by Subject|0|||
48808296|NCT03328143|157140184|FG000|Overall Study|Declined|3|||
48808297|NCT03328143|157140184|FG000|Overall Study|Required increased sedation|4|||
48808298|NCT03328143|157140184|FG000|Overall Study|Couldn't smell the lavender in the OR|1|||
48808299|NCT03328143|157140184|FG000|Overall Study|Surgery cancelled|1|||
48808300|NCT03610737|157140185|FG000|Overall Study|Withdrawal by Subject|1|||
48808301|NCT03610737|157140186|FG001|Overall Study|Withdrawal by Subject|5|||
48808302|NCT03610737|157140185|FG000|Overall Study|Death|1|||
48808303|NCT03610737|157140186|FG001|Overall Study|Death|0|||
48808304|NCT03610737|157140185|FG000|Overall Study|Not treated|5|||
48808305|NCT03610737|157140186|FG001|Overall Study|Not treated|2|||
48808306|NCT03610737|157140185|FG000|Overall Study|Missed Visit|1|||
48808307|NCT03610737|157140186|FG001|Overall Study|Missed Visit|2|||
48808308|NCT00944658|157140187|FG000|Treatment 12 Weeks|Adverse Event|0|||
48808309|NCT00944658|157140188|FG001|Treatment 12 Weeks|Adverse Event|2|||
48917586|NCT00845650|157534117|FG004|Overall Study|Withdrawal by Subject|2|||
48808310|NCT02254408|157140192|FG000|Overall Study|Randomized But Not Treated|1|||
48808311|NCT02254408|157140193|FG001|Overall Study|Randomized But Not Treated|3|||
48808312|NCT02254408|157140192|FG000|Overall Study|Adverse Event|1|||
48808313|NCT02254408|157140193|FG001|Overall Study|Adverse Event|0|||
48808314|NCT02254408|157140192|FG000|Overall Study|Death|2|||
48808315|NCT02254408|157140193|FG001|Overall Study|Death|3|||
48808316|NCT02254408|157140192|FG000|Overall Study|Investigator's Discretion|0|||
48808317|NCT02254408|157140193|FG001|Overall Study|Investigator's Discretion|1|||
48808318|NCT02254408|157140192|FG000|Overall Study|Withdrawal by Subject|3|||
48917587|NCT00845650|157534118|FG005|Overall Study|Withdrawal by Subject|0|||
48917588|NCT00845650|157534113|FG000|Overall Study|Lost to Follow-up|0|||
48917589|NCT00845650|157534114|FG001|Overall Study|Lost to Follow-up|0|||
48917590|NCT00845650|157534115|FG002|Overall Study|Lost to Follow-up|3|||
48917591|NCT00845650|157534116|FG003|Overall Study|Lost to Follow-up|1|||
48917592|NCT00845650|157534117|FG004|Overall Study|Lost to Follow-up|0|||
48917593|NCT00845650|157534118|FG005|Overall Study|Lost to Follow-up|1|||
48917594|NCT00845650|157534113|FG000|Overall Study|Sponsor hold on dosing|0|||
48917595|NCT00845650|157534114|FG001|Overall Study|Sponsor hold on dosing|0|||
48917596|NCT00845650|157534115|FG002|Overall Study|Sponsor hold on dosing|0|||
48917597|NCT00845650|157534116|FG003|Overall Study|Sponsor hold on dosing|0|||
48917598|NCT00845650|157534117|FG004|Overall Study|Sponsor hold on dosing|1|||
48917599|NCT00845650|157534118|FG005|Overall Study|Sponsor hold on dosing|1|||
48917600|NCT00845650|157534113|FG000|Overall Study|Unable to access IV line|1|||
48917601|NCT00845650|157534114|FG001|Overall Study|Unable to access IV line|0|||
48917602|NCT00845650|157534115|FG002|Overall Study|Unable to access IV line|0|||
48917603|NCT00845650|157534116|FG003|Overall Study|Unable to access IV line|0|||
48917604|NCT00845650|157534117|FG004|Overall Study|Unable to access IV line|0|||
48917605|NCT00845650|157534118|FG005|Overall Study|Unable to access IV line|0|||
48917606|NCT03803059|157534119|FG000|Overall Study|Protocol Violation|2|||
48917607|NCT03803059|157534119|FG000|Overall Study|Lost to Follow-up|1|||
48917608|NCT00081159|157534121|FG000|Overall Study|Withdrawal by Subject|0|||
48917609|NCT00081159|157534122|FG001|Overall Study|Withdrawal by Subject|3|||
48917610|NCT00081159|157534121|FG000|Overall Study|Myelosuppression prior to treatment|0|||
48917611|NCT00081159|157534122|FG001|Overall Study|Myelosuppression prior to treatment|1|||
48917612|NCT00081159|157534121|FG000|Overall Study|Lost to Follow-up|2|||
48917613|NCT00081159|157534122|FG001|Overall Study|Lost to Follow-up|1|||
48917614|NCT03075527|157534123|FG000|Overall Study|Ongoing treatment|2|||
48917615|NCT04194528|157534125|FG000|Overall Study|Adverse Event|1|||
48917616|NCT00271817|157534126|FG000|Part 1|Adverse Event|68|||
48917617|NCT00271817|157534127|FG001|Part 1|Adverse Event|25|||
48808319|NCT02254408|157140193|FG001|Overall Study|Withdrawal by Subject|3|||
48808320|NCT02254408|157140192|FG000|Overall Study|Lost to Follow-up|1|||
48917618|NCT00271817|157534128|FG002|Part 1|Adverse Event|156|||
48808321|NCT02254408|157140193|FG001|Overall Study|Lost to Follow-up|0|||
48808322|NCT01993017|157140194|FG000|Overall Study|Death|23|||
48808323|NCT01993017|157140195|FG001|Overall Study|Death|26|||
48808324|NCT01993017|157140196|FG002|Overall Study|Death|18|||
48808325|NCT01993017|157140194|FG000|Overall Study|Could not be contacted|43|||
48808326|NCT01993017|157140195|FG001|Overall Study|Could not be contacted|42|||
48808327|NCT01993017|157140196|FG002|Overall Study|Could not be contacted|38|||
48808328|NCT01993017|157140194|FG000|Overall Study|Dropped out|19|||
48808329|NCT01993017|157140195|FG001|Overall Study|Dropped out|6|||
48808330|NCT01993017|157140196|FG002|Overall Study|Dropped out|11|||
48808331|NCT01993017|157140194|FG000|Overall Study|Other reasons|17|||
48808332|NCT01993017|157140195|FG001|Overall Study|Other reasons|11|||
48808333|NCT01993017|157140196|FG002|Overall Study|Other reasons|7|||
48808334|NCT01993017|157140194|FG000|Overall Study|Ineligible after randomization|4|||
48808335|NCT01993017|157140195|FG001|Overall Study|Ineligible after randomization|5|||
48808336|NCT01993017|157140196|FG002|Overall Study|Ineligible after randomization|5|||
48808337|NCT01161472|157140197|FG000|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1|||
48808338|NCT01161472|157140198|FG001|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
48808339|NCT01161472|157140199|FG002|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
48808340|NCT01161472|157140200|FG003|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
48808341|NCT00003511|157140201|FG000|Overall Study|Not evaluable|4|||
48808342|NCT00603265|157140219|FG000|Overall Study|Adverse Event|2|||
48917619|NCT00271817|157534126|FG000|Part 1|Lost to Follow-up|6|||
48917620|NCT00271817|157534127|FG001|Part 1|Lost to Follow-up|8|||
48917621|NCT00271817|157534128|FG002|Part 1|Lost to Follow-up|24|||
48917622|NCT00271817|157534126|FG000|Part 1|Protocol Violation|5|||
48917623|NCT00271817|157534127|FG001|Part 1|Protocol Violation|4|||
48917624|NCT00271817|157534128|FG002|Part 1|Protocol Violation|7|||
48808343|NCT00603265|157140220|FG001|Overall Study|Adverse Event|11|||
48808344|NCT00603265|157140221|FG002|Overall Study|Adverse Event|1|||
48808345|NCT00603265|157140219|FG000|Overall Study|Withdrawal by Subject|1|||
48917625|NCT00271817|157534126|FG000|Part 1|Patient Moved|3|||
48808346|NCT00603265|157140220|FG001|Overall Study|Withdrawal by Subject|2|||
48917626|NCT00271817|157534127|FG001|Part 1|Patient Moved|1|||
48917627|NCT00271817|157534128|FG002|Part 1|Patient Moved|5|||
48917628|NCT00271817|157534126|FG000|Part 1|Withdrawal by Subject|23|||
48917629|NCT00271817|157534127|FG001|Part 1|Withdrawal by Subject|17|||
48917630|NCT00271817|157534128|FG002|Part 1|Withdrawal by Subject|45|||
48808347|NCT00603265|157140221|FG002|Overall Study|Withdrawal by Subject|1|||
48808348|NCT00603265|157140219|FG000|Overall Study|Lack of Efficacy|3|||
48808349|NCT00603265|157140220|FG001|Overall Study|Lack of Efficacy|0|||
48808350|NCT00603265|157140221|FG002|Overall Study|Lack of Efficacy|3|||
48917631|NCT00271817|157534126|FG000|Part 1|LDL < 50 mg/dL|1|||
48917632|NCT00271817|157534127|FG001|Part 1|LDL < 50 mg/dL|4|||
48808351|NCT00603265|157140219|FG000|Overall Study|Lost to Follow-up|0|||
48808352|NCT00603265|157140220|FG001|Overall Study|Lost to Follow-up|1|||
48808353|NCT00603265|157140221|FG002|Overall Study|Lost to Follow-up|0|||
48808354|NCT00603265|157140219|FG000|Overall Study|Out of Town, Ran Out of Study Drug|0|||
48808355|NCT00603265|157140220|FG001|Overall Study|Out of Town, Ran Out of Study Drug|1|||
48808356|NCT00603265|157140221|FG002|Overall Study|Out of Town, Ran Out of Study Drug|0|||
48808357|NCT00603265|157140219|FG000|Overall Study|Participant Left Country, No Responses|0|||
48808358|NCT00603265|157140220|FG001|Overall Study|Participant Left Country, No Responses|1|||
48808359|NCT00603265|157140221|FG002|Overall Study|Participant Left Country, No Responses|0|||
48808360|NCT00603265|157140219|FG000|Overall Study|Protocol Violation|1|||
48808361|NCT00603265|157140220|FG001|Overall Study|Protocol Violation|0|||
48808362|NCT00603265|157140221|FG002|Overall Study|Protocol Violation|0|||
48808363|NCT02002884|157140223|FG000|Main Period (MP)|Other|0|||
48808364|NCT02002884|157140224|FG001|Main Period (MP)|Other|3|||
48808365|NCT02002884|157140225|FG002|Main Period (MP)|Other|3|||
48808366|NCT02002884|157140226|FG003|Main Period (MP)|Other|0|||
48808367|NCT02002884|157140223|FG000|Main Period (MP)|Adverse Event|0|||
48808368|NCT02002884|157140224|FG001|Main Period (MP)|Adverse Event|1|||
48808369|NCT02002884|157140225|FG002|Main Period (MP)|Adverse Event|1|||
48808370|NCT02002884|157140226|FG003|Main Period (MP)|Adverse Event|0|||
48808371|NCT02002884|157140223|FG000|Main Period (MP)|Withdrawal by Subject|6|||
48808372|NCT02002884|157140224|FG001|Main Period (MP)|Withdrawal by Subject|2|||
48808373|NCT02002884|157140225|FG002|Main Period (MP)|Withdrawal by Subject|2|||
48808374|NCT02002884|157140226|FG003|Main Period (MP)|Withdrawal by Subject|0|||
48808375|NCT02002884|157140223|FG000|Main Period (MP)|Lost to Follow-up|0|||
48808376|NCT02002884|157140224|FG001|Main Period (MP)|Lost to Follow-up|0|||
48808377|NCT02002884|157140225|FG002|Main Period (MP)|Lost to Follow-up|2|||
48808378|NCT02002884|157140226|FG003|Main Period (MP)|Lost to Follow-up|0|||
48808379|NCT02002884|157140223|FG000|Open-Label Extension Period (OLEX)|Other|0|||
48808380|NCT02002884|157140224|FG001|Open-Label Extension Period (OLEX)|Other|0|||
48808381|NCT02002884|157140225|FG002|Open-Label Extension Period (OLEX)|Other|0|||
48808382|NCT02002884|157140226|FG003|Open-Label Extension Period (OLEX)|Other|24|||
48808383|NCT02002884|157140223|FG000|Open-Label Extension Period (OLEX)|Physician Decision|0|||
48808384|NCT02002884|157140224|FG001|Open-Label Extension Period (OLEX)|Physician Decision|0|||
48808385|NCT02002884|157140225|FG002|Open-Label Extension Period (OLEX)|Physician Decision|0|||
48808386|NCT02002884|157140226|FG003|Open-Label Extension Period (OLEX)|Physician Decision|1|||
48808387|NCT02002884|157140223|FG000|Open-Label Extension Period (OLEX)|Adverse Event|0|||
48917633|NCT00271817|157534128|FG002|Part 1|LDL < 50 mg/dL|48|||
48917634|NCT00271817|157534126|FG000|Part 2|Adverse Event|0|||
48917635|NCT00271817|157534127|FG001|Part 2|Adverse Event|17|||
48917636|NCT00271817|157534128|FG002|Part 2|Adverse Event|33|||
48917637|NCT00271817|157534126|FG000|Part 2|Lack of Efficacy|0|||
48917638|NCT00271817|157534127|FG001|Part 2|Lack of Efficacy|1|||
48917639|NCT00271817|157534128|FG002|Part 2|Lack of Efficacy|6|||
48917640|NCT00271817|157534126|FG000|Part 2|Lost to Follow-up|0|||
48917641|NCT00271817|157534127|FG001|Part 2|Lost to Follow-up|6|||
48917642|NCT00271817|157534128|FG002|Part 2|Lost to Follow-up|18|||
48917643|NCT00271817|157534126|FG000|Part 2|Protocol Violation|0|||
48917644|NCT00271817|157534127|FG001|Part 2|Protocol Violation|3|||
48917645|NCT00271817|157534128|FG002|Part 2|Protocol Violation|5|||
48917646|NCT00271817|157534126|FG000|Part 2|Patient Moved|0|||
48917647|NCT00271817|157534127|FG001|Part 2|Patient Moved|0|||
48917648|NCT00271817|157534128|FG002|Part 2|Patient Moved|5|||
48917649|NCT00271817|157534126|FG000|Part 2|Withdrawal by Subject|0|||
48917650|NCT00271817|157534127|FG001|Part 2|Withdrawal by Subject|2|||
48917651|NCT00271817|157534128|FG002|Part 2|Withdrawal by Subject|13|||
48917652|NCT00271817|157534126|FG000|Part 2|LDL < 50 mg/dL|0|||
48917653|NCT00271817|157534127|FG001|Part 2|LDL < 50 mg/dL|3|||
48917654|NCT00271817|157534128|FG002|Part 2|LDL < 50 mg/dL|4|||
48917655|NCT05054114|157534133|FG000|Overall Study|Protocol Violation|13|||
48808388|NCT02002884|157140224|FG001|Open-Label Extension Period (OLEX)|Adverse Event|0|||
48917656|NCT05054114|157534134|FG001|Overall Study|Protocol Violation|1|||
48917657|NCT05054114|157534133|FG000|Overall Study|Pregnancy|0|||
48917658|NCT05054114|157534134|FG001|Overall Study|Pregnancy|1|||
48808389|NCT02002884|157140225|FG002|Open-Label Extension Period (OLEX)|Adverse Event|0|||
48917659|NCT04360551|157535758|FG000|Overall Study|Withdrawal by Subject|1|||
48917660|NCT04360551|157535759|FG001|Overall Study|Withdrawal by Subject|0|||
48917661|NCT02807480|157535760|FG000|Overall Study|Withdrawal by Subject|14|||
48917662|NCT02807480|157535761|FG001|Overall Study|Withdrawal by Subject|10|||
48917663|NCT01611974|157535762|FG000|Overall Study|Death|10|||
48808390|NCT02002884|157140226|FG003|Open-Label Extension Period (OLEX)|Adverse Event|5|||
48808391|NCT02002884|157140223|FG000|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
48808392|NCT02002884|157140224|FG001|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
48808393|NCT02002884|157140225|FG002|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
48917664|NCT01611974|157535763|FG001|Overall Study|Death|12|||
48917665|NCT01611974|157535764|FG002|Overall Study|Death|10|||
48917666|NCT01611974|157535762|FG000|Overall Study|Lost to Follow-up|0|||
48917667|NCT01611974|157535763|FG001|Overall Study|Lost to Follow-up|1|||
48917668|NCT01611974|157535764|FG002|Overall Study|Lost to Follow-up|0|||
48917669|NCT01611974|157535762|FG000|Overall Study|Physician Decision|5|||
48808394|NCT02002884|157140226|FG003|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10|||
48808395|NCT02002884|157140223|FG000|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
48808396|NCT02002884|157140224|FG001|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
48808397|NCT02002884|157140225|FG002|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
48808398|NCT02002884|157140226|FG003|Open-Label Extension Period (OLEX)|Lost to Follow-up|10|||
48808399|NCT00462670|157140227|FG000|Overall Study|Adverse Event|3|||
48808400|NCT00462670|157140228|FG001|Overall Study|Adverse Event|5|||
48808401|NCT00462670|157140227|FG000|Overall Study|Lack of Efficacy|1|||
48808402|NCT00462670|157140228|FG001|Overall Study|Lack of Efficacy|0|||
48808403|NCT00462670|157140227|FG000|Overall Study|Protocol Violation|1|||
48808404|NCT00462670|157140228|FG001|Overall Study|Protocol Violation|0|||
48808405|NCT00462670|157140227|FG000|Overall Study|Resolution of signs and symptoms|0|||
48808406|NCT00462670|157140228|FG001|Overall Study|Resolution of signs and symptoms|2|||
48808407|NCT02966002|157140229|FG000|Overall Study|Withdrawal by Subject|2|||
48808408|NCT02966002|157140229|FG000|Overall Study|Adverse Event|1|||
48808409|NCT02966002|157140229|FG000|Overall Study|Lost to Follow-up|1|||
48808410|NCT05340751|157140230|FG000|Overall Study|Physician Decision|3|||
48808411|NCT02110732|157140243|FG000|Overall Study|Physician Decision|5|||
48808412|NCT02110732|157140244|FG001|Overall Study|Physician Decision|2|||
48808413|NCT02110732|157140243|FG000|Overall Study|Lost to Follow-up|1|||
48808414|NCT02110732|157140244|FG001|Overall Study|Lost to Follow-up|1|||
48808415|NCT01642602|157140245|FG000|Overall Study|Adverse Event|2|||
48808416|NCT04887948|157140246|FG000|Overall Study|Death|1|||
48808417|NCT04887948|157140247|FG001|Overall Study|Death|0|||
48808418|NCT04887948|157140248|FG002|Overall Study|Death|0|||
48808419|NCT04887948|157140246|FG000|Overall Study|Lost to Follow-up|1|||
48808420|NCT04887948|157140247|FG001|Overall Study|Lost to Follow-up|0|||
48808421|NCT04887948|157140248|FG002|Overall Study|Lost to Follow-up|3|||
48808422|NCT04887948|157140246|FG000|Overall Study|Physician Decision|0|||
48808423|NCT04887948|157140247|FG001|Overall Study|Physician Decision|4|||
48808424|NCT04887948|157140248|FG002|Overall Study|Physician Decision|1|||
48808425|NCT04887948|157140246|FG000|Overall Study|Protocol Violation|1|||
48808426|NCT04887948|157140247|FG001|Overall Study|Protocol Violation|1|||
48808427|NCT04887948|157140248|FG002|Overall Study|Protocol Violation|0|||
48808428|NCT04887948|157140246|FG000|Overall Study|Withdrawal by Subject|0|||
48808429|NCT04887948|157140247|FG001|Overall Study|Withdrawal by Subject|6|||
48808430|NCT04887948|157140248|FG002|Overall Study|Withdrawal by Subject|1|||
48808431|NCT04887948|157140246|FG000|Overall Study|No longer met eligibility criteria|1|||
48808432|NCT04887948|157140247|FG001|Overall Study|No longer met eligibility criteria|2|||
48808433|NCT04887948|157140248|FG002|Overall Study|No longer met eligibility criteria|1|||
48808434|NCT04887948|157140246|FG000|Overall Study|Other|2|||
48808435|NCT04887948|157140247|FG001|Overall Study|Other|1|||
48808436|NCT04887948|157140248|FG002|Overall Study|Other|1|||
48808437|NCT02748694|157140251|FG000|Overall Study|Voluntary Withdrawal|0|||
48808438|NCT02748694|157140252|FG001|Overall Study|Voluntary Withdrawal|0|||
48808439|NCT02748694|157140253|FG002|Overall Study|Voluntary Withdrawal|0|||
48808440|NCT02748694|157140254|FG003|Overall Study|Voluntary Withdrawal|0|||
48808441|NCT02748694|157140255|FG004|Overall Study|Voluntary Withdrawal|0|||
48808442|NCT02748694|157140256|FG005|Overall Study|Voluntary Withdrawal|0|||
48808443|NCT02748694|157140257|FG006|Overall Study|Voluntary Withdrawal|0|||
48808444|NCT02748694|157140258|FG007|Overall Study|Voluntary Withdrawal|0|||
48808445|NCT02748694|157140259|FG008|Overall Study|Voluntary Withdrawal|0|||
48808446|NCT02748694|157140260|FG009|Overall Study|Voluntary Withdrawal|0|||
48808447|NCT02748694|157140261|FG010|Overall Study|Voluntary Withdrawal|0|||
48808448|NCT02748694|157140262|FG011|Overall Study|Voluntary Withdrawal|0|||
49120597|NCT02326272|158280509|FG001|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
49120598|NCT02326272|158280510|FG002|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1|||
49120599|NCT02326272|158280511|FG003|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
49120600|NCT02326272|158280512|FG004|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
49120601|NCT02326272|158280513|FG005|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
48808449|NCT02748694|157140263|FG012|Overall Study|Voluntary Withdrawal|0|||
48808450|NCT02748694|157140264|FG013|Overall Study|Voluntary Withdrawal|0|||
48808451|NCT02748694|157140265|FG014|Overall Study|Voluntary Withdrawal|2|||
48917670|NCT01611974|157535763|FG001|Overall Study|Physician Decision|1|||
48808452|NCT01350141|157140266|FG000|Overall Study|Lost to Follow-up|1|||
48808453|NCT01350141|157140267|FG001|Overall Study|Lost to Follow-up|0|||
48808454|NCT01350141|157140268|FG002|Overall Study|Lost to Follow-up|1|||
48808455|NCT01350141|157140266|FG000|Overall Study|Withdrawal by Subject|1|||
48808456|NCT01350141|157140267|FG001|Overall Study|Withdrawal by Subject|0|||
48808457|NCT01350141|157140268|FG002|Overall Study|Withdrawal by Subject|0|||
48808458|NCT01350141|157140266|FG000|Overall Study|Randomized but not treated|1|||
48808459|NCT01350141|157140267|FG001|Overall Study|Randomized but not treated|0|||
48808460|NCT01350141|157140268|FG002|Overall Study|Randomized but not treated|0|||
48917671|NCT01611974|157535764|FG002|Overall Study|Physician Decision|2|||
48808461|NCT00539643|157140271|FG000|Overall Study|Adverse Event|1|||
48808462|NCT00539643|157140272|FG001|Overall Study|Adverse Event|0|||
48808463|NCT00539643|157140271|FG000|Overall Study|Death|2|||
48808464|NCT00539643|157140272|FG001|Overall Study|Death|1|||
48808465|NCT00539643|157140271|FG000|Overall Study|Physician Decision|3|||
48808466|NCT00539643|157140272|FG001|Overall Study|Physician Decision|1|||
48808467|NCT00539643|157140271|FG000|Overall Study|Withdrawal by Subject|0|||
48808468|NCT00539643|157140272|FG001|Overall Study|Withdrawal by Subject|1|||
48808469|NCT02508532|157140273|FG000|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
48808470|NCT02508532|157140274|FG001|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
48808471|NCT02508532|157140275|FG002|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
48808472|NCT02508532|157140276|FG003|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
48808473|NCT02508532|157140277|FG004|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
48808474|NCT02508532|157140278|FG005|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
48808475|NCT02508532|157140279|FG006|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1|||
48808476|NCT02508532|157140280|FG007|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
48808477|NCT02508532|157140281|FG008|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
48808478|NCT02508532|157140273|FG000|Part 1 - Dose Determining Period|Not Evaluable|0|||
48808479|NCT02508532|157140274|FG001|Part 1 - Dose Determining Period|Not Evaluable|0|||
48808480|NCT02508532|157140275|FG002|Part 1 - Dose Determining Period|Not Evaluable|0|||
48808481|NCT02508532|157140276|FG003|Part 1 - Dose Determining Period|Not Evaluable|0|||
48808482|NCT02508532|157140277|FG004|Part 1 - Dose Determining Period|Not Evaluable|0|||
48808483|NCT02508532|157140278|FG005|Part 1 - Dose Determining Period|Not Evaluable|0|||
48808484|NCT02508532|157140279|FG006|Part 1 - Dose Determining Period|Not Evaluable|0|||
48808485|NCT02508532|157140280|FG007|Part 1 - Dose Determining Period|Not Evaluable|1|||
48808486|NCT02508532|157140281|FG008|Part 1 - Dose Determining Period|Not Evaluable|0|||
48808487|NCT02508532|157140273|FG000|Part 2 - Treatment|Disease Progression|0|||
48808488|NCT02508532|157140274|FG001|Part 2 - Treatment|Disease Progression|0|||
48808489|NCT02508532|157140275|FG002|Part 2 - Treatment|Disease Progression|0|||
48808490|NCT02508532|157140276|FG003|Part 2 - Treatment|Disease Progression|0|||
48808491|NCT02508532|157140277|FG004|Part 2 - Treatment|Disease Progression|0|||
48808492|NCT02508532|157140278|FG005|Part 2 - Treatment|Disease Progression|0|||
48808493|NCT02508532|157140279|FG006|Part 2 - Treatment|Disease Progression|0|||
48808494|NCT02508532|157140280|FG007|Part 2 - Treatment|Disease Progression|0|||
48808495|NCT02508532|157140281|FG008|Part 2 - Treatment|Disease Progression|118|||
48808496|NCT02508532|157140273|FG000|Part 2 - Treatment|Adverse Event|0|||
48808497|NCT02508532|157140274|FG001|Part 2 - Treatment|Adverse Event|0|||
48808498|NCT02508532|157140275|FG002|Part 2 - Treatment|Adverse Event|0|||
48808499|NCT02508532|157140276|FG003|Part 2 - Treatment|Adverse Event|0|||
48808500|NCT02508532|157140277|FG004|Part 2 - Treatment|Adverse Event|0|||
48808501|NCT02508532|157140278|FG005|Part 2 - Treatment|Adverse Event|0|||
48808502|NCT02508532|157140279|FG006|Part 2 - Treatment|Adverse Event|0|||
48808503|NCT02508532|157140280|FG007|Part 2 - Treatment|Adverse Event|0|||
48808504|NCT02508532|157140281|FG008|Part 2 - Treatment|Adverse Event|49|||
48808505|NCT02508532|157140273|FG000|Part 2 - Treatment|Physician Decision|0|||
48808506|NCT02508532|157140274|FG001|Part 2 - Treatment|Physician Decision|0|||
48808507|NCT02508532|157140275|FG002|Part 2 - Treatment|Physician Decision|0|||
48808508|NCT02508532|157140276|FG003|Part 2 - Treatment|Physician Decision|0|||
48808509|NCT02508532|157140277|FG004|Part 2 - Treatment|Physician Decision|0|||
48808510|NCT02508532|157140278|FG005|Part 2 - Treatment|Physician Decision|0|||
48808511|NCT02508532|157140279|FG006|Part 2 - Treatment|Physician Decision|0|||
48808512|NCT02508532|157140280|FG007|Part 2 - Treatment|Physician Decision|0|||
48808513|NCT02508532|157140281|FG008|Part 2 - Treatment|Physician Decision|12|||
48808514|NCT02508532|157140273|FG000|Part 2 - Treatment|Administrative|0|||
48808515|NCT02508532|157140274|FG001|Part 2 - Treatment|Administrative|0|||
48808516|NCT02508532|157140275|FG002|Part 2 - Treatment|Administrative|0|||
48808517|NCT02508532|157140276|FG003|Part 2 - Treatment|Administrative|0|||
48808518|NCT02508532|157140277|FG004|Part 2 - Treatment|Administrative|0|||
48808519|NCT02508532|157140278|FG005|Part 2 - Treatment|Administrative|0|||
48808520|NCT02508532|157140279|FG006|Part 2 - Treatment|Administrative|0|||
49120602|NCT02326272|158280514|FG006|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
49120603|NCT02326272|158280515|FG007|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
49120604|NCT02326272|158280516|FG008|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
48808521|NCT02508532|157140280|FG007|Part 2 - Treatment|Administrative|0|||
48808522|NCT02508532|157140281|FG008|Part 2 - Treatment|Administrative|3|||
48808523|NCT02508532|157140273|FG000|Part 2 - Treatment|Sponsor Decision|0|||
48808524|NCT02508532|157140274|FG001|Part 2 - Treatment|Sponsor Decision|0|||
48808525|NCT02508532|157140275|FG002|Part 2 - Treatment|Sponsor Decision|0|||
48808526|NCT02508532|157140276|FG003|Part 2 - Treatment|Sponsor Decision|0|||
48808527|NCT02508532|157140277|FG004|Part 2 - Treatment|Sponsor Decision|0|||
48808528|NCT02508532|157140278|FG005|Part 2 - Treatment|Sponsor Decision|0|||
48808529|NCT02508532|157140279|FG006|Part 2 - Treatment|Sponsor Decision|0|||
48808530|NCT02508532|157140280|FG007|Part 2 - Treatment|Sponsor Decision|0|||
48808531|NCT02508532|157140281|FG008|Part 2 - Treatment|Sponsor Decision|28|||
48808532|NCT02508532|157140273|FG000|Part 2 - Treatment|Death|0|||
48808533|NCT02508532|157140274|FG001|Part 2 - Treatment|Death|0|||
48808534|NCT02508532|157140275|FG002|Part 2 - Treatment|Death|0|||
48808535|NCT02508532|157140276|FG003|Part 2 - Treatment|Death|0|||
48808536|NCT02508532|157140277|FG004|Part 2 - Treatment|Death|0|||
48808537|NCT02508532|157140278|FG005|Part 2 - Treatment|Death|0|||
48808538|NCT02508532|157140279|FG006|Part 2 - Treatment|Death|0|||
48808539|NCT02508532|157140280|FG007|Part 2 - Treatment|Death|0|||
48808540|NCT02508532|157140281|FG008|Part 2 - Treatment|Death|1|||
48808541|NCT02508532|157140273|FG000|Part 2 - Treatment|Withdrawal by Subject|0|||
48808542|NCT02508532|157140274|FG001|Part 2 - Treatment|Withdrawal by Subject|0|||
48808543|NCT02508532|157140275|FG002|Part 2 - Treatment|Withdrawal by Subject|0|||
48808544|NCT02508532|157140276|FG003|Part 2 - Treatment|Withdrawal by Subject|0|||
48808545|NCT02508532|157140277|FG004|Part 2 - Treatment|Withdrawal by Subject|0|||
48808546|NCT02508532|157140278|FG005|Part 2 - Treatment|Withdrawal by Subject|0|||
48808547|NCT02508532|157140279|FG006|Part 2 - Treatment|Withdrawal by Subject|0|||
48808548|NCT02508532|157140280|FG007|Part 2 - Treatment|Withdrawal by Subject|0|||
48808549|NCT02508532|157140281|FG008|Part 2 - Treatment|Withdrawal by Subject|6|||
48808550|NCT02508532|157140273|FG000|Part 1 and Part 2 End of Study|Disease Progression|2|||
48808551|NCT02508532|157140274|FG001|Part 1 and Part 2 End of Study|Disease Progression|0|||
48808552|NCT02508532|157140275|FG002|Part 1 and Part 2 End of Study|Disease Progression|0|||
48808553|NCT02508532|157140276|FG003|Part 1 and Part 2 End of Study|Disease Progression|0|||
48808554|NCT02508532|157140277|FG004|Part 1 and Part 2 End of Study|Disease Progression|0|||
48808555|NCT02508532|157140278|FG005|Part 1 and Part 2 End of Study|Disease Progression|0|||
48808556|NCT02508532|157140279|FG006|Part 1 and Part 2 End of Study|Disease Progression|0|||
48808557|NCT02508532|157140280|FG007|Part 1 and Part 2 End of Study|Disease Progression|1|||
48808558|NCT02508532|157140281|FG008|Part 1 and Part 2 End of Study|Disease Progression|6|||
48808559|NCT02508532|157140273|FG000|Part 1 and Part 2 End of Study|Adverse Event|1|||
48808560|NCT02508532|157140274|FG001|Part 1 and Part 2 End of Study|Adverse Event|0|||
48808561|NCT02508532|157140275|FG002|Part 1 and Part 2 End of Study|Adverse Event|1|||
48808562|NCT02508532|157140276|FG003|Part 1 and Part 2 End of Study|Adverse Event|0|||
48808563|NCT02508532|157140277|FG004|Part 1 and Part 2 End of Study|Adverse Event|0|||
48808564|NCT02508532|157140278|FG005|Part 1 and Part 2 End of Study|Adverse Event|0|||
48808565|NCT02508532|157140279|FG006|Part 1 and Part 2 End of Study|Adverse Event|0|||
48808566|NCT02508532|157140280|FG007|Part 1 and Part 2 End of Study|Adverse Event|0|||
48808567|NCT02508532|157140281|FG008|Part 1 and Part 2 End of Study|Adverse Event|2|||
48808568|NCT02508532|157140273|FG000|Part 1 and Part 2 End of Study|Death|0|||
48808569|NCT02508532|157140274|FG001|Part 1 and Part 2 End of Study|Death|4|||
48808570|NCT02508532|157140275|FG002|Part 1 and Part 2 End of Study|Death|2|||
48808571|NCT02508532|157140276|FG003|Part 1 and Part 2 End of Study|Death|4|||
48808572|NCT02508532|157140277|FG004|Part 1 and Part 2 End of Study|Death|3|||
48808573|NCT02508532|157140278|FG005|Part 1 and Part 2 End of Study|Death|0|||
48808574|NCT02508532|157140279|FG006|Part 1 and Part 2 End of Study|Death|0|||
48808575|NCT02508532|157140280|FG007|Part 1 and Part 2 End of Study|Death|1|||
48808576|NCT02508532|157140281|FG008|Part 1 and Part 2 End of Study|Death|111|||
48808577|NCT02508532|157140273|FG000|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
48808578|NCT02508532|157140274|FG001|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
48808579|NCT02508532|157140275|FG002|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
48808580|NCT02508532|157140276|FG003|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
48808581|NCT02508532|157140277|FG004|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
48808582|NCT02508532|157140278|FG005|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
48808583|NCT02508532|157140279|FG006|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
48808584|NCT02508532|157140280|FG007|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
48808585|NCT02508532|157140281|FG008|Part 1 and Part 2 End of Study|Lost to Follow-up|6|||
48808586|NCT02508532|157140273|FG000|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
48808587|NCT02508532|157140274|FG001|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
48808588|NCT02508532|157140275|FG002|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
48808589|NCT02508532|157140276|FG003|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
48808590|NCT02508532|157140277|FG004|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
48808591|NCT02508532|157140278|FG005|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
48808592|NCT02508532|157140279|FG006|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
48808593|NCT02508532|157140280|FG007|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
48808594|NCT02508532|157140281|FG008|Part 1 and Part 2 End of Study|Withdrawal by Subject|15|||
48808595|NCT02508532|157140273|FG000|Part 1 and Part 2 End of Study|Physician Decision|0|||
49010752|NCT03705169|157875692|FG009|Overall Study|Concerns about study visit compliance|0|||
49010753|NCT00185211|157875695|FG000|Placebo-controlled Study (92012)|Adverse Event|8|||
49010754|NCT00185211|157875696|FG001|Placebo-controlled Study (92012)|Adverse Event|0|||
49010755|NCT00185211|157875695|FG000|Placebo-controlled Study (92012)|Lost to Follow-up|3|||
49010756|NCT00185211|157875696|FG001|Placebo-controlled Study (92012)|Lost to Follow-up|2|||
49010757|NCT00185211|157875695|FG000|Placebo-controlled Study (92012)|Withdrawal by Subject|9|||
48710969|NCT02152956|156791420|FG001|Overall Study|Withdrawal by Subject|0|||
48710970|NCT02152956|156791421|FG002|Overall Study|Withdrawal by Subject|1|||
48710971|NCT02152956|156791422|FG003|Overall Study|Withdrawal by Subject|0|||
48710972|NCT02152956|156791423|FG004|Overall Study|Withdrawal by Subject|2|||
48710973|NCT02152956|156791424|FG005|Overall Study|Withdrawal by Subject|2|||
48710974|NCT02152956|156791425|FG006|Overall Study|Withdrawal by Subject|0|||
48710975|NCT02152956|156791426|FG007|Overall Study|Withdrawal by Subject|0|||
48710976|NCT02152956|156791427|FG008|Overall Study|Withdrawal by Subject|1|||
48710977|NCT02152956|156791428|FG009|Overall Study|Withdrawal by Subject|0|||
48710978|NCT02152956|156791429|FG010|Overall Study|Withdrawal by Subject|0|||
48710979|NCT02152956|156791430|FG011|Overall Study|Withdrawal by Subject|4|||
48710980|NCT02152956|156791431|FG012|Overall Study|Withdrawal by Subject|0|||
48710981|NCT02152956|156791419|FG000|Overall Study|Physician Decision|0|||
48710982|NCT02152956|156791420|FG001|Overall Study|Physician Decision|0|||
48710983|NCT02152956|156791421|FG002|Overall Study|Physician Decision|0|||
48710984|NCT02152956|156791422|FG003|Overall Study|Physician Decision|0|||
48710985|NCT02152956|156791423|FG004|Overall Study|Physician Decision|0|||
48710986|NCT02152956|156791424|FG005|Overall Study|Physician Decision|0|||
48710987|NCT02152956|156791425|FG006|Overall Study|Physician Decision|0|||
48710988|NCT02152956|156791426|FG007|Overall Study|Physician Decision|0|||
48710989|NCT02152956|156791427|FG008|Overall Study|Physician Decision|0|||
48710990|NCT02152956|156791428|FG009|Overall Study|Physician Decision|0|||
48710991|NCT02152956|156791429|FG010|Overall Study|Physician Decision|0|||
48710992|NCT02152956|156791430|FG011|Overall Study|Physician Decision|1|||
48710993|NCT02152956|156791431|FG012|Overall Study|Physician Decision|0|||
48710994|NCT02152956|156791419|FG000|Overall Study|Study terminated by sponsor|0|||
48710995|NCT02152956|156791420|FG001|Overall Study|Study terminated by sponsor|0|||
48710996|NCT02152956|156791421|FG002|Overall Study|Study terminated by sponsor|0|||
48710997|NCT02152956|156791422|FG003|Overall Study|Study terminated by sponsor|0|||
48710998|NCT02152956|156791423|FG004|Overall Study|Study terminated by sponsor|0|||
48710999|NCT02152956|156791424|FG005|Overall Study|Study terminated by sponsor|0|||
48711000|NCT02152956|156791425|FG006|Overall Study|Study terminated by sponsor|0|||
48711001|NCT02152956|156791426|FG007|Overall Study|Study terminated by sponsor|0|||
48711002|NCT02152956|156791427|FG008|Overall Study|Study terminated by sponsor|0|||
48711003|NCT02152956|156791428|FG009|Overall Study|Study terminated by sponsor|0|||
48711004|NCT02152956|156791429|FG010|Overall Study|Study terminated by sponsor|0|||
48711005|NCT02152956|156791430|FG011|Overall Study|Study terminated by sponsor|29|||
48711006|NCT02152956|156791431|FG012|Overall Study|Study terminated by sponsor|0|||
48711007|NCT02152956|156791419|FG000|Overall Study|progressive disease|0|||
48711008|NCT02152956|156791420|FG001|Overall Study|progressive disease|0|||
48711009|NCT02152956|156791421|FG002|Overall Study|progressive disease|0|||
48711010|NCT02152956|156791422|FG003|Overall Study|progressive disease|0|||
48711011|NCT02152956|156791423|FG004|Overall Study|progressive disease|0|||
48711012|NCT02152956|156791424|FG005|Overall Study|progressive disease|0|||
48711013|NCT02152956|156791425|FG006|Overall Study|progressive disease|0|||
48711014|NCT02152956|156791426|FG007|Overall Study|progressive disease|0|||
48711015|NCT02152956|156791427|FG008|Overall Study|progressive disease|1|||
48711016|NCT02152956|156791428|FG009|Overall Study|progressive disease|0|||
48711017|NCT02152956|156791429|FG010|Overall Study|progressive disease|0|||
48711018|NCT02152956|156791430|FG011|Overall Study|progressive disease|1|||
48711019|NCT02152956|156791431|FG012|Overall Study|progressive disease|0|||
48711020|NCT02527421|156791432|FG000|Overall Study|Withdrawal by Subject|1|||
48711021|NCT02527421|156791433|FG001|Overall Study|Withdrawal by Subject|0|||
48711022|NCT00782834|156791434|FG000|Treatment Phase|fibrous tumor not GIST|1|||
48711023|NCT02259088|156791435|FG000|Overall Study|Adverse Event|6|||
48711024|NCT02259088|156791436|FG001|Overall Study|Adverse Event|4|||
48711025|NCT02259088|156791435|FG000|Overall Study|Lost to Follow-up|2|||
48711026|NCT02259088|156791436|FG001|Overall Study|Lost to Follow-up|0|||
48808596|NCT02508532|157140274|FG001|Part 1 and Part 2 End of Study|Physician Decision|0|||
48917672|NCT01611974|157535762|FG000|Overall Study|Withdrawal by Subject|0|||
48917673|NCT01611974|157535763|FG001|Overall Study|Withdrawal by Subject|1|||
48917674|NCT01611974|157535764|FG002|Overall Study|Withdrawal by Subject|4|||
48917675|NCT02347098|157535767|FG000|Overall Study|Death|1|||
48711027|NCT02259088|156791435|FG000|Overall Study|Death|2|||
48711028|NCT02259088|156791436|FG001|Overall Study|Death|0|||
48711029|NCT02259088|156791435|FG000|Overall Study|Physician Decision|5|||
48711030|NCT02259088|156791436|FG001|Overall Study|Physician Decision|2|||
48711031|NCT02259088|156791435|FG000|Overall Study|Protocol deviation|5|||
48711032|NCT02259088|156791436|FG001|Overall Study|Protocol deviation|0|||
48711033|NCT02259088|156791435|FG000|Overall Study|Subject/guardian decision|8|||
48711034|NCT02259088|156791436|FG001|Overall Study|Subject/guardian decision|8|||
48711035|NCT02252939|156791439|FG000|Overall Study|Lost to Follow-up|3|||
48711036|NCT02660983|156791440|FG000|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1|||
48711037|NCT02660983|156791441|FG001|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5|||
48711038|NCT02660983|156791440|FG000|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15|||
48711039|NCT02660983|156791441|FG001|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12|||
48917676|NCT02347098|157535768|FG001|Overall Study|Death|0|||
48917677|NCT02347098|157535767|FG000|Overall Study|Withdrawal by Subject|1|||
48917678|NCT02347098|157535768|FG001|Overall Study|Withdrawal by Subject|0|||
48917679|NCT02347098|157535767|FG000|Overall Study|Lost to Follow-up|2|||
48917680|NCT02347098|157535768|FG001|Overall Study|Lost to Follow-up|2|||
48917681|NCT02347098|157535767|FG000|Overall Study|Refuse Follow-up Visit|1|||
48917682|NCT02347098|157535768|FG001|Overall Study|Refuse Follow-up Visit|5|||
48917683|NCT02347098|157535767|FG000|Overall Study|no visit due to illness|2|||
48917684|NCT02347098|157535768|FG001|Overall Study|no visit due to illness|1|||
48917685|NCT04640272|157535769|FG000|Overall Study|Subject moved out of area|1|||
48917686|NCT00294060|157535770|FG000|Overall Study|Death|225|||
48917687|NCT00294060|157535770|FG000|Overall Study|Other|59|||
48917688|NCT00294060|157535770|FG000|Overall Study|Lost to Follow-up|55|||
48917689|NCT00294060|157535770|FG000|Overall Study|Withdrawal by Subject|11|||
48917690|NCT00294060|157535770|FG000|Overall Study|Physician Decision|797|||
48917691|NCT00294060|157535770|FG000|Overall Study|Medical condition|3|||
48917692|NCT00294060|157535770|FG000|Overall Study|Device explanted/not replaced|23|||
48917693|NCT00573430|157535781|FG000|Overall Study|Incorrect enrollment of randomization|0|||
48917694|NCT00573430|157535782|FG001|Overall Study|Incorrect enrollment of randomization|4|||
48917695|NCT00573430|157535783|FG002|Overall Study|Incorrect enrollment of randomization|3|||
48917696|NCT00573430|157535781|FG000|Overall Study|Adverse Event|0|||
48917697|NCT00573430|157535782|FG001|Overall Study|Adverse Event|0|||
48917698|NCT00573430|157535783|FG002|Overall Study|Adverse Event|2|||
48917699|NCT00573430|157535781|FG000|Overall Study|Withdrawal by Subject|1|||
48917700|NCT00573430|157535782|FG001|Overall Study|Withdrawal by Subject|0|||
48917701|NCT00573430|157535783|FG002|Overall Study|Withdrawal by Subject|1|||
48917702|NCT00573430|157535781|FG000|Overall Study|Protocol Violation|0|||
48917703|NCT00573430|157535782|FG001|Overall Study|Protocol Violation|1|||
48917704|NCT00573430|157535783|FG002|Overall Study|Protocol Violation|1|||
48917705|NCT00573430|157535781|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
48917706|NCT00573430|157535782|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
48917707|NCT00573430|157535783|FG002|Overall Study|Eligibility criteria not fulfilled|3|||
48917708|NCT01263483|157535785|FG000|Overall Study|Adverse Event|4|||
48917709|NCT01263483|157535786|FG001|Overall Study|Adverse Event|0|||
48808597|NCT02508532|157140275|FG002|Part 1 and Part 2 End of Study|Physician Decision|1|||
48808598|NCT02508532|157140276|FG003|Part 1 and Part 2 End of Study|Physician Decision|0|||
48808599|NCT02508532|157140277|FG004|Part 1 and Part 2 End of Study|Physician Decision|1|||
48808600|NCT02508532|157140278|FG005|Part 1 and Part 2 End of Study|Physician Decision|0|||
48808601|NCT02508532|157140279|FG006|Part 1 and Part 2 End of Study|Physician Decision|0|||
48808602|NCT02508532|157140280|FG007|Part 1 and Part 2 End of Study|Physician Decision|0|||
48808603|NCT02508532|157140281|FG008|Part 1 and Part 2 End of Study|Physician Decision|8|||
48808604|NCT02508532|157140273|FG000|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
48808605|NCT02508532|157140274|FG001|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
48808606|NCT02508532|157140275|FG002|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
48808607|NCT02508532|157140276|FG003|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
48808608|NCT02508532|157140277|FG004|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
48808609|NCT02508532|157140278|FG005|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
48808610|NCT02508532|157140279|FG006|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
48808611|NCT02508532|157140280|FG007|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
48808612|NCT02508532|157140281|FG008|Part 1 and Part 2 End of Study|Initiation of another therapy|1|||
48808613|NCT02508532|157140273|FG000|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
48808614|NCT02508532|157140274|FG001|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
48808615|NCT02508532|157140275|FG002|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
48808616|NCT02508532|157140276|FG003|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
48808617|NCT02508532|157140277|FG004|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
48808618|NCT02508532|157140278|FG005|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
48808619|NCT02508532|157140279|FG006|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
48808620|NCT02508532|157140280|FG007|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
48808621|NCT02508532|157140281|FG008|Part 1 and Part 2 End of Study|Sponsor Decision|68|||
48808622|NCT00927355|157140285|FG000|Overall Study|Adverse Event|1|||
48808623|NCT00927355|157140286|FG001|Overall Study|Adverse Event|1|||
48917710|NCT01263483|157535787|FG002|Overall Study|Adverse Event|3|||
48917711|NCT01263483|157535785|FG000|Overall Study|Withdrawal by Subject|1|||
48917712|NCT01263483|157535786|FG001|Overall Study|Withdrawal by Subject|0|||
48917713|NCT01263483|157535787|FG002|Overall Study|Withdrawal by Subject|0|||
48917714|NCT01263483|157535785|FG000|Overall Study|Lack of Efficacy|2|||
48917715|NCT01263483|157535786|FG001|Overall Study|Lack of Efficacy|0|||
48917716|NCT01263483|157535787|FG002|Overall Study|Lack of Efficacy|0|||
48917717|NCT01263483|157535785|FG000|Overall Study|Protocol Violation|0|||
48917718|NCT01263483|157535786|FG001|Overall Study|Protocol Violation|1|||
48808624|NCT03097861|157140290|FG000|Overall Study|Adverse Event|3|||
48808625|NCT03097861|157140291|FG001|Overall Study|Adverse Event|8|||
48917719|NCT01263483|157535787|FG002|Overall Study|Protocol Violation|1|||
48917720|NCT01263483|157535785|FG000|Overall Study|Participant Unavailability|0|||
49120605|NCT02326272|158280517|FG009|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
49120606|NCT02326272|158280518|FG010|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
49120607|NCT02326272|158280519|FG011|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
48711040|NCT02660983|156791440|FG000|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8|||
48711041|NCT02660983|156791441|FG001|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9|||
48711042|NCT02660983|156791440|FG000|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
48711043|NCT02660983|156791441|FG001|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
48711044|NCT02660983|156791440|FG000|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1|||
48711045|NCT02660983|156791441|FG001|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4|||
48711046|NCT02660983|156791440|FG000|Open Label Extension Phase (24 Weeks)|Adverse Event|1|||
48808626|NCT03097861|157140292|FG002|Overall Study|Adverse Event|4|||
48808627|NCT03097861|157140290|FG000|Overall Study|Investigator Decision|0|||
48711047|NCT02660983|156791441|FG001|Open Label Extension Phase (24 Weeks)|Adverse Event|3|||
48711048|NCT02660983|156791440|FG000|Open Label Extension Phase (24 Weeks)|Other|0|||
48711049|NCT02660983|156791441|FG001|Open Label Extension Phase (24 Weeks)|Other|1|||
48711050|NCT01497366|156791445|FG000|Overall Study|Virologic failure|2|||
48711051|NCT01497366|156791446|FG001|Overall Study|Virologic failure|50|||
48711052|NCT01497366|156791445|FG000|Overall Study|Lost to Follow-up|11|||
48711053|NCT01497366|156791446|FG001|Overall Study|Lost to Follow-up|10|||
48711054|NCT01497366|156791445|FG000|Overall Study|Withdrawal by Subject|6|||
48808628|NCT03097861|157140291|FG001|Overall Study|Investigator Decision|1|||
48808629|NCT03097861|157140292|FG002|Overall Study|Investigator Decision|0|||
48808630|NCT03097861|157140290|FG000|Overall Study|Lost to Follow-up|0|||
48808631|NCT03097861|157140291|FG001|Overall Study|Lost to Follow-up|7|||
48808632|NCT03097861|157140292|FG002|Overall Study|Lost to Follow-up|1|||
48808633|NCT03097861|157140290|FG000|Overall Study|Withdrawal by Subject|1|||
48808634|NCT03097861|157140291|FG001|Overall Study|Withdrawal by Subject|5|||
48808635|NCT03097861|157140292|FG002|Overall Study|Withdrawal by Subject|3|||
48808636|NCT03097861|157140290|FG000|Overall Study|Reason not provided|3|||
48808637|NCT03097861|157140291|FG001|Overall Study|Reason not provided|1|||
48808638|NCT03097861|157140292|FG002|Overall Study|Reason not provided|1|||
48808639|NCT04503096|157140294|FG000|Overall Study|Withdrawal by Subject|3|||
48917721|NCT01263483|157535786|FG001|Overall Study|Participant Unavailability|1|||
48917722|NCT01263483|157535787|FG002|Overall Study|Participant Unavailability|1|||
48917723|NCT00876187|157535791|FG000|Overall Study|Adverse Event|14|||
48917724|NCT00876187|157535792|FG001|Overall Study|Adverse Event|12|||
48917725|NCT00876187|157535793|FG002|Overall Study|Adverse Event|19|||
49120608|NCT02326272|158280520|FG012|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
49120609|NCT02326272|158280521|FG013|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
49120610|NCT02326272|158280522|FG014|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
49120611|NCT02326272|158280508|FG000|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
49120612|NCT02326272|158280509|FG001|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
49120613|NCT02326272|158280510|FG002|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1|||
49120614|NCT02326272|158280511|FG003|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
49120615|NCT02326272|158280512|FG004|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
49120616|NCT02326272|158280513|FG005|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
49120617|NCT02326272|158280514|FG006|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
49120618|NCT02326272|158280515|FG007|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
49120619|NCT02326272|158280516|FG008|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
49120620|NCT02326272|158280517|FG009|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
49120621|NCT02326272|158280518|FG010|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
49120622|NCT02326272|158280519|FG011|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
49120623|NCT02326272|158280520|FG012|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
49120624|NCT02326272|158280521|FG013|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
49120625|NCT02326272|158280522|FG014|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
49120626|NCT02326272|158280508|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48711055|NCT01497366|156791446|FG001|Overall Study|Withdrawal by Subject|6|||
48917726|NCT00876187|157535794|FG003|Overall Study|Adverse Event|29|||
48917727|NCT00876187|157535795|FG004|Overall Study|Adverse Event|10|||
48917728|NCT00876187|157535791|FG000|Overall Study|Lack of Efficacy|59|||
48917729|NCT00876187|157535792|FG001|Overall Study|Lack of Efficacy|34|||
48711056|NCT01497366|156791445|FG000|Overall Study|Initiated Non-protocol HCV Treatment|7|||
48808640|NCT01153269|157140298|FG000|Overall Study|Withdrawal by Subject|1|||
48808641|NCT01153269|157140298|FG000|Overall Study|Antiretroviral therapy break|1|||
48917730|NCT00876187|157535793|FG002|Overall Study|Lack of Efficacy|45|||
48711057|NCT01497366|156791446|FG001|Overall Study|Initiated Non-protocol HCV Treatment|0|||
48711058|NCT01497366|156791445|FG000|Overall Study|Other|5|||
48711059|NCT01497366|156791446|FG001|Overall Study|Other|0|||
48808642|NCT03541044|157140299|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
48808643|NCT03541044|157140300|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
48808644|NCT03541044|157140299|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
48808645|NCT03541044|157140300|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
48808646|NCT03560258|157140301|FG000|Overall Study|Lost to Follow-up|3|||
48711060|NCT01497366|156791445|FG000|Overall Study|Death|1|||
48711061|NCT01497366|156791446|FG001|Overall Study|Death|1|||
48711062|NCT01497366|156791445|FG000|Overall Study|Randomized but not treated|7|||
48711063|NCT01497366|156791446|FG001|Overall Study|Randomized but not treated|21|||
48711064|NCT02703337|156791447|FG000|Period One (Part A)|Withdrawal by Subject|0|||
48711065|NCT02703337|156791448|FG001|Period One (Part A)|Withdrawal by Subject|0|||
48711066|NCT02703337|156791449|FG002|Period One (Part A)|Withdrawal by Subject|0|||
48711067|NCT02703337|156791450|FG003|Period One (Part A)|Withdrawal by Subject|0|||
48711068|NCT02703337|156791451|FG004|Period One (Part A)|Withdrawal by Subject|1|||
48711069|NCT02703337|156791452|FG005|Period One (Part A)|Withdrawal by Subject|0|||
48808647|NCT03560258|157140302|FG001|Overall Study|Lost to Follow-up|0|||
48808648|NCT03560258|157140303|FG002|Overall Study|Lost to Follow-up|0|||
48808649|NCT03560258|157140301|FG000|Overall Study|Protocol Violation|0|||
48808650|NCT03560258|157140302|FG001|Overall Study|Protocol Violation|1|||
48808651|NCT03560258|157140303|FG002|Overall Study|Protocol Violation|0|||
48808652|NCT03560258|157140301|FG000|Overall Study|Withdrawal by Subject|0|||
48808653|NCT03560258|157140302|FG001|Overall Study|Withdrawal by Subject|0|||
48808654|NCT03560258|157140303|FG002|Overall Study|Withdrawal by Subject|1|||
48917731|NCT00876187|157535794|FG003|Overall Study|Lack of Efficacy|34|||
48917732|NCT00876187|157535795|FG004|Overall Study|Lack of Efficacy|59|||
48917733|NCT00876187|157535791|FG000|Overall Study|Lost to Follow-up|9|||
48917734|NCT00876187|157535792|FG001|Overall Study|Lost to Follow-up|10|||
48917735|NCT00876187|157535793|FG002|Overall Study|Lost to Follow-up|8|||
48917736|NCT00876187|157535794|FG003|Overall Study|Lost to Follow-up|8|||
48917737|NCT00876187|157535795|FG004|Overall Study|Lost to Follow-up|11|||
48917738|NCT00876187|157535791|FG000|Overall Study|Protocol Violation|6|||
48917739|NCT00876187|157535792|FG001|Overall Study|Protocol Violation|7|||
48917740|NCT00876187|157535793|FG002|Overall Study|Protocol Violation|7|||
48917741|NCT00876187|157535794|FG003|Overall Study|Protocol Violation|6|||
48917742|NCT00876187|157535795|FG004|Overall Study|Protocol Violation|3|||
48917743|NCT00876187|157535791|FG000|Overall Study|Withdrawal by Subject|16|||
48917744|NCT00876187|157535792|FG001|Overall Study|Withdrawal by Subject|26|||
48917745|NCT00876187|157535793|FG002|Overall Study|Withdrawal by Subject|32|||
48917746|NCT00876187|157535794|FG003|Overall Study|Withdrawal by Subject|38|||
48917747|NCT00876187|157535795|FG004|Overall Study|Withdrawal by Subject|37|||
48917748|NCT00876187|157535791|FG000|Overall Study|Entered extension study|101|||
48917749|NCT00876187|157535792|FG001|Overall Study|Entered extension study|120|||
48917750|NCT00876187|157535793|FG002|Overall Study|Entered extension study|156|||
48917751|NCT00876187|157535794|FG003|Overall Study|Entered extension study|151|||
48917752|NCT00876187|157535795|FG004|Overall Study|Entered extension study|144|||
48917753|NCT00876187|157535791|FG000|Overall Study|Randomized but not treated|3|||
49120627|NCT02326272|158280509|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48711070|NCT02703337|156791453|FG006|Period One (Part A)|Withdrawal by Subject|0|||
48711071|NCT02703337|156791454|FG007|Period One (Part A)|Withdrawal by Subject|0|||
48711072|NCT02745080|156791463|FG000|Overall Study|Adverse Event|13|||
48711073|NCT02745080|156791464|FG001|Overall Study|Adverse Event|21|||
48808655|NCT01460160|157140304|FG000|Treatment Phase|Lack of Efficacy|3|||
48808656|NCT01460160|157140304|FG000|Treatment Phase|Study Drug Toxicity|2|||
48917754|NCT00876187|157535792|FG001|Overall Study|Randomized but not treated|1|||
48917755|NCT00876187|157535793|FG002|Overall Study|Randomized but not treated|3|||
48917756|NCT00876187|157535794|FG003|Overall Study|Randomized but not treated|2|||
48917757|NCT00876187|157535795|FG004|Overall Study|Randomized but not treated|3|||
48917758|NCT00876187|157535791|FG000|Overall Study|Other|2|||
48917759|NCT00876187|157535792|FG001|Overall Study|Other|5|||
48917760|NCT00876187|157535793|FG002|Overall Study|Other|9|||
48917761|NCT00876187|157535794|FG003|Overall Study|Other|7|||
48917762|NCT00876187|157535795|FG004|Overall Study|Other|4|||
49120628|NCT02326272|158280510|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
49120629|NCT02326272|158280511|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48808657|NCT01460160|157140304|FG000|Treatment Phase|Adverse Event|8|||
48917763|NCT00405067|157535796|FG000|Overall Study|Adverse Event|4|||
48917764|NCT00405067|157535797|FG001|Overall Study|Adverse Event|9|||
49120630|NCT02326272|158280512|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
48711074|NCT02745080|156791463|FG000|Overall Study|Lack of Efficacy|11|||
48808658|NCT01460160|157140304|FG000|Treatment Phase|Withdrawal by Subject|4|||
48711075|NCT02745080|156791464|FG001|Overall Study|Lack of Efficacy|23|||
48711076|NCT02745080|156791463|FG000|Overall Study|Lost to Follow-up|3|||
48808659|NCT01460160|157140304|FG000|Treatment Phase|Death|2|||
48917765|NCT00405067|157535798|FG002|Overall Study|Adverse Event|4|||
48917766|NCT00405067|157535796|FG000|Overall Study|Lost to Follow-up|0|||
48711077|NCT02745080|156791464|FG001|Overall Study|Lost to Follow-up|3|||
48711078|NCT02745080|156791463|FG000|Overall Study|Physician Decision|3|||
48711079|NCT02745080|156791464|FG001|Overall Study|Physician Decision|0|||
48711080|NCT02745080|156791463|FG000|Overall Study|Protocol Violation|3|||
48711081|NCT02745080|156791464|FG001|Overall Study|Protocol Violation|1|||
48711082|NCT02745080|156791463|FG000|Overall Study|Withdrawal by Subject|22|||
48711083|NCT02745080|156791464|FG001|Overall Study|Withdrawal by Subject|41|||
48711084|NCT00282308|156791470|FG000|Treatment Period|Lost to Follow-up|1|||
48711085|NCT00282308|156791471|FG001|Treatment Period|Lost to Follow-up|0|||
48711086|NCT00282308|156791472|FG002|Treatment Period|Lost to Follow-up|0|||
48711087|NCT00282308|156791470|FG000|Treatment Period|Subject/Guardian Decision to Withdraw|2|||
48711088|NCT00282308|156791471|FG001|Treatment Period|Subject/Guardian Decision to Withdraw|4|||
48711089|NCT00282308|156791472|FG002|Treatment Period|Subject/Guardian Decision to Withdraw|0|||
48711090|NCT00282308|156791470|FG000|Treatment Period|Adverse Event|0|||
48711091|NCT00282308|156791471|FG001|Treatment Period|Adverse Event|2|||
48711092|NCT00282308|156791472|FG002|Treatment Period|Adverse Event|0|||
48711093|NCT00282308|156791470|FG000|Treatment Period|Not Treated with Study Drug|1|||
48711094|NCT00282308|156791471|FG001|Treatment Period|Not Treated with Study Drug|0|||
48711095|NCT00282308|156791472|FG002|Treatment Period|Not Treated with Study Drug|0|||
48711096|NCT00282308|156791470|FG000|Optional Extension Re-treatment Period|Adverse Event|0|||
48711097|NCT00282308|156791471|FG001|Optional Extension Re-treatment Period|Adverse Event|0|||
48711098|NCT00282308|156791472|FG002|Optional Extension Re-treatment Period|Adverse Event|4|||
48711099|NCT00282308|156791470|FG000|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
48808660|NCT01460160|157140304|FG000|Treatment Phase|Other reasons|9|||
48808661|NCT01460160|157140304|FG000|Follow-up Phase|Withdrawal by Subject|4|||
48808662|NCT01460160|157140304|FG000|Follow-up Phase|Death|14|||
48808663|NCT01460160|157140304|FG000|Follow-up Phase|Lost to Follow-up|7|||
48808664|NCT01460160|157140304|FG000|Follow-up Phase|Follow-up no longer required per protocol|70|||
48808665|NCT01460160|157140304|FG000|Follow-up Phase|Other and not reported reasons|5|||
48808666|NCT01872910|157140305|FG000|Overall Study|Lost to Follow-up|2|||
48808667|NCT01872910|157140306|FG001|Overall Study|Lost to Follow-up|0|||
48808668|NCT01872910|157140307|FG002|Overall Study|Lost to Follow-up|2|||
48808669|NCT01872910|157140308|FG003|Overall Study|Lost to Follow-up|0|||
48808670|NCT01872910|157140309|FG004|Overall Study|Lost to Follow-up|0|||
48808671|NCT01872910|157140310|FG005|Overall Study|Lost to Follow-up|0|||
48808672|NCT02635724|157140311|FG000|Overall Study|Withdrawal by Subject|0|||
48808673|NCT02635724|157140312|FG001|Overall Study|Withdrawal by Subject|1|||
48808674|NCT02635724|157140313|FG002|Overall Study|Withdrawal by Subject|0|||
48808675|NCT00860067|157140314|FG000|Overall Study|Lost to Follow-up|46|||
48808676|NCT00860067|157140315|FG001|Overall Study|Lost to Follow-up|9|||
48808677|NCT00860067|157140316|FG002|Overall Study|Lost to Follow-up|9|||
48808678|NCT00860067|157140314|FG000|Overall Study|Withdrawal by Subject|4|||
48808679|NCT00860067|157140315|FG001|Overall Study|Withdrawal by Subject|0|||
48808680|NCT00860067|157140316|FG002|Overall Study|Withdrawal by Subject|0|||
48808681|NCT00860067|157140314|FG000|Overall Study|Pregnancy|1|||
48808682|NCT00860067|157140315|FG001|Overall Study|Pregnancy|0|||
48808683|NCT00860067|157140316|FG002|Overall Study|Pregnancy|0|||
48808684|NCT00100932|157140317|FG000|Overall Study|Adverse Event|11|||
48808685|NCT00100932|157140318|FG001|Overall Study|Adverse Event|2|||
48808686|NCT00100932|157140317|FG000|Overall Study|Withdrawal by Subject|6|||
48808687|NCT00100932|157140318|FG001|Overall Study|Withdrawal by Subject|0|||
48808688|NCT00100932|157140317|FG000|Overall Study|Progressive Disease|44|||
48711100|NCT00282308|156791471|FG001|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
48808689|NCT00100932|157140318|FG001|Overall Study|Progressive Disease|18|||
48808690|NCT00100932|157140317|FG000|Overall Study|Physician Decision|7|||
48808691|NCT00100932|157140318|FG001|Overall Study|Physician Decision|5|||
48808692|NCT00100932|157140317|FG000|Overall Study|Other|5|||
48808693|NCT00100932|157140318|FG001|Overall Study|Other|2|||
48808694|NCT00744328|157140319|FG000|Overall Study|Lost to Follow-up|2|||
48808695|NCT00744328|157140320|FG001|Overall Study|Lost to Follow-up|5|||
48808696|NCT00744328|157140321|FG002|Overall Study|Lost to Follow-up|3|||
48808697|NCT00744328|157140319|FG000|Overall Study|Withdrawal by Subject|5|||
48808698|NCT00744328|157140320|FG001|Overall Study|Withdrawal by Subject|3|||
48711101|NCT00282308|156791472|FG002|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1|||
49120631|NCT02326272|158280513|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|3|||
48711102|NCT00282308|156791470|FG000|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
48808699|NCT00744328|157140321|FG002|Overall Study|Withdrawal by Subject|4|||
48808700|NCT00744328|157140319|FG000|Overall Study|Found ineligible after randomization|0|||
48808701|NCT00744328|157140320|FG001|Overall Study|Found ineligible after randomization|0|||
48808702|NCT00744328|157140321|FG002|Overall Study|Found ineligible after randomization|1|||
48808703|NCT02387996|157140324|FG000|Overall Study|Disease Progression|167|||
48808704|NCT02387996|157140324|FG000|Overall Study|Study Drug Toxicity|31|||
48808705|NCT02387996|157140324|FG000|Overall Study|Adverse Event Unrelated to Study Drug|39|||
48808706|NCT02387996|157140324|FG000|Overall Study|Participant Request to Discontinue Treatment|20|||
48808707|NCT02387996|157140324|FG000|Overall Study|Subject Withdrew Consent|5|||
48808708|NCT02387996|157140324|FG000|Overall Study|Lost to Follow-up|1|||
48808709|NCT02387996|157140324|FG000|Overall Study|Poor/Non-Compliance|1|||
48808710|NCT02387996|157140324|FG000|Overall Study|Other Reasons|5|||
48808711|NCT02387996|157140324|FG000|Overall Study|Death|1|||
48808712|NCT00770432|157140325|FG000|Overall Study|Other|4|||
48808713|NCT00770432|157140326|FG001|Overall Study|Other|6|||
48808714|NCT00770432|157140325|FG000|Overall Study|Non-compliance|0|||
48808715|NCT00770432|157140326|FG001|Overall Study|Non-compliance|1|||
48808716|NCT02756832|157140332|FG000|Overall Study|Lost for Observation after Baseline|6|||
48808717|NCT02756832|157140332|FG000|Overall Study|Lost for Observation|13|||
48808718|NCT02756832|157140332|FG000|Overall Study|Patient's Unwillingness|12|||
48808719|NCT02756832|157140332|FG000|Overall Study|Insufficient Efficacy|2|||
48808720|NCT02756832|157140332|FG000|Overall Study|Sponsor Decision/Regulatory Requirement|1|||
48808721|NCT02756832|157140332|FG000|Overall Study|Reason not Specified|9|||
48808722|NCT02756832|157140332|FG000|Overall Study|Protocol Deviation|10|||
48808723|NCT04522180|157140333|FG000|Overall Study|Investigator judgement|3|||
48808724|NCT04522180|157140334|FG001|Overall Study|Investigator judgement|4|||
48808725|NCT04522180|157140333|FG000|Overall Study|Voluntary withdrawal|1|||
48808726|NCT04522180|157140334|FG001|Overall Study|Voluntary withdrawal|0|||
48808727|NCT04522180|157140333|FG000|Overall Study|Pregnancy|0|||
48808728|NCT04522180|157140334|FG001|Overall Study|Pregnancy|1|||
48808729|NCT04522180|157140333|FG000|Overall Study|Adverse Event or Serious Adverse event|1|||
48808730|NCT04522180|157140334|FG001|Overall Study|Adverse Event or Serious Adverse event|3|||
48808731|NCT04522180|157140333|FG000|Overall Study|Reason not specified|8|||
48808732|NCT04522180|157140334|FG001|Overall Study|Reason not specified|5|||
48808733|NCT03691948|157140335|FG000|Overall Study|Lost to Follow-up|1|||
48808734|NCT03691948|157140336|FG001|Overall Study|Lost to Follow-up|3|||
48808735|NCT00402337|157140339|FG000|Overall Study|Adverse Event|0|||
48808736|NCT00402337|157140340|FG001|Overall Study|Adverse Event|2|||
48808737|NCT00402337|157140341|FG002|Overall Study|Adverse Event|2|||
48808738|NCT00402337|157140342|FG003|Overall Study|Adverse Event|3|||
48808739|NCT00402337|157140343|FG004|Overall Study|Adverse Event|2|||
48808740|NCT00402337|157140339|FG000|Overall Study|Noncompliance|0|||
48808741|NCT00402337|157140340|FG001|Overall Study|Noncompliance|0|||
48808742|NCT00402337|157140341|FG002|Overall Study|Noncompliance|0|||
48808743|NCT00402337|157140342|FG003|Overall Study|Noncompliance|0|||
48808744|NCT00402337|157140343|FG004|Overall Study|Noncompliance|2|||
48808745|NCT00402337|157140339|FG000|Overall Study|Withdrawal by Subject|5|||
48808746|NCT00402337|157140340|FG001|Overall Study|Withdrawal by Subject|3|||
48808747|NCT00402337|157140341|FG002|Overall Study|Withdrawal by Subject|1|||
48808748|NCT00402337|157140342|FG003|Overall Study|Withdrawal by Subject|6|||
48808749|NCT00402337|157140343|FG004|Overall Study|Withdrawal by Subject|4|||
48808750|NCT00402337|157140339|FG000|Overall Study|Lost to Follow-up|0|||
48808751|NCT00402337|157140340|FG001|Overall Study|Lost to Follow-up|0|||
48808752|NCT00402337|157140341|FG002|Overall Study|Lost to Follow-up|1|||
48808753|NCT00402337|157140342|FG003|Overall Study|Lost to Follow-up|2|||
48808754|NCT00402337|157140343|FG004|Overall Study|Lost to Follow-up|0|||
48808755|NCT00402337|157140339|FG000|Overall Study|Physician Decision|0|||
48808756|NCT00402337|157140340|FG001|Overall Study|Physician Decision|0|||
48808757|NCT00402337|157140341|FG002|Overall Study|Physician Decision|0|||
48808758|NCT00402337|157140342|FG003|Overall Study|Physician Decision|1|||
48808759|NCT00402337|157140343|FG004|Overall Study|Physician Decision|0|||
48808760|NCT00402337|157140339|FG000|Overall Study|Other Reason|0|||
48808761|NCT00402337|157140340|FG001|Overall Study|Other Reason|1|||
48808762|NCT00402337|157140341|FG002|Overall Study|Other Reason|0|||
48917767|NCT00405067|157535797|FG001|Overall Study|Lost to Follow-up|0|||
48917768|NCT00405067|157535798|FG002|Overall Study|Lost to Follow-up|1|||
48917769|NCT03548935|157535801|FG000|Overall Study|Withdrawal by Subject|26|||
48917770|NCT03548935|157535802|FG001|Overall Study|Withdrawal by Subject|17|||
48808763|NCT00402337|157140342|FG003|Overall Study|Other Reason|0|||
48808764|NCT00402337|157140343|FG004|Overall Study|Other Reason|0|||
48808765|NCT04152343|157140348|FG000|Overall Study|Transplanted|5|||
48808766|NCT04152343|157140348|FG000|Overall Study|Death|20|||
48808767|NCT04152343|157140348|FG000|Overall Study|Lost to Follow-up|3|||
48808768|NCT03824366|157140349|FG000|Overall Study|Death|1|||
48808769|NCT03824366|157140349|FG000|Overall Study|Previously unidentified metal artifact|1|||
48808770|NCT03824366|157140349|FG000|Overall Study|Unable to tolerate lying flat on MR table|1|||
48808771|NCT03824366|157140349|FG000|Overall Study|Withdrawal by Subject|1|||
48808772|NCT01464021|157141510|FG000|Overall Study|Withdrawal by Subject|13|||
48808773|NCT01464021|157141510|FG000|Overall Study|Lost to Follow-up|1|||
48808774|NCT01464021|157141510|FG000|Overall Study|Lack of Efficacy|1|||
48808775|NCT01464021|157141510|FG000|Overall Study|various|11|||
48808776|NCT01108458|157141511|FG000|Overall Study|Withdrawal by Subject|1|||
48917771|NCT03548935|157535801|FG000|Overall Study|Lost to Follow-up|39|||
48917772|NCT03548935|157535802|FG001|Overall Study|Lost to Follow-up|28|||
48917773|NCT03548935|157535801|FG000|Overall Study|Death|1|||
48917774|NCT03548935|157535802|FG001|Overall Study|Death|1|||
48917775|NCT03972969|157535803|FG000|3-month Follow-up|Death|1|||
48808777|NCT01382602|157141512|FG000|Overall Study|Protocol Violation|0|||
48808778|NCT01382602|157141513|FG001|Overall Study|Protocol Violation|3|||
48808779|NCT01382602|157141512|FG000|Overall Study|Withdrawal by Subject|0|||
48808780|NCT01382602|157141513|FG001|Overall Study|Withdrawal by Subject|1|||
48808781|NCT02790073|157141514|FG000|Overall Study|Death|1|||
48808782|NCT02790073|157141514|FG000|Overall Study|Withdrawal from HD|1|||
48808783|NCT02790073|157141514|FG000|Overall Study|Withdrawal by Subject|1|||
48808784|NCT04524390|157141517|FG000|Double Blind|Consent Withdrawal by subject|2|||
48808785|NCT04524390|157141518|FG001|Double Blind|Consent Withdrawal by subject|1|||
48808786|NCT04524390|157141519|FG002|Double Blind|Consent Withdrawal by subject|0|||
48808787|NCT04524390|157141517|FG000|Double Blind|Adverse Event|5|||
48808788|NCT04524390|157141518|FG001|Double Blind|Adverse Event|3|||
48808789|NCT04524390|157141519|FG002|Double Blind|Adverse Event|0|||
48808790|NCT04524390|157141517|FG000|Double Blind|Liver Transplant|5|||
48808791|NCT04524390|157141518|FG001|Double Blind|Liver Transplant|6|||
48808792|NCT04524390|157141519|FG002|Double Blind|Liver Transplant|0|||
48808793|NCT04524390|157141517|FG000|Double Blind|Disease Progression|0|||
48808794|NCT04524390|157141518|FG001|Double Blind|Disease Progression|1|||
48808795|NCT04524390|157141519|FG002|Double Blind|Disease Progression|0|||
48808796|NCT04524390|157141517|FG000|Open-Label|Drug interruption criteria|0|||
48808797|NCT04524390|157141518|FG001|Open-Label|Drug interruption criteria|0|||
48808798|NCT04524390|157141519|FG002|Open-Label|Drug interruption criteria|1|||
48808799|NCT04524390|157141517|FG000|Open-Label|Liver Transplant|0|||
48808800|NCT04524390|157141518|FG001|Open-Label|Liver Transplant|0|||
48808801|NCT04524390|157141519|FG002|Open-Label|Liver Transplant|1|||
48808802|NCT04524390|157141517|FG000|Open-Label|Disease Progression|0|||
48808803|NCT04524390|157141518|FG001|Open-Label|Disease Progression|0|||
48808804|NCT04524390|157141519|FG002|Open-Label|Disease Progression|1|||
48808805|NCT04524390|157141517|FG000|Open-Label|Adverse Event|0|||
48808806|NCT04524390|157141518|FG001|Open-Label|Adverse Event|0|||
48808807|NCT04524390|157141519|FG002|Open-Label|Adverse Event|3|||
48808808|NCT04524390|157141517|FG000|Open-Label|Study Termination by sponsor|0|||
48808809|NCT04524390|157141518|FG001|Open-Label|Study Termination by sponsor|0|||
48808810|NCT04524390|157141519|FG002|Open-Label|Study Termination by sponsor|45|||
48808811|NCT01336634|157141523|FG000|Overall Study|Study closed/terminated|5|||
48808812|NCT01336634|157141524|FG001|Overall Study|Study closed/terminated|6|||
48808813|NCT01336634|157141525|FG002|Overall Study|Study closed/terminated|6|||
48808814|NCT01336634|157141523|FG000|Overall Study|Lost to Follow-up|2|||
48808815|NCT01336634|157141524|FG001|Overall Study|Lost to Follow-up|1|||
48808816|NCT01336634|157141525|FG002|Overall Study|Lost to Follow-up|1|||
48808817|NCT01336634|157141523|FG000|Overall Study|Physician Decision|1|||
48808818|NCT01336634|157141524|FG001|Overall Study|Physician Decision|1|||
48808819|NCT01336634|157141525|FG002|Overall Study|Physician Decision|0|||
48808820|NCT01336634|157141523|FG000|Overall Study|Withdrawal by Subject|6|||
48808821|NCT01336634|157141524|FG001|Overall Study|Withdrawal by Subject|0|||
48808822|NCT01336634|157141525|FG002|Overall Study|Withdrawal by Subject|2|||
48808823|NCT02798211|157141530|FG000|Period 1|Adverse Event|1|||
48808824|NCT02798211|157141531|FG001|Period 1|Adverse Event|1|||
48808825|NCT02798211|157141532|FG002|Period 1|Adverse Event|0|||
48808826|NCT02798211|157141533|FG003|Period 1|Adverse Event|0|||
48808827|NCT02798211|157141534|FG004|Period 1|Adverse Event|0|||
48808828|NCT02798211|157141535|FG005|Period 1|Adverse Event|0|||
48808829|NCT02798211|157141530|FG000|Period 1|Lost to Follow-up|2|||
48808830|NCT02798211|157141531|FG001|Period 1|Lost to Follow-up|1|||
48808831|NCT02798211|157141532|FG002|Period 1|Lost to Follow-up|0|||
48808832|NCT02798211|157141533|FG003|Period 1|Lost to Follow-up|0|||
48808833|NCT02798211|157141534|FG004|Period 1|Lost to Follow-up|0|||
48808834|NCT02798211|157141535|FG005|Period 1|Lost to Follow-up|0|||
48917776|NCT03972969|157535804|FG001|3-month Follow-up|Death|1|||
48917777|NCT03972969|157535805|FG002|3-month Follow-up|Death|0|||
48917778|NCT03972969|157535803|FG000|6-month Follow-up|Death|1|||
49120632|NCT02326272|158280514|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
48808835|NCT02798211|157141530|FG000|Period 1|Protocol Violation|0|||
48808836|NCT02798211|157141531|FG001|Period 1|Protocol Violation|0|||
48808837|NCT02798211|157141532|FG002|Period 1|Protocol Violation|2|||
48808838|NCT02798211|157141533|FG003|Period 1|Protocol Violation|0|||
48808839|NCT02798211|157141534|FG004|Period 1|Protocol Violation|0|||
48808840|NCT02798211|157141535|FG005|Period 1|Protocol Violation|0|||
48808841|NCT02798211|157141530|FG000|Period 1|Withdrawal by Subject|1|||
48808842|NCT02798211|157141531|FG001|Period 1|Withdrawal by Subject|1|||
48917779|NCT03972969|157535804|FG001|6-month Follow-up|Death|1|||
48808843|NCT02798211|157141532|FG002|Period 1|Withdrawal by Subject|0|||
48808844|NCT02798211|157141533|FG003|Period 1|Withdrawal by Subject|0|||
48808845|NCT02798211|157141534|FG004|Period 1|Withdrawal by Subject|0|||
48917780|NCT03972969|157535805|FG002|6-month Follow-up|Death|1|||
48917781|NCT03972969|157535803|FG000|6-month Follow-up|Lost to Follow-up|2|||
48917782|NCT03972969|157535804|FG001|6-month Follow-up|Lost to Follow-up|2|||
48917783|NCT03972969|157535805|FG002|6-month Follow-up|Lost to Follow-up|2|||
48917784|NCT00535132|157535806|FG000|Safety Analysis Set|Did Not Receive Study Medication|2|||
48917785|NCT00535132|157535807|FG001|Safety Analysis Set|Did Not Receive Study Medication|2|||
48917786|NCT00535132|157535806|FG000|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
48917787|NCT00535132|157535807|FG001|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
48917788|NCT01074190|157535814|FG000|Overall Study|Emergency Cesarean Delivery|1|||
48917789|NCT01074190|157535815|FG001|Overall Study|Emergency Cesarean Delivery|2|||
48917790|NCT01074190|157535816|FG002|Overall Study|Emergency Cesarean Delivery|1|||
48917791|NCT01074190|157535814|FG000|Overall Study|Protocol Violation|2|||
48917792|NCT01074190|157535815|FG001|Overall Study|Protocol Violation|1|||
48917793|NCT01074190|157535816|FG002|Overall Study|Protocol Violation|0|||
48917794|NCT01074190|157535814|FG000|Overall Study|Delivered in under 90 minutes|0|||
48917795|NCT01074190|157535815|FG001|Overall Study|Delivered in under 90 minutes|2|||
48917796|NCT01074190|157535816|FG002|Overall Study|Delivered in under 90 minutes|1|||
48917797|NCT01074190|157535814|FG000|Overall Study|Subject withdrew consent|1|||
48917798|NCT01074190|157535815|FG001|Overall Study|Subject withdrew consent|1|||
48917799|NCT01074190|157535816|FG002|Overall Study|Subject withdrew consent|1|||
48917800|NCT04707157|157535817|FG000|Overall Study|Adverse Event|12|||
48917801|NCT04707157|157535818|FG001|Overall Study|Adverse Event|3|||
48917802|NCT04707157|157535817|FG000|Overall Study|Lost to Follow-up|2|||
48917803|NCT04707157|157535818|FG001|Overall Study|Lost to Follow-up|0|||
48917804|NCT04707157|157535817|FG000|Overall Study|Sponsor's decision|1|||
48917805|NCT04707157|157535818|FG001|Overall Study|Sponsor's decision|0|||
48917806|NCT04707157|157535817|FG000|Overall Study|Physician Decision|8|||
48917807|NCT04707157|157535818|FG001|Overall Study|Physician Decision|5|||
48917808|NCT04707157|157535817|FG000|Overall Study|Protocol Deviation|1|||
48917809|NCT04707157|157535818|FG001|Overall Study|Protocol Deviation|0|||
48917810|NCT04707157|157535817|FG000|Overall Study|Withdrawal by Subject|1|||
48917811|NCT04707157|157535818|FG001|Overall Study|Withdrawal by Subject|1|||
48917812|NCT01500278|157535820|FG000|Week 0 - Week 12|Lack of Efficacy|0|||
48917813|NCT01500278|157535821|FG001|Week 0 - Week 12|Lack of Efficacy|1|||
48917814|NCT01500278|157535820|FG000|Week 0 - Week 12|Protocol Violation|10|||
48917815|NCT01500278|157535821|FG001|Week 0 - Week 12|Protocol Violation|16|||
48917816|NCT01500278|157535820|FG000|Week 0 - Week 12|Lost to Follow-up|1|||
48917817|NCT01500278|157535821|FG001|Week 0 - Week 12|Lost to Follow-up|1|||
48917818|NCT01500278|157535820|FG000|Week 0 - Week 12|Withdrawal by Subject|7|||
48917819|NCT01500278|157535821|FG001|Week 0 - Week 12|Withdrawal by Subject|2|||
48711103|NCT00282308|156791471|FG001|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
48711104|NCT00282308|156791472|FG002|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1|||
48711105|NCT00282308|156791470|FG000|Safety Follow-up Period|Adverse Event|0|||
48711106|NCT00282308|156791471|FG001|Safety Follow-up Period|Adverse Event|0|||
48711107|NCT00282308|156791472|FG002|Safety Follow-up Period|Adverse Event|1|||
48711108|NCT00282308|156791470|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
48711109|NCT00282308|156791471|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
48711110|NCT00282308|156791472|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
48711111|NCT00282308|156791470|FG000|Safety Follow-up Period|Physician Decision to Withdraw|0|||
48711112|NCT00282308|156791471|FG001|Safety Follow-up Period|Physician Decision to Withdraw|0|||
48711113|NCT00282308|156791472|FG002|Safety Follow-up Period|Physician Decision to Withdraw|1|||
48711114|NCT00282308|156791470|FG000|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
48711115|NCT00282308|156791471|FG001|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
48711116|NCT00282308|156791472|FG002|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12|||
48711117|NCT00946153|156791474|FG000|Phase 2|Adverse Event|0|||
48711118|NCT00946153|156791475|FG001|Phase 2|Adverse Event|0|||
48711119|NCT00946153|156791476|FG002|Phase 2|Adverse Event|0|||
48711120|NCT00946153|156791477|FG003|Phase 2|Adverse Event|0|||
48711121|NCT00946153|156791478|FG004|Phase 2|Adverse Event|6|||
48711122|NCT00946153|156791474|FG000|Phase 2|Need more reduction of dose|0|||
48711123|NCT00946153|156791475|FG001|Phase 2|Need more reduction of dose|0|||
48711124|NCT00946153|156791476|FG002|Phase 2|Need more reduction of dose|0|||
48711125|NCT00946153|156791477|FG003|Phase 2|Need more reduction of dose|0|||
48711126|NCT00946153|156791478|FG004|Phase 2|Need more reduction of dose|2|||
48711127|NCT00946153|156791474|FG000|Phase 2|Physician Decision|0|||
48711128|NCT00946153|156791475|FG001|Phase 2|Physician Decision|0|||
48711129|NCT00946153|156791476|FG002|Phase 2|Physician Decision|0|||
48711130|NCT00946153|156791477|FG003|Phase 2|Physician Decision|0|||
48711131|NCT00946153|156791478|FG004|Phase 2|Physician Decision|1|||
48711132|NCT00946153|156791474|FG000|Phase 2|14 days washout for recovery due to AE|0|||
48711133|NCT00946153|156791475|FG001|Phase 2|14 days washout for recovery due to AE|0|||
48711134|NCT00946153|156791476|FG002|Phase 2|14 days washout for recovery due to AE|0|||
48917820|NCT01500278|157535820|FG000|Week 0 - Week 12|Protocol violation on screening X-ray|1|||
48917821|NCT01500278|157535821|FG001|Week 0 - Week 12|Protocol violation on screening X-ray|0|||
48917822|NCT01500278|157535820|FG000|Week 0 - Week 12|Patient decision|1|||
48917823|NCT01500278|157535821|FG001|Week 0 - Week 12|Patient decision|0|||
48917824|NCT01500278|157535820|FG000|Week 0 - Week 12|Exclusion criteria not met|1|||
48808846|NCT02798211|157141535|FG005|Period 1|Withdrawal by Subject|0|||
48808847|NCT02798211|157141530|FG000|Period 1|Death|0|||
48808848|NCT02798211|157141531|FG001|Period 1|Death|0|||
48808849|NCT02798211|157141532|FG002|Period 1|Death|1|||
48808850|NCT02798211|157141533|FG003|Period 1|Death|0|||
48808851|NCT02798211|157141534|FG004|Period 1|Death|0|||
48917825|NCT01500278|157535821|FG001|Week 0 - Week 12|Exclusion criteria not met|0|||
48917826|NCT01500278|157535820|FG000|Week 0 - Week 12|Investigator decision|1|||
48917827|NCT01500278|157535821|FG001|Week 0 - Week 12|Investigator decision|0|||
48917828|NCT01500278|157535820|FG000|Week 0 - Week 12|Prior history of serious disease|1|||
48917829|NCT01500278|157535821|FG001|Week 0 - Week 12|Prior history of serious disease|0|||
48917830|NCT01500278|157535820|FG000|Week 0 - Week 12|Sponsor decision|1|||
48917831|NCT01500278|157535821|FG001|Week 0 - Week 12|Sponsor decision|0|||
48917832|NCT01500278|157535820|FG000|Week 0 - Week 12|Personal reason|0|||
48917833|NCT01500278|157535821|FG001|Week 0 - Week 12|Personal reason|1|||
48808852|NCT02798211|157141535|FG005|Period 1|Death|0|||
48808853|NCT02798211|157141530|FG000|Period 1|Withdrawal of Informed Consent|2|||
48808854|NCT02798211|157141531|FG001|Period 1|Withdrawal of Informed Consent|7|||
48808855|NCT02798211|157141532|FG002|Period 1|Withdrawal of Informed Consent|3|||
48808856|NCT02798211|157141533|FG003|Period 1|Withdrawal of Informed Consent|0|||
48808857|NCT02798211|157141534|FG004|Period 1|Withdrawal of Informed Consent|0|||
48808858|NCT02798211|157141535|FG005|Period 1|Withdrawal of Informed Consent|0|||
48808859|NCT02798211|157141530|FG000|Period 2|Withdrawal by Subject|2|||
48808860|NCT02798211|157141531|FG001|Period 2|Withdrawal by Subject|0|||
48808861|NCT02798211|157141532|FG002|Period 2|Withdrawal by Subject|0|||
48808862|NCT02798211|157141533|FG003|Period 2|Withdrawal by Subject|0|||
48808863|NCT02798211|157141534|FG004|Period 2|Withdrawal by Subject|2|||
48808864|NCT02798211|157141535|FG005|Period 2|Withdrawal by Subject|2|||
48808865|NCT02798211|157141530|FG000|Period 2|Adverse Event|5|||
48808866|NCT02798211|157141531|FG001|Period 2|Adverse Event|0|||
48808867|NCT02798211|157141532|FG002|Period 2|Adverse Event|0|||
48808868|NCT02798211|157141533|FG003|Period 2|Adverse Event|0|||
48808869|NCT02798211|157141534|FG004|Period 2|Adverse Event|1|||
48808870|NCT02798211|157141535|FG005|Period 2|Adverse Event|0|||
48808871|NCT02798211|157141530|FG000|Period 2|Lack of Efficacy|1|||
48808872|NCT02798211|157141531|FG001|Period 2|Lack of Efficacy|0|||
48808873|NCT02798211|157141532|FG002|Period 2|Lack of Efficacy|0|||
48808874|NCT02798211|157141533|FG003|Period 2|Lack of Efficacy|1|||
48808875|NCT02798211|157141534|FG004|Period 2|Lack of Efficacy|0|||
48808876|NCT02798211|157141535|FG005|Period 2|Lack of Efficacy|1|||
48808877|NCT02798211|157141530|FG000|Period 2|Lost to Follow-up|3|||
48808878|NCT02798211|157141531|FG001|Period 2|Lost to Follow-up|0|||
48808879|NCT02798211|157141532|FG002|Period 2|Lost to Follow-up|0|||
48808880|NCT02798211|157141533|FG003|Period 2|Lost to Follow-up|0|||
48808881|NCT02798211|157141534|FG004|Period 2|Lost to Follow-up|2|||
48808882|NCT02798211|157141535|FG005|Period 2|Lost to Follow-up|0|||
48808883|NCT02798211|157141530|FG000|Period 2|Physician Decision|1|||
48808884|NCT02798211|157141531|FG001|Period 2|Physician Decision|0|||
48808885|NCT02798211|157141532|FG002|Period 2|Physician Decision|0|||
48808886|NCT02798211|157141533|FG003|Period 2|Physician Decision|1|||
48808887|NCT02798211|157141534|FG004|Period 2|Physician Decision|1|||
48808888|NCT02798211|157141535|FG005|Period 2|Physician Decision|0|||
48808889|NCT02798211|157141530|FG000|Period 2|Pregnancy|0|||
48808890|NCT02798211|157141531|FG001|Period 2|Pregnancy|0|||
48808891|NCT02798211|157141532|FG002|Period 2|Pregnancy|0|||
48808892|NCT02798211|157141533|FG003|Period 2|Pregnancy|2|||
48808893|NCT02798211|157141534|FG004|Period 2|Pregnancy|0|||
48808894|NCT02798211|157141535|FG005|Period 2|Pregnancy|0|||
48808895|NCT02798211|157141530|FG000|Period 2|Technical problems|1|||
48808896|NCT02798211|157141531|FG001|Period 2|Technical problems|0|||
48917834|NCT01500278|157535820|FG000|Week 0 - Week 12|Other serious disease|0|||
48917835|NCT01500278|157535821|FG001|Week 0 - Week 12|Other serious disease|1|||
48917836|NCT01500278|157535820|FG000|Week 0 - Week 12|Adverse event (AE), not fatal|7|||
48808897|NCT02798211|157141532|FG002|Period 2|Technical problems|0|||
48808898|NCT02798211|157141533|FG003|Period 2|Technical problems|1|||
48808899|NCT02798211|157141534|FG004|Period 2|Technical problems|0|||
48808900|NCT02798211|157141535|FG005|Period 2|Technical problems|0|||
48808901|NCT02798211|157141530|FG000|Period 2|Withdrawal of Informed Consent|1|||
48808902|NCT02798211|157141531|FG001|Period 2|Withdrawal of Informed Consent|0|||
48808903|NCT02798211|157141532|FG002|Period 2|Withdrawal of Informed Consent|0|||
48808904|NCT02798211|157141533|FG003|Period 2|Withdrawal of Informed Consent|2|||
48808905|NCT02798211|157141534|FG004|Period 2|Withdrawal of Informed Consent|2|||
48808906|NCT02798211|157141535|FG005|Period 2|Withdrawal of Informed Consent|3|||
48808907|NCT02281760|157141536|FG000|Overall Study|Withdrawal by Subject|1|||
48808908|NCT04581200|157141537|FG000|Overall Study|Lost to Follow-up|6|||
48808909|NCT04581200|157141538|FG001|Overall Study|Lost to Follow-up|5|||
48808910|NCT04488003|157141540|FG000|Assessed for Eligibility|Screen Failure|24|||
48808911|NCT04488003|157141541|FG001|Assessed for Eligibility|Screen Failure|0|||
48808912|NCT04488003|157141542|FG002|Assessed for Eligibility|Screen Failure|0|||
48808913|NCT04488003|157141540|FG000|Assessed for Eligibility|Adverse Event|1|||
48917837|NCT01500278|157535821|FG001|Week 0 - Week 12|Adverse event (AE), not fatal|8|||
48917838|NCT01500278|157535820|FG000|Week 13 - Week 104|Lack of Efficacy|11|||
48917839|NCT01500278|157535821|FG001|Week 13 - Week 104|Lack of Efficacy|12|||
48917840|NCT01500278|157535820|FG000|Week 13 - Week 104|Protocol Violation|6|||
48917841|NCT01500278|157535821|FG001|Week 13 - Week 104|Protocol Violation|6|||
48917842|NCT01500278|157535820|FG000|Week 13 - Week 104|Lost to Follow-up|6|||
48917843|NCT01500278|157535821|FG001|Week 13 - Week 104|Lost to Follow-up|5|||
48917844|NCT01500278|157535820|FG000|Week 13 - Week 104|Withdrawal by Subject|22|||
48917845|NCT01500278|157535821|FG001|Week 13 - Week 104|Withdrawal by Subject|13|||
48917846|NCT01500278|157535820|FG000|Week 13 - Week 104|Week 24 Non-Responder|20|||
48917847|NCT01500278|157535821|FG001|Week 13 - Week 104|Week 24 Non-Responder|16|||
48917848|NCT01500278|157535820|FG000|Week 13 - Week 104|Non/bad compliance|7|||
48917849|NCT01500278|157535821|FG001|Week 13 - Week 104|Non/bad compliance|5|||
48917850|NCT01500278|157535820|FG000|Week 13 - Week 104|Recurrent infections|1|||
48917851|NCT01500278|157535821|FG001|Week 13 - Week 104|Recurrent infections|0|||
48917852|NCT01500278|157535820|FG000|Week 13 - Week 104|False positive test|1|||
48917853|NCT01500278|157535821|FG001|Week 13 - Week 104|False positive test|2|||
48917854|NCT01500278|157535820|FG000|Week 13 - Week 104|Sponsor request|4|||
48917855|NCT01500278|157535821|FG001|Week 13 - Week 104|Sponsor request|0|||
48917856|NCT01500278|157535820|FG000|Week 13 - Week 104|Withdrawn in error|1|||
48917857|NCT01500278|157535821|FG001|Week 13 - Week 104|Withdrawn in error|0|||
48711135|NCT00946153|156791477|FG003|Phase 2|14 days washout for recovery due to AE|0|||
48711136|NCT00946153|156791478|FG004|Phase 2|14 days washout for recovery due to AE|4|||
48711137|NCT01001325|156791479|FG000|Overall Study|Lost to Follow-up|16|||
48711138|NCT01001325|156791480|FG001|Overall Study|Lost to Follow-up|10|||
48711139|NCT01001325|156791479|FG000|Overall Study|Protocol Violation|2|||
48711140|NCT01001325|156791480|FG001|Overall Study|Protocol Violation|0|||
48711141|NCT01584440|156791481|FG000|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|1|||
48711142|NCT01584440|156791482|FG001|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
48711143|NCT01584440|156791483|FG002|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
48711144|NCT01584440|156791484|FG003|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
48711145|NCT01584440|156791485|FG004|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
48711146|NCT01584440|156791481|FG000|Stage 1 (5 Weeks)|Adverse Event|5|||
48711147|NCT01584440|156791482|FG001|Stage 1 (5 Weeks)|Adverse Event|3|||
48711148|NCT01584440|156791483|FG002|Stage 1 (5 Weeks)|Adverse Event|0|||
48711149|NCT01584440|156791484|FG003|Stage 1 (5 Weeks)|Adverse Event|0|||
48711150|NCT01584440|156791485|FG004|Stage 1 (5 Weeks)|Adverse Event|0|||
48711151|NCT01584440|156791481|FG000|Stage 1 (5 Weeks)|Lost to Follow-up|1|||
48711152|NCT01584440|156791482|FG001|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
48711153|NCT01584440|156791483|FG002|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
48711154|NCT01584440|156791484|FG003|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
48711155|NCT01584440|156791485|FG004|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
48711156|NCT01584440|156791481|FG000|Stage 1 (5 Weeks)|Protocol Violation|2|||
48711157|NCT01584440|156791482|FG001|Stage 1 (5 Weeks)|Protocol Violation|3|||
48711158|NCT01584440|156791483|FG002|Stage 1 (5 Weeks)|Protocol Violation|0|||
48711159|NCT01584440|156791484|FG003|Stage 1 (5 Weeks)|Protocol Violation|0|||
48711160|NCT01584440|156791485|FG004|Stage 1 (5 Weeks)|Protocol Violation|0|||
48711161|NCT01584440|156791481|FG000|Stage 1 (5 Weeks)|Withdrawal by Subject|1|||
48711162|NCT01584440|156791482|FG001|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
48711163|NCT01584440|156791483|FG002|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
48711164|NCT01584440|156791484|FG003|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
48711165|NCT01584440|156791485|FG004|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
48711166|NCT01584440|156791481|FG000|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
48711167|NCT01584440|156791482|FG001|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|2|||
48711168|NCT01584440|156791483|FG002|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
48711169|NCT01584440|156791484|FG003|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
48711170|NCT01584440|156791485|FG004|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
48711171|NCT01584440|156791481|FG000|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
48711172|NCT01584440|156791482|FG001|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
48711173|NCT01584440|156791483|FG002|Stage 2 (5 Weeks)|Withdrawal by Subject|1|||
48711174|NCT01584440|156791484|FG003|Stage 2 (5 Weeks)|Withdrawal by Subject|2|||
48917858|NCT01500278|157535820|FG000|Week 13 - Week 104|Exclusion criteria not met|1|||
48917859|NCT01500278|157535821|FG001|Week 13 - Week 104|Exclusion criteria not met|0|||
49010758|NCT00185211|157875696|FG001|Placebo-controlled Study (92012)|Withdrawal by Subject|7|||
48711175|NCT01584440|156791485|FG004|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
48711176|NCT01584440|156791481|FG000|Stage 2 (5 Weeks)|Adverse Event|0|||
48711177|NCT01584440|156791482|FG001|Stage 2 (5 Weeks)|Adverse Event|0|||
48711178|NCT01584440|156791483|FG002|Stage 2 (5 Weeks)|Adverse Event|1|||
48711179|NCT01584440|156791484|FG003|Stage 2 (5 Weeks)|Adverse Event|2|||
48711180|NCT01584440|156791485|FG004|Stage 2 (5 Weeks)|Adverse Event|1|||
48711181|NCT01584440|156791481|FG000|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
48711182|NCT01584440|156791482|FG001|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
48711183|NCT01584440|156791483|FG002|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|1|||
48917860|NCT01500278|157535820|FG000|Week 13 - Week 104|Protocol deviation|1|||
48808914|NCT04488003|157141541|FG001|Assessed for Eligibility|Adverse Event|0|||
48808915|NCT04488003|157141542|FG002|Assessed for Eligibility|Adverse Event|0|||
48808916|NCT04488003|157141540|FG000|Assessed for Eligibility|Death|1|||
48808917|NCT04488003|157141541|FG001|Assessed for Eligibility|Death|0|||
48808918|NCT04488003|157141542|FG002|Assessed for Eligibility|Death|0|||
48808919|NCT04488003|157141540|FG000|Assessed for Eligibility|Physician Decision|1|||
48808920|NCT04488003|157141541|FG001|Assessed for Eligibility|Physician Decision|0|||
48808921|NCT04488003|157141542|FG002|Assessed for Eligibility|Physician Decision|0|||
48808922|NCT04488003|157141540|FG000|Allocated to Treatment|Progressive Disease|51|||
48808923|NCT04488003|157141541|FG001|Allocated to Treatment|Progressive Disease|0|||
48808924|NCT04488003|157141542|FG002|Allocated to Treatment|Progressive Disease|0|||
48808925|NCT04488003|157141540|FG000|Allocated to Treatment|Withdrawal by Subject|7|||
48917861|NCT01500278|157535821|FG001|Week 13 - Week 104|Protocol deviation|0|||
48808926|NCT04488003|157141541|FG001|Allocated to Treatment|Withdrawal by Subject|0|||
48808927|NCT04488003|157141542|FG002|Allocated to Treatment|Withdrawal by Subject|0|||
48808928|NCT04488003|157141540|FG000|Allocated to Treatment|Adverse Event|6|||
48808929|NCT04488003|157141541|FG001|Allocated to Treatment|Adverse Event|0|||
48808930|NCT04488003|157141542|FG002|Allocated to Treatment|Adverse Event|0|||
48808931|NCT04488003|157141540|FG000|Allocated to Treatment|Other|5|||
48808932|NCT04488003|157141541|FG001|Allocated to Treatment|Other|0|||
48808933|NCT04488003|157141542|FG002|Allocated to Treatment|Other|0|||
48808934|NCT04488003|157141540|FG000|Allocated to Treatment|Physician Decision|4|||
48808935|NCT04488003|157141541|FG001|Allocated to Treatment|Physician Decision|0|||
48808936|NCT04488003|157141542|FG002|Allocated to Treatment|Physician Decision|0|||
48808937|NCT04488003|157141540|FG000|Allocated to Treatment|Death|4|||
48808938|NCT04488003|157141541|FG001|Allocated to Treatment|Death|0|||
48808939|NCT04488003|157141542|FG002|Allocated to Treatment|Death|0|||
48808940|NCT01737996|157141543|FG000|Overall Study|Adverse Event|0|||
48808941|NCT01737996|157141544|FG001|Overall Study|Adverse Event|1|||
48808942|NCT01737996|157141545|FG002|Overall Study|Adverse Event|1|||
48808943|NCT01737996|157141543|FG000|Overall Study|Withdrawal by Subject|0|||
48808944|NCT01737996|157141544|FG001|Overall Study|Withdrawal by Subject|0|||
48808945|NCT01737996|157141545|FG002|Overall Study|Withdrawal by Subject|1|||
48808946|NCT03283696|157141546|FG000|Overall Study|Physician Decision|5|||
48808947|NCT03283696|157141547|FG001|Overall Study|Physician Decision|6|||
48808948|NCT03283696|157141546|FG000|Overall Study|Withdrawal by Subject|2|||
48808949|NCT03283696|157141547|FG001|Overall Study|Withdrawal by Subject|0|||
48808950|NCT00007475|157141548|FG000|Overall Study|Withdrawal by Subject|1|||
48808951|NCT00007475|157141549|FG001|Overall Study|Withdrawal by Subject|0|||
48808952|NCT00007475|157141550|FG002|Overall Study|Withdrawal by Subject|0|||
48808953|NCT00007475|157141551|FG003|Overall Study|Withdrawal by Subject|0|||
48808954|NCT00007475|157141548|FG000|Overall Study|Adverse Event|3|||
48808955|NCT00007475|157141549|FG001|Overall Study|Adverse Event|0|||
48808956|NCT00007475|157141550|FG002|Overall Study|Adverse Event|0|||
48808957|NCT00007475|157141551|FG003|Overall Study|Adverse Event|0|||
48808958|NCT02904902|157141553|FG000|Overall Study|Withdrawal by Subject|1|||
48808959|NCT01372605|157141557|FG000|Overall Study|Death|1|||
48808960|NCT01372605|157141558|FG001|Overall Study|Death|2|||
48808961|NCT01372605|157141557|FG000|Overall Study|Lost to Follow-up|2|||
48808962|NCT01372605|157141558|FG001|Overall Study|Lost to Follow-up|1|||
48808963|NCT01372605|157141557|FG000|Overall Study|Withdrawal by Subject|4|||
48808964|NCT01372605|157141558|FG001|Overall Study|Withdrawal by Subject|7|||
48808965|NCT01372605|157141557|FG000|Overall Study|Moved|3|||
48808966|NCT01372605|157141558|FG001|Overall Study|Moved|0|||
48917862|NCT01500278|157535820|FG000|Week 13 - Week 104|Principal investigator retiring|1|||
48808967|NCT01372605|157141557|FG000|Overall Study|Changed medical home|2|||
48808968|NCT01372605|157141558|FG001|Overall Study|Changed medical home|0|||
48808969|NCT02912468|157141559|FG000|Overall Study|Adverse Event|3|||
48808970|NCT02912468|157141560|FG001|Overall Study|Adverse Event|2|||
48808971|NCT02912468|157141559|FG000|Overall Study|Withdrawal by Subject|6|||
48808972|NCT02912468|157141560|FG001|Overall Study|Withdrawal by Subject|2|||
48808973|NCT02912468|157141559|FG000|Overall Study|Randomized and not treated|0|||
48808974|NCT02912468|157141560|FG001|Overall Study|Randomized and not treated|1|||
48808975|NCT00692406|157141566|FG000|Overall Study|PI dropped, bad data|57|||
48808976|NCT04145037|157141567|FG000|Overall Study|Study terminated|2|||
48808977|NCT04145037|157141568|FG001|Overall Study|Study terminated|0|||
48808978|NCT04145037|157141567|FG000|Overall Study|Withdrawal by Subject|1|||
48808979|NCT04145037|157141568|FG001|Overall Study|Withdrawal by Subject|0|||
48917863|NCT01500278|157535821|FG001|Week 13 - Week 104|Principal investigator retiring|0|||
48917864|NCT01500278|157535820|FG000|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1|||
48917865|NCT01500278|157535821|FG001|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0|||
48917866|NCT01500278|157535820|FG000|Week 13 - Week 104|Abnormal questionable chest X-ray|0|||
48808980|NCT04145037|157141567|FG000|Overall Study|Lost to Follow-up|1|||
48808981|NCT04145037|157141568|FG001|Overall Study|Lost to Follow-up|0|||
48808982|NCT04599101|157141569|FG000|Overall Study|Lost to Follow-up|5|||
48808983|NCT04599101|157141570|FG001|Overall Study|Lost to Follow-up|5|||
48808984|NCT00525265|157141571|FG000|Overall Study|Protocol Violation|1|||
48808985|NCT00525265|157141572|FG001|Overall Study|Protocol Violation|0|||
48808986|NCT00960752|157141578|FG000|Overall Study|Adverse Event|0|||
48808987|NCT00960752|157141579|FG001|Overall Study|Adverse Event|0|||
48808988|NCT00960752|157141580|FG002|Overall Study|Adverse Event|1|||
48808989|NCT00960752|157141578|FG000|Overall Study|Progression|0|||
48808990|NCT00960752|157141579|FG001|Overall Study|Progression|0|||
48808991|NCT00960752|157141580|FG002|Overall Study|Progression|1|||
48808992|NCT01975220|157141583|FG000|Test Period 1|Not treated|0|||
48808993|NCT01975220|157141584|FG001|Test Period 1|Not treated|1|||
48808994|NCT01975220|157141585|FG002|Test Period 1|Not treated|0|||
48808995|NCT01975220|157141586|FG003|Test Period 1|Not treated|0|||
48808996|NCT01975220|157141587|FG004|Test Period 1|Not treated|0|||
48808997|NCT01975220|157141588|FG005|Test Period 1|Not treated|0|||
48808998|NCT02460263|157141589|FG000|Transition Period|Withdrawal by Subject|1|||
48808999|NCT02460263|157141589|FG000|Transition Period|Death|1|||
48809000|NCT03176238|157141590|FG000|Overall Study|Unacceptable AEs|15|||
48809001|NCT03176238|157141591|FG001|Overall Study|Unacceptable AEs|8|||
48809002|NCT03176238|157141590|FG000|Overall Study|Abnormal lab value(s)|2|||
48809003|NCT03176238|157141591|FG001|Overall Study|Abnormal lab value(s)|0|||
48809004|NCT03176238|157141590|FG000|Overall Study|Inter-current illness|0|||
48809005|NCT03176238|157141591|FG001|Overall Study|Inter-current illness|1|||
48809006|NCT03176238|157141590|FG000|Overall Study|Consent withdrawal|14|||
48809007|NCT03176238|157141591|FG001|Overall Study|Consent withdrawal|2|||
48809008|NCT03176238|157141590|FG000|Overall Study|Lost to Follow-up|3|||
48809009|NCT03176238|157141591|FG001|Overall Study|Lost to Follow-up|0|||
48809010|NCT03176238|157141590|FG000|Overall Study|Administrative problems|1|||
48809011|NCT03176238|157141591|FG001|Overall Study|Administrative problems|0|||
48809012|NCT03176238|157141590|FG000|Overall Study|Death|3|||
48809013|NCT03176238|157141591|FG001|Overall Study|Death|0|||
48809014|NCT03176238|157141590|FG000|Overall Study|Disease Progression|133|||
48809015|NCT03176238|157141591|FG001|Overall Study|Disease Progression|22|||
48809016|NCT03176238|157141590|FG000|Overall Study|Tx duration completed per EAP|0|||
48809017|NCT03176238|157141591|FG001|Overall Study|Tx duration completed per EAP|1|||
48809018|NCT03176238|157141590|FG000|Overall Study|Patient is switched to commercial drug|16|||
48809019|NCT03176238|157141591|FG001|Overall Study|Patient is switched to commercial drug|1|||
48809020|NCT03176238|157141590|FG000|Overall Study|Protocol Violation|1|||
48809021|NCT03176238|157141591|FG001|Overall Study|Protocol Violation|0|||
48809022|NCT03176238|157141590|FG000|Overall Study|Changes in the patient's condition|2|||
48809023|NCT03176238|157141591|FG001|Overall Study|Changes in the patient's condition|1|||
48809024|NCT03176238|157141590|FG000|Overall Study|Everolimus dose interrupt > 4 wks|9|||
48809025|NCT03176238|157141591|FG001|Overall Study|Everolimus dose interrupt > 4 wks|0|||
48809026|NCT03556358|157141592|FG000|Overall Study|Subjects Randomized that did not Treat|3|||
48809027|NCT03556358|157141593|FG001|Overall Study|Subjects Randomized that did not Treat|0|||
48809028|NCT03556358|157141592|FG000|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|7|||
48809029|NCT03556358|157141593|FG001|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|5|||
48809030|NCT03556358|157141592|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|0|||
48809031|NCT03556358|157141593|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|1|||
48809032|NCT03556358|157141592|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Death|0|||
48809033|NCT03556358|157141593|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Death|1|||
48809034|NCT03556358|157141592|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|0|||
48809035|NCT03556358|157141593|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|2|||
48809036|NCT03556358|157141592|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|0|||
48809037|NCT03556358|157141593|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|1|||
48856435|NCT02066636|157312852|FG002|Overall Study|Administrative reasons by sponsor|0|||
48856436|NCT02066636|157312850|FG000|Overall Study|Other reasons|16|||
48856437|NCT02066636|157312851|FG001|Overall Study|Other reasons|15|||
48856438|NCT02066636|157312852|FG002|Overall Study|Other reasons|50|||
48856439|NCT02991118|157312856|FG000|Overall Study|Death|3|||
48856440|NCT02991118|157312857|FG001|Overall Study|Death|8|||
48917867|NCT01500278|157535821|FG001|Week 13 - Week 104|Abnormal questionable chest X-ray|2|||
48917868|NCT01500278|157535820|FG000|Week 13 - Week 104|Relocation|0|||
48917869|NCT01500278|157535821|FG001|Week 13 - Week 104|Relocation|1|||
48917870|NCT01500278|157535820|FG000|Week 13 - Week 104|Sponsor decision|0|||
48917871|NCT01500278|157535821|FG001|Week 13 - Week 104|Sponsor decision|2|||
48917872|NCT01500278|157535820|FG000|Week 13 - Week 104|Medical monitor decision|0|||
48917873|NCT01500278|157535821|FG001|Week 13 - Week 104|Medical monitor decision|2|||
48917874|NCT01500278|157535820|FG000|Week 13 - Week 104|Personal reason|0|||
48917875|NCT01500278|157535821|FG001|Week 13 - Week 104|Personal reason|1|||
48917876|NCT01500278|157535820|FG000|Week 13 - Week 104|Not completed|0|||
48917877|NCT01500278|157535821|FG001|Week 13 - Week 104|Not completed|1|||
48917878|NCT01500278|157535820|FG000|Week 13 - Week 104|Death|2|||
48809038|NCT03556358|157141592|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|1|||
48809039|NCT03556358|157141593|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|2|||
48809040|NCT01351025|157141596|FG000|Week 0 - 20|Lost to Follow-up|2|||
48809041|NCT01351025|157141597|FG001|Week 0 - 20|Lost to Follow-up|1|||
48809042|NCT01351025|157141596|FG000|Week 0 - 20|Withdrawal by Subject|1|||
48809043|NCT01351025|157141597|FG001|Week 0 - 20|Withdrawal by Subject|0|||
48809044|NCT01351025|157141596|FG000|Week 24 - 44|Lost to Follow-up|0|||
48809045|NCT01351025|157141597|FG001|Week 24 - 44|Lost to Follow-up|2|||
48809046|NCT01351025|157141596|FG000|Week 24 - 44|Site closed|0|||
48809047|NCT01351025|157141597|FG001|Week 24 - 44|Site closed|1|||
48809048|NCT01351025|157141596|FG000|Week 24 - 44|unable to get to clinic|1|||
48809049|NCT01351025|157141597|FG001|Week 24 - 44|unable to get to clinic|1|||
48809050|NCT03012061|157141608|FG000|Overall Study|Withdrawal by Subject|1|||
48809051|NCT03012061|157141609|FG001|Overall Study|Withdrawal by Subject|5|||
48809052|NCT03012061|157141610|FG002|Overall Study|Withdrawal by Subject|4|||
48809053|NCT03012061|157141608|FG000|Overall Study|Investigator Site Closed|1|||
48809054|NCT03012061|157141609|FG001|Overall Study|Investigator Site Closed|2|||
48809055|NCT03012061|157141610|FG002|Overall Study|Investigator Site Closed|0|||
48809056|NCT03012061|157141608|FG000|Overall Study|Lost to Follow-up|2|||
48809057|NCT03012061|157141609|FG001|Overall Study|Lost to Follow-up|1|||
48809058|NCT03012061|157141610|FG002|Overall Study|Lost to Follow-up|0|||
48809059|NCT03012061|157141608|FG000|Overall Study|Study closed/ Terminated|0|||
48809060|NCT03012061|157141609|FG001|Overall Study|Study closed/ Terminated|0|||
48809061|NCT03012061|157141610|FG002|Overall Study|Study closed/ Terminated|1|||
48809062|NCT03012061|157141608|FG000|Overall Study|Met Protocol Withdrawal Criterion|0|||
48917879|NCT01500278|157535821|FG001|Week 13 - Week 104|Death|4|||
48917880|NCT01500278|157535820|FG000|Week 13 - Week 104|Adverse Event|54|||
48917881|NCT01500278|157535821|FG001|Week 13 - Week 104|Adverse Event|54|||
48917882|NCT01970995|157535822|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
48917883|NCT01970995|157535823|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
48917884|NCT01970995|157535824|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
48917885|NCT01970995|157535822|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
48917886|NCT01970995|157535823|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|0|||
48917887|NCT01970995|157535824|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
48917888|NCT04225923|157535825|FG000|Overall Study|Protocol Violation|1|||
48917889|NCT04225923|157535826|FG001|Overall Study|Protocol Violation|0|||
48917890|NCT04225923|157535827|FG002|Overall Study|Protocol Violation|1|||
48809063|NCT03012061|157141609|FG001|Overall Study|Met Protocol Withdrawal Criterion|0|||
48809064|NCT03012061|157141610|FG002|Overall Study|Met Protocol Withdrawal Criterion|1|||
48809065|NCT03012061|157141608|FG000|Overall Study|Protocol Violation|0|||
48809066|NCT03012061|157141609|FG001|Overall Study|Protocol Violation|0|||
48809067|NCT03012061|157141610|FG002|Overall Study|Protocol Violation|2|||
48809068|NCT03012061|157141608|FG000|Overall Study|Lack of Efficacy|0|||
48809069|NCT03012061|157141609|FG001|Overall Study|Lack of Efficacy|1|||
48809070|NCT03012061|157141610|FG002|Overall Study|Lack of Efficacy|0|||
48809071|NCT03012061|157141608|FG000|Overall Study|Adverse Event|2|||
48809072|NCT03012061|157141609|FG001|Overall Study|Adverse Event|0|||
48809073|NCT03012061|157141610|FG002|Overall Study|Adverse Event|0|||
48809074|NCT00510458|157141611|FG000|Overall Study|5 year not evaluable/missed|21|||
48809075|NCT00510458|157141611|FG000|Overall Study|Death|1|||
48809076|NCT00510458|157141611|FG000|Overall Study|Terminated|14|||
48917891|NCT04225923|157535825|FG000|Overall Study|Withdrawal by Subject|4|||
48917892|NCT04225923|157535826|FG001|Overall Study|Withdrawal by Subject|1|||
48917893|NCT04225923|157535827|FG002|Overall Study|Withdrawal by Subject|3|||
48917894|NCT04225923|157535825|FG000|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
48917895|NCT04225923|157535826|FG001|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
48917896|NCT04225923|157535827|FG002|Overall Study|A subject completed the study but was reported incorrectly in the report form|1|||
48917897|NCT01157364|157535828|FG000|Overall Study|Other Reasons|1|||
48917898|NCT01157364|157535829|FG001|Overall Study|Other Reasons|1|||
48917899|NCT01157364|157535830|FG002|Overall Study|Other Reasons|2|||
48917900|NCT01157364|157535831|FG003|Overall Study|Other Reasons|1|||
48917901|NCT01157364|157535832|FG004|Overall Study|Other Reasons|0|||
48809077|NCT00510458|157141611|FG000|Overall Study|Lost to Follow-up|6|||
48809078|NCT00510458|157141611|FG000|Overall Study|Withdrawal by Subject|3|||
48809079|NCT00510458|157141611|FG000|Overall Study|Revision|2|||
48809080|NCT01871558|157141612|FG000|Overall Study|Other reason|0|||
48809081|NCT01871558|157141613|FG001|Overall Study|Other reason|1|||
48809082|NCT01871558|157141612|FG000|Overall Study|antidiabetic drug prematurely stopped|1|||
48809083|NCT01871558|157141613|FG001|Overall Study|antidiabetic drug prematurely stopped|1|||
48809084|NCT01871558|157141612|FG000|Overall Study|Withdrawal by Subject|2|||
48809085|NCT01871558|157141613|FG001|Overall Study|Withdrawal by Subject|0|||
48809086|NCT00171873|157141614|FG000|Overall Study|Withdrawal by Subject|4|||
48809087|NCT00171873|157141615|FG001|Overall Study|Withdrawal by Subject|2|||
48809088|NCT00171873|157141614|FG000|Overall Study|Adverse Event|5|||
48809089|NCT00171873|157141615|FG001|Overall Study|Adverse Event|0|||
48809090|NCT00171873|157141614|FG000|Overall Study|Switched to Octreotide|0|||
48809091|NCT00171873|157141615|FG001|Overall Study|Switched to Octreotide|1|||
48809092|NCT01338012|157141619|FG000|Overall Study|Death|4|||
48809093|NCT01338012|157141619|FG000|Overall Study|Study terminated|4|||
48809094|NCT04179175|157142605|FG000|Overall Study|Ongoing at the time of the data cut-off date|94|||
48809095|NCT04179175|157142606|FG001|Overall Study|Ongoing at the time of the data cut-off date|54|||
48809096|NCT04179175|157142607|FG002|Overall Study|Ongoing at the time of the data cut-off date|95|||
48809097|NCT04179175|157142608|FG003|Overall Study|Ongoing at the time of the data cut-off date|43|||
48917902|NCT01157364|157535833|FG005|Overall Study|Other Reasons|0|||
49120633|NCT02326272|158280515|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
49120634|NCT02326272|158280516|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
49120635|NCT02326272|158280517|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48809098|NCT04179175|157142609|FG004|Overall Study|Ongoing at the time of the data cut-off date|98|||
48809099|NCT04179175|157142610|FG005|Overall Study|Ongoing at the time of the data cut-off date|105|||
48809100|NCT04179175|157142605|FG000|Overall Study|Adverse Event|5|||
49120636|NCT02326272|158280518|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
49120637|NCT02326272|158280519|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
49120638|NCT02326272|158280520|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
49120639|NCT02326272|158280521|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
49120640|NCT02326272|158280522|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
49120641|NCT02326272|158280508|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
49120642|NCT02326272|158280509|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
49120643|NCT02326272|158280510|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
49120644|NCT02326272|158280511|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
49120645|NCT02326272|158280512|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
49120646|NCT02326272|158280513|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2|||
49120647|NCT02326272|158280514|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
49120648|NCT02326272|158280515|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
49120649|NCT02326272|158280516|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
49120650|NCT02326272|158280517|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
49120651|NCT02326272|158280518|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
49120652|NCT02326272|158280519|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
49120653|NCT02326272|158280520|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
49120654|NCT02326272|158280521|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
49120655|NCT02326272|158280522|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
49120656|NCT02326272|158280508|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
49120657|NCT02326272|158280509|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
49120658|NCT02326272|158280510|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
49120659|NCT02326272|158280511|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
49120660|NCT02326272|158280512|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
49120661|NCT02326272|158280513|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
49120662|NCT02326272|158280514|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
49120663|NCT02326272|158280515|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
49120664|NCT02326272|158280516|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
49120665|NCT02326272|158280517|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
49120666|NCT02326272|158280518|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
49120667|NCT02326272|158280519|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
49120668|NCT02326272|158280520|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
49120669|NCT02326272|158280521|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
49120670|NCT02326272|158280522|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
49120671|NCT02326272|158280508|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
49120672|NCT02326272|158280509|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
49120673|NCT02326272|158280510|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
49120674|NCT02326272|158280511|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
49120675|NCT02326272|158280512|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
49120676|NCT02326272|158280513|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
49120677|NCT02326272|158280514|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
49120678|NCT02326272|158280515|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
49120679|NCT02326272|158280516|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
49120680|NCT02326272|158280517|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
49120681|NCT02326272|158280518|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
49120682|NCT02326272|158280519|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
49120683|NCT02326272|158280520|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
49120684|NCT02326272|158280521|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
49120685|NCT02326272|158280522|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
49120686|NCT02326272|158280508|FG000|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
49120687|NCT02326272|158280509|FG001|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
49120688|NCT02326272|158280510|FG002|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
49120689|NCT02326272|158280511|FG003|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
49120690|NCT02326272|158280512|FG004|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
49120691|NCT02326272|158280513|FG005|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
49120692|NCT02326272|158280514|FG006|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
49120693|NCT02326272|158280515|FG007|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1|||
49120694|NCT02326272|158280516|FG008|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
49120695|NCT02326272|158280517|FG009|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
49120696|NCT02326272|158280518|FG010|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
49120697|NCT02326272|158280519|FG011|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
49120698|NCT02326272|158280520|FG012|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
49120699|NCT02326272|158280521|FG013|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
49120700|NCT02326272|158280522|FG014|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
49120701|NCT02326272|158280508|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
49120702|NCT02326272|158280509|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
49120703|NCT02326272|158280510|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
49120704|NCT02326272|158280511|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
49120705|NCT02326272|158280512|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
48809101|NCT04179175|157142606|FG001|Overall Study|Adverse Event|3|||
48809102|NCT04179175|157142607|FG002|Overall Study|Adverse Event|3|||
48809103|NCT04179175|157142608|FG003|Overall Study|Adverse Event|4|||
48809104|NCT04179175|157142609|FG004|Overall Study|Adverse Event|6|||
48809105|NCT04179175|157142610|FG005|Overall Study|Adverse Event|6|||
48809106|NCT04179175|157142605|FG000|Overall Study|Lack of Efficacy|5|||
48809107|NCT04179175|157142606|FG001|Overall Study|Lack of Efficacy|1|||
48809108|NCT04179175|157142607|FG002|Overall Study|Lack of Efficacy|3|||
48809109|NCT04179175|157142608|FG003|Overall Study|Lack of Efficacy|2|||
48809110|NCT04179175|157142609|FG004|Overall Study|Lack of Efficacy|18|||
48809111|NCT04179175|157142610|FG005|Overall Study|Lack of Efficacy|7|||
48809112|NCT04179175|157142605|FG000|Overall Study|Lost to Follow-up|5|||
48809113|NCT04179175|157142606|FG001|Overall Study|Lost to Follow-up|3|||
48809114|NCT04179175|157142607|FG002|Overall Study|Lost to Follow-up|2|||
48809115|NCT04179175|157142608|FG003|Overall Study|Lost to Follow-up|2|||
48809116|NCT04179175|157142609|FG004|Overall Study|Lost to Follow-up|4|||
48809117|NCT04179175|157142610|FG005|Overall Study|Lost to Follow-up|5|||
48711184|NCT01584440|156791484|FG003|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
48711185|NCT01584440|156791485|FG004|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
48711186|NCT00899431|156791486|FG000|Overall Study|Physician Decision|1|||
48711187|NCT00899431|156791487|FG001|Overall Study|Physician Decision|0|||
48711188|NCT00899431|156791488|FG002|Overall Study|Physician Decision|0|||
48711189|NCT01821560|156791493|FG000|Overall Study|Lost to Follow-up|5|||
48711190|NCT01821560|156791494|FG001|Overall Study|Lost to Follow-up|5|||
48711191|NCT01821560|156791493|FG000|Overall Study|Withdrawal by Subject|1|||
48711192|NCT01821560|156791494|FG001|Overall Study|Withdrawal by Subject|1|||
48711193|NCT01821560|156791493|FG000|Overall Study|Protocol Violation|0|||
48711194|NCT01821560|156791494|FG001|Overall Study|Protocol Violation|1|||
48711195|NCT01253577|156791505|FG000|Overall Study|Lost to Follow-up|3|||
48711196|NCT00334113|156791508|FG000|Overall Study|Lost to Follow-up|2|||
48711197|NCT00334113|156791509|FG001|Overall Study|Lost to Follow-up|2|||
48711198|NCT00334113|156791508|FG000|Overall Study|Withdrawal by Subject|0|||
48711199|NCT00334113|156791509|FG001|Overall Study|Withdrawal by Subject|1|||
48711200|NCT02509026|156791510|FG000|Induction Period (24 Weeks)|Adverse Event|5|||
48711201|NCT02509026|156791510|FG000|Induction Period (24 Weeks)|Eligibility Criteria|5|||
48711202|NCT02509026|156791510|FG000|Induction Period (24 Weeks)|Lack of Efficacy|6|||
48711203|NCT02509026|156791510|FG000|Induction Period (24 Weeks)|Lost to Follow-up|1|||
48711204|NCT02509026|156791510|FG000|Induction Period (24 Weeks)|Other|2|||
48711205|NCT02509026|156791510|FG000|Induction Period (24 Weeks)|Protocol Violation|1|||
48711206|NCT02509026|156791510|FG000|Induction Period (24 Weeks)|Withdrawal by Subject|1|||
48711207|NCT02509026|156791510|FG000|Induction Period (24 Weeks)|Enrolled but not treated|1|||
48711208|NCT02509026|156791510|FG000|Withdrawal Period (40 Weeks)|Protocol Violation|2|||
48711209|NCT02509026|156791510|FG000|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5|||
48711210|NCT02509026|156791510|FG000|Retreatment Period (12 Weeks)|Lost to Follow-up|1|||
48711211|NCT02509026|156791510|FG000|Retreatment Period (12 Weeks)|Withdrawal by Subject|2|||
48711212|NCT02509026|156791510|FG000|Retreatment Period (12 Weeks)|Enrolled but not treated|1|||
48711213|NCT01165216|156791511|FG000|Overall Study|Adverse Event|6|||
48711214|NCT01165216|156791512|FG001|Overall Study|Adverse Event|3|||
48809118|NCT04179175|157142605|FG000|Overall Study|Physician Decision|2|||
48809119|NCT04179175|157142606|FG001|Overall Study|Physician Decision|0|||
48809120|NCT04179175|157142607|FG002|Overall Study|Physician Decision|2|||
48809121|NCT04179175|157142608|FG003|Overall Study|Physician Decision|3|||
48809122|NCT04179175|157142609|FG004|Overall Study|Physician Decision|1|||
48809123|NCT04179175|157142610|FG005|Overall Study|Physician Decision|1|||
48809124|NCT04179175|157142605|FG000|Overall Study|Pregnancy|3|||
49120706|NCT02326272|158280513|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
48711215|NCT01165216|156791511|FG000|Overall Study|Withdrawal by Subject|1|||
48809125|NCT04179175|157142606|FG001|Overall Study|Pregnancy|0|||
48809126|NCT04179175|157142607|FG002|Overall Study|Pregnancy|3|||
49120707|NCT02326272|158280514|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
49120708|NCT02326272|158280515|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
49120709|NCT02326272|158280516|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
49120710|NCT02326272|158280517|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
49120711|NCT02326272|158280518|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
49120712|NCT02326272|158280519|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
49120713|NCT02326272|158280520|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
49120714|NCT02326272|158280521|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
49120715|NCT02326272|158280522|FG014|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
49120716|NCT02326272|158280508|FG000|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
49120717|NCT02326272|158280509|FG001|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
49120718|NCT02326272|158280510|FG002|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
49120719|NCT02326272|158280511|FG003|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
49120720|NCT02326272|158280512|FG004|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
49120721|NCT02326272|158280513|FG005|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
49120722|NCT02326272|158280514|FG006|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
49120723|NCT02326272|158280515|FG007|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
49120724|NCT02326272|158280516|FG008|Maintenance Period (Week 16 to Week 48)|Non-compliance|1|||
49120725|NCT02326272|158280517|FG009|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
49120726|NCT02326272|158280518|FG010|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
49120727|NCT02326272|158280519|FG011|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
49120728|NCT02326272|158280520|FG012|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
49120729|NCT02326272|158280521|FG013|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
49120730|NCT02326272|158280522|FG014|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
49120731|NCT02326272|158280508|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
48711216|NCT01165216|156791512|FG001|Overall Study|Withdrawal by Subject|1|||
48711217|NCT01165216|156791511|FG000|Overall Study|Disease progression|1|||
48809127|NCT04179175|157142608|FG003|Overall Study|Pregnancy|0|||
48809128|NCT04179175|157142609|FG004|Overall Study|Pregnancy|1|||
48809129|NCT04179175|157142610|FG005|Overall Study|Pregnancy|2|||
48711218|NCT01165216|156791512|FG001|Overall Study|Disease progression|3|||
48711219|NCT03645434|156791513|FG000|Period 1|Adverse Event|0|||
48711220|NCT03645434|156791514|FG001|Period 1|Adverse Event|0|||
48711221|NCT03645434|156791515|FG002|Period 1|Adverse Event|0|||
48711222|NCT03645434|156791516|FG003|Period 1|Adverse Event|1|||
48917903|NCT01157364|157535828|FG000|Overall Study|Personal Reasons|0|||
48917904|NCT01157364|157535829|FG001|Overall Study|Personal Reasons|2|||
48917905|NCT01157364|157535830|FG002|Overall Study|Personal Reasons|0|||
48917906|NCT01157364|157535831|FG003|Overall Study|Personal Reasons|0|||
48917907|NCT01157364|157535832|FG004|Overall Study|Personal Reasons|1|||
48917908|NCT01157364|157535833|FG005|Overall Study|Personal Reasons|1|||
48917909|NCT01157364|157535828|FG000|Overall Study|Lost to Follow-up|1|||
48917910|NCT01157364|157535829|FG001|Overall Study|Lost to Follow-up|0|||
48917911|NCT01157364|157535830|FG002|Overall Study|Lost to Follow-up|1|||
48917912|NCT01157364|157535831|FG003|Overall Study|Lost to Follow-up|0|||
48917913|NCT01157364|157535832|FG004|Overall Study|Lost to Follow-up|0|||
48917914|NCT01157364|157535833|FG005|Overall Study|Lost to Follow-up|0|||
48917915|NCT01157364|157535828|FG000|Overall Study|Lack of Efficacy|0|||
48917916|NCT01157364|157535829|FG001|Overall Study|Lack of Efficacy|0|||
48917917|NCT01157364|157535830|FG002|Overall Study|Lack of Efficacy|0|||
48917918|NCT01157364|157535831|FG003|Overall Study|Lack of Efficacy|1|||
48917919|NCT01157364|157535832|FG004|Overall Study|Lack of Efficacy|0|||
48917920|NCT01157364|157535833|FG005|Overall Study|Lack of Efficacy|0|||
48917921|NCT01157364|157535828|FG000|Overall Study|Adverse Event|0|||
48917922|NCT01157364|157535829|FG001|Overall Study|Adverse Event|1|||
48917923|NCT01157364|157535830|FG002|Overall Study|Adverse Event|1|||
48917924|NCT01157364|157535831|FG003|Overall Study|Adverse Event|0|||
48917925|NCT01157364|157535832|FG004|Overall Study|Adverse Event|1|||
48917926|NCT01157364|157535833|FG005|Overall Study|Adverse Event|0|||
48917927|NCT01576549|157535834|FG000|Overall Study|Sponsor Decision|2|||
48917928|NCT00053417|157535835|FG000|Overall Study|Adverse Event|1|||
48917929|NCT00053417|157535836|FG001|Overall Study|Adverse Event|0|||
48917930|NCT00053417|157535837|FG002|Overall Study|Adverse Event|1|||
48917931|NCT00053417|157535838|FG003|Overall Study|Adverse Event|5|||
48917932|NCT00053417|157535835|FG000|Overall Study|Non-Compliance|0|||
48917933|NCT00053417|157535836|FG001|Overall Study|Non-Compliance|0|||
48917934|NCT00053417|157535837|FG002|Overall Study|Non-Compliance|0|||
48917935|NCT00053417|157535838|FG003|Overall Study|Non-Compliance|1|||
48917936|NCT00053417|157535835|FG000|Overall Study|Withdrawal by Subject|0|||
48917937|NCT00053417|157535836|FG001|Overall Study|Withdrawal by Subject|1|||
48917938|NCT00053417|157535837|FG002|Overall Study|Withdrawal by Subject|0|||
48917939|NCT00053417|157535838|FG003|Overall Study|Withdrawal by Subject|0|||
48917940|NCT00053417|157535835|FG000|Overall Study|Lost to Follow-up|1|||
48917941|NCT00053417|157535836|FG001|Overall Study|Lost to Follow-up|1|||
48917942|NCT00053417|157535837|FG002|Overall Study|Lost to Follow-up|0|||
48917943|NCT00053417|157535838|FG003|Overall Study|Lost to Follow-up|0|||
48917944|NCT04315181|157535839|FG000|Overall Study|Non-responsive to drug conditions.|1|||
48917945|NCT03901079|157535840|FG000|Overall Study|8 of the 20 subjects already enrolled were unable to complete the the 12-month follow-up|8|||
48917946|NCT00912028|157535842|FG000|Overall Study|Lost to Follow-up|2|||
48711223|NCT03645434|156791517|FG004|Period 1|Adverse Event|0|||
48711224|NCT03645434|156791518|FG005|Period 1|Adverse Event|0|||
48711225|NCT03645434|156791513|FG000|Period 1|COPD exacerbation|0|||
48711226|NCT03645434|156791514|FG001|Period 1|COPD exacerbation|0|||
48711227|NCT03645434|156791515|FG002|Period 1|COPD exacerbation|0|||
48711228|NCT03645434|156791516|FG003|Period 1|COPD exacerbation|0|||
48711229|NCT03645434|156791517|FG004|Period 1|COPD exacerbation|1|||
48711230|NCT03645434|156791518|FG005|Period 1|COPD exacerbation|0|||
48711231|NCT01379508|156791519|FG000|Treatment to Week 104|Adverse Event|2|||
48711232|NCT01379508|156791520|FG001|Treatment to Week 104|Adverse Event|0|||
48711233|NCT01379508|156791521|FG002|Treatment to Week 104|Adverse Event|5|||
48711234|NCT01379508|156791522|FG003|Treatment to Week 104|Adverse Event|0|||
48711235|NCT01379508|156791519|FG000|Treatment to Week 104|Abnormal lab value|1|||
48711236|NCT01379508|156791520|FG001|Treatment to Week 104|Abnormal lab value|0|||
48711237|NCT01379508|156791521|FG002|Treatment to Week 104|Abnormal lab value|0|||
48711238|NCT01379508|156791522|FG003|Treatment to Week 104|Abnormal lab value|0|||
48711239|NCT01379508|156791519|FG000|Treatment to Week 104|Abnormal test procedure result(s)|1|||
48711240|NCT01379508|156791520|FG001|Treatment to Week 104|Abnormal test procedure result(s)|0|||
48711241|NCT01379508|156791521|FG002|Treatment to Week 104|Abnormal test procedure result(s)|0|||
48917947|NCT00912028|157535843|FG001|Overall Study|Lost to Follow-up|3|||
48917948|NCT00912028|157535844|FG002|Overall Study|Lost to Follow-up|0|||
49015356|NCT00673790|157892153|FG001|Overall Study|Randomization criteria not met|1|||
48711242|NCT01379508|156791522|FG003|Treatment to Week 104|Abnormal test procedure result(s)|0|||
48711243|NCT01379508|156791519|FG000|Treatment to Week 104|Withdrawal by Subject|6|||
48711244|NCT01379508|156791520|FG001|Treatment to Week 104|Withdrawal by Subject|1|||
48711245|NCT01379508|156791521|FG002|Treatment to Week 104|Withdrawal by Subject|4|||
48711246|NCT01379508|156791522|FG003|Treatment to Week 104|Withdrawal by Subject|0|||
48711247|NCT01379508|156791519|FG000|Treatment to Week 104|Lost to Follow-up|5|||
48711248|NCT01379508|156791520|FG001|Treatment to Week 104|Lost to Follow-up|0|||
48917949|NCT00912028|157535845|FG003|Overall Study|Lost to Follow-up|1|||
48917950|NCT00912028|157535846|FG004|Overall Study|Lost to Follow-up|3|||
48917951|NCT00912028|157535842|FG000|Overall Study|Withdrawal by Subject|3|||
48917952|NCT00912028|157535843|FG001|Overall Study|Withdrawal by Subject|0|||
48917953|NCT00912028|157535844|FG002|Overall Study|Withdrawal by Subject|0|||
48917954|NCT00912028|157535845|FG003|Overall Study|Withdrawal by Subject|0|||
48917955|NCT00912028|157535846|FG004|Overall Study|Withdrawal by Subject|0|||
48917956|NCT02830776|157535850|FG000|Overall Study|Lost to Follow-up|1|||
48917957|NCT00906087|157535851|FG000|Initial Washout|Withdrawal by Subject|1|||
48917958|NCT00906087|157535851|FG000|Initial Washout|Physician Decision|1|||
48917959|NCT01765920|157535854|FG000|Overall Study|Incorrect inclusion ineligible patient|2|||
48917960|NCT01765920|157535855|FG001|Overall Study|Incorrect inclusion ineligible patient|5|||
48917961|NCT01765920|157535854|FG000|Overall Study|Patient code disclosure|0|||
48917962|NCT01765920|157535855|FG001|Overall Study|Patient code disclosure|1|||
48917963|NCT01081249|157535856|FG000|Overall Study|Diagnosed with Bipolar Disorder|0|||
48917964|NCT01081249|157535857|FG001|Overall Study|Diagnosed with Bipolar Disorder|1|||
48917965|NCT00777101|157535861|FG000|Overall Study|Death|48|||
48917966|NCT00777101|157535862|FG001|Overall Study|Death|43|||
48917967|NCT00777101|157535861|FG000|Overall Study|Withdrawal by Subject|11|||
48917968|NCT00777101|157535862|FG001|Overall Study|Withdrawal by Subject|6|||
48917969|NCT00777101|157535861|FG000|Overall Study|Lost to Follow-up|2|||
48917970|NCT00777101|157535862|FG001|Overall Study|Lost to Follow-up|1|||
48917971|NCT00777101|157535861|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
48917972|NCT00777101|157535862|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
48917973|NCT00777101|157535861|FG000|Overall Study|Failed to Return|0|||
48917974|NCT00777101|157535862|FG001|Overall Study|Failed to Return|1|||
48917975|NCT02411539|157535863|FG000|Overall Study|Lost to Follow-up|2|||
48917976|NCT02411539|157535864|FG001|Overall Study|Lost to Follow-up|0|||
48917977|NCT02411539|157535863|FG000|Overall Study|Confounding medical condition|0|||
48917978|NCT02411539|157535864|FG001|Overall Study|Confounding medical condition|1|||
48917979|NCT03917823|157535868|FG000|Overall Study|Lost to Follow-up|1|||
48917980|NCT03917823|157535869|FG001|Overall Study|Lost to Follow-up|1|||
48917981|NCT03917823|157535868|FG000|Overall Study|Withdrawal by Subject|0|||
48917982|NCT03917823|157535869|FG001|Overall Study|Withdrawal by Subject|1|||
48917983|NCT00135668|157535870|FG000|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|1|||
48917984|NCT00135668|157535871|FG001|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
48917985|NCT00135668|157535872|FG002|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|2|||
48917986|NCT00135668|157535873|FG003|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
48917987|NCT00473343|157535874|FG000|Overall Study|Adverse Event|9|||
48917988|NCT00473343|157535874|FG000|Overall Study|Lost to Follow-up|8|||
48917989|NCT00473343|157535874|FG000|Overall Study|Treatment failure|27|||
48917990|NCT00473343|157535874|FG000|Overall Study|Withdrew consent|3|||
48917991|NCT00473343|157535874|FG000|Overall Study|Other un-specified reason|3|||
48917992|NCT00258674|157535875|FG000|Overall Study|Death|32|||
48917993|NCT00258674|157535876|FG001|Overall Study|Death|53|||
48917994|NCT00258674|157535877|FG002|Overall Study|Death|34|||
48917995|NCT03891264|157535878|FG000|Overall Study|Adverse Event|1|||
48917996|NCT03891264|157535878|FG000|Overall Study|Withdrawal by Subject|2|||
48917997|NCT03891264|157535878|FG000|Overall Study|Physician Decision|2|||
48917998|NCT00574275|157535881|FG000|Overall Study|Randomized but not treated|2|||
48917999|NCT00574275|157535882|FG001|Overall Study|Randomized but not treated|3|||
48918000|NCT00574275|157535881|FG000|Overall Study|Adverse Event|32|||
48918001|NCT00574275|157535882|FG001|Overall Study|Adverse Event|76|||
48918002|NCT00574275|157535881|FG000|Overall Study|Disease progression|160|||
48918003|NCT00574275|157535882|FG001|Overall Study|Disease progression|146|||
48918004|NCT00574275|157535881|FG000|Overall Study|Lost to Follow-up|2|||
48918005|NCT00574275|157535882|FG001|Overall Study|Lost to Follow-up|1|||
48918006|NCT00574275|157535881|FG000|Overall Study|Study stopped based on DMC decision|62|||
48918007|NCT00574275|157535882|FG001|Overall Study|Study stopped based on DMC decision|23|||
48918008|NCT00574275|157535881|FG000|Overall Study|Withdrawal by Subject|15|||
48918009|NCT00574275|157535882|FG001|Overall Study|Withdrawal by Subject|17|||
49120732|NCT02326272|158280509|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
49120733|NCT02326272|158280510|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
49120734|NCT02326272|158280511|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
49120735|NCT02326272|158280512|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
49120736|NCT02326272|158280513|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
49120737|NCT02326272|158280514|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
49120738|NCT02326272|158280515|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
49120739|NCT02326272|158280516|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
49120740|NCT02326272|158280517|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
49120741|NCT02326272|158280518|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
48918010|NCT00574275|157535881|FG000|Overall Study|Error calculating tumor measurement|1|||
48918011|NCT00574275|157535882|FG001|Overall Study|Error calculating tumor measurement|0|||
48918012|NCT00574275|157535881|FG000|Overall Study|Physician Decision|1|||
48918013|NCT00574275|157535882|FG001|Overall Study|Physician Decision|1|||
48918014|NCT00574275|157535881|FG000|Overall Study|Protocol Violation|0|||
48918015|NCT00574275|157535882|FG001|Overall Study|Protocol Violation|1|||
48918016|NCT00574275|157535881|FG000|Overall Study|Patient and Investigator decision|0|||
48918017|NCT00574275|157535882|FG001|Overall Study|Patient and Investigator decision|1|||
48918018|NCT00574275|157535881|FG000|Overall Study|Insurance change|0|||
48918019|NCT00574275|157535882|FG001|Overall Study|Insurance change|1|||
48918020|NCT00574275|157535881|FG000|Overall Study|Operation for curative intent|0|||
48918021|NCT00574275|157535882|FG001|Overall Study|Operation for curative intent|1|||
48918022|NCT02703311|157535887|FG000|Overall Study|Death|5|||
48918023|NCT02703311|157535887|FG000|Overall Study|Withdrawal by Subject|3|||
48918024|NCT00950664|157535893|FG000|First Intervention|Lost to Follow-up|1|||
48918025|NCT00950664|157535894|FG001|First Intervention|Lost to Follow-up|3|||
48918026|NCT00950664|157535893|FG000|First Intervention|Withdrawal by Subject|2|||
48918027|NCT00950664|157535894|FG001|First Intervention|Withdrawal by Subject|2|||
48918028|NCT00677014|157535895|FG000|Overall Study|Lost to Follow-up|20|||
48918029|NCT00677014|157535896|FG001|Overall Study|Lost to Follow-up|12|||
48918030|NCT00677014|157535897|FG002|Overall Study|Lost to Follow-up|24|||
48918031|NCT00677014|157535895|FG000|Overall Study|Death|6|||
48809130|NCT04179175|157142605|FG000|Overall Study|Withdrawal by Subject|22|||
48809131|NCT04179175|157142606|FG001|Overall Study|Withdrawal by Subject|10|||
48809132|NCT04179175|157142607|FG002|Overall Study|Withdrawal by Subject|12|||
48809133|NCT04179175|157142608|FG003|Overall Study|Withdrawal by Subject|8|||
48809134|NCT04179175|157142609|FG004|Overall Study|Withdrawal by Subject|23|||
48809135|NCT04179175|157142610|FG005|Overall Study|Withdrawal by Subject|31|||
48809136|NCT04179175|157142605|FG000|Overall Study|Technical problems|0|||
48809137|NCT04179175|157142606|FG001|Overall Study|Technical problems|0|||
48809138|NCT04179175|157142607|FG002|Overall Study|Technical problems|1|||
48809139|NCT04179175|157142608|FG003|Overall Study|Technical problems|1|||
48809140|NCT04179175|157142609|FG004|Overall Study|Technical problems|0|||
48809141|NCT04179175|157142610|FG005|Overall Study|Technical problems|0|||
48809142|NCT02576509|157142611|FG000|Pre-Treatment Period|Participant request to stop therapy|0|||
48809143|NCT02576509|157142612|FG001|Pre-Treatment Period|Participant request to stop therapy|2|||
48809144|NCT02576509|157142611|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
48809145|NCT02576509|157142612|FG001|Pre-Treatment Period|Participant withdrew consent|5|||
48809146|NCT02576509|157142611|FG000|Pre-Treatment Period|Participant no longer meets criteria|3|||
48809147|NCT02576509|157142612|FG001|Pre-Treatment Period|Participant no longer meets criteria|2|||
48809148|NCT02576509|157142611|FG000|Treatment Period|Disease progression|263|||
48809149|NCT02576509|157142612|FG001|Treatment Period|Disease progression|244|||
48809150|NCT02576509|157142611|FG000|Treatment Period|Study drug toxicity|37|||
48809151|NCT02576509|157142612|FG001|Treatment Period|Study drug toxicity|41|||
48809152|NCT02576509|157142611|FG000|Treatment Period|Death|1|||
48809153|NCT02576509|157142612|FG001|Treatment Period|Death|1|||
48809154|NCT02576509|157142611|FG000|Treatment Period|Adverse event unrelated to study drug|39|||
48809155|NCT02576509|157142612|FG001|Treatment Period|Adverse event unrelated to study drug|41|||
48809156|NCT02576509|157142611|FG000|Treatment Period|Participant request to stop treatment|8|||
48809157|NCT02576509|157142612|FG001|Treatment Period|Participant request to stop treatment|18|||
48809158|NCT02576509|157142611|FG000|Treatment Period|Participant withdrew consent|3|||
48809159|NCT02576509|157142612|FG001|Treatment Period|Participant withdrew consent|7|||
48918032|NCT00677014|157535896|FG001|Overall Study|Death|15|||
48918033|NCT00677014|157535897|FG002|Overall Study|Death|7|||
48918034|NCT00677014|157535895|FG000|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
48918035|NCT00677014|157535896|FG001|Overall Study|Unavailable or unreadable 6 month LVESV|14|||
48918036|NCT00677014|157535897|FG002|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
48809160|NCT02576509|157142611|FG000|Treatment Period|Lost to Follow-up|0|||
48809161|NCT02576509|157142612|FG001|Treatment Period|Lost to Follow-up|1|||
48809162|NCT02576509|157142611|FG000|Treatment Period|Maximum clinical benefit|1|||
48809163|NCT02576509|157142612|FG001|Treatment Period|Maximum clinical benefit|0|||
48809164|NCT02576509|157142611|FG000|Treatment Period|Poor/non-compliance|1|||
48918037|NCT01714687|157535900|FG000|Overall Study|Withdrawal by Subject|1|||
48918038|NCT01714687|157535901|FG001|Overall Study|Withdrawal by Subject|0|||
48918039|NCT01714687|157535900|FG000|Overall Study|Lost to Follow-up|2|||
48918040|NCT01714687|157535901|FG001|Overall Study|Lost to Follow-up|4|||
48809165|NCT02576509|157142612|FG001|Treatment Period|Poor/non-compliance|1|||
48918041|NCT03116698|157535902|FG000|Overall Study|Adverse Event|1|||
48918042|NCT03116698|157535903|FG001|Overall Study|Adverse Event|1|||
48918043|NCT03116698|157535904|FG002|Overall Study|Adverse Event|1|||
48918044|NCT03116698|157535905|FG003|Overall Study|Adverse Event|0|||
48918045|NCT03116698|157535902|FG000|Overall Study|Withdrawal by Subject|1|||
48918046|NCT03116698|157535903|FG001|Overall Study|Withdrawal by Subject|4|||
48918047|NCT03116698|157535904|FG002|Overall Study|Withdrawal by Subject|5|||
48918048|NCT03116698|157535905|FG003|Overall Study|Withdrawal by Subject|2|||
48918049|NCT03116698|157535902|FG000|Overall Study|Lost to Follow-up|2|||
48918050|NCT03116698|157535903|FG001|Overall Study|Lost to Follow-up|0|||
48918051|NCT03116698|157535904|FG002|Overall Study|Lost to Follow-up|0|||
48918052|NCT03116698|157535905|FG003|Overall Study|Lost to Follow-up|0|||
48918053|NCT03116698|157535902|FG000|Overall Study|Physician Decision|1|||
48918054|NCT03116698|157535903|FG001|Overall Study|Physician Decision|1|||
48918055|NCT03116698|157535904|FG002|Overall Study|Physician Decision|0|||
48918056|NCT03116698|157535905|FG003|Overall Study|Physician Decision|0|||
48918057|NCT03116698|157535902|FG000|Overall Study|Protocol Violation|1|||
48918058|NCT03116698|157535903|FG001|Overall Study|Protocol Violation|0|||
48918059|NCT03116698|157535904|FG002|Overall Study|Protocol Violation|0|||
48918060|NCT03116698|157535905|FG003|Overall Study|Protocol Violation|0|||
48918061|NCT03116698|157535902|FG000|Overall Study|Death|0|||
48918062|NCT03116698|157535903|FG001|Overall Study|Death|0|||
48918063|NCT03116698|157535904|FG002|Overall Study|Death|2|||
48918064|NCT03116698|157535905|FG003|Overall Study|Death|0|||
48918065|NCT00317109|157535906|FG000|Overall Study|Withdrawal by Subject|2|||
48918066|NCT00317109|157535907|FG001|Overall Study|Withdrawal by Subject|0|||
48918067|NCT00317109|157535906|FG000|Overall Study|Migated/moved from study area|1|||
48918068|NCT00317109|157535907|FG001|Overall Study|Migated/moved from study area|0|||
48918069|NCT01508702|157535908|FG000|Overall Study|Adverse Event|7|||
48918070|NCT01508702|157535909|FG001|Overall Study|Adverse Event|3|||
48918071|NCT01508702|157535908|FG000|Overall Study|Gout flare|2|||
48918072|NCT01508702|157535909|FG001|Overall Study|Gout flare|0|||
48711249|NCT01379508|156791521|FG002|Treatment to Week 104|Lost to Follow-up|3|||
48711250|NCT01379508|156791522|FG003|Treatment to Week 104|Lost to Follow-up|0|||
48711251|NCT01379508|156791519|FG000|Treatment to Week 104|Administrative problems|3|||
48711252|NCT01379508|156791520|FG001|Treatment to Week 104|Administrative problems|1|||
48711253|NCT01379508|156791521|FG002|Treatment to Week 104|Administrative problems|0|||
48711254|NCT01379508|156791522|FG003|Treatment to Week 104|Administrative problems|0|||
48711255|NCT01379508|156791519|FG000|Treatment to Week 104|Protocol Violation|1|||
48809166|NCT02576509|157142611|FG000|Treatment Period|Participant no longer meets criteria|1|||
48918073|NCT01508702|157535908|FG000|Overall Study|Protocol Violation|2|||
48918074|NCT01508702|157535909|FG001|Overall Study|Protocol Violation|1|||
48918075|NCT01508702|157535908|FG000|Overall Study|Lost to Follow-up|1|||
49120742|NCT02326272|158280519|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
48918076|NCT01508702|157535909|FG001|Overall Study|Lost to Follow-up|2|||
48918077|NCT01508702|157535908|FG000|Overall Study|Withdrawal by Subject|11|||
48918078|NCT01508702|157535909|FG001|Overall Study|Withdrawal by Subject|7|||
48918079|NCT00844753|157535910|FG000|Overall Study|Lack of Efficacy|1|||
48918080|NCT00844753|157535911|FG001|Overall Study|Lack of Efficacy|0|||
49120743|NCT02326272|158280520|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
49120744|NCT02326272|158280521|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
49120745|NCT02326272|158280522|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
49120746|NCT02326272|158280508|FG000|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
49120747|NCT02326272|158280509|FG001|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
49120748|NCT02326272|158280510|FG002|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
49120749|NCT02326272|158280511|FG003|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
49120750|NCT02326272|158280512|FG004|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
49120751|NCT02326272|158280513|FG005|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1|||
49120752|NCT02326272|158280514|FG006|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
49120753|NCT02326272|158280515|FG007|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
49120754|NCT02326272|158280516|FG008|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
49120755|NCT02326272|158280517|FG009|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
49120756|NCT02326272|158280518|FG010|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
49120757|NCT02326272|158280519|FG011|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
49120758|NCT02326272|158280520|FG012|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
49120759|NCT02326272|158280521|FG013|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
49120760|NCT02326272|158280522|FG014|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
49120761|NCT02326272|158280508|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
49120762|NCT02326272|158280509|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
49120763|NCT02326272|158280510|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
48809167|NCT02576509|157142612|FG001|Treatment Period|Participant no longer meets criteria|0|||
48809168|NCT02576509|157142611|FG000|Treatment Period|Other reason|12|||
48809169|NCT02576509|157142612|FG001|Treatment Period|Other reason|8|||
48809170|NCT02576509|157142611|FG000|Treatment Period|NOT REPORTED|1|||
48809171|NCT02576509|157142612|FG001|Treatment Period|NOT REPORTED|0|||
48809172|NCT02576509|157142611|FG000|Treatment Period|Administrative reason by sponsor|0|||
48809173|NCT02576509|157142612|FG001|Treatment Period|Administrative reason by sponsor|1|||
48809174|NCT03152786|157142614|FG000|Overall Study|Withdrawal by Subject|2|||
48809175|NCT03152786|157142615|FG001|Overall Study|Withdrawal by Subject|1|||
48809176|NCT05934292|157142619|FG000|Overall Study|Lost to Follow-up|0|||
48809177|NCT05934292|157142620|FG001|Overall Study|Lost to Follow-up|0|||
48809178|NCT05934292|157142621|FG002|Overall Study|Lost to Follow-up|1|||
48809179|NCT05934292|157142622|FG003|Overall Study|Lost to Follow-up|0|||
48809180|NCT05672667|157142625|FG000|Overall Study|Vasovagal reaction with IV cannulation. Oxytocin was not infused and subject was withdrawn.|1|||
48809181|NCT03416023|157142626|FG000|Overall Study|Exclusion criteria failure|1|||
48809182|NCT03416023|157142626|FG000|Overall Study|Withdrawal by Subject|6|||
48809183|NCT03416023|157142626|FG000|Overall Study|Explanted|7|||
48809184|NCT03416023|157142626|FG000|Overall Study|Physician Decision|1|||
48809185|NCT03416023|157142626|FG000|Overall Study|Lost to Follow-up|1|||
48809186|NCT03416023|157142626|FG000|Overall Study|Death|1|||
48809187|NCT05110495|157142627|FG000|Overall Study|Lost to Follow-up|1|||
48809188|NCT05110495|157142627|FG000|Overall Study|Completed treatment with IMP but disease progressed prior to surgery.|1|||
48809189|NCT02387216|157142628|FG000|Overall Study|Progressive disease|2|||
48809190|NCT02387216|157142629|FG001|Overall Study|Progressive disease|0|||
48809191|NCT02387216|157142628|FG000|Overall Study|Withdrawal by Subject|3|||
48809192|NCT02387216|157142629|FG001|Overall Study|Withdrawal by Subject|5|||
48809193|NCT02387216|157142628|FG000|Overall Study|Physician Decision|2|||
48809194|NCT02387216|157142629|FG001|Overall Study|Physician Decision|0|||
48809195|NCT02387216|157142628|FG000|Overall Study|Sponsor Decision|28|||
48809196|NCT02387216|157142629|FG001|Overall Study|Sponsor Decision|12|||
48809197|NCT02387216|157142628|FG000|Overall Study|Death|60|||
48809198|NCT02387216|157142629|FG001|Overall Study|Death|23|||
48809199|NCT02387216|157142628|FG000|Overall Study|Other|5|||
48809200|NCT02387216|157142629|FG001|Overall Study|Other|4|||
48809201|NCT02387216|157142628|FG000|Overall Study|Lost to Follow-up|0|||
48809202|NCT02387216|157142629|FG001|Overall Study|Lost to Follow-up|3|||
48809203|NCT00154310|157142630|FG000|Overall Study|Adverse Event|19|||
48809204|NCT00154310|157142631|FG001|Overall Study|Adverse Event|9|||
48809205|NCT00154310|157142630|FG000|Overall Study|Lack of Efficacy|5|||
48809206|NCT00154310|157142631|FG001|Overall Study|Lack of Efficacy|4|||
48809207|NCT00154310|157142630|FG000|Overall Study|Protocol Violation|4|||
48809208|NCT00154310|157142631|FG001|Overall Study|Protocol Violation|2|||
48809209|NCT00154310|157142630|FG000|Overall Study|Withdrawal by Subject|9|||
48809210|NCT00154310|157142631|FG001|Overall Study|Withdrawal by Subject|3|||
48809211|NCT00154310|157142630|FG000|Overall Study|Lost to Follow-up|0|||
48809212|NCT00154310|157142631|FG001|Overall Study|Lost to Follow-up|8|||
48809213|NCT00154310|157142630|FG000|Overall Study|Administrative problems|0|||
48809214|NCT00154310|157142631|FG001|Overall Study|Administrative problems|1|||
48809215|NCT00154310|157142630|FG000|Overall Study|Death|0|||
48809216|NCT00154310|157142631|FG001|Overall Study|Death|1|||
48809217|NCT01540565|157142632|FG000|Overall Study|Ineligible|2|||
48809218|NCT03101241|157142633|FG000|Overall Study|Intercurrent condition necessitating discontinuation|4|||
48809219|NCT03101241|157142634|FG001|Overall Study|Intercurrent condition necessitating discontinuation|2|||
48809220|NCT03101241|157142633|FG000|Overall Study|Participant withdrew consent|3|||
48809221|NCT03101241|157142634|FG001|Overall Study|Participant withdrew consent|1|||
48809222|NCT03101241|157142633|FG000|Overall Study|Investigator decision that withdrawal was in best interest of participant|2|||
48809223|NCT03101241|157142634|FG001|Overall Study|Investigator decision that withdrawal was in best interest of participant|0|||
48809224|NCT03101241|157142633|FG000|Overall Study|Lost to Follow-up|2|||
48809225|NCT03101241|157142634|FG001|Overall Study|Lost to Follow-up|0|||
48809226|NCT03101241|157142633|FG000|Overall Study|Lack of Efficacy|0|||
48809227|NCT03101241|157142634|FG001|Overall Study|Lack of Efficacy|1|||
48809228|NCT03101241|157142633|FG000|Overall Study|Lack of efficacy/subject withdrew consent|0|||
48809229|NCT03101241|157142634|FG001|Overall Study|Lack of efficacy/subject withdrew consent|1|||
48809230|NCT03592277|157142642|FG000|Overall Study|Withdrawal by Subject|6|||
48809231|NCT03592277|157142643|FG001|Overall Study|Withdrawal by Subject|8|||
48809232|NCT00669903|157142644|FG000|Overall Study|Adverse Event|0|||
48809233|NCT00669903|157142645|FG001|Overall Study|Adverse Event|1|||
48809234|NCT00669903|157142646|FG002|Overall Study|Adverse Event|3|||
48809235|NCT00669903|157142647|FG003|Overall Study|Adverse Event|1|||
48809236|NCT00669903|157142644|FG000|Overall Study|Withdrawal by Subject|0|||
48809237|NCT00669903|157142645|FG001|Overall Study|Withdrawal by Subject|2|||
48809238|NCT00669903|157142646|FG002|Overall Study|Withdrawal by Subject|2|||
48809239|NCT00669903|157142647|FG003|Overall Study|Withdrawal by Subject|2|||
48809240|NCT00669903|157142644|FG000|Overall Study|Lost to Follow-up|1|||
48809241|NCT00669903|157142645|FG001|Overall Study|Lost to Follow-up|1|||
48809242|NCT00669903|157142646|FG002|Overall Study|Lost to Follow-up|0|||
48809243|NCT00669903|157142647|FG003|Overall Study|Lost to Follow-up|1|||
48809244|NCT00669903|157142644|FG000|Overall Study|Protocol Violation|0|||
48809245|NCT00669903|157142645|FG001|Overall Study|Protocol Violation|1|||
48809246|NCT00669903|157142646|FG002|Overall Study|Protocol Violation|0|||
48809247|NCT00669903|157142647|FG003|Overall Study|Protocol Violation|0|||
48809248|NCT01678820|157142648|FG000|Overall Study|Study Terminated by Sponsor|45|||
48809249|NCT01678820|157142649|FG001|Overall Study|Study Terminated by Sponsor|43|||
48809250|NCT01678820|157142650|FG002|Overall Study|Study Terminated by Sponsor|43|||
48809251|NCT01678820|157142648|FG000|Overall Study|Withdrawal by Subject|2|||
48809252|NCT01678820|157142649|FG001|Overall Study|Withdrawal by Subject|5|||
48809253|NCT01678820|157142650|FG002|Overall Study|Withdrawal by Subject|2|||
48809254|NCT01678820|157142648|FG000|Overall Study|Protocol Specified Criteria|2|||
48809255|NCT01678820|157142649|FG001|Overall Study|Protocol Specified Criteria|3|||
48809256|NCT01678820|157142650|FG002|Overall Study|Protocol Specified Criteria|1|||
48809257|NCT01678820|157142648|FG000|Overall Study|Adverse Event|2|||
48809258|NCT01678820|157142649|FG001|Overall Study|Adverse Event|2|||
48809259|NCT01678820|157142650|FG002|Overall Study|Adverse Event|2|||
48809260|NCT01678820|157142648|FG000|Overall Study|Lost to Follow-up|7|||
48809261|NCT01678820|157142649|FG001|Overall Study|Lost to Follow-up|2|||
48809262|NCT01678820|157142650|FG002|Overall Study|Lost to Follow-up|2|||
48809263|NCT01678820|157142648|FG000|Overall Study|Non-compliance with study drug|0|||
48809264|NCT01678820|157142649|FG001|Overall Study|Non-compliance with study drug|1|||
48809265|NCT01678820|157142650|FG002|Overall Study|Non-compliance with study drug|0|||
48809266|NCT01678820|157142648|FG000|Overall Study|Physician Decision|0|||
48809267|NCT01678820|157142649|FG001|Overall Study|Physician Decision|0|||
48809268|NCT01678820|157142650|FG002|Overall Study|Physician Decision|1|||
48809269|NCT01678820|157142648|FG000|Overall Study|Protocol Violation|4|||
48809270|NCT01678820|157142649|FG001|Overall Study|Protocol Violation|5|||
48809271|NCT01678820|157142650|FG002|Overall Study|Protocol Violation|4|||
48809272|NCT01678820|157142648|FG000|Overall Study|Not treated with double-blind study drug|0|||
48809273|NCT01678820|157142649|FG001|Overall Study|Not treated with double-blind study drug|2|||
48809274|NCT01678820|157142650|FG002|Overall Study|Not treated with double-blind study drug|2|||
48809275|NCT04041440|157142651|FG000|Overall Study|Withdrawal by Subject|0|||
48809276|NCT04041440|157142652|FG001|Overall Study|Withdrawal by Subject|1|||
48809277|NCT04041440|157142651|FG000|Overall Study|Lost to Follow-up|0|||
48809278|NCT04041440|157142652|FG001|Overall Study|Lost to Follow-up|1|||
48809279|NCT01381874|157142653|FG000|Overall Study|Lost to Follow-up|1|||
48809280|NCT01381874|157142654|FG001|Overall Study|Lost to Follow-up|1|||
48809281|NCT01381874|157142655|FG002|Overall Study|Lost to Follow-up|0|||
48809282|NCT01381874|157142653|FG000|Overall Study|Withdrawal by Subject|9|||
48809283|NCT01381874|157142654|FG001|Overall Study|Withdrawal by Subject|10|||
48809284|NCT01381874|157142655|FG002|Overall Study|Withdrawal by Subject|9|||
48809285|NCT01381874|157142653|FG000|Overall Study|Other|67|||
48809286|NCT01381874|157142654|FG001|Overall Study|Other|52|||
48809287|NCT01381874|157142655|FG002|Overall Study|Other|67|||
48809288|NCT02086162|157142656|FG000|Overall Study|Withdrawal by Subject|4|||
48809289|NCT02086162|157142657|FG001|Overall Study|Withdrawal by Subject|4|||
48809290|NCT02086162|157142656|FG000|Overall Study|moved|1|||
48809291|NCT02086162|157142657|FG001|Overall Study|moved|1|||
48809292|NCT02086162|157142656|FG000|Overall Study|Lost to Follow-up|4|||
48809293|NCT02086162|157142657|FG001|Overall Study|Lost to Follow-up|2|||
48809294|NCT02086162|157142656|FG000|Overall Study|Death|1|||
48809295|NCT02086162|157142657|FG001|Overall Study|Death|0|||
48809296|NCT00452413|157142658|FG000|Overall Study|Progressive Disease|4|||
48809297|NCT00452413|157142659|FG001|Overall Study|Progressive Disease|11|||
48809298|NCT00452413|157142660|FG002|Overall Study|Progressive Disease|30|||
48809299|NCT00452413|157142658|FG000|Overall Study|Withdrawal by Subject|0|||
48809300|NCT00452413|157142659|FG001|Overall Study|Withdrawal by Subject|1|||
48809301|NCT00452413|157142660|FG002|Overall Study|Withdrawal by Subject|4|||
48809302|NCT00452413|157142658|FG000|Overall Study|Adverse Event|0|||
48809303|NCT00452413|157142659|FG001|Overall Study|Adverse Event|0|||
48809304|NCT00452413|157142660|FG002|Overall Study|Adverse Event|5|||
48809305|NCT00452413|157142658|FG000|Overall Study|Physician Decision|0|||
48809306|NCT00452413|157142659|FG001|Overall Study|Physician Decision|0|||
48809307|NCT00452413|157142660|FG002|Overall Study|Physician Decision|4|||
48809308|NCT00452413|157142658|FG000|Overall Study|Death due to study disease|0|||
48809309|NCT00452413|157142659|FG001|Overall Study|Death due to study disease|0|||
48809310|NCT00452413|157142660|FG002|Overall Study|Death due to study disease|2|||
48809311|NCT00452413|157142658|FG000|Overall Study|Death due to adverse event (AE)|0|||
48809312|NCT00452413|157142659|FG001|Overall Study|Death due to adverse event (AE)|0|||
48809313|NCT00452413|157142660|FG002|Overall Study|Death due to adverse event (AE)|1|||
48809314|NCT00452413|157142658|FG000|Overall Study|On treatment|0|||
48809315|NCT00452413|157142659|FG001|Overall Study|On treatment|0|||
48809316|NCT00452413|157142660|FG002|Overall Study|On treatment|3|||
48809317|NCT00114634|157142661|FG000|Overall Study|failure to return forms|3|||
48809318|NCT01346514|157142662|FG000|Overall Study|Lost to Follow-up|19|||
48809319|NCT01346514|157142663|FG001|Overall Study|Lost to Follow-up|30|||
48809320|NCT01346514|157142662|FG000|Overall Study|Withdrawal by Subject|7|||
48809321|NCT01346514|157142663|FG001|Overall Study|Withdrawal by Subject|3|||
48809322|NCT01346514|157142662|FG000|Overall Study|Death|3|||
48809323|NCT01346514|157142663|FG001|Overall Study|Death|4|||
48809324|NCT00684762|157142664|FG000|Washout Period of 7 Days|Withdrawal by Subject|2|||
48809325|NCT00684762|157142665|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
48809326|NCT01215357|157142666|FG000|Overall Study|Withdrawal by Subject|3|||
48809327|NCT01215357|157142666|FG000|Overall Study|Protocol Violation|9|||
48809328|NCT04562649|157142675|FG000|Overall Study|Withdrawal by Subject|11|||
48809329|NCT04562649|157142676|FG001|Overall Study|Withdrawal by Subject|8|||
48809330|NCT04562649|157142675|FG000|Overall Study|Lost to Follow-up|26|||
48809331|NCT04562649|157142676|FG001|Overall Study|Lost to Follow-up|20|||
48809332|NCT03997383|157142677|FG000|Double-blind Treatment Period|Adverse Event|4|||
48809333|NCT03997383|157142678|FG001|Double-blind Treatment Period|Adverse Event|3|||
48809334|NCT03997383|157142677|FG000|Double-blind Treatment Period|Death|4|||
48809335|NCT03997383|157142678|FG001|Double-blind Treatment Period|Death|4|||
48809336|NCT03997383|157142677|FG000|Double-blind Treatment Period|Physician Decision|2|||
48809337|NCT03997383|157142678|FG001|Double-blind Treatment Period|Physician Decision|0|||
48809338|NCT03997383|157142677|FG000|Double-blind Treatment Period|Withdrawal by Subject|3|||
48809339|NCT03997383|157142678|FG001|Double-blind Treatment Period|Withdrawal by Subject|6|||
48809340|NCT03997383|157142677|FG000|Open-label Extension Period|Ongoing|148|||
48918081|NCT00844753|157535912|FG002|Overall Study|Lack of Efficacy|2|||
48918082|NCT00844753|157535913|FG003|Overall Study|Lack of Efficacy|2|||
48918083|NCT00844753|157535910|FG000|Overall Study|Adverse Event|3|||
48918084|NCT00844753|157535911|FG001|Overall Study|Adverse Event|2|||
48918085|NCT00844753|157535912|FG002|Overall Study|Adverse Event|5|||
49120764|NCT02326272|158280511|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
49120765|NCT02326272|158280512|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
49120766|NCT02326272|158280513|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
49120767|NCT02326272|158280514|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1|||
48809341|NCT03997383|157142678|FG001|Open-label Extension Period|Ongoing|151|||
48809342|NCT03997383|157142677|FG000|Open-label Extension Period|Adverse Event|4|||
48809343|NCT03997383|157142678|FG001|Open-label Extension Period|Adverse Event|1|||
48809344|NCT03997383|157142677|FG000|Open-label Extension Period|Death|8|||
48809345|NCT03997383|157142678|FG001|Open-label Extension Period|Death|9|||
48809346|NCT03997383|157142677|FG000|Open-label Extension Period|Physician Decision|1|||
48809347|NCT03997383|157142678|FG001|Open-label Extension Period|Physician Decision|1|||
48918086|NCT00844753|157535913|FG003|Overall Study|Adverse Event|5|||
48918087|NCT00844753|157535910|FG000|Overall Study|Lost to Follow-up|1|||
48918088|NCT00844753|157535911|FG001|Overall Study|Lost to Follow-up|1|||
48918089|NCT00844753|157535912|FG002|Overall Study|Lost to Follow-up|0|||
48918090|NCT00844753|157535913|FG003|Overall Study|Lost to Follow-up|1|||
48918091|NCT00844753|157535910|FG000|Overall Study|could not swallow medication|2|||
48918092|NCT00844753|157535911|FG001|Overall Study|could not swallow medication|0|||
48918093|NCT00844753|157535912|FG002|Overall Study|could not swallow medication|0|||
48918094|NCT00844753|157535913|FG003|Overall Study|could not swallow medication|0|||
48918095|NCT00844753|157535910|FG000|Overall Study|Withdrawal by Subject|1|||
48918096|NCT00844753|157535911|FG001|Overall Study|Withdrawal by Subject|0|||
48918097|NCT00844753|157535912|FG002|Overall Study|Withdrawal by Subject|0|||
48918098|NCT00844753|157535913|FG003|Overall Study|Withdrawal by Subject|3|||
48918099|NCT03084536|157535917|FG000|Overall Study|Determined to be ineligible|0|||
48918100|NCT03084536|157535918|FG001|Overall Study|Determined to be ineligible|0|||
48918101|NCT03084536|157535919|FG002|Overall Study|Determined to be ineligible|16|||
48918102|NCT03084536|157535917|FG000|Overall Study|Withdrawal by Subject|0|||
48918103|NCT03084536|157535918|FG001|Overall Study|Withdrawal by Subject|0|||
48918104|NCT03084536|157535919|FG002|Overall Study|Withdrawal by Subject|4|||
48918105|NCT03084536|157535917|FG000|Overall Study|Physician Decision|0|||
48918106|NCT03084536|157535918|FG001|Overall Study|Physician Decision|0|||
48918107|NCT03084536|157535919|FG002|Overall Study|Physician Decision|3|||
48918108|NCT03084536|157535917|FG000|Overall Study|Death|0|||
48918109|NCT03084536|157535918|FG001|Overall Study|Death|0|||
48918110|NCT03084536|157535919|FG002|Overall Study|Death|1|||
48918111|NCT03084536|157535917|FG000|Overall Study|Lost to Follow-up|0|||
48918112|NCT03084536|157535918|FG001|Overall Study|Lost to Follow-up|0|||
48918113|NCT03084536|157535919|FG002|Overall Study|Lost to Follow-up|1|||
48918114|NCT03084536|157535917|FG000|Overall Study|Protocol Violation|0|||
48809348|NCT03997383|157142677|FG000|Open-label Extension Period|Subject Stopped Participation in the Study|3|||
48809349|NCT03997383|157142678|FG001|Open-label Extension Period|Subject Stopped Participation in the Study|6|||
48809350|NCT03997383|157142677|FG000|Open-label Extension Period|Reason Not Specified|2|||
48809351|NCT03997383|157142678|FG001|Open-label Extension Period|Reason Not Specified|0|||
48809352|NCT01821898|157142680|FG000|Overall Study|Withdrawal by Subject|2|||
48809353|NCT01821898|157142681|FG001|Overall Study|Withdrawal by Subject|1|||
48809354|NCT01535274|157142682|FG000|Overall Study|Determined to be ineligible|0|||
48809355|NCT01535274|157142683|FG001|Overall Study|Determined to be ineligible|1|||
48809356|NCT01535274|157142682|FG000|Overall Study|Misallocated to propofol intervention|0|||
48809357|NCT01535274|157142683|FG001|Overall Study|Misallocated to propofol intervention|1|||
48809358|NCT02690077|157142684|FG000|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|5|||
48809359|NCT02690077|157142685|FG001|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|8|||
48809360|NCT02690077|157142684|FG000|Overall Study|Withdrawal by Subject|0|||
48809361|NCT02690077|157142685|FG001|Overall Study|Withdrawal by Subject|5|||
48809362|NCT02690077|157142684|FG000|Overall Study|Excluded by IRB|0|||
48809363|NCT02690077|157142685|FG001|Overall Study|Excluded by IRB|2|||
48809364|NCT00337662|157142690|FG000|Study Period II|Lost to Follow-up|0|||
48809365|NCT00337662|157142691|FG001|Study Period II|Lost to Follow-up|0|||
48809366|NCT00337662|157142692|FG002|Study Period II|Lost to Follow-up|0|||
48809367|NCT00337662|157142693|FG003|Study Period II|Lost to Follow-up|35|||
48809368|NCT00337662|157142690|FG000|Study Period II|Withdrawal by Subject|0|||
48809369|NCT00337662|157142691|FG001|Study Period II|Withdrawal by Subject|0|||
48809370|NCT00337662|157142692|FG002|Study Period II|Withdrawal by Subject|0|||
48809371|NCT00337662|157142693|FG003|Study Period II|Withdrawal by Subject|20|||
48809372|NCT00337662|157142690|FG000|Study Period II|Adverse Event|0|||
48809373|NCT00337662|157142691|FG001|Study Period II|Adverse Event|0|||
48809374|NCT00337662|157142692|FG002|Study Period II|Adverse Event|0|||
48809375|NCT00337662|157142693|FG003|Study Period II|Adverse Event|16|||
48809376|NCT00337662|157142690|FG000|Study Period II|Physician Decision|0|||
48809377|NCT00337662|157142691|FG001|Study Period II|Physician Decision|0|||
48809378|NCT00337662|157142692|FG002|Study Period II|Physician Decision|0|||
48809379|NCT00337662|157142693|FG003|Study Period II|Physician Decision|13|||
48809380|NCT00337662|157142690|FG000|Study Period II|Entry Criteria Not Met|0|||
48809381|NCT00337662|157142691|FG001|Study Period II|Entry Criteria Not Met|0|||
48809382|NCT00337662|157142692|FG002|Study Period II|Entry Criteria Not Met|0|||
48809383|NCT00337662|157142693|FG003|Study Period II|Entry Criteria Not Met|6|||
48809384|NCT00337662|157142690|FG000|Study Period II|Protocol Violation|0|||
48809385|NCT00337662|157142691|FG001|Study Period II|Protocol Violation|0|||
48809386|NCT00337662|157142692|FG002|Study Period II|Protocol Violation|0|||
48809387|NCT00337662|157142693|FG003|Study Period II|Protocol Violation|6|||
48809388|NCT00337662|157142690|FG000|Study Period II|Lack of Efficacy|0|||
48809389|NCT00337662|157142691|FG001|Study Period II|Lack of Efficacy|0|||
48809390|NCT00337662|157142692|FG002|Study Period II|Lack of Efficacy|0|||
48809391|NCT00337662|157142693|FG003|Study Period II|Lack of Efficacy|7|||
48809392|NCT00337662|157142690|FG000|Study Period II|Sponsor Decision|0|||
48809393|NCT00337662|157142691|FG001|Study Period II|Sponsor Decision|0|||
48809394|NCT00337662|157142692|FG002|Study Period II|Sponsor Decision|0|||
48809395|NCT00337662|157142693|FG003|Study Period II|Sponsor Decision|2|||
48809396|NCT00337662|157142690|FG000|Study Period II|Parent/Caregiver Decision|0|||
48809397|NCT00337662|157142691|FG001|Study Period II|Parent/Caregiver Decision|0|||
48809398|NCT00337662|157142692|FG002|Study Period II|Parent/Caregiver Decision|0|||
48809399|NCT00337662|157142693|FG003|Study Period II|Parent/Caregiver Decision|1|||
48809400|NCT00337662|157142690|FG000|Study Period III|Lost to Follow-up|14|||
48809401|NCT00337662|157142691|FG001|Study Period III|Lost to Follow-up|16|||
48809402|NCT00337662|157142692|FG002|Study Period III|Lost to Follow-up|14|||
48918115|NCT03084536|157535918|FG001|Overall Study|Protocol Violation|0|||
48918116|NCT03084536|157535919|FG002|Overall Study|Protocol Violation|1|||
48918117|NCT03084536|157535917|FG000|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
48809403|NCT00337662|157142693|FG003|Study Period III|Lost to Follow-up|0|||
48809404|NCT00337662|157142690|FG000|Study Period III|Withdrawal by Subject|18|||
48809405|NCT00337662|157142691|FG001|Study Period III|Withdrawal by Subject|14|||
48809406|NCT00337662|157142692|FG002|Study Period III|Withdrawal by Subject|12|||
48809407|NCT00337662|157142693|FG003|Study Period III|Withdrawal by Subject|0|||
48809408|NCT00337662|157142690|FG000|Study Period III|Adverse Event|9|||
48918118|NCT03084536|157535918|FG001|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
48809409|NCT00337662|157142691|FG001|Study Period III|Adverse Event|10|||
48809410|NCT00337662|157142692|FG002|Study Period III|Adverse Event|8|||
48809411|NCT00337662|157142693|FG003|Study Period III|Adverse Event|0|||
48918119|NCT03084536|157535919|FG002|Overall Study|Withdrawn due to time of surgery being moved up.|1|||
48918120|NCT02124564|157535920|FG000|Treatment Period|Adverse Event|2|||
48809412|NCT00337662|157142690|FG000|Study Period III|Protocol Violation|3|||
48809413|NCT00337662|157142691|FG001|Study Period III|Protocol Violation|8|||
48809414|NCT00337662|157142692|FG002|Study Period III|Protocol Violation|2|||
48918121|NCT02124564|157535920|FG000|Treatment Period|Lack of Efficacy|3|||
48918122|NCT02124564|157535920|FG000|Treatment Period|Withdrawal by Subject|2|||
48918123|NCT03099187|157535921|FG000|Double-blind Treatment|Adverse Event|19|||
48918124|NCT03099187|157535922|FG001|Double-blind Treatment|Adverse Event|1|||
48918125|NCT03099187|157535923|FG002|Double-blind Treatment|Adverse Event|0|||
48918126|NCT03099187|157535924|FG003|Double-blind Treatment|Adverse Event|0|||
48918127|NCT03099187|157535921|FG000|Double-blind Treatment|Death|1|||
48918128|NCT03099187|157535922|FG001|Double-blind Treatment|Death|3|||
48918129|NCT03099187|157535923|FG002|Double-blind Treatment|Death|0|||
48918130|NCT03099187|157535924|FG003|Double-blind Treatment|Death|0|||
48918131|NCT03099187|157535921|FG000|Double-blind Treatment|Lack of Efficacy|1|||
48918132|NCT03099187|157535922|FG001|Double-blind Treatment|Lack of Efficacy|0|||
48918133|NCT03099187|157535923|FG002|Double-blind Treatment|Lack of Efficacy|0|||
48918134|NCT03099187|157535924|FG003|Double-blind Treatment|Lack of Efficacy|0|||
48711256|NCT01379508|156791520|FG001|Treatment to Week 104|Protocol Violation|1|||
48711257|NCT01379508|156791521|FG002|Treatment to Week 104|Protocol Violation|1|||
48711258|NCT01379508|156791522|FG003|Treatment to Week 104|Protocol Violation|0|||
48711259|NCT01379508|156791519|FG000|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
48711260|NCT01379508|156791520|FG001|Extension Period Weeks 109-156|Withdrawal by Subject|1|||
48711261|NCT01379508|156791521|FG002|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
48711262|NCT01379508|156791522|FG003|Extension Period Weeks 109-156|Withdrawal by Subject|0|||
48711263|NCT01379508|156791519|FG000|Extension Period Weeks 109-156|Lost to Follow-up|6|||
48711264|NCT01379508|156791520|FG001|Extension Period Weeks 109-156|Lost to Follow-up|1|||
48711265|NCT01379508|156791521|FG002|Extension Period Weeks 109-156|Lost to Follow-up|5|||
48711266|NCT01379508|156791522|FG003|Extension Period Weeks 109-156|Lost to Follow-up|0|||
48711267|NCT01379508|156791519|FG000|Extension Period Weeks 109-156|Administrative problems|3|||
48711268|NCT01379508|156791520|FG001|Extension Period Weeks 109-156|Administrative problems|0|||
48711269|NCT01379508|156791521|FG002|Extension Period Weeks 109-156|Administrative problems|1|||
48711270|NCT01379508|156791522|FG003|Extension Period Weeks 109-156|Administrative problems|0|||
48711271|NCT01379508|156791519|FG000|Extension Period Weeks 109-156|Protocol Violation|2|||
48711272|NCT01379508|156791520|FG001|Extension Period Weeks 109-156|Protocol Violation|1|||
48711273|NCT01379508|156791521|FG002|Extension Period Weeks 109-156|Protocol Violation|0|||
48711274|NCT01379508|156791522|FG003|Extension Period Weeks 109-156|Protocol Violation|0|||
48711275|NCT01590888|156793155|FG000|Overall Study|Adverse Event|3|||
48711276|NCT01590888|156793156|FG001|Overall Study|Adverse Event|0|||
48711277|NCT01590888|156793157|FG002|Overall Study|Adverse Event|1|||
48711278|NCT01590888|156793155|FG000|Overall Study|Lost to Follow-up|1|||
48711279|NCT01590888|156793156|FG001|Overall Study|Lost to Follow-up|0|||
48711280|NCT01590888|156793157|FG002|Overall Study|Lost to Follow-up|0|||
48711281|NCT00684060|156793160|FG000|Overall Study|Lost to Follow-up|1|||
48711282|NCT00684060|156793161|FG001|Overall Study|Lost to Follow-up|0|||
48711283|NCT00684060|156793160|FG000|Overall Study|New stenosis identified|1|||
48711284|NCT00684060|156793161|FG001|Overall Study|New stenosis identified|0|||
48711285|NCT00684060|156793160|FG000|Overall Study|Unable to collect MRI|1|||
48711286|NCT00684060|156793161|FG001|Overall Study|Unable to collect MRI|2|||
48711287|NCT00684060|156793160|FG000|Overall Study|Death|0|||
48711288|NCT00684060|156793161|FG001|Overall Study|Death|1|||
48711289|NCT02331277|156793162|FG000|Overall Study|Withdrawal by Subject|1|||
48711290|NCT02331277|156793163|FG001|Overall Study|Withdrawal by Subject|0|||
48711291|NCT02269267|156793164|FG000|Overall Study|Death|5|||
48711292|NCT01474239|156793165|FG000|Overall Study|Disease Progression|37|||
48711293|NCT01474239|156793166|FG001|Overall Study|Disease Progression|25|||
48711294|NCT01474239|156793165|FG000|Overall Study|Adverse Event|12|||
48711295|NCT01474239|156793166|FG001|Overall Study|Adverse Event|3|||
48711296|NCT01474239|156793165|FG000|Overall Study|Withdrawal by Subject|1|||
48711297|NCT01474239|156793166|FG001|Overall Study|Withdrawal by Subject|2|||
48711298|NCT01474239|156793165|FG000|Overall Study|Death|1|||
48711299|NCT01474239|156793166|FG001|Overall Study|Death|1|||
48711300|NCT01474239|156793165|FG000|Overall Study|Clinical Disease Progression|7|||
48711301|NCT01474239|156793166|FG001|Overall Study|Clinical Disease Progression|1|||
48711302|NCT01474239|156793165|FG000|Overall Study|Withdrawal for Economic Reason|1|||
48711303|NCT01474239|156793166|FG001|Overall Study|Withdrawal for Economic Reason|0|||
48711304|NCT02139592|156793172|FG000|Overall Study|Case Report Forms Uncollected|8|||
48711305|NCT00145158|156793175|FG000|Overall Study|premature withdrawal|2|||
48711306|NCT00145158|156793176|FG001|Overall Study|premature withdrawal|3|||
48711307|NCT03180840|156793177|FG000|Overall Study|Withdrawal by Subject|1|||
48711308|NCT03887702|156793178|FG000|Overall Study|Study terminated|0|||
48711309|NCT03887702|156793179|FG001|Overall Study|Study terminated|0|||
48711310|NCT03887702|156793180|FG002|Overall Study|Study terminated|2|||
48711311|NCT03887702|156793181|FG003|Overall Study|Study terminated|2|||
48711312|NCT01705509|156793182|FG000|Inclusion CPET|Screen Failure|5|||
48711313|NCT01705509|156793182|FG000|Inclusion CPET|Withdrawal by Subject|2|||
48711314|NCT01705509|156793182|FG000|CPET w/ Ranexa|Screen Failure|2|||
48711315|NCT00950859|156793183|FG000|Overall Study|Adverse Event|3|||
48711316|NCT00950859|156793184|FG001|Overall Study|Adverse Event|3|||
48809415|NCT00337662|157142693|FG003|Study Period III|Protocol Violation|0|||
48809416|NCT00337662|157142690|FG000|Study Period III|Physician Decision|6|||
48809417|NCT00337662|157142691|FG001|Study Period III|Physician Decision|5|||
48809418|NCT00337662|157142692|FG002|Study Period III|Physician Decision|0|||
48809419|NCT00337662|157142693|FG003|Study Period III|Physician Decision|0|||
48809420|NCT00337662|157142690|FG000|Study Period III|Entry Criteria Not Met|4|||
48809421|NCT00337662|157142691|FG001|Study Period III|Entry Criteria Not Met|1|||
48809422|NCT00337662|157142692|FG002|Study Period III|Entry Criteria Not Met|3|||
48809423|NCT00337662|157142693|FG003|Study Period III|Entry Criteria Not Met|0|||
48918135|NCT03099187|157535921|FG000|Double-blind Treatment|Physician Decision|2|||
48918136|NCT03099187|157535922|FG001|Double-blind Treatment|Physician Decision|1|||
48918137|NCT03099187|157535923|FG002|Double-blind Treatment|Physician Decision|0|||
48918138|NCT03099187|157535924|FG003|Double-blind Treatment|Physician Decision|0|||
48918139|NCT03099187|157535921|FG000|Double-blind Treatment|Withdrawal by Subject|9|||
48918140|NCT03099187|157535922|FG001|Double-blind Treatment|Withdrawal by Subject|4|||
48918141|NCT03099187|157535923|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
48918142|NCT03099187|157535924|FG003|Double-blind Treatment|Withdrawal by Subject|0|||
48918143|NCT03099187|157535921|FG000|Double-blind Treatment|Lung transplantation|0|||
48918144|NCT03099187|157535922|FG001|Double-blind Treatment|Lung transplantation|1|||
48918145|NCT03099187|157535923|FG002|Double-blind Treatment|Lung transplantation|0|||
48918146|NCT03099187|157535924|FG003|Double-blind Treatment|Lung transplantation|0|||
48809424|NCT00337662|157142690|FG000|Study Period III|Lack of Efficacy|4|||
48809425|NCT00337662|157142691|FG001|Study Period III|Lack of Efficacy|4|||
48809426|NCT00337662|157142692|FG002|Study Period III|Lack of Efficacy|2|||
48809427|NCT00337662|157142693|FG003|Study Period III|Lack of Efficacy|0|||
48809428|NCT00337662|157142690|FG000|Study Period III|Parent/Caregiver Decision|0|||
48809429|NCT00337662|157142691|FG001|Study Period III|Parent/Caregiver Decision|0|||
48809430|NCT00337662|157142692|FG002|Study Period III|Parent/Caregiver Decision|2|||
48918147|NCT03099187|157535921|FG000|Double-blind Treatment|Non-compliance with study drug|0|||
48918148|NCT03099187|157535922|FG001|Double-blind Treatment|Non-compliance with study drug|2|||
48918149|NCT03099187|157535923|FG002|Double-blind Treatment|Non-compliance with study drug|0|||
48918150|NCT03099187|157535924|FG003|Double-blind Treatment|Non-compliance with study drug|0|||
48918151|NCT03099187|157535921|FG000|Double-blind Treatment|Disease progression|0|||
48918152|NCT03099187|157535922|FG001|Double-blind Treatment|Disease progression|1|||
48918153|NCT03099187|157535923|FG002|Double-blind Treatment|Disease progression|0|||
48918154|NCT03099187|157535924|FG003|Double-blind Treatment|Disease progression|0|||
48918155|NCT03099187|157535921|FG000|Double-blind Treatment|Randomization error|0|||
48918156|NCT03099187|157535922|FG001|Double-blind Treatment|Randomization error|2|||
48918157|NCT03099187|157535923|FG002|Double-blind Treatment|Randomization error|0|||
48918158|NCT03099187|157535924|FG003|Double-blind Treatment|Randomization error|0|||
48918159|NCT03099187|157535921|FG000|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
48918160|NCT03099187|157535922|FG001|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
48918161|NCT03099187|157535923|FG002|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
48918162|NCT03099187|157535924|FG003|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
48918163|NCT03099187|157535921|FG000|12-month Safety Follow-up|Adverse Event|0|||
48918164|NCT03099187|157535922|FG001|12-month Safety Follow-up|Adverse Event|0|||
48918165|NCT03099187|157535923|FG002|12-month Safety Follow-up|Adverse Event|5|||
48918166|NCT03099187|157535924|FG003|12-month Safety Follow-up|Adverse Event|12|||
48918167|NCT03099187|157535921|FG000|12-month Safety Follow-up|Death|0|||
48918168|NCT03099187|157535922|FG001|12-month Safety Follow-up|Death|0|||
48918169|NCT03099187|157535923|FG002|12-month Safety Follow-up|Death|7|||
48918170|NCT03099187|157535924|FG003|12-month Safety Follow-up|Death|9|||
48918171|NCT03099187|157535921|FG000|12-month Safety Follow-up|Lung transplantation|0|||
48918172|NCT03099187|157535922|FG001|12-month Safety Follow-up|Lung transplantation|0|||
48918173|NCT03099187|157535923|FG002|12-month Safety Follow-up|Lung transplantation|2|||
48918174|NCT03099187|157535924|FG003|12-month Safety Follow-up|Lung transplantation|1|||
48918175|NCT03099187|157535921|FG000|12-month Safety Follow-up|Lost to Follow-up|0|||
48918176|NCT03099187|157535922|FG001|12-month Safety Follow-up|Lost to Follow-up|0|||
48918177|NCT03099187|157535923|FG002|12-month Safety Follow-up|Lost to Follow-up|1|||
48918178|NCT03099187|157535924|FG003|12-month Safety Follow-up|Lost to Follow-up|0|||
48918179|NCT03099187|157535921|FG000|12-month Safety Follow-up|Symptomatic deterioration|0|||
48918180|NCT03099187|157535922|FG001|12-month Safety Follow-up|Symptomatic deterioration|0|||
48918181|NCT03099187|157535923|FG002|12-month Safety Follow-up|Symptomatic deterioration|1|||
48918182|NCT03099187|157535924|FG003|12-month Safety Follow-up|Symptomatic deterioration|1|||
48918183|NCT03099187|157535921|FG000|12-month Safety Follow-up|Withdrawal by Subject|0|||
49120768|NCT02326272|158280515|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
48809431|NCT00337662|157142693|FG003|Study Period III|Parent/Caregiver Decision|0|||
48809432|NCT00337662|157142690|FG000|Study Period III|Sponsor Decision|1|||
48809433|NCT00337662|157142691|FG001|Study Period III|Sponsor Decision|0|||
48918184|NCT03099187|157535922|FG001|12-month Safety Follow-up|Withdrawal by Subject|0|||
48809434|NCT00337662|157142692|FG002|Study Period III|Sponsor Decision|1|||
48809435|NCT00337662|157142693|FG003|Study Period III|Sponsor Decision|0|||
48918185|NCT03099187|157535923|FG002|12-month Safety Follow-up|Withdrawal by Subject|3|||
48918186|NCT03099187|157535924|FG003|12-month Safety Follow-up|Withdrawal by Subject|2|||
48918187|NCT03099187|157535921|FG000|12-month Safety Follow-up|Due to hospitalization|0|||
48918188|NCT03099187|157535922|FG001|12-month Safety Follow-up|Due to hospitalization|0|||
48918189|NCT03099187|157535923|FG002|12-month Safety Follow-up|Due to hospitalization|0|||
48918190|NCT03099187|157535924|FG003|12-month Safety Follow-up|Due to hospitalization|1|||
48918191|NCT01439555|157535927|FG000|Overall Study|Protocol Violation|1|||
48918192|NCT00333359|157535930|FG000|Overall Study|Adverse Event|29|||
48918193|NCT00333359|157535931|FG001|Overall Study|Adverse Event|35|||
48918194|NCT00333359|157535930|FG000|Overall Study|Withdrawal by Subject|19|||
48918195|NCT00333359|157535931|FG001|Overall Study|Withdrawal by Subject|37|||
48918196|NCT00333359|157535930|FG000|Overall Study|Physician Decision|2|||
48918197|NCT00333359|157535931|FG001|Overall Study|Physician Decision|2|||
48918198|NCT00333359|157535930|FG000|Overall Study|Protocol Non-compliance|2|||
48918199|NCT00333359|157535931|FG001|Overall Study|Protocol Non-compliance|8|||
48918200|NCT00333359|157535930|FG000|Overall Study|Lost to Follow-up|15|||
48809436|NCT00337662|157142690|FG000|Study Period III|Clinical Relapse|1|||
48809437|NCT00337662|157142691|FG001|Study Period III|Clinical Relapse|0|||
48918201|NCT00333359|157535931|FG001|Overall Study|Lost to Follow-up|25|||
48918202|NCT00333359|157535930|FG000|Overall Study|Termination or Withdrawal by Sponsor|1|||
48918203|NCT00333359|157535931|FG001|Overall Study|Termination or Withdrawal by Sponsor|1|||
48918204|NCT00333359|157535930|FG000|Overall Study|Treatment Failure|3|||
48918205|NCT00333359|157535931|FG001|Overall Study|Treatment Failure|8|||
48918206|NCT00333359|157535930|FG000|Overall Study|Withdrew before Receiving One Dose|2|||
48809438|NCT00337662|157142692|FG002|Study Period III|Clinical Relapse|0|||
48918207|NCT00333359|157535931|FG001|Overall Study|Withdrew before Receiving One Dose|6|||
48918208|NCT02833974|157537676|FG000|Overall Study|Lost to Follow-up|1|||
48918209|NCT02833974|157537677|FG001|Overall Study|Lost to Follow-up|0|||
48918210|NCT02833974|157537676|FG000|Overall Study|Adverse Event|0|||
48918211|NCT02833974|157537677|FG001|Overall Study|Adverse Event|3|||
48918212|NCT02232802|157537678|FG000|Period 1|Sponsor request|1|||
48918213|NCT02232802|157537679|FG001|Period 1|Sponsor request|0|||
48809439|NCT00337662|157142693|FG003|Study Period III|Clinical Relapse|0|||
48809440|NCT02213328|157142696|FG000|Overall Study|Withdrawal by Subject|10|||
48809441|NCT02213328|157142696|FG000|Overall Study|Physician Decision|2|||
48809442|NCT02213328|157142696|FG000|Overall Study|Lost to Follow-up|16|||
48809443|NCT02344537|157142697|FG000|Overall Study|Protocol Violation|1|||
48809444|NCT02344537|157142698|FG001|Overall Study|Protocol Violation|1|||
48809445|NCT02344537|157142697|FG000|Overall Study|Subject started another treatment after wk 6|1|||
48809446|NCT02344537|157142698|FG001|Overall Study|Subject started another treatment after wk 6|0|||
48809447|NCT02344537|157142697|FG000|Overall Study|Participants completed the treatment but the week 8 data not available.|2|||
48809448|NCT02344537|157142698|FG001|Overall Study|Participants completed the treatment but the week 8 data not available.|1|||
48809449|NCT02302066|157142699|FG000|Overall Study|Adverse Event|1|||
48809450|NCT02302066|157142700|FG001|Overall Study|Adverse Event|1|||
48809451|NCT02302066|157142701|FG002|Overall Study|Adverse Event|3|||
48809452|NCT02302066|157142702|FG003|Overall Study|Adverse Event|0|||
48809453|NCT02302066|157142699|FG000|Overall Study|Lost to Follow-up|4|||
48809454|NCT02302066|157142700|FG001|Overall Study|Lost to Follow-up|5|||
48809455|NCT02302066|157142701|FG002|Overall Study|Lost to Follow-up|24|||
48809456|NCT02302066|157142702|FG003|Overall Study|Lost to Follow-up|7|||
48809457|NCT02302066|157142699|FG000|Overall Study|Withdrawal by Subject|25|||
48809458|NCT02302066|157142700|FG001|Overall Study|Withdrawal by Subject|58|||
48809459|NCT02302066|157142701|FG002|Overall Study|Withdrawal by Subject|124|||
48809460|NCT02302066|157142702|FG003|Overall Study|Withdrawal by Subject|33|||
48809461|NCT02302066|157142699|FG000|Overall Study|Pregnancy|2|||
48918214|NCT02232802|157537678|FG000|Period 1|Adverse Event|1|||
48918215|NCT02232802|157537679|FG001|Period 1|Adverse Event|1|||
48918216|NCT01183143|157537680|FG000|Overall Study|Protocol Violation|115|||
48918217|NCT01183143|157537680|FG000|Overall Study|Withdrawal by Subject|19|||
48918218|NCT01183143|157537680|FG000|Overall Study|Subject Questionnaires not returned|5|||
48918219|NCT01183143|157537680|FG000|Overall Study|Subjects enrolled, but not treated|11|||
48809462|NCT02302066|157142700|FG001|Overall Study|Pregnancy|10|||
48918220|NCT00307151|157537681|FG000|Overall Study|Death|4|||
48918221|NCT00307151|157537682|FG001|Overall Study|Death|3|||
48918222|NCT00307151|157537683|FG002|Overall Study|Death|10|||
48918223|NCT00307151|157537684|FG003|Overall Study|Death|3|||
48809463|NCT02302066|157142701|FG002|Overall Study|Pregnancy|12|||
48918224|NCT00307151|157537681|FG000|Overall Study|Severe debilitation, unable to continue|1|||
48918225|NCT00307151|157537682|FG001|Overall Study|Severe debilitation, unable to continue|0|||
48809464|NCT02302066|157142702|FG003|Overall Study|Pregnancy|0|||
48809465|NCT02302066|157142699|FG000|Overall Study|Reason Not Specified|1|||
48918226|NCT00307151|157537683|FG002|Overall Study|Severe debilitation, unable to continue|0|||
48809466|NCT02302066|157142700|FG001|Overall Study|Reason Not Specified|1|||
48809467|NCT02302066|157142701|FG002|Overall Study|Reason Not Specified|9|||
48918227|NCT00307151|157537684|FG003|Overall Study|Severe debilitation, unable to continue|0|||
48918228|NCT00307151|157537681|FG000|Overall Study|Subject unable to get to clinic|1|||
48918229|NCT00307151|157537682|FG001|Overall Study|Subject unable to get to clinic|0|||
48918230|NCT00307151|157537683|FG002|Overall Study|Subject unable to get to clinic|6|||
48918231|NCT00307151|157537684|FG003|Overall Study|Subject unable to get to clinic|2|||
48809468|NCT02302066|157142702|FG003|Overall Study|Reason Not Specified|1|||
48809469|NCT02917941|157142704|FG000|Treatment Period|Adverse Event|11|||
48809470|NCT02917941|157142704|FG000|Treatment Period|Progressive Disease|11|||
48809471|NCT02917941|157142704|FG000|Treatment Period|Reason not Specified|2|||
48809472|NCT02917941|157142704|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
48809473|NCT02917941|157142704|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
48809474|NCT00926003|157142705|FG000|Post-Training Evaluation|Withdrawal by Subject|1|||
48809475|NCT00926003|157142706|FG001|Post-Training Evaluation|Withdrawal by Subject|0|||
48809476|NCT00926003|157142707|FG002|Post-Training Evaluation|Withdrawal by Subject|0|||
48809477|NCT00926003|157142705|FG000|Post-Training 3-month Follow-up|Lost to Follow-up|1|||
48809478|NCT00926003|157142706|FG001|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
48809479|NCT00926003|157142707|FG002|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
48809480|NCT03203694|157142708|FG000|Overall Study|Withdrawal by Subject|2|||
48809481|NCT03203694|157142709|FG001|Overall Study|Withdrawal by Subject|0|||
48809482|NCT03203694|157142710|FG002|Overall Study|Withdrawal by Subject|0|||
48809483|NCT03203694|157142711|FG003|Overall Study|Withdrawal by Subject|0|||
48809484|NCT03203694|157142712|FG004|Overall Study|Withdrawal by Subject|0|||
48809485|NCT03203694|157142713|FG005|Overall Study|Withdrawal by Subject|0|||
48809486|NCT02401308|157142714|FG000|Overall Study|Study was terminated by the PI due to lack of enrollment.|0|||
48809487|NCT02401308|157142715|FG001|Overall Study|Study was terminated by the PI due to lack of enrollment.|1|||
48809488|NCT02736968|157142719|FG000|Overall Study|Lost to Follow-up|0|||
48809489|NCT02736968|157142720|FG001|Overall Study|Lost to Follow-up|0|||
48809490|NCT02736968|157142721|FG002|Overall Study|Lost to Follow-up|0|||
48809491|NCT02736968|157142722|FG003|Overall Study|Lost to Follow-up|0|||
48809492|NCT02736968|157142723|FG004|Overall Study|Lost to Follow-up|0|||
48809493|NCT02736968|157142724|FG005|Overall Study|Lost to Follow-up|0|||
48809494|NCT02736968|157142725|FG006|Overall Study|Lost to Follow-up|5|||
48809495|NCT02736968|157142726|FG007|Overall Study|Lost to Follow-up|2|||
48809496|NCT02736968|157142719|FG000|Overall Study|COVID-19 Pandemic|0|||
48809497|NCT02736968|157142720|FG001|Overall Study|COVID-19 Pandemic|0|||
48809498|NCT02736968|157142721|FG002|Overall Study|COVID-19 Pandemic|0|||
48809499|NCT02736968|157142722|FG003|Overall Study|COVID-19 Pandemic|0|||
48809500|NCT02736968|157142723|FG004|Overall Study|COVID-19 Pandemic|0|||
48809501|NCT02736968|157142724|FG005|Overall Study|COVID-19 Pandemic|0|||
48809502|NCT02736968|157142725|FG006|Overall Study|COVID-19 Pandemic|2|||
48809503|NCT02736968|157142726|FG007|Overall Study|COVID-19 Pandemic|0|||
48809504|NCT02736968|157142719|FG000|Overall Study|Withdrawal by Subject|0|||
48809505|NCT02736968|157142720|FG001|Overall Study|Withdrawal by Subject|0|||
48809506|NCT02736968|157142721|FG002|Overall Study|Withdrawal by Subject|0|||
48809507|NCT02736968|157142722|FG003|Overall Study|Withdrawal by Subject|0|||
48809508|NCT02736968|157142723|FG004|Overall Study|Withdrawal by Subject|0|||
48809509|NCT02736968|157142724|FG005|Overall Study|Withdrawal by Subject|0|||
48809510|NCT02736968|157142725|FG006|Overall Study|Withdrawal by Subject|1|||
48809511|NCT02736968|157142726|FG007|Overall Study|Withdrawal by Subject|0|||
48809512|NCT01709305|157142727|FG000|Phase 1|Clinical Adverse Event|80|||
48809513|NCT01709305|157142728|FG001|Phase 1|Clinical Adverse Event|0|||
48809514|NCT01709305|157142729|FG002|Phase 1|Clinical Adverse Event|0|||
48809515|NCT01709305|157142730|FG003|Phase 1|Clinical Adverse Event|0|||
48809516|NCT01709305|157142731|FG004|Phase 1|Clinical Adverse Event|0|||
48809517|NCT01709305|157142727|FG000|Phase 1|Death|2|||
48809518|NCT01709305|157142728|FG001|Phase 1|Death|0|||
48809519|NCT01709305|157142729|FG002|Phase 1|Death|0|||
48809520|NCT01709305|157142730|FG003|Phase 1|Death|0|||
48809521|NCT01709305|157142731|FG004|Phase 1|Death|0|||
48918232|NCT00307151|157537681|FG000|Overall Study|Withdrew consent|0|||
48809522|NCT01709305|157142727|FG000|Phase 1|Hyperglycemia (lack of efficacy)|13|||
48809523|NCT01709305|157142728|FG001|Phase 1|Hyperglycemia (lack of efficacy)|0|||
48809524|NCT01709305|157142729|FG002|Phase 1|Hyperglycemia (lack of efficacy)|0|||
48809525|NCT01709305|157142730|FG003|Phase 1|Hyperglycemia (lack of efficacy)|0|||
48809526|NCT01709305|157142731|FG004|Phase 1|Hyperglycemia (lack of efficacy)|0|||
48809527|NCT01709305|157142727|FG000|Phase 1|Laboratory Adverse Event|16|||
48809528|NCT01709305|157142728|FG001|Phase 1|Laboratory Adverse Event|0|||
48809529|NCT01709305|157142729|FG002|Phase 1|Laboratory Adverse Event|0|||
48809530|NCT01709305|157142730|FG003|Phase 1|Laboratory Adverse Event|0|||
48809531|NCT01709305|157142731|FG004|Phase 1|Laboratory Adverse Event|0|||
48918233|NCT00307151|157537682|FG001|Overall Study|Withdrew consent|1|||
48809532|NCT01709305|157142727|FG000|Phase 1|Lost to Follow-up|147|||
48809533|NCT01709305|157142728|FG001|Phase 1|Lost to Follow-up|0|||
48809534|NCT01709305|157142729|FG002|Phase 1|Lost to Follow-up|0|||
48809535|NCT01709305|157142730|FG003|Phase 1|Lost to Follow-up|0|||
48809536|NCT01709305|157142731|FG004|Phase 1|Lost to Follow-up|0|||
48809537|NCT01709305|157142727|FG000|Phase 1|Travel, moving, etc.|30|||
48809538|NCT01709305|157142728|FG001|Phase 1|Travel, moving, etc.|0|||
48809539|NCT01709305|157142729|FG002|Phase 1|Travel, moving, etc.|0|||
48809540|NCT01709305|157142730|FG003|Phase 1|Travel, moving, etc.|0|||
48809541|NCT01709305|157142731|FG004|Phase 1|Travel, moving, etc.|0|||
48809542|NCT01709305|157142727|FG000|Phase 1|Physician Decision|13|||
48809543|NCT01709305|157142728|FG001|Phase 1|Physician Decision|0|||
48809544|NCT01709305|157142729|FG002|Phase 1|Physician Decision|0|||
48809545|NCT01709305|157142730|FG003|Phase 1|Physician Decision|0|||
48809546|NCT01709305|157142731|FG004|Phase 1|Physician Decision|0|||
48809547|NCT01709305|157142727|FG000|Phase 1|Protocol Violation|118|||
48809548|NCT01709305|157142728|FG001|Phase 1|Protocol Violation|0|||
48809549|NCT01709305|157142729|FG002|Phase 1|Protocol Violation|0|||
48809550|NCT01709305|157142730|FG003|Phase 1|Protocol Violation|0|||
48809551|NCT01709305|157142731|FG004|Phase 1|Protocol Violation|0|||
48809552|NCT01709305|157142727|FG000|Phase 1|Withdrawal by Subject|218|||
48809553|NCT01709305|157142728|FG001|Phase 1|Withdrawal by Subject|0|||
48809554|NCT01709305|157142729|FG002|Phase 1|Withdrawal by Subject|0|||
48809555|NCT01709305|157142730|FG003|Phase 1|Withdrawal by Subject|0|||
48809556|NCT01709305|157142731|FG004|Phase 1|Withdrawal by Subject|0|||
48809557|NCT01709305|157142727|FG000|Phase 2|Clinical Adverse Event|0|||
48809558|NCT01709305|157142728|FG001|Phase 2|Clinical Adverse Event|10|||
48809559|NCT01709305|157142729|FG002|Phase 2|Clinical Adverse Event|10|||
48809560|NCT01709305|157142730|FG003|Phase 2|Clinical Adverse Event|6|||
48809561|NCT01709305|157142731|FG004|Phase 2|Clinical Adverse Event|11|||
48809562|NCT01709305|157142727|FG000|Phase 2|Death|0|||
48809563|NCT01709305|157142728|FG001|Phase 2|Death|0|||
48809564|NCT01709305|157142729|FG002|Phase 2|Death|1|||
48809565|NCT01709305|157142730|FG003|Phase 2|Death|0|||
48809566|NCT01709305|157142731|FG004|Phase 2|Death|0|||
48809567|NCT01709305|157142727|FG000|Phase 2|Hyperglycemia (lack of efficacy)|0|||
48809568|NCT01709305|157142728|FG001|Phase 2|Hyperglycemia (lack of efficacy)|0|||
48809569|NCT01709305|157142729|FG002|Phase 2|Hyperglycemia (lack of efficacy)|0|||
48809570|NCT01709305|157142730|FG003|Phase 2|Hyperglycemia (lack of efficacy)|0|||
48809571|NCT01709305|157142731|FG004|Phase 2|Hyperglycemia (lack of efficacy)|2|||
48809572|NCT01709305|157142727|FG000|Phase 2|Laboratory Adverse Event|0|||
48809573|NCT01709305|157142728|FG001|Phase 2|Laboratory Adverse Event|1|||
48809574|NCT01709305|157142729|FG002|Phase 2|Laboratory Adverse Event|0|||
48809575|NCT01709305|157142730|FG003|Phase 2|Laboratory Adverse Event|1|||
48809576|NCT01709305|157142731|FG004|Phase 2|Laboratory Adverse Event|1|||
48809577|NCT01709305|157142727|FG000|Phase 2|Lost to Follow-up|0|||
48809578|NCT01709305|157142728|FG001|Phase 2|Lost to Follow-up|10|||
48809579|NCT01709305|157142729|FG002|Phase 2|Lost to Follow-up|6|||
48809580|NCT01709305|157142730|FG003|Phase 2|Lost to Follow-up|9|||
48809581|NCT01709305|157142731|FG004|Phase 2|Lost to Follow-up|5|||
48809582|NCT01709305|157142727|FG000|Phase 2|Travel, moving, etc.|0|||
48809583|NCT01709305|157142728|FG001|Phase 2|Travel, moving, etc.|2|||
48809584|NCT01709305|157142729|FG002|Phase 2|Travel, moving, etc.|3|||
48809585|NCT01709305|157142730|FG003|Phase 2|Travel, moving, etc.|3|||
48809586|NCT01709305|157142731|FG004|Phase 2|Travel, moving, etc.|5|||
48809587|NCT01709305|157142727|FG000|Phase 2|Physician Decision|0|||
48809588|NCT01709305|157142728|FG001|Phase 2|Physician Decision|2|||
48809589|NCT01709305|157142729|FG002|Phase 2|Physician Decision|0|||
48809590|NCT01709305|157142730|FG003|Phase 2|Physician Decision|1|||
48809591|NCT01709305|157142731|FG004|Phase 2|Physician Decision|2|||
48809592|NCT01709305|157142727|FG000|Phase 2|Protocol Violation|0|||
48809593|NCT01709305|157142728|FG001|Phase 2|Protocol Violation|19|||
48809594|NCT01709305|157142729|FG002|Phase 2|Protocol Violation|19|||
48809595|NCT01709305|157142730|FG003|Phase 2|Protocol Violation|13|||
48809596|NCT01709305|157142731|FG004|Phase 2|Protocol Violation|9|||
48809597|NCT01709305|157142727|FG000|Phase 2|Withdrawal by Subject|0|||
48809598|NCT01709305|157142728|FG001|Phase 2|Withdrawal by Subject|8|||
48809599|NCT01709305|157142729|FG002|Phase 2|Withdrawal by Subject|6|||
48809600|NCT01709305|157142730|FG003|Phase 2|Withdrawal by Subject|15|||
48809601|NCT01709305|157142731|FG004|Phase 2|Withdrawal by Subject|12|||
48809602|NCT01103960|157142732|FG000|Overall Study|Adverse Event|2|||
48809603|NCT01103960|157142733|FG001|Overall Study|Adverse Event|1|||
48809604|NCT01103960|157142732|FG000|Overall Study|Withdrawal by Subject|2|||
48809605|NCT01103960|157142733|FG001|Overall Study|Withdrawal by Subject|1|||
48809606|NCT01103960|157142732|FG000|Overall Study|Other|1|||
48809607|NCT01103960|157142733|FG001|Overall Study|Other|0|||
48809608|NCT01032044|157142734|FG000|Overall Study|Protocol Violation|14|||
48809609|NCT01032044|157142735|FG001|Overall Study|Protocol Violation|8|||
48809610|NCT01032044|157142734|FG000|Overall Study|Adverse Event|0|||
48809611|NCT01032044|157142735|FG001|Overall Study|Adverse Event|1|||
48809612|NCT01032044|157142734|FG000|Overall Study|Lost to Follow-up|11|||
48809613|NCT01032044|157142735|FG001|Overall Study|Lost to Follow-up|11|||
48809614|NCT02961374|157142736|FG000|Overall Study|Adverse Event|4|||
48809615|NCT02924389|157142737|FG000|Overall Study|Lost to Follow-up|1|||
48809616|NCT02924389|157142738|FG001|Overall Study|Lost to Follow-up|0|||
48809617|NCT02924389|157142737|FG000|Overall Study|Physician Decision|2|||
48809618|NCT02924389|157142738|FG001|Overall Study|Physician Decision|0|||
48809619|NCT02924389|157142737|FG000|Overall Study|Withdrawal by Subject|3|||
48809620|NCT02924389|157142738|FG001|Overall Study|Withdrawal by Subject|0|||
48809621|NCT02924389|157142737|FG000|Overall Study|Participant began ARVs prior to study intervention|2|||
48809622|NCT02924389|157142738|FG001|Overall Study|Participant began ARVs prior to study intervention|0|||
48809623|NCT02824029|157143504|FG000|Overall Study|Didn't receive treatment|2|||
48809624|NCT02824029|157143504|FG000|Overall Study|Patient decision to discontinue treatment|3|||
48809625|NCT02824029|157143504|FG000|Overall Study|Non-compliant|5|||
48809626|NCT02824029|157143504|FG000|Overall Study|Progression of disease|15|||
48809627|NCT02824029|157143504|FG000|Overall Study|Inadequate response to therapy|2|||
48809628|NCT02824029|157143504|FG000|Overall Study|Possible progression per treating physician|1|||
48809629|NCT01894061|157143507|FG000|Overall Study|Screen failure|1|||
48809630|NCT01894061|157143507|FG000|Overall Study|Withdrawal by Subject|1|||
48809631|NCT03789656|157143508|FG000|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
48809632|NCT03789656|157143509|FG001|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
48809633|NCT03789656|157143510|FG002|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
48809634|NCT03789656|157143511|FG003|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
48809635|NCT03789656|157143512|FG004|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
48809636|NCT03789656|157143508|FG000|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
48809637|NCT03789656|157143509|FG001|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
48809638|NCT03789656|157143510|FG002|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|1|||
48809639|NCT03789656|157143511|FG003|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
48809640|NCT03789656|157143512|FG004|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
48809641|NCT03789656|157143508|FG000|Treatment Period: up to 13 Weeks|Unable to Travel|1|||
48809642|NCT03789656|157143509|FG001|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
48809643|NCT03789656|157143510|FG002|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
48809644|NCT03789656|157143511|FG003|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
48809645|NCT03789656|157143512|FG004|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
48809646|NCT03789656|157143508|FG000|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|1|||
48809647|NCT03789656|157143509|FG001|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
48809648|NCT03789656|157143510|FG002|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
48809649|NCT03789656|157143511|FG003|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
48809650|NCT03789656|157143512|FG004|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
48809651|NCT05714059|157143513|FG000|Overall Study|Withdrawal by Subject|2|||
48809652|NCT05714059|157143514|FG001|Overall Study|Withdrawal by Subject|2|||
48809653|NCT05714059|157143513|FG000|Overall Study|Adverse Event|0|||
48809654|NCT05714059|157143514|FG001|Overall Study|Adverse Event|1|||
48809655|NCT05714059|157143513|FG000|Overall Study|Lost to Follow-up|0|||
48809656|NCT05714059|157143514|FG001|Overall Study|Lost to Follow-up|1|||
48809657|NCT05714059|157143513|FG000|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|3|||
48809658|NCT05714059|157143514|FG001|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|0|||
48809659|NCT05714059|157143513|FG000|Overall Study|TECHNICAL PROBLEMS|0|||
48809660|NCT05714059|157143514|FG001|Overall Study|TECHNICAL PROBLEMS|1|||
48809661|NCT02991807|157143515|FG000|Overall Study|Withdrawal by Subject|2|||
48809662|NCT02991807|157143516|FG001|Overall Study|Withdrawal by Subject|1|||
48809663|NCT02991807|157143515|FG000|Overall Study|Physician Decision|0|||
48809664|NCT02991807|157143516|FG001|Overall Study|Physician Decision|1|||
48809665|NCT02991807|157143515|FG000|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|1|||
48809666|NCT02991807|157143516|FG001|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|0|||
48809667|NCT03774472|157143517|FG000|Overall Study|Physician Decision|1|||
48809668|NCT03774472|157143518|FG001|Overall Study|Physician Decision|0|||
48809669|NCT03774472|157143519|FG002|Overall Study|Physician Decision|0|||
48809670|NCT03774472|157143517|FG000|Overall Study|Progression prior to 4 weeks|0|||
48809671|NCT03774472|157143518|FG001|Overall Study|Progression prior to 4 weeks|1|||
48809672|NCT03774472|157143519|FG002|Overall Study|Progression prior to 4 weeks|0|||
48809673|NCT03774472|157143517|FG000|Overall Study|Withdrawal by Subject|0|||
48809674|NCT03774472|157143518|FG001|Overall Study|Withdrawal by Subject|1|||
48809675|NCT03774472|157143519|FG002|Overall Study|Withdrawal by Subject|0|||
48809676|NCT05018143|157143524|FG000|Overall Study|Lost to Follow-up|5|||
48918234|NCT00307151|157537683|FG002|Overall Study|Withdrew consent|1|||
48809677|NCT05018143|157143525|FG001|Overall Study|Lost to Follow-up|4|||
48809678|NCT05018143|157143524|FG000|Overall Study|Withdrawal by Subject|0|||
48918235|NCT00307151|157537684|FG003|Overall Study|Withdrew consent|3|||
48809679|NCT05018143|157143525|FG001|Overall Study|Withdrawal by Subject|1|||
48809680|NCT05141903|157143526|FG000|Overall Study|Withdrawal by Subject|0|||
48809681|NCT05141903|157143527|FG001|Overall Study|Withdrawal by Subject|1|||
48809682|NCT05141903|157143528|FG002|Overall Study|Withdrawal by Subject|1|||
48918236|NCT00307151|157537681|FG000|Overall Study|Not willing to adhere to study reqs|2|||
48918237|NCT00307151|157537682|FG001|Overall Study|Not willing to adhere to study reqs|0|||
48918238|NCT00307151|157537683|FG002|Overall Study|Not willing to adhere to study reqs|2|||
48918239|NCT00307151|157537684|FG003|Overall Study|Not willing to adhere to study reqs|2|||
48918240|NCT00307151|157537681|FG000|Overall Study|Clinic unable to contact subject|3|||
48918241|NCT00307151|157537682|FG001|Overall Study|Clinic unable to contact subject|3|||
48918242|NCT00307151|157537683|FG002|Overall Study|Clinic unable to contact subject|1|||
48809683|NCT05141903|157143529|FG003|Overall Study|Withdrawal by Subject|0|||
48809684|NCT05141903|157143530|FG004|Overall Study|Withdrawal by Subject|0|||
48809685|NCT05141903|157143526|FG000|Overall Study|Other|1|||
48809686|NCT05141903|157143527|FG001|Overall Study|Other|1|||
48809687|NCT05141903|157143528|FG002|Overall Study|Other|0|||
48809688|NCT05141903|157143529|FG003|Overall Study|Other|0|||
48809689|NCT05141903|157143530|FG004|Overall Study|Other|0|||
48809690|NCT03066622|157143533|FG000|Overall Study|Lost to Follow-up|24|||
48809691|NCT03066622|157143534|FG001|Overall Study|Lost to Follow-up|25|||
48809692|NCT03066622|157143533|FG000|Overall Study|Withdrawal by Subject|2|||
48809693|NCT03066622|157143534|FG001|Overall Study|Withdrawal by Subject|1|||
48809694|NCT02006121|157143535|FG000|Double Blind Phase|Adverse Event|6|||
48809695|NCT02006121|157143536|FG001|Double Blind Phase|Adverse Event|0|||
48809696|NCT02006121|157143535|FG000|Double Blind Phase|Lack of Efficacy|1|||
48809697|NCT02006121|157143536|FG001|Double Blind Phase|Lack of Efficacy|16|||
48918243|NCT00307151|157537684|FG003|Overall Study|Clinic unable to contact subject|1|||
48918244|NCT01617460|157537685|FG000|Overall Study|Adverse Event|10|||
48918245|NCT01617460|157537685|FG000|Overall Study|Physician Decision|16|||
48918246|NCT01617460|157537685|FG000|Overall Study|Protocol Violation|5|||
49120769|NCT02326272|158280516|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
49120770|NCT02326272|158280517|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
49120771|NCT02326272|158280518|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
49120772|NCT02326272|158280519|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
49120773|NCT02326272|158280520|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
49120774|NCT02326272|158280521|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
49120775|NCT02326272|158280522|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
49120776|NCT02326272|158280508|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
49120777|NCT02326272|158280509|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
49120778|NCT02326272|158280510|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
49120779|NCT02326272|158280511|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
49120780|NCT02326272|158280512|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
48809698|NCT02006121|157143535|FG000|Double Blind Phase|Withdrawal by Subject|3|||
49120781|NCT02326272|158280513|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
49120782|NCT02326272|158280514|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
49120783|NCT02326272|158280515|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
49120784|NCT02326272|158280516|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
48809699|NCT02006121|157143536|FG001|Double Blind Phase|Withdrawal by Subject|4|||
48809700|NCT02006121|157143535|FG000|Double Blind Phase|Non-compliance with study drug|1|||
48809701|NCT02006121|157143536|FG001|Double Blind Phase|Non-compliance with study drug|3|||
48809702|NCT02006121|157143535|FG000|Double Blind Phase|Minimum infusion rate poorly tolerated|1|||
48809703|NCT02006121|157143536|FG001|Double Blind Phase|Minimum infusion rate poorly tolerated|0|||
48809704|NCT02006121|157143535|FG000|Double Blind Phase|Inconvenience of infusion system|0|||
48809705|NCT02006121|157143536|FG001|Double Blind Phase|Inconvenience of infusion system|1|||
48809706|NCT02006121|157143535|FG000|Open Label Phase|Adverse Event|15|||
48809707|NCT02006121|157143536|FG001|Open Label Phase|Adverse Event|0|||
48809708|NCT02006121|157143535|FG000|Open Label Phase|Lack of Efficacy|2|||
49120785|NCT02326272|158280517|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
49120786|NCT02326272|158280518|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
48809709|NCT02006121|157143536|FG001|Open Label Phase|Lack of Efficacy|0|||
48809710|NCT02006121|157143535|FG000|Open Label Phase|Protocol Violation|2|||
48809711|NCT02006121|157143536|FG001|Open Label Phase|Protocol Violation|0|||
48809712|NCT02006121|157143535|FG000|Open Label Phase|Withdrawal by Subject|3|||
48809713|NCT02006121|157143536|FG001|Open Label Phase|Withdrawal by Subject|0|||
48918247|NCT01617460|157537685|FG000|Overall Study|Withdrawal by Subject|9|||
48918248|NCT00457015|157537686|FG000|Overall Study|Left study site against medical advice|0|||
48918249|NCT00457015|157537687|FG001|Overall Study|Left study site against medical advice|1|||
48809714|NCT02006121|157143535|FG000|Open Label Phase|Non-compliance with study drug|3|||
48918250|NCT02982954|157537688|FG000|Overall Study|Death|55|||
48918251|NCT02982954|157537689|FG001|Overall Study|Death|29|||
48918252|NCT02982954|157537690|FG002|Overall Study|Death|15|||
48809715|NCT02006121|157143536|FG001|Open Label Phase|Non-compliance with study drug|0|||
48711317|NCT00950859|156793183|FG000|Overall Study|Insufficient Viral Load Response|12|||
48918253|NCT02982954|157537691|FG003|Overall Study|Death|20|||
48918254|NCT02982954|157537688|FG000|Overall Study|Lost to Follow-up|2|||
48918255|NCT02982954|157537689|FG001|Overall Study|Lost to Follow-up|1|||
48918256|NCT02982954|157537690|FG002|Overall Study|Lost to Follow-up|0|||
48918257|NCT02982954|157537691|FG003|Overall Study|Lost to Follow-up|0|||
48918258|NCT02982954|157537688|FG000|Overall Study|Participant withdrew consent|7|||
48918259|NCT02982954|157537689|FG001|Overall Study|Participant withdrew consent|5|||
48918260|NCT02982954|157537690|FG002|Overall Study|Participant withdrew consent|1|||
48918261|NCT02982954|157537691|FG003|Overall Study|Participant withdrew consent|1|||
48918262|NCT02982954|157537688|FG000|Overall Study|Other reasons|42|||
48918263|NCT02982954|157537689|FG001|Overall Study|Other reasons|17|||
48918264|NCT02982954|157537690|FG002|Overall Study|Other reasons|12|||
48918265|NCT02982954|157537691|FG003|Overall Study|Other reasons|3|||
48918266|NCT02982954|157537688|FG000|Overall Study|Premature site closure|0|||
48918267|NCT02982954|157537689|FG001|Overall Study|Premature site closure|0|||
48918268|NCT02982954|157537690|FG002|Overall Study|Premature site closure|0|||
48918269|NCT02982954|157537691|FG003|Overall Study|Premature site closure|1|||
48918270|NCT02263079|157537692|FG000|Overall Study|Physician Decision|1|||
48918271|NCT02263079|157537693|FG001|Overall Study|Physician Decision|0|||
48711318|NCT00950859|156793184|FG001|Overall Study|Insufficient Viral Load Response|3|||
48711319|NCT00950859|156793183|FG000|Overall Study|Protocol Violation|1|||
48711320|NCT00950859|156793184|FG001|Overall Study|Protocol Violation|1|||
48711321|NCT00950859|156793183|FG000|Overall Study|Lost to Follow-up|0|||
48711322|NCT00950859|156793184|FG001|Overall Study|Lost to Follow-up|3|||
48711323|NCT01358721|156793185|FG000|Overall Study|Withdrawal by Subject|0|||
48711324|NCT01358721|156793186|FG001|Overall Study|Withdrawal by Subject|0|||
48711325|NCT01358721|156793187|FG002|Overall Study|Withdrawal by Subject|0|||
48711326|NCT01358721|156793188|FG003|Overall Study|Withdrawal by Subject|1|||
48711327|NCT01358721|156793185|FG000|Overall Study|Death|0|||
48711328|NCT01358721|156793186|FG001|Overall Study|Death|2|||
48711329|NCT01358721|156793187|FG002|Overall Study|Death|0|||
48711330|NCT01358721|156793188|FG003|Overall Study|Death|0|||
48711331|NCT01358721|156793185|FG000|Overall Study|Study Drug Toxicity|1|||
48711332|NCT01358721|156793186|FG001|Overall Study|Study Drug Toxicity|3|||
48711333|NCT01358721|156793187|FG002|Overall Study|Study Drug Toxicity|4|||
48711334|NCT01358721|156793188|FG003|Overall Study|Study Drug Toxicity|5|||
48711335|NCT01358721|156793185|FG000|Overall Study|SUBJ request to discontinue study TRT|0|||
48711336|NCT01358721|156793186|FG001|Overall Study|SUBJ request to discontinue study TRT|0|||
48711337|NCT01358721|156793187|FG002|Overall Study|SUBJ request to discontinue study TRT|0|||
48711338|NCT01358721|156793188|FG003|Overall Study|SUBJ request to discontinue study TRT|1|||
48711339|NCT01358721|156793185|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
48711340|NCT01358721|156793186|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
48711341|NCT01358721|156793187|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
48711342|NCT01358721|156793188|FG003|Overall Study|Subject No Longer Meets Study Criteria|1|||
48711343|NCT01358721|156793185|FG000|Overall Study|Adverse Event related to study drug|1|||
48711344|NCT01358721|156793186|FG001|Overall Study|Adverse Event related to study drug|0|||
48711345|NCT01358721|156793187|FG002|Overall Study|Adverse Event related to study drug|0|||
48711346|NCT01358721|156793188|FG003|Overall Study|Adverse Event related to study drug|1|||
48711347|NCT01358721|156793185|FG000|Overall Study|Disease Progression|19|||
48711348|NCT01358721|156793186|FG001|Overall Study|Disease Progression|15|||
48711349|NCT01358721|156793187|FG002|Overall Study|Disease Progression|17|||
48711350|NCT01358721|156793188|FG003|Overall Study|Disease Progression|15|||
48711351|NCT01358721|156793185|FG000|Overall Study|Out of State/Unmet Criteria|0|||
48711352|NCT01358721|156793186|FG001|Overall Study|Out of State/Unmet Criteria|0|||
48711353|NCT01358721|156793187|FG002|Overall Study|Out of State/Unmet Criteria|1|||
48711354|NCT01358721|156793188|FG003|Overall Study|Out of State/Unmet Criteria|0|||
48711355|NCT00436345|156793189|FG000|Overall Study|ICU resident beyond follow-up period|3|||
48711356|NCT00436345|156793190|FG001|Overall Study|ICU resident beyond follow-up period|0|||
48711357|NCT04248491|156793191|FG000|Overall Study|Lost to Follow-up|1|||
48711358|NCT04248491|156793192|FG001|Overall Study|Lost to Follow-up|0|||
48711359|NCT03830892|156793193|FG000|Overall Study|Physician Decision|2|||
48711360|NCT03830892|156793194|FG001|Overall Study|Physician Decision|3|||
48711361|NCT03830892|156793193|FG000|Overall Study|Study terminated due to COVID|4|||
48711362|NCT03830892|156793194|FG001|Overall Study|Study terminated due to COVID|0|||
48711363|NCT03830892|156793193|FG000|Overall Study|Protocol Violation|0|||
48711364|NCT03830892|156793194|FG001|Overall Study|Protocol Violation|1|||
48711365|NCT03830892|156793193|FG000|Overall Study|Withdrawal by Subject|0|||
48918272|NCT02263079|157537694|FG002|Overall Study|Physician Decision|0|||
48918273|NCT02263079|157537692|FG000|Overall Study|Withdrawal by Subject|2|||
48918274|NCT02263079|157537693|FG001|Overall Study|Withdrawal by Subject|8|||
49015357|NCT00673790|157892154|FG002|Overall Study|Randomization criteria not met|0|||
48711366|NCT03830892|156793194|FG001|Overall Study|Withdrawal by Subject|2|||
48711367|NCT01499277|156793195|FG000|Overall Study|Adverse Event|3|||
48711368|NCT01499277|156793196|FG001|Overall Study|Adverse Event|6|||
48711369|NCT01499277|156793195|FG000|Overall Study|Death|3|||
48918275|NCT02263079|157537694|FG002|Overall Study|Withdrawal by Subject|0|||
48918276|NCT01227187|157537700|FG000|Overall Study|Physician Decision|0|||
48918277|NCT01227187|157537701|FG001|Overall Study|Physician Decision|0|||
48809716|NCT01748448|157143540|FG000|Treatment Period|Consent withdrawn by subject|1|||
48809717|NCT01748448|157143541|FG001|Treatment Period|Consent withdrawn by subject|0|||
48809718|NCT01748448|157143540|FG000|Treatment Period|Adverse Event|1|||
48809719|NCT01748448|157143541|FG001|Treatment Period|Adverse Event|0|||
48809720|NCT01748448|157143540|FG000|Treatment Period|Personal|0|||
48918278|NCT01227187|157537702|FG002|Overall Study|Physician Decision|0|||
48918279|NCT01227187|157537703|FG003|Overall Study|Physician Decision|1|||
48918280|NCT00066703|157537706|FG000|Overall Study|Adverse Event|80|||
48918281|NCT00066703|157537707|FG001|Overall Study|Adverse Event|111|||
48918282|NCT00066703|157537706|FG000|Overall Study|Death|3|||
48918283|NCT00066703|157537707|FG001|Overall Study|Death|0|||
48918284|NCT00066703|157537706|FG000|Overall Study|Lack of Efficacy|114|||
48918285|NCT00066703|157537707|FG001|Overall Study|Lack of Efficacy|69|||
48918286|NCT00066703|157537706|FG000|Overall Study|Lost to Follow-up|31|||
48809721|NCT01748448|157143541|FG001|Treatment Period|Personal|1|||
48918287|NCT00066703|157537707|FG001|Overall Study|Lost to Follow-up|28|||
48918288|NCT00066703|157537706|FG000|Overall Study|Withdrawal by Subject|38|||
48918289|NCT00066703|157537707|FG001|Overall Study|Withdrawal by Subject|63|||
48918290|NCT00066703|157537706|FG000|Overall Study|Treatment ongoing|346|||
48918291|NCT00066703|157537707|FG001|Overall Study|Treatment ongoing|311|||
48918292|NCT04329702|157537708|FG000|Overall Study|illness|3|||
48918293|NCT04329702|157537709|FG001|Overall Study|illness|4|||
48809722|NCT03691493|157143542|FG000|Overall Study|Withdrawal by Subject|1|||
48918294|NCT04329702|157537710|FG002|Overall Study|illness|0|||
48918295|NCT04329702|157537708|FG000|Overall Study|Lost to Follow-up|0|||
48918296|NCT04329702|157537709|FG001|Overall Study|Lost to Follow-up|0|||
48918297|NCT04329702|157537710|FG002|Overall Study|Lost to Follow-up|2|||
48918298|NCT04329702|157537708|FG000|Overall Study|Death|0|||
48918299|NCT04329702|157537709|FG001|Overall Study|Death|2|||
48918300|NCT04329702|157537710|FG002|Overall Study|Death|0|||
48918301|NCT03923426|157537711|FG000|Overall Study|Other|19|||
48918302|NCT03923426|157537711|FG000|Overall Study|Lost to Follow-up|16|||
48918303|NCT03923426|157537711|FG000|Overall Study|Death|107|||
48918304|NCT03923426|157537711|FG000|Overall Study|Incomplete response to question|13|||
48918305|NCT02234284|157537712|FG000|Overall Study|Death|4|||
48809723|NCT01155661|157143555|FG000|Overall Study|Adverse Event|101|||
48809724|NCT01155661|157143555|FG000|Overall Study|Death|1|||
48809725|NCT01155661|157143555|FG000|Overall Study|Lack of Efficacy|32|||
48809726|NCT01155661|157143555|FG000|Overall Study|Lost to Follow-up|22|||
48809727|NCT01155661|157143555|FG000|Overall Study|Physician Decision|3|||
48809728|NCT01155661|157143555|FG000|Overall Study|Protocol Violation|35|||
48809729|NCT01155661|157143555|FG000|Overall Study|Withdrawal by Subject|73|||
48809730|NCT01155661|157143555|FG000|Overall Study|Sponsor Decision|13|||
48809731|NCT03679767|157143556|FG000|Overall Study|Death|16|||
48809732|NCT03679767|157143557|FG001|Overall Study|Death|11|||
48809733|NCT03679767|157143558|FG002|Overall Study|Death|17|||
48809734|NCT03679767|157143559|FG003|Overall Study|Death|10|||
48809735|NCT03679767|157143556|FG000|Overall Study|Lost to Follow-up|1|||
48809736|NCT03679767|157143557|FG001|Overall Study|Lost to Follow-up|1|||
48809737|NCT03679767|157143558|FG002|Overall Study|Lost to Follow-up|1|||
48809738|NCT03679767|157143559|FG003|Overall Study|Lost to Follow-up|1|||
48809739|NCT03679767|157143556|FG000|Overall Study|Withdrawal by Subject|0|||
48809740|NCT03679767|157143557|FG001|Overall Study|Withdrawal by Subject|0|||
48809741|NCT03679767|157143558|FG002|Overall Study|Withdrawal by Subject|0|||
48809742|NCT03679767|157143559|FG003|Overall Study|Withdrawal by Subject|1|||
48809743|NCT03679767|157143556|FG000|Overall Study|Follow-up Completed|18|||
48809744|NCT03679767|157143557|FG001|Overall Study|Follow-up Completed|11|||
48809745|NCT03679767|157143558|FG002|Overall Study|Follow-up Completed|11|||
48809746|NCT03679767|157143559|FG003|Overall Study|Follow-up Completed|20|||
48809747|NCT03679767|157143556|FG000|Overall Study|Entered Hospice Care|0|||
48809748|NCT03679767|157143557|FG001|Overall Study|Entered Hospice Care|0|||
48809749|NCT03679767|157143558|FG002|Overall Study|Entered Hospice Care|0|||
48809750|NCT03679767|157143559|FG003|Overall Study|Entered Hospice Care|1|||
48809751|NCT03679767|157143556|FG000|Overall Study|Progressive Disease|0|||
48809752|NCT03679767|157143557|FG001|Overall Study|Progressive Disease|0|||
48809753|NCT03679767|157143558|FG002|Overall Study|Progressive Disease|0|||
48809754|NCT03679767|157143559|FG003|Overall Study|Progressive Disease|1|||
48809755|NCT02180438|157143563|FG000|Overall Study|Lost to Follow-up|1|||
48918306|NCT02234284|157537713|FG001|Overall Study|Death|2|||
48918307|NCT02234284|157537712|FG000|Overall Study|Withdrawal by Subject|1|||
48918308|NCT02234284|157537713|FG001|Overall Study|Withdrawal by Subject|0|||
48918309|NCT02234284|157537712|FG000|Overall Study|Lost to Follow-up|20|||
48918310|NCT02234284|157537713|FG001|Overall Study|Lost to Follow-up|7|||
48809756|NCT00105586|157143566|FG000|Overall Study|Adverse Event|4|||
48809757|NCT00105586|157143567|FG001|Overall Study|Adverse Event|3|||
48809758|NCT00105586|157143566|FG000|Overall Study|Physician Decision|13|||
48918311|NCT01918007|157537716|FG000|Overall Study|Baseline oximetry not acceptable|11|||
48918312|NCT01918007|157537717|FG001|Overall Study|Baseline oximetry not acceptable|7|||
48918313|NCT01918007|157537716|FG000|Overall Study|Follow-up oximetry not acceptable|10|||
48918314|NCT01918007|157537717|FG001|Overall Study|Follow-up oximetry not acceptable|7|||
48918315|NCT01918007|157537716|FG000|Overall Study|Lost to Follow-up|4|||
48918316|NCT01918007|157537717|FG001|Overall Study|Lost to Follow-up|7|||
48918317|NCT01399788|157537724|FG000|First Intervention Period|Adverse Event|1|||
48918318|NCT01399788|157537725|FG001|First Intervention Period|Adverse Event|0|||
48918319|NCT04951037|157537726|FG000|Overall Study|Lost to Follow-up|16|||
48918320|NCT04951037|157537726|FG000|Overall Study|Withdrawal by Subject|5|||
48918321|NCT04951037|157537726|FG000|Overall Study|Completed study assessments but did not complete the intervention|10|||
48918322|NCT01006265|157537728|FG000|Overall Study|Lost to Follow-up|1|||
48711370|NCT01499277|156793196|FG001|Overall Study|Death|2|||
48711371|NCT01499277|156793195|FG000|Overall Study|Lost to Follow-up|15|||
48711372|NCT01499277|156793196|FG001|Overall Study|Lost to Follow-up|8|||
48711373|NCT01499277|156793195|FG000|Overall Study|Protocol Violation|2|||
48809759|NCT00105586|157143567|FG001|Overall Study|Physician Decision|13|||
48809760|NCT05822921|157143568|FG000|Overall Study|Lost to Follow-up|1|||
48809761|NCT05822921|157143569|FG001|Overall Study|Lost to Follow-up|1|||
48809762|NCT01567865|157143578|FG000|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0|||
48711374|NCT01499277|156793196|FG001|Overall Study|Protocol Violation|3|||
48711375|NCT01499277|156793195|FG000|Overall Study|Withdrawal by Subject|16|||
48711376|NCT01499277|156793196|FG001|Overall Study|Withdrawal by Subject|6|||
48711377|NCT01499277|156793195|FG000|Overall Study|Lack of therapeutic response and other|8|||
48711378|NCT01499277|156793196|FG001|Overall Study|Lack of therapeutic response and other|7|||
48711379|NCT01652469|156793200|FG000|Overall Study|Withdrawal by Subject|1|||
48711380|NCT01652469|156793201|FG001|Overall Study|Withdrawal by Subject|4|||
48711381|NCT01652469|156793200|FG000|Overall Study|Lost to Follow-up|0|||
48711382|NCT01652469|156793201|FG001|Overall Study|Lost to Follow-up|2|||
48711383|NCT00567398|156793202|FG000|Overall Study|Adverse Event|6|||
48711384|NCT00567398|156793203|FG001|Overall Study|Adverse Event|14|||
48711385|NCT00567398|156793202|FG000|Overall Study|Physician Decision|0|||
48809763|NCT01567865|157143579|FG001|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1|||
48809764|NCT01567865|157143580|FG002|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3|||
48809765|NCT01567865|157143581|FG003|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2|||
48809766|NCT01567865|157143578|FG000|Evaluated for Immunogenicity|Missing blood sample|17|||
48809767|NCT01567865|157143579|FG001|Evaluated for Immunogenicity|Missing blood sample|24|||
48809768|NCT01567865|157143580|FG002|Evaluated for Immunogenicity|Missing blood sample|16|||
48809769|NCT01567865|157143581|FG003|Evaluated for Immunogenicity|Missing blood sample|28|||
48809770|NCT02049710|157143584|FG000|Overall Study|Lost to Follow-up|319|||
48809771|NCT02049710|157143585|FG001|Overall Study|Lost to Follow-up|324|||
48809772|NCT01078662|157143586|FG000|Overall Study|Death|41|||
48809773|NCT01078662|157143587|FG001|Overall Study|Death|103|||
48918323|NCT01006265|157537729|FG001|Overall Study|Lost to Follow-up|0|||
48918324|NCT01006265|157537730|FG002|Overall Study|Lost to Follow-up|1|||
49120787|NCT02326272|158280519|FG011|Open-label Period (Week 48 to Week 144)|Death|0|||
49120788|NCT02326272|158280520|FG012|Open-label Period (Week 48 to Week 144)|Death|1|||
49120789|NCT02326272|158280521|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
48711386|NCT00567398|156793203|FG001|Overall Study|Physician Decision|4|||
48809774|NCT01078662|157143588|FG002|Overall Study|Death|18|||
48809775|NCT01078662|157143589|FG003|Overall Study|Death|5|||
48809776|NCT01078662|157143590|FG004|Overall Study|Death|8|||
48918325|NCT01006265|157537731|FG003|Overall Study|Lost to Follow-up|0|||
49120790|NCT02326272|158280522|FG014|Open-label Period (Week 48 to Week 144)|Death|0|||
49120791|NCT02326272|158280508|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
49120792|NCT02326272|158280509|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
49120793|NCT02326272|158280510|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
49120794|NCT02326272|158280511|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
49120795|NCT02326272|158280512|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
49120796|NCT02326272|158280513|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
49120797|NCT02326272|158280514|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
49120798|NCT02326272|158280515|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
49120799|NCT02326272|158280516|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
49120800|NCT02326272|158280517|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
49120801|NCT02326272|158280518|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
49120802|NCT02326272|158280519|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|8|||
49120803|NCT02326272|158280520|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
49120804|NCT02326272|158280521|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
48711387|NCT00567398|156793202|FG000|Overall Study|Withdrawal by Subject|0|||
48711388|NCT00567398|156793203|FG001|Overall Study|Withdrawal by Subject|2|||
48711389|NCT00567398|156793202|FG000|Overall Study|Renal Transplantation|0|||
48711390|NCT00567398|156793203|FG001|Overall Study|Renal Transplantation|3|||
48711391|NCT00567398|156793202|FG000|Overall Study|Other|1|||
48918326|NCT01006265|157537728|FG000|Overall Study|Withdrawal by Subject|4|||
48711392|NCT00567398|156793203|FG001|Overall Study|Other|0|||
48711393|NCT03120351|156793204|FG000|Overall Study|Physician Decision|1|||
48711394|NCT03120351|156793205|FG001|Overall Study|Physician Decision|1|||
48711395|NCT00337675|156793206|FG000|Overall Study|Adverse Event|10|||
48711396|NCT00337675|156793207|FG001|Overall Study|Adverse Event|9|||
48711397|NCT00337675|156793208|FG002|Overall Study|Adverse Event|19|||
48711398|NCT00337675|156793206|FG000|Overall Study|Lack of Efficacy|10|||
48809777|NCT01078662|157143586|FG000|Overall Study|Patients reached data cut-off|12|||
48809778|NCT01078662|157143587|FG001|Overall Study|Patients reached data cut-off|53|||
48809779|NCT01078662|157143588|FG002|Overall Study|Patients reached data cut-off|2|||
48809780|NCT01078662|157143589|FG003|Overall Study|Patients reached data cut-off|2|||
48809781|NCT01078662|157143590|FG004|Overall Study|Patients reached data cut-off|3|||
48809782|NCT01078662|157143586|FG000|Overall Study|Withdrawal by Subject|4|||
48809783|NCT01078662|157143587|FG001|Overall Study|Withdrawal by Subject|11|||
48809784|NCT01078662|157143588|FG002|Overall Study|Withdrawal by Subject|1|||
48918327|NCT01006265|157537729|FG001|Overall Study|Withdrawal by Subject|7|||
49120805|NCT02326272|158280522|FG014|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
48809785|NCT01078662|157143589|FG003|Overall Study|Withdrawal by Subject|0|||
48809786|NCT01078662|157143590|FG004|Overall Study|Withdrawal by Subject|0|||
48809787|NCT01078662|157143586|FG000|Overall Study|Protocol Violation|0|||
48809788|NCT01078662|157143587|FG001|Overall Study|Protocol Violation|1|||
48809789|NCT01078662|157143588|FG002|Overall Study|Protocol Violation|0|||
48809790|NCT01078662|157143589|FG003|Overall Study|Protocol Violation|0|||
48809791|NCT01078662|157143590|FG004|Overall Study|Protocol Violation|0|||
48809792|NCT01078662|157143586|FG000|Overall Study|Lost to Follow-up|1|||
48809793|NCT01078662|157143587|FG001|Overall Study|Lost to Follow-up|0|||
48809794|NCT01078662|157143588|FG002|Overall Study|Lost to Follow-up|0|||
48809795|NCT01078662|157143589|FG003|Overall Study|Lost to Follow-up|0|||
48809796|NCT01078662|157143590|FG004|Overall Study|Lost to Follow-up|0|||
48809797|NCT00874432|157143591|FG000|Overall Study|Withdrawal by Subject|1|||
48809798|NCT00874432|157143592|FG001|Overall Study|Withdrawal by Subject|0|||
48809799|NCT00874432|157143593|FG002|Overall Study|Withdrawal by Subject|0|||
48809800|NCT00874432|157143594|FG003|Overall Study|Withdrawal by Subject|0|||
48809801|NCT00874432|157143591|FG000|Overall Study|Physician Decision|1|||
48809802|NCT00874432|157143592|FG001|Overall Study|Physician Decision|0|||
48809803|NCT00874432|157143593|FG002|Overall Study|Physician Decision|0|||
48809804|NCT00874432|157143594|FG003|Overall Study|Physician Decision|0|||
48809805|NCT00874432|157143591|FG000|Overall Study|Other|1|||
48809806|NCT00874432|157143592|FG001|Overall Study|Other|2|||
48809807|NCT00874432|157143593|FG002|Overall Study|Other|8|||
48809808|NCT00874432|157143594|FG003|Overall Study|Other|3|||
48809809|NCT04088227|157143597|FG000|Overall Study|Withdrawal by Subject|1|||
48809810|NCT04088227|157143598|FG001|Overall Study|Withdrawal by Subject|0|||
48809811|NCT04088227|157143597|FG000|Overall Study|Surgery postponed >5weeks|1|||
48809812|NCT04088227|157143598|FG001|Overall Study|Surgery postponed >5weeks|0|||
48809813|NCT03516942|157143599|FG000|Registration Through Baseline Survey Com|Withdrawal by Subject|36|||
48809814|NCT03516942|157143599|FG000|Registration Through Baseline Survey Com|Death|8|||
48809815|NCT03516942|157143599|FG000|Registration Through Baseline Survey Com|Could not contact patient after enrollment|58|||
48809816|NCT03516942|157143599|FG000|T0: Baseline|LOST|13|||
48809817|NCT03516942|157143599|FG000|T1: 3 Months Survey|Withdrawal by Subject|13|||
48809818|NCT03516942|157143599|FG000|T1: 3 Months Survey|Death|10|||
48809819|NCT03516942|157143599|FG000|T1: 3 Months Survey|Lost|163|||
48809820|NCT03516942|157143599|FG000|T2: 6 Month Survey|Withdrawal by Subject|15|||
48809821|NCT03516942|157143599|FG000|T2: 6 Month Survey|Death|14|||
48809822|NCT03516942|157143599|FG000|T2: 6 Month Survey|Lost|180|||
48809823|NCT03516942|157143599|FG000|T3: 12 Month Survey|Withdrawal by Subject|15|||
48809824|NCT03516942|157143599|FG000|T3: 12 Month Survey|Death|19|||
48809825|NCT03516942|157143599|FG000|T3: 12 Month Survey|Lost|209|||
48809826|NCT00041756|157144459|FG000|Overall Study|Adverse Event|4|||
48809827|NCT00041756|157144460|FG001|Overall Study|Adverse Event|10|||
48809828|NCT00041756|157144461|FG002|Overall Study|Adverse Event|6|||
48809829|NCT00041756|157144462|FG003|Overall Study|Adverse Event|11|||
48809830|NCT00041756|157144463|FG004|Overall Study|Adverse Event|34|||
48711399|NCT00337675|156793207|FG001|Overall Study|Lack of Efficacy|7|||
48809831|NCT00041756|157144459|FG000|Overall Study|Protocol Violation|1|||
48809832|NCT00041756|157144460|FG001|Overall Study|Protocol Violation|1|||
48809833|NCT00041756|157144461|FG002|Overall Study|Protocol Violation|2|||
48711400|NCT00337675|156793208|FG002|Overall Study|Lack of Efficacy|9|||
48711401|NCT00337675|156793206|FG000|Overall Study|Lost to Follow-up|22|||
48809834|NCT00041756|157144462|FG003|Overall Study|Protocol Violation|2|||
48809835|NCT00041756|157144463|FG004|Overall Study|Protocol Violation|1|||
48809836|NCT00041756|157144459|FG000|Overall Study|Withdrawal by Subject|3|||
48711402|NCT00337675|156793207|FG001|Overall Study|Lost to Follow-up|19|||
48809837|NCT00041756|157144460|FG001|Overall Study|Withdrawal by Subject|3|||
48809838|NCT00041756|157144461|FG002|Overall Study|Withdrawal by Subject|4|||
48809839|NCT00041756|157144462|FG003|Overall Study|Withdrawal by Subject|2|||
48809840|NCT00041756|157144463|FG004|Overall Study|Withdrawal by Subject|3|||
48711403|NCT00337675|156793208|FG002|Overall Study|Lost to Follow-up|17|||
48809841|NCT00041756|157144459|FG000|Overall Study|Lost to Follow-up|0|||
48918328|NCT01006265|157537730|FG002|Overall Study|Withdrawal by Subject|5|||
48809842|NCT00041756|157144460|FG001|Overall Study|Lost to Follow-up|1|||
48809843|NCT00041756|157144461|FG002|Overall Study|Lost to Follow-up|0|||
48809844|NCT00041756|157144462|FG003|Overall Study|Lost to Follow-up|1|||
48809845|NCT00041756|157144463|FG004|Overall Study|Lost to Follow-up|0|||
48809846|NCT00041756|157144459|FG000|Overall Study|Unable to meet protocol criteria|0|||
48809847|NCT00041756|157144460|FG001|Overall Study|Unable to meet protocol criteria|0|||
48809848|NCT00041756|157144461|FG002|Overall Study|Unable to meet protocol criteria|1|||
48809849|NCT00041756|157144462|FG003|Overall Study|Unable to meet protocol criteria|0|||
48809850|NCT00041756|157144463|FG004|Overall Study|Unable to meet protocol criteria|1|||
48809851|NCT00041756|157144459|FG000|Overall Study|Data Monitoring Committee Recommendation|0|||
48809852|NCT00041756|157144460|FG001|Overall Study|Data Monitoring Committee Recommendation|0|||
48918329|NCT01006265|157537731|FG003|Overall Study|Withdrawal by Subject|5|||
48918330|NCT01006265|157537728|FG000|Overall Study|Administrative reason|1|||
48918331|NCT01006265|157537729|FG001|Overall Study|Administrative reason|2|||
48918332|NCT01006265|157537730|FG002|Overall Study|Administrative reason|3|||
48918333|NCT01006265|157537731|FG003|Overall Study|Administrative reason|0|||
48918334|NCT04191382|157537734|FG000|Overall Study|Withdrawal by Subject|1|||
48918335|NCT04191382|157537735|FG001|Overall Study|Withdrawal by Subject|0|||
48918336|NCT04191382|157537736|FG002|Overall Study|Withdrawal by Subject|0|||
48918337|NCT00708500|157537738|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
48918338|NCT00708500|157537739|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3|||
48918339|NCT00708500|157537740|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
48918340|NCT00708500|157537738|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1|||
48918341|NCT00708500|157537739|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
48918342|NCT00708500|157537740|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
48918343|NCT00708500|157537738|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
48918344|NCT00708500|157537739|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1|||
48918345|NCT00708500|157537740|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
48918346|NCT00708500|157537738|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
48918347|NCT00708500|157537739|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2|||
48918348|NCT00708500|157537740|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
48918349|NCT00708500|157537738|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
48918350|NCT00708500|157537739|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
48918351|NCT00708500|157537740|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1|||
48918352|NCT00708500|157537738|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1|||
48918353|NCT00708500|157537739|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10|||
48918354|NCT00708500|157537740|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19|||
48918355|NCT00708500|157537738|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49|||
48918356|NCT00708500|157537739|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36|||
48918357|NCT00708500|157537740|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29|||
48918358|NCT00708500|157537738|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
48918359|NCT00708500|157537739|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1|||
48809853|NCT00041756|157144461|FG002|Overall Study|Data Monitoring Committee Recommendation|0|||
48809854|NCT00041756|157144462|FG003|Overall Study|Data Monitoring Committee Recommendation|0|||
48809855|NCT00041756|157144463|FG004|Overall Study|Data Monitoring Committee Recommendation|21|||
48809856|NCT03980184|157144464|FG000|Overall Study|Dropped out before treatment|2|||
48809857|NCT03980184|157144465|FG001|Overall Study|Dropped out before treatment|2|||
48809858|NCT03980184|157144464|FG000|Overall Study|Lost to Follow-up|11|||
48809859|NCT03980184|157144465|FG001|Overall Study|Lost to Follow-up|13|||
48809860|NCT00482274|157144466|FG000|Overall Study|Adverse Event|1|||
48809861|NCT02440594|157144467|FG000|Overall Study|Lost to Follow-up|34|||
48809862|NCT02440594|157144468|FG001|Overall Study|Lost to Follow-up|33|||
48918360|NCT00708500|157537740|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
48918361|NCT00708500|157537738|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3|||
48918362|NCT00708500|157537739|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1|||
48918363|NCT00708500|157537740|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4|||
48918364|NCT00708500|157537738|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2|||
48918365|NCT00708500|157537739|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0|||
48918366|NCT00708500|157537740|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1|||
48918367|NCT00708500|157537738|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0|||
48918368|NCT00708500|157537739|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2|||
48809863|NCT02440594|157144469|FG002|Overall Study|Lost to Follow-up|54|||
48918369|NCT00708500|157537740|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1|||
48918370|NCT00708500|157537738|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0|||
48918371|NCT00708500|157537739|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
48809864|NCT02440594|157144470|FG003|Overall Study|Lost to Follow-up|47|||
48918372|NCT00708500|157537740|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
48918373|NCT00708500|157537738|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
48918374|NCT00708500|157537739|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1|||
48918375|NCT00708500|157537740|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
48918376|NCT00708500|157537738|FG000|FOLLOWUP|Adverse Event|0|||
48918377|NCT00708500|157537739|FG001|FOLLOWUP|Adverse Event|1|||
48918378|NCT00708500|157537740|FG002|FOLLOWUP|Adverse Event|0|||
48918379|NCT00708500|157537738|FG000|FOLLOWUP|Lost to Follow-up|1|||
48918380|NCT00708500|157537739|FG001|FOLLOWUP|Lost to Follow-up|6|||
48918381|NCT00708500|157537740|FG002|FOLLOWUP|Lost to Follow-up|4|||
48918382|NCT00708500|157537738|FG000|FOLLOWUP|Subject withdrawal unrelated to Tx|3|||
48918383|NCT00708500|157537739|FG001|FOLLOWUP|Subject withdrawal unrelated to Tx|4|||
48918384|NCT00708500|157537740|FG002|FOLLOWUP|Subject withdrawal unrelated to Tx|5|||
48918385|NCT00708500|157537738|FG000|FOLLOWUP|Subject withdrew consent|31|||
48918386|NCT00708500|157537739|FG001|FOLLOWUP|Subject withdrew consent|4|||
48918387|NCT00708500|157537740|FG002|FOLLOWUP|Subject withdrew consent|5|||
48918388|NCT00708500|157537738|FG000|FOLLOWUP|Non-compliance with protocol|5|||
48918389|NCT00708500|157537739|FG001|FOLLOWUP|Non-compliance with protocol|0|||
48918390|NCT00708500|157537740|FG002|FOLLOWUP|Non-compliance with protocol|1|||
48918391|NCT00440947|157537755|FG000|36-Week Induction Phase|Adverse Event|16|||
48918392|NCT00440947|157537756|FG001|36-Week Induction Phase|Adverse Event|0|||
48918393|NCT00440947|157537757|FG002|36-Week Induction Phase|Adverse Event|0|||
48918394|NCT00440947|157537758|FG003|36-Week Induction Phase|Adverse Event|0|||
48918395|NCT00440947|157537759|FG004|36-Week Induction Phase|Adverse Event|0|||
48918396|NCT00440947|157537755|FG000|36-Week Induction Phase|Insufficient Viral Load Response|11|||
48918397|NCT00440947|157537756|FG001|36-Week Induction Phase|Insufficient Viral Load Response|0|||
48918398|NCT00440947|157537757|FG002|36-Week Induction Phase|Insufficient Viral Load Response|0|||
48711404|NCT00337675|156793206|FG000|Overall Study|Physician Decision|9|||
48918399|NCT00440947|157537758|FG003|36-Week Induction Phase|Insufficient Viral Load Response|0|||
48918400|NCT00440947|157537759|FG004|36-Week Induction Phase|Insufficient Viral Load Response|0|||
48918401|NCT00440947|157537755|FG000|36-Week Induction Phase|Protocol-defined Virologic Failure|5|||
48918402|NCT00440947|157537756|FG001|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
48711405|NCT00337675|156793207|FG001|Overall Study|Physician Decision|17|||
48711406|NCT00337675|156793208|FG002|Overall Study|Physician Decision|14|||
48711407|NCT00337675|156793206|FG000|Overall Study|Protocol Violation|21|||
48711408|NCT00337675|156793207|FG001|Overall Study|Protocol Violation|24|||
48711409|NCT00337675|156793208|FG002|Overall Study|Protocol Violation|19|||
48711410|NCT00337675|156793206|FG000|Overall Study|Withdrawal by Subject|25|||
48711411|NCT00337675|156793207|FG001|Overall Study|Withdrawal by Subject|25|||
48711412|NCT00337675|156793208|FG002|Overall Study|Withdrawal by Subject|19|||
48711413|NCT00337675|156793206|FG000|Overall Study|Progressive Disease|0|||
48711414|NCT00337675|156793207|FG001|Overall Study|Progressive Disease|2|||
48711415|NCT00337675|156793208|FG002|Overall Study|Progressive Disease|0|||
48711416|NCT00337675|156793206|FG000|Overall Study|Trial Terminated|0|||
48711417|NCT00337675|156793207|FG001|Overall Study|Trial Terminated|0|||
48809865|NCT02440594|157144471|FG004|Overall Study|Lost to Follow-up|5|||
48809866|NCT02440594|157144472|FG005|Overall Study|Lost to Follow-up|4|||
48809867|NCT02440594|157144473|FG006|Overall Study|Lost to Follow-up|28|||
48809868|NCT02440594|157144474|FG007|Overall Study|Lost to Follow-up|48|||
48809869|NCT02440594|157144467|FG000|Overall Study|Cognitive Impairment/Communication Issue|14|||
48809870|NCT02440594|157144468|FG001|Overall Study|Cognitive Impairment/Communication Issue|6|||
48809871|NCT02440594|157144469|FG002|Overall Study|Cognitive Impairment/Communication Issue|4|||
48809872|NCT02440594|157144470|FG003|Overall Study|Cognitive Impairment/Communication Issue|4|||
48809873|NCT02440594|157144471|FG004|Overall Study|Cognitive Impairment/Communication Issue|2|||
48809874|NCT02440594|157144472|FG005|Overall Study|Cognitive Impairment/Communication Issue|1|||
48809875|NCT02440594|157144473|FG006|Overall Study|Cognitive Impairment/Communication Issue|0|||
48809876|NCT02440594|157144474|FG007|Overall Study|Cognitive Impairment/Communication Issue|0|||
48809877|NCT02440594|157144467|FG000|Overall Study|Withdrawal by Subject|81|||
48809878|NCT02440594|157144468|FG001|Overall Study|Withdrawal by Subject|67|||
48809879|NCT02440594|157144469|FG002|Overall Study|Withdrawal by Subject|59|||
48809880|NCT02440594|157144470|FG003|Overall Study|Withdrawal by Subject|38|||
48809881|NCT02440594|157144471|FG004|Overall Study|Withdrawal by Subject|2|||
48809882|NCT02440594|157144472|FG005|Overall Study|Withdrawal by Subject|2|||
48809883|NCT02440594|157144473|FG006|Overall Study|Withdrawal by Subject|7|||
48809884|NCT02440594|157144474|FG007|Overall Study|Withdrawal by Subject|7|||
48809885|NCT02440594|157144467|FG000|Overall Study|Administratively w/drawn|3|||
48809886|NCT02440594|157144468|FG001|Overall Study|Administratively w/drawn|2|||
48809887|NCT02440594|157144469|FG002|Overall Study|Administratively w/drawn|0|||
48809888|NCT02440594|157144470|FG003|Overall Study|Administratively w/drawn|0|||
48809889|NCT02440594|157144471|FG004|Overall Study|Administratively w/drawn|0|||
48809890|NCT02440594|157144472|FG005|Overall Study|Administratively w/drawn|0|||
48809891|NCT02440594|157144473|FG006|Overall Study|Administratively w/drawn|2|||
48809892|NCT02440594|157144474|FG007|Overall Study|Administratively w/drawn|1|||
48809893|NCT04250337|157144475|FG000|Overall Study|Adverse Event|0|||
48809894|NCT04250337|157144476|FG001|Overall Study|Adverse Event|3|||
48809895|NCT04250337|157144475|FG000|Overall Study|Lack of Efficacy|1|||
48809896|NCT04250337|157144476|FG001|Overall Study|Lack of Efficacy|3|||
48809897|NCT04250337|157144475|FG000|Overall Study|Physician Decision|1|||
48809898|NCT04250337|157144476|FG001|Overall Study|Physician Decision|0|||
48809899|NCT04250337|157144475|FG000|Overall Study|Protocol Deviation|2|||
48809900|NCT04250337|157144476|FG001|Overall Study|Protocol Deviation|2|||
48809901|NCT04250337|157144475|FG000|Overall Study|Withdrawal by Subject|4|||
48809902|NCT04250337|157144476|FG001|Overall Study|Withdrawal by Subject|3|||
48809903|NCT00641719|157144477|FG000|Overall Study|Lack of Efficacy|1|||
48809904|NCT00641719|157144478|FG001|Overall Study|Lack of Efficacy|2|||
48809905|NCT00641719|157144477|FG000|Overall Study|Adverse Event|24|||
48809906|NCT00641719|157144478|FG001|Overall Study|Adverse Event|29|||
48809907|NCT00641719|157144477|FG000|Overall Study|Withdrawal by Subject|4|||
48809908|NCT00641719|157144478|FG001|Overall Study|Withdrawal by Subject|4|||
48809909|NCT00641719|157144477|FG000|Overall Study|Reason Not Specified|1|||
48809910|NCT00641719|157144478|FG001|Overall Study|Reason Not Specified|2|||
48809911|NCT00885352|157144479|FG000|Overall Study|Adverse Event|2|||
48809912|NCT00885352|157144480|FG001|Overall Study|Adverse Event|3|||
48809913|NCT00885352|157144479|FG000|Overall Study|Lost to Follow-up|2|||
48809914|NCT00885352|157144480|FG001|Overall Study|Lost to Follow-up|2|||
48809915|NCT00885352|157144479|FG000|Overall Study|Physician Decision|0|||
48809916|NCT00885352|157144480|FG001|Overall Study|Physician Decision|3|||
48809917|NCT00885352|157144479|FG000|Overall Study|Protocol Violation|0|||
48918403|NCT00440947|157537757|FG002|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
48918404|NCT00440947|157537758|FG003|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
48918405|NCT00440947|157537759|FG004|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
48918406|NCT00440947|157537755|FG000|36-Week Induction Phase|Non-compliance|10|||
48918407|NCT00440947|157537756|FG001|36-Week Induction Phase|Non-compliance|0|||
48918408|NCT00440947|157537757|FG002|36-Week Induction Phase|Non-compliance|0|||
48918409|NCT00440947|157537758|FG003|36-Week Induction Phase|Non-compliance|0|||
48918410|NCT00440947|157537759|FG004|36-Week Induction Phase|Non-compliance|0|||
48918411|NCT00440947|157537755|FG000|36-Week Induction Phase|Lost to Follow-up|16|||
48918412|NCT00440947|157537756|FG001|36-Week Induction Phase|Lost to Follow-up|0|||
48918413|NCT00440947|157537757|FG002|36-Week Induction Phase|Lost to Follow-up|0|||
48918414|NCT00440947|157537758|FG003|36-Week Induction Phase|Lost to Follow-up|0|||
48918415|NCT00440947|157537759|FG004|36-Week Induction Phase|Lost to Follow-up|0|||
48918416|NCT00440947|157537755|FG000|36-Week Induction Phase|Withdrawal by Subject|7|||
48809918|NCT00885352|157144480|FG001|Overall Study|Protocol Violation|2|||
48809919|NCT00885352|157144479|FG000|Overall Study|Withdrawal by Subject|1|||
48809920|NCT00885352|157144480|FG001|Overall Study|Withdrawal by Subject|5|||
48809921|NCT00885352|157144479|FG000|Overall Study|Contradiction to study medication|0|||
48809922|NCT00885352|157144480|FG001|Overall Study|Contradiction to study medication|2|||
48809923|NCT00885352|157144479|FG000|Overall Study|Excluded medication|2|||
48809924|NCT00885352|157144480|FG001|Overall Study|Excluded medication|2|||
48711418|NCT00337675|156793208|FG002|Overall Study|Trial Terminated|2|||
48711419|NCT02350478|156793218|FG000|Overall Study|Lost to Follow-up|5|||
48711420|NCT02350478|156793219|FG001|Overall Study|Lost to Follow-up|1|||
48711421|NCT02223858|156793220|FG000|Overall Study|Death|1|||
48711422|NCT02223858|156793221|FG001|Overall Study|Death|1|||
48711423|NCT02223858|156793220|FG000|Overall Study|Lost to Follow-up|6|||
48711424|NCT02223858|156793221|FG001|Overall Study|Lost to Follow-up|11|||
48711425|NCT02223858|156793220|FG000|Overall Study|Withdrawal by Subject|8|||
48711426|NCT02223858|156793221|FG001|Overall Study|Withdrawal by Subject|5|||
48711427|NCT02223858|156793220|FG000|Overall Study|Refused|9|||
48711428|NCT02223858|156793221|FG001|Overall Study|Refused|9|||
48711429|NCT03565497|156793222|FG000|Overall Study|COVID-19 halt to human subjects research|0|||
48711430|NCT03565497|156793223|FG001|Overall Study|COVID-19 halt to human subjects research|1|||
48711431|NCT03565497|156793224|FG002|Overall Study|COVID-19 halt to human subjects research|1|||
48711432|NCT03565497|156793222|FG000|Overall Study|Lost to Follow-up|1|||
48711433|NCT03565497|156793223|FG001|Overall Study|Lost to Follow-up|1|||
48711434|NCT03565497|156793224|FG002|Overall Study|Lost to Follow-up|2|||
48711435|NCT03565497|156793222|FG000|Overall Study|Withdrawal by Subject|1|||
48711436|NCT03565497|156793223|FG001|Overall Study|Withdrawal by Subject|1|||
48711437|NCT03565497|156793224|FG002|Overall Study|Withdrawal by Subject|1|||
48711438|NCT00380367|156793225|FG000|Overall Study|Lost to Follow-up|1|||
48711439|NCT00380367|156793225|FG000|Overall Study|Withdrawal by Subject|1|||
48711440|NCT02238080|156793226|FG000|Overall Study|Death|13|||
48711441|NCT02238080|156793226|FG000|Overall Study|Treatment interrupted|6|||
48711442|NCT02238080|156793226|FG000|Overall Study|Withdrawal by Subject|2|||
48711443|NCT02238080|156793226|FG000|Overall Study|Other|4|||
48711444|NCT01519869|156793237|FG000|Overall Study|Lost to Follow-up|1|||
48711445|NCT02920242|156793246|FG000|Overall Study|Withdrawal by Subject|1|||
48711446|NCT02920242|156793247|FG001|Overall Study|Withdrawal by Subject|0|||
48711447|NCT02920242|156793248|FG002|Overall Study|Withdrawal by Subject|1|||
48711448|NCT02920242|156793246|FG000|Overall Study|Did not meet inc./exc. criteria|1|||
48711449|NCT02920242|156793247|FG001|Overall Study|Did not meet inc./exc. criteria|0|||
48711450|NCT02920242|156793248|FG002|Overall Study|Did not meet inc./exc. criteria|0|||
48711451|NCT01474018|156793249|FG000|Overall Study|Lost to Follow-up|0|||
48711452|NCT01474018|156793250|FG001|Overall Study|Lost to Follow-up|1|||
48711453|NCT01474018|156793249|FG000|Overall Study|Withdrawal by Subject|0|||
48711454|NCT01474018|156793250|FG001|Overall Study|Withdrawal by Subject|2|||
48711455|NCT02433080|156793252|FG000|Overall Study|Lost to Follow-up|1|||
48711456|NCT02433080|156793253|FG001|Overall Study|Lost to Follow-up|2|||
48711457|NCT02433080|156793252|FG000|Overall Study|Withdrawal by Subject|0|||
48711458|NCT02433080|156793253|FG001|Overall Study|Withdrawal by Subject|2|||
48711459|NCT00486291|156793259|FG000|Overall Study|Adverse Event|3|||
48711460|NCT00486291|156793260|FG001|Overall Study|Adverse Event|4|||
48711461|NCT00486291|156793259|FG000|Overall Study|Lost to Follow-up|3|||
48711462|NCT00486291|156793260|FG001|Overall Study|Lost to Follow-up|7|||
48711463|NCT00486291|156793259|FG000|Overall Study|protocol non-compliance|10|||
48711464|NCT00486291|156793260|FG001|Overall Study|protocol non-compliance|15|||
48711465|NCT00486291|156793259|FG000|Overall Study|requirement for restricted medication|0|||
48711466|NCT00486291|156793260|FG001|Overall Study|requirement for restricted medication|3|||
48711467|NCT00126490|156793265|FG000|Overall Study|Stopped after 1 infusion (fall/injury)|1|||
48711468|NCT00759564|156793271|FG000|Washout Period (at Least 14 Days)|Adverse Event|0|||
48711469|NCT00759564|156793272|FG001|Washout Period (at Least 14 Days)|Adverse Event|0|||
48711470|NCT00759564|156793273|FG002|Washout Period (at Least 14 Days)|Adverse Event|0|||
48711471|NCT00759564|156793274|FG003|Washout Period (at Least 14 Days)|Adverse Event|0|||
48711472|NCT00759564|156793275|FG004|Washout Period (at Least 14 Days)|Adverse Event|1|||
48711473|NCT02657408|156793281|FG000|Overall Study|Adverse Event|3|||
48711474|NCT02657408|156793282|FG001|Overall Study|Adverse Event|7|||
48711475|NCT00080899|156793292|FG000|Overall Study|Adverse Event|1|||
48711476|NCT02872935|156793293|FG000|Overall Study|Other|0|||
48711477|NCT02872935|156793294|FG001|Overall Study|Other|1|||
48711478|NCT03237286|156793295|FG000|Overall Study|Withdrawal by Subject|1|||
48711479|NCT03237286|156793296|FG001|Overall Study|Withdrawal by Subject|0|||
48711480|NCT03237286|156793297|FG002|Overall Study|Withdrawal by Subject|2|||
48711481|NCT03237286|156793295|FG000|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
48711482|NCT03237286|156793296|FG001|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
48711483|NCT03237286|156793297|FG002|Overall Study|Study withdrew participant due to repeated non-compliance|1|||
48711484|NCT03783078|156793298|FG000|Overall Study|Death|31|||
48711485|NCT03783078|156793298|FG000|Overall Study|Sponsor Decision|23|||
48711486|NCT03783078|156793298|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
48711487|NCT01519167|156793299|FG000|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0|||
48711488|NCT01519167|156793300|FG001|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3|||
48711489|NCT01519167|156793299|FG000|Overall Study|Adverse Event|0|||
48711490|NCT01519167|156793300|FG001|Overall Study|Adverse Event|1|||
48711491|NCT01519167|156793299|FG000|Overall Study|Lack of Efficacy|0|||
48711492|NCT01519167|156793300|FG001|Overall Study|Lack of Efficacy|1|||
48918417|NCT00440947|157537756|FG001|36-Week Induction Phase|Withdrawal by Subject|0|||
48918418|NCT00440947|157537757|FG002|36-Week Induction Phase|Withdrawal by Subject|0|||
48918419|NCT00440947|157537758|FG003|36-Week Induction Phase|Withdrawal by Subject|0|||
48918420|NCT00440947|157537759|FG004|36-Week Induction Phase|Withdrawal by Subject|0|||
48918421|NCT00440947|157537755|FG000|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1|||
48918422|NCT00440947|157537756|FG001|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
48918423|NCT00440947|157537757|FG002|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
48918424|NCT00440947|157537758|FG003|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
48918425|NCT00440947|157537759|FG004|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
48918426|NCT00440947|157537755|FG000|36-Week Induction Phase|Took Exclusionary Medications|1|||
48918427|NCT00440947|157537756|FG001|36-Week Induction Phase|Took Exclusionary Medications|0|||
48918428|NCT00440947|157537757|FG002|36-Week Induction Phase|Took Exclusionary Medications|0|||
48918429|NCT00440947|157537758|FG003|36-Week Induction Phase|Took Exclusionary Medications|0|||
48918430|NCT00440947|157537759|FG004|36-Week Induction Phase|Took Exclusionary Medications|0|||
48918431|NCT00440947|157537755|FG000|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1|||
48918432|NCT00440947|157537756|FG001|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
48918433|NCT00440947|157537757|FG002|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
49120806|NCT02326272|158280508|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
49120807|NCT02326272|158280509|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48711493|NCT01519167|156793299|FG000|Overall Study|Medical condition changes&deep sedation|0|||
48711494|NCT01519167|156793300|FG001|Overall Study|Medical condition changes&deep sedation|2|||
48711495|NCT01519167|156793299|FG000|Overall Study|Physician Decision|0|||
48711496|NCT01519167|156793300|FG001|Overall Study|Physician Decision|1|||
48711497|NCT03304249|156793303|FG000|Overall Study|Lost to Follow-up|8|||
48711498|NCT03304249|156793304|FG001|Overall Study|Lost to Follow-up|10|||
48711499|NCT03304249|156793303|FG000|Overall Study|Withdrawal by Subject|12|||
48711500|NCT03304249|156793304|FG001|Overall Study|Withdrawal by Subject|2|||
48711501|NCT03304249|156793303|FG000|Overall Study|Moved Out of District|4|||
48711502|NCT03304249|156793304|FG001|Overall Study|Moved Out of District|2|||
48711503|NCT01601652|156793305|FG000|Overall Study|Death|1|||
48711504|NCT00777153|156794841|FG000|Overall Study|Lost to Follow-up|1|||
48711505|NCT00777153|156794842|FG001|Overall Study|Lost to Follow-up|1|||
48711506|NCT00777153|156794843|FG002|Overall Study|Lost to Follow-up|0|||
48711507|NCT00777153|156794841|FG000|Overall Study|Death|85|||
48711508|NCT00777153|156794842|FG001|Overall Study|Death|73|||
48711509|NCT00777153|156794843|FG002|Overall Study|Death|33|||
48711510|NCT00777153|156794841|FG000|Overall Study|Withdrawal by Subject|3|||
48711511|NCT00777153|156794842|FG001|Overall Study|Withdrawal by Subject|4|||
48711512|NCT00777153|156794843|FG002|Overall Study|Withdrawal by Subject|3|||
48711513|NCT00777153|156794841|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
48711514|NCT00777153|156794842|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|5|||
48711515|NCT00777153|156794843|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
48711516|NCT01354899|156794844|FG000|Overall Study|discharge from the hospital|2|||
48711517|NCT01354899|156794844|FG000|Overall Study|Protocol Violation|1|||
48711518|NCT00479687|156794845|FG000|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
48711519|NCT00479687|156794846|FG001|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2|||
48711520|NCT00479687|156794847|FG002|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
48711521|NCT00479687|156794845|FG000|Ph 1: Blinded, Randomized, Controlled|Death|0|||
48711522|NCT00479687|156794846|FG001|Ph 1: Blinded, Randomized, Controlled|Death|1|||
48711523|NCT00479687|156794847|FG002|Ph 1: Blinded, Randomized, Controlled|Death|0|||
48711524|NCT00479687|156794845|FG000|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4|||
48711525|NCT00479687|156794846|FG001|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5|||
48711526|NCT00479687|156794847|FG002|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0|||
48711527|NCT00479687|156794845|FG000|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2|||
48711528|NCT00479687|156794846|FG001|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
48711529|NCT00479687|156794847|FG002|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
48711530|NCT00479687|156794845|FG000|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19|||
48711531|NCT00479687|156794846|FG001|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11|||
48711532|NCT00479687|156794847|FG002|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0|||
48711533|NCT00479687|156794845|FG000|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
48711534|NCT00479687|156794846|FG001|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
48711535|NCT00479687|156794847|FG002|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4|||
48711536|NCT00479687|156794845|FG000|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
48711537|NCT00479687|156794846|FG001|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
48711538|NCT00479687|156794847|FG002|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3|||
48711539|NCT00479687|156794845|FG000|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
48711540|NCT00479687|156794846|FG001|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
48711541|NCT00479687|156794847|FG002|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1|||
48711542|NCT00479687|156794845|FG000|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
48711543|NCT00479687|156794846|FG001|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
48711544|NCT00479687|156794847|FG002|Ph 2: Open Label, Single (Supartz) Arm|Death|1|||
48711545|NCT00295880|156794848|FG000|Overall Study|IBMI unit could not be volume reduced|1|||
48711546|NCT00295880|156794848|FG000|Overall Study|Unit randomization did not occur|1|||
48711547|NCT01235741|156794851|FG000|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9|||
48711548|NCT01235741|156794852|FG001|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
48711549|NCT01235741|156794853|FG002|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
48711550|NCT01235741|156794851|FG000|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121|||
48711551|NCT01235741|156794852|FG001|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
48809925|NCT00885352|157144479|FG000|Overall Study|Lab abnormalities|1|||
48809926|NCT00885352|157144480|FG001|Overall Study|Lab abnormalities|1|||
48809927|NCT00365378|157144481|FG000|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11|||
48809928|NCT00365378|157144482|FG001|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7|||
48809929|NCT00365378|157144483|FG002|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
48809930|NCT00365378|157144481|FG000|Vaccination (Day 1 to Month 7)|Adverse Event|4|||
48809931|NCT00365378|157144482|FG001|Vaccination (Day 1 to Month 7)|Adverse Event|5|||
48809932|NCT00365378|157144483|FG002|Vaccination (Day 1 to Month 7)|Adverse Event|0|||
48809933|NCT00365378|157144481|FG000|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88|||
48809934|NCT00365378|157144482|FG001|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75|||
48809935|NCT00365378|157144483|FG002|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0|||
48809936|NCT00365378|157144481|FG000|Vaccination (Day 1 to Month 7)|Pregnancy|19|||
48809937|NCT00365378|157144482|FG001|Vaccination (Day 1 to Month 7)|Pregnancy|14|||
48809938|NCT00365378|157144483|FG002|Vaccination (Day 1 to Month 7)|Pregnancy|0|||
48809939|NCT00365378|157144481|FG000|Vaccination (Day 1 to Month 7)|Protocol Violation|22|||
48809940|NCT00365378|157144482|FG001|Vaccination (Day 1 to Month 7)|Protocol Violation|13|||
48809941|NCT00365378|157144483|FG002|Vaccination (Day 1 to Month 7)|Protocol Violation|0|||
48809942|NCT00365378|157144481|FG000|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50|||
48809943|NCT00365378|157144482|FG001|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44|||
48809944|NCT00365378|157144483|FG002|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0|||
48809945|NCT00365378|157144481|FG000|Vaccination (Day 1 to Month 7)|Other|17|||
48809946|NCT00365378|157144482|FG001|Vaccination (Day 1 to Month 7)|Other|9|||
48809947|NCT00365378|157144483|FG002|Vaccination (Day 1 to Month 7)|Other|0|||
48809948|NCT00365378|157144481|FG000|Follow-up (Month 7 Though Month 48)|Moved|6|||
48918434|NCT00440947|157537758|FG003|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
48918435|NCT00440947|157537759|FG004|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
49120808|NCT02326272|158280510|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
49120809|NCT02326272|158280511|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
49120810|NCT02326272|158280512|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
49120811|NCT02326272|158280513|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
49120812|NCT02326272|158280514|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
49120813|NCT02326272|158280515|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
49120814|NCT02326272|158280516|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
49120815|NCT02326272|158280517|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
49120816|NCT02326272|158280518|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
49120817|NCT02326272|158280519|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
49120818|NCT02326272|158280520|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
49120819|NCT02326272|158280521|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
49120820|NCT02326272|158280522|FG014|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
49120821|NCT02326272|158280508|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
49120822|NCT02326272|158280509|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
49120823|NCT02326272|158280510|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
49120824|NCT02326272|158280511|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
49120825|NCT02326272|158280512|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
49120826|NCT02326272|158280513|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
49120827|NCT02326272|158280514|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
49120828|NCT02326272|158280515|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
49120829|NCT02326272|158280516|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
49120830|NCT02326272|158280517|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
49120831|NCT02326272|158280518|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
49120832|NCT02326272|158280519|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|1|||
49120833|NCT02326272|158280520|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
49120834|NCT02326272|158280521|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
48711552|NCT01235741|156794853|FG002|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
48809949|NCT00365378|157144482|FG001|Follow-up (Month 7 Though Month 48)|Moved|5|||
48809950|NCT00365378|157144483|FG002|Follow-up (Month 7 Though Month 48)|Moved|0|||
48711553|NCT01235741|156794851|FG000|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1|||
48711554|NCT01235741|156794852|FG001|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
48711555|NCT01235741|156794853|FG002|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
48711556|NCT01235741|156794851|FG000|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1|||
48711557|NCT01235741|156794852|FG001|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
48711558|NCT01235741|156794853|FG002|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
48711559|NCT01235741|156794851|FG000|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5|||
48711560|NCT01235741|156794852|FG001|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
48711561|NCT01235741|156794853|FG002|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
48711562|NCT01235741|156794851|FG000|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4|||
48711563|NCT01235741|156794852|FG001|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
48742939|NCT01550289|156910420|FG001|Overall Study|Withdrawal by Subject|3|||
48742940|NCT02469298|156910422|FG000|Overall Study|Protocol Violation|0|||
48742941|NCT02469298|156910423|FG001|Overall Study|Protocol Violation|1|||
48742942|NCT02469298|156910424|FG002|Overall Study|Protocol Violation|1|||
48742943|NCT02469298|156910425|FG003|Overall Study|Protocol Violation|0|||
48742944|NCT02469298|156910422|FG000|Overall Study|Lost to Follow-up|1|||
48742945|NCT02469298|156910423|FG001|Overall Study|Lost to Follow-up|0|||
48742946|NCT02469298|156910424|FG002|Overall Study|Lost to Follow-up|1|||
48742947|NCT02469298|156910425|FG003|Overall Study|Lost to Follow-up|0|||
48742948|NCT02469298|156910422|FG000|Overall Study|Physician Decision|0|||
48742949|NCT02469298|156910423|FG001|Overall Study|Physician Decision|0|||
48742950|NCT02469298|156910424|FG002|Overall Study|Physician Decision|0|||
48742951|NCT02469298|156910425|FG003|Overall Study|Physician Decision|1|||
48742952|NCT02469298|156910422|FG000|Overall Study|Withdrawal by Subject|0|||
48742953|NCT02469298|156910423|FG001|Overall Study|Withdrawal by Subject|0|||
48742954|NCT02469298|156910424|FG002|Overall Study|Withdrawal by Subject|0|||
48742955|NCT02469298|156910425|FG003|Overall Study|Withdrawal by Subject|1|||
48742956|NCT02955602|156910430|FG000|Overall Study|Adverse Event|0|||
48742957|NCT02955602|156910431|FG001|Overall Study|Adverse Event|3|||
48742958|NCT02955602|156910432|FG002|Overall Study|Adverse Event|0|||
48742959|NCT02955602|156910430|FG000|Overall Study|Withdrawal of informed consent|1|||
48742960|NCT02955602|156910431|FG001|Overall Study|Withdrawal of informed consent|3|||
48742961|NCT02955602|156910432|FG002|Overall Study|Withdrawal of informed consent|2|||
48742962|NCT02955602|156910430|FG000|Overall Study|Lost to Follow-up|0|||
48742963|NCT02955602|156910431|FG001|Overall Study|Lost to Follow-up|0|||
48742964|NCT02955602|156910432|FG002|Overall Study|Lost to Follow-up|1|||
48742965|NCT02955602|156910430|FG000|Overall Study|Other|0|||
48742966|NCT02955602|156910431|FG001|Overall Study|Other|1|||
48742967|NCT02955602|156910432|FG002|Overall Study|Other|3|||
48742968|NCT00844831|156910433|FG000|Overall Study|Withdrawal by Subject|4|||
48742969|NCT00844831|156910433|FG000|Overall Study|Adverse Event|1|||
48742970|NCT00844831|156910433|FG000|Overall Study|Physician Decision|1|||
48742971|NCT04015336|156910446|FG000|Overall Study|Participant signed consent and was later deemed a screen failure. Participant was not treated|1|||
48742972|NCT02478632|156910449|FG000|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4|||
48742973|NCT02478632|156910450|FG001|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5|||
48742974|NCT02478632|156910449|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2|||
48742975|NCT02478632|156910450|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3|||
48742976|NCT02478632|156910449|FG000|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5|||
48742977|NCT02478632|156910450|FG001|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1|||
48742978|NCT04678661|156910451|FG000|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|17|||
48742979|NCT04678661|156910452|FG001|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|0|||
48742980|NCT04678661|156910451|FG000|Overall Study|Protocol Violation|2|||
48742981|NCT04678661|156910452|FG001|Overall Study|Protocol Violation|0|||
48742982|NCT04678661|156910451|FG000|Overall Study|Withdrawal by Subject|1|||
48742983|NCT04678661|156910452|FG001|Overall Study|Withdrawal by Subject|0|||
48742984|NCT04678661|156910451|FG000|Overall Study|Lost to Follow-up|2|||
48742985|NCT04678661|156910452|FG001|Overall Study|Lost to Follow-up|0|||
48742986|NCT04678661|156910451|FG000|Overall Study|Death|2|||
48742987|NCT04678661|156910452|FG001|Overall Study|Death|0|||
48742988|NCT01086033|156910453|FG000|Overall Study|Lack of efficacy/Exacerbation of RA|86|||
48742989|NCT01086033|156910453|FG000|Overall Study|Lost to Follow-up|86|||
48742990|NCT01086033|156910453|FG000|Overall Study|Adverse Event|42|||
48742991|NCT01086033|156910453|FG000|Overall Study|Withdrawal by Subject|41|||
48742992|NCT01086033|156910453|FG000|Overall Study|Other|14|||
48742993|NCT01086033|156910453|FG000|Overall Study|Other|13|||
48742994|NCT01086033|156910453|FG000|Overall Study|AE and Withdrew Consent|5|||
48742995|NCT01086033|156910453|FG000|Overall Study|Withdrew Consent and Lack of Efficacy|5|||
48742996|NCT01086033|156910453|FG000|Overall Study|Withdrew consent and Other Reason|4|||
48711564|NCT01235741|156794853|FG002|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
48711565|NCT01235741|156794851|FG000|Randomized to Treatment|Withdrawal by Subject|0|||
48711566|NCT01235741|156794852|FG001|Randomized to Treatment|Withdrawal by Subject|0|||
48711567|NCT01235741|156794853|FG002|Randomized to Treatment|Withdrawal by Subject|1|||
48711568|NCT01235741|156794851|FG000|Randomized to Treatment|Adverse Event|0|||
48711569|NCT01235741|156794852|FG001|Randomized to Treatment|Adverse Event|1|||
48711570|NCT01235741|156794853|FG002|Randomized to Treatment|Adverse Event|1|||
48711571|NCT01235741|156794851|FG000|Randomized to Treatment|Sponsor terminated study|0|||
48711572|NCT01235741|156794852|FG001|Randomized to Treatment|Sponsor terminated study|35|||
48711573|NCT01235741|156794853|FG002|Randomized to Treatment|Sponsor terminated study|34|||
48711574|NCT01235741|156794851|FG000|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0|||
48711575|NCT01235741|156794852|FG001|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3|||
48711576|NCT01235741|156794853|FG002|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6|||
48711577|NCT01235741|156794851|FG000|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0|||
48711578|NCT01235741|156794852|FG001|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5|||
48711579|NCT01235741|156794853|FG002|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1|||
48711580|NCT01235741|156794851|FG000|Follow-Up Post Treatment up to Month 6|Other|0|||
48711581|NCT01235741|156794852|FG001|Follow-Up Post Treatment up to Month 6|Other|1|||
48711582|NCT01235741|156794853|FG002|Follow-Up Post Treatment up to Month 6|Other|0|||
48711583|NCT00539864|156794858|FG000|Overall Study|Lost to Follow-up|0|||
48711584|NCT00539864|156794859|FG001|Overall Study|Lost to Follow-up|1|||
48711585|NCT00539864|156794858|FG000|Overall Study|Withdrawal by Subject|1|||
48711586|NCT00539864|156794859|FG001|Overall Study|Withdrawal by Subject|1|||
48711587|NCT01250145|156794860|FG000|Overall Study|Adverse Event|2|||
48711588|NCT01250145|156794861|FG001|Overall Study|Adverse Event|1|||
48711589|NCT01250145|156794860|FG000|Overall Study|Withdrawal by Subject|0|||
48711590|NCT01250145|156794861|FG001|Overall Study|Withdrawal by Subject|4|||
48711591|NCT02273596|156794862|FG000|24-Week Treatment Period|Adverse Event|3|||
48711592|NCT02273596|156794862|FG000|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1|||
48711593|NCT02273596|156794862|FG000|24-Week Treatment Period|Participant was unable to Come|1|||
48711594|NCT02273596|156794862|FG000|24-Week Treatment Period|Physician Decision|1|||
48711595|NCT02273596|156794862|FG000|24-Week Treatment Period|Protocol Deviation|1|||
48711596|NCT02273596|156794862|FG000|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19|||
48711597|NCT02273596|156794862|FG000|Extension Period|Participant Withdrew for Personal Reasons|1|||
48711598|NCT02273596|156794862|FG000|Extension Period|Lost to Follow-up|1|||
48809951|NCT00365378|157144481|FG000|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67|||
48809952|NCT00365378|157144482|FG001|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69|||
48809953|NCT00365378|157144483|FG002|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0|||
48809954|NCT00365378|157144481|FG000|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
48809955|NCT00365378|157144482|FG001|Follow-up (Month 7 Though Month 48)|Pregnancy|1|||
48809956|NCT00365378|157144483|FG002|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
48809957|NCT00365378|157144481|FG000|Follow-up (Month 7 Though Month 48)|Protocol Violation|1|||
48809958|NCT00365378|157144482|FG001|Follow-up (Month 7 Though Month 48)|Protocol Violation|2|||
49120835|NCT02326272|158280522|FG014|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
49120836|NCT02326272|158280508|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
49120837|NCT02326272|158280509|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48809959|NCT00365378|157144483|FG002|Follow-up (Month 7 Though Month 48)|Protocol Violation|0|||
48809960|NCT00365378|157144481|FG000|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73|||
48711599|NCT02273596|156794862|FG000|Extension Period|Protocol Deviation|1|||
48711600|NCT02604160|156794863|FG000|Overall Study|Protocol Violation|0|||
48809961|NCT00365378|157144482|FG001|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104|||
48809962|NCT00365378|157144483|FG002|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0|||
48809963|NCT00365378|157144481|FG000|Follow-up (Month 7 Though Month 48)|Other|11|||
48809964|NCT00365378|157144482|FG001|Follow-up (Month 7 Though Month 48)|Other|21|||
48809965|NCT00365378|157144483|FG002|Follow-up (Month 7 Though Month 48)|Other|0|||
48809966|NCT00365378|157144481|FG000|Extension|Adverse Event|0|||
48809967|NCT00365378|157144482|FG001|Extension|Adverse Event|0|||
48809968|NCT00365378|157144483|FG002|Extension|Adverse Event|1|||
48918436|NCT00440947|157537755|FG000|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1|||
48711601|NCT02604160|156794864|FG001|Overall Study|Protocol Violation|1|||
48711602|NCT02604160|156794863|FG000|Overall Study|Physician Decision|0|||
49120838|NCT02326272|158280510|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48711603|NCT02604160|156794864|FG001|Overall Study|Physician Decision|1|||
48711604|NCT04610281|156794865|FG000|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|1|||
48711605|NCT04610281|156794866|FG001|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|4|||
48711606|NCT01088048|156794867|FG000|Overall Study|Adverse Event|7|||
48711607|NCT01088048|156794868|FG001|Overall Study|Adverse Event|9|||
48711608|NCT01088048|156794869|FG002|Overall Study|Adverse Event|7|||
48809969|NCT00365378|157144481|FG000|Extension|Moved|0|||
48809970|NCT00365378|157144482|FG001|Extension|Moved|0|||
48809971|NCT00365378|157144483|FG002|Extension|Moved|8|||
48809972|NCT00365378|157144481|FG000|Extension|Lost to Follow-up|0|||
48809973|NCT00365378|157144482|FG001|Extension|Lost to Follow-up|0|||
48809974|NCT00365378|157144483|FG002|Extension|Lost to Follow-up|57|||
48809975|NCT00365378|157144481|FG000|Extension|Protocol Violation|0|||
48809976|NCT00365378|157144482|FG001|Extension|Protocol Violation|0|||
48809977|NCT00365378|157144483|FG002|Extension|Protocol Violation|2|||
48809978|NCT00365378|157144481|FG000|Extension|Withdrawal by Subject|0|||
48809979|NCT00365378|157144482|FG001|Extension|Withdrawal by Subject|0|||
48809980|NCT00365378|157144483|FG002|Extension|Withdrawal by Subject|98|||
48809981|NCT00365378|157144481|FG000|Extension|Other|0|||
48809982|NCT00365378|157144482|FG001|Extension|Other|0|||
48809983|NCT00365378|157144483|FG002|Extension|Other|31|||
48809984|NCT02693834|157144484|FG000|Baseline Measurement|Withdrawal by Subject|1|||
48711609|NCT01088048|156794870|FG003|Overall Study|Adverse Event|5|||
48711610|NCT01088048|156794871|FG004|Overall Study|Adverse Event|6|||
48711611|NCT01088048|156794872|FG005|Overall Study|Adverse Event|3|||
48711612|NCT01088048|156794873|FG006|Overall Study|Adverse Event|3|||
48711613|NCT01088048|156794874|FG007|Overall Study|Adverse Event|0|||
48711614|NCT01088048|156794875|FG008|Overall Study|Adverse Event|2|||
48711615|NCT01088048|156794876|FG009|Overall Study|Adverse Event|2|||
48711616|NCT01088048|156794867|FG000|Overall Study|Withdrew Consent|1|||
48711617|NCT01088048|156794868|FG001|Overall Study|Withdrew Consent|1|||
48711618|NCT01088048|156794869|FG002|Overall Study|Withdrew Consent|1|||
48711619|NCT01088048|156794870|FG003|Overall Study|Withdrew Consent|1|||
48809985|NCT02693834|157144485|FG001|Baseline Measurement|Withdrawal by Subject|0|||
48809986|NCT02693834|157144484|FG000|Baseline Measurement|Adverse Event|1|||
48809987|NCT02693834|157144485|FG001|Baseline Measurement|Adverse Event|0|||
48809988|NCT02693834|157144484|FG000|Week 2 Practice|Adverse Event|0|||
48809989|NCT02693834|157144485|FG001|Week 2 Practice|Adverse Event|1|||
48809990|NCT02441946|157144492|FG000|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
48809991|NCT02441946|157144493|FG001|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
48809992|NCT02441946|157144494|FG002|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0|||
48809993|NCT02441946|157144492|FG000|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1|||
48809994|NCT02441946|157144493|FG001|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
48809995|NCT02441946|157144494|FG002|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
48809996|NCT02441946|157144492|FG000|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
48809997|NCT02441946|157144493|FG001|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3|||
48809998|NCT02441946|157144494|FG002|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
48809999|NCT02441946|157144492|FG000|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
48810000|NCT02441946|157144493|FG001|Cycle 1 Period 1 (2 Weeks)|Never Treated|1|||
48810001|NCT02441946|157144494|FG002|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
48711620|NCT01088048|156794871|FG004|Overall Study|Withdrew Consent|2|||
48711621|NCT01088048|156794872|FG005|Overall Study|Withdrew Consent|1|||
48711622|NCT01088048|156794873|FG006|Overall Study|Withdrew Consent|0|||
48711623|NCT01088048|156794874|FG007|Overall Study|Withdrew Consent|2|||
48711624|NCT01088048|156794875|FG008|Overall Study|Withdrew Consent|2|||
48810002|NCT02441946|157144492|FG000|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15|||
48810003|NCT02441946|157144493|FG001|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
48810004|NCT02441946|157144494|FG002|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
48810005|NCT02441946|157144492|FG000|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1|||
48810006|NCT02441946|157144493|FG001|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
48810007|NCT02441946|157144494|FG002|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
48810008|NCT02441946|157144492|FG000|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1|||
48810009|NCT02441946|157144493|FG001|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
48810010|NCT02441946|157144494|FG002|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
48810011|NCT02441946|157144492|FG000|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1|||
48810012|NCT02441946|157144493|FG001|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
48810013|NCT02441946|157144494|FG002|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
48810014|NCT02441946|157144492|FG000|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9|||
48810015|NCT02441946|157144493|FG001|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
48810016|NCT02441946|157144494|FG002|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
48711625|NCT01088048|156794876|FG009|Overall Study|Withdrew Consent|1|||
48810017|NCT02441946|157144492|FG000|Extension Period (8 Weeks)|Adverse Event|1|||
48810018|NCT02441946|157144493|FG001|Extension Period (8 Weeks)|Adverse Event|0|||
48810019|NCT02441946|157144494|FG002|Extension Period (8 Weeks)|Adverse Event|0|||
48810020|NCT02441946|157144492|FG000|Extension Period (8 Weeks)|Withdrawal by Subject|1|||
48810021|NCT02441946|157144493|FG001|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
48810022|NCT02441946|157144494|FG002|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
48810023|NCT01719224|157144495|FG000|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4|||
48711626|NCT01088048|156794867|FG000|Overall Study|Concomitant Medication Prohibited|1|||
48711627|NCT01088048|156794868|FG001|Overall Study|Concomitant Medication Prohibited|0|||
48810024|NCT01719224|157144496|FG001|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2|||
48711628|NCT01088048|156794869|FG002|Overall Study|Concomitant Medication Prohibited|0|||
48711629|NCT01088048|156794870|FG003|Overall Study|Concomitant Medication Prohibited|0|||
48711630|NCT01088048|156794871|FG004|Overall Study|Concomitant Medication Prohibited|0|||
48711631|NCT01088048|156794872|FG005|Overall Study|Concomitant Medication Prohibited|0|||
48711632|NCT01088048|156794873|FG006|Overall Study|Concomitant Medication Prohibited|0|||
48711633|NCT01088048|156794874|FG007|Overall Study|Concomitant Medication Prohibited|0|||
48711634|NCT01088048|156794875|FG008|Overall Study|Concomitant Medication Prohibited|0|||
48711635|NCT01088048|156794876|FG009|Overall Study|Concomitant Medication Prohibited|0|||
48711636|NCT01088048|156794867|FG000|Overall Study|Investigator Request|2|||
48711637|NCT01088048|156794868|FG001|Overall Study|Investigator Request|2|||
48711638|NCT01088048|156794869|FG002|Overall Study|Investigator Request|0|||
48810025|NCT00879996|157144498|FG000|Overall Study|Lost to Follow-up|7|||
48810026|NCT00879996|157144499|FG001|Overall Study|Lost to Follow-up|6|||
48810027|NCT00879996|157144498|FG000|Overall Study|non-compliance|6|||
48810028|NCT00879996|157144499|FG001|Overall Study|non-compliance|4|||
48810029|NCT00879996|157144498|FG000|Overall Study|Physician Decision|1|||
48918437|NCT00440947|157537756|FG001|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
48918438|NCT00440947|157537757|FG002|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
48918439|NCT00440947|157537758|FG003|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
48918440|NCT00440947|157537759|FG004|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
48918441|NCT00440947|157537755|FG000|36-Week Induction Phase|Incarceration|3|||
48918442|NCT00440947|157537756|FG001|36-Week Induction Phase|Incarceration|0|||
48918443|NCT00440947|157537757|FG002|36-Week Induction Phase|Incarceration|0|||
48711639|NCT01088048|156794870|FG003|Overall Study|Investigator Request|0|||
48711640|NCT01088048|156794871|FG004|Overall Study|Investigator Request|3|||
48711641|NCT01088048|156794872|FG005|Overall Study|Investigator Request|1|||
48711642|NCT01088048|156794873|FG006|Overall Study|Investigator Request|1|||
48711643|NCT01088048|156794874|FG007|Overall Study|Investigator Request|0|||
48711644|NCT01088048|156794875|FG008|Overall Study|Investigator Request|0|||
48810030|NCT00879996|157144499|FG001|Overall Study|Physician Decision|2|||
48810031|NCT00879996|157144498|FG000|Overall Study|psychiatric problem|0|||
48810032|NCT00879996|157144499|FG001|Overall Study|psychiatric problem|1|||
48810033|NCT00879996|157144498|FG000|Overall Study|put on parole|1|||
48810034|NCT00879996|157144499|FG001|Overall Study|put on parole|0|||
48810035|NCT00423852|157144500|FG000|Overall Study|Removed pior to the high-dose portion|3|||
48810036|NCT00980005|157144501|FG000|Overall Study|Withdrawal by Subject|6|||
48810037|NCT00980005|157144502|FG001|Overall Study|Withdrawal by Subject|17|||
48810038|NCT00980005|157144501|FG000|Overall Study|Lost to Follow-up|37|||
48810039|NCT00980005|157144502|FG001|Overall Study|Lost to Follow-up|43|||
48810040|NCT00980005|157144501|FG000|Overall Study|Other|4|||
48810041|NCT00980005|157144502|FG001|Overall Study|Other|3|||
48810042|NCT02307513|157144506|FG000|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4|||
48810043|NCT02307513|157144507|FG001|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3|||
48810044|NCT02307513|157144506|FG000|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8|||
48810045|NCT02307513|157144507|FG001|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0|||
48810046|NCT02307513|157144506|FG000|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1|||
48810047|NCT02307513|157144507|FG001|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0|||
48810048|NCT02307513|157144506|FG000|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5|||
48810049|NCT02307513|157144507|FG001|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4|||
48810050|NCT02307513|157144506|FG000|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1|||
48810051|NCT02307513|157144507|FG001|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0|||
48810052|NCT02307513|157144506|FG000|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
48810053|NCT02307513|157144507|FG001|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
48810054|NCT02307513|157144506|FG000|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0|||
48810055|NCT02307513|157144507|FG001|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1|||
48810056|NCT02307513|157144506|FG000|Active Treatment Phase (Weeks 13-64)|Adverse Event|4|||
48810057|NCT02307513|157144507|FG001|Active Treatment Phase (Weeks 13-64)|Adverse Event|9|||
48810058|NCT02307513|157144506|FG000|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
48810059|NCT02307513|157144507|FG001|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
48810060|NCT02307513|157144506|FG000|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
48810061|NCT02307513|157144507|FG001|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
48810062|NCT02307513|157144506|FG000|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
48810063|NCT02307513|157144507|FG001|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
48810064|NCT02307513|157144506|FG000|Active Treatment Phase (Weeks 13-64)|Pregnancy|1|||
48810065|NCT02307513|157144507|FG001|Active Treatment Phase (Weeks 13-64)|Pregnancy|0|||
48810066|NCT02307513|157144506|FG000|Long-term Extension|Physician Decision|1|||
48810067|NCT02307513|157144507|FG001|Long-term Extension|Physician Decision|0|||
48918444|NCT00440947|157537758|FG003|36-Week Induction Phase|Incarceration|0|||
48918445|NCT00440947|157537759|FG004|36-Week Induction Phase|Incarceration|0|||
48918446|NCT00440947|157537755|FG000|36-Week Induction Phase|Pregnancy|1|||
48918447|NCT00440947|157537756|FG001|36-Week Induction Phase|Pregnancy|0|||
48918448|NCT00440947|157537757|FG002|36-Week Induction Phase|Pregnancy|0|||
48711645|NCT01088048|156794876|FG009|Overall Study|Investigator Request|0|||
48918449|NCT00440947|157537758|FG003|36-Week Induction Phase|Pregnancy|0|||
48918450|NCT00440947|157537759|FG004|36-Week Induction Phase|Pregnancy|0|||
48918451|NCT00440947|157537755|FG000|48-Week Randomization Phase|Adverse Event|0|||
48918452|NCT00440947|157537756|FG001|48-Week Randomization Phase|Adverse Event|2|||
48918453|NCT00440947|157537757|FG002|48-Week Randomization Phase|Adverse Event|5|||
48918454|NCT00440947|157537758|FG003|48-Week Randomization Phase|Adverse Event|0|||
48918455|NCT00440947|157537759|FG004|48-Week Randomization Phase|Adverse Event|0|||
48918456|NCT00440947|157537755|FG000|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
48918457|NCT00440947|157537756|FG001|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
48918458|NCT00440947|157537757|FG002|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
48918459|NCT00440947|157537758|FG003|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
48918460|NCT00440947|157537759|FG004|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
48918461|NCT00440947|157537755|FG000|48-Week Randomization Phase|Non-compliance|0|||
48918462|NCT00440947|157537756|FG001|48-Week Randomization Phase|Non-compliance|3|||
48918463|NCT00440947|157537757|FG002|48-Week Randomization Phase|Non-compliance|4|||
48918464|NCT00440947|157537758|FG003|48-Week Randomization Phase|Non-compliance|0|||
48918465|NCT00440947|157537759|FG004|48-Week Randomization Phase|Non-compliance|0|||
48918466|NCT00440947|157537755|FG000|48-Week Randomization Phase|Lost to Follow-up|0|||
48918467|NCT00440947|157537756|FG001|48-Week Randomization Phase|Lost to Follow-up|2|||
48918468|NCT00440947|157537757|FG002|48-Week Randomization Phase|Lost to Follow-up|8|||
48918469|NCT00440947|157537758|FG003|48-Week Randomization Phase|Lost to Follow-up|0|||
48918470|NCT00440947|157537759|FG004|48-Week Randomization Phase|Lost to Follow-up|0|||
48918471|NCT00440947|157537755|FG000|48-Week Randomization Phase|Protocol Violation|0|||
48918472|NCT00440947|157537756|FG001|48-Week Randomization Phase|Protocol Violation|0|||
48918473|NCT00440947|157537757|FG002|48-Week Randomization Phase|Protocol Violation|1|||
48918474|NCT00440947|157537758|FG003|48-Week Randomization Phase|Protocol Violation|0|||
48918475|NCT00440947|157537759|FG004|48-Week Randomization Phase|Protocol Violation|0|||
48918476|NCT00440947|157537755|FG000|48-Week Randomization Phase|Withdrawal by Subject|0|||
48918477|NCT00440947|157537756|FG001|48-Week Randomization Phase|Withdrawal by Subject|2|||
48918478|NCT00440947|157537757|FG002|48-Week Randomization Phase|Withdrawal by Subject|4|||
48918479|NCT00440947|157537758|FG003|48-Week Randomization Phase|Withdrawal by Subject|0|||
48918480|NCT00440947|157537759|FG004|48-Week Randomization Phase|Withdrawal by Subject|0|||
48918481|NCT00440947|157537755|FG000|48-Week Randomization Phase|Pregnancy|0|||
48918482|NCT00440947|157537756|FG001|48-Week Randomization Phase|Pregnancy|0|||
48918483|NCT00440947|157537757|FG002|48-Week Randomization Phase|Pregnancy|1|||
48918484|NCT00440947|157537758|FG003|48-Week Randomization Phase|Pregnancy|0|||
48918485|NCT00440947|157537759|FG004|48-Week Randomization Phase|Pregnancy|0|||
48918486|NCT00440947|157537755|FG000|48-Week Randomization Phase|Incarceration|0|||
48918487|NCT00440947|157537756|FG001|48-Week Randomization Phase|Incarceration|3|||
48918488|NCT00440947|157537757|FG002|48-Week Randomization Phase|Incarceration|0|||
48918489|NCT00440947|157537758|FG003|48-Week Randomization Phase|Incarceration|0|||
48918490|NCT00440947|157537759|FG004|48-Week Randomization Phase|Incarceration|0|||
48918491|NCT00440947|157537755|FG000|48-Week Randomization Phase|Trying to Get Pregnant|0|||
48918492|NCT00440947|157537756|FG001|48-Week Randomization Phase|Trying to Get Pregnant|1|||
48918493|NCT00440947|157537757|FG002|48-Week Randomization Phase|Trying to Get Pregnant|0|||
48918494|NCT00440947|157537758|FG003|48-Week Randomization Phase|Trying to Get Pregnant|0|||
48918495|NCT00440947|157537759|FG004|48-Week Randomization Phase|Trying to Get Pregnant|0|||
48918496|NCT00440947|157537755|FG000|48-Week Randomization Phase|Physician Decision|0|||
48918497|NCT00440947|157537756|FG001|48-Week Randomization Phase|Physician Decision|2|||
48918498|NCT00440947|157537757|FG002|48-Week Randomization Phase|Physician Decision|0|||
48918499|NCT00440947|157537758|FG003|48-Week Randomization Phase|Physician Decision|0|||
48918500|NCT00440947|157537759|FG004|48-Week Randomization Phase|Physician Decision|0|||
48918501|NCT00440947|157537755|FG000|Optional 60-Week Extension Phase|Adverse Event|0|||
48918502|NCT00440947|157537756|FG001|Optional 60-Week Extension Phase|Adverse Event|0|||
48918503|NCT00440947|157537757|FG002|Optional 60-Week Extension Phase|Adverse Event|0|||
48918504|NCT00440947|157537758|FG003|Optional 60-Week Extension Phase|Adverse Event|1|||
48918505|NCT00440947|157537759|FG004|Optional 60-Week Extension Phase|Adverse Event|3|||
48918506|NCT00440947|157537755|FG000|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
48918507|NCT00440947|157537756|FG001|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
48918508|NCT00440947|157537757|FG002|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
48918509|NCT00440947|157537758|FG003|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
48711646|NCT01088048|156794867|FG000|Overall Study|Patient Non-compliance|0|||
48711647|NCT01088048|156794868|FG001|Overall Study|Patient Non-compliance|1|||
48918510|NCT00440947|157537759|FG004|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
48918511|NCT00440947|157537755|FG000|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
48918512|NCT00440947|157537756|FG001|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
48918513|NCT00440947|157537757|FG002|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
48918514|NCT00440947|157537758|FG003|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3|||
48918515|NCT00440947|157537759|FG004|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2|||
49120839|NCT02326272|158280511|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
49120840|NCT02326272|158280512|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
49120841|NCT02326272|158280513|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48711648|NCT01088048|156794869|FG002|Overall Study|Patient Non-compliance|0|||
48711649|NCT01088048|156794870|FG003|Overall Study|Patient Non-compliance|0|||
48711650|NCT01088048|156794871|FG004|Overall Study|Patient Non-compliance|0|||
48711651|NCT01088048|156794872|FG005|Overall Study|Patient Non-compliance|0|||
49120842|NCT02326272|158280514|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
49120843|NCT02326272|158280515|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
49120844|NCT02326272|158280516|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
49120845|NCT02326272|158280517|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48711652|NCT01088048|156794873|FG006|Overall Study|Patient Non-compliance|0|||
48711653|NCT01088048|156794874|FG007|Overall Study|Patient Non-compliance|0|||
48711654|NCT01088048|156794875|FG008|Overall Study|Patient Non-compliance|0|||
48711655|NCT01088048|156794876|FG009|Overall Study|Patient Non-compliance|0|||
48711656|NCT01088048|156794867|FG000|Overall Study|Disease Progression|7|||
48711657|NCT01088048|156794868|FG001|Overall Study|Disease Progression|4|||
48711658|NCT01088048|156794869|FG002|Overall Study|Disease Progression|3|||
48711659|NCT01088048|156794870|FG003|Overall Study|Disease Progression|5|||
48711660|NCT01088048|156794871|FG004|Overall Study|Disease Progression|3|||
48711661|NCT01088048|156794872|FG005|Overall Study|Disease Progression|3|||
48711662|NCT01088048|156794873|FG006|Overall Study|Disease Progression|2|||
48711663|NCT01088048|156794874|FG007|Overall Study|Disease Progression|1|||
48711664|NCT01088048|156794875|FG008|Overall Study|Disease Progression|0|||
48711665|NCT01088048|156794876|FG009|Overall Study|Disease Progression|0|||
48711666|NCT01088048|156794867|FG000|Overall Study|Death|1|||
48711667|NCT01088048|156794868|FG001|Overall Study|Death|5|||
48711668|NCT01088048|156794869|FG002|Overall Study|Death|3|||
48711669|NCT01088048|156794870|FG003|Overall Study|Death|3|||
48711670|NCT01088048|156794871|FG004|Overall Study|Death|1|||
48711671|NCT01088048|156794872|FG005|Overall Study|Death|3|||
48711672|NCT01088048|156794873|FG006|Overall Study|Death|0|||
48711673|NCT01088048|156794874|FG007|Overall Study|Death|0|||
48711674|NCT01088048|156794875|FG008|Overall Study|Death|3|||
48711675|NCT01088048|156794876|FG009|Overall Study|Death|1|||
48711676|NCT01088048|156794867|FG000|Overall Study|Other|3|||
48711677|NCT01088048|156794868|FG001|Overall Study|Other|5|||
48711678|NCT01088048|156794869|FG002|Overall Study|Other|0|||
48711679|NCT01088048|156794870|FG003|Overall Study|Other|0|||
48711680|NCT01088048|156794871|FG004|Overall Study|Other|2|||
48711681|NCT01088048|156794872|FG005|Overall Study|Other|0|||
49120846|NCT02326272|158280518|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
49120847|NCT02326272|158280519|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48711682|NCT01088048|156794873|FG006|Overall Study|Other|0|||
48711683|NCT01088048|156794874|FG007|Overall Study|Other|2|||
48711684|NCT01088048|156794875|FG008|Overall Study|Other|0|||
48711685|NCT01088048|156794876|FG009|Overall Study|Other|0|||
48711686|NCT00488683|156794877|FG000|Overall Study|Withdrawal by Subject|1|||
48711687|NCT00488683|156794878|FG001|Overall Study|Withdrawal by Subject|2|||
48711688|NCT00488683|156794879|FG002|Overall Study|Withdrawal by Subject|2|||
48711689|NCT00488683|156794877|FG000|Overall Study|Lost to Follow-up|5|||
48711690|NCT00488683|156794878|FG001|Overall Study|Lost to Follow-up|3|||
48711691|NCT00488683|156794879|FG002|Overall Study|Lost to Follow-up|0|||
48711692|NCT00488683|156794877|FG000|Overall Study|Protocol Violation|5|||
48711693|NCT00488683|156794878|FG001|Overall Study|Protocol Violation|1|||
48711694|NCT00488683|156794879|FG002|Overall Study|Protocol Violation|0|||
48711695|NCT00488683|156794877|FG000|Overall Study|Unable to Classify|1|||
48711696|NCT00488683|156794878|FG001|Overall Study|Unable to Classify|0|||
48711697|NCT00488683|156794879|FG002|Overall Study|Unable to Classify|0|||
48711698|NCT00970684|156794880|FG000|Overall Study|Lack of Efficacy|5|||
48711699|NCT00970684|156794880|FG000|Overall Study|Adverse Event|4|||
48711700|NCT00970684|156794880|FG000|Overall Study|Withdrawal by Subject|1|||
48711701|NCT00084136|156794881|FG000|PI Comparison|Death|10|||
48711702|NCT00084136|156794882|FG001|PI Comparison|Death|9|||
48711703|NCT00084136|156794883|FG002|PI Comparison|Death|0|||
48711704|NCT00084136|156794881|FG000|PI Comparison|Lost to Follow-up|11|||
48711705|NCT00084136|156794882|FG001|PI Comparison|Lost to Follow-up|8|||
48711706|NCT00084136|156794883|FG002|PI Comparison|Lost to Follow-up|0|||
48918516|NCT00440947|157537755|FG000|Optional 60-Week Extension Phase|Non-compliance|0|||
48918517|NCT00440947|157537756|FG001|Optional 60-Week Extension Phase|Non-compliance|0|||
48918518|NCT00440947|157537757|FG002|Optional 60-Week Extension Phase|Non-compliance|0|||
48918519|NCT00440947|157537758|FG003|Optional 60-Week Extension Phase|Non-compliance|1|||
48918520|NCT00440947|157537759|FG004|Optional 60-Week Extension Phase|Non-compliance|1|||
48918521|NCT00440947|157537755|FG000|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
48810068|NCT00318149|157144521|FG000|Overall Study|Adverse Event|0|||
48810069|NCT00318149|157144522|FG001|Overall Study|Adverse Event|0|||
48810070|NCT00318149|157144523|FG002|Overall Study|Adverse Event|0|||
48810071|NCT00318149|157144524|FG003|Overall Study|Adverse Event|0|||
48810072|NCT00318149|157144525|FG004|Overall Study|Adverse Event|0|||
48810073|NCT00318149|157144526|FG005|Overall Study|Adverse Event|2|||
48810074|NCT04296890|157144527|FG000|Overall Study|Withdrawal by Subject|1|||
48810075|NCT04296890|157144527|FG000|Overall Study|Death|62|||
48810076|NCT04296890|157144527|FG000|Overall Study|Lost to Follow-up|3|||
48810077|NCT04296890|157144527|FG000|Overall Study|Other than specified|2|||
48810078|NCT03734991|157144531|FG000|Overall Study|Adverse Event|4|||
48810079|NCT03734991|157144532|FG001|Overall Study|Adverse Event|0|||
48810080|NCT03734991|157144531|FG000|Overall Study|Lost to Follow-up|4|||
48810081|NCT03734991|157144532|FG001|Overall Study|Lost to Follow-up|0|||
48810082|NCT03734991|157144531|FG000|Overall Study|Physician Decision|0|||
48810083|NCT03734991|157144532|FG001|Overall Study|Physician Decision|1|||
48810084|NCT03734991|157144531|FG000|Overall Study|Pregnancy|1|||
48810085|NCT03734991|157144532|FG001|Overall Study|Pregnancy|0|||
48810086|NCT03734991|157144531|FG000|Overall Study|Withdrawal by Subject|6|||
48810087|NCT03734991|157144532|FG001|Overall Study|Withdrawal by Subject|3|||
48810088|NCT03734991|157144531|FG000|Overall Study|Lack of efficacy and or/use of antifungal therapy|49|||
48810089|NCT03734991|157144532|FG001|Overall Study|Lack of efficacy and or/use of antifungal therapy|41|||
48810090|NCT03734991|157144531|FG000|Overall Study|Other|2|||
48810091|NCT03734991|157144532|FG001|Overall Study|Other|2|||
48810092|NCT04182880|157144533|FG000|Overall Study|Pregnancy|1|||
48810093|NCT04182880|157144534|FG001|Overall Study|Pregnancy|0|||
48810094|NCT02716038|157144535|FG000|Overall Study|Not evaluable|1|||
48918522|NCT00440947|157537756|FG001|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
48918523|NCT00440947|157537757|FG002|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
48918524|NCT00440947|157537758|FG003|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
48918525|NCT00440947|157537759|FG004|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
48918526|NCT00440947|157537755|FG000|Optional 60-Week Extension Phase|Protocol Violation|0|||
48918527|NCT00440947|157537756|FG001|Optional 60-Week Extension Phase|Protocol Violation|0|||
48918528|NCT00440947|157537757|FG002|Optional 60-Week Extension Phase|Protocol Violation|0|||
48918529|NCT00440947|157537758|FG003|Optional 60-Week Extension Phase|Protocol Violation|1|||
48711707|NCT00084136|156794881|FG000|PI Comparison|Withdrawal by Subject|33|||
48711708|NCT00084136|156794882|FG001|PI Comparison|Withdrawal by Subject|30|||
48711709|NCT00084136|156794883|FG002|PI Comparison|Withdrawal by Subject|0|||
48711710|NCT00084136|156794881|FG000|PI Comparison|Clinic site closed|1|||
48711711|NCT00084136|156794882|FG001|PI Comparison|Clinic site closed|0|||
48711712|NCT00084136|156794883|FG002|PI Comparison|Clinic site closed|0|||
48711713|NCT00084136|156794881|FG000|NRTI Comparison|Death|20|||
48711714|NCT00084136|156794882|FG001|NRTI Comparison|Death|0|||
48711715|NCT00084136|156794883|FG002|NRTI Comparison|Death|18|||
48711716|NCT00084136|156794881|FG000|NRTI Comparison|Lost to Follow-up|14|||
48711717|NCT00084136|156794882|FG001|NRTI Comparison|Lost to Follow-up|0|||
48711718|NCT00084136|156794883|FG002|NRTI Comparison|Lost to Follow-up|12|||
48711719|NCT00084136|156794881|FG000|NRTI Comparison|Withdrawal by Subject|54|||
48711720|NCT00084136|156794882|FG001|NRTI Comparison|Withdrawal by Subject|0|||
48711721|NCT00084136|156794883|FG002|NRTI Comparison|Withdrawal by Subject|38|||
48711722|NCT00084136|156794881|FG000|NRTI Comparison|Clinic site closed|12|||
48711723|NCT00084136|156794882|FG001|NRTI Comparison|Clinic site closed|0|||
48711724|NCT00084136|156794883|FG002|NRTI Comparison|Clinic site closed|14|||
48711725|NCT00084136|156794881|FG000|NRTI Comparison|Not reason above|1|||
48711726|NCT00084136|156794882|FG001|NRTI Comparison|Not reason above|0|||
48711727|NCT00084136|156794883|FG002|NRTI Comparison|Not reason above|0|||
48711728|NCT01296672|156794884|FG000|Overall Study|Lost to Follow-up|73|||
48711729|NCT01296672|156794885|FG001|Overall Study|Lost to Follow-up|18|||
48711730|NCT04661579|156794888|FG000|Overall Study|Lost to Follow-up|19|||
48711731|NCT04661579|156794889|FG001|Overall Study|Lost to Follow-up|10|||
48711732|NCT04661579|156794890|FG002|Overall Study|Lost to Follow-up|2|||
48711733|NCT04661579|156794891|FG003|Overall Study|Lost to Follow-up|7|||
48711734|NCT04661579|156794892|FG004|Overall Study|Lost to Follow-up|11|||
48711735|NCT04661579|156794888|FG000|Overall Study|Physician Decision|2|||
48711736|NCT04661579|156794889|FG001|Overall Study|Physician Decision|0|||
48810095|NCT02716038|157144535|FG000|Overall Study|Not brought to surgery due to brain metastasis|1|||
48810096|NCT02716038|157144535|FG000|Overall Study|Unresectable|3|||
48810097|NCT00591864|157144536|FG000|Overall Study|Incomplete Imaging|5|||
48810098|NCT02459093|157144537|FG000|Overall Study|Protocol Violation|6|||
48810099|NCT02459093|157144538|FG001|Overall Study|Protocol Violation|11|||
48810100|NCT02459093|157144537|FG000|Overall Study|Lost to Follow-up|6|||
48810101|NCT02459093|157144538|FG001|Overall Study|Lost to Follow-up|7|||
49120848|NCT02326272|158280520|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
48810102|NCT00383240|157144539|FG000|Overall Study|Adverse Event|4|||
48810103|NCT00383240|157144540|FG001|Overall Study|Adverse Event|6|||
48810104|NCT00383240|157144541|FG002|Overall Study|Adverse Event|9|||
48810105|NCT00383240|157144542|FG003|Overall Study|Adverse Event|7|||
48810106|NCT00383240|157144539|FG000|Overall Study|Treatment Failure|8|||
48810107|NCT00383240|157144540|FG001|Overall Study|Treatment Failure|13|||
48810108|NCT00383240|157144541|FG002|Overall Study|Treatment Failure|47|||
48810109|NCT00383240|157144542|FG003|Overall Study|Treatment Failure|46|||
48810110|NCT00383240|157144539|FG000|Overall Study|Lost to Follow-up|3|||
49120849|NCT02326272|158280521|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
49120850|NCT02326272|158280522|FG014|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
49120851|NCT02326272|158280508|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
49120852|NCT02326272|158280509|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
49120853|NCT02326272|158280510|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48810111|NCT00383240|157144540|FG001|Overall Study|Lost to Follow-up|0|||
48810112|NCT00383240|157144541|FG002|Overall Study|Lost to Follow-up|0|||
48810113|NCT00383240|157144542|FG003|Overall Study|Lost to Follow-up|2|||
48810114|NCT00383240|157144539|FG000|Overall Study|Withdrawal by subject, reasons unrelated|6|||
48810115|NCT00383240|157144540|FG001|Overall Study|Withdrawal by subject, reasons unrelated|3|||
48810116|NCT00383240|157144541|FG002|Overall Study|Withdrawal by subject, reasons unrelated|8|||
48810117|NCT00383240|157144542|FG003|Overall Study|Withdrawal by subject, reasons unrelated|8|||
48856441|NCT02991118|157312856|FG000|Overall Study|Protocol Violation|0|||
48856442|NCT02991118|157312857|FG001|Overall Study|Protocol Violation|3|||
48856443|NCT02991118|157312856|FG000|Overall Study|Physician Decision|0|||
48856444|NCT02991118|157312857|FG001|Overall Study|Physician Decision|1|||
48856445|NCT02991118|157312856|FG000|Overall Study|Moved out of the country|0|||
48856446|NCT02991118|157312857|FG001|Overall Study|Moved out of the country|1|||
48856447|NCT02991118|157312856|FG000|Overall Study|Adverse Event|2|||
48856448|NCT02991118|157312857|FG001|Overall Study|Adverse Event|2|||
48856449|NCT02991118|157312856|FG000|Overall Study|Withdrawal by Subject|1|||
48856450|NCT02991118|157312857|FG001|Overall Study|Withdrawal by Subject|7|||
48856451|NCT02991118|157312856|FG000|Overall Study|Could not attend study visits|0|||
48856452|NCT02991118|157312857|FG001|Overall Study|Could not attend study visits|1|||
48856453|NCT02991118|157312856|FG000|Overall Study|Lost to Follow-up|1|||
48856454|NCT02991118|157312857|FG001|Overall Study|Lost to Follow-up|9|||
48856455|NCT01777932|157312860|FG000|Overall Study|Disease progression|136|||
48856456|NCT01777932|157312860|FG000|Overall Study|Death|3|||
48856457|NCT01777932|157312860|FG000|Overall Study|Adverse Event|34|||
48856458|NCT01777932|157312860|FG000|Overall Study|Lost to Follow-up|3|||
48856459|NCT01777932|157312860|FG000|Overall Study|Investigator decision|10|||
48856460|NCT01777932|157312860|FG000|Overall Study|Reimbursement limit|9|||
48856461|NCT01777932|157312860|FG000|Overall Study|Patient refused further treatment|10|||
48856462|NCT01159600|157312861|FG000|Overall Study|Not treated|0|||
48856463|NCT01159600|157312862|FG001|Overall Study|Not treated|0|||
48856464|NCT01159600|157312863|FG002|Overall Study|Not treated|1|||
48856465|NCT01159600|157312864|FG003|Overall Study|Not treated|0|||
48856466|NCT01159600|157312865|FG004|Overall Study|Not treated|0|||
48856467|NCT01159600|157312866|FG005|Overall Study|Not treated|1|||
48856468|NCT01159600|157312867|FG006|Overall Study|Not treated|2|||
48856469|NCT01159600|157312868|FG007|Overall Study|Not treated|2|||
48856470|NCT01159600|157312861|FG000|Overall Study|Adverse Event|7|||
48856471|NCT01159600|157312862|FG001|Overall Study|Adverse Event|2|||
48856472|NCT01159600|157312863|FG002|Overall Study|Adverse Event|5|||
48856473|NCT01159600|157312864|FG003|Overall Study|Adverse Event|1|||
48856474|NCT01159600|157312865|FG004|Overall Study|Adverse Event|8|||
48856475|NCT01159600|157312866|FG005|Overall Study|Adverse Event|6|||
48856476|NCT01159600|157312867|FG006|Overall Study|Adverse Event|7|||
48856477|NCT01159600|157312868|FG007|Overall Study|Adverse Event|5|||
48856478|NCT01159600|157312861|FG000|Overall Study|Lack of Efficacy|0|||
48856479|NCT01159600|157312862|FG001|Overall Study|Lack of Efficacy|0|||
48856480|NCT01159600|157312863|FG002|Overall Study|Lack of Efficacy|0|||
48856481|NCT01159600|157312864|FG003|Overall Study|Lack of Efficacy|0|||
48856482|NCT01159600|157312865|FG004|Overall Study|Lack of Efficacy|2|||
48856483|NCT01159600|157312866|FG005|Overall Study|Lack of Efficacy|0|||
48856484|NCT01159600|157312867|FG006|Overall Study|Lack of Efficacy|0|||
48856485|NCT01159600|157312868|FG007|Overall Study|Lack of Efficacy|1|||
48856486|NCT01159600|157312861|FG000|Overall Study|Non compliant with protocol|2|||
48856487|NCT01159600|157312862|FG001|Overall Study|Non compliant with protocol|1|||
48856488|NCT01159600|157312863|FG002|Overall Study|Non compliant with protocol|0|||
48856489|NCT01159600|157312864|FG003|Overall Study|Non compliant with protocol|0|||
48856490|NCT01159600|157312865|FG004|Overall Study|Non compliant with protocol|2|||
48856491|NCT01159600|157312866|FG005|Overall Study|Non compliant with protocol|0|||
48856492|NCT01159600|157312867|FG006|Overall Study|Non compliant with protocol|2|||
48856493|NCT01159600|157312868|FG007|Overall Study|Non compliant with protocol|0|||
49120854|NCT02326272|158280511|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
49120855|NCT02326272|158280512|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
49120856|NCT02326272|158280513|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
49120857|NCT02326272|158280514|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
49120858|NCT02326272|158280515|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
49120859|NCT02326272|158280516|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48810118|NCT00383240|157144539|FG000|Overall Study|Withdrawal by subjects, reasons related|0|||
48810119|NCT00383240|157144540|FG001|Overall Study|Withdrawal by subjects, reasons related|1|||
48810120|NCT00383240|157144541|FG002|Overall Study|Withdrawal by subjects, reasons related|3|||
48810121|NCT00383240|157144542|FG003|Overall Study|Withdrawal by subjects, reasons related|5|||
48810122|NCT00383240|157144539|FG000|Overall Study|Protocol Violation|4|||
48810123|NCT00383240|157144540|FG001|Overall Study|Protocol Violation|5|||
48810124|NCT00383240|157144541|FG002|Overall Study|Protocol Violation|9|||
48810125|NCT00383240|157144542|FG003|Overall Study|Protocol Violation|6|||
48810126|NCT00383240|157144539|FG000|Overall Study|Did not meet protocol eligibility|9|||
48810127|NCT00383240|157144540|FG001|Overall Study|Did not meet protocol eligibility|4|||
48810128|NCT00383240|157144541|FG002|Overall Study|Did not meet protocol eligibility|9|||
48810129|NCT00383240|157144542|FG003|Overall Study|Did not meet protocol eligibility|3|||
48810130|NCT00383240|157144539|FG000|Overall Study|Administrative|1|||
48918530|NCT00440947|157537759|FG004|Optional 60-Week Extension Phase|Protocol Violation|0|||
49120860|NCT02326272|158280517|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48918531|NCT00440947|157537755|FG000|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
48918532|NCT00440947|157537756|FG001|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
48918533|NCT00440947|157537757|FG002|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
48918534|NCT00440947|157537758|FG003|Optional 60-Week Extension Phase|Withdrawal by Subject|4|||
49120861|NCT02326272|158280518|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
49120862|NCT02326272|158280519|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
49120863|NCT02326272|158280520|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
49120864|NCT02326272|158280521|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
49120865|NCT02326272|158280522|FG014|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
48810131|NCT00383240|157144540|FG001|Overall Study|Administrative|1|||
48810132|NCT00383240|157144541|FG002|Overall Study|Administrative|0|||
48918535|NCT00440947|157537759|FG004|Optional 60-Week Extension Phase|Withdrawal by Subject|3|||
48918536|NCT00440947|157537755|FG000|Optional 60-Week Extension Phase|Pregnancy|0|||
48918537|NCT00440947|157537756|FG001|Optional 60-Week Extension Phase|Pregnancy|0|||
48918538|NCT00440947|157537757|FG002|Optional 60-Week Extension Phase|Pregnancy|0|||
48918539|NCT00440947|157537758|FG003|Optional 60-Week Extension Phase|Pregnancy|3|||
48918540|NCT00440947|157537759|FG004|Optional 60-Week Extension Phase|Pregnancy|0|||
48918541|NCT00440947|157537755|FG000|Optional 60-Week Extension Phase|Participant Moved|0|||
48918542|NCT00440947|157537756|FG001|Optional 60-Week Extension Phase|Participant Moved|0|||
48918543|NCT00440947|157537757|FG002|Optional 60-Week Extension Phase|Participant Moved|0|||
48918544|NCT00440947|157537758|FG003|Optional 60-Week Extension Phase|Participant Moved|1|||
48918545|NCT00440947|157537759|FG004|Optional 60-Week Extension Phase|Participant Moved|1|||
48918546|NCT00440947|157537755|FG000|Optional 60-Week Extension Phase|Sponsor Request|0|||
48918547|NCT00440947|157537756|FG001|Optional 60-Week Extension Phase|Sponsor Request|0|||
48918548|NCT00440947|157537757|FG002|Optional 60-Week Extension Phase|Sponsor Request|0|||
48918549|NCT00440947|157537758|FG003|Optional 60-Week Extension Phase|Sponsor Request|1|||
48918550|NCT00440947|157537759|FG004|Optional 60-Week Extension Phase|Sponsor Request|1|||
48918551|NCT00440947|157537755|FG000|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
48918552|NCT00440947|157537756|FG001|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
48918553|NCT00440947|157537757|FG002|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
48918554|NCT00440947|157537758|FG003|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
48918555|NCT00440947|157537759|FG004|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
48918556|NCT00440947|157537755|FG000|Optional 60-Week Extension Phase|Other|0|||
48918557|NCT00440947|157537756|FG001|Optional 60-Week Extension Phase|Other|0|||
48918558|NCT00440947|157537757|FG002|Optional 60-Week Extension Phase|Other|0|||
48918559|NCT00440947|157537758|FG003|Optional 60-Week Extension Phase|Other|1|||
48918560|NCT00440947|157537759|FG004|Optional 60-Week Extension Phase|Other|0|||
48918561|NCT00440947|157537755|FG000|Optional 60-Week Extension Phase|Physician Decision|0|||
48918562|NCT00440947|157537756|FG001|Optional 60-Week Extension Phase|Physician Decision|0|||
49120866|NCT02326272|158280508|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
48810133|NCT00383240|157144542|FG003|Overall Study|Administrative|0|||
48810134|NCT01370603|157144543|FG000|Period 1|Adverse Event|5|||
48810135|NCT01370603|157144544|FG001|Period 1|Adverse Event|3|||
48810136|NCT01370603|157144543|FG000|Period 1|Lost to Follow-up|2|||
48810137|NCT01370603|157144544|FG001|Period 1|Lost to Follow-up|0|||
48810138|NCT01370603|157144543|FG000|Period 1|Protocol Violation|2|||
48810139|NCT01370603|157144544|FG001|Period 1|Protocol Violation|2|||
48810140|NCT01370603|157144543|FG000|Period 1|Withdrawal by Subject|5|||
48810141|NCT01370603|157144544|FG001|Period 1|Withdrawal by Subject|5|||
48810142|NCT01370603|157144543|FG000|Crossover Washout|Adverse Event|2|||
48810143|NCT01370603|157144544|FG001|Crossover Washout|Adverse Event|1|||
48810144|NCT01370603|157144543|FG000|Crossover Washout|Lost to Follow-up|2|||
48810145|NCT01370603|157144544|FG001|Crossover Washout|Lost to Follow-up|0|||
48810146|NCT01370603|157144543|FG000|Crossover Washout|Protocol Violation|1|||
48810147|NCT01370603|157144544|FG001|Crossover Washout|Protocol Violation|0|||
48810148|NCT01370603|157144543|FG000|Crossover Washout|Withdrawal by Subject|4|||
48918563|NCT00440947|157537757|FG002|Optional 60-Week Extension Phase|Physician Decision|0|||
49120867|NCT02326272|158280509|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
49120868|NCT02326272|158280510|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
48918564|NCT00440947|157537758|FG003|Optional 60-Week Extension Phase|Physician Decision|0|||
48918565|NCT00440947|157537759|FG004|Optional 60-Week Extension Phase|Physician Decision|1|||
48918566|NCT00440947|157537755|FG000|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
48918567|NCT00440947|157537756|FG001|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
48918568|NCT00440947|157537757|FG002|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
48918569|NCT00440947|157537758|FG003|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
48918570|NCT00440947|157537759|FG004|Optional 60-Week Extension Phase|Participant Remained in Cuba|1|||
48918571|NCT00974675|157537760|FG000|Overall Study|Adverse Event|2|||
48918572|NCT00974675|157537761|FG001|Overall Study|Adverse Event|1|||
48918573|NCT00974675|157537762|FG002|Overall Study|Adverse Event|1|||
48918574|NCT00974675|157537763|FG003|Overall Study|Adverse Event|1|||
48918575|NCT00974675|157537760|FG000|Overall Study|Physician Decision|0|||
48918576|NCT00974675|157537761|FG001|Overall Study|Physician Decision|0|||
48918577|NCT00974675|157537762|FG002|Overall Study|Physician Decision|1|||
48918578|NCT00974675|157537763|FG003|Overall Study|Physician Decision|0|||
48918579|NCT00974675|157537760|FG000|Overall Study|Participant on holiday; unable to attend|0|||
48918580|NCT00974675|157537761|FG001|Overall Study|Participant on holiday; unable to attend|0|||
48918581|NCT00974675|157537762|FG002|Overall Study|Participant on holiday; unable to attend|0|||
48918582|NCT00974675|157537763|FG003|Overall Study|Participant on holiday; unable to attend|1|||
48918583|NCT02121262|157537764|FG000|Overall Study|Adverse Event|6|||
48918584|NCT02121262|157537765|FG001|Overall Study|Adverse Event|3|||
48918585|NCT02121262|157537764|FG000|Overall Study|Lack of Efficacy|3|||
48918586|NCT02121262|157537765|FG001|Overall Study|Lack of Efficacy|0|||
48918587|NCT02121262|157537764|FG000|Overall Study|Personal Reasons|19|||
48918588|NCT02121262|157537765|FG001|Overall Study|Personal Reasons|5|||
48918589|NCT02121262|157537764|FG000|Overall Study|Protocol Violation|1|||
48918590|NCT02121262|157537765|FG001|Overall Study|Protocol Violation|1|||
48918591|NCT02121262|157537764|FG000|Overall Study|Participant Dropped-out|0|||
48918592|NCT02121262|157537765|FG001|Overall Study|Participant Dropped-out|1|||
48918593|NCT02121262|157537764|FG000|Overall Study|Participant was Deemed Unsuitable|1|||
48918594|NCT02121262|157537765|FG001|Overall Study|Participant was Deemed Unsuitable|0|||
48918595|NCT02121262|157537764|FG000|Overall Study|Consent Withdrawn|1|||
48918596|NCT02121262|157537765|FG001|Overall Study|Consent Withdrawn|0|||
48918597|NCT02716987|157537766|FG000|Overall Study|Ligand synthesis failure|0|||
48918598|NCT02716987|157537767|FG001|Overall Study|Ligand synthesis failure|0|||
48918599|NCT02716987|157537768|FG002|Overall Study|Ligand synthesis failure|1|||
48918600|NCT02716987|157537769|FG003|Overall Study|Ligand synthesis failure|0|||
48918601|NCT02716987|157537770|FG004|Overall Study|Ligand synthesis failure|0|||
48918602|NCT02716987|157537771|FG005|Overall Study|Ligand synthesis failure|0|||
48918603|NCT02716987|157537766|FG000|Overall Study|Withdrawal by Subject|0|||
48918604|NCT02716987|157537767|FG001|Overall Study|Withdrawal by Subject|0|||
48918605|NCT02716987|157537768|FG002|Overall Study|Withdrawal by Subject|0|||
48918606|NCT02716987|157537769|FG003|Overall Study|Withdrawal by Subject|0|||
48918607|NCT02716987|157537770|FG004|Overall Study|Withdrawal by Subject|1|||
48918608|NCT02716987|157537771|FG005|Overall Study|Withdrawal by Subject|1|||
48918609|NCT04744207|157537774|FG000|Treatment|Withdrawal by Subject|2|||
48918610|NCT04744207|157537775|FG001|Treatment|Withdrawal by Subject|0|||
49120869|NCT02326272|158280511|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
49120870|NCT02326272|158280512|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
48810149|NCT01370603|157144544|FG001|Crossover Washout|Withdrawal by Subject|1|||
48810150|NCT01370603|157144543|FG000|Crossover Washout|Non-compliance with Study Drug|0|||
48810151|NCT01370603|157144544|FG001|Crossover Washout|Non-compliance with Study Drug|2|||
48918611|NCT04744207|157537774|FG000|Treatment|Adverse Event|1|||
48918612|NCT04744207|157537775|FG001|Treatment|Adverse Event|2|||
49120871|NCT02326272|158280513|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
48810152|NCT01370603|157144543|FG000|Period 2|Adverse Event|1|||
48918613|NCT00117598|157537780|FG000|Prior to Treatment Cross Over|Death|40|||
48918614|NCT00117598|157537781|FG001|Prior to Treatment Cross Over|Death|41|||
48918615|NCT00117598|157537782|FG002|Prior to Treatment Cross Over|Death|37|||
48918616|NCT00117598|157537783|FG003|Prior to Treatment Cross Over|Death|0|||
48918617|NCT00117598|157537784|FG004|Prior to Treatment Cross Over|Death|0|||
49120872|NCT02326272|158280514|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
48810153|NCT01370603|157144544|FG001|Period 2|Adverse Event|4|||
48810154|NCT01370603|157144543|FG000|Period 2|Lost to Follow-up|1|||
48810155|NCT01370603|157144544|FG001|Period 2|Lost to Follow-up|0|||
48810156|NCT01370603|157144543|FG000|Period 2|Withdrawal by Subject|1|||
48810157|NCT01370603|157144544|FG001|Period 2|Withdrawal by Subject|0|||
48810158|NCT03872388|157144546|FG000|Overall Study|Disease Progression|0|||
48810159|NCT03872388|157144547|FG001|Overall Study|Disease Progression|0|||
48810160|NCT03872388|157144548|FG002|Overall Study|Disease Progression|0|||
48810161|NCT03872388|157144549|FG003|Overall Study|Disease Progression|0|||
48810162|NCT03872388|157144550|FG004|Overall Study|Disease Progression|0|||
48810163|NCT03872388|157144551|FG005|Overall Study|Disease Progression|0|||
48810164|NCT03872388|157144552|FG006|Overall Study|Disease Progression|1|||
48810165|NCT03872388|157144553|FG007|Overall Study|Disease Progression|1|||
48810166|NCT03008382|157144554|FG000|Overall Study|Withdrawal by Subject|2|||
48810167|NCT03008382|157144555|FG001|Overall Study|Withdrawal by Subject|5|||
48810168|NCT03008382|157144556|FG002|Overall Study|Withdrawal by Subject|2|||
48810169|NCT03008382|157144557|FG003|Overall Study|Withdrawal by Subject|0|||
48810170|NCT03008382|157144554|FG000|Overall Study|Protocol Violation|1|||
48810171|NCT03008382|157144555|FG001|Overall Study|Protocol Violation|0|||
48810172|NCT03008382|157144556|FG002|Overall Study|Protocol Violation|0|||
48810173|NCT03008382|157144557|FG003|Overall Study|Protocol Violation|0|||
48810174|NCT03008382|157144554|FG000|Overall Study|Withdrew from study but did not withdraw consent|0|||
48810175|NCT03008382|157144555|FG001|Overall Study|Withdrew from study but did not withdraw consent|1|||
48810176|NCT03008382|157144556|FG002|Overall Study|Withdrew from study but did not withdraw consent|0|||
48810177|NCT03008382|157144557|FG003|Overall Study|Withdrew from study but did not withdraw consent|0|||
48810178|NCT03008382|157144554|FG000|Overall Study|Lost to Follow-up|0|||
48810179|NCT03008382|157144555|FG001|Overall Study|Lost to Follow-up|0|||
48810180|NCT03008382|157144556|FG002|Overall Study|Lost to Follow-up|1|||
48810181|NCT03008382|157144557|FG003|Overall Study|Lost to Follow-up|0|||
48810182|NCT03008382|157144554|FG000|Overall Study|Screenfail|0|||
48810183|NCT03008382|157144555|FG001|Overall Study|Screenfail|0|||
48810184|NCT03008382|157144556|FG002|Overall Study|Screenfail|2|||
48810185|NCT03008382|157144557|FG003|Overall Study|Screenfail|0|||
48810186|NCT06688357|157144558|FG000|Overall Study|Adverse Event|0|||
48810187|NCT06688357|157144559|FG001|Overall Study|Adverse Event|1|||
48810188|NCT02678689|157144560|FG000|Overall Study|Participant chose to receive commercial drug in their home country|1|||
48810189|NCT02678689|157144561|FG001|Overall Study|Participant chose to receive commercial drug in their home country|0|||
48810190|NCT04306367|157144564|FG000|Overall Study|Progression of Disease|9|||
48810191|NCT04306367|157144564|FG000|Overall Study|Adverse Event|3|||
48810192|NCT04306367|157144564|FG000|Overall Study|Withdrawal by Subject|1|||
48810193|NCT02337686|157144565|FG000|Overall Study|Adverse Event|1|||
48810194|NCT01266642|157144568|FG000|Overall Study|Protocol Violation|0|||
48810195|NCT01266642|157144569|FG001|Overall Study|Protocol Violation|1|||
48810196|NCT00332332|157146292|FG000|Overall Study|Adverse Event|13|||
48810197|NCT00332332|157146292|FG000|Overall Study|Death|1|||
48810198|NCT00332332|157146292|FG000|Overall Study|Withdrawal by Subject|8|||
48918618|NCT00117598|157537780|FG000|Prior to Treatment Cross Over|Lost to Follow-up|0|||
48918619|NCT00117598|157537781|FG001|Prior to Treatment Cross Over|Lost to Follow-up|2|||
48918620|NCT00117598|157537782|FG002|Prior to Treatment Cross Over|Lost to Follow-up|2|||
48918621|NCT00117598|157537783|FG003|Prior to Treatment Cross Over|Lost to Follow-up|0|||
48810199|NCT00332332|157146292|FG000|Overall Study|Physician Decision|1|||
48810200|NCT00332332|157146292|FG000|Overall Study|Lost to Follow-up|3|||
48810201|NCT00332332|157146292|FG000|Overall Study|Protocol deviation|4|||
48810202|NCT00332332|157146292|FG000|Overall Study|Noncompliance|2|||
48810203|NCT00332332|157146292|FG000|Overall Study|Disease progression|2|||
49120873|NCT02326272|158280515|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
49120874|NCT02326272|158280516|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
49120875|NCT02326272|158280517|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
49120876|NCT02326272|158280518|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
49120877|NCT02326272|158280519|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1|||
49120878|NCT02326272|158280520|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
49120879|NCT02326272|158280521|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
49120880|NCT02326272|158280522|FG014|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
49120881|NCT02326272|158280508|FG000|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
49120882|NCT02326272|158280509|FG001|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
48711737|NCT04661579|156794890|FG002|Overall Study|Physician Decision|0|||
48711738|NCT04661579|156794891|FG003|Overall Study|Physician Decision|1|||
49120883|NCT02326272|158280510|FG002|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
49120884|NCT02326272|158280511|FG003|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
49120885|NCT02326272|158280512|FG004|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
49120886|NCT02326272|158280513|FG005|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
49120887|NCT02326272|158280514|FG006|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
49120888|NCT02326272|158280515|FG007|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
49120889|NCT02326272|158280516|FG008|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
49120890|NCT02326272|158280517|FG009|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
48711739|NCT04661579|156794892|FG004|Overall Study|Physician Decision|0|||
48711740|NCT04661579|156794888|FG000|Overall Study|Withdrawal by Subject|1|||
48711741|NCT04661579|156794889|FG001|Overall Study|Withdrawal by Subject|4|||
48711742|NCT04661579|156794890|FG002|Overall Study|Withdrawal by Subject|0|||
48711743|NCT04661579|156794891|FG003|Overall Study|Withdrawal by Subject|2|||
48711744|NCT04661579|156794892|FG004|Overall Study|Withdrawal by Subject|0|||
48810204|NCT00332332|157146292|FG000|Overall Study|Other|18|||
48810205|NCT00332332|157146292|FG000|Overall Study|Did not receive study treatment|16|||
48810206|NCT02200939|157146293|FG000|Overall Study|Participant withdrew consent|0|||
48810207|NCT02200939|157146294|FG001|Overall Study|Participant withdrew consent|1|||
48810208|NCT02200939|157146293|FG000|Overall Study|Lost to Follow-up|2|||
48810209|NCT02200939|157146294|FG001|Overall Study|Lost to Follow-up|9|||
48810210|NCT02200939|157146293|FG000|Overall Study|Subject moved out of town and unable to make it back to study|0|||
48810211|NCT02200939|157146294|FG001|Overall Study|Subject moved out of town and unable to make it back to study|1|||
48810212|NCT00244374|157146299|FG000|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105|||
48810213|NCT00244374|157146300|FG001|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
48810214|NCT00244374|157146301|FG002|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
48810215|NCT00244374|157146302|FG003|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
48810216|NCT00244374|157146303|FG004|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
48810217|NCT00244374|157146299|FG000|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17|||
48810218|NCT00244374|157146300|FG001|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
48810219|NCT00244374|157146301|FG002|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
48810220|NCT00244374|157146302|FG003|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
48810221|NCT00244374|157146303|FG004|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
48810222|NCT00244374|157146299|FG000|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14|||
48810223|NCT00244374|157146300|FG001|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
48810224|NCT00244374|157146301|FG002|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
48810225|NCT00244374|157146302|FG003|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
48810226|NCT00244374|157146303|FG004|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
48810227|NCT00244374|157146299|FG000|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1|||
48810228|NCT00244374|157146300|FG001|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
48856494|NCT01159600|157312861|FG000|Overall Study|Lost to Follow-up|2|||
48856495|NCT01159600|157312862|FG001|Overall Study|Lost to Follow-up|3|||
48856496|NCT01159600|157312863|FG002|Overall Study|Lost to Follow-up|4|||
48856497|NCT01159600|157312864|FG003|Overall Study|Lost to Follow-up|3|||
48856498|NCT01159600|157312865|FG004|Overall Study|Lost to Follow-up|3|||
48856499|NCT01159600|157312866|FG005|Overall Study|Lost to Follow-up|0|||
48856500|NCT01159600|157312867|FG006|Overall Study|Lost to Follow-up|3|||
48856501|NCT01159600|157312868|FG007|Overall Study|Lost to Follow-up|2|||
48856502|NCT01159600|157312861|FG000|Overall Study|Patient refusal to continue,not due toAE|7|||
48711745|NCT04661579|156794888|FG000|Overall Study|Death|1|||
48711746|NCT04661579|156794889|FG001|Overall Study|Death|0|||
48856503|NCT01159600|157312862|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
48856504|NCT01159600|157312863|FG002|Overall Study|Patient refusal to continue,not due toAE|4|||
48856505|NCT01159600|157312864|FG003|Overall Study|Patient refusal to continue,not due toAE|5|||
48918622|NCT00117598|157537784|FG004|Prior to Treatment Cross Over|Lost to Follow-up|0|||
48918623|NCT00117598|157537780|FG000|Prior to Treatment Cross Over|Withdrawal by Subject|2|||
48918624|NCT00117598|157537781|FG001|Prior to Treatment Cross Over|Withdrawal by Subject|1|||
48918625|NCT00117598|157537782|FG002|Prior to Treatment Cross Over|Withdrawal by Subject|4|||
48918626|NCT00117598|157537783|FG003|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
48918627|NCT00117598|157537784|FG004|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
48918628|NCT00117598|157537780|FG000|Prior to Treatment Cross Over|Other|15|||
48918629|NCT00117598|157537781|FG001|Prior to Treatment Cross Over|Other|9|||
48918630|NCT00117598|157537782|FG002|Prior to Treatment Cross Over|Other|9|||
48918631|NCT00117598|157537783|FG003|Prior to Treatment Cross Over|Other|0|||
48918632|NCT00117598|157537784|FG004|Prior to Treatment Cross Over|Other|0|||
48918633|NCT00117598|157537780|FG000|After Treament Cross Over|Death|0|||
48918634|NCT00117598|157537781|FG001|After Treament Cross Over|Death|0|||
48918635|NCT00117598|157537782|FG002|After Treament Cross Over|Death|0|||
48918636|NCT00117598|157537783|FG003|After Treament Cross Over|Death|1|||
48918637|NCT00117598|157537784|FG004|After Treament Cross Over|Death|2|||
48918638|NCT00117598|157537780|FG000|After Treament Cross Over|Withdrawal by Subject|0|||
48918639|NCT00117598|157537781|FG001|After Treament Cross Over|Withdrawal by Subject|0|||
48918640|NCT00117598|157537782|FG002|After Treament Cross Over|Withdrawal by Subject|0|||
48918641|NCT00117598|157537783|FG003|After Treament Cross Over|Withdrawal by Subject|1|||
48918642|NCT00117598|157537784|FG004|After Treament Cross Over|Withdrawal by Subject|0|||
48918643|NCT00117598|157537780|FG000|After Treament Cross Over|Other|0|||
48918644|NCT00117598|157537781|FG001|After Treament Cross Over|Other|0|||
48918645|NCT00117598|157537782|FG002|After Treament Cross Over|Other|0|||
48918646|NCT00117598|157537783|FG003|After Treament Cross Over|Other|1|||
49120891|NCT02326272|158280518|FG010|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
49120892|NCT02326272|158280519|FG011|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1|||
49120893|NCT02326272|158280520|FG012|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
49120894|NCT02326272|158280521|FG013|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
49120895|NCT02326272|158280522|FG014|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
49120896|NCT02326272|158280508|FG000|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
49120897|NCT02326272|158280509|FG001|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
48711747|NCT04661579|156794890|FG002|Overall Study|Death|0|||
48711748|NCT04661579|156794891|FG003|Overall Study|Death|0|||
48711749|NCT04661579|156794892|FG004|Overall Study|Death|0|||
48711750|NCT04661579|156794888|FG000|Overall Study|Other|1|||
48711751|NCT04661579|156794889|FG001|Overall Study|Other|2|||
48711752|NCT04661579|156794890|FG002|Overall Study|Other|1|||
48711753|NCT04661579|156794891|FG003|Overall Study|Other|1|||
48711754|NCT04661579|156794892|FG004|Overall Study|Other|1|||
48711755|NCT04661579|156794888|FG000|Overall Study|Randomized but Did Not Receive Study Product|4|||
48711756|NCT04661579|156794889|FG001|Overall Study|Randomized but Did Not Receive Study Product|4|||
48711757|NCT04661579|156794890|FG002|Overall Study|Randomized but Did Not Receive Study Product|1|||
48711758|NCT04661579|156794891|FG003|Overall Study|Randomized but Did Not Receive Study Product|5|||
48711759|NCT04661579|156794892|FG004|Overall Study|Randomized but Did Not Receive Study Product|1|||
48711760|NCT01305577|156794894|FG000|Overall Study|Adverse Event|2|||
48711761|NCT01305577|156794895|FG001|Overall Study|Adverse Event|2|||
48711762|NCT01305577|156794896|FG002|Overall Study|Adverse Event|1|||
48711763|NCT01305577|156794894|FG000|Overall Study|Withdrawal by Subject|7|||
48711764|NCT01305577|156794895|FG001|Overall Study|Withdrawal by Subject|5|||
48711765|NCT01305577|156794896|FG002|Overall Study|Withdrawal by Subject|6|||
48711766|NCT01305577|156794894|FG000|Overall Study|Lost to Follow-up|4|||
48711767|NCT01305577|156794895|FG001|Overall Study|Lost to Follow-up|3|||
48711768|NCT01305577|156794896|FG002|Overall Study|Lost to Follow-up|2|||
48711769|NCT01305577|156794894|FG000|Overall Study|Protocol Deviation|0|||
48918647|NCT00117598|157537784|FG004|After Treament Cross Over|Other|2|||
48918648|NCT03223428|157537785|FG000|Overall Study|No longer taking Xermelo|27|||
48918649|NCT03223428|157537785|FG000|Overall Study|Declined Consent|1|||
48918650|NCT03223428|157537785|FG000|Overall Study|Non-responders|56|||
48918651|NCT03223428|157537785|FG000|Overall Study|Withdrawal by Subject|14|||
48918652|NCT01834274|157537786|FG000|Overall Study|Study Termination|41|||
49120898|NCT02326272|158280510|FG002|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
49120899|NCT02326272|158280511|FG003|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
49120900|NCT02326272|158280512|FG004|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
49120901|NCT02326272|158280513|FG005|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
49120902|NCT02326272|158280514|FG006|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
49120903|NCT02326272|158280515|FG007|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
49120904|NCT02326272|158280516|FG008|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
48711770|NCT01305577|156794895|FG001|Overall Study|Protocol Deviation|1|||
48711771|NCT01305577|156794896|FG002|Overall Study|Protocol Deviation|1|||
48711772|NCT00856518|156794912|FG000|Overall Study|Lost to Follow-up|4|||
48711773|NCT00856518|156794913|FG001|Overall Study|Lost to Follow-up|2|||
48711774|NCT01317277|156794915|FG000|Overall Study|Lost to Follow-up|3|||
48810229|NCT00244374|157146301|FG002|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
48810230|NCT00244374|157146302|FG003|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
48810231|NCT00244374|157146303|FG004|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
48810232|NCT00244374|157146299|FG000|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172|||
48810233|NCT00244374|157146300|FG001|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
48810234|NCT00244374|157146301|FG002|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
49120905|NCT02326272|158280517|FG009|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
49120906|NCT02326272|158280518|FG010|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
49120907|NCT02326272|158280519|FG011|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
49120908|NCT02326272|158280520|FG012|Open-label Period (Week 48 to Week 144)|Pregnancy|1|||
49120909|NCT02326272|158280521|FG013|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
49120910|NCT02326272|158280522|FG014|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
49120911|NCT01265394|158280529|FG000|Overall Study|Subjects withdrawn|37|||
49120912|NCT00735943|158280530|FG000|Overall Study|Lost to Follow-up|1|||
49120913|NCT00735943|158280530|FG000|Overall Study|Adverse Event|1|||
49120914|NCT02595502|158280540|FG000|Period 1|Adverse Event|0|||
48810235|NCT00244374|157146302|FG003|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
48810236|NCT00244374|157146303|FG004|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
48810237|NCT00244374|157146299|FG000|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51|||
48810238|NCT00244374|157146300|FG001|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
48810239|NCT00244374|157146301|FG002|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
48918653|NCT01834274|157537787|FG001|Overall Study|Study Termination|38|||
48918654|NCT01834274|157537786|FG000|Overall Study|Withdrawal by Subject|1|||
48918655|NCT01834274|157537787|FG001|Overall Study|Withdrawal by Subject|1|||
49120915|NCT02595502|158280541|FG001|Period 1|Adverse Event|1|||
48918656|NCT01834274|157537786|FG000|Overall Study|Lost to Follow-up|3|||
48918657|NCT01834274|157537787|FG001|Overall Study|Lost to Follow-up|1|||
48918658|NCT01834274|157537786|FG000|Overall Study|Other|2|||
48918659|NCT01834274|157537787|FG001|Overall Study|Other|1|||
48918660|NCT01827670|157537788|FG000|Overall Study|Withdrawal of Consent|3|||
48918661|NCT01827670|157537789|FG001|Overall Study|Withdrawal of Consent|2|||
48918662|NCT01827670|157537788|FG000|Overall Study|Lost to Follow-up|0|||
48918663|NCT01827670|157537789|FG001|Overall Study|Lost to Follow-up|1|||
48918664|NCT02025907|157537790|FG000|Overall Study|Lack of Efficacy|1|||
49120916|NCT02595502|158280540|FG000|Period 1|Withdrawal by Subject|1|||
49120917|NCT02595502|158280541|FG001|Period 1|Withdrawal by Subject|0|||
49120918|NCT02595502|158280540|FG000|Period 1|Lost to Follow-up|0|||
49120919|NCT02595502|158280541|FG001|Period 1|Lost to Follow-up|1|||
49120920|NCT02595502|158280540|FG000|Period 2|Adverse Event|1|||
49120921|NCT02595502|158280541|FG001|Period 2|Adverse Event|1|||
49120922|NCT02595502|158280540|FG000|Period 2|Received incorrect lens at Period 1|0|||
49120923|NCT02595502|158280541|FG001|Period 2|Received incorrect lens at Period 1|1|||
49120924|NCT02595502|158280540|FG000|Period 3|Protocol Violation|0|||
49120925|NCT02595502|158280541|FG001|Period 3|Protocol Violation|1|||
49120926|NCT02595502|158280540|FG000|Period 3|Lost to Follow-up|1|||
49120927|NCT02595502|158280541|FG001|Period 3|Lost to Follow-up|0|||
49120928|NCT02595502|158280540|FG000|Period 3|Received Incorrect Treatment at period 3|0|||
48918665|NCT02025907|157537791|FG001|Overall Study|Lack of Efficacy|0|||
48918666|NCT02025907|157537790|FG000|Overall Study|Withdrawal by Subject|15|||
48918667|NCT02025907|157537791|FG001|Overall Study|Withdrawal by Subject|8|||
48918668|NCT02025907|157537790|FG000|Overall Study|Protocol Violation|2|||
48918669|NCT02025907|157537791|FG001|Overall Study|Protocol Violation|0|||
48918670|NCT02025907|157537790|FG000|Overall Study|Physician Decision|2|||
48918671|NCT02025907|157537791|FG001|Overall Study|Physician Decision|0|||
48918672|NCT02025907|157537790|FG000|Overall Study|Lost to Follow-up|2|||
48918673|NCT02025907|157537791|FG001|Overall Study|Lost to Follow-up|2|||
48918674|NCT02025907|157537790|FG000|Overall Study|Adverse Event|3|||
48918675|NCT02025907|157537791|FG001|Overall Study|Adverse Event|1|||
48918676|NCT02025907|157537790|FG000|Overall Study|Potential misconduct,GCPcompliance issue|2|||
48918677|NCT02025907|157537791|FG001|Overall Study|Potential misconduct,GCPcompliance issue|1|||
48918678|NCT00961220|157537795|FG000|Overall Study|Adverse Event|3|||
48918679|NCT00961220|157537795|FG000|Overall Study|Lack of Efficacy|1|||
48918680|NCT00961220|157537795|FG000|Overall Study|No IV access for O6BG|1|||
48918681|NCT00961220|157537795|FG000|Overall Study|O6BG no longer supplied|1|||
48918682|NCT00961220|157537795|FG000|Overall Study|Complete Response prior to 12 courses|1|||
48918683|NCT00606320|157537800|FG000|Overall Study|Adverse Event|3|||
49120929|NCT02595502|158280541|FG001|Period 3|Received Incorrect Treatment at period 3|1|||
49120930|NCT01029262|158280542|FG000|Overall Study|Adverse Event|9|||
49120931|NCT01029262|158280543|FG001|Overall Study|Adverse Event|52|||
48918684|NCT00606320|157537800|FG000|Overall Study|Lack of Efficacy|5|||
48918685|NCT00606320|157537800|FG000|Overall Study|Physician Decision|7|||
49120932|NCT01029262|158280542|FG000|Overall Study|Lack of therapeutic effect|57|||
48918686|NCT00606320|157537800|FG000|Overall Study|Protocol Violation|8|||
48810240|NCT00244374|157146302|FG003|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
48810241|NCT00244374|157146303|FG004|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
48810242|NCT00244374|157146299|FG000|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34|||
48810243|NCT00244374|157146300|FG001|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
48810244|NCT00244374|157146301|FG002|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
48810245|NCT00244374|157146302|FG003|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
48810246|NCT00244374|157146303|FG004|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
48810247|NCT00244374|157146299|FG000|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4|||
48810248|NCT00244374|157146300|FG001|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
48810249|NCT00244374|157146301|FG002|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
48810250|NCT00244374|157146302|FG003|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
48810251|NCT00244374|157146303|FG004|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
48810252|NCT00244374|157146299|FG000|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12|||
48810253|NCT00244374|157146300|FG001|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
48810254|NCT00244374|157146301|FG002|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
48810255|NCT00244374|157146302|FG003|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
48810256|NCT00244374|157146303|FG004|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
49120933|NCT01029262|158280543|FG001|Overall Study|Lack of therapeutic effect|76|||
49120934|NCT01029262|158280542|FG000|Overall Study|Withdrawal by Subject|10|||
49120935|NCT01029262|158280543|FG001|Overall Study|Withdrawal by Subject|17|||
49120936|NCT01029262|158280542|FG000|Overall Study|Protocol Violation|2|||
49120937|NCT01029262|158280543|FG001|Overall Study|Protocol Violation|3|||
49120938|NCT01029262|158280542|FG000|Overall Study|Miscellaneous|1|||
49120939|NCT01029262|158280543|FG001|Overall Study|Miscellaneous|9|||
49120940|NCT01029262|158280542|FG000|Overall Study|Death|0|||
49120941|NCT01029262|158280543|FG001|Overall Study|Death|3|||
48711775|NCT01317277|156794916|FG001|Overall Study|Lost to Follow-up|1|||
48711776|NCT01317277|156794915|FG000|Overall Study|Lost MEMS|1|||
48711777|NCT01317277|156794916|FG001|Overall Study|Lost MEMS|1|||
49120942|NCT03410992|158280546|FG000|Initial Treatment Period: up to Wk16|Adverse Event|0|||
48711778|NCT01317277|156794915|FG000|Overall Study|Unable to comply with intervention|1|||
48711779|NCT01317277|156794916|FG001|Overall Study|Unable to comply with intervention|0|||
48711780|NCT01317277|156794915|FG000|Overall Study|Withdrawal by Subject|1|||
48711781|NCT01317277|156794916|FG001|Overall Study|Withdrawal by Subject|0|||
48711782|NCT01317277|156794915|FG000|Overall Study|Adverse Event|1|||
48711783|NCT01317277|156794916|FG001|Overall Study|Adverse Event|0|||
48711784|NCT04380519|156794917|FG000|Overall Study|Withdrawal by Subject|4|||
48711785|NCT04380519|156794918|FG001|Overall Study|Withdrawal by Subject|0|||
48711786|NCT04380519|156794919|FG002|Overall Study|Withdrawal by Subject|1|||
48711787|NCT04380519|156794917|FG000|Overall Study|Death|14|||
48711788|NCT04380519|156794918|FG001|Overall Study|Death|9|||
48711789|NCT04380519|156794919|FG002|Overall Study|Death|6|||
48711790|NCT04380519|156794917|FG000|Overall Study|Adverse Event|0|||
48711791|NCT04380519|156794918|FG001|Overall Study|Adverse Event|1|||
48711792|NCT04380519|156794919|FG002|Overall Study|Adverse Event|0|||
48711793|NCT04380519|156794917|FG000|Overall Study|relatives' decision|0|||
48711794|NCT04380519|156794918|FG001|Overall Study|relatives' decision|1|||
48711795|NCT04380519|156794919|FG002|Overall Study|relatives' decision|0|||
48711796|NCT01485172|156794920|FG000|Overall Study|Adverse Event|2|||
48711797|NCT01485172|156794921|FG001|Overall Study|Adverse Event|1|||
48711798|NCT01485172|156794922|FG002|Overall Study|Adverse Event|2|||
48711799|NCT01485172|156794923|FG003|Overall Study|Adverse Event|2|||
48711800|NCT01485172|156794924|FG004|Overall Study|Adverse Event|1|||
48711801|NCT01485172|156794925|FG005|Overall Study|Adverse Event|2|||
48711802|NCT01485172|156794920|FG000|Overall Study|Lack of Efficacy|2|||
48711803|NCT01485172|156794921|FG001|Overall Study|Lack of Efficacy|0|||
48711804|NCT01485172|156794922|FG002|Overall Study|Lack of Efficacy|0|||
48711805|NCT01485172|156794923|FG003|Overall Study|Lack of Efficacy|0|||
48711806|NCT01485172|156794924|FG004|Overall Study|Lack of Efficacy|0|||
48711807|NCT01485172|156794925|FG005|Overall Study|Lack of Efficacy|0|||
48711808|NCT01485172|156794920|FG000|Overall Study|Protocol Violation|0|||
48711809|NCT01485172|156794921|FG001|Overall Study|Protocol Violation|0|||
48711810|NCT01485172|156794922|FG002|Overall Study|Protocol Violation|4|||
48711811|NCT01485172|156794923|FG003|Overall Study|Protocol Violation|5|||
48711812|NCT01485172|156794924|FG004|Overall Study|Protocol Violation|1|||
48711813|NCT01485172|156794925|FG005|Overall Study|Protocol Violation|0|||
48711814|NCT01485172|156794920|FG000|Overall Study|Protocol defined stopping criteria|1|||
48711815|NCT01485172|156794921|FG001|Overall Study|Protocol defined stopping criteria|0|||
48711816|NCT01485172|156794922|FG002|Overall Study|Protocol defined stopping criteria|0|||
48711817|NCT01485172|156794923|FG003|Overall Study|Protocol defined stopping criteria|0|||
48711818|NCT01485172|156794924|FG004|Overall Study|Protocol defined stopping criteria|1|||
48711819|NCT01485172|156794925|FG005|Overall Study|Protocol defined stopping criteria|0|||
48711820|NCT01485172|156794920|FG000|Overall Study|Lost to Follow-up|0|||
48711821|NCT01485172|156794921|FG001|Overall Study|Lost to Follow-up|0|||
48711822|NCT01485172|156794922|FG002|Overall Study|Lost to Follow-up|1|||
48711823|NCT01485172|156794923|FG003|Overall Study|Lost to Follow-up|0|||
48711824|NCT01485172|156794924|FG004|Overall Study|Lost to Follow-up|0|||
48711825|NCT01485172|156794925|FG005|Overall Study|Lost to Follow-up|1|||
48711826|NCT01485172|156794920|FG000|Overall Study|Physician Decision|0|||
48711827|NCT01485172|156794921|FG001|Overall Study|Physician Decision|0|||
49120943|NCT03410992|158280547|FG001|Initial Treatment Period: up to Wk16|Adverse Event|5|||
49120944|NCT03410992|158280548|FG002|Initial Treatment Period: up to Wk16|Adverse Event|0|||
49120945|NCT03410992|158280549|FG003|Initial Treatment Period: up to Wk16|Adverse Event|0|||
49120946|NCT03410992|158280550|FG004|Initial Treatment Period: up to Wk16|Adverse Event|0|||
49120947|NCT03410992|158280551|FG005|Initial Treatment Period: up to Wk16|Adverse Event|0|||
49120948|NCT03410992|158280552|FG006|Initial Treatment Period: up to Wk16|Adverse Event|0|||
49120949|NCT03410992|158280553|FG007|Initial Treatment Period: up to Wk16|Adverse Event|0|||
49120950|NCT03410992|158280554|FG008|Initial Treatment Period: up to Wk16|Adverse Event|0|||
49120951|NCT03410992|158280555|FG009|Initial Treatment Period: up to Wk16|Adverse Event|0|||
48711828|NCT01485172|156794922|FG002|Overall Study|Physician Decision|0|||
48711829|NCT01485172|156794923|FG003|Overall Study|Physician Decision|0|||
48711830|NCT01485172|156794924|FG004|Overall Study|Physician Decision|1|||
48711831|NCT01485172|156794925|FG005|Overall Study|Physician Decision|0|||
48711832|NCT01485172|156794920|FG000|Overall Study|Withdrawal by Subject|2|||
48711833|NCT01485172|156794921|FG001|Overall Study|Withdrawal by Subject|0|||
48711834|NCT01485172|156794922|FG002|Overall Study|Withdrawal by Subject|0|||
48711835|NCT01485172|156794923|FG003|Overall Study|Withdrawal by Subject|1|||
48711836|NCT01485172|156794924|FG004|Overall Study|Withdrawal by Subject|1|||
48711837|NCT01485172|156794925|FG005|Overall Study|Withdrawal by Subject|1|||
48711838|NCT01297491|156794931|FG000|Overall Study|Adverse Event|11|||
48711839|NCT01297491|156794932|FG001|Overall Study|Adverse Event|6|||
48711840|NCT01297491|156794931|FG000|Overall Study|Physician Decision|3|||
48711841|NCT01297491|156794932|FG001|Overall Study|Physician Decision|2|||
48711842|NCT01297491|156794931|FG000|Overall Study|Progressive disease|11|||
48711843|NCT01297491|156794932|FG001|Overall Study|Progressive disease|20|||
48711844|NCT01297491|156794931|FG000|Overall Study|Patient/Guardian decision|3|||
48711845|NCT01297491|156794932|FG001|Overall Study|Patient/Guardian decision|4|||
48711846|NCT01297491|156794931|FG000|Overall Study|Death|2|||
48711847|NCT01297491|156794932|FG001|Overall Study|Death|1|||
48711848|NCT01015638|156794933|FG000|Overall Study|Withdrawal by Subject|1|||
48711849|NCT01015638|156794934|FG001|Overall Study|Withdrawal by Subject|0|||
48711850|NCT01932437|156794935|FG000|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
48711851|NCT01932437|156794936|FG001|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
48711852|NCT01932437|156794937|FG002|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
48711853|NCT01932437|156794938|FG003|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
48711854|NCT01932437|156794939|FG004|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
48711855|NCT01932437|156794940|FG005|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1|||
48711856|NCT01640314|156794941|FG000|Overall Study|Protocol Violation|0|||
48711857|NCT01640314|156794942|FG001|Overall Study|Protocol Violation|1|||
48711858|NCT00329797|156794944|FG000|Overall Study|Protocol Violation|1|||
48711859|NCT00329797|156794945|FG001|Overall Study|Protocol Violation|0|||
48711860|NCT00329797|156794944|FG000|Overall Study|Withdrawal by Subject|6|||
48711861|NCT00329797|156794945|FG001|Overall Study|Withdrawal by Subject|6|||
48711862|NCT03091348|156794946|FG000|Overall Study|Lost to Follow-up|2|||
48711863|NCT03091348|156794947|FG001|Overall Study|Lost to Follow-up|1|||
48711864|NCT01032889|156794953|FG000|Overall Study|Adverse Event|2|||
48711865|NCT01032889|156794954|FG001|Overall Study|Adverse Event|2|||
48711866|NCT01032889|156794955|FG002|Overall Study|Adverse Event|0|||
48711867|NCT01032889|156794953|FG000|Overall Study|Withdrawal of Consent|1|||
48711868|NCT01032889|156794954|FG001|Overall Study|Withdrawal of Consent|2|||
48711869|NCT01032889|156794955|FG002|Overall Study|Withdrawal of Consent|1|||
48711870|NCT01032889|156794953|FG000|Overall Study|Patient Request|0|||
48711871|NCT01032889|156794954|FG001|Overall Study|Patient Request|1|||
48711872|NCT01032889|156794955|FG002|Overall Study|Patient Request|0|||
48711873|NCT01032889|156794953|FG000|Overall Study|Lost to Follow-up|1|||
48711874|NCT01032889|156794954|FG001|Overall Study|Lost to Follow-up|1|||
48711875|NCT01032889|156794955|FG002|Overall Study|Lost to Follow-up|0|||
48711876|NCT01032889|156794953|FG000|Overall Study|Lack of Submental Fat|2|||
48711877|NCT01032889|156794954|FG001|Overall Study|Lack of Submental Fat|8|||
48711878|NCT01032889|156794955|FG002|Overall Study|Lack of Submental Fat|1|||
48711879|NCT01032889|156794953|FG000|Overall Study|Miscellaneous Reasons|2|||
48711880|NCT01032889|156794954|FG001|Overall Study|Miscellaneous Reasons|1|||
48711881|NCT01032889|156794955|FG002|Overall Study|Miscellaneous Reasons|1|||
48711882|NCT04530136|156794956|FG000|Overall Study|Lost to Follow-up|2|||
48711883|NCT04530136|156794957|FG001|Overall Study|Lost to Follow-up|3|||
48711884|NCT04530136|156794956|FG000|Overall Study|Withdrawal by Subject|1|||
48711885|NCT04530136|156794957|FG001|Overall Study|Withdrawal by Subject|0|||
48711886|NCT04530136|156794956|FG000|Overall Study|Death|0|||
48711887|NCT04530136|156794957|FG001|Overall Study|Death|1|||
48711888|NCT02228980|156794960|FG000|Overall Study|Adverse Event|14|||
48711889|NCT02228980|156794961|FG001|Overall Study|Adverse Event|0|||
48711890|NCT02228980|156794962|FG002|Overall Study|Adverse Event|0|||
48711891|NCT02228980|156794963|FG003|Overall Study|Adverse Event|0|||
48711892|NCT02228980|156794960|FG000|Overall Study|Protocol Violation|7|||
48711893|NCT02228980|156794961|FG001|Overall Study|Protocol Violation|0|||
48711894|NCT02228980|156794962|FG002|Overall Study|Protocol Violation|0|||
48711895|NCT02228980|156794963|FG003|Overall Study|Protocol Violation|0|||
48711896|NCT02228980|156794960|FG000|Overall Study|Withdrawal by Subject|3|||
48711897|NCT02228980|156794961|FG001|Overall Study|Withdrawal by Subject|3|||
48711898|NCT02228980|156794962|FG002|Overall Study|Withdrawal by Subject|2|||
48711899|NCT02228980|156794963|FG003|Overall Study|Withdrawal by Subject|3|||
48711900|NCT04270370|156794964|FG000|Overall Study|Lost to Follow-up|1|||
48711901|NCT04270370|156794965|FG001|Overall Study|Lost to Follow-up|0|||
48711902|NCT04270370|156794966|FG002|Overall Study|Lost to Follow-up|0|||
48711903|NCT04270370|156794967|FG003|Overall Study|Lost to Follow-up|0|||
48810257|NCT00720902|157146306|FG000|Overall Study|Withdrawal by Subject|1|||
48711904|NCT04270370|156794968|FG004|Overall Study|Lost to Follow-up|0|||
48711905|NCT04270370|156794969|FG005|Overall Study|Lost to Follow-up|0|||
48711906|NCT04270370|156794970|FG006|Overall Study|Lost to Follow-up|0|||
48711907|NCT04270370|156794971|FG007|Overall Study|Lost to Follow-up|0|||
48810258|NCT00720902|157146307|FG001|Overall Study|Withdrawal by Subject|0|||
48711908|NCT04270370|156794972|FG008|Overall Study|Lost to Follow-up|1|||
48711909|NCT04270370|156794973|FG009|Overall Study|Lost to Follow-up|0|||
48711910|NCT04270370|156794974|FG010|Overall Study|Lost to Follow-up|0|||
48711911|NCT04270370|156794975|FG011|Overall Study|Lost to Follow-up|0|||
48711912|NCT02744040|156794976|FG000|Overall Study|Withdrawal by Subject|3|||
48711913|NCT02744040|156794977|FG001|Overall Study|Withdrawal by Subject|2|||
48711914|NCT02744040|156794978|FG002|Overall Study|Withdrawal by Subject|2|||
48711915|NCT02744040|156794976|FG000|Overall Study|Physician Decision|0|||
48711916|NCT02744040|156794977|FG001|Overall Study|Physician Decision|8|||
48711917|NCT02744040|156794978|FG002|Overall Study|Physician Decision|13|||
48810259|NCT00720902|157146306|FG000|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|3|||
48810260|NCT00720902|157146307|FG001|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|0|||
48810261|NCT01062763|157146308|FG000|Overall Study|Adverse Event|3|||
48810262|NCT01062763|157146309|FG001|Overall Study|Adverse Event|4|||
48810263|NCT02392611|157146311|FG000|Overall Study|Adverse Event|0|||
48810264|NCT02392611|157146312|FG001|Overall Study|Adverse Event|0|||
48810265|NCT02392611|157146313|FG002|Overall Study|Adverse Event|0|||
48810266|NCT02392611|157146314|FG003|Overall Study|Adverse Event|1|||
48810267|NCT02392611|157146315|FG004|Overall Study|Adverse Event|0|||
48810268|NCT02392611|157146316|FG005|Overall Study|Adverse Event|0|||
48810269|NCT02392611|157146317|FG006|Overall Study|Adverse Event|0|||
48810270|NCT02392611|157146318|FG007|Overall Study|Adverse Event|0|||
48810271|NCT02392611|157146319|FG008|Overall Study|Adverse Event|0|||
48810272|NCT02392611|157146311|FG000|Overall Study|Progressive disease|0|||
48810273|NCT02392611|157146312|FG001|Overall Study|Progressive disease|0|||
48810274|NCT02392611|157146313|FG002|Overall Study|Progressive disease|0|||
48810275|NCT02392611|157146314|FG003|Overall Study|Progressive disease|2|||
48810276|NCT02392611|157146315|FG004|Overall Study|Progressive disease|1|||
48810277|NCT02392611|157146316|FG005|Overall Study|Progressive disease|0|||
48810278|NCT02392611|157146317|FG006|Overall Study|Progressive disease|0|||
48810279|NCT02392611|157146318|FG007|Overall Study|Progressive disease|0|||
48810280|NCT02392611|157146319|FG008|Overall Study|Progressive disease|0|||
48810281|NCT02392611|157146311|FG000|Overall Study|Death|1|||
48810282|NCT02392611|157146312|FG001|Overall Study|Death|0|||
48810283|NCT02392611|157146313|FG002|Overall Study|Death|0|||
48810284|NCT02392611|157146314|FG003|Overall Study|Death|0|||
48810285|NCT02392611|157146315|FG004|Overall Study|Death|0|||
48810286|NCT02392611|157146316|FG005|Overall Study|Death|1|||
48810287|NCT02392611|157146317|FG006|Overall Study|Death|0|||
48810288|NCT02392611|157146318|FG007|Overall Study|Death|0|||
48810289|NCT02392611|157146319|FG008|Overall Study|Death|0|||
48810290|NCT02392611|157146311|FG000|Overall Study|Withdrawal by Subject|0|||
48810291|NCT02392611|157146312|FG001|Overall Study|Withdrawal by Subject|0|||
48810292|NCT02392611|157146313|FG002|Overall Study|Withdrawal by Subject|0|||
48810293|NCT02392611|157146314|FG003|Overall Study|Withdrawal by Subject|1|||
48810294|NCT02392611|157146315|FG004|Overall Study|Withdrawal by Subject|0|||
48810295|NCT02392611|157146316|FG005|Overall Study|Withdrawal by Subject|0|||
48810296|NCT02392611|157146317|FG006|Overall Study|Withdrawal by Subject|0|||
48810297|NCT02392611|157146318|FG007|Overall Study|Withdrawal by Subject|0|||
48810298|NCT02392611|157146319|FG008|Overall Study|Withdrawal by Subject|0|||
48810299|NCT02392611|157146311|FG000|Overall Study|Lost to Follow-up|0|||
48810300|NCT02392611|157146312|FG001|Overall Study|Lost to Follow-up|0|||
48810301|NCT02392611|157146313|FG002|Overall Study|Lost to Follow-up|0|||
48810302|NCT02392611|157146314|FG003|Overall Study|Lost to Follow-up|0|||
48810303|NCT02392611|157146315|FG004|Overall Study|Lost to Follow-up|0|||
48810304|NCT02392611|157146316|FG005|Overall Study|Lost to Follow-up|0|||
48810305|NCT02392611|157146317|FG006|Overall Study|Lost to Follow-up|1|||
48810306|NCT02392611|157146318|FG007|Overall Study|Lost to Follow-up|0|||
48810307|NCT02392611|157146319|FG008|Overall Study|Lost to Follow-up|0|||
48810308|NCT02392611|157146311|FG000|Overall Study|Enrolled, not treated|0|||
48810309|NCT02392611|157146312|FG001|Overall Study|Enrolled, not treated|0|||
48810310|NCT02392611|157146313|FG002|Overall Study|Enrolled, not treated|0|||
48810311|NCT02392611|157146314|FG003|Overall Study|Enrolled, not treated|2|||
48810312|NCT02392611|157146315|FG004|Overall Study|Enrolled, not treated|0|||
48810313|NCT02392611|157146316|FG005|Overall Study|Enrolled, not treated|0|||
48810314|NCT02392611|157146317|FG006|Overall Study|Enrolled, not treated|0|||
48810315|NCT02392611|157146318|FG007|Overall Study|Enrolled, not treated|0|||
48810316|NCT02392611|157146319|FG008|Overall Study|Enrolled, not treated|0|||
48810317|NCT02714868|157146324|FG000|Overall Study|Withdrawal by Subject|3|||
48810318|NCT02714868|157146325|FG001|Overall Study|Withdrawal by Subject|0|||
48810319|NCT02714868|157146324|FG000|Overall Study|PI withdrawal safety risk self/others|1|||
48810320|NCT02714868|157146325|FG001|Overall Study|PI withdrawal safety risk self/others|0|||
48810321|NCT02714868|157146324|FG000|Overall Study|PI withdraw did not meet inclusion|1|||
48810322|NCT02714868|157146325|FG001|Overall Study|PI withdraw did not meet inclusion|0|||
48810323|NCT00369681|157146326|FG000|Overall Study|Death|1|||
48810324|NCT02914184|157146329|FG000|Overall Study|Lost to Follow-up|7|||
48810325|NCT02914184|157146330|FG001|Overall Study|Lost to Follow-up|10|||
48810326|NCT02914184|157146331|FG002|Overall Study|Lost to Follow-up|8|||
48810327|NCT02914184|157146332|FG003|Overall Study|Lost to Follow-up|7|||
48810328|NCT02914184|157146329|FG000|Overall Study|Withdrawal by Subject|4|||
48810329|NCT02914184|157146330|FG001|Overall Study|Withdrawal by Subject|2|||
48810330|NCT02914184|157146331|FG002|Overall Study|Withdrawal by Subject|7|||
48810331|NCT02914184|157146332|FG003|Overall Study|Withdrawal by Subject|3|||
48810332|NCT02914184|157146329|FG000|Overall Study|Other|1|||
48810333|NCT02914184|157146330|FG001|Overall Study|Other|0|||
48810334|NCT02914184|157146331|FG002|Overall Study|Other|0|||
48810335|NCT02914184|157146332|FG003|Overall Study|Other|0|||
48810336|NCT02914184|157146329|FG000|Overall Study|Migrated/moved from the study area|2|||
48711918|NCT02744040|156794976|FG000|Overall Study|Lost to Follow-up|3|||
48711919|NCT02744040|156794977|FG001|Overall Study|Lost to Follow-up|1|||
48711920|NCT02744040|156794978|FG002|Overall Study|Lost to Follow-up|7|||
48711921|NCT00781885|156794987|FG000|Overall Study|Physician Decision|1|||
48711922|NCT03698591|156794988|FG000|Overall Study|Withdrawal by Subject|2|||
48711923|NCT03698591|156794989|FG001|Overall Study|Withdrawal by Subject|2|||
48711924|NCT03698591|156794988|FG000|Overall Study|Failed drug screen|1|||
48711925|NCT03698591|156794989|FG001|Overall Study|Failed drug screen|1|||
48711926|NCT03698591|156794988|FG000|Overall Study|Failed health screen|0|||
48711927|NCT03698591|156794989|FG001|Overall Study|Failed health screen|1|||
48711928|NCT03698591|156794988|FG000|Overall Study|Ineligible for financial compensation|1|||
48711929|NCT03698591|156794989|FG001|Overall Study|Ineligible for financial compensation|0|||
48711930|NCT03698591|156794988|FG000|Overall Study|Equipment Error|1|||
48711931|NCT03698591|156794989|FG001|Overall Study|Equipment Error|0|||
48711932|NCT03698591|156794988|FG000|Overall Study|Could not establish TMS dosage|0|||
48711933|NCT03698591|156794989|FG001|Overall Study|Could not establish TMS dosage|1|||
48711934|NCT00661427|156794993|FG000|Overall Study|Adverse Event|5|||
48711935|NCT00661427|156794994|FG001|Overall Study|Adverse Event|5|||
48711936|NCT00661427|156794993|FG000|Overall Study|Patient not treated|0|||
48711937|NCT00661427|156794994|FG001|Overall Study|Patient not treated|2|||
48711938|NCT01011309|156794995|FG000|Overall Study|Adverse Event|2|||
48711939|NCT01011309|156794996|FG001|Overall Study|Adverse Event|1|||
48711940|NCT01011309|156794997|FG002|Overall Study|Adverse Event|2|||
49120952|NCT03410992|158280556|FG010|Initial Treatment Period: up to Wk16|Adverse Event|0|||
49120953|NCT03410992|158280546|FG000|Initial Treatment Period: up to Wk16|Lack of Efficacy|2|||
49120954|NCT03410992|158280547|FG001|Initial Treatment Period: up to Wk16|Lack of Efficacy|1|||
49120955|NCT03410992|158280548|FG002|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
49120956|NCT03410992|158280549|FG003|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
49120957|NCT03410992|158280550|FG004|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
49120958|NCT03410992|158280551|FG005|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
49120959|NCT03410992|158280552|FG006|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
49120960|NCT03410992|158280553|FG007|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
49120961|NCT03410992|158280554|FG008|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
49120962|NCT03410992|158280555|FG009|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
49120963|NCT03410992|158280556|FG010|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
49120964|NCT03410992|158280546|FG000|Initial Treatment Period: up to Wk16|Lost to Follow-up|1|||
49120965|NCT03410992|158280547|FG001|Initial Treatment Period: up to Wk16|Lost to Follow-up|3|||
49120966|NCT03410992|158280548|FG002|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
49120967|NCT03410992|158280549|FG003|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
49120968|NCT03410992|158280550|FG004|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
49120969|NCT03410992|158280551|FG005|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
49120970|NCT03410992|158280552|FG006|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
49120971|NCT03410992|158280553|FG007|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
49120972|NCT03410992|158280554|FG008|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
49120973|NCT03410992|158280555|FG009|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
49120974|NCT03410992|158280556|FG010|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
49120975|NCT03410992|158280546|FG000|Initial Treatment Period: up to Wk16|Withdrawal by Subject|1|||
49120976|NCT03410992|158280547|FG001|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
49120977|NCT03410992|158280548|FG002|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
49120978|NCT03410992|158280549|FG003|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
48711941|NCT01011309|156794995|FG000|Overall Study|Lack of Efficacy|0|||
48711942|NCT01011309|156794996|FG001|Overall Study|Lack of Efficacy|1|||
48711943|NCT01011309|156794997|FG002|Overall Study|Lack of Efficacy|0|||
48711944|NCT01011309|156794995|FG000|Overall Study|Protocol Violation|0|||
48711945|NCT01011309|156794996|FG001|Overall Study|Protocol Violation|1|||
48711946|NCT01011309|156794997|FG002|Overall Study|Protocol Violation|3|||
48711947|NCT00530504|156794998|FG000|Overall Study|Death|54|||
48711948|NCT00530504|156794998|FG000|Overall Study|Lost to Follow-up|26|||
48711949|NCT00530504|156794998|FG000|Overall Study|Withdrawal by Subject|39|||
48711950|NCT00530504|156794998|FG000|Overall Study|Exited study due to other reasons|33|||
48918687|NCT00606320|157537800|FG000|Overall Study|Withdrawal by Subject|10|||
49120979|NCT03410992|158280550|FG004|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
49120980|NCT03410992|158280551|FG005|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
49120981|NCT03410992|158280552|FG006|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
49120982|NCT03410992|158280553|FG007|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
49120983|NCT03410992|158280554|FG008|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
48711951|NCT00006289|156794999|FG000|First Intervention (5 Weeks)|Adverse Event|1|||
48711952|NCT00006289|156795000|FG001|First Intervention (5 Weeks)|Adverse Event|0|||
48711953|NCT00006289|156794999|FG000|Second Intervention (5 Weeks)|Protocol Violation|1|||
48711954|NCT00006289|156795000|FG001|Second Intervention (5 Weeks)|Protocol Violation|1|||
49120984|NCT03410992|158280555|FG009|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
49120985|NCT03410992|158280556|FG010|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
49120986|NCT03410992|158280546|FG000|Week 16 Assessment|PASI90 Non-Response at Week 16|81|||
49120987|NCT03410992|158280547|FG001|Week 16 Assessment|PASI90 Non-Response at Week 16|23|||
49120988|NCT03410992|158280548|FG002|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
49120989|NCT03410992|158280549|FG003|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
49120990|NCT03410992|158280550|FG004|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
49120991|NCT03410992|158280551|FG005|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
49120992|NCT03410992|158280552|FG006|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
49120993|NCT03410992|158280553|FG007|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
49120994|NCT03410992|158280554|FG008|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
49120995|NCT03410992|158280555|FG009|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
49120996|NCT03410992|158280556|FG010|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
49120997|NCT03410992|158280546|FG000|Week 16 Assessment|Incorrect escapers|0|||
49120998|NCT03410992|158280547|FG001|Week 16 Assessment|Incorrect escapers|6|||
49120999|NCT03410992|158280548|FG002|Week 16 Assessment|Incorrect escapers|0|||
48711955|NCT01675167|156795007|FG000|Open-label Titration Phase|Adverse Event|81|||
48711956|NCT01675167|156795008|FG001|Open-label Titration Phase|Adverse Event|0|||
48711957|NCT01675167|156795009|FG002|Open-label Titration Phase|Adverse Event|0|||
48711958|NCT01675167|156795007|FG000|Open-label Titration Phase|Lack of Efficacy|63|||
48711959|NCT01675167|156795008|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
48711960|NCT01675167|156795009|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
48711961|NCT01675167|156795007|FG000|Open-label Titration Phase|Withdrawal by Subject|46|||
49121000|NCT03410992|158280549|FG003|Week 16 Assessment|Incorrect escapers|0|||
49121001|NCT03410992|158280550|FG004|Week 16 Assessment|Incorrect escapers|0|||
49121002|NCT03410992|158280551|FG005|Week 16 Assessment|Incorrect escapers|0|||
49121003|NCT03410992|158280552|FG006|Week 16 Assessment|Incorrect escapers|0|||
49121004|NCT03410992|158280553|FG007|Week 16 Assessment|Incorrect escapers|0|||
49121005|NCT03410992|158280554|FG008|Week 16 Assessment|Incorrect escapers|0|||
49121006|NCT03410992|158280555|FG009|Week 16 Assessment|Incorrect escapers|0|||
49121007|NCT03410992|158280556|FG010|Week 16 Assessment|Incorrect escapers|0|||
49121008|NCT03410992|158280546|FG000|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
49121009|NCT03410992|158280547|FG001|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
49121010|NCT03410992|158280548|FG002|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
49121011|NCT03410992|158280549|FG003|Randomized-Withdrawal Period: up to Wk56|Adverse Event|3|||
49121012|NCT03410992|158280550|FG004|Randomized-Withdrawal Period: up to Wk56|Adverse Event|2|||
49121013|NCT03410992|158280551|FG005|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
49121014|NCT03410992|158280552|FG006|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
49121015|NCT03410992|158280553|FG007|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
49121016|NCT03410992|158280554|FG008|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
49121017|NCT03410992|158280555|FG009|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
49121018|NCT03410992|158280556|FG010|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
49121019|NCT03410992|158280546|FG000|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
49121020|NCT03410992|158280547|FG001|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
49121021|NCT03410992|158280548|FG002|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
49121022|NCT03410992|158280549|FG003|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
49121023|NCT03410992|158280550|FG004|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|1|||
49121024|NCT03410992|158280551|FG005|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
49121025|NCT03410992|158280552|FG006|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
49121026|NCT03410992|158280553|FG007|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
49121027|NCT03410992|158280554|FG008|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
49121028|NCT03410992|158280555|FG009|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
49121029|NCT03410992|158280556|FG010|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
49121030|NCT03410992|158280546|FG000|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
49121031|NCT03410992|158280547|FG001|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
49121032|NCT03410992|158280548|FG002|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
49121033|NCT03410992|158280549|FG003|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
49121034|NCT03410992|158280550|FG004|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
49121035|NCT03410992|158280551|FG005|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|3|||
49121036|NCT03410992|158280552|FG006|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
49121037|NCT03410992|158280553|FG007|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
49121038|NCT03410992|158280554|FG008|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
49121039|NCT03410992|158280555|FG009|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
49121040|NCT03410992|158280556|FG010|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
48711962|NCT01675167|156795008|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
48711963|NCT01675167|156795009|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
48711964|NCT01675167|156795007|FG000|Open-label Titration Phase|Protocol Violation|43|||
48711965|NCT01675167|156795008|FG001|Open-label Titration Phase|Protocol Violation|0|||
48711966|NCT01675167|156795009|FG002|Open-label Titration Phase|Protocol Violation|0|||
48711967|NCT01675167|156795007|FG000|Open-label Titration Phase|Lost to Follow-up|15|||
48711968|NCT01675167|156795008|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
48711969|NCT01675167|156795009|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
48711970|NCT01675167|156795007|FG000|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1|||
48711971|NCT01675167|156795008|FG001|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
48711972|NCT01675167|156795009|FG002|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
48711973|NCT01675167|156795007|FG000|Open-label Titration Phase|Other|55|||
48711974|NCT01675167|156795008|FG001|Open-label Titration Phase|Other|0|||
48711975|NCT01675167|156795009|FG002|Open-label Titration Phase|Other|0|||
48711976|NCT01675167|156795007|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
48711977|NCT01675167|156795008|FG001|Double-blind Treatment Phase|Lack of Efficacy|19|||
48711978|NCT01675167|156795009|FG002|Double-blind Treatment Phase|Lack of Efficacy|61|||
48711979|NCT01675167|156795007|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
48711980|NCT01675167|156795008|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
48711981|NCT01675167|156795009|FG002|Double-blind Treatment Phase|Withdrawal by Subject|6|||
48711982|NCT01675167|156795007|FG000|Double-blind Treatment Phase|Adverse Event|0|||
48810337|NCT02914184|157146330|FG001|Overall Study|Migrated/moved from the study area|1|||
48810338|NCT02914184|157146331|FG002|Overall Study|Migrated/moved from the study area|2|||
48810339|NCT02914184|157146332|FG003|Overall Study|Migrated/moved from the study area|1|||
48810340|NCT00409786|157146335|FG000|Overall Study|Withdrawal by Subject|3|||
48810341|NCT03075904|157146338|FG000|Overall Study|Physician Decision|3|||
48810342|NCT03075904|157146338|FG000|Overall Study|Need for Medication not Permitted|1|||
48810343|NCT00519896|157146339|FG000|Overall Study|Protocol Violation|1|||
48810344|NCT00519896|157146339|FG000|Overall Study|Adverse Event|1|||
48810345|NCT03327402|157146340|FG000|Overall Study|Withdrawal by Subject|1|||
48810346|NCT03327402|157146340|FG000|Overall Study|Other (Visit Out-Of-Window)|1|||
48810347|NCT02367716|157146348|FG000|Overall Study|Patient did not meet inclusion criteria|1|||
48810348|NCT01473381|157146349|FG000|Overall Study|Adverse Event|8|||
48810349|NCT01473381|157146350|FG001|Overall Study|Adverse Event|20|||
48810350|NCT01473381|157146351|FG002|Overall Study|Adverse Event|25|||
48810351|NCT01473381|157146352|FG003|Overall Study|Adverse Event|17|||
48810352|NCT01473381|157146349|FG000|Overall Study|Insufficient Therapeutic Response|10|||
48810353|NCT01473381|157146350|FG001|Overall Study|Insufficient Therapeutic Response|1|||
48810354|NCT01473381|157146351|FG002|Overall Study|Insufficient Therapeutic Response|2|||
48810355|NCT01473381|157146352|FG003|Overall Study|Insufficient Therapeutic Response|3|||
48810356|NCT01473381|157146349|FG000|Overall Study|Protocol Violation|17|||
48810357|NCT01473381|157146350|FG001|Overall Study|Protocol Violation|23|||
48810358|NCT01473381|157146351|FG002|Overall Study|Protocol Violation|19|||
48810359|NCT01473381|157146352|FG003|Overall Study|Protocol Violation|17|||
48810360|NCT01473381|157146349|FG000|Overall Study|Withdrawal of Consent|20|||
48810361|NCT01473381|157146350|FG001|Overall Study|Withdrawal of Consent|21|||
48810362|NCT01473381|157146351|FG002|Overall Study|Withdrawal of Consent|20|||
48810363|NCT01473381|157146352|FG003|Overall Study|Withdrawal of Consent|26|||
48810364|NCT01473381|157146349|FG000|Overall Study|Lost to Follow-up|25|||
48810365|NCT01473381|157146350|FG001|Overall Study|Lost to Follow-up|28|||
48810366|NCT01473381|157146351|FG002|Overall Study|Lost to Follow-up|35|||
48810367|NCT01473381|157146352|FG003|Overall Study|Lost to Follow-up|23|||
48810368|NCT01473381|157146349|FG000|Overall Study|Other Reasons|0|||
48810369|NCT01473381|157146350|FG001|Overall Study|Other Reasons|0|||
48810370|NCT01473381|157146351|FG002|Overall Study|Other Reasons|1|||
49121041|NCT03410992|158280546|FG000|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
49121042|NCT03410992|158280547|FG001|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
48711983|NCT01675167|156795008|FG001|Double-blind Treatment Phase|Adverse Event|5|||
48711984|NCT01675167|156795009|FG002|Double-blind Treatment Phase|Adverse Event|13|||
48711985|NCT01675167|156795007|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
48711986|NCT01675167|156795008|FG001|Double-blind Treatment Phase|Protocol Violation|4|||
48711987|NCT01675167|156795009|FG002|Double-blind Treatment Phase|Protocol Violation|11|||
48810371|NCT01473381|157146352|FG003|Overall Study|Other Reasons|3|||
48810372|NCT04741802|157146353|FG000|Overall Study|Death|1|||
48810373|NCT04741802|157146353|FG000|Overall Study|Lost to Follow-up|11|||
48810374|NCT01616771|157146354|FG000|Smaller Sized GVL for 5 Sec|lack of GVL size|4|||
48810375|NCT00988221|157146358|FG000|Part I|Adverse Event|0|||
48810376|NCT00988221|157146359|FG001|Part I|Adverse Event|1|||
48810377|NCT00988221|157146360|FG002|Part I|Adverse Event|2|||
48810378|NCT00988221|157146361|FG003|Part I|Adverse Event|0|||
48810379|NCT00988221|157146358|FG000|Part I|Insufficient Therapeutic Response|4|||
48810380|NCT00988221|157146359|FG001|Part I|Insufficient Therapeutic Response|6|||
48810381|NCT00988221|157146360|FG002|Part I|Insufficient Therapeutic Response|5|||
48810382|NCT00988221|157146361|FG003|Part I|Insufficient Therapeutic Response|0|||
48810383|NCT00988221|157146358|FG000|Part I|Refused Treatment|0|||
48810384|NCT00988221|157146359|FG001|Part I|Refused Treatment|2|||
48810385|NCT00988221|157146360|FG002|Part I|Refused Treatment|1|||
48810386|NCT00988221|157146361|FG003|Part I|Refused Treatment|0|||
48810387|NCT00988221|157146358|FG000|Part I|Lost to Follow-up|0|||
48810388|NCT00988221|157146359|FG001|Part I|Lost to Follow-up|1|||
48810389|NCT00988221|157146360|FG002|Part I|Lost to Follow-up|0|||
48810390|NCT00988221|157146361|FG003|Part I|Lost to Follow-up|0|||
48810391|NCT00988221|157146358|FG000|Part II|Adverse Event|1|||
48918688|NCT00606320|157537800|FG000|Overall Study|Progression to depressive phase|4|||
48918689|NCT00879645|157537801|FG000|Overall Study|Adverse Event|1|||
48918690|NCT00879645|157537802|FG001|Overall Study|Adverse Event|0|||
48918691|NCT00879645|157537803|FG002|Overall Study|Adverse Event|0|||
48918692|NCT00879645|157537804|FG003|Overall Study|Adverse Event|0|||
48918693|NCT01549002|157537805|FG000|Overall Study|Excessive pain|0|||
48918694|NCT01549002|157537806|FG001|Overall Study|Excessive pain|2|||
48918695|NCT01549002|157537805|FG000|Overall Study|Moderate sedation required|0|||
48918696|NCT01549002|157537806|FG001|Overall Study|Moderate sedation required|2|||
48918697|NCT01439204|157537807|FG000|Overall Study|Withdrawal by Subject|0|||
48918698|NCT01439204|157537808|FG001|Overall Study|Withdrawal by Subject|1|||
48918699|NCT01439204|157537807|FG000|Overall Study|Lost to Follow-up|0|||
48918700|NCT01439204|157537808|FG001|Overall Study|Lost to Follow-up|2|||
48918701|NCT01439204|157537807|FG000|Overall Study|No longer meets study criteria|1|||
48918702|NCT01439204|157537808|FG001|Overall Study|No longer meets study criteria|0|||
48918703|NCT01439204|157537807|FG000|Overall Study|poor/non-compliance|3|||
48918704|NCT01439204|157537808|FG001|Overall Study|poor/non-compliance|0|||
48918705|NCT04288154|157537809|FG000|Overall Study|Withdrawal by Subject|9|||
48918706|NCT04288154|157537810|FG001|Overall Study|Withdrawal by Subject|9|||
48918707|NCT01251367|157537812|FG000|Overall Study|Protocol Violation|1|||
48918708|NCT01251367|157537812|FG000|Overall Study|Lack of Efficacy|2|||
48918709|NCT01251367|157537812|FG000|Overall Study|Adverse Event|19|||
48918710|NCT01251367|157537812|FG000|Overall Study|Withdrawal by Subject|36|||
48918711|NCT01251367|157537812|FG000|Overall Study|Lost to Follow-up|5|||
48918712|NCT01251367|157537812|FG000|Overall Study|Subject Required Alternative Treatment|7|||
48918713|NCT01251367|157537812|FG000|Overall Study|No Study Drug Available|1|||
48918714|NCT01251367|157537812|FG000|Overall Study|Subject had Personal or Medical Issues|4|||
48918715|NCT01251367|157537812|FG000|Overall Study|End of Study Visit Performed in Error|1|||
48918716|NCT00004259|157537813|FG000|Overall Study|Protocol Violation|1|||
48918717|NCT00004259|157537814|FG001|Overall Study|Protocol Violation|2|||
48918718|NCT00004259|157537815|FG002|Overall Study|Protocol Violation|0|||
48918719|NCT00004259|157537816|FG003|Overall Study|Protocol Violation|0|||
49121043|NCT03410992|158280548|FG002|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
49121044|NCT03410992|158280549|FG003|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|67|||
49121045|NCT03410992|158280550|FG004|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|4|||
49121046|NCT03410992|158280551|FG005|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|7|||
48810392|NCT00988221|157146359|FG001|Part II|Adverse Event|0|||
48810393|NCT00988221|157146360|FG002|Part II|Adverse Event|0|||
49121047|NCT03410992|158280552|FG006|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
48810394|NCT00988221|157146361|FG003|Part II|Adverse Event|1|||
48810395|NCT00988221|157146358|FG000|Part II|Withdrawal by Subject|0|||
48810396|NCT00988221|157146359|FG001|Part II|Withdrawal by Subject|0|||
49121048|NCT03410992|158280553|FG007|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
49121049|NCT03410992|158280554|FG008|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
49121050|NCT03410992|158280555|FG009|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
48918720|NCT00004259|157537813|FG000|Overall Study|Withdrawal by Subject|0|||
48918721|NCT00004259|157537814|FG001|Overall Study|Withdrawal by Subject|2|||
48918722|NCT00004259|157537815|FG002|Overall Study|Withdrawal by Subject|0|||
48918723|NCT00004259|157537816|FG003|Overall Study|Withdrawal by Subject|0|||
48918724|NCT00996944|157537817|FG000|Double-blind Treatment Period|Adverse Event|2|||
49121051|NCT03410992|158280556|FG010|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
49121052|NCT03410992|158280546|FG000|Escape Treatment: 12 Weeks|Adverse Event|0|||
48918725|NCT00996944|157537818|FG001|Double-blind Treatment Period|Adverse Event|1|||
48918726|NCT00996944|157537817|FG000|Double-blind Treatment Period|Protocol Violation|1|||
48918727|NCT00996944|157537818|FG001|Double-blind Treatment Period|Protocol Violation|0|||
48918728|NCT00996944|157537817|FG000|Double-blind Treatment Period|Study Closed/Terminated|6|||
48810397|NCT00988221|157146360|FG002|Part II|Withdrawal by Subject|2|||
48810398|NCT00988221|157146361|FG003|Part II|Withdrawal by Subject|2|||
48810399|NCT00988221|157146358|FG000|Part II|Reason not Specified|0|||
48810400|NCT00988221|157146359|FG001|Part II|Reason not Specified|0|||
48810401|NCT00988221|157146360|FG002|Part II|Reason not Specified|1|||
48810402|NCT00988221|157146361|FG003|Part II|Reason not Specified|0|||
48810403|NCT00988221|157146358|FG000|Part III|Adverse Event|1|||
48810404|NCT00988221|157146359|FG001|Part III|Adverse Event|0|||
48810405|NCT00988221|157146360|FG002|Part III|Adverse Event|1|||
48810406|NCT00988221|157146361|FG003|Part III|Adverse Event|0|||
48810407|NCT00988221|157146358|FG000|Part III|Insufficient Therapeutic Response|0|||
48918729|NCT00996944|157537818|FG001|Double-blind Treatment Period|Study Closed/Terminated|5|||
49121053|NCT03410992|158280547|FG001|Escape Treatment: 12 Weeks|Adverse Event|0|||
49121054|NCT03410992|158280548|FG002|Escape Treatment: 12 Weeks|Adverse Event|0|||
49121055|NCT03410992|158280549|FG003|Escape Treatment: 12 Weeks|Adverse Event|0|||
49121056|NCT03410992|158280550|FG004|Escape Treatment: 12 Weeks|Adverse Event|0|||
48810408|NCT00988221|157146359|FG001|Part III|Insufficient Therapeutic Response|1|||
48810409|NCT00988221|157146360|FG002|Part III|Insufficient Therapeutic Response|1|||
48810410|NCT00988221|157146361|FG003|Part III|Insufficient Therapeutic Response|0|||
48810411|NCT00988221|157146358|FG000|Part III|Refused Treatment|0|||
48810412|NCT00988221|157146359|FG001|Part III|Refused Treatment|0|||
48810413|NCT00988221|157146360|FG002|Part III|Refused Treatment|1|||
48810414|NCT00988221|157146361|FG003|Part III|Refused Treatment|0|||
48810415|NCT02086552|157146364|FG000|Overall Study|Withdrawal by Subject|1|||
48810416|NCT02091739|157146367|FG000|MP: 16 Weeks|Adverse Event|1|||
48810417|NCT02091739|157146368|FG001|MP: 16 Weeks|Adverse Event|1|||
48810418|NCT02091739|157146369|FG002|MP: 16 Weeks|Adverse Event|1|||
48810419|NCT02091739|157146370|FG003|MP: 16 Weeks|Adverse Event|0|||
48810420|NCT02091739|157146371|FG004|MP: 16 Weeks|Adverse Event|0|||
48810421|NCT02091739|157146367|FG000|MP: 16 Weeks|Withdrawal by Subject|3|||
48810422|NCT02091739|157146368|FG001|MP: 16 Weeks|Withdrawal by Subject|4|||
48810423|NCT02091739|157146369|FG002|MP: 16 Weeks|Withdrawal by Subject|0|||
48810424|NCT02091739|157146370|FG003|MP: 16 Weeks|Withdrawal by Subject|0|||
48810425|NCT02091739|157146371|FG004|MP: 16 Weeks|Withdrawal by Subject|0|||
48810426|NCT02091739|157146367|FG000|MP: 16 Weeks|Lost to Follow-up|0|||
48810427|NCT02091739|157146368|FG001|MP: 16 Weeks|Lost to Follow-up|0|||
48810428|NCT02091739|157146369|FG002|MP: 16 Weeks|Lost to Follow-up|1|||
48810429|NCT02091739|157146370|FG003|MP: 16 Weeks|Lost to Follow-up|0|||
48810430|NCT02091739|157146371|FG004|MP: 16 Weeks|Lost to Follow-up|0|||
48810431|NCT02091739|157146367|FG000|EP: 48 Weeks|Other|0|||
48810432|NCT02091739|157146368|FG001|EP: 48 Weeks|Other|0|||
48810433|NCT02091739|157146369|FG002|EP: 48 Weeks|Other|0|||
48810434|NCT02091739|157146370|FG003|EP: 48 Weeks|Other|1|||
48810435|NCT02091739|157146371|FG004|EP: 48 Weeks|Other|0|||
48810436|NCT02091739|157146367|FG000|EP: 48 Weeks|Death|0|||
48810437|NCT02091739|157146368|FG001|EP: 48 Weeks|Death|0|||
48810438|NCT02091739|157146369|FG002|EP: 48 Weeks|Death|0|||
48810439|NCT02091739|157146370|FG003|EP: 48 Weeks|Death|3|||
48810440|NCT02091739|157146371|FG004|EP: 48 Weeks|Death|2|||
48810441|NCT02091739|157146367|FG000|EP: 48 Weeks|Adverse Event|0|||
48810442|NCT02091739|157146368|FG001|EP: 48 Weeks|Adverse Event|0|||
49121057|NCT03410992|158280551|FG005|Escape Treatment: 12 Weeks|Adverse Event|0|||
49121058|NCT03410992|158280552|FG006|Escape Treatment: 12 Weeks|Adverse Event|0|||
49121059|NCT03410992|158280553|FG007|Escape Treatment: 12 Weeks|Adverse Event|1|||
49121060|NCT03410992|158280554|FG008|Escape Treatment: 12 Weeks|Adverse Event|0|||
49121061|NCT03410992|158280555|FG009|Escape Treatment: 12 Weeks|Adverse Event|0|||
49121062|NCT03410992|158280556|FG010|Escape Treatment: 12 Weeks|Adverse Event|0|||
49121063|NCT03410992|158280546|FG000|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
49121064|NCT03410992|158280547|FG001|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
49121065|NCT03410992|158280548|FG002|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
49121066|NCT03410992|158280549|FG003|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
49121067|NCT03410992|158280550|FG004|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
49121068|NCT03410992|158280551|FG005|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
49121069|NCT03410992|158280552|FG006|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
49121070|NCT03410992|158280553|FG007|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
49121071|NCT03410992|158280554|FG008|Escape Treatment: 12 Weeks|Withdrawal by Subject|1|||
49121072|NCT03410992|158280555|FG009|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
49121073|NCT03410992|158280556|FG010|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
49121074|NCT02260817|158280557|FG000|Overall Study|Lost to Follow-up|0|||
49121075|NCT02260817|158280558|FG001|Overall Study|Lost to Follow-up|14|||
49121076|NCT02260817|158280557|FG000|Overall Study|Androgen deprivation therapy, no biopsy|0|||
49121077|NCT02260817|158280558|FG001|Overall Study|Androgen deprivation therapy, no biopsy|7|||
49121078|NCT02260817|158280557|FG000|Overall Study|Observation, no biopsy|0|||
49121079|NCT02260817|158280558|FG001|Overall Study|Observation, no biopsy|1|||
49121080|NCT02260817|158280557|FG000|Overall Study|Biopsy infeasible, ADT & rad. therapy|0|||
49121081|NCT02260817|158280558|FG001|Overall Study|Biopsy infeasible, ADT & rad. therapy|1|||
48810443|NCT02091739|157146369|FG002|EP: 48 Weeks|Adverse Event|0|||
48810444|NCT02091739|157146370|FG003|EP: 48 Weeks|Adverse Event|2|||
48810445|NCT02091739|157146371|FG004|EP: 48 Weeks|Adverse Event|6|||
48810446|NCT02091739|157146367|FG000|EP: 48 Weeks|Withdrawal by Subject|0|||
48810447|NCT02091739|157146368|FG001|EP: 48 Weeks|Withdrawal by Subject|0|||
48810448|NCT02091739|157146369|FG002|EP: 48 Weeks|Withdrawal by Subject|0|||
48810449|NCT02091739|157146370|FG003|EP: 48 Weeks|Withdrawal by Subject|2|||
48810450|NCT02091739|157146371|FG004|EP: 48 Weeks|Withdrawal by Subject|6|||
48810451|NCT00192023|157146373|FG000|Period III - Double-Blind|Adverse Event|3|||
48810452|NCT00192023|157146374|FG001|Period III - Double-Blind|Adverse Event|0|||
48810453|NCT00192023|157146373|FG000|Period III - Double-Blind|Physician Decision|2|||
48810454|NCT00192023|157146374|FG001|Period III - Double-Blind|Physician Decision|0|||
48810455|NCT00192023|157146373|FG000|Period III - Double-Blind|Parent/Caregiver Decision|2|||
48810456|NCT00192023|157146374|FG001|Period III - Double-Blind|Parent/Caregiver Decision|0|||
48810457|NCT00192023|157146373|FG000|Period IV - Optional Open-Label|Adverse Event|6|||
49121082|NCT02260817|158280557|FG000|Overall Study|Protocol Violation|0|||
49121083|NCT02260817|158280558|FG001|Overall Study|Protocol Violation|14|||
49121084|NCT04435808|158280559|FG000|Overall Study|Study stopped by DSMB|0|||
49121085|NCT04435808|158280560|FG001|Overall Study|Study stopped by DSMB|1|||
48711988|NCT01675167|156795007|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
48711989|NCT01675167|156795008|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
48810458|NCT00192023|157146374|FG001|Period IV - Optional Open-Label|Adverse Event|0|||
48810459|NCT00192023|157146373|FG000|Period IV - Optional Open-Label|Lack of Efficacy|7|||
48810460|NCT00192023|157146374|FG001|Period IV - Optional Open-Label|Lack of Efficacy|0|||
48810461|NCT00192023|157146373|FG000|Period IV - Optional Open-Label|Patient/Caregiver Decision|46|||
48810462|NCT00192023|157146374|FG001|Period IV - Optional Open-Label|Patient/Caregiver Decision|0|||
48810463|NCT00192023|157146373|FG000|Period IV - Optional Open-Label|Lost to Follow-up|2|||
48810464|NCT00192023|157146374|FG001|Period IV - Optional Open-Label|Lost to Follow-up|0|||
48810465|NCT00192023|157146373|FG000|Period IV - Optional Open-Label|Protocol Violation|1|||
48810466|NCT00192023|157146374|FG001|Period IV - Optional Open-Label|Protocol Violation|0|||
48810467|NCT00192023|157146373|FG000|Period IV - Optional Open-Label|Withdrawal by Subject|4|||
48810468|NCT00192023|157146374|FG001|Period IV - Optional Open-Label|Withdrawal by Subject|0|||
48810469|NCT00192023|157146373|FG000|Period IV - Optional Open-Label|Physician Decision|9|||
48810470|NCT00192023|157146374|FG001|Period IV - Optional Open-Label|Physician Decision|0|||
48810471|NCT00251927|157146378|FG000|Overall Study|Adverse Event|3|||
48810472|NCT00251927|157146379|FG001|Overall Study|Adverse Event|15|||
48810473|NCT00251927|157146378|FG000|Overall Study|Lack of Efficacy|22|||
48810474|NCT00251927|157146379|FG001|Overall Study|Lack of Efficacy|16|||
48810475|NCT00251927|157146378|FG000|Overall Study|Lost to Follow-up|22|||
48810476|NCT00251927|157146379|FG001|Overall Study|Lost to Follow-up|8|||
48810477|NCT00251927|157146378|FG000|Overall Study|Protocol Violation|1|||
48810478|NCT00251927|157146379|FG001|Overall Study|Protocol Violation|2|||
48810479|NCT00251927|157146378|FG000|Overall Study|Pregnancy|2|||
48810480|NCT00251927|157146379|FG001|Overall Study|Pregnancy|0|||
48810481|NCT00251927|157146378|FG000|Overall Study|Withdrawal by Subject|40|||
48810482|NCT00251927|157146379|FG001|Overall Study|Withdrawal by Subject|25|||
48810483|NCT00251927|157146378|FG000|Overall Study|Study-specific discont. achieved|13|||
48810484|NCT00251927|157146379|FG001|Overall Study|Study-specific discont. achieved|2|||
48810485|NCT00251927|157146378|FG000|Overall Study|Study procedure non-compliance|5|||
48810486|NCT00251927|157146379|FG001|Overall Study|Study procedure non-compliance|6|||
48810487|NCT00245856|157146384|FG000|Period Two|Withdrawal by Subject|0|||
48810488|NCT00245856|157146385|FG001|Period Two|Withdrawal by Subject|1|||
48810489|NCT02357810|157146386|FG000|Registered and Started Treatment|Withdrawal by Subject|1|||
48810490|NCT02357810|157146386|FG000|Registered and Started Treatment|Found not to be eligible for the study|26|||
48810491|NCT02357810|157146386|FG000|Reached 12 Weeks Response|Adverse Event|5|||
48810492|NCT02357810|157146386|FG000|Reached 12 Weeks Response|Progressive Disease|39|||
48810493|NCT02357810|157146386|FG000|Reached 12 Weeks Response|Withdrawal by Subject|8|||
48810494|NCT02357810|157146386|FG000|Reached 12 Weeks Response|Protocol Violation|1|||
48810495|NCT02357810|157146386|FG000|Reached 12 Weeks Response|Death|1|||
48810496|NCT02357810|157146386|FG000|Reached 12 Weeks Response|Physician Decision|1|||
48810497|NCT02357810|157146386|FG000|Reached 12 Weeks Response|Other|1|||
48810498|NCT02357810|157146386|FG000|12 Week Response and Further Treatment|Adverse Event|5|||
48810499|NCT02357810|157146386|FG000|12 Week Response and Further Treatment|Withdrawal by Subject|1|||
48810500|NCT02357810|157146386|FG000|12 Week Response and Further Treatment|Progressive Disease|15|||
49121086|NCT02896569|158280561|FG000|Overall Study|Lost to Follow-up|2|||
49121087|NCT02896569|158280562|FG001|Overall Study|Lost to Follow-up|1|||
49121088|NCT02896569|158280561|FG000|Overall Study|Physician Decision|1|||
49121089|NCT02896569|158280562|FG001|Overall Study|Physician Decision|3|||
49121090|NCT02896569|158280561|FG000|Overall Study|Adverse Event|0|||
49121091|NCT02896569|158280562|FG001|Overall Study|Adverse Event|1|||
49121092|NCT02896569|158280561|FG000|Overall Study|Withdrawal by Subject|1|||
48711990|NCT01675167|156795009|FG002|Double-blind Treatment Phase|Lost to Follow-up|5|||
48711991|NCT01675167|156795007|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
48711992|NCT01675167|156795008|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
48711993|NCT01675167|156795009|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9|||
48711994|NCT01675167|156795007|FG000|Double-blind Treatment Phase|Other|0|||
48810501|NCT02357810|157146386|FG000|12 Week Response and Further Treatment|Wound Complications|1|||
48810502|NCT02357810|157146386|FG000|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4|||
48810503|NCT02357810|157146386|FG000|Follow-up at Treatment Discontinuation|Lost to Follow-up|3|||
48810504|NCT00572624|157146387|FG000|Overall Study|Lost to Follow-up|10|||
48810505|NCT00572624|157146388|FG001|Overall Study|Lost to Follow-up|4|||
49121093|NCT02896569|158280562|FG001|Overall Study|Withdrawal by Subject|0|||
49121094|NCT03075267|158280564|FG000|Overall Study|Protocol Violation|1|||
49121095|NCT03075267|158280565|FG001|Overall Study|Protocol Violation|0|||
48810506|NCT00572624|157146387|FG000|Overall Study|Wanted to do a different diet program|1|||
48810507|NCT00572624|157146388|FG001|Overall Study|Wanted to do a different diet program|0|||
48810508|NCT00572624|157146387|FG000|Overall Study|Medication change|1|||
48810509|NCT00572624|157146388|FG001|Overall Study|Medication change|0|||
48810510|NCT00572624|157146387|FG000|Overall Study|Started a new job-- no time for study|1|||
48810511|NCT00572624|157146388|FG001|Overall Study|Started a new job-- no time for study|0|||
48810512|NCT00572624|157146387|FG000|Overall Study|Admitted to being a smoker|1|||
48810513|NCT00572624|157146388|FG001|Overall Study|Admitted to being a smoker|0|||
48810514|NCT00572624|157146387|FG000|Overall Study|Refused to do the stress test|1|||
48810515|NCT00572624|157146388|FG001|Overall Study|Refused to do the stress test|0|||
48810516|NCT00572624|157146387|FG000|Overall Study|Problem with vascular access|1|||
48810517|NCT00572624|157146388|FG001|Overall Study|Problem with vascular access|0|||
48810518|NCT00572624|157146387|FG000|Overall Study|Health issues unrelated to the study|1|||
48810519|NCT00572624|157146388|FG001|Overall Study|Health issues unrelated to the study|0|||
48810520|NCT04844918|157146389|FG000|Overall Study|Adverse Event|7|||
48810521|NCT04844918|157146390|FG001|Overall Study|Adverse Event|8|||
48810522|NCT04844918|157146391|FG002|Overall Study|Adverse Event|5|||
48810523|NCT04844918|157146389|FG000|Overall Study|Physician Decision|0|||
48810524|NCT04844918|157146390|FG001|Overall Study|Physician Decision|1|||
48810525|NCT04844918|157146391|FG002|Overall Study|Physician Decision|0|||
48810526|NCT04844918|157146389|FG000|Overall Study|Withdrawal by Subject|6|||
48810527|NCT04844918|157146390|FG001|Overall Study|Withdrawal by Subject|3|||
48810528|NCT04844918|157146391|FG002|Overall Study|Withdrawal by Subject|3|||
48810529|NCT04844918|157146389|FG000|Overall Study|Participants Excluded Due to GCP Compliance Issue|15|||
48810530|NCT04844918|157146390|FG001|Overall Study|Participants Excluded Due to GCP Compliance Issue|13|||
48810531|NCT04844918|157146391|FG002|Overall Study|Participants Excluded Due to GCP Compliance Issue|14|||
48810532|NCT00779584|157146392|FG000|Overall Study|Protocol Violation|0|||
48810533|NCT00779584|157146393|FG001|Overall Study|Protocol Violation|0|||
48810534|NCT00779584|157146394|FG002|Overall Study|Protocol Violation|0|||
48810535|NCT00779584|157146395|FG003|Overall Study|Protocol Violation|0|||
48810536|NCT00779584|157146396|FG004|Overall Study|Protocol Violation|0|||
48810537|NCT00779584|157146397|FG005|Overall Study|Protocol Violation|1|||
48810538|NCT00779584|157146398|FG006|Overall Study|Protocol Violation|0|||
48810539|NCT00779584|157146399|FG007|Overall Study|Protocol Violation|0|||
48810540|NCT00779584|157146400|FG008|Overall Study|Protocol Violation|0|||
48810541|NCT00779584|157146392|FG000|Overall Study|Withdrawal by Subject|1|||
48810542|NCT00779584|157146393|FG001|Overall Study|Withdrawal by Subject|1|||
48810543|NCT00779584|157146394|FG002|Overall Study|Withdrawal by Subject|2|||
48810544|NCT00779584|157146395|FG003|Overall Study|Withdrawal by Subject|0|||
48810545|NCT00779584|157146396|FG004|Overall Study|Withdrawal by Subject|0|||
48810546|NCT00779584|157146397|FG005|Overall Study|Withdrawal by Subject|2|||
48810547|NCT00779584|157146398|FG006|Overall Study|Withdrawal by Subject|1|||
48810548|NCT00779584|157146399|FG007|Overall Study|Withdrawal by Subject|0|||
48810549|NCT00779584|157146400|FG008|Overall Study|Withdrawal by Subject|0|||
48810550|NCT00779584|157146392|FG000|Overall Study|Lost to Follow-up|0|||
48810551|NCT00779584|157146393|FG001|Overall Study|Lost to Follow-up|0|||
48810552|NCT00779584|157146394|FG002|Overall Study|Lost to Follow-up|0|||
48810553|NCT00779584|157146395|FG003|Overall Study|Lost to Follow-up|0|||
48810554|NCT00779584|157146396|FG004|Overall Study|Lost to Follow-up|1|||
48810555|NCT00779584|157146397|FG005|Overall Study|Lost to Follow-up|0|||
48810556|NCT00779584|157146398|FG006|Overall Study|Lost to Follow-up|0|||
48810557|NCT00779584|157146399|FG007|Overall Study|Lost to Follow-up|0|||
48810558|NCT00779584|157146400|FG008|Overall Study|Lost to Follow-up|0|||
48810559|NCT00779584|157146392|FG000|Overall Study|Progression of Disease|0|||
48810560|NCT00779584|157146393|FG001|Overall Study|Progression of Disease|1|||
48810561|NCT00779584|157146394|FG002|Overall Study|Progression of Disease|2|||
48810562|NCT00779584|157146395|FG003|Overall Study|Progression of Disease|6|||
49121096|NCT03075267|158280566|FG002|Overall Study|Protocol Violation|0|||
49121097|NCT00527826|158280568|FG000|Overall Study|Adverse Event|10|||
49121098|NCT00527826|158280569|FG001|Overall Study|Adverse Event|10|||
48810563|NCT00779584|157146396|FG004|Overall Study|Progression of Disease|5|||
48810564|NCT00779584|157146397|FG005|Overall Study|Progression of Disease|1|||
49121099|NCT00527826|158280568|FG000|Overall Study|Lost to Follow-up|3|||
48810565|NCT00779584|157146398|FG006|Overall Study|Progression of Disease|4|||
48810566|NCT00779584|157146399|FG007|Overall Study|Progression of Disease|2|||
48810567|NCT00779584|157146400|FG008|Overall Study|Progression of Disease|1|||
48810568|NCT00779584|157146392|FG000|Overall Study|Adverse Event|1|||
48810569|NCT00779584|157146393|FG001|Overall Study|Adverse Event|0|||
48810570|NCT00779584|157146394|FG002|Overall Study|Adverse Event|2|||
48810571|NCT00779584|157146395|FG003|Overall Study|Adverse Event|0|||
48810572|NCT00779584|157146396|FG004|Overall Study|Adverse Event|0|||
48810573|NCT00779584|157146397|FG005|Overall Study|Adverse Event|0|||
48810574|NCT00779584|157146398|FG006|Overall Study|Adverse Event|2|||
48810575|NCT00779584|157146399|FG007|Overall Study|Adverse Event|1|||
48810576|NCT00779584|157146400|FG008|Overall Study|Adverse Event|1|||
49121100|NCT00527826|158280569|FG001|Overall Study|Lost to Follow-up|2|||
49121101|NCT00527826|158280568|FG000|Overall Study|Withdrawal by Subject|5|||
49121102|NCT00527826|158280569|FG001|Overall Study|Withdrawal by Subject|8|||
49121103|NCT00527826|158280568|FG000|Overall Study|Inclusion Criteria Not Met|3|||
49121104|NCT00527826|158280569|FG001|Overall Study|Inclusion Criteria Not Met|3|||
49121105|NCT00527826|158280568|FG000|Overall Study|Alpha-1 Antitrypsin Deficiency|0|||
49121106|NCT00527826|158280569|FG001|Overall Study|Alpha-1 Antitrypsin Deficiency|1|||
49121107|NCT00527826|158280568|FG000|Overall Study|Additional Intake of Viani forte|0|||
49121108|NCT00527826|158280569|FG001|Overall Study|Additional Intake of Viani forte|1|||
49121109|NCT00527826|158280568|FG000|Overall Study|Participant moved away|0|||
49121110|NCT00527826|158280569|FG001|Overall Study|Participant moved away|1|||
49121111|NCT00810069|158280570|FG000|Lead-in Period I|Adverse Event|43|||
49121112|NCT00810069|158280571|FG001|Lead-in Period I|Adverse Event|0|||
49121113|NCT00810069|158280572|FG002|Lead-in Period I|Adverse Event|0|||
48711995|NCT01675167|156795008|FG001|Double-blind Treatment Phase|Other|7|||
48711996|NCT01675167|156795009|FG002|Double-blind Treatment Phase|Other|5|||
48711997|NCT01525225|156795011|FG000|Enrollment|No longer met study criteria|1|||
49121114|NCT00810069|158280570|FG000|Lead-in Period I|Lack of Efficacy|1|||
49121115|NCT00810069|158280571|FG001|Lead-in Period I|Lack of Efficacy|0|||
49121116|NCT00810069|158280572|FG002|Lead-in Period I|Lack of Efficacy|0|||
49121117|NCT00810069|158280570|FG000|Lead-in Period I|Lost to Follow-up|19|||
49121118|NCT00810069|158280571|FG001|Lead-in Period I|Lost to Follow-up|0|||
49121119|NCT00810069|158280572|FG002|Lead-in Period I|Lost to Follow-up|0|||
49121120|NCT00810069|158280570|FG000|Lead-in Period I|Physician Decision|1|||
49121121|NCT00810069|158280571|FG001|Lead-in Period I|Physician Decision|0|||
49121122|NCT00810069|158280572|FG002|Lead-in Period I|Physician Decision|0|||
49121123|NCT00810069|158280570|FG000|Lead-in Period I|Protocol Violation|1|||
49121124|NCT00810069|158280571|FG001|Lead-in Period I|Protocol Violation|0|||
49121125|NCT00810069|158280572|FG002|Lead-in Period I|Protocol Violation|0|||
49121126|NCT00810069|158280570|FG000|Lead-in Period I|Withdrawal by Subject|46|||
48711998|NCT01525225|156795011|FG000|Enrollment|Other|1|||
48711999|NCT00881868|156795013|FG000|Overall Study|Adverse Event|0|||
48712000|NCT00881868|156795014|FG001|Overall Study|Adverse Event|1|||
48712001|NCT00881868|156795013|FG000|Overall Study|Lost to Follow-up|2|||
48712002|NCT00881868|156795014|FG001|Overall Study|Lost to Follow-up|1|||
48712003|NCT00881868|156795013|FG000|Overall Study|Physician Decision|4|||
48712004|NCT00881868|156795014|FG001|Overall Study|Physician Decision|0|||
48712005|NCT00881868|156795013|FG000|Overall Study|Protocol Violation|2|||
48712006|NCT00881868|156795014|FG001|Overall Study|Protocol Violation|0|||
48712007|NCT02537015|156795015|FG000|Overall Study|Adverse Event|3|||
48712008|NCT02537015|156795015|FG000|Overall Study|Withdrawal by Subject|2|||
48712009|NCT02537015|156795015|FG000|Overall Study|Other Miscellaneous Reasons|1|||
48712010|NCT01006291|156796987|FG000|Overall Study|Adverse Event|2|||
48712011|NCT01006291|156796988|FG001|Overall Study|Adverse Event|1|||
48712012|NCT01006291|156796989|FG002|Overall Study|Adverse Event|2|||
48712013|NCT01006291|156796987|FG000|Overall Study|Lack of Efficacy|2|||
48712014|NCT01006291|156796988|FG001|Overall Study|Lack of Efficacy|2|||
48712015|NCT01006291|156796989|FG002|Overall Study|Lack of Efficacy|1|||
48712016|NCT01006291|156796987|FG000|Overall Study|Protocol Violation|3|||
48712017|NCT01006291|156796988|FG001|Overall Study|Protocol Violation|3|||
48712018|NCT01006291|156796989|FG002|Overall Study|Protocol Violation|3|||
48712019|NCT01006291|156796987|FG000|Overall Study|Withdrawal criteria|5|||
48712020|NCT01006291|156796988|FG001|Overall Study|Withdrawal criteria|4|||
48712021|NCT01006291|156796989|FG002|Overall Study|Withdrawal criteria|4|||
48712022|NCT01006291|156796987|FG000|Overall Study|Other|14|||
48712023|NCT01006291|156796988|FG001|Overall Study|Other|14|||
48712024|NCT01006291|156796989|FG002|Overall Study|Other|17|||
48712025|NCT02105662|156796990|FG000|Overall Study|Lost to Follow-up|5|||
48712026|NCT02105662|156796990|FG000|Overall Study|Withdrawal by Subject|1|||
48712027|NCT02605122|156796991|FG000|Overall Study|Withdrawal by Subject|4|||
48712028|NCT02605122|156796992|FG001|Overall Study|Withdrawal by Subject|1|||
48712029|NCT02605122|156796991|FG000|Overall Study|Lost to Follow-up|1|||
48712030|NCT02605122|156796992|FG001|Overall Study|Lost to Follow-up|1|||
48712031|NCT01657461|156796997|FG000|Overall Study|Death|9|||
48712032|NCT01657461|156796998|FG001|Overall Study|Death|12|||
48712033|NCT01657461|156796997|FG000|Overall Study|Lost to Follow-up|0|||
48712034|NCT01657461|156796998|FG001|Overall Study|Lost to Follow-up|3|||
48712035|NCT01657461|156796997|FG000|Overall Study|Physician Decision|0|||
48712036|NCT01657461|156796998|FG001|Overall Study|Physician Decision|2|||
48712037|NCT01657461|156796997|FG000|Overall Study|Withdrawal by Subject|1|||
48712038|NCT01657461|156796998|FG001|Overall Study|Withdrawal by Subject|3|||
49121127|NCT00810069|158280571|FG001|Lead-in Period I|Withdrawal by Subject|0|||
49121128|NCT00810069|158280572|FG002|Lead-in Period I|Withdrawal by Subject|0|||
49121129|NCT00810069|158280570|FG000|Lead-in Period I|Protocol entry criterion not met|5|||
48712039|NCT03079102|156796999|FG000|Overall Study|Physician Decision|0|||
48712040|NCT03079102|156797000|FG001|Overall Study|Physician Decision|1|||
49121130|NCT00810069|158280571|FG001|Lead-in Period I|Protocol entry criterion not met|0|||
49121131|NCT00810069|158280572|FG002|Lead-in Period I|Protocol entry criterion not met|0|||
48810577|NCT00779584|157146392|FG000|Overall Study|Symptomatic Deterioration|1|||
48810578|NCT00779584|157146393|FG001|Overall Study|Symptomatic Deterioration|1|||
48810579|NCT00779584|157146394|FG002|Overall Study|Symptomatic Deterioration|1|||
48810580|NCT00779584|157146395|FG003|Overall Study|Symptomatic Deterioration|0|||
48810581|NCT00779584|157146396|FG004|Overall Study|Symptomatic Deterioration|0|||
48810582|NCT00779584|157146397|FG005|Overall Study|Symptomatic Deterioration|1|||
48810583|NCT00779584|157146398|FG006|Overall Study|Symptomatic Deterioration|1|||
48918730|NCT00996944|157537817|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
49121132|NCT00810069|158280570|FG000|Lead-in Period I|Randomization criteria not met|158|||
49121133|NCT00810069|158280571|FG001|Lead-in Period I|Randomization criteria not met|0|||
49121134|NCT00810069|158280572|FG002|Lead-in Period I|Randomization criteria not met|0|||
49121135|NCT00810069|158280570|FG000|Double-Blind Period II|Adverse Event|0|||
49121136|NCT00810069|158280571|FG001|Double-Blind Period II|Adverse Event|9|||
49121137|NCT00810069|158280572|FG002|Double-Blind Period II|Adverse Event|8|||
49121138|NCT00810069|158280570|FG000|Double-Blind Period II|Lack of Efficacy|0|||
49121139|NCT00810069|158280571|FG001|Double-Blind Period II|Lack of Efficacy|7|||
49121140|NCT00810069|158280572|FG002|Double-Blind Period II|Lack of Efficacy|12|||
49121141|NCT00810069|158280570|FG000|Double-Blind Period II|Lost to Follow-up|0|||
49121142|NCT00810069|158280571|FG001|Double-Blind Period II|Lost to Follow-up|9|||
49121143|NCT00810069|158280572|FG002|Double-Blind Period II|Lost to Follow-up|9|||
49121144|NCT00810069|158280570|FG000|Double-Blind Period II|Physician Decision|0|||
49121145|NCT00810069|158280571|FG001|Double-Blind Period II|Physician Decision|0|||
49121146|NCT00810069|158280572|FG002|Double-Blind Period II|Physician Decision|1|||
49121147|NCT00810069|158280570|FG000|Double-Blind Period II|Withdrawal by Subject|0|||
49121148|NCT00810069|158280571|FG001|Double-Blind Period II|Withdrawal by Subject|21|||
48810584|NCT00779584|157146399|FG007|Overall Study|Symptomatic Deterioration|0|||
48918731|NCT00996944|157537818|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
48918732|NCT00996944|157537817|FG000|Long-term Treatment Period|Study Closed/Terminated|12|||
48918733|NCT00996944|157537818|FG001|Long-term Treatment Period|Study Closed/Terminated|5|||
48918734|NCT03594227|157537820|FG000|Overall Study|Adverse Event|2|||
48918735|NCT03594227|157537821|FG001|Overall Study|Adverse Event|1|||
48918736|NCT03594227|157537822|FG002|Overall Study|Adverse Event|0|||
48918737|NCT03594227|157537823|FG003|Overall Study|Adverse Event|2|||
48918738|NCT03594227|157537820|FG000|Overall Study|Lost to Follow-up|1|||
48918739|NCT03594227|157537821|FG001|Overall Study|Lost to Follow-up|1|||
48918740|NCT03594227|157537822|FG002|Overall Study|Lost to Follow-up|1|||
48918741|NCT03594227|157537823|FG003|Overall Study|Lost to Follow-up|0|||
48918742|NCT03594227|157537820|FG000|Overall Study|Withdrawal by Subject|1|||
48918743|NCT03594227|157537821|FG001|Overall Study|Withdrawal by Subject|1|||
48918744|NCT03594227|157537822|FG002|Overall Study|Withdrawal by Subject|1|||
48918745|NCT03594227|157537823|FG003|Overall Study|Withdrawal by Subject|1|||
48918746|NCT03594227|157537820|FG000|Overall Study|Pregnancy|0|||
48918747|NCT03594227|157537821|FG001|Overall Study|Pregnancy|1|||
48918748|NCT03594227|157537822|FG002|Overall Study|Pregnancy|0|||
48918749|NCT03594227|157537823|FG003|Overall Study|Pregnancy|0|||
48918750|NCT03594227|157537820|FG000|Overall Study|Sponsor Decision|0|||
48918751|NCT03594227|157537821|FG001|Overall Study|Sponsor Decision|0|||
48918752|NCT03594227|157537822|FG002|Overall Study|Sponsor Decision|0|||
48918753|NCT03594227|157537823|FG003|Overall Study|Sponsor Decision|1|||
48918754|NCT03594227|157537820|FG000|Overall Study|Programmatic Analysis Non-completer|1|||
48918755|NCT03594227|157537821|FG001|Overall Study|Programmatic Analysis Non-completer|0|||
48918756|NCT03594227|157537822|FG002|Overall Study|Programmatic Analysis Non-completer|1|||
48918757|NCT03594227|157537823|FG003|Overall Study|Programmatic Analysis Non-completer|1|||
48918758|NCT01888640|157537824|FG000|Overall Study|Lost to Follow-up|1|||
48918759|NCT01888640|157537825|FG001|Overall Study|Lost to Follow-up|2|||
48918760|NCT01888640|157537826|FG002|Overall Study|Lost to Follow-up|0|||
48918761|NCT01888640|157537824|FG000|Overall Study|Withdrawal by Subject|15|||
48918762|NCT01888640|157537825|FG001|Overall Study|Withdrawal by Subject|11|||
48918763|NCT01888640|157537826|FG002|Overall Study|Withdrawal by Subject|4|||
48918764|NCT01888640|157537824|FG000|Overall Study|Minimum dose not met|10|||
48918765|NCT01888640|157537825|FG001|Overall Study|Minimum dose not met|16|||
48918766|NCT01888640|157537826|FG002|Overall Study|Minimum dose not met|0|||
48918767|NCT01888640|157537824|FG000|Overall Study|Given wrong unit (placebo)|1|||
48918768|NCT01888640|157537825|FG001|Overall Study|Given wrong unit (placebo)|0|||
48918769|NCT01888640|157537826|FG002|Overall Study|Given wrong unit (placebo)|0|||
48918770|NCT01888640|157537824|FG000|Overall Study|Excluded for prior TENS|0|||
48918771|NCT01888640|157537825|FG001|Overall Study|Excluded for prior TENS|1|||
48918772|NCT01888640|157537826|FG002|Overall Study|Excluded for prior TENS|0|||
48918773|NCT01888640|157537824|FG000|Overall Study|Researcher Termination of Participant|0|||
48918774|NCT01888640|157537825|FG001|Overall Study|Researcher Termination of Participant|1|||
49121149|NCT00810069|158280572|FG002|Double-Blind Period II|Withdrawal by Subject|35|||
49121150|NCT00810069|158280570|FG000|Double-Blind Period II|Protocol entry criterion not met|0|||
48810585|NCT00779584|157146400|FG008|Overall Study|Symptomatic Deterioration|0|||
48810586|NCT00779584|157146392|FG000|Overall Study|Ongoing in Study|0|||
48712041|NCT00843284|156797002|FG000|Overall Study|Adverse Event|39|||
48712042|NCT00843284|156797002|FG000|Overall Study|Lack of Efficacy|5|||
48712043|NCT00843284|156797002|FG000|Overall Study|Lost to Follow-up|11|||
48712044|NCT00843284|156797002|FG000|Overall Study|Other|10|||
48712045|NCT00843284|156797002|FG000|Overall Study|Withdrawal by Subject|4|||
48712046|NCT00843284|156797002|FG000|Overall Study|Death|3|||
48712047|NCT03773796|156797003|FG000|Overall Study|Adverse Event|1|||
48712048|NCT03773796|156797003|FG000|Overall Study|Withdrawal by Subject|1|||
48712049|NCT03773796|156797003|FG000|Overall Study|Lack of Efficacy|1|||
48712050|NCT00122980|156797008|FG000|Overall Study|Death|0|||
48712051|NCT00122980|156797009|FG001|Overall Study|Death|1|||
48712052|NCT00122980|156797008|FG000|Overall Study|Physician Decision|2|||
48712053|NCT00122980|156797009|FG001|Overall Study|Physician Decision|0|||
48712054|NCT00122980|156797008|FG000|Overall Study|Protocol Violation|5|||
48712055|NCT00122980|156797009|FG001|Overall Study|Protocol Violation|1|||
48712056|NCT00122980|156797008|FG000|Overall Study|Withdrawal by Subject|2|||
48712057|NCT00122980|156797009|FG001|Overall Study|Withdrawal by Subject|3|||
48712058|NCT00122980|156797008|FG000|Overall Study|Adjudicated stroke (study endpoint)|7|||
48712059|NCT00122980|156797009|FG001|Overall Study|Adjudicated stroke (study endpoint)|0|||
48712060|NCT00122980|156797008|FG000|Overall Study|Study termination|27|||
48712061|NCT00122980|156797009|FG001|Overall Study|Study termination|35|||
48712062|NCT02175199|156797010|FG000|Overall Study|Withdrawal by Subject|1|||
48712063|NCT02175199|156797011|FG001|Overall Study|Withdrawal by Subject|5|||
48712064|NCT02175199|156797010|FG000|Overall Study|Randomized in Error|1|||
48712065|NCT02175199|156797011|FG001|Overall Study|Randomized in Error|0|||
48712066|NCT02175199|156797010|FG000|Overall Study|Sponsor Decision|1|||
48712067|NCT02175199|156797011|FG001|Overall Study|Sponsor Decision|0|||
48712068|NCT00854113|156797014|FG000|Overall Study|Adverse Event|0|||
48712069|NCT00854113|156797015|FG001|Overall Study|Adverse Event|0|||
48712070|NCT00854113|156797016|FG002|Overall Study|Adverse Event|0|||
48712071|NCT00854113|156797017|FG003|Overall Study|Adverse Event|0|||
48712072|NCT00854113|156797018|FG004|Overall Study|Adverse Event|0|||
48712073|NCT00854113|156797019|FG005|Overall Study|Adverse Event|0|||
48712074|NCT00854113|156797020|FG006|Overall Study|Adverse Event|0|||
48712075|NCT00854113|156797021|FG007|Overall Study|Adverse Event|2|||
48712076|NCT00854113|156797022|FG008|Overall Study|Adverse Event|0|||
48712077|NCT00854113|156797023|FG009|Overall Study|Adverse Event|0|||
48712078|NCT00854113|156797024|FG010|Overall Study|Adverse Event|0|||
48712079|NCT00854113|156797014|FG000|Overall Study|Withdrawal by Subject|0|||
48712080|NCT00854113|156797015|FG001|Overall Study|Withdrawal by Subject|0|||
48712081|NCT00854113|156797016|FG002|Overall Study|Withdrawal by Subject|0|||
48712082|NCT00854113|156797017|FG003|Overall Study|Withdrawal by Subject|0|||
48712083|NCT00854113|156797018|FG004|Overall Study|Withdrawal by Subject|0|||
48712084|NCT00854113|156797019|FG005|Overall Study|Withdrawal by Subject|0|||
48712085|NCT00854113|156797020|FG006|Overall Study|Withdrawal by Subject|0|||
48712086|NCT00854113|156797021|FG007|Overall Study|Withdrawal by Subject|1|||
48712087|NCT00854113|156797022|FG008|Overall Study|Withdrawal by Subject|1|||
48712088|NCT00854113|156797023|FG009|Overall Study|Withdrawal by Subject|0|||
48712089|NCT00854113|156797024|FG010|Overall Study|Withdrawal by Subject|0|||
48712090|NCT02260180|156797025|FG000|Overall Study|Adverse Event|2|||
48712091|NCT02260180|156797026|FG001|Overall Study|Adverse Event|0|||
48712092|NCT02260180|156797027|FG002|Overall Study|Adverse Event|1|||
48712093|NCT01675544|156797036|FG000|Overall Study|Withdrawal by Subject|2|||
48712094|NCT00904033|156797041|FG000|Overall Study|Withdrawal by Subject|1|||
48712095|NCT00904033|156797042|FG001|Overall Study|Withdrawal by Subject|1|||
48712096|NCT00904033|156797043|FG002|Overall Study|Withdrawal by Subject|0|||
48712097|NCT00904033|156797044|FG003|Overall Study|Withdrawal by Subject|0|||
48712098|NCT00904033|156797041|FG000|Overall Study|Physician Decision|0|||
48712099|NCT00904033|156797042|FG001|Overall Study|Physician Decision|0|||
48712100|NCT00904033|156797043|FG002|Overall Study|Physician Decision|1|||
48712101|NCT00904033|156797044|FG003|Overall Study|Physician Decision|0|||
48712102|NCT00904033|156797041|FG000|Overall Study|Unable to obtain final blood draw|0|||
48712103|NCT00904033|156797042|FG001|Overall Study|Unable to obtain final blood draw|0|||
48712104|NCT00904033|156797043|FG002|Overall Study|Unable to obtain final blood draw|0|||
49010759|NCT00185211|157875695|FG000|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0|||
49010760|NCT00185211|157875696|FG001|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1|||
49010761|NCT00185211|157875695|FG000|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1|||
49010762|NCT00185211|157875696|FG001|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0|||
49010763|NCT00185211|157875695|FG000|Follow-up Study (91031 - This Study)|Adverse Event|5|||
49010764|NCT00185211|157875696|FG001|Follow-up Study (91031 - This Study)|Adverse Event|6|||
49010765|NCT00185211|157875695|FG000|Follow-up Study (91031 - This Study)|Lack of Efficacy|1|||
49010766|NCT00185211|157875696|FG001|Follow-up Study (91031 - This Study)|Lack of Efficacy|0|||
49010767|NCT00185211|157875695|FG000|Follow-up Study (91031 - This Study)|Lost to Follow-up|6|||
49010768|NCT00185211|157875696|FG001|Follow-up Study (91031 - This Study)|Lost to Follow-up|4|||
49010769|NCT00185211|157875695|FG000|Follow-up Study (91031 - This Study)|Physician Decision|1|||
49121151|NCT00810069|158280571|FG001|Double-Blind Period II|Protocol entry criterion not met|0|||
49121152|NCT00810069|158280572|FG002|Double-Blind Period II|Protocol entry criterion not met|1|||
49121153|NCT00810069|158280570|FG000|Double-Blind Period II|Clinical relapse|0|||
49121154|NCT00810069|158280571|FG001|Double-Blind Period II|Clinical relapse|3|||
49121155|NCT00810069|158280572|FG002|Double-Blind Period II|Clinical relapse|0|||
48712105|NCT00904033|156797044|FG003|Overall Study|Unable to obtain final blood draw|2|||
48712106|NCT02600819|156797045|FG000|GEN Phase|Adverse Event|2|||
48712107|NCT02600819|156797046|FG001|GEN Phase|Adverse Event|0|||
48712108|NCT02600819|156797045|FG000|GEN Phase|Death|2|||
48712109|NCT02600819|156797046|FG001|GEN Phase|Death|0|||
48712110|NCT02600819|156797045|FG000|GEN Phase|Investigator's Discretion|4|||
48712111|NCT02600819|156797046|FG001|GEN Phase|Investigator's Discretion|0|||
48712112|NCT02600819|156797045|FG000|GEN Phase|Non-Compliance with Study Drug|1|||
48712113|NCT02600819|156797046|FG001|GEN Phase|Non-Compliance with Study Drug|0|||
48712114|NCT02600819|156797045|FG000|GEN Phase|Withdrew Consent|5|||
48712115|NCT02600819|156797046|FG001|GEN Phase|Withdrew Consent|0|||
48712116|NCT02600819|156797045|FG000|GEN Phase|Lost to Follow-up|2|||
48712117|NCT02600819|156797046|FG001|GEN Phase|Lost to Follow-up|0|||
48810587|NCT00779584|157146393|FG001|Overall Study|Ongoing in Study|0|||
48810588|NCT00779584|157146394|FG002|Overall Study|Ongoing in Study|0|||
48810589|NCT00779584|157146395|FG003|Overall Study|Ongoing in Study|0|||
48810590|NCT00779584|157146396|FG004|Overall Study|Ongoing in Study|1|||
48810591|NCT00779584|157146397|FG005|Overall Study|Ongoing in Study|1|||
48810592|NCT00779584|157146398|FG006|Overall Study|Ongoing in Study|0|||
48810593|NCT00779584|157146399|FG007|Overall Study|Ongoing in Study|0|||
48810594|NCT00779584|157146400|FG008|Overall Study|Ongoing in Study|0|||
48810595|NCT00130793|157146403|FG000|Overall Study|Lost to Follow-up|1|||
48810596|NCT00130793|157146404|FG001|Overall Study|Lost to Follow-up|4|||
48810597|NCT00130793|157146403|FG000|Overall Study|Withdrew consent|2|||
48810598|NCT00130793|157146404|FG001|Overall Study|Withdrew consent|0|||
48810599|NCT01650519|157146407|FG000|Overall Study|Withdrawal by Subject|1|||
48810600|NCT01650519|157146408|FG001|Overall Study|Withdrawal by Subject|0|||
48918775|NCT01888640|157537826|FG002|Overall Study|Researcher Termination of Participant|1|||
48918776|NCT01227044|157537827|FG000|Overall Study|Lost to Follow-up|5|||
48918777|NCT01227044|157537828|FG001|Overall Study|Lost to Follow-up|7|||
48918778|NCT01227044|157537827|FG000|Overall Study|Discontinued Intervention|1|||
48918779|NCT01227044|157537828|FG001|Overall Study|Discontinued Intervention|2|||
48918780|NCT00884273|157537829|FG000|Overall Study|Adverse Event|0|||
48918781|NCT00884273|157537830|FG001|Overall Study|Adverse Event|2|||
48918782|NCT00884273|157537829|FG000|Overall Study|Protocol Violation|1|||
48918783|NCT00884273|157537830|FG001|Overall Study|Protocol Violation|3|||
48918784|NCT00884273|157537829|FG000|Overall Study|Practical reasons|1|||
48918785|NCT00884273|157537830|FG001|Overall Study|Practical reasons|0|||
48918786|NCT00623428|157537831|FG000|Treatment Period|Adverse event/intercurrent illness|0|||
48918787|NCT00623428|157537832|FG001|Treatment Period|Adverse event/intercurrent illness|9|||
48918788|NCT00623428|157537831|FG000|Treatment Period|Death|0|||
48918789|NCT00623428|157537832|FG001|Treatment Period|Death|1|||
48918790|NCT00623428|157537831|FG000|Treatment Period|Did not cooperate / refused treatment|0|||
48918791|NCT00623428|157537832|FG001|Treatment Period|Did not cooperate / refused treatment|13|||
48918792|NCT00623428|157537831|FG000|Treatment Period|Insufficient therapeutic response|0|||
48918793|NCT00623428|157537832|FG001|Treatment Period|Insufficient therapeutic response|2|||
48918794|NCT00623428|157537831|FG000|Treatment Period|Other|0|||
48918795|NCT00623428|157537832|FG001|Treatment Period|Other|1|||
48918796|NCT00623428|157537831|FG000|Treatment Period|Withdrawal by Subject|0|||
48918797|NCT00623428|157537832|FG001|Treatment Period|Withdrawal by Subject|1|||
48918798|NCT00623428|157537831|FG000|Follow-up Period|Relapse post-treatment|11|||
48918799|NCT00623428|157537832|FG001|Follow-up Period|Relapse post-treatment|3|||
48918800|NCT00623428|157537831|FG000|Follow-up Period|Failure to return|10|||
48918801|NCT00623428|157537832|FG001|Follow-up Period|Failure to return|2|||
48918802|NCT00623428|157537831|FG000|Follow-up Period|Patient withdrew consent|5|||
48918803|NCT00623428|157537832|FG001|Follow-up Period|Patient withdrew consent|4|||
48918804|NCT00623428|157537831|FG000|Follow-up Period|HCV-RNA detectable at end of treatment|2|||
48918805|NCT00623428|157537832|FG001|Follow-up Period|HCV-RNA detectable at end of treatment|1|||
48918806|NCT00623428|157537831|FG000|Follow-up Period|Did not cooperate|0|||
48918807|NCT00623428|157537832|FG001|Follow-up Period|Did not cooperate|3|||
48918808|NCT00623428|157537831|FG000|Follow-up Period|Reason not specified|1|||
48712118|NCT01754727|156797047|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
48712119|NCT02736890|156797048|FG000|Crossover Next 12 Weeks|Lost to Follow-up|1|||
48712120|NCT02736890|156797049|FG001|Crossover Next 12 Weeks|Lost to Follow-up|2|||
48918809|NCT00623428|157537832|FG001|Follow-up Period|Reason not specified|1|||
48918810|NCT00623428|157537831|FG000|Follow-up Period|Death|0|||
48810601|NCT02667886|157146409|FG000|Dose Escalation (Part A)|Adverse Event|1|||
49121156|NCT00810069|158280570|FG000|Double-Blind Period II|Protocol Violation|0|||
48810602|NCT02667886|157146410|FG001|Dose Escalation (Part A)|Adverse Event|3|||
48918811|NCT00623428|157537832|FG001|Follow-up Period|Death|1|||
49121157|NCT00810069|158280571|FG001|Double-Blind Period II|Protocol Violation|7|||
48918812|NCT03215771|157537833|FG000|Overall Study|Withdrawal by Subject|2|||
48918813|NCT03215771|157537833|FG000|Overall Study|Physician Decision|1|||
48918814|NCT02054897|157537837|FG000|Overall Study|Withdrawal by Subject|2|||
48918815|NCT02054897|157537838|FG001|Overall Study|Withdrawal by Subject|0|||
48918816|NCT02054897|157537839|FG002|Overall Study|Withdrawal by Subject|2|||
48918817|NCT02054897|157537837|FG000|Overall Study|Missing follow-up information|3|||
48918818|NCT02054897|157537838|FG001|Overall Study|Missing follow-up information|5|||
48918819|NCT02054897|157537839|FG002|Overall Study|Missing follow-up information|3|||
48918820|NCT02054897|157537837|FG000|Overall Study|Lost to Follow-up|4|||
48918821|NCT02054897|157537838|FG001|Overall Study|Lost to Follow-up|2|||
48918822|NCT02054897|157537839|FG002|Overall Study|Lost to Follow-up|7|||
48918823|NCT02054897|157537837|FG000|Overall Study|Randomized but not exposed|1|||
48918824|NCT02054897|157537838|FG001|Overall Study|Randomized but not exposed|0|||
48918825|NCT02054897|157537839|FG002|Overall Study|Randomized but not exposed|0|||
48918826|NCT00492752|157537840|FG000|Double Blind Treatment|Death|13|||
48918827|NCT00492752|157537841|FG001|Double Blind Treatment|Death|0|||
48810603|NCT02667886|157146411|FG002|Dose Escalation (Part A)|Adverse Event|1|||
48810604|NCT02667886|157146412|FG003|Dose Escalation (Part A)|Adverse Event|0|||
48810605|NCT02667886|157146413|FG004|Dose Escalation (Part A)|Adverse Event|0|||
48810606|NCT02667886|157146409|FG000|Dose Escalation (Part A)|Disease Progression|1|||
48810607|NCT02667886|157146410|FG001|Dose Escalation (Part A)|Disease Progression|4|||
48810608|NCT02667886|157146411|FG002|Dose Escalation (Part A)|Disease Progression|3|||
48810609|NCT02667886|157146412|FG003|Dose Escalation (Part A)|Disease Progression|0|||
48810610|NCT02667886|157146413|FG004|Dose Escalation (Part A)|Disease Progression|0|||
48810611|NCT02667886|157146409|FG000|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
48810612|NCT02667886|157146410|FG001|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
48810613|NCT02667886|157146411|FG002|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|2|||
48810614|NCT02667886|157146412|FG003|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
48810615|NCT02667886|157146413|FG004|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
48810616|NCT02667886|157146409|FG000|Dose Expansion (Part B)|Adverse Event|0|||
48810617|NCT02667886|157146410|FG001|Dose Expansion (Part B)|Adverse Event|0|||
48810618|NCT02667886|157146411|FG002|Dose Expansion (Part B)|Adverse Event|0|||
48810619|NCT02667886|157146412|FG003|Dose Expansion (Part B)|Adverse Event|9|||
48810620|NCT02667886|157146413|FG004|Dose Expansion (Part B)|Adverse Event|0|||
48810621|NCT02667886|157146409|FG000|Dose Expansion (Part B)|Clinical Deterioration|0|||
48810622|NCT02667886|157146410|FG001|Dose Expansion (Part B)|Clinical Deterioration|0|||
48810623|NCT02667886|157146411|FG002|Dose Expansion (Part B)|Clinical Deterioration|0|||
48810624|NCT02667886|157146412|FG003|Dose Expansion (Part B)|Clinical Deterioration|3|||
48810625|NCT02667886|157146413|FG004|Dose Expansion (Part B)|Clinical Deterioration|0|||
48810626|NCT02667886|157146409|FG000|Dose Expansion (Part B)|Disease Progression|0|||
48810627|NCT02667886|157146410|FG001|Dose Expansion (Part B)|Disease Progression|0|||
48810628|NCT02667886|157146411|FG002|Dose Expansion (Part B)|Disease Progression|0|||
48810629|NCT02667886|157146412|FG003|Dose Expansion (Part B)|Disease Progression|38|||
48810630|NCT02667886|157146413|FG004|Dose Expansion (Part B)|Disease Progression|0|||
48810631|NCT02667886|157146409|FG000|Dose Expansion (Part B)|Withdrawal by Subject|0|||
48810632|NCT02667886|157146410|FG001|Dose Expansion (Part B)|Withdrawal by Subject|0|||
48810633|NCT02667886|157146411|FG002|Dose Expansion (Part B)|Withdrawal by Subject|0|||
48810634|NCT02667886|157146412|FG003|Dose Expansion (Part B)|Withdrawal by Subject|4|||
48810635|NCT02667886|157146413|FG004|Dose Expansion (Part B)|Withdrawal by Subject|0|||
48810636|NCT02667886|157146409|FG000|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
48810637|NCT02667886|157146410|FG001|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
48810638|NCT02667886|157146411|FG002|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
48810639|NCT02667886|157146412|FG003|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
48810640|NCT02667886|157146413|FG004|Dose Escalation and Expansion (Part C)|Adverse Event|1|||
48810641|NCT02667886|157146409|FG000|Dose Escalation and Expansion (Part C)|DLT|0|||
48810642|NCT02667886|157146410|FG001|Dose Escalation and Expansion (Part C)|DLT|0|||
48810643|NCT02667886|157146411|FG002|Dose Escalation and Expansion (Part C)|DLT|0|||
48810644|NCT02667886|157146412|FG003|Dose Escalation and Expansion (Part C)|DLT|0|||
48918828|NCT00492752|157537842|FG002|Double Blind Treatment|Death|2|||
48918829|NCT00492752|157537843|FG003|Double Blind Treatment|Death|0|||
48918830|NCT00492752|157537840|FG000|Double Blind Treatment|Adverse Event|1|||
48918831|NCT00492752|157537841|FG001|Double Blind Treatment|Adverse Event|0|||
48810645|NCT02667886|157146413|FG004|Dose Escalation and Expansion (Part C)|DLT|2|||
48810646|NCT00747123|157146414|FG000|Overall Study|Investigator's request|0|||
48810647|NCT00747123|157146415|FG001|Overall Study|Investigator's request|0|||
48810648|NCT00747123|157146416|FG002|Overall Study|Investigator's request|1|||
48810649|NCT00747123|157146417|FG003|Overall Study|Investigator's request|0|||
48810650|NCT00747123|157146414|FG000|Overall Study|Withdrew consent|0|||
48810651|NCT00747123|157146415|FG001|Overall Study|Withdrew consent|1|||
48810652|NCT00747123|157146416|FG002|Overall Study|Withdrew consent|0|||
48918832|NCT00492752|157537842|FG002|Double Blind Treatment|Adverse Event|0|||
48918833|NCT00492752|157537843|FG003|Double Blind Treatment|Adverse Event|0|||
48918834|NCT00492752|157537840|FG000|Double Blind Treatment|Protocol Violation|0|||
48712121|NCT02736890|156797048|FG000|Crossover Next 12 Weeks|Withdrawal by Subject|1|||
48712122|NCT02736890|156797049|FG001|Crossover Next 12 Weeks|Withdrawal by Subject|0|||
48712123|NCT02249832|156797052|FG000|Overall Study|Withdrawal by Subject|3|||
48712124|NCT02249832|156797052|FG000|Overall Study|Lost to Follow-up|10|||
48712125|NCT02230670|156797059|FG000|Overall Study|Adverse Event|1|||
48712126|NCT02230670|156797060|FG001|Overall Study|Adverse Event|2|||
48712127|NCT02230670|156797059|FG000|Overall Study|Withdrawal by Subject|2|||
48712128|NCT02230670|156797060|FG001|Overall Study|Withdrawal by Subject|2|||
48712129|NCT02230670|156797059|FG000|Overall Study|Physician Decision|0|||
48712130|NCT02230670|156797060|FG001|Overall Study|Physician Decision|1|||
48712131|NCT02230670|156797059|FG000|Overall Study|Protocol Violation|0|||
48712132|NCT02230670|156797060|FG001|Overall Study|Protocol Violation|1|||
48712133|NCT02230670|156797059|FG000|Overall Study|Progression to Child-Pugh C|1|||
48712134|NCT02230670|156797060|FG001|Overall Study|Progression to Child-Pugh C|2|||
48712135|NCT04849559|156797066|FG000|Overall Study|Withdrawal by Subject|2|||
48712136|NCT04849559|156797067|FG001|Overall Study|Withdrawal by Subject|1|||
48712137|NCT01262989|156797069|FG000|Period 1|Lost to Follow-up|1|||
48712138|NCT01262989|156797070|FG001|Period 1|Lost to Follow-up|1|||
48712139|NCT01262989|156797069|FG000|Period 1|Intercurrent disease|0|||
48712140|NCT01262989|156797070|FG001|Period 1|Intercurrent disease|1|||
48712141|NCT01262989|156797069|FG000|Period 1|Positive answer for exclusion criteria|0|||
48712142|NCT01262989|156797070|FG001|Period 1|Positive answer for exclusion criteria|1|||
48712143|NCT01262989|156797069|FG000|Period 2|Intercurrent disease|0|||
48712144|NCT01262989|156797070|FG001|Period 2|Intercurrent disease|1|||
48712145|NCT01068600|156797071|FG000|Overall Study|Withdrawal by Subject|5|||
48712146|NCT01068600|156797072|FG001|Overall Study|Withdrawal by Subject|6|||
48712147|NCT01068600|156797071|FG000|Overall Study|Adverse Event|3|||
48712148|NCT01068600|156797072|FG001|Overall Study|Adverse Event|3|||
48712149|NCT01068600|156797071|FG000|Overall Study|Abnormal laboratory value(s)|1|||
48712150|NCT01068600|156797072|FG001|Overall Study|Abnormal laboratory value(s)|0|||
48712151|NCT01068600|156797071|FG000|Overall Study|Lost to Follow-up|1|||
48712152|NCT01068600|156797072|FG001|Overall Study|Lost to Follow-up|2|||
48712153|NCT01068600|156797071|FG000|Overall Study|Protocol deviation|1|||
48712154|NCT01068600|156797072|FG001|Overall Study|Protocol deviation|1|||
48712155|NCT01068600|156797071|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
48712156|NCT01068600|156797072|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
48712157|NCT01068600|156797071|FG000|Overall Study|Administrative problems|0|||
48712158|NCT01068600|156797072|FG001|Overall Study|Administrative problems|1|||
48712159|NCT02644109|156797073|FG000|Overall Study|Adverse Event|0|||
48712160|NCT02644109|156797074|FG001|Overall Study|Adverse Event|4|||
48712161|NCT01802073|156797075|FG000|Overall Study|Lost to Follow-up|0|||
48712162|NCT01802073|156797076|FG001|Overall Study|Lost to Follow-up|1|||
48712163|NCT01802073|156797075|FG000|Overall Study|Non-compliant|4|||
48712164|NCT01802073|156797076|FG001|Overall Study|Non-compliant|2|||
48712165|NCT01802073|156797075|FG000|Overall Study|Withdrawal by Subject|1|||
48712166|NCT01802073|156797076|FG001|Overall Study|Withdrawal by Subject|1|||
48712167|NCT01802073|156797075|FG000|Overall Study|Physician Decision|0|||
48712168|NCT01802073|156797076|FG001|Overall Study|Physician Decision|7|||
48712169|NCT04075734|156797077|FG000|Overall Study|Lost to Follow-up|1|||
48712170|NCT04075734|156797078|FG001|Overall Study|Lost to Follow-up|1|||
48712171|NCT04075734|156797079|FG002|Overall Study|Lost to Follow-up|0|||
48712172|NCT04075734|156797077|FG000|Overall Study|Withdrawal by Subject|3|||
48712173|NCT04075734|156797078|FG001|Overall Study|Withdrawal by Subject|0|||
48712174|NCT04075734|156797079|FG002|Overall Study|Withdrawal by Subject|0|||
48712175|NCT00459186|156797080|FG000|Single Agent RAD001|Withdrawal by Subject|1|||
48712176|NCT00459186|156797080|FG000|PET Imaging and Assessment|Adverse Event|3|||
48712177|NCT01598129|156797081|FG000|Overall Study|Disease progression|6|||
48712178|NCT01598129|156797081|FG000|Overall Study|Deterioration of WHO status to WHO 4|2|||
48712179|NCT01598129|156797081|FG000|Overall Study|Withdrawal by Subject|1|||
48712180|NCT01942733|156797083|FG000|Overall Study|Lost to Follow-up|1|||
48712181|NCT01942733|156797083|FG000|Overall Study|Non-compliance with IMP|1|||
48712182|NCT01942733|156797083|FG000|Overall Study|Administrative|1|||
48712183|NCT00634101|156797084|FG000|Overall Study|Study Terminated|3|||
48712184|NCT00634101|156797085|FG001|Overall Study|Study Terminated|3|||
48712185|NCT00634101|156797084|FG000|Overall Study|Lost to Follow-up|2|||
48712186|NCT00634101|156797085|FG001|Overall Study|Lost to Follow-up|0|||
48712187|NCT04074161|156797087|FG000|Overall Study|Withdrawal by Subject|2|||
48712188|NCT04074161|156797088|FG001|Overall Study|Withdrawal by Subject|4|||
48712189|NCT04074161|156797089|FG002|Overall Study|Withdrawal by Subject|1|||
48712190|NCT04074161|156797087|FG000|Overall Study|Lost to Follow-up|4|||
48712191|NCT04074161|156797088|FG001|Overall Study|Lost to Follow-up|5|||
48712192|NCT04074161|156797089|FG002|Overall Study|Lost to Follow-up|3|||
48712193|NCT01018810|156797092|FG000|Overall Study|Withdrawal by Subject|0|||
48712194|NCT01018810|156797093|FG001|Overall Study|Withdrawal by Subject|1|||
49121158|NCT00810069|158280572|FG002|Double-Blind Period II|Protocol Violation|6|||
49121159|NCT03143101|158280573|FG000|Overall Study|Withdrawal by Subject|0|||
49121160|NCT03143101|158280574|FG001|Overall Study|Withdrawal by Subject|1|||
49121161|NCT03143101|158280575|FG002|Overall Study|Withdrawal by Subject|0|||
49121162|NCT03143101|158280573|FG000|Overall Study|Lost to Follow-up|2|||
49121163|NCT03143101|158280574|FG001|Overall Study|Lost to Follow-up|2|||
49121164|NCT03143101|158280575|FG002|Overall Study|Lost to Follow-up|0|||
49121165|NCT00991289|158280578|FG000|Overall Study|Adverse Event|1|||
49121166|NCT00991289|158280578|FG000|Overall Study|Physician Decision|2|||
49121167|NCT00991289|158280578|FG000|Overall Study|Withdrawal by Subject|3|||
49121168|NCT00991289|158280578|FG000|Overall Study|Lost to Follow-up|4|||
49121169|NCT00991289|158280578|FG000|Overall Study|Protocol Violation|2|||
49121170|NCT00227539|158280579|FG000|Overall Study|Protocol Violation|1|||
49121171|NCT01166750|158280582|FG000|Overall Study|Lost to Follow-up|1|||
49121172|NCT01166750|158280583|FG001|Overall Study|Lost to Follow-up|0|||
49121173|NCT04552132|158280586|FG000|Overall Study|Lost to Follow-up|4|||
49121174|NCT04552132|158280587|FG001|Overall Study|Lost to Follow-up|3|||
49121175|NCT04552132|158280586|FG000|Overall Study|Protocol Violation|1|||
49121176|NCT04552132|158280587|FG001|Overall Study|Protocol Violation|0|||
49121177|NCT00792909|158280588|FG000|Overall Study|Withdrawal by Subject|0|||
49121178|NCT00792909|158280589|FG001|Overall Study|Withdrawal by Subject|1|||
49121179|NCT00792909|158280590|FG002|Overall Study|Withdrawal by Subject|0|||
49121180|NCT03293394|158280591|FG000|Follow-up (6 Months)|Adverse Event|4|||
49121181|NCT03293394|158280592|FG001|Follow-up (6 Months)|Adverse Event|2|||
49121182|NCT00385918|158280593|FG000|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
49121183|NCT00385918|158280594|FG001|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
49121184|NCT00385918|158280595|FG002|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8|||
49121185|NCT00385918|158280593|FG000|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
49121186|NCT00385918|158280594|FG001|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
49121187|NCT00385918|158280595|FG002|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5|||
49121188|NCT00385918|158280593|FG000|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
49121189|NCT00385918|158280594|FG001|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
49121190|NCT00385918|158280595|FG002|Feasibility & Baseline Measurement Phase|Physician Decision|1|||
49121191|NCT00385918|158280593|FG000|Intervention Phase After Randomization|Withdrawal by Subject|1|||
49121192|NCT00385918|158280594|FG001|Intervention Phase After Randomization|Withdrawal by Subject|0|||
49121193|NCT00385918|158280595|FG002|Intervention Phase After Randomization|Withdrawal by Subject|0|||
49121194|NCT00385918|158280593|FG000|Intervention Phase After Randomization|Physician Decision|1|||
49121195|NCT00385918|158280594|FG001|Intervention Phase After Randomization|Physician Decision|0|||
49121196|NCT00385918|158280595|FG002|Intervention Phase After Randomization|Physician Decision|0|||
49121197|NCT00385918|158280593|FG000|Intervention Phase After Randomization|Lost to Follow-up|1|||
49121198|NCT00385918|158280594|FG001|Intervention Phase After Randomization|Lost to Follow-up|0|||
49121199|NCT00385918|158280595|FG002|Intervention Phase After Randomization|Lost to Follow-up|0|||
49121200|NCT03421379|158280596|FG000|Period 1|Withdrawal by Subject|0|||
49121201|NCT03421379|158280597|FG001|Period 1|Withdrawal by Subject|1|||
49121202|NCT03421379|158280596|FG000|Period 1|Physician Decision|1|||
49121203|NCT03421379|158280597|FG001|Period 1|Physician Decision|1|||
49121204|NCT03421379|158280596|FG000|Period 1|Did not receive treatment|1|||
49121205|NCT03421379|158280597|FG001|Period 1|Did not receive treatment|2|||
49121206|NCT04978337|158280598|FG000|Overall Study|Withdrawal by Subject|0|||
48712195|NCT01018810|156797094|FG002|Overall Study|Withdrawal by Subject|0|||
48712196|NCT01018810|156797095|FG003|Overall Study|Withdrawal by Subject|0|||
48712197|NCT01018810|156797096|FG004|Overall Study|Withdrawal by Subject|0|||
48712198|NCT01018810|156797092|FG000|Overall Study|Sponsor Decision|2|||
48712199|NCT01018810|156797093|FG001|Overall Study|Sponsor Decision|0|||
48712200|NCT01018810|156797094|FG002|Overall Study|Sponsor Decision|1|||
48712201|NCT01018810|156797095|FG003|Overall Study|Sponsor Decision|1|||
48712202|NCT01018810|156797096|FG004|Overall Study|Sponsor Decision|1|||
48712203|NCT03672097|156797097|FG000|Period 1|Withdrawal by Subject|2|||
48712204|NCT03672097|156797097|FG000|Period 1|Adverse Event|1|||
48712205|NCT03672097|156797097|FG000|Period 1|Did not receive treatment|1|||
48712206|NCT03672097|156797097|FG000|Period 2|Withdrawal by Subject|3|||
48712207|NCT03672097|156797097|FG000|Period 2|Other|1|||
48712208|NCT00324961|156797100|FG000|Overall Study|Adverse Event|5|||
48712209|NCT00324961|156797100|FG000|Overall Study|Consent Withdrawn|11|||
48712210|NCT00324961|156797100|FG000|Overall Study|Lost to Follow-up|22|||
48712211|NCT00324961|156797100|FG000|Overall Study|Protocol Violation|3|||
48712212|NCT00324961|156797100|FG000|Overall Study|Other|2|||
48712213|NCT00223080|156797101|FG000|Overall Study|Withdrawal by Subject|253|||
48712214|NCT00223080|156797102|FG001|Overall Study|Withdrawal by Subject|232|||
48712215|NCT00223080|156797101|FG000|Overall Study|Required contraindicated med|0|||
49121207|NCT04978337|158280599|FG001|Overall Study|Withdrawal by Subject|1|||
48712216|NCT00223080|156797102|FG001|Overall Study|Required contraindicated med|1|||
49121208|NCT00196105|158280601|FG000|Overall Study|Lost to Follow-up|4|||
49121209|NCT00196105|158280602|FG001|Overall Study|Lost to Follow-up|5|||
48810653|NCT00747123|157146417|FG003|Overall Study|Withdrew consent|0|||
48810654|NCT00747123|157146414|FG000|Overall Study|Adverse Event|0|||
48810655|NCT00747123|157146415|FG001|Overall Study|Adverse Event|1|||
48810656|NCT00747123|157146416|FG002|Overall Study|Adverse Event|0|||
48810657|NCT00747123|157146417|FG003|Overall Study|Adverse Event|1|||
48810658|NCT04186403|157146418|FG000|Overall Study|Adverse Event|1|||
48810659|NCT04186403|157146419|FG001|Overall Study|Adverse Event|8|||
48810660|NCT04186403|157146418|FG000|Overall Study|Lost to Follow-up|7|||
48810661|NCT04186403|157146419|FG001|Overall Study|Lost to Follow-up|3|||
48810662|NCT04186403|157146418|FG000|Overall Study|Physician Decision|1|||
48810663|NCT04186403|157146419|FG001|Overall Study|Physician Decision|0|||
48810664|NCT04186403|157146418|FG000|Overall Study|Withdrawal by Subject|7|||
48810665|NCT04186403|157146419|FG001|Overall Study|Withdrawal by Subject|8|||
48810666|NCT04186403|157146418|FG000|Overall Study|Other: Not Related to Covid-19|3|||
48810667|NCT04186403|157146419|FG001|Overall Study|Other: Not Related to Covid-19|0|||
48810668|NCT02696902|157146420|FG000|Overall Study|Lost to Follow-up|0|||
48810669|NCT02696902|157146421|FG001|Overall Study|Lost to Follow-up|1|||
48810670|NCT02696902|157146422|FG002|Overall Study|Lost to Follow-up|1|||
48810671|NCT02696902|157146420|FG000|Overall Study|Withdrawal by Subject|0|||
48810672|NCT02696902|157146421|FG001|Overall Study|Withdrawal by Subject|0|||
48810673|NCT02696902|157146422|FG002|Overall Study|Withdrawal by Subject|1|||
48810674|NCT02696902|157146420|FG000|Overall Study|Death|19|||
48810675|NCT02696902|157146421|FG001|Overall Study|Death|3|||
48810676|NCT02696902|157146422|FG002|Overall Study|Death|24|||
48810677|NCT02696902|157146420|FG000|Overall Study|Participant not fit post-randomization|0|||
49121210|NCT00196105|158280603|FG002|Overall Study|Lost to Follow-up|7|||
49121211|NCT04346199|158280606|FG000|Overall Study|Death|8|||
48810678|NCT02696902|157146421|FG001|Overall Study|Participant not fit post-randomization|0|||
48810679|NCT02696902|157146422|FG002|Overall Study|Participant not fit post-randomization|1|||
49121212|NCT04346199|158280607|FG001|Overall Study|Death|9|||
49121213|NCT04346199|158280606|FG000|Overall Study|Lost to Follow-up|0|||
49121214|NCT04346199|158280607|FG001|Overall Study|Lost to Follow-up|1|||
49121215|NCT04346199|158280606|FG000|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|2|||
49121216|NCT04346199|158280607|FG001|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|0|||
49121217|NCT04346199|158280606|FG000|Overall Study|Withdrawal by Subject|5|||
49121218|NCT04346199|158280607|FG001|Overall Study|Withdrawal by Subject|1|||
49121219|NCT03797898|158280609|FG000|Overall Study|Lost to Follow-up|60|||
49121220|NCT03797898|158280610|FG001|Overall Study|Lost to Follow-up|69|||
49121221|NCT03797898|158280609|FG000|Overall Study|Withdrawal by Subject|9|||
49121222|NCT03797898|158280610|FG001|Overall Study|Withdrawal by Subject|7|||
49121223|NCT03797898|158280609|FG000|Overall Study|Became ineligible|5|||
49121224|NCT03797898|158280610|FG001|Overall Study|Became ineligible|2|||
49121225|NCT01151345|158280611|FG000|First Intervention Period|Protocol Violation|0|||
49121226|NCT01151345|158280612|FG001|First Intervention Period|Protocol Violation|1|||
49121227|NCT03066830|158280613|FG000|Overall Study|At the Participant's own Request|16|||
49121228|NCT03066830|158280614|FG001|Overall Study|At the Participant's own Request|17|||
49121229|NCT03066830|158280613|FG000|Overall Study|Other|3|||
49121230|NCT03066830|158280614|FG001|Overall Study|Other|0|||
49121231|NCT03066830|158280613|FG000|Overall Study|Poor Compliance to Protocol|1|||
49121232|NCT03066830|158280614|FG001|Overall Study|Poor Compliance to Protocol|0|||
49121233|NCT03066830|158280613|FG000|Overall Study|Adverse Event|2|||
49121234|NCT03066830|158280614|FG001|Overall Study|Adverse Event|2|||
49121235|NCT03066830|158280613|FG000|Overall Study|Lost to Follow-up|11|||
49121236|NCT03066830|158280614|FG001|Overall Study|Lost to Follow-up|3|||
49121237|NCT02686164|158280619|FG000|Overall Study|Adverse Event|1|||
49121238|NCT02686164|158280619|FG000|Overall Study|Withdrawal of consent|1|||
49121239|NCT02686164|158280619|FG000|Overall Study|Clinical progression|1|||
49121240|NCT04378569|158283157|FG000|Overall Study|Adverse Event|0|||
49121241|NCT04378569|158283158|FG001|Overall Study|Adverse Event|0|||
49121242|NCT04378569|158283159|FG002|Overall Study|Adverse Event|2|||
49121243|NCT04378569|158283160|FG003|Overall Study|Adverse Event|0|||
49121244|NCT04378569|158283161|FG004|Overall Study|Adverse Event|3|||
49121245|NCT04378569|158283162|FG005|Overall Study|Adverse Event|3|||
49121246|NCT04378569|158283157|FG000|Overall Study|Lost to Follow-up|0|||
48810680|NCT02696902|157146420|FG000|Overall Study|Participant not eligible (negative PCR)|0|||
49121247|NCT04378569|158283158|FG001|Overall Study|Lost to Follow-up|3|||
49121248|NCT04378569|158283159|FG002|Overall Study|Lost to Follow-up|1|||
48810681|NCT02696902|157146421|FG001|Overall Study|Participant not eligible (negative PCR)|0|||
48810682|NCT02696902|157146422|FG002|Overall Study|Participant not eligible (negative PCR)|1|||
49121249|NCT04378569|158283160|FG003|Overall Study|Lost to Follow-up|0|||
49121250|NCT04378569|158283161|FG004|Overall Study|Lost to Follow-up|1|||
49121251|NCT04378569|158283162|FG005|Overall Study|Lost to Follow-up|1|||
49121252|NCT04378569|158283157|FG000|Overall Study|Protocol Violation|0|||
48918835|NCT00492752|157537841|FG001|Double Blind Treatment|Protocol Violation|0|||
48918836|NCT00492752|157537842|FG002|Double Blind Treatment|Protocol Violation|1|||
48918837|NCT00492752|157537843|FG003|Double Blind Treatment|Protocol Violation|0|||
48918838|NCT00492752|157537840|FG000|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
48918839|NCT00492752|157537841|FG001|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
48918840|NCT00492752|157537842|FG002|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
48918841|NCT00492752|157537843|FG003|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
48918842|NCT00492752|157537840|FG000|Follow-up and/or Open Label Sorafenib|Death|75|||
48918843|NCT00492752|157537841|FG001|Follow-up and/or Open Label Sorafenib|Death|5|||
48918844|NCT00492752|157537842|FG002|Follow-up and/or Open Label Sorafenib|Death|45|||
48918845|NCT00492752|157537843|FG003|Follow-up and/or Open Label Sorafenib|Death|1|||
48918846|NCT00492752|157537840|FG000|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8|||
48918847|NCT00492752|157537841|FG001|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1|||
48918848|NCT00492752|157537842|FG002|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2|||
48918849|NCT00492752|157537843|FG003|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0|||
48918850|NCT00492752|157537840|FG000|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2|||
48918851|NCT00492752|157537841|FG001|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1|||
48918852|NCT00492752|157537842|FG002|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
48918853|NCT00492752|157537843|FG003|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
48918854|NCT00492752|157537840|FG000|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
48918855|NCT00492752|157537841|FG001|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1|||
48918856|NCT00492752|157537842|FG002|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
48918857|NCT00492752|157537843|FG003|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2|||
48918858|NCT00492752|157537840|FG000|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
48918859|NCT00492752|157537841|FG001|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
48918860|NCT00492752|157537842|FG002|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
49121253|NCT04378569|158283158|FG001|Overall Study|Protocol Violation|0|||
48918861|NCT00492752|157537843|FG003|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1|||
48918862|NCT00492752|157537840|FG000|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
48918863|NCT00492752|157537841|FG001|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6|||
48918864|NCT00492752|157537842|FG002|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
48918865|NCT00492752|157537843|FG003|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
48918866|NCT00492752|157537840|FG000|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1|||
48918867|NCT00492752|157537841|FG001|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
48918868|NCT00492752|157537842|FG002|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
48918869|NCT00492752|157537843|FG003|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
48918870|NCT00736255|157539639|FG000|Overall Study|Adverse Event|1|||
48918871|NCT00736255|157539640|FG001|Overall Study|Adverse Event|0|||
49121254|NCT04378569|158283159|FG002|Overall Study|Protocol Violation|0|||
49121255|NCT04378569|158283160|FG003|Overall Study|Protocol Violation|0|||
49121256|NCT04378569|158283161|FG004|Overall Study|Protocol Violation|0|||
49121257|NCT04378569|158283162|FG005|Overall Study|Protocol Violation|1|||
49121258|NCT04378569|158283157|FG000|Overall Study|Withdrawal by Subject|0|||
49121259|NCT04378569|158283158|FG001|Overall Study|Withdrawal by Subject|6|||
49121260|NCT04378569|158283159|FG002|Overall Study|Withdrawal by Subject|7|||
49121261|NCT04378569|158283160|FG003|Overall Study|Withdrawal by Subject|4|||
49121262|NCT04378569|158283161|FG004|Overall Study|Withdrawal by Subject|5|||
48712217|NCT00223080|156797101|FG000|Overall Study|Non-compliant|7|||
48712218|NCT00223080|156797102|FG001|Overall Study|Non-compliant|7|||
48712219|NCT00223080|156797101|FG000|Overall Study|Moved from study area|37|||
48712220|NCT00223080|156797102|FG001|Overall Study|Moved from study area|47|||
48712221|NCT00223080|156797101|FG000|Overall Study|Lost to Follow-up|259|||
48712222|NCT00223080|156797102|FG001|Overall Study|Lost to Follow-up|284|||
48712223|NCT00223080|156797101|FG000|Overall Study|Death|85|||
48712224|NCT00223080|156797102|FG001|Overall Study|Death|74|||
48712225|NCT00223080|156797101|FG000|Overall Study|Other|14|||
48712226|NCT00223080|156797102|FG001|Overall Study|Other|11|||
48712227|NCT00223080|156797101|FG000|Overall Study|Reason not provided|141|||
48712228|NCT00223080|156797102|FG001|Overall Study|Reason not provided|140|||
48712229|NCT00223080|156797101|FG000|Overall Study|Adverse Event|0|||
48712230|NCT00223080|156797102|FG001|Overall Study|Adverse Event|1|||
48712231|NCT01763996|156797103|FG000|Treatment Period 2|Adverse Event|0|||
48712232|NCT01763996|156797104|FG001|Treatment Period 2|Adverse Event|1|||
48712233|NCT01616693|156797105|FG000|Evaluated for Safety|Physician Decision|1|||
48712234|NCT01616693|156797106|FG001|Evaluated for Safety|Physician Decision|0|||
48712235|NCT01616693|156797107|FG002|Evaluated for Safety|Physician Decision|1|||
48712236|NCT01616693|156797108|FG003|Evaluated for Safety|Physician Decision|0|||
48712237|NCT01616693|156797105|FG000|Received Both Vaccines|Adverse Event|2|||
48712238|NCT01616693|156797106|FG001|Received Both Vaccines|Adverse Event|0|||
48712239|NCT01616693|156797107|FG002|Received Both Vaccines|Adverse Event|0|||
48712240|NCT01616693|156797108|FG003|Received Both Vaccines|Adverse Event|0|||
48712241|NCT01616693|156797105|FG000|Received Both Vaccines|Withdrawal by Subject|7|||
48712242|NCT01616693|156797106|FG001|Received Both Vaccines|Withdrawal by Subject|7|||
48712243|NCT01616693|156797107|FG002|Received Both Vaccines|Withdrawal by Subject|8|||
48712244|NCT01616693|156797108|FG003|Received Both Vaccines|Withdrawal by Subject|15|||
48712245|NCT01616693|156797105|FG000|Received Both Vaccines|Lost to Follow-up|4|||
48712246|NCT01616693|156797106|FG001|Received Both Vaccines|Lost to Follow-up|3|||
48712247|NCT01616693|156797107|FG002|Received Both Vaccines|Lost to Follow-up|4|||
48712248|NCT01616693|156797108|FG003|Received Both Vaccines|Lost to Follow-up|4|||
48712249|NCT01616693|156797105|FG000|Blood Analyzed for Immunogenicity|Protocol Violation|4|||
48712250|NCT01616693|156797106|FG001|Blood Analyzed for Immunogenicity|Protocol Violation|2|||
48712251|NCT01616693|156797107|FG002|Blood Analyzed for Immunogenicity|Protocol Violation|6|||
48712252|NCT01616693|156797108|FG003|Blood Analyzed for Immunogenicity|Protocol Violation|1|||
48712253|NCT03116152|156797109|FG000|Overall Study|Disease Progression|49|||
48712254|NCT03116152|156797110|FG001|Overall Study|Disease Progression|47|||
48712255|NCT03116152|156797109|FG000|Overall Study|Death|5|||
48712256|NCT03116152|156797110|FG001|Overall Study|Death|2|||
48712257|NCT03116152|156797109|FG000|Overall Study|Adverse Event|21|||
48712258|NCT03116152|156797110|FG001|Overall Study|Adverse Event|7|||
48712259|NCT03116152|156797109|FG000|Overall Study|Protocol Violation|2|||
48712260|NCT03116152|156797110|FG001|Overall Study|Protocol Violation|2|||
48712261|NCT03116152|156797109|FG000|Overall Study|Withdrawal by Subject|0|||
48712262|NCT03116152|156797110|FG001|Overall Study|Withdrawal by Subject|1|||
48712263|NCT03116152|156797109|FG000|Overall Study|Physician Decision|3|||
48712264|NCT03116152|156797110|FG001|Overall Study|Physician Decision|2|||
48712265|NCT03116152|156797109|FG000|Overall Study|other|11|||
48712266|NCT03116152|156797110|FG001|Overall Study|other|34|||
48712267|NCT02791763|156797111|FG000|Overall Study|Protocol Violation|0|||
48712268|NCT02791763|156797112|FG001|Overall Study|Protocol Violation|0|||
48712269|NCT02791763|156797113|FG002|Overall Study|Protocol Violation|1|||
48712270|NCT02791763|156797111|FG000|Overall Study|Withdrawal by Subject|5|||
48712271|NCT02791763|156797112|FG001|Overall Study|Withdrawal by Subject|1|||
48712272|NCT02791763|156797113|FG002|Overall Study|Withdrawal by Subject|0|||
48712273|NCT02791763|156797111|FG000|Overall Study|Physician Decision|0|||
48712274|NCT02791763|156797112|FG001|Overall Study|Physician Decision|1|||
48712275|NCT02791763|156797113|FG002|Overall Study|Physician Decision|0|||
48712276|NCT02791763|156797111|FG000|Overall Study|Needs maintenance/changes in dialysis|16|||
48712277|NCT02791763|156797112|FG001|Overall Study|Needs maintenance/changes in dialysis|19|||
48712278|NCT02791763|156797113|FG002|Overall Study|Needs maintenance/changes in dialysis|5|||
48712279|NCT02791763|156797111|FG000|Overall Study|Cancer event|1|||
48712280|NCT02791763|156797112|FG001|Overall Study|Cancer event|3|||
48712281|NCT02791763|156797113|FG002|Overall Study|Cancer event|0|||
48712282|NCT02791763|156797111|FG000|Overall Study|Participant had renal transplant|3|||
48712283|NCT02791763|156797112|FG001|Overall Study|Participant had renal transplant|0|||
48712284|NCT02791763|156797113|FG002|Overall Study|Participant had renal transplant|0|||
48712285|NCT02791763|156797111|FG000|Overall Study|Met hemoglobin stopping criteria|1|||
48712286|NCT02791763|156797112|FG001|Overall Study|Met hemoglobin stopping criteria|0|||
48712287|NCT02791763|156797113|FG002|Overall Study|Met hemoglobin stopping criteria|0|||
48712288|NCT02791763|156797111|FG000|Overall Study|Adverse Event|12|||
48712289|NCT02791763|156797112|FG001|Overall Study|Adverse Event|13|||
48712290|NCT02791763|156797113|FG002|Overall Study|Adverse Event|7|||
48712291|NCT00711477|156797121|FG000|Overall Study|Adverse Event|3|||
48712292|NCT00711477|156797122|FG001|Overall Study|Adverse Event|1|||
48712293|NCT00711477|156797121|FG000|Overall Study|Lost to Follow-up|0|||
48712294|NCT00711477|156797122|FG001|Overall Study|Lost to Follow-up|1|||
48712295|NCT00711477|156797121|FG000|Overall Study|Noncompliance|0|||
48712296|NCT00711477|156797122|FG001|Overall Study|Noncompliance|1|||
48712297|NCT01456897|156797123|FG000|Overall Study|Adverse Event|19|||
48712298|NCT01456897|156797124|FG001|Overall Study|Adverse Event|22|||
48712299|NCT01456897|156797123|FG000|Overall Study|Protocol Violation|3|||
48712300|NCT01456897|156797124|FG001|Overall Study|Protocol Violation|4|||
48712301|NCT01456897|156797123|FG000|Overall Study|Physician Decision|5|||
48712302|NCT01456897|156797124|FG001|Overall Study|Physician Decision|3|||
48712303|NCT01456897|156797123|FG000|Overall Study|Withdrawal by Subject|44|||
48712304|NCT01456897|156797124|FG001|Overall Study|Withdrawal by Subject|17|||
48712305|NCT01456897|156797123|FG000|Overall Study|Lack of Efficacy|4|||
48712306|NCT01456897|156797124|FG001|Overall Study|Lack of Efficacy|11|||
48712307|NCT02032238|156797128|FG000|Overall Study|Lost to Follow-up|2|||
48712308|NCT02032238|156797129|FG001|Overall Study|Lost to Follow-up|0|||
48712309|NCT00743106|156797130|FG000|Overall Study|Met intraoperative exclusion criterion|8|||
48712310|NCT00743106|156797131|FG001|Overall Study|Met intraoperative exclusion criterion|5|||
48712311|NCT01765218|156797133|FG000|Overall Study|Protocol Violation|1|||
48712312|NCT01765218|156797134|FG001|Overall Study|Protocol Violation|2|||
48712313|NCT01309282|156797135|FG000|Overall Study|Lost to Follow-up|1|||
48712314|NCT01761240|156797138|FG000|Overall Study|Progressive disease:radiology assessment|3|||
48712315|NCT01761240|156797139|FG001|Overall Study|Progressive disease:radiology assessment|3|||
48810683|NCT02696902|157146420|FG000|Overall Study|Principal investigator's decision|1|||
48810684|NCT02696902|157146421|FG001|Overall Study|Principal investigator's decision|0|||
48810685|NCT02696902|157146422|FG002|Overall Study|Principal investigator's decision|0|||
48810686|NCT02696902|157146420|FG000|Overall Study|Sponsor's decision|1|||
48810687|NCT02696902|157146421|FG001|Overall Study|Sponsor's decision|0|||
48810688|NCT02696902|157146422|FG002|Overall Study|Sponsor's decision|0|||
48810689|NCT02696902|157146420|FG000|Overall Study|Transferred to other hospital|1|||
48810690|NCT02696902|157146421|FG001|Overall Study|Transferred to other hospital|0|||
48810691|NCT02696902|157146422|FG002|Overall Study|Transferred to other hospital|0|||
48810692|NCT01857622|157146425|FG000|Overall Study|Adverse Event|5|||
48810693|NCT01857622|157146426|FG001|Overall Study|Adverse Event|0|||
48810694|NCT01857622|157146427|FG002|Overall Study|Adverse Event|2|||
48810695|NCT01857622|157146425|FG000|Overall Study|Physician Decision|1|||
48810696|NCT01857622|157146426|FG001|Overall Study|Physician Decision|0|||
48810697|NCT01857622|157146427|FG002|Overall Study|Physician Decision|0|||
48810698|NCT01857622|157146425|FG000|Overall Study|Protocol Violation|4|||
48810699|NCT01857622|157146426|FG001|Overall Study|Protocol Violation|1|||
48810700|NCT01857622|157146427|FG002|Overall Study|Protocol Violation|0|||
48810701|NCT01857622|157146425|FG000|Overall Study|Withdrawal by Subject|1|||
48810702|NCT01857622|157146426|FG001|Overall Study|Withdrawal by Subject|0|||
48810703|NCT01857622|157146427|FG002|Overall Study|Withdrawal by Subject|0|||
48810704|NCT02875834|157146433|FG000|Open-label Phase|Withdrawal by Subject|3|||
48810705|NCT02875834|157146434|FG001|Open-label Phase|Withdrawal by Subject|0|||
48810706|NCT02875834|157146435|FG002|Open-label Phase|Withdrawal by Subject|0|||
48810707|NCT02875834|157146436|FG003|Open-label Phase|Withdrawal by Subject|0|||
48810708|NCT02875834|157146433|FG000|Open-label Phase|(Not collected)|4|||
48810709|NCT02875834|157146434|FG001|Open-label Phase|(Not collected)|0|||
48810710|NCT02875834|157146435|FG002|Open-label Phase|(Not collected)|0|||
48810711|NCT02875834|157146436|FG003|Open-label Phase|(Not collected)|0|||
48810712|NCT02875834|157146433|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
48810713|NCT02875834|157146434|FG001|Randomized Treatment Phase|Withdrawal by Subject|3|||
48810714|NCT02875834|157146435|FG002|Randomized Treatment Phase|Withdrawal by Subject|1|||
48810715|NCT02875834|157146436|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
48810716|NCT02875834|157146433|FG000|Randomized Treatment Phase|Protocol Violation|0|||
48810717|NCT02875834|157146434|FG001|Randomized Treatment Phase|Protocol Violation|2|||
48810718|NCT02875834|157146435|FG002|Randomized Treatment Phase|Protocol Violation|0|||
48810719|NCT02875834|157146436|FG003|Randomized Treatment Phase|Protocol Violation|0|||
48810720|NCT02875834|157146433|FG000|Randomized Treatment Phase|(Not collected)|0|||
48810721|NCT02875834|157146434|FG001|Randomized Treatment Phase|(Not collected)|9|||
48810722|NCT02875834|157146435|FG002|Randomized Treatment Phase|(Not collected)|10|||
48810723|NCT02875834|157146436|FG003|Randomized Treatment Phase|(Not collected)|9|||
48810724|NCT04318093|157146437|FG000|Overall Study|Adverse Event|2|||
48810725|NCT04318093|157146438|FG001|Overall Study|Adverse Event|2|||
48810726|NCT04318093|157146437|FG000|Overall Study|Participant withdrew consent|1|||
48810727|NCT04318093|157146438|FG001|Overall Study|Participant withdrew consent|0|||
48810728|NCT04318093|157146437|FG000|Overall Study|Other reasons|0|||
48810729|NCT04318093|157146438|FG001|Overall Study|Other reasons|1|||
48810730|NCT02998021|157146442|FG000|Overall Study|Withdrawal by Subject|3|||
48810731|NCT02998021|157146443|FG001|Overall Study|Withdrawal by Subject|1|||
48810732|NCT02998021|157146442|FG000|Overall Study|unsafe home|0|||
48918872|NCT00736255|157539639|FG000|Overall Study|Physician Decision|1|||
48918873|NCT00736255|157539640|FG001|Overall Study|Physician Decision|0|||
48918874|NCT00736255|157539639|FG000|Overall Study|Non-compliance|1|||
48918875|NCT00736255|157539640|FG001|Overall Study|Non-compliance|1|||
48918876|NCT00766038|157539641|FG000|Overall Study|Lost to Follow-up|15|||
48918877|NCT00766038|157539642|FG001|Overall Study|Lost to Follow-up|14|||
48918878|NCT00075023|157539653|FG000|Pilot Study|Physician Decision|1|||
48918879|NCT00075023|157539654|FG001|Pilot Study|Physician Decision|2|||
48918880|NCT00075023|157539653|FG000|Pilot Study|Withdrawal by Subject|1|||
48918881|NCT00075023|157539654|FG001|Pilot Study|Withdrawal by Subject|0|||
48918882|NCT00916357|157539657|FG000|Period 1|Withdrawal by Subject|1|||
48918883|NCT00916357|157539658|FG001|Period 1|Withdrawal by Subject|0|||
48918884|NCT00916357|157539659|FG002|Period 1|Withdrawal by Subject|0|||
48918885|NCT00916357|157539660|FG003|Period 1|Withdrawal by Subject|0|||
48810733|NCT02998021|157146443|FG001|Overall Study|unsafe home|1|||
48810734|NCT03342053|157146444|FG000|Overall Study|Adverse Event|2|||
48810735|NCT03342053|157146445|FG001|Overall Study|Adverse Event|0|||
48810736|NCT03342053|157146444|FG000|Overall Study|Withdrawal by Subject|0|||
48810737|NCT03342053|157146445|FG001|Overall Study|Withdrawal by Subject|1|||
48810738|NCT01254890|157146447|FG000|Overall Study|Ineligible|0|||
48810739|NCT01254890|157146448|FG001|Overall Study|Ineligible|3|||
48810740|NCT01254890|157146447|FG000|Overall Study|Withdrawal by Subject|1|||
48810741|NCT01254890|157146448|FG001|Overall Study|Withdrawal by Subject|2|||
48810742|NCT01254890|157146447|FG000|Overall Study|Disease Progression|0|||
48810743|NCT01254890|157146448|FG001|Overall Study|Disease Progression|5|||
48810744|NCT02044458|157146449|FG000|Overall Study|Protocol Violation|3|||
48918886|NCT00916357|157539661|FG004|Period 1|Withdrawal by Subject|0|||
48810745|NCT02044458|157146450|FG001|Overall Study|Protocol Violation|8|||
48810746|NCT01216293|157146451|FG000|Main Study|Adverse Event|1|||
49121263|NCT04378569|158283162|FG005|Overall Study|Withdrawal by Subject|4|||
49121264|NCT04378569|158283157|FG000|Overall Study|Lack of response|0|||
49121265|NCT04378569|158283158|FG001|Overall Study|Lack of response|0|||
49121266|NCT04378569|158283159|FG002|Overall Study|Lack of response|1|||
49121267|NCT04378569|158283160|FG003|Overall Study|Lack of response|0|||
49121268|NCT04378569|158283161|FG004|Overall Study|Lack of response|1|||
49121269|NCT04378569|158283162|FG005|Overall Study|Lack of response|1|||
49121270|NCT01844817|158283163|FG000|Enrolled and Randomized|Withdrawal by Subject|2|||
49121271|NCT01844817|158283164|FG001|Enrolled and Randomized|Withdrawal by Subject|3|||
49121272|NCT01844817|158283163|FG000|Treatment|Progressive Disease|27|||
49121273|NCT01844817|158283164|FG001|Treatment|Progressive Disease|36|||
49121274|NCT01844817|158283163|FG000|Treatment|Adverse Event|17|||
49121275|NCT01844817|158283164|FG001|Treatment|Adverse Event|9|||
49121276|NCT01844817|158283163|FG000|Treatment|Withdrawal by Subject|10|||
49121277|NCT01844817|158283164|FG001|Treatment|Withdrawal by Subject|6|||
49121278|NCT01844817|158283163|FG000|Treatment|Death|10|||
49121279|NCT01844817|158283164|FG001|Treatment|Death|8|||
49121280|NCT01844817|158283163|FG000|Treatment|Lost to Follow-up|0|||
49121281|NCT01844817|158283164|FG001|Treatment|Lost to Follow-up|1|||
49121282|NCT01844817|158283163|FG000|Treatment|Other|0|||
49121283|NCT01844817|158283164|FG001|Treatment|Other|3|||
49121284|NCT00762762|158283165|FG000|Overall Study|Did not return for appointments|6|||
49121285|NCT00762762|158283166|FG001|Overall Study|Did not return for appointments|8|||
49121286|NCT02250300|158283167|FG000|Expansion Phase|Death|6|||
49121287|NCT02250300|158283168|FG001|Expansion Phase|Death|7|||
49121288|NCT02250300|158283169|FG002|Expansion Phase|Death|0|||
49121289|NCT02250300|158283170|FG003|Expansion Phase|Death|0|||
49121290|NCT03512353|158283171|FG000|Overall Study|Sponsor Decision|3|||
49121291|NCT03512353|158283171|FG000|Overall Study|Death|1|||
49121292|NCT02171429|158283172|FG000|Overall Study|Other|0|||
49121293|NCT02171429|158283173|FG001|Overall Study|Other|1|||
49121294|NCT02171429|158283174|FG002|Overall Study|Other|1|||
49121295|NCT02171429|158283172|FG000|Overall Study|Non-Compliance|0|||
49121296|NCT02171429|158283173|FG001|Overall Study|Non-Compliance|0|||
49121297|NCT02171429|158283174|FG002|Overall Study|Non-Compliance|1|||
49121298|NCT02171429|158283172|FG000|Overall Study|Physician Decision|0|||
49121299|NCT02171429|158283173|FG001|Overall Study|Physician Decision|0|||
49121300|NCT02171429|158283174|FG002|Overall Study|Physician Decision|1|||
49121301|NCT02171429|158283172|FG000|Overall Study|Withdrawal by Subject|1|||
49121302|NCT02171429|158283173|FG001|Overall Study|Withdrawal by Subject|1|||
49121303|NCT02171429|158283174|FG002|Overall Study|Withdrawal by Subject|1|||
49121304|NCT02171429|158283172|FG000|Overall Study|Lost to Follow-up|0|||
49121305|NCT02171429|158283173|FG001|Overall Study|Lost to Follow-up|1|||
49121306|NCT02171429|158283174|FG002|Overall Study|Lost to Follow-up|0|||
49121307|NCT02171429|158283172|FG000|Overall Study|Death|0|||
49121308|NCT02171429|158283173|FG001|Overall Study|Death|0|||
49121309|NCT02171429|158283174|FG002|Overall Study|Death|1|||
49121310|NCT00493012|158283177|FG000|Overall Study|Lost to Follow-up|18|||
49121311|NCT00493012|158283178|FG001|Overall Study|Lost to Follow-up|17|||
49121312|NCT01519817|158283179|FG000|Overall Study|Withdrawal by Subject|1|||
49121313|NCT01519817|158283180|FG001|Overall Study|Withdrawal by Subject|0|||
49121314|NCT01519817|158283181|FG002|Overall Study|Withdrawal by Subject|0|||
49121315|NCT01519817|158283182|FG003|Overall Study|Withdrawal by Subject|0|||
49121316|NCT01519817|158283179|FG000|Overall Study|Off study due to infection|0|||
49121317|NCT01519817|158283180|FG001|Overall Study|Off study due to infection|0|||
49121318|NCT01519817|158283181|FG002|Overall Study|Off study due to infection|0|||
49121319|NCT01519817|158283182|FG003|Overall Study|Off study due to infection|1|||
49121320|NCT00305227|158283183|FG000|Overall Study|Lost to Follow-up|7|||
48810747|NCT01216293|157146452|FG001|Main Study|Adverse Event|4|||
48810748|NCT01216293|157146453|FG002|Main Study|Adverse Event|2|||
49121321|NCT00305227|158283184|FG001|Overall Study|Lost to Follow-up|6|||
48810749|NCT01216293|157146451|FG000|Main Study|Major Protocol Deviation|1|||
49121322|NCT01704755|158283185|FG000|Overall Study|Adverse Event|4|||
49121323|NCT01704755|158283186|FG001|Overall Study|Adverse Event|1|||
49121324|NCT01704755|158283185|FG000|Overall Study|Lost to Follow-up|3|||
49121325|NCT01704755|158283186|FG001|Overall Study|Lost to Follow-up|4|||
49121326|NCT01704755|158283185|FG000|Overall Study|Withdrew consent|1|||
49121327|NCT01704755|158283186|FG001|Overall Study|Withdrew consent|1|||
49121328|NCT01704755|158283185|FG000|Overall Study|Other (not specified)|3|||
49121329|NCT01704755|158283186|FG001|Overall Study|Other (not specified)|1|||
49121330|NCT01704755|158283185|FG000|Overall Study|Withdrew consent and personal issues|1|||
49121331|NCT01704755|158283186|FG001|Overall Study|Withdrew consent and personal issues|0|||
49121332|NCT00281697|158283187|FG000|Overall Study|> 60 days since last dose of study drug|4|||
48810750|NCT01216293|157146452|FG001|Main Study|Major Protocol Deviation|0|||
48810751|NCT01216293|157146453|FG002|Main Study|Major Protocol Deviation|1|||
49121333|NCT00281697|158283188|FG001|Overall Study|> 60 days since last dose of study drug|4|||
49121334|NCT00281697|158283187|FG000|Overall Study|Adverse Event|54|||
49121335|NCT00281697|158283188|FG001|Overall Study|Adverse Event|15|||
48810752|NCT01216293|157146451|FG000|Main Study|Lost to Follow-up|3|||
48810753|NCT01216293|157146452|FG001|Main Study|Lost to Follow-up|1|||
48810754|NCT01216293|157146453|FG002|Main Study|Lost to Follow-up|0|||
48810755|NCT01216293|157146451|FG000|Main Study|Voluntary Withdrawal|2|||
48810756|NCT01216293|157146452|FG001|Main Study|Voluntary Withdrawal|2|||
48810757|NCT01216293|157146453|FG002|Main Study|Voluntary Withdrawal|2|||
48810758|NCT01216293|157146451|FG000|Main Study|Other Reason Not Specified|0|||
48810759|NCT01216293|157146452|FG001|Main Study|Other Reason Not Specified|1|||
48810760|NCT01216293|157146453|FG002|Main Study|Other Reason Not Specified|1|||
48810761|NCT01216293|157146451|FG000|Main Study|Randomized, Not Treated|1|||
48810762|NCT01216293|157146452|FG001|Main Study|Randomized, Not Treated|0|||
48810763|NCT01216293|157146453|FG002|Main Study|Randomized, Not Treated|0|||
48810764|NCT01216293|157146451|FG000|Calcium Absorption Substudy|Adverse Event|0|||
48810765|NCT01216293|157146452|FG001|Calcium Absorption Substudy|Adverse Event|2|||
48810766|NCT01216293|157146453|FG002|Calcium Absorption Substudy|Adverse Event|0|||
48810767|NCT01216293|157146451|FG000|Calcium Absorption Substudy|Major Protocol Deviation|1|||
48810768|NCT01216293|157146452|FG001|Calcium Absorption Substudy|Major Protocol Deviation|0|||
48810769|NCT01216293|157146453|FG002|Calcium Absorption Substudy|Major Protocol Deviation|0|||
48810770|NCT01216293|157146451|FG000|Calcium Absorption Substudy|Voluntary Withdrawal|1|||
48810771|NCT01216293|157146452|FG001|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
48810772|NCT01216293|157146453|FG002|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
48810773|NCT01493960|157148094|FG000|Overall Study|Adverse Event|0|||
48810774|NCT01493960|157148095|FG001|Overall Study|Adverse Event|1|||
48810775|NCT01493960|157148094|FG000|Overall Study|Lack of Efficacy|15|||
48810776|NCT01493960|157148095|FG001|Overall Study|Lack of Efficacy|9|||
48810777|NCT01493960|157148094|FG000|Overall Study|Protocol Violation|3|||
48810778|NCT01493960|157148095|FG001|Overall Study|Protocol Violation|0|||
48810779|NCT01493960|157148094|FG000|Overall Study|Withdrawal by Subject|10|||
48810780|NCT01493960|157148095|FG001|Overall Study|Withdrawal by Subject|4|||
48810781|NCT01493960|157148094|FG000|Overall Study|Non-specified|4|||
48810782|NCT01493960|157148095|FG001|Overall Study|Non-specified|4|||
48810783|NCT01679236|157148096|FG000|Overall Study|Lost to Follow-up|15|||
48810784|NCT01679236|157148097|FG001|Overall Study|Lost to Follow-up|15|||
48810785|NCT01590771|157148098|FG000|Overall Study|Other Protocol Specified Criteria|5|||
48810786|NCT01590771|157148099|FG001|Overall Study|Other Protocol Specified Criteria|14|||
48810787|NCT01590771|157148098|FG000|Overall Study|Withdrawal by Subject|8|||
48810788|NCT01590771|157148099|FG001|Overall Study|Withdrawal by Subject|15|||
48810789|NCT01590771|157148098|FG000|Overall Study|Protocol Violation|1|||
48810790|NCT01590771|157148099|FG001|Overall Study|Protocol Violation|2|||
48810791|NCT01590771|157148098|FG000|Overall Study|Lost to Follow-up|1|||
48810792|NCT01590771|157148099|FG001|Overall Study|Lost to Follow-up|1|||
48810793|NCT01590771|157148098|FG000|Overall Study|Lack of Efficacy|1|||
48810794|NCT01590771|157148099|FG001|Overall Study|Lack of Efficacy|0|||
48810795|NCT01590771|157148098|FG000|Overall Study|Adverse Event|3|||
48712316|NCT01761240|156797140|FG002|Overall Study|Progressive disease:radiology assessment|0|||
48712317|NCT01761240|156797141|FG003|Overall Study|Progressive disease:radiology assessment|0|||
48712318|NCT01761240|156797142|FG004|Overall Study|Progressive disease:radiology assessment|0|||
48712319|NCT01761240|156797138|FG000|Overall Study|Progressive disease:clinical assessment|0|||
48712320|NCT01761240|156797139|FG001|Overall Study|Progressive disease:clinical assessment|0|||
48712321|NCT01761240|156797140|FG002|Overall Study|Progressive disease:clinical assessment|3|||
48810796|NCT01590771|157148099|FG001|Overall Study|Adverse Event|7|||
48810797|NCT01806740|157148107|FG000|Overall Study|Withdrawal by Subject|4|||
48810798|NCT01806740|157148107|FG000|Overall Study|Physician Decision|1|||
48712322|NCT01761240|156797141|FG003|Overall Study|Progressive disease:clinical assessment|1|||
48810799|NCT01806740|157148107|FG000|Overall Study|Patient's refusal of treatment|1|||
48810800|NCT00957931|157148109|FG000|Overall Study|Death|4|||
48810801|NCT03462706|157148110|FG000|Overall Study|Polyp was pedunculated|1|||
48918887|NCT00916357|157539662|FG005|Period 1|Withdrawal by Subject|0|||
48810802|NCT03462706|157148111|FG001|Overall Study|Polyp was pedunculated|0|||
48810803|NCT03462706|157148112|FG002|Overall Study|Polyp was pedunculated|1|||
48810804|NCT03462706|157148113|FG003|Overall Study|Polyp was pedunculated|0|||
48810805|NCT03462706|157148110|FG000|Overall Study|Polyp was next to a cancer and not removed|0|||
48810806|NCT03462706|157148111|FG001|Overall Study|Polyp was next to a cancer and not removed|0|||
48810807|NCT03462706|157148112|FG002|Overall Study|Polyp was next to a cancer and not removed|0|||
48810808|NCT03462706|157148113|FG003|Overall Study|Polyp was next to a cancer and not removed|1|||
48810809|NCT04651114|157148118|FG000|Overall Study|Withdrawal by Subject|8|||
49010770|NCT00185211|157875696|FG001|Follow-up Study (91031 - This Study)|Physician Decision|0|||
49010771|NCT00185211|157875695|FG000|Follow-up Study (91031 - This Study)|Pregnancy|0|||
49010772|NCT00185211|157875696|FG001|Follow-up Study (91031 - This Study)|Pregnancy|1|||
49010773|NCT00185211|157875695|FG000|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13|||
49010774|NCT00185211|157875696|FG001|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21|||
49010775|NCT00185211|157875695|FG000|Follow-up Study (91031 - This Study)|other disease modif. treatment|0|||
49010776|NCT00185211|157875696|FG001|Follow-up Study (91031 - This Study)|other disease modif. treatment|2|||
49121336|NCT00281697|158283187|FG000|Overall Study|Death|8|||
49121337|NCT00281697|158283188|FG001|Overall Study|Death|3|||
49121338|NCT00281697|158283187|FG000|Overall Study|Disease progression|279|||
49121339|NCT00281697|158283188|FG001|Overall Study|Disease progression|149|||
49121340|NCT00281697|158283187|FG000|Overall Study|Other|5|||
49121341|NCT00281697|158283188|FG001|Overall Study|Other|6|||
49121342|NCT00281697|158283187|FG000|Overall Study|Physician's decision to withdraw|15|||
49121343|NCT00281697|158283188|FG001|Overall Study|Physician's decision to withdraw|12|||
49121344|NCT00281697|158283187|FG000|Overall Study|Subject/guardian's decision to withdraw|33|||
49121345|NCT00281697|158283188|FG001|Overall Study|Subject/guardian's decision to withdraw|6|||
49121346|NCT00281697|158283187|FG000|Overall Study|Did not receive study drug|3|||
49121347|NCT00281697|158283188|FG001|Overall Study|Did not receive study drug|2|||
49121348|NCT00667563|158283189|FG000|Overall Study|Protocol Violation|24|||
49121349|NCT05133323|158283190|FG000|Overall Study|Lack of Efficacy|0|||
49121350|NCT05133323|158283191|FG001|Overall Study|Lack of Efficacy|0|||
49121351|NCT05133323|158283192|FG002|Overall Study|Lack of Efficacy|1|||
49121352|NCT05133323|158283190|FG000|Overall Study|Withdrawal by Subject|2|||
49121353|NCT05133323|158283191|FG001|Overall Study|Withdrawal by Subject|1|||
49121354|NCT05133323|158283192|FG002|Overall Study|Withdrawal by Subject|0|||
49121355|NCT00113295|158283193|FG000|Overall Study|Adverse Event|4|||
49121356|NCT00113295|158283194|FG001|Overall Study|Adverse Event|1|||
49121357|NCT00113295|158283193|FG000|Overall Study|Unrelated Medical Illness|1|||
49121358|NCT00113295|158283194|FG001|Overall Study|Unrelated Medical Illness|0|||
49121359|NCT03130959|158283197|FG000|Overall Study|Disease progression|19|||
49121360|NCT03130959|158283198|FG001|Overall Study|Disease progression|7|||
49121361|NCT03130959|158283199|FG002|Overall Study|Disease progression|12|||
49121362|NCT03130959|158283200|FG003|Overall Study|Disease progression|7|||
49121363|NCT03130959|158283201|FG004|Overall Study|Disease progression|12|||
49121364|NCT03130959|158283202|FG005|Overall Study|Disease progression|3|||
49121365|NCT03130959|158283203|FG006|Overall Study|Disease progression|6|||
49121366|NCT03130959|158283204|FG007|Overall Study|Disease progression|3|||
49121367|NCT03130959|158283205|FG008|Overall Study|Disease progression|15|||
49121368|NCT03130959|158283206|FG009|Overall Study|Disease progression|8|||
49121369|NCT03130959|158283197|FG000|Overall Study|Study drug toxicity|2|||
49121370|NCT03130959|158283198|FG001|Overall Study|Study drug toxicity|2|||
49121371|NCT03130959|158283199|FG002|Overall Study|Study drug toxicity|1|||
49121372|NCT03130959|158283200|FG003|Overall Study|Study drug toxicity|2|||
49121373|NCT03130959|158283201|FG004|Overall Study|Study drug toxicity|1|||
49121374|NCT03130959|158283202|FG005|Overall Study|Study drug toxicity|1|||
49121375|NCT03130959|158283203|FG006|Overall Study|Study drug toxicity|3|||
49121376|NCT03130959|158283204|FG007|Overall Study|Study drug toxicity|0|||
49121377|NCT03130959|158283205|FG008|Overall Study|Study drug toxicity|3|||
49121378|NCT03130959|158283206|FG009|Overall Study|Study drug toxicity|3|||
49121379|NCT03130959|158283197|FG000|Overall Study|Other reasons|0|||
49121380|NCT03130959|158283198|FG001|Overall Study|Other reasons|0|||
49121381|NCT03130959|158283199|FG002|Overall Study|Other reasons|0|||
49121382|NCT03130959|158283200|FG003|Overall Study|Other reasons|0|||
49121383|NCT03130959|158283201|FG004|Overall Study|Other reasons|0|||
49121384|NCT03130959|158283202|FG005|Overall Study|Other reasons|1|||
49121385|NCT03130959|158283203|FG006|Overall Study|Other reasons|1|||
49121386|NCT03130959|158283204|FG007|Overall Study|Other reasons|0|||
49121387|NCT03130959|158283205|FG008|Overall Study|Other reasons|0|||
49121388|NCT03130959|158283206|FG009|Overall Study|Other reasons|0|||
49121389|NCT03130959|158283197|FG000|Overall Study|Subject request to discontinue therapy|0|||
49121390|NCT03130959|158283198|FG001|Overall Study|Subject request to discontinue therapy|0|||
49121391|NCT03130959|158283199|FG002|Overall Study|Subject request to discontinue therapy|1|||
49121392|NCT03130959|158283200|FG003|Overall Study|Subject request to discontinue therapy|1|||
49121393|NCT03130959|158283201|FG004|Overall Study|Subject request to discontinue therapy|0|||
49121394|NCT03130959|158283202|FG005|Overall Study|Subject request to discontinue therapy|0|||
49121395|NCT03130959|158283203|FG006|Overall Study|Subject request to discontinue therapy|1|||
49121396|NCT03130959|158283204|FG007|Overall Study|Subject request to discontinue therapy|1|||
49121397|NCT03130959|158283205|FG008|Overall Study|Subject request to discontinue therapy|0|||
48712323|NCT01761240|156797142|FG004|Overall Study|Progressive disease:clinical assessment|0|||
49121398|NCT03130959|158283206|FG009|Overall Study|Subject request to discontinue therapy|0|||
49121399|NCT03130959|158283197|FG000|Overall Study|Not reported|0|||
49121400|NCT03130959|158283198|FG001|Overall Study|Not reported|0|||
48712324|NCT01761240|156797138|FG000|Overall Study|Withdrawal by Subject|0|||
49121401|NCT03130959|158283199|FG002|Overall Study|Not reported|0|||
49121402|NCT03130959|158283200|FG003|Overall Study|Not reported|1|||
49121403|NCT03130959|158283201|FG004|Overall Study|Not reported|0|||
49121404|NCT03130959|158283202|FG005|Overall Study|Not reported|1|||
49121405|NCT03130959|158283203|FG006|Overall Study|Not reported|0|||
49121406|NCT03130959|158283204|FG007|Overall Study|Not reported|0|||
49121407|NCT03130959|158283205|FG008|Overall Study|Not reported|0|||
48712325|NCT01761240|156797139|FG001|Overall Study|Withdrawal by Subject|0|||
49121408|NCT03130959|158283206|FG009|Overall Study|Not reported|1|||
49121409|NCT03130959|158283197|FG000|Overall Study|Adverse Event unrelated to drug|0|||
48810810|NCT00235443|157148121|FG000|Overall Study|Adverse Event|4|||
48810811|NCT00235443|157148122|FG001|Overall Study|Adverse Event|12|||
48810812|NCT00235443|157148123|FG002|Overall Study|Adverse Event|17|||
48810813|NCT00235443|157148124|FG003|Overall Study|Adverse Event|44|||
48810814|NCT00235443|157148125|FG004|Overall Study|Adverse Event|10|||
48810815|NCT00235443|157148126|FG005|Overall Study|Adverse Event|15|||
48810816|NCT00235443|157148121|FG000|Overall Study|Lack of Efficacy|0|||
48810817|NCT00235443|157148122|FG001|Overall Study|Lack of Efficacy|1|||
48810818|NCT00235443|157148123|FG002|Overall Study|Lack of Efficacy|5|||
48810819|NCT00235443|157148124|FG003|Overall Study|Lack of Efficacy|12|||
48810820|NCT00235443|157148125|FG004|Overall Study|Lack of Efficacy|2|||
48810821|NCT00235443|157148126|FG005|Overall Study|Lack of Efficacy|9|||
48810822|NCT00235443|157148121|FG000|Overall Study|Withdrawal by Subject|3|||
48712326|NCT01761240|156797140|FG002|Overall Study|Withdrawal by Subject|0|||
48712327|NCT01761240|156797141|FG003|Overall Study|Withdrawal by Subject|3|||
48712328|NCT01761240|156797142|FG004|Overall Study|Withdrawal by Subject|1|||
48712329|NCT01761240|156797138|FG000|Overall Study|Adverse Event|0|||
48712330|NCT01761240|156797139|FG001|Overall Study|Adverse Event|0|||
48712331|NCT01761240|156797140|FG002|Overall Study|Adverse Event|0|||
48712332|NCT01761240|156797141|FG003|Overall Study|Adverse Event|1|||
48712333|NCT01761240|156797142|FG004|Overall Study|Adverse Event|6|||
48712334|NCT01761240|156797138|FG000|Overall Study|Death|0|||
48712335|NCT01761240|156797139|FG001|Overall Study|Death|1|||
48712336|NCT01761240|156797140|FG002|Overall Study|Death|1|||
48712337|NCT01761240|156797141|FG003|Overall Study|Death|2|||
48712338|NCT01761240|156797142|FG004|Overall Study|Death|1|||
48712339|NCT01761240|156797138|FG000|Overall Study|Non-compliance|0|||
48712340|NCT01761240|156797139|FG001|Overall Study|Non-compliance|0|||
48712341|NCT01761240|156797140|FG002|Overall Study|Non-compliance|1|||
48712342|NCT01761240|156797141|FG003|Overall Study|Non-compliance|0|||
48712343|NCT01761240|156797142|FG004|Overall Study|Non-compliance|0|||
48712344|NCT02762370|156797143|FG000|Overall Study|Protocol Violation|1|||
48712345|NCT02762370|156797144|FG001|Overall Study|Protocol Violation|0|||
48712346|NCT00509145|156797145|FG000|Overall Study|Death|0|||
48712347|NCT00509145|156797146|FG001|Overall Study|Death|2|||
48712348|NCT00509145|156797145|FG000|Overall Study|Adverse Event|42|||
48712349|NCT00509145|156797146|FG001|Overall Study|Adverse Event|28|||
48712350|NCT00509145|156797145|FG000|Overall Study|Withdrawal by Subject|32|||
48712351|NCT00509145|156797146|FG001|Overall Study|Withdrawal by Subject|38|||
48712352|NCT00509145|156797145|FG000|Overall Study|Physician Decision|11|||
48712353|NCT00509145|156797146|FG001|Overall Study|Physician Decision|14|||
48712354|NCT00509145|156797145|FG000|Overall Study|Protocol Violation|1|||
48712355|NCT00509145|156797146|FG001|Overall Study|Protocol Violation|6|||
48712356|NCT00509145|156797145|FG000|Overall Study|Pregnancy|3|||
48810823|NCT00235443|157148122|FG001|Overall Study|Withdrawal by Subject|9|||
48810824|NCT00235443|157148123|FG002|Overall Study|Withdrawal by Subject|25|||
48810825|NCT00235443|157148124|FG003|Overall Study|Withdrawal by Subject|24|||
48810826|NCT00235443|157148125|FG004|Overall Study|Withdrawal by Subject|10|||
48810827|NCT00235443|157148126|FG005|Overall Study|Withdrawal by Subject|12|||
48810828|NCT00235443|157148121|FG000|Overall Study|Lost to Follow-up|0|||
48810829|NCT00235443|157148122|FG001|Overall Study|Lost to Follow-up|8|||
48810830|NCT00235443|157148123|FG002|Overall Study|Lost to Follow-up|6|||
48810831|NCT00235443|157148124|FG003|Overall Study|Lost to Follow-up|6|||
48810832|NCT00235443|157148125|FG004|Overall Study|Lost to Follow-up|4|||
48810833|NCT00235443|157148126|FG005|Overall Study|Lost to Follow-up|3|||
48810834|NCT00235443|157148121|FG000|Overall Study|Unsatisfactory compliance|0|||
48810835|NCT00235443|157148122|FG001|Overall Study|Unsatisfactory compliance|2|||
48810836|NCT00235443|157148123|FG002|Overall Study|Unsatisfactory compliance|3|||
48712357|NCT00509145|156797146|FG001|Overall Study|Pregnancy|8|||
48810837|NCT00235443|157148124|FG003|Overall Study|Unsatisfactory compliance|4|||
48918888|NCT00916357|157539657|FG000|Period 2|Weight loss > 3 kilograms (kg)|0|||
49121410|NCT03130959|158283198|FG001|Overall Study|Adverse Event unrelated to drug|0|||
49121411|NCT03130959|158283199|FG002|Overall Study|Adverse Event unrelated to drug|1|||
49121412|NCT03130959|158283200|FG003|Overall Study|Adverse Event unrelated to drug|1|||
48712358|NCT00509145|156797145|FG000|Overall Study|Lost to Follow-up|6|||
48712359|NCT00509145|156797146|FG001|Overall Study|Lost to Follow-up|5|||
48712360|NCT00509145|156797145|FG000|Overall Study|Withdrawal by participant after confirmed relapse|12|||
48712361|NCT00509145|156797146|FG001|Overall Study|Withdrawal by participant after confirmed relapse|22|||
48810838|NCT00235443|157148125|FG004|Overall Study|Unsatisfactory compliance|1|||
48810839|NCT00235443|157148126|FG005|Overall Study|Unsatisfactory compliance|0|||
48810840|NCT00235443|157148121|FG000|Overall Study|Other reasons for premature termination|1|||
48810841|NCT00235443|157148122|FG001|Overall Study|Other reasons for premature termination|6|||
48712362|NCT00509145|156797145|FG000|Overall Study|Other|6|||
48712363|NCT00509145|156797146|FG001|Overall Study|Other|6|||
48712364|NCT00246740|156797147|FG000|Initial Enrollment|Death|1|||
48712365|NCT00246740|156797148|FG001|Initial Enrollment|Death|0|||
48712366|NCT00246740|156797147|FG000|Initial Enrollment|Additional surgery scheduled|0|||
48712367|NCT00246740|156797148|FG001|Initial Enrollment|Additional surgery scheduled|2|||
48810842|NCT00235443|157148123|FG002|Overall Study|Other reasons for premature termination|6|||
48712368|NCT00246740|156797147|FG000|Initial Enrollment|Surgery schedule change|4|||
48712369|NCT00246740|156797148|FG001|Initial Enrollment|Surgery schedule change|4|||
48712370|NCT00246740|156797147|FG000|Initial Enrollment|Other|1|||
48712371|NCT00246740|156797148|FG001|Initial Enrollment|Other|2|||
48712372|NCT00101452|156797149|FG000|Overall Study|Adverse Event|2|||
48712373|NCT00101452|156797150|FG001|Overall Study|Adverse Event|0|||
48810843|NCT00235443|157148124|FG003|Overall Study|Other reasons for premature termination|7|||
48712374|NCT00101452|156797151|FG002|Overall Study|Adverse Event|1|||
48712375|NCT00101452|156797149|FG000|Overall Study|Lost to Follow-up|13|||
48712376|NCT00101452|156797150|FG001|Overall Study|Lost to Follow-up|8|||
48712377|NCT00101452|156797151|FG002|Overall Study|Lost to Follow-up|14|||
48810844|NCT00235443|157148125|FG004|Overall Study|Other reasons for premature termination|3|||
48810845|NCT00235443|157148126|FG005|Overall Study|Other reasons for premature termination|6|||
48810846|NCT03661996|157148134|FG000|Overall Study|Adverse Event|0|||
48810847|NCT03661996|157148135|FG001|Overall Study|Adverse Event|0|||
48810848|NCT03661996|157148136|FG002|Overall Study|Adverse Event|1|||
48810849|NCT03661996|157148137|FG003|Overall Study|Adverse Event|1|||
48712378|NCT00101452|156797149|FG000|Overall Study|Withdrawal by Subject|10|||
48712379|NCT00101452|156797150|FG001|Overall Study|Withdrawal by Subject|14|||
48712380|NCT00101452|156797151|FG002|Overall Study|Withdrawal by Subject|9|||
48712381|NCT00101452|156797149|FG000|Overall Study|Baseline Fail|2|||
48712382|NCT00101452|156797150|FG001|Overall Study|Baseline Fail|1|||
48712383|NCT00101452|156797151|FG002|Overall Study|Baseline Fail|2|||
48712384|NCT00101452|156797149|FG000|Overall Study|Physician Decision|0|||
48712385|NCT00101452|156797150|FG001|Overall Study|Physician Decision|3|||
48712386|NCT00101452|156797151|FG002|Overall Study|Physician Decision|2|||
48712387|NCT00101452|156797149|FG000|Overall Study|Protocol Violation|2|||
48712388|NCT00101452|156797150|FG001|Overall Study|Protocol Violation|1|||
48712389|NCT00101452|156797151|FG002|Overall Study|Protocol Violation|3|||
48712390|NCT00101452|156797149|FG000|Overall Study|Other|15|||
48712391|NCT00101452|156797150|FG001|Overall Study|Other|16|||
48712392|NCT00101452|156797151|FG002|Overall Study|Other|12|||
48712393|NCT02969655|156797152|FG000|Overall Study|Withdrawal by Subject|3|||
48712394|NCT02969655|156797153|FG001|Overall Study|Withdrawal by Subject|2|||
48712395|NCT02969655|156797152|FG000|Overall Study|Physician Decision|4|||
48712396|NCT02969655|156797153|FG001|Overall Study|Physician Decision|3|||
48712397|NCT02969655|156797152|FG000|Overall Study|Protocol-specified withdrawal criteria|4|||
48712398|NCT02969655|156797153|FG001|Overall Study|Protocol-specified withdrawal criteria|2|||
48712399|NCT02969655|156797152|FG000|Overall Study|Adverse Event|10|||
48712400|NCT02969655|156797153|FG001|Overall Study|Adverse Event|8|||
48712401|NCT00929643|156797154|FG000|Overall Study|Protocol Violation|2|||
48712402|NCT00702715|156799298|FG000|Overall Study|Lost to Follow-up|1|||
48712403|NCT00702715|156799299|FG001|Overall Study|Lost to Follow-up|0|||
48712404|NCT02741518|156799308|FG000|Overall Study|Withdrawal by Subject|1|||
48712405|NCT02741518|156799309|FG001|Overall Study|Withdrawal by Subject|1|||
48712406|NCT02160899|156799310|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
48712407|NCT02160899|156799311|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
48712408|NCT02160899|156799312|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
48712409|NCT02160899|156799313|FG003|Overall Study|Adverse Event or Serious Adverse Event|1|||
48712410|NCT02160899|156799314|FG004|Overall Study|Adverse Event or Serious Adverse Event|2|||
48712411|NCT02160899|156799315|FG005|Overall Study|Adverse Event or Serious Adverse Event|0|||
48712412|NCT01715857|156799318|FG000|Overall Study|Did Not Meet Eligibility Criteria|96|||
48712413|NCT00499616|156799320|FG000|Overall Study|Death|1|||
48810850|NCT03661996|157148138|FG004|Overall Study|Adverse Event|0|||
48810851|NCT03661996|157148134|FG000|Overall Study|Lost to Follow-up|5|||
48712414|NCT00499616|156799321|FG001|Overall Study|Death|5|||
48712415|NCT00499616|156799322|FG002|Overall Study|Death|3|||
48712416|NCT00499616|156799323|FG003|Overall Study|Death|1|||
48712417|NCT00499616|156799320|FG000|Overall Study|Lack of Efficacy|5|||
48712418|NCT00499616|156799321|FG001|Overall Study|Lack of Efficacy|0|||
48810852|NCT03661996|157148135|FG001|Overall Study|Lost to Follow-up|1|||
48712419|NCT00499616|156799322|FG002|Overall Study|Lack of Efficacy|19|||
48712420|NCT00499616|156799323|FG003|Overall Study|Lack of Efficacy|0|||
48712421|NCT00499616|156799320|FG000|Overall Study|Lost to Follow-up|0|||
48712422|NCT00499616|156799321|FG001|Overall Study|Lost to Follow-up|0|||
48712423|NCT00499616|156799322|FG002|Overall Study|Lost to Follow-up|1|||
48712424|NCT00499616|156799323|FG003|Overall Study|Lost to Follow-up|0|||
49010777|NCT00911859|157875697|FG000|Treatment Period|Adverse Event|3|||
48712425|NCT00499616|156799320|FG000|Overall Study|Physician Decision|6|||
48712426|NCT00499616|156799321|FG001|Overall Study|Physician Decision|16|||
48712427|NCT00499616|156799322|FG002|Overall Study|Physician Decision|9|||
48712428|NCT00499616|156799323|FG003|Overall Study|Physician Decision|0|||
48712429|NCT00499616|156799320|FG000|Overall Study|Withdrawal by Subject|1|||
48712430|NCT00499616|156799321|FG001|Overall Study|Withdrawal by Subject|0|||
48712431|NCT00499616|156799322|FG002|Overall Study|Withdrawal by Subject|1|||
48712432|NCT00499616|156799323|FG003|Overall Study|Withdrawal by Subject|0|||
48810853|NCT03661996|157148136|FG002|Overall Study|Lost to Follow-up|2|||
48810854|NCT03661996|157148137|FG003|Overall Study|Lost to Follow-up|2|||
48810855|NCT03661996|157148138|FG004|Overall Study|Lost to Follow-up|6|||
48810856|NCT03661996|157148134|FG000|Overall Study|Physician Decision|1|||
48810857|NCT03661996|157148135|FG001|Overall Study|Physician Decision|1|||
48810858|NCT03661996|157148136|FG002|Overall Study|Physician Decision|1|||
48810859|NCT03661996|157148137|FG003|Overall Study|Physician Decision|2|||
48810860|NCT03661996|157148138|FG004|Overall Study|Physician Decision|0|||
48810861|NCT03661996|157148134|FG000|Overall Study|Protocol Violation|0|||
48712433|NCT00499616|156799320|FG000|Overall Study|Ineligible|1|||
48712434|NCT00499616|156799321|FG001|Overall Study|Ineligible|2|||
48712435|NCT00499616|156799322|FG002|Overall Study|Ineligible|0|||
48712436|NCT00499616|156799323|FG003|Overall Study|Ineligible|15|||
48712437|NCT00499616|156799320|FG000|Overall Study|Not evaluable|0|||
48712438|NCT00499616|156799321|FG001|Overall Study|Not evaluable|0|||
48712439|NCT00499616|156799322|FG002|Overall Study|Not evaluable|0|||
48712440|NCT00499616|156799323|FG003|Overall Study|Not evaluable|41|||
48712441|NCT00499616|156799320|FG000|Overall Study|Patient/Parent Refusal|1|||
48712442|NCT00499616|156799321|FG001|Overall Study|Patient/Parent Refusal|5|||
48712443|NCT00499616|156799322|FG002|Overall Study|Patient/Parent Refusal|3|||
48712444|NCT00499616|156799323|FG003|Overall Study|Patient/Parent Refusal|0|||
48712445|NCT00942994|156799324|FG000|Overall Study|Adverse Event|7|||
48712446|NCT00942994|156799325|FG001|Overall Study|Adverse Event|4|||
48712447|NCT00942994|156799324|FG000|Overall Study|Abnormal laboratory value(s)|1|||
48712448|NCT00942994|156799325|FG001|Overall Study|Abnormal laboratory value(s)|0|||
48712449|NCT00942994|156799324|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
48712450|NCT00942994|156799325|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
48712451|NCT00942994|156799324|FG000|Overall Study|Patient withdrew consent|5|||
48712452|NCT00942994|156799325|FG001|Overall Study|Patient withdrew consent|8|||
48712453|NCT00942994|156799324|FG000|Overall Study|Lost to Follow-up|1|||
48712454|NCT00942994|156799325|FG001|Overall Study|Lost to Follow-up|4|||
48810862|NCT03661996|157148135|FG001|Overall Study|Protocol Violation|0|||
48810863|NCT03661996|157148136|FG002|Overall Study|Protocol Violation|0|||
48810864|NCT03661996|157148137|FG003|Overall Study|Protocol Violation|0|||
48810865|NCT03661996|157148138|FG004|Overall Study|Protocol Violation|1|||
48810866|NCT03661996|157148134|FG000|Overall Study|Withdrawal by Subject|3|||
48810867|NCT03661996|157148135|FG001|Overall Study|Withdrawal by Subject|5|||
48810868|NCT03661996|157148136|FG002|Overall Study|Withdrawal by Subject|1|||
48810869|NCT03661996|157148137|FG003|Overall Study|Withdrawal by Subject|7|||
48810870|NCT03661996|157148138|FG004|Overall Study|Withdrawal by Subject|7|||
48810871|NCT03661996|157148134|FG000|Overall Study|Sponsors Decision|2|||
48810872|NCT03661996|157148135|FG001|Overall Study|Sponsors Decision|0|||
48810873|NCT03661996|157148136|FG002|Overall Study|Sponsors Decision|0|||
48918889|NCT00916357|157539658|FG001|Period 2|Weight loss > 3 kilograms (kg)|0|||
48918890|NCT00916357|157539659|FG002|Period 2|Weight loss > 3 kilograms (kg)|0|||
48918891|NCT00916357|157539660|FG003|Period 2|Weight loss > 3 kilograms (kg)|1|||
48712455|NCT00942994|156799324|FG000|Overall Study|Protocol deviation|1|||
48712456|NCT00942994|156799325|FG001|Overall Study|Protocol deviation|2|||
48712457|NCT00243269|156799326|FG000|Overall Study|Protocol Violation|2|||
48918892|NCT00916357|157539661|FG004|Period 2|Weight loss > 3 kilograms (kg)|0|||
48918893|NCT00916357|157539662|FG005|Period 2|Weight loss > 3 kilograms (kg)|0|||
48918894|NCT00772954|157539663|FG000|Overall Study|Adverse Event|0|||
49121413|NCT03130959|158283201|FG004|Overall Study|Adverse Event unrelated to drug|1|||
48918895|NCT00772954|157539664|FG001|Overall Study|Adverse Event|0|||
48918896|NCT00772954|157539665|FG002|Overall Study|Adverse Event|1|||
48918897|NCT01773109|157539666|FG000|Overall Study|Symptomatic Progression|2|||
49121414|NCT03130959|158283202|FG005|Overall Study|Adverse Event unrelated to drug|0|||
49121415|NCT03130959|158283203|FG006|Overall Study|Adverse Event unrelated to drug|1|||
49121416|NCT03130959|158283204|FG007|Overall Study|Adverse Event unrelated to drug|0|||
49121417|NCT03130959|158283205|FG008|Overall Study|Adverse Event unrelated to drug|1|||
49121418|NCT03130959|158283206|FG009|Overall Study|Adverse Event unrelated to drug|1|||
49121419|NCT03130959|158283197|FG000|Overall Study|Participant withdrew consent|0|||
49121420|NCT03130959|158283198|FG001|Overall Study|Participant withdrew consent|1|||
49121421|NCT03130959|158283199|FG002|Overall Study|Participant withdrew consent|0|||
49121422|NCT03130959|158283200|FG003|Overall Study|Participant withdrew consent|2|||
49121423|NCT03130959|158283201|FG004|Overall Study|Participant withdrew consent|1|||
49121424|NCT03130959|158283202|FG005|Overall Study|Participant withdrew consent|0|||
49121425|NCT03130959|158283203|FG006|Overall Study|Participant withdrew consent|0|||
49121426|NCT03130959|158283204|FG007|Overall Study|Participant withdrew consent|0|||
49121427|NCT03130959|158283205|FG008|Overall Study|Participant withdrew consent|0|||
49121428|NCT03130959|158283206|FG009|Overall Study|Participant withdrew consent|2|||
48712458|NCT00243269|156799327|FG001|Overall Study|Protocol Violation|1|||
48810874|NCT03661996|157148137|FG003|Overall Study|Sponsors Decision|0|||
48810875|NCT03661996|157148138|FG004|Overall Study|Sponsors Decision|0|||
48810876|NCT03661996|157148134|FG000|Overall Study|Other|1|||
48810877|NCT03661996|157148135|FG001|Overall Study|Other|1|||
48810878|NCT03661996|157148136|FG002|Overall Study|Other|1|||
48810879|NCT03661996|157148137|FG003|Overall Study|Other|1|||
48810880|NCT03661996|157148138|FG004|Overall Study|Other|0|||
48918898|NCT01773109|157539666|FG000|Overall Study|Death|1|||
48918899|NCT00094770|157539669|FG000|Year 1 ( Week 0 to Week 52)|Adverse Event|25|||
48918900|NCT00094770|157539670|FG001|Year 1 ( Week 0 to Week 52)|Adverse Event|26|||
48918901|NCT00094770|157539669|FG000|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86|||
48918902|NCT00094770|157539670|FG001|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58|||
48918903|NCT00094770|157539669|FG000|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19|||
48918904|NCT00094770|157539670|FG001|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10|||
48918905|NCT00094770|157539669|FG000|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
48918906|NCT00094770|157539670|FG001|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
48918907|NCT00094770|157539669|FG000|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19|||
48918908|NCT00094770|157539670|FG001|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25|||
48918909|NCT00094770|157539669|FG000|Year 1 ( Week 0 to Week 52)|Patient Moved|6|||
48918910|NCT00094770|157539670|FG001|Year 1 ( Week 0 to Week 52)|Patient Moved|2|||
48918911|NCT00094770|157539669|FG000|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25|||
48918912|NCT00094770|157539670|FG001|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28|||
48712459|NCT00243269|156799328|FG002|Overall Study|Protocol Violation|0|||
48712460|NCT00243269|156799329|FG003|Overall Study|Protocol Violation|1|||
48918913|NCT00094770|157539669|FG000|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
48918914|NCT00094770|157539670|FG001|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
48918915|NCT00094770|157539669|FG000|Year 1 ( Week 0 to Week 52)|Other|10|||
48918916|NCT00094770|157539670|FG001|Year 1 ( Week 0 to Week 52)|Other|11|||
48918917|NCT00094770|157539669|FG000|Year 2 (Week 0 to Week 104)|Adverse Event|35|||
48918918|NCT00094770|157539670|FG001|Year 2 (Week 0 to Week 104)|Adverse Event|36|||
48918919|NCT00094770|157539669|FG000|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180|||
48918920|NCT00094770|157539670|FG001|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162|||
48918921|NCT00094770|157539669|FG000|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25|||
48918922|NCT00094770|157539670|FG001|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15|||
48918923|NCT00094770|157539669|FG000|Year 2 (Week 0 to Week 104)|Protocol Violation|13|||
48712461|NCT00243269|156799326|FG000|Overall Study|Lost to Follow-up|1|||
48918924|NCT00094770|157539670|FG001|Year 2 (Week 0 to Week 104)|Protocol Violation|12|||
48918925|NCT00094770|157539669|FG000|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29|||
48918926|NCT00094770|157539670|FG001|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30|||
48918927|NCT00094770|157539669|FG000|Year 2 (Week 0 to Week 104)|Patient Moved|6|||
48918928|NCT00094770|157539670|FG001|Year 2 (Week 0 to Week 104)|Patient Moved|2|||
48918929|NCT00094770|157539669|FG000|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28|||
48918930|NCT00094770|157539670|FG001|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38|||
48918931|NCT00094770|157539669|FG000|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
48918932|NCT00094770|157539670|FG001|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
48918933|NCT00094770|157539669|FG000|Year 2 (Week 0 to Week 104)|Other|15|||
48918934|NCT00094770|157539670|FG001|Year 2 (Week 0 to Week 104)|Other|23|||
48918935|NCT00530894|157539671|FG000|Overall Study|Death|84|||
48918936|NCT00530894|157539672|FG001|Overall Study|Death|89|||
48712462|NCT00243269|156799327|FG001|Overall Study|Lost to Follow-up|0|||
48712463|NCT00243269|156799328|FG002|Overall Study|Lost to Follow-up|1|||
48712464|NCT00243269|156799329|FG003|Overall Study|Lost to Follow-up|3|||
48712465|NCT03052400|156799330|FG000|Overall Study|Lost to Follow-up|1|||
48712466|NCT03052400|156799331|FG001|Overall Study|Lost to Follow-up|0|||
48712467|NCT03052400|156799330|FG000|Overall Study|Withdrawal by Subject|0|||
48712468|NCT03052400|156799331|FG001|Overall Study|Withdrawal by Subject|1|||
48712469|NCT02314637|156799332|FG000|Overall Study|Adverse Event|4|||
48712470|NCT02314637|156799333|FG001|Overall Study|Adverse Event|8|||
48712471|NCT02314637|156799332|FG000|Overall Study|Lack of Efficacy|1|||
48712472|NCT02314637|156799333|FG001|Overall Study|Lack of Efficacy|0|||
48712473|NCT02314637|156799332|FG000|Overall Study|Physician Decision|5|||
48712474|NCT02314637|156799333|FG001|Overall Study|Physician Decision|2|||
48712475|NCT02314637|156799332|FG000|Overall Study|Withdrawal by Subject|5|||
48712476|NCT02314637|156799333|FG001|Overall Study|Withdrawal by Subject|4|||
48712477|NCT02314637|156799332|FG000|Overall Study|Other Reason|1|||
48712478|NCT02314637|156799333|FG001|Overall Study|Other Reason|0|||
48712479|NCT04027608|156799334|FG000|Overall Study|Withdrawal by Subject|13|||
48712480|NCT04027608|156799335|FG001|Overall Study|Withdrawal by Subject|2|||
48712481|NCT04027608|156799334|FG000|Overall Study|Protocol Violation|2|||
48712482|NCT04027608|156799335|FG001|Overall Study|Protocol Violation|1|||
48712483|NCT04027608|156799334|FG000|Overall Study|Physician Decision|1|||
48712484|NCT04027608|156799335|FG001|Overall Study|Physician Decision|0|||
48712485|NCT04027608|156799334|FG000|Overall Study|Lost to Follow-up|20|||
48712486|NCT04027608|156799335|FG001|Overall Study|Lost to Follow-up|4|||
48712487|NCT01396447|156799336|FG000|Overall Study|Did Not Receive Treatment|3|||
48918937|NCT00530894|157539673|FG002|Overall Study|Death|55|||
48918938|NCT00530894|157539674|FG003|Overall Study|Death|89|||
48918939|NCT00530894|157539671|FG000|Overall Study|Lost to Follow-up|1|||
48918940|NCT00530894|157539672|FG001|Overall Study|Lost to Follow-up|3|||
48918941|NCT00530894|157539673|FG002|Overall Study|Lost to Follow-up|0|||
48918942|NCT00530894|157539674|FG003|Overall Study|Lost to Follow-up|0|||
48918943|NCT00530894|157539671|FG000|Overall Study|Withdrawal by Subject|1|||
48712488|NCT01396447|156799337|FG001|Overall Study|Did Not Receive Treatment|2|||
49121429|NCT03130959|158283197|FG000|Overall Study|Administrative reason by sponsor|1|||
49121430|NCT03130959|158283198|FG001|Overall Study|Administrative reason by sponsor|0|||
49121431|NCT03130959|158283199|FG002|Overall Study|Administrative reason by sponsor|1|||
49121432|NCT03130959|158283200|FG003|Overall Study|Administrative reason by sponsor|0|||
49121433|NCT03130959|158283201|FG004|Overall Study|Administrative reason by sponsor|0|||
49121434|NCT03130959|158283202|FG005|Overall Study|Administrative reason by sponsor|0|||
49121435|NCT03130959|158283203|FG006|Overall Study|Administrative reason by sponsor|0|||
49121436|NCT03130959|158283204|FG007|Overall Study|Administrative reason by sponsor|0|||
49121437|NCT03130959|158283205|FG008|Overall Study|Administrative reason by sponsor|0|||
49121438|NCT03130959|158283206|FG009|Overall Study|Administrative reason by sponsor|0|||
49121439|NCT03130959|158283197|FG000|Overall Study|Lost to Follow-up|1|||
49121440|NCT03130959|158283198|FG001|Overall Study|Lost to Follow-up|0|||
48810881|NCT03321513|157148139|FG000|Overall Study|Death|11|||
48810882|NCT03321513|157148140|FG001|Overall Study|Death|5|||
48810883|NCT03321513|157148139|FG000|Overall Study|Withdrawal by Subject|5|||
48810884|NCT03321513|157148140|FG001|Overall Study|Withdrawal by Subject|10|||
48810885|NCT03321513|157148139|FG000|Overall Study|Lost to Follow-up|10|||
48810886|NCT03321513|157148140|FG001|Overall Study|Lost to Follow-up|11|||
48810887|NCT01190215|157148142|FG000|Up to Month 6|Lost to Follow-up|2|||
48810888|NCT01190215|157148143|FG001|Up to Month 6|Lost to Follow-up|0|||
48810889|NCT01478113|157148156|FG000|Overall Study|Withdrawal by Subject|0|||
48810890|NCT01478113|157148157|FG001|Overall Study|Withdrawal by Subject|1|||
48810891|NCT01478113|157148156|FG000|Overall Study|Physician Decision|1|||
48810892|NCT01478113|157148157|FG001|Overall Study|Physician Decision|0|||
48810893|NCT00423293|157148158|FG000|Overall Study|Ineligible / No protocol treatment|11|||
48810894|NCT04399551|157148163|FG000|Overall Study|Adverse Event|15|||
48810895|NCT04399551|157148163|FG000|Overall Study|Withdrawal by Subject|6|||
48810896|NCT04399551|157148163|FG000|Overall Study|Physician Decision|3|||
48810897|NCT04399551|157148163|FG000|Overall Study|Lost to Follow-up|2|||
48810898|NCT04399551|157148163|FG000|Overall Study|Protocol Deviation|2|||
48810899|NCT01014975|157148164|FG000|Overall Study|Withdrawal by Subject|1|||
48810900|NCT01014975|157148165|FG001|Overall Study|Withdrawal by Subject|0|||
48810901|NCT01014975|157148166|FG002|Overall Study|Withdrawal by Subject|1|||
48810902|NCT01014975|157148164|FG000|Overall Study|Death|3|||
48810903|NCT01014975|157148165|FG001|Overall Study|Death|3|||
48810904|NCT01014975|157148166|FG002|Overall Study|Death|4|||
48810905|NCT01014975|157148164|FG000|Overall Study|Lost to Follow-up|0|||
48810906|NCT01014975|157148165|FG001|Overall Study|Lost to Follow-up|0|||
48810907|NCT01014975|157148166|FG002|Overall Study|Lost to Follow-up|1|||
48810908|NCT00633932|157148168|FG000|Overall Study|Adverse Event|1|||
48810909|NCT00633932|157148169|FG001|Overall Study|Adverse Event|3|||
48810910|NCT00633932|157148170|FG002|Overall Study|Adverse Event|4|||
48810911|NCT00633932|157148168|FG000|Overall Study|Withdrawal by Subject|3|||
48810912|NCT00633932|157148169|FG001|Overall Study|Withdrawal by Subject|9|||
48810913|NCT00633932|157148170|FG002|Overall Study|Withdrawal by Subject|1|||
48810914|NCT00633932|157148168|FG000|Overall Study|Lost to Follow-up|1|||
48810915|NCT00633932|157148169|FG001|Overall Study|Lost to Follow-up|0|||
48810916|NCT00633932|157148170|FG002|Overall Study|Lost to Follow-up|2|||
48810917|NCT00633932|157148168|FG000|Overall Study|Protocol Violation|5|||
48810918|NCT00633932|157148169|FG001|Overall Study|Protocol Violation|2|||
48810919|NCT00633932|157148170|FG002|Overall Study|Protocol Violation|3|||
48810920|NCT00633932|157148168|FG000|Overall Study|Physician Decision|0|||
48810921|NCT00633932|157148169|FG001|Overall Study|Physician Decision|0|||
48810922|NCT00633932|157148170|FG002|Overall Study|Physician Decision|1|||
48810923|NCT00633932|157148168|FG000|Overall Study|Doctor's judgement|1|||
48810924|NCT00633932|157148169|FG001|Overall Study|Doctor's judgement|0|||
48810925|NCT00633932|157148170|FG002|Overall Study|Doctor's judgement|0|||
48810926|NCT00633932|157148168|FG000|Overall Study|Moved Away|1|||
48810927|NCT00633932|157148169|FG001|Overall Study|Moved Away|0|||
48810928|NCT00633932|157148170|FG002|Overall Study|Moved Away|0|||
48810929|NCT00067990|157148171|FG000|Overall Study|Death|5|||
49121441|NCT03130959|158283199|FG002|Overall Study|Lost to Follow-up|0|||
49121442|NCT03130959|158283200|FG003|Overall Study|Lost to Follow-up|0|||
49121443|NCT03130959|158283201|FG004|Overall Study|Lost to Follow-up|0|||
49121444|NCT03130959|158283202|FG005|Overall Study|Lost to Follow-up|0|||
48810930|NCT00067990|157148172|FG001|Overall Study|Death|7|||
48810931|NCT00067990|157148171|FG000|Overall Study|ESRD, Non IF/TA|1|||
48810932|NCT00067990|157148172|FG001|Overall Study|ESRD, Non IF/TA|3|||
48810933|NCT00067990|157148171|FG000|Overall Study|Withdrawal by Subject|4|||
48810934|NCT00067990|157148172|FG001|Overall Study|Withdrawal by Subject|12|||
48810935|NCT01112514|157148175|FG000|Overall Study|Lost to Follow-up|1|||
48810936|NCT02961881|157148176|FG000|Overall Study|Adverse Event|1|||
48810937|NCT02961881|157148177|FG001|Overall Study|Adverse Event|2|||
48810938|NCT02961881|157148178|FG002|Overall Study|Adverse Event|2|||
48810939|NCT02961881|157148179|FG003|Overall Study|Adverse Event|0|||
49121445|NCT03130959|158283203|FG006|Overall Study|Lost to Follow-up|0|||
48810940|NCT02961881|157148180|FG004|Overall Study|Adverse Event|1|||
48810941|NCT02961881|157148176|FG000|Overall Study|Participant request|0|||
48810942|NCT02961881|157148177|FG001|Overall Study|Participant request|2|||
48810943|NCT02961881|157148178|FG002|Overall Study|Participant request|0|||
48810944|NCT02961881|157148179|FG003|Overall Study|Participant request|0|||
48810945|NCT02961881|157148180|FG004|Overall Study|Participant request|0|||
48810946|NCT02961881|157148176|FG000|Overall Study|Disease progression|1|||
48810947|NCT02961881|157148177|FG001|Overall Study|Disease progression|0|||
48810948|NCT02961881|157148178|FG002|Overall Study|Disease progression|1|||
48810949|NCT02961881|157148179|FG003|Overall Study|Disease progression|0|||
48810950|NCT02961881|157148180|FG004|Overall Study|Disease progression|0|||
48810951|NCT01118455|157148181|FG000|Baseline [Visits 1 & 2]|Adverse Event|1|||
48810952|NCT01118455|157148182|FG001|Baseline [Visits 1 & 2]|Adverse Event|0|||
48810953|NCT02176421|157148183|FG000|Overall Study|Lost to Follow-up|4|||
48810954|NCT02176421|157148183|FG000|Overall Study|Adverse Event|1|||
48810955|NCT03430063|157148184|FG000|Overall Study|Adverse Event|0|||
48810956|NCT03430063|157148185|FG001|Overall Study|Adverse Event|1|||
48810957|NCT03430063|157148186|FG002|Overall Study|Adverse Event|0|||
48810958|NCT03430063|157148184|FG000|Overall Study|Death|3|||
48810959|NCT03430063|157148185|FG001|Overall Study|Death|2|||
48810960|NCT03430063|157148186|FG002|Overall Study|Death|3|||
48810961|NCT03430063|157148184|FG000|Overall Study|Lost to Follow-up|0|||
48810962|NCT03430063|157148185|FG001|Overall Study|Lost to Follow-up|1|||
48810963|NCT03430063|157148186|FG002|Overall Study|Lost to Follow-up|0|||
48810964|NCT03430063|157148184|FG000|Overall Study|Withdrawal by Subject|0|||
48810965|NCT03430063|157148185|FG001|Overall Study|Withdrawal by Subject|0|||
48810966|NCT03430063|157148186|FG002|Overall Study|Withdrawal by Subject|1|||
48810967|NCT03430063|157148184|FG000|Overall Study|Withdrawal of consent|3|||
48810968|NCT03430063|157148185|FG001|Overall Study|Withdrawal of consent|1|||
48810969|NCT03430063|157148186|FG002|Overall Study|Withdrawal of consent|2|||
48810970|NCT03430063|157148184|FG000|Overall Study|Progressive disease|1|||
48810971|NCT03430063|157148185|FG001|Overall Study|Progressive disease|2|||
48810972|NCT03430063|157148186|FG002|Overall Study|Progressive disease|1|||
48810973|NCT03430063|157148184|FG000|Overall Study|Other un-specified|1|||
48810974|NCT03430063|157148185|FG001|Overall Study|Other un-specified|1|||
48810975|NCT03430063|157148186|FG002|Overall Study|Other un-specified|0|||
48810976|NCT03430063|157148184|FG000|Overall Study|Randomized, but never treated|0|||
48810977|NCT03430063|157148185|FG001|Overall Study|Randomized, but never treated|0|||
48810978|NCT03430063|157148186|FG002|Overall Study|Randomized, but never treated|1|||
48810979|NCT02396537|157148187|FG000|Overall Study|Protocol Violation|0|||
48810980|NCT02396537|157148188|FG001|Overall Study|Protocol Violation|1|||
48810981|NCT02948959|157148193|FG000|52 Weeks Treatment Period|Poor compliance to protocol|0|||
48810982|NCT02948959|157148194|FG001|52 Weeks Treatment Period|Poor compliance to protocol|2|||
48810983|NCT02948959|157148193|FG000|52 Weeks Treatment Period|Adverse Event|2|||
48810984|NCT02948959|157148194|FG001|52 Weeks Treatment Period|Adverse Event|5|||
48810985|NCT02948959|157148193|FG000|52 Weeks Treatment Period|Withdrawal by Subject|2|||
48810986|NCT02948959|157148194|FG001|52 Weeks Treatment Period|Withdrawal by Subject|2|||
48810987|NCT02948959|157148193|FG000|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1|||
48810988|NCT02948959|157148194|FG001|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6|||
48810989|NCT02948959|157148193|FG000|52 Weeks Treatment Period|Randomized by error|0|||
48810990|NCT02948959|157148194|FG001|52 Weeks Treatment Period|Randomized by error|5|||
48810991|NCT02948959|157148193|FG000|52 Weeks Treatment Period|Randomized and not treated|0|||
48810992|NCT02948959|157148194|FG001|52 Weeks Treatment Period|Randomized and not treated|3|||
48810993|NCT02948959|157148193|FG000|52 Weeks Treatment Period|Non-compliant to study treatment|0|||
48810994|NCT02948959|157148194|FG001|52 Weeks Treatment Period|Non-compliant to study treatment|1|||
48810995|NCT02948959|157148193|FG000|52 Weeks Treatment Period|Change of residence location|0|||
48810996|NCT02948959|157148194|FG001|52 Weeks Treatment Period|Change of residence location|1|||
48810997|NCT02948959|157148193|FG000|12 Weeks Follow-up Period|Adverse Event|0|||
48810998|NCT02948959|157148194|FG001|12 Weeks Follow-up Period|Adverse Event|2|||
48810999|NCT02948959|157148193|FG000|12 Weeks Follow-up Period|Poor compliance to protocol|1|||
48811000|NCT02948959|157148194|FG001|12 Weeks Follow-up Period|Poor compliance to protocol|2|||
48811001|NCT02948959|157148193|FG000|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
48811002|NCT02948959|157148194|FG001|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
48811003|NCT02948959|157148193|FG000|12 Weeks Follow-up Period|Randomized by error|0|||
48811004|NCT02948959|157148194|FG001|12 Weeks Follow-up Period|Randomized by error|3|||
49121446|NCT03130959|158283204|FG007|Overall Study|Lost to Follow-up|0|||
48811005|NCT02948959|157148193|FG000|12 Weeks Follow-up Period|Change of residence location|0|||
48811006|NCT02948959|157148194|FG001|12 Weeks Follow-up Period|Change of residence location|2|||
48811007|NCT02948959|157148193|FG000|12 Weeks Follow-up Period|Study site closure|1|||
48811008|NCT02948959|157148194|FG001|12 Weeks Follow-up Period|Study site closure|0|||
48811009|NCT02291432|157148195|FG000|Overall Study|Withdrawal by Subject|2|||
48811010|NCT01932294|157148196|FG000|Overall Study|Death|43|||
48811011|NCT01932294|157148196|FG000|Overall Study|Lost to Follow-up|8|||
48811012|NCT01932294|157148196|FG000|Overall Study|VAD Implantation|20|||
49121447|NCT03130959|158283205|FG008|Overall Study|Lost to Follow-up|0|||
49121448|NCT03130959|158283206|FG009|Overall Study|Lost to Follow-up|0|||
49121449|NCT00666211|158283207|FG000|Overall Study|Withdrawal by Subject|10|||
49121450|NCT00666211|158283208|FG001|Overall Study|Withdrawal by Subject|13|||
49121451|NCT00666211|158283207|FG000|Overall Study|went off medication, no more pain|1|||
48811013|NCT01932294|157148196|FG000|Overall Study|Heart Transplantation|16|||
48811014|NCT01932294|157148196|FG000|Overall Study|Transferred to other hospitals|12|||
48811015|NCT03377790|157148198|FG000|Overall Study|Withdrawal by Subject|1|||
48811016|NCT03377790|157148199|FG001|Overall Study|Withdrawal by Subject|0|||
49121452|NCT00666211|158283208|FG001|Overall Study|went off medication, no more pain|0|||
49121453|NCT00666211|158283207|FG000|Overall Study|patient non-compliant|6|||
49121454|NCT00666211|158283208|FG001|Overall Study|patient non-compliant|6|||
49121455|NCT00666211|158283207|FG000|Overall Study|disease progression|1|||
49121456|NCT00666211|158283208|FG001|Overall Study|disease progression|8|||
49121457|NCT00666211|158283207|FG000|Overall Study|Lost to Follow-up|2|||
49121458|NCT00666211|158283208|FG001|Overall Study|Lost to Follow-up|0|||
49121459|NCT00666211|158283207|FG000|Overall Study|toxicity|0|||
49121460|NCT00666211|158283208|FG001|Overall Study|toxicity|2|||
49121461|NCT00666211|158283207|FG000|Overall Study|hospital admission|0|||
49121462|NCT00666211|158283208|FG001|Overall Study|hospital admission|5|||
49121463|NCT00666211|158283207|FG000|Overall Study|Death|0|||
49121464|NCT00666211|158283208|FG001|Overall Study|Death|2|||
49121465|NCT00666211|158283207|FG000|Overall Study|off tx for other complicating disease|0|||
49121466|NCT00666211|158283208|FG001|Overall Study|off tx for other complicating disease|1|||
49121467|NCT00666211|158283207|FG000|Overall Study|Physician Decision|0|||
49121468|NCT00666211|158283208|FG001|Overall Study|Physician Decision|1|||
49121469|NCT03280056|158283209|FG000|Overall Study|Withdrawal by Subject|12|||
49121470|NCT03280056|158283210|FG001|Overall Study|Withdrawal by Subject|14|||
48811017|NCT03377790|157148198|FG000|Overall Study|Adverse Event|1|||
48811018|NCT03377790|157148199|FG001|Overall Study|Adverse Event|0|||
48811019|NCT03377790|157148198|FG000|Overall Study|Lost to Follow-up|0|||
48811020|NCT03377790|157148199|FG001|Overall Study|Lost to Follow-up|2|||
48811021|NCT03377790|157148198|FG000|Overall Study|Randomized but not treated|1|||
48811022|NCT03377790|157148199|FG001|Overall Study|Randomized but not treated|0|||
48811023|NCT03377790|157148198|FG000|Overall Study|Withdrawn by Parent/Guardian|7|||
48811024|NCT03377790|157148199|FG001|Overall Study|Withdrawn by Parent/Guardian|4|||
48811025|NCT02145078|157148200|FG000|Overall Study|Death|1|||
48811026|NCT02145078|157148200|FG000|Overall Study|Reason not given|3|||
48811027|NCT02632786|157148201|FG000|Overall Study|Adverse Event|2|||
48811028|NCT02632786|157148202|FG001|Overall Study|Adverse Event|1|||
48811029|NCT02632786|157148201|FG000|Overall Study|Death|3|||
48811030|NCT02632786|157148202|FG001|Overall Study|Death|2|||
48811031|NCT02632786|157148201|FG000|Overall Study|Physician Decision|5|||
48811032|NCT02632786|157148202|FG001|Overall Study|Physician Decision|4|||
48811033|NCT02632786|157148201|FG000|Overall Study|Withdrawal by Subject|1|||
48811034|NCT02632786|157148202|FG001|Overall Study|Withdrawal by Subject|0|||
48811035|NCT00597714|157148203|FG000|Overall Study|Death|56|||
48811036|NCT00597714|157148204|FG001|Overall Study|Death|46|||
48918944|NCT00530894|157539672|FG001|Overall Study|Withdrawal by Subject|23|||
48918945|NCT00530894|157539673|FG002|Overall Study|Withdrawal by Subject|0|||
48918946|NCT00530894|157539674|FG003|Overall Study|Withdrawal by Subject|5|||
48918947|NCT00530894|157539671|FG000|Overall Study|Alive and censored prior to 1 year|2|||
48918948|NCT00530894|157539672|FG001|Overall Study|Alive and censored prior to 1 year|0|||
48918949|NCT00530894|157539673|FG002|Overall Study|Alive and censored prior to 1 year|0|||
48918950|NCT00530894|157539674|FG003|Overall Study|Alive and censored prior to 1 year|0|||
48918951|NCT01081912|157539675|FG000|Conversion/Titration|Adverse Event|47|||
48918952|NCT01081912|157539676|FG001|Conversion/Titration|Adverse Event|0|||
48918953|NCT01081912|157539677|FG002|Conversion/Titration|Adverse Event|0|||
48918954|NCT01081912|157539675|FG000|Conversion/Titration|Lack of Efficacy|17|||
48918955|NCT01081912|157539676|FG001|Conversion/Titration|Lack of Efficacy|0|||
48811037|NCT00597714|157148205|FG002|Overall Study|Death|0|||
48811038|NCT00597714|157148203|FG000|Overall Study|Recipient death|0|||
48811039|NCT00597714|157148204|FG001|Overall Study|Recipient death|0|||
48811040|NCT00597714|157148205|FG002|Overall Study|Recipient death|10|||
48811041|NCT00810082|157148206|FG000|Overall Study|Lost to Follow-up|0|||
48811042|NCT00810082|157148207|FG001|Overall Study|Lost to Follow-up|4|||
48811043|NCT03810313|157148208|FG000|Overall Study|Study terminated by sponsor|164|||
48918956|NCT01081912|157539677|FG002|Conversion/Titration|Lack of Efficacy|0|||
49121471|NCT03280056|158283209|FG000|Overall Study|Death|9|||
49121472|NCT03280056|158283210|FG001|Overall Study|Death|2|||
49121473|NCT03280056|158283209|FG000|Overall Study|Adverse Event|1|||
49121474|NCT03280056|158283210|FG001|Overall Study|Adverse Event|3|||
49121475|NCT03280056|158283209|FG000|Overall Study|Lost to Follow-up|1|||
48811044|NCT03810313|157148209|FG001|Overall Study|Study terminated by sponsor|159|||
48811045|NCT03810313|157148208|FG000|Overall Study|Subject decision|10|||
48811046|NCT03810313|157148209|FG001|Overall Study|Subject decision|11|||
49121476|NCT03280056|158283210|FG001|Overall Study|Lost to Follow-up|1|||
49121477|NCT03280056|158283209|FG000|Overall Study|Physician Decision|0|||
49121478|NCT03280056|158283210|FG001|Overall Study|Physician Decision|1|||
48811047|NCT03810313|157148208|FG000|Overall Study|Lost to Follow-up|3|||
48811048|NCT03810313|157148209|FG001|Overall Study|Lost to Follow-up|3|||
48811049|NCT03810313|157148208|FG000|Overall Study|Adverse Event|2|||
48811050|NCT03810313|157148209|FG001|Overall Study|Adverse Event|1|||
48811051|NCT03810313|157148208|FG000|Overall Study|Death|2|||
48811052|NCT03810313|157148209|FG001|Overall Study|Death|1|||
48811053|NCT03810313|157148208|FG000|Overall Study|Physician Decision|0|||
48811054|NCT03810313|157148209|FG001|Overall Study|Physician Decision|1|||
48811055|NCT00152763|157148210|FG000|Overall Study|Death|4|||
48811056|NCT00152763|157148211|FG001|Overall Study|Death|1|||
48811057|NCT00152763|157148212|FG002|Overall Study|Death|2|||
48811058|NCT00152763|157148213|FG003|Overall Study|Death|1|||
48811059|NCT00152763|157148210|FG000|Overall Study|Lost to Follow-up|6|||
48811060|NCT00152763|157148211|FG001|Overall Study|Lost to Follow-up|4|||
48811061|NCT00152763|157148212|FG002|Overall Study|Lost to Follow-up|2|||
48918957|NCT01081912|157539675|FG000|Conversion/Titration|Lost to Follow-up|5|||
48918958|NCT01081912|157539676|FG001|Conversion/Titration|Lost to Follow-up|0|||
48918959|NCT01081912|157539677|FG002|Conversion/Titration|Lost to Follow-up|0|||
48918960|NCT01081912|157539675|FG000|Conversion/Titration|Physician Decision|2|||
48918961|NCT01081912|157539676|FG001|Conversion/Titration|Physician Decision|0|||
48918962|NCT01081912|157539677|FG002|Conversion/Titration|Physician Decision|0|||
48918963|NCT01081912|157539675|FG000|Conversion/Titration|Protocol Violation|67|||
48918964|NCT01081912|157539676|FG001|Conversion/Titration|Protocol Violation|0|||
48918965|NCT01081912|157539677|FG002|Conversion/Titration|Protocol Violation|0|||
48918966|NCT01081912|157539675|FG000|Conversion/Titration|Withdrawal by Subject|23|||
48918967|NCT01081912|157539676|FG001|Conversion/Titration|Withdrawal by Subject|0|||
48918968|NCT01081912|157539677|FG002|Conversion/Titration|Withdrawal by Subject|0|||
48918969|NCT01081912|157539675|FG000|Conversion/Titration|Non-Compliance|47|||
48918970|NCT01081912|157539676|FG001|Conversion/Titration|Non-Compliance|0|||
48918971|NCT01081912|157539677|FG002|Conversion/Titration|Non-Compliance|0|||
48918972|NCT01081912|157539675|FG000|Maintenance Treatment|Adverse Event|0|||
48918973|NCT01081912|157539676|FG001|Maintenance Treatment|Adverse Event|2|||
48918974|NCT01081912|157539677|FG002|Maintenance Treatment|Adverse Event|12|||
48918975|NCT01081912|157539675|FG000|Maintenance Treatment|Lack of Efficacy|0|||
48918976|NCT01081912|157539676|FG001|Maintenance Treatment|Lack of Efficacy|14|||
48918977|NCT01081912|157539677|FG002|Maintenance Treatment|Lack of Efficacy|64|||
48918978|NCT01081912|157539675|FG000|Maintenance Treatment|Lost to Follow-up|0|||
48918979|NCT01081912|157539676|FG001|Maintenance Treatment|Lost to Follow-up|1|||
48918980|NCT01081912|157539677|FG002|Maintenance Treatment|Lost to Follow-up|0|||
48918981|NCT01081912|157539675|FG000|Maintenance Treatment|Physician Decision|0|||
48918982|NCT01081912|157539676|FG001|Maintenance Treatment|Physician Decision|0|||
48918983|NCT01081912|157539677|FG002|Maintenance Treatment|Physician Decision|1|||
48918984|NCT01081912|157539675|FG000|Maintenance Treatment|Protocol Violation|0|||
48918985|NCT01081912|157539676|FG001|Maintenance Treatment|Protocol Violation|1|||
48918986|NCT01081912|157539677|FG002|Maintenance Treatment|Protocol Violation|2|||
48918987|NCT01081912|157539675|FG000|Maintenance Treatment|Withdrawal by Subject|0|||
48918988|NCT01081912|157539676|FG001|Maintenance Treatment|Withdrawal by Subject|5|||
48918989|NCT01081912|157539677|FG002|Maintenance Treatment|Withdrawal by Subject|5|||
48918990|NCT01081912|157539675|FG000|Maintenance Treatment|Non-Compliance|0|||
48918991|NCT01081912|157539676|FG001|Maintenance Treatment|Non-Compliance|4|||
48918992|NCT01081912|157539677|FG002|Maintenance Treatment|Non-Compliance|7|||
48918993|NCT01081912|157539675|FG000|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
48918994|NCT01081912|157539676|FG001|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
48918995|NCT01081912|157539677|FG002|Maintenance Treatment|Withdrawal by Medical Monitor|1|||
48918996|NCT00751400|157539683|FG000|Overall Study|Lost to Follow-up|10|||
48918997|NCT02055820|157539692|FG000|Phase I: Dose-Finding|Death|1|||
48918998|NCT02055820|157539693|FG001|Phase I: Dose-Finding|Death|0|||
48918999|NCT02055820|157539694|FG002|Phase I: Dose-Finding|Death|1|||
48919000|NCT02055820|157539695|FG003|Phase I: Dose-Finding|Death|2|||
48811062|NCT00152763|157148213|FG003|Overall Study|Lost to Follow-up|13|||
48811063|NCT01965158|157148214|FG000|Overall Study|Adverse Event|14|||
48811064|NCT01965158|157148215|FG001|Overall Study|Adverse Event|5|||
48919001|NCT02055820|157539696|FG004|Phase I: Dose-Finding|Death|0|||
48919002|NCT02055820|157539697|FG005|Phase I: Dose-Finding|Death|1|||
48919003|NCT02055820|157539698|FG006|Phase I: Dose-Finding|Death|1|||
48919004|NCT02055820|157539699|FG007|Phase I: Dose-Finding|Death|0|||
48919005|NCT02055820|157539700|FG008|Phase I: Dose-Finding|Death|0|||
48919006|NCT02055820|157539701|FG009|Phase I: Dose-Finding|Death|0|||
48919007|NCT02055820|157539692|FG000|Phase I: Dose-Finding|Withdrawal by Subject|0|||
48919008|NCT02055820|157539693|FG001|Phase I: Dose-Finding|Withdrawal by Subject|0|||
48919009|NCT02055820|157539694|FG002|Phase I: Dose-Finding|Withdrawal by Subject|0|||
48919010|NCT02055820|157539695|FG003|Phase I: Dose-Finding|Withdrawal by Subject|0|||
49010778|NCT00911859|157875698|FG001|Treatment Period|Adverse Event|3|||
49010779|NCT00911859|157875699|FG002|Treatment Period|Adverse Event|7|||
49010780|NCT00911859|157875697|FG000|Treatment Period|Death|1|||
49010781|NCT00911859|157875698|FG001|Treatment Period|Death|3|||
49121479|NCT03280056|158283209|FG000|Overall Study|Early Discontinuation|1|||
49121480|NCT03280056|158283210|FG001|Overall Study|Early Discontinuation|0|||
49121481|NCT01869777|158283216|FG000|Overall Study|Excluded from the analysis, ineligible|1|||
49121482|NCT00130689|158283221|FG000|Overall Study|Progressive Disease|29|||
49121483|NCT00130689|158283221|FG000|Overall Study|Death|1|||
49121484|NCT00130689|158283221|FG000|Overall Study|Clinical Deterioration|4|||
49121485|NCT00130689|158283221|FG000|Overall Study|Withdrawal by Subject|3|||
49121486|NCT00130689|158283221|FG000|Overall Study|Ineligible|6|||
49121487|NCT00766597|158283222|FG000|Overall Study|Unexpected closure of study|4|||
49121488|NCT00766597|158283222|FG000|Overall Study|Without CCR5-tropic virus|5|||
49121489|NCT02829047|158283225|FG000|Overall Study|Withdrawal by Subject|1|||
49121490|NCT03318003|158283226|FG000|Overall Study|Withdrawal by Subject|1|||
49121491|NCT03318003|158283227|FG001|Overall Study|Withdrawal by Subject|1|||
49121492|NCT03318003|158283226|FG000|Overall Study|fetal loss|0|||
49121493|NCT03318003|158283227|FG001|Overall Study|fetal loss|1|||
49121494|NCT02907463|158283229|FG000|Overall Study|Lost to Follow-up|17|||
49121495|NCT02907463|158283229|FG000|Overall Study|Death|10|||
49121496|NCT02907463|158283229|FG000|Overall Study|Withdrawal by Subject|4|||
49121497|NCT02907463|158283229|FG000|Overall Study|MIS Approach was not used|2|||
48811065|NCT01965158|157148214|FG000|Overall Study|Withdrawal by Subject|16|||
48811066|NCT01965158|157148215|FG001|Overall Study|Withdrawal by Subject|24|||
48811067|NCT01965158|157148214|FG000|Overall Study|Lost to Follow-up|7|||
48811068|NCT01965158|157148215|FG001|Overall Study|Lost to Follow-up|5|||
48811069|NCT01965158|157148214|FG000|Overall Study|Protocol Violation|1|||
48811070|NCT01965158|157148215|FG001|Overall Study|Protocol Violation|1|||
48811071|NCT01965158|157148214|FG000|Overall Study|Other - Miscellaneous|3|||
48811072|NCT01965158|157148215|FG001|Overall Study|Other - Miscellaneous|0|||
48811073|NCT00301080|157148217|FG000|Original Version (2 Arms & 4 Weeks)|Never received drug|1|||
48811074|NCT00301080|157148218|FG001|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
48811075|NCT00301080|157148219|FG002|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
48811076|NCT00301080|157148220|FG003|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
48811077|NCT00301080|157148221|FG004|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
49121498|NCT02907463|158283229|FG000|Overall Study|Not Implanted with Study Device|2|||
49121499|NCT02907463|158283229|FG000|Overall Study|Device Explanted|1|||
49121500|NCT02907463|158283229|FG000|Overall Study|Missing Exit Form|1|||
49121501|NCT04878055|158283230|FG000|Overall Study|Patient transferred in another department|0|||
49121502|NCT04878055|158283231|FG001|Overall Study|Patient transferred in another department|2|||
49121503|NCT04878055|158283230|FG000|Overall Study|Physician Decision|1|||
49121504|NCT04878055|158283231|FG001|Overall Study|Physician Decision|1|||
49121505|NCT04878055|158283230|FG000|Overall Study|Day 60 visit not performed by mistake|0|||
49121506|NCT04878055|158283231|FG001|Overall Study|Day 60 visit not performed by mistake|4|||
49121507|NCT04878055|158283230|FG000|Overall Study|Adverse Event|12|||
49121508|NCT04878055|158283231|FG001|Overall Study|Adverse Event|7|||
49121509|NCT04878055|158283230|FG000|Overall Study|Other|5|||
49121510|NCT04878055|158283231|FG001|Overall Study|Other|0|||
49121511|NCT04878055|158283230|FG000|Overall Study|Withdrawal by Subject|7|||
49121512|NCT04878055|158283231|FG001|Overall Study|Withdrawal by Subject|3|||
49121513|NCT04878055|158283230|FG000|Overall Study|Lost to Follow-up|10|||
49121514|NCT04878055|158283231|FG001|Overall Study|Lost to Follow-up|1|||
49121515|NCT01968811|158283232|FG000|Overall Study|Protocol Violation|4|||
49121516|NCT01968811|158283232|FG000|Overall Study|post op.ref. of subject to other hospita|1|||
49121517|NCT01247350|158283233|FG000|Overall Study|Adverse Event|0|||
49121518|NCT01247350|158283234|FG001|Overall Study|Adverse Event|0|||
49121519|NCT01247350|158283235|FG002|Overall Study|Adverse Event|1|||
49121520|NCT01247350|158283236|FG003|Overall Study|Adverse Event|0|||
49121521|NCT01247350|158283237|FG004|Overall Study|Adverse Event|0|||
49121522|NCT01247350|158283233|FG000|Overall Study|Withdrawal by Subject|0|||
49121523|NCT01247350|158283234|FG001|Overall Study|Withdrawal by Subject|0|||
49121524|NCT01247350|158283235|FG002|Overall Study|Withdrawal by Subject|0|||
49121525|NCT01247350|158283236|FG003|Overall Study|Withdrawal by Subject|1|||
49121526|NCT01247350|158283237|FG004|Overall Study|Withdrawal by Subject|0|||
49121527|NCT01247350|158283233|FG000|Overall Study|Entry criteria not met|0|||
49121528|NCT01247350|158283234|FG001|Overall Study|Entry criteria not met|0|||
48811078|NCT01234649|157148223|FG000|Overall Study|Withdrawal by Subject|32|||
48811079|NCT01234649|157148224|FG001|Overall Study|Withdrawal by Subject|26|||
49121529|NCT01247350|158283235|FG002|Overall Study|Entry criteria not met|0|||
49121530|NCT01247350|158283236|FG003|Overall Study|Entry criteria not met|0|||
49121531|NCT01247350|158283237|FG004|Overall Study|Entry criteria not met|1|||
49121532|NCT01896193|158283242|FG000|Overall Study|Lack of Efficacy|20|||
49121533|NCT01896193|158283243|FG001|Overall Study|Lack of Efficacy|11|||
49121534|NCT01896193|158283242|FG000|Overall Study|Protocol Violation|0|||
49121535|NCT01896193|158283243|FG001|Overall Study|Protocol Violation|1|||
48811080|NCT01234649|157148223|FG000|Overall Study|Pregnancy|6|||
48811081|NCT01234649|157148224|FG001|Overall Study|Pregnancy|6|||
48811082|NCT01234649|157148223|FG000|Overall Study|intolerant to side effects|4|||
49121536|NCT01896193|158283242|FG000|Overall Study|Withdrew Consent|1|||
49121537|NCT01896193|158283243|FG001|Overall Study|Withdrew Consent|0|||
48811083|NCT01234649|157148224|FG001|Overall Study|intolerant to side effects|3|||
48811084|NCT01234649|157148223|FG000|Overall Study|Allergic reaction|1|||
48811085|NCT01234649|157148224|FG001|Overall Study|Allergic reaction|0|||
48811086|NCT01234649|157148223|FG000|Overall Study|Lack of Efficacy|0|||
48811087|NCT01234649|157148224|FG001|Overall Study|Lack of Efficacy|3|||
48811088|NCT01088529|157148225|FG000|Overall Study|Did not receive study treatment|0|||
48811089|NCT01088529|157148226|FG001|Overall Study|Did not receive study treatment|1|||
48811090|NCT03560245|157148227|FG000|Overall Study|Withdrawal by Subject|3|||
48811091|NCT03560245|157148228|FG001|Overall Study|Withdrawal by Subject|2|||
48811092|NCT03560245|157148227|FG000|Overall Study|Adverse Event|1|||
48811093|NCT03560245|157148228|FG001|Overall Study|Adverse Event|1|||
48811094|NCT03560245|157148227|FG000|Overall Study|Protocol Violation|1|||
48811095|NCT03560245|157148228|FG001|Overall Study|Protocol Violation|0|||
48811096|NCT03560245|157148227|FG000|Overall Study|Death|0|||
48811097|NCT03560245|157148228|FG001|Overall Study|Death|1|||
48811098|NCT03560245|157148227|FG000|Overall Study|Lost to Follow-up|0|||
48811099|NCT03560245|157148228|FG001|Overall Study|Lost to Follow-up|1|||
48811100|NCT03560245|157148227|FG000|Overall Study|Physician Decision|0|||
48811101|NCT03560245|157148228|FG001|Overall Study|Physician Decision|1|||
48811102|NCT03560245|157148227|FG000|Overall Study|Other|0|||
48811103|NCT03560245|157148228|FG001|Overall Study|Other|1|||
48811104|NCT00195715|157148236|FG000|Overall Study|Adverse Event|122|||
48811105|NCT00195715|157148236|FG000|Overall Study|Withdrawal by Subject|58|||
48811106|NCT00195715|157148236|FG000|Overall Study|Lost to Follow-up|27|||
48811107|NCT00195715|157148236|FG000|Overall Study|Protocol Violation|13|||
48811108|NCT00195715|157148236|FG000|Overall Study|Lack of Efficacy|93|||
48811109|NCT00195715|157148236|FG000|Overall Study|Pregnancy|14|||
48811110|NCT00195715|157148236|FG000|Overall Study|Investigative site closure|8|||
48811111|NCT00195715|157148236|FG000|Overall Study|Subject moved/relocated|7|||
48811112|NCT00195715|157148236|FG000|Overall Study|Subject non-compliance|6|||
48811113|NCT00195715|157148236|FG000|Overall Study|Subject started commercial Humira|5|||
48811114|NCT00195715|157148236|FG000|Overall Study|Subject choice|3|||
48811115|NCT00195715|157148236|FG000|Overall Study|Loss of response/no improvement|3|||
48811116|NCT00195715|157148236|FG000|Overall Study|Sponsor stopped study|1|||
48811117|NCT00195715|157148236|FG000|Overall Study|Administrative reasons|2|||
48811118|NCT00195715|157148236|FG000|Overall Study|Investigator's decision|2|||
48811119|NCT00195715|157148236|FG000|Overall Study|Subject wants to get pregnant|4|||
48811120|NCT00195715|157148236|FG000|Overall Study|Use of prohibited medication|2|||
48811121|NCT00195715|157148236|FG000|Overall Study|Planned surgery|2|||
48811122|NCT00195715|157148236|FG000|Overall Study|Increased infection rate|1|||
48811123|NCT00195715|157148236|FG000|Overall Study|Ineligible|1|||
48811124|NCT00195715|157148236|FG000|Overall Study|Colonic stricture|1|||
48811125|NCT00195715|157148236|FG000|Overall Study|Sponsor discontinued trial|1|||
48811126|NCT00195715|157148236|FG000|Overall Study|Sponsor discretion - trial ended early|1|||
48811127|NCT00547911|157148242|FG000|Overall Study|Adverse Event|0|||
48811128|NCT00547911|157148243|FG001|Overall Study|Adverse Event|0|||
48811129|NCT00547911|157148244|FG002|Overall Study|Adverse Event|0|||
48811130|NCT00547911|157148245|FG003|Overall Study|Adverse Event|1|||
48811131|NCT00547911|157148246|FG004|Overall Study|Adverse Event|0|||
48811132|NCT00547911|157148247|FG005|Overall Study|Adverse Event|0|||
48811133|NCT03363659|157148248|FG000|Overall Study|Adverse Event|1|||
48811134|NCT03363659|157148248|FG000|Overall Study|Screen fail|1|||
48811135|NCT03363659|157148248|FG000|Overall Study|Withdrawal by Subject|1|||
48811136|NCT03075501|157149862|FG000|Overall Study|Scheduling difficulties|15|||
48811137|NCT03075501|157149863|FG001|Overall Study|Scheduling difficulties|9|||
48811138|NCT04567693|157149864|FG000|Overall Study|Death|0|||
48811139|NCT04567693|157149865|FG001|Overall Study|Death|0|||
48811140|NCT04567693|157149866|FG002|Overall Study|Death|2|||
48811141|NCT04567693|157149864|FG000|Overall Study|Lost to Follow-up|1|||
48811142|NCT04567693|157149865|FG001|Overall Study|Lost to Follow-up|0|||
48811143|NCT04567693|157149866|FG002|Overall Study|Lost to Follow-up|2|||
48811144|NCT04567693|157149864|FG000|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|1|||
49121538|NCT01932697|158283244|FG000|Overall Study|Received a different amount of tx|1|||
48811145|NCT04567693|157149865|FG001|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|0|||
48811146|NCT04567693|157149866|FG002|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|2|||
48811147|NCT02959671|157149867|FG000|Overall Study|Adverse Event|2|||
48811148|NCT02959671|157149867|FG000|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3|||
49121539|NCT01932697|158283245|FG001|Overall Study|Received a different amount of tx|0|||
48811149|NCT01027364|157149881|FG000|Overall Study|Adverse Event|1|||
48811150|NCT01027364|157149882|FG001|Overall Study|Adverse Event|0|||
48811151|NCT01027364|157149883|FG002|Overall Study|Adverse Event|1|||
48811152|NCT01027364|157149884|FG003|Overall Study|Adverse Event|0|||
48811153|NCT01027364|157149881|FG000|Overall Study|Lost to Follow-up|1|||
48811154|NCT01027364|157149882|FG001|Overall Study|Lost to Follow-up|0|||
49121540|NCT01932697|158283244|FG000|Overall Study|Ineligible|1|||
48811155|NCT01027364|157149883|FG002|Overall Study|Lost to Follow-up|0|||
48811156|NCT01027364|157149884|FG003|Overall Study|Lost to Follow-up|0|||
49121541|NCT01932697|158283245|FG001|Overall Study|Ineligible|0|||
48811157|NCT01027364|157149881|FG000|Overall Study|Protocol Violation|1|||
48811158|NCT01027364|157149882|FG001|Overall Study|Protocol Violation|0|||
48811159|NCT01027364|157149883|FG002|Overall Study|Protocol Violation|0|||
48811160|NCT01027364|157149884|FG003|Overall Study|Protocol Violation|1|||
48811161|NCT01027364|157149881|FG000|Overall Study|Withdrawal by Subject|1|||
48811162|NCT01027364|157149882|FG001|Overall Study|Withdrawal by Subject|2|||
48811163|NCT01027364|157149883|FG002|Overall Study|Withdrawal by Subject|0|||
48811164|NCT01027364|157149884|FG003|Overall Study|Withdrawal by Subject|0|||
48811165|NCT04076020|157149886|FG000|Overall Study|Death|4|||
48811166|NCT04076020|157149887|FG001|Overall Study|Death|6|||
48811167|NCT04076020|157149886|FG000|Overall Study|Withdrawal by Subject|12|||
48811168|NCT04076020|157149887|FG001|Overall Study|Withdrawal by Subject|8|||
48811169|NCT00562978|157149891|FG000|Overall Study|Patient had imaging dose only|1|||
48811170|NCT00562978|157149892|FG001|Overall Study|Patient had imaging dose only|11|||
48811171|NCT00152971|157149893|FG000|Overall Study|Adverse Event|12|||
48811172|NCT00152971|157149894|FG001|Overall Study|Adverse Event|10|||
48811173|NCT00152971|157149895|FG002|Overall Study|Adverse Event|9|||
48811174|NCT00152971|157149893|FG000|Overall Study|Protocol Violation|10|||
48811175|NCT00152971|157149894|FG001|Overall Study|Protocol Violation|11|||
48811176|NCT00152971|157149895|FG002|Overall Study|Protocol Violation|8|||
48811177|NCT00152971|157149893|FG000|Overall Study|Lost to Follow-up|17|||
48811178|NCT00152971|157149894|FG001|Overall Study|Lost to Follow-up|14|||
48811179|NCT00152971|157149895|FG002|Overall Study|Lost to Follow-up|13|||
48811180|NCT00152971|157149893|FG000|Overall Study|Withdrawal by Subject|9|||
48811181|NCT00152971|157149894|FG001|Overall Study|Withdrawal by Subject|8|||
48811182|NCT00152971|157149895|FG002|Overall Study|Withdrawal by Subject|14|||
48811183|NCT00152971|157149893|FG000|Overall Study|Other|3|||
48811184|NCT00152971|157149894|FG001|Overall Study|Other|5|||
48811185|NCT00152971|157149895|FG002|Overall Study|Other|5|||
48811186|NCT00152971|157149893|FG000|Treatment|Adverse Event|49|||
48811187|NCT00152971|157149894|FG001|Treatment|Adverse Event|40|||
48811188|NCT00152971|157149895|FG002|Treatment|Adverse Event|54|||
48811189|NCT00152971|157149893|FG000|Treatment|Protocol Violation|8|||
48811190|NCT00152971|157149894|FG001|Treatment|Protocol Violation|6|||
48811191|NCT00152971|157149895|FG002|Treatment|Protocol Violation|10|||
48811192|NCT00152971|157149893|FG000|Treatment|Lost to Follow-up|1|||
48811193|NCT00152971|157149894|FG001|Treatment|Lost to Follow-up|2|||
48811194|NCT00152971|157149895|FG002|Treatment|Lost to Follow-up|1|||
48811195|NCT00152971|157149893|FG000|Treatment|Withdrawal by Subject|4|||
48811196|NCT00152971|157149894|FG001|Treatment|Withdrawal by Subject|4|||
48811197|NCT00152971|157149895|FG002|Treatment|Withdrawal by Subject|5|||
48811198|NCT00152971|157149893|FG000|Treatment|Other|9|||
48811199|NCT00152971|157149894|FG001|Treatment|Other|11|||
48811200|NCT00152971|157149895|FG002|Treatment|Other|10|||
48811201|NCT00545363|157149896|FG000|Overall Study|Adverse Event|6|||
48811202|NCT00545363|157149897|FG001|Overall Study|Adverse Event|7|||
48811203|NCT00545363|157149896|FG000|Overall Study|Withdrawal by Subject|6|||
48811204|NCT00545363|157149897|FG001|Overall Study|Withdrawal by Subject|5|||
48811205|NCT00545363|157149896|FG000|Overall Study|Non-compliance|3|||
48811206|NCT00545363|157149897|FG001|Overall Study|Non-compliance|1|||
48811207|NCT00545363|157149896|FG000|Overall Study|Did not meet entry criteria|1|||
48811208|NCT00545363|157149897|FG001|Overall Study|Did not meet entry criteria|1|||
48811209|NCT00545363|157149896|FG000|Overall Study|Lost to Follow-up|2|||
48811210|NCT00545363|157149897|FG001|Overall Study|Lost to Follow-up|0|||
48811211|NCT00545363|157149896|FG000|Overall Study|Other|1|||
48811212|NCT00545363|157149897|FG001|Overall Study|Other|1|||
48811213|NCT02001974|157149898|FG000|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|2|||
48811214|NCT02001974|157149899|FG001|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|3|||
48919011|NCT02055820|157539696|FG004|Phase I: Dose-Finding|Withdrawal by Subject|0|||
48919012|NCT02055820|157539697|FG005|Phase I: Dose-Finding|Withdrawal by Subject|1|||
48919013|NCT02055820|157539698|FG006|Phase I: Dose-Finding|Withdrawal by Subject|0|||
48919014|NCT02055820|157539699|FG007|Phase I: Dose-Finding|Withdrawal by Subject|0|||
48919015|NCT02055820|157539700|FG008|Phase I: Dose-Finding|Withdrawal by Subject|0|||
48919016|NCT02055820|157539701|FG009|Phase I: Dose-Finding|Withdrawal by Subject|0|||
48919017|NCT02055820|157539692|FG000|Phase I: Dose-Finding|Lost to Follow-up|0|||
48919018|NCT02055820|157539693|FG001|Phase I: Dose-Finding|Lost to Follow-up|0|||
48919019|NCT02055820|157539694|FG002|Phase I: Dose-Finding|Lost to Follow-up|0|||
48919020|NCT02055820|157539695|FG003|Phase I: Dose-Finding|Lost to Follow-up|1|||
48919021|NCT02055820|157539696|FG004|Phase I: Dose-Finding|Lost to Follow-up|0|||
48919022|NCT02055820|157539697|FG005|Phase I: Dose-Finding|Lost to Follow-up|0|||
48919023|NCT02055820|157539698|FG006|Phase I: Dose-Finding|Lost to Follow-up|1|||
48811215|NCT02001974|157149900|FG002|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|14|||
48811216|NCT02001974|157149898|FG000|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|1|||
48919024|NCT02055820|157539699|FG007|Phase I: Dose-Finding|Lost to Follow-up|0|||
48919025|NCT02055820|157539700|FG008|Phase I: Dose-Finding|Lost to Follow-up|0|||
48919026|NCT02055820|157539701|FG009|Phase I: Dose-Finding|Lost to Follow-up|0|||
48919027|NCT02055820|157539692|FG000|Phase II: Expansion|Death|0|||
48811217|NCT02001974|157149899|FG001|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|0|||
48811218|NCT02001974|157149900|FG002|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|4|||
48811219|NCT02001974|157149898|FG000|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|1|||
48811220|NCT02001974|157149899|FG001|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|0|||
48811221|NCT02001974|157149900|FG002|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|6|||
48811222|NCT02001974|157149898|FG000|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
48811223|NCT02001974|157149899|FG001|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
48811224|NCT02001974|157149900|FG002|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|2|||
48811225|NCT01306201|157149901|FG000|Overall Study|Arrhythmia|4|||
48811226|NCT01306201|157149901|FG000|Overall Study|Files could not be processed|3|||
48811227|NCT01306201|157149901|FG000|Overall Study|Files unreadable|3|||
48811228|NCT02597933|157149904|FG000|Overall Study|Withdrawal by Subject|7|||
48811229|NCT02597933|157149905|FG001|Overall Study|Withdrawal by Subject|5|||
48811230|NCT02597933|157149904|FG000|Overall Study|Protocol Violation|2|||
48811231|NCT02597933|157149905|FG001|Overall Study|Protocol Violation|2|||
48811232|NCT02597933|157149904|FG000|Overall Study|Adverse Event|20|||
48811233|NCT02597933|157149905|FG001|Overall Study|Adverse Event|28|||
48811234|NCT02597933|157149904|FG000|Overall Study|Not treated|2|||
48811235|NCT02597933|157149905|FG001|Overall Study|Not treated|2|||
48811236|NCT02597933|157149904|FG000|Overall Study|Other than stated above|7|||
48811237|NCT02597933|157149905|FG001|Overall Study|Other than stated above|14|||
48811238|NCT01107743|157149922|FG000|Overall Study|Protocol Violation|46|||
48811239|NCT01225822|157149925|FG000|Overall Study|Adverse Event|13|||
48811240|NCT01225822|157149926|FG001|Overall Study|Adverse Event|31|||
48811241|NCT01225822|157149927|FG002|Overall Study|Adverse Event|18|||
48811242|NCT01225822|157149928|FG003|Overall Study|Adverse Event|23|||
48811243|NCT01225822|157149929|FG004|Overall Study|Adverse Event|14|||
48811244|NCT01225822|157149925|FG000|Overall Study|Protocol Violation|6|||
48811245|NCT01225822|157149926|FG001|Overall Study|Protocol Violation|8|||
48811246|NCT01225822|157149927|FG002|Overall Study|Protocol Violation|6|||
48811247|NCT01225822|157149928|FG003|Overall Study|Protocol Violation|7|||
48811248|NCT01225822|157149929|FG004|Overall Study|Protocol Violation|4|||
48811249|NCT01225822|157149925|FG000|Overall Study|Lost to Follow-up|0|||
48811250|NCT01225822|157149926|FG001|Overall Study|Lost to Follow-up|0|||
48811251|NCT01225822|157149927|FG002|Overall Study|Lost to Follow-up|0|||
48811252|NCT01225822|157149928|FG003|Overall Study|Lost to Follow-up|1|||
48811253|NCT01225822|157149929|FG004|Overall Study|Lost to Follow-up|0|||
48811254|NCT01225822|157149925|FG000|Overall Study|Withdrawal by Subject|6|||
48811255|NCT01225822|157149926|FG001|Overall Study|Withdrawal by Subject|7|||
48811256|NCT01225822|157149927|FG002|Overall Study|Withdrawal by Subject|7|||
48811257|NCT01225822|157149928|FG003|Overall Study|Withdrawal by Subject|11|||
48811258|NCT01225822|157149929|FG004|Overall Study|Withdrawal by Subject|6|||
48811259|NCT01225822|157149925|FG000|Overall Study|Other|13|||
48811260|NCT01225822|157149926|FG001|Overall Study|Other|10|||
48811261|NCT01225822|157149927|FG002|Overall Study|Other|7|||
48811262|NCT01225822|157149928|FG003|Overall Study|Other|10|||
48811263|NCT01225822|157149929|FG004|Overall Study|Other|7|||
48811264|NCT00630058|157149930|FG000|Overall Study|Adverse Event|1|||
48811265|NCT00630058|157149931|FG001|Overall Study|Adverse Event|1|||
48811266|NCT00630058|157149930|FG000|Overall Study|Withdrawal by Subject|0|||
48811267|NCT00630058|157149931|FG001|Overall Study|Withdrawal by Subject|1|||
48811268|NCT00630058|157149930|FG000|Overall Study|stopping criteria|3|||
48811269|NCT00630058|157149931|FG001|Overall Study|stopping criteria|2|||
48811270|NCT01597505|157149932|FG000|Overall Study|Physician Decision|5|||
48811271|NCT01597505|157149933|FG001|Overall Study|Physician Decision|0|||
48811272|NCT01597505|157149932|FG000|Overall Study|Adverse Event|19|||
48811273|NCT01597505|157149933|FG001|Overall Study|Adverse Event|7|||
49121542|NCT00809445|158283253|FG000|1 Month Follow-up|Lost contact|1|||
48811274|NCT01597505|157149932|FG000|Overall Study|Lost to Follow-up|4|||
48811275|NCT01597505|157149933|FG001|Overall Study|Lost to Follow-up|2|||
48811276|NCT01597505|157149932|FG000|Overall Study|Withdrawal by Subject|10|||
48811277|NCT01597505|157149933|FG001|Overall Study|Withdrawal by Subject|18|||
48811278|NCT01597505|157149932|FG000|Overall Study|Other|5|||
48811279|NCT01597505|157149933|FG001|Overall Study|Other|6|||
48811280|NCT01597505|157149932|FG000|Overall Study|Missing|1|||
48811281|NCT01597505|157149933|FG001|Overall Study|Missing|0|||
48811282|NCT03856996|157149936|FG000|Overall Study|Withdrawal by Subject|1|||
48811283|NCT03856996|157149937|FG001|Overall Study|Withdrawal by Subject|0|||
48811284|NCT03856996|157149936|FG000|Overall Study|Lost to Follow-up|0|||
48811285|NCT03856996|157149937|FG001|Overall Study|Lost to Follow-up|1|||
48811286|NCT03856996|157149936|FG000|Overall Study|Adverse Event|1|||
48811287|NCT03856996|157149937|FG001|Overall Study|Adverse Event|1|||
49121543|NCT00809445|158283254|FG001|1 Month Follow-up|Lost contact|2|||
48811288|NCT03856996|157149936|FG000|Overall Study|Other|1|||
48811289|NCT03856996|157149937|FG001|Overall Study|Other|0|||
48811290|NCT01290822|157149938|FG000|Overall Study|Withdrawal by Subject|1|||
49121544|NCT00809445|158283255|FG002|1 Month Follow-up|Lost contact|1|||
48811291|NCT01290822|157149938|FG000|Overall Study|Physician Decision|10|||
48811292|NCT01003639|157149939|FG000|Overall Study|Lost to Follow-up|6|||
49121545|NCT00809445|158283253|FG000|1 Month Follow-up|Withdrew consent|1|||
49121546|NCT00809445|158283254|FG001|1 Month Follow-up|Withdrew consent|1|||
49121547|NCT00809445|158283255|FG002|1 Month Follow-up|Withdrew consent|1|||
49121548|NCT00809445|158283253|FG000|1 Month Follow-up|Death|0|||
49121549|NCT00809445|158283254|FG001|1 Month Follow-up|Death|1|||
49121550|NCT00809445|158283255|FG002|1 Month Follow-up|Death|1|||
49121551|NCT00809445|158283253|FG000|1 Month Follow-up|Incarcerated|0|||
49121552|NCT00809445|158283254|FG001|1 Month Follow-up|Incarcerated|0|||
49121553|NCT00809445|158283255|FG002|1 Month Follow-up|Incarcerated|1|||
49121554|NCT00809445|158283253|FG000|6 Month Follow-up|Lost contact|16|||
49121555|NCT00809445|158283254|FG001|6 Month Follow-up|Lost contact|14|||
49121556|NCT00809445|158283255|FG002|6 Month Follow-up|Lost contact|14|||
49121557|NCT00809445|158283253|FG000|6 Month Follow-up|Death|2|||
49121558|NCT00809445|158283254|FG001|6 Month Follow-up|Death|1|||
49121559|NCT00809445|158283255|FG002|6 Month Follow-up|Death|1|||
49121560|NCT00809445|158283253|FG000|6 Month Follow-up|Incarcerated|6|||
49121561|NCT00809445|158283254|FG001|6 Month Follow-up|Incarcerated|8|||
49121562|NCT00809445|158283255|FG002|6 Month Follow-up|Incarcerated|8|||
49121563|NCT00809445|158283253|FG000|6 Month Follow-up|Withdrew consent|0|||
49121564|NCT00809445|158283254|FG001|6 Month Follow-up|Withdrew consent|0|||
49121565|NCT00809445|158283255|FG002|6 Month Follow-up|Withdrew consent|1|||
49121566|NCT03874013|158283256|FG000|Overall Study|Adverse Event|0|||
49121567|NCT03874013|158283257|FG001|Overall Study|Adverse Event|1|||
49121568|NCT01096160|158283258|FG000|Overall Study|Adverse Event|0|||
49121569|NCT01096160|158283259|FG001|Overall Study|Adverse Event|0|||
49121570|NCT01096160|158283260|FG002|Overall Study|Adverse Event|1|||
49121571|NCT01096160|158283261|FG003|Overall Study|Adverse Event|0|||
49121572|NCT01096160|158283262|FG004|Overall Study|Adverse Event|0|||
49121573|NCT01096160|158283263|FG005|Overall Study|Adverse Event|0|||
49121574|NCT01096160|158283264|FG006|Overall Study|Adverse Event|0|||
48919028|NCT02055820|157539693|FG001|Phase II: Expansion|Death|0|||
48919029|NCT02055820|157539694|FG002|Phase II: Expansion|Death|0|||
48919030|NCT02055820|157539695|FG003|Phase II: Expansion|Death|0|||
48919031|NCT02055820|157539696|FG004|Phase II: Expansion|Death|33|||
48919032|NCT02055820|157539697|FG005|Phase II: Expansion|Death|0|||
48919033|NCT02055820|157539698|FG006|Phase II: Expansion|Death|0|||
48919034|NCT02055820|157539699|FG007|Phase II: Expansion|Death|0|||
48919035|NCT02055820|157539700|FG008|Phase II: Expansion|Death|0|||
48919036|NCT02055820|157539701|FG009|Phase II: Expansion|Death|0|||
48919037|NCT02055820|157539692|FG000|Phase II: Expansion|Lost to Follow-up|0|||
49121575|NCT01096160|158283265|FG007|Overall Study|Adverse Event|0|||
49121576|NCT01096160|158283266|FG008|Overall Study|Adverse Event|0|||
49121577|NCT01096160|158283267|FG009|Overall Study|Adverse Event|1|||
49121578|NCT01096160|158283258|FG000|Overall Study|Met stopping criteria per protocol|0|||
49121579|NCT01096160|158283259|FG001|Overall Study|Met stopping criteria per protocol|0|||
49121580|NCT01096160|158283260|FG002|Overall Study|Met stopping criteria per protocol|0|||
49121581|NCT01096160|158283261|FG003|Overall Study|Met stopping criteria per protocol|0|||
49121582|NCT01096160|158283262|FG004|Overall Study|Met stopping criteria per protocol|1|||
49121583|NCT01096160|158283263|FG005|Overall Study|Met stopping criteria per protocol|0|||
49121584|NCT01096160|158283264|FG006|Overall Study|Met stopping criteria per protocol|2|||
49121585|NCT01096160|158283265|FG007|Overall Study|Met stopping criteria per protocol|0|||
49121586|NCT01096160|158283266|FG008|Overall Study|Met stopping criteria per protocol|2|||
49121587|NCT01096160|158283267|FG009|Overall Study|Met stopping criteria per protocol|0|||
49121588|NCT00627497|158283268|FG000|Overall Study|Lost to Follow-up|1|||
49121589|NCT00627497|158283269|FG001|Overall Study|Lost to Follow-up|1|||
48919038|NCT02055820|157539693|FG001|Phase II: Expansion|Lost to Follow-up|0|||
48919039|NCT02055820|157539694|FG002|Phase II: Expansion|Lost to Follow-up|0|||
48919040|NCT02055820|157539695|FG003|Phase II: Expansion|Lost to Follow-up|0|||
48919041|NCT02055820|157539696|FG004|Phase II: Expansion|Lost to Follow-up|4|||
48919042|NCT02055820|157539697|FG005|Phase II: Expansion|Lost to Follow-up|0|||
48919043|NCT02055820|157539698|FG006|Phase II: Expansion|Lost to Follow-up|0|||
48919044|NCT02055820|157539699|FG007|Phase II: Expansion|Lost to Follow-up|0|||
48919045|NCT02055820|157539700|FG008|Phase II: Expansion|Lost to Follow-up|0|||
48919046|NCT02055820|157539701|FG009|Phase II: Expansion|Lost to Follow-up|0|||
48919047|NCT02055820|157539692|FG000|Phase II: Expansion|Withdrawal by Subject|0|||
49121590|NCT00627497|158283270|FG002|Overall Study|Lost to Follow-up|0|||
49121591|NCT00627497|158283271|FG003|Overall Study|Lost to Follow-up|0|||
49121592|NCT00705757|158283272|FG000|Overall Study|Lack of Efficacy|5|||
49121593|NCT00705757|158283273|FG001|Overall Study|Lack of Efficacy|1|||
49121594|NCT00705757|158283274|FG002|Overall Study|Lack of Efficacy|3|||
49121595|NCT00705757|158283272|FG000|Overall Study|Lost to Follow-up|7|||
48919048|NCT02055820|157539693|FG001|Phase II: Expansion|Withdrawal by Subject|0|||
49121596|NCT00705757|158283273|FG001|Overall Study|Lost to Follow-up|6|||
49121597|NCT00705757|158283274|FG002|Overall Study|Lost to Follow-up|6|||
49121598|NCT00705757|158283272|FG000|Overall Study|Withdrawal by Subject|1|||
49121599|NCT00705757|158283273|FG001|Overall Study|Withdrawal by Subject|1|||
49121600|NCT00705757|158283274|FG002|Overall Study|Withdrawal by Subject|2|||
49121601|NCT01272908|158283277|FG000|Initial Treatment Period|Adverse Event|1|||
49121602|NCT01272908|158283277|FG000|Initial Treatment Period|Lack of Efficacy|5|||
48811293|NCT01003639|157149940|FG001|Overall Study|Lost to Follow-up|9|||
48811294|NCT01003639|157149939|FG000|Overall Study|Withdrawal by Subject|9|||
48811295|NCT01003639|157149940|FG001|Overall Study|Withdrawal by Subject|5|||
48811296|NCT01003639|157149939|FG000|Overall Study|Lack of Efficacy|1|||
48811297|NCT01003639|157149940|FG001|Overall Study|Lack of Efficacy|6|||
48811298|NCT01003639|157149939|FG000|Overall Study|Adverse Event|0|||
48811299|NCT01003639|157149940|FG001|Overall Study|Adverse Event|1|||
48811300|NCT01003639|157149939|FG000|Overall Study|Protocol Violation|0|||
48811301|NCT01003639|157149940|FG001|Overall Study|Protocol Violation|1|||
48811302|NCT01003639|157149939|FG000|Overall Study|Physician Decision|1|||
48811303|NCT01003639|157149940|FG001|Overall Study|Physician Decision|0|||
48811304|NCT05284019|157149941|FG000|Overall Study|Study terminated|2|||
48811305|NCT05284019|157149942|FG001|Overall Study|Study terminated|2|||
48811306|NCT05284019|157149943|FG002|Overall Study|Study terminated|2|||
48811307|NCT05284019|157149944|FG003|Overall Study|Study terminated|5|||
48811308|NCT05284019|157149945|FG004|Overall Study|Study terminated|15|||
48811309|NCT05284019|157149941|FG000|Overall Study|Withdrawal by Subject|0|||
48811310|NCT05284019|157149942|FG001|Overall Study|Withdrawal by Subject|0|||
48811311|NCT05284019|157149943|FG002|Overall Study|Withdrawal by Subject|0|||
48811312|NCT05284019|157149944|FG003|Overall Study|Withdrawal by Subject|1|||
48811313|NCT05284019|157149945|FG004|Overall Study|Withdrawal by Subject|1|||
48811314|NCT05284019|157149941|FG000|Overall Study|Lost to Follow-up|1|||
48811315|NCT05284019|157149942|FG001|Overall Study|Lost to Follow-up|0|||
48811316|NCT05284019|157149943|FG002|Overall Study|Lost to Follow-up|0|||
48811317|NCT05284019|157149944|FG003|Overall Study|Lost to Follow-up|2|||
48811318|NCT05284019|157149945|FG004|Overall Study|Lost to Follow-up|1|||
48811319|NCT00089895|157149947|FG000|Overall Study|Consent Withdrawn|11|||
48811320|NCT00089895|157149948|FG001|Overall Study|Consent Withdrawn|14|||
48811321|NCT00089895|157149947|FG000|Overall Study|Technical reason|7|||
48811322|NCT00089895|157149948|FG001|Overall Study|Technical reason|2|||
48811323|NCT00089895|157149947|FG000|Overall Study|Surgery|0|||
48811324|NCT00089895|157149948|FG001|Overall Study|Surgery|1|||
48811325|NCT00089895|157149947|FG000|Overall Study|Bleeding|0|||
48811326|NCT00089895|157149948|FG001|Overall Study|Bleeding|2|||
48811327|NCT00089895|157149947|FG000|Overall Study|Physician Decision|3|||
48811328|NCT00089895|157149948|FG001|Overall Study|Physician Decision|7|||
48811329|NCT00089895|157149947|FG000|Overall Study|Exclusion criteria met|6|||
48811330|NCT00089895|157149948|FG001|Overall Study|Exclusion criteria met|6|||
48811331|NCT00089895|157149947|FG000|Overall Study|Not otherwise specified|4|||
48811332|NCT00089895|157149948|FG001|Overall Study|Not otherwise specified|8|||
48811333|NCT00089895|157149947|FG000|Overall Study|Missing|4|||
48811334|NCT00089895|157149948|FG001|Overall Study|Missing|2|||
48811335|NCT05033080|157149953|FG000|Overall Study|Adverse Event|4|||
48811336|NCT05033080|157149954|FG001|Overall Study|Adverse Event|4|||
48811337|NCT05033080|157149953|FG000|Overall Study|Withdrawal of consent (not due to AE)|5|||
48811338|NCT05033080|157149954|FG001|Overall Study|Withdrawal of consent (not due to AE)|5|||
48811339|NCT05033080|157149953|FG000|Overall Study|Lost to Follow-up|1|||
48811340|NCT05033080|157149954|FG001|Overall Study|Lost to Follow-up|0|||
48811341|NCT05033080|157149953|FG000|Overall Study|Other non-compliance|0|||
48811342|NCT05033080|157149954|FG001|Overall Study|Other non-compliance|1|||
48811343|NCT05033080|157149953|FG000|Overall Study|Physician Decision|0|||
48811344|NCT05033080|157149954|FG001|Overall Study|Physician Decision|1|||
48811345|NCT05033080|157149953|FG000|Overall Study|Other|1|||
48811346|NCT05033080|157149954|FG001|Overall Study|Other|1|||
48811347|NCT02778399|157149955|FG000|Up to Week 12 Treatment Period|Adverse Event|1|||
48811348|NCT02778399|157149956|FG001|Up to Week 12 Treatment Period|Adverse Event|2|||
48811349|NCT02778399|157149957|FG002|Up to Week 12 Treatment Period|Adverse Event|3|||
48811350|NCT02778399|157149958|FG003|Up to Week 12 Treatment Period|Adverse Event|2|||
48811351|NCT02778399|157149959|FG004|Up to Week 12 Treatment Period|Adverse Event|3|||
48811352|NCT02778399|157149960|FG005|Up to Week 12 Treatment Period|Adverse Event|3|||
48811353|NCT02778399|157149955|FG000|Up to Week 12 Treatment Period|Withdrawal by Subject|5|||
48811354|NCT02778399|157149956|FG001|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
48811355|NCT02778399|157149957|FG002|Up to Week 12 Treatment Period|Withdrawal by Subject|1|||
48811356|NCT02778399|157149958|FG003|Up to Week 12 Treatment Period|Withdrawal by Subject|4|||
48811357|NCT02778399|157149959|FG004|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
48919049|NCT02055820|157539694|FG002|Phase II: Expansion|Withdrawal by Subject|0|||
48919050|NCT02055820|157539695|FG003|Phase II: Expansion|Withdrawal by Subject|0|||
48919051|NCT02055820|157539696|FG004|Phase II: Expansion|Withdrawal by Subject|12|||
48811358|NCT02778399|157149960|FG005|Up to Week 12 Treatment Period|Withdrawal by Subject|3|||
48811359|NCT02778399|157149955|FG000|Up to Week 12 Treatment Period|Protocol Violation|0|||
48811360|NCT02778399|157149956|FG001|Up to Week 12 Treatment Period|Protocol Violation|0|||
48811361|NCT02778399|157149957|FG002|Up to Week 12 Treatment Period|Protocol Violation|0|||
48811362|NCT02778399|157149958|FG003|Up to Week 12 Treatment Period|Protocol Violation|0|||
48811363|NCT02778399|157149959|FG004|Up to Week 12 Treatment Period|Protocol Violation|1|||
49010782|NCT00911859|157875699|FG002|Treatment Period|Death|5|||
48811364|NCT02778399|157149960|FG005|Up to Week 12 Treatment Period|Protocol Violation|0|||
48811365|NCT02778399|157149955|FG000|Up to Week 12 Treatment Period|Lost to Follow-up|3|||
48811366|NCT02778399|157149956|FG001|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
48811367|NCT02778399|157149957|FG002|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
48811368|NCT02778399|157149958|FG003|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
48811369|NCT02778399|157149959|FG004|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
48811370|NCT02778399|157149960|FG005|Up to Week 12 Treatment Period|Lost to Follow-up|2|||
48811371|NCT02778399|157149955|FG000|Up to Week 12 Treatment Period|other - reason not stated|0|||
48811372|NCT02778399|157149956|FG001|Up to Week 12 Treatment Period|other - reason not stated|0|||
48811373|NCT02778399|157149957|FG002|Up to Week 12 Treatment Period|other - reason not stated|0|||
48811374|NCT02778399|157149958|FG003|Up to Week 12 Treatment Period|other - reason not stated|1|||
48811375|NCT02778399|157149959|FG004|Up to Week 12 Treatment Period|other - reason not stated|2|||
48811376|NCT02778399|157149960|FG005|Up to Week 12 Treatment Period|other - reason not stated|0|||
48811377|NCT02778399|157149955|FG000|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
48811378|NCT02778399|157149956|FG001|Week 12 to Week 24 Treatment Period|Adverse Event|0|||
48811379|NCT02778399|157149957|FG002|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
48811380|NCT02778399|157149958|FG003|Week 12 to Week 24 Treatment Period|Adverse Event|1|||
48811381|NCT02778399|157149959|FG004|Week 12 to Week 24 Treatment Period|Adverse Event|3|||
48811382|NCT02778399|157149960|FG005|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
48811383|NCT02778399|157149955|FG000|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
48811384|NCT02778399|157149956|FG001|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
48811385|NCT02778399|157149957|FG002|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|0|||
48811386|NCT02778399|157149958|FG003|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
48811387|NCT02778399|157149959|FG004|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
48811388|NCT02778399|157149960|FG005|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
48811389|NCT02778399|157149955|FG000|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
48811390|NCT02778399|157149956|FG001|Week 12 to Week 24 Treatment Period|Protocol Violation|1|||
48811391|NCT02778399|157149957|FG002|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
48811392|NCT02778399|157149958|FG003|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
48811393|NCT02778399|157149959|FG004|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
48811394|NCT02778399|157149960|FG005|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
48811395|NCT02778399|157149955|FG000|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
48811396|NCT02778399|157149956|FG001|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
48811397|NCT02778399|157149957|FG002|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
48811398|NCT02778399|157149958|FG003|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
48811399|NCT02778399|157149959|FG004|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
48811400|NCT02778399|157149960|FG005|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
48811401|NCT02778399|157149955|FG000|Week 12 to Week 24 Treatment Period|Pregnancy|1|||
48811402|NCT02778399|157149956|FG001|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
48811403|NCT02778399|157149957|FG002|Week 12 to Week 24 Treatment Period|Pregnancy|2|||
48811404|NCT02778399|157149958|FG003|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
48811405|NCT02778399|157149959|FG004|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
48811406|NCT02778399|157149960|FG005|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
48811407|NCT02778399|157149955|FG000|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
48811408|NCT02778399|157149956|FG001|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
48811409|NCT02778399|157149957|FG002|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
48811410|NCT02778399|157149958|FG003|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
48811411|NCT02778399|157149959|FG004|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
48811412|NCT02778399|157149960|FG005|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
48811413|NCT00882921|157149961|FG000|Overall Study|Death|2|||
48811414|NCT00882921|157149961|FG000|Overall Study|Other|3|||
48811415|NCT00882921|157149961|FG000|Overall Study|Lost to Follow-up|2|||
48811416|NCT00882921|157149961|FG000|Overall Study|Termination By Investigator|3|||
48811417|NCT00882921|157149961|FG000|Overall Study|Withdrawal Of Consent|1|||
48811418|NCT02138747|157149967|FG000|Treatment Period 1|Adverse Event|10|||
48811419|NCT02138747|157149968|FG001|Treatment Period 1|Adverse Event|14|||
48811420|NCT02138747|157149969|FG002|Treatment Period 1|Adverse Event|2|||
48811421|NCT02138747|157149970|FG003|Treatment Period 1|Adverse Event|1|||
48811422|NCT02138747|157149967|FG000|Treatment Period 1|Lost to Follow-up|0|||
48811423|NCT02138747|157149968|FG001|Treatment Period 1|Lost to Follow-up|1|||
48811424|NCT02138747|157149969|FG002|Treatment Period 1|Lost to Follow-up|1|||
48811425|NCT02138747|157149970|FG003|Treatment Period 1|Lost to Follow-up|0|||
48811426|NCT02138747|157149967|FG000|Treatment Period 1|Protocol Violation|0|||
48811427|NCT02138747|157149968|FG001|Treatment Period 1|Protocol Violation|2|||
48811428|NCT02138747|157149969|FG002|Treatment Period 1|Protocol Violation|0|||
48811429|NCT02138747|157149970|FG003|Treatment Period 1|Protocol Violation|0|||
49010783|NCT00911859|157875697|FG000|Treatment Period|Lack of Efficacy|1|||
49121603|NCT01272908|158283277|FG000|Initial Treatment Period|Protocol Violation|1|||
49121604|NCT01272908|158283277|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
49121605|NCT01272908|158283277|FG000|Re-Treatment Period|Adverse Event|2|||
49121606|NCT01272908|158283277|FG000|Re-Treatment Period|Lack of Efficacy|3|||
49121607|NCT01272908|158283277|FG000|Re-Treatment Period|Withdrawal by Subject|1|||
48811430|NCT02138747|157149967|FG000|Treatment Period 1|Withdrawal by Subject|8|||
48811431|NCT02138747|157149968|FG001|Treatment Period 1|Withdrawal by Subject|4|||
48811432|NCT02138747|157149969|FG002|Treatment Period 1|Withdrawal by Subject|1|||
48811433|NCT02138747|157149970|FG003|Treatment Period 1|Withdrawal by Subject|3|||
48811434|NCT02138747|157149967|FG000|Treatment Period 1|Other - Miscellaneous|2|||
48811435|NCT02138747|157149968|FG001|Treatment Period 1|Other - Miscellaneous|4|||
48811436|NCT02138747|157149969|FG002|Treatment Period 1|Other - Miscellaneous|0|||
48811437|NCT02138747|157149970|FG003|Treatment Period 1|Other - Miscellaneous|0|||
48811438|NCT02138747|157149967|FG000|Treatment Period 2|Adverse Event|6|||
48811439|NCT02138747|157149968|FG001|Treatment Period 2|Adverse Event|3|||
48811440|NCT02138747|157149969|FG002|Treatment Period 2|Adverse Event|1|||
48811441|NCT02138747|157149970|FG003|Treatment Period 2|Adverse Event|1|||
48811442|NCT02138747|157149967|FG000|Treatment Period 2|Lost to Follow-up|2|||
48811443|NCT02138747|157149968|FG001|Treatment Period 2|Lost to Follow-up|0|||
48811444|NCT02138747|157149969|FG002|Treatment Period 2|Lost to Follow-up|0|||
48811445|NCT02138747|157149970|FG003|Treatment Period 2|Lost to Follow-up|0|||
48811446|NCT02138747|157149967|FG000|Treatment Period 2|Protocol Violation|1|||
48811447|NCT02138747|157149968|FG001|Treatment Period 2|Protocol Violation|0|||
48811448|NCT02138747|157149969|FG002|Treatment Period 2|Protocol Violation|0|||
48811449|NCT02138747|157149970|FG003|Treatment Period 2|Protocol Violation|0|||
48811450|NCT02138747|157149967|FG000|Treatment Period 2|Withdrawal by Subject|5|||
48811451|NCT02138747|157149968|FG001|Treatment Period 2|Withdrawal by Subject|4|||
48811452|NCT02138747|157149969|FG002|Treatment Period 2|Withdrawal by Subject|1|||
48811453|NCT02138747|157149970|FG003|Treatment Period 2|Withdrawal by Subject|2|||
48811454|NCT02138747|157149967|FG000|Treatment Period 2|Other - Miscellaneous|3|||
48811455|NCT02138747|157149968|FG001|Treatment Period 2|Other - Miscellaneous|0|||
48811456|NCT02138747|157149969|FG002|Treatment Period 2|Other - Miscellaneous|0|||
48811457|NCT02138747|157149970|FG003|Treatment Period 2|Other - Miscellaneous|0|||
48811458|NCT02611830|157149972|FG000|OL Induction Phase|Pretreatment Event/Adverse Event|9|||
48811459|NCT02611830|157149973|FG001|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
48811460|NCT02611830|157149974|FG002|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
48811461|NCT02611830|157149975|FG003|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
48811462|NCT02611830|157149972|FG000|OL Induction Phase|Significant Protocol Deviation|4|||
48811463|NCT02611830|157149973|FG001|OL Induction Phase|Significant Protocol Deviation|0|||
49121608|NCT01038687|158283284|FG000|Overall Study|Adverse Event|0|||
49121609|NCT01038687|158283285|FG001|Overall Study|Adverse Event|2|||
49121610|NCT01038687|158283286|FG002|Overall Study|Adverse Event|1|||
49121611|NCT05227118|158283287|FG000|Overall Study|Adverse Event|0|||
49121612|NCT05227118|158283288|FG001|Overall Study|Adverse Event|0|||
49121613|NCT05227118|158283289|FG002|Overall Study|Adverse Event|1|||
49121614|NCT05227118|158283290|FG003|Overall Study|Adverse Event|0|||
49121615|NCT05227118|158283287|FG000|Overall Study|Withdrawal by Subject|0|||
49121616|NCT05227118|158283288|FG001|Overall Study|Withdrawal by Subject|0|||
49121617|NCT05227118|158283289|FG002|Overall Study|Withdrawal by Subject|2|||
49121618|NCT05227118|158283290|FG003|Overall Study|Withdrawal by Subject|0|||
49121619|NCT01435759|158283291|FG000|Antidepressant Lead-in Phase|Adverse Event|40|||
49121620|NCT01435759|158283292|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
49121621|NCT01435759|158283293|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
49121622|NCT01435759|158283294|FG003|Antidepressant Lead-in Phase|Adverse Event|0|||
49121623|NCT01435759|158283295|FG004|Antidepressant Lead-in Phase|Adverse Event|0|||
49121624|NCT01435759|158283296|FG005|Antidepressant Lead-in Phase|Adverse Event|0|||
49121625|NCT01435759|158283291|FG000|Antidepressant Lead-in Phase|Protocol Violation|16|||
49121626|NCT01435759|158283292|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
49121627|NCT01435759|158283293|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
49121628|NCT01435759|158283294|FG003|Antidepressant Lead-in Phase|Protocol Violation|0|||
49121629|NCT01435759|158283295|FG004|Antidepressant Lead-in Phase|Protocol Violation|0|||
49121630|NCT01435759|158283296|FG005|Antidepressant Lead-in Phase|Protocol Violation|0|||
49121631|NCT01435759|158283291|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|74|||
49121632|NCT01435759|158283292|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
49121633|NCT01435759|158283293|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
49121634|NCT01435759|158283294|FG003|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
49121635|NCT01435759|158283295|FG004|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
48811464|NCT02611830|157149974|FG002|OL Induction Phase|Significant Protocol Deviation|0|||
48811465|NCT02611830|157149975|FG003|OL Induction Phase|Significant Protocol Deviation|0|||
49121636|NCT01435759|158283296|FG005|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
49121637|NCT01435759|158283291|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|83|||
49121638|NCT01435759|158283292|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
49121639|NCT01435759|158283293|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
49121640|NCT01435759|158283294|FG003|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
49121641|NCT01435759|158283295|FG004|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
49121642|NCT01435759|158283296|FG005|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
49121643|NCT01435759|158283291|FG000|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10|||
48811466|NCT02611830|157149972|FG000|OL Induction Phase|Voluntary Withdrawal|5|||
49121644|NCT01435759|158283292|FG001|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
49121645|NCT01435759|158283293|FG002|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
49121646|NCT01435759|158283294|FG003|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
48811467|NCT02611830|157149973|FG001|OL Induction Phase|Voluntary Withdrawal|0|||
48811468|NCT02611830|157149974|FG002|OL Induction Phase|Voluntary Withdrawal|0|||
48811469|NCT02611830|157149975|FG003|OL Induction Phase|Voluntary Withdrawal|0|||
48811470|NCT02611830|157149972|FG000|OL Induction Phase|Lack of Efficacy|9|||
48811471|NCT02611830|157149973|FG001|OL Induction Phase|Lack of Efficacy|0|||
48811472|NCT02611830|157149974|FG002|OL Induction Phase|Lack of Efficacy|0|||
48811473|NCT02611830|157149975|FG003|OL Induction Phase|Lack of Efficacy|0|||
48811474|NCT02611830|157149972|FG000|OL Induction Phase|Reason not specified|3|||
48811475|NCT02611830|157149973|FG001|OL Induction Phase|Reason not specified|0|||
48811476|NCT02611830|157149974|FG002|OL Induction Phase|Reason not specified|0|||
48811477|NCT02611830|157149975|FG003|OL Induction Phase|Reason not specified|0|||
48811478|NCT02611830|157149972|FG000|Maintenance Phase|Lack of Efficacy|0|||
49121647|NCT01435759|158283295|FG004|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
48811479|NCT02611830|157149973|FG001|Maintenance Phase|Lack of Efficacy|29|||
48811480|NCT02611830|157149974|FG002|Maintenance Phase|Lack of Efficacy|18|||
48811481|NCT02611830|157149975|FG003|Maintenance Phase|Lack of Efficacy|6|||
48811482|NCT02611830|157149972|FG000|Maintenance Phase|Pretreatment Event/Adverse Event|0|||
48811483|NCT02611830|157149973|FG001|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
48811484|NCT02611830|157149974|FG002|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
48811485|NCT02611830|157149975|FG003|Maintenance Phase|Pretreatment Event/Adverse Event|2|||
48919052|NCT02055820|157539697|FG005|Phase II: Expansion|Withdrawal by Subject|0|||
48919053|NCT02055820|157539698|FG006|Phase II: Expansion|Withdrawal by Subject|0|||
48919054|NCT02055820|157539699|FG007|Phase II: Expansion|Withdrawal by Subject|0|||
49121648|NCT01435759|158283296|FG005|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
49121649|NCT01435759|158283291|FG000|Antidepressant Lead-in Phase|Other|119|||
48811486|NCT02611830|157149972|FG000|Maintenance Phase|Significant Protocol Deviation|0|||
48811487|NCT02611830|157149973|FG001|Maintenance Phase|Significant Protocol Deviation|0|||
48811488|NCT02611830|157149974|FG002|Maintenance Phase|Significant Protocol Deviation|1|||
48811489|NCT02611830|157149975|FG003|Maintenance Phase|Significant Protocol Deviation|1|||
48811490|NCT02611830|157149972|FG000|Maintenance Phase|Lost to Follow-up|0|||
48811491|NCT02611830|157149973|FG001|Maintenance Phase|Lost to Follow-up|0|||
48811492|NCT02611830|157149974|FG002|Maintenance Phase|Lost to Follow-up|0|||
48811493|NCT02611830|157149975|FG003|Maintenance Phase|Lost to Follow-up|1|||
48811494|NCT02611830|157149972|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
48811495|NCT02611830|157149973|FG001|Maintenance Phase|Voluntary Withdrawal|1|||
48811496|NCT02611830|157149974|FG002|Maintenance Phase|Voluntary Withdrawal|2|||
48811497|NCT02611830|157149975|FG003|Maintenance Phase|Voluntary Withdrawal|5|||
48811498|NCT02611830|157149972|FG000|Maintenance Phase|Pregnancy|0|||
48811499|NCT02611830|157149973|FG001|Maintenance Phase|Pregnancy|0|||
48811500|NCT02611830|157149974|FG002|Maintenance Phase|Pregnancy|1|||
48811501|NCT02611830|157149975|FG003|Maintenance Phase|Pregnancy|0|||
48811502|NCT02611830|157149972|FG000|Maintenance Phase|Reason not specified|0|||
48811503|NCT02611830|157149973|FG001|Maintenance Phase|Reason not specified|1|||
48811504|NCT02611830|157149974|FG002|Maintenance Phase|Reason not specified|4|||
48712489|NCT01396447|156799338|FG002|Overall Study|Did Not Receive Treatment|1|||
48712490|NCT01396447|156799339|FG003|Overall Study|Did Not Receive Treatment|0|||
48712491|NCT01396447|156799336|FG000|Overall Study|Adverse Event|15|||
48712492|NCT01396447|156799337|FG001|Overall Study|Adverse Event|12|||
48712493|NCT01396447|156799338|FG002|Overall Study|Adverse Event|12|||
48712494|NCT01396447|156799339|FG003|Overall Study|Adverse Event|17|||
48712495|NCT01396447|156799336|FG000|Overall Study|Insufficient Therapeutic Response|5|||
48712496|NCT01396447|156799337|FG001|Overall Study|Insufficient Therapeutic Response|5|||
48712497|NCT01396447|156799338|FG002|Overall Study|Insufficient Therapeutic Response|2|||
48712498|NCT01396447|156799339|FG003|Overall Study|Insufficient Therapeutic Response|4|||
48712499|NCT01396447|156799336|FG000|Overall Study|Protocol Violation|5|||
48811505|NCT02611830|157149975|FG003|Maintenance Phase|Reason not specified|0|||
48811506|NCT02120664|157149977|FG000|Overall Study|Withdrawal by Subject|0|||
48811507|NCT02120664|157149978|FG001|Overall Study|Withdrawal by Subject|0|||
48811508|NCT02120664|157149979|FG002|Overall Study|Withdrawal by Subject|0|||
48811509|NCT02120664|157149980|FG003|Overall Study|Withdrawal by Subject|1|||
48811510|NCT02120664|157149981|FG004|Overall Study|Withdrawal by Subject|0|||
48811511|NCT02223754|157149982|FG000|Period 1|Adverse Event|1|||
48811512|NCT02223754|157149983|FG001|Period 1|Adverse Event|0|||
48811513|NCT02223754|157149982|FG000|Period 1|Lost to Follow-up|0|||
48811514|NCT02223754|157149983|FG001|Period 1|Lost to Follow-up|1|||
48919055|NCT02055820|157539700|FG008|Phase II: Expansion|Withdrawal by Subject|0|||
48919056|NCT02055820|157539701|FG009|Phase II: Expansion|Withdrawal by Subject|0|||
48919057|NCT01032915|157539702|FG000|Overall Study|Adverse Event|2|||
48919058|NCT01032915|157539703|FG001|Overall Study|Adverse Event|2|||
48919059|NCT01032915|157539704|FG002|Overall Study|Adverse Event|1|||
48919060|NCT01032915|157539705|FG003|Overall Study|Adverse Event|1|||
49121650|NCT01435759|158283292|FG001|Antidepressant Lead-in Phase|Other|0|||
49121651|NCT01435759|158283293|FG002|Antidepressant Lead-in Phase|Other|0|||
49121652|NCT01435759|158283294|FG003|Antidepressant Lead-in Phase|Other|0|||
48712500|NCT01396447|156799337|FG001|Overall Study|Protocol Violation|2|||
48712501|NCT01396447|156799338|FG002|Overall Study|Protocol Violation|3|||
48712502|NCT01396447|156799339|FG003|Overall Study|Protocol Violation|7|||
48811515|NCT02223754|157149982|FG000|Period 1|Protocol Violation|2|||
48811516|NCT02223754|157149983|FG001|Period 1|Protocol Violation|4|||
48811517|NCT02223754|157149982|FG000|Period 1|Withdrawal by Subject|0|||
48811518|NCT02223754|157149983|FG001|Period 1|Withdrawal by Subject|4|||
48811519|NCT02223754|157149982|FG000|Period 1|Test Article No Longer Available|1|||
48811520|NCT02223754|157149983|FG001|Period 1|Test Article No Longer Available|5|||
48811521|NCT02223754|157149982|FG000|Period 1|Unsatisfactory Visual Response|0|||
48919061|NCT01032915|157539702|FG000|Overall Study|Abnormal test procedure result|0|||
48712503|NCT01396447|156799336|FG000|Overall Study|Withdrawal of Consent|11|||
48811522|NCT02223754|157149983|FG001|Period 1|Unsatisfactory Visual Response|1|||
48919062|NCT01032915|157539703|FG001|Overall Study|Abnormal test procedure result|0|||
48712504|NCT01396447|156799337|FG001|Overall Study|Withdrawal of Consent|9|||
48712505|NCT01396447|156799338|FG002|Overall Study|Withdrawal of Consent|4|||
48712506|NCT01396447|156799339|FG003|Overall Study|Withdrawal of Consent|15|||
48712507|NCT01396447|156799336|FG000|Overall Study|Lost to Follow-up|4|||
48712508|NCT01396447|156799337|FG001|Overall Study|Lost to Follow-up|8|||
48712509|NCT01396447|156799338|FG002|Overall Study|Lost to Follow-up|7|||
48712510|NCT01396447|156799339|FG003|Overall Study|Lost to Follow-up|9|||
48712511|NCT01396447|156799336|FG000|Overall Study|Other Miscellaneous Reasons|0|||
48712512|NCT01396447|156799337|FG001|Overall Study|Other Miscellaneous Reasons|2|||
48712513|NCT01396447|156799338|FG002|Overall Study|Other Miscellaneous Reasons|1|||
48712514|NCT01396447|156799339|FG003|Overall Study|Other Miscellaneous Reasons|0|||
48712515|NCT00796978|156799340|FG000|Overall Study|Cardiac adverse event|5|||
48712516|NCT00796978|156799340|FG000|Overall Study|Adverse Event|4|||
48712517|NCT00796978|156799340|FG000|Overall Study|Withdrawal by Subject|3|||
48712518|NCT01237899|156799341|FG000|Washout Period of at Least 7 Days|Adverse Event|0|||
48712519|NCT01237899|156799342|FG001|Washout Period of at Least 7 Days|Adverse Event|0|||
48712520|NCT01237899|156799343|FG002|Washout Period of at Least 7 Days|Adverse Event|1|||
48712521|NCT01237899|156799344|FG003|Washout Period of at Least 7 Days|Adverse Event|0|||
48712522|NCT01237899|156799345|FG004|Washout Period of at Least 7 Days|Adverse Event|0|||
48712523|NCT01237899|156799346|FG005|Washout Period of at Least 7 Days|Adverse Event|0|||
48712524|NCT01237899|156799347|FG006|Washout Period of at Least 7 Days|Adverse Event|0|||
48712525|NCT01237899|156799348|FG007|Washout Period of at Least 7 Days|Adverse Event|0|||
48712526|NCT01237899|156799349|FG008|Washout Period of at Least 7 Days|Adverse Event|0|||
48712527|NCT01237899|156799350|FG009|Washout Period of at Least 7 Days|Adverse Event|0|||
48712528|NCT01237899|156799351|FG010|Washout Period of at Least 7 Days|Adverse Event|0|||
48712529|NCT02834793|156799352|FG000|Core Study (Up to 18 Weeks)|Withdrawal by Subject|2|||
48712530|NCT02834793|156799353|FG001|Core Study (Up to 18 Weeks)|Withdrawal by Subject|1|||
48712531|NCT02834793|156799354|FG002|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
48712532|NCT02834793|156799355|FG003|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
48712533|NCT02834793|156799352|FG000|Core Study (Up to 18 Weeks)|Lack of Efficacy|1|||
48712534|NCT02834793|156799353|FG001|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
48712535|NCT02834793|156799354|FG002|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
48712536|NCT02834793|156799355|FG003|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
48712537|NCT02834793|156799352|FG000|Core Study (Up to 18 Weeks)|Lost to Follow-up|1|||
48712538|NCT02834793|156799353|FG001|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
48712539|NCT02834793|156799354|FG002|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
48712540|NCT02834793|156799355|FG003|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
48712541|NCT02834793|156799352|FG000|Core Study (Up to 18 Weeks)|Adverse Event|0|||
48712542|NCT02834793|156799353|FG001|Core Study (Up to 18 Weeks)|Adverse Event|3|||
48712543|NCT02834793|156799354|FG002|Core Study (Up to 18 Weeks)|Adverse Event|0|||
48811523|NCT02223754|157149982|FG000|Period 2|Adverse Event|0|||
48811524|NCT02223754|157149983|FG001|Period 2|Adverse Event|1|||
48811525|NCT02223754|157149982|FG000|Period 2|Protocol Violation|1|||
48811526|NCT02223754|157149983|FG001|Period 2|Protocol Violation|0|||
48811527|NCT02223754|157149982|FG000|Period 2|Lens Discomfort|1|||
48811528|NCT02223754|157149983|FG001|Period 2|Lens Discomfort|1|||
48811529|NCT02223754|157149982|FG000|Period 2|Lost to Follow-up|1|||
49121653|NCT01435759|158283295|FG004|Antidepressant Lead-in Phase|Other|0|||
49121654|NCT01435759|158283296|FG005|Antidepressant Lead-in Phase|Other|0|||
49121655|NCT01435759|158283291|FG000|Double-blind Phase|Adverse Event|7|||
49121656|NCT01435759|158283292|FG001|Double-blind Phase|Adverse Event|0|||
49121657|NCT01435759|158283293|FG002|Double-blind Phase|Adverse Event|1|||
49121658|NCT01435759|158283294|FG003|Double-blind Phase|Adverse Event|1|||
49121659|NCT01435759|158283295|FG004|Double-blind Phase|Adverse Event|1|||
49121660|NCT01435759|158283296|FG005|Double-blind Phase|Adverse Event|3|||
49121661|NCT01435759|158283291|FG000|Double-blind Phase|Protocol Violation|2|||
49121662|NCT01435759|158283292|FG001|Double-blind Phase|Protocol Violation|0|||
49121663|NCT01435759|158283293|FG002|Double-blind Phase|Protocol Violation|1|||
49121664|NCT01435759|158283294|FG003|Double-blind Phase|Protocol Violation|2|||
49121665|NCT01435759|158283295|FG004|Double-blind Phase|Protocol Violation|0|||
49121666|NCT01435759|158283296|FG005|Double-blind Phase|Protocol Violation|1|||
49121667|NCT01435759|158283291|FG000|Double-blind Phase|Withdrawal by Subject|17|||
49121668|NCT01435759|158283292|FG001|Double-blind Phase|Withdrawal by Subject|4|||
49121669|NCT01435759|158283293|FG002|Double-blind Phase|Withdrawal by Subject|3|||
49121670|NCT01435759|158283294|FG003|Double-blind Phase|Withdrawal by Subject|4|||
49121671|NCT01435759|158283295|FG004|Double-blind Phase|Withdrawal by Subject|2|||
48712544|NCT02834793|156799355|FG003|Core Study (Up to 18 Weeks)|Adverse Event|0|||
48712545|NCT02834793|156799352|FG000|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
48712546|NCT02834793|156799353|FG001|Core Study (Up to 18 Weeks)|Study terminated by sponsor|1|||
48712547|NCT02834793|156799354|FG002|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
48712548|NCT02834793|156799355|FG003|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
48712549|NCT02834793|156799352|FG000|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
48712550|NCT02834793|156799353|FG001|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
48712551|NCT02834793|156799354|FG002|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|7|||
48712552|NCT02834793|156799355|FG003|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
48919063|NCT01032915|157539704|FG002|Overall Study|Abnormal test procedure result|1|||
48712553|NCT02834793|156799352|FG000|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
48712554|NCT02834793|156799353|FG001|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
48712555|NCT02834793|156799354|FG002|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|4|||
48712556|NCT02834793|156799355|FG003|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
48712557|NCT02834793|156799352|FG000|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
48712558|NCT02834793|156799353|FG001|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
48712559|NCT02834793|156799354|FG002|Extension Phase A (up to 52 Weeks)|Adverse Event|5|||
48712560|NCT02834793|156799355|FG003|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
48712561|NCT02834793|156799352|FG000|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
48712562|NCT02834793|156799353|FG001|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
48712563|NCT02834793|156799354|FG002|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|9|||
48712564|NCT02834793|156799355|FG003|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
48712565|NCT02834793|156799352|FG000|Extension Phase A (up to 52 Weeks)|Other|0|||
48712566|NCT02834793|156799353|FG001|Extension Phase A (up to 52 Weeks)|Other|0|||
48712567|NCT02834793|156799354|FG002|Extension Phase A (up to 52 Weeks)|Other|1|||
48712568|NCT02834793|156799355|FG003|Extension Phase A (up to 52 Weeks)|Other|0|||
48712569|NCT02834793|156799352|FG000|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
48712570|NCT02834793|156799353|FG001|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
48712571|NCT02834793|156799354|FG002|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
48919064|NCT01032915|157539705|FG003|Overall Study|Abnormal test procedure result|0|||
48919065|NCT01032915|157539702|FG000|Overall Study|Withdrawal by Subject|0|||
48919066|NCT01032915|157539703|FG001|Overall Study|Withdrawal by Subject|3|||
48919067|NCT01032915|157539704|FG002|Overall Study|Withdrawal by Subject|1|||
48919068|NCT01032915|157539705|FG003|Overall Study|Withdrawal by Subject|1|||
48919069|NCT01032915|157539702|FG000|Overall Study|Administrative reasons|5|||
48919070|NCT01032915|157539703|FG001|Overall Study|Administrative reasons|6|||
48712572|NCT02834793|156799355|FG003|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|1|||
48811530|NCT02223754|157149983|FG001|Period 2|Lost to Follow-up|0|||
48811531|NCT02223754|157149982|FG000|Period 2|Test Article No Longer Available|0|||
48811532|NCT02223754|157149983|FG001|Period 2|Test Article No Longer Available|1|||
48811533|NCT02058290|157149984|FG000|Overall Study|Protocol Violation|2|||
48811534|NCT02058290|157149985|FG001|Overall Study|Protocol Violation|1|||
48811535|NCT02058290|157149984|FG000|Overall Study|Physician Decision|1|||
48811536|NCT02058290|157149985|FG001|Overall Study|Physician Decision|0|||
48811537|NCT02058290|157149984|FG000|Overall Study|Didn't meet intraoperative criteria|8|||
48919071|NCT01032915|157539704|FG002|Overall Study|Administrative reasons|4|||
48919072|NCT01032915|157539705|FG003|Overall Study|Administrative reasons|4|||
48919073|NCT01032915|157539702|FG000|Overall Study|Protocol Violation|1|||
48919074|NCT01032915|157539703|FG001|Overall Study|Protocol Violation|0|||
48919075|NCT01032915|157539704|FG002|Overall Study|Protocol Violation|0|||
48919076|NCT01032915|157539705|FG003|Overall Study|Protocol Violation|1|||
48919077|NCT04718974|157539713|FG000|Overall Study|Death|0|||
48919078|NCT04718974|157539714|FG001|Overall Study|Death|2|||
48919079|NCT04718974|157539713|FG000|Overall Study|Lost to Follow-up|10|||
48919080|NCT04718974|157539714|FG001|Overall Study|Lost to Follow-up|20|||
48919081|NCT04718974|157539713|FG000|Overall Study|Transferred out|2|||
48919082|NCT04718974|157539714|FG001|Overall Study|Transferred out|4|||
48919083|NCT03259074|157539715|FG000|Overall Study|Adverse Event|9|||
48919084|NCT03259074|157539716|FG001|Overall Study|Adverse Event|12|||
48919085|NCT03259074|157539717|FG002|Overall Study|Adverse Event|8|||
48919086|NCT03259074|157539715|FG000|Overall Study|Death|1|||
48919087|NCT03259074|157539716|FG001|Overall Study|Death|1|||
48919088|NCT03259074|157539717|FG002|Overall Study|Death|3|||
48919089|NCT03259074|157539715|FG000|Overall Study|Lost to Follow-up|2|||
48919090|NCT03259074|157539716|FG001|Overall Study|Lost to Follow-up|4|||
48919091|NCT03259074|157539717|FG002|Overall Study|Lost to Follow-up|3|||
48811538|NCT02058290|157149985|FG001|Overall Study|Didn't meet intraoperative criteria|7|||
48919092|NCT03259074|157539715|FG000|Overall Study|New Therapy For Study Indication|1|||
48919093|NCT03259074|157539716|FG001|Overall Study|New Therapy For Study Indication|2|||
48919094|NCT03259074|157539717|FG002|Overall Study|New Therapy For Study Indication|2|||
48919095|NCT03259074|157539715|FG000|Overall Study|Physician Decision|4|||
48919096|NCT03259074|157539716|FG001|Overall Study|Physician Decision|12|||
48919097|NCT03259074|157539717|FG002|Overall Study|Physician Decision|10|||
48919098|NCT03259074|157539715|FG000|Overall Study|Pregnancy|1|||
48919099|NCT03259074|157539716|FG001|Overall Study|Pregnancy|1|||
48919100|NCT03259074|157539717|FG002|Overall Study|Pregnancy|0|||
48919101|NCT03259074|157539715|FG000|Overall Study|Progressive Disease|1|||
48919102|NCT03259074|157539716|FG001|Overall Study|Progressive Disease|0|||
48919103|NCT03259074|157539717|FG002|Overall Study|Progressive Disease|0|||
48919104|NCT03259074|157539715|FG000|Overall Study|Protocol Deviation|1|||
48919105|NCT03259074|157539716|FG001|Overall Study|Protocol Deviation|1|||
48919106|NCT03259074|157539717|FG002|Overall Study|Protocol Deviation|3|||
48919107|NCT03259074|157539715|FG000|Overall Study|Subject/Guardian Decision|13|||
48919108|NCT03259074|157539716|FG001|Overall Study|Subject/Guardian Decision|16|||
48919109|NCT03259074|157539717|FG002|Overall Study|Subject/Guardian Decision|14|||
48919110|NCT00183274|157539718|FG000|Phase 1: Open-Label|Adverse Event|31|||
48919111|NCT00183274|157539719|FG001|Phase 1: Open-Label|Adverse Event|0|||
48919112|NCT00183274|157539720|FG002|Phase 1: Open-Label|Adverse Event|0|||
48919113|NCT00183274|157539721|FG003|Phase 1: Open-Label|Adverse Event|0|||
48919114|NCT00183274|157539722|FG004|Phase 1: Open-Label|Adverse Event|0|||
48919115|NCT00183274|157539723|FG005|Phase 1: Open-Label|Adverse Event|0|||
48919116|NCT00183274|157539718|FG000|Phase 1: Open-Label|Lack of Efficacy|13|||
48919117|NCT00183274|157539719|FG001|Phase 1: Open-Label|Lack of Efficacy|0|||
48919118|NCT00183274|157539720|FG002|Phase 1: Open-Label|Lack of Efficacy|0|||
48919119|NCT00183274|157539721|FG003|Phase 1: Open-Label|Lack of Efficacy|0|||
48919120|NCT00183274|157539722|FG004|Phase 1: Open-Label|Lack of Efficacy|0|||
48919121|NCT00183274|157539723|FG005|Phase 1: Open-Label|Lack of Efficacy|0|||
49121672|NCT01435759|158283296|FG005|Double-blind Phase|Withdrawal by Subject|2|||
49121673|NCT01435759|158283291|FG000|Double-blind Phase|Lost to Follow-up|31|||
49121674|NCT01435759|158283292|FG001|Double-blind Phase|Lost to Follow-up|1|||
49121675|NCT01435759|158283293|FG002|Double-blind Phase|Lost to Follow-up|2|||
49121676|NCT01435759|158283294|FG003|Double-blind Phase|Lost to Follow-up|0|||
49121677|NCT01435759|158283295|FG004|Double-blind Phase|Lost to Follow-up|3|||
49121678|NCT01435759|158283296|FG005|Double-blind Phase|Lost to Follow-up|3|||
49121679|NCT01435759|158283291|FG000|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1|||
49121680|NCT01435759|158283292|FG001|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
49121681|NCT01435759|158283293|FG002|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
49121682|NCT01435759|158283294|FG003|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
49121683|NCT01435759|158283295|FG004|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3|||
49121684|NCT01435759|158283296|FG005|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
49121685|NCT01435759|158283291|FG000|Double-blind Phase|Other|8|||
49121686|NCT01435759|158283292|FG001|Double-blind Phase|Other|2|||
49121687|NCT01435759|158283293|FG002|Double-blind Phase|Other|0|||
49121688|NCT01435759|158283294|FG003|Double-blind Phase|Other|2|||
49121689|NCT01435759|158283295|FG004|Double-blind Phase|Other|0|||
49121690|NCT01435759|158283296|FG005|Double-blind Phase|Other|0|||
49121691|NCT03113968|158283297|FG000|Overall Study|Withdrawal by Subject|31|||
49121692|NCT03113968|158283298|FG001|Overall Study|Withdrawal by Subject|4|||
49121693|NCT00784719|158283303|FG000|Overall Study|Adverse Event|0|||
49121694|NCT00784719|158283304|FG001|Overall Study|Adverse Event|2|||
49121695|NCT00784719|158283305|FG002|Overall Study|Adverse Event|0|||
49121696|NCT00784719|158283306|FG003|Overall Study|Adverse Event|0|||
49121697|NCT00784719|158283307|FG004|Overall Study|Adverse Event|1|||
49121698|NCT00784719|158283308|FG005|Overall Study|Adverse Event|1|||
49121699|NCT00784719|158283309|FG006|Overall Study|Adverse Event|1|||
49121700|NCT00784719|158283303|FG000|Overall Study|Lost to Follow-up|0|||
49121701|NCT00784719|158283304|FG001|Overall Study|Lost to Follow-up|0|||
49121702|NCT00784719|158283305|FG002|Overall Study|Lost to Follow-up|0|||
48811539|NCT02058290|157149984|FG000|Overall Study|Withdrawal by Subject|0|||
48811540|NCT02058290|157149985|FG001|Overall Study|Withdrawal by Subject|1|||
48811541|NCT02906202|157149986|FG000|Overall Study|Discontinued after mobilization due to pregnancy|1|||
48811542|NCT01302938|157150005|FG000|Overall Study|Withdrawal by Subject|1|||
48811543|NCT01302938|157150006|FG001|Overall Study|Withdrawal by Subject|0|||
48811544|NCT01302938|157150005|FG000|Overall Study|Adverse Event|1|||
49121703|NCT00784719|158283306|FG003|Overall Study|Lost to Follow-up|0|||
48811545|NCT01302938|157150006|FG001|Overall Study|Adverse Event|0|||
48811546|NCT01233609|157150007|FG000|Overall Study|Death|1|||
48811547|NCT01233609|157150008|FG001|Overall Study|Death|0|||
48811548|NCT01233609|157150007|FG000|Overall Study|Lost to Follow-up|3|||
48811549|NCT01233609|157150008|FG001|Overall Study|Lost to Follow-up|1|||
48919122|NCT00183274|157539718|FG000|Phase 1: Open-Label|Protocol Violation|11|||
48919123|NCT00183274|157539719|FG001|Phase 1: Open-Label|Protocol Violation|0|||
48919124|NCT00183274|157539720|FG002|Phase 1: Open-Label|Protocol Violation|0|||
49121704|NCT00784719|158283307|FG004|Overall Study|Lost to Follow-up|1|||
49121705|NCT00784719|158283308|FG005|Overall Study|Lost to Follow-up|1|||
49121706|NCT00784719|158283309|FG006|Overall Study|Lost to Follow-up|0|||
49121707|NCT00784719|158283303|FG000|Overall Study|Other|2|||
48811550|NCT01233609|157150007|FG000|Overall Study|Adverse Event|2|||
48811551|NCT01233609|157150008|FG001|Overall Study|Adverse Event|1|||
48919125|NCT00183274|157539721|FG003|Phase 1: Open-Label|Protocol Violation|0|||
49121708|NCT00784719|158283304|FG001|Overall Study|Other|1|||
49121709|NCT00784719|158283305|FG002|Overall Study|Other|1|||
49121710|NCT00784719|158283306|FG003|Overall Study|Other|0|||
49121711|NCT00784719|158283307|FG004|Overall Study|Other|2|||
49121712|NCT00784719|158283308|FG005|Overall Study|Other|1|||
49121713|NCT00784719|158283309|FG006|Overall Study|Other|3|||
49121714|NCT00784719|158283303|FG000|Overall Study|Withdrawal by Subject|1|||
49121715|NCT00784719|158283304|FG001|Overall Study|Withdrawal by Subject|0|||
49121716|NCT00784719|158283305|FG002|Overall Study|Withdrawal by Subject|0|||
49121717|NCT00784719|158283306|FG003|Overall Study|Withdrawal by Subject|0|||
48712573|NCT02834793|156799352|FG000|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
49121718|NCT00784719|158283307|FG004|Overall Study|Withdrawal by Subject|2|||
49121719|NCT00784719|158283308|FG005|Overall Study|Withdrawal by Subject|0|||
49121720|NCT00784719|158283309|FG006|Overall Study|Withdrawal by Subject|1|||
49121721|NCT04157088|158283310|FG000|Overall Study|Study terminated by sponsor|23|||
49121722|NCT04157088|158283310|FG000|Overall Study|Withdrawal by Subject|4|||
49121723|NCT04157088|158283310|FG000|Overall Study|Lost to Follow-up|2|||
49121724|NCT04157088|158283310|FG000|Overall Study|Death|1|||
49121725|NCT01951417|158283311|FG000|Overall Study|Withdrawal by Subject|1|||
49121726|NCT01951417|158283311|FG000|Overall Study|Protocol Violation|2|||
49121727|NCT01951417|158283311|FG000|Overall Study|Lost to Follow-up|6|||
49121728|NCT04010461|158283312|FG000|Overall Study|COVID based withdrawal|5|||
49121729|NCT04010461|158283312|FG000|Overall Study|Withdrawal by Subject|5|||
49121730|NCT04010461|158283312|FG000|Overall Study|Adverse Event|1|||
49121731|NCT04010461|158283312|FG000|Overall Study|No Motor Threshold obtainable|1|||
49121732|NCT04010461|158283312|FG000|Overall Study|Physician Decision|1|||
49121733|NCT04058028|158283313|FG000|Overall Study|Withdrawal of Consent from Study|12|||
49121734|NCT04058028|158283314|FG001|Overall Study|Withdrawal of Consent from Study|8|||
49121735|NCT04058028|158283315|FG002|Overall Study|Withdrawal of Consent from Study|6|||
49121736|NCT04058028|158283316|FG003|Overall Study|Withdrawal of Consent from Study|7|||
49121737|NCT04058028|158283313|FG000|Overall Study|Decision by Sponsor|13|||
49121738|NCT04058028|158283314|FG001|Overall Study|Decision by Sponsor|4|||
49121739|NCT04058028|158283315|FG002|Overall Study|Decision by Sponsor|1|||
49121740|NCT04058028|158283316|FG003|Overall Study|Decision by Sponsor|35|||
49121741|NCT04058028|158283313|FG000|Overall Study|Lost to Follow-up|1|||
49121742|NCT04058028|158283314|FG001|Overall Study|Lost to Follow-up|1|||
49121743|NCT04058028|158283315|FG002|Overall Study|Lost to Follow-up|1|||
49121744|NCT04058028|158283316|FG003|Overall Study|Lost to Follow-up|0|||
49121745|NCT04058028|158283313|FG000|Overall Study|Death|0|||
49121746|NCT04058028|158283314|FG001|Overall Study|Death|1|||
49121747|NCT04058028|158283315|FG002|Overall Study|Death|0|||
49121748|NCT04058028|158283316|FG003|Overall Study|Death|0|||
49121749|NCT01598610|158283317|FG000|Overall Study|Adverse Event|1|||
49121750|NCT00571662|158283321|FG000|Overall Study|Withdrawal by Subject|2|||
49121751|NCT00571662|158283321|FG000|Overall Study|psychiatric instability|1|||
49121752|NCT00571662|158283321|FG000|Overall Study|Adverse Event|5|||
49121753|NCT00402727|158283325|FG000|Overall Study|Adverse Event|10|||
49121754|NCT00402727|158283326|FG001|Overall Study|Adverse Event|6|||
49121755|NCT00402727|158283325|FG000|Overall Study|Death|1|||
49121756|NCT00402727|158283326|FG001|Overall Study|Death|0|||
49121757|NCT00402727|158283325|FG000|Overall Study|Lack of Efficacy|1|||
49121758|NCT00402727|158283326|FG001|Overall Study|Lack of Efficacy|3|||
49121759|NCT00402727|158283325|FG000|Overall Study|Lost to Follow-up|24|||
49121760|NCT00402727|158283326|FG001|Overall Study|Lost to Follow-up|11|||
49121761|NCT00402727|158283325|FG000|Overall Study|Physician Decision|1|||
49121762|NCT00402727|158283326|FG001|Overall Study|Physician Decision|1|||
48712574|NCT02834793|156799353|FG001|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
48712575|NCT02834793|156799354|FG002|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
48712576|NCT02834793|156799355|FG003|Extension Phase B (up to 188 Weeks)|Adverse Event|1|||
48712577|NCT02834793|156799352|FG000|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
48712578|NCT02834793|156799353|FG001|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
48712579|NCT02834793|156799354|FG002|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
48712580|NCT02834793|156799355|FG003|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|8|||
48712581|NCT02834793|156799352|FG000|Extension Phase B (up to 188 Weeks)|Other|0|||
49121763|NCT00402727|158283325|FG000|Overall Study|Protocol Violation|0|||
49121764|NCT00402727|158283326|FG001|Overall Study|Protocol Violation|4|||
49121765|NCT00402727|158283325|FG000|Overall Study|Withdrawal by Subject|3|||
49121766|NCT00402727|158283326|FG001|Overall Study|Withdrawal by Subject|7|||
49121767|NCT00402727|158283325|FG000|Overall Study|supply problems|2|||
49121768|NCT00402727|158283326|FG001|Overall Study|supply problems|1|||
49121769|NCT00402727|158283325|FG000|Overall Study|non-compliance|0|||
49121770|NCT00402727|158283326|FG001|Overall Study|non-compliance|1|||
49121771|NCT02573259|158283327|FG000|Overall Study|Death|1|||
49121772|NCT02573259|158283328|FG001|Overall Study|Death|6|||
49121773|NCT02573259|158283329|FG002|Overall Study|Death|5|||
49121774|NCT02573259|158283330|FG003|Overall Study|Death|6|||
49121775|NCT02573259|158283331|FG004|Overall Study|Death|9|||
49121776|NCT02573259|158283332|FG005|Overall Study|Death|32|||
49121777|NCT02573259|158283333|FG006|Overall Study|Death|21|||
49121778|NCT02573259|158283327|FG000|Overall Study|Lost to Follow-up|0|||
49121779|NCT02573259|158283328|FG001|Overall Study|Lost to Follow-up|0|||
49121780|NCT02573259|158283329|FG002|Overall Study|Lost to Follow-up|0|||
49121781|NCT02573259|158283330|FG003|Overall Study|Lost to Follow-up|0|||
49121782|NCT02573259|158283331|FG004|Overall Study|Lost to Follow-up|0|||
49121783|NCT02573259|158283332|FG005|Overall Study|Lost to Follow-up|2|||
49121784|NCT02573259|158283333|FG006|Overall Study|Lost to Follow-up|1|||
49121785|NCT02573259|158283327|FG000|Overall Study|Participant refused further follow-up|0|||
49121786|NCT02573259|158283328|FG001|Overall Study|Participant refused further follow-up|2|||
49121787|NCT02573259|158283329|FG002|Overall Study|Participant refused further follow-up|1|||
49121788|NCT02573259|158283330|FG003|Overall Study|Participant refused further follow-up|0|||
49121789|NCT02573259|158283331|FG004|Overall Study|Participant refused further follow-up|3|||
49121790|NCT02573259|158283332|FG005|Overall Study|Participant refused further follow-up|20|||
49121791|NCT02573259|158283333|FG006|Overall Study|Participant refused further follow-up|7|||
49121792|NCT02573259|158283327|FG000|Overall Study|Other|0|||
49121793|NCT02573259|158283328|FG001|Overall Study|Other|0|||
49121794|NCT02573259|158283329|FG002|Overall Study|Other|0|||
49121795|NCT02573259|158283330|FG003|Overall Study|Other|0|||
49121796|NCT02573259|158283331|FG004|Overall Study|Other|1|||
49121797|NCT02573259|158283332|FG005|Overall Study|Other|4|||
48919126|NCT00183274|157539722|FG004|Phase 1: Open-Label|Protocol Violation|0|||
48919127|NCT00183274|157539723|FG005|Phase 1: Open-Label|Protocol Violation|0|||
48919128|NCT00183274|157539718|FG000|Phase 1: Open-Label|Withdrawal by Subject|13|||
48919129|NCT00183274|157539719|FG001|Phase 1: Open-Label|Withdrawal by Subject|0|||
48919130|NCT00183274|157539720|FG002|Phase 1: Open-Label|Withdrawal by Subject|0|||
48919131|NCT00183274|157539721|FG003|Phase 1: Open-Label|Withdrawal by Subject|0|||
48919132|NCT00183274|157539722|FG004|Phase 1: Open-Label|Withdrawal by Subject|0|||
48919133|NCT00183274|157539723|FG005|Phase 1: Open-Label|Withdrawal by Subject|0|||
48919134|NCT00183274|157539718|FG000|Phase 1: Open-Label|Lost to Follow-up|33|||
48919135|NCT00183274|157539719|FG001|Phase 1: Open-Label|Lost to Follow-up|0|||
48919136|NCT00183274|157539720|FG002|Phase 1: Open-Label|Lost to Follow-up|0|||
48919137|NCT00183274|157539721|FG003|Phase 1: Open-Label|Lost to Follow-up|0|||
48919138|NCT00183274|157539722|FG004|Phase 1: Open-Label|Lost to Follow-up|0|||
48919139|NCT00183274|157539723|FG005|Phase 1: Open-Label|Lost to Follow-up|0|||
48919140|NCT00183274|157539718|FG000|Phase 1: Open-Label|Other|9|||
49121798|NCT02573259|158283333|FG006|Overall Study|Other|5|||
49121799|NCT01628848|158283334|FG000|Overall Study|Adverse Event|9|||
49121800|NCT01628848|158283335|FG001|Overall Study|Adverse Event|7|||
49121801|NCT01628848|158283334|FG000|Overall Study|Lack of Efficacy|0|||
49121802|NCT01628848|158283335|FG001|Overall Study|Lack of Efficacy|4|||
49121803|NCT01628848|158283334|FG000|Overall Study|Withdrawal by Subject|0|||
48712582|NCT02834793|156799353|FG001|Extension Phase B (up to 188 Weeks)|Other|0|||
48712583|NCT02834793|156799354|FG002|Extension Phase B (up to 188 Weeks)|Other|0|||
48712584|NCT02834793|156799355|FG003|Extension Phase B (up to 188 Weeks)|Other|1|||
48712585|NCT02834793|156799352|FG000|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
48712586|NCT02834793|156799353|FG001|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
48712587|NCT02834793|156799354|FG002|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
48712588|NCT02834793|156799355|FG003|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|1|||
48712589|NCT00771953|156799356|FG000|Overall Study|Adverse Event|5|||
48712590|NCT00771953|156799357|FG001|Overall Study|Adverse Event|3|||
48712591|NCT00771953|156799356|FG000|Overall Study|Death|2|||
48712592|NCT00771953|156799357|FG001|Overall Study|Death|2|||
48712593|NCT00771953|156799356|FG000|Overall Study|Progression before active Tx|1|||
48712594|NCT00771953|156799357|FG001|Overall Study|Progression before active Tx|2|||
48712595|NCT00771953|156799356|FG000|Overall Study|Sponsor decision|1|||
48712596|NCT00771953|156799357|FG001|Overall Study|Sponsor decision|0|||
48712597|NCT00771953|156799356|FG000|Overall Study|Other complicating disease|1|||
48712598|NCT00771953|156799357|FG001|Overall Study|Other complicating disease|0|||
48712599|NCT00771953|156799356|FG000|Overall Study|Withdrawal by Subject|0|||
48712600|NCT00771953|156799357|FG001|Overall Study|Withdrawal by Subject|3|||
48712601|NCT01086358|156799358|FG000|First Intervention|Lost to Follow-up|9|||
48712602|NCT01086358|156799359|FG001|First Intervention|Lost to Follow-up|4|||
48712603|NCT01086358|156799358|FG000|First Intervention|Withdrawal by Subject|0|||
48712604|NCT01086358|156799359|FG001|First Intervention|Withdrawal by Subject|1|||
48712605|NCT01086358|156799358|FG000|Second Intervention|Lost to Follow-up|4|||
48712606|NCT01086358|156799359|FG001|Second Intervention|Lost to Follow-up|4|||
48712607|NCT00578292|156799360|FG000|Overall Study|Death|1|||
48919141|NCT00183274|157539719|FG001|Phase 1: Open-Label|Other|0|||
48919142|NCT00183274|157539720|FG002|Phase 1: Open-Label|Other|0|||
49121804|NCT01628848|158283335|FG001|Overall Study|Withdrawal by Subject|2|||
49121805|NCT01628848|158283334|FG000|Overall Study|Physician Decision|3|||
49121806|NCT01628848|158283335|FG001|Overall Study|Physician Decision|1|||
49121807|NCT01405898|158283338|FG000|Overall Study|Withdrawal by Subject|2|||
48712608|NCT00578292|156799360|FG000|Overall Study|Graft failure|2|||
48712609|NCT00947193|156799363|FG000|Overall Study|Lost to Follow-up|1|||
48712610|NCT00947193|156799364|FG001|Overall Study|Lost to Follow-up|0|||
48712611|NCT00947193|156799363|FG000|Overall Study|Withdrawal by Subject|1|||
48712612|NCT00947193|156799364|FG001|Overall Study|Withdrawal by Subject|0|||
48811552|NCT01233609|157150007|FG000|Overall Study|Withdrawal by Subject|3|||
48811553|NCT01233609|157150008|FG001|Overall Study|Withdrawal by Subject|0|||
48811554|NCT00735644|157150009|FG000|Overall Study|Did not receive study vaccine|0|||
48811555|NCT00735644|157150010|FG001|Overall Study|Did not receive study vaccine|1|||
48811556|NCT00735644|157150011|FG002|Overall Study|Did not receive study vaccine|0|||
48811557|NCT00735644|157150012|FG003|Overall Study|Did not receive study vaccine|0|||
48811558|NCT00735644|157150013|FG004|Overall Study|Did not receive study vaccine|0|||
48811559|NCT00735644|157150009|FG000|Overall Study|Withdrawal by Subject|0|||
48811560|NCT00735644|157150010|FG001|Overall Study|Withdrawal by Subject|1|||
48811561|NCT00735644|157150011|FG002|Overall Study|Withdrawal by Subject|1|||
48811562|NCT00735644|157150012|FG003|Overall Study|Withdrawal by Subject|1|||
48811563|NCT00735644|157150013|FG004|Overall Study|Withdrawal by Subject|0|||
48811564|NCT01734434|157150015|FG000|Overall Study|Death Infant|3|||
48811565|NCT01734434|157150016|FG001|Overall Study|Death Infant|1|||
48811566|NCT01734434|157150017|FG002|Overall Study|Death Infant|17|||
48811567|NCT01734434|157150018|FG003|Overall Study|Death Infant|5|||
48811568|NCT01734434|157150015|FG000|Overall Study|Lost to Follow-up|2|||
49121808|NCT01405898|158283339|FG001|Overall Study|Withdrawal by Subject|2|||
49121809|NCT02283658|158283340|FG000|Overall Study|Withdrawal by Subject|1|||
49121810|NCT01789047|158283342|FG000|Overall Study|Adverse Event|3|||
49121811|NCT01789047|158283343|FG001|Overall Study|Adverse Event|2|||
49121812|NCT01789047|158283342|FG000|Overall Study|Withdrawal by Subject|1|||
49121813|NCT01789047|158283343|FG001|Overall Study|Withdrawal by Subject|2|||
49121814|NCT01839916|158283344|FG000|Overall Study|Death|9|||
49121815|NCT01839916|158283344|FG000|Overall Study|Physician Decision|17|||
49121816|NCT01839916|158283344|FG000|Overall Study|Relapse|12|||
49121817|NCT01839916|158283344|FG000|Overall Study|GVHD|2|||
49121818|NCT01839916|158283344|FG000|Overall Study|Graft Failure|1|||
49121819|NCT00964028|158283345|FG000|Overall Study|Withdrawal by Subject|0|||
48712613|NCT00947193|156799363|FG000|Overall Study|Factor VIII >1%|1|||
48712614|NCT00947193|156799364|FG001|Overall Study|Factor VIII >1%|0|||
48712615|NCT04364984|156799367|FG000|Overall Study|Death|2|||
48712616|NCT04364984|156799368|FG001|Overall Study|Death|2|||
48712617|NCT04364984|156799369|FG002|Overall Study|Death|0|||
48712618|NCT02105961|156799370|FG000|Overall Study|Adverse Event|18|||
48712619|NCT02105961|156799371|FG001|Overall Study|Adverse Event|7|||
48712620|NCT02105961|156799372|FG002|Overall Study|Adverse Event|13|||
48712621|NCT02105961|156799370|FG000|Overall Study|Lack of Efficacy|3|||
48712622|NCT02105961|156799371|FG001|Overall Study|Lack of Efficacy|0|||
48712623|NCT02105961|156799372|FG002|Overall Study|Lack of Efficacy|3|||
48712624|NCT02105961|156799370|FG000|Overall Study|Lost to Follow-up|2|||
48712625|NCT02105961|156799371|FG001|Overall Study|Lost to Follow-up|0|||
48712626|NCT02105961|156799372|FG002|Overall Study|Lost to Follow-up|1|||
48712627|NCT02105961|156799370|FG000|Overall Study|Physician Decision|3|||
48712628|NCT02105961|156799371|FG001|Overall Study|Physician Decision|3|||
48712629|NCT02105961|156799372|FG002|Overall Study|Physician Decision|2|||
48712630|NCT02105961|156799370|FG000|Overall Study|Withdrawal by Subject|15|||
48712631|NCT02105961|156799371|FG001|Overall Study|Withdrawal by Subject|7|||
48712632|NCT02105961|156799372|FG002|Overall Study|Withdrawal by Subject|11|||
48712633|NCT03196349|156799373|FG000|Overall Study|Did not receive study drug|0|||
48712634|NCT03196349|156799374|FG001|Overall Study|Did not receive study drug|1|||
48712635|NCT03196349|156799375|FG002|Overall Study|Did not receive study drug|2|||
48712636|NCT03196349|156799373|FG000|Overall Study|No data entered|2|||
48712637|NCT03196349|156799374|FG001|Overall Study|No data entered|4|||
48712638|NCT03196349|156799375|FG002|Overall Study|No data entered|0|||
48712639|NCT03196349|156799373|FG000|Overall Study|Study Terminated early|15|||
48712640|NCT03196349|156799374|FG001|Overall Study|Study Terminated early|9|||
48712641|NCT03196349|156799375|FG002|Overall Study|Study Terminated early|11|||
48712642|NCT02722304|156799376|FG000|Overall Study|Study Terminated by Sponsor|1|||
48712643|NCT02722304|156799377|FG001|Overall Study|Study Terminated by Sponsor|0|||
49121820|NCT00964028|158283346|FG001|Overall Study|Withdrawal by Subject|1|||
49121821|NCT02104895|158283347|FG000|Overall Study|Withdrawal by Subject|0|||
49121822|NCT02104895|158283348|FG001|Overall Study|Withdrawal by Subject|14|||
49121823|NCT00369343|158283351|FG000|Double-blind Phase|Adverse Event|19|||
48712644|NCT02722304|156799378|FG002|Overall Study|Study Terminated by Sponsor|2|||
48712645|NCT02722304|156799379|FG003|Overall Study|Study Terminated by Sponsor|1|||
48712646|NCT02722304|156799380|FG004|Overall Study|Study Terminated by Sponsor|1|||
48712647|NCT02722304|156799376|FG000|Overall Study|Other|0|||
48712648|NCT02722304|156799377|FG001|Overall Study|Other|0|||
48712649|NCT02722304|156799378|FG002|Overall Study|Other|0|||
48811569|NCT01734434|157150016|FG001|Overall Study|Lost to Follow-up|9|||
48811570|NCT01734434|157150017|FG002|Overall Study|Lost to Follow-up|67|||
48811571|NCT01734434|157150018|FG003|Overall Study|Lost to Follow-up|11|||
48811572|NCT01734434|157150015|FG000|Overall Study|No Live Birth|1|||
48811573|NCT01734434|157150016|FG001|Overall Study|No Live Birth|2|||
49121824|NCT00369343|158283352|FG001|Double-blind Phase|Adverse Event|4|||
48712650|NCT02722304|156799379|FG003|Overall Study|Other|1|||
48712651|NCT02722304|156799380|FG004|Overall Study|Other|1|||
49121825|NCT00369343|158283351|FG000|Double-blind Phase|Failed to return|2|||
49121826|NCT00369343|158283352|FG001|Double-blind Phase|Failed to return|0|||
49121827|NCT00369343|158283351|FG000|Double-blind Phase|Lost to Follow-up|9|||
49121828|NCT00369343|158283352|FG001|Double-blind Phase|Lost to Follow-up|2|||
49121829|NCT00369343|158283351|FG000|Double-blind Phase|Protocol Violation|2|||
49121830|NCT00369343|158283352|FG001|Double-blind Phase|Protocol Violation|0|||
49121831|NCT00369343|158283351|FG000|Double-blind Phase|Withdrawal by Subject|8|||
49121832|NCT00369343|158283352|FG001|Double-blind Phase|Withdrawal by Subject|6|||
49121833|NCT00369343|158283351|FG000|Double-blind Phase|Lack of Efficacy|0|||
49121834|NCT00369343|158283352|FG001|Double-blind Phase|Lack of Efficacy|4|||
49121835|NCT00369343|158283351|FG000|Double-blind Phase|Protocol deviation|4|||
49121836|NCT00369343|158283352|FG001|Double-blind Phase|Protocol deviation|0|||
49121837|NCT00369343|158283351|FG000|Open-label Phase|Adverse Event|19|||
49121838|NCT00369343|158283352|FG001|Open-label Phase|Adverse Event|7|||
49121839|NCT00369343|158283351|FG000|Open-label Phase|Failed to return|4|||
49121840|NCT00369343|158283352|FG001|Open-label Phase|Failed to return|0|||
49121841|NCT00369343|158283351|FG000|Open-label Phase|Physician Decision|2|||
49121842|NCT00369343|158283352|FG001|Open-label Phase|Physician Decision|0|||
49121843|NCT00369343|158283351|FG000|Open-label Phase|Lost to Follow-up|5|||
49121844|NCT00369343|158283352|FG001|Open-label Phase|Lost to Follow-up|3|||
49121845|NCT00369343|158283351|FG000|Open-label Phase|inadvertently reported study completers|3|||
49121846|NCT00369343|158283352|FG001|Open-label Phase|inadvertently reported study completers|2|||
49121847|NCT00369343|158283351|FG000|Open-label Phase|Protocol Violation|1|||
49121848|NCT00369343|158283352|FG001|Open-label Phase|Protocol Violation|3|||
49121849|NCT00369343|158283351|FG000|Open-label Phase|Withdrawal by Subject|15|||
49121850|NCT00369343|158283352|FG001|Open-label Phase|Withdrawal by Subject|6|||
49121851|NCT00369343|158283351|FG000|Open-label Phase|Lack of Efficacy|4|||
49121852|NCT00369343|158283352|FG001|Open-label Phase|Lack of Efficacy|3|||
49121853|NCT00369343|158283351|FG000|Open-label Phase|Lack of continuance tolerability|3|||
49121854|NCT00369343|158283352|FG001|Open-label Phase|Lack of continuance tolerability|4|||
49121855|NCT00369343|158283351|FG000|Open-label Phase|did not take study drug|1|||
49121856|NCT00369343|158283352|FG001|Open-label Phase|did not take study drug|2|||
49121857|NCT04001803|158283353|FG000|Intervention Phase (Up to Month 12)|Adverse Event|5|||
49121858|NCT04001803|158283353|FG000|Intervention Phase (Up to Month 12)|Protocol Violation|3|||
49121859|NCT04001803|158283353|FG000|Intervention Phase (Up to Month 12)|Physician Decision|1|||
49121860|NCT04001803|158283353|FG000|Intervention Phase (Up to Month 12)|Withdrawal by Subject|4|||
49121861|NCT04001803|158283353|FG000|Extension Phase (From Months 13 to 30)|Adverse Event|2|||
49121862|NCT04001803|158283353|FG000|Extension Phase (From Months 13 to 30)|Protocol Violation|1|||
49121863|NCT04001803|158283353|FG000|Extension Phase (From Months 13 to 30)|Lost to Follow-up|1|||
49121864|NCT04001803|158283353|FG000|Extension Phase (From Months 13 to 30)|Withdrawal by Subject|2|||
49121865|NCT04001803|158283353|FG000|Long-term Follow-up Phase(Up to Week 52)|Lost to Follow-up|1|||
49121866|NCT04001803|158283353|FG000|Long-term Follow-up Phase(Up to Week 52)|Withdrawal by Subject|2|||
49121867|NCT01971567|158284981|FG000|Overall Study|Withdrawal by Subject|3|||
49121868|NCT01971567|158284982|FG001|Overall Study|Withdrawal by Subject|2|||
49121869|NCT01971567|158284981|FG000|Overall Study|Lost to Follow-up|1|||
49121870|NCT01971567|158284982|FG001|Overall Study|Lost to Follow-up|0|||
49121871|NCT01239394|158284983|FG000|Overall Study|Adverse Event|1|||
49121872|NCT01697800|158284984|FG000|Overall Study|Death|0|||
49121873|NCT01697800|158284985|FG001|Overall Study|Death|1|||
49121874|NCT04771013|158284989|FG000|Overall Study|Withdrawal by Subject|2|||
49121875|NCT04771013|158284990|FG001|Overall Study|Withdrawal by Subject|0|||
49121876|NCT04771013|158284989|FG000|Overall Study|Death|0|||
49121877|NCT04771013|158284990|FG001|Overall Study|Death|5|||
49121878|NCT04771013|158284989|FG000|Overall Study|Referred to another hospital before day 20|0|||
49121879|NCT04771013|158284990|FG001|Overall Study|Referred to another hospital before day 20|1|||
49121880|NCT01255904|158284991|FG000|Overall Study|Physician Decision|1|||
49121881|NCT01255904|158284992|FG001|Overall Study|Physician Decision|4|||
49121882|NCT02915159|158285001|FG000|Overall Study|Participant no longer meets criteria|2|||
49121883|NCT02915159|158285002|FG001|Overall Study|Participant no longer meets criteria|0|||
49121884|NCT02915159|158285001|FG000|Overall Study|poor/non-compliance|1|||
49121885|NCT02915159|158285002|FG001|Overall Study|poor/non-compliance|0|||
49121886|NCT02915159|158285001|FG000|Overall Study|Participant withdrew consent|5|||
48712652|NCT04173494|156799381|FG000|Randomized DB TP (Up to Week 24)|Adverse Event|16|||
48712653|NCT04173494|156799382|FG001|Randomized DB TP (Up to Week 24)|Adverse Event|11|||
48712654|NCT04173494|156799381|FG000|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|6|||
49121887|NCT02915159|158285002|FG001|Overall Study|Participant withdrew consent|1|||
49121888|NCT02915159|158285001|FG000|Overall Study|Request to discontinue treatment|1|||
49121889|NCT02915159|158285002|FG001|Overall Study|Request to discontinue treatment|2|||
49121890|NCT02915159|158285001|FG000|Overall Study|Adverse Event|2|||
49121891|NCT02915159|158285002|FG001|Overall Study|Adverse Event|2|||
49121892|NCT02915159|158285001|FG000|Overall Study|Lack of Efficacy|0|||
49121893|NCT02915159|158285002|FG001|Overall Study|Lack of Efficacy|3|||
49121894|NCT00003483|158285009|FG000|Overall Study|Not evaluable|1|||
49121895|NCT00873730|158285010|FG000|Overall Study|Protocol Deviation|5|||
49121896|NCT00873730|158285011|FG001|Overall Study|Protocol Deviation|2|||
49121897|NCT00873730|158285010|FG000|Overall Study|Adverse Event|0|||
49121898|NCT00873730|158285011|FG001|Overall Study|Adverse Event|2|||
49121899|NCT00873730|158285010|FG000|Overall Study|Withdrawal by Subject|0|||
49121900|NCT00873730|158285011|FG001|Overall Study|Withdrawal by Subject|1|||
49121901|NCT00873730|158285010|FG000|Overall Study|Sponsor decision|1|||
49121902|NCT00873730|158285011|FG001|Overall Study|Sponsor decision|0|||
49121903|NCT04613739|158285012|FG000|Overall Study|Lost to Follow-up|6|||
49121904|NCT04613739|158285013|FG001|Overall Study|Lost to Follow-up|9|||
49121905|NCT04613739|158285012|FG000|Overall Study|potentially duplicative/fraudulent|1|||
49121906|NCT04613739|158285013|FG001|Overall Study|potentially duplicative/fraudulent|3|||
49121907|NCT03373760|158285014|FG000|Overall Study|Adverse Event|8|||
49121908|NCT03373760|158285014|FG000|Overall Study|Disease Progression|46|||
49121909|NCT03373760|158285014|FG000|Overall Study|Death|4|||
49121910|NCT00357877|158285020|FG000|Overall Study|Death|2|||
49121911|NCT00357877|158285021|FG001|Overall Study|Death|1|||
49121912|NCT00357877|158285020|FG000|Overall Study|Lost to Follow-up|20|||
49121913|NCT00357877|158285021|FG001|Overall Study|Lost to Follow-up|23|||
49121914|NCT00357877|158285020|FG000|Overall Study|Withdrawal by Subject|3|||
49121915|NCT00357877|158285021|FG001|Overall Study|Withdrawal by Subject|3|||
49121916|NCT00357877|158285020|FG000|Overall Study|Administrative withdrawal|1|||
49121917|NCT00357877|158285021|FG001|Overall Study|Administrative withdrawal|1|||
49121918|NCT00357877|158285020|FG000|Overall Study|Other|0|||
49121919|NCT00357877|158285021|FG001|Overall Study|Other|2|||
49121920|NCT01051557|158285022|FG000|Overall Study|Physician Decision|1|||
49121921|NCT01051557|158285023|FG001|Overall Study|Physician Decision|0|||
49121922|NCT01051557|158285024|FG002|Overall Study|Physician Decision|0|||
49121923|NCT01051557|158285025|FG003|Overall Study|Physician Decision|0|||
49121924|NCT01051557|158285026|FG004|Overall Study|Physician Decision|0|||
49121925|NCT01051557|158285027|FG005|Overall Study|Physician Decision|0|||
49121926|NCT01051557|158285028|FG006|Overall Study|Physician Decision|0|||
49121927|NCT01051557|158285022|FG000|Overall Study|disease progression|3|||
49121928|NCT01051557|158285023|FG001|Overall Study|disease progression|3|||
49121929|NCT01051557|158285024|FG002|Overall Study|disease progression|5|||
49121930|NCT01051557|158285025|FG003|Overall Study|disease progression|2|||
49121931|NCT01051557|158285026|FG004|Overall Study|disease progression|4|||
49121932|NCT01051557|158285027|FG005|Overall Study|disease progression|3|||
49121933|NCT01051557|158285028|FG006|Overall Study|disease progression|1|||
49121934|NCT01051557|158285022|FG000|Overall Study|Withdrawal by Subject|0|||
49121935|NCT01051557|158285023|FG001|Overall Study|Withdrawal by Subject|0|||
49121936|NCT01051557|158285024|FG002|Overall Study|Withdrawal by Subject|1|||
49121937|NCT01051557|158285025|FG003|Overall Study|Withdrawal by Subject|0|||
49121938|NCT01051557|158285026|FG004|Overall Study|Withdrawal by Subject|2|||
49121939|NCT01051557|158285027|FG005|Overall Study|Withdrawal by Subject|0|||
49121940|NCT01051557|158285028|FG006|Overall Study|Withdrawal by Subject|1|||
49121941|NCT01051557|158285022|FG000|Overall Study|Adverse Event|0|||
49121942|NCT01051557|158285023|FG001|Overall Study|Adverse Event|0|||
49121943|NCT01051557|158285024|FG002|Overall Study|Adverse Event|0|||
49121944|NCT01051557|158285025|FG003|Overall Study|Adverse Event|1|||
49121945|NCT01051557|158285026|FG004|Overall Study|Adverse Event|1|||
49121946|NCT01051557|158285027|FG005|Overall Study|Adverse Event|3|||
49121947|NCT01051557|158285028|FG006|Overall Study|Adverse Event|4|||
49121948|NCT02169505|158285029|FG000|Overall Study|Withdrawal by Subject|1|||
49121949|NCT01266824|158285030|FG000|Overall Study|Study terminated prior to completion|2|||
49121950|NCT01266824|158285031|FG001|Overall Study|Study terminated prior to completion|3|||
49121951|NCT00509899|158285032|FG000|Overall Study|Progressive disease|1|||
49121952|NCT00509899|158285033|FG001|Overall Study|Progressive disease|3|||
49121953|NCT00509899|158285034|FG002|Overall Study|Progressive disease|5|||
49121954|NCT00509899|158285035|FG003|Overall Study|Progressive disease|1|||
49121955|NCT00509899|158285036|FG004|Overall Study|Progressive disease|0|||
48712655|NCT04173494|156799382|FG001|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|5|||
48712656|NCT04173494|156799381|FG000|Randomized DB TP (Up to Week 24)|Lack of Efficacy|6|||
48811574|NCT01734434|157150017|FG002|Overall Study|No Live Birth|32|||
49121956|NCT00509899|158285037|FG005|Overall Study|Progressive disease|1|||
49121957|NCT00509899|158285038|FG006|Overall Study|Progressive disease|0|||
49121958|NCT00509899|158285039|FG007|Overall Study|Progressive disease|0|||
49121959|NCT00509899|158285032|FG000|Overall Study|Unacceptable Toxicity|1|||
49121960|NCT00509899|158285033|FG001|Overall Study|Unacceptable Toxicity|0|||
49121961|NCT00509899|158285034|FG002|Overall Study|Unacceptable Toxicity|0|||
49121962|NCT00509899|158285035|FG003|Overall Study|Unacceptable Toxicity|2|||
49121963|NCT00509899|158285036|FG004|Overall Study|Unacceptable Toxicity|0|||
49121964|NCT00509899|158285037|FG005|Overall Study|Unacceptable Toxicity|0|||
49121965|NCT00509899|158285038|FG006|Overall Study|Unacceptable Toxicity|0|||
49121966|NCT00509899|158285039|FG007|Overall Study|Unacceptable Toxicity|0|||
49121967|NCT00509899|158285032|FG000|Overall Study|Withdrawal by Subject|6|||
49121968|NCT00509899|158285033|FG001|Overall Study|Withdrawal by Subject|2|||
49121969|NCT00509899|158285034|FG002|Overall Study|Withdrawal by Subject|3|||
49121970|NCT00509899|158285035|FG003|Overall Study|Withdrawal by Subject|0|||
49121971|NCT00509899|158285036|FG004|Overall Study|Withdrawal by Subject|3|||
49121972|NCT00509899|158285037|FG005|Overall Study|Withdrawal by Subject|2|||
49121973|NCT00509899|158285038|FG006|Overall Study|Withdrawal by Subject|0|||
49121974|NCT00509899|158285039|FG007|Overall Study|Withdrawal by Subject|0|||
49121975|NCT00509899|158285032|FG000|Overall Study|Physician Decision|4|||
49121976|NCT00509899|158285033|FG001|Overall Study|Physician Decision|2|||
49121977|NCT00509899|158285034|FG002|Overall Study|Physician Decision|7|||
49121978|NCT00509899|158285035|FG003|Overall Study|Physician Decision|0|||
49121979|NCT00509899|158285036|FG004|Overall Study|Physician Decision|1|||
49121980|NCT00509899|158285037|FG005|Overall Study|Physician Decision|4|||
49121981|NCT00509899|158285038|FG006|Overall Study|Physician Decision|0|||
49121982|NCT00509899|158285039|FG007|Overall Study|Physician Decision|0|||
49121983|NCT00509899|158285032|FG000|Overall Study|Intercurrent Illness|1|||
49121984|NCT00509899|158285033|FG001|Overall Study|Intercurrent Illness|0|||
49121985|NCT00509899|158285034|FG002|Overall Study|Intercurrent Illness|0|||
49121986|NCT00509899|158285035|FG003|Overall Study|Intercurrent Illness|1|||
49121987|NCT00509899|158285036|FG004|Overall Study|Intercurrent Illness|0|||
49121988|NCT00509899|158285037|FG005|Overall Study|Intercurrent Illness|1|||
49121989|NCT00509899|158285038|FG006|Overall Study|Intercurrent Illness|0|||
49121990|NCT00509899|158285039|FG007|Overall Study|Intercurrent Illness|0|||
49121991|NCT00509899|158285032|FG000|Overall Study|Death|2|||
49121992|NCT00509899|158285033|FG001|Overall Study|Death|2|||
49121993|NCT00509899|158285034|FG002|Overall Study|Death|3|||
49121994|NCT00509899|158285035|FG003|Overall Study|Death|0|||
49121995|NCT00509899|158285036|FG004|Overall Study|Death|1|||
49121996|NCT00509899|158285037|FG005|Overall Study|Death|1|||
49121997|NCT00509899|158285038|FG006|Overall Study|Death|1|||
49121998|NCT00509899|158285039|FG007|Overall Study|Death|1|||
49121999|NCT00509899|158285032|FG000|Overall Study|Lack of Efficacy|1|||
49122000|NCT00509899|158285033|FG001|Overall Study|Lack of Efficacy|0|||
49122001|NCT00509899|158285034|FG002|Overall Study|Lack of Efficacy|2|||
49122002|NCT00509899|158285035|FG003|Overall Study|Lack of Efficacy|0|||
49122003|NCT00509899|158285036|FG004|Overall Study|Lack of Efficacy|0|||
49122004|NCT00509899|158285037|FG005|Overall Study|Lack of Efficacy|1|||
49122005|NCT00509899|158285038|FG006|Overall Study|Lack of Efficacy|0|||
49122006|NCT00509899|158285039|FG007|Overall Study|Lack of Efficacy|0|||
49122007|NCT01716663|158285048|FG000|Overall Study|Withdrawn prior to procedure|4|||
49122008|NCT01716663|158285048|FG000|Overall Study|Treated with non-study catheter|2|||
49122009|NCT01059773|158285052|FG000|Overall Study|Adverse Event|2|||
49122010|NCT01059773|158285053|FG001|Overall Study|Adverse Event|2|||
49122011|NCT01059773|158285052|FG000|Overall Study|Withdrawal by Subject|1|||
49122012|NCT01059773|158285053|FG001|Overall Study|Withdrawal by Subject|5|||
49122013|NCT01059773|158285052|FG000|Overall Study|Lost to Follow-up|1|||
49122014|NCT01059773|158285053|FG001|Overall Study|Lost to Follow-up|1|||
49122015|NCT01059773|158285052|FG000|Overall Study|Pregnancy|1|||
48811575|NCT01734434|157150018|FG003|Overall Study|No Live Birth|6|||
48811576|NCT01734434|157150015|FG000|Overall Study|Withdrawal by Subject|4|||
48811577|NCT01734434|157150016|FG001|Overall Study|Withdrawal by Subject|0|||
48811578|NCT01734434|157150017|FG002|Overall Study|Withdrawal by Subject|8|||
48811579|NCT01734434|157150018|FG003|Overall Study|Withdrawal by Subject|1|||
48811580|NCT01734434|157150015|FG000|Overall Study|Signed Adult Version of Consent Form|0|||
48811581|NCT01734434|157150016|FG001|Overall Study|Signed Adult Version of Consent Form|0|||
48811582|NCT01734434|157150017|FG002|Overall Study|Signed Adult Version of Consent Form|1|||
48811583|NCT01734434|157150018|FG003|Overall Study|Signed Adult Version of Consent Form|0|||
48811584|NCT01734434|157150015|FG000|Overall Study|Subject Not Reachable|0|||
48811585|NCT01734434|157150016|FG001|Overall Study|Subject Not Reachable|0|||
49122016|NCT01059773|158285053|FG001|Overall Study|Pregnancy|1|||
48811586|NCT01734434|157150017|FG002|Overall Study|Subject Not Reachable|1|||
48811587|NCT01734434|157150018|FG003|Overall Study|Subject Not Reachable|0|||
48811588|NCT01734434|157150015|FG000|Overall Study|Treatment Defaulter|0|||
49122017|NCT01059773|158285052|FG000|Overall Study|Protocol Violation|6|||
48811589|NCT01734434|157150016|FG001|Overall Study|Treatment Defaulter|0|||
48811590|NCT01734434|157150017|FG002|Overall Study|Treatment Defaulter|1|||
48811591|NCT01734434|157150018|FG003|Overall Study|Treatment Defaulter|0|||
48811592|NCT01734434|157150015|FG000|Overall Study|Wrong Version of Consent Form Signed|0|||
49122018|NCT01059773|158285053|FG001|Overall Study|Protocol Violation|2|||
49122019|NCT01059773|158285052|FG000|Overall Study|Physician Decision|5|||
49122020|NCT01059773|158285053|FG001|Overall Study|Physician Decision|4|||
49122021|NCT01059773|158285052|FG000|Overall Study|Lack of Efficacy|3|||
49122022|NCT01059773|158285053|FG001|Overall Study|Lack of Efficacy|3|||
49122023|NCT01059773|158285052|FG000|Overall Study|Death|0|||
49122024|NCT01059773|158285053|FG001|Overall Study|Death|1|||
49122025|NCT01059773|158285052|FG000|Overall Study|Malignancy including squamous cell skin|0|||
49122026|NCT01059773|158285053|FG001|Overall Study|Malignancy including squamous cell skin|1|||
48811593|NCT01734434|157150016|FG001|Overall Study|Wrong Version of Consent Form Signed|0|||
48811594|NCT01734434|157150017|FG002|Overall Study|Wrong Version of Consent Form Signed|1|||
48811595|NCT01734434|157150018|FG003|Overall Study|Wrong Version of Consent Form Signed|0|||
48811596|NCT01734434|157150015|FG000|Overall Study|17 Yr Old Subject Signed Consent form|0|||
48811597|NCT01734434|157150016|FG001|Overall Study|17 Yr Old Subject Signed Consent form|0|||
48811598|NCT01734434|157150017|FG002|Overall Study|17 Yr Old Subject Signed Consent form|1|||
48811599|NCT01734434|157150018|FG003|Overall Study|17 Yr Old Subject Signed Consent form|0|||
48811600|NCT00871351|157152006|FG000|Overall Study|Withdrawal by Subject|1|||
48811601|NCT00871351|157152007|FG001|Overall Study|Withdrawal by Subject|0|||
48811602|NCT00871351|157152008|FG002|Overall Study|Withdrawal by Subject|0|||
48811603|NCT00871351|157152006|FG000|Overall Study|Adverse Event|3|||
48811604|NCT00871351|157152007|FG001|Overall Study|Adverse Event|1|||
48811605|NCT00871351|157152008|FG002|Overall Study|Adverse Event|0|||
48811606|NCT01289041|157152009|FG000|Overall Study|Adverse Event|24|||
48811607|NCT01289041|157152009|FG000|Overall Study|Physician Decision|1|||
48811608|NCT01289041|157152009|FG000|Overall Study|Progressive Disease|41|||
48811609|NCT01289041|157152009|FG000|Overall Study|Withdrawal by Subject|3|||
48811610|NCT01289041|157152009|FG000|Overall Study|Death|1|||
48811611|NCT01486758|157152010|FG000|Overall Study|Lost to Follow-up|0|||
48811612|NCT01486758|157152011|FG001|Overall Study|Lost to Follow-up|1|||
48811613|NCT02494921|157152019|FG000|Phase 1b, Dose Level I|Adverse Event|2|||
48811614|NCT02494921|157152020|FG001|Phase 1b, Dose Level I|Adverse Event|0|||
48811615|NCT02494921|157152021|FG002|Phase 1b, Dose Level I|Adverse Event|0|||
48811616|NCT02494921|157152022|FG003|Phase 1b, Dose Level I|Adverse Event|0|||
49122027|NCT01059773|158285052|FG000|Overall Study|Ineligible follow TB screening criteria|0|||
49122028|NCT01059773|158285053|FG001|Overall Study|Ineligible follow TB screening criteria|1|||
49122029|NCT01059773|158285052|FG000|Overall Study|Other|1|||
49122030|NCT01059773|158285053|FG001|Overall Study|Other|3|||
49122031|NCT00872521|158285056|FG000|Completed PAD Induction|Patient choice|0|||
49122032|NCT00872521|158285057|FG001|Completed PAD Induction|Patient choice|1|||
48811617|NCT02494921|157152023|FG004|Phase 1b, Dose Level I|Adverse Event|0|||
48811618|NCT02494921|157152019|FG000|Phase 1b, Dose Level IA|Adverse Event|0|||
48919143|NCT00183274|157539721|FG003|Phase 1: Open-Label|Other|0|||
48919144|NCT00183274|157539722|FG004|Phase 1: Open-Label|Other|0|||
48919145|NCT00183274|157539723|FG005|Phase 1: Open-Label|Other|0|||
48919146|NCT00183274|157539718|FG000|Phase 2: Double-Blind|Relapsed|0|||
48919147|NCT00183274|157539719|FG001|Phase 2: Double-Blind|Relapsed|8|||
48919148|NCT00183274|157539720|FG002|Phase 2: Double-Blind|Relapsed|29|||
48919149|NCT00183274|157539721|FG003|Phase 2: Double-Blind|Relapsed|0|||
48919150|NCT00183274|157539722|FG004|Phase 2: Double-Blind|Relapsed|0|||
48919151|NCT00183274|157539723|FG005|Phase 2: Double-Blind|Relapsed|0|||
48919152|NCT00183274|157539718|FG000|Phase 2: Double-Blind|Withdrawal by Subject|0|||
48919153|NCT00183274|157539719|FG001|Phase 2: Double-Blind|Withdrawal by Subject|18|||
48919154|NCT00183274|157539720|FG002|Phase 2: Double-Blind|Withdrawal by Subject|14|||
48919155|NCT00183274|157539721|FG003|Phase 2: Double-Blind|Withdrawal by Subject|0|||
48919156|NCT00183274|157539722|FG004|Phase 2: Double-Blind|Withdrawal by Subject|0|||
48919157|NCT00183274|157539723|FG005|Phase 2: Double-Blind|Withdrawal by Subject|0|||
48919158|NCT00183274|157539718|FG000|Phase 3: Double-Blind|Withdrawal by Subject|0|||
48919159|NCT00183274|157539719|FG001|Phase 3: Double-Blind|Withdrawal by Subject|0|||
48919160|NCT00183274|157539720|FG002|Phase 3: Double-Blind|Withdrawal by Subject|0|||
48919161|NCT00183274|157539721|FG003|Phase 3: Double-Blind|Withdrawal by Subject|1|||
48919162|NCT00183274|157539722|FG004|Phase 3: Double-Blind|Withdrawal by Subject|9|||
48919163|NCT00183274|157539723|FG005|Phase 3: Double-Blind|Withdrawal by Subject|2|||
48919164|NCT00183274|157539718|FG000|Phase 3: Double-Blind|Relapsed|0|||
48919165|NCT00183274|157539719|FG001|Phase 3: Double-Blind|Relapsed|0|||
48919166|NCT00183274|157539720|FG002|Phase 3: Double-Blind|Relapsed|0|||
48919167|NCT00183274|157539721|FG003|Phase 3: Double-Blind|Relapsed|1|||
48811619|NCT02494921|157152020|FG001|Phase 1b, Dose Level IA|Adverse Event|1|||
48811620|NCT02494921|157152021|FG002|Phase 1b, Dose Level IA|Adverse Event|0|||
48811621|NCT02494921|157152022|FG003|Phase 1b, Dose Level IA|Adverse Event|0|||
48919168|NCT00183274|157539722|FG004|Phase 3: Double-Blind|Relapsed|11|||
48919169|NCT00183274|157539723|FG005|Phase 3: Double-Blind|Relapsed|2|||
48919170|NCT04081363|157539724|FG000|Overall Study|Withdrawal by Subject|1|||
48919171|NCT04081363|157539725|FG001|Overall Study|Withdrawal by Subject|0|||
48919172|NCT00133991|157539726|FG000|Overall Study|Death|4|||
48919173|NCT00143312|157539727|FG000|Overall Study|Death|11|||
48919174|NCT00143312|157539727|FG000|Overall Study|Adverse Event|2|||
48919175|NCT00143312|157539727|FG000|Overall Study|Lost to Follow-up|1|||
48919176|NCT00143312|157539727|FG000|Overall Study|Other|1|||
48919177|NCT00143312|157539727|FG000|Overall Study|Withdrawal by Subject|1|||
49122033|NCT00872521|158285058|FG002|Completed PAD Induction|Patient choice|0|||
49122034|NCT00872521|158285056|FG000|Completed PAD Induction|Disease progression|0|||
49122035|NCT00872521|158285057|FG001|Completed PAD Induction|Disease progression|2|||
49122036|NCT00872521|158285058|FG002|Completed PAD Induction|Disease progression|0|||
49122037|NCT00872521|158285056|FG000|Completed PAD Induction|Adverse Event|4|||
49122038|NCT00872521|158285057|FG001|Completed PAD Induction|Adverse Event|0|||
48919178|NCT01029366|157539728|FG000|Overall Study|Withdrawal by Subject|1|||
48919179|NCT01029366|157539729|FG001|Overall Study|Withdrawal by Subject|0|||
48919180|NCT01029366|157539728|FG000|Overall Study|Death|1|||
48919181|NCT01029366|157539729|FG001|Overall Study|Death|1|||
48919182|NCT01029366|157539728|FG000|Overall Study|disease progression|2|||
48919183|NCT01029366|157539729|FG001|Overall Study|disease progression|0|||
48919184|NCT01029366|157539728|FG000|Overall Study|manufacturing failure|0|||
48919185|NCT01029366|157539729|FG001|Overall Study|manufacturing failure|1|||
48919186|NCT03029143|157539730|FG000|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|8|||
48919187|NCT03029143|157539731|FG001|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
48919188|NCT03029143|157539732|FG002|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
48919189|NCT03029143|157539730|FG000|Lead-in Period (6 Weeks)|Significant Protocol Deviation|12|||
48919190|NCT03029143|157539731|FG001|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
48919191|NCT03029143|157539732|FG002|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
48919192|NCT03029143|157539730|FG000|Lead-in Period (6 Weeks)|Lost to Follow-up|1|||
48919193|NCT03029143|157539731|FG001|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
48919194|NCT03029143|157539732|FG002|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
48919195|NCT03029143|157539730|FG000|Lead-in Period (6 Weeks)|Voluntary Withdrawal|6|||
48919196|NCT03029143|157539731|FG001|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
48919197|NCT03029143|157539732|FG002|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
48919198|NCT03029143|157539730|FG000|Lead-in Period (6 Weeks)|Randomized but not Treated|142|||
48919199|NCT03029143|157539731|FG001|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
48919200|NCT03029143|157539732|FG002|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
48919201|NCT03029143|157539730|FG000|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|0|||
48919202|NCT03029143|157539731|FG001|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|3|||
48919203|NCT03029143|157539732|FG002|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|9|||
48919204|NCT03029143|157539730|FG000|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|0|||
48919205|NCT03029143|157539731|FG001|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|1|||
48919206|NCT03029143|157539732|FG002|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|3|||
48919207|NCT03029143|157539730|FG000|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|0|||
48919208|NCT03029143|157539731|FG001|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|1|||
48919209|NCT03029143|157539732|FG002|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|3|||
48919210|NCT03029143|157539730|FG000|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|0|||
48919211|NCT03029143|157539731|FG001|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|10|||
48919212|NCT03029143|157539732|FG002|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|1|||
48919213|NCT03029143|157539730|FG000|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|0|||
49122039|NCT00872521|158285058|FG002|Completed PAD Induction|Adverse Event|0|||
49122040|NCT00872521|158285056|FG000|Completed PAD Induction|Death|1|||
49122041|NCT00872521|158285057|FG001|Completed PAD Induction|Death|1|||
49122042|NCT00872521|158285058|FG002|Completed PAD Induction|Death|0|||
49122043|NCT00872521|158285056|FG000|Primary Endpoint Analysis|Other|1|||
49122044|NCT00872521|158285057|FG001|Primary Endpoint Analysis|Other|2|||
49122045|NCT00872521|158285058|FG002|Primary Endpoint Analysis|Other|0|||
48919214|NCT03029143|157539731|FG001|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|6|||
48919215|NCT03029143|157539732|FG002|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|7|||
48919216|NCT03029143|157539730|FG000|Randomized Treatment Period (24 Weeks)|Reason not Specified|0|||
49122046|NCT00872521|158285056|FG000|Primary Endpoint Analysis|Patient choice|0|||
49122047|NCT00872521|158285057|FG001|Primary Endpoint Analysis|Patient choice|1|||
49122048|NCT00872521|158285058|FG002|Primary Endpoint Analysis|Patient choice|0|||
49122049|NCT00872521|158285056|FG000|Primary Endpoint Analysis|Efficacy data unavailable|0|||
49122050|NCT00872521|158285057|FG001|Primary Endpoint Analysis|Efficacy data unavailable|2|||
49122051|NCT00872521|158285058|FG002|Primary Endpoint Analysis|Efficacy data unavailable|0|||
49122052|NCT00872521|158285056|FG000|Primary Endpoint Analysis|Patient response missing|0|||
49122053|NCT00872521|158285057|FG001|Primary Endpoint Analysis|Patient response missing|0|||
49122054|NCT00872521|158285058|FG002|Primary Endpoint Analysis|Patient response missing|1|||
49122055|NCT00872521|158285056|FG000|Completed 3-month Follow up|Other|0|||
49122056|NCT00872521|158285057|FG001|Completed 3-month Follow up|Other|2|||
49122057|NCT00872521|158285058|FG002|Completed 3-month Follow up|Other|0|||
49122058|NCT00872521|158285056|FG000|Completed 3-month Follow up|Physician Decision|0|||
49122059|NCT00872521|158285057|FG001|Completed 3-month Follow up|Physician Decision|1|||
49122060|NCT00872521|158285058|FG002|Completed 3-month Follow up|Physician Decision|0|||
49122061|NCT00872521|158285056|FG000|Secondary Endpoint Analysis|Efficacy data unavailable|0|||
49122062|NCT00872521|158285057|FG001|Secondary Endpoint Analysis|Efficacy data unavailable|2|||
48712657|NCT04173494|156799382|FG001|Randomized DB TP (Up to Week 24)|Lack of Efficacy|3|||
48712658|NCT04173494|156799381|FG000|Randomized DB TP (Up to Week 24)|Death|4|||
48712659|NCT04173494|156799382|FG001|Randomized DB TP (Up to Week 24)|Death|3|||
48712660|NCT04173494|156799381|FG000|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
48712661|NCT04173494|156799382|FG001|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
48712662|NCT04173494|156799381|FG000|Randomized DB TP (Up to Week 24)|Disease Progression|1|||
48712663|NCT04173494|156799382|FG001|Randomized DB TP (Up to Week 24)|Disease Progression|2|||
48712664|NCT04173494|156799381|FG000|Randomized DB TP (Up to Week 24)|Lost to Follow-up|1|||
48712665|NCT04173494|156799382|FG001|Randomized DB TP (Up to Week 24)|Lost to Follow-up|0|||
48712666|NCT04173494|156799381|FG000|Randomized DB TP (Up to Week 24)|Physician Decision|0|||
48712667|NCT04173494|156799382|FG001|Randomized DB TP (Up to Week 24)|Physician Decision|1|||
48712668|NCT04173494|156799381|FG000|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|11|||
48712669|NCT04173494|156799382|FG001|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|1|||
48712670|NCT04173494|156799381|FG000|Open-Label Extended TP(Weeks 24 to 151)|Death|6|||
48811622|NCT02494921|157152023|FG004|Phase 1b, Dose Level IA|Adverse Event|0|||
48811623|NCT02494921|157152019|FG000|Phase 1b, Dose Level IIC|Physician Decision|0|||
49122063|NCT00872521|158285058|FG002|Secondary Endpoint Analysis|Efficacy data unavailable|1|||
49122064|NCT01468454|158285070|FG000|Overall Study|Did not have surgery after PET|9|||
49122065|NCT03299101|158285071|FG000|Overall Study|Lost to Follow-up|1|||
49122066|NCT03299101|158285071|FG000|Overall Study|Withdrawal by Subject|5|||
49122067|NCT03299101|158285071|FG000|Overall Study|Surgery was changed|3|||
49122068|NCT03299101|158285071|FG000|Overall Study|Not enough time to complete prehab|1|||
49122069|NCT01462630|158285074|FG000|Overall Study|Did not initiate therapy|3|||
49122070|NCT01462630|158285074|FG000|Overall Study|Death|1|||
49122071|NCT01462630|158285074|FG000|Overall Study|Protocol Violation|2|||
49122072|NCT01462630|158285074|FG000|Overall Study|Adverse Event|1|||
49122073|NCT03193047|158285075|FG000|Overall Study|Physician Decision|1|||
49122074|NCT03193047|158285076|FG001|Overall Study|Physician Decision|0|||
49122075|NCT03193047|158285075|FG000|Overall Study|Participant Left State|1|||
49122076|NCT03193047|158285076|FG001|Overall Study|Participant Left State|0|||
49122077|NCT02131064|158285077|FG000|Overall Study|Death|5|||
49122078|NCT02131064|158285078|FG001|Overall Study|Death|6|||
49122079|NCT02131064|158285077|FG000|Overall Study|Lost to Follow-up|4|||
49122080|NCT02131064|158285078|FG001|Overall Study|Lost to Follow-up|8|||
49122081|NCT02131064|158285077|FG000|Overall Study|Withdrawal by Subject|14|||
49122082|NCT02131064|158285078|FG001|Overall Study|Withdrawal by Subject|18|||
49122083|NCT02131064|158285077|FG000|Overall Study|Other|2|||
49122084|NCT02131064|158285078|FG001|Overall Study|Other|2|||
49122085|NCT00379899|158285081|FG000|Overall Study|Adverse Event|7|||
49122086|NCT00379899|158285082|FG001|Overall Study|Adverse Event|3|||
49122087|NCT00379899|158285081|FG000|Overall Study|Death|10|||
49122088|NCT00379899|158285082|FG001|Overall Study|Death|10|||
49122089|NCT00379899|158285081|FG000|Overall Study|Lost to Follow-up|2|||
49122090|NCT00379899|158285082|FG001|Overall Study|Lost to Follow-up|4|||
49122091|NCT00379899|158285081|FG000|Overall Study|Physician Decision|3|||
49122092|NCT00379899|158285082|FG001|Overall Study|Physician Decision|4|||
49122093|NCT00379899|158285081|FG000|Overall Study|Withdrawal by Subject|5|||
49122094|NCT00379899|158285082|FG001|Overall Study|Withdrawal by Subject|5|||
49122095|NCT00379899|158285081|FG000|Overall Study|Ineligibility determined|0|||
49122096|NCT00379899|158285082|FG001|Overall Study|Ineligibility determined|1|||
48712671|NCT04173494|156799382|FG001|Open-Label Extended TP(Weeks 24 to 151)|Death|3|||
48811624|NCT02494921|157152020|FG001|Phase 1b, Dose Level IIC|Physician Decision|0|||
48811625|NCT02494921|157152021|FG002|Phase 1b, Dose Level IIC|Physician Decision|1|||
48811626|NCT02494921|157152022|FG003|Phase 1b, Dose Level IIC|Physician Decision|0|||
49122097|NCT00379899|158285081|FG000|Overall Study|Noncompliance|1|||
49122098|NCT00379899|158285082|FG001|Overall Study|Noncompliance|1|||
49122099|NCT00379899|158285081|FG000|Overall Study|Parathyroidectomy|0|||
49122100|NCT00379899|158285082|FG001|Overall Study|Parathyroidectomy|2|||
49122101|NCT00379899|158285081|FG000|Overall Study|Renal transplantation|5|||
49122102|NCT00379899|158285082|FG001|Overall Study|Renal transplantation|4|||
49122103|NCT00379899|158285081|FG000|Overall Study|Coronary artery bypass graft|1|||
49122104|NCT00379899|158285082|FG001|Overall Study|Coronary artery bypass graft|1|||
49122105|NCT00379899|158285081|FG000|Overall Study|Other protocol-specified criteria|3|||
49122106|NCT00379899|158285082|FG001|Overall Study|Other protocol-specified criteria|4|||
49122107|NCT00379899|158285081|FG000|Overall Study|Other|3|||
49122108|NCT00379899|158285082|FG001|Overall Study|Other|1|||
49122109|NCT01747499|158285085|FG000|Overall Study|Steroid refractory aGvHD|1|||
49122110|NCT01747499|158285086|FG001|Overall Study|Steroid refractory aGvHD|0|||
49122111|NCT01747499|158285087|FG002|Overall Study|Steroid refractory aGvHD|0|||
49122112|NCT01747499|158285088|FG003|Overall Study|Steroid refractory aGvHD|1|||
49122113|NCT01747499|158285089|FG004|Overall Study|Steroid refractory aGvHD|4|||
48712672|NCT04173494|156799381|FG000|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|6|||
48712673|NCT04173494|156799382|FG001|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|2|||
48712674|NCT04173494|156799381|FG000|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|4|||
48712675|NCT04173494|156799382|FG001|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|3|||
48712676|NCT04173494|156799381|FG000|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|4|||
48712677|NCT04173494|156799382|FG001|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|3|||
48712678|NCT04173494|156799381|FG000|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|0|||
48712679|NCT04173494|156799382|FG001|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|1|||
48712680|NCT04173494|156799381|FG000|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
48712681|NCT04173494|156799382|FG001|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
48712682|NCT04173494|156799381|FG000|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|61|||
48919217|NCT03029143|157539731|FG001|Randomized Treatment Period (24 Weeks)|Reason not Specified|2|||
49122114|NCT01747499|158285085|FG000|Overall Study|Physician Decision|0|||
49122115|NCT01747499|158285086|FG001|Overall Study|Physician Decision|1|||
49122116|NCT01747499|158285087|FG002|Overall Study|Physician Decision|0|||
49122117|NCT01747499|158285088|FG003|Overall Study|Physician Decision|0|||
49122118|NCT01747499|158285089|FG004|Overall Study|Physician Decision|2|||
49122119|NCT01747499|158285085|FG000|Overall Study|Death|0|||
49122120|NCT01747499|158285086|FG001|Overall Study|Death|0|||
49122121|NCT01747499|158285087|FG002|Overall Study|Death|0|||
49122122|NCT01747499|158285088|FG003|Overall Study|Death|1|||
49122123|NCT01747499|158285089|FG004|Overall Study|Death|1|||
49122124|NCT01747499|158285085|FG000|Overall Study|Withdrawal by Subject|0|||
49122125|NCT01747499|158285086|FG001|Overall Study|Withdrawal by Subject|0|||
49122126|NCT01747499|158285087|FG002|Overall Study|Withdrawal by Subject|0|||
49122127|NCT01747499|158285088|FG003|Overall Study|Withdrawal by Subject|0|||
49122128|NCT01747499|158285089|FG004|Overall Study|Withdrawal by Subject|6|||
49122129|NCT01747499|158285085|FG000|Overall Study|Developed AML and death|0|||
49122130|NCT01747499|158285086|FG001|Overall Study|Developed AML and death|0|||
49122131|NCT01747499|158285087|FG002|Overall Study|Developed AML and death|0|||
49122132|NCT01747499|158285088|FG003|Overall Study|Developed AML and death|0|||
49122133|NCT01747499|158285089|FG004|Overall Study|Developed AML and death|1|||
49122134|NCT01747499|158285085|FG000|Overall Study|Determined not to be eligible|0|||
49122135|NCT01747499|158285086|FG001|Overall Study|Determined not to be eligible|0|||
49122136|NCT01747499|158285087|FG002|Overall Study|Determined not to be eligible|0|||
49122137|NCT01747499|158285088|FG003|Overall Study|Determined not to be eligible|0|||
49122138|NCT01747499|158285089|FG004|Overall Study|Determined not to be eligible|1|||
49122139|NCT01676701|158285090|FG000|Overall Study|Protocol Violation|1|||
49122140|NCT01676701|158285091|FG001|Overall Study|Protocol Violation|0|||
48712683|NCT04173494|156799382|FG001|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|27|||
48712684|NCT00635219|156799383|FG000|Overall Study|Adverse Event|12|||
48712685|NCT00635219|156799384|FG001|Overall Study|Adverse Event|10|||
48712686|NCT00635219|156799385|FG002|Overall Study|Adverse Event|18|||
48919218|NCT03029143|157539732|FG002|Randomized Treatment Period (24 Weeks)|Reason not Specified|1|||
48919219|NCT00607386|157539733|FG000|Overall Study|Physician Decision|1|||
49122141|NCT01676701|158285090|FG000|Overall Study|Sponsor Decision|3|||
49122142|NCT01676701|158285091|FG001|Overall Study|Sponsor Decision|4|||
49122143|NCT03771963|158285092|FG000|Overall Study|Lost to Follow-up|22|||
49122144|NCT03771963|158285092|FG000|Overall Study|Withdrawal of Consent|10|||
48712687|NCT00635219|156799386|FG003|Overall Study|Adverse Event|15|||
48712688|NCT00635219|156799387|FG004|Overall Study|Adverse Event|19|||
48919220|NCT01394627|157539734|FG000|First Intervention (1 Day)|poor intravenous access|0|||
48919221|NCT01394627|157539735|FG001|First Intervention (1 Day)|poor intravenous access|1|||
48919222|NCT01394627|157539734|FG000|Washout (1-3 Months)|concurrent enrollment in another study|1|||
48919223|NCT01394627|157539735|FG001|Washout (1-3 Months)|concurrent enrollment in another study|0|||
48919224|NCT00282334|157539738|FG000|Overall Study|Withdrawal by Subject|8|||
48919225|NCT00282334|157539739|FG001|Overall Study|Withdrawal by Subject|5|||
48919226|NCT03016325|157539742|FG000|Treatment Period|Participant withdrew consent|0|||
49122145|NCT00753675|158285103|FG000|Overall Study|other reason|11|||
49122146|NCT00753675|158285104|FG001|Overall Study|other reason|12|||
49122147|NCT00753675|158285105|FG002|Overall Study|other reason|13|||
49122148|NCT00753675|158285103|FG000|Overall Study|Death|1|||
49122149|NCT00753675|158285104|FG001|Overall Study|Death|2|||
49122150|NCT00753675|158285105|FG002|Overall Study|Death|4|||
49122151|NCT00753675|158285103|FG000|Overall Study|Adverse Event|11|||
49122152|NCT00753675|158285104|FG001|Overall Study|Adverse Event|9|||
49122153|NCT00753675|158285105|FG002|Overall Study|Adverse Event|4|||
49122154|NCT00753675|158285103|FG000|Overall Study|Objective progression of disease|35|||
49122155|NCT00753675|158285104|FG001|Overall Study|Objective progression of disease|35|||
49122156|NCT00753675|158285105|FG002|Overall Study|Objective progression of disease|35|||
49122157|NCT00753675|158285103|FG000|Overall Study|Withdrawal by Subject|0|||
49122158|NCT00753675|158285104|FG001|Overall Study|Withdrawal by Subject|1|||
49122159|NCT00753675|158285105|FG002|Overall Study|Withdrawal by Subject|0|||
49122160|NCT00753675|158285103|FG000|Overall Study|Lost to Follow-up|1|||
49122161|NCT00753675|158285104|FG001|Overall Study|Lost to Follow-up|0|||
49122162|NCT00753675|158285105|FG002|Overall Study|Lost to Follow-up|0|||
49122163|NCT02895347|158285111|FG000|Overall Study|Withdrawal by Subject|3|||
49122164|NCT02895347|158285112|FG001|Overall Study|Withdrawal by Subject|1|||
49122165|NCT04794751|158285113|FG000|Period 1|incorrect fitting guide was used to fit subject|2|||
49122166|NCT04794751|158285114|FG001|Period 1|incorrect fitting guide was used to fit subject|1|||
48712689|NCT00635219|156799383|FG000|Overall Study|Lack of Efficacy|5|||
48712690|NCT00635219|156799384|FG001|Overall Study|Lack of Efficacy|6|||
48712691|NCT00635219|156799385|FG002|Overall Study|Lack of Efficacy|3|||
48712692|NCT00635219|156799386|FG003|Overall Study|Lack of Efficacy|4|||
48712693|NCT00635219|156799387|FG004|Overall Study|Lack of Efficacy|6|||
48712694|NCT00635219|156799383|FG000|Overall Study|Non-compliance With Study Product|0|||
48712695|NCT00635219|156799384|FG001|Overall Study|Non-compliance With Study Product|0|||
48712696|NCT00635219|156799385|FG002|Overall Study|Non-compliance With Study Product|0|||
48712697|NCT00635219|156799386|FG003|Overall Study|Non-compliance With Study Product|2|||
48712698|NCT00635219|156799387|FG004|Overall Study|Non-compliance With Study Product|1|||
48712699|NCT00635219|156799383|FG000|Overall Study|Protocol Violation|0|||
48712700|NCT00635219|156799384|FG001|Overall Study|Protocol Violation|2|||
49122167|NCT04794751|158285113|FG000|Period 1|Subject no longer meets eligibility criteria|0|||
48712701|NCT00635219|156799385|FG002|Overall Study|Protocol Violation|3|||
48712702|NCT00635219|156799386|FG003|Overall Study|Protocol Violation|2|||
48811627|NCT02494921|157152023|FG004|Phase 1b, Dose Level IIC|Physician Decision|0|||
48811628|NCT01984424|157152024|FG000|Overall Study|Withdrawal by Subject|3|||
48811629|NCT01984424|157152025|FG001|Overall Study|Withdrawal by Subject|5|||
48811630|NCT01984424|157152024|FG000|Overall Study|Sponsor Decision|0|||
48811631|NCT01984424|157152025|FG001|Overall Study|Sponsor Decision|1|||
48811632|NCT01984424|157152024|FG000|Overall Study|Lost to Follow-up|0|||
48811633|NCT01984424|157152025|FG001|Overall Study|Lost to Follow-up|1|||
48919227|NCT03016325|157539743|FG001|Treatment Period|Participant withdrew consent|1|||
48919228|NCT03016325|157539744|FG002|Treatment Period|Participant withdrew consent|0|||
48919229|NCT03016325|157539745|FG003|Treatment Period|Participant withdrew consent|0|||
48919230|NCT03016325|157539746|FG004|Treatment Period|Participant withdrew consent|0|||
48919231|NCT03016325|157539747|FG005|Treatment Period|Participant withdrew consent|0|||
48919232|NCT03016325|157539748|FG006|Treatment Period|Participant withdrew consent|0|||
48811634|NCT01250119|157152028|FG000|Diagnostic Phase|Failed to Produce a Test Results|69|||
48811635|NCT01250119|157152029|FG001|Diagnostic Phase|Failed to Produce a Test Results|0|||
48811636|NCT01250119|157152028|FG000|Diagnostic Phase|Participants Not Tested|44|||
48811637|NCT01250119|157152029|FG001|Diagnostic Phase|Participants Not Tested|0|||
48811638|NCT01250119|157152028|FG000|Treatment Phase|Progressive Disease|0|||
48811639|NCT01250119|157152029|FG001|Treatment Phase|Progressive Disease|32|||
48811640|NCT01250119|157152028|FG000|Treatment Phase|Death|0|||
48811641|NCT01250119|157152029|FG001|Treatment Phase|Death|2|||
48811642|NCT01250119|157152028|FG000|Treatment Phase|Withdrawal by Subject|0|||
48811643|NCT01250119|157152029|FG001|Treatment Phase|Withdrawal by Subject|1|||
48919233|NCT03016325|157539749|FG007|Treatment Period|Participant withdrew consent|0|||
48919234|NCT03016325|157539742|FG000|Treatment Period|Death|0|||
48919235|NCT03016325|157539743|FG001|Treatment Period|Death|0|||
49122168|NCT04794751|158285114|FG001|Period 1|Subject no longer meets eligibility criteria|1|||
49122169|NCT04794751|158285113|FG000|Period 1|Protocol Violation|0|||
49122170|NCT04794751|158285114|FG001|Period 1|Protocol Violation|2|||
49122171|NCT04794751|158285113|FG000|Period 1|Withdrawal by Subject|0|||
48712703|NCT00635219|156799387|FG004|Overall Study|Protocol Violation|4|||
48712704|NCT00635219|156799383|FG000|Overall Study|Withdrawal of Consent|8|||
48712705|NCT00635219|156799384|FG001|Overall Study|Withdrawal of Consent|6|||
48712706|NCT00635219|156799385|FG002|Overall Study|Withdrawal of Consent|8|||
48811644|NCT01250119|157152028|FG000|Treatment Phase|Adverse Event|0|||
48811645|NCT01250119|157152029|FG001|Treatment Phase|Adverse Event|2|||
48811646|NCT01250119|157152028|FG000|Treatment Phase|Unknown reason|0|||
48811647|NCT01250119|157152029|FG001|Treatment Phase|Unknown reason|4|||
48811648|NCT00871403|157152032|FG000|Combination Treatment Phase|Randomized but Not Treated|1|||
48811649|NCT00871403|157152033|FG001|Combination Treatment Phase|Randomized but Not Treated|1|||
48811650|NCT00871403|157152034|FG002|Combination Treatment Phase|Randomized but Not Treated|1|||
48919236|NCT03016325|157539744|FG002|Treatment Period|Death|0|||
48919237|NCT03016325|157539745|FG003|Treatment Period|Death|0|||
49122172|NCT04794751|158285114|FG001|Period 1|Withdrawal by Subject|1|||
49122173|NCT04794751|158285113|FG000|Period 2|Withdrawal by Subject|0|||
49122174|NCT04794751|158285114|FG001|Period 2|Withdrawal by Subject|1|||
48712707|NCT00635219|156799386|FG003|Overall Study|Withdrawal of Consent|11|||
48712708|NCT00635219|156799387|FG004|Overall Study|Withdrawal of Consent|8|||
48712709|NCT00635219|156799383|FG000|Overall Study|Lost to Follow-up|0|||
48712710|NCT00635219|156799384|FG001|Overall Study|Lost to Follow-up|0|||
49122175|NCT04794751|158285113|FG000|Period 2|incorrect fitting guide was used to fit subject|0|||
49122176|NCT04794751|158285114|FG001|Period 2|incorrect fitting guide was used to fit subject|2|||
49122177|NCT04794751|158285113|FG000|Period 2|Protocol Violation|1|||
48712711|NCT00635219|156799385|FG002|Overall Study|Lost to Follow-up|2|||
48712712|NCT00635219|156799386|FG003|Overall Study|Lost to Follow-up|0|||
48712713|NCT00635219|156799387|FG004|Overall Study|Lost to Follow-up|3|||
48712714|NCT00635219|156799383|FG000|Overall Study|Administrative or Other Reasons|0|||
48712715|NCT00635219|156799384|FG001|Overall Study|Administrative or Other Reasons|1|||
48712716|NCT00635219|156799385|FG002|Overall Study|Administrative or Other Reasons|1|||
48712717|NCT00635219|156799386|FG003|Overall Study|Administrative or Other Reasons|0|||
48712718|NCT00635219|156799387|FG004|Overall Study|Administrative or Other Reasons|1|||
48712719|NCT02147561|156799388|FG000|Overall Study|Lost to Follow-up|3|||
48712720|NCT02147561|156799388|FG000|Overall Study|Subjects who didn't receive BOTOX|1|||
48712721|NCT01191762|156799389|FG000|Overall Study|Adverse Event|1|||
48712722|NCT01191762|156799390|FG001|Overall Study|Adverse Event|0|||
48712723|NCT00441064|156799391|FG000|Overall Study|Adverse Event|1|||
48712724|NCT00441064|156799392|FG001|Overall Study|Adverse Event|0|||
48712725|NCT00441064|156799391|FG000|Overall Study|Abnormal laboratory values|0|||
48712726|NCT00441064|156799392|FG001|Overall Study|Abnormal laboratory values|2|||
48712727|NCT00441064|156799391|FG000|Overall Study|Abnormal test procedure results|0|||
48712728|NCT00441064|156799392|FG001|Overall Study|Abnormal test procedure results|1|||
48712729|NCT00441064|156799391|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
48712730|NCT00441064|156799392|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
48712731|NCT00441064|156799391|FG000|Overall Study|Protocol Deviation|3|||
48712732|NCT00441064|156799392|FG001|Overall Study|Protocol Deviation|2|||
48712733|NCT00441064|156799391|FG000|Overall Study|Patient withdrew consent|5|||
48712734|NCT00441064|156799392|FG001|Overall Study|Patient withdrew consent|2|||
48712735|NCT04195893|156799393|FG000|Second Intervention|Withdrawal by Subject|1|||
48712736|NCT04195893|156799394|FG001|Second Intervention|Withdrawal by Subject|0|||
48712737|NCT01738646|156799397|FG000|Overall Study|Still Receiving Treatment|2|||
48712738|NCT03023813|156799398|FG000|Overall Study|Lost to Follow-up|1|||
48712739|NCT03023813|156799399|FG001|Overall Study|Lost to Follow-up|2|||
48712740|NCT03023813|156799400|FG002|Overall Study|Lost to Follow-up|0|||
48712741|NCT00393861|156799401|FG000|Overall Study|Adverse Event|2|||
48712742|NCT00393861|156799401|FG000|Overall Study|Disease Progression|24|||
48712743|NCT01727024|156799402|FG000|Period 1|Lost to Follow-up|1|||
48712744|NCT01727024|156799403|FG001|Period 1|Lost to Follow-up|1|||
48712745|NCT01727024|156799402|FG000|Period 1|Withdrawal by Subject|2|||
48712746|NCT01727024|156799403|FG001|Period 1|Withdrawal by Subject|3|||
48712747|NCT00139477|156799404|FG000|First Intervention -Baseline to 6Months|No Longer Interested|6|||
48712748|NCT00139477|156799405|FG001|First Intervention -Baseline to 6Months|No Longer Interested|7|||
48712749|NCT00139477|156799404|FG000|First Intervention -Baseline to 6Months|Relocation|1|||
48712750|NCT00139477|156799405|FG001|First Intervention -Baseline to 6Months|Relocation|2|||
48712751|NCT00139477|156799404|FG000|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
48712752|NCT00139477|156799405|FG001|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
48712753|NCT00139477|156799404|FG000|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2|||
48712754|NCT00139477|156799405|FG001|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0|||
48712755|NCT00139477|156799404|FG000|Second Intervention -6Months to 12Months|No Longer Interested|0|||
48712756|NCT00139477|156799405|FG001|Second Intervention -6Months to 12Months|No Longer Interested|2|||
48712757|NCT00139477|156799404|FG000|Second Intervention -6Months to 12Months|Relocation|1|||
48712758|NCT00139477|156799405|FG001|Second Intervention -6Months to 12Months|Relocation|0|||
48712759|NCT00139477|156799404|FG000|Second Intervention -6Months to 12Months|Lost to Follow-up|4|||
48712760|NCT00139477|156799405|FG001|Second Intervention -6Months to 12Months|Lost to Follow-up|3|||
49122178|NCT04794751|158285114|FG001|Period 2|Protocol Violation|0|||
49122179|NCT01526785|158285115|FG000|Overall Study|Study Terminated by Sponsor|8|||
49122180|NCT01526785|158285115|FG000|Overall Study|Death|2|||
49122181|NCT01526785|158285115|FG000|Overall Study|Physician Decision|1|||
49122182|NCT01526785|158285115|FG000|Overall Study|Withdrawal by Subject|2|||
49122183|NCT01945944|158285116|FG000|Overall Study|Adverse Event|0|||
49122184|NCT01945944|158285117|FG001|Overall Study|Adverse Event|2|||
49122185|NCT01945944|158285116|FG000|Overall Study|Physician Decision|1|||
49122186|NCT01945944|158285117|FG001|Overall Study|Physician Decision|0|||
49122187|NCT01945944|158285116|FG000|Overall Study|Withdrawal by Subject|0|||
49122188|NCT01945944|158285117|FG001|Overall Study|Withdrawal by Subject|1|||
49122189|NCT02346877|158285118|FG000|Overall Study|Adverse Event|1|||
49122190|NCT02346877|158285119|FG001|Overall Study|Adverse Event|0|||
49122191|NCT02346877|158285118|FG000|Overall Study|Administrative Decision|1|||
49122192|NCT02346877|158285119|FG001|Overall Study|Administrative Decision|0|||
48712761|NCT02267317|156799406|FG000|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1|||
48712762|NCT02267317|156799407|FG001|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
48919238|NCT03016325|157539746|FG004|Treatment Period|Death|2|||
49122193|NCT02346877|158285118|FG000|Overall Study|Sponsor Decision|12|||
49122194|NCT02346877|158285119|FG001|Overall Study|Sponsor Decision|0|||
49122195|NCT02346877|158285118|FG000|Overall Study|Missing|5|||
49122196|NCT02346877|158285119|FG001|Overall Study|Missing|0|||
49122197|NCT00807365|158285120|FG000|Overall Study|Study Terminated|5|||
49122198|NCT03810456|158285121|FG000|Treatment|Urgent Family Matters|3|||
49122199|NCT03810456|158285122|FG001|Treatment|Urgent Family Matters|0|||
49122200|NCT03810456|158285123|FG002|Treatment|Urgent Family Matters|0|||
49122201|NCT03810456|158285121|FG000|Treatment|Scheduling Conflicts|0|||
49122202|NCT03810456|158285122|FG001|Treatment|Scheduling Conflicts|11|||
49122203|NCT03810456|158285123|FG002|Treatment|Scheduling Conflicts|0|||
48712763|NCT02267317|156799408|FG002|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
49122204|NCT03810456|158285121|FG000|Treatment|No Longer Interested|0|||
49122205|NCT03810456|158285122|FG001|Treatment|No Longer Interested|12|||
49122206|NCT03810456|158285123|FG002|Treatment|No Longer Interested|0|||
49122207|NCT03810456|158285121|FG000|Treatment|Transportation Issues|0|||
49122208|NCT03810456|158285122|FG001|Treatment|Transportation Issues|1|||
49122209|NCT03810456|158285123|FG002|Treatment|Transportation Issues|0|||
49122210|NCT03810456|158285121|FG000|1 Month Follow-Up|Lost to Follow-up|7|||
49122211|NCT03810456|158285122|FG001|1 Month Follow-Up|Lost to Follow-up|4|||
49122212|NCT03810456|158285123|FG002|1 Month Follow-Up|Lost to Follow-up|15|||
49122213|NCT03810456|158285121|FG000|1 Month Follow-Up|Relocated to Different State|1|||
49122214|NCT03810456|158285122|FG001|1 Month Follow-Up|Relocated to Different State|0|||
49122215|NCT03810456|158285123|FG002|1 Month Follow-Up|Relocated to Different State|1|||
49122216|NCT03810456|158285121|FG000|1 Month Follow-Up|Withdrawal by Subject|1|||
49122217|NCT03810456|158285122|FG001|1 Month Follow-Up|Withdrawal by Subject|0|||
49122218|NCT03810456|158285123|FG002|1 Month Follow-Up|Withdrawal by Subject|0|||
49122219|NCT03810456|158285121|FG000|3 Month Follow-Up|Lost to Follow-up|11|||
49122220|NCT03810456|158285122|FG001|3 Month Follow-Up|Lost to Follow-up|11|||
49122221|NCT03810456|158285123|FG002|3 Month Follow-Up|Lost to Follow-up|14|||
49122222|NCT03810456|158285121|FG000|3 Month Follow-Up|Withdrawal by Subject|1|||
49122223|NCT03810456|158285122|FG001|3 Month Follow-Up|Withdrawal by Subject|0|||
49122224|NCT03810456|158285123|FG002|3 Month Follow-Up|Withdrawal by Subject|0|||
49122225|NCT03810456|158285121|FG000|6 Month Follow-Up|Lost to Follow-up|12|||
49122226|NCT03810456|158285122|FG001|6 Month Follow-Up|Lost to Follow-up|9|||
49122227|NCT03810456|158285123|FG002|6 Month Follow-Up|Lost to Follow-up|18|||
49122228|NCT03810456|158285121|FG000|6 Month Follow-Up|Withdrawal by Subject|1|||
49122229|NCT03810456|158285122|FG001|6 Month Follow-Up|Withdrawal by Subject|0|||
49122230|NCT03810456|158285123|FG002|6 Month Follow-Up|Withdrawal by Subject|0|||
49122231|NCT01128400|158286761|FG000|Overall Study|Lost to Follow-up|1|||
49122232|NCT01128400|158286762|FG001|Overall Study|Lost to Follow-up|0|||
49122233|NCT01128400|158286763|FG002|Overall Study|Lost to Follow-up|1|||
48712764|NCT02267317|156799409|FG003|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
48712765|NCT02267317|156799410|FG004|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
48712766|NCT02267317|156799411|FG005|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
48712767|NCT02267317|156799406|FG000|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1|||
48712768|NCT02267317|156799407|FG001|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
48712769|NCT02267317|156799408|FG002|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
48712770|NCT02267317|156799409|FG003|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
48712771|NCT02267317|156799410|FG004|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
48712772|NCT02267317|156799411|FG005|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
48712773|NCT05194579|156799412|FG000|Overall Study|Lost to Follow-up|2|||
48712774|NCT05194579|156799413|FG001|Overall Study|Lost to Follow-up|3|||
48712775|NCT05194579|156799412|FG000|Overall Study|Withdrawal by Subject|3|||
48712776|NCT05194579|156799413|FG001|Overall Study|Withdrawal by Subject|4|||
48712777|NCT05194579|156799412|FG000|Overall Study|Refused further study procedures|0|||
48712778|NCT05194579|156799413|FG001|Overall Study|Refused further study procedures|1|||
48712779|NCT05194579|156799412|FG000|Overall Study|Protocol deviation|1|||
49122234|NCT01128400|158286761|FG000|Overall Study|Screening failure|1|||
49122235|NCT01128400|158286762|FG001|Overall Study|Screening failure|0|||
48712780|NCT05194579|156799413|FG001|Overall Study|Protocol deviation|0|||
48712781|NCT03554486|156799418|FG000|Run-in Period (2 Weeks)|Need for steroid injection|1|||
48712782|NCT03554486|156799419|FG001|Run-in Period (2 Weeks)|Need for steroid injection|0|||
49122236|NCT01128400|158286763|FG002|Overall Study|Screening failure|0|||
48712783|NCT03554486|156799420|FG002|Run-in Period (2 Weeks)|Need for steroid injection|0|||
48712784|NCT03554486|156799418|FG000|Run-in Period (2 Weeks)|Lost to Follow-up|2|||
48811651|NCT00871403|157152032|FG000|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8|||
49122237|NCT01128400|158286761|FG000|Overall Study|were not invited to participate on taste|0|||
48811652|NCT00871403|157152033|FG001|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19|||
48811653|NCT00871403|157152034|FG002|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0|||
49122238|NCT01128400|158286762|FG001|Overall Study|were not invited to participate on taste|0|||
49122239|NCT01128400|158286763|FG002|Overall Study|were not invited to participate on taste|15|||
49122240|NCT01128400|158286761|FG000|Overall Study|Excluded due to sinus problems|0|||
49122241|NCT01128400|158286762|FG001|Overall Study|Excluded due to sinus problems|1|||
49122242|NCT01128400|158286763|FG002|Overall Study|Excluded due to sinus problems|0|||
49122243|NCT00803712|158286764|FG000|Overall Study|Noncompliance|3|||
48712785|NCT03554486|156799419|FG001|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
48712786|NCT03554486|156799420|FG002|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
48811654|NCT00871403|157152032|FG000|Combination Treatment Phase|Adverse Event|0|||
48811655|NCT00871403|157152033|FG001|Combination Treatment Phase|Adverse Event|17|||
48811656|NCT00871403|157152034|FG002|Combination Treatment Phase|Adverse Event|2|||
48811657|NCT00871403|157152032|FG000|Combination Treatment Phase|Disease Progression|0|||
48919239|NCT03016325|157539747|FG005|Treatment Period|Death|0|||
48919240|NCT03016325|157539748|FG006|Treatment Period|Death|0|||
48919241|NCT03016325|157539749|FG007|Treatment Period|Death|0|||
48919242|NCT03016325|157539742|FG000|Treatment Period|Participant refuses assessments|0|||
48919243|NCT03016325|157539743|FG001|Treatment Period|Participant refuses assessments|0|||
48919244|NCT03016325|157539744|FG002|Treatment Period|Participant refuses assessments|1|||
48919245|NCT03016325|157539745|FG003|Treatment Period|Participant refuses assessments|0|||
48919246|NCT03016325|157539746|FG004|Treatment Period|Participant refuses assessments|0|||
48919247|NCT03016325|157539747|FG005|Treatment Period|Participant refuses assessments|0|||
48919248|NCT03016325|157539748|FG006|Treatment Period|Participant refuses assessments|0|||
48919249|NCT03016325|157539749|FG007|Treatment Period|Participant refuses assessments|0|||
48919250|NCT03016325|157539742|FG000|32-Day Follow-Up Period|Death|2|||
48919251|NCT03016325|157539743|FG001|32-Day Follow-Up Period|Death|0|||
48919252|NCT03016325|157539744|FG002|32-Day Follow-Up Period|Death|5|||
48919253|NCT03016325|157539745|FG003|32-Day Follow-Up Period|Death|6|||
48919254|NCT03016325|157539746|FG004|32-Day Follow-Up Period|Death|3|||
48919255|NCT03016325|157539747|FG005|32-Day Follow-Up Period|Death|0|||
48919256|NCT03016325|157539748|FG006|32-Day Follow-Up Period|Death|0|||
48919257|NCT03016325|157539749|FG007|32-Day Follow-Up Period|Death|0|||
48919258|NCT03016325|157539742|FG000|32-Day Follow-Up Period|Lost to Follow-up|1|||
48919259|NCT03016325|157539743|FG001|32-Day Follow-Up Period|Lost to Follow-up|0|||
48919260|NCT03016325|157539744|FG002|32-Day Follow-Up Period|Lost to Follow-up|1|||
48919261|NCT03016325|157539745|FG003|32-Day Follow-Up Period|Lost to Follow-up|1|||
49122244|NCT00803712|158286765|FG001|Overall Study|Noncompliance|0|||
49122245|NCT00803712|158286764|FG000|Overall Study|Adverse Event|5|||
49122246|NCT00803712|158286765|FG001|Overall Study|Adverse Event|0|||
49122247|NCT00803712|158286764|FG000|Overall Study|Death|8|||
49122248|NCT00803712|158286765|FG001|Overall Study|Death|7|||
49122249|NCT00803712|158286764|FG000|Overall Study|Lost to Follow-up|3|||
49122250|NCT00803712|158286765|FG001|Overall Study|Lost to Follow-up|1|||
49122251|NCT00803712|158286764|FG000|Overall Study|Withdrawal by Subject|2|||
49122252|NCT00803712|158286765|FG001|Overall Study|Withdrawal by Subject|4|||
49122253|NCT00803712|158286764|FG000|Overall Study|"Other in electronic Case Report Form"|0|||
49122254|NCT00803712|158286765|FG001|Overall Study|"Other in electronic Case Report Form"|1|||
49122255|NCT00803712|158286764|FG000|Overall Study|Protocol criteria (other)|0|||
49122256|NCT00803712|158286765|FG001|Overall Study|Protocol criteria (other)|2|||
49122257|NCT00803712|158286764|FG000|Overall Study|Protocol criteria (renal transplant)|12|||
49122258|NCT00803712|158286765|FG001|Overall Study|Protocol criteria (renal transplant)|8|||
48712787|NCT03554486|156799418|FG000|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0|||
48712788|NCT03554486|156799419|FG001|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
48712789|NCT03554486|156799420|FG002|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
48712790|NCT02640508|156799423|FG000|Overall Study|Death|19|||
48712791|NCT02640508|156799423|FG000|Overall Study|Withdrawal by Subject|8|||
48712792|NCT02640508|156799423|FG000|Overall Study|Physician Decision|1|||
48712793|NCT02640508|156799423|FG000|Overall Study|Lost to Follow-up|1|||
48712794|NCT04343235|156799424|FG000|Overall Study|Lost to Follow-up|3|||
48712795|NCT04343235|156799425|FG001|Overall Study|Lost to Follow-up|2|||
48712796|NCT00280748|156799426|FG000|Overall Study|Decline in performance|3|||
48712797|NCT00280748|156799426|FG000|Overall Study|Extra-cranial disease progression|1|||
48712798|NCT00029146|156799427|FG000|Overall Study|Lost to Follow-up|2|||
48712799|NCT00029146|156799428|FG001|Overall Study|Lost to Follow-up|1|||
49122259|NCT00803712|158286764|FG000|Overall Study|Administrative decision|2|||
49122260|NCT00803712|158286765|FG001|Overall Study|Administrative decision|3|||
49122261|NCT00803712|158286764|FG000|Overall Study|Protocol criteria (parathyroidectomy)|1|||
49122262|NCT00803712|158286765|FG001|Overall Study|Protocol criteria (parathyroidectomy)|1|||
49122263|NCT02699996|158286775|FG000|Overall Study|Withdrawal by Subject|5|||
48919262|NCT03016325|157539746|FG004|32-Day Follow-Up Period|Lost to Follow-up|0|||
49122264|NCT02699996|158286776|FG001|Overall Study|Withdrawal by Subject|2|||
49122265|NCT04194489|158286778|FG000|Overall Study|Withdrawal by Subject|5|||
49122266|NCT04194489|158286778|FG000|Overall Study|Lost to Follow-up|48|||
49122267|NCT02630563|158286789|FG000|Overall Study|Administrative|1|||
49122268|NCT02239640|158286790|FG000|Overall Study|Withdrawal by Subject|3|||
49122269|NCT02239640|158286790|FG000|Overall Study|Lost to Follow-up|72|||
49122270|NCT02239640|158286790|FG000|Overall Study|Death|142|||
49122271|NCT02485483|158286793|FG000|Overall Study|Depression at baseline|15|||
49122272|NCT02485483|158286794|FG001|Overall Study|Depression at baseline|0|||
49122273|NCT02485483|158286793|FG000|Overall Study|Discontinued after baseline|39|||
49122274|NCT02485483|158286794|FG001|Overall Study|Discontinued after baseline|0|||
49122275|NCT00929994|158286795|FG000|Overall Study|Withdrawal by Subject|1|||
49122276|NCT00929994|158286795|FG000|Overall Study|medical issue unrelated to intervention|4|||
49122277|NCT00929994|158286795|FG000|Overall Study|employment|1|||
49122278|NCT00268983|158286800|FG000|Overall Study|Death|3|||
49122279|NCT00268983|158286801|FG001|Overall Study|Death|0|||
49122280|NCT00875563|158286802|FG000|Overall Study|Death|4|||
49122281|NCT00875563|158286802|FG000|Overall Study|Withdrawal by Subject|7|||
49122282|NCT00875563|158286802|FG000|Overall Study|No long-term (3-5 year) consent|6|||
49122283|NCT00875563|158286802|FG000|Overall Study|Still be eligible for follow-up|7|||
49122284|NCT00970489|158286803|FG000|Overall Study|Death/Withdrew/Criteria Violation|54|||
49122285|NCT00970489|158286804|FG001|Overall Study|Death/Withdrew/Criteria Violation|41|||
49122286|NCT05417412|158286805|FG000|Overall Study|Lost to Follow-up|2|||
49122287|NCT01841970|158286806|FG000|Overall Study|Withdrawal by Subject|1|||
49122288|NCT01841970|158286806|FG000|Overall Study|Physician Decision|2|||
49122289|NCT01841970|158286806|FG000|Overall Study|Lost to Follow-up|8|||
49122290|NCT03478371|158286807|FG000|Overall Study|non-compliance|1|||
49122291|NCT03478371|158286807|FG000|Overall Study|Lost to Follow-up|4|||
49122292|NCT03428100|158286808|FG000|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
49122293|NCT03428100|158286809|FG001|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
49122294|NCT03428100|158286810|FG002|Double-Blind Treatment Week 0 to Week 52|Adverse Event|3|||
49122295|NCT03428100|158286811|FG003|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
49122296|NCT03428100|158286812|FG004|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
49122297|NCT03428100|158286813|FG005|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
49122298|NCT03428100|158286814|FG006|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
49122299|NCT03428100|158286815|FG007|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
49122300|NCT03428100|158286816|FG008|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
49122301|NCT03428100|158286817|FG009|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
48712800|NCT02878798|156799432|FG000|Overall Study|Withdrawal by Subject|5|||
48712801|NCT02878798|156799433|FG001|Overall Study|Withdrawal by Subject|4|||
48712802|NCT02878798|156799432|FG000|Overall Study|Lost to Follow-up|2|||
48712803|NCT02878798|156799433|FG001|Overall Study|Lost to Follow-up|2|||
48712804|NCT02878798|156799432|FG000|Overall Study|Protocol Violation|0|||
48712805|NCT02878798|156799433|FG001|Overall Study|Protocol Violation|1|||
48712806|NCT04556383|156799434|FG000|PCP|Lack of Efficacy|28|||
48712807|NCT04556383|156799435|FG001|PCP|Lack of Efficacy|23|||
48712808|NCT04556383|156799436|FG002|PCP|Lack of Efficacy|23|||
48712809|NCT04556383|156799437|FG003|PCP|Lack of Efficacy|0|||
48712810|NCT04556383|156799434|FG000|PCP|Study terminated by sponsor|15|||
48712811|NCT04556383|156799435|FG001|PCP|Study terminated by sponsor|13|||
48712812|NCT04556383|156799436|FG002|PCP|Study terminated by sponsor|16|||
48712813|NCT04556383|156799437|FG003|PCP|Study terminated by sponsor|0|||
48712814|NCT04556383|156799434|FG000|PCP|Withdrawal by Subject|8|||
48712815|NCT04556383|156799435|FG001|PCP|Withdrawal by Subject|6|||
48712816|NCT04556383|156799436|FG002|PCP|Withdrawal by Subject|6|||
48712817|NCT04556383|156799437|FG003|PCP|Withdrawal by Subject|0|||
48712818|NCT04556383|156799434|FG000|PCP|Adverse Event|1|||
48712819|NCT04556383|156799435|FG001|PCP|Adverse Event|7|||
48712820|NCT04556383|156799436|FG002|PCP|Adverse Event|7|||
48712821|NCT04556383|156799437|FG003|PCP|Adverse Event|0|||
48712822|NCT04556383|156799434|FG000|PCP|Other, Not Specified|1|||
48712823|NCT04556383|156799435|FG001|PCP|Other, Not Specified|2|||
48712824|NCT04556383|156799436|FG002|PCP|Other, Not Specified|1|||
48712825|NCT04556383|156799437|FG003|PCP|Other, Not Specified|0|||
48712826|NCT04556383|156799434|FG000|PCP|Protocol Violation|1|||
48712827|NCT04556383|156799435|FG001|PCP|Protocol Violation|0|||
48712828|NCT04556383|156799436|FG002|PCP|Protocol Violation|1|||
48712829|NCT04556383|156799437|FG003|PCP|Protocol Violation|0|||
48712830|NCT04556383|156799434|FG000|PCP|Lost to Follow-up|1|||
48712831|NCT04556383|156799435|FG001|PCP|Lost to Follow-up|0|||
48712832|NCT04556383|156799436|FG002|PCP|Lost to Follow-up|0|||
48712833|NCT04556383|156799437|FG003|PCP|Lost to Follow-up|0|||
48712834|NCT04556383|156799434|FG000|PCP|Physician Decision|0|||
48712835|NCT04556383|156799435|FG001|PCP|Physician Decision|1|||
48712836|NCT04556383|156799436|FG002|PCP|Physician Decision|0|||
49122302|NCT03428100|158286818|FG010|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
49122303|NCT03428100|158286819|FG011|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
49122304|NCT03428100|158286820|FG012|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
49122305|NCT03428100|158286821|FG013|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
49122306|NCT03428100|158286822|FG014|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
49122307|NCT03428100|158286823|FG015|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
49122308|NCT03428100|158286824|FG016|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
49122309|NCT03428100|158286825|FG017|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
49122310|NCT03428100|158286826|FG018|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
49122311|NCT03428100|158286808|FG000|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|16|||
49122312|NCT03428100|158286809|FG001|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|10|||
48811658|NCT00871403|157152033|FG001|Combination Treatment Phase|Disease Progression|8|||
48811659|NCT00871403|157152034|FG002|Combination Treatment Phase|Disease Progression|5|||
48811660|NCT00871403|157152032|FG000|Combination Treatment Phase|Withdrawal by Subject|0|||
48811661|NCT00871403|157152033|FG001|Combination Treatment Phase|Withdrawal by Subject|3|||
48811662|NCT00871403|157152034|FG002|Combination Treatment Phase|Withdrawal by Subject|1|||
48811663|NCT00871403|157152032|FG000|Combination Treatment Phase|Physician Decision|0|||
48811664|NCT00871403|157152033|FG001|Combination Treatment Phase|Physician Decision|1|||
48811665|NCT00871403|157152034|FG002|Combination Treatment Phase|Physician Decision|3|||
48811666|NCT00871403|157152032|FG000|Monotherapy Treatment Phase|Disease Progression|0|||
48811667|NCT00871403|157152033|FG001|Monotherapy Treatment Phase|Disease Progression|9|||
48811668|NCT00871403|157152034|FG002|Monotherapy Treatment Phase|Disease Progression|1|||
48811669|NCT00871403|157152032|FG000|Monotherapy Treatment Phase|Adverse Event|0|||
48811670|NCT00871403|157152033|FG001|Monotherapy Treatment Phase|Adverse Event|4|||
48811671|NCT00871403|157152034|FG002|Monotherapy Treatment Phase|Adverse Event|0|||
48811672|NCT01588990|157152042|FG000|Phase A|Withdrawal by Subject|5|||
48811673|NCT01588990|157152042|FG000|Phase A|Physician Decision|11|||
48919263|NCT03016325|157539747|FG005|32-Day Follow-Up Period|Lost to Follow-up|0|||
48919264|NCT03016325|157539748|FG006|32-Day Follow-Up Period|Lost to Follow-up|0|||
48919265|NCT03016325|157539749|FG007|32-Day Follow-Up Period|Lost to Follow-up|0|||
48919266|NCT03016325|157539742|FG000|32-Day Follow-Up Period|Poor/non-compliance|1|||
48919267|NCT03016325|157539743|FG001|32-Day Follow-Up Period|Poor/non-compliance|0|||
48919268|NCT03016325|157539744|FG002|32-Day Follow-Up Period|Poor/non-compliance|0|||
48811674|NCT01588990|157152042|FG000|Phase A|Other|14|||
48811675|NCT01588990|157152042|FG000|Phase A|Lost to Follow-up|1|||
48919269|NCT03016325|157539745|FG003|32-Day Follow-Up Period|Poor/non-compliance|1|||
48919270|NCT03016325|157539746|FG004|32-Day Follow-Up Period|Poor/non-compliance|1|||
48919271|NCT03016325|157539747|FG005|32-Day Follow-Up Period|Poor/non-compliance|0|||
48919272|NCT03016325|157539748|FG006|32-Day Follow-Up Period|Poor/non-compliance|0|||
48919273|NCT03016325|157539749|FG007|32-Day Follow-Up Period|Poor/non-compliance|0|||
48919274|NCT03016325|157539742|FG000|32-Day Follow-Up Period|Participant refused to visit|0|||
48919275|NCT03016325|157539743|FG001|32-Day Follow-Up Period|Participant refused to visit|1|||
48919276|NCT03016325|157539744|FG002|32-Day Follow-Up Period|Participant refused to visit|2|||
48919277|NCT03016325|157539745|FG003|32-Day Follow-Up Period|Participant refused to visit|0|||
48919278|NCT03016325|157539746|FG004|32-Day Follow-Up Period|Participant refused to visit|2|||
48919279|NCT03016325|157539747|FG005|32-Day Follow-Up Period|Participant refused to visit|0|||
48919280|NCT03016325|157539748|FG006|32-Day Follow-Up Period|Participant refused to visit|0|||
48919281|NCT03016325|157539749|FG007|32-Day Follow-Up Period|Participant refused to visit|0|||
48919282|NCT03016325|157539742|FG000|32-Day Follow-Up Period|Participant withdrew consent|0|||
48919283|NCT03016325|157539743|FG001|32-Day Follow-Up Period|Participant withdrew consent|0|||
48919284|NCT03016325|157539744|FG002|32-Day Follow-Up Period|Participant withdrew consent|0|||
48919285|NCT03016325|157539745|FG003|32-Day Follow-Up Period|Participant withdrew consent|0|||
48919286|NCT03016325|157539746|FG004|32-Day Follow-Up Period|Participant withdrew consent|2|||
48919287|NCT03016325|157539747|FG005|32-Day Follow-Up Period|Participant withdrew consent|0|||
48919288|NCT03016325|157539748|FG006|32-Day Follow-Up Period|Participant withdrew consent|1|||
48919289|NCT03016325|157539749|FG007|32-Day Follow-Up Period|Participant withdrew consent|0|||
48919290|NCT03016325|157539742|FG000|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
48919291|NCT03016325|157539743|FG001|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
49010784|NCT00911859|157875698|FG001|Treatment Period|Lack of Efficacy|7|||
49122313|NCT03428100|158286810|FG002|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|7|||
49122314|NCT03428100|158286811|FG003|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|6|||
49122315|NCT03428100|158286812|FG004|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
49122316|NCT03428100|158286813|FG005|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
49122317|NCT03428100|158286814|FG006|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
49122318|NCT03428100|158286815|FG007|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
49122319|NCT03428100|158286816|FG008|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
49122320|NCT03428100|158286817|FG009|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
49122321|NCT03428100|158286818|FG010|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
48811676|NCT01588990|157152042|FG000|Phase A|Death|5|||
48811677|NCT01588990|157152042|FG000|Phase A|Adverse Event|28|||
48811678|NCT01588990|157152042|FG000|Phase A|Still on therapy at end of study|6|||
49122322|NCT03428100|158286819|FG011|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
49122323|NCT03428100|158286820|FG012|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
49122324|NCT03428100|158286821|FG013|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
48811679|NCT01588990|157152042|FG000|Phase B|Adverse Event|2|||
49122325|NCT03428100|158286822|FG014|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
49122326|NCT03428100|158286823|FG015|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
49122327|NCT03428100|158286824|FG016|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
49122328|NCT03428100|158286825|FG017|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
49122329|NCT03428100|158286826|FG018|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
49122330|NCT03428100|158286808|FG000|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
49122331|NCT03428100|158286809|FG001|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
49122332|NCT03428100|158286810|FG002|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
49122333|NCT03428100|158286811|FG003|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
49122334|NCT03428100|158286812|FG004|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
49122335|NCT03428100|158286813|FG005|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
49122336|NCT03428100|158286814|FG006|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
49122337|NCT03428100|158286815|FG007|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
49122338|NCT03428100|158286816|FG008|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
49122339|NCT03428100|158286817|FG009|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
49122340|NCT03428100|158286818|FG010|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
49122341|NCT03428100|158286819|FG011|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
49122342|NCT03428100|158286820|FG012|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
49122343|NCT03428100|158286821|FG013|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
49122344|NCT03428100|158286822|FG014|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
49122345|NCT03428100|158286823|FG015|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
49122346|NCT03428100|158286824|FG016|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
49122347|NCT03428100|158286825|FG017|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
49122348|NCT03428100|158286826|FG018|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
49122349|NCT03428100|158286808|FG000|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|4|||
49122350|NCT03428100|158286809|FG001|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
49122351|NCT03428100|158286810|FG002|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
48811680|NCT01588990|157152042|FG000|Phase B|Still on therapy at end of study|5|||
48811681|NCT01588990|157152042|FG000|Phase B|Withdrawal by Subject|3|||
48811682|NCT01588990|157152042|FG000|Phase B|Physician Decision|4|||
48811683|NCT01588990|157152042|FG000|Phase B|Other|2|||
48919292|NCT03016325|157539744|FG002|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1|||
48919293|NCT03016325|157539745|FG003|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
48919294|NCT03016325|157539746|FG004|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
48919295|NCT03016325|157539747|FG005|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
48919296|NCT03016325|157539748|FG006|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
48919297|NCT03016325|157539749|FG007|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
48919298|NCT03016325|157539742|FG000|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
48919299|NCT03016325|157539743|FG001|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1|||
48919300|NCT03016325|157539744|FG002|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
49122352|NCT03428100|158286811|FG003|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
48811694|NCT00569803|157152047|FG000|Overall Study|Lost to Follow-up|1|||
48811695|NCT00569803|157152048|FG001|Overall Study|Lost to Follow-up|0|||
48811696|NCT00569803|157152049|FG002|Overall Study|Lost to Follow-up|0|||
48811697|NCT00569803|157152050|FG003|Overall Study|Lost to Follow-up|0|||
48811698|NCT00569803|157152051|FG004|Overall Study|Lost to Follow-up|0|||
48811699|NCT00569803|157152052|FG005|Overall Study|Lost to Follow-up|0|||
48811700|NCT00569803|157152053|FG006|Overall Study|Lost to Follow-up|0|||
48811701|NCT00569803|157152054|FG007|Overall Study|Lost to Follow-up|0|||
48811702|NCT00569803|157152047|FG000|Overall Study|injection syringe leaked during dosing|0|||
48811703|NCT00569803|157152048|FG001|Overall Study|injection syringe leaked during dosing|0|||
48811704|NCT00569803|157152049|FG002|Overall Study|injection syringe leaked during dosing|0|||
48811705|NCT00569803|157152050|FG003|Overall Study|injection syringe leaked during dosing|1|||
48811706|NCT00569803|157152051|FG004|Overall Study|injection syringe leaked during dosing|0|||
48811707|NCT00569803|157152052|FG005|Overall Study|injection syringe leaked during dosing|0|||
48811708|NCT00569803|157152053|FG006|Overall Study|injection syringe leaked during dosing|0|||
48811709|NCT00569803|157152054|FG007|Overall Study|injection syringe leaked during dosing|0|||
48811710|NCT00569803|157152047|FG000|Overall Study|Withdrawal by Subject|0|||
49122353|NCT03428100|158286812|FG004|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
48811711|NCT00569803|157152048|FG001|Overall Study|Withdrawal by Subject|0|||
48811712|NCT00569803|157152049|FG002|Overall Study|Withdrawal by Subject|0|||
48811713|NCT00569803|157152050|FG003|Overall Study|Withdrawal by Subject|0|||
48811714|NCT00569803|157152051|FG004|Overall Study|Withdrawal by Subject|0|||
48811715|NCT00569803|157152052|FG005|Overall Study|Withdrawal by Subject|0|||
48811716|NCT00569803|157152053|FG006|Overall Study|Withdrawal by Subject|0|||
48811717|NCT00569803|157152054|FG007|Overall Study|Withdrawal by Subject|1|||
49122354|NCT03428100|158286813|FG005|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
49122355|NCT03428100|158286814|FG006|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
49122356|NCT03428100|158286815|FG007|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
49122357|NCT03428100|158286816|FG008|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
49122358|NCT03428100|158286817|FG009|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
49122359|NCT03428100|158286818|FG010|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
49122360|NCT03428100|158286819|FG011|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
49122361|NCT03428100|158286820|FG012|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
49122362|NCT03428100|158286821|FG013|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
49122363|NCT03428100|158286822|FG014|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
49122364|NCT03428100|158286823|FG015|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
49122365|NCT03428100|158286824|FG016|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
49122366|NCT03428100|158286825|FG017|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
49122367|NCT03428100|158286826|FG018|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
49122368|NCT03428100|158286808|FG000|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
49122369|NCT03428100|158286809|FG001|Double-Blind Treatment Week 0 to Week 52|Physician Decision|1|||
49122370|NCT03428100|158286810|FG002|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
49122371|NCT03428100|158286811|FG003|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
49122372|NCT03428100|158286812|FG004|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
49122373|NCT03428100|158286813|FG005|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
49122374|NCT03428100|158286814|FG006|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
49122375|NCT03428100|158286815|FG007|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
49122376|NCT03428100|158286816|FG008|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
49122377|NCT03428100|158286817|FG009|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
49122378|NCT03428100|158286818|FG010|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
49122379|NCT03428100|158286819|FG011|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
49122380|NCT03428100|158286820|FG012|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
49122381|NCT03428100|158286821|FG013|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
49122382|NCT03428100|158286822|FG014|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
49122383|NCT03428100|158286823|FG015|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
48712837|NCT04556383|156799437|FG003|PCP|Physician Decision|0|||
48712838|NCT04556383|156799434|FG000|PCP|Site terminated by sponsor|0|||
49122384|NCT03428100|158286824|FG016|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
49122385|NCT03428100|158286825|FG017|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
49122386|NCT03428100|158286826|FG018|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
49122387|NCT03428100|158286808|FG000|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
49122388|NCT03428100|158286809|FG001|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
49122389|NCT03428100|158286810|FG002|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
49122390|NCT03428100|158286811|FG003|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
49122391|NCT03428100|158286812|FG004|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
49122392|NCT03428100|158286813|FG005|Long-Term Extension Week 52 to Week 200|Adverse Event|4|||
49122393|NCT03428100|158286814|FG006|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
49122394|NCT03428100|158286815|FG007|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
49122395|NCT03428100|158286816|FG008|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
49122396|NCT03428100|158286817|FG009|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
49122397|NCT03428100|158286818|FG010|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
49122398|NCT03428100|158286819|FG011|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
49122399|NCT03428100|158286820|FG012|Long-Term Extension Week 52 to Week 200|Adverse Event|3|||
49122400|NCT03428100|158286821|FG013|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
49122401|NCT03428100|158286822|FG014|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
49122402|NCT03428100|158286823|FG015|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
49122403|NCT03428100|158286824|FG016|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
49122404|NCT03428100|158286825|FG017|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
49122405|NCT03428100|158286826|FG018|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
49122406|NCT03428100|158286808|FG000|Long-Term Extension Week 52 to Week 200|Death|0|||
49122407|NCT03428100|158286809|FG001|Long-Term Extension Week 52 to Week 200|Death|0|||
49122408|NCT03428100|158286810|FG002|Long-Term Extension Week 52 to Week 200|Death|0|||
48712839|NCT04556383|156799435|FG001|PCP|Site terminated by sponsor|1|||
48712840|NCT04556383|156799436|FG002|PCP|Site terminated by sponsor|0|||
48712841|NCT04556383|156799437|FG003|PCP|Site terminated by sponsor|0|||
48712842|NCT04556383|156799434|FG000|OLE|Study terminated by sponsor|0|||
48712843|NCT04556383|156799435|FG001|OLE|Study terminated by sponsor|0|||
48712844|NCT04556383|156799436|FG002|OLE|Study terminated by sponsor|0|||
48712845|NCT04556383|156799437|FG003|OLE|Study terminated by sponsor|68|||
48712846|NCT04556383|156799434|FG000|OLE|Withdrawal by Subject|0|||
49122409|NCT03428100|158286811|FG003|Long-Term Extension Week 52 to Week 200|Death|0|||
49122410|NCT03428100|158286812|FG004|Long-Term Extension Week 52 to Week 200|Death|0|||
49122411|NCT03428100|158286813|FG005|Long-Term Extension Week 52 to Week 200|Death|0|||
49122412|NCT03428100|158286814|FG006|Long-Term Extension Week 52 to Week 200|Death|0|||
49122413|NCT03428100|158286815|FG007|Long-Term Extension Week 52 to Week 200|Death|1|||
49122414|NCT03428100|158286816|FG008|Long-Term Extension Week 52 to Week 200|Death|0|||
49122415|NCT03428100|158286817|FG009|Long-Term Extension Week 52 to Week 200|Death|0|||
49122416|NCT03428100|158286818|FG010|Long-Term Extension Week 52 to Week 200|Death|0|||
49122417|NCT03428100|158286819|FG011|Long-Term Extension Week 52 to Week 200|Death|0|||
49122418|NCT03428100|158286820|FG012|Long-Term Extension Week 52 to Week 200|Death|0|||
49122419|NCT03428100|158286821|FG013|Long-Term Extension Week 52 to Week 200|Death|0|||
49122420|NCT03428100|158286822|FG014|Long-Term Extension Week 52 to Week 200|Death|0|||
49122421|NCT03428100|158286823|FG015|Long-Term Extension Week 52 to Week 200|Death|0|||
49122422|NCT03428100|158286824|FG016|Long-Term Extension Week 52 to Week 200|Death|0|||
49122423|NCT03428100|158286825|FG017|Long-Term Extension Week 52 to Week 200|Death|0|||
49122424|NCT03428100|158286826|FG018|Long-Term Extension Week 52 to Week 200|Death|0|||
49122425|NCT03428100|158286808|FG000|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
49122426|NCT03428100|158286809|FG001|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
49122427|NCT03428100|158286810|FG002|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
49122428|NCT03428100|158286811|FG003|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
49122429|NCT03428100|158286812|FG004|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
49122430|NCT03428100|158286813|FG005|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
49122431|NCT03428100|158286814|FG006|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
49122432|NCT03428100|158286815|FG007|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
49122433|NCT03428100|158286816|FG008|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
49122434|NCT03428100|158286817|FG009|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
49122435|NCT03428100|158286818|FG010|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
49122436|NCT03428100|158286819|FG011|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
49122437|NCT03428100|158286820|FG012|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
49122438|NCT03428100|158286821|FG013|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
49122439|NCT03428100|158286822|FG014|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|6|||
49122440|NCT03428100|158286823|FG015|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
49122441|NCT03428100|158286824|FG016|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
49122442|NCT03428100|158286825|FG017|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
49122443|NCT03428100|158286826|FG018|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|1|||
49122444|NCT03428100|158286808|FG000|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
49122445|NCT03428100|158286809|FG001|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
49122446|NCT03428100|158286810|FG002|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
49122447|NCT03428100|158286811|FG003|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
49122448|NCT03428100|158286812|FG004|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
49122449|NCT03428100|158286813|FG005|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
49122450|NCT03428100|158286814|FG006|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
49122451|NCT03428100|158286815|FG007|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
49122452|NCT03428100|158286816|FG008|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
49122453|NCT03428100|158286817|FG009|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
48712847|NCT04556383|156799435|FG001|OLE|Withdrawal by Subject|0|||
48712848|NCT04556383|156799436|FG002|OLE|Withdrawal by Subject|0|||
49122454|NCT03428100|158286818|FG010|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
49122455|NCT03428100|158286819|FG011|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
49122456|NCT03428100|158286820|FG012|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
49122457|NCT03428100|158286821|FG013|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
49122458|NCT03428100|158286822|FG014|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
49122459|NCT03428100|158286823|FG015|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
49122460|NCT03428100|158286824|FG016|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
49122461|NCT03428100|158286825|FG017|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
49122462|NCT03428100|158286826|FG018|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
49122463|NCT03428100|158286808|FG000|Long-Term Extension Week 52 to Week 200|Other|0|||
49122464|NCT03428100|158286809|FG001|Long-Term Extension Week 52 to Week 200|Other|0|||
49122465|NCT03428100|158286810|FG002|Long-Term Extension Week 52 to Week 200|Other|0|||
49122466|NCT03428100|158286811|FG003|Long-Term Extension Week 52 to Week 200|Other|0|||
49122467|NCT03428100|158286812|FG004|Long-Term Extension Week 52 to Week 200|Other|0|||
49122468|NCT03428100|158286813|FG005|Long-Term Extension Week 52 to Week 200|Other|0|||
49122469|NCT03428100|158286814|FG006|Long-Term Extension Week 52 to Week 200|Other|2|||
49122470|NCT03428100|158286815|FG007|Long-Term Extension Week 52 to Week 200|Other|0|||
49122471|NCT03428100|158286816|FG008|Long-Term Extension Week 52 to Week 200|Other|0|||
49122472|NCT03428100|158286817|FG009|Long-Term Extension Week 52 to Week 200|Other|0|||
49122473|NCT03428100|158286818|FG010|Long-Term Extension Week 52 to Week 200|Other|0|||
49122474|NCT03428100|158286819|FG011|Long-Term Extension Week 52 to Week 200|Other|1|||
49122475|NCT03428100|158286820|FG012|Long-Term Extension Week 52 to Week 200|Other|0|||
49122476|NCT03428100|158286821|FG013|Long-Term Extension Week 52 to Week 200|Other|0|||
49122477|NCT03428100|158286822|FG014|Long-Term Extension Week 52 to Week 200|Other|0|||
49122478|NCT03428100|158286823|FG015|Long-Term Extension Week 52 to Week 200|Other|0|||
49122479|NCT03428100|158286824|FG016|Long-Term Extension Week 52 to Week 200|Other|0|||
49122480|NCT03428100|158286825|FG017|Long-Term Extension Week 52 to Week 200|Other|2|||
49122481|NCT03428100|158286826|FG018|Long-Term Extension Week 52 to Week 200|Other|1|||
49122482|NCT03428100|158286808|FG000|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
49122483|NCT03428100|158286809|FG001|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
49122484|NCT03428100|158286810|FG002|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
49122485|NCT03428100|158286811|FG003|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
49122486|NCT03428100|158286812|FG004|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
49122487|NCT03428100|158286813|FG005|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
49122488|NCT03428100|158286814|FG006|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
48712849|NCT04556383|156799437|FG003|OLE|Withdrawal by Subject|10|||
48712850|NCT04556383|156799434|FG000|OLE|Lack of Efficacy|0|||
48712851|NCT04556383|156799435|FG001|OLE|Lack of Efficacy|0|||
48712852|NCT04556383|156799436|FG002|OLE|Lack of Efficacy|0|||
48712853|NCT04556383|156799437|FG003|OLE|Lack of Efficacy|7|||
48712854|NCT04556383|156799434|FG000|OLE|Adverse Event|0|||
48712855|NCT04556383|156799435|FG001|OLE|Adverse Event|0|||
48712856|NCT04556383|156799436|FG002|OLE|Adverse Event|0|||
48712857|NCT04556383|156799437|FG003|OLE|Adverse Event|2|||
48712858|NCT04556383|156799434|FG000|OLE|Other, Not Specified|0|||
48712859|NCT04556383|156799435|FG001|OLE|Other, Not Specified|0|||
48712860|NCT04556383|156799436|FG002|OLE|Other, Not Specified|0|||
48712861|NCT04556383|156799437|FG003|OLE|Other, Not Specified|2|||
48712862|NCT04556383|156799434|FG000|OLE|Death|0|||
48712863|NCT04556383|156799435|FG001|OLE|Death|0|||
48712864|NCT04556383|156799436|FG002|OLE|Death|0|||
48712865|NCT04556383|156799437|FG003|OLE|Death|1|||
48712866|NCT04556383|156799434|FG000|OLE|Lost to Follow-up|0|||
48712867|NCT04556383|156799435|FG001|OLE|Lost to Follow-up|0|||
48712868|NCT04556383|156799436|FG002|OLE|Lost to Follow-up|0|||
48712869|NCT04556383|156799437|FG003|OLE|Lost to Follow-up|1|||
48712870|NCT01387542|156799438|FG000|Overall Study|Adverse Event|3|||
48712871|NCT01387542|156799438|FG000|Overall Study|Withdrawal by Subject|1|||
48919301|NCT03016325|157539745|FG003|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
48919302|NCT03016325|157539746|FG004|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
48919303|NCT03016325|157539747|FG005|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
48919304|NCT03016325|157539748|FG006|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
48919305|NCT03016325|157539749|FG007|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
48919306|NCT03016325|157539742|FG000|182-Day Follow-Up Period|Death|3|||
48919307|NCT03016325|157539743|FG001|182-Day Follow-Up Period|Death|3|||
48919308|NCT03016325|157539744|FG002|182-Day Follow-Up Period|Death|11|||
48919309|NCT03016325|157539745|FG003|182-Day Follow-Up Period|Death|12|||
48919310|NCT03016325|157539746|FG004|182-Day Follow-Up Period|Death|9|||
48919311|NCT03016325|157539747|FG005|182-Day Follow-Up Period|Death|0|||
49122489|NCT03428100|158286815|FG007|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
49122490|NCT03428100|158286816|FG008|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
49122491|NCT03428100|158286817|FG009|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
49122492|NCT03428100|158286818|FG010|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
49122493|NCT03428100|158286819|FG011|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
48919312|NCT03016325|157539748|FG006|182-Day Follow-Up Period|Death|0|||
48919313|NCT03016325|157539749|FG007|182-Day Follow-Up Period|Death|1|||
48919314|NCT03016325|157539742|FG000|182-Day Follow-Up Period|Alive, per national insurance system|1|||
48919315|NCT03016325|157539743|FG001|182-Day Follow-Up Period|Alive, per national insurance system|0|||
48919316|NCT03016325|157539744|FG002|182-Day Follow-Up Period|Alive, per national insurance system|0|||
48919317|NCT03016325|157539745|FG003|182-Day Follow-Up Period|Alive, per national insurance system|0|||
48919318|NCT03016325|157539746|FG004|182-Day Follow-Up Period|Alive, per national insurance system|0|||
48919319|NCT03016325|157539747|FG005|182-Day Follow-Up Period|Alive, per national insurance system|0|||
48919320|NCT03016325|157539748|FG006|182-Day Follow-Up Period|Alive, per national insurance system|0|||
48919321|NCT03016325|157539749|FG007|182-Day Follow-Up Period|Alive, per national insurance system|0|||
48919322|NCT03016325|157539742|FG000|182-Day Follow-Up Period|Participant withdrew consent|0|||
48919323|NCT03016325|157539743|FG001|182-Day Follow-Up Period|Participant withdrew consent|0|||
48919324|NCT03016325|157539744|FG002|182-Day Follow-Up Period|Participant withdrew consent|0|||
48919325|NCT03016325|157539745|FG003|182-Day Follow-Up Period|Participant withdrew consent|0|||
48919326|NCT03016325|157539746|FG004|182-Day Follow-Up Period|Participant withdrew consent|1|||
48919327|NCT03016325|157539747|FG005|182-Day Follow-Up Period|Participant withdrew consent|0|||
48919328|NCT03016325|157539748|FG006|182-Day Follow-Up Period|Participant withdrew consent|1|||
48919329|NCT03016325|157539749|FG007|182-Day Follow-Up Period|Participant withdrew consent|0|||
48919330|NCT03016325|157539742|FG000|182-Day Follow-Up Period|Alive, per Family doctor|0|||
48919331|NCT03016325|157539743|FG001|182-Day Follow-Up Period|Alive, per Family doctor|0|||
48919332|NCT03016325|157539744|FG002|182-Day Follow-Up Period|Alive, per Family doctor|0|||
48919333|NCT03016325|157539745|FG003|182-Day Follow-Up Period|Alive, per Family doctor|0|||
49122494|NCT03428100|158286820|FG012|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
49122495|NCT03428100|158286821|FG013|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
49122496|NCT03428100|158286822|FG014|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
49122497|NCT03428100|158286823|FG015|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
49122498|NCT03428100|158286824|FG016|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
49122499|NCT03428100|158286825|FG017|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
49122500|NCT03428100|158286826|FG018|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
49122501|NCT03428100|158286808|FG000|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
49122502|NCT03428100|158286809|FG001|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
49122503|NCT03428100|158286810|FG002|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
49122504|NCT03428100|158286811|FG003|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
49122505|NCT03428100|158286812|FG004|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|10|||
49122506|NCT03428100|158286813|FG005|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|4|||
49122507|NCT03428100|158286814|FG006|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
49122508|NCT03428100|158286815|FG007|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
49122509|NCT03428100|158286816|FG008|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
49122510|NCT03428100|158286817|FG009|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
49122511|NCT03428100|158286818|FG010|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
49122512|NCT03428100|158286819|FG011|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
49122513|NCT03428100|158286820|FG012|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
49122514|NCT03428100|158286821|FG013|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|6|||
49122515|NCT03428100|158286822|FG014|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|12|||
49122516|NCT03428100|158286823|FG015|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|5|||
49122517|NCT03428100|158286824|FG016|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
49122518|NCT03428100|158286825|FG017|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|1|||
48712872|NCT01387542|156799438|FG000|Overall Study|Changed diagnosis|1|||
48712873|NCT01387542|156799438|FG000|Overall Study|Insufficient response|1|||
48712874|NCT01387542|156799438|FG000|Overall Study|Non-compliant|1|||
48712875|NCT01387542|156799438|FG000|Overall Study|Lost to Follow-up|1|||
48712876|NCT02720042|156799439|FG000|Overall Study|Death|3|||
48712877|NCT02720042|156799439|FG000|Overall Study|Lost to Follow-up|4|||
48712878|NCT02720042|156799439|FG000|Overall Study|Withdrawal by Subject|1|||
48712879|NCT02720042|156799439|FG000|Overall Study|Physician Decision|3|||
48712880|NCT02720042|156799439|FG000|Overall Study|Phasix Mesh explanted|1|||
48712881|NCT02720042|156799439|FG000|Overall Study|unable due to non-study-related illness|3|||
48712882|NCT01994889|156799440|FG000|Overall Study|Adverse Event|5|||
48712883|NCT01994889|156799441|FG001|Overall Study|Adverse Event|12|||
48712884|NCT01994889|156799442|FG002|Overall Study|Adverse Event|11|||
48712885|NCT01994889|156799440|FG000|Overall Study|Cardiac Device Implantation|0|||
48712886|NCT01994889|156799441|FG001|Overall Study|Cardiac Device Implantation|2|||
48712887|NCT01994889|156799442|FG002|Overall Study|Cardiac Device Implantation|0|||
48712888|NCT01994889|156799440|FG000|Overall Study|Organ Transplantation|1|||
48712889|NCT01994889|156799441|FG001|Overall Study|Organ Transplantation|5|||
48712890|NCT01994889|156799442|FG002|Overall Study|Organ Transplantation|5|||
48712891|NCT01994889|156799440|FG000|Overall Study|No longer willing to participate|8|||
48712892|NCT01994889|156799441|FG001|Overall Study|No longer willing to participate|17|||
48712893|NCT01994889|156799442|FG002|Overall Study|No longer willing to participate|37|||
48712894|NCT01994889|156799440|FG000|Overall Study|Lost to Follow-up|0|||
48712895|NCT01994889|156799441|FG001|Overall Study|Lost to Follow-up|1|||
48712896|NCT01994889|156799442|FG002|Overall Study|Lost to Follow-up|0|||
48712897|NCT01994889|156799440|FG000|Overall Study|Protocol Violation|0|||
48712898|NCT01994889|156799441|FG001|Overall Study|Protocol Violation|1|||
48712899|NCT01994889|156799442|FG002|Overall Study|Protocol Violation|1|||
48712900|NCT01994889|156799440|FG000|Overall Study|Death|14|||
48712901|NCT01994889|156799441|FG001|Overall Study|Death|25|||
48712902|NCT01994889|156799442|FG002|Overall Study|Death|38|||
48712903|NCT00335764|156799443|FG000|Overall Study|wrong histology|1|||
48712904|NCT00335764|156799444|FG001|Overall Study|wrong histology|0|||
48712905|NCT00335764|156799445|FG002|Overall Study|wrong histology|0|||
48712906|NCT00335764|156799446|FG003|Overall Study|wrong histology|0|||
48712907|NCT00335764|156799447|FG004|Overall Study|wrong histology|1|||
48712908|NCT01388985|156799452|FG000|Overall Study|Death|0|||
48712909|NCT01388985|156799453|FG001|Overall Study|Death|1|||
48712910|NCT01388985|156799452|FG000|Overall Study|Lost to Follow-up|30|||
48712911|NCT01388985|156799453|FG001|Overall Study|Lost to Follow-up|30|||
48712912|NCT01388985|156799452|FG000|Overall Study|Withdrawal by Subject|13|||
48712913|NCT01388985|156799453|FG001|Overall Study|Withdrawal by Subject|4|||
48712914|NCT01388985|156799452|FG000|Overall Study|Subject unavailable|1|||
48712915|NCT01388985|156799453|FG001|Overall Study|Subject unavailable|1|||
48712916|NCT01388985|156799452|FG000|Overall Study|Other (no reason)|0|||
48712917|NCT01388985|156799453|FG001|Overall Study|Other (no reason)|1|||
48712918|NCT01388985|156799452|FG000|Overall Study|Error of nurse|5|||
48712919|NCT01388985|156799453|FG001|Overall Study|Error of nurse|1|||
48712920|NCT03158285|156799454|FG000|Placebo-controlled Period: Week 0 - 24|Adverse Event|4|||
48712921|NCT03158285|156799455|FG001|Placebo-controlled Period: Week 0 - 24|Adverse Event|2|||
48712922|NCT03158285|156799456|FG002|Placebo-controlled Period: Week 0 - 24|Adverse Event|6|||
48712923|NCT03158285|156799454|FG000|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0|||
48712924|NCT03158285|156799455|FG001|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
48712925|NCT03158285|156799456|FG002|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
49122519|NCT03428100|158286826|FG018|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
49122520|NCT03428100|158286808|FG000|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
48712926|NCT03158285|156799454|FG000|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
48712927|NCT03158285|156799455|FG001|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
48712928|NCT03158285|156799456|FG002|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
48712929|NCT03158285|156799454|FG000|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
49122521|NCT03428100|158286809|FG001|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
49122522|NCT03428100|158286810|FG002|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
49122523|NCT03428100|158286811|FG003|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
49122524|NCT03428100|158286812|FG004|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
49122525|NCT03428100|158286813|FG005|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
49122526|NCT03428100|158286814|FG006|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
49122527|NCT03428100|158286815|FG007|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
49122528|NCT03428100|158286816|FG008|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
49122529|NCT03428100|158286817|FG009|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|6|||
48712930|NCT03158285|156799455|FG001|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1|||
48712931|NCT03158285|156799456|FG002|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
48712932|NCT03158285|156799454|FG000|Placebo-controlled Period: Week 0 - 24|Other|1|||
48712933|NCT03158285|156799455|FG001|Placebo-controlled Period: Week 0 - 24|Other|1|||
49122530|NCT03428100|158286818|FG010|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|13|||
49122531|NCT03428100|158286819|FG011|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
49122532|NCT03428100|158286820|FG012|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
49122533|NCT03428100|158286821|FG013|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
49122534|NCT03428100|158286822|FG014|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|1|||
49122535|NCT03428100|158286823|FG015|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
49122536|NCT03428100|158286824|FG016|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|4|||
49122537|NCT03428100|158286825|FG017|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
49122538|NCT03428100|158286826|FG018|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
49122539|NCT02849743|158286827|FG000|First Intervention (8 Weeks)|Stopping Criteria Met|0|||
49122540|NCT02849743|158286828|FG001|First Intervention (8 Weeks)|Stopping Criteria Met|1|||
49122541|NCT02849743|158286827|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
49122542|NCT02849743|158286828|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
49122543|NCT01656395|158286829|FG000|Overall Study|Adverse Event|1|||
49122544|NCT01656395|158286830|FG001|Overall Study|Adverse Event|14|||
49122545|NCT01656395|158286831|FG002|Overall Study|Adverse Event|5|||
49122546|NCT01656395|158286832|FG003|Overall Study|Adverse Event|4|||
49122547|NCT01656395|158286833|FG004|Overall Study|Adverse Event|5|||
49122548|NCT01656395|158286834|FG005|Overall Study|Adverse Event|7|||
49122549|NCT01656395|158286835|FG006|Overall Study|Adverse Event|0|||
49122550|NCT01656395|158286836|FG007|Overall Study|Adverse Event|0|||
48712934|NCT03158285|156799456|FG002|Placebo-controlled Period: Week 0 - 24|Other|0|||
48712935|NCT03158285|156799454|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
48712936|NCT03158285|156799455|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
48712937|NCT03158285|156799456|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|1|||
48712938|NCT03158285|156799454|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5|||
48712939|NCT03158285|156799455|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
48712940|NCT03158285|156799456|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
48712941|NCT03158285|156799454|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
48712942|NCT03158285|156799455|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
48712943|NCT03158285|156799456|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
48712944|NCT03158285|156799454|FG000|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
48712945|NCT03158285|156799455|FG001|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
48712946|NCT03158285|156799456|FG002|Active Treatment Period: Week 24 - 52|Pregnancy|1|||
48712947|NCT03158285|156799454|FG000|Active Treatment Period: Week 24 - 52|Other|1|||
48712948|NCT03158285|156799455|FG001|Active Treatment Period: Week 24 - 52|Other|1|||
48712949|NCT03158285|156799456|FG002|Active Treatment Period: Week 24 - 52|Other|0|||
48712950|NCT03158285|156799454|FG000|Active Treatment Period: Week 52-100|Adverse Event|7|||
48712951|NCT03158285|156799455|FG001|Active Treatment Period: Week 52-100|Adverse Event|5|||
48712952|NCT03158285|156799456|FG002|Active Treatment Period: Week 52-100|Adverse Event|3|||
48712953|NCT03158285|156799454|FG000|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
48712954|NCT03158285|156799455|FG001|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
48712955|NCT03158285|156799456|FG002|Active Treatment Period: Week 52-100|Lack of Efficacy|3|||
48712956|NCT03158285|156799454|FG000|Active Treatment Period: Week 52-100|Withdrawal by Subject|5|||
48712957|NCT03158285|156799455|FG001|Active Treatment Period: Week 52-100|Withdrawal by Subject|2|||
48712958|NCT03158285|156799456|FG002|Active Treatment Period: Week 52-100|Withdrawal by Subject|1|||
48712959|NCT03158285|156799454|FG000|Active Treatment Period: Week 52-100|Pregnancy|0|||
48712960|NCT03158285|156799455|FG001|Active Treatment Period: Week 52-100|Pregnancy|0|||
48712961|NCT03158285|156799456|FG002|Active Treatment Period: Week 52-100|Pregnancy|1|||
48712962|NCT03158285|156799454|FG000|Active Treatment Period: Week 52-100|Death|1|||
48712963|NCT03158285|156799455|FG001|Active Treatment Period: Week 52-100|Death|0|||
48712964|NCT03158285|156799456|FG002|Active Treatment Period: Week 52-100|Death|0|||
48712965|NCT03158285|156799454|FG000|Active Treatment Period: Week 52-100|Other|4|||
48712966|NCT03158285|156799455|FG001|Active Treatment Period: Week 52-100|Other|1|||
48712967|NCT03158285|156799456|FG002|Active Treatment Period: Week 52-100|Other|0|||
49122551|NCT01656395|158286829|FG000|Overall Study|Lack of Efficacy|1|||
49122552|NCT01656395|158286830|FG001|Overall Study|Lack of Efficacy|8|||
48712968|NCT00402740|156799461|FG000|Overall Study|Withdrawal by Subject|18|||
48712969|NCT00402740|156799461|FG000|Overall Study|Death|50|||
48712970|NCT00402740|156799461|FG000|Overall Study|Lost to Follow-up|6|||
48712971|NCT00402740|156799461|FG000|Overall Study|No stent. Completed FU at 30 days.|5|||
48712972|NCT00402740|156799461|FG000|Overall Study|Subject disposition unknown.|1|||
48712973|NCT01700387|156799465|FG000|Overall Study|Withdrawal by Subject|1|||
48712974|NCT01700387|156799466|FG001|Overall Study|Withdrawal by Subject|2|||
48712975|NCT01700387|156799465|FG000|Overall Study|Adverse Event|1|||
48712976|NCT01700387|156799466|FG001|Overall Study|Adverse Event|1|||
48712977|NCT01700387|156799465|FG000|Overall Study|Lost to Follow-up|2|||
48712978|NCT01700387|156799466|FG001|Overall Study|Lost to Follow-up|1|||
48712979|NCT02034409|156799467|FG000|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4|||
48712980|NCT02034409|156799468|FG001|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0|||
48712981|NCT02034409|156799467|FG000|Sham-Controlled Treatment Period|Adverse Event|1|||
48712982|NCT02034409|156799468|FG001|Sham-Controlled Treatment Period|Adverse Event|1|||
48712983|NCT02034409|156799467|FG000|Sham-Controlled Treatment Period|Lost to Follow-up|0|||
48712984|NCT02034409|156799468|FG001|Sham-Controlled Treatment Period|Lost to Follow-up|1|||
48712985|NCT02034409|156799467|FG000|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
48712986|NCT02034409|156799468|FG001|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
48712987|NCT02034409|156799467|FG000|Sham-Controlled Treatment Period|Physician Decision|1|||
48712988|NCT02034409|156799468|FG001|Sham-Controlled Treatment Period|Physician Decision|3|||
48712989|NCT02034409|156799467|FG000|Sham-Controlled Treatment Period|misrandomized|2|||
48712990|NCT02034409|156799468|FG001|Sham-Controlled Treatment Period|misrandomized|2|||
48712991|NCT01306929|156799469|FG000|Overall Study|Withdrawal by Subject|23|||
48712992|NCT01306929|156799469|FG000|Overall Study|Adverse Event|21|||
48712993|NCT01306929|156799469|FG000|Overall Study|Physician Decision|13|||
48712994|NCT01306929|156799469|FG000|Overall Study|Death|8|||
48712995|NCT01306929|156799469|FG000|Overall Study|Withdrawal by parent/guardian|5|||
48712996|NCT01306929|156799469|FG000|Overall Study|Protocol Violation|3|||
48712997|NCT01306929|156799469|FG000|Overall Study|Non-compliance with study drug|2|||
48712998|NCT01306929|156799469|FG000|Overall Study|Lost to Follow-up|2|||
48712999|NCT01306929|156799469|FG000|Overall Study|Various|17|||
48713000|NCT01870076|156799470|FG000|Overall Study|Withdrawal by Subject|1|||
48713001|NCT01870076|156799471|FG001|Overall Study|Withdrawal by Subject|0|||
48713002|NCT01870076|156799472|FG002|Overall Study|Withdrawal by Subject|1|||
48713003|NCT01870076|156799473|FG003|Overall Study|Withdrawal by Subject|0|||
48713004|NCT04463069|156799475|FG000|Overall Study|Withdrawal by Subject|2|||
48713005|NCT04463069|156799476|FG001|Overall Study|Withdrawal by Subject|10|||
48713006|NCT04463069|156799475|FG000|Overall Study|Participants' parents refused to participate after learning the assignment results|0|||
48713007|NCT04463069|156799476|FG001|Overall Study|Participants' parents refused to participate after learning the assignment results|13|||
48713008|NCT00831493|156799477|FG000|Overall Study|Intractable nausea and vomiting|1|||
48713009|NCT00534599|156799478|FG000|Overall Study|Adverse Event|25|||
48713010|NCT00534599|156799479|FG001|Overall Study|Adverse Event|4|||
48713011|NCT00534599|156799478|FG000|Overall Study|Incorrect enrollment|2|||
48713012|NCT00534599|156799479|FG001|Overall Study|Incorrect enrollment|1|||
48713013|NCT00534599|156799478|FG000|Overall Study|Mis-randomization|2|||
48713014|NCT00534599|156799479|FG001|Overall Study|Mis-randomization|2|||
48713015|NCT00534599|156799478|FG000|Overall Study|Developed study-specific d/c criteria|5|||
48713016|NCT00534599|156799479|FG001|Overall Study|Developed study-specific d/c criteria|0|||
48713017|NCT00534599|156799478|FG000|Overall Study|Lack of Efficacy|0|||
48713018|NCT00534599|156799479|FG001|Overall Study|Lack of Efficacy|1|||
48713019|NCT00534599|156799478|FG000|Overall Study|Generalized anxiety disorder worsened|0|||
48713020|NCT00534599|156799479|FG001|Overall Study|Generalized anxiety disorder worsened|1|||
48713021|NCT00534599|156799478|FG000|Overall Study|Protocol Violation|1|||
48713022|NCT00534599|156799479|FG001|Overall Study|Protocol Violation|3|||
48713023|NCT00534599|156799478|FG000|Overall Study|Lost to Follow-up|11|||
48713024|NCT00534599|156799479|FG001|Overall Study|Lost to Follow-up|14|||
49010785|NCT00911859|157875699|FG002|Treatment Period|Lack of Efficacy|5|||
49010786|NCT00911859|157875697|FG000|Treatment Period|Physician Decision|3|||
49010787|NCT00911859|157875698|FG001|Treatment Period|Physician Decision|3|||
49010788|NCT00911859|157875699|FG002|Treatment Period|Physician Decision|3|||
49010789|NCT00911859|157875697|FG000|Treatment Period|Withdrawal by Subject|0|||
49010790|NCT00911859|157875698|FG001|Treatment Period|Withdrawal by Subject|4|||
49010791|NCT00911859|157875699|FG002|Treatment Period|Withdrawal by Subject|5|||
49010792|NCT00911859|157875697|FG000|Treatment Period|Did not receive study treatment|0|||
49010793|NCT00911859|157875698|FG001|Treatment Period|Did not receive study treatment|1|||
49010794|NCT00911859|157875699|FG002|Treatment Period|Did not receive study treatment|0|||
49010795|NCT00911859|157875697|FG000|Maintainance Period|Lack of Efficacy|0|||
49010796|NCT00911859|157875698|FG001|Maintainance Period|Lack of Efficacy|0|||
49010797|NCT00911859|157875699|FG002|Maintainance Period|Lack of Efficacy|9|||
49010798|NCT00911859|157875697|FG000|Maintainance Period|Physician Decision|0|||
49010799|NCT00911859|157875698|FG001|Maintainance Period|Physician Decision|0|||
49010800|NCT00911859|157875699|FG002|Maintainance Period|Physician Decision|9|||
48919334|NCT03016325|157539746|FG004|182-Day Follow-Up Period|Alive, per Family doctor|1|||
48919335|NCT03016325|157539747|FG005|182-Day Follow-Up Period|Alive, per Family doctor|0|||
48919336|NCT03016325|157539748|FG006|182-Day Follow-Up Period|Alive, per Family doctor|0|||
48919337|NCT03016325|157539749|FG007|182-Day Follow-Up Period|Alive, per Family doctor|0|||
48919338|NCT03016325|157539742|FG000|182-Day Follow-Up Period|Alive, per civil unit|0|||
48919339|NCT03016325|157539743|FG001|182-Day Follow-Up Period|Alive, per civil unit|0|||
48919340|NCT03016325|157539744|FG002|182-Day Follow-Up Period|Alive, per civil unit|0|||
48919341|NCT03016325|157539745|FG003|182-Day Follow-Up Period|Alive, per civil unit|0|||
48919342|NCT03016325|157539746|FG004|182-Day Follow-Up Period|Alive, per civil unit|1|||
48919343|NCT03016325|157539747|FG005|182-Day Follow-Up Period|Alive, per civil unit|0|||
48919344|NCT03016325|157539748|FG006|182-Day Follow-Up Period|Alive, per civil unit|0|||
48919345|NCT03016325|157539749|FG007|182-Day Follow-Up Period|Alive, per civil unit|0|||
48919346|NCT03016325|157539742|FG000|182-Day Follow-Up Period|Vital status collected via EMR|0|||
48919347|NCT03016325|157539743|FG001|182-Day Follow-Up Period|Vital status collected via EMR|0|||
48919348|NCT03016325|157539744|FG002|182-Day Follow-Up Period|Vital status collected via EMR|0|||
48919349|NCT03016325|157539745|FG003|182-Day Follow-Up Period|Vital status collected via EMR|1|||
48919350|NCT03016325|157539746|FG004|182-Day Follow-Up Period|Vital status collected via EMR|0|||
48919351|NCT03016325|157539747|FG005|182-Day Follow-Up Period|Vital status collected via EMR|0|||
48919352|NCT03016325|157539748|FG006|182-Day Follow-Up Period|Vital status collected via EMR|0|||
48919353|NCT03016325|157539749|FG007|182-Day Follow-Up Period|Vital status collected via EMR|0|||
48919354|NCT03016325|157539742|FG000|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
48919355|NCT03016325|157539743|FG001|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1|||
48919356|NCT03016325|157539744|FG002|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
48919357|NCT03016325|157539745|FG003|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
48919358|NCT03016325|157539746|FG004|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
48919359|NCT03016325|157539747|FG005|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
48919360|NCT03016325|157539748|FG006|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
48919361|NCT03016325|157539749|FG007|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
48919362|NCT03016325|157539742|FG000|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
48919363|NCT03016325|157539743|FG001|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
48919364|NCT03016325|157539744|FG002|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
48919365|NCT03016325|157539745|FG003|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
48919366|NCT03016325|157539746|FG004|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
48919367|NCT03016325|157539747|FG005|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5|||
48919368|NCT03016325|157539748|FG006|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3|||
48919369|NCT03016325|157539749|FG007|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4|||
48919370|NCT03681119|157539750|FG000|Overall Study|No specific reason|4|||
48919371|NCT03681119|157539751|FG001|Overall Study|No specific reason|0|||
48919372|NCT03681119|157539750|FG000|Overall Study|Sickness|2|||
48919373|NCT03681119|157539751|FG001|Overall Study|Sickness|0|||
48919374|NCT02813694|157539752|FG000|Overall Study|Physician Decision|0|||
48919375|NCT02813694|157539753|FG001|Overall Study|Physician Decision|1|||
48919376|NCT02813694|157539752|FG000|Overall Study|Withdrawal by Subject|10|||
48811718|NCT01993823|157152055|FG000|Overall Study|Requested by the patient|6|||
48811719|NCT01993823|157152056|FG001|Overall Study|Requested by the patient|11|||
48811720|NCT01993823|157152055|FG000|Overall Study|Protocol Violation|0|||
48811721|NCT01993823|157152056|FG001|Overall Study|Protocol Violation|1|||
48811722|NCT01993823|157152055|FG000|Overall Study|Lost to Follow-up|1|||
48811723|NCT01993823|157152056|FG001|Overall Study|Lost to Follow-up|4|||
48811724|NCT03321006|157152062|FG000|Overall Study|Death|1|||
48811725|NCT03321006|157152063|FG001|Overall Study|Death|0|||
48811726|NCT03321006|157152062|FG000|Overall Study|Lack of Efficacy|1|||
48811727|NCT03321006|157152063|FG001|Overall Study|Lack of Efficacy|0|||
48811728|NCT00708305|157152069|FG000|Period 1|Protocol Violation|1|||
48811729|NCT00708305|157152070|FG001|Period 1|Protocol Violation|0|||
48811730|NCT00708305|157152071|FG002|Period 1|Protocol Violation|1|||
48811731|NCT00708305|157152072|FG003|Period 1|Protocol Violation|0|||
48811732|NCT00708305|157152069|FG000|Period 1|Other Reason|0|||
48811733|NCT00708305|157152070|FG001|Period 1|Other Reason|0|||
48919377|NCT02813694|157539753|FG001|Overall Study|Withdrawal by Subject|9|||
48919378|NCT02813694|157539752|FG000|Overall Study|Lost to Follow-up|1|||
48919379|NCT02813694|157539753|FG001|Overall Study|Lost to Follow-up|1|||
48919380|NCT02813694|157539752|FG000|Overall Study|Death|3|||
48919381|NCT02813694|157539753|FG001|Overall Study|Death|3|||
48919382|NCT02813694|157539752|FG000|Overall Study|Randomized- did not receive study drug|2|||
48919383|NCT02813694|157539753|FG001|Overall Study|Randomized- did not receive study drug|0|||
48919384|NCT02813694|157539752|FG000|Overall Study|Patient hospitalized|1|||
48919385|NCT02813694|157539753|FG001|Overall Study|Patient hospitalized|0|||
48919386|NCT01152021|157539754|FG000|Overall Study|Adverse Event|4|||
48811734|NCT00708305|157152071|FG002|Period 1|Other Reason|0|||
48811735|NCT00708305|157152072|FG003|Period 1|Other Reason|2|||
48811736|NCT00708305|157152069|FG000|Period 2|Lost to Follow-up|0|||
48811737|NCT00708305|157152070|FG001|Period 2|Lost to Follow-up|1|||
48811738|NCT00708305|157152071|FG002|Period 2|Lost to Follow-up|0|||
48811739|NCT00708305|157152072|FG003|Period 2|Lost to Follow-up|0|||
48811740|NCT00708305|157152069|FG000|Period 2|Protocol Violation|0|||
48811741|NCT00708305|157152070|FG001|Period 2|Protocol Violation|1|||
48811742|NCT00708305|157152071|FG002|Period 2|Protocol Violation|0|||
48811743|NCT00708305|157152072|FG003|Period 2|Protocol Violation|0|||
48811744|NCT00708305|157152069|FG000|Period 2|Other Reason|1|||
48811745|NCT00708305|157152070|FG001|Period 2|Other Reason|0|||
48811746|NCT00708305|157152071|FG002|Period 2|Other Reason|0|||
48811747|NCT00708305|157152072|FG003|Period 2|Other Reason|1|||
48811748|NCT00708305|157152069|FG000|Period 3|Protocol Violation|0|||
48811749|NCT00708305|157152070|FG001|Period 3|Protocol Violation|2|||
48811750|NCT00708305|157152071|FG002|Period 3|Protocol Violation|0|||
48811751|NCT00708305|157152072|FG003|Period 3|Protocol Violation|0|||
48811752|NCT00708305|157152069|FG000|Period 3|Other Reason|1|||
48811753|NCT00708305|157152070|FG001|Period 3|Other Reason|0|||
48811754|NCT00708305|157152071|FG002|Period 3|Other Reason|0|||
48811755|NCT00708305|157152072|FG003|Period 3|Other Reason|0|||
48811756|NCT02823964|157152079|FG000|Overall Study|Adverse Event|2|||
48811757|NCT02823964|157152079|FG000|Overall Study|Physician Decision|1|||
48811758|NCT02823964|157152079|FG000|Overall Study|Lack of Efficacy|1|||
48811759|NCT02823964|157152079|FG000|Overall Study|Withdrawal by Subject|1|||
48811760|NCT04498247|157152082|FG000|Overall Study|Lost to Follow-up|0|||
48811761|NCT04498247|157152083|FG001|Overall Study|Lost to Follow-up|0|||
48811762|NCT04498247|157152084|FG002|Overall Study|Lost to Follow-up|0|||
48811763|NCT04498247|157152085|FG003|Overall Study|Lost to Follow-up|1|||
48811764|NCT04498247|157152086|FG004|Overall Study|Lost to Follow-up|0|||
48811765|NCT04498247|157152087|FG005|Overall Study|Lost to Follow-up|0|||
48811766|NCT04498247|157152088|FG006|Overall Study|Lost to Follow-up|0|||
48811767|NCT04498247|157152089|FG007|Overall Study|Lost to Follow-up|0|||
48811768|NCT04498247|157152082|FG000|Overall Study|Mistakenly Randomized; Not Treated|1|||
48811769|NCT04498247|157152083|FG001|Overall Study|Mistakenly Randomized; Not Treated|0|||
48811770|NCT04498247|157152084|FG002|Overall Study|Mistakenly Randomized; Not Treated|0|||
48811771|NCT04498247|157152085|FG003|Overall Study|Mistakenly Randomized; Not Treated|0|||
48811772|NCT04498247|157152086|FG004|Overall Study|Mistakenly Randomized; Not Treated|0|||
48811773|NCT04498247|157152087|FG005|Overall Study|Mistakenly Randomized; Not Treated|0|||
48811774|NCT04498247|157152088|FG006|Overall Study|Mistakenly Randomized; Not Treated|0|||
48811775|NCT04498247|157152089|FG007|Overall Study|Mistakenly Randomized; Not Treated|0|||
48811776|NCT04498247|157152082|FG000|Overall Study|Withdrawal by Subject|0|||
48811777|NCT04498247|157152083|FG001|Overall Study|Withdrawal by Subject|8|||
48811778|NCT04498247|157152084|FG002|Overall Study|Withdrawal by Subject|0|||
48811779|NCT04498247|157152085|FG003|Overall Study|Withdrawal by Subject|7|||
48811780|NCT04498247|157152086|FG004|Overall Study|Withdrawal by Subject|0|||
48811781|NCT04498247|157152087|FG005|Overall Study|Withdrawal by Subject|0|||
48811782|NCT04498247|157152088|FG006|Overall Study|Withdrawal by Subject|1|||
48811783|NCT04498247|157152089|FG007|Overall Study|Withdrawal by Subject|0|||
48811784|NCT04498247|157152082|FG000|Overall Study|Received a non-study COVID-19 vaccine.|0|||
48811785|NCT04498247|157152083|FG001|Overall Study|Received a non-study COVID-19 vaccine.|4|||
48811786|NCT04498247|157152084|FG002|Overall Study|Received a non-study COVID-19 vaccine.|0|||
48811787|NCT04498247|157152085|FG003|Overall Study|Received a non-study COVID-19 vaccine.|3|||
48811788|NCT04498247|157152086|FG004|Overall Study|Received a non-study COVID-19 vaccine.|0|||
48811789|NCT04498247|157152087|FG005|Overall Study|Received a non-study COVID-19 vaccine.|0|||
48811790|NCT04498247|157152088|FG006|Overall Study|Received a non-study COVID-19 vaccine.|7|||
48811791|NCT04498247|157152089|FG007|Overall Study|Received a non-study COVID-19 vaccine.|0|||
48811792|NCT03469349|157152090|FG000|Overall Study|Withdrawal by Subject|1|||
48811793|NCT03469349|157152091|FG001|Overall Study|Withdrawal by Subject|3|||
48811794|NCT03469349|157152090|FG000|Overall Study|Progressive Disease|0|||
48811795|NCT03469349|157152091|FG001|Overall Study|Progressive Disease|1|||
48811796|NCT03469349|157152090|FG000|Overall Study|Lost to Follow-up|2|||
48811797|NCT03469349|157152091|FG001|Overall Study|Lost to Follow-up|2|||
48811798|NCT03469349|157152090|FG000|Overall Study|Adverse Event|2|||
48811799|NCT03469349|157152091|FG001|Overall Study|Adverse Event|4|||
48811800|NCT02247804|157152093|FG000|Treatment Period 1|Adverse Event|9|||
48811801|NCT02247804|157152094|FG001|Treatment Period 1|Adverse Event|2|||
49122553|NCT01656395|158286831|FG002|Overall Study|Lack of Efficacy|6|||
49122554|NCT01656395|158286832|FG003|Overall Study|Lack of Efficacy|1|||
48811802|NCT02247804|157152095|FG002|Treatment Period 1|Adverse Event|0|||
48811803|NCT02247804|157152093|FG000|Treatment Period 1|Lack of Efficacy|0|||
48811804|NCT02247804|157152094|FG001|Treatment Period 1|Lack of Efficacy|0|||
49122555|NCT01656395|158286833|FG004|Overall Study|Lack of Efficacy|1|||
48811805|NCT02247804|157152095|FG002|Treatment Period 1|Lack of Efficacy|2|||
48811806|NCT02247804|157152093|FG000|Treatment Period 1|Lost to Follow-up|1|||
48919387|NCT01152021|157539755|FG001|Overall Study|Adverse Event|4|||
48811807|NCT02247804|157152094|FG001|Treatment Period 1|Lost to Follow-up|0|||
48811808|NCT02247804|157152095|FG002|Treatment Period 1|Lost to Follow-up|2|||
48811809|NCT02247804|157152093|FG000|Treatment Period 1|Personal Reasons|7|||
48811810|NCT02247804|157152094|FG001|Treatment Period 1|Personal Reasons|1|||
48811811|NCT02247804|157152095|FG002|Treatment Period 1|Personal Reasons|2|||
48811812|NCT02247804|157152093|FG000|Treatment Period 1|Protocol Deviation|0|||
48811813|NCT02247804|157152094|FG001|Treatment Period 1|Protocol Deviation|0|||
48811814|NCT02247804|157152095|FG002|Treatment Period 1|Protocol Deviation|1|||
48811815|NCT02247804|157152093|FG000|Treatment Period 1|Randomized but not Treated|5|||
48811816|NCT02247804|157152094|FG001|Treatment Period 1|Randomized but not Treated|1|||
48811817|NCT02247804|157152095|FG002|Treatment Period 1|Randomized but not Treated|1|||
48811818|NCT02247804|157152093|FG000|Treatment Period 2|Adverse Event|6|||
48811819|NCT02247804|157152094|FG001|Treatment Period 2|Adverse Event|3|||
48811820|NCT02247804|157152095|FG002|Treatment Period 2|Adverse Event|3|||
48811821|NCT02247804|157152093|FG000|Treatment Period 2|Lack of Efficacy|0|||
48811822|NCT02247804|157152094|FG001|Treatment Period 2|Lack of Efficacy|0|||
48811823|NCT02247804|157152095|FG002|Treatment Period 2|Lack of Efficacy|1|||
48713025|NCT00534599|156799478|FG000|Overall Study|Withdrawal by Subject|4|||
48811824|NCT02247804|157152093|FG000|Treatment Period 2|Lost to Follow-up|0|||
48919388|NCT01152021|157539754|FG000|Overall Study|Study drug had expired|1|||
48713026|NCT00534599|156799479|FG001|Overall Study|Withdrawal by Subject|6|||
48713027|NCT00534599|156799478|FG000|Overall Study|Other|7|||
48713028|NCT00534599|156799479|FG001|Overall Study|Other|0|||
48713029|NCT01124864|156801303|FG000|Overall Study|Follow up phase competed as per protocol|18|||
48713030|NCT01124864|156801304|FG001|Overall Study|Follow up phase competed as per protocol|22|||
48713031|NCT01124864|156801305|FG002|Overall Study|Follow up phase competed as per protocol|24|||
48713032|NCT01124864|156801306|FG003|Overall Study|Follow up phase competed as per protocol|18|||
48713033|NCT01124864|156801307|FG004|Overall Study|Follow up phase competed as per protocol|26|||
48713034|NCT01124864|156801308|FG005|Overall Study|Follow up phase competed as per protocol|2|||
48713035|NCT01124864|156801303|FG000|Overall Study|Death|6|||
48713036|NCT01124864|156801304|FG001|Overall Study|Death|9|||
48713037|NCT01124864|156801305|FG002|Overall Study|Death|6|||
48713038|NCT01124864|156801306|FG003|Overall Study|Death|2|||
48713039|NCT01124864|156801307|FG004|Overall Study|Death|1|||
48713040|NCT01124864|156801308|FG005|Overall Study|Death|0|||
48713041|NCT01124864|156801303|FG000|Overall Study|Withdrawal by Subject|2|||
48713042|NCT01124864|156801304|FG001|Overall Study|Withdrawal by Subject|3|||
48713043|NCT01124864|156801305|FG002|Overall Study|Withdrawal by Subject|4|||
48713044|NCT01124864|156801306|FG003|Overall Study|Withdrawal by Subject|0|||
48713045|NCT01124864|156801307|FG004|Overall Study|Withdrawal by Subject|2|||
48713046|NCT01124864|156801308|FG005|Overall Study|Withdrawal by Subject|1|||
48713047|NCT01124864|156801303|FG000|Overall Study|Lost to Follow-up|1|||
48713048|NCT01124864|156801304|FG001|Overall Study|Lost to Follow-up|1|||
48713049|NCT01124864|156801305|FG002|Overall Study|Lost to Follow-up|0|||
48713050|NCT01124864|156801306|FG003|Overall Study|Lost to Follow-up|1|||
48713051|NCT01124864|156801307|FG004|Overall Study|Lost to Follow-up|0|||
48713052|NCT01124864|156801308|FG005|Overall Study|Lost to Follow-up|0|||
48713053|NCT01124864|156801303|FG000|Overall Study|Protocol Violation|1|||
48713054|NCT01124864|156801304|FG001|Overall Study|Protocol Violation|0|||
48713055|NCT01124864|156801305|FG002|Overall Study|Protocol Violation|0|||
48713056|NCT01124864|156801306|FG003|Overall Study|Protocol Violation|0|||
48713057|NCT01124864|156801307|FG004|Overall Study|Protocol Violation|1|||
48713058|NCT01124864|156801308|FG005|Overall Study|Protocol Violation|0|||
48713059|NCT01243242|156801309|FG000|Overall Study|Adverse Event|1|||
48713060|NCT01243242|156801310|FG001|Overall Study|Adverse Event|1|||
48713061|NCT01243242|156801309|FG000|Overall Study|Withdrawal by Subject|1|||
48713062|NCT01243242|156801310|FG001|Overall Study|Withdrawal by Subject|1|||
48713063|NCT01243242|156801309|FG000|Overall Study|Physician Decision|0|||
48713064|NCT01243242|156801310|FG001|Overall Study|Physician Decision|1|||
48713065|NCT01243242|156801309|FG000|Overall Study|sponsor decision|0|||
48713066|NCT01243242|156801310|FG001|Overall Study|sponsor decision|1|||
48713067|NCT01243242|156801309|FG000|Overall Study|non compliance|1|||
48713068|NCT01243242|156801310|FG001|Overall Study|non compliance|0|||
48713069|NCT00552188|156801313|FG000|Overall Study|Adverse Event|0|||
48713070|NCT00552188|156801314|FG001|Overall Study|Adverse Event|2|||
48713071|NCT00552188|156801313|FG000|Overall Study|Lost to Follow-up|2|||
48713072|NCT00552188|156801314|FG001|Overall Study|Lost to Follow-up|1|||
48713073|NCT00552188|156801313|FG000|Overall Study|Withdrawal of consent|0|||
48713074|NCT00552188|156801314|FG001|Overall Study|Withdrawal of consent|1|||
48713075|NCT00552188|156801313|FG000|Overall Study|Subject returned to home country|0|||
48713076|NCT00552188|156801314|FG001|Overall Study|Subject returned to home country|1|||
48713077|NCT01874340|156801326|FG000|Overall Study|Study terminated by Sponsor|6|||
48713078|NCT01874340|156801327|FG001|Overall Study|Study terminated by Sponsor|8|||
48713079|NCT01874340|156801328|FG002|Overall Study|Study terminated by Sponsor|8|||
48713080|NCT01874340|156801329|FG003|Overall Study|Study terminated by Sponsor|4|||
48713081|NCT01874340|156801326|FG000|Overall Study|Withdrawal by Subject|0|||
48713082|NCT01874340|156801327|FG001|Overall Study|Withdrawal by Subject|0|||
48811825|NCT02247804|157152094|FG001|Treatment Period 2|Lost to Follow-up|1|||
48713083|NCT01874340|156801328|FG002|Overall Study|Withdrawal by Subject|0|||
48713084|NCT01874340|156801329|FG003|Overall Study|Withdrawal by Subject|1|||
48919389|NCT01152021|157539755|FG001|Overall Study|Study drug had expired|0|||
48811826|NCT02247804|157152095|FG002|Treatment Period 2|Lost to Follow-up|1|||
48811827|NCT02247804|157152093|FG000|Treatment Period 2|Personal Reasons|2|||
48811828|NCT02247804|157152094|FG001|Treatment Period 2|Personal Reasons|1|||
48811829|NCT02247804|157152095|FG002|Treatment Period 2|Personal Reasons|1|||
48811830|NCT02247804|157152093|FG000|Treatment Period 2|Reason not Specified|0|||
48811831|NCT02247804|157152094|FG001|Treatment Period 2|Reason not Specified|0|||
48811832|NCT02247804|157152095|FG002|Treatment Period 2|Reason not Specified|2|||
48811833|NCT02247804|157152093|FG000|Treatment Period 3|Adverse Event|4|||
48811834|NCT02247804|157152094|FG001|Treatment Period 3|Adverse Event|3|||
48811835|NCT02247804|157152095|FG002|Treatment Period 3|Adverse Event|3|||
48811836|NCT02247804|157152093|FG000|Treatment Period 3|Lack of Efficacy|0|||
48811837|NCT02247804|157152094|FG001|Treatment Period 3|Lack of Efficacy|1|||
48811838|NCT02247804|157152095|FG002|Treatment Period 3|Lack of Efficacy|0|||
48811839|NCT02247804|157152093|FG000|Treatment Period 3|Lost to Follow-up|1|||
48811840|NCT02247804|157152094|FG001|Treatment Period 3|Lost to Follow-up|2|||
48811841|NCT02247804|157152095|FG002|Treatment Period 3|Lost to Follow-up|2|||
48811842|NCT02247804|157152093|FG000|Treatment Period 3|Personal Reasons|4|||
48811843|NCT02247804|157152094|FG001|Treatment Period 3|Personal Reasons|3|||
48811844|NCT02247804|157152095|FG002|Treatment Period 3|Personal Reasons|2|||
48811845|NCT02247804|157152093|FG000|Treatment Period 3|Reason not Specified|2|||
48811846|NCT02247804|157152094|FG001|Treatment Period 3|Reason not Specified|1|||
48811847|NCT02247804|157152095|FG002|Treatment Period 3|Reason not Specified|3|||
48811848|NCT00390455|157152098|FG000|Overall Study|Adverse Event|17|||
48811849|NCT00390455|157152099|FG001|Overall Study|Adverse Event|3|||
48811850|NCT00390455|157152098|FG000|Overall Study|Withdrawal by Subject|8|||
48811851|NCT00390455|157152099|FG001|Overall Study|Withdrawal by Subject|8|||
48811852|NCT00390455|157152098|FG000|Overall Study|Alternate Treatment|0|||
48811853|NCT00390455|157152099|FG001|Overall Study|Alternate Treatment|1|||
48811854|NCT00390455|157152098|FG000|Overall Study|Other Medical Reasons|7|||
48811855|NCT00390455|157152099|FG001|Overall Study|Other Medical Reasons|11|||
48811856|NCT02917265|157152100|FG000|Overall Study|Physician Decision|1|||
48811857|NCT02917265|157152101|FG001|Overall Study|Physician Decision|0|||
48811858|NCT02917265|157152100|FG000|Overall Study|Withdrawal by Subject|1|||
48811859|NCT02917265|157152101|FG001|Overall Study|Withdrawal by Subject|0|||
48811860|NCT03447730|157152102|FG000|Overall Study|Adverse Event|0|||
48919390|NCT01152021|157539754|FG000|Overall Study|Physician Decision|1|||
48919391|NCT01152021|157539755|FG001|Overall Study|Physician Decision|1|||
48919392|NCT01152021|157539754|FG000|Overall Study|No access to study drug in Pharmacy|0|||
48919393|NCT01152021|157539755|FG001|Overall Study|No access to study drug in Pharmacy|1|||
48919394|NCT01087905|157539756|FG000|Overall Study|Lost to Follow-up|24|||
48919395|NCT01087905|157539757|FG001|Overall Study|Lost to Follow-up|28|||
48919396|NCT01087905|157539758|FG002|Overall Study|Lost to Follow-up|18|||
48919397|NCT01087905|157539759|FG003|Overall Study|Lost to Follow-up|31|||
48919398|NCT01087905|157539760|FG004|Overall Study|Lost to Follow-up|27|||
48919399|NCT01087905|157539761|FG005|Overall Study|Lost to Follow-up|25|||
48919400|NCT01087905|157539762|FG006|Overall Study|Lost to Follow-up|20|||
48919401|NCT01087905|157539763|FG007|Overall Study|Lost to Follow-up|24|||
48919402|NCT01087905|157539756|FG000|Overall Study|Withdrawal by Subject|5|||
48919403|NCT01087905|157539757|FG001|Overall Study|Withdrawal by Subject|4|||
48919404|NCT01087905|157539758|FG002|Overall Study|Withdrawal by Subject|4|||
48919405|NCT01087905|157539759|FG003|Overall Study|Withdrawal by Subject|5|||
48919406|NCT01087905|157539760|FG004|Overall Study|Withdrawal by Subject|4|||
49122556|NCT01656395|158286834|FG005|Overall Study|Lack of Efficacy|6|||
49122557|NCT01656395|158286835|FG006|Overall Study|Lack of Efficacy|0|||
49122558|NCT01656395|158286836|FG007|Overall Study|Lack of Efficacy|0|||
49122559|NCT01656395|158286829|FG000|Overall Study|Lost to Follow-up|1|||
49122560|NCT01656395|158286830|FG001|Overall Study|Lost to Follow-up|0|||
49122561|NCT01656395|158286831|FG002|Overall Study|Lost to Follow-up|0|||
49122562|NCT01656395|158286832|FG003|Overall Study|Lost to Follow-up|0|||
49122563|NCT01656395|158286833|FG004|Overall Study|Lost to Follow-up|0|||
49122564|NCT01656395|158286834|FG005|Overall Study|Lost to Follow-up|0|||
49122565|NCT01656395|158286835|FG006|Overall Study|Lost to Follow-up|0|||
48811861|NCT03447730|157152103|FG001|Overall Study|Adverse Event|2|||
48811862|NCT03447730|157152104|FG002|Overall Study|Adverse Event|0|||
48811863|NCT01275196|157152107|FG000|Overall Study|Adverse Event|3|||
48811864|NCT01275196|157152108|FG001|Overall Study|Adverse Event|5|||
48811865|NCT01275196|157152107|FG000|Overall Study|Withdrawal by Subject|4|||
48919407|NCT01087905|157539761|FG005|Overall Study|Withdrawal by Subject|3|||
48919408|NCT01087905|157539762|FG006|Overall Study|Withdrawal by Subject|3|||
48919409|NCT01087905|157539763|FG007|Overall Study|Withdrawal by Subject|5|||
48919410|NCT01347554|157539764|FG000|Overall Study|Lack of Efficacy|7|||
48919411|NCT01347554|157539765|FG001|Overall Study|Lack of Efficacy|11|||
49122566|NCT01656395|158286836|FG007|Overall Study|Lost to Follow-up|0|||
48811866|NCT01275196|157152108|FG001|Overall Study|Withdrawal by Subject|5|||
48811867|NCT01275196|157152107|FG000|Overall Study|Lost to Follow-up|1|||
49122567|NCT01656395|158286829|FG000|Overall Study|Non-Compliance with Study Drug|1|||
49122568|NCT01656395|158286830|FG001|Overall Study|Non-Compliance with Study Drug|1|||
48713085|NCT02934503|156801330|FG000|Overall Study|progression of disease|3|||
48713086|NCT02934503|156801330|FG000|Overall Study|Withdrawal by Subject|1|||
48713087|NCT00555061|156801331|FG000|Overall Study|Adverse Event|3|||
48713088|NCT00555061|156801331|FG000|Overall Study|Protocol Violation|1|||
48713089|NCT00555061|156801331|FG000|Overall Study|Lost to Follow-up|2|||
48811868|NCT01275196|157152108|FG001|Overall Study|Lost to Follow-up|0|||
48811869|NCT01275196|157152107|FG000|Overall Study|Disease Progression|6|||
48811870|NCT01275196|157152108|FG001|Overall Study|Disease Progression|5|||
48811871|NCT01275196|157152107|FG000|Overall Study|Protocol Violation|1|||
48811872|NCT01275196|157152108|FG001|Overall Study|Protocol Violation|0|||
48811873|NCT01275196|157152107|FG000|Overall Study|Suboptimal response/treatment failure|5|||
48811874|NCT01275196|157152108|FG001|Overall Study|Suboptimal response/treatment failure|6|||
48811875|NCT01248962|157152109|FG000|Overall Study|Withdrawal by Subject|1|||
48811876|NCT01248962|157152110|FG001|Overall Study|Withdrawal by Subject|1|||
48811877|NCT01248962|157152109|FG000|Overall Study|Adverse Event|2|||
48811878|NCT01248962|157152110|FG001|Overall Study|Adverse Event|1|||
48811879|NCT01248962|157152109|FG000|Overall Study|Complete Response after 4 Cycles|1|||
48811880|NCT01248962|157152110|FG001|Overall Study|Complete Response after 4 Cycles|0|||
48811881|NCT01248962|157152109|FG000|Overall Study|Complete Response after 3 Cycles|0|||
48811882|NCT01248962|157152110|FG001|Overall Study|Complete Response after 3 Cycles|1|||
48811883|NCT01248962|157152109|FG000|Overall Study|Progression of Disease prior to 5 Cycles|12|||
48811884|NCT01248962|157152110|FG001|Overall Study|Progression of Disease prior to 5 Cycles|13|||
48811885|NCT02572817|157152114|FG000|Overall Study|Death|6|||
48811886|NCT02572817|157152115|FG001|Overall Study|Death|3|||
48713090|NCT00555061|156801331|FG000|Overall Study|Withdrawal by Subject|2|||
48713091|NCT00555061|156801331|FG000|Overall Study|Participant enrolled, but never treated|1|||
48713092|NCT03926611|156801335|FG000|Overall Study|Adverse Event|0|||
48713093|NCT03926611|156801336|FG001|Overall Study|Adverse Event|0|||
48713094|NCT03926611|156801337|FG002|Overall Study|Adverse Event|0|||
48713095|NCT03926611|156801338|FG003|Overall Study|Adverse Event|3|||
48713096|NCT03926611|156801339|FG004|Overall Study|Adverse Event|1|||
48713097|NCT03926611|156801340|FG005|Overall Study|Adverse Event|3|||
48713098|NCT03926611|156801341|FG006|Overall Study|Adverse Event|0|||
48811887|NCT02572817|157152114|FG000|Overall Study|Lost to Follow-up|3|||
48811888|NCT02572817|157152115|FG001|Overall Study|Lost to Follow-up|3|||
48811889|NCT00258440|157152123|FG000|Overall Study|Withdrawal by Subject|0|||
48811890|NCT00258440|157152124|FG001|Overall Study|Withdrawal by Subject|0|||
48811891|NCT00258440|157152125|FG002|Overall Study|Withdrawal by Subject|1|||
48811892|NCT00979602|157152126|FG000|Overall Study|Serious Adverse Event|5|||
48811893|NCT00979602|157152127|FG001|Overall Study|Serious Adverse Event|3|||
48811894|NCT00979602|157152126|FG000|Overall Study|Protocol Violation|3|||
48811895|NCT00979602|157152127|FG001|Overall Study|Protocol Violation|0|||
48811896|NCT00979602|157152126|FG000|Overall Study|Withdrawal by Subject|31|||
48811897|NCT00979602|157152127|FG001|Overall Study|Withdrawal by Subject|25|||
48811898|NCT00979602|157152126|FG000|Overall Study|Lost to Follow-up|100|||
48811899|NCT00979602|157152127|FG001|Overall Study|Lost to Follow-up|96|||
48811900|NCT00979602|157152126|FG000|Overall Study|Migrated/moved from study area|3|||
48811901|NCT00979602|157152127|FG001|Overall Study|Migrated/moved from study area|6|||
48811902|NCT00979602|157152126|FG000|Overall Study|Others|3|||
48811903|NCT00979602|157152127|FG001|Overall Study|Others|3|||
48811904|NCT01719237|157152131|FG000|Overall Study|Physician Decision|0|||
48811905|NCT01719237|157152132|FG001|Overall Study|Physician Decision|1|||
48811906|NCT03820323|157152133|FG000|Overall Study|Lost to Follow-up|2|||
48811907|NCT03820323|157152134|FG001|Overall Study|Lost to Follow-up|1|||
48811908|NCT03820323|157152133|FG000|Overall Study|Missed 12-month visit|22|||
48811909|NCT03820323|157152134|FG001|Overall Study|Missed 12-month visit|14|||
48919412|NCT03631732|157539766|FG000|Randomized Phase Up to Week 24|Lost to Follow-up|3|||
48919413|NCT03631732|157539767|FG001|Randomized Phase Up to Week 24|Lost to Follow-up|0|||
48919414|NCT03631732|157539766|FG000|Randomized Phase Up to Week 24|Withdrew Consent|1|||
48919415|NCT03631732|157539767|FG001|Randomized Phase Up to Week 24|Withdrew Consent|2|||
48919416|NCT03631732|157539766|FG000|Randomized Phase Up to Week 24|Adverse Event|2|||
48811910|NCT03820323|157152133|FG000|Overall Study|Death|2|||
48919417|NCT03631732|157539767|FG001|Randomized Phase Up to Week 24|Adverse Event|0|||
48919418|NCT03631732|157539766|FG000|Randomized Phase Up to Week 24|Randomized but not treated|1|||
48919419|NCT03631732|157539767|FG001|Randomized Phase Up to Week 24|Randomized but not treated|0|||
48811911|NCT03820323|157152134|FG001|Overall Study|Death|1|||
48811912|NCT03820323|157152133|FG000|Overall Study|Transferred out|13|||
48811913|NCT03820323|157152134|FG001|Overall Study|Transferred out|11|||
48811914|NCT03820323|157152133|FG000|Overall Study|Terminated|0|||
48811915|NCT03820323|157152134|FG001|Overall Study|Terminated|3|||
48811916|NCT03820323|157152133|FG000|Overall Study|Withdrawal by Subject|1|||
48811917|NCT03820323|157152134|FG001|Overall Study|Withdrawal by Subject|6|||
48811918|NCT01844115|157152135|FG000|Overall Study|Adverse Event|4|||
48811919|NCT01844115|157152136|FG001|Overall Study|Adverse Event|22|||
48919420|NCT03631732|157539766|FG000|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6|||
48713099|NCT03926611|156801335|FG000|Overall Study|Lack of Efficacy|1|||
48811920|NCT01844115|157152135|FG000|Overall Study|Lack of Efficacy|1|||
48811921|NCT01844115|157152136|FG001|Overall Study|Lack of Efficacy|4|||
48811922|NCT01844115|157152135|FG000|Overall Study|Protocol Violation|12|||
48811923|NCT01844115|157152136|FG001|Overall Study|Protocol Violation|10|||
48811924|NCT01844115|157152135|FG000|Overall Study|Withdrawal by Subject|11|||
48811925|NCT01844115|157152136|FG001|Overall Study|Withdrawal by Subject|11|||
48811926|NCT01844115|157152135|FG000|Overall Study|Lost to Follow-up|11|||
48811927|NCT01844115|157152136|FG001|Overall Study|Lost to Follow-up|10|||
48811928|NCT01844115|157152135|FG000|Overall Study|Pregnancy|0|||
48811929|NCT01844115|157152136|FG001|Overall Study|Pregnancy|1|||
48811930|NCT00366301|157152139|FG000|Overall Study|Lost to Follow-up|4|||
48811931|NCT00366301|157152140|FG001|Overall Study|Lost to Follow-up|4|||
48811932|NCT00366301|157152141|FG002|Overall Study|Lost to Follow-up|3|||
48811933|NCT00366301|157152142|FG003|Overall Study|Lost to Follow-up|7|||
48811934|NCT00366301|157152139|FG000|Overall Study|Withdrawal by Subject|4|||
48811935|NCT00366301|157152140|FG001|Overall Study|Withdrawal by Subject|2|||
48811936|NCT00366301|157152141|FG002|Overall Study|Withdrawal by Subject|1|||
48811937|NCT00366301|157152142|FG003|Overall Study|Withdrawal by Subject|1|||
48811938|NCT00579982|157152147|FG000|Overall Study|Adverse Event|4|||
48811939|NCT00579982|157152147|FG000|Overall Study|Protocol Violation|4|||
48811940|NCT04091360|157152148|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
48811941|NCT04091360|157152149|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
48811942|NCT04091360|157152150|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
48811943|NCT04091360|157152151|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
48811944|NCT04091360|157152152|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
48811945|NCT04091360|157152153|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
48811946|NCT04091360|157152154|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
49122569|NCT01656395|158286831|FG002|Overall Study|Non-Compliance with Study Drug|0|||
49122570|NCT01656395|158286832|FG003|Overall Study|Non-Compliance with Study Drug|0|||
49122571|NCT01656395|158286833|FG004|Overall Study|Non-Compliance with Study Drug|1|||
49122572|NCT01656395|158286834|FG005|Overall Study|Non-Compliance with Study Drug|1|||
49122573|NCT01656395|158286835|FG006|Overall Study|Non-Compliance with Study Drug|0|||
49122574|NCT01656395|158286836|FG007|Overall Study|Non-Compliance with Study Drug|0|||
49122575|NCT01656395|158286829|FG000|Overall Study|Other|0|||
49122576|NCT01656395|158286830|FG001|Overall Study|Other|0|||
49122577|NCT01656395|158286831|FG002|Overall Study|Other|1|||
49122578|NCT01656395|158286832|FG003|Overall Study|Other|0|||
49122579|NCT01656395|158286833|FG004|Overall Study|Other|0|||
49122580|NCT01656395|158286834|FG005|Overall Study|Other|1|||
49122581|NCT01656395|158286835|FG006|Overall Study|Other|0|||
49122582|NCT01656395|158286836|FG007|Overall Study|Other|0|||
49122583|NCT01656395|158286829|FG000|Overall Study|Physician Decision|2|||
49122584|NCT01656395|158286830|FG001|Overall Study|Physician Decision|3|||
48811947|NCT04091360|157152155|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
48811948|NCT04091360|157152156|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
48811949|NCT04091360|157152157|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
48811950|NCT04091360|157152148|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
48811951|NCT04091360|157152149|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
48811952|NCT04091360|157152150|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
48811953|NCT04091360|157152151|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
48811954|NCT04091360|157152152|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
48811955|NCT04091360|157152153|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
48811956|NCT04091360|157152154|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
48811957|NCT04091360|157152155|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
48811958|NCT04091360|157152156|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
48811959|NCT04091360|157152157|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
48811960|NCT04091360|157152148|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
48811961|NCT04091360|157152149|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
48811962|NCT04091360|157152150|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
48811963|NCT04091360|157152151|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
48811964|NCT04091360|157152152|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
48811965|NCT04091360|157152153|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
48811966|NCT04091360|157152154|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
48811967|NCT04091360|157152155|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
48811968|NCT04091360|157152156|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
49122585|NCT01656395|158286831|FG002|Overall Study|Physician Decision|3|||
49122586|NCT01656395|158286832|FG003|Overall Study|Physician Decision|2|||
49122587|NCT01656395|158286833|FG004|Overall Study|Physician Decision|3|||
49122588|NCT01656395|158286834|FG005|Overall Study|Physician Decision|3|||
49122589|NCT01656395|158286835|FG006|Overall Study|Physician Decision|0|||
49122590|NCT01656395|158286836|FG007|Overall Study|Physician Decision|0|||
49122591|NCT01656395|158286829|FG000|Overall Study|Pregnancy|0|||
49122592|NCT01656395|158286830|FG001|Overall Study|Pregnancy|0|||
49122593|NCT01656395|158286831|FG002|Overall Study|Pregnancy|1|||
49122594|NCT01656395|158286832|FG003|Overall Study|Pregnancy|0|||
49122595|NCT01656395|158286833|FG004|Overall Study|Pregnancy|0|||
49122596|NCT01656395|158286834|FG005|Overall Study|Pregnancy|0|||
49122597|NCT01656395|158286835|FG006|Overall Study|Pregnancy|0|||
49122598|NCT01656395|158286836|FG007|Overall Study|Pregnancy|0|||
49122599|NCT01656395|158286829|FG000|Overall Study|Progressive Disease|0|||
49122600|NCT01656395|158286830|FG001|Overall Study|Progressive Disease|0|||
49122601|NCT01656395|158286831|FG002|Overall Study|Progressive Disease|0|||
49122602|NCT01656395|158286832|FG003|Overall Study|Progressive Disease|0|||
49122603|NCT01656395|158286833|FG004|Overall Study|Progressive Disease|0|||
49122604|NCT01656395|158286834|FG005|Overall Study|Progressive Disease|1|||
49122605|NCT01656395|158286835|FG006|Overall Study|Progressive Disease|0|||
49122606|NCT01656395|158286836|FG007|Overall Study|Progressive Disease|0|||
49122607|NCT01656395|158286829|FG000|Overall Study|Protocol Violation|6|||
49122608|NCT01656395|158286830|FG001|Overall Study|Protocol Violation|6|||
49122609|NCT01656395|158286831|FG002|Overall Study|Protocol Violation|9|||
49122610|NCT01656395|158286832|FG003|Overall Study|Protocol Violation|2|||
49122611|NCT01656395|158286833|FG004|Overall Study|Protocol Violation|4|||
49122612|NCT01656395|158286834|FG005|Overall Study|Protocol Violation|10|||
49122613|NCT01656395|158286835|FG006|Overall Study|Protocol Violation|0|||
49122614|NCT01656395|158286836|FG007|Overall Study|Protocol Violation|0|||
49122615|NCT01656395|158286829|FG000|Overall Study|Screen Failure|2|||
49122616|NCT01656395|158286830|FG001|Overall Study|Screen Failure|1|||
49122617|NCT01656395|158286831|FG002|Overall Study|Screen Failure|7|||
49122618|NCT01656395|158286832|FG003|Overall Study|Screen Failure|1|||
49122619|NCT01656395|158286833|FG004|Overall Study|Screen Failure|0|||
49122620|NCT01656395|158286834|FG005|Overall Study|Screen Failure|8|||
49122621|NCT01656395|158286835|FG006|Overall Study|Screen Failure|0|||
49122622|NCT01656395|158286836|FG007|Overall Study|Screen Failure|0|||
49122623|NCT01656395|158286829|FG000|Overall Study|Withdrawal by Subject|3|||
49122624|NCT01656395|158286830|FG001|Overall Study|Withdrawal by Subject|1|||
49122625|NCT01656395|158286831|FG002|Overall Study|Withdrawal by Subject|4|||
49122626|NCT01656395|158286832|FG003|Overall Study|Withdrawal by Subject|2|||
49122627|NCT01656395|158286833|FG004|Overall Study|Withdrawal by Subject|0|||
49122628|NCT01656395|158286834|FG005|Overall Study|Withdrawal by Subject|3|||
49122629|NCT01656395|158286835|FG006|Overall Study|Withdrawal by Subject|0|||
49122630|NCT01656395|158286836|FG007|Overall Study|Withdrawal by Subject|0|||
49122631|NCT02168491|158286837|FG000|Overall Study|Withdrawal by Subject|1|||
49122632|NCT01610037|158286838|FG000|All Patients|Adverse Event|27|||
49122633|NCT01610037|158286839|FG001|All Patients|Adverse Event|22|||
49122634|NCT01610037|158286840|FG002|All Patients|Adverse Event|26|||
49122635|NCT01610037|158286838|FG000|All Patients|Withdrawal by Subject|12|||
49122636|NCT01610037|158286839|FG001|All Patients|Withdrawal by Subject|10|||
49122637|NCT01610037|158286840|FG002|All Patients|Withdrawal by Subject|20|||
49122638|NCT01610037|158286838|FG000|All Patients|Unsatisfactory therapeutic effect|9|||
49122639|NCT01610037|158286839|FG001|All Patients|Unsatisfactory therapeutic effect|8|||
49122640|NCT01610037|158286840|FG002|All Patients|Unsatisfactory therapeutic effect|27|||
49122641|NCT01610037|158286838|FG000|All Patients|Death|4|||
49122642|NCT01610037|158286839|FG001|All Patients|Death|2|||
49122643|NCT01610037|158286840|FG002|All Patients|Death|1|||
49122644|NCT01610037|158286838|FG000|All Patients|Protocol deviation|4|||
49122645|NCT01610037|158286839|FG001|All Patients|Protocol deviation|3|||
49122646|NCT01610037|158286840|FG002|All Patients|Protocol deviation|3|||
49122647|NCT01610037|158286838|FG000|All Patients|Abnormal laboratory value|1|||
49122648|NCT01610037|158286839|FG001|All Patients|Abnormal laboratory value|1|||
49122649|NCT01610037|158286840|FG002|All Patients|Abnormal laboratory value|0|||
49122650|NCT01610037|158286838|FG000|All Patients|Administrative problems|1|||
49122651|NCT01610037|158286839|FG001|All Patients|Administrative problems|4|||
49122652|NCT01610037|158286840|FG002|All Patients|Administrative problems|4|||
48811969|NCT04091360|157152157|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
48811970|NCT00119262|157152159|FG000|Overall Study|Lack of Efficacy|0|||
48811971|NCT00119262|157152160|FG001|Overall Study|Lack of Efficacy|3|||
48811972|NCT00119262|157152159|FG000|Overall Study|Withdrawal by Subject|12|||
48811973|NCT00119262|157152160|FG001|Overall Study|Withdrawal by Subject|11|||
48811974|NCT00119262|157152159|FG000|Overall Study|Adverse Event|33|||
49122653|NCT01610037|158286838|FG000|All Patients|Lost to Follow-up|1|||
49122654|NCT01610037|158286839|FG001|All Patients|Lost to Follow-up|0|||
49122655|NCT01610037|158286840|FG002|All Patients|Lost to Follow-up|0|||
49122656|NCT01610037|158286838|FG000|All Patients|Abnormal test procedure result(s)|0|||
49122657|NCT01610037|158286839|FG001|All Patients|Abnormal test procedure result(s)|1|||
49122658|NCT01610037|158286840|FG002|All Patients|Abnormal test procedure result(s)|3|||
49122659|NCT01610037|158286838|FG000|Treatment and Follow up Period|Subject withdrew consent|13|||
49122660|NCT01610037|158286839|FG001|Treatment and Follow up Period|Subject withdrew consent|14|||
49122661|NCT01610037|158286840|FG002|Treatment and Follow up Period|Subject withdrew consent|16|||
49122662|NCT01610037|158286838|FG000|Treatment and Follow up Period|Death|10|||
49122663|NCT01610037|158286839|FG001|Treatment and Follow up Period|Death|5|||
49122664|NCT01610037|158286840|FG002|Treatment and Follow up Period|Death|4|||
49122665|NCT01610037|158286838|FG000|Treatment and Follow up Period|Administrative problems|1|||
49122666|NCT01610037|158286839|FG001|Treatment and Follow up Period|Administrative problems|3|||
49122667|NCT01610037|158286840|FG002|Treatment and Follow up Period|Administrative problems|2|||
49122668|NCT01610037|158286838|FG000|Treatment and Follow up Period|Lost to Follow-up|1|||
49122669|NCT01610037|158286839|FG001|Treatment and Follow up Period|Lost to Follow-up|6|||
49122670|NCT01610037|158286840|FG002|Treatment and Follow up Period|Lost to Follow-up|4|||
49122671|NCT01048541|158286841|FG000|Overall Study|Withdrawal by Subject|1|||
49122672|NCT01048541|158286842|FG001|Overall Study|Withdrawal by Subject|0|||
49122673|NCT00922116|158286844|FG000|Overall Study|Adverse Event|4|||
49122674|NCT00922116|158286844|FG000|Overall Study|Death|1|||
49122675|NCT00922116|158286844|FG000|Overall Study|Lost to Follow-up|1|||
49122676|NCT00922116|158286844|FG000|Overall Study|Withdrawal by Subject|4|||
49122677|NCT00922116|158286844|FG000|Overall Study|Other|5|||
49122678|NCT02221648|158286848|FG000|Overall Study|Withdrawal by Subject|3|||
49122679|NCT02221648|158286849|FG001|Overall Study|Withdrawal by Subject|3|||
49122680|NCT04613518|158286852|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
49122681|NCT04613518|158286853|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
49122682|NCT04613518|158286854|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
48713100|NCT03926611|156801336|FG001|Overall Study|Lack of Efficacy|2|||
48713101|NCT03926611|156801337|FG002|Overall Study|Lack of Efficacy|0|||
48713102|NCT03926611|156801338|FG003|Overall Study|Lack of Efficacy|0|||
48713103|NCT03926611|156801339|FG004|Overall Study|Lack of Efficacy|1|||
48713104|NCT03926611|156801340|FG005|Overall Study|Lack of Efficacy|0|||
48713105|NCT03926611|156801341|FG006|Overall Study|Lack of Efficacy|1|||
48713106|NCT03926611|156801335|FG000|Overall Study|Physician Decision|0|||
48713107|NCT03926611|156801336|FG001|Overall Study|Physician Decision|0|||
48713108|NCT03926611|156801337|FG002|Overall Study|Physician Decision|0|||
48713109|NCT03926611|156801338|FG003|Overall Study|Physician Decision|0|||
48713110|NCT03926611|156801339|FG004|Overall Study|Physician Decision|0|||
48713111|NCT03926611|156801340|FG005|Overall Study|Physician Decision|1|||
48713112|NCT03926611|156801341|FG006|Overall Study|Physician Decision|0|||
48713113|NCT03926611|156801335|FG000|Overall Study|Protocol Violation|1|||
48811975|NCT00119262|157152160|FG001|Overall Study|Adverse Event|35|||
48811976|NCT00119262|157152159|FG000|Overall Study|other disease|0|||
48811977|NCT00119262|157152160|FG001|Overall Study|other disease|2|||
49122683|NCT04613518|158286852|FG000|Double-Blind Treatment Period|Adverse Event|2|||
49122684|NCT04613518|158286853|FG001|Double-Blind Treatment Period|Adverse Event|0|||
49122685|NCT04613518|158286854|FG002|Double-Blind Treatment Period|Adverse Event|1|||
48713114|NCT03926611|156801336|FG001|Overall Study|Protocol Violation|0|||
49122686|NCT04613518|158286852|FG000|Double-Blind Treatment Period|Participant request to discontinue treatment|1|||
49122687|NCT04613518|158286853|FG001|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
48713115|NCT03926611|156801337|FG002|Overall Study|Protocol Violation|0|||
48713116|NCT03926611|156801338|FG003|Overall Study|Protocol Violation|1|||
48811978|NCT00119262|157152159|FG000|Overall Study|ineligble|1|||
48713117|NCT03926611|156801339|FG004|Overall Study|Protocol Violation|1|||
48713118|NCT03926611|156801340|FG005|Overall Study|Protocol Violation|1|||
49010801|NCT00911859|157875697|FG000|Maintainance Period|Withdrawal by Subject|0|||
49010802|NCT00911859|157875698|FG001|Maintainance Period|Withdrawal by Subject|0|||
49010803|NCT00911859|157875699|FG002|Maintainance Period|Withdrawal by Subject|3|||
49010804|NCT00911859|157875697|FG000|Follow-up Period|Death|5|||
49010805|NCT00911859|157875698|FG001|Follow-up Period|Death|8|||
49010806|NCT00911859|157875699|FG002|Follow-up Period|Death|10|||
49010807|NCT00911859|157875697|FG000|Follow-up Period|Lost to Follow-up|1|||
49010808|NCT00911859|157875698|FG001|Follow-up Period|Lost to Follow-up|1|||
49010809|NCT00911859|157875699|FG002|Follow-up Period|Lost to Follow-up|0|||
49010810|NCT00911859|157875697|FG000|Follow-up Period|Withdrawal by Subject|0|||
49010811|NCT00911859|157875698|FG001|Follow-up Period|Withdrawal by Subject|4|||
49010812|NCT00911859|157875699|FG002|Follow-up Period|Withdrawal by Subject|4|||
49010813|NCT00911859|157875697|FG000|Follow-up Period|Study terminated by sponsor|5|||
49010814|NCT00911859|157875698|FG001|Follow-up Period|Study terminated by sponsor|33|||
49010815|NCT00911859|157875699|FG002|Follow-up Period|Study terminated by sponsor|27|||
49010816|NCT01070394|157875700|FG000|Overall Study|Adverse Event|6|||
49010817|NCT01070394|157875700|FG000|Overall Study|Withdrawal by Subject|1|||
49010818|NCT02995837|157875701|FG000|Overall Study|Lost to Follow-up|9|||
49010819|NCT02995837|157875702|FG001|Overall Study|Lost to Follow-up|8|||
49010820|NCT01859702|157875704|FG000|Overall Study|Protocol deviation|3|||
49010821|NCT01859702|157875704|FG000|Overall Study|Adverse Event|2|||
49010822|NCT01623830|157877314|FG000|Overall Study|Withdrawal by Subject|6|||
49010823|NCT01623830|157877315|FG001|Overall Study|Withdrawal by Subject|7|||
49010824|NCT01623830|157877314|FG000|Overall Study|Exclusion from Study|1|||
49010825|NCT01623830|157877315|FG001|Overall Study|Exclusion from Study|2|||
49010826|NCT02513459|157877322|FG000|Overall Study|Adverse Event|7|||
49010827|NCT02513459|157877322|FG000|Overall Study|Withdrew consent|5|||
49010828|NCT02513459|157877322|FG000|Overall Study|Loss of efficacy|2|||
49010829|NCT02513459|157877322|FG000|Overall Study|Pregnancy|2|||
49010830|NCT02513459|157877322|FG000|Overall Study|Subject decision|2|||
49010831|NCT02513459|157877322|FG000|Overall Study|Lack of response|1|||
49010832|NCT02513459|157877322|FG000|Overall Study|Reproductive plans|1|||
49010833|NCT02513459|157877322|FG000|Overall Study|Surgery planned-- not done|1|||
49010834|NCT01605461|157877324|FG000|Overall Study|Lost to Follow-up|3|||
49010835|NCT01605461|157877324|FG000|Overall Study|Withdrawal by Subject|1|||
49010836|NCT03237611|157877325|FG000|Overall Study|Withdrawal by Subject|1|||
49010837|NCT03237611|157877325|FG000|Overall Study|Ineligible|1|||
49010838|NCT02024698|157877330|FG000|First Intervention (7 Days)|Withdrawal by Subject|0|||
49010839|NCT02024698|157877331|FG001|First Intervention (7 Days)|Withdrawal by Subject|1|||
49010840|NCT01613131|157877332|FG000|Overall Study|Withdrawal by Subject|3|||
49010841|NCT01613131|157877333|FG001|Overall Study|Withdrawal by Subject|5|||
49010842|NCT02454972|157877336|FG000|Overall Study|Progressive disease|17|||
49010843|NCT02454972|157877337|FG001|Overall Study|Progressive disease|16|||
49010844|NCT02454972|157877338|FG002|Overall Study|Progressive disease|59|||
49010845|NCT02454972|157877339|FG003|Overall Study|Progressive disease|23|||
49010846|NCT02454972|157877340|FG004|Overall Study|Progressive disease|16|||
49010847|NCT02454972|157877341|FG005|Overall Study|Progressive disease|12|||
49010848|NCT02454972|157877342|FG006|Overall Study|Progressive disease|19|||
49010849|NCT02454972|157877343|FG007|Overall Study|Progressive disease|27|||
49010850|NCT02454972|157877344|FG008|Overall Study|Progressive disease|0|||
49010851|NCT02454972|157877336|FG000|Overall Study|Death|0|||
49010852|NCT02454972|157877337|FG001|Overall Study|Death|0|||
49010853|NCT02454972|157877338|FG002|Overall Study|Death|5|||
49010854|NCT02454972|157877339|FG003|Overall Study|Death|1|||
49010855|NCT02454972|157877340|FG004|Overall Study|Death|0|||
49010856|NCT02454972|157877341|FG005|Overall Study|Death|0|||
49010857|NCT02454972|157877342|FG006|Overall Study|Death|0|||
49010858|NCT02454972|157877343|FG007|Overall Study|Death|0|||
49010859|NCT02454972|157877344|FG008|Overall Study|Death|95|||
49010860|NCT02454972|157877336|FG000|Overall Study|Physician Decision|0|||
49010861|NCT02454972|157877337|FG001|Overall Study|Physician Decision|1|||
49010862|NCT02454972|157877338|FG002|Overall Study|Physician Decision|2|||
49010863|NCT02454972|157877339|FG003|Overall Study|Physician Decision|1|||
49010864|NCT02454972|157877340|FG004|Overall Study|Physician Decision|2|||
49010865|NCT02454972|157877341|FG005|Overall Study|Physician Decision|0|||
49010866|NCT02454972|157877342|FG006|Overall Study|Physician Decision|0|||
49010867|NCT02454972|157877343|FG007|Overall Study|Physician Decision|1|||
49010868|NCT02454972|157877344|FG008|Overall Study|Physician Decision|0|||
49010869|NCT02454972|157877336|FG000|Overall Study|Non treatment-related adverse event|2|||
49010870|NCT02454972|157877337|FG001|Overall Study|Non treatment-related adverse event|0|||
49010871|NCT02454972|157877338|FG002|Overall Study|Non treatment-related adverse event|1|||
49010872|NCT02454972|157877339|FG003|Overall Study|Non treatment-related adverse event|0|||
49010873|NCT02454972|157877340|FG004|Overall Study|Non treatment-related adverse event|0|||
49010874|NCT02454972|157877341|FG005|Overall Study|Non treatment-related adverse event|1|||
49010875|NCT02454972|157877342|FG006|Overall Study|Non treatment-related adverse event|0|||
49010876|NCT02454972|157877343|FG007|Overall Study|Non treatment-related adverse event|1|||
49010877|NCT02454972|157877344|FG008|Overall Study|Non treatment-related adverse event|0|||
48811979|NCT00119262|157152160|FG001|Overall Study|ineligble|2|||
48811980|NCT00119262|157152159|FG000|Overall Study|others|0|||
48811981|NCT00119262|157152160|FG001|Overall Study|others|5|||
48811982|NCT01258660|157152161|FG000|Overall Study|Adverse Event|2|||
48811983|NCT01258660|157152162|FG001|Overall Study|Adverse Event|4|||
48811984|NCT01258660|157152161|FG000|Overall Study|Withdrawal by Subject|3|||
48811985|NCT01258660|157152162|FG001|Overall Study|Withdrawal by Subject|0|||
48811986|NCT01258660|157152161|FG000|Overall Study|due to relocation|2|||
48811987|NCT01258660|157152162|FG001|Overall Study|due to relocation|0|||
48811988|NCT01258660|157152161|FG000|Overall Study|Protocol Violation|0|||
48811989|NCT01258660|157152162|FG001|Overall Study|Protocol Violation|1|||
48811990|NCT01258660|157152161|FG000|Overall Study|Invalid for primary analysis data set|4|||
48811991|NCT01258660|157152162|FG001|Overall Study|Invalid for primary analysis data set|6|||
48811992|NCT03853317|157152163|FG000|Overall Study|Progressive Disease|5|||
48811993|NCT03853317|157152163|FG000|Overall Study|Adverse Event|1|||
48811994|NCT03853317|157152163|FG000|Overall Study|Death|1|||
48811995|NCT03853317|157152163|FG000|Overall Study|other event|2|||
48811996|NCT00406419|157152168|FG000|Overall Study|Death|3|||
48811997|NCT00406419|157152169|FG001|Overall Study|Death|1|||
48811998|NCT00406419|157152170|FG002|Overall Study|Death|4|||
48811999|NCT00406419|157152168|FG000|Overall Study|Protocol Violation|6|||
48812000|NCT00406419|157152169|FG001|Overall Study|Protocol Violation|2|||
48812001|NCT00406419|157152170|FG002|Overall Study|Protocol Violation|5|||
48919421|NCT03631732|157539767|FG001|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1|||
48919422|NCT03631732|157539766|FG000|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
48919423|NCT03631732|157539767|FG001|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
48919424|NCT03631732|157539766|FG000|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4|||
48919425|NCT03631732|157539767|FG001|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1|||
48919426|NCT03631732|157539766|FG000|B/F/TAF Treatment Phase (After Week 24)|Death|1|||
48919427|NCT03631732|157539767|FG001|B/F/TAF Treatment Phase (After Week 24)|Death|0|||
48919428|NCT03631732|157539766|FG000|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1|||
48919429|NCT03631732|157539767|FG001|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0|||
48919430|NCT03631732|157539766|FG000|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1|||
49122688|NCT04613518|158286854|FG002|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
48812002|NCT00406419|157152168|FG000|Overall Study|Study Terminated by Sponsor|260|||
48919431|NCT03631732|157539767|FG001|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0|||
48919432|NCT01445951|157539770|FG000|Overall Study|Adverse Event|16|||
48919433|NCT01445951|157539771|FG001|Overall Study|Adverse Event|9|||
48919434|NCT01445951|157539772|FG002|Overall Study|Adverse Event|0|||
48919435|NCT01445951|157539770|FG000|Overall Study|Protocol Violation|2|||
48919436|NCT01445951|157539771|FG001|Overall Study|Protocol Violation|2|||
48919437|NCT01445951|157539772|FG002|Overall Study|Protocol Violation|2|||
48919438|NCT01445951|157539770|FG000|Overall Study|Withdrawal by Subject|21|||
48919439|NCT01445951|157539771|FG001|Overall Study|Withdrawal by Subject|16|||
48919440|NCT01445951|157539772|FG002|Overall Study|Withdrawal by Subject|8|||
48919441|NCT01445951|157539770|FG000|Overall Study|Physician Decision|3|||
48919442|NCT01445951|157539771|FG001|Overall Study|Physician Decision|1|||
48919443|NCT01445951|157539772|FG002|Overall Study|Physician Decision|0|||
48919444|NCT01445951|157539770|FG000|Overall Study|Lost to Follow-up|1|||
48919445|NCT01445951|157539771|FG001|Overall Study|Lost to Follow-up|2|||
48919446|NCT01445951|157539772|FG002|Overall Study|Lost to Follow-up|4|||
48919447|NCT01445951|157539770|FG000|Overall Study|Pregnancy|0|||
48919448|NCT01445951|157539771|FG001|Overall Study|Pregnancy|1|||
48919449|NCT01445951|157539772|FG002|Overall Study|Pregnancy|4|||
48919450|NCT01445951|157539770|FG000|Overall Study|Death|0|||
48919451|NCT01445951|157539771|FG001|Overall Study|Death|0|||
48919452|NCT01445951|157539772|FG002|Overall Study|Death|1|||
48919453|NCT01445951|157539770|FG000|Overall Study|Non-compliance with study drug|1|||
48919454|NCT01445951|157539771|FG001|Overall Study|Non-compliance with study drug|2|||
48919455|NCT01445951|157539772|FG002|Overall Study|Non-compliance with study drug|0|||
48919456|NCT01445951|157539770|FG000|Overall Study|Non-compliance with protocol|0|||
48919457|NCT01445951|157539771|FG001|Overall Study|Non-compliance with protocol|1|||
49122689|NCT04613518|158286852|FG000|Double-Blind Treatment Period|Participant withdrew consent|1|||
48919458|NCT01445951|157539772|FG002|Overall Study|Non-compliance with protocol|0|||
49122690|NCT04613518|158286853|FG001|Double-Blind Treatment Period|Participant withdrew consent|1|||
49122691|NCT04613518|158286854|FG002|Double-Blind Treatment Period|Participant withdrew consent|0|||
49122692|NCT04613518|158286852|FG000|Double-Blind Treatment Period|Other Reasons|2|||
49122693|NCT04613518|158286853|FG001|Double-Blind Treatment Period|Other Reasons|0|||
49122694|NCT04613518|158286854|FG002|Double-Blind Treatment Period|Other Reasons|0|||
49122695|NCT04613518|158286852|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
49122696|NCT04613518|158286853|FG001|Open-Label Treatment Period|Lack of Efficacy|3|||
48812003|NCT00406419|157152169|FG001|Overall Study|Study Terminated by Sponsor|288|||
48812004|NCT00406419|157152170|FG002|Overall Study|Study Terminated by Sponsor|282|||
48812005|NCT00406419|157152168|FG000|Overall Study|Withdrawal by Subject|17|||
48919459|NCT01445951|157539770|FG000|Overall Study|Sponsor decision - subject travel|0|||
49122697|NCT04613518|158286854|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
49122698|NCT04613518|158286852|FG000|Open-Label Treatment Period|Adverse Event|1|||
49122699|NCT04613518|158286853|FG001|Open-Label Treatment Period|Adverse Event|0|||
49122700|NCT04613518|158286854|FG002|Open-Label Treatment Period|Adverse Event|3|||
49122701|NCT04613518|158286852|FG000|Open-Label Treatment Period|Participant request to discontinue treatment|1|||
49122702|NCT04613518|158286853|FG001|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
49122703|NCT04613518|158286854|FG002|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
49122704|NCT04613518|158286852|FG000|Open-Label Treatment Period|Participant withdrew consent|1|||
49122705|NCT04613518|158286853|FG001|Open-Label Treatment Period|Participant withdrew consent|0|||
49122706|NCT04613518|158286854|FG002|Open-Label Treatment Period|Participant withdrew consent|3|||
49122707|NCT04613518|158286852|FG000|Open-Label Treatment Period|Administrative reason by sponsor|4|||
49122708|NCT04613518|158286853|FG001|Open-Label Treatment Period|Administrative reason by sponsor|0|||
49122709|NCT04613518|158286854|FG002|Open-Label Treatment Period|Administrative reason by sponsor|0|||
49122710|NCT04613518|158286852|FG000|Open-Label Treatment Period|Other reasons|1|||
49122711|NCT04613518|158286853|FG001|Open-Label Treatment Period|Other reasons|0|||
49122712|NCT04613518|158286854|FG002|Open-Label Treatment Period|Other reasons|0|||
49122713|NCT00149396|158286855|FG000|Overall Study|Death|15|||
49122714|NCT00149396|158286855|FG000|Overall Study|Withdrawal by Subject|1|||
49122715|NCT00149396|158286855|FG000|Overall Study|Subject noncompliance|2|||
49122716|NCT00149396|158286855|FG000|Overall Study|other treatment|5|||
49122717|NCT00807885|158286856|FG000|Overall Study|Lost to Follow-up|0|||
49122718|NCT00807885|158286857|FG001|Overall Study|Lost to Follow-up|0|||
49122719|NCT00807885|158286858|FG002|Overall Study|Lost to Follow-up|0|||
49122720|NCT00807885|158286859|FG003|Overall Study|Lost to Follow-up|0|||
49122721|NCT00807885|158286860|FG004|Overall Study|Lost to Follow-up|0|||
49122722|NCT00807885|158286861|FG005|Overall Study|Lost to Follow-up|1|||
49122723|NCT00807885|158286862|FG006|Overall Study|Lost to Follow-up|0|||
49122724|NCT00807885|158286863|FG007|Overall Study|Lost to Follow-up|0|||
49122725|NCT00807885|158286864|FG008|Overall Study|Lost to Follow-up|0|||
49122726|NCT03489343|158286866|FG000|Overall Study|Documented progressive disease|1|||
49122727|NCT03489343|158286867|FG001|Overall Study|Documented progressive disease|0|||
49122728|NCT03489343|158286868|FG002|Overall Study|Documented progressive disease|3|||
49122729|NCT03489343|158286869|FG003|Overall Study|Documented progressive disease|1|||
49122730|NCT03489343|158286870|FG004|Overall Study|Documented progressive disease|3|||
49122731|NCT03489343|158286871|FG005|Overall Study|Documented progressive disease|5|||
49122732|NCT03489343|158286872|FG006|Overall Study|Documented progressive disease|4|||
49122733|NCT03489343|158286866|FG000|Overall Study|Adverse Event|0|||
49122734|NCT03489343|158286867|FG001|Overall Study|Adverse Event|1|||
49122735|NCT03489343|158286868|FG002|Overall Study|Adverse Event|0|||
49122736|NCT03489343|158286869|FG003|Overall Study|Adverse Event|0|||
49122737|NCT03489343|158286870|FG004|Overall Study|Adverse Event|0|||
49122738|NCT03489343|158286871|FG005|Overall Study|Adverse Event|1|||
49122739|NCT03489343|158286872|FG006|Overall Study|Adverse Event|0|||
49122740|NCT03489343|158286866|FG000|Overall Study|Withdrawal by Subject|0|||
49122741|NCT03489343|158286867|FG001|Overall Study|Withdrawal by Subject|0|||
49122742|NCT03489343|158286868|FG002|Overall Study|Withdrawal by Subject|0|||
49122743|NCT03489343|158286869|FG003|Overall Study|Withdrawal by Subject|1|||
49122744|NCT03489343|158286870|FG004|Overall Study|Withdrawal by Subject|0|||
49122745|NCT03489343|158286871|FG005|Overall Study|Withdrawal by Subject|1|||
49122746|NCT03489343|158286872|FG006|Overall Study|Withdrawal by Subject|1|||
49122747|NCT03489343|158286866|FG000|Overall Study|Clinical progression|0|||
49122748|NCT03489343|158286867|FG001|Overall Study|Clinical progression|0|||
49122749|NCT03489343|158286868|FG002|Overall Study|Clinical progression|0|||
49122750|NCT03489343|158286869|FG003|Overall Study|Clinical progression|1|||
49122751|NCT03489343|158286870|FG004|Overall Study|Clinical progression|0|||
49122752|NCT03489343|158286871|FG005|Overall Study|Clinical progression|0|||
49122753|NCT03489343|158286872|FG006|Overall Study|Clinical progression|1|||
49122754|NCT02364388|158286875|FG000|Overall Study|Protocol Violation|1|||
49122755|NCT02364388|158286875|FG000|Overall Study|Technical Failure|3|||
49122756|NCT02364388|158286875|FG000|Overall Study|No OA/US data|2|||
49122757|NCT02364388|158286875|FG000|Overall Study|No Biopsy|2|||
49122758|NCT00327717|158286876|FG000|Overall Study|Adverse Event|6|||
49122759|NCT00327717|158286877|FG001|Overall Study|Adverse Event|6|||
49122760|NCT00327717|158286876|FG000|Overall Study|Lack of Efficacy|0|||
49122761|NCT00327717|158286877|FG001|Overall Study|Lack of Efficacy|1|||
49122762|NCT00327717|158286876|FG000|Overall Study|Withdrawal by Subject|3|||
49122763|NCT00327717|158286877|FG001|Overall Study|Withdrawal by Subject|7|||
49122764|NCT01158261|158286878|FG000|Overall Study|Lost to Follow-up|9|||
48713119|NCT03926611|156801341|FG006|Overall Study|Protocol Violation|1|||
49122765|NCT01158261|158286878|FG000|Overall Study|Death|7|||
49122766|NCT01158261|158286878|FG000|Overall Study|Withdrawal by Subject|1|||
49122767|NCT02899065|158286882|FG000|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|1|||
49122768|NCT02899065|158286883|FG001|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|5|||
48713120|NCT03926611|156801335|FG000|Overall Study|Technical problems|0|||
48713121|NCT03926611|156801336|FG001|Overall Study|Technical problems|0|||
48713122|NCT03926611|156801337|FG002|Overall Study|Technical problems|0|||
48713123|NCT03926611|156801338|FG003|Overall Study|Technical problems|0|||
48713124|NCT03926611|156801339|FG004|Overall Study|Technical problems|0|||
48713125|NCT03926611|156801340|FG005|Overall Study|Technical problems|1|||
48713126|NCT03926611|156801341|FG006|Overall Study|Technical problems|0|||
48713127|NCT03926611|156801335|FG000|Overall Study|Withdrawal by Subject|1|||
48713128|NCT03926611|156801336|FG001|Overall Study|Withdrawal by Subject|1|||
48713129|NCT03926611|156801337|FG002|Overall Study|Withdrawal by Subject|1|||
48713130|NCT03926611|156801338|FG003|Overall Study|Withdrawal by Subject|0|||
48713131|NCT03926611|156801339|FG004|Overall Study|Withdrawal by Subject|0|||
48713132|NCT03926611|156801340|FG005|Overall Study|Withdrawal by Subject|1|||
48713133|NCT03926611|156801341|FG006|Overall Study|Withdrawal by Subject|3|||
48713134|NCT03926611|156801335|FG000|Overall Study|Covid-19 pandemic|0|||
48713135|NCT03926611|156801336|FG001|Overall Study|Covid-19 pandemic|0|||
48713136|NCT03926611|156801337|FG002|Overall Study|Covid-19 pandemic|1|||
48713137|NCT03926611|156801338|FG003|Overall Study|Covid-19 pandemic|0|||
48713138|NCT03926611|156801339|FG004|Overall Study|Covid-19 pandemic|1|||
48713139|NCT03926611|156801340|FG005|Overall Study|Covid-19 pandemic|2|||
48713140|NCT03926611|156801341|FG006|Overall Study|Covid-19 pandemic|0|||
48713141|NCT03539549|156801342|FG000|Overall Study|Adverse Event|12|||
48713142|NCT03539549|156801342|FG000|Overall Study|Lost to Follow-up|1|||
48713143|NCT03539549|156801342|FG000|Overall Study|Death|2|||
48713144|NCT03539549|156801342|FG000|Overall Study|Progressive Disease|1|||
48713145|NCT03539549|156801342|FG000|Overall Study|Reason not Specified|1|||
48713146|NCT04050202|156801343|FG000|Overall Study|Lost to Follow-up|2|||
48713147|NCT00481091|156801344|FG000|Overall Study|Withdrawal by Subject|0|||
48713148|NCT00481091|156801345|FG001|Overall Study|Withdrawal by Subject|1|||
48713149|NCT00481091|156801346|FG002|Overall Study|Withdrawal by Subject|1|||
48713150|NCT00481091|156801347|FG003|Overall Study|Withdrawal by Subject|0|||
48713151|NCT00481091|156801348|FG004|Overall Study|Withdrawal by Subject|0|||
48713152|NCT00481091|156801349|FG005|Overall Study|Withdrawal by Subject|0|||
48713153|NCT00481091|156801350|FG006|Overall Study|Withdrawal by Subject|0|||
48713154|NCT00481091|156801351|FG007|Overall Study|Withdrawal by Subject|0|||
48713155|NCT00481091|156801352|FG008|Overall Study|Withdrawal by Subject|1|||
48713156|NCT00481091|156801353|FG009|Overall Study|Withdrawal by Subject|6|||
48713157|NCT00481091|156801344|FG000|Overall Study|Other, Not Specified|0|||
48713158|NCT00481091|156801345|FG001|Overall Study|Other, Not Specified|1|||
49122769|NCT02899065|158286882|FG000|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|3|||
49122770|NCT02899065|158286883|FG001|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|0|||
48713159|NCT00481091|156801346|FG002|Overall Study|Other, Not Specified|1|||
48713160|NCT00481091|156801347|FG003|Overall Study|Other, Not Specified|0|||
48713161|NCT00481091|156801348|FG004|Overall Study|Other, Not Specified|0|||
48713162|NCT00481091|156801349|FG005|Overall Study|Other, Not Specified|1|||
48713163|NCT00481091|156801350|FG006|Overall Study|Other, Not Specified|0|||
48713164|NCT00481091|156801351|FG007|Overall Study|Other, Not Specified|0|||
48713165|NCT00481091|156801352|FG008|Overall Study|Other, Not Specified|0|||
48713166|NCT00481091|156801353|FG009|Overall Study|Other, Not Specified|4|||
48713167|NCT00481091|156801344|FG000|Overall Study|Adverse Event|1|||
48713168|NCT00481091|156801345|FG001|Overall Study|Adverse Event|2|||
48713169|NCT00481091|156801346|FG002|Overall Study|Adverse Event|0|||
48713170|NCT00481091|156801347|FG003|Overall Study|Adverse Event|1|||
48713171|NCT00481091|156801348|FG004|Overall Study|Adverse Event|1|||
48713172|NCT00481091|156801349|FG005|Overall Study|Adverse Event|1|||
48713173|NCT00481091|156801350|FG006|Overall Study|Adverse Event|2|||
48713174|NCT00481091|156801351|FG007|Overall Study|Adverse Event|1|||
48713175|NCT00481091|156801352|FG008|Overall Study|Adverse Event|1|||
48713176|NCT00481091|156801353|FG009|Overall Study|Adverse Event|6|||
48713177|NCT00481091|156801344|FG000|Overall Study|Progressive disease clinical|0|||
48713178|NCT00481091|156801345|FG001|Overall Study|Progressive disease clinical|0|||
48713179|NCT00481091|156801346|FG002|Overall Study|Progressive disease clinical|0|||
48713180|NCT00481091|156801347|FG003|Overall Study|Progressive disease clinical|0|||
48812006|NCT00406419|157152169|FG001|Overall Study|Withdrawal by Subject|24|||
48812007|NCT00406419|157152170|FG002|Overall Study|Withdrawal by Subject|26|||
48812008|NCT00406419|157152168|FG000|Overall Study|Lack of Efficacy|12|||
48812009|NCT00406419|157152169|FG001|Overall Study|Lack of Efficacy|1|||
48812010|NCT00406419|157152170|FG002|Overall Study|Lack of Efficacy|6|||
49122771|NCT02899065|158286882|FG000|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|21|||
49122772|NCT02899065|158286883|FG001|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|16|||
48713181|NCT00481091|156801348|FG004|Overall Study|Progressive disease clinical|0|||
48713182|NCT00481091|156801349|FG005|Overall Study|Progressive disease clinical|0|||
48713183|NCT00481091|156801350|FG006|Overall Study|Progressive disease clinical|0|||
48713184|NCT00481091|156801351|FG007|Overall Study|Progressive disease clinical|0|||
48713185|NCT00481091|156801352|FG008|Overall Study|Progressive disease clinical|1|||
48713186|NCT00481091|156801353|FG009|Overall Study|Progressive disease clinical|7|||
48812011|NCT00406419|157152168|FG000|Overall Study|Non-Compliance with Study Drug|5|||
48713187|NCT00481091|156801344|FG000|Overall Study|Progressive disease clinical National Cancer Institute|1|||
49122773|NCT00971867|158286884|FG000|Overall Study|Adverse Event|4|||
49122774|NCT00971867|158286884|FG000|Overall Study|Participant Withdrew Consent|1|||
49122775|NCT00971867|158286884|FG000|Overall Study|Disease Progression|6|||
48812012|NCT00406419|157152169|FG001|Overall Study|Non-Compliance with Study Drug|6|||
48812013|NCT00406419|157152170|FG002|Overall Study|Non-Compliance with Study Drug|3|||
48812014|NCT00406419|157152168|FG000|Overall Study|Adverse Event|10|||
48812015|NCT00406419|157152169|FG001|Overall Study|Adverse Event|12|||
48713188|NCT00481091|156801345|FG001|Overall Study|Progressive disease clinical National Cancer Institute|1|||
48713189|NCT00481091|156801346|FG002|Overall Study|Progressive disease clinical National Cancer Institute|0|||
48713190|NCT00481091|156801347|FG003|Overall Study|Progressive disease clinical National Cancer Institute|0|||
48713191|NCT00481091|156801348|FG004|Overall Study|Progressive disease clinical National Cancer Institute|0|||
48713192|NCT00481091|156801349|FG005|Overall Study|Progressive disease clinical National Cancer Institute|1|||
48713193|NCT00481091|156801350|FG006|Overall Study|Progressive disease clinical National Cancer Institute|0|||
48713194|NCT00481091|156801351|FG007|Overall Study|Progressive disease clinical National Cancer Institute|0|||
48713195|NCT00481091|156801352|FG008|Overall Study|Progressive disease clinical National Cancer Institute|0|||
48812016|NCT00406419|157152170|FG002|Overall Study|Adverse Event|16|||
48812017|NCT00406419|157152168|FG000|Overall Study|Lost to Follow-up|11|||
48812018|NCT00406419|157152169|FG001|Overall Study|Lost to Follow-up|10|||
48812019|NCT00406419|157152170|FG002|Overall Study|Lost to Follow-up|5|||
48812020|NCT02366936|157152171|FG000|Overall Study|Withdrawal by Subject|2|||
48812021|NCT02366936|157152171|FG000|Overall Study|Lost to Follow-up|4|||
48812022|NCT02366936|157152171|FG000|Overall Study|Physician Decision|2|||
48812023|NCT00098254|157152172|FG000|Overall Study|Adverse Event|2|||
48812024|NCT00098254|157152172|FG000|Overall Study|Death|1|||
48812025|NCT00308737|157152173|FG000|Overall Study|Adverse Event|104|||
48812026|NCT00308737|157152174|FG001|Overall Study|Adverse Event|9|||
48919460|NCT01445951|157539771|FG001|Overall Study|Sponsor decision - subject travel|1|||
48919461|NCT01445951|157539772|FG002|Overall Study|Sponsor decision - subject travel|0|||
48919462|NCT01445951|157539770|FG000|Overall Study|Cough|0|||
48919463|NCT01445951|157539771|FG001|Overall Study|Cough|1|||
48713196|NCT00481091|156801353|FG009|Overall Study|Progressive disease clinical National Cancer Institute|0|||
48713197|NCT00481091|156801344|FG000|Overall Study|Progressive disease other|1|||
48713198|NCT00481091|156801345|FG001|Overall Study|Progressive disease other|1|||
48713199|NCT00481091|156801346|FG002|Overall Study|Progressive disease other|0|||
48713200|NCT00481091|156801347|FG003|Overall Study|Progressive disease other|1|||
48713201|NCT00481091|156801348|FG004|Overall Study|Progressive disease other|1|||
48713202|NCT00481091|156801349|FG005|Overall Study|Progressive disease other|1|||
48713203|NCT00481091|156801350|FG006|Overall Study|Progressive disease other|0|||
48713204|NCT00481091|156801351|FG007|Overall Study|Progressive disease other|2|||
48713205|NCT00481091|156801352|FG008|Overall Study|Progressive disease other|0|||
48713206|NCT00481091|156801353|FG009|Overall Study|Progressive disease other|0|||
48713207|NCT00481091|156801344|FG000|Overall Study|No reason given|0|||
48713208|NCT00481091|156801345|FG001|Overall Study|No reason given|0|||
48812027|NCT00308737|157152175|FG002|Overall Study|Adverse Event|0|||
48919464|NCT01445951|157539772|FG002|Overall Study|Cough|0|||
48919465|NCT00645593|157539775|FG000|Overall Study|Later found to be ineligible|1|||
48919466|NCT00645593|157539776|FG001|Overall Study|Later found to be ineligible|0|||
48919467|NCT00343889|157539779|FG000|Overall Study|Lost to Follow-up|2|||
48919468|NCT00343889|157539780|FG001|Overall Study|Lost to Follow-up|0|||
48919469|NCT00343889|157539779|FG000|Overall Study|Withdrawal by Subject|0|||
48919470|NCT00343889|157539780|FG001|Overall Study|Withdrawal by Subject|1|||
48919471|NCT00343889|157539779|FG000|Overall Study|Protocol Violation|1|||
48919472|NCT00343889|157539780|FG001|Overall Study|Protocol Violation|0|||
48919473|NCT00542269|157539781|FG000|Overall Study|Adverse Event|10|||
48919474|NCT00542269|157539782|FG001|Overall Study|Adverse Event|4|||
48919475|NCT00542269|157539783|FG002|Overall Study|Adverse Event|5|||
48919476|NCT00542269|157539781|FG000|Overall Study|Protocol Violation|1|||
48919477|NCT00542269|157539782|FG001|Overall Study|Protocol Violation|1|||
48919478|NCT00542269|157539783|FG002|Overall Study|Protocol Violation|0|||
48919479|NCT00542269|157539781|FG000|Overall Study|Withdrawal by Subject|1|||
48919480|NCT00542269|157539782|FG001|Overall Study|Withdrawal by Subject|0|||
48919481|NCT00542269|157539783|FG002|Overall Study|Withdrawal by Subject|0|||
48919482|NCT00542269|157539781|FG000|Overall Study|Administrative problems|1|||
48919483|NCT00542269|157539782|FG001|Overall Study|Administrative problems|1|||
49122776|NCT03586050|158286887|FG000|Overall Study|Death|3|||
48812028|NCT00308737|157152173|FG000|Overall Study|Death|4|||
48812029|NCT00308737|157152174|FG001|Overall Study|Death|3|||
49122777|NCT03586050|158286887|FG000|Overall Study|Withdrawal by Subject|2|||
48812030|NCT00308737|157152175|FG002|Overall Study|Death|0|||
48812031|NCT00308737|157152173|FG000|Overall Study|Lost to Follow-up|56|||
48812032|NCT00308737|157152174|FG001|Overall Study|Lost to Follow-up|80|||
48919484|NCT00542269|157539783|FG002|Overall Study|Administrative problems|1|||
48919485|NCT01692275|157539791|FG000|Overall Study|Lost to Follow-up|57|||
48919486|NCT01692275|157539792|FG001|Overall Study|Lost to Follow-up|48|||
49122778|NCT02689804|158286888|FG000|Overall Study|Withdrawal by Subject|2|||
49122779|NCT02689804|158286889|FG001|Overall Study|Withdrawal by Subject|0|||
49122780|NCT00901342|158286896|FG000|Overall Study|Adverse Event|1|||
49122781|NCT00901342|158286896|FG000|Overall Study|Death|4|||
49122782|NCT00901342|158286896|FG000|Overall Study|Disease progression|1|||
49122783|NCT00901342|158286896|FG000|Overall Study|Withdrawal by Subject|9|||
49122784|NCT01261390|158286899|FG000|Overall Study|Significant Concurrent Illness|1|||
49122785|NCT01261390|158286900|FG001|Overall Study|Significant Concurrent Illness|0|||
49122786|NCT01261390|158286901|FG002|Overall Study|Significant Concurrent Illness|1|||
49122787|NCT01261390|158286902|FG003|Overall Study|Significant Concurrent Illness|0|||
49122788|NCT01261390|158286899|FG000|Overall Study|Dissatisfaction with Treatment|2|||
49122789|NCT01261390|158286900|FG001|Overall Study|Dissatisfaction with Treatment|1|||
49122790|NCT01261390|158286901|FG002|Overall Study|Dissatisfaction with Treatment|1|||
49122791|NCT01261390|158286902|FG003|Overall Study|Dissatisfaction with Treatment|2|||
49122792|NCT01261390|158286899|FG000|Overall Study|Relocation|0|||
49122793|NCT01261390|158286900|FG001|Overall Study|Relocation|1|||
49122794|NCT01261390|158286901|FG002|Overall Study|Relocation|0|||
49122795|NCT01261390|158286902|FG003|Overall Study|Relocation|0|||
49122796|NCT01261390|158286899|FG000|Overall Study|Loss of Interest in the Study|3|||
49122797|NCT01261390|158286900|FG001|Overall Study|Loss of Interest in the Study|1|||
49122798|NCT01261390|158286901|FG002|Overall Study|Loss of Interest in the Study|0|||
49122799|NCT01261390|158286902|FG003|Overall Study|Loss of Interest in the Study|0|||
49122800|NCT01261390|158286899|FG000|Overall Study|Lost to Follow-up|1|||
49122801|NCT01261390|158286900|FG001|Overall Study|Lost to Follow-up|6|||
49122802|NCT01261390|158286901|FG002|Overall Study|Lost to Follow-up|5|||
49122803|NCT01261390|158286902|FG003|Overall Study|Lost to Follow-up|6|||
49122804|NCT00828113|158286905|FG000|Overall Study|Withdrawal by Subject|27|||
49122805|NCT00828113|158286906|FG001|Overall Study|Withdrawal by Subject|26|||
49122806|NCT00828113|158286905|FG000|Overall Study|Lost to Follow-up|3|||
49122807|NCT00828113|158286906|FG001|Overall Study|Lost to Follow-up|5|||
49122808|NCT02329327|158286907|FG000|Overall Study|Death|78|||
49122809|NCT02329327|158286908|FG001|Overall Study|Death|0|||
49122810|NCT02329327|158286907|FG000|Overall Study|Withdrawal by Subject|3|||
49122811|NCT02329327|158286908|FG001|Overall Study|Withdrawal by Subject|0|||
49122812|NCT02329327|158286907|FG000|Overall Study|Lost to Follow-up|4|||
49122813|NCT02329327|158286908|FG001|Overall Study|Lost to Follow-up|0|||
49122814|NCT02493517|158286909|FG000|Overall Study|Protocol Violation|1|||
49122815|NCT02493517|158286910|FG001|Overall Study|Protocol Violation|2|||
49122816|NCT02493517|158286909|FG000|Overall Study|Withdrawal by Subject|1|||
49122817|NCT02493517|158286910|FG001|Overall Study|Withdrawal by Subject|2|||
49122818|NCT02493517|158286909|FG000|Overall Study|Adverse Event|0|||
48713209|NCT00481091|156801346|FG002|Overall Study|No reason given|1|||
48713210|NCT00481091|156801347|FG003|Overall Study|No reason given|1|||
48713211|NCT00481091|156801348|FG004|Overall Study|No reason given|1|||
48713212|NCT00481091|156801349|FG005|Overall Study|No reason given|0|||
48713213|NCT00481091|156801350|FG006|Overall Study|No reason given|1|||
48713214|NCT00481091|156801351|FG007|Overall Study|No reason given|1|||
48713215|NCT00481091|156801352|FG008|Overall Study|No reason given|1|||
48713216|NCT00481091|156801353|FG009|Overall Study|No reason given|4|||
48713217|NCT00475306|156801354|FG000|Overall Study|Protocol Violation|1|||
48713218|NCT00475306|156801355|FG001|Overall Study|Protocol Violation|1|||
48713219|NCT00475306|156801356|FG002|Overall Study|Protocol Violation|0|||
48713220|NCT00475306|156801357|FG003|Overall Study|Protocol Violation|1|||
48713221|NCT02405442|156801359|FG000|Double-Blind Phase (up to Week 8)|Adverse Event|0|||
48713222|NCT02405442|156801360|FG001|Double-Blind Phase (up to Week 8)|Adverse Event|2|||
48713223|NCT02405442|156801361|FG002|Double-Blind Phase (up to Week 8)|Adverse Event|4|||
48713224|NCT02405442|156801362|FG003|Double-Blind Phase (up to Week 8)|Adverse Event|1|||
48713225|NCT02405442|156801359|FG000|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
48713226|NCT02405442|156801360|FG001|Double-Blind Phase (up to Week 8)|Withdrew Consent|1|||
48713227|NCT02405442|156801361|FG002|Double-Blind Phase (up to Week 8)|Withdrew Consent|2|||
48713228|NCT02405442|156801362|FG003|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
48713229|NCT02405442|156801359|FG000|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
48713230|NCT02405442|156801360|FG001|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
48713231|NCT02405442|156801361|FG002|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
48713232|NCT02405442|156801362|FG003|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
48713233|NCT02405442|156801359|FG000|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
48713234|NCT02405442|156801360|FG001|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1|||
48713235|NCT02405442|156801361|FG002|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
48713236|NCT02405442|156801362|FG003|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
48713237|NCT02405442|156801359|FG000|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27|||
48713238|NCT02405442|156801360|FG001|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
48919487|NCT01692275|157539791|FG000|Overall Study|Withdrawal by Subject|9|||
48919488|NCT01692275|157539792|FG001|Overall Study|Withdrawal by Subject|11|||
48919489|NCT00531752|157539795|FG000|First Double-blind Intervention Period|Adverse Event|2|||
48919490|NCT00531752|157539796|FG001|First Double-blind Intervention Period|Adverse Event|0|||
48919491|NCT00531752|157539797|FG002|First Double-blind Intervention Period|Adverse Event|1|||
48919492|NCT00531752|157539798|FG003|First Double-blind Intervention Period|Adverse Event|1|||
48919493|NCT00531752|157539795|FG000|First Double-blind Intervention Period|Other|1|||
48919494|NCT00531752|157539796|FG001|First Double-blind Intervention Period|Other|4|||
48919495|NCT00531752|157539797|FG002|First Double-blind Intervention Period|Other|4|||
48919496|NCT00531752|157539798|FG003|First Double-blind Intervention Period|Other|0|||
48919497|NCT00531752|157539795|FG000|First Double-blind Intervention Period|Withdrawal by Subject|2|||
48919498|NCT00531752|157539796|FG001|First Double-blind Intervention Period|Withdrawal by Subject|0|||
48919499|NCT00531752|157539797|FG002|First Double-blind Intervention Period|Withdrawal by Subject|1|||
48919500|NCT00531752|157539798|FG003|First Double-blind Intervention Period|Withdrawal by Subject|1|||
48919501|NCT00531752|157539795|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
48919502|NCT00531752|157539796|FG001|First Double-blind Intervention Period|Lost to Follow-up|0|||
48919503|NCT00531752|157539797|FG002|First Double-blind Intervention Period|Lost to Follow-up|1|||
48919504|NCT00531752|157539798|FG003|First Double-blind Intervention Period|Lost to Follow-up|1|||
48919505|NCT00531752|157539795|FG000|First Double-blind Intervention Period|Randomized but not treated|1|||
48919506|NCT00531752|157539796|FG001|First Double-blind Intervention Period|Randomized but not treated|0|||
48919507|NCT00531752|157539797|FG002|First Double-blind Intervention Period|Randomized but not treated|0|||
49122819|NCT02493517|158286910|FG001|Overall Study|Adverse Event|2|||
49122820|NCT02493517|158286909|FG000|Overall Study|Missed study visit|0|||
48919508|NCT00531752|157539798|FG003|First Double-blind Intervention Period|Randomized but not treated|0|||
48919509|NCT00531752|157539795|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
48919510|NCT00531752|157539796|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
48919511|NCT00531752|157539797|FG002|Second Double-blind Intervention Period|Adverse Event|0|||
48919512|NCT00531752|157539798|FG003|Second Double-blind Intervention Period|Adverse Event|0|||
48812033|NCT00308737|157152175|FG002|Overall Study|Lost to Follow-up|5|||
48812034|NCT00308737|157152173|FG000|Overall Study|Physician Decision|15|||
48812035|NCT00308737|157152174|FG001|Overall Study|Physician Decision|2|||
48812036|NCT00308737|157152175|FG002|Overall Study|Physician Decision|1|||
48812037|NCT00308737|157152173|FG000|Overall Study|Protocol Violation|34|||
48812038|NCT00308737|157152174|FG001|Overall Study|Protocol Violation|9|||
48812039|NCT00308737|157152175|FG002|Overall Study|Protocol Violation|5|||
48812040|NCT00308737|157152173|FG000|Overall Study|Withdrawal by Subject|218|||
48812041|NCT00308737|157152174|FG001|Overall Study|Withdrawal by Subject|166|||
48812042|NCT00308737|157152175|FG002|Overall Study|Withdrawal by Subject|18|||
49122821|NCT02493517|158286910|FG001|Overall Study|Missed study visit|1|||
48812043|NCT00308737|157152173|FG000|Overall Study|Various|32|||
48812044|NCT00308737|157152174|FG001|Overall Study|Various|20|||
48812045|NCT00308737|157152175|FG002|Overall Study|Various|8|||
48919513|NCT00531752|157539795|FG000|Second Double-blind Intervention Period|Other|1|||
48919514|NCT00531752|157539796|FG001|Second Double-blind Intervention Period|Other|1|||
48919515|NCT00531752|157539797|FG002|Second Double-blind Intervention Period|Other|0|||
48919516|NCT00531752|157539798|FG003|Second Double-blind Intervention Period|Other|0|||
48919517|NCT00531752|157539795|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
48919518|NCT00531752|157539796|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
48919519|NCT00531752|157539797|FG002|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
48919520|NCT00531752|157539798|FG003|Second Double-blind Intervention Period|Withdrawal by Subject|1|||
48919521|NCT00531752|157539795|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
48919522|NCT00531752|157539796|FG001|Second Double-blind Intervention Period|Lost to Follow-up|0|||
49122822|NCT01367249|158286911|FG000|Overall Study|Withdrawal by Subject|6|||
49122823|NCT01367249|158286912|FG001|Overall Study|Withdrawal by Subject|6|||
49122824|NCT01367249|158286911|FG000|Overall Study|Other|3|||
49122825|NCT01367249|158286912|FG001|Overall Study|Other|10|||
49122826|NCT02007720|158286913|FG000|Overall Study|Withdrawal by Subject|9|||
49122827|NCT02007720|158286914|FG001|Overall Study|Withdrawal by Subject|11|||
49122828|NCT02007720|158286913|FG000|Overall Study|study terminated by sponsor|58|||
49122829|NCT02007720|158286914|FG001|Overall Study|study terminated by sponsor|54|||
49122830|NCT02007720|158286913|FG000|Overall Study|technical problem|4|||
49122831|NCT02007720|158286914|FG001|Overall Study|technical problem|2|||
49122832|NCT02007720|158286913|FG000|Overall Study|patient followd less than 165 days|11|||
49122833|NCT02007720|158286914|FG001|Overall Study|patient followd less than 165 days|5|||
49122834|NCT01296412|158286920|FG000|Overall Study|Adverse Event|8|||
49122835|NCT01296412|158286921|FG001|Overall Study|Adverse Event|29|||
48812046|NCT00924469|157152176|FG000|Overall Study|Adverse Event|2|||
48812047|NCT00924469|157152177|FG001|Overall Study|Adverse Event|0|||
48812048|NCT00924469|157152176|FG000|Overall Study|Withdrawal by Subject|0|||
48812049|NCT00924469|157152177|FG001|Overall Study|Withdrawal by Subject|1|||
48812050|NCT00924469|157152176|FG000|Overall Study|Lost to Follow-up|0|||
48812051|NCT00924469|157152177|FG001|Overall Study|Lost to Follow-up|1|||
48919523|NCT00531752|157539797|FG002|Second Double-blind Intervention Period|Lost to Follow-up|0|||
48713239|NCT02405442|156801361|FG002|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
48713240|NCT02405442|156801362|FG003|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13|||
48919524|NCT00531752|157539798|FG003|Second Double-blind Intervention Period|Lost to Follow-up|1|||
48919525|NCT04486950|157539799|FG000|Overall Study|Lost to Follow-up|0|||
48919526|NCT04486950|157539800|FG001|Overall Study|Lost to Follow-up|0|||
48919527|NCT04486950|157539801|FG002|Overall Study|Lost to Follow-up|0|||
48919528|NCT04486950|157539802|FG003|Overall Study|Lost to Follow-up|0|||
48919529|NCT04486950|157539803|FG004|Overall Study|Lost to Follow-up|0|||
48919530|NCT04486950|157539804|FG005|Overall Study|Lost to Follow-up|1|||
48919531|NCT04486950|157539805|FG006|Overall Study|Lost to Follow-up|0|||
48919532|NCT00490451|157539806|FG000|Overall Study|Adverse Event|3|||
48919533|NCT00490451|157539807|FG001|Overall Study|Adverse Event|3|||
48919534|NCT00490451|157539806|FG000|Overall Study|Death|3|||
48713241|NCT02405442|156801359|FG000|Open-Label Phase (up to Week 52)|Investigator's Discretion|14|||
48713242|NCT02405442|156801360|FG001|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
48713243|NCT02405442|156801361|FG002|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
48713244|NCT02405442|156801362|FG003|Open-Label Phase (up to Week 52)|Investigator's Discretion|2|||
48713245|NCT02405442|156801359|FG000|Open-Label Phase (up to Week 52)|Adverse Event|6|||
48713246|NCT02405442|156801360|FG001|Open-Label Phase (up to Week 52)|Adverse Event|1|||
48713247|NCT02405442|156801361|FG002|Open-Label Phase (up to Week 52)|Adverse Event|2|||
48713248|NCT02405442|156801362|FG003|Open-Label Phase (up to Week 52)|Adverse Event|6|||
48713249|NCT02405442|156801359|FG000|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0|||
48713250|NCT02405442|156801360|FG001|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1|||
48713251|NCT02405442|156801361|FG002|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3|||
48713252|NCT02405442|156801362|FG003|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2|||
48713253|NCT02405442|156801359|FG000|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
48713254|NCT02405442|156801360|FG001|Open-Label Phase (up to Week 52)|Withdrew Consent|2|||
48713255|NCT02405442|156801361|FG002|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
48713256|NCT02405442|156801362|FG003|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
48713257|NCT02405442|156801359|FG000|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
48713258|NCT02405442|156801360|FG001|Open-Label Phase (up to Week 52)|Lack of Efficacy|1|||
48713259|NCT02405442|156801361|FG002|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
48713260|NCT02405442|156801362|FG003|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
48713261|NCT02405442|156801359|FG000|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
48713262|NCT02405442|156801360|FG001|Open-Label Phase (up to Week 52)|Lost to Follow-up|1|||
48713263|NCT02405442|156801361|FG002|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
48713264|NCT02405442|156801362|FG003|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
48713265|NCT02405442|156801359|FG000|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
48713266|NCT02405442|156801360|FG001|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1|||
48713267|NCT02405442|156801361|FG002|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
48713268|NCT02405442|156801362|FG003|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
48713269|NCT02405442|156801359|FG000|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
48713270|NCT02405442|156801360|FG001|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1|||
48713271|NCT02405442|156801361|FG002|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
48713272|NCT02405442|156801362|FG003|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
48713273|NCT02405442|156801359|FG000|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1|||
48713274|NCT02405442|156801360|FG001|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
48713275|NCT02405442|156801361|FG002|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
48713276|NCT02405442|156801362|FG003|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
48713277|NCT01311024|156801364|FG000|Overall Study|Protocol Violation|35|||
48713278|NCT01311024|156801365|FG001|Overall Study|Protocol Violation|22|||
48713279|NCT02194985|156801366|FG000|Overall Study|Adverse Event|1|||
48713280|NCT02194985|156801366|FG000|Overall Study|Met Protocol Defined Stopping Criteria|3|||
48713281|NCT02194985|156801366|FG000|Overall Study|Physician Decision|4|||
48713282|NCT02194985|156801366|FG000|Overall Study|Lost to Follow-up|1|||
48713283|NCT02194985|156801366|FG000|Overall Study|Withdrawal by Subject|2|||
48713284|NCT00918736|156801369|FG000|Overall Study|Withdrawal by Subject|4|||
48713285|NCT03642132|156801370|FG000|Chemotherapy Period|Adverse Event|1|||
48713286|NCT03642132|156801371|FG001|Chemotherapy Period|Adverse Event|1|||
48713287|NCT03642132|156801372|FG002|Chemotherapy Period|Adverse Event|0|||
48713288|NCT03642132|156801370|FG000|Chemotherapy Period|Physician's decision|4|||
48713289|NCT03642132|156801371|FG001|Chemotherapy Period|Physician's decision|1|||
48713290|NCT03642132|156801372|FG002|Chemotherapy Period|Physician's decision|0|||
48713291|NCT03642132|156801370|FG000|Chemotherapy Period|Progressive disease|0|||
48713292|NCT03642132|156801371|FG001|Chemotherapy Period|Progressive disease|0|||
48812052|NCT02340520|157152180|FG000|Overall Study|Lost to Follow-up|1|||
48919535|NCT00490451|157539807|FG001|Overall Study|Death|1|||
48919536|NCT00490451|157539806|FG000|Overall Study|Withdrawal by Subject|2|||
48812053|NCT02340520|157152180|FG000|Overall Study|Patient did not take drug as specified|1|||
48812054|NCT02340520|157152180|FG000|Overall Study|Withdrawal by Subject|1|||
48812055|NCT04078035|157152181|FG000|Session 2|Lost to Follow-up|3|||
48812056|NCT04078035|157152182|FG001|Session 2|Lost to Follow-up|1|||
48812057|NCT04078035|157152181|FG000|Session 2|Unable to insert IV - participant elected to withdraw|8|||
48812058|NCT04078035|157152182|FG001|Session 2|Unable to insert IV - participant elected to withdraw|8|||
48812059|NCT01263106|157152190|FG000|Washout (at Least 7 Days)|Lost to Follow-up|1|||
49122836|NCT01296412|158286920|FG000|Overall Study|Lack of Efficacy|1|||
49122837|NCT01296412|158286921|FG001|Overall Study|Lack of Efficacy|0|||
49122838|NCT01296412|158286920|FG000|Overall Study|Lost to Follow-up|10|||
49122839|NCT01296412|158286921|FG001|Overall Study|Lost to Follow-up|7|||
49122840|NCT01296412|158286920|FG000|Overall Study|Non-compliance with study drug|1|||
49122841|NCT01296412|158286921|FG001|Overall Study|Non-compliance with study drug|2|||
49122842|NCT01296412|158286920|FG000|Overall Study|Other reason not specified|20|||
49122843|NCT01296412|158286921|FG001|Overall Study|Other reason not specified|15|||
49122844|NCT01296412|158286920|FG000|Overall Study|Physician Decision|1|||
49122845|NCT01296412|158286921|FG001|Overall Study|Physician Decision|3|||
49122846|NCT01296412|158286920|FG000|Overall Study|Pregnancy|0|||
49122847|NCT01296412|158286921|FG001|Overall Study|Pregnancy|1|||
49122848|NCT01296412|158286920|FG000|Overall Study|Withdrawal by Subject|10|||
49122849|NCT01296412|158286921|FG001|Overall Study|Withdrawal by Subject|13|||
49122850|NCT05259163|158289137|FG000|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|1|||
49122851|NCT05259163|158289138|FG001|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|0|||
49122852|NCT01381926|158289139|FG000|Low/High Dose of 1st Treatment (2months)|Adverse Event|2|||
49122853|NCT01381926|158289140|FG001|Low/High Dose of 1st Treatment (2months)|Adverse Event|0|||
49122854|NCT01381926|158289139|FG000|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0|||
49122855|NCT01381926|158289140|FG001|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1|||
49122856|NCT01212094|158289141|FG000|Year 1: Baseline Monitoring|Study terminated|7|||
49122857|NCT01212094|158289142|FG001|Year 1: Baseline Monitoring|Study terminated|0|||
49122858|NCT01212094|158289143|FG002|Year 1: Baseline Monitoring|Study terminated|0|||
49122859|NCT01212094|158289141|FG000|Year 1: Baseline Monitoring|Withdrawal by Subject|7|||
49122860|NCT01212094|158289142|FG001|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
49122861|NCT01212094|158289143|FG002|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
49122862|NCT01212094|158289141|FG000|Year 1: Baseline Monitoring|Started on DMT|2|||
49122863|NCT01212094|158289142|FG001|Year 1: Baseline Monitoring|Started on DMT|0|||
49122864|NCT01212094|158289143|FG002|Year 1: Baseline Monitoring|Started on DMT|0|||
49122865|NCT01212094|158289141|FG000|Years 2 & 3: Treatment Randomization|Study terminated|0|||
48713293|NCT03642132|156801372|FG002|Chemotherapy Period|Progressive disease|1|||
48713294|NCT03642132|156801370|FG000|Chemotherapy Period|Study terminated by sponsor|0|||
48713295|NCT03642132|156801371|FG001|Chemotherapy Period|Study terminated by sponsor|0|||
48713296|NCT03642132|156801372|FG002|Chemotherapy Period|Study terminated by sponsor|3|||
48713297|NCT03642132|156801370|FG000|Chemotherapy Period|Other|1|||
48713298|NCT03642132|156801371|FG001|Chemotherapy Period|Other|0|||
48713299|NCT03642132|156801372|FG002|Chemotherapy Period|Other|2|||
48713300|NCT03642132|156801370|FG000|Chemotherapy Period|Withdrawal by Subject|7|||
48713301|NCT03642132|156801371|FG001|Chemotherapy Period|Withdrawal by Subject|3|||
48713302|NCT03642132|156801372|FG002|Chemotherapy Period|Withdrawal by Subject|1|||
48713303|NCT03642132|156801370|FG000|Maintenance Period|Adverse Event|1|||
48713304|NCT03642132|156801371|FG001|Maintenance Period|Adverse Event|2|||
48713305|NCT03642132|156801372|FG002|Maintenance Period|Adverse Event|0|||
48713306|NCT03642132|156801370|FG000|Maintenance Period|Non-compliance with study drug|0|||
48713307|NCT03642132|156801371|FG001|Maintenance Period|Non-compliance with study drug|0|||
48713308|NCT03642132|156801372|FG002|Maintenance Period|Non-compliance with study drug|1|||
48713309|NCT03642132|156801370|FG000|Maintenance Period|Physician's decision|2|||
48713310|NCT03642132|156801371|FG001|Maintenance Period|Physician's decision|2|||
48713311|NCT03642132|156801372|FG002|Maintenance Period|Physician's decision|2|||
48713312|NCT03642132|156801370|FG000|Maintenance Period|Progressive disease|9|||
48713313|NCT03642132|156801371|FG001|Maintenance Period|Progressive disease|3|||
48713314|NCT03642132|156801372|FG002|Maintenance Period|Progressive disease|6|||
48713315|NCT03642132|156801370|FG000|Maintenance Period|Other|0|||
48713316|NCT03642132|156801371|FG001|Maintenance Period|Other|0|||
48713317|NCT03642132|156801372|FG002|Maintenance Period|Other|3|||
48713318|NCT03642132|156801370|FG000|Maintenance Period|Withdrawal by Subject|1|||
48713319|NCT03642132|156801371|FG001|Maintenance Period|Withdrawal by Subject|1|||
48713320|NCT03642132|156801372|FG002|Maintenance Period|Withdrawal by Subject|2|||
48713321|NCT03642132|156801370|FG000|Follow-up Period|Other|0|||
48713322|NCT03642132|156801371|FG001|Follow-up Period|Other|0|||
48713323|NCT03642132|156801372|FG002|Follow-up Period|Other|1|||
48713324|NCT03642132|156801370|FG000|Follow-up Period|Withdrawal by Subject|1|||
48713325|NCT03642132|156801371|FG001|Follow-up Period|Withdrawal by Subject|2|||
48713326|NCT03642132|156801372|FG002|Follow-up Period|Withdrawal by Subject|0|||
48713327|NCT03642132|156801370|FG000|Follow-up Period|Study terminated by sponsor|1|||
48713328|NCT03642132|156801371|FG001|Follow-up Period|Study terminated by sponsor|0|||
49122866|NCT01212094|158289142|FG001|Years 2 & 3: Treatment Randomization|Study terminated|4|||
49122867|NCT01212094|158289143|FG002|Years 2 & 3: Treatment Randomization|Study terminated|7|||
49122868|NCT01212094|158289141|FG000|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
49122869|NCT01212094|158289142|FG001|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
49122870|NCT01212094|158289143|FG002|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3|||
49122871|NCT01212094|158289141|FG000|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
49122872|NCT01212094|158289142|FG001|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
49122873|NCT01212094|158289143|FG002|Years 2 & 3: Treatment Randomization|Adverse Event|1|||
49122874|NCT02486692|158289144|FG000|Overall Study|did not login for randomization|4|||
49122875|NCT02486692|158289145|FG001|Overall Study|did not login for randomization|7|||
49122876|NCT05137717|158289149|FG000|Overall Study|Death|2|||
49122877|NCT05137717|158289149|FG000|Overall Study|Withdrawal by Subject|6|||
49122878|NCT05556148|158289150|FG000|Overall Study|Early Termination|29|||
49122879|NCT05556148|158289150|FG000|Overall Study|Baseline Tasks Expired|4|||
49122880|NCT05556148|158289150|FG000|Overall Study|Family Emergency: Could no longer take part|1|||
49122881|NCT05556148|158289150|FG000|Overall Study|No Longer Wished to Participate|1|||
49122882|NCT05556148|158289150|FG000|Overall Study|Bacterial Conjunctivitis|1|||
49122883|NCT03131167|158289155|FG000|Overall Study|Other (Unspecified)|0|||
49122884|NCT03131167|158289156|FG001|Overall Study|Other (Unspecified)|0|||
49122885|NCT03131167|158289157|FG002|Overall Study|Other (Unspecified)|0|||
49122886|NCT03131167|158289158|FG003|Overall Study|Other (Unspecified)|0|||
49122887|NCT03131167|158289159|FG004|Overall Study|Other (Unspecified)|0|||
49122888|NCT03131167|158289160|FG005|Overall Study|Other (Unspecified)|1|||
49122889|NCT03131167|158289161|FG006|Overall Study|Other (Unspecified)|0|||
49122890|NCT03131167|158289162|FG007|Overall Study|Other (Unspecified)|0|||
49122891|NCT03131167|158289163|FG008|Overall Study|Other (Unspecified)|0|||
49122892|NCT03131167|158289164|FG009|Overall Study|Other (Unspecified)|0|||
49122893|NCT03131167|158289165|FG010|Overall Study|Other (Unspecified)|0|||
49122894|NCT03131167|158289166|FG011|Overall Study|Other (Unspecified)|0|||
49122895|NCT03131167|158289167|FG012|Overall Study|Other (Unspecified)|0|||
49122896|NCT03286218|158289168|FG000|Qualification Phase Period 1|Adverse Event|1|||
49122897|NCT03286218|158289169|FG001|Qualification Phase Period 1|Adverse Event|0|||
49122898|NCT03286218|158289170|FG002|Qualification Phase Period 1|Adverse Event|0|||
49122899|NCT03286218|158289171|FG003|Qualification Phase Period 1|Adverse Event|0|||
49122900|NCT03286218|158289172|FG004|Qualification Phase Period 1|Adverse Event|0|||
49122901|NCT03286218|158289173|FG005|Qualification Phase Period 1|Adverse Event|0|||
49122902|NCT03286218|158289174|FG006|Qualification Phase Period 1|Adverse Event|0|||
49122903|NCT03286218|158289175|FG007|Qualification Phase Period 1|Adverse Event|0|||
49122904|NCT03286218|158289176|FG008|Qualification Phase Period 1|Adverse Event|0|||
49122905|NCT03286218|158289177|FG009|Qualification Phase Period 1|Adverse Event|0|||
49122906|NCT03286218|158289178|FG010|Qualification Phase Period 1|Adverse Event|0|||
49122907|NCT03286218|158289179|FG011|Qualification Phase Period 1|Adverse Event|0|||
49122908|NCT03286218|158289168|FG000|Qualification Phase Period 1|Withdrawal by Subject|0|||
49122909|NCT03286218|158289169|FG001|Qualification Phase Period 1|Withdrawal by Subject|1|||
49122910|NCT03286218|158289170|FG002|Qualification Phase Period 1|Withdrawal by Subject|0|||
49122911|NCT03286218|158289171|FG003|Qualification Phase Period 1|Withdrawal by Subject|0|||
49122912|NCT03286218|158289172|FG004|Qualification Phase Period 1|Withdrawal by Subject|0|||
49122913|NCT03286218|158289173|FG005|Qualification Phase Period 1|Withdrawal by Subject|0|||
48812060|NCT01263106|157152191|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
48812061|NCT02009696|157152194|FG000|Overall Study|Withdrawal by Subject|2|||
48812062|NCT02936037|157153461|FG000|Double-Blind Treatment Period|Protocol Violation|1|||
48812063|NCT02936037|157153462|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
48812064|NCT02936037|157153461|FG000|Double-Blind Treatment Period|Suicidal risk, etc.|2|||
48812065|NCT02936037|157153462|FG001|Double-Blind Treatment Period|Suicidal risk, etc.|8|||
48812066|NCT02936037|157153461|FG000|Double-Blind Treatment Period|Lack of Efficacy|4|||
48812067|NCT02936037|157153462|FG001|Double-Blind Treatment Period|Lack of Efficacy|12|||
48812068|NCT02936037|157153461|FG000|Double-Blind Treatment Period|Death|0|||
48812069|NCT02936037|157153462|FG001|Double-Blind Treatment Period|Death|1|||
48812070|NCT02936037|157153461|FG000|Double-Blind Treatment Period|Adverse Event|11|||
48812071|NCT02936037|157153462|FG001|Double-Blind Treatment Period|Adverse Event|11|||
48812072|NCT02936037|157153461|FG000|Double-Blind Treatment Period|Withdrawal by Subject|31|||
48812073|NCT02936037|157153462|FG001|Double-Blind Treatment Period|Withdrawal by Subject|28|||
49122914|NCT03286218|158289174|FG006|Qualification Phase Period 1|Withdrawal by Subject|0|||
49122915|NCT03286218|158289175|FG007|Qualification Phase Period 1|Withdrawal by Subject|0|||
49122916|NCT03286218|158289176|FG008|Qualification Phase Period 1|Withdrawal by Subject|0|||
49122917|NCT03286218|158289177|FG009|Qualification Phase Period 1|Withdrawal by Subject|0|||
49122918|NCT03286218|158289178|FG010|Qualification Phase Period 1|Withdrawal by Subject|0|||
49122919|NCT03286218|158289179|FG011|Qualification Phase Period 1|Withdrawal by Subject|0|||
49122920|NCT03286218|158289168|FG000|Qualification Phase Period 2|Adverse Event|0|||
49122921|NCT03286218|158289169|FG001|Qualification Phase Period 2|Adverse Event|1|||
49122922|NCT03286218|158289170|FG002|Qualification Phase Period 2|Adverse Event|0|||
49122923|NCT03286218|158289171|FG003|Qualification Phase Period 2|Adverse Event|0|||
49122924|NCT03286218|158289172|FG004|Qualification Phase Period 2|Adverse Event|0|||
49122925|NCT03286218|158289173|FG005|Qualification Phase Period 2|Adverse Event|0|||
49122926|NCT03286218|158289174|FG006|Qualification Phase Period 2|Adverse Event|0|||
49122927|NCT03286218|158289175|FG007|Qualification Phase Period 2|Adverse Event|0|||
49122928|NCT03286218|158289176|FG008|Qualification Phase Period 2|Adverse Event|0|||
48812074|NCT02936037|157153461|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
48812075|NCT02936037|157153462|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
48812076|NCT02936037|157153461|FG000|Open Label Extension|Adverse Event|0|||
48812077|NCT02936037|157153462|FG001|Open Label Extension|Adverse Event|3|||
48812078|NCT02936037|157153461|FG000|Open Label Extension|Other|0|||
48812079|NCT02936037|157153462|FG001|Open Label Extension|Other|3|||
48812080|NCT02936037|157153461|FG000|Open Label Extension|Withdrawal by Subject|0|||
48812081|NCT02936037|157153462|FG001|Open Label Extension|Withdrawal by Subject|4|||
48812082|NCT01862991|157153463|FG000|Overall Study|Lost to Follow-up|2|||
48812083|NCT01862991|157153464|FG001|Overall Study|Lost to Follow-up|1|||
48812084|NCT01862991|157153465|FG002|Overall Study|Lost to Follow-up|1|||
48812085|NCT01862991|157153463|FG000|Overall Study|Protocol Violation|1|||
48812086|NCT01862991|157153464|FG001|Overall Study|Protocol Violation|0|||
48812087|NCT01862991|157153465|FG002|Overall Study|Protocol Violation|0|||
48812088|NCT00453310|157153469|FG000|Overall Study|Progression of Disease|10|||
48812089|NCT04666922|157153470|FG000|Overall Study|Withdrawal by Subject|1|||
48812090|NCT04666922|157153471|FG001|Overall Study|Withdrawal by Subject|0|||
48812091|NCT04666922|157153472|FG002|Overall Study|Withdrawal by Subject|0|||
48812092|NCT04666922|157153473|FG003|Overall Study|Withdrawal by Subject|0|||
48812093|NCT04666922|157153474|FG004|Overall Study|Withdrawal by Subject|0|||
48812094|NCT04666922|157153475|FG005|Overall Study|Withdrawal by Subject|0|||
48812095|NCT04666922|157153476|FG006|Overall Study|Withdrawal by Subject|0|||
48812096|NCT00857805|157153480|FG000|Overall Study|Withdrawal by Subject|1|||
48812097|NCT00857805|157153481|FG001|Overall Study|Withdrawal by Subject|1|||
48812098|NCT04105972|157153483|FG000|Overall Study|Adverse Event|2|||
48812099|NCT04105972|157153484|FG001|Overall Study|Adverse Event|1|||
48812100|NCT02305381|157153485|FG000|Overall Study|Unclassified|5|||
48812101|NCT02305381|157153486|FG001|Overall Study|Unclassified|5|||
48919537|NCT00490451|157539807|FG001|Overall Study|Withdrawal by Subject|0|||
48919538|NCT00490451|157539806|FG000|Overall Study|Investigator Decision|1|||
48919539|NCT00490451|157539807|FG001|Overall Study|Investigator Decision|0|||
48713329|NCT03642132|156801372|FG002|Follow-up Period|Study terminated by sponsor|1|||
48713330|NCT03642132|156801370|FG000|Follow-up Period|Lack of Efficacy|1|||
48713331|NCT03642132|156801371|FG001|Follow-up Period|Lack of Efficacy|0|||
48713332|NCT03642132|156801372|FG002|Follow-up Period|Lack of Efficacy|0|||
48713333|NCT03642132|156801370|FG000|Follow-up Period|Death|1|||
48713334|NCT03642132|156801371|FG001|Follow-up Period|Death|0|||
48713335|NCT03642132|156801372|FG002|Follow-up Period|Death|2|||
48713336|NCT03642132|156801370|FG000|Follow-up Period|Adverse Event|1|||
48713337|NCT03642132|156801371|FG001|Follow-up Period|Adverse Event|0|||
48713338|NCT03642132|156801372|FG002|Follow-up Period|Adverse Event|0|||
48713339|NCT03801031|156801377|FG000|Overall Study|Lost to Follow-up|1|||
48713340|NCT03801031|156801378|FG001|Overall Study|Lost to Follow-up|0|||
48713341|NCT03801031|156801377|FG000|Overall Study|Unable to comply|1|||
48713342|NCT03801031|156801378|FG001|Overall Study|Unable to comply|0|||
48713343|NCT03801031|156801377|FG000|Overall Study|Withdrawal by Subject|0|||
48713344|NCT03801031|156801378|FG001|Overall Study|Withdrawal by Subject|1|||
48713345|NCT02948088|156801379|FG000|Overall Study|Lost to Follow-up|8|||
48713346|NCT02948088|156801379|FG000|Overall Study|Death|1|||
48713347|NCT02948088|156801379|FG000|Overall Study|Withdrawal by Subject|4|||
48713348|NCT02948088|156801379|FG000|Overall Study|Other|2|||
48713349|NCT03337490|156801383|FG000|Overall Study|Withdrawal by Subject|1|||
48713350|NCT03337490|156801384|FG001|Overall Study|Withdrawal by Subject|0|||
48713351|NCT03337490|156801385|FG002|Overall Study|Withdrawal by Subject|0|||
48713352|NCT03337490|156801383|FG000|Overall Study|Lack of Efficacy|10|||
48713353|NCT03337490|156801384|FG001|Overall Study|Lack of Efficacy|12|||
48713354|NCT03337490|156801385|FG002|Overall Study|Lack of Efficacy|35|||
48713355|NCT03337490|156801383|FG000|Overall Study|Physician Decision|0|||
48713356|NCT03337490|156801384|FG001|Overall Study|Physician Decision|1|||
48713357|NCT03337490|156801385|FG002|Overall Study|Physician Decision|0|||
48713358|NCT03337490|156801383|FG000|Overall Study|Lost to Follow-up|0|||
48713359|NCT03337490|156801384|FG001|Overall Study|Lost to Follow-up|1|||
48713360|NCT03337490|156801385|FG002|Overall Study|Lost to Follow-up|0|||
48713361|NCT01776307|156801386|FG000|Overall Study|Not dosed|0|||
48713362|NCT01776307|156801387|FG001|Overall Study|Not dosed|0|||
48713363|NCT01776307|156801388|FG002|Overall Study|Not dosed|1|||
48713364|NCT00573144|156801389|FG000|Overall Study|Withdrawal by Subject|2|||
48713365|NCT00573144|156801390|FG001|Overall Study|Withdrawal by Subject|3|||
48713366|NCT04450381|156801391|FG000|Overall Study|Protocol Violation|4|||
48812102|NCT02305381|157153487|FG002|Overall Study|Unclassified|7|||
48812103|NCT00553202|157153495|FG000|Overall Study|Death|16|||
48812104|NCT00553202|157153495|FG000|Overall Study|Lost to Follow-up|1|||
48812105|NCT00553202|157153495|FG000|Overall Study|Physician Decision|28|||
48812106|NCT00553202|157153495|FG000|Overall Study|Withdrawal by Subject|1|||
48812107|NCT00553202|157153495|FG000|Overall Study|No donor identified|16|||
48812108|NCT00553202|157153495|FG000|Overall Study|Fails to meet organ function|6|||
48812109|NCT00077636|157153496|FG000|Overall Study|Refused Treatment|9|||
48812110|NCT00077636|157153497|FG001|Overall Study|Refused Treatment|31|||
48812111|NCT00077636|157153496|FG000|Overall Study|Admin|3|||
48812112|NCT00077636|157153497|FG001|Overall Study|Admin|3|||
48812113|NCT00077636|157153496|FG000|Overall Study|Withdrawal by Subject|2|||
48812114|NCT00077636|157153497|FG001|Overall Study|Withdrawal by Subject|2|||
48812115|NCT00077636|157153496|FG000|Overall Study|Adverse Event|17|||
48812116|NCT00077636|157153497|FG001|Overall Study|Adverse Event|34|||
48812117|NCT00077636|157153496|FG000|Overall Study|Protocol Violation|0|||
48812118|NCT00077636|157153497|FG001|Overall Study|Protocol Violation|2|||
48812119|NCT00077636|157153496|FG000|Overall Study|Lost to Follow-up|10|||
48812120|NCT00077636|157153497|FG001|Overall Study|Lost to Follow-up|18|||
48812121|NCT00077636|157153496|FG000|Overall Study|Abnormality Of Laboratory Test|3|||
48812122|NCT00077636|157153497|FG001|Overall Study|Abnormality Of Laboratory Test|2|||
48812123|NCT01923896|157153502|FG000|Overall Study|Adverse Event|1|||
48812124|NCT01923896|157153503|FG001|Overall Study|Adverse Event|0|||
48812125|NCT00474929|157153508|FG000|Overall Study|Withdrawal by Subject|0|||
48812126|NCT00474929|157153509|FG001|Overall Study|Withdrawal by Subject|1|||
48812127|NCT00474929|157153510|FG002|Overall Study|Withdrawal by Subject|0|||
48812128|NCT00474929|157153511|FG003|Overall Study|Withdrawal by Subject|0|||
48812129|NCT00474929|157153512|FG004|Overall Study|Withdrawal by Subject|0|||
48812130|NCT00474929|157153508|FG000|Overall Study|Unrelated medical condition|0|||
48812131|NCT00474929|157153509|FG001|Overall Study|Unrelated medical condition|0|||
48812132|NCT00474929|157153510|FG002|Overall Study|Unrelated medical condition|1|||
48812133|NCT00474929|157153511|FG003|Overall Study|Unrelated medical condition|0|||
48812134|NCT00474929|157153512|FG004|Overall Study|Unrelated medical condition|0|||
48812135|NCT00474929|157153508|FG000|Overall Study|Physician Decision|0|||
48812136|NCT00474929|157153509|FG001|Overall Study|Physician Decision|0|||
48812137|NCT00474929|157153510|FG002|Overall Study|Physician Decision|1|||
48812138|NCT00474929|157153511|FG003|Overall Study|Physician Decision|2|||
48812139|NCT00474929|157153512|FG004|Overall Study|Physician Decision|0|||
48812140|NCT00068380|157153513|FG000|Overall Study|Withdrawal by Subject|3|||
48812141|NCT00068380|157153513|FG000|Overall Study|Adverse Event|2|||
48812142|NCT01976364|157153514|FG000|Main Study (36 Months)|Adverse Event|63|||
48812143|NCT01976364|157153515|FG001|Main Study (36 Months)|Adverse Event|0|||
48812144|NCT01976364|157153516|FG002|Main Study (36 Months)|Adverse Event|0|||
48812145|NCT01976364|157153514|FG000|Main Study (36 Months)|Withdrawn due to pregnancy|5|||
48812146|NCT01976364|157153515|FG001|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
48812147|NCT01976364|157153516|FG002|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
48812148|NCT01976364|157153514|FG000|Main Study (36 Months)|Other|13|||
48812149|NCT01976364|157153515|FG001|Main Study (36 Months)|Other|0|||
48812150|NCT01976364|157153516|FG002|Main Study (36 Months)|Other|0|||
48812151|NCT01976364|157153514|FG000|Main Study (36 Months)|No longer met eligibility criteria|2|||
48812152|NCT01976364|157153515|FG001|Main Study (36 Months)|No longer met eligibility criteria|0|||
48812153|NCT01976364|157153516|FG002|Main Study (36 Months)|No longer met eligibility criteria|0|||
48812154|NCT01976364|157153514|FG000|Main Study (36 Months)|Medication error|1|||
48812155|NCT01976364|157153515|FG001|Main Study (36 Months)|Medication error|0|||
48812156|NCT01976364|157153516|FG002|Main Study (36 Months)|Medication error|0|||
48812157|NCT01976364|157153514|FG000|Main Study (36 Months)|Lost to Follow-up|10|||
48812158|NCT01976364|157153515|FG001|Main Study (36 Months)|Lost to Follow-up|0|||
48812159|NCT01976364|157153516|FG002|Main Study (36 Months)|Lost to Follow-up|0|||
48812160|NCT01976364|157153514|FG000|Main Study (36 Months)|Lack of Efficacy|40|||
48812161|NCT01976364|157153515|FG001|Main Study (36 Months)|Lack of Efficacy|0|||
48812162|NCT01976364|157153516|FG002|Main Study (36 Months)|Lack of Efficacy|0|||
48812163|NCT01976364|157153514|FG000|Main Study (36 Months)|Protocol Violation|13|||
48812164|NCT01976364|157153515|FG001|Main Study (36 Months)|Protocol Violation|0|||
48812165|NCT01976364|157153516|FG002|Main Study (36 Months)|Protocol Violation|0|||
48812166|NCT01976364|157153514|FG000|Main Study (36 Months)|Withdrawal by Subject|69|||
48812167|NCT01976364|157153515|FG001|Main Study (36 Months)|Withdrawal by Subject|0|||
48812168|NCT01976364|157153516|FG002|Main Study (36 Months)|Withdrawal by Subject|0|||
48812169|NCT01976364|157153514|FG000|Main Study (36 Months)|Death|5|||
48812170|NCT01976364|157153515|FG001|Main Study (36 Months)|Death|0|||
48812171|NCT01976364|157153516|FG002|Main Study (36 Months)|Death|0|||
48812172|NCT01976364|157153514|FG000|Sub-study (12 Months)|Lost to Follow-up|0|||
48812173|NCT01976364|157153515|FG001|Sub-study (12 Months)|Lost to Follow-up|1|||
48812174|NCT01976364|157153516|FG002|Sub-study (12 Months)|Lost to Follow-up|0|||
48812175|NCT01976364|157153514|FG000|Sub-study (12 Months)|Withdrawal by Subject|0|||
48812176|NCT01976364|157153515|FG001|Sub-study (12 Months)|Withdrawal by Subject|0|||
48812177|NCT01976364|157153516|FG002|Sub-study (12 Months)|Withdrawal by Subject|1|||
49122929|NCT03286218|158289177|FG009|Qualification Phase Period 2|Adverse Event|0|||
49122930|NCT03286218|158289178|FG010|Qualification Phase Period 2|Adverse Event|0|||
48812178|NCT01976364|157153514|FG000|Sub-study (12 Months)|Protocol Violation|0|||
48919540|NCT00490451|157539806|FG000|Overall Study|Protocol Violation|1|||
48919541|NCT00490451|157539807|FG001|Overall Study|Protocol Violation|0|||
48919542|NCT00490451|157539806|FG000|Overall Study|Progressive Disease|53|||
48919543|NCT00490451|157539807|FG001|Overall Study|Progressive Disease|34|||
48919544|NCT01624662|157539808|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
48713367|NCT04450381|156801391|FG000|Overall Study|Wrong device setting|2|||
48713368|NCT01090323|156801392|FG000|Overall Study|Adverse Event|12|||
48713369|NCT01090323|156801393|FG001|Overall Study|Adverse Event|2|||
48919545|NCT01624662|157539809|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
48919546|NCT01624662|157539810|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
48919547|NCT01624662|157539811|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0|||
48919548|NCT01624662|157539808|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5|||
48919549|NCT01624662|157539809|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1|||
48919550|NCT01624662|157539810|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
48919551|NCT01624662|157539811|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
48919552|NCT01624662|157539808|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
48919553|NCT01624662|157539809|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
48919554|NCT01624662|157539810|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
48919555|NCT01624662|157539811|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
48919556|NCT01624662|157539808|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
48919557|NCT01624662|157539809|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
48919558|NCT01624662|157539810|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
48919559|NCT01624662|157539811|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
48919560|NCT01624662|157539808|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
48919561|NCT01624662|157539809|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
48919562|NCT01624662|157539810|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
48919563|NCT01624662|157539811|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
48919564|NCT01624662|157539808|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
48919565|NCT01624662|157539809|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
48919566|NCT01624662|157539810|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
48919567|NCT01624662|157539811|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
48919568|NCT01624662|157539808|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
48919569|NCT01624662|157539809|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
48919570|NCT01624662|157539810|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
48919571|NCT01624662|157539811|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
48919572|NCT00401375|157539812|FG000|Overall Study|Protocol Violation|2|||
48919573|NCT00401375|157539813|FG001|Overall Study|Protocol Violation|2|||
48919574|NCT00401375|157539814|FG002|Overall Study|Protocol Violation|1|||
49122931|NCT03286218|158289179|FG011|Qualification Phase Period 2|Adverse Event|0|||
49122932|NCT03286218|158289168|FG000|Qualification Phase Period 2|Failure to meet randomization criteria|14|||
49122933|NCT03286218|158289169|FG001|Qualification Phase Period 2|Failure to meet randomization criteria|15|||
49122934|NCT03286218|158289170|FG002|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
49122935|NCT03286218|158289171|FG003|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
48713370|NCT01090323|156801392|FG000|Overall Study|Abnormal Lab Values|3|||
48713371|NCT01090323|156801393|FG001|Overall Study|Abnormal Lab Values|1|||
48713372|NCT01090323|156801392|FG000|Overall Study|Abnormal Test Procedure Results|2|||
48713373|NCT01090323|156801393|FG001|Overall Study|Abnormal Test Procedure Results|0|||
48713374|NCT01090323|156801392|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
48713375|NCT01090323|156801393|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
48713376|NCT01090323|156801392|FG000|Overall Study|Condition no longer requires drug|5|||
48713377|NCT01090323|156801393|FG001|Overall Study|Condition no longer requires drug|4|||
48713378|NCT01090323|156801392|FG000|Overall Study|Protocol Violation|2|||
48713379|NCT01090323|156801393|FG001|Overall Study|Protocol Violation|1|||
48713380|NCT01090323|156801392|FG000|Overall Study|Withdrew consent|33|||
48713381|NCT01090323|156801393|FG001|Overall Study|Withdrew consent|11|||
48713382|NCT01090323|156801392|FG000|Overall Study|Lost to Follow-up|11|||
48713383|NCT01090323|156801393|FG001|Overall Study|Lost to Follow-up|6|||
48713384|NCT01090323|156801392|FG000|Overall Study|Administrative problems|6|||
48713385|NCT01090323|156801393|FG001|Overall Study|Administrative problems|4|||
48713386|NCT01090323|156801392|FG000|Overall Study|Death|1|||
48713387|NCT01090323|156801393|FG001|Overall Study|Death|2|||
48713388|NCT01090323|156801392|FG000|Overall Study|Stopped end of core|7|||
48713389|NCT01090323|156801393|FG001|Overall Study|Stopped end of core|0|||
48713390|NCT01090323|156801392|FG000|Overall Study|Stopped end of extension 1#|3|||
48919575|NCT00401375|157539812|FG000|Overall Study|Adverse Event|6|||
48919576|NCT00401375|157539813|FG001|Overall Study|Adverse Event|11|||
48713391|NCT01090323|156801393|FG001|Overall Study|Stopped end of extension 1#|1|||
48713392|NCT01864005|156801394|FG000|Overall Study|Protocol Violation|0|||
48713393|NCT01864005|156801395|FG001|Overall Study|Protocol Violation|1|||
48812179|NCT01976364|157153515|FG001|Sub-study (12 Months)|Protocol Violation|1|||
48919577|NCT00401375|157539814|FG002|Overall Study|Adverse Event|10|||
48919578|NCT00401375|157539812|FG000|Overall Study|Withdrawal by Subject|9|||
48919579|NCT00401375|157539813|FG001|Overall Study|Withdrawal by Subject|7|||
48919580|NCT00401375|157539814|FG002|Overall Study|Withdrawal by Subject|7|||
48919581|NCT00401375|157539812|FG000|Overall Study|Lost to Follow-up|0|||
48919582|NCT00401375|157539813|FG001|Overall Study|Lost to Follow-up|1|||
48919583|NCT00401375|157539814|FG002|Overall Study|Lost to Follow-up|1|||
48919584|NCT00401375|157539812|FG000|Overall Study|Other than specified|2|||
48919585|NCT00401375|157539813|FG001|Overall Study|Other than specified|1|||
48919586|NCT00401375|157539814|FG002|Overall Study|Other than specified|3|||
48919587|NCT00401375|157539812|FG000|Overall Study|Randomized but not treated|3|||
48919588|NCT00401375|157539813|FG001|Overall Study|Randomized but not treated|3|||
48919589|NCT00401375|157539814|FG002|Overall Study|Randomized but not treated|3|||
48919590|NCT00361270|157539815|FG000|Overall Study|Death|0|||
48919591|NCT00361270|157539816|FG001|Overall Study|Death|0|||
48919592|NCT00361270|157539817|FG002|Overall Study|Death|0|||
48919593|NCT00361270|157539818|FG003|Overall Study|Death|2|||
48919594|NCT00361270|157539815|FG000|Overall Study|Lost to Follow-up|4|||
48713394|NCT01864005|156801394|FG000|Overall Study|Withdrawal by Subject|0|||
48713395|NCT01864005|156801395|FG001|Overall Study|Withdrawal by Subject|1|||
48713396|NCT01864005|156801394|FG000|Overall Study|Incorrect enrolment|1|||
48713397|NCT01864005|156801395|FG001|Overall Study|Incorrect enrolment|0|||
48713398|NCT01864005|156801394|FG000|Overall Study|Disease need|1|||
48713399|NCT01864005|156801395|FG001|Overall Study|Disease need|1|||
48713400|NCT01864005|156801394|FG000|Overall Study|Need GP IIb/IIIa|1|||
48713401|NCT01864005|156801395|FG001|Overall Study|Need GP IIb/IIIa|3|||
48919595|NCT00361270|157539816|FG001|Overall Study|Lost to Follow-up|1|||
48919596|NCT00361270|157539817|FG002|Overall Study|Lost to Follow-up|0|||
48919597|NCT00361270|157539818|FG003|Overall Study|Lost to Follow-up|0|||
48919598|NCT00361270|157539815|FG000|Overall Study|Physician Decision|0|||
48713402|NCT00763698|156801398|FG000|Overall Study|Unsuccessful Implant|5|||
48713403|NCT00763698|156801398|FG000|Overall Study|Death|4|||
48713404|NCT00763698|156801398|FG000|Overall Study|Withdrawal by Subject|1|||
48919599|NCT00361270|157539816|FG001|Overall Study|Physician Decision|0|||
48919600|NCT00361270|157539817|FG002|Overall Study|Physician Decision|1|||
48919601|NCT00361270|157539818|FG003|Overall Study|Physician Decision|0|||
48919602|NCT00361270|157539815|FG000|Overall Study|Protocol Violation|9|||
48919603|NCT00361270|157539816|FG001|Overall Study|Protocol Violation|4|||
48919604|NCT00361270|157539817|FG002|Overall Study|Protocol Violation|5|||
48919605|NCT00361270|157539818|FG003|Overall Study|Protocol Violation|4|||
48713405|NCT00344487|156801399|FG000|Overall Study|immunologic failure|1|||
48713406|NCT02059291|156801400|FG000|Epoch 2|Lack of Efficacy|0|||
48713407|NCT02059291|156801401|FG001|Epoch 2|Lack of Efficacy|0|||
48713408|NCT02059291|156801402|FG002|Epoch 2|Lack of Efficacy|0|||
48713409|NCT02059291|156801403|FG003|Epoch 2|Lack of Efficacy|1|||
48713410|NCT02059291|156801404|FG004|Epoch 2|Lack of Efficacy|0|||
48713411|NCT02059291|156801405|FG005|Epoch 2|Lack of Efficacy|1|||
48713412|NCT02059291|156801406|FG006|Epoch 2|Lack of Efficacy|0|||
48713413|NCT02059291|156801407|FG007|Epoch 2|Lack of Efficacy|0|||
48812180|NCT01976364|157153516|FG002|Sub-study (12 Months)|Protocol Violation|1|||
48919606|NCT00361270|157539815|FG000|Overall Study|Withdrawal by Subject|6|||
48919607|NCT00361270|157539816|FG001|Overall Study|Withdrawal by Subject|6|||
48919608|NCT00361270|157539817|FG002|Overall Study|Withdrawal by Subject|3|||
48919609|NCT00361270|157539818|FG003|Overall Study|Withdrawal by Subject|7|||
48919610|NCT00361270|157539815|FG000|Overall Study|Afraid of Hypnosis|1|||
49010878|NCT02454972|157877336|FG000|Overall Study|Treatment-related adverse events|0|||
49010879|NCT02454972|157877337|FG001|Overall Study|Treatment-related adverse events|1|||
49010880|NCT02454972|157877338|FG002|Overall Study|Treatment-related adverse events|1|||
49010881|NCT02454972|157877339|FG003|Overall Study|Treatment-related adverse events|0|||
49010882|NCT02454972|157877340|FG004|Overall Study|Treatment-related adverse events|2|||
49010883|NCT02454972|157877341|FG005|Overall Study|Treatment-related adverse events|0|||
49010884|NCT02454972|157877342|FG006|Overall Study|Treatment-related adverse events|0|||
49010885|NCT02454972|157877343|FG007|Overall Study|Treatment-related adverse events|2|||
49010886|NCT02454972|157877344|FG008|Overall Study|Treatment-related adverse events|0|||
49010887|NCT02454972|157877336|FG000|Overall Study|Patient moves to compassionate use|0|||
49010888|NCT02454972|157877337|FG001|Overall Study|Patient moves to compassionate use|0|||
49010889|NCT02454972|157877338|FG002|Overall Study|Patient moves to compassionate use|0|||
49010890|NCT02454972|157877339|FG003|Overall Study|Patient moves to compassionate use|0|||
49010891|NCT02454972|157877340|FG004|Overall Study|Patient moves to compassionate use|0|||
49010892|NCT02454972|157877341|FG005|Overall Study|Patient moves to compassionate use|0|||
49010893|NCT02454972|157877342|FG006|Overall Study|Patient moves to compassionate use|2|||
49010894|NCT02454972|157877343|FG007|Overall Study|Patient moves to compassionate use|0|||
49010895|NCT02454972|157877344|FG008|Overall Study|Patient moves to compassionate use|0|||
49010896|NCT02454972|157877336|FG000|Overall Study|Withdrawal by Subject|0|||
49010897|NCT02454972|157877337|FG001|Overall Study|Withdrawal by Subject|1|||
49010898|NCT02454972|157877338|FG002|Overall Study|Withdrawal by Subject|5|||
49010899|NCT02454972|157877339|FG003|Overall Study|Withdrawal by Subject|2|||
49010900|NCT02454972|157877340|FG004|Overall Study|Withdrawal by Subject|3|||
49122936|NCT03286218|158289172|FG004|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
49122937|NCT03286218|158289173|FG005|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
49122938|NCT03286218|158289174|FG006|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
49122939|NCT03286218|158289175|FG007|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
49122940|NCT03286218|158289176|FG008|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
49122941|NCT03286218|158289177|FG009|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
49122942|NCT03286218|158289178|FG010|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
49122943|NCT03286218|158289179|FG011|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
49122944|NCT03286218|158289168|FG000|Qualification Phase Period 2|Lost to Follow-up|0|||
48713414|NCT02059291|156801408|FG008|Epoch 2|Lack of Efficacy|0|||
48713415|NCT02059291|156801409|FG009|Epoch 2|Lack of Efficacy|0|||
48713416|NCT02059291|156801410|FG010|Epoch 2|Lack of Efficacy|0|||
49122945|NCT03286218|158289169|FG001|Qualification Phase Period 2|Lost to Follow-up|1|||
49122946|NCT03286218|158289170|FG002|Qualification Phase Period 2|Lost to Follow-up|0|||
48713417|NCT02059291|156801411|FG011|Epoch 2|Lack of Efficacy|0|||
48713418|NCT02059291|156801412|FG012|Epoch 2|Lack of Efficacy|0|||
48713419|NCT02059291|156801413|FG013|Epoch 2|Lack of Efficacy|0|||
48713420|NCT02059291|156801414|FG014|Epoch 2|Lack of Efficacy|0|||
48812181|NCT01976364|157153514|FG000|Sub-study (12 Months)|Adverse Event|0|||
48812182|NCT01976364|157153515|FG001|Sub-study (12 Months)|Adverse Event|4|||
48812183|NCT01976364|157153516|FG002|Sub-study (12 Months)|Adverse Event|3|||
48812184|NCT03239873|157153517|FG000|Overall Study|Lost to Follow-up|15|||
48812185|NCT03239873|157153518|FG001|Overall Study|Lost to Follow-up|16|||
48812186|NCT03239873|157153517|FG000|Overall Study|Physician Decision|1|||
48812187|NCT03239873|157153518|FG001|Overall Study|Physician Decision|0|||
48812188|NCT03239873|157153517|FG000|Overall Study|Withdrawal by Parent/Guardian|12|||
48812189|NCT03239873|157153518|FG001|Overall Study|Withdrawal by Parent/Guardian|11|||
48812190|NCT03239873|157153517|FG000|Overall Study|Withdrawal by Subject|2|||
48812191|NCT03239873|157153518|FG001|Overall Study|Withdrawal by Subject|0|||
48812192|NCT03239873|157153517|FG000|Overall Study|Contraindication to study medication|1|||
48812193|NCT03239873|157153518|FG001|Overall Study|Contraindication to study medication|0|||
48812194|NCT03239873|157153517|FG000|Overall Study|Protocol Violation|1|||
48812195|NCT03239873|157153518|FG001|Overall Study|Protocol Violation|0|||
48812196|NCT02960763|157153519|FG000|Step 1|Withdrawal by Subject|10|||
48812197|NCT02960763|157153520|FG001|Step 1|Withdrawal by Subject|8|||
48812198|NCT02960763|157153521|FG002|Step 1|Withdrawal by Subject|13|||
48812199|NCT02960763|157153522|FG003|Step 1|Withdrawal by Subject|0|||
48812200|NCT02960763|157153523|FG004|Step 1|Withdrawal by Subject|0|||
48812201|NCT02960763|157153519|FG000|Step 1|Lost to Follow-up|7|||
48812202|NCT02960763|157153520|FG001|Step 1|Lost to Follow-up|9|||
48812203|NCT02960763|157153521|FG002|Step 1|Lost to Follow-up|12|||
48812204|NCT02960763|157153522|FG003|Step 1|Lost to Follow-up|0|||
48812205|NCT02960763|157153523|FG004|Step 1|Lost to Follow-up|0|||
48919611|NCT00361270|157539816|FG001|Overall Study|Afraid of Hypnosis|2|||
48919612|NCT00361270|157539817|FG002|Overall Study|Afraid of Hypnosis|0|||
48919613|NCT00361270|157539818|FG003|Overall Study|Afraid of Hypnosis|0|||
48919614|NCT00361270|157539815|FG000|Overall Study|Problems with Transportation|4|||
48919615|NCT00361270|157539816|FG001|Overall Study|Problems with Transportation|0|||
48919616|NCT00361270|157539817|FG002|Overall Study|Problems with Transportation|0|||
48812206|NCT02960763|157153519|FG000|Step 1|Death|1|||
48812207|NCT02960763|157153520|FG001|Step 1|Death|1|||
48812208|NCT02960763|157153521|FG002|Step 1|Death|1|||
48812209|NCT02960763|157153522|FG003|Step 1|Death|0|||
48919617|NCT00361270|157539818|FG003|Overall Study|Problems with Transportation|0|||
48919618|NCT00361270|157539815|FG000|Overall Study|Adverse Event|0|||
48919619|NCT00361270|157539816|FG001|Overall Study|Adverse Event|1|||
48919620|NCT00361270|157539817|FG002|Overall Study|Adverse Event|1|||
48919621|NCT00361270|157539818|FG003|Overall Study|Adverse Event|0|||
48919622|NCT02821715|157539820|FG000|Overall Study|Protocol Violation|1|||
49122947|NCT03286218|158289171|FG003|Qualification Phase Period 2|Lost to Follow-up|0|||
49122948|NCT03286218|158289172|FG004|Qualification Phase Period 2|Lost to Follow-up|0|||
49122949|NCT03286218|158289173|FG005|Qualification Phase Period 2|Lost to Follow-up|0|||
49122950|NCT03286218|158289174|FG006|Qualification Phase Period 2|Lost to Follow-up|0|||
49122951|NCT03286218|158289175|FG007|Qualification Phase Period 2|Lost to Follow-up|0|||
49122952|NCT03286218|158289176|FG008|Qualification Phase Period 2|Lost to Follow-up|0|||
48812210|NCT02960763|157153523|FG004|Step 1|Death|0|||
48812211|NCT02960763|157153519|FG000|Step 1|Investigator discretion|1|||
48812212|NCT02960763|157153520|FG001|Step 1|Investigator discretion|0|||
48812213|NCT02960763|157153521|FG002|Step 1|Investigator discretion|1|||
48812214|NCT02960763|157153522|FG003|Step 1|Investigator discretion|0|||
48713421|NCT02059291|156801415|FG015|Epoch 2|Lack of Efficacy|0|||
48713422|NCT02059291|156801416|FG016|Epoch 2|Lack of Efficacy|0|||
48812215|NCT02960763|157153523|FG004|Step 1|Investigator discretion|0|||
48713423|NCT02059291|156801417|FG017|Epoch 2|Lack of Efficacy|0|||
48812216|NCT02960763|157153519|FG000|Step 1|Other|0|||
48812217|NCT02960763|157153520|FG001|Step 1|Other|0|||
48919623|NCT02821715|157539821|FG001|Overall Study|Protocol Violation|0|||
48713424|NCT02059291|156801418|FG018|Epoch 2|Lack of Efficacy|0|||
49122953|NCT03286218|158289177|FG009|Qualification Phase Period 2|Lost to Follow-up|0|||
49122954|NCT03286218|158289178|FG010|Qualification Phase Period 2|Lost to Follow-up|0|||
49122955|NCT03286218|158289179|FG011|Qualification Phase Period 2|Lost to Follow-up|0|||
49122956|NCT03286218|158289168|FG000|Qualification Phase Period 2|Protocol Violation|2|||
49122957|NCT03286218|158289169|FG001|Qualification Phase Period 2|Protocol Violation|0|||
49122958|NCT03286218|158289170|FG002|Qualification Phase Period 2|Protocol Violation|0|||
49122959|NCT03286218|158289171|FG003|Qualification Phase Period 2|Protocol Violation|0|||
48713425|NCT02059291|156801419|FG019|Epoch 2|Lack of Efficacy|0|||
48713426|NCT02059291|156801420|FG020|Epoch 2|Lack of Efficacy|0|||
48713427|NCT02059291|156801421|FG021|Epoch 2|Lack of Efficacy|0|||
48713428|NCT02059291|156801422|FG022|Epoch 2|Lack of Efficacy|0|||
48713429|NCT02059291|156801423|FG023|Epoch 2|Lack of Efficacy|0|||
48713430|NCT02059291|156801424|FG024|Epoch 2|Lack of Efficacy|0|||
48713431|NCT02059291|156801400|FG000|Epoch 2|Adverse Event|0|||
48713432|NCT02059291|156801401|FG001|Epoch 2|Adverse Event|0|||
48713433|NCT02059291|156801402|FG002|Epoch 2|Adverse Event|1|||
48713434|NCT02059291|156801403|FG003|Epoch 2|Adverse Event|1|||
48713435|NCT02059291|156801404|FG004|Epoch 2|Adverse Event|0|||
48713436|NCT02059291|156801405|FG005|Epoch 2|Adverse Event|0|||
48713437|NCT02059291|156801406|FG006|Epoch 2|Adverse Event|0|||
48713438|NCT02059291|156801407|FG007|Epoch 2|Adverse Event|1|||
48713439|NCT02059291|156801408|FG008|Epoch 2|Adverse Event|1|||
48713440|NCT02059291|156801409|FG009|Epoch 2|Adverse Event|0|||
48713441|NCT02059291|156801410|FG010|Epoch 2|Adverse Event|0|||
48713442|NCT02059291|156801411|FG011|Epoch 2|Adverse Event|0|||
48713443|NCT02059291|156801412|FG012|Epoch 2|Adverse Event|0|||
48713444|NCT02059291|156801413|FG013|Epoch 2|Adverse Event|0|||
48713445|NCT02059291|156801414|FG014|Epoch 2|Adverse Event|0|||
48713446|NCT02059291|156801415|FG015|Epoch 2|Adverse Event|0|||
48713447|NCT02059291|156801416|FG016|Epoch 2|Adverse Event|0|||
48713448|NCT02059291|156801417|FG017|Epoch 2|Adverse Event|0|||
48713449|NCT02059291|156801418|FG018|Epoch 2|Adverse Event|0|||
48713450|NCT02059291|156801419|FG019|Epoch 2|Adverse Event|0|||
48713451|NCT02059291|156801420|FG020|Epoch 2|Adverse Event|0|||
48713452|NCT02059291|156801421|FG021|Epoch 2|Adverse Event|0|||
48713453|NCT02059291|156801422|FG022|Epoch 2|Adverse Event|0|||
48713454|NCT02059291|156801423|FG023|Epoch 2|Adverse Event|0|||
48713455|NCT02059291|156801424|FG024|Epoch 2|Adverse Event|0|||
48713456|NCT02059291|156801400|FG000|Epoch 2|Withdrawal by Subject|0|||
48713457|NCT02059291|156801401|FG001|Epoch 2|Withdrawal by Subject|1|||
48713458|NCT02059291|156801402|FG002|Epoch 2|Withdrawal by Subject|0|||
48713459|NCT02059291|156801403|FG003|Epoch 2|Withdrawal by Subject|0|||
48713460|NCT02059291|156801404|FG004|Epoch 2|Withdrawal by Subject|0|||
48713461|NCT02059291|156801405|FG005|Epoch 2|Withdrawal by Subject|1|||
48713462|NCT02059291|156801406|FG006|Epoch 2|Withdrawal by Subject|0|||
48713463|NCT02059291|156801407|FG007|Epoch 2|Withdrawal by Subject|0|||
48713464|NCT02059291|156801408|FG008|Epoch 2|Withdrawal by Subject|1|||
48713465|NCT02059291|156801409|FG009|Epoch 2|Withdrawal by Subject|0|||
48713466|NCT02059291|156801410|FG010|Epoch 2|Withdrawal by Subject|0|||
48713467|NCT02059291|156801411|FG011|Epoch 2|Withdrawal by Subject|0|||
48713468|NCT02059291|156801412|FG012|Epoch 2|Withdrawal by Subject|0|||
48713469|NCT02059291|156801413|FG013|Epoch 2|Withdrawal by Subject|0|||
48713470|NCT02059291|156801414|FG014|Epoch 2|Withdrawal by Subject|0|||
48713471|NCT02059291|156801415|FG015|Epoch 2|Withdrawal by Subject|0|||
48713472|NCT02059291|156801416|FG016|Epoch 2|Withdrawal by Subject|0|||
48713473|NCT02059291|156801417|FG017|Epoch 2|Withdrawal by Subject|0|||
48713474|NCT02059291|156801418|FG018|Epoch 2|Withdrawal by Subject|0|||
48713475|NCT02059291|156801419|FG019|Epoch 2|Withdrawal by Subject|0|||
49122960|NCT03286218|158289172|FG004|Qualification Phase Period 2|Protocol Violation|0|||
49122961|NCT03286218|158289173|FG005|Qualification Phase Period 2|Protocol Violation|0|||
49122962|NCT03286218|158289174|FG006|Qualification Phase Period 2|Protocol Violation|0|||
49122963|NCT03286218|158289175|FG007|Qualification Phase Period 2|Protocol Violation|0|||
49122964|NCT03286218|158289176|FG008|Qualification Phase Period 2|Protocol Violation|0|||
49122965|NCT03286218|158289177|FG009|Qualification Phase Period 2|Protocol Violation|0|||
49122966|NCT03286218|158289178|FG010|Qualification Phase Period 2|Protocol Violation|0|||
49122967|NCT03286218|158289179|FG011|Qualification Phase Period 2|Protocol Violation|0|||
49122968|NCT03286218|158289168|FG000|Qualification Phase Period 2|Withdrawal by Subject|1|||
49122969|NCT03286218|158289169|FG001|Qualification Phase Period 2|Withdrawal by Subject|2|||
49122970|NCT03286218|158289170|FG002|Qualification Phase Period 2|Withdrawal by Subject|0|||
49122971|NCT03286218|158289171|FG003|Qualification Phase Period 2|Withdrawal by Subject|0|||
49122972|NCT03286218|158289172|FG004|Qualification Phase Period 2|Withdrawal by Subject|0|||
49122973|NCT03286218|158289173|FG005|Qualification Phase Period 2|Withdrawal by Subject|0|||
49122974|NCT03286218|158289174|FG006|Qualification Phase Period 2|Withdrawal by Subject|0|||
48713476|NCT02059291|156801420|FG020|Epoch 2|Withdrawal by Subject|0|||
48713477|NCT02059291|156801421|FG021|Epoch 2|Withdrawal by Subject|0|||
48713478|NCT02059291|156801422|FG022|Epoch 2|Withdrawal by Subject|0|||
48713479|NCT02059291|156801423|FG023|Epoch 2|Withdrawal by Subject|0|||
48713480|NCT02059291|156801424|FG024|Epoch 2|Withdrawal by Subject|0|||
48919624|NCT02821715|157539822|FG002|Overall Study|Protocol Violation|0|||
48919625|NCT02821715|157539823|FG003|Overall Study|Protocol Violation|0|||
48919626|NCT02821715|157539824|FG004|Overall Study|Protocol Violation|0|||
48919627|NCT02821715|157539825|FG005|Overall Study|Protocol Violation|0|||
48919628|NCT01967537|157539826|FG000|Overall Study|Withdrawal by Subject|52|||
48919629|NCT01967537|157539826|FG000|Overall Study|Refuse treatment|2|||
48919630|NCT01967537|157539826|FG000|Overall Study|Lost to Follow-up|6|||
49122975|NCT03286218|158289175|FG007|Qualification Phase Period 2|Withdrawal by Subject|0|||
49122976|NCT03286218|158289176|FG008|Qualification Phase Period 2|Withdrawal by Subject|0|||
49122977|NCT03286218|158289177|FG009|Qualification Phase Period 2|Withdrawal by Subject|0|||
49122978|NCT03286218|158289178|FG010|Qualification Phase Period 2|Withdrawal by Subject|0|||
49122979|NCT03286218|158289179|FG011|Qualification Phase Period 2|Withdrawal by Subject|0|||
49122980|NCT03286218|158289168|FG000|Treatment Phase Period 1|Withdrawal by Subject|0|||
49122981|NCT03286218|158289169|FG001|Treatment Phase Period 1|Withdrawal by Subject|0|||
49122982|NCT03286218|158289170|FG002|Treatment Phase Period 1|Withdrawal by Subject|1|||
49122983|NCT03286218|158289171|FG003|Treatment Phase Period 1|Withdrawal by Subject|1|||
49122984|NCT03286218|158289172|FG004|Treatment Phase Period 1|Withdrawal by Subject|0|||
49122985|NCT03286218|158289173|FG005|Treatment Phase Period 1|Withdrawal by Subject|1|||
49122986|NCT03286218|158289174|FG006|Treatment Phase Period 1|Withdrawal by Subject|0|||
49122987|NCT03286218|158289175|FG007|Treatment Phase Period 1|Withdrawal by Subject|0|||
49122988|NCT03286218|158289176|FG008|Treatment Phase Period 1|Withdrawal by Subject|0|||
49122989|NCT03286218|158289177|FG009|Treatment Phase Period 1|Withdrawal by Subject|0|||
49122990|NCT03286218|158289178|FG010|Treatment Phase Period 1|Withdrawal by Subject|0|||
49122991|NCT03286218|158289179|FG011|Treatment Phase Period 1|Withdrawal by Subject|1|||
49122992|NCT03286218|158289168|FG000|Treatment Phase Period 4|Withdrawal by Subject|0|||
49122993|NCT03286218|158289169|FG001|Treatment Phase Period 4|Withdrawal by Subject|0|||
49122994|NCT03286218|158289170|FG002|Treatment Phase Period 4|Withdrawal by Subject|0|||
49122995|NCT03286218|158289171|FG003|Treatment Phase Period 4|Withdrawal by Subject|0|||
49122996|NCT03286218|158289172|FG004|Treatment Phase Period 4|Withdrawal by Subject|0|||
49122997|NCT03286218|158289173|FG005|Treatment Phase Period 4|Withdrawal by Subject|0|||
49122998|NCT03286218|158289174|FG006|Treatment Phase Period 4|Withdrawal by Subject|0|||
49122999|NCT03286218|158289175|FG007|Treatment Phase Period 4|Withdrawal by Subject|0|||
49123000|NCT03286218|158289176|FG008|Treatment Phase Period 4|Withdrawal by Subject|0|||
49123001|NCT03286218|158289177|FG009|Treatment Phase Period 4|Withdrawal by Subject|0|||
49123002|NCT03286218|158289178|FG010|Treatment Phase Period 4|Withdrawal by Subject|0|||
49123003|NCT03286218|158289179|FG011|Treatment Phase Period 4|Withdrawal by Subject|1|||
49123004|NCT02532374|158289180|FG000|Overall Study|Withdrawal by Subject|1|||
49123005|NCT02532374|158289180|FG000|Overall Study|Physician Decision|1|||
49123006|NCT01781962|158289181|FG000|Overall Study|Other Miscellaneous Reasons|5|||
49123007|NCT01089127|158289186|FG000|Overall Study|Adverse Event|5|||
49123008|NCT01089127|158289187|FG001|Overall Study|Adverse Event|1|||
49123009|NCT01089127|158289188|FG002|Overall Study|Adverse Event|1|||
49123010|NCT01089127|158289189|FG003|Overall Study|Adverse Event|0|||
49123011|NCT01089127|158289190|FG004|Overall Study|Adverse Event|0|||
49123012|NCT01089127|158289191|FG005|Overall Study|Adverse Event|1|||
49123013|NCT01089127|158289186|FG000|Overall Study|Subject withdrew consent|0|||
49123014|NCT01089127|158289187|FG001|Overall Study|Subject withdrew consent|1|||
49123015|NCT01089127|158289188|FG002|Overall Study|Subject withdrew consent|1|||
49123016|NCT01089127|158289189|FG003|Overall Study|Subject withdrew consent|1|||
49123017|NCT01089127|158289190|FG004|Overall Study|Subject withdrew consent|0|||
49123018|NCT01089127|158289191|FG005|Overall Study|Subject withdrew consent|2|||
49123019|NCT01089127|158289186|FG000|Overall Study|Abnormal test procedure result(s)|2|||
49123020|NCT01089127|158289187|FG001|Overall Study|Abnormal test procedure result(s)|1|||
49123021|NCT01089127|158289188|FG002|Overall Study|Abnormal test procedure result(s)|0|||
49123022|NCT01089127|158289189|FG003|Overall Study|Abnormal test procedure result(s)|0|||
49123023|NCT01089127|158289190|FG004|Overall Study|Abnormal test procedure result(s)|0|||
49123024|NCT01089127|158289191|FG005|Overall Study|Abnormal test procedure result(s)|0|||
49123025|NCT01089127|158289186|FG000|Overall Study|Lost to Follow-up|1|||
49123026|NCT01089127|158289187|FG001|Overall Study|Lost to Follow-up|1|||
49123027|NCT01089127|158289188|FG002|Overall Study|Lost to Follow-up|0|||
49123028|NCT01089127|158289189|FG003|Overall Study|Lost to Follow-up|0|||
49123029|NCT01089127|158289190|FG004|Overall Study|Lost to Follow-up|1|||
49123030|NCT01089127|158289191|FG005|Overall Study|Lost to Follow-up|0|||
49123031|NCT01089127|158289186|FG000|Overall Study|Protocol deviation|0|||
49123032|NCT01089127|158289187|FG001|Overall Study|Protocol deviation|1|||
49123033|NCT01089127|158289188|FG002|Overall Study|Protocol deviation|0|||
49123034|NCT01089127|158289189|FG003|Overall Study|Protocol deviation|0|||
49123035|NCT01089127|158289190|FG004|Overall Study|Protocol deviation|1|||
49123036|NCT01089127|158289191|FG005|Overall Study|Protocol deviation|0|||
49123037|NCT01278342|158289194|FG000|Overall Study|Physician Decision|0|||
49123038|NCT01278342|158289195|FG001|Overall Study|Physician Decision|1|||
49123039|NCT01278342|158289196|FG002|Overall Study|Physician Decision|0|||
48919631|NCT00562354|157539832|FG000|Overall Study|Physician Decision|0|||
48919632|NCT00562354|157539833|FG001|Overall Study|Physician Decision|1|||
48713481|NCT02059291|156801400|FG000|Epoch 3|Physician Decision|0|||
48713482|NCT02059291|156801401|FG001|Epoch 3|Physician Decision|0|||
48713483|NCT02059291|156801402|FG002|Epoch 3|Physician Decision|0|||
48713484|NCT02059291|156801403|FG003|Epoch 3|Physician Decision|0|||
48713485|NCT02059291|156801404|FG004|Epoch 3|Physician Decision|0|||
48713486|NCT02059291|156801405|FG005|Epoch 3|Physician Decision|0|||
48713487|NCT02059291|156801406|FG006|Epoch 3|Physician Decision|0|||
48713488|NCT02059291|156801407|FG007|Epoch 3|Physician Decision|0|||
48919633|NCT00562354|157539832|FG000|Overall Study|Lost to Follow-up|0|||
48919634|NCT00562354|157539833|FG001|Overall Study|Lost to Follow-up|1|||
48919635|NCT00250835|157539834|FG000|Overall Study|Withdrawal by Subject|1|||
48919636|NCT01187953|157539835|FG000|Overall Study|Death|11|||
48919637|NCT01187953|157539836|FG001|Overall Study|Death|13|||
48919638|NCT01187953|157539835|FG000|Overall Study|Adverse Event|1|||
48919639|NCT01187953|157539836|FG001|Overall Study|Adverse Event|2|||
48919640|NCT01187953|157539835|FG000|Overall Study|Lost to Follow-up|0|||
48919641|NCT01187953|157539836|FG001|Overall Study|Lost to Follow-up|3|||
48919642|NCT01187953|157539835|FG000|Overall Study|Withdrawal by Subject|3|||
48919643|NCT01187953|157539836|FG001|Overall Study|Withdrawal by Subject|3|||
48919644|NCT00879697|157539840|FG000|Overall Study|Physician Decision|2|||
48919645|NCT00879697|157539841|FG001|Overall Study|Physician Decision|2|||
48919646|NCT02500121|157539842|FG000|Overall Study|Lost to Follow-up|0|||
48919647|NCT02500121|157539843|FG001|Overall Study|Lost to Follow-up|1|||
48919648|NCT02500121|157539842|FG000|Overall Study|Withdrawal by Subject|1|||
48919649|NCT02500121|157539843|FG001|Overall Study|Withdrawal by Subject|1|||
48919650|NCT02500121|157539842|FG000|Overall Study|Death|26|||
48919651|NCT02500121|157539843|FG001|Overall Study|Death|24|||
48919652|NCT02678390|157539844|FG000|AE (1 Day)|Withdrawal by Subject|0|||
48919653|NCT02678390|157539845|FG001|AE (1 Day)|Withdrawal by Subject|1|||
48919654|NCT01627899|157539846|FG000|Overall Study|Study terminated early by sponsor.|5|||
48919655|NCT01806779|157539847|FG000|Overall Study|Physician Decision|2|||
48919656|NCT01806779|157539848|FG001|Overall Study|Physician Decision|0|||
49123040|NCT01278342|158289194|FG000|Overall Study|Lost to Follow-up|1|||
49123041|NCT01278342|158289195|FG001|Overall Study|Lost to Follow-up|0|||
49123042|NCT01278342|158289196|FG002|Overall Study|Lost to Follow-up|0|||
49123043|NCT01278342|158289194|FG000|Overall Study|Administrative problems|2|||
49123044|NCT01278342|158289195|FG001|Overall Study|Administrative problems|0|||
49123045|NCT01278342|158289196|FG002|Overall Study|Administrative problems|0|||
49123046|NCT01278342|158289194|FG000|Overall Study|Other|1|||
49123047|NCT01278342|158289195|FG001|Overall Study|Other|0|||
49123048|NCT01278342|158289196|FG002|Overall Study|Other|0|||
49123049|NCT02982863|158289199|FG000|Overall Study|Not eligible patients|809|||
49123050|NCT02982863|158289200|FG001|Overall Study|Not eligible patients|4261|||
49123051|NCT02982863|158289201|FG002|Overall Study|Not eligible patients|1852|||
49123052|NCT02982863|158289202|FG003|Overall Study|Not eligible patients|1400|||
49123053|NCT02982863|158289203|FG004|Overall Study|Not eligible patients|492|||
48713489|NCT02059291|156801408|FG008|Epoch 3|Physician Decision|0|||
48713490|NCT02059291|156801409|FG009|Epoch 3|Physician Decision|0|||
48713491|NCT02059291|156801410|FG010|Epoch 3|Physician Decision|0|||
48713492|NCT02059291|156801411|FG011|Epoch 3|Physician Decision|0|||
48713493|NCT02059291|156801412|FG012|Epoch 3|Physician Decision|0|||
48713494|NCT02059291|156801413|FG013|Epoch 3|Physician Decision|1|||
48713495|NCT02059291|156801414|FG014|Epoch 3|Physician Decision|0|||
48713496|NCT02059291|156801415|FG015|Epoch 3|Physician Decision|1|||
48713497|NCT02059291|156801416|FG016|Epoch 3|Physician Decision|0|||
48713498|NCT02059291|156801417|FG017|Epoch 3|Physician Decision|0|||
48713499|NCT02059291|156801418|FG018|Epoch 3|Physician Decision|0|||
48919657|NCT01806779|157539849|FG002|Overall Study|Physician Decision|1|||
48919658|NCT01806779|157539847|FG000|Overall Study|Lack of Efficacy|1|||
48919659|NCT01806779|157539848|FG001|Overall Study|Lack of Efficacy|1|||
48919660|NCT01806779|157539849|FG002|Overall Study|Lack of Efficacy|0|||
48919661|NCT01806779|157539847|FG000|Overall Study|Lost to Follow-up|19|||
48919662|NCT01806779|157539848|FG001|Overall Study|Lost to Follow-up|20|||
49123054|NCT03257436|158289210|FG000|Overall Study|Withdrawal by Subject|76|||
49123055|NCT03257436|158289210|FG000|Overall Study|Death|19|||
49123056|NCT00698815|158289211|FG000|Overall Study|Death|1|||
49123057|NCT00698815|158289212|FG001|Overall Study|Death|2|||
48713500|NCT02059291|156801419|FG019|Epoch 3|Physician Decision|0|||
48713501|NCT02059291|156801420|FG020|Epoch 3|Physician Decision|0|||
48713502|NCT02059291|156801421|FG021|Epoch 3|Physician Decision|0|||
48713503|NCT02059291|156801422|FG022|Epoch 3|Physician Decision|0|||
48713504|NCT02059291|156801423|FG023|Epoch 3|Physician Decision|0|||
48713505|NCT02059291|156801424|FG024|Epoch 3|Physician Decision|0|||
48713506|NCT02059291|156801400|FG000|Epoch 3|Adverse Event|0|||
48713507|NCT02059291|156801401|FG001|Epoch 3|Adverse Event|0|||
48713508|NCT02059291|156801402|FG002|Epoch 3|Adverse Event|0|||
48713509|NCT02059291|156801403|FG003|Epoch 3|Adverse Event|0|||
48713510|NCT02059291|156801404|FG004|Epoch 3|Adverse Event|0|||
48713511|NCT02059291|156801405|FG005|Epoch 3|Adverse Event|0|||
48713512|NCT02059291|156801406|FG006|Epoch 3|Adverse Event|0|||
48713513|NCT02059291|156801407|FG007|Epoch 3|Adverse Event|0|||
48713514|NCT02059291|156801408|FG008|Epoch 3|Adverse Event|0|||
48713515|NCT02059291|156801409|FG009|Epoch 3|Adverse Event|0|||
48713516|NCT02059291|156801410|FG010|Epoch 3|Adverse Event|0|||
48713517|NCT02059291|156801411|FG011|Epoch 3|Adverse Event|0|||
48713518|NCT02059291|156801412|FG012|Epoch 3|Adverse Event|0|||
48713519|NCT02059291|156801413|FG013|Epoch 3|Adverse Event|0|||
48713520|NCT02059291|156801414|FG014|Epoch 3|Adverse Event|0|||
49010901|NCT02454972|157877341|FG005|Overall Study|Withdrawal by Subject|2|||
49010902|NCT02454972|157877342|FG006|Overall Study|Withdrawal by Subject|0|||
49010903|NCT02454972|157877343|FG007|Overall Study|Withdrawal by Subject|1|||
49010904|NCT02454972|157877344|FG008|Overall Study|Withdrawal by Subject|2|||
49010905|NCT02454972|157877336|FG000|Overall Study|Multiple delay/holds on treatment|0|||
49010906|NCT02454972|157877337|FG001|Overall Study|Multiple delay/holds on treatment|0|||
49010907|NCT02454972|157877338|FG002|Overall Study|Multiple delay/holds on treatment|0|||
49010908|NCT02454972|157877339|FG003|Overall Study|Multiple delay/holds on treatment|1|||
49010909|NCT02454972|157877340|FG004|Overall Study|Multiple delay/holds on treatment|0|||
49010910|NCT02454972|157877341|FG005|Overall Study|Multiple delay/holds on treatment|0|||
49010911|NCT02454972|157877342|FG006|Overall Study|Multiple delay/holds on treatment|0|||
49010912|NCT02454972|157877343|FG007|Overall Study|Multiple delay/holds on treatment|0|||
49010913|NCT02454972|157877344|FG008|Overall Study|Multiple delay/holds on treatment|0|||
49010914|NCT02454972|157877336|FG000|Overall Study|Never treated|0|||
49010915|NCT02454972|157877337|FG001|Overall Study|Never treated|0|||
49010916|NCT02454972|157877338|FG002|Overall Study|Never treated|3|||
49010917|NCT02454972|157877339|FG003|Overall Study|Never treated|1|||
49010918|NCT02454972|157877340|FG004|Overall Study|Never treated|1|||
49010919|NCT02454972|157877341|FG005|Overall Study|Never treated|0|||
49010920|NCT02454972|157877342|FG006|Overall Study|Never treated|0|||
49010921|NCT02454972|157877343|FG007|Overall Study|Never treated|0|||
49010922|NCT02454972|157877344|FG008|Overall Study|Never treated|5|||
49010923|NCT02454972|157877336|FG000|Overall Study|Lost to Follow-up|0|||
49010924|NCT02454972|157877337|FG001|Overall Study|Lost to Follow-up|0|||
49010925|NCT02454972|157877338|FG002|Overall Study|Lost to Follow-up|0|||
49010926|NCT02454972|157877339|FG003|Overall Study|Lost to Follow-up|0|||
49010927|NCT02454972|157877340|FG004|Overall Study|Lost to Follow-up|0|||
49010928|NCT02454972|157877341|FG005|Overall Study|Lost to Follow-up|0|||
49010929|NCT02454972|157877342|FG006|Overall Study|Lost to Follow-up|0|||
49010930|NCT02454972|157877343|FG007|Overall Study|Lost to Follow-up|0|||
49010931|NCT02454972|157877344|FG008|Overall Study|Lost to Follow-up|2|||
49010932|NCT02454972|157877336|FG000|Overall Study|Study termination|0|||
49010933|NCT02454972|157877337|FG001|Overall Study|Study termination|0|||
49010934|NCT02454972|157877338|FG002|Overall Study|Study termination|0|||
49010935|NCT02454972|157877339|FG003|Overall Study|Study termination|0|||
49010936|NCT02454972|157877340|FG004|Overall Study|Study termination|0|||
49010937|NCT02454972|157877341|FG005|Overall Study|Study termination|0|||
49010938|NCT02454972|157877342|FG006|Overall Study|Study termination|0|||
49010939|NCT02454972|157877343|FG007|Overall Study|Study termination|0|||
49010940|NCT02454972|157877344|FG008|Overall Study|Study termination|6|||
49010941|NCT00787566|157877345|FG000|Overall Study|AE related to chemotherapy|0|||
49010942|NCT00787566|157877346|FG001|Overall Study|AE related to chemotherapy|1|||
49010943|NCT00787566|157877347|FG002|Overall Study|AE related to chemotherapy|0|||
49010944|NCT03548207|157877348|FG000|Overall Study|Death|10|||
49010945|NCT03548207|157877349|FG001|Overall Study|Death|23|||
49010946|NCT03548207|157877350|FG002|Overall Study|Death|3|||
49010947|NCT03548207|157877348|FG000|Overall Study|Lost to Follow-up|0|||
49010948|NCT03548207|157877349|FG001|Overall Study|Lost to Follow-up|2|||
49010949|NCT03548207|157877350|FG002|Overall Study|Lost to Follow-up|0|||
49010950|NCT03548207|157877348|FG000|Overall Study|Withdrawal by Subject|0|||
49010951|NCT03548207|157877349|FG001|Overall Study|Withdrawal by Subject|3|||
49010952|NCT03548207|157877350|FG002|Overall Study|Withdrawal by Subject|0|||
49010953|NCT03548207|157877348|FG000|Overall Study|Sponsor decision|19|||
49010954|NCT03548207|157877349|FG001|Overall Study|Sponsor decision|40|||
49010955|NCT03548207|157877350|FG002|Overall Study|Sponsor decision|6|||
49010956|NCT03548207|157877348|FG000|Overall Study|Randomized but not treated|6|||
49010957|NCT03548207|157877349|FG001|Overall Study|Randomized but not treated|10|||
49010958|NCT03548207|157877350|FG002|Overall Study|Randomized but not treated|4|||
49010959|NCT01785875|157877351|FG000|Overall Study|Withdrawal by Subject|41|||
48713521|NCT02059291|156801415|FG015|Epoch 3|Adverse Event|1|||
48713522|NCT02059291|156801416|FG016|Epoch 3|Adverse Event|0|||
48713523|NCT02059291|156801417|FG017|Epoch 3|Adverse Event|0|||
48713524|NCT02059291|156801418|FG018|Epoch 3|Adverse Event|0|||
48713525|NCT02059291|156801419|FG019|Epoch 3|Adverse Event|0|||
48713526|NCT02059291|156801420|FG020|Epoch 3|Adverse Event|0|||
48713527|NCT02059291|156801421|FG021|Epoch 3|Adverse Event|0|||
49123058|NCT00698815|158289213|FG002|Overall Study|Death|4|||
49123059|NCT00698815|158289211|FG000|Overall Study|Withdrawal by Subject|6|||
49123060|NCT00698815|158289212|FG001|Overall Study|Withdrawal by Subject|3|||
49123061|NCT00698815|158289213|FG002|Overall Study|Withdrawal by Subject|2|||
49123062|NCT00698815|158289211|FG000|Overall Study|MD discretion|2|||
49123063|NCT00698815|158289212|FG001|Overall Study|MD discretion|7|||
49123064|NCT00698815|158289213|FG002|Overall Study|MD discretion|2|||
49123065|NCT00698815|158289211|FG000|Overall Study|Did not receive protocol treatment|1|||
49123066|NCT00698815|158289212|FG001|Overall Study|Did not receive protocol treatment|2|||
49123067|NCT00698815|158289213|FG002|Overall Study|Did not receive protocol treatment|2|||
49123068|NCT02048722|158289214|FG000|2 Cycles of Treatment|Adverse Event|2|||
49123069|NCT02048722|158289214|FG000|2 Cycles of Treatment|Withdrawal by Subject|4|||
49123070|NCT02048722|158289214|FG000|2 Cycles of Treatment|Progressive Disease|2|||
49123071|NCT02048722|158289214|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|10|||
49123072|NCT02048722|158289214|FG000|Follow up 5 Years or Cut of Timepoint|Death|24|||
49123073|NCT02048722|158289214|FG000|Follow up 5 Years or Cut of Timepoint|Withdrawal by Subject|3|||
49123074|NCT01619865|158289217|FG000|Overall Study|Adverse Event|1|||
49123075|NCT01619865|158289217|FG000|Overall Study|Death|2|||
49123076|NCT01619865|158289217|FG000|Overall Study|subject not able to comply|1|||
49123077|NCT02111174|158289220|FG000|Treatment and Primary Outcome|Ineligible (not used in analysis)|1|||
49123078|NCT02111174|158289221|FG001|Treatment and Primary Outcome|Ineligible (not used in analysis)|0|||
49123079|NCT02111174|158289220|FG000|Treatment and Primary Outcome|Withdrawal by Subject|2|||
49123080|NCT02111174|158289221|FG001|Treatment and Primary Outcome|Withdrawal by Subject|2|||
49123081|NCT02111174|158289220|FG000|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8|||
49123082|NCT02111174|158289221|FG001|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6|||
49123083|NCT02111174|158289220|FG000|Secondary Outcomes (2 and 3 Month f/u)|Death|0|||
49123084|NCT02111174|158289221|FG001|Secondary Outcomes (2 and 3 Month f/u)|Death|1|||
49123085|NCT01077323|158289222|FG000|Overall Study|<9 months enroll before drug dispensed|11226|||
49123086|NCT01077323|158289223|FG001|Overall Study|<9 months enroll before drug dispensed|263954|||
49123087|NCT01077323|158289224|FG002|Overall Study|<9 months enroll before drug dispensed|11655523|||
49123088|NCT01077323|158289222|FG000|Overall Study|Dispensing of drug in baseline period|0|||
49123089|NCT01077323|158289223|FG001|Overall Study|Dispensing of drug in baseline period|120229|||
49123090|NCT01077323|158289224|FG002|Overall Study|Dispensing of drug in baseline period|256446|||
49123091|NCT01077323|158289222|FG000|Overall Study|Baseline diagnosis of pancreatic disease|152|||
49123092|NCT01077323|158289223|FG001|Overall Study|Baseline diagnosis of pancreatic disease|2080|||
49123093|NCT01077323|158289224|FG002|Overall Study|Baseline diagnosis of pancreatic disease|120|||
49123094|NCT00838097|158289227|FG000|Overall Study|Ineligibility determined|6|||
49123095|NCT00838097|158289227|FG000|Overall Study|Adverse Event|2|||
49123096|NCT00838097|158289227|FG000|Overall Study|Withdrawal by Subject|3|||
49123097|NCT00838097|158289227|FG000|Overall Study|Requirement for alternative therapy|2|||
49123098|NCT00838097|158289227|FG000|Overall Study|Physician Decision|4|||
49123099|NCT00838097|158289227|FG000|Overall Study|Lost to Follow-up|11|||
49123100|NCT00838097|158289227|FG000|Overall Study|Death|6|||
49123101|NCT00838097|158289227|FG000|Overall Study|Protocol-specified criteria|142|||
49123102|NCT00871234|158289228|FG000|Overall Study|Adverse Event|2|||
49123103|NCT00871234|158289228|FG000|Overall Study|Lost to Follow-up|3|||
49123104|NCT00325819|158289250|FG000|Overall Study|Study product lost in mail|2|||
49123105|NCT00325819|158289251|FG001|Overall Study|Study product lost in mail|1|||
49123106|NCT00325819|158289250|FG000|Overall Study|Did not take a dose of study product|4|||
49123107|NCT00325819|158289251|FG001|Overall Study|Did not take a dose of study product|9|||
49123108|NCT00325819|158289250|FG000|Overall Study|Lost to Follow-up|3|||
49123109|NCT00325819|158289251|FG001|Overall Study|Lost to Follow-up|3|||
49123110|NCT01026948|158289258|FG000|Overall Study|Physician Decision|8|||
48713528|NCT02059291|156801422|FG022|Epoch 3|Adverse Event|0|||
48713529|NCT02059291|156801423|FG023|Epoch 3|Adverse Event|0|||
48713530|NCT02059291|156801424|FG024|Epoch 3|Adverse Event|0|||
48713531|NCT02059291|156801400|FG000|Epoch 3|Lack of Efficacy|0|||
48713532|NCT02059291|156801401|FG001|Epoch 3|Lack of Efficacy|0|||
48713533|NCT02059291|156801402|FG002|Epoch 3|Lack of Efficacy|0|||
48713534|NCT02059291|156801403|FG003|Epoch 3|Lack of Efficacy|0|||
48713535|NCT02059291|156801404|FG004|Epoch 3|Lack of Efficacy|0|||
48713536|NCT02059291|156801405|FG005|Epoch 3|Lack of Efficacy|0|||
48713537|NCT02059291|156801406|FG006|Epoch 3|Lack of Efficacy|0|||
48713538|NCT02059291|156801407|FG007|Epoch 3|Lack of Efficacy|0|||
48713539|NCT02059291|156801408|FG008|Epoch 3|Lack of Efficacy|0|||
48713540|NCT02059291|156801409|FG009|Epoch 3|Lack of Efficacy|0|||
48713541|NCT02059291|156801410|FG010|Epoch 3|Lack of Efficacy|0|||
48713542|NCT02059291|156801411|FG011|Epoch 3|Lack of Efficacy|0|||
48713543|NCT02059291|156801412|FG012|Epoch 3|Lack of Efficacy|0|||
48713544|NCT02059291|156801413|FG013|Epoch 3|Lack of Efficacy|0|||
48713545|NCT02059291|156801414|FG014|Epoch 3|Lack of Efficacy|0|||
48713546|NCT02059291|156801415|FG015|Epoch 3|Lack of Efficacy|3|||
48812218|NCT02960763|157153521|FG002|Step 1|Other|1|||
48812219|NCT02960763|157153522|FG003|Step 1|Other|0|||
48812220|NCT02960763|157153523|FG004|Step 1|Other|0|||
48812221|NCT02960763|157153519|FG000|Step 2|Withdrawal by Subject|0|||
48812222|NCT02960763|157153520|FG001|Step 2|Withdrawal by Subject|0|||
48812223|NCT02960763|157153521|FG002|Step 2|Withdrawal by Subject|0|||
48812224|NCT02960763|157153522|FG003|Step 2|Withdrawal by Subject|7|||
48812225|NCT02960763|157153523|FG004|Step 2|Withdrawal by Subject|3|||
48812226|NCT02960763|157153519|FG000|Step 2|Lost to Follow-up|0|||
48812227|NCT02960763|157153520|FG001|Step 2|Lost to Follow-up|0|||
48812228|NCT02960763|157153521|FG002|Step 2|Lost to Follow-up|0|||
48812229|NCT02960763|157153522|FG003|Step 2|Lost to Follow-up|4|||
48812230|NCT02960763|157153523|FG004|Step 2|Lost to Follow-up|1|||
48812231|NCT02960763|157153519|FG000|Step 2|Investigator discretion|0|||
48812232|NCT02960763|157153520|FG001|Step 2|Investigator discretion|0|||
48812233|NCT02960763|157153521|FG002|Step 2|Investigator discretion|0|||
48812234|NCT02960763|157153522|FG003|Step 2|Investigator discretion|0|||
48812235|NCT02960763|157153523|FG004|Step 2|Investigator discretion|1|||
48812236|NCT00674323|157153524|FG000|Overall Study|Adverse Event|0|||
48812237|NCT00674323|157153525|FG001|Overall Study|Adverse Event|1|||
48812238|NCT00674323|157153526|FG002|Overall Study|Adverse Event|0|||
48812239|NCT00674323|157153524|FG000|Overall Study|Protocol Violation|1|||
48812240|NCT00674323|157153525|FG001|Overall Study|Protocol Violation|0|||
48812241|NCT00674323|157153526|FG002|Overall Study|Protocol Violation|0|||
48812242|NCT01868035|157153527|FG000|Overall Study|Lost to Follow-up|3|||
48812243|NCT01868035|157153527|FG000|Overall Study|Withdrawal by Subject|1|||
48919663|NCT01806779|157539849|FG002|Overall Study|Lost to Follow-up|0|||
48919664|NCT01806779|157539847|FG000|Overall Study|Withdrawal by Subject|20|||
48919665|NCT01806779|157539848|FG001|Overall Study|Withdrawal by Subject|23|||
48919666|NCT01806779|157539849|FG002|Overall Study|Withdrawal by Subject|22|||
48919667|NCT00936208|157539850|FG000|Overall Study|Protocol Violation|37|||
48919668|NCT00936208|157539851|FG001|Overall Study|Protocol Violation|22|||
48812244|NCT01868035|157153527|FG000|Overall Study|Progressive Disease|2|||
48812245|NCT01868035|157153527|FG000|Overall Study|Non-compliance|1|||
48812246|NCT02318719|157153528|FG000|Double-blind Phase|Adverse Event|7|||
48812247|NCT02318719|157153529|FG001|Double-blind Phase|Adverse Event|6|||
48812248|NCT02318719|157153530|FG002|Double-blind Phase|Adverse Event|12|||
48812249|NCT02318719|157153531|FG003|Double-blind Phase|Adverse Event|4|||
48812250|NCT02318719|157153532|FG004|Double-blind Phase|Adverse Event|0|||
48812251|NCT02318719|157153528|FG000|Double-blind Phase|Lack of Efficacy|5|||
48812252|NCT02318719|157153529|FG001|Double-blind Phase|Lack of Efficacy|0|||
48812253|NCT02318719|157153530|FG002|Double-blind Phase|Lack of Efficacy|1|||
48812254|NCT02318719|157153531|FG003|Double-blind Phase|Lack of Efficacy|1|||
48812255|NCT02318719|157153532|FG004|Double-blind Phase|Lack of Efficacy|0|||
48919669|NCT01934556|157539855|FG000|Overall Study|Withdrawal by Subject|0|||
48919670|NCT01934556|157539856|FG001|Overall Study|Withdrawal by Subject|1|||
49123111|NCT03191552|158289259|FG000|Overall Study|Lost to Follow-up|1|||
49123112|NCT03191552|158289260|FG001|Overall Study|Lost to Follow-up|0|||
49123113|NCT03191552|158289261|FG002|Overall Study|Lost to Follow-up|0|||
49123114|NCT03191552|158289259|FG000|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
49123115|NCT03191552|158289260|FG001|Overall Study|Undergone surgery (Progressive hip dyspl|1|||
49123116|NCT03191552|158289261|FG002|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
49123117|NCT00102596|158289262|FG000|Part A|Screen failures|6|||
49123118|NCT00102596|158289263|FG001|Part A|Screen failures|0|||
48713547|NCT02059291|156801416|FG016|Epoch 3|Lack of Efficacy|0|||
48713548|NCT02059291|156801417|FG017|Epoch 3|Lack of Efficacy|0|||
48713549|NCT02059291|156801418|FG018|Epoch 3|Lack of Efficacy|0|||
48713550|NCT02059291|156801419|FG019|Epoch 3|Lack of Efficacy|0|||
48713551|NCT02059291|156801420|FG020|Epoch 3|Lack of Efficacy|0|||
48713552|NCT02059291|156801421|FG021|Epoch 3|Lack of Efficacy|0|||
48713553|NCT02059291|156801422|FG022|Epoch 3|Lack of Efficacy|0|||
48713554|NCT02059291|156801423|FG023|Epoch 3|Lack of Efficacy|0|||
48812256|NCT02318719|157153528|FG000|Double-blind Phase|Protocol Violation|0|||
48812257|NCT02318719|157153529|FG001|Double-blind Phase|Protocol Violation|1|||
48812258|NCT02318719|157153530|FG002|Double-blind Phase|Protocol Violation|3|||
48812259|NCT02318719|157153531|FG003|Double-blind Phase|Protocol Violation|0|||
48812260|NCT02318719|157153532|FG004|Double-blind Phase|Protocol Violation|0|||
48812261|NCT02318719|157153528|FG000|Double-blind Phase|Withdrawal by Subject|25|||
48812262|NCT02318719|157153529|FG001|Double-blind Phase|Withdrawal by Subject|7|||
48812263|NCT02318719|157153530|FG002|Double-blind Phase|Withdrawal by Subject|9|||
48812264|NCT02318719|157153531|FG003|Double-blind Phase|Withdrawal by Subject|10|||
48812265|NCT02318719|157153532|FG004|Double-blind Phase|Withdrawal by Subject|0|||
48812266|NCT02318719|157153528|FG000|Double-blind Phase|Other|1|||
48812267|NCT02318719|157153529|FG001|Double-blind Phase|Other|2|||
48812268|NCT02318719|157153530|FG002|Double-blind Phase|Other|0|||
48812269|NCT02318719|157153531|FG003|Double-blind Phase|Other|0|||
48812270|NCT02318719|157153532|FG004|Double-blind Phase|Other|0|||
48812271|NCT02318719|157153528|FG000|Open-label Extension Phase|Adverse Event|0|||
48812272|NCT02318719|157153529|FG001|Open-label Extension Phase|Adverse Event|0|||
48812273|NCT02318719|157153530|FG002|Open-label Extension Phase|Adverse Event|0|||
48812274|NCT02318719|157153531|FG003|Open-label Extension Phase|Adverse Event|0|||
48812275|NCT02318719|157153532|FG004|Open-label Extension Phase|Adverse Event|15|||
48812276|NCT02318719|157153528|FG000|Open-label Extension Phase|Death|0|||
48812277|NCT02318719|157153529|FG001|Open-label Extension Phase|Death|0|||
48812278|NCT02318719|157153530|FG002|Open-label Extension Phase|Death|0|||
48812279|NCT02318719|157153531|FG003|Open-label Extension Phase|Death|0|||
48812280|NCT02318719|157153532|FG004|Open-label Extension Phase|Death|1|||
48812281|NCT02318719|157153528|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
48812282|NCT02318719|157153529|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
48812283|NCT02318719|157153530|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
48812284|NCT02318719|157153531|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
48812285|NCT02318719|157153532|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
48812286|NCT02318719|157153528|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
48812287|NCT02318719|157153529|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
48812288|NCT02318719|157153530|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
48812289|NCT02318719|157153531|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
48812290|NCT02318719|157153532|FG004|Open-label Extension Phase|Withdrawal by Subject|31|||
48812291|NCT02318719|157153528|FG000|Open-label Extension Phase|Other|0|||
48812292|NCT02318719|157153529|FG001|Open-label Extension Phase|Other|0|||
48812293|NCT02318719|157153530|FG002|Open-label Extension Phase|Other|0|||
48812294|NCT02318719|157153531|FG003|Open-label Extension Phase|Other|0|||
48812295|NCT02318719|157153532|FG004|Open-label Extension Phase|Other|7|||
48812296|NCT03249376|157153542|FG000|Overall Study|Adverse Event|11|||
48812297|NCT03249376|157153543|FG001|Overall Study|Adverse Event|5|||
48812298|NCT03249376|157153542|FG000|Overall Study|Lack of Efficacy|2|||
48812299|NCT03249376|157153543|FG001|Overall Study|Lack of Efficacy|4|||
48812300|NCT03249376|157153542|FG000|Overall Study|Protocol Violation|3|||
48812301|NCT03249376|157153543|FG001|Overall Study|Protocol Violation|2|||
48812302|NCT03249376|157153542|FG000|Overall Study|Physician Decision|0|||
48812303|NCT03249376|157153543|FG001|Overall Study|Physician Decision|2|||
48812304|NCT03249376|157153542|FG000|Overall Study|Withdrawal by Subject|3|||
48812305|NCT03249376|157153543|FG001|Overall Study|Withdrawal by Subject|9|||
48812306|NCT03249376|157153542|FG000|Overall Study|LTFU|2|||
48812307|NCT03249376|157153543|FG001|Overall Study|LTFU|1|||
48812308|NCT01827254|157153545|FG000|Overall Study|Death|10|||
48812309|NCT01827254|157153545|FG000|Overall Study|Case report form not completed|4|||
49123119|NCT00102596|158289262|FG000|Part A|Adverse Event|1|||
49123120|NCT00102596|158289263|FG001|Part A|Adverse Event|0|||
49123121|NCT00485069|158289264|FG000|Overall Study|Adverse Event|10|||
49123122|NCT00485069|158289265|FG001|Overall Study|Adverse Event|4|||
49123123|NCT00485069|158289264|FG000|Overall Study|Lack of Efficacy|2|||
49123124|NCT00485069|158289265|FG001|Overall Study|Lack of Efficacy|1|||
49123125|NCT00485069|158289264|FG000|Overall Study|Protocol Violation|0|||
49123126|NCT00485069|158289265|FG001|Overall Study|Protocol Violation|1|||
49123127|NCT00485069|158289264|FG000|Overall Study|Withdrawal by Subject|6|||
49123128|NCT00485069|158289265|FG001|Overall Study|Withdrawal by Subject|6|||
49123129|NCT02314728|158289266|FG000|Overall Study|Protocol Violation|1|||
49123130|NCT02314728|158289267|FG001|Overall Study|Protocol Violation|0|||
49123131|NCT02314728|158289266|FG000|Overall Study|Lost to Follow-up|0|||
49123132|NCT02314728|158289267|FG001|Overall Study|Lost to Follow-up|1|||
49123133|NCT02688933|158289268|FG000|Overall Study|Adverse Event|3|||
49123134|NCT02688933|158289269|FG001|Overall Study|Adverse Event|1|||
49123135|NCT02688933|158289268|FG000|Overall Study|Lack of Efficacy|2|||
49123136|NCT02688933|158289269|FG001|Overall Study|Lack of Efficacy|2|||
49123137|NCT02688933|158289268|FG000|Overall Study|Poor compliance to protocol|7|||
48812310|NCT01827254|157153545|FG000|Overall Study|Invalidated centre|3|||
48812311|NCT01827254|157153545|FG000|Overall Study|Discontinued prior initiation: sunitinib|1|||
48812312|NCT01827254|157153545|FG000|Overall Study|Did not complete re-challenge|1|||
48812313|NCT01827254|157153545|FG000|Overall Study|Disease progression|36|||
48812314|NCT01827254|157153545|FG000|Overall Study|Intolerance to treatment|4|||
48812315|NCT01512745|157153550|FG000|Overall Study|Adverse Event|22|||
48812316|NCT01512745|157153551|FG001|Overall Study|Adverse Event|3|||
48812317|NCT01512745|157153550|FG000|Overall Study|Death|9|||
48812318|NCT01512745|157153551|FG001|Overall Study|Death|13|||
48812319|NCT01512745|157153550|FG000|Overall Study|Withdrawal by Subject|2|||
48812320|NCT01512745|157153551|FG001|Overall Study|Withdrawal by Subject|2|||
48812321|NCT01512745|157153550|FG000|Overall Study|Lost to Follow-up|4|||
49123138|NCT02688933|158289269|FG001|Overall Study|Poor compliance to protocol|4|||
49123139|NCT02688933|158289268|FG000|Overall Study|Hypoglycemia|2|||
49123140|NCT02688933|158289269|FG001|Overall Study|Hypoglycemia|0|||
49123141|NCT02688933|158289268|FG000|Overall Study|Other than Specified|14|||
49123142|NCT02688933|158289269|FG001|Overall Study|Other than Specified|25|||
49123143|NCT02688933|158289268|FG000|Overall Study|Lost to Follow-up|1|||
49123144|NCT02688933|158289269|FG001|Overall Study|Lost to Follow-up|5|||
49123145|NCT02039778|158289270|FG000|Overall Study|Death|2|||
49123146|NCT02039778|158289270|FG000|Overall Study|Withdrawal by Subject|1|||
49123147|NCT02039778|158289270|FG000|Overall Study|Never started the protocol treatment|1|||
49123148|NCT00810199|158289272|FG000|Overall Study|Adverse Event|24|||
49123149|NCT00810199|158289273|FG001|Overall Study|Adverse Event|26|||
49123150|NCT00810199|158289272|FG000|Overall Study|Death|4|||
49123151|NCT00810199|158289273|FG001|Overall Study|Death|6|||
49123152|NCT00810199|158289272|FG000|Overall Study|Withdrew consent|9|||
49123153|NCT00810199|158289273|FG001|Overall Study|Withdrew consent|12|||
49123154|NCT00810199|158289272|FG000|Overall Study|Insufficient therapeutic response|5|||
49123155|NCT00810199|158289273|FG001|Overall Study|Insufficient therapeutic response|14|||
49123156|NCT00810199|158289272|FG000|Overall Study|Refused treatment/Did not cooperate|7|||
49123157|NCT00810199|158289273|FG001|Overall Study|Refused treatment/Did not cooperate|7|||
49123158|NCT00810199|158289272|FG000|Overall Study|Administrative/Other|5|||
49123159|NCT00810199|158289273|FG001|Overall Study|Administrative/Other|6|||
49123160|NCT00810199|158289272|FG000|Overall Study|Protocol Violation|2|||
49123161|NCT00810199|158289273|FG001|Overall Study|Protocol Violation|6|||
49123162|NCT00810199|158289272|FG000|Overall Study|Failure to return|1|||
48919671|NCT01934556|157539857|FG002|Overall Study|Withdrawal by Subject|1|||
49123163|NCT00810199|158289273|FG001|Overall Study|Failure to return|4|||
49123164|NCT00810199|158289272|FG000|Overall Study|Did not receive study drug|2|||
49123165|NCT00810199|158289273|FG001|Overall Study|Did not receive study drug|1|||
49123166|NCT01091246|158289275|FG000|Overall Study|Lost to Follow-up|23|||
49123167|NCT01091246|158289276|FG001|Overall Study|Lost to Follow-up|11|||
48713555|NCT02059291|156801424|FG024|Epoch 3|Lack of Efficacy|0|||
48713556|NCT02059291|156801400|FG000|Epoch 3|Withdrawal by Subject|0|||
48713557|NCT02059291|156801401|FG001|Epoch 3|Withdrawal by Subject|0|||
48713558|NCT02059291|156801402|FG002|Epoch 3|Withdrawal by Subject|0|||
48713559|NCT02059291|156801403|FG003|Epoch 3|Withdrawal by Subject|0|||
48713560|NCT02059291|156801404|FG004|Epoch 3|Withdrawal by Subject|0|||
48713561|NCT02059291|156801405|FG005|Epoch 3|Withdrawal by Subject|0|||
48713562|NCT02059291|156801406|FG006|Epoch 3|Withdrawal by Subject|0|||
48713563|NCT02059291|156801407|FG007|Epoch 3|Withdrawal by Subject|0|||
48713564|NCT02059291|156801408|FG008|Epoch 3|Withdrawal by Subject|0|||
48713565|NCT02059291|156801409|FG009|Epoch 3|Withdrawal by Subject|0|||
48713566|NCT02059291|156801410|FG010|Epoch 3|Withdrawal by Subject|0|||
48713567|NCT02059291|156801411|FG011|Epoch 3|Withdrawal by Subject|0|||
48713568|NCT02059291|156801412|FG012|Epoch 3|Withdrawal by Subject|0|||
48713569|NCT02059291|156801413|FG013|Epoch 3|Withdrawal by Subject|0|||
48713570|NCT02059291|156801414|FG014|Epoch 3|Withdrawal by Subject|0|||
48713571|NCT02059291|156801415|FG015|Epoch 3|Withdrawal by Subject|1|||
48713572|NCT02059291|156801416|FG016|Epoch 3|Withdrawal by Subject|0|||
48713573|NCT02059291|156801417|FG017|Epoch 3|Withdrawal by Subject|0|||
48713574|NCT02059291|156801418|FG018|Epoch 3|Withdrawal by Subject|0|||
48713575|NCT02059291|156801419|FG019|Epoch 3|Withdrawal by Subject|0|||
48713576|NCT02059291|156801420|FG020|Epoch 3|Withdrawal by Subject|0|||
48713577|NCT02059291|156801421|FG021|Epoch 3|Withdrawal by Subject|0|||
48713578|NCT02059291|156801422|FG022|Epoch 3|Withdrawal by Subject|0|||
48713579|NCT02059291|156801423|FG023|Epoch 3|Withdrawal by Subject|0|||
48713580|NCT02059291|156801424|FG024|Epoch 3|Withdrawal by Subject|0|||
48713581|NCT02059291|156801400|FG000|Epoch 4|Adverse Event|0|||
48713582|NCT02059291|156801401|FG001|Epoch 4|Adverse Event|0|||
48713583|NCT02059291|156801402|FG002|Epoch 4|Adverse Event|0|||
48713584|NCT02059291|156801403|FG003|Epoch 4|Adverse Event|0|||
48713585|NCT02059291|156801404|FG004|Epoch 4|Adverse Event|0|||
48713586|NCT02059291|156801405|FG005|Epoch 4|Adverse Event|0|||
48713587|NCT02059291|156801406|FG006|Epoch 4|Adverse Event|0|||
48713588|NCT02059291|156801407|FG007|Epoch 4|Adverse Event|0|||
48713589|NCT02059291|156801408|FG008|Epoch 4|Adverse Event|0|||
48713590|NCT02059291|156801409|FG009|Epoch 4|Adverse Event|0|||
48713591|NCT02059291|156801410|FG010|Epoch 4|Adverse Event|0|||
48713592|NCT02059291|156801411|FG011|Epoch 4|Adverse Event|0|||
48713593|NCT02059291|156801412|FG012|Epoch 4|Adverse Event|0|||
48713594|NCT02059291|156801413|FG013|Epoch 4|Adverse Event|0|||
48713595|NCT02059291|156801414|FG014|Epoch 4|Adverse Event|0|||
48713596|NCT02059291|156801415|FG015|Epoch 4|Adverse Event|0|||
48713597|NCT02059291|156801416|FG016|Epoch 4|Adverse Event|1|||
48713598|NCT02059291|156801417|FG017|Epoch 4|Adverse Event|0|||
48713599|NCT02059291|156801418|FG018|Epoch 4|Adverse Event|0|||
48713600|NCT02059291|156801419|FG019|Epoch 4|Adverse Event|0|||
48713601|NCT02059291|156801420|FG020|Epoch 4|Adverse Event|0|||
49123168|NCT01091246|158289277|FG002|Overall Study|Lost to Follow-up|7|||
48713602|NCT02059291|156801421|FG021|Epoch 4|Adverse Event|0|||
48713603|NCT02059291|156801422|FG022|Epoch 4|Adverse Event|1|||
48713604|NCT02059291|156801423|FG023|Epoch 4|Adverse Event|0|||
49123169|NCT01091246|158289275|FG000|Overall Study|Adverse Event|1|||
49123170|NCT01091246|158289276|FG001|Overall Study|Adverse Event|0|||
49123171|NCT01091246|158289277|FG002|Overall Study|Adverse Event|1|||
49123172|NCT01091246|158289275|FG000|Overall Study|Withdrawal by Subject|9|||
49123173|NCT01091246|158289276|FG001|Overall Study|Withdrawal by Subject|5|||
49123174|NCT01091246|158289277|FG002|Overall Study|Withdrawal by Subject|4|||
49123175|NCT01091246|158289275|FG000|Overall Study|Subject not dosed|2|||
49123176|NCT01091246|158289276|FG001|Overall Study|Subject not dosed|0|||
49123177|NCT01091246|158289277|FG002|Overall Study|Subject not dosed|1|||
49123178|NCT01673178|158289278|FG000|Overall Study|Lost to Follow-up|0|||
49123179|NCT01673178|158289279|FG001|Overall Study|Lost to Follow-up|1|||
49123180|NCT01673178|158289280|FG002|Overall Study|Lost to Follow-up|0|||
49123181|NCT01673178|158289281|FG003|Overall Study|Lost to Follow-up|0|||
49123182|NCT01673178|158289282|FG004|Overall Study|Lost to Follow-up|0|||
48713605|NCT02059291|156801424|FG024|Epoch 4|Adverse Event|0|||
49123183|NCT01673178|158289278|FG000|Overall Study|Withdrawal by Subject|0|||
49123184|NCT01673178|158289279|FG001|Overall Study|Withdrawal by Subject|0|||
49123185|NCT01673178|158289280|FG002|Overall Study|Withdrawal by Subject|1|||
49123186|NCT01673178|158289281|FG003|Overall Study|Withdrawal by Subject|4|||
49123187|NCT01673178|158289282|FG004|Overall Study|Withdrawal by Subject|2|||
49123188|NCT01673178|158289278|FG000|Overall Study|Protocol Violation|1|||
49123189|NCT01673178|158289279|FG001|Overall Study|Protocol Violation|1|||
49123190|NCT01673178|158289280|FG002|Overall Study|Protocol Violation|0|||
49123191|NCT01673178|158289281|FG003|Overall Study|Protocol Violation|1|||
49123192|NCT01673178|158289282|FG004|Overall Study|Protocol Violation|0|||
49123193|NCT01673178|158289278|FG000|Overall Study|Adverse Event|1|||
49123194|NCT01673178|158289279|FG001|Overall Study|Adverse Event|0|||
49123195|NCT01673178|158289280|FG002|Overall Study|Adverse Event|0|||
49123196|NCT01673178|158289281|FG003|Overall Study|Adverse Event|2|||
49123197|NCT01673178|158289282|FG004|Overall Study|Adverse Event|0|||
49123198|NCT01673178|158289278|FG000|Overall Study|Other|1|||
49123199|NCT01673178|158289279|FG001|Overall Study|Other|0|||
49123200|NCT01673178|158289280|FG002|Overall Study|Other|2|||
49123201|NCT01673178|158289281|FG003|Overall Study|Other|1|||
49123202|NCT01673178|158289282|FG004|Overall Study|Other|0|||
49123203|NCT02667301|158289291|FG000|Overall Study|Adverse Event|1|||
49123204|NCT02667301|158289291|FG000|Overall Study|Lack of Efficacy|1|||
49123205|NCT00003471|158289292|FG000|Overall Study|Not evaluable|4|||
49123206|NCT00689338|158289293|FG000|Overall Study|Death|65|||
49123207|NCT00689338|158289293|FG000|Overall Study|Adverse Event|13|||
49123208|NCT00689338|158289293|FG000|Overall Study|Insufficient Clinical Response|1|||
49123209|NCT00689338|158289293|FG000|Overall Study|Lack of Efficacy|6|||
49123210|NCT00689338|158289293|FG000|Overall Study|Other|8|||
49123211|NCT00689338|158289293|FG000|Overall Study|Did not Meet Entrance Criteria|27|||
49123212|NCT00689338|158289293|FG000|Overall Study|Lost to Follow-up|5|||
49123213|NCT00689338|158289293|FG000|Overall Study|Withdrawal by Subject|3|||
49123214|NCT00689338|158289293|FG000|Overall Study|Protocol Violation|15|||
49123215|NCT02949947|158289299|FG000|Overall Study|Non Compliance|0|||
49123216|NCT02949947|158289300|FG001|Overall Study|Non Compliance|1|||
49123217|NCT02949947|158289299|FG000|Overall Study|Insurance change|1|||
49123218|NCT02949947|158289300|FG001|Overall Study|Insurance change|0|||
49123219|NCT01190813|158289306|FG000|Overall Study|Lost to Follow-up|1|||
49123220|NCT01190813|158289307|FG001|Overall Study|Lost to Follow-up|2|||
49123221|NCT01190813|158289306|FG000|Overall Study|Withdrawal by Subject|2|||
48713606|NCT02059291|156801400|FG000|Epoch 4|Pregnancy|0|||
48713607|NCT02059291|156801401|FG001|Epoch 4|Pregnancy|0|||
48713608|NCT02059291|156801402|FG002|Epoch 4|Pregnancy|0|||
48713609|NCT02059291|156801403|FG003|Epoch 4|Pregnancy|0|||
48713610|NCT02059291|156801404|FG004|Epoch 4|Pregnancy|0|||
48713611|NCT02059291|156801405|FG005|Epoch 4|Pregnancy|0|||
48713612|NCT02059291|156801406|FG006|Epoch 4|Pregnancy|0|||
48713613|NCT02059291|156801407|FG007|Epoch 4|Pregnancy|0|||
48713614|NCT02059291|156801408|FG008|Epoch 4|Pregnancy|0|||
48713615|NCT02059291|156801409|FG009|Epoch 4|Pregnancy|0|||
48713616|NCT02059291|156801410|FG010|Epoch 4|Pregnancy|0|||
48713617|NCT02059291|156801411|FG011|Epoch 4|Pregnancy|0|||
48713618|NCT02059291|156801412|FG012|Epoch 4|Pregnancy|0|||
48713619|NCT02059291|156801413|FG013|Epoch 4|Pregnancy|0|||
48713620|NCT02059291|156801414|FG014|Epoch 4|Pregnancy|0|||
49123222|NCT01190813|158289307|FG001|Overall Study|Withdrawal by Subject|1|||
49123223|NCT01190813|158289306|FG000|Overall Study|Refused study treatment after randomized|1|||
48713621|NCT02059291|156801415|FG015|Epoch 4|Pregnancy|0|||
48713622|NCT02059291|156801416|FG016|Epoch 4|Pregnancy|1|||
48713623|NCT02059291|156801417|FG017|Epoch 4|Pregnancy|0|||
48713624|NCT02059291|156801418|FG018|Epoch 4|Pregnancy|0|||
48713625|NCT02059291|156801419|FG019|Epoch 4|Pregnancy|0|||
48713626|NCT02059291|156801420|FG020|Epoch 4|Pregnancy|0|||
49123224|NCT01190813|158289307|FG001|Overall Study|Refused study treatment after randomized|0|||
49123225|NCT01190813|158289306|FG000|Overall Study|Adverse Event|0|||
49123226|NCT01190813|158289307|FG001|Overall Study|Adverse Event|1|||
49123227|NCT01817075|158289308|FG000|Overall Study|Adverse Event|7|||
49123228|NCT01817075|158289309|FG001|Overall Study|Adverse Event|5|||
49123229|NCT01817075|158289308|FG000|Overall Study|Physician Decision|9|||
49123230|NCT01817075|158289309|FG001|Overall Study|Physician Decision|12|||
49123231|NCT01817075|158289308|FG000|Overall Study|Withdrawal by Subject|31|||
49123232|NCT01817075|158289309|FG001|Overall Study|Withdrawal by Subject|15|||
49123233|NCT01817075|158289308|FG000|Overall Study|Received Sorafenib after enrollment|0|||
49123234|NCT01817075|158289309|FG001|Overall Study|Received Sorafenib after enrollment|1|||
49123235|NCT01817075|158289308|FG000|Overall Study|Ineligible|0|||
49123236|NCT01817075|158289309|FG001|Overall Study|Ineligible|2|||
49123237|NCT00490971|158289311|FG000|Acute/Continuation|Adverse Event|62|||
49123238|NCT00490971|158289312|FG001|Acute/Continuation|Adverse Event|13|||
49123239|NCT00490971|158289313|FG002|Acute/Continuation|Adverse Event|0|||
49123240|NCT00490971|158289314|FG003|Acute/Continuation|Adverse Event|0|||
49123241|NCT00490971|158289315|FG004|Acute/Continuation|Adverse Event|0|||
49123242|NCT00490971|158289311|FG000|Acute/Continuation|Death|2|||
49123243|NCT00490971|158289312|FG001|Acute/Continuation|Death|0|||
49123244|NCT00490971|158289313|FG002|Acute/Continuation|Death|0|||
49123245|NCT00490971|158289314|FG003|Acute/Continuation|Death|0|||
49123246|NCT00490971|158289315|FG004|Acute/Continuation|Death|0|||
49123247|NCT00490971|158289311|FG000|Acute/Continuation|Lack of Efficacy|106|||
49123248|NCT00490971|158289312|FG001|Acute/Continuation|Lack of Efficacy|12|||
49123249|NCT00490971|158289313|FG002|Acute/Continuation|Lack of Efficacy|0|||
49123250|NCT00490971|158289314|FG003|Acute/Continuation|Lack of Efficacy|0|||
49123251|NCT00490971|158289315|FG004|Acute/Continuation|Lack of Efficacy|0|||
49123252|NCT00490971|158289311|FG000|Acute/Continuation|Lost to Follow-up|23|||
49123253|NCT00490971|158289312|FG001|Acute/Continuation|Lost to Follow-up|7|||
49123254|NCT00490971|158289313|FG002|Acute/Continuation|Lost to Follow-up|0|||
49123255|NCT00490971|158289314|FG003|Acute/Continuation|Lost to Follow-up|0|||
49123256|NCT00490971|158289315|FG004|Acute/Continuation|Lost to Follow-up|0|||
49123257|NCT00490971|158289311|FG000|Acute/Continuation|Protocol Violation|10|||
49123258|NCT00490971|158289312|FG001|Acute/Continuation|Protocol Violation|2|||
49123259|NCT00490971|158289313|FG002|Acute/Continuation|Protocol Violation|0|||
49123260|NCT00490971|158289314|FG003|Acute/Continuation|Protocol Violation|0|||
49123261|NCT00490971|158289315|FG004|Acute/Continuation|Protocol Violation|0|||
49123262|NCT00490971|158289311|FG000|Acute/Continuation|Withdrawal by Subject|92|||
49123263|NCT00490971|158289312|FG001|Acute/Continuation|Withdrawal by Subject|24|||
49123264|NCT00490971|158289313|FG002|Acute/Continuation|Withdrawal by Subject|0|||
49123265|NCT00490971|158289314|FG003|Acute/Continuation|Withdrawal by Subject|0|||
49123266|NCT00490971|158289315|FG004|Acute/Continuation|Withdrawal by Subject|0|||
49123267|NCT00490971|158289311|FG000|Acute/Continuation|Other|11|||
49123268|NCT00490971|158289312|FG001|Acute/Continuation|Other|4|||
49123269|NCT00490971|158289313|FG002|Acute/Continuation|Other|0|||
49123270|NCT00490971|158289314|FG003|Acute/Continuation|Other|0|||
49123271|NCT00490971|158289315|FG004|Acute/Continuation|Other|0|||
49123272|NCT00490971|158289311|FG000|Maintenance|Adverse Event|0|||
49123273|NCT00490971|158289312|FG001|Maintenance|Adverse Event|0|||
49123274|NCT00490971|158289313|FG002|Maintenance|Adverse Event|4|||
48713627|NCT02059291|156801421|FG021|Epoch 4|Pregnancy|0|||
48812322|NCT01512745|157153551|FG001|Overall Study|Lost to Follow-up|0|||
48919672|NCT01934556|157539855|FG000|Overall Study|Lost to Follow-up|4|||
48919673|NCT01934556|157539856|FG001|Overall Study|Lost to Follow-up|10|||
48919674|NCT01934556|157539857|FG002|Overall Study|Lost to Follow-up|7|||
48919675|NCT01934556|157539855|FG000|Overall Study|Death|1|||
48919676|NCT01934556|157539856|FG001|Overall Study|Death|5|||
48919677|NCT01934556|157539857|FG002|Overall Study|Death|2|||
48919678|NCT04649255|157541310|FG000|Overall Study|Death|9|||
48812323|NCT01512745|157153550|FG000|Overall Study|Lack of Efficacy|2|||
48812324|NCT01512745|157153551|FG001|Overall Study|Lack of Efficacy|2|||
49123275|NCT00490971|158289314|FG003|Maintenance|Adverse Event|5|||
49123276|NCT00490971|158289315|FG004|Maintenance|Adverse Event|7|||
49123277|NCT00490971|158289311|FG000|Maintenance|Death|0|||
48713628|NCT02059291|156801422|FG022|Epoch 4|Pregnancy|0|||
48713629|NCT02059291|156801423|FG023|Epoch 4|Pregnancy|0|||
48713630|NCT02059291|156801424|FG024|Epoch 4|Pregnancy|0|||
48713631|NCT02059291|156801400|FG000|Epoch 4|Withdrawal by Subject|0|||
48713632|NCT02059291|156801401|FG001|Epoch 4|Withdrawal by Subject|0|||
48713633|NCT02059291|156801402|FG002|Epoch 4|Withdrawal by Subject|0|||
48713634|NCT02059291|156801403|FG003|Epoch 4|Withdrawal by Subject|0|||
48713635|NCT02059291|156801404|FG004|Epoch 4|Withdrawal by Subject|0|||
48713636|NCT02059291|156801405|FG005|Epoch 4|Withdrawal by Subject|0|||
48713637|NCT02059291|156801406|FG006|Epoch 4|Withdrawal by Subject|0|||
48713638|NCT02059291|156801407|FG007|Epoch 4|Withdrawal by Subject|0|||
48919679|NCT04649255|157541310|FG000|Overall Study|Withdrawal by Subject|1|||
49123278|NCT00490971|158289312|FG001|Maintenance|Death|0|||
49123279|NCT00490971|158289313|FG002|Maintenance|Death|0|||
49123280|NCT00490971|158289314|FG003|Maintenance|Death|2|||
49123281|NCT00490971|158289315|FG004|Maintenance|Death|0|||
49123282|NCT00490971|158289311|FG000|Maintenance|Lost to Follow-up|0|||
49123283|NCT00490971|158289312|FG001|Maintenance|Lost to Follow-up|0|||
49123284|NCT00490971|158289313|FG002|Maintenance|Lost to Follow-up|5|||
48713639|NCT02059291|156801408|FG008|Epoch 4|Withdrawal by Subject|0|||
48713640|NCT02059291|156801409|FG009|Epoch 4|Withdrawal by Subject|0|||
48812325|NCT01512745|157153550|FG000|Overall Study|Protocol Violation|1|||
48919680|NCT04096274|157541316|FG000|Phase I|Lost to Follow-up|5|||
49123285|NCT00490971|158289314|FG003|Maintenance|Lost to Follow-up|8|||
49123286|NCT00490971|158289315|FG004|Maintenance|Lost to Follow-up|10|||
49123287|NCT00490971|158289311|FG000|Maintenance|Pregnancy|0|||
49123288|NCT00490971|158289312|FG001|Maintenance|Pregnancy|0|||
49123289|NCT00490971|158289313|FG002|Maintenance|Pregnancy|1|||
48919681|NCT04096274|157541317|FG001|Phase I|Lost to Follow-up|5|||
48919682|NCT04096274|157541316|FG000|Phase II|Lost to Follow-up|11|||
48919683|NCT04096274|157541317|FG001|Phase II|Lost to Follow-up|11|||
48919684|NCT02603120|157541323|FG000|Double-Blind Treatment Phase|Withdrew consent|4|||
48919685|NCT02603120|157541324|FG001|Double-Blind Treatment Phase|Withdrew consent|8|||
48919686|NCT02603120|157541323|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
48919687|NCT02603120|157541324|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
49123290|NCT00490971|158289314|FG003|Maintenance|Pregnancy|0|||
49123291|NCT00490971|158289315|FG004|Maintenance|Pregnancy|0|||
49123292|NCT00490971|158289311|FG000|Maintenance|Protocol Violation|0|||
49123293|NCT00490971|158289312|FG001|Maintenance|Protocol Violation|0|||
49123294|NCT00490971|158289313|FG002|Maintenance|Protocol Violation|4|||
49123295|NCT00490971|158289314|FG003|Maintenance|Protocol Violation|1|||
49123296|NCT00490971|158289315|FG004|Maintenance|Protocol Violation|1|||
49123297|NCT00490971|158289311|FG000|Maintenance|Withdrawal by Subject|0|||
49123298|NCT00490971|158289312|FG001|Maintenance|Withdrawal by Subject|0|||
49123299|NCT00490971|158289313|FG002|Maintenance|Withdrawal by Subject|26|||
49123300|NCT00490971|158289314|FG003|Maintenance|Withdrawal by Subject|28|||
49123301|NCT00490971|158289315|FG004|Maintenance|Withdrawal by Subject|18|||
49123302|NCT00490971|158289311|FG000|Maintenance|Other|0|||
49123303|NCT00490971|158289312|FG001|Maintenance|Other|0|||
49123304|NCT00490971|158289313|FG002|Maintenance|Other|11|||
49123305|NCT00490971|158289314|FG003|Maintenance|Other|9|||
49123306|NCT00490971|158289315|FG004|Maintenance|Other|3|||
49123307|NCT01683604|158289320|FG000|Overall Study|Adverse Event|2|||
49123308|NCT01683604|158289320|FG000|Overall Study|Lack of Efficacy|1|||
49123309|NCT01683604|158289320|FG000|Overall Study|Other|2|||
49123310|NCT00919633|158289321|FG000|Overall Study|Adverse Event|1|||
49123311|NCT00919633|158289322|FG001|Overall Study|Adverse Event|9|||
49123312|NCT00919633|158289323|FG002|Overall Study|Adverse Event|12|||
49123313|NCT00919633|158289324|FG003|Overall Study|Adverse Event|10|||
49123314|NCT00919633|158289321|FG000|Overall Study|Death|0|||
49123315|NCT00919633|158289322|FG001|Overall Study|Death|0|||
49123316|NCT00919633|158289323|FG002|Overall Study|Death|2|||
49123317|NCT00919633|158289324|FG003|Overall Study|Death|0|||
49123318|NCT00919633|158289321|FG000|Overall Study|Lack of Efficacy|17|||
49123319|NCT00919633|158289322|FG001|Overall Study|Lack of Efficacy|3|||
49123320|NCT00919633|158289323|FG002|Overall Study|Lack of Efficacy|2|||
49123321|NCT00919633|158289324|FG003|Overall Study|Lack of Efficacy|3|||
49123322|NCT00919633|158289321|FG000|Overall Study|Withdrawal by Subject|1|||
49123323|NCT00919633|158289322|FG001|Overall Study|Withdrawal by Subject|2|||
49123324|NCT00919633|158289323|FG002|Overall Study|Withdrawal by Subject|4|||
49123325|NCT00919633|158289324|FG003|Overall Study|Withdrawal by Subject|3|||
49123326|NCT00919633|158289321|FG000|Overall Study|Lost to Follow-up|3|||
49123327|NCT00919633|158289322|FG001|Overall Study|Lost to Follow-up|1|||
49123328|NCT00919633|158289323|FG002|Overall Study|Lost to Follow-up|0|||
49123329|NCT00919633|158289324|FG003|Overall Study|Lost to Follow-up|2|||
49123330|NCT00919633|158289321|FG000|Overall Study|Withdraw consent post transition to SOC|0|||
49123331|NCT00919633|158289322|FG001|Overall Study|Withdraw consent post transition to SOC|0|||
49123332|NCT00919633|158289323|FG002|Overall Study|Withdraw consent post transition to SOC|1|||
49123333|NCT00919633|158289324|FG003|Overall Study|Withdraw consent post transition to SOC|1|||
49123334|NCT00919633|158289321|FG000|Overall Study|Protocol Violation|0|||
49123335|NCT00919633|158289322|FG001|Overall Study|Protocol Violation|0|||
49123336|NCT00919633|158289323|FG002|Overall Study|Protocol Violation|0|||
49123337|NCT00919633|158289324|FG003|Overall Study|Protocol Violation|1|||
49123338|NCT00919633|158289321|FG000|Overall Study|Physician Decision|0|||
49123339|NCT00919633|158289322|FG001|Overall Study|Physician Decision|0|||
48713641|NCT02059291|156801410|FG010|Epoch 4|Withdrawal by Subject|0|||
48713642|NCT02059291|156801411|FG011|Epoch 4|Withdrawal by Subject|0|||
48713643|NCT02059291|156801412|FG012|Epoch 4|Withdrawal by Subject|0|||
48713644|NCT02059291|156801413|FG013|Epoch 4|Withdrawal by Subject|0|||
48713645|NCT02059291|156801414|FG014|Epoch 4|Withdrawal by Subject|0|||
48713646|NCT02059291|156801415|FG015|Epoch 4|Withdrawal by Subject|0|||
48713647|NCT02059291|156801416|FG016|Epoch 4|Withdrawal by Subject|0|||
48713648|NCT02059291|156801417|FG017|Epoch 4|Withdrawal by Subject|0|||
48713649|NCT02059291|156801418|FG018|Epoch 4|Withdrawal by Subject|0|||
48812326|NCT01512745|157153551|FG001|Overall Study|Protocol Violation|0|||
49123340|NCT00919633|158289323|FG002|Overall Study|Physician Decision|0|||
49123341|NCT00919633|158289324|FG003|Overall Study|Physician Decision|1|||
49123342|NCT00919633|158289321|FG000|Overall Study|Request of withdrawal w/o future contact|0|||
49123343|NCT00919633|158289322|FG001|Overall Study|Request of withdrawal w/o future contact|0|||
49123344|NCT00919633|158289323|FG002|Overall Study|Request of withdrawal w/o future contact|1|||
49123345|NCT00919633|158289324|FG003|Overall Study|Request of withdrawal w/o future contact|0|||
49123346|NCT00919633|158289321|FG000|Overall Study|Viral rebound outside protocol timepoint|0|||
49123347|NCT00919633|158289322|FG001|Overall Study|Viral rebound outside protocol timepoint|0|||
48713650|NCT02059291|156801419|FG019|Epoch 4|Withdrawal by Subject|0|||
48713651|NCT02059291|156801420|FG020|Epoch 4|Withdrawal by Subject|1|||
48919688|NCT02603120|157541323|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
48919689|NCT02603120|157541324|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
48919690|NCT02603120|157541323|FG000|Double-Blind Treatment Phase|Death|2|||
48919691|NCT02603120|157541324|FG001|Double-Blind Treatment Phase|Death|0|||
49123348|NCT00919633|158289323|FG002|Overall Study|Viral rebound outside protocol timepoint|1|||
49123349|NCT00919633|158289324|FG003|Overall Study|Viral rebound outside protocol timepoint|0|||
48919692|NCT02603120|157541323|FG000|Double-Blind Treatment Phase|Investigator's discretion|2|||
48919693|NCT02603120|157541324|FG001|Double-Blind Treatment Phase|Investigator's discretion|0|||
48919694|NCT02603120|157541323|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
48919695|NCT02603120|157541324|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
48919696|NCT02603120|157541323|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
48919697|NCT02603120|157541324|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
48919698|NCT02603120|157541323|FG000|Double-Blind Treatment Phase|Did not receive study drug|2|||
48919699|NCT02603120|157541324|FG001|Double-Blind Treatment Phase|Did not receive study drug|2|||
48919700|NCT02603120|157541323|FG000|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3|||
48919701|NCT02603120|157541324|FG001|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4|||
48919702|NCT02603120|157541323|FG000|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1|||
48919703|NCT02603120|157541324|FG001|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2|||
48919704|NCT02603120|157541323|FG000|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1|||
48919705|NCT02603120|157541324|FG001|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2|||
48919706|NCT02603120|157541323|FG000|OL Extension B/F/TAF Treatment Phase|Adverse Event|0|||
48919707|NCT02603120|157541324|FG001|OL Extension B/F/TAF Treatment Phase|Adverse Event|1|||
48919708|NCT02603120|157541323|FG000|OL Extension B/F/TAF Treatment Phase|Death|0|||
48919709|NCT02603120|157541324|FG001|OL Extension B/F/TAF Treatment Phase|Death|1|||
48919710|NCT02603120|157541323|FG000|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0|||
49123350|NCT00960804|158289327|FG000|Overall Study|Adverse Event|1|||
48713652|NCT02059291|156801421|FG021|Epoch 4|Withdrawal by Subject|0|||
48713653|NCT02059291|156801422|FG022|Epoch 4|Withdrawal by Subject|0|||
48713654|NCT02059291|156801423|FG023|Epoch 4|Withdrawal by Subject|0|||
48713655|NCT02059291|156801424|FG024|Epoch 4|Withdrawal by Subject|0|||
48713656|NCT02059291|156801400|FG000|Epoch 4|Lack of Efficacy|0|||
48713657|NCT02059291|156801401|FG001|Epoch 4|Lack of Efficacy|0|||
48713658|NCT02059291|156801402|FG002|Epoch 4|Lack of Efficacy|0|||
48713659|NCT02059291|156801403|FG003|Epoch 4|Lack of Efficacy|0|||
48713660|NCT02059291|156801404|FG004|Epoch 4|Lack of Efficacy|0|||
48713661|NCT02059291|156801405|FG005|Epoch 4|Lack of Efficacy|0|||
48713662|NCT02059291|156801406|FG006|Epoch 4|Lack of Efficacy|0|||
48713663|NCT02059291|156801407|FG007|Epoch 4|Lack of Efficacy|0|||
48713664|NCT02059291|156801408|FG008|Epoch 4|Lack of Efficacy|0|||
48713665|NCT02059291|156801409|FG009|Epoch 4|Lack of Efficacy|0|||
48713666|NCT02059291|156801410|FG010|Epoch 4|Lack of Efficacy|0|||
48713667|NCT02059291|156801411|FG011|Epoch 4|Lack of Efficacy|0|||
48713668|NCT02059291|156801412|FG012|Epoch 4|Lack of Efficacy|0|||
48713669|NCT02059291|156801413|FG013|Epoch 4|Lack of Efficacy|0|||
48713670|NCT02059291|156801414|FG014|Epoch 4|Lack of Efficacy|0|||
48713671|NCT02059291|156801415|FG015|Epoch 4|Lack of Efficacy|0|||
48713672|NCT02059291|156801416|FG016|Epoch 4|Lack of Efficacy|0|||
48713673|NCT02059291|156801417|FG017|Epoch 4|Lack of Efficacy|0|||
48713674|NCT02059291|156801418|FG018|Epoch 4|Lack of Efficacy|0|||
48713675|NCT02059291|156801419|FG019|Epoch 4|Lack of Efficacy|0|||
48713676|NCT02059291|156801420|FG020|Epoch 4|Lack of Efficacy|0|||
48713677|NCT02059291|156801421|FG021|Epoch 4|Lack of Efficacy|0|||
48713678|NCT02059291|156801422|FG022|Epoch 4|Lack of Efficacy|0|||
48713679|NCT02059291|156801423|FG023|Epoch 4|Lack of Efficacy|1|||
48713680|NCT02059291|156801424|FG024|Epoch 4|Lack of Efficacy|0|||
48713681|NCT01433289|156801426|FG000|Overall Study|Pregnancy|0|||
48713682|NCT01433289|156801427|FG001|Overall Study|Pregnancy|1|||
48713683|NCT01433289|156801428|FG002|Overall Study|Pregnancy|0|||
48713684|NCT01433289|156801429|FG003|Overall Study|Pregnancy|0|||
48713685|NCT00452361|156801432|FG000|Overall Study|Adverse Event|8|||
48713686|NCT00452361|156801433|FG001|Overall Study|Adverse Event|0|||
48713687|NCT00452361|156801432|FG000|Overall Study|Withdrawal by Subject|0|||
48713688|NCT00452361|156801433|FG001|Overall Study|Withdrawal by Subject|1|||
48713689|NCT00452361|156801432|FG000|Overall Study|Premature termination|13|||
48713690|NCT00452361|156801433|FG001|Overall Study|Premature termination|9|||
48713691|NCT03179605|156801434|FG000|Overall Study|Withdrawal by Subject|1|||
48713692|NCT01014910|156801435|FG000|Overall Study|Withdrawal by Subject|0|||
48713693|NCT01014910|156801436|FG001|Overall Study|Withdrawal by Subject|2|||
48713694|NCT02445794|156801437|FG000|Overall Study|Adverse Event|0|||
48713695|NCT02445794|156801438|FG001|Overall Study|Adverse Event|0|||
48713696|NCT02445794|156801439|FG002|Overall Study|Adverse Event|2|||
48713697|NCT02445794|156801440|FG003|Overall Study|Adverse Event|0|||
48713698|NCT01516034|156801443|FG000|Overall Study|Physician Decision|1|||
48713699|NCT01516034|156801443|FG000|Overall Study|Lack of Efficacy|7|||
48713700|NCT01818752|156801444|FG000|Overall Study|Adverse Event|64|||
49123351|NCT00960804|158289328|FG001|Overall Study|Adverse Event|0|||
49123352|NCT00960804|158289329|FG002|Overall Study|Adverse Event|0|||
49123353|NCT00960804|158289327|FG000|Overall Study|Withdrawal by Subject|1|||
49123354|NCT00960804|158289328|FG001|Overall Study|Withdrawal by Subject|0|||
49123355|NCT00960804|158289329|FG002|Overall Study|Withdrawal by Subject|0|||
49123356|NCT00960804|158289327|FG000|Overall Study|Study terminated by the sponsor|5|||
49123357|NCT00960804|158289328|FG001|Overall Study|Study terminated by the sponsor|4|||
49123358|NCT00960804|158289329|FG002|Overall Study|Study terminated by the sponsor|10|||
49123359|NCT00669318|158291270|FG000|Overall Study|Withdrawal by Subject|2|||
49123360|NCT01223404|158291271|FG000|First Intervention (1 Day)|Adverse Event|0|||
49123361|NCT01223404|158291272|FG001|First Intervention (1 Day)|Adverse Event|0|||
48919711|NCT02603120|157541324|FG001|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1|||
48919712|NCT01135498|157541325|FG000|Overall Study|Adverse Event|20|||
48919713|NCT01135498|157541325|FG000|Overall Study|Progressive disease|38|||
48919714|NCT01135498|157541325|FG000|Overall Study|Investigator judgement|25|||
49123362|NCT01223404|158291273|FG002|First Intervention (1 Day)|Adverse Event|0|||
48919715|NCT01135498|157541325|FG000|Overall Study|Withdrawal by Subject|4|||
48919716|NCT01135498|157541325|FG000|Overall Study|Death|1|||
48919717|NCT01135498|157541325|FG000|Overall Study|Ongoing at time of analysis|2|||
48919718|NCT01849874|157541326|FG000|Overall Study|Death|89|||
48919719|NCT01849874|157541327|FG001|Overall Study|Death|42|||
48919720|NCT01849874|157541326|FG000|Overall Study|Withdrawal by Subject|17|||
48919721|NCT01849874|157541327|FG001|Overall Study|Withdrawal by Subject|16|||
48919722|NCT01849874|157541326|FG000|Overall Study|Lost to Follow-up|3|||
48919723|NCT01849874|157541327|FG001|Overall Study|Lost to Follow-up|2|||
48919724|NCT01849874|157541326|FG000|Overall Study|Study Termination By Sponsor|93|||
48919725|NCT01849874|157541327|FG001|Overall Study|Study Termination By Sponsor|48|||
48919726|NCT01849874|157541326|FG000|Overall Study|Completed as per protocol amendment 6|3|||
48919727|NCT01849874|157541327|FG001|Overall Study|Completed as per protocol amendment 6|0|||
48919728|NCT01849874|157541326|FG000|Overall Study|Physician Decision|7|||
49123363|NCT01223404|158291274|FG003|First Intervention (1 Day)|Adverse Event|1|||
49123364|NCT01223404|158291275|FG004|First Intervention (1 Day)|Adverse Event|0|||
49123365|NCT01223404|158291276|FG005|First Intervention (1 Day)|Adverse Event|0|||
49123366|NCT01223404|158291271|FG000|Second Intervention (1 Day)|Adverse Event|1|||
49123367|NCT01223404|158291272|FG001|Second Intervention (1 Day)|Adverse Event|0|||
49123368|NCT01223404|158291273|FG002|Second Intervention (1 Day)|Adverse Event|0|||
49123369|NCT01223404|158291274|FG003|Second Intervention (1 Day)|Adverse Event|0|||
49123370|NCT01223404|158291275|FG004|Second Intervention (1 Day)|Adverse Event|0|||
49123371|NCT01223404|158291276|FG005|Second Intervention (1 Day)|Adverse Event|0|||
49123372|NCT01223404|158291271|FG000|Third Intervention (1 Day)|Non-compliance (slept)|0|||
49123373|NCT01223404|158291272|FG001|Third Intervention (1 Day)|Non-compliance (slept)|0|||
49123374|NCT01223404|158291273|FG002|Third Intervention (1 Day)|Non-compliance (slept)|0|||
49123375|NCT01223404|158291274|FG003|Third Intervention (1 Day)|Non-compliance (slept)|1|||
49123376|NCT01223404|158291275|FG004|Third Intervention (1 Day)|Non-compliance (slept)|0|||
49123377|NCT01223404|158291276|FG005|Third Intervention (1 Day)|Non-compliance (slept)|0|||
49123378|NCT00954122|158291277|FG000|Overall Study|Withdrawal by Subject|5|||
49123379|NCT00954122|158291277|FG000|Overall Study|Adverse Event|1|||
49123380|NCT00954122|158291277|FG000|Overall Study|Safety Reason|1|||
49123381|NCT01921517|158291278|FG000|Overall Study|Lost to Follow-up|5|||
49123382|NCT01921517|158291279|FG001|Overall Study|Lost to Follow-up|0|||
49123383|NCT01921517|158291278|FG000|Overall Study|Newly diagnosed health concern|2|||
49123384|NCT01921517|158291279|FG001|Overall Study|Newly diagnosed health concern|0|||
48713701|NCT01818752|156801445|FG001|Overall Study|Adverse Event|74|||
48713702|NCT01818752|156801444|FG000|Overall Study|Death|14|||
48713703|NCT01818752|156801445|FG001|Overall Study|Death|18|||
48713704|NCT01818752|156801444|FG000|Overall Study|Non-compliance|16|||
48713705|NCT01818752|156801445|FG001|Overall Study|Non-compliance|20|||
48713706|NCT01818752|156801444|FG000|Overall Study|Withdrawal by Subject|15|||
48713707|NCT01818752|156801445|FG001|Overall Study|Withdrawal by Subject|14|||
48713708|NCT01818752|156801444|FG000|Overall Study|Physician Decision|9|||
48713709|NCT01818752|156801445|FG001|Overall Study|Physician Decision|8|||
48713710|NCT01818752|156801444|FG000|Overall Study|Disease Progression|54|||
48713711|NCT01818752|156801445|FG001|Overall Study|Disease Progression|48|||
48713712|NCT01818752|156801444|FG000|Overall Study|Other|7|||
48713713|NCT01818752|156801445|FG001|Overall Study|Other|8|||
48713714|NCT01818752|156801444|FG000|Overall Study|Continuing Treatment|1|||
48713715|NCT01818752|156801445|FG001|Overall Study|Continuing Treatment|4|||
48713716|NCT01818752|156801444|FG000|Overall Study|Randomized but not Dosed|7|||
48713717|NCT01818752|156801445|FG001|Overall Study|Randomized but not Dosed|4|||
48713718|NCT01324141|156801446|FG000|Overall Study|Declined to participate before treatment started|1|||
48713719|NCT01324141|156801446|FG000|Overall Study|Disease progression on study|1|||
48713720|NCT04629066|156801449|FG000|Overall Study|Lost to Follow-up|3|||
48713721|NCT04629066|156801450|FG001|Overall Study|Lost to Follow-up|2|||
48713722|NCT00978757|156801452|FG000|Overall Study|Physician Decision|1|||
49123385|NCT01921517|158291278|FG000|Overall Study|Physician Decision|0|||
49123386|NCT01921517|158291279|FG001|Overall Study|Physician Decision|2|||
49123387|NCT01921517|158291278|FG000|Overall Study|Withdrawal by Subject|7|||
49123388|NCT01921517|158291279|FG001|Overall Study|Withdrawal by Subject|3|||
49123389|NCT01921517|158291278|FG000|Overall Study|Subject missed final imaging|1|||
49123390|NCT01921517|158291279|FG001|Overall Study|Subject missed final imaging|4|||
49123391|NCT03205150|158291280|FG000|Overall Study|Protocol deviation|1|||
49123392|NCT03205150|158291281|FG001|Overall Study|Protocol deviation|3|||
48919729|NCT01849874|157541327|FG001|Overall Study|Physician Decision|1|||
48919730|NCT01849874|157541326|FG000|Overall Study|Other|16|||
48919731|NCT01849874|157541327|FG001|Overall Study|Other|4|||
48919732|NCT02104583|157541328|FG000|Overall Study|New ICD or CRT-D implanted|2|||
48919733|NCT02104583|157541329|FG001|Overall Study|New ICD or CRT-D implanted|0|||
48919734|NCT02104583|157541330|FG002|Overall Study|New ICD or CRT-D implanted|1|||
48919735|NCT02104583|157541331|FG003|Overall Study|New ICD or CRT-D implanted|0|||
48919736|NCT02104583|157541332|FG004|Overall Study|New ICD or CRT-D implanted|0|||
48919737|NCT02104583|157541328|FG000|Overall Study|Death|2|||
48919738|NCT02104583|157541329|FG001|Overall Study|Death|1|||
48919739|NCT02104583|157541330|FG002|Overall Study|Death|3|||
48919740|NCT02104583|157541331|FG003|Overall Study|Death|3|||
49123393|NCT03205150|158291282|FG002|Overall Study|Protocol deviation|0|||
49123394|NCT03205150|158291280|FG000|Overall Study|Patient/guardian decision|0|||
49123395|NCT03205150|158291281|FG001|Overall Study|Patient/guardian decision|3|||
49123396|NCT03205150|158291282|FG002|Overall Study|Patient/guardian decision|0|||
49123397|NCT03205150|158291280|FG000|Overall Study|Adverse Event|1|||
48919741|NCT02104583|157541332|FG004|Overall Study|Death|5|||
48919742|NCT02104583|157541328|FG000|Overall Study|Subject required cardiac ablation|6|||
49123398|NCT03205150|158291281|FG001|Overall Study|Adverse Event|1|||
49123399|NCT03205150|158291282|FG002|Overall Study|Adverse Event|1|||
49123400|NCT03205150|158291280|FG000|Overall Study|Lost to Follow-up|0|||
49123401|NCT03205150|158291281|FG001|Overall Study|Lost to Follow-up|0|||
49123402|NCT03205150|158291282|FG002|Overall Study|Lost to Follow-up|1|||
49123403|NCT01411319|158291283|FG000|Overall Study|Lost to Follow-up|1|||
49123404|NCT00419757|158291284|FG000|Overall Study|Adverse Event|1|||
49123405|NCT00419757|158291285|FG001|Overall Study|Adverse Event|4|||
49123406|NCT00419757|158291284|FG000|Overall Study|Lost to Follow-up|1|||
49123407|NCT00419757|158291285|FG001|Overall Study|Lost to Follow-up|4|||
49123408|NCT00419757|158291284|FG000|Overall Study|Withdrawal by Subject|7|||
49123409|NCT00419757|158291285|FG001|Overall Study|Withdrawal by Subject|1|||
49123410|NCT00419757|158291284|FG000|Overall Study|Protocol Violation|2|||
49123411|NCT00419757|158291285|FG001|Overall Study|Protocol Violation|3|||
49123412|NCT00419757|158291284|FG000|Overall Study|Study specific discontinuation criteria|4|||
49123413|NCT00419757|158291285|FG001|Overall Study|Study specific discontinuation criteria|8|||
49123414|NCT00419757|158291284|FG000|Overall Study|Multiple reasons|3|||
49123415|NCT00419757|158291285|FG001|Overall Study|Multiple reasons|1|||
49123416|NCT00823264|158291288|FG000|Overall Study|Protocol Violation|2|||
49123417|NCT00823264|158291289|FG001|Overall Study|Protocol Violation|0|||
49123418|NCT01396083|158291290|FG000|Overall Study|Adverse Event|2|||
49123419|NCT01396083|158291291|FG001|Overall Study|Adverse Event|28|||
49123420|NCT01396083|158291290|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
49123421|NCT01396083|158291291|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
49123422|NCT01396083|158291290|FG000|Overall Study|Consent withdrawn|4|||
49123423|NCT01396083|158291291|FG001|Overall Study|Consent withdrawn|5|||
49123424|NCT01396083|158291290|FG000|Overall Study|Protocol deviation(s)|0|||
48713723|NCT00978757|156801453|FG001|Overall Study|Physician Decision|3|||
48713724|NCT03288142|156801454|FG000|Overall Study|Lost to Follow-up|22|||
48713725|NCT03288142|156801455|FG001|Overall Study|Lost to Follow-up|15|||
48713726|NCT00715910|156801458|FG000|Booster and ESFU Phase|Lost to Follow-up|0|||
48713727|NCT00715910|156801459|FG001|Booster and ESFU Phase|Lost to Follow-up|0|||
48713728|NCT00715910|156801460|FG002|Booster and ESFU Phase|Lost to Follow-up|0|||
48713729|NCT00715910|156801461|FG003|Booster and ESFU Phase|Lost to Follow-up|6|||
48713730|NCT00715910|156801462|FG004|Booster and ESFU Phase|Lost to Follow-up|1|||
48713731|NCT00715910|156801463|FG005|Booster and ESFU Phase|Lost to Follow-up|13|||
48713732|NCT00715910|156801458|FG000|Booster and ESFU Phase|Other|0|||
48713733|NCT00715910|156801459|FG001|Booster and ESFU Phase|Other|0|||
48713734|NCT00715910|156801460|FG002|Booster and ESFU Phase|Other|0|||
48713735|NCT00715910|156801461|FG003|Booster and ESFU Phase|Other|5|||
48713736|NCT00715910|156801462|FG004|Booster and ESFU Phase|Other|1|||
48713737|NCT00715910|156801463|FG005|Booster and ESFU Phase|Other|0|||
48713738|NCT00531427|156801465|FG000|Overall Study|Withdrawal by Subject|7|||
48919743|NCT02104583|157541329|FG001|Overall Study|Subject required cardiac ablation|4|||
48919744|NCT02104583|157541330|FG002|Overall Study|Subject required cardiac ablation|4|||
49123425|NCT01396083|158291291|FG001|Overall Study|Protocol deviation(s)|1|||
49123426|NCT01396083|158291290|FG000|Overall Study|Abnormal laboratory value(s)|1|||
49123427|NCT01396083|158291291|FG001|Overall Study|Abnormal laboratory value(s)|0|||
48713739|NCT00531427|156801466|FG001|Overall Study|Withdrawal by Subject|13|||
49123428|NCT01396083|158291290|FG000|Overall Study|Administrative problems|1|||
49123429|NCT01396083|158291291|FG001|Overall Study|Administrative problems|0|||
49123430|NCT01396083|158291290|FG000|Overall Study|Lost to Follow-up|1|||
49123431|NCT01396083|158291291|FG001|Overall Study|Lost to Follow-up|0|||
49123432|NCT00577772|158291292|FG000|Overall Study|Lost to Follow-up|0|||
49123433|NCT00577772|158291293|FG001|Overall Study|Lost to Follow-up|1|||
49123434|NCT01249417|158291295|FG000|Randomised Population|Study treatment not received|0|||
49123435|NCT01249417|158291296|FG001|Randomised Population|Study treatment not received|0|||
49123436|NCT01249417|158291297|FG002|Randomised Population|Study treatment not received|2|||
49123437|NCT01249417|158291295|FG000|Randomised Population|No MAS score at baseline and/or Week 4|1|||
49123438|NCT01249417|158291296|FG001|Randomised Population|No MAS score at baseline and/or Week 4|1|||
49123439|NCT01249417|158291297|FG002|Randomised Population|No MAS score at baseline and/or Week 4|2|||
49123440|NCT01249417|158291295|FG000|Treatment Phase - ITT Population|Other|0|||
49123441|NCT01249417|158291296|FG001|Treatment Phase - ITT Population|Other|0|||
49123442|NCT01249417|158291297|FG002|Treatment Phase - ITT Population|Other|1|||
49123443|NCT01249417|158291295|FG000|Treatment Phase - ITT Population|Adverse Event|0|||
49123444|NCT01249417|158291296|FG001|Treatment Phase - ITT Population|Adverse Event|0|||
49123445|NCT01249417|158291297|FG002|Treatment Phase - ITT Population|Adverse Event|1|||
49123446|NCT01249417|158291295|FG000|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
49123447|NCT01249417|158291296|FG001|Treatment Phase - ITT Population|Withdrawal by Subject|3|||
49123448|NCT01249417|158291297|FG002|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
49123449|NCT01249417|158291295|FG000|Treatment Phase - ITT Population|Lost to Follow-up|0|||
49123450|NCT01249417|158291296|FG001|Treatment Phase - ITT Population|Lost to Follow-up|1|||
49123451|NCT01249417|158291297|FG002|Treatment Phase - ITT Population|Lost to Follow-up|1|||
49123452|NCT00613821|158291298|FG000|Overall Study|Withdrawal by Subject|1|||
49123453|NCT00613821|158291299|FG001|Overall Study|Withdrawal by Subject|0|||
49123454|NCT00613821|158291298|FG000|Overall Study|Physician Decision|1|||
49123455|NCT00613821|158291299|FG001|Overall Study|Physician Decision|1|||
49123456|NCT04110314|158291300|FG000|Overall Study|Did not meet inclusion criteria|35255|||
49123457|NCT04110314|158291301|FG001|Overall Study|Did not meet inclusion criteria|35104|||
49123458|NCT04110314|158291302|FG002|Overall Study|Did not meet inclusion criteria|35636|||
49123459|NCT04110314|158291303|FG003|Overall Study|Did not meet inclusion criteria|35135|||
49123460|NCT04110314|158291304|FG004|Overall Study|Did not meet inclusion criteria|35247|||
49123461|NCT04110314|158291305|FG005|Overall Study|Did not meet inclusion criteria|35727|||
49123462|NCT02735980|158291310|FG000|Overall Study|Adverse Event|0|||
49123463|NCT02735980|158291311|FG001|Overall Study|Adverse Event|4|||
49123464|NCT02735980|158291312|FG002|Overall Study|Adverse Event|1|||
49123465|NCT02735980|158291310|FG000|Overall Study|Death|5|||
49123466|NCT02735980|158291311|FG001|Overall Study|Death|4|||
49123467|NCT02735980|158291312|FG002|Overall Study|Death|0|||
49123468|NCT02735980|158291310|FG000|Overall Study|Physician Decision|3|||
49123469|NCT02735980|158291311|FG001|Overall Study|Physician Decision|1|||
49123470|NCT02735980|158291312|FG002|Overall Study|Physician Decision|0|||
49123471|NCT02735980|158291310|FG000|Overall Study|Screen failure|1|||
49123472|NCT02735980|158291311|FG001|Overall Study|Screen failure|0|||
49123473|NCT02735980|158291312|FG002|Overall Study|Screen failure|0|||
49123474|NCT02735980|158291310|FG000|Overall Study|Withdrawal by Subject|1|||
49123475|NCT02735980|158291311|FG001|Overall Study|Withdrawal by Subject|2|||
48713740|NCT00531427|156801465|FG000|Overall Study|Adverse Event|44|||
48812327|NCT00936221|157153552|FG000|Overall Study|Withdrawal by Subject|1|||
48812328|NCT00936221|157153553|FG001|Overall Study|Withdrawal by Subject|1|||
48812329|NCT00758160|157153554|FG000|Overall Study|No Longer Requires Study Medication|4|||
48812330|NCT00758160|157153554|FG000|Overall Study|Administration Problems|3|||
48812331|NCT00758160|157153554|FG000|Overall Study|Adverse Event|15|||
48812332|NCT00758160|157153554|FG000|Overall Study|Lack of Efficacy|10|||
48812333|NCT00758160|157153554|FG000|Overall Study|Lost to Follow-up|14|||
48812334|NCT00758160|157153554|FG000|Overall Study|Protocol Violation|12|||
48812335|NCT00758160|157153554|FG000|Overall Study|Withdrawal by Subject|8|||
48812336|NCT01380990|157153555|FG000|Overall Study|Treatment Failure|1|||
48812337|NCT01380990|157153556|FG001|Overall Study|Treatment Failure|0|||
48812338|NCT01380990|157153555|FG000|Overall Study|Death|0|||
49123476|NCT02735980|158291312|FG002|Overall Study|Withdrawal by Subject|0|||
49123477|NCT00369915|158291313|FG000|Overall Study|expected side effects|2|||
49123478|NCT00369915|158291314|FG001|Overall Study|expected side effects|1|||
49123479|NCT00369915|158291313|FG000|Overall Study|Withdrawal by Subject|4|||
48713741|NCT00531427|156801466|FG001|Overall Study|Adverse Event|30|||
48713742|NCT00531427|156801465|FG000|Overall Study|Lost to Follow-up|4|||
48713743|NCT00531427|156801466|FG001|Overall Study|Lost to Follow-up|3|||
48713744|NCT00531427|156801465|FG000|Overall Study|Lack of Efficacy|14|||
48713745|NCT00531427|156801466|FG001|Overall Study|Lack of Efficacy|39|||
48713746|NCT00531427|156801465|FG000|Overall Study|Administrative|4|||
48713747|NCT00531427|156801466|FG001|Overall Study|Administrative|9|||
48713748|NCT03073733|156801467|FG000|Overall Study|Lost to Follow-up|1|||
48713749|NCT03073733|156801468|FG001|Overall Study|Lost to Follow-up|0|||
48713750|NCT03073733|156801469|FG002|Overall Study|Lost to Follow-up|0|||
48812339|NCT01380990|157153556|FG001|Overall Study|Death|1|||
48812340|NCT02153359|157153557|FG000|Intervention 2 (1 Month)|Lost to Follow-up|0|||
48919745|NCT02104583|157541331|FG003|Overall Study|Subject required cardiac ablation|5|||
48919746|NCT02104583|157541332|FG004|Overall Study|Subject required cardiac ablation|4|||
48919747|NCT02104583|157541328|FG000|Overall Study|Subject required prohibited medication|0|||
48919748|NCT02104583|157541329|FG001|Overall Study|Subject required prohibited medication|1|||
48919749|NCT02104583|157541330|FG002|Overall Study|Subject required prohibited medication|1|||
48919750|NCT02104583|157541331|FG003|Overall Study|Subject required prohibited medication|0|||
48919751|NCT02104583|157541332|FG004|Overall Study|Subject required prohibited medication|1|||
48919752|NCT02104583|157541328|FG000|Overall Study|Withdrew Consent|3|||
48919753|NCT02104583|157541329|FG001|Overall Study|Withdrew Consent|2|||
48919754|NCT02104583|157541330|FG002|Overall Study|Withdrew Consent|0|||
48919755|NCT02104583|157541331|FG003|Overall Study|Withdrew Consent|2|||
48919756|NCT02104583|157541332|FG004|Overall Study|Withdrew Consent|1|||
48919757|NCT02104583|157541328|FG000|Overall Study|Investigator's Discretion|1|||
48919758|NCT02104583|157541329|FG001|Overall Study|Investigator's Discretion|0|||
48919759|NCT02104583|157541330|FG002|Overall Study|Investigator's Discretion|0|||
48919760|NCT02104583|157541331|FG003|Overall Study|Investigator's Discretion|0|||
48919761|NCT02104583|157541332|FG004|Overall Study|Investigator's Discretion|0|||
48919762|NCT02104583|157541328|FG000|Overall Study|Protocol Violation|0|||
48919763|NCT02104583|157541329|FG001|Overall Study|Protocol Violation|0|||
48919764|NCT02104583|157541330|FG002|Overall Study|Protocol Violation|1|||
48919765|NCT02104583|157541331|FG003|Overall Study|Protocol Violation|0|||
48919766|NCT02104583|157541332|FG004|Overall Study|Protocol Violation|0|||
48919767|NCT02104583|157541328|FG000|Overall Study|Adverse Event|3|||
48919768|NCT02104583|157541329|FG001|Overall Study|Adverse Event|3|||
48919769|NCT02104583|157541330|FG002|Overall Study|Adverse Event|6|||
49123480|NCT00369915|158291314|FG001|Overall Study|Withdrawal by Subject|1|||
49123481|NCT00369915|158291313|FG000|Overall Study|W/drawl by investigators|0|||
49123482|NCT00369915|158291314|FG001|Overall Study|W/drawl by investigators|1|||
49123483|NCT00411450|158291315|FG000|Overall Study|Ongoing at time of data cut-off.|3|||
49123484|NCT00141518|158291324|FG000|Overall Study|Withdrew Consent Prior to Treatment|1|||
49123485|NCT00141518|158291325|FG001|Overall Study|Withdrew Consent Prior to Treatment|0|||
49123486|NCT00141518|158291326|FG002|Overall Study|Withdrew Consent Prior to Treatment|0|||
49123487|NCT00141518|158291324|FG000|Overall Study|Adverse Event|7|||
49123488|NCT00141518|158291325|FG001|Overall Study|Adverse Event|5|||
49123489|NCT00141518|158291326|FG002|Overall Study|Adverse Event|2|||
49123490|NCT00141518|158291324|FG000|Overall Study|Withdrawal by Subject|2|||
49123491|NCT00141518|158291325|FG001|Overall Study|Withdrawal by Subject|0|||
49123492|NCT00141518|158291326|FG002|Overall Study|Withdrawal by Subject|2|||
49123493|NCT00141518|158291324|FG000|Overall Study|Protocol Violation|1|||
49123494|NCT00141518|158291325|FG001|Overall Study|Protocol Violation|1|||
49123495|NCT00141518|158291326|FG002|Overall Study|Protocol Violation|2|||
49123496|NCT00141518|158291324|FG000|Overall Study|Lack of Efficacy|5|||
49123497|NCT00141518|158291325|FG001|Overall Study|Lack of Efficacy|0|||
49123498|NCT00141518|158291326|FG002|Overall Study|Lack of Efficacy|0|||
49123499|NCT01064414|158291327|FG000|Core Period: Baseline to Week 26|Adverse Event|4|||
48812341|NCT02153359|157153558|FG001|Intervention 2 (1 Month)|Lost to Follow-up|2|||
49123500|NCT01064414|158291328|FG001|Core Period: Baseline to Week 26|Adverse Event|4|||
49123501|NCT01064414|158291329|FG002|Core Period: Baseline to Week 26|Adverse Event|2|||
49123502|NCT01064414|158291327|FG000|Core Period: Baseline to Week 26|Death|0|||
48812342|NCT01964521|157153559|FG000|Overall Study|Lost to Follow-up|4|||
48812343|NCT01108510|157153563|FG000|Overall Study|Randomized but Not Treated|5|||
48812344|NCT01108510|157153564|FG001|Overall Study|Randomized but Not Treated|1|||
48812345|NCT01108510|157153563|FG000|Overall Study|Joined Another Gilead-sponsored Study|186|||
48812346|NCT01108510|157153564|FG001|Overall Study|Joined Another Gilead-sponsored Study|195|||
48812347|NCT01108510|157153563|FG000|Overall Study|Adverse Event|26|||
48919770|NCT02104583|157541331|FG003|Overall Study|Adverse Event|6|||
49123503|NCT01064414|158291328|FG001|Core Period: Baseline to Week 26|Death|1|||
49123504|NCT01064414|158291329|FG002|Core Period: Baseline to Week 26|Death|0|||
49123505|NCT01064414|158291327|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
49123506|NCT01064414|158291328|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
49123507|NCT01064414|158291329|FG002|Core Period: Baseline to Week 26|Protocol Violation|1|||
49123508|NCT01064414|158291327|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
48812348|NCT01108510|157153564|FG001|Overall Study|Adverse Event|19|||
48812349|NCT01108510|157153563|FG000|Overall Study|Lost to Follow-up|20|||
48919771|NCT02104583|157541332|FG004|Overall Study|Adverse Event|1|||
48919772|NCT02104583|157541328|FG000|Overall Study|Lost to Follow-up|1|||
49123509|NCT01064414|158291328|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
49123510|NCT01064414|158291329|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
49123511|NCT01064414|158291327|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
48919773|NCT02104583|157541329|FG001|Overall Study|Lost to Follow-up|0|||
48919774|NCT02104583|157541330|FG002|Overall Study|Lost to Follow-up|0|||
48919775|NCT02104583|157541331|FG003|Overall Study|Lost to Follow-up|0|||
48919776|NCT02104583|157541332|FG004|Overall Study|Lost to Follow-up|0|||
48812350|NCT01108510|157153564|FG001|Overall Study|Lost to Follow-up|17|||
48919777|NCT02104583|157541328|FG000|Overall Study|Randomized but Never Treated|0|||
49123512|NCT01064414|158291328|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
49123513|NCT01064414|158291329|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
49123514|NCT01064414|158291327|FG000|Core Period: Baseline to Week 26|Other|4|||
49123515|NCT01064414|158291328|FG001|Core Period: Baseline to Week 26|Other|7|||
49123516|NCT01064414|158291329|FG002|Core Period: Baseline to Week 26|Other|2|||
49123517|NCT01064414|158291327|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
49123518|NCT01064414|158291328|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
49123519|NCT01064414|158291329|FG002|Extension Period: Week 26 to Week 52|Adverse Event|2|||
49123520|NCT01064414|158291327|FG000|Extension Period: Week 26 to Week 52|Death|0|||
49123521|NCT01064414|158291328|FG001|Extension Period: Week 26 to Week 52|Death|1|||
49123522|NCT01064414|158291329|FG002|Extension Period: Week 26 to Week 52|Death|0|||
49123523|NCT01064414|158291327|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
49123524|NCT01064414|158291328|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
49123525|NCT01064414|158291329|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
49123526|NCT01064414|158291327|FG000|Extension Period: Week 26 to Week 52|Physician Decision|1|||
49123527|NCT01064414|158291328|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
49123528|NCT01064414|158291329|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
49123529|NCT01064414|158291327|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
49123530|NCT01064414|158291328|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
49123531|NCT01064414|158291329|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
49123532|NCT01064414|158291327|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
49123533|NCT01064414|158291328|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
49123534|NCT01064414|158291329|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
49123535|NCT01064414|158291327|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
49123536|NCT01064414|158291328|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
49123537|NCT01064414|158291329|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
49123538|NCT01064414|158291327|FG000|Extension Period: Week 26 to Week 52|Other|5|||
49123539|NCT01064414|158291328|FG001|Extension Period: Week 26 to Week 52|Other|2|||
49123540|NCT01064414|158291329|FG002|Extension Period: Week 26 to Week 52|Other|1|||
49123541|NCT02185417|158291330|FG000|Overall Study|Death|448|||
49123542|NCT02185417|158291331|FG001|Overall Study|Death|446|||
49123543|NCT02185417|158291332|FG002|Overall Study|Death|0|||
49123544|NCT02185417|158291330|FG000|Overall Study|Withdrawal by Subject|7|||
48812351|NCT01108510|157153563|FG000|Overall Study|Withdrew Consent|21|||
48812352|NCT01108510|157153564|FG001|Overall Study|Withdrew Consent|15|||
48812353|NCT01108510|157153563|FG000|Overall Study|Investigator's Discretion|12|||
48812354|NCT01108510|157153564|FG001|Overall Study|Investigator's Discretion|10|||
48812355|NCT01108510|157153563|FG000|Overall Study|Participant Noncompliance|5|||
48812356|NCT01108510|157153564|FG001|Overall Study|Participant Noncompliance|7|||
48812357|NCT01108510|157153563|FG000|Overall Study|Lack of Efficacy|3|||
48812358|NCT01108510|157153564|FG001|Overall Study|Lack of Efficacy|0|||
48812359|NCT01108510|157153563|FG000|Overall Study|Pregnancy|0|||
48812360|NCT01108510|157153564|FG001|Overall Study|Pregnancy|3|||
48812361|NCT01108510|157153563|FG000|Overall Study|Death|1|||
48812362|NCT01108510|157153564|FG001|Overall Study|Death|1|||
48812363|NCT01284140|157153565|FG000|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
48812364|NCT01284140|157153566|FG001|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
48812365|NCT01284140|157153565|FG000|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0|||
48812366|NCT01284140|157153566|FG001|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1|||
48812367|NCT01463293|157153567|FG000|Overall Study|Lost to Follow-up|1|||
48812368|NCT01463293|157153568|FG001|Overall Study|Lost to Follow-up|4|||
48812369|NCT01463293|157153569|FG002|Overall Study|Lost to Follow-up|5|||
48812370|NCT01463293|157153567|FG000|Overall Study|Adverse Event|1|||
48812371|NCT01463293|157153568|FG001|Overall Study|Adverse Event|2|||
48812372|NCT01463293|157153569|FG002|Overall Study|Adverse Event|0|||
48812373|NCT01463293|157153567|FG000|Overall Study|Withdrawal by Subject|4|||
48812374|NCT01463293|157153568|FG001|Overall Study|Withdrawal by Subject|10|||
48812375|NCT01463293|157153569|FG002|Overall Study|Withdrawal by Subject|5|||
48812376|NCT01463293|157153567|FG000|Overall Study|Other|0|||
48812377|NCT01463293|157153568|FG001|Overall Study|Other|0|||
48812378|NCT01463293|157153569|FG002|Overall Study|Other|2|||
48812379|NCT02796963|157153570|FG000|Overall Study|Lost to Follow-up|89|||
48812380|NCT02796963|157153571|FG001|Overall Study|Lost to Follow-up|76|||
48812381|NCT02796963|157153572|FG002|Overall Study|Lost to Follow-up|69|||
48812382|NCT02796963|157153573|FG003|Overall Study|Lost to Follow-up|72|||
48812383|NCT00210119|157153574|FG000|Overall Study|Protocol Violation|1|||
48812384|NCT00210119|157153574|FG000|Overall Study|Withdrawal by Subject|1|||
49123545|NCT02185417|158291331|FG001|Overall Study|Withdrawal by Subject|12|||
48812385|NCT04192630|157153575|FG000|Overall Study|Discontinued before surgery|2|||
48812386|NCT04192630|157153576|FG001|Overall Study|Discontinued before surgery|0|||
48812387|NCT04192630|157153575|FG000|Overall Study|Discontinued after surgery|5|||
48812388|NCT04192630|157153576|FG001|Overall Study|Discontinued after surgery|3|||
49123546|NCT02185417|158291332|FG002|Overall Study|Withdrawal by Subject|0|||
49123547|NCT01806168|158291334|FG000|Overall Study|Adverse Event|1|||
49123548|NCT01806168|158291335|FG001|Overall Study|Adverse Event|0|||
49123549|NCT01806168|158291336|FG002|Overall Study|Adverse Event|0|||
49123550|NCT01806168|158291334|FG000|Overall Study|Withdrawal by Subject|0|||
49123551|NCT01806168|158291335|FG001|Overall Study|Withdrawal by Subject|1|||
49123552|NCT01806168|158291336|FG002|Overall Study|Withdrawal by Subject|2|||
49123553|NCT01806168|158291334|FG000|Overall Study|Protocol Violation|0|||
49123554|NCT01806168|158291335|FG001|Overall Study|Protocol Violation|0|||
49123555|NCT01806168|158291336|FG002|Overall Study|Protocol Violation|1|||
49123556|NCT02219685|158291337|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
49123557|NCT02219685|158291338|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
49123558|NCT02219685|158291337|FG000|Blinded Treatment Phase|Withdrew Consent|1|||
49123559|NCT02219685|158291338|FG001|Blinded Treatment Phase|Withdrew Consent|0|||
49123560|NCT00661089|158291339|FG000|Overall Study|1 subject withdrawal|0|||
49123561|NCT00661089|158291340|FG001|Overall Study|1 subject withdrawal|1|||
49123562|NCT00661089|158291339|FG000|Overall Study|death at 8 weeks due to new stroke|0|||
48713751|NCT03073733|156801467|FG000|Overall Study|Physician Decision|0|||
48713752|NCT03073733|156801468|FG001|Overall Study|Physician Decision|1|||
49123563|NCT00661089|158291340|FG001|Overall Study|death at 8 weeks due to new stroke|1|||
49123564|NCT01545388|158291341|FG000|Overall Study|Adverse Event|2|||
49123565|NCT01545388|158291342|FG001|Overall Study|Adverse Event|4|||
49123566|NCT01545388|158291343|FG002|Overall Study|Adverse Event|1|||
49123567|NCT01545388|158291341|FG000|Overall Study|Lack of Efficacy|3|||
49123568|NCT01545388|158291342|FG001|Overall Study|Lack of Efficacy|2|||
49123569|NCT01545388|158291343|FG002|Overall Study|Lack of Efficacy|5|||
49123570|NCT01545388|158291341|FG000|Overall Study|Participant moved or relocated|1|||
49123571|NCT01545388|158291342|FG001|Overall Study|Participant moved or relocated|0|||
49123572|NCT01545388|158291343|FG002|Overall Study|Participant moved or relocated|0|||
49123573|NCT01545388|158291341|FG000|Overall Study|Withdrawal by Subject|1|||
49123574|NCT01545388|158291342|FG001|Overall Study|Withdrawal by Subject|4|||
49123575|NCT01545388|158291343|FG002|Overall Study|Withdrawal by Subject|2|||
49123576|NCT01545388|158291341|FG000|Overall Study|Other|1|||
49123577|NCT01545388|158291342|FG001|Overall Study|Other|1|||
48713753|NCT03073733|156801469|FG002|Overall Study|Physician Decision|0|||
48713754|NCT03073733|156801467|FG000|Overall Study|Withdrawal by Subject|0|||
48713755|NCT03073733|156801468|FG001|Overall Study|Withdrawal by Subject|0|||
48713756|NCT03073733|156801469|FG002|Overall Study|Withdrawal by Subject|1|||
48713757|NCT01338298|156801470|FG000|Overall Study|Withdrawal by Subject|1|||
48713758|NCT01338298|156801471|FG001|Overall Study|Withdrawal by Subject|1|||
48713759|NCT01338298|156801470|FG000|Overall Study|Abdominal Pain and scheduled surgery|0|||
48713760|NCT01338298|156801471|FG001|Overall Study|Abdominal Pain and scheduled surgery|1|||
48713761|NCT01338298|156801470|FG000|Overall Study|Administrative error|0|||
48713762|NCT01338298|156801471|FG001|Overall Study|Administrative error|1|||
48713763|NCT01338298|156801470|FG000|Overall Study|Positive symptom worsening|1|||
48713764|NCT01338298|156801471|FG001|Overall Study|Positive symptom worsening|0|||
48713765|NCT01338298|156801470|FG000|Overall Study|Depressive symptoms and nausea|1|||
48713766|NCT01338298|156801471|FG001|Overall Study|Depressive symptoms and nausea|0|||
48713767|NCT01338298|156801470|FG000|Overall Study|Non-adherence|1|||
48713768|NCT01338298|156801471|FG001|Overall Study|Non-adherence|0|||
48713769|NCT04359901|156801473|FG000|Overall Study|Withdrawal by Subject|0|||
48713770|NCT04359901|156801474|FG001|Overall Study|Withdrawal by Subject|1|||
48713771|NCT04359901|156801473|FG000|Overall Study|Death|6|||
48713772|NCT04359901|156801474|FG001|Overall Study|Death|2|||
48713773|NCT02872285|156801475|FG000|Overall Study|Withdrawal by Subject|2|||
48713774|NCT02872285|156801476|FG001|Overall Study|Withdrawal by Subject|0|||
48713775|NCT02872285|156801475|FG000|Overall Study|Lost to Follow-up|2|||
48713776|NCT02872285|156801476|FG001|Overall Study|Lost to Follow-up|2|||
48713777|NCT02872285|156801475|FG000|Overall Study|Discontinued due to back surgery|1|||
48713778|NCT02872285|156801476|FG001|Overall Study|Discontinued due to back surgery|0|||
48713779|NCT01112306|156801482|FG000|Overall Study|Death|175|||
48713780|NCT01112306|156801482|FG000|Overall Study|Lost to Follow-up|9|||
48713781|NCT01112306|156801482|FG000|Overall Study|Withdrawal by Subject|31|||
48713782|NCT01112306|156801482|FG000|Overall Study|Other|70|||
48713783|NCT03976648|156801483|FG000|Overall Study|Adverse Event|0|||
48713784|NCT03976648|156801484|FG001|Overall Study|Adverse Event|2|||
48713785|NCT03976648|156801483|FG000|Overall Study|Study terminated by sponsor|21|||
48713786|NCT03976648|156801484|FG001|Overall Study|Study terminated by sponsor|8|||
48713787|NCT01182844|156801487|FG000|Overall Study|Withdrawal by Subject|0|||
48713788|NCT01182844|156801488|FG001|Overall Study|Withdrawal by Subject|2|||
48713789|NCT00960570|156801489|FG000|21 Day Washout Period|Adverse Event|1|||
48713790|NCT00960570|156801489|FG000|21 Day Washout Period|Withdrawal by Subject|1|||
48713791|NCT00960570|156801489|FG000|1 Day Period Between Dosing|Adverse Event|2|||
48713792|NCT00960570|156801489|FG000|1 Day Period Between Dosing|Withdrawal by Subject|1|||
49123578|NCT01545388|158291343|FG002|Overall Study|Other|0|||
48713793|NCT01451437|156801492|FG000|Overall Study|Adverse Event|0|||
48812389|NCT01193582|157153577|FG000|Vaccination Series|Withdrawal by Subject|11|||
48812390|NCT01193582|157153578|FG001|Vaccination Series|Withdrawal by Subject|13|||
48812391|NCT01193582|157153579|FG002|Vaccination Series|Withdrawal by Subject|8|||
48812392|NCT01193582|157153580|FG003|Vaccination Series|Withdrawal by Subject|3|||
48812393|NCT01193582|157153577|FG000|12 Month Follow-up|Death|0|||
48812394|NCT01193582|157153578|FG001|12 Month Follow-up|Death|0|||
48812395|NCT01193582|157153579|FG002|12 Month Follow-up|Death|1|||
48812396|NCT01193582|157153580|FG003|12 Month Follow-up|Death|0|||
48713794|NCT01451437|156801493|FG001|Overall Study|Adverse Event|0|||
48713795|NCT01451437|156801494|FG002|Overall Study|Adverse Event|0|||
48713796|NCT01451437|156801495|FG003|Overall Study|Adverse Event|0|||
48713797|NCT01451437|156801496|FG004|Overall Study|Adverse Event|0|||
48713798|NCT01451437|156801497|FG005|Overall Study|Adverse Event|1|||
48713799|NCT01451437|156801498|FG006|Overall Study|Adverse Event|1|||
48812397|NCT01193582|157153577|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
48812398|NCT01193582|157153578|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
48919778|NCT02104583|157541329|FG001|Overall Study|Randomized but Never Treated|0|||
48919779|NCT02104583|157541330|FG002|Overall Study|Randomized but Never Treated|0|||
48919780|NCT02104583|157541331|FG003|Overall Study|Randomized but Never Treated|1|||
48919781|NCT02104583|157541332|FG004|Overall Study|Randomized but Never Treated|0|||
48919782|NCT02699892|157541333|FG000|Overall Study|Other|36|||
48919783|NCT04091087|157541336|FG000|Overall Study|Not treated|1|||
48919784|NCT04091087|157541337|FG001|Overall Study|Not treated|0|||
48919785|NCT04091087|157541336|FG000|Overall Study|Adverse Event|4|||
48919786|NCT04091087|157541337|FG001|Overall Study|Adverse Event|4|||
48919787|NCT04091087|157541336|FG000|Overall Study|Protocol Violation|0|||
48919788|NCT04091087|157541337|FG001|Overall Study|Protocol Violation|1|||
48919789|NCT04091087|157541336|FG000|Overall Study|Withdrawal by Subject|5|||
48919790|NCT04091087|157541337|FG001|Overall Study|Withdrawal by Subject|2|||
48919791|NCT02919436|157541340|FG000|Overall Study|Did not undergo surgery|16|||
48919792|NCT02919436|157541341|FG001|Overall Study|Did not undergo surgery|20|||
48919793|NCT02919436|157541340|FG000|Overall Study|Enrolled before trial registration|44|||
48919794|NCT02919436|157541341|FG001|Overall Study|Enrolled before trial registration|33|||
48919795|NCT01709435|157541346|FG000|Overall Study|Adverse Event|1|||
48919796|NCT01709435|157541347|FG001|Overall Study|Adverse Event|1|||
48919797|NCT01709435|157541348|FG002|Overall Study|Adverse Event|1|||
48919798|NCT01709435|157541349|FG003|Overall Study|Adverse Event|0|||
48919799|NCT01709435|157541350|FG004|Overall Study|Adverse Event|0|||
48919800|NCT01709435|157541351|FG005|Overall Study|Adverse Event|1|||
48919801|NCT01709435|157541346|FG000|Overall Study|Lack of Efficacy|5|||
48919802|NCT01709435|157541347|FG001|Overall Study|Lack of Efficacy|7|||
48919803|NCT01709435|157541348|FG002|Overall Study|Lack of Efficacy|2|||
48919804|NCT01709435|157541349|FG003|Overall Study|Lack of Efficacy|2|||
48919805|NCT01709435|157541350|FG004|Overall Study|Lack of Efficacy|6|||
48919806|NCT01709435|157541351|FG005|Overall Study|Lack of Efficacy|3|||
48919807|NCT01709435|157541346|FG000|Overall Study|Physician Decision|0|||
48919808|NCT01709435|157541347|FG001|Overall Study|Physician Decision|1|||
48919809|NCT01709435|157541348|FG002|Overall Study|Physician Decision|0|||
48919810|NCT01709435|157541349|FG003|Overall Study|Physician Decision|1|||
48919811|NCT01709435|157541350|FG004|Overall Study|Physician Decision|2|||
48919812|NCT01709435|157541351|FG005|Overall Study|Physician Decision|0|||
48919813|NCT01709435|157541346|FG000|Overall Study|Withdrawal by Subject|0|||
48919814|NCT01709435|157541347|FG001|Overall Study|Withdrawal by Subject|0|||
48919815|NCT01709435|157541348|FG002|Overall Study|Withdrawal by Subject|3|||
48919816|NCT01709435|157541349|FG003|Overall Study|Withdrawal by Subject|0|||
48919817|NCT01709435|157541350|FG004|Overall Study|Withdrawal by Subject|2|||
48919818|NCT01709435|157541351|FG005|Overall Study|Withdrawal by Subject|2|||
48919819|NCT00769184|157541355|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1|||
48919820|NCT00769184|157541356|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0|||
48919821|NCT00769184|157541355|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0|||
48919822|NCT00769184|157541356|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1|||
48919823|NCT00769184|157541355|FG000|No Treatment (6 Weeks)|Adverse Event|1|||
48919824|NCT00769184|157541356|FG001|No Treatment (6 Weeks)|Adverse Event|1|||
48812399|NCT01193582|157153579|FG002|12 Month Follow-up|Withdrawal by Subject|3|||
48919825|NCT03775421|157541357|FG000|Overall Study|Lost to Follow-up|2|||
48919826|NCT03775421|157541357|FG000|Overall Study|Withdrawal by Subject|10|||
48812400|NCT01193582|157153580|FG003|12 Month Follow-up|Withdrawal by Subject|11|||
48812401|NCT01617005|157153581|FG000|Overall Study|Pregnancy|1|||
48919827|NCT03775421|157541357|FG000|Overall Study|Physician Decision|3|||
48919828|NCT03775421|157541357|FG000|Overall Study|Death|1|||
48812402|NCT01617005|157153581|FG000|Overall Study|Lack of motivation for treatment|1|||
48812403|NCT01320735|157153582|FG000|Overall Study|Adverse Event|3|||
48812404|NCT01320735|157153582|FG000|Overall Study|Withdrawal by Subject|3|||
48919829|NCT03775421|157541357|FG000|Overall Study|Study Terminated by Sponsor|94|||
48919830|NCT00517829|157541358|FG000|Overall Study|Adverse Event|22|||
48713800|NCT01451437|156801499|FG007|Overall Study|Adverse Event|2|||
49123579|NCT02567188|158291344|FG000|Overall Study|Death|10|||
49123580|NCT02567188|158291344|FG000|Overall Study|Terminated Mircera Treatment|9|||
49123581|NCT02567188|158291344|FG000|Overall Study|Lost to Follow-up|5|||
49123582|NCT02567188|158291344|FG000|Overall Study|Adverse Event|1|||
49123583|NCT02567188|158291344|FG000|Overall Study|Withdrawal by Subject|1|||
49123584|NCT02567188|158291344|FG000|Overall Study|Refused Treatment/ Did not Cooperate|1|||
49123585|NCT02567188|158291344|FG000|Overall Study|Moved and Changed Clinic|1|||
49123586|NCT02567188|158291344|FG000|Overall Study|Started Hemodialysis|2|||
49123587|NCT02567188|158291344|FG000|Overall Study|Protocol Violation|5|||
49123588|NCT00072384|158291345|FG000|Overall Study|Physician Decision|1|||
49123589|NCT00072384|158291345|FG000|Overall Study|Ineligible|8|||
49123590|NCT02718911|158291346|FG000|Overall Study|Adverse Event|0|||
49123591|NCT02718911|158291347|FG001|Overall Study|Adverse Event|0|||
49123592|NCT02718911|158291348|FG002|Overall Study|Adverse Event|0|||
49123593|NCT02718911|158291349|FG003|Overall Study|Adverse Event|0|||
49123594|NCT02718911|158291350|FG004|Overall Study|Adverse Event|0|||
49123595|NCT02718911|158291351|FG005|Overall Study|Adverse Event|0|||
49123596|NCT02718911|158291352|FG006|Overall Study|Adverse Event|0|||
49123597|NCT02718911|158291353|FG007|Overall Study|Adverse Event|0|||
49123598|NCT02718911|158291354|FG008|Overall Study|Adverse Event|0|||
49123599|NCT02718911|158291355|FG009|Overall Study|Adverse Event|2|||
49123600|NCT02718911|158291346|FG000|Overall Study|Death|2|||
49123601|NCT02718911|158291347|FG001|Overall Study|Death|3|||
49123602|NCT02718911|158291348|FG002|Overall Study|Death|1|||
49123603|NCT02718911|158291349|FG003|Overall Study|Death|0|||
49123604|NCT02718911|158291350|FG004|Overall Study|Death|1|||
49123605|NCT02718911|158291351|FG005|Overall Study|Death|3|||
49123606|NCT02718911|158291352|FG006|Overall Study|Death|1|||
49123607|NCT02718911|158291353|FG007|Overall Study|Death|1|||
49123608|NCT02718911|158291354|FG008|Overall Study|Death|4|||
49123609|NCT02718911|158291355|FG009|Overall Study|Death|3|||
49123610|NCT02718911|158291346|FG000|Overall Study|Lost to Follow-up|0|||
49123611|NCT02718911|158291347|FG001|Overall Study|Lost to Follow-up|0|||
49123612|NCT02718911|158291348|FG002|Overall Study|Lost to Follow-up|0|||
49123613|NCT02718911|158291349|FG003|Overall Study|Lost to Follow-up|0|||
49123614|NCT02718911|158291350|FG004|Overall Study|Lost to Follow-up|0|||
49123615|NCT02718911|158291351|FG005|Overall Study|Lost to Follow-up|0|||
49123616|NCT02718911|158291352|FG006|Overall Study|Lost to Follow-up|0|||
49123617|NCT02718911|158291353|FG007|Overall Study|Lost to Follow-up|0|||
49123618|NCT02718911|158291354|FG008|Overall Study|Lost to Follow-up|1|||
48713801|NCT01451437|156801500|FG008|Overall Study|Adverse Event|1|||
48713802|NCT01451437|156801492|FG000|Overall Study|Physician Decision|1|||
49123619|NCT02718911|158291355|FG009|Overall Study|Lost to Follow-up|0|||
49123620|NCT02718911|158291346|FG000|Overall Study|Physician Decision|2|||
49123621|NCT02718911|158291347|FG001|Overall Study|Physician Decision|0|||
49123622|NCT02718911|158291348|FG002|Overall Study|Physician Decision|1|||
49123623|NCT02718911|158291349|FG003|Overall Study|Physician Decision|1|||
49123624|NCT02718911|158291350|FG004|Overall Study|Physician Decision|0|||
49123625|NCT02718911|158291351|FG005|Overall Study|Physician Decision|0|||
49123626|NCT02718911|158291352|FG006|Overall Study|Physician Decision|0|||
49123627|NCT02718911|158291353|FG007|Overall Study|Physician Decision|1|||
49123628|NCT02718911|158291354|FG008|Overall Study|Physician Decision|2|||
49123629|NCT02718911|158291355|FG009|Overall Study|Physician Decision|1|||
48812405|NCT01320735|157153582|FG000|Overall Study|Lost to Follow-up|13|||
49123630|NCT02718911|158291346|FG000|Overall Study|Withdrawal by Subject|0|||
49123631|NCT02718911|158291347|FG001|Overall Study|Withdrawal by Subject|0|||
49123632|NCT02718911|158291348|FG002|Overall Study|Withdrawal by Subject|0|||
49123633|NCT02718911|158291349|FG003|Overall Study|Withdrawal by Subject|0|||
49123634|NCT02718911|158291350|FG004|Overall Study|Withdrawal by Subject|1|||
49123635|NCT02718911|158291351|FG005|Overall Study|Withdrawal by Subject|0|||
49123636|NCT02718911|158291352|FG006|Overall Study|Withdrawal by Subject|0|||
49123637|NCT02718911|158291353|FG007|Overall Study|Withdrawal by Subject|0|||
49123638|NCT02718911|158291354|FG008|Overall Study|Withdrawal by Subject|1|||
49123639|NCT02718911|158291355|FG009|Overall Study|Withdrawal by Subject|4|||
49123640|NCT02718911|158291346|FG000|Overall Study|Reason Not Collected|0|||
49123641|NCT02718911|158291347|FG001|Overall Study|Reason Not Collected|0|||
49123642|NCT02718911|158291348|FG002|Overall Study|Reason Not Collected|1|||
49123643|NCT02718911|158291349|FG003|Overall Study|Reason Not Collected|0|||
49123644|NCT02718911|158291350|FG004|Overall Study|Reason Not Collected|0|||
49123645|NCT02718911|158291351|FG005|Overall Study|Reason Not Collected|0|||
49123646|NCT02718911|158291352|FG006|Overall Study|Reason Not Collected|2|||
49123647|NCT02718911|158291353|FG007|Overall Study|Reason Not Collected|1|||
49123648|NCT02718911|158291354|FG008|Overall Study|Reason Not Collected|4|||
49123649|NCT02718911|158291355|FG009|Overall Study|Reason Not Collected|9|||
49123650|NCT02053493|158291356|FG000|Overall Study|Withdrawal by Subject|1|||
49123651|NCT02053493|158291357|FG001|Overall Study|Withdrawal by Subject|1|||
49123652|NCT03589807|158291361|FG000|Overall Study|Lost to Follow-up|0|||
49123653|NCT03589807|158291362|FG001|Overall Study|Lost to Follow-up|2|||
49123654|NCT03589807|158291363|FG002|Overall Study|Lost to Follow-up|2|||
49123655|NCT03589807|158291364|FG003|Overall Study|Lost to Follow-up|3|||
49123656|NCT03589807|158291365|FG004|Overall Study|Lost to Follow-up|1|||
49123657|NCT03589807|158291366|FG005|Overall Study|Lost to Follow-up|1|||
49123658|NCT03589807|158291361|FG000|Overall Study|Withdrawal by Subject|0|||
49123659|NCT03589807|158291362|FG001|Overall Study|Withdrawal by Subject|5|||
49123660|NCT03589807|158291363|FG002|Overall Study|Withdrawal by Subject|0|||
49123661|NCT03589807|158291364|FG003|Overall Study|Withdrawal by Subject|0|||
49123662|NCT03589807|158291365|FG004|Overall Study|Withdrawal by Subject|0|||
49123663|NCT03589807|158291366|FG005|Overall Study|Withdrawal by Subject|0|||
49123664|NCT03589807|158291361|FG000|Overall Study|Protocol Violation|0|||
49123665|NCT03589807|158291362|FG001|Overall Study|Protocol Violation|0|||
49123666|NCT03589807|158291363|FG002|Overall Study|Protocol Violation|0|||
49123667|NCT03589807|158291364|FG003|Overall Study|Protocol Violation|1|||
49123668|NCT03589807|158291365|FG004|Overall Study|Protocol Violation|0|||
49123669|NCT03589807|158291366|FG005|Overall Study|Protocol Violation|0|||
49123670|NCT03589807|158291361|FG000|Overall Study|Enrolled but treatment not administered|0|||
49123671|NCT03589807|158291362|FG001|Overall Study|Enrolled but treatment not administered|0|||
49123672|NCT03589807|158291363|FG002|Overall Study|Enrolled but treatment not administered|0|||
49123673|NCT03589807|158291364|FG003|Overall Study|Enrolled but treatment not administered|0|||
49123674|NCT03589807|158291365|FG004|Overall Study|Enrolled but treatment not administered|1|||
49123675|NCT03589807|158291366|FG005|Overall Study|Enrolled but treatment not administered|0|||
48919831|NCT00517829|157541359|FG001|Overall Study|Adverse Event|34|||
48919832|NCT00517829|157541358|FG000|Overall Study|Disease Progression|39|||
48919833|NCT00517829|157541359|FG001|Overall Study|Disease Progression|32|||
48919834|NCT00517829|157541358|FG000|Overall Study|Patient Request|6|||
48919835|NCT00517829|157541359|FG001|Overall Study|Patient Request|5|||
48919836|NCT00517829|157541358|FG000|Overall Study|Investigator Request|5|||
48919837|NCT00517829|157541359|FG001|Overall Study|Investigator Request|3|||
48919838|NCT00517829|157541358|FG000|Overall Study|Other|3|||
48919839|NCT00517829|157541359|FG001|Overall Study|Other|1|||
48919840|NCT00385255|157541360|FG000|Overall Study|Serious Adverse Event|1|||
48919841|NCT00385255|157541361|FG001|Overall Study|Serious Adverse Event|2|||
48919842|NCT00385255|157541360|FG000|Overall Study|Protocol Violation|0|||
48919843|NCT00385255|157541361|FG001|Overall Study|Protocol Violation|4|||
48919844|NCT00385255|157541360|FG000|Overall Study|Withdrawal by Subject|0|||
48919845|NCT00385255|157541361|FG001|Overall Study|Withdrawal by Subject|8|||
48919846|NCT00385255|157541360|FG000|Overall Study|Migrated/moved from study area|0|||
48919847|NCT00385255|157541361|FG001|Overall Study|Migrated/moved from study area|1|||
48919848|NCT00385255|157541360|FG000|Overall Study|Lost to Follow-up|20|||
49123676|NCT01076543|158291368|FG000|Overall Study|Withdrawal by Subject|2|||
49123677|NCT01076543|158291369|FG001|Overall Study|Withdrawal by Subject|0|||
49123678|NCT01076543|158291370|FG002|Overall Study|Withdrawal by Subject|0|||
49123679|NCT01076543|158291371|FG003|Overall Study|Withdrawal by Subject|0|||
49123680|NCT01076543|158291372|FG004|Overall Study|Withdrawal by Subject|0|||
49123681|NCT01076543|158291373|FG005|Overall Study|Withdrawal by Subject|0|||
49123682|NCT01630135|158291374|FG000|Overall Study|Protocol-defined Stopping Criteria Met|0|||
49123683|NCT01630135|158291375|FG001|Overall Study|Protocol-defined Stopping Criteria Met|2|||
49123684|NCT04396626|158291383|FG000|Overall Study|Premature termination of study|975|||
49123685|NCT02782741|158291386|FG000|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
49123686|NCT02782741|158291387|FG001|Blinded Treatment Period: up to Week 49|Adverse Event|4|||
49123687|NCT02782741|158291388|FG002|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
49123688|NCT02782741|158291386|FG000|Blinded Treatment Period: up to Week 49|Other|0|||
49123689|NCT02782741|158291387|FG001|Blinded Treatment Period: up to Week 49|Other|1|||
49123690|NCT02782741|158291388|FG002|Blinded Treatment Period: up to Week 49|Other|0|||
49123691|NCT02782741|158291386|FG000|Open-label Long-term: Week 50 to 289|Adverse Event|2|||
49123692|NCT02782741|158291387|FG001|Open-label Long-term: Week 50 to 289|Adverse Event|3|||
49123693|NCT02782741|158291388|FG002|Open-label Long-term: Week 50 to 289|Adverse Event|0|||
49123694|NCT02782741|158291386|FG000|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
49123695|NCT02782741|158291387|FG001|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|1|||
49123696|NCT02782741|158291388|FG002|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
49123697|NCT02782741|158291386|FG000|Open-label Long-term: Week 50 to 289|Other|5|||
49123698|NCT02782741|158291387|FG001|Open-label Long-term: Week 50 to 289|Other|4|||
49123699|NCT02782741|158291388|FG002|Open-label Long-term: Week 50 to 289|Other|0|||
49123700|NCT01705977|158291389|FG000|Treatment Period (Year 1)|Withdrawal by Subject|128|||
49123701|NCT01705977|158291390|FG001|Treatment Period (Year 1)|Withdrawal by Subject|128|||
49123702|NCT01705977|158291389|FG000|Treatment Period (Year 1)|Adverse Event|57|||
49123703|NCT01705977|158291390|FG001|Treatment Period (Year 1)|Adverse Event|49|||
49123704|NCT01705977|158291389|FG000|Treatment Period (Year 1)|Protocol Violation|2|||
49123705|NCT01705977|158291390|FG001|Treatment Period (Year 1)|Protocol Violation|4|||
49123706|NCT01705977|158291389|FG000|Treatment Period (Year 1)|Site closure|3|||
49123707|NCT01705977|158291390|FG001|Treatment Period (Year 1)|Site closure|2|||
49123708|NCT01705977|158291389|FG000|Treatment Period (Year 1)|Lost to Follow-up|33|||
49123709|NCT01705977|158291390|FG001|Treatment Period (Year 1)|Lost to Follow-up|37|||
49123710|NCT01705977|158291389|FG000|Treatment Period (Year 1)|Physician Decision|48|||
49123711|NCT01705977|158291390|FG001|Treatment Period (Year 1)|Physician Decision|38|||
49123712|NCT01705977|158291389|FG000|Treatment Period (Year 1)|Missing study conclusion form|2|||
49123713|NCT01705977|158291390|FG001|Treatment Period (Year 1)|Missing study conclusion form|2|||
49123714|NCT01705977|158291389|FG000|Treatment Period (Year 1)|Randomized but not treated|7|||
49123715|NCT01705977|158291390|FG001|Treatment Period (Year 1)|Randomized but not treated|9|||
49123716|NCT01705977|158291389|FG000|Follow-up Period (Years 2 to 5)|Death|58|||
49123717|NCT01705977|158291390|FG001|Follow-up Period (Years 2 to 5)|Death|38|||
49123718|NCT01705977|158291389|FG000|Follow-up Period (Years 2 to 5)|Lost to Follow-up|75|||
49123719|NCT01705977|158291390|FG001|Follow-up Period (Years 2 to 5)|Lost to Follow-up|89|||
49123720|NCT01705977|158291389|FG000|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|44|||
49123721|NCT01705977|158291390|FG001|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|36|||
49123722|NCT01705977|158291389|FG000|Follow-up Period (Years 2 to 5)|Missing|19|||
49123723|NCT01705977|158291390|FG001|Follow-up Period (Years 2 to 5)|Missing|18|||
49123724|NCT02989402|158291391|FG000|Overall Study|Adverse event, or serious adverse event|4|||
49123725|NCT02989402|158291391|FG000|Overall Study|Death|2|||
49123726|NCT02989402|158291391|FG000|Overall Study|Discontinuation of study treatment and premature patient withdrawal|3|||
49123727|NCT02989402|158291391|FG000|Overall Study|Lost to Follow-up|8|||
49123728|NCT02989402|158291391|FG000|Overall Study|Patient no longer on monotherapy|1|||
49123729|NCT02989402|158291391|FG000|Overall Study|Patient stopped Exelon® patch treatment|1|||
49123730|NCT02989402|158291391|FG000|Overall Study|Withdrawal by Subject|7|||
49123731|NCT02989402|158291391|FG000|Overall Study|Other|2|||
49123732|NCT01275144|158291392|FG000|Second Intervention (6 Days)|Withdrawal by Subject|1|||
49123733|NCT01275144|158291393|FG001|Second Intervention (6 Days)|Withdrawal by Subject|0|||
49123734|NCT01419314|158291396|FG000|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3|||
49123735|NCT01419314|158291397|FG001|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1|||
49123736|NCT01419314|158291396|FG000|Follow-up at Week 3 of the Trial|Lost to Follow-up|3|||
49123737|NCT01419314|158291397|FG001|Follow-up at Week 3 of the Trial|Lost to Follow-up|0|||
49123738|NCT01419314|158291396|FG000|Follow-up at Week 6 of the Trial|Lost to Follow-up|1|||
49123739|NCT01419314|158291397|FG001|Follow-up at Week 6 of the Trial|Lost to Follow-up|2|||
49123740|NCT03372798|158291409|FG000|Overall Study|Patient not attending post-procedural CT scan|1|||
49123741|NCT03372798|158291410|FG001|Overall Study|Patient not attending post-procedural CT scan|0|||
49123742|NCT03372798|158291409|FG000|Overall Study|Failure of imaging probe|0|||
49123743|NCT03372798|158291410|FG001|Overall Study|Failure of imaging probe|1|||
49123744|NCT03188055|158291411|FG000|Overall Study|Unavailable for training|0|||
49123745|NCT03188055|158291412|FG001|Overall Study|Unavailable for training|0|||
49123746|NCT03188055|158291413|FG002|Overall Study|Unavailable for training|19|||
49123747|NCT03188055|158291414|FG003|Overall Study|Unavailable for training|0|||
49123748|NCT03188055|158291415|FG004|Overall Study|Unavailable for training|0|||
49123749|NCT03188055|158291416|FG005|Overall Study|Unavailable for training|0|||
49123750|NCT03188055|158291411|FG000|Overall Study|Lost to Follow-up|0|||
49123751|NCT03188055|158291412|FG001|Overall Study|Lost to Follow-up|18|||
49123752|NCT03188055|158291413|FG002|Overall Study|Lost to Follow-up|0|||
49123753|NCT03188055|158291414|FG003|Overall Study|Lost to Follow-up|11|||
49123754|NCT03188055|158291415|FG004|Overall Study|Lost to Follow-up|0|||
49123755|NCT03188055|158291416|FG005|Overall Study|Lost to Follow-up|0|||
49123756|NCT03188055|158291411|FG000|Overall Study|Withdrawal by Subject|0|||
49123757|NCT03188055|158291412|FG001|Overall Study|Withdrawal by Subject|1|||
49123758|NCT03188055|158291413|FG002|Overall Study|Withdrawal by Subject|0|||
49123759|NCT03188055|158291414|FG003|Overall Study|Withdrawal by Subject|1|||
49123760|NCT03188055|158291415|FG004|Overall Study|Withdrawal by Subject|0|||
49123761|NCT03188055|158291416|FG005|Overall Study|Withdrawal by Subject|0|||
49123762|NCT04030598|158291417|FG000|Overall Study|Voluntary Withdrawal|0|||
49123763|NCT04030598|158291418|FG001|Overall Study|Voluntary Withdrawal|1|||
49123764|NCT04030598|158291419|FG002|Overall Study|Voluntary Withdrawal|0|||
49123765|NCT02823470|158292849|FG000|Overall Study|Adverse Event|1|||
49123766|NCT02823470|158292850|FG001|Overall Study|Adverse Event|0|||
49123767|NCT02823470|158292849|FG000|Overall Study|Study terminated by sponsor|8|||
49123768|NCT02823470|158292850|FG001|Overall Study|Study terminated by sponsor|15|||
49123769|NCT02492165|158292853|FG000|Overall Study|Withdrawal by Subject|0|||
49123770|NCT02492165|158292854|FG001|Overall Study|Withdrawal by Subject|1|||
49123771|NCT02492165|158292855|FG002|Overall Study|Withdrawal by Subject|0|||
49123772|NCT02492165|158292856|FG003|Overall Study|Withdrawal by Subject|0|||
49123773|NCT01705080|158292857|FG000|Overall Study|Missed visit|10|||
49123774|NCT01705080|158292858|FG001|Overall Study|Missed visit|4|||
49123775|NCT01705080|158292859|FG002|Overall Study|Missed visit|1|||
49123776|NCT01705080|158292857|FG000|Overall Study|Death|4|||
49123777|NCT01705080|158292858|FG001|Overall Study|Death|4|||
49123778|NCT01705080|158292859|FG002|Overall Study|Death|6|||
49123779|NCT01705080|158292857|FG000|Overall Study|Withdrawal by Subject|61|||
49123780|NCT01705080|158292858|FG001|Overall Study|Withdrawal by Subject|44|||
49123781|NCT01705080|158292859|FG002|Overall Study|Withdrawal by Subject|9|||
49123782|NCT03492437|158292865|FG000|Treatment Period 2|Withdrawal by Subject|0|||
49123783|NCT03492437|158292866|FG001|Treatment Period 2|Withdrawal by Subject|1|||
49123784|NCT01298700|158292867|FG000|Overall Study|Adverse Event|50|||
49123785|NCT01298700|158292868|FG001|Overall Study|Adverse Event|51|||
49123786|NCT01298700|158292867|FG000|Overall Study|Lack of Efficacy|9|||
49123787|NCT01298700|158292868|FG001|Overall Study|Lack of Efficacy|14|||
49123788|NCT01298700|158292867|FG000|Overall Study|Lost to Follow-up|5|||
49123789|NCT01298700|158292868|FG001|Overall Study|Lost to Follow-up|2|||
49123790|NCT01298700|158292867|FG000|Overall Study|Withdrawal by Subject|12|||
49123791|NCT01298700|158292868|FG001|Overall Study|Withdrawal by Subject|9|||
49123792|NCT01298700|158292867|FG000|Overall Study|Protocol Violation|6|||
49123793|NCT01298700|158292868|FG001|Overall Study|Protocol Violation|4|||
49123794|NCT01298700|158292867|FG000|Overall Study|Other Miscellaneous Reasons|16|||
49123795|NCT01298700|158292868|FG001|Overall Study|Other Miscellaneous Reasons|15|||
49123796|NCT01298700|158292867|FG000|Overall Study|Did not Receive Study Drug|3|||
49123797|NCT01298700|158292868|FG001|Overall Study|Did not Receive Study Drug|5|||
49123798|NCT04534517|158292869|FG000|Overall Study|Adverse Event|1|||
49123799|NCT04534517|158292869|FG000|Overall Study|Withdrawal by Subject|1|||
49123800|NCT04534517|158292869|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
49123801|NCT04534517|158292869|FG000|Overall Study|COVID-19 Related|1|||
49123802|NCT01716806|158292870|FG000|Overall Study|Patient withdrawal of consent|4|||
49123803|NCT01716806|158292871|FG001|Overall Study|Patient withdrawal of consent|2|||
49123804|NCT01716806|158292872|FG002|Overall Study|Patient withdrawal of consent|4|||
49123805|NCT01716806|158292873|FG003|Overall Study|Patient withdrawal of consent|3|||
49123806|NCT01716806|158292874|FG004|Overall Study|Patient withdrawal of consent|2|||
49123807|NCT01716806|158292875|FG005|Overall Study|Patient withdrawal of consent|0|||
49123808|NCT01716806|158292870|FG000|Overall Study|Lost to Follow-up|3|||
49123809|NCT01716806|158292871|FG001|Overall Study|Lost to Follow-up|3|||
49123810|NCT01716806|158292872|FG002|Overall Study|Lost to Follow-up|0|||
49123811|NCT01716806|158292873|FG003|Overall Study|Lost to Follow-up|2|||
49123812|NCT01716806|158292874|FG004|Overall Study|Lost to Follow-up|1|||
49123813|NCT01716806|158292875|FG005|Overall Study|Lost to Follow-up|0|||
49123814|NCT01716806|158292870|FG000|Overall Study|Death|13|||
49123815|NCT01716806|158292871|FG001|Overall Study|Death|9|||
49123816|NCT01716806|158292872|FG002|Overall Study|Death|12|||
49123817|NCT01716806|158292873|FG003|Overall Study|Death|4|||
49123818|NCT01716806|158292874|FG004|Overall Study|Death|10|||
49123819|NCT01716806|158292875|FG005|Overall Study|Death|5|||
49123820|NCT01716806|158292870|FG000|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
49123821|NCT01716806|158292871|FG001|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
49123822|NCT01716806|158292872|FG002|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
49123823|NCT01716806|158292873|FG003|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
49123824|NCT01716806|158292874|FG004|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
49123825|NCT01716806|158292875|FG005|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
49123826|NCT01716806|158292870|FG000|Overall Study|PI decision|0|||
49123827|NCT01716806|158292871|FG001|Overall Study|PI decision|0|||
49123828|NCT01716806|158292872|FG002|Overall Study|PI decision|0|||
49123829|NCT01716806|158292873|FG003|Overall Study|PI decision|0|||
49123830|NCT01716806|158292874|FG004|Overall Study|PI decision|1|||
49123831|NCT01716806|158292875|FG005|Overall Study|PI decision|0|||
49123832|NCT01716806|158292870|FG000|Overall Study|Change in performance status|1|||
49123833|NCT01716806|158292871|FG001|Overall Study|Change in performance status|0|||
49123834|NCT01716806|158292872|FG002|Overall Study|Change in performance status|0|||
49123835|NCT01716806|158292873|FG003|Overall Study|Change in performance status|0|||
49123836|NCT01716806|158292874|FG004|Overall Study|Change in performance status|0|||
49123837|NCT01716806|158292875|FG005|Overall Study|Change in performance status|0|||
49123838|NCT01716806|158292870|FG000|Overall Study|Sponsor terminated enrollment into Part C|0|||
49123839|NCT01716806|158292871|FG001|Overall Study|Sponsor terminated enrollment into Part C|0|||
49123840|NCT01716806|158292872|FG002|Overall Study|Sponsor terminated enrollment into Part C|1|||
49123841|NCT01716806|158292873|FG003|Overall Study|Sponsor terminated enrollment into Part C|0|||
49123842|NCT01716806|158292874|FG004|Overall Study|Sponsor terminated enrollment into Part C|0|||
49123843|NCT01716806|158292875|FG005|Overall Study|Sponsor terminated enrollment into Part C|0|||
49123844|NCT01716806|158292870|FG000|Overall Study|Sponsor direction|7|||
49123845|NCT01716806|158292871|FG001|Overall Study|Sponsor direction|8|||
49123846|NCT01716806|158292872|FG002|Overall Study|Sponsor direction|5|||
49123847|NCT01716806|158292873|FG003|Overall Study|Sponsor direction|12|||
49123848|NCT01716806|158292874|FG004|Overall Study|Sponsor direction|16|||
49123849|NCT01716806|158292875|FG005|Overall Study|Sponsor direction|1|||
49123850|NCT02692586|158292876|FG000|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1|||
49123851|NCT02692586|158292876|FG000|Overall Study|Received adjunctive thrombolytics|2|||
49123852|NCT01128296|158292877|FG000|Overall Study|Physician Decision|0|||
49123853|NCT01128296|158292878|FG001|Overall Study|Physician Decision|0|||
49123854|NCT01128296|158292879|FG002|Overall Study|Physician Decision|0|||
49123855|NCT01128296|158292880|FG003|Overall Study|Physician Decision|0|||
49123856|NCT01128296|158292881|FG004|Overall Study|Physician Decision|0|||
49123857|NCT01128296|158292882|FG005|Overall Study|Physician Decision|3|||
49123858|NCT01128296|158292877|FG000|Overall Study|Withdrawal by Subject|0|||
49123859|NCT01128296|158292878|FG001|Overall Study|Withdrawal by Subject|0|||
49123860|NCT01128296|158292879|FG002|Overall Study|Withdrawal by Subject|0|||
49123861|NCT01128296|158292880|FG003|Overall Study|Withdrawal by Subject|0|||
49123862|NCT01128296|158292881|FG004|Overall Study|Withdrawal by Subject|0|||
49123863|NCT01128296|158292882|FG005|Overall Study|Withdrawal by Subject|2|||
49123864|NCT01714544|158292883|FG000|Overall Study|Lost to Follow-up|1|||
49123865|NCT01714544|158292883|FG000|Overall Study|Physician Decision|1|||
49123866|NCT01714544|158292883|FG000|Overall Study|Withdrawal by Subject|1|||
49123867|NCT03934216|158292884|FG000|Overall Study|Other Reasons|5|||
49123868|NCT03934216|158292885|FG001|Overall Study|Other Reasons|5|||
49123869|NCT03934216|158292884|FG000|Overall Study|Adverse Event|22|||
49123870|NCT03934216|158292885|FG001|Overall Study|Adverse Event|11|||
49123871|NCT03934216|158292884|FG000|Overall Study|Lack of Efficacy|8|||
48812406|NCT01320735|157153582|FG000|Overall Study|Administrative Reason|6|||
49123872|NCT03934216|158292885|FG001|Overall Study|Lack of Efficacy|7|||
49123873|NCT03934216|158292884|FG000|Overall Study|Lost to Follow-up|2|||
48812407|NCT01320735|157153582|FG000|Overall Study|Progression/Hormone-Refractory Pca|55|||
48812408|NCT01320735|157153582|FG000|Overall Study|Protocol Violation|1|||
48812409|NCT01320735|157153582|FG000|Overall Study|Other|1|||
48812410|NCT01320735|157153582|FG000|Overall Study|No Decrease of Prostate Specific Antigen|7|||
48812411|NCT01320735|157153582|FG000|Overall Study|Investigator Unable to be Contacted|17|||
48812412|NCT03632434|157153583|FG000|Overall Study|Withdrawal by Subject|2|||
48812413|NCT00544544|157153586|FG000|Overall Study|Withdrawal by Subject|1|||
48812414|NCT00544544|157153586|FG000|Overall Study|Adverse Event|1|||
48812415|NCT00544544|157153586|FG000|Overall Study|Lost to Follow-up|1|||
48812416|NCT01051063|157153590|FG000|Overall Study|Death|2|||
48812417|NCT01051063|157153591|FG001|Overall Study|Death|2|||
48812418|NCT01051063|157153590|FG000|Overall Study|Withdrawal by Subject|1|||
48812419|NCT01051063|157153591|FG001|Overall Study|Withdrawal by Subject|1|||
48812420|NCT01051063|157153590|FG000|Overall Study|Termination of the study|5|||
48812421|NCT01051063|157153591|FG001|Overall Study|Termination of the study|0|||
49123874|NCT03934216|158292885|FG001|Overall Study|Lost to Follow-up|0|||
49123875|NCT03934216|158292884|FG000|Overall Study|Non-Compliance with Study Drug|1|||
49123876|NCT03934216|158292885|FG001|Overall Study|Non-Compliance with Study Drug|1|||
49123877|NCT03934216|158292884|FG000|Overall Study|Pregnancy|1|||
49123878|NCT03934216|158292885|FG001|Overall Study|Pregnancy|0|||
49123879|NCT03934216|158292884|FG000|Overall Study|Withdrawal by Subject|18|||
49123880|NCT03934216|158292885|FG001|Overall Study|Withdrawal by Subject|6|||
49123881|NCT03934216|158292884|FG000|Overall Study|Randomized but not treated|1|||
49123882|NCT03934216|158292885|FG001|Overall Study|Randomized but not treated|1|||
48812422|NCT01051063|157153590|FG000|Overall Study|Moved from the study site area|1|||
48812423|NCT01051063|157153591|FG001|Overall Study|Moved from the study site area|0|||
48812424|NCT01051063|157153590|FG000|Overall Study|Other|1|||
48713803|NCT01451437|156801493|FG001|Overall Study|Physician Decision|1|||
48713804|NCT01451437|156801494|FG002|Overall Study|Physician Decision|2|||
48713805|NCT01451437|156801495|FG003|Overall Study|Physician Decision|0|||
48713806|NCT01451437|156801496|FG004|Overall Study|Physician Decision|0|||
48713807|NCT01451437|156801497|FG005|Overall Study|Physician Decision|0|||
48713808|NCT01451437|156801498|FG006|Overall Study|Physician Decision|0|||
48713809|NCT01451437|156801499|FG007|Overall Study|Physician Decision|0|||
48713810|NCT01451437|156801500|FG008|Overall Study|Physician Decision|0|||
48713811|NCT01451437|156801492|FG000|Overall Study|Disease Progression|0|||
48713812|NCT01451437|156801493|FG001|Overall Study|Disease Progression|0|||
48713813|NCT01451437|156801494|FG002|Overall Study|Disease Progression|1|||
48713814|NCT01451437|156801495|FG003|Overall Study|Disease Progression|1|||
48713815|NCT01451437|156801496|FG004|Overall Study|Disease Progression|3|||
48812425|NCT01051063|157153591|FG001|Overall Study|Other|0|||
48812426|NCT01051063|157153590|FG000|Overall Study|Lost to Follow-up|0|||
48812427|NCT01051063|157153591|FG001|Overall Study|Lost to Follow-up|1|||
48812428|NCT00519636|157153592|FG000|Treatment Period 1|Adverse Event|1|||
48812429|NCT00519636|157153593|FG001|Treatment Period 1|Adverse Event|0|||
48812430|NCT00519636|157153594|FG002|Treatment Period 1|Adverse Event|1|||
48812431|NCT00519636|157153595|FG003|Treatment Period 1|Adverse Event|0|||
48812432|NCT00519636|157153592|FG000|Treatment Period 1|Sponsor request due to missed visit|1|||
48812433|NCT00519636|157153593|FG001|Treatment Period 1|Sponsor request due to missed visit|0|||
48812434|NCT00519636|157153594|FG002|Treatment Period 1|Sponsor request due to missed visit|0|||
48812435|NCT00519636|157153595|FG003|Treatment Period 1|Sponsor request due to missed visit|0|||
48919849|NCT00385255|157541361|FG001|Overall Study|Lost to Follow-up|58|||
48919850|NCT02443883|157541362|FG000|Overall Study|Adverse Event|0|||
48919851|NCT02443883|157541363|FG001|Overall Study|Adverse Event|1|||
48919852|NCT02443883|157541364|FG002|Overall Study|Adverse Event|0|||
48919853|NCT02443883|157541365|FG003|Overall Study|Adverse Event|0|||
48919854|NCT02443883|157541362|FG000|Overall Study|Lost to Follow-up|3|||
48919855|NCT02443883|157541363|FG001|Overall Study|Lost to Follow-up|2|||
48919856|NCT02443883|157541364|FG002|Overall Study|Lost to Follow-up|1|||
48919857|NCT02443883|157541365|FG003|Overall Study|Lost to Follow-up|0|||
48919858|NCT02443883|157541362|FG000|Overall Study|Physician Decision|1|||
48919859|NCT02443883|157541363|FG001|Overall Study|Physician Decision|1|||
48919860|NCT02443883|157541364|FG002|Overall Study|Physician Decision|0|||
48919861|NCT02443883|157541365|FG003|Overall Study|Physician Decision|3|||
48919862|NCT02443883|157541362|FG000|Overall Study|Withdrawal by Subject|1|||
48919863|NCT02443883|157541363|FG001|Overall Study|Withdrawal by Subject|0|||
48919864|NCT02443883|157541364|FG002|Overall Study|Withdrawal by Subject|0|||
48919865|NCT02443883|157541365|FG003|Overall Study|Withdrawal by Subject|2|||
48919866|NCT02443883|157541362|FG000|Overall Study|Randomized, but never treated|1|||
48919867|NCT02443883|157541363|FG001|Overall Study|Randomized, but never treated|0|||
48919868|NCT02443883|157541364|FG002|Overall Study|Randomized, but never treated|0|||
48919869|NCT02443883|157541365|FG003|Overall Study|Randomized, but never treated|0|||
48919870|NCT02228590|157541380|FG000|Overall Study|Withdrawal by Subject|1|||
48919871|NCT00137111|157541381|FG000|Total Therapy|Death|35|||
48919872|NCT00137111|157541382|FG001|Total Therapy|Death|0|||
48919873|NCT00137111|157541383|FG002|Total Therapy|Death|0|||
48919874|NCT00137111|157541384|FG003|Total Therapy|Death|0|||
48919875|NCT00137111|157541381|FG000|Total Therapy|Non Compliance|5|||
48919876|NCT00137111|157541382|FG001|Total Therapy|Non Compliance|0|||
48919877|NCT00137111|157541383|FG002|Total Therapy|Non Compliance|0|||
48919878|NCT00137111|157541384|FG003|Total Therapy|Non Compliance|0|||
48919879|NCT03861559|157541387|FG000|Overall Study|Adverse Event|0|||
48919880|NCT03861559|157541388|FG001|Overall Study|Adverse Event|2|||
48919881|NCT03861559|157541387|FG000|Overall Study|Treatment failure|0|||
48919882|NCT03861559|157541388|FG001|Overall Study|Treatment failure|2|||
48919883|NCT03861559|157541387|FG000|Overall Study|Noncompliance|1|||
48919884|NCT03861559|157541388|FG001|Overall Study|Noncompliance|1|||
48919885|NCT03861559|157541387|FG000|Overall Study|Did not meet eligibility requirements|1|||
48919886|NCT03861559|157541388|FG001|Overall Study|Did not meet eligibility requirements|0|||
48919887|NCT03440814|157541390|FG000|Overall Study|Adverse Event|2|||
48919888|NCT03440814|157541391|FG001|Overall Study|Adverse Event|1|||
48713816|NCT01451437|156801497|FG005|Overall Study|Disease Progression|2|||
48713817|NCT01451437|156801498|FG006|Overall Study|Disease Progression|3|||
48812436|NCT00519636|157153592|FG000|Washout Period|Adverse Event|2|||
48812437|NCT00519636|157153593|FG001|Washout Period|Adverse Event|1|||
48812438|NCT00519636|157153594|FG002|Washout Period|Adverse Event|1|||
48919889|NCT03440814|157541390|FG000|Overall Study|Lost to Follow-up|2|||
48919890|NCT03440814|157541391|FG001|Overall Study|Lost to Follow-up|0|||
48919891|NCT03440814|157541390|FG000|Overall Study|Consent withdrawn by parent/legal guardian|1|||
48919892|NCT03440814|157541391|FG001|Overall Study|Consent withdrawn by parent/legal guardian|0|||
48919893|NCT02457637|157541392|FG000|Clinic or Telephone Follow-up|Lost to Follow-up|71|||
48919894|NCT01437397|157541393|FG000|Overall Study|Lost to Follow-up|9|||
48713818|NCT01451437|156801499|FG007|Overall Study|Disease Progression|1|||
48713819|NCT01451437|156801500|FG008|Overall Study|Disease Progression|3|||
48713820|NCT01451437|156801492|FG000|Overall Study|Protocol Violation|0|||
48919895|NCT01437397|157541394|FG001|Overall Study|Lost to Follow-up|4|||
48919896|NCT01437397|157541395|FG002|Overall Study|Lost to Follow-up|2|||
48919897|NCT01437397|157541396|FG003|Overall Study|Lost to Follow-up|4|||
48919898|NCT01437397|157541397|FG004|Overall Study|Lost to Follow-up|5|||
48919899|NCT01437397|157541393|FG000|Overall Study|Withdrawal by Subject|11|||
48919900|NCT01437397|157541394|FG001|Overall Study|Withdrawal by Subject|12|||
48919901|NCT01437397|157541395|FG002|Overall Study|Withdrawal by Subject|24|||
48919902|NCT01437397|157541396|FG003|Overall Study|Withdrawal by Subject|11|||
48919903|NCT01437397|157541397|FG004|Overall Study|Withdrawal by Subject|22|||
48919904|NCT01437397|157541393|FG000|Overall Study|Protocol Violation|10|||
48919905|NCT01437397|157541394|FG001|Overall Study|Protocol Violation|12|||
48919906|NCT01437397|157541395|FG002|Overall Study|Protocol Violation|13|||
48919907|NCT01437397|157541396|FG003|Overall Study|Protocol Violation|21|||
48919908|NCT01437397|157541397|FG004|Overall Study|Protocol Violation|19|||
48919909|NCT01437397|157541393|FG000|Overall Study|Lack of Efficacy|5|||
48919910|NCT01437397|157541394|FG001|Overall Study|Lack of Efficacy|4|||
48919911|NCT01437397|157541395|FG002|Overall Study|Lack of Efficacy|8|||
48919912|NCT01437397|157541396|FG003|Overall Study|Lack of Efficacy|10|||
48919913|NCT01437397|157541397|FG004|Overall Study|Lack of Efficacy|20|||
48919914|NCT01437397|157541393|FG000|Overall Study|Adverse Event|21|||
48919915|NCT01437397|157541394|FG001|Overall Study|Adverse Event|22|||
48919916|NCT01437397|157541395|FG002|Overall Study|Adverse Event|16|||
48919917|NCT01437397|157541396|FG003|Overall Study|Adverse Event|14|||
49123883|NCT00994110|158292886|FG000|Overall Study|Withdrawal by Subject|9|||
49123884|NCT00994110|158292887|FG001|Overall Study|Withdrawal by Subject|9|||
49123885|NCT00994110|158292886|FG000|Overall Study|Not Treated|4|||
49123886|NCT00994110|158292887|FG001|Overall Study|Not Treated|8|||
48713821|NCT01451437|156801493|FG001|Overall Study|Protocol Violation|0|||
48713822|NCT01451437|156801494|FG002|Overall Study|Protocol Violation|0|||
48713823|NCT01451437|156801495|FG003|Overall Study|Protocol Violation|0|||
48713824|NCT01451437|156801496|FG004|Overall Study|Protocol Violation|0|||
48713825|NCT01451437|156801497|FG005|Overall Study|Protocol Violation|0|||
48713826|NCT01451437|156801498|FG006|Overall Study|Protocol Violation|1|||
48713827|NCT01451437|156801499|FG007|Overall Study|Protocol Violation|0|||
48713828|NCT01451437|156801500|FG008|Overall Study|Protocol Violation|0|||
48713829|NCT01451437|156801492|FG000|Overall Study|Withdrawal by Subject|0|||
48713830|NCT01451437|156801493|FG001|Overall Study|Withdrawal by Subject|0|||
48713831|NCT01451437|156801494|FG002|Overall Study|Withdrawal by Subject|0|||
48713832|NCT01451437|156801495|FG003|Overall Study|Withdrawal by Subject|0|||
48713833|NCT01451437|156801496|FG004|Overall Study|Withdrawal by Subject|1|||
48713834|NCT01451437|156801497|FG005|Overall Study|Withdrawal by Subject|0|||
48713835|NCT01451437|156801498|FG006|Overall Study|Withdrawal by Subject|1|||
48713836|NCT01451437|156801499|FG007|Overall Study|Withdrawal by Subject|0|||
48713837|NCT01451437|156801500|FG008|Overall Study|Withdrawal by Subject|0|||
48713838|NCT02529553|156801503|FG000|Overall Study|Progressive Disease|1|||
48713839|NCT02529553|156801504|FG001|Overall Study|Progressive Disease|0|||
48713840|NCT02529553|156801505|FG002|Overall Study|Progressive Disease|1|||
48713841|NCT02529553|156801506|FG003|Overall Study|Progressive Disease|3|||
48713842|NCT02529553|156801507|FG004|Overall Study|Progressive Disease|2|||
48713843|NCT02529553|156801508|FG005|Overall Study|Progressive Disease|3|||
48713844|NCT02529553|156801509|FG006|Overall Study|Progressive Disease|3|||
48713845|NCT02529553|156801510|FG007|Overall Study|Progressive Disease|5|||
48713846|NCT02529553|156801511|FG008|Overall Study|Progressive Disease|3|||
48713847|NCT02529553|156801503|FG000|Overall Study|Physician Decision|0|||
48713848|NCT02529553|156801504|FG001|Overall Study|Physician Decision|1|||
48713849|NCT02529553|156801505|FG002|Overall Study|Physician Decision|0|||
48713850|NCT02529553|156801506|FG003|Overall Study|Physician Decision|0|||
48713851|NCT02529553|156801507|FG004|Overall Study|Physician Decision|1|||
48713852|NCT02529553|156801508|FG005|Overall Study|Physician Decision|0|||
48713853|NCT02529553|156801509|FG006|Overall Study|Physician Decision|0|||
48713854|NCT02529553|156801510|FG007|Overall Study|Physician Decision|0|||
48713855|NCT02529553|156801511|FG008|Overall Study|Physician Decision|0|||
48713856|NCT02529553|156801503|FG000|Overall Study|Withdrawal by Subject|0|||
48713857|NCT02529553|156801504|FG001|Overall Study|Withdrawal by Subject|0|||
48713858|NCT02529553|156801505|FG002|Overall Study|Withdrawal by Subject|0|||
48713859|NCT02529553|156801506|FG003|Overall Study|Withdrawal by Subject|0|||
48919918|NCT01437397|157541397|FG004|Overall Study|Adverse Event|21|||
49123887|NCT00994110|158292886|FG000|Overall Study|Adverse Event|1|||
48713860|NCT02529553|156801507|FG004|Overall Study|Withdrawal by Subject|0|||
48713861|NCT02529553|156801508|FG005|Overall Study|Withdrawal by Subject|1|||
48713862|NCT02529553|156801509|FG006|Overall Study|Withdrawal by Subject|0|||
48713863|NCT02529553|156801510|FG007|Overall Study|Withdrawal by Subject|1|||
48919919|NCT01437397|157541393|FG000|Overall Study|Site termination/COPD exacerbation/other|10|||
48919920|NCT01437397|157541394|FG001|Overall Study|Site termination/COPD exacerbation/other|8|||
48919921|NCT01437397|157541395|FG002|Overall Study|Site termination/COPD exacerbation/other|9|||
48919922|NCT01437397|157541396|FG003|Overall Study|Site termination/COPD exacerbation/other|9|||
49123888|NCT00994110|158292887|FG001|Overall Study|Adverse Event|0|||
49123889|NCT00994110|158292886|FG000|Overall Study|Patient not resected|41|||
48812439|NCT00519636|157153595|FG003|Washout Period|Adverse Event|0|||
48812440|NCT00519636|157153592|FG000|Washout Period|Lost to Follow-up|1|||
48812441|NCT00519636|157153593|FG001|Washout Period|Lost to Follow-up|0|||
48812442|NCT00519636|157153594|FG002|Washout Period|Lost to Follow-up|0|||
48812443|NCT00519636|157153595|FG003|Washout Period|Lost to Follow-up|0|||
48812444|NCT00519636|157153592|FG000|Washout Period|Protocol Violation|0|||
48812445|NCT00519636|157153593|FG001|Washout Period|Protocol Violation|0|||
48812446|NCT00519636|157153594|FG002|Washout Period|Protocol Violation|1|||
48812447|NCT00519636|157153595|FG003|Washout Period|Protocol Violation|2|||
48812448|NCT00519636|157153592|FG000|Washout Period|Withdrawal by Subject|1|||
48812449|NCT00519636|157153593|FG001|Washout Period|Withdrawal by Subject|0|||
48812450|NCT00519636|157153594|FG002|Washout Period|Withdrawal by Subject|1|||
48812451|NCT00519636|157153595|FG003|Washout Period|Withdrawal by Subject|0|||
48812452|NCT00519636|157153592|FG000|Washout Period|Failed to meet continuation criteria|14|||
48812453|NCT00519636|157153593|FG001|Washout Period|Failed to meet continuation criteria|11|||
48812454|NCT00519636|157153594|FG002|Washout Period|Failed to meet continuation criteria|9|||
48812455|NCT00519636|157153595|FG003|Washout Period|Failed to meet continuation criteria|3|||
48812456|NCT00519636|157153592|FG000|Washout Period|Out of pollen area > 48 hours|1|||
48812457|NCT00519636|157153593|FG001|Washout Period|Out of pollen area > 48 hours|0|||
48812458|NCT00519636|157153594|FG002|Washout Period|Out of pollen area > 48 hours|0|||
48812459|NCT00519636|157153595|FG003|Washout Period|Out of pollen area > 48 hours|0|||
48812460|NCT00519636|157153592|FG000|Washout Period|Participating in study at another site|1|||
48812461|NCT00519636|157153593|FG001|Washout Period|Participating in study at another site|0|||
48812462|NCT00519636|157153594|FG002|Washout Period|Participating in study at another site|0|||
48812463|NCT00519636|157153595|FG003|Washout Period|Participating in study at another site|0|||
48812464|NCT00519636|157153592|FG000|Washout Period|Non-compliant|0|||
48812465|NCT00519636|157153593|FG001|Washout Period|Non-compliant|1|||
48812466|NCT00519636|157153594|FG002|Washout Period|Non-compliant|0|||
48812467|NCT00519636|157153595|FG003|Washout Period|Non-compliant|0|||
48812468|NCT00519636|157153592|FG000|Washout Period|Per doctors request|0|||
48812469|NCT00519636|157153593|FG001|Washout Period|Per doctors request|1|||
48812470|NCT00519636|157153594|FG002|Washout Period|Per doctors request|0|||
48812471|NCT00519636|157153595|FG003|Washout Period|Per doctors request|0|||
48812472|NCT00519636|157153592|FG000|Washout Period|Subject randomized in error|0|||
48812473|NCT00519636|157153593|FG001|Washout Period|Subject randomized in error|0|||
48812474|NCT00519636|157153594|FG002|Washout Period|Subject randomized in error|1|||
48812475|NCT00519636|157153595|FG003|Washout Period|Subject randomized in error|0|||
48812476|NCT00519636|157153592|FG000|Washout Period|Prohibited medications|0|||
48812477|NCT00519636|157153593|FG001|Washout Period|Prohibited medications|0|||
48812478|NCT00519636|157153594|FG002|Washout Period|Prohibited medications|1|||
48812479|NCT00519636|157153595|FG003|Washout Period|Prohibited medications|0|||
48812480|NCT00519636|157153592|FG000|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
48812481|NCT00519636|157153593|FG001|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
48812482|NCT00519636|157153594|FG002|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
48812483|NCT00519636|157153595|FG003|Treatment Period 2|Failed To Meet Continuation Criteria|1|||
48812484|NCT00519636|157153592|FG000|Treatment Period 2|Subject randomized in error|0|||
48812485|NCT00519636|157153593|FG001|Treatment Period 2|Subject randomized in error|1|||
48812486|NCT00519636|157153594|FG002|Treatment Period 2|Subject randomized in error|0|||
48812487|NCT00519636|157153595|FG003|Treatment Period 2|Subject randomized in error|0|||
48812488|NCT00519636|157153592|FG000|Treatment Period 2|Per doctors request|0|||
48812489|NCT00519636|157153593|FG001|Treatment Period 2|Per doctors request|0|||
48812490|NCT00519636|157153594|FG002|Treatment Period 2|Per doctors request|1|||
48812491|NCT00519636|157153595|FG003|Treatment Period 2|Per doctors request|0|||
48812492|NCT00519636|157153592|FG000|Treatment Period 2|Subject misrandomized|0|||
48812493|NCT00519636|157153593|FG001|Treatment Period 2|Subject misrandomized|0|||
48812494|NCT00519636|157153594|FG002|Treatment Period 2|Subject misrandomized|0|||
48812495|NCT00519636|157153595|FG003|Treatment Period 2|Subject misrandomized|1|||
48812496|NCT00519636|157153592|FG000|Post Study Period|Subject randomized in error|0|||
48812497|NCT00519636|157153593|FG001|Post Study Period|Subject randomized in error|0|||
48812498|NCT00519636|157153594|FG002|Post Study Period|Subject randomized in error|0|||
48812499|NCT00519636|157153595|FG003|Post Study Period|Subject randomized in error|1|||
48812500|NCT02388074|157153596|FG000|Overall Study|Lost in Transit|2|||
48812501|NCT02388074|157153596|FG000|Overall Study|Sample Not Returned|1|||
48812502|NCT02023879|157153598|FG000|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
49123890|NCT00994110|158292887|FG001|Overall Study|Patient not resected|52|||
48812503|NCT02023879|157153599|FG001|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
48812504|NCT02023879|157153600|FG002|Period 1: 24-Week Double-blind Treatment|Adverse Event|5|||
49123891|NCT00994110|158292886|FG000|Overall Study|Pt not eligible|10|||
49123892|NCT00994110|158292887|FG001|Overall Study|Pt not eligible|5|||
48812505|NCT02023879|157153598|FG000|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0|||
48812506|NCT02023879|157153599|FG001|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2|||
49123893|NCT01063855|158292888|FG000|Overall Study|Adverse Event|4|||
49123894|NCT01063855|158292889|FG001|Overall Study|Adverse Event|4|||
48812507|NCT02023879|157153600|FG002|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1|||
48919923|NCT01437397|157541397|FG004|Overall Study|Site termination/COPD exacerbation/other|14|||
48919924|NCT01273883|157541398|FG000|First Intervention|Adverse Event|2|||
48919925|NCT01273883|157541399|FG001|First Intervention|Adverse Event|1|||
48919926|NCT01273883|157541398|FG000|Second Intervention|Lost to Follow-up|1|||
48919927|NCT01273883|157541399|FG001|Second Intervention|Lost to Follow-up|1|||
48919928|NCT01273883|157541398|FG000|Second Intervention|Lack of Efficacy|1|||
48919929|NCT01273883|157541399|FG001|Second Intervention|Lack of Efficacy|0|||
48919930|NCT00371865|157541400|FG000|Overall Study|Lack of Efficacy|0|||
48919931|NCT00371865|157541401|FG001|Overall Study|Lack of Efficacy|2|||
48919932|NCT00371865|157541400|FG000|Overall Study|Protocol Violation|3|||
48919933|NCT00371865|157541401|FG001|Overall Study|Protocol Violation|2|||
48812508|NCT02023879|157153598|FG000|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
48812509|NCT02023879|157153599|FG001|Period 1: 24-Week Double-blind Treatment|Physician Decision|1|||
48812510|NCT02023879|157153600|FG002|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
48812511|NCT02023879|157153598|FG000|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
48812512|NCT02023879|157153599|FG001|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0|||
48812513|NCT02023879|157153600|FG002|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
48812514|NCT02023879|157153598|FG000|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0|||
48812515|NCT02023879|157153599|FG001|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
48812516|NCT02023879|157153600|FG002|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
48812517|NCT02023879|157153598|FG000|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
48812518|NCT02023879|157153599|FG001|Period 1: 24-Week Double-blind Treatment|Other than specified above|3|||
48812519|NCT02023879|157153600|FG002|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
48812520|NCT02023879|157153598|FG000|Extension Open Label Treatment|Adverse Event|1|||
48812521|NCT02023879|157153599|FG001|Extension Open Label Treatment|Adverse Event|7|||
48812522|NCT02023879|157153600|FG002|Extension Open Label Treatment|Adverse Event|3|||
48919934|NCT00371865|157541400|FG000|Overall Study|Withdrawal by Subject|12|||
48919935|NCT00371865|157541401|FG001|Overall Study|Withdrawal by Subject|10|||
48919936|NCT04042103|157541404|FG000|Overall Study|Lost to Follow-up|1|||
48919937|NCT04042103|157541404|FG000|Overall Study|Withdrawal by Subject|1|||
48919938|NCT00894556|157541409|FG000|Baseline Phase|Did not meet Randomization Criteria|0|||
48919939|NCT00894556|157541410|FG001|Baseline Phase|Did not meet Randomization Criteria|0|||
48919940|NCT00894556|157541411|FG002|Baseline Phase|Did not meet Randomization Criteria|0|||
48919941|NCT00894556|157541412|FG003|Baseline Phase|Did not meet Randomization Criteria|85|||
48919942|NCT00894556|157541409|FG000|Treatment Phase|Lost to Follow-up|2|||
48919943|NCT00894556|157541410|FG001|Treatment Phase|Lost to Follow-up|3|||
48919944|NCT00894556|157541411|FG002|Treatment Phase|Lost to Follow-up|1|||
48919945|NCT00894556|157541412|FG003|Treatment Phase|Lost to Follow-up|0|||
48919946|NCT00894556|157541409|FG000|Treatment Phase|Lack of Qualifying Event|2|||
48919947|NCT00894556|157541410|FG001|Treatment Phase|Lack of Qualifying Event|1|||
48919948|NCT00894556|157541411|FG002|Treatment Phase|Lack of Qualifying Event|0|||
48919949|NCT00894556|157541412|FG003|Treatment Phase|Lack of Qualifying Event|0|||
48919950|NCT02289950|157541413|FG000|Overall Study|Progressive disease by RECIST 1.1|99|||
48919951|NCT02289950|157541414|FG001|Overall Study|Progressive disease by RECIST 1.1|52|||
48919952|NCT02289950|157541413|FG000|Overall Study|Progressive disease by Clinical Assessment|4|||
48919953|NCT02289950|157541414|FG001|Overall Study|Progressive disease by Clinical Assessment|4|||
48919954|NCT02289950|157541413|FG000|Overall Study|Lost to Follow-up|1|||
48919955|NCT02289950|157541414|FG001|Overall Study|Lost to Follow-up|0|||
48919956|NCT02289950|157541413|FG000|Overall Study|Physician Decision|9|||
48919957|NCT02289950|157541414|FG001|Overall Study|Physician Decision|3|||
48919958|NCT02289950|157541413|FG000|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9|||
48919959|NCT02289950|157541414|FG001|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2|||
48919960|NCT02289950|157541413|FG000|Overall Study|Withdrawal by Subject|1|||
48919961|NCT02289950|157541414|FG001|Overall Study|Withdrawal by Subject|3|||
48919962|NCT02289950|157541413|FG000|Overall Study|Test article held for greater than 28 days|0|||
48919963|NCT02289950|157541414|FG001|Overall Study|Test article held for greater than 28 days|1|||
48919964|NCT02289950|157541413|FG000|Overall Study|Adverse Event|11|||
48919965|NCT02289950|157541414|FG001|Overall Study|Adverse Event|3|||
48812523|NCT02023879|157153598|FG000|Extension Open Label Treatment|Poor compliance to protocol|1|||
48812524|NCT02023879|157153599|FG001|Extension Open Label Treatment|Poor compliance to protocol|1|||
48919966|NCT02289950|157541413|FG000|Overall Study|Death|1|||
48919967|NCT02289950|157541414|FG001|Overall Study|Death|1|||
48919968|NCT02289950|157541413|FG000|Overall Study|Other|5|||
48919969|NCT02289950|157541414|FG001|Overall Study|Other|2|||
48919970|NCT02289950|157541413|FG000|Overall Study|Not Treated|2|||
48919971|NCT02289950|157541414|FG001|Overall Study|Not Treated|1|||
48919972|NCT03829657|157541419|FG000|OL Treatment Period (Week 1 to Week 16)|Adverse Event|12|||
48919973|NCT03829657|157541420|FG001|OL Treatment Period (Week 1 to Week 16)|Adverse Event|4|||
48919974|NCT03829657|157541421|FG002|OL Treatment Period (Week 1 to Week 16)|Adverse Event|2|||
48919975|NCT03829657|157541422|FG003|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
48919976|NCT03829657|157541423|FG004|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
48919977|NCT03829657|157541419|FG000|OL Treatment Period (Week 1 to Week 16)|Physician Decision|1|||
48919978|NCT03829657|157541420|FG001|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
48919979|NCT03829657|157541421|FG002|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
48919980|NCT03829657|157541422|FG003|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
48919981|NCT03829657|157541423|FG004|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
48919982|NCT03829657|157541419|FG000|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|1|||
48919983|NCT03829657|157541420|FG001|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|3|||
48919984|NCT03829657|157541421|FG002|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|9|||
48919985|NCT03829657|157541422|FG003|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
48919986|NCT03829657|157541423|FG004|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
48919987|NCT03829657|157541419|FG000|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|6|||
48919988|NCT03829657|157541420|FG001|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|7|||
48919989|NCT03829657|157541421|FG002|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|5|||
48919990|NCT03829657|157541422|FG003|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
48919991|NCT03829657|157541423|FG004|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
48919992|NCT03829657|157541419|FG000|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|10|||
48919993|NCT03829657|157541420|FG001|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|6|||
48919994|NCT03829657|157541421|FG002|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|4|||
48919995|NCT03829657|157541422|FG003|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
48919996|NCT03829657|157541423|FG004|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
48919997|NCT03829657|157541419|FG000|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|3|||
48919998|NCT03829657|157541420|FG001|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
48919999|NCT03829657|157541421|FG002|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
48920000|NCT03829657|157541422|FG003|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
48920001|NCT03829657|157541423|FG004|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
48920002|NCT03829657|157541419|FG000|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
48920003|NCT03829657|157541420|FG001|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
48920004|NCT03829657|157541421|FG002|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
48920005|NCT03829657|157541422|FG003|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
48920006|NCT03829657|157541423|FG004|RW Treatment Period (Week 16 to Week 24)|Adverse Event|1|||
48920007|NCT03829657|157541419|FG000|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
48920008|NCT03829657|157541420|FG001|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
48812525|NCT02023879|157153600|FG002|Extension Open Label Treatment|Poor compliance to protocol|0|||
48812526|NCT02023879|157153598|FG000|Extension Open Label Treatment|Participant moved|1|||
48812527|NCT02023879|157153599|FG001|Extension Open Label Treatment|Participant moved|2|||
48812528|NCT02023879|157153600|FG002|Extension Open Label Treatment|Participant moved|0|||
48812529|NCT02023879|157153598|FG000|Extension Open Label Treatment|Other than specified above|2|||
48812530|NCT02023879|157153599|FG001|Extension Open Label Treatment|Other than specified above|7|||
48812531|NCT02023879|157153600|FG002|Extension Open Label Treatment|Other than specified above|2|||
48812532|NCT03857841|157153601|FG000|Overall Study|Death|1|||
48812533|NCT03857841|157153602|FG001|Overall Study|Death|0|||
48812534|NCT03857841|157153603|FG002|Overall Study|Death|0|||
48812535|NCT03857841|157153604|FG003|Overall Study|Death|0|||
48812536|NCT03857841|157153601|FG000|Overall Study|Study Terminated by Sponsor|1|||
48812537|NCT03857841|157153602|FG001|Overall Study|Study Terminated by Sponsor|0|||
48812538|NCT03857841|157153603|FG002|Overall Study|Study Terminated by Sponsor|0|||
48812539|NCT03857841|157153604|FG003|Overall Study|Study Terminated by Sponsor|0|||
48812540|NCT01671748|157153605|FG000|4 Week run-in Phase|Withdrawal by Subject|1|||
48812541|NCT01671748|157153606|FG001|4 Week run-in Phase|Withdrawal by Subject|0|||
48812542|NCT01671748|157153605|FG000|4 Week run-in Phase|Adverse Event|1|||
48812543|NCT01671748|157153606|FG001|4 Week run-in Phase|Adverse Event|0|||
48812544|NCT01671748|157153605|FG000|4 Week run-in Phase|Not eligible|9|||
48812545|NCT01671748|157153606|FG001|4 Week run-in Phase|Not eligible|0|||
48812546|NCT04249336|157155365|FG000|Overall Study|Lost to Follow-up|3|||
48812547|NCT04249336|157155366|FG001|Overall Study|Lost to Follow-up|3|||
48812548|NCT04249336|157155367|FG002|Overall Study|Lost to Follow-up|3|||
48812549|NCT04249336|157155368|FG003|Overall Study|Lost to Follow-up|3|||
48812550|NCT03029247|157155370|FG000|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3|||
48812551|NCT03029247|157155371|FG001|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0|||
48812552|NCT03029247|157155370|FG000|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
48812553|NCT03029247|157155371|FG001|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
48812554|NCT03029247|157155370|FG000|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7|||
48812555|NCT03029247|157155371|FG001|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4|||
48812556|NCT03029247|157155370|FG000|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
48812557|NCT03029247|157155371|FG001|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
48920009|NCT03829657|157541421|FG002|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
48920010|NCT03829657|157541422|FG003|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|2|||
48920011|NCT03829657|157541423|FG004|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|3|||
48920012|NCT03829657|157541419|FG000|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
48920013|NCT03829657|157541420|FG001|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
48920014|NCT03829657|157541421|FG002|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
48920015|NCT03829657|157541422|FG003|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
48920016|NCT03829657|157541423|FG004|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
48920017|NCT03829657|157541419|FG000|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
48920018|NCT03829657|157541420|FG001|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
48920019|NCT03829657|157541421|FG002|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
48920020|NCT03829657|157541422|FG003|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
48920021|NCT03829657|157541423|FG004|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|1|||
48920022|NCT01014689|157541426|FG000|Overall Study|Lack of Efficacy|0|||
48920023|NCT01014689|157541427|FG001|Overall Study|Lack of Efficacy|1|||
48920024|NCT01014689|157541426|FG000|Overall Study|Adverse Event|3|||
48920025|NCT01014689|157541427|FG001|Overall Study|Adverse Event|0|||
48920026|NCT01014689|157541426|FG000|Overall Study|Withdrawal by Subject|5|||
48920027|NCT01014689|157541427|FG001|Overall Study|Withdrawal by Subject|4|||
48920028|NCT01014689|157541426|FG000|Overall Study|Protocol Violation|1|||
48920029|NCT01014689|157541427|FG001|Overall Study|Protocol Violation|1|||
48920030|NCT01014689|157541426|FG000|Overall Study|Lost to Follow-up|3|||
48920031|NCT01014689|157541427|FG001|Overall Study|Lost to Follow-up|7|||
48920032|NCT01014689|157541426|FG000|Overall Study|Pregnancy|1|||
48920033|NCT01014689|157541427|FG001|Overall Study|Pregnancy|0|||
48920034|NCT04153188|157541428|FG000|Overall Study|Lost to Follow-up|1|||
48920035|NCT04153188|157541429|FG001|Overall Study|Lost to Follow-up|1|||
48920036|NCT04153188|157541428|FG000|Overall Study|Withdrawal by Subject|2|||
48920037|NCT04153188|157541429|FG001|Overall Study|Withdrawal by Subject|0|||
48920038|NCT04153188|157541428|FG000|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|0|||
48920039|NCT04153188|157541429|FG001|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|1|||
48920040|NCT04418076|157541431|FG000|Overall Study|Death|1|||
48920041|NCT04418076|157541432|FG001|Overall Study|Death|0|||
48920042|NCT04418076|157541433|FG002|Overall Study|Death|0|||
48920043|NCT04418076|157541434|FG003|Overall Study|Death|0|||
48713864|NCT02529553|156801511|FG008|Overall Study|Withdrawal by Subject|0|||
48713865|NCT01808092|156801514|FG000|Overall Study|Death|39|||
48713866|NCT01808092|156801515|FG001|Overall Study|Death|29|||
48713867|NCT01808092|156801514|FG000|Overall Study|Lost to Follow-up|3|||
48713868|NCT01808092|156801515|FG001|Overall Study|Lost to Follow-up|7|||
48713869|NCT01808092|156801514|FG000|Overall Study|Withdrawal by Subject|9|||
48713870|NCT01808092|156801515|FG001|Overall Study|Withdrawal by Subject|4|||
48713871|NCT01808092|156801514|FG000|Overall Study|Other Eligibility criteria|3|||
48713872|NCT01808092|156801515|FG001|Overall Study|Other Eligibility criteria|5|||
48713873|NCT03207763|156803072|FG000|Overall Study|Lost to Follow-up|1|||
48713874|NCT03207763|156803073|FG001|Overall Study|Lost to Follow-up|0|||
48713875|NCT03844945|156803074|FG000|Overall Study|Adverse Event|1|||
48713876|NCT03844945|156803075|FG001|Overall Study|Adverse Event|1|||
48713877|NCT03844945|156803076|FG002|Overall Study|Adverse Event|4|||
48713878|NCT03844945|156803077|FG003|Overall Study|Adverse Event|0|||
48713879|NCT03844945|156803074|FG000|Overall Study|Withdrawal by Subject|0|||
48713880|NCT03844945|156803075|FG001|Overall Study|Withdrawal by Subject|0|||
48713881|NCT03844945|156803076|FG002|Overall Study|Withdrawal by Subject|1|||
48713882|NCT03844945|156803077|FG003|Overall Study|Withdrawal by Subject|0|||
48713883|NCT03844945|156803074|FG000|Overall Study|Lack of Efficacy|0|||
48713884|NCT03844945|156803075|FG001|Overall Study|Lack of Efficacy|0|||
48713885|NCT03844945|156803076|FG002|Overall Study|Lack of Efficacy|0|||
48713886|NCT03844945|156803077|FG003|Overall Study|Lack of Efficacy|1|||
48713887|NCT02565784|156803078|FG000|First Treatment|Adverse Event|1|||
48713888|NCT02565784|156803078|FG000|First Treatment|Withdrawal by Subject|1|||
48713889|NCT02565784|156803078|FG000|Second Treatment|Withdrawal by Subject|2|||
48713890|NCT00476008|156803080|FG000|Overall Study|Adverse Event|4|||
48713891|NCT00476008|156803081|FG001|Overall Study|Adverse Event|4|||
48713892|NCT00476008|156803080|FG000|Overall Study|Placebo concerns|2|||
48713893|NCT00476008|156803081|FG001|Overall Study|Placebo concerns|2|||
48713894|NCT00476008|156803080|FG000|Overall Study|Physician Decision: Medication Noncompli|2|||
48713895|NCT00476008|156803081|FG001|Overall Study|Physician Decision: Medication Noncompli|1|||
48713896|NCT00476008|156803080|FG000|Overall Study|Withdrawal by Subject|0|||
48713897|NCT00476008|156803081|FG001|Overall Study|Withdrawal by Subject|1|||
48713898|NCT00476008|156803080|FG000|Overall Study|Death|1|||
48713899|NCT00476008|156803081|FG001|Overall Study|Death|0|||
48713900|NCT00375609|156803082|FG000|Overall Study|Did not receive treatment|1|||
48713901|NCT00375609|156803083|FG001|Overall Study|Did not receive treatment|0|||
48713902|NCT00375609|156803084|FG002|Overall Study|Did not receive treatment|0|||
48713903|NCT00375609|156803082|FG000|Overall Study|Adverse Event|0|||
48713904|NCT00375609|156803083|FG001|Overall Study|Adverse Event|3|||
48713905|NCT00375609|156803084|FG002|Overall Study|Adverse Event|0|||
48713906|NCT00375609|156803082|FG000|Overall Study|Lost to Follow-up|1|||
48713907|NCT00375609|156803083|FG001|Overall Study|Lost to Follow-up|0|||
48713908|NCT00375609|156803084|FG002|Overall Study|Lost to Follow-up|0|||
48713909|NCT00375609|156803082|FG000|Overall Study|Physician Decision|0|||
48713910|NCT00375609|156803083|FG001|Overall Study|Physician Decision|0|||
48713911|NCT00375609|156803084|FG002|Overall Study|Physician Decision|1|||
48713912|NCT00375609|156803082|FG000|Overall Study|Withdrawal by Subject|1|||
48713913|NCT00375609|156803083|FG001|Overall Study|Withdrawal by Subject|4|||
48713914|NCT00375609|156803084|FG002|Overall Study|Withdrawal by Subject|0|||
48713915|NCT00375609|156803082|FG000|Overall Study|Neurologist Wanted Pt to start Plavix|1|||
48713916|NCT00375609|156803083|FG001|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
48713917|NCT00375609|156803084|FG002|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
48713918|NCT03860818|156803085|FG000|Overall Study|Death|144|||
48713919|NCT03860818|156803086|FG001|Overall Study|Death|195|||
48713920|NCT03860818|156803085|FG000|Overall Study|Graft Loss|32|||
48713921|NCT03860818|156803086|FG001|Overall Study|Graft Loss|45|||
48812558|NCT02593305|157155374|FG000|Post 1|Comparison only group. No intervention.|0|||
48812559|NCT02593305|157155375|FG001|Post 1|Comparison only group. No intervention.|0|||
48812560|NCT02593305|157155376|FG002|Post 1|Comparison only group. No intervention.|10|||
48812561|NCT02757521|157155377|FG000|Overall Study|Adverse Event|1|||
48812562|NCT02757521|157155378|FG001|Overall Study|Adverse Event|0|||
48812563|NCT01317875|157155379|FG000|Overall Study|Other|0|||
48713922|NCT03126344|156803087|FG000|Overall Study|Lost to Follow-up|0|||
48713923|NCT03126344|156803088|FG001|Overall Study|Lost to Follow-up|0|||
48713924|NCT03126344|156803089|FG002|Overall Study|Lost to Follow-up|5|||
48713925|NCT02078960|156803091|FG000|Treatment Period|Other|0|||
48713926|NCT02078960|156803092|FG001|Treatment Period|Other|0|||
48713927|NCT02078960|156803093|FG002|Treatment Period|Other|1|||
48713928|NCT02078960|156803091|FG000|Treatment Period|Lack of Efficacy|0|||
48713929|NCT02078960|156803092|FG001|Treatment Period|Lack of Efficacy|1|||
48713930|NCT02078960|156803093|FG002|Treatment Period|Lack of Efficacy|0|||
48713931|NCT02078960|156803091|FG000|Treatment Period|Disease progression - accelerated phase|0|||
48713932|NCT02078960|156803092|FG001|Treatment Period|Disease progression - accelerated phase|1|||
48713933|NCT02078960|156803093|FG002|Treatment Period|Disease progression - accelerated phase|0|||
48812564|NCT01317875|157155380|FG001|Overall Study|Other|0|||
48713934|NCT02078960|156803091|FG000|Treatment Period|Disease progression - blast phase|1|||
48713935|NCT02078960|156803092|FG001|Treatment Period|Disease progression - blast phase|0|||
48713936|NCT02078960|156803093|FG002|Treatment Period|Disease progression - blast phase|0|||
48713937|NCT02078960|156803091|FG000|Treatment Period|Withdrawal by Subject|0|||
48713938|NCT02078960|156803092|FG001|Treatment Period|Withdrawal by Subject|1|||
48713939|NCT02078960|156803093|FG002|Treatment Period|Withdrawal by Subject|1|||
48713940|NCT02078960|156803091|FG000|Treatment Period|Adverse Event|1|||
48713941|NCT02078960|156803092|FG001|Treatment Period|Adverse Event|0|||
48713942|NCT02078960|156803093|FG002|Treatment Period|Adverse Event|0|||
48713943|NCT02078960|156803091|FG000|Treatment Period|Death|0|||
48713944|NCT02078960|156803092|FG001|Treatment Period|Death|0|||
48713945|NCT02078960|156803093|FG002|Treatment Period|Death|1|||
48713946|NCT02078960|156803091|FG000|Follow-up Period|Death|2|||
48713947|NCT02078960|156803092|FG001|Follow-up Period|Death|0|||
48713948|NCT02078960|156803093|FG002|Follow-up Period|Death|0|||
48713949|NCT02078960|156803091|FG000|Follow-up Period|Lost to Follow-up|0|||
48713950|NCT02078960|156803092|FG001|Follow-up Period|Lost to Follow-up|1|||
48713951|NCT02078960|156803093|FG002|Follow-up Period|Lost to Follow-up|0|||
48713952|NCT00874939|156803099|FG000|Overall Study|Study terminated|4|||
48713953|NCT04657666|156803100|FG000|Period 1|Withdrawal of participant consent|2|||
48713954|NCT04657666|156803101|FG001|Period 1|Withdrawal of participant consent|1|||
48713955|NCT04657666|156803100|FG000|Period 1|Withdrawn/discontinued due to AE|1|||
48713956|NCT04657666|156803101|FG001|Period 1|Withdrawn/discontinued due to AE|0|||
48713957|NCT04657666|156803100|FG000|Period 1|Administrative decision by investigator, GW, or a regulatory authority|0|||
48713958|NCT04657666|156803101|FG001|Period 1|Administrative decision by investigator, GW, or a regulatory authority|1|||
48713959|NCT04657666|156803100|FG000|Period 2|Other|2|||
48713960|NCT04657666|156803101|FG001|Period 2|Other|0|||
48713961|NCT04657666|156803100|FG000|Period 2|Withdrawn/discontinued due to AE|0|||
48713962|NCT04657666|156803101|FG001|Period 2|Withdrawn/discontinued due to AE|3|||
48713963|NCT00606905|156803102|FG000|Overall Study|No Pregnancy|9|||
48713964|NCT00606905|156803103|FG001|Overall Study|No Pregnancy|6|||
48713965|NCT00606905|156803102|FG000|Overall Study|Non-Index Pregnancy|1|||
48713966|NCT00606905|156803103|FG001|Overall Study|Non-Index Pregnancy|4|||
48713967|NCT00606905|156803102|FG000|Overall Study|Withdrew|5|||
48713968|NCT00606905|156803103|FG001|Overall Study|Withdrew|5|||
48713969|NCT00790088|156803109|FG000|Overall Study|Protocol Violation|11|||
48713970|NCT00790088|156803109|FG000|Overall Study|Withdrawal by Subject|17|||
48713971|NCT00790088|156803109|FG000|Overall Study|Lost to Follow-up|7|||
48713972|NCT00790088|156803109|FG000|Overall Study|Physician Decision|4|||
48713973|NCT01386970|156803110|FG000|Overall Study|Withdrawal by Subject|0|||
48713974|NCT01386970|156803111|FG001|Overall Study|Withdrawal by Subject|1|||
48713975|NCT01386970|156803110|FG000|Overall Study|Adverse Event|4|||
48713976|NCT01386970|156803111|FG001|Overall Study|Adverse Event|1|||
48713977|NCT01049009|156803112|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
48713978|NCT01049009|156803113|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
48713979|NCT01049009|156803112|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
48713980|NCT01049009|156803113|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
48713981|NCT01049009|156803112|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
48713982|NCT01049009|156803113|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3|||
48713983|NCT01049009|156803112|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|8|||
48713984|NCT01049009|156803113|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|7|||
48713985|NCT02036970|156803114|FG000|Part 1: Day 1 Through Week 16|Adverse Event|0|||
48713986|NCT02036970|156803115|FG001|Part 1: Day 1 Through Week 16|Adverse Event|0|||
48713987|NCT02036970|156803116|FG002|Part 1: Day 1 Through Week 16|Adverse Event|3|||
48713988|NCT02036970|156803117|FG003|Part 1: Day 1 Through Week 16|Adverse Event|2|||
48713989|NCT02036970|156803118|FG004|Part 1: Day 1 Through Week 16|Adverse Event|0|||
48713990|NCT02036970|156803119|FG005|Part 1: Day 1 Through Week 16|Adverse Event|1|||
48713991|NCT02036970|156803120|FG006|Part 1: Day 1 Through Week 16|Adverse Event|0|||
48713992|NCT02036970|156803121|FG007|Part 1: Day 1 Through Week 16|Adverse Event|1|||
48713993|NCT02036970|156803122|FG008|Part 1: Day 1 Through Week 16|Adverse Event|3|||
48713994|NCT02036970|156803123|FG009|Part 1: Day 1 Through Week 16|Adverse Event|1|||
48713995|NCT02036970|156803114|FG000|Part 1: Day 1 Through Week 16|Death|0|||
48713996|NCT02036970|156803115|FG001|Part 1: Day 1 Through Week 16|Death|0|||
48713997|NCT02036970|156803116|FG002|Part 1: Day 1 Through Week 16|Death|0|||
48713998|NCT02036970|156803117|FG003|Part 1: Day 1 Through Week 16|Death|0|||
48713999|NCT02036970|156803118|FG004|Part 1: Day 1 Through Week 16|Death|0|||
48714000|NCT02036970|156803119|FG005|Part 1: Day 1 Through Week 16|Death|0|||
48714001|NCT02036970|156803120|FG006|Part 1: Day 1 Through Week 16|Death|0|||
48714002|NCT02036970|156803121|FG007|Part 1: Day 1 Through Week 16|Death|0|||
48714003|NCT02036970|156803122|FG008|Part 1: Day 1 Through Week 16|Death|1|||
48714004|NCT02036970|156803123|FG009|Part 1: Day 1 Through Week 16|Death|0|||
48714005|NCT02036970|156803114|FG000|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
48714006|NCT02036970|156803115|FG001|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
48714007|NCT02036970|156803116|FG002|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
48714008|NCT02036970|156803117|FG003|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
48714009|NCT02036970|156803118|FG004|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
48714010|NCT02036970|156803119|FG005|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
48714011|NCT02036970|156803120|FG006|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
48714012|NCT02036970|156803121|FG007|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
48714013|NCT02036970|156803122|FG008|Part 1: Day 1 Through Week 16|Protocol Violation|2|||
48714014|NCT02036970|156803123|FG009|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
48714015|NCT02036970|156803114|FG000|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
48714016|NCT02036970|156803115|FG001|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
48714017|NCT02036970|156803116|FG002|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
48714018|NCT02036970|156803117|FG003|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
48714019|NCT02036970|156803118|FG004|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1|||
48714020|NCT02036970|156803119|FG005|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
48714021|NCT02036970|156803120|FG006|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
48714022|NCT02036970|156803121|FG007|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
48714023|NCT02036970|156803122|FG008|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2|||
48714024|NCT02036970|156803123|FG009|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4|||
48714025|NCT02036970|156803114|FG000|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
48714026|NCT02036970|156803115|FG001|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
48714027|NCT02036970|156803116|FG002|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
48714028|NCT02036970|156803117|FG003|Part 1: Day 1 Through Week 16|Progressive Disease|1|||
48714029|NCT02036970|156803118|FG004|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
48714030|NCT02036970|156803119|FG005|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
48714031|NCT02036970|156803120|FG006|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
48714032|NCT02036970|156803121|FG007|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
48714033|NCT02036970|156803122|FG008|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
48714034|NCT02036970|156803123|FG009|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
48714035|NCT02036970|156803114|FG000|Part 2: Week 16 Onwards|Adverse Event|0|||
49123895|NCT01063855|158292888|FG000|Overall Study|Death|0|||
49123896|NCT01063855|158292889|FG001|Overall Study|Death|1|||
48714036|NCT02036970|156803115|FG001|Part 2: Week 16 Onwards|Adverse Event|2|||
48714037|NCT02036970|156803116|FG002|Part 2: Week 16 Onwards|Adverse Event|1|||
48714038|NCT02036970|156803117|FG003|Part 2: Week 16 Onwards|Adverse Event|1|||
49123897|NCT01063855|158292888|FG000|Overall Study|Lost to Follow-up|8|||
49123898|NCT01063855|158292889|FG001|Overall Study|Lost to Follow-up|4|||
49123899|NCT01063855|158292888|FG000|Overall Study|Pregnancy|1|||
48714039|NCT02036970|156803118|FG004|Part 2: Week 16 Onwards|Adverse Event|1|||
48714040|NCT02036970|156803119|FG005|Part 2: Week 16 Onwards|Adverse Event|0|||
48714041|NCT02036970|156803120|FG006|Part 2: Week 16 Onwards|Adverse Event|1|||
48714042|NCT02036970|156803121|FG007|Part 2: Week 16 Onwards|Adverse Event|0|||
48714043|NCT02036970|156803122|FG008|Part 2: Week 16 Onwards|Adverse Event|6|||
48714044|NCT02036970|156803123|FG009|Part 2: Week 16 Onwards|Adverse Event|3|||
48714045|NCT02036970|156803114|FG000|Part 2: Week 16 Onwards|Protocol Violation|0|||
48714046|NCT02036970|156803115|FG001|Part 2: Week 16 Onwards|Protocol Violation|0|||
48714047|NCT02036970|156803116|FG002|Part 2: Week 16 Onwards|Protocol Violation|0|||
48714048|NCT02036970|156803117|FG003|Part 2: Week 16 Onwards|Protocol Violation|0|||
48714049|NCT02036970|156803118|FG004|Part 2: Week 16 Onwards|Protocol Violation|0|||
48714050|NCT02036970|156803119|FG005|Part 2: Week 16 Onwards|Protocol Violation|0|||
48714051|NCT02036970|156803120|FG006|Part 2: Week 16 Onwards|Protocol Violation|0|||
48714052|NCT02036970|156803121|FG007|Part 2: Week 16 Onwards|Protocol Violation|1|||
48714053|NCT02036970|156803122|FG008|Part 2: Week 16 Onwards|Protocol Violation|0|||
48714054|NCT02036970|156803123|FG009|Part 2: Week 16 Onwards|Protocol Violation|0|||
48714055|NCT02036970|156803114|FG000|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
48714056|NCT02036970|156803115|FG001|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
48714057|NCT02036970|156803116|FG002|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
48714058|NCT02036970|156803117|FG003|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
48714059|NCT02036970|156803118|FG004|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
48714060|NCT02036970|156803119|FG005|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
48714061|NCT02036970|156803120|FG006|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
48714062|NCT02036970|156803121|FG007|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
48714063|NCT02036970|156803122|FG008|Part 2: Week 16 Onwards|Withdrawal by Subject|3|||
48714064|NCT02036970|156803123|FG009|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
48714065|NCT02036970|156803114|FG000|Part 2: Week 16 Onwards|Progressive Disease|0|||
48714066|NCT02036970|156803115|FG001|Part 2: Week 16 Onwards|Progressive Disease|2|||
48714067|NCT02036970|156803116|FG002|Part 2: Week 16 Onwards|Progressive Disease|1|||
48714068|NCT02036970|156803117|FG003|Part 2: Week 16 Onwards|Progressive Disease|1|||
48714069|NCT02036970|156803118|FG004|Part 2: Week 16 Onwards|Progressive Disease|0|||
48714070|NCT02036970|156803119|FG005|Part 2: Week 16 Onwards|Progressive Disease|0|||
48714071|NCT02036970|156803120|FG006|Part 2: Week 16 Onwards|Progressive Disease|0|||
48714072|NCT02036970|156803121|FG007|Part 2: Week 16 Onwards|Progressive Disease|0|||
48714073|NCT02036970|156803122|FG008|Part 2: Week 16 Onwards|Progressive Disease|0|||
48714074|NCT02036970|156803123|FG009|Part 2: Week 16 Onwards|Progressive Disease|2|||
48714075|NCT00640224|156803124|FG000|Overall Study|Lost to Follow-up|5|||
48714076|NCT00640224|156803125|FG001|Overall Study|Lost to Follow-up|2|||
48714077|NCT00640224|156803126|FG002|Overall Study|Lost to Follow-up|0|||
48714078|NCT00640224|156803127|FG003|Overall Study|Lost to Follow-up|0|||
48714079|NCT00640224|156803124|FG000|Overall Study|Withdrawal by Subject|1|||
48714080|NCT00640224|156803125|FG001|Overall Study|Withdrawal by Subject|0|||
48714081|NCT00640224|156803126|FG002|Overall Study|Withdrawal by Subject|0|||
48714082|NCT00640224|156803127|FG003|Overall Study|Withdrawal by Subject|0|||
48714083|NCT00640224|156803124|FG000|Overall Study|Headaches|0|||
48714084|NCT00640224|156803125|FG001|Overall Study|Headaches|1|||
48714085|NCT00640224|156803126|FG002|Overall Study|Headaches|0|||
48714086|NCT00640224|156803127|FG003|Overall Study|Headaches|0|||
48714087|NCT01667419|156803130|FG000|Overall Study|Reason Not Specified|1|||
48714088|NCT01667419|156803131|FG001|Overall Study|Reason Not Specified|0|||
48714089|NCT01667419|156803132|FG002|Overall Study|Reason Not Specified|0|||
48714090|NCT01667419|156803133|FG003|Overall Study|Reason Not Specified|0|||
48714091|NCT01667419|156803130|FG000|Overall Study|Withdrawal by Subject|16|||
48714092|NCT01667419|156803131|FG001|Overall Study|Withdrawal by Subject|8|||
48920044|NCT04418076|157541431|FG000|Overall Study|Lost to Follow-up|2|||
48714093|NCT01667419|156803132|FG002|Overall Study|Withdrawal by Subject|9|||
48714094|NCT01667419|156803133|FG003|Overall Study|Withdrawal by Subject|8|||
48714095|NCT01667419|156803130|FG000|Overall Study|Non-compliance|0|||
48714096|NCT01667419|156803131|FG001|Overall Study|Non-compliance|0|||
48714097|NCT01667419|156803132|FG002|Overall Study|Non-compliance|0|||
48920045|NCT04418076|157541432|FG001|Overall Study|Lost to Follow-up|5|||
48714098|NCT01667419|156803133|FG003|Overall Study|Non-compliance|1|||
48714099|NCT01667419|156803130|FG000|Overall Study|Protocol Violation|1|||
48714100|NCT01667419|156803131|FG001|Overall Study|Protocol Violation|0|||
48714101|NCT01667419|156803132|FG002|Overall Study|Protocol Violation|0|||
48714102|NCT01667419|156803133|FG003|Overall Study|Protocol Violation|0|||
48714103|NCT01667419|156803130|FG000|Overall Study|Lost to Follow-up|7|||
48714104|NCT01667419|156803131|FG001|Overall Study|Lost to Follow-up|6|||
48714105|NCT01667419|156803132|FG002|Overall Study|Lost to Follow-up|2|||
48714106|NCT01667419|156803133|FG003|Overall Study|Lost to Follow-up|4|||
48714107|NCT01667419|156803130|FG000|Overall Study|Death|18|||
48714108|NCT01667419|156803131|FG001|Overall Study|Death|33|||
48714109|NCT01667419|156803132|FG002|Overall Study|Death|25|||
48714110|NCT01667419|156803133|FG003|Overall Study|Death|26|||
49123900|NCT01063855|158292889|FG001|Overall Study|Pregnancy|0|||
49123901|NCT01063855|158292888|FG000|Overall Study|Lack of Efficacy|0|||
49123902|NCT01063855|158292889|FG001|Overall Study|Lack of Efficacy|1|||
49123903|NCT01063855|158292888|FG000|Overall Study|Withdrawal by Subject|11|||
48714111|NCT00926029|156803134|FG000|Overall Study|Lost to Follow-up|2|||
48714112|NCT00926029|156803135|FG001|Overall Study|Lost to Follow-up|1|||
48714113|NCT00926029|156803136|FG002|Overall Study|Lost to Follow-up|1|||
49123904|NCT01063855|158292889|FG001|Overall Study|Withdrawal by Subject|8|||
49123905|NCT01063855|158292888|FG000|Overall Study|Reason not specified|13|||
49123906|NCT01063855|158292889|FG001|Overall Study|Reason not specified|11|||
49123907|NCT02806713|158292890|FG000|Overall Study|Urethral injury during procedure|1|||
49123908|NCT02806713|158292891|FG001|Overall Study|Urethral injury during procedure|0|||
49123909|NCT02806713|158292890|FG000|Overall Study|cancelled surgery|1|||
49123910|NCT02806713|158292891|FG001|Overall Study|cancelled surgery|2|||
49123911|NCT00115778|158292892|FG000|Overall Study|Withdrawal by Subject|0|||
49123912|NCT00115778|158292893|FG001|Overall Study|Withdrawal by Subject|1|||
49123913|NCT02762084|158292894|FG000|Overall Study|Withdrawal by Subject|1|||
49123914|NCT02762084|158292895|FG001|Overall Study|Withdrawal by Subject|0|||
49123915|NCT02762084|158292896|FG002|Overall Study|Withdrawal by Subject|0|||
49123916|NCT02762084|158292894|FG000|Overall Study|Adverse Event|0|||
49123917|NCT02762084|158292895|FG001|Overall Study|Adverse Event|0|||
49123918|NCT02762084|158292896|FG002|Overall Study|Adverse Event|1|||
49123919|NCT00165503|158292899|FG000|Overall Study|Death|1|||
49123920|NCT00165503|158292899|FG000|Overall Study|Lost to Follow-up|12|||
49123921|NCT00165503|158292899|FG000|Overall Study|Unresectable|3|||
49123922|NCT02346708|158292900|FG000|Overall Study|Adverse Event|2|||
49123923|NCT02346708|158292901|FG001|Overall Study|Adverse Event|0|||
49123924|NCT02346708|158292900|FG000|Overall Study|Protocol Violation|0|||
49123925|NCT02346708|158292901|FG001|Overall Study|Protocol Violation|1|||
49123926|NCT03904420|158292902|FG000|Overall Study|Study terminated|2|||
49123927|NCT03904420|158292903|FG001|Overall Study|Study terminated|2|||
49123928|NCT00614874|158292904|FG000|Overall Study|Protocol Violation|1|||
49123929|NCT00614874|158292904|FG000|Overall Study|Withdrawal by Subject|1|||
49123930|NCT01001910|158292905|FG000|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6|||
49123931|NCT01765296|158292908|FG000|Overall Study|Protocol Violation|0|||
49123932|NCT01765296|158292909|FG001|Overall Study|Protocol Violation|5|||
49123933|NCT01765296|158292910|FG002|Overall Study|Protocol Violation|4|||
49123934|NCT01765296|158292908|FG000|Overall Study|Withdrawal by Subject|4|||
49123935|NCT01765296|158292909|FG001|Overall Study|Withdrawal by Subject|2|||
49123936|NCT01765296|158292910|FG002|Overall Study|Withdrawal by Subject|2|||
49123937|NCT01765296|158292908|FG000|Overall Study|Adverse Event|1|||
49123938|NCT01765296|158292909|FG001|Overall Study|Adverse Event|13|||
49123939|NCT01765296|158292910|FG002|Overall Study|Adverse Event|5|||
49123940|NCT01765296|158292908|FG000|Overall Study|Lack of Efficacy|0|||
49123941|NCT01765296|158292909|FG001|Overall Study|Lack of Efficacy|0|||
49123942|NCT01765296|158292910|FG002|Overall Study|Lack of Efficacy|2|||
49123943|NCT01619852|158292911|FG000|24 Hour Assessment|Withdrawal by Subject|1|||
49123944|NCT01619852|158292912|FG001|24 Hour Assessment|Withdrawal by Subject|1|||
48714114|NCT03615040|156803142|FG000|Overall Study|Withdrawal by Subject|2|||
48714115|NCT03615040|156803143|FG001|Overall Study|Withdrawal by Subject|1|||
48714116|NCT03615040|156803142|FG000|Overall Study|Physician Decision|2|||
49123945|NCT01619852|158292911|FG000|3 Month Follow up|Lost to Follow-up|31|||
49123946|NCT01619852|158292912|FG001|3 Month Follow up|Lost to Follow-up|34|||
49123947|NCT03933449|158292913|FG000|Overall Study|Adverse Event|6|||
48714117|NCT03615040|156803143|FG001|Overall Study|Physician Decision|2|||
48714118|NCT03615040|156803142|FG000|Overall Study|Clinical diagnosis of lung cancer|1|||
49123948|NCT03933449|158292914|FG001|Overall Study|Adverse Event|4|||
49123949|NCT03933449|158292913|FG000|Overall Study|Death|55|||
49123950|NCT03933449|158292914|FG001|Overall Study|Death|57|||
49123951|NCT03933449|158292913|FG000|Overall Study|Sponsor Decision|1|||
49123952|NCT03933449|158292914|FG001|Overall Study|Sponsor Decision|0|||
49123953|NCT01576575|158292915|FG000|Buprenorphine Control|Withdrawal by Subject|3|||
49123954|NCT01576575|158292915|FG000|Buprenorphine + Rifampin|Withdrawal by Subject|3|||
49123955|NCT01576575|158292915|FG000|Buprenorphine + Grapefruit|Withdrawal by Subject|1|||
49123956|NCT02592447|158292918|FG000|Overall Study|Lost to Follow-up|1|||
49123957|NCT02592447|158292919|FG001|Overall Study|Lost to Follow-up|0|||
49123958|NCT02592447|158292918|FG000|Overall Study|Ineligible after randomization|1|||
48812565|NCT01317875|157155381|FG002|Overall Study|Other|1|||
48812566|NCT01317875|157155382|FG003|Overall Study|Other|0|||
48812567|NCT01317875|157155383|FG004|Overall Study|Other|0|||
48812568|NCT01317875|157155384|FG005|Overall Study|Other|0|||
48812569|NCT01317875|157155385|FG006|Overall Study|Other|0|||
48812570|NCT01317875|157155386|FG007|Overall Study|Other|0|||
48812571|NCT01317875|157155387|FG008|Overall Study|Other|0|||
48812572|NCT01317875|157155388|FG009|Overall Study|Other|0|||
48812573|NCT01317875|157155379|FG000|Overall Study|Noncompliance with study drug|0|||
48812574|NCT01317875|157155380|FG001|Overall Study|Noncompliance with study drug|0|||
48812575|NCT01317875|157155381|FG002|Overall Study|Noncompliance with study drug|1|||
48812576|NCT01317875|157155382|FG003|Overall Study|Noncompliance with study drug|0|||
48812577|NCT01317875|157155383|FG004|Overall Study|Noncompliance with study drug|0|||
48812578|NCT01317875|157155384|FG005|Overall Study|Noncompliance with study drug|0|||
48812579|NCT01317875|157155385|FG006|Overall Study|Noncompliance with study drug|0|||
48812580|NCT01317875|157155386|FG007|Overall Study|Noncompliance with study drug|0|||
48812581|NCT01317875|157155387|FG008|Overall Study|Noncompliance with study drug|0|||
48812582|NCT01317875|157155388|FG009|Overall Study|Noncompliance with study drug|0|||
48812583|NCT01317875|157155379|FG000|Overall Study|Progressive Disease|1|||
48812584|NCT01317875|157155380|FG001|Overall Study|Progressive Disease|0|||
48812585|NCT01317875|157155381|FG002|Overall Study|Progressive Disease|2|||
48812586|NCT01317875|157155382|FG003|Overall Study|Progressive Disease|0|||
48812587|NCT01317875|157155383|FG004|Overall Study|Progressive Disease|1|||
48812588|NCT01317875|157155384|FG005|Overall Study|Progressive Disease|0|||
48812589|NCT01317875|157155385|FG006|Overall Study|Progressive Disease|0|||
48812590|NCT01317875|157155386|FG007|Overall Study|Progressive Disease|1|||
48812591|NCT01317875|157155387|FG008|Overall Study|Progressive Disease|0|||
48812592|NCT01317875|157155388|FG009|Overall Study|Progressive Disease|0|||
48812593|NCT01317875|157155379|FG000|Overall Study|Withdrawal by Subject|0|||
48812594|NCT01317875|157155380|FG001|Overall Study|Withdrawal by Subject|0|||
48812595|NCT01317875|157155381|FG002|Overall Study|Withdrawal by Subject|0|||
48812596|NCT01317875|157155382|FG003|Overall Study|Withdrawal by Subject|0|||
48812597|NCT01317875|157155383|FG004|Overall Study|Withdrawal by Subject|1|||
48812598|NCT01317875|157155384|FG005|Overall Study|Withdrawal by Subject|0|||
48812599|NCT01317875|157155385|FG006|Overall Study|Withdrawal by Subject|0|||
48812600|NCT01317875|157155386|FG007|Overall Study|Withdrawal by Subject|3|||
48812601|NCT01317875|157155387|FG008|Overall Study|Withdrawal by Subject|0|||
48812602|NCT01317875|157155388|FG009|Overall Study|Withdrawal by Subject|0|||
48812603|NCT01317875|157155379|FG000|Overall Study|Physician Decision|0|||
48812604|NCT01317875|157155380|FG001|Overall Study|Physician Decision|1|||
48812605|NCT01317875|157155381|FG002|Overall Study|Physician Decision|1|||
48812606|NCT01317875|157155382|FG003|Overall Study|Physician Decision|0|||
48812607|NCT01317875|157155383|FG004|Overall Study|Physician Decision|2|||
48812608|NCT01317875|157155384|FG005|Overall Study|Physician Decision|0|||
48812609|NCT01317875|157155385|FG006|Overall Study|Physician Decision|0|||
48812610|NCT01317875|157155386|FG007|Overall Study|Physician Decision|2|||
48812611|NCT01317875|157155387|FG008|Overall Study|Physician Decision|0|||
48812612|NCT01317875|157155388|FG009|Overall Study|Physician Decision|0|||
48812613|NCT01317875|157155379|FG000|Overall Study|Death|0|||
48812614|NCT01317875|157155380|FG001|Overall Study|Death|0|||
48812615|NCT01317875|157155381|FG002|Overall Study|Death|2|||
48812616|NCT01317875|157155382|FG003|Overall Study|Death|1|||
48812617|NCT01317875|157155383|FG004|Overall Study|Death|0|||
48812618|NCT01317875|157155384|FG005|Overall Study|Death|1|||
48812619|NCT01317875|157155385|FG006|Overall Study|Death|0|||
48812620|NCT01317875|157155386|FG007|Overall Study|Death|4|||
48812621|NCT01317875|157155387|FG008|Overall Study|Death|0|||
48920046|NCT04418076|157541433|FG002|Overall Study|Lost to Follow-up|1|||
48920047|NCT04418076|157541434|FG003|Overall Study|Lost to Follow-up|2|||
48920048|NCT04418076|157541431|FG000|Overall Study|Withdrawal by Subject|1|||
48920049|NCT04418076|157541432|FG001|Overall Study|Withdrawal by Subject|0|||
48920050|NCT04418076|157541433|FG002|Overall Study|Withdrawal by Subject|1|||
48920051|NCT04418076|157541434|FG003|Overall Study|Withdrawal by Subject|1|||
48920052|NCT04418076|157541431|FG000|Overall Study|Dropped out after receiving pillbox and phone|2|||
48920053|NCT04418076|157541432|FG001|Overall Study|Dropped out after receiving pillbox and phone|0|||
49010960|NCT01785875|157877352|FG001|Overall Study|Withdrawal by Subject|34|||
49010961|NCT01785875|157877353|FG002|Overall Study|Withdrawal by Subject|36|||
48920054|NCT04418076|157541433|FG002|Overall Study|Dropped out after receiving pillbox and phone|2|||
49010962|NCT01785875|157877351|FG000|Overall Study|Lost to Follow-up|19|||
49010963|NCT01785875|157877352|FG001|Overall Study|Lost to Follow-up|22|||
49010964|NCT01785875|157877353|FG002|Overall Study|Lost to Follow-up|6|||
49010965|NCT01785875|157877351|FG000|Overall Study|Death|27|||
49010966|NCT01785875|157877352|FG001|Overall Study|Death|16|||
49010967|NCT01785875|157877353|FG002|Overall Study|Death|7|||
49010968|NCT01785875|157877351|FG000|Overall Study|Sponsor Decision|0|||
49010969|NCT01785875|157877352|FG001|Overall Study|Sponsor Decision|2|||
49010970|NCT01785875|157877353|FG002|Overall Study|Sponsor Decision|0|||
49010971|NCT01785875|157877351|FG000|Overall Study|Protocol Specified Criteria|207|||
49010972|NCT01785875|157877352|FG001|Overall Study|Protocol Specified Criteria|214|||
48920055|NCT04418076|157541434|FG003|Overall Study|Dropped out after receiving pillbox and phone|3|||
48920056|NCT01471782|157541436|FG000|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
48920057|NCT01471782|157541437|FG001|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
48920058|NCT01471782|157541438|FG002|Overall Study|Hematopoietic Stem Cell Transplantation|1|||
48920059|NCT01471782|157541439|FG003|Overall Study|Hematopoietic Stem Cell Transplantation|0|||
48920060|NCT01471782|157541440|FG004|Overall Study|Hematopoietic Stem Cell Transplantation|5|||
48920061|NCT01471782|157541441|FG005|Overall Study|Hematopoietic Stem Cell Transplantation|3|||
48920062|NCT01471782|157541436|FG000|Overall Study|Lack of Efficacy|1|||
48920063|NCT01471782|157541437|FG001|Overall Study|Lack of Efficacy|2|||
48920064|NCT01471782|157541438|FG002|Overall Study|Lack of Efficacy|1|||
48812622|NCT01317875|157155388|FG009|Overall Study|Death|0|||
48812623|NCT01317875|157155379|FG000|Overall Study|Adverse Event|2|||
48812624|NCT01317875|157155380|FG001|Overall Study|Adverse Event|1|||
48812625|NCT01317875|157155381|FG002|Overall Study|Adverse Event|2|||
48812626|NCT01317875|157155382|FG003|Overall Study|Adverse Event|1|||
48812627|NCT01317875|157155383|FG004|Overall Study|Adverse Event|5|||
48812628|NCT01317875|157155384|FG005|Overall Study|Adverse Event|1|||
48812629|NCT01317875|157155385|FG006|Overall Study|Adverse Event|2|||
48812630|NCT01317875|157155386|FG007|Overall Study|Adverse Event|5|||
48812631|NCT01317875|157155387|FG008|Overall Study|Adverse Event|0|||
48812632|NCT01317875|157155388|FG009|Overall Study|Adverse Event|0|||
48812633|NCT02670538|157155389|FG000|Overall Study|Withdrawal of Consent|8|||
48812634|NCT02670538|157155390|FG001|Overall Study|Withdrawal of Consent|6|||
48812635|NCT02670538|157155391|FG002|Overall Study|Withdrawal of Consent|5|||
48812636|NCT02670538|157155389|FG000|Overall Study|Lost to Follow-up|8|||
48920065|NCT01471782|157541439|FG003|Overall Study|Lack of Efficacy|1|||
48920066|NCT01471782|157541440|FG004|Overall Study|Lack of Efficacy|5|||
48920067|NCT01471782|157541441|FG005|Overall Study|Lack of Efficacy|18|||
48920068|NCT01471782|157541436|FG000|Overall Study|Adverse Event|1|||
48920069|NCT01471782|157541437|FG001|Overall Study|Adverse Event|1|||
48920070|NCT01471782|157541438|FG002|Overall Study|Adverse Event|2|||
48920071|NCT01471782|157541439|FG003|Overall Study|Adverse Event|2|||
48920072|NCT01471782|157541440|FG004|Overall Study|Adverse Event|3|||
48920073|NCT01471782|157541441|FG005|Overall Study|Adverse Event|1|||
48920074|NCT01471782|157541436|FG000|Overall Study|Other|0|||
48920075|NCT01471782|157541437|FG001|Overall Study|Other|0|||
48920076|NCT01471782|157541438|FG002|Overall Study|Other|1|||
48920077|NCT01471782|157541439|FG003|Overall Study|Other|1|||
48920078|NCT01471782|157541440|FG004|Overall Study|Other|6|||
48920079|NCT01471782|157541441|FG005|Overall Study|Other|5|||
48920080|NCT01471782|157541436|FG000|Overall Study|Change of Chemotherapy|1|||
48920081|NCT01471782|157541437|FG001|Overall Study|Change of Chemotherapy|1|||
48920082|NCT01471782|157541438|FG002|Overall Study|Change of Chemotherapy|0|||
48920083|NCT01471782|157541439|FG003|Overall Study|Change of Chemotherapy|0|||
48920084|NCT01471782|157541440|FG004|Overall Study|Change of Chemotherapy|1|||
48920085|NCT01471782|157541441|FG005|Overall Study|Change of Chemotherapy|4|||
48920086|NCT01471782|157541436|FG000|Overall Study|Disease Relapse|0|||
48920087|NCT01471782|157541437|FG001|Overall Study|Disease Relapse|0|||
48920088|NCT01471782|157541438|FG002|Overall Study|Disease Relapse|0|||
48920089|NCT01471782|157541439|FG003|Overall Study|Disease Relapse|1|||
48920090|NCT01471782|157541440|FG004|Overall Study|Disease Relapse|2|||
48920091|NCT01471782|157541441|FG005|Overall Study|Disease Relapse|1|||
48920092|NCT01471782|157541436|FG000|Overall Study|Physician Decision|0|||
48714119|NCT03615040|156803143|FG001|Overall Study|Clinical diagnosis of lung cancer|0|||
48714120|NCT03615040|156803142|FG000|Overall Study|Clinical diagnosis of oesophageal cancer|1|||
48714121|NCT03615040|156803143|FG001|Overall Study|Clinical diagnosis of oesophageal cancer|0|||
48714122|NCT03615040|156803142|FG000|Overall Study|Death|0|||
48714123|NCT03615040|156803143|FG001|Overall Study|Death|2|||
48714124|NCT01689532|156803144|FG000|Overall Study|Adverse Event|9|||
48714125|NCT01689532|156803145|FG001|Overall Study|Adverse Event|5|||
48714126|NCT01689532|156803144|FG000|Overall Study|Lack of Efficacy|2|||
48714127|NCT01689532|156803145|FG001|Overall Study|Lack of Efficacy|2|||
48714128|NCT01689532|156803144|FG000|Overall Study|Withdrawal by Subject|1|||
48714129|NCT01689532|156803145|FG001|Overall Study|Withdrawal by Subject|2|||
48714130|NCT01689532|156803144|FG000|Overall Study|Physician Decision|2|||
49010973|NCT01785875|157877353|FG002|Overall Study|Protocol Specified Criteria|55|||
49010974|NCT01785875|157877351|FG000|Overall Study|Missing|0|||
48812637|NCT02670538|157155390|FG001|Overall Study|Lost to Follow-up|12|||
48812638|NCT02670538|157155391|FG002|Overall Study|Lost to Follow-up|7|||
48812639|NCT02670538|157155389|FG000|Overall Study|Adverse Event|5|||
48812640|NCT02670538|157155390|FG001|Overall Study|Adverse Event|5|||
48920093|NCT01471782|157541437|FG001|Overall Study|Physician Decision|0|||
48920094|NCT01471782|157541438|FG002|Overall Study|Physician Decision|0|||
48920095|NCT01471782|157541439|FG003|Overall Study|Physician Decision|0|||
48920096|NCT01471782|157541440|FG004|Overall Study|Physician Decision|3|||
48920097|NCT01471782|157541441|FG005|Overall Study|Physician Decision|8|||
48920098|NCT01471782|157541436|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
48920099|NCT01471782|157541437|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
48920100|NCT01471782|157541438|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
48920101|NCT01471782|157541439|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
48920102|NCT01471782|157541440|FG004|Overall Study|Withdrawal by Parent/Guardian|1|||
48920103|NCT01471782|157541441|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
48920104|NCT01471782|157541436|FG000|Overall Study|Death|0|||
48920105|NCT01471782|157541437|FG001|Overall Study|Death|0|||
48920106|NCT01471782|157541438|FG002|Overall Study|Death|0|||
48920107|NCT01471782|157541439|FG003|Overall Study|Death|0|||
48920108|NCT01471782|157541440|FG004|Overall Study|Death|0|||
48920109|NCT01471782|157541441|FG005|Overall Study|Death|1|||
48920110|NCT01425008|157541442|FG000|Dose Escalation Phase|Progressive Disease|2|||
48920111|NCT01425008|157541443|FG001|Dose Escalation Phase|Progressive Disease|3|||
48920112|NCT01425008|157541444|FG002|Dose Escalation Phase|Progressive Disease|2|||
48920113|NCT01425008|157541445|FG003|Dose Escalation Phase|Progressive Disease|3|||
48920114|NCT01425008|157541446|FG004|Dose Escalation Phase|Progressive Disease|5|||
48920115|NCT01425008|157541447|FG005|Dose Escalation Phase|Progressive Disease|4|||
48920116|NCT01425008|157541448|FG006|Dose Escalation Phase|Progressive Disease|0|||
48920117|NCT01425008|157541449|FG007|Dose Escalation Phase|Progressive Disease|2|||
48920118|NCT01425008|157541450|FG008|Dose Escalation Phase|Progressive Disease|6|||
48920119|NCT01425008|157541451|FG009|Dose Escalation Phase|Progressive Disease|2|||
48920120|NCT01425008|157541452|FG010|Dose Escalation Phase|Progressive Disease|0|||
48920121|NCT01425008|157541453|FG011|Dose Escalation Phase|Progressive Disease|0|||
48812641|NCT02670538|157155391|FG002|Overall Study|Adverse Event|11|||
48812642|NCT02670538|157155389|FG000|Overall Study|Lack of Efficacy|7|||
48812643|NCT02670538|157155390|FG001|Overall Study|Lack of Efficacy|1|||
48812644|NCT02670538|157155391|FG002|Overall Study|Lack of Efficacy|2|||
48812645|NCT02670538|157155389|FG000|Overall Study|Protocol Violation|3|||
48812646|NCT02670538|157155390|FG001|Overall Study|Protocol Violation|4|||
48812647|NCT02670538|157155391|FG002|Overall Study|Protocol Violation|1|||
48812648|NCT02670538|157155389|FG000|Overall Study|Noncompliance with Study Drug|1|||
48812649|NCT02670538|157155390|FG001|Overall Study|Noncompliance with Study Drug|3|||
48812650|NCT02670538|157155391|FG002|Overall Study|Noncompliance with Study Drug|2|||
48812651|NCT02670538|157155389|FG000|Overall Study|Other Miscellaneous Reasons|0|||
48812652|NCT02670538|157155390|FG001|Overall Study|Other Miscellaneous Reasons|1|||
48812653|NCT02670538|157155391|FG002|Overall Study|Other Miscellaneous Reasons|2|||
48812654|NCT02887989|157155392|FG000|Overall Study|Withdrawal by Subject|8|||
48812655|NCT02887989|157155393|FG001|Overall Study|Withdrawal by Subject|11|||
48812656|NCT02887989|157155392|FG000|Overall Study|Death|1|||
48812657|NCT02887989|157155393|FG001|Overall Study|Death|0|||
48812658|NCT00358150|157155399|FG000|Overall Study|Adverse Event|3|||
48920122|NCT01425008|157541454|FG012|Dose Escalation Phase|Progressive Disease|0|||
48812659|NCT00358150|157155399|FG000|Overall Study|Withdrawal by Subject|1|||
48920123|NCT01425008|157541455|FG013|Dose Escalation Phase|Progressive Disease|0|||
48920124|NCT01425008|157541456|FG014|Dose Escalation Phase|Progressive Disease|0|||
48920125|NCT01425008|157541457|FG015|Dose Escalation Phase|Progressive Disease|0|||
48920126|NCT01425008|157541458|FG016|Dose Escalation Phase|Progressive Disease|0|||
48920127|NCT01425008|157541459|FG017|Dose Escalation Phase|Progressive Disease|0|||
48920128|NCT01425008|157541460|FG018|Dose Escalation Phase|Progressive Disease|0|||
48920129|NCT01425008|157541442|FG000|Dose Escalation Phase|Adverse Event|2|||
48920130|NCT01425008|157541443|FG001|Dose Escalation Phase|Adverse Event|0|||
48920131|NCT01425008|157541444|FG002|Dose Escalation Phase|Adverse Event|0|||
48920132|NCT01425008|157541445|FG003|Dose Escalation Phase|Adverse Event|0|||
48920133|NCT01425008|157541446|FG004|Dose Escalation Phase|Adverse Event|0|||
48920134|NCT01425008|157541447|FG005|Dose Escalation Phase|Adverse Event|2|||
48920135|NCT01425008|157541448|FG006|Dose Escalation Phase|Adverse Event|0|||
48920136|NCT01425008|157541449|FG007|Dose Escalation Phase|Adverse Event|0|||
48920137|NCT01425008|157541450|FG008|Dose Escalation Phase|Adverse Event|2|||
48920138|NCT01425008|157541451|FG009|Dose Escalation Phase|Adverse Event|0|||
48812660|NCT00358150|157155399|FG000|Overall Study|Undefined|3|||
48812661|NCT03119610|157155402|FG000|Overall Study|Adverse Event|1|||
48812662|NCT03119610|157155403|FG001|Overall Study|Adverse Event|0|||
48812663|NCT03119610|157155402|FG000|Overall Study|Lost to Follow-up|0|||
48812664|NCT03119610|157155403|FG001|Overall Study|Lost to Follow-up|1|||
48920139|NCT01425008|157541452|FG010|Dose Escalation Phase|Adverse Event|0|||
48920140|NCT01425008|157541453|FG011|Dose Escalation Phase|Adverse Event|0|||
48920141|NCT01425008|157541454|FG012|Dose Escalation Phase|Adverse Event|0|||
48920142|NCT01425008|157541455|FG013|Dose Escalation Phase|Adverse Event|0|||
48920143|NCT01425008|157541456|FG014|Dose Escalation Phase|Adverse Event|0|||
48920144|NCT01425008|157541457|FG015|Dose Escalation Phase|Adverse Event|0|||
48920145|NCT01425008|157541458|FG016|Dose Escalation Phase|Adverse Event|0|||
48920146|NCT01425008|157541459|FG017|Dose Escalation Phase|Adverse Event|0|||
48920147|NCT01425008|157541460|FG018|Dose Escalation Phase|Adverse Event|0|||
48920148|NCT01425008|157541442|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
48920149|NCT01425008|157541443|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
48920150|NCT01425008|157541444|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
48920151|NCT01425008|157541445|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
48920152|NCT01425008|157541446|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
48920153|NCT01425008|157541447|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
48920154|NCT01425008|157541448|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2|||
48920155|NCT01425008|157541449|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
49123959|NCT02592447|158292919|FG001|Overall Study|Ineligible after randomization|0|||
49123960|NCT02592447|158292918|FG000|Overall Study|Withdrawal by Subject|0|||
49123961|NCT02592447|158292919|FG001|Overall Study|Withdrawal by Subject|1|||
49123962|NCT02021292|158292921|FG000|Overall Study|Physician Decision|0|||
49123963|NCT02021292|158292922|FG001|Overall Study|Physician Decision|1|||
49123964|NCT02021292|158292921|FG000|Overall Study|Lost to Follow-up|0|||
49123965|NCT02021292|158292922|FG001|Overall Study|Lost to Follow-up|1|||
49123966|NCT02021292|158292921|FG000|Overall Study|Death|0|||
49123967|NCT02021292|158292922|FG001|Overall Study|Death|1|||
49123968|NCT03669549|158292926|FG000|Overall Study|Adverse Event|4|||
49123969|NCT03669549|158292926|FG000|Overall Study|Withdrawal by Subject|1|||
49123970|NCT03669549|158292926|FG000|Overall Study|Study terminated by the Sponsor|1|||
49123971|NCT00676403|158292930|FG000|Overall Study|Adverse Event|1|||
49123972|NCT00676403|158292931|FG001|Overall Study|Adverse Event|2|||
49123973|NCT00676403|158292932|FG002|Overall Study|Adverse Event|0|||
49123974|NCT00676403|158292933|FG003|Overall Study|Adverse Event|5|||
49123975|NCT00676403|158292934|FG004|Overall Study|Adverse Event|1|||
49123976|NCT00676403|158292935|FG005|Overall Study|Adverse Event|2|||
49123977|NCT00676403|158292930|FG000|Overall Study|Lost to Follow-up|0|||
49123978|NCT00676403|158292931|FG001|Overall Study|Lost to Follow-up|0|||
49123979|NCT00676403|158292932|FG002|Overall Study|Lost to Follow-up|0|||
49123980|NCT00676403|158292933|FG003|Overall Study|Lost to Follow-up|0|||
49123981|NCT00676403|158292934|FG004|Overall Study|Lost to Follow-up|0|||
49123982|NCT00676403|158292935|FG005|Overall Study|Lost to Follow-up|1|||
49123983|NCT00676403|158292930|FG000|Overall Study|Reason Unspecified|1|||
49123984|NCT00676403|158292931|FG001|Overall Study|Reason Unspecified|0|||
49123985|NCT00676403|158292932|FG002|Overall Study|Reason Unspecified|1|||
49123986|NCT00676403|158292933|FG003|Overall Study|Reason Unspecified|0|||
49123987|NCT00676403|158292934|FG004|Overall Study|Reason Unspecified|0|||
49123988|NCT00676403|158292935|FG005|Overall Study|Reason Unspecified|1|||
49123989|NCT00676403|158292930|FG000|Overall Study|Withdrawal by Subject|0|||
49123990|NCT00676403|158292931|FG001|Overall Study|Withdrawal by Subject|0|||
49123991|NCT00676403|158292932|FG002|Overall Study|Withdrawal by Subject|0|||
49123992|NCT00676403|158292933|FG003|Overall Study|Withdrawal by Subject|0|||
49123993|NCT00676403|158292934|FG004|Overall Study|Withdrawal by Subject|0|||
49123994|NCT00676403|158292935|FG005|Overall Study|Withdrawal by Subject|1|||
49123995|NCT01566604|158292936|FG000|Overall Study|Patient's inability to use the device|1|||
49123996|NCT01566604|158292937|FG001|Overall Study|Patient's inability to use the device|0|||
49123997|NCT01566604|158292936|FG000|Overall Study|Administrative problems|1|||
49123998|NCT01566604|158292937|FG001|Overall Study|Administrative problems|0|||
49123999|NCT01566604|158292936|FG000|Overall Study|Lack of Efficacy|1|||
49124000|NCT01566604|158292937|FG001|Overall Study|Lack of Efficacy|2|||
49124001|NCT01566604|158292936|FG000|Overall Study|Protocol deviation|2|||
48714131|NCT01689532|156803145|FG001|Overall Study|Physician Decision|0|||
48714132|NCT01363349|156803146|FG000|Overall Study|Adverse Event|6|||
48920156|NCT01425008|157541450|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
49124002|NCT01566604|158292937|FG001|Overall Study|Protocol deviation|0|||
49124003|NCT01566604|158292936|FG000|Overall Study|Abnormal laboratory value|2|||
49124004|NCT01566604|158292937|FG001|Overall Study|Abnormal laboratory value|0|||
49124005|NCT01566604|158292936|FG000|Overall Study|Death|4|||
49124006|NCT01566604|158292937|FG001|Overall Study|Death|1|||
49124007|NCT01566604|158292936|FG000|Overall Study|Adverse Event|4|||
49124008|NCT01566604|158292937|FG001|Overall Study|Adverse Event|2|||
49124009|NCT01566604|158292936|FG000|Overall Study|Withdrawal by Subject|9|||
49124010|NCT01566604|158292937|FG001|Overall Study|Withdrawal by Subject|6|||
49124011|NCT03225170|158292939|FG000|Overall Study|Lost to Follow-up|4|||
49124012|NCT03225170|158292940|FG001|Overall Study|Lost to Follow-up|4|||
49124013|NCT03225170|158292941|FG002|Overall Study|Lost to Follow-up|0|||
49124014|NCT03225170|158292939|FG000|Overall Study|Did not complete intervention/control writing exercise|0|||
48714133|NCT01363349|156803147|FG001|Overall Study|Adverse Event|7|||
48714134|NCT01363349|156803146|FG000|Overall Study|Lack of Efficacy|3|||
48714135|NCT01363349|156803147|FG001|Overall Study|Lack of Efficacy|10|||
48714136|NCT01363349|156803146|FG000|Overall Study|Non compliance/Protocol deviations|2|||
48714137|NCT01363349|156803147|FG001|Overall Study|Non compliance/Protocol deviations|2|||
49124015|NCT03225170|158292940|FG001|Overall Study|Did not complete intervention/control writing exercise|1|||
49124016|NCT03225170|158292941|FG002|Overall Study|Did not complete intervention/control writing exercise|0|||
49124017|NCT00248651|158292947|FG000|Overall Study|Withdrawal by Subject|28|||
49124018|NCT00248651|158292948|FG001|Overall Study|Withdrawal by Subject|40|||
49124019|NCT00248651|158292949|FG002|Overall Study|Withdrawal by Subject|32|||
48714138|NCT01363349|156803146|FG000|Overall Study|Withdrawal by Subject|14|||
49124020|NCT01365130|158292952|FG000|Overall Study|Progression/worsening of Dx prior to txt|2|||
49124021|NCT01691378|158292961|FG000|Overall Study|Withdrawal by Subject|2|||
49124022|NCT01691378|158292962|FG001|Overall Study|Withdrawal by Subject|0|||
49124023|NCT01691378|158292961|FG000|Overall Study|Lost to Follow-up|5|||
49124024|NCT01691378|158292962|FG001|Overall Study|Lost to Follow-up|2|||
49124025|NCT01687218|158292963|FG000|Overall Study|Withdrawal by Subject|2|||
49124026|NCT01687218|158292964|FG001|Overall Study|Withdrawal by Subject|3|||
49124027|NCT01687218|158292965|FG002|Overall Study|Withdrawal by Subject|0|||
49124028|NCT01687218|158292966|FG003|Overall Study|Withdrawal by Subject|1|||
49124029|NCT01687218|158292967|FG004|Overall Study|Withdrawal by Subject|1|||
49124030|NCT01687218|158292968|FG005|Overall Study|Withdrawal by Subject|0|||
49124031|NCT01687218|158292963|FG000|Overall Study|Relocated, no follow-up planned|1|||
49124032|NCT01687218|158292964|FG001|Overall Study|Relocated, no follow-up planned|0|||
49124033|NCT01687218|158292965|FG002|Overall Study|Relocated, no follow-up planned|1|||
49124034|NCT01687218|158292966|FG003|Overall Study|Relocated, no follow-up planned|1|||
49124035|NCT01687218|158292967|FG004|Overall Study|Relocated, no follow-up planned|0|||
49124036|NCT01687218|158292968|FG005|Overall Study|Relocated, no follow-up planned|0|||
49124037|NCT03139552|158292970|FG000|Overall Study|unable to attend tasting due to schedule|3|||
49124038|NCT03528551|158292971|FG000|Overall Study|Lost to Follow-up|0|||
49124039|NCT03528551|158292972|FG001|Overall Study|Lost to Follow-up|1|||
49124040|NCT03528551|158292973|FG002|Overall Study|Lost to Follow-up|0|||
48714139|NCT01363349|156803147|FG001|Overall Study|Withdrawal by Subject|6|||
49124041|NCT03528551|158292971|FG000|Overall Study|Transferred to other arm/group|2|||
49124042|NCT03528551|158292972|FG001|Overall Study|Transferred to other arm/group|3|||
49124043|NCT03528551|158292973|FG002|Overall Study|Transferred to other arm/group|0|||
49124044|NCT03528551|158292971|FG000|Overall Study|Withdrawal by parent/guardian|0|||
49124045|NCT03528551|158292972|FG001|Overall Study|Withdrawal by parent/guardian|5|||
49124046|NCT03528551|158292973|FG002|Overall Study|Withdrawal by parent/guardian|0|||
49124047|NCT03528551|158292971|FG000|Overall Study|Protocol Violation|0|||
49124048|NCT03528551|158292972|FG001|Overall Study|Protocol Violation|3|||
49124049|NCT03528551|158292973|FG002|Overall Study|Protocol Violation|0|||
49124050|NCT03528551|158292971|FG000|Overall Study|Withdrawal by Subject|0|||
49124051|NCT03528551|158292972|FG001|Overall Study|Withdrawal by Subject|7|||
49124052|NCT03528551|158292973|FG002|Overall Study|Withdrawal by Subject|0|||
49124053|NCT00808067|158292974|FG000|Overall Study|Major/minor bleed|30|||
49124054|NCT00808067|158292975|FG001|Overall Study|Major/minor bleed|44|||
49124055|NCT00808067|158292974|FG000|Overall Study|Outcome event - other|33|||
49124056|NCT00808067|158292975|FG001|Overall Study|Outcome event - other|25|||
49124057|NCT00808067|158292974|FG000|Overall Study|Adverse Event|111|||
49124058|NCT00808067|158292975|FG001|Overall Study|Adverse Event|121|||
49124059|NCT00808067|158292974|FG000|Overall Study|Hospitalization (not including surgery)|18|||
49124060|NCT00808067|158292975|FG001|Overall Study|Hospitalization (not including surgery)|17|||
49124061|NCT00808067|158292974|FG000|Overall Study|Hospitalization due to surgery|37|||
49124062|NCT00808067|158292975|FG001|Overall Study|Hospitalization due to surgery|40|||
49124063|NCT00808067|158292974|FG000|Overall Study|Reduced creatinine clearance|53|||
49124064|NCT00808067|158292975|FG001|Overall Study|Reduced creatinine clearance|55|||
49124065|NCT00808067|158292974|FG000|Overall Study|Elevated LFT results|7|||
49124066|NCT00808067|158292975|FG001|Overall Study|Elevated LFT results|3|||
49124067|NCT00808067|158292974|FG000|Overall Study|Patient refused to take study medication|65|||
49124068|NCT00808067|158292975|FG001|Overall Study|Patient refused to take study medication|76|||
49124069|NCT00808067|158292974|FG000|Overall Study|Missing|1|||
49124070|NCT00808067|158292975|FG001|Overall Study|Missing|0|||
49124071|NCT00808067|158292974|FG000|Overall Study|Death|1|||
49124072|NCT00808067|158292975|FG001|Overall Study|Death|1|||
49124073|NCT00808067|158292974|FG000|Overall Study|Procedure|6|||
49124074|NCT00808067|158292975|FG001|Overall Study|Procedure|7|||
49124075|NCT00808067|158292974|FG000|Overall Study|Withdrawal by Subject|21|||
49124076|NCT00808067|158292975|FG001|Overall Study|Withdrawal by Subject|25|||
49124077|NCT00808067|158292974|FG000|Overall Study|Site closed|4|||
49124078|NCT00808067|158292975|FG001|Overall Study|Site closed|3|||
49124079|NCT00808067|158292974|FG000|Overall Study|Physician Decision|47|||
49124080|NCT00808067|158292975|FG001|Overall Study|Physician Decision|38|||
49124081|NCT00808067|158292974|FG000|Overall Study|Protocol Violation|3|||
49124082|NCT00808067|158292975|FG001|Overall Study|Protocol Violation|11|||
49124083|NCT00808067|158292974|FG000|Overall Study|Patient elected|7|||
49124084|NCT00808067|158292975|FG001|Overall Study|Patient elected|9|||
49124085|NCT00808067|158292974|FG000|Overall Study|Site closed for cause|19|||
49124086|NCT00808067|158292975|FG001|Overall Study|Site closed for cause|19|||
49124087|NCT00808067|158292974|FG000|Overall Study|Other reason not defined above|5|||
49124088|NCT00808067|158292975|FG001|Overall Study|Other reason not defined above|5|||
49124089|NCT00808067|158292974|FG000|Overall Study|Excluded from analysis|13|||
49124090|NCT00808067|158292975|FG001|Overall Study|Excluded from analysis|19|||
48714140|NCT01363349|156803146|FG000|Overall Study|Lost to Follow-up|5|||
48714141|NCT01363349|156803147|FG001|Overall Study|Lost to Follow-up|6|||
48714142|NCT01363349|156803146|FG000|Overall Study|Not reported|36|||
48714143|NCT01363349|156803147|FG001|Overall Study|Not reported|37|||
48714144|NCT01363349|156803146|FG000|Overall Study|missing|1|||
48714145|NCT01363349|156803147|FG001|Overall Study|missing|2|||
48714146|NCT01958489|156803148|FG000|Period 2|Adverse Event|0|||
48714147|NCT01958489|156803149|FG001|Period 2|Adverse Event|1|||
48714148|NCT03462511|156803150|FG000|Overall Study|Withdrawal by Subject|2|||
48714149|NCT03462511|156803151|FG001|Overall Study|Withdrawal by Subject|3|||
48714150|NCT03890666|156803152|FG000|Overall Study|Withdrawal by Subject|0|||
48714151|NCT03890666|156803153|FG001|Overall Study|Withdrawal by Subject|1|||
48714152|NCT03890666|156803152|FG000|Overall Study|Protocol deviation|1|||
48714153|NCT03890666|156803153|FG001|Overall Study|Protocol deviation|4|||
48714154|NCT03890666|156803152|FG000|Overall Study|Lost to Follow-up|2|||
48714155|NCT03890666|156803153|FG001|Overall Study|Lost to Follow-up|5|||
48714156|NCT03890666|156803152|FG000|Overall Study|Other than specified|1|||
48714157|NCT03890666|156803153|FG001|Overall Study|Other than specified|8|||
48714158|NCT03595228|156803154|FG000|Overall Study|Death|2|||
48714159|NCT03595228|156803154|FG000|Overall Study|Lack of Efficacy|13|||
48714160|NCT03595228|156803154|FG000|Overall Study|Withdrawal by Subject|3|||
48714161|NCT03595228|156803154|FG000|Overall Study|Withdrawal by Sponsor|1|||
48714162|NCT01639729|156803155|FG000|Overall Study|Withdrawal by Subject|1|||
48714163|NCT01639729|156803156|FG001|Overall Study|Withdrawal by Subject|0|||
48714164|NCT01639729|156803157|FG002|Overall Study|Withdrawal by Subject|1|||
49124091|NCT00846586|158292976|FG000|Overall Study|Adverse Event|20|||
49124092|NCT00846586|158292977|FG001|Overall Study|Adverse Event|10|||
49124093|NCT00846586|158292976|FG000|Overall Study|Subject withdrew consent|8|||
48714165|NCT01639729|156803158|FG003|Overall Study|Withdrawal by Subject|1|||
48714166|NCT01639729|156803159|FG004|Overall Study|Withdrawal by Subject|0|||
48714167|NCT01639729|156803160|FG005|Overall Study|Withdrawal by Subject|0|||
48714168|NCT00200356|156803161|FG000|Overall Study|Lack of Efficacy|3|||
48714169|NCT00200356|156803162|FG001|Overall Study|Lack of Efficacy|3|||
48714170|NCT00200356|156803161|FG000|Overall Study|Protocol Violation|4|||
48714171|NCT00200356|156803162|FG001|Overall Study|Protocol Violation|4|||
48714172|NCT00200356|156803161|FG000|Overall Study|Nontreatment|1|||
48714173|NCT00200356|156803162|FG001|Overall Study|Nontreatment|0|||
48714174|NCT02238067|156803164|FG000|Overall Study|Not completed survey at Month 6|45|||
48714175|NCT00862641|156803173|FG000|Overall Study|Randomized, but drug not received|1|||
48714176|NCT00862641|156803174|FG001|Overall Study|Randomized, but drug not received|4|||
48714177|NCT00862641|156803175|FG002|Overall Study|Randomized, but drug not received|1|||
48714178|NCT00862641|156803176|FG003|Overall Study|Randomized, but drug not received|4|||
48714179|NCT01419197|156803178|FG000|Overall Study|Death|247|||
48714180|NCT01419197|156803179|FG001|Overall Study|Death|122|||
48920157|NCT01425008|157541451|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
48920158|NCT01425008|157541452|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
48920159|NCT01425008|157541453|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
48920160|NCT01425008|157541454|FG012|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
48920161|NCT01425008|157541455|FG013|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
48920162|NCT01425008|157541456|FG014|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
48920163|NCT01425008|157541457|FG015|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
48920164|NCT01425008|157541458|FG016|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
48920165|NCT01425008|157541459|FG017|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
48920166|NCT01425008|157541460|FG018|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
48920167|NCT01425008|157541442|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
48920168|NCT01425008|157541443|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
48920169|NCT01425008|157541444|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
48920170|NCT01425008|157541445|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
49124094|NCT00846586|158292977|FG001|Overall Study|Subject withdrew consent|10|||
49124095|NCT00846586|158292976|FG000|Overall Study|Administrative problems|5|||
49124096|NCT00846586|158292977|FG001|Overall Study|Administrative problems|4|||
49124097|NCT00846586|158292976|FG000|Overall Study|Death|2|||
49124098|NCT00846586|158292977|FG001|Overall Study|Death|0|||
49124099|NCT00846586|158292976|FG000|Overall Study|Protocol deviation|2|||
49124100|NCT00846586|158292977|FG001|Overall Study|Protocol deviation|6|||
49124101|NCT00846586|158292976|FG000|Overall Study|Abnormal test procedure result(s)|1|||
49124102|NCT00846586|158292977|FG001|Overall Study|Abnormal test procedure result(s)|0|||
49124103|NCT00846586|158292976|FG000|Overall Study|Lost to Follow-up|1|||
49124104|NCT00846586|158292977|FG001|Overall Study|Lost to Follow-up|4|||
49124105|NCT00846586|158292976|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
49124106|NCT00846586|158292977|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
49124107|NCT00780975|158292981|FG000|Overall Study|Progressive disease|3|||
49124108|NCT00780975|158292981|FG000|Overall Study|Toxicity|5|||
49124109|NCT01973218|158292984|FG000|Overall Study|Adverse Event|1|||
49124110|NCT01973218|158292985|FG001|Overall Study|Adverse Event|0|||
49124111|NCT01973218|158292984|FG000|Overall Study|Withdrawal by Subject|1|||
49124112|NCT01973218|158292985|FG001|Overall Study|Withdrawal by Subject|0|||
49124113|NCT01305564|158292986|FG000|Overall Study|Death|21|||
49124114|NCT01305564|158292986|FG000|Overall Study|Lost to Follow-up|12|||
49124115|NCT01305564|158292986|FG000|Overall Study|Withdrawal by Subject|1|||
49124116|NCT01305564|158292986|FG000|Overall Study|Physician Decision|3|||
49124117|NCT02247466|158292987|FG000|Overall Study|Procedure changed to open surgery|0|||
49124118|NCT02247466|158292988|FG001|Overall Study|Procedure changed to open surgery|3|||
49124119|NCT00492726|158292989|FG000|Overall Study|Adverse Event|10|||
49124120|NCT00492726|158292990|FG001|Overall Study|Adverse Event|6|||
49124121|NCT00492726|158292989|FG000|Overall Study|Death|7|||
49124122|NCT00492726|158292990|FG001|Overall Study|Death|2|||
49124123|NCT00492726|158292989|FG000|Overall Study|Lack of Efficacy|0|||
49124124|NCT00492726|158292990|FG001|Overall Study|Lack of Efficacy|2|||
49124125|NCT00492726|158292989|FG000|Overall Study|Lost to Follow-up|27|||
49124126|NCT00492726|158292990|FG001|Overall Study|Lost to Follow-up|19|||
49124127|NCT00492726|158292989|FG000|Overall Study|Physician Decision|0|||
49124128|NCT00492726|158292990|FG001|Overall Study|Physician Decision|1|||
49124129|NCT00492726|158292989|FG000|Overall Study|Withdrawal by Subject|6|||
48714181|NCT01419197|156803178|FG000|Overall Study|Physician Decision|4|||
48920171|NCT01425008|157541446|FG004|Dose Escalation Phase|Withdrawal by Subject|1|||
48920172|NCT01425008|157541447|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
49124130|NCT00492726|158292990|FG001|Overall Study|Withdrawal by Subject|3|||
49124131|NCT00492726|158292989|FG000|Overall Study|Non compliant with study medication|0|||
48714182|NCT01419197|156803179|FG001|Overall Study|Physician Decision|4|||
49124132|NCT00492726|158292990|FG001|Overall Study|Non compliant with study medication|3|||
49124133|NCT02230891|158292991|FG000|Baseline|Did not meet inclusion|0|||
49124134|NCT02230891|158292992|FG001|Baseline|Did not meet inclusion|1|||
49124135|NCT02230891|158292993|FG002|Baseline|Did not meet inclusion|1|||
49124136|NCT02230891|158292991|FG000|2 Week|Withdrawal by Subject|2|||
49124137|NCT02230891|158292992|FG001|2 Week|Withdrawal by Subject|2|||
49124138|NCT02230891|158292993|FG002|2 Week|Withdrawal by Subject|0|||
49124139|NCT02230891|158292991|FG000|2 Week|Consent withdrawn|1|||
49124140|NCT02230891|158292992|FG001|2 Week|Consent withdrawn|0|||
49124141|NCT02230891|158292993|FG002|2 Week|Consent withdrawn|0|||
49124142|NCT02230891|158292991|FG000|6 Month|Withdrawal by Subject|1|||
49124143|NCT02230891|158292992|FG001|6 Month|Withdrawal by Subject|1|||
49124144|NCT02230891|158292993|FG002|6 Month|Withdrawal by Subject|1|||
49124145|NCT02230891|158292991|FG000|6 Month|Physician Decision|0|||
49124146|NCT02230891|158292992|FG001|6 Month|Physician Decision|2|||
49124147|NCT02230891|158292993|FG002|6 Month|Physician Decision|0|||
49124148|NCT02230891|158292991|FG000|12 Month|Death|1|||
49124149|NCT02230891|158292992|FG001|12 Month|Death|0|||
48920173|NCT01425008|157541448|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
48920174|NCT01425008|157541449|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
48920175|NCT01425008|157541450|FG008|Dose Escalation Phase|Withdrawal by Subject|1|||
48920176|NCT01425008|157541451|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
48920177|NCT01425008|157541452|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
48920178|NCT01425008|157541453|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
48920179|NCT01425008|157541454|FG012|Dose Escalation Phase|Withdrawal by Subject|0|||
48920180|NCT01425008|157541455|FG013|Dose Escalation Phase|Withdrawal by Subject|0|||
48920181|NCT01425008|157541456|FG014|Dose Escalation Phase|Withdrawal by Subject|0|||
48920182|NCT01425008|157541457|FG015|Dose Escalation Phase|Withdrawal by Subject|0|||
48920183|NCT01425008|157541458|FG016|Dose Escalation Phase|Withdrawal by Subject|0|||
48920184|NCT01425008|157541459|FG017|Dose Escalation Phase|Withdrawal by Subject|0|||
48920185|NCT01425008|157541460|FG018|Dose Escalation Phase|Withdrawal by Subject|0|||
49124150|NCT02230891|158292993|FG002|12 Month|Death|0|||
49124151|NCT02230891|158292991|FG000|12 Month|Lost to Follow-up|0|||
49124152|NCT02230891|158292992|FG001|12 Month|Lost to Follow-up|1|||
49124153|NCT02230891|158292993|FG002|12 Month|Lost to Follow-up|0|||
49124154|NCT02230891|158292991|FG000|12 Month|Withdrawal by Subject|0|||
49124155|NCT02230891|158292992|FG001|12 Month|Withdrawal by Subject|2|||
49124156|NCT02230891|158292993|FG002|12 Month|Withdrawal by Subject|0|||
49124157|NCT02230891|158292991|FG000|18 Month End of Study|Death|0|||
49124158|NCT02230891|158292992|FG001|18 Month End of Study|Death|0|||
49124159|NCT02230891|158292993|FG002|18 Month End of Study|Death|1|||
49124160|NCT02230891|158292991|FG000|18 Month End of Study|Hear failure, lost to follow up|1|||
49124161|NCT02230891|158292992|FG001|18 Month End of Study|Hear failure, lost to follow up|0|||
49124162|NCT02230891|158292993|FG002|18 Month End of Study|Hear failure, lost to follow up|0|||
49124163|NCT03718429|158292994|FG000|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
49124164|NCT03718429|158292995|FG001|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
49124165|NCT03718429|158292996|FG002|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
49124166|NCT03718429|158292997|FG003|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
49124167|NCT02370511|158292998|FG000|Overall Study|Death|10|||
49124168|NCT02370511|158292999|FG001|Overall Study|Death|7|||
49124169|NCT02370511|158293000|FG002|Overall Study|Death|1|||
49124170|NCT02370511|158292998|FG000|Overall Study|Withdrawal by Subject|2|||
49124171|NCT02370511|158292999|FG001|Overall Study|Withdrawal by Subject|0|||
49124172|NCT02370511|158293000|FG002|Overall Study|Withdrawal by Subject|0|||
49124173|NCT02370511|158292998|FG000|Overall Study|Lost to Follow-up|0|||
49124174|NCT02370511|158292999|FG001|Overall Study|Lost to Follow-up|4|||
49124175|NCT02370511|158293000|FG002|Overall Study|Lost to Follow-up|0|||
48714183|NCT01419197|156803178|FG000|Overall Study|Non-compliance|3|||
49010975|NCT01785875|157877352|FG001|Overall Study|Missing|1|||
49124176|NCT01149655|158293001|FG000|Period 1 - Conversion Phase|Lost to Follow-up|1|||
49124177|NCT01149655|158293002|FG001|Period 1 - Conversion Phase|Lost to Follow-up|0|||
49124178|NCT01149655|158293003|FG002|Period 1 - Conversion Phase|Lost to Follow-up|0|||
49124179|NCT01149655|158293004|FG003|Period 1 - Conversion Phase|Lost to Follow-up|0|||
49124180|NCT01149655|158293001|FG000|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4|||
49124181|NCT01149655|158293002|FG001|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
49124182|NCT01149655|158293003|FG002|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
49124183|NCT01149655|158293004|FG003|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
49124184|NCT01149655|158293001|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
49124185|NCT01149655|158293002|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
49124186|NCT01149655|158293003|FG002|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
49124187|NCT01149655|158293004|FG003|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
49124188|NCT01149655|158293001|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
49124189|NCT01149655|158293002|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
49124190|NCT01149655|158293003|FG002|Period 1 - Conversion Phase|Physician Decision|0|||
49124191|NCT01149655|158293004|FG003|Period 1 - Conversion Phase|Physician Decision|0|||
49124192|NCT01149655|158293001|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
49124193|NCT01149655|158293002|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
49124194|NCT01149655|158293003|FG002|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
49124195|NCT01149655|158293004|FG003|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
49124196|NCT01149655|158293001|FG000|Period 1 - Conversion Phase|Adverse Event Without Relapse|3|||
49124197|NCT01149655|158293002|FG001|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
49124198|NCT01149655|158293003|FG002|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
49124199|NCT01149655|158293004|FG003|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
49124200|NCT01149655|158293001|FG000|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
49124201|NCT01149655|158293002|FG001|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16|||
49124202|NCT01149655|158293003|FG002|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
49124203|NCT01149655|158293004|FG003|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
49124204|NCT01149655|158293001|FG000|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
49124205|NCT01149655|158293002|FG001|Period 2-Stabilization Phase|Met Withdrawal Criteria|7|||
49124206|NCT01149655|158293003|FG002|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
49124207|NCT01149655|158293004|FG003|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
49124208|NCT01149655|158293001|FG000|Period 2-Stabilization Phase|Physician Decision|0|||
49124209|NCT01149655|158293002|FG001|Period 2-Stabilization Phase|Physician Decision|3|||
49124210|NCT01149655|158293003|FG002|Period 2-Stabilization Phase|Physician Decision|0|||
49124211|NCT01149655|158293004|FG003|Period 2-Stabilization Phase|Physician Decision|0|||
49124212|NCT01149655|158293001|FG000|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
49124213|NCT01149655|158293002|FG001|Period 2-Stabilization Phase|Withdrawal by Subject|5|||
49124214|NCT01149655|158293003|FG002|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
49124215|NCT01149655|158293004|FG003|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
49124216|NCT01149655|158293001|FG000|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
49124217|NCT01149655|158293002|FG001|Period 2-Stabilization Phase|Adverse Event Without Relapse|6|||
49124218|NCT01149655|158293003|FG002|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
49124219|NCT01149655|158293004|FG003|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
49124220|NCT01149655|158293001|FG000|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
49124221|NCT01149655|158293002|FG001|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
49124222|NCT01149655|158293003|FG002|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58|||
49124223|NCT01149655|158293004|FG003|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19|||
49124224|NCT01149655|158293001|FG000|Period 3-DB Maintenance Phase|Physician Decision|0|||
49124225|NCT01149655|158293002|FG001|Period 3-DB Maintenance Phase|Physician Decision|0|||
49124226|NCT01149655|158293003|FG002|Period 3-DB Maintenance Phase|Physician Decision|1|||
49124227|NCT01149655|158293004|FG003|Period 3-DB Maintenance Phase|Physician Decision|0|||
49124228|NCT01149655|158293001|FG000|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
49124229|NCT01149655|158293002|FG001|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
49124230|NCT01149655|158293003|FG002|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
49124231|NCT01149655|158293004|FG003|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
49124232|NCT01149655|158293001|FG000|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
49124233|NCT01149655|158293002|FG001|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
49124234|NCT01149655|158293003|FG002|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
49124235|NCT01149655|158293004|FG003|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
49124236|NCT01149655|158293001|FG000|Period 3-DB Maintenance Phase|Relapse With AE|0|||
49124237|NCT01149655|158293002|FG001|Period 3-DB Maintenance Phase|Relapse With AE|0|||
49124238|NCT01149655|158293003|FG002|Period 3-DB Maintenance Phase|Relapse With AE|19|||
49124239|NCT01149655|158293004|FG003|Period 3-DB Maintenance Phase|Relapse With AE|18|||
49124240|NCT04158219|158293009|FG000|Overall Study|Lost to Follow-up|1|||
49124241|NCT01093846|158293010|FG000|Overall Study|Adverse Event|0|||
49124242|NCT01093846|158293011|FG001|Overall Study|Adverse Event|0|||
49124243|NCT01093846|158293012|FG002|Overall Study|Adverse Event|1|||
49124244|NCT01093846|158293010|FG000|Overall Study|Lack of Efficacy|0|||
49124245|NCT01093846|158293011|FG001|Overall Study|Lack of Efficacy|0|||
49124246|NCT01093846|158293012|FG002|Overall Study|Lack of Efficacy|4|||
49124247|NCT01093846|158293010|FG000|Overall Study|Condition no longer required study drug|1|||
49124248|NCT01093846|158293011|FG001|Overall Study|Condition no longer required study drug|1|||
49124249|NCT01093846|158293012|FG002|Overall Study|Condition no longer required study drug|1|||
49124250|NCT01093846|158293010|FG000|Overall Study|Administrative Problems|18|||
49124251|NCT01093846|158293011|FG001|Overall Study|Administrative Problems|17|||
49124252|NCT01093846|158293012|FG002|Overall Study|Administrative Problems|15|||
49124253|NCT02922153|158294716|FG000|Overall Study|Death|8|||
49124254|NCT02922153|158294717|FG001|Overall Study|Death|1|||
48920186|NCT01425008|157541442|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
48920187|NCT01425008|157541443|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
48920188|NCT01425008|157541444|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
48920189|NCT01425008|157541445|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
48920190|NCT01425008|157541446|FG004|Dose Escalation Phase|Symptomatic Deterioration|0|||
48920191|NCT01425008|157541447|FG005|Dose Escalation Phase|Symptomatic Deterioration|0|||
48920192|NCT01425008|157541448|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
48920193|NCT01425008|157541449|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
48920194|NCT01425008|157541450|FG008|Dose Escalation Phase|Symptomatic Deterioration|2|||
48920195|NCT01425008|157541451|FG009|Dose Escalation Phase|Symptomatic Deterioration|2|||
48920196|NCT01425008|157541452|FG010|Dose Escalation Phase|Symptomatic Deterioration|0|||
48920197|NCT01425008|157541453|FG011|Dose Escalation Phase|Symptomatic Deterioration|0|||
48920198|NCT01425008|157541454|FG012|Dose Escalation Phase|Symptomatic Deterioration|0|||
48920199|NCT01425008|157541455|FG013|Dose Escalation Phase|Symptomatic Deterioration|0|||
48920200|NCT01425008|157541456|FG014|Dose Escalation Phase|Symptomatic Deterioration|0|||
48920201|NCT01425008|157541457|FG015|Dose Escalation Phase|Symptomatic Deterioration|0|||
48920202|NCT01425008|157541458|FG016|Dose Escalation Phase|Symptomatic Deterioration|0|||
48920203|NCT01425008|157541459|FG017|Dose Escalation Phase|Symptomatic Deterioration|0|||
48920204|NCT01425008|157541460|FG018|Dose Escalation Phase|Symptomatic Deterioration|0|||
48920205|NCT01425008|157541442|FG000|Dose Escalation Phase|Other|0|||
48920206|NCT01425008|157541443|FG001|Dose Escalation Phase|Other|0|||
49124255|NCT02922153|158294716|FG000|Overall Study|Lost to Follow-up|1|||
49124256|NCT02922153|158294717|FG001|Overall Study|Lost to Follow-up|0|||
48920207|NCT01425008|157541444|FG002|Dose Escalation Phase|Other|0|||
48920208|NCT01425008|157541445|FG003|Dose Escalation Phase|Other|0|||
48920209|NCT01425008|157541446|FG004|Dose Escalation Phase|Other|0|||
49124257|NCT02922153|158294716|FG000|Overall Study|Physician Decision|1|||
49124258|NCT02922153|158294717|FG001|Overall Study|Physician Decision|1|||
49124259|NCT00327340|158294718|FG000|Overall Study|Withdrawal by Subject|1|||
49124260|NCT00327340|158294719|FG001|Overall Study|Withdrawal by Subject|5|||
49124261|NCT00327340|158294718|FG000|Overall Study|Physician Decision|1|||
49124262|NCT00327340|158294719|FG001|Overall Study|Physician Decision|1|||
49124263|NCT00327340|158294718|FG000|Overall Study|Disease Progression|10|||
49124264|NCT00327340|158294719|FG001|Overall Study|Disease Progression|19|||
49124265|NCT00327340|158294718|FG000|Overall Study|Symptomatic Disease|0|||
49124266|NCT00327340|158294719|FG001|Overall Study|Symptomatic Disease|2|||
49124267|NCT00327340|158294718|FG000|Overall Study|Adverse Event|3|||
49124268|NCT00327340|158294719|FG001|Overall Study|Adverse Event|3|||
49124269|NCT01325350|158294722|FG000|Overall Study|Adverse Event|3|||
49124270|NCT01325350|158294723|FG001|Overall Study|Adverse Event|3|||
49124271|NCT01325350|158294724|FG002|Overall Study|Adverse Event|3|||
49124272|NCT01325350|158294725|FG003|Overall Study|Adverse Event|1|||
49124273|NCT01325350|158294726|FG004|Overall Study|Adverse Event|2|||
49124274|NCT01325350|158294722|FG000|Overall Study|Pregnancy|0|||
49124275|NCT01325350|158294723|FG001|Overall Study|Pregnancy|0|||
49124276|NCT01325350|158294724|FG002|Overall Study|Pregnancy|1|||
49124277|NCT01325350|158294725|FG003|Overall Study|Pregnancy|0|||
49124278|NCT01325350|158294726|FG004|Overall Study|Pregnancy|1|||
49124279|NCT01325350|158294722|FG000|Overall Study|Lost to Follow-up|1|||
49124280|NCT01325350|158294723|FG001|Overall Study|Lost to Follow-up|0|||
49124281|NCT01325350|158294724|FG002|Overall Study|Lost to Follow-up|5|||
49124282|NCT01325350|158294725|FG003|Overall Study|Lost to Follow-up|1|||
49124283|NCT01325350|158294726|FG004|Overall Study|Lost to Follow-up|5|||
49124284|NCT01325350|158294722|FG000|Overall Study|Personal Reasons|2|||
49124285|NCT01325350|158294723|FG001|Overall Study|Personal Reasons|1|||
49124286|NCT01325350|158294724|FG002|Overall Study|Personal Reasons|6|||
49124287|NCT01325350|158294725|FG003|Overall Study|Personal Reasons|5|||
49124288|NCT01325350|158294726|FG004|Overall Study|Personal Reasons|3|||
49124289|NCT01325350|158294722|FG000|Overall Study|Protocol Violation|0|||
49124290|NCT01325350|158294723|FG001|Overall Study|Protocol Violation|0|||
49124291|NCT01325350|158294724|FG002|Overall Study|Protocol Violation|0|||
49124292|NCT01325350|158294725|FG003|Overall Study|Protocol Violation|1|||
49124293|NCT01325350|158294726|FG004|Overall Study|Protocol Violation|0|||
49124294|NCT01325350|158294722|FG000|Overall Study|Withdrawal by Subject|0|||
49124295|NCT01325350|158294723|FG001|Overall Study|Withdrawal by Subject|0|||
49124296|NCT01325350|158294724|FG002|Overall Study|Withdrawal by Subject|1|||
49124297|NCT01325350|158294725|FG003|Overall Study|Withdrawal by Subject|1|||
49124298|NCT01325350|158294726|FG004|Overall Study|Withdrawal by Subject|0|||
49124299|NCT01325350|158294722|FG000|Overall Study|Did Not Receive Treatment|0|||
49124300|NCT01325350|158294723|FG001|Overall Study|Did Not Receive Treatment|1|||
49124301|NCT01325350|158294724|FG002|Overall Study|Did Not Receive Treatment|1|||
49124302|NCT01325350|158294725|FG003|Overall Study|Did Not Receive Treatment|0|||
49124303|NCT01325350|158294726|FG004|Overall Study|Did Not Receive Treatment|1|||
49124304|NCT01484951|158294728|FG000|Overall Study|Adverse Event|3|||
49124305|NCT01484951|158294728|FG000|Overall Study|Personal Reasons|1|||
49124306|NCT01484951|158294728|FG000|Overall Study|Non-Compliance|1|||
49124307|NCT02224625|158294730|FG000|Irritation|Adverse Event|6|||
49124308|NCT02224625|158294730|FG000|Sensitization|Adverse Event|55|||
49124309|NCT00956839|158294731|FG000|Overall Study|Lost to Follow-up|3|||
49124310|NCT00956839|158294732|FG001|Overall Study|Lost to Follow-up|0|||
49124311|NCT00956839|158294733|FG002|Overall Study|Lost to Follow-up|3|||
48812665|NCT01003184|157155404|FG000|Overall Study|Adverse Event|12|||
48812666|NCT01003184|157155405|FG001|Overall Study|Adverse Event|5|||
48812667|NCT01003184|157155404|FG000|Overall Study|Lost to Follow-up|1|||
48812668|NCT01003184|157155405|FG001|Overall Study|Lost to Follow-up|0|||
48812669|NCT01003184|157155404|FG000|Overall Study|Loss of glucose control|1|||
48812670|NCT01003184|157155405|FG001|Overall Study|Loss of glucose control|1|||
48812671|NCT01003184|157155404|FG000|Overall Study|Protocol Violation|3|||
48812672|NCT01003184|157155405|FG001|Overall Study|Protocol Violation|0|||
48812673|NCT01003184|157155404|FG000|Overall Study|Withdrawal by Subject|1|||
48812674|NCT01003184|157155405|FG001|Overall Study|Withdrawal by Subject|6|||
48812675|NCT01003184|157155404|FG000|Overall Study|Physician Decision|1|||
48812676|NCT01003184|157155405|FG001|Overall Study|Physician Decision|0|||
48812677|NCT02765490|157155406|FG000|Overall Study|Lost to Follow-up|1|||
48812678|NCT02765490|157155407|FG001|Overall Study|Lost to Follow-up|1|||
48812679|NCT02765490|157155406|FG000|Overall Study|Other|0|||
48812680|NCT02765490|157155407|FG001|Overall Study|Other|1|||
48812681|NCT02765490|157155406|FG000|Overall Study|Death|0|||
48812682|NCT02765490|157155407|FG001|Overall Study|Death|1|||
48812683|NCT03662997|157155408|FG000|Overall Study|Adverse Event|0|||
48812684|NCT03662997|157155409|FG001|Overall Study|Adverse Event|2|||
49124312|NCT02121795|158294736|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
49124313|NCT02121795|158294737|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
49124314|NCT02121795|158294736|FG000|Double-Blind Phase|Withdrawal by Subject|19|||
49124315|NCT02121795|158294737|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
49124316|NCT02121795|158294736|FG000|Double-Blind Phase|Lost to Follow-up|7|||
49124317|NCT02121795|158294737|FG001|Double-Blind Phase|Lost to Follow-up|4|||
49124318|NCT02121795|158294736|FG000|Double-Blind Phase|Physician Decision|2|||
49124319|NCT02121795|158294737|FG001|Double-Blind Phase|Physician Decision|5|||
49124320|NCT02121795|158294736|FG000|Double-Blind Phase|Adverse Event|5|||
48812685|NCT03662997|157155410|FG002|Overall Study|Adverse Event|0|||
48812686|NCT03662997|157155411|FG003|Overall Study|Adverse Event|0|||
48920210|NCT01425008|157541447|FG005|Dose Escalation Phase|Other|0|||
48920211|NCT01425008|157541448|FG006|Dose Escalation Phase|Other|0|||
48920212|NCT01425008|157541449|FG007|Dose Escalation Phase|Other|0|||
48920213|NCT01425008|157541450|FG008|Dose Escalation Phase|Other|1|||
48920214|NCT01425008|157541451|FG009|Dose Escalation Phase|Other|0|||
48920215|NCT01425008|157541452|FG010|Dose Escalation Phase|Other|0|||
48920216|NCT01425008|157541453|FG011|Dose Escalation Phase|Other|0|||
48920217|NCT01425008|157541454|FG012|Dose Escalation Phase|Other|0|||
48920218|NCT01425008|157541455|FG013|Dose Escalation Phase|Other|0|||
48920219|NCT01425008|157541456|FG014|Dose Escalation Phase|Other|0|||
48920220|NCT01425008|157541457|FG015|Dose Escalation Phase|Other|0|||
48920221|NCT01425008|157541458|FG016|Dose Escalation Phase|Other|0|||
48920222|NCT01425008|157541459|FG017|Dose Escalation Phase|Other|0|||
48920223|NCT01425008|157541460|FG018|Dose Escalation Phase|Other|0|||
48920224|NCT01425008|157541442|FG000|Dose Expansion Phase|Progressive Disease|0|||
48920225|NCT01425008|157541443|FG001|Dose Expansion Phase|Progressive Disease|0|||
48920226|NCT01425008|157541444|FG002|Dose Expansion Phase|Progressive Disease|0|||
48920227|NCT01425008|157541445|FG003|Dose Expansion Phase|Progressive Disease|0|||
48920228|NCT01425008|157541446|FG004|Dose Expansion Phase|Progressive Disease|0|||
48920229|NCT01425008|157541447|FG005|Dose Expansion Phase|Progressive Disease|0|||
48920230|NCT01425008|157541448|FG006|Dose Expansion Phase|Progressive Disease|0|||
48920231|NCT01425008|157541449|FG007|Dose Expansion Phase|Progressive Disease|0|||
49124321|NCT02121795|158294737|FG001|Double-Blind Phase|Adverse Event|0|||
48812687|NCT01865617|157155412|FG000|Overall Study|Death|27|||
48812688|NCT01865617|157155413|FG001|Overall Study|Death|3|||
48812689|NCT01865617|157155414|FG002|Overall Study|Death|1|||
48812690|NCT01865617|157155415|FG003|Overall Study|Death|1|||
48812691|NCT01865617|157155416|FG004|Overall Study|Death|5|||
48812692|NCT01865617|157155417|FG005|Overall Study|Death|1|||
49124322|NCT02121795|158294736|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
49124323|NCT02121795|158294737|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
48920232|NCT01425008|157541450|FG008|Dose Expansion Phase|Progressive Disease|0|||
48920233|NCT01425008|157541451|FG009|Dose Expansion Phase|Progressive Disease|0|||
48920234|NCT01425008|157541452|FG010|Dose Expansion Phase|Progressive Disease|10|||
48920235|NCT01425008|157541453|FG011|Dose Expansion Phase|Progressive Disease|4|||
48812693|NCT01865617|157155418|FG006|Overall Study|Death|11|||
48812694|NCT01865617|157155419|FG007|Overall Study|Death|1|||
48812695|NCT01865617|157155420|FG008|Overall Study|Death|11|||
48812696|NCT01865617|157155421|FG009|Overall Study|Death|3|||
48812697|NCT01865617|157155422|FG010|Overall Study|Death|32|||
48812698|NCT01865617|157155423|FG011|Overall Study|Death|6|||
48812699|NCT01865617|157155424|FG012|Overall Study|Death|13|||
48812700|NCT01865617|157155412|FG000|Overall Study|Lost to Follow-up|2|||
48812701|NCT01865617|157155413|FG001|Overall Study|Lost to Follow-up|0|||
48812702|NCT01865617|157155414|FG002|Overall Study|Lost to Follow-up|0|||
48812703|NCT01865617|157155415|FG003|Overall Study|Lost to Follow-up|0|||
48812704|NCT01865617|157155416|FG004|Overall Study|Lost to Follow-up|0|||
48812705|NCT01865617|157155417|FG005|Overall Study|Lost to Follow-up|0|||
48812706|NCT01865617|157155418|FG006|Overall Study|Lost to Follow-up|0|||
48812707|NCT01865617|157155419|FG007|Overall Study|Lost to Follow-up|0|||
48920236|NCT01425008|157541454|FG012|Dose Expansion Phase|Progressive Disease|12|||
48920237|NCT01425008|157541455|FG013|Dose Expansion Phase|Progressive Disease|1|||
48920238|NCT01425008|157541456|FG014|Dose Expansion Phase|Progressive Disease|5|||
48920239|NCT01425008|157541457|FG015|Dose Expansion Phase|Progressive Disease|8|||
48920240|NCT01425008|157541458|FG016|Dose Expansion Phase|Progressive Disease|9|||
48920241|NCT01425008|157541459|FG017|Dose Expansion Phase|Progressive Disease|2|||
48920242|NCT01425008|157541460|FG018|Dose Expansion Phase|Progressive Disease|10|||
48920243|NCT01425008|157541442|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
48920244|NCT01425008|157541443|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
48920245|NCT01425008|157541444|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
48920246|NCT01425008|157541445|FG003|Dose Expansion Phase|Withdrawal by Subject|0|||
48920247|NCT01425008|157541446|FG004|Dose Expansion Phase|Withdrawal by Subject|0|||
48920248|NCT01425008|157541447|FG005|Dose Expansion Phase|Withdrawal by Subject|0|||
48920249|NCT01425008|157541448|FG006|Dose Expansion Phase|Withdrawal by Subject|0|||
48920250|NCT01425008|157541449|FG007|Dose Expansion Phase|Withdrawal by Subject|0|||
48920251|NCT01425008|157541450|FG008|Dose Expansion Phase|Withdrawal by Subject|0|||
48920252|NCT01425008|157541451|FG009|Dose Expansion Phase|Withdrawal by Subject|0|||
48920253|NCT01425008|157541452|FG010|Dose Expansion Phase|Withdrawal by Subject|1|||
48920254|NCT01425008|157541453|FG011|Dose Expansion Phase|Withdrawal by Subject|0|||
48920255|NCT01425008|157541454|FG012|Dose Expansion Phase|Withdrawal by Subject|0|||
48920256|NCT01425008|157541455|FG013|Dose Expansion Phase|Withdrawal by Subject|0|||
48920257|NCT01425008|157541456|FG014|Dose Expansion Phase|Withdrawal by Subject|0|||
48920258|NCT01425008|157541457|FG015|Dose Expansion Phase|Withdrawal by Subject|1|||
48920259|NCT01425008|157541458|FG016|Dose Expansion Phase|Withdrawal by Subject|1|||
48920260|NCT01425008|157541459|FG017|Dose Expansion Phase|Withdrawal by Subject|0|||
48920261|NCT01425008|157541460|FG018|Dose Expansion Phase|Withdrawal by Subject|0|||
48920262|NCT01425008|157541442|FG000|Dose Expansion Phase|Other|0|||
48920263|NCT01425008|157541443|FG001|Dose Expansion Phase|Other|0|||
49124324|NCT02121795|158294736|FG000|Double-Blind Phase|Protocol Violation|0|||
49124325|NCT02121795|158294737|FG001|Double-Blind Phase|Protocol Violation|3|||
48812708|NCT01865617|157155420|FG008|Overall Study|Lost to Follow-up|0|||
48812709|NCT01865617|157155421|FG009|Overall Study|Lost to Follow-up|0|||
48812710|NCT01865617|157155422|FG010|Overall Study|Lost to Follow-up|0|||
48812711|NCT01865617|157155423|FG011|Overall Study|Lost to Follow-up|0|||
48812712|NCT01865617|157155424|FG012|Overall Study|Lost to Follow-up|0|||
48920264|NCT01425008|157541444|FG002|Dose Expansion Phase|Other|0|||
48920265|NCT01425008|157541445|FG003|Dose Expansion Phase|Other|0|||
48920266|NCT01425008|157541446|FG004|Dose Expansion Phase|Other|0|||
48920267|NCT01425008|157541447|FG005|Dose Expansion Phase|Other|0|||
48920268|NCT01425008|157541448|FG006|Dose Expansion Phase|Other|0|||
48920269|NCT01425008|157541449|FG007|Dose Expansion Phase|Other|0|||
48920270|NCT01425008|157541450|FG008|Dose Expansion Phase|Other|0|||
48920271|NCT01425008|157541451|FG009|Dose Expansion Phase|Other|0|||
48920272|NCT01425008|157541452|FG010|Dose Expansion Phase|Other|0|||
48920273|NCT01425008|157541453|FG011|Dose Expansion Phase|Other|0|||
48920274|NCT01425008|157541454|FG012|Dose Expansion Phase|Other|1|||
48920275|NCT01425008|157541455|FG013|Dose Expansion Phase|Other|0|||
48920276|NCT01425008|157541456|FG014|Dose Expansion Phase|Other|0|||
48920277|NCT01425008|157541457|FG015|Dose Expansion Phase|Other|0|||
48920278|NCT01425008|157541458|FG016|Dose Expansion Phase|Other|2|||
48920279|NCT01425008|157541459|FG017|Dose Expansion Phase|Other|0|||
48920280|NCT01425008|157541460|FG018|Dose Expansion Phase|Other|4|||
48920281|NCT01425008|157541442|FG000|Dose Expansion Phase|Symptomatic Deterioration|0|||
48920282|NCT01425008|157541443|FG001|Dose Expansion Phase|Symptomatic Deterioration|0|||
49124326|NCT02121795|158294736|FG000|Double-Blind Phase|Death|1|||
48812713|NCT01865617|157155412|FG000|Overall Study|Withdrawal by Subject|1|||
48812714|NCT01865617|157155413|FG001|Overall Study|Withdrawal by Subject|0|||
48812715|NCT01865617|157155414|FG002|Overall Study|Withdrawal by Subject|0|||
48812716|NCT01865617|157155415|FG003|Overall Study|Withdrawal by Subject|0|||
48920283|NCT01425008|157541444|FG002|Dose Expansion Phase|Symptomatic Deterioration|0|||
48920284|NCT01425008|157541445|FG003|Dose Expansion Phase|Symptomatic Deterioration|0|||
48920285|NCT01425008|157541446|FG004|Dose Expansion Phase|Symptomatic Deterioration|0|||
48920286|NCT01425008|157541447|FG005|Dose Expansion Phase|Symptomatic Deterioration|0|||
48920287|NCT01425008|157541448|FG006|Dose Expansion Phase|Symptomatic Deterioration|0|||
48812717|NCT01865617|157155416|FG004|Overall Study|Withdrawal by Subject|0|||
48812718|NCT01865617|157155417|FG005|Overall Study|Withdrawal by Subject|0|||
48812719|NCT01865617|157155418|FG006|Overall Study|Withdrawal by Subject|0|||
48812720|NCT01865617|157155419|FG007|Overall Study|Withdrawal by Subject|0|||
48812721|NCT01865617|157155420|FG008|Overall Study|Withdrawal by Subject|0|||
48812722|NCT01865617|157155421|FG009|Overall Study|Withdrawal by Subject|0|||
48812723|NCT01865617|157155422|FG010|Overall Study|Withdrawal by Subject|0|||
48812724|NCT01865617|157155423|FG011|Overall Study|Withdrawal by Subject|0|||
48812725|NCT01865617|157155424|FG012|Overall Study|Withdrawal by Subject|0|||
48812726|NCT01865617|157155412|FG000|Overall Study|Patient proceeded to new therapy|0|||
48812727|NCT01865617|157155413|FG001|Overall Study|Patient proceeded to new therapy|0|||
48812728|NCT01865617|157155414|FG002|Overall Study|Patient proceeded to new therapy|0|||
48812729|NCT01865617|157155415|FG003|Overall Study|Patient proceeded to new therapy|0|||
48812730|NCT01865617|157155416|FG004|Overall Study|Patient proceeded to new therapy|2|||
48812731|NCT01865617|157155417|FG005|Overall Study|Patient proceeded to new therapy|0|||
48812732|NCT01865617|157155418|FG006|Overall Study|Patient proceeded to new therapy|0|||
48812733|NCT01865617|157155419|FG007|Overall Study|Patient proceeded to new therapy|0|||
48812734|NCT01865617|157155420|FG008|Overall Study|Patient proceeded to new therapy|0|||
48812735|NCT01865617|157155421|FG009|Overall Study|Patient proceeded to new therapy|0|||
48812736|NCT01865617|157155422|FG010|Overall Study|Patient proceeded to new therapy|0|||
48812737|NCT01865617|157155423|FG011|Overall Study|Patient proceeded to new therapy|0|||
48812738|NCT01865617|157155424|FG012|Overall Study|Patient proceeded to new therapy|0|||
48812739|NCT01865617|157155412|FG000|Overall Study|Other|0|||
48812740|NCT01865617|157155413|FG001|Overall Study|Other|0|||
48812741|NCT01865617|157155414|FG002|Overall Study|Other|0|||
48812742|NCT01865617|157155415|FG003|Overall Study|Other|0|||
48812743|NCT01865617|157155416|FG004|Overall Study|Other|0|||
48812744|NCT01865617|157155417|FG005|Overall Study|Other|0|||
48812745|NCT01865617|157155418|FG006|Overall Study|Other|1|||
48812746|NCT01865617|157155419|FG007|Overall Study|Other|0|||
48812747|NCT01865617|157155420|FG008|Overall Study|Other|0|||
48812748|NCT01865617|157155421|FG009|Overall Study|Other|0|||
48812749|NCT01865617|157155422|FG010|Overall Study|Other|0|||
48812750|NCT01865617|157155423|FG011|Overall Study|Other|0|||
48812751|NCT01865617|157155424|FG012|Overall Study|Other|0|||
48812752|NCT02500979|157155425|FG000|Period 1|Hyperglycemia|1|||
48812753|NCT02500979|157155426|FG001|Period 1|Hyperglycemia|0|||
48812754|NCT02500979|157155425|FG000|Period 1|Severe non-compliance to protocol|0|||
48812755|NCT02500979|157155426|FG001|Period 1|Severe non-compliance to protocol|1|||
48812756|NCT02500979|157155425|FG000|Period 1|Adverse Event|1|||
48812757|NCT02500979|157155426|FG001|Period 1|Adverse Event|0|||
48812758|NCT02500979|157155425|FG000|Period 1|Subject decision|2|||
48812759|NCT02500979|157155426|FG001|Period 1|Subject decision|0|||
48812760|NCT02500979|157155425|FG000|Period 2|Change in risk|1|||
48812761|NCT02500979|157155426|FG001|Period 2|Change in risk|0|||
48812762|NCT00675506|157155428|FG000|Overall Study|Lost to Follow-up|1|||
48812763|NCT00675506|157155429|FG001|Overall Study|Lost to Follow-up|5|||
48812764|NCT00675506|157155428|FG000|Overall Study|Lost interest|3|||
48812765|NCT00675506|157155429|FG001|Overall Study|Lost interest|5|||
48812766|NCT00675506|157155428|FG000|Overall Study|Elevated fasting glucose|2|||
48812767|NCT00675506|157155429|FG001|Overall Study|Elevated fasting glucose|1|||
48920288|NCT01425008|157541449|FG007|Dose Expansion Phase|Symptomatic Deterioration|0|||
48812768|NCT00675506|157155428|FG000|Overall Study|Elevated IGF-1 prior to treatment|1|||
48812769|NCT00675506|157155429|FG001|Overall Study|Elevated IGF-1 prior to treatment|0|||
48812770|NCT00675506|157155428|FG000|Overall Study|Elevated IGF-1|2|||
48812771|NCT00675506|157155429|FG001|Overall Study|Elevated IGF-1|0|||
48812772|NCT00675506|157155428|FG000|Overall Study|Hypersensitivity Reaction|1|||
48920289|NCT01425008|157541450|FG008|Dose Expansion Phase|Symptomatic Deterioration|0|||
48920290|NCT01425008|157541451|FG009|Dose Expansion Phase|Symptomatic Deterioration|0|||
48920291|NCT01425008|157541452|FG010|Dose Expansion Phase|Symptomatic Deterioration|2|||
48920292|NCT01425008|157541453|FG011|Dose Expansion Phase|Symptomatic Deterioration|1|||
48920293|NCT01425008|157541454|FG012|Dose Expansion Phase|Symptomatic Deterioration|0|||
48812773|NCT00675506|157155429|FG001|Overall Study|Hypersensitivity Reaction|0|||
48812774|NCT00675506|157155428|FG000|Overall Study|Disclosed history of cancer|1|||
48812775|NCT00675506|157155429|FG001|Overall Study|Disclosed history of cancer|0|||
48812776|NCT00675506|157155428|FG000|Overall Study|Declined participation|1|||
48812777|NCT00675506|157155429|FG001|Overall Study|Declined participation|0|||
48812778|NCT00675506|157155428|FG000|Overall Study|Schedule conflict|0|||
48812779|NCT00675506|157155429|FG001|Overall Study|Schedule conflict|1|||
48812780|NCT03292146|157155430|FG000|Baseline to 12 Months|Relocation|1|||
48812781|NCT03292146|157155431|FG001|Baseline to 12 Months|Relocation|0|||
48812782|NCT03292146|157155430|FG000|Baseline to 12 Months|Seeking higher level of care for eating disorder|1|||
48812783|NCT03292146|157155431|FG001|Baseline to 12 Months|Seeking higher level of care for eating disorder|0|||
48812784|NCT03292146|157155430|FG000|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|0|||
49124327|NCT02121795|158294737|FG001|Double-Blind Phase|Death|1|||
49124328|NCT02121795|158294736|FG000|Open-Label Phase|Physician Decision|8|||
49124329|NCT02121795|158294737|FG001|Open-Label Phase|Physician Decision|8|||
49124330|NCT02121795|158294736|FG000|Open-Label Phase|Withdrawal by Subject|3|||
49124331|NCT02121795|158294737|FG001|Open-Label Phase|Withdrawal by Subject|2|||
49124332|NCT02121795|158294736|FG000|Open-Label Phase|Lost to Follow-up|1|||
49124333|NCT02121795|158294737|FG001|Open-Label Phase|Lost to Follow-up|0|||
49124334|NCT01100853|158294740|FG000|Overall Study|Lost to Follow-up|11|||
49124335|NCT01100853|158294741|FG001|Overall Study|Lost to Follow-up|6|||
49124336|NCT01100853|158294740|FG000|Overall Study|Received <4 study injections|10|||
49124337|NCT01100853|158294741|FG001|Overall Study|Received <4 study injections|13|||
49124338|NCT01100853|158294740|FG000|Overall Study|Withdrawal by Subject|6|||
49124339|NCT01100853|158294741|FG001|Overall Study|Withdrawal by Subject|4|||
49124340|NCT01811732|158294747|FG000|Overall Study|Lost to Follow-up|24|||
49124341|NCT01811732|158294748|FG001|Overall Study|Lost to Follow-up|30|||
49124342|NCT01811732|158294747|FG000|Overall Study|Withdrawal by Subject|16|||
49124343|NCT01811732|158294748|FG001|Overall Study|Withdrawal by Subject|10|||
49124344|NCT01811732|158294747|FG000|Overall Study|Adverse Event|3|||
49124345|NCT01811732|158294748|FG001|Overall Study|Adverse Event|9|||
49124346|NCT01811732|158294747|FG000|Overall Study|Lack of Efficacy|3|||
49124347|NCT01811732|158294748|FG001|Overall Study|Lack of Efficacy|1|||
49124348|NCT01811732|158294747|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
49124349|NCT01811732|158294748|FG001|Overall Study|Non-compliance with study drug/procedure|3|||
49124350|NCT01811732|158294747|FG000|Overall Study|Physician Decision|2|||
49124351|NCT01811732|158294748|FG001|Overall Study|Physician Decision|0|||
49124352|NCT01811732|158294747|FG000|Overall Study|Death|1|||
49124353|NCT01811732|158294748|FG001|Overall Study|Death|1|||
49124354|NCT01811732|158294747|FG000|Overall Study|Insufficient venous access|0|||
49124355|NCT01811732|158294748|FG001|Overall Study|Insufficient venous access|1|||
49124356|NCT01811732|158294747|FG000|Overall Study|Protocol Violation|0|||
49124357|NCT01811732|158294748|FG001|Overall Study|Protocol Violation|1|||
49124358|NCT01811732|158294747|FG000|Overall Study|Subject incarcerated|1|||
49124359|NCT01811732|158294748|FG001|Overall Study|Subject incarcerated|2|||
49124360|NCT01811732|158294747|FG000|Overall Study|Admitted to another facility|1|||
49124361|NCT01811732|158294748|FG001|Overall Study|Admitted to another facility|0|||
49124362|NCT01811732|158294747|FG000|Overall Study|Correct study drug not available on site|1|||
49124363|NCT01811732|158294748|FG001|Overall Study|Correct study drug not available on site|0|||
49124364|NCT00610168|158294750|FG000|Overall Study|Withdrawal by Subject|2|||
49124365|NCT00610168|158294751|FG001|Overall Study|Withdrawal by Subject|0|||
49124366|NCT00048035|158294752|FG000|Core Period|Early Withdrawals|4|||
49124367|NCT00048035|158294753|FG001|Core Period|Early Withdrawals|2|||
49124368|NCT00048035|158294754|FG002|Core Period|Early Withdrawals|1|||
48714184|NCT01419197|156803179|FG001|Overall Study|Non-compliance|1|||
48714185|NCT01419197|156803178|FG000|Overall Study|Withdrawal by Subject|33|||
48714186|NCT01419197|156803179|FG001|Overall Study|Withdrawal by Subject|32|||
48714187|NCT01419197|156803178|FG000|Overall Study|Study Completed by Sponsor|103|||
48714188|NCT01419197|156803179|FG001|Overall Study|Study Completed by Sponsor|34|||
48714189|NCT01419197|156803178|FG000|Overall Study|Reason Not Specified|0|||
48714190|NCT01419197|156803179|FG001|Overall Study|Reason Not Specified|1|||
48714191|NCT01419197|156803178|FG000|Overall Study|Lost to Follow-up|14|||
48714192|NCT01419197|156803179|FG001|Overall Study|Lost to Follow-up|4|||
48714193|NCT00653939|156803180|FG000|Overall Study|Adverse Event|1|||
48812785|NCT03292146|157155431|FG001|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|1|||
48812786|NCT03292146|157155430|FG000|12 Months to 24 Months|Planning pregnancy|2|||
48812787|NCT03292146|157155431|FG001|12 Months to 24 Months|Planning pregnancy|2|||
48812788|NCT03292146|157155430|FG000|12 Months to 24 Months|Personal reasons|1|||
48812789|NCT03292146|157155431|FG001|12 Months to 24 Months|Personal reasons|0|||
48812790|NCT03292146|157155430|FG000|12 Months to 24 Months|Lost to Follow-up|0|||
48812791|NCT03292146|157155431|FG001|12 Months to 24 Months|Lost to Follow-up|1|||
48812792|NCT01613027|157155436|FG000|Overall Study|Lost to Follow-up|5|||
48812793|NCT01613027|157155436|FG000|Overall Study|Switched Physician|1|||
48812794|NCT01613027|157155436|FG000|Overall Study|Lack of Efficacy|1|||
48812795|NCT01613027|157155436|FG000|Overall Study|Patient's Decision Due to Adverse Event|1|||
48812796|NCT00993317|157155437|FG000|Overall Study|Adverse Event|2|||
49124369|NCT00048035|158294755|FG003|Core Period|Early Withdrawals|1|||
49124370|NCT00048035|158294756|FG004|Core Period|Early Withdrawals|1|||
49124371|NCT00048035|158294757|FG005|Core Period|Early Withdrawals|1|||
49124372|NCT00048035|158294758|FG006|Core Period|Early Withdrawals|0|||
49124373|NCT00048035|158294759|FG007|Core Period|Early Withdrawals|0|||
49124374|NCT00048035|158294752|FG000|Extension Year 1|Early Withdrawals|0|||
49124375|NCT00048035|158294753|FG001|Extension Year 1|Early Withdrawals|0|||
49124376|NCT00048035|158294754|FG002|Extension Year 1|Early Withdrawals|0|||
49124377|NCT00048035|158294755|FG003|Extension Year 1|Early Withdrawals|0|||
49124378|NCT00048035|158294756|FG004|Extension Year 1|Early Withdrawals|0|||
49124379|NCT00048035|158294757|FG005|Extension Year 1|Early Withdrawals|0|||
49124380|NCT00048035|158294758|FG006|Extension Year 1|Early Withdrawals|11|||
49124381|NCT00048035|158294759|FG007|Extension Year 1|Early Withdrawals|11|||
49124382|NCT00048035|158294752|FG000|Extension Year 2|Early Withdrawals|0|||
49124383|NCT00048035|158294753|FG001|Extension Year 2|Early Withdrawals|0|||
49124384|NCT00048035|158294754|FG002|Extension Year 2|Early Withdrawals|0|||
49124385|NCT00048035|158294755|FG003|Extension Year 2|Early Withdrawals|0|||
49124386|NCT00048035|158294756|FG004|Extension Year 2|Early Withdrawals|0|||
48920294|NCT01425008|157541455|FG013|Dose Expansion Phase|Symptomatic Deterioration|0|||
48920295|NCT01425008|157541456|FG014|Dose Expansion Phase|Symptomatic Deterioration|0|||
48920296|NCT01425008|157541457|FG015|Dose Expansion Phase|Symptomatic Deterioration|1|||
48920297|NCT01425008|157541458|FG016|Dose Expansion Phase|Symptomatic Deterioration|2|||
48920298|NCT01425008|157541459|FG017|Dose Expansion Phase|Symptomatic Deterioration|0|||
48920299|NCT01425008|157541460|FG018|Dose Expansion Phase|Symptomatic Deterioration|1|||
48920300|NCT01425008|157541442|FG000|Dose Expansion Phase|Adverse Event|0|||
48920301|NCT01425008|157541443|FG001|Dose Expansion Phase|Adverse Event|0|||
48920302|NCT01425008|157541444|FG002|Dose Expansion Phase|Adverse Event|0|||
48920303|NCT01425008|157541445|FG003|Dose Expansion Phase|Adverse Event|0|||
49124387|NCT00048035|158294757|FG005|Extension Year 2|Early Withdrawals|0|||
49124388|NCT00048035|158294758|FG006|Extension Year 2|Early Withdrawals|3|||
49124389|NCT00048035|158294759|FG007|Extension Year 2|Early Withdrawals|3|||
49124390|NCT01587885|158294760|FG000|Treatment Period 1|Failure to Return|0|||
49124391|NCT01587885|158294761|FG001|Treatment Period 1|Failure to Return|1|||
49124392|NCT01587885|158294760|FG000|Treatment Period 1|Protocol Violation|0|||
49124393|NCT01587885|158294761|FG001|Treatment Period 1|Protocol Violation|2|||
49124394|NCT02619617|158294762|FG000|Period 2 SOM230 - 2nd Attack|Protocol Violation|0|||
49124395|NCT02619617|158294763|FG001|Period 2 SOM230 - 2nd Attack|Protocol Violation|1|||
49124396|NCT02619617|158294762|FG000|Period 2 SOM230 - 2nd Attack|Physician Decision|0|||
49124397|NCT02619617|158294763|FG001|Period 2 SOM230 - 2nd Attack|Physician Decision|3|||
49124398|NCT03200548|158294764|FG000|Overall Study|Withdrawal by Subject|5|||
49124399|NCT03200548|158294765|FG001|Overall Study|Withdrawal by Subject|11|||
49124400|NCT03200548|158294766|FG002|Overall Study|Withdrawal by Subject|7|||
49124401|NCT03200548|158294767|FG003|Overall Study|Withdrawal by Subject|6|||
49124402|NCT00447772|158294768|FG000|Overall Study|Lack of Efficacy|3|||
49124403|NCT00447772|158294768|FG000|Overall Study|Insufficient compliance|6|||
49124404|NCT00447772|158294768|FG000|Overall Study|Discontinuation of drug therapy|1|||
49124405|NCT00447772|158294768|FG000|Overall Study|Lost to Follow-up|9|||
49124406|NCT00447772|158294768|FG000|Overall Study|Withdrawal by Subject|1|||
49124407|NCT00447772|158294768|FG000|Overall Study|Unable to attend all study visits|2|||
49124408|NCT00447772|158294768|FG000|Overall Study|Adverse Event|1|||
48714194|NCT00653939|156803181|FG001|Overall Study|Adverse Event|3|||
48714195|NCT00653939|156803180|FG000|Overall Study|Withdrawal by Subject|3|||
48714196|NCT00653939|156803181|FG001|Overall Study|Withdrawal by Subject|3|||
48714197|NCT00653939|156803180|FG000|Overall Study|Physician Decision|4|||
48714198|NCT00653939|156803181|FG001|Overall Study|Physician Decision|0|||
48714199|NCT00653939|156803180|FG000|Overall Study|Disease Progression|2|||
48714200|NCT00653939|156803181|FG001|Overall Study|Disease Progression|3|||
48714201|NCT00653939|156803180|FG000|Overall Study|Other|2|||
48714202|NCT00653939|156803181|FG001|Overall Study|Other|6|||
48714203|NCT01396057|156803182|FG000|Overall Study|Adverse Event|2|||
48714204|NCT01396057|156803183|FG001|Overall Study|Adverse Event|6|||
48714205|NCT01396057|156803182|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
48714206|NCT01396057|156803183|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
48714207|NCT01396057|156803182|FG000|Overall Study|Protocol deviation|4|||
48714208|NCT01396057|156803183|FG001|Overall Study|Protocol deviation|4|||
48714209|NCT01396057|156803182|FG000|Overall Study|Consent withdrawn|3|||
48714210|NCT01396057|156803183|FG001|Overall Study|Consent withdrawn|2|||
48714211|NCT00636363|156803185|FG000|Overall Study|Conjunctivitis|0|||
48714212|NCT00636363|156803186|FG001|Overall Study|Conjunctivitis|0|||
48714213|NCT00636363|156803187|FG002|Overall Study|Conjunctivitis|1|||
48714214|NCT00636363|156803185|FG000|Overall Study|Adverse Event|0|||
48714215|NCT00636363|156803186|FG001|Overall Study|Adverse Event|0|||
48714216|NCT00636363|156803187|FG002|Overall Study|Adverse Event|1|||
48714217|NCT00636363|156803185|FG000|Overall Study|Positive slit lamp finding|0|||
48714218|NCT00636363|156803186|FG001|Overall Study|Positive slit lamp finding|2|||
48714219|NCT00636363|156803187|FG002|Overall Study|Positive slit lamp finding|1|||
48714220|NCT00636363|156803185|FG000|Overall Study|Study related symptoms/complaints|8|||
48714221|NCT00636363|156803186|FG001|Overall Study|Study related symptoms/complaints|7|||
48714222|NCT00636363|156803187|FG002|Overall Study|Study related symptoms/complaints|4|||
48920304|NCT01425008|157541446|FG004|Dose Expansion Phase|Adverse Event|0|||
49124409|NCT00447772|158294768|FG000|Overall Study|Patient relocated|1|||
49124410|NCT00447772|158294768|FG000|Overall Study|Incomplete documentation at visit 1|1|||
49124411|NCT00447772|158294768|FG000|Overall Study|Chemotherapy for lung cancer|1|||
48714223|NCT00636363|156803185|FG000|Overall Study|Met ineligibility criteria|0|||
48714224|NCT00636363|156803186|FG001|Overall Study|Met ineligibility criteria|0|||
48714225|NCT00636363|156803187|FG002|Overall Study|Met ineligibility criteria|3|||
49124412|NCT00447772|158294768|FG000|Overall Study|Premature re-injection required|1|||
49124413|NCT00716456|158294769|FG000|Overall Study|Adverse Event|0|||
49124414|NCT00716456|158294770|FG001|Overall Study|Adverse Event|2|||
49124415|NCT00716456|158294771|FG002|Overall Study|Adverse Event|0|||
49124416|NCT02457195|158294774|FG000|Overall Study|Adverse Event|3|||
49124417|NCT02457195|158294774|FG000|Overall Study|Protocol Violation|2|||
49124418|NCT02457195|158294774|FG000|Overall Study|Withdrawal by Subject|4|||
49124419|NCT01232790|158294778|FG000|Randomization|Withdrawal by Subject|2|||
49124420|NCT01232790|158294779|FG001|Randomization|Withdrawal by Subject|0|||
49124421|NCT01232790|158294778|FG000|Randomization|Protocol Violation|0|||
48812797|NCT00993317|157155438|FG001|Overall Study|Adverse Event|4|||
48812798|NCT00993317|157155437|FG000|Overall Study|Lack of Efficacy|18|||
49124422|NCT01232790|158294779|FG001|Randomization|Protocol Violation|1|||
49124423|NCT01232790|158294778|FG000|Randomization|Physician Decision|0|||
48812799|NCT00993317|157155438|FG001|Overall Study|Lack of Efficacy|18|||
48812800|NCT00993317|157155437|FG000|Overall Study|Withdrawal by Subject|0|||
48812801|NCT00993317|157155438|FG001|Overall Study|Withdrawal by Subject|2|||
48812802|NCT00993317|157155437|FG000|Overall Study|Investigator's opinion|0|||
48812803|NCT00993317|157155438|FG001|Overall Study|Investigator's opinion|1|||
48812804|NCT00993317|157155437|FG000|Overall Study|Early study termination at the site|1|||
49124424|NCT01232790|158294779|FG001|Randomization|Physician Decision|1|||
49124425|NCT01232790|158294778|FG000|Initial Assessment|Withdrawal by Subject|0|||
49124426|NCT01232790|158294779|FG001|Initial Assessment|Withdrawal by Subject|1|||
49124427|NCT01232790|158294778|FG000|First Crossover|Withdrawal by Subject|1|||
49124428|NCT01232790|158294779|FG001|First Crossover|Withdrawal by Subject|0|||
49124429|NCT01232790|158294778|FG000|Second Crossover|Withdrawal by Subject|1|||
49124430|NCT01232790|158294779|FG001|Second Crossover|Withdrawal by Subject|2|||
49124431|NCT03769649|158294780|FG000|Overall Study|Lost to Follow-up|4|||
49124432|NCT02427841|158294781|FG000|Overall Study|Lack of Efficacy|5|||
49124433|NCT02427841|158294781|FG000|Overall Study|Physician Decision|2|||
49124434|NCT02427841|158294781|FG000|Overall Study|Withdrawal by Subject|1|||
49124435|NCT02154139|158294785|FG000|Overall Study|Injection not administered|2|||
49124436|NCT02154139|158294785|FG000|Overall Study|Other|2|||
49124437|NCT02154139|158294785|FG000|Overall Study|Investigator transferred|3|||
49124438|NCT02127658|158294789|FG000|Overall Study|Screen Fail (Not MRSA on culture check)|2|||
49124439|NCT02127658|158294790|FG001|Overall Study|Screen Fail (Not MRSA on culture check)|0|||
49124440|NCT02127658|158294789|FG000|Overall Study|Withdrawal by Subject|0|||
49124441|NCT02127658|158294790|FG001|Overall Study|Withdrawal by Subject|2|||
49124442|NCT02127658|158294789|FG000|Overall Study|Physician Decision|0|||
49124443|NCT02127658|158294790|FG001|Overall Study|Physician Decision|1|||
49124444|NCT01909804|158294797|FG000|Overall Study|Randomized but Never Treated|0|||
49124445|NCT01909804|158294798|FG001|Overall Study|Randomized but Never Treated|0|||
49124446|NCT01909804|158294799|FG002|Overall Study|Randomized but Never Treated|0|||
49124447|NCT01909804|158294800|FG003|Overall Study|Randomized but Never Treated|0|||
49124448|NCT01909804|158294801|FG004|Overall Study|Randomized but Never Treated|0|||
49124449|NCT01909804|158294802|FG005|Overall Study|Randomized but Never Treated|0|||
49124450|NCT01909804|158294803|FG006|Overall Study|Randomized but Never Treated|1|||
48812805|NCT00993317|157155438|FG001|Overall Study|Early study termination at the site|0|||
48812806|NCT00672958|157155439|FG000|Overall Study|Adverse Event|11|||
48812807|NCT00672958|157155440|FG001|Overall Study|Adverse Event|9|||
48812808|NCT00672958|157155439|FG000|Overall Study|Lack of Efficacy|6|||
48812809|NCT00672958|157155440|FG001|Overall Study|Lack of Efficacy|11|||
48812810|NCT00672958|157155439|FG000|Overall Study|Non-compliance with study drug|2|||
48812811|NCT00672958|157155440|FG001|Overall Study|Non-compliance with study drug|3|||
48812812|NCT00672958|157155439|FG000|Overall Study|Protocol deviations|11|||
48812813|NCT00672958|157155440|FG001|Overall Study|Protocol deviations|5|||
48920305|NCT01425008|157541447|FG005|Dose Expansion Phase|Adverse Event|0|||
48920306|NCT01425008|157541448|FG006|Dose Expansion Phase|Adverse Event|0|||
48920307|NCT01425008|157541449|FG007|Dose Expansion Phase|Adverse Event|0|||
48920308|NCT01425008|157541450|FG008|Dose Expansion Phase|Adverse Event|0|||
48920309|NCT01425008|157541451|FG009|Dose Expansion Phase|Adverse Event|0|||
48920310|NCT01425008|157541452|FG010|Dose Expansion Phase|Adverse Event|2|||
48920311|NCT01425008|157541453|FG011|Dose Expansion Phase|Adverse Event|3|||
48920312|NCT01425008|157541454|FG012|Dose Expansion Phase|Adverse Event|3|||
48920313|NCT01425008|157541455|FG013|Dose Expansion Phase|Adverse Event|0|||
48920314|NCT01425008|157541456|FG014|Dose Expansion Phase|Adverse Event|1|||
49124451|NCT01909804|158294804|FG007|Overall Study|Randomized but Never Treated|0|||
49124452|NCT01909804|158294805|FG008|Overall Study|Randomized but Never Treated|0|||
49124453|NCT01909804|158294806|FG009|Overall Study|Randomized but Never Treated|0|||
48812814|NCT00672958|157155439|FG000|Overall Study|Voluntary withdrawal|12|||
48920315|NCT01425008|157541457|FG015|Dose Expansion Phase|Adverse Event|1|||
48920316|NCT01425008|157541458|FG016|Dose Expansion Phase|Adverse Event|5|||
48920317|NCT01425008|157541459|FG017|Dose Expansion Phase|Adverse Event|0|||
48920318|NCT01425008|157541460|FG018|Dose Expansion Phase|Adverse Event|3|||
49124454|NCT01909804|158294807|FG010|Overall Study|Randomized but Never Treated|0|||
49124455|NCT01909804|158294808|FG011|Overall Study|Randomized but Never Treated|1|||
49124456|NCT01909804|158294797|FG000|Overall Study|Death|0|||
49124457|NCT01909804|158294798|FG001|Overall Study|Death|0|||
49124458|NCT01909804|158294799|FG002|Overall Study|Death|0|||
49124459|NCT01909804|158294800|FG003|Overall Study|Death|0|||
49124460|NCT01909804|158294801|FG004|Overall Study|Death|0|||
49124461|NCT01909804|158294802|FG005|Overall Study|Death|0|||
49124462|NCT01909804|158294803|FG006|Overall Study|Death|0|||
49124463|NCT01909804|158294804|FG007|Overall Study|Death|0|||
49124464|NCT01909804|158294805|FG008|Overall Study|Death|0|||
49124465|NCT01909804|158294806|FG009|Overall Study|Death|0|||
49124466|NCT01909804|158294807|FG010|Overall Study|Death|1|||
49124467|NCT01909804|158294808|FG011|Overall Study|Death|0|||
49124468|NCT01909804|158294797|FG000|Overall Study|Lack of Efficacy|4|||
49124469|NCT01909804|158294798|FG001|Overall Study|Lack of Efficacy|1|||
49124470|NCT01909804|158294799|FG002|Overall Study|Lack of Efficacy|0|||
49124471|NCT01909804|158294800|FG003|Overall Study|Lack of Efficacy|0|||
49124472|NCT01909804|158294801|FG004|Overall Study|Lack of Efficacy|7|||
49124473|NCT01909804|158294802|FG005|Overall Study|Lack of Efficacy|3|||
49124474|NCT01909804|158294803|FG006|Overall Study|Lack of Efficacy|1|||
48714226|NCT00636363|156803185|FG000|Overall Study|Missed > 1 visit|0|||
48714227|NCT00636363|156803186|FG001|Overall Study|Missed > 1 visit|1|||
48714228|NCT00636363|156803187|FG002|Overall Study|Missed > 1 visit|3|||
48714229|NCT00636363|156803185|FG000|Overall Study|Lack of motivation|1|||
48714230|NCT00636363|156803186|FG001|Overall Study|Lack of motivation|0|||
48714231|NCT00636363|156803187|FG002|Overall Study|Lack of motivation|1|||
48714232|NCT00636363|156803185|FG000|Overall Study|Protocol Violation|0|||
48714233|NCT00636363|156803186|FG001|Overall Study|Protocol Violation|3|||
48714234|NCT00636363|156803187|FG002|Overall Study|Protocol Violation|0|||
48714235|NCT00636363|156803185|FG000|Overall Study|Lost to Follow-up|3|||
48714236|NCT00636363|156803186|FG001|Overall Study|Lost to Follow-up|4|||
48714237|NCT00636363|156803187|FG002|Overall Study|Lost to Follow-up|2|||
48714238|NCT00636363|156803185|FG000|Overall Study|Withdrawal by Subject|1|||
48714239|NCT00636363|156803186|FG001|Overall Study|Withdrawal by Subject|3|||
48714240|NCT00636363|156803187|FG002|Overall Study|Withdrawal by Subject|2|||
48714241|NCT00796991|156803191|FG000|Overall Study|Adverse Event|0|||
48714242|NCT00796991|156803192|FG001|Overall Study|Adverse Event|0|||
48714243|NCT00796991|156803193|FG002|Overall Study|Adverse Event|1|||
48714244|NCT00796991|156803191|FG000|Overall Study|Death|2|||
48714245|NCT00796991|156803192|FG001|Overall Study|Death|0|||
48714246|NCT00796991|156803193|FG002|Overall Study|Death|0|||
48714247|NCT00796991|156803191|FG000|Overall Study|Disease Progression|10|||
48714248|NCT00796991|156803192|FG001|Overall Study|Disease Progression|9|||
48714249|NCT00796991|156803193|FG002|Overall Study|Disease Progression|7|||
48714250|NCT00796991|156803191|FG000|Overall Study|Study Drug Toxicity|3|||
48714251|NCT00796991|156803192|FG001|Overall Study|Study Drug Toxicity|3|||
48714252|NCT00796991|156803193|FG002|Overall Study|Study Drug Toxicity|5|||
48714253|NCT00796991|156803191|FG000|Overall Study|Withdrawal by Subject|0|||
48714254|NCT00796991|156803192|FG001|Overall Study|Withdrawal by Subject|0|||
48714255|NCT00796991|156803193|FG002|Overall Study|Withdrawal by Subject|1|||
48714256|NCT00946985|156803194|FG000|Stabilization Phase (25 Weeks)|Adverse Event|4|||
48714257|NCT00946985|156803194|FG000|Stabilization Phase (25 Weeks)|Lack of Efficacy|3|||
48714258|NCT00946985|156803194|FG000|Stabilization Phase (25 Weeks)|Lost to Follow-up|5|||
48714259|NCT00946985|156803194|FG000|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4|||
48714260|NCT00946985|156803194|FG000|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139|||
48714261|NCT00946985|156803194|FG000|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2|||
48714262|NCT00946985|156803194|FG000|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1|||
48714263|NCT00946985|156803194|FG000|Stabilization Phase (25 Weeks)|Patient Moved Away|2|||
48714264|NCT00946985|156803194|FG000|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2|||
48714265|NCT00899392|156803195|FG000|Overall Study|Subject didn't finish/partial pilot data|21|||
48714266|NCT00899392|156803196|FG001|Overall Study|Subject didn't finish/partial pilot data|24|||
48714267|NCT03753789|156803197|FG000|Overall Study|Withdrawal by Subject|2|||
48714268|NCT00171834|156803198|FG000|Overall Study|Adverse Event|2|||
48714269|NCT00171834|156803199|FG001|Overall Study|Adverse Event|1|||
48714270|NCT00171834|156803200|FG002|Overall Study|Adverse Event|3|||
48714271|NCT00171834|156803201|FG003|Overall Study|Adverse Event|2|||
48920319|NCT01425008|157541442|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
48714272|NCT00171834|156803202|FG004|Overall Study|Adverse Event|2|||
48714273|NCT00171834|156803203|FG005|Overall Study|Adverse Event|15|||
48714274|NCT00171834|156803204|FG006|Overall Study|Adverse Event|1|||
48714275|NCT00171834|156803198|FG000|Overall Study|Withdrawal by Subject|0|||
49124475|NCT01909804|158294804|FG007|Overall Study|Lack of Efficacy|1|||
49124476|NCT01909804|158294805|FG008|Overall Study|Lack of Efficacy|0|||
49124477|NCT01909804|158294806|FG009|Overall Study|Lack of Efficacy|1|||
49124478|NCT01909804|158294807|FG010|Overall Study|Lack of Efficacy|0|||
49124479|NCT01909804|158294808|FG011|Overall Study|Lack of Efficacy|1|||
49124480|NCT01909804|158294797|FG000|Overall Study|Withdrew Consent|0|||
49124481|NCT01909804|158294798|FG001|Overall Study|Withdrew Consent|0|||
49124482|NCT01909804|158294799|FG002|Overall Study|Withdrew Consent|0|||
48812815|NCT00672958|157155440|FG001|Overall Study|Voluntary withdrawal|8|||
48920320|NCT01425008|157541443|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
48920321|NCT01425008|157541444|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
48920322|NCT01425008|157541445|FG003|Dose Expansion Phase|Lost to Follow-up|0|||
48920323|NCT01425008|157541446|FG004|Dose Expansion Phase|Lost to Follow-up|0|||
48920324|NCT01425008|157541447|FG005|Dose Expansion Phase|Lost to Follow-up|0|||
49124483|NCT01909804|158294800|FG003|Overall Study|Withdrew Consent|0|||
49124484|NCT01909804|158294801|FG004|Overall Study|Withdrew Consent|1|||
49124485|NCT01909804|158294802|FG005|Overall Study|Withdrew Consent|1|||
49124486|NCT01909804|158294803|FG006|Overall Study|Withdrew Consent|0|||
48714276|NCT00171834|156803199|FG001|Overall Study|Withdrawal by Subject|2|||
48714277|NCT00171834|156803200|FG002|Overall Study|Withdrawal by Subject|0|||
48920325|NCT01425008|157541448|FG006|Dose Expansion Phase|Lost to Follow-up|0|||
48920326|NCT01425008|157541449|FG007|Dose Expansion Phase|Lost to Follow-up|0|||
48920327|NCT01425008|157541450|FG008|Dose Expansion Phase|Lost to Follow-up|0|||
48920328|NCT01425008|157541451|FG009|Dose Expansion Phase|Lost to Follow-up|0|||
49124487|NCT01909804|158294804|FG007|Overall Study|Withdrew Consent|0|||
49124488|NCT01909804|158294805|FG008|Overall Study|Withdrew Consent|0|||
49124489|NCT01909804|158294806|FG009|Overall Study|Withdrew Consent|0|||
49124490|NCT01909804|158294807|FG010|Overall Study|Withdrew Consent|0|||
49124491|NCT01909804|158294808|FG011|Overall Study|Withdrew Consent|0|||
49124492|NCT01909804|158294797|FG000|Overall Study|Protocol Violation|0|||
49124493|NCT01909804|158294798|FG001|Overall Study|Protocol Violation|0|||
49124494|NCT01909804|158294799|FG002|Overall Study|Protocol Violation|0|||
49124495|NCT01909804|158294800|FG003|Overall Study|Protocol Violation|0|||
49124496|NCT01909804|158294801|FG004|Overall Study|Protocol Violation|0|||
49124497|NCT01909804|158294802|FG005|Overall Study|Protocol Violation|0|||
49124498|NCT01909804|158294803|FG006|Overall Study|Protocol Violation|0|||
49124499|NCT01909804|158294804|FG007|Overall Study|Protocol Violation|0|||
49124500|NCT01909804|158294805|FG008|Overall Study|Protocol Violation|0|||
49124501|NCT01909804|158294806|FG009|Overall Study|Protocol Violation|0|||
49124502|NCT01909804|158294807|FG010|Overall Study|Protocol Violation|0|||
49124503|NCT01909804|158294808|FG011|Overall Study|Protocol Violation|1|||
49124504|NCT03804268|158294811|FG000|Overall Study|Adverse Event|2|||
49124505|NCT03804268|158294812|FG001|Overall Study|Adverse Event|2|||
49124506|NCT03804268|158294811|FG000|Overall Study|Withdrawal by Subject|2|||
49124507|NCT03804268|158294812|FG001|Overall Study|Withdrawal by Subject|0|||
49124508|NCT03804268|158294811|FG000|Overall Study|Lost to Follow-up|1|||
48920329|NCT01425008|157541452|FG010|Dose Expansion Phase|Lost to Follow-up|0|||
48920330|NCT01425008|157541453|FG011|Dose Expansion Phase|Lost to Follow-up|0|||
48920331|NCT01425008|157541454|FG012|Dose Expansion Phase|Lost to Follow-up|0|||
48920332|NCT01425008|157541455|FG013|Dose Expansion Phase|Lost to Follow-up|0|||
48920333|NCT01425008|157541456|FG014|Dose Expansion Phase|Lost to Follow-up|0|||
48920334|NCT01425008|157541457|FG015|Dose Expansion Phase|Lost to Follow-up|0|||
48920335|NCT01425008|157541458|FG016|Dose Expansion Phase|Lost to Follow-up|1|||
48920336|NCT01425008|157541459|FG017|Dose Expansion Phase|Lost to Follow-up|0|||
48920337|NCT01425008|157541460|FG018|Dose Expansion Phase|Lost to Follow-up|0|||
48920338|NCT01425008|157541442|FG000|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
48920339|NCT01425008|157541443|FG001|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
48920340|NCT01425008|157541444|FG002|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
48920341|NCT01425008|157541445|FG003|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
48920342|NCT01425008|157541446|FG004|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
48920343|NCT01425008|157541447|FG005|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
49124509|NCT03804268|158294812|FG001|Overall Study|Lost to Follow-up|0|||
49124510|NCT03804268|158294811|FG000|Overall Study|Physician Decision|2|||
49124511|NCT03804268|158294812|FG001|Overall Study|Physician Decision|0|||
49124512|NCT00128661|158294815|FG000|Overall Study|Adverse Event|14|||
49124513|NCT00128661|158294816|FG001|Overall Study|Adverse Event|11|||
49124514|NCT00128661|158294815|FG000|Overall Study|Lost to Follow-up|10|||
49124515|NCT00128661|158294816|FG001|Overall Study|Lost to Follow-up|7|||
49124516|NCT00128661|158294815|FG000|Overall Study|Withdrawal by Subject|243|||
48714278|NCT00171834|156803201|FG003|Overall Study|Withdrawal by Subject|1|||
48714279|NCT00171834|156803202|FG004|Overall Study|Withdrawal by Subject|1|||
48714280|NCT00171834|156803203|FG005|Overall Study|Withdrawal by Subject|1|||
48714281|NCT00171834|156803204|FG006|Overall Study|Withdrawal by Subject|0|||
48714282|NCT00171834|156803198|FG000|Overall Study|Death from study indication|0|||
48812816|NCT00672958|157155439|FG000|Overall Study|Lost to Follow-up|22|||
48812817|NCT00672958|157155440|FG001|Overall Study|Lost to Follow-up|17|||
48920344|NCT01425008|157541448|FG006|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
48920345|NCT01425008|157541449|FG007|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
49124517|NCT00128661|158294816|FG001|Overall Study|Withdrawal by Subject|232|||
49124518|NCT00128661|158294815|FG000|Overall Study|Other|7|||
49124519|NCT00128661|158294816|FG001|Overall Study|Other|8|||
49124520|NCT02616783|158294817|FG000|Overall Study|Randomized but Not Treated|1|||
48714283|NCT00171834|156803199|FG001|Overall Study|Death from study indication|1|||
49124521|NCT02616783|158294818|FG001|Overall Study|Randomized but Not Treated|0|||
49124522|NCT02616783|158294817|FG000|Overall Study|Adverse Event|1|||
49124523|NCT02616783|158294818|FG001|Overall Study|Adverse Event|0|||
49124524|NCT02616783|158294817|FG000|Overall Study|Death|1|||
49124525|NCT02616783|158294818|FG001|Overall Study|Death|0|||
49124526|NCT02616783|158294817|FG000|Overall Study|Non-Compliance with Study Drug|1|||
49124527|NCT02616783|158294818|FG001|Overall Study|Non-Compliance with Study Drug|0|||
49124528|NCT02616783|158294817|FG000|Overall Study|Protocol Violation|1|||
49124529|NCT02616783|158294818|FG001|Overall Study|Protocol Violation|1|||
48714284|NCT00171834|156803200|FG002|Overall Study|Death from study indication|0|||
48714285|NCT00171834|156803201|FG003|Overall Study|Death from study indication|0|||
48714286|NCT00171834|156803202|FG004|Overall Study|Death from study indication|1|||
48714287|NCT00171834|156803203|FG005|Overall Study|Death from study indication|0|||
48714288|NCT00171834|156803204|FG006|Overall Study|Death from study indication|0|||
48714289|NCT00171834|156803198|FG000|Overall Study|Disease Progression|4|||
48714290|NCT00171834|156803199|FG001|Overall Study|Disease Progression|8|||
48714291|NCT00171834|156803200|FG002|Overall Study|Disease Progression|8|||
48920346|NCT01425008|157541450|FG008|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
48920347|NCT01425008|157541451|FG009|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
48920348|NCT01425008|157541452|FG010|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
48920349|NCT01425008|157541453|FG011|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
48920350|NCT01425008|157541454|FG012|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
48920351|NCT01425008|157541455|FG013|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
48920352|NCT01425008|157541456|FG014|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
48920353|NCT01425008|157541457|FG015|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
48920354|NCT01425008|157541458|FG016|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
48920355|NCT01425008|157541459|FG017|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
48920356|NCT01425008|157541460|FG018|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1|||
48920357|NCT02595450|157541461|FG000|Overall Study|Unspecified (only completed 1 cycle)|73|||
48920358|NCT02595450|157541461|FG000|Overall Study|Enrolled, but not treated|8|||
48920359|NCT00176605|157543071|FG000|Overall Study|Withdrawal by Subject|2|||
48920360|NCT01321710|157543072|FG000|Overall Study|Lost to Follow-up|4|||
48920361|NCT01321710|157543073|FG001|Overall Study|Lost to Follow-up|5|||
48920362|NCT01321710|157543074|FG002|Overall Study|Lost to Follow-up|0|||
48920363|NCT01761292|157543075|FG000|Part 1|Adverse Event|1|||
48920364|NCT01761292|157543075|FG000|Part 1|not receiving treatment in Part 1|1|||
48920365|NCT01761292|157543075|FG000|Extension 1|Withdrawal by Subject|1|||
48920366|NCT01566773|157543076|FG000|Overall Study|Protocol specified criteria|4|||
48920367|NCT01566773|157543076|FG000|Overall Study|Protocol Violation|4|||
48920368|NCT01566773|157543076|FG000|Overall Study|Withdrawal by Subject|9|||
48920369|NCT01566773|157543076|FG000|Overall Study|Administrative reason|1|||
48920370|NCT01566773|157543076|FG000|Overall Study|Adverse Event|10|||
48920371|NCT01566773|157543076|FG000|Overall Study|Physician Decision|2|||
48920372|NCT01097746|157543077|FG000|Overall Study|Adverse Event|4|||
48920373|NCT01097746|157543077|FG000|Overall Study|taken off study before any treatment given|1|||
48920374|NCT02236520|157543078|FG000|Overall Study|Physician Decision|0|||
48920375|NCT02236520|157543079|FG001|Overall Study|Physician Decision|5|||
48920376|NCT02236520|157543080|FG002|Overall Study|Physician Decision|0|||
48920377|NCT02236520|157543081|FG003|Overall Study|Physician Decision|0|||
48920378|NCT02236520|157543078|FG000|Overall Study|Withdrawal by Subject|1|||
48920379|NCT02236520|157543079|FG001|Overall Study|Withdrawal by Subject|0|||
48920380|NCT02236520|157543080|FG002|Overall Study|Withdrawal by Subject|0|||
48920381|NCT02236520|157543081|FG003|Overall Study|Withdrawal by Subject|1|||
48920382|NCT02236520|157543078|FG000|Overall Study|Pregnancy|1|||
48920383|NCT02236520|157543079|FG001|Overall Study|Pregnancy|0|||
48920384|NCT02236520|157543080|FG002|Overall Study|Pregnancy|0|||
48920385|NCT02236520|157543081|FG003|Overall Study|Pregnancy|0|||
48920386|NCT00390546|157543082|FG000|Overall Study|Renal impairment|1|||
48920387|NCT00390546|157543083|FG001|Overall Study|Renal impairment|0|||
48920388|NCT00390546|157543082|FG000|Overall Study|Physician Decision|5|||
49124530|NCT02616783|158294817|FG000|Overall Study|Withdrew Consent|1|||
48714292|NCT00171834|156803201|FG003|Overall Study|Disease Progression|9|||
48714293|NCT00171834|156803202|FG004|Overall Study|Disease Progression|2|||
48920389|NCT00390546|157543083|FG001|Overall Study|Physician Decision|5|||
48920390|NCT02081534|157543084|FG000|Overall Study|Adverse Event|5|||
48920391|NCT02081534|157543085|FG001|Overall Study|Adverse Event|4|||
48920392|NCT02081534|157543086|FG002|Overall Study|Adverse Event|3|||
48920393|NCT02081534|157543087|FG003|Overall Study|Adverse Event|10|||
48920394|NCT02081534|157543088|FG004|Overall Study|Adverse Event|2|||
48920395|NCT02081534|157543089|FG005|Overall Study|Adverse Event|8|||
48920396|NCT02081534|157543090|FG006|Overall Study|Adverse Event|2|||
48920397|NCT02081534|157543084|FG000|Overall Study|Withdrawal by Subject|0|||
48920398|NCT02081534|157543085|FG001|Overall Study|Withdrawal by Subject|1|||
49124531|NCT02616783|158294818|FG001|Overall Study|Withdrew Consent|1|||
48714294|NCT00171834|156803203|FG005|Overall Study|Disease Progression|18|||
48714295|NCT00171834|156803204|FG006|Overall Study|Disease Progression|3|||
48714296|NCT00171834|156803198|FG000|Overall Study|Treatment Duration Completed|0|||
48714297|NCT00171834|156803199|FG001|Overall Study|Treatment Duration Completed|0|||
48714298|NCT00171834|156803200|FG002|Overall Study|Treatment Duration Completed|1|||
49124532|NCT03327324|158294820|FG000|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
49124533|NCT03327324|158294821|FG001|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
49124534|NCT03327324|158294822|FG002|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
49124535|NCT03327324|158294823|FG003|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
48714299|NCT00171834|156803201|FG003|Overall Study|Treatment Duration Completed|0|||
48714300|NCT00171834|156803202|FG004|Overall Study|Treatment Duration Completed|2|||
48714301|NCT00171834|156803203|FG005|Overall Study|Treatment Duration Completed|1|||
49124536|NCT03327324|158294824|FG004|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
49124537|NCT03327324|158294825|FG005|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|5|||
49124538|NCT03327324|158294820|FG000|Baseline (Month 0-Month 3)|Refused|0|||
49124539|NCT03327324|158294821|FG001|Baseline (Month 0-Month 3)|Refused|0|||
49124540|NCT03327324|158294822|FG002|Baseline (Month 0-Month 3)|Refused|0|||
49124541|NCT03327324|158294823|FG003|Baseline (Month 0-Month 3)|Refused|0|||
49124542|NCT03327324|158294824|FG004|Baseline (Month 0-Month 3)|Refused|1|||
49124543|NCT03327324|158294825|FG005|Baseline (Month 0-Month 3)|Refused|0|||
49124544|NCT03327324|158294820|FG000|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
49124545|NCT03327324|158294821|FG001|Baseline (Month 0-Month 3)|Withdrawal by Subject|2|||
49124546|NCT03327324|158294822|FG002|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
49124547|NCT03327324|158294823|FG003|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
49124548|NCT03327324|158294824|FG004|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
49124549|NCT03327324|158294825|FG005|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
49124550|NCT03327324|158294820|FG000|Baseline (Month 0-Month 3)|Death|0|||
49124551|NCT03327324|158294821|FG001|Baseline (Month 0-Month 3)|Death|0|||
49124552|NCT03327324|158294822|FG002|Baseline (Month 0-Month 3)|Death|0|||
49124553|NCT03327324|158294823|FG003|Baseline (Month 0-Month 3)|Death|0|||
49124554|NCT03327324|158294824|FG004|Baseline (Month 0-Month 3)|Death|1|||
49124555|NCT03327324|158294825|FG005|Baseline (Month 0-Month 3)|Death|0|||
49124556|NCT03327324|158294820|FG000|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
49124557|NCT03327324|158294821|FG001|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
49124558|NCT03327324|158294822|FG002|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
49124559|NCT03327324|158294823|FG003|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
49124560|NCT03327324|158294824|FG004|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
49124561|NCT03327324|158294825|FG005|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|1|||
49124562|NCT03327324|158294820|FG000|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
49124563|NCT03327324|158294821|FG001|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
49124564|NCT03327324|158294822|FG002|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|1|||
49124565|NCT03327324|158294823|FG003|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
49124566|NCT03327324|158294824|FG004|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
49124567|NCT03327324|158294825|FG005|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
49124568|NCT03327324|158294820|FG000|Intervention (Month 3-Month 6)|Withdrawal by Subject|2|||
49124569|NCT03327324|158294821|FG001|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
49124570|NCT03327324|158294822|FG002|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
49124571|NCT03327324|158294823|FG003|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
49124572|NCT03327324|158294824|FG004|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
49124573|NCT03327324|158294825|FG005|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
49124574|NCT03327324|158294820|FG000|Intervention (Month 3-Month 6)|Left Nursing Home Facility|2|||
49124575|NCT03327324|158294821|FG001|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
49124576|NCT03327324|158294822|FG002|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
49124577|NCT03327324|158294823|FG003|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
49124578|NCT03327324|158294824|FG004|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
49124579|NCT03327324|158294825|FG005|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
49124580|NCT03327324|158294820|FG000|Intervention (Month 3-Month 6)|Death|1|||
49124581|NCT03327324|158294821|FG001|Intervention (Month 3-Month 6)|Death|0|||
49124582|NCT03327324|158294822|FG002|Intervention (Month 3-Month 6)|Death|1|||
48714302|NCT00171834|156803204|FG006|Overall Study|Treatment Duration Completed|0|||
48714303|NCT02873429|156803207|FG000|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10|||
48714304|NCT02873429|156803208|FG001|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1|||
49124583|NCT03327324|158294823|FG003|Intervention (Month 3-Month 6)|Death|1|||
49124584|NCT03327324|158294824|FG004|Intervention (Month 3-Month 6)|Death|1|||
49124585|NCT03327324|158294825|FG005|Intervention (Month 3-Month 6)|Death|0|||
49124586|NCT03327324|158294820|FG000|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
49124587|NCT03327324|158294821|FG001|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
49124588|NCT03327324|158294822|FG002|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
49124589|NCT03327324|158294823|FG003|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
49124590|NCT03327324|158294824|FG004|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
49124591|NCT03327324|158294825|FG005|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|14|||
49124592|NCT03327324|158294820|FG000|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|1|||
49124593|NCT03327324|158294821|FG001|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
49124594|NCT03327324|158294822|FG002|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
49124595|NCT03327324|158294823|FG003|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
49124596|NCT03327324|158294824|FG004|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
49124597|NCT03327324|158294825|FG005|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
49124598|NCT03327324|158294820|FG000|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|2|||
49124599|NCT03327324|158294821|FG001|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|1|||
49124600|NCT03327324|158294822|FG002|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
49124601|NCT03327324|158294823|FG003|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
49124602|NCT03327324|158294824|FG004|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
49124603|NCT03327324|158294825|FG005|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
49124604|NCT03327324|158294820|FG000|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
49124605|NCT03327324|158294821|FG001|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
49124606|NCT03327324|158294822|FG002|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
49124607|NCT03327324|158294823|FG003|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
49124608|NCT03327324|158294824|FG004|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
49124609|NCT03327324|158294825|FG005|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
48714305|NCT02873429|156803207|FG000|16 Weeks|Completed 6-8 week, missed 16 week|2|||
48714306|NCT02873429|156803208|FG001|16 Weeks|Completed 6-8 week, missed 16 week|2|||
48714307|NCT02873429|156803207|FG000|16 Weeks|Lost to Follow-up|3|||
48714308|NCT02873429|156803208|FG001|16 Weeks|Lost to Follow-up|0|||
48714309|NCT00612807|156803209|FG000|Overall Study|Withdrawal by Subject|2|||
48714310|NCT00612807|156803210|FG001|Overall Study|Withdrawal by Subject|0|||
48714311|NCT00145977|156803211|FG000|Overall Study|Lack of Efficacy|0|||
48714312|NCT00145977|156803212|FG001|Overall Study|Lack of Efficacy|4|||
48714313|NCT00145977|156803211|FG000|Overall Study|Lost to Follow-up|1|||
48714314|NCT00145977|156803212|FG001|Overall Study|Lost to Follow-up|0|||
48714315|NCT00145977|156803211|FG000|Overall Study|Withdrawal by Subject|1|||
48714316|NCT00145977|156803212|FG001|Overall Study|Withdrawal by Subject|0|||
48714317|NCT01057589|156803215|FG000|Overall Study|Disease Progression|35|||
48714318|NCT01057589|156803215|FG000|Overall Study|Adverse Event|10|||
48714319|NCT01057589|156803215|FG000|Overall Study|Physician Decision|8|||
48714320|NCT01057589|156803215|FG000|Overall Study|Withdrawal by Subject|3|||
48714321|NCT01057589|156803215|FG000|Overall Study|Sponsor Decision|1|||
48714322|NCT01057589|156803215|FG000|Overall Study|Death|8|||
48714323|NCT01057589|156803215|FG000|Overall Study|Lost to Follow-up|1|||
48812818|NCT00672958|157155439|FG000|Overall Study|Reason not specified|0|||
48812819|NCT00672958|157155440|FG001|Overall Study|Reason not specified|3|||
48812820|NCT04422639|157155443|FG000|Overall Study|Death|1|||
48714324|NCT00243841|156803216|FG000|Overall Study|Physician Decision|0|||
48714325|NCT00243841|156803217|FG001|Overall Study|Physician Decision|0|||
48714326|NCT00243841|156803218|FG002|Overall Study|Physician Decision|1|||
48714327|NCT00243841|156803219|FG003|Overall Study|Physician Decision|0|||
48714328|NCT00243841|156803220|FG004|Overall Study|Physician Decision|0|||
48714329|NCT00243841|156803221|FG005|Overall Study|Physician Decision|2|||
48714330|NCT01981551|156803222|FG000|Overall Study|Refused further treatment|8|||
48714331|NCT01981551|156803222|FG000|Overall Study|Adverse Event|1|||
48714332|NCT01217307|156804815|FG000|Overall Study|Withdrawal by Subject|0|||
48714333|NCT01217307|156804816|FG001|Overall Study|Withdrawal by Subject|1|||
48714334|NCT01868542|156804817|FG000|Overall Study|Protocol Violation|0|||
48714335|NCT01868542|156804818|FG001|Overall Study|Protocol Violation|1|||
48714336|NCT01868542|156804817|FG000|Overall Study|Unclassified|0|||
48714337|NCT01868542|156804818|FG001|Overall Study|Unclassified|1|||
48714338|NCT02923921|156804821|FG000|Overall Study|Sponsor Decision|39|||
48714339|NCT02923921|156804822|FG001|Overall Study|Sponsor Decision|38|||
48714340|NCT02923921|156804821|FG000|Overall Study|Lost to Follow-up|1|||
48714341|NCT02923921|156804822|FG001|Overall Study|Lost to Follow-up|0|||
48714342|NCT02923921|156804821|FG000|Overall Study|Withdrawal by Subject|6|||
48714343|NCT02923921|156804822|FG001|Overall Study|Withdrawal by Subject|13|||
48714344|NCT02923921|156804821|FG000|Overall Study|Unknown, Not Collected|7|||
48714345|NCT02923921|156804822|FG001|Overall Study|Unknown, Not Collected|6|||
48714346|NCT03805659|156804823|FG000|Overall Study|Withdrawal by Subject|0|||
48714347|NCT03805659|156804824|FG001|Overall Study|Withdrawal by Subject|1|||
48714348|NCT01761162|156804825|FG000|Overall Study|Withdrawal by Subject|3|||
48714349|NCT02687191|156804826|FG000|Overall Study|Death|0|||
48714350|NCT02687191|156804827|FG001|Overall Study|Death|1|||
48714351|NCT02687191|156804828|FG002|Overall Study|Death|1|||
48714352|NCT02687191|156804829|FG003|Overall Study|Death|0|||
48714353|NCT02687191|156804830|FG004|Overall Study|Death|1|||
48714354|NCT02687191|156804831|FG005|Overall Study|Death|1|||
48714355|NCT02687191|156804826|FG000|Overall Study|Withdrawal by Subject|0|||
48714356|NCT02687191|156804827|FG001|Overall Study|Withdrawal by Subject|0|||
48714357|NCT02687191|156804828|FG002|Overall Study|Withdrawal by Subject|0|||
48714358|NCT02687191|156804829|FG003|Overall Study|Withdrawal by Subject|1|||
48714359|NCT02687191|156804830|FG004|Overall Study|Withdrawal by Subject|0|||
48714360|NCT02687191|156804831|FG005|Overall Study|Withdrawal by Subject|0|||
48714361|NCT00545272|156804838|FG000|Overall Study|Protocol deviation|0|||
48714362|NCT00545272|156804839|FG001|Overall Study|Protocol deviation|1|||
48714363|NCT00545272|156804840|FG002|Overall Study|Protocol deviation|0|||
48714364|NCT00545272|156804841|FG003|Overall Study|Protocol deviation|1|||
48714365|NCT00545272|156804842|FG004|Overall Study|Protocol deviation|0|||
48714366|NCT00545272|156804843|FG005|Overall Study|Protocol deviation|1|||
48714367|NCT00545272|156804838|FG000|Overall Study|Adverse Event|0|||
48714368|NCT00545272|156804839|FG001|Overall Study|Adverse Event|0|||
48714369|NCT00545272|156804840|FG002|Overall Study|Adverse Event|1|||
48714370|NCT00545272|156804841|FG003|Overall Study|Adverse Event|0|||
48714371|NCT00545272|156804842|FG004|Overall Study|Adverse Event|0|||
48714372|NCT00545272|156804843|FG005|Overall Study|Adverse Event|1|||
48714373|NCT00545272|156804838|FG000|Overall Study|Abnormal laboratory value(s)|0|||
48714374|NCT00545272|156804839|FG001|Overall Study|Abnormal laboratory value(s)|0|||
48714375|NCT00545272|156804840|FG002|Overall Study|Abnormal laboratory value(s)|0|||
48714376|NCT00545272|156804841|FG003|Overall Study|Abnormal laboratory value(s)|0|||
48714377|NCT00545272|156804842|FG004|Overall Study|Abnormal laboratory value(s)|0|||
48714378|NCT00545272|156804843|FG005|Overall Study|Abnormal laboratory value(s)|1|||
48714379|NCT00545272|156804838|FG000|Overall Study|Abnormal test procedure result(s)|0|||
48714380|NCT00545272|156804839|FG001|Overall Study|Abnormal test procedure result(s)|0|||
48714381|NCT00545272|156804840|FG002|Overall Study|Abnormal test procedure result(s)|0|||
48714382|NCT00545272|156804841|FG003|Overall Study|Abnormal test procedure result(s)|0|||
48714383|NCT00545272|156804842|FG004|Overall Study|Abnormal test procedure result(s)|1|||
48714384|NCT00545272|156804843|FG005|Overall Study|Abnormal test procedure result(s)|0|||
48714385|NCT00545272|156804838|FG000|Overall Study|Lost to Follow-up|0|||
48714386|NCT00545272|156804839|FG001|Overall Study|Lost to Follow-up|0|||
48714387|NCT00545272|156804840|FG002|Overall Study|Lost to Follow-up|0|||
48714388|NCT00545272|156804841|FG003|Overall Study|Lost to Follow-up|0|||
48714389|NCT00545272|156804842|FG004|Overall Study|Lost to Follow-up|1|||
48714390|NCT00545272|156804843|FG005|Overall Study|Lost to Follow-up|0|||
48714391|NCT00724867|156804846|FG000|Overall Study|Adverse Event|25|||
48714392|NCT00724867|156804846|FG000|Overall Study|Lack of Efficacy|14|||
48714393|NCT00724867|156804846|FG000|Overall Study|Lost to Follow-up|12|||
48714394|NCT00724867|156804846|FG000|Overall Study|Non-compliance with study drug|6|||
48714395|NCT00724867|156804846|FG000|Overall Study|Physician Decision|17|||
48714396|NCT00724867|156804846|FG000|Overall Study|Protocol Violation|1|||
48714397|NCT00724867|156804846|FG000|Overall Study|Withdrawal by Subject|31|||
48714398|NCT00724867|156804846|FG000|Overall Study|Sponsor decision to end study|14|||
48714399|NCT00724867|156804846|FG000|Overall Study|Subject incarcerated|1|||
48714400|NCT00724867|156804846|FG000|Overall Study|Developed withdrawal criteria- pregnancy|4|||
48920399|NCT02081534|157543086|FG002|Overall Study|Withdrawal by Subject|1|||
48920400|NCT02081534|157543087|FG003|Overall Study|Withdrawal by Subject|1|||
48920401|NCT02081534|157543088|FG004|Overall Study|Withdrawal by Subject|1|||
48920402|NCT02081534|157543089|FG005|Overall Study|Withdrawal by Subject|0|||
48920403|NCT02081534|157543090|FG006|Overall Study|Withdrawal by Subject|1|||
48920404|NCT02081534|157543084|FG000|Overall Study|Protocol Violation|0|||
48920405|NCT02081534|157543085|FG001|Overall Study|Protocol Violation|3|||
48920406|NCT02081534|157543086|FG002|Overall Study|Protocol Violation|0|||
48920407|NCT02081534|157543087|FG003|Overall Study|Protocol Violation|0|||
48920408|NCT02081534|157543088|FG004|Overall Study|Protocol Violation|0|||
48920409|NCT02081534|157543089|FG005|Overall Study|Protocol Violation|0|||
48920410|NCT02081534|157543090|FG006|Overall Study|Protocol Violation|1|||
48920411|NCT02081534|157543084|FG000|Overall Study|Lost to Follow-up|0|||
48920412|NCT02081534|157543085|FG001|Overall Study|Lost to Follow-up|0|||
48920413|NCT02081534|157543086|FG002|Overall Study|Lost to Follow-up|0|||
48920414|NCT02081534|157543087|FG003|Overall Study|Lost to Follow-up|2|||
48920415|NCT02081534|157543088|FG004|Overall Study|Lost to Follow-up|1|||
48920416|NCT02081534|157543089|FG005|Overall Study|Lost to Follow-up|1|||
48920417|NCT02081534|157543090|FG006|Overall Study|Lost to Follow-up|0|||
48920418|NCT01308008|157543091|FG000|4 Weeks|Illness, disinterest, time|9|||
48920419|NCT01308008|157543092|FG001|4 Weeks|Illness, disinterest, time|2|||
48920420|NCT03577730|157543096|FG000|Overall Study|Physician Decision|3|||
48920421|NCT03577730|157543097|FG001|Overall Study|Physician Decision|1|||
48920422|NCT03577730|157543096|FG000|Overall Study|Did not receive allocated intervention|1|||
48920423|NCT03577730|157543097|FG001|Overall Study|Did not receive allocated intervention|0|||
48920424|NCT03709654|157543098|FG000|Overall Study|Lost to Follow-up|1|||
48920425|NCT03709654|157543099|FG001|Overall Study|Lost to Follow-up|1|||
49010976|NCT01785875|157877353|FG002|Overall Study|Missing|3|||
49010977|NCT00775983|157877359|FG000|Overall Study|Protocol Violation|1|||
49010978|NCT00775983|157877360|FG001|Overall Study|Protocol Violation|2|||
48714401|NCT00724867|156804846|FG000|Overall Study|Subject moved out of state|1|||
48714402|NCT00724867|156804846|FG000|Overall Study|Elected to exit due to site closure|2|||
48714403|NCT02864862|156804854|FG000|Overall Study|Lost to Follow-up|1|||
48714404|NCT02864862|156804855|FG001|Overall Study|Lost to Follow-up|0|||
48714405|NCT02864862|156804856|FG002|Overall Study|Lost to Follow-up|1|||
48714406|NCT02864862|156804854|FG000|Overall Study|Protocol Violation|0|||
48714407|NCT02864862|156804855|FG001|Overall Study|Protocol Violation|0|||
48714408|NCT02864862|156804856|FG002|Overall Study|Protocol Violation|1|||
48714409|NCT00615901|156804857|FG000|Overall Study|Withdrawal by Subject|2|||
48714410|NCT00615901|156804857|FG000|Overall Study|Adverse Event|7|||
48714411|NCT01523275|156804858|FG000|Overall Study|Lost to Follow-up|1|||
48714412|NCT01523275|156804859|FG001|Overall Study|Lost to Follow-up|2|||
48714413|NCT01523275|156804858|FG000|Overall Study|Withdrawal by Subject|1|||
48714414|NCT01523275|156804859|FG001|Overall Study|Withdrawal by Subject|0|||
48714415|NCT03263702|156804860|FG000|Overall Study|Lost to Follow-up|2|||
48714416|NCT03263702|156804861|FG001|Overall Study|Lost to Follow-up|2|||
48714417|NCT03263702|156804860|FG000|Overall Study|Withdrawal by Subject|1|||
48714418|NCT03263702|156804861|FG001|Overall Study|Withdrawal by Subject|2|||
48714419|NCT01250496|156804865|FG000|Overall Study|Study terminated|124|||
48714420|NCT01250496|156804866|FG001|Overall Study|Study terminated|124|||
48714421|NCT01589653|156804869|FG000|Overall Study|Protocol Violation|3|||
48714422|NCT01589653|156804870|FG001|Overall Study|Protocol Violation|1|||
48714423|NCT01589653|156804869|FG000|Overall Study|Withdrawal criteria|4|||
48714424|NCT01589653|156804870|FG001|Overall Study|Withdrawal criteria|7|||
48714425|NCT01589653|156804869|FG000|Overall Study|Unclassified|0|||
48714426|NCT01589653|156804870|FG001|Overall Study|Unclassified|3|||
48714427|NCT01536067|156804871|FG000|Overall Study|Disease Progression|1|||
48714428|NCT00668733|156804872|FG000|Overall Study|Lost to Follow-up|2|||
48714429|NCT00668733|156804873|FG001|Overall Study|Lost to Follow-up|3|||
48714430|NCT00668733|156804872|FG000|Overall Study|Withdrawal by Subject|0|||
48714431|NCT00668733|156804873|FG001|Overall Study|Withdrawal by Subject|4|||
48714432|NCT00905645|156804874|FG000|Overall Study|Death (not device related)|10|||
48714433|NCT00905645|156804875|FG001|Overall Study|Death (not device related)|4|||
48714434|NCT00905645|156804876|FG002|Overall Study|Death (not device related)|15|||
48714435|NCT00905645|156804877|FG003|Overall Study|Death (not device related)|8|||
48714436|NCT00905645|156804874|FG000|Overall Study|Explantation of study device(s)|78|||
48714437|NCT00905645|156804875|FG001|Overall Study|Explantation of study device(s)|47|||
48812821|NCT04422639|157155444|FG001|Overall Study|Death|0|||
48920426|NCT03709654|157543098|FG000|Overall Study|Withdrawal by Subject|1|||
49010979|NCT01663714|157877361|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
49010980|NCT01663714|157877361|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|11|||
49010981|NCT01663714|157877361|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16|||
48920427|NCT03709654|157543099|FG001|Overall Study|Withdrawal by Subject|1|||
48920428|NCT03709654|157543098|FG000|Overall Study|Adverse Event|1|||
48920429|NCT03709654|157543099|FG001|Overall Study|Adverse Event|0|||
48920430|NCT01230242|157543100|FG000|Overall Study|Physician Decision|2|||
48920431|NCT01230242|157543100|FG000|Overall Study|Withdrawal by Subject|1|||
48920432|NCT01486927|157543103|FG000|Overall Study|Knee surgery (prior to surgery substudy)|1|||
48920433|NCT01486927|157543103|FG000|Overall Study|Physician Decision|1|||
48920434|NCT01486927|157543103|FG000|Overall Study|50 Exposure days not reached|2|||
48920435|NCT01486927|157543103|FG000|Overall Study|Withdrawal by Subject|8|||
48920436|NCT01486927|157543103|FG000|Overall Study|Subject did not reach 6 mo of treatment|1|||
48920437|NCT00766532|157543107|FG000|Overall Study|Protocol Violation|2|||
48920438|NCT02636582|157543108|FG000|Overall Study|Surgical Pathology|1|||
48920439|NCT02636582|157543109|FG001|Overall Study|Surgical Pathology|0|||
48920440|NCT00714285|157543112|FG000|Overall Study|Lost to Follow-up|0|||
48920441|NCT00714285|157543113|FG001|Overall Study|Lost to Follow-up|2|||
48920442|NCT00714285|157543114|FG002|Overall Study|Lost to Follow-up|0|||
48920443|NCT00714285|157543115|FG003|Overall Study|Lost to Follow-up|1|||
48920444|NCT00714285|157543112|FG000|Overall Study|Migrated/moved from study area|0|||
48920445|NCT00714285|157543113|FG001|Overall Study|Migrated/moved from study area|1|||
48920446|NCT00714285|157543114|FG002|Overall Study|Migrated/moved from study area|0|||
48920447|NCT00714285|157543115|FG003|Overall Study|Migrated/moved from study area|0|||
48920448|NCT01140451|157543120|FG000|Overall Study|Withdrawal by Subject|26|||
48920449|NCT01140451|157543121|FG001|Overall Study|Withdrawal by Subject|33|||
48920450|NCT01140451|157543120|FG000|Overall Study|Adverse Event|2|||
48920451|NCT01140451|157543121|FG001|Overall Study|Adverse Event|6|||
48920452|NCT01140451|157543120|FG000|Overall Study|Physician Decision|5|||
48920453|NCT01140451|157543121|FG001|Overall Study|Physician Decision|3|||
48920454|NCT01140451|157543120|FG000|Overall Study|Lost to Follow-up|2|||
48920455|NCT01140451|157543121|FG001|Overall Study|Lost to Follow-up|0|||
48920456|NCT01140451|157543120|FG000|Overall Study|Participants Planning Pregnancy|3|||
48920457|NCT01140451|157543121|FG001|Overall Study|Participants Planning Pregnancy|0|||
48920458|NCT02363686|157543125|FG000|Overall Study|Withdrawal by Subject|22|||
48920459|NCT02363686|157543125|FG000|Overall Study|incomplete FEES examinations|13|||
48920460|NCT01485627|157543126|FG000|Overall Study|Patient withdrew|6|||
48920461|NCT01485627|157543127|FG001|Overall Study|Patient withdrew|5|||
48920462|NCT01485627|157543126|FG000|Overall Study|Patient died|3|||
48920463|NCT01485627|157543127|FG001|Overall Study|Patient died|1|||
48920464|NCT01485627|157543126|FG000|Overall Study|Patient lost to followup|0|||
48920465|NCT01485627|157543127|FG001|Overall Study|Patient lost to followup|1|||
48920466|NCT01485627|157543126|FG000|Overall Study|Caregiver withdrew|3|||
48920467|NCT01485627|157543127|FG001|Overall Study|Caregiver withdrew|3|||
48920468|NCT01485627|157543126|FG000|Overall Study|Caregiver lost to follow up|11|||
48920469|NCT01485627|157543127|FG001|Overall Study|Caregiver lost to follow up|12|||
48920470|NCT01485627|157543126|FG000|Overall Study|Caregiver died|1|||
48920471|NCT01485627|157543127|FG001|Overall Study|Caregiver died|0|||
48920472|NCT01485627|157543126|FG000|Overall Study|caregiver was not bereaved|42|||
48920473|NCT01485627|157543127|FG001|Overall Study|caregiver was not bereaved|35|||
48920474|NCT01709149|157543132|FG000|Open-label Lead-in Phase|Adverse Event|109|||
48920475|NCT01709149|157543133|FG001|Open-label Lead-in Phase|Adverse Event|0|||
48920476|NCT01709149|157543134|FG002|Open-label Lead-in Phase|Adverse Event|0|||
48920477|NCT01709149|157543132|FG000|Open-label Lead-in Phase|Withdrawal by Subject|2|||
48920478|NCT01709149|157543133|FG001|Open-label Lead-in Phase|Withdrawal by Subject|0|||
48920479|NCT01709149|157543134|FG002|Open-label Lead-in Phase|Withdrawal by Subject|0|||
48920480|NCT01709149|157543132|FG000|Open-label Lead-in Phase|Death|1|||
48920481|NCT01709149|157543133|FG001|Open-label Lead-in Phase|Death|0|||
48920482|NCT01709149|157543134|FG002|Open-label Lead-in Phase|Death|0|||
48920483|NCT01709149|157543132|FG000|Open-label Lead-in Phase|Protocol Violation|3|||
48920484|NCT01709149|157543133|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
48920485|NCT01709149|157543134|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
48920486|NCT01709149|157543132|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
48920487|NCT01709149|157543133|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|12|||
48920488|NCT01709149|157543134|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|78|||
48920489|NCT01709149|157543132|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
48920490|NCT01709149|157543133|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7|||
48920491|NCT01709149|157543134|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12|||
48920492|NCT01709149|157543132|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
48920493|NCT01709149|157543133|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|2|||
48920494|NCT01709149|157543134|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|5|||
48920495|NCT01709149|157543132|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
48920496|NCT01709149|157543133|FG001|Double-blind, Placebo-controlled Phase|Death|2|||
48920497|NCT01709149|157543134|FG002|Double-blind, Placebo-controlled Phase|Death|0|||
48920498|NCT01709149|157543132|FG000|Double-blind, Placebo-controlled Phase|not defined|0|||
48920499|NCT01709149|157543133|FG001|Double-blind, Placebo-controlled Phase|not defined|1|||
48920500|NCT01709149|157543134|FG002|Double-blind, Placebo-controlled Phase|not defined|2|||
49124610|NCT03327324|158294820|FG000|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
48812822|NCT04422639|157155443|FG000|Overall Study|study closed prior to completion of FU visits|0|||
48812823|NCT04422639|157155444|FG001|Overall Study|study closed prior to completion of FU visits|2|||
48812824|NCT01348776|157155445|FG000|Overall Study|Lost to Follow-up|3|||
48812825|NCT01913639|157155448|FG000|Overall Study|Not Eligible|3|||
48812826|NCT02491892|157155450|FG000|Overall Study|Adverse Event|1|||
48812827|NCT02491892|157155451|FG001|Overall Study|Adverse Event|1|||
48812828|NCT02491892|157155450|FG000|Overall Study|Death|1|||
48812829|NCT02491892|157155451|FG001|Overall Study|Death|1|||
48812830|NCT02491892|157155450|FG000|Overall Study|Lack of Efficacy|37|||
48812831|NCT02491892|157155451|FG001|Overall Study|Lack of Efficacy|36|||
48812832|NCT02491892|157155450|FG000|Overall Study|Refused Treatment|1|||
48812833|NCT02491892|157155451|FG001|Overall Study|Refused Treatment|0|||
48812834|NCT02491892|157155450|FG000|Overall Study|Lost to Follow-up|1|||
48812835|NCT02491892|157155451|FG001|Overall Study|Lost to Follow-up|0|||
48812836|NCT01231503|157155456|FG000|Overall Study|Adverse Event|0|||
48812837|NCT01231503|157155457|FG001|Overall Study|Adverse Event|0|||
48812838|NCT01231503|157155458|FG002|Overall Study|Adverse Event|0|||
48812839|NCT01231503|157155459|FG003|Overall Study|Adverse Event|0|||
48812840|NCT01231503|157155460|FG004|Overall Study|Adverse Event|0|||
48812841|NCT01231503|157155461|FG005|Overall Study|Adverse Event|1|||
48812842|NCT01231503|157155462|FG006|Overall Study|Adverse Event|0|||
48812843|NCT01231503|157155463|FG007|Overall Study|Adverse Event|0|||
48812844|NCT01231503|157155456|FG000|Overall Study|Adverse event, serious fatal|0|||
48812845|NCT01231503|157155457|FG001|Overall Study|Adverse event, serious fatal|0|||
48812846|NCT01231503|157155458|FG002|Overall Study|Adverse event, serious fatal|1|||
48812847|NCT01231503|157155459|FG003|Overall Study|Adverse event, serious fatal|1|||
48812848|NCT01231503|157155460|FG004|Overall Study|Adverse event, serious fatal|0|||
48812849|NCT01231503|157155461|FG005|Overall Study|Adverse event, serious fatal|1|||
48812850|NCT01231503|157155462|FG006|Overall Study|Adverse event, serious fatal|0|||
48812851|NCT01231503|157155463|FG007|Overall Study|Adverse event, serious fatal|0|||
48812852|NCT01231503|157155456|FG000|Overall Study|Withdrawal by Subject|6|||
48812853|NCT01231503|157155457|FG001|Overall Study|Withdrawal by Subject|3|||
48812854|NCT01231503|157155458|FG002|Overall Study|Withdrawal by Subject|3|||
48812855|NCT01231503|157155459|FG003|Overall Study|Withdrawal by Subject|1|||
48812856|NCT01231503|157155460|FG004|Overall Study|Withdrawal by Subject|3|||
48812857|NCT01231503|157155461|FG005|Overall Study|Withdrawal by Subject|5|||
48812858|NCT01231503|157155462|FG006|Overall Study|Withdrawal by Subject|1|||
48812859|NCT01231503|157155463|FG007|Overall Study|Withdrawal by Subject|2|||
48812860|NCT01231503|157155456|FG000|Overall Study|Lost to Follow-up|8|||
48812861|NCT01231503|157155457|FG001|Overall Study|Lost to Follow-up|10|||
48812862|NCT01231503|157155458|FG002|Overall Study|Lost to Follow-up|8|||
48812863|NCT01231503|157155459|FG003|Overall Study|Lost to Follow-up|5|||
48812864|NCT01231503|157155460|FG004|Overall Study|Lost to Follow-up|7|||
48812865|NCT01231503|157155461|FG005|Overall Study|Lost to Follow-up|9|||
48812866|NCT01231503|157155462|FG006|Overall Study|Lost to Follow-up|6|||
48812867|NCT01231503|157155463|FG007|Overall Study|Lost to Follow-up|6|||
48812868|NCT01231503|157155456|FG000|Overall Study|Protocol Violation|0|||
48812869|NCT01231503|157155457|FG001|Overall Study|Protocol Violation|0|||
48812870|NCT01231503|157155458|FG002|Overall Study|Protocol Violation|0|||
48812871|NCT01231503|157155459|FG003|Overall Study|Protocol Violation|1|||
48812872|NCT01231503|157155460|FG004|Overall Study|Protocol Violation|0|||
48812873|NCT01231503|157155461|FG005|Overall Study|Protocol Violation|0|||
48812874|NCT01231503|157155462|FG006|Overall Study|Protocol Violation|0|||
48812875|NCT01231503|157155463|FG007|Overall Study|Protocol Violation|0|||
48812876|NCT01586338|157155464|FG000|Overall Study|Adverse Event|3|||
48812877|NCT01586338|157155464|FG000|Overall Study|Lost to Follow-up|1|||
48812878|NCT01586338|157155464|FG000|Overall Study|Withdrawal by participant|3|||
48812879|NCT01586338|157155464|FG000|Overall Study|Other|1|||
48812880|NCT00284089|157155467|FG000|Multiple Dose Phase|Adverse Event|1|||
48812881|NCT00284089|157155468|FG001|Multiple Dose Phase|Adverse Event|0|||
48812882|NCT00284089|157155469|FG002|Multiple Dose Phase|Adverse Event|1|||
48812883|NCT00284089|157155470|FG003|Multiple Dose Phase|Adverse Event|1|||
48812884|NCT00284089|157155467|FG000|Multiple Dose Phase|Protocol Violation|0|||
48812885|NCT00284089|157155468|FG001|Multiple Dose Phase|Protocol Violation|0|||
49124611|NCT03327324|158294821|FG001|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
48812886|NCT00284089|157155469|FG002|Multiple Dose Phase|Protocol Violation|1|||
48812887|NCT00284089|157155470|FG003|Multiple Dose Phase|Protocol Violation|0|||
48812888|NCT00284089|157155467|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
48812889|NCT00284089|157155468|FG001|Multiple Dose Phase|Withdrawal by Subject|0|||
48812890|NCT00284089|157155469|FG002|Multiple Dose Phase|Withdrawal by Subject|1|||
48812891|NCT00284089|157155470|FG003|Multiple Dose Phase|Withdrawal by Subject|2|||
48812892|NCT00284089|157155467|FG000|Multiple Dose Phase|Death|0|||
48812893|NCT00284089|157155468|FG001|Multiple Dose Phase|Death|0|||
48812894|NCT00284089|157155469|FG002|Multiple Dose Phase|Death|1|||
48920501|NCT01709149|157543132|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
48812895|NCT00284089|157155470|FG003|Multiple Dose Phase|Death|1|||
48812896|NCT00284089|157155467|FG000|Extension Phase|Adverse Event|0|||
48812897|NCT00284089|157155468|FG001|Extension Phase|Adverse Event|0|||
48812898|NCT00284089|157155469|FG002|Extension Phase|Adverse Event|2|||
48812899|NCT00284089|157155470|FG003|Extension Phase|Adverse Event|2|||
48812900|NCT00284089|157155467|FG000|Extension Phase|condition no longer requires study drug|2|||
48812901|NCT00284089|157155468|FG001|Extension Phase|condition no longer requires study drug|0|||
49124612|NCT03327324|158294822|FG002|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
48812902|NCT00284089|157155469|FG002|Extension Phase|condition no longer requires study drug|2|||
48812903|NCT00284089|157155470|FG003|Extension Phase|condition no longer requires study drug|7|||
48812904|NCT00284089|157155467|FG000|Extension Phase|Protocol Violation|0|||
48812905|NCT00284089|157155468|FG001|Extension Phase|Protocol Violation|0|||
48812906|NCT00284089|157155469|FG002|Extension Phase|Protocol Violation|1|||
48812907|NCT00284089|157155470|FG003|Extension Phase|Protocol Violation|0|||
48812908|NCT00284089|157155467|FG000|Extension Phase|Withdrawal by Subject|0|||
48812909|NCT00284089|157155468|FG001|Extension Phase|Withdrawal by Subject|0|||
48812910|NCT00284089|157155469|FG002|Extension Phase|Withdrawal by Subject|1|||
48812911|NCT00284089|157155470|FG003|Extension Phase|Withdrawal by Subject|3|||
48812912|NCT00453102|157155471|FG000|Overall Study|Withdrawal by Subject|2|||
48812913|NCT03051659|157155472|FG000|Treatment Period|Withdrawal by Subject|0|||
48812914|NCT03051659|157155473|FG001|Treatment Period|Withdrawal by Subject|2|||
48812915|NCT03051659|157155472|FG000|Survival Follow-up|Lost to Follow-up|23|||
48920502|NCT01709149|157543133|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
48920503|NCT01709149|157543134|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
48920504|NCT01577186|157543135|FG000|Overall Study|Adverse Event|23|||
48920505|NCT01577186|157543135|FG000|Overall Study|Death|1|||
48920506|NCT01577186|157543135|FG000|Overall Study|Lost to Follow-up|28|||
48920507|NCT01577186|157543135|FG000|Overall Study|Withdrawal by Subject|35|||
48920508|NCT01577186|157543135|FG000|Overall Study|Insufficient Response|18|||
48920509|NCT01577186|157543135|FG000|Overall Study|Ineligible to Continue|15|||
48920510|NCT01577186|157543135|FG000|Overall Study|Non-Compliant|8|||
48920511|NCT01577186|157543135|FG000|Overall Study|Other|2|||
48920512|NCT02915523|157543136|FG000|Dose Determination Phase (Phase 1B)|Death|5|||
48920513|NCT02915523|157543137|FG001|Dose Determination Phase (Phase 1B)|Death|4|||
48920514|NCT02915523|157543138|FG002|Dose Determination Phase (Phase 1B)|Death|0|||
48920515|NCT02915523|157543139|FG003|Dose Determination Phase (Phase 1B)|Death|0|||
48920516|NCT02915523|157543136|FG000|Dose Determination Phase (Phase 1B)|Sponsor Decision|1|||
48920517|NCT02915523|157543137|FG001|Dose Determination Phase (Phase 1B)|Sponsor Decision|3|||
49124613|NCT03327324|158294823|FG003|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|3|||
49124614|NCT03327324|158294824|FG004|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|5|||
49124615|NCT03327324|158294825|FG005|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
49124616|NCT03327324|158294820|FG000|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|1|||
49124617|NCT03327324|158294821|FG001|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
49124618|NCT03327324|158294822|FG002|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
49124619|NCT03327324|158294823|FG003|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
49124620|NCT03327324|158294824|FG004|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
49124621|NCT03327324|158294825|FG005|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
49124622|NCT03327324|158294820|FG000|Sustainability Follow-Up 2 (Month 9-12)|Death|1|||
49124623|NCT03327324|158294821|FG001|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
49124624|NCT03327324|158294822|FG002|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
49124625|NCT03327324|158294823|FG003|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
49124626|NCT03327324|158294824|FG004|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
49124627|NCT03327324|158294825|FG005|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
49124628|NCT00072410|158294826|FG000|Overall Study|Progressive disease|0|||
49124629|NCT00072410|158294827|FG001|Overall Study|Progressive disease|3|||
49124630|NCT01791595|158294828|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|1|||
49124631|NCT01791595|158294829|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
49124632|NCT01791595|158294830|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
49124633|NCT01791595|158294831|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
48812916|NCT03051659|157155473|FG001|Survival Follow-up|Lost to Follow-up|22|||
48812917|NCT04362137|157155474|FG000|Overall Study|Death|9|||
48920518|NCT02915523|157543138|FG002|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
48920519|NCT02915523|157543139|FG003|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
48812918|NCT04362137|157155475|FG001|Overall Study|Death|3|||
48812919|NCT04362137|157155474|FG000|Overall Study|Patient decision|6|||
48812920|NCT04362137|157155475|FG001|Overall Study|Patient decision|3|||
48812921|NCT04362137|157155474|FG000|Overall Study|Adverse Event|1|||
48920520|NCT02915523|157543136|FG000|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
48920521|NCT02915523|157543137|FG001|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|1|||
48920522|NCT02915523|157543138|FG002|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
48920523|NCT02915523|157543139|FG003|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
48812922|NCT04362137|157155475|FG001|Overall Study|Adverse Event|0|||
49124634|NCT01791595|158294832|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
48920524|NCT02915523|157543136|FG000|Expansion Phase (Phase 2)|Death|0|||
48920525|NCT02915523|157543137|FG001|Expansion Phase (Phase 2)|Death|0|||
48920526|NCT02915523|157543138|FG002|Expansion Phase (Phase 2)|Death|26|||
48920527|NCT02915523|157543139|FG003|Expansion Phase (Phase 2)|Death|53|||
48920528|NCT02915523|157543136|FG000|Expansion Phase (Phase 2)|Sponsor Decision|0|||
48920529|NCT02915523|157543137|FG001|Expansion Phase (Phase 2)|Sponsor Decision|0|||
48920530|NCT02915523|157543138|FG002|Expansion Phase (Phase 2)|Sponsor Decision|4|||
48920531|NCT02915523|157543139|FG003|Expansion Phase (Phase 2)|Sponsor Decision|22|||
48920532|NCT02915523|157543136|FG000|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
48920533|NCT02915523|157543137|FG001|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
48920534|NCT02915523|157543138|FG002|Expansion Phase (Phase 2)|Withdrawal by Subject|6|||
48920535|NCT02915523|157543139|FG003|Expansion Phase (Phase 2)|Withdrawal by Subject|8|||
48920536|NCT02915523|157543136|FG000|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
48920537|NCT02915523|157543137|FG001|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
48920538|NCT02915523|157543138|FG002|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
48920539|NCT02915523|157543139|FG003|Expansion Phase (Phase 2)|Lost to Follow-up|2|||
49124635|NCT01791595|158294833|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
49124636|NCT01791595|158294834|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
49124637|NCT01791595|158294828|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|2|||
48812923|NCT04362137|157155474|FG000|Overall Study|Lost to Follow-up|1|||
48812924|NCT04362137|157155475|FG001|Overall Study|Lost to Follow-up|0|||
48812925|NCT04362137|157155474|FG000|Overall Study|Protocol deviation|1|||
48812926|NCT04362137|157155475|FG001|Overall Study|Protocol deviation|0|||
48812927|NCT02066532|157155476|FG000|Phase II|Withdrawal by Subject|1|||
48812928|NCT02066532|157155477|FG001|Phase II|Withdrawal by Subject|0|||
48812929|NCT02066532|157155478|FG002|Phase II|Withdrawal by Subject|0|||
48812930|NCT02066532|157155479|FG003|Phase II|Withdrawal by Subject|0|||
48812931|NCT02040090|157155480|FG000|Overall Study|Adverse Event|2|||
48812932|NCT02040090|157155481|FG001|Overall Study|Adverse Event|0|||
48812933|NCT02040090|157155480|FG000|Overall Study|Physician Decision|1|||
48812934|NCT02040090|157155481|FG001|Overall Study|Physician Decision|0|||
48812935|NCT02040090|157155480|FG000|Overall Study|Withdrawal by Subject|0|||
48812936|NCT02040090|157155481|FG001|Overall Study|Withdrawal by Subject|1|||
48812937|NCT02040090|157155480|FG000|Overall Study|Lost to Follow-up|0|||
48920540|NCT03287219|157543140|FG000|Overall Study|Protocol Violation|0|||
48920541|NCT03287219|157543141|FG001|Overall Study|Protocol Violation|2|||
48920542|NCT01118351|157543142|FG000|Overall Study|Adverse Event|3|||
48920543|NCT01118351|157543142|FG000|Overall Study|Withdrawal by Subject|1|||
48920544|NCT02264990|157543143|FG000|Overall Study|Death|255|||
48920545|NCT02264990|157543144|FG001|Overall Study|Death|250|||
48920546|NCT02264990|157543143|FG000|Overall Study|Withdrawal by Subject|4|||
48920547|NCT02264990|157543144|FG001|Overall Study|Withdrawal by Subject|5|||
48920548|NCT02264990|157543143|FG000|Overall Study|Lost to Follow-up|1|||
48920549|NCT02264990|157543144|FG001|Overall Study|Lost to Follow-up|3|||
48920550|NCT02264990|157543143|FG000|Overall Study|Other|0|||
48920551|NCT02264990|157543144|FG001|Overall Study|Other|1|||
48920552|NCT02429414|157543145|FG000|Overall Study|Physician Decision|0|||
48920553|NCT02429414|157543146|FG001|Overall Study|Physician Decision|1|||
48920554|NCT01604265|157543149|FG000|Overall Study|Adverse Event|1|||
48920555|NCT01604265|157543150|FG001|Overall Study|Adverse Event|0|||
48920556|NCT01604265|157543149|FG000|Overall Study|Withdrawal by Subject|1|||
48920557|NCT01604265|157543150|FG001|Overall Study|Withdrawal by Subject|0|||
49124638|NCT01791595|158294829|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
48920558|NCT02182687|157543151|FG000|Overall Study|Withdrawal by Subject|4|||
48920559|NCT02182687|157543152|FG001|Overall Study|Withdrawal by Subject|0|||
48920560|NCT02182687|157543151|FG000|Overall Study|Adverse Event|1|||
49124639|NCT01791595|158294830|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
49124640|NCT01791595|158294831|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
48920561|NCT02182687|157543152|FG001|Overall Study|Adverse Event|0|||
48920562|NCT02182687|157543151|FG000|Overall Study|Lost to Follow-up|0|||
48920563|NCT02182687|157543152|FG001|Overall Study|Lost to Follow-up|1|||
48920564|NCT03882970|157543157|FG000|Overall Study|Adverse Event|5|||
49124641|NCT01791595|158294832|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
48920565|NCT03882970|157543158|FG001|Overall Study|Adverse Event|7|||
48920566|NCT03882970|157543159|FG002|Overall Study|Adverse Event|3|||
48812938|NCT02040090|157155481|FG001|Overall Study|Lost to Follow-up|1|||
48812939|NCT02258464|157155486|FG000|Overall Study|Progressive disease (PD)|9|||
48812940|NCT02258464|157155487|FG001|Overall Study|Progressive disease (PD)|17|||
48812941|NCT02258464|157155486|FG000|Overall Study|Study drug never administered|1|||
48812942|NCT02258464|157155487|FG001|Overall Study|Study drug never administered|1|||
48920567|NCT03882970|157543160|FG003|Overall Study|Adverse Event|1|||
48920568|NCT03882970|157543157|FG000|Overall Study|Death|1|||
48920569|NCT03882970|157543158|FG001|Overall Study|Death|2|||
48920570|NCT03882970|157543159|FG002|Overall Study|Death|1|||
48920571|NCT03882970|157543160|FG003|Overall Study|Death|1|||
48920572|NCT03882970|157543157|FG000|Overall Study|Lost to Follow-up|8|||
48920573|NCT03882970|157543158|FG001|Overall Study|Lost to Follow-up|9|||
48920574|NCT03882970|157543159|FG002|Overall Study|Lost to Follow-up|5|||
48920575|NCT03882970|157543160|FG003|Overall Study|Lost to Follow-up|5|||
48920576|NCT03882970|157543157|FG000|Overall Study|Physician Decision|0|||
48920577|NCT03882970|157543158|FG001|Overall Study|Physician Decision|2|||
48920578|NCT03882970|157543159|FG002|Overall Study|Physician Decision|2|||
48920579|NCT03882970|157543160|FG003|Overall Study|Physician Decision|2|||
48920580|NCT03882970|157543157|FG000|Overall Study|Protocol Violation|2|||
48920581|NCT03882970|157543158|FG001|Overall Study|Protocol Violation|0|||
48920582|NCT03882970|157543159|FG002|Overall Study|Protocol Violation|0|||
48920583|NCT03882970|157543160|FG003|Overall Study|Protocol Violation|0|||
48920584|NCT03882970|157543157|FG000|Overall Study|Withdrawal by Subject|8|||
48920585|NCT03882970|157543158|FG001|Overall Study|Withdrawal by Subject|17|||
48920586|NCT03882970|157543159|FG002|Overall Study|Withdrawal by Subject|7|||
48920587|NCT03882970|157543160|FG003|Overall Study|Withdrawal by Subject|22|||
48920588|NCT03882970|157543157|FG000|Overall Study|Personal Reason|2|||
48920589|NCT03882970|157543158|FG001|Overall Study|Personal Reason|3|||
48920590|NCT03882970|157543159|FG002|Overall Study|Personal Reason|1|||
48920591|NCT03882970|157543160|FG003|Overall Study|Personal Reason|3|||
48920592|NCT03002155|157543161|FG000|Overall Study|Lost to Follow-up|1|||
48920593|NCT03002155|157543162|FG001|Overall Study|Lost to Follow-up|2|||
48920594|NCT03002155|157543161|FG000|Overall Study|Withdrawal by Subject|1|||
48920595|NCT03002155|157543162|FG001|Overall Study|Withdrawal by Subject|0|||
48920596|NCT03002155|157543161|FG000|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
48920597|NCT03002155|157543162|FG001|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
48920598|NCT02898259|157543163|FG000|Overall Study|Adverse Event|0|||
48920599|NCT02898259|157543164|FG001|Overall Study|Adverse Event|0|||
48920600|NCT02898259|157543165|FG002|Overall Study|Adverse Event|1|||
48920601|NCT02898259|157543166|FG003|Overall Study|Adverse Event|0|||
48920602|NCT02898259|157543167|FG004|Overall Study|Adverse Event|0|||
48920603|NCT02898259|157543163|FG000|Overall Study|Lack of Efficacy|1|||
48920604|NCT02898259|157543164|FG001|Overall Study|Lack of Efficacy|1|||
48920605|NCT02898259|157543165|FG002|Overall Study|Lack of Efficacy|3|||
48920606|NCT02898259|157543166|FG003|Overall Study|Lack of Efficacy|0|||
48920607|NCT02898259|157543167|FG004|Overall Study|Lack of Efficacy|0|||
48920608|NCT02898259|157543163|FG000|Overall Study|Lost to Follow-up|0|||
48920609|NCT02898259|157543164|FG001|Overall Study|Lost to Follow-up|0|||
48812943|NCT02258464|157155486|FG000|Overall Study|AE not related to clinical PD|1|||
48812944|NCT02258464|157155487|FG001|Overall Study|AE not related to clinical PD|3|||
48812945|NCT02258464|157155486|FG000|Overall Study|Withdrawal by Subject|5|||
48812946|NCT02258464|157155487|FG001|Overall Study|Withdrawal by Subject|4|||
48812947|NCT02258464|157155486|FG000|Overall Study|AE related to clinical PD|1|||
48812948|NCT02258464|157155487|FG001|Overall Study|AE related to clinical PD|0|||
48920610|NCT02898259|157543165|FG002|Overall Study|Lost to Follow-up|1|||
48920611|NCT02898259|157543166|FG003|Overall Study|Lost to Follow-up|0|||
48920612|NCT02898259|157543167|FG004|Overall Study|Lost to Follow-up|0|||
48920613|NCT02898259|157543163|FG000|Overall Study|Transformation before study began|0|||
49124642|NCT01791595|158294833|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
49124643|NCT01791595|158294834|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
48920614|NCT02898259|157543164|FG001|Overall Study|Transformation before study began|0|||
48920615|NCT02898259|157543165|FG002|Overall Study|Transformation before study began|0|||
48920616|NCT02898259|157543166|FG003|Overall Study|Transformation before study began|1|||
48920617|NCT02898259|157543167|FG004|Overall Study|Transformation before study began|0|||
48920618|NCT02829138|157543176|FG000|Overall Study|Withdrawal by Subject|1|||
48920619|NCT02829138|157543177|FG001|Overall Study|Withdrawal by Subject|0|||
49124644|NCT01791595|158294828|FG000|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
49124645|NCT01791595|158294829|FG001|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|5|||
49124646|NCT01791595|158294830|FG002|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
49124647|NCT01791595|158294831|FG003|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
49124648|NCT01791595|158294832|FG004|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
49124649|NCT01791595|158294833|FG005|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
49124650|NCT01791595|158294834|FG006|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
49124651|NCT01791595|158294828|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
49124652|NCT01791595|158294829|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
49124653|NCT01791595|158294830|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|1|||
49124654|NCT01791595|158294831|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
48920620|NCT02728830|157543182|FG000|Overall Study|Exclusionary Surgery|9|||
48920621|NCT02728830|157543182|FG000|Overall Study|Exclusionary Pathology|6|||
48812949|NCT00932646|157155488|FG000|Overall Study|Adverse Event|2|||
48812950|NCT00932646|157155489|FG001|Overall Study|Adverse Event|1|||
48812951|NCT00932646|157155490|FG002|Overall Study|Adverse Event|1|||
48812952|NCT00932646|157155491|FG003|Overall Study|Adverse Event|1|||
48812953|NCT00932646|157155488|FG000|Overall Study|Lost to Follow-up|2|||
48812954|NCT00932646|157155489|FG001|Overall Study|Lost to Follow-up|1|||
48812955|NCT00932646|157155490|FG002|Overall Study|Lost to Follow-up|0|||
48812956|NCT00932646|157155491|FG003|Overall Study|Lost to Follow-up|0|||
48812957|NCT00932646|157155488|FG000|Overall Study|Withdrawal by Subject|1|||
48812958|NCT00932646|157155489|FG001|Overall Study|Withdrawal by Subject|1|||
48812959|NCT00932646|157155490|FG002|Overall Study|Withdrawal by Subject|3|||
48812960|NCT00932646|157155491|FG003|Overall Study|Withdrawal by Subject|0|||
48812961|NCT04170296|157155492|FG000|Overall Study|Adverse Event|1|||
48812962|NCT04170296|157155493|FG001|Overall Study|Adverse Event|0|||
48812963|NCT04170296|157155492|FG000|Overall Study|Withdrawal by Subject|3|||
48812964|NCT04170296|157155493|FG001|Overall Study|Withdrawal by Subject|2|||
48812965|NCT04170296|157155492|FG000|Overall Study|Lost to Follow-up|4|||
48812966|NCT04170296|157155493|FG001|Overall Study|Lost to Follow-up|2|||
48812967|NCT04278417|157155499|FG000|Overall Study|Withdrawal by Subject|13|||
48812968|NCT04278417|157155500|FG001|Overall Study|Withdrawal by Subject|12|||
48812969|NCT04278417|157155499|FG000|Overall Study|Progressive disease|0|||
48812970|NCT04278417|157155500|FG001|Overall Study|Progressive disease|1|||
48812971|NCT04278417|157155499|FG000|Overall Study|Physician Decision|2|||
48812972|NCT04278417|157155500|FG001|Overall Study|Physician Decision|1|||
48812973|NCT04278417|157155499|FG000|Overall Study|Lost to Follow-up|7|||
48812974|NCT04278417|157155500|FG001|Overall Study|Lost to Follow-up|8|||
48812975|NCT04278417|157155499|FG000|Overall Study|Death|6|||
48812976|NCT04278417|157155500|FG001|Overall Study|Death|3|||
48812977|NCT04278417|157155499|FG000|Overall Study|Adverse Event|2|||
48812978|NCT04278417|157155500|FG001|Overall Study|Adverse Event|4|||
48812979|NCT04278417|157155499|FG000|Overall Study|Ongoing, did not complete Week 54|31|||
48812980|NCT04278417|157155500|FG001|Overall Study|Ongoing, did not complete Week 54|27|||
48812981|NCT03406702|157155501|FG000|Overall Study|Missed Day 27 Dosing|1|||
48812982|NCT01291225|157155505|FG000|Overall Study|Lost to Follow-up|85|||
48812983|NCT01291225|157155506|FG001|Overall Study|Lost to Follow-up|39|||
48812984|NCT01267253|157155507|FG000|Overall Study|Ineligible - required test not done|1|||
48812985|NCT01267253|157155507|FG000|Overall Study|Inevaluable-never received study treatme|2|||
48812986|NCT00147225|157155508|FG000|Overall Study|Withdrawal by Subject|1|||
48812987|NCT00147225|157155509|FG001|Overall Study|Withdrawal by Subject|0|||
48812988|NCT00147225|157155510|FG002|Overall Study|Withdrawal by Subject|1|||
48812989|NCT00147225|157155511|FG003|Overall Study|Withdrawal by Subject|0|||
48812990|NCT00147225|157155512|FG004|Overall Study|Withdrawal by Subject|0|||
48812991|NCT00147225|157155513|FG005|Overall Study|Withdrawal by Subject|1|||
48812992|NCT00147225|157155508|FG000|Overall Study|Adverse Event|0|||
48812993|NCT00147225|157155509|FG001|Overall Study|Adverse Event|0|||
48812994|NCT00147225|157155510|FG002|Overall Study|Adverse Event|1|||
48812995|NCT00147225|157155511|FG003|Overall Study|Adverse Event|1|||
48812996|NCT00147225|157155512|FG004|Overall Study|Adverse Event|0|||
48812997|NCT00147225|157155513|FG005|Overall Study|Adverse Event|0|||
48812998|NCT00147225|157155508|FG000|Overall Study|Screen Failure|0|||
48812999|NCT00147225|157155509|FG001|Overall Study|Screen Failure|0|||
48813000|NCT00147225|157155510|FG002|Overall Study|Screen Failure|0|||
48813001|NCT00147225|157155511|FG003|Overall Study|Screen Failure|0|||
48813002|NCT00147225|157155512|FG004|Overall Study|Screen Failure|1|||
48813003|NCT00147225|157155513|FG005|Overall Study|Screen Failure|0|||
48813004|NCT00147225|157155508|FG000|Overall Study|Chemotherapy Changed|0|||
48813005|NCT00147225|157155509|FG001|Overall Study|Chemotherapy Changed|0|||
48813006|NCT00147225|157155510|FG002|Overall Study|Chemotherapy Changed|0|||
48813007|NCT00147225|157155511|FG003|Overall Study|Chemotherapy Changed|0|||
48813008|NCT00147225|157155512|FG004|Overall Study|Chemotherapy Changed|0|||
48813009|NCT00147225|157155513|FG005|Overall Study|Chemotherapy Changed|1|||
48813010|NCT00514046|157155520|FG000|Overall Study|transferred to another protocol|2|||
48813011|NCT00514046|157155521|FG001|Overall Study|transferred to another protocol|1|||
48813012|NCT00514046|157155522|FG002|Overall Study|transferred to another protocol|3|||
48813013|NCT00514046|157155523|FG003|Overall Study|transferred to another protocol|0|||
48813014|NCT00514046|157155524|FG004|Overall Study|transferred to another protocol|1|||
48813015|NCT00514046|157155525|FG005|Overall Study|transferred to another protocol|0|||
48813016|NCT00514046|157155526|FG006|Overall Study|transferred to another protocol|0|||
48813017|NCT00514046|157155527|FG007|Overall Study|transferred to another protocol|0|||
48813018|NCT00514046|157155528|FG008|Overall Study|transferred to another protocol|0|||
48813019|NCT00514046|157155520|FG000|Overall Study|Getting vandetanib via the REMS program|1|||
48813020|NCT00514046|157155521|FG001|Overall Study|Getting vandetanib via the REMS program|0|||
48813021|NCT00514046|157155522|FG002|Overall Study|Getting vandetanib via the REMS program|0|||
48813022|NCT00514046|157155523|FG003|Overall Study|Getting vandetanib via the REMS program|0|||
48813023|NCT00514046|157155524|FG004|Overall Study|Getting vandetanib via the REMS program|0|||
48813024|NCT00514046|157155525|FG005|Overall Study|Getting vandetanib via the REMS program|0|||
48813025|NCT00514046|157155526|FG006|Overall Study|Getting vandetanib via the REMS program|0|||
48813026|NCT00514046|157155527|FG007|Overall Study|Getting vandetanib via the REMS program|1|||
48813027|NCT00514046|157155528|FG008|Overall Study|Getting vandetanib via the REMS program|1|||
48813028|NCT00514046|157155520|FG000|Overall Study|Disease progression on study|0|||
48813029|NCT00514046|157155521|FG001|Overall Study|Disease progression on study|0|||
48813030|NCT00514046|157155522|FG002|Overall Study|Disease progression on study|2|||
48813031|NCT00514046|157155523|FG003|Overall Study|Disease progression on study|0|||
48813032|NCT00514046|157155524|FG004|Overall Study|Disease progression on study|0|||
48813033|NCT00514046|157155525|FG005|Overall Study|Disease progression on study|1|||
48813034|NCT00514046|157155526|FG006|Overall Study|Disease progression on study|0|||
48813035|NCT00514046|157155527|FG007|Overall Study|Disease progression on study|0|||
48813036|NCT00514046|157155528|FG008|Overall Study|Disease progression on study|0|||
48813037|NCT03077620|157155529|FG000|Overall Study|Unable to place lumbar catheter|1|||
48813038|NCT03077620|157155530|FG001|Overall Study|Unable to place lumbar catheter|0|||
48813039|NCT03077620|157155531|FG002|Overall Study|Unable to place lumbar catheter|1|||
48813040|NCT03077620|157155532|FG003|Overall Study|Unable to place lumbar catheter|0|||
48813041|NCT03077620|157155529|FG000|Overall Study|Withdrawal by Subject|0|||
48813042|NCT03077620|157155530|FG001|Overall Study|Withdrawal by Subject|1|||
48813043|NCT03077620|157155531|FG002|Overall Study|Withdrawal by Subject|0|||
48813044|NCT03077620|157155532|FG003|Overall Study|Withdrawal by Subject|0|||
48813045|NCT03077620|157155529|FG000|Overall Study|Physician Decision|0|||
48813046|NCT03077620|157155530|FG001|Overall Study|Physician Decision|0|||
48813047|NCT03077620|157155531|FG002|Overall Study|Physician Decision|1|||
48813048|NCT03077620|157155532|FG003|Overall Study|Physician Decision|0|||
48813049|NCT02468934|157155533|FG000|Overall Study|Withdrawal by Subject|4|||
48813050|NCT02468934|157155533|FG000|Overall Study|Screen Failure|3|||
48813051|NCT00976703|157157345|FG000|Overall Study|Physician Decision|1|||
48813052|NCT00976703|157157346|FG001|Overall Study|Physician Decision|1|||
48813053|NCT00976703|157157345|FG000|Overall Study|ineligible for study|2|||
48813054|NCT00976703|157157346|FG001|Overall Study|ineligible for study|2|||
48813055|NCT01785628|157157351|FG000|Overall Study|Lost to Follow-up|2|||
48813056|NCT01785628|157157352|FG001|Overall Study|Lost to Follow-up|3|||
48813057|NCT00767104|157157353|FG000|Overall Study|Lost to Follow-up|1|||
48813058|NCT00767104|157157354|FG001|Overall Study|Lost to Follow-up|2|||
48813059|NCT00840996|157157355|FG000|Overall Study|Withdrawal by Subject|1|||
48813060|NCT00840996|157157356|FG001|Overall Study|Withdrawal by Subject|0|||
48813061|NCT04022889|157157357|FG000|Stage 1: Period 1|Adverse Event|1|||
48813062|NCT04022889|157157358|FG001|Stage 1: Period 1|Adverse Event|0|||
48813063|NCT04022889|157157359|FG002|Stage 1: Period 1|Adverse Event|0|||
48813064|NCT04022889|157157357|FG000|Stage 1: Period 1|Platelet component did not meet input specifications|1|||
48813065|NCT04022889|157157358|FG001|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
48813066|NCT04022889|157157359|FG002|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
48813067|NCT04022889|157157357|FG000|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
48813068|NCT04022889|157157358|FG001|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
48813069|NCT04022889|157157359|FG002|Stage 1: Period 2|Site closure due to COVID-19 pandemic|0|||
48813070|NCT04022889|157157357|FG000|Stage 2|Screen Failure|0|||
48813071|NCT04022889|157157358|FG001|Stage 2|Screen Failure|0|||
48920622|NCT02728830|157543182|FG000|Overall Study|Physician Decision|3|||
48920623|NCT02728830|157543182|FG000|Overall Study|Withdrawal by Subject|2|||
48920624|NCT02728830|157543182|FG000|Overall Study|Lost to Follow-up|1|||
48920625|NCT02728830|157543182|FG000|Overall Study|Exclusionary Lab Values|1|||
48920626|NCT02728830|157543182|FG000|Overall Study|Contraindicated Illness|1|||
48920627|NCT02728830|157543182|FG000|Overall Study|Language Barrier|1|||
48920628|NCT02980224|157543185|FG000|Overall Study|Adverse Event|4|||
48920629|NCT02980224|157543186|FG001|Overall Study|Adverse Event|1|||
48920630|NCT02980224|157543185|FG000|Overall Study|Withdrawal by Subject|0|||
48920631|NCT02980224|157543186|FG001|Overall Study|Withdrawal by Subject|2|||
48920632|NCT02941627|157543187|FG000|Overall Study|Death|1|||
48920633|NCT02941627|157543187|FG000|Overall Study|Surgical failure|1|||
48920634|NCT02941627|157543187|FG000|Overall Study|cholesteatoma prevented implantation|1|||
48920635|NCT00563186|157543188|FG000|Overall Study|LOS<48 hours|97|||
48920636|NCT00563186|157543189|FG001|Overall Study|LOS<48 hours|74|||
48920637|NCT00563186|157543188|FG000|Overall Study|Incomplete data|1|||
48920638|NCT00563186|157543189|FG001|Overall Study|Incomplete data|1|||
48920639|NCT00513500|157543192|FG000|Overall Study|Lost to Follow-up|35|||
48920640|NCT00513500|157543193|FG001|Overall Study|Lost to Follow-up|39|||
48920641|NCT00513500|157543192|FG000|Overall Study|Death|2|||
48920642|NCT00513500|157543193|FG001|Overall Study|Death|1|||
48813072|NCT04022889|157157359|FG002|Stage 2|Screen Failure|3|||
48813073|NCT04022889|157157357|FG000|Stage 2|Ineligible for apheresis donation|0|||
48813074|NCT04022889|157157358|FG001|Stage 2|Ineligible for apheresis donation|0|||
48813075|NCT04022889|157157359|FG002|Stage 2|Ineligible for apheresis donation|2|||
48920643|NCT00513500|157543192|FG000|Overall Study|Hospitalized|4|||
48714438|NCT00905645|156804876|FG002|Overall Study|Explantation of study device(s)|28|||
48714439|NCT00905645|156804877|FG003|Overall Study|Explantation of study device(s)|21|||
48714440|NCT00905645|156804874|FG000|Overall Study|Subject Request|41|||
48714441|NCT00905645|156804875|FG001|Overall Study|Subject Request|17|||
48714442|NCT00905645|156804876|FG002|Overall Study|Subject Request|13|||
48714443|NCT00905645|156804877|FG003|Overall Study|Subject Request|11|||
48714444|NCT00905645|156804874|FG000|Overall Study|Lost to Follow-up|299|||
48714445|NCT00905645|156804875|FG001|Overall Study|Lost to Follow-up|103|||
48714446|NCT00905645|156804876|FG002|Overall Study|Lost to Follow-up|51|||
48714447|NCT00905645|156804877|FG003|Overall Study|Lost to Follow-up|12|||
48714448|NCT01731938|156804879|FG000|Preliminary Part I|Withdrawal by Subject|2|||
48714449|NCT01731938|156804880|FG001|Preliminary Part I|Withdrawal by Subject|2|||
48714450|NCT01731938|156804879|FG000|Preliminary Part I|Physician Decision|1|||
48714451|NCT01731938|156804880|FG001|Preliminary Part I|Physician Decision|0|||
48920644|NCT00513500|157543193|FG001|Overall Study|Hospitalized|14|||
48920645|NCT00886600|157543194|FG000|Double-blind Monotherapy|Adverse Event|1|||
48920646|NCT00886600|157543195|FG001|Double-blind Monotherapy|Adverse Event|1|||
48920647|NCT00886600|157543196|FG002|Double-blind Monotherapy|Adverse Event|1|||
48920648|NCT00886600|157543197|FG003|Double-blind Monotherapy|Adverse Event|1|||
48920649|NCT00886600|157543194|FG000|Double-blind Monotherapy|Protocol Violation|0|||
48920650|NCT00886600|157543195|FG001|Double-blind Monotherapy|Protocol Violation|0|||
48920651|NCT00886600|157543196|FG002|Double-blind Monotherapy|Protocol Violation|0|||
48920652|NCT00886600|157543197|FG003|Double-blind Monotherapy|Protocol Violation|1|||
48920653|NCT00886600|157543194|FG000|Double-blind Monotherapy|Withdrawal by Subject|1|||
48920654|NCT00886600|157543195|FG001|Double-blind Monotherapy|Withdrawal by Subject|0|||
48920655|NCT00886600|157543196|FG002|Double-blind Monotherapy|Withdrawal by Subject|0|||
48920656|NCT00886600|157543197|FG003|Double-blind Monotherapy|Withdrawal by Subject|0|||
48920657|NCT00886600|157543194|FG000|Combination Therapy Period|Adverse Event|0|||
48920658|NCT00886600|157543195|FG001|Combination Therapy Period|Adverse Event|0|||
48920659|NCT00886600|157543196|FG002|Combination Therapy Period|Adverse Event|1|||
48920660|NCT00886600|157543197|FG003|Combination Therapy Period|Adverse Event|0|||
48920661|NCT00886600|157543194|FG000|Combination Therapy Period|Protocol Violation|0|||
48920662|NCT00886600|157543195|FG001|Combination Therapy Period|Protocol Violation|0|||
48920663|NCT00886600|157543196|FG002|Combination Therapy Period|Protocol Violation|1|||
48920664|NCT00886600|157543197|FG003|Combination Therapy Period|Protocol Violation|0|||
48920665|NCT00790907|157543198|FG000|Overall Study|Adverse Event|9|||
48920666|NCT00790907|157543199|FG001|Overall Study|Adverse Event|7|||
48920667|NCT00790907|157543200|FG002|Overall Study|Adverse Event|6|||
48920668|NCT00790907|157543198|FG000|Overall Study|Physician Decision|304|||
49124655|NCT01791595|158294832|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
49124656|NCT01791595|158294833|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
49124657|NCT01791595|158294834|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
49124658|NCT01791595|158294828|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
49124659|NCT01791595|158294829|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
49124660|NCT01791595|158294830|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|6|||
49124661|NCT01791595|158294831|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
49124662|NCT01791595|158294832|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
49124663|NCT01791595|158294833|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
49124664|NCT01791595|158294834|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
49124665|NCT01791595|158294828|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
49124666|NCT01791595|158294829|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
49124667|NCT01791595|158294830|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|1|||
49124668|NCT01791595|158294831|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
49124669|NCT01791595|158294832|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
49124670|NCT01791595|158294833|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
48920669|NCT00790907|157543199|FG001|Overall Study|Physician Decision|271|||
48714452|NCT01731938|156804879|FG000|Preliminary Part I|Lost to Follow-up|0|||
48714453|NCT01731938|156804880|FG001|Preliminary Part I|Lost to Follow-up|3|||
48714454|NCT01731938|156804879|FG000|Preliminary Part I|Missed Week 6 visit|0|||
48714455|NCT01731938|156804880|FG001|Preliminary Part I|Missed Week 6 visit|3|||
48920670|NCT00790907|157543200|FG002|Overall Study|Physician Decision|255|||
48920671|NCT00790907|157543198|FG000|Overall Study|Withdrawal by Subject|1|||
48920672|NCT00790907|157543199|FG001|Overall Study|Withdrawal by Subject|7|||
48920673|NCT00790907|157543200|FG002|Overall Study|Withdrawal by Subject|5|||
48920674|NCT00790907|157543198|FG000|Overall Study|Bleeding Event|11|||
48920675|NCT00790907|157543199|FG001|Overall Study|Bleeding Event|16|||
48920676|NCT00790907|157543200|FG002|Overall Study|Bleeding Event|21|||
48920677|NCT00790907|157543198|FG000|Overall Study|Required Protocol-prohibited Therapy|17|||
48920678|NCT00790907|157543199|FG001|Overall Study|Required Protocol-prohibited Therapy|5|||
48920679|NCT00790907|157543200|FG002|Overall Study|Required Protocol-prohibited Therapy|7|||
48920680|NCT00790907|157543198|FG000|Overall Study|Qualifying Condition Not Present|29|||
48920681|NCT00790907|157543199|FG001|Overall Study|Qualifying Condition Not Present|14|||
48920682|NCT00790907|157543200|FG002|Overall Study|Qualifying Condition Not Present|16|||
49124671|NCT01791595|158294834|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
49124672|NCT01791595|158294828|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
49124673|NCT01791595|158294829|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
49124674|NCT01791595|158294830|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
49124675|NCT01791595|158294831|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|2|||
49124676|NCT01791595|158294832|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
49124677|NCT01791595|158294833|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
49124678|NCT01791595|158294834|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
49124679|NCT01791595|158294828|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
48920683|NCT00790907|157543198|FG000|Overall Study|Verbatim Reason on the Case Report Form|74|||
48920684|NCT00790907|157543199|FG001|Overall Study|Verbatim Reason on the Case Report Form|20|||
49124680|NCT01791595|158294829|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
49124681|NCT01791595|158294830|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
49124682|NCT01791595|158294831|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|2|||
49124683|NCT01791595|158294832|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
49124684|NCT01791595|158294833|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
48714456|NCT01731938|156804879|FG000|Primary Part II|Withdrawal by Subject|5|||
48714457|NCT01731938|156804880|FG001|Primary Part II|Withdrawal by Subject|4|||
48714458|NCT01731938|156804879|FG000|Primary Part II|Lost to Follow-up|4|||
48714459|NCT01731938|156804880|FG001|Primary Part II|Lost to Follow-up|5|||
48714460|NCT01731938|156804879|FG000|Primary Part II|Death|2|||
48714461|NCT01731938|156804880|FG001|Primary Part II|Death|1|||
48714462|NCT01731938|156804879|FG000|Primary Part II|Missed Week 6 visit|2|||
48714463|NCT01731938|156804880|FG001|Primary Part II|Missed Week 6 visit|3|||
48714464|NCT01155011|156804882|FG000|Baseline to 6 Months|Withdrawal by Subject|18|||
48714465|NCT01155011|156804883|FG001|Baseline to 6 Months|Withdrawal by Subject|19|||
48714466|NCT01155011|156804882|FG000|Baseline to 6 Months|investigator decision, moved|4|||
48714467|NCT01155011|156804883|FG001|Baseline to 6 Months|investigator decision, moved|5|||
48714468|NCT01155011|156804882|FG000|Baseline to 6 Months|Death|0|||
48714469|NCT01155011|156804883|FG001|Baseline to 6 Months|Death|1|||
48714470|NCT01155011|156804882|FG000|6 to 12 Months|Withdrawal by Subject|8|||
48714471|NCT01155011|156804883|FG001|6 to 12 Months|Withdrawal by Subject|5|||
48714472|NCT01155011|156804882|FG000|6 to 12 Months|Death|1|||
48714473|NCT01155011|156804883|FG001|6 to 12 Months|Death|5|||
48714474|NCT01087736|156804884|FG000|Overall Study|Lost to Follow-up|1|||
48714475|NCT01087736|156804885|FG001|Overall Study|Lost to Follow-up|0|||
48714476|NCT01087736|156804884|FG000|Overall Study|Death|0|||
48714477|NCT01087736|156804885|FG001|Overall Study|Death|1|||
48714478|NCT01087736|156804884|FG000|Overall Study|Withdrawal by Subject|0|||
48714479|NCT01087736|156804885|FG001|Overall Study|Withdrawal by Subject|1|||
48714480|NCT03083990|156804886|FG000|Overall Study|Adverse Event|1|||
48714481|NCT03083990|156804887|FG001|Overall Study|Adverse Event|0|||
48920685|NCT00790907|157543200|FG002|Overall Study|Verbatim Reason on the Case Report Form|29|||
48920686|NCT00790907|157543198|FG000|Overall Study|Did Not Receive Study Drug|10|||
48920687|NCT00790907|157543199|FG001|Overall Study|Did Not Receive Study Drug|0|||
48920688|NCT00790907|157543200|FG002|Overall Study|Did Not Receive Study Drug|0|||
48920689|NCT00109707|157543205|FG000|Overall Study|Discontinued in core study without entering the extension study|215|||
48920690|NCT00109707|157543206|FG001|Overall Study|Discontinued in core study without entering the extension study|122|||
48920691|NCT00109707|157543207|FG002|Overall Study|Discontinued in core study without entering the extension study|34|||
48920692|NCT00109707|157543205|FG000|Overall Study|Abnormal laboratory values|1|||
48920693|NCT00109707|157543206|FG001|Overall Study|Abnormal laboratory values|0|||
48920694|NCT00109707|157543207|FG002|Overall Study|Abnormal laboratory values|0|||
48920695|NCT00109707|157543205|FG000|Overall Study|Administrative problems|2|||
48920696|NCT00109707|157543206|FG001|Overall Study|Administrative problems|0|||
48920697|NCT00109707|157543207|FG002|Overall Study|Administrative problems|1|||
48920698|NCT00109707|157543205|FG000|Overall Study|Adverse Event|10|||
48920699|NCT00109707|157543206|FG001|Overall Study|Adverse Event|2|||
48920700|NCT00109707|157543207|FG002|Overall Study|Adverse Event|3|||
48920701|NCT00109707|157543205|FG000|Overall Study|Death|4|||
48920702|NCT00109707|157543206|FG001|Overall Study|Death|0|||
48920703|NCT00109707|157543207|FG002|Overall Study|Death|0|||
48920704|NCT00109707|157543205|FG000|Overall Study|Disease progression|12|||
48920705|NCT00109707|157543206|FG001|Overall Study|Disease progression|4|||
48920706|NCT00109707|157543207|FG002|Overall Study|Disease progression|3|||
48920707|NCT00109707|157543205|FG000|Overall Study|Lost to Follow-up|3|||
49124685|NCT01791595|158294834|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
49124686|NCT01791595|158294828|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
48714482|NCT01509053|156804888|FG000|Oral Aripirazole (Phase A)|Sponsor discontinued study|11|||
48714483|NCT01509053|156804888|FG000|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1|||
48714484|NCT01509053|156804888|FG000|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13|||
48714485|NCT01509053|156804888|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1|||
48714486|NCT01509053|156804888|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1|||
48920708|NCT00109707|157543206|FG001|Overall Study|Lost to Follow-up|0|||
48920709|NCT00109707|157543207|FG002|Overall Study|Lost to Follow-up|0|||
48920710|NCT00109707|157543205|FG000|Overall Study|Protocol Violation|1|||
48813076|NCT04022889|157157357|FG000|Stage 2|Adverse Event|0|||
48714487|NCT01509053|156804888|FG000|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3|||
48714488|NCT00776919|156804890|FG000|Overall Study|Withdrawal by Subject|16|||
48714489|NCT00776919|156804891|FG001|Overall Study|Withdrawal by Subject|14|||
48714490|NCT00776919|156804892|FG002|Overall Study|Withdrawal by Subject|15|||
48714491|NCT00776919|156804893|FG003|Overall Study|Withdrawal by Subject|26|||
48714492|NCT00776919|156804890|FG000|Overall Study|Lost to Follow-up|8|||
48714493|NCT00776919|156804891|FG001|Overall Study|Lost to Follow-up|12|||
48714494|NCT00776919|156804892|FG002|Overall Study|Lost to Follow-up|11|||
48714495|NCT00776919|156804893|FG003|Overall Study|Lost to Follow-up|8|||
48714496|NCT00776919|156804890|FG000|Overall Study|Adverse Event|1|||
48714497|NCT00776919|156804891|FG001|Overall Study|Adverse Event|0|||
48714498|NCT00776919|156804892|FG002|Overall Study|Adverse Event|2|||
48714499|NCT00776919|156804893|FG003|Overall Study|Adverse Event|2|||
48714500|NCT00776919|156804890|FG000|Overall Study|Protocol Violation|1|||
48714501|NCT00776919|156804891|FG001|Overall Study|Protocol Violation|2|||
48714502|NCT00776919|156804892|FG002|Overall Study|Protocol Violation|0|||
48714503|NCT00776919|156804893|FG003|Overall Study|Protocol Violation|1|||
48714504|NCT00776919|156804890|FG000|Overall Study|Other: Lack of Efficacy/Lost Medication|1|||
48714505|NCT00776919|156804891|FG001|Overall Study|Other: Lack of Efficacy/Lost Medication|5|||
48714506|NCT00776919|156804892|FG002|Overall Study|Other: Lack of Efficacy/Lost Medication|4|||
48714507|NCT00776919|156804893|FG003|Overall Study|Other: Lack of Efficacy/Lost Medication|2|||
48714508|NCT00441116|156804894|FG000|Overall Study|Adverse Event|1|||
48714509|NCT00441116|156804895|FG001|Overall Study|Adverse Event|1|||
48714510|NCT00441116|156804894|FG000|Overall Study|Withdrawal by Subject|1|||
48714511|NCT00441116|156804895|FG001|Overall Study|Withdrawal by Subject|0|||
48714512|NCT00441116|156804894|FG000|Overall Study|Did not meet Eligibility Criteria|1|||
48714513|NCT00441116|156804895|FG001|Overall Study|Did not meet Eligibility Criteria|1|||
48714514|NCT00275340|156804896|FG000|Overall Study|Lost to Follow-up|2|||
48714515|NCT00275340|156804897|FG001|Overall Study|Lost to Follow-up|4|||
48714516|NCT01950013|156804898|FG000|Overall Study|Withdrawal by Subject|0|||
48714517|NCT01950013|156804899|FG001|Overall Study|Withdrawal by Subject|2|||
48714518|NCT01950013|156804900|FG002|Overall Study|Withdrawal by Subject|0|||
48714519|NCT02509117|156804905|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
48714520|NCT02509117|156804906|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1|||
48714521|NCT02509117|156804907|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
48714522|NCT02509117|156804908|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
48714523|NCT02509117|156804909|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
48714524|NCT02509117|156804910|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
48714525|NCT02509117|156804911|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
48714526|NCT02509117|156804912|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
48714527|NCT02509117|156804913|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
48714528|NCT02509117|156804914|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
48714529|NCT02509117|156804905|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
48714530|NCT02509117|156804906|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
48714531|NCT02509117|156804907|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
48714532|NCT02509117|156804908|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
48714533|NCT02509117|156804909|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
48714534|NCT02509117|156804910|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
48714535|NCT02509117|156804911|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
48714536|NCT02509117|156804912|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
48714537|NCT02509117|156804913|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
48714538|NCT02509117|156804914|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1|||
48714539|NCT02509117|156804905|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
48714540|NCT02509117|156804906|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
48813077|NCT04022889|157157358|FG001|Stage 2|Adverse Event|0|||
48813078|NCT04022889|157157359|FG002|Stage 2|Adverse Event|2|||
48813079|NCT04022889|157157357|FG000|Stage 2|Protocol Violation|0|||
48813080|NCT04022889|157157358|FG001|Stage 2|Protocol Violation|0|||
48813081|NCT04022889|157157359|FG002|Stage 2|Protocol Violation|1|||
48813082|NCT04022889|157157357|FG000|Stage 2|Site closure due to COVID-19 pandemic|1|||
48813083|NCT04022889|157157358|FG001|Stage 2|Site closure due to COVID-19 pandemic|0|||
48813084|NCT04022889|157157359|FG002|Stage 2|Site closure due to COVID-19 pandemic|0|||
48714541|NCT02509117|156804907|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
48714542|NCT02509117|156804908|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
48813085|NCT02248961|157157360|FG000|Overall Study|Adverse Event|1|||
48813086|NCT02248961|157157361|FG001|Overall Study|Adverse Event|0|||
48714543|NCT02509117|156804909|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
48813087|NCT02248961|157157360|FG000|Overall Study|Withdrawal by Subject|1|||
48813088|NCT02248961|157157361|FG001|Overall Study|Withdrawal by Subject|2|||
48920711|NCT00109707|157543206|FG001|Overall Study|Protocol Violation|0|||
48920712|NCT00109707|157543207|FG002|Overall Study|Protocol Violation|0|||
48920713|NCT00109707|157543205|FG000|Overall Study|Patient withdrew consent|6|||
48920714|NCT00109707|157543206|FG001|Overall Study|Patient withdrew consent|1|||
48920715|NCT00109707|157543207|FG002|Overall Study|Patient withdrew consent|0|||
48920716|NCT02199080|157543210|FG000|Overall Study|Protocol Violation|12|||
48920717|NCT02250274|157543213|FG000|Overall Study|Insufficient blood draw amount|7|||
48920718|NCT02250274|157543214|FG001|Overall Study|Insufficient blood draw amount|6|||
48920719|NCT01277549|157543215|FG000|Overall Study|Failed to meet eligibility criteria|13|||
48920720|NCT01277549|157543216|FG001|Overall Study|Failed to meet eligibility criteria|9|||
48920721|NCT01277549|157543215|FG000|Overall Study|Withdrawal by Subject|1|||
49124687|NCT01791595|158294829|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
49124688|NCT01791595|158294830|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
49124689|NCT01791595|158294831|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
49124690|NCT01791595|158294832|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|4|||
49124691|NCT01791595|158294833|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
49124692|NCT01791595|158294834|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
49124693|NCT01791595|158294828|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
49124694|NCT01791595|158294829|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
49124695|NCT01791595|158294830|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
49124696|NCT01791595|158294831|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
49124697|NCT01791595|158294832|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|5|||
49124698|NCT01791595|158294833|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
49124699|NCT01791595|158294834|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
49124700|NCT01791595|158294828|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
49124701|NCT01791595|158294829|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
49124702|NCT01791595|158294830|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
49124703|NCT01791595|158294831|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
49124704|NCT01791595|158294832|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|1|||
49124705|NCT01791595|158294833|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
49124706|NCT01791595|158294834|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
49124707|NCT01791595|158294828|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
49124708|NCT01791595|158294829|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
49124709|NCT01791595|158294830|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
49124710|NCT01791595|158294831|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
49124711|NCT01791595|158294832|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|1|||
49124712|NCT01791595|158294833|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
49124713|NCT01791595|158294834|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
49124714|NCT01791595|158294828|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
49124715|NCT01791595|158294829|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
49124716|NCT01791595|158294830|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
48813089|NCT02248961|157157360|FG000|Overall Study|Unmet inclusion/exclusion criteria|1|||
48813090|NCT02248961|157157361|FG001|Overall Study|Unmet inclusion/exclusion criteria|0|||
48813091|NCT01900054|157157364|FG000|Overall Study|Physician Decision|1|||
48813092|NCT01900054|157157364|FG000|Overall Study|Withdrawal by Subject|1|||
48813093|NCT03285295|157157365|FG000|Alinity s HBsAg|Protocol Violation|11|||
48813094|NCT03285295|157157366|FG001|Alinity s HBsAg|Protocol Violation|0|||
48813095|NCT03285295|157157367|FG002|Alinity s HBsAg|Protocol Violation|0|||
48813096|NCT03285295|157157368|FG003|Alinity s HBsAg|Protocol Violation|0|||
48813097|NCT03285295|157157369|FG004|Alinity s HBsAg|Protocol Violation|0|||
48813098|NCT03285295|157157365|FG000|Alinity s HBsAg|No Result on Comparator Assay|17|||
48813099|NCT03285295|157157366|FG001|Alinity s HBsAg|No Result on Comparator Assay|0|||
48813100|NCT03285295|157157367|FG002|Alinity s HBsAg|No Result on Comparator Assay|0|||
48813101|NCT03285295|157157368|FG003|Alinity s HBsAg|No Result on Comparator Assay|0|||
48813102|NCT03285295|157157369|FG004|Alinity s HBsAg|No Result on Comparator Assay|0|||
48813103|NCT03285295|157157365|FG000|Alinity s HBsAg|No Results Generated|74|||
48813104|NCT03285295|157157366|FG001|Alinity s HBsAg|No Results Generated|6|||
48813105|NCT03285295|157157367|FG002|Alinity s HBsAg|No Results Generated|0|||
48813106|NCT03285295|157157368|FG003|Alinity s HBsAg|No Results Generated|0|||
48813107|NCT03285295|157157369|FG004|Alinity s HBsAg|No Results Generated|0|||
48813108|NCT03285295|157157365|FG000|Alinity s HTLV I/II|Protocol Violation|6|||
48920722|NCT01277549|157543216|FG001|Overall Study|Withdrawal by Subject|3|||
49124717|NCT01791595|158294831|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
49124718|NCT01791595|158294832|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
49124719|NCT01791595|158294833|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|5|||
48813109|NCT03285295|157157366|FG001|Alinity s HTLV I/II|Protocol Violation|0|||
48813110|NCT03285295|157157367|FG002|Alinity s HTLV I/II|Protocol Violation|0|||
48813111|NCT03285295|157157368|FG003|Alinity s HTLV I/II|Protocol Violation|0|||
48920723|NCT01277549|157543215|FG000|Overall Study|Protocol Violation|10|||
48920724|NCT01277549|157543216|FG001|Overall Study|Protocol Violation|1|||
49124720|NCT01791595|158294834|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
49124721|NCT01791595|158294828|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
49124722|NCT01791595|158294829|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
49124723|NCT01791595|158294830|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
49124724|NCT01791595|158294831|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
49124725|NCT01791595|158294832|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
49124726|NCT01791595|158294833|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|3|||
49124727|NCT01791595|158294834|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
49124728|NCT01791595|158294828|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
49124729|NCT01791595|158294829|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
49124730|NCT01791595|158294830|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
49124731|NCT01791595|158294831|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
49124732|NCT01791595|158294832|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
49124733|NCT01791595|158294833|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
49124734|NCT01791595|158294834|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|1|||
49124735|NCT01791595|158294828|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
49124736|NCT01791595|158294829|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
49124737|NCT01791595|158294830|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
49124738|NCT01791595|158294831|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
49124739|NCT01791595|158294832|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
49124740|NCT01791595|158294833|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
49124741|NCT01791595|158294834|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|6|||
49124742|NCT01791595|158294828|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
48714544|NCT02509117|156804910|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
49124743|NCT01791595|158294829|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
48714545|NCT02509117|156804911|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
48714546|NCT02509117|156804912|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
48714547|NCT02509117|156804913|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
48920725|NCT01277549|157543215|FG000|Overall Study|Physician Decision|2|||
48920726|NCT01277549|157543216|FG001|Overall Study|Physician Decision|1|||
48920727|NCT02424253|157543217|FG000|Overall Study|Other, unspecified|1|||
48920728|NCT02424253|157543218|FG001|Overall Study|Other, unspecified|0|||
48920729|NCT02424253|157543217|FG000|Overall Study|Compliance problems|1|||
48920730|NCT02424253|157543218|FG001|Overall Study|Compliance problems|0|||
48920731|NCT02424253|157543217|FG000|Overall Study|Physician Decision|2|||
48920732|NCT02424253|157543218|FG001|Overall Study|Physician Decision|0|||
48920733|NCT02424253|157543217|FG000|Overall Study|Lack of Efficacy|0|||
48920734|NCT02424253|157543218|FG001|Overall Study|Lack of Efficacy|7|||
48920735|NCT02424253|157543217|FG000|Overall Study|Adverse Event|2|||
49124744|NCT01791595|158294830|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
48714548|NCT02509117|156804914|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1|||
48714549|NCT00145119|156804915|FG000|Overall Study|Death|45|||
48714550|NCT00832624|156804916|FG000|Overall Study|Study Terminated|10|||
48714551|NCT02636361|156804917|FG000|Period 4|Physician Decision|0|||
48714552|NCT02636361|156804918|FG001|Period 4|Physician Decision|0|||
48714553|NCT02636361|156804919|FG002|Period 4|Physician Decision|0|||
48714554|NCT02636361|156804920|FG003|Period 4|Physician Decision|1|||
48714555|NCT02636361|156804921|FG004|Period 4|Physician Decision|0|||
48714556|NCT02466659|156804922|FG000|Overall Study|Lost to Follow-up|5|||
48714557|NCT02466659|156804923|FG001|Overall Study|Lost to Follow-up|2|||
48714558|NCT03425253|156804924|FG000|Overall Study|Adverse Event|2|||
48714559|NCT03425253|156804924|FG000|Overall Study|Lost to Follow-up|3|||
48714560|NCT03425253|156804924|FG000|Overall Study|Withdrew Consent|6|||
48714561|NCT03425253|156804924|FG000|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5|||
48714562|NCT01590758|156804925|FG000|Overall Study|Withdrawal by Subject|0|||
48714563|NCT01590758|156804926|FG001|Overall Study|Withdrawal by Subject|3|||
48714564|NCT01590758|156804925|FG000|Overall Study|Physician Decision|1|||
48714565|NCT01590758|156804926|FG001|Overall Study|Physician Decision|2|||
48714566|NCT01590758|156804925|FG000|Overall Study|Lost to Follow-up|4|||
48714567|NCT01590758|156804926|FG001|Overall Study|Lost to Follow-up|2|||
48714568|NCT02717832|156804927|FG000|Overall Study|Inability to place IV|3|||
48714569|NCT00096356|156804928|FG000|Overall Study|Adverse Event|11|||
48714570|NCT00096356|156804929|FG001|Overall Study|Adverse Event|9|||
48714571|NCT00096356|156804928|FG000|Overall Study|Physician Decision|5|||
48714572|NCT00096356|156804929|FG001|Overall Study|Physician Decision|3|||
48920736|NCT02424253|157543218|FG001|Overall Study|Adverse Event|0|||
48920737|NCT02424253|157543217|FG000|Overall Study|Consent withdrawn by subject|4|||
48920738|NCT02424253|157543218|FG001|Overall Study|Consent withdrawn by subject|1|||
48714573|NCT00096356|156804928|FG000|Overall Study|Withdrawal by Subject|17|||
48714574|NCT00096356|156804929|FG001|Overall Study|Withdrawal by Subject|23|||
48714575|NCT00096356|156804928|FG000|Overall Study|Lack of Efficacy|1|||
48813112|NCT03285295|157157369|FG004|Alinity s HTLV I/II|Protocol Violation|0|||
48813113|NCT03285295|157157365|FG000|Alinity s HTLV I/II|No Result on Comparator Assay|15|||
48813114|NCT03285295|157157366|FG001|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
48813115|NCT03285295|157157367|FG002|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
48813116|NCT03285295|157157368|FG003|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
48813117|NCT03285295|157157369|FG004|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
48813118|NCT03285295|157157365|FG000|Alinity s HTLV I/II|No Results Generated|70|||
48813119|NCT03285295|157157366|FG001|Alinity s HTLV I/II|No Results Generated|0|||
49124745|NCT01791595|158294831|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
49124746|NCT01791595|158294832|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
49124747|NCT01791595|158294833|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
49124748|NCT01791595|158294834|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|2|||
49124749|NCT01791595|158294828|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
49124750|NCT01791595|158294829|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
49124751|NCT01791595|158294830|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
49124752|NCT01791595|158294831|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
49124753|NCT01791595|158294832|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
49124754|NCT01791595|158294833|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
49124755|NCT01791595|158294834|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|1|||
49124756|NCT02287038|158294838|FG000|Overall Study|Stopped attending appointments|3|||
49124757|NCT02287038|158294839|FG001|Overall Study|Stopped attending appointments|2|||
48920739|NCT02424253|157543217|FG000|Overall Study|Lost to Follow-up|1|||
48920740|NCT02424253|157543218|FG001|Overall Study|Lost to Follow-up|1|||
48920741|NCT00583362|157543219|FG000|Overall Study|Adverse Event|44|||
48920742|NCT00583362|157543219|FG000|Overall Study|Lack of Efficacy|22|||
48920743|NCT00583362|157543219|FG000|Overall Study|Lost to Follow-up|4|||
48920744|NCT00583362|157543219|FG000|Overall Study|Non-compliance with study drug|28|||
48920745|NCT00583362|157543219|FG000|Overall Study|Pregnancy|7|||
48920746|NCT00583362|157543219|FG000|Overall Study|Miscommunication of visit window|5|||
48920747|NCT00583362|157543219|FG000|Overall Study|Current site closed|7|||
48920748|NCT00583362|157543219|FG000|Overall Study|Subject not dosed in LBSL99|1|||
48920749|NCT00583362|157543219|FG000|Overall Study|Subject moved out of the country/state|2|||
48920750|NCT00583362|157543219|FG000|Overall Study|Missed visits due to staff changes|1|||
48920751|NCT00583362|157543219|FG000|Overall Study|Misunderstanding of protocol|1|||
48920752|NCT00583362|157543219|FG000|Overall Study|Behavioral problems and non-compliance|1|||
48920753|NCT00583362|157543219|FG000|Overall Study|Sponsor request due to missed doses|1|||
48920754|NCT00583362|157543219|FG000|Overall Study|Physician Decision|19|||
48920755|NCT00583362|157543219|FG000|Overall Study|Protocol Violation|2|||
48920756|NCT00583362|157543219|FG000|Overall Study|Withdrawal by Subject|57|||
48920757|NCT00205855|157543220|FG000|Overall Study|Only received temporary implants|16|||
48920758|NCT00205855|157543220|FG000|Overall Study|Withdrawal by Subject|5|||
48920759|NCT00805480|157543221|FG000|Overall Study|Withdrawal by Subject|13|||
48920760|NCT00805480|157543222|FG001|Overall Study|Withdrawal by Subject|5|||
48920761|NCT00805480|157543223|FG002|Overall Study|Withdrawal by Subject|11|||
48920762|NCT00805480|157543224|FG003|Overall Study|Withdrawal by Subject|5|||
48920763|NCT00805480|157543221|FG000|Overall Study|Lost to Follow-up|1|||
48920764|NCT00805480|157543222|FG001|Overall Study|Lost to Follow-up|2|||
48920765|NCT00805480|157543223|FG002|Overall Study|Lost to Follow-up|0|||
49124758|NCT02287038|158294838|FG000|Overall Study|Anxiety after starting medication|0|||
49124759|NCT02287038|158294839|FG001|Overall Study|Anxiety after starting medication|1|||
49124760|NCT02287038|158294838|FG000|Overall Study|Nausea after starting medication|1|||
49124761|NCT02287038|158294839|FG001|Overall Study|Nausea after starting medication|0|||
49124762|NCT02287038|158294838|FG000|Overall Study|Abnormal ECG after starting medication|1|||
49124763|NCT02287038|158294839|FG001|Overall Study|Abnormal ECG after starting medication|0|||
49124764|NCT03177148|158294842|FG000|Overall Study|Lost to Follow-up|50|||
49124765|NCT03177148|158294843|FG001|Overall Study|Lost to Follow-up|1|||
49124766|NCT03177148|158294842|FG000|Overall Study|Death|1|||
49124767|NCT03177148|158294843|FG001|Overall Study|Death|0|||
49124768|NCT02848664|158294844|FG000|Overall Study|Withdrawal by Subject|2|||
48813120|NCT03285295|157157367|FG002|Alinity s HTLV I/II|No Results Generated|0|||
48813121|NCT03285295|157157368|FG003|Alinity s HTLV I/II|No Results Generated|0|||
48920766|NCT00805480|157543224|FG003|Overall Study|Lost to Follow-up|0|||
48813122|NCT03285295|157157369|FG004|Alinity s HTLV I/II|No Results Generated|0|||
48920767|NCT00805480|157543221|FG000|Overall Study|Adverse Event|0|||
48920768|NCT00805480|157543222|FG001|Overall Study|Adverse Event|0|||
48920769|NCT00805480|157543223|FG002|Overall Study|Adverse Event|1|||
48920770|NCT00805480|157543224|FG003|Overall Study|Adverse Event|0|||
48920771|NCT01928381|157543225|FG000|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60|||
49124769|NCT02848664|158294844|FG000|Overall Study|Adverse Event|1|||
49124770|NCT02848664|158294844|FG000|Overall Study|no assistance for device training|1|||
49124771|NCT00931632|158294847|FG000|Overall Study|Withdrawal by Subject|2|||
49124772|NCT00931632|158294848|FG001|Overall Study|Withdrawal by Subject|3|||
49124773|NCT00931632|158294847|FG000|Overall Study|Adverse Event|19|||
48813123|NCT03285295|157157365|FG000|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4|||
48813124|NCT03285295|157157366|FG001|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
48813125|NCT03285295|157157367|FG002|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
48813126|NCT03285295|157157368|FG003|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
48813127|NCT03285295|157157369|FG004|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
48813128|NCT03285295|157157365|FG000|Alinity s Anti-HCV|Protocol Violation|12|||
48813129|NCT03285295|157157366|FG001|Alinity s Anti-HCV|Protocol Violation|0|||
48813130|NCT03285295|157157367|FG002|Alinity s Anti-HCV|Protocol Violation|0|||
48813131|NCT03285295|157157368|FG003|Alinity s Anti-HCV|Protocol Violation|0|||
48813132|NCT03285295|157157369|FG004|Alinity s Anti-HCV|Protocol Violation|0|||
48813133|NCT03285295|157157365|FG000|Alinity s Anti-HCV|No Results on Comparator Assay|13|||
48813134|NCT03285295|157157366|FG001|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
48813135|NCT03285295|157157367|FG002|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
48813136|NCT03285295|157157368|FG003|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
48813137|NCT03285295|157157369|FG004|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
48813138|NCT03285295|157157365|FG000|Alinity s Anti-HCV|No Results Generated|71|||
48813139|NCT03285295|157157366|FG001|Alinity s Anti-HCV|No Results Generated|0|||
48813140|NCT03285295|157157367|FG002|Alinity s Anti-HCV|No Results Generated|0|||
48813141|NCT03285295|157157368|FG003|Alinity s Anti-HCV|No Results Generated|0|||
48813142|NCT03285295|157157369|FG004|Alinity s Anti-HCV|No Results Generated|0|||
48813143|NCT03285295|157157365|FG000|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18|||
48813144|NCT03285295|157157366|FG001|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
48813145|NCT03285295|157157367|FG002|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
48813146|NCT03285295|157157368|FG003|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
48813147|NCT03285295|157157369|FG004|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
48813148|NCT03285295|157157365|FG000|Alinity s HIV Ag/Ab Combo|Protocol Violation|11|||
48813149|NCT03285295|157157366|FG001|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
48813150|NCT03285295|157157367|FG002|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
48813151|NCT03285295|157157368|FG003|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
48813152|NCT03285295|157157369|FG004|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
49124774|NCT00931632|158294848|FG001|Overall Study|Adverse Event|15|||
49124775|NCT01819727|158294850|FG000|Overall Study|Adverse Event|8|||
49124776|NCT01819727|158294851|FG001|Overall Study|Adverse Event|9|||
49124777|NCT01819727|158294850|FG000|Overall Study|Death|1|||
49124778|NCT01819727|158294851|FG001|Overall Study|Death|0|||
48813153|NCT03285295|157157365|FG000|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16|||
48920772|NCT01928381|157543226|FG001|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
48920773|NCT01928381|157543227|FG002|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
48920774|NCT01928381|157543228|FG003|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
48920775|NCT01928381|157543229|FG004|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
48920776|NCT01928381|157543230|FG005|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
48920777|NCT01928381|157543231|FG006|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
48920778|NCT01928381|157543225|FG000|Part 1 - Pain Training|Pain training criteria not met|29|||
48920779|NCT01928381|157543226|FG001|Part 1 - Pain Training|Pain training criteria not met|0|||
48920780|NCT01928381|157543227|FG002|Part 1 - Pain Training|Pain training criteria not met|0|||
48920781|NCT01928381|157543228|FG003|Part 1 - Pain Training|Pain training criteria not met|0|||
48920782|NCT01928381|157543229|FG004|Part 1 - Pain Training|Pain training criteria not met|0|||
48920783|NCT01928381|157543230|FG005|Part 1 - Pain Training|Pain training criteria not met|0|||
48920784|NCT01928381|157543231|FG006|Part 1 - Pain Training|Pain training criteria not met|0|||
48920785|NCT01928381|157543225|FG000|Part 1 - Pain Training|Withdrawal by Subject|1|||
48920786|NCT01928381|157543226|FG001|Part 1 - Pain Training|Withdrawal by Subject|0|||
48920787|NCT01928381|157543227|FG002|Part 1 - Pain Training|Withdrawal by Subject|0|||
48920788|NCT01928381|157543228|FG003|Part 1 - Pain Training|Withdrawal by Subject|0|||
48920789|NCT01928381|157543229|FG004|Part 1 - Pain Training|Withdrawal by Subject|0|||
48920790|NCT01928381|157543230|FG005|Part 1 - Pain Training|Withdrawal by Subject|0|||
48920791|NCT01928381|157543231|FG006|Part 1 - Pain Training|Withdrawal by Subject|0|||
48920792|NCT01928381|157543225|FG000|Part 1 - Pain Training|Lost to Follow-up|4|||
48920793|NCT01928381|157543226|FG001|Part 1 - Pain Training|Lost to Follow-up|0|||
48920794|NCT01928381|157543227|FG002|Part 1 - Pain Training|Lost to Follow-up|0|||
48920795|NCT01928381|157543228|FG003|Part 1 - Pain Training|Lost to Follow-up|0|||
48920796|NCT01928381|157543229|FG004|Part 1 - Pain Training|Lost to Follow-up|0|||
49124779|NCT01819727|158294850|FG000|Overall Study|Lost to Follow-up|1|||
49124780|NCT01819727|158294851|FG001|Overall Study|Lost to Follow-up|1|||
49124781|NCT01819727|158294850|FG000|Overall Study|Physician Decision|3|||
49124782|NCT01819727|158294851|FG001|Overall Study|Physician Decision|2|||
49124783|NCT01819727|158294850|FG000|Overall Study|Pregnancy|1|||
49124784|NCT01819727|158294851|FG001|Overall Study|Pregnancy|0|||
48813154|NCT03285295|157157366|FG001|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
48813155|NCT03285295|157157367|FG002|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
48813156|NCT03285295|157157368|FG003|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
48813157|NCT03285295|157157369|FG004|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
48813158|NCT03285295|157157365|FG000|Alinity s HIV Ag/Ab Combo|No Results Generated|72|||
48813159|NCT03285295|157157366|FG001|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
48813160|NCT03285295|157157367|FG002|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
48813161|NCT03285295|157157368|FG003|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
48813162|NCT03285295|157157369|FG004|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
48813163|NCT03285295|157157365|FG000|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11|||
48813164|NCT03285295|157157366|FG001|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
48813165|NCT03285295|157157367|FG002|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
48813166|NCT03285295|157157368|FG003|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
48813167|NCT03285295|157157369|FG004|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
48813168|NCT03285295|157157365|FG000|Alinity s Anti-HBc|Protocol Violation|8|||
48813169|NCT03285295|157157366|FG001|Alinity s Anti-HBc|Protocol Violation|0|||
48813170|NCT03285295|157157367|FG002|Alinity s Anti-HBc|Protocol Violation|0|||
48813171|NCT03285295|157157368|FG003|Alinity s Anti-HBc|Protocol Violation|0|||
48813172|NCT03285295|157157369|FG004|Alinity s Anti-HBc|Protocol Violation|0|||
48813173|NCT03285295|157157365|FG000|Alinity s Anti-HBc|No Results on Comparator Assay|13|||
48813174|NCT03285295|157157366|FG001|Alinity s Anti-HBc|No Results on Comparator Assay|1|||
48813175|NCT03285295|157157367|FG002|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
48813176|NCT03285295|157157368|FG003|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
48813177|NCT03285295|157157369|FG004|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
48813178|NCT03285295|157157365|FG000|Alinity s Anti-HBc|No Results Generated|70|||
48813179|NCT03285295|157157366|FG001|Alinity s Anti-HBc|No Results Generated|0|||
48813180|NCT03285295|157157367|FG002|Alinity s Anti-HBc|No Results Generated|0|||
48920797|NCT01928381|157543230|FG005|Part 1 - Pain Training|Lost to Follow-up|0|||
48920798|NCT01928381|157543231|FG006|Part 1 - Pain Training|Lost to Follow-up|0|||
48920799|NCT01928381|157543225|FG000|Part 1 - Pain Training|Protocol Violation|1|||
48920800|NCT01928381|157543226|FG001|Part 1 - Pain Training|Protocol Violation|0|||
48920801|NCT01928381|157543227|FG002|Part 1 - Pain Training|Protocol Violation|0|||
48920802|NCT01928381|157543228|FG003|Part 1 - Pain Training|Protocol Violation|0|||
48920803|NCT01928381|157543229|FG004|Part 1 - Pain Training|Protocol Violation|0|||
48920804|NCT01928381|157543230|FG005|Part 1 - Pain Training|Protocol Violation|0|||
48920805|NCT01928381|157543231|FG006|Part 1 - Pain Training|Protocol Violation|0|||
48920806|NCT01928381|157543225|FG000|Placebo run-in & Part 2 Eligibility|Adverse Event|1|||
49124785|NCT01819727|158294850|FG000|Overall Study|Protocol Violation|0|||
49124786|NCT01819727|158294851|FG001|Overall Study|Protocol Violation|2|||
49124787|NCT01819727|158294850|FG000|Overall Study|Study Terminated by Sponsor|0|||
49124788|NCT01819727|158294851|FG001|Overall Study|Study Terminated by Sponsor|1|||
49124789|NCT01819727|158294850|FG000|Overall Study|Withdrawal by Subject|6|||
49124790|NCT01819727|158294851|FG001|Overall Study|Withdrawal by Subject|11|||
49124791|NCT01819727|158294850|FG000|Overall Study|Unable to demostrate ability self-inject|0|||
49124792|NCT01819727|158294851|FG001|Overall Study|Unable to demostrate ability self-inject|1|||
49124793|NCT01819727|158294850|FG000|Overall Study|Quit due to lack of health benifits|0|||
49124794|NCT01819727|158294851|FG001|Overall Study|Quit due to lack of health benifits|1|||
49124795|NCT00715403|158294857|FG000|Overall Study|Progressive disease|0|||
49124796|NCT00715403|158294858|FG001|Overall Study|Progressive disease|1|||
49124797|NCT00715403|158294859|FG002|Overall Study|Progressive disease|3|||
49124798|NCT00715403|158294860|FG003|Overall Study|Progressive disease|9|||
49124799|NCT00715403|158294861|FG004|Overall Study|Progressive disease|5|||
48920807|NCT01928381|157543226|FG001|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
49124800|NCT00715403|158294862|FG005|Overall Study|Progressive disease|14|||
49124801|NCT00715403|158294863|FG006|Overall Study|Progressive disease|1|||
49124802|NCT00715403|158294857|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
49124803|NCT00715403|158294858|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
49124804|NCT00715403|158294859|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
49124805|NCT00715403|158294860|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
49124806|NCT00715403|158294861|FG004|Overall Study|Dose limiting Toxicity (DLT)|0|||
49124807|NCT00715403|158294862|FG005|Overall Study|Dose limiting Toxicity (DLT)|1|||
49124808|NCT00715403|158294863|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
49124809|NCT00715403|158294857|FG000|Overall Study|Other Adverse Event than DLT|1|||
49124810|NCT00715403|158294858|FG001|Overall Study|Other Adverse Event than DLT|0|||
49124811|NCT00715403|158294859|FG002|Overall Study|Other Adverse Event than DLT|0|||
48920808|NCT01928381|157543227|FG002|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
49124812|NCT00715403|158294860|FG003|Overall Study|Other Adverse Event than DLT|0|||
49124813|NCT00715403|158294861|FG004|Overall Study|Other Adverse Event than DLT|0|||
49124814|NCT00715403|158294862|FG005|Overall Study|Other Adverse Event than DLT|2|||
48813181|NCT03285295|157157368|FG003|Alinity s Anti-HBc|No Results Generated|0|||
48920809|NCT01928381|157543228|FG003|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
48813182|NCT03285295|157157369|FG004|Alinity s Anti-HBc|No Results Generated|0|||
48813183|NCT03285295|157157365|FG000|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14|||
48813184|NCT03285295|157157366|FG001|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
48920810|NCT01928381|157543229|FG004|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
49124815|NCT00715403|158294863|FG006|Overall Study|Other Adverse Event than DLT|0|||
49124816|NCT00715403|158294857|FG000|Overall Study|Protocol Violation|0|||
49124817|NCT00715403|158294858|FG001|Overall Study|Protocol Violation|0|||
49124818|NCT00715403|158294859|FG002|Overall Study|Protocol Violation|0|||
49124819|NCT00715403|158294860|FG003|Overall Study|Protocol Violation|0|||
49124820|NCT00715403|158294861|FG004|Overall Study|Protocol Violation|0|||
49124821|NCT00715403|158294862|FG005|Overall Study|Protocol Violation|1|||
49124822|NCT00715403|158294863|FG006|Overall Study|Protocol Violation|0|||
49124823|NCT00715403|158294857|FG000|Overall Study|Other reason not defined above|0|||
49124824|NCT00715403|158294858|FG001|Overall Study|Other reason not defined above|0|||
49124825|NCT00715403|158294859|FG002|Overall Study|Other reason not defined above|1|||
49124826|NCT00715403|158294860|FG003|Overall Study|Other reason not defined above|0|||
49124827|NCT00715403|158294861|FG004|Overall Study|Other reason not defined above|1|||
49124828|NCT00715403|158294862|FG005|Overall Study|Other reason not defined above|1|||
49124829|NCT00715403|158294863|FG006|Overall Study|Other reason not defined above|0|||
49124830|NCT01316224|158294864|FG000|Overall Study|Protocol Violation|3|||
49124831|NCT01316224|158294864|FG000|Overall Study|Adverse Event|3|||
49124832|NCT01316224|158294864|FG000|Overall Study|Lack of Efficacy|1|||
49124833|NCT01316224|158294864|FG000|Overall Study|Withdrawal by Subject|1|||
49124834|NCT01316224|158294864|FG000|Overall Study|Adverse Event With Treatment Failure|1|||
49124835|NCT01316224|158294864|FG000|Overall Study|Other|1|||
49124836|NCT02175225|158294865|FG000|Overall Study|Withdrawal by Subject|1|||
49124837|NCT02175225|158294866|FG001|Overall Study|Withdrawal by Subject|2|||
49124838|NCT02175225|158294865|FG000|Overall Study|Lost to Follow-up|6|||
49124839|NCT02175225|158294866|FG001|Overall Study|Lost to Follow-up|7|||
49124840|NCT02175225|158294865|FG000|Overall Study|Study drug not administered|1|||
49124841|NCT02175225|158294866|FG001|Overall Study|Study drug not administered|2|||
49124842|NCT02340000|158294867|FG000|Time Period 1|Withdrawal by Subject|6|||
49124843|NCT02340000|158294868|FG001|Time Period 1|Withdrawal by Subject|8|||
49124844|NCT02340000|158294867|FG000|Time Period 1|Lost to Follow-up|6|||
49124845|NCT02340000|158294868|FG001|Time Period 1|Lost to Follow-up|7|||
49124846|NCT02340000|158294867|FG000|Time Period 2|Withdrawal by Subject|9|||
49124847|NCT02340000|158294868|FG001|Time Period 2|Withdrawal by Subject|7|||
49124848|NCT02340000|158294867|FG000|Time Period 2|Lost to Follow-up|10|||
49124849|NCT02340000|158294868|FG001|Time Period 2|Lost to Follow-up|8|||
49124850|NCT00449163|158294871|FG000|Overall Study|Physician Decision|3|||
49124851|NCT00606307|158294872|FG000|Overall Study|Adverse Event|2|||
49124852|NCT00606307|158294872|FG000|Overall Study|Withdrawal by Subject|2|||
49124853|NCT00606307|158294872|FG000|Overall Study|Disease progression|6|||
49124854|NCT00606307|158294872|FG000|Overall Study|QTc prolongation|1|||
49124855|NCT02563899|158294873|FG000|Overall Study|Protocol Violation|1|||
49124856|NCT02563899|158294874|FG001|Overall Study|Protocol Violation|0|||
49124857|NCT02563899|158294875|FG002|Overall Study|Protocol Violation|0|||
49124858|NCT02563899|158294876|FG003|Overall Study|Protocol Violation|0|||
49124859|NCT02563899|158294873|FG000|Overall Study|Withdrawal by Subject|0|||
49124860|NCT02563899|158294874|FG001|Overall Study|Withdrawal by Subject|0|||
49124861|NCT02563899|158294875|FG002|Overall Study|Withdrawal by Subject|1|||
49124862|NCT02563899|158294876|FG003|Overall Study|Withdrawal by Subject|0|||
49124863|NCT01107925|158294878|FG000|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
48920811|NCT01928381|157543230|FG005|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
48920812|NCT01928381|157543231|FG006|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
48920813|NCT01928381|157543225|FG000|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2|||
48920814|NCT01928381|157543226|FG001|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
48920815|NCT01928381|157543227|FG002|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
48920816|NCT01928381|157543228|FG003|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
48920817|NCT01928381|157543229|FG004|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
48920818|NCT01928381|157543230|FG005|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
48920819|NCT01928381|157543231|FG006|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
49124864|NCT01107925|158294879|FG001|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
49124865|NCT01107925|158294880|FG002|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
49124866|NCT01107925|158294881|FG003|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
49124867|NCT01107925|158294882|FG004|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
49124868|NCT01107925|158294883|FG005|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
49124869|NCT01107925|158294878|FG000|Period 2|Withdrawal by Subject|0|||
49124870|NCT01107925|158294879|FG001|Period 2|Withdrawal by Subject|1|||
48813185|NCT03285295|157157367|FG002|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
49124871|NCT01107925|158294880|FG002|Period 2|Withdrawal by Subject|0|||
49124872|NCT01107925|158294881|FG003|Period 2|Withdrawal by Subject|0|||
49124873|NCT01107925|158294882|FG004|Period 2|Withdrawal by Subject|0|||
49124874|NCT01107925|158294883|FG005|Period 2|Withdrawal by Subject|1|||
49124875|NCT02322749|158294886|FG000|Period 2|Adverse Event|0|||
49124876|NCT02322749|158294887|FG001|Period 2|Adverse Event|0|||
49124877|NCT02322749|158294888|FG002|Period 2|Adverse Event|0|||
49124878|NCT02322749|158294889|FG003|Period 2|Adverse Event|1|||
49124879|NCT02322749|158294890|FG004|Period 2|Adverse Event|0|||
49124880|NCT02322749|158294891|FG005|Period 2|Adverse Event|0|||
49124881|NCT02322749|158294886|FG000|Period 2|Withdrawal by Subject|0|||
49124882|NCT02322749|158294887|FG001|Period 2|Withdrawal by Subject|0|||
49124883|NCT02322749|158294888|FG002|Period 2|Withdrawal by Subject|0|||
49124884|NCT02322749|158294889|FG003|Period 2|Withdrawal by Subject|1|||
49124885|NCT02322749|158294890|FG004|Period 2|Withdrawal by Subject|0|||
49124886|NCT02322749|158294891|FG005|Period 2|Withdrawal by Subject|0|||
49124887|NCT02322749|158294886|FG000|Period 3|Withdrawal by Subject|0|||
49124888|NCT02322749|158294887|FG001|Period 3|Withdrawal by Subject|0|||
49124889|NCT02322749|158294888|FG002|Period 3|Withdrawal by Subject|1|||
49124890|NCT02322749|158294889|FG003|Period 3|Withdrawal by Subject|0|||
49124891|NCT02322749|158294890|FG004|Period 3|Withdrawal by Subject|0|||
49124892|NCT02322749|158294891|FG005|Period 3|Withdrawal by Subject|0|||
49124893|NCT03641508|158294892|FG000|First Injection|Lost to Follow-up|2|||
49124894|NCT03641508|158294893|FG001|First Injection|Lost to Follow-up|0|||
49124895|NCT02717195|158294894|FG000|Prospective Confirmation (PC) Period|Adverse Event|19|||
49124896|NCT02717195|158294895|FG001|Prospective Confirmation (PC) Period|Adverse Event|7|||
49124897|NCT02717195|158294896|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
49124898|NCT02717195|158294897|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
49124899|NCT02717195|158294898|FG004|Prospective Confirmation (PC) Period|Adverse Event|0|||
49124900|NCT02717195|158294894|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
49124901|NCT02717195|158294895|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|1|||
48813186|NCT03285295|157157368|FG003|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
49124902|NCT02717195|158294896|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
48813187|NCT03285295|157157369|FG004|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
48813188|NCT03285295|157157365|FG000|Alinity s Chagas|Protocol Violation|76|||
49124903|NCT02717195|158294897|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
49124904|NCT02717195|158294898|FG004|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
48813189|NCT03285295|157157366|FG001|Alinity s Chagas|Protocol Violation|0|||
48813190|NCT03285295|157157367|FG002|Alinity s Chagas|Protocol Violation|0|||
48813191|NCT03285295|157157368|FG003|Alinity s Chagas|Protocol Violation|0|||
48813192|NCT03285295|157157369|FG004|Alinity s Chagas|Protocol Violation|0|||
48813193|NCT03285295|157157365|FG000|Alinity s Chagas|No Results on Comparator Assay|38|||
48813194|NCT03285295|157157366|FG001|Alinity s Chagas|No Results on Comparator Assay|0|||
48813195|NCT03285295|157157367|FG002|Alinity s Chagas|No Results on Comparator Assay|0|||
48813196|NCT03285295|157157368|FG003|Alinity s Chagas|No Results on Comparator Assay|0|||
48813197|NCT03285295|157157369|FG004|Alinity s Chagas|No Results on Comparator Assay|0|||
48920820|NCT01928381|157543225|FG000|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1|||
48920821|NCT01928381|157543226|FG001|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
48920822|NCT01928381|157543227|FG002|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
48920823|NCT01928381|157543228|FG003|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
48920824|NCT01928381|157543229|FG004|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
48920825|NCT01928381|157543230|FG005|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
48920826|NCT01928381|157543231|FG006|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
48920827|NCT01928381|157543225|FG000|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10|||
48920828|NCT01928381|157543226|FG001|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
48920829|NCT01928381|157543227|FG002|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
48920830|NCT01928381|157543228|FG003|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
48920831|NCT01928381|157543229|FG004|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
48920832|NCT01928381|157543230|FG005|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
48920833|NCT01928381|157543231|FG006|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
48920834|NCT01928381|157543225|FG000|Part 2 - First Intervention|Withdrawal by Subject|0|||
48920835|NCT01928381|157543226|FG001|Part 2 - First Intervention|Withdrawal by Subject|0|||
49124905|NCT02717195|158294894|FG000|Prospective Confirmation (PC) Period|Non-compliance with IMP|7|||
49124906|NCT02717195|158294895|FG001|Prospective Confirmation (PC) Period|Non-compliance with IMP|1|||
49124907|NCT02717195|158294896|FG002|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
49124908|NCT02717195|158294897|FG003|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
49124909|NCT02717195|158294898|FG004|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
49124910|NCT02717195|158294894|FG000|Prospective Confirmation (PC) Period|Protocol Violation|3|||
48813198|NCT03285295|157157365|FG000|Alinity s Chagas|No Results Generated|105|||
48813199|NCT03285295|157157366|FG001|Alinity s Chagas|No Results Generated|0|||
49124911|NCT02717195|158294895|FG001|Prospective Confirmation (PC) Period|Protocol Violation|1|||
49124912|NCT02717195|158294896|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
49124913|NCT02717195|158294897|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
49124914|NCT02717195|158294898|FG004|Prospective Confirmation (PC) Period|Protocol Violation|0|||
49124915|NCT02717195|158294894|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|43|||
49124916|NCT02717195|158294895|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|12|||
49124917|NCT02717195|158294896|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
49124918|NCT02717195|158294897|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
49124919|NCT02717195|158294898|FG004|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
49124920|NCT02717195|158294894|FG000|Prospective Confirmation (PC) Period|Lost to Follow-up|9|||
49124921|NCT02717195|158294895|FG001|Prospective Confirmation (PC) Period|Lost to Follow-up|4|||
49124922|NCT02717195|158294896|FG002|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
49124923|NCT02717195|158294897|FG003|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
49124924|NCT02717195|158294898|FG004|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
49124925|NCT02717195|158294894|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189|||
49124926|NCT02717195|158294895|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75|||
49124927|NCT02717195|158294896|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
49124928|NCT02717195|158294897|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
49124929|NCT02717195|158294898|FG004|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
49124930|NCT02717195|158294894|FG000|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
49124931|NCT02717195|158294895|FG001|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
49124932|NCT02717195|158294896|FG002|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
49124933|NCT02717195|158294897|FG003|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
49124934|NCT02717195|158294898|FG004|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
49124935|NCT02717195|158294894|FG000|Prospective Confirmation (PC) Period|Lack of results for blood levels|1|||
48714576|NCT00096356|156804929|FG001|Overall Study|Lack of Efficacy|0|||
49124936|NCT02717195|158294895|FG001|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
48714577|NCT00096356|156804928|FG000|Overall Study|multiple reasons|10|||
48714578|NCT00096356|156804929|FG001|Overall Study|multiple reasons|18|||
48714579|NCT02560025|156804930|FG000|Overall Study|Ineligible after consent/ registration|3|||
48714580|NCT01755026|156804934|FG000|Overall Study|Adverse Event|1|||
48714581|NCT01755026|156804935|FG001|Overall Study|Adverse Event|0|||
48714582|NCT01755026|156804934|FG000|Overall Study|Withdrawal by Subject|1|||
48714583|NCT01755026|156804935|FG001|Overall Study|Withdrawal by Subject|1|||
48714584|NCT00095147|156804936|FG000|Double-blind Period 1 (Days 1-197)|Death|1|||
49124937|NCT02717195|158294896|FG002|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
49124938|NCT02717195|158294897|FG003|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
49124939|NCT02717195|158294898|FG004|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
49124940|NCT02717195|158294894|FG000|Prospective Confirmation (PC) Period|Technical error|1|||
49124941|NCT02717195|158294895|FG001|Prospective Confirmation (PC) Period|Technical error|0|||
49124942|NCT02717195|158294896|FG002|Prospective Confirmation (PC) Period|Technical error|0|||
49124943|NCT02717195|158294897|FG003|Prospective Confirmation (PC) Period|Technical error|0|||
49124944|NCT02717195|158294898|FG004|Prospective Confirmation (PC) Period|Technical error|0|||
49124945|NCT02717195|158294894|FG000|Prospective Confirmation (PC) Period|Patient decision|5|||
49124946|NCT02717195|158294895|FG001|Prospective Confirmation (PC) Period|Patient decision|2|||
49124947|NCT02717195|158294896|FG002|Prospective Confirmation (PC) Period|Patient decision|0|||
49124948|NCT02717195|158294897|FG003|Prospective Confirmation (PC) Period|Patient decision|0|||
48714585|NCT00095147|156804937|FG001|Double-blind Period 1 (Days 1-197)|Death|0|||
49124949|NCT02717195|158294898|FG004|Prospective Confirmation (PC) Period|Patient decision|0|||
49124950|NCT02717195|158294894|FG000|Prospective Confirmation (PC) Period|Low level of drug in the blood|1|||
49124951|NCT02717195|158294895|FG001|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
49124952|NCT02717195|158294896|FG002|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
49124953|NCT02717195|158294897|FG003|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
49124954|NCT02717195|158294898|FG004|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
49124955|NCT02717195|158294894|FG000|Prospective Confirmation (PC) Period|Change of place of residence|1|||
49124956|NCT02717195|158294895|FG001|Prospective Confirmation (PC) Period|Change of place of residence|0|||
49124957|NCT02717195|158294896|FG002|Prospective Confirmation (PC) Period|Change of place of residence|0|||
49124958|NCT02717195|158294897|FG003|Prospective Confirmation (PC) Period|Change of place of residence|0|||
49124959|NCT02717195|158294898|FG004|Prospective Confirmation (PC) Period|Change of place of residence|0|||
49124960|NCT02717195|158294894|FG000|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
48714586|NCT00095147|156804938|FG002|Double-blind Period 1 (Days 1-197)|Death|0|||
48714587|NCT00095147|156804939|FG003|Double-blind Period 1 (Days 1-197)|Death|0|||
48714588|NCT00095147|156804940|FG004|Double-blind Period 1 (Days 1-197)|Death|0|||
48920836|NCT01928381|157543227|FG002|Part 2 - First Intervention|Withdrawal by Subject|1|||
48714589|NCT00095147|156804936|FG000|Double-blind Period 1 (Days 1-197)|Adverse Event|2|||
48714590|NCT00095147|156804937|FG001|Double-blind Period 1 (Days 1-197)|Adverse Event|8|||
48714591|NCT00095147|156804938|FG002|Double-blind Period 1 (Days 1-197)|Adverse Event|1|||
48714592|NCT00095147|156804939|FG003|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
48714593|NCT00095147|156804940|FG004|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
48714594|NCT00095147|156804936|FG000|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
48714595|NCT00095147|156804937|FG001|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
48714596|NCT00095147|156804938|FG002|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1|||
48714597|NCT00095147|156804939|FG003|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
48714598|NCT00095147|156804940|FG004|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
48714599|NCT00095147|156804936|FG000|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
48714600|NCT00095147|156804937|FG001|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
48714601|NCT00095147|156804938|FG002|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
48714602|NCT00095147|156804939|FG003|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
48714603|NCT00095147|156804940|FG004|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
48714604|NCT00095147|156804936|FG000|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
48714605|NCT00095147|156804937|FG001|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
48714606|NCT00095147|156804938|FG002|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
48714607|NCT00095147|156804939|FG003|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
48714608|NCT00095147|156804940|FG004|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
48714609|NCT00095147|156804936|FG000|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
48714610|NCT00095147|156804937|FG001|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
48714611|NCT00095147|156804938|FG002|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
48714612|NCT00095147|156804939|FG003|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
48714613|NCT00095147|156804940|FG004|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
48920837|NCT01928381|157543228|FG003|Part 2 - First Intervention|Withdrawal by Subject|0|||
48920838|NCT01928381|157543229|FG004|Part 2 - First Intervention|Withdrawal by Subject|0|||
48920839|NCT01928381|157543230|FG005|Part 2 - First Intervention|Withdrawal by Subject|0|||
48920840|NCT01928381|157543231|FG006|Part 2 - First Intervention|Withdrawal by Subject|0|||
48920841|NCT01928381|157543225|FG000|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
48920842|NCT01928381|157543226|FG001|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
48920843|NCT01928381|157543227|FG002|Part 2 - First Intervention|Study specific withdrawal criteria|1|||
48920844|NCT01928381|157543228|FG003|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
48920845|NCT01928381|157543229|FG004|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
48920846|NCT01928381|157543230|FG005|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
49124961|NCT02717195|158294895|FG001|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1|||
49124962|NCT02717195|158294896|FG002|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
48714614|NCT00095147|156804936|FG000|Double-blind Period 2 (Days 198-365)|Death|0|||
48714615|NCT00095147|156804937|FG001|Double-blind Period 2 (Days 198-365)|Death|1|||
48714616|NCT00095147|156804938|FG002|Double-blind Period 2 (Days 198-365)|Death|0|||
48714617|NCT00095147|156804939|FG003|Double-blind Period 2 (Days 198-365)|Death|1|||
48714618|NCT00095147|156804940|FG004|Double-blind Period 2 (Days 198-365)|Death|0|||
48714619|NCT00095147|156804936|FG000|Double-blind Period 2 (Days 198-365)|Adverse Event|2|||
48714620|NCT00095147|156804937|FG001|Double-blind Period 2 (Days 198-365)|Adverse Event|4|||
48714621|NCT00095147|156804938|FG002|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
48714622|NCT00095147|156804939|FG003|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
48714623|NCT00095147|156804940|FG004|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
48714624|NCT00095147|156804936|FG000|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2|||
48714625|NCT00095147|156804937|FG001|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4|||
48714626|NCT00095147|156804938|FG002|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
48714627|NCT00095147|156804939|FG003|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1|||
48714628|NCT00095147|156804940|FG004|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
48714629|NCT00095147|156804936|FG000|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3|||
48714630|NCT00095147|156804937|FG001|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2|||
48714631|NCT00095147|156804938|FG002|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
48714632|NCT00095147|156804939|FG003|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
48714633|NCT00095147|156804940|FG004|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
48714634|NCT00095147|156804936|FG000|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
48714635|NCT00095147|156804937|FG001|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
49124963|NCT02717195|158294897|FG003|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
49124964|NCT02717195|158294898|FG004|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
49124965|NCT02717195|158294894|FG000|Prospective Confirmation (PC) Period|Investigator decision|2|||
49124966|NCT02717195|158294895|FG001|Prospective Confirmation (PC) Period|Investigator decision|1|||
49124967|NCT02717195|158294896|FG002|Prospective Confirmation (PC) Period|Investigator decision|0|||
48714636|NCT00095147|156804938|FG002|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
48714637|NCT00095147|156804939|FG003|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
48714638|NCT00095147|156804940|FG004|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
48714639|NCT00095147|156804936|FG000|Long-term Extension Period|Death|0|||
48714640|NCT00095147|156804937|FG001|Long-term Extension Period|Death|0|||
48714641|NCT00095147|156804938|FG002|Long-term Extension Period|Death|0|||
48714642|NCT00095147|156804939|FG003|Long-term Extension Period|Death|0|||
49124968|NCT02717195|158294897|FG003|Prospective Confirmation (PC) Period|Investigator decision|0|||
49124969|NCT02717195|158294898|FG004|Prospective Confirmation (PC) Period|Investigator decision|0|||
49124970|NCT02717195|158294894|FG000|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
49124971|NCT02717195|158294895|FG001|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1|||
49124972|NCT02717195|158294896|FG002|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
49124973|NCT02717195|158294897|FG003|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
49124974|NCT02717195|158294898|FG004|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
49124975|NCT02717195|158294894|FG000|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1|||
49124976|NCT02717195|158294895|FG001|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
49124977|NCT02717195|158294896|FG002|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
49124978|NCT02717195|158294897|FG003|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
49124979|NCT02717195|158294898|FG004|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
48714643|NCT00095147|156804940|FG004|Long-term Extension Period|Death|3|||
49124980|NCT02717195|158294894|FG000|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
48714644|NCT00095147|156804936|FG000|Long-term Extension Period|Adverse Event|0|||
49124981|NCT02717195|158294895|FG001|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1|||
49124982|NCT02717195|158294896|FG002|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
48714645|NCT00095147|156804937|FG001|Long-term Extension Period|Adverse Event|0|||
48714646|NCT00095147|156804938|FG002|Long-term Extension Period|Adverse Event|0|||
48714647|NCT00095147|156804939|FG003|Long-term Extension Period|Adverse Event|0|||
48714648|NCT00095147|156804940|FG004|Long-term Extension Period|Adverse Event|11|||
49124983|NCT02717195|158294897|FG003|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
49124984|NCT02717195|158294898|FG004|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
49124985|NCT02717195|158294894|FG000|Prospective Confirmation (PC) Period|Duplicate subject|1|||
49124986|NCT02717195|158294895|FG001|Prospective Confirmation (PC) Period|Duplicate subject|0|||
49124987|NCT02717195|158294896|FG002|Prospective Confirmation (PC) Period|Duplicate subject|0|||
49124988|NCT02717195|158294897|FG003|Prospective Confirmation (PC) Period|Duplicate subject|0|||
49124989|NCT02717195|158294898|FG004|Prospective Confirmation (PC) Period|Duplicate subject|0|||
49124990|NCT02717195|158294894|FG000|Prospective Confirmation (PC) Period|Sponsor requested|0|||
49124991|NCT02717195|158294895|FG001|Prospective Confirmation (PC) Period|Sponsor requested|1|||
49124992|NCT02717195|158294896|FG002|Prospective Confirmation (PC) Period|Sponsor requested|0|||
49124993|NCT02717195|158294897|FG003|Prospective Confirmation (PC) Period|Sponsor requested|0|||
49124994|NCT02717195|158294898|FG004|Prospective Confirmation (PC) Period|Sponsor requested|0|||
48714649|NCT00095147|156804936|FG000|Long-term Extension Period|Lack of Efficacy|0|||
48714650|NCT00095147|156804937|FG001|Long-term Extension Period|Lack of Efficacy|0|||
48714651|NCT00095147|156804938|FG002|Long-term Extension Period|Lack of Efficacy|0|||
48714652|NCT00095147|156804939|FG003|Long-term Extension Period|Lack of Efficacy|0|||
48714653|NCT00095147|156804940|FG004|Long-term Extension Period|Lack of Efficacy|9|||
48714654|NCT00095147|156804936|FG000|Long-term Extension Period|Lost to Follow-up|0|||
48714655|NCT00095147|156804937|FG001|Long-term Extension Period|Lost to Follow-up|0|||
48714656|NCT00095147|156804938|FG002|Long-term Extension Period|Lost to Follow-up|0|||
48714657|NCT00095147|156804939|FG003|Long-term Extension Period|Lost to Follow-up|0|||
48714658|NCT00095147|156804940|FG004|Long-term Extension Period|Lost to Follow-up|6|||
48813200|NCT03285295|157157367|FG002|Alinity s Chagas|No Results Generated|0|||
48813201|NCT03285295|157157368|FG003|Alinity s Chagas|No Results Generated|0|||
49124995|NCT02717195|158294894|FG000|Prospective Confirmation (PC) Period|Patient fraud with payment|1|||
48714659|NCT00095147|156804936|FG000|Long-term Extension Period|Withdrawal of consent|0|||
48714660|NCT00095147|156804937|FG001|Long-term Extension Period|Withdrawal of consent|0|||
48714661|NCT00095147|156804938|FG002|Long-term Extension Period|Withdrawal of consent|0|||
48714662|NCT00095147|156804939|FG003|Long-term Extension Period|Withdrawal of consent|0|||
48714663|NCT00095147|156804940|FG004|Long-term Extension Period|Withdrawal of consent|12|||
48714664|NCT00095147|156804936|FG000|Long-term Extension Period|Pregnancy|0|||
48714665|NCT00095147|156804937|FG001|Long-term Extension Period|Pregnancy|0|||
48714666|NCT00095147|156804938|FG002|Long-term Extension Period|Pregnancy|0|||
48714667|NCT00095147|156804939|FG003|Long-term Extension Period|Pregnancy|0|||
48714668|NCT00095147|156804940|FG004|Long-term Extension Period|Pregnancy|1|||
48714669|NCT00095147|156804936|FG000|Long-term Extension Period|No longer meets study criteria|0|||
48813202|NCT03285295|157157369|FG004|Alinity s Chagas|No Results Generated|0|||
49124996|NCT02717195|158294895|FG001|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
49124997|NCT02717195|158294896|FG002|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
49124998|NCT02717195|158294897|FG003|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
49124999|NCT02717195|158294898|FG004|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
49125000|NCT02717195|158294894|FG000|Prospective Confirmation (PC) Period|Noncompliance with protocol|1|||
49125001|NCT02717195|158294895|FG001|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
49125002|NCT02717195|158294896|FG002|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
49125003|NCT02717195|158294897|FG003|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
49125004|NCT02717195|158294898|FG004|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
49125005|NCT02717195|158294894|FG000|Double-blind Treatment (DBT) Period|Adverse Event|0|||
49125006|NCT02717195|158294895|FG001|Double-blind Treatment (DBT) Period|Adverse Event|0|||
49125007|NCT02717195|158294896|FG002|Double-blind Treatment (DBT) Period|Adverse Event|10|||
49125008|NCT02717195|158294897|FG003|Double-blind Treatment (DBT) Period|Adverse Event|11|||
49125009|NCT02717195|158294898|FG004|Double-blind Treatment (DBT) Period|Adverse Event|8|||
49125010|NCT02717195|158294894|FG000|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
49125011|NCT02717195|158294895|FG001|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
48714670|NCT00095147|156804937|FG001|Long-term Extension Period|No longer meets study criteria|0|||
48714671|NCT00095147|156804938|FG002|Long-term Extension Period|No longer meets study criteria|0|||
48714672|NCT00095147|156804939|FG003|Long-term Extension Period|No longer meets study criteria|0|||
48714673|NCT00095147|156804940|FG004|Long-term Extension Period|No longer meets study criteria|1|||
48714674|NCT00095147|156804936|FG000|Long-term Extension Period|Participant chose to use Revellex|0|||
48714675|NCT00095147|156804937|FG001|Long-term Extension Period|Participant chose to use Revellex|0|||
48714676|NCT00095147|156804938|FG002|Long-term Extension Period|Participant chose to use Revellex|0|||
48714677|NCT00095147|156804939|FG003|Long-term Extension Period|Participant chose to use Revellex|0|||
48714678|NCT00095147|156804940|FG004|Long-term Extension Period|Participant chose to use Revellex|1|||
48714679|NCT00095147|156804936|FG000|Long-term Extension Period|Leaving country|0|||
48714680|NCT00095147|156804937|FG001|Long-term Extension Period|Leaving country|0|||
48714681|NCT00095147|156804938|FG002|Long-term Extension Period|Leaving country|0|||
48714682|NCT00095147|156804939|FG003|Long-term Extension Period|Leaving country|0|||
48714683|NCT00095147|156804940|FG004|Long-term Extension Period|Leaving country|1|||
48714684|NCT01087788|156804941|FG000|24-weeks Double-blind Period|Lack of Efficacy|2|||
48714685|NCT01087788|156804942|FG001|24-weeks Double-blind Period|Lack of Efficacy|0|||
48714686|NCT01087788|156804943|FG002|24-weeks Double-blind Period|Lack of Efficacy|1|||
48813203|NCT03285295|157157365|FG000|Alinity s Chagas Follow-Up|Lost to Follow-up|13|||
49125012|NCT02717195|158294896|FG002|Double-blind Treatment (DBT) Period|Lack of Efficacy|6|||
49125013|NCT02717195|158294897|FG003|Double-blind Treatment (DBT) Period|Lack of Efficacy|9|||
49125014|NCT02717195|158294898|FG004|Double-blind Treatment (DBT) Period|Lack of Efficacy|2|||
49125015|NCT02717195|158294894|FG000|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
49125016|NCT02717195|158294895|FG001|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
49125017|NCT02717195|158294896|FG002|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4|||
49125018|NCT02717195|158294897|FG003|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3|||
49125019|NCT02717195|158294898|FG004|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2|||
49125020|NCT02717195|158294894|FG000|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
49125021|NCT02717195|158294895|FG001|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
49125022|NCT02717195|158294896|FG002|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
49125023|NCT02717195|158294897|FG003|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
49125024|NCT02717195|158294898|FG004|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
49125025|NCT02717195|158294894|FG000|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
49125026|NCT02717195|158294895|FG001|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
49125027|NCT02717195|158294896|FG002|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14|||
49125028|NCT02717195|158294897|FG003|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13|||
49125029|NCT02717195|158294898|FG004|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8|||
49125030|NCT02717195|158294894|FG000|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
49125031|NCT02717195|158294895|FG001|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
49125032|NCT02717195|158294896|FG002|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
49125033|NCT02717195|158294897|FG003|Double-blind Treatment (DBT) Period|Lost to Follow-up|3|||
48813204|NCT03285295|157157366|FG001|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
48813205|NCT03285295|157157367|FG002|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
48813206|NCT03285295|157157368|FG003|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
48813207|NCT03285295|157157369|FG004|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
48813208|NCT02746575|157157370|FG000|Overall Study|Surgery cancelled or time chaned|13|||
48813209|NCT02746575|157157370|FG000|Overall Study|Received epidural|10|||
48813210|NCT02746575|157157370|FG000|Overall Study|Withdrawal by Subject|3|||
48813211|NCT02746575|157157370|FG000|Overall Study|Bradycardia/hypotension|9|||
48920847|NCT01928381|157543231|FG006|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
48920848|NCT01928381|157543225|FG000|Part 2 - First Intervention|Eligibility criterion not met|0|||
48920849|NCT01928381|157543226|FG001|Part 2 - First Intervention|Eligibility criterion not met|0|||
48920850|NCT01928381|157543227|FG002|Part 2 - First Intervention|Eligibility criterion not met|0|||
48920851|NCT01928381|157543228|FG003|Part 2 - First Intervention|Eligibility criterion not met|0|||
48920852|NCT01928381|157543229|FG004|Part 2 - First Intervention|Eligibility criterion not met|0|||
48920853|NCT01928381|157543230|FG005|Part 2 - First Intervention|Eligibility criterion not met|1|||
48920854|NCT01928381|157543231|FG006|Part 2 - First Intervention|Eligibility criterion not met|1|||
48920855|NCT01928381|157543225|FG000|Part 2 - First Intervention|Lost to Follow-up|0|||
48920856|NCT01928381|157543226|FG001|Part 2 - First Intervention|Lost to Follow-up|0|||
48920857|NCT01928381|157543227|FG002|Part 2 - First Intervention|Lost to Follow-up|0|||
48920858|NCT01928381|157543228|FG003|Part 2 - First Intervention|Lost to Follow-up|1|||
48920859|NCT01928381|157543229|FG004|Part 2 - First Intervention|Lost to Follow-up|0|||
48920860|NCT01928381|157543230|FG005|Part 2 - First Intervention|Lost to Follow-up|0|||
48920861|NCT01928381|157543231|FG006|Part 2 - First Intervention|Lost to Follow-up|0|||
48714687|NCT01087788|156804941|FG000|24-weeks Double-blind Period|Protocol Violation|0|||
48920862|NCT01928381|157543225|FG000|Washout First Intervention|Protocol Violation|0|||
48920863|NCT01928381|157543226|FG001|Washout First Intervention|Protocol Violation|0|||
48920864|NCT01928381|157543227|FG002|Washout First Intervention|Protocol Violation|0|||
49125034|NCT02717195|158294898|FG004|Double-blind Treatment (DBT) Period|Lost to Follow-up|2|||
49125035|NCT02717195|158294894|FG000|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
49125036|NCT02717195|158294895|FG001|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
49125037|NCT02717195|158294896|FG002|Double-blind Treatment (DBT) Period|Enrolled but not treated|1|||
49125038|NCT02717195|158294897|FG003|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
49125039|NCT02717195|158294898|FG004|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
49125040|NCT02717195|158294894|FG000|Double-blind Treatment (DBT) Period|Patient decision|0|||
49125041|NCT02717195|158294895|FG001|Double-blind Treatment (DBT) Period|Patient decision|0|||
49125042|NCT02717195|158294896|FG002|Double-blind Treatment (DBT) Period|Patient decision|0|||
49125043|NCT02717195|158294897|FG003|Double-blind Treatment (DBT) Period|Patient decision|2|||
49125044|NCT02717195|158294898|FG004|Double-blind Treatment (DBT) Period|Patient decision|2|||
49125045|NCT02717195|158294894|FG000|Double-blind Treatment (DBT) Period|Investigator decision|0|||
49125046|NCT02717195|158294895|FG001|Double-blind Treatment (DBT) Period|Investigator decision|0|||
49125047|NCT02717195|158294896|FG002|Double-blind Treatment (DBT) Period|Investigator decision|0|||
48714688|NCT01087788|156804942|FG001|24-weeks Double-blind Period|Protocol Violation|1|||
48714689|NCT01087788|156804943|FG002|24-weeks Double-blind Period|Protocol Violation|0|||
48714690|NCT01087788|156804941|FG000|24-weeks Double-blind Period|Lost to Follow-up|4|||
48714691|NCT01087788|156804942|FG001|24-weeks Double-blind Period|Lost to Follow-up|1|||
48714692|NCT01087788|156804943|FG002|24-weeks Double-blind Period|Lost to Follow-up|1|||
48714693|NCT01087788|156804941|FG000|24-weeks Double-blind Period|Withdrawal by Subject|7|||
48714694|NCT01087788|156804942|FG001|24-weeks Double-blind Period|Withdrawal by Subject|2|||
48714695|NCT01087788|156804943|FG002|24-weeks Double-blind Period|Withdrawal by Subject|5|||
48714696|NCT01087788|156804941|FG000|24-weeks Double-blind Period|AE, serious fatal|0|||
48714697|NCT01087788|156804942|FG001|24-weeks Double-blind Period|AE, serious fatal|1|||
48714698|NCT01087788|156804943|FG002|24-weeks Double-blind Period|AE, serious fatal|1|||
48714699|NCT01087788|156804941|FG000|24-weeks Double-blind Period|AE, serious non-fatal|0|||
48714700|NCT01087788|156804942|FG001|24-weeks Double-blind Period|AE, serious non-fatal|2|||
48714701|NCT01087788|156804943|FG002|24-weeks Double-blind Period|AE, serious non-fatal|3|||
48714702|NCT01087788|156804941|FG000|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
48714703|NCT01087788|156804942|FG001|24-weeks Double-blind Period|AE, non-serious non-fatal|1|||
48714704|NCT01087788|156804943|FG002|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
48714705|NCT01087788|156804941|FG000|24-weeks Double-blind Period|AE, unknown type|0|||
48714706|NCT01087788|156804942|FG001|24-weeks Double-blind Period|AE, unknown type|0|||
48714707|NCT01087788|156804943|FG002|24-weeks Double-blind Period|AE, unknown type|1|||
48714708|NCT01087788|156804941|FG000|24-weeks Double-blind Period|Patient (P) does not want to attend|1|||
48714709|NCT01087788|156804942|FG001|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
48920865|NCT01928381|157543228|FG003|Washout First Intervention|Protocol Violation|0|||
48714710|NCT01087788|156804943|FG002|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
48714711|NCT01087788|156804941|FG000|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
48714712|NCT01087788|156804942|FG001|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1|||
48714713|NCT01087788|156804943|FG002|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
48714714|NCT01087788|156804941|FG000|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
48714715|NCT01087788|156804942|FG001|24-weeks Double-blind Period|Exclusion criteria were not met|1|||
48714716|NCT01087788|156804943|FG002|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
48714717|NCT01087788|156804941|FG000|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
48714718|NCT01087788|156804942|FG001|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
48714719|NCT01087788|156804943|FG002|24-weeks Double-blind Period|P cannot comply with scheduled visits|1|||
48714720|NCT01087788|156804941|FG000|24-weeks Dose-blind Period|Lack of Efficacy|0|||
48714721|NCT01087788|156804942|FG001|24-weeks Dose-blind Period|Lack of Efficacy|2|||
48714722|NCT01087788|156804943|FG002|24-weeks Dose-blind Period|Lack of Efficacy|1|||
48714723|NCT01087788|156804941|FG000|24-weeks Dose-blind Period|Lost to Follow-up|1|||
48813212|NCT02746575|157157370|FG000|Overall Study|Study paused|8|||
48813213|NCT02746575|157157370|FG000|Overall Study|put on beta-blocker|3|||
48813214|NCT02746575|157157370|FG000|Overall Study|type of surgery|1|||
48813215|NCT02746575|157157370|FG000|Overall Study|typ of surgery|1|||
48813216|NCT02746575|157157370|FG000|Overall Study|PI unavailable|1|||
48813217|NCT02746575|157157370|FG000|Overall Study|Unknown history of CVA|1|||
48813218|NCT02762981|157157375|FG000|Overall Study|Adverse Event|2|||
48813219|NCT02762981|157157376|FG001|Overall Study|Adverse Event|3|||
48714724|NCT01087788|156804942|FG001|24-weeks Dose-blind Period|Lost to Follow-up|0|||
48714725|NCT01087788|156804943|FG002|24-weeks Dose-blind Period|Lost to Follow-up|1|||
48714726|NCT01087788|156804941|FG000|24-weeks Dose-blind Period|Withdrawal by Subject|1|||
48714727|NCT01087788|156804942|FG001|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
48714728|NCT01087788|156804943|FG002|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
48714729|NCT01087788|156804941|FG000|24-weeks Dose-blind Period|AE, serious fatal|0|||
48714730|NCT01087788|156804942|FG001|24-weeks Dose-blind Period|AE, serious fatal|1|||
48714731|NCT01087788|156804943|FG002|24-weeks Dose-blind Period|AE, serious fatal|0|||
48714732|NCT01087788|156804941|FG000|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
48714733|NCT01087788|156804942|FG001|24-weeks Dose-blind Period|AE, serious non-fatal|1|||
48813220|NCT02762981|157157377|FG002|Overall Study|Adverse Event|1|||
48813221|NCT02762981|157157378|FG003|Overall Study|Adverse Event|1|||
48813222|NCT02762981|157157379|FG004|Overall Study|Adverse Event|3|||
48813223|NCT02762981|157157375|FG000|Overall Study|Physician Decision|0|||
48813224|NCT02762981|157157376|FG001|Overall Study|Physician Decision|1|||
48813225|NCT02762981|157157377|FG002|Overall Study|Physician Decision|0|||
48813226|NCT02762981|157157378|FG003|Overall Study|Physician Decision|0|||
48813227|NCT02762981|157157379|FG004|Overall Study|Physician Decision|1|||
48813228|NCT02762981|157157375|FG000|Overall Study|Disease progression|11|||
48813229|NCT02762981|157157376|FG001|Overall Study|Disease progression|23|||
48813230|NCT02762981|157157377|FG002|Overall Study|Disease progression|4|||
49125048|NCT02717195|158294897|FG003|Double-blind Treatment (DBT) Period|Investigator decision|1|||
49125049|NCT02717195|158294898|FG004|Double-blind Treatment (DBT) Period|Investigator decision|1|||
49125050|NCT02717195|158294894|FG000|Double-blind Treatment (DBT) Period|Family circumstances|0|||
49125051|NCT02717195|158294895|FG001|Double-blind Treatment (DBT) Period|Family circumstances|0|||
49125052|NCT02717195|158294896|FG002|Double-blind Treatment (DBT) Period|Family circumstances|0|||
49125053|NCT02717195|158294897|FG003|Double-blind Treatment (DBT) Period|Family circumstances|0|||
49125054|NCT02717195|158294898|FG004|Double-blind Treatment (DBT) Period|Family circumstances|1|||
49125055|NCT02717195|158294894|FG000|Double-blind Treatment (DBT) Period|Change of residence|0|||
49125056|NCT02717195|158294895|FG001|Double-blind Treatment (DBT) Period|Change of residence|0|||
49125057|NCT02717195|158294896|FG002|Double-blind Treatment (DBT) Period|Change of residence|0|||
49125058|NCT02717195|158294897|FG003|Double-blind Treatment (DBT) Period|Change of residence|1|||
49125059|NCT02717195|158294898|FG004|Double-blind Treatment (DBT) Period|Change of residence|1|||
48714734|NCT01087788|156804943|FG002|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
48714735|NCT01087788|156804941|FG000|24-weeks Dose-blind Period|AE, non-serious non-fatal|2|||
48714736|NCT01087788|156804942|FG001|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
48714737|NCT01087788|156804943|FG002|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
48714738|NCT01087788|156804941|FG000|24-weeks Dose-blind Period|Sponsor decision following missed visits|1|||
49125060|NCT02717195|158294894|FG000|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
49125061|NCT02717195|158294895|FG001|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
49125062|NCT02717195|158294896|FG002|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
48714739|NCT01087788|156804942|FG001|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
48714740|NCT01087788|156804943|FG002|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
48714741|NCT01087788|156804941|FG000|24-weeks Dose-blind Period|Patient moved|0|||
48714742|NCT01087788|156804942|FG001|24-weeks Dose-blind Period|Patient moved|0|||
48714743|NCT01087788|156804943|FG002|24-weeks Dose-blind Period|Patient moved|1|||
48714744|NCT01087788|156804941|FG000|Open-Label Period (OL-P)|Lack of Efficacy|4|||
48714745|NCT01087788|156804942|FG001|Open-Label Period (OL-P)|Lack of Efficacy|2|||
48714746|NCT01087788|156804943|FG002|Open-Label Period (OL-P)|Lack of Efficacy|3|||
48714747|NCT01087788|156804941|FG000|Open-Label Period (OL-P)|Protocol Violation|2|||
48714748|NCT01087788|156804942|FG001|Open-Label Period (OL-P)|Protocol Violation|1|||
48714749|NCT01087788|156804943|FG002|Open-Label Period (OL-P)|Protocol Violation|0|||
48714750|NCT01087788|156804941|FG000|Open-Label Period (OL-P)|Lost to Follow-up|0|||
48714751|NCT01087788|156804942|FG001|Open-Label Period (OL-P)|Lost to Follow-up|4|||
48714752|NCT01087788|156804943|FG002|Open-Label Period (OL-P)|Lost to Follow-up|2|||
48714753|NCT01087788|156804941|FG000|Open-Label Period (OL-P)|Withdrawal by Subject|13|||
48714754|NCT01087788|156804942|FG001|Open-Label Period (OL-P)|Withdrawal by Subject|8|||
48714755|NCT01087788|156804943|FG002|Open-Label Period (OL-P)|Withdrawal by Subject|10|||
48714756|NCT01087788|156804941|FG000|Open-Label Period (OL-P)|AE, serious fatal|2|||
48714757|NCT01087788|156804942|FG001|Open-Label Period (OL-P)|AE, serious fatal|0|||
48714758|NCT01087788|156804943|FG002|Open-Label Period (OL-P)|AE, serious fatal|1|||
48714759|NCT01087788|156804941|FG000|Open-Label Period (OL-P)|AE, serious non-fatal|1|||
48714760|NCT01087788|156804942|FG001|Open-Label Period (OL-P)|AE, serious non-fatal|3|||
48714761|NCT01087788|156804943|FG002|Open-Label Period (OL-P)|AE, serious non-fatal|4|||
48714762|NCT01087788|156804941|FG000|Open-Label Period (OL-P)|AE, non-serious non-fatal|6|||
48714763|NCT01087788|156804942|FG001|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
48714764|NCT01087788|156804943|FG002|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
48714765|NCT01087788|156804941|FG000|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
48714766|NCT01087788|156804942|FG001|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1|||
48714767|NCT01087788|156804943|FG002|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
48714768|NCT01087788|156804941|FG000|Open-Label Period (OL-P)|AE, non-serious unknown|1|||
48714769|NCT01087788|156804942|FG001|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
48714770|NCT01087788|156804943|FG002|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
48714771|NCT01087788|156804941|FG000|Open-Label Period (OL-P)|Sponsor request|1|||
48714772|NCT01087788|156804942|FG001|Open-Label Period (OL-P)|Sponsor request|0|||
48714773|NCT01087788|156804943|FG002|Open-Label Period (OL-P)|Sponsor request|0|||
48714774|NCT01087788|156804941|FG000|Open-Label Period (OL-P)|Principal investigator decision|0|||
48714775|NCT01087788|156804942|FG001|Open-Label Period (OL-P)|Principal investigator decision|1|||
48714776|NCT01087788|156804943|FG002|Open-Label Period (OL-P)|Principal investigator decision|2|||
48714777|NCT01087788|156804941|FG000|Open-Label Period (OL-P)|No participation in study extension|0|||
48714778|NCT01087788|156804942|FG001|Open-Label Period (OL-P)|No participation in study extension|0|||
48714779|NCT01087788|156804943|FG002|Open-Label Period (OL-P)|No participation in study extension|1|||
48714780|NCT01087788|156804941|FG000|Open-Label Period (OL-P)|Personal reasons|0|||
48714781|NCT01087788|156804942|FG001|Open-Label Period (OL-P)|Personal reasons|0|||
48714782|NCT01087788|156804943|FG002|Open-Label Period (OL-P)|Personal reasons|1|||
48714783|NCT00934843|156804944|FG000|Overall Study|Protocol Violation|0|||
48714784|NCT00934843|156804945|FG001|Overall Study|Protocol Violation|1|||
48714785|NCT00160667|156804946|FG000|Overall Study|Adverse Event|3|||
48714786|NCT00160667|156804947|FG001|Overall Study|Adverse Event|1|||
48714787|NCT00160667|156804948|FG002|Overall Study|Adverse Event|4|||
48714788|NCT00160667|156804946|FG000|Overall Study|Withdrawal by Subject|2|||
48714789|NCT00160667|156804947|FG001|Overall Study|Withdrawal by Subject|0|||
48714790|NCT00160667|156804948|FG002|Overall Study|Withdrawal by Subject|1|||
48714791|NCT00160667|156804946|FG000|Overall Study|Lack of Efficacy|0|||
48714792|NCT00160667|156804947|FG001|Overall Study|Lack of Efficacy|1|||
48714793|NCT00160667|156804948|FG002|Overall Study|Lack of Efficacy|0|||
48714794|NCT00160667|156804946|FG000|Overall Study|Protocol Violation|0|||
48714795|NCT00160667|156804947|FG001|Overall Study|Protocol Violation|1|||
48714796|NCT00160667|156804948|FG002|Overall Study|Protocol Violation|0|||
48714797|NCT00160667|156804946|FG000|Overall Study|Patient decision|0|||
48714798|NCT00160667|156804947|FG001|Overall Study|Patient decision|0|||
48714799|NCT00160667|156804948|FG002|Overall Study|Patient decision|1|||
48714800|NCT01144299|156804951|FG000|Overall Study|Lost to Follow-up|1|||
48714801|NCT01144299|156804952|FG001|Overall Study|Lost to Follow-up|0|||
48714802|NCT01144299|156804951|FG000|Overall Study|Withdrawal by Subject|1|||
48714803|NCT01144299|156804952|FG001|Overall Study|Withdrawal by Subject|0|||
48714804|NCT03041129|156804956|FG000|Overall Study|Withdrawal by Subject|2|||
48714805|NCT03041129|156804957|FG001|Overall Study|Withdrawal by Subject|0|||
48714806|NCT03041129|156804958|FG002|Overall Study|Withdrawal by Subject|0|||
48714807|NCT03041129|156804959|FG003|Overall Study|Withdrawal by Subject|0|||
48714808|NCT01947855|156804960|FG000|Overall Study|Withdrawal by Subject|1|||
48714809|NCT01947855|156804961|FG001|Overall Study|Withdrawal by Subject|0|||
48714810|NCT01947855|156804962|FG002|Overall Study|Withdrawal by Subject|0|||
48714811|NCT02282293|156804963|FG000|Overall Study|Lost to Follow-up|2|||
48714812|NCT02282293|156804964|FG001|Overall Study|Lost to Follow-up|2|||
48714813|NCT02282293|156804963|FG000|Overall Study|Unable to comply with study procedures|1|||
48714814|NCT02282293|156804964|FG001|Overall Study|Unable to comply with study procedures|0|||
48714815|NCT02282293|156804963|FG000|Overall Study|Moved out of study area|0|||
48714816|NCT02282293|156804964|FG001|Overall Study|Moved out of study area|1|||
48714817|NCT03720652|156804965|FG000|Overall Study|Withdrawal by Subject|2|||
48714818|NCT03720652|156804966|FG001|Overall Study|Withdrawal by Subject|7|||
48714819|NCT03720652|156804965|FG000|Overall Study|Lost to Follow-up|0|||
48714820|NCT03720652|156804966|FG001|Overall Study|Lost to Follow-up|4|||
48714821|NCT01395524|156806515|FG000|Overall Study|Non-compliance with study schedule|1|||
48714822|NCT01395524|156806516|FG001|Overall Study|Non-compliance with study schedule|0|||
48714823|NCT01395524|156806517|FG002|Overall Study|Non-compliance with study schedule|1|||
48714824|NCT01395524|156806515|FG000|Overall Study|Lost to Follow-up|3|||
48714825|NCT01395524|156806516|FG001|Overall Study|Lost to Follow-up|1|||
48714826|NCT01395524|156806517|FG002|Overall Study|Lost to Follow-up|1|||
48714827|NCT01395524|156806515|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
48714828|NCT01395524|156806516|FG001|Overall Study|Study-Specific Withdrawal Criteria|2|||
48714829|NCT01395524|156806517|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
48714830|NCT01395524|156806515|FG000|Overall Study|Severe noncompliance with protocol|1|||
48714831|NCT01395524|156806516|FG001|Overall Study|Severe noncompliance with protocol|0|||
48714832|NCT01395524|156806517|FG002|Overall Study|Severe noncompliance with protocol|0|||
48813231|NCT02762981|157157378|FG003|Overall Study|Disease progression|10|||
48813232|NCT02762981|157157379|FG004|Overall Study|Disease progression|1|||
48813233|NCT02762981|157157375|FG000|Overall Study|Enrolled not treated|1|||
48813234|NCT02762981|157157376|FG001|Overall Study|Enrolled not treated|5|||
48813235|NCT02762981|157157377|FG002|Overall Study|Enrolled not treated|0|||
48813236|NCT02762981|157157378|FG003|Overall Study|Enrolled not treated|2|||
48813237|NCT02762981|157157379|FG004|Overall Study|Enrolled not treated|0|||
48813238|NCT02762981|157157375|FG000|Overall Study|Other|2|||
48813239|NCT02762981|157157376|FG001|Overall Study|Other|3|||
48813240|NCT02762981|157157377|FG002|Overall Study|Other|1|||
48813241|NCT02762981|157157378|FG003|Overall Study|Other|0|||
48813242|NCT02762981|157157379|FG004|Overall Study|Other|0|||
48813243|NCT02762981|157157375|FG000|Overall Study|Missing|1|||
48813244|NCT02762981|157157376|FG001|Overall Study|Missing|0|||
48813245|NCT02762981|157157377|FG002|Overall Study|Missing|0|||
48813246|NCT02762981|157157378|FG003|Overall Study|Missing|0|||
48813247|NCT02762981|157157379|FG004|Overall Study|Missing|0|||
48813248|NCT02762981|157157375|FG000|Overall Study|Withdrawal by Subject|0|||
48813249|NCT02762981|157157376|FG001|Overall Study|Withdrawal by Subject|5|||
48813250|NCT02762981|157157377|FG002|Overall Study|Withdrawal by Subject|1|||
48813251|NCT02762981|157157378|FG003|Overall Study|Withdrawal by Subject|3|||
48813252|NCT02762981|157157379|FG004|Overall Study|Withdrawal by Subject|0|||
48813253|NCT01382940|157157382|FG000|Overall Study|Adverse Event|19|||
48714833|NCT01395524|156806515|FG000|Overall Study|Adverse Event|4|||
48714834|NCT01395524|156806516|FG001|Overall Study|Adverse Event|4|||
48714835|NCT01395524|156806517|FG002|Overall Study|Adverse Event|3|||
48714836|NCT01395524|156806515|FG000|Overall Study|Death|1|||
48714837|NCT01395524|156806516|FG001|Overall Study|Death|0|||
48714838|NCT01395524|156806517|FG002|Overall Study|Death|0|||
48714839|NCT01395524|156806515|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
48714840|NCT01395524|156806516|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
48714841|NCT01395524|156806517|FG002|Overall Study|Eligibility Criteria Not Fulfilled|0|||
48714842|NCT01395524|156806515|FG000|Overall Study|Withdrawal by Subject|4|||
48714843|NCT01395524|156806516|FG001|Overall Study|Withdrawal by Subject|8|||
48714844|NCT01395524|156806517|FG002|Overall Study|Withdrawal by Subject|8|||
48714845|NCT01395524|156806515|FG000|Overall Study|Did not receive treatment|1|||
48714846|NCT01395524|156806516|FG001|Overall Study|Did not receive treatment|1|||
48714847|NCT01395524|156806517|FG002|Overall Study|Did not receive treatment|3|||
48813254|NCT01382940|157157382|FG000|Overall Study|Lost to Follow-up|4|||
48813255|NCT01382940|157157382|FG000|Overall Study|Physician Decision|7|||
48813256|NCT01382940|157157382|FG000|Overall Study|Withdrawal by Subject|23|||
48813257|NCT01382940|157157382|FG000|Overall Study|Protocol Violation|20|||
48813258|NCT01242176|157157383|FG000|Washout Period of 7 Days|Adverse Event|0|||
48813259|NCT01242176|157157384|FG001|Washout Period of 7 Days|Adverse Event|2|||
48813260|NCT01242176|157157383|FG000|Washout Period of 7 Days|Non-compliant with protocol|1|||
48920866|NCT01928381|157543229|FG004|Washout First Intervention|Protocol Violation|1|||
49125063|NCT02717195|158294897|FG003|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
49125064|NCT02717195|158294898|FG004|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1|||
49125065|NCT02717195|158294894|FG000|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
49125066|NCT02717195|158294895|FG001|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
49125067|NCT02717195|158294896|FG002|Double-blind Treatment (DBT) Period|Psychosocial issues|1|||
49125068|NCT02717195|158294897|FG003|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
49125069|NCT02717195|158294898|FG004|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
49125070|NCT02717195|158294894|FG000|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
49125071|NCT02717195|158294895|FG001|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
49125072|NCT02717195|158294896|FG002|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
49125073|NCT02717195|158294897|FG003|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
49125074|NCT02717195|158294898|FG004|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
49125075|NCT01441973|158294899|FG000|Overall Study|Disease progression|8|||
49125076|NCT01441973|158294900|FG001|Overall Study|Disease progression|6|||
49125077|NCT01441973|158294899|FG000|Overall Study|Adverse event unrelated to study drug|3|||
49125078|NCT01441973|158294900|FG001|Overall Study|Adverse event unrelated to study drug|2|||
49125079|NCT01441973|158294899|FG000|Overall Study|Participant request to discontinue|1|||
49125080|NCT01441973|158294900|FG001|Overall Study|Participant request to discontinue|1|||
49125081|NCT01441973|158294899|FG000|Overall Study|Poor compliance/noncompliance|0|||
49125082|NCT01441973|158294900|FG001|Overall Study|Poor compliance/noncompliance|1|||
49125083|NCT01441973|158294899|FG000|Overall Study|Administrative reason by sponsor|3|||
49125084|NCT01441973|158294900|FG001|Overall Study|Administrative reason by sponsor|5|||
48714848|NCT01395524|156806515|FG000|Overall Study|Subject had spinal surgery|0|||
48714849|NCT01395524|156806516|FG001|Overall Study|Subject had spinal surgery|0|||
48714850|NCT01395524|156806517|FG002|Overall Study|Subject had spinal surgery|1|||
48714851|NCT01596062|156806518|FG000|Overall Study|Adverse Event|1|||
48714852|NCT01596062|156806519|FG001|Overall Study|Adverse Event|0|||
48714853|NCT01596062|156806520|FG002|Overall Study|Adverse Event|2|||
48714854|NCT01596062|156806518|FG000|Overall Study|Lack of Efficacy|0|||
48714855|NCT01596062|156806519|FG001|Overall Study|Lack of Efficacy|0|||
48714856|NCT01596062|156806520|FG002|Overall Study|Lack of Efficacy|1|||
48714857|NCT03137069|156806523|FG000|Overall Study|Withdrawal by Subject|1|||
48714858|NCT03137069|156806524|FG001|Overall Study|Withdrawal by Subject|2|||
48714859|NCT03137069|156806525|FG002|Overall Study|Withdrawal by Subject|2|||
48714860|NCT03137069|156806526|FG003|Overall Study|Withdrawal by Subject|2|||
48714861|NCT03137069|156806527|FG004|Overall Study|Withdrawal by Subject|0|||
48714862|NCT03137069|156806528|FG005|Overall Study|Withdrawal by Subject|0|||
48714863|NCT03137069|156806523|FG000|Overall Study|Adverse Event|0|||
48714864|NCT03137069|156806524|FG001|Overall Study|Adverse Event|3|||
48714865|NCT03137069|156806525|FG002|Overall Study|Adverse Event|1|||
48714866|NCT03137069|156806526|FG003|Overall Study|Adverse Event|1|||
48714867|NCT03137069|156806527|FG004|Overall Study|Adverse Event|0|||
48714868|NCT03137069|156806528|FG005|Overall Study|Adverse Event|1|||
48714869|NCT03137069|156806523|FG000|Overall Study|Protocol Violation|0|||
48714870|NCT03137069|156806524|FG001|Overall Study|Protocol Violation|1|||
48714871|NCT03137069|156806525|FG002|Overall Study|Protocol Violation|0|||
48714872|NCT03137069|156806526|FG003|Overall Study|Protocol Violation|1|||
48714873|NCT03137069|156806527|FG004|Overall Study|Protocol Violation|1|||
48714874|NCT03137069|156806528|FG005|Overall Study|Protocol Violation|1|||
48714875|NCT03137069|156806523|FG000|Overall Study|Physician Decision|0|||
48714876|NCT03137069|156806524|FG001|Overall Study|Physician Decision|0|||
48714877|NCT03137069|156806525|FG002|Overall Study|Physician Decision|0|||
48714878|NCT03137069|156806526|FG003|Overall Study|Physician Decision|1|||
48714879|NCT03137069|156806527|FG004|Overall Study|Physician Decision|0|||
48714880|NCT03137069|156806528|FG005|Overall Study|Physician Decision|0|||
48714881|NCT03137069|156806523|FG000|Overall Study|Study Terminated by Sponsor|0|||
48714882|NCT03137069|156806524|FG001|Overall Study|Study Terminated by Sponsor|0|||
48714883|NCT03137069|156806525|FG002|Overall Study|Study Terminated by Sponsor|0|||
48714884|NCT03137069|156806526|FG003|Overall Study|Study Terminated by Sponsor|0|||
48714885|NCT03137069|156806527|FG004|Overall Study|Study Terminated by Sponsor|1|||
48714886|NCT03137069|156806528|FG005|Overall Study|Study Terminated by Sponsor|0|||
48714887|NCT03137069|156806523|FG000|Overall Study|Data Entry Error|0|||
48714888|NCT03137069|156806524|FG001|Overall Study|Data Entry Error|0|||
48714889|NCT03137069|156806525|FG002|Overall Study|Data Entry Error|0|||
48714890|NCT03137069|156806526|FG003|Overall Study|Data Entry Error|1|||
48714891|NCT03137069|156806527|FG004|Overall Study|Data Entry Error|0|||
48714892|NCT03137069|156806528|FG005|Overall Study|Data Entry Error|0|||
48714893|NCT00943072|156806533|FG000|Overall Study|Adverse Event|0|||
48714894|NCT00943072|156806534|FG001|Overall Study|Adverse Event|3|||
48714895|NCT00943072|156806533|FG000|Overall Study|Death|0|||
48920867|NCT01928381|157543230|FG005|Washout First Intervention|Protocol Violation|0|||
48714896|NCT00943072|156806534|FG001|Overall Study|Death|2|||
48813261|NCT01242176|157157384|FG001|Washout Period of 7 Days|Non-compliant with protocol|0|||
48813262|NCT00976482|157157388|FG000|Overall Study|Death|208|||
48813263|NCT00976482|157157388|FG000|Overall Study|Withdrawal by Subject|45|||
48813264|NCT00976482|157157388|FG000|Overall Study|Center terminated|1|||
48813265|NCT00976482|157157388|FG000|Overall Study|Protocol Violation|5|||
48813266|NCT03548064|157157389|FG000|Overall Study|Withdrawal by Subject|0|||
48813267|NCT03548064|157157390|FG001|Overall Study|Withdrawal by Subject|0|||
48813268|NCT03548064|157157391|FG002|Overall Study|Withdrawal by Subject|0|||
48813269|NCT03548064|157157392|FG003|Overall Study|Withdrawal by Subject|1|||
48813270|NCT03548064|157157393|FG004|Overall Study|Withdrawal by Subject|0|||
48813271|NCT03548064|157157394|FG005|Overall Study|Withdrawal by Subject|0|||
48813272|NCT03548064|157157395|FG006|Overall Study|Withdrawal by Subject|0|||
48813273|NCT03548064|157157396|FG007|Overall Study|Withdrawal by Subject|0|||
48813274|NCT03548064|157157389|FG000|Overall Study|Lost to Follow-up|0|||
48813275|NCT03548064|157157390|FG001|Overall Study|Lost to Follow-up|0|||
48813276|NCT03548064|157157391|FG002|Overall Study|Lost to Follow-up|0|||
48813277|NCT03548064|157157392|FG003|Overall Study|Lost to Follow-up|0|||
48813278|NCT03548064|157157393|FG004|Overall Study|Lost to Follow-up|2|||
48813279|NCT03548064|157157394|FG005|Overall Study|Lost to Follow-up|0|||
48813280|NCT03548064|157157395|FG006|Overall Study|Lost to Follow-up|0|||
48813281|NCT03548064|157157396|FG007|Overall Study|Lost to Follow-up|0|||
48813282|NCT03548064|157157389|FG000|Overall Study|Covid-19 Pandemic|0|||
48813283|NCT03548064|157157390|FG001|Overall Study|Covid-19 Pandemic|0|||
48813284|NCT03548064|157157391|FG002|Overall Study|Covid-19 Pandemic|0|||
48813285|NCT03548064|157157392|FG003|Overall Study|Covid-19 Pandemic|0|||
48813286|NCT03548064|157157393|FG004|Overall Study|Covid-19 Pandemic|10|||
48813287|NCT03548064|157157394|FG005|Overall Study|Covid-19 Pandemic|3|||
48813288|NCT03548064|157157395|FG006|Overall Study|Covid-19 Pandemic|0|||
48813289|NCT03548064|157157396|FG007|Overall Study|Covid-19 Pandemic|0|||
48813290|NCT04867785|157157397|FG000|Overall Study|Adverse Event|1|||
48813291|NCT04867785|157157398|FG001|Overall Study|Adverse Event|0|||
48813292|NCT04867785|157157399|FG002|Overall Study|Adverse Event|1|||
48813293|NCT04867785|157157400|FG003|Overall Study|Adverse Event|0|||
48813294|NCT04867785|157157401|FG004|Overall Study|Adverse Event|0|||
48813295|NCT04867785|157157402|FG005|Overall Study|Adverse Event|0|||
48813296|NCT04867785|157157403|FG006|Overall Study|Adverse Event|0|||
48813297|NCT04867785|157157404|FG007|Overall Study|Adverse Event|2|||
48813298|NCT04867785|157157397|FG000|Overall Study|Lost to Follow-up|4|||
48813299|NCT04867785|157157398|FG001|Overall Study|Lost to Follow-up|4|||
48813300|NCT04867785|157157399|FG002|Overall Study|Lost to Follow-up|3|||
48813301|NCT04867785|157157400|FG003|Overall Study|Lost to Follow-up|2|||
48813302|NCT04867785|157157401|FG004|Overall Study|Lost to Follow-up|0|||
48813303|NCT04867785|157157402|FG005|Overall Study|Lost to Follow-up|1|||
48813304|NCT04867785|157157403|FG006|Overall Study|Lost to Follow-up|0|||
48813305|NCT04867785|157157404|FG007|Overall Study|Lost to Follow-up|1|||
48714897|NCT00943072|156806533|FG000|Overall Study|Withdrawal by Subject|3|||
48714898|NCT00943072|156806534|FG001|Overall Study|Withdrawal by Subject|1|||
48714899|NCT00943072|156806533|FG000|Overall Study|Protocol Violation|0|||
48714900|NCT00943072|156806534|FG001|Overall Study|Protocol Violation|1|||
48714901|NCT00943072|156806533|FG000|Overall Study|Lost to Follow-up|1|||
48714902|NCT00943072|156806534|FG001|Overall Study|Lost to Follow-up|2|||
48714903|NCT00943072|156806533|FG000|Overall Study|Lack of Efficacy|0|||
48714904|NCT00943072|156806534|FG001|Overall Study|Lack of Efficacy|4|||
48714905|NCT00943072|156806533|FG000|Overall Study|Other|1|||
48714906|NCT00943072|156806534|FG001|Overall Study|Other|1|||
48714907|NCT01349049|156806535|FG000|Overall Study|Disease progression|3|||
48714908|NCT01349049|156806536|FG001|Overall Study|Disease progression|5|||
48714909|NCT01349049|156806537|FG002|Overall Study|Disease progression|3|||
48714910|NCT01349049|156806538|FG003|Overall Study|Disease progression|2|||
48714911|NCT01349049|156806539|FG004|Overall Study|Disease progression|2|||
48714912|NCT01349049|156806540|FG005|Overall Study|Disease progression|2|||
48813306|NCT04867785|157157397|FG000|Overall Study|Withdrawal by Subject|6|||
48813307|NCT04867785|157157398|FG001|Overall Study|Withdrawal by Subject|2|||
48813308|NCT04867785|157157399|FG002|Overall Study|Withdrawal by Subject|2|||
48813309|NCT04867785|157157400|FG003|Overall Study|Withdrawal by Subject|1|||
48714913|NCT01349049|156806541|FG006|Overall Study|Disease progression|3|||
48714914|NCT01349049|156806542|FG007|Overall Study|Disease progression|2|||
48813310|NCT04867785|157157401|FG004|Overall Study|Withdrawal by Subject|2|||
48813311|NCT04867785|157157402|FG005|Overall Study|Withdrawal by Subject|0|||
48813312|NCT04867785|157157403|FG006|Overall Study|Withdrawal by Subject|2|||
48813313|NCT04867785|157157404|FG007|Overall Study|Withdrawal by Subject|5|||
48813314|NCT04867785|157157397|FG000|Overall Study|Physician Decision|0|||
48813315|NCT04867785|157157398|FG001|Overall Study|Physician Decision|0|||
48813316|NCT04867785|157157399|FG002|Overall Study|Physician Decision|0|||
48813317|NCT04867785|157157400|FG003|Overall Study|Physician Decision|0|||
48714915|NCT01349049|156806543|FG008|Overall Study|Disease progression|33|||
48813318|NCT04867785|157157401|FG004|Overall Study|Physician Decision|0|||
48813319|NCT04867785|157157402|FG005|Overall Study|Physician Decision|0|||
48813320|NCT04867785|157157403|FG006|Overall Study|Physician Decision|0|||
49125085|NCT01441973|158294899|FG000|Overall Study|Participant withdrew consent|0|||
49125086|NCT01441973|158294900|FG001|Overall Study|Participant withdrew consent|1|||
49125087|NCT05117060|158294905|FG000|Overall Study|Adverse Event|3|||
49125088|NCT05117060|158294906|FG001|Overall Study|Adverse Event|5|||
49125089|NCT05117060|158294907|FG002|Overall Study|Adverse Event|6|||
49125090|NCT05117060|158294908|FG003|Overall Study|Adverse Event|1|||
49125091|NCT05117060|158294905|FG000|Overall Study|Lost to Follow-up|0|||
49125092|NCT05117060|158294906|FG001|Overall Study|Lost to Follow-up|0|||
49125093|NCT05117060|158294907|FG002|Overall Study|Lost to Follow-up|0|||
49125094|NCT05117060|158294908|FG003|Overall Study|Lost to Follow-up|1|||
49125095|NCT05117060|158294905|FG000|Overall Study|Lack of Efficacy|4|||
49125096|NCT05117060|158294906|FG001|Overall Study|Lack of Efficacy|5|||
49125097|NCT05117060|158294907|FG002|Overall Study|Lack of Efficacy|2|||
49125098|NCT05117060|158294908|FG003|Overall Study|Lack of Efficacy|6|||
49125099|NCT05117060|158294905|FG000|Overall Study|Withdrawal by Subject|8|||
49125100|NCT05117060|158294906|FG001|Overall Study|Withdrawal by Subject|5|||
49125101|NCT05117060|158294907|FG002|Overall Study|Withdrawal by Subject|5|||
49125102|NCT05117060|158294908|FG003|Overall Study|Withdrawal by Subject|6|||
49125103|NCT05117060|158294905|FG000|Overall Study|Other|2|||
49125104|NCT05117060|158294906|FG001|Overall Study|Other|1|||
49125105|NCT05117060|158294907|FG002|Overall Study|Other|3|||
49125106|NCT05117060|158294908|FG003|Overall Study|Other|1|||
49125107|NCT01081626|158294911|FG000|Overall Study|Dosing error|1|||
49125108|NCT01081626|158294912|FG001|Overall Study|Dosing error|1|||
49125109|NCT01081626|158294911|FG000|Overall Study|Missing Estradiol|25|||
49125110|NCT01081626|158294912|FG001|Overall Study|Missing Estradiol|28|||
49125111|NCT01081626|158294911|FG000|Overall Study|Low antral follicle count|1|||
49125112|NCT01081626|158294912|FG001|Overall Study|Low antral follicle count|0|||
49125113|NCT01081626|158294911|FG000|Overall Study|Overstimulation|0|||
49125114|NCT01081626|158294912|FG001|Overall Study|Overstimulation|1|||
49125115|NCT01081626|158294911|FG000|Overall Study|Lost to Follow-up|0|||
49125116|NCT01081626|158294912|FG001|Overall Study|Lost to Follow-up|1|||
49125117|NCT01081626|158294911|FG000|Overall Study|Other|33|||
49125118|NCT01081626|158294912|FG001|Overall Study|Other|30|||
49125119|NCT02003144|158294913|FG000|Open Label Maintenance Phase|Other than specified|2|||
49125120|NCT02003144|158294914|FG001|Open Label Maintenance Phase|Other than specified|4|||
49125121|NCT02003144|158294913|FG000|Open Label Maintenance Phase|Withdrawal by Subject|4|||
49125122|NCT02003144|158294914|FG001|Open Label Maintenance Phase|Withdrawal by Subject|5|||
49125123|NCT02003144|158294913|FG000|Open Label Maintenance Phase|Pregnancy|0|||
49125124|NCT02003144|158294914|FG001|Open Label Maintenance Phase|Pregnancy|2|||
49125125|NCT02003144|158294913|FG000|Open Label Maintenance Phase|Physician Decision|1|||
49125126|NCT02003144|158294914|FG001|Open Label Maintenance Phase|Physician Decision|1|||
49125127|NCT02003144|158294913|FG000|Open Label Maintenance Phase|Lost to Follow-up|0|||
49125128|NCT02003144|158294914|FG001|Open Label Maintenance Phase|Lost to Follow-up|1|||
49125129|NCT02003144|158294913|FG000|Open Label Maintenance Phase|Adverse Event|2|||
49125130|NCT02003144|158294914|FG001|Open Label Maintenance Phase|Adverse Event|1|||
49125131|NCT01814007|158294916|FG000|Overall Study|Withdrawal by Subject|1|||
49125132|NCT01919164|158296810|FG000|Overall Study|Adverse Event|6|||
49125133|NCT01919164|158296811|FG001|Overall Study|Adverse Event|4|||
49125134|NCT01919164|158296812|FG002|Overall Study|Adverse Event|9|||
49125135|NCT01919164|158296813|FG003|Overall Study|Adverse Event|3|||
49125136|NCT01919164|158296814|FG004|Overall Study|Adverse Event|2|||
49125137|NCT01919164|158296810|FG000|Overall Study|Lost to Follow-up|2|||
49125138|NCT01919164|158296811|FG001|Overall Study|Lost to Follow-up|2|||
49125139|NCT01919164|158296812|FG002|Overall Study|Lost to Follow-up|2|||
49125140|NCT01919164|158296813|FG003|Overall Study|Lost to Follow-up|0|||
49125141|NCT01919164|158296814|FG004|Overall Study|Lost to Follow-up|4|||
49125142|NCT01919164|158296810|FG000|Overall Study|Death|1|||
49125143|NCT01919164|158296811|FG001|Overall Study|Death|0|||
48813321|NCT04867785|157157404|FG007|Overall Study|Physician Decision|1|||
48813322|NCT04867785|157157397|FG000|Overall Study|Inadvertent Enrollment|0|||
48813323|NCT04867785|157157398|FG001|Overall Study|Inadvertent Enrollment|0|||
48813324|NCT04867785|157157399|FG002|Overall Study|Inadvertent Enrollment|0|||
48813325|NCT04867785|157157400|FG003|Overall Study|Inadvertent Enrollment|1|||
48813326|NCT04867785|157157401|FG004|Overall Study|Inadvertent Enrollment|1|||
48813327|NCT04867785|157157402|FG005|Overall Study|Inadvertent Enrollment|0|||
48813328|NCT04867785|157157403|FG006|Overall Study|Inadvertent Enrollment|0|||
48813329|NCT04867785|157157404|FG007|Overall Study|Inadvertent Enrollment|1|||
48813330|NCT04867785|157157397|FG000|Overall Study|Eligibility Criteria Not Met|0|||
49125144|NCT01919164|158296812|FG002|Overall Study|Death|0|||
49125145|NCT01919164|158296813|FG003|Overall Study|Death|0|||
49125146|NCT01919164|158296814|FG004|Overall Study|Death|0|||
48813331|NCT04867785|157157398|FG001|Overall Study|Eligibility Criteria Not Met|0|||
48813332|NCT04867785|157157399|FG002|Overall Study|Eligibility Criteria Not Met|0|||
49125147|NCT01919164|158296810|FG000|Overall Study|Protocol Violation|6|||
49125148|NCT01919164|158296811|FG001|Overall Study|Protocol Violation|0|||
49125149|NCT01919164|158296812|FG002|Overall Study|Protocol Violation|3|||
49125150|NCT01919164|158296813|FG003|Overall Study|Protocol Violation|2|||
49125151|NCT01919164|158296814|FG004|Overall Study|Protocol Violation|2|||
49125152|NCT01919164|158296810|FG000|Overall Study|Disease progression|2|||
49125153|NCT01919164|158296811|FG001|Overall Study|Disease progression|2|||
49125154|NCT01919164|158296812|FG002|Overall Study|Disease progression|1|||
49125155|NCT01919164|158296813|FG003|Overall Study|Disease progression|2|||
49125156|NCT01919164|158296814|FG004|Overall Study|Disease progression|1|||
49125157|NCT01919164|158296810|FG000|Overall Study|Withdrew consent|13|||
49125158|NCT01919164|158296811|FG001|Overall Study|Withdrew consent|13|||
49125159|NCT01919164|158296812|FG002|Overall Study|Withdrew consent|14|||
49125160|NCT01919164|158296813|FG003|Overall Study|Withdrew consent|14|||
49125161|NCT01919164|158296814|FG004|Overall Study|Withdrew consent|9|||
49125162|NCT01919164|158296810|FG000|Overall Study|Other Un-specified|13|||
49125163|NCT01919164|158296811|FG001|Overall Study|Other Un-specified|9|||
49125164|NCT01919164|158296812|FG002|Overall Study|Other Un-specified|8|||
49125165|NCT01919164|158296813|FG003|Overall Study|Other Un-specified|7|||
49125166|NCT01919164|158296814|FG004|Overall Study|Other Un-specified|15|||
49125167|NCT03638128|158296821|FG000|Overall Study|Withdrawal by Subject|1|||
49125168|NCT03638128|158296822|FG001|Overall Study|Withdrawal by Subject|7|||
49125169|NCT03638128|158296823|FG002|Overall Study|Withdrawal by Subject|6|||
49125170|NCT03638128|158296821|FG000|Overall Study|Sponsor Decision|15|||
49125171|NCT03638128|158296822|FG001|Overall Study|Sponsor Decision|12|||
49125172|NCT03638128|158296823|FG002|Overall Study|Sponsor Decision|19|||
49125173|NCT03638128|158296821|FG000|Overall Study|Lost to Follow-up|0|||
49125174|NCT03638128|158296822|FG001|Overall Study|Lost to Follow-up|0|||
49125175|NCT03638128|158296823|FG002|Overall Study|Lost to Follow-up|1|||
49125176|NCT01228591|158296825|FG000|Baseline|Lack of Efficacy|1|||
49125177|NCT01228591|158296826|FG001|Baseline|Lack of Efficacy|2|||
49125178|NCT04980014|158296827|FG000|Overall Study|Participants who are Duplicated|1|||
49125179|NCT04980014|158296827|FG000|Overall Study|Follow-up Failure|13|||
49125180|NCT04980014|158296827|FG000|Overall Study|Participants who did not Receive NesinaAct® Tablet|2|||
49125181|NCT04980014|158296827|FG000|Overall Study|Participants who Have Been Administered NesinaAct® Tablet prior to the consent|2|||
49125182|NCT04980014|158296827|FG000|Overall Study|Participants who Violated Inclusion/Exclusion Criteria|57|||
49125183|NCT03569098|158296828|FG000|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
49125184|NCT03569098|158296829|FG001|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2|||
49125185|NCT03569098|158296830|FG002|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
49125186|NCT03569098|158296828|FG000|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0|||
49125187|NCT03569098|158296829|FG001|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6|||
49125188|NCT03569098|158296830|FG002|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3|||
49125189|NCT03569098|158296828|FG000|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
49125190|NCT03569098|158296829|FG001|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
49125191|NCT03569098|158296830|FG002|Double-Blind Treatment Cycle 1|Lost to Follow-up|0|||
49125192|NCT03569098|158296828|FG000|Double-Blind Treatment Cycle 1|Technical problems|0|||
49125193|NCT03569098|158296829|FG001|Double-Blind Treatment Cycle 1|Technical problems|0|||
49125194|NCT03569098|158296830|FG002|Double-Blind Treatment Cycle 1|Technical problems|2|||
49125195|NCT03569098|158296828|FG000|Double-Blind Treatment Cycle 1|Physician Decision|1|||
49125196|NCT03569098|158296829|FG001|Double-Blind Treatment Cycle 1|Physician Decision|0|||
49125197|NCT03569098|158296830|FG002|Double-Blind Treatment Cycle 1|Physician Decision|0|||
49125198|NCT03569098|158296828|FG000|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
49125199|NCT03569098|158296829|FG001|Double-Blind Treatment Cycle 1|Protocol deviation|1|||
49125200|NCT03569098|158296830|FG002|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
49125201|NCT03569098|158296828|FG000|Double-Blind Treatment Cycle 1|Other|1|||
49125202|NCT03569098|158296829|FG001|Double-Blind Treatment Cycle 1|Other|0|||
49125203|NCT03569098|158296830|FG002|Double-Blind Treatment Cycle 1|Other|1|||
49125204|NCT03569098|158296828|FG000|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
49125205|NCT03569098|158296829|FG001|Open-Label Treatment Cycle 2|Study terminated by sponsor|21|||
49125206|NCT03569098|158296830|FG002|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
49125207|NCT03569098|158296828|FG000|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
49125208|NCT03569098|158296829|FG001|Open-Label Treatment Cycle 2|Withdrawal by Subject|11|||
49125209|NCT03569098|158296830|FG002|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
49125210|NCT03569098|158296828|FG000|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
49125211|NCT03569098|158296829|FG001|Open-Label Treatment Cycle 2|Lost to Follow-up|3|||
49125212|NCT03569098|158296830|FG002|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
49125213|NCT03569098|158296828|FG000|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
49125214|NCT03569098|158296829|FG001|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
49125215|NCT03569098|158296830|FG002|Open-Label Treatment Cycle 3|Withdrawal by Subject|4|||
49125216|NCT03569098|158296828|FG000|Open-Label Treatment Cycle 3|Study terminated by sponsor|0|||
49125217|NCT03569098|158296829|FG001|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
49125218|NCT03569098|158296830|FG002|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
49125219|NCT03569098|158296828|FG000|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
49125220|NCT03569098|158296829|FG001|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
49125221|NCT03569098|158296830|FG002|Open-Label Treatment Cycle 3|Lost to Follow-up|1|||
49125222|NCT02317991|158296831|FG000|Overall Study|Adverse Event|12|||
49125223|NCT02317991|158296831|FG000|Overall Study|Death|4|||
49125224|NCT02317991|158296831|FG000|Overall Study|Withdrawal by Subject|8|||
49125225|NCT02317991|158296831|FG000|Overall Study|Progressive Disease|41|||
49125226|NCT04069715|158296834|FG000|Overall Study|Lost to Follow-up|1|||
49125227|NCT04069715|158296835|FG001|Overall Study|Lost to Follow-up|1|||
48813333|NCT04867785|157157400|FG003|Overall Study|Eligibility Criteria Not Met|0|||
48813334|NCT04867785|157157401|FG004|Overall Study|Eligibility Criteria Not Met|0|||
48813335|NCT04867785|157157402|FG005|Overall Study|Eligibility Criteria Not Met|0|||
48813336|NCT04867785|157157403|FG006|Overall Study|Eligibility Criteria Not Met|0|||
48813337|NCT04867785|157157404|FG007|Overall Study|Eligibility Criteria Not Met|1|||
48813338|NCT02802319|157157417|FG000|Overall Study|Physician Decision|2|||
48813339|NCT02802319|157157418|FG001|Overall Study|Physician Decision|1|||
48813340|NCT02802319|157157417|FG000|Overall Study|Lost to Follow-up|0|||
48813341|NCT02802319|157157418|FG001|Overall Study|Lost to Follow-up|4|||
48813342|NCT00592319|157157421|FG000|Overall Study|Lost to Follow-up|0|||
48813343|NCT00592319|157157422|FG001|Overall Study|Lost to Follow-up|3|||
48813344|NCT02254421|157157427|FG000|Overall Study|Randomized but Not Treated|1|||
48813345|NCT02254421|157157428|FG001|Overall Study|Randomized but Not Treated|0|||
48813346|NCT02254421|157157427|FG000|Overall Study|Death|0|||
48813347|NCT02254421|157157428|FG001|Overall Study|Death|2|||
48813348|NCT02254421|157157427|FG000|Overall Study|Withdrew Consent|1|||
48813349|NCT02254421|157157428|FG001|Overall Study|Withdrew Consent|1|||
48813350|NCT01024959|157157429|FG000|Overall Study|ineligible|12|||
48813351|NCT01024959|157157429|FG000|Overall Study|results not evaluable|12|||
48813352|NCT01024959|157157429|FG000|Overall Study|missing results required for analysis|17|||
48813353|NCT01973491|157157430|FG000|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17|||
48813354|NCT01973491|157157430|FG000|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1|||
48813355|NCT01973491|157157430|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
48813356|NCT01863043|157157434|FG000|Overall Study|Death|6|||
48813357|NCT01863043|157157435|FG001|Overall Study|Death|1|||
48813358|NCT01863043|157157434|FG000|Overall Study|Withdrawal by Subject|0|||
48813359|NCT01863043|157157435|FG001|Overall Study|Withdrawal by Subject|2|||
48813360|NCT01863043|157157434|FG000|Overall Study|Adverse Event|7|||
48813361|NCT01863043|157157435|FG001|Overall Study|Adverse Event|8|||
48813362|NCT01863043|157157434|FG000|Overall Study|exclusion criteria found after enrollment|0|||
48813363|NCT01863043|157157435|FG001|Overall Study|exclusion criteria found after enrollment|1|||
48813364|NCT00313911|157157436|FG000|Overall Study|Serious adverse event|6|||
48813365|NCT00313911|157157437|FG001|Overall Study|Serious adverse event|1|||
48813366|NCT00313911|157157436|FG000|Overall Study|Adverse Event|2|||
48813367|NCT00313911|157157437|FG001|Overall Study|Adverse Event|3|||
48813368|NCT00313911|157157436|FG000|Overall Study|Protocol Violation|19|||
48813369|NCT00313911|157157437|FG001|Overall Study|Protocol Violation|10|||
48813370|NCT00313911|157157436|FG000|Overall Study|Lost to Follow-up|27|||
48813371|NCT00313911|157157437|FG001|Overall Study|Lost to Follow-up|14|||
48813372|NCT00313911|157157436|FG000|Overall Study|Withdrawal by Subject|39|||
48813373|NCT00313911|157157437|FG001|Overall Study|Withdrawal by Subject|12|||
48813374|NCT00313911|157157436|FG000|Overall Study|Did not meet age criteria|1|||
48813375|NCT00313911|157157437|FG001|Overall Study|Did not meet age criteria|1|||
48813376|NCT00636792|157157438|FG000|Overall Study|Adverse Event|16|||
48813377|NCT00636792|157157438|FG000|Overall Study|Physician Decision|7|||
48813378|NCT00636792|157157438|FG000|Overall Study|Progressive Disease|4|||
48813379|NCT00636792|157157438|FG000|Overall Study|Withdrawal by Subject|3|||
48813380|NCT00636792|157157438|FG000|Overall Study|Other|3|||
48813381|NCT01912781|157157439|FG000|Overall Study|Withdrawal by Subject|2|||
48813382|NCT01912781|157157440|FG001|Overall Study|Withdrawal by Subject|0|||
48813383|NCT01928225|157157443|FG000|Overall Study|Pregnancy|1|||
48813384|NCT01928225|157157444|FG001|Overall Study|Pregnancy|0|||
48813385|NCT01928225|157157443|FG000|Overall Study|basaloid cervical cancer|1|||
48813386|NCT01928225|157157444|FG001|Overall Study|basaloid cervical cancer|0|||
48813387|NCT01928225|157157443|FG000|Overall Study|Lost to Follow-up|1|||
48813388|NCT01928225|157157444|FG001|Overall Study|Lost to Follow-up|3|||
48813389|NCT03154359|157157445|FG000|Overall Study|Adverse Event|1|||
48813390|NCT03154359|157157445|FG000|Overall Study|Lack of Efficacy|2|||
49125228|NCT04069715|158296834|FG000|Overall Study|Physician Decision|1|||
49125229|NCT04069715|158296835|FG001|Overall Study|Physician Decision|1|||
49125230|NCT04069715|158296834|FG000|Overall Study|Withdrawal by Subject|3|||
48813391|NCT03154359|157157445|FG000|Overall Study|Lost to Follow-up|3|||
48813392|NCT03154359|157157445|FG000|Overall Study|Physician Decision|3|||
48813393|NCT03154359|157157445|FG000|Overall Study|Protocol Violation|4|||
49125231|NCT04069715|158296835|FG001|Overall Study|Withdrawal by Subject|3|||
49125232|NCT00823134|158296837|FG000|Overall Study|Invalid measurement|1|||
49125233|NCT02723188|158296838|FG000|Overall Study|Withdrawal by Subject|1|||
49125234|NCT02723188|158296839|FG001|Overall Study|Withdrawal by Subject|0|||
49125235|NCT02723188|158296840|FG002|Overall Study|Withdrawal by Subject|0|||
49125236|NCT01051921|158296841|FG000|Overall Study|Physician Decision|9|||
49125237|NCT01051921|158296841|FG000|Overall Study|Adverse Event|8|||
49125238|NCT01051921|158296841|FG000|Overall Study|Withdrawal by Subject|7|||
49125239|NCT01051921|158296841|FG000|Overall Study|Lost to Follow-up|4|||
49125240|NCT01051921|158296841|FG000|Overall Study|virological failure|1|||
49125241|NCT01051921|158296841|FG000|Overall Study|patient moved|1|||
49125242|NCT00377637|158296842|FG000|Induction Phase|Adverse Event|12|||
49125243|NCT00377637|158296843|FG001|Induction Phase|Adverse Event|21|||
49125244|NCT00377637|158296844|FG002|Induction Phase|Adverse Event|0|||
49125245|NCT00377637|158296845|FG003|Induction Phase|Adverse Event|0|||
49125246|NCT00377637|158296842|FG000|Induction Phase|Deterioration/serum creatinine|2|||
49125247|NCT00377637|158296843|FG001|Induction Phase|Deterioration/serum creatinine|0|||
49125248|NCT00377637|158296844|FG002|Induction Phase|Deterioration/serum creatinine|0|||
49125249|NCT00377637|158296845|FG003|Induction Phase|Deterioration/serum creatinine|0|||
49125250|NCT00377637|158296842|FG000|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
49125251|NCT00377637|158296843|FG001|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1|||
49125252|NCT00377637|158296844|FG002|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
49125253|NCT00377637|158296845|FG003|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
49125254|NCT00377637|158296842|FG000|Induction Phase|Lost to Follow-up|2|||
49125255|NCT00377637|158296843|FG001|Induction Phase|Lost to Follow-up|1|||
49125256|NCT00377637|158296844|FG002|Induction Phase|Lost to Follow-up|0|||
49125257|NCT00377637|158296845|FG003|Induction Phase|Lost to Follow-up|0|||
49125258|NCT00377637|158296842|FG000|Induction Phase|Death|1|||
49125259|NCT00377637|158296843|FG001|Induction Phase|Death|3|||
49125260|NCT00377637|158296844|FG002|Induction Phase|Death|0|||
49125261|NCT00377637|158296845|FG003|Induction Phase|Death|0|||
49125262|NCT00377637|158296842|FG000|Induction Phase|Withdrawal by Subject|5|||
49125263|NCT00377637|158296843|FG001|Induction Phase|Withdrawal by Subject|6|||
49125264|NCT00377637|158296844|FG002|Induction Phase|Withdrawal by Subject|0|||
49125265|NCT00377637|158296845|FG003|Induction Phase|Withdrawal by Subject|0|||
48714916|NCT01349049|156806535|FG000|Overall Study|Adverse Event|0|||
48714917|NCT01349049|156806536|FG001|Overall Study|Adverse Event|1|||
48714918|NCT01349049|156806537|FG002|Overall Study|Adverse Event|0|||
48714919|NCT01349049|156806538|FG003|Overall Study|Adverse Event|0|||
48714920|NCT01349049|156806539|FG004|Overall Study|Adverse Event|0|||
48714921|NCT01349049|156806540|FG005|Overall Study|Adverse Event|3|||
48714922|NCT01349049|156806541|FG006|Overall Study|Adverse Event|1|||
48714923|NCT01349049|156806542|FG007|Overall Study|Adverse Event|0|||
48714924|NCT01349049|156806543|FG008|Overall Study|Adverse Event|4|||
48714925|NCT01349049|156806535|FG000|Overall Study|Physician Decision|0|||
48714926|NCT01349049|156806536|FG001|Overall Study|Physician Decision|1|||
48714927|NCT01349049|156806537|FG002|Overall Study|Physician Decision|0|||
48714928|NCT01349049|156806538|FG003|Overall Study|Physician Decision|0|||
48714929|NCT01349049|156806539|FG004|Overall Study|Physician Decision|0|||
48714930|NCT01349049|156806540|FG005|Overall Study|Physician Decision|0|||
48714931|NCT01349049|156806541|FG006|Overall Study|Physician Decision|0|||
48714932|NCT01349049|156806542|FG007|Overall Study|Physician Decision|0|||
48714933|NCT01349049|156806543|FG008|Overall Study|Physician Decision|2|||
48714934|NCT01349049|156806535|FG000|Overall Study|Protocol Violation|0|||
48714935|NCT01349049|156806536|FG001|Overall Study|Protocol Violation|0|||
48714936|NCT01349049|156806537|FG002|Overall Study|Protocol Violation|0|||
48714937|NCT01349049|156806538|FG003|Overall Study|Protocol Violation|0|||
48714938|NCT01349049|156806539|FG004|Overall Study|Protocol Violation|0|||
48714939|NCT01349049|156806540|FG005|Overall Study|Protocol Violation|0|||
48714940|NCT01349049|156806541|FG006|Overall Study|Protocol Violation|0|||
48714941|NCT01349049|156806542|FG007|Overall Study|Protocol Violation|0|||
48714942|NCT01349049|156806543|FG008|Overall Study|Protocol Violation|1|||
48714943|NCT01349049|156806535|FG000|Overall Study|Hematopoietic stem cell transplant|0|||
48714944|NCT01349049|156806536|FG001|Overall Study|Hematopoietic stem cell transplant|0|||
48714945|NCT01349049|156806537|FG002|Overall Study|Hematopoietic stem cell transplant|0|||
48714946|NCT01349049|156806538|FG003|Overall Study|Hematopoietic stem cell transplant|0|||
49125266|NCT00377637|158296842|FG000|Induction Phase|Physician Decision|3|||
49125267|NCT00377637|158296843|FG001|Induction Phase|Physician Decision|1|||
49125268|NCT00377637|158296844|FG002|Induction Phase|Physician Decision|0|||
49125269|NCT00377637|158296845|FG003|Induction Phase|Physician Decision|0|||
49125270|NCT00377637|158296842|FG000|Induction Phase|Sponsor decision|1|||
49125271|NCT00377637|158296843|FG001|Induction Phase|Sponsor decision|2|||
49125272|NCT00377637|158296844|FG002|Induction Phase|Sponsor decision|0|||
49125273|NCT00377637|158296845|FG003|Induction Phase|Sponsor decision|0|||
48714947|NCT01349049|156806539|FG004|Overall Study|Hematopoietic stem cell transplant|1|||
48714948|NCT01349049|156806540|FG005|Overall Study|Hematopoietic stem cell transplant|0|||
48714949|NCT01349049|156806541|FG006|Overall Study|Hematopoietic stem cell transplant|1|||
48920868|NCT01928381|157543231|FG006|Washout First Intervention|Protocol Violation|0|||
49125274|NCT00377637|158296842|FG000|Induction Phase|Non-Compliance|1|||
49125275|NCT00377637|158296843|FG001|Induction Phase|Non-Compliance|0|||
49125276|NCT00377637|158296844|FG002|Induction Phase|Non-Compliance|0|||
48714950|NCT01349049|156806542|FG007|Overall Study|Hematopoietic stem cell transplant|1|||
49125277|NCT00377637|158296845|FG003|Induction Phase|Non-Compliance|0|||
49125278|NCT00377637|158296842|FG000|Induction Phase|Reason for withdrawal is not noted|2|||
49125279|NCT00377637|158296843|FG001|Induction Phase|Reason for withdrawal is not noted|0|||
49125280|NCT00377637|158296844|FG002|Induction Phase|Reason for withdrawal is not noted|0|||
49125281|NCT00377637|158296845|FG003|Induction Phase|Reason for withdrawal is not noted|0|||
49125282|NCT00377637|158296842|FG000|Maintenance Phase|Adverse Event|0|||
49125283|NCT00377637|158296843|FG001|Maintenance Phase|Adverse Event|0|||
49125284|NCT00377637|158296844|FG002|Maintenance Phase|Adverse Event|29|||
49125285|NCT00377637|158296845|FG003|Maintenance Phase|Adverse Event|43|||
48714951|NCT01349049|156806543|FG008|Overall Study|Hematopoietic stem cell transplant|0|||
48714952|NCT01349049|156806535|FG000|Overall Study|Other|0|||
48714953|NCT01349049|156806536|FG001|Overall Study|Other|0|||
48714954|NCT01349049|156806537|FG002|Overall Study|Other|0|||
48714955|NCT01349049|156806538|FG003|Overall Study|Other|0|||
48714956|NCT01349049|156806539|FG004|Overall Study|Other|0|||
48714957|NCT01349049|156806540|FG005|Overall Study|Other|1|||
48714958|NCT01349049|156806541|FG006|Overall Study|Other|0|||
48813394|NCT03154359|157157445|FG000|Overall Study|Withdrawal by Subject|5|||
48920869|NCT01928381|157543225|FG000|Part 2 - Second Intervention|Lost to Follow-up|0|||
48920870|NCT01928381|157543226|FG001|Part 2 - Second Intervention|Lost to Follow-up|1|||
48920871|NCT01928381|157543227|FG002|Part 2 - Second Intervention|Lost to Follow-up|0|||
48920872|NCT01928381|157543228|FG003|Part 2 - Second Intervention|Lost to Follow-up|1|||
48920873|NCT01928381|157543229|FG004|Part 2 - Second Intervention|Lost to Follow-up|0|||
48920874|NCT01928381|157543230|FG005|Part 2 - Second Intervention|Lost to Follow-up|0|||
48920875|NCT01928381|157543231|FG006|Part 2 - Second Intervention|Lost to Follow-up|0|||
48920876|NCT01928381|157543225|FG000|Part 2 - Post Third Intervention|Protocol Violation|0|||
48920877|NCT01928381|157543226|FG001|Part 2 - Post Third Intervention|Protocol Violation|0|||
48920878|NCT01928381|157543227|FG002|Part 2 - Post Third Intervention|Protocol Violation|1|||
48920879|NCT01928381|157543228|FG003|Part 2 - Post Third Intervention|Protocol Violation|0|||
48920880|NCT01928381|157543229|FG004|Part 2 - Post Third Intervention|Protocol Violation|0|||
48920881|NCT01928381|157543230|FG005|Part 2 - Post Third Intervention|Protocol Violation|0|||
48920882|NCT01928381|157543231|FG006|Part 2 - Post Third Intervention|Protocol Violation|0|||
49125286|NCT00377637|158296842|FG000|Maintenance Phase|Physician Decision|0|||
49125287|NCT00377637|158296843|FG001|Maintenance Phase|Physician Decision|0|||
49125288|NCT00377637|158296844|FG002|Maintenance Phase|Physician Decision|5|||
49125289|NCT00377637|158296845|FG003|Maintenance Phase|Physician Decision|4|||
49125290|NCT00377637|158296842|FG000|Maintenance Phase|Lost to Follow-up|0|||
49125291|NCT00377637|158296843|FG001|Maintenance Phase|Lost to Follow-up|0|||
49125292|NCT00377637|158296844|FG002|Maintenance Phase|Lost to Follow-up|3|||
49125293|NCT00377637|158296845|FG003|Maintenance Phase|Lost to Follow-up|1|||
49125294|NCT00377637|158296842|FG000|Maintenance Phase|Withdrawal by Subject|0|||
49125295|NCT00377637|158296843|FG001|Maintenance Phase|Withdrawal by Subject|0|||
49125296|NCT00377637|158296844|FG002|Maintenance Phase|Withdrawal by Subject|3|||
49125297|NCT00377637|158296845|FG003|Maintenance Phase|Withdrawal by Subject|3|||
49125298|NCT00377637|158296842|FG000|Maintenance Phase|Sponsor decision|0|||
49125299|NCT00377637|158296843|FG001|Maintenance Phase|Sponsor decision|0|||
49125300|NCT00377637|158296844|FG002|Maintenance Phase|Sponsor decision|2|||
49125301|NCT00377637|158296845|FG003|Maintenance Phase|Sponsor decision|3|||
48714959|NCT01349049|156806542|FG007|Overall Study|Other|0|||
48714960|NCT01349049|156806543|FG008|Overall Study|Other|4|||
48714961|NCT01349049|156806535|FG000|Overall Study|Death|0|||
48714962|NCT01349049|156806536|FG001|Overall Study|Death|0|||
48714963|NCT01349049|156806537|FG002|Overall Study|Death|0|||
48714964|NCT01349049|156806538|FG003|Overall Study|Death|0|||
48714965|NCT01349049|156806539|FG004|Overall Study|Death|0|||
48714966|NCT01349049|156806540|FG005|Overall Study|Death|0|||
48714967|NCT01349049|156806541|FG006|Overall Study|Death|0|||
48714968|NCT01349049|156806542|FG007|Overall Study|Death|1|||
48714969|NCT01349049|156806543|FG008|Overall Study|Death|5|||
49125302|NCT00377637|158296842|FG000|Maintenance Phase|Non-compliance|0|||
49125303|NCT00377637|158296843|FG001|Maintenance Phase|Non-compliance|0|||
49125304|NCT00377637|158296844|FG002|Maintenance Phase|Non-compliance|1|||
49125305|NCT00377637|158296845|FG003|Maintenance Phase|Non-compliance|1|||
49125306|NCT00377637|158296842|FG000|Maintenance Phase|Study medication stopped > 14 days|0|||
49125307|NCT00377637|158296843|FG001|Maintenance Phase|Study medication stopped > 14 days|0|||
49125308|NCT00377637|158296844|FG002|Maintenance Phase|Study medication stopped > 14 days|0|||
49125309|NCT00377637|158296845|FG003|Maintenance Phase|Study medication stopped > 14 days|1|||
49125310|NCT00377637|158296842|FG000|Maintenance Phase|Death|0|||
49125311|NCT00377637|158296843|FG001|Maintenance Phase|Death|0|||
49125312|NCT00377637|158296844|FG002|Maintenance Phase|Death|0|||
49125313|NCT00377637|158296845|FG003|Maintenance Phase|Death|1|||
49125314|NCT03028142|158296846|FG000|Overall Study|Adverse Event|1|||
49125315|NCT03028142|158296847|FG001|Overall Study|Adverse Event|1|||
49125316|NCT03028142|158296848|FG002|Overall Study|Adverse Event|0|||
49125317|NCT03028142|158296849|FG003|Overall Study|Adverse Event|0|||
49125318|NCT03028142|158296850|FG004|Overall Study|Adverse Event|0|||
49125319|NCT03028142|158296851|FG005|Overall Study|Adverse Event|1|||
49125320|NCT03028142|158296846|FG000|Overall Study|Withdrawal by Subject|0|||
49125321|NCT03028142|158296847|FG001|Overall Study|Withdrawal by Subject|0|||
49125322|NCT03028142|158296848|FG002|Overall Study|Withdrawal by Subject|0|||
49125323|NCT03028142|158296849|FG003|Overall Study|Withdrawal by Subject|0|||
49125324|NCT03028142|158296850|FG004|Overall Study|Withdrawal by Subject|1|||
49125325|NCT03028142|158296851|FG005|Overall Study|Withdrawal by Subject|0|||
49125326|NCT04085601|158296856|FG000|Overall Study|Lost to Follow-up|1|||
49125327|NCT04085601|158296857|FG001|Overall Study|Lost to Follow-up|0|||
49125328|NCT04085601|158296856|FG000|Overall Study|Death|1|||
49125329|NCT04085601|158296857|FG001|Overall Study|Death|1|||
49125330|NCT02810418|158296858|FG000|Arm A Dose Escalation|Adverse Event|2|||
49125331|NCT02810418|158296859|FG001|Arm A Dose Escalation|Adverse Event|1|||
49125332|NCT02810418|158296860|FG002|Arm A Dose Escalation|Adverse Event|0|||
49125333|NCT02810418|158296861|FG003|Arm A Dose Escalation|Adverse Event|0|||
49125334|NCT02810418|158296862|FG004|Arm A Dose Escalation|Adverse Event|0|||
49125335|NCT02810418|158296863|FG005|Arm A Dose Escalation|Adverse Event|0|||
49125336|NCT02810418|158296864|FG006|Arm A Dose Escalation|Adverse Event|0|||
49125337|NCT02810418|158296858|FG000|Dose Expansion|Adverse Event|0|||
49125338|NCT02810418|158296859|FG001|Dose Expansion|Adverse Event|1|||
49125339|NCT02810418|158296860|FG002|Dose Expansion|Adverse Event|1|||
49125340|NCT02810418|158296861|FG003|Dose Expansion|Adverse Event|0|||
49125341|NCT02810418|158296862|FG004|Dose Expansion|Adverse Event|0|||
49125342|NCT02810418|158296863|FG005|Dose Expansion|Adverse Event|0|||
49125343|NCT02810418|158296864|FG006|Dose Expansion|Adverse Event|0|||
49125344|NCT02810418|158296858|FG000|Dose Expansion|Physician Decision|0|||
49125345|NCT02810418|158296859|FG001|Dose Expansion|Physician Decision|0|||
49125346|NCT02810418|158296860|FG002|Dose Expansion|Physician Decision|2|||
49125347|NCT02810418|158296861|FG003|Dose Expansion|Physician Decision|0|||
49125348|NCT02810418|158296862|FG004|Dose Expansion|Physician Decision|0|||
49125349|NCT02810418|158296863|FG005|Dose Expansion|Physician Decision|0|||
49125350|NCT02810418|158296864|FG006|Dose Expansion|Physician Decision|0|||
49125351|NCT02810418|158296858|FG000|Arm B Dose Escalation|Adverse Event|0|||
49125352|NCT02810418|158296859|FG001|Arm B Dose Escalation|Adverse Event|0|||
49125353|NCT02810418|158296860|FG002|Arm B Dose Escalation|Adverse Event|0|||
49125354|NCT02810418|158296861|FG003|Arm B Dose Escalation|Adverse Event|0|||
49125355|NCT02810418|158296862|FG004|Arm B Dose Escalation|Adverse Event|1|||
49125356|NCT02810418|158296863|FG005|Arm B Dose Escalation|Adverse Event|2|||
49125357|NCT02810418|158296864|FG006|Arm B Dose Escalation|Adverse Event|0|||
49125358|NCT00010257|158296865|FG000|Overall Study|Withdrawal by Subject|1|||
49125359|NCT00010257|158296866|FG001|Overall Study|Withdrawal by Subject|0|||
49125360|NCT03506438|158296867|FG000|Overall Study|Lost to Follow-up|8|||
49125361|NCT03506438|158296868|FG001|Overall Study|Lost to Follow-up|7|||
49125362|NCT03506438|158296869|FG002|Overall Study|Lost to Follow-up|8|||
49125363|NCT03506438|158296870|FG003|Overall Study|Lost to Follow-up|7|||
49125364|NCT03506438|158296871|FG004|Overall Study|Lost to Follow-up|0|||
48714970|NCT01349049|156806535|FG000|Overall Study|Non-compliance|0|||
48714971|NCT01349049|156806536|FG001|Overall Study|Non-compliance|0|||
49125365|NCT03506438|158296872|FG005|Overall Study|Lost to Follow-up|0|||
49125366|NCT03234036|158296879|FG000|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
49125367|NCT03234036|158296880|FG001|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
49125368|NCT03234036|158296881|FG002|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
49125369|NCT03234036|158296882|FG003|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
48714972|NCT01349049|156806537|FG002|Overall Study|Non-compliance|0|||
48714973|NCT01349049|156806538|FG003|Overall Study|Non-compliance|1|||
49125370|NCT00368108|158296899|FG000|Overall Study|Adverse Event|38|||
49125371|NCT00368108|158296900|FG001|Overall Study|Adverse Event|26|||
49125372|NCT00368108|158296901|FG002|Overall Study|Adverse Event|44|||
49125373|NCT00368108|158296899|FG000|Overall Study|Abnormal Laboratory Value|0|||
49125374|NCT00368108|158296900|FG001|Overall Study|Abnormal Laboratory Value|0|||
49125375|NCT00368108|158296901|FG002|Overall Study|Abnormal Laboratory Value|3|||
49125376|NCT00368108|158296899|FG000|Overall Study|Protocol Violation|5|||
49125377|NCT00368108|158296900|FG001|Overall Study|Protocol Violation|9|||
49125378|NCT00368108|158296901|FG002|Overall Study|Protocol Violation|9|||
49125379|NCT00368108|158296899|FG000|Overall Study|Withdrawal by Subject|9|||
49125380|NCT00368108|158296900|FG001|Overall Study|Withdrawal by Subject|3|||
49125381|NCT00368108|158296901|FG002|Overall Study|Withdrawal by Subject|5|||
49125382|NCT00368108|158296899|FG000|Overall Study|Lack of Efficacy|7|||
49125383|NCT00368108|158296900|FG001|Overall Study|Lack of Efficacy|8|||
49125384|NCT00368108|158296901|FG002|Overall Study|Lack of Efficacy|5|||
49125385|NCT00368108|158296899|FG000|Overall Study|Physician Decision|2|||
49125386|NCT00368108|158296900|FG001|Overall Study|Physician Decision|0|||
49125387|NCT00368108|158296901|FG002|Overall Study|Physician Decision|1|||
49125388|NCT00368108|158296899|FG000|Overall Study|Other|3|||
49125389|NCT00368108|158296900|FG001|Overall Study|Other|7|||
49125390|NCT00368108|158296901|FG002|Overall Study|Other|1|||
49125391|NCT01241279|158296902|FG000|Overall Study|Lost to Follow-up|0|||
49125392|NCT01241279|158296903|FG001|Overall Study|Lost to Follow-up|1|||
49125393|NCT02302846|158296906|FG000|Overall Study|Withdrawal by Subject|1|||
49125394|NCT02948829|158296907|FG000|Overall Study|Lost to Follow-up|2|||
49125395|NCT02948829|158296907|FG000|Overall Study|Withdrawal by Subject and/or Subject's Parent(s)/ Legally Authorized Representative (LAR)|5|||
49125396|NCT02948829|158296907|FG000|Overall Study|Pregnancy|1|||
49125397|NCT02948829|158296907|FG000|Overall Study|Other: Reason not Specified|8|||
49125398|NCT01450813|158296910|FG000|Overall Study|Physician Decision|1|||
49125399|NCT01450813|158296911|FG001|Overall Study|Physician Decision|1|||
49125400|NCT01450813|158296912|FG002|Overall Study|Physician Decision|0|||
49125401|NCT01450813|158296913|FG003|Overall Study|Physician Decision|3|||
49125402|NCT00917124|158296914|FG000|Overall Study|Protocol Violation|4|||
49125403|NCT00917124|158296915|FG001|Overall Study|Protocol Violation|6|||
49125404|NCT01935089|158296916|FG000|Overall Study|Adverse Event|2|||
49125405|NCT01935089|158296916|FG000|Overall Study|Withdrawal by Subject|1|||
49125406|NCT00737100|158296929|FG000|Overall Study|Adverse Event|6|||
49125407|NCT00737100|158296930|FG001|Overall Study|Adverse Event|5|||
49125408|NCT00737100|158296931|FG002|Overall Study|Adverse Event|3|||
49125409|NCT00737100|158296929|FG000|Overall Study|Lost to Follow-up|0|||
49125410|NCT00737100|158296930|FG001|Overall Study|Lost to Follow-up|1|||
49125411|NCT00737100|158296931|FG002|Overall Study|Lost to Follow-up|0|||
49125412|NCT00737100|158296929|FG000|Overall Study|Withdrawal by Subject|0|||
49125413|NCT00737100|158296930|FG001|Overall Study|Withdrawal by Subject|0|||
49125414|NCT00737100|158296931|FG002|Overall Study|Withdrawal by Subject|3|||
49125415|NCT00737100|158296929|FG000|Overall Study|Reason discontinued not explained above|1|||
49125416|NCT00737100|158296930|FG001|Overall Study|Reason discontinued not explained above|1|||
49125417|NCT00737100|158296931|FG002|Overall Study|Reason discontinued not explained above|1|||
49125418|NCT00232557|158296932|FG000|Overall Study|Lost to Follow-up|3|||
49125419|NCT00232557|158296933|FG001|Overall Study|Lost to Follow-up|5|||
49125420|NCT01447407|158296934|FG000|Overall Study|Withdrawal by Subject|2|||
49125421|NCT01447407|158296935|FG001|Overall Study|Withdrawal by Subject|0|||
49125422|NCT01447407|158296936|FG002|Overall Study|Withdrawal by Subject|0|||
49125423|NCT01447407|158296937|FG003|Overall Study|Withdrawal by Subject|1|||
49125424|NCT01447407|158296934|FG000|Overall Study|Physician Decision|0|||
49125425|NCT01447407|158296935|FG001|Overall Study|Physician Decision|0|||
49125426|NCT01447407|158296936|FG002|Overall Study|Physician Decision|1|||
49125427|NCT01447407|158296937|FG003|Overall Study|Physician Decision|1|||
49125428|NCT01783743|158296940|FG000|Screening of Subjects by CTA During MDA|Absent at MDA|3427|||
49125429|NCT01783743|158296941|FG001|Screening of Subjects by CTA During MDA|Absent at MDA|4439|||
49125430|NCT01783743|158296940|FG000|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591|||
49125431|NCT01783743|158296941|FG001|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684|||
49125432|NCT01783743|158296940|FG000|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305|||
49125433|NCT01783743|158296941|FG001|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236|||
49125434|NCT01607593|158296942|FG000|Overall Study|Adverse Event|15|||
49125435|NCT01607593|158296942|FG000|Overall Study|Lack of Efficacy|16|||
48813395|NCT03154359|157157445|FG000|Overall Study|Disruption of study due to COVID-19|4|||
49125436|NCT01607593|158296942|FG000|Overall Study|Lost to Follow-up|25|||
49125437|NCT01607593|158296942|FG000|Overall Study|Continuation|33|||
49125438|NCT01607593|158296942|FG000|Overall Study|Other|4|||
49125439|NCT00458003|158296945|FG000|Overall Study|Non protocol spinal anesthesia|1|||
49125440|NCT00458003|158296946|FG001|Overall Study|Non protocol spinal anesthesia|1|||
49125441|NCT01348139|158296947|FG000|Period 1|Adverse Event|1|||
49125442|NCT01348139|158296948|FG001|Period 1|Adverse Event|0|||
49125443|NCT01348139|158296949|FG002|Period 1|Adverse Event|0|||
49125444|NCT01348139|158296950|FG003|Period 1|Adverse Event|0|||
49125445|NCT01348139|158296951|FG004|Period 1|Adverse Event|0|||
48920883|NCT03451773|157544776|FG000|Overall Study|Death on study|1|||
49125446|NCT01348139|158296952|FG005|Period 1|Adverse Event|0|||
49125447|NCT01249131|158296956|FG000|Washout Period of 10 Days|Adverse Event|0|||
48714974|NCT01349049|156806539|FG004|Overall Study|Non-compliance|0|||
48714975|NCT01349049|156806540|FG005|Overall Study|Non-compliance|0|||
48714976|NCT01349049|156806541|FG006|Overall Study|Non-compliance|0|||
48714977|NCT01349049|156806542|FG007|Overall Study|Non-compliance|0|||
48714978|NCT01349049|156806543|FG008|Overall Study|Non-compliance|0|||
48714979|NCT01349049|156806535|FG000|Overall Study|Withdrawal by Subject|0|||
48714980|NCT01349049|156806536|FG001|Overall Study|Withdrawal by Subject|0|||
48714981|NCT01349049|156806537|FG002|Overall Study|Withdrawal by Subject|0|||
48920884|NCT03451773|157544777|FG001|Overall Study|Death on study|5|||
48920885|NCT03451773|157544776|FG000|Overall Study|Death during follow-up period|0|||
48813396|NCT01454830|157157446|FG000|Overall Study|Withdrawal by Subject|4|||
48813397|NCT01454830|157157447|FG001|Overall Study|Withdrawal by Subject|4|||
48813398|NCT01454830|157157446|FG000|Overall Study|Post-allocation Exclude- AHI<10|18|||
48813399|NCT01454830|157157447|FG001|Overall Study|Post-allocation Exclude- AHI<10|12|||
48813400|NCT01454830|157157446|FG000|Overall Study|Post-allocation Exclude-refused PAP|0|||
48813401|NCT01454830|157157447|FG001|Overall Study|Post-allocation Exclude-refused PAP|2|||
48813402|NCT01454830|157157446|FG000|Overall Study|Post-allocation Exclude-other treatment|6|||
48813403|NCT01454830|157157447|FG001|Overall Study|Post-allocation Exclude-other treatment|7|||
48813404|NCT01454830|157157446|FG000|Overall Study|Withdrawal - no polysomnography|3|||
48714982|NCT01349049|156806538|FG003|Overall Study|Withdrawal by Subject|0|||
48714983|NCT01349049|156806539|FG004|Overall Study|Withdrawal by Subject|0|||
48714984|NCT01349049|156806540|FG005|Overall Study|Withdrawal by Subject|0|||
48714985|NCT01349049|156806541|FG006|Overall Study|Withdrawal by Subject|0|||
48714986|NCT01349049|156806542|FG007|Overall Study|Withdrawal by Subject|0|||
48714987|NCT01349049|156806543|FG008|Overall Study|Withdrawal by Subject|6|||
48714988|NCT04129151|156806546|FG000|Overall Study|Adverse Event|1|||
48714989|NCT04129151|156806546|FG000|Overall Study|Disease Progression|7|||
48714990|NCT04129151|156806546|FG000|Overall Study|Study closure|1|||
48714991|NCT01643772|156806547|FG000|Overall Study|Protocol Violation|0|||
48714992|NCT01643772|156806548|FG001|Overall Study|Protocol Violation|0|||
48714993|NCT01643772|156806549|FG002|Overall Study|Protocol Violation|0|||
48714994|NCT01643772|156806550|FG003|Overall Study|Protocol Violation|1|||
48714995|NCT01643772|156806547|FG000|Overall Study|Adverse Event|0|||
48714996|NCT01643772|156806548|FG001|Overall Study|Adverse Event|0|||
48714997|NCT01643772|156806549|FG002|Overall Study|Adverse Event|0|||
48714998|NCT01643772|156806550|FG003|Overall Study|Adverse Event|1|||
48714999|NCT01754402|156806551|FG000|Overall Study|Death|0|||
48715000|NCT01754402|156806552|FG001|Overall Study|Death|0|||
48715001|NCT01754402|156806553|FG002|Overall Study|Death|1|||
48715002|NCT01754402|156806551|FG000|Overall Study|Adverse Event|2|||
48715003|NCT01754402|156806552|FG001|Overall Study|Adverse Event|2|||
48715004|NCT01754402|156806553|FG002|Overall Study|Adverse Event|1|||
48715005|NCT01754402|156806551|FG000|Overall Study|Withdrawal by Subject|0|||
48715006|NCT01754402|156806552|FG001|Overall Study|Withdrawal by Subject|0|||
48715007|NCT01754402|156806553|FG002|Overall Study|Withdrawal by Subject|1|||
48715008|NCT01754402|156806551|FG000|Overall Study|Lack of Efficacy|0|||
48715009|NCT01754402|156806552|FG001|Overall Study|Lack of Efficacy|0|||
48715010|NCT01754402|156806553|FG002|Overall Study|Lack of Efficacy|1|||
48715011|NCT01282463|156806554|FG000|Overall Study|Lost to Follow-up|1|||
48715012|NCT01282463|156806555|FG001|Overall Study|Lost to Follow-up|0|||
48715013|NCT01282463|156806556|FG002|Overall Study|Lost to Follow-up|0|||
48715014|NCT01282463|156806554|FG000|Overall Study|Withdrawal by Subject|6|||
48715015|NCT01282463|156806555|FG001|Overall Study|Withdrawal by Subject|2|||
48715016|NCT01282463|156806556|FG002|Overall Study|Withdrawal by Subject|3|||
48715017|NCT01282463|156806554|FG000|Overall Study|"Never Treated Death"|0|||
48715018|NCT01282463|156806555|FG001|Overall Study|"Never Treated Death"|1|||
48715019|NCT01282463|156806556|FG002|Overall Study|"Never Treated Death"|0|||
48715020|NCT01282463|156806554|FG000|Overall Study|"Never Treated PD"|0|||
48715021|NCT01282463|156806555|FG001|Overall Study|"Never Treated PD"|1|||
48715022|NCT01282463|156806556|FG002|Overall Study|"Never Treated PD"|0|||
48920886|NCT03451773|157544777|FG001|Overall Study|Death during follow-up period|1|||
48920887|NCT02222207|157544778|FG000|Overall Study|Death|1|||
48920888|NCT02222207|157544778|FG000|Overall Study|Other reasons|2|||
48920889|NCT02222207|157544778|FG000|Overall Study|Adverse Event|1|||
48920890|NCT01982292|157544779|FG000|Overall Study|Adverse Event|2|||
48920891|NCT01982292|157544780|FG001|Overall Study|Adverse Event|0|||
48920892|NCT01982292|157544779|FG000|Overall Study|Death|1|||
48715023|NCT01282463|156806554|FG000|Overall Study|Protocol Violation|0|||
48715024|NCT01282463|156806555|FG001|Overall Study|Protocol Violation|0|||
48715025|NCT01282463|156806556|FG002|Overall Study|Protocol Violation|1|||
48715026|NCT01282463|156806554|FG000|Overall Study|Physician Decision|1|||
48715027|NCT01282463|156806555|FG001|Overall Study|Physician Decision|0|||
48715028|NCT01282463|156806556|FG002|Overall Study|Physician Decision|0|||
48715029|NCT01788358|156806558|FG000|Overall Study|Other|11|||
48715030|NCT01788358|156806558|FG000|Overall Study|Logistical difficulties|1|||
48813405|NCT01454830|157157447|FG001|Overall Study|Withdrawal - no polysomnography|2|||
48715031|NCT01788358|156806558|FG000|Overall Study|Lost to Follow-up|5|||
48715032|NCT01788358|156806558|FG000|Overall Study|Protocol Violation|3|||
48715033|NCT01788358|156806558|FG000|Overall Study|Withdrawal by Subject|26|||
48715034|NCT01788358|156806558|FG000|Overall Study|Lack of Efficacy|1|||
48715035|NCT01788358|156806558|FG000|Overall Study|Adverse Event|51|||
48715036|NCT01357850|156806561|FG000|Overall Study|Lost to Follow-up|1|||
48715037|NCT01357850|156806562|FG001|Overall Study|Lost to Follow-up|0|||
48715038|NCT01357850|156806563|FG002|Overall Study|Lost to Follow-up|0|||
48715039|NCT01357850|156806564|FG003|Overall Study|Lost to Follow-up|0|||
48715040|NCT00490529|156806565|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Death|4|||
48715041|NCT00490529|156806565|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4|||
48715042|NCT00490529|156806565|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1|||
48715043|NCT00490529|156806565|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1|||
48715044|NCT00490529|156806565|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1|||
48715045|NCT00490529|156806565|FG000|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1|||
48715046|NCT00792571|156806566|FG000|Overall Study|Death|1|||
48715047|NCT00792571|156806566|FG000|Overall Study|Adverse Event|4|||
48715048|NCT00792571|156806566|FG000|Overall Study|Withdrawal by Subject|1|||
48715049|NCT00792571|156806566|FG000|Overall Study|Other|4|||
48715050|NCT02338882|156806567|FG000|Overall Study|Death|1|||
48715051|NCT02338882|156806568|FG001|Overall Study|Death|0|||
48715052|NCT02338882|156806567|FG000|Overall Study|Lost to Follow-up|6|||
48715053|NCT02338882|156806568|FG001|Overall Study|Lost to Follow-up|3|||
48715054|NCT00505778|156806569|FG000|Overall Study|Adverse Event|2|||
48715055|NCT00505778|156806570|FG001|Overall Study|Adverse Event|7|||
48715056|NCT00505778|156806569|FG000|Overall Study|Physician Decision|8|||
48715057|NCT00505778|156806570|FG001|Overall Study|Physician Decision|14|||
48715058|NCT00505778|156806569|FG000|Overall Study|Lost to Follow-up|17|||
48715059|NCT00505778|156806570|FG001|Overall Study|Lost to Follow-up|23|||
48715060|NCT00505778|156806569|FG000|Overall Study|Unable to Meet Protocol Criteria|4|||
48715061|NCT00505778|156806570|FG001|Overall Study|Unable to Meet Protocol Criteria|1|||
48715062|NCT00505778|156806569|FG000|Overall Study|Protocol Violation|7|||
48715063|NCT00505778|156806570|FG001|Overall Study|Protocol Violation|9|||
48715064|NCT00505778|156806569|FG000|Overall Study|Withdrawal by Subject|29|||
48715065|NCT00505778|156806570|FG001|Overall Study|Withdrawal by Subject|14|||
48715066|NCT00505778|156806569|FG000|Overall Study|Relapse|65|||
48715067|NCT00505778|156806570|FG001|Overall Study|Relapse|65|||
48715068|NCT00505778|156806569|FG000|Overall Study|Took No Study Drug|2|||
48715069|NCT00505778|156806570|FG001|Overall Study|Took No Study Drug|2|||
48715070|NCT01343693|156806573|FG000|Overall Study|Lost to Follow-up|9|||
48715071|NCT02891070|156806574|FG000|Overall Study|Adverse Event|1|||
48715072|NCT02891070|156806575|FG001|Overall Study|Adverse Event|0|||
48715073|NCT02891070|156806574|FG000|Overall Study|Physician Decision|0|||
48715074|NCT02891070|156806575|FG001|Overall Study|Physician Decision|1|||
48715075|NCT02891070|156806574|FG000|Overall Study|Lost to Follow-up|4|||
48715076|NCT02891070|156806575|FG001|Overall Study|Lost to Follow-up|4|||
48715077|NCT02891070|156806574|FG000|Overall Study|Other|1|||
48715078|NCT02891070|156806575|FG001|Overall Study|Other|0|||
48715079|NCT02891070|156806574|FG000|Overall Study|Protocol Violation|0|||
48715080|NCT02891070|156806575|FG001|Overall Study|Protocol Violation|1|||
48715081|NCT02891070|156806574|FG000|Overall Study|Withdrawal by Subject|1|||
48715082|NCT02891070|156806575|FG001|Overall Study|Withdrawal by Subject|2|||
48715083|NCT02891070|156806574|FG000|Overall Study|Death|3|||
48715084|NCT02891070|156806575|FG001|Overall Study|Death|0|||
48715085|NCT04881942|156806576|FG000|Overall Study|Adverse Event|0|||
48715086|NCT04881942|156806577|FG001|Overall Study|Adverse Event|0|||
48715087|NCT04881942|156806578|FG002|Overall Study|Adverse Event|0|||
48715088|NCT04881942|156806579|FG003|Overall Study|Adverse Event|0|||
48715089|NCT04881942|156806580|FG004|Overall Study|Adverse Event|1|||
48715090|NCT04881942|156806576|FG000|Overall Study|Alternates|0|||
48715091|NCT04881942|156806577|FG001|Overall Study|Alternates|0|||
48715092|NCT04881942|156806578|FG002|Overall Study|Alternates|0|||
48715093|NCT04881942|156806579|FG003|Overall Study|Alternates|0|||
48715094|NCT04881942|156806580|FG004|Overall Study|Alternates|2|||
48715095|NCT00470834|156806583|FG000|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16|||
48715096|NCT00470834|156806584|FG001|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14|||
48715097|NCT00470834|156806583|FG000|Treatment Period (18 Months)|Adverse Event|7|||
48715098|NCT00470834|156806584|FG001|Treatment Period (18 Months)|Adverse Event|6|||
48920893|NCT01982292|157544780|FG001|Overall Study|Death|0|||
48715099|NCT00470834|156806583|FG000|Treatment Period (18 Months)|Withdrawal by Subject|4|||
48715100|NCT00470834|156806584|FG001|Treatment Period (18 Months)|Withdrawal by Subject|5|||
48715101|NCT00470834|156806583|FG000|Treatment Period (18 Months)|Physician Decision|4|||
48715102|NCT00470834|156806584|FG001|Treatment Period (18 Months)|Physician Decision|4|||
48715103|NCT00470834|156806583|FG000|Treatment Period (18 Months)|Protocol Violation|3|||
48715104|NCT00470834|156806584|FG001|Treatment Period (18 Months)|Protocol Violation|1|||
48715105|NCT00470834|156806583|FG000|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
48715106|NCT00470834|156806584|FG001|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
48715107|NCT00470834|156806583|FG000|Treatment Period (18 Months)|Lost to Follow-up|1|||
48715108|NCT00470834|156806584|FG001|Treatment Period (18 Months)|Lost to Follow-up|0|||
48715109|NCT00470834|156806583|FG000|Treatment Period (18 Months)|Non-compliance|1|||
48715110|NCT00470834|156806584|FG001|Treatment Period (18 Months)|Non-compliance|0|||
48715111|NCT00470834|156806583|FG000|Treatment Period (18 Months)|Lack of Efficacy|1|||
48715112|NCT00470834|156806584|FG001|Treatment Period (18 Months)|Lack of Efficacy|0|||
48715113|NCT00470834|156806583|FG000|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6|||
48715114|NCT00470834|156806584|FG001|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7|||
48715115|NCT00470834|156806583|FG000|Extension Period (24 Months)|Adverse Event|3|||
48715116|NCT00470834|156806584|FG001|Extension Period (24 Months)|Adverse Event|4|||
48715117|NCT00470834|156806583|FG000|Extension Period (24 Months)|Withdrawal by Subject|2|||
48715118|NCT00470834|156806584|FG001|Extension Period (24 Months)|Withdrawal by Subject|5|||
48715119|NCT00470834|156806583|FG000|Extension Period (24 Months)|Physician Decision|4|||
48715120|NCT00470834|156806584|FG001|Extension Period (24 Months)|Physician Decision|3|||
48715121|NCT00470834|156806583|FG000|Extension Period (24 Months)|Sponsor Terminated Study|0|||
48715122|NCT00470834|156806584|FG001|Extension Period (24 Months)|Sponsor Terminated Study|1|||
48715123|NCT00470834|156806583|FG000|Extension Period (24 Months)|Lost to Follow-up|0|||
48715124|NCT00470834|156806584|FG001|Extension Period (24 Months)|Lost to Follow-up|1|||
48715125|NCT00470834|156806583|FG000|Extension Period (24 Months)|Non-compliance|0|||
49125448|NCT01249131|158296957|FG001|Washout Period of 10 Days|Adverse Event|0|||
49125449|NCT01249131|158296958|FG002|Washout Period of 10 Days|Adverse Event|0|||
48715126|NCT00470834|156806584|FG001|Extension Period (24 Months)|Non-compliance|1|||
48715127|NCT00470834|156806583|FG000|Extension Period (24 Months)|Disease Progression|0|||
48715128|NCT00470834|156806584|FG001|Extension Period (24 Months)|Disease Progression|1|||
48715129|NCT02925338|156806585|FG000|Overall Study|Death|0|||
48715130|NCT02925338|156806586|FG001|Overall Study|Death|2|||
48715131|NCT02925338|156806587|FG002|Overall Study|Death|1|||
48715132|NCT02925338|156806588|FG003|Overall Study|Death|0|||
48715133|NCT02925338|156806589|FG004|Overall Study|Death|0|||
48715134|NCT02925338|156806585|FG000|Overall Study|Lost to Follow-up|30|||
48715135|NCT02925338|156806586|FG001|Overall Study|Lost to Follow-up|10|||
48715136|NCT02925338|156806587|FG002|Overall Study|Lost to Follow-up|1|||
48715137|NCT02925338|156806588|FG003|Overall Study|Lost to Follow-up|16|||
48715138|NCT02925338|156806589|FG004|Overall Study|Lost to Follow-up|3|||
48715139|NCT02925338|156806585|FG000|Overall Study|Withdrawal by Subject|3|||
48715140|NCT02925338|156806586|FG001|Overall Study|Withdrawal by Subject|0|||
48715141|NCT02925338|156806587|FG002|Overall Study|Withdrawal by Subject|3|||
48715142|NCT02925338|156806588|FG003|Overall Study|Withdrawal by Subject|2|||
48715143|NCT02925338|156806589|FG004|Overall Study|Withdrawal by Subject|2|||
48715144|NCT02925338|156806585|FG000|Overall Study|Missing|38|||
48715145|NCT02925338|156806586|FG001|Overall Study|Missing|27|||
48715146|NCT02925338|156806587|FG002|Overall Study|Missing|0|||
49125450|NCT01249131|158296959|FG003|Washout Period of 10 Days|Adverse Event|0|||
49125451|NCT01249131|158296960|FG004|Washout Period of 10 Days|Adverse Event|1|||
49125452|NCT01249131|158296961|FG005|Washout Period of 10 Days|Adverse Event|0|||
49125453|NCT02087774|158296962|FG000|Overall Study|Were absent day of data collection|8|||
49125454|NCT02087774|158296963|FG001|Overall Study|Were absent day of data collection|20|||
49125455|NCT02659943|158296964|FG000|Overall Study|Switched to alternative treatment|1|||
49125456|NCT02659943|158296965|FG001|Overall Study|Switched to alternative treatment|1|||
49125457|NCT02659943|158296966|FG002|Overall Study|Switched to alternative treatment|0|||
48813406|NCT01533714|157157448|FG000|Overall Study|Adverse Event|0|||
48813407|NCT01533714|157157449|FG001|Overall Study|Adverse Event|1|||
48813408|NCT01533714|157157450|FG002|Overall Study|Adverse Event|2|||
48813409|NCT01533714|157157451|FG003|Overall Study|Adverse Event|2|||
48715147|NCT02925338|156806588|FG003|Overall Study|Missing|3|||
48715148|NCT02925338|156806589|FG004|Overall Study|Missing|2|||
49125458|NCT02659943|158296967|FG003|Overall Study|Switched to alternative treatment|2|||
48715149|NCT02925338|156806585|FG000|Overall Study|Participant's Decision|11|||
48715150|NCT02925338|156806586|FG001|Overall Study|Participant's Decision|7|||
48715151|NCT02925338|156806587|FG002|Overall Study|Participant's Decision|3|||
48715152|NCT02925338|156806588|FG003|Overall Study|Participant's Decision|8|||
48715153|NCT02925338|156806589|FG004|Overall Study|Participant's Decision|1|||
48715154|NCT02925338|156806585|FG000|Overall Study|Treatment Discontinuation|144|||
48715155|NCT02925338|156806586|FG001|Overall Study|Treatment Discontinuation|65|||
48813410|NCT01533714|157157452|FG004|Overall Study|Adverse Event|2|||
48813411|NCT01533714|157157453|FG005|Overall Study|Adverse Event|1|||
49125459|NCT02659943|158296968|FG004|Overall Study|Switched to alternative treatment|1|||
48715156|NCT02925338|156806587|FG002|Overall Study|Treatment Discontinuation|56|||
48715157|NCT02925338|156806588|FG003|Overall Study|Treatment Discontinuation|131|||
48715158|NCT02925338|156806589|FG004|Overall Study|Treatment Discontinuation|22|||
48715159|NCT00146848|156806593|FG000|Pre-randomization|Death|19|||
48715160|NCT00146848|156806594|FG001|Pre-randomization|Death|0|||
48715161|NCT00146848|156806595|FG002|Pre-randomization|Death|0|||
48813412|NCT01533714|157157448|FG000|Overall Study|Lack of Efficacy|0|||
48813413|NCT01533714|157157449|FG001|Overall Study|Lack of Efficacy|0|||
48715162|NCT00146848|156806593|FG000|Pre-randomization|Lost to Follow-up|70|||
48715163|NCT00146848|156806594|FG001|Pre-randomization|Lost to Follow-up|0|||
48715164|NCT00146848|156806595|FG002|Pre-randomization|Lost to Follow-up|0|||
48715165|NCT00146848|156806593|FG000|Pre-randomization|Physician Decision|8|||
48715166|NCT00146848|156806594|FG001|Pre-randomization|Physician Decision|0|||
48715167|NCT00146848|156806595|FG002|Pre-randomization|Physician Decision|0|||
48715168|NCT00146848|156806593|FG000|Pre-randomization|Protocol Violation|172|||
48715169|NCT00146848|156806594|FG001|Pre-randomization|Protocol Violation|0|||
48715170|NCT00146848|156806595|FG002|Pre-randomization|Protocol Violation|0|||
48715171|NCT00146848|156806593|FG000|Pre-randomization|Withdrawal by Subject|40|||
48715172|NCT00146848|156806594|FG001|Pre-randomization|Withdrawal by Subject|0|||
48715173|NCT00146848|156806595|FG002|Pre-randomization|Withdrawal by Subject|0|||
48715174|NCT00146848|156806593|FG000|Post-randomization|Lost to Follow-up|12|||
48715175|NCT00146848|156806594|FG001|Post-randomization|Lost to Follow-up|15|||
48715176|NCT00146848|156806595|FG002|Post-randomization|Lost to Follow-up|12|||
48715177|NCT00146848|156806593|FG000|Post-randomization|Withdrawn|26|||
48715178|NCT00146848|156806594|FG001|Post-randomization|Withdrawn|32|||
48715179|NCT00146848|156806595|FG002|Post-randomization|Withdrawn|27|||
48715180|NCT00612105|156806596|FG000|Period Title 1: 6-Week Titration Phase|Adverse Event|18|||
48715181|NCT00612105|156806597|FG001|Period Title 1: 6-Week Titration Phase|Adverse Event|1|||
48715182|NCT00612105|156806596|FG000|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6|||
48715183|NCT00612105|156806597|FG001|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1|||
48715184|NCT00612105|156806596|FG000|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2|||
48715185|NCT00612105|156806597|FG001|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0|||
48715186|NCT00612105|156806596|FG000|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
48715187|NCT00612105|156806597|FG001|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
48715188|NCT00612105|156806596|FG000|Period Title 1: 6-Week Titration Phase|Protocol Violation|1|||
48715189|NCT00612105|156806597|FG001|Period Title 1: 6-Week Titration Phase|Protocol Violation|0|||
48715190|NCT00612105|156806596|FG000|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3|||
48715191|NCT00612105|156806597|FG001|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1|||
48715192|NCT00612105|156806596|FG000|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5|||
48715193|NCT00612105|156806597|FG001|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0|||
48715194|NCT00612105|156806596|FG000|Period Title 1: 6-Week Titration Phase|Other|0|||
48715195|NCT00612105|156806597|FG001|Period Title 1: 6-Week Titration Phase|Other|1|||
48715196|NCT00612105|156806596|FG000|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9|||
48715197|NCT00612105|156806597|FG001|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1|||
48715198|NCT00612105|156806596|FG000|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
48715199|NCT00612105|156806597|FG001|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
48715200|NCT00612105|156806596|FG000|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1|||
48715201|NCT00612105|156806597|FG001|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0|||
48715202|NCT00612105|156806596|FG000|Period Title 3: 3-Week Taper Phase|Other|1|||
48715203|NCT00612105|156806597|FG001|Period Title 3: 3-Week Taper Phase|Other|0|||
48715204|NCT00475982|156806598|FG000|Overall Study|surgery rescheduled|7|||
48715205|NCT00475982|156806599|FG001|Overall Study|surgery rescheduled|3|||
48715206|NCT01105767|156806600|FG000|Overall Study|Lost to Follow-up|1160|||
48715207|NCT01105767|156806601|FG001|Overall Study|Lost to Follow-up|1614|||
48715208|NCT01105767|156806602|FG002|Overall Study|Lost to Follow-up|1184|||
48715209|NCT00783198|156806606|FG000|Overall Study|Adverse Event|15|||
48715210|NCT00783198|156806607|FG001|Overall Study|Adverse Event|19|||
48715211|NCT00783198|156806608|FG002|Overall Study|Adverse Event|3|||
48715212|NCT00783198|156806606|FG000|Overall Study|Lost to Follow-up|11|||
48715213|NCT00783198|156806607|FG001|Overall Study|Lost to Follow-up|1|||
48715214|NCT00783198|156806608|FG002|Overall Study|Lost to Follow-up|7|||
48715215|NCT00783198|156806606|FG000|Overall Study|Withdrawal by Subject|22|||
48715216|NCT00783198|156806607|FG001|Overall Study|Withdrawal by Subject|14|||
48715217|NCT00783198|156806608|FG002|Overall Study|Withdrawal by Subject|20|||
48715218|NCT00783198|156806606|FG000|Overall Study|Noncompliance with protocol|7|||
48715219|NCT00783198|156806607|FG001|Overall Study|Noncompliance with protocol|7|||
48715220|NCT00783198|156806608|FG002|Overall Study|Noncompliance with protocol|10|||
48715221|NCT00783198|156806606|FG000|Overall Study|Did not meet protocol eligibility|0|||
48715222|NCT00783198|156806607|FG001|Overall Study|Did not meet protocol eligibility|1|||
48715223|NCT00783198|156806608|FG002|Overall Study|Did not meet protocol eligibility|0|||
48920894|NCT01982292|157544779|FG000|Overall Study|Lost to Follow-up|2|||
48920895|NCT01982292|157544780|FG001|Overall Study|Lost to Follow-up|0|||
48920896|NCT01982292|157544779|FG000|Overall Study|Non-Compliance With Study Treatment|1|||
48920897|NCT01982292|157544780|FG001|Overall Study|Non-Compliance With Study Treatment|0|||
48920898|NCT01982292|157544779|FG000|Overall Study|Protocol Deviation|1|||
48920899|NCT01982292|157544780|FG001|Overall Study|Protocol Deviation|0|||
48920900|NCT01982292|157544779|FG000|Overall Study|Patient/Guardian Decision|3|||
48920901|NCT01982292|157544780|FG001|Overall Study|Patient/Guardian Decision|1|||
48920902|NCT01982292|157544779|FG000|Overall Study|Technical Problems|2|||
49125460|NCT02659943|158296969|FG005|Overall Study|Switched to alternative treatment|0|||
48715224|NCT00783198|156806606|FG000|Overall Study|Administrative|2|||
48715225|NCT00783198|156806607|FG001|Overall Study|Administrative|1|||
48715226|NCT00783198|156806608|FG002|Overall Study|Administrative|2|||
48715227|NCT00228553|156806614|FG000|Overall Study|Adverse Event|112|||
48715228|NCT00228553|156806614|FG000|Overall Study|Lack of Efficacy|34|||
48715229|NCT00228553|156806614|FG000|Overall Study|Lost to Follow-up|67|||
48715230|NCT00228553|156806614|FG000|Overall Study|Physician Decision|48|||
48715231|NCT00228553|156806614|FG000|Overall Study|Protocol Violation|6|||
49125461|NCT02659943|158296970|FG006|Overall Study|Switched to alternative treatment|1|||
49125462|NCT02659943|158296964|FG000|Overall Study|Disease progression on study|0|||
49125463|NCT02659943|158296965|FG001|Overall Study|Disease progression on study|1|||
49125464|NCT02659943|158296966|FG002|Overall Study|Disease progression on study|1|||
49125465|NCT02659943|158296967|FG003|Overall Study|Disease progression on study|1|||
49125466|NCT02659943|158296968|FG004|Overall Study|Disease progression on study|1|||
49125467|NCT02659943|158296969|FG005|Overall Study|Disease progression on study|4|||
49125468|NCT02659943|158296970|FG006|Overall Study|Disease progression on study|0|||
49125469|NCT02659943|158296964|FG000|Overall Study|Patient's condition per principal investigator|0|||
49125470|NCT02659943|158296965|FG001|Overall Study|Patient's condition per principal investigator|0|||
49125471|NCT02659943|158296966|FG002|Overall Study|Patient's condition per principal investigator|0|||
49125472|NCT02659943|158296967|FG003|Overall Study|Patient's condition per principal investigator|0|||
49125473|NCT02659943|158296968|FG004|Overall Study|Patient's condition per principal investigator|0|||
49125474|NCT02659943|158296969|FG005|Overall Study|Patient's condition per principal investigator|1|||
49125475|NCT02659943|158296970|FG006|Overall Study|Patient's condition per principal investigator|0|||
49125476|NCT02659943|158296964|FG000|Overall Study|Ineligible|0|||
49125477|NCT02659943|158296965|FG001|Overall Study|Ineligible|0|||
48715232|NCT00228553|156806614|FG000|Overall Study|Withdrawal by Subject|115|||
48813414|NCT01533714|157157450|FG002|Overall Study|Lack of Efficacy|0|||
48813415|NCT01533714|157157451|FG003|Overall Study|Lack of Efficacy|0|||
48813416|NCT01533714|157157452|FG004|Overall Study|Lack of Efficacy|0|||
48813417|NCT01533714|157157453|FG005|Overall Study|Lack of Efficacy|1|||
48813418|NCT01533714|157157448|FG000|Overall Study|Withdrawal by Subject|0|||
48813419|NCT01533714|157157449|FG001|Overall Study|Withdrawal by Subject|1|||
48813420|NCT01533714|157157450|FG002|Overall Study|Withdrawal by Subject|0|||
48920903|NCT01982292|157544780|FG001|Overall Study|Technical Problems|0|||
48920904|NCT02187471|157544781|FG000|Overall Study|Protocol Violation|4|||
48920905|NCT02187471|157544782|FG001|Overall Study|Protocol Violation|5|||
48920906|NCT02187471|157544783|FG002|Overall Study|Protocol Violation|4|||
48920907|NCT02187471|157544784|FG003|Overall Study|Protocol Violation|4|||
48920908|NCT02187471|157544781|FG000|Overall Study|Missing|0|||
48920909|NCT02187471|157544782|FG001|Overall Study|Missing|0|||
48920910|NCT02187471|157544783|FG002|Overall Study|Missing|0|||
48920911|NCT02187471|157544784|FG003|Overall Study|Missing|1|||
48920912|NCT02187471|157544781|FG000|Overall Study|Lack of Efficacy|18|||
48920913|NCT02187471|157544782|FG001|Overall Study|Lack of Efficacy|9|||
48920914|NCT02187471|157544783|FG002|Overall Study|Lack of Efficacy|13|||
48920915|NCT02187471|157544784|FG003|Overall Study|Lack of Efficacy|11|||
48920916|NCT02187471|157544781|FG000|Overall Study|Adverse Event|24|||
48920917|NCT02187471|157544782|FG001|Overall Study|Adverse Event|34|||
48920918|NCT02187471|157544783|FG002|Overall Study|Adverse Event|44|||
48920919|NCT02187471|157544784|FG003|Overall Study|Adverse Event|36|||
48920920|NCT02187471|157544781|FG000|Overall Study|Withdrawal by Subject|23|||
48920921|NCT02187471|157544782|FG001|Overall Study|Withdrawal by Subject|29|||
48920922|NCT02187471|157544783|FG002|Overall Study|Withdrawal by Subject|22|||
48920923|NCT02187471|157544784|FG003|Overall Study|Withdrawal by Subject|24|||
48920924|NCT02187471|157544781|FG000|Overall Study|Other|7|||
48920925|NCT02187471|157544782|FG001|Overall Study|Other|5|||
48920926|NCT02187471|157544783|FG002|Overall Study|Other|3|||
48920927|NCT02187471|157544784|FG003|Overall Study|Other|4|||
48920928|NCT00522431|157544785|FG000|Overall Study|Adverse Event|5|||
48920929|NCT00522431|157544785|FG000|Overall Study|Protocol Violation|2|||
48920930|NCT00522431|157544785|FG000|Overall Study|Withdrawal by Subject|2|||
49125478|NCT02659943|158296966|FG002|Overall Study|Ineligible|0|||
49125479|NCT02659943|158296967|FG003|Overall Study|Ineligible|0|||
49125480|NCT02659943|158296968|FG004|Overall Study|Ineligible|0|||
49125481|NCT02659943|158296969|FG005|Overall Study|Ineligible|0|||
49125482|NCT02659943|158296970|FG006|Overall Study|Ineligible|1|||
48715233|NCT00228553|156806614|FG000|Overall Study|Pregnancy|2|||
48715234|NCT00228553|156806614|FG000|Overall Study|Miscellaneous|46|||
48813421|NCT01533714|157157451|FG003|Overall Study|Withdrawal by Subject|1|||
48813422|NCT01533714|157157452|FG004|Overall Study|Withdrawal by Subject|1|||
48920931|NCT00522431|157544785|FG000|Overall Study|Subject non-compliance|1|||
48920932|NCT00522431|157544785|FG000|Overall Study|Other/unknown|1|||
48920933|NCT00631371|157544786|FG000|Overall Study|Lost to Follow-up|24|||
48920934|NCT00631371|157544787|FG001|Overall Study|Lost to Follow-up|19|||
48920935|NCT00631371|157544786|FG000|Overall Study|Other reason|5|||
48813423|NCT01533714|157157453|FG005|Overall Study|Withdrawal by Subject|0|||
48920936|NCT00631371|157544787|FG001|Overall Study|Other reason|12|||
48920937|NCT00631371|157544786|FG000|Overall Study|subject request|38|||
49125483|NCT02659943|158296964|FG000|Overall Study|No longer meets eligibility|0|||
49125484|NCT02659943|158296965|FG001|Overall Study|No longer meets eligibility|0|||
49125485|NCT02659943|158296966|FG002|Overall Study|No longer meets eligibility|0|||
49125486|NCT02659943|158296967|FG003|Overall Study|No longer meets eligibility|0|||
49125487|NCT02659943|158296968|FG004|Overall Study|No longer meets eligibility|0|||
49125488|NCT02659943|158296969|FG005|Overall Study|No longer meets eligibility|0|||
49125489|NCT02659943|158296970|FG006|Overall Study|No longer meets eligibility|1|||
49125490|NCT02659943|158296964|FG000|Overall Study|No treatment, per protocol|0|||
49125491|NCT02659943|158296965|FG001|Overall Study|No treatment, per protocol|0|||
49125492|NCT02659943|158296966|FG002|Overall Study|No treatment, per protocol|0|||
49125493|NCT02659943|158296967|FG003|Overall Study|No treatment, per protocol|0|||
49125494|NCT02659943|158296968|FG004|Overall Study|No treatment, per protocol|0|||
49125495|NCT02659943|158296969|FG005|Overall Study|No treatment, per protocol|0|||
49125496|NCT02659943|158296970|FG006|Overall Study|No treatment, per protocol|3|||
49125497|NCT01408706|158296971|FG000|Overall Study|Physician Decision|1|||
49125498|NCT01408706|158296972|FG001|Overall Study|Physician Decision|0|||
49125499|NCT02157519|158296977|FG000|Overall Study|Death|3|||
49125500|NCT02157519|158296978|FG001|Overall Study|Death|1|||
49125501|NCT02157519|158296977|FG000|Overall Study|Withdrawal by Subject|7|||
49125502|NCT02157519|158296978|FG001|Overall Study|Withdrawal by Subject|0|||
49125503|NCT02157519|158296977|FG000|Overall Study|Lost to Follow-up|1|||
49125504|NCT02157519|158296978|FG001|Overall Study|Lost to Follow-up|0|||
49125505|NCT01825200|158296981|FG000|Overall Study|Lost to Follow-up|5|||
49125506|NCT01825200|158296982|FG001|Overall Study|Lost to Follow-up|6|||
49125507|NCT01825200|158296981|FG000|Overall Study|Withdrawal by Subject|0|||
49125508|NCT01825200|158296982|FG001|Overall Study|Withdrawal by Subject|1|||
49125509|NCT01443858|158296983|FG000|Overall Study|Withdrawal by Subject|9|||
49125510|NCT01443858|158296984|FG001|Overall Study|Withdrawal by Subject|8|||
49125511|NCT01443858|158296985|FG002|Overall Study|Withdrawal by Subject|5|||
49125512|NCT01443858|158296983|FG000|Overall Study|Lack of Efficacy|1|||
49125513|NCT01443858|158296984|FG001|Overall Study|Lack of Efficacy|0|||
49125514|NCT01443858|158296985|FG002|Overall Study|Lack of Efficacy|0|||
49125515|NCT01443858|158296983|FG000|Overall Study|Lost to Follow-up|5|||
49125516|NCT01443858|158296984|FG001|Overall Study|Lost to Follow-up|5|||
49125517|NCT01443858|158296985|FG002|Overall Study|Lost to Follow-up|2|||
49125518|NCT02277028|158296986|FG000|Overall Study|Lost to Follow-up|1|||
49125519|NCT02277028|158296987|FG001|Overall Study|Lost to Follow-up|0|||
49125520|NCT02277028|158296986|FG000|Overall Study|Withdrawal by Subject|0|||
49125521|NCT02277028|158296987|FG001|Overall Study|Withdrawal by Subject|1|||
49125522|NCT02983045|158296991|FG000|Overall Study|Withdrawal by Subject|0|||
49125523|NCT02983045|158296992|FG001|Overall Study|Withdrawal by Subject|1|||
49125524|NCT02983045|158296993|FG002|Overall Study|Withdrawal by Subject|0|||
49125525|NCT02983045|158296994|FG003|Overall Study|Withdrawal by Subject|5|||
49125526|NCT02983045|158296995|FG004|Overall Study|Withdrawal by Subject|0|||
49125527|NCT02983045|158296996|FG005|Overall Study|Withdrawal by Subject|72|||
49125528|NCT02983045|158296997|FG006|Overall Study|Withdrawal by Subject|0|||
49125529|NCT02983045|158296998|FG007|Overall Study|Withdrawal by Subject|0|||
49125530|NCT02983045|158296999|FG008|Overall Study|Withdrawal by Subject|0|||
49125531|NCT02983045|158297000|FG009|Overall Study|Withdrawal by Subject|2|||
49125532|NCT02983045|158296991|FG000|Overall Study|Lost to Follow-up|0|||
49125533|NCT02983045|158296992|FG001|Overall Study|Lost to Follow-up|0|||
49125534|NCT02983045|158296993|FG002|Overall Study|Lost to Follow-up|0|||
49125535|NCT02983045|158296994|FG003|Overall Study|Lost to Follow-up|0|||
49125536|NCT02983045|158296995|FG004|Overall Study|Lost to Follow-up|0|||
49125537|NCT02983045|158296996|FG005|Overall Study|Lost to Follow-up|10|||
49125538|NCT02983045|158296997|FG006|Overall Study|Lost to Follow-up|0|||
49125539|NCT02983045|158296998|FG007|Overall Study|Lost to Follow-up|0|||
49125540|NCT02983045|158296999|FG008|Overall Study|Lost to Follow-up|0|||
49125541|NCT02983045|158297000|FG009|Overall Study|Lost to Follow-up|0|||
49125542|NCT00791999|158297001|FG000|Overall Study|Protocol planed withdrawal|14|||
49125543|NCT00791999|158297002|FG001|Overall Study|Protocol planed withdrawal|11|||
49125544|NCT00791999|158297003|FG002|Overall Study|Protocol planed withdrawal|11|||
49125545|NCT00791999|158297004|FG003|Overall Study|Protocol planed withdrawal|45|||
49125546|NCT00791999|158297001|FG000|Overall Study|Withdrawal by Subject|0|||
49125547|NCT00791999|158297002|FG001|Overall Study|Withdrawal by Subject|1|||
49125548|NCT00791999|158297003|FG002|Overall Study|Withdrawal by Subject|0|||
49125549|NCT00791999|158297004|FG003|Overall Study|Withdrawal by Subject|2|||
48715235|NCT00539188|156806617|FG000|Overall Study|Withdrawal by Subject|1|||
49125550|NCT00791999|158297001|FG000|Overall Study|Protocol Violation|3|||
49125551|NCT00791999|158297002|FG001|Overall Study|Protocol Violation|0|||
49125552|NCT00791999|158297003|FG002|Overall Study|Protocol Violation|1|||
49125553|NCT00791999|158297004|FG003|Overall Study|Protocol Violation|0|||
49125554|NCT00791999|158297001|FG000|Overall Study|Adverse Event|3|||
49125555|NCT00791999|158297002|FG001|Overall Study|Adverse Event|3|||
49125556|NCT00791999|158297003|FG002|Overall Study|Adverse Event|7|||
48715236|NCT00539188|156806618|FG001|Overall Study|Withdrawal by Subject|0|||
48715237|NCT00539188|156806617|FG000|Overall Study|Lost to Follow-up|2|||
48715238|NCT00539188|156806618|FG001|Overall Study|Lost to Follow-up|1|||
49125557|NCT00791999|158297004|FG003|Overall Study|Adverse Event|3|||
49125558|NCT00791999|158297001|FG000|Overall Study|Lack of Efficacy|0|||
49125559|NCT00791999|158297002|FG001|Overall Study|Lack of Efficacy|1|||
49125560|NCT00791999|158297003|FG002|Overall Study|Lack of Efficacy|0|||
49125561|NCT00791999|158297004|FG003|Overall Study|Lack of Efficacy|2|||
49125562|NCT00791999|158297001|FG000|Overall Study|Reason other than those above|1|||
49125563|NCT00791999|158297002|FG001|Overall Study|Reason other than those above|0|||
49125564|NCT00791999|158297003|FG002|Overall Study|Reason other than those above|1|||
49125565|NCT00791999|158297004|FG003|Overall Study|Reason other than those above|0|||
49125566|NCT02417753|158297005|FG000|Overall Study|Death|1|||
49125567|NCT04805671|158297006|FG000|Overall Study|Death|2|||
49125568|NCT04805671|158297007|FG001|Overall Study|Death|7|||
49125569|NCT04805671|158297006|FG000|Overall Study|Lost to Follow-up|1|||
49125570|NCT04805671|158297007|FG001|Overall Study|Lost to Follow-up|0|||
49125571|NCT04805671|158297006|FG000|Overall Study|Withdrawal by Subject|9|||
49125572|NCT04805671|158297007|FG001|Overall Study|Withdrawal by Subject|7|||
49125573|NCT04805671|158297006|FG000|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|178|||
49125574|NCT04805671|158297007|FG001|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|177|||
49125575|NCT01657162|158297008|FG000|Overall Study|Adverse Event|26|||
49125576|NCT01657162|158297009|FG001|Overall Study|Adverse Event|36|||
49125577|NCT01657162|158297008|FG000|Overall Study|Withdrawal by Subject|13|||
49125578|NCT01657162|158297009|FG001|Overall Study|Withdrawal by Subject|13|||
49125579|NCT01657162|158297008|FG000|Overall Study|Continuing Significant Deterioration|9|||
48715239|NCT01233232|156806619|FG000|Overall Study|Voluntary Discontinuation by Subject|1|||
48715240|NCT01233232|156806620|FG001|Overall Study|Voluntary Discontinuation by Subject|0|||
48715241|NCT01233232|156806621|FG002|Overall Study|Voluntary Discontinuation by Subject|0|||
49125580|NCT01657162|158297009|FG001|Overall Study|Continuing Significant Deterioration|3|||
49125581|NCT01657162|158297008|FG000|Overall Study|Refusal of Treatment|4|||
49125582|NCT01657162|158297009|FG001|Overall Study|Refusal of Treatment|6|||
49125583|NCT01657162|158297008|FG000|Overall Study|Lost to Follow-up|3|||
49125584|NCT01657162|158297009|FG001|Overall Study|Lost to Follow-up|4|||
49125585|NCT01657162|158297008|FG000|Overall Study|Death|2|||
49125586|NCT01657162|158297009|FG001|Overall Study|Death|3|||
49125587|NCT01657162|158297008|FG000|Overall Study|Inability to Complete Study Procedures|1|||
49125588|NCT01657162|158297009|FG001|Overall Study|Inability to Complete Study Procedures|7|||
48715242|NCT01536392|156806627|FG000|Overall Study|Adverse Event|2|||
48715243|NCT01536392|156806628|FG001|Overall Study|Adverse Event|2|||
48715244|NCT01536392|156806627|FG000|Overall Study|Physician Decision|2|||
48715245|NCT01536392|156806628|FG001|Overall Study|Physician Decision|3|||
48715246|NCT01536392|156806627|FG000|Overall Study|Withdrawal by Subject|3|||
48715247|NCT01536392|156806628|FG001|Overall Study|Withdrawal by Subject|6|||
48715248|NCT01536392|156806627|FG000|Overall Study|Non Compliance|3|||
48715249|NCT01536392|156806628|FG001|Overall Study|Non Compliance|4|||
48715250|NCT01536392|156806627|FG000|Overall Study|Completed therapy early|3|||
48715251|NCT01536392|156806628|FG001|Overall Study|Completed therapy early|0|||
48715252|NCT03113136|156806630|FG000|Overall Study|Lost to Follow-up|22|||
48715253|NCT03113136|156806631|FG001|Overall Study|Lost to Follow-up|47|||
48715254|NCT03113136|156806632|FG002|Overall Study|Lost to Follow-up|54|||
48715255|NCT03113136|156806630|FG000|Overall Study|Withdrawal by Subject|4|||
48715256|NCT03113136|156806631|FG001|Overall Study|Withdrawal by Subject|13|||
48715257|NCT03113136|156806632|FG002|Overall Study|Withdrawal by Subject|14|||
48715258|NCT03113136|156806630|FG000|Overall Study|Ineligible|0|||
48715259|NCT03113136|156806631|FG001|Overall Study|Ineligible|2|||
48715260|NCT03113136|156806632|FG002|Overall Study|Ineligible|1|||
48715261|NCT03113136|156806630|FG000|Overall Study|Study Team Decision|1|||
48715262|NCT03113136|156806631|FG001|Overall Study|Study Team Decision|4|||
48715263|NCT03113136|156806632|FG002|Overall Study|Study Team Decision|0|||
48715264|NCT04345367|156806633|FG000|Overall Study|Other|3|||
48715265|NCT04345367|156806634|FG001|Overall Study|Other|4|||
49125589|NCT01657162|158297008|FG000|Overall Study|Protocol Violation|1|||
49125590|NCT01657162|158297009|FG001|Overall Study|Protocol Violation|0|||
49125591|NCT01657162|158297008|FG000|Overall Study|Hypersensitivity to Alendronate|0|||
49125592|NCT01657162|158297009|FG001|Overall Study|Hypersensitivity to Alendronate|1|||
49125593|NCT01657162|158297008|FG000|Overall Study|Other than Specified|0|||
49125594|NCT01657162|158297009|FG001|Overall Study|Other than Specified|2|||
49125595|NCT02849587|158297010|FG000|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
49125596|NCT02849587|158297011|FG001|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|3|||
48715266|NCT04345367|156806633|FG000|Overall Study|Medication Error Without Associated Adverse Event|1|||
48715267|NCT04345367|156806634|FG001|Overall Study|Medication Error Without Associated Adverse Event|0|||
48715268|NCT04345367|156806633|FG000|Overall Study|Withdrawal by Subject|11|||
48715269|NCT04345367|156806634|FG001|Overall Study|Withdrawal by Subject|11|||
48715270|NCT04345367|156806633|FG000|Overall Study|Protocol Violation|4|||
49125597|NCT02849587|158297012|FG002|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
49125598|NCT02849587|158297010|FG000|Overall Study|Withdrawal by Subject|0|||
49125599|NCT02849587|158297011|FG001|Overall Study|Withdrawal by Subject|1|||
49125600|NCT02849587|158297012|FG002|Overall Study|Withdrawal by Subject|0|||
49125601|NCT04202497|158297013|FG000|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1|||
49125602|NCT04202497|158297014|FG001|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
49125603|NCT04202497|158297015|FG002|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
49125604|NCT04202497|158297016|FG003|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
49125605|NCT02700048|158297017|FG000|Overall Study|The device failed so the study wasn't completed and participants were dropped|0|||
48715271|NCT04345367|156806634|FG001|Overall Study|Protocol Violation|3|||
48715272|NCT04345367|156806633|FG000|Overall Study|Lost to Follow-up|2|||
48715273|NCT04345367|156806634|FG001|Overall Study|Lost to Follow-up|4|||
48715274|NCT04345367|156806633|FG000|Overall Study|Lack of Efficacy|2|||
49125606|NCT02700048|158297018|FG001|Overall Study|The device failed so the study wasn't completed and participants were dropped|3|||
49125607|NCT02100839|158298221|FG000|Multiple Ascending Dose|Adverse Event|2|||
49125608|NCT02100839|158298222|FG001|Multiple Ascending Dose|Adverse Event|0|||
48715275|NCT04345367|156806634|FG001|Overall Study|Lack of Efficacy|0|||
48715276|NCT04345367|156806633|FG000|Overall Study|Death|2|||
48715277|NCT04345367|156806634|FG001|Overall Study|Death|0|||
48715278|NCT04345367|156806633|FG000|Overall Study|Adverse Event|10|||
48715279|NCT04345367|156806634|FG001|Overall Study|Adverse Event|9|||
48715280|NCT01578850|156806635|FG000|Period 1|Insufficient Clinical Response|1|||
48715281|NCT01578850|156806636|FG001|Period 1|Insufficient Clinical Response|0|||
48715282|NCT01578850|156806637|FG002|Period 1|Insufficient Clinical Response|0|||
48715283|NCT01578850|156806635|FG000|Period 1|Adverse Event|11|||
48715284|NCT01578850|156806636|FG001|Period 1|Adverse Event|0|||
48715285|NCT01578850|156806637|FG002|Period 1|Adverse Event|0|||
48715286|NCT01578850|156806635|FG000|Period 1|Death|1|||
48715287|NCT01578850|156806636|FG001|Period 1|Death|0|||
48715288|NCT01578850|156806637|FG002|Period 1|Death|0|||
48715289|NCT01578850|156806635|FG000|Period 1|Does Not Meet Entrance Criteria|12|||
48715290|NCT01578850|156806636|FG001|Period 1|Does Not Meet Entrance Criteria|0|||
48715291|NCT01578850|156806637|FG002|Period 1|Does Not Meet Entrance Criteria|0|||
48715292|NCT01578850|156806635|FG000|Period 1|Withdrawal by Subject|9|||
48715293|NCT01578850|156806636|FG001|Period 1|Withdrawal by Subject|0|||
48715294|NCT01578850|156806637|FG002|Period 1|Withdrawal by Subject|0|||
49125609|NCT02100839|158298221|FG000|Multiple Ascending Dose|Withdrawal by Subject|2|||
49125610|NCT02100839|158298222|FG001|Multiple Ascending Dose|Withdrawal by Subject|0|||
49125611|NCT04155463|158298223|FG000|First Intervention (1 Week)|out of town during dietary intervention|0|||
49125612|NCT04155463|158298224|FG001|First Intervention (1 Week)|out of town during dietary intervention|1|||
49125613|NCT01307787|158298226|FG000|Overall Study|Withdrawal by Subject|2|||
49125614|NCT01307787|158298227|FG001|Overall Study|Withdrawal by Subject|0|||
49125615|NCT01573000|158298230|FG000|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27|||
49125616|NCT01573000|158298231|FG001|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32|||
49125617|NCT01573000|158298230|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4|||
49125618|NCT01573000|158298231|FG001|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
49125619|NCT01573000|158298230|FG000|Dosimetric and Therapeutic Treatment|Death|0|||
49125620|NCT01573000|158298231|FG001|Dosimetric and Therapeutic Treatment|Death|1|||
49125621|NCT01573000|158298230|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2|||
49125622|NCT01573000|158298231|FG001|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0|||
49125623|NCT01573000|158298230|FG000|Dosimetric and Therapeutic Treatment|Received Other Treatment|2|||
49125624|NCT01573000|158298231|FG001|Dosimetric and Therapeutic Treatment|Received Other Treatment|0|||
49125625|NCT01573000|158298230|FG000|Crossover Phase|Lack of Efficacy|0|||
49125626|NCT01573000|158298231|FG001|Crossover Phase|Lack of Efficacy|13|||
49125627|NCT01573000|158298230|FG000|Crossover Phase|Lost to Follow-up|0|||
49125628|NCT01573000|158298231|FG001|Crossover Phase|Lost to Follow-up|2|||
49125629|NCT01573000|158298230|FG000|Crossover Phase|Death|0|||
49125630|NCT01573000|158298231|FG001|Crossover Phase|Death|3|||
49125631|NCT01573000|158298230|FG000|Long-Term Follow-Up|Death|3|||
49125632|NCT01573000|158298231|FG001|Long-Term Follow-Up|Death|0|||
49125633|NCT01573000|158298230|FG000|Long-Term Follow-Up|Lost to Follow-up|0|||
49125634|NCT01573000|158298231|FG001|Long-Term Follow-Up|Lost to Follow-up|1|||
49125635|NCT02999789|158298236|FG000|Overall Study|Withdrawal by Subject|0|||
49125636|NCT02999789|158298237|FG001|Overall Study|Withdrawal by Subject|1|||
49125637|NCT02999789|158298236|FG000|Overall Study|Became ineligible|1|||
49125638|NCT02999789|158298237|FG001|Overall Study|Became ineligible|2|||
49125639|NCT03713684|158298239|FG000|Overall Study|Adverse Event|1|||
49125640|NCT03713684|158298240|FG001|Overall Study|Adverse Event|3|||
48715295|NCT01578850|156806635|FG000|Period 1|Study Terminated by Sponsor|3|||
48715296|NCT01578850|156806636|FG001|Period 1|Study Terminated by Sponsor|0|||
48715297|NCT01578850|156806637|FG002|Period 1|Study Terminated by Sponsor|0|||
48715298|NCT01578850|156806635|FG000|Period 2|Insufficient Clinical Response|0|||
48715299|NCT01578850|156806636|FG001|Period 2|Insufficient Clinical Response|1|||
48715300|NCT01578850|156806637|FG002|Period 2|Insufficient Clinical Response|0|||
48715301|NCT01578850|156806635|FG000|Period 2|Adverse Event|0|||
48715302|NCT01578850|156806636|FG001|Period 2|Adverse Event|3|||
49125641|NCT03713684|158298241|FG002|Overall Study|Adverse Event|1|||
49125642|NCT03713684|158298242|FG003|Overall Study|Adverse Event|0|||
49125643|NCT03713684|158298239|FG000|Overall Study|Poor compliance to protocol|2|||
49125644|NCT03713684|158298240|FG001|Overall Study|Poor compliance to protocol|1|||
49125645|NCT03713684|158298241|FG002|Overall Study|Poor compliance to protocol|0|||
49125646|NCT03713684|158298242|FG003|Overall Study|Poor compliance to protocol|1|||
49125647|NCT03713684|158298239|FG000|Overall Study|Withdrawal by Subject|14|||
49125648|NCT03713684|158298240|FG001|Overall Study|Withdrawal by Subject|6|||
49125649|NCT03713684|158298241|FG002|Overall Study|Withdrawal by Subject|14|||
49125650|NCT03713684|158298242|FG003|Overall Study|Withdrawal by Subject|16|||
49125651|NCT03713684|158298239|FG000|Overall Study|Other than specified|69|||
49125652|NCT03713684|158298240|FG001|Overall Study|Other than specified|77|||
49125653|NCT03713684|158298241|FG002|Overall Study|Other than specified|73|||
49125654|NCT03713684|158298242|FG003|Overall Study|Other than specified|70|||
49125655|NCT00249873|158298243|FG000|Overall Study|Not treated|7|||
49125656|NCT00249873|158298244|FG001|Overall Study|Not treated|8|||
49125657|NCT00249873|158298243|FG000|Overall Study|Significant thrombocytopenia|9|||
49125658|NCT00249873|158298244|FG001|Overall Study|Significant thrombocytopenia|8|||
49125659|NCT00249873|158298243|FG000|Overall Study|Severe allergic reaction|8|||
49125660|NCT00249873|158298244|FG001|Overall Study|Severe allergic reaction|1|||
49125661|NCT00249873|158298243|FG000|Overall Study|Serious haemorrhagic Adverse Event|74|||
49125662|NCT00249873|158298244|FG001|Overall Study|Serious haemorrhagic Adverse Event|30|||
49125663|NCT00249873|158298243|FG000|Overall Study|Other Serious Adverse Event|86|||
49125664|NCT00249873|158298244|FG001|Overall Study|Other Serious Adverse Event|97|||
49125665|NCT00249873|158298243|FG000|Overall Study|Qualifying condition not present|20|||
49125666|NCT00249873|158298244|FG001|Overall Study|Qualifying condition not present|23|||
49125667|NCT00249873|158298243|FG000|Overall Study|Contraindication to oral anticoagulant|4|||
49125668|NCT00249873|158298244|FG001|Overall Study|Contraindication to oral anticoagulant|8|||
49125669|NCT00249873|158298243|FG000|Overall Study|Withdrawal by Subject|504|||
49125670|NCT00249873|158298244|FG001|Overall Study|Withdrawal by Subject|466|||
49125671|NCT00249873|158298243|FG000|Overall Study|Lost to Follow-up|4|||
49125672|NCT00249873|158298244|FG001|Overall Study|Lost to Follow-up|7|||
49125673|NCT00249873|158298243|FG000|Overall Study|Minor bleeding|99|||
49125674|NCT00249873|158298244|FG001|Overall Study|Minor bleeding|37|||
49125675|NCT00249873|158298243|FG000|Overall Study|Non-compliance|41|||
49125676|NCT00249873|158298244|FG001|Overall Study|Non-compliance|46|||
49125677|NCT00249873|158298243|FG000|Overall Study|Other non serious Adverse Event|112|||
49125678|NCT00249873|158298244|FG001|Overall Study|Other non serious Adverse Event|108|||
49125679|NCT00249873|158298243|FG000|Overall Study|Other contraindicated medication|1|||
49125680|NCT00249873|158298244|FG001|Overall Study|Other contraindicated medication|0|||
48715303|NCT01578850|156806637|FG002|Period 2|Adverse Event|6|||
48715304|NCT01578850|156806635|FG000|Period 2|Lost to Follow-up|0|||
48715305|NCT01578850|156806636|FG001|Period 2|Lost to Follow-up|1|||
48715306|NCT01578850|156806637|FG002|Period 2|Lost to Follow-up|2|||
48715307|NCT01578850|156806635|FG000|Period 2|Withdrawal by Subject|0|||
48715308|NCT01578850|156806636|FG001|Period 2|Withdrawal by Subject|2|||
48715309|NCT01578850|156806637|FG002|Period 2|Withdrawal by Subject|2|||
49125681|NCT00249873|158298243|FG000|Overall Study|Patient not wish to continue after May08|3|||
49125682|NCT00249873|158298244|FG001|Overall Study|Patient not wish to continue after May08|4|||
49125683|NCT00249873|158298243|FG000|Overall Study|Physician withdrew consent|59|||
48715310|NCT01578850|156806635|FG000|Period 2|Study Terminated by Sponsor|0|||
48715311|NCT01578850|156806636|FG001|Period 2|Study Terminated by Sponsor|5|||
48715312|NCT01578850|156806637|FG002|Period 2|Study Terminated by Sponsor|4|||
48715313|NCT01578850|156806635|FG000|Period 2|Unspecified Reasons|0|||
48715314|NCT01578850|156806636|FG001|Period 2|Unspecified Reasons|1|||
48715315|NCT01578850|156806637|FG002|Period 2|Unspecified Reasons|0|||
48715316|NCT02756806|156806639|FG000|Overall Study|Study terminated early|5|||
48715317|NCT00750152|156806640|FG000|Overall Study|Adverse Event|2|||
48715318|NCT00750152|156806641|FG001|Overall Study|Adverse Event|1|||
48715319|NCT00750152|156806640|FG000|Overall Study|Lost to Follow-up|8|||
48715320|NCT00750152|156806641|FG001|Overall Study|Lost to Follow-up|13|||
48715321|NCT00750152|156806640|FG000|Overall Study|Withdrawal by Subject|3|||
48715322|NCT00750152|156806641|FG001|Overall Study|Withdrawal by Subject|3|||
48715323|NCT00750152|156806640|FG000|Overall Study|Physician Decision|1|||
48715324|NCT00750152|156806641|FG001|Overall Study|Physician Decision|1|||
48715325|NCT00750152|156806640|FG000|Overall Study|Non-compliance|0|||
49125684|NCT00249873|158298244|FG001|Overall Study|Physician withdrew consent|60|||
49125685|NCT00249873|158298243|FG000|Overall Study|Open label clopidogrel required|31|||
49125686|NCT00249873|158298244|FG001|Overall Study|Open label clopidogrel required|42|||
49125687|NCT00249873|158298243|FG000|Overall Study|Angiotensin II receptor blocker required|1|||
49125688|NCT00249873|158298244|FG001|Overall Study|Angiotensin II receptor blocker required|0|||
49125689|NCT00249873|158298243|FG000|Overall Study|Oral anticoagulant required|159|||
49125690|NCT00249873|158298244|FG001|Overall Study|Oral anticoagulant required|157|||
48715326|NCT00750152|156806641|FG001|Overall Study|Non-compliance|1|||
48715327|NCT00750152|156806640|FG000|Overall Study|Termination by sponsor|1|||
48715328|NCT00750152|156806641|FG001|Overall Study|Termination by sponsor|0|||
48715329|NCT00750152|156806640|FG000|Overall Study|Other|7|||
48715330|NCT00750152|156806641|FG001|Overall Study|Other|8|||
48715331|NCT01008423|156806642|FG000|Overall Study|Adverse Event|13|||
48715332|NCT01008423|156806643|FG001|Overall Study|Adverse Event|6|||
48715333|NCT01008423|156806642|FG000|Overall Study|Withdrawal by Subject|4|||
48715334|NCT01008423|156806643|FG001|Overall Study|Withdrawal by Subject|7|||
48715335|NCT01008423|156806642|FG000|Overall Study|Lost to Follow-up|0|||
48715336|NCT01008423|156806643|FG001|Overall Study|Lost to Follow-up|2|||
48715337|NCT01008423|156806642|FG000|Overall Study|Low Cortisol|0|||
48715338|NCT01008423|156806643|FG001|Overall Study|Low Cortisol|1|||
48715339|NCT01008423|156806642|FG000|Overall Study|Lack of Efficacy|0|||
48715340|NCT01008423|156806643|FG001|Overall Study|Lack of Efficacy|5|||
48715341|NCT01008423|156806642|FG000|Overall Study|Disease Extent 70 centimeters (cm)|1|||
48715342|NCT01008423|156806643|FG001|Overall Study|Disease Extent 70 centimeters (cm)|0|||
48715343|NCT01008423|156806642|FG000|Overall Study|Personal Conflict|1|||
48715344|NCT01008423|156806643|FG001|Overall Study|Personal Conflict|0|||
48715345|NCT01008423|156806642|FG000|Overall Study|Other|0|||
48715346|NCT01008423|156806643|FG001|Overall Study|Other|1|||
48715347|NCT01214395|156806644|FG000|Overall Study|All patients had infection|5|||
48715348|NCT02365233|156806646|FG000|Overall Study|IRB withheld the data|1|||
48715349|NCT02365233|156806647|FG001|Overall Study|IRB withheld the data|2|||
48715350|NCT02365233|156806648|FG002|Overall Study|IRB withheld the data|2|||
48715351|NCT02270944|156806649|FG000|Overall Study|Lost to Follow-up|9|||
48715352|NCT02270944|156806650|FG001|Overall Study|Lost to Follow-up|4|||
48715353|NCT02270944|156806649|FG000|Overall Study|Withdrawal by Subject|2|||
48715354|NCT02270944|156806650|FG001|Overall Study|Withdrawal by Subject|1|||
48715355|NCT01030666|156806651|FG000|Overall Study|Lost to Follow-up|3|||
48715356|NCT01030666|156806652|FG001|Overall Study|Lost to Follow-up|2|||
48715357|NCT01700439|156806659|FG000|Overall Study|Lost to Follow-up|47|||
48715358|NCT01700439|156806659|FG000|Overall Study|Withdrawal by Subject|183|||
48715359|NCT01700439|156806659|FG000|Overall Study|Death|186|||
48715360|NCT01865552|156808213|FG000|Period 1|Adverse Event|1|||
48715361|NCT01865552|156808214|FG001|Period 1|Adverse Event|0|||
48715362|NCT01865552|156808215|FG002|Period 1|Adverse Event|0|||
48715363|NCT01865552|156808216|FG003|Period 1|Adverse Event|1|||
48715364|NCT01865552|156808217|FG004|Period 1|Adverse Event|1|||
48715365|NCT01865552|156808218|FG005|Period 1|Adverse Event|1|||
48715366|NCT01865552|156808213|FG000|Period 1|Pathological lab|0|||
48715367|NCT01865552|156808214|FG001|Period 1|Pathological lab|0|||
48715368|NCT01865552|156808215|FG002|Period 1|Pathological lab|0|||
48715369|NCT01865552|156808216|FG003|Period 1|Pathological lab|0|||
48715370|NCT01865552|156808217|FG004|Period 1|Pathological lab|1|||
48715371|NCT01865552|156808218|FG005|Period 1|Pathological lab|0|||
48715372|NCT01865552|156808213|FG000|Period 1|Other|0|||
48715373|NCT01865552|156808214|FG001|Period 1|Other|0|||
48715374|NCT01865552|156808215|FG002|Period 1|Other|0|||
48715375|NCT01865552|156808216|FG003|Period 1|Other|0|||
48715376|NCT01865552|156808217|FG004|Period 1|Other|1|||
48715377|NCT01865552|156808218|FG005|Period 1|Other|0|||
49125691|NCT00249873|158298243|FG000|Overall Study|Study drug intolerance|5|||
49125692|NCT00249873|158298244|FG001|Overall Study|Study drug intolerance|0|||
49125693|NCT00249873|158298243|FG000|Overall Study|Surgery/ procedure|9|||
49125694|NCT00249873|158298244|FG001|Overall Study|Surgery/ procedure|9|||
49125695|NCT00249873|158298243|FG000|Overall Study|Event related to cardiac condition|12|||
49125696|NCT00249873|158298244|FG001|Overall Study|Event related to cardiac condition|21|||
49125697|NCT00249873|158298243|FG000|Overall Study|Thromboembolic/outcome event|82|||
49125698|NCT00249873|158298244|FG001|Overall Study|Thromboembolic/outcome event|122|||
49125699|NCT00928434|158298251|FG000|Overall Study|Adverse Event|14|||
49125700|NCT00928434|158298252|FG001|Overall Study|Adverse Event|5|||
49125701|NCT00928434|158298253|FG002|Overall Study|Adverse Event|18|||
49125702|NCT00928434|158298251|FG000|Overall Study|Protocol Violation|5|||
49125703|NCT00928434|158298252|FG001|Overall Study|Protocol Violation|0|||
49125704|NCT00928434|158298253|FG002|Overall Study|Protocol Violation|8|||
49125705|NCT00928434|158298251|FG000|Overall Study|Physician Decision|2|||
49125706|NCT00928434|158298252|FG001|Overall Study|Physician Decision|0|||
49125707|NCT00928434|158298253|FG002|Overall Study|Physician Decision|3|||
49125708|NCT00928434|158298251|FG000|Overall Study|Lost to Follow-up|1|||
49125709|NCT00928434|158298252|FG001|Overall Study|Lost to Follow-up|0|||
49125710|NCT00928434|158298253|FG002|Overall Study|Lost to Follow-up|3|||
49125711|NCT00928434|158298251|FG000|Overall Study|Withdrawal by Subject|5|||
48715378|NCT01256294|156808223|FG000|Overall Study|Adverse Event|1|||
48715379|NCT01256294|156808224|FG001|Overall Study|Adverse Event|0|||
48715380|NCT01256294|156808223|FG000|Overall Study|Withdrawal by Subject|1|||
48715381|NCT01256294|156808224|FG001|Overall Study|Withdrawal by Subject|1|||
48715382|NCT01256294|156808223|FG000|Overall Study|Protocol deviation|2|||
48715383|NCT01256294|156808224|FG001|Overall Study|Protocol deviation|1|||
48715384|NCT04681352|156808225|FG000|Overall Study|Lost to Follow-up|2|||
48715385|NCT04681352|156808225|FG000|Overall Study|Withdrawal by Subject|22|||
48715386|NCT01193257|156808228|FG000|Overall Study|Death|202|||
48715387|NCT01193257|156808229|FG001|Overall Study|Death|391|||
48813424|NCT01533714|157157448|FG000|Overall Study|Exclusion criteria|0|||
48715388|NCT01193257|156808228|FG000|Overall Study|Study termination by sponsor|0|||
48715389|NCT01193257|156808229|FG001|Overall Study|Study termination by sponsor|3|||
48715390|NCT01193257|156808228|FG000|Overall Study|Withdrawal by Subject|26|||
48715391|NCT01193257|156808229|FG001|Overall Study|Withdrawal by Subject|86|||
48715392|NCT01193257|156808228|FG000|Overall Study|Lost to Follow-up|2|||
48715393|NCT01193257|156808229|FG001|Overall Study|Lost to Follow-up|3|||
48715394|NCT01193257|156808228|FG000|Overall Study|Unblinded due to futility|135|||
48715395|NCT01193257|156808229|FG001|Overall Study|Unblinded due to futility|251|||
48715396|NCT02156271|156808230|FG000|Overall Study|Physician Decision|4|||
48715397|NCT02156271|156808231|FG001|Overall Study|Physician Decision|3|||
48715398|NCT02123251|156808232|FG000|Overall Study|Death|1|||
48715399|NCT02123251|156808233|FG001|Overall Study|Death|1|||
49125712|NCT00928434|158298252|FG001|Overall Study|Withdrawal by Subject|3|||
49125713|NCT00928434|158298253|FG002|Overall Study|Withdrawal by Subject|2|||
48715400|NCT02123251|156808232|FG000|Overall Study|Withdrawal by Subject|0|||
48715401|NCT02123251|156808233|FG001|Overall Study|Withdrawal by Subject|3|||
48715402|NCT02123251|156808232|FG000|Overall Study|Lost Medicaid eligibility|29|||
48715403|NCT02123251|156808233|FG001|Overall Study|Lost Medicaid eligibility|22|||
48715404|NCT02123251|156808232|FG000|Overall Study|Switched Managed Care Organization (MCO)|4|||
48715405|NCT02123251|156808233|FG001|Overall Study|Switched Managed Care Organization (MCO)|4|||
48715406|NCT00724711|156808234|FG000|Overall Study|Adverse Event|7|||
48715407|NCT00724711|156808235|FG001|Overall Study|Adverse Event|3|||
48715408|NCT00724711|156808234|FG000|Overall Study|Pregnancy|0|||
48715409|NCT00724711|156808235|FG001|Overall Study|Pregnancy|1|||
48715410|NCT00724711|156808234|FG000|Overall Study|Lack of Efficacy|0|||
48715411|NCT00724711|156808235|FG001|Overall Study|Lack of Efficacy|1|||
48715412|NCT00724711|156808234|FG000|Overall Study|Physician Decision|0|||
48715413|NCT00724711|156808235|FG001|Overall Study|Physician Decision|3|||
48715414|NCT00724711|156808234|FG000|Overall Study|Withdrawal by Subject|5|||
48715415|NCT00724711|156808235|FG001|Overall Study|Withdrawal by Subject|4|||
48715416|NCT00724711|156808234|FG000|Overall Study|Lost to Follow-up|4|||
48715417|NCT00724711|156808235|FG001|Overall Study|Lost to Follow-up|5|||
48715418|NCT00724711|156808234|FG000|Overall Study|Protocol Violation|1|||
48715419|NCT00724711|156808235|FG001|Overall Study|Protocol Violation|0|||
48715420|NCT01168219|156808236|FG000|Overall Study|off study before starting treatment|2|||
48715421|NCT01168219|156808236|FG000|Overall Study|withdrew before transplant|1|||
48715422|NCT01168219|156808236|FG000|Overall Study|ineligible due to CML|2|||
48715423|NCT03254108|156808237|FG000|Overall Study|Adverse Event|0|||
48715424|NCT03254108|156808238|FG001|Overall Study|Adverse Event|2|||
48715425|NCT03254108|156808239|FG002|Overall Study|Adverse Event|0|||
48715426|NCT03254108|156808240|FG003|Overall Study|Adverse Event|1|||
48715427|NCT03254108|156808241|FG004|Overall Study|Adverse Event|1|||
48715428|NCT03254108|156808237|FG000|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
48715429|NCT03254108|156808238|FG001|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
48813425|NCT01533714|157157449|FG001|Overall Study|Exclusion criteria|1|||
48813426|NCT01533714|157157450|FG002|Overall Study|Exclusion criteria|0|||
48813427|NCT01533714|157157451|FG003|Overall Study|Exclusion criteria|0|||
48813428|NCT01533714|157157452|FG004|Overall Study|Exclusion criteria|0|||
48813429|NCT01533714|157157453|FG005|Overall Study|Exclusion criteria|0|||
48813430|NCT01533714|157157448|FG000|Overall Study|Positive for purified protein derivative|0|||
48813431|NCT01533714|157157449|FG001|Overall Study|Positive for purified protein derivative|0|||
48813432|NCT01533714|157157450|FG002|Overall Study|Positive for purified protein derivative|1|||
48813433|NCT01533714|157157451|FG003|Overall Study|Positive for purified protein derivative|0|||
48813434|NCT01533714|157157452|FG004|Overall Study|Positive for purified protein derivative|1|||
48813435|NCT01533714|157157453|FG005|Overall Study|Positive for purified protein derivative|0|||
48813436|NCT01533714|157157448|FG000|Overall Study|Withdrawal criteria|0|||
49125714|NCT00928434|158298251|FG000|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10|||
49125715|NCT00928434|158298252|FG001|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4|||
48715430|NCT03254108|156808239|FG002|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
48715431|NCT03254108|156808240|FG003|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
48813437|NCT01533714|157157449|FG001|Overall Study|Withdrawal criteria|0|||
48813438|NCT01533714|157157450|FG002|Overall Study|Withdrawal criteria|1|||
48813439|NCT01533714|157157451|FG003|Overall Study|Withdrawal criteria|0|||
48813440|NCT01533714|157157452|FG004|Overall Study|Withdrawal criteria|3|||
48813441|NCT01533714|157157453|FG005|Overall Study|Withdrawal criteria|1|||
49125716|NCT00928434|158298253|FG002|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7|||
49125717|NCT00928434|158298251|FG000|Overall Study|PSA failure (>2 ng/mL) on other visit|2|||
48715432|NCT03254108|156808241|FG004|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2|||
48813442|NCT01533714|157157448|FG000|Overall Study|Ineligibility reason|0|||
48715433|NCT00095940|156808244|FG000|Lapatinib Continuation/Phase II|Disease Progression|1|||
48715434|NCT00095940|156808245|FG001|Lapatinib Continuation/Phase II|Disease Progression|1|||
48813443|NCT01533714|157157449|FG001|Overall Study|Ineligibility reason|0|||
48813444|NCT01533714|157157450|FG002|Overall Study|Ineligibility reason|0|||
48813445|NCT01533714|157157451|FG003|Overall Study|Ineligibility reason|1|||
49125718|NCT00928434|158298252|FG001|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
49125719|NCT00928434|158298253|FG002|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
49125720|NCT00928434|158298251|FG000|Overall Study|Other (not meeting above criteria)|5|||
49125721|NCT00928434|158298252|FG001|Overall Study|Other (not meeting above criteria)|1|||
49125722|NCT00928434|158298253|FG002|Overall Study|Other (not meeting above criteria)|2|||
49125723|NCT00752089|158298258|FG000|Overall Study|Adverse Event|1|||
49125724|NCT00752089|158298258|FG000|Overall Study|Protocol Deviation|2|||
49125725|NCT00752089|158298258|FG000|Overall Study|Could not attend visit 9|1|||
49125726|NCT00752089|158298258|FG000|Overall Study|Not capable of wearing partial denture|1|||
49125727|NCT00752089|158298258|FG000|Overall Study|Cannot continue the study|1|||
49125728|NCT00468585|158298261|FG000|Overall Study|Patient not treated|1|||
49125729|NCT00468585|158298262|FG001|Overall Study|Patient not treated|0|||
49125730|NCT00468585|158298263|FG002|Overall Study|Patient not treated|1|||
49125731|NCT00468585|158298264|FG003|Overall Study|Patient not treated|0|||
49125732|NCT00468585|158298261|FG000|Overall Study|Patient found to be ineligible|0|||
48813446|NCT01533714|157157452|FG004|Overall Study|Ineligibility reason|0|||
48813447|NCT01533714|157157453|FG005|Overall Study|Ineligibility reason|0|||
48813448|NCT00839917|157157454|FG000|Overall Study|Lost to Follow-up|1|||
48813449|NCT00839917|157157455|FG001|Overall Study|Lost to Follow-up|0|||
48813450|NCT00839917|157157454|FG000|Overall Study|Did not receive vaccine|0|||
48813451|NCT00839917|157157455|FG001|Overall Study|Did not receive vaccine|1|||
48813452|NCT03525574|157157456|FG000|Overall Study|Adverse Event|15|||
48920938|NCT00631371|157544787|FG001|Overall Study|subject request|45|||
49125733|NCT00468585|158298262|FG001|Overall Study|Patient found to be ineligible|0|||
49125734|NCT00468585|158298263|FG002|Overall Study|Patient found to be ineligible|1|||
49125735|NCT00468585|158298264|FG003|Overall Study|Patient found to be ineligible|0|||
49125736|NCT00468585|158298261|FG000|Overall Study|Adverse Event|0|||
48715435|NCT00095940|156808246|FG002|Lapatinib Continuation/Phase II|Disease Progression|15|||
48715436|NCT00095940|156808247|FG003|Lapatinib Continuation/Phase II|Disease Progression|0|||
48715437|NCT00095940|156808248|FG004|Lapatinib Continuation/Phase II|Disease Progression|0|||
48715438|NCT00095940|156808249|FG005|Lapatinib Continuation/Phase II|Disease Progression|13|||
48715439|NCT00095940|156808250|FG006|Lapatinib Continuation/Phase II|Disease Progression|2|||
48715440|NCT00095940|156808251|FG007|Lapatinib Continuation/Phase II|Disease Progression|1|||
48715441|NCT00095940|156808252|FG008|Lapatinib Continuation/Phase II|Disease Progression|12|||
48715442|NCT00095940|156808244|FG000|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
48715443|NCT00095940|156808245|FG001|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
48715444|NCT00095940|156808246|FG002|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
48715445|NCT00095940|156808247|FG003|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
48715446|NCT00095940|156808248|FG004|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
48715447|NCT00095940|156808249|FG005|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
48715448|NCT00095940|156808250|FG006|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
48715449|NCT00095940|156808251|FG007|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
48715450|NCT00095940|156808252|FG008|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
48715451|NCT00095940|156808244|FG000|Lapatinib Continuation/Phase II|Adverse Event|0|||
48715452|NCT00095940|156808245|FG001|Lapatinib Continuation/Phase II|Adverse Event|0|||
48715453|NCT00095940|156808246|FG002|Lapatinib Continuation/Phase II|Adverse Event|0|||
48715454|NCT00095940|156808247|FG003|Lapatinib Continuation/Phase II|Adverse Event|0|||
48715455|NCT00095940|156808248|FG004|Lapatinib Continuation/Phase II|Adverse Event|0|||
48715456|NCT00095940|156808249|FG005|Lapatinib Continuation/Phase II|Adverse Event|0|||
48715457|NCT00095940|156808250|FG006|Lapatinib Continuation/Phase II|Adverse Event|0|||
48715458|NCT00095940|156808251|FG007|Lapatinib Continuation/Phase II|Adverse Event|1|||
48715459|NCT00095940|156808252|FG008|Lapatinib Continuation/Phase II|Adverse Event|0|||
48715460|NCT04491604|156808253|FG000|Overall Study|Withdrawal by Subject|3|||
48715461|NCT01175083|156808254|FG000|Primary Epoch|Withdrawal by Subject|0|||
48715462|NCT01175083|156808255|FG001|Primary Epoch|Withdrawal by Subject|0|||
48920939|NCT00631371|157544786|FG000|Overall Study|Discontinuation of study by Sponsor|70|||
48920940|NCT00631371|157544787|FG001|Overall Study|Discontinuation of study by Sponsor|76|||
48920941|NCT00631371|157544786|FG000|Overall Study|Death|263|||
48920942|NCT00631371|157544787|FG001|Overall Study|Death|239|||
48920943|NCT00762892|157544788|FG000|Overall Study|Lost to Follow-up|2|||
48920944|NCT00762892|157544789|FG001|Overall Study|Lost to Follow-up|5|||
49125737|NCT00468585|158298262|FG001|Overall Study|Adverse Event|0|||
49125738|NCT00468585|158298263|FG002|Overall Study|Adverse Event|1|||
49125739|NCT00468585|158298264|FG003|Overall Study|Adverse Event|0|||
49125740|NCT00468585|158298261|FG000|Overall Study|Withdrawal by Subject|0|||
49125741|NCT00468585|158298262|FG001|Overall Study|Withdrawal by Subject|0|||
48715463|NCT01175083|156808256|FG002|Primary Epoch|Withdrawal by Subject|0|||
48715464|NCT01175083|156808257|FG003|Primary Epoch|Withdrawal by Subject|0|||
48715465|NCT01175083|156808258|FG004|Primary Epoch|Withdrawal by Subject|0|||
48715466|NCT01175083|156808259|FG005|Primary Epoch|Withdrawal by Subject|2|||
48813453|NCT03525574|157157457|FG001|Overall Study|Adverse Event|0|||
48813454|NCT03525574|157157456|FG000|Overall Study|Withdrawal of consent (not due to AE)|18|||
48813455|NCT03525574|157157457|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
48813456|NCT03525574|157157456|FG000|Overall Study|Lost to Follow-up|4|||
48813457|NCT03525574|157157457|FG001|Overall Study|Lost to Follow-up|0|||
48813458|NCT03525574|157157456|FG000|Overall Study|Commercial drug is Available for participant|48|||
48813459|NCT03525574|157157457|FG001|Overall Study|Commercial drug is Available for participant|0|||
48813460|NCT03525574|157157456|FG000|Overall Study|Death|1|||
48813461|NCT03525574|157157457|FG001|Overall Study|Death|0|||
48813462|NCT03525574|157157456|FG000|Overall Study|Other non-compliance|2|||
48813463|NCT03525574|157157457|FG001|Overall Study|Other non-compliance|0|||
48813464|NCT03525574|157157456|FG000|Overall Study|Physician Decision|6|||
48813465|NCT03525574|157157457|FG001|Overall Study|Physician Decision|0|||
48813466|NCT03525574|157157456|FG000|Overall Study|Other|58|||
48813467|NCT03525574|157157457|FG001|Overall Study|Other|0|||
48813468|NCT03525574|157157456|FG000|Overall Study|Enrolled but never dosed|1|||
48813469|NCT03525574|157157457|FG001|Overall Study|Enrolled but never dosed|0|||
48813470|NCT03525574|157157456|FG000|Overall Study|Not enrolled in 105 study|0|||
48813471|NCT03525574|157157457|FG001|Overall Study|Not enrolled in 105 study|3|||
48813472|NCT03354637|157157458|FG000|Double-blind Period|Protocol Violation|2|||
48813473|NCT03354637|157157459|FG001|Double-blind Period|Protocol Violation|0|||
48813474|NCT03354637|157157460|FG002|Double-blind Period|Protocol Violation|0|||
48813475|NCT03354637|157157458|FG000|Double-blind Period|Adverse Event|1|||
48813476|NCT03354637|157157459|FG001|Double-blind Period|Adverse Event|2|||
48813477|NCT03354637|157157460|FG002|Double-blind Period|Adverse Event|0|||
48813478|NCT03354637|157157458|FG000|Double-blind Period|Lost to Follow-up|3|||
48813479|NCT03354637|157157459|FG001|Double-blind Period|Lost to Follow-up|4|||
48813480|NCT03354637|157157460|FG002|Double-blind Period|Lost to Follow-up|3|||
48813481|NCT03354637|157157458|FG000|Double-blind Period|Withdrawal by Subject|10|||
48813482|NCT03354637|157157459|FG001|Double-blind Period|Withdrawal by Subject|6|||
48813483|NCT03354637|157157460|FG002|Double-blind Period|Withdrawal by Subject|4|||
48813484|NCT03354637|157157458|FG000|Double-blind Period|Incomplete Efficacy Data Collection|1|||
48813485|NCT03354637|157157459|FG001|Double-blind Period|Incomplete Efficacy Data Collection|1|||
48813486|NCT03354637|157157460|FG002|Double-blind Period|Incomplete Efficacy Data Collection|0|||
48813487|NCT03354637|157157458|FG000|Open Label Extension|Adverse Event|0|||
48813488|NCT03354637|157157459|FG001|Open Label Extension|Adverse Event|0|||
48813489|NCT03354637|157157460|FG002|Open Label Extension|Adverse Event|1|||
48813490|NCT03354637|157157458|FG000|Open Label Extension|Lost to Follow-up|0|||
48813491|NCT03354637|157157459|FG001|Open Label Extension|Lost to Follow-up|0|||
48813492|NCT03354637|157157460|FG002|Open Label Extension|Lost to Follow-up|2|||
48813493|NCT03354637|157157458|FG000|Open Label Extension|Withdrawal by Subject|0|||
48813494|NCT03354637|157157459|FG001|Open Label Extension|Withdrawal by Subject|0|||
48813495|NCT03354637|157157460|FG002|Open Label Extension|Withdrawal by Subject|5|||
49125742|NCT00468585|158298263|FG002|Overall Study|Withdrawal by Subject|2|||
49125743|NCT00468585|158298264|FG003|Overall Study|Withdrawal by Subject|1|||
49125744|NCT00511810|158298265|FG000|Overall Study|Lost to Follow-up|1|||
49125745|NCT00511810|158298266|FG001|Overall Study|Lost to Follow-up|2|||
49125746|NCT00511810|158298265|FG000|Overall Study|Lack of Efficacy|0|||
48715467|NCT01175083|156808254|FG000|Primary Epoch|Lost to Follow-up|0|||
48715468|NCT01175083|156808255|FG001|Primary Epoch|Lost to Follow-up|0|||
48715469|NCT01175083|156808256|FG002|Primary Epoch|Lost to Follow-up|0|||
48715470|NCT01175083|156808257|FG003|Primary Epoch|Lost to Follow-up|0|||
48715471|NCT01175083|156808258|FG004|Primary Epoch|Lost to Follow-up|0|||
48715472|NCT01175083|156808259|FG005|Primary Epoch|Lost to Follow-up|1|||
48715473|NCT01175083|156808254|FG000|Booster Epoch|Death|0|||
48715474|NCT01175083|156808255|FG001|Booster Epoch|Death|0|||
48715475|NCT01175083|156808256|FG002|Booster Epoch|Death|1|||
48715476|NCT01175083|156808257|FG003|Booster Epoch|Death|0|||
48715477|NCT01175083|156808258|FG004|Booster Epoch|Death|0|||
48715478|NCT01175083|156808259|FG005|Booster Epoch|Death|0|||
48715479|NCT01175083|156808254|FG000|Booster Epoch|Withdrawal by Subject|0|||
48715480|NCT01175083|156808255|FG001|Booster Epoch|Withdrawal by Subject|0|||
48813496|NCT03354637|157157458|FG000|Open Label Extension|Study Terminated by Sponsor|0|||
49125747|NCT00511810|158298266|FG001|Overall Study|Lack of Efficacy|2|||
49125748|NCT00511810|158298265|FG000|Overall Study|Refused second scn|0|||
49125749|NCT00511810|158298266|FG001|Overall Study|Refused second scn|1|||
49125750|NCT03322293|158298267|FG000|Overall Study|Lost to Follow-up|0|||
49125751|NCT03322293|158298268|FG001|Overall Study|Lost to Follow-up|0|||
49125752|NCT03322293|158298269|FG002|Overall Study|Lost to Follow-up|1|||
49125753|NCT00230048|158298270|FG000|Overall Study|Lost to Follow-up|13|||
48715481|NCT01175083|156808256|FG002|Booster Epoch|Withdrawal by Subject|0|||
48715482|NCT01175083|156808257|FG003|Booster Epoch|Withdrawal by Subject|1|||
48715483|NCT01175083|156808258|FG004|Booster Epoch|Withdrawal by Subject|0|||
48715484|NCT01175083|156808259|FG005|Booster Epoch|Withdrawal by Subject|0|||
48715485|NCT02386189|156808271|FG000|Overall Study|Lost to Follow-up|2|||
48813497|NCT03354637|157157459|FG001|Open Label Extension|Study Terminated by Sponsor|0|||
48813498|NCT03354637|157157460|FG002|Open Label Extension|Study Terminated by Sponsor|17|||
48813499|NCT03354637|157157458|FG000|Open Label Extension|Subject Noncompliance|0|||
49125754|NCT00230048|158298271|FG001|Overall Study|Lost to Follow-up|18|||
48715486|NCT02386189|156808272|FG001|Overall Study|Lost to Follow-up|3|||
48715487|NCT02386189|156808271|FG000|Overall Study|Withdrawal by Subject|1|||
48715488|NCT02386189|156808272|FG001|Overall Study|Withdrawal by Subject|0|||
48715489|NCT02386189|156808271|FG000|Overall Study|Death|1|||
48715490|NCT02386189|156808272|FG001|Overall Study|Death|0|||
48715491|NCT01256190|156808275|FG000|Overall Study|Lost to Follow-up|2|||
48715492|NCT01256190|156808276|FG001|Overall Study|Lost to Follow-up|0|||
48715493|NCT02364336|156808277|FG000|Overall Study|Adverse Event|0|||
49125755|NCT00297648|158298272|FG000|Overall Study|Adverse Event|13|||
49125756|NCT00297648|158298272|FG000|Overall Study|Lack of Efficacy|18|||
49125757|NCT00297648|158298272|FG000|Overall Study|Lost to Follow-up|1|||
49125758|NCT00297648|158298272|FG000|Overall Study|Withdrawal by Subject|3|||
49125759|NCT00297648|158298272|FG000|Overall Study|Other: Incompliance|1|||
49125760|NCT03810183|158298273|FG000|Overall Study|Study terminated by Sponsor|2|||
49125761|NCT03810183|158298274|FG001|Overall Study|Study terminated by Sponsor|1|||
49125762|NCT03167242|158298276|FG000|Overall Study|Patient/Guardian Decision|0|||
49125763|NCT03167242|158298277|FG001|Overall Study|Patient/Guardian Decision|1|||
49125764|NCT03167242|158298278|FG002|Overall Study|Patient/Guardian Decision|2|||
49125765|NCT03167242|158298279|FG003|Overall Study|Patient/Guardian Decision|1|||
49125766|NCT03167242|158298280|FG004|Overall Study|Patient/Guardian Decision|1|||
49125767|NCT03167242|158298281|FG005|Overall Study|Patient/Guardian Decision|1|||
49125768|NCT03167242|158298282|FG006|Overall Study|Patient/Guardian Decision|0|||
49125769|NCT03167242|158298283|FG007|Overall Study|Patient/Guardian Decision|0|||
49125770|NCT03167242|158298284|FG008|Overall Study|Patient/Guardian Decision|0|||
49125771|NCT03167242|158298285|FG009|Overall Study|Patient/Guardian Decision|0|||
49125772|NCT03167242|158298286|FG010|Overall Study|Patient/Guardian Decision|1|||
49125773|NCT03167242|158298287|FG011|Overall Study|Patient/Guardian Decision|0|||
49125774|NCT03167242|158298276|FG000|Overall Study|Lost to Follow-up|0|||
49125775|NCT03167242|158298277|FG001|Overall Study|Lost to Follow-up|0|||
49125776|NCT03167242|158298278|FG002|Overall Study|Lost to Follow-up|1|||
49125777|NCT03167242|158298279|FG003|Overall Study|Lost to Follow-up|0|||
49125778|NCT03167242|158298280|FG004|Overall Study|Lost to Follow-up|0|||
49125779|NCT03167242|158298281|FG005|Overall Study|Lost to Follow-up|1|||
49125780|NCT03167242|158298282|FG006|Overall Study|Lost to Follow-up|2|||
49125781|NCT03167242|158298283|FG007|Overall Study|Lost to Follow-up|1|||
49125782|NCT03167242|158298284|FG008|Overall Study|Lost to Follow-up|0|||
49125783|NCT03167242|158298285|FG009|Overall Study|Lost to Follow-up|0|||
49125784|NCT03167242|158298286|FG010|Overall Study|Lost to Follow-up|1|||
49125785|NCT03167242|158298287|FG011|Overall Study|Lost to Follow-up|1|||
48715494|NCT02364336|156808278|FG001|Overall Study|Adverse Event|1|||
48715495|NCT00859456|156808283|FG000|Overall Study|Adverse Event|3|||
48813500|NCT03354637|157157459|FG001|Open Label Extension|Subject Noncompliance|0|||
48813501|NCT03354637|157157460|FG002|Open Label Extension|Subject Noncompliance|1|||
48813502|NCT03354637|157157458|FG000|Open Label Extension|Lack of Efficacy|0|||
48813503|NCT03354637|157157459|FG001|Open Label Extension|Lack of Efficacy|0|||
48813504|NCT03354637|157157460|FG002|Open Label Extension|Lack of Efficacy|1|||
48813505|NCT03354637|157157458|FG000|Open Label Extension|Physician Decision|0|||
48813506|NCT03354637|157157459|FG001|Open Label Extension|Physician Decision|0|||
48813507|NCT03354637|157157460|FG002|Open Label Extension|Physician Decision|1|||
48813508|NCT00584805|157157461|FG000|Overall Study|No longer at risk of exposure|39|||
48813509|NCT00584805|157157461|FG000|Overall Study|Relocation|36|||
48813510|NCT00584805|157157461|FG000|Overall Study|Withdrawal by Subject|18|||
48813511|NCT00584805|157157461|FG000|Overall Study|Non-compliance|1|||
48813512|NCT00584805|157157461|FG000|Overall Study|Lost to follow up|3|||
48813513|NCT00584805|157157461|FG000|Overall Study|Screen failures|2|||
48813514|NCT01763788|157157462|FG000|Overall Study|Lost to Follow-up|0|||
48813515|NCT01763788|157157463|FG001|Overall Study|Lost to Follow-up|0|||
48813516|NCT01763788|157157464|FG002|Overall Study|Lost to Follow-up|1|||
48813517|NCT01763788|157157465|FG003|Overall Study|Lost to Follow-up|0|||
48813518|NCT03893825|157157468|FG000|Overall Study|Death|2|||
48813519|NCT03893825|157157469|FG001|Overall Study|Death|1|||
48813520|NCT03893825|157157468|FG000|Overall Study|Adverse Event|0|||
48813521|NCT03893825|157157469|FG001|Overall Study|Adverse Event|2|||
48813522|NCT03893825|157157468|FG000|Overall Study|Withdrawal by Subject|19|||
48813523|NCT03893825|157157469|FG001|Overall Study|Withdrawal by Subject|21|||
49125786|NCT03167242|158298276|FG000|Overall Study|Reason not provided|0|||
49125787|NCT03167242|158298277|FG001|Overall Study|Reason not provided|0|||
49125788|NCT03167242|158298278|FG002|Overall Study|Reason not provided|0|||
49125789|NCT03167242|158298279|FG003|Overall Study|Reason not provided|0|||
48715496|NCT00859456|156808283|FG000|Overall Study|Progressive disease|2|||
48715497|NCT00859456|156808283|FG000|Overall Study|Non-compliance|3|||
48715498|NCT03085914|156808285|FG000|Overall Study|Death|6|||
48715499|NCT03085914|156808286|FG001|Overall Study|Death|6|||
48715500|NCT03085914|156808287|FG002|Overall Study|Death|4|||
49125790|NCT03167242|158298280|FG004|Overall Study|Reason not provided|0|||
49125791|NCT03167242|158298281|FG005|Overall Study|Reason not provided|0|||
49125792|NCT03167242|158298282|FG006|Overall Study|Reason not provided|0|||
49125793|NCT03167242|158298283|FG007|Overall Study|Reason not provided|0|||
49125794|NCT03167242|158298284|FG008|Overall Study|Reason not provided|1|||
49125795|NCT03167242|158298285|FG009|Overall Study|Reason not provided|0|||
49125796|NCT03167242|158298286|FG010|Overall Study|Reason not provided|0|||
49125797|NCT03167242|158298287|FG011|Overall Study|Reason not provided|0|||
49125798|NCT01411852|158298288|FG000|Prehospital Intervention Phase|No qualifying SBP|5|||
49125799|NCT01411852|158298289|FG001|Prehospital Intervention Phase|No qualifying SBP|4|||
49125800|NCT01411852|158298288|FG000|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
49125801|NCT01411852|158298289|FG001|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
49125802|NCT01411852|158298288|FG000|Prehospital Intervention Phase|Found to be under age|0|||
49125803|NCT01411852|158298289|FG001|Prehospital Intervention Phase|Found to be under age|1|||
49125804|NCT01411852|158298288|FG000|Prehospital Intervention Phase|Severe head injury with GCS≤8|5|||
49125805|NCT01411852|158298289|FG001|Prehospital Intervention Phase|Severe head injury with GCS≤8|0|||
49125806|NCT01411852|158298288|FG000|Hospital Intervention Phase|Severe head injury|5|||
49125807|NCT01411852|158298289|FG001|Hospital Intervention Phase|Severe head injury|4|||
49125808|NCT01411852|158298288|FG000|Hospital Intervention Phase|No qualifying SBP|5|||
49125809|NCT01411852|158298289|FG001|Hospital Intervention Phase|No qualifying SBP|1|||
48715501|NCT03085914|156808288|FG003|Overall Study|Death|1|||
48715502|NCT03085914|156808289|FG004|Overall Study|Death|5|||
48715503|NCT03085914|156808290|FG005|Overall Study|Death|2|||
48715504|NCT03085914|156808291|FG006|Overall Study|Death|2|||
48715505|NCT03085914|156808285|FG000|Overall Study|Withdrawal by Subject|1|||
48715506|NCT03085914|156808286|FG001|Overall Study|Withdrawal by Subject|1|||
48715507|NCT03085914|156808287|FG002|Overall Study|Withdrawal by Subject|2|||
48715508|NCT03085914|156808288|FG003|Overall Study|Withdrawal by Subject|2|||
48715509|NCT03085914|156808289|FG004|Overall Study|Withdrawal by Subject|2|||
48715510|NCT03085914|156808290|FG005|Overall Study|Withdrawal by Subject|0|||
48715511|NCT03085914|156808291|FG006|Overall Study|Withdrawal by Subject|1|||
48813524|NCT03893825|157157468|FG000|Overall Study|Protocol deviation|1|||
48715512|NCT03085914|156808285|FG000|Overall Study|Lost to Follow-up|0|||
48715513|NCT03085914|156808286|FG001|Overall Study|Lost to Follow-up|0|||
48715514|NCT03085914|156808287|FG002|Overall Study|Lost to Follow-up|1|||
48715515|NCT03085914|156808288|FG003|Overall Study|Lost to Follow-up|0|||
48715516|NCT03085914|156808289|FG004|Overall Study|Lost to Follow-up|0|||
48715517|NCT03085914|156808290|FG005|Overall Study|Lost to Follow-up|1|||
48715518|NCT03085914|156808291|FG006|Overall Study|Lost to Follow-up|1|||
48715519|NCT03085914|156808285|FG000|Overall Study|Reason was not specified,|2|||
48715520|NCT03085914|156808286|FG001|Overall Study|Reason was not specified,|2|||
48715521|NCT03085914|156808287|FG002|Overall Study|Reason was not specified,|2|||
48715522|NCT03085914|156808288|FG003|Overall Study|Reason was not specified,|3|||
48715523|NCT03085914|156808289|FG004|Overall Study|Reason was not specified,|3|||
48715524|NCT03085914|156808290|FG005|Overall Study|Reason was not specified,|3|||
48715525|NCT03085914|156808291|FG006|Overall Study|Reason was not specified,|6|||
48715526|NCT03085914|156808285|FG000|Overall Study|Progressive Disease|0|||
48715527|NCT03085914|156808286|FG001|Overall Study|Progressive Disease|0|||
48715528|NCT03085914|156808287|FG002|Overall Study|Progressive Disease|2|||
48715529|NCT03085914|156808288|FG003|Overall Study|Progressive Disease|2|||
48715530|NCT03085914|156808289|FG004|Overall Study|Progressive Disease|1|||
48715531|NCT03085914|156808290|FG005|Overall Study|Progressive Disease|1|||
48715532|NCT03085914|156808291|FG006|Overall Study|Progressive Disease|1|||
48715533|NCT03085914|156808285|FG000|Overall Study|Study Terminated by the Sponsor|0|||
48715534|NCT03085914|156808286|FG001|Overall Study|Study Terminated by the Sponsor|0|||
49125810|NCT01411852|158298288|FG000|Hospital Intervention Phase|Miscommunication error|1|||
48715535|NCT03085914|156808287|FG002|Overall Study|Study Terminated by the Sponsor|0|||
48813525|NCT03893825|157157469|FG001|Overall Study|Protocol deviation|0|||
48813526|NCT03893825|157157468|FG000|Overall Study|Lost to Follow-up|10|||
48813527|NCT03893825|157157469|FG001|Overall Study|Lost to Follow-up|10|||
48813528|NCT03893825|157157468|FG000|Overall Study|Other than specified|7|||
48813529|NCT03893825|157157469|FG001|Overall Study|Other than specified|6|||
48813530|NCT04161807|157157470|FG000|Overall Study|Withdrawal by Subject|2|||
48813531|NCT04161807|157157470|FG000|Overall Study|Performed only 1 treatment|2|||
48813532|NCT02306265|157157479|FG000|Overall Study|Withdrawal by Subject|1|||
48813533|NCT02207374|157157480|FG000|Overall Study|Withdrawal by Subject|5|||
48813534|NCT02207374|157157481|FG001|Overall Study|Withdrawal by Subject|9|||
48813535|NCT02207374|157157482|FG002|Overall Study|Withdrawal by Subject|4|||
48813536|NCT02207374|157157480|FG000|Overall Study|Death|1|||
48813537|NCT02207374|157157481|FG001|Overall Study|Death|0|||
48813538|NCT02207374|157157482|FG002|Overall Study|Death|1|||
48813539|NCT02207374|157157480|FG000|Overall Study|Missing follow-up information|0|||
48813540|NCT02207374|157157481|FG001|Overall Study|Missing follow-up information|1|||
49125811|NCT01411852|158298289|FG001|Hospital Intervention Phase|Miscommunication error|2|||
48715536|NCT03085914|156808288|FG003|Overall Study|Study Terminated by the Sponsor|1|||
48715537|NCT03085914|156808289|FG004|Overall Study|Study Terminated by the Sponsor|2|||
48715538|NCT03085914|156808290|FG005|Overall Study|Study Terminated by the Sponsor|1|||
48813541|NCT02207374|157157482|FG002|Overall Study|Missing follow-up information|1|||
48813542|NCT00785538|157157483|FG000|Treatment Period|Adverse Event|1|||
49125812|NCT01411852|158298288|FG000|Hospital Intervention Phase|CPR administered|3|||
48813543|NCT00785538|157157484|FG001|Treatment Period|Adverse Event|2|||
48813544|NCT00785538|157157485|FG002|Treatment Period|Adverse Event|2|||
48813545|NCT00785538|157157486|FG003|Treatment Period|Adverse Event|0|||
48813546|NCT00785538|157157483|FG000|Treatment Period|Withdrawal by Subject|0|||
48715539|NCT03085914|156808291|FG006|Overall Study|Study Terminated by the Sponsor|0|||
48715540|NCT01478048|156808292|FG000|Overall Study|Disease Progression|52|||
48715541|NCT01478048|156808293|FG001|Overall Study|Disease Progression|35|||
48715542|NCT01478048|156808292|FG000|Overall Study|study drug toxicity|11|||
48715543|NCT01478048|156808293|FG001|Overall Study|study drug toxicity|14|||
48715544|NCT01478048|156808292|FG000|Overall Study|Adverse Event|2|||
48715545|NCT01478048|156808293|FG001|Overall Study|Adverse Event|11|||
48715546|NCT01478048|156808292|FG000|Overall Study|subject request to discontinue treatment|3|||
48715547|NCT01478048|156808293|FG001|Overall Study|subject request to discontinue treatment|5|||
48715548|NCT01478048|156808292|FG000|Overall Study|Withdrawal by Subject|2|||
48715549|NCT01478048|156808293|FG001|Overall Study|Withdrawal by Subject|5|||
48715550|NCT01478048|156808292|FG000|Overall Study|non-specified|6|||
48715551|NCT01478048|156808293|FG001|Overall Study|non-specified|4|||
48715552|NCT01478048|156808292|FG000|Overall Study|poor/non-compliance|0|||
48715553|NCT01478048|156808293|FG001|Overall Study|poor/non-compliance|1|||
48715554|NCT01478048|156808292|FG000|Overall Study|no longer meets study criteria|1|||
48715555|NCT01478048|156808293|FG001|Overall Study|no longer meets study criteria|0|||
48715556|NCT00647270|156808295|FG000|Period 1, Placebo-control (12 Weeks)|Adverse Event|2|||
48813547|NCT00785538|157157484|FG001|Treatment Period|Withdrawal by Subject|0|||
48813548|NCT00785538|157157485|FG002|Treatment Period|Withdrawal by Subject|0|||
48813549|NCT00785538|157157486|FG003|Treatment Period|Withdrawal by Subject|1|||
48813550|NCT02494206|157157487|FG000|Overall Study|Adverse Event|1|||
48813551|NCT02494206|157157487|FG000|Overall Study|Disease Progression|1|||
48813552|NCT02584855|157157494|FG000|Open-Label Treatment Period|Lack of Efficacy|61|||
48813553|NCT02584855|157157495|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
48813554|NCT02584855|157157496|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
48813555|NCT02584855|157157497|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
48813556|NCT02584855|157157498|FG004|Open-Label Treatment Period|Lack of Efficacy|0|||
48813557|NCT02584855|157157499|FG005|Open-Label Treatment Period|Lack of Efficacy|0|||
48813558|NCT02584855|157157494|FG000|Open-Label Treatment Period|Withdrawal by Subject|21|||
48813559|NCT02584855|157157495|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
48813560|NCT02584855|157157496|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
48813561|NCT02584855|157157497|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
48813562|NCT02584855|157157498|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
48813563|NCT02584855|157157499|FG005|Open-Label Treatment Period|Withdrawal by Subject|0|||
48813564|NCT02584855|157157494|FG000|Open-Label Treatment Period|Adverse Event|14|||
48813565|NCT02584855|157157495|FG001|Open-Label Treatment Period|Adverse Event|0|||
48813566|NCT02584855|157157496|FG002|Open-Label Treatment Period|Adverse Event|0|||
48813567|NCT02584855|157157497|FG003|Open-Label Treatment Period|Adverse Event|0|||
48813568|NCT02584855|157157498|FG004|Open-Label Treatment Period|Adverse Event|0|||
48813569|NCT02584855|157157499|FG005|Open-Label Treatment Period|Adverse Event|0|||
48813570|NCT02584855|157157494|FG000|Open-Label Treatment Period|Death|2|||
48813571|NCT02584855|157157495|FG001|Open-Label Treatment Period|Death|0|||
48813572|NCT02584855|157157496|FG002|Open-Label Treatment Period|Death|0|||
48813573|NCT02584855|157157497|FG003|Open-Label Treatment Period|Death|0|||
48813574|NCT02584855|157157498|FG004|Open-Label Treatment Period|Death|0|||
48813575|NCT02584855|157157499|FG005|Open-Label Treatment Period|Death|0|||
48813576|NCT02584855|157157494|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
48813577|NCT02584855|157157495|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
48813578|NCT02584855|157157496|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
48813579|NCT02584855|157157497|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
48813580|NCT02584855|157157498|FG004|Open-Label Treatment Period|Lost to Follow-up|0|||
48813581|NCT02584855|157157499|FG005|Open-Label Treatment Period|Lost to Follow-up|0|||
48813582|NCT02584855|157157494|FG000|Open-Label Treatment Period|Protocol Violation|1|||
48813583|NCT02584855|157157495|FG001|Open-Label Treatment Period|Protocol Violation|0|||
48813584|NCT02584855|157157496|FG002|Open-Label Treatment Period|Protocol Violation|0|||
48813585|NCT02584855|157157497|FG003|Open-Label Treatment Period|Protocol Violation|0|||
48813586|NCT02584855|157157498|FG004|Open-Label Treatment Period|Protocol Violation|0|||
48813587|NCT02584855|157157499|FG005|Open-Label Treatment Period|Protocol Violation|0|||
48813588|NCT02584855|157157494|FG000|Open-Label Treatment Period|No PI Available|2|||
48813589|NCT02584855|157157495|FG001|Open-Label Treatment Period|No PI Available|0|||
48715557|NCT00647270|156808296|FG001|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
48715558|NCT00647270|156808297|FG002|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
48715559|NCT00647270|156808295|FG000|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0|||
48715560|NCT00647270|156808296|FG001|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
48813590|NCT02584855|157157496|FG002|Open-Label Treatment Period|No PI Available|0|||
48813591|NCT02584855|157157497|FG003|Open-Label Treatment Period|No PI Available|0|||
48813592|NCT02584855|157157498|FG004|Open-Label Treatment Period|No PI Available|0|||
48813593|NCT02584855|157157499|FG005|Open-Label Treatment Period|No PI Available|0|||
48715561|NCT00647270|156808297|FG002|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
48715562|NCT00647270|156808295|FG000|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2|||
48715563|NCT00647270|156808296|FG001|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1|||
48715564|NCT00647270|156808297|FG002|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7|||
48715565|NCT00647270|156808295|FG000|Period 1, Placebo-control (12 Weeks)|Other|4|||
48715566|NCT00647270|156808296|FG001|Period 1, Placebo-control (12 Weeks)|Other|4|||
48715567|NCT00647270|156808297|FG002|Period 1, Placebo-control (12 Weeks)|Other|8|||
48715568|NCT00647270|156808295|FG000|Period 2, Placebo Switched to Adalimumab|Adverse Event|1|||
48715569|NCT00647270|156808296|FG001|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
48715570|NCT00647270|156808297|FG002|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
48715571|NCT00647270|156808295|FG000|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
48715572|NCT00647270|156808296|FG001|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
48715573|NCT00647270|156808297|FG002|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4|||
48715574|NCT00647270|156808295|FG000|Period 2, Placebo Switched to Adalimumab|Other|2|||
48715575|NCT00647270|156808296|FG001|Period 2, Placebo Switched to Adalimumab|Other|6|||
48715576|NCT00647270|156808297|FG002|Period 2, Placebo Switched to Adalimumab|Other|0|||
48715577|NCT05277337|156808300|FG000|Overall Study|Lost to Follow-up|2|||
48715578|NCT05277337|156808301|FG001|Overall Study|Lost to Follow-up|0|||
48715579|NCT05277337|156808300|FG000|Overall Study|Withdrawal by Subject|1|||
48715580|NCT05277337|156808301|FG001|Overall Study|Withdrawal by Subject|0|||
48715581|NCT00357760|156808302|FG000|Overall Study|Disease progression|44|||
48715582|NCT00357760|156808303|FG001|Overall Study|Disease progression|17|||
48715583|NCT00357760|156808302|FG000|Overall Study|Adverse Event|10|||
48715584|NCT00357760|156808303|FG001|Overall Study|Adverse Event|7|||
48715585|NCT00357760|156808302|FG000|Overall Study|Death|0|||
48715586|NCT00357760|156808303|FG001|Overall Study|Death|3|||
48715587|NCT00357760|156808302|FG000|Overall Study|Alternative therapy|1|||
48715588|NCT00357760|156808303|FG001|Overall Study|Alternative therapy|0|||
48715589|NCT00357760|156808302|FG000|Overall Study|Withdrawal by Subject|0|||
48715590|NCT00357760|156808303|FG001|Overall Study|Withdrawal by Subject|2|||
48715591|NCT00357760|156808302|FG000|Overall Study|Never started treatment|2|||
48715592|NCT00357760|156808303|FG001|Overall Study|Never started treatment|1|||
48715593|NCT00357760|156808302|FG000|Overall Study|Ineligible|0|||
48715594|NCT00357760|156808303|FG001|Overall Study|Ineligible|2|||
48715595|NCT00357760|156808302|FG000|Overall Study|Physician Decision|2|||
48715596|NCT00357760|156808303|FG001|Overall Study|Physician Decision|1|||
48715597|NCT00357760|156808302|FG000|Overall Study|Protocol Violation|0|||
48715598|NCT00357760|156808303|FG001|Overall Study|Protocol Violation|1|||
48715599|NCT00357760|156808302|FG000|Overall Study|To receive hospice care|0|||
48715600|NCT00357760|156808303|FG001|Overall Study|To receive hospice care|1|||
48715601|NCT00984620|156808304|FG000|Overall Study|Adverse Event|5|||
48715602|NCT00984620|156808305|FG001|Overall Study|Adverse Event|5|||
48715603|NCT00984620|156808304|FG000|Overall Study|Lost to Follow-up|1|||
48715604|NCT00984620|156808305|FG001|Overall Study|Lost to Follow-up|1|||
48715605|NCT00984620|156808304|FG000|Overall Study|Withdrawal by Subject|0|||
48715606|NCT00984620|156808305|FG001|Overall Study|Withdrawal by Subject|2|||
48715607|NCT00984620|156808304|FG000|Overall Study|reason other than listed above|0|||
48715608|NCT00984620|156808305|FG001|Overall Study|reason other than listed above|4|||
48715609|NCT01853839|156808306|FG000|Overall Study|Violated inclusion criteria|2|||
48715610|NCT01853839|156808306|FG000|Overall Study|Not meet ITT population definition|58|||
48715611|NCT01853839|156808306|FG000|Overall Study|End of treatment visit too early|33|||
48715612|NCT01853839|156808306|FG000|Overall Study|Lost to follow-up or no valid BP measure|336|||
48715613|NCT02709538|156808308|FG000|Overall Study|Adverse Event|13|||
48715614|NCT02709538|156808309|FG001|Overall Study|Adverse Event|2|||
48715615|NCT02709538|156808310|FG002|Overall Study|Adverse Event|3|||
48715616|NCT02709538|156808308|FG000|Overall Study|Lack of Efficacy|1|||
48715617|NCT02709538|156808309|FG001|Overall Study|Lack of Efficacy|0|||
48715618|NCT02709538|156808310|FG002|Overall Study|Lack of Efficacy|0|||
48715619|NCT02709538|156808308|FG000|Overall Study|Lost to Follow-up|24|||
48715620|NCT02709538|156808309|FG001|Overall Study|Lost to Follow-up|8|||
48715621|NCT02709538|156808310|FG002|Overall Study|Lost to Follow-up|4|||
48715622|NCT02709538|156808308|FG000|Overall Study|Physician Decision|1|||
48715623|NCT02709538|156808309|FG001|Overall Study|Physician Decision|0|||
48715624|NCT02709538|156808310|FG002|Overall Study|Physician Decision|0|||
48715625|NCT02709538|156808308|FG000|Overall Study|Withdrawal by Subject|40|||
48715626|NCT02709538|156808309|FG001|Overall Study|Withdrawal by Subject|7|||
48715627|NCT02709538|156808310|FG002|Overall Study|Withdrawal by Subject|4|||
48715628|NCT02709538|156808308|FG000|Overall Study|Non-compliance with study procedures|5|||
48715629|NCT02709538|156808309|FG001|Overall Study|Non-compliance with study procedures|0|||
48715630|NCT02709538|156808310|FG002|Overall Study|Non-compliance with study procedures|0|||
48715631|NCT02709538|156808308|FG000|Overall Study|Non-compliance with study drug|2|||
48715632|NCT02709538|156808309|FG001|Overall Study|Non-compliance with study drug|0|||
48715633|NCT02709538|156808310|FG002|Overall Study|Non-compliance with study drug|0|||
48715634|NCT02709538|156808308|FG000|Overall Study|Protocol deviation|10|||
48715635|NCT02709538|156808309|FG001|Overall Study|Protocol deviation|4|||
48715636|NCT02709538|156808310|FG002|Overall Study|Protocol deviation|4|||
48715637|NCT02709538|156808308|FG000|Overall Study|Withdrawal by Parent or Legal Guardian|1|||
48715638|NCT02709538|156808309|FG001|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
48715639|NCT02709538|156808310|FG002|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
48715640|NCT02709538|156808308|FG000|Overall Study|Other|16|||
48715641|NCT02709538|156808309|FG001|Overall Study|Other|7|||
48715642|NCT02709538|156808310|FG002|Overall Study|Other|5|||
48715643|NCT00835211|156808311|FG000|First Intervention|Withdrawal by Subject|0|||
48715644|NCT00835211|156808312|FG001|First Intervention|Withdrawal by Subject|1|||
48715645|NCT00835211|156808311|FG000|Washout: 7 Days|Adverse Event|2|||
48715646|NCT00835211|156808312|FG001|Washout: 7 Days|Adverse Event|1|||
48813594|NCT02584855|157157494|FG000|Open-Label Treatment Period|Sponsor Decision|1|||
48813595|NCT02584855|157157495|FG001|Open-Label Treatment Period|Sponsor Decision|0|||
48813596|NCT02584855|157157496|FG002|Open-Label Treatment Period|Sponsor Decision|0|||
48813597|NCT02584855|157157497|FG003|Open-Label Treatment Period|Sponsor Decision|0|||
48813598|NCT02584855|157157498|FG004|Open-Label Treatment Period|Sponsor Decision|0|||
48813599|NCT02584855|157157499|FG005|Open-Label Treatment Period|Sponsor Decision|0|||
48813600|NCT02584855|157157494|FG000|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
48715647|NCT00835211|156808311|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
48715648|NCT00835211|156808312|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
48715649|NCT02343549|156808313|FG000|Overall Study|Death|11|||
48715650|NCT02343549|156808313|FG000|Overall Study|Withdrawal by Subject|2|||
48715651|NCT02160041|156808315|FG000|Overall Study|Adverse Event|11|||
48715652|NCT02160041|156808315|FG000|Overall Study|Death|2|||
48715653|NCT02160041|156808315|FG000|Overall Study|disease progression|57|||
48715654|NCT02160041|156808315|FG000|Overall Study|Protocol Violation|1|||
48715655|NCT02160041|156808315|FG000|Overall Study|non-compliance with study|1|||
48715656|NCT02160041|156808315|FG000|Overall Study|Physician Decision|3|||
48715657|NCT02160041|156808315|FG000|Overall Study|Withdrawal by Subject|8|||
48715658|NCT02160041|156808315|FG000|Overall Study|study terminated by by sponsor|1|||
48715659|NCT00638183|156808316|FG000|Overall Study|Adverse Event|23|||
48715660|NCT00638183|156808316|FG000|Overall Study|Lack of Efficacy|14|||
48715661|NCT00638183|156808316|FG000|Overall Study|Physician Decision|9|||
48715662|NCT00638183|156808316|FG000|Overall Study|Lost to Follow-up|46|||
48715663|NCT00638183|156808316|FG000|Overall Study|Other reason not defined above|27|||
48715664|NCT00271505|156808317|FG000|Overall Study|Screen Failure|3|||
48715665|NCT00271505|156808317|FG000|Overall Study|Adverse Event|1|||
48715666|NCT00271505|156808317|FG000|Overall Study|Death|1|||
48715667|NCT01546623|156808320|FG000|Overall Study|Adverse Event|2|||
48715668|NCT01546623|156808321|FG001|Overall Study|Adverse Event|3|||
48715669|NCT01546623|156808320|FG000|Overall Study|Major Protocol Deviation|1|||
48715670|NCT01546623|156808321|FG001|Overall Study|Major Protocol Deviation|1|||
48715671|NCT01546623|156808320|FG000|Overall Study|High Prostate specific antigen|2|||
48715672|NCT01546623|156808321|FG001|Overall Study|High Prostate specific antigen|1|||
48715673|NCT01546623|156808320|FG000|Overall Study|Did Not Receive Study Drug|1|||
48715674|NCT01546623|156808321|FG001|Overall Study|Did Not Receive Study Drug|1|||
48715675|NCT03567343|156808323|FG000|Overall Study|Lost to Follow-up|2|||
48715676|NCT03567343|156808324|FG001|Overall Study|Lost to Follow-up|1|||
48715677|NCT03567343|156808323|FG000|Overall Study|No longer eligible|2|||
48715678|NCT03567343|156808324|FG001|Overall Study|No longer eligible|1|||
48715679|NCT03567343|156808323|FG000|Overall Study|Adverse Event|1|||
48715680|NCT03567343|156808324|FG001|Overall Study|Adverse Event|0|||
48715681|NCT03567343|156808323|FG000|Overall Study|Protocol Violation|1|||
48715682|NCT03567343|156808324|FG001|Overall Study|Protocol Violation|1|||
48715683|NCT04784442|156808325|FG000|Overall Study|Adverse Event|1|||
48715684|NCT04784442|156808326|FG001|Overall Study|Adverse Event|0|||
48715685|NCT04784442|156808327|FG002|Overall Study|Adverse Event|2|||
48813601|NCT02584855|157157495|FG001|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
48813602|NCT02584855|157157496|FG002|Double-Blind Withdrawal Period|Withdrawal by Subject|2|||
48813603|NCT02584855|157157497|FG003|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
48813604|NCT02584855|157157498|FG004|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
48813605|NCT02584855|157157499|FG005|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
48813606|NCT02584855|157157494|FG000|Double-Blind Withdrawal Period|Adverse Event|0|||
48813607|NCT02584855|157157495|FG001|Double-Blind Withdrawal Period|Adverse Event|4|||
48715686|NCT04784442|156808328|FG003|Overall Study|Adverse Event|1|||
48715687|NCT04784442|156808325|FG000|Overall Study|Protocol Violation|1|||
48715688|NCT04784442|156808326|FG001|Overall Study|Protocol Violation|0|||
49010982|NCT01663714|157877361|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
48715689|NCT04784442|156808327|FG002|Overall Study|Protocol Violation|0|||
48715690|NCT04784442|156808328|FG003|Overall Study|Protocol Violation|0|||
48715691|NCT04784442|156808325|FG000|Overall Study|Non-compliance with study drug|1|||
48715692|NCT04784442|156808326|FG001|Overall Study|Non-compliance with study drug|0|||
48715693|NCT04784442|156808327|FG002|Overall Study|Non-compliance with study drug|0|||
48715694|NCT04784442|156808328|FG003|Overall Study|Non-compliance with study drug|0|||
48813608|NCT02584855|157157496|FG002|Double-Blind Withdrawal Period|Adverse Event|0|||
48715695|NCT01510769|156808329|FG000|Overall Study|Adverse Event|7|||
48715696|NCT01510769|156808330|FG001|Overall Study|Adverse Event|6|||
48715697|NCT01510769|156808331|FG002|Overall Study|Adverse Event|4|||
48715698|NCT01510769|156808329|FG000|Overall Study|Gout Flare|0|||
48715699|NCT01510769|156808330|FG001|Overall Study|Gout Flare|3|||
48715700|NCT01510769|156808331|FG002|Overall Study|Gout Flare|1|||
48715701|NCT01510769|156808329|FG000|Overall Study|Protocol Violation|11|||
48715702|NCT01510769|156808330|FG001|Overall Study|Protocol Violation|10|||
48715703|NCT01510769|156808331|FG002|Overall Study|Protocol Violation|9|||
48715704|NCT01510769|156808329|FG000|Overall Study|Lost to Follow-up|5|||
48715705|NCT01510769|156808330|FG001|Overall Study|Lost to Follow-up|1|||
48715706|NCT01510769|156808331|FG002|Overall Study|Lost to Follow-up|5|||
48715707|NCT01510769|156808329|FG000|Overall Study|Withdrawal by Subject|3|||
48715708|NCT01510769|156808330|FG001|Overall Study|Withdrawal by Subject|4|||
48715709|NCT01510769|156808331|FG002|Overall Study|Withdrawal by Subject|3|||
48715710|NCT01510769|156808329|FG000|Overall Study|Death|1|||
48715711|NCT01510769|156808330|FG001|Overall Study|Death|1|||
48715712|NCT01510769|156808331|FG002|Overall Study|Death|0|||
48715713|NCT02874144|156808335|FG000|Overall Study|Lost to Follow-up|3|||
48715714|NCT02874144|156808336|FG001|Overall Study|Lost to Follow-up|5|||
48715715|NCT00934440|156808337|FG000|Overall Study|Lost to Follow-up|1|||
48715716|NCT02547363|156808340|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
48715717|NCT02547363|156808341|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
48715718|NCT02547363|156808340|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
48715719|NCT02547363|156808341|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8|||
48715720|NCT02547363|156808340|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
48715721|NCT02547363|156808341|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
48715722|NCT02547363|156808340|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
48715723|NCT02547363|156808341|FG001|3-day Treatment and 8-week Follow-up|Other|1|||
48715724|NCT02547363|156808340|FG000|12-month Follow-up|Withdrawal by Subject|4|||
48715725|NCT02547363|156808341|FG001|12-month Follow-up|Withdrawal by Subject|3|||
48715726|NCT02547363|156808340|FG000|12-month Follow-up|Lost to Follow-up|4|||
48715727|NCT02547363|156808341|FG001|12-month Follow-up|Lost to Follow-up|1|||
48715728|NCT02547363|156808340|FG000|12-month Follow-up|Lack of Efficacy|1|||
48715729|NCT02547363|156808341|FG001|12-month Follow-up|Lack of Efficacy|1|||
48715730|NCT02547363|156808340|FG000|12-month Follow-up|Other|1|||
48715731|NCT02547363|156808341|FG001|12-month Follow-up|Other|0|||
48715732|NCT01159431|156808345|FG000|Overall Study|Adverse Event|1|||
48715733|NCT01159431|156808346|FG001|Overall Study|Adverse Event|2|||
48715734|NCT01159431|156808345|FG000|Overall Study|non-compliance|1|||
48715735|NCT01159431|156808346|FG001|Overall Study|non-compliance|1|||
48715736|NCT01159431|156808345|FG000|Overall Study|Lack of Efficacy|0|||
48715737|NCT01159431|156808346|FG001|Overall Study|Lack of Efficacy|3|||
48715738|NCT01454778|156808347|FG000|Overall Study|Lost to Follow-up|2|||
48715739|NCT01454778|156808347|FG000|Overall Study|Death|1|||
48715740|NCT01097005|156808348|FG000|Overall Study|Case Report Form not collected|18|||
48715741|NCT01097005|156808348|FG000|Overall Study|Subjects cannot visit the hospital|1|||
48715742|NCT01097005|156808348|FG000|Overall Study|Poor medication compliance|1|||
48715743|NCT01097005|156808348|FG000|Overall Study|No examination data available|244|||
48715744|NCT01097005|156808348|FG000|Overall Study|Deviation from exclusion criteria|37|||
48715745|NCT01097005|156808348|FG000|Overall Study|Adverse Event|14|||
48715746|NCT01097005|156808348|FG000|Overall Study|Discontinuance by complication|50|||
48715747|NCT02654717|156808349|FG000|Overall Study|Adverse Event|2|||
48715748|NCT02654717|156808350|FG001|Overall Study|Adverse Event|2|||
48715749|NCT02654717|156808349|FG000|Overall Study|Protocol Violation|1|||
48715750|NCT02654717|156808350|FG001|Overall Study|Protocol Violation|2|||
48715751|NCT02654717|156808349|FG000|Overall Study|Withdrawal by Subject|0|||
48715752|NCT02654717|156808350|FG001|Overall Study|Withdrawal by Subject|1|||
48715753|NCT02654717|156808349|FG000|Overall Study|Non-permitted medication|3|||
48715754|NCT02654717|156808350|FG001|Overall Study|Non-permitted medication|0|||
48715755|NCT02102204|156809939|FG000|Overall Study|Withdrawal by Subject|137|||
48715756|NCT02102204|156809939|FG000|Overall Study|Death|92|||
48715757|NCT02102204|156809939|FG000|Overall Study|Lost to Follow-up|65|||
48715758|NCT02102204|156809939|FG000|Overall Study|Sponsor Decision|5|||
48715759|NCT02102204|156809939|FG000|Overall Study|Ongoing|5|||
48715760|NCT03254459|156809945|FG000|Overall Study|Adverse Event|7|||
48715761|NCT03254459|156809946|FG001|Overall Study|Adverse Event|20|||
48715762|NCT03254459|156809945|FG000|Overall Study|Withdrawal by Subject Consent|3|||
48715763|NCT03254459|156809946|FG001|Overall Study|Withdrawal by Subject Consent|1|||
48715764|NCT03254459|156809945|FG000|Overall Study|Lost to Follow-up|0|||
48715765|NCT03254459|156809946|FG001|Overall Study|Lost to Follow-up|1|||
48715766|NCT03254459|156809945|FG000|Overall Study|Miscellaneous|0|||
48715767|NCT03254459|156809946|FG001|Overall Study|Miscellaneous|1|||
48715768|NCT01139008|156809949|FG000|Overall Study|Withdrawal by Subject|5|||
48715769|NCT01139008|156809949|FG000|Overall Study|Non-compliant, lost product|1|||
48715770|NCT02785770|156809950|FG000|Intervention Period 2 (1 Day)|Adverse Event|0|||
48715771|NCT02785770|156809951|FG001|Intervention Period 2 (1 Day)|Adverse Event|1|||
48715772|NCT02785770|156809952|FG002|Intervention Period 2 (1 Day)|Adverse Event|0|||
48715773|NCT02785770|156809953|FG003|Intervention Period 2 (1 Day)|Adverse Event|0|||
48715774|NCT02785770|156809950|FG000|Intervention Period 2 (1 Day)|Family related obligations|0|||
48715775|NCT02785770|156809951|FG001|Intervention Period 2 (1 Day)|Family related obligations|0|||
48715776|NCT02785770|156809952|FG002|Intervention Period 2 (1 Day)|Family related obligations|1|||
48715777|NCT02785770|156809953|FG003|Intervention Period 2 (1 Day)|Family related obligations|0|||
48715778|NCT02785770|156809950|FG000|Intervention Period 3 (1 Day)|Adverse Event|0|||
48715779|NCT02785770|156809951|FG001|Intervention Period 3 (1 Day)|Adverse Event|0|||
48715780|NCT02785770|156809952|FG002|Intervention Period 3 (1 Day)|Adverse Event|0|||
48715781|NCT02785770|156809953|FG003|Intervention Period 3 (1 Day)|Adverse Event|1|||
48715782|NCT04518995|156809963|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|2|||
48715783|NCT04518995|156809964|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|8|||
48715784|NCT04518995|156809965|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|4|||
48715785|NCT04518995|156809963|FG000|Overall Study|Lack of Efficacy|2|||
48715786|NCT04518995|156809964|FG001|Overall Study|Lack of Efficacy|1|||
48715787|NCT04518995|156809965|FG002|Overall Study|Lack of Efficacy|0|||
48715788|NCT04518995|156809963|FG000|Overall Study|Non-compliance With Study Drug|0|||
48715789|NCT04518995|156809964|FG001|Overall Study|Non-compliance With Study Drug|3|||
48715790|NCT04518995|156809965|FG002|Overall Study|Non-compliance With Study Drug|2|||
48715791|NCT04518995|156809963|FG000|Overall Study|Pregnancy|0|||
48715792|NCT04518995|156809964|FG001|Overall Study|Pregnancy|0|||
48715793|NCT04518995|156809965|FG002|Overall Study|Pregnancy|1|||
48715794|NCT04518995|156809963|FG000|Overall Study|Protocol Violation|2|||
48715795|NCT04518995|156809964|FG001|Overall Study|Protocol Violation|0|||
48715796|NCT04518995|156809965|FG002|Overall Study|Protocol Violation|1|||
48715797|NCT04518995|156809963|FG000|Overall Study|Reason not Specified|4|||
48715798|NCT04518995|156809964|FG001|Overall Study|Reason not Specified|11|||
48715799|NCT04518995|156809965|FG002|Overall Study|Reason not Specified|2|||
48715800|NCT04518995|156809963|FG000|Overall Study|Lost to Follow-up|1|||
48715801|NCT04518995|156809964|FG001|Overall Study|Lost to Follow-up|10|||
48715802|NCT04518995|156809965|FG002|Overall Study|Lost to Follow-up|6|||
48715803|NCT02248675|156809966|FG000|Overall Study|Lost to Follow-up|3|||
48715804|NCT02248675|156809967|FG001|Overall Study|Lost to Follow-up|1|||
48715805|NCT02704143|156809968|FG000|Overall Study|disease progression|10|||
48715806|NCT01235598|156809969|FG000|Overall Study|Adverse Event|0|||
48715807|NCT01235598|156809970|FG001|Overall Study|Adverse Event|3|||
48715808|NCT01235598|156809969|FG000|Overall Study|Lack of Efficacy|0|||
48715809|NCT01235598|156809970|FG001|Overall Study|Lack of Efficacy|1|||
48715810|NCT01235598|156809969|FG000|Overall Study|Withdrawal by Subject|1|||
48715811|NCT01235598|156809970|FG001|Overall Study|Withdrawal by Subject|0|||
48715812|NCT00689117|156809974|FG000|Overall Study|Adverse Event|6|||
48715813|NCT00689117|156809975|FG001|Overall Study|Adverse Event|0|||
48715814|NCT00689117|156809976|FG002|Overall Study|Adverse Event|5|||
48715815|NCT00689117|156809977|FG003|Overall Study|Adverse Event|0|||
48715816|NCT00689117|156809974|FG000|Overall Study|Lost to Follow-up|26|||
48715817|NCT00689117|156809975|FG001|Overall Study|Lost to Follow-up|19|||
48715818|NCT00689117|156809976|FG002|Overall Study|Lost to Follow-up|17|||
48715819|NCT00689117|156809977|FG003|Overall Study|Lost to Follow-up|11|||
48715820|NCT00689117|156809974|FG000|Overall Study|Lack of Efficacy|1|||
48715821|NCT00689117|156809975|FG001|Overall Study|Lack of Efficacy|2|||
48715822|NCT00689117|156809976|FG002|Overall Study|Lack of Efficacy|2|||
48715823|NCT00689117|156809977|FG003|Overall Study|Lack of Efficacy|2|||
48715824|NCT00689117|156809974|FG000|Overall Study|Non-Compliance with Study Treatment|3|||
48715825|NCT00689117|156809975|FG001|Overall Study|Non-Compliance with Study Treatment|3|||
48715826|NCT00689117|156809976|FG002|Overall Study|Non-Compliance with Study Treatment|3|||
48715827|NCT00689117|156809977|FG003|Overall Study|Non-Compliance with Study Treatment|1|||
48715828|NCT00689117|156809974|FG000|Overall Study|Withdrawal by Subject|19|||
48715829|NCT00689117|156809975|FG001|Overall Study|Withdrawal by Subject|18|||
48715830|NCT00689117|156809976|FG002|Overall Study|Withdrawal by Subject|26|||
48715831|NCT00689117|156809977|FG003|Overall Study|Withdrawal by Subject|13|||
48715832|NCT00689117|156809974|FG000|Overall Study|Unable to Comply with Visit Schedule|0|||
49125813|NCT01411852|158298289|FG001|Hospital Intervention Phase|CPR administered|1|||
49125814|NCT01411852|158298288|FG000|Hospital Intervention Phase|Misunderstanding of protocol|4|||
48715833|NCT00689117|156809975|FG001|Overall Study|Unable to Comply with Visit Schedule|0|||
48715834|NCT00689117|156809976|FG002|Overall Study|Unable to Comply with Visit Schedule|1|||
49125815|NCT01411852|158298289|FG001|Hospital Intervention Phase|Misunderstanding of protocol|1|||
49125816|NCT01411852|158298288|FG000|Hospital Intervention Phase|Diagnosis of sepsis|0|||
49125817|NCT01411852|158298289|FG001|Hospital Intervention Phase|Diagnosis of sepsis|2|||
49125818|NCT01411852|158298288|FG000|Hospital Intervention Phase|Diagnosis of dehydration|0|||
49125819|NCT01411852|158298289|FG001|Hospital Intervention Phase|Diagnosis of dehydration|1|||
48715835|NCT00689117|156809977|FG003|Overall Study|Unable to Comply with Visit Schedule|1|||
48715836|NCT00689117|156809974|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
48715837|NCT00689117|156809975|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
49010983|NCT01663714|157877361|FG000|Long-Term Follow-Up|Death|4|||
48715838|NCT00689117|156809976|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
48715839|NCT00689117|156809977|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
48715840|NCT00689117|156809974|FG000|Overall Study|Non-compliance with Treatment Regimen|0|||
48715841|NCT00689117|156809975|FG001|Overall Study|Non-compliance with Treatment Regimen|1|||
48715842|NCT00689117|156809976|FG002|Overall Study|Non-compliance with Treatment Regimen|0|||
48715843|NCT00689117|156809977|FG003|Overall Study|Non-compliance with Treatment Regimen|0|||
48715844|NCT00689117|156809974|FG000|Overall Study|Change/Discontinuation of Birth Control|1|||
48715845|NCT00689117|156809975|FG001|Overall Study|Change/Discontinuation of Birth Control|1|||
48715846|NCT00689117|156809976|FG002|Overall Study|Change/Discontinuation of Birth Control|1|||
48715847|NCT00689117|156809977|FG003|Overall Study|Change/Discontinuation of Birth Control|0|||
48715848|NCT00689117|156809974|FG000|Overall Study|Use of Prohibitive Medication|2|||
48715849|NCT00689117|156809975|FG001|Overall Study|Use of Prohibitive Medication|1|||
48715850|NCT00689117|156809976|FG002|Overall Study|Use of Prohibitive Medication|3|||
48715851|NCT00689117|156809977|FG003|Overall Study|Use of Prohibitive Medication|0|||
48715852|NCT00689117|156809974|FG000|Overall Study|Pregnancy|0|||
48715853|NCT00689117|156809975|FG001|Overall Study|Pregnancy|2|||
48715854|NCT00689117|156809976|FG002|Overall Study|Pregnancy|0|||
48715855|NCT00689117|156809977|FG003|Overall Study|Pregnancy|2|||
48715856|NCT00689117|156809974|FG000|Overall Study|Incarceration|2|||
48715857|NCT00689117|156809975|FG001|Overall Study|Incarceration|0|||
48715858|NCT00689117|156809976|FG002|Overall Study|Incarceration|0|||
48715859|NCT00689117|156809977|FG003|Overall Study|Incarceration|0|||
48715860|NCT00689117|156809974|FG000|Overall Study|Fear of Birth Defects|0|||
48715861|NCT00689117|156809975|FG001|Overall Study|Fear of Birth Defects|0|||
48715862|NCT00689117|156809976|FG002|Overall Study|Fear of Birth Defects|1|||
48715863|NCT00689117|156809977|FG003|Overall Study|Fear of Birth Defects|0|||
48715864|NCT00689117|156809974|FG000|Overall Study|Transportation|1|||
48715865|NCT00689117|156809975|FG001|Overall Study|Transportation|0|||
48715866|NCT00689117|156809976|FG002|Overall Study|Transportation|0|||
48813609|NCT02584855|157157497|FG003|Double-Blind Withdrawal Period|Adverse Event|1|||
48715867|NCT00689117|156809977|FG003|Overall Study|Transportation|0|||
48715868|NCT00689117|156809974|FG000|Overall Study|Patient Withdrew from Study|0|||
48715869|NCT00689117|156809975|FG001|Overall Study|Patient Withdrew from Study|0|||
48715870|NCT00689117|156809976|FG002|Overall Study|Patient Withdrew from Study|0|||
48715871|NCT00689117|156809977|FG003|Overall Study|Patient Withdrew from Study|1|||
48715872|NCT00689117|156809974|FG000|Overall Study|Personal Reason|0|||
48715873|NCT00689117|156809975|FG001|Overall Study|Personal Reason|1|||
48715874|NCT00689117|156809976|FG002|Overall Study|Personal Reason|0|||
48715875|NCT00689117|156809977|FG003|Overall Study|Personal Reason|0|||
48715876|NCT00689117|156809974|FG000|Overall Study|Dispensing Error|0|||
48715877|NCT00689117|156809975|FG001|Overall Study|Dispensing Error|1|||
48715878|NCT00689117|156809976|FG002|Overall Study|Dispensing Error|0|||
48715879|NCT00689117|156809977|FG003|Overall Study|Dispensing Error|0|||
48715880|NCT00444678|156809980|FG000|Overall Study|Toxicity|11|||
48715881|NCT00444678|156809980|FG000|Overall Study|Disease Progression|12|||
48715882|NCT00444678|156809980|FG000|Overall Study|Death|3|||
48715883|NCT00444678|156809980|FG000|Overall Study|Physician Decision|3|||
48715884|NCT00444678|156809980|FG000|Overall Study|Withdrawal by Subject|2|||
48715885|NCT00003590|156809981|FG000|Overall Study|Ineligible Patient|1|||
48715886|NCT00003590|156809981|FG000|Overall Study|Adverse Event|7|||
48715887|NCT00003590|156809981|FG000|Overall Study|Withdrawal by Subject|1|||
48715888|NCT00003590|156809981|FG000|Overall Study|Lack of Efficacy|11|||
48715889|NCT00003590|156809981|FG000|Overall Study|Death|1|||
48715890|NCT00003590|156809981|FG000|Overall Study|Physician Decision|1|||
48715891|NCT03319745|156809984|FG000|Overall Study|Death|1|||
48715892|NCT03319745|156809984|FG000|Overall Study|Toxicity Precluding Surgery|1|||
48715893|NCT02855541|156809986|FG000|Overall Study|Change in health status|2|||
48715894|NCT02855541|156809986|FG000|Overall Study|Withdrawal by Subject|2|||
48715895|NCT01242813|156809987|FG000|Overall Study|Lost to Follow-up|2|||
48715896|NCT03135119|156809988|FG000|Overall Study|Lost to Follow-up|2|||
48715897|NCT03135119|156809989|FG001|Overall Study|Lost to Follow-up|0|||
48715898|NCT03135119|156809988|FG000|Overall Study|Physician Decision|1|||
48715899|NCT03135119|156809989|FG001|Overall Study|Physician Decision|1|||
48715900|NCT03135119|156809988|FG000|Overall Study|COVID-19 Shutdown|2|||
48715901|NCT03135119|156809989|FG001|Overall Study|COVID-19 Shutdown|2|||
48715902|NCT00361634|156809995|FG000|Overall Study|Lost to Follow-up|1|||
48715903|NCT00361634|156809995|FG000|Overall Study|Withdrawal by Subject|1|||
48715904|NCT01561898|156809996|FG000|Overall Study|Withdrawal by Subject|0|||
48715905|NCT01561898|156809997|FG001|Overall Study|Withdrawal by Subject|8|||
48715906|NCT01561898|156809998|FG002|Overall Study|Withdrawal by Subject|12|||
48715907|NCT01561898|156809999|FG003|Overall Study|Withdrawal by Subject|5|||
48715908|NCT01561898|156809996|FG000|Overall Study|Lack of Efficacy|0|||
48715909|NCT01561898|156809997|FG001|Overall Study|Lack of Efficacy|8|||
48715910|NCT01561898|156809998|FG002|Overall Study|Lack of Efficacy|10|||
48715911|NCT01561898|156809999|FG003|Overall Study|Lack of Efficacy|5|||
48715912|NCT01561898|156809996|FG000|Overall Study|Worsening of complications|0|||
48715913|NCT01561898|156809997|FG001|Overall Study|Worsening of complications|1|||
48715914|NCT01561898|156809998|FG002|Overall Study|Worsening of complications|0|||
48715915|NCT01561898|156809999|FG003|Overall Study|Worsening of complications|0|||
48715916|NCT01561898|156809996|FG000|Overall Study|Lost to Follow-up|0|||
48715917|NCT01561898|156809997|FG001|Overall Study|Lost to Follow-up|0|||
48715918|NCT01561898|156809998|FG002|Overall Study|Lost to Follow-up|1|||
48715919|NCT01561898|156809999|FG003|Overall Study|Lost to Follow-up|0|||
48715920|NCT01561898|156809996|FG000|Overall Study|Adverse Event|1|||
48715921|NCT01561898|156809997|FG001|Overall Study|Adverse Event|19|||
48715922|NCT01561898|156809998|FG002|Overall Study|Adverse Event|14|||
48715923|NCT01561898|156809999|FG003|Overall Study|Adverse Event|9|||
48715924|NCT01561898|156809996|FG000|Overall Study|Physician Decision|1|||
48715925|NCT01561898|156809997|FG001|Overall Study|Physician Decision|5|||
48715926|NCT01561898|156809998|FG002|Overall Study|Physician Decision|7|||
48715927|NCT01561898|156809999|FG003|Overall Study|Physician Decision|1|||
48715928|NCT00505076|156810000|FG000|Overall Study|Adverse Event|1|||
48715929|NCT00505076|156810001|FG001|Overall Study|Adverse Event|0|||
48715930|NCT00505076|156810002|FG002|Overall Study|Adverse Event|1|||
48715931|NCT00505076|156810000|FG000|Overall Study|Protocol Violation|2|||
48715932|NCT00505076|156810001|FG001|Overall Study|Protocol Violation|1|||
48715933|NCT00505076|156810002|FG002|Overall Study|Protocol Violation|2|||
48715934|NCT00505076|156810000|FG000|Overall Study|Withdrawal by Subject|0|||
48715935|NCT00505076|156810001|FG001|Overall Study|Withdrawal by Subject|1|||
49125820|NCT01411852|158298288|FG000|Hospital Intervention Phase|Physician/hospital staff noncompliance|0|||
49125821|NCT01411852|158298289|FG001|Hospital Intervention Phase|Physician/hospital staff noncompliance|4|||
48715936|NCT00505076|156810002|FG002|Overall Study|Withdrawal by Subject|2|||
48715937|NCT00591318|156810005|FG000|Overall Study|Lack of Efficacy|2|||
48715938|NCT00591318|156810006|FG001|Overall Study|Lack of Efficacy|0|||
48715939|NCT00591318|156810005|FG000|Overall Study|Adverse Event|2|||
48715940|NCT00591318|156810006|FG001|Overall Study|Adverse Event|0|||
48715941|NCT04493892|156810014|FG000|Overall Study|Withdrawal by Subject|15|||
48715942|NCT00233454|156810019|FG000|Overall Study|Death|6|||
48715943|NCT03595618|156810020|FG000|Overall Study|Adverse Event|16|||
48715944|NCT03595618|156810021|FG001|Overall Study|Adverse Event|17|||
48715945|NCT03595618|156810022|FG002|Overall Study|Adverse Event|20|||
48715946|NCT03595618|156810023|FG003|Overall Study|Adverse Event|8|||
48715947|NCT03595618|156810020|FG000|Overall Study|Withdrawal by Subject|12|||
48715948|NCT03595618|156810021|FG001|Overall Study|Withdrawal by Subject|14|||
48715949|NCT03595618|156810022|FG002|Overall Study|Withdrawal by Subject|14|||
48715950|NCT03595618|156810023|FG003|Overall Study|Withdrawal by Subject|10|||
48715951|NCT03595618|156810020|FG000|Overall Study|Lost to Follow-up|6|||
48715952|NCT03595618|156810021|FG001|Overall Study|Lost to Follow-up|4|||
48715953|NCT03595618|156810022|FG002|Overall Study|Lost to Follow-up|5|||
48715954|NCT03595618|156810023|FG003|Overall Study|Lost to Follow-up|6|||
48813610|NCT02584855|157157498|FG004|Double-Blind Withdrawal Period|Adverse Event|0|||
49125822|NCT01411852|158298288|FG000|Hospital Intervention Phase|Other ineligible|2|||
49125823|NCT01411852|158298289|FG001|Hospital Intervention Phase|Other ineligible|2|||
49125824|NCT01411852|158298288|FG000|Hospital Intervention Phase|Spinal cord injury|2|||
49125825|NCT01411852|158298289|FG001|Hospital Intervention Phase|Spinal cord injury|0|||
49125826|NCT01411852|158298288|FG000|Hospital Intervention Phase|Withdrawal by Subject|1|||
49125827|NCT01411852|158298289|FG001|Hospital Intervention Phase|Withdrawal by Subject|0|||
49125828|NCT01411852|158298288|FG000|Hospital Intervention Phase|Vascular access failed|1|||
49125829|NCT01411852|158298289|FG001|Hospital Intervention Phase|Vascular access failed|0|||
49125830|NCT04817332|158298290|FG000|Overall Study|Lost to Follow-up|3|||
49125831|NCT04817332|158298291|FG001|Overall Study|Lost to Follow-up|3|||
48715955|NCT03595618|156810020|FG000|Overall Study|Protocol Violation|2|||
48715956|NCT03595618|156810021|FG001|Overall Study|Protocol Violation|0|||
48715957|NCT03595618|156810022|FG002|Overall Study|Protocol Violation|6|||
48715958|NCT03595618|156810023|FG003|Overall Study|Protocol Violation|2|||
48715959|NCT03595618|156810020|FG000|Overall Study|Physician Decision|0|||
48715960|NCT03595618|156810021|FG001|Overall Study|Physician Decision|0|||
48715961|NCT03595618|156810022|FG002|Overall Study|Physician Decision|1|||
48715962|NCT03595618|156810023|FG003|Overall Study|Physician Decision|2|||
48715963|NCT03595618|156810020|FG000|Overall Study|Miscellaneous|7|||
48715964|NCT03595618|156810021|FG001|Overall Study|Miscellaneous|5|||
49125832|NCT04817332|158298290|FG000|Overall Study|Protocol Violation|2|||
49125833|NCT04817332|158298291|FG001|Overall Study|Protocol Violation|0|||
49125834|NCT01172873|158298294|FG000|Overall Study|Withdrawal by Subject|3|||
49125835|NCT01172873|158298295|FG001|Overall Study|Withdrawal by Subject|2|||
49125836|NCT00338741|158298297|FG000|Overall Study|Lost to Follow-up|2|||
49125837|NCT00338741|158298298|FG001|Overall Study|Lost to Follow-up|0|||
49125838|NCT01534273|158298299|FG000|Period 1|Physician Decision|0|||
49125839|NCT01534273|158298300|FG001|Period 1|Physician Decision|0|||
48813611|NCT02584855|157157499|FG005|Double-Blind Withdrawal Period|Adverse Event|0|||
48813612|NCT02584855|157157494|FG000|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
48813613|NCT02584855|157157495|FG001|Double-Blind Withdrawal Period|Lack of Efficacy|10|||
48813614|NCT02584855|157157496|FG002|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
48813615|NCT02584855|157157497|FG003|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
48813616|NCT02584855|157157498|FG004|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
48813617|NCT02584855|157157499|FG005|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
48813618|NCT02584855|157157494|FG000|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
48813619|NCT02584855|157157495|FG001|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1|||
48813620|NCT02584855|157157496|FG002|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
48813621|NCT02584855|157157497|FG003|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
48813622|NCT02584855|157157498|FG004|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
48813623|NCT02584855|157157499|FG005|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
48813624|NCT02584855|157157494|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
48813625|NCT02584855|157157495|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
48813626|NCT02584855|157157496|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
48813627|NCT02584855|157157497|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
48813628|NCT02584855|157157498|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|7|||
48813629|NCT02584855|157157499|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
48813630|NCT02584855|157157494|FG000|Post Treatment Follow-up Period|Protocol Violation|0|||
48813631|NCT02584855|157157495|FG001|Post Treatment Follow-up Period|Protocol Violation|0|||
48813632|NCT02584855|157157496|FG002|Post Treatment Follow-up Period|Protocol Violation|0|||
48813633|NCT02584855|157157497|FG003|Post Treatment Follow-up Period|Protocol Violation|0|||
48813634|NCT02584855|157157498|FG004|Post Treatment Follow-up Period|Protocol Violation|1|||
48813635|NCT02584855|157157499|FG005|Post Treatment Follow-up Period|Protocol Violation|0|||
48813636|NCT02550873|157157500|FG000|Randomized Double Blind|Adverse Event|3|||
48813637|NCT02550873|157157501|FG001|Randomized Double Blind|Adverse Event|1|||
48813638|NCT02550873|157157502|FG002|Randomized Double Blind|Adverse Event|0|||
48813639|NCT02550873|157157500|FG000|Randomized Double Blind|Disease progression|1|||
48813640|NCT02550873|157157501|FG001|Randomized Double Blind|Disease progression|1|||
48715965|NCT03595618|156810022|FG002|Overall Study|Miscellaneous|10|||
48715966|NCT03595618|156810023|FG003|Overall Study|Miscellaneous|6|||
48715967|NCT00006409|156810028|FG000|Baseline|Protocol Violation|48|||
48813641|NCT02550873|157157502|FG002|Randomized Double Blind|Disease progression|0|||
49125840|NCT01534273|158298301|FG002|Period 1|Physician Decision|0|||
49125841|NCT01534273|158298302|FG003|Period 1|Physician Decision|1|||
49125842|NCT01534273|158298303|FG004|Period 1|Physician Decision|0|||
49125843|NCT01534273|158298304|FG005|Period 1|Physician Decision|0|||
48715968|NCT00006409|156810029|FG001|Baseline|Protocol Violation|70|||
48715969|NCT00006409|156810030|FG002|Baseline|Protocol Violation|0|||
49125844|NCT01534273|158298305|FG006|Period 1|Physician Decision|0|||
48715970|NCT00006409|156810031|FG003|Baseline|Protocol Violation|0|||
48715971|NCT00006409|156810032|FG004|Baseline|Protocol Violation|0|||
48715972|NCT00006409|156810033|FG005|Baseline|Protocol Violation|0|||
48715973|NCT00006409|156810028|FG000|Post-2 Year Intervention|Protocol Violation|0|||
48715974|NCT00006409|156810029|FG001|Post-2 Year Intervention|Protocol Violation|0|||
48715975|NCT00006409|156810030|FG002|Post-2 Year Intervention|Protocol Violation|251|||
48715976|NCT00006409|156810031|FG003|Post-2 Year Intervention|Protocol Violation|168|||
48715977|NCT00006409|156810032|FG004|Post-2 Year Intervention|Protocol Violation|0|||
48715978|NCT00006409|156810033|FG005|Post-2 Year Intervention|Protocol Violation|0|||
48715979|NCT00006409|156810028|FG000|Post-3 Year Intervention|Protocol Violation|0|||
48715980|NCT00006409|156810029|FG001|Post-3 Year Intervention|Protocol Violation|0|||
48715981|NCT00006409|156810030|FG002|Post-3 Year Intervention|Protocol Violation|0|||
48715982|NCT00006409|156810031|FG003|Post-3 Year Intervention|Protocol Violation|0|||
48715983|NCT00006409|156810032|FG004|Post-3 Year Intervention|Protocol Violation|62|||
48715984|NCT00006409|156810033|FG005|Post-3 Year Intervention|Protocol Violation|62|||
48715985|NCT03180619|156810034|FG000|Overall Study|Withdrew Consent|5|||
48715986|NCT03180619|156810035|FG001|Overall Study|Withdrew Consent|0|||
48715987|NCT03180619|156810036|FG002|Overall Study|Withdrew Consent|2|||
48715988|NCT03180619|156810034|FG000|Overall Study|Death|2|||
48715989|NCT03180619|156810035|FG001|Overall Study|Death|1|||
48715990|NCT03180619|156810036|FG002|Overall Study|Death|2|||
48715991|NCT03180619|156810034|FG000|Overall Study|Adverse Event|2|||
48715992|NCT03180619|156810035|FG001|Overall Study|Adverse Event|0|||
48715993|NCT03180619|156810036|FG002|Overall Study|Adverse Event|1|||
48715994|NCT03180619|156810034|FG000|Overall Study|Investigator's discretion|2|||
48715995|NCT03180619|156810035|FG001|Overall Study|Investigator's discretion|0|||
48715996|NCT03180619|156810036|FG002|Overall Study|Investigator's discretion|1|||
48715997|NCT01270802|156810037|FG000|Overall Study|Withdrawal by Subject|1|||
48715998|NCT01270802|156810038|FG001|Overall Study|Withdrawal by Subject|0|||
48715999|NCT01270802|156810037|FG000|Overall Study|Adverse Event|1|||
48716000|NCT01270802|156810038|FG001|Overall Study|Adverse Event|0|||
48716001|NCT01270802|156810037|FG000|Overall Study|Lost to Follow-up|0|||
48716002|NCT01270802|156810038|FG001|Overall Study|Lost to Follow-up|1|||
48716003|NCT03077087|156810041|FG000|Overall Study|Physician Decision|2|||
48716004|NCT04620798|156810042|FG000|Overall Study|Lost to Follow-up|126|||
48716005|NCT04620798|156810043|FG001|Overall Study|Lost to Follow-up|138|||
48716006|NCT01587898|156810047|FG000|Overall Study|Adverse Event|1|||
48716007|NCT01587898|156810048|FG001|Overall Study|Adverse Event|1|||
48716008|NCT01587898|156810049|FG002|Overall Study|Adverse Event|0|||
48716009|NCT01587898|156810050|FG003|Overall Study|Adverse Event|0|||
48716010|NCT01587898|156810047|FG000|Overall Study|Protocol Violation|0|||
48716011|NCT01587898|156810048|FG001|Overall Study|Protocol Violation|2|||
48716012|NCT01587898|156810049|FG002|Overall Study|Protocol Violation|1|||
48716013|NCT01587898|156810050|FG003|Overall Study|Protocol Violation|1|||
48716014|NCT01587898|156810047|FG000|Overall Study|Lost to Follow-up|0|||
48716015|NCT01587898|156810048|FG001|Overall Study|Lost to Follow-up|0|||
48716016|NCT01587898|156810049|FG002|Overall Study|Lost to Follow-up|0|||
48716017|NCT01587898|156810050|FG003|Overall Study|Lost to Follow-up|1|||
48716018|NCT01587898|156810047|FG000|Overall Study|Withdrawal by Subject|2|||
48716019|NCT01587898|156810048|FG001|Overall Study|Withdrawal by Subject|1|||
48716020|NCT01587898|156810049|FG002|Overall Study|Withdrawal by Subject|0|||
48716021|NCT01587898|156810050|FG003|Overall Study|Withdrawal by Subject|0|||
48716022|NCT01587898|156810047|FG000|Overall Study|Met haemoglobin stopping criteria|1|||
48716023|NCT01587898|156810048|FG001|Overall Study|Met haemoglobin stopping criteria|1|||
48716024|NCT01587898|156810049|FG002|Overall Study|Met haemoglobin stopping criteria|1|||
48716025|NCT01587898|156810050|FG003|Overall Study|Met haemoglobin stopping criteria|0|||
48716026|NCT01788215|156810054|FG000|Overall Study|Withdrawal by Subject|0|||
48716027|NCT01788215|156810055|FG001|Overall Study|Withdrawal by Subject|1|||
48716028|NCT01788215|156810054|FG000|Overall Study|Lost to Follow-up|2|||
48716029|NCT01788215|156810055|FG001|Overall Study|Lost to Follow-up|0|||
48716030|NCT01738477|156810056|FG000|Overall Study|Lost to Follow-up|1|||
48716031|NCT01738477|156810057|FG001|Overall Study|Lost to Follow-up|4|||
48716032|NCT02365480|156810060|FG000|Overall Study|Withdrawal by Subject|2|||
48716033|NCT02365480|156810061|FG001|Overall Study|Withdrawal by Subject|0|||
48716034|NCT01915303|156810062|FG000|Core Phase|Adverse Event|7|||
48716035|NCT01915303|156810062|FG000|Core Phase|Unsatisfactory therapeutic effect|3|||
48716036|NCT01915303|156810062|FG000|Core Phase|Death|2|||
48716037|NCT01915303|156810062|FG000|Core Phase|Protocol Violation|2|||
48716038|NCT01915303|156810062|FG000|Core Phase|Abnormal lab value|1|||
48716039|NCT01915303|156810062|FG000|Core Phase|Withdrawal by Subject|1|||
49125845|NCT01710020|158298310|FG000|Period 1|Protocol Violation|1|||
48716040|NCT01915303|156810062|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
48716041|NCT01915303|156810062|FG000|Extension Phase|Withdrawal by Subject|4|||
48716042|NCT01915303|156810062|FG000|Extension Phase|Adverse Event|3|||
48716043|NCT01915303|156810062|FG000|Extension Phase|Death|1|||
48716044|NCT01915303|156810062|FG000|Extension Phase|Protocol Violation|1|||
48716045|NCT01136785|156810066|FG000|Overall Study|Protocol Violation|2|||
48716046|NCT01136785|156810067|FG001|Overall Study|Protocol Violation|1|||
48716047|NCT00744042|156810068|FG000|Overall Study|Withdrawal by Subject|1|||
48716048|NCT01181986|156810071|FG000|Phase 1|Lost to Follow-up|0|||
48813642|NCT02550873|157157500|FG000|Open Label Extension|Study ongoing|0|||
48813643|NCT02550873|157157501|FG001|Open Label Extension|Study ongoing|0|||
48813644|NCT02550873|157157502|FG002|Open Label Extension|Study ongoing|111|||
48813645|NCT00895843|157157504|FG000|Overall Study|Protocol Violation|12|||
48813646|NCT00895843|157157505|FG001|Overall Study|Protocol Violation|12|||
48813647|NCT02285595|157157511|FG000|Overall Study|Lost to Follow-up|14|||
48813648|NCT02285595|157157511|FG000|Overall Study|Withdrawal by Subject|1|||
48813649|NCT01960790|157157512|FG000|Overall Study|Survey forms could not be recovered|3|||
48813650|NCT01960790|157157512|FG000|Overall Study|Treat with Humira outside survey period|3|||
48813651|NCT01960790|157157512|FG000|Overall Study|Transferred to another hospital|4|||
48813652|NCT01960790|157157512|FG000|Overall Study|Unevaluable for safety|1|||
48813653|NCT01987830|157157515|FG000|Overall Study|Never received baseline scan|1|||
48813654|NCT01794117|157157516|FG000|Overall Study|Adverse Event|1|||
48813655|NCT01794117|157157517|FG001|Overall Study|Adverse Event|0|||
48813656|NCT01794117|157157518|FG002|Overall Study|Adverse Event|0|||
48813657|NCT01794117|157157519|FG003|Overall Study|Adverse Event|0|||
48813658|NCT01794117|157157516|FG000|Overall Study|Participant noncompliance|0|||
48813659|NCT01794117|157157517|FG001|Overall Study|Participant noncompliance|1|||
48813660|NCT01794117|157157518|FG002|Overall Study|Participant noncompliance|0|||
48813661|NCT01794117|157157519|FG003|Overall Study|Participant noncompliance|0|||
48813662|NCT01794117|157157516|FG000|Overall Study|Refused further treatment|0|||
48813663|NCT01794117|157157517|FG001|Overall Study|Refused further treatment|2|||
48813664|NCT01794117|157157518|FG002|Overall Study|Refused further treatment|0|||
48813665|NCT01794117|157157519|FG003|Overall Study|Refused further treatment|0|||
48813666|NCT00180713|157157523|FG000|Overall Study|Withdrawal by Subject|2|||
48813667|NCT00180713|157157524|FG001|Overall Study|Withdrawal by Subject|0|||
48813668|NCT00180713|157157523|FG000|Overall Study|Adverse Event|3|||
48813669|NCT00180713|157157524|FG001|Overall Study|Adverse Event|3|||
48813670|NCT00556374|157157525|FG000|Overall Study|Withdrawal by Subject|235|||
48813671|NCT00556374|157157526|FG001|Overall Study|Withdrawal by Subject|205|||
48813672|NCT00556374|157157525|FG000|Overall Study|Death|158|||
48813673|NCT00556374|157157526|FG001|Overall Study|Death|127|||
48813674|NCT00556374|157157525|FG000|Overall Study|Lost to Follow-up|24|||
48813675|NCT00556374|157157526|FG001|Overall Study|Lost to Follow-up|17|||
48813676|NCT00556374|157157525|FG000|Overall Study|Continuing into Zoledronic Acid Substudy|50|||
48813677|NCT00556374|157157526|FG001|Overall Study|Continuing into Zoledronic Acid Substudy|0|||
48813678|NCT00847301|157157527|FG000|Overall Study|Adverse Event|35|||
48813679|NCT00847301|157157527|FG000|Overall Study|Switch to other anticoagulants|16|||
48813680|NCT00847301|157157527|FG000|Overall Study|Lost to Follow-up|1|||
48813681|NCT00847301|157157527|FG000|Overall Study|No prescription after hospital discharge|1|||
48813682|NCT00847301|157157527|FG000|Overall Study|Other reason not defined above|1|||
48813683|NCT00845871|157157528|FG000|Assessment Period|Adverse Event|2|||
48813684|NCT00845871|157157528|FG000|Assessment Period|Abnormal laboratory values|1|||
48813685|NCT00845871|157157528|FG000|Assessment Period|Abnormal test procedure results|1|||
48813686|NCT00845871|157157528|FG000|Assessment Period|Patient withdrew consent|3|||
48813687|NCT01816763|157159916|FG000|Overall Study|The main reason for an incomplete survey|4|||
48813688|NCT01816763|157159917|FG001|Overall Study|The main reason for an incomplete survey|15|||
48813689|NCT01816763|157159918|FG002|Overall Study|The main reason for an incomplete survey|11|||
48813690|NCT02769065|157159924|FG000|Overall Study|Voluntary Withdrawal|1|||
48716049|NCT01181986|156810072|FG001|Phase 1|Lost to Follow-up|1|||
48716050|NCT01181986|156810073|FG002|Phase 1|Lost to Follow-up|1|||
48716051|NCT01181986|156810071|FG000|Phase 1|Adverse Event|0|||
48716052|NCT01181986|156810072|FG001|Phase 1|Adverse Event|0|||
48716053|NCT01181986|156810073|FG002|Phase 1|Adverse Event|1|||
48716054|NCT01181986|156810071|FG000|Phase 1|Protocol Violation|1|||
48716055|NCT01181986|156810072|FG001|Phase 1|Protocol Violation|0|||
48716056|NCT01181986|156810073|FG002|Phase 1|Protocol Violation|0|||
48716057|NCT01181986|156810071|FG000|Phase 2|Adverse Event|0|||
48716058|NCT01181986|156810072|FG001|Phase 2|Adverse Event|3|||
48716059|NCT01181986|156810073|FG002|Phase 2|Adverse Event|0|||
48716060|NCT01181986|156810071|FG000|Phase 2|Medical condition|0|||
48716061|NCT01181986|156810072|FG001|Phase 2|Medical condition|1|||
48716062|NCT01181986|156810073|FG002|Phase 2|Medical condition|0|||
48716063|NCT00348881|156810074|FG000|Overall Study|Lost to Follow-up|12|||
48716064|NCT00348881|156810075|FG001|Overall Study|Lost to Follow-up|6|||
48716065|NCT00348881|156810074|FG000|Overall Study|Withdrawal by Subject|3|||
48813691|NCT02769065|157159925|FG001|Overall Study|Voluntary Withdrawal|0|||
48813692|NCT02769065|157159926|FG002|Overall Study|Voluntary Withdrawal|0|||
48813693|NCT02769065|157159927|FG003|Overall Study|Voluntary Withdrawal|0|||
48813694|NCT02769065|157159928|FG004|Overall Study|Voluntary Withdrawal|0|||
48813695|NCT02769065|157159929|FG005|Overall Study|Voluntary Withdrawal|0|||
48813696|NCT02769065|157159930|FG006|Overall Study|Voluntary Withdrawal|0|||
48813697|NCT02769065|157159931|FG007|Overall Study|Voluntary Withdrawal|0|||
48813698|NCT02769065|157159932|FG008|Overall Study|Voluntary Withdrawal|0|||
48716066|NCT00348881|156810075|FG001|Overall Study|Withdrawal by Subject|4|||
48716067|NCT00348881|156810074|FG000|Overall Study|Adverse Event|2|||
48716068|NCT00348881|156810075|FG001|Overall Study|Adverse Event|0|||
48716069|NCT00348881|156810074|FG000|Overall Study|Serious Adverse Event|0|||
48716070|NCT00348881|156810075|FG001|Overall Study|Serious Adverse Event|2|||
48716071|NCT03255083|156810081|FG000|Overall Study|Clinical progression|1|||
48716072|NCT03255083|156810082|FG001|Overall Study|Clinical progression|0|||
48716073|NCT03255083|156810083|FG002|Overall Study|Clinical progression|0|||
48716074|NCT03255083|156810084|FG003|Overall Study|Clinical progression|0|||
48716075|NCT03255083|156810081|FG000|Overall Study|Adverse Event|0|||
48716076|NCT03255083|156810082|FG001|Overall Study|Adverse Event|1|||
48716077|NCT03255083|156810083|FG002|Overall Study|Adverse Event|0|||
48716078|NCT03255083|156810084|FG003|Overall Study|Adverse Event|0|||
48716079|NCT03255083|156810081|FG000|Overall Study|Progressive disease by RECIST version 1.1|4|||
48716080|NCT03255083|156810082|FG001|Overall Study|Progressive disease by RECIST version 1.1|1|||
48716081|NCT03255083|156810083|FG002|Overall Study|Progressive disease by RECIST version 1.1|2|||
48716082|NCT03255083|156810084|FG003|Overall Study|Progressive disease by RECIST version 1.1|1|||
48716083|NCT03255083|156810081|FG000|Overall Study|Withdrawal by Subject|1|||
48716084|NCT03255083|156810082|FG001|Overall Study|Withdrawal by Subject|1|||
48716085|NCT03255083|156810083|FG002|Overall Study|Withdrawal by Subject|1|||
48716086|NCT03255083|156810084|FG003|Overall Study|Withdrawal by Subject|0|||
48716087|NCT02051933|156811178|FG000|Overall Study|Physician Decision|0|||
48716088|NCT02051933|156811179|FG001|Overall Study|Physician Decision|1|||
48716089|NCT00798759|156811180|FG000|Overall Study|Adverse Event|3|||
48716090|NCT00798759|156811181|FG001|Overall Study|Adverse Event|3|||
48716091|NCT00798759|156811180|FG000|Overall Study|Lost to Follow-up|1|||
48716092|NCT00798759|156811181|FG001|Overall Study|Lost to Follow-up|1|||
48716093|NCT00798759|156811180|FG000|Overall Study|Protocol Violation|4|||
49125846|NCT00467519|158298311|FG000|Overall Study|Protocol Violation|8|||
49125847|NCT00467519|158298312|FG001|Overall Study|Protocol Violation|4|||
49125848|NCT00467519|158298311|FG000|Overall Study|Lost to Follow-up|2|||
49125849|NCT00467519|158298312|FG001|Overall Study|Lost to Follow-up|9|||
48813699|NCT02769065|157159933|FG009|Overall Study|Voluntary Withdrawal|0|||
48813700|NCT02769065|157159934|FG010|Overall Study|Voluntary Withdrawal|0|||
49125850|NCT00467519|158298311|FG000|Overall Study|Withdrawal by Subject|4|||
49125851|NCT00467519|158298312|FG001|Overall Study|Withdrawal by Subject|10|||
49125852|NCT01791985|158298313|FG000|Overall Study|Adverse Event|7|||
49125853|NCT01791985|158298313|FG000|Overall Study|Withdrawal by Subject|1|||
49125854|NCT00372424|158298314|FG000|Overall Study|Adverse Event|2|||
49125855|NCT00372424|158298314|FG000|Overall Study|Withdrawal by Subject|1|||
49125856|NCT00372424|158298314|FG000|Overall Study|Death|1|||
48716094|NCT00798759|156811181|FG001|Overall Study|Protocol Violation|8|||
48716095|NCT00798759|156811180|FG000|Overall Study|Other|0|||
48813701|NCT02769065|157159935|FG011|Overall Study|Voluntary Withdrawal|0|||
48716096|NCT00798759|156811181|FG001|Overall Study|Other|1|||
48716097|NCT00109590|156811183|FG000|Overall Study|Lost to Follow-up|1|||
48716098|NCT00109590|156811184|FG001|Overall Study|Lost to Follow-up|0|||
48716099|NCT00109590|156811185|FG002|Overall Study|Lost to Follow-up|1|||
48813702|NCT02769065|157159936|FG012|Overall Study|Voluntary Withdrawal|0|||
49125857|NCT00372424|158298314|FG000|Overall Study|Objective Progression or Relapse|14|||
49125858|NCT00372424|158298314|FG000|Overall Study|Other|7|||
49125859|NCT00372424|158298314|FG000|Overall Study|Enrolled, Not Treated|1|||
48716100|NCT00109590|156811183|FG000|Overall Study|Never Started Treatment|1|||
48716101|NCT00109590|156811184|FG001|Overall Study|Never Started Treatment|2|||
48813703|NCT02769065|157159937|FG013|Overall Study|Voluntary Withdrawal|0|||
48813704|NCT02769065|157159938|FG014|Overall Study|Voluntary Withdrawal|0|||
48813705|NCT02769065|157159939|FG015|Overall Study|Voluntary Withdrawal|0|||
48813706|NCT02769065|157159940|FG016|Overall Study|Voluntary Withdrawal|0|||
48813707|NCT02769065|157159941|FG017|Overall Study|Voluntary Withdrawal|0|||
48813708|NCT02769065|157159942|FG018|Overall Study|Voluntary Withdrawal|0|||
48813709|NCT02769065|157159943|FG019|Overall Study|Voluntary Withdrawal|0|||
48813710|NCT02769065|157159944|FG020|Overall Study|Voluntary Withdrawal|0|||
48813711|NCT02769065|157159945|FG021|Overall Study|Voluntary Withdrawal|0|||
48813712|NCT02769065|157159946|FG022|Overall Study|Voluntary Withdrawal|0|||
48813713|NCT02769065|157159947|FG023|Overall Study|Voluntary Withdrawal|0|||
48813714|NCT02769065|157159948|FG024|Overall Study|Voluntary Withdrawal|0|||
48813715|NCT02769065|157159949|FG025|Overall Study|Voluntary Withdrawal|0|||
48813716|NCT02769065|157159950|FG026|Overall Study|Voluntary Withdrawal|0|||
48813717|NCT02769065|157159951|FG027|Overall Study|Voluntary Withdrawal|0|||
48813718|NCT02769065|157159952|FG028|Overall Study|Voluntary Withdrawal|0|||
48813719|NCT02769065|157159953|FG029|Overall Study|Voluntary Withdrawal|0|||
48813720|NCT02769065|157159924|FG000|Overall Study|Reason Not Specified|0|||
48813721|NCT02769065|157159925|FG001|Overall Study|Reason Not Specified|0|||
48813722|NCT02769065|157159926|FG002|Overall Study|Reason Not Specified|0|||
48813723|NCT02769065|157159927|FG003|Overall Study|Reason Not Specified|0|||
48813724|NCT02769065|157159928|FG004|Overall Study|Reason Not Specified|0|||
48813725|NCT02769065|157159929|FG005|Overall Study|Reason Not Specified|0|||
48813726|NCT02769065|157159930|FG006|Overall Study|Reason Not Specified|1|||
48813727|NCT02769065|157159931|FG007|Overall Study|Reason Not Specified|0|||
48813728|NCT02769065|157159932|FG008|Overall Study|Reason Not Specified|0|||
48813729|NCT02769065|157159933|FG009|Overall Study|Reason Not Specified|0|||
48813730|NCT02769065|157159934|FG010|Overall Study|Reason Not Specified|0|||
48813731|NCT02769065|157159935|FG011|Overall Study|Reason Not Specified|0|||
48813732|NCT02769065|157159936|FG012|Overall Study|Reason Not Specified|0|||
48813733|NCT02769065|157159937|FG013|Overall Study|Reason Not Specified|0|||
48813734|NCT02769065|157159938|FG014|Overall Study|Reason Not Specified|0|||
48813735|NCT02769065|157159939|FG015|Overall Study|Reason Not Specified|0|||
48813736|NCT02769065|157159940|FG016|Overall Study|Reason Not Specified|0|||
48813737|NCT02769065|157159941|FG017|Overall Study|Reason Not Specified|0|||
48813738|NCT02769065|157159942|FG018|Overall Study|Reason Not Specified|0|||
48813739|NCT02769065|157159943|FG019|Overall Study|Reason Not Specified|0|||
49125860|NCT03080935|158298315|FG000|Overall Study|Death|34|||
49125861|NCT03080935|158298316|FG001|Overall Study|Death|50|||
49125862|NCT03080935|158298315|FG000|Overall Study|Lost to Follow-up|5|||
49125863|NCT03080935|158298316|FG001|Overall Study|Lost to Follow-up|4|||
49125864|NCT03080935|158298315|FG000|Overall Study|Withdrawal by Subject|11|||
49125865|NCT03080935|158298316|FG001|Overall Study|Withdrawal by Subject|15|||
49125866|NCT01614470|158298317|FG000|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
49125867|NCT01614470|158298318|FG001|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
49125868|NCT01614470|158298319|FG002|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
48716102|NCT00109590|156811185|FG002|Overall Study|Never Started Treatment|3|||
48716103|NCT01221285|156811186|FG000|Overall Study|Withdrawal by Subject|1|||
48716104|NCT00588861|156811190|FG000|Pre-Operative|Patients Did Not Complete Preop Data|95|||
48716105|NCT00588861|156811191|FG001|Pre-Operative|Patients Did Not Complete Preop Data|86|||
48716106|NCT00588861|156811190|FG000|6 Months|Patients did not return for follow-up|98|||
48716107|NCT00588861|156811191|FG001|6 Months|Patients did not return for follow-up|73|||
48716108|NCT00588861|156811190|FG000|1 Year|Patients did not return for follow-up|89|||
48716109|NCT00588861|156811191|FG001|1 Year|Patients did not return for follow-up|82|||
48813740|NCT02769065|157159944|FG020|Overall Study|Reason Not Specified|0|||
48813741|NCT02769065|157159945|FG021|Overall Study|Reason Not Specified|0|||
48813742|NCT02769065|157159946|FG022|Overall Study|Reason Not Specified|0|||
48813743|NCT02769065|157159947|FG023|Overall Study|Reason Not Specified|0|||
48813744|NCT02769065|157159948|FG024|Overall Study|Reason Not Specified|0|||
48813745|NCT02769065|157159949|FG025|Overall Study|Reason Not Specified|0|||
48813746|NCT02769065|157159950|FG026|Overall Study|Reason Not Specified|0|||
48813747|NCT02769065|157159951|FG027|Overall Study|Reason Not Specified|0|||
48813748|NCT02769065|157159952|FG028|Overall Study|Reason Not Specified|0|||
48716110|NCT00588861|156811190|FG000|2 Years|Patients did not return for follow-up|92|||
48716111|NCT00588861|156811191|FG001|2 Years|Patients did not return for follow-up|87|||
49125869|NCT01614470|158298317|FG000|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
48716112|NCT00588861|156811190|FG000|4 Years|Patients did not return for follow-up|91|||
48716113|NCT00588861|156811191|FG001|4 Years|Patients did not return for follow-up|103|||
49125870|NCT01614470|158298318|FG001|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
48813749|NCT02769065|157159953|FG029|Overall Study|Reason Not Specified|0|||
48813750|NCT02769065|157159924|FG000|Overall Study|Pre-treatment Event/Adverse Event|0|||
48813751|NCT02769065|157159925|FG001|Overall Study|Pre-treatment Event/Adverse Event|0|||
48813752|NCT02769065|157159926|FG002|Overall Study|Pre-treatment Event/Adverse Event|0|||
49125871|NCT01614470|158298319|FG002|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0|||
49125872|NCT04249427|158298321|FG000|Overall Study|Adverse Event|3|||
49125873|NCT04249427|158298322|FG001|Overall Study|Adverse Event|1|||
49125874|NCT04249427|158298321|FG000|Overall Study|Lack of Efficacy|0|||
49125875|NCT04249427|158298322|FG001|Overall Study|Lack of Efficacy|1|||
49125876|NCT04249427|158298321|FG000|Overall Study|Withdrawal by Subject|1|||
49125877|NCT04249427|158298322|FG001|Overall Study|Withdrawal by Subject|2|||
49125878|NCT02557399|158298323|FG000|Overall Study|Adverse Event|6|||
49125879|NCT02557399|158298324|FG001|Overall Study|Adverse Event|5|||
49125880|NCT02557399|158298323|FG000|Overall Study|Protocol Violation|0|||
48813753|NCT02769065|157159927|FG003|Overall Study|Pre-treatment Event/Adverse Event|0|||
48813754|NCT02769065|157159928|FG004|Overall Study|Pre-treatment Event/Adverse Event|0|||
48813755|NCT02769065|157159929|FG005|Overall Study|Pre-treatment Event/Adverse Event|0|||
48813756|NCT02769065|157159930|FG006|Overall Study|Pre-treatment Event/Adverse Event|0|||
48813757|NCT02769065|157159931|FG007|Overall Study|Pre-treatment Event/Adverse Event|0|||
49125881|NCT02557399|158298324|FG001|Overall Study|Protocol Violation|1|||
49125882|NCT02557399|158298323|FG000|Overall Study|Protocol-defined stopping criteria|0|||
49125883|NCT02557399|158298324|FG001|Overall Study|Protocol-defined stopping criteria|1|||
49125884|NCT02557399|158298323|FG000|Overall Study|Withdrawal by Subject|1|||
49125885|NCT02557399|158298324|FG001|Overall Study|Withdrawal by Subject|1|||
49125886|NCT00577317|158298331|FG000|Overall Study|Study Terminated|0|||
48716114|NCT00588861|156811190|FG000|6 Years|Patients did not return for follow-up|104|||
48716115|NCT00588861|156811191|FG001|6 Years|Patients did not return for follow-up|109|||
48716116|NCT00588861|156811190|FG000|8 Years|Patients did not return for follow-up|105|||
48716117|NCT00588861|156811191|FG001|8 Years|Patients did not return for follow-up|114|||
48716118|NCT00588861|156811190|FG000|10 Years|Incomplete due to study termination|107|||
48716119|NCT00588861|156811191|FG001|10 Years|Incomplete due to study termination|114|||
48716120|NCT02730195|156811192|FG000|Overall Study|Withdrawal by Subject|1|||
48716121|NCT01368562|156811193|FG000|Overall Study|Adverse Event|1|||
48716122|NCT01368562|156811193|FG000|Overall Study|Disease progression|1|||
49125887|NCT00577317|158298332|FG001|Overall Study|Study Terminated|2|||
49125888|NCT03160716|158298334|FG000|Overall Study|Lost to Follow-up|1|||
49125889|NCT02033759|158298342|FG000|Overall Study|Withdrawal by Subject|2|||
49125890|NCT02033759|158298343|FG001|Overall Study|Withdrawal by Subject|1|||
49125891|NCT02033759|158298342|FG000|Overall Study|Protocol Violation|1|||
49125892|NCT02033759|158298343|FG001|Overall Study|Protocol Violation|1|||
49125893|NCT00764790|158298344|FG000|Overall Study|Protocol Violation|0|||
49125894|NCT00764790|158298345|FG001|Overall Study|Protocol Violation|0|||
49125895|NCT00764790|158298346|FG002|Overall Study|Protocol Violation|1|||
49125896|NCT00764790|158298344|FG000|Overall Study|Withdrawal by Subject|10|||
49125897|NCT00764790|158298345|FG001|Overall Study|Withdrawal by Subject|12|||
49125898|NCT00764790|158298346|FG002|Overall Study|Withdrawal by Subject|6|||
49125899|NCT00764790|158298344|FG000|Overall Study|Lost to Follow-up|28|||
49125900|NCT00764790|158298345|FG001|Overall Study|Lost to Follow-up|29|||
49125901|NCT00764790|158298346|FG002|Overall Study|Lost to Follow-up|23|||
49125902|NCT02404545|158298351|FG000|Overall Study|Sponsor Termination|6|||
49125903|NCT02404545|158298352|FG001|Overall Study|Sponsor Termination|6|||
48716123|NCT01368562|156811193|FG000|Overall Study|Lost to Follow-up|1|||
48716124|NCT01368562|156811193|FG000|Overall Study|Death|6|||
48716125|NCT01368562|156811193|FG000|Overall Study|Unresponsive to treatment|5|||
48716126|NCT01368562|156811193|FG000|Overall Study|Other|3|||
48813758|NCT02769065|157159932|FG008|Overall Study|Pre-treatment Event/Adverse Event|0|||
48813759|NCT02769065|157159933|FG009|Overall Study|Pre-treatment Event/Adverse Event|0|||
48813760|NCT02769065|157159934|FG010|Overall Study|Pre-treatment Event/Adverse Event|1|||
48813761|NCT02769065|157159935|FG011|Overall Study|Pre-treatment Event/Adverse Event|0|||
48813762|NCT02769065|157159936|FG012|Overall Study|Pre-treatment Event/Adverse Event|0|||
48813763|NCT02769065|157159937|FG013|Overall Study|Pre-treatment Event/Adverse Event|0|||
48813764|NCT02769065|157159938|FG014|Overall Study|Pre-treatment Event/Adverse Event|0|||
48813765|NCT02769065|157159939|FG015|Overall Study|Pre-treatment Event/Adverse Event|0|||
48813766|NCT02769065|157159940|FG016|Overall Study|Pre-treatment Event/Adverse Event|0|||
48813767|NCT02769065|157159941|FG017|Overall Study|Pre-treatment Event/Adverse Event|0|||
48813768|NCT02769065|157159942|FG018|Overall Study|Pre-treatment Event/Adverse Event|0|||
48813769|NCT02769065|157159943|FG019|Overall Study|Pre-treatment Event/Adverse Event|0|||
48813770|NCT02769065|157159944|FG020|Overall Study|Pre-treatment Event/Adverse Event|0|||
48813771|NCT02769065|157159945|FG021|Overall Study|Pre-treatment Event/Adverse Event|0|||
48813772|NCT02769065|157159946|FG022|Overall Study|Pre-treatment Event/Adverse Event|0|||
48813773|NCT02769065|157159947|FG023|Overall Study|Pre-treatment Event/Adverse Event|0|||
48813774|NCT02769065|157159948|FG024|Overall Study|Pre-treatment Event/Adverse Event|0|||
48813775|NCT02769065|157159949|FG025|Overall Study|Pre-treatment Event/Adverse Event|0|||
49125904|NCT00103285|158299543|FG000|Induction|Adverse Event|14|||
49125905|NCT00103285|158299544|FG001|Induction|Adverse Event|0|||
49125906|NCT00103285|158299545|FG002|Induction|Adverse Event|0|||
48716127|NCT01368562|156811193|FG000|Overall Study|Other than specified|2|||
48813776|NCT02769065|157159950|FG026|Overall Study|Pre-treatment Event/Adverse Event|0|||
49125907|NCT00103285|158299546|FG003|Induction|Adverse Event|0|||
49125908|NCT00103285|158299547|FG004|Induction|Adverse Event|0|||
49125909|NCT00103285|158299548|FG005|Induction|Adverse Event|0|||
49125910|NCT00103285|158299549|FG006|Induction|Adverse Event|0|||
49125911|NCT00103285|158299550|FG007|Induction|Adverse Event|0|||
49125912|NCT00103285|158299543|FG000|Induction|Death|24|||
49125913|NCT00103285|158299544|FG001|Induction|Death|0|||
49125914|NCT00103285|158299545|FG002|Induction|Death|0|||
49125915|NCT00103285|158299546|FG003|Induction|Death|0|||
49125916|NCT00103285|158299547|FG004|Induction|Death|0|||
49125917|NCT00103285|158299548|FG005|Induction|Death|0|||
49125918|NCT00103285|158299549|FG006|Induction|Death|0|||
49125919|NCT00103285|158299550|FG007|Induction|Death|0|||
49125920|NCT00103285|158299543|FG000|Induction|Physician Decision|103|||
49125921|NCT00103285|158299544|FG001|Induction|Physician Decision|0|||
49125922|NCT00103285|158299545|FG002|Induction|Physician Decision|0|||
49125923|NCT00103285|158299546|FG003|Induction|Physician Decision|0|||
49125924|NCT00103285|158299547|FG004|Induction|Physician Decision|0|||
49125925|NCT00103285|158299548|FG005|Induction|Physician Decision|0|||
49125926|NCT00103285|158299549|FG006|Induction|Physician Decision|0|||
49125927|NCT00103285|158299550|FG007|Induction|Physician Decision|0|||
49125928|NCT00103285|158299543|FG000|Induction|Withdrawal by Subject|1|||
48716128|NCT01325337|156811194|FG000|Overall Study|Adverse Event|0|||
48716129|NCT01325337|156811195|FG001|Overall Study|Adverse Event|2|||
48716130|NCT01325337|156811196|FG002|Overall Study|Adverse Event|2|||
48716131|NCT01325337|156811197|FG003|Overall Study|Adverse Event|1|||
48716132|NCT01325337|156811198|FG004|Overall Study|Adverse Event|2|||
48716133|NCT01325337|156811194|FG000|Overall Study|Lost to Follow-up|2|||
48716134|NCT01325337|156811195|FG001|Overall Study|Lost to Follow-up|2|||
48716135|NCT01325337|156811196|FG002|Overall Study|Lost to Follow-up|2|||
48716136|NCT01325337|156811197|FG003|Overall Study|Lost to Follow-up|1|||
48716137|NCT01325337|156811198|FG004|Overall Study|Lost to Follow-up|2|||
48716138|NCT01325337|156811194|FG000|Overall Study|Personal Reasons|2|||
48716139|NCT01325337|156811195|FG001|Overall Study|Personal Reasons|5|||
48716140|NCT01325337|156811196|FG002|Overall Study|Personal Reasons|4|||
48716141|NCT01325337|156811197|FG003|Overall Study|Personal Reasons|8|||
48716142|NCT01325337|156811198|FG004|Overall Study|Personal Reasons|3|||
48716143|NCT01325337|156811194|FG000|Overall Study|Withdrawal by Subject|1|||
48716144|NCT01325337|156811195|FG001|Overall Study|Withdrawal by Subject|0|||
48716145|NCT01325337|156811196|FG002|Overall Study|Withdrawal by Subject|1|||
48716146|NCT01325337|156811197|FG003|Overall Study|Withdrawal by Subject|0|||
48716147|NCT01325337|156811198|FG004|Overall Study|Withdrawal by Subject|1|||
48716148|NCT02881567|156811199|FG000|Overall Study|Adverse Event|1|||
48716149|NCT02881567|156811199|FG000|Overall Study|Lost to Follow-up|3|||
49010984|NCT01663714|157877361|FG000|Long-Term Follow-Up|Non-compliance|1|||
49010985|NCT01664494|157877364|FG000|Overall Study|Withdrawal by Subject|27|||
49010986|NCT01664494|157877364|FG000|Overall Study|Death|18|||
49010987|NCT01664494|157877364|FG000|Overall Study|Other|49|||
49010988|NCT01664494|157877364|FG000|Overall Study|Lost to Follow-up|99|||
49010989|NCT03196791|157877365|FG000|Overall Study|Protocol Violation|7|||
49010990|NCT03196791|157877366|FG001|Overall Study|Protocol Violation|3|||
49010991|NCT03196791|157877365|FG000|Overall Study|Withdrawal by Subject|3|||
49010992|NCT03196791|157877366|FG001|Overall Study|Withdrawal by Subject|2|||
49010993|NCT01814137|157877368|FG000|Overall Study|Adverse Event|0|||
49010994|NCT01814137|157877369|FG001|Overall Study|Adverse Event|1|||
49010995|NCT01814137|157877368|FG000|Overall Study|Withdrawal by Subject|2|||
49010996|NCT01814137|157877369|FG001|Overall Study|Withdrawal by Subject|2|||
49010997|NCT01814137|157877368|FG000|Overall Study|Physician Decision|1|||
49010998|NCT01814137|157877369|FG001|Overall Study|Physician Decision|1|||
49010999|NCT01814137|157877368|FG000|Overall Study|Unclassified|2|||
49011000|NCT01814137|157877369|FG001|Overall Study|Unclassified|1|||
49011001|NCT01689974|157877370|FG000|Overall Study|Termination of Study|5|||
49011002|NCT01689974|157877371|FG001|Overall Study|Termination of Study|5|||
49011003|NCT00219557|157877373|FG000|Phase 1|Lack of Efficacy|3|||
49011004|NCT00219557|157877374|FG001|Phase 1|Lack of Efficacy|0|||
49011005|NCT00219557|157877375|FG002|Phase 1|Lack of Efficacy|0|||
49011006|NCT00219557|157877373|FG000|Phase 1|Adverse Event|2|||
49011007|NCT00219557|157877374|FG001|Phase 1|Adverse Event|0|||
49011008|NCT00219557|157877375|FG002|Phase 1|Adverse Event|0|||
49011009|NCT00219557|157877373|FG000|Phase 1|Withdrawal by Subject|1|||
49011010|NCT00219557|157877374|FG001|Phase 1|Withdrawal by Subject|0|||
49125929|NCT00103285|158299544|FG001|Induction|Withdrawal by Subject|0|||
48813777|NCT02769065|157159951|FG027|Overall Study|Pre-treatment Event/Adverse Event|0|||
49125930|NCT00103285|158299545|FG002|Induction|Withdrawal by Subject|0|||
49125931|NCT00103285|158299546|FG003|Induction|Withdrawal by Subject|0|||
49125932|NCT00103285|158299547|FG004|Induction|Withdrawal by Subject|0|||
49125933|NCT00103285|158299548|FG005|Induction|Withdrawal by Subject|0|||
49125934|NCT00103285|158299549|FG006|Induction|Withdrawal by Subject|0|||
49125935|NCT00103285|158299550|FG007|Induction|Withdrawal by Subject|0|||
49125936|NCT00103285|158299543|FG000|Induction|Ineligible|43|||
49125937|NCT00103285|158299544|FG001|Induction|Ineligible|0|||
49125938|NCT00103285|158299545|FG002|Induction|Ineligible|0|||
49125939|NCT00103285|158299546|FG003|Induction|Ineligible|0|||
49125940|NCT00103285|158299547|FG004|Induction|Ineligible|0|||
49125941|NCT00103285|158299548|FG005|Induction|Ineligible|0|||
49125942|NCT00103285|158299549|FG006|Induction|Ineligible|0|||
49125943|NCT00103285|158299550|FG007|Induction|Ineligible|0|||
49125944|NCT00103285|158299543|FG000|Induction|Refusal|906|||
49125945|NCT00103285|158299544|FG001|Induction|Refusal|0|||
49125946|NCT00103285|158299545|FG002|Induction|Refusal|0|||
48813778|NCT02769065|157159952|FG028|Overall Study|Pre-treatment Event/Adverse Event|0|||
48813779|NCT02769065|157159953|FG029|Overall Study|Pre-treatment Event/Adverse Event|0|||
48813780|NCT00429494|157159960|FG000|Overall Study|Withdrawal by Subject|9|||
48813781|NCT00429494|157159960|FG000|Overall Study|Death|6|||
48813782|NCT00975221|157159961|FG000|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2|||
48813783|NCT00975221|157159962|FG001|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3|||
48813784|NCT00975221|157159961|FG000|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1|||
48813785|NCT00975221|157159962|FG001|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0|||
48813786|NCT00975221|157159961|FG000|Titration Phase (Weeks 1-12)|Other|0|||
49125947|NCT00103285|158299546|FG003|Induction|Refusal|0|||
49125948|NCT00103285|158299547|FG004|Induction|Refusal|0|||
49125949|NCT00103285|158299548|FG005|Induction|Refusal|0|||
49125950|NCT00103285|158299549|FG006|Induction|Refusal|0|||
49125951|NCT00103285|158299550|FG007|Induction|Refusal|0|||
49125952|NCT00103285|158299543|FG000|Induction|Other|258|||
49125953|NCT00103285|158299544|FG001|Induction|Other|0|||
49125954|NCT00103285|158299545|FG002|Induction|Other|0|||
49125955|NCT00103285|158299546|FG003|Induction|Other|0|||
49125956|NCT00103285|158299547|FG004|Induction|Other|0|||
49125957|NCT00103285|158299548|FG005|Induction|Other|0|||
48813787|NCT00975221|157159962|FG001|Titration Phase (Weeks 1-12)|Other|1|||
48813788|NCT00975221|157159961|FG000|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0|||
48813789|NCT00975221|157159962|FG001|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1|||
48813790|NCT00975221|157159961|FG000|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
48813791|NCT00975221|157159962|FG001|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
48813792|NCT00975221|157159961|FG000|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1|||
48813793|NCT00975221|157159962|FG001|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0|||
48813794|NCT03935217|157159965|FG000|Overall Study|Adverse Event|1|||
48813795|NCT03935217|157159966|FG001|Overall Study|Adverse Event|0|||
48813796|NCT03935217|157159965|FG000|Overall Study|Lost to Follow-up|0|||
48813797|NCT03935217|157159966|FG001|Overall Study|Lost to Follow-up|1|||
48813798|NCT03935217|157159965|FG000|Overall Study|Withdrawal by Subject|0|||
48813799|NCT03935217|157159966|FG001|Overall Study|Withdrawal by Subject|2|||
48813800|NCT01992549|157159967|FG000|Overall Study|Lost to Follow-up|2|||
48813801|NCT01992549|157159967|FG000|Overall Study|Serious Adverse Event|1|||
48813802|NCT01992549|157159967|FG000|Overall Study|Product Switch to Extend Half Life|1|||
48813803|NCT02791490|157159968|FG000|Overall Study|Lost to Follow-up|1|||
48813804|NCT02791490|157159969|FG001|Overall Study|Lost to Follow-up|2|||
48813805|NCT02791490|157159968|FG000|Overall Study|Withdrawal by Subject|2|||
48813806|NCT02791490|157159969|FG001|Overall Study|Withdrawal by Subject|6|||
48813807|NCT01912222|157159971|FG000|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1|||
48813808|NCT01912222|157159972|FG001|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
48813809|NCT01912222|157159973|FG002|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
48813810|NCT01912222|157159971|FG000|Part B: Treatment Period|Progressive disease|10|||
48813811|NCT01912222|157159972|FG001|Part B: Treatment Period|Progressive disease|12|||
48813812|NCT01912222|157159973|FG002|Part B: Treatment Period|Progressive disease|15|||
48813813|NCT01912222|157159971|FG000|Part B: Treatment Period|Adverse Event|1|||
48813814|NCT01912222|157159972|FG001|Part B: Treatment Period|Adverse Event|2|||
49125958|NCT00103285|158299549|FG006|Induction|Other|0|||
49125959|NCT00103285|158299550|FG007|Induction|Other|0|||
49125960|NCT00103285|158299543|FG000|Response Assignment|Adverse Event|0|||
49125961|NCT00103285|158299544|FG001|Response Assignment|Adverse Event|8|||
49125962|NCT00103285|158299545|FG002|Response Assignment|Adverse Event|3|||
49125963|NCT00103285|158299546|FG003|Response Assignment|Adverse Event|2|||
49125964|NCT00103285|158299547|FG004|Response Assignment|Adverse Event|3|||
49125965|NCT00103285|158299548|FG005|Response Assignment|Adverse Event|1|||
49125966|NCT00103285|158299549|FG006|Response Assignment|Adverse Event|1|||
49125967|NCT00103285|158299550|FG007|Response Assignment|Adverse Event|2|||
49125968|NCT00103285|158299543|FG000|Response Assignment|Death|0|||
49125969|NCT00103285|158299544|FG001|Response Assignment|Death|5|||
49125970|NCT00103285|158299545|FG002|Response Assignment|Death|2|||
48813815|NCT01912222|157159973|FG002|Part B: Treatment Period|Adverse Event|3|||
48813816|NCT01912222|157159971|FG000|Part B: Treatment Period|Withdrawal by Subject|2|||
48813817|NCT01912222|157159972|FG001|Part B: Treatment Period|Withdrawal by Subject|1|||
48813818|NCT01912222|157159973|FG002|Part B: Treatment Period|Withdrawal by Subject|2|||
48813819|NCT00154063|157159974|FG000|Overall Study|Adverse Event|4|||
48813820|NCT00154063|157159975|FG001|Overall Study|Adverse Event|8|||
48813821|NCT00154063|157159974|FG000|Overall Study|Protocol Violation|1|||
48813822|NCT00154063|157159975|FG001|Overall Study|Protocol Violation|1|||
48813823|NCT00154063|157159974|FG000|Overall Study|Investigator or Sponsor Request|0|||
48813824|NCT00154063|157159975|FG001|Overall Study|Investigator or Sponsor Request|1|||
49125971|NCT00103285|158299546|FG003|Response Assignment|Death|2|||
48716150|NCT02881567|156811199|FG000|Overall Study|Consent withdrawn|1|||
48716151|NCT02881567|156811199|FG000|Overall Study|Investigator decision|1|||
48716152|NCT02881567|156811199|FG000|Overall Study|Study terminated by sponsor|9|||
48716153|NCT02881567|156811199|FG000|Overall Study|Reason not Specified|3|||
48716154|NCT01012219|156811200|FG000|Period 1|Withdrawal by Subject|1|||
48716155|NCT01012219|156811200|FG000|Period 2|Withdrawal by Subject|1|||
48716156|NCT02894502|156811201|FG000|Baseline|Withdrawal by Subject|24|||
48716157|NCT02894502|156811202|FG001|Baseline|Withdrawal by Subject|31|||
48716158|NCT02894502|156811203|FG002|Baseline|Withdrawal by Subject|36|||
48716159|NCT02894502|156811201|FG000|Baseline|Death|3|||
48716160|NCT02894502|156811202|FG001|Baseline|Death|1|||
48716161|NCT02894502|156811203|FG002|Baseline|Death|9|||
48716162|NCT02894502|156811201|FG000|First Follow up|Withdrawal by Subject|32|||
48716163|NCT02894502|156811202|FG001|First Follow up|Withdrawal by Subject|29|||
48716164|NCT02894502|156811203|FG002|First Follow up|Withdrawal by Subject|37|||
48716165|NCT02894502|156811201|FG000|First Follow up|Death|2|||
48716166|NCT02894502|156811202|FG001|First Follow up|Death|2|||
48716167|NCT02894502|156811203|FG002|First Follow up|Death|3|||
48716168|NCT02894502|156811201|FG000|Second Follow up|Withdrawal by Subject|13|||
48716169|NCT02894502|156811202|FG001|Second Follow up|Withdrawal by Subject|15|||
48716170|NCT02894502|156811203|FG002|Second Follow up|Withdrawal by Subject|13|||
48716171|NCT02894502|156811201|FG000|Second Follow up|Death|2|||
48716172|NCT02894502|156811202|FG001|Second Follow up|Death|3|||
48716173|NCT02894502|156811203|FG002|Second Follow up|Death|1|||
48716174|NCT02894502|156811201|FG000|Third Follow up|Withdrawal by Subject|5|||
48716175|NCT02894502|156811202|FG001|Third Follow up|Withdrawal by Subject|6|||
48716176|NCT02894502|156811203|FG002|Third Follow up|Withdrawal by Subject|3|||
48716177|NCT02894502|156811201|FG000|Third Follow up|Death|1|||
48716178|NCT02894502|156811202|FG001|Third Follow up|Death|1|||
48716179|NCT02894502|156811203|FG002|Third Follow up|Death|0|||
48716180|NCT02870933|156811209|FG000|Overall Study|Death|2|||
48716181|NCT02870933|156811210|FG001|Overall Study|Death|1|||
48716182|NCT02870933|156811209|FG000|Overall Study|Withdrawal by Subject|0|||
48716183|NCT02870933|156811210|FG001|Overall Study|Withdrawal by Subject|1|||
48716184|NCT01206322|156811211|FG000|Overall Study|Adverse Event|0|||
48716185|NCT01206322|156811212|FG001|Overall Study|Adverse Event|0|||
48716186|NCT01206322|156811213|FG002|Overall Study|Adverse Event|0|||
48716187|NCT01206322|156811214|FG003|Overall Study|Adverse Event|1|||
48716188|NCT01425463|156811215|FG000|Overall Study|Adverse Event|5|||
48716189|NCT01425463|156811216|FG001|Overall Study|Adverse Event|7|||
48716190|NCT01425463|156811215|FG000|Overall Study|Lack of Efficacy|1|||
48716191|NCT01425463|156811216|FG001|Overall Study|Lack of Efficacy|1|||
48716192|NCT01425463|156811215|FG000|Overall Study|Protocol Violation|2|||
48716193|NCT01425463|156811216|FG001|Overall Study|Protocol Violation|2|||
48716194|NCT01425463|156811215|FG000|Overall Study|Lost to Follow-up|5|||
48716195|NCT01425463|156811216|FG001|Overall Study|Lost to Follow-up|2|||
48716196|NCT01425463|156811215|FG000|Overall Study|Withdrawal by Subject|7|||
48716197|NCT01425463|156811216|FG001|Overall Study|Withdrawal by Subject|5|||
48716198|NCT01425463|156811215|FG000|Overall Study|Unknown Reason|4|||
48716199|NCT01425463|156811216|FG001|Overall Study|Unknown Reason|7|||
48716200|NCT04931888|156811217|FG000|Overall Study|Excluded families participated in EMPOWER previously|4|||
48716201|NCT04931888|156811218|FG001|Overall Study|Excluded families participated in EMPOWER previously|2|||
48716202|NCT04931888|156811219|FG002|Overall Study|Excluded families participated in EMPOWER previously|0|||
48716203|NCT04931888|156811220|FG003|Overall Study|Excluded families participated in EMPOWER previously|0|||
48716204|NCT01317550|156811221|FG000|Overall Study|Withdrawal by Subject|1|||
49125972|NCT00103285|158299547|FG004|Response Assignment|Death|3|||
49125973|NCT00103285|158299548|FG005|Response Assignment|Death|1|||
49125974|NCT00103285|158299549|FG006|Response Assignment|Death|0|||
49125975|NCT00103285|158299550|FG007|Response Assignment|Death|8|||
49125976|NCT00103285|158299543|FG000|Response Assignment|Lost to Follow-up|0|||
49125977|NCT00103285|158299544|FG001|Response Assignment|Lost to Follow-up|9|||
49125978|NCT00103285|158299545|FG002|Response Assignment|Lost to Follow-up|5|||
48716205|NCT01317550|156811222|FG001|Overall Study|Withdrawal by Subject|0|||
48716206|NCT01317550|156811223|FG002|Overall Study|Withdrawal by Subject|0|||
48813825|NCT00154063|157159974|FG000|Overall Study|Withdrawal by Subject|4|||
49125979|NCT00103285|158299546|FG003|Response Assignment|Lost to Follow-up|5|||
49125980|NCT00103285|158299547|FG004|Response Assignment|Lost to Follow-up|1|||
49125981|NCT00103285|158299548|FG005|Response Assignment|Lost to Follow-up|2|||
49125982|NCT00103285|158299549|FG006|Response Assignment|Lost to Follow-up|2|||
49125983|NCT00103285|158299550|FG007|Response Assignment|Lost to Follow-up|5|||
49125984|NCT00103285|158299543|FG000|Response Assignment|Physician Decision|0|||
49125985|NCT00103285|158299544|FG001|Response Assignment|Physician Decision|13|||
49125986|NCT00103285|158299545|FG002|Response Assignment|Physician Decision|14|||
49125987|NCT00103285|158299546|FG003|Response Assignment|Physician Decision|9|||
48813826|NCT00154063|157159975|FG001|Overall Study|Withdrawal by Subject|9|||
48813827|NCT00154063|157159974|FG000|Overall Study|Other|3|||
49125988|NCT00103285|158299547|FG004|Response Assignment|Physician Decision|13|||
49125989|NCT00103285|158299548|FG005|Response Assignment|Physician Decision|7|||
49125990|NCT00103285|158299549|FG006|Response Assignment|Physician Decision|4|||
49125991|NCT00103285|158299550|FG007|Response Assignment|Physician Decision|35|||
49125992|NCT00103285|158299543|FG000|Response Assignment|Protocol Violation|0|||
49125993|NCT00103285|158299544|FG001|Response Assignment|Protocol Violation|2|||
49125994|NCT00103285|158299545|FG002|Response Assignment|Protocol Violation|0|||
49125995|NCT00103285|158299546|FG003|Response Assignment|Protocol Violation|0|||
49125996|NCT00103285|158299547|FG004|Response Assignment|Protocol Violation|0|||
49125997|NCT00103285|158299548|FG005|Response Assignment|Protocol Violation|0|||
49125998|NCT00103285|158299549|FG006|Response Assignment|Protocol Violation|0|||
49125999|NCT00103285|158299550|FG007|Response Assignment|Protocol Violation|0|||
49126000|NCT00103285|158299543|FG000|Response Assignment|Withdrawal by Subject|0|||
49126001|NCT00103285|158299544|FG001|Response Assignment|Withdrawal by Subject|4|||
49126002|NCT00103285|158299545|FG002|Response Assignment|Withdrawal by Subject|1|||
49126003|NCT00103285|158299546|FG003|Response Assignment|Withdrawal by Subject|1|||
49126004|NCT00103285|158299547|FG004|Response Assignment|Withdrawal by Subject|2|||
49126005|NCT00103285|158299548|FG005|Response Assignment|Withdrawal by Subject|2|||
49126006|NCT00103285|158299549|FG006|Response Assignment|Withdrawal by Subject|0|||
49126007|NCT00103285|158299550|FG007|Response Assignment|Withdrawal by Subject|2|||
48813828|NCT00154063|157159975|FG001|Overall Study|Other|3|||
48813829|NCT00962585|157159976|FG000|Overall Study|Adverse Event|0|||
48813830|NCT00962585|157159977|FG001|Overall Study|Adverse Event|2|||
48813831|NCT00962585|157159978|FG002|Overall Study|Adverse Event|1|||
48813832|NCT00962585|157159979|FG003|Overall Study|Adverse Event|0|||
48813833|NCT00962585|157159976|FG000|Overall Study|Lost to Follow-up|3|||
48813834|NCT00962585|157159977|FG001|Overall Study|Lost to Follow-up|0|||
48813835|NCT00962585|157159978|FG002|Overall Study|Lost to Follow-up|1|||
48813836|NCT00962585|157159979|FG003|Overall Study|Lost to Follow-up|0|||
48813837|NCT00962585|157159976|FG000|Overall Study|Protocol Violation|0|||
48813838|NCT00962585|157159977|FG001|Overall Study|Protocol Violation|0|||
48813839|NCT00962585|157159978|FG002|Overall Study|Protocol Violation|1|||
48813840|NCT00962585|157159979|FG003|Overall Study|Protocol Violation|0|||
48813841|NCT00962585|157159976|FG000|Overall Study|Withdrawal by Subject|1|||
48813842|NCT00962585|157159977|FG001|Overall Study|Withdrawal by Subject|0|||
48813843|NCT00962585|157159978|FG002|Overall Study|Withdrawal by Subject|0|||
49126008|NCT00103285|158299543|FG000|Response Assignment|Ineligible|0|||
49126009|NCT00103285|158299544|FG001|Response Assignment|Ineligible|8|||
49126010|NCT00103285|158299545|FG002|Response Assignment|Ineligible|6|||
49126011|NCT00103285|158299546|FG003|Response Assignment|Ineligible|2|||
49126012|NCT00103285|158299547|FG004|Response Assignment|Ineligible|0|||
49126013|NCT00103285|158299548|FG005|Response Assignment|Ineligible|3|||
49126014|NCT00103285|158299549|FG006|Response Assignment|Ineligible|1|||
49126015|NCT00103285|158299550|FG007|Response Assignment|Ineligible|5|||
49126016|NCT00103285|158299543|FG000|Response Assignment|Refusal|0|||
49126017|NCT00103285|158299544|FG001|Response Assignment|Refusal|53|||
49126018|NCT00103285|158299545|FG002|Response Assignment|Refusal|5|||
49126019|NCT00103285|158299546|FG003|Response Assignment|Refusal|3|||
49126020|NCT00103285|158299547|FG004|Response Assignment|Refusal|25|||
49126021|NCT00103285|158299548|FG005|Response Assignment|Refusal|15|||
49126022|NCT00103285|158299549|FG006|Response Assignment|Refusal|30|||
49126023|NCT00103285|158299550|FG007|Response Assignment|Refusal|10|||
49126024|NCT00103285|158299543|FG000|Response Assignment|Other|0|||
49126025|NCT00103285|158299544|FG001|Response Assignment|Other|30|||
49126026|NCT00103285|158299545|FG002|Response Assignment|Other|48|||
49126027|NCT00103285|158299546|FG003|Response Assignment|Other|38|||
49126028|NCT00103285|158299547|FG004|Response Assignment|Other|37|||
49126029|NCT00103285|158299548|FG005|Response Assignment|Other|17|||
49126030|NCT00103285|158299549|FG006|Response Assignment|Other|11|||
49126031|NCT00103285|158299550|FG007|Response Assignment|Other|53|||
49126032|NCT00452439|158299551|FG000|Overall Study|Lost to Follow-up|1|||
48813844|NCT00962585|157159979|FG003|Overall Study|Withdrawal by Subject|0|||
48813845|NCT00962585|157159976|FG000|Overall Study|Withdrew Consent|2|||
48813846|NCT00962585|157159977|FG001|Overall Study|Withdrew Consent|0|||
48813847|NCT00962585|157159978|FG002|Overall Study|Withdrew Consent|0|||
49126033|NCT00452439|158299552|FG001|Overall Study|Lost to Follow-up|1|||
49126034|NCT00452439|158299551|FG000|Overall Study|Refused Treatment|4|||
49126035|NCT00452439|158299552|FG001|Overall Study|Refused Treatment|3|||
49126036|NCT00452439|158299551|FG000|Overall Study|Death|3|||
49126037|NCT00452439|158299552|FG001|Overall Study|Death|1|||
49126038|NCT00452439|158299551|FG000|Overall Study|Bone Marrow Transplant|0|||
49126039|NCT00452439|158299552|FG001|Overall Study|Bone Marrow Transplant|1|||
49126040|NCT00452439|158299551|FG000|Overall Study|Too Ill to Continue|0|||
49126041|NCT00452439|158299552|FG001|Overall Study|Too Ill to Continue|1|||
49126042|NCT00452439|158299551|FG000|Overall Study|Failed to achieve complete response|2|||
49126043|NCT00452439|158299552|FG001|Overall Study|Failed to achieve complete response|0|||
49126044|NCT00452439|158299551|FG000|Overall Study|Relapse|3|||
49126045|NCT00452439|158299552|FG001|Overall Study|Relapse|0|||
49126046|NCT00452439|158299551|FG000|Overall Study|Fracture|1|||
49126047|NCT00452439|158299552|FG001|Overall Study|Fracture|0|||
49126048|NCT00715559|158299555|FG000|Overall Study|medication not tolerated - nausea|1|||
49126049|NCT02291029|158299560|FG000|Overall Study|Withdrawal by Subject|0|||
49126050|NCT02291029|158299561|FG001|Overall Study|Withdrawal by Subject|0|||
49126051|NCT02291029|158299562|FG002|Overall Study|Withdrawal by Subject|1|||
49126052|NCT02291029|158299563|FG003|Overall Study|Withdrawal by Subject|0|||
49126053|NCT02291029|158299564|FG004|Overall Study|Withdrawal by Subject|0|||
49126054|NCT02291029|158299565|FG005|Overall Study|Withdrawal by Subject|0|||
49126055|NCT02291029|158299560|FG000|Overall Study|Adverse Event|0|||
49126056|NCT02291029|158299561|FG001|Overall Study|Adverse Event|1|||
49126057|NCT02291029|158299562|FG002|Overall Study|Adverse Event|0|||
49126058|NCT02291029|158299563|FG003|Overall Study|Adverse Event|0|||
49126059|NCT02291029|158299564|FG004|Overall Study|Adverse Event|0|||
49126060|NCT02291029|158299565|FG005|Overall Study|Adverse Event|0|||
49126061|NCT01095835|158299566|FG000|Overall Study|Adverse Event|8|||
49126062|NCT01095835|158299567|FG001|Overall Study|Adverse Event|6|||
49126063|NCT01095835|158299568|FG002|Overall Study|Adverse Event|6|||
49126064|NCT01095835|158299566|FG000|Overall Study|Lack of Efficacy|0|||
49126065|NCT01095835|158299567|FG001|Overall Study|Lack of Efficacy|1|||
49126066|NCT01095835|158299568|FG002|Overall Study|Lack of Efficacy|0|||
49126067|NCT01095835|158299566|FG000|Overall Study|Physician Decision|0|||
49126068|NCT01095835|158299567|FG001|Overall Study|Physician Decision|0|||
49126069|NCT01095835|158299568|FG002|Overall Study|Physician Decision|1|||
49126070|NCT01095835|158299566|FG000|Overall Study|Withdrawal by Subject|1|||
48813848|NCT00962585|157159979|FG003|Overall Study|Withdrew Consent|0|||
49126071|NCT01095835|158299567|FG001|Overall Study|Withdrawal by Subject|3|||
49126072|NCT01095835|158299568|FG002|Overall Study|Withdrawal by Subject|0|||
49126073|NCT01095835|158299566|FG000|Overall Study|Non study compliance|0|||
48813849|NCT01987596|157159980|FG000|Overall Study|Physician Decision|1|||
48813850|NCT01987596|157159981|FG001|Overall Study|Physician Decision|0|||
48813851|NCT01987596|157159980|FG000|Overall Study|Progressive Disease; missing all period|0|||
48813852|NCT01987596|157159981|FG001|Overall Study|Progressive Disease; missing all period|1|||
48813853|NCT02341456|157159988|FG000|Overall Study|Disease progression|2|||
48813854|NCT02341456|157159989|FG001|Overall Study|Disease progression|3|||
48813855|NCT02341456|157159990|FG002|Overall Study|Disease progression|1|||
48813856|NCT02341456|157159988|FG000|Overall Study|Death|1|||
48813857|NCT02341456|157159989|FG001|Overall Study|Death|1|||
48813858|NCT02341456|157159990|FG002|Overall Study|Death|1|||
48813859|NCT02341456|157159988|FG000|Overall Study|Withdrawal by Subject|0|||
48813860|NCT02341456|157159989|FG001|Overall Study|Withdrawal by Subject|1|||
48813861|NCT02341456|157159990|FG002|Overall Study|Withdrawal by Subject|1|||
48813862|NCT02341456|157159988|FG000|Overall Study|Moved to local access programme.|0|||
48813863|NCT02341456|157159989|FG001|Overall Study|Moved to local access programme.|1|||
48813864|NCT02341456|157159990|FG002|Overall Study|Moved to local access programme.|1|||
48813865|NCT02341456|157159988|FG000|Overall Study|Physician Decision|1|||
48813866|NCT02341456|157159989|FG001|Overall Study|Physician Decision|0|||
48813867|NCT02341456|157159990|FG002|Overall Study|Physician Decision|0|||
48813868|NCT01077362|157159991|FG000|Overall Study|Lack of Efficacy|13|||
48813869|NCT01077362|157159992|FG001|Overall Study|Lack of Efficacy|8|||
48813870|NCT01077362|157159993|FG002|Overall Study|Lack of Efficacy|10|||
48813871|NCT01077362|157159991|FG000|Overall Study|Lost to Follow-up|1|||
48813872|NCT01077362|157159992|FG001|Overall Study|Lost to Follow-up|0|||
48813873|NCT01077362|157159993|FG002|Overall Study|Lost to Follow-up|3|||
48813874|NCT01077362|157159991|FG000|Overall Study|Adverse Event|12|||
48813875|NCT01077362|157159992|FG001|Overall Study|Adverse Event|7|||
48813876|NCT01077362|157159993|FG002|Overall Study|Adverse Event|4|||
48813877|NCT01077362|157159991|FG000|Overall Study|Withdrawal by Subject|5|||
48813878|NCT01077362|157159992|FG001|Overall Study|Withdrawal by Subject|3|||
48813879|NCT01077362|157159993|FG002|Overall Study|Withdrawal by Subject|5|||
48813880|NCT01077362|157159991|FG000|Overall Study|Other|0|||
48813881|NCT01077362|157159992|FG001|Overall Study|Other|1|||
48813882|NCT01077362|157159993|FG002|Overall Study|Other|2|||
48813883|NCT00791921|157159994|FG000|Overall Study|Protocol planed|24|||
48813884|NCT00791921|157159995|FG001|Overall Study|Protocol planed|88|||
48813885|NCT00791921|157159994|FG000|Overall Study|Withdrawal by Subject|1|||
48813886|NCT00791921|157159995|FG001|Overall Study|Withdrawal by Subject|2|||
49126074|NCT01095835|158299567|FG001|Overall Study|Non study compliance|0|||
49126075|NCT01095835|158299568|FG002|Overall Study|Non study compliance|1|||
49126076|NCT01095835|158299566|FG000|Overall Study|Protocol Violation|1|||
49126077|NCT01095835|158299567|FG001|Overall Study|Protocol Violation|2|||
49126078|NCT01095835|158299568|FG002|Overall Study|Protocol Violation|0|||
49126079|NCT02498678|158299573|FG000|Overall Study|interference from the surgical team|0|||
49126080|NCT02498678|158299574|FG001|Overall Study|interference from the surgical team|2|||
49126081|NCT00521365|158299577|FG000|Overall Study|Adverse Event|3|||
49126082|NCT00521365|158299577|FG000|Overall Study|Lost to Follow-up|6|||
49126083|NCT00521365|158299577|FG000|Overall Study|Protocol deviation|2|||
49126084|NCT00521365|158299577|FG000|Overall Study|Drug compliance|3|||
49126085|NCT00521365|158299577|FG000|Overall Study|Usage of not allowed drugs|6|||
49126086|NCT03627832|158299580|FG000|Overall Study|Withdrawal by Subject|10|||
49126087|NCT03627832|158299581|FG001|Overall Study|Withdrawal by Subject|1|||
49126088|NCT01190891|158299582|FG000|Overall Study|Protocol Violation|1|||
49126089|NCT01190891|158299583|FG001|Overall Study|Protocol Violation|0|||
49126090|NCT01190891|158299582|FG000|Overall Study|Withdrawal by Subject|5|||
49126091|NCT01190891|158299583|FG001|Overall Study|Withdrawal by Subject|0|||
49126092|NCT01926028|158299584|FG000|Overall Study|Lost to Follow-up|7|||
49126093|NCT01926028|158299585|FG001|Overall Study|Lost to Follow-up|6|||
49126094|NCT01926028|158299586|FG002|Overall Study|Lost to Follow-up|0|||
49126095|NCT01926028|158299584|FG000|Overall Study|Physician Decision|1|||
49126096|NCT01926028|158299585|FG001|Overall Study|Physician Decision|5|||
49126097|NCT01926028|158299586|FG002|Overall Study|Physician Decision|0|||
49126098|NCT01926028|158299584|FG000|Overall Study|Withdrawal by Subject|9|||
49126099|NCT01926028|158299585|FG001|Overall Study|Withdrawal by Subject|9|||
49126100|NCT01926028|158299586|FG002|Overall Study|Withdrawal by Subject|2|||
49126101|NCT01926028|158299584|FG000|Overall Study|Non compliance or other reasons|4|||
49126102|NCT01926028|158299585|FG001|Overall Study|Non compliance or other reasons|2|||
49126103|NCT01926028|158299586|FG002|Overall Study|Non compliance or other reasons|0|||
49126104|NCT03150082|158299587|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1|||
49126105|NCT03150082|158299588|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
49126106|NCT01718483|158299589|FG000|Overall Study|Withdrawal by Subject|14|||
49126107|NCT01718483|158299590|FG001|Overall Study|Withdrawal by Subject|12|||
49126108|NCT01718483|158299589|FG000|Overall Study|Adverse Event|5|||
48716207|NCT01317550|156811224|FG003|Overall Study|Withdrawal by Subject|0|||
49126109|NCT01718483|158299590|FG001|Overall Study|Adverse Event|12|||
49126110|NCT01718483|158299589|FG000|Overall Study|Lost to Follow-up|8|||
49126111|NCT01718483|158299590|FG001|Overall Study|Lost to Follow-up|3|||
49126112|NCT01718483|158299589|FG000|Overall Study|Protocol Violation|4|||
49126113|NCT01718483|158299590|FG001|Overall Study|Protocol Violation|2|||
49126114|NCT01718483|158299589|FG000|Overall Study|Other|1|||
49126115|NCT01718483|158299590|FG001|Overall Study|Other|4|||
49126116|NCT01718483|158299589|FG000|Overall Study|Pregnancy|1|||
49126117|NCT01718483|158299590|FG001|Overall Study|Pregnancy|1|||
49126118|NCT01718483|158299589|FG000|Overall Study|Lack of Efficacy|1|||
49126119|NCT01718483|158299590|FG001|Overall Study|Lack of Efficacy|0|||
49126120|NCT01405560|158299597|FG000|Overall Study|Physician Decision|1|||
49126121|NCT02683109|158299598|FG000|Overall Study|Adverse Event|1|||
49126122|NCT02683109|158299599|FG001|Overall Study|Adverse Event|0|||
49126123|NCT00003537|158299602|FG000|Overall Study|Not evalauable|1|||
49126124|NCT02419807|158299603|FG000|Overall Study|Withdrawal by Subject|4|||
49126125|NCT02419807|158299603|FG000|Overall Study|Physician Decision|1|||
49126126|NCT02419807|158299603|FG000|Overall Study|Protocol Violation|5|||
49126127|NCT01065818|158299605|FG000|Overall Study|Withdrawal by Subject|1|||
49126128|NCT01065818|158299605|FG000|Overall Study|Not a candidate for surgery|1|||
49126129|NCT01309386|158299609|FG000|Overall Study|Other|2|||
49126130|NCT01309386|158299610|FG001|Overall Study|Other|0|||
48716208|NCT01317550|156811221|FG000|Overall Study|Lack of compliance study med|1|||
48813887|NCT00791921|157159994|FG000|Overall Study|Adverse Event|8|||
49126131|NCT01309386|158299609|FG000|Overall Study|Withdrawal by Subject|2|||
49126132|NCT01309386|158299610|FG001|Overall Study|Withdrawal by Subject|0|||
49126133|NCT01309386|158299609|FG000|Overall Study|Progressive disease|9|||
49126134|NCT01309386|158299610|FG001|Overall Study|Progressive disease|11|||
49126135|NCT01309386|158299609|FG000|Overall Study|Physician Decision|1|||
49126136|NCT01309386|158299610|FG001|Overall Study|Physician Decision|1|||
49126137|NCT01309386|158299609|FG000|Overall Study|Lack of Efficacy|3|||
49126138|NCT01309386|158299610|FG001|Overall Study|Lack of Efficacy|1|||
49126139|NCT01309386|158299609|FG000|Overall Study|Adverse Event|5|||
49126140|NCT01309386|158299610|FG001|Overall Study|Adverse Event|8|||
49126141|NCT02062437|158299611|FG000|Overall Study|Pt. didn't want to come for the 2y visit|31|||
49126142|NCT02062437|158299611|FG000|Overall Study|Patient not available for the 2y visit|18|||
49126143|NCT02062437|158299611|FG000|Overall Study|Death|2|||
48716209|NCT01317550|156811222|FG001|Overall Study|Lack of compliance study med|0|||
48716210|NCT01317550|156811223|FG002|Overall Study|Lack of compliance study med|0|||
48716211|NCT01317550|156811224|FG003|Overall Study|Lack of compliance study med|0|||
48716212|NCT03032380|156811226|FG000|Overall Study|Adverse Event|0|||
48716213|NCT03032380|156811227|FG001|Overall Study|Adverse Event|1|||
48716214|NCT03032380|156811226|FG000|Overall Study|Lack of Efficacy|1|||
48716215|NCT03032380|156811227|FG001|Overall Study|Lack of Efficacy|0|||
48716216|NCT03032380|156811226|FG000|Overall Study|Withdrawal by Subject|2|||
48716217|NCT03032380|156811227|FG001|Overall Study|Withdrawal by Subject|3|||
48716218|NCT03032380|156811226|FG000|Overall Study|Recovery|0|||
48716219|NCT03032380|156811227|FG001|Overall Study|Recovery|1|||
48716220|NCT03032380|156811226|FG000|Overall Study|Death|39|||
48716221|NCT03032380|156811227|FG001|Overall Study|Death|34|||
48716222|NCT03032380|156811226|FG000|Overall Study|Other - Miscellaneous|0|||
48716223|NCT03032380|156811227|FG001|Overall Study|Other - Miscellaneous|1|||
48716224|NCT00294762|156811228|FG000|Overall Study|Did not receive study treatment|3|||
48716225|NCT00294762|156811229|FG001|Overall Study|Did not receive study treatment|3|||
48716226|NCT04093024|156811232|FG000|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
48716227|NCT04093024|156811233|FG001|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
48716228|NCT04093024|156811232|FG000|Double-blind Period|Discontinued treatment due to adverse event|0|||
48716229|NCT04093024|156811233|FG001|Double-blind Period|Discontinued treatment due to adverse event|2|||
48716230|NCT04093024|156811232|FG000|Double-blind Period|Discontinued treatment due to other reason|0|||
48716231|NCT04093024|156811233|FG001|Double-blind Period|Discontinued treatment due to other reason|1|||
48716232|NCT04093024|156811232|FG000|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|0|||
48716233|NCT04093024|156811233|FG001|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|1|||
48813888|NCT00791921|157159995|FG001|Overall Study|Adverse Event|2|||
48813889|NCT00791921|157159994|FG000|Overall Study|Lack of Efficacy|0|||
48813890|NCT00791921|157159995|FG001|Overall Study|Lack of Efficacy|2|||
48813891|NCT00791921|157159994|FG000|Overall Study|Lack of study drug administration|1|||
48813892|NCT00791921|157159995|FG001|Overall Study|Lack of study drug administration|1|||
48813893|NCT00791921|157159994|FG000|Overall Study|Reason other than those above|0|||
48813894|NCT00791921|157159995|FG001|Overall Study|Reason other than those above|1|||
48813895|NCT00557622|157160005|FG000|4-Week Run-in Phase|Withdrawal by Subject|1|||
48813896|NCT00557622|157160006|FG001|4-Week Run-in Phase|Withdrawal by Subject|0|||
48813897|NCT00557622|157160005|FG000|4-Week Run-in Phase|Protocol-defined stopping criteria|1|||
48813898|NCT00557622|157160006|FG001|4-Week Run-in Phase|Protocol-defined stopping criteria|0|||
48813899|NCT00557622|157160005|FG000|12-Week Treatment Phase|Lost to Follow-up|0|||
48716234|NCT00701662|156811234|FG000|Overall Study|Lack of Efficacy|1|||
48813900|NCT00557622|157160006|FG001|12-Week Treatment Phase|Lost to Follow-up|1|||
48813901|NCT01539863|157160007|FG000|Overall Study|Lost to Follow-up|5|||
48813902|NCT01539863|157160008|FG001|Overall Study|Lost to Follow-up|4|||
48813903|NCT01468922|157160014|FG000|Overall Study|Screening failure|0|||
48813904|NCT01468922|157160015|FG001|Overall Study|Screening failure|0|||
48813905|NCT01468922|157160016|FG002|Overall Study|Screening failure|0|||
48813906|NCT01468922|157160017|FG003|Overall Study|Screening failure|0|||
48813907|NCT01468922|157160018|FG004|Overall Study|Screening failure|0|||
48813908|NCT01468922|157160019|FG005|Overall Study|Screening failure|0|||
48813909|NCT01468922|157160020|FG006|Overall Study|Screening failure|0|||
48716235|NCT01541397|156811235|FG000|Overall Study|Study ended prior to data collection|4|||
48716236|NCT01541397|156811236|FG001|Overall Study|Study ended prior to data collection|2|||
48716237|NCT02577887|156811237|FG000|Overall Study|Death|93|||
48813910|NCT01468922|157160021|FG007|Overall Study|Screening failure|0|||
48813911|NCT01468922|157160022|FG008|Overall Study|Screening failure|1|||
48813912|NCT01468922|157160014|FG000|Overall Study|Per patient choice|1|||
49126144|NCT02062437|158299611|FG000|Overall Study|Pt. couldn't come due to med. condition|1|||
49126145|NCT02515630|158299612|FG000|Overall Study|Withdrawal by Subject|5|||
49126146|NCT02515630|158299612|FG000|Overall Study|Adverse Event|4|||
49126147|NCT02515630|158299612|FG000|Overall Study|Physician Decision|4|||
49126148|NCT02515630|158299612|FG000|Overall Study|Death|2|||
49126149|NCT02515630|158299612|FG000|Overall Study|Disease Progression|1|||
49126150|NCT02976519|158299613|FG000|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
49126151|NCT02976519|158299614|FG001|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1|||
49126152|NCT02976519|158299615|FG002|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
49126153|NCT02976519|158299616|FG003|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
49126154|NCT02976519|158299617|FG004|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
49126155|NCT02976519|158299618|FG005|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
48716238|NCT02577887|156811237|FG000|Overall Study|Protocol Violation|125|||
48716239|NCT02577887|156811237|FG000|Overall Study|Withdrawal by Subject|80|||
49126156|NCT02976519|158299619|FG006|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
49126157|NCT02976519|158299613|FG000|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
49126158|NCT02976519|158299614|FG001|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
49126159|NCT02976519|158299615|FG002|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
49126160|NCT02976519|158299616|FG003|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1|||
49126161|NCT02976519|158299617|FG004|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
49126162|NCT02976519|158299618|FG005|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
49126163|NCT02976519|158299619|FG006|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
49126164|NCT02976519|158299613|FG000|Wash-out Period (Part 2 Only)|Reason not listed|0|||
49126165|NCT02976519|158299614|FG001|Wash-out Period (Part 2 Only)|Reason not listed|0|||
49126166|NCT02976519|158299615|FG002|Wash-out Period (Part 2 Only)|Reason not listed|0|||
49126167|NCT02976519|158299616|FG003|Wash-out Period (Part 2 Only)|Reason not listed|0|||
49126168|NCT02976519|158299617|FG004|Wash-out Period (Part 2 Only)|Reason not listed|0|||
49126169|NCT02976519|158299618|FG005|Wash-out Period (Part 2 Only)|Reason not listed|0|||
49126170|NCT02976519|158299619|FG006|Wash-out Period (Part 2 Only)|Reason not listed|1|||
49126171|NCT02976519|158299613|FG000|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
49126172|NCT02976519|158299614|FG001|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
49126173|NCT02976519|158299615|FG002|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
49126174|NCT02976519|158299616|FG003|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
49126175|NCT02976519|158299617|FG004|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
48716240|NCT00388583|156811245|FG000|Overall Study|Protocol Violation|1|||
48716241|NCT00388583|156811246|FG001|Overall Study|Protocol Violation|0|||
48716242|NCT00388583|156811245|FG000|Overall Study|Withdrawal by Subject|3|||
48716243|NCT00388583|156811246|FG001|Overall Study|Withdrawal by Subject|3|||
48716244|NCT00388583|156811245|FG000|Overall Study|Serious Adverse Event|2|||
48716245|NCT00388583|156811246|FG001|Overall Study|Serious Adverse Event|0|||
48716246|NCT00388583|156811245|FG000|Overall Study|Did not receive vaccine|0|||
48716247|NCT00388583|156811246|FG001|Overall Study|Did not receive vaccine|1|||
48716248|NCT02366091|156811247|FG000|Overall Study|Withdrawal by Subject|3|||
48716249|NCT02366091|156811248|FG001|Overall Study|Withdrawal by Subject|7|||
48716250|NCT02366091|156811249|FG002|Overall Study|Withdrawal by Subject|3|||
48716251|NCT02366091|156811250|FG003|Overall Study|Withdrawal by Subject|1|||
48716252|NCT02500056|156811251|FG000|Overall Study|Lost to Follow-up|3|||
48716253|NCT02500056|156811252|FG001|Overall Study|Lost to Follow-up|7|||
48716254|NCT02500056|156811251|FG000|Overall Study|Recurrence|1|||
48716255|NCT02500056|156811252|FG001|Overall Study|Recurrence|0|||
48716256|NCT02500056|156811251|FG000|Overall Study|Death|3|||
48716257|NCT02500056|156811252|FG001|Overall Study|Death|1|||
48716258|NCT02925416|156811253|FG000|Overall Study|Adverse Event|2|||
48716259|NCT02925416|156811254|FG001|Overall Study|Adverse Event|0|||
48716260|NCT01290796|156811264|FG000|Overall Study|Lost to Follow-up|21|||
48716261|NCT01290796|156811264|FG000|Overall Study|Withdrawal by Subject|4|||
48716262|NCT01290796|156811264|FG000|Overall Study|Physician Decision|2|||
48716263|NCT01290796|156811264|FG000|Overall Study|Secondary Surgical Intervention|2|||
48716264|NCT01290796|156811264|FG000|Overall Study|Withdrawal by Sponsor|1|||
48716265|NCT03087617|156811265|FG000|Overall Study|Lost to Follow-up|32|||
48716266|NCT03087617|156811266|FG001|Overall Study|Lost to Follow-up|30|||
48716267|NCT03087617|156811267|FG002|Overall Study|Lost to Follow-up|30|||
48716268|NCT03087617|156811268|FG003|Overall Study|Lost to Follow-up|39|||
48716269|NCT00065429|156811272|FG000|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
48716270|NCT00065429|156811273|FG001|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
48716271|NCT00065429|156811274|FG002|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
48716272|NCT00065429|156811275|FG003|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
48716273|NCT00065429|156811276|FG004|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
48716274|NCT00065429|156811277|FG005|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1|||
48716275|NCT00065429|156811278|FG006|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
48716276|NCT00065429|156811272|FG000|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
48716277|NCT00065429|156811273|FG001|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
48813913|NCT01468922|157160015|FG001|Overall Study|Per patient choice|0|||
48716278|NCT00065429|156811274|FG002|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1|||
48716279|NCT00065429|156811275|FG003|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
48716280|NCT00065429|156811276|FG004|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
48716281|NCT00065429|156811277|FG005|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
48813914|NCT01468922|157160016|FG002|Overall Study|Per patient choice|0|||
48813915|NCT01468922|157160017|FG003|Overall Study|Per patient choice|0|||
48813916|NCT01468922|157160018|FG004|Overall Study|Per patient choice|0|||
48813917|NCT01468922|157160019|FG005|Overall Study|Per patient choice|0|||
48813918|NCT01468922|157160020|FG006|Overall Study|Per patient choice|0|||
48813919|NCT01468922|157160021|FG007|Overall Study|Per patient choice|0|||
48813920|NCT01468922|157160022|FG008|Overall Study|Per patient choice|0|||
48813921|NCT01468922|157160014|FG000|Overall Study|Switched to alternative treatment|1|||
48813922|NCT01468922|157160015|FG001|Overall Study|Switched to alternative treatment|0|||
48716282|NCT00065429|156811278|FG006|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
49126176|NCT02976519|158299618|FG005|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
49126177|NCT02976519|158299619|FG006|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1|||
49126178|NCT02976519|158299613|FG000|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
49126179|NCT02976519|158299614|FG001|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
49126180|NCT02976519|158299615|FG002|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
49126181|NCT02976519|158299616|FG003|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
49126182|NCT02976519|158299617|FG004|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
49126183|NCT02976519|158299618|FG005|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
49126184|NCT02976519|158299619|FG006|Treatment Period 2 (Part 2 Only)|Adverse Event|1|||
49126185|NCT00095979|158299623|FG000|Overall Study|Ineligible: Second primary cancer site|2|||
49126186|NCT00785356|158299624|FG000|Overall Study|Study prematurely terminated|8|||
49126187|NCT00313846|158299625|FG000|Overall Study|Withdrawal by Subject|2|||
49126188|NCT00313846|158299626|FG001|Overall Study|Withdrawal by Subject|0|||
49126189|NCT00313846|158299625|FG000|Overall Study|Adverse Event|1|||
49126190|NCT00313846|158299626|FG001|Overall Study|Adverse Event|8|||
48813923|NCT01468922|157160016|FG002|Overall Study|Switched to alternative treatment|0|||
48813924|NCT01468922|157160017|FG003|Overall Study|Switched to alternative treatment|0|||
48813925|NCT01468922|157160018|FG004|Overall Study|Switched to alternative treatment|1|||
48813926|NCT01468922|157160019|FG005|Overall Study|Switched to alternative treatment|0|||
48813927|NCT01468922|157160020|FG006|Overall Study|Switched to alternative treatment|0|||
48813928|NCT01468922|157160021|FG007|Overall Study|Switched to alternative treatment|0|||
48813929|NCT01468922|157160022|FG008|Overall Study|Switched to alternative treatment|0|||
48813930|NCT01468922|157160014|FG000|Overall Study|Enrolled on new protocol|0|||
48813931|NCT01468922|157160015|FG001|Overall Study|Enrolled on new protocol|0|||
48813932|NCT01468922|157160016|FG002|Overall Study|Enrolled on new protocol|0|||
48813933|NCT01468922|157160017|FG003|Overall Study|Enrolled on new protocol|0|||
48813934|NCT01468922|157160018|FG004|Overall Study|Enrolled on new protocol|1|||
48813935|NCT01468922|157160019|FG005|Overall Study|Enrolled on new protocol|0|||
48813936|NCT01468922|157160020|FG006|Overall Study|Enrolled on new protocol|0|||
48813937|NCT01468922|157160021|FG007|Overall Study|Enrolled on new protocol|0|||
48813938|NCT01468922|157160022|FG008|Overall Study|Enrolled on new protocol|0|||
48813939|NCT01468922|157160014|FG000|Overall Study|Adverse Event|0|||
48813940|NCT01468922|157160015|FG001|Overall Study|Adverse Event|0|||
48813941|NCT01468922|157160016|FG002|Overall Study|Adverse Event|0|||
48813942|NCT01468922|157160017|FG003|Overall Study|Adverse Event|0|||
48813943|NCT01468922|157160018|FG004|Overall Study|Adverse Event|0|||
48813944|NCT01468922|157160019|FG005|Overall Study|Adverse Event|0|||
48716283|NCT00065429|156811272|FG000|Phase I - May 2001 - Oct 2002|Physician Decision|1|||
48813945|NCT01468922|157160020|FG006|Overall Study|Adverse Event|0|||
48813946|NCT01468922|157160021|FG007|Overall Study|Adverse Event|1|||
48813947|NCT01468922|157160022|FG008|Overall Study|Adverse Event|0|||
48813948|NCT01468922|157160014|FG000|Overall Study|Infection of blood|0|||
48813949|NCT01468922|157160015|FG001|Overall Study|Infection of blood|0|||
48813950|NCT01468922|157160016|FG002|Overall Study|Infection of blood|0|||
48813951|NCT01468922|157160017|FG003|Overall Study|Infection of blood|0|||
48813952|NCT01468922|157160018|FG004|Overall Study|Infection of blood|0|||
48716284|NCT00065429|156811273|FG001|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
48716285|NCT00065429|156811274|FG002|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
48716286|NCT00065429|156811275|FG003|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
48716287|NCT00065429|156811276|FG004|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
48716288|NCT00065429|156811277|FG005|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
48716289|NCT00065429|156811278|FG006|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
48716290|NCT00065429|156811272|FG000|Phase I - May 2001 - Oct 2002|Death|0|||
48716291|NCT00065429|156811273|FG001|Phase I - May 2001 - Oct 2002|Death|0|||
48716292|NCT00065429|156811274|FG002|Phase I - May 2001 - Oct 2002|Death|0|||
48716293|NCT00065429|156811275|FG003|Phase I - May 2001 - Oct 2002|Death|0|||
48716294|NCT00065429|156811276|FG004|Phase I - May 2001 - Oct 2002|Death|1|||
48716295|NCT00065429|156811277|FG005|Phase I - May 2001 - Oct 2002|Death|0|||
48716296|NCT00065429|156811278|FG006|Phase I - May 2001 - Oct 2002|Death|0|||
48716297|NCT00065429|156811272|FG000|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
48716298|NCT00065429|156811273|FG001|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
48716299|NCT00065429|156811274|FG002|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
48716300|NCT00065429|156811275|FG003|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
49126191|NCT00313846|158299625|FG000|Overall Study|Administrative|2|||
49126192|NCT00313846|158299626|FG001|Overall Study|Administrative|3|||
48716301|NCT00065429|156811276|FG004|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
48716302|NCT00065429|156811277|FG005|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
48813953|NCT01468922|157160019|FG005|Overall Study|Infection of blood|0|||
48813954|NCT01468922|157160020|FG006|Overall Study|Infection of blood|0|||
48813955|NCT01468922|157160021|FG007|Overall Study|Infection of blood|1|||
48813956|NCT01468922|157160022|FG008|Overall Study|Infection of blood|0|||
48813957|NCT01468922|157160014|FG000|Overall Study|Patient choice - surgery|0|||
49126193|NCT01663402|158299638|FG000|Overall Study|Randomized but not treated|19|||
49126194|NCT01663402|158299639|FG001|Overall Study|Randomized but not treated|11|||
49126195|NCT01663402|158299638|FG000|Overall Study|Adverse Event|347|||
49126196|NCT01663402|158299639|FG001|Overall Study|Adverse Event|362|||
49126197|NCT01663402|158299638|FG000|Overall Study|Two consecutive LDL-C <15 mg/dL|0|||
48716303|NCT00065429|156811278|FG006|Phase I - May 2001 - Oct 2002|Adverse Event|2|||
48716304|NCT00065429|156811272|FG000|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
48716305|NCT00065429|156811273|FG001|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
48716306|NCT00065429|156811274|FG002|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
48716307|NCT00065429|156811275|FG003|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
48716308|NCT00065429|156811276|FG004|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4|||
48716309|NCT00065429|156811277|FG005|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
48716310|NCT00065429|156811278|FG006|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
48716311|NCT00065429|156811272|FG000|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
48716312|NCT00065429|156811273|FG001|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
48716313|NCT00065429|156811274|FG002|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
48716314|NCT00065429|156811275|FG003|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
48716315|NCT00065429|156811276|FG004|Phase II - Apr 2003 - Aug 2008|Adverse Event|2|||
48716316|NCT00065429|156811277|FG005|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
48716317|NCT00065429|156811278|FG006|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
48716318|NCT00502203|156811279|FG000|Overall Study|Inevaluable|1|||
48716319|NCT00548184|156811280|FG000|Overall Study|Adverse Event|3|||
48716320|NCT00548184|156811280|FG000|Overall Study|took other drug|1|||
48716321|NCT00548184|156811280|FG000|Overall Study|Found Her2 negative|1|||
48716322|NCT00796523|156811281|FG000|Overall Study|Lost to Follow-up|9|||
48716323|NCT00796523|156811282|FG001|Overall Study|Lost to Follow-up|7|||
48716324|NCT03060551|156811283|FG000|Overall Study|Withdrawal by Subject|1|||
48716325|NCT03060551|156811283|FG000|Overall Study|Adverse Event|1|||
48813958|NCT01468922|157160015|FG001|Overall Study|Patient choice - surgery|0|||
48813959|NCT01468922|157160016|FG002|Overall Study|Patient choice - surgery|0|||
48813960|NCT01468922|157160017|FG003|Overall Study|Patient choice - surgery|0|||
48813961|NCT01468922|157160018|FG004|Overall Study|Patient choice - surgery|0|||
48813962|NCT01468922|157160019|FG005|Overall Study|Patient choice - surgery|0|||
48813963|NCT01468922|157160020|FG006|Overall Study|Patient choice - surgery|0|||
48813964|NCT01468922|157160021|FG007|Overall Study|Patient choice - surgery|1|||
48813965|NCT01468922|157160022|FG008|Overall Study|Patient choice - surgery|0|||
48813966|NCT01468922|157160014|FG000|Overall Study|Refused further treatment|0|||
48813967|NCT01468922|157160015|FG001|Overall Study|Refused further treatment|0|||
48813968|NCT01468922|157160016|FG002|Overall Study|Refused further treatment|0|||
48813969|NCT01468922|157160017|FG003|Overall Study|Refused further treatment|0|||
48813970|NCT01468922|157160018|FG004|Overall Study|Refused further treatment|0|||
48813971|NCT01468922|157160019|FG005|Overall Study|Refused further treatment|0|||
48813972|NCT01468922|157160020|FG006|Overall Study|Refused further treatment|0|||
48813973|NCT01468922|157160021|FG007|Overall Study|Refused further treatment|1|||
48813974|NCT01468922|157160022|FG008|Overall Study|Refused further treatment|0|||
48813975|NCT04848662|157160023|FG000|Period 2 (Second Treatment Intervention)|Physician Decision|1|||
48813976|NCT04848662|157160024|FG001|Period 2 (Second Treatment Intervention)|Physician Decision|0|||
48813977|NCT02226172|157160027|FG000|Overall Study|Participant refused further follow-up|4|||
48813978|NCT02226172|157160027|FG000|Overall Study|Other|5|||
48813979|NCT02226172|157160027|FG000|Overall Study|Death|1|||
48813980|NCT02226172|157160027|FG000|Overall Study|Study terminated by sponsor|1|||
48813981|NCT02226172|157160027|FG000|Overall Study|Adverse Event|6|||
48716326|NCT02929498|156811284|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3|||
48716327|NCT02929498|156811285|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
48716328|NCT02929498|156811286|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
48716329|NCT02929498|156811284|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Death|2|||
48716330|NCT02929498|156811285|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
48716331|NCT02929498|156811286|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
48716332|NCT00870584|156811289|FG000|Overall Study|Adverse Event|3|||
48716333|NCT00870584|156811290|FG001|Overall Study|Adverse Event|3|||
48716334|NCT00870584|156811289|FG000|Overall Study|Withdrawal by Subject|6|||
48716335|NCT00870584|156811290|FG001|Overall Study|Withdrawal by Subject|7|||
48716336|NCT00870584|156811289|FG000|Overall Study|Lost to Follow-up|5|||
48716337|NCT00870584|156811290|FG001|Overall Study|Lost to Follow-up|1|||
48716338|NCT00870584|156811289|FG000|Overall Study|Protocol Deviation|2|||
48716339|NCT00870584|156811290|FG001|Overall Study|Protocol Deviation|2|||
48813982|NCT01729728|157160028|FG000|Overall Study|Adverse Event|0|||
48813983|NCT01729728|157160029|FG001|Overall Study|Adverse Event|6|||
48716340|NCT01028300|156811291|FG000|Overall Study|Study Terminated|4|||
48716341|NCT02730793|156811295|FG000|Overall Study|Physician Decision|0|||
48716342|NCT02730793|156811296|FG001|Overall Study|Physician Decision|1|||
48716343|NCT02730793|156811295|FG000|Overall Study|Withdrawal by Subject|0|||
48716344|NCT02730793|156811296|FG001|Overall Study|Withdrawal by Subject|1|||
48716345|NCT01284491|156811297|FG000|Overall Study|Study termination|13|||
48813984|NCT01729728|157160030|FG002|Overall Study|Adverse Event|0|||
48813985|NCT01729728|157160028|FG000|Overall Study|Protocol Violation|1|||
48813986|NCT01729728|157160029|FG001|Overall Study|Protocol Violation|0|||
49126198|NCT01663402|158299639|FG001|Overall Study|Two consecutive LDL-C <15 mg/dL|730|||
48716346|NCT01978938|156811301|FG000|Overall Study|Lost to Follow-up|12|||
48716347|NCT01978938|156811302|FG001|Overall Study|Lost to Follow-up|6|||
48716348|NCT01978938|156811301|FG000|Overall Study|Withdrawal by Subject|8|||
48716349|NCT01978938|156811302|FG001|Overall Study|Withdrawal by Subject|4|||
48716350|NCT01978938|156811301|FG000|Overall Study|Adverse Event, non-fatal|2|||
48716351|NCT01978938|156811302|FG001|Overall Study|Adverse Event, non-fatal|1|||
48716352|NCT01978938|156811301|FG000|Overall Study|Participant noncompliance|1|||
48716353|NCT01978938|156811302|FG001|Overall Study|Participant noncompliance|1|||
48716354|NCT01978938|156811301|FG000|Overall Study|Did not meet inclusion criteria|0|||
48716355|NCT01978938|156811302|FG001|Overall Study|Did not meet inclusion criteria|1|||
48716356|NCT01978938|156811301|FG000|Overall Study|Previously scheduled procedure|0|||
48716357|NCT01978938|156811302|FG001|Overall Study|Previously scheduled procedure|1|||
48716358|NCT02520089|156811309|FG000|Overall Study|Lost to Follow-up|3|||
48716359|NCT02520089|156811310|FG001|Overall Study|Lost to Follow-up|4|||
48716360|NCT03658876|156813475|FG000|Overall Study|Protocol Violation|3|||
48716361|NCT03658876|156813476|FG001|Overall Study|Protocol Violation|2|||
49126199|NCT01663402|158299638|FG000|Overall Study|Poor compliance to protocol|529|||
49126200|NCT01663402|158299639|FG001|Overall Study|Poor compliance to protocol|454|||
49126201|NCT01663402|158299638|FG000|Overall Study|Physician Decision|77|||
49126202|NCT01663402|158299639|FG001|Overall Study|Physician Decision|62|||
49126203|NCT01663402|158299638|FG000|Overall Study|Site terminated by sponsor|1|||
49126204|NCT01663402|158299639|FG001|Overall Study|Site terminated by sponsor|3|||
49126205|NCT01663402|158299638|FG000|Overall Study|Participant moved|139|||
49126206|NCT01663402|158299639|FG001|Overall Study|Participant moved|104|||
49126207|NCT01663402|158299638|FG000|Overall Study|Withdrawal by Subject|118|||
49126208|NCT01663402|158299639|FG001|Overall Study|Withdrawal by Subject|91|||
49126209|NCT01663402|158299638|FG000|Overall Study|Related to study drug administration|96|||
49126210|NCT01663402|158299639|FG001|Overall Study|Related to study drug administration|105|||
48716362|NCT03658876|156813475|FG000|Overall Study|Withdrawal by Subject|2|||
48716363|NCT03658876|156813476|FG001|Overall Study|Withdrawal by Subject|0|||
48716364|NCT03658876|156813475|FG000|Overall Study|Death|0|||
48716365|NCT03658876|156813476|FG001|Overall Study|Death|1|||
48716366|NCT03658876|156813475|FG000|Overall Study|Intercurrent illness|6|||
48716367|NCT03658876|156813476|FG001|Overall Study|Intercurrent illness|4|||
49126211|NCT01663402|158299638|FG000|Overall Study|Lost to Follow-up|17|||
49126212|NCT01663402|158299639|FG001|Overall Study|Lost to Follow-up|15|||
49126213|NCT01663402|158299638|FG000|Overall Study|Other than specified above|172|||
49126214|NCT01663402|158299639|FG001|Overall Study|Other than specified above|147|||
49126215|NCT01774591|158299642|FG000|Overall Study|Physician Decision|1|||
49126216|NCT01774591|158299643|FG001|Overall Study|Physician Decision|1|||
49126217|NCT01774591|158299642|FG000|Overall Study|Withdrawal by Subject|0|||
49126218|NCT01774591|158299643|FG001|Overall Study|Withdrawal by Subject|1|||
49126219|NCT01774591|158299642|FG000|Overall Study|Adverse Event|0|||
49126220|NCT01774591|158299643|FG001|Overall Study|Adverse Event|2|||
49126221|NCT00274742|158299644|FG000|Overall Study|Adverse Event|0|||
49126222|NCT00274742|158299645|FG001|Overall Study|Adverse Event|4|||
49126223|NCT00274742|158299646|FG002|Overall Study|Adverse Event|1|||
49126224|NCT00274742|158299647|FG003|Overall Study|Adverse Event|4|||
49126225|NCT00274742|158299648|FG004|Overall Study|Adverse Event|12|||
49126226|NCT00274742|158299649|FG005|Overall Study|Adverse Event|3|||
48716368|NCT03658876|156813475|FG000|Overall Study|Transplantation/other operation|1|||
48716369|NCT03658876|156813476|FG001|Overall Study|Transplantation/other operation|5|||
48716370|NCT03751657|156813477|FG000|Overall Study|Physician Decision|0|||
48716371|NCT03751657|156813478|FG001|Overall Study|Physician Decision|1|||
48716372|NCT03751657|156813477|FG000|Overall Study|Withdrawal by Subject|1|||
48716373|NCT03751657|156813478|FG001|Overall Study|Withdrawal by Subject|1|||
48716374|NCT03751657|156813477|FG000|Overall Study|Lost to Follow-up|2|||
48716375|NCT03751657|156813478|FG001|Overall Study|Lost to Follow-up|1|||
48716376|NCT02255435|156813479|FG000|Overall Study|Patient's Limited Time Availability|0|||
48716377|NCT02255435|156813480|FG001|Overall Study|Patient's Limited Time Availability|0|||
48716378|NCT02255435|156813481|FG002|Overall Study|Patient's Limited Time Availability|0|||
48813987|NCT01729728|157160030|FG002|Overall Study|Protocol Violation|1|||
48716379|NCT02255435|156813482|FG003|Overall Study|Patient's Limited Time Availability|0|||
48716380|NCT02255435|156813483|FG004|Overall Study|Patient's Limited Time Availability|0|||
48716381|NCT02255435|156813484|FG005|Overall Study|Patient's Limited Time Availability|0|||
48716382|NCT02255435|156813485|FG006|Overall Study|Patient's Limited Time Availability|0|||
48716383|NCT02255435|156813486|FG007|Overall Study|Patient's Limited Time Availability|1|||
48716384|NCT02255435|156813487|FG008|Overall Study|Patient's Limited Time Availability|0|||
48813988|NCT01536145|157160036|FG000|Overall Study|Progressive disease|3|||
48813989|NCT01536145|157160037|FG001|Overall Study|Progressive disease|4|||
49126227|NCT00274742|158299644|FG000|Overall Study|Lost to Follow-up|0|||
49126228|NCT00274742|158299645|FG001|Overall Study|Lost to Follow-up|0|||
49126229|NCT00274742|158299646|FG002|Overall Study|Lost to Follow-up|0|||
49126230|NCT00274742|158299647|FG003|Overall Study|Lost to Follow-up|0|||
49126231|NCT00274742|158299648|FG004|Overall Study|Lost to Follow-up|1|||
48813990|NCT01536145|157160038|FG002|Overall Study|Progressive disease|1|||
48813991|NCT01536145|157160039|FG003|Overall Study|Progressive disease|2|||
48813992|NCT01536145|157160040|FG004|Overall Study|Progressive disease|1|||
48813993|NCT01536145|157160041|FG005|Overall Study|Progressive disease|2|||
48813994|NCT01536145|157160042|FG006|Overall Study|Progressive disease|1|||
48813995|NCT01536145|157160043|FG007|Overall Study|Progressive disease|2|||
48813996|NCT01536145|157160044|FG008|Overall Study|Progressive disease|1|||
48813997|NCT01536145|157160045|FG009|Overall Study|Progressive disease|3|||
48813998|NCT01536145|157160046|FG010|Overall Study|Progressive disease|3|||
48813999|NCT01536145|157160036|FG000|Overall Study|Withdrawal by Subject|0|||
48814000|NCT01536145|157160037|FG001|Overall Study|Withdrawal by Subject|0|||
48814001|NCT01536145|157160038|FG002|Overall Study|Withdrawal by Subject|1|||
48814002|NCT01536145|157160039|FG003|Overall Study|Withdrawal by Subject|0|||
48814003|NCT01536145|157160040|FG004|Overall Study|Withdrawal by Subject|0|||
48814004|NCT01536145|157160041|FG005|Overall Study|Withdrawal by Subject|1|||
48814005|NCT01536145|157160042|FG006|Overall Study|Withdrawal by Subject|0|||
48814006|NCT01536145|157160043|FG007|Overall Study|Withdrawal by Subject|0|||
48814007|NCT01536145|157160044|FG008|Overall Study|Withdrawal by Subject|2|||
48814008|NCT01536145|157160045|FG009|Overall Study|Withdrawal by Subject|0|||
48814009|NCT01536145|157160046|FG010|Overall Study|Withdrawal by Subject|2|||
48814010|NCT01536145|157160036|FG000|Overall Study|Other|0|||
48716385|NCT02255435|156813488|FG009|Overall Study|Patient's Limited Time Availability|0|||
48716386|NCT02255435|156813479|FG000|Overall Study|Withdrawal by Subject|0|||
48716387|NCT02255435|156813480|FG001|Overall Study|Withdrawal by Subject|0|||
48716388|NCT02255435|156813481|FG002|Overall Study|Withdrawal by Subject|0|||
48716389|NCT02255435|156813482|FG003|Overall Study|Withdrawal by Subject|0|||
48716390|NCT02255435|156813483|FG004|Overall Study|Withdrawal by Subject|0|||
48716391|NCT02255435|156813484|FG005|Overall Study|Withdrawal by Subject|0|||
48716392|NCT02255435|156813485|FG006|Overall Study|Withdrawal by Subject|0|||
48716393|NCT02255435|156813486|FG007|Overall Study|Withdrawal by Subject|0|||
48716394|NCT02255435|156813487|FG008|Overall Study|Withdrawal by Subject|1|||
48716395|NCT02255435|156813488|FG009|Overall Study|Withdrawal by Subject|4|||
48716396|NCT02255435|156813479|FG000|Overall Study|Administrative reasons|0|||
48716397|NCT02255435|156813480|FG001|Overall Study|Administrative reasons|0|||
48716398|NCT02255435|156813481|FG002|Overall Study|Administrative reasons|0|||
48716399|NCT02255435|156813482|FG003|Overall Study|Administrative reasons|0|||
48716400|NCT02255435|156813483|FG004|Overall Study|Administrative reasons|0|||
48716401|NCT02255435|156813484|FG005|Overall Study|Administrative reasons|0|||
48716402|NCT02255435|156813485|FG006|Overall Study|Administrative reasons|0|||
48716403|NCT02255435|156813486|FG007|Overall Study|Administrative reasons|0|||
48716404|NCT02255435|156813487|FG008|Overall Study|Administrative reasons|0|||
48716405|NCT02255435|156813488|FG009|Overall Study|Administrative reasons|2|||
48716406|NCT01239992|156813489|FG000|Overall Study|Withdrawal by Subject|2|||
48716407|NCT02810444|156813490|FG000|Overall Study|Screen Failures|14|||
48716408|NCT02810444|156813490|FG000|Overall Study|Withdrawal by Subject|4|||
48716409|NCT02810444|156813490|FG000|Overall Study|Adverse Event|3|||
48716410|NCT02880956|156813502|FG000|Overall Study|Adverse Event|3|||
48716411|NCT02880956|156813503|FG001|Overall Study|Adverse Event|6|||
48716412|NCT02880956|156813504|FG002|Overall Study|Adverse Event|5|||
48716413|NCT02880956|156813505|FG003|Overall Study|Adverse Event|4|||
48716414|NCT02880956|156813502|FG000|Overall Study|Withdrawal by Subject|9|||
48716415|NCT02880956|156813503|FG001|Overall Study|Withdrawal by Subject|4|||
48716416|NCT02880956|156813504|FG002|Overall Study|Withdrawal by Subject|6|||
48716417|NCT02880956|156813505|FG003|Overall Study|Withdrawal by Subject|11|||
48716418|NCT02880956|156813502|FG000|Overall Study|Lost to Follow-up|0|||
48716419|NCT02880956|156813503|FG001|Overall Study|Lost to Follow-up|1|||
48716420|NCT02880956|156813504|FG002|Overall Study|Lost to Follow-up|0|||
48716421|NCT02880956|156813505|FG003|Overall Study|Lost to Follow-up|0|||
48716422|NCT02880956|156813502|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
48716423|NCT02880956|156813503|FG001|Overall Study|COVID-19 Logistical Restrictions|2|||
48716424|NCT02880956|156813504|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
48716425|NCT02880956|156813505|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
48716426|NCT02880956|156813502|FG000|Overall Study|Other, Not Specified|4|||
48716427|NCT02880956|156813503|FG001|Overall Study|Other, Not Specified|2|||
48716428|NCT02880956|156813504|FG002|Overall Study|Other, Not Specified|0|||
48814011|NCT01536145|157160037|FG001|Overall Study|Other|0|||
48814012|NCT01536145|157160038|FG002|Overall Study|Other|0|||
48814013|NCT01536145|157160039|FG003|Overall Study|Other|0|||
48814014|NCT01536145|157160040|FG004|Overall Study|Other|1|||
48716429|NCT02880956|156813505|FG003|Overall Study|Other, Not Specified|3|||
48716430|NCT00363545|156813506|FG000|Overall Study|Serious Adverse Event|0|||
48716431|NCT00363545|156813507|FG001|Overall Study|Serious Adverse Event|1|||
48716432|NCT00363545|156813506|FG000|Overall Study|Withdrawal by Subject|12|||
48716433|NCT00363545|156813507|FG001|Overall Study|Withdrawal by Subject|15|||
48814015|NCT01536145|157160041|FG005|Overall Study|Other|0|||
48814016|NCT01536145|157160042|FG006|Overall Study|Other|0|||
48814017|NCT01536145|157160043|FG007|Overall Study|Other|0|||
48814018|NCT01536145|157160044|FG008|Overall Study|Other|0|||
48716434|NCT00363545|156813506|FG000|Overall Study|Migrated/moved from study area|3|||
48716435|NCT00363545|156813507|FG001|Overall Study|Migrated/moved from study area|6|||
48716436|NCT00363545|156813506|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|14|||
48716437|NCT00363545|156813507|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|18|||
48716438|NCT00363545|156813506|FG000|Overall Study|Lost to follow-up (complete vaccination)|14|||
48716439|NCT00363545|156813507|FG001|Overall Study|Lost to follow-up (complete vaccination)|17|||
48814019|NCT01536145|157160045|FG009|Overall Study|Other|3|||
48814020|NCT01536145|157160046|FG010|Overall Study|Other|2|||
48814021|NCT01536145|157160036|FG000|Overall Study|Death|0|||
48814022|NCT01536145|157160037|FG001|Overall Study|Death|0|||
48814023|NCT01536145|157160038|FG002|Overall Study|Death|0|||
48814024|NCT01536145|157160039|FG003|Overall Study|Death|0|||
48814025|NCT01536145|157160040|FG004|Overall Study|Death|0|||
48814026|NCT01536145|157160041|FG005|Overall Study|Death|0|||
48814027|NCT01536145|157160042|FG006|Overall Study|Death|1|||
48814028|NCT01536145|157160043|FG007|Overall Study|Death|0|||
48814029|NCT01536145|157160044|FG008|Overall Study|Death|0|||
48814030|NCT01536145|157160045|FG009|Overall Study|Death|0|||
48814031|NCT01536145|157160046|FG010|Overall Study|Death|0|||
48814032|NCT01536145|157160036|FG000|Overall Study|Adverse Event|0|||
48814033|NCT01536145|157160037|FG001|Overall Study|Adverse Event|0|||
48814034|NCT01536145|157160038|FG002|Overall Study|Adverse Event|0|||
48814035|NCT01536145|157160039|FG003|Overall Study|Adverse Event|0|||
48814036|NCT01536145|157160040|FG004|Overall Study|Adverse Event|0|||
48814037|NCT01536145|157160041|FG005|Overall Study|Adverse Event|0|||
48814038|NCT01536145|157160042|FG006|Overall Study|Adverse Event|0|||
48814039|NCT01536145|157160043|FG007|Overall Study|Adverse Event|2|||
48814040|NCT01536145|157160044|FG008|Overall Study|Adverse Event|0|||
48814041|NCT01536145|157160045|FG009|Overall Study|Adverse Event|0|||
48814042|NCT01536145|157160046|FG010|Overall Study|Adverse Event|3|||
48716440|NCT00363545|156813506|FG000|Overall Study|Others|1|||
49126232|NCT00274742|158299649|FG005|Overall Study|Lost to Follow-up|0|||
49126233|NCT00274742|158299644|FG000|Overall Study|End of Study|0|||
49126234|NCT00274742|158299645|FG001|Overall Study|End of Study|0|||
49126235|NCT00274742|158299646|FG002|Overall Study|End of Study|0|||
49126236|NCT00274742|158299647|FG003|Overall Study|End of Study|1|||
48814043|NCT03151395|157160047|FG000|Overall Study|Adverse Event|2|||
48814044|NCT03151395|157160047|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
48814045|NCT03151395|157160047|FG000|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3|||
48814046|NCT03151395|157160047|FG000|Overall Study|Unspecified reason|4|||
48814047|NCT04827134|157160051|FG000|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
48814048|NCT04827134|157160052|FG001|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
48814049|NCT04827134|157160053|FG002|Treatment Period 1 (1 Day)|Withdrawal by Subject|1|||
48814050|NCT04827134|157160054|FG003|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
48814051|NCT03125941|157160056|FG000|Overall Study|did not receive intervention|1|||
49126237|NCT00274742|158299648|FG004|Overall Study|End of Study|0|||
49126238|NCT00274742|158299649|FG005|Overall Study|End of Study|0|||
49126239|NCT00274742|158299644|FG000|Overall Study|Disease Progression|0|||
48716441|NCT00363545|156813507|FG001|Overall Study|Others|0|||
48716442|NCT00966875|156813511|FG000|Part A|Adverse Event|2|||
48716443|NCT00966875|156813512|FG001|Part A|Adverse Event|1|||
48716444|NCT00966875|156813513|FG002|Part A|Adverse Event|0|||
48716445|NCT00966875|156813514|FG003|Part A|Adverse Event|1|||
49126240|NCT00274742|158299645|FG001|Overall Study|Disease Progression|1|||
49126241|NCT00274742|158299646|FG002|Overall Study|Disease Progression|1|||
49126242|NCT00274742|158299647|FG003|Overall Study|Disease Progression|0|||
49126243|NCT00274742|158299648|FG004|Overall Study|Disease Progression|1|||
49126244|NCT00274742|158299649|FG005|Overall Study|Disease Progression|0|||
49126245|NCT00274742|158299644|FG000|Overall Study|Other|0|||
48716446|NCT00966875|156813515|FG004|Part A|Adverse Event|0|||
48716447|NCT00966875|156813516|FG005|Part A|Adverse Event|1|||
48716448|NCT00966875|156813517|FG006|Part A|Adverse Event|0|||
48716449|NCT00966875|156813518|FG007|Part A|Adverse Event|3|||
48716450|NCT00966875|156813519|FG008|Part A|Adverse Event|3|||
48716451|NCT00966875|156813511|FG000|Part A|Entry Criteria|0|||
48716452|NCT00966875|156813512|FG001|Part A|Entry Criteria|0|||
48716453|NCT00966875|156813513|FG002|Part A|Entry Criteria|0|||
49126246|NCT00274742|158299645|FG001|Overall Study|Other|3|||
48716454|NCT00966875|156813514|FG003|Part A|Entry Criteria|0|||
48716455|NCT00966875|156813515|FG004|Part A|Entry Criteria|0|||
48814052|NCT03125941|157160057|FG001|Overall Study|did not receive intervention|2|||
48814053|NCT00734214|157160058|FG000|Overall Study|Withdrawal by Subject|3|||
48814054|NCT00734214|157160059|FG001|Overall Study|Withdrawal by Subject|4|||
48814055|NCT00734214|157160058|FG000|Overall Study|MD withdrawal|1|||
48814056|NCT00734214|157160059|FG001|Overall Study|MD withdrawal|0|||
48814057|NCT01630590|157160062|FG000|Overall Study|Adverse Event|9|||
48814058|NCT01630590|157160062|FG000|Overall Study|Lack of Efficacy|37|||
48814059|NCT01630590|157160062|FG000|Overall Study|Withdrawal by Subject|4|||
49126247|NCT00274742|158299646|FG002|Overall Study|Other|0|||
49126248|NCT00274742|158299647|FG003|Overall Study|Other|0|||
48814060|NCT01630590|157160062|FG000|Overall Study|2nd primary tumor|2|||
48814061|NCT01630590|157160062|FG000|Overall Study|Automobile accident|1|||
48814062|NCT01630590|157160062|FG000|Overall Study|Maximum benefit|4|||
48814063|NCT01551303|157160063|FG000|Overall Study|failed awareness check on vision test|4|||
48814064|NCT01551303|157160064|FG001|Overall Study|failed awareness check on vision test|7|||
48814065|NCT00211237|157160068|FG000|Baseline|Withdrew|1|||
48814066|NCT00211237|157160069|FG001|Baseline|Withdrew|3|||
48814067|NCT00211237|157160070|FG002|Baseline|Withdrew|0|||
48814068|NCT00211237|157160068|FG000|Baseline|Refused random assignment|1|||
48814069|NCT00211237|157160069|FG001|Baseline|Refused random assignment|0|||
48814070|NCT00211237|157160070|FG002|Baseline|Refused random assignment|0|||
48814071|NCT00211237|157160068|FG000|1 Month|Death|2|||
48814072|NCT00211237|157160069|FG001|1 Month|Death|1|||
48814073|NCT00211237|157160070|FG002|1 Month|Death|0|||
48814074|NCT00211237|157160068|FG000|1 Month|Lost to Follow-up|0|||
48814075|NCT00211237|157160069|FG001|1 Month|Lost to Follow-up|2|||
48814076|NCT00211237|157160070|FG002|1 Month|Lost to Follow-up|0|||
48814077|NCT00211237|157160068|FG000|1 Month|Withdrew|0|||
48814078|NCT00211237|157160069|FG001|1 Month|Withdrew|4|||
48814079|NCT00211237|157160070|FG002|1 Month|Withdrew|0|||
48814080|NCT00211237|157160068|FG000|1 Month|Additional surgery needed|1|||
48814081|NCT00211237|157160069|FG001|1 Month|Additional surgery needed|0|||
48814082|NCT00211237|157160070|FG002|1 Month|Additional surgery needed|0|||
48814083|NCT00211237|157160068|FG000|1 Month|Non-medical problem|0|||
48814084|NCT00211237|157160069|FG001|1 Month|Non-medical problem|2|||
48814085|NCT00211237|157160070|FG002|1 Month|Non-medical problem|0|||
48814086|NCT00211237|157160068|FG000|3 Months|Death|7|||
48814087|NCT00211237|157160069|FG001|3 Months|Death|3|||
48814088|NCT00211237|157160070|FG002|3 Months|Death|0|||
48814089|NCT00211237|157160068|FG000|3 Months|Could not comply with protocol|1|||
48814090|NCT00211237|157160069|FG001|3 Months|Could not comply with protocol|0|||
48814091|NCT00211237|157160070|FG002|3 Months|Could not comply with protocol|0|||
48814092|NCT00211237|157160068|FG000|3 Months|Withdrew|0|||
48814093|NCT00211237|157160069|FG001|3 Months|Withdrew|1|||
48814094|NCT00211237|157160070|FG002|3 Months|Withdrew|0|||
48814095|NCT00211237|157160068|FG000|3 Months|Non-medical problem|0|||
48814096|NCT00211237|157160069|FG001|3 Months|Non-medical problem|0|||
48814097|NCT00211237|157160070|FG002|3 Months|Non-medical problem|1|||
48814098|NCT00211237|157160068|FG000|6 Months|Death|6|||
48814099|NCT00211237|157160069|FG001|6 Months|Death|0|||
48814100|NCT00211237|157160070|FG002|6 Months|Death|3|||
48814101|NCT00211237|157160068|FG000|6 Months|Lost to Follow-up|2|||
48716456|NCT00966875|156813516|FG005|Part A|Entry Criteria|2|||
48716457|NCT00966875|156813517|FG006|Part A|Entry Criteria|0|||
48716458|NCT00966875|156813518|FG007|Part A|Entry Criteria|0|||
48716459|NCT00966875|156813519|FG008|Part A|Entry Criteria|0|||
48716460|NCT00966875|156813511|FG000|Part A|Lack of Efficacy|0|||
48716461|NCT00966875|156813512|FG001|Part A|Lack of Efficacy|1|||
48716462|NCT00966875|156813513|FG002|Part A|Lack of Efficacy|0|||
48716463|NCT00966875|156813514|FG003|Part A|Lack of Efficacy|0|||
48716464|NCT00966875|156813515|FG004|Part A|Lack of Efficacy|0|||
48716465|NCT00966875|156813516|FG005|Part A|Lack of Efficacy|0|||
48716466|NCT00966875|156813517|FG006|Part A|Lack of Efficacy|4|||
48716467|NCT00966875|156813518|FG007|Part A|Lack of Efficacy|0|||
48716468|NCT00966875|156813519|FG008|Part A|Lack of Efficacy|0|||
48716469|NCT00966875|156813511|FG000|Part A|Lost to Follow-up|2|||
48716470|NCT00966875|156813512|FG001|Part A|Lost to Follow-up|0|||
48716471|NCT00966875|156813513|FG002|Part A|Lost to Follow-up|0|||
48716472|NCT00966875|156813514|FG003|Part A|Lost to Follow-up|0|||
48716473|NCT00966875|156813515|FG004|Part A|Lost to Follow-up|0|||
48716474|NCT00966875|156813516|FG005|Part A|Lost to Follow-up|1|||
49126249|NCT00274742|158299648|FG004|Overall Study|Other|2|||
49126250|NCT00274742|158299649|FG005|Overall Study|Other|0|||
49126251|NCT00731822|158299650|FG000|Overall Study|Adverse Event|2|||
49126252|NCT00731822|158299651|FG001|Overall Study|Adverse Event|1|||
48814102|NCT00211237|157160069|FG001|6 Months|Lost to Follow-up|0|||
48716475|NCT00966875|156813517|FG006|Part A|Lost to Follow-up|0|||
48814103|NCT00211237|157160070|FG002|6 Months|Lost to Follow-up|0|||
48814104|NCT00211237|157160068|FG000|6 Months|Could not comply with protocol|0|||
48814105|NCT00211237|157160069|FG001|6 Months|Could not comply with protocol|2|||
48814106|NCT00211237|157160070|FG002|6 Months|Could not comply with protocol|0|||
48716476|NCT00966875|156813518|FG007|Part A|Lost to Follow-up|0|||
48814107|NCT00211237|157160068|FG000|12 Months|Death|8|||
48814108|NCT00211237|157160069|FG001|12 Months|Death|2|||
48814109|NCT00211237|157160070|FG002|12 Months|Death|3|||
48814110|NCT00211237|157160068|FG000|12 Months|Lost to Follow-up|1|||
48716477|NCT00966875|156813519|FG008|Part A|Lost to Follow-up|0|||
48716478|NCT00966875|156813511|FG000|Part A|Parent/Caregiver Decision|0|||
48716479|NCT00966875|156813512|FG001|Part A|Parent/Caregiver Decision|0|||
48716480|NCT00966875|156813513|FG002|Part A|Parent/Caregiver Decision|0|||
48716481|NCT00966875|156813514|FG003|Part A|Parent/Caregiver Decision|1|||
48814111|NCT00211237|157160069|FG001|12 Months|Lost to Follow-up|0|||
48814112|NCT00211237|157160070|FG002|12 Months|Lost to Follow-up|1|||
48814113|NCT00211237|157160068|FG000|12 Months|Withdrew|0|||
48814114|NCT00211237|157160069|FG001|12 Months|Withdrew|0|||
48814115|NCT00211237|157160070|FG002|12 Months|Withdrew|1|||
48814116|NCT00211237|157160068|FG000|12 Months|unrelated medical problem|0|||
48814117|NCT00211237|157160069|FG001|12 Months|unrelated medical problem|0|||
48814118|NCT00211237|157160070|FG002|12 Months|unrelated medical problem|1|||
48814119|NCT01464255|157160075|FG000|Overall Study|unresolve corneal staining|0|||
48814120|NCT01464255|157160076|FG001|Overall Study|unresolve corneal staining|1|||
48814121|NCT02743793|157160083|FG000|Overall Study|Death|1|||
48814122|NCT02743793|157160084|FG001|Overall Study|Death|1|||
48814123|NCT02743793|157160083|FG000|Overall Study|Withdrawal by Subject|0|||
48814124|NCT02743793|157160084|FG001|Overall Study|Withdrawal by Subject|1|||
48814125|NCT02743793|157160083|FG000|Overall Study|Screen Failure|4|||
48814126|NCT02743793|157160084|FG001|Overall Study|Screen Failure|0|||
48814127|NCT02743793|157160083|FG000|Overall Study|No Primary Care Physician|0|||
48814128|NCT02743793|157160084|FG001|Overall Study|No Primary Care Physician|1|||
48814129|NCT02743793|157160083|FG000|Overall Study|Travel/remote visits could not be performed at nursing facility|0|||
48814130|NCT02743793|157160084|FG001|Overall Study|Travel/remote visits could not be performed at nursing facility|1|||
48814131|NCT02743793|157160083|FG000|Overall Study|Study stopped due to COVID-19 pandemic|0|||
48814132|NCT02743793|157160084|FG001|Overall Study|Study stopped due to COVID-19 pandemic|32|||
48814133|NCT04276090|157160088|FG000|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|1|||
48814134|NCT04276090|157160089|FG001|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|0|||
48814135|NCT01951092|157160093|FG000|Overall Study|Lost to Follow-up|10|||
48814136|NCT01951092|157160093|FG000|Overall Study|Incarceration|1|||
48814137|NCT01951092|157160093|FG000|Overall Study|Transfer of Care|1|||
48814138|NCT03714022|157160097|FG000|Overall Study|Adverse Event|1|||
48814139|NCT03714022|157160098|FG001|Overall Study|Adverse Event|0|||
48814140|NCT03714022|157160097|FG000|Overall Study|Consent withdrawal|0|||
48814141|NCT03714022|157160098|FG001|Overall Study|Consent withdrawal|1|||
49126253|NCT00731822|158299650|FG000|Overall Study|Protocol Violation|1|||
49126254|NCT00731822|158299651|FG001|Overall Study|Protocol Violation|0|||
49126255|NCT00731822|158299650|FG000|Overall Study|Lost to Follow-up|1|||
49126256|NCT00731822|158299651|FG001|Overall Study|Lost to Follow-up|0|||
49126257|NCT03585270|158299652|FG000|Overall Study|Withdrawal by Subject|2|||
49126258|NCT03585270|158299653|FG001|Overall Study|Withdrawal by Subject|6|||
49126259|NCT03585270|158299652|FG000|Overall Study|Withdrawal by proxy/legal representative|1|||
49126260|NCT03585270|158299653|FG001|Overall Study|Withdrawal by proxy/legal representative|0|||
49126261|NCT03585270|158299652|FG000|Overall Study|Adverse Event|5|||
49126262|NCT03585270|158299653|FG001|Overall Study|Adverse Event|2|||
49126263|NCT03585270|158299652|FG000|Overall Study|Lost to Follow-up|1|||
49126264|NCT03585270|158299653|FG001|Overall Study|Lost to Follow-up|4|||
49126265|NCT03585270|158299652|FG000|Overall Study|Death|5|||
49126266|NCT03585270|158299653|FG001|Overall Study|Death|3|||
49126267|NCT03585270|158299652|FG000|Overall Study|Other reasons|2|||
49126268|NCT03585270|158299653|FG001|Overall Study|Other reasons|2|||
49126269|NCT01802385|158299654|FG000|Overall Study|Death|106|||
49126270|NCT01802385|158299655|FG001|Overall Study|Death|120|||
49126271|NCT03786380|158299656|FG000|Overall Study|Adverse Event|1|||
49126272|NCT03786380|158299657|FG001|Overall Study|Adverse Event|0|||
49126273|NCT03786380|158299658|FG002|Overall Study|Adverse Event|0|||
49126274|NCT03786380|158299659|FG003|Overall Study|Adverse Event|3|||
49126275|NCT03786380|158299660|FG004|Overall Study|Adverse Event|1|||
49126276|NCT03786380|158299656|FG000|Overall Study|Lack of Efficacy|0|||
49126277|NCT03786380|158299657|FG001|Overall Study|Lack of Efficacy|0|||
49126278|NCT03786380|158299658|FG002|Overall Study|Lack of Efficacy|0|||
49126279|NCT03786380|158299659|FG003|Overall Study|Lack of Efficacy|0|||
49126280|NCT03786380|158299660|FG004|Overall Study|Lack of Efficacy|1|||
48814142|NCT03714022|157160097|FG000|Overall Study|Lost to Follow-up|3|||
48814143|NCT03714022|157160098|FG001|Overall Study|Lost to Follow-up|2|||
48814144|NCT01018563|157160101|FG000|Overall Study|Termination of the study by Sponsor|2|||
48814145|NCT01018563|157160102|FG001|Overall Study|Termination of the study by Sponsor|1|||
48814146|NCT02294474|157160103|FG000|Overall Study|Adverse Event|7|||
48814147|NCT02294474|157160104|FG001|Overall Study|Adverse Event|7|||
48814148|NCT02294474|157160103|FG000|Overall Study|Lack of Efficacy|2|||
49126281|NCT03786380|158299656|FG000|Overall Study|Withdrawal by Subject|1|||
48814149|NCT02294474|157160104|FG001|Overall Study|Lack of Efficacy|1|||
48814150|NCT02294474|157160103|FG000|Overall Study|Protocol Violation|4|||
48814151|NCT02294474|157160104|FG001|Overall Study|Protocol Violation|2|||
48814152|NCT02294474|157160103|FG000|Overall Study|Other than specified above|12|||
48814153|NCT02294474|157160104|FG001|Overall Study|Other than specified above|12|||
48814154|NCT00309608|157160105|FG000|Overall Study|Adverse Event|1|||
48814155|NCT00309608|157160106|FG001|Overall Study|Adverse Event|5|||
49126282|NCT03786380|158299657|FG001|Overall Study|Withdrawal by Subject|2|||
49126283|NCT03786380|158299658|FG002|Overall Study|Withdrawal by Subject|2|||
48814156|NCT00309608|157160107|FG002|Overall Study|Adverse Event|3|||
48814157|NCT00309608|157160108|FG003|Overall Study|Adverse Event|2|||
48814158|NCT00309608|157160109|FG004|Overall Study|Adverse Event|3|||
48814159|NCT00309608|157160105|FG000|Overall Study|Protocol Violation|2|||
49126284|NCT03786380|158299659|FG003|Overall Study|Withdrawal by Subject|1|||
48814160|NCT00309608|157160106|FG001|Overall Study|Protocol Violation|0|||
48814161|NCT00309608|157160107|FG002|Overall Study|Protocol Violation|0|||
48814162|NCT00309608|157160108|FG003|Overall Study|Protocol Violation|0|||
48814163|NCT00309608|157160109|FG004|Overall Study|Protocol Violation|0|||
48814164|NCT00309608|157160105|FG000|Overall Study|Lost to Follow-up|0|||
48814165|NCT00309608|157160106|FG001|Overall Study|Lost to Follow-up|0|||
48814166|NCT00309608|157160107|FG002|Overall Study|Lost to Follow-up|2|||
48814167|NCT00309608|157160108|FG003|Overall Study|Lost to Follow-up|0|||
48814168|NCT00309608|157160109|FG004|Overall Study|Lost to Follow-up|1|||
48814169|NCT00309608|157160105|FG000|Overall Study|Withdrawal by Subject|1|||
48814170|NCT00309608|157160106|FG001|Overall Study|Withdrawal by Subject|4|||
48814171|NCT00309608|157160107|FG002|Overall Study|Withdrawal by Subject|2|||
48814172|NCT00309608|157160108|FG003|Overall Study|Withdrawal by Subject|0|||
48814173|NCT00309608|157160109|FG004|Overall Study|Withdrawal by Subject|0|||
48814174|NCT00309608|157160105|FG000|Overall Study|Other incl. Lack of efficacy|10|||
48814175|NCT00309608|157160106|FG001|Overall Study|Other incl. Lack of efficacy|4|||
48814176|NCT00309608|157160107|FG002|Overall Study|Other incl. Lack of efficacy|3|||
48814177|NCT00309608|157160108|FG003|Overall Study|Other incl. Lack of efficacy|4|||
48814178|NCT00309608|157160109|FG004|Overall Study|Other incl. Lack of efficacy|0|||
48814179|NCT00641186|157160112|FG000|Overall Study|Adverse Event|3|||
48814180|NCT02684903|157160119|FG000|Overall Study|COVID-19 shutdown of lab|4|||
48814181|NCT02684903|157160120|FG001|Overall Study|COVID-19 shutdown of lab|6|||
48814182|NCT02684903|157160119|FG000|Overall Study|Lost to Follow-up|31|||
48814183|NCT02684903|157160120|FG001|Overall Study|Lost to Follow-up|41|||
48814184|NCT00904150|157160121|FG000|Saliva Samples (DNA)|saliva samples not suitable for assay|3|||
48814185|NCT00904150|157160122|FG001|Saliva Samples (DNA)|saliva samples not suitable for assay|0|||
48814186|NCT00904150|157160121|FG000|Saliva Samples (DNA)|Australian samples of different genotype|0|||
48814187|NCT00904150|157160122|FG001|Saliva Samples (DNA)|Australian samples of different genotype|145|||
48814188|NCT04880161|157160123|FG000|Overall Study|Withdrawal by Subject|1|||
48814189|NCT04880161|157160124|FG001|Overall Study|Withdrawal by Subject|0|||
48814190|NCT04880161|157160123|FG000|Overall Study|Lack of Compliance|1|||
48814191|NCT04880161|157160124|FG001|Overall Study|Lack of Compliance|1|||
48814192|NCT04880161|157160123|FG000|Overall Study|Incorrectly Randomized followed for Safety|0|||
48814193|NCT04880161|157160124|FG001|Overall Study|Incorrectly Randomized followed for Safety|1|||
48814194|NCT04880161|157160123|FG000|Overall Study|Screen Failure|0|||
48814195|NCT04880161|157160124|FG001|Overall Study|Screen Failure|1|||
48814196|NCT01354106|157160125|FG000|Overall Study|Withdrawal by Subject|2|||
48814197|NCT00798174|157161730|FG000|Overall Study|inability to implant azygos coil|3|||
48814198|NCT00798174|157161731|FG001|Overall Study|inability to implant azygos coil|3|||
48814199|NCT00798174|157161730|FG000|Overall Study|Inability to sedate for DFT testing|1|||
48814200|NCT00798174|157161731|FG001|Overall Study|Inability to sedate for DFT testing|0|||
48814201|NCT00917267|157161739|FG000|Overall Study|Adverse Event|15|||
48814202|NCT00917267|157161740|FG001|Overall Study|Adverse Event|36|||
48814203|NCT00917267|157161739|FG000|Overall Study|Physician Decision|2|||
48814204|NCT00917267|157161740|FG001|Overall Study|Physician Decision|4|||
48814205|NCT00917267|157161739|FG000|Overall Study|Protocol Violation|9|||
48814206|NCT00917267|157161740|FG001|Overall Study|Protocol Violation|18|||
48814207|NCT00917267|157161739|FG000|Overall Study|Withdrawal by Subject|5|||
48814208|NCT00917267|157161740|FG001|Overall Study|Withdrawal by Subject|12|||
48814209|NCT00917267|157161739|FG000|Overall Study|Lost to follow up|0|||
48814210|NCT00917267|157161740|FG001|Overall Study|Lost to follow up|2|||
48814211|NCT00917267|157161739|FG000|Overall Study|Entry Criteria Not Met|1|||
48814212|NCT00917267|157161740|FG001|Overall Study|Entry Criteria Not Met|0|||
48814213|NCT00917267|157161739|FG000|Overall Study|Sponsor Decision|5|||
48814214|NCT00917267|157161740|FG001|Overall Study|Sponsor Decision|5|||
48814215|NCT00917267|157161739|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
48814216|NCT00917267|157161740|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
48814217|NCT00432835|157161745|FG000|Overall Study|Adverse event: lead dislodgement.|6|||
48814218|NCT00432835|157161746|FG001|Overall Study|Adverse event: lead dislodgement.|7|||
48814219|NCT02045433|157161747|FG000|Overall Study|Withdrawal by Subject|1|||
48814220|NCT00594906|157161748|FG000|Overall Study|Physician Decision|1|||
48814221|NCT00594906|157161749|FG001|Overall Study|Physician Decision|0|||
48814222|NCT00594906|157161748|FG000|Overall Study|Physician Decision|0|||
48814223|NCT00594906|157161749|FG001|Overall Study|Physician Decision|1|||
48814224|NCT00594906|157161748|FG000|Overall Study|Death|0|||
48814225|NCT00594906|157161749|FG001|Overall Study|Death|1|||
49011011|NCT00219557|157877375|FG002|Phase 1|Withdrawal by Subject|0|||
48814226|NCT00451217|157161751|FG000|Overall Study|Lost to Follow-up|0|||
48814227|NCT00451217|157161752|FG001|Overall Study|Lost to Follow-up|1|||
48814228|NCT00451217|157161753|FG002|Overall Study|Lost to Follow-up|1|||
48814229|NCT00451217|157161754|FG003|Overall Study|Lost to Follow-up|1|||
48814230|NCT00451217|157161751|FG000|Overall Study|Withdrawal by Subject|1|||
48814231|NCT00451217|157161752|FG001|Overall Study|Withdrawal by Subject|0|||
48814232|NCT00451217|157161753|FG002|Overall Study|Withdrawal by Subject|0|||
48814233|NCT00451217|157161754|FG003|Overall Study|Withdrawal by Subject|0|||
48814234|NCT00451217|157161751|FG000|Overall Study|Not Treated|1|||
48814235|NCT00451217|157161752|FG001|Overall Study|Not Treated|1|||
48814236|NCT00451217|157161753|FG002|Overall Study|Not Treated|3|||
48814237|NCT00451217|157161754|FG003|Overall Study|Not Treated|4|||
48814238|NCT00867490|157161756|FG000|Phase 1 - Candesartan+HCTZ|Adverse Event|5|||
48814239|NCT00867490|157161756|FG000|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4|||
48814240|NCT00867490|157161756|FG000|Phase 1 - Candesartan+HCTZ|Administrative Problems|1|||
48814241|NCT00867490|157161756|FG000|Phase 2 - Aliskiren+HCTZ|Adverse Event|2|||
48814242|NCT00867490|157161756|FG000|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1|||
48814243|NCT01129336|157161757|FG000|Overall Study|Protocol Violation|1|||
48814244|NCT01129336|157161758|FG001|Overall Study|Protocol Violation|0|||
48814245|NCT01129336|157161757|FG000|Overall Study|Disease Progression|1|||
48814246|NCT01129336|157161758|FG001|Overall Study|Disease Progression|4|||
48814247|NCT01129336|157161757|FG000|Overall Study|Lost to Follow-up|1|||
48814248|NCT01129336|157161758|FG001|Overall Study|Lost to Follow-up|0|||
48814249|NCT01129336|157161757|FG000|Overall Study|Withdrawal by Subject|7|||
48814250|NCT01129336|157161758|FG001|Overall Study|Withdrawal by Subject|4|||
48814251|NCT01129336|157161757|FG000|Overall Study|Adverse Event|0|||
48814252|NCT01129336|157161758|FG001|Overall Study|Adverse Event|1|||
48814253|NCT01129336|157161757|FG000|Overall Study|Missing Study Completion Status|2|||
48814254|NCT01129336|157161758|FG001|Overall Study|Missing Study Completion Status|3|||
48814255|NCT01129336|157161757|FG000|Overall Study|Death|0|||
48814256|NCT01129336|157161758|FG001|Overall Study|Death|4|||
48814257|NCT01950273|157161761|FG000|Overall Study|Protocol Violation|1|||
48814258|NCT01950273|157161762|FG001|Overall Study|Protocol Violation|0|||
48814259|NCT01950273|157161761|FG000|Overall Study|Withdrawal by Subject|2|||
48814260|NCT01950273|157161762|FG001|Overall Study|Withdrawal by Subject|0|||
48814261|NCT01950273|157161761|FG000|Overall Study|Other not defined above|1|||
48814262|NCT01950273|157161762|FG001|Overall Study|Other not defined above|0|||
48814263|NCT01254565|157161763|FG000|Overall Study|Non-compliance to Study Procedures|0|||
48814264|NCT01254565|157161764|FG001|Overall Study|Non-compliance to Study Procedures|0|||
48814265|NCT01254565|157161765|FG002|Overall Study|Non-compliance to Study Procedures|0|||
48814266|NCT01254565|157161766|FG003|Overall Study|Non-compliance to Study Procedures|0|||
48814267|NCT01254565|157161767|FG004|Overall Study|Non-compliance to Study Procedures|1|||
48814268|NCT01254565|157161768|FG005|Overall Study|Non-compliance to Study Procedures|0|||
48814269|NCT01254565|157161763|FG000|Overall Study|Did not Receive Treatment|1|||
48814270|NCT01254565|157161764|FG001|Overall Study|Did not Receive Treatment|1|||
48814271|NCT01254565|157161765|FG002|Overall Study|Did not Receive Treatment|0|||
48814272|NCT01254565|157161766|FG003|Overall Study|Did not Receive Treatment|0|||
48814273|NCT01254565|157161767|FG004|Overall Study|Did not Receive Treatment|3|||
48814274|NCT01254565|157161768|FG005|Overall Study|Did not Receive Treatment|4|||
48814275|NCT01254565|157161763|FG000|Overall Study|Other|0|||
48814276|NCT01254565|157161764|FG001|Overall Study|Other|0|||
48814277|NCT01254565|157161765|FG002|Overall Study|Other|0|||
48814278|NCT01254565|157161766|FG003|Overall Study|Other|1|||
48814279|NCT01254565|157161767|FG004|Overall Study|Other|0|||
48814280|NCT01254565|157161768|FG005|Overall Study|Other|0|||
48814281|NCT00472186|157161769|FG000|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|1|||
48814282|NCT00472186|157161770|FG001|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|0|||
48814283|NCT01235975|157161773|FG000|Overall Study|Serious Adverse Event|0|||
48814284|NCT01235975|157161774|FG001|Overall Study|Serious Adverse Event|1|||
48814285|NCT01235975|157161773|FG000|Overall Study|Withdrawal by Subject|8|||
48814286|NCT01235975|157161774|FG001|Overall Study|Withdrawal by Subject|2|||
48814287|NCT01235975|157161773|FG000|Overall Study|Migrated/moved from study area|2|||
48814288|NCT01235975|157161774|FG001|Overall Study|Migrated/moved from study area|1|||
48814289|NCT01235975|157161773|FG000|Overall Study|Lost to Follow-up|7|||
48814290|NCT01235975|157161774|FG001|Overall Study|Lost to Follow-up|3|||
49126285|NCT03786380|158299660|FG004|Overall Study|Withdrawal by Subject|2|||
49126286|NCT03786380|158299656|FG000|Overall Study|Lost to Follow-up|3|||
49126287|NCT03786380|158299657|FG001|Overall Study|Lost to Follow-up|0|||
49126288|NCT03786380|158299658|FG002|Overall Study|Lost to Follow-up|1|||
49126289|NCT03786380|158299659|FG003|Overall Study|Lost to Follow-up|2|||
49126290|NCT03786380|158299660|FG004|Overall Study|Lost to Follow-up|0|||
49126291|NCT03786380|158299656|FG000|Overall Study|Physician Decision|0|||
49126292|NCT03786380|158299657|FG001|Overall Study|Physician Decision|0|||
49126293|NCT03786380|158299658|FG002|Overall Study|Physician Decision|1|||
49126294|NCT03786380|158299659|FG003|Overall Study|Physician Decision|0|||
49126295|NCT03786380|158299660|FG004|Overall Study|Physician Decision|0|||
49126296|NCT03786380|158299656|FG000|Overall Study|Study Terminated by the Sponsor|30|||
48814291|NCT01622348|157161775|FG000|Overall Study|Withdrawal by Subject|1|||
48814292|NCT01622348|157161776|FG001|Overall Study|Withdrawal by Subject|0|||
48814293|NCT01622348|157161777|FG002|Overall Study|Withdrawal by Subject|1|||
48814294|NCT04397523|157161778|FG000|Overall Study|Lost to Follow-up|3|||
48814295|NCT04397523|157161778|FG000|Overall Study|Transfer from/to other hospital|8|||
48814296|NCT00951509|157161787|FG000|Overall Study|Withdrawal by Subject|2|||
48814297|NCT01830881|157161788|FG000|Overall Study|Changed decision to have an abortion|0|||
48814298|NCT01830881|157161789|FG001|Overall Study|Changed decision to have an abortion|1|||
48814299|NCT02038764|157161792|FG000|Overall Study|Adverse Event|0|||
48814300|NCT02038764|157161793|FG001|Overall Study|Adverse Event|0|||
48814301|NCT02038764|157161794|FG002|Overall Study|Adverse Event|1|||
48814302|NCT02038764|157161795|FG003|Overall Study|Adverse Event|0|||
48814303|NCT02038764|157161796|FG004|Overall Study|Adverse Event|0|||
48814304|NCT02038764|157161792|FG000|Overall Study|Lost to Follow-up|0|||
48814305|NCT02038764|157161793|FG001|Overall Study|Lost to Follow-up|1|||
48814306|NCT02038764|157161794|FG002|Overall Study|Lost to Follow-up|0|||
48814307|NCT02038764|157161795|FG003|Overall Study|Lost to Follow-up|0|||
48814308|NCT02038764|157161796|FG004|Overall Study|Lost to Follow-up|0|||
48814309|NCT02038764|157161792|FG000|Overall Study|Withdrawal by Subject|0|||
48814310|NCT02038764|157161793|FG001|Overall Study|Withdrawal by Subject|0|||
48814311|NCT02038764|157161794|FG002|Overall Study|Withdrawal by Subject|0|||
48814312|NCT02038764|157161795|FG003|Overall Study|Withdrawal by Subject|0|||
48814313|NCT02038764|157161796|FG004|Overall Study|Withdrawal by Subject|1|||
48814314|NCT02038764|157161792|FG000|Overall Study|Other|1|||
48814315|NCT02038764|157161793|FG001|Overall Study|Other|0|||
48814316|NCT02038764|157161794|FG002|Overall Study|Other|1|||
48814317|NCT02038764|157161795|FG003|Overall Study|Other|0|||
48814318|NCT02038764|157161796|FG004|Overall Study|Other|0|||
48814319|NCT00582491|157161797|FG000|Overall Study|Withdrawal by Subject|1|||
48814320|NCT00582491|157161798|FG001|Overall Study|Withdrawal by Subject|0|||
48814321|NCT01775930|157161809|FG000|Overall Study|Futility stopping boundary met|1|||
48814322|NCT02471404|157161820|FG000|Overall Study|Adverse Event|7|||
48814323|NCT02471404|157161821|FG001|Overall Study|Adverse Event|1|||
48814324|NCT02471404|157161822|FG002|Overall Study|Adverse Event|2|||
48814325|NCT02471404|157161820|FG000|Overall Study|Developed Study Withdrawal Criteria|4|||
48814326|NCT02471404|157161821|FG001|Overall Study|Developed Study Withdrawal Criteria|1|||
48814327|NCT02471404|157161822|FG002|Overall Study|Developed Study Withdrawal Criteria|2|||
48814328|NCT02471404|157161820|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
48814329|NCT02471404|157161821|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
48814330|NCT02471404|157161822|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
48814331|NCT02471404|157161820|FG000|Overall Study|Lost to Follow-up|1|||
48814332|NCT02471404|157161821|FG001|Overall Study|Lost to Follow-up|1|||
48814333|NCT02471404|157161822|FG002|Overall Study|Lost to Follow-up|3|||
48814334|NCT02471404|157161820|FG000|Overall Study|Protocol Violation|1|||
48814335|NCT02471404|157161821|FG001|Overall Study|Protocol Violation|0|||
48814336|NCT02471404|157161822|FG002|Overall Study|Protocol Violation|0|||
48814337|NCT02471404|157161820|FG000|Overall Study|Withdrawal by Subject|8|||
48814338|NCT02471404|157161821|FG001|Overall Study|Withdrawal by Subject|4|||
48814339|NCT02471404|157161822|FG002|Overall Study|Withdrawal by Subject|5|||
48814340|NCT02471404|157161820|FG000|Overall Study|Other reasons not specified|10|||
48814341|NCT02471404|157161821|FG001|Overall Study|Other reasons not specified|7|||
48814342|NCT02471404|157161822|FG002|Overall Study|Other reasons not specified|12|||
48814343|NCT01927731|157161823|FG000|Overall Study|Graft Failure|1|||
48814344|NCT01927731|157161824|FG001|Overall Study|Graft Failure|2|||
48814345|NCT01927731|157161823|FG000|Overall Study|Physician Decision|2|||
48814346|NCT01927731|157161824|FG001|Overall Study|Physician Decision|3|||
48814347|NCT01927731|157161823|FG000|Overall Study|Withdrawal by Subject|0|||
48814348|NCT01927731|157161824|FG001|Overall Study|Withdrawal by Subject|2|||
48814349|NCT01927731|157161823|FG000|Overall Study|Death|0|||
48814350|NCT01927731|157161824|FG001|Overall Study|Death|3|||
48814351|NCT00305864|157161825|FG000|Overall Study|Ineligible / No protocol treatment|0|||
48814352|NCT00305864|157161826|FG001|Overall Study|Ineligible / No protocol treatment|1|||
48814353|NCT00305864|157161827|FG002|Overall Study|Ineligible / No protocol treatment|1|||
48814354|NCT00305864|157161828|FG003|Overall Study|Ineligible / No protocol treatment|13|||
48814355|NCT01734850|157161829|FG000|Overall Study|Continued to Week 48 but recommenced ART|3|||
49126297|NCT03786380|158299657|FG001|Overall Study|Study Terminated by the Sponsor|20|||
49126298|NCT03786380|158299658|FG002|Overall Study|Study Terminated by the Sponsor|50|||
49126299|NCT03786380|158299659|FG003|Overall Study|Study Terminated by the Sponsor|57|||
49126300|NCT03786380|158299660|FG004|Overall Study|Study Terminated by the Sponsor|23|||
49126301|NCT03786380|158299656|FG000|Overall Study|Reason Not Specified|0|||
49126302|NCT03786380|158299657|FG001|Overall Study|Reason Not Specified|0|||
49126303|NCT03786380|158299658|FG002|Overall Study|Reason Not Specified|0|||
49126304|NCT03786380|158299659|FG003|Overall Study|Reason Not Specified|0|||
49126305|NCT03786380|158299660|FG004|Overall Study|Reason Not Specified|1|||
48814356|NCT01734850|157161830|FG001|Overall Study|Continued to Week 48 but recommenced ART|2|||
48814357|NCT01734850|157161831|FG002|Overall Study|Continued to Week 48 but recommenced ART|3|||
48814358|NCT01734850|157161829|FG000|Overall Study|Not infused due to manufacturing failure|0|||
48814359|NCT01734850|157161830|FG001|Overall Study|Not infused due to manufacturing failure|0|||
48814360|NCT01734850|157161831|FG002|Overall Study|Not infused due to manufacturing failure|1|||
48814361|NCT03881059|157161832|FG000|Treatment Period - Part A|Adverse Event|1|||
48814362|NCT03881059|157161833|FG001|Treatment Period - Part A|Adverse Event|3|||
48814363|NCT03881059|157161834|FG002|Treatment Period - Part A|Adverse Event|4|||
48814364|NCT03881059|157161832|FG000|Treatment Period - Part A|Randomized by mistake with study treatment|0|||
49126306|NCT01494818|158299662|FG000|Overall Study|Relocation|1|||
48814365|NCT03881059|157161833|FG001|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
48814366|NCT03881059|157161834|FG002|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
48814367|NCT03881059|157161832|FG000|Treatment Period - Part A|Withdrawal by Subject|5|||
48814368|NCT03881059|157161833|FG001|Treatment Period - Part A|Withdrawal by Subject|2|||
48814369|NCT03881059|157161834|FG002|Treatment Period - Part A|Withdrawal by Subject|3|||
48814370|NCT03881059|157161832|FG000|Treatment Period - Part A|Other reasons|2|||
48814371|NCT03881059|157161833|FG001|Treatment Period - Part A|Other reasons|1|||
48814372|NCT03881059|157161834|FG002|Treatment Period - Part A|Other reasons|0|||
48814373|NCT03881059|157161832|FG000|Treatment Period - Part B|Adverse Event|0|||
48814374|NCT03881059|157161833|FG001|Treatment Period - Part B|Adverse Event|0|||
48814375|NCT03881059|157161834|FG002|Treatment Period - Part B|Adverse Event|3|||
48814376|NCT03881059|157161832|FG000|Treatment Period - Part B|Death|0|||
48814377|NCT03881059|157161833|FG001|Treatment Period - Part B|Death|1|||
48814378|NCT03881059|157161834|FG002|Treatment Period - Part B|Death|1|||
48814379|NCT03881059|157161832|FG000|Treatment Period - Part B|Lack of Efficacy|1|||
48814380|NCT03881059|157161833|FG001|Treatment Period - Part B|Lack of Efficacy|1|||
48814381|NCT03881059|157161834|FG002|Treatment Period - Part B|Lack of Efficacy|0|||
48814382|NCT03881059|157161832|FG000|Treatment Period - Part B|Lost to Follow-up|1|||
48814383|NCT03881059|157161833|FG001|Treatment Period - Part B|Lost to Follow-up|1|||
48814384|NCT03881059|157161834|FG002|Treatment Period - Part B|Lost to Follow-up|0|||
48814385|NCT03881059|157161832|FG000|Treatment Period - Part B|Site terminated by sponsor|1|||
48814386|NCT03881059|157161833|FG001|Treatment Period - Part B|Site terminated by sponsor|0|||
48814387|NCT03881059|157161834|FG002|Treatment Period - Part B|Site terminated by sponsor|3|||
48814388|NCT03881059|157161832|FG000|Treatment Period - Part B|Withdrawal by Subject|1|||
48814389|NCT03881059|157161833|FG001|Treatment Period - Part B|Withdrawal by Subject|0|||
48814390|NCT03881059|157161834|FG002|Treatment Period - Part B|Withdrawal by Subject|1|||
48814391|NCT03881059|157161832|FG000|Treatment Period - Part B|Other reasons|4|||
48814392|NCT03881059|157161833|FG001|Treatment Period - Part B|Other reasons|3|||
48814393|NCT03881059|157161834|FG002|Treatment Period - Part B|Other reasons|3|||
48814394|NCT02204293|157161835|FG000|Core Study Part I|Met one or more exclusion criteria|1|||
48814395|NCT02204293|157161836|FG001|Core Study Part I|Met one or more exclusion criteria|0|||
48814396|NCT02204293|157161837|FG002|Core Study Part I|Met one or more exclusion criteria|0|||
48814397|NCT02204293|157161838|FG003|Core Study Part I|Met one or more exclusion criteria|0|||
48814398|NCT02204293|157161839|FG004|Core Study Part I|Met one or more exclusion criteria|0|||
48814399|NCT02204293|157161840|FG005|Core Study Part I|Met one or more exclusion criteria|0|||
48814400|NCT02204293|157161835|FG000|Core Study Part I|Adverse Event|1|||
48814401|NCT02204293|157161836|FG001|Core Study Part I|Adverse Event|0|||
48814402|NCT02204293|157161837|FG002|Core Study Part I|Adverse Event|0|||
48814403|NCT02204293|157161838|FG003|Core Study Part I|Adverse Event|0|||
48814404|NCT02204293|157161839|FG004|Core Study Part I|Adverse Event|0|||
48814405|NCT02204293|157161840|FG005|Core Study Part I|Adverse Event|0|||
48814406|NCT02204293|157161835|FG000|Core Study Part I|Physician Decision|0|||
48814407|NCT02204293|157161836|FG001|Core Study Part I|Physician Decision|3|||
48814408|NCT02204293|157161837|FG002|Core Study Part I|Physician Decision|0|||
48814409|NCT02204293|157161838|FG003|Core Study Part I|Physician Decision|0|||
48814410|NCT02204293|157161839|FG004|Core Study Part I|Physician Decision|0|||
48814411|NCT02204293|157161840|FG005|Core Study Part I|Physician Decision|0|||
48814412|NCT02204293|157161835|FG000|LTE Phase|Study Suspended|0|||
48814413|NCT02204293|157161836|FG001|LTE Phase|Study Suspended|0|||
48814414|NCT02204293|157161837|FG002|LTE Phase|Study Suspended|0|||
48814415|NCT02204293|157161838|FG003|LTE Phase|Study Suspended|0|||
48814416|NCT02204293|157161839|FG004|LTE Phase|Study Suspended|0|||
48814417|NCT02204293|157161840|FG005|LTE Phase|Study Suspended|7|||
48814418|NCT00661258|157161841|FG000|Overall Study|Death|1|||
48814419|NCT00661258|157161842|FG001|Overall Study|Death|0|||
48814420|NCT00661258|157161841|FG000|Overall Study|caught by police and in detox center|2|||
48814421|NCT00661258|157161842|FG001|Overall Study|caught by police and in detox center|1|||
48814422|NCT01146574|157161843|FG000|Overall Study|Death|0|||
48814423|NCT01146574|157161844|FG001|Overall Study|Death|1|||
48814424|NCT01146574|157161845|FG002|Overall Study|Death|1|||
48814425|NCT01146574|157161846|FG003|Overall Study|Death|0|||
48814426|NCT01146574|157161847|FG004|Overall Study|Death|0|||
48814427|NCT01146574|157161848|FG005|Overall Study|Death|0|||
48814428|NCT01146574|157161849|FG006|Overall Study|Death|0|||
48814429|NCT01146574|157161843|FG000|Overall Study|Other reasons|0|||
48814430|NCT01146574|157161844|FG001|Overall Study|Other reasons|0|||
49126307|NCT01494818|158299663|FG001|Overall Study|Relocation|2|||
49126308|NCT01494818|158299662|FG000|Overall Study|Lost to Follow-up|1|||
49126309|NCT01494818|158299663|FG001|Overall Study|Lost to Follow-up|0|||
49126310|NCT00617357|158299666|FG000|Overall Study|Lost to Follow-up|7|||
49126311|NCT00617357|158299666|FG000|Overall Study|Death|5|||
49126312|NCT00617357|158299666|FG000|Overall Study|insurance concerns|2|||
49126313|NCT00617357|158299666|FG000|Overall Study|Withdrawal by Subject|1|||
48814431|NCT01146574|157161845|FG002|Overall Study|Other reasons|3|||
49126314|NCT00617357|158299666|FG000|Overall Study|Physician Decision|1|||
49126315|NCT03118934|158299670|FG000|Overall Study|Adverse Event|0|||
48716482|NCT00966875|156813515|FG004|Part A|Parent/Caregiver Decision|0|||
48716483|NCT00966875|156813516|FG005|Part A|Parent/Caregiver Decision|0|||
48716484|NCT00966875|156813517|FG006|Part A|Parent/Caregiver Decision|0|||
48716485|NCT00966875|156813518|FG007|Part A|Parent/Caregiver Decision|0|||
48716486|NCT00966875|156813519|FG008|Part A|Parent/Caregiver Decision|0|||
48716487|NCT00966875|156813511|FG000|Part A|Physician Decision|0|||
48716488|NCT00966875|156813512|FG001|Part A|Physician Decision|0|||
48716489|NCT00966875|156813513|FG002|Part A|Physician Decision|0|||
48716490|NCT00966875|156813514|FG003|Part A|Physician Decision|0|||
48716491|NCT00966875|156813515|FG004|Part A|Physician Decision|1|||
48716492|NCT00966875|156813516|FG005|Part A|Physician Decision|0|||
48716493|NCT00966875|156813517|FG006|Part A|Physician Decision|1|||
48716494|NCT00966875|156813518|FG007|Part A|Physician Decision|0|||
48716495|NCT00966875|156813519|FG008|Part A|Physician Decision|2|||
48716496|NCT00966875|156813511|FG000|Part A|Sponsor Decision|0|||
48716497|NCT00966875|156813512|FG001|Part A|Sponsor Decision|0|||
48716498|NCT00966875|156813513|FG002|Part A|Sponsor Decision|1|||
48716499|NCT00966875|156813514|FG003|Part A|Sponsor Decision|0|||
48716500|NCT00966875|156813515|FG004|Part A|Sponsor Decision|1|||
48716501|NCT00966875|156813516|FG005|Part A|Sponsor Decision|0|||
48716502|NCT00966875|156813517|FG006|Part A|Sponsor Decision|0|||
48716503|NCT00966875|156813518|FG007|Part A|Sponsor Decision|2|||
48716504|NCT00966875|156813519|FG008|Part A|Sponsor Decision|1|||
48716505|NCT00966875|156813511|FG000|Part A|Withdrawal by Subject|2|||
48716506|NCT00966875|156813512|FG001|Part A|Withdrawal by Subject|2|||
48716507|NCT00966875|156813513|FG002|Part A|Withdrawal by Subject|1|||
48716508|NCT00966875|156813514|FG003|Part A|Withdrawal by Subject|1|||
48716509|NCT00966875|156813515|FG004|Part A|Withdrawal by Subject|3|||
48716510|NCT00966875|156813516|FG005|Part A|Withdrawal by Subject|0|||
48716511|NCT00966875|156813517|FG006|Part A|Withdrawal by Subject|5|||
48716512|NCT00966875|156813518|FG007|Part A|Withdrawal by Subject|1|||
48716513|NCT00966875|156813519|FG008|Part A|Withdrawal by Subject|1|||
48716514|NCT00966875|156813511|FG000|Part A|Protocol Violation|0|||
48716515|NCT00966875|156813512|FG001|Part A|Protocol Violation|0|||
48716516|NCT00966875|156813513|FG002|Part A|Protocol Violation|0|||
48716517|NCT00966875|156813514|FG003|Part A|Protocol Violation|0|||
48716518|NCT00966875|156813515|FG004|Part A|Protocol Violation|0|||
48716519|NCT00966875|156813516|FG005|Part A|Protocol Violation|0|||
48716520|NCT00966875|156813517|FG006|Part A|Protocol Violation|2|||
48716521|NCT00966875|156813518|FG007|Part A|Protocol Violation|1|||
48716522|NCT00966875|156813519|FG008|Part A|Protocol Violation|1|||
48716523|NCT00966875|156813511|FG000|Part B|Adverse Event|0|||
48716524|NCT00966875|156813512|FG001|Part B|Adverse Event|1|||
48716525|NCT00966875|156813513|FG002|Part B|Adverse Event|1|||
48716526|NCT00966875|156813514|FG003|Part B|Adverse Event|0|||
48716527|NCT00966875|156813515|FG004|Part B|Adverse Event|1|||
48716528|NCT00966875|156813516|FG005|Part B|Adverse Event|0|||
48716529|NCT00966875|156813517|FG006|Part B|Adverse Event|5|||
48716530|NCT00966875|156813518|FG007|Part B|Adverse Event|2|||
48716531|NCT00966875|156813519|FG008|Part B|Adverse Event|2|||
48716532|NCT00966875|156813511|FG000|Part B|Death|0|||
48716533|NCT00966875|156813512|FG001|Part B|Death|0|||
48716534|NCT00966875|156813513|FG002|Part B|Death|1|||
48716535|NCT00966875|156813514|FG003|Part B|Death|0|||
48716536|NCT00966875|156813515|FG004|Part B|Death|0|||
48716537|NCT00966875|156813516|FG005|Part B|Death|0|||
48716538|NCT00966875|156813517|FG006|Part B|Death|0|||
48716539|NCT00966875|156813518|FG007|Part B|Death|1|||
48716540|NCT00966875|156813519|FG008|Part B|Death|0|||
48716541|NCT00966875|156813511|FG000|Part B|Lack of Efficacy|2|||
48716542|NCT00966875|156813512|FG001|Part B|Lack of Efficacy|1|||
48716543|NCT00966875|156813513|FG002|Part B|Lack of Efficacy|1|||
48716544|NCT00966875|156813514|FG003|Part B|Lack of Efficacy|1|||
49126316|NCT03118934|158299671|FG001|Overall Study|Adverse Event|0|||
48716545|NCT00966875|156813515|FG004|Part B|Lack of Efficacy|2|||
48716546|NCT00966875|156813516|FG005|Part B|Lack of Efficacy|3|||
48716547|NCT00966875|156813517|FG006|Part B|Lack of Efficacy|12|||
48716548|NCT00966875|156813518|FG007|Part B|Lack of Efficacy|9|||
48716549|NCT00966875|156813519|FG008|Part B|Lack of Efficacy|6|||
48716550|NCT00966875|156813511|FG000|Part B|Lost to Follow-up|0|||
48716551|NCT00966875|156813512|FG001|Part B|Lost to Follow-up|0|||
48716552|NCT00966875|156813513|FG002|Part B|Lost to Follow-up|0|||
48716553|NCT00966875|156813514|FG003|Part B|Lost to Follow-up|1|||
48716554|NCT00966875|156813515|FG004|Part B|Lost to Follow-up|0|||
49126317|NCT03118934|158299672|FG002|Overall Study|Adverse Event|0|||
48716555|NCT00966875|156813516|FG005|Part B|Lost to Follow-up|0|||
48716556|NCT00966875|156813517|FG006|Part B|Lost to Follow-up|0|||
48716557|NCT00966875|156813518|FG007|Part B|Lost to Follow-up|0|||
48716558|NCT00966875|156813519|FG008|Part B|Lost to Follow-up|1|||
48716559|NCT00966875|156813511|FG000|Part B|Physician Decision|0|||
48716560|NCT00966875|156813512|FG001|Part B|Physician Decision|0|||
48716561|NCT00966875|156813513|FG002|Part B|Physician Decision|1|||
48716562|NCT00966875|156813514|FG003|Part B|Physician Decision|0|||
48716563|NCT00966875|156813515|FG004|Part B|Physician Decision|2|||
48716564|NCT00966875|156813516|FG005|Part B|Physician Decision|1|||
48716565|NCT00966875|156813517|FG006|Part B|Physician Decision|0|||
48716566|NCT00966875|156813518|FG007|Part B|Physician Decision|0|||
49126318|NCT03118934|158299673|FG003|Overall Study|Adverse Event|0|||
48814432|NCT01146574|157161846|FG003|Overall Study|Other reasons|0|||
48814433|NCT01146574|157161847|FG004|Overall Study|Other reasons|0|||
48814434|NCT01146574|157161848|FG005|Overall Study|Other reasons|0|||
48814435|NCT01146574|157161849|FG006|Overall Study|Other reasons|0|||
48814436|NCT01146574|157161843|FG000|Overall Study|Kidney transplant|0|||
48814437|NCT01146574|157161844|FG001|Overall Study|Kidney transplant|0|||
48814438|NCT01146574|157161845|FG002|Overall Study|Kidney transplant|1|||
48814439|NCT01146574|157161846|FG003|Overall Study|Kidney transplant|1|||
48814440|NCT01146574|157161847|FG004|Overall Study|Kidney transplant|0|||
48814441|NCT01146574|157161848|FG005|Overall Study|Kidney transplant|0|||
48814442|NCT01146574|157161849|FG006|Overall Study|Kidney transplant|0|||
48814443|NCT01146574|157161843|FG000|Overall Study|Withdrew consent|0|||
48814444|NCT01146574|157161844|FG001|Overall Study|Withdrew consent|0|||
48814445|NCT01146574|157161845|FG002|Overall Study|Withdrew consent|1|||
48814446|NCT01146574|157161846|FG003|Overall Study|Withdrew consent|1|||
48814447|NCT01146574|157161847|FG004|Overall Study|Withdrew consent|2|||
48814448|NCT01146574|157161848|FG005|Overall Study|Withdrew consent|1|||
48814449|NCT01146574|157161849|FG006|Overall Study|Withdrew consent|1|||
48814450|NCT02293837|157161850|FG000|Overall Study|Lost to Follow-up|0|||
48814451|NCT02293837|157161851|FG001|Overall Study|Lost to Follow-up|2|||
48814452|NCT02293837|157161852|FG002|Overall Study|Lost to Follow-up|1|||
48814453|NCT02293837|157161853|FG003|Overall Study|Lost to Follow-up|0|||
48814454|NCT02293837|157161850|FG000|Overall Study|Withdrawal by Subject|2|||
48814455|NCT02293837|157161851|FG001|Overall Study|Withdrawal by Subject|1|||
48814456|NCT02293837|157161852|FG002|Overall Study|Withdrawal by Subject|2|||
48814457|NCT02293837|157161853|FG003|Overall Study|Withdrawal by Subject|1|||
48814458|NCT02293837|157161850|FG000|Overall Study|COVID-19 Related|1|||
48814459|NCT02293837|157161851|FG001|Overall Study|COVID-19 Related|1|||
48814460|NCT02293837|157161852|FG002|Overall Study|COVID-19 Related|0|||
48814461|NCT02293837|157161853|FG003|Overall Study|COVID-19 Related|0|||
48814462|NCT02293837|157161850|FG000|Overall Study|Participant ill and could not be infused|0|||
48814463|NCT02293837|157161851|FG001|Overall Study|Participant ill and could not be infused|0|||
48814464|NCT02293837|157161852|FG002|Overall Study|Participant ill and could not be infused|1|||
48814465|NCT02293837|157161853|FG003|Overall Study|Participant ill and could not be infused|0|||
49126319|NCT03118934|158299674|FG004|Overall Study|Adverse Event|0|||
49126320|NCT03118934|158299675|FG005|Overall Study|Adverse Event|1|||
48716567|NCT00966875|156813519|FG008|Part B|Physician Decision|2|||
48716568|NCT00966875|156813511|FG000|Part B|Sponsor Decision|1|||
48716569|NCT00966875|156813512|FG001|Part B|Sponsor Decision|0|||
48716570|NCT00966875|156813513|FG002|Part B|Sponsor Decision|0|||
48716571|NCT00966875|156813514|FG003|Part B|Sponsor Decision|0|||
48716572|NCT00966875|156813515|FG004|Part B|Sponsor Decision|0|||
48716573|NCT00966875|156813516|FG005|Part B|Sponsor Decision|1|||
48716574|NCT00966875|156813517|FG006|Part B|Sponsor Decision|0|||
48716575|NCT00966875|156813518|FG007|Part B|Sponsor Decision|2|||
48716576|NCT00966875|156813519|FG008|Part B|Sponsor Decision|1|||
48716577|NCT00966875|156813511|FG000|Part B|Withdrawal by Subject|2|||
48716578|NCT00966875|156813512|FG001|Part B|Withdrawal by Subject|1|||
48716579|NCT00966875|156813513|FG002|Part B|Withdrawal by Subject|2|||
48716580|NCT00966875|156813514|FG003|Part B|Withdrawal by Subject|1|||
48716581|NCT00966875|156813515|FG004|Part B|Withdrawal by Subject|2|||
48716582|NCT00966875|156813516|FG005|Part B|Withdrawal by Subject|1|||
48716583|NCT00966875|156813517|FG006|Part B|Withdrawal by Subject|4|||
48716584|NCT00966875|156813518|FG007|Part B|Withdrawal by Subject|5|||
48716585|NCT00966875|156813519|FG008|Part B|Withdrawal by Subject|5|||
48716586|NCT00966875|156813511|FG000|Part B|Entry Criteria|0|||
48716587|NCT00966875|156813512|FG001|Part B|Entry Criteria|0|||
48716588|NCT00966875|156813513|FG002|Part B|Entry Criteria|0|||
48716589|NCT00966875|156813514|FG003|Part B|Entry Criteria|0|||
48716590|NCT00966875|156813515|FG004|Part B|Entry Criteria|0|||
48716591|NCT00966875|156813516|FG005|Part B|Entry Criteria|0|||
48716592|NCT00966875|156813517|FG006|Part B|Entry Criteria|1|||
48716593|NCT00966875|156813518|FG007|Part B|Entry Criteria|0|||
48716594|NCT00966875|156813519|FG008|Part B|Entry Criteria|1|||
48716595|NCT01625260|156813520|FG000|Overall Study|Adverse Event|3|||
48814466|NCT00786474|157161854|FG000|Overall Study|Death|5|||
48814467|NCT00786474|157161855|FG001|Overall Study|Death|4|||
48814468|NCT00786474|157161854|FG000|Overall Study|Withdrawal by Subject|23|||
48814469|NCT00786474|157161855|FG001|Overall Study|Withdrawal by Subject|31|||
48716596|NCT01625260|156813521|FG001|Overall Study|Adverse Event|0|||
48716597|NCT01625260|156813520|FG000|Overall Study|Study Terminated by Investigator|2|||
48716598|NCT01625260|156813521|FG001|Overall Study|Study Terminated by Investigator|0|||
48716599|NCT01625260|156813520|FG000|Overall Study|Disease Progression|2|||
48716600|NCT01625260|156813521|FG001|Overall Study|Disease Progression|0|||
48716601|NCT01625260|156813520|FG000|Overall Study|PI and subject decided to terminate treatment|0|||
48716602|NCT01625260|156813521|FG001|Overall Study|PI and subject decided to terminate treatment|1|||
48716603|NCT02123472|156813522|FG000|Period 2 (7 Days)|Withdrawal by Subject|0|||
48814470|NCT00786474|157161854|FG000|Overall Study|Lost to Follow-up|3|||
48814471|NCT00786474|157161855|FG001|Overall Study|Lost to Follow-up|3|||
48814472|NCT00786474|157161854|FG000|Overall Study|Physician Decision|2|||
49126321|NCT03118934|158299670|FG000|Overall Study|Physician Decision|0|||
48814473|NCT00786474|157161855|FG001|Overall Study|Physician Decision|1|||
48814474|NCT00786474|157161854|FG000|Overall Study|Other|4|||
48814475|NCT00786474|157161855|FG001|Overall Study|Other|4|||
48814476|NCT00849680|157161856|FG000|Overall Study|Adverse Event|0|||
48814477|NCT00849680|157161857|FG001|Overall Study|Adverse Event|0|||
48814478|NCT00849680|157161858|FG002|Overall Study|Adverse Event|0|||
48814479|NCT00849680|157161859|FG003|Overall Study|Adverse Event|0|||
48814480|NCT00849680|157161860|FG004|Overall Study|Adverse Event|0|||
48814481|NCT00849680|157161861|FG005|Overall Study|Adverse Event|0|||
48814482|NCT00849680|157161862|FG006|Overall Study|Adverse Event|2|||
48814483|NCT00849680|157161863|FG007|Overall Study|Adverse Event|0|||
48814484|NCT00849680|157161856|FG000|Overall Study|Lost to Follow-up|7|||
48814485|NCT00849680|157161857|FG001|Overall Study|Lost to Follow-up|3|||
48814486|NCT00849680|157161858|FG002|Overall Study|Lost to Follow-up|12|||
48814487|NCT00849680|157161859|FG003|Overall Study|Lost to Follow-up|11|||
48814488|NCT00849680|157161860|FG004|Overall Study|Lost to Follow-up|8|||
48814489|NCT00849680|157161861|FG005|Overall Study|Lost to Follow-up|11|||
48814490|NCT00849680|157161862|FG006|Overall Study|Lost to Follow-up|12|||
48814491|NCT00849680|157161863|FG007|Overall Study|Lost to Follow-up|5|||
48814492|NCT00849680|157161856|FG000|Overall Study|Subject moved|1|||
48814493|NCT00849680|157161857|FG001|Overall Study|Subject moved|0|||
48814494|NCT00849680|157161858|FG002|Overall Study|Subject moved|3|||
48814495|NCT00849680|157161859|FG003|Overall Study|Subject moved|1|||
48814496|NCT00849680|157161860|FG004|Overall Study|Subject moved|0|||
48814497|NCT00849680|157161861|FG005|Overall Study|Subject moved|2|||
48814498|NCT00849680|157161862|FG006|Overall Study|Subject moved|2|||
48814499|NCT00849680|157161863|FG007|Overall Study|Subject moved|2|||
48814500|NCT00849680|157161856|FG000|Overall Study|Withdrawal by Subject|2|||
48814501|NCT00849680|157161857|FG001|Overall Study|Withdrawal by Subject|0|||
48814502|NCT00849680|157161858|FG002|Overall Study|Withdrawal by Subject|0|||
48814503|NCT00849680|157161859|FG003|Overall Study|Withdrawal by Subject|2|||
48814504|NCT00849680|157161860|FG004|Overall Study|Withdrawal by Subject|2|||
48814505|NCT00849680|157161861|FG005|Overall Study|Withdrawal by Subject|2|||
49126322|NCT03118934|158299671|FG001|Overall Study|Physician Decision|0|||
49126323|NCT03118934|158299672|FG002|Overall Study|Physician Decision|0|||
48814506|NCT00849680|157161862|FG006|Overall Study|Withdrawal by Subject|1|||
48814507|NCT00849680|157161863|FG007|Overall Study|Withdrawal by Subject|1|||
48814508|NCT00849680|157161856|FG000|Overall Study|Subject unable to comply with protocol|1|||
48814509|NCT00849680|157161857|FG001|Overall Study|Subject unable to comply with protocol|0|||
48814510|NCT00849680|157161858|FG002|Overall Study|Subject unable to comply with protocol|0|||
48814511|NCT00849680|157161859|FG003|Overall Study|Subject unable to comply with protocol|0|||
48814512|NCT00849680|157161860|FG004|Overall Study|Subject unable to comply with protocol|0|||
48814513|NCT00849680|157161861|FG005|Overall Study|Subject unable to comply with protocol|0|||
48814514|NCT00849680|157161862|FG006|Overall Study|Subject unable to comply with protocol|0|||
48814515|NCT00849680|157161863|FG007|Overall Study|Subject unable to comply with protocol|0|||
48814516|NCT01265823|157161871|FG000|Overall Study|Unsatisfactory Response Efficacy|1|||
48814517|NCT01265823|157161871|FG000|Overall Study|Failure to Return|4|||
48814518|NCT01265823|157161871|FG000|Overall Study|Protocol Violation|1|||
48814519|NCT01265823|157161871|FG000|Overall Study|Participant Request|1|||
48814520|NCT04320615|157161872|FG000|Overall Study|Withdrawal by Subject|4|||
48814521|NCT04320615|157161873|FG001|Overall Study|Withdrawal by Subject|10|||
48814522|NCT04320615|157161872|FG000|Overall Study|Physician Decision|2|||
48814523|NCT04320615|157161873|FG001|Overall Study|Physician Decision|0|||
48814524|NCT04320615|157161872|FG000|Overall Study|Other|2|||
48814525|NCT04320615|157161873|FG001|Overall Study|Other|0|||
48814526|NCT04320615|157161872|FG000|Overall Study|Lost to Follow-up|5|||
48814527|NCT04320615|157161873|FG001|Overall Study|Lost to Follow-up|23|||
48814528|NCT04320615|157161872|FG000|Overall Study|Death|35|||
49126324|NCT03118934|158299673|FG003|Overall Study|Physician Decision|0|||
49126325|NCT03118934|158299674|FG004|Overall Study|Physician Decision|0|||
49126326|NCT03118934|158299675|FG005|Overall Study|Physician Decision|1|||
49126327|NCT03118934|158299670|FG000|Overall Study|Discontinued prior to exposure|0|||
49126328|NCT03118934|158299671|FG001|Overall Study|Discontinued prior to exposure|1|||
49126329|NCT03118934|158299672|FG002|Overall Study|Discontinued prior to exposure|1|||
49126330|NCT03118934|158299673|FG003|Overall Study|Discontinued prior to exposure|1|||
49126331|NCT03118934|158299674|FG004|Overall Study|Discontinued prior to exposure|2|||
48814529|NCT04320615|157161873|FG001|Overall Study|Death|71|||
48814530|NCT01213173|157161884|FG000|Overall Study|Protocol Violation|2|||
48814531|NCT01213173|157161885|FG001|Overall Study|Protocol Violation|0|||
48814532|NCT01213173|157161884|FG000|Overall Study|Adverse Event|4|||
48814533|NCT01213173|157161885|FG001|Overall Study|Adverse Event|8|||
48814534|NCT01213173|157161884|FG000|Overall Study|Withdrawal by Subject|5|||
48814535|NCT01213173|157161885|FG001|Overall Study|Withdrawal by Subject|5|||
48814536|NCT01213173|157161884|FG000|Overall Study|Incorrect Enrollment|1|||
48814537|NCT01213173|157161885|FG001|Overall Study|Incorrect Enrollment|3|||
49126332|NCT03118934|158299675|FG005|Overall Study|Discontinued prior to exposure|0|||
49126333|NCT04350827|158299676|FG000|Overall Study|Lost to Follow-up|1|||
48814538|NCT00581113|157163500|FG000|Overall Study|Withdrawal by Subject|0|||
48814539|NCT00581113|157163501|FG001|Overall Study|Withdrawal by Subject|1|||
48814540|NCT04781647|157163512|FG000|Overall Study|Study terminated by Sponsor|11|||
48814541|NCT04781647|157163513|FG001|Overall Study|Study terminated by Sponsor|9|||
48814542|NCT04781647|157163514|FG002|Overall Study|Study terminated by Sponsor|9|||
48814543|NCT04781647|157163512|FG000|Overall Study|Withdrawal by Subject|1|||
48814544|NCT04781647|157163513|FG001|Overall Study|Withdrawal by Subject|2|||
48814545|NCT04781647|157163514|FG002|Overall Study|Withdrawal by Subject|0|||
48814546|NCT04781647|157163512|FG000|Overall Study|Adverse Event|0|||
48814547|NCT04781647|157163513|FG001|Overall Study|Adverse Event|1|||
48814548|NCT04781647|157163514|FG002|Overall Study|Adverse Event|1|||
48814549|NCT04781647|157163512|FG000|Overall Study|Protocol Violation|1|||
48814550|NCT04781647|157163513|FG001|Overall Study|Protocol Violation|0|||
48814551|NCT04781647|157163514|FG002|Overall Study|Protocol Violation|0|||
48814552|NCT04781647|157163512|FG000|Overall Study|Pregnancy|0|||
48814553|NCT04781647|157163513|FG001|Overall Study|Pregnancy|0|||
48716604|NCT02123472|156813523|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
48716605|NCT03560518|156813524|FG000|Double Blind Treatment Period|Miscellaneous Reasons|1|||
48716606|NCT03560518|156813525|FG001|Double Blind Treatment Period|Miscellaneous Reasons|0|||
48716607|NCT03560518|156813526|FG002|Double Blind Treatment Period|Miscellaneous Reasons|0|||
48716608|NCT03560518|156813524|FG000|Double Blind Treatment Period|Study Terminated by the Sponsor|6|||
48716609|NCT03560518|156813525|FG001|Double Blind Treatment Period|Study Terminated by the Sponsor|9|||
48716610|NCT03560518|156813526|FG002|Double Blind Treatment Period|Study Terminated by the Sponsor|10|||
48716611|NCT03560518|156813524|FG000|Double Blind Treatment Period|Protocol Violation|1|||
48716612|NCT03560518|156813525|FG001|Double Blind Treatment Period|Protocol Violation|2|||
48716613|NCT03560518|156813526|FG002|Double Blind Treatment Period|Protocol Violation|0|||
48716614|NCT03560518|156813524|FG000|Double Blind Treatment Period|Pregnancy|0|||
48716615|NCT03560518|156813525|FG001|Double Blind Treatment Period|Pregnancy|2|||
48716616|NCT03560518|156813526|FG002|Double Blind Treatment Period|Pregnancy|0|||
48716617|NCT03560518|156813524|FG000|Double Blind Treatment Period|Lost to Follow-up|5|||
48716618|NCT03560518|156813525|FG001|Double Blind Treatment Period|Lost to Follow-up|6|||
48716619|NCT03560518|156813526|FG002|Double Blind Treatment Period|Lost to Follow-up|6|||
48716620|NCT03560518|156813524|FG000|Double Blind Treatment Period|Withdrawal by Subject|10|||
48716621|NCT03560518|156813525|FG001|Double Blind Treatment Period|Withdrawal by Subject|6|||
48716622|NCT03560518|156813526|FG002|Double Blind Treatment Period|Withdrawal by Subject|5|||
48716623|NCT03560518|156813524|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
48716624|NCT03560518|156813525|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
48716625|NCT03560518|156813526|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
48716626|NCT03560518|156813524|FG000|Double Blind Treatment Period|Adverse Event|0|||
48716627|NCT03560518|156813525|FG001|Double Blind Treatment Period|Adverse Event|3|||
48716628|NCT03560518|156813526|FG002|Double Blind Treatment Period|Adverse Event|1|||
48716629|NCT01128621|156813527|FG000|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0|||
48716630|NCT01128621|156813528|FG001|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2|||
48716631|NCT02745145|156813529|FG000|Overall Study|Adverse Event|1|||
48716632|NCT02745145|156813530|FG001|Overall Study|Adverse Event|0|||
48716633|NCT02745145|156813531|FG002|Overall Study|Adverse Event|0|||
48716634|NCT02745145|156813529|FG000|Overall Study|Death|0|||
48716635|NCT02745145|156813530|FG001|Overall Study|Death|1|||
48716636|NCT02745145|156813531|FG002|Overall Study|Death|0|||
48716637|NCT02745145|156813529|FG000|Overall Study|Progressive disease|0|||
48716638|NCT02745145|156813530|FG001|Overall Study|Progressive disease|0|||
48716639|NCT02745145|156813531|FG002|Overall Study|Progressive disease|1|||
48716640|NCT02745145|156813529|FG000|Overall Study|Withdrew consent|1|||
48716641|NCT02745145|156813530|FG001|Overall Study|Withdrew consent|1|||
48716642|NCT02745145|156813531|FG002|Overall Study|Withdrew consent|1|||
48716643|NCT02745145|156813529|FG000|Overall Study|Study Termination|8|||
48716644|NCT02745145|156813530|FG001|Overall Study|Study Termination|3|||
48716645|NCT02745145|156813531|FG002|Overall Study|Study Termination|7|||
48716646|NCT00796445|156813532|FG000|Overall Study|Protocol Violation|5|||
48716647|NCT00796445|156813533|FG001|Overall Study|Protocol Violation|3|||
48814554|NCT04781647|157163514|FG002|Overall Study|Pregnancy|1|||
48814555|NCT04781647|157163512|FG000|Overall Study|Virology rebounded|1|||
49126334|NCT04350827|158299677|FG001|Overall Study|Lost to Follow-up|2|||
48814556|NCT04781647|157163513|FG001|Overall Study|Virology rebounded|0|||
49126335|NCT01775670|158301914|FG000|Overall Study|Lost to Follow-up|1|||
49126336|NCT01775670|158301915|FG001|Overall Study|Lost to Follow-up|1|||
48814557|NCT04781647|157163514|FG002|Overall Study|Virology rebounded|0|||
48716648|NCT00796445|156813532|FG000|Overall Study|Adverse event, serious fatal|10|||
48716649|NCT00796445|156813533|FG001|Overall Study|Adverse event, serious fatal|5|||
48716650|NCT00796445|156813532|FG000|Overall Study|Adverse event, non-fatal|4|||
48814558|NCT00649389|157163515|FG000|Overall Study|Adverse Event|22|||
48814559|NCT00649389|157163516|FG001|Overall Study|Adverse Event|46|||
49126337|NCT01111565|158301921|FG000|Phase B (Weeks 0 to 8)|Lost to Follow-up|3|||
49126338|NCT01111565|158301922|FG001|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
49126339|NCT01111565|158301923|FG002|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
48716651|NCT00796445|156813533|FG001|Overall Study|Adverse event, non-fatal|0|||
48716652|NCT00796445|156813532|FG000|Overall Study|Disease progression/recurrence|537|||
48716653|NCT00796445|156813533|FG001|Overall Study|Disease progression/recurrence|268|||
48716654|NCT00796445|156813532|FG000|Overall Study|Other|10|||
48716655|NCT00796445|156813533|FG001|Overall Study|Other|7|||
48716656|NCT00796445|156813532|FG000|Overall Study|Withdrawal by Subject|18|||
48716657|NCT00796445|156813533|FG001|Overall Study|Withdrawal by Subject|9|||
48716658|NCT00796445|156813532|FG000|Overall Study|Invalid Informed Consent Form|1|||
48716659|NCT00796445|156813533|FG001|Overall Study|Invalid Informed Consent Form|0|||
48716660|NCT00913458|156813534|FG000|Phase 1|Non-Responder|54|||
48716661|NCT00913458|156813535|FG001|Phase 1|Non-Responder|0|||
48716662|NCT00913458|156813536|FG002|Phase 1|Non-Responder|0|||
48716663|NCT00913458|156813537|FG003|Phase 1|Non-Responder|0|||
48716664|NCT00913458|156813538|FG004|Phase 1|Non-Responder|0|||
48716665|NCT00913458|156813539|FG005|Phase 1|Non-Responder|0|||
48716666|NCT00913458|156813540|FG006|Phase 1|Non-Responder|0|||
48716667|NCT00913458|156813534|FG000|Phase 1|Subject Request|17|||
48716668|NCT00913458|156813535|FG001|Phase 1|Subject Request|0|||
49126340|NCT01111565|158301924|FG003|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
49126341|NCT01111565|158301925|FG004|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
49126342|NCT01111565|158301921|FG000|Phase B (Weeks 0 to 8)|Adverse Event|1|||
49126343|NCT01111565|158301922|FG001|Phase B (Weeks 0 to 8)|Adverse Event|0|||
49126344|NCT01111565|158301923|FG002|Phase B (Weeks 0 to 8)|Adverse Event|0|||
49126345|NCT01111565|158301924|FG003|Phase B (Weeks 0 to 8)|Adverse Event|0|||
49126346|NCT01111565|158301925|FG004|Phase B (Weeks 0 to 8)|Adverse Event|0|||
49126347|NCT01111565|158301921|FG000|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|58|||
49126348|NCT01111565|158301922|FG001|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
49126349|NCT01111565|158301923|FG002|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
49126350|NCT01111565|158301924|FG003|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
49126351|NCT01111565|158301925|FG004|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
49126352|NCT01111565|158301921|FG000|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|1|||
49126353|NCT01111565|158301922|FG001|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
49126354|NCT01111565|158301923|FG002|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
48716669|NCT00913458|156813536|FG002|Phase 1|Subject Request|0|||
48716670|NCT00913458|156813537|FG003|Phase 1|Subject Request|0|||
48716671|NCT00913458|156813538|FG004|Phase 1|Subject Request|0|||
48716672|NCT00913458|156813539|FG005|Phase 1|Subject Request|0|||
48716673|NCT00913458|156813540|FG006|Phase 1|Subject Request|0|||
48716674|NCT00913458|156813534|FG000|Phase 1|Adverse Event|20|||
48716675|NCT00913458|156813535|FG001|Phase 1|Adverse Event|0|||
48716676|NCT00913458|156813536|FG002|Phase 1|Adverse Event|0|||
48716677|NCT00913458|156813537|FG003|Phase 1|Adverse Event|0|||
48716678|NCT00913458|156813538|FG004|Phase 1|Adverse Event|0|||
48716679|NCT00913458|156813539|FG005|Phase 1|Adverse Event|0|||
48716680|NCT00913458|156813540|FG006|Phase 1|Adverse Event|0|||
48716681|NCT00913458|156813534|FG000|Phase 1|Lost to Follow-up|2|||
48716682|NCT00913458|156813535|FG001|Phase 1|Lost to Follow-up|0|||
48716683|NCT00913458|156813536|FG002|Phase 1|Lost to Follow-up|0|||
48716684|NCT00913458|156813537|FG003|Phase 1|Lost to Follow-up|0|||
48716685|NCT00913458|156813538|FG004|Phase 1|Lost to Follow-up|0|||
48716686|NCT00913458|156813539|FG005|Phase 1|Lost to Follow-up|0|||
48716687|NCT00913458|156813540|FG006|Phase 1|Lost to Follow-up|0|||
49126355|NCT01111565|158301924|FG003|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
49126356|NCT01111565|158301925|FG004|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
49126357|NCT01111565|158301921|FG000|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|1|||
49126358|NCT01111565|158301922|FG001|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
49126359|NCT01111565|158301923|FG002|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
49126360|NCT01111565|158301924|FG003|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
49126361|NCT01111565|158301925|FG004|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
49126362|NCT01111565|158301921|FG000|Phase B (Weeks 0 to 8)|Protocol Deviation|1|||
49126363|NCT01111565|158301922|FG001|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
49126364|NCT01111565|158301923|FG002|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
49126365|NCT01111565|158301924|FG003|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
49126366|NCT01111565|158301925|FG004|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
49126367|NCT01111565|158301921|FG000|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|1|||
49126368|NCT01111565|158301922|FG001|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
48716688|NCT00913458|156813534|FG000|Phase 1|Protocol Violation|10|||
48716689|NCT00913458|156813535|FG001|Phase 1|Protocol Violation|0|||
48716690|NCT00913458|156813536|FG002|Phase 1|Protocol Violation|0|||
48716691|NCT00913458|156813537|FG003|Phase 1|Protocol Violation|0|||
48716692|NCT00913458|156813538|FG004|Phase 1|Protocol Violation|0|||
48716693|NCT00913458|156813539|FG005|Phase 1|Protocol Violation|0|||
48716694|NCT00913458|156813540|FG006|Phase 1|Protocol Violation|0|||
48716695|NCT00913458|156813534|FG000|Phase 1|Sponsor|2|||
48716696|NCT00913458|156813535|FG001|Phase 1|Sponsor|0|||
48716697|NCT00913458|156813536|FG002|Phase 1|Sponsor|0|||
48716698|NCT00913458|156813537|FG003|Phase 1|Sponsor|0|||
48716699|NCT00913458|156813538|FG004|Phase 1|Sponsor|0|||
49126369|NCT01111565|158301923|FG002|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
49126370|NCT01111565|158301924|FG003|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
49126371|NCT01111565|158301925|FG004|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
49126372|NCT01111565|158301921|FG000|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
49126373|NCT01111565|158301922|FG001|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
49126374|NCT01111565|158301923|FG002|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
49126375|NCT01111565|158301924|FG003|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
49126376|NCT01111565|158301925|FG004|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
49126377|NCT01111565|158301921|FG000|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
49126378|NCT01111565|158301922|FG001|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
49126379|NCT01111565|158301923|FG002|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|2|||
49126380|NCT01111565|158301924|FG003|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
49126381|NCT01111565|158301925|FG004|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
49126382|NCT01111565|158301921|FG000|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
49126383|NCT01111565|158301922|FG001|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
49126384|NCT01111565|158301923|FG002|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
49126385|NCT01111565|158301924|FG003|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|2|||
49126386|NCT01111565|158301925|FG004|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
49126387|NCT01111565|158301921|FG000|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
49126388|NCT01111565|158301922|FG001|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
49126389|NCT01111565|158301923|FG002|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
49126390|NCT01111565|158301924|FG003|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|1|||
49126391|NCT01111565|158301925|FG004|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
49126392|NCT01111565|158301921|FG000|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
49126393|NCT01111565|158301922|FG001|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
49126394|NCT01111565|158301923|FG002|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
49126395|NCT01111565|158301924|FG003|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
49126396|NCT01111565|158301925|FG004|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|1|||
49126397|NCT01719380|158301928|FG000|Overall Study|Adverse Event|0|||
49126398|NCT01719380|158301929|FG001|Overall Study|Adverse Event|0|||
49126399|NCT01719380|158301930|FG002|Overall Study|Adverse Event|1|||
49126400|NCT01719380|158301931|FG003|Overall Study|Adverse Event|2|||
49126401|NCT01719380|158301932|FG004|Overall Study|Adverse Event|0|||
49126402|NCT01719380|158301933|FG005|Overall Study|Adverse Event|1|||
49126403|NCT01719380|158301934|FG006|Overall Study|Adverse Event|0|||
49126404|NCT01719380|158301935|FG007|Overall Study|Adverse Event|1|||
49126405|NCT01719380|158301936|FG008|Overall Study|Adverse Event|4|||
49126406|NCT01719380|158301937|FG009|Overall Study|Adverse Event|3|||
49126407|NCT01719380|158301928|FG000|Overall Study|Death|0|||
49126408|NCT01719380|158301929|FG001|Overall Study|Death|1|||
49126409|NCT01719380|158301930|FG002|Overall Study|Death|0|||
49126410|NCT01719380|158301931|FG003|Overall Study|Death|0|||
49126411|NCT01719380|158301932|FG004|Overall Study|Death|0|||
49126412|NCT01719380|158301933|FG005|Overall Study|Death|0|||
49126413|NCT01719380|158301934|FG006|Overall Study|Death|0|||
49126414|NCT01719380|158301935|FG007|Overall Study|Death|0|||
49126415|NCT01719380|158301936|FG008|Overall Study|Death|3|||
49126416|NCT01719380|158301937|FG009|Overall Study|Death|3|||
49126417|NCT01719380|158301928|FG000|Overall Study|Participant/Guardian Decision|0|||
49126418|NCT01719380|158301929|FG001|Overall Study|Participant/Guardian Decision|0|||
49126419|NCT01719380|158301930|FG002|Overall Study|Participant/Guardian Decision|1|||
49126420|NCT01719380|158301931|FG003|Overall Study|Participant/Guardian Decision|0|||
49126421|NCT01719380|158301932|FG004|Overall Study|Participant/Guardian Decision|0|||
49126422|NCT01719380|158301933|FG005|Overall Study|Participant/Guardian Decision|0|||
49126423|NCT01719380|158301934|FG006|Overall Study|Participant/Guardian Decision|0|||
49126424|NCT01719380|158301935|FG007|Overall Study|Participant/Guardian Decision|0|||
49126425|NCT01719380|158301936|FG008|Overall Study|Participant/Guardian Decision|2|||
49126426|NCT01719380|158301937|FG009|Overall Study|Participant/Guardian Decision|2|||
49126427|NCT01719380|158301928|FG000|Overall Study|Physician Decision|0|||
49126428|NCT01719380|158301929|FG001|Overall Study|Physician Decision|0|||
49126429|NCT01719380|158301930|FG002|Overall Study|Physician Decision|2|||
48716700|NCT00913458|156813539|FG005|Phase 1|Sponsor|0|||
49126430|NCT01719380|158301931|FG003|Overall Study|Physician Decision|0|||
49126431|NCT01719380|158301932|FG004|Overall Study|Physician Decision|0|||
49126432|NCT01719380|158301933|FG005|Overall Study|Physician Decision|0|||
48716701|NCT00913458|156813540|FG006|Phase 1|Sponsor|0|||
48716702|NCT00913458|156813534|FG000|Phase 1|Unsatisfactory Response per Investigator|7|||
49126433|NCT01719380|158301934|FG006|Overall Study|Physician Decision|0|||
48716703|NCT00913458|156813535|FG001|Phase 1|Unsatisfactory Response per Investigator|0|||
49126434|NCT01719380|158301935|FG007|Overall Study|Physician Decision|0|||
49126435|NCT01719380|158301936|FG008|Overall Study|Physician Decision|1|||
49126436|NCT01719380|158301937|FG009|Overall Study|Physician Decision|1|||
49126437|NCT01719380|158301928|FG000|Overall Study|Lack of Efficacy|2|||
49126438|NCT01719380|158301929|FG001|Overall Study|Lack of Efficacy|6|||
49126439|NCT01719380|158301930|FG002|Overall Study|Lack of Efficacy|5|||
49126440|NCT01719380|158301931|FG003|Overall Study|Lack of Efficacy|6|||
49126441|NCT01719380|158301932|FG004|Overall Study|Lack of Efficacy|3|||
49126442|NCT01719380|158301933|FG005|Overall Study|Lack of Efficacy|7|||
49126443|NCT01719380|158301934|FG006|Overall Study|Lack of Efficacy|10|||
49126444|NCT01719380|158301935|FG007|Overall Study|Lack of Efficacy|6|||
49126445|NCT01719380|158301936|FG008|Overall Study|Lack of Efficacy|39|||
49126446|NCT01719380|158301937|FG009|Overall Study|Lack of Efficacy|42|||
49126447|NCT01719380|158301928|FG000|Overall Study|Progressive Disease|0|||
49126448|NCT01719380|158301929|FG001|Overall Study|Progressive Disease|0|||
49126449|NCT01719380|158301930|FG002|Overall Study|Progressive Disease|0|||
49126450|NCT01719380|158301931|FG003|Overall Study|Progressive Disease|0|||
48716704|NCT00913458|156813536|FG002|Phase 1|Unsatisfactory Response per Investigator|0|||
48716705|NCT00913458|156813537|FG003|Phase 1|Unsatisfactory Response per Investigator|0|||
48716706|NCT00913458|156813538|FG004|Phase 1|Unsatisfactory Response per Investigator|0|||
48716707|NCT00913458|156813539|FG005|Phase 1|Unsatisfactory Response per Investigator|0|||
48716708|NCT00913458|156813540|FG006|Phase 1|Unsatisfactory Response per Investigator|0|||
48716709|NCT00913458|156813534|FG000|Phase 2|Non-Responder|0|||
48716710|NCT00913458|156813535|FG001|Phase 2|Non-Responder|5|||
48716711|NCT00913458|156813536|FG002|Phase 2|Non-Responder|7|||
48716712|NCT00913458|156813537|FG003|Phase 2|Non-Responder|12|||
48716713|NCT00913458|156813538|FG004|Phase 2|Non-Responder|0|||
48716714|NCT00913458|156813539|FG005|Phase 2|Non-Responder|0|||
48716715|NCT00913458|156813540|FG006|Phase 2|Non-Responder|0|||
48716716|NCT00913458|156813534|FG000|Phase 2|Subject Request|0|||
48716717|NCT00913458|156813535|FG001|Phase 2|Subject Request|0|||
48716718|NCT00913458|156813536|FG002|Phase 2|Subject Request|1|||
48716719|NCT00913458|156813537|FG003|Phase 2|Subject Request|2|||
48716720|NCT00913458|156813538|FG004|Phase 2|Subject Request|0|||
48716721|NCT00913458|156813539|FG005|Phase 2|Subject Request|0|||
49126451|NCT01719380|158301932|FG004|Overall Study|Progressive Disease|0|||
49126452|NCT01719380|158301933|FG005|Overall Study|Progressive Disease|0|||
49126453|NCT01719380|158301934|FG006|Overall Study|Progressive Disease|0|||
49126454|NCT01719380|158301935|FG007|Overall Study|Progressive Disease|0|||
48716722|NCT00913458|156813540|FG006|Phase 2|Subject Request|0|||
48716723|NCT00913458|156813534|FG000|Phase 2|Adverse Event|0|||
49126455|NCT01719380|158301936|FG008|Overall Study|Progressive Disease|1|||
49126456|NCT01719380|158301937|FG009|Overall Study|Progressive Disease|0|||
49126457|NCT00723229|158301938|FG000|First Intervention|Lost to Follow-up|7|||
49126458|NCT00723229|158301939|FG001|First Intervention|Lost to Follow-up|3|||
49126459|NCT00528424|158301940|FG000|Overall Study|Lost to Follow-up|13|||
49126460|NCT00528424|158301940|FG000|Overall Study|Withdrew consent|2|||
49126461|NCT00528424|158301940|FG000|Overall Study|Administrative reason|2|||
49126462|NCT00528424|158301940|FG000|Overall Study|Other|12|||
49126463|NCT02254772|158301943|FG000|Overall Study|Ineligible|1|||
49126464|NCT02254772|158301943|FG000|Overall Study|Withdrawal by Subject|1|||
49126465|NCT03102762|158301944|FG000|Overall Study|Lost to Follow-up|1|||
49126466|NCT03102762|158301945|FG001|Overall Study|Lost to Follow-up|0|||
49126467|NCT02900352|158301946|FG000|Overall Study|Lost to Follow-up|28|||
49126468|NCT02900352|158301947|FG001|Overall Study|Lost to Follow-up|17|||
49126469|NCT00960193|158301948|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
49126470|NCT00728494|158301949|FG000|Overall Study|Adverse Event|7|||
48716724|NCT00913458|156813535|FG001|Phase 2|Adverse Event|3|||
48716725|NCT00913458|156813536|FG002|Phase 2|Adverse Event|0|||
48716726|NCT00913458|156813537|FG003|Phase 2|Adverse Event|1|||
48716727|NCT00913458|156813538|FG004|Phase 2|Adverse Event|0|||
48814560|NCT00649389|157163517|FG002|Overall Study|Adverse Event|38|||
49126471|NCT00728494|158301950|FG001|Overall Study|Adverse Event|0|||
49126472|NCT00728494|158301949|FG000|Overall Study|Withdrawal by Subject|0|||
48716728|NCT00913458|156813539|FG005|Phase 2|Adverse Event|0|||
48716729|NCT00913458|156813540|FG006|Phase 2|Adverse Event|0|||
49126473|NCT00728494|158301950|FG001|Overall Study|Withdrawal by Subject|2|||
49126474|NCT00728494|158301949|FG000|Overall Study|Lack of Efficacy|2|||
49126475|NCT00728494|158301950|FG001|Overall Study|Lack of Efficacy|4|||
49126476|NCT00728494|158301949|FG000|Overall Study|No data available|0|||
48716730|NCT00913458|156813534|FG000|Phase 2|Lost to Follow-up|0|||
48716731|NCT00913458|156813535|FG001|Phase 2|Lost to Follow-up|0|||
48814561|NCT00649389|157163518|FG003|Overall Study|Adverse Event|48|||
48814562|NCT00649389|157163515|FG000|Overall Study|Lost to Follow-up|15|||
48814563|NCT00649389|157163516|FG001|Overall Study|Lost to Follow-up|17|||
48814564|NCT00649389|157163517|FG002|Overall Study|Lost to Follow-up|21|||
48814565|NCT00649389|157163518|FG003|Overall Study|Lost to Follow-up|26|||
48814566|NCT00649389|157163515|FG000|Overall Study|Protocol Violation|11|||
48814567|NCT00649389|157163516|FG001|Overall Study|Protocol Violation|13|||
48814568|NCT00649389|157163517|FG002|Overall Study|Protocol Violation|9|||
48814569|NCT00649389|157163518|FG003|Overall Study|Protocol Violation|8|||
48814570|NCT00649389|157163515|FG000|Overall Study|Withdrawal by Subject|20|||
48814571|NCT00649389|157163516|FG001|Overall Study|Withdrawal by Subject|21|||
48814572|NCT00649389|157163517|FG002|Overall Study|Withdrawal by Subject|19|||
48814573|NCT00649389|157163518|FG003|Overall Study|Withdrawal by Subject|23|||
48814574|NCT00649389|157163515|FG000|Overall Study|Other|3|||
48814575|NCT00649389|157163516|FG001|Overall Study|Other|9|||
48814576|NCT00649389|157163517|FG002|Overall Study|Other|1|||
48814577|NCT00649389|157163518|FG003|Overall Study|Other|6|||
48814578|NCT01186328|157163519|FG000|Overall Study|Death|1|||
48814579|NCT01186328|157163520|FG001|Overall Study|Death|0|||
48814580|NCT01186328|157163521|FG002|Overall Study|Death|0|||
48814581|NCT04424290|157163524|FG000|Overall Study|Not treated|0|||
48814582|NCT04424290|157163525|FG001|Overall Study|Not treated|0|||
48814583|NCT04424290|157163526|FG002|Overall Study|Not treated|1|||
48814584|NCT04424290|157163527|FG003|Overall Study|Not treated|0|||
48716732|NCT00913458|156813536|FG002|Phase 2|Lost to Follow-up|0|||
48716733|NCT00913458|156813537|FG003|Phase 2|Lost to Follow-up|1|||
48716734|NCT00913458|156813538|FG004|Phase 2|Lost to Follow-up|0|||
48716735|NCT00913458|156813539|FG005|Phase 2|Lost to Follow-up|0|||
48716736|NCT00913458|156813540|FG006|Phase 2|Lost to Follow-up|0|||
48716737|NCT00913458|156813534|FG000|Phase 2|Protocol Violation|0|||
48716738|NCT00913458|156813535|FG001|Phase 2|Protocol Violation|2|||
48716739|NCT00913458|156813536|FG002|Phase 2|Protocol Violation|0|||
48716740|NCT00913458|156813537|FG003|Phase 2|Protocol Violation|0|||
48716741|NCT00913458|156813538|FG004|Phase 2|Protocol Violation|0|||
48716742|NCT00913458|156813539|FG005|Phase 2|Protocol Violation|0|||
48716743|NCT00913458|156813540|FG006|Phase 2|Protocol Violation|0|||
48716744|NCT00913458|156813534|FG000|Phase 2|Unsatisfactory Response per Investigator|0|||
48716745|NCT00913458|156813535|FG001|Phase 2|Unsatisfactory Response per Investigator|0|||
48716746|NCT00913458|156813536|FG002|Phase 2|Unsatisfactory Response per Investigator|11|||
48716747|NCT00913458|156813537|FG003|Phase 2|Unsatisfactory Response per Investigator|17|||
48716748|NCT00913458|156813538|FG004|Phase 2|Unsatisfactory Response per Investigator|0|||
48716749|NCT00913458|156813539|FG005|Phase 2|Unsatisfactory Response per Investigator|0|||
48716750|NCT00913458|156813540|FG006|Phase 2|Unsatisfactory Response per Investigator|0|||
49126477|NCT00728494|158301950|FG001|Overall Study|No data available|1|||
49126478|NCT00902577|158301951|FG000|Overall Study|Withdrawal by Subject|6|||
49126479|NCT00902577|158301951|FG000|Overall Study|FMISO production failure|2|||
49126480|NCT01290718|158301956|FG000|Overall Study|Early termination of the study|4|||
48716751|NCT00913458|156813534|FG000|Phase 3|Adverse Event|0|||
48716752|NCT00913458|156813535|FG001|Phase 3|Adverse Event|0|||
48716753|NCT00913458|156813536|FG002|Phase 3|Adverse Event|0|||
48814585|NCT04424290|157163528|FG004|Overall Study|Not treated|1|||
49126481|NCT02869789|158301958|FG000|Overall Study|Disease progression|184|||
48716754|NCT00913458|156813537|FG003|Phase 3|Adverse Event|0|||
48716755|NCT00913458|156813538|FG004|Phase 3|Adverse Event|5|||
48716756|NCT00913458|156813539|FG005|Phase 3|Adverse Event|4|||
48716757|NCT00913458|156813540|FG006|Phase 3|Adverse Event|1|||
48716758|NCT00913458|156813534|FG000|Phase 3|Lost to Follow-up|0|||
48814586|NCT04424290|157163524|FG000|Overall Study|Adverse Event|0|||
48814587|NCT04424290|157163525|FG001|Overall Study|Adverse Event|0|||
48716759|NCT00913458|156813535|FG001|Phase 3|Lost to Follow-up|0|||
48716760|NCT00913458|156813536|FG002|Phase 3|Lost to Follow-up|0|||
48716761|NCT00913458|156813537|FG003|Phase 3|Lost to Follow-up|0|||
48716762|NCT00913458|156813538|FG004|Phase 3|Lost to Follow-up|2|||
48716763|NCT00913458|156813539|FG005|Phase 3|Lost to Follow-up|0|||
48716764|NCT00913458|156813540|FG006|Phase 3|Lost to Follow-up|0|||
48716765|NCT00913458|156813534|FG000|Phase 3|Non-Responder|0|||
48716766|NCT00913458|156813535|FG001|Phase 3|Non-Responder|0|||
48716767|NCT00913458|156813536|FG002|Phase 3|Non-Responder|0|||
48716768|NCT00913458|156813537|FG003|Phase 3|Non-Responder|0|||
48716769|NCT00913458|156813538|FG004|Phase 3|Non-Responder|0|||
48716770|NCT00913458|156813539|FG005|Phase 3|Non-Responder|1|||
48716771|NCT00913458|156813540|FG006|Phase 3|Non-Responder|3|||
48716772|NCT00913458|156813534|FG000|Phase 3|Withdrawal by Subject|0|||
48716773|NCT00913458|156813535|FG001|Phase 3|Withdrawal by Subject|0|||
48716774|NCT00913458|156813536|FG002|Phase 3|Withdrawal by Subject|0|||
48716775|NCT00913458|156813537|FG003|Phase 3|Withdrawal by Subject|0|||
48716776|NCT00913458|156813538|FG004|Phase 3|Withdrawal by Subject|1|||
48716777|NCT00913458|156813539|FG005|Phase 3|Withdrawal by Subject|2|||
48716778|NCT00913458|156813540|FG006|Phase 3|Withdrawal by Subject|0|||
48716779|NCT00913458|156813534|FG000|Phase 3|Unsatisfactory Response per Investigator|0|||
48716780|NCT00913458|156813535|FG001|Phase 3|Unsatisfactory Response per Investigator|0|||
48716781|NCT00913458|156813536|FG002|Phase 3|Unsatisfactory Response per Investigator|0|||
48716782|NCT00913458|156813537|FG003|Phase 3|Unsatisfactory Response per Investigator|0|||
48716783|NCT00913458|156813538|FG004|Phase 3|Unsatisfactory Response per Investigator|14|||
48716784|NCT00913458|156813539|FG005|Phase 3|Unsatisfactory Response per Investigator|11|||
48716785|NCT00913458|156813540|FG006|Phase 3|Unsatisfactory Response per Investigator|4|||
48716786|NCT02338232|156813541|FG000|Overall Study|Screen Failure|3|||
48716787|NCT02338232|156813541|FG000|Overall Study|Withdrawal by Subject|6|||
48716788|NCT02338232|156813541|FG000|Overall Study|Adverse Event|2|||
48716789|NCT00992589|156813542|FG000|Open-Label Phase|Adverse Event|4|||
48716790|NCT00992589|156813543|FG001|Open-Label Phase|Adverse Event|0|||
48716791|NCT00992589|156813544|FG002|Open-Label Phase|Adverse Event|0|||
48716792|NCT00992589|156813545|FG003|Open-Label Phase|Adverse Event|0|||
48716793|NCT00992589|156813542|FG000|Open-Label Phase|Withdrawal by Subject|20|||
48716794|NCT00992589|156813543|FG001|Open-Label Phase|Withdrawal by Subject|0|||
48716795|NCT00992589|156813544|FG002|Open-Label Phase|Withdrawal by Subject|0|||
48716796|NCT00992589|156813545|FG003|Open-Label Phase|Withdrawal by Subject|0|||
48716797|NCT00992589|156813542|FG000|Open-Label Phase|Lost to Follow-up|1|||
48716798|NCT00992589|156813543|FG001|Open-Label Phase|Lost to Follow-up|0|||
48716799|NCT00992589|156813544|FG002|Open-Label Phase|Lost to Follow-up|0|||
48716800|NCT00992589|156813545|FG003|Open-Label Phase|Lost to Follow-up|0|||
48716801|NCT00992589|156813542|FG000|Open-Label Phase|Protocol Violation|3|||
48716802|NCT00992589|156813543|FG001|Open-Label Phase|Protocol Violation|0|||
48716803|NCT00992589|156813544|FG002|Open-Label Phase|Protocol Violation|0|||
48716804|NCT00992589|156813545|FG003|Open-Label Phase|Protocol Violation|0|||
48716805|NCT00992589|156813542|FG000|Open-Label Phase|Physician Decision|4|||
48716806|NCT00992589|156813543|FG001|Open-Label Phase|Physician Decision|0|||
48716807|NCT00992589|156813544|FG002|Open-Label Phase|Physician Decision|0|||
48716808|NCT00992589|156813545|FG003|Open-Label Phase|Physician Decision|0|||
48716809|NCT00992589|156813542|FG000|Open-Label Phase|Other|45|||
48716810|NCT00992589|156813543|FG001|Open-Label Phase|Other|0|||
48716811|NCT00992589|156813544|FG002|Open-Label Phase|Other|0|||
48716812|NCT00992589|156813545|FG003|Open-Label Phase|Other|0|||
48716813|NCT00992589|156813542|FG000|Double-Blind Phase|Adverse Event|0|||
48716814|NCT00992589|156813543|FG001|Double-Blind Phase|Adverse Event|6|||
48716815|NCT00992589|156813544|FG002|Double-Blind Phase|Adverse Event|2|||
48716816|NCT00992589|156813545|FG003|Double-Blind Phase|Adverse Event|3|||
48716817|NCT00992589|156813542|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
48716818|NCT00992589|156813543|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
48716819|NCT00992589|156813544|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
48716820|NCT00992589|156813545|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
48716821|NCT00992589|156813542|FG000|Double-Blind Phase|Lost to Follow-up|0|||
48716822|NCT00992589|156813543|FG001|Double-Blind Phase|Lost to Follow-up|0|||
48716823|NCT00992589|156813544|FG002|Double-Blind Phase|Lost to Follow-up|0|||
48716824|NCT00992589|156813545|FG003|Double-Blind Phase|Lost to Follow-up|2|||
48716825|NCT00992589|156813542|FG000|Double-Blind Phase|Other|0|||
48716826|NCT00992589|156813543|FG001|Double-Blind Phase|Other|1|||
48716827|NCT00992589|156813544|FG002|Double-Blind Phase|Other|6|||
48716828|NCT00992589|156813545|FG003|Double-Blind Phase|Other|3|||
48716829|NCT03232333|156813546|FG000|Overall Study|Infection or Osteomyelitis|9|||
48716830|NCT03232333|156813546|FG000|Overall Study|Lost to Follow-up|4|||
48716831|NCT03232333|156813546|FG000|Overall Study|Withdrawal by Subject|2|||
48716832|NCT00422084|156813547|FG000|Overall Study|Adverse Event|21|||
48716833|NCT00422084|156813548|FG001|Overall Study|Adverse Event|7|||
48716834|NCT00422084|156813547|FG000|Overall Study|Withdrawal by Subject|12|||
48716835|NCT00422084|156813548|FG001|Overall Study|Withdrawal by Subject|9|||
48716836|NCT00422084|156813547|FG000|Overall Study|Lost to Follow-up|14|||
48716837|NCT00422084|156813548|FG001|Overall Study|Lost to Follow-up|9|||
48716838|NCT00422084|156813547|FG000|Overall Study|Protocol Violation|4|||
48716839|NCT00422084|156813548|FG001|Overall Study|Protocol Violation|1|||
48716840|NCT00422084|156813547|FG000|Overall Study|Lack of Efficacy|40|||
48716841|NCT00422084|156813548|FG001|Overall Study|Lack of Efficacy|42|||
48716842|NCT00422084|156813547|FG000|Overall Study|P. vivax infection|3|||
48716843|NCT00422084|156813548|FG001|Overall Study|P. vivax infection|6|||
48716844|NCT00422084|156813547|FG000|Overall Study|Cyesis|1|||
48716845|NCT00422084|156813548|FG001|Overall Study|Cyesis|0|||
48716846|NCT00422084|156813547|FG000|Overall Study|Withdrawn from study accidentally|1|||
48716847|NCT00422084|156813548|FG001|Overall Study|Withdrawn from study accidentally|0|||
48716848|NCT00422084|156813547|FG000|Overall Study|Non-compliance|1|||
48716849|NCT00422084|156813548|FG001|Overall Study|Non-compliance|0|||
48716850|NCT00422084|156813547|FG000|Overall Study|Re-location|0|||
48716851|NCT00422084|156813548|FG001|Overall Study|Re-location|1|||
48716852|NCT00422084|156813547|FG000|Overall Study|Not defined|1|||
48716853|NCT00422084|156813548|FG001|Overall Study|Not defined|1|||
48716854|NCT00662532|156813556|FG000|Overall Study|Adverse Event|0|||
48716855|NCT00662532|156813557|FG001|Overall Study|Adverse Event|1|||
48716856|NCT00662532|156813556|FG000|Overall Study|Lost to Follow-up|0|||
48716857|NCT00662532|156813557|FG001|Overall Study|Lost to Follow-up|1|||
48716858|NCT02184572|156813558|FG000|Overall Study|Lost to Follow-up|29|||
48716859|NCT02184572|156813559|FG001|Overall Study|Lost to Follow-up|21|||
48716860|NCT02184572|156813558|FG000|Overall Study|Family Out Of Country Until 9/29/2015|1|||
48716861|NCT02184572|156813559|FG001|Overall Study|Family Out Of Country Until 9/29/2015|0|||
48716862|NCT02184572|156813558|FG000|Overall Study|Loss Of Kaiser Insurance|1|||
48716863|NCT02184572|156813559|FG001|Overall Study|Loss Of Kaiser Insurance|0|||
48716864|NCT02184572|156813558|FG000|Overall Study|2nd blooddraw & diary card incomplete|1|||
48716865|NCT02184572|156813559|FG001|Overall Study|2nd blooddraw & diary card incomplete|0|||
48716866|NCT02184572|156813558|FG000|Overall Study|Traveling Outside The Country|1|||
48716867|NCT02184572|156813559|FG001|Overall Study|Traveling Outside The Country|0|||
48716868|NCT02184572|156813558|FG000|Overall Study|Withdrawal by Subject|14|||
48716869|NCT02184572|156813559|FG001|Overall Study|Withdrawal by Subject|9|||
48716870|NCT02350764|156813563|FG000|Overall Study|Adverse Event|4|||
48716871|NCT02350764|156813563|FG000|Overall Study|Death|3|||
48716872|NCT02350764|156813563|FG000|Overall Study|Physician Decision|2|||
48716873|NCT02350764|156813563|FG000|Overall Study|Withdrawal by Subject|2|||
49126482|NCT02869789|158301959|FG001|Overall Study|Disease progression|109|||
49126483|NCT02869789|158301960|FG002|Overall Study|Disease progression|260|||
49126484|NCT02869789|158301961|FG003|Overall Study|Disease progression|19|||
49126485|NCT02869789|158301958|FG000|Overall Study|Study drug toxicity|90|||
49126486|NCT02869789|158301959|FG001|Overall Study|Study drug toxicity|32|||
49126487|NCT02869789|158301960|FG002|Overall Study|Study drug toxicity|55|||
49126488|NCT02869789|158301961|FG003|Overall Study|Study drug toxicity|14|||
49126489|NCT02869789|158301958|FG000|Overall Study|Death|7|||
49126490|NCT02869789|158301959|FG001|Overall Study|Death|3|||
49126491|NCT02869789|158301960|FG002|Overall Study|Death|5|||
49126492|NCT02869789|158301961|FG003|Overall Study|Death|1|||
49126493|NCT02869789|158301958|FG000|Overall Study|Adverse Event unrelated to study drug|30|||
49126494|NCT02869789|158301959|FG001|Overall Study|Adverse Event unrelated to study drug|18|||
49126495|NCT02869789|158301960|FG002|Overall Study|Adverse Event unrelated to study drug|21|||
49126496|NCT02869789|158301961|FG003|Overall Study|Adverse Event unrelated to study drug|6|||
48716874|NCT02743611|156813564|FG000|Overall Study|Early study termination due to Sponsor discretion|4|||
48716875|NCT02743611|156813565|FG001|Overall Study|Early study termination due to Sponsor discretion|0|||
48716876|NCT02743611|156813566|FG002|Overall Study|Early study termination due to Sponsor discretion|0|||
48716877|NCT02743611|156813567|FG003|Overall Study|Early study termination due to Sponsor discretion|0|||
48716878|NCT00600119|156813568|FG000|Single-blind Placebo run-in Period|Other - Not specified|1|||
48716879|NCT00600119|156813569|FG001|Single-blind Placebo run-in Period|Other - Not specified|0|||
48716880|NCT00600119|156813570|FG002|Single-blind Placebo run-in Period|Other - Not specified|0|||
48716881|NCT00600119|156813571|FG003|Single-blind Placebo run-in Period|Other - Not specified|0|||
48716882|NCT00600119|156813572|FG004|Single-blind Placebo run-in Period|Other - Not specified|1|||
48716883|NCT00600119|156813573|FG005|Single-blind Placebo run-in Period|Other - Not specified|1|||
48716884|NCT00600119|156813568|FG000|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
48716885|NCT00600119|156813569|FG001|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
48716886|NCT00600119|156813570|FG002|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
48716887|NCT00600119|156813571|FG003|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
48716888|NCT00600119|156813572|FG004|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
48716889|NCT00600119|156813573|FG005|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
48716890|NCT00600119|156813568|FG000|Single-blind Placebo run-in Period|Sponsor Decision|0|||
48716891|NCT00600119|156813569|FG001|Single-blind Placebo run-in Period|Sponsor Decision|0|||
48716892|NCT00600119|156813570|FG002|Single-blind Placebo run-in Period|Sponsor Decision|1|||
48716893|NCT00600119|156813571|FG003|Single-blind Placebo run-in Period|Sponsor Decision|0|||
48716894|NCT00600119|156813572|FG004|Single-blind Placebo run-in Period|Sponsor Decision|1|||
48716895|NCT00600119|156813573|FG005|Single-blind Placebo run-in Period|Sponsor Decision|0|||
48716896|NCT00600119|156813568|FG000|Single-blind Placebo run-in Period|Lost to Follow-up|1|||
48716897|NCT00600119|156813569|FG001|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
48716898|NCT00600119|156813570|FG002|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
48716899|NCT00600119|156813571|FG003|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
48716900|NCT00600119|156813572|FG004|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
48716901|NCT00600119|156813573|FG005|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
48716902|NCT00600119|156813568|FG000|Single-blind Placebo run-in Period|Adverse Event|0|||
48716903|NCT00600119|156813569|FG001|Single-blind Placebo run-in Period|Adverse Event|0|||
48716904|NCT00600119|156813570|FG002|Single-blind Placebo run-in Period|Adverse Event|0|||
48716905|NCT00600119|156813571|FG003|Single-blind Placebo run-in Period|Adverse Event|1|||
48716906|NCT00600119|156813572|FG004|Single-blind Placebo run-in Period|Adverse Event|0|||
48716907|NCT00600119|156813573|FG005|Single-blind Placebo run-in Period|Adverse Event|1|||
48716908|NCT00600119|156813568|FG000|Single-blind Placebo run-in Period|Withdrawal by Subject|2|||
48716909|NCT00600119|156813569|FG001|Single-blind Placebo run-in Period|Withdrawal by Subject|1|||
48716910|NCT00600119|156813570|FG002|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
48716911|NCT00600119|156813571|FG003|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
48716912|NCT00600119|156813572|FG004|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
48716913|NCT00600119|156813573|FG005|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
48716914|NCT00600119|156813568|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
48716915|NCT00600119|156813569|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
48716916|NCT00600119|156813570|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
48716917|NCT00600119|156813571|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
48716918|NCT00600119|156813572|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
48716919|NCT00600119|156813573|FG005|Double-blind Treatment Period|Withdrawal by Subject|3|||
48920945|NCT00762892|157544788|FG000|Overall Study|Withdrawal by Subject|0|||
49126497|NCT02869789|158301958|FG000|Overall Study|Participant request to discontinue study treatment|10|||
49126498|NCT02869789|158301959|FG001|Overall Study|Participant request to discontinue study treatment|5|||
49126499|NCT02869789|158301960|FG002|Overall Study|Participant request to discontinue study treatment|5|||
49126500|NCT02869789|158301961|FG003|Overall Study|Participant request to discontinue study treatment|3|||
48716920|NCT00600119|156813568|FG000|Double-blind Treatment Period|Other|0|||
48716921|NCT00600119|156813569|FG001|Double-blind Treatment Period|Other|0|||
48716922|NCT00600119|156813570|FG002|Double-blind Treatment Period|Other|0|||
48716923|NCT00600119|156813571|FG003|Double-blind Treatment Period|Other|0|||
48716924|NCT00600119|156813572|FG004|Double-blind Treatment Period|Other|2|||
48716925|NCT00600119|156813573|FG005|Double-blind Treatment Period|Other|1|||
48716926|NCT00600119|156813568|FG000|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
48716927|NCT00600119|156813569|FG001|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
48716928|NCT00600119|156813570|FG002|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
48716929|NCT00600119|156813571|FG003|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
48716930|NCT00600119|156813572|FG004|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
48716931|NCT00600119|156813573|FG005|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
48716932|NCT00600119|156813568|FG000|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
48716933|NCT00600119|156813569|FG001|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1|||
48716934|NCT00600119|156813570|FG002|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
48716935|NCT00600119|156813571|FG003|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
48716936|NCT00600119|156813572|FG004|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
48716937|NCT00600119|156813573|FG005|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
48716938|NCT00600119|156813568|FG000|Double-blind Treatment Period|Sponsor Decision|0|||
48716939|NCT00600119|156813569|FG001|Double-blind Treatment Period|Sponsor Decision|1|||
48716940|NCT00600119|156813570|FG002|Double-blind Treatment Period|Sponsor Decision|0|||
48716941|NCT00600119|156813571|FG003|Double-blind Treatment Period|Sponsor Decision|0|||
48716942|NCT00600119|156813572|FG004|Double-blind Treatment Period|Sponsor Decision|1|||
48716943|NCT00600119|156813573|FG005|Double-blind Treatment Period|Sponsor Decision|0|||
48716944|NCT00600119|156813568|FG000|Double-blind Treatment Period|Physician Decision|2|||
48716945|NCT00600119|156813569|FG001|Double-blind Treatment Period|Physician Decision|0|||
48716946|NCT00600119|156813570|FG002|Double-blind Treatment Period|Physician Decision|0|||
48716947|NCT00600119|156813571|FG003|Double-blind Treatment Period|Physician Decision|0|||
48716948|NCT00600119|156813572|FG004|Double-blind Treatment Period|Physician Decision|0|||
48716949|NCT00600119|156813573|FG005|Double-blind Treatment Period|Physician Decision|0|||
48716950|NCT00600119|156813568|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
48716951|NCT00600119|156813569|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
48716952|NCT00600119|156813570|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
48716953|NCT00600119|156813571|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
48716954|NCT00600119|156813572|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
48716955|NCT00600119|156813573|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
48716956|NCT00600119|156813568|FG000|Double-blind Treatment Period|Adverse Event|1|||
48716957|NCT00600119|156813569|FG001|Double-blind Treatment Period|Adverse Event|1|||
48716958|NCT00600119|156813570|FG002|Double-blind Treatment Period|Adverse Event|0|||
48716959|NCT00600119|156813571|FG003|Double-blind Treatment Period|Adverse Event|1|||
48716960|NCT00600119|156813572|FG004|Double-blind Treatment Period|Adverse Event|2|||
48716961|NCT00600119|156813573|FG005|Double-blind Treatment Period|Adverse Event|10|||
48716962|NCT00600119|156813568|FG000|Follow-up Period|Adverse Event|0|||
48716963|NCT00600119|156813569|FG001|Follow-up Period|Adverse Event|0|||
48716964|NCT00600119|156813570|FG002|Follow-up Period|Adverse Event|0|||
48716965|NCT00600119|156813571|FG003|Follow-up Period|Adverse Event|0|||
48716966|NCT00600119|156813572|FG004|Follow-up Period|Adverse Event|0|||
48716967|NCT00600119|156813573|FG005|Follow-up Period|Adverse Event|1|||
48716968|NCT00600119|156813568|FG000|Follow-up Period|Other|1|||
48716969|NCT00600119|156813569|FG001|Follow-up Period|Other|0|||
48716970|NCT00600119|156813570|FG002|Follow-up Period|Other|0|||
48716971|NCT00600119|156813571|FG003|Follow-up Period|Other|0|||
48716972|NCT00600119|156813572|FG004|Follow-up Period|Other|0|||
48716973|NCT00600119|156813573|FG005|Follow-up Period|Other|0|||
48716974|NCT03051620|156813574|FG000|Overall Study|Lost to Follow-up|6|||
48716975|NCT03051620|156813574|FG000|Overall Study|n=124 enrolled in extension (all completed)|12|||
48716976|NCT01989468|156813575|FG000|Overall Study|Adverse Event|10|||
48716977|NCT01989468|156813576|FG001|Overall Study|Adverse Event|15|||
48716978|NCT01989468|156813577|FG002|Overall Study|Adverse Event|4|||
48716979|NCT01989468|156813578|FG003|Overall Study|Adverse Event|5|||
48716980|NCT01989468|156813579|FG004|Overall Study|Adverse Event|4|||
48716981|NCT01989468|156813575|FG000|Overall Study|Lack of Efficacy|11|||
48716982|NCT01989468|156813576|FG001|Overall Study|Lack of Efficacy|11|||
48716983|NCT01989468|156813577|FG002|Overall Study|Lack of Efficacy|7|||
48716984|NCT01989468|156813578|FG003|Overall Study|Lack of Efficacy|4|||
48716985|NCT01989468|156813579|FG004|Overall Study|Lack of Efficacy|2|||
48716986|NCT01989468|156813575|FG000|Overall Study|Lost to Follow-up|5|||
48716987|NCT01989468|156813576|FG001|Overall Study|Lost to Follow-up|2|||
48716988|NCT01989468|156813577|FG002|Overall Study|Lost to Follow-up|0|||
48716989|NCT01989468|156813578|FG003|Overall Study|Lost to Follow-up|1|||
48716990|NCT01989468|156813579|FG004|Overall Study|Lost to Follow-up|1|||
48716991|NCT01989468|156813575|FG000|Overall Study|Physician Decision|4|||
48716992|NCT01989468|156813576|FG001|Overall Study|Physician Decision|1|||
48716993|NCT01989468|156813577|FG002|Overall Study|Physician Decision|0|||
48716994|NCT01989468|156813578|FG003|Overall Study|Physician Decision|1|||
48716995|NCT01989468|156813579|FG004|Overall Study|Physician Decision|0|||
48716996|NCT01989468|156813575|FG000|Overall Study|Pregnancy|0|||
48716997|NCT01989468|156813576|FG001|Overall Study|Pregnancy|1|||
48716998|NCT01989468|156813577|FG002|Overall Study|Pregnancy|0|||
48716999|NCT01989468|156813578|FG003|Overall Study|Pregnancy|0|||
48717000|NCT01989468|156813579|FG004|Overall Study|Pregnancy|0|||
48717001|NCT01989468|156813575|FG000|Overall Study|Technical Problems|3|||
48717002|NCT01989468|156813576|FG001|Overall Study|Technical Problems|1|||
48717003|NCT01989468|156813577|FG002|Overall Study|Technical Problems|3|||
48717004|NCT01989468|156813578|FG003|Overall Study|Technical Problems|1|||
48717005|NCT01989468|156813579|FG004|Overall Study|Technical Problems|0|||
48717006|NCT01989468|156813575|FG000|Overall Study|Subject Guardian Decision|11|||
48717007|NCT01989468|156813576|FG001|Overall Study|Subject Guardian Decision|6|||
48717008|NCT01989468|156813577|FG002|Overall Study|Subject Guardian Decision|4|||
48717009|NCT01989468|156813578|FG003|Overall Study|Subject Guardian Decision|4|||
48717010|NCT01989468|156813579|FG004|Overall Study|Subject Guardian Decision|1|||
48717011|NCT01989468|156813575|FG000|Overall Study|Death|3|||
48717012|NCT01989468|156813576|FG001|Overall Study|Death|0|||
48717013|NCT01989468|156813577|FG002|Overall Study|Death|1|||
48717014|NCT01989468|156813578|FG003|Overall Study|Death|0|||
48717015|NCT01989468|156813579|FG004|Overall Study|Death|0|||
48717016|NCT01989208|156813585|FG000|200 mg (7 Days)|Protocol Violation|0|||
48717017|NCT01989208|156813586|FG001|200 mg (7 Days)|Protocol Violation|1|||
48717018|NCT02395172|156813587|FG000|Overall Study|Participants randomized but not treated|3|||
48717019|NCT02395172|156813588|FG001|Overall Study|Participants randomized but not treated|31|||
48717020|NCT00717236|156813589|FG000|Double-Blind Period|Adverse Event|33|||
48717021|NCT00717236|156813590|FG001|Double-Blind Period|Adverse Event|6|||
48717022|NCT00717236|156813589|FG000|Double-Blind Period|Lack of Efficacy|6|||
48717023|NCT00717236|156813590|FG001|Double-Blind Period|Lack of Efficacy|6|||
48717024|NCT00717236|156813589|FG000|Double-Blind Period|Lost to Follow-up|3|||
48717025|NCT00717236|156813590|FG001|Double-Blind Period|Lost to Follow-up|5|||
48717026|NCT00717236|156813589|FG000|Double-Blind Period|Withdrawal by Subject|10|||
48717027|NCT00717236|156813590|FG001|Double-Blind Period|Withdrawal by Subject|2|||
48717028|NCT00717236|156813589|FG000|Double-Blind Period|Loss of efficacy|3|||
48717029|NCT00717236|156813590|FG001|Double-Blind Period|Loss of efficacy|0|||
48717030|NCT00717236|156813589|FG000|Double-Blind Period|Other: Death|1|||
48717031|NCT00717236|156813590|FG001|Double-Blind Period|Other: Death|0|||
48717032|NCT00717236|156813589|FG000|Double-Blind Period|Other: Pregnancy|1|||
48717033|NCT00717236|156813590|FG001|Double-Blind Period|Other: Pregnancy|0|||
48717034|NCT00717236|156813589|FG000|Double-Blind Period|Other: Protocol Violation|2|||
48814588|NCT04424290|157163526|FG002|Overall Study|Adverse Event|0|||
48814589|NCT04424290|157163527|FG003|Overall Study|Adverse Event|2|||
48814590|NCT04424290|157163528|FG004|Overall Study|Adverse Event|0|||
48814591|NCT04424290|157163524|FG000|Overall Study|Withdrawal by Subject|0|||
48717035|NCT00717236|156813590|FG001|Double-Blind Period|Other: Protocol Violation|0|||
48717036|NCT00717236|156813589|FG000|Double-Blind Period|Other: Inclusion/Exclusion criteria|6|||
48814592|NCT04424290|157163525|FG001|Overall Study|Withdrawal by Subject|0|||
48814593|NCT04424290|157163526|FG002|Overall Study|Withdrawal by Subject|0|||
48814594|NCT04424290|157163527|FG003|Overall Study|Withdrawal by Subject|0|||
48814595|NCT04424290|157163528|FG004|Overall Study|Withdrawal by Subject|1|||
48814596|NCT04424290|157163524|FG000|Overall Study|Other than listed|0|||
48814597|NCT04424290|157163525|FG001|Overall Study|Other than listed|0|||
48814598|NCT04424290|157163526|FG002|Overall Study|Other than listed|0|||
48814599|NCT04424290|157163527|FG003|Overall Study|Other than listed|1|||
48814600|NCT04424290|157163528|FG004|Overall Study|Other than listed|0|||
48814601|NCT03015116|157163529|FG000|Overall Study|Lost to Follow-up|3|||
48814602|NCT03015116|157163530|FG001|Overall Study|Lost to Follow-up|0|||
48814603|NCT03015116|157163531|FG002|Overall Study|Lost to Follow-up|2|||
49011012|NCT00219557|157877373|FG000|Phase 1|Started chemotherapy at other institute|1|||
49011013|NCT00219557|157877374|FG001|Phase 1|Started chemotherapy at other institute|0|||
49011014|NCT00219557|157877375|FG002|Phase 1|Started chemotherapy at other institute|0|||
49011015|NCT00219557|157877373|FG000|Phase 2|Lack of Efficacy|0|||
49011016|NCT00219557|157877374|FG001|Phase 2|Lack of Efficacy|21|||
49011017|NCT00219557|157877375|FG002|Phase 2|Lack of Efficacy|15|||
49011018|NCT00219557|157877373|FG000|Phase 2|Adverse Event|0|||
49011019|NCT00219557|157877374|FG001|Phase 2|Adverse Event|22|||
49011020|NCT00219557|157877375|FG002|Phase 2|Adverse Event|2|||
49011021|NCT00219557|157877373|FG000|Phase 2|Death|0|||
49011022|NCT00219557|157877374|FG001|Phase 2|Death|8|||
49011023|NCT00219557|157877375|FG002|Phase 2|Death|2|||
49011024|NCT00219557|157877373|FG000|Phase 2|Other|0|||
49011025|NCT00219557|157877374|FG001|Phase 2|Other|8|||
49011026|NCT00219557|157877375|FG002|Phase 2|Other|6|||
49011027|NCT00219557|157877373|FG000|Phase 2|Withdrawal by Subject|0|||
49011028|NCT00219557|157877374|FG001|Phase 2|Withdrawal by Subject|9|||
49011029|NCT00219557|157877375|FG002|Phase 2|Withdrawal by Subject|5|||
49011030|NCT00219557|157877373|FG000|Phase 2|Treatment not received|0|||
49126501|NCT02869789|158301958|FG000|Overall Study|Withdrawal by Subject|5|||
49126502|NCT02869789|158301959|FG001|Overall Study|Withdrawal by Subject|2|||
49126503|NCT02869789|158301960|FG002|Overall Study|Withdrawal by Subject|7|||
49126504|NCT02869789|158301961|FG003|Overall Study|Withdrawal by Subject|2|||
49126505|NCT02869789|158301958|FG000|Overall Study|Lost to Follow-up|0|||
49126506|NCT02869789|158301959|FG001|Overall Study|Lost to Follow-up|0|||
49126507|NCT02869789|158301960|FG002|Overall Study|Lost to Follow-up|2|||
49126508|NCT02869789|158301961|FG003|Overall Study|Lost to Follow-up|0|||
49126509|NCT02869789|158301958|FG000|Overall Study|Maximum clinical benefit|5|||
49126510|NCT02869789|158301959|FG001|Overall Study|Maximum clinical benefit|2|||
49126511|NCT02869789|158301960|FG002|Overall Study|Maximum clinical benefit|1|||
49126512|NCT02869789|158301961|FG003|Overall Study|Maximum clinical benefit|0|||
49126513|NCT02869789|158301958|FG000|Overall Study|Poor/Non-compliance|0|||
49126514|NCT02869789|158301959|FG001|Overall Study|Poor/Non-compliance|2|||
48717037|NCT00717236|156813590|FG001|Double-Blind Period|Other: Inclusion/Exclusion criteria|2|||
48717038|NCT00717236|156813589|FG000|Double-Blind Period|Other: Site withdrew|2|||
48717039|NCT00717236|156813590|FG001|Double-Blind Period|Other: Site withdrew|0|||
48717040|NCT00717236|156813589|FG000|Double-Blind Period|Other: Screening failure|1|||
48717041|NCT00717236|156813590|FG001|Double-Blind Period|Other: Screening failure|0|||
48717042|NCT00717236|156813589|FG000|Double-Blind Period|Other: subject withdrew consent|1|||
48814604|NCT03015116|157163529|FG000|Overall Study|Withdrawal by Subject|3|||
48814605|NCT03015116|157163530|FG001|Overall Study|Withdrawal by Subject|1|||
49126515|NCT02869789|158301960|FG002|Overall Study|Poor/Non-compliance|1|||
49126516|NCT02869789|158301961|FG003|Overall Study|Poor/Non-compliance|0|||
49126517|NCT02869789|158301958|FG000|Overall Study|Participant no longer meets study criteria|0|||
49126518|NCT02869789|158301959|FG001|Overall Study|Participant no longer meets study criteria|1|||
49126519|NCT02869789|158301960|FG002|Overall Study|Participant no longer meets study criteria|1|||
49126520|NCT02869789|158301961|FG003|Overall Study|Participant no longer meets study criteria|0|||
49126521|NCT02869789|158301958|FG000|Overall Study|Administrative reason by sponsor|0|||
49126522|NCT02869789|158301959|FG001|Overall Study|Administrative reason by sponsor|0|||
49126523|NCT02869789|158301960|FG002|Overall Study|Administrative reason by sponsor|1|||
49126524|NCT02869789|158301961|FG003|Overall Study|Administrative reason by sponsor|0|||
49126525|NCT02869789|158301958|FG000|Overall Study|Other reasons|4|||
49126526|NCT02869789|158301959|FG001|Overall Study|Other reasons|8|||
49126527|NCT02869789|158301960|FG002|Overall Study|Other reasons|6|||
49126528|NCT02869789|158301961|FG003|Overall Study|Other reasons|0|||
49126529|NCT00749398|158301962|FG000|Overall Study|Lack of Efficacy|7|||
49126530|NCT00749398|158301962|FG000|Overall Study|Adverse Event|4|||
49126531|NCT00749398|158301962|FG000|Overall Study|Serious adverse event|11|||
49126532|NCT00749398|158301962|FG000|Overall Study|Withdrawal by Subject|17|||
49126533|NCT00749398|158301962|FG000|Overall Study|Lost to Follow-up|11|||
49126534|NCT00749398|158301962|FG000|Overall Study|Reason not specified|2|||
49126535|NCT00749398|158301962|FG000|Overall Study|Unknown reason|1|||
49126536|NCT00846053|158301963|FG000|Overall Study|Physician Decision|3|||
49126537|NCT00846053|158301964|FG001|Overall Study|Physician Decision|0|||
49126538|NCT00570401|158301967|FG000|Overall Study|Adverse Event|2|||
49126539|NCT03902613|158301969|FG000|Overall Study|Physician Decision|1|||
49126540|NCT00069264|158301974|FG000|Overall Study|Adverse Event|3|||
49126541|NCT00069264|158301974|FG000|Overall Study|Progressive Disease|23|||
48717043|NCT00717236|156813590|FG001|Double-Blind Period|Other: subject withdrew consent|1|||
48717044|NCT00717236|156813589|FG000|Double-Blind Period|Other: Abnormal chest X-ray|2|||
48717045|NCT00717236|156813590|FG001|Double-Blind Period|Other: Abnormal chest X-ray|1|||
48717046|NCT00717236|156813589|FG000|Double-Blind Period|Other: History of adenoid grown|1|||
49126542|NCT00069264|158301974|FG000|Overall Study|Withdrawal by Subject|3|||
48717047|NCT00717236|156813590|FG001|Double-Blind Period|Other: History of adenoid grown|0|||
48717048|NCT00717236|156813589|FG000|Double-Blind Period|Other: History of cancer|1|||
49126543|NCT00069264|158301974|FG000|Overall Study|Discon Therapy|3|||
49126544|NCT00732069|158301986|FG000|Washout After First Study Drug|Adverse Event|1|||
49126545|NCT00732069|158301987|FG001|Washout After First Study Drug|Adverse Event|0|||
49126546|NCT00732069|158301988|FG002|Washout After First Study Drug|Adverse Event|0|||
49126547|NCT00732069|158301989|FG003|Washout After First Study Drug|Adverse Event|0|||
48717049|NCT00717236|156813590|FG001|Double-Blind Period|Other: History of cancer|0|||
48717050|NCT00717236|156813589|FG000|Double-Blind Period|Other: Sponsor request|1|||
48717051|NCT00717236|156813590|FG001|Double-Blind Period|Other: Sponsor request|0|||
48717052|NCT00717236|156813589|FG000|Double-Blind Period|Other: Inappropriate randomization|1|||
48717053|NCT00717236|156813590|FG001|Double-Blind Period|Other: Inappropriate randomization|0|||
48717054|NCT00717236|156813589|FG000|Double-Blind Period|Other: Detection of Hepatitis C Virus|1|||
48717055|NCT00717236|156813590|FG001|Double-Blind Period|Other: Detection of Hepatitis C Virus|0|||
48717056|NCT00717236|156813589|FG000|Double-Blind Period|Other: Subject moved|1|||
48814606|NCT03015116|157163531|FG002|Overall Study|Withdrawal by Subject|0|||
48814607|NCT03015116|157163529|FG000|Overall Study|Subject has New Medical Status|1|||
48814608|NCT03015116|157163530|FG001|Overall Study|Subject has New Medical Status|0|||
48814609|NCT03015116|157163531|FG002|Overall Study|Subject has New Medical Status|0|||
48814610|NCT03015116|157163529|FG000|Overall Study|Physician Decision|0|||
48814611|NCT03015116|157163530|FG001|Overall Study|Physician Decision|1|||
48814612|NCT03015116|157163531|FG002|Overall Study|Physician Decision|0|||
48814613|NCT01267825|157163532|FG000|Overall Study|study terminated. no data collected.|1|||
48814614|NCT01267825|157163533|FG001|Overall Study|study terminated. no data collected.|0|||
48814615|NCT00358215|157163536|FG000|Overall Study|Ineligibility determined|4|||
48814616|NCT00358215|157163537|FG001|Overall Study|Ineligibility determined|3|||
48814617|NCT00358215|157163536|FG000|Overall Study|Adverse Event|83|||
48814618|NCT00358215|157163537|FG001|Overall Study|Adverse Event|65|||
48814619|NCT00358215|157163536|FG000|Overall Study|Withdrawal by Subject|111|||
48814620|NCT00358215|157163537|FG001|Overall Study|Withdrawal by Subject|102|||
48814621|NCT00358215|157163536|FG000|Overall Study|Participant request|65|||
48814622|NCT00358215|157163537|FG001|Overall Study|Participant request|64|||
48814623|NCT00358215|157163536|FG000|Overall Study|Physician Decision|47|||
48814624|NCT00358215|157163537|FG001|Overall Study|Physician Decision|39|||
49126548|NCT00732069|158301990|FG004|Washout After First Study Drug|Adverse Event|0|||
49126549|NCT00732069|158301991|FG005|Washout After First Study Drug|Adverse Event|0|||
48717057|NCT00717236|156813590|FG001|Double-Blind Period|Other: Subject moved|1|||
48717058|NCT00717236|156813589|FG000|Double-Blind Period|Other: Stopped taking DMARD|1|||
48717059|NCT00717236|156813590|FG001|Double-Blind Period|Other: Stopped taking DMARD|0|||
48717060|NCT00717236|156813589|FG000|Double-Blind Period|Other: Prohibited medication taken|2|||
48717061|NCT00717236|156813590|FG001|Double-Blind Period|Other: Prohibited medication taken|2|||
48717062|NCT00717236|156813589|FG000|Double-Blind Period|Other: Transportation problems|0|||
48717063|NCT00717236|156813590|FG001|Double-Blind Period|Other: Transportation problems|1|||
48717064|NCT00717236|156813589|FG000|Double-Blind Period|Other: Investigator Decision|0|||
48717065|NCT00717236|156813590|FG001|Double-Blind Period|Other: Investigator Decision|1|||
48717066|NCT00717236|156813589|FG000|Open-Label Period|Adverse Event|29|||
48717067|NCT00717236|156813590|FG001|Open-Label Period|Adverse Event|4|||
48717068|NCT00717236|156813589|FG000|Open-Label Period|Lack of Efficacy|30|||
48717069|NCT00717236|156813590|FG001|Open-Label Period|Lack of Efficacy|8|||
48717070|NCT00717236|156813589|FG000|Open-Label Period|Lost to Follow-up|28|||
48717071|NCT00717236|156813590|FG001|Open-Label Period|Lost to Follow-up|4|||
48717072|NCT00717236|156813589|FG000|Open-Label Period|Withdrawal by Subject|20|||
48717073|NCT00717236|156813590|FG001|Open-Label Period|Withdrawal by Subject|2|||
48814625|NCT00358215|157163536|FG000|Overall Study|Lost to Follow-up|16|||
49126550|NCT04460326|158301992|FG000|Completed at Least 4 Meals|Early discharge|5|||
49126551|NCT04460326|158301993|FG001|Completed at Least 4 Meals|Early discharge|5|||
49126552|NCT04460326|158301992|FG000|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
49126553|NCT04460326|158301993|FG001|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
49126554|NCT04460326|158301992|FG000|Completed at Least 4 Meals|Nutrition method changed|1|||
49126555|NCT04460326|158301993|FG001|Completed at Least 4 Meals|Nutrition method changed|0|||
49126556|NCT04460326|158301992|FG000|Completed at Least 4 Meals|Transfer to ICU|0|||
49126557|NCT04460326|158301993|FG001|Completed at Least 4 Meals|Transfer to ICU|1|||
49126558|NCT04460326|158301992|FG000|Completed at Least 4 Meals|Bleeding at CGM site|0|||
49126559|NCT04460326|158301993|FG001|Completed at Least 4 Meals|Bleeding at CGM site|1|||
49126560|NCT04460326|158301992|FG000|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|5|||
49126561|NCT04460326|158301993|FG001|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|12|||
49126562|NCT01499810|158301994|FG000|Overall Study|Lost to Follow-up|10|||
49126563|NCT01499810|158301994|FG000|Overall Study|Protocol Violation|1|||
49126564|NCT01499810|158301994|FG000|Overall Study|Withdrawal by Subject|1|||
49126565|NCT01939314|158302005|FG000|Overall Study|Withdrawal by Subject|3|||
49126566|NCT01939314|158302006|FG001|Overall Study|Withdrawal by Subject|1|||
49126567|NCT01939314|158302005|FG000|Overall Study|Protocol Violation|1|||
49126568|NCT01939314|158302006|FG001|Overall Study|Protocol Violation|0|||
49126569|NCT01939314|158302005|FG000|Overall Study|Pregnancy|0|||
49126570|NCT01939314|158302006|FG001|Overall Study|Pregnancy|1|||
48814626|NCT00358215|157163537|FG001|Overall Study|Lost to Follow-up|22|||
48814627|NCT00358215|157163536|FG000|Overall Study|Death|265|||
48814628|NCT00358215|157163537|FG001|Overall Study|Death|281|||
48814629|NCT00358215|157163536|FG000|Overall Study|Protocol Violation|64|||
48814630|NCT00358215|157163537|FG001|Overall Study|Protocol Violation|59|||
49126571|NCT01939314|158302005|FG000|Overall Study|Lost to Follow-up|5|||
49126572|NCT01939314|158302006|FG001|Overall Study|Lost to Follow-up|6|||
48717074|NCT00717236|156813589|FG000|Open-Label Period|Loss of Efficacy|6|||
48814631|NCT00358215|157163536|FG000|Overall Study|Pregnancy|1|||
48814632|NCT00358215|157163537|FG001|Overall Study|Pregnancy|0|||
48814633|NCT00358215|157163536|FG000|Overall Study|Other|21|||
48814634|NCT00358215|157163537|FG001|Overall Study|Other|14|||
48814635|NCT00358215|157163536|FG000|Overall Study|Did not receive investigational product|2|||
48814636|NCT00358215|157163537|FG001|Overall Study|Did not receive investigational product|3|||
48814637|NCT00744237|157163538|FG000|Overall Study|Lack of Efficacy|1|||
48814638|NCT00744237|157163539|FG001|Overall Study|Lack of Efficacy|1|||
48814639|NCT00744237|157163540|FG002|Overall Study|Lack of Efficacy|0|||
48814640|NCT00744237|157163538|FG000|Overall Study|Withdrawal by Subject|9|||
48814641|NCT00744237|157163539|FG001|Overall Study|Withdrawal by Subject|5|||
48814642|NCT00744237|157163540|FG002|Overall Study|Withdrawal by Subject|3|||
48814643|NCT00744237|157163538|FG000|Overall Study|Lost to Follow-up|1|||
48717075|NCT00717236|156813590|FG001|Open-Label Period|Loss of Efficacy|1|||
48717076|NCT00717236|156813589|FG000|Open-Label Period|Other: Peripheral Neuropathy|0|||
48814644|NCT00744237|157163539|FG001|Overall Study|Lost to Follow-up|1|||
48814645|NCT00744237|157163540|FG002|Overall Study|Lost to Follow-up|1|||
48814646|NCT00744237|157163538|FG000|Overall Study|Protocol Violation|3|||
48814647|NCT00744237|157163539|FG001|Overall Study|Protocol Violation|4|||
48814648|NCT00744237|157163540|FG002|Overall Study|Protocol Violation|3|||
48814649|NCT00744237|157163538|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
48814650|NCT00744237|157163539|FG001|Overall Study|Inclusion/Exclusion criteria not met|0|||
48814651|NCT00744237|157163540|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
48814652|NCT00744237|157163538|FG000|Overall Study|Dosing Error|1|||
48814653|NCT00744237|157163539|FG001|Overall Study|Dosing Error|0|||
48814654|NCT00744237|157163540|FG002|Overall Study|Dosing Error|1|||
48814655|NCT00744237|157163538|FG000|Overall Study|Study Drug Error|1|||
48814656|NCT00744237|157163539|FG001|Overall Study|Study Drug Error|0|||
48814657|NCT00744237|157163540|FG002|Overall Study|Study Drug Error|0|||
48814658|NCT00744237|157163538|FG000|Overall Study|Prohibited Concomitant Medication|0|||
48814659|NCT00744237|157163539|FG001|Overall Study|Prohibited Concomitant Medication|0|||
48814660|NCT00744237|157163540|FG002|Overall Study|Prohibited Concomitant Medication|1|||
48814661|NCT00744237|157163538|FG000|Overall Study|Poor Compliance|0|||
48814662|NCT00744237|157163539|FG001|Overall Study|Poor Compliance|2|||
48920946|NCT00762892|157544789|FG001|Overall Study|Withdrawal by Subject|1|||
48717077|NCT00717236|156813590|FG001|Open-Label Period|Other: Peripheral Neuropathy|1|||
48717078|NCT00717236|156813589|FG000|Open-Label Period|Other: Lack of Compliance|1|||
48717079|NCT00717236|156813590|FG001|Open-Label Period|Other: Lack of Compliance|1|||
48717080|NCT00717236|156813589|FG000|Open-Label Period|Other: History of Basal Cell Carcinoma|1|||
48717081|NCT00717236|156813590|FG001|Open-Label Period|Other: History of Basal Cell Carcinoma|0|||
48717082|NCT00717236|156813589|FG000|Open-Label Period|Other: Moved|1|||
48717083|NCT00717236|156813590|FG001|Open-Label Period|Other: Moved|0|||
48717084|NCT00717236|156813589|FG000|Open-Label Period|Other: Investigator Decision|1|||
48717085|NCT00717236|156813590|FG001|Open-Label Period|Other: Investigator Decision|0|||
48717086|NCT00717236|156813589|FG000|Open-Label Period|Other: Loss of Staff (unblinded)|1|||
48717087|NCT00717236|156813590|FG001|Open-Label Period|Other: Loss of Staff (unblinded)|0|||
48717088|NCT00717236|156813589|FG000|Open-Label Period|Other: Sponsor Request|3|||
48717089|NCT00717236|156813590|FG001|Open-Label Period|Other: Sponsor Request|0|||
48717090|NCT00717236|156813589|FG000|Open-Label Period|Other: Cataract Surgery|1|||
48717091|NCT00717236|156813590|FG001|Open-Label Period|Other: Cataract Surgery|0|||
48717092|NCT00717236|156813589|FG000|Open-Label Period|Other: Administration of Golimumab|1|||
48717093|NCT00717236|156813590|FG001|Open-Label Period|Other: Administration of Golimumab|0|||
48717094|NCT00717236|156813589|FG000|Open-Label Period|Other: Completion Accidently Performed|1|||
48717095|NCT00717236|156813590|FG001|Open-Label Period|Other: Completion Accidently Performed|0|||
48717096|NCT00717236|156813589|FG000|Open-Label Period|Other: Medical Monitor Recommendation|1|||
48717097|NCT00717236|156813590|FG001|Open-Label Period|Other: Medical Monitor Recommendation|0|||
48717098|NCT02410343|156813598|FG000|Core Period (24 Weeks)|Adverse Event|1|||
48717099|NCT02410343|156813599|FG001|Core Period (24 Weeks)|Adverse Event|0|||
48717100|NCT02410343|156813598|FG000|Core Period (24 Weeks)|Early termination of study by sponsor|4|||
48717101|NCT02410343|156813599|FG001|Core Period (24 Weeks)|Early termination of study by sponsor|7|||
48717102|NCT02410343|156813598|FG000|Extension Period (12 Months)|Adverse Event|1|||
48814663|NCT00744237|157163540|FG002|Overall Study|Poor Compliance|0|||
48814664|NCT00744237|157163538|FG000|Overall Study|Administrative. Site Closed|1|||
48814665|NCT00744237|157163539|FG001|Overall Study|Administrative. Site Closed|1|||
48814666|NCT00744237|157163540|FG002|Overall Study|Administrative. Site Closed|1|||
48814667|NCT00744237|157163538|FG000|Overall Study|Adverse Event|9|||
48814668|NCT00744237|157163539|FG001|Overall Study|Adverse Event|13|||
48814669|NCT00744237|157163540|FG002|Overall Study|Adverse Event|5|||
48814670|NCT02609659|157163543|FG000|Overall Study|Adverse Event|1|||
48814671|NCT02609659|157163543|FG000|Overall Study|Lost to Follow-up|6|||
48920947|NCT00762892|157544788|FG000|Overall Study|Death|1|||
48814672|NCT02609659|157163543|FG000|Overall Study|Other|1|||
48814673|NCT02032173|157163544|FG000|Overall Study|Discontinuation due to sponsor decision|31|||
48814674|NCT01004250|157163545|FG000|Induction Therapy Period|Adverse Event|10|||
48814675|NCT01004250|157163545|FG000|Induction Therapy Period|Entry Criteria Not Met|1|||
48814676|NCT01004250|157163545|FG000|Induction Therapy Period|Withdrawal by Subject|2|||
48814677|NCT01004250|157163545|FG000|Induction Therapy Period|Physician Decision|2|||
48814678|NCT01004250|157163545|FG000|Maintenance Therapy Period|Adverse Event|15|||
48814679|NCT01004250|157163545|FG000|Maintenance Therapy Period|Lost to Follow-up|1|||
48814680|NCT01004250|157163545|FG000|Maintenance Therapy Period|Protocol Violation|1|||
48717103|NCT02410343|156813599|FG001|Extension Period (12 Months)|Adverse Event|0|||
48717104|NCT02410343|156813598|FG000|Extension Period (12 Months)|Early termination of study by sponsor|0|||
48717105|NCT02410343|156813599|FG001|Extension Period (12 Months)|Early termination of study by sponsor|1|||
48717106|NCT00119678|156813601|FG000|Double-blind Treatment Period|Death|1|||
48717107|NCT00119678|156813602|FG001|Double-blind Treatment Period|Death|0|||
48717108|NCT00119678|156813601|FG000|Double-blind Treatment Period|Adverse Event|7|||
48717109|NCT00119678|156813602|FG001|Double-blind Treatment Period|Adverse Event|1|||
48717110|NCT00119678|156813601|FG000|Double-blind Treatment Period|Lack of Efficacy|21|||
48717111|NCT00119678|156813602|FG001|Double-blind Treatment Period|Lack of Efficacy|12|||
48717112|NCT00119678|156813601|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
48717113|NCT00119678|156813602|FG001|Double-blind Treatment Period|Lost to Follow-up|2|||
48717114|NCT00119678|156813601|FG000|Double-blind Treatment Period|Participant withdrew consent|4|||
48717115|NCT00119678|156813602|FG001|Double-blind Treatment Period|Participant withdrew consent|4|||
48717116|NCT00119678|156813601|FG000|Double-blind Treatment Period|Participants not meeting study criteria|0|||
48717117|NCT00119678|156813602|FG001|Double-blind Treatment Period|Participants not meeting study criteria|1|||
48717118|NCT00119678|156813601|FG000|Double-blind Treatment Period|Poor/Non-compliance|3|||
48717119|NCT00119678|156813602|FG001|Double-blind Treatment Period|Poor/Non-compliance|0|||
48717120|NCT00119678|156813601|FG000|Double-blind Treatment Period|Pregnancy|0|||
48717121|NCT00119678|156813602|FG001|Double-blind Treatment Period|Pregnancy|2|||
48717122|NCT00119678|156813601|FG000|Double-blind Treatment Period|Not treated|1|||
48717123|NCT00119678|156813602|FG001|Double-blind Treatment Period|Not treated|2|||
48717124|NCT00119678|156813601|FG000|Double-blind Treatment Period|Site closed due to non-compliance|3|||
48717125|NCT00119678|156813602|FG001|Double-blind Treatment Period|Site closed due to non-compliance|2|||
48717126|NCT00119678|156813601|FG000|Open-label Treatment Period|Death|1|||
48717127|NCT00119678|156813602|FG001|Open-label Treatment Period|Death|0|||
48717128|NCT00119678|156813601|FG000|Open-label Treatment Period|Adverse Event|3|||
48717129|NCT00119678|156813602|FG001|Open-label Treatment Period|Adverse Event|0|||
48717130|NCT00119678|156813601|FG000|Open-label Treatment Period|Lack of Efficacy|9|||
48717131|NCT00119678|156813602|FG001|Open-label Treatment Period|Lack of Efficacy|0|||
48717132|NCT00119678|156813601|FG000|Open-label Treatment Period|Lost to Follow-up|3|||
48717133|NCT00119678|156813602|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
48717134|NCT00119678|156813601|FG000|Open-label Treatment Period|Participant withdrew consent|4|||
48717135|NCT00119678|156813602|FG001|Open-label Treatment Period|Participant withdrew consent|0|||
48717136|NCT00119678|156813601|FG000|Open-label Treatment Period|Participants not meeting study criteria|2|||
48717137|NCT00119678|156813602|FG001|Open-label Treatment Period|Participants not meeting study criteria|0|||
48717138|NCT00119678|156813601|FG000|Open-label Treatment Period|Pregnancy|1|||
48717139|NCT00119678|156813602|FG001|Open-label Treatment Period|Pregnancy|0|||
48717140|NCT00119678|156813601|FG000|Open-label Treatment Period|Administrative reasons by sponsor|87|||
48717141|NCT00119678|156813602|FG001|Open-label Treatment Period|Administrative reasons by sponsor|0|||
48717142|NCT00486811|156813605|FG000|Overall Study|Adverse Event|28|||
48717143|NCT00486811|156813606|FG001|Overall Study|Adverse Event|60|||
48717144|NCT00486811|156813607|FG002|Overall Study|Adverse Event|135|||
48717145|NCT00486811|156813605|FG000|Overall Study|Lack of Efficacy|34|||
48717146|NCT00486811|156813606|FG001|Overall Study|Lack of Efficacy|14|||
48717147|NCT00486811|156813607|FG002|Overall Study|Lack of Efficacy|7|||
48717148|NCT00486811|156813605|FG000|Overall Study|Lost to Follow-up|4|||
48717149|NCT00486811|156813606|FG001|Overall Study|Lost to Follow-up|6|||
48717150|NCT00486811|156813607|FG002|Overall Study|Lost to Follow-up|4|||
48717151|NCT00486811|156813605|FG000|Overall Study|Withdrawal by Subject|33|||
48717152|NCT00486811|156813606|FG001|Overall Study|Withdrawal by Subject|44|||
48717153|NCT00486811|156813607|FG002|Overall Study|Withdrawal by Subject|58|||
48717154|NCT00486811|156813605|FG000|Overall Study|Study drug non-compliant|5|||
48717155|NCT00486811|156813606|FG001|Overall Study|Study drug non-compliant|6|||
48717156|NCT00486811|156813607|FG002|Overall Study|Study drug non-compliant|3|||
48717157|NCT00486811|156813605|FG000|Overall Study|All other|18|||
48717158|NCT00486811|156813606|FG001|Overall Study|All other|11|||
48717159|NCT00486811|156813607|FG002|Overall Study|All other|7|||
48717160|NCT00834080|156813608|FG000|Overall Study|Adverse Event|7|||
48717161|NCT00834080|156813608|FG000|Overall Study|Lost to Follow-up|7|||
48717162|NCT00834080|156813608|FG000|Overall Study|Withdrawal by Subject|5|||
48717163|NCT00834080|156813608|FG000|Overall Study|Other - Pregnancy|1|||
48717164|NCT00834080|156813608|FG000|Overall Study|Other - False positive tests of the UDS|1|||
48717165|NCT00834080|156813608|FG000|Overall Study|Physician Decision|1|||
48814681|NCT01004250|157163545|FG000|Maintenance Therapy Period|Withdrawal by Subject|5|||
48717166|NCT00834080|156813608|FG000|Overall Study|Subject Relocated|1|||
48717167|NCT01642615|156813613|FG000|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1|||
48717168|NCT01642615|156813614|FG001|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
48717169|NCT01642615|156813615|FG002|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
48717170|NCT01642615|156813613|FG000|Open Label Maintenance Phase|Major Protocol Deviation|1|||
48717171|NCT01642615|156813614|FG001|Open Label Maintenance Phase|Major Protocol Deviation|0|||
48814682|NCT01004250|157163545|FG000|Maintenance Therapy Period|Physician Decision|4|||
48814683|NCT01004250|157163545|FG000|Follow-Up (FU) Period|Lost to Follow-up|1|||
48814684|NCT01383993|157163547|FG000|Overall Study|Adverse Event|1|||
48814685|NCT01383993|157163548|FG001|Overall Study|Adverse Event|1|||
49126573|NCT00887484|158302007|FG000|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1|||
49126574|NCT00887484|158302007|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
48717172|NCT01642615|156813615|FG002|Open Label Maintenance Phase|Major Protocol Deviation|0|||
48717173|NCT01642615|156813613|FG000|Open Label Maintenance Phase|Lost to Follow-up|1|||
48717174|NCT01642615|156813614|FG001|Open Label Maintenance Phase|Lost to Follow-up|0|||
48717175|NCT01642615|156813615|FG002|Open Label Maintenance Phase|Lost to Follow-up|0|||
48717176|NCT01642615|156813613|FG000|Open Label Maintenance Phase|Voluntary Withdrawal|1|||
48717177|NCT01642615|156813614|FG001|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
48717178|NCT01642615|156813615|FG002|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
48717179|NCT01642615|156813613|FG000|Open Label Maintenance Phase|Did not receive treatment|1|||
48717180|NCT01642615|156813614|FG001|Open Label Maintenance Phase|Did not receive treatment|0|||
48717181|NCT01642615|156813615|FG002|Open Label Maintenance Phase|Did not receive treatment|0|||
48717182|NCT01642615|156813613|FG000|Double Blind Maintenance Phase|Lack of Efficacy|0|||
48717183|NCT01642615|156813614|FG001|Double Blind Maintenance Phase|Lack of Efficacy|1|||
48717184|NCT01642615|156813615|FG002|Double Blind Maintenance Phase|Lack of Efficacy|3|||
48717185|NCT01642615|156813613|FG000|Double Blind Maintenance Phase|Voluntary Withdrawal|0|||
48717186|NCT01642615|156813614|FG001|Double Blind Maintenance Phase|Voluntary Withdrawal|5|||
48717187|NCT01642615|156813615|FG002|Double Blind Maintenance Phase|Voluntary Withdrawal|2|||
48717188|NCT01642615|156813613|FG000|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
48717189|NCT01642615|156813614|FG001|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1|||
48717190|NCT01642615|156813615|FG002|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
48717191|NCT01642615|156813613|FG000|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
48717192|NCT01642615|156813614|FG001|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
48717193|NCT01642615|156813615|FG002|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1|||
48717194|NCT00439738|156813616|FG000|Overall Study|Withdrawal by Subject|16|||
48717195|NCT00439738|156813617|FG001|Overall Study|Withdrawal by Subject|13|||
48717196|NCT00439738|156813616|FG000|Overall Study|Adverse Event|6|||
48717197|NCT00439738|156813617|FG001|Overall Study|Adverse Event|4|||
48717198|NCT00439738|156813616|FG000|Overall Study|Lost to Follow-up|5|||
48717199|NCT00439738|156813617|FG001|Overall Study|Lost to Follow-up|6|||
48717200|NCT00439738|156813616|FG000|Overall Study|Protocol Violation|6|||
48717201|NCT00439738|156813617|FG001|Overall Study|Protocol Violation|3|||
48717202|NCT00439738|156813616|FG000|Overall Study|Lack of Efficacy|2|||
48717203|NCT00439738|156813617|FG001|Overall Study|Lack of Efficacy|2|||
48717204|NCT00439738|156813616|FG000|Overall Study|Abnormal Lab Values|1|||
48717205|NCT00439738|156813617|FG001|Overall Study|Abnormal Lab Values|0|||
48717206|NCT01457352|156813618|FG000|Period 1|Adverse Event|2|||
48717207|NCT01457352|156813619|FG001|Period 1|Adverse Event|0|||
48717208|NCT01457352|156813618|FG000|Period 1|Withdrawal by Subject|2|||
48717209|NCT01457352|156813619|FG001|Period 1|Withdrawal by Subject|0|||
48717210|NCT01457352|156813618|FG000|Period 1|Physician Decision|2|||
48717211|NCT01457352|156813619|FG001|Period 1|Physician Decision|0|||
48717212|NCT01457352|156813618|FG000|Period 1|MS related disease progression|1|||
48717213|NCT01457352|156813619|FG001|Period 1|MS related disease progression|0|||
48717214|NCT01457352|156813618|FG000|Period 1|Withdrawn|1|||
48717215|NCT01457352|156813619|FG001|Period 1|Withdrawn|0|||
48717216|NCT01457352|156813618|FG000|Period 1|withdrew per sponsor|1|||
48717217|NCT01457352|156813619|FG001|Period 1|withdrew per sponsor|0|||
48717218|NCT01457352|156813618|FG000|Period 1|Protocol Violation|4|||
48717219|NCT01457352|156813619|FG001|Period 1|Protocol Violation|0|||
48717220|NCT01457352|156813618|FG000|Period 1|Did not meet eligibility criteria|3|||
48717221|NCT01457352|156813619|FG001|Period 1|Did not meet eligibility criteria|0|||
48717222|NCT01457352|156813618|FG000|Period 2|Withdrawal by Subject|23|||
48717223|NCT01457352|156813619|FG001|Period 2|Withdrawal by Subject|0|||
48717224|NCT01457352|156813618|FG000|Period 2|Adverse Event|22|||
48717225|NCT01457352|156813619|FG001|Period 2|Adverse Event|0|||
48717226|NCT01457352|156813618|FG000|Period 2|no analysis|10|||
48717227|NCT01457352|156813619|FG001|Period 2|no analysis|0|||
48717228|NCT01457352|156813618|FG000|Period 2|Lack of Efficacy|8|||
48717229|NCT01457352|156813619|FG001|Period 2|Lack of Efficacy|0|||
48717230|NCT01457352|156813618|FG000|Period 2|Protocol Violation|4|||
48717231|NCT01457352|156813619|FG001|Period 2|Protocol Violation|0|||
48717232|NCT01457352|156813618|FG000|Period 2|Sponsor's withdrawal|7|||
48717233|NCT01457352|156813619|FG001|Period 2|Sponsor's withdrawal|0|||
48717234|NCT01457352|156813618|FG000|Period 2|Lost to Follow-up|1|||
48717235|NCT01457352|156813619|FG001|Period 2|Lost to Follow-up|0|||
48717236|NCT01457352|156813618|FG000|Period 2|dose change|1|||
48717237|NCT01457352|156813619|FG001|Period 2|dose change|0|||
48717238|NCT01457352|156813618|FG000|Period 2|Physician Decision|1|||
48814686|NCT01383993|157163549|FG002|Overall Study|Adverse Event|0|||
48717239|NCT01457352|156813619|FG001|Period 2|Physician Decision|0|||
48814687|NCT01383993|157163547|FG000|Overall Study|Withdrawal by Subject|0|||
48717240|NCT01457352|156813618|FG000|Period 2|Did not meet eligibility criteria|3|||
48717241|NCT01457352|156813619|FG001|Period 2|Did not meet eligibility criteria|0|||
48717242|NCT01457352|156813618|FG000|Period 3|Adverse Event|1|||
48717243|NCT01457352|156813619|FG001|Period 3|Adverse Event|1|||
48717244|NCT01457352|156813618|FG000|Period 3|Withdrawal by Subject|0|||
48717245|NCT01457352|156813619|FG001|Period 3|Withdrawal by Subject|2|||
48717246|NCT01457352|156813618|FG000|Period 3|incorrect treatment|0|||
48717247|NCT01457352|156813619|FG001|Period 3|incorrect treatment|1|||
48717248|NCT01457352|156813618|FG000|Period 3|Sponsor's withdrawal|0|||
48717249|NCT01457352|156813619|FG001|Period 3|Sponsor's withdrawal|1|||
48717250|NCT02576145|156813620|FG000|Overall Study|Adverse Event|1|||
48717251|NCT02576145|156813621|FG001|Overall Study|Adverse Event|0|||
48717252|NCT02576145|156813620|FG000|Overall Study|Withdrawal by Subject|1|||
48814688|NCT01383993|157163548|FG001|Overall Study|Withdrawal by Subject|0|||
48814689|NCT01383993|157163549|FG002|Overall Study|Withdrawal by Subject|1|||
48814690|NCT01383993|157163547|FG000|Overall Study|Marketed voriconazole in post-therapy|2|||
48814691|NCT01383993|157163548|FG001|Overall Study|Marketed voriconazole in post-therapy|0|||
48814692|NCT01383993|157163549|FG002|Overall Study|Marketed voriconazole in post-therapy|0|||
48814693|NCT00312858|157163550|FG000|Overall Study|Adverse Event|0|||
48814694|NCT00312858|157163551|FG001|Overall Study|Adverse Event|1|||
48814695|NCT00312858|157163550|FG000|Overall Study|Lost to Follow-up|25|||
48814696|NCT00312858|157163551|FG001|Overall Study|Lost to Follow-up|42|||
48814697|NCT00312858|157163550|FG000|Overall Study|Protocol Violation|3|||
48814698|NCT00312858|157163551|FG001|Overall Study|Protocol Violation|8|||
49126575|NCT00887484|158302007|FG000|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1|||
49126576|NCT01061606|158302008|FG000|Overall Study|Adverse Event|1|||
49126577|NCT01061606|158302008|FG000|Overall Study|Death|1|||
49126578|NCT01061606|158302008|FG000|Overall Study|Disease Progression|4|||
49126579|NCT01061606|158302008|FG000|Overall Study|alternative therapy|2|||
49126580|NCT00735007|158302009|FG000|Overall Study|Adverse Event|4|||
49126581|NCT00735007|158302009|FG000|Overall Study|Protocol Violation|1|||
49126582|NCT03044314|158302011|FG000|Overall Study|Physician Decision|2|||
49126583|NCT03044314|158302011|FG000|Overall Study|Withdrawal by Subject|1|||
49126584|NCT03044314|158302011|FG000|Overall Study|Connector tubing not available|1|||
49126585|NCT03644017|158302012|FG000|Overall Study|Access Abandonment|5|||
49126586|NCT03644017|158302012|FG000|Overall Study|Kidney Transplant|2|||
49126587|NCT00830765|158302013|FG000|Overall Study|Protocol Violation|3|||
49126588|NCT00830765|158302014|FG001|Overall Study|Protocol Violation|2|||
49126589|NCT01204671|158302015|FG000|Overall Study|Adverse Event|4|||
49126590|NCT01204671|158302016|FG001|Overall Study|Adverse Event|3|||
49126591|NCT01204671|158302017|FG002|Overall Study|Adverse Event|3|||
49126592|NCT01204671|158302018|FG003|Overall Study|Adverse Event|3|||
49126593|NCT01204671|158302019|FG004|Overall Study|Adverse Event|1|||
49126594|NCT01204671|158302015|FG000|Overall Study|Withdrawal by Subject|2|||
49126595|NCT01204671|158302016|FG001|Overall Study|Withdrawal by Subject|3|||
49126596|NCT01204671|158302017|FG002|Overall Study|Withdrawal by Subject|4|||
49126597|NCT01204671|158302018|FG003|Overall Study|Withdrawal by Subject|5|||
49126598|NCT01204671|158302019|FG004|Overall Study|Withdrawal by Subject|3|||
49126599|NCT01204671|158302015|FG000|Overall Study|Lost to Follow-up|7|||
49126600|NCT01204671|158302016|FG001|Overall Study|Lost to Follow-up|8|||
49126601|NCT01204671|158302017|FG002|Overall Study|Lost to Follow-up|6|||
49126602|NCT01204671|158302018|FG003|Overall Study|Lost to Follow-up|4|||
49126603|NCT01204671|158302019|FG004|Overall Study|Lost to Follow-up|0|||
49126604|NCT01204671|158302015|FG000|Overall Study|Unknown Completion Status|1|||
49126605|NCT01204671|158302016|FG001|Overall Study|Unknown Completion Status|1|||
49126606|NCT01204671|158302017|FG002|Overall Study|Unknown Completion Status|0|||
49126607|NCT01204671|158302018|FG003|Overall Study|Unknown Completion Status|0|||
49126608|NCT01204671|158302019|FG004|Overall Study|Unknown Completion Status|0|||
49126609|NCT01204671|158302015|FG000|Overall Study|Physician Decision|0|||
49126610|NCT01204671|158302016|FG001|Overall Study|Physician Decision|0|||
48717253|NCT02576145|156813621|FG001|Overall Study|Withdrawal by Subject|0|||
48717254|NCT02576145|156813620|FG000|Overall Study|Acute rejection|1|||
48717255|NCT02576145|156813621|FG001|Overall Study|Acute rejection|0|||
48717256|NCT02576145|156813620|FG000|Overall Study|Tetanus Titers Decreased|0|||
48814699|NCT00312858|157163550|FG000|Overall Study|Withdraw by Participant|20|||
48814700|NCT00312858|157163551|FG001|Overall Study|Withdraw by Participant|20|||
48814701|NCT00312858|157163550|FG000|Overall Study|Participant Moved|11|||
48814702|NCT00312858|157163551|FG001|Overall Study|Participant Moved|10|||
48814703|NCT00312858|157163550|FG000|Overall Study|Other|9|||
48814704|NCT00312858|157163551|FG001|Overall Study|Other|12|||
49126611|NCT01204671|158302017|FG002|Overall Study|Physician Decision|0|||
49126612|NCT01204671|158302018|FG003|Overall Study|Physician Decision|1|||
49126613|NCT01204671|158302019|FG004|Overall Study|Physician Decision|0|||
48717257|NCT02576145|156813621|FG001|Overall Study|Tetanus Titers Decreased|1|||
48717258|NCT02660138|156813622|FG000|Overall Study|Adverse Event|0|||
48717259|NCT02660138|156813623|FG001|Overall Study|Adverse Event|3|||
48814705|NCT00422799|157163553|FG000|Overall Study|Withdrawal by Subject|6|||
49126614|NCT00264147|158302020|FG000|Treatment I Period|Adverse Event|3|||
48717260|NCT02660138|156813624|FG002|Overall Study|Adverse Event|2|||
49126615|NCT00264147|158302021|FG001|Treatment I Period|Adverse Event|6|||
49126616|NCT00264147|158302022|FG002|Treatment I Period|Adverse Event|3|||
48717261|NCT02660138|156813622|FG000|Overall Study|Lack of Efficacy|1|||
49126617|NCT00264147|158302023|FG003|Treatment I Period|Adverse Event|5|||
49126618|NCT00264147|158302024|FG004|Treatment I Period|Adverse Event|7|||
49126619|NCT00264147|158302025|FG005|Treatment I Period|Adverse Event|0|||
49126620|NCT00264147|158302020|FG000|Treatment I Period|Laboratory Adverse Event|0|||
49126621|NCT00264147|158302021|FG001|Treatment I Period|Laboratory Adverse Event|0|||
49126622|NCT00264147|158302022|FG002|Treatment I Period|Laboratory Adverse Event|0|||
49126623|NCT00264147|158302023|FG003|Treatment I Period|Laboratory Adverse Event|1|||
49126624|NCT00264147|158302024|FG004|Treatment I Period|Laboratory Adverse Event|0|||
49126625|NCT00264147|158302025|FG005|Treatment I Period|Laboratory Adverse Event|0|||
49126626|NCT00264147|158302020|FG000|Treatment I Period|Lack of Efficacy|6|||
49126627|NCT00264147|158302021|FG001|Treatment I Period|Lack of Efficacy|2|||
49126628|NCT00264147|158302022|FG002|Treatment I Period|Lack of Efficacy|8|||
49126629|NCT00264147|158302023|FG003|Treatment I Period|Lack of Efficacy|0|||
49126630|NCT00264147|158302024|FG004|Treatment I Period|Lack of Efficacy|1|||
49126631|NCT00264147|158302025|FG005|Treatment I Period|Lack of Efficacy|0|||
49126632|NCT00264147|158302020|FG000|Treatment I Period|Lost to Follow-up|1|||
49126633|NCT00264147|158302021|FG001|Treatment I Period|Lost to Follow-up|0|||
49126634|NCT00264147|158302022|FG002|Treatment I Period|Lost to Follow-up|0|||
49126635|NCT00264147|158302023|FG003|Treatment I Period|Lost to Follow-up|1|||
49126636|NCT00264147|158302024|FG004|Treatment I Period|Lost to Follow-up|1|||
49126637|NCT00264147|158302025|FG005|Treatment I Period|Lost to Follow-up|0|||
49126638|NCT00264147|158302020|FG000|Treatment I Period|Protocol Violation|2|||
49126639|NCT00264147|158302021|FG001|Treatment I Period|Protocol Violation|2|||
49126640|NCT00264147|158302022|FG002|Treatment I Period|Protocol Violation|0|||
49126641|NCT00264147|158302023|FG003|Treatment I Period|Protocol Violation|0|||
49126642|NCT00264147|158302024|FG004|Treatment I Period|Protocol Violation|0|||
49126643|NCT00264147|158302025|FG005|Treatment I Period|Protocol Violation|0|||
49126644|NCT00264147|158302020|FG000|Treatment I Period|Withdrawal by Subject|2|||
49126645|NCT00264147|158302021|FG001|Treatment I Period|Withdrawal by Subject|0|||
49126646|NCT00264147|158302022|FG002|Treatment I Period|Withdrawal by Subject|0|||
49126647|NCT00264147|158302023|FG003|Treatment I Period|Withdrawal by Subject|2|||
49126648|NCT00264147|158302024|FG004|Treatment I Period|Withdrawal by Subject|2|||
49126649|NCT00264147|158302025|FG005|Treatment I Period|Withdrawal by Subject|0|||
49126650|NCT00264147|158302020|FG000|Treatment I Period|Patient out of town for an extended time|0|||
48814706|NCT00422799|157163553|FG000|Overall Study|Adverse Event|7|||
48814707|NCT02406261|157163554|FG000|Period 1|Lost to Follow-up|2|||
48814708|NCT02406261|157163555|FG001|Period 1|Lost to Follow-up|0|||
48814709|NCT02406261|157163554|FG000|Period 1|Adverse Event|1|||
48814710|NCT02406261|157163555|FG001|Period 1|Adverse Event|0|||
48814711|NCT02406261|157163554|FG000|Period 2|Physician Decision|0|||
48814712|NCT02406261|157163555|FG001|Period 2|Physician Decision|1|||
48814713|NCT02406261|157163554|FG000|Period 2|Protocol Violation|0|||
48717262|NCT02660138|156813623|FG001|Overall Study|Lack of Efficacy|2|||
48717263|NCT02660138|156813624|FG002|Overall Study|Lack of Efficacy|1|||
48717264|NCT02660138|156813622|FG000|Overall Study|Withdrawal by Subject|7|||
48717265|NCT02660138|156813623|FG001|Overall Study|Withdrawal by Subject|6|||
48717266|NCT02660138|156813624|FG002|Overall Study|Withdrawal by Subject|6|||
48717267|NCT02660138|156813622|FG000|Overall Study|Lost to Follow-up|4|||
48717268|NCT02660138|156813623|FG001|Overall Study|Lost to Follow-up|4|||
48717269|NCT02660138|156813624|FG002|Overall Study|Lost to Follow-up|1|||
48717270|NCT02660138|156813622|FG000|Overall Study|Sponsor Decision to Terminate Study|57|||
48717271|NCT02660138|156813623|FG001|Overall Study|Sponsor Decision to Terminate Study|57|||
48717272|NCT02660138|156813624|FG002|Overall Study|Sponsor Decision to Terminate Study|62|||
48717273|NCT02660138|156813622|FG000|Overall Study|Other|1|||
48717274|NCT02660138|156813623|FG001|Overall Study|Other|1|||
48717275|NCT02660138|156813624|FG002|Overall Study|Other|0|||
48717276|NCT02660138|156813622|FG000|Overall Study|Not treated|0|||
48717277|NCT02660138|156813623|FG001|Overall Study|Not treated|1|||
48717278|NCT02660138|156813624|FG002|Overall Study|Not treated|0|||
48717279|NCT01185353|156813627|FG000|Part A (Weeks 0 Through 12)|Adverse Event|1|||
48717280|NCT01185353|156813628|FG001|Part A (Weeks 0 Through 12)|Adverse Event|1|||
48717281|NCT01185353|156813629|FG002|Part A (Weeks 0 Through 12)|Adverse Event|1|||
48717282|NCT01185353|156813630|FG003|Part A (Weeks 0 Through 12)|Adverse Event|1|||
48814714|NCT02406261|157163555|FG001|Period 2|Protocol Violation|1|||
48814715|NCT02406261|157163554|FG000|Period 2|Withdrawal by Subject|0|||
49126651|NCT00264147|158302021|FG001|Treatment I Period|Patient out of town for an extended time|1|||
49126652|NCT00264147|158302022|FG002|Treatment I Period|Patient out of town for an extended time|0|||
48717283|NCT01185353|156813631|FG004|Part A (Weeks 0 Through 12)|Adverse Event|5|||
48717284|NCT01185353|156813632|FG005|Part A (Weeks 0 Through 12)|Adverse Event|0|||
48717285|NCT01185353|156813633|FG006|Part A (Weeks 0 Through 12)|Adverse Event|0|||
48814716|NCT02406261|157163555|FG001|Period 2|Withdrawal by Subject|1|||
49126653|NCT00264147|158302023|FG003|Treatment I Period|Patient out of town for an extended time|0|||
49126654|NCT00264147|158302024|FG004|Treatment I Period|Patient out of town for an extended time|0|||
49126655|NCT00264147|158302025|FG005|Treatment I Period|Patient out of town for an extended time|0|||
49126656|NCT00264147|158302020|FG000|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
49126657|NCT00264147|158302021|FG001|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
49126658|NCT00264147|158302022|FG002|Treatment I Period|Unblinded due to Serious Adverse Event|1|||
49126659|NCT00264147|158302023|FG003|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
49126660|NCT00264147|158302024|FG004|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
49126661|NCT00264147|158302025|FG005|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
49126662|NCT00264147|158302020|FG000|Treatment I Period|Reassigned to Treatment II Period|84|||
49126663|NCT00264147|158302021|FG001|Treatment I Period|Reassigned to Treatment II Period|72|||
49126664|NCT00264147|158302022|FG002|Treatment I Period|Reassigned to Treatment II Period|65|||
49126665|NCT00264147|158302023|FG003|Treatment I Period|Reassigned to Treatment II Period|63|||
49126666|NCT00264147|158302024|FG004|Treatment I Period|Reassigned to Treatment II Period|45|||
49126667|NCT00264147|158302025|FG005|Treatment I Period|Reassigned to Treatment II Period|0|||
49126668|NCT00264147|158302020|FG000|Treatment II Period|Adverse Event|0|||
48814717|NCT01394250|157163556|FG000|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14|||
48814718|NCT01394250|157163557|FG001|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13|||
48814719|NCT01394250|157163556|FG000|Successful IV Placement & Follow-Up|Withdrawal by Subject|6|||
48814720|NCT01394250|157163557|FG001|Successful IV Placement & Follow-Up|Withdrawal by Subject|11|||
48814721|NCT03000673|157163560|FG000|Overall Study|Withdrawal by Subject|1|||
48814722|NCT03000673|157163561|FG001|Overall Study|Withdrawal by Subject|0|||
48814723|NCT03000673|157163562|FG002|Overall Study|Withdrawal by Subject|0|||
48814724|NCT03000673|157163563|FG003|Overall Study|Withdrawal by Subject|0|||
48814725|NCT02374593|157163564|FG000|Overall Study|non-compliant|2|||
49126669|NCT00264147|158302021|FG001|Treatment II Period|Adverse Event|0|||
49126670|NCT00264147|158302022|FG002|Treatment II Period|Adverse Event|0|||
49126671|NCT00264147|158302023|FG003|Treatment II Period|Adverse Event|0|||
49126672|NCT00264147|158302024|FG004|Treatment II Period|Adverse Event|9|||
49126673|NCT00264147|158302025|FG005|Treatment II Period|Adverse Event|9|||
49126674|NCT00264147|158302020|FG000|Treatment II Period|Laboratory Adverse Event|0|||
49126675|NCT00264147|158302021|FG001|Treatment II Period|Laboratory Adverse Event|0|||
49126676|NCT00264147|158302022|FG002|Treatment II Period|Laboratory Adverse Event|0|||
49126677|NCT00264147|158302023|FG003|Treatment II Period|Laboratory Adverse Event|0|||
49126678|NCT00264147|158302024|FG004|Treatment II Period|Laboratory Adverse Event|0|||
49126679|NCT00264147|158302025|FG005|Treatment II Period|Laboratory Adverse Event|1|||
49126680|NCT00264147|158302020|FG000|Treatment II Period|Lack of Efficacy|0|||
49126681|NCT00264147|158302021|FG001|Treatment II Period|Lack of Efficacy|0|||
49126682|NCT00264147|158302022|FG002|Treatment II Period|Lack of Efficacy|0|||
49126683|NCT00264147|158302023|FG003|Treatment II Period|Lack of Efficacy|0|||
49126684|NCT00264147|158302024|FG004|Treatment II Period|Lack of Efficacy|20|||
49126685|NCT00264147|158302025|FG005|Treatment II Period|Lack of Efficacy|19|||
49126686|NCT00264147|158302020|FG000|Treatment II Period|Lost to Follow-up|0|||
49126687|NCT00264147|158302021|FG001|Treatment II Period|Lost to Follow-up|0|||
49126688|NCT00264147|158302022|FG002|Treatment II Period|Lost to Follow-up|0|||
48717286|NCT01185353|156813634|FG007|Part A (Weeks 0 Through 12)|Adverse Event|0|||
48717287|NCT01185353|156813635|FG008|Part A (Weeks 0 Through 12)|Adverse Event|0|||
48717288|NCT01185353|156813636|FG009|Part A (Weeks 0 Through 12)|Adverse Event|0|||
48717289|NCT01185353|156813627|FG000|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
48717290|NCT01185353|156813628|FG001|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
48717291|NCT01185353|156813629|FG002|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
48717292|NCT01185353|156813630|FG003|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
48717293|NCT01185353|156813631|FG004|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4|||
48717294|NCT01185353|156813632|FG005|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
48717295|NCT01185353|156813633|FG006|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
49126689|NCT00264147|158302023|FG003|Treatment II Period|Lost to Follow-up|0|||
49126690|NCT00264147|158302024|FG004|Treatment II Period|Lost to Follow-up|1|||
49126691|NCT00264147|158302025|FG005|Treatment II Period|Lost to Follow-up|1|||
49126692|NCT00264147|158302020|FG000|Treatment II Period|Withdrawal by Subject|0|||
49126693|NCT00264147|158302021|FG001|Treatment II Period|Withdrawal by Subject|0|||
49126694|NCT00264147|158302022|FG002|Treatment II Period|Withdrawal by Subject|0|||
49126695|NCT00264147|158302023|FG003|Treatment II Period|Withdrawal by Subject|0|||
49126696|NCT00264147|158302024|FG004|Treatment II Period|Withdrawal by Subject|3|||
49126697|NCT00264147|158302025|FG005|Treatment II Period|Withdrawal by Subject|2|||
49126698|NCT00264147|158302020|FG000|Treatment II Period|Pre-scheduled total hip replacement|0|||
49126699|NCT00264147|158302021|FG001|Treatment II Period|Pre-scheduled total hip replacement|0|||
49126700|NCT00264147|158302022|FG002|Treatment II Period|Pre-scheduled total hip replacement|0|||
49126701|NCT00264147|158302023|FG003|Treatment II Period|Pre-scheduled total hip replacement|0|||
49126702|NCT00264147|158302024|FG004|Treatment II Period|Pre-scheduled total hip replacement|0|||
49126703|NCT00264147|158302025|FG005|Treatment II Period|Pre-scheduled total hip replacement|1|||
49126704|NCT01316575|158302028|FG000|Overall Study|Withdrawal by Subject|2|||
49126705|NCT01316575|158302029|FG001|Overall Study|Withdrawal by Subject|0|||
49126706|NCT01316575|158302028|FG000|Overall Study|Required alternate treatment|0|||
48717296|NCT01185353|156813634|FG007|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
48717297|NCT01185353|156813635|FG008|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
48717298|NCT01185353|156813636|FG009|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
48717299|NCT01185353|156813627|FG000|Part A (Weeks 0 Through 12)|Lack of Efficacy|2|||
48717300|NCT01185353|156813628|FG001|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
48717301|NCT01185353|156813629|FG002|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
48717302|NCT01185353|156813630|FG003|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
48717303|NCT01185353|156813631|FG004|Part A (Weeks 0 Through 12)|Lack of Efficacy|1|||
48717304|NCT01185353|156813632|FG005|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
48717305|NCT01185353|156813633|FG006|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
48717306|NCT01185353|156813634|FG007|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
49126707|NCT01316575|158302029|FG001|Overall Study|Required alternate treatment|1|||
49126708|NCT00315445|158302030|FG000|Overall Study|Adverse Event|7|||
49126709|NCT00315445|158302031|FG001|Overall Study|Adverse Event|12|||
49126710|NCT00315445|158302032|FG002|Overall Study|Adverse Event|15|||
49126711|NCT00315445|158302030|FG000|Overall Study|Lack of Efficacy|16|||
49126712|NCT00315445|158302031|FG001|Overall Study|Lack of Efficacy|1|||
49126713|NCT00315445|158302032|FG002|Overall Study|Lack of Efficacy|7|||
49126714|NCT00315445|158302030|FG000|Overall Study|Lost to Follow-up|1|||
49126715|NCT00315445|158302031|FG001|Overall Study|Lost to Follow-up|0|||
49126716|NCT00315445|158302032|FG002|Overall Study|Lost to Follow-up|1|||
48717307|NCT01185353|156813635|FG008|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
48717308|NCT01185353|156813636|FG009|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
48717309|NCT01185353|156813627|FG000|Part A (Weeks 0 Through 12)|Physician Decision|0|||
48717310|NCT01185353|156813628|FG001|Part A (Weeks 0 Through 12)|Physician Decision|0|||
48717311|NCT01185353|156813629|FG002|Part A (Weeks 0 Through 12)|Physician Decision|1|||
48717312|NCT01185353|156813630|FG003|Part A (Weeks 0 Through 12)|Physician Decision|0|||
48717313|NCT01185353|156813631|FG004|Part A (Weeks 0 Through 12)|Physician Decision|2|||
48717314|NCT01185353|156813632|FG005|Part A (Weeks 0 Through 12)|Physician Decision|0|||
48717315|NCT01185353|156813633|FG006|Part A (Weeks 0 Through 12)|Physician Decision|0|||
48920948|NCT00762892|157544789|FG001|Overall Study|Death|0|||
49126717|NCT00315445|158302030|FG000|Overall Study|Protocol Violation|2|||
49126718|NCT00315445|158302031|FG001|Overall Study|Protocol Violation|0|||
49126719|NCT00315445|158302032|FG002|Overall Study|Protocol Violation|1|||
49126720|NCT00315445|158302030|FG000|Overall Study|Other|1|||
49126721|NCT00315445|158302031|FG001|Overall Study|Other|3|||
49126722|NCT00315445|158302032|FG002|Overall Study|Other|0|||
49126723|NCT00969228|158302033|FG000|Overall Study|Adverse Event|1|||
49126724|NCT00969228|158302034|FG001|Overall Study|Adverse Event|0|||
49126725|NCT00969228|158302033|FG000|Overall Study|Withdrawal by Subject|4|||
49126726|NCT00969228|158302034|FG001|Overall Study|Withdrawal by Subject|0|||
49126727|NCT00969228|158302033|FG000|Overall Study|Porcine circovirus detection in vaccine|38|||
49126728|NCT00969228|158302034|FG001|Overall Study|Porcine circovirus detection in vaccine|14|||
49126729|NCT01677741|158302051|FG000|Overall Study|Death|0|||
49126730|NCT01677741|158302052|FG001|Overall Study|Death|0|||
49126731|NCT01677741|158302053|FG002|Overall Study|Death|0|||
49126732|NCT01677741|158302054|FG003|Overall Study|Death|1|||
49126733|NCT01677741|158302055|FG004|Overall Study|Death|0|||
49126734|NCT01677741|158302056|FG005|Overall Study|Death|1|||
49126735|NCT01677741|158302057|FG006|Overall Study|Death|0|||
49126736|NCT01677741|158302058|FG007|Overall Study|Death|0|||
49126737|NCT01677741|158302051|FG000|Overall Study|Withdrawal by Subject|2|||
49126738|NCT01677741|158302052|FG001|Overall Study|Withdrawal by Subject|7|||
49126739|NCT01677741|158302053|FG002|Overall Study|Withdrawal by Subject|5|||
49126740|NCT01677741|158302054|FG003|Overall Study|Withdrawal by Subject|4|||
49126741|NCT01677741|158302055|FG004|Overall Study|Withdrawal by Subject|11|||
48717316|NCT01185353|156813634|FG007|Part A (Weeks 0 Through 12)|Physician Decision|0|||
48717317|NCT01185353|156813635|FG008|Part A (Weeks 0 Through 12)|Physician Decision|0|||
48717318|NCT01185353|156813636|FG009|Part A (Weeks 0 Through 12)|Physician Decision|0|||
48717319|NCT01185353|156813627|FG000|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
48717320|NCT01185353|156813628|FG001|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
48717321|NCT01185353|156813629|FG002|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
49126742|NCT01677741|158302056|FG005|Overall Study|Withdrawal by Subject|20|||
49126743|NCT01677741|158302057|FG006|Overall Study|Withdrawal by Subject|4|||
49126744|NCT01677741|158302058|FG007|Overall Study|Withdrawal by Subject|2|||
49126745|NCT01677741|158302051|FG000|Overall Study|Enrolled in a rollover study|0|||
49126746|NCT01677741|158302052|FG001|Overall Study|Enrolled in a rollover study|3|||
48717322|NCT01185353|156813630|FG003|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
48717323|NCT01185353|156813631|FG004|Part A (Weeks 0 Through 12)|Protocol Violation|1|||
48717324|NCT01185353|156813632|FG005|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
48717325|NCT01185353|156813633|FG006|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
48717326|NCT01185353|156813634|FG007|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
48717327|NCT01185353|156813635|FG008|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
49126747|NCT01677741|158302053|FG002|Overall Study|Enrolled in a rollover study|2|||
49126748|NCT01677741|158302054|FG003|Overall Study|Enrolled in a rollover study|1|||
48717328|NCT01185353|156813636|FG009|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
48717329|NCT01185353|156813627|FG000|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2|||
49126749|NCT01677741|158302055|FG004|Overall Study|Enrolled in a rollover study|6|||
48717330|NCT01185353|156813628|FG001|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
48717331|NCT01185353|156813629|FG002|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
48717332|NCT01185353|156813630|FG003|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
48717333|NCT01185353|156813631|FG004|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3|||
48717334|NCT01185353|156813632|FG005|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
48717335|NCT01185353|156813633|FG006|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
48717336|NCT01185353|156813634|FG007|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
48717337|NCT01185353|156813635|FG008|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
48717338|NCT01185353|156813636|FG009|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
48717339|NCT01185353|156813627|FG000|Part B (Weeks 12 Through 24)|Adverse Event|0|||
48717340|NCT01185353|156813628|FG001|Part B (Weeks 12 Through 24)|Adverse Event|0|||
48717341|NCT01185353|156813629|FG002|Part B (Weeks 12 Through 24)|Adverse Event|1|||
48717342|NCT01185353|156813630|FG003|Part B (Weeks 12 Through 24)|Adverse Event|0|||
48717343|NCT01185353|156813631|FG004|Part B (Weeks 12 Through 24)|Adverse Event|0|||
48717344|NCT01185353|156813632|FG005|Part B (Weeks 12 Through 24)|Adverse Event|1|||
48717345|NCT01185353|156813633|FG006|Part B (Weeks 12 Through 24)|Adverse Event|0|||
48717346|NCT01185353|156813634|FG007|Part B (Weeks 12 Through 24)|Adverse Event|0|||
48717347|NCT01185353|156813635|FG008|Part B (Weeks 12 Through 24)|Adverse Event|0|||
48717348|NCT01185353|156813636|FG009|Part B (Weeks 12 Through 24)|Adverse Event|0|||
48717349|NCT01185353|156813627|FG000|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
48717350|NCT01185353|156813628|FG001|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
48717351|NCT01185353|156813629|FG002|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
48717352|NCT01185353|156813630|FG003|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
48717353|NCT01185353|156813631|FG004|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
48717354|NCT01185353|156813632|FG005|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
48717355|NCT01185353|156813633|FG006|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
48717356|NCT01185353|156813634|FG007|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
48717357|NCT01185353|156813635|FG008|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
48717358|NCT01185353|156813636|FG009|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
48717359|NCT01185353|156813627|FG000|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
48717360|NCT01185353|156813628|FG001|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
48717361|NCT01185353|156813629|FG002|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
48717362|NCT01185353|156813630|FG003|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
48717363|NCT01185353|156813631|FG004|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
48717364|NCT01185353|156813632|FG005|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
48717365|NCT01185353|156813633|FG006|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
48717366|NCT01185353|156813634|FG007|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
48717367|NCT01185353|156813635|FG008|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
48717368|NCT01185353|156813636|FG009|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
48717369|NCT01185353|156813627|FG000|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
48717370|NCT01185353|156813628|FG001|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
48717371|NCT01185353|156813629|FG002|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1|||
48717372|NCT01185353|156813630|FG003|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2|||
48717373|NCT01185353|156813631|FG004|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
49126750|NCT01677741|158302056|FG005|Overall Study|Enrolled in a rollover study|6|||
49126751|NCT01677741|158302057|FG006|Overall Study|Enrolled in a rollover study|7|||
49126752|NCT01677741|158302058|FG007|Overall Study|Enrolled in a rollover study|0|||
49126753|NCT01677741|158302051|FG000|Overall Study|Progressive disease|1|||
49126754|NCT01677741|158302052|FG001|Overall Study|Progressive disease|0|||
49126755|NCT01677741|158302053|FG002|Overall Study|Progressive disease|1|||
49126756|NCT01677741|158302054|FG003|Overall Study|Progressive disease|0|||
49126757|NCT01677741|158302055|FG004|Overall Study|Progressive disease|0|||
49126758|NCT01677741|158302056|FG005|Overall Study|Progressive disease|1|||
49126759|NCT01677741|158302057|FG006|Overall Study|Progressive disease|0|||
49126760|NCT01677741|158302058|FG007|Overall Study|Progressive disease|0|||
49126761|NCT01883895|158302059|FG000|Overall Study|Lost to Follow-up|2|||
49126762|NCT04386902|158302064|FG000|Overall Study|Withdrawal by Subject|5|||
49126763|NCT04386902|158302064|FG000|Overall Study|Technical problems in the recording|5|||
48814726|NCT02374593|157163565|FG001|Overall Study|non-compliant|0|||
48814727|NCT01425632|157163566|FG000|Overall Study|Adverse Event|0|||
48814728|NCT01425632|157163567|FG001|Overall Study|Adverse Event|1|||
48814729|NCT01425632|157163568|FG002|Overall Study|Adverse Event|1|||
48814730|NCT01425632|157163566|FG000|Overall Study|Physician Decision|1|||
48814731|NCT01425632|157163567|FG001|Overall Study|Physician Decision|0|||
48717374|NCT01185353|156813632|FG005|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3|||
48717375|NCT01185353|156813633|FG006|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4|||
48717376|NCT01185353|156813634|FG007|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
48717377|NCT01185353|156813635|FG008|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
49126764|NCT03054428|158302065|FG000|Overall Study|Physician Decision|0|||
49126765|NCT03054428|158302066|FG001|Overall Study|Physician Decision|1|||
49126766|NCT03054428|158302067|FG002|Overall Study|Physician Decision|1|||
49126767|NCT03054428|158302065|FG000|Overall Study|Lack of Efficacy|3|||
48717378|NCT01185353|156813636|FG009|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
48717379|NCT01185353|156813627|FG000|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
48717380|NCT01185353|156813628|FG001|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
48814732|NCT01425632|157163568|FG002|Overall Study|Physician Decision|0|||
48814733|NCT01425632|157163566|FG000|Overall Study|Protocol Violation|0|||
48814734|NCT01425632|157163567|FG001|Overall Study|Protocol Violation|0|||
48814735|NCT01425632|157163568|FG002|Overall Study|Protocol Violation|2|||
48814736|NCT01425632|157163566|FG000|Overall Study|Withdrawal by Subject|0|||
48717381|NCT01185353|156813629|FG002|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
48717382|NCT01185353|156813630|FG003|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
48717383|NCT01185353|156813631|FG004|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
48717384|NCT01185353|156813632|FG005|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
48717385|NCT01185353|156813633|FG006|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1|||
48717386|NCT01185353|156813634|FG007|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
48717387|NCT01185353|156813635|FG008|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
48717388|NCT01185353|156813636|FG009|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
48717389|NCT01185353|156813627|FG000|Part C (Weeks 24 Through 76)|Adverse Event|0|||
48717390|NCT01185353|156813628|FG001|Part C (Weeks 24 Through 76)|Adverse Event|0|||
48814737|NCT01425632|157163567|FG001|Overall Study|Withdrawal by Subject|0|||
48814738|NCT01425632|157163568|FG002|Overall Study|Withdrawal by Subject|1|||
48814739|NCT02443103|157163574|FG000|Overall Study|Adverse Event|2|||
48814740|NCT02443103|157163574|FG000|Overall Study|Noncompliance|1|||
49126768|NCT03054428|158302066|FG001|Overall Study|Lack of Efficacy|1|||
48814741|NCT01751113|157163580|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
49126769|NCT03054428|158302067|FG002|Overall Study|Lack of Efficacy|0|||
49126770|NCT03054428|158302065|FG000|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
48717391|NCT01185353|156813629|FG002|Part C (Weeks 24 Through 76)|Adverse Event|0|||
48814742|NCT01751113|157163581|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
49126771|NCT03054428|158302066|FG001|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
48717392|NCT01185353|156813630|FG003|Part C (Weeks 24 Through 76)|Adverse Event|0|||
48717393|NCT01185353|156813631|FG004|Part C (Weeks 24 Through 76)|Adverse Event|0|||
48717394|NCT01185353|156813632|FG005|Part C (Weeks 24 Through 76)|Adverse Event|0|||
48717395|NCT01185353|156813633|FG006|Part C (Weeks 24 Through 76)|Adverse Event|0|||
48717396|NCT01185353|156813634|FG007|Part C (Weeks 24 Through 76)|Adverse Event|8|||
48717397|NCT01185353|156813635|FG008|Part C (Weeks 24 Through 76)|Adverse Event|2|||
48717398|NCT01185353|156813636|FG009|Part C (Weeks 24 Through 76)|Adverse Event|2|||
48717399|NCT01185353|156813627|FG000|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
48717400|NCT01185353|156813628|FG001|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
48717401|NCT01185353|156813629|FG002|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
48717402|NCT01185353|156813630|FG003|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
48717403|NCT01185353|156813631|FG004|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
48717404|NCT01185353|156813632|FG005|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
48717405|NCT01185353|156813633|FG006|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
48717406|NCT01185353|156813634|FG007|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6|||
48717407|NCT01185353|156813635|FG008|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
48717408|NCT01185353|156813636|FG009|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
48717409|NCT01185353|156813627|FG000|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
48717410|NCT01185353|156813628|FG001|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
48717411|NCT01185353|156813629|FG002|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
49126772|NCT03054428|158302067|FG002|Overall Study|Discontinued to enroll in OLE: enrolled|1|||
49126773|NCT03054428|158302065|FG000|Overall Study|Discont'd to enroll in OLE: not enrolled|1|||
49126774|NCT03054428|158302066|FG001|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
49126775|NCT03054428|158302067|FG002|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
49126776|NCT03054428|158302065|FG000|Overall Study|Transitioned to OLE study|76|||
49126777|NCT03054428|158302066|FG001|Overall Study|Transitioned to OLE study|76|||
49126778|NCT03054428|158302067|FG002|Overall Study|Transitioned to OLE study|73|||
49126779|NCT03054428|158302065|FG000|Overall Study|Withdrawal by Subject|3|||
49126780|NCT03054428|158302066|FG001|Overall Study|Withdrawal by Subject|2|||
49126781|NCT03054428|158302067|FG002|Overall Study|Withdrawal by Subject|3|||
49126782|NCT03054428|158302065|FG000|Overall Study|Lost to Follow-up|0|||
49126783|NCT03054428|158302066|FG001|Overall Study|Lost to Follow-up|0|||
49126784|NCT03054428|158302067|FG002|Overall Study|Lost to Follow-up|1|||
49126785|NCT01884597|158302068|FG000|Overall Study|Adverse Event|0|||
49126786|NCT01884597|158302069|FG001|Overall Study|Adverse Event|0|||
49126787|NCT01884597|158302070|FG002|Overall Study|Adverse Event|1|||
49126788|NCT01884597|158302068|FG000|Overall Study|Lack of Efficacy|1|||
49126789|NCT01884597|158302069|FG001|Overall Study|Lack of Efficacy|0|||
49126790|NCT01884597|158302070|FG002|Overall Study|Lack of Efficacy|0|||
49126791|NCT01884597|158302068|FG000|Overall Study|Death|0|||
49126792|NCT01884597|158302069|FG001|Overall Study|Death|1|||
49126793|NCT01884597|158302070|FG002|Overall Study|Death|0|||
49126794|NCT00269152|158302071|FG000|Overall Study|Adverse Event|9|||
49126795|NCT00269152|158302072|FG001|Overall Study|Adverse Event|3|||
49126796|NCT00269152|158302071|FG000|Overall Study|Withdrawal by Subject|7|||
49126797|NCT00269152|158302072|FG001|Overall Study|Withdrawal by Subject|3|||
49126798|NCT00269152|158302071|FG000|Overall Study|Physician Decision|2|||
49126799|NCT00269152|158302072|FG001|Overall Study|Physician Decision|3|||
49126800|NCT00269152|158302071|FG000|Overall Study|Protocol Violation|0|||
49126801|NCT00269152|158302072|FG001|Overall Study|Protocol Violation|1|||
49126802|NCT01265498|158302073|FG000|Overall Study|Protocol modified to eliminate wk72 bx|31|||
49126803|NCT01265498|158302074|FG001|Overall Study|Protocol modified to eliminate wk72 bx|33|||
49126804|NCT03533751|158302075|FG000|Overall Study|Withdrawal by Subject|12|||
49126805|NCT03533751|158302076|FG001|Overall Study|Withdrawal by Subject|6|||
49126806|NCT03533751|158302077|FG002|Overall Study|Withdrawal by Subject|11|||
49126807|NCT03533751|158302078|FG003|Overall Study|Withdrawal by Subject|9|||
49126808|NCT03533751|158302079|FG004|Overall Study|Withdrawal by Subject|10|||
49126809|NCT03533751|158302075|FG000|Overall Study|Adverse Event|4|||
49126810|NCT03533751|158302076|FG001|Overall Study|Adverse Event|7|||
49126811|NCT03533751|158302077|FG002|Overall Study|Adverse Event|2|||
49126812|NCT03533751|158302078|FG003|Overall Study|Adverse Event|4|||
49126813|NCT03533751|158302079|FG004|Overall Study|Adverse Event|5|||
49126814|NCT03533751|158302075|FG000|Overall Study|Physician Decision|0|||
49126815|NCT03533751|158302076|FG001|Overall Study|Physician Decision|2|||
48717412|NCT01185353|156813630|FG003|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
48717413|NCT01185353|156813631|FG004|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
48717414|NCT01185353|156813632|FG005|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
49126816|NCT03533751|158302077|FG002|Overall Study|Physician Decision|1|||
49126817|NCT03533751|158302078|FG003|Overall Study|Physician Decision|2|||
49126818|NCT03533751|158302079|FG004|Overall Study|Physician Decision|1|||
49126819|NCT03533751|158302075|FG000|Overall Study|Sponsor Decision|0|||
49126820|NCT03533751|158302076|FG001|Overall Study|Sponsor Decision|0|||
49126821|NCT03533751|158302077|FG002|Overall Study|Sponsor Decision|1|||
48717415|NCT01185353|156813633|FG006|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
48717416|NCT01185353|156813634|FG007|Part C (Weeks 24 Through 76)|Lost to Follow-up|2|||
48717417|NCT01185353|156813635|FG008|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
48717418|NCT01185353|156813636|FG009|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
48717419|NCT01185353|156813627|FG000|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
48717420|NCT01185353|156813628|FG001|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
48717421|NCT01185353|156813629|FG002|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
48717422|NCT01185353|156813630|FG003|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
48717423|NCT01185353|156813631|FG004|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
48717424|NCT01185353|156813632|FG005|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
48717425|NCT01185353|156813633|FG006|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
48717426|NCT01185353|156813634|FG007|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
48717427|NCT01185353|156813635|FG008|Part C (Weeks 24 Through 76)|Lack of Efficacy|2|||
48717428|NCT01185353|156813636|FG009|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
48717429|NCT01185353|156813627|FG000|Part C (Weeks 24 Through 76)|Death|0|||
48717430|NCT01185353|156813628|FG001|Part C (Weeks 24 Through 76)|Death|0|||
48717431|NCT01185353|156813629|FG002|Part C (Weeks 24 Through 76)|Death|0|||
48717432|NCT01185353|156813630|FG003|Part C (Weeks 24 Through 76)|Death|0|||
48717433|NCT01185353|156813631|FG004|Part C (Weeks 24 Through 76)|Death|0|||
48717434|NCT01185353|156813632|FG005|Part C (Weeks 24 Through 76)|Death|0|||
48717435|NCT01185353|156813633|FG006|Part C (Weeks 24 Through 76)|Death|0|||
48717436|NCT01185353|156813634|FG007|Part C (Weeks 24 Through 76)|Death|0|||
48717437|NCT01185353|156813635|FG008|Part C (Weeks 24 Through 76)|Death|0|||
48717438|NCT01185353|156813636|FG009|Part C (Weeks 24 Through 76)|Death|1|||
48717439|NCT01185353|156813627|FG000|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
48717440|NCT01185353|156813628|FG001|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
48717441|NCT01185353|156813629|FG002|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
48717442|NCT01185353|156813630|FG003|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
48717443|NCT01185353|156813631|FG004|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
48717444|NCT01185353|156813632|FG005|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
48717445|NCT01185353|156813633|FG006|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
48717446|NCT01185353|156813634|FG007|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
48717447|NCT01185353|156813635|FG008|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
48717448|NCT01185353|156813636|FG009|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1|||
48717449|NCT01185353|156813627|FG000|Part C (Weeks 24 Through 76)|Physician Decision|0|||
48717450|NCT01185353|156813628|FG001|Part C (Weeks 24 Through 76)|Physician Decision|0|||
48717451|NCT01185353|156813629|FG002|Part C (Weeks 24 Through 76)|Physician Decision|0|||
48717452|NCT01185353|156813630|FG003|Part C (Weeks 24 Through 76)|Physician Decision|0|||
48717453|NCT01185353|156813631|FG004|Part C (Weeks 24 Through 76)|Physician Decision|0|||
48814743|NCT01751113|157163582|FG002|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
48814744|NCT01751113|157163583|FG003|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
48814745|NCT01751113|157163584|FG004|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
48814746|NCT01751113|157163585|FG005|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
49126822|NCT03533751|158302078|FG003|Overall Study|Sponsor Decision|1|||
48814747|NCT01751113|157163580|FG000|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
48814748|NCT01751113|157163581|FG001|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
48814749|NCT01751113|157163582|FG002|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
48814750|NCT01751113|157163583|FG003|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
49126823|NCT03533751|158302079|FG004|Overall Study|Sponsor Decision|0|||
49126824|NCT03533751|158302075|FG000|Overall Study|Lost to Follow-up|3|||
49126825|NCT03533751|158302076|FG001|Overall Study|Lost to Follow-up|7|||
49126826|NCT03533751|158302077|FG002|Overall Study|Lost to Follow-up|6|||
49126827|NCT03533751|158302078|FG003|Overall Study|Lost to Follow-up|4|||
49126828|NCT03533751|158302079|FG004|Overall Study|Lost to Follow-up|3|||
49126829|NCT03533751|158302075|FG000|Overall Study|Use of any excluded/prohibited medications|0|||
48717454|NCT01185353|156813632|FG005|Part C (Weeks 24 Through 76)|Physician Decision|0|||
48814751|NCT01751113|157163584|FG004|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
48814752|NCT01751113|157163585|FG005|Treatment Period 3 (4 Weeks)|Adverse Event|1|||
48814753|NCT01115491|157163587|FG000|Overall Study|Death|22|||
48814754|NCT01115491|157163587|FG000|Overall Study|Adverse Event|3|||
48814755|NCT01115491|157163587|FG000|Overall Study|Lost to Follow-up|3|||
48814756|NCT01115491|157163587|FG000|Overall Study|Withdrawal by Subject|1|||
48814757|NCT01115491|157163587|FG000|Overall Study|Physician Decision|1|||
48814758|NCT00363896|157163588|FG000|Overall Study|Withdrawal by Subject|29|||
48814759|NCT00363896|157163589|FG001|Overall Study|Withdrawal by Subject|16|||
48717455|NCT01185353|156813633|FG006|Part C (Weeks 24 Through 76)|Physician Decision|0|||
48717456|NCT01185353|156813634|FG007|Part C (Weeks 24 Through 76)|Physician Decision|0|||
48717457|NCT01185353|156813635|FG008|Part C (Weeks 24 Through 76)|Physician Decision|0|||
48717458|NCT01185353|156813636|FG009|Part C (Weeks 24 Through 76)|Physician Decision|1|||
48814760|NCT00363896|157163588|FG000|Overall Study|Adverse Event|24|||
49126830|NCT03533751|158302076|FG001|Overall Study|Use of any excluded/prohibited medications|1|||
49126831|NCT03533751|158302077|FG002|Overall Study|Use of any excluded/prohibited medications|0|||
48717459|NCT01185353|156813627|FG000|Part C (Weeks 24 Through 76)|Reason missing|0|||
48717460|NCT01185353|156813628|FG001|Part C (Weeks 24 Through 76)|Reason missing|0|||
48717461|NCT01185353|156813629|FG002|Part C (Weeks 24 Through 76)|Reason missing|0|||
48717462|NCT01185353|156813630|FG003|Part C (Weeks 24 Through 76)|Reason missing|0|||
48717463|NCT01185353|156813631|FG004|Part C (Weeks 24 Through 76)|Reason missing|0|||
48717464|NCT01185353|156813632|FG005|Part C (Weeks 24 Through 76)|Reason missing|0|||
48717465|NCT01185353|156813633|FG006|Part C (Weeks 24 Through 76)|Reason missing|0|||
48717466|NCT01185353|156813634|FG007|Part C (Weeks 24 Through 76)|Reason missing|0|||
48717467|NCT01185353|156813635|FG008|Part C (Weeks 24 Through 76)|Reason missing|1|||
48717468|NCT01185353|156813636|FG009|Part C (Weeks 24 Through 76)|Reason missing|0|||
48717469|NCT01185353|156813627|FG000|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
48717470|NCT01185353|156813628|FG001|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
48717471|NCT01185353|156813629|FG002|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
48814761|NCT00363896|157163589|FG001|Overall Study|Adverse Event|13|||
48814762|NCT00363896|157163588|FG000|Overall Study|COPD exacerbation|13|||
48814763|NCT00363896|157163589|FG001|Overall Study|COPD exacerbation|7|||
48814764|NCT00363896|157163588|FG000|Overall Study|Lack of Efficacy|12|||
48814765|NCT00363896|157163589|FG001|Overall Study|Lack of Efficacy|8|||
49126832|NCT03533751|158302078|FG003|Overall Study|Use of any excluded/prohibited medications|0|||
49126833|NCT03533751|158302079|FG004|Overall Study|Use of any excluded/prohibited medications|1|||
49126834|NCT03533751|158302075|FG000|Overall Study|Other|0|||
49126835|NCT03533751|158302076|FG001|Overall Study|Other|2|||
49126836|NCT03533751|158302077|FG002|Overall Study|Other|1|||
49126837|NCT03533751|158302078|FG003|Overall Study|Other|0|||
49126838|NCT03533751|158302079|FG004|Overall Study|Other|3|||
49126839|NCT03225287|158302080|FG000|Overall Study|Adverse Event|0|||
49126840|NCT03225287|158302081|FG001|Overall Study|Adverse Event|0|||
49126841|NCT03225287|158302082|FG002|Overall Study|Adverse Event|1|||
49126842|NCT03225287|158302080|FG000|Overall Study|Protocol non-compliance|0|||
49126843|NCT03225287|158302081|FG001|Overall Study|Protocol non-compliance|0|||
49126844|NCT03225287|158302082|FG002|Overall Study|Protocol non-compliance|1|||
49126845|NCT03225287|158302080|FG000|Overall Study|Subject withdraws consent|3|||
49126846|NCT03225287|158302081|FG001|Overall Study|Subject withdraws consent|0|||
49126847|NCT03225287|158302082|FG002|Overall Study|Subject withdraws consent|0|||
49126848|NCT03225287|158302080|FG000|Overall Study|Sponsor, regulatory, or EC/IRB request|7|||
49126849|NCT03225287|158302081|FG001|Overall Study|Sponsor, regulatory, or EC/IRB request|3|||
49126850|NCT03225287|158302082|FG002|Overall Study|Sponsor, regulatory, or EC/IRB request|1|||
49126851|NCT03225287|158302080|FG000|Overall Study|Trial drug not effective|0|||
49126852|NCT03225287|158302081|FG001|Overall Study|Trial drug not effective|1|||
49126853|NCT03225287|158302082|FG002|Overall Study|Trial drug not effective|0|||
49126854|NCT03225287|158302080|FG000|Overall Study|Need of transfusions and signs of hemolysis|0|||
49126855|NCT03225287|158302081|FG001|Overall Study|Need of transfusions and signs of hemolysis|1|||
49126856|NCT03225287|158302082|FG002|Overall Study|Need of transfusions and signs of hemolysis|0|||
49126857|NCT03225287|158302080|FG000|Overall Study|Stem cell transplantation|0|||
49126858|NCT03225287|158302081|FG001|Overall Study|Stem cell transplantation|1|||
49126859|NCT03225287|158302082|FG002|Overall Study|Stem cell transplantation|0|||
49126860|NCT02097823|158302083|FG000|Overall Study|Withdrawal by Subject|1|||
49126861|NCT02097823|158302084|FG001|Overall Study|Withdrawal by Subject|1|||
49126862|NCT03082729|158302085|FG000|Overall Study|Lost to Follow-up|7|||
49126863|NCT03082729|158302085|FG000|Overall Study|Physician Decision|2|||
49126864|NCT03082729|158302085|FG000|Overall Study|Withdrawal by Subject|1|||
49126865|NCT03082729|158302085|FG000|Overall Study|Lack of Efficacy|9|||
49126866|NCT03082729|158302085|FG000|Overall Study|Adverse Event|4|||
49126867|NCT03082729|158302085|FG000|Overall Study|Protocol Violation|6|||
49126868|NCT03082729|158302085|FG000|Overall Study|Fear of study procedure|1|||
49126869|NCT03082729|158302085|FG000|Overall Study|Scheduling conflict|1|||
49126870|NCT01274351|158302086|FG000|Overall Study|Lost to Follow-up|1|||
49126871|NCT01274351|158302086|FG000|Overall Study|patient not compliant with the protocol|1|||
49126872|NCT01274351|158302086|FG000|Overall Study|Pregnancy|1|||
49126873|NCT01274351|158302086|FG000|Overall Study|Death|2|||
49126874|NCT01274351|158302086|FG000|Overall Study|Withdrawal by Subject|3|||
49126875|NCT01274351|158302086|FG000|Overall Study|Adverse Event|8|||
49126876|NCT01274351|158302086|FG000|Overall Study|progression of disease|3|||
49126877|NCT01274351|158302086|FG000|Overall Study|hospitalization|1|||
49126878|NCT02783170|158304222|FG000|Overall Study|Randomized but not Vaccinated|1|||
48717472|NCT01185353|156813630|FG003|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
48814766|NCT00363896|157163588|FG000|Overall Study|Protocol Violation|6|||
49126879|NCT02783170|158304223|FG001|Overall Study|Randomized but not Vaccinated|0|||
49126880|NCT01251952|158304224|FG000|Overall Study|Adverse Event|1|||
49126881|NCT03110354|158304225|FG000|Overall Study|Death|1|||
49126882|NCT03110354|158304226|FG001|Overall Study|Death|0|||
49126883|NCT03110354|158304227|FG002|Overall Study|Death|0|||
49126884|NCT03110354|158304228|FG003|Overall Study|Death|1|||
49126885|NCT03110354|158304229|FG004|Overall Study|Death|0|||
49126886|NCT03110354|158304225|FG000|Overall Study|Start of new therapy|0|||
48814767|NCT00363896|157163589|FG001|Overall Study|Protocol Violation|1|||
48814768|NCT00363896|157163588|FG000|Overall Study|Lost to Follow-up|3|||
48814769|NCT00363896|157163589|FG001|Overall Study|Lost to Follow-up|0|||
48814770|NCT00363896|157163588|FG000|Overall Study|Non-fulfilment of entry criteria|1|||
48814771|NCT00363896|157163589|FG001|Overall Study|Non-fulfilment of entry criteria|0|||
48814772|NCT00363896|157163588|FG000|Overall Study|Other|1|||
48814773|NCT00363896|157163589|FG001|Overall Study|Other|2|||
48814774|NCT01651936|157163590|FG000|Base Study|Adverse Event|3|||
48814775|NCT01651936|157163591|FG001|Base Study|Adverse Event|0|||
48814776|NCT01651936|157163592|FG002|Base Study|Adverse Event|0|||
48814777|NCT01651936|157163590|FG000|Base Study|Withdrawal by Subject|1|||
48814778|NCT01651936|157163591|FG001|Base Study|Withdrawal by Subject|1|||
48814779|NCT01651936|157163592|FG002|Base Study|Withdrawal by Subject|0|||
48814780|NCT01651936|157163590|FG000|Base Study|Early Escape|2|||
48814781|NCT01651936|157163591|FG001|Base Study|Early Escape|8|||
48814782|NCT01651936|157163592|FG002|Base Study|Early Escape|0|||
48814783|NCT01651936|157163590|FG000|Base Study|Study terminated by sponsor|21|||
48814784|NCT01651936|157163591|FG001|Base Study|Study terminated by sponsor|16|||
48814785|NCT01651936|157163592|FG002|Base Study|Study terminated by sponsor|0|||
48814786|NCT01651936|157163590|FG000|Extension Study|Lack of Efficacy|0|||
48814787|NCT01651936|157163591|FG001|Extension Study|Lack of Efficacy|0|||
48814788|NCT01651936|157163592|FG002|Extension Study|Lack of Efficacy|1|||
48814789|NCT01651936|157163590|FG000|Extension Study|Study terminated by sponsor|0|||
48814790|NCT01651936|157163591|FG001|Extension Study|Study terminated by sponsor|0|||
48814791|NCT01651936|157163592|FG002|Extension Study|Study terminated by sponsor|13|||
48814792|NCT01799720|157163599|FG000|Overall Study|Withdrawal by Subject|3|||
48814793|NCT01799720|157163600|FG001|Overall Study|Withdrawal by Subject|0|||
48814794|NCT01799720|157163601|FG002|Overall Study|Withdrawal by Subject|0|||
48814795|NCT01799720|157163599|FG000|Overall Study|Protocol Violation|0|||
48814796|NCT01799720|157163600|FG001|Overall Study|Protocol Violation|1|||
48814797|NCT01799720|157163601|FG002|Overall Study|Protocol Violation|0|||
48814798|NCT01799720|157163599|FG000|Overall Study|Pregnancy|0|||
48814799|NCT01799720|157163600|FG001|Overall Study|Pregnancy|0|||
48814800|NCT01799720|157163601|FG002|Overall Study|Pregnancy|1|||
49126887|NCT03110354|158304226|FG001|Overall Study|Start of new therapy|0|||
49126888|NCT03110354|158304227|FG002|Overall Study|Start of new therapy|0|||
49126889|NCT03110354|158304228|FG003|Overall Study|Start of new therapy|0|||
49126890|NCT03110354|158304229|FG004|Overall Study|Start of new therapy|1|||
49126891|NCT03110354|158304225|FG000|Overall Study|Failure to achieve response|2|||
49126892|NCT03110354|158304226|FG001|Overall Study|Failure to achieve response|3|||
49126893|NCT03110354|158304227|FG002|Overall Study|Failure to achieve response|0|||
49126894|NCT03110354|158304228|FG003|Overall Study|Failure to achieve response|2|||
48717473|NCT01185353|156813631|FG004|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
48717474|NCT01185353|156813632|FG005|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
48717475|NCT01185353|156813633|FG006|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
48717476|NCT01185353|156813634|FG007|Part D (Weeks 76 Through 128)|Lost to Follow-up|1|||
48717477|NCT01185353|156813635|FG008|Part D (Weeks 76 Through 128)|Lost to Follow-up|3|||
48717478|NCT01185353|156813636|FG009|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
48717479|NCT01185353|156813627|FG000|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
48717480|NCT01185353|156813628|FG001|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
48717481|NCT01185353|156813629|FG002|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
48717482|NCT01185353|156813630|FG003|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
48717483|NCT01185353|156813631|FG004|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
48717484|NCT01185353|156813632|FG005|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
48717485|NCT01185353|156813633|FG006|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
48717486|NCT01185353|156813634|FG007|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
48717487|NCT01185353|156813635|FG008|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2|||
48717488|NCT01185353|156813636|FG009|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
48717489|NCT01185353|156813627|FG000|Part D (Weeks 76 Through 128)|Adverse Event|0|||
48717490|NCT01185353|156813628|FG001|Part D (Weeks 76 Through 128)|Adverse Event|0|||
48717491|NCT01185353|156813629|FG002|Part D (Weeks 76 Through 128)|Adverse Event|0|||
48717492|NCT01185353|156813630|FG003|Part D (Weeks 76 Through 128)|Adverse Event|0|||
48717493|NCT01185353|156813631|FG004|Part D (Weeks 76 Through 128)|Adverse Event|0|||
48717494|NCT01185353|156813632|FG005|Part D (Weeks 76 Through 128)|Adverse Event|0|||
48717495|NCT01185353|156813633|FG006|Part D (Weeks 76 Through 128)|Adverse Event|0|||
48717496|NCT01185353|156813634|FG007|Part D (Weeks 76 Through 128)|Adverse Event|1|||
48717497|NCT01185353|156813635|FG008|Part D (Weeks 76 Through 128)|Adverse Event|2|||
48717498|NCT01185353|156813636|FG009|Part D (Weeks 76 Through 128)|Adverse Event|0|||
48717499|NCT02081859|156813637|FG000|Overall Study|No fertilization|2|||
48717500|NCT02081859|156813638|FG001|Overall Study|No fertilization|2|||
48717501|NCT02081859|156813637|FG000|Overall Study|No sperm|1|||
48717502|NCT02081859|156813638|FG001|Overall Study|No sperm|0|||
48717503|NCT02081859|156813637|FG000|Overall Study|Unanticipated freeze all cycle|2|||
48717504|NCT02081859|156813638|FG001|Overall Study|Unanticipated freeze all cycle|6|||
48717505|NCT02081859|156813637|FG000|Overall Study|< 4 embryos|27|||
48717506|NCT02081859|156813638|FG001|Overall Study|< 4 embryos|23|||
48717507|NCT02081859|156813637|FG000|Overall Study|Other reasons|2|||
48717508|NCT02081859|156813638|FG001|Overall Study|Other reasons|0|||
48717509|NCT01576159|156813645|FG000|Overall Study|Withdrawal by Subject|0|||
48717510|NCT01576159|156813646|FG001|Overall Study|Withdrawal by Subject|1|||
48717511|NCT01576159|156813647|FG002|Overall Study|Withdrawal by Subject|0|||
48717512|NCT01576159|156813648|FG003|Overall Study|Withdrawal by Subject|0|||
48717513|NCT01576159|156813645|FG000|Overall Study|Physician Decision|0|||
48717514|NCT01576159|156813646|FG001|Overall Study|Physician Decision|0|||
48717515|NCT01576159|156813647|FG002|Overall Study|Physician Decision|1|||
48717516|NCT01576159|156813648|FG003|Overall Study|Physician Decision|0|||
48717517|NCT01576159|156813645|FG000|Overall Study|Lost to Follow-up|0|||
48717518|NCT01576159|156813646|FG001|Overall Study|Lost to Follow-up|0|||
48717519|NCT01576159|156813647|FG002|Overall Study|Lost to Follow-up|0|||
48717520|NCT01576159|156813648|FG003|Overall Study|Lost to Follow-up|1|||
48717521|NCT01576159|156813645|FG000|Overall Study|Protocol Violation|1|||
48717522|NCT01576159|156813646|FG001|Overall Study|Protocol Violation|0|||
48717523|NCT01576159|156813647|FG002|Overall Study|Protocol Violation|0|||
48717524|NCT01576159|156813648|FG003|Overall Study|Protocol Violation|0|||
48717525|NCT01155167|156813655|FG000|Overall Study|Insufficient ultrasound data|2|||
48717526|NCT01155167|156813656|FG001|Overall Study|Insufficient ultrasound data|0|||
48717527|NCT01155167|156813655|FG000|Overall Study|Access site changed to femoral artery|1|||
48717528|NCT01155167|156813656|FG001|Overall Study|Access site changed to femoral artery|0|||
48717529|NCT01964755|156815021|FG000|Overall Study|Death|2|||
48717530|NCT03598114|156815022|FG000|Overall Study|Staff turnover/left the program|3|||
48717531|NCT03598114|156815023|FG001|Overall Study|Staff turnover/left the program|39|||
48717532|NCT01332799|156815025|FG000|Overall Study|Insufficient funding|10|||
48717533|NCT01332799|156815026|FG001|Overall Study|Insufficient funding|10|||
48717534|NCT03179202|156815027|FG000|Overall Study|Screen Failure|67|||
48717535|NCT03179202|156815027|FG000|Overall Study|Subject Lost to Follow Up|12|||
48717536|NCT03179202|156815027|FG000|Overall Study|Withdrawal by Subject|7|||
48717537|NCT03179202|156815027|FG000|Overall Study|Adverse Event|3|||
48717538|NCT03179202|156815027|FG000|Overall Study|Unrelated Death Reported in All-Cause Mortality|1|||
48717539|NCT03179202|156815027|FG000|Overall Study|Other Reason: Incarceration after Enrollment|1|||
48717540|NCT01120782|156815028|FG000|Overall Study|Test article shipping error|11|||
48717541|NCT03255629|156815029|FG000|Overall Study|Adverse Event|1|||
48717542|NCT03255629|156815030|FG001|Overall Study|Adverse Event|0|||
48717543|NCT03255629|156815029|FG000|Overall Study|did not experience hypoglycemia|2|||
48717544|NCT03255629|156815030|FG001|Overall Study|did not experience hypoglycemia|1|||
48717545|NCT00910624|156815031|FG000|Treatment Phase|Adverse Event|2|||
48717546|NCT00910624|156815032|FG001|Treatment Phase|Adverse Event|6|||
48717547|NCT00910624|156815033|FG002|Treatment Phase|Adverse Event|6|||
48717548|NCT00910624|156815034|FG003|Treatment Phase|Adverse Event|0|||
48717549|NCT00910624|156815031|FG000|Treatment Phase|Treatment Failure|23|||
48717550|NCT00910624|156815032|FG001|Treatment Phase|Treatment Failure|10|||
48717551|NCT00910624|156815033|FG002|Treatment Phase|Treatment Failure|0|||
48717552|NCT00910624|156815034|FG003|Treatment Phase|Treatment Failure|0|||
48717553|NCT00910624|156815031|FG000|Treatment Phase|Lost to Follow-up|0|||
48717554|NCT00910624|156815032|FG001|Treatment Phase|Lost to Follow-up|0|||
48717555|NCT00910624|156815033|FG002|Treatment Phase|Lost to Follow-up|1|||
48717556|NCT00910624|156815034|FG003|Treatment Phase|Lost to Follow-up|0|||
48717557|NCT00910624|156815031|FG000|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
48717558|NCT00910624|156815032|FG001|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
48717559|NCT00910624|156815033|FG002|Treatment Phase|Reasons Unrelated To Assigned Treatment|1|||
48717560|NCT00910624|156815034|FG003|Treatment Phase|Reasons Unrelated To Assigned Treatment|0|||
48717561|NCT00910624|156815031|FG000|Treatment Phase|Withdrawal by Subject|2|||
48717562|NCT00910624|156815032|FG001|Treatment Phase|Withdrawal by Subject|1|||
48717563|NCT00910624|156815033|FG002|Treatment Phase|Withdrawal by Subject|0|||
48717564|NCT00910624|156815034|FG003|Treatment Phase|Withdrawal by Subject|0|||
48717565|NCT00910624|156815031|FG000|Treatment Phase|Non-Compliance With Protocol|0|||
48717566|NCT00910624|156815032|FG001|Treatment Phase|Non-Compliance With Protocol|1|||
48717567|NCT00910624|156815033|FG002|Treatment Phase|Non-Compliance With Protocol|1|||
48717568|NCT00910624|156815034|FG003|Treatment Phase|Non-Compliance With Protocol|0|||
48717569|NCT00910624|156815031|FG000|Follow-Up Phase|Adverse Event|0|||
48717570|NCT00910624|156815032|FG001|Follow-Up Phase|Adverse Event|0|||
48717571|NCT00910624|156815033|FG002|Follow-Up Phase|Adverse Event|1|||
49126895|NCT03110354|158304229|FG004|Overall Study|Failure to achieve response|1|||
49126896|NCT03110354|158304225|FG000|Overall Study|Progressive disease|1|||
49126897|NCT03110354|158304226|FG001|Overall Study|Progressive disease|1|||
49126898|NCT03110354|158304227|FG002|Overall Study|Progressive disease|3|||
49126899|NCT03110354|158304228|FG003|Overall Study|Progressive disease|4|||
49126900|NCT03110354|158304229|FG004|Overall Study|Progressive disease|2|||
49126901|NCT03110354|158304225|FG000|Overall Study|Adverse Event|0|||
49126902|NCT03110354|158304226|FG001|Overall Study|Adverse Event|0|||
49126903|NCT03110354|158304227|FG002|Overall Study|Adverse Event|0|||
49126904|NCT03110354|158304228|FG003|Overall Study|Adverse Event|2|||
49126905|NCT03110354|158304229|FG004|Overall Study|Adverse Event|2|||
49126906|NCT03110354|158304225|FG000|Overall Study|Other|0|||
49126907|NCT03110354|158304226|FG001|Overall Study|Other|0|||
49126908|NCT03110354|158304227|FG002|Overall Study|Other|0|||
48717572|NCT00910624|156815034|FG003|Follow-Up Phase|Adverse Event|0|||
48717573|NCT00910624|156815031|FG000|Follow-Up Phase|Lost to Follow-up|3|||
48717574|NCT00910624|156815032|FG001|Follow-Up Phase|Lost to Follow-up|1|||
48717575|NCT00910624|156815033|FG002|Follow-Up Phase|Lost to Follow-up|2|||
48717576|NCT00910624|156815034|FG003|Follow-Up Phase|Lost to Follow-up|0|||
48717577|NCT00910624|156815031|FG000|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1|||
48717578|NCT00910624|156815032|FG001|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2|||
48717579|NCT00910624|156815033|FG002|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
48717580|NCT00910624|156815034|FG003|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
48717581|NCT00910624|156815031|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
48717582|NCT00910624|156815032|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
48717583|NCT00910624|156815033|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
48717584|NCT00910624|156815034|FG003|Follow-Up Phase|Withdrawal by Subject|0|||
48717585|NCT00910624|156815031|FG000|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1|||
48717586|NCT00910624|156815032|FG001|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
48717587|NCT00910624|156815033|FG002|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
48717588|NCT00910624|156815034|FG003|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
48717589|NCT00910624|156815031|FG000|Follow-Up Phase|Administrative|0|||
48717590|NCT00910624|156815032|FG001|Follow-Up Phase|Administrative|1|||
49126909|NCT03110354|158304228|FG003|Overall Study|Other|1|||
49126910|NCT03110354|158304229|FG004|Overall Study|Other|1|||
49126911|NCT02456727|158304247|FG000|Overall Study|Lost to Follow-up|63|||
48717591|NCT00910624|156815033|FG002|Follow-Up Phase|Administrative|1|||
48717592|NCT00910624|156815034|FG003|Follow-Up Phase|Administrative|0|||
48717593|NCT03005873|156815035|FG000|Overall Study|Prohibited medication use post radnomization|1|||
48717594|NCT03005873|156815036|FG001|Overall Study|Prohibited medication use post radnomization|1|||
48717595|NCT03005873|156815037|FG002|Overall Study|Prohibited medication use post radnomization|1|||
48717596|NCT03005873|156815035|FG000|Overall Study|Withdrew consent|0|||
48717597|NCT03005873|156815036|FG001|Overall Study|Withdrew consent|1|||
48717598|NCT03005873|156815037|FG002|Overall Study|Withdrew consent|2|||
48717599|NCT03005873|156815035|FG000|Overall Study|Lost to Follow-up|0|||
48717600|NCT03005873|156815036|FG001|Overall Study|Lost to Follow-up|1|||
48717601|NCT03005873|156815037|FG002|Overall Study|Lost to Follow-up|0|||
48717602|NCT03005873|156815035|FG000|Overall Study|Ineligible post randomization|0|||
49126912|NCT02456727|158304248|FG001|Overall Study|Lost to Follow-up|65|||
49126913|NCT02456727|158304247|FG000|Overall Study|Death|2|||
49126914|NCT02456727|158304248|FG001|Overall Study|Death|1|||
48717603|NCT03005873|156815036|FG001|Overall Study|Ineligible post randomization|0|||
48717604|NCT03005873|156815037|FG002|Overall Study|Ineligible post randomization|1|||
48717605|NCT00097981|156815038|FG000|Overall Study|Adverse Event|31|||
48717606|NCT00097981|156815039|FG001|Overall Study|Adverse Event|44|||
48717607|NCT00097981|156815038|FG000|Overall Study|Withdrawal by Subject|10|||
48717608|NCT00097981|156815039|FG001|Overall Study|Withdrawal by Subject|8|||
48814801|NCT02838628|157163603|FG000|Recurrence Follow-up Period|AK Recurrence|18|||
49126915|NCT02456727|158304247|FG000|Overall Study|Withdrawal by Subject|1|||
49126916|NCT02456727|158304248|FG001|Overall Study|Withdrawal by Subject|10|||
48717609|NCT00097981|156815038|FG000|Overall Study|Protocol Violation|1|||
48717610|NCT00097981|156815039|FG001|Overall Study|Protocol Violation|1|||
48814802|NCT02838628|157163604|FG001|Recurrence Follow-up Period|AK Recurrence|13|||
48814803|NCT02838628|157163603|FG000|Recurrence Follow-up Period|Adverse Event|1|||
48814804|NCT02838628|157163604|FG001|Recurrence Follow-up Period|Adverse Event|0|||
48814805|NCT02838628|157163603|FG000|Recurrence Follow-up Period|Non-compliance|0|||
48814806|NCT02838628|157163604|FG001|Recurrence Follow-up Period|Non-compliance|1|||
48814807|NCT02838628|157163603|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
48814808|NCT02838628|157163604|FG001|Recurrence Follow-up Period|Withdrawal by Subject|2|||
48814809|NCT02838628|157163603|FG000|Recurrence Follow-up Period|Other un-specified|1|||
48814810|NCT02838628|157163604|FG001|Recurrence Follow-up Period|Other un-specified|1|||
48814811|NCT03567993|157163609|FG000|Overall Study|Lost to Follow-up|4|||
48814812|NCT03567993|157163610|FG001|Overall Study|Lost to Follow-up|2|||
48814813|NCT03567993|157163609|FG000|Overall Study|Death|1|||
48814814|NCT03567993|157163610|FG001|Overall Study|Death|1|||
48814815|NCT03567993|157163609|FG000|Overall Study|Withdrawal by Subject|1|||
48814816|NCT03567993|157163610|FG001|Overall Study|Withdrawal by Subject|0|||
48814817|NCT01368211|157163614|FG000|Second Platelets Transfusion|No need for additional transfusion|1|||
48814818|NCT01368211|157163615|FG001|Second Platelets Transfusion|No need for additional transfusion|2|||
48814819|NCT03990363|157163616|FG000|Overall Study|Withdrawal by Subject|10|||
48814820|NCT03990363|157163617|FG001|Overall Study|Withdrawal by Subject|9|||
48814821|NCT03990363|157163618|FG002|Overall Study|Withdrawal by Subject|18|||
48814822|NCT03990363|157163619|FG003|Overall Study|Withdrawal by Subject|11|||
48814823|NCT03990363|157163620|FG004|Overall Study|Withdrawal by Subject|9|||
48814824|NCT03990363|157163616|FG000|Overall Study|Physician Decision|1|||
48814825|NCT03990363|157163617|FG001|Overall Study|Physician Decision|0|||
48814826|NCT03990363|157163618|FG002|Overall Study|Physician Decision|0|||
48814827|NCT03990363|157163619|FG003|Overall Study|Physician Decision|0|||
48814828|NCT03990363|157163620|FG004|Overall Study|Physician Decision|0|||
48814829|NCT03990363|157163616|FG000|Overall Study|Adverse Event|1|||
48814830|NCT03990363|157163617|FG001|Overall Study|Adverse Event|3|||
48814831|NCT03990363|157163618|FG002|Overall Study|Adverse Event|2|||
48814832|NCT03990363|157163619|FG003|Overall Study|Adverse Event|2|||
48814833|NCT03990363|157163620|FG004|Overall Study|Adverse Event|0|||
48814834|NCT03990363|157163616|FG000|Overall Study|Death|14|||
48814835|NCT03990363|157163617|FG001|Overall Study|Death|8|||
48814836|NCT03990363|157163618|FG002|Overall Study|Death|14|||
48814837|NCT03990363|157163619|FG003|Overall Study|Death|10|||
48814838|NCT03990363|157163620|FG004|Overall Study|Death|11|||
48814839|NCT03990363|157163616|FG000|Overall Study|Failure to meet randomization criteria|0|||
48814840|NCT03990363|157163617|FG001|Overall Study|Failure to meet randomization criteria|1|||
48814841|NCT03990363|157163618|FG002|Overall Study|Failure to meet randomization criteria|1|||
48814842|NCT03990363|157163619|FG003|Overall Study|Failure to meet randomization criteria|0|||
49126917|NCT02456727|158304247|FG000|Overall Study|Never Initiated Treatment|43|||
49126918|NCT02456727|158304248|FG001|Overall Study|Never Initiated Treatment|30|||
49126919|NCT02446691|158304249|FG000|Overall Study|Withdrawal by Subject|2|||
49126920|NCT02446691|158304249|FG000|Overall Study|Lost to Follow-up|8|||
49126921|NCT02446691|158304249|FG000|Overall Study|Protocol Violation|1|||
49126922|NCT00243919|158304250|FG000|Overall Study|Death|3|||
49126923|NCT00243919|158304251|FG001|Overall Study|Death|4|||
49126924|NCT00243919|158304252|FG002|Overall Study|Death|6|||
49126925|NCT00243919|158304250|FG000|Overall Study|Withdrawal by Subject|6|||
49126926|NCT00243919|158304251|FG001|Overall Study|Withdrawal by Subject|6|||
49126927|NCT00243919|158304252|FG002|Overall Study|Withdrawal by Subject|2|||
49126928|NCT00243919|158304250|FG000|Overall Study|Lost to Follow-up|6|||
49126929|NCT00243919|158304251|FG001|Overall Study|Lost to Follow-up|7|||
49126930|NCT00243919|158304252|FG002|Overall Study|Lost to Follow-up|3|||
48717611|NCT00097981|156815038|FG000|Overall Study|Death|2|||
48814843|NCT03990363|157163620|FG004|Overall Study|Failure to meet randomization criteria|0|||
48814844|NCT03990363|157163616|FG000|Overall Study|Lost to Follow-up|0|||
48814845|NCT03990363|157163617|FG001|Overall Study|Lost to Follow-up|0|||
48814846|NCT03990363|157163618|FG002|Overall Study|Lost to Follow-up|0|||
48814847|NCT03990363|157163619|FG003|Overall Study|Lost to Follow-up|1|||
48814848|NCT03990363|157163620|FG004|Overall Study|Lost to Follow-up|2|||
48920949|NCT00762892|157544788|FG000|Overall Study|Pregnancy|1|||
48717612|NCT00097981|156815039|FG001|Overall Study|Death|4|||
48717613|NCT00097981|156815038|FG000|Overall Study|Physician Decision|7|||
49126931|NCT00243919|158304250|FG000|Overall Study|Administrative Error|1|||
48814849|NCT03990363|157163616|FG000|Overall Study|Non-compliance with study drug|2|||
48814850|NCT03990363|157163617|FG001|Overall Study|Non-compliance with study drug|1|||
48814851|NCT03990363|157163618|FG002|Overall Study|Non-compliance with study drug|2|||
48814852|NCT03990363|157163619|FG003|Overall Study|Non-compliance with study drug|0|||
48814853|NCT03990363|157163620|FG004|Overall Study|Non-compliance with study drug|0|||
49126932|NCT00243919|158304251|FG001|Overall Study|Administrative Error|0|||
49126933|NCT00243919|158304252|FG002|Overall Study|Administrative Error|0|||
49126934|NCT00243919|158304250|FG000|Overall Study|Physician Decision|1|||
49126935|NCT00243919|158304251|FG001|Overall Study|Physician Decision|1|||
49126936|NCT00243919|158304252|FG002|Overall Study|Physician Decision|0|||
49126937|NCT00192114|158304253|FG000|Overall Study|Objective Tumor Progression|19|||
49126938|NCT00192114|158304253|FG000|Overall Study|Adverse Event|2|||
49126939|NCT00192114|158304253|FG000|Overall Study|Clinical Progression|2|||
49126940|NCT00192114|158304253|FG000|Overall Study|Death|1|||
49126941|NCT01222104|158304256|FG000|Overall Study|Lost to Follow-up|37|||
49126942|NCT01222104|158304256|FG000|Overall Study|Death|10|||
49126943|NCT01418339|158304263|FG000|Overall Study|Adverse Event|5|||
49126944|NCT01418339|158304264|FG001|Overall Study|Adverse Event|2|||
49126945|NCT01418339|158304263|FG000|Overall Study|Subject Withdrew Consent|1|||
49126946|NCT01418339|158304264|FG001|Overall Study|Subject Withdrew Consent|2|||
49126947|NCT01418339|158304263|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
49126948|NCT01418339|158304264|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
49126949|NCT02204917|158304265|FG000|Overall Study|Protocol Violation|1|||
49126950|NCT01401322|158304266|FG000|Overall Study|Withdrawal by Subject|1|||
49126951|NCT01401322|158304266|FG000|Overall Study|Physician Decision|1|||
49126952|NCT02974868|158304267|FG000|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
49126953|NCT02974868|158304268|FG001|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
49126954|NCT02974868|158304269|FG002|Initial 24-Week Treatment Period (TP)|Adverse Event|2|||
49126955|NCT02974868|158304270|FG003|Initial 24-Week Treatment Period (TP)|Adverse Event|4|||
49126956|NCT02974868|158304267|FG000|Initial 24-Week Treatment Period (TP)|others|3|||
49126957|NCT02974868|158304268|FG001|Initial 24-Week Treatment Period (TP)|others|8|||
49126958|NCT02974868|158304269|FG002|Initial 24-Week Treatment Period (TP)|others|1|||
49126959|NCT02974868|158304270|FG003|Initial 24-Week Treatment Period (TP)|others|8|||
49126960|NCT02974868|158304267|FG000|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2|||
49126961|NCT02974868|158304268|FG001|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1|||
49126962|NCT02974868|158304269|FG002|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11|||
48717614|NCT00097981|156815039|FG001|Overall Study|Physician Decision|1|||
48717615|NCT00097981|156815038|FG000|Overall Study|Disease Progression|8|||
48717616|NCT00097981|156815039|FG001|Overall Study|Disease Progression|2|||
48717617|NCT00097981|156815038|FG000|Overall Study|Transplant planned|28|||
48717618|NCT00097981|156815039|FG001|Overall Study|Transplant planned|27|||
48717619|NCT00097981|156815038|FG000|Overall Study|Other|19|||
48717620|NCT00097981|156815039|FG001|Overall Study|Other|13|||
48717621|NCT01767142|156815040|FG000|Overall Study|Lost to Follow-up|3|||
48717622|NCT02471612|156815041|FG000|Overall Study|Lost to Follow-up|2|||
48717623|NCT02082340|156815042|FG000|Overall Study|Lost to Follow-up|1|||
48717624|NCT02082340|156815043|FG001|Overall Study|Lost to Follow-up|1|||
48717625|NCT05315908|156815046|FG000|Overall Study|Lost to Follow-up|4477|||
48717626|NCT05315908|156815047|FG001|Overall Study|Lost to Follow-up|4606|||
48717627|NCT01883453|156815048|FG000|Overall Study|No episode of common cold|25|||
48717628|NCT01883453|156815049|FG001|Overall Study|No episode of common cold|23|||
48717629|NCT01024309|156815054|FG000|Overall Study|Physician Decision|4|||
48717630|NCT01024309|156815055|FG001|Overall Study|Physician Decision|0|||
48717631|NCT01024309|156815054|FG000|Overall Study|Withdrawal by Subject|4|||
48717632|NCT01024309|156815055|FG001|Overall Study|Withdrawal by Subject|4|||
48717633|NCT02208063|156815056|FG000|Overall Study|Death|3|||
48717634|NCT02208063|156815057|FG001|Overall Study|Death|5|||
48717635|NCT02208063|156815056|FG000|Overall Study|Not Specified in report|3|||
48717636|NCT02208063|156815057|FG001|Overall Study|Not Specified in report|4|||
48717637|NCT02208063|156815056|FG000|Overall Study|Withdrawal by Subject|5|||
48717638|NCT02208063|156815057|FG001|Overall Study|Withdrawal by Subject|2|||
48717639|NCT02208063|156815056|FG000|Overall Study|Lost to Follow-up|1|||
48717640|NCT02208063|156815057|FG001|Overall Study|Lost to Follow-up|0|||
48717641|NCT01105065|156815058|FG000|Overall Study|Adverse Event|5|||
48717642|NCT01105065|156815058|FG000|Overall Study|Technical Problems|1|||
48717643|NCT01395784|156815059|FG000|Overall Study|Lost to Follow-up|7|||
49126963|NCT02974868|158304270|FG003|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6|||
48717644|NCT01395784|156815059|FG000|Overall Study|Withdrawal by Subject|3|||
48717645|NCT01395784|156815059|FG000|Overall Study|Physician Decision|5|||
48717646|NCT00329849|156815060|FG000|Overall Study|Withdrawal by Subject|6|||
48717647|NCT00329849|156815061|FG001|Overall Study|Withdrawal by Subject|4|||
48717648|NCT00435045|156815062|FG000|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
48717649|NCT00435045|156815063|FG001|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
48717650|NCT00435045|156815062|FG000|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
48717651|NCT00435045|156815063|FG001|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
49126964|NCT02974868|158304267|FG000|Cross-Over Extension (COE) Period|Withdrawal by Subject|2|||
49126965|NCT02974868|158304268|FG001|Cross-Over Extension (COE) Period|Withdrawal by Subject|1|||
49126966|NCT02974868|158304269|FG002|Cross-Over Extension (COE) Period|Withdrawal by Subject|3|||
49126967|NCT02974868|158304270|FG003|Cross-Over Extension (COE) Period|Withdrawal by Subject|0|||
49126968|NCT03154086|158304275|FG000|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
49126969|NCT03154086|158304276|FG001|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
48814854|NCT03990363|157163616|FG000|Overall Study|Study terminated by sponsor|0|||
48814855|NCT03990363|157163617|FG001|Overall Study|Study terminated by sponsor|1|||
48814856|NCT03990363|157163618|FG002|Overall Study|Study terminated by sponsor|0|||
48814857|NCT03990363|157163619|FG003|Overall Study|Study terminated by sponsor|0|||
48814858|NCT03990363|157163620|FG004|Overall Study|Study terminated by sponsor|0|||
48814859|NCT03990363|157163616|FG000|Overall Study|Site terminated by sponsor|2|||
48814860|NCT03990363|157163617|FG001|Overall Study|Site terminated by sponsor|1|||
48814861|NCT03990363|157163618|FG002|Overall Study|Site terminated by sponsor|2|||
48814862|NCT03990363|157163619|FG003|Overall Study|Site terminated by sponsor|0|||
48814863|NCT03990363|157163620|FG004|Overall Study|Site terminated by sponsor|2|||
48814864|NCT03990363|157163616|FG000|Overall Study|Not categorized|5|||
48814865|NCT03990363|157163617|FG001|Overall Study|Not categorized|5|||
48814866|NCT03990363|157163618|FG002|Overall Study|Not categorized|3|||
48814867|NCT03990363|157163619|FG003|Overall Study|Not categorized|2|||
48814868|NCT03990363|157163620|FG004|Overall Study|Not categorized|2|||
48814869|NCT03225846|157163633|FG000|Overall Study|Adverse Event|0|||
48814870|NCT03225846|157163634|FG001|Overall Study|Adverse Event|0|||
49126970|NCT03154086|158304277|FG002|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
49126971|NCT03154086|158304278|FG003|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1|||
48717652|NCT00435045|156815062|FG000|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2|||
48717653|NCT00435045|156815063|FG001|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1|||
48717654|NCT00435045|156815062|FG000|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1|||
48717655|NCT00435045|156815063|FG001|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0|||
48717656|NCT00435045|156815062|FG000|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0|||
48717657|NCT00435045|156815063|FG001|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1|||
48717658|NCT00435045|156815062|FG000|Weeks 9-12 / 20mg Dose Level|Adverse Event|4|||
48717659|NCT00435045|156815063|FG001|Weeks 9-12 / 20mg Dose Level|Adverse Event|3|||
48717660|NCT00435045|156815062|FG000|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
48717661|NCT00435045|156815063|FG001|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
48717662|NCT00435045|156815062|FG000|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0|||
48717663|NCT00435045|156815063|FG001|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1|||
48717664|NCT00435045|156815062|FG000|Weeks 13-16 / 40mg Dose Level|Adverse Event|3|||
48717665|NCT00435045|156815063|FG001|Weeks 13-16 / 40mg Dose Level|Adverse Event|2|||
48717666|NCT00435045|156815062|FG000|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1|||
48717667|NCT00435045|156815063|FG001|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0|||
48717668|NCT00435045|156815062|FG000|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1|||
48717669|NCT00435045|156815063|FG001|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0|||
48717670|NCT01782469|156815065|FG000|Overall Study|Lost to Follow-up|1|||
48717671|NCT00322621|156815066|FG000|Period II - Acute Therapy Phase|Adverse Event|20|||
48717672|NCT00322621|156815067|FG001|Period II - Acute Therapy Phase|Adverse Event|0|||
48717673|NCT00322621|156815068|FG002|Period II - Acute Therapy Phase|Adverse Event|0|||
48717674|NCT00322621|156815066|FG000|Period II - Acute Therapy Phase|Lack of Efficacy|1|||
48717675|NCT00322621|156815067|FG001|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
48717676|NCT00322621|156815068|FG002|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
48717677|NCT00322621|156815066|FG000|Period II - Acute Therapy Phase|Withdrawal by Subject|8|||
48717678|NCT00322621|156815067|FG001|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
48717679|NCT00322621|156815068|FG002|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
48717680|NCT00322621|156815066|FG000|Period II - Acute Therapy Phase|Protocol Violation|2|||
48717681|NCT00322621|156815067|FG001|Period II - Acute Therapy Phase|Protocol Violation|0|||
48717682|NCT00322621|156815068|FG002|Period II - Acute Therapy Phase|Protocol Violation|0|||
48717683|NCT00322621|156815066|FG000|Period II - Acute Therapy Phase|Physician Decision|1|||
48717684|NCT00322621|156815067|FG001|Period II - Acute Therapy Phase|Physician Decision|0|||
48717685|NCT00322621|156815068|FG002|Period II - Acute Therapy Phase|Physician Decision|0|||
48717686|NCT00322621|156815066|FG000|Period III - Maintenance / Rescue Phase|Adverse Event|0|||
48717687|NCT00322621|156815067|FG001|Period III - Maintenance / Rescue Phase|Adverse Event|14|||
48717688|NCT00322621|156815068|FG002|Period III - Maintenance / Rescue Phase|Adverse Event|5|||
48717689|NCT00322621|156815066|FG000|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0|||
48717690|NCT00322621|156815067|FG001|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4|||
48717691|NCT00322621|156815068|FG002|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24|||
48717692|NCT00322621|156815066|FG000|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0|||
48717693|NCT00322621|156815067|FG001|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7|||
48717694|NCT00322621|156815068|FG002|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1|||
48717695|NCT00322621|156815066|FG000|Period III - Maintenance / Rescue Phase|Protocol Violation|0|||
48717696|NCT00322621|156815067|FG001|Period III - Maintenance / Rescue Phase|Protocol Violation|2|||
48717697|NCT00322621|156815068|FG002|Period III - Maintenance / Rescue Phase|Protocol Violation|5|||
48717698|NCT00322621|156815066|FG000|Period III - Maintenance / Rescue Phase|Death|0|||
48717699|NCT00322621|156815067|FG001|Period III - Maintenance / Rescue Phase|Death|1|||
48717700|NCT00322621|156815068|FG002|Period III - Maintenance / Rescue Phase|Death|0|||
48717701|NCT00322621|156815066|FG000|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0|||
48717702|NCT00322621|156815067|FG001|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
48717703|NCT00322621|156815068|FG002|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
48717704|NCT01038869|156815071|FG000|Overall Study|Withdrawal by Subject|1|||
48717705|NCT01038869|156815071|FG000|Overall Study|Lost to Follow-up|6|||
48717706|NCT01328444|156815074|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
48717707|NCT01328444|156815075|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
48717708|NCT01328444|156815076|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
48717709|NCT01328444|156815077|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
48717710|NCT01328444|156815078|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|5|||
48717711|NCT01328444|156815079|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
48717712|NCT01328444|156815074|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
48717713|NCT01328444|156815075|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
48717714|NCT01328444|156815076|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
48717715|NCT01328444|156815077|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
48717716|NCT01328444|156815078|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
48717717|NCT01328444|156815079|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
48717718|NCT01328444|156815074|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
48717719|NCT01328444|156815075|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
48717720|NCT01328444|156815076|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
48717721|NCT01328444|156815077|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
48717722|NCT01328444|156815078|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
48717723|NCT01328444|156815079|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
48717724|NCT01328444|156815074|FG000|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
48717725|NCT01328444|156815075|FG001|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1|||
48717726|NCT01328444|156815076|FG002|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
48717727|NCT01328444|156815077|FG003|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
48717728|NCT01328444|156815078|FG004|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2|||
48717729|NCT01328444|156815079|FG005|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
48717730|NCT01328444|156815074|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2|||
48717731|NCT01328444|156815075|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
48717732|NCT01328444|156815076|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
48717733|NCT01328444|156815077|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
48717734|NCT01328444|156815078|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
48717735|NCT01328444|156815079|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
48717736|NCT01328444|156815074|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
48717737|NCT01328444|156815075|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
48717738|NCT01328444|156815076|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
48717739|NCT01328444|156815077|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
48717740|NCT01328444|156815078|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
48717741|NCT01328444|156815079|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
48717742|NCT01328444|156815074|FG000|Washout Period (14 Days)|Adverse Event|1|||
48717743|NCT01328444|156815075|FG001|Washout Period (14 Days)|Adverse Event|1|||
48717744|NCT01328444|156815076|FG002|Washout Period (14 Days)|Adverse Event|0|||
48717745|NCT01328444|156815077|FG003|Washout Period (14 Days)|Adverse Event|1|||
48717746|NCT01328444|156815078|FG004|Washout Period (14 Days)|Adverse Event|1|||
48717747|NCT01328444|156815079|FG005|Washout Period (14 Days)|Adverse Event|2|||
48814871|NCT03225846|157163635|FG002|Overall Study|Adverse Event|0|||
48814872|NCT03225846|157163636|FG003|Overall Study|Adverse Event|0|||
48814873|NCT03225846|157163637|FG004|Overall Study|Adverse Event|0|||
48814874|NCT03225846|157163638|FG005|Overall Study|Adverse Event|0|||
48814875|NCT03225846|157163639|FG006|Overall Study|Adverse Event|6|||
48814876|NCT03225846|157163633|FG000|Overall Study|Withdrawal by Subject|0|||
48814877|NCT03225846|157163634|FG001|Overall Study|Withdrawal by Subject|1|||
48814878|NCT03225846|157163635|FG002|Overall Study|Withdrawal by Subject|0|||
48814879|NCT03225846|157163636|FG003|Overall Study|Withdrawal by Subject|0|||
48814880|NCT03225846|157163637|FG004|Overall Study|Withdrawal by Subject|0|||
48814881|NCT03225846|157163638|FG005|Overall Study|Withdrawal by Subject|0|||
48814882|NCT03225846|157163639|FG006|Overall Study|Withdrawal by Subject|0|||
48717748|NCT01328444|156815074|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
48717749|NCT01328444|156815075|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
48717750|NCT01328444|156815076|FG002|Washout Period (14 Days)|Lack of Efficacy|0|||
48717751|NCT01328444|156815077|FG003|Washout Period (14 Days)|Lack of Efficacy|0|||
48814883|NCT03225846|157163633|FG000|Overall Study|Death|0|||
48717752|NCT01328444|156815078|FG004|Washout Period (14 Days)|Lack of Efficacy|0|||
48717753|NCT01328444|156815079|FG005|Washout Period (14 Days)|Lack of Efficacy|1|||
48717754|NCT01328444|156815074|FG000|Washout Period (14 Days)|Withdrawal by Subject|0|||
48717755|NCT01328444|156815075|FG001|Washout Period (14 Days)|Withdrawal by Subject|0|||
48717756|NCT01328444|156815076|FG002|Washout Period (14 Days)|Withdrawal by Subject|0|||
48717757|NCT01328444|156815077|FG003|Washout Period (14 Days)|Withdrawal by Subject|0|||
48717758|NCT01328444|156815078|FG004|Washout Period (14 Days)|Withdrawal by Subject|0|||
48717759|NCT01328444|156815079|FG005|Washout Period (14 Days)|Withdrawal by Subject|1|||
48717760|NCT01328444|156815074|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|5|||
48717761|NCT01328444|156815075|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
48717762|NCT01328444|156815076|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
48717763|NCT01328444|156815077|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
48717764|NCT01328444|156815078|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
48717765|NCT01328444|156815079|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
48717766|NCT01328444|156815074|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5|||
48717767|NCT01328444|156815075|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
48717768|NCT01328444|156815076|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
48920950|NCT00762892|157544789|FG001|Overall Study|Pregnancy|0|||
49126972|NCT03154086|158304279|FG004|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
49126973|NCT03154086|158304280|FG005|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
49126974|NCT03154086|158304281|FG006|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
49126975|NCT03154086|158304282|FG007|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
49126976|NCT03154086|158304283|FG008|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
49126977|NCT03154086|158304284|FG009|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
49126978|NCT03154086|158304285|FG010|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
49126979|NCT03154086|158304286|FG011|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
49126980|NCT03154086|158304287|FG012|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
49126981|NCT03154086|158304288|FG013|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
49126982|NCT03154086|158304289|FG014|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
49126983|NCT03154086|158304275|FG000|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
49126984|NCT03154086|158304276|FG001|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1|||
49126985|NCT03154086|158304277|FG002|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
49126986|NCT03154086|158304278|FG003|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
49126987|NCT03154086|158304279|FG004|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
49126988|NCT03154086|158304280|FG005|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
49126989|NCT03154086|158304281|FG006|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
49126990|NCT03154086|158304282|FG007|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
49126991|NCT03154086|158304283|FG008|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
49126992|NCT03154086|158304284|FG009|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
49126993|NCT03154086|158304285|FG010|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
49126994|NCT03154086|158304286|FG011|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
49126995|NCT03154086|158304287|FG012|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
49126996|NCT03154086|158304288|FG013|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
49126997|NCT03154086|158304289|FG014|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
49126998|NCT03154086|158304275|FG000|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
49126999|NCT03154086|158304276|FG001|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
49127000|NCT03154086|158304277|FG002|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1|||
49127001|NCT03154086|158304278|FG003|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
49127002|NCT03154086|158304279|FG004|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
49127003|NCT03154086|158304280|FG005|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
49127004|NCT03154086|158304281|FG006|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
49127005|NCT03154086|158304282|FG007|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
49127006|NCT03154086|158304283|FG008|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
49127007|NCT03154086|158304284|FG009|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
49127008|NCT03154086|158304285|FG010|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
49127009|NCT03154086|158304286|FG011|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
49127010|NCT03154086|158304287|FG012|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
49127011|NCT03154086|158304288|FG013|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
49127012|NCT03154086|158304289|FG014|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
49127013|NCT03154086|158304275|FG000|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1|||
49127014|NCT03154086|158304276|FG001|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
49127015|NCT03154086|158304277|FG002|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
49127016|NCT03154086|158304278|FG003|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
48717769|NCT01328444|156815077|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
48717770|NCT01328444|156815078|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
48717771|NCT01328444|156815079|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4|||
48717772|NCT01328444|156815074|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
48717773|NCT01328444|156815075|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
48717774|NCT01328444|156815076|FG002|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
48717775|NCT01328444|156815077|FG003|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
48717776|NCT01328444|156815078|FG004|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
48717777|NCT01328444|156815079|FG005|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
48717778|NCT01328444|156815074|FG000|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
48717779|NCT01328444|156815075|FG001|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
48717780|NCT01328444|156815076|FG002|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
48717781|NCT01328444|156815077|FG003|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
48717782|NCT01328444|156815078|FG004|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
48717783|NCT01328444|156815079|FG005|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
48717784|NCT01328444|156815074|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
48717785|NCT01328444|156815075|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
48717786|NCT01328444|156815076|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
48717787|NCT01328444|156815077|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
48717788|NCT01328444|156815078|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
48717789|NCT01328444|156815079|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
48717790|NCT01328444|156815074|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
48717791|NCT01328444|156815075|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
48717792|NCT01328444|156815076|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
48717793|NCT01328444|156815077|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
48717794|NCT01328444|156815078|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
48717795|NCT01328444|156815079|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
48717796|NCT03531632|156815080|FG000|Overall Study|Adverse Event|0|||
48717797|NCT03531632|156815081|FG001|Overall Study|Adverse Event|0|||
48717798|NCT03531632|156815082|FG002|Overall Study|Adverse Event|1|||
48717799|NCT03531632|156815080|FG000|Overall Study|Death|4|||
49127017|NCT03154086|158304279|FG004|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
48717800|NCT03531632|156815081|FG001|Overall Study|Death|0|||
48717801|NCT03531632|156815082|FG002|Overall Study|Death|14|||
48717802|NCT03531632|156815080|FG000|Overall Study|Study Terminated|1|||
48717803|NCT03531632|156815081|FG001|Overall Study|Study Terminated|3|||
48717804|NCT03531632|156815082|FG002|Overall Study|Study Terminated|11|||
48717805|NCT00729469|156815083|FG000|Overall Study|Adverse Event|14|||
48717806|NCT00729469|156815084|FG001|Overall Study|Adverse Event|25|||
48717807|NCT00729469|156815083|FG000|Overall Study|Lost to Follow-up|9|||
48717808|NCT00729469|156815084|FG001|Overall Study|Lost to Follow-up|9|||
48717809|NCT00729469|156815083|FG000|Overall Study|Protocol Violation|2|||
48717810|NCT00729469|156815084|FG001|Overall Study|Protocol Violation|1|||
48717811|NCT00729469|156815083|FG000|Overall Study|Withdrawal by Subject|19|||
48717812|NCT00729469|156815084|FG001|Overall Study|Withdrawal by Subject|8|||
48717813|NCT00729469|156815083|FG000|Overall Study|Other-Not mentioned|9|||
48717814|NCT00729469|156815084|FG001|Overall Study|Other-Not mentioned|4|||
48717815|NCT00393510|156815085|FG000|Overall Study|Physician Decision|3|||
48717816|NCT00393510|156815086|FG001|Overall Study|Physician Decision|9|||
48717817|NCT02674204|156815090|FG000|Overall Study|Adverse Event|1|||
49127018|NCT03154086|158304280|FG005|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
49127019|NCT03154086|158304281|FG006|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
49127020|NCT03154086|158304282|FG007|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
49127021|NCT03154086|158304283|FG008|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
49127022|NCT03154086|158304284|FG009|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
49127023|NCT03154086|158304285|FG010|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
49127024|NCT03154086|158304286|FG011|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
49127025|NCT03154086|158304287|FG012|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
49127026|NCT03154086|158304288|FG013|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
49127027|NCT03154086|158304289|FG014|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
49127028|NCT03154086|158304275|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
49127029|NCT03154086|158304276|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
49127030|NCT03154086|158304277|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
49127031|NCT03154086|158304278|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
48717818|NCT02674204|156815091|FG001|Overall Study|Adverse Event|0|||
48717819|NCT00773838|156815099|FG000|Overall Study|Adverse Event|29|||
48717820|NCT00773838|156815099|FG000|Overall Study|Lost to Follow-up|1|||
48717821|NCT00773838|156815099|FG000|Overall Study|Physician Decision|8|||
48717822|NCT00773838|156815099|FG000|Overall Study|Progressive Disease|82|||
48717823|NCT00773838|156815099|FG000|Overall Study|Protocol Violation|2|||
48717824|NCT00773838|156815099|FG000|Overall Study|Withdrawal by Subject|21|||
48717825|NCT00392379|156815100|FG000|Overall Study|Withdrawal by Subject|17|||
48717826|NCT00392379|156815101|FG001|Overall Study|Withdrawal by Subject|28|||
48717827|NCT00392379|156815100|FG000|Overall Study|Lost to Follow-up|4|||
49127032|NCT03154086|158304279|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
49127033|NCT03154086|158304280|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
49127034|NCT03154086|158304281|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
49127035|NCT03154086|158304282|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
49127036|NCT03154086|158304283|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1|||
48717828|NCT00392379|156815101|FG001|Overall Study|Lost to Follow-up|9|||
48717829|NCT00392379|156815100|FG000|Overall Study|Adverse Event|1|||
48717830|NCT00392379|156815101|FG001|Overall Study|Adverse Event|1|||
48717831|NCT00308581|156815102|FG000|Induction Phase|Adverse Event|0|||
48717832|NCT00308581|156815103|FG001|Induction Phase|Adverse Event|0|||
48717833|NCT00308581|156815104|FG002|Induction Phase|Adverse Event|37|||
48717834|NCT00308581|156815102|FG000|Induction Phase|Lack of Efficacy|0|||
48717835|NCT00308581|156815103|FG001|Induction Phase|Lack of Efficacy|0|||
48717836|NCT00308581|156815104|FG002|Induction Phase|Lack of Efficacy|121|||
48717837|NCT00308581|156815102|FG000|Induction Phase|Withdrawal by Subject|0|||
48717838|NCT00308581|156815103|FG001|Induction Phase|Withdrawal by Subject|0|||
48717839|NCT00308581|156815104|FG002|Induction Phase|Withdrawal by Subject|5|||
48717840|NCT00308581|156815102|FG000|Induction Phase|Unknown reason|0|||
48717841|NCT00308581|156815103|FG001|Induction Phase|Unknown reason|0|||
48717842|NCT00308581|156815104|FG002|Induction Phase|Unknown reason|3|||
48717843|NCT00308581|156815102|FG000|Randomized Maintenance Phase|Adverse Event|10|||
48717844|NCT00308581|156815103|FG001|Randomized Maintenance Phase|Adverse Event|17|||
48717845|NCT00308581|156815104|FG002|Randomized Maintenance Phase|Adverse Event|0|||
48717846|NCT00308581|156815102|FG000|Randomized Maintenance Phase|Lack of Efficacy|9|||
48717847|NCT00308581|156815103|FG001|Randomized Maintenance Phase|Lack of Efficacy|21|||
48717848|NCT00308581|156815104|FG002|Randomized Maintenance Phase|Lack of Efficacy|0|||
48717849|NCT00308581|156815102|FG000|Randomized Maintenance Phase|Lost to Follow-up|0|||
48717850|NCT00308581|156815103|FG001|Randomized Maintenance Phase|Lost to Follow-up|2|||
48717851|NCT00308581|156815104|FG002|Randomized Maintenance Phase|Lost to Follow-up|0|||
48717852|NCT00308581|156815102|FG000|Randomized Maintenance Phase|Withdrawal by Subject|1|||
48717853|NCT00308581|156815103|FG001|Randomized Maintenance Phase|Withdrawal by Subject|4|||
48717854|NCT00308581|156815104|FG002|Randomized Maintenance Phase|Withdrawal by Subject|0|||
48717855|NCT00308581|156815102|FG000|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82|||
48717856|NCT00308581|156815103|FG001|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59|||
48717857|NCT00308581|156815104|FG002|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0|||
48717858|NCT00308581|156815102|FG000|Randomized Maintenance Phase|Unknown reason|3|||
48717859|NCT00308581|156815103|FG001|Randomized Maintenance Phase|Unknown reason|0|||
48717860|NCT00308581|156815104|FG002|Randomized Maintenance Phase|Unknown reason|0|||
48717861|NCT01699867|156815113|FG000|Overall Study|Screening Failure|3|||
48717862|NCT02342418|156815114|FG000|Overall Study|Adverse Event|0|||
48717863|NCT02342418|156815115|FG001|Overall Study|Adverse Event|1|||
48717864|NCT04255394|156815116|FG000|Overall Study|Death|35|||
48717865|NCT04255394|156815117|FG001|Overall Study|Death|25|||
48717866|NCT04255394|156815116|FG000|Overall Study|Device removed|2|||
48717867|NCT04255394|156815117|FG001|Overall Study|Device removed|10|||
48717868|NCT04255394|156815116|FG000|Overall Study|Withdrawal by Subject|9|||
48717869|NCT04255394|156815117|FG001|Overall Study|Withdrawal by Subject|8|||
48717870|NCT04255394|156815116|FG000|Overall Study|Screen Failure/Not treated|12|||
48717871|NCT04255394|156815117|FG001|Overall Study|Screen Failure/Not treated|8|||
48717872|NCT04255394|156815116|FG000|Overall Study|Lost to Follow-up|123|||
48814884|NCT03225846|157163634|FG001|Overall Study|Death|1|||
48814885|NCT03225846|157163635|FG002|Overall Study|Death|0|||
48814886|NCT03225846|157163636|FG003|Overall Study|Death|0|||
49127037|NCT03154086|158304284|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
49127038|NCT03154086|158304285|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
49127039|NCT03154086|158304286|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
49127040|NCT03154086|158304287|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
49127041|NCT03154086|158304288|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
49127042|NCT03154086|158304289|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
48814887|NCT03225846|157163637|FG004|Overall Study|Death|0|||
48814888|NCT03225846|157163638|FG005|Overall Study|Death|0|||
48814889|NCT03225846|157163639|FG006|Overall Study|Death|0|||
48920951|NCT00762892|157544788|FG000|Overall Study|Incarceration|1|||
48717873|NCT04255394|156815117|FG001|Overall Study|Lost to Follow-up|265|||
48717874|NCT04255394|156815116|FG000|Overall Study|Adverse Event|1|||
48717875|NCT04255394|156815117|FG001|Overall Study|Adverse Event|3|||
48717876|NCT00725842|156815118|FG000|Overall Study|Lost to Follow-up|19|||
48717877|NCT00725842|156815118|FG000|Overall Study|Death|1|||
48717878|NCT00725842|156815118|FG000|Overall Study|Positive HCV-RNA at Visit 2|13|||
48717879|NCT00725842|156815118|FG000|Overall Study|Consent date prior to study start date|5|||
48717880|NCT00725842|156815118|FG000|Overall Study|Inclusion criterion not met|1|||
48717881|NCT00725842|156815118|FG000|Overall Study|No Visit 1 data|1|||
48814890|NCT03225846|157163633|FG000|Overall Study|Patient did not wish to comply with IC/EC|0|||
48717882|NCT01806662|156815119|FG000|First Intervention (Weeks 0-16)|Withdrawal by Subject|4|||
48717883|NCT01806662|156815120|FG001|First Intervention (Weeks 0-16)|Withdrawal by Subject|0|||
48717884|NCT01806662|156815119|FG000|First Intervention (Weeks 0-16)|Adverse Event|0|||
48717885|NCT01806662|156815120|FG001|First Intervention (Weeks 0-16)|Adverse Event|1|||
48717886|NCT01806662|156815119|FG000|Second Intervention (Weeks 16-32)|Lack of Efficacy|2|||
48717887|NCT01806662|156815120|FG001|Second Intervention (Weeks 16-32)|Lack of Efficacy|3|||
48717888|NCT01806662|156815119|FG000|Second Intervention (Weeks 16-32)|Lost to Follow-up|0|||
48717889|NCT01806662|156815120|FG001|Second Intervention (Weeks 16-32)|Lost to Follow-up|1|||
48717890|NCT01375075|156815121|FG000|Overall Study|Adverse Event|0|||
48717891|NCT01375075|156815122|FG001|Overall Study|Adverse Event|0|||
48717892|NCT01375075|156815123|FG002|Overall Study|Adverse Event|3|||
48717893|NCT01375075|156815124|FG003|Overall Study|Adverse Event|1|||
48717894|NCT01375075|156815125|FG004|Overall Study|Adverse Event|0|||
48717895|NCT01375075|156815126|FG005|Overall Study|Adverse Event|1|||
48717896|NCT01375075|156815121|FG000|Overall Study|Entry Criterion Not Met|1|||
48717897|NCT01375075|156815122|FG001|Overall Study|Entry Criterion Not Met|0|||
48717898|NCT01375075|156815123|FG002|Overall Study|Entry Criterion Not Met|0|||
48717899|NCT01375075|156815124|FG003|Overall Study|Entry Criterion Not Met|0|||
48717900|NCT01375075|156815125|FG004|Overall Study|Entry Criterion Not Met|0|||
48717901|NCT01375075|156815126|FG005|Overall Study|Entry Criterion Not Met|1|||
48717902|NCT01375075|156815121|FG000|Overall Study|Withdrawal by Subject|0|||
48717903|NCT01375075|156815122|FG001|Overall Study|Withdrawal by Subject|1|||
48717904|NCT01375075|156815123|FG002|Overall Study|Withdrawal by Subject|0|||
48717905|NCT01375075|156815124|FG003|Overall Study|Withdrawal by Subject|0|||
48717906|NCT01375075|156815125|FG004|Overall Study|Withdrawal by Subject|0|||
48717907|NCT01375075|156815126|FG005|Overall Study|Withdrawal by Subject|1|||
48717908|NCT00311584|156815127|FG000|Overall Study|Death|1|||
48717909|NCT00311584|156815128|FG001|Overall Study|Death|0|||
48717910|NCT00311584|156815127|FG000|Overall Study|Lack of Efficacy|12|||
48717911|NCT00311584|156815128|FG001|Overall Study|Lack of Efficacy|15|||
48717912|NCT00311584|156815127|FG000|Overall Study|Physician Decision|4|||
48717913|NCT00311584|156815128|FG001|Overall Study|Physician Decision|5|||
48717914|NCT00311584|156815127|FG000|Overall Study|Withdrawal by Subject|1|||
48717915|NCT00311584|156815128|FG001|Overall Study|Withdrawal by Subject|1|||
48717916|NCT00311584|156815127|FG000|Overall Study|ineligible|2|||
48717917|NCT00311584|156815128|FG001|Overall Study|ineligible|2|||
48717918|NCT00835731|156815134|FG000|Overall Study|Withdrawal by Subject|1|||
48717919|NCT00835731|156815135|FG001|Overall Study|Withdrawal by Subject|0|||
48717920|NCT00835731|156815134|FG000|Overall Study|Physician Decision|1|||
48717921|NCT00835731|156815135|FG001|Overall Study|Physician Decision|1|||
48717922|NCT02216812|156815139|FG000|Overall Study|Lost to Follow-up|10|||
48717923|NCT02216812|156815140|FG001|Overall Study|Lost to Follow-up|5|||
48717924|NCT00129311|156815142|FG000|Overall Study|Withdrawal by Subject|12|||
48717925|NCT00129311|156815143|FG001|Overall Study|Withdrawal by Subject|19|||
48717926|NCT02207946|156815145|FG000|Overall Study|Lost to Follow-up|1|||
48717927|NCT02207946|156815146|FG001|Overall Study|Lost to Follow-up|0|||
48717928|NCT02207946|156815145|FG000|Overall Study|Adverse Event|0|||
48717929|NCT02207946|156815146|FG001|Overall Study|Adverse Event|1|||
48717930|NCT00167778|156815147|FG000|Overall Study|Withdrawal by Subject|1|||
48717931|NCT00734747|156815151|FG000|SRS Procedure|No staples placed|3|||
48717932|NCT00734747|156815151|FG000|6 Month Follow-up|Did not meet inclusion criteria|3|||
48717933|NCT00853970|156815154|FG000|Overall Study|Withdrawal by Subject|2|||
48717934|NCT00853970|156815155|FG001|Overall Study|Withdrawal by Subject|1|||
48717935|NCT00853970|156815154|FG000|Overall Study|Cancelled surgery|4|||
48717936|NCT00853970|156815155|FG001|Overall Study|Cancelled surgery|2|||
48920952|NCT00762892|157544789|FG001|Overall Study|Incarceration|0|||
49127043|NCT03154086|158304275|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
49127044|NCT03154086|158304276|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
49127045|NCT03154086|158304277|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
49127046|NCT03154086|158304278|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
49127047|NCT03154086|158304279|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
49127048|NCT03154086|158304280|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
49127049|NCT03154086|158304281|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
49127050|NCT03154086|158304282|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1|||
48717937|NCT00130247|156816603|FG000|Overall Study|Pregnancy|1|||
48717938|NCT00130247|156816604|FG001|Overall Study|Pregnancy|0|||
48717939|NCT00130247|156816603|FG000|Overall Study|Post-randomization exclusion|1|||
48717940|NCT00130247|156816604|FG001|Overall Study|Post-randomization exclusion|2|||
48717941|NCT00130247|156816603|FG000|Overall Study|Not compliant with DOT|0|||
48717942|NCT00130247|156816604|FG001|Overall Study|Not compliant with DOT|2|||
48717943|NCT01794338|156816605|FG000|Overall Study|Death|2|||
48717944|NCT01794338|156816606|FG001|Overall Study|Death|0|||
48717945|NCT01794338|156816605|FG000|Overall Study|Lost to Follow-up|6|||
48717946|NCT01794338|156816606|FG001|Overall Study|Lost to Follow-up|9|||
48717947|NCT04473235|156816607|FG000|Overall Study|Lost to Follow-up|6|||
48920953|NCT00513409|157544793|FG000|Overall Study|Adverse Event|0|||
48814891|NCT03225846|157163634|FG001|Overall Study|Patient did not wish to comply with IC/EC|0|||
49011031|NCT00219557|157877374|FG001|Phase 2|Treatment not received|1|||
49011032|NCT00219557|157877375|FG002|Phase 2|Treatment not received|3|||
49011033|NCT01427803|157877380|FG000|Overall Study|Lost to Follow-up|32|||
49011034|NCT01427803|157877381|FG001|Overall Study|Lost to Follow-up|26|||
49011035|NCT01427803|157877380|FG000|Overall Study|Withdrawal by Subject|20|||
49011036|NCT01427803|157877381|FG001|Overall Study|Withdrawal by Subject|0|||
49011037|NCT01427803|157877380|FG000|Overall Study|Unable to complete full treatment period|6|||
49011038|NCT01427803|157877381|FG001|Overall Study|Unable to complete full treatment period|0|||
49011039|NCT01427803|157877380|FG000|Overall Study|Protocol Violation|1|||
49011040|NCT01427803|157877381|FG001|Overall Study|Protocol Violation|0|||
49011041|NCT01427803|157877380|FG000|Overall Study|Physician Decision|3|||
49011042|NCT01427803|157877381|FG001|Overall Study|Physician Decision|0|||
49011043|NCT01427803|157877380|FG000|Overall Study|did not take product|1|||
49011044|NCT01427803|157877381|FG001|Overall Study|did not take product|0|||
49011045|NCT00879970|157877383|FG000|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
49011046|NCT00879970|157877384|FG001|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
49011047|NCT00879970|157877385|FG002|Period 1 TZD Randomization|Refused to Attend Final Visit|4|||
49011048|NCT00879970|157877386|FG003|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
49011049|NCT00879970|157877387|FG004|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
49011050|NCT00879970|157877383|FG000|Period 1 TZD Randomization|Lost to Follow-up|1|||
49011051|NCT00879970|157877384|FG001|Period 1 TZD Randomization|Lost to Follow-up|0|||
49011052|NCT00879970|157877385|FG002|Period 1 TZD Randomization|Lost to Follow-up|1|||
49011053|NCT00879970|157877386|FG003|Period 1 TZD Randomization|Lost to Follow-up|0|||
49011054|NCT00879970|157877387|FG004|Period 1 TZD Randomization|Lost to Follow-up|0|||
49011055|NCT00879970|157877383|FG000|Period 1 TZD Randomization|Death|2|||
49011056|NCT00879970|157877384|FG001|Period 1 TZD Randomization|Death|1|||
49011057|NCT00879970|157877385|FG002|Period 1 TZD Randomization|Death|0|||
49011058|NCT00879970|157877386|FG003|Period 1 TZD Randomization|Death|0|||
49011059|NCT00879970|157877387|FG004|Period 1 TZD Randomization|Death|0|||
49011060|NCT00879970|157877383|FG000|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2|||
49011061|NCT00879970|157877384|FG001|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
49011062|NCT00879970|157877385|FG002|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1|||
48717948|NCT04473235|156816608|FG001|Overall Study|Lost to Follow-up|5|||
48717949|NCT04473235|156816607|FG000|Overall Study|Declined continuation|2|||
48717950|NCT04473235|156816608|FG001|Overall Study|Declined continuation|0|||
48717951|NCT04473235|156816607|FG000|Overall Study|Physician Decision|1|||
48717952|NCT04473235|156816608|FG001|Overall Study|Physician Decision|1|||
48717953|NCT04473235|156816607|FG000|Overall Study|Protocol Violation|10|||
48717954|NCT04473235|156816608|FG001|Overall Study|Protocol Violation|6|||
48717955|NCT02522624|156816609|FG000|Overall Study|Technical failure|1|||
48717956|NCT02522624|156816610|FG001|Overall Study|Technical failure|0|||
48717957|NCT01771809|156816618|FG000|Overall Study|Adverse Event|4|||
48717958|NCT01771809|156816619|FG001|Overall Study|Adverse Event|12|||
48717959|NCT01771809|156816618|FG000|Overall Study|Protocol Violation|0|||
48717960|NCT01771809|156816619|FG001|Overall Study|Protocol Violation|1|||
48717961|NCT01771809|156816618|FG000|Overall Study|Withdrawal by Subject|34|||
48717962|NCT01771809|156816619|FG001|Overall Study|Withdrawal by Subject|42|||
48717963|NCT01771809|156816618|FG000|Overall Study|Lost to Follow-up|1|||
48717964|NCT01771809|156816619|FG001|Overall Study|Lost to Follow-up|3|||
48717965|NCT01771809|156816618|FG000|Overall Study|Other (Insufficient clinical response)|22|||
48717966|NCT01771809|156816619|FG001|Overall Study|Other (Insufficient clinical response)|20|||
48717967|NCT01771809|156816618|FG000|Overall Study|Death|1|||
48717968|NCT01771809|156816619|FG001|Overall Study|Death|0|||
48717969|NCT01771809|156816618|FG000|Overall Study|Other (other)|9|||
48717970|NCT01771809|156816619|FG001|Overall Study|Other (other)|5|||
48717971|NCT01106092|156816620|FG000|Overall Study|Withdrawal by Subject|0|||
48717972|NCT01106092|156816621|FG001|Overall Study|Withdrawal by Subject|0|||
48717973|NCT01106092|156816622|FG002|Overall Study|Withdrawal by Subject|0|||
48717974|NCT01106092|156816623|FG003|Overall Study|Withdrawal by Subject|1|||
48717975|NCT00727441|156816624|FG000|Overall Study|Disease Progression|11|||
48717976|NCT00727441|156816625|FG001|Overall Study|Disease Progression|14|||
48717977|NCT00727441|156816626|FG002|Overall Study|Disease Progression|17|||
48717978|NCT00727441|156816624|FG000|Overall Study|Eligibility|7|||
48717979|NCT00727441|156816625|FG001|Overall Study|Eligibility|5|||
48717980|NCT00727441|156816626|FG002|Overall Study|Eligibility|7|||
48717981|NCT00727441|156816624|FG000|Overall Study|Death|0|||
48717982|NCT00727441|156816625|FG001|Overall Study|Death|1|||
48717983|NCT00727441|156816626|FG002|Overall Study|Death|1|||
48717984|NCT00727441|156816624|FG000|Overall Study|Physician Decision|0|||
48717985|NCT00727441|156816625|FG001|Overall Study|Physician Decision|1|||
48717986|NCT00727441|156816626|FG002|Overall Study|Physician Decision|0|||
48717987|NCT00727441|156816624|FG000|Overall Study|Withdrawal by Subject|0|||
48717988|NCT00727441|156816625|FG001|Overall Study|Withdrawal by Subject|1|||
48717989|NCT00727441|156816626|FG002|Overall Study|Withdrawal by Subject|0|||
48717990|NCT00220779|156816627|FG000|Overall Study|Adverse Event|1|||
48717991|NCT00220779|156816628|FG001|Overall Study|Adverse Event|0|||
48717992|NCT00220779|156816629|FG002|Overall Study|Adverse Event|0|||
48717993|NCT00220779|156816627|FG000|Overall Study|Withdrawal by Subject|1|||
48717994|NCT00220779|156816628|FG001|Overall Study|Withdrawal by Subject|4|||
49011063|NCT00879970|157877386|FG003|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
49011064|NCT00879970|157877387|FG004|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
49011065|NCT00879970|157877383|FG000|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
49011066|NCT00879970|157877384|FG001|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
49011067|NCT00879970|157877385|FG002|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
49011068|NCT00879970|157877386|FG003|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2|||
49011069|NCT00879970|157877387|FG004|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6|||
49011070|NCT00879970|157877383|FG000|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
49011071|NCT00879970|157877384|FG001|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
49011072|NCT00879970|157877385|FG002|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
49011073|NCT00879970|157877386|FG003|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
49011074|NCT00879970|157877387|FG004|Period 2 Vitamin D Randomization|Lost to Follow-up|1|||
49011075|NCT00879970|157877383|FG000|Period 2 Vitamin D Randomization|Death|0|||
49011076|NCT00879970|157877384|FG001|Period 2 Vitamin D Randomization|Death|0|||
49011077|NCT00879970|157877385|FG002|Period 2 Vitamin D Randomization|Death|0|||
49011078|NCT00879970|157877386|FG003|Period 2 Vitamin D Randomization|Death|2|||
49011079|NCT00879970|157877387|FG004|Period 2 Vitamin D Randomization|Death|0|||
49011080|NCT01580020|157877388|FG000|Overall Study|Lack of Efficacy|0|||
49011081|NCT01580020|157877389|FG001|Overall Study|Lack of Efficacy|5|||
49011082|NCT01580020|157877390|FG002|Overall Study|Lack of Efficacy|0|||
49011083|NCT01580020|157877391|FG003|Overall Study|Lack of Efficacy|1|||
49011084|NCT01580020|157877388|FG000|Overall Study|Withdrawal by Subject|0|||
49011085|NCT01580020|157877389|FG001|Overall Study|Withdrawal by Subject|1|||
49011086|NCT01580020|157877390|FG002|Overall Study|Withdrawal by Subject|1|||
49011087|NCT01580020|157877391|FG003|Overall Study|Withdrawal by Subject|0|||
49011088|NCT01580020|157877388|FG000|Overall Study|Adverse Event|1|||
49011089|NCT01580020|157877389|FG001|Overall Study|Adverse Event|1|||
49011090|NCT01580020|157877390|FG002|Overall Study|Adverse Event|1|||
49011091|NCT01580020|157877391|FG003|Overall Study|Adverse Event|1|||
49127051|NCT03154086|158304283|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
48717995|NCT00220779|156816629|FG002|Overall Study|Withdrawal by Subject|1|||
48717996|NCT00220779|156816627|FG000|Overall Study|Non-compliance|1|||
48717997|NCT00220779|156816628|FG001|Overall Study|Non-compliance|0|||
48717998|NCT00220779|156816629|FG002|Overall Study|Non-compliance|0|||
48717999|NCT00220779|156816627|FG000|Overall Study|Too time consuming|1|||
48718000|NCT00220779|156816628|FG001|Overall Study|Too time consuming|0|||
48718001|NCT00220779|156816629|FG002|Overall Study|Too time consuming|0|||
48718002|NCT00220779|156816627|FG000|Overall Study|Pregnancy|0|||
48718003|NCT00220779|156816628|FG001|Overall Study|Pregnancy|0|||
48718004|NCT00220779|156816629|FG002|Overall Study|Pregnancy|2|||
48718005|NCT00220779|156816627|FG000|Overall Study|Lack of Efficacy|3|||
48718006|NCT00220779|156816628|FG001|Overall Study|Lack of Efficacy|0|||
48718007|NCT00220779|156816629|FG002|Overall Study|Lack of Efficacy|1|||
48718008|NCT02184455|156816630|FG000|Overall Study|Lost to Follow-up|1|||
48718009|NCT00281658|156816631|FG000|Randomized Phase|Adverse Event|0|||
48718010|NCT00281658|156816632|FG001|Randomized Phase|Adverse Event|2|||
48718011|NCT00281658|156816633|FG002|Randomized Phase|Adverse Event|0|||
48718012|NCT00281658|156816634|FG003|Randomized Phase|Adverse Event|0|||
48718013|NCT00281658|156816631|FG000|Randomized Phase|Lost to Follow-up|34|||
48718014|NCT00281658|156816632|FG001|Randomized Phase|Lost to Follow-up|27|||
48718015|NCT00281658|156816633|FG002|Randomized Phase|Lost to Follow-up|0|||
48718016|NCT00281658|156816634|FG003|Randomized Phase|Lost to Follow-up|0|||
48718017|NCT00281658|156816631|FG000|Randomized Phase|Withdrawal by Subject|8|||
48718018|NCT00281658|156816632|FG001|Randomized Phase|Withdrawal by Subject|7|||
48718019|NCT00281658|156816633|FG002|Randomized Phase|Withdrawal by Subject|0|||
48718020|NCT00281658|156816634|FG003|Randomized Phase|Withdrawal by Subject|0|||
49127052|NCT03154086|158304284|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
49127053|NCT03154086|158304285|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
49127054|NCT03154086|158304286|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
49127055|NCT03154086|158304287|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
49127056|NCT03154086|158304288|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
49127057|NCT03154086|158304289|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
49127058|NCT03154086|158304275|FG000|Part B (Up to 25 Days)|Adverse Event|0|||
49127059|NCT03154086|158304276|FG001|Part B (Up to 25 Days)|Adverse Event|0|||
49127060|NCT03154086|158304277|FG002|Part B (Up to 25 Days)|Adverse Event|0|||
49127061|NCT03154086|158304278|FG003|Part B (Up to 25 Days)|Adverse Event|0|||
49127062|NCT03154086|158304279|FG004|Part B (Up to 25 Days)|Adverse Event|0|||
49127063|NCT03154086|158304280|FG005|Part B (Up to 25 Days)|Adverse Event|0|||
49127064|NCT03154086|158304281|FG006|Part B (Up to 25 Days)|Adverse Event|0|||
49127065|NCT03154086|158304282|FG007|Part B (Up to 25 Days)|Adverse Event|0|||
49127066|NCT03154086|158304283|FG008|Part B (Up to 25 Days)|Adverse Event|0|||
49127067|NCT03154086|158304284|FG009|Part B (Up to 25 Days)|Adverse Event|0|||
49127068|NCT03154086|158304285|FG010|Part B (Up to 25 Days)|Adverse Event|1|||
49127069|NCT03154086|158304286|FG011|Part B (Up to 25 Days)|Adverse Event|0|||
49127070|NCT03154086|158304287|FG012|Part B (Up to 25 Days)|Adverse Event|0|||
49127071|NCT03154086|158304288|FG013|Part B (Up to 25 Days)|Adverse Event|0|||
49127072|NCT03154086|158304289|FG014|Part B (Up to 25 Days)|Adverse Event|0|||
49127073|NCT03575702|158304290|FG000|Overall Study|Withdrawal by Subject|1|||
49127074|NCT03575702|158304291|FG001|Overall Study|Withdrawal by Subject|1|||
49127075|NCT03575702|158304290|FG000|Overall Study|Lost to Follow-up|1|||
49127076|NCT03575702|158304291|FG001|Overall Study|Lost to Follow-up|2|||
49127077|NCT03575702|158304290|FG000|Overall Study|Protocol Violation|0|||
49127078|NCT03575702|158304291|FG001|Overall Study|Protocol Violation|1|||
49127079|NCT03575702|158304290|FG000|Overall Study|Patient non compliance|4|||
49127080|NCT03575702|158304291|FG001|Overall Study|Patient non compliance|0|||
49127081|NCT04210986|158304292|FG000|Overall Study|Lost to Follow-up|5|||
49127082|NCT04210986|158304293|FG001|Overall Study|Lost to Follow-up|2|||
49127083|NCT04210986|158304292|FG000|Overall Study|Withdrawal by Subject|3|||
49127084|NCT04210986|158304293|FG001|Overall Study|Withdrawal by Subject|1|||
49127085|NCT04210986|158304292|FG000|Overall Study|Protocol Violation|1|||
49127086|NCT04210986|158304293|FG001|Overall Study|Protocol Violation|1|||
49127087|NCT04210986|158304292|FG000|Overall Study|Physician Decision|0|||
49127088|NCT04210986|158304293|FG001|Overall Study|Physician Decision|1|||
49127089|NCT01529606|158304308|FG000|Overall Study|Lost to Follow-up|21|||
49127090|NCT01529606|158304309|FG001|Overall Study|Lost to Follow-up|18|||
49127091|NCT03555149|158304310|FG000|Overall Study|Death|18|||
49127092|NCT03555149|158304311|FG001|Overall Study|Death|15|||
49127093|NCT03555149|158304312|FG002|Overall Study|Death|15|||
48718021|NCT00281658|156816631|FG000|Randomized Phase|Study closed/terminated|1|||
48718022|NCT00281658|156816632|FG001|Randomized Phase|Study closed/terminated|1|||
48718023|NCT00281658|156816633|FG002|Randomized Phase|Study closed/terminated|0|||
48718024|NCT00281658|156816634|FG003|Randomized Phase|Study closed/terminated|0|||
48718025|NCT00281658|156816631|FG000|Randomized Phase|Disease progression|36|||
48718026|NCT00281658|156816632|FG001|Randomized Phase|Disease progression|27|||
48718027|NCT00281658|156816633|FG002|Randomized Phase|Disease progression|0|||
48718028|NCT00281658|156816634|FG003|Randomized Phase|Disease progression|0|||
48718029|NCT00281658|156816631|FG000|Randomized Phase|Physician Decision|1|||
48718030|NCT00281658|156816632|FG001|Randomized Phase|Physician Decision|1|||
48718031|NCT00281658|156816633|FG002|Randomized Phase|Physician Decision|0|||
48718032|NCT00281658|156816634|FG003|Randomized Phase|Physician Decision|0|||
48718033|NCT00281658|156816631|FG000|Randomized Phase|Other reasons as defined per protocol|4|||
48718034|NCT00281658|156816632|FG001|Randomized Phase|Other reasons as defined per protocol|3|||
48718035|NCT00281658|156816633|FG002|Randomized Phase|Other reasons as defined per protocol|0|||
48718036|NCT00281658|156816634|FG003|Randomized Phase|Other reasons as defined per protocol|0|||
48718037|NCT00281658|156816631|FG000|Randomized Phase|Reason for withdrawal unspecified|4|||
48718038|NCT00281658|156816632|FG001|Randomized Phase|Reason for withdrawal unspecified|5|||
48718039|NCT00281658|156816633|FG002|Randomized Phase|Reason for withdrawal unspecified|0|||
48718040|NCT00281658|156816634|FG003|Randomized Phase|Reason for withdrawal unspecified|0|||
48718041|NCT00281658|156816631|FG000|Randomized Phase|Treatment ongoing|1|||
48718042|NCT00281658|156816632|FG001|Randomized Phase|Treatment ongoing|0|||
48718043|NCT00281658|156816633|FG002|Randomized Phase|Treatment ongoing|0|||
48718044|NCT00281658|156816634|FG003|Randomized Phase|Treatment ongoing|0|||
48718045|NCT00281658|156816631|FG000|Open Label Phase|Adverse Event|0|||
48718046|NCT00281658|156816632|FG001|Open Label Phase|Adverse Event|0|||
48718047|NCT00281658|156816633|FG002|Open Label Phase|Adverse Event|1|||
48718048|NCT00281658|156816634|FG003|Open Label Phase|Adverse Event|0|||
48718049|NCT00281658|156816631|FG000|Open Label Phase|Lost to Follow-up|0|||
48718050|NCT00281658|156816632|FG001|Open Label Phase|Lost to Follow-up|0|||
48718051|NCT00281658|156816633|FG002|Open Label Phase|Lost to Follow-up|16|||
48718052|NCT00281658|156816634|FG003|Open Label Phase|Lost to Follow-up|2|||
48718053|NCT00281658|156816631|FG000|Open Label Phase|Withdrawal by Subject|0|||
48718054|NCT00281658|156816632|FG001|Open Label Phase|Withdrawal by Subject|0|||
48718055|NCT00281658|156816633|FG002|Open Label Phase|Withdrawal by Subject|3|||
48718056|NCT00281658|156816634|FG003|Open Label Phase|Withdrawal by Subject|2|||
48718057|NCT00281658|156816631|FG000|Open Label Phase|Disease progression|0|||
48718058|NCT00281658|156816632|FG001|Open Label Phase|Disease progression|0|||
48718059|NCT00281658|156816633|FG002|Open Label Phase|Disease progression|18|||
48718060|NCT00281658|156816634|FG003|Open Label Phase|Disease progression|0|||
48718061|NCT00281658|156816631|FG000|Open Label Phase|Physician Decision|0|||
48718062|NCT00281658|156816632|FG001|Open Label Phase|Physician Decision|0|||
48718063|NCT00281658|156816633|FG002|Open Label Phase|Physician Decision|1|||
48718064|NCT00281658|156816634|FG003|Open Label Phase|Physician Decision|0|||
48718065|NCT00281658|156816631|FG000|Open Label Phase|Relocation of patient|0|||
48718066|NCT00281658|156816632|FG001|Open Label Phase|Relocation of patient|0|||
48718067|NCT00281658|156816633|FG002|Open Label Phase|Relocation of patient|1|||
48718068|NCT00281658|156816634|FG003|Open Label Phase|Relocation of patient|0|||
48718069|NCT00281658|156816631|FG000|Open Label Phase|Reason for withdrawal unspecified|0|||
48718070|NCT00281658|156816632|FG001|Open Label Phase|Reason for withdrawal unspecified|0|||
48718071|NCT00281658|156816633|FG002|Open Label Phase|Reason for withdrawal unspecified|5|||
48718072|NCT00281658|156816634|FG003|Open Label Phase|Reason for withdrawal unspecified|0|||
48718073|NCT02551991|156816635|FG000|Overall Study|Death|5|||
48718074|NCT02551991|156816636|FG001|Overall Study|Death|7|||
48718075|NCT02551991|156816637|FG002|Overall Study|Death|8|||
48718076|NCT02551991|156816638|FG003|Overall Study|Death|7|||
48718077|NCT02551991|156816639|FG004|Overall Study|Death|17|||
48718078|NCT02551991|156816635|FG000|Overall Study|Withdrawal by Subject|1|||
48718079|NCT02551991|156816636|FG001|Overall Study|Withdrawal by Subject|0|||
48718080|NCT02551991|156816637|FG002|Overall Study|Withdrawal by Subject|0|||
48718081|NCT02551991|156816638|FG003|Overall Study|Withdrawal by Subject|0|||
48718082|NCT02551991|156816639|FG004|Overall Study|Withdrawal by Subject|2|||
48718083|NCT02551991|156816635|FG000|Overall Study|Lost to Follow-up|0|||
48718084|NCT02551991|156816636|FG001|Overall Study|Lost to Follow-up|0|||
48718085|NCT02551991|156816637|FG002|Overall Study|Lost to Follow-up|1|||
48718086|NCT02551991|156816638|FG003|Overall Study|Lost to Follow-up|0|||
48718087|NCT02551991|156816639|FG004|Overall Study|Lost to Follow-up|0|||
48718088|NCT02551991|156816635|FG000|Overall Study|Sponsor Decision|1|||
48814892|NCT03225846|157163635|FG002|Overall Study|Patient did not wish to comply with IC/EC|1|||
48718089|NCT02551991|156816636|FG001|Overall Study|Sponsor Decision|0|||
48718090|NCT02551991|156816637|FG002|Overall Study|Sponsor Decision|1|||
48718091|NCT02551991|156816638|FG003|Overall Study|Sponsor Decision|0|||
48718092|NCT02551991|156816639|FG004|Overall Study|Sponsor Decision|5|||
48718093|NCT02551991|156816635|FG000|Overall Study|Other|0|||
48718094|NCT02551991|156816636|FG001|Overall Study|Other|0|||
48718095|NCT02551991|156816637|FG002|Overall Study|Other|0|||
48718096|NCT02551991|156816638|FG003|Overall Study|Other|0|||
48718097|NCT02551991|156816639|FG004|Overall Study|Other|1|||
48718098|NCT02151773|156816640|FG000|Overall Study|Protocol Deviation|64|||
48718099|NCT00395343|156816641|FG000|Overall Study|Adverse Event|13|||
48718100|NCT00395343|156816642|FG001|Overall Study|Adverse Event|5|||
48718101|NCT00395343|156816641|FG000|Overall Study|Lack of Efficacy|0|||
48718102|NCT00395343|156816642|FG001|Overall Study|Lack of Efficacy|1|||
48718103|NCT00395343|156816641|FG000|Overall Study|Lost to Follow-up|4|||
48718104|NCT00395343|156816642|FG001|Overall Study|Lost to Follow-up|4|||
48718105|NCT00395343|156816641|FG000|Overall Study|Physician Decision|2|||
48718106|NCT00395343|156816642|FG001|Overall Study|Physician Decision|4|||
48718107|NCT00395343|156816641|FG000|Overall Study|Protocol Violation|6|||
48718108|NCT00395343|156816642|FG001|Overall Study|Protocol Violation|8|||
48718109|NCT00395343|156816641|FG000|Overall Study|Withdrawal by Subject|11|||
48718110|NCT00395343|156816642|FG001|Overall Study|Withdrawal by Subject|12|||
48718111|NCT00395343|156816641|FG000|Overall Study|Other|5|||
48718112|NCT00395343|156816642|FG001|Overall Study|Other|2|||
48718113|NCT00265148|156816643|FG000|Overall Study|Adverse Event|2|||
48718114|NCT00265148|156816644|FG001|Overall Study|Adverse Event|2|||
48718115|NCT00265148|156816643|FG000|Overall Study|Lack of Efficacy|0|||
48718116|NCT00265148|156816644|FG001|Overall Study|Lack of Efficacy|2|||
48718117|NCT00265148|156816643|FG000|Overall Study|Protocol Violation|3|||
48718118|NCT00265148|156816644|FG001|Overall Study|Protocol Violation|2|||
48814893|NCT03225846|157163636|FG003|Overall Study|Patient did not wish to comply with IC/EC|0|||
48814894|NCT03225846|157163637|FG004|Overall Study|Patient did not wish to comply with IC/EC|0|||
48814895|NCT03225846|157163638|FG005|Overall Study|Patient did not wish to comply with IC/EC|0|||
48814896|NCT03225846|157163639|FG006|Overall Study|Patient did not wish to comply with IC/EC|0|||
48814897|NCT03225846|157163633|FG000|Overall Study|Patient decision|0|||
48814898|NCT03225846|157163634|FG001|Overall Study|Patient decision|0|||
48814899|NCT03225846|157163635|FG002|Overall Study|Patient decision|0|||
48814900|NCT03225846|157163636|FG003|Overall Study|Patient decision|0|||
48814901|NCT03225846|157163637|FG004|Overall Study|Patient decision|0|||
48814902|NCT03225846|157163638|FG005|Overall Study|Patient decision|0|||
48814903|NCT03225846|157163639|FG006|Overall Study|Patient decision|1|||
48814904|NCT02855164|157163640|FG000|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
48814905|NCT02855164|157163641|FG001|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
48814906|NCT02855164|157163642|FG002|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
48814907|NCT02855164|157163643|FG003|Parts A + B (Randomized Set)|Withdrawal by Subject|2|||
48814908|NCT02855164|157163644|FG004|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
48814909|NCT02855164|157163645|FG005|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
48814910|NCT02855164|157163646|FG006|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
48814911|NCT02855164|157163647|FG007|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
48814912|NCT02855164|157163640|FG000|Parts A + B (Randomized Set)|Physician Decision|0|||
48814913|NCT02855164|157163641|FG001|Parts A + B (Randomized Set)|Physician Decision|0|||
48814914|NCT02855164|157163642|FG002|Parts A + B (Randomized Set)|Physician Decision|0|||
48814915|NCT02855164|157163643|FG003|Parts A + B (Randomized Set)|Physician Decision|2|||
48814916|NCT02855164|157163644|FG004|Parts A + B (Randomized Set)|Physician Decision|0|||
48718119|NCT00265148|156816643|FG000|Overall Study|Lost to Follow-up|0|||
48718120|NCT00265148|156816644|FG001|Overall Study|Lost to Follow-up|1|||
48814917|NCT02855164|157163645|FG005|Parts A + B (Randomized Set)|Physician Decision|0|||
49127094|NCT03555149|158304313|FG003|Overall Study|Death|4|||
48718121|NCT00265148|156816643|FG000|Overall Study|Withdrawal by Subject|2|||
48718122|NCT00265148|156816644|FG001|Overall Study|Withdrawal by Subject|1|||
48718123|NCT00265148|156816643|FG000|Overall Study|Physician Decision|1|||
48718124|NCT00265148|156816644|FG001|Overall Study|Physician Decision|0|||
48718125|NCT00265148|156816643|FG000|Overall Study|Increasing frailty|0|||
48718126|NCT00265148|156816644|FG001|Overall Study|Increasing frailty|1|||
48814918|NCT02855164|157163646|FG006|Parts A + B (Randomized Set)|Physician Decision|0|||
48814919|NCT02855164|157163647|FG007|Parts A + B (Randomized Set)|Physician Decision|0|||
48920954|NCT00513409|157544794|FG001|Overall Study|Adverse Event|1|||
49127095|NCT03555149|158304314|FG004|Overall Study|Death|4|||
49127096|NCT03555149|158304315|FG005|Overall Study|Death|11|||
49127097|NCT03555149|158304316|FG006|Overall Study|Death|12|||
49127098|NCT03555149|158304317|FG007|Overall Study|Death|1|||
49127099|NCT03555149|158304310|FG000|Overall Study|Lost to Follow-up|1|||
49127100|NCT03555149|158304311|FG001|Overall Study|Lost to Follow-up|0|||
49127101|NCT03555149|158304312|FG002|Overall Study|Lost to Follow-up|0|||
49127102|NCT03555149|158304313|FG003|Overall Study|Lost to Follow-up|0|||
49127103|NCT03555149|158304314|FG004|Overall Study|Lost to Follow-up|0|||
49127104|NCT03555149|158304315|FG005|Overall Study|Lost to Follow-up|1|||
49127105|NCT03555149|158304316|FG006|Overall Study|Lost to Follow-up|0|||
49127106|NCT03555149|158304317|FG007|Overall Study|Lost to Follow-up|0|||
49127107|NCT03555149|158304310|FG000|Overall Study|Physician Decision|1|||
49127108|NCT03555149|158304311|FG001|Overall Study|Physician Decision|0|||
49127109|NCT03555149|158304312|FG002|Overall Study|Physician Decision|0|||
49127110|NCT03555149|158304313|FG003|Overall Study|Physician Decision|0|||
49127111|NCT03555149|158304314|FG004|Overall Study|Physician Decision|0|||
49127112|NCT03555149|158304315|FG005|Overall Study|Physician Decision|0|||
49127113|NCT03555149|158304316|FG006|Overall Study|Physician Decision|0|||
49127114|NCT03555149|158304317|FG007|Overall Study|Physician Decision|0|||
49127115|NCT03555149|158304310|FG000|Overall Study|Study Terminated By Sponsor|1|||
49127116|NCT03555149|158304311|FG001|Overall Study|Study Terminated By Sponsor|0|||
49127117|NCT03555149|158304312|FG002|Overall Study|Study Terminated By Sponsor|0|||
49127118|NCT03555149|158304313|FG003|Overall Study|Study Terminated By Sponsor|0|||
49127119|NCT03555149|158304314|FG004|Overall Study|Study Terminated By Sponsor|0|||
49127120|NCT03555149|158304315|FG005|Overall Study|Study Terminated By Sponsor|2|||
49127121|NCT03555149|158304316|FG006|Overall Study|Study Terminated By Sponsor|3|||
49127122|NCT03555149|158304317|FG007|Overall Study|Study Terminated By Sponsor|1|||
48718127|NCT00265148|156816643|FG000|Overall Study|Subject chose to change of the dose|1|||
48718128|NCT00265148|156816644|FG001|Overall Study|Subject chose to change of the dose|0|||
48718129|NCT01410357|156816645|FG000|Overall Study|Death|2|||
48718130|NCT01410357|156816646|FG001|Overall Study|Death|1|||
48718131|NCT01410357|156816645|FG000|Overall Study|Withdrawal by Subject|1|||
48718132|NCT01410357|156816646|FG001|Overall Study|Withdrawal by Subject|2|||
48718133|NCT01410357|156816645|FG000|Overall Study|Lost to Follow-up|23|||
48718134|NCT01410357|156816646|FG001|Overall Study|Lost to Follow-up|21|||
48718135|NCT00945906|156816648|FG000|Overall Study|Withdrawal by Subject|1|||
48718136|NCT00945906|156816648|FG000|Overall Study|Did not want to return for last visit|2|||
48718137|NCT00945906|156816648|FG000|Overall Study|Unable to return for last visit|2|||
48718138|NCT00945906|156816648|FG000|Overall Study|Moved to another country|2|||
48718139|NCT01022398|156816650|FG000|Overall Study|Study terminated|2|||
48718140|NCT01022398|156816651|FG001|Overall Study|Study terminated|2|||
48718141|NCT03565367|156816652|FG000|Overall Study|No scan due to technical issues|4|||
48718142|NCT03565367|156816653|FG001|Overall Study|No scan due to technical issues|0|||
48718143|NCT01104376|156816654|FG000|Overall Study|Withdrawal by Subject|15|||
48718144|NCT01104376|156816654|FG000|Overall Study|Consented but excluded after labs|13|||
48814920|NCT02855164|157163640|FG000|Parts A + B (Randomized Set)|Adverse Event|0|||
48920955|NCT00513409|157544793|FG000|Overall Study|Withdrawal by Subject|0|||
49127123|NCT03555149|158304310|FG000|Overall Study|Withdrawal by Subject|3|||
49127124|NCT03555149|158304311|FG001|Overall Study|Withdrawal by Subject|0|||
48718145|NCT02160002|156816656|FG000|Overall Study|Withdrawal by Subject|2|||
48718146|NCT02160002|156816657|FG001|Overall Study|Withdrawal by Subject|1|||
48718147|NCT00869778|156816671|FG000|Overall Study|Adverse Event|2|||
48718148|NCT00869778|156816672|FG001|Overall Study|Adverse Event|0|||
48718149|NCT00869778|156816673|FG002|Overall Study|Adverse Event|0|||
48718150|NCT00869778|156816671|FG000|Overall Study|Withdrawal by Subject|3|||
48718151|NCT00869778|156816672|FG001|Overall Study|Withdrawal by Subject|4|||
48718152|NCT00869778|156816673|FG002|Overall Study|Withdrawal by Subject|5|||
48718153|NCT00869778|156816671|FG000|Overall Study|Pregnancy|1|||
48814921|NCT02855164|157163641|FG001|Parts A + B (Randomized Set)|Adverse Event|0|||
48814922|NCT02855164|157163642|FG002|Parts A + B (Randomized Set)|Adverse Event|0|||
48814923|NCT02855164|157163643|FG003|Parts A + B (Randomized Set)|Adverse Event|4|||
48718154|NCT00869778|156816672|FG001|Overall Study|Pregnancy|0|||
48718155|NCT00869778|156816673|FG002|Overall Study|Pregnancy|0|||
48718156|NCT00869778|156816671|FG000|Overall Study|Protocol Violation|5|||
48718157|NCT00869778|156816672|FG001|Overall Study|Protocol Violation|3|||
48718158|NCT00869778|156816673|FG002|Overall Study|Protocol Violation|5|||
48718159|NCT00869778|156816671|FG000|Overall Study|Unblinding|1|||
48718160|NCT00869778|156816672|FG001|Overall Study|Unblinding|0|||
48718161|NCT00869778|156816673|FG002|Overall Study|Unblinding|0|||
48718162|NCT01403948|156816674|FG000|Overall Study|Progressive disease|0|||
48718163|NCT01403948|156816675|FG001|Overall Study|Progressive disease|2|||
48718164|NCT01403948|156816676|FG002|Overall Study|Progressive disease|2|||
48718165|NCT01403948|156816677|FG003|Overall Study|Progressive disease|4|||
48718166|NCT01403948|156816678|FG004|Overall Study|Progressive disease|2|||
48814924|NCT02855164|157163644|FG004|Parts A + B (Randomized Set)|Adverse Event|0|||
48814925|NCT02855164|157163645|FG005|Parts A + B (Randomized Set)|Adverse Event|0|||
48814926|NCT02855164|157163646|FG006|Parts A + B (Randomized Set)|Adverse Event|0|||
48814927|NCT02855164|157163647|FG007|Parts A + B (Randomized Set)|Adverse Event|0|||
48718167|NCT01403948|156816679|FG005|Overall Study|Progressive disease|6|||
48718168|NCT01403948|156816680|FG006|Overall Study|Progressive disease|2|||
48718169|NCT01403948|156816681|FG007|Overall Study|Progressive disease|4|||
48718170|NCT01403948|156816682|FG008|Overall Study|Progressive disease|5|||
48718171|NCT01403948|156816683|FG009|Overall Study|Progressive disease|5|||
48718172|NCT01403948|156816674|FG000|Overall Study|Other Adverse Event (Other than DLT)|0|||
48814928|NCT02855164|157163640|FG000|Part C (Randomized Set)|Adverse Event|0|||
48814929|NCT02855164|157163641|FG001|Part C (Randomized Set)|Adverse Event|0|||
48814930|NCT02855164|157163642|FG002|Part C (Randomized Set)|Adverse Event|0|||
48814931|NCT02855164|157163643|FG003|Part C (Randomized Set)|Adverse Event|0|||
48814932|NCT02855164|157163644|FG004|Part C (Randomized Set)|Adverse Event|0|||
48814933|NCT02855164|157163645|FG005|Part C (Randomized Set)|Adverse Event|5|||
48814934|NCT02855164|157163646|FG006|Part C (Randomized Set)|Adverse Event|9|||
48814935|NCT02855164|157163647|FG007|Part C (Randomized Set)|Adverse Event|2|||
48814936|NCT02855164|157163640|FG000|Part C (Randomized Set)|Lost to Follow-up|0|||
48814937|NCT02855164|157163641|FG001|Part C (Randomized Set)|Lost to Follow-up|0|||
48814938|NCT02855164|157163642|FG002|Part C (Randomized Set)|Lost to Follow-up|0|||
48814939|NCT02855164|157163643|FG003|Part C (Randomized Set)|Lost to Follow-up|0|||
48814940|NCT02855164|157163644|FG004|Part C (Randomized Set)|Lost to Follow-up|0|||
48814941|NCT02855164|157163645|FG005|Part C (Randomized Set)|Lost to Follow-up|1|||
48814942|NCT02855164|157163646|FG006|Part C (Randomized Set)|Lost to Follow-up|1|||
48814943|NCT02855164|157163647|FG007|Part C (Randomized Set)|Lost to Follow-up|1|||
48814944|NCT02855164|157163640|FG000|Part C (Randomized Set)|Physician Decision|0|||
48814945|NCT02855164|157163641|FG001|Part C (Randomized Set)|Physician Decision|0|||
48814946|NCT02855164|157163642|FG002|Part C (Randomized Set)|Physician Decision|0|||
48814947|NCT02855164|157163643|FG003|Part C (Randomized Set)|Physician Decision|0|||
48814948|NCT02855164|157163644|FG004|Part C (Randomized Set)|Physician Decision|0|||
48814949|NCT02855164|157163645|FG005|Part C (Randomized Set)|Physician Decision|1|||
48814950|NCT02855164|157163646|FG006|Part C (Randomized Set)|Physician Decision|0|||
48814951|NCT02855164|157163647|FG007|Part C (Randomized Set)|Physician Decision|1|||
48814952|NCT02855164|157163640|FG000|Part C (Randomized Set)|Withdrawal by Subject|0|||
48814953|NCT02855164|157163641|FG001|Part C (Randomized Set)|Withdrawal by Subject|0|||
48814954|NCT02855164|157163642|FG002|Part C (Randomized Set)|Withdrawal by Subject|0|||
48718173|NCT01403948|156816675|FG001|Overall Study|Other Adverse Event (Other than DLT)|0|||
48718174|NCT01403948|156816676|FG002|Overall Study|Other Adverse Event (Other than DLT)|0|||
48718175|NCT01403948|156816677|FG003|Overall Study|Other Adverse Event (Other than DLT)|0|||
48718176|NCT01403948|156816678|FG004|Overall Study|Other Adverse Event (Other than DLT)|2|||
48814955|NCT02855164|157163643|FG003|Part C (Randomized Set)|Withdrawal by Subject|0|||
48718177|NCT01403948|156816679|FG005|Overall Study|Other Adverse Event (Other than DLT)|0|||
48718178|NCT01403948|156816680|FG006|Overall Study|Other Adverse Event (Other than DLT)|2|||
48718179|NCT01403948|156816681|FG007|Overall Study|Other Adverse Event (Other than DLT)|0|||
48718180|NCT01403948|156816682|FG008|Overall Study|Other Adverse Event (Other than DLT)|1|||
48718181|NCT01403948|156816683|FG009|Overall Study|Other Adverse Event (Other than DLT)|0|||
48718182|NCT01403948|156816674|FG000|Overall Study|Lost to Follow-up|0|||
48718183|NCT01403948|156816675|FG001|Overall Study|Lost to Follow-up|0|||
48718184|NCT01403948|156816676|FG002|Overall Study|Lost to Follow-up|0|||
48718185|NCT01403948|156816677|FG003|Overall Study|Lost to Follow-up|0|||
48718186|NCT01403948|156816678|FG004|Overall Study|Lost to Follow-up|0|||
48718187|NCT01403948|156816679|FG005|Overall Study|Lost to Follow-up|0|||
48718188|NCT01403948|156816680|FG006|Overall Study|Lost to Follow-up|0|||
48718189|NCT01403948|156816681|FG007|Overall Study|Lost to Follow-up|0|||
48718190|NCT01403948|156816682|FG008|Overall Study|Lost to Follow-up|0|||
48718191|NCT01403948|156816683|FG009|Overall Study|Lost to Follow-up|1|||
48814956|NCT02855164|157163644|FG004|Part C (Randomized Set)|Withdrawal by Subject|0|||
48814957|NCT02855164|157163645|FG005|Part C (Randomized Set)|Withdrawal by Subject|5|||
48814958|NCT02855164|157163646|FG006|Part C (Randomized Set)|Withdrawal by Subject|4|||
48718192|NCT01403948|156816674|FG000|Overall Study|Refused cont. medication|0|||
48718193|NCT01403948|156816675|FG001|Overall Study|Refused cont. medication|0|||
48718194|NCT01403948|156816676|FG002|Overall Study|Refused cont. medication|0|||
48718195|NCT01403948|156816677|FG003|Overall Study|Refused cont. medication|0|||
48718196|NCT01403948|156816678|FG004|Overall Study|Refused cont. medication|1|||
48718197|NCT01403948|156816679|FG005|Overall Study|Refused cont. medication|0|||
48718198|NCT01403948|156816680|FG006|Overall Study|Refused cont. medication|0|||
48718199|NCT01403948|156816681|FG007|Overall Study|Refused cont. medication|0|||
48718200|NCT01403948|156816682|FG008|Overall Study|Refused cont. medication|0|||
48718201|NCT01403948|156816683|FG009|Overall Study|Refused cont. medication|1|||
48718202|NCT01403948|156816674|FG000|Overall Study|other than above|1|||
48718203|NCT01403948|156816675|FG001|Overall Study|other than above|2|||
48718204|NCT01403948|156816676|FG002|Overall Study|other than above|1|||
48718205|NCT01403948|156816677|FG003|Overall Study|other than above|0|||
48718206|NCT01403948|156816678|FG004|Overall Study|other than above|1|||
48718207|NCT01403948|156816679|FG005|Overall Study|other than above|1|||
48718208|NCT01403948|156816680|FG006|Overall Study|other than above|2|||
48718209|NCT01403948|156816681|FG007|Overall Study|other than above|0|||
48718210|NCT01403948|156816682|FG008|Overall Study|other than above|0|||
48718211|NCT01403948|156816683|FG009|Overall Study|other than above|0|||
48718212|NCT03459690|156816690|FG000|Overall Study|Lost to Follow-up|0|||
48718213|NCT03459690|156816691|FG001|Overall Study|Lost to Follow-up|1|||
48718214|NCT03459690|156816690|FG000|Overall Study|Withdrawal by Subject|1|||
48718215|NCT03459690|156816691|FG001|Overall Study|Withdrawal by Subject|1|||
48718216|NCT00910299|156816697|FG000|Overall Study|Withdrawal by Subject|16|||
48718217|NCT00910299|156816698|FG001|Overall Study|Withdrawal by Subject|13|||
48718218|NCT00910299|156816697|FG000|Overall Study|Sponsor Decision|58|||
48718219|NCT00910299|156816698|FG001|Overall Study|Sponsor Decision|60|||
48718220|NCT00910299|156816697|FG000|Overall Study|Didn't receive any study drug|2|||
48718221|NCT00910299|156816698|FG001|Overall Study|Didn't receive any study drug|1|||
49127125|NCT03555149|158304312|FG002|Overall Study|Withdrawal by Subject|0|||
49127126|NCT03555149|158304313|FG003|Overall Study|Withdrawal by Subject|2|||
49127127|NCT03555149|158304314|FG004|Overall Study|Withdrawal by Subject|0|||
49127128|NCT03555149|158304315|FG005|Overall Study|Withdrawal by Subject|1|||
49127129|NCT03555149|158304316|FG006|Overall Study|Withdrawal by Subject|0|||
49127130|NCT03555149|158304317|FG007|Overall Study|Withdrawal by Subject|0|||
49127131|NCT01746862|158304320|FG000|Overall Study|Withdrawal by Subject|1|||
49127132|NCT01746862|158304321|FG001|Overall Study|Withdrawal by Subject|1|||
49127133|NCT01746862|158304320|FG000|Overall Study|Protocol Violation|1|||
49127134|NCT01746862|158304321|FG001|Overall Study|Protocol Violation|0|||
49127135|NCT01746862|158304320|FG000|Overall Study|Consent withdrawal by parent's guardian|5|||
49127136|NCT01746862|158304321|FG001|Overall Study|Consent withdrawal by parent's guardian|2|||
49127137|NCT01746862|158304320|FG000|Overall Study|Entered puberty during the study|1|||
49127138|NCT01746862|158304321|FG001|Overall Study|Entered puberty during the study|0|||
49127139|NCT03292016|158304329|FG000|Second Washout|Adverse Event|0|||
49127140|NCT03292016|158304330|FG001|Second Washout|Adverse Event|1|||
49127141|NCT03292016|158304331|FG002|Second Washout|Adverse Event|0|||
49127142|NCT03292016|158304332|FG003|Second Washout|Adverse Event|0|||
49127143|NCT03292016|158304333|FG004|Second Washout|Adverse Event|0|||
49127144|NCT03292016|158304334|FG005|Second Washout|Adverse Event|0|||
49127145|NCT00465517|158304335|FG000|Overall Study|Adverse Event|7|||
49127146|NCT00465517|158304336|FG001|Overall Study|Adverse Event|3|||
49127147|NCT00465517|158304335|FG000|Overall Study|Lost to Follow-up|1|||
49127148|NCT00465517|158304336|FG001|Overall Study|Lost to Follow-up|0|||
49127149|NCT00465517|158304335|FG000|Overall Study|Withdrawal by Subject|4|||
49127150|NCT00465517|158304336|FG001|Overall Study|Withdrawal by Subject|1|||
49127151|NCT05222880|158304337|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
49127152|NCT05222880|158304337|FG000|Overall Study|Withdrew Consent during Study|1|||
49127153|NCT05222880|158304337|FG000|Overall Study|COVID-19 Related|1|||
49127154|NCT00830128|158304338|FG000|Overall Study|Adverse Event|5|||
49127155|NCT00830128|158304338|FG000|Overall Study|Lack of Efficacy|7|||
49127156|NCT00830128|158304338|FG000|Overall Study|Protocol Violation|1|||
49127157|NCT00830128|158304338|FG000|Overall Study|Withdrawal by Subject|2|||
49127158|NCT00830128|158304338|FG000|Overall Study|Family obligation|1|||
49127159|NCT00830128|158304338|FG000|Overall Study|Relocation|1|||
49127160|NCT00830128|158304338|FG000|Overall Study|Work obligation|1|||
49127161|NCT00830128|158304338|FG000|Overall Study|Operating a vehicle|1|||
49127162|NCT05401565|158304339|FG000|Overall Study|Lost to Follow-up|1|||
49127163|NCT05401565|158304340|FG001|Overall Study|Lost to Follow-up|0|||
49127164|NCT05401565|158304339|FG000|Overall Study|Adverse Event|2|||
49127165|NCT05401565|158304340|FG001|Overall Study|Adverse Event|0|||
49127166|NCT02984982|158304346|FG000|Overall Study|Adverse Event|2|||
49127167|NCT02984982|158304347|FG001|Overall Study|Adverse Event|5|||
48718222|NCT03704636|156816707|FG000|Overall Study|Inadequate Venous Flow|3|||
48718223|NCT00313781|156816708|FG000|Before Crossover|Death|22|||
48718224|NCT00313781|156816709|FG001|Before Crossover|Death|8|||
49127168|NCT02984982|158304346|FG000|Overall Study|Poor Compliance to Protocol|4|||
48718225|NCT00313781|156816710|FG002|Before Crossover|Death|0|||
48718226|NCT00313781|156816708|FG000|Before Crossover|Lost to Follow-up|0|||
48718227|NCT00313781|156816709|FG001|Before Crossover|Lost to Follow-up|3|||
48718228|NCT00313781|156816710|FG002|Before Crossover|Lost to Follow-up|0|||
48718229|NCT00313781|156816708|FG000|Before Crossover|Withdrawal by Subject|3|||
48814959|NCT02855164|157163647|FG007|Part C (Randomized Set)|Withdrawal by Subject|3|||
48814960|NCT01544582|157163648|FG000|Screening/Eligibility|Initiated Different CHC Treatment|1|||
48718230|NCT00313781|156816709|FG001|Before Crossover|Withdrawal by Subject|1|||
48718231|NCT00313781|156816710|FG002|Before Crossover|Withdrawal by Subject|0|||
48718232|NCT00313781|156816708|FG000|Before Crossover|Other|45|||
48718233|NCT00313781|156816709|FG001|Before Crossover|Other|30|||
48718234|NCT00313781|156816710|FG002|Before Crossover|Other|0|||
48718235|NCT00313781|156816708|FG000|Before Crossover|Crossover|0|||
48718236|NCT00313781|156816709|FG001|Before Crossover|Crossover|37|||
48718237|NCT00313781|156816710|FG002|Before Crossover|Crossover|0|||
48718238|NCT00313781|156816708|FG000|Before Crossover|Randomized, not treated|5|||
48718239|NCT00313781|156816709|FG001|Before Crossover|Randomized, not treated|0|||
48718240|NCT00313781|156816710|FG002|Before Crossover|Randomized, not treated|0|||
48718241|NCT00313781|156816708|FG000|After Crossover|Death|0|||
48718242|NCT00313781|156816709|FG001|After Crossover|Death|0|||
48718243|NCT00313781|156816710|FG002|After Crossover|Death|6|||
48718244|NCT00313781|156816708|FG000|After Crossover|Withdrawal by Subject|0|||
48718245|NCT00313781|156816709|FG001|After Crossover|Withdrawal by Subject|0|||
48718246|NCT00313781|156816710|FG002|After Crossover|Withdrawal by Subject|3|||
48718247|NCT00313781|156816708|FG000|After Crossover|Other|0|||
48718248|NCT00313781|156816709|FG001|After Crossover|Other|0|||
48718249|NCT00313781|156816710|FG002|After Crossover|Other|18|||
48718250|NCT03148691|156816711|FG000|Overall Study|Protocol Violation|1|||
48718251|NCT03148691|156816712|FG001|Overall Study|Protocol Violation|2|||
48718252|NCT03148691|156816713|FG002|Overall Study|Protocol Violation|7|||
48718253|NCT03148691|156816711|FG000|Overall Study|Lost to Follow-up|0|||
48718254|NCT03148691|156816712|FG001|Overall Study|Lost to Follow-up|0|||
48718255|NCT03148691|156816713|FG002|Overall Study|Lost to Follow-up|1|||
48814961|NCT01544582|157163649|FG001|Screening/Eligibility|Initiated Different CHC Treatment|0|||
48814962|NCT01544582|157163650|FG002|Screening/Eligibility|Initiated Different CHC Treatment|0|||
48814963|NCT01544582|157163651|FG003|Screening/Eligibility|Initiated Different CHC Treatment|0|||
48814964|NCT01544582|157163648|FG000|Screening/Eligibility|Eligibility Criteria Not Met|33|||
48814965|NCT01544582|157163649|FG001|Screening/Eligibility|Eligibility Criteria Not Met|0|||
48814966|NCT01544582|157163650|FG002|Screening/Eligibility|Eligibility Criteria Not Met|0|||
48814967|NCT01544582|157163651|FG003|Screening/Eligibility|Eligibility Criteria Not Met|0|||
48814968|NCT01544582|157163648|FG000|Analysis Population|Participant Refuses to Continue Study|0|||
48718256|NCT03148691|156816711|FG000|Overall Study|Other|1|||
48814969|NCT01544582|157163649|FG001|Analysis Population|Participant Refuses to Continue Study|15|||
48814970|NCT01544582|157163650|FG002|Analysis Population|Participant Refuses to Continue Study|17|||
48814971|NCT01544582|157163651|FG003|Analysis Population|Participant Refuses to Continue Study|4|||
48718257|NCT03148691|156816712|FG001|Overall Study|Other|0|||
48718258|NCT03148691|156816713|FG002|Overall Study|Other|0|||
48718259|NCT03148691|156816711|FG000|Overall Study|Withdrawal by Subject|1|||
48718260|NCT03148691|156816712|FG001|Overall Study|Withdrawal by Subject|0|||
48718261|NCT03148691|156816713|FG002|Overall Study|Withdrawal by Subject|0|||
48718262|NCT02437110|156816714|FG000|Screening|Lost to Follow-up|3|||
48718263|NCT02437110|156816714|FG000|Screening|Physician Decision|1|||
48718264|NCT02437110|156816714|FG000|ART|Adverse Event|3|||
48718265|NCT02437110|156816714|FG000|ART|Protocol Violation|3|||
48718266|NCT02437110|156816714|FG000|ART|Withdrawal by Subject|4|||
48718267|NCT02437110|156816714|FG000|ART|Lost to follow-up prior to start of intervention|1|||
48718268|NCT02437110|156816714|FG000|ART|Physician decision prior to start of intervention|2|||
48718269|NCT02437110|156816714|FG000|ART|Withdrawal by subject prior to starting intervention|1|||
48718270|NCT02437110|156816714|FG000|Post-ART|Lost to Follow-up|3|||
48718271|NCT02437110|156816714|FG000|Post-ART|Protocol Violation|4|||
48718272|NCT02437110|156816714|FG000|Post-ART|Withdrawal by Subject|3|||
48718273|NCT04525885|156816715|FG000|Overall Study|Screen Failure|1|||
48718274|NCT04525885|156816716|FG001|Overall Study|Screen Failure|0|||
48718275|NCT04525885|156816717|FG002|Overall Study|Screen Failure|0|||
48718276|NCT04525885|156816715|FG000|Overall Study|Withdrawal by Subject|14|||
48718277|NCT04525885|156816716|FG001|Overall Study|Withdrawal by Subject|6|||
48718278|NCT04525885|156816717|FG002|Overall Study|Withdrawal by Subject|20|||
48718279|NCT04525885|156816715|FG000|Overall Study|Physician Decision|1|||
48718280|NCT04525885|156816716|FG001|Overall Study|Physician Decision|0|||
48718281|NCT04525885|156816717|FG002|Overall Study|Physician Decision|1|||
48718282|NCT03836001|156816725|FG000|Blinded Phase (2 Months)|Adverse Event|0|||
48718283|NCT03836001|156816726|FG001|Blinded Phase (2 Months)|Adverse Event|1|||
48718284|NCT03836001|156816727|FG002|Blinded Phase (2 Months)|Adverse Event|0|||
48718285|NCT03836001|156816725|FG000|Blinded Phase (2 Months)|Physician Decision|0|||
48718286|NCT03836001|156816726|FG001|Blinded Phase (2 Months)|Physician Decision|1|||
48718287|NCT03836001|156816727|FG002|Blinded Phase (2 Months)|Physician Decision|0|||
48718288|NCT03836001|156816725|FG000|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
48718289|NCT03836001|156816726|FG001|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
48718290|NCT03836001|156816727|FG002|Open-label Extension (3 or 12 Months)|Lost to Follow-up|1|||
48718291|NCT03836001|156816725|FG000|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
48718292|NCT03836001|156816726|FG001|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
48718293|NCT03836001|156816727|FG002|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|1|||
48718294|NCT00534313|156816728|FG000|Short-term Period|Adverse Event|1|||
48718295|NCT00534313|156816729|FG001|Short-term Period|Adverse Event|2|||
48718296|NCT00534313|156816730|FG002|Short-term Period|Adverse Event|1|||
48718297|NCT00534313|156816731|FG003|Short-term Period|Adverse Event|3|||
48718298|NCT00534313|156816728|FG000|Short-term Period|Lack of Efficacy|3|||
48718299|NCT00534313|156816729|FG001|Short-term Period|Lack of Efficacy|4|||
49127169|NCT02984982|158304347|FG001|Overall Study|Poor Compliance to Protocol|4|||
49127170|NCT02984982|158304346|FG000|Overall Study|Withdrawal by Subject|2|||
49127171|NCT02984982|158304347|FG001|Overall Study|Withdrawal by Subject|0|||
49127172|NCT02984982|158304346|FG000|Overall Study|Randomized but not treated|0|||
49127173|NCT02984982|158304347|FG001|Overall Study|Randomized but not treated|1|||
49127174|NCT03217591|158304348|FG000|Overall Study|Adverse Event|1|||
49127175|NCT03217591|158304349|FG001|Overall Study|Adverse Event|2|||
49127176|NCT03217591|158304350|FG002|Overall Study|Adverse Event|6|||
49127177|NCT03217591|158304348|FG000|Overall Study|Withdrawal by Subject|0|||
49127178|NCT03217591|158304349|FG001|Overall Study|Withdrawal by Subject|1|||
49127179|NCT03217591|158304350|FG002|Overall Study|Withdrawal by Subject|3|||
49127180|NCT03217591|158304348|FG000|Overall Study|Lost to Follow-up|1|||
49127181|NCT03217591|158304349|FG001|Overall Study|Lost to Follow-up|0|||
49127182|NCT03217591|158304350|FG002|Overall Study|Lost to Follow-up|0|||
49127183|NCT03217591|158304348|FG000|Overall Study|Protocol Violation|1|||
49127184|NCT03217591|158304349|FG001|Overall Study|Protocol Violation|0|||
48718300|NCT00534313|156816730|FG002|Short-term Period|Lack of Efficacy|0|||
48718301|NCT00534313|156816731|FG003|Short-term Period|Lack of Efficacy|3|||
48718302|NCT00534313|156816728|FG000|Short-term Period|Participant not meeting study criteria|0|||
49127185|NCT03217591|158304350|FG002|Overall Study|Protocol Violation|1|||
49127186|NCT02175121|158304351|FG000|Overall Study|Lack of Efficacy|1|||
49127187|NCT02175121|158304352|FG001|Overall Study|Lack of Efficacy|0|||
49127188|NCT02175121|158304353|FG002|Overall Study|Lack of Efficacy|0|||
49127189|NCT02175121|158304354|FG003|Overall Study|Lack of Efficacy|0|||
49127190|NCT02175121|158304355|FG004|Overall Study|Lack of Efficacy|0|||
49127191|NCT02175121|158304351|FG000|Overall Study|Lost to Follow-up|0|||
49127192|NCT02175121|158304352|FG001|Overall Study|Lost to Follow-up|1|||
49127193|NCT02175121|158304353|FG002|Overall Study|Lost to Follow-up|0|||
49127194|NCT02175121|158304354|FG003|Overall Study|Lost to Follow-up|1|||
49127195|NCT02175121|158304355|FG004|Overall Study|Lost to Follow-up|0|||
49127196|NCT02175121|158304351|FG000|Overall Study|Personal emergency|0|||
49127197|NCT02175121|158304352|FG001|Overall Study|Personal emergency|0|||
49127198|NCT02175121|158304353|FG002|Overall Study|Personal emergency|0|||
49127199|NCT02175121|158304354|FG003|Overall Study|Personal emergency|0|||
49127200|NCT02175121|158304355|FG004|Overall Study|Personal emergency|1|||
49127201|NCT02175121|158304351|FG000|Overall Study|Schedule conflict|0|||
49127202|NCT02175121|158304352|FG001|Overall Study|Schedule conflict|0|||
49127203|NCT02175121|158304353|FG002|Overall Study|Schedule conflict|1|||
49127204|NCT02175121|158304354|FG003|Overall Study|Schedule conflict|0|||
49127205|NCT02175121|158304355|FG004|Overall Study|Schedule conflict|0|||
49127206|NCT02175121|158304351|FG000|Overall Study|Time issues|0|||
49127207|NCT02175121|158304352|FG001|Overall Study|Time issues|0|||
49127208|NCT02175121|158304353|FG002|Overall Study|Time issues|1|||
49127209|NCT02175121|158304354|FG003|Overall Study|Time issues|0|||
49127210|NCT02175121|158304355|FG004|Overall Study|Time issues|0|||
49127211|NCT02027025|158304356|FG000|Overall Study|Adverse Event|0|||
49127212|NCT02027025|158304357|FG001|Overall Study|Adverse Event|1|||
49127213|NCT02027025|158304358|FG002|Overall Study|Adverse Event|1|||
49127214|NCT02027025|158304356|FG000|Overall Study|Protocol Violation|1|||
49127215|NCT02027025|158304357|FG001|Overall Study|Protocol Violation|0|||
49127216|NCT02027025|158304358|FG002|Overall Study|Protocol Violation|0|||
49127217|NCT02027025|158304356|FG000|Overall Study|Lost to Follow-up|0|||
49127218|NCT02027025|158304357|FG001|Overall Study|Lost to Follow-up|2|||
49127219|NCT02027025|158304358|FG002|Overall Study|Lost to Follow-up|0|||
49127220|NCT02027025|158304356|FG000|Overall Study|Withdrawal by Subject|0|||
49127221|NCT02027025|158304357|FG001|Overall Study|Withdrawal by Subject|1|||
49127222|NCT02027025|158304358|FG002|Overall Study|Withdrawal by Subject|0|||
49127223|NCT02027025|158304356|FG000|Overall Study|Sponsor's decision|0|||
49127224|NCT02027025|158304357|FG001|Overall Study|Sponsor's decision|1|||
49127225|NCT02027025|158304358|FG002|Overall Study|Sponsor's decision|0|||
49127226|NCT01232283|158304364|FG000|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12|||
49127227|NCT01232283|158304365|FG001|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8|||
49127228|NCT01232283|158304366|FG002|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
49127229|NCT01232283|158304367|FG003|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
49127230|NCT01232283|158304368|FG004|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
49127231|NCT01232283|158304369|FG005|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
49127232|NCT01232283|158304370|FG006|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
49127233|NCT01232283|158304371|FG007|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
49127234|NCT01232283|158304372|FG008|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
49127235|NCT01232283|158304373|FG009|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
49127236|NCT01232283|158304364|FG000|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3|||
49127237|NCT01232283|158304365|FG001|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2|||
49127238|NCT01232283|158304366|FG002|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
49127239|NCT01232283|158304367|FG003|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
49127240|NCT01232283|158304368|FG004|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
49127241|NCT01232283|158304369|FG005|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
49127242|NCT01232283|158304370|FG006|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
49127243|NCT01232283|158304371|FG007|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
49127244|NCT01232283|158304372|FG008|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
49127245|NCT01232283|158304373|FG009|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
49127246|NCT01232283|158304364|FG000|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1|||
49127247|NCT01232283|158304365|FG001|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
49127248|NCT01232283|158304366|FG002|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
49127249|NCT01232283|158304367|FG003|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
49127250|NCT01232283|158304368|FG004|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
49127251|NCT01232283|158304369|FG005|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
49127252|NCT01232283|158304370|FG006|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
49127253|NCT01232283|158304371|FG007|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
49127254|NCT01232283|158304372|FG008|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
49127255|NCT01232283|158304373|FG009|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
49127256|NCT01232283|158304364|FG000|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9|||
49127257|NCT01232283|158304365|FG001|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7|||
49127258|NCT01232283|158304366|FG002|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
49127259|NCT01232283|158304367|FG003|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
49127260|NCT01232283|158304368|FG004|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
49127261|NCT01232283|158304369|FG005|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
49127262|NCT01232283|158304370|FG006|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
49127263|NCT01232283|158304371|FG007|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
49127264|NCT01232283|158304372|FG008|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
49127265|NCT01232283|158304373|FG009|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
49127266|NCT01232283|158304364|FG000|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
49127267|NCT01232283|158304365|FG001|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
49127268|NCT01232283|158304366|FG002|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
49127269|NCT01232283|158304367|FG003|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
49127270|NCT01232283|158304368|FG004|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
49127271|NCT01232283|158304369|FG005|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
49127272|NCT01232283|158304370|FG006|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
49127273|NCT01232283|158304371|FG007|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
49127274|NCT01232283|158304372|FG008|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
49127275|NCT01232283|158304373|FG009|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
49127276|NCT01232283|158304364|FG000|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3|||
49127277|NCT01232283|158304365|FG001|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2|||
49127278|NCT01232283|158304366|FG002|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
49127279|NCT01232283|158304367|FG003|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
49127280|NCT01232283|158304368|FG004|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
49127281|NCT01232283|158304369|FG005|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
49127282|NCT01232283|158304370|FG006|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
49127283|NCT01232283|158304371|FG007|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
49127284|NCT01232283|158304372|FG008|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
49127285|NCT01232283|158304373|FG009|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
49127286|NCT01232283|158304364|FG000|Placebo Controlled Phase (Weeks 0-16)|Other|2|||
49127287|NCT01232283|158304365|FG001|Placebo Controlled Phase (Weeks 0-16)|Other|1|||
49127288|NCT01232283|158304366|FG002|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
49127289|NCT01232283|158304367|FG003|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
49127290|NCT01232283|158304368|FG004|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
49127291|NCT01232283|158304369|FG005|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
49127292|NCT01232283|158304370|FG006|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
49127293|NCT01232283|158304371|FG007|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
49127294|NCT01232283|158304372|FG008|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
49127295|NCT01232283|158304373|FG009|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
49127296|NCT01232283|158304364|FG000|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
49127297|NCT01232283|158304365|FG001|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
49127298|NCT01232283|158304366|FG002|Maintenance Phase (Weeks16-32)|Adverse Event|8|||
49127299|NCT01232283|158304367|FG003|Maintenance Phase (Weeks16-32)|Adverse Event|2|||
49127300|NCT01232283|158304368|FG004|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
49127301|NCT01232283|158304369|FG005|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
49127302|NCT01232283|158304370|FG006|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
48814972|NCT01544582|157163648|FG000|Analysis Population|Physician Decision|0|||
48814973|NCT01544582|157163649|FG001|Analysis Population|Physician Decision|13|||
48814974|NCT01544582|157163650|FG002|Analysis Population|Physician Decision|10|||
48814975|NCT01544582|157163651|FG003|Analysis Population|Physician Decision|9|||
48814976|NCT01544582|157163648|FG000|Analysis Population|Safety Reason|0|||
48814977|NCT01544582|157163649|FG001|Analysis Population|Safety Reason|33|||
48814978|NCT01544582|157163650|FG002|Analysis Population|Safety Reason|31|||
48814979|NCT01544582|157163651|FG003|Analysis Population|Safety Reason|8|||
48814980|NCT01544582|157163648|FG000|Analysis Population|Effectiveness Reason|0|||
48814981|NCT01544582|157163649|FG001|Analysis Population|Effectiveness Reason|48|||
48814982|NCT01544582|157163650|FG002|Analysis Population|Effectiveness Reason|29|||
48814983|NCT01544582|157163651|FG003|Analysis Population|Effectiveness Reason|12|||
48814984|NCT01544582|157163648|FG000|Analysis Population|New Contraindication-Alcohol Abuse|0|||
48814985|NCT01544582|157163649|FG001|Analysis Population|New Contraindication-Alcohol Abuse|0|||
48814986|NCT01544582|157163650|FG002|Analysis Population|New Contraindication-Alcohol Abuse|0|||
49127303|NCT01232283|158304371|FG007|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
49127304|NCT01232283|158304372|FG008|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
48814987|NCT01544582|157163651|FG003|Analysis Population|New Contraindication-Alcohol Abuse|1|||
48814988|NCT01544582|157163648|FG000|Analysis Population|Lost to Follow-up|0|||
48814989|NCT01544582|157163649|FG001|Analysis Population|Lost to Follow-up|6|||
48814990|NCT01544582|157163650|FG002|Analysis Population|Lost to Follow-up|6|||
48814991|NCT01544582|157163651|FG003|Analysis Population|Lost to Follow-up|5|||
48814992|NCT01544582|157163648|FG000|Analysis Population|Bad Tolerance to Treatment|0|||
48814993|NCT01544582|157163649|FG001|Analysis Population|Bad Tolerance to Treatment|0|||
48814994|NCT01544582|157163650|FG002|Analysis Population|Bad Tolerance to Treatment|2|||
49127305|NCT01232283|158304373|FG009|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
49127306|NCT01232283|158304364|FG000|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
49127307|NCT01232283|158304365|FG001|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
49127308|NCT01232283|158304366|FG002|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19|||
49127309|NCT01232283|158304367|FG003|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3|||
49127310|NCT01232283|158304368|FG004|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
49127311|NCT01232283|158304369|FG005|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
49127312|NCT01232283|158304370|FG006|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
49127313|NCT01232283|158304371|FG007|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
49127314|NCT01232283|158304372|FG008|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
49127315|NCT01232283|158304373|FG009|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
49127316|NCT01232283|158304364|FG000|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
49127317|NCT01232283|158304365|FG001|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
49127318|NCT01232283|158304366|FG002|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1|||
49127319|NCT01232283|158304367|FG003|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
49127320|NCT01232283|158304368|FG004|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
49127321|NCT01232283|158304369|FG005|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
49127322|NCT01232283|158304370|FG006|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
49127323|NCT01232283|158304371|FG007|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
49127324|NCT01232283|158304372|FG008|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
49127325|NCT01232283|158304373|FG009|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
49127326|NCT01232283|158304364|FG000|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
49127327|NCT01232283|158304365|FG001|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
49127328|NCT01232283|158304366|FG002|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7|||
49127329|NCT01232283|158304367|FG003|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1|||
49127330|NCT01232283|158304368|FG004|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
49127331|NCT01232283|158304369|FG005|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
49127332|NCT01232283|158304370|FG006|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
49127333|NCT01232283|158304371|FG007|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
49127334|NCT01232283|158304372|FG008|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
49127335|NCT01232283|158304373|FG009|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
48718303|NCT00534313|156816729|FG001|Short-term Period|Participant not meeting study criteria|0|||
48718304|NCT00534313|156816730|FG002|Short-term Period|Participant not meeting study criteria|0|||
48718305|NCT00534313|156816731|FG003|Short-term Period|Participant not meeting study criteria|1|||
48718306|NCT00534313|156816728|FG000|Short-term Period|Participant withdrew consent|2|||
48718307|NCT00534313|156816729|FG001|Short-term Period|Participant withdrew consent|0|||
48718308|NCT00534313|156816730|FG002|Short-term Period|Participant withdrew consent|0|||
48718309|NCT00534313|156816731|FG003|Short-term Period|Participant withdrew consent|2|||
48718310|NCT00534313|156816728|FG000|Short-term Period|Pregnancy|0|||
48718311|NCT00534313|156816729|FG001|Short-term Period|Pregnancy|0|||
48718312|NCT00534313|156816730|FG002|Short-term Period|Pregnancy|1|||
48718313|NCT00534313|156816731|FG003|Short-term Period|Pregnancy|0|||
48718314|NCT00534313|156816728|FG000|Long-term Period|Adverse Event|2|||
48718315|NCT00534313|156816729|FG001|Long-term Period|Adverse Event|1|||
48718316|NCT00534313|156816730|FG002|Long-term Period|Adverse Event|0|||
48718317|NCT00534313|156816731|FG003|Long-term Period|Adverse Event|1|||
48718318|NCT00534313|156816728|FG000|Long-term Period|Lack of Efficacy|14|||
48718319|NCT00534313|156816729|FG001|Long-term Period|Lack of Efficacy|10|||
48718320|NCT00534313|156816730|FG002|Long-term Period|Lack of Efficacy|14|||
48718321|NCT00534313|156816731|FG003|Long-term Period|Lack of Efficacy|12|||
48718322|NCT00534313|156816728|FG000|Long-term Period|Lost to Follow-up|1|||
48718323|NCT00534313|156816729|FG001|Long-term Period|Lost to Follow-up|2|||
48718324|NCT00534313|156816730|FG002|Long-term Period|Lost to Follow-up|0|||
48718325|NCT00534313|156816731|FG003|Long-term Period|Lost to Follow-up|0|||
48718326|NCT00534313|156816728|FG000|Long-term Period|Withdrawal by Subject|2|||
48718327|NCT00534313|156816729|FG001|Long-term Period|Withdrawal by Subject|2|||
48718328|NCT00534313|156816730|FG002|Long-term Period|Withdrawal by Subject|0|||
48718329|NCT00534313|156816731|FG003|Long-term Period|Withdrawal by Subject|0|||
48718330|NCT00534313|156816728|FG000|Long-term Period|No longer meets study criteria|0|||
48718331|NCT00534313|156816729|FG001|Long-term Period|No longer meets study criteria|1|||
48718332|NCT00534313|156816730|FG002|Long-term Period|No longer meets study criteria|0|||
48718333|NCT00534313|156816731|FG003|Long-term Period|No longer meets study criteria|0|||
48718334|NCT00534313|156816728|FG000|Long-term Period|Poor compliance/noncompliance|0|||
48718335|NCT00534313|156816729|FG001|Long-term Period|Poor compliance/noncompliance|1|||
48718336|NCT00534313|156816730|FG002|Long-term Period|Poor compliance/noncompliance|1|||
48718337|NCT00534313|156816731|FG003|Long-term Period|Poor compliance/noncompliance|0|||
48718338|NCT00534313|156816728|FG000|Long-term Period|Administrative reason by sponsor|17|||
48718339|NCT00534313|156816729|FG001|Long-term Period|Administrative reason by sponsor|15|||
48718340|NCT00534313|156816730|FG002|Long-term Period|Administrative reason by sponsor|26|||
48718341|NCT00534313|156816731|FG003|Long-term Period|Administrative reason by sponsor|18|||
48718342|NCT00534313|156816728|FG000|Long-term Period|Other|1|||
48718343|NCT00534313|156816729|FG001|Long-term Period|Other|2|||
48718344|NCT00534313|156816730|FG002|Long-term Period|Other|2|||
48718345|NCT00534313|156816731|FG003|Long-term Period|Other|2|||
48718346|NCT00995566|156816736|FG000|Overall Study|Adverse Event|2|||
48718347|NCT00995566|156816736|FG000|Overall Study|Early study termination|52|||
48718348|NCT00483756|156816739|FG000|Overall Study|Death|2|||
48718349|NCT00483756|156816740|FG001|Overall Study|Death|0|||
48718350|NCT00483756|156816741|FG002|Overall Study|Death|1|||
48718351|NCT00483756|156816739|FG000|Overall Study|Adverse Event|19|||
48718352|NCT00483756|156816740|FG001|Overall Study|Adverse Event|38|||
48718353|NCT00483756|156816741|FG002|Overall Study|Adverse Event|40|||
48718354|NCT00483756|156816739|FG000|Overall Study|Lack of Efficacy|1|||
48718355|NCT00483756|156816740|FG001|Overall Study|Lack of Efficacy|0|||
49127336|NCT01232283|158304364|FG000|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
49127337|NCT01232283|158304365|FG001|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
49127338|NCT01232283|158304366|FG002|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3|||
49127339|NCT01232283|158304367|FG003|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2|||
48718356|NCT00483756|156816741|FG002|Overall Study|Lack of Efficacy|0|||
49127340|NCT01232283|158304368|FG004|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
49127341|NCT01232283|158304369|FG005|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
49127342|NCT01232283|158304370|FG006|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
49127343|NCT01232283|158304371|FG007|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
49127344|NCT01232283|158304372|FG008|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
49127345|NCT01232283|158304373|FG009|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
49127346|NCT01232283|158304364|FG000|Maintenance Phase (Weeks16-32)|Other|0|||
49127347|NCT01232283|158304365|FG001|Maintenance Phase (Weeks16-32)|Other|0|||
49127348|NCT01232283|158304366|FG002|Maintenance Phase (Weeks16-32)|Other|2|||
49127349|NCT01232283|158304367|FG003|Maintenance Phase (Weeks16-32)|Other|0|||
49127350|NCT01232283|158304368|FG004|Maintenance Phase (Weeks16-32)|Other|0|||
49127351|NCT01232283|158304369|FG005|Maintenance Phase (Weeks16-32)|Other|0|||
49127352|NCT01232283|158304370|FG006|Maintenance Phase (Weeks16-32)|Other|0|||
49127353|NCT01232283|158304371|FG007|Maintenance Phase (Weeks16-32)|Other|0|||
49127354|NCT01232283|158304372|FG008|Maintenance Phase (Weeks16-32)|Other|0|||
49127355|NCT01232283|158304373|FG009|Maintenance Phase (Weeks16-32)|Other|0|||
49127356|NCT01232283|158304364|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
49127357|NCT01232283|158304365|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
49127358|NCT01232283|158304366|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
49127359|NCT01232283|158304367|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
49127360|NCT01232283|158304368|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2|||
49127361|NCT01232283|158304369|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
49127362|NCT01232283|158304370|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
49127363|NCT01232283|158304371|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
49127364|NCT01232283|158304372|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
49127365|NCT01232283|158304373|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
49127366|NCT01232283|158304364|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
49127367|NCT01232283|158304365|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
49127368|NCT01232283|158304366|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
48718357|NCT00483756|156816739|FG000|Overall Study|Lost to Follow-up|3|||
48718358|NCT00483756|156816740|FG001|Overall Study|Lost to Follow-up|1|||
48718359|NCT00483756|156816741|FG002|Overall Study|Lost to Follow-up|0|||
48718360|NCT00483756|156816739|FG000|Overall Study|Withdrawal by Subject|5|||
48718361|NCT00483756|156816740|FG001|Overall Study|Withdrawal by Subject|3|||
48718362|NCT00483756|156816741|FG002|Overall Study|Withdrawal by Subject|4|||
48718363|NCT00483756|156816739|FG000|Overall Study|Other|2|||
48718364|NCT00483756|156816740|FG001|Overall Study|Other|4|||
48718365|NCT00483756|156816741|FG002|Overall Study|Other|3|||
48718366|NCT00483756|156816739|FG000|Overall Study|Randomized, Not Treated|1|||
49127369|NCT01232283|158304367|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
49127370|NCT01232283|158304368|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4|||
49127371|NCT01232283|158304369|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
49127372|NCT01232283|158304370|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13|||
48718367|NCT00483756|156816740|FG001|Overall Study|Randomized, Not Treated|4|||
48718368|NCT00483756|156816741|FG002|Overall Study|Randomized, Not Treated|4|||
48718369|NCT00545129|156816758|FG000|Overall Study|Lack of Efficacy|2|||
48718370|NCT00545129|156816759|FG001|Overall Study|Lack of Efficacy|5|||
48718371|NCT00545129|156816758|FG000|Overall Study|Death|2|||
48718372|NCT00545129|156816759|FG001|Overall Study|Death|1|||
48718373|NCT00545129|156816758|FG000|Overall Study|Adverse Event|1|||
48718374|NCT00545129|156816759|FG001|Overall Study|Adverse Event|1|||
48718375|NCT00545129|156816758|FG000|Overall Study|Rollover to Study A4091029 (NCT00830180)|9|||
48718376|NCT00545129|156816759|FG001|Overall Study|Rollover to Study A4091029 (NCT00830180)|14|||
48718377|NCT00545129|156816758|FG000|Overall Study|Other|3|||
48718378|NCT00545129|156816759|FG001|Overall Study|Other|3|||
49127373|NCT01232283|158304371|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5|||
49127374|NCT01232283|158304372|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
49127375|NCT01232283|158304373|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
49127376|NCT01232283|158304364|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
49127377|NCT01232283|158304365|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
49127378|NCT01232283|158304366|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
49127379|NCT01232283|158304367|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
49127380|NCT01232283|158304368|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
49127381|NCT01232283|158304369|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
49127382|NCT01232283|158304370|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
49127383|NCT01232283|158304371|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4|||
49127384|NCT01232283|158304372|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
49127385|NCT01232283|158304373|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
49127386|NCT01232283|158304364|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
49127387|NCT01232283|158304365|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
49127388|NCT01232283|158304366|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
49127389|NCT01232283|158304367|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
49127390|NCT01232283|158304368|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Death|1|||
49127391|NCT01232283|158304369|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
49127392|NCT01232283|158304370|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
49127393|NCT01232283|158304371|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
49127394|NCT01232283|158304372|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
49127395|NCT01232283|158304373|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
49127396|NCT01232283|158304364|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
48814995|NCT01544582|157163651|FG003|Analysis Population|Bad Tolerance to Treatment|0|||
48814996|NCT01544582|157163648|FG000|Analysis Population|Did Not Meet Inclusion Criteria|0|||
48814997|NCT01544582|157163649|FG001|Analysis Population|Did Not Meet Inclusion Criteria|0|||
48814998|NCT01544582|157163650|FG002|Analysis Population|Did Not Meet Inclusion Criteria|3|||
48814999|NCT01544582|157163651|FG003|Analysis Population|Did Not Meet Inclusion Criteria|0|||
48815000|NCT01544582|157163648|FG000|Analysis Population|Intolerance|0|||
48815001|NCT01544582|157163649|FG001|Analysis Population|Intolerance|1|||
48815002|NCT01544582|157163650|FG002|Analysis Population|Intolerance|0|||
48815003|NCT01544582|157163651|FG003|Analysis Population|Intolerance|0|||
48815004|NCT01544582|157163648|FG000|Analysis Population|Liver Transplantation|0|||
49127397|NCT01232283|158304365|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
49127398|NCT01232283|158304366|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
49127399|NCT01232283|158304367|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
49127400|NCT01232283|158304368|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2|||
49127401|NCT01232283|158304369|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
49127402|NCT01232283|158304370|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
49127403|NCT01232283|158304371|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
49127404|NCT01232283|158304372|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
49127405|NCT01232283|158304373|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
49127406|NCT01232283|158304364|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
49127407|NCT01232283|158304365|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
49127408|NCT01232283|158304366|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
49127409|NCT01232283|158304367|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
48815005|NCT01544582|157163649|FG001|Analysis Population|Liver Transplantation|0|||
49127410|NCT01232283|158304368|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
49127411|NCT01232283|158304369|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
49127412|NCT01232283|158304370|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
49127413|NCT01232283|158304371|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1|||
49127414|NCT01232283|158304372|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
49127415|NCT01232283|158304373|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
49127416|NCT01232283|158304364|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
49127417|NCT01232283|158304365|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
49127418|NCT01232283|158304366|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
49127419|NCT01232283|158304367|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
49127420|NCT01232283|158304368|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
49127421|NCT01232283|158304369|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Other|1|||
49127422|NCT01232283|158304370|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
49127423|NCT01232283|158304371|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
49127424|NCT01232283|158304372|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
49127425|NCT01232283|158304373|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
49127426|NCT01232283|158304364|FG000|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
49127427|NCT01232283|158304365|FG001|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
49127428|NCT01232283|158304366|FG002|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
49127429|NCT01232283|158304367|FG003|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
49127430|NCT01232283|158304368|FG004|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
49127431|NCT01232283|158304369|FG005|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
49127432|NCT01232283|158304370|FG006|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
49127433|NCT01232283|158304371|FG007|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
49127434|NCT01232283|158304372|FG008|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11|||
49127435|NCT01232283|158304373|FG009|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6|||
49127436|NCT01232283|158304364|FG000|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
49127437|NCT01232283|158304365|FG001|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
49127438|NCT01232283|158304366|FG002|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
49127439|NCT01232283|158304367|FG003|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
49127440|NCT01232283|158304368|FG004|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
49127441|NCT01232283|158304369|FG005|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
49127442|NCT01232283|158304370|FG006|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
49127443|NCT01232283|158304371|FG007|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
49127444|NCT01232283|158304372|FG008|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46|||
49127445|NCT01232283|158304373|FG009|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30|||
49127446|NCT01232283|158304364|FG000|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
49127447|NCT01232283|158304365|FG001|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
49127448|NCT01232283|158304366|FG002|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
49127449|NCT01232283|158304367|FG003|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
49127450|NCT01232283|158304368|FG004|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
48920956|NCT00513409|157544794|FG001|Overall Study|Withdrawal by Subject|2|||
48920957|NCT00513409|157544793|FG000|Overall Study|Lost to Follow-up|0|||
49127451|NCT01232283|158304369|FG005|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
49127452|NCT01232283|158304370|FG006|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
49127453|NCT01232283|158304371|FG007|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
49127454|NCT01232283|158304372|FG008|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3|||
49127455|NCT01232283|158304373|FG009|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2|||
49127456|NCT01232283|158304364|FG000|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
48920958|NCT00513409|157544794|FG001|Overall Study|Lost to Follow-up|1|||
48920959|NCT00513409|157544793|FG000|Overall Study|Physician Decision|1|||
49127457|NCT01232283|158304365|FG001|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
49127458|NCT01232283|158304366|FG002|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
49127459|NCT01232283|158304367|FG003|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
49127460|NCT01232283|158304368|FG004|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
49127461|NCT01232283|158304369|FG005|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
49127462|NCT01232283|158304370|FG006|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
49127463|NCT01232283|158304371|FG007|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
49127464|NCT01232283|158304372|FG008|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30|||
49127465|NCT01232283|158304373|FG009|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14|||
49127466|NCT01232283|158304364|FG000|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
49127467|NCT01232283|158304365|FG001|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
49127468|NCT01232283|158304366|FG002|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
49127469|NCT01232283|158304367|FG003|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
49127470|NCT01232283|158304368|FG004|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
49127471|NCT01232283|158304369|FG005|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
49127472|NCT01232283|158304370|FG006|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
49127473|NCT01232283|158304371|FG007|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
49127474|NCT01232283|158304372|FG008|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9|||
49127475|NCT01232283|158304373|FG009|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6|||
49127476|NCT01232283|158304364|FG000|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
49127477|NCT01232283|158304365|FG001|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
49127478|NCT01232283|158304366|FG002|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
49127479|NCT01232283|158304367|FG003|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
49127480|NCT01232283|158304368|FG004|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
49127481|NCT01232283|158304369|FG005|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
49127482|NCT01232283|158304370|FG006|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
49127483|NCT01232283|158304371|FG007|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
49127484|NCT01232283|158304372|FG008|Long-Term Extension Phase (Weeks 52-260)|Death|1|||
49127485|NCT01232283|158304373|FG009|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
49127486|NCT01232283|158304364|FG000|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
49127487|NCT01232283|158304365|FG001|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
49127488|NCT01232283|158304366|FG002|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
49127489|NCT01232283|158304367|FG003|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
49127490|NCT01232283|158304368|FG004|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
49127491|NCT01232283|158304369|FG005|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
49127492|NCT01232283|158304370|FG006|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
49127493|NCT01232283|158304371|FG007|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
49127494|NCT01232283|158304372|FG008|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1|||
49127495|NCT01232283|158304373|FG009|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
49127496|NCT01232283|158304364|FG000|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
49127497|NCT01232283|158304365|FG001|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
49127498|NCT01232283|158304366|FG002|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
49127499|NCT01232283|158304367|FG003|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
49127500|NCT01232283|158304368|FG004|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
49127501|NCT01232283|158304369|FG005|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
49127502|NCT01232283|158304370|FG006|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
49127503|NCT01232283|158304371|FG007|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
49127504|NCT01232283|158304372|FG008|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7|||
49127505|NCT01232283|158304373|FG009|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3|||
49127506|NCT03106077|158304374|FG000|Overall Study|Screen Failure|94|||
49127507|NCT03106077|158304375|FG001|Overall Study|Screen Failure|0|||
49127508|NCT01274533|158304378|FG000|Overall Study|Withdrawal by Subject|1|||
49127509|NCT01274533|158304378|FG000|Overall Study|Non-compliance|1|||
49127510|NCT01274533|158304378|FG000|Overall Study|Disease progression|2|||
49127511|NCT03368807|158304379|FG000|Period 1 (Blinded CGM)|Withdrawal by Subject|3|||
49127512|NCT03368807|158304379|FG000|Period 1 (Blinded CGM)|Protocol Violation|1|||
49127513|NCT03368807|158304379|FG000|Period 1 (Blinded CGM)|Sponsor Decision|1|||
49127514|NCT03368807|158304379|FG000|Period 1 (Blinded CGM)|Lost to Follow-up|1|||
49127515|NCT03669588|158304387|FG000|Overall Study|Adverse Event|1|||
49127516|NCT03669588|158304388|FG001|Overall Study|Adverse Event|0|||
49127517|NCT03669588|158304387|FG000|Overall Study|Physician Decision|0|||
49127518|NCT03669588|158304388|FG001|Overall Study|Physician Decision|1|||
49127519|NCT03669588|158304387|FG000|Overall Study|Protocol Violation|1|||
49127520|NCT03669588|158304388|FG001|Overall Study|Protocol Violation|0|||
49127521|NCT03669588|158304387|FG000|Overall Study|Sponsor Decision|1|||
49127522|NCT03669588|158304388|FG001|Overall Study|Sponsor Decision|1|||
49127523|NCT03669588|158304387|FG000|Overall Study|Withdrawal by Subject|1|||
49127524|NCT03669588|158304388|FG001|Overall Study|Withdrawal by Subject|4|||
49127525|NCT03669588|158304387|FG000|Overall Study|Rescue Therapy Needed|0|||
49127526|NCT03669588|158304388|FG001|Overall Study|Rescue Therapy Needed|1|||
49127527|NCT01118052|158304389|FG000|Overall Study|Never treated|2|||
49127528|NCT00828711|158304391|FG000|Overall Study|Lost to Follow-up|1|||
49127529|NCT00828711|158304392|FG001|Overall Study|Lost to Follow-up|0|||
49127530|NCT00828711|158304393|FG002|Overall Study|Lost to Follow-up|0|||
49127531|NCT04356937|158304395|FG000|Treatment (mITT Population)|Intubated before receiving study treatment|0|||
49127532|NCT04356937|158304396|FG001|Treatment (mITT Population)|Intubated before receiving study treatment|1|||
49127533|NCT03092752|158304397|FG000|Overall Study|Aged <40 years|14209|||
49127534|NCT03092752|158304397|FG000|Overall Study|At least one claim with T2DM|61299|||
49127535|NCT03092752|158304397|FG000|Overall Study|Having no claim of study drugs|29282|||
49127536|NCT03092752|158304397|FG000|Overall Study|Average hospital visit interval >92 days|10779|||
49127537|NCT03092752|158304397|FG000|Overall Study|<6 month history|245900|||
49127538|NCT00617279|158304399|FG000|Overall Study|Study terminated by Sponsor|10|||
49127539|NCT00617279|158304400|FG001|Overall Study|Study terminated by Sponsor|15|||
49127540|NCT00617279|158304399|FG000|Overall Study|Graft abandonment|2|||
49127541|NCT00617279|158304400|FG001|Overall Study|Graft abandonment|0|||
49127542|NCT00617279|158304399|FG000|Overall Study|Lost to Follow-up|1|||
49127543|NCT00617279|158304400|FG001|Overall Study|Lost to Follow-up|0|||
48815006|NCT01544582|157163650|FG002|Analysis Population|Liver Transplantation|1|||
48815007|NCT01544582|157163651|FG003|Analysis Population|Liver Transplantation|0|||
48815008|NCT01544582|157163648|FG000|Analysis Population|No Social Insurance|0|||
48815009|NCT01544582|157163649|FG001|Analysis Population|No Social Insurance|0|||
48815010|NCT01544582|157163650|FG002|Analysis Population|No Social Insurance|1|||
48815011|NCT01544582|157163651|FG003|Analysis Population|No Social Insurance|0|||
49127544|NCT00617279|158304399|FG000|Overall Study|Death|1|||
49127545|NCT00617279|158304400|FG001|Overall Study|Death|2|||
49127546|NCT01324947|158304405|FG000|Overall Study|Adverse Event|7|||
49127547|NCT01324947|158304405|FG000|Overall Study|Death|10|||
49127548|NCT01324947|158304405|FG000|Overall Study|Other|3|||
49127549|NCT01324947|158304405|FG000|Overall Study|Progressive Disease|50|||
48718379|NCT04605991|156818353|FG000|Overall Study|Adverse Event|5|||
48718380|NCT04605991|156818353|FG000|Overall Study|Lack of Efficacy|1|||
48718381|NCT04605991|156818353|FG000|Overall Study|Lost to Follow-up|8|||
48718382|NCT04605991|156818353|FG000|Overall Study|Physician Decision|4|||
48718383|NCT04605991|156818353|FG000|Overall Study|Withdrawal by Subject|14|||
48718384|NCT04605991|156818353|FG000|Overall Study|Non-compliance with study|1|||
48718385|NCT02168387|156818354|FG000|Overall Study|Planned exubation|6|||
48718386|NCT02168387|156818355|FG001|Overall Study|Planned exubation|3|||
48718387|NCT02168387|156818354|FG000|Overall Study|Death|1|||
48718388|NCT02168387|156818355|FG001|Overall Study|Death|0|||
48718389|NCT03700684|156818358|FG000|Overall Study|COVID-19|0|||
48718390|NCT03700684|156818359|FG001|Overall Study|COVID-19|0|||
48718391|NCT03700684|156818360|FG002|Overall Study|COVID-19|2|||
48718392|NCT01713933|156818372|FG000|Overall Study|Lost to Follow-up|2|||
48718393|NCT01713933|156818372|FG000|Overall Study|Withdrawal by Subject|3|||
48718394|NCT01713933|156818372|FG000|Overall Study|Excluded from analysis as a BMI outlier|1|||
48718395|NCT00859638|156818375|FG000|Overall Study|Lost to Follow-up|6|||
48718396|NCT00859638|156818376|FG001|Overall Study|Lost to Follow-up|1|||
48920960|NCT00513409|157544794|FG001|Overall Study|Physician Decision|0|||
48718397|NCT00859638|156818375|FG000|Overall Study|Withdrawal by Subject|3|||
48718398|NCT00859638|156818376|FG001|Overall Study|Withdrawal by Subject|2|||
48718399|NCT00859638|156818375|FG000|Overall Study|Ill health|1|||
48718400|NCT00859638|156818376|FG001|Overall Study|Ill health|1|||
49127550|NCT01324947|158304405|FG000|Overall Study|Withdrawal by Subject|3|||
49127551|NCT01324947|158304405|FG000|Overall Study|1 discontinued before starting drug|1|||
49127552|NCT02100124|158304409|FG000|Overall Study|Lost to Follow-up|5|||
49127553|NCT02100124|158304410|FG001|Overall Study|Lost to Follow-up|11|||
49127554|NCT02100124|158304411|FG002|Overall Study|Lost to Follow-up|3|||
49127555|NCT02100124|158304409|FG000|Overall Study|Withdrawal by Subject|1|||
49127556|NCT02100124|158304410|FG001|Overall Study|Withdrawal by Subject|0|||
49127557|NCT02100124|158304411|FG002|Overall Study|Withdrawal by Subject|0|||
49127558|NCT03321721|158304412|FG000|Overall Study|Lost to Follow-up|4|||
49127559|NCT03321721|158304413|FG001|Overall Study|Lost to Follow-up|8|||
49127560|NCT03321721|158304414|FG002|Overall Study|Lost to Follow-up|11|||
49127561|NCT02481050|158306865|FG000|Overall Study|Adverse Event|1|||
49127562|NCT02481050|158306865|FG000|Overall Study|Disease Progression|47|||
49127563|NCT02481050|158306865|FG000|Overall Study|Withdrawal by Subject|7|||
49127564|NCT02481050|158306865|FG000|Overall Study|Other|3|||
48920961|NCT00513409|157544793|FG000|Overall Study|Visit 3 not done|1|||
49127565|NCT01386606|158306866|FG000|Overall Study|Adverse Event|0|||
49127566|NCT01386606|158306867|FG001|Overall Study|Adverse Event|1|||
49127567|NCT01386606|158306868|FG002|Overall Study|Adverse Event|0|||
49127568|NCT01386606|158306869|FG003|Overall Study|Adverse Event|0|||
49127569|NCT01386606|158306866|FG000|Overall Study|Withdrawal by Subject|0|||
48718401|NCT01009840|156818378|FG000|Overall Study|Lost to Follow-up|1|||
48718402|NCT01009840|156818378|FG000|Overall Study|Adverse Event|4|||
48718403|NCT01009840|156818378|FG000|Overall Study|Subject Met Withdrawal Criteria|7|||
48718404|NCT01009840|156818378|FG000|Overall Study|Subject was Withdrawn by Investigator|1|||
48718405|NCT01009840|156818378|FG000|Overall Study|Subject Withdrew Consent to Participate|1|||
48718406|NCT04022733|156818379|FG000|Overall Study|conversion to open surgery|3|||
48718407|NCT04022733|156818380|FG001|Overall Study|conversion to open surgery|2|||
48718408|NCT04022733|156818379|FG000|Overall Study|bradycardia|0|||
48718409|NCT04022733|156818380|FG001|Overall Study|bradycardia|1|||
48718410|NCT00797966|156818384|FG000|Phase A|Lost to Follow-up|0|||
48718411|NCT00797966|156818385|FG001|Phase A|Lost to Follow-up|0|||
48718412|NCT00797966|156818386|FG002|Phase A|Lost to Follow-up|0|||
48718413|NCT00797966|156818387|FG003|Phase A|Lost to Follow-up|0|||
48718414|NCT00797966|156818388|FG004|Phase A|Lost to Follow-up|33|||
48718415|NCT00797966|156818389|FG005|Phase A|Lost to Follow-up|0|||
48718416|NCT00797966|156818384|FG000|Phase A|Adverse Event|0|||
48718417|NCT00797966|156818385|FG001|Phase A|Adverse Event|0|||
48718418|NCT00797966|156818386|FG002|Phase A|Adverse Event|0|||
48718419|NCT00797966|156818387|FG003|Phase A|Adverse Event|0|||
48718420|NCT00797966|156818388|FG004|Phase A|Adverse Event|46|||
48718421|NCT00797966|156818389|FG005|Phase A|Adverse Event|0|||
48718422|NCT00797966|156818384|FG000|Phase A|Met withdrawal criteria|0|||
48718423|NCT00797966|156818385|FG001|Phase A|Met withdrawal criteria|0|||
48718424|NCT00797966|156818386|FG002|Phase A|Met withdrawal criteria|0|||
48718425|NCT00797966|156818387|FG003|Phase A|Met withdrawal criteria|0|||
48718426|NCT00797966|156818388|FG004|Phase A|Met withdrawal criteria|4|||
48718427|NCT00797966|156818389|FG005|Phase A|Met withdrawal criteria|0|||
48718428|NCT00797966|156818384|FG000|Phase A|Physician Decision|0|||
48718429|NCT00797966|156818385|FG001|Phase A|Physician Decision|0|||
48718430|NCT00797966|156818386|FG002|Phase A|Physician Decision|0|||
48718431|NCT00797966|156818387|FG003|Phase A|Physician Decision|0|||
48718432|NCT00797966|156818388|FG004|Phase A|Physician Decision|13|||
48718433|NCT00797966|156818389|FG005|Phase A|Physician Decision|0|||
48718434|NCT00797966|156818384|FG000|Phase A|Withdrawal by Subject|0|||
48718435|NCT00797966|156818385|FG001|Phase A|Withdrawal by Subject|0|||
48718436|NCT00797966|156818386|FG002|Phase A|Withdrawal by Subject|0|||
48718437|NCT00797966|156818387|FG003|Phase A|Withdrawal by Subject|0|||
48718438|NCT00797966|156818388|FG004|Phase A|Withdrawal by Subject|33|||
48718439|NCT00797966|156818389|FG005|Phase A|Withdrawal by Subject|0|||
48718440|NCT00797966|156818384|FG000|Phase A|Protocol deviation|0|||
48718441|NCT00797966|156818385|FG001|Phase A|Protocol deviation|0|||
48718442|NCT00797966|156818386|FG002|Phase A|Protocol deviation|0|||
48718443|NCT00797966|156818387|FG003|Phase A|Protocol deviation|0|||
48718444|NCT00797966|156818388|FG004|Phase A|Protocol deviation|56|||
48718445|NCT00797966|156818389|FG005|Phase A|Protocol deviation|0|||
48718446|NCT00797966|156818384|FG000|Phase B|Lost to Follow-up|0|||
48718447|NCT00797966|156818385|FG001|Phase B|Lost to Follow-up|1|||
48718448|NCT00797966|156818386|FG002|Phase B|Lost to Follow-up|3|||
48718449|NCT00797966|156818387|FG003|Phase B|Lost to Follow-up|0|||
48718450|NCT00797966|156818388|FG004|Phase B|Lost to Follow-up|0|||
48718451|NCT00797966|156818389|FG005|Phase B|Lost to Follow-up|0|||
48718452|NCT00797966|156818384|FG000|Phase B|Adverse Event|2|||
48718453|NCT00797966|156818385|FG001|Phase B|Adverse Event|1|||
48718454|NCT00797966|156818386|FG002|Phase B|Adverse Event|3|||
48718455|NCT00797966|156818387|FG003|Phase B|Adverse Event|1|||
48718456|NCT00797966|156818388|FG004|Phase B|Adverse Event|0|||
48718457|NCT00797966|156818389|FG005|Phase B|Adverse Event|0|||
48718458|NCT00797966|156818384|FG000|Phase B|Met Withdrawal Criteria|3|||
48718459|NCT00797966|156818385|FG001|Phase B|Met Withdrawal Criteria|3|||
48718460|NCT00797966|156818386|FG002|Phase B|Met Withdrawal Criteria|6|||
48718461|NCT00797966|156818387|FG003|Phase B|Met Withdrawal Criteria|1|||
48718462|NCT00797966|156818388|FG004|Phase B|Met Withdrawal Criteria|0|||
48718463|NCT00797966|156818389|FG005|Phase B|Met Withdrawal Criteria|0|||
49127570|NCT01386606|158306867|FG001|Overall Study|Withdrawal by Subject|1|||
49127571|NCT01386606|158306868|FG002|Overall Study|Withdrawal by Subject|1|||
49127572|NCT01386606|158306869|FG003|Overall Study|Withdrawal by Subject|0|||
49127573|NCT01386606|158306866|FG000|Overall Study|Protocol Violation|1|||
49127574|NCT01386606|158306867|FG001|Overall Study|Protocol Violation|0|||
49127575|NCT01386606|158306868|FG002|Overall Study|Protocol Violation|1|||
49127576|NCT01386606|158306869|FG003|Overall Study|Protocol Violation|1|||
49127577|NCT01386606|158306866|FG000|Overall Study|Lost to Follow-up|2|||
49127578|NCT01386606|158306867|FG001|Overall Study|Lost to Follow-up|0|||
48920962|NCT00513409|157544794|FG001|Overall Study|Visit 3 not done|2|||
48718464|NCT00797966|156818384|FG000|Phase B|Physician Decision|1|||
48718465|NCT00797966|156818385|FG001|Phase B|Physician Decision|0|||
48718466|NCT00797966|156818386|FG002|Phase B|Physician Decision|3|||
48718467|NCT00797966|156818387|FG003|Phase B|Physician Decision|1|||
48718468|NCT00797966|156818388|FG004|Phase B|Physician Decision|0|||
48718469|NCT00797966|156818389|FG005|Phase B|Physician Decision|0|||
48718470|NCT00797966|156818384|FG000|Phase B|Withdrawal by Subject|1|||
48718471|NCT00797966|156818385|FG001|Phase B|Withdrawal by Subject|4|||
48718472|NCT00797966|156818386|FG002|Phase B|Withdrawal by Subject|3|||
48718473|NCT00797966|156818387|FG003|Phase B|Withdrawal by Subject|3|||
48718474|NCT00797966|156818388|FG004|Phase B|Withdrawal by Subject|0|||
48718475|NCT00797966|156818389|FG005|Phase B|Withdrawal by Subject|0|||
48920963|NCT04036708|157544795|FG000|Overall Study|Lost to Follow-up|14|||
49127579|NCT01386606|158306868|FG002|Overall Study|Lost to Follow-up|0|||
48718476|NCT00797966|156818384|FG000|Phase B|Protocol Deviation|4|||
48718477|NCT00797966|156818385|FG001|Phase B|Protocol Deviation|8|||
49127580|NCT01386606|158306869|FG003|Overall Study|Lost to Follow-up|0|||
49127581|NCT01386606|158306866|FG000|Overall Study|Subject incarcerated|0|||
49127582|NCT01386606|158306867|FG001|Overall Study|Subject incarcerated|1|||
49127583|NCT01386606|158306868|FG002|Overall Study|Subject incarcerated|0|||
49127584|NCT01386606|158306869|FG003|Overall Study|Subject incarcerated|0|||
49127585|NCT01386606|158306866|FG000|Overall Study|Unable to draw PK|1|||
49127586|NCT01386606|158306867|FG001|Overall Study|Unable to draw PK|0|||
49127587|NCT01386606|158306868|FG002|Overall Study|Unable to draw PK|0|||
49127588|NCT01386606|158306869|FG003|Overall Study|Unable to draw PK|0|||
49127589|NCT01386606|158306866|FG000|Overall Study|T levels too high|0|||
49127590|NCT01386606|158306867|FG001|Overall Study|T levels too high|1|||
49127591|NCT01386606|158306868|FG002|Overall Study|T levels too high|1|||
49127592|NCT01386606|158306869|FG003|Overall Study|T levels too high|0|||
49127593|NCT03101150|158306870|FG000|Overall Study|Lost to Follow-up|2|||
48718478|NCT00797966|156818386|FG002|Phase B|Protocol Deviation|2|||
48718479|NCT00797966|156818387|FG003|Phase B|Protocol Deviation|6|||
48718480|NCT00797966|156818388|FG004|Phase B|Protocol Deviation|0|||
48718481|NCT00797966|156818389|FG005|Phase B|Protocol Deviation|0|||
48718482|NCT00797966|156818384|FG000|Phase B|Lack of Efficacy|0|||
48718483|NCT00797966|156818385|FG001|Phase B|Lack of Efficacy|1|||
48718484|NCT00797966|156818386|FG002|Phase B|Lack of Efficacy|1|||
48718485|NCT00797966|156818387|FG003|Phase B|Lack of Efficacy|4|||
48718486|NCT00797966|156818388|FG004|Phase B|Lack of Efficacy|0|||
48718487|NCT00797966|156818389|FG005|Phase B|Lack of Efficacy|0|||
48718488|NCT00797966|156818384|FG000|Phase A+|Lost to Follow-up|0|||
48718489|NCT00797966|156818385|FG001|Phase A+|Lost to Follow-up|0|||
48718490|NCT00797966|156818386|FG002|Phase A+|Lost to Follow-up|0|||
48718491|NCT00797966|156818387|FG003|Phase A+|Lost to Follow-up|0|||
48718492|NCT00797966|156818388|FG004|Phase A+|Lost to Follow-up|0|||
48718493|NCT00797966|156818389|FG005|Phase A+|Lost to Follow-up|9|||
48718494|NCT00797966|156818384|FG000|Phase A+|Met withdrawal criteria|0|||
48718495|NCT00797966|156818385|FG001|Phase A+|Met withdrawal criteria|0|||
48718496|NCT00797966|156818386|FG002|Phase A+|Met withdrawal criteria|0|||
48718497|NCT00797966|156818387|FG003|Phase A+|Met withdrawal criteria|0|||
48718498|NCT00797966|156818388|FG004|Phase A+|Met withdrawal criteria|0|||
48718499|NCT00797966|156818389|FG005|Phase A+|Met withdrawal criteria|5|||
48718500|NCT00797966|156818384|FG000|Phase A+|Withdrawal by Subject|0|||
48718501|NCT00797966|156818385|FG001|Phase A+|Withdrawal by Subject|0|||
48718502|NCT00797966|156818386|FG002|Phase A+|Withdrawal by Subject|0|||
48718503|NCT00797966|156818387|FG003|Phase A+|Withdrawal by Subject|0|||
48718504|NCT00797966|156818388|FG004|Phase A+|Withdrawal by Subject|0|||
48718505|NCT00797966|156818389|FG005|Phase A+|Withdrawal by Subject|6|||
48718506|NCT00797966|156818384|FG000|Phase A+|Adverse Event|0|||
48718507|NCT00797966|156818385|FG001|Phase A+|Adverse Event|0|||
48718508|NCT00797966|156818386|FG002|Phase A+|Adverse Event|0|||
48718509|NCT00797966|156818387|FG003|Phase A+|Adverse Event|0|||
48718510|NCT00797966|156818388|FG004|Phase A+|Adverse Event|0|||
48718511|NCT00797966|156818389|FG005|Phase A+|Adverse Event|4|||
48718512|NCT00797966|156818384|FG000|Phase A+|Protocol deviation|0|||
48718513|NCT00797966|156818385|FG001|Phase A+|Protocol deviation|0|||
48718514|NCT00797966|156818386|FG002|Phase A+|Protocol deviation|0|||
48718515|NCT00797966|156818387|FG003|Phase A+|Protocol deviation|0|||
48718516|NCT00797966|156818388|FG004|Phase A+|Protocol deviation|0|||
48718517|NCT00797966|156818389|FG005|Phase A+|Protocol deviation|4|||
48718518|NCT04644315|156818390|FG000|Overall Study|Subject withdrawal of consent|1|||
48718519|NCT03874429|156818391|FG000|Overall Study|Adverse Event|2|||
48718520|NCT03874429|156818392|FG001|Overall Study|Adverse Event|2|||
48718521|NCT03874429|156818391|FG000|Overall Study|Lack of Efficacy|0|||
48718522|NCT03874429|156818392|FG001|Overall Study|Lack of Efficacy|1|||
48718523|NCT03874429|156818391|FG000|Overall Study|Covid-19 pandemic|4|||
48718524|NCT03874429|156818392|FG001|Overall Study|Covid-19 pandemic|2|||
48718525|NCT00331552|156818393|FG000|Period 3: Phase II|Neurological Symptoms|1|||
49127594|NCT03101150|158306871|FG001|Overall Study|Lost to Follow-up|4|||
48718526|NCT00331552|156818394|FG001|Period 3: Phase II|Neurological Symptoms|0|||
48718527|NCT00331552|156818393|FG000|Period 3: Phase II|Severe Nausea|1|||
48718528|NCT00331552|156818394|FG001|Period 3: Phase II|Severe Nausea|0|||
48718529|NCT02937584|156818395|FG000|Period 1|Adverse Event|1|||
48718530|NCT02937584|156818396|FG001|Period 1|Adverse Event|2|||
48718531|NCT02937584|156818395|FG000|Washout|Adverse Event|0|||
48718532|NCT02937584|156818396|FG001|Washout|Adverse Event|1|||
48718533|NCT04224688|156818400|FG000|Overall Study|Withdrawal by Subject|1|||
48718534|NCT04224688|156818401|FG001|Overall Study|Withdrawal by Subject|3|||
48718535|NCT04224688|156818400|FG000|Overall Study|Lack of Efficacy|1|||
48718536|NCT04224688|156818401|FG001|Overall Study|Lack of Efficacy|1|||
48718537|NCT04224688|156818400|FG000|Overall Study|Adverse event, not fatal|0|||
48718538|NCT04224688|156818401|FG001|Overall Study|Adverse event, not fatal|2|||
48718539|NCT04224688|156818400|FG000|Overall Study|COVID-19|0|||
48718540|NCT04224688|156818401|FG001|Overall Study|COVID-19|1|||
48718541|NCT00329901|156818404|FG000|Overall Study|Withdrawal by Subject|4|||
48718542|NCT00329901|156818405|FG001|Overall Study|Withdrawal by Subject|3|||
48718543|NCT00329901|156818406|FG002|Overall Study|Withdrawal by Subject|2|||
48718544|NCT00329901|156818404|FG000|Overall Study|Lost to Follow-up|2|||
48718545|NCT00329901|156818405|FG001|Overall Study|Lost to Follow-up|0|||
48718546|NCT00329901|156818406|FG002|Overall Study|Lost to Follow-up|1|||
48718547|NCT00329901|156818404|FG000|Overall Study|Protocol Violation|1|||
48718548|NCT00329901|156818405|FG001|Overall Study|Protocol Violation|0|||
48718549|NCT00329901|156818406|FG002|Overall Study|Protocol Violation|1|||
48718550|NCT00329901|156818404|FG000|Overall Study|Unable to classify|2|||
48718551|NCT00329901|156818405|FG001|Overall Study|Unable to classify|2|||
48718552|NCT00329901|156818406|FG002|Overall Study|Unable to classify|0|||
48718553|NCT01215916|156818407|FG000|Overall Study|Progressive Disease|0|||
48718554|NCT01215916|156818408|FG001|Overall Study|Progressive Disease|2|||
48718555|NCT01215916|156818409|FG002|Overall Study|Progressive Disease|1|||
48718556|NCT01215916|156818410|FG003|Overall Study|Progressive Disease|2|||
48718557|NCT01215916|156818411|FG004|Overall Study|Progressive Disease|5|||
48718558|NCT01215916|156818412|FG005|Overall Study|Progressive Disease|4|||
48718559|NCT01215916|156818413|FG006|Overall Study|Progressive Disease|5|||
48718560|NCT01215916|156818414|FG007|Overall Study|Progressive Disease|3|||
48718561|NCT01215916|156818415|FG008|Overall Study|Progressive Disease|1|||
48718562|NCT01215916|156818407|FG000|Overall Study|Adverse Event|1|||
48718563|NCT01215916|156818408|FG001|Overall Study|Adverse Event|1|||
48815012|NCT01544582|157163648|FG000|Analysis Population|Poor Adherence|0|||
48815013|NCT01544582|157163649|FG001|Analysis Population|Poor Adherence|0|||
48815014|NCT01544582|157163650|FG002|Analysis Population|Poor Adherence|1|||
48815015|NCT01544582|157163651|FG003|Analysis Population|Poor Adherence|0|||
48815016|NCT01544582|157163648|FG000|Analysis Population|Poor Participant Compliance|0|||
48815017|NCT01544582|157163649|FG001|Analysis Population|Poor Participant Compliance|1|||
48815018|NCT01544582|157163650|FG002|Analysis Population|Poor Participant Compliance|0|||
48815019|NCT01544582|157163651|FG003|Analysis Population|Poor Participant Compliance|0|||
48815020|NCT01544582|157163648|FG000|Analysis Population|Programmed Surgery|0|||
48815021|NCT01544582|157163649|FG001|Analysis Population|Programmed Surgery|1|||
48815022|NCT01544582|157163650|FG002|Analysis Population|Programmed Surgery|0|||
48815023|NCT01544582|157163651|FG003|Analysis Population|Programmed Surgery|0|||
48815024|NCT01544582|157163648|FG000|Analysis Population|Participant in Jail|0|||
49127595|NCT03101150|158306870|FG000|Overall Study|Miscarriage|3|||
49127596|NCT03101150|158306871|FG001|Overall Study|Miscarriage|6|||
48718564|NCT01215916|156818409|FG002|Overall Study|Adverse Event|0|||
48718565|NCT01215916|156818410|FG003|Overall Study|Adverse Event|1|||
48718566|NCT01215916|156818411|FG004|Overall Study|Adverse Event|0|||
48718567|NCT01215916|156818412|FG005|Overall Study|Adverse Event|0|||
48718568|NCT01215916|156818413|FG006|Overall Study|Adverse Event|3|||
48718569|NCT01215916|156818414|FG007|Overall Study|Adverse Event|0|||
48718570|NCT01215916|156818415|FG008|Overall Study|Adverse Event|0|||
48718571|NCT01215916|156818407|FG000|Overall Study|Withdrawal by Subject|0|||
48718572|NCT01215916|156818408|FG001|Overall Study|Withdrawal by Subject|1|||
48718573|NCT01215916|156818409|FG002|Overall Study|Withdrawal by Subject|1|||
48718574|NCT01215916|156818410|FG003|Overall Study|Withdrawal by Subject|2|||
48718575|NCT01215916|156818411|FG004|Overall Study|Withdrawal by Subject|0|||
48718576|NCT01215916|156818412|FG005|Overall Study|Withdrawal by Subject|0|||
48718577|NCT01215916|156818413|FG006|Overall Study|Withdrawal by Subject|1|||
48718578|NCT01215916|156818414|FG007|Overall Study|Withdrawal by Subject|0|||
48718579|NCT01215916|156818415|FG008|Overall Study|Withdrawal by Subject|0|||
48718580|NCT01215916|156818407|FG000|Overall Study|Death|0|||
48718581|NCT01215916|156818408|FG001|Overall Study|Death|1|||
49127597|NCT01022203|158306873|FG000|Post Treatment Assessment|Withdrawal by Subject|12|||
49127598|NCT01022203|158306874|FG001|Post Treatment Assessment|Withdrawal by Subject|12|||
49127599|NCT01022203|158306873|FG000|Post Treatment Assessment|Physician Decision|2|||
49127600|NCT01022203|158306874|FG001|Post Treatment Assessment|Physician Decision|0|||
49127601|NCT01022203|158306873|FG000|Post Treatment Assessment|Adverse Event|0|||
49127602|NCT01022203|158306874|FG001|Post Treatment Assessment|Adverse Event|2|||
49127603|NCT01022203|158306873|FG000|Follow-Up Assessment|Lost to Follow-up|2|||
48718582|NCT01215916|156818409|FG002|Overall Study|Death|0|||
48718583|NCT01215916|156818410|FG003|Overall Study|Death|0|||
48718584|NCT01215916|156818411|FG004|Overall Study|Death|1|||
48718585|NCT01215916|156818412|FG005|Overall Study|Death|0|||
48718586|NCT01215916|156818413|FG006|Overall Study|Death|0|||
48718587|NCT01215916|156818414|FG007|Overall Study|Death|0|||
48815025|NCT01544582|157163649|FG001|Analysis Population|Participant in Jail|0|||
48718588|NCT01215916|156818415|FG008|Overall Study|Death|1|||
48718589|NCT01215916|156818407|FG000|Overall Study|Physician Decision|0|||
48718590|NCT01215916|156818408|FG001|Overall Study|Physician Decision|0|||
48718591|NCT01215916|156818409|FG002|Overall Study|Physician Decision|1|||
48718592|NCT01215916|156818410|FG003|Overall Study|Physician Decision|1|||
48718593|NCT01215916|156818411|FG004|Overall Study|Physician Decision|0|||
48718594|NCT01215916|156818412|FG005|Overall Study|Physician Decision|0|||
49127604|NCT01022203|158306874|FG001|Follow-Up Assessment|Lost to Follow-up|2|||
48718595|NCT01215916|156818413|FG006|Overall Study|Physician Decision|0|||
48718596|NCT01215916|156818414|FG007|Overall Study|Physician Decision|0|||
48718597|NCT01215916|156818415|FG008|Overall Study|Physician Decision|0|||
48718598|NCT00934648|156818418|FG000|Overall Study|Failure to return|8|||
48718599|NCT00934648|156818418|FG000|Overall Study|Withdrawal by Subject|1|||
48718600|NCT01253811|156818419|FG000|Overall Study|Withdrawal criteria|1|||
48718601|NCT02788279|156818420|FG000|Overall Study|Death|62|||
48718602|NCT02788279|156818421|FG001|Overall Study|Death|136|||
48718603|NCT02788279|156818422|FG002|Overall Study|Death|72|||
48718604|NCT02788279|156818420|FG000|Overall Study|Withdrawal by Subject|10|||
48718605|NCT02788279|156818421|FG001|Overall Study|Withdrawal by Subject|15|||
48718606|NCT02788279|156818422|FG002|Overall Study|Withdrawal by Subject|5|||
48718607|NCT02788279|156818420|FG000|Overall Study|Lost to Follow-up|0|||
48718608|NCT02788279|156818421|FG001|Overall Study|Lost to Follow-up|3|||
48718609|NCT02788279|156818422|FG002|Overall Study|Lost to Follow-up|2|||
48718610|NCT02788279|156818420|FG000|Overall Study|Sponsor decision|18|||
48718611|NCT02788279|156818421|FG001|Overall Study|Sponsor decision|29|||
48718612|NCT02788279|156818422|FG002|Overall Study|Sponsor decision|11|||
48718613|NCT05028361|156818423|FG000|Overall Study|Withdrawal by Subject|1|||
48718614|NCT05028361|156818424|FG001|Overall Study|Withdrawal by Subject|0|||
48718615|NCT00779259|156818427|FG000|Quinine Alone|Adverse Event|2|||
48718616|NCT00711516|156818431|FG000|Overall Study|Adverse Event|1|||
48718617|NCT00711516|156818432|FG001|Overall Study|Adverse Event|1|||
48718618|NCT00711516|156818431|FG000|Overall Study|Withdrawal by Subject|0|||
48718619|NCT00711516|156818432|FG001|Overall Study|Withdrawal by Subject|1|||
48718620|NCT00711516|156818431|FG000|Overall Study|Protocol Violation|0|||
48718621|NCT00711516|156818432|FG001|Overall Study|Protocol Violation|1|||
48718622|NCT01565343|156818433|FG000|Overall Study|Administrative decision/technical issues|1|||
48718623|NCT01565343|156818434|FG001|Overall Study|Administrative decision/technical issues|0|||
48718624|NCT01565343|156818435|FG002|Overall Study|Administrative decision/technical issues|0|||
48718625|NCT03339297|156818436|FG000|Overall Study|Relapse of Hematologic Disease|1|||
48718626|NCT03339297|156818437|FG001|Overall Study|Relapse of Hematologic Disease|0|||
48718627|NCT03339297|156818436|FG000|Overall Study|Death|10|||
48718628|NCT03339297|156818437|FG001|Overall Study|Death|7|||
48718629|NCT03339297|156818436|FG000|Overall Study|Hepatic Candidosis|1|||
48718630|NCT03339297|156818437|FG001|Overall Study|Hepatic Candidosis|0|||
48718631|NCT03339297|156818436|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
48718632|NCT03339297|156818437|FG001|Overall Study|Adverse Event, Serious Fatal|2|||
48718633|NCT03339297|156818436|FG000|Overall Study|Consent Withdrawn by Participant|3|||
48718634|NCT03339297|156818437|FG001|Overall Study|Consent Withdrawn by Participant|3|||
48718635|NCT03339297|156818436|FG000|Overall Study|Disease Relapse|2|||
48718636|NCT03339297|156818437|FG001|Overall Study|Disease Relapse|0|||
48718637|NCT03339297|156818436|FG000|Overall Study|Physician Decision|1|||
48718638|NCT03339297|156818437|FG001|Overall Study|Physician Decision|1|||
48718639|NCT03339297|156818436|FG000|Overall Study|Relapse of Disease New Transplant Performed|1|||
48718640|NCT03339297|156818437|FG001|Overall Study|Relapse of Disease New Transplant Performed|0|||
48718641|NCT03339297|156818436|FG000|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1|||
48718642|NCT03339297|156818437|FG001|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0|||
48718643|NCT03339297|156818436|FG000|Overall Study|Early Termination, Did Not Proceed to Transplant|1|||
48718644|NCT03339297|156818437|FG001|Overall Study|Early Termination, Did Not Proceed to Transplant|0|||
48718645|NCT03339297|156818436|FG000|Overall Study|Adverse Event, Non-fatal|1|||
48718646|NCT03339297|156818437|FG001|Overall Study|Adverse Event, Non-fatal|0|||
48718647|NCT03339297|156818436|FG000|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0|||
48718648|NCT03339297|156818437|FG001|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1|||
48718649|NCT03339297|156818436|FG000|Overall Study|Patient Was Not Eligible|1|||
48718650|NCT03339297|156818437|FG001|Overall Study|Patient Was Not Eligible|0|||
48718651|NCT02586506|156818438|FG000|Overall Study|Protocol Violation|6|||
48718652|NCT02586506|156818438|FG000|Overall Study|Lost to Follow-up|1|||
48718653|NCT02586506|156818438|FG000|Overall Study|Other Reason|2|||
48718654|NCT01566214|156818439|FG000|Overall Study|Lost to Follow-up|3|||
48718655|NCT01566214|156818440|FG001|Overall Study|Lost to Follow-up|0|||
48718656|NCT02536404|156818446|FG000|Overall Study|Adverse Event|5|||
48718657|NCT02536404|156818447|FG001|Overall Study|Adverse Event|0|||
48718658|NCT02536404|156818446|FG000|Overall Study|Withdrawal by Subject|4|||
48718659|NCT02536404|156818447|FG001|Overall Study|Withdrawal by Subject|1|||
48718660|NCT02536404|156818446|FG000|Overall Study|Physician Decision|10|||
48718661|NCT02536404|156818447|FG001|Overall Study|Physician Decision|0|||
48718662|NCT02536404|156818446|FG000|Overall Study|Sponsor decision|1|||
48718663|NCT02536404|156818447|FG001|Overall Study|Sponsor decision|0|||
48718664|NCT01431638|156818450|FG000|Overall Study|Adverse Event|1|||
48718665|NCT01431638|156818451|FG001|Overall Study|Adverse Event|3|||
48718666|NCT01431638|156818452|FG002|Overall Study|Adverse Event|1|||
48718667|NCT01431638|156818450|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
48718668|NCT01431638|156818451|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
48718669|NCT01431638|156818452|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
48718670|NCT01431638|156818450|FG000|Overall Study|Participants condition no longer requires study drug|0|||
48718671|NCT01431638|156818451|FG001|Overall Study|Participants condition no longer requires study drug|1|||
48718672|NCT01431638|156818452|FG002|Overall Study|Participants condition no longer requires study drug|0|||
48718673|NCT01431638|156818450|FG000|Overall Study|Participant withdrew consent|14|||
48815026|NCT01544582|157163650|FG002|Analysis Population|Participant in Jail|1|||
48815027|NCT01544582|157163651|FG003|Analysis Population|Participant in Jail|0|||
48815028|NCT01644474|157163655|FG000|Overall Study|Poor compliance to protocol|1|||
48815029|NCT01644474|157163656|FG001|Overall Study|Poor compliance to protocol|0|||
48815030|NCT01644474|157163655|FG000|Overall Study|Consent withdrawn by participant|0|||
48815031|NCT01644474|157163656|FG001|Overall Study|Consent withdrawn by participant|1|||
48815032|NCT01644474|157163655|FG000|Overall Study|Participant moved|0|||
48815033|NCT01644474|157163656|FG001|Overall Study|Participant moved|1|||
48815034|NCT01644474|157163655|FG000|Overall Study|Adverse Event|4|||
48815035|NCT01644474|157163656|FG001|Overall Study|Adverse Event|5|||
48815036|NCT01644474|157163655|FG000|Overall Study|Site scheduling error|1|||
48815037|NCT01644474|157163656|FG001|Overall Study|Site scheduling error|1|||
48815038|NCT01644474|157163655|FG000|Overall Study|Protocol Violation|1|||
48815039|NCT01644474|157163656|FG001|Overall Study|Protocol Violation|0|||
48815040|NCT03317379|157163660|FG000|Overall Study|Lost to Follow-up|0|||
48718674|NCT01431638|156818451|FG001|Overall Study|Participant withdrew consent|5|||
48718675|NCT01431638|156818452|FG002|Overall Study|Participant withdrew consent|8|||
48718676|NCT01431638|156818450|FG000|Overall Study|Lost to Follow-up|7|||
48718677|NCT01431638|156818451|FG001|Overall Study|Lost to Follow-up|9|||
48718678|NCT01431638|156818452|FG002|Overall Study|Lost to Follow-up|7|||
48718679|NCT01431638|156818450|FG000|Overall Study|Administrative problems|1|||
48718680|NCT01431638|156818451|FG001|Overall Study|Administrative problems|4|||
48718681|NCT01431638|156818452|FG002|Overall Study|Administrative problems|6|||
48718682|NCT01431638|156818450|FG000|Overall Study|Death|1|||
48718683|NCT01431638|156818451|FG001|Overall Study|Death|0|||
48718684|NCT01431638|156818452|FG002|Overall Study|Death|0|||
48718685|NCT01431638|156818450|FG000|Overall Study|Protocol deviation|1|||
48718686|NCT01431638|156818451|FG001|Overall Study|Protocol deviation|1|||
48718687|NCT01431638|156818452|FG002|Overall Study|Protocol deviation|4|||
48718688|NCT01431638|156818450|FG000|Overall Study|Participants Did not enter extension study from core study|39|||
48718689|NCT01431638|156818451|FG001|Overall Study|Participants Did not enter extension study from core study|46|||
48718690|NCT01431638|156818452|FG002|Overall Study|Participants Did not enter extension study from core study|32|||
48718691|NCT00899353|156818453|FG000|Overall Study|Adverse Event|2|||
48718692|NCT00899353|156818453|FG000|Overall Study|Lost to Follow-up|1|||
48718693|NCT00899353|156818453|FG000|Overall Study|Withdrawal by Subject|2|||
48718694|NCT02395302|156818459|FG000|Overall Study|Screen Failure|3|||
48718695|NCT02395302|156818459|FG000|Overall Study|Run In Failure|7|||
48718696|NCT02395302|156818459|FG000|Overall Study|Withdrawal by Subject|2|||
48718697|NCT02395302|156818459|FG000|Overall Study|Physician Decision|2|||
48718698|NCT04268823|156818460|FG000|Overall Study|Adverse Event|1|||
48815041|NCT03317379|157163661|FG001|Overall Study|Lost to Follow-up|3|||
49127605|NCT03163446|158306875|FG000|Overall Study|Unable to return for Day 180 visit|2|||
49127606|NCT03163446|158306876|FG001|Overall Study|Unable to return for Day 180 visit|0|||
48815042|NCT03317379|157163662|FG002|Overall Study|Lost to Follow-up|2|||
48815043|NCT05886777|157163665|FG000|Overall Study|Lost to Follow-up|1|||
48815044|NCT05886777|157163666|FG001|Overall Study|Lost to Follow-up|0|||
48815045|NCT05886777|157163667|FG002|Overall Study|Lost to Follow-up|2|||
48815046|NCT05886777|157163668|FG003|Overall Study|Lost to Follow-up|1|||
48815047|NCT05886777|157163669|FG004|Overall Study|Lost to Follow-up|0|||
48815048|NCT05886777|157163670|FG005|Overall Study|Lost to Follow-up|2|||
48815049|NCT05886777|157163671|FG006|Overall Study|Lost to Follow-up|0|||
48815050|NCT05886777|157163665|FG000|Overall Study|Other|0|||
48815051|NCT05886777|157163666|FG001|Overall Study|Other|2|||
48815052|NCT05886777|157163667|FG002|Overall Study|Other|1|||
48815053|NCT05886777|157163668|FG003|Overall Study|Other|0|||
48815054|NCT05886777|157163669|FG004|Overall Study|Other|0|||
49127607|NCT03163446|158306875|FG000|Overall Study|Withdrawal by Subject|2|||
49127608|NCT03163446|158306876|FG001|Overall Study|Withdrawal by Subject|6|||
49127609|NCT03163446|158306875|FG000|Overall Study|Death|16|||
49127610|NCT03163446|158306876|FG001|Overall Study|Death|5|||
49127611|NCT03163446|158306875|FG000|Overall Study|Lost to Follow-up|6|||
49127612|NCT03163446|158306876|FG001|Overall Study|Lost to Follow-up|5|||
49127613|NCT03163446|158306875|FG000|Overall Study|Physician Decision|1|||
49127614|NCT03163446|158306876|FG001|Overall Study|Physician Decision|1|||
49127615|NCT03163446|158306875|FG000|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1|||
49127616|NCT03163446|158306876|FG001|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0|||
49127617|NCT00611806|158306877|FG000|Overall Study|Withdrawal by Subject|8|||
49127618|NCT00611806|158306878|FG001|Overall Study|Withdrawal by Subject|2|||
49127619|NCT00611806|158306877|FG000|Overall Study|Adverse Event|2|||
48718699|NCT04268823|156818461|FG001|Overall Study|Adverse Event|0|||
48718700|NCT04268823|156818460|FG000|Overall Study|Participant Decision|1|||
48718701|NCT04268823|156818461|FG001|Overall Study|Participant Decision|0|||
48815055|NCT05886777|157163670|FG005|Overall Study|Other|0|||
48815056|NCT05886777|157163671|FG006|Overall Study|Other|0|||
48718702|NCT04604132|156818462|FG000|Overall Study|Adverse Event|2|||
48718703|NCT04604132|156818463|FG001|Overall Study|Adverse Event|0|||
48815057|NCT05886777|157163665|FG000|Overall Study|Withdrawal by Subject|1|||
48815058|NCT05886777|157163666|FG001|Overall Study|Withdrawal by Subject|0|||
48815059|NCT05886777|157163667|FG002|Overall Study|Withdrawal by Subject|1|||
48815060|NCT05886777|157163668|FG003|Overall Study|Withdrawal by Subject|4|||
48815061|NCT05886777|157163669|FG004|Overall Study|Withdrawal by Subject|3|||
48815062|NCT05886777|157163670|FG005|Overall Study|Withdrawal by Subject|1|||
48815063|NCT05886777|157163671|FG006|Overall Study|Withdrawal by Subject|1|||
48815064|NCT05886777|157163665|FG000|Overall Study|Protocol Violation|0|||
48815065|NCT05886777|157163666|FG001|Overall Study|Protocol Violation|0|||
48815066|NCT05886777|157163667|FG002|Overall Study|Protocol Violation|1|||
48815067|NCT05886777|157163668|FG003|Overall Study|Protocol Violation|0|||
48815068|NCT05886777|157163669|FG004|Overall Study|Protocol Violation|0|||
48718704|NCT04604132|156818464|FG002|Overall Study|Adverse Event|0|||
48718705|NCT04604132|156818465|FG003|Overall Study|Adverse Event|1|||
49127620|NCT00611806|158306878|FG001|Overall Study|Adverse Event|1|||
49127621|NCT00611806|158306877|FG000|Overall Study|Lost to Follow-up|6|||
49127622|NCT00611806|158306878|FG001|Overall Study|Lost to Follow-up|0|||
49127623|NCT02611882|158306881|FG000|Overall Study|Did not complete prostatectomy per protocol stipulation|33|||
49127624|NCT02611882|158306882|FG001|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
49127625|NCT02611882|158306883|FG002|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
49127626|NCT01317940|158306884|FG000|Overall Study|Death|1|||
49127627|NCT01317940|158306885|FG001|Overall Study|Death|0|||
49127628|NCT01317940|158306886|FG002|Overall Study|Death|1|||
49127629|NCT01317940|158306887|FG003|Overall Study|Death|0|||
49127630|NCT01317940|158306888|FG004|Overall Study|Death|0|||
49127631|NCT01317940|158306889|FG005|Overall Study|Death|0|||
49127632|NCT01317940|158306884|FG000|Overall Study|Lost to Follow-up|0|||
49127633|NCT01317940|158306885|FG001|Overall Study|Lost to Follow-up|0|||
49127634|NCT01317940|158306886|FG002|Overall Study|Lost to Follow-up|1|||
49127635|NCT01317940|158306887|FG003|Overall Study|Lost to Follow-up|1|||
49127636|NCT01317940|158306888|FG004|Overall Study|Lost to Follow-up|1|||
49127637|NCT01317940|158306889|FG005|Overall Study|Lost to Follow-up|0|||
49127638|NCT01317940|158306884|FG000|Overall Study|Change in therapy plan|0|||
49127639|NCT01317940|158306885|FG001|Overall Study|Change in therapy plan|0|||
49127640|NCT01317940|158306886|FG002|Overall Study|Change in therapy plan|3|||
49127641|NCT01317940|158306887|FG003|Overall Study|Change in therapy plan|0|||
49127642|NCT01317940|158306888|FG004|Overall Study|Change in therapy plan|0|||
49127643|NCT01317940|158306889|FG005|Overall Study|Change in therapy plan|0|||
49127644|NCT02990000|158306890|FG000|Overall Study|Failed to provide data beyond baseline|36|||
49127645|NCT02990000|158306891|FG001|Overall Study|Failed to provide data beyond baseline|34|||
49127646|NCT00922636|158306893|FG000|Overall Study|Adverse Event|3|||
49127647|NCT00922636|158306894|FG001|Overall Study|Adverse Event|3|||
49127648|NCT00922636|158306895|FG002|Overall Study|Adverse Event|2|||
49127649|NCT00922636|158306896|FG003|Overall Study|Adverse Event|3|||
49127650|NCT00922636|158306897|FG004|Overall Study|Adverse Event|2|||
49127651|NCT00922636|158306893|FG000|Overall Study|Lack of Efficacy|1|||
49127652|NCT00922636|158306894|FG001|Overall Study|Lack of Efficacy|7|||
48718706|NCT04604132|156818466|FG004|Overall Study|Adverse Event|2|||
48718707|NCT04604132|156818462|FG000|Overall Study|Study terminated by sponsor|0|||
48718708|NCT04604132|156818463|FG001|Overall Study|Study terminated by sponsor|0|||
48718709|NCT04604132|156818464|FG002|Overall Study|Study terminated by sponsor|0|||
49127653|NCT00922636|158306895|FG002|Overall Study|Lack of Efficacy|3|||
49127654|NCT00922636|158306896|FG003|Overall Study|Lack of Efficacy|2|||
49127655|NCT00922636|158306897|FG004|Overall Study|Lack of Efficacy|4|||
48718710|NCT04604132|156818465|FG003|Overall Study|Study terminated by sponsor|0|||
48815069|NCT05886777|157163670|FG005|Overall Study|Protocol Violation|0|||
49127656|NCT00922636|158306893|FG000|Overall Study|Sponsor Decision|0|||
49127657|NCT00922636|158306894|FG001|Overall Study|Sponsor Decision|0|||
49127658|NCT00922636|158306895|FG002|Overall Study|Sponsor Decision|2|||
49127659|NCT00922636|158306896|FG003|Overall Study|Sponsor Decision|0|||
49127660|NCT00922636|158306897|FG004|Overall Study|Sponsor Decision|0|||
49127661|NCT00922636|158306893|FG000|Overall Study|Withdrawal by Subject|0|||
48815070|NCT05886777|157163671|FG006|Overall Study|Protocol Violation|0|||
49127662|NCT00922636|158306894|FG001|Overall Study|Withdrawal by Subject|0|||
49127663|NCT00922636|158306895|FG002|Overall Study|Withdrawal by Subject|5|||
49127664|NCT00922636|158306896|FG003|Overall Study|Withdrawal by Subject|2|||
49127665|NCT00922636|158306897|FG004|Overall Study|Withdrawal by Subject|4|||
49127666|NCT00922636|158306893|FG000|Overall Study|Protocol Violation|0|||
49127667|NCT00922636|158306894|FG001|Overall Study|Protocol Violation|0|||
49127668|NCT00922636|158306895|FG002|Overall Study|Protocol Violation|2|||
49127669|NCT00922636|158306896|FG003|Overall Study|Protocol Violation|2|||
49127670|NCT00922636|158306897|FG004|Overall Study|Protocol Violation|0|||
49127671|NCT00922636|158306893|FG000|Overall Study|Entry Criteria Not Met|0|||
49127672|NCT00922636|158306894|FG001|Overall Study|Entry Criteria Not Met|0|||
49127673|NCT00922636|158306895|FG002|Overall Study|Entry Criteria Not Met|1|||
49127674|NCT00922636|158306896|FG003|Overall Study|Entry Criteria Not Met|1|||
49127675|NCT00922636|158306897|FG004|Overall Study|Entry Criteria Not Met|0|||
49127676|NCT00922636|158306893|FG000|Overall Study|Parent/Caregiver Decision|2|||
49127677|NCT00922636|158306894|FG001|Overall Study|Parent/Caregiver Decision|4|||
49127678|NCT00922636|158306895|FG002|Overall Study|Parent/Caregiver Decision|3|||
49127679|NCT00922636|158306896|FG003|Overall Study|Parent/Caregiver Decision|5|||
49127680|NCT00922636|158306897|FG004|Overall Study|Parent/Caregiver Decision|2|||
49127681|NCT00922636|158306893|FG000|Overall Study|Lost to Follow-up|1|||
49127682|NCT00922636|158306894|FG001|Overall Study|Lost to Follow-up|2|||
49127683|NCT00922636|158306895|FG002|Overall Study|Lost to Follow-up|2|||
49127684|NCT00922636|158306896|FG003|Overall Study|Lost to Follow-up|2|||
49127685|NCT00922636|158306897|FG004|Overall Study|Lost to Follow-up|4|||
49127686|NCT00379834|158306900|FG000|Overall Study|Time constraints|2|||
49127687|NCT00116688|158306905|FG000|Overall Study|Protocol deviation|1|||
49127688|NCT00116688|158306906|FG001|Overall Study|Protocol deviation|0|||
49127689|NCT00116688|158306905|FG000|Overall Study|Noncompliance|3|||
49127690|NCT00116688|158306906|FG001|Overall Study|Noncompliance|1|||
49127691|NCT00116688|158306905|FG000|Overall Study|Adverse Event|11|||
49127692|NCT00116688|158306906|FG001|Overall Study|Adverse Event|0|||
49127693|NCT00116688|158306905|FG000|Overall Study|Withdrawal by Subject|26|||
49127694|NCT00116688|158306906|FG001|Overall Study|Withdrawal by Subject|2|||
49127695|NCT00116688|158306905|FG000|Overall Study|Requirement for alternative therapy|11|||
49127696|NCT00116688|158306906|FG001|Overall Study|Requirement for alternative therapy|1|||
49127697|NCT00116688|158306905|FG000|Overall Study|Physician Decision|7|||
49127698|NCT00116688|158306906|FG001|Overall Study|Physician Decision|0|||
49127699|NCT00116688|158306905|FG000|Overall Study|Lost to Follow-up|3|||
49127700|NCT00116688|158306906|FG001|Overall Study|Lost to Follow-up|0|||
49127701|NCT00116688|158306905|FG000|Overall Study|Death|15|||
49127702|NCT00116688|158306906|FG001|Overall Study|Death|0|||
49127703|NCT00116688|158306905|FG000|Overall Study|Protocol-specified criteria|3|||
49127704|NCT00116688|158306906|FG001|Overall Study|Protocol-specified criteria|0|||
49127705|NCT00116688|158306905|FG000|Overall Study|Pregnancy|1|||
49127706|NCT00116688|158306906|FG001|Overall Study|Pregnancy|0|||
49127707|NCT00116688|158306905|FG000|Overall Study|Other|11|||
49127708|NCT00116688|158306906|FG001|Overall Study|Other|0|||
49127709|NCT02812186|158306907|FG000|Period 1|Post randomization screen failure|5|||
49127710|NCT02812186|158306908|FG001|Period 1|Post randomization screen failure|9|||
49127711|NCT02812186|158306907|FG000|Period 1|nonevaluable data sets|6|||
49127712|NCT02812186|158306908|FG001|Period 1|nonevaluable data sets|6|||
48920964|NCT04036708|157544796|FG001|Overall Study|Lost to Follow-up|4|||
49127713|NCT03316586|158306911|FG000|Overall Study|Adverse Event|2|||
49127714|NCT03316586|158306911|FG000|Overall Study|Physician Decision|3|||
49127715|NCT03316586|158306911|FG000|Overall Study|Lack of Efficacy|10|||
49127716|NCT03316586|158306911|FG000|Overall Study|still on treatment|1|||
49127717|NCT03316586|158306911|FG000|Overall Study|Patient needed radiation therapy|1|||
49127718|NCT03316586|158306911|FG000|Overall Study|Physician Decision to send patient for breast surgery|1|||
49127719|NCT00643760|158306916|FG000|Overall Study|Adverse Event|11|||
49127720|NCT00643760|158306917|FG001|Overall Study|Adverse Event|5|||
49127721|NCT00643760|158306918|FG002|Overall Study|Adverse Event|12|||
49127722|NCT00643760|158306919|FG003|Overall Study|Adverse Event|21|||
49127723|NCT00643760|158306920|FG004|Overall Study|Adverse Event|6|||
49127724|NCT00643760|158306916|FG000|Overall Study|Lack of Efficacy|3|||
49127725|NCT00643760|158306917|FG001|Overall Study|Lack of Efficacy|1|||
49127726|NCT00643760|158306918|FG002|Overall Study|Lack of Efficacy|0|||
49127727|NCT00643760|158306919|FG003|Overall Study|Lack of Efficacy|4|||
49127728|NCT00643760|158306920|FG004|Overall Study|Lack of Efficacy|3|||
49127729|NCT00643760|158306916|FG000|Overall Study|Protocol Violation|7|||
49127730|NCT00643760|158306917|FG001|Overall Study|Protocol Violation|6|||
49127731|NCT00643760|158306918|FG002|Overall Study|Protocol Violation|4|||
49127732|NCT00643760|158306919|FG003|Overall Study|Protocol Violation|4|||
49127733|NCT00643760|158306920|FG004|Overall Study|Protocol Violation|6|||
49127734|NCT00643760|158306916|FG000|Overall Study|Lost to Follow-up|6|||
49127735|NCT00643760|158306917|FG001|Overall Study|Lost to Follow-up|2|||
49127736|NCT00643760|158306918|FG002|Overall Study|Lost to Follow-up|1|||
49127737|NCT00643760|158306919|FG003|Overall Study|Lost to Follow-up|3|||
49127738|NCT00643760|158306920|FG004|Overall Study|Lost to Follow-up|3|||
49127739|NCT00643760|158306916|FG000|Overall Study|Investigator Discretion|0|||
49127740|NCT00643760|158306917|FG001|Overall Study|Investigator Discretion|0|||
49127741|NCT00643760|158306918|FG002|Overall Study|Investigator Discretion|0|||
49127742|NCT00643760|158306919|FG003|Overall Study|Investigator Discretion|2|||
49127743|NCT00643760|158306920|FG004|Overall Study|Investigator Discretion|0|||
49127744|NCT00643760|158306916|FG000|Overall Study|Withdrawal by Subject|3|||
49127745|NCT00643760|158306917|FG001|Overall Study|Withdrawal by Subject|1|||
49127746|NCT00643760|158306918|FG002|Overall Study|Withdrawal by Subject|2|||
49127747|NCT00643760|158306919|FG003|Overall Study|Withdrawal by Subject|4|||
49127748|NCT00643760|158306920|FG004|Overall Study|Withdrawal by Subject|1|||
49127749|NCT02063672|158306921|FG000|Overall Study|Ongoing Follow-up|27|||
49127750|NCT02063672|158306922|FG001|Overall Study|Ongoing Follow-up|14|||
49127751|NCT02063672|158306921|FG000|Overall Study|Death|5|||
49127752|NCT02063672|158306922|FG001|Overall Study|Death|3|||
49127753|NCT02063672|158306921|FG000|Overall Study|Lost to Follow-up|1|||
49127754|NCT02063672|158306922|FG001|Overall Study|Lost to Follow-up|3|||
49127755|NCT02063672|158306921|FG000|Overall Study|Withdrawal by Subject|2|||
49127756|NCT02063672|158306922|FG001|Overall Study|Withdrawal by Subject|2|||
49127757|NCT01053741|158306923|FG000|2nd Study Intervention|Physician Decision|0|||
49127758|NCT01053741|158306924|FG001|2nd Study Intervention|Physician Decision|1|||
49127759|NCT01914393|158306929|FG000|Overall Study|Protocol Violation|11|||
49127760|NCT01914393|158306930|FG001|Overall Study|Protocol Violation|3|||
49127761|NCT01914393|158306931|FG002|Overall Study|Protocol Violation|19|||
49127762|NCT01914393|158306929|FG000|Overall Study|Lack of Efficacy|11|||
49127763|NCT01914393|158306930|FG001|Overall Study|Lack of Efficacy|16|||
49127764|NCT01914393|158306931|FG002|Overall Study|Lack of Efficacy|5|||
49127765|NCT01914393|158306929|FG000|Overall Study|no reason given|14|||
49127766|NCT01914393|158306930|FG001|Overall Study|no reason given|8|||
49127767|NCT01914393|158306931|FG002|Overall Study|no reason given|16|||
49127768|NCT01914393|158306929|FG000|Overall Study|Adverse Event|29|||
49127769|NCT01914393|158306930|FG001|Overall Study|Adverse Event|18|||
49127770|NCT01914393|158306931|FG002|Overall Study|Adverse Event|31|||
49127771|NCT01914393|158306929|FG000|Overall Study|Withdrawal by Subject|38|||
49127772|NCT01914393|158306930|FG001|Overall Study|Withdrawal by Subject|20|||
49127773|NCT01914393|158306931|FG002|Overall Study|Withdrawal by Subject|47|||
49127774|NCT01914393|158306929|FG000|Overall Study|Lost to Follow-up|12|||
49127775|NCT01914393|158306930|FG001|Overall Study|Lost to Follow-up|6|||
49127776|NCT01914393|158306931|FG002|Overall Study|Lost to Follow-up|19|||
49127777|NCT01914393|158306929|FG000|Overall Study|subject never dosed|0|||
49127778|NCT01914393|158306930|FG001|Overall Study|subject never dosed|0|||
49127779|NCT01914393|158306931|FG002|Overall Study|subject never dosed|1|||
49127780|NCT00619827|158306932|FG000|Overall Study|Adverse Event|1|||
49127781|NCT00619827|158306933|FG001|Overall Study|Adverse Event|2|||
49127782|NCT00619827|158306932|FG000|Overall Study|Withdrawal by Subject|2|||
49127783|NCT00619827|158306933|FG001|Overall Study|Withdrawal by Subject|2|||
49127784|NCT01165307|158306935|FG000|Overall Study|Lost to Follow-up|11|||
49127785|NCT01165307|158306936|FG001|Overall Study|Lost to Follow-up|3|||
49127786|NCT01165307|158306935|FG000|Overall Study|Withdrawal by Subject|2|||
49127787|NCT01165307|158306936|FG001|Overall Study|Withdrawal by Subject|0|||
49127788|NCT01165307|158306935|FG000|Overall Study|Subject not available for contact|1|||
49127789|NCT01165307|158306936|FG001|Overall Study|Subject not available for contact|0|||
49127790|NCT00104052|158306937|FG000|Overall Study|Adverse Event|1|||
49127791|NCT00104052|158306937|FG000|Overall Study|Lack of Efficacy|26|||
49127792|NCT00104052|158306937|FG000|Overall Study|Discontinuation unrelated to treatment|2|||
49127793|NCT04644029|158306938|FG000|Overall Study|Death|1|||
49127794|NCT04644029|158306939|FG001|Overall Study|Death|0|||
49127795|NCT04644029|158306938|FG000|Overall Study|Physician Decision|1|||
49127796|NCT04644029|158306939|FG001|Overall Study|Physician Decision|2|||
49127797|NCT04644029|158306938|FG000|Overall Study|Withdrawal by Subject|21|||
49127798|NCT04644029|158306939|FG001|Overall Study|Withdrawal by Subject|19|||
49127799|NCT04644029|158306938|FG000|Overall Study|Lost to Follow-up|31|||
49127800|NCT04644029|158306939|FG001|Overall Study|Lost to Follow-up|34|||
49127801|NCT04644029|158306938|FG000|Overall Study|Study Terminated by Sponsor|305|||
49127802|NCT04644029|158306939|FG001|Overall Study|Study Terminated by Sponsor|301|||
49127803|NCT04644029|158306938|FG000|Overall Study|Status Not Recorded|3|||
49127804|NCT04644029|158306939|FG001|Overall Study|Status Not Recorded|8|||
49127805|NCT04644029|158306938|FG000|Overall Study|Randomized in Error|2|||
49127806|NCT04644029|158306939|FG001|Overall Study|Randomized in Error|1|||
49127807|NCT04644029|158306938|FG000|Overall Study|Other|0|||
48718711|NCT04604132|156818466|FG004|Overall Study|Study terminated by sponsor|1|||
48718712|NCT04604132|156818462|FG000|Overall Study|Progressive disease: Clinical progression|0|||
48718713|NCT04604132|156818463|FG001|Overall Study|Progressive disease: Clinical progression|0|||
48718714|NCT04604132|156818464|FG002|Overall Study|Progressive disease: Clinical progression|1|||
48718715|NCT04604132|156818465|FG003|Overall Study|Progressive disease: Clinical progression|0|||
48718716|NCT04604132|156818466|FG004|Overall Study|Progressive disease: Clinical progression|0|||
48718717|NCT04604132|156818462|FG000|Overall Study|Progressive disease: Radiological progression|8|||
48718718|NCT04604132|156818463|FG001|Overall Study|Progressive disease: Radiological progression|7|||
48718719|NCT04604132|156818464|FG002|Overall Study|Progressive disease: Radiological progression|10|||
48718720|NCT04604132|156818465|FG003|Overall Study|Progressive disease: Radiological progression|4|||
48718721|NCT04604132|156818466|FG004|Overall Study|Progressive disease: Radiological progression|3|||
48718722|NCT04604132|156818462|FG000|Overall Study|Death|3|||
48718723|NCT04604132|156818463|FG001|Overall Study|Death|1|||
48718724|NCT04604132|156818464|FG002|Overall Study|Death|2|||
48718725|NCT04604132|156818465|FG003|Overall Study|Death|1|||
48718726|NCT04604132|156818466|FG004|Overall Study|Death|0|||
48718727|NCT00952380|156818467|FG000|Overall Study|Other|0|||
48718728|NCT00952380|156818468|FG001|Overall Study|Other|0|||
48718729|NCT00952380|156818469|FG002|Overall Study|Other|0|||
48718730|NCT00952380|156818470|FG003|Overall Study|Other|0|||
49127808|NCT04644029|158306939|FG001|Overall Study|Other|1|||
49127809|NCT03652818|158306941|FG000|Overall Study|Adverse Event|1|||
49127810|NCT03652818|158306942|FG001|Overall Study|Adverse Event|0|||
49127811|NCT03652818|158306943|FG002|Overall Study|Adverse Event|0|||
49127812|NCT03652818|158306944|FG003|Overall Study|Adverse Event|0|||
48718731|NCT00952380|156818471|FG004|Overall Study|Other|1|||
48718732|NCT00952380|156818467|FG000|Overall Study|Withdrawal by Subject|0|||
48718733|NCT00952380|156818468|FG001|Overall Study|Withdrawal by Subject|0|||
48718734|NCT00952380|156818469|FG002|Overall Study|Withdrawal by Subject|1|||
48718735|NCT00952380|156818470|FG003|Overall Study|Withdrawal by Subject|0|||
48718736|NCT00952380|156818471|FG004|Overall Study|Withdrawal by Subject|2|||
48718737|NCT00952380|156818467|FG000|Overall Study|Adverse Event|0|||
48718738|NCT00952380|156818468|FG001|Overall Study|Adverse Event|1|||
48718739|NCT00952380|156818469|FG002|Overall Study|Adverse Event|0|||
48718740|NCT00952380|156818470|FG003|Overall Study|Adverse Event|0|||
48718741|NCT00952380|156818471|FG004|Overall Study|Adverse Event|3|||
48718742|NCT00952380|156818467|FG000|Overall Study|Physician Decision|0|||
48718743|NCT00952380|156818468|FG001|Overall Study|Physician Decision|0|||
48718744|NCT00952380|156818469|FG002|Overall Study|Physician Decision|1|||
48718745|NCT00952380|156818470|FG003|Overall Study|Physician Decision|2|||
48718746|NCT00952380|156818471|FG004|Overall Study|Physician Decision|0|||
48718747|NCT00952380|156818467|FG000|Overall Study|Non-compliant to protocol|0|||
48718748|NCT00952380|156818468|FG001|Overall Study|Non-compliant to protocol|0|||
48718749|NCT00952380|156818469|FG002|Overall Study|Non-compliant to protocol|0|||
48718750|NCT00952380|156818470|FG003|Overall Study|Non-compliant to protocol|1|||
48718751|NCT00952380|156818471|FG004|Overall Study|Non-compliant to protocol|0|||
48718752|NCT00510653|156818477|FG000|Overall Study|Withdrawal by Subject|8|||
48718753|NCT00510653|156818477|FG000|Overall Study|Monetary|3|||
48718754|NCT01075191|156818478|FG000|Overall Study|Death|1|||
48718755|NCT01075191|156818478|FG000|Overall Study|Intensification|3|||
48718756|NCT01075191|156818478|FG000|Overall Study|Co-morbidities|1|||
48815071|NCT05886777|157163665|FG000|Overall Study|No longer met eligibility criteria|0|||
48815072|NCT05886777|157163666|FG001|Overall Study|No longer met eligibility criteria|1|||
48815073|NCT05886777|157163667|FG002|Overall Study|No longer met eligibility criteria|0|||
49127813|NCT03652818|158306945|FG004|Overall Study|Adverse Event|0|||
49127814|NCT03652818|158306941|FG000|Overall Study|Physician Decision|1|||
49127815|NCT03652818|158306942|FG001|Overall Study|Physician Decision|0|||
48718757|NCT01075191|156818478|FG000|Overall Study|Adverse Event|4|||
49127816|NCT03652818|158306943|FG002|Overall Study|Physician Decision|0|||
49127817|NCT03652818|158306944|FG003|Overall Study|Physician Decision|0|||
49127818|NCT03652818|158306945|FG004|Overall Study|Physician Decision|0|||
49127819|NCT03652818|158306941|FG000|Overall Study|Lost to Follow-up|0|||
49127820|NCT03652818|158306942|FG001|Overall Study|Lost to Follow-up|1|||
49127821|NCT03652818|158306943|FG002|Overall Study|Lost to Follow-up|2|||
49127822|NCT03652818|158306944|FG003|Overall Study|Lost to Follow-up|1|||
49127823|NCT03652818|158306945|FG004|Overall Study|Lost to Follow-up|1|||
49127824|NCT01855958|158306946|FG000|Overall Study|Withdrawal by Subject|1|||
49127825|NCT01855958|158306947|FG001|Overall Study|Withdrawal by Subject|0|||
49127826|NCT00239720|158306955|FG000|Overall Study|Adverse Event|1|||
49127827|NCT00239720|158306956|FG001|Overall Study|Adverse Event|0|||
49127828|NCT00239720|158306955|FG000|Overall Study|Lost to Follow-up|0|||
49127829|NCT00239720|158306956|FG001|Overall Study|Lost to Follow-up|1|||
49127830|NCT02791269|158306957|FG000|Overall Study|Lost to Follow-up|0|||
49127831|NCT02791269|158306958|FG001|Overall Study|Lost to Follow-up|1|||
49127832|NCT00368251|158306959|FG000|Overall Study|SAE, non-fatal|1|||
49127833|NCT00368251|158306960|FG001|Overall Study|SAE, non-fatal|0|||
49127834|NCT00368251|158306961|FG002|Overall Study|SAE, non-fatal|0|||
49127835|NCT00368251|158306959|FG000|Overall Study|AE, non-serious non-fatal|0|||
48718758|NCT01075191|156818478|FG000|Overall Study|Noncompliance|3|||
48718759|NCT01075191|156818478|FG000|Overall Study|Therapy Break|3|||
48718760|NCT01075191|156818478|FG000|Overall Study|Patient's Wish|2|||
48718761|NCT01075191|156818478|FG000|Overall Study|Unknown Reasons|1|||
48718762|NCT00436501|156818479|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0|||
48718763|NCT00436501|156818480|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2|||
48718764|NCT00436501|156818479|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0|||
48718765|NCT00436501|156818480|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1|||
48718766|NCT00495040|156818482|FG000|Overall Study|Withdrawal by Subject|3|||
48718767|NCT01892384|156818486|FG000|Overall Study|Withdrawal by Subject|1|||
48718768|NCT01892384|156818487|FG001|Overall Study|Withdrawal by Subject|1|||
48718769|NCT01892384|156818488|FG002|Overall Study|Withdrawal by Subject|0|||
48718770|NCT01892384|156818489|FG003|Overall Study|Withdrawal by Subject|0|||
48718771|NCT02518464|156818490|FG000|Overall Study|Adverse Event|2|||
48718772|NCT01829243|156818491|FG000|First Intervention|Screen Failure|4|||
48718773|NCT01829243|156818492|FG001|First Intervention|Screen Failure|2|||
48718774|NCT00608569|156818493|FG000|Overall Study|Death|4|||
48718775|NCT00608569|156818494|FG001|Overall Study|Death|3|||
48718776|NCT00608569|156818493|FG000|Overall Study|Lost to Follow-up|4|||
48718777|NCT00608569|156818494|FG001|Overall Study|Lost to Follow-up|5|||
48718778|NCT00608569|156818493|FG000|Overall Study|Withdrawal by Subject|1|||
48718779|NCT00608569|156818494|FG001|Overall Study|Withdrawal by Subject|0|||
48718780|NCT00608569|156818493|FG000|Overall Study|Adverse Event|1|||
48718781|NCT00608569|156818494|FG001|Overall Study|Adverse Event|0|||
49127836|NCT00368251|158306960|FG001|Overall Study|AE, non-serious non-fatal|0|||
49127837|NCT00368251|158306961|FG002|Overall Study|AE, non-serious non-fatal|1|||
49127838|NCT01218308|158306965|FG000|Overall Study|Adverse Event|1|||
49127839|NCT01218308|158306966|FG001|Overall Study|Adverse Event|2|||
49127840|NCT01218308|158306965|FG000|Overall Study|Protocol Violation|0|||
49127841|NCT01218308|158306966|FG001|Overall Study|Protocol Violation|2|||
49127842|NCT01218308|158306965|FG000|Overall Study|Withdrawal by Subject|61|||
49127843|NCT01218308|158306966|FG001|Overall Study|Withdrawal by Subject|64|||
49127844|NCT01218308|158306965|FG000|Overall Study|Lost to Follow-up|27|||
49127845|NCT01218308|158306966|FG001|Overall Study|Lost to Follow-up|31|||
48718782|NCT00608569|156818493|FG000|Overall Study|Unable to adhere with study requirements|0|||
48718783|NCT00608569|156818494|FG001|Overall Study|Unable to adhere with study requirements|1|||
48718784|NCT00053898|156818495|FG000|Overall Study|No follow-up data from any source|9|||
48718785|NCT00053898|156818496|FG001|Overall Study|No follow-up data from any source|12|||
48718786|NCT00053898|156818495|FG000|Overall Study|Follow-up from telephone contact only|5|||
48718787|NCT00053898|156818496|FG001|Overall Study|Follow-up from telephone contact only|1|||
48718788|NCT00906971|156818499|FG000|Overall Study|Withdrawal by Subject|8|||
48718789|NCT00906971|156818500|FG001|Overall Study|Withdrawal by Subject|2|||
48718790|NCT00906971|156818499|FG000|Overall Study|Lost to Follow-up|0|||
48718791|NCT00906971|156818500|FG001|Overall Study|Lost to Follow-up|1|||
49127846|NCT01218308|158306965|FG000|Overall Study|Other|14|||
48718792|NCT00821509|156818501|FG000|Overall Study|Withdrawal by Subject|12|||
48718793|NCT00821509|156818502|FG001|Overall Study|Withdrawal by Subject|11|||
48718794|NCT00821509|156818503|FG002|Overall Study|Withdrawal by Subject|34|||
48718795|NCT03678870|156818504|FG000|Overall Study|prescribed non- protocol medications|10|||
48718796|NCT03678870|156818505|FG001|Overall Study|prescribed non- protocol medications|6|||
48718797|NCT03678870|156818504|FG000|Overall Study|Lost to Follow-up|3|||
48718798|NCT03678870|156818505|FG001|Overall Study|Lost to Follow-up|2|||
48718799|NCT03104816|156818507|FG000|Overall Study|Lack of Efficacy|0|||
48718800|NCT03104816|156818508|FG001|Overall Study|Lack of Efficacy|2|||
48718801|NCT03104816|156818509|FG002|Overall Study|Lack of Efficacy|0|||
48718802|NCT03104816|156818507|FG000|Overall Study|Protocol Violation|2|||
48718803|NCT03104816|156818508|FG001|Overall Study|Protocol Violation|0|||
49127847|NCT01218308|158306966|FG001|Overall Study|Other|21|||
48718804|NCT03104816|156818509|FG002|Overall Study|Protocol Violation|2|||
48718805|NCT00807573|156818514|FG000|Overall Study|Withdrawal by Subject|1|||
49127848|NCT00974311|158306969|FG000|DB Phase (up to 24 Months)|Lost to Follow-up|5|||
48718806|NCT00807573|156818514|FG000|Overall Study|Adverse Event|1|||
48718807|NCT04054947|156818515|FG000|Overall Study|Withdrawal by Subject|1|||
48718808|NCT04054947|156818516|FG001|Overall Study|Withdrawal by Subject|0|||
48718809|NCT04054947|156818515|FG000|Overall Study|Lost to Follow-up|2|||
48718810|NCT04054947|156818516|FG001|Overall Study|Lost to Follow-up|5|||
48718811|NCT03353740|156818521|FG000|Overall Study|Images for these participants not viable|52|||
48718812|NCT01888432|156821211|FG000|12-month Analysis (FAS)|Lost to Follow-up|0|||
48718813|NCT01888432|156821212|FG001|12-month Analysis (FAS)|Lost to Follow-up|2|||
48718814|NCT01888432|156821211|FG000|12-month Analysis (FAS)|Physician Decision|1|||
48718815|NCT01888432|156821212|FG001|12-month Analysis (FAS)|Physician Decision|1|||
48718816|NCT01888432|156821211|FG000|12-month Analysis (FAS)|Withdrawal by Subject|6|||
48718817|NCT01888432|156821212|FG001|12-month Analysis (FAS)|Withdrawal by Subject|3|||
48718818|NCT01888432|156821211|FG000|12-month Analysis (FAS)|Death|4|||
48718819|NCT01888432|156821212|FG001|12-month Analysis (FAS)|Death|3|||
48718820|NCT01888432|156821211|FG000|24-month Analysis (FAS)|Graft loss|0|||
48718821|NCT01888432|156821212|FG001|24-month Analysis (FAS)|Graft loss|1|||
48718822|NCT01888432|156821211|FG000|24-month Analysis (FAS)|Lost to Follow-up|0|||
48718823|NCT01888432|156821212|FG001|24-month Analysis (FAS)|Lost to Follow-up|2|||
48718824|NCT01888432|156821211|FG000|24-month Analysis (FAS)|Physician Decision|2|||
48718825|NCT01888432|156821212|FG001|24-month Analysis (FAS)|Physician Decision|4|||
48718826|NCT01888432|156821211|FG000|24-month Analysis (FAS)|Withdrawal by Subject|7|||
48718827|NCT01888432|156821212|FG001|24-month Analysis (FAS)|Withdrawal by Subject|6|||
48718828|NCT01888432|156821211|FG000|24-month Analysis (FAS)|Death|8|||
48718829|NCT01888432|156821212|FG001|24-month Analysis (FAS)|Death|4|||
48718830|NCT01888432|156821211|FG000|36-month Analysis (Extension)|Death|1|||
48718831|NCT01888432|156821212|FG001|36-month Analysis (Extension)|Death|0|||
48718832|NCT00336856|156821214|FG000|Overall Study|Withdrawal by Subject|3|||
48718833|NCT00336856|156821214|FG000|Overall Study|Found ineligible at time of analysis|1|||
48718834|NCT02043899|156821215|FG000|Overall Study|Adverse Event|3|||
48718835|NCT02043899|156821215|FG000|Overall Study|Physician Decision|1|||
48718836|NCT02043899|156821215|FG000|Overall Study|Withdrawal by Subject|2|||
48718837|NCT02043899|156821215|FG000|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5|||
48718838|NCT02043899|156821215|FG000|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12|||
48718839|NCT02043899|156821215|FG000|Overall Study|Temporary halt due to out of specification radioactivity|2|||
48718840|NCT02043899|156821215|FG000|Overall Study|Clinical progression necessitating urgent treatment|1|||
48718841|NCT02043899|156821215|FG000|Overall Study|Treatment delayed|1|||
48718842|NCT01954927|156821217|FG000|Overall Study|Withdrawal by Subject|3|||
48718843|NCT01954927|156821218|FG001|Overall Study|Withdrawal by Subject|1|||
48718844|NCT03320824|156821219|FG000|Overall Study|Withdrawal by Subject|8|||
48718845|NCT03320824|156821220|FG001|Overall Study|Withdrawal by Subject|1|||
48718846|NCT03320824|156821219|FG000|Overall Study|Lost to Follow-up|10|||
48718847|NCT03320824|156821220|FG001|Overall Study|Lost to Follow-up|1|||
48718848|NCT03320824|156821219|FG000|Overall Study|moved out of state|0|||
48718849|NCT03320824|156821220|FG001|Overall Study|moved out of state|1|||
48718850|NCT03320824|156821219|FG000|Overall Study|could not complete final visit|0|||
48718851|NCT03320824|156821220|FG001|Overall Study|could not complete final visit|1|||
48718852|NCT00955305|156821221|FG000|Overall Study|Disease progression|39|||
48718853|NCT00955305|156821222|FG001|Overall Study|Disease progression|41|||
48815074|NCT05886777|157163668|FG003|Overall Study|No longer met eligibility criteria|0|||
48815075|NCT05886777|157163669|FG004|Overall Study|No longer met eligibility criteria|0|||
48815076|NCT05886777|157163670|FG005|Overall Study|No longer met eligibility criteria|0|||
48815077|NCT05886777|157163671|FG006|Overall Study|No longer met eligibility criteria|0|||
48815078|NCT01591460|157165680|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
48815079|NCT01591460|157165680|FG000|Overall Study|Futility Rule (Week 12)|7|||
48815080|NCT01591460|157165680|FG000|Overall Study|Futility Rule (Week 24)|3|||
48815081|NCT01591460|157165680|FG000|Overall Study|Rebound or Breakthrough|3|||
48815082|NCT01591460|157165680|FG000|Overall Study|Treatment Discontinued by Error|1|||
48815083|NCT01591460|157165680|FG000|Overall Study|Lost to Follow-up|1|||
49127849|NCT00974311|158306970|FG001|DB Phase (up to 24 Months)|Lost to Follow-up|2|||
49127850|NCT00974311|158306969|FG000|DB Phase (up to 24 Months)|Death|561|||
49127851|NCT00974311|158306970|FG001|DB Phase (up to 24 Months)|Death|298|||
49127852|NCT00974311|158306969|FG000|DB Phase (up to 24 Months)|Withdrawal by Subject|16|||
49127853|NCT00974311|158306970|FG001|DB Phase (up to 24 Months)|Withdrawal by Subject|7|||
49127854|NCT00974311|158306969|FG000|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108|||
49127855|NCT00974311|158306970|FG001|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42|||
49127856|NCT00974311|158306969|FG000|DB Phase (up to 24 Months)|Other|1|||
49127857|NCT00974311|158306970|FG001|DB Phase (up to 24 Months)|Other|0|||
49127858|NCT00974311|158306969|FG000|OLE Phase (up to 77 Months)|Death|14|||
49127859|NCT00974311|158306970|FG001|OLE Phase (up to 77 Months)|Death|21|||
49127860|NCT00974311|158306969|FG000|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78|||
49127861|NCT00974311|158306970|FG001|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26|||
49127862|NCT00974311|158306969|FG000|OLE Phase (up to 77 Months)|Other|15|||
49127863|NCT00974311|158306970|FG001|OLE Phase (up to 77 Months)|Other|2|||
48718854|NCT00955305|156821221|FG000|Overall Study|Adverse Event|22|||
48718855|NCT00955305|156821222|FG001|Overall Study|Adverse Event|22|||
48718856|NCT00955305|156821221|FG000|Overall Study|Death|2|||
48718857|NCT00955305|156821222|FG001|Overall Study|Death|1|||
48718858|NCT00955305|156821221|FG000|Overall Study|Withdrawal by Subject|5|||
48718859|NCT00955305|156821222|FG001|Overall Study|Withdrawal by Subject|4|||
48718860|NCT00955305|156821221|FG000|Overall Study|Alternative therapy|4|||
48718861|NCT00955305|156821222|FG001|Overall Study|Alternative therapy|0|||
48718862|NCT00955305|156821221|FG000|Overall Study|Other complicating disease|2|||
48718863|NCT00955305|156821222|FG001|Overall Study|Other complicating disease|4|||
48718864|NCT00955305|156821221|FG000|Overall Study|Physician Decision|1|||
48718865|NCT00955305|156821222|FG001|Overall Study|Physician Decision|0|||
48718866|NCT00955305|156821221|FG000|Overall Study|Continued presence of residual disease|0|||
48718867|NCT00955305|156821222|FG001|Overall Study|Continued presence of residual disease|1|||
48718868|NCT00955305|156821221|FG000|Overall Study|Functional decline|2|||
48718869|NCT00955305|156821222|FG001|Overall Study|Functional decline|0|||
48718870|NCT00955305|156821221|FG000|Overall Study|Maximum response achieved|0|||
48718871|NCT00955305|156821222|FG001|Overall Study|Maximum response achieved|1|||
48718872|NCT00955305|156821221|FG000|Overall Study|Lost to Follow-up|0|||
48718873|NCT00955305|156821222|FG001|Overall Study|Lost to Follow-up|1|||
48718874|NCT00955305|156821221|FG000|Overall Study|No off-treatment reason submitted|1|||
48718875|NCT00955305|156821222|FG001|Overall Study|No off-treatment reason submitted|0|||
48718876|NCT00955305|156821221|FG000|Overall Study|Never started protocol treatment|5|||
48718877|NCT00955305|156821222|FG001|Overall Study|Never started protocol treatment|5|||
48718878|NCT00955305|156821221|FG000|Overall Study|Ineligible|5|||
48718879|NCT00955305|156821222|FG001|Overall Study|Ineligible|7|||
48718880|NCT01945710|156821223|FG000|Overall Study|Progressive Disease|5|||
48718881|NCT01945710|156821224|FG001|Overall Study|Progressive Disease|4|||
48718882|NCT01945710|156821225|FG002|Overall Study|Progressive Disease|3|||
48718883|NCT01945710|156821226|FG003|Overall Study|Progressive Disease|2|||
48718884|NCT01945710|156821227|FG004|Overall Study|Progressive Disease|7|||
48718885|NCT01945710|156821228|FG005|Overall Study|Progressive Disease|3|||
48718886|NCT01945710|156821229|FG006|Overall Study|Progressive Disease|19|||
48718887|NCT01945710|156821223|FG000|Overall Study|Adverse Event|0|||
48718888|NCT01945710|156821224|FG001|Overall Study|Adverse Event|1|||
48718889|NCT01945710|156821225|FG002|Overall Study|Adverse Event|0|||
48718890|NCT01945710|156821226|FG003|Overall Study|Adverse Event|0|||
48718891|NCT01945710|156821227|FG004|Overall Study|Adverse Event|0|||
48718892|NCT01945710|156821228|FG005|Overall Study|Adverse Event|0|||
48718893|NCT01945710|156821229|FG006|Overall Study|Adverse Event|0|||
48718894|NCT01945710|156821223|FG000|Overall Study|Other|2|||
48718895|NCT01945710|156821224|FG001|Overall Study|Other|0|||
48718896|NCT01945710|156821225|FG002|Overall Study|Other|3|||
48718897|NCT01945710|156821226|FG003|Overall Study|Other|1|||
48718898|NCT01945710|156821227|FG004|Overall Study|Other|1|||
48718899|NCT01945710|156821228|FG005|Overall Study|Other|0|||
48718900|NCT01945710|156821229|FG006|Overall Study|Other|4|||
48718901|NCT01945710|156821223|FG000|Overall Study|Withdrawal by Subject|0|||
48815084|NCT01591460|157165680|FG000|Overall Study|Noncompliance|1|||
48815085|NCT01591460|157165680|FG000|Overall Study|Participant Refusal|3|||
48815086|NCT01591460|157165680|FG000|Overall Study|Withdrawal by Subject|1|||
48815087|NCT01591460|157165680|FG000|Overall Study|Protocol Violation|1|||
49127864|NCT00974311|158306969|FG000|OLE Phase (up to 77 Months)|Withdrawal by Subject|2|||
49127865|NCT00974311|158306970|FG001|OLE Phase (up to 77 Months)|Withdrawal by Subject|1|||
49127866|NCT00643201|158306971|FG000|Randomized, Completed 6 Months of Study|Death|20|||
49127867|NCT00643201|158306972|FG001|Randomized, Completed 6 Months of Study|Death|26|||
49127868|NCT00643201|158306971|FG000|Randomized, Completed 6 Months of Study|Adverse Event|150|||
49127869|NCT00643201|158306972|FG001|Randomized, Completed 6 Months of Study|Adverse Event|182|||
49127870|NCT00643201|158306971|FG000|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
48718902|NCT01945710|156821224|FG001|Overall Study|Withdrawal by Subject|1|||
48718903|NCT01945710|156821225|FG002|Overall Study|Withdrawal by Subject|1|||
48718904|NCT01945710|156821226|FG003|Overall Study|Withdrawal by Subject|0|||
48718905|NCT01945710|156821227|FG004|Overall Study|Withdrawal by Subject|1|||
48718906|NCT01945710|156821228|FG005|Overall Study|Withdrawal by Subject|0|||
48718907|NCT01945710|156821229|FG006|Overall Study|Withdrawal by Subject|0|||
48718908|NCT03472547|156821230|FG000|Overall Study|Withdrawal by Subject|30|||
48718909|NCT02434471|156821231|FG000|Overall Study|Physician Decision|9|||
48718910|NCT00843778|156821232|FG000|Overall Study|Adverse Event|15|||
48718911|NCT00843778|156821232|FG000|Overall Study|Lack of Efficacy|14|||
48718912|NCT00843778|156821232|FG000|Overall Study|Loss of efficacy|2|||
48718913|NCT00843778|156821232|FG000|Overall Study|Withdrawal by Subject|4|||
48718914|NCT02600871|156821233|FG000|Overall Study|Lost to Follow-up|13|||
48718915|NCT02600871|156821234|FG001|Overall Study|Lost to Follow-up|10|||
48718916|NCT02848729|156821242|FG000|Overall Study|Withdrawal by Subject|1|||
48718917|NCT02848729|156821243|FG001|Overall Study|Withdrawal by Subject|0|||
48815088|NCT02310126|157165681|FG000|Period 1 (15 Minutes)|Lost to Follow-up|0|||
48718918|NCT02848729|156821242|FG000|Overall Study|Emesis|15|||
48718919|NCT02848729|156821243|FG001|Overall Study|Emesis|11|||
48718920|NCT01998984|156821244|FG000|Overall Study|Adverse Event|0|||
48718921|NCT01998984|156821245|FG001|Overall Study|Adverse Event|0|||
48718922|NCT01998984|156821246|FG002|Overall Study|Adverse Event|0|||
48718923|NCT01998984|156821247|FG003|Overall Study|Adverse Event|1|||
48718924|NCT01998984|156821244|FG000|Overall Study|Lost to Follow-up|0|||
48718925|NCT01998984|156821245|FG001|Overall Study|Lost to Follow-up|1|||
48718926|NCT01998984|156821246|FG002|Overall Study|Lost to Follow-up|0|||
48718927|NCT01998984|156821247|FG003|Overall Study|Lost to Follow-up|1|||
48718928|NCT01998984|156821244|FG000|Overall Study|Withdrawal by Subject|0|||
48718929|NCT01998984|156821245|FG001|Overall Study|Withdrawal by Subject|0|||
48718930|NCT01998984|156821246|FG002|Overall Study|Withdrawal by Subject|1|||
48718931|NCT01998984|156821247|FG003|Overall Study|Withdrawal by Subject|0|||
48718932|NCT01998984|156821244|FG000|Overall Study|Other|0|||
48718933|NCT01998984|156821245|FG001|Overall Study|Other|0|||
48718934|NCT01998984|156821246|FG002|Overall Study|Other|0|||
48718935|NCT01998984|156821247|FG003|Overall Study|Other|1|||
48718936|NCT04966910|156821248|FG000|Baseline|Participant did not complete measure|0|||
48718937|NCT04966910|156821249|FG001|Baseline|Participant did not complete measure|0|||
48718938|NCT04966910|156821250|FG002|Baseline|Participant did not complete measure|1|||
48718939|NCT04966910|156821251|FG003|Baseline|Participant did not complete measure|0|||
48718940|NCT04966910|156821248|FG000|4-Week Follow-Up|Clients did not complete measure at this timepoint|5|||
48718941|NCT04966910|156821249|FG001|4-Week Follow-Up|Clients did not complete measure at this timepoint|4|||
48718942|NCT04966910|156821250|FG002|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
48718943|NCT04966910|156821251|FG003|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
48718944|NCT04966910|156821248|FG000|9-Week Follow-Up|Withdrawal by Subject|0|||
48718945|NCT04966910|156821249|FG001|9-Week Follow-Up|Withdrawal by Subject|0|||
48718946|NCT04966910|156821250|FG002|9-Week Follow-Up|Withdrawal by Subject|0|||
48718947|NCT04966910|156821251|FG003|9-Week Follow-Up|Withdrawal by Subject|2|||
48718948|NCT04966910|156821248|FG000|9-Week Follow-Up|Participant did not complete measure|3|||
48718949|NCT04966910|156821249|FG001|9-Week Follow-Up|Participant did not complete measure|1|||
48718950|NCT04966910|156821250|FG002|9-Week Follow-Up|Participant did not complete measure|0|||
48718951|NCT04966910|156821251|FG003|9-Week Follow-Up|Participant did not complete measure|0|||
48718952|NCT02617485|156821253|FG000|Treatment and Observation Period|Adverse Event|9|||
48718953|NCT02617485|156821254|FG001|Treatment and Observation Period|Adverse Event|1|||
48718954|NCT02617485|156821253|FG000|Treatment and Observation Period|Withdrawal by Subject|4|||
48718955|NCT02617485|156821254|FG001|Treatment and Observation Period|Withdrawal by Subject|1|||
48718956|NCT02617485|156821253|FG000|Treatment and Observation Period|Patient needed radiotherapy|1|||
48718957|NCT02617485|156821254|FG001|Treatment and Observation Period|Patient needed radiotherapy|0|||
48718958|NCT02617485|156821253|FG000|Treatment and Observation Period|Lack of Efficacy|1|||
48718959|NCT02617485|156821254|FG001|Treatment and Observation Period|Lack of Efficacy|2|||
48718960|NCT02617485|156821253|FG000|Treatment and Observation Period|Physician Decision|0|||
48718961|NCT02617485|156821254|FG001|Treatment and Observation Period|Physician Decision|1|||
48718962|NCT02617485|156821253|FG000|Follow-up Period|Adverse Event|1|||
48718963|NCT02617485|156821254|FG001|Follow-up Period|Adverse Event|0|||
48718964|NCT02617485|156821253|FG000|Follow-up Period|Withdrawal by Subject|1|||
48718965|NCT02617485|156821254|FG001|Follow-up Period|Withdrawal by Subject|0|||
48718966|NCT02617485|156821253|FG000|Follow-up Period|Disease progression|2|||
48718967|NCT02617485|156821254|FG001|Follow-up Period|Disease progression|1|||
48718968|NCT02617485|156821253|FG000|Follow-up Period|Need for CNS prophylaxis|1|||
48718969|NCT02617485|156821254|FG001|Follow-up Period|Need for CNS prophylaxis|0|||
48718970|NCT02617485|156821253|FG000|Follow-up Period|Patient needed radiotherapy|9|||
48718971|NCT02617485|156821254|FG001|Follow-up Period|Patient needed radiotherapy|5|||
49127871|NCT00643201|158306972|FG001|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
49127872|NCT00643201|158306971|FG000|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
49127873|NCT00643201|158306972|FG001|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
49127874|NCT00643201|158306971|FG000|Randomized, Completed 6 Months of Study|Poor or non-compliance|20|||
49127875|NCT00643201|158306972|FG001|Randomized, Completed 6 Months of Study|Poor or non-compliance|23|||
49127876|NCT00643201|158306971|FG000|Randomized, Completed 6 Months of Study|Pregnancy|3|||
49127877|NCT00643201|158306972|FG001|Randomized, Completed 6 Months of Study|Pregnancy|2|||
49127878|NCT00643201|158306971|FG000|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13|||
49127879|NCT00643201|158306972|FG001|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9|||
49127880|NCT00643201|158306971|FG000|Randomized, Completed 6 Months of Study|Administrative reason|1|||
49127881|NCT00643201|158306972|FG001|Randomized, Completed 6 Months of Study|Administrative reason|1|||
49127882|NCT00643201|158306971|FG000|Randomized, Completed 6 Months of Study|Other|107|||
49127883|NCT00643201|158306972|FG001|Randomized, Completed 6 Months of Study|Other|107|||
49127884|NCT00643201|158306971|FG000|Completed Study Follow Up|Death|28|||
49127885|NCT00643201|158306972|FG001|Completed Study Follow Up|Death|34|||
49127886|NCT00643201|158306971|FG000|Completed Study Follow Up|Withdrawal by Subject|23|||
48718972|NCT02617485|156821253|FG000|Follow-up Period|Patient needed bone marrow transplantation|1|||
48815089|NCT02310126|157165682|FG001|Period 1 (15 Minutes)|Lost to Follow-up|1|||
48718973|NCT02617485|156821254|FG001|Follow-up Period|Patient needed bone marrow transplantation|0|||
48718974|NCT00409331|156821255|FG000|Overall Study|Physician Decision|1|||
48718975|NCT03680742|156821264|FG000|Overall Study|Unsuccessful Implant Attempt|2|||
48718976|NCT00003472|156821268|FG000|Overall Study|Not evaluable|3|||
48718977|NCT02527200|156821269|FG000|Overall Study|Withdrawal by Subject|3|||
48718978|NCT02527200|156821270|FG001|Overall Study|Withdrawal by Subject|2|||
48718979|NCT02527200|156821271|FG002|Overall Study|Withdrawal by Subject|1|||
48718980|NCT02527200|156821272|FG003|Overall Study|Withdrawal by Subject|0|||
48718981|NCT02527200|156821269|FG000|Overall Study|Unclassified|0|||
48718982|NCT02527200|156821270|FG001|Overall Study|Unclassified|1|||
48718983|NCT02527200|156821271|FG002|Overall Study|Unclassified|0|||
48718984|NCT02527200|156821272|FG003|Overall Study|Unclassified|0|||
48718985|NCT02527200|156821269|FG000|Overall Study|Lost to Follow-up|0|||
48718986|NCT02527200|156821270|FG001|Overall Study|Lost to Follow-up|0|||
48718987|NCT02527200|156821271|FG002|Overall Study|Lost to Follow-up|1|||
48718988|NCT02527200|156821272|FG003|Overall Study|Lost to Follow-up|0|||
48718989|NCT00883688|156821286|FG000|Overall Study|Ineligible|2|||
48718990|NCT01909791|156821289|FG000|Overall Study|Death|9|||
48718991|NCT01909791|156821290|FG001|Overall Study|Death|8|||
48718992|NCT01909791|156821291|FG002|Overall Study|Death|4|||
48815090|NCT02310126|157165681|FG000|Period 1 (15 Minutes)|Protocol Violation|0|||
48815091|NCT02310126|157165682|FG001|Period 1 (15 Minutes)|Protocol Violation|1|||
48815092|NCT02533258|157165689|FG000|Overall Study|Adverse Event|1|||
48815093|NCT02533258|157165689|FG000|Overall Study|Death|2|||
48718993|NCT01909791|156821289|FG000|Overall Study|Withdrawal by Subject|5|||
48718994|NCT01909791|156821290|FG001|Overall Study|Withdrawal by Subject|9|||
48718995|NCT01909791|156821291|FG002|Overall Study|Withdrawal by Subject|13|||
48718996|NCT01909791|156821289|FG000|Overall Study|Lost to Follow-up|5|||
48718997|NCT01909791|156821290|FG001|Overall Study|Lost to Follow-up|11|||
48815094|NCT02533258|157165689|FG000|Overall Study|Other|1|||
48815095|NCT02533258|157165689|FG000|Overall Study|Economic factor|1|||
48718998|NCT01909791|156821291|FG002|Overall Study|Lost to Follow-up|10|||
48718999|NCT01909791|156821289|FG000|Overall Study|Missed Visit|2|||
48719000|NCT01909791|156821290|FG001|Overall Study|Missed Visit|0|||
48719001|NCT01909791|156821291|FG002|Overall Study|Missed Visit|1|||
48719002|NCT02984943|156821294|FG000|Overall Study|Withdrawal by Subject|3|||
48719003|NCT02984943|156821294|FG000|Overall Study|Physician Decision|1|||
48719004|NCT03316911|156821300|FG000|Overall Study|Lost to Follow-up|33|||
48719005|NCT03316911|156821301|FG001|Overall Study|Lost to Follow-up|29|||
48719006|NCT04740905|156821302|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
49127887|NCT00643201|158306972|FG001|Completed Study Follow Up|Withdrawal by Subject|29|||
49127888|NCT00643201|158306971|FG000|Completed Study Follow Up|Lost to Follow-up|18|||
49127889|NCT00643201|158306972|FG001|Completed Study Follow Up|Lost to Follow-up|16|||
49127890|NCT00643201|158306971|FG000|Completed Study Follow Up|non-specified|1|||
49127891|NCT00643201|158306972|FG001|Completed Study Follow Up|non-specified|0|||
48719007|NCT04740905|156821303|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|3|||
48719008|NCT04740905|156821302|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|2|||
48719009|NCT04740905|156821303|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
48719010|NCT04740905|156821302|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
48719011|NCT04740905|156821303|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|0|||
49127892|NCT00483652|158306973|FG000|Double-blind Treatment Period|Protocol Violation|2|||
49127893|NCT00483652|158306974|FG001|Double-blind Treatment Period|Protocol Violation|1|||
49127894|NCT00483652|158306973|FG000|Double-blind Treatment Period|Adverse Event|3|||
49127895|NCT00483652|158306974|FG001|Double-blind Treatment Period|Adverse Event|4|||
49127896|NCT00483652|158306973|FG000|Double-blind Treatment Period|Protocol inclusion deviation|1|||
48815096|NCT02533258|157165689|FG000|Overall Study|Progression of pleural effusion|1|||
48815097|NCT02533258|157165689|FG000|Overall Study|Lack of Efficacy|2|||
48815098|NCT01009047|157165690|FG000|Overall Study|Adverse Event|5|||
48815099|NCT01009047|157165691|FG001|Overall Study|Adverse Event|0|||
48815100|NCT01009047|157165690|FG000|Overall Study|Lost to Follow-up|0|||
48815101|NCT01009047|157165691|FG001|Overall Study|Lost to Follow-up|2|||
48815102|NCT01009047|157165690|FG000|Overall Study|Lack of Efficacy|4|||
48815103|NCT01009047|157165691|FG001|Overall Study|Lack of Efficacy|11|||
48815104|NCT01009047|157165690|FG000|Overall Study|Withdrawal by consent|16|||
48815105|NCT01009047|157165691|FG001|Overall Study|Withdrawal by consent|11|||
49127897|NCT00483652|158306974|FG001|Double-blind Treatment Period|Protocol inclusion deviation|0|||
49127898|NCT00483652|158306973|FG000|Double-blind Treatment Period|Withdrawal due to AE before study began|1|||
49127899|NCT00483652|158306974|FG001|Double-blind Treatment Period|Withdrawal due to AE before study began|0|||
49127900|NCT01245101|158306975|FG000|Period 1 (Treatment)|Withdrawal by Subject|2|||
49127901|NCT01245101|158306976|FG001|Period 1 (Treatment)|Withdrawal by Subject|0|||
49127902|NCT01245101|158306975|FG000|Period 2 (Washout)|Withdrawal by Subject|1|||
49127903|NCT01245101|158306976|FG001|Period 2 (Washout)|Withdrawal by Subject|0|||
49127904|NCT01245101|158306975|FG000|Period 3 (Treatment)|Withdrawal by Subject|1|||
49127905|NCT01245101|158306976|FG001|Period 3 (Treatment)|Withdrawal by Subject|0|||
49127906|NCT02858401|158306979|FG000|Overall Study|Withdrew Consent|0|||
49127907|NCT02858401|158306980|FG001|Overall Study|Withdrew Consent|0|||
49127908|NCT02858401|158306981|FG002|Overall Study|Withdrew Consent|0|||
49127909|NCT02858401|158306982|FG003|Overall Study|Withdrew Consent|0|||
49127910|NCT02858401|158306983|FG004|Overall Study|Withdrew Consent|0|||
49127911|NCT02858401|158306984|FG005|Overall Study|Withdrew Consent|1|||
48719012|NCT04740905|156821302|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|1|||
48815106|NCT01009047|157165690|FG000|Overall Study|Other|3|||
48815107|NCT01009047|157165691|FG001|Overall Study|Other|2|||
48815108|NCT02982720|157165694|FG000|Overall Study|Adverse Event|3|||
49127912|NCT02858401|158306985|FG006|Overall Study|Withdrew Consent|0|||
49127913|NCT02858401|158306979|FG000|Overall Study|Lost to Follow-up|0|||
49127914|NCT02858401|158306980|FG001|Overall Study|Lost to Follow-up|1|||
49127915|NCT02858401|158306981|FG002|Overall Study|Lost to Follow-up|0|||
49127916|NCT02858401|158306982|FG003|Overall Study|Lost to Follow-up|0|||
49127917|NCT02858401|158306983|FG004|Overall Study|Lost to Follow-up|0|||
48719013|NCT04740905|156821303|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
48815109|NCT02982720|157165694|FG000|Overall Study|Death|1|||
48815110|NCT03875911|157165697|FG000|Overall Study|Lost to Follow-up|3|||
48815111|NCT03875911|157165698|FG001|Overall Study|Lost to Follow-up|6|||
48815112|NCT03875911|157165699|FG002|Overall Study|Lost to Follow-up|2|||
48815113|NCT03875911|157165697|FG000|Overall Study|Surgery cancelled|1|||
48815114|NCT03875911|157165698|FG001|Overall Study|Surgery cancelled|0|||
48815115|NCT03875911|157165699|FG002|Overall Study|Surgery cancelled|1|||
48815116|NCT03875911|157165697|FG000|Overall Study|Insurance changed, standard of care visit not covered|0|||
48815117|NCT03875911|157165698|FG001|Overall Study|Insurance changed, standard of care visit not covered|0|||
48815118|NCT03875911|157165699|FG002|Overall Study|Insurance changed, standard of care visit not covered|1|||
48815119|NCT01388530|157165700|FG000|Overall Study|Lost to Follow-up|5|||
48815120|NCT02065570|157165703|FG000|Induction Study|Adverse Event|5|||
48815121|NCT02065570|157165704|FG001|Induction Study|Adverse Event|12|||
48815122|NCT02065570|157165705|FG002|Induction Study|Adverse Event|0|||
49127918|NCT02858401|158306984|FG005|Overall Study|Lost to Follow-up|0|||
49127919|NCT02858401|158306985|FG006|Overall Study|Lost to Follow-up|0|||
49127920|NCT01723072|158306986|FG000|Overall Study|Withdrawal by Subject|7|||
49127921|NCT01723072|158306987|FG001|Overall Study|Withdrawal by Subject|13|||
49127922|NCT01723072|158306986|FG000|Overall Study|Discon for rescue medication after wk 24|0|||
49127923|NCT01723072|158306987|FG001|Overall Study|Discon for rescue medication after wk 24|5|||
48815123|NCT02065570|157165706|FG003|Induction Study|Adverse Event|0|||
48815124|NCT02065570|157165703|FG000|Induction Study|Withdrawal by Subject|2|||
48815125|NCT02065570|157165704|FG001|Induction Study|Withdrawal by Subject|3|||
48815126|NCT02065570|157165705|FG002|Induction Study|Withdrawal by Subject|0|||
48815127|NCT02065570|157165706|FG003|Induction Study|Withdrawal by Subject|0|||
48815128|NCT02065570|157165703|FG000|Induction Study|Lost to Follow-up|1|||
48815129|NCT02065570|157165704|FG001|Induction Study|Lost to Follow-up|1|||
48815130|NCT02065570|157165705|FG002|Induction Study|Lost to Follow-up|0|||
48815131|NCT02065570|157165706|FG003|Induction Study|Lost to Follow-up|0|||
48815132|NCT02065570|157165703|FG000|Induction Study|Other, Not Specified|6|||
48815133|NCT02065570|157165704|FG001|Induction Study|Other, Not Specified|5|||
48815134|NCT02065570|157165705|FG002|Induction Study|Other, Not Specified|0|||
48815135|NCT02065570|157165706|FG003|Induction Study|Other, Not Specified|0|||
48815136|NCT02065570|157165703|FG000|Maintenance Study|Adverse Event|0|||
48815137|NCT02065570|157165704|FG001|Maintenance Study|Adverse Event|0|||
49127924|NCT01723072|158306986|FG000|Overall Study|Other|4|||
48815138|NCT02065570|157165705|FG002|Maintenance Study|Adverse Event|8|||
49127925|NCT01723072|158306987|FG001|Overall Study|Other|3|||
49127926|NCT04556760|158306993|FG000|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
49127927|NCT04556760|158306994|FG001|Treatment Period 1 (72 Hours)|Withdrawal by Subject|1|||
49127928|NCT04556760|158306995|FG002|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
49127929|NCT04556760|158306996|FG003|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
49127930|NCT04556760|158306997|FG004|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
49127931|NCT04556760|158306998|FG005|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
49127932|NCT04556760|158306993|FG000|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
49127933|NCT04556760|158306994|FG001|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
49127934|NCT04556760|158306995|FG002|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
49127935|NCT04556760|158306996|FG003|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|1|||
49127936|NCT04556760|158306997|FG004|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
49127937|NCT04556760|158306998|FG005|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
49127938|NCT05081388|158306999|FG000|Overall Study|Adverse Event|1|||
49127939|NCT05081388|158307000|FG001|Overall Study|Adverse Event|0|||
49127940|NCT05081388|158307001|FG002|Overall Study|Adverse Event|0|||
49127941|NCT05081388|158307002|FG003|Overall Study|Adverse Event|0|||
49127942|NCT05081388|158307003|FG004|Overall Study|Adverse Event|0|||
49127943|NCT05081388|158306999|FG000|Overall Study|Lost to Follow-up|0|||
49127944|NCT05081388|158307000|FG001|Overall Study|Lost to Follow-up|1|||
49127945|NCT05081388|158307001|FG002|Overall Study|Lost to Follow-up|0|||
49127946|NCT05081388|158307002|FG003|Overall Study|Lost to Follow-up|0|||
49127947|NCT05081388|158307003|FG004|Overall Study|Lost to Follow-up|0|||
49127948|NCT05081388|158306999|FG000|Overall Study|Subject decision|0|||
49127949|NCT05081388|158307000|FG001|Overall Study|Subject decision|0|||
49127950|NCT05081388|158307001|FG002|Overall Study|Subject decision|0|||
49127951|NCT05081388|158307002|FG003|Overall Study|Subject decision|1|||
49127952|NCT05081388|158307003|FG004|Overall Study|Subject decision|0|||
49127953|NCT00706004|158307007|FG000|Overall Study|Did not meet eligibility criteria|2|||
49127954|NCT01064479|158307010|FG000|Overall Study|Death|10|||
48815139|NCT02065570|157165706|FG003|Maintenance Study|Adverse Event|8|||
48815140|NCT02065570|157165703|FG000|Maintenance Study|Withdrawal by Subject|0|||
48815141|NCT02065570|157165704|FG001|Maintenance Study|Withdrawal by Subject|0|||
48815142|NCT02065570|157165705|FG002|Maintenance Study|Withdrawal by Subject|1|||
49127955|NCT01064479|158307011|FG001|Overall Study|Death|11|||
49127956|NCT01064479|158307010|FG000|Overall Study|Withdrawal by Subject|2|||
49127957|NCT01064479|158307011|FG001|Overall Study|Withdrawal by Subject|2|||
49127958|NCT01064479|158307010|FG000|Overall Study|Disease progression|1|||
49127959|NCT01064479|158307011|FG001|Overall Study|Disease progression|1|||
49127960|NCT01064479|158307010|FG000|Overall Study|Toxicity|1|||
49127961|NCT01064479|158307011|FG001|Overall Study|Toxicity|1|||
48815143|NCT02065570|157165706|FG003|Maintenance Study|Withdrawal by Subject|4|||
48815144|NCT02065570|157165703|FG000|Maintenance Study|Lost to Follow-up|0|||
48815145|NCT02065570|157165704|FG001|Maintenance Study|Lost to Follow-up|0|||
48815146|NCT02065570|157165705|FG002|Maintenance Study|Lost to Follow-up|2|||
48815147|NCT02065570|157165706|FG003|Maintenance Study|Lost to Follow-up|2|||
48815148|NCT02065570|157165703|FG000|Maintenance Study|Other, Not Specified|0|||
48815149|NCT02065570|157165704|FG001|Maintenance Study|Other, Not Specified|0|||
48815150|NCT02065570|157165705|FG002|Maintenance Study|Other, Not Specified|11|||
48815151|NCT02065570|157165706|FG003|Maintenance Study|Other, Not Specified|5|||
48815152|NCT01868074|157165710|FG000|Overall Study|Lost to Follow-up|3|||
48815153|NCT01868074|157165711|FG001|Overall Study|Lost to Follow-up|2|||
48815154|NCT01868074|157165710|FG000|Overall Study|Withdrawal by Subject|4|||
48815155|NCT01868074|157165711|FG001|Overall Study|Withdrawal by Subject|2|||
48815156|NCT03770273|157165712|FG000|Overall Study|Adverse Event|2|||
48815157|NCT03770273|157165713|FG001|Overall Study|Adverse Event|0|||
48815158|NCT03770273|157165712|FG000|Overall Study|Lost to Follow-up|1|||
48815159|NCT03770273|157165713|FG001|Overall Study|Lost to Follow-up|1|||
48815160|NCT03306043|157165714|FG000|Overall Study|Adverse Event|1|||
48815161|NCT03306043|157165714|FG000|Overall Study|Lost to Follow-up|1|||
48815162|NCT03306043|157165714|FG000|Overall Study|Withdrawal by Subject|2|||
48815163|NCT02087150|157165715|FG000|Overall Study|Death|0|||
48815164|NCT02087150|157165716|FG001|Overall Study|Death|1|||
48815165|NCT02087150|157165717|FG002|Overall Study|Death|0|||
48815166|NCT02087150|157165715|FG000|Overall Study|Lost to Follow-up|6|||
48815167|NCT02087150|157165716|FG001|Overall Study|Lost to Follow-up|13|||
48815168|NCT02087150|157165717|FG002|Overall Study|Lost to Follow-up|7|||
48815169|NCT02087150|157165715|FG000|Overall Study|Withdrawal by Subject|2|||
48815170|NCT02087150|157165716|FG001|Overall Study|Withdrawal by Subject|5|||
49127962|NCT01064479|158307010|FG000|Overall Study|Other|1|||
49127963|NCT01064479|158307011|FG001|Overall Study|Other|2|||
49127964|NCT02785939|158307014|FG000|Overall Study|Progression|25|||
49127965|NCT02785939|158307015|FG001|Overall Study|Progression|8|||
49127966|NCT02785939|158307014|FG000|Overall Study|Adverse Event|3|||
49127967|NCT02785939|158307015|FG001|Overall Study|Adverse Event|1|||
49127968|NCT02785939|158307014|FG000|Overall Study|Death|1|||
49127969|NCT02785939|158307015|FG001|Overall Study|Death|0|||
49127970|NCT02785939|158307014|FG000|Overall Study|Refusal|1|||
49127971|NCT02785939|158307015|FG001|Overall Study|Refusal|0|||
49127972|NCT02785939|158307014|FG000|Overall Study|Deteriorating health|1|||
49127973|NCT02785939|158307015|FG001|Overall Study|Deteriorating health|0|||
49127974|NCT02785939|158307014|FG000|Overall Study|Not protocol specified|0|||
49127975|NCT02785939|158307015|FG001|Overall Study|Not protocol specified|1|||
49127976|NCT01474486|158307016|FG000|Overall Study|Death|2|||
49127977|NCT01474486|158307016|FG000|Overall Study|Withdrawal by Subject|4|||
49127978|NCT01474486|158307016|FG000|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2|||
49127979|NCT01255163|158307017|FG000|Overall Study|Withdrawal by Subject|1|||
49127980|NCT01255163|158307018|FG001|Overall Study|Withdrawal by Subject|0|||
49127981|NCT01255163|158307017|FG000|Overall Study|Lost to Follow-up|2|||
49127982|NCT01255163|158307018|FG001|Overall Study|Lost to Follow-up|0|||
49127983|NCT01255163|158307017|FG000|Overall Study|Adverse Event|0|||
49127984|NCT01255163|158307018|FG001|Overall Study|Adverse Event|2|||
49127985|NCT01255163|158307017|FG000|Overall Study|AstraZeneca stopped support of the study|1|||
49127986|NCT01255163|158307018|FG001|Overall Study|AstraZeneca stopped support of the study|3|||
49127987|NCT00490035|158307019|FG000|Overall Study|AE, non-serious non-fatal|3|||
49127988|NCT00490035|158307020|FG001|Overall Study|AE, non-serious non-fatal|4|||
49127989|NCT00490035|158307021|FG002|Overall Study|AE, non-serious non-fatal|4|||
49127990|NCT00490035|158307022|FG003|Overall Study|AE, non-serious non-fatal|5|||
49127991|NCT00490035|158307019|FG000|Overall Study|Lost to Follow-up|2|||
49127992|NCT00490035|158307020|FG001|Overall Study|Lost to Follow-up|0|||
49127993|NCT00490035|158307021|FG002|Overall Study|Lost to Follow-up|1|||
49127994|NCT00490035|158307022|FG003|Overall Study|Lost to Follow-up|0|||
49127995|NCT00490035|158307019|FG000|Overall Study|Withdrawal by Subject|2|||
49127996|NCT00490035|158307020|FG001|Overall Study|Withdrawal by Subject|1|||
49127997|NCT00490035|158307021|FG002|Overall Study|Withdrawal by Subject|1|||
49127998|NCT00490035|158307022|FG003|Overall Study|Withdrawal by Subject|0|||
49127999|NCT00490035|158307019|FG000|Overall Study|Other reason|0|||
49128000|NCT00490035|158307020|FG001|Overall Study|Other reason|1|||
49128001|NCT00490035|158307021|FG002|Overall Study|Other reason|3|||
49128002|NCT00490035|158307022|FG003|Overall Study|Other reason|1|||
49128003|NCT00490035|158307019|FG000|Overall Study|AE, serious fatal|1|||
49128004|NCT00490035|158307020|FG001|Overall Study|AE, serious fatal|0|||
49128005|NCT00490035|158307021|FG002|Overall Study|AE, serious fatal|0|||
49128006|NCT00490035|158307022|FG003|Overall Study|AE, serious fatal|0|||
48815171|NCT02087150|157165717|FG002|Overall Study|Withdrawal by Subject|3|||
48815172|NCT02087150|157165715|FG000|Overall Study|Physician Decision|0|||
48815173|NCT02087150|157165716|FG001|Overall Study|Physician Decision|1|||
48815174|NCT02087150|157165717|FG002|Overall Study|Physician Decision|0|||
48815175|NCT02087150|157165715|FG000|Overall Study|Procedure not done|1|||
48719014|NCT04740905|156821302|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
48719015|NCT04740905|156821303|FG001|Part 1 (Baseline up to Week 24)|Death|0|||
48719016|NCT04740905|156821302|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|13|||
48719017|NCT04740905|156821303|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|12|||
48719018|NCT04740905|156821302|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|7|||
48719019|NCT04740905|156821303|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|6|||
48815176|NCT02087150|157165716|FG001|Overall Study|Procedure not done|13|||
48815177|NCT02087150|157165717|FG002|Overall Study|Procedure not done|0|||
48815178|NCT02087150|157165715|FG000|Overall Study|F/U not completed w/in study window|0|||
48815179|NCT02087150|157165716|FG001|Overall Study|F/U not completed w/in study window|0|||
48719020|NCT04740905|156821302|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|0|||
48719021|NCT04740905|156821303|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|4|||
48719022|NCT04740905|156821302|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|0|||
48719023|NCT04740905|156821303|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|4|||
48815180|NCT02087150|157165717|FG002|Overall Study|F/U not completed w/in study window|1|||
48815181|NCT02087150|157165715|FG000|Overall Study|Other|1|||
48815182|NCT02087150|157165716|FG001|Overall Study|Other|0|||
48815183|NCT02087150|157165717|FG002|Overall Study|Other|0|||
48815184|NCT02087150|157165715|FG000|Overall Study|Pt moved out of town|0|||
48815185|NCT02087150|157165716|FG001|Overall Study|Pt moved out of town|1|||
48815186|NCT02087150|157165717|FG002|Overall Study|Pt moved out of town|0|||
48815187|NCT00393094|157165719|FG000|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1|||
48815188|NCT00393094|157165719|FG000|Disease Progression After Trtmt: Onstudy|Refused further treatment|1|||
48815189|NCT02019602|157165720|FG000|Screening Period|Ineligibility|4|||
48815190|NCT02019602|157165721|FG001|Screening Period|Ineligibility|0|||
48815191|NCT02019602|157165720|FG000|Screening Period|Adverse Event|1|||
48815192|NCT02019602|157165721|FG001|Screening Period|Adverse Event|0|||
48815193|NCT01448044|157165722|FG000|Treatment Period|Adverse Event|4|||
48815194|NCT01448044|157165723|FG001|Treatment Period|Adverse Event|3|||
48815195|NCT01448044|157165722|FG000|Treatment Period|Lack of Efficacy|5|||
48815196|NCT01448044|157165723|FG001|Treatment Period|Lack of Efficacy|12|||
48815197|NCT01448044|157165722|FG000|Treatment Period|Subject requested discontinue study drug|1|||
48815198|NCT01448044|157165723|FG001|Treatment Period|Subject requested discontinue study drug|0|||
48815199|NCT01448044|157165722|FG000|Treatment Period|Completed 24 weeks treatment period only|8|||
48815200|NCT01448044|157165723|FG001|Treatment Period|Completed 24 weeks treatment period only|0|||
48815201|NCT01448044|157165722|FG000|Treatment Period|Participant does not meet study criteria|1|||
48815202|NCT01448044|157165723|FG001|Treatment Period|Participant does not meet study criteria|0|||
48815203|NCT01448044|157165722|FG000|Treatment Period|Lost to Follow-up|2|||
48815204|NCT01448044|157165723|FG001|Treatment Period|Lost to Follow-up|1|||
48815205|NCT01448044|157165722|FG000|Treatment Period|Other reason|2|||
48815206|NCT01448044|157165723|FG001|Treatment Period|Other reason|0|||
48815207|NCT01448044|157165722|FG000|Follow Up Period|Withdrawal by Subject|1|||
48815208|NCT01448044|157165723|FG001|Follow Up Period|Withdrawal by Subject|1|||
48815209|NCT01448044|157165722|FG000|Follow Up Period|Lost to Follow-up|6|||
48815210|NCT01448044|157165723|FG001|Follow Up Period|Lost to Follow-up|2|||
48815211|NCT01448044|157165722|FG000|Follow Up Period|Other|5|||
48815212|NCT01448044|157165723|FG001|Follow Up Period|Other|11|||
48815213|NCT02372058|157165725|FG000|Overall Study|Withdrawal by Subject|3|||
49128007|NCT00490035|158307019|FG000|Overall Study|Serious adverse event (SAE), non-fatal|0|||
49128008|NCT00490035|158307020|FG001|Overall Study|Serious adverse event (SAE), non-fatal|0|||
49128009|NCT00490035|158307021|FG002|Overall Study|Serious adverse event (SAE), non-fatal|1|||
49128010|NCT00490035|158307022|FG003|Overall Study|Serious adverse event (SAE), non-fatal|0|||
49128011|NCT00490035|158307019|FG000|Overall Study|AE of unknown type|0|||
49128012|NCT00490035|158307020|FG001|Overall Study|AE of unknown type|0|||
49128013|NCT00490035|158307021|FG002|Overall Study|AE of unknown type|2|||
49128014|NCT00490035|158307022|FG003|Overall Study|AE of unknown type|0|||
49128015|NCT02295644|158307023|FG000|Overall Study|Did not meet inclusion criterion|0|||
49128016|NCT02295644|158307024|FG001|Overall Study|Did not meet inclusion criterion|0|||
49128017|NCT02295644|158307025|FG002|Overall Study|Did not meet inclusion criterion|1|||
49128018|NCT02295644|158307026|FG003|Overall Study|Did not meet inclusion criterion|2|||
49128019|NCT01103323|158307027|FG000|Without/Before Drug Switch|Adverse Event|50|||
49128020|NCT01103323|158307028|FG001|Without/Before Drug Switch|Adverse Event|7|||
49128021|NCT01103323|158307027|FG000|Without/Before Drug Switch|Withdrawal by Subject|17|||
49128022|NCT01103323|158307028|FG001|Without/Before Drug Switch|Withdrawal by Subject|5|||
49128023|NCT01103323|158307027|FG000|Without/Before Drug Switch|Protocol Violation|2|||
48815214|NCT02788006|157165726|FG000|Overall Study|Patient not treated|1|||
48815215|NCT02397460|157165728|FG000|Treatment Period 2|Adverse Event|0|||
48815216|NCT02397460|157165729|FG001|Treatment Period 2|Adverse Event|0|||
48815217|NCT02397460|157165730|FG002|Treatment Period 2|Adverse Event|0|||
48815218|NCT02397460|157165731|FG003|Treatment Period 2|Adverse Event|0|||
48815219|NCT02397460|157165732|FG004|Treatment Period 2|Adverse Event|0|||
48815220|NCT02397460|157165733|FG005|Treatment Period 2|Adverse Event|0|||
48815221|NCT02397460|157165734|FG006|Treatment Period 2|Adverse Event|0|||
48815222|NCT02397460|157165735|FG007|Treatment Period 2|Adverse Event|1|||
49128024|NCT01103323|158307028|FG001|Without/Before Drug Switch|Protocol Violation|0|||
49128025|NCT01103323|158307027|FG000|Without/Before Drug Switch|Physician Decision|2|||
48815223|NCT02397460|157165728|FG000|Treatment Period 4|Adverse Event|0|||
48815224|NCT02397460|157165729|FG001|Treatment Period 4|Adverse Event|1|||
48815225|NCT02397460|157165730|FG002|Treatment Period 4|Adverse Event|0|||
48815226|NCT02397460|157165731|FG003|Treatment Period 4|Adverse Event|0|||
48815227|NCT02397460|157165732|FG004|Treatment Period 4|Adverse Event|0|||
48815228|NCT02397460|157165733|FG005|Treatment Period 4|Adverse Event|0|||
48815229|NCT02397460|157165734|FG006|Treatment Period 4|Adverse Event|0|||
48815230|NCT02397460|157165735|FG007|Treatment Period 4|Adverse Event|0|||
48815231|NCT02397460|157165728|FG000|Treatment Period 4|Physician Decision|0|||
48815232|NCT02397460|157165729|FG001|Treatment Period 4|Physician Decision|0|||
48815233|NCT02397460|157165730|FG002|Treatment Period 4|Physician Decision|0|||
48815234|NCT02397460|157165731|FG003|Treatment Period 4|Physician Decision|0|||
49128026|NCT01103323|158307028|FG001|Without/Before Drug Switch|Physician Decision|0|||
49128027|NCT01103323|158307027|FG000|Without/Before Drug Switch|did not receive study treatment|5|||
49128028|NCT01103323|158307028|FG001|Without/Before Drug Switch|did not receive study treatment|2|||
49128029|NCT01103323|158307027|FG000|Without/Before Drug Switch|Switch to Regorafenib|0|||
49128030|NCT01103323|158307028|FG001|Without/Before Drug Switch|Switch to Regorafenib|4|||
49128031|NCT01103323|158307027|FG000|Switched From Placebo to Regorafenib|Adverse Event|0|||
49128032|NCT01103323|158307028|FG001|Switched From Placebo to Regorafenib|Adverse Event|1|||
49128033|NCT00086190|158307041|FG000|Overall Study|Adverse Event|6|||
49128034|NCT00086190|158307042|FG001|Overall Study|Adverse Event|2|||
49128035|NCT00086190|158307043|FG002|Overall Study|Adverse Event|2|||
49128036|NCT00086190|158307041|FG000|Overall Study|Withdrawal by Subject|0|||
48719024|NCT04740905|156821302|FG000|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
48719025|NCT04740905|156821303|FG001|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
48719026|NCT04740905|156821302|FG000|Part 2 (Week 24 to Week 72)|Death|1|||
48719027|NCT04740905|156821303|FG001|Part 2 (Week 24 to Week 72)|Death|2|||
48719028|NCT04740905|156821302|FG000|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|2|||
48719029|NCT04740905|156821303|FG001|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|1|||
48719030|NCT04740905|156821302|FG000|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|1|||
48719031|NCT04740905|156821303|FG001|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|0|||
48719032|NCT04740905|156821302|FG000|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|1|||
48719033|NCT04740905|156821303|FG001|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|0|||
48719034|NCT01073462|156821304|FG000|Overall Study|Death|14|||
48719035|NCT01073462|156821304|FG000|Overall Study|Kidney transplant|10|||
48719036|NCT01073462|156821304|FG000|Overall Study|Low parathyroid hormone levels|8|||
48719037|NCT01073462|156821304|FG000|Overall Study|Serious adverse event|2|||
48719038|NCT01073462|156821304|FG000|Overall Study|Lost to Follow-up|7|||
48719039|NCT01433250|156821309|FG000|Overall Study|Protocol Violation|0|||
48719040|NCT01433250|156821310|FG001|Overall Study|Protocol Violation|1|||
48719041|NCT01433250|156821309|FG000|Overall Study|Withdrawal by Subject|3|||
48719042|NCT01433250|156821310|FG001|Overall Study|Withdrawal by Subject|2|||
48719043|NCT01261780|156821314|FG000|Overall Study|Withdrawal by Subject|1|||
48719044|NCT01261780|156821315|FG001|Overall Study|Withdrawal by Subject|0|||
48719045|NCT01261780|156821314|FG000|Overall Study|Event not related to subject|1|||
48719046|NCT01261780|156821315|FG001|Overall Study|Event not related to subject|2|||
48719047|NCT01239732|156821316|FG000|Overall Study|Termination of study per protocol|667|||
48719048|NCT01239732|156821316|FG000|Overall Study|Death|226|||
48719049|NCT01239732|156821316|FG000|Overall Study|Withdrawal by Subject|87|||
48719050|NCT01239732|156821316|FG000|Overall Study|Adverse Event|6|||
48719051|NCT01239732|156821316|FG000|Overall Study|Protocol Violation|3|||
48719052|NCT01239732|156821316|FG000|Overall Study|Participant non compliance|5|||
48719053|NCT01239732|156821316|FG000|Overall Study|Study termination by sponsor|2|||
48719054|NCT01239732|156821316|FG000|Overall Study|Investigator's decision|4|||
48719055|NCT01239732|156821316|FG000|Overall Study|Treatment failure|2|||
48719056|NCT01239732|156821316|FG000|Overall Study|Other|19|||
48719057|NCT02431260|156821317|FG000|Overall Study|Subject Decision|0|||
48719058|NCT02431260|156821318|FG001|Overall Study|Subject Decision|1|||
48719059|NCT02431260|156821319|FG002|Overall Study|Subject Decision|1|||
48719060|NCT02431260|156821320|FG003|Overall Study|Subject Decision|0|||
48719061|NCT02431260|156821321|FG004|Overall Study|Subject Decision|0|||
48719062|NCT02431260|156821322|FG005|Overall Study|Subject Decision|0|||
48719063|NCT02431260|156821323|FG006|Overall Study|Subject Decision|0|||
48719064|NCT02431260|156821324|FG007|Overall Study|Subject Decision|0|||
48719065|NCT02431260|156821325|FG008|Overall Study|Subject Decision|1|||
48719066|NCT02431260|156821326|FG009|Overall Study|Subject Decision|1|||
48719067|NCT02431260|156821327|FG010|Overall Study|Subject Decision|0|||
48719068|NCT02431260|156821328|FG011|Overall Study|Subject Decision|1|||
48719069|NCT02431260|156821329|FG012|Overall Study|Subject Decision|0|||
48719070|NCT02431260|156821330|FG013|Overall Study|Subject Decision|0|||
48719071|NCT02431260|156821317|FG000|Overall Study|Death|4|||
48719072|NCT02431260|156821318|FG001|Overall Study|Death|4|||
48719073|NCT02431260|156821319|FG002|Overall Study|Death|3|||
48719074|NCT02431260|156821320|FG003|Overall Study|Death|4|||
48719075|NCT02431260|156821321|FG004|Overall Study|Death|2|||
48815235|NCT02397460|157165732|FG004|Treatment Period 4|Physician Decision|1|||
48815236|NCT02397460|157165733|FG005|Treatment Period 4|Physician Decision|0|||
48815237|NCT02397460|157165734|FG006|Treatment Period 4|Physician Decision|0|||
48815238|NCT02397460|157165735|FG007|Treatment Period 4|Physician Decision|0|||
48815239|NCT01349660|157165740|FG000|Overall Study|Still Receiving Study Treatment|0|||
48815240|NCT01349660|157165741|FG001|Overall Study|Still Receiving Study Treatment|0|||
48815241|NCT01349660|157165742|FG002|Overall Study|Still Receiving Study Treatment|1|||
48815242|NCT01349660|157165740|FG000|Overall Study|Disease Progression|2|||
48815243|NCT01349660|157165741|FG001|Overall Study|Disease Progression|4|||
48719076|NCT02431260|156821322|FG005|Overall Study|Death|2|||
48719077|NCT02431260|156821323|FG006|Overall Study|Death|3|||
48719078|NCT02431260|156821324|FG007|Overall Study|Death|1|||
48719079|NCT02431260|156821325|FG008|Overall Study|Death|6|||
48719080|NCT02431260|156821326|FG009|Overall Study|Death|6|||
49128037|NCT00086190|158307042|FG001|Overall Study|Withdrawal by Subject|2|||
48815244|NCT01349660|157165742|FG002|Overall Study|Disease Progression|50|||
48815245|NCT01349660|157165740|FG000|Overall Study|Adverse Event|1|||
48815246|NCT01349660|157165741|FG001|Overall Study|Adverse Event|1|||
48815247|NCT01349660|157165742|FG002|Overall Study|Adverse Event|12|||
48815248|NCT01349660|157165740|FG000|Overall Study|Withdrawal by Subject|2|||
48815249|NCT01349660|157165741|FG001|Overall Study|Withdrawal by Subject|0|||
49128038|NCT00086190|158307043|FG002|Overall Study|Withdrawal by Subject|2|||
49128039|NCT00086190|158307041|FG000|Overall Study|Protocol Violation|1|||
49128040|NCT00086190|158307042|FG001|Overall Study|Protocol Violation|0|||
49128041|NCT00086190|158307043|FG002|Overall Study|Protocol Violation|0|||
49128042|NCT00086190|158307041|FG000|Overall Study|Moved|1|||
49128043|NCT00086190|158307042|FG001|Overall Study|Moved|0|||
49128044|NCT00086190|158307043|FG002|Overall Study|Moved|0|||
49128045|NCT00086190|158307041|FG000|Overall Study|Worsening depression|0|||
49128046|NCT00086190|158307042|FG001|Overall Study|Worsening depression|0|||
49128047|NCT00086190|158307043|FG002|Overall Study|Worsening depression|2|||
49128048|NCT00249834|158307044|FG000|Overall Study|Ovarian stimulation failed|1|||
49128049|NCT00249834|158307045|FG001|Overall Study|Ovarian stimulation failed|0|||
49128050|NCT00249834|158307046|FG002|Overall Study|Ovarian stimulation failed|0|||
49128051|NCT00249834|158307047|FG003|Overall Study|Ovarian stimulation failed|0|||
49128052|NCT00249834|158307048|FG004|Overall Study|Ovarian stimulation failed|0|||
49128053|NCT00249834|158307049|FG005|Overall Study|Ovarian stimulation failed|0|||
49128054|NCT00249834|158307050|FG006|Overall Study|Ovarian stimulation failed|0|||
49128055|NCT00249834|158307051|FG007|Overall Study|Ovarian stimulation failed|0|||
49128056|NCT00249834|158307044|FG000|Overall Study|Failure of down-regulation|0|||
49128057|NCT00249834|158307045|FG001|Overall Study|Failure of down-regulation|0|||
49128058|NCT00249834|158307046|FG002|Overall Study|Failure of down-regulation|0|||
49128059|NCT00249834|158307047|FG003|Overall Study|Failure of down-regulation|0|||
49128060|NCT00249834|158307048|FG004|Overall Study|Failure of down-regulation|0|||
49128061|NCT00249834|158307049|FG005|Overall Study|Failure of down-regulation|0|||
49128062|NCT00249834|158307050|FG006|Overall Study|Failure of down-regulation|1|||
49128063|NCT00249834|158307051|FG007|Overall Study|Failure of down-regulation|0|||
49128064|NCT00249834|158307044|FG000|Overall Study|Protocol Violation|0|||
49128065|NCT00249834|158307045|FG001|Overall Study|Protocol Violation|19|||
49128066|NCT00249834|158307046|FG002|Overall Study|Protocol Violation|14|||
49128067|NCT00249834|158307047|FG003|Overall Study|Protocol Violation|8|||
49128068|NCT00249834|158307048|FG004|Overall Study|Protocol Violation|5|||
49128069|NCT00249834|158307049|FG005|Overall Study|Protocol Violation|2|||
49128070|NCT00249834|158307050|FG006|Overall Study|Protocol Violation|0|||
49128071|NCT00249834|158307051|FG007|Overall Study|Protocol Violation|0|||
49128072|NCT02187783|158307052|FG000|Overall Study|Adverse Event|8|||
49128073|NCT02187783|158307052|FG000|Overall Study|Death|3|||
49128074|NCT02187783|158307052|FG000|Overall Study|Progressive disease|80|||
49128075|NCT02187783|158307052|FG000|Overall Study|Protocol Violation|3|||
49128076|NCT02187783|158307052|FG000|Overall Study|Physician Decision|2|||
49128077|NCT02187783|158307052|FG000|Overall Study|Withdrawal by Subject|9|||
49128078|NCT02187783|158307052|FG000|Overall Study|Study terminated by sponsor|1|||
49128079|NCT02801331|158307053|FG000|Overall Study|Transferred to another hospital|8|||
49128080|NCT02801331|158307054|FG001|Overall Study|Transferred to another hospital|7|||
49128081|NCT02801331|158307053|FG000|Overall Study|Withdrawal by Subject|0|||
48719081|NCT02431260|156821327|FG010|Overall Study|Death|3|||
49128082|NCT02801331|158307054|FG001|Overall Study|Withdrawal by Subject|4|||
49128083|NCT02801331|158307053|FG000|Overall Study|Subsequently met exclusion/withdrawal criteria|3|||
49128084|NCT02801331|158307054|FG001|Overall Study|Subsequently met exclusion/withdrawal criteria|5|||
49128085|NCT00875810|158307055|FG000|Overall Study|Withdrawal by Subject|1|||
49128086|NCT00875810|158307055|FG000|Overall Study|Physician Decision|3|||
48719082|NCT02431260|156821328|FG011|Overall Study|Death|2|||
49128087|NCT00875810|158307055|FG000|Overall Study|Lost to Follow-up|39|||
48719083|NCT02431260|156821329|FG012|Overall Study|Death|5|||
48719084|NCT02431260|156821330|FG013|Overall Study|Death|1|||
48719085|NCT02431260|156821317|FG000|Overall Study|Lost to Follow-up|0|||
48719086|NCT02431260|156821318|FG001|Overall Study|Lost to Follow-up|0|||
48719087|NCT02431260|156821319|FG002|Overall Study|Lost to Follow-up|0|||
48719088|NCT02431260|156821320|FG003|Overall Study|Lost to Follow-up|0|||
48719089|NCT02431260|156821321|FG004|Overall Study|Lost to Follow-up|0|||
48719090|NCT02431260|156821322|FG005|Overall Study|Lost to Follow-up|1|||
48719091|NCT02431260|156821323|FG006|Overall Study|Lost to Follow-up|0|||
48719092|NCT02431260|156821324|FG007|Overall Study|Lost to Follow-up|0|||
48719093|NCT02431260|156821325|FG008|Overall Study|Lost to Follow-up|0|||
48719094|NCT02431260|156821326|FG009|Overall Study|Lost to Follow-up|0|||
48719095|NCT02431260|156821327|FG010|Overall Study|Lost to Follow-up|0|||
48719096|NCT02431260|156821328|FG011|Overall Study|Lost to Follow-up|0|||
48719097|NCT02431260|156821329|FG012|Overall Study|Lost to Follow-up|0|||
48719098|NCT02431260|156821330|FG013|Overall Study|Lost to Follow-up|0|||
48719099|NCT02431260|156821317|FG000|Overall Study|Study Terminated by the Sponsor|0|||
48719100|NCT02431260|156821318|FG001|Overall Study|Study Terminated by the Sponsor|0|||
48719101|NCT02431260|156821319|FG002|Overall Study|Study Terminated by the Sponsor|2|||
48719102|NCT02431260|156821320|FG003|Overall Study|Study Terminated by the Sponsor|1|||
48719103|NCT02431260|156821321|FG004|Overall Study|Study Terminated by the Sponsor|1|||
48719104|NCT02431260|156821322|FG005|Overall Study|Study Terminated by the Sponsor|0|||
48815250|NCT01349660|157165742|FG002|Overall Study|Withdrawal by Subject|9|||
48815251|NCT01349660|157165740|FG000|Overall Study|Death|1|||
48815252|NCT01349660|157165741|FG001|Overall Study|Death|1|||
48815253|NCT01349660|157165742|FG002|Overall Study|Death|0|||
48815254|NCT01349660|157165740|FG000|Overall Study|Non-Permitted Interventions|0|||
48815255|NCT01349660|157165741|FG001|Overall Study|Non-Permitted Interventions|0|||
48719105|NCT02431260|156821323|FG006|Overall Study|Study Terminated by the Sponsor|1|||
48719106|NCT02431260|156821324|FG007|Overall Study|Study Terminated by the Sponsor|2|||
48719107|NCT02431260|156821325|FG008|Overall Study|Study Terminated by the Sponsor|1|||
48719108|NCT02431260|156821326|FG009|Overall Study|Study Terminated by the Sponsor|1|||
49128088|NCT00875810|158307055|FG000|Overall Study|Patient enroled but not implanted|2|||
49128089|NCT00875810|158307055|FG000|Overall Study|Device explanted|1|||
49128090|NCT03234465|158307056|FG000|Overall Study|Adverse Event|4|||
49128091|NCT03234465|158307057|FG001|Overall Study|Adverse Event|2|||
49128092|NCT03234465|158307056|FG000|Overall Study|Death|0|||
49128093|NCT03234465|158307057|FG001|Overall Study|Death|1|||
49128094|NCT03234465|158307056|FG000|Overall Study|Lost to Follow-up|1|||
49128095|NCT03234465|158307057|FG001|Overall Study|Lost to Follow-up|1|||
49128096|NCT03234465|158307056|FG000|Overall Study|Withdrawal by Subject|12|||
49128097|NCT03234465|158307057|FG001|Overall Study|Withdrawal by Subject|27|||
49128098|NCT03234465|158307056|FG000|Overall Study|Symptomatic deterioration|0|||
49128099|NCT03234465|158307057|FG001|Overall Study|Symptomatic deterioration|1|||
49128100|NCT03234465|158307056|FG000|Overall Study|Non-compliance|2|||
49128101|NCT03234465|158307057|FG001|Overall Study|Non-compliance|0|||
49128102|NCT03234465|158307056|FG000|Overall Study|Other|14|||
49128103|NCT03234465|158307057|FG001|Overall Study|Other|8|||
49128104|NCT03368664|158307058|FG000|Phase1: Prior DMT:Month -4 to Month 0|Physician Decision|1|||
49128105|NCT03368664|158307058|FG000|Phase1: Prior DMT:Month -4 to Month 0|Participant was withdrawn from study|1|||
49128106|NCT03368664|158307058|FG000|Phase1: Prior DMT:Month -4 to Month 0|Principal Investigator and Parents Decision|1|||
49128107|NCT03368664|158307058|FG000|Phase1: Prior DMT:Month -4 to Month 0|Still on Prior DMT Phase or missing Completion|1|||
49128108|NCT00843492|158307065|FG000|Overall Study|Adverse Event|0|||
49128109|NCT00843492|158307066|FG001|Overall Study|Adverse Event|3|||
49128110|NCT00843492|158307065|FG000|Overall Study|Lost to Follow-up|4|||
48719109|NCT02431260|156821327|FG010|Overall Study|Study Terminated by the Sponsor|1|||
48815256|NCT01349660|157165742|FG002|Overall Study|Non-Permitted Interventions|2|||
48815257|NCT01349660|157165740|FG000|Overall Study|Study Compliance|0|||
48719110|NCT02431260|156821328|FG011|Overall Study|Study Terminated by the Sponsor|0|||
49128111|NCT00843492|158307066|FG001|Overall Study|Lost to Follow-up|4|||
48719111|NCT02431260|156821329|FG012|Overall Study|Study Terminated by the Sponsor|4|||
48719112|NCT02431260|156821330|FG013|Overall Study|Study Terminated by the Sponsor|0|||
48719113|NCT02431260|156821317|FG000|Overall Study|Physician Decision|0|||
48719114|NCT02431260|156821318|FG001|Overall Study|Physician Decision|0|||
48719115|NCT02431260|156821319|FG002|Overall Study|Physician Decision|0|||
48815258|NCT01349660|157165741|FG001|Overall Study|Study Compliance|0|||
48815259|NCT01349660|157165742|FG002|Overall Study|Study Compliance|1|||
49128112|NCT00843492|158307065|FG000|Overall Study|Withdrawal by Subject|0|||
49128113|NCT00843492|158307066|FG001|Overall Study|Withdrawal by Subject|4|||
48719116|NCT02431260|156821320|FG003|Overall Study|Physician Decision|0|||
48719117|NCT02431260|156821321|FG004|Overall Study|Physician Decision|0|||
48719118|NCT02431260|156821322|FG005|Overall Study|Physician Decision|1|||
48719119|NCT02431260|156821323|FG006|Overall Study|Physician Decision|0|||
48719120|NCT02431260|156821324|FG007|Overall Study|Physician Decision|0|||
48719121|NCT02431260|156821325|FG008|Overall Study|Physician Decision|0|||
48719122|NCT02431260|156821326|FG009|Overall Study|Physician Decision|0|||
48719123|NCT02431260|156821327|FG010|Overall Study|Physician Decision|0|||
48719124|NCT02431260|156821328|FG011|Overall Study|Physician Decision|0|||
48719125|NCT02431260|156821329|FG012|Overall Study|Physician Decision|0|||
48719126|NCT02431260|156821330|FG013|Overall Study|Physician Decision|0|||
48719127|NCT02431260|156821317|FG000|Overall Study|Other Unspecified|0|||
48719128|NCT02431260|156821318|FG001|Overall Study|Other Unspecified|0|||
48719129|NCT02431260|156821319|FG002|Overall Study|Other Unspecified|0|||
48719130|NCT02431260|156821320|FG003|Overall Study|Other Unspecified|0|||
48719131|NCT02431260|156821321|FG004|Overall Study|Other Unspecified|0|||
48719132|NCT02431260|156821322|FG005|Overall Study|Other Unspecified|0|||
48719133|NCT02431260|156821323|FG006|Overall Study|Other Unspecified|0|||
48719134|NCT02431260|156821324|FG007|Overall Study|Other Unspecified|0|||
48719135|NCT02431260|156821325|FG008|Overall Study|Other Unspecified|0|||
48719136|NCT02431260|156821326|FG009|Overall Study|Other Unspecified|0|||
48719137|NCT02431260|156821327|FG010|Overall Study|Other Unspecified|0|||
48719138|NCT02431260|156821328|FG011|Overall Study|Other Unspecified|1|||
48719139|NCT02431260|156821329|FG012|Overall Study|Other Unspecified|1|||
48719140|NCT02431260|156821330|FG013|Overall Study|Other Unspecified|0|||
48719141|NCT00321646|156821331|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
48719142|NCT00321646|156821331|FG000|Neoadjuvant Chemotherapy|Adverse Event|2|||
48719143|NCT00321646|156821331|FG000|Neoadjuvant Chemotherapy|Disease progression|1|||
48719144|NCT01381562|156821337|FG000|Overall Study|Adverse Event|0|||
48719145|NCT01381562|156821338|FG001|Overall Study|Adverse Event|1|||
48719146|NCT01381562|156821339|FG002|Overall Study|Adverse Event|0|||
48815260|NCT01349660|157165740|FG000|Overall Study|Declining Performance Status|0|||
48815261|NCT01349660|157165741|FG001|Overall Study|Declining Performance Status|0|||
48815262|NCT01349660|157165742|FG002|Overall Study|Declining Performance Status|1|||
48815263|NCT01563978|157165751|FG000|Overall Study|Physician Decision|1|||
48815264|NCT01563978|157165752|FG001|Overall Study|Physician Decision|0|||
49128114|NCT00843492|158307065|FG000|Overall Study|Immobilization Stopped|1|||
49128115|NCT00843492|158307066|FG001|Overall Study|Immobilization Stopped|0|||
49128116|NCT00843492|158307065|FG000|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
49128117|NCT00843492|158307066|FG001|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
49128118|NCT00843492|158307065|FG000|Overall Study|Orthopedic Surgery|0|||
49128119|NCT00843492|158307066|FG001|Overall Study|Orthopedic Surgery|2|||
49128120|NCT00843492|158307065|FG000|Overall Study|Visit Not Performed|1|||
49128121|NCT00843492|158307066|FG001|Overall Study|Visit Not Performed|0|||
49128122|NCT00843492|158307065|FG000|Overall Study|Deep-vein Thrombosis|1|||
49128123|NCT00843492|158307066|FG001|Overall Study|Deep-vein Thrombosis|0|||
49128124|NCT01100502|158307068|FG000|Overall Study|Withdrawal by Subject|18|||
49128125|NCT01100502|158307069|FG001|Overall Study|Withdrawal by Subject|25|||
49128126|NCT01100502|158307068|FG000|Overall Study|Lost to Follow-up|13|||
49128127|NCT01100502|158307069|FG001|Overall Study|Lost to Follow-up|28|||
49128128|NCT01100502|158307068|FG000|Overall Study|Site request to end participation in study|0|||
49128129|NCT01100502|158307069|FG001|Overall Study|Site request to end participation in study|1|||
49128130|NCT01100502|158307068|FG000|Overall Study|Death|45|||
49128131|NCT01100502|158307069|FG001|Overall Study|Death|40|||
49128132|NCT01618968|158307070|FG000|Overall Study|Adverse Event|1|||
49128133|NCT01618968|158307071|FG001|Overall Study|Adverse Event|0|||
49128134|NCT01618968|158307072|FG002|Overall Study|Adverse Event|0|||
49128135|NCT01618968|158307073|FG003|Overall Study|Adverse Event|0|||
49128136|NCT01618968|158307070|FG000|Overall Study|Death|0|||
49128137|NCT01618968|158307071|FG001|Overall Study|Death|0|||
49128138|NCT01618968|158307072|FG002|Overall Study|Death|0|||
49128139|NCT01618968|158307073|FG003|Overall Study|Death|1|||
49128140|NCT00073918|158307075|FG000|Overall Study|Eligibility requirement not met - HAMA+|1|||
49128141|NCT00073918|158307075|FG000|Overall Study|Rapid disease progression|2|||
49128142|NCT00073918|158307075|FG000|Overall Study|Eligibility requirement not met-low CD20|1|||
49128143|NCT00496769|158308834|FG000|Double Blind|>=1 reason assigned per patient|558|||
49128144|NCT00496769|158308835|FG001|Double Blind|>=1 reason assigned per patient|649|||
49128145|NCT00496769|158308836|FG002|Double Blind|>=1 reason assigned per patient|0|||
49128146|NCT00496769|158308834|FG000|Open Label|>=1 reason assigned per patient|0|||
48719147|NCT01642732|156821340|FG000|Overall Study|Withdrawal by Subject|1|||
48719148|NCT03400956|156821341|FG000|Treatment Period 1|Adverse Event|0|||
48815265|NCT01563978|157165751|FG000|Overall Study|Lost to Follow-up|1|||
49128147|NCT00496769|158308835|FG001|Open Label|>=1 reason assigned per patient|0|||
49128148|NCT00496769|158308836|FG002|Open Label|>=1 reason assigned per patient|1011|||
48719149|NCT03400956|156821342|FG001|Treatment Period 1|Adverse Event|1|||
48719150|NCT03400956|156821343|FG002|Treatment Period 1|Adverse Event|0|||
48719151|NCT03400956|156821341|FG000|Treatment Period 1|Lost to Follow-up|0|||
48719152|NCT03400956|156821342|FG001|Treatment Period 1|Lost to Follow-up|0|||
48719153|NCT03400956|156821343|FG002|Treatment Period 1|Lost to Follow-up|1|||
48719154|NCT03400956|156821341|FG000|Treatment Period 1|Protocol Violation|0|||
48719155|NCT03400956|156821342|FG001|Treatment Period 1|Protocol Violation|2|||
48719156|NCT03400956|156821343|FG002|Treatment Period 1|Protocol Violation|0|||
48719157|NCT03400956|156821341|FG000|Treatment Period 1|Study terminated by sponsor|3|||
48719158|NCT03400956|156821342|FG001|Treatment Period 1|Study terminated by sponsor|1|||
48719159|NCT03400956|156821343|FG002|Treatment Period 1|Study terminated by sponsor|1|||
48719160|NCT03400956|156821341|FG000|Treatment Period 1|Withdrawal by Subject|0|||
48719161|NCT03400956|156821342|FG001|Treatment Period 1|Withdrawal by Subject|2|||
48719162|NCT03400956|156821343|FG002|Treatment Period 1|Withdrawal by Subject|4|||
48719163|NCT03400956|156821341|FG000|Treatment Period 1|Other|1|||
48719164|NCT03400956|156821342|FG001|Treatment Period 1|Other|2|||
48719165|NCT03400956|156821343|FG002|Treatment Period 1|Other|3|||
48719166|NCT03400956|156821341|FG000|Post-treatment Period 1|Adverse Event|0|||
48719167|NCT03400956|156821342|FG001|Post-treatment Period 1|Adverse Event|0|||
48719168|NCT03400956|156821343|FG002|Post-treatment Period 1|Adverse Event|1|||
48719169|NCT03400956|156821341|FG000|Post-treatment Period 1|Physician Decision|2|||
48719170|NCT03400956|156821342|FG001|Post-treatment Period 1|Physician Decision|3|||
48719171|NCT03400956|156821343|FG002|Post-treatment Period 1|Physician Decision|0|||
48719172|NCT03400956|156821341|FG000|Post-treatment Period 1|Study terminated by sponsor|11|||
49128149|NCT01198002|158308837|FG000|Treatment Period 1 (Weeks 0-52)|Adverse Event|18|||
49128150|NCT01198002|158308838|FG001|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
49128151|NCT01198002|158308839|FG002|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
49128152|NCT01198002|158308837|FG000|Treatment Period 1 (Weeks 0-52)|Death|2|||
49128153|NCT01198002|158308838|FG001|Treatment Period 1 (Weeks 0-52)|Death|0|||
49128154|NCT01198002|158308839|FG002|Treatment Period 1 (Weeks 0-52)|Death|1|||
49128155|NCT01198002|158308837|FG000|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10|||
49128156|NCT01198002|158308838|FG001|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9|||
48719173|NCT03400956|156821342|FG001|Post-treatment Period 1|Study terminated by sponsor|10|||
48719174|NCT03400956|156821343|FG002|Post-treatment Period 1|Study terminated by sponsor|11|||
48719175|NCT03400956|156821341|FG000|Post-treatment Period 1|Withdrawal by Subject|5|||
49128157|NCT01198002|158308839|FG002|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6|||
49128158|NCT01198002|158308837|FG000|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1|||
49128159|NCT01198002|158308838|FG001|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
49128160|NCT01198002|158308839|FG002|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
49128161|NCT01198002|158308837|FG000|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
49128162|NCT01198002|158308838|FG001|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2|||
49128163|NCT01198002|158308839|FG002|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
49128164|NCT01198002|158308837|FG000|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16|||
49128165|NCT01198002|158308838|FG001|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21|||
49128166|NCT01198002|158308839|FG002|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12|||
49128167|NCT01198002|158308837|FG000|Treatment Period 1 (Weeks 0-52)|Physician Decision|1|||
49128168|NCT01198002|158308838|FG001|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
49128169|NCT01198002|158308839|FG002|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
49128170|NCT01198002|158308837|FG000|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14|||
49128171|NCT01198002|158308838|FG001|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
49128172|NCT01198002|158308839|FG002|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
49128173|NCT01198002|158308837|FG000|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213|||
49128174|NCT01198002|158308838|FG001|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216|||
49128175|NCT01198002|158308839|FG002|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224|||
49128176|NCT01198002|158308837|FG000|Treatment Period 2 (Weeks 52-100)|Adverse Event|2|||
49128177|NCT01198002|158308838|FG001|Treatment Period 2 (Weeks 52-100)|Adverse Event|0|||
49128178|NCT01198002|158308839|FG002|Treatment Period 2 (Weeks 52-100)|Adverse Event|1|||
49128179|NCT01198002|158308837|FG000|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3|||
49128180|NCT01198002|158308838|FG001|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
49128181|NCT01198002|158308839|FG002|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
49128182|NCT01198002|158308837|FG000|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1|||
49128183|NCT01198002|158308838|FG001|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
49128184|NCT01198002|158308839|FG002|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
49128185|NCT01198002|158308837|FG000|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
49128186|NCT01198002|158308838|FG001|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2|||
49128187|NCT01198002|158308839|FG002|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
49128188|NCT01198002|158308837|FG000|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
49128189|NCT01198002|158308838|FG001|Treatment Period 2 (Weeks 52-100)|Physician Decision|0|||
48719176|NCT03400956|156821342|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
48719177|NCT03400956|156821343|FG002|Post-treatment Period 1|Withdrawal by Subject|0|||
48719178|NCT03400956|156821341|FG000|Post-treatment Period 1|Other|4|||
48719179|NCT03400956|156821342|FG001|Post-treatment Period 1|Other|3|||
48719180|NCT03400956|156821343|FG002|Post-treatment Period 1|Other|4|||
48719181|NCT03400956|156821341|FG000|Treatment Period 2|Adverse Event|2|||
48719182|NCT03400956|156821342|FG001|Treatment Period 2|Adverse Event|1|||
48719183|NCT03400956|156821343|FG002|Treatment Period 2|Adverse Event|1|||
48719184|NCT03400956|156821341|FG000|Treatment Period 2|Lost to Follow-up|1|||
48719185|NCT03400956|156821342|FG001|Treatment Period 2|Lost to Follow-up|1|||
48719186|NCT03400956|156821343|FG002|Treatment Period 2|Lost to Follow-up|0|||
48719187|NCT03400956|156821341|FG000|Treatment Period 2|Withdrawal by Subject|0|||
48719188|NCT03400956|156821342|FG001|Treatment Period 2|Withdrawal by Subject|0|||
48719189|NCT03400956|156821343|FG002|Treatment Period 2|Withdrawal by Subject|3|||
48719190|NCT03400956|156821341|FG000|Treatment Period 2|Other|1|||
48719191|NCT03400956|156821342|FG001|Treatment Period 2|Other|1|||
48719192|NCT03400956|156821343|FG002|Treatment Period 2|Other|0|||
48719193|NCT03400956|156821341|FG000|Follow-up Period|Withdrawal by Subject|0|||
48719194|NCT03400956|156821342|FG001|Follow-up Period|Withdrawal by Subject|0|||
48719195|NCT03400956|156821343|FG002|Follow-up Period|Withdrawal by Subject|1|||
48719196|NCT03400956|156821341|FG000|Follow-up Period|Other|0|||
48719197|NCT03400956|156821342|FG001|Follow-up Period|Other|0|||
48719198|NCT03400956|156821343|FG002|Follow-up Period|Other|1|||
48719199|NCT00043550|156821344|FG000|Overall Study|Withdrawal by Subject|22|||
48719200|NCT00043550|156821345|FG001|Overall Study|Withdrawal by Subject|12|||
48719201|NCT00043550|156821346|FG002|Overall Study|Withdrawal by Subject|20|||
48719202|NCT01917656|156821347|FG000|Overall Study|Adverse Event|11|||
48719203|NCT01917656|156821348|FG001|Overall Study|Adverse Event|0|||
48719204|NCT01917656|156821347|FG000|Overall Study|Withdrawal criteria|8|||
48719205|NCT01917656|156821348|FG001|Overall Study|Withdrawal criteria|14|||
48719206|NCT01917656|156821347|FG000|Overall Study|Unclassified|0|||
48719207|NCT01917656|156821348|FG001|Overall Study|Unclassified|3|||
48719208|NCT01917656|156821347|FG000|Overall Study|Withdrawal by Subject|4|||
48719209|NCT01917656|156821348|FG001|Overall Study|Withdrawal by Subject|3|||
48719210|NCT01917656|156821347|FG000|Overall Study|Lost to Follow-up|3|||
48719211|NCT01917656|156821348|FG001|Overall Study|Lost to Follow-up|4|||
48719212|NCT02015221|156821349|FG000|Overall Study|Withdrawal by Subject|8|||
48719213|NCT02015221|156821350|FG001|Overall Study|Withdrawal by Subject|6|||
48719214|NCT02015221|156821349|FG000|Overall Study|Lost to Follow-up|1|||
48719215|NCT02015221|156821350|FG001|Overall Study|Lost to Follow-up|0|||
48719216|NCT03579602|156821351|FG000|Overall Study|Subject unable to receive study drug|0|||
48719217|NCT03579602|156821352|FG001|Overall Study|Subject unable to receive study drug|2|||
48719218|NCT03579602|156821351|FG000|Overall Study|Subject did not complete all study visits as planned|0|||
48719219|NCT03579602|156821352|FG001|Overall Study|Subject did not complete all study visits as planned|1|||
48719220|NCT03149848|156821366|FG000|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1|||
48719221|NCT03149848|156821366|FG000|Period 2 (Day 15 to Day 28)|Adverse Event|2|||
48719222|NCT01924429|156821368|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|3|||
48719223|NCT01924429|156821369|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
48719224|NCT00217464|156821370|FG000|Overall Study|Progression|15|||
48719225|NCT00217464|156821370|FG000|Overall Study|Other|2|||
48719226|NCT01227629|156821371|FG000|Overall Study|Adverse Event|2|||
48719227|NCT01227629|156821372|FG001|Overall Study|Adverse Event|2|||
48719228|NCT01227629|156821373|FG002|Overall Study|Adverse Event|1|||
48719229|NCT01227629|156821374|FG003|Overall Study|Adverse Event|6|||
48719230|NCT01227629|156821375|FG004|Overall Study|Adverse Event|1|||
48719231|NCT01227629|156821376|FG005|Overall Study|Adverse Event|1|||
48719232|NCT01227629|156821377|FG006|Overall Study|Adverse Event|6|||
48719233|NCT01227629|156821378|FG007|Overall Study|Adverse Event|6|||
48719234|NCT01227629|156821379|FG008|Overall Study|Adverse Event|4|||
48815266|NCT01563978|157165752|FG001|Overall Study|Lost to Follow-up|0|||
48719235|NCT01227629|156821380|FG009|Overall Study|Adverse Event|0|||
48719236|NCT01227629|156821371|FG000|Overall Study|Protocol Violation|0|||
48719237|NCT01227629|156821372|FG001|Overall Study|Protocol Violation|0|||
48719238|NCT01227629|156821373|FG002|Overall Study|Protocol Violation|0|||
48719239|NCT01227629|156821374|FG003|Overall Study|Protocol Violation|1|||
48719240|NCT01227629|156821375|FG004|Overall Study|Protocol Violation|0|||
48719241|NCT01227629|156821376|FG005|Overall Study|Protocol Violation|0|||
48719242|NCT01227629|156821377|FG006|Overall Study|Protocol Violation|0|||
48719243|NCT01227629|156821378|FG007|Overall Study|Protocol Violation|0|||
48719244|NCT01227629|156821379|FG008|Overall Study|Protocol Violation|0|||
48719245|NCT01227629|156821380|FG009|Overall Study|Protocol Violation|0|||
48719246|NCT01227629|156821371|FG000|Overall Study|Lost to Follow-up|0|||
48719247|NCT01227629|156821372|FG001|Overall Study|Lost to Follow-up|0|||
48719248|NCT01227629|156821373|FG002|Overall Study|Lost to Follow-up|0|||
48719249|NCT01227629|156821374|FG003|Overall Study|Lost to Follow-up|0|||
48719250|NCT01227629|156821375|FG004|Overall Study|Lost to Follow-up|1|||
48719251|NCT01227629|156821376|FG005|Overall Study|Lost to Follow-up|0|||
49128190|NCT01198002|158308839|FG002|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
48719252|NCT01227629|156821377|FG006|Overall Study|Lost to Follow-up|0|||
48719253|NCT01227629|156821378|FG007|Overall Study|Lost to Follow-up|0|||
48719254|NCT01227629|156821379|FG008|Overall Study|Lost to Follow-up|0|||
48719255|NCT01227629|156821380|FG009|Overall Study|Lost to Follow-up|0|||
48719256|NCT01227629|156821371|FG000|Overall Study|Withdrawal by Subject|0|||
48719257|NCT01227629|156821372|FG001|Overall Study|Withdrawal by Subject|0|||
48719258|NCT01227629|156821373|FG002|Overall Study|Withdrawal by Subject|0|||
48719259|NCT01227629|156821374|FG003|Overall Study|Withdrawal by Subject|0|||
48719260|NCT01227629|156821375|FG004|Overall Study|Withdrawal by Subject|0|||
48719261|NCT01227629|156821376|FG005|Overall Study|Withdrawal by Subject|0|||
49128191|NCT01198002|158308837|FG000|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62|||
49128192|NCT01198002|158308838|FG001|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70|||
49128193|NCT01198002|158308839|FG002|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75|||
49128194|NCT01001429|158308845|FG000|Overall Study|surgery cancelled|0|||
49128195|NCT01001429|158308846|FG001|Overall Study|surgery cancelled|1|||
49128196|NCT03353792|158308849|FG000|Overall Study|Lost to Follow-up|1|||
49128197|NCT03353792|158308850|FG001|Overall Study|Lost to Follow-up|0|||
49128198|NCT03353792|158308849|FG000|Overall Study|Participant Unable to Manage Device|1|||
49128199|NCT03353792|158308850|FG001|Overall Study|Participant Unable to Manage Device|0|||
49128200|NCT00735709|158308851|FG000|Overall Study|Adverse Event|2|||
49128201|NCT00735709|158308852|FG001|Overall Study|Adverse Event|3|||
49128202|NCT00735709|158308853|FG002|Overall Study|Adverse Event|1|||
49128203|NCT00735709|158308854|FG003|Overall Study|Adverse Event|5|||
49128204|NCT00735709|158308851|FG000|Overall Study|Lack of Efficacy|8|||
49128205|NCT00735709|158308852|FG001|Overall Study|Lack of Efficacy|4|||
49128206|NCT00735709|158308853|FG002|Overall Study|Lack of Efficacy|2|||
49128207|NCT00735709|158308854|FG003|Overall Study|Lack of Efficacy|3|||
49128208|NCT00735709|158308851|FG000|Overall Study|Noncompliance|0|||
49128209|NCT00735709|158308852|FG001|Overall Study|Noncompliance|0|||
49128210|NCT00735709|158308853|FG002|Overall Study|Noncompliance|1|||
49128211|NCT00735709|158308854|FG003|Overall Study|Noncompliance|0|||
49128212|NCT00735709|158308851|FG000|Overall Study|Protocol deviations|1|||
49128213|NCT00735709|158308852|FG001|Overall Study|Protocol deviations|2|||
49128214|NCT00735709|158308853|FG002|Overall Study|Protocol deviations|1|||
49128215|NCT00735709|158308854|FG003|Overall Study|Protocol deviations|1|||
49128216|NCT00735709|158308851|FG000|Overall Study|Voluntary Withdrawal|1|||
49128217|NCT00735709|158308852|FG001|Overall Study|Voluntary Withdrawal|3|||
49128218|NCT00735709|158308853|FG002|Overall Study|Voluntary Withdrawal|5|||
49128219|NCT00735709|158308854|FG003|Overall Study|Voluntary Withdrawal|7|||
49128220|NCT00735709|158308851|FG000|Overall Study|Lost to Follow-up|0|||
49128221|NCT00735709|158308852|FG001|Overall Study|Lost to Follow-up|1|||
49128222|NCT00735709|158308853|FG002|Overall Study|Lost to Follow-up|1|||
49128223|NCT00735709|158308854|FG003|Overall Study|Lost to Follow-up|1|||
49128224|NCT00735709|158308851|FG000|Overall Study|Excluded medication|1|||
49128225|NCT00735709|158308852|FG001|Overall Study|Excluded medication|0|||
49128226|NCT00735709|158308853|FG002|Overall Study|Excluded medication|0|||
49128227|NCT00735709|158308854|FG003|Overall Study|Excluded medication|1|||
49128228|NCT00789321|158308855|FG000|Overall Study|Adverse Event|0|||
49128229|NCT00789321|158308856|FG001|Overall Study|Adverse Event|1|||
49128230|NCT02163395|158308860|FG000|Overall Study|Withdrawal by Subject|1|||
49128231|NCT02163395|158308860|FG000|Overall Study|Lost to Follow-up|3|||
49128232|NCT02163395|158308860|FG000|Overall Study|Adverse Event|1|||
49128233|NCT01965327|158308861|FG000|Overall Study|Physician Decision|2|||
49128234|NCT03342001|158308862|FG000|Overall Study|Adverse Event|1|||
49128235|NCT03342001|158308862|FG000|Overall Study|Lost to Follow-up|1|||
49128236|NCT01930539|158308876|FG000|Overall Study|Withdrawal by Subject|2|||
49128237|NCT01930539|158308877|FG001|Overall Study|Withdrawal by Subject|2|||
49128238|NCT00896493|158308878|FG000|Overall Study|Early disease relapse|3|||
49128239|NCT02737358|158308879|FG000|Overall Study|Withdrawal by Subject|7|||
49128240|NCT02737358|158308880|FG001|Overall Study|Withdrawal by Subject|12|||
49128241|NCT02737358|158308879|FG000|Overall Study|Lost to Follow-up|2|||
49128242|NCT02737358|158308880|FG001|Overall Study|Lost to Follow-up|3|||
49128243|NCT01868646|158308882|FG000|Overall Study|Do not meet inclusion criteria|3|||
48719262|NCT01227629|156821377|FG006|Overall Study|Withdrawal by Subject|2|||
48719263|NCT01227629|156821378|FG007|Overall Study|Withdrawal by Subject|0|||
48719264|NCT01227629|156821379|FG008|Overall Study|Withdrawal by Subject|0|||
48719265|NCT01227629|156821380|FG009|Overall Study|Withdrawal by Subject|1|||
49128244|NCT01868646|158308883|FG001|Overall Study|Do not meet inclusion criteria|5|||
49128245|NCT01863771|158308892|FG000|Induction Phase|Adverse Event|9|||
49128246|NCT01863771|158308893|FG001|Induction Phase|Adverse Event|0|||
49128247|NCT01863771|158308894|FG002|Induction Phase|Adverse Event|0|||
49128248|NCT01863771|158308895|FG003|Induction Phase|Adverse Event|0|||
49128249|NCT01863771|158308892|FG000|Induction Phase|Lack of Efficacy|10|||
48719266|NCT01227629|156821371|FG000|Overall Study|Other|0|||
48719267|NCT01227629|156821372|FG001|Overall Study|Other|0|||
48719268|NCT01227629|156821373|FG002|Overall Study|Other|0|||
48719269|NCT01227629|156821374|FG003|Overall Study|Other|1|||
48719270|NCT01227629|156821375|FG004|Overall Study|Other|0|||
48719271|NCT01227629|156821376|FG005|Overall Study|Other|0|||
48719272|NCT01227629|156821377|FG006|Overall Study|Other|0|||
48719273|NCT01227629|156821378|FG007|Overall Study|Other|0|||
48719274|NCT01227629|156821379|FG008|Overall Study|Other|2|||
48719275|NCT01227629|156821380|FG009|Overall Study|Other|1|||
48719276|NCT02545543|156821381|FG000|Overall Study|Lost to Follow-up|67|||
48719277|NCT02545543|156821382|FG001|Overall Study|Lost to Follow-up|25|||
48719278|NCT02545543|156821381|FG000|Overall Study|Physician Decision|3|||
48719279|NCT02545543|156821382|FG001|Overall Study|Physician Decision|0|||
48719280|NCT02545543|156821381|FG000|Overall Study|Withdrawal by Subject|9|||
48719281|NCT02545543|156821382|FG001|Overall Study|Withdrawal by Subject|8|||
48719282|NCT02545543|156821381|FG000|Overall Study|Noncomplaince|1|||
48719283|NCT02545543|156821382|FG001|Overall Study|Noncomplaince|0|||
49128250|NCT01863771|158308893|FG001|Induction Phase|Lack of Efficacy|0|||
49128251|NCT01863771|158308894|FG002|Induction Phase|Lack of Efficacy|0|||
49128252|NCT01863771|158308895|FG003|Induction Phase|Lack of Efficacy|0|||
49128253|NCT01863771|158308892|FG000|Induction Phase|Withdrawal by Subject|2|||
49128254|NCT01863771|158308893|FG001|Induction Phase|Withdrawal by Subject|0|||
49128255|NCT01863771|158308894|FG002|Induction Phase|Withdrawal by Subject|0|||
49128256|NCT01863771|158308895|FG003|Induction Phase|Withdrawal by Subject|0|||
49128257|NCT01863771|158308892|FG000|Maintenance Phase|Adverse Event|0|||
49128258|NCT01863771|158308893|FG001|Maintenance Phase|Adverse Event|0|||
49128259|NCT01863771|158308894|FG002|Maintenance Phase|Adverse Event|1|||
49128260|NCT01863771|158308895|FG003|Maintenance Phase|Adverse Event|1|||
49128261|NCT01863771|158308892|FG000|Maintenance Phase|Lack of Efficacy|0|||
49128262|NCT01863771|158308893|FG001|Maintenance Phase|Lack of Efficacy|3|||
49128263|NCT01863771|158308894|FG002|Maintenance Phase|Lack of Efficacy|7|||
49128264|NCT01863771|158308895|FG003|Maintenance Phase|Lack of Efficacy|38|||
49128265|NCT01863771|158308892|FG000|Maintenance Phase|Physician Decision|0|||
49128266|NCT01863771|158308893|FG001|Maintenance Phase|Physician Decision|0|||
49128267|NCT01863771|158308894|FG002|Maintenance Phase|Physician Decision|2|||
49128268|NCT01863771|158308895|FG003|Maintenance Phase|Physician Decision|1|||
49128269|NCT01863771|158308892|FG000|Maintenance Phase|Pregnancy|0|||
49128270|NCT01863771|158308893|FG001|Maintenance Phase|Pregnancy|1|||
48719284|NCT02545543|156821381|FG000|Overall Study|Enrolment of subject at >1 study site|1|||
49128271|NCT01863771|158308894|FG002|Maintenance Phase|Pregnancy|0|||
49128272|NCT01863771|158308895|FG003|Maintenance Phase|Pregnancy|0|||
49128273|NCT01863771|158308892|FG000|Maintenance Phase|Withdrawal by Subject|0|||
49128274|NCT01863771|158308893|FG001|Maintenance Phase|Withdrawal by Subject|1|||
48719285|NCT02545543|156821382|FG001|Overall Study|Enrolment of subject at >1 study site|1|||
48719286|NCT00523367|156821383|FG000|Overall Study|19 screen failures|19|||
48719287|NCT00523367|156821383|FG000|Overall Study|4 Withdrawn by PI|4|||
48719288|NCT03387111|156822876|FG000|Overall Study|Progressive Disease|3|||
48719289|NCT03387111|156822876|FG000|Overall Study|Other|1|||
49128275|NCT01863771|158308894|FG002|Maintenance Phase|Withdrawal by Subject|2|||
49128276|NCT01863771|158308895|FG003|Maintenance Phase|Withdrawal by Subject|3|||
49128277|NCT02337491|158308898|FG000|Overall Study|Death|1|||
49128278|NCT02337491|158308899|FG001|Overall Study|Death|1|||
48815267|NCT01563978|157165751|FG000|Overall Study|Dev. of study specific discont. criteria|1|||
48815268|NCT01563978|157165752|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
48815269|NCT01563978|157165751|FG000|Overall Study|Adverse Event|1|||
48815270|NCT01563978|157165752|FG001|Overall Study|Adverse Event|2|||
48815271|NCT05764239|157165753|FG000|DEP (Part 1)|Study terminated by Sponsor|28|||
48815272|NCT05764239|157165753|FG000|DEP (Part 1)|Withdrawal by Subject|3|||
48815273|NCT05764239|157165753|FG000|DEP (Part 1)|Non-compliance with study drug|2|||
48815274|NCT05764239|157165753|FG000|DEP (Part 1)|Adverse Event|1|||
48815275|NCT05764239|157165753|FG000|DEP (Part 1)|Lost to Follow-up|1|||
48815276|NCT05764239|157165753|FG000|RWP (Part 2, SYNB1934v1)|Study terminated by Sponsor|7|||
48815277|NCT05764239|157165753|FG000|RWP (Part 2, SYNB1934v1)|Non-compliance with study drug|2|||
48815278|NCT05764239|157165753|FG000|RWP (Part 2, Placebo)|Study terminated by Sponsor|8|||
48815279|NCT05764239|157165753|FG000|OLE (Part 3)|Study terminated by Sponsor|10|||
48815280|NCT00729690|157165754|FG000|Overall Study|IT Catheter Malfunction|0|||
48815281|NCT00729690|157165755|FG001|Overall Study|IT Catheter Malfunction|2|||
48815282|NCT00729690|157165756|FG002|Overall Study|IT Catheter Malfunction|2|||
48815283|NCT05593211|157165758|FG000|Overall Study|Withdrawal by Subject|1|||
48815284|NCT00996580|157165762|FG000|Overall Study|Adverse Event|466|||
48815285|NCT00996580|157165762|FG000|Overall Study|Lost to Follow-up|480|||
48815286|NCT00996580|157165762|FG000|Overall Study|Noncompliance with the protocol|137|||
48815287|NCT00996580|157165762|FG000|Overall Study|Physician Decision|5|||
48815288|NCT00996580|157165762|FG000|Overall Study|Pregnancy|68|||
48815289|NCT00996580|157165762|FG000|Overall Study|Protocol Violation|16|||
48815290|NCT00996580|157165762|FG000|Overall Study|Sponsor requested participant withdrawal|35|||
48815291|NCT00996580|157165762|FG000|Overall Study|Withdrawal by Subject|217|||
48815292|NCT00996580|157165762|FG000|Overall Study|Other|29|||
48815293|NCT04248465|157165765|FG000|Randomized-Controlled Period|Death|12|||
48815294|NCT04248465|157165766|FG001|Randomized-Controlled Period|Death|5|||
48815295|NCT04248465|157165765|FG000|Randomized-Controlled Period|Adverse Event|2|||
48815296|NCT04248465|157165766|FG001|Randomized-Controlled Period|Adverse Event|0|||
49128279|NCT02337491|158308898|FG000|Overall Study|Adverse Event|0|||
49128280|NCT02337491|158308899|FG001|Overall Study|Adverse Event|1|||
49128281|NCT02337491|158308898|FG000|Overall Study|Withdrawal by Subject|3|||
49128282|NCT02337491|158308899|FG001|Overall Study|Withdrawal by Subject|0|||
49128283|NCT02337491|158308898|FG000|Overall Study|Progressive Disease|44|||
49128284|NCT02337491|158308899|FG001|Overall Study|Progressive Disease|28|||
49128285|NCT02337491|158308898|FG000|Overall Study|On Treatment|2|||
49128286|NCT02337491|158308899|FG001|Overall Study|On Treatment|0|||
49128287|NCT02771275|158308900|FG000|Overall Study|Reoperation|3|||
49128288|NCT02771275|158308900|FG000|Overall Study|Exit - subject did not reconsent to extended follow-up|1|||
49128289|NCT03006562|158308901|FG000|Overall Study|Lost to Follow-up|0|||
49128290|NCT03006562|158308902|FG001|Overall Study|Lost to Follow-up|1|||
49128291|NCT00126594|158308915|FG000|Overall Study|Ineligible|2|||
49128292|NCT00126594|158308916|FG001|Overall Study|Ineligible|0|||
49128293|NCT00126594|158308915|FG000|Overall Study|Withdrawal by Subject|0|||
49128294|NCT00126594|158308916|FG001|Overall Study|Withdrawal by Subject|4|||
49128295|NCT00126594|158308915|FG000|Overall Study|Physician Decision|1|||
49128296|NCT00126594|158308916|FG001|Overall Study|Physician Decision|3|||
48815297|NCT04248465|157165765|FG000|Randomized-Controlled Period|Study Terminated by Sponsor|194|||
48815298|NCT04248465|157165766|FG001|Randomized-Controlled Period|Study Terminated by Sponsor|99|||
48815299|NCT04248465|157165765|FG000|Randomized-Controlled Period|Withdrawal by Subject|30|||
48815300|NCT04248465|157165766|FG001|Randomized-Controlled Period|Withdrawal by Subject|17|||
48815301|NCT04248465|157165765|FG000|Randomized-Controlled Period|Physician Decision|1|||
48815302|NCT04248465|157165766|FG001|Randomized-Controlled Period|Physician Decision|1|||
49128297|NCT00126594|158308915|FG000|Overall Study|Adverse Event|7|||
49128298|NCT00126594|158308916|FG001|Overall Study|Adverse Event|5|||
49128299|NCT00126594|158308915|FG000|Overall Study|Non-compliance|0|||
49128300|NCT00126594|158308916|FG001|Overall Study|Non-compliance|1|||
49128301|NCT00126594|158308915|FG000|Overall Study|Disease Progression|29|||
48719290|NCT00535288|156822889|FG000|Overall Study|Adverse Event|20|||
48719291|NCT00535288|156822890|FG001|Overall Study|Adverse Event|19|||
48719292|NCT00535288|156822891|FG002|Overall Study|Adverse Event|25|||
48719293|NCT00535288|156822892|FG003|Overall Study|Adverse Event|20|||
48719294|NCT00535288|156822893|FG004|Overall Study|Adverse Event|30|||
48719295|NCT00535288|156822889|FG000|Overall Study|Lost to Follow-up|0|||
48719296|NCT00535288|156822890|FG001|Overall Study|Lost to Follow-up|3|||
48719297|NCT00535288|156822891|FG002|Overall Study|Lost to Follow-up|0|||
48719298|NCT00535288|156822892|FG003|Overall Study|Lost to Follow-up|0|||
48719299|NCT00535288|156822893|FG004|Overall Study|Lost to Follow-up|0|||
48719300|NCT00535288|156822889|FG000|Overall Study|Lack of Efficacy|26|||
48719301|NCT00535288|156822890|FG001|Overall Study|Lack of Efficacy|3|||
48719302|NCT00535288|156822891|FG002|Overall Study|Lack of Efficacy|4|||
48719303|NCT00535288|156822892|FG003|Overall Study|Lack of Efficacy|4|||
48719304|NCT00535288|156822893|FG004|Overall Study|Lack of Efficacy|7|||
48719305|NCT00535288|156822889|FG000|Overall Study|Unwilling to cooperate|6|||
48719306|NCT00535288|156822890|FG001|Overall Study|Unwilling to cooperate|6|||
48719307|NCT00535288|156822891|FG002|Overall Study|Unwilling to cooperate|3|||
48719308|NCT00535288|156822892|FG003|Overall Study|Unwilling to cooperate|3|||
48719309|NCT00535288|156822893|FG004|Overall Study|Unwilling to cooperate|4|||
48719310|NCT00535288|156822889|FG000|Overall Study|Other|2|||
48719311|NCT00535288|156822890|FG001|Overall Study|Other|1|||
48719312|NCT00535288|156822891|FG002|Overall Study|Other|1|||
48719313|NCT00535288|156822892|FG003|Overall Study|Other|2|||
48719314|NCT00535288|156822893|FG004|Overall Study|Other|1|||
48719315|NCT00369629|156822894|FG000|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
48719316|NCT00369629|156822895|FG001|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
48719317|NCT00369629|156822896|FG002|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
48719318|NCT00369629|156822897|FG003|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
48719319|NCT00369629|156822894|FG000|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
48719320|NCT00369629|156822895|FG001|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
48719321|NCT00369629|156822896|FG002|Treated 2 Cycles/Reached First Response|Adverse Event|1|||
48719322|NCT00369629|156822897|FG003|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
48719323|NCT00369629|156822894|FG000|Treated 2 Cycles/Reached First Response|Progressive disease|2|||
48719324|NCT00369629|156822895|FG001|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
48719325|NCT00369629|156822896|FG002|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
48719326|NCT00369629|156822897|FG003|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
48719327|NCT00369629|156822894|FG000|Moved on to 4 More Cycles|Progressive Disease|0|||
48719328|NCT00369629|156822895|FG001|Moved on to 4 More Cycles|Progressive Disease|0|||
48719329|NCT00369629|156822896|FG002|Moved on to 4 More Cycles|Progressive Disease|1|||
48719330|NCT00369629|156822897|FG003|Moved on to 4 More Cycles|Progressive Disease|0|||
48719331|NCT00369629|156822894|FG000|Completed 4 More Cycles|Withdrawal by Subject|2|||
48719332|NCT00369629|156822895|FG001|Completed 4 More Cycles|Withdrawal by Subject|1|||
48719333|NCT00369629|156822896|FG002|Completed 4 More Cycles|Withdrawal by Subject|0|||
48719334|NCT00369629|156822897|FG003|Completed 4 More Cycles|Withdrawal by Subject|0|||
48719335|NCT00369629|156822894|FG000|Completed 4 More Cycles|Progressive disease|2|||
48719336|NCT00369629|156822895|FG001|Completed 4 More Cycles|Progressive disease|1|||
48719337|NCT00369629|156822896|FG002|Completed 4 More Cycles|Progressive disease|2|||
48719338|NCT00369629|156822897|FG003|Completed 4 More Cycles|Progressive disease|0|||
48719339|NCT00369629|156822894|FG000|Follow up for 1 Year|Death|2|||
48719340|NCT00369629|156822895|FG001|Follow up for 1 Year|Death|1|||
48719341|NCT00369629|156822896|FG002|Follow up for 1 Year|Death|1|||
48719342|NCT00369629|156822897|FG003|Follow up for 1 Year|Death|0|||
48719343|NCT00369629|156822894|FG000|Follow up for 1 Year|Lost to Follow-up|0|||
48719344|NCT00369629|156822895|FG001|Follow up for 1 Year|Lost to Follow-up|1|||
48719345|NCT00369629|156822896|FG002|Follow up for 1 Year|Lost to Follow-up|0|||
48719346|NCT00369629|156822897|FG003|Follow up for 1 Year|Lost to Follow-up|0|||
48719347|NCT00369629|156822894|FG000|Follow up for 1 Year|stopped being followed as study closed|0|||
48719348|NCT00369629|156822895|FG001|Follow up for 1 Year|stopped being followed as study closed|0|||
48719349|NCT00369629|156822896|FG002|Follow up for 1 Year|stopped being followed as study closed|2|||
48815303|NCT04248465|157165765|FG000|Randomized-Controlled Period|Lost to Follow-up|1|||
48719350|NCT00369629|156822897|FG003|Follow up for 1 Year|stopped being followed as study closed|0|||
48719351|NCT01129583|156822898|FG000|Overall Study|Death|1|||
48719352|NCT01129583|156822899|FG001|Overall Study|Death|0|||
48719353|NCT01129583|156822898|FG000|Overall Study|Lost to Follow-up|1|||
48719354|NCT01129583|156822899|FG001|Overall Study|Lost to Follow-up|1|||
48719355|NCT01129583|156822898|FG000|Overall Study|Ipsilateral Upper Extremity Injury|1|||
48719356|NCT01129583|156822899|FG001|Overall Study|Ipsilateral Upper Extremity Injury|1|||
48719357|NCT01604278|156822900|FG000|Overall Study|Lack of Efficacy|0|||
48719358|NCT01604278|156822901|FG001|Overall Study|Lack of Efficacy|1|||
48719359|NCT01604278|156822900|FG000|Overall Study|Lost to Follow-up|1|||
48719360|NCT01604278|156822901|FG001|Overall Study|Lost to Follow-up|0|||
48719361|NCT01604278|156822900|FG000|Overall Study|Administrative problems|2|||
49128302|NCT00126594|158308916|FG001|Overall Study|Disease Progression|24|||
49128303|NCT03238417|158308919|FG000|Overall|non-response|955|||
49128304|NCT03238417|158308920|FG001|Overall|non-response|1920|||
49128305|NCT03238417|158308919|FG000|Overall|partial completion|48|||
49128306|NCT03238417|158308920|FG001|Overall|partial completion|68|||
49128307|NCT03238417|158308919|FG000|Baseline|Partial completion|17|||
49128308|NCT03238417|158308920|FG001|Baseline|Partial completion|48|||
49128309|NCT03238417|158308919|FG000|Baseline|non-response|372|||
49128310|NCT03238417|158308920|FG001|Baseline|non-response|669|||
49128311|NCT03238417|158308919|FG000|12-month|non-response|296|||
49128312|NCT03238417|158308920|FG001|12-month|non-response|669|||
49128313|NCT03238417|158308919|FG000|12-month|partial completion|23|||
49128314|NCT03238417|158308920|FG001|12-month|partial completion|37|||
49128315|NCT03238417|158308919|FG000|24-month|non-response|287|||
49128316|NCT03238417|158308920|FG001|24-month|non-response|594|||
49128317|NCT03238417|158308919|FG000|24-month|partial completion|8|||
49128318|NCT03238417|158308920|FG001|24-month|partial completion|31|||
49128319|NCT00001566|158308921|FG000|Overall Study|patients' choice to discontinue protocol|3|||
49128320|NCT00001566|158308921|FG000|Overall Study|stopped after C3 due to symptomatic PD|1|||
49128321|NCT00001566|158308921|FG000|Overall Study|Death|13|||
49128322|NCT00001566|158308921|FG000|Overall Study|Lost to Follow-up|1|||
49128323|NCT00001566|158308921|FG000|Overall Study|unable to complete initial apheresis|1|||
49128324|NCT00853762|158308922|FG000|Overall Study|Premature Termination|16|||
49128325|NCT00853762|158308923|FG001|Overall Study|Premature Termination|15|||
49128326|NCT00853762|158308924|FG002|Overall Study|Premature Termination|14|||
49128327|NCT00853762|158308925|FG003|Overall Study|Premature Termination|21|||
49128328|NCT00853762|158308922|FG000|Overall Study|Protocol Violation|0|||
49128329|NCT00853762|158308923|FG001|Overall Study|Protocol Violation|0|||
49128330|NCT00853762|158308924|FG002|Overall Study|Protocol Violation|0|||
49128331|NCT00853762|158308925|FG003|Overall Study|Protocol Violation|1|||
49128332|NCT00853762|158308922|FG000|Overall Study|Withdrawal by Subject|0|||
49128333|NCT00853762|158308923|FG001|Overall Study|Withdrawal by Subject|0|||
49128334|NCT00853762|158308924|FG002|Overall Study|Withdrawal by Subject|1|||
49128335|NCT00853762|158308925|FG003|Overall Study|Withdrawal by Subject|0|||
49128336|NCT00853762|158308922|FG000|Overall Study|Other|0|||
49128337|NCT00853762|158308923|FG001|Overall Study|Other|2|||
49128338|NCT00853762|158308924|FG002|Overall Study|Other|0|||
49128339|NCT00853762|158308925|FG003|Overall Study|Other|0|||
49128340|NCT00853762|158308922|FG000|Overall Study|Randomised but not Treated|0|||
49128341|NCT00853762|158308923|FG001|Overall Study|Randomised but not Treated|2|||
49128342|NCT00853762|158308924|FG002|Overall Study|Randomised but not Treated|2|||
49128343|NCT00853762|158308925|FG003|Overall Study|Randomised but not Treated|0|||
49128344|NCT00492297|158308926|FG000|Treatment|Death|2|||
49128345|NCT00492297|158308926|FG000|Treatment|Study terminated by sponsor|3|||
48719362|NCT01604278|156822901|FG001|Overall Study|Administrative problems|1|||
48815304|NCT04248465|157165766|FG001|Randomized-Controlled Period|Lost to Follow-up|0|||
48920965|NCT04036708|157544797|FG002|Overall Study|Lost to Follow-up|14|||
49128346|NCT00492297|158308926|FG000|Active Follow-up 30(+4) Days Duration|Death|17|||
49128347|NCT00492297|158308926|FG000|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2|||
49128348|NCT00492297|158308926|FG000|Survival Only Follow-up|Death|46|||
48719363|NCT01604278|156822900|FG000|Overall Study|Withdrawal by Subject|3|||
49128349|NCT00492297|158308926|FG000|Survival Only Follow-up|Lack of Efficacy|1|||
49128350|NCT00492297|158308926|FG000|Survival Only Follow-up|Study terminated by sponsor|12|||
49128351|NCT03885908|158308927|FG000|Overall Study|Patient deemed to be ineligible due to language preference|1|||
49128352|NCT03885908|158308928|FG001|Overall Study|Patient deemed to be ineligible due to language preference|0|||
49128353|NCT03885908|158308927|FG000|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|1|||
49128354|NCT03885908|158308928|FG001|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|0|||
48719364|NCT01604278|156822901|FG001|Overall Study|Withdrawal by Subject|3|||
48719365|NCT01604278|156822900|FG000|Overall Study|Adverse Event|3|||
48719366|NCT01604278|156822901|FG001|Overall Study|Adverse Event|5|||
48719367|NCT01604278|156822900|FG000|Overall Study|Protocol Deviation|5|||
48719368|NCT01604278|156822901|FG001|Overall Study|Protocol Deviation|3|||
48719369|NCT03390101|156822905|FG000|Weeks 0-12|Withdrawal by Subject|0|||
48719370|NCT03390101|156822906|FG001|Weeks 0-12|Withdrawal by Subject|1|||
48719371|NCT03390101|156822907|FG002|Weeks 0-12|Withdrawal by Subject|1|||
48719372|NCT03390101|156822905|FG000|Weeks 0-12|Lost to Follow-up|0|||
48719373|NCT03390101|156822906|FG001|Weeks 0-12|Lost to Follow-up|1|||
48719374|NCT03390101|156822907|FG002|Weeks 0-12|Lost to Follow-up|0|||
48719375|NCT03390101|156822905|FG000|Weeks 12-54|Withdrawal by Subject|0|||
48719376|NCT03390101|156822906|FG001|Weeks 12-54|Withdrawal by Subject|3|||
48719377|NCT03390101|156822907|FG002|Weeks 12-54|Withdrawal by Subject|1|||
48719378|NCT03390101|156822905|FG000|Weeks 12-54|Pregnancy|1|||
48719379|NCT03390101|156822906|FG001|Weeks 12-54|Pregnancy|0|||
48719380|NCT03390101|156822907|FG002|Weeks 12-54|Pregnancy|0|||
48719381|NCT03390101|156822905|FG000|Weeks 12-54|Adverse Event|2|||
48719382|NCT03390101|156822906|FG001|Weeks 12-54|Adverse Event|1|||
48719383|NCT03390101|156822907|FG002|Weeks 12-54|Adverse Event|1|||
49128355|NCT03885908|158308927|FG000|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
49128356|NCT03885908|158308928|FG001|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
49128357|NCT03885908|158308927|FG000|Overall Study|Patient unable to complete appointment - withdrawn from study|0|||
49128358|NCT03885908|158308928|FG001|Overall Study|Patient unable to complete appointment - withdrawn from study|1|||
49128359|NCT02662569|158308932|FG000|Overall Study|Withdrawal by Subject|6|||
49128360|NCT02662569|158308933|FG001|Overall Study|Withdrawal by Subject|1|||
49128361|NCT02662569|158308934|FG002|Overall Study|Withdrawal by Subject|6|||
49128362|NCT02662569|158308935|FG003|Overall Study|Withdrawal by Subject|4|||
49128363|NCT02662569|158308932|FG000|Overall Study|Lost to Follow-up|1|||
49128364|NCT02662569|158308933|FG001|Overall Study|Lost to Follow-up|0|||
49128365|NCT02662569|158308934|FG002|Overall Study|Lost to Follow-up|0|||
49128366|NCT02662569|158308935|FG003|Overall Study|Lost to Follow-up|0|||
49128367|NCT01159574|158308936|FG000|Treatment Phase|non-evaluable/not included in analysis|1|||
49128368|NCT01159574|158308936|FG000|Treatment Phase|Adverse Event|3|||
49128369|NCT01159574|158308936|FG000|Treatment Phase|Death|6|||
49128370|NCT01159574|158308936|FG000|Treatment Phase|Physician Decision|2|||
49128371|NCT01159574|158308936|FG000|Treatment Phase|Withdrawal by Subject|7|||
49128372|NCT01159574|158308936|FG000|Treatment Phase|still on treatment|2|||
49128373|NCT01159574|158308936|FG000|Follow Up Phase|Lost to Follow-up|2|||
49128374|NCT01159574|158308936|FG000|Follow Up Phase|still being followed for overall surviva|18|||
49128375|NCT02666222|158308939|FG000|Overall Study|Death|2|||
49128376|NCT01692119|158308944|FG000|Overall Study|Protocol Violation|3|||
49128377|NCT01692119|158308945|FG001|Overall Study|Protocol Violation|1|||
49128378|NCT01692119|158308944|FG000|Overall Study|Intervention: pts. did not present to participating pharmacy|17|||
49128379|NCT01692119|158308945|FG001|Overall Study|Intervention: pts. did not present to participating pharmacy|0|||
49128380|NCT03307174|158308947|FG000|Overall Study|Unplanned ICU Administrion|5|||
49128381|NCT03307174|158308948|FG001|Overall Study|Unplanned ICU Administrion|3|||
49128382|NCT03307174|158308947|FG000|Overall Study|Aborted Surgery|1|||
49128383|NCT03307174|158308948|FG001|Overall Study|Aborted Surgery|2|||
49128384|NCT03307174|158308947|FG000|Overall Study|Hypotension|6|||
49128385|NCT03307174|158308948|FG001|Overall Study|Hypotension|0|||
49128386|NCT03307174|158308947|FG000|Overall Study|Nonfunctional epidural|1|||
49128387|NCT03307174|158308948|FG001|Overall Study|Nonfunctional epidural|1|||
48719384|NCT01511055|156822909|FG000|Overall Study|Withdrawal by Subject|6|||
48719385|NCT01122264|156822910|FG000|Overall Study|Adverse Event|6|||
48719386|NCT01122264|156822911|FG001|Overall Study|Adverse Event|5|||
48719387|NCT01122264|156822912|FG002|Overall Study|Adverse Event|7|||
48719388|NCT01122264|156822910|FG000|Overall Study|Death|1|||
48719389|NCT01122264|156822911|FG001|Overall Study|Death|0|||
48719390|NCT01122264|156822912|FG002|Overall Study|Death|0|||
48719391|NCT01122264|156822910|FG000|Overall Study|Lost to Follow-up|5|||
48719392|NCT01122264|156822911|FG001|Overall Study|Lost to Follow-up|9|||
48719393|NCT01122264|156822912|FG002|Overall Study|Lost to Follow-up|13|||
48719394|NCT01122264|156822910|FG000|Overall Study|Entry Criteria Not Met|1|||
48719395|NCT01122264|156822911|FG001|Overall Study|Entry Criteria Not Met|0|||
48719396|NCT01122264|156822912|FG002|Overall Study|Entry Criteria Not Met|0|||
48719397|NCT01122264|156822910|FG000|Overall Study|Protocol Violation|7|||
48719398|NCT01122264|156822911|FG001|Overall Study|Protocol Violation|7|||
48719399|NCT01122264|156822912|FG002|Overall Study|Protocol Violation|9|||
48719400|NCT01122264|156822910|FG000|Overall Study|Withdrawal by Subject|6|||
48719401|NCT01122264|156822911|FG001|Overall Study|Withdrawal by Subject|6|||
48719402|NCT01122264|156822912|FG002|Overall Study|Withdrawal by Subject|16|||
49128388|NCT03307174|158308947|FG000|Overall Study|Planned epidural removal|1|||
49128389|NCT03307174|158308948|FG001|Overall Study|Planned epidural removal|0|||
48719403|NCT01122264|156822910|FG000|Overall Study|Physician Decision|3|||
48719404|NCT01122264|156822911|FG001|Overall Study|Physician Decision|1|||
48719405|NCT01122264|156822912|FG002|Overall Study|Physician Decision|1|||
49128390|NCT03307174|158308947|FG000|Overall Study|Intrathecal catheter placement|0|||
49128391|NCT03307174|158308948|FG001|Overall Study|Intrathecal catheter placement|1|||
48719406|NCT01122264|156822910|FG000|Overall Study|Lack of Efficacy|3|||
48719407|NCT01122264|156822911|FG001|Overall Study|Lack of Efficacy|1|||
48719408|NCT01122264|156822912|FG002|Overall Study|Lack of Efficacy|1|||
48719409|NCT04585009|156822915|FG000|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|1|||
48719410|NCT04585009|156822916|FG001|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
48719411|NCT04585009|156822917|FG002|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
48719412|NCT04585009|156822918|FG003|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
48719413|NCT04585009|156822919|FG004|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
48719414|NCT04585009|156822920|FG005|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
48719415|NCT04585009|156822921|FG006|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
48719416|NCT04585009|156822922|FG007|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
48719417|NCT04585009|156822923|FG008|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
48719418|NCT04585009|156822924|FG009|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
48719419|NCT04585009|156822925|FG010|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
48719420|NCT04585009|156822926|FG011|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
48719421|NCT04585009|156822915|FG000|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|1|||
48719422|NCT04585009|156822916|FG001|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
48719423|NCT04585009|156822917|FG002|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
48719424|NCT04585009|156822918|FG003|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
48719425|NCT04585009|156822919|FG004|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
48719426|NCT04585009|156822920|FG005|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
48719427|NCT04585009|156822921|FG006|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
48719428|NCT04585009|156822922|FG007|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
48719429|NCT04585009|156822923|FG008|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
48719430|NCT04585009|156822924|FG009|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
48719431|NCT04585009|156822925|FG010|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
48719432|NCT04585009|156822926|FG011|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
48719433|NCT04585009|156822915|FG000|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
48719434|NCT04585009|156822916|FG001|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
48719435|NCT04585009|156822917|FG002|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
48719436|NCT04585009|156822918|FG003|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
48719437|NCT04585009|156822919|FG004|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
48719438|NCT04585009|156822920|FG005|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
48719439|NCT04585009|156822921|FG006|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
48719440|NCT04585009|156822922|FG007|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|1|||
48719441|NCT04585009|156822923|FG008|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
48719442|NCT04585009|156822924|FG009|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
48719443|NCT04585009|156822925|FG010|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
48719444|NCT04585009|156822926|FG011|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
48719445|NCT04585009|156822915|FG000|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
48719446|NCT04585009|156822916|FG001|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
48719447|NCT04585009|156822917|FG002|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
48719448|NCT04585009|156822918|FG003|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
48719449|NCT04585009|156822919|FG004|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|1|||
48719450|NCT04585009|156822920|FG005|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
48719451|NCT04585009|156822921|FG006|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
48719452|NCT04585009|156822922|FG007|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
48719453|NCT04585009|156822923|FG008|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
48719454|NCT04585009|156822924|FG009|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
48719455|NCT04585009|156822925|FG010|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
48719456|NCT04585009|156822926|FG011|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
48719457|NCT04585009|156822915|FG000|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
48719458|NCT04585009|156822916|FG001|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
48719459|NCT04585009|156822917|FG002|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
48719460|NCT04585009|156822918|FG003|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
48719461|NCT04585009|156822919|FG004|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
48719462|NCT04585009|156822920|FG005|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
48719463|NCT04585009|156822921|FG006|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
48719464|NCT04585009|156822922|FG007|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
48815305|NCT04248465|157165765|FG000|Open-label Extension Period|Study Terminated by Sponsor|14|||
49128392|NCT00863707|158308949|FG000|Overall Study|Randomized, but drug not received|4|||
49128393|NCT00863707|158308950|FG001|Overall Study|Randomized, but drug not received|3|||
49128394|NCT01664091|158308951|FG000|Overall Study|Death|1|||
49128395|NCT01664091|158308951|FG000|Overall Study|Disease Progression|2|||
49128396|NCT01664091|158308951|FG000|Overall Study|Lost to Follow-up|2|||
49128397|NCT01664091|158308951|FG000|Overall Study|Withdrawal by Subject|1|||
49128398|NCT01867008|158308952|FG000|Overall Study|Withdrawal by Subject|1|||
49128399|NCT02391337|158308959|FG000|6 Months Follow-up|Death|5|||
49128400|NCT02391337|158308960|FG001|6 Months Follow-up|Death|4|||
49128401|NCT02391337|158308959|FG000|6 Months Follow-up|Withdrawal by Subject|1|||
49128402|NCT02391337|158308960|FG001|6 Months Follow-up|Withdrawal by Subject|1|||
49128403|NCT02391337|158308959|FG000|12 Months Follow-up|Death|2|||
48815306|NCT04248465|157165766|FG001|Open-label Extension Period|Study Terminated by Sponsor|4|||
49128404|NCT02391337|158308960|FG001|12 Months Follow-up|Death|0|||
49128405|NCT02391337|158308959|FG000|12 Months Follow-up|Withdrawal by Subject|0|||
49128406|NCT02391337|158308960|FG001|12 Months Follow-up|Withdrawal by Subject|1|||
49128407|NCT02391337|158308959|FG000|12 Months Follow-up|Lost to Follow-up|0|||
49128408|NCT02391337|158308960|FG001|12 Months Follow-up|Lost to Follow-up|2|||
49128409|NCT00289276|158308961|FG000|Second Part of FAST Study (Expansion)|Death|0|||
49128410|NCT00289276|158308962|FG001|Second Part of FAST Study (Expansion)|Death|2|||
49128411|NCT00289276|158308961|FG000|Second Part of FAST Study (Expansion)|Lost to Follow-up|0|||
49128412|NCT00289276|158308962|FG001|Second Part of FAST Study (Expansion)|Lost to Follow-up|1|||
49128413|NCT00746551|158308963|FG000|At Gestational Age of 36 Weeks|Lost to Follow-up|2|||
49128414|NCT00746551|158308964|FG001|At Gestational Age of 36 Weeks|Lost to Follow-up|4|||
49128415|NCT00746551|158308963|FG000|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9|||
49128416|NCT00746551|158308964|FG001|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7|||
49128417|NCT00746551|158308963|FG000|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6|||
49128418|NCT00746551|158308964|FG001|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8|||
49128419|NCT00885118|158308966|FG000|Overall Study|Adverse Event|1|||
49128420|NCT00885118|158308967|FG001|Overall Study|Adverse Event|0|||
49128421|NCT00885118|158308968|FG002|Overall Study|Adverse Event|0|||
49128422|NCT00885118|158308969|FG003|Overall Study|Adverse Event|0|||
49128423|NCT00885118|158308970|FG004|Overall Study|Adverse Event|0|||
49128424|NCT00885118|158308966|FG000|Overall Study|Withdrawal by Subject|0|||
49128425|NCT00885118|158308967|FG001|Overall Study|Withdrawal by Subject|0|||
49128426|NCT00885118|158308968|FG002|Overall Study|Withdrawal by Subject|0|||
49128427|NCT00885118|158308969|FG003|Overall Study|Withdrawal by Subject|0|||
49128428|NCT00885118|158308970|FG004|Overall Study|Withdrawal by Subject|1|||
49128429|NCT00885118|158308966|FG000|Overall Study|Other reason not defined above|0|||
49128430|NCT00885118|158308967|FG001|Overall Study|Other reason not defined above|0|||
49128431|NCT00885118|158308968|FG002|Overall Study|Other reason not defined above|1|||
49128432|NCT00885118|158308969|FG003|Overall Study|Other reason not defined above|0|||
49128433|NCT00885118|158308970|FG004|Overall Study|Other reason not defined above|0|||
49128434|NCT01035138|158308971|FG000|Overall Study|Adverse Event|4|||
49128435|NCT01035138|158308972|FG001|Overall Study|Adverse Event|0|||
49128436|NCT01035138|158308973|FG002|Overall Study|Adverse Event|2|||
49128437|NCT01035138|158308971|FG000|Overall Study|Caregiver Decision|2|||
49128438|NCT01035138|158308972|FG001|Overall Study|Caregiver Decision|0|||
49128439|NCT01035138|158308973|FG002|Overall Study|Caregiver Decision|1|||
49128440|NCT01035138|158308971|FG000|Overall Study|Withdrawal by Subject|1|||
49128441|NCT01035138|158308972|FG001|Overall Study|Withdrawal by Subject|0|||
49128442|NCT01035138|158308973|FG002|Overall Study|Withdrawal by Subject|0|||
49128443|NCT01035138|158308971|FG000|Overall Study|Physician Decision|0|||
49128444|NCT01035138|158308972|FG001|Overall Study|Physician Decision|0|||
49128445|NCT01035138|158308973|FG002|Overall Study|Physician Decision|1|||
49128446|NCT01035138|158308971|FG000|Overall Study|Sponsor Decision|66|||
49128447|NCT01035138|158308972|FG001|Overall Study|Sponsor Decision|60|||
49128448|NCT01035138|158308973|FG002|Overall Study|Sponsor Decision|42|||
49128449|NCT01035138|158308971|FG000|Overall Study|Lost to Follow-up|0|||
49128450|NCT01035138|158308972|FG001|Overall Study|Lost to Follow-up|0|||
48815307|NCT04248465|157165765|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
49128451|NCT01035138|158308973|FG002|Overall Study|Lost to Follow-up|1|||
49128452|NCT00794664|158308977|FG000|Treatment Period|Withdrawal by Subject|0|||
49128453|NCT00794664|158308978|FG001|Treatment Period|Withdrawal by Subject|2|||
49128454|NCT00794664|158308977|FG000|Treatment Period|Protocol non-compliance|0|||
49128455|NCT00794664|158308978|FG001|Treatment Period|Protocol non-compliance|1|||
49128456|NCT00794664|158308977|FG000|Treatment Period|Other|0|||
49128457|NCT00794664|158308978|FG001|Treatment Period|Other|1|||
49128458|NCT00794664|158308977|FG000|Treatment Period|Adverse Event|1|||
48815308|NCT04248465|157165766|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
49128459|NCT00794664|158308978|FG001|Treatment Period|Adverse Event|8|||
49128460|NCT00794664|158308977|FG000|Follow-up Period|Other|1|||
49128461|NCT00794664|158308978|FG001|Follow-up Period|Other|2|||
49128462|NCT00794664|158308977|FG000|Follow-up Period|Withdrawal by Subject|0|||
49128463|NCT00794664|158308978|FG001|Follow-up Period|Withdrawal by Subject|2|||
48719465|NCT04585009|156822923|FG008|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
48719466|NCT04585009|156822924|FG009|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|1|||
48719467|NCT04585009|156822925|FG010|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
48719468|NCT04585009|156822926|FG011|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
48719469|NCT04585009|156822915|FG000|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
48719470|NCT04585009|156822916|FG001|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
48719471|NCT04585009|156822917|FG002|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
48719472|NCT04585009|156822918|FG003|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
48719473|NCT04585009|156822919|FG004|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
48719474|NCT04585009|156822920|FG005|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
48719475|NCT04585009|156822921|FG006|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
48719476|NCT04585009|156822922|FG007|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
48719477|NCT04585009|156822923|FG008|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
48719478|NCT04585009|156822924|FG009|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
48719479|NCT04585009|156822925|FG010|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
48719480|NCT04585009|156822926|FG011|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|1|||
48719481|NCT04140227|156822927|FG000|Overall Study|Withdrawal by Subject|26|||
48719482|NCT04140227|156822927|FG000|Overall Study|Lost to Follow-up|8|||
48719483|NCT04140227|156822927|FG000|Overall Study|Adverse Event|8|||
48719484|NCT04140227|156822927|FG000|Overall Study|Death|1|||
48719485|NCT04140227|156822927|FG000|Overall Study|Other|3|||
48719486|NCT04140227|156822927|FG000|Overall Study|Protocol Violation|2|||
48719487|NCT00412373|156822928|FG000|Overall Study|Adverse Event|8|||
48719488|NCT00412373|156822929|FG001|Overall Study|Adverse Event|13|||
48719489|NCT00412373|156822928|FG000|Overall Study|Lack of Efficacy|16|||
48719490|NCT00412373|156822929|FG001|Overall Study|Lack of Efficacy|22|||
48719491|NCT00412373|156822928|FG000|Overall Study|Lost to Follow-up|7|||
48719492|NCT00412373|156822929|FG001|Overall Study|Lost to Follow-up|13|||
48719493|NCT00412373|156822928|FG000|Overall Study|Withdrawal by Subject|8|||
48719494|NCT00412373|156822929|FG001|Overall Study|Withdrawal by Subject|27|||
48719495|NCT00412373|156822928|FG000|Overall Study|Other|2|||
48719496|NCT00412373|156822929|FG001|Overall Study|Other|2|||
48719497|NCT02969408|156822930|FG000|Overall Study|Adverse Event|2|||
48719498|NCT02969408|156822930|FG000|Overall Study|Withdrawal by Subject|8|||
48719499|NCT02969408|156822930|FG000|Overall Study|Lost to Follow-up|4|||
48719500|NCT02969408|156822930|FG000|Overall Study|Protocol Violation|1|||
48719501|NCT02969408|156822930|FG000|Overall Study|Other than specified|1|||
48719502|NCT00538785|156822931|FG000|Overall Study|Death|9|||
48719503|NCT00538785|156822932|FG001|Overall Study|Death|10|||
48719504|NCT00538785|156822931|FG000|Overall Study|Withdrawal of consent|9|||
48719505|NCT00538785|156822932|FG001|Overall Study|Withdrawal of consent|7|||
48719506|NCT00538785|156822931|FG000|Overall Study|Lost to Follow-up|1|||
48719507|NCT00538785|156822932|FG001|Overall Study|Lost to Follow-up|0|||
48719508|NCT00422513|156822937|FG000|Overall Study|Lack of Efficacy|4|||
48719509|NCT00422513|156822938|FG001|Overall Study|Lack of Efficacy|5|||
48719510|NCT00422513|156822937|FG000|Overall Study|Protocol Violation|23|||
48719511|NCT00422513|156822938|FG001|Overall Study|Protocol Violation|7|||
48719512|NCT00422513|156822937|FG000|Overall Study|Refused Treatment|4|||
48719513|NCT00422513|156822938|FG001|Overall Study|Refused Treatment|2|||
48719514|NCT00422513|156822937|FG000|Overall Study|Withdrawal by Subject|2|||
48719515|NCT00422513|156822938|FG001|Overall Study|Withdrawal by Subject|1|||
48719516|NCT00422513|156822937|FG000|Overall Study|early termination of the study|67|||
48815309|NCT00064025|157165767|FG000|Overall Study|Ineligible|4|||
48815310|NCT00064025|157165767|FG000|Overall Study|Inevaluable|3|||
48815311|NCT02036515|157165768|FG000|Overall Study|Adverse Event|1|||
48815312|NCT02036515|157165769|FG001|Overall Study|Adverse Event|1|||
48815313|NCT02036515|157165770|FG002|Overall Study|Adverse Event|2|||
48815314|NCT02036515|157165768|FG000|Overall Study|Lost to Follow-up|0|||
48815315|NCT02036515|157165769|FG001|Overall Study|Lost to Follow-up|2|||
48815316|NCT02036515|157165770|FG002|Overall Study|Lost to Follow-up|0|||
48815317|NCT02036515|157165768|FG000|Overall Study|Non-compliance with study drug|0|||
48815318|NCT02036515|157165769|FG001|Overall Study|Non-compliance with study drug|0|||
48719517|NCT00422513|156822938|FG001|Overall Study|early termination of the study|80|||
48719518|NCT00422513|156822937|FG000|Overall Study|Adverse Event|4|||
48719519|NCT00422513|156822938|FG001|Overall Study|Adverse Event|4|||
48719520|NCT00422513|156822937|FG000|Overall Study|Death|3|||
48719521|NCT00422513|156822938|FG001|Overall Study|Death|7|||
48719522|NCT01252667|156822943|FG000|Overall Study|Transplant aborted post-conditioning|0|||
48719523|NCT01252667|156822944|FG001|Overall Study|Transplant aborted post-conditioning|0|||
48719524|NCT01252667|156822945|FG002|Overall Study|Transplant aborted post-conditioning|0|||
48719525|NCT01252667|156822946|FG003|Overall Study|Transplant aborted post-conditioning|0|||
48719526|NCT01252667|156822947|FG004|Overall Study|Transplant aborted post-conditioning|0|||
48719527|NCT01252667|156822948|FG005|Overall Study|Transplant aborted post-conditioning|1|||
48719528|NCT00833417|156822949|FG000|Overall Study|Adverse Event|5|||
48719529|NCT00833417|156822950|FG001|Overall Study|Adverse Event|16|||
48719530|NCT00833417|156822949|FG000|Overall Study|Death|1|||
48719531|NCT00833417|156822950|FG001|Overall Study|Death|3|||
48719532|NCT00833417|156822949|FG000|Overall Study|Lost to Follow-up|1|||
48719533|NCT00833417|156822950|FG001|Overall Study|Lost to Follow-up|2|||
48719534|NCT00833417|156822949|FG000|Overall Study|Physician Decision to Withdraw Patient|3|||
48719535|NCT00833417|156822950|FG001|Overall Study|Physician Decision to Withdraw Patient|7|||
48719536|NCT00833417|156822949|FG000|Overall Study|Patient Decision to Withdraw|4|||
48719537|NCT00833417|156822950|FG001|Overall Study|Patient Decision to Withdraw|23|||
48719538|NCT00833417|156822949|FG000|Overall Study|Sponsor Decision to Terminate Study|1|||
48719539|NCT00833417|156822950|FG001|Overall Study|Sponsor Decision to Terminate Study|2|||
48719540|NCT00833417|156822949|FG000|Overall Study|Disease Progression|18|||
49128464|NCT00794664|158308977|FG000|Follow-up Period|Protocol non-compliance|0|||
49128465|NCT00794664|158308978|FG001|Follow-up Period|Protocol non-compliance|1|||
49128466|NCT01200329|158308981|FG000|Overall Study|Lack of financial coverage|2|||
49128467|NCT01200329|158308981|FG000|Overall Study|Progressive disease|1|||
49128468|NCT01850641|158308982|FG000|Overall Study|Physician Decision|1|||
49128469|NCT01850641|158308982|FG000|Overall Study|Decrease in serum phosphorus|1|||
48719541|NCT00833417|156822950|FG001|Overall Study|Disease Progression|17|||
48719542|NCT00833417|156822949|FG000|Overall Study|Reason Not Specified|0|||
48719543|NCT00833417|156822950|FG001|Overall Study|Reason Not Specified|1|||
48719544|NCT01836276|156822951|FG000|Overall Study|Lost to Follow-up|28|||
48719545|NCT01836276|156822952|FG001|Overall Study|Lost to Follow-up|51|||
48719546|NCT01445548|156822953|FG000|Overall Study|Adverse Event|1|||
48719547|NCT00864916|156822956|FG000|Overall Study|Lost to Follow-up|4|||
48719548|NCT00864916|156822957|FG001|Overall Study|Lost to Follow-up|4|||
48719549|NCT00864916|156822956|FG000|Overall Study|Protocol Violation|1|||
48719550|NCT00864916|156822957|FG001|Overall Study|Protocol Violation|0|||
48719551|NCT00864916|156822956|FG000|Overall Study|Withdrawal by Subject|1|||
48719552|NCT00864916|156822957|FG001|Overall Study|Withdrawal by Subject|0|||
48719553|NCT00958438|156822958|FG000|Overall Study|Protocol Violation|3|||
48719554|NCT00958438|156822959|FG001|Overall Study|Protocol Violation|2|||
48719555|NCT00958438|156822960|FG002|Overall Study|Protocol Violation|2|||
48719556|NCT00958438|156822958|FG000|Overall Study|Withdrawal by Subject|4|||
48719557|NCT00958438|156822959|FG001|Overall Study|Withdrawal by Subject|2|||
48719558|NCT00958438|156822960|FG002|Overall Study|Withdrawal by Subject|1|||
48719559|NCT00958438|156822958|FG000|Overall Study|Adverse Event|0|||
48719560|NCT00958438|156822959|FG001|Overall Study|Adverse Event|3|||
48719561|NCT00958438|156822960|FG002|Overall Study|Adverse Event|0|||
48719562|NCT00958438|156822958|FG000|Overall Study|Physician Decision|1|||
48719563|NCT00958438|156822959|FG001|Overall Study|Physician Decision|0|||
48719564|NCT00958438|156822960|FG002|Overall Study|Physician Decision|1|||
48719565|NCT00958438|156822958|FG000|Overall Study|Other than specified above|2|||
48815319|NCT02036515|157165770|FG002|Overall Study|Non-compliance with study drug|2|||
48815320|NCT02036515|157165768|FG000|Overall Study|Screen failure|0|||
48815321|NCT02036515|157165769|FG001|Overall Study|Screen failure|2|||
48815322|NCT02036515|157165770|FG002|Overall Study|Screen failure|0|||
48815323|NCT02036515|157165768|FG000|Overall Study|Withdrawal by Subject|4|||
48815324|NCT02036515|157165769|FG001|Overall Study|Withdrawal by Subject|7|||
48815325|NCT02036515|157165770|FG002|Overall Study|Withdrawal by Subject|9|||
48815326|NCT02036515|157165768|FG000|Overall Study|Hyperglycemia|0|||
48815327|NCT02036515|157165769|FG001|Overall Study|Hyperglycemia|0|||
48815328|NCT02036515|157165770|FG002|Overall Study|Hyperglycemia|1|||
48719566|NCT00958438|156822959|FG001|Overall Study|Other than specified above|3|||
48719567|NCT00958438|156822960|FG002|Overall Study|Other than specified above|2|||
48815329|NCT03621982|157165771|FG000|Overall Study|Withdrawal by Subject|1|||
48815330|NCT03621982|157165772|FG001|Overall Study|Withdrawal by Subject|0|||
48815331|NCT03621982|157165773|FG002|Overall Study|Withdrawal by Subject|0|||
48815332|NCT03621982|157165774|FG003|Overall Study|Withdrawal by Subject|1|||
48815333|NCT03621982|157165775|FG004|Overall Study|Withdrawal by Subject|0|||
48815334|NCT03621982|157165776|FG005|Overall Study|Withdrawal by Subject|1|||
49128470|NCT01850641|158308982|FG000|Overall Study|Decrease in serum calcium|2|||
48719568|NCT02122783|156822961|FG000|Overall Study|Adverse Event|0|||
48719569|NCT02122783|156822962|FG001|Overall Study|Adverse Event|1|||
48719570|NCT01101308|156822967|FG000|Period 1|Adverse Event|2|||
48719571|NCT01101308|156822968|FG001|Period 1|Adverse Event|1|||
48719572|NCT01101308|156822967|FG000|Period 1|Positive for cotinine|1|||
48719573|NCT01101308|156822968|FG001|Period 1|Positive for cotinine|0|||
48719574|NCT00653432|156822969|FG000|Overall Study|Adverse Event|4|||
48719575|NCT00653432|156822970|FG001|Overall Study|Adverse Event|1|||
48719576|NCT00653432|156822969|FG000|Overall Study|Withdrawal by Subject|4|||
48719577|NCT00653432|156822970|FG001|Overall Study|Withdrawal by Subject|5|||
48719578|NCT00653432|156822969|FG000|Overall Study|Lost to Follow-up|7|||
48719579|NCT00653432|156822970|FG001|Overall Study|Lost to Follow-up|6|||
48719580|NCT00653432|156822969|FG000|Overall Study|Use/Need of Con Therapy|2|||
48719581|NCT00653432|156822970|FG001|Overall Study|Use/Need of Con Therapy|1|||
48719582|NCT00653432|156822969|FG000|Overall Study|Other - Reason Not Provided|5|||
48719583|NCT00653432|156822970|FG001|Overall Study|Other - Reason Not Provided|3|||
48719584|NCT00686634|156822972|FG000|Overall Study|Protocol Violation|6|||
48719585|NCT00567255|156822973|FG000|Overall Study|Adverse Event|241|||
48719586|NCT00567255|156822974|FG001|Overall Study|Adverse Event|68|||
48719587|NCT00567255|156822973|FG000|Overall Study|Lost to Follow-up|77|||
48719588|NCT00567255|156822974|FG001|Overall Study|Lost to Follow-up|48|||
48719589|NCT00567255|156822973|FG000|Overall Study|Withdrawal by Subject|75|||
48719590|NCT00567255|156822974|FG001|Overall Study|Withdrawal by Subject|56|||
48719591|NCT00567255|156822973|FG000|Overall Study|Lack of Efficacy|19|||
48719592|NCT00567255|156822974|FG001|Overall Study|Lack of Efficacy|33|||
48719593|NCT00567255|156822973|FG000|Overall Study|Protocol Violation|20|||
48719594|NCT00567255|156822974|FG001|Overall Study|Protocol Violation|8|||
48719595|NCT00567255|156822973|FG000|Overall Study|Pregnancy|6|||
48719596|NCT00567255|156822974|FG001|Overall Study|Pregnancy|0|||
48719597|NCT00567255|156822973|FG000|Overall Study|Drug noncompliance,moved,other|25|||
48719598|NCT00567255|156822974|FG001|Overall Study|Drug noncompliance,moved,other|15|||
48719599|NCT02282345|156822978|FG000|Overall Study|Progression|0|||
48719600|NCT02282345|156822979|FG001|Overall Study|Progression|1|||
48719601|NCT02296138|156822981|FG000|Overall Study|Adverse Event|348|||
48719602|NCT02296138|156822982|FG001|Overall Study|Adverse Event|259|||
48719603|NCT02296138|156822981|FG000|Overall Study|Lack of Efficacy|59|||
48719604|NCT02296138|156822982|FG001|Overall Study|Lack of Efficacy|37|||
48719605|NCT02296138|156822981|FG000|Overall Study|Protocol Violation|35|||
48719606|NCT02296138|156822982|FG001|Overall Study|Protocol Violation|36|||
48719607|NCT02296138|156822981|FG000|Overall Study|Lost to Follow-up|9|||
48719608|NCT02296138|156822982|FG001|Overall Study|Lost to Follow-up|12|||
48719609|NCT02296138|156822981|FG000|Overall Study|Withdrawal by Subject|184|||
48719610|NCT02296138|156822982|FG001|Overall Study|Withdrawal by Subject|131|||
48719611|NCT02296138|156822981|FG000|Overall Study|Not Treated|1|||
48719612|NCT02296138|156822982|FG001|Overall Study|Not Treated|1|||
48719613|NCT02296138|156822981|FG000|Overall Study|Patients with data irregularities|10|||
48719614|NCT02296138|156822982|FG001|Overall Study|Patients with data irregularities|11|||
48719615|NCT02296138|156822981|FG000|Overall Study|Other than specified|15|||
48719616|NCT02296138|156822982|FG001|Overall Study|Other than specified|13|||
48719617|NCT02353143|156822983|FG000|Overall Study|Withdrawal by Subject|1|||
48719618|NCT02353143|156822984|FG001|Overall Study|Withdrawal by Subject|0|||
48815335|NCT03621982|157165777|FG006|Overall Study|Withdrawal by Subject|1|||
48815336|NCT03621982|157165778|FG007|Overall Study|Withdrawal by Subject|0|||
48815337|NCT03621982|157165779|FG008|Overall Study|Withdrawal by Subject|1|||
48719619|NCT02353143|156822985|FG002|Overall Study|Withdrawal by Subject|0|||
48719620|NCT02353143|156822986|FG003|Overall Study|Withdrawal by Subject|0|||
48815338|NCT03621982|157165780|FG009|Overall Study|Withdrawal by Subject|0|||
48815339|NCT03621982|157165781|FG010|Overall Study|Withdrawal by Subject|2|||
48815340|NCT03621982|157165782|FG011|Overall Study|Withdrawal by Subject|1|||
48815341|NCT03621982|157165783|FG012|Overall Study|Withdrawal by Subject|2|||
48815342|NCT03621982|157165784|FG013|Overall Study|Withdrawal by Subject|2|||
48815343|NCT03621982|157165771|FG000|Overall Study|Investigator/Sponsor decision|0|||
48815344|NCT03621982|157165772|FG001|Overall Study|Investigator/Sponsor decision|0|||
48815345|NCT03621982|157165773|FG002|Overall Study|Investigator/Sponsor decision|0|||
48815346|NCT03621982|157165774|FG003|Overall Study|Investigator/Sponsor decision|0|||
48815347|NCT03621982|157165775|FG004|Overall Study|Investigator/Sponsor decision|0|||
48815348|NCT03621982|157165776|FG005|Overall Study|Investigator/Sponsor decision|0|||
48815349|NCT03621982|157165777|FG006|Overall Study|Investigator/Sponsor decision|0|||
48815350|NCT03621982|157165778|FG007|Overall Study|Investigator/Sponsor decision|0|||
48815351|NCT03621982|157165779|FG008|Overall Study|Investigator/Sponsor decision|0|||
48815352|NCT03621982|157165780|FG009|Overall Study|Investigator/Sponsor decision|0|||
48815353|NCT03621982|157165781|FG010|Overall Study|Investigator/Sponsor decision|0|||
48815354|NCT03621982|157165782|FG011|Overall Study|Investigator/Sponsor decision|4|||
48815355|NCT03621982|157165783|FG012|Overall Study|Investigator/Sponsor decision|0|||
48815356|NCT03621982|157165784|FG013|Overall Study|Investigator/Sponsor decision|2|||
48719621|NCT02353143|156822987|FG004|Overall Study|Withdrawal by Subject|1|||
48719622|NCT02353143|156822988|FG005|Overall Study|Withdrawal by Subject|0|||
48719623|NCT02353143|156822989|FG006|Overall Study|Withdrawal by Subject|0|||
48719624|NCT02353143|156822990|FG007|Overall Study|Withdrawal by Subject|1|||
48719625|NCT02353143|156822991|FG008|Overall Study|Withdrawal by Subject|1|||
48815357|NCT03621982|157165771|FG000|Overall Study|Death|2|||
48815358|NCT03621982|157165772|FG001|Overall Study|Death|4|||
48815359|NCT03621982|157165773|FG002|Overall Study|Death|4|||
48815360|NCT03621982|157165774|FG003|Overall Study|Death|3|||
48815361|NCT03621982|157165775|FG004|Overall Study|Death|8|||
48815362|NCT03621982|157165776|FG005|Overall Study|Death|4|||
48719626|NCT02353143|156822983|FG000|Overall Study|Lack of Efficacy|2|||
48719627|NCT02353143|156822984|FG001|Overall Study|Lack of Efficacy|1|||
48719628|NCT02353143|156822985|FG002|Overall Study|Lack of Efficacy|2|||
48719629|NCT02353143|156822986|FG003|Overall Study|Lack of Efficacy|4|||
48719630|NCT02353143|156822987|FG004|Overall Study|Lack of Efficacy|13|||
48719631|NCT02353143|156822988|FG005|Overall Study|Lack of Efficacy|2|||
48719632|NCT02353143|156822989|FG006|Overall Study|Lack of Efficacy|2|||
48719633|NCT02353143|156822990|FG007|Overall Study|Lack of Efficacy|2|||
48719634|NCT02353143|156822991|FG008|Overall Study|Lack of Efficacy|1|||
48719635|NCT02353143|156822983|FG000|Overall Study|reason not specified|1|||
48719636|NCT02353143|156822984|FG001|Overall Study|reason not specified|2|||
48719637|NCT02353143|156822985|FG002|Overall Study|reason not specified|0|||
48719638|NCT02353143|156822986|FG003|Overall Study|reason not specified|0|||
48719639|NCT02353143|156822987|FG004|Overall Study|reason not specified|6|||
48719640|NCT02353143|156822988|FG005|Overall Study|reason not specified|1|||
48815363|NCT03621982|157165777|FG006|Overall Study|Death|6|||
48815364|NCT03621982|157165778|FG007|Overall Study|Death|3|||
48815365|NCT03621982|157165779|FG008|Overall Study|Death|0|||
48815366|NCT03621982|157165780|FG009|Overall Study|Death|3|||
48815367|NCT03621982|157165781|FG010|Overall Study|Death|8|||
48815368|NCT03621982|157165782|FG011|Overall Study|Death|4|||
48815369|NCT03621982|157165783|FG012|Overall Study|Death|2|||
48815370|NCT03621982|157165784|FG013|Overall Study|Death|2|||
48815371|NCT03621982|157165771|FG000|Overall Study|Lost to Follow-up|0|||
48815372|NCT03621982|157165772|FG001|Overall Study|Lost to Follow-up|0|||
48815373|NCT03621982|157165773|FG002|Overall Study|Lost to Follow-up|1|||
48815374|NCT03621982|157165774|FG003|Overall Study|Lost to Follow-up|0|||
48815375|NCT03621982|157165775|FG004|Overall Study|Lost to Follow-up|0|||
48815376|NCT03621982|157165776|FG005|Overall Study|Lost to Follow-up|0|||
48815377|NCT03621982|157165777|FG006|Overall Study|Lost to Follow-up|1|||
48815378|NCT03621982|157165778|FG007|Overall Study|Lost to Follow-up|0|||
48815379|NCT03621982|157165779|FG008|Overall Study|Lost to Follow-up|0|||
48815380|NCT03621982|157165780|FG009|Overall Study|Lost to Follow-up|1|||
48815381|NCT03621982|157165781|FG010|Overall Study|Lost to Follow-up|0|||
48815382|NCT03621982|157165782|FG011|Overall Study|Lost to Follow-up|0|||
48719641|NCT02353143|156822989|FG006|Overall Study|reason not specified|0|||
48719642|NCT02353143|156822990|FG007|Overall Study|reason not specified|3|||
48815383|NCT03621982|157165783|FG012|Overall Study|Lost to Follow-up|0|||
48815384|NCT03621982|157165784|FG013|Overall Study|Lost to Follow-up|0|||
48815385|NCT01342887|157165785|FG000|Overall Study|Death|2|||
48815386|NCT00127413|157165786|FG000|Overall Study|Lost to Follow-up|6|||
48815387|NCT00127413|157165787|FG001|Overall Study|Lost to Follow-up|4|||
48719643|NCT02353143|156822991|FG008|Overall Study|reason not specified|1|||
48719644|NCT02353143|156822983|FG000|Overall Study|Physician Decision|0|||
48815388|NCT00127413|157165788|FG002|Overall Study|Lost to Follow-up|8|||
48815389|NCT00127413|157165789|FG003|Overall Study|Lost to Follow-up|2|||
48815390|NCT00663962|157165790|FG000|Overall Study|somnolence|1|||
48815391|NCT00663962|157165791|FG001|Overall Study|somnolence|0|||
48719645|NCT02353143|156822984|FG001|Overall Study|Physician Decision|4|||
48719646|NCT02353143|156822985|FG002|Overall Study|Physician Decision|2|||
48719647|NCT02353143|156822986|FG003|Overall Study|Physician Decision|3|||
48719648|NCT02353143|156822987|FG004|Overall Study|Physician Decision|4|||
48719649|NCT02353143|156822988|FG005|Overall Study|Physician Decision|0|||
48719650|NCT02353143|156822989|FG006|Overall Study|Physician Decision|1|||
48719651|NCT02353143|156822990|FG007|Overall Study|Physician Decision|2|||
48815392|NCT05221749|157165794|FG000|Overall Study|Lost to Follow-up|2|||
48815393|NCT05221749|157165795|FG001|Overall Study|Lost to Follow-up|3|||
48815394|NCT02404493|157165796|FG000|Overall Study|Adverse Event|1|||
48815395|NCT02404493|157165797|FG001|Overall Study|Adverse Event|1|||
48815396|NCT01700348|157165798|FG000|Overall Study|Withdrawal by Subject|22|||
48815397|NCT01700348|157165798|FG000|Overall Study|Lost to Follow-up|1|||
48815398|NCT04140890|157165799|FG000|Overall Study|Withdrawal by Subject|0|||
48815399|NCT04140890|157165800|FG001|Overall Study|Withdrawal by Subject|1|||
48815400|NCT02102464|157165801|FG000|Randomized Study|Withdrawal by Subject|0|||
48719652|NCT02353143|156822991|FG008|Overall Study|Physician Decision|0|||
48719653|NCT02353143|156822983|FG000|Overall Study|Adverse Event|0|||
48719654|NCT02353143|156822984|FG001|Overall Study|Adverse Event|0|||
48719655|NCT02353143|156822985|FG002|Overall Study|Adverse Event|1|||
48719656|NCT02353143|156822986|FG003|Overall Study|Adverse Event|0|||
48719657|NCT02353143|156822987|FG004|Overall Study|Adverse Event|1|||
48719658|NCT02353143|156822988|FG005|Overall Study|Adverse Event|1|||
48719659|NCT02353143|156822989|FG006|Overall Study|Adverse Event|0|||
48719660|NCT02353143|156822990|FG007|Overall Study|Adverse Event|0|||
48719661|NCT02353143|156822991|FG008|Overall Study|Adverse Event|0|||
48719662|NCT02353143|156822983|FG000|Overall Study|patient receiving other treatment for AML|0|||
48719663|NCT02353143|156822984|FG001|Overall Study|patient receiving other treatment for AML|0|||
48719664|NCT02353143|156822985|FG002|Overall Study|patient receiving other treatment for AML|1|||
48719665|NCT02353143|156822986|FG003|Overall Study|patient receiving other treatment for AML|0|||
48719666|NCT02353143|156822987|FG004|Overall Study|patient receiving other treatment for AML|0|||
48719667|NCT02353143|156822988|FG005|Overall Study|patient receiving other treatment for AML|0|||
48719668|NCT02353143|156822989|FG006|Overall Study|patient receiving other treatment for AML|0|||
48719669|NCT02353143|156822990|FG007|Overall Study|patient receiving other treatment for AML|0|||
48719670|NCT02353143|156822991|FG008|Overall Study|patient receiving other treatment for AML|0|||
48719671|NCT02353143|156822983|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
48815401|NCT02102464|157165802|FG001|Randomized Study|Withdrawal by Subject|1|||
48815402|NCT02102464|157165803|FG002|Randomized Study|Withdrawal by Subject|0|||
48815403|NCT01778062|157165804|FG000|Overall Study|Adverse Event|1|||
48815404|NCT01778062|157165805|FG001|Overall Study|Adverse Event|3|||
48815405|NCT01778062|157165804|FG000|Overall Study|Consent Withdrawal|1|||
48719672|NCT02353143|156822984|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
48719673|NCT02353143|156822985|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
48719674|NCT02353143|156822986|FG003|Overall Study|Dose limiting toxicity (DLT)|1|||
48719675|NCT02353143|156822987|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
48719676|NCT02353143|156822988|FG005|Overall Study|Dose limiting toxicity (DLT)|1|||
48719677|NCT02353143|156822989|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
48719678|NCT02353143|156822990|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
48719679|NCT02353143|156822991|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
48719680|NCT04136444|156822992|FG000|Overall Study|Sponsor request due to undisclosed concomitant medication|0|||
48719681|NCT04136444|156822993|FG001|Overall Study|Sponsor request due to undisclosed concomitant medication|1|||
48719682|NCT01029405|156822998|FG000|Overall Study|Withdrawal by Subject|0|||
48719683|NCT01029405|156822999|FG001|Overall Study|Withdrawal by Subject|1|||
48719684|NCT01029405|156823000|FG002|Overall Study|Withdrawal by Subject|2|||
49128471|NCT01850641|158308982|FG000|Overall Study|Increase in serum ferritin|1|||
49128472|NCT01420536|158308985|FG000|Period 1 (30 Days)|Withdrawal by Subject|3|||
49128473|NCT01420536|158308986|FG001|Period 1 (30 Days)|Withdrawal by Subject|0|||
49128474|NCT01157845|158308988|FG000|Overall Study|Lost to Follow-up|5|||
49128475|NCT01157845|158308988|FG000|Overall Study|Withdrawal by Subject|12|||
49128476|NCT01157845|158308988|FG000|Overall Study|Physician Decision|3|||
49128477|NCT01157845|158308988|FG000|Overall Study|Protocol Violation|13|||
49128478|NCT01157845|158308988|FG000|Overall Study|Study was ended|1|||
49128479|NCT01157845|158308988|FG000|Overall Study|Device malfunction|1|||
49128480|NCT02781324|158308991|FG000|Overall Study|Withdrawal by Subject|1|||
49128481|NCT02781324|158308992|FG001|Overall Study|Withdrawal by Subject|0|||
49128482|NCT02781324|158308991|FG000|Overall Study|Physician Decision|1|||
49128483|NCT02781324|158308992|FG001|Overall Study|Physician Decision|2|||
49128484|NCT03499795|158310741|FG000|Overall Study|Adverse Event|1|||
49128485|NCT03499795|158310741|FG000|Overall Study|Lost to Follow-up|1|||
49128486|NCT01774981|158310742|FG000|Overall Study|Adverse Event|0|||
49128487|NCT01774981|158310743|FG001|Overall Study|Adverse Event|0|||
49128488|NCT01774981|158310744|FG002|Overall Study|Adverse Event|0|||
49128489|NCT01774981|158310745|FG003|Overall Study|Adverse Event|0|||
49128490|NCT01774981|158310746|FG004|Overall Study|Adverse Event|0|||
49128491|NCT01774981|158310747|FG005|Overall Study|Adverse Event|1|||
49128492|NCT01774981|158310748|FG006|Overall Study|Adverse Event|0|||
49128493|NCT01774981|158310749|FG007|Overall Study|Adverse Event|0|||
49128494|NCT01774981|158310742|FG000|Overall Study|Withdrawal by Subject|0|||
49128495|NCT01774981|158310743|FG001|Overall Study|Withdrawal by Subject|0|||
49128496|NCT01774981|158310744|FG002|Overall Study|Withdrawal by Subject|0|||
49128497|NCT01774981|158310745|FG003|Overall Study|Withdrawal by Subject|0|||
49128498|NCT01774981|158310746|FG004|Overall Study|Withdrawal by Subject|0|||
49128499|NCT01774981|158310747|FG005|Overall Study|Withdrawal by Subject|0|||
49128500|NCT01774981|158310748|FG006|Overall Study|Withdrawal by Subject|0|||
49128501|NCT01774981|158310749|FG007|Overall Study|Withdrawal by Subject|1|||
49128502|NCT01774981|158310742|FG000|Overall Study|Death|0|||
48719685|NCT01029405|156823001|FG003|Overall Study|Withdrawal by Subject|0|||
49128503|NCT01774981|158310743|FG001|Overall Study|Death|0|||
49128504|NCT01774981|158310744|FG002|Overall Study|Death|0|||
49128505|NCT01774981|158310745|FG003|Overall Study|Death|0|||
49128506|NCT01774981|158310746|FG004|Overall Study|Death|1|||
49128507|NCT01774981|158310747|FG005|Overall Study|Death|0|||
48719686|NCT01029405|156822998|FG000|Overall Study|Protocol Violation|0|||
48719687|NCT01029405|156822999|FG001|Overall Study|Protocol Violation|0|||
48719688|NCT01029405|156823000|FG002|Overall Study|Protocol Violation|0|||
48719689|NCT01029405|156823001|FG003|Overall Study|Protocol Violation|1|||
48719690|NCT01029405|156822998|FG000|Overall Study|Adverse Event|0|||
48719691|NCT01029405|156822999|FG001|Overall Study|Adverse Event|0|||
48719692|NCT01029405|156823000|FG002|Overall Study|Adverse Event|1|||
48719693|NCT01029405|156823001|FG003|Overall Study|Adverse Event|1|||
48719694|NCT01029405|156822998|FG000|Overall Study|Lost to Follow-up|2|||
48719695|NCT01029405|156822999|FG001|Overall Study|Lost to Follow-up|1|||
48719696|NCT01029405|156823000|FG002|Overall Study|Lost to Follow-up|1|||
48719697|NCT01029405|156823001|FG003|Overall Study|Lost to Follow-up|2|||
48719698|NCT01029405|156822998|FG000|Overall Study|Other|0|||
48719699|NCT01029405|156822999|FG001|Overall Study|Other|1|||
48719700|NCT01029405|156823000|FG002|Overall Study|Other|0|||
48719701|NCT01029405|156823001|FG003|Overall Study|Other|1|||
48719702|NCT02946931|156823002|FG000|Overall Study|Did not require collection of CRFs|588|||
48719703|NCT02946931|156823002|FG000|Overall Study|Other than listed|37|||
48719704|NCT02946931|156823002|FG000|Overall Study|Discharge from hospital|118|||
48719705|NCT02946931|156823002|FG000|Overall Study|Adverse Event|81|||
48719706|NCT02946931|156823002|FG000|Overall Study|CRFs not valid|1|||
48719707|NCT02946931|156823002|FG000|Overall Study|CRFs with missing information on the date of termination of PMS|6|||
48719708|NCT00561977|156823003|FG000|Overall Study|Withdrawal by Subject|0|||
48719709|NCT00561977|156823004|FG001|Overall Study|Withdrawal by Subject|2|||
48719710|NCT00561977|156823005|FG002|Overall Study|Withdrawal by Subject|1|||
48719711|NCT00561977|156823003|FG000|Overall Study|Pregnancy|0|||
48719712|NCT00561977|156823004|FG001|Overall Study|Pregnancy|1|||
48719713|NCT00561977|156823005|FG002|Overall Study|Pregnancy|1|||
48719714|NCT00732940|156823008|FG000|Overall Study|Withdrawal by Subject|1|||
48719715|NCT00732940|156823009|FG001|Overall Study|Withdrawal by Subject|2|||
49128508|NCT01774981|158310748|FG006|Overall Study|Death|0|||
48719716|NCT00732940|156823008|FG000|Overall Study|Adverse Event|0|||
48719717|NCT00732940|156823009|FG001|Overall Study|Adverse Event|1|||
48719718|NCT00732940|156823008|FG000|Overall Study|Lost to Follow-up|1|||
48719719|NCT00732940|156823009|FG001|Overall Study|Lost to Follow-up|0|||
48719720|NCT00509262|156823010|FG000|Overall Study|Adverse Event|16|||
48719721|NCT00509262|156823011|FG001|Overall Study|Adverse Event|18|||
48719722|NCT00509262|156823010|FG000|Overall Study|Other|2|||
48719723|NCT00509262|156823011|FG001|Overall Study|Other|2|||
48719724|NCT00509262|156823010|FG000|Overall Study|Lack of Efficacy|1|||
48719725|NCT00509262|156823011|FG001|Overall Study|Lack of Efficacy|0|||
48719726|NCT00509262|156823010|FG000|Overall Study|Lost to Follow-up|1|||
48719727|NCT00509262|156823011|FG001|Overall Study|Lost to Follow-up|6|||
48719728|NCT00509262|156823010|FG000|Overall Study|Physician Decision|1|||
48719729|NCT00509262|156823011|FG001|Overall Study|Physician Decision|3|||
48719730|NCT00509262|156823010|FG000|Overall Study|Protocol Violation|2|||
48719731|NCT00509262|156823011|FG001|Overall Study|Protocol Violation|2|||
48815406|NCT01778062|157165805|FG001|Overall Study|Consent Withdrawal|5|||
48815407|NCT01778062|157165804|FG000|Overall Study|major protocol deviation|4|||
48815408|NCT01778062|157165805|FG001|Overall Study|major protocol deviation|3|||
48815409|NCT00003458|157165809|FG000|Overall Study|Not evaluable|4|||
48815410|NCT02133924|157165810|FG000|Overall Study|Death|38|||
48815411|NCT02133924|157165810|FG000|Overall Study|Physician Decision|1|||
48719732|NCT00509262|156823010|FG000|Overall Study|Withdrawal by Subject|24|||
48719733|NCT00509262|156823011|FG001|Overall Study|Withdrawal by Subject|11|||
48719734|NCT03709576|156823014|FG000|Overall Study|progression prior to enrollment|1|||
48719735|NCT00621621|156823019|FG000|Overall Study|Subjects were exited at EP study|30|||
48719736|NCT00621621|156823020|FG001|Overall Study|Subjects were exited at EP study|0|||
48719737|NCT01226121|156823023|FG000|Overall Study|Lost to Follow-up|2|||
48719738|NCT01226121|156823024|FG001|Overall Study|Lost to Follow-up|0|||
48719739|NCT01226121|156823025|FG002|Overall Study|Lost to Follow-up|1|||
48719740|NCT00169442|156823026|FG000|Overall Study|Withdrawal by Subject|0|||
48719741|NCT00169442|156823027|FG001|Overall Study|Withdrawal by Subject|0|||
48719742|NCT00169442|156823028|FG002|Overall Study|Withdrawal by Subject|1|||
48719743|NCT00169442|156823029|FG003|Overall Study|Withdrawal by Subject|0|||
48719744|NCT00169442|156823030|FG004|Overall Study|Withdrawal by Subject|0|||
48719745|NCT00169442|156823031|FG005|Overall Study|Withdrawal by Subject|0|||
48719746|NCT00169442|156823026|FG000|Overall Study|Migrated/moved from study area|0|||
48719747|NCT00169442|156823027|FG001|Overall Study|Migrated/moved from study area|0|||
48719748|NCT00169442|156823028|FG002|Overall Study|Migrated/moved from study area|0|||
48719749|NCT00169442|156823029|FG003|Overall Study|Migrated/moved from study area|0|||
48719750|NCT00169442|156823030|FG004|Overall Study|Migrated/moved from study area|0|||
48719751|NCT00169442|156823031|FG005|Overall Study|Migrated/moved from study area|2|||
48719752|NCT00169442|156823026|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
48719753|NCT00169442|156823027|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
48719754|NCT00169442|156823028|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
48815412|NCT02133924|157165810|FG000|Overall Study|Withdrawal by Subject|3|||
48815413|NCT04039503|157165817|FG000|Overall Study|Adverse Event|3|||
49128509|NCT01774981|158310749|FG007|Overall Study|Death|0|||
49128510|NCT01324102|158310752|FG000|Overall Study|illness|1|||
49128511|NCT01324102|158310753|FG001|Overall Study|illness|6|||
49128512|NCT02914834|158310756|FG000|Overall Study|Study halted due to COVID|1|||
49128513|NCT02914834|158310757|FG001|Overall Study|Study halted due to COVID|1|||
49128514|NCT02914834|158310756|FG000|Overall Study|1 subject withdrew|0|||
49128515|NCT02914834|158310757|FG001|Overall Study|1 subject withdrew|1|||
49128516|NCT00473655|158310758|FG000|Overall Study|Lost to Follow-up|9|||
49128517|NCT00473655|158310759|FG001|Overall Study|Lost to Follow-up|5|||
49128518|NCT00473655|158310760|FG002|Overall Study|Lost to Follow-up|8|||
49128519|NCT02631941|158310769|FG000|Overall Study|Physician Decision|0|||
49128520|NCT02631941|158310770|FG001|Overall Study|Physician Decision|1|||
49128521|NCT02631941|158310771|FG002|Overall Study|Physician Decision|0|||
49128522|NCT02631941|158310772|FG003|Overall Study|Physician Decision|0|||
49128523|NCT02631941|158310773|FG004|Overall Study|Physician Decision|0|||
49128524|NCT02631941|158310774|FG005|Overall Study|Physician Decision|0|||
49128525|NCT02631941|158310775|FG006|Overall Study|Physician Decision|0|||
49128526|NCT02631941|158310776|FG007|Overall Study|Physician Decision|0|||
48719755|NCT00169442|156823029|FG003|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
48719756|NCT00169442|156823030|FG004|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
48719757|NCT00169442|156823031|FG005|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
48719758|NCT00169442|156823026|FG000|Overall Study|Lost to follow-up (compl. vaccination)|0|||
48719759|NCT00169442|156823027|FG001|Overall Study|Lost to follow-up (compl. vaccination)|1|||
48719760|NCT00169442|156823028|FG002|Overall Study|Lost to follow-up (compl. vaccination)|0|||
48719761|NCT00169442|156823029|FG003|Overall Study|Lost to follow-up (compl. vaccination)|0|||
48719762|NCT00169442|156823030|FG004|Overall Study|Lost to follow-up (compl. vaccination)|0|||
48719763|NCT00169442|156823031|FG005|Overall Study|Lost to follow-up (compl. vaccination)|0|||
48815414|NCT04039503|157165818|FG001|Overall Study|Adverse Event|0|||
48815415|NCT04039503|157165819|FG002|Overall Study|Adverse Event|2|||
48719764|NCT00811642|156823040|FG000|Overall Study|Adverse Event|3|||
48719765|NCT00811642|156823040|FG000|Overall Study|Protocol Violation|1|||
48719766|NCT00811642|156823040|FG000|Overall Study|Death|2|||
48719767|NCT00811642|156823040|FG000|Overall Study|Withdrawal by Subject|7|||
48719768|NCT00811642|156823040|FG000|Overall Study|Cumulative use of antifungal agent|2|||
48719769|NCT01246466|156824793|FG000|Overall Study|Death|1|||
48719770|NCT01246466|156824793|FG000|Overall Study|Withdrawal by Subject|1|||
48719771|NCT02446171|156824800|FG000|Overall Study|Withdrawal by Subject|0|||
48719772|NCT02446171|156824801|FG001|Overall Study|Withdrawal by Subject|0|||
48719773|NCT02446171|156824802|FG002|Overall Study|Withdrawal by Subject|2|||
48719774|NCT02446171|156824803|FG003|Overall Study|Withdrawal by Subject|0|||
48719775|NCT01027273|156824805|FG000|Overall Study|Lost to Follow-up|57|||
48719776|NCT01027273|156824806|FG001|Overall Study|Lost to Follow-up|31|||
48719777|NCT01027273|156824805|FG000|Overall Study|Death|2|||
48719778|NCT01027273|156824806|FG001|Overall Study|Death|2|||
48719779|NCT03745820|156824811|FG000|Overall Study|Adverse Event|0|||
48719780|NCT03745820|156824812|FG001|Overall Study|Adverse Event|3|||
48719781|NCT03745820|156824813|FG002|Overall Study|Adverse Event|2|||
48719782|NCT03745820|156824811|FG000|Overall Study|Non-Compliance with Study Drug|4|||
48719783|NCT03745820|156824812|FG001|Overall Study|Non-Compliance with Study Drug|3|||
48719784|NCT03745820|156824813|FG002|Overall Study|Non-Compliance with Study Drug|0|||
48719785|NCT03745820|156824811|FG000|Overall Study|Withdrawal by Subject|4|||
48719786|NCT03745820|156824812|FG001|Overall Study|Withdrawal by Subject|4|||
48719787|NCT03745820|156824813|FG002|Overall Study|Withdrawal by Subject|4|||
48719788|NCT03745820|156824811|FG000|Overall Study|Physician decision unrelated to safety/efficacy|0|||
48719789|NCT03745820|156824812|FG001|Overall Study|Physician decision unrelated to safety/efficacy|0|||
48719790|NCT03745820|156824813|FG002|Overall Study|Physician decision unrelated to safety/efficacy|4|||
48719791|NCT03745820|156824811|FG000|Overall Study|Lost to Follow-up|2|||
48719792|NCT03745820|156824812|FG001|Overall Study|Lost to Follow-up|0|||
48719793|NCT03745820|156824813|FG002|Overall Study|Lost to Follow-up|3|||
48719794|NCT03745820|156824811|FG000|Overall Study|Reason not Specified|2|||
48719795|NCT03745820|156824812|FG001|Overall Study|Reason not Specified|4|||
48719796|NCT03745820|156824813|FG002|Overall Study|Reason not Specified|1|||
48719797|NCT00669409|156824814|FG000|Part 2|Withdrawal by Subject|0|||
48719798|NCT00669409|156824815|FG001|Part 2|Withdrawal by Subject|0|||
48719799|NCT00669409|156824816|FG002|Part 2|Withdrawal by Subject|0|||
48719800|NCT00669409|156824817|FG003|Part 2|Withdrawal by Subject|0|||
48719801|NCT00669409|156824818|FG004|Part 2|Withdrawal by Subject|0|||
48719802|NCT00669409|156824819|FG005|Part 2|Withdrawal by Subject|0|||
48719803|NCT00669409|156824820|FG006|Part 2|Withdrawal by Subject|0|||
48719804|NCT00669409|156824821|FG007|Part 2|Withdrawal by Subject|0|||
48719805|NCT00669409|156824822|FG008|Part 2|Withdrawal by Subject|0|||
48719806|NCT00669409|156824823|FG009|Part 2|Withdrawal by Subject|1|||
48719807|NCT00669409|156824824|FG010|Part 2|Withdrawal by Subject|0|||
48719808|NCT02052414|156824827|FG000|Overall Study|Adverse Event|12|||
48719809|NCT02052414|156824827|FG000|Overall Study|Lack of Efficacy|2|||
48719810|NCT02052414|156824827|FG000|Overall Study|Withdrawal by Subject|3|||
48719811|NCT01489111|156824828|FG000|Overall Study|Withdrawal criterion|1|||
48719812|NCT00813943|156824830|FG000|Overall Study|Ongoing at cut-off date|5|||
48719813|NCT00813943|156824831|FG001|Overall Study|Ongoing at cut-off date|5|||
48719814|NCT00813943|156824832|FG002|Overall Study|Ongoing at cut-off date|3|||
48719815|NCT01463007|156824836|FG000|Overall Study|Physician Decision|1|||
49128527|NCT02631941|158310777|FG008|Overall Study|Physician Decision|0|||
49128528|NCT02631941|158310778|FG009|Overall Study|Physician Decision|0|||
49128529|NCT02631941|158310769|FG000|Overall Study|Adverse Event|0|||
49128530|NCT02631941|158310770|FG001|Overall Study|Adverse Event|1|||
49128531|NCT02631941|158310771|FG002|Overall Study|Adverse Event|0|||
49128532|NCT02631941|158310772|FG003|Overall Study|Adverse Event|0|||
49128533|NCT02631941|158310773|FG004|Overall Study|Adverse Event|0|||
49128534|NCT02631941|158310774|FG005|Overall Study|Adverse Event|0|||
49128535|NCT02631941|158310775|FG006|Overall Study|Adverse Event|0|||
49128536|NCT02631941|158310776|FG007|Overall Study|Adverse Event|0|||
49128537|NCT02631941|158310777|FG008|Overall Study|Adverse Event|0|||
49128538|NCT02631941|158310778|FG009|Overall Study|Adverse Event|0|||
49128539|NCT02631941|158310769|FG000|Overall Study|Withdrawal by Subject|0|||
49128540|NCT02631941|158310770|FG001|Overall Study|Withdrawal by Subject|0|||
49128541|NCT02631941|158310771|FG002|Overall Study|Withdrawal by Subject|0|||
49128542|NCT02631941|158310772|FG003|Overall Study|Withdrawal by Subject|0|||
49128543|NCT02631941|158310773|FG004|Overall Study|Withdrawal by Subject|1|||
49128544|NCT02631941|158310774|FG005|Overall Study|Withdrawal by Subject|0|||
48719816|NCT01095094|156824842|FG000|Overall Study|Withdrawal by Subject|1|||
48719817|NCT01095094|156824842|FG000|Overall Study|Death|1|||
48719818|NCT01095094|156824842|FG000|Overall Study|Physician Decision|1|||
48719819|NCT03467152|156824843|FG000|Overall Study|Adverse Event|4|||
48719820|NCT03467152|156824844|FG001|Overall Study|Adverse Event|5|||
49128545|NCT02631941|158310775|FG006|Overall Study|Withdrawal by Subject|0|||
49128546|NCT02631941|158310776|FG007|Overall Study|Withdrawal by Subject|1|||
48719821|NCT03467152|156824845|FG002|Overall Study|Adverse Event|0|||
48815416|NCT04039503|157165820|FG003|Overall Study|Adverse Event|0|||
48815417|NCT04039503|157165817|FG000|Overall Study|Lost to Follow-up|0|||
48815418|NCT04039503|157165818|FG001|Overall Study|Lost to Follow-up|0|||
48815419|NCT04039503|157165819|FG002|Overall Study|Lost to Follow-up|1|||
48815420|NCT04039503|157165820|FG003|Overall Study|Lost to Follow-up|0|||
48815421|NCT04039503|157165817|FG000|Overall Study|Protocol Violation|0|||
48815422|NCT04039503|157165818|FG001|Overall Study|Protocol Violation|1|||
48815423|NCT04039503|157165819|FG002|Overall Study|Protocol Violation|2|||
48815424|NCT04039503|157165820|FG003|Overall Study|Protocol Violation|1|||
48815425|NCT04039503|157165817|FG000|Overall Study|Withdrawal by Subject|4|||
48815426|NCT04039503|157165818|FG001|Overall Study|Withdrawal by Subject|3|||
48815427|NCT04039503|157165819|FG002|Overall Study|Withdrawal by Subject|5|||
48815428|NCT04039503|157165820|FG003|Overall Study|Withdrawal by Subject|2|||
48815429|NCT03387514|157165821|FG000|Overall Study|Withdrawal by Subject|2|||
48815430|NCT03387514|157165821|FG000|Overall Study|Physician Decision|1|||
48815431|NCT03387514|157165821|FG000|Overall Study|Lost to Follow-up|2|||
48815432|NCT00245011|157165822|FG000|Overall Study|Lack of Efficacy|1|||
48815433|NCT03040687|157165823|FG000|Overall Study|Withdrawal by Subject|1|||
48815434|NCT03040687|157165824|FG001|Overall Study|Withdrawal by Subject|0|||
48815435|NCT03040687|157165825|FG002|Overall Study|Withdrawal by Subject|0|||
48815436|NCT02846558|157165826|FG000|Overall Study|Adverse Event|1|||
48815437|NCT02846558|157165827|FG001|Overall Study|Adverse Event|0|||
48815438|NCT02846558|157165828|FG002|Overall Study|Adverse Event|0|||
48815439|NCT02846558|157165829|FG003|Overall Study|Adverse Event|0|||
48815440|NCT02846558|157165826|FG000|Overall Study|Withdrawal by Subject|5|||
48815441|NCT02846558|157165827|FG001|Overall Study|Withdrawal by Subject|4|||
48815442|NCT02846558|157165828|FG002|Overall Study|Withdrawal by Subject|2|||
48815443|NCT02846558|157165829|FG003|Overall Study|Withdrawal by Subject|2|||
48815444|NCT02846558|157165826|FG000|Overall Study|Lost to Follow-up|2|||
48815445|NCT02846558|157165827|FG001|Overall Study|Lost to Follow-up|0|||
48815446|NCT02846558|157165828|FG002|Overall Study|Lost to Follow-up|0|||
48815447|NCT02846558|157165829|FG003|Overall Study|Lost to Follow-up|0|||
48815448|NCT04157686|157165830|FG000|Overall Study|Adverse Event|1|||
48815449|NCT04157686|157165831|FG001|Overall Study|Adverse Event|0|||
48815450|NCT04157686|157165832|FG002|Overall Study|Adverse Event|1|||
48815451|NCT04157686|157165833|FG003|Overall Study|Adverse Event|0|||
48815452|NCT04157686|157165834|FG004|Overall Study|Adverse Event|1|||
48815453|NCT04157686|157165835|FG005|Overall Study|Adverse Event|0|||
48815454|NCT04157686|157165836|FG006|Overall Study|Adverse Event|0|||
48815455|NCT04157686|157165837|FG007|Overall Study|Adverse Event|0|||
48815456|NCT04157686|157165830|FG000|Overall Study|Pregnancy|0|||
48815457|NCT04157686|157165831|FG001|Overall Study|Pregnancy|1|||
48815458|NCT04157686|157165832|FG002|Overall Study|Pregnancy|3|||
48815459|NCT04157686|157165833|FG003|Overall Study|Pregnancy|0|||
48815460|NCT04157686|157165834|FG004|Overall Study|Pregnancy|0|||
48815461|NCT04157686|157165835|FG005|Overall Study|Pregnancy|0|||
48815462|NCT04157686|157165836|FG006|Overall Study|Pregnancy|3|||
48815463|NCT04157686|157165837|FG007|Overall Study|Pregnancy|0|||
48815464|NCT04157686|157165830|FG000|Overall Study|Lost to Follow-up|1|||
48815465|NCT04157686|157165831|FG001|Overall Study|Lost to Follow-up|2|||
49128547|NCT02631941|158310777|FG008|Overall Study|Withdrawal by Subject|0|||
49128548|NCT02631941|158310778|FG009|Overall Study|Withdrawal by Subject|0|||
49128549|NCT02631941|158310769|FG000|Overall Study|Lost to Follow-up|0|||
49128550|NCT02631941|158310770|FG001|Overall Study|Lost to Follow-up|0|||
49128551|NCT02631941|158310771|FG002|Overall Study|Lost to Follow-up|0|||
49128552|NCT02631941|158310772|FG003|Overall Study|Lost to Follow-up|0|||
49128553|NCT02631941|158310773|FG004|Overall Study|Lost to Follow-up|0|||
49128554|NCT02631941|158310774|FG005|Overall Study|Lost to Follow-up|0|||
49128555|NCT02631941|158310775|FG006|Overall Study|Lost to Follow-up|0|||
49128556|NCT02631941|158310776|FG007|Overall Study|Lost to Follow-up|0|||
49128557|NCT02631941|158310777|FG008|Overall Study|Lost to Follow-up|1|||
49128558|NCT02631941|158310778|FG009|Overall Study|Lost to Follow-up|0|||
49128559|NCT01225549|158310779|FG000|Period 4 - Washout|Disallowed medication|0|||
49128560|NCT01225549|158310780|FG001|Period 4 - Washout|Disallowed medication|1|||
49128561|NCT01225549|158310781|FG002|Period 4 - Washout|Disallowed medication|0|||
49128562|NCT01225549|158310782|FG003|Period 4 - Washout|Disallowed medication|0|||
48815466|NCT04157686|157165832|FG002|Overall Study|Lost to Follow-up|8|||
48815467|NCT04157686|157165833|FG003|Overall Study|Lost to Follow-up|6|||
48815468|NCT04157686|157165834|FG004|Overall Study|Lost to Follow-up|6|||
48815469|NCT04157686|157165835|FG005|Overall Study|Lost to Follow-up|3|||
48815470|NCT04157686|157165836|FG006|Overall Study|Lost to Follow-up|7|||
48815471|NCT04157686|157165837|FG007|Overall Study|Lost to Follow-up|9|||
48815472|NCT04157686|157165830|FG000|Overall Study|Lack of Efficacy|0|||
48815473|NCT04157686|157165831|FG001|Overall Study|Lack of Efficacy|0|||
48815474|NCT04157686|157165832|FG002|Overall Study|Lack of Efficacy|0|||
48815475|NCT04157686|157165833|FG003|Overall Study|Lack of Efficacy|0|||
49128563|NCT01225549|158310783|FG004|Period 4 - Washout|Disallowed medication|0|||
49128564|NCT01225549|158310784|FG005|Period 4 - Washout|Disallowed medication|0|||
48815476|NCT04157686|157165834|FG004|Overall Study|Lack of Efficacy|0|||
48815477|NCT04157686|157165835|FG005|Overall Study|Lack of Efficacy|2|||
48719822|NCT03467152|156824843|FG000|Overall Study|Subject Choice|1|||
48719823|NCT03467152|156824844|FG001|Overall Study|Subject Choice|3|||
48719824|NCT03467152|156824845|FG002|Overall Study|Subject Choice|0|||
48719825|NCT03467152|156824843|FG000|Overall Study|Lost to Follow-up|1|||
48719826|NCT03467152|156824844|FG001|Overall Study|Lost to Follow-up|0|||
48719827|NCT03467152|156824845|FG002|Overall Study|Lost to Follow-up|0|||
48719828|NCT03467152|156824843|FG000|Overall Study|Withdrawal by Subject|4|||
48719829|NCT03467152|156824844|FG001|Overall Study|Withdrawal by Subject|2|||
48719830|NCT03467152|156824845|FG002|Overall Study|Withdrawal by Subject|0|||
48719831|NCT03467152|156824843|FG000|Overall Study|Others|3|||
48719832|NCT03467152|156824844|FG001|Overall Study|Others|0|||
48719833|NCT03467152|156824845|FG002|Overall Study|Others|0|||
48719834|NCT03467152|156824843|FG000|Overall Study|Not treated|3|||
48719835|NCT03467152|156824844|FG001|Overall Study|Not treated|1|||
48719836|NCT03467152|156824845|FG002|Overall Study|Not treated|6|||
48719837|NCT01236547|156824846|FG000|Overall Study|Protocol Violation|0|||
48719838|NCT01236547|156824847|FG001|Overall Study|Protocol Violation|1|||
48719839|NCT01236547|156824848|FG002|Overall Study|Protocol Violation|1|||
48719840|NCT01236547|156824849|FG003|Overall Study|Protocol Violation|6|||
48719841|NCT01236547|156824850|FG004|Overall Study|Protocol Violation|12|||
48719842|NCT04250077|156824851|FG000|Overall Study|Withdrawal by Subject|0|||
48719843|NCT04250077|156824852|FG001|Overall Study|Withdrawal by Subject|1|||
48719844|NCT04250077|156824853|FG002|Overall Study|Withdrawal by Subject|0|||
48719845|NCT04250077|156824851|FG000|Overall Study|Lost to Follow-up|2|||
48719846|NCT04250077|156824852|FG001|Overall Study|Lost to Follow-up|3|||
48719847|NCT04250077|156824853|FG002|Overall Study|Lost to Follow-up|0|||
48719848|NCT00528970|156824854|FG000|Overall Study|Adverse Event|6|||
48719849|NCT00528970|156824855|FG001|Overall Study|Adverse Event|8|||
48719850|NCT00528970|156824856|FG002|Overall Study|Adverse Event|5|||
48719851|NCT00528970|156824854|FG000|Overall Study|Lost to Follow-up|0|||
48719852|NCT00528970|156824855|FG001|Overall Study|Lost to Follow-up|0|||
48719853|NCT00528970|156824856|FG002|Overall Study|Lost to Follow-up|1|||
48719854|NCT00528970|156824854|FG000|Overall Study|Other than specified|2|||
48719855|NCT00528970|156824855|FG001|Overall Study|Other than specified|3|||
48719856|NCT00528970|156824856|FG002|Overall Study|Other than specified|3|||
48719857|NCT00528970|156824854|FG000|Overall Study|Protocol Violation|2|||
48719858|NCT00528970|156824855|FG001|Overall Study|Protocol Violation|1|||
48719859|NCT00528970|156824856|FG002|Overall Study|Protocol Violation|4|||
48719860|NCT00528970|156824854|FG000|Overall Study|Lack of Efficacy|0|||
48719861|NCT00528970|156824855|FG001|Overall Study|Lack of Efficacy|0|||
48719862|NCT00528970|156824856|FG002|Overall Study|Lack of Efficacy|1|||
48719863|NCT00528970|156824854|FG000|Overall Study|Withdrawal by Subject|4|||
48719864|NCT00528970|156824855|FG001|Overall Study|Withdrawal by Subject|3|||
48719865|NCT00528970|156824856|FG002|Overall Study|Withdrawal by Subject|5|||
48719866|NCT00528970|156824854|FG000|Overall Study|Randomized but not treated|0|||
48719867|NCT00528970|156824855|FG001|Overall Study|Randomized but not treated|0|||
48719868|NCT00528970|156824856|FG002|Overall Study|Randomized but not treated|1|||
48719869|NCT01002820|156824858|FG000|Overall Study|Adverse Event|1|||
48719870|NCT01002820|156824858|FG000|Overall Study|Withdrawal by Subject|2|||
48719871|NCT01002820|156824858|FG000|Overall Study|Lack of Efficacy|1|||
48719872|NCT03859973|156824862|FG000|Overall Study|Other reason than listed|3|||
48719873|NCT03859973|156824863|FG001|Overall Study|Other reason than listed|2|||
48719874|NCT03859973|156824862|FG000|Overall Study|COVID-19 related, not due to AE|3|||
48719875|NCT03859973|156824863|FG001|Overall Study|COVID-19 related, not due to AE|4|||
48719876|NCT03859973|156824862|FG000|Overall Study|Withdrawal by Subject|8|||
48719877|NCT03859973|156824863|FG001|Overall Study|Withdrawal by Subject|9|||
48719878|NCT03859973|156824862|FG000|Overall Study|Lost to Follow-up|2|||
48719879|NCT03859973|156824863|FG001|Overall Study|Lost to Follow-up|3|||
48719880|NCT03859973|156824862|FG000|Overall Study|Protocol Violation|1|||
48719881|NCT03859973|156824863|FG001|Overall Study|Protocol Violation|3|||
48719882|NCT03859973|156824862|FG000|Overall Study|Adverse Event|3|||
48719883|NCT03859973|156824863|FG001|Overall Study|Adverse Event|5|||
48719884|NCT01369329|156824866|FG000|Overall Study|Withdrawal by Subject|8|||
48719885|NCT01369329|156824867|FG001|Overall Study|Withdrawal by Subject|6|||
48719886|NCT01369329|156824868|FG002|Overall Study|Withdrawal by Subject|10|||
48719887|NCT01369329|156824866|FG000|Overall Study|Lost to Follow-up|2|||
48719888|NCT01369329|156824867|FG001|Overall Study|Lost to Follow-up|2|||
48719889|NCT01369329|156824868|FG002|Overall Study|Lost to Follow-up|2|||
48719890|NCT01369329|156824866|FG000|Overall Study|Other|2|||
48719891|NCT01369329|156824867|FG001|Overall Study|Other|3|||
48719892|NCT01369329|156824868|FG002|Overall Study|Other|2|||
48719893|NCT03206788|156824869|FG000|Overall Study|Withdrawal by Subject|0|||
48719894|NCT03206788|156824870|FG001|Overall Study|Withdrawal by Subject|1|||
48719895|NCT03206788|156824869|FG000|Overall Study|Adverse Event|0|||
48719896|NCT03206788|156824870|FG001|Overall Study|Adverse Event|1|||
48719897|NCT03206788|156824869|FG000|Overall Study|Physician Decision|0|||
48719898|NCT03206788|156824870|FG001|Overall Study|Physician Decision|1|||
48719899|NCT03330002|156824871|FG000|Overall Study|Lost to Follow-up|15|||
48719900|NCT03330002|156824871|FG000|Overall Study|Death|7|||
48815478|NCT04157686|157165836|FG006|Overall Study|Lack of Efficacy|0|||
49128565|NCT01225549|158310785|FG006|Period 4 - Washout|Disallowed medication|0|||
49128566|NCT01225549|158310786|FG007|Period 4 - Washout|Disallowed medication|0|||
49128567|NCT01225549|158310787|FG008|Period 4 - Washout|Disallowed medication|0|||
49128568|NCT01225549|158310788|FG009|Period 4 - Washout|Disallowed medication|0|||
49128569|NCT01225549|158310779|FG000|Period 6 - Washout|Disallowed medication|0|||
49128570|NCT01225549|158310780|FG001|Period 6 - Washout|Disallowed medication|0|||
49128571|NCT01225549|158310781|FG002|Period 6 - Washout|Disallowed medication|0|||
49128572|NCT01225549|158310782|FG003|Period 6 - Washout|Disallowed medication|1|||
49128573|NCT01225549|158310783|FG004|Period 6 - Washout|Disallowed medication|0|||
49128574|NCT01225549|158310784|FG005|Period 6 - Washout|Disallowed medication|0|||
49128575|NCT01225549|158310785|FG006|Period 6 - Washout|Disallowed medication|0|||
49128576|NCT01225549|158310786|FG007|Period 6 - Washout|Disallowed medication|0|||
49128577|NCT01225549|158310787|FG008|Period 6 - Washout|Disallowed medication|0|||
49128578|NCT01225549|158310788|FG009|Period 6 - Washout|Disallowed medication|0|||
49128579|NCT02732639|158310791|FG000|Overall Study|Lost to Follow-up|1|||
49128580|NCT00473083|158310792|FG000|Overall Study|Adverse Event|1|||
49128581|NCT00473083|158310793|FG001|Overall Study|Adverse Event|0|||
49128582|NCT00473083|158310794|FG002|Overall Study|Adverse Event|0|||
49128583|NCT02513550|158310795|FG000|Double Blind Treatment Period|Withdrawal by Subject|11|||
49128584|NCT02513550|158310796|FG001|Double Blind Treatment Period|Withdrawal by Subject|11|||
49128585|NCT02513550|158310797|FG002|Double Blind Treatment Period|Withdrawal by Subject|25|||
49128586|NCT02513550|158310798|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
49128587|NCT02513550|158310799|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
49128588|NCT02513550|158310800|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
49128589|NCT02513550|158310795|FG000|Double Blind Treatment Period|Adverse Event|5|||
49128590|NCT02513550|158310796|FG001|Double Blind Treatment Period|Adverse Event|13|||
49128591|NCT02513550|158310797|FG002|Double Blind Treatment Period|Adverse Event|17|||
49128592|NCT02513550|158310798|FG003|Double Blind Treatment Period|Adverse Event|0|||
49128593|NCT02513550|158310799|FG004|Double Blind Treatment Period|Adverse Event|1|||
49128594|NCT02513550|158310800|FG005|Double Blind Treatment Period|Adverse Event|0|||
49128595|NCT02513550|158310795|FG000|Double Blind Treatment Period|Lost to Follow-up|9|||
49128596|NCT02513550|158310796|FG001|Double Blind Treatment Period|Lost to Follow-up|7|||
49128597|NCT02513550|158310797|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
49128598|NCT02513550|158310798|FG003|Double Blind Treatment Period|Lost to Follow-up|0|||
49128599|NCT02513550|158310799|FG004|Double Blind Treatment Period|Lost to Follow-up|0|||
49128600|NCT02513550|158310800|FG005|Double Blind Treatment Period|Lost to Follow-up|1|||
49128601|NCT02513550|158310795|FG000|Double Blind Treatment Period|Lack of Efficacy|4|||
49128602|NCT02513550|158310796|FG001|Double Blind Treatment Period|Lack of Efficacy|5|||
49128603|NCT02513550|158310797|FG002|Double Blind Treatment Period|Lack of Efficacy|6|||
49128604|NCT02513550|158310798|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
49128605|NCT02513550|158310799|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
49128606|NCT02513550|158310800|FG005|Double Blind Treatment Period|Lack of Efficacy|0|||
49128607|NCT02513550|158310795|FG000|Double Blind Treatment Period|Protocol Violation|1|||
49128608|NCT02513550|158310796|FG001|Double Blind Treatment Period|Protocol Violation|1|||
49128609|NCT02513550|158310797|FG002|Double Blind Treatment Period|Protocol Violation|4|||
49128610|NCT02513550|158310798|FG003|Double Blind Treatment Period|Protocol Violation|0|||
49128611|NCT02513550|158310799|FG004|Double Blind Treatment Period|Protocol Violation|0|||
48719901|NCT00917644|156824876|FG000|Period: Washout Period of > = 2 Weeks|Protocol Violation|1|||
48719902|NCT00917644|156824877|FG001|Period: Washout Period of > = 2 Weeks|Protocol Violation|0|||
48719903|NCT00917644|156824876|FG000|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1|||
48719904|NCT00917644|156824877|FG001|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0|||
48719905|NCT00917644|156824876|FG000|Period 2: Second Intervention|family emergency|1|||
48719906|NCT00917644|156824877|FG001|Period 2: Second Intervention|family emergency|0|||
48719907|NCT02142387|156824878|FG000|Overall Study|<19 years old|49|||
48719908|NCT02142387|156824879|FG001|Overall Study|<19 years old|326|||
48719909|NCT02142387|156824878|FG000|Overall Study|non-cardiac etiology|504|||
48719910|NCT02142387|156824879|FG001|Overall Study|non-cardiac etiology|3431|||
48719911|NCT02142387|156824878|FG000|Overall Study|CPR not performed|74|||
48719912|NCT02142387|156824879|FG001|Overall Study|CPR not performed|473|||
48719913|NCT02142387|156824878|FG000|Overall Study|witnessed by paramedic|139|||
48719914|NCT02142387|156824879|FG001|Overall Study|witnessed by paramedic|917|||
48719915|NCT02142387|156824878|FG000|Overall Study|incomplete data|1|||
48719916|NCT02142387|156824879|FG001|Overall Study|incomplete data|9|||
48719917|NCT02142387|156824878|FG000|Overall Study|occurred not at home|298|||
48719918|NCT02142387|156824879|FG001|Overall Study|occurred not at home|2474|||
48719919|NCT03996369|156824881|FG000|Overall Study|Protocol deviation|1|||
48719920|NCT03996369|156824882|FG001|Overall Study|Protocol deviation|1|||
48719921|NCT03996369|156824881|FG000|Overall Study|Physician Decision|4|||
48719922|NCT03996369|156824882|FG001|Overall Study|Physician Decision|2|||
48719923|NCT03996369|156824881|FG000|Overall Study|Participant decision|0|||
48719924|NCT03996369|156824882|FG001|Overall Study|Participant decision|1|||
48719925|NCT03996369|156824881|FG000|Overall Study|Lack of Efficacy|4|||
48719926|NCT03996369|156824882|FG001|Overall Study|Lack of Efficacy|0|||
48719927|NCT03996369|156824881|FG000|Overall Study|Adverse Event|9|||
48719928|NCT03996369|156824882|FG001|Overall Study|Adverse Event|0|||
48719929|NCT03996369|156824881|FG000|Overall Study|Withdrawal by Subject|6|||
48719930|NCT03996369|156824882|FG001|Overall Study|Withdrawal by Subject|8|||
48719931|NCT03996369|156824881|FG000|Overall Study|Didn't meet Inclusion/Exclusion criteria|1|||
48719932|NCT03996369|156824882|FG001|Overall Study|Didn't meet Inclusion/Exclusion criteria|0|||
48719933|NCT03996369|156824881|FG000|Overall Study|Lost to Follow-up|0|||
48719934|NCT03996369|156824882|FG001|Overall Study|Lost to Follow-up|1|||
48815479|NCT04157686|157165837|FG007|Overall Study|Lack of Efficacy|1|||
48815480|NCT04157686|157165830|FG000|Overall Study|Withdrawal by Subject|10|||
48815481|NCT04157686|157165831|FG001|Overall Study|Withdrawal by Subject|10|||
48815482|NCT04157686|157165832|FG002|Overall Study|Withdrawal by Subject|12|||
48815483|NCT04157686|157165833|FG003|Overall Study|Withdrawal by Subject|20|||
48815484|NCT04157686|157165834|FG004|Overall Study|Withdrawal by Subject|12|||
48815485|NCT04157686|157165835|FG005|Overall Study|Withdrawal by Subject|11|||
48815486|NCT04157686|157165836|FG006|Overall Study|Withdrawal by Subject|18|||
48815487|NCT04157686|157165837|FG007|Overall Study|Withdrawal by Subject|24|||
48815488|NCT04157686|157165830|FG000|Overall Study|Physician Decision|0|||
48815489|NCT04157686|157165831|FG001|Overall Study|Physician Decision|0|||
48815490|NCT04157686|157165832|FG002|Overall Study|Physician Decision|1|||
48815491|NCT04157686|157165833|FG003|Overall Study|Physician Decision|0|||
48815492|NCT04157686|157165834|FG004|Overall Study|Physician Decision|1|||
48815493|NCT04157686|157165835|FG005|Overall Study|Physician Decision|0|||
48815494|NCT04157686|157165836|FG006|Overall Study|Physician Decision|3|||
48815495|NCT04157686|157165837|FG007|Overall Study|Physician Decision|0|||
48815496|NCT04157686|157165830|FG000|Overall Study|Death|0|||
48815497|NCT04157686|157165831|FG001|Overall Study|Death|0|||
48815498|NCT04157686|157165832|FG002|Overall Study|Death|0|||
48815499|NCT04157686|157165833|FG003|Overall Study|Death|2|||
48815500|NCT04157686|157165834|FG004|Overall Study|Death|0|||
48815501|NCT04157686|157165835|FG005|Overall Study|Death|0|||
48815502|NCT04157686|157165836|FG006|Overall Study|Death|0|||
48815503|NCT04157686|157165837|FG007|Overall Study|Death|0|||
48815504|NCT04157686|157165830|FG000|Overall Study|Protocol Violation|0|||
48815505|NCT04157686|157165831|FG001|Overall Study|Protocol Violation|0|||
48815506|NCT04157686|157165832|FG002|Overall Study|Protocol Violation|0|||
48815507|NCT04157686|157165833|FG003|Overall Study|Protocol Violation|0|||
48815508|NCT04157686|157165834|FG004|Overall Study|Protocol Violation|1|||
48815509|NCT04157686|157165835|FG005|Overall Study|Protocol Violation|0|||
48815510|NCT04157686|157165836|FG006|Overall Study|Protocol Violation|0|||
48719935|NCT01579812|156824883|FG000|Overall Study|Ineligible after treatment start|40|||
48719936|NCT01579812|156824883|FG000|Overall Study|Patient choice|3|||
48719937|NCT01579812|156824883|FG000|Overall Study|Noncompliance|3|||
48719938|NCT01579812|156824883|FG000|Overall Study|Withdrawal by Subject|6|||
48719939|NCT01743001|156824885|FG000|Overall Study|Physician Decision|1|||
48719940|NCT01743001|156824886|FG001|Overall Study|Physician Decision|0|||
48719941|NCT01743001|156824885|FG000|Overall Study|Pregnancy|1|||
48719942|NCT01743001|156824886|FG001|Overall Study|Pregnancy|0|||
48719943|NCT01743001|156824885|FG000|Overall Study|Death|1|||
48719944|NCT01743001|156824886|FG001|Overall Study|Death|0|||
48719945|NCT02683746|156824887|FG000|Overall Study|Adverse Event|3|||
48719946|NCT02683746|156824888|FG001|Overall Study|Adverse Event|2|||
48719947|NCT02683746|156824887|FG000|Overall Study|Lost to Follow-up|5|||
48719948|NCT02683746|156824888|FG001|Overall Study|Lost to Follow-up|6|||
48719949|NCT02683746|156824887|FG000|Overall Study|Withdrawal by Subject|6|||
48719950|NCT02683746|156824888|FG001|Overall Study|Withdrawal by Subject|5|||
48719951|NCT02683746|156824887|FG000|Overall Study|Physician Decision|2|||
48719952|NCT02683746|156824888|FG001|Overall Study|Physician Decision|1|||
48719953|NCT04987944|156824893|FG000|Overall Study|Adverse Event|0|||
48719954|NCT04987944|156824894|FG001|Overall Study|Adverse Event|1|||
48719955|NCT04987944|156824893|FG000|Overall Study|Withdrawal by Subject|0|||
48719956|NCT04987944|156824894|FG001|Overall Study|Withdrawal by Subject|1|||
48719957|NCT02108262|156824895|FG000|Overall Study|Non-compliance|0|||
48719958|NCT02108262|156824896|FG001|Overall Study|Non-compliance|2|||
48719959|NCT02108262|156824897|FG002|Overall Study|Non-compliance|1|||
48719960|NCT02108262|156824898|FG003|Overall Study|Non-compliance|1|||
48815511|NCT04157686|157165837|FG007|Overall Study|Protocol Violation|0|||
48815512|NCT04157686|157165830|FG000|Overall Study|COVID-19, Family Reasons etc.|0|||
48815513|NCT04157686|157165831|FG001|Overall Study|COVID-19, Family Reasons etc.|2|||
48815514|NCT04157686|157165832|FG002|Overall Study|COVID-19, Family Reasons etc.|4|||
48815515|NCT04157686|157165833|FG003|Overall Study|COVID-19, Family Reasons etc.|1|||
48719961|NCT02108262|156824895|FG000|Overall Study|Randomized by error/screen failure|0|||
48719962|NCT02108262|156824896|FG001|Overall Study|Randomized by error/screen failure|0|||
48719963|NCT02108262|156824897|FG002|Overall Study|Randomized by error/screen failure|1|||
48719964|NCT02108262|156824898|FG003|Overall Study|Randomized by error/screen failure|0|||
48815516|NCT04157686|157165834|FG004|Overall Study|COVID-19, Family Reasons etc.|4|||
48815517|NCT04157686|157165835|FG005|Overall Study|COVID-19, Family Reasons etc.|6|||
48815518|NCT04157686|157165836|FG006|Overall Study|COVID-19, Family Reasons etc.|0|||
48920966|NCT04036708|157544798|FG003|Overall Study|Lost to Follow-up|4|||
49128612|NCT02513550|158310800|FG005|Double Blind Treatment Period|Protocol Violation|0|||
49128613|NCT02513550|158310795|FG000|Double Blind Treatment Period|Physician Decision|2|||
49128614|NCT02513550|158310796|FG001|Double Blind Treatment Period|Physician Decision|0|||
49128615|NCT02513550|158310797|FG002|Double Blind Treatment Period|Physician Decision|4|||
49128616|NCT02513550|158310798|FG003|Double Blind Treatment Period|Physician Decision|0|||
49128617|NCT02513550|158310799|FG004|Double Blind Treatment Period|Physician Decision|0|||
49128618|NCT02513550|158310800|FG005|Double Blind Treatment Period|Physician Decision|0|||
49128619|NCT02513550|158310795|FG000|Double Blind Treatment Period|Site terminated by sponsor|1|||
49128620|NCT02513550|158310796|FG001|Double Blind Treatment Period|Site terminated by sponsor|1|||
49128621|NCT02513550|158310797|FG002|Double Blind Treatment Period|Site terminated by sponsor|3|||
49128622|NCT02513550|158310798|FG003|Double Blind Treatment Period|Site terminated by sponsor|0|||
49128623|NCT02513550|158310799|FG004|Double Blind Treatment Period|Site terminated by sponsor|0|||
49128624|NCT02513550|158310800|FG005|Double Blind Treatment Period|Site terminated by sponsor|0|||
49128625|NCT02513550|158310795|FG000|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
49128626|NCT02513550|158310796|FG001|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
49128627|NCT02513550|158310797|FG002|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1|||
49128628|NCT02513550|158310798|FG003|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
49128629|NCT02513550|158310799|FG004|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
49128630|NCT02513550|158310800|FG005|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
49128631|NCT02513550|158310795|FG000|Double Blind Treatment Period|Due to personal business|2|||
49128632|NCT02513550|158310796|FG001|Double Blind Treatment Period|Due to personal business|0|||
49128633|NCT02513550|158310797|FG002|Double Blind Treatment Period|Due to personal business|1|||
49128634|NCT02513550|158310798|FG003|Double Blind Treatment Period|Due to personal business|0|||
49128635|NCT02513550|158310799|FG004|Double Blind Treatment Period|Due to personal business|0|||
49128636|NCT02513550|158310800|FG005|Double Blind Treatment Period|Due to personal business|0|||
49128637|NCT02513550|158310795|FG000|Double Blind Treatment Period|Death|1|||
49128638|NCT02513550|158310796|FG001|Double Blind Treatment Period|Death|0|||
49128639|NCT02513550|158310797|FG002|Double Blind Treatment Period|Death|2|||
49128640|NCT02513550|158310798|FG003|Double Blind Treatment Period|Death|0|||
49128641|NCT02513550|158310799|FG004|Double Blind Treatment Period|Death|0|||
49128642|NCT02513550|158310800|FG005|Double Blind Treatment Period|Death|0|||
48719965|NCT02108262|156824895|FG000|Overall Study|Distance to center|0|||
49128643|NCT02513550|158310795|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|12|||
48719966|NCT02108262|156824896|FG001|Overall Study|Distance to center|1|||
48719967|NCT02108262|156824897|FG002|Overall Study|Distance to center|1|||
48719968|NCT02108262|156824898|FG003|Overall Study|Distance to center|0|||
48719969|NCT02108262|156824895|FG000|Overall Study|Adverse Event|0|||
48719970|NCT02108262|156824896|FG001|Overall Study|Adverse Event|11|||
48719971|NCT02108262|156824897|FG002|Overall Study|Adverse Event|6|||
48719972|NCT02108262|156824898|FG003|Overall Study|Adverse Event|12|||
48719973|NCT02108262|156824895|FG000|Overall Study|Death|0|||
48719974|NCT02108262|156824896|FG001|Overall Study|Death|2|||
48719975|NCT02108262|156824897|FG002|Overall Study|Death|2|||
48719976|NCT02108262|156824898|FG003|Overall Study|Death|1|||
48719977|NCT02108262|156824895|FG000|Overall Study|Lost to Follow-up|0|||
48719978|NCT02108262|156824896|FG001|Overall Study|Lost to Follow-up|0|||
48719979|NCT02108262|156824897|FG002|Overall Study|Lost to Follow-up|1|||
48719980|NCT02108262|156824898|FG003|Overall Study|Lost to Follow-up|0|||
48719981|NCT02108262|156824895|FG000|Overall Study|Physician Decision|0|||
48719982|NCT02108262|156824896|FG001|Overall Study|Physician Decision|0|||
48719983|NCT02108262|156824897|FG002|Overall Study|Physician Decision|2|||
48719984|NCT02108262|156824898|FG003|Overall Study|Physician Decision|0|||
48719985|NCT02108262|156824895|FG000|Overall Study|Withdrawal by Subject|0|||
48719986|NCT02108262|156824896|FG001|Overall Study|Withdrawal by Subject|7|||
48719987|NCT02108262|156824897|FG002|Overall Study|Withdrawal by Subject|3|||
48719988|NCT02108262|156824898|FG003|Overall Study|Withdrawal by Subject|4|||
48719989|NCT02108262|156824895|FG000|Overall Study|Due to key hepatic values|0|||
48719990|NCT02108262|156824896|FG001|Overall Study|Due to key hepatic values|1|||
48719991|NCT02108262|156824897|FG002|Overall Study|Due to key hepatic values|0|||
48719992|NCT02108262|156824898|FG003|Overall Study|Due to key hepatic values|0|||
48719993|NCT02108262|156824895|FG000|Overall Study|Unable to contact patient|0|||
48719994|NCT02108262|156824896|FG001|Overall Study|Unable to contact patient|3|||
48719995|NCT02108262|156824897|FG002|Overall Study|Unable to contact patient|1|||
48719996|NCT02108262|156824898|FG003|Overall Study|Unable to contact patient|2|||
48719997|NCT02108262|156824895|FG000|Overall Study|Patient unable to come to site/attend visit|0|||
48719998|NCT02108262|156824896|FG001|Overall Study|Patient unable to come to site/attend visit|6|||
48719999|NCT02108262|156824897|FG002|Overall Study|Patient unable to come to site/attend visit|11|||
48720000|NCT02108262|156824898|FG003|Overall Study|Patient unable to come to site/attend visit|6|||
48720001|NCT02108262|156824895|FG000|Overall Study|Patient did not want another infusion|0|||
48720002|NCT02108262|156824896|FG001|Overall Study|Patient did not want another infusion|3|||
48720003|NCT02108262|156824897|FG002|Overall Study|Patient did not want another infusion|3|||
48815519|NCT04157686|157165837|FG007|Overall Study|COVID-19, Family Reasons etc.|1|||
48815520|NCT04445155|157165838|FG000|Overall Study|Lost to Follow-up|11|||
48815521|NCT04445155|157165839|FG001|Overall Study|Lost to Follow-up|2|||
48815522|NCT04445155|157165840|FG002|Overall Study|Lost to Follow-up|3|||
48815523|NCT04445155|157165841|FG003|Overall Study|Lost to Follow-up|0|||
48815524|NCT04445155|157165838|FG000|Overall Study|Withdrawal by Subject|8|||
48815525|NCT04445155|157165839|FG001|Overall Study|Withdrawal by Subject|0|||
48720004|NCT02108262|156824898|FG003|Overall Study|Patient did not want another infusion|2|||
48720005|NCT02108262|156824895|FG000|Overall Study|Vacation|0|||
49128644|NCT02513550|158310796|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|20|||
49128645|NCT02513550|158310797|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|26|||
49128646|NCT02513550|158310798|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
49128647|NCT02513550|158310799|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
49128648|NCT02513550|158310800|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
49128649|NCT02513550|158310795|FG000|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12|||
49128650|NCT02513550|158310796|FG001|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16|||
48720006|NCT02108262|156824896|FG001|Overall Study|Vacation|1|||
48720007|NCT02108262|156824897|FG002|Overall Study|Vacation|0|||
48720008|NCT02108262|156824898|FG003|Overall Study|Vacation|0|||
48720009|NCT02108262|156824895|FG000|Overall Study|Patient decision|0|||
48720010|NCT02108262|156824896|FG001|Overall Study|Patient decision|7|||
48720011|NCT02108262|156824897|FG002|Overall Study|Patient decision|9|||
48815526|NCT04445155|157165840|FG002|Overall Study|Withdrawal by Subject|0|||
48815527|NCT04445155|157165841|FG003|Overall Study|Withdrawal by Subject|0|||
48815528|NCT04445155|157165838|FG000|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|12|||
48815529|NCT04445155|157165839|FG001|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
48815530|NCT04445155|157165840|FG002|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
48815531|NCT04445155|157165841|FG003|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
48815532|NCT04445155|157165838|FG000|Overall Study|Only completed a portion of the final outcome measures (T2)|4|||
48815533|NCT04445155|157165839|FG001|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
48815534|NCT04445155|157165840|FG002|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
48815535|NCT04445155|157165841|FG003|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
48815536|NCT00810641|157165842|FG000|Overall Study|Withdrawal by Subject|0|||
48720012|NCT02108262|156824898|FG003|Overall Study|Patient decision|14|||
48720013|NCT02108262|156824895|FG000|Overall Study|Missed IV due to pharmacy error|0|||
48720014|NCT02108262|156824896|FG001|Overall Study|Missed IV due to pharmacy error|0|||
48720015|NCT02108262|156824897|FG002|Overall Study|Missed IV due to pharmacy error|1|||
48720016|NCT02108262|156824898|FG003|Overall Study|Missed IV due to pharmacy error|0|||
48720017|NCT02692651|156824899|FG000|Study Treatment|Death|7|||
48720018|NCT02692651|156824900|FG001|Study Treatment|Death|3|||
48720019|NCT02692651|156824899|FG000|Study Treatment|comfort care|1|||
48720020|NCT02692651|156824900|FG001|Study Treatment|comfort care|1|||
48720021|NCT02692651|156824899|FG000|Study Treatment|Protocol violation per treating team preference|8|||
48720022|NCT02692651|156824900|FG001|Study Treatment|Protocol violation per treating team preference|6|||
48720023|NCT02692651|156824899|FG000|Post Study Treatment Follow-up|Death|4|||
48720024|NCT02692651|156824900|FG001|Post Study Treatment Follow-up|Death|4|||
48720025|NCT02239120|156824901|FG000|Overall Study|Death|56|||
48720026|NCT02239120|156824902|FG001|Overall Study|Death|58|||
48720027|NCT02239120|156824901|FG000|Overall Study|Lost to Follow-up|19|||
48720028|NCT02239120|156824902|FG001|Overall Study|Lost to Follow-up|14|||
48720029|NCT02213133|156824903|FG000|Overall Study|Participant discontinued study therapy|2|||
48720030|NCT02213133|156824904|FG001|Overall Study|Participant discontinued study therapy|0|||
48720031|NCT02213133|156824905|FG002|Overall Study|Participant discontinued study therapy|0|||
48720032|NCT02213133|156824903|FG000|Overall Study|Participant withdrew informed consent|2|||
48720033|NCT02213133|156824904|FG001|Overall Study|Participant withdrew informed consent|1|||
48720034|NCT02213133|156824905|FG002|Overall Study|Participant withdrew informed consent|2|||
48720035|NCT02213133|156824903|FG000|Overall Study|Disease progression|11|||
48720036|NCT02213133|156824904|FG001|Overall Study|Disease progression|2|||
48720037|NCT02213133|156824905|FG002|Overall Study|Disease progression|0|||
48720038|NCT02213133|156824903|FG000|Overall Study|Adverse Event (AE)|1|||
48815537|NCT00810641|157165843|FG001|Overall Study|Withdrawal by Subject|1|||
48815538|NCT00810641|157165844|FG002|Overall Study|Withdrawal by Subject|2|||
48720039|NCT02213133|156824904|FG001|Overall Study|Adverse Event (AE)|0|||
48720040|NCT02213133|156824905|FG002|Overall Study|Adverse Event (AE)|0|||
48815539|NCT02325713|157165851|FG000|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
48815540|NCT02325713|157165852|FG001|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
48720041|NCT02213133|156824903|FG000|Overall Study|Death|16|||
48720042|NCT02213133|156824904|FG001|Overall Study|Death|2|||
48720043|NCT02213133|156824905|FG002|Overall Study|Death|1|||
48720044|NCT02213133|156824903|FG000|Overall Study|Other|5|||
48720045|NCT02213133|156824904|FG001|Overall Study|Other|0|||
48815541|NCT02325713|157165853|FG002|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
48920967|NCT04766021|157544799|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|9|||
49128651|NCT02513550|158310797|FG002|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20|||
49128652|NCT02513550|158310798|FG003|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
49128653|NCT02513550|158310799|FG004|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
49128654|NCT02513550|158310800|FG005|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
49128655|NCT02513550|158310795|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|4|||
49128656|NCT02513550|158310796|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|2|||
49128657|NCT02513550|158310797|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|7|||
49128658|NCT02513550|158310798|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
49128659|NCT02513550|158310799|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
49128660|NCT02513550|158310800|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
49128661|NCT02513550|158310795|FG000|Post-Treatment Follow-up Period|Adverse Event|1|||
49128662|NCT02513550|158310796|FG001|Post-Treatment Follow-up Period|Adverse Event|1|||
49128663|NCT02513550|158310797|FG002|Post-Treatment Follow-up Period|Adverse Event|4|||
49128664|NCT02513550|158310798|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
49128665|NCT02513550|158310799|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
49128666|NCT02513550|158310800|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
49128667|NCT02513550|158310795|FG000|Post-Treatment Follow-up Period|Physician Decision|2|||
49128668|NCT02513550|158310796|FG001|Post-Treatment Follow-up Period|Physician Decision|0|||
49128669|NCT02513550|158310797|FG002|Post-Treatment Follow-up Period|Physician Decision|0|||
49128670|NCT02513550|158310798|FG003|Post-Treatment Follow-up Period|Physician Decision|0|||
49128671|NCT02513550|158310799|FG004|Post-Treatment Follow-up Period|Physician Decision|0|||
49128672|NCT02513550|158310800|FG005|Post-Treatment Follow-up Period|Physician Decision|0|||
49128673|NCT02513550|158310795|FG000|Post-Treatment Follow-up Period|Death|0|||
49128674|NCT02513550|158310796|FG001|Post-Treatment Follow-up Period|Death|0|||
49128675|NCT02513550|158310797|FG002|Post-Treatment Follow-up Period|Death|1|||
49128676|NCT02513550|158310798|FG003|Post-Treatment Follow-up Period|Death|0|||
49128677|NCT02513550|158310799|FG004|Post-Treatment Follow-up Period|Death|0|||
49128678|NCT02513550|158310800|FG005|Post-Treatment Follow-up Period|Death|0|||
49128679|NCT02513550|158310795|FG000|Post-Treatment Follow-up Period|Subject move out of town|0|||
49128680|NCT02513550|158310796|FG001|Post-Treatment Follow-up Period|Subject move out of town|0|||
49128681|NCT02513550|158310797|FG002|Post-Treatment Follow-up Period|Subject move out of town|1|||
49128682|NCT02513550|158310798|FG003|Post-Treatment Follow-up Period|Subject move out of town|0|||
49128683|NCT02513550|158310799|FG004|Post-Treatment Follow-up Period|Subject move out of town|0|||
48815542|NCT02325713|157165854|FG003|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
48720046|NCT02213133|156824905|FG002|Overall Study|Other|0|||
48720047|NCT01925989|156824906|FG000|Period 1|Sponsor Decision|1|||
48720048|NCT01925989|156824907|FG001|Period 1|Sponsor Decision|1|||
48720049|NCT01925989|156824908|FG002|Period 1|Sponsor Decision|0|||
48720050|NCT01925989|156824906|FG000|Period 1|Withdrawal by Subject|0|||
48720051|NCT01925989|156824907|FG001|Period 1|Withdrawal by Subject|1|||
48720052|NCT01925989|156824908|FG002|Period 1|Withdrawal by Subject|0|||
48720053|NCT00770146|156824911|FG000|Treatment Period|Withdrawal by Subject|6|||
48720054|NCT00770146|156824912|FG001|Treatment Period|Withdrawal by Subject|13|||
48720055|NCT00770146|156824911|FG000|Treatment Period|Adverse Event|2|||
48720056|NCT00770146|156824912|FG001|Treatment Period|Adverse Event|26|||
48720057|NCT00770146|156824911|FG000|Treatment Period|Other|1|||
48720058|NCT00770146|156824912|FG001|Treatment Period|Other|5|||
48720059|NCT00770146|156824911|FG000|Treatment Period|Protocol non-compliance|0|||
48720060|NCT00770146|156824912|FG001|Treatment Period|Protocol non-compliance|1|||
48720061|NCT00770146|156824911|FG000|Follow-up Period|Withdrawal by Subject|7|||
48720062|NCT00770146|156824912|FG001|Follow-up Period|Withdrawal by Subject|13|||
48720063|NCT00770146|156824911|FG000|Follow-up Period|Adverse Event|0|||
48720064|NCT00770146|156824912|FG001|Follow-up Period|Adverse Event|2|||
48720065|NCT00770146|156824911|FG000|Follow-up Period|Other|4|||
48720066|NCT00770146|156824912|FG001|Follow-up Period|Other|5|||
48720067|NCT04658940|156824916|FG000|Overall Study|Withdrawal by Subject|1|||
48720068|NCT01853618|156824917|FG000|Overall Study|Bile duct stent blockage/progressive dis|1|||
48720069|NCT01853618|156824918|FG001|Overall Study|Bile duct stent blockage/progressive dis|0|||
48720070|NCT01853618|156824919|FG002|Overall Study|Bile duct stent blockage/progressive dis|0|||
48720071|NCT01853618|156824920|FG003|Overall Study|Bile duct stent blockage/progressive dis|0|||
48720072|NCT01853618|156824921|FG004|Overall Study|Bile duct stent blockage/progressive dis|0|||
48720073|NCT01853618|156824917|FG000|Overall Study|Progressive disease|1|||
48720074|NCT01853618|156824918|FG001|Overall Study|Progressive disease|1|||
48720075|NCT01853618|156824919|FG002|Overall Study|Progressive disease|1|||
48720076|NCT01853618|156824920|FG003|Overall Study|Progressive disease|1|||
48720077|NCT01853618|156824921|FG004|Overall Study|Progressive disease|2|||
48720078|NCT01853618|156824917|FG000|Overall Study|Physician Decision|0|||
48720079|NCT01853618|156824918|FG001|Overall Study|Physician Decision|1|||
48720080|NCT01853618|156824919|FG002|Overall Study|Physician Decision|1|||
48720081|NCT01853618|156824920|FG003|Overall Study|Physician Decision|0|||
48720082|NCT01853618|156824921|FG004|Overall Study|Physician Decision|0|||
48720083|NCT01853618|156824917|FG000|Overall Study|Refused further treatment|0|||
48720084|NCT01853618|156824918|FG001|Overall Study|Refused further treatment|0|||
48720085|NCT01853618|156824919|FG002|Overall Study|Refused further treatment|0|||
48720086|NCT01853618|156824920|FG003|Overall Study|Refused further treatment|0|||
48720087|NCT01853618|156824921|FG004|Overall Study|Refused further treatment|1|||
48720088|NCT00938886|156824922|FG000|Overall Study|Death|0|||
48720089|NCT00938886|156824923|FG001|Overall Study|Death|1|||
48720090|NCT00938886|156824922|FG000|Overall Study|Withdrawal by Subject|4|||
48720091|NCT00938886|156824923|FG001|Overall Study|Withdrawal by Subject|7|||
48720092|NCT00938886|156824922|FG000|Overall Study|Lost to Follow-up|3|||
48720093|NCT00938886|156824923|FG001|Overall Study|Lost to Follow-up|2|||
48720094|NCT02009384|156824926|FG000|Overall Study|Death|2|||
48720095|NCT00710762|156824927|FG000|Overall Study|Progressive disease|27|||
48720096|NCT00710762|156824928|FG001|Overall Study|Progressive disease|30|||
48720097|NCT00710762|156824927|FG000|Overall Study|Adverse Event other disease worsening|2|||
48720098|NCT00710762|156824928|FG001|Overall Study|Adverse Event other disease worsening|1|||
48720099|NCT00710762|156824927|FG000|Overall Study|Other Adverse Event|7|||
48720100|NCT00710762|156824928|FG001|Overall Study|Other Adverse Event|7|||
48720101|NCT00710762|156824927|FG000|Overall Study|Lost to Follow-up|1|||
49011092|NCT01580020|157877388|FG000|Overall Study|Administrative Problems|0|||
49011093|NCT01580020|157877389|FG001|Overall Study|Administrative Problems|0|||
49011094|NCT01580020|157877390|FG002|Overall Study|Administrative Problems|1|||
49011095|NCT01580020|157877391|FG003|Overall Study|Administrative Problems|0|||
49011096|NCT01580020|157877388|FG000|Overall Study|Lost to Follow-up|0|||
49011097|NCT01580020|157877389|FG001|Overall Study|Lost to Follow-up|0|||
49011098|NCT01580020|157877390|FG002|Overall Study|Lost to Follow-up|1|||
49011099|NCT01580020|157877391|FG003|Overall Study|Lost to Follow-up|0|||
49011100|NCT01724359|157877392|FG000|Overall Study|Adverse Event|10|||
49011101|NCT01724359|157877392|FG000|Overall Study|Death|1|||
49011102|NCT01724359|157877392|FG000|Overall Study|Other|20|||
49011103|NCT00320593|157877393|FG000|Overall Study|Lost to Follow-up|3|||
49011104|NCT00320593|157877394|FG001|Overall Study|Lost to Follow-up|0|||
49011105|NCT00320593|157877393|FG000|Overall Study|Moved to another state|1|||
49011106|NCT00320593|157877394|FG001|Overall Study|Moved to another state|0|||
49011107|NCT00320593|157877393|FG000|Overall Study|Withdrawal by Subject|2|||
49011108|NCT00320593|157877394|FG001|Overall Study|Withdrawal by Subject|1|||
49011109|NCT00320593|157877393|FG000|Overall Study|Withdrawal by clinical center|1|||
49011110|NCT00320593|157877394|FG001|Overall Study|Withdrawal by clinical center|0|||
49128684|NCT02513550|158310800|FG005|Post-Treatment Follow-up Period|Subject move out of town|0|||
49128685|NCT02513550|158310795|FG000|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
49128686|NCT02513550|158310796|FG001|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
49128687|NCT02513550|158310797|FG002|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3|||
49128688|NCT02513550|158310798|FG003|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
49128689|NCT02513550|158310799|FG004|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
49128690|NCT02513550|158310800|FG005|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
49128691|NCT02513550|158310795|FG000|Post-Treatment Follow-up Period|Labor Reasons|0|||
49128692|NCT02513550|158310796|FG001|Post-Treatment Follow-up Period|Labor Reasons|0|||
49128693|NCT02513550|158310797|FG002|Post-Treatment Follow-up Period|Labor Reasons|1|||
49128694|NCT02513550|158310798|FG003|Post-Treatment Follow-up Period|Labor Reasons|0|||
49128695|NCT02513550|158310799|FG004|Post-Treatment Follow-up Period|Labor Reasons|0|||
49128696|NCT02513550|158310800|FG005|Post-Treatment Follow-up Period|Labor Reasons|0|||
49128697|NCT00888654|158310801|FG000|Overall Study|Problems swallowing oral meds.|1|||
49128698|NCT00888654|158310801|FG000|Overall Study|Not enough oral meds before surgery|3|||
49128699|NCT00888654|158310801|FG000|Overall Study|Surgery aborted|2|||
49128700|NCT00888654|158310801|FG000|Overall Study|Withdrawal by Subject|1|||
49128701|NCT00888654|158310801|FG000|Overall Study|Inelig. due to contraindication of med|1|||
49128702|NCT00888654|158310801|FG000|Overall Study|Change in surg date|1|||
49128703|NCT00888654|158310801|FG000|Overall Study|Stopped meds due to headaches|1|||
49128704|NCT02674516|158310803|FG000|Overall Study|Lost to Follow-up|3|||
48720102|NCT00710762|156824928|FG001|Overall Study|Lost to Follow-up|0|||
48720103|NCT00710762|156824927|FG000|Overall Study|Reason other than listed above|2|||
48720104|NCT00710762|156824928|FG001|Overall Study|Reason other than listed above|2|||
48720105|NCT03011892|156824931|FG000|Double Blind (DB) Period|Adverse Event|0|||
48720106|NCT03011892|156824932|FG001|Double Blind (DB) Period|Adverse Event|1|||
48720107|NCT03011892|156824933|FG002|Double Blind (DB) Period|Adverse Event|1|||
48720108|NCT03011892|156824934|FG003|Double Blind (DB) Period|Adverse Event|0|||
48720109|NCT03011892|156824935|FG004|Double Blind (DB) Period|Adverse Event|0|||
48815543|NCT02325713|157165855|FG004|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
48815544|NCT02325713|157165856|FG005|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
48815545|NCT02325713|157165857|FG006|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
48815546|NCT02325713|157165858|FG007|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
48815547|NCT02325713|157165859|FG008|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
48815548|NCT02325713|157165860|FG009|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
48815549|NCT02325713|157165861|FG010|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1|||
48815550|NCT02325713|157165862|FG011|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
48815551|NCT02325713|157165863|FG012|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
48815552|NCT02325713|157165864|FG013|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
48815553|NCT02325713|157165865|FG014|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
48815554|NCT02325713|157165866|FG015|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
48815555|NCT02325713|157165851|FG000|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1|||
48815556|NCT02325713|157165852|FG001|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
48815557|NCT02325713|157165853|FG002|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
48815558|NCT02325713|157165854|FG003|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
48815559|NCT02325713|157165855|FG004|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
48815560|NCT02325713|157165856|FG005|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
48815561|NCT02325713|157165857|FG006|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
48815562|NCT02325713|157165858|FG007|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
48815563|NCT02325713|157165859|FG008|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
48815564|NCT02325713|157165860|FG009|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
48815565|NCT02325713|157165861|FG010|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
48815566|NCT02325713|157165862|FG011|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
48815567|NCT02325713|157165863|FG012|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
48815568|NCT02325713|157165864|FG013|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
48815569|NCT02325713|157165865|FG014|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
48815570|NCT02325713|157165866|FG015|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
49128705|NCT02674516|158310804|FG001|Overall Study|Lost to Follow-up|0|||
49128706|NCT02674516|158310803|FG000|Overall Study|Protocol Violation|0|||
49128707|NCT02674516|158310804|FG001|Overall Study|Protocol Violation|4|||
49128708|NCT02674516|158310803|FG000|Overall Study|Knowledge of study hypothesis|1|||
49128709|NCT02674516|158310804|FG001|Overall Study|Knowledge of study hypothesis|0|||
49128710|NCT04494646|158310805|FG000|Overall Study|Adverse Event|0|||
49128711|NCT04494646|158310806|FG001|Overall Study|Adverse Event|1|||
49128712|NCT04494646|158310805|FG000|Overall Study|Withdrawal by Subject|0|||
49128713|NCT04494646|158310806|FG001|Overall Study|Withdrawal by Subject|1|||
48815571|NCT02325713|157165851|FG000|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
48815572|NCT02325713|157165852|FG001|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
48815573|NCT02325713|157165853|FG002|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
48815574|NCT02325713|157165854|FG003|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
48815575|NCT02325713|157165855|FG004|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
48815576|NCT02325713|157165856|FG005|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
48815577|NCT02325713|157165857|FG006|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
48815578|NCT02325713|157165858|FG007|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
48815579|NCT02325713|157165859|FG008|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
48815580|NCT02325713|157165860|FG009|Intervention Period 3 (2 Days)|Withdrawal by Subject|1|||
48815581|NCT02325713|157165861|FG010|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
48815582|NCT02325713|157165862|FG011|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
48815583|NCT02325713|157165863|FG012|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
48815584|NCT02325713|157165864|FG013|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
48815585|NCT02325713|157165865|FG014|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
48815586|NCT02325713|157165866|FG015|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
48815587|NCT05035654|157165867|FG000|Overall Study|Physician Decision|0|||
48815588|NCT05035654|157165868|FG001|Overall Study|Physician Decision|1|||
48815589|NCT05035654|157165869|FG002|Overall Study|Physician Decision|0|||
48815590|NCT05035654|157165867|FG000|Overall Study|Adverse Event|0|||
48815591|NCT05035654|157165868|FG001|Overall Study|Adverse Event|1|||
48815592|NCT05035654|157165869|FG002|Overall Study|Adverse Event|0|||
48815593|NCT05035654|157165867|FG000|Overall Study|Withdrawal by Subject|0|||
48815594|NCT05035654|157165868|FG001|Overall Study|Withdrawal by Subject|0|||
48815595|NCT05035654|157165869|FG002|Overall Study|Withdrawal by Subject|4|||
48815596|NCT05035654|157165867|FG000|Overall Study|Bilateral Dislodgement|1|||
48815597|NCT05035654|157165868|FG001|Overall Study|Bilateral Dislodgement|0|||
48815598|NCT05035654|157165869|FG002|Overall Study|Bilateral Dislodgement|0|||
48815599|NCT02353832|157165870|FG000|Overall Study|Ineligible after enrollment|1|||
48815600|NCT02353832|157165870|FG000|Overall Study|Lost to Follow-up|1|||
48815601|NCT03864926|157167330|FG000|Overall Study|Death|0|||
48815602|NCT03864926|157167331|FG001|Overall Study|Death|2|||
48720110|NCT03011892|156824936|FG005|Double Blind (DB) Period|Adverse Event|0|||
48720111|NCT03011892|156824937|FG006|Double Blind (DB) Period|Adverse Event|0|||
48720112|NCT03011892|156824938|FG007|Double Blind (DB) Period|Adverse Event|0|||
48720113|NCT03011892|156824939|FG008|Double Blind (DB) Period|Adverse Event|0|||
48720114|NCT03011892|156824940|FG009|Double Blind (DB) Period|Adverse Event|0|||
48720115|NCT03011892|156824941|FG010|Double Blind (DB) Period|Adverse Event|0|||
48720116|NCT03011892|156824942|FG011|Double Blind (DB) Period|Adverse Event|0|||
48720117|NCT03011892|156824931|FG000|Double Blind (DB) Period|Lack of Efficacy|1|||
48720118|NCT03011892|156824932|FG001|Double Blind (DB) Period|Lack of Efficacy|0|||
48720119|NCT03011892|156824933|FG002|Double Blind (DB) Period|Lack of Efficacy|0|||
48720120|NCT03011892|156824934|FG003|Double Blind (DB) Period|Lack of Efficacy|0|||
48720121|NCT03011892|156824935|FG004|Double Blind (DB) Period|Lack of Efficacy|0|||
48720122|NCT03011892|156824936|FG005|Double Blind (DB) Period|Lack of Efficacy|0|||
48720123|NCT03011892|156824937|FG006|Double Blind (DB) Period|Lack of Efficacy|0|||
48720124|NCT03011892|156824938|FG007|Double Blind (DB) Period|Lack of Efficacy|0|||
48720125|NCT03011892|156824939|FG008|Double Blind (DB) Period|Lack of Efficacy|0|||
48720126|NCT03011892|156824940|FG009|Double Blind (DB) Period|Lack of Efficacy|0|||
48720127|NCT03011892|156824941|FG010|Double Blind (DB) Period|Lack of Efficacy|0|||
48720128|NCT03011892|156824942|FG011|Double Blind (DB) Period|Lack of Efficacy|0|||
48720129|NCT03011892|156824931|FG000|Double Blind (DB) Period|Lost to Follow-up|0|||
48720130|NCT03011892|156824932|FG001|Double Blind (DB) Period|Lost to Follow-up|3|||
48720131|NCT03011892|156824933|FG002|Double Blind (DB) Period|Lost to Follow-up|2|||
48720132|NCT03011892|156824934|FG003|Double Blind (DB) Period|Lost to Follow-up|5|||
48720133|NCT03011892|156824935|FG004|Double Blind (DB) Period|Lost to Follow-up|0|||
48720134|NCT03011892|156824936|FG005|Double Blind (DB) Period|Lost to Follow-up|2|||
48720135|NCT03011892|156824937|FG006|Double Blind (DB) Period|Lost to Follow-up|0|||
48720136|NCT03011892|156824938|FG007|Double Blind (DB) Period|Lost to Follow-up|0|||
48720137|NCT03011892|156824939|FG008|Double Blind (DB) Period|Lost to Follow-up|0|||
48720138|NCT03011892|156824940|FG009|Double Blind (DB) Period|Lost to Follow-up|0|||
48720139|NCT03011892|156824941|FG010|Double Blind (DB) Period|Lost to Follow-up|0|||
48720140|NCT03011892|156824942|FG011|Double Blind (DB) Period|Lost to Follow-up|0|||
48720141|NCT03011892|156824931|FG000|Double Blind (DB) Period|Other|1|||
48720142|NCT03011892|156824932|FG001|Double Blind (DB) Period|Other|1|||
48720143|NCT03011892|156824933|FG002|Double Blind (DB) Period|Other|1|||
48720144|NCT03011892|156824934|FG003|Double Blind (DB) Period|Other|0|||
48720145|NCT03011892|156824935|FG004|Double Blind (DB) Period|Other|1|||
48815603|NCT03017235|157167332|FG000|Overall Study|Withdrawal by Subject|4|||
48815604|NCT03017235|157167333|FG001|Overall Study|Withdrawal by Subject|3|||
48815605|NCT03017235|157167332|FG000|Overall Study|Lost to Follow-up|2|||
48815606|NCT03017235|157167333|FG001|Overall Study|Lost to Follow-up|7|||
48815607|NCT03017235|157167332|FG000|Overall Study|Adverse Event|0|||
48720146|NCT03011892|156824936|FG005|Double Blind (DB) Period|Other|0|||
48720147|NCT03011892|156824937|FG006|Double Blind (DB) Period|Other|0|||
48720148|NCT03011892|156824938|FG007|Double Blind (DB) Period|Other|0|||
48720149|NCT03011892|156824939|FG008|Double Blind (DB) Period|Other|0|||
48720150|NCT03011892|156824940|FG009|Double Blind (DB) Period|Other|0|||
48720151|NCT03011892|156824941|FG010|Double Blind (DB) Period|Other|0|||
48720152|NCT03011892|156824942|FG011|Double Blind (DB) Period|Other|0|||
48720153|NCT03011892|156824931|FG000|Double Blind (DB) Period|Physician Decision|1|||
48720154|NCT03011892|156824932|FG001|Double Blind (DB) Period|Physician Decision|0|||
48720155|NCT03011892|156824933|FG002|Double Blind (DB) Period|Physician Decision|1|||
48720156|NCT03011892|156824934|FG003|Double Blind (DB) Period|Physician Decision|0|||
48720157|NCT03011892|156824935|FG004|Double Blind (DB) Period|Physician Decision|0|||
48720158|NCT03011892|156824936|FG005|Double Blind (DB) Period|Physician Decision|0|||
48720159|NCT03011892|156824937|FG006|Double Blind (DB) Period|Physician Decision|0|||
48720160|NCT03011892|156824938|FG007|Double Blind (DB) Period|Physician Decision|0|||
48720161|NCT03011892|156824939|FG008|Double Blind (DB) Period|Physician Decision|0|||
48720162|NCT03011892|156824940|FG009|Double Blind (DB) Period|Physician Decision|0|||
48720163|NCT03011892|156824941|FG010|Double Blind (DB) Period|Physician Decision|0|||
48720164|NCT03011892|156824942|FG011|Double Blind (DB) Period|Physician Decision|0|||
48720165|NCT03011892|156824931|FG000|Double Blind (DB) Period|Pregnancy|0|||
48720166|NCT03011892|156824932|FG001|Double Blind (DB) Period|Pregnancy|0|||
48720167|NCT03011892|156824933|FG002|Double Blind (DB) Period|Pregnancy|0|||
48720168|NCT03011892|156824934|FG003|Double Blind (DB) Period|Pregnancy|0|||
48720169|NCT03011892|156824935|FG004|Double Blind (DB) Period|Pregnancy|1|||
48720170|NCT03011892|156824936|FG005|Double Blind (DB) Period|Pregnancy|0|||
48720171|NCT03011892|156824937|FG006|Double Blind (DB) Period|Pregnancy|0|||
48720172|NCT03011892|156824938|FG007|Double Blind (DB) Period|Pregnancy|0|||
48720173|NCT03011892|156824939|FG008|Double Blind (DB) Period|Pregnancy|0|||
48720174|NCT03011892|156824940|FG009|Double Blind (DB) Period|Pregnancy|0|||
48720175|NCT03011892|156824941|FG010|Double Blind (DB) Period|Pregnancy|0|||
48720176|NCT03011892|156824942|FG011|Double Blind (DB) Period|Pregnancy|0|||
48720177|NCT03011892|156824931|FG000|Double Blind (DB) Period|Protocol Violation|1|||
48720178|NCT03011892|156824932|FG001|Double Blind (DB) Period|Protocol Violation|0|||
48720179|NCT03011892|156824933|FG002|Double Blind (DB) Period|Protocol Violation|0|||
48720180|NCT03011892|156824934|FG003|Double Blind (DB) Period|Protocol Violation|0|||
48720181|NCT03011892|156824935|FG004|Double Blind (DB) Period|Protocol Violation|0|||
48720182|NCT03011892|156824936|FG005|Double Blind (DB) Period|Protocol Violation|0|||
48720183|NCT03011892|156824937|FG006|Double Blind (DB) Period|Protocol Violation|0|||
48720184|NCT03011892|156824938|FG007|Double Blind (DB) Period|Protocol Violation|0|||
48720185|NCT03011892|156824939|FG008|Double Blind (DB) Period|Protocol Violation|0|||
48720186|NCT03011892|156824940|FG009|Double Blind (DB) Period|Protocol Violation|0|||
48720187|NCT03011892|156824941|FG010|Double Blind (DB) Period|Protocol Violation|0|||
48720188|NCT03011892|156824942|FG011|Double Blind (DB) Period|Protocol Violation|0|||
48720189|NCT03011892|156824931|FG000|Double Blind (DB) Period|Withdrawal by Subject|7|||
48720190|NCT03011892|156824932|FG001|Double Blind (DB) Period|Withdrawal by Subject|5|||
48720191|NCT03011892|156824933|FG002|Double Blind (DB) Period|Withdrawal by Subject|1|||
48720192|NCT03011892|156824934|FG003|Double Blind (DB) Period|Withdrawal by Subject|2|||
48720193|NCT03011892|156824935|FG004|Double Blind (DB) Period|Withdrawal by Subject|4|||
48720194|NCT03011892|156824936|FG005|Double Blind (DB) Period|Withdrawal by Subject|3|||
48720195|NCT03011892|156824937|FG006|Double Blind (DB) Period|Withdrawal by Subject|0|||
48720196|NCT03011892|156824938|FG007|Double Blind (DB) Period|Withdrawal by Subject|0|||
48720197|NCT03011892|156824939|FG008|Double Blind (DB) Period|Withdrawal by Subject|0|||
48720198|NCT03011892|156824940|FG009|Double Blind (DB) Period|Withdrawal by Subject|0|||
48720199|NCT03011892|156824941|FG010|Double Blind (DB) Period|Withdrawal by Subject|0|||
48720200|NCT03011892|156824942|FG011|Double Blind (DB) Period|Withdrawal by Subject|0|||
49128714|NCT03504917|158310807|FG000|Blinded Treatment Period|Protocol Violation|1|||
49128715|NCT03504917|158310808|FG001|Blinded Treatment Period|Protocol Violation|0|||
49128716|NCT03504917|158310807|FG000|Blinded Treatment Period|Withdrawal by Subject|12|||
48720201|NCT03011892|156824931|FG000|Double Blind (DB) Period|Randomized but not treated|0|||
49128717|NCT03504917|158310808|FG001|Blinded Treatment Period|Withdrawal by Subject|9|||
49128718|NCT03504917|158310807|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
49128719|NCT03504917|158310808|FG001|Blinded Treatment Period|Lack of Efficacy|1|||
49128720|NCT03504917|158310807|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
49128721|NCT03504917|158310808|FG001|Blinded Treatment Period|Lost to Follow-up|4|||
49128722|NCT03504917|158310807|FG000|Blinded Treatment Period|Adverse Event|4|||
49128723|NCT03504917|158310808|FG001|Blinded Treatment Period|Adverse Event|4|||
49128724|NCT03504917|158310807|FG000|Blinded Treatment Period|Physician Decision|1|||
49128725|NCT03504917|158310808|FG001|Blinded Treatment Period|Physician Decision|0|||
49128726|NCT03504917|158310807|FG000|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1|||
48720202|NCT03011892|156824932|FG001|Double Blind (DB) Period|Randomized but not treated|0|||
48720203|NCT03011892|156824933|FG002|Double Blind (DB) Period|Randomized but not treated|0|||
48720204|NCT03011892|156824934|FG003|Double Blind (DB) Period|Randomized but not treated|0|||
48720205|NCT03011892|156824935|FG004|Double Blind (DB) Period|Randomized but not treated|1|||
48720206|NCT03011892|156824936|FG005|Double Blind (DB) Period|Randomized but not treated|0|||
48720207|NCT03011892|156824937|FG006|Double Blind (DB) Period|Randomized but not treated|0|||
48720208|NCT03011892|156824938|FG007|Double Blind (DB) Period|Randomized but not treated|0|||
48720209|NCT03011892|156824939|FG008|Double Blind (DB) Period|Randomized but not treated|0|||
48720210|NCT03011892|156824940|FG009|Double Blind (DB) Period|Randomized but not treated|0|||
48720211|NCT03011892|156824941|FG010|Double Blind (DB) Period|Randomized but not treated|0|||
48720212|NCT03011892|156824942|FG011|Double Blind (DB) Period|Randomized but not treated|0|||
48720213|NCT03011892|156824931|FG000|Open Label (OL) Period|Lost to Follow-up|0|||
48720214|NCT03011892|156824932|FG001|Open Label (OL) Period|Lost to Follow-up|0|||
48720215|NCT03011892|156824933|FG002|Open Label (OL) Period|Lost to Follow-up|0|||
48720216|NCT03011892|156824934|FG003|Open Label (OL) Period|Lost to Follow-up|0|||
48720217|NCT03011892|156824935|FG004|Open Label (OL) Period|Lost to Follow-up|0|||
48720218|NCT03011892|156824936|FG005|Open Label (OL) Period|Lost to Follow-up|0|||
48720219|NCT03011892|156824937|FG006|Open Label (OL) Period|Lost to Follow-up|4|||
48720220|NCT03011892|156824938|FG007|Open Label (OL) Period|Lost to Follow-up|2|||
48720221|NCT03011892|156824939|FG008|Open Label (OL) Period|Lost to Follow-up|1|||
49128727|NCT03504917|158310808|FG001|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3|||
49128728|NCT03504917|158310807|FG000|Blinded Treatment Period|Study terminated by sponsor|39|||
49128729|NCT03504917|158310808|FG001|Blinded Treatment Period|Study terminated by sponsor|34|||
49128730|NCT03504917|158310807|FG000|Blinded Treatment Period|Non-compliance with study drug|0|||
49128731|NCT03504917|158310808|FG001|Blinded Treatment Period|Non-compliance with study drug|1|||
49128732|NCT03504917|158310807|FG000|Open Label Extension Treatment Period|The participant left the study site|0|||
49128733|NCT03504917|158310808|FG001|Open Label Extension Treatment Period|The participant left the study site|1|||
49128734|NCT03504917|158310807|FG000|Open Label Extension Treatment Period|Withdrawal by Subject|8|||
49128735|NCT03504917|158310808|FG001|Open Label Extension Treatment Period|Withdrawal by Subject|2|||
49128736|NCT03504917|158310807|FG000|Open Label Extension Treatment Period|Lost to Follow-up|1|||
49128737|NCT03504917|158310808|FG001|Open Label Extension Treatment Period|Lost to Follow-up|4|||
49128738|NCT03504917|158310807|FG000|Open Label Extension Treatment Period|Lack of Efficacy|3|||
49128739|NCT03504917|158310808|FG001|Open Label Extension Treatment Period|Lack of Efficacy|1|||
49128740|NCT03504917|158310807|FG000|Open Label Extension Treatment Period|Adverse Event|7|||
49128741|NCT03504917|158310808|FG001|Open Label Extension Treatment Period|Adverse Event|0|||
49128742|NCT03504917|158310807|FG000|Open Label Extension Treatment Period|Non-compliance with study drug|0|||
49128743|NCT03504917|158310808|FG001|Open Label Extension Treatment Period|Non-compliance with study drug|1|||
49128744|NCT03504917|158310807|FG000|Open Label Extension Treatment Period|Study terminated by sponsor|81|||
49128745|NCT03504917|158310808|FG001|Open Label Extension Treatment Period|Study terminated by sponsor|88|||
49128746|NCT00321763|158310809|FG000|Overall Study|Adverse Event|1|||
49128747|NCT00321763|158310810|FG001|Overall Study|Adverse Event|1|||
49128748|NCT00321763|158310811|FG002|Overall Study|Adverse Event|0|||
49128749|NCT00321763|158310812|FG003|Overall Study|Adverse Event|1|||
49128750|NCT00321763|158310809|FG000|Overall Study|Withdrawal by Subject|2|||
49128751|NCT00321763|158310810|FG001|Overall Study|Withdrawal by Subject|0|||
49128752|NCT00321763|158310811|FG002|Overall Study|Withdrawal by Subject|1|||
49128753|NCT00321763|158310812|FG003|Overall Study|Withdrawal by Subject|0|||
49128754|NCT00321763|158310809|FG000|Overall Study|Lost to Follow-up|3|||
49128755|NCT00321763|158310810|FG001|Overall Study|Lost to Follow-up|1|||
49128756|NCT00321763|158310811|FG002|Overall Study|Lost to Follow-up|5|||
49128757|NCT00321763|158310812|FG003|Overall Study|Lost to Follow-up|4|||
49128758|NCT03863353|158310820|FG000|Overall Study|incomplete baseline; surgical complication; no opioid prescription|24|||
49128759|NCT03863353|158310821|FG001|Overall Study|incomplete baseline; surgical complication; no opioid prescription|20|||
49128760|NCT02495389|158310828|FG000|Overall Study|Withdrawal by Subject|40|||
49128761|NCT04079790|158310831|FG000|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1|||
49128762|NCT04079790|158310832|FG001|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
49128763|NCT04079790|158310833|FG002|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
49128764|NCT04079790|158310834|FG003|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
49128765|NCT04079790|158310831|FG000|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
49128766|NCT04079790|158310832|FG001|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
49128767|NCT04079790|158310833|FG002|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1|||
49128768|NCT04079790|158310834|FG003|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
48720222|NCT03011892|156824940|FG009|Open Label (OL) Period|Lost to Follow-up|0|||
48720223|NCT03011892|156824941|FG010|Open Label (OL) Period|Lost to Follow-up|1|||
48720224|NCT03011892|156824942|FG011|Open Label (OL) Period|Lost to Follow-up|1|||
48815608|NCT03017235|157167333|FG001|Overall Study|Adverse Event|1|||
49128769|NCT04079790|158310831|FG000|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
49128770|NCT04079790|158310832|FG001|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
48720225|NCT03011892|156824931|FG000|Open Label (OL) Period|Withdrawal by Subject|0|||
48720226|NCT03011892|156824932|FG001|Open Label (OL) Period|Withdrawal by Subject|0|||
48720227|NCT03011892|156824933|FG002|Open Label (OL) Period|Withdrawal by Subject|0|||
48720228|NCT03011892|156824934|FG003|Open Label (OL) Period|Withdrawal by Subject|0|||
48720229|NCT03011892|156824935|FG004|Open Label (OL) Period|Withdrawal by Subject|0|||
48720230|NCT03011892|156824936|FG005|Open Label (OL) Period|Withdrawal by Subject|0|||
48720231|NCT03011892|156824937|FG006|Open Label (OL) Period|Withdrawal by Subject|3|||
48720232|NCT03011892|156824938|FG007|Open Label (OL) Period|Withdrawal by Subject|0|||
48720233|NCT03011892|156824939|FG008|Open Label (OL) Period|Withdrawal by Subject|1|||
48720234|NCT03011892|156824940|FG009|Open Label (OL) Period|Withdrawal by Subject|0|||
48720235|NCT03011892|156824941|FG010|Open Label (OL) Period|Withdrawal by Subject|1|||
49128771|NCT04079790|158310833|FG002|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2|||
49128772|NCT04079790|158310834|FG003|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
49128773|NCT01253161|158310835|FG000|Overall Study|Adverse Event|1|||
49128774|NCT01924533|158310836|FG000|Overall Study|Death|181|||
49128775|NCT01924533|158310837|FG001|Overall Study|Death|200|||
49128776|NCT01924533|158310836|FG000|Overall Study|Lost to Follow-up|0|||
48815609|NCT03017235|157167332|FG000|Overall Study|Protocol Violation|2|||
48815610|NCT03017235|157167333|FG001|Overall Study|Protocol Violation|1|||
49128777|NCT01924533|158310837|FG001|Overall Study|Lost to Follow-up|1|||
49128778|NCT01924533|158310836|FG000|Overall Study|Withdrawal by Subject|7|||
49128779|NCT01924533|158310837|FG001|Overall Study|Withdrawal by Subject|3|||
49128780|NCT01924533|158310836|FG000|Overall Study|Other Eligibility criteria|1|||
49128781|NCT01924533|158310837|FG001|Overall Study|Other Eligibility criteria|1|||
49128782|NCT05002972|158310841|FG000|Overall Study|Withdrawal by Subject|2|||
49128783|NCT00427908|158310842|FG000|Primary Phase|Lost to Follow-up|4|||
49128784|NCT00427908|158310843|FG001|Primary Phase|Lost to Follow-up|0|||
49128785|NCT00427908|158310844|FG002|Primary Phase|Lost to Follow-up|2|||
49128786|NCT00427908|158310845|FG003|Primary Phase|Lost to Follow-up|0|||
49128787|NCT00427908|158310842|FG000|Primary Phase|Withdrawal by Subject|1|||
49128788|NCT00427908|158310843|FG001|Primary Phase|Withdrawal by Subject|2|||
49128789|NCT00427908|158310844|FG002|Primary Phase|Withdrawal by Subject|1|||
49128790|NCT00427908|158310845|FG003|Primary Phase|Withdrawal by Subject|0|||
48815611|NCT03017235|157167332|FG000|Overall Study|Cancer, emergency, allergy, active UTI|4|||
48815612|NCT03017235|157167333|FG001|Overall Study|Cancer, emergency, allergy, active UTI|2|||
48815613|NCT01818141|157167335|FG000|Overall Study|Withdrawal by Subject|2|||
48815614|NCT01818141|157167336|FG001|Overall Study|Withdrawal by Subject|0|||
48815615|NCT01818141|157167335|FG000|Overall Study|No baseline C.diff colonies|1|||
48815616|NCT01818141|157167336|FG001|Overall Study|No baseline C.diff colonies|1|||
48815617|NCT01818141|157167335|FG000|Overall Study|Lost to Follow-up|0|||
48815618|NCT01818141|157167336|FG001|Overall Study|Lost to Follow-up|2|||
48815619|NCT03518658|157167337|FG000|Overall Study|Other|51|||
48815620|NCT03518658|157167338|FG001|Overall Study|Other|0|||
48815621|NCT04213989|157167339|FG000|Overall Study|Withdrawal by Subject|3|||
48815622|NCT04213989|157167340|FG001|Overall Study|Withdrawal by Subject|2|||
48815623|NCT04213989|157167339|FG000|Overall Study|Physician Decision|1|||
48815624|NCT04213989|157167340|FG001|Overall Study|Physician Decision|0|||
48815625|NCT04213989|157167339|FG000|Overall Study|Lost to Follow-up|0|||
48815626|NCT04213989|157167340|FG001|Overall Study|Lost to Follow-up|4|||
48815627|NCT01087723|157167345|FG000|Overall Study|1 Year Visit Too Early (<335 days)|0|||
48815628|NCT01087723|157167346|FG001|Overall Study|1 Year Visit Too Early (<335 days)|1|||
48815629|NCT01087723|157167345|FG000|Overall Study|Withdrawal by Subject|10|||
48815630|NCT01087723|157167346|FG001|Overall Study|Withdrawal by Subject|13|||
48815631|NCT01087723|157167345|FG000|Overall Study|Physician Decision|2|||
48815632|NCT01087723|157167346|FG001|Overall Study|Physician Decision|0|||
48815633|NCT01087723|157167345|FG000|Overall Study|Lost to Follow-up|1|||
48815634|NCT01087723|157167346|FG001|Overall Study|Lost to Follow-up|4|||
48815635|NCT01087723|157167345|FG000|Overall Study|Reason Not Specified|1|||
48815636|NCT01087723|157167346|FG001|Overall Study|Reason Not Specified|2|||
48815637|NCT03638635|157167347|FG000|Initial Hospitalization|Study terminated prematurely|0|||
48815638|NCT03638635|157167348|FG001|Initial Hospitalization|Study terminated prematurely|1|||
48815639|NCT03638635|157167347|FG000|Initial Hospitalization|Withdrawal by study personnel|0|||
48815640|NCT03638635|157167348|FG001|Initial Hospitalization|Withdrawal by study personnel|1|||
48815641|NCT03638635|157167347|FG000|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39|||
48815642|NCT03638635|157167348|FG001|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22|||
48815643|NCT02091869|157167357|FG000|Overall Study|Withdrawal by Subject|0|||
48815644|NCT02091869|157167358|FG001|Overall Study|Withdrawal by Subject|3|||
48815645|NCT00627042|157167366|FG000|Overall Study|Withdrawal by Subject|2|||
48815646|NCT04747275|157167367|FG000|Overall Study|Study terminated|0|||
48815647|NCT04747275|157167368|FG001|Overall Study|Study terminated|1|||
48815648|NCT04537897|157167369|FG000|Overall Study|Other than listed|0|||
48815649|NCT04537897|157167370|FG001|Overall Study|Other than listed|0|||
48815650|NCT04537897|157167371|FG002|Overall Study|Other than listed|0|||
48815651|NCT04537897|157167372|FG003|Overall Study|Other than listed|0|||
48815652|NCT04537897|157167373|FG004|Overall Study|Other than listed|0|||
48815653|NCT04537897|157167374|FG005|Overall Study|Other than listed|0|||
48815654|NCT04537897|157167375|FG006|Overall Study|Other than listed|1|||
48815655|NCT04537897|157167376|FG007|Overall Study|Other than listed|0|||
48815656|NCT04537897|157167377|FG008|Overall Study|Other than listed|0|||
48815657|NCT04537897|157167369|FG000|Overall Study|Adverse Event|0|||
48815658|NCT04537897|157167370|FG001|Overall Study|Adverse Event|0|||
48815659|NCT04537897|157167371|FG002|Overall Study|Adverse Event|0|||
48815660|NCT04537897|157167372|FG003|Overall Study|Adverse Event|1|||
49128791|NCT00427908|158310842|FG000|Primary Phase|Adverse Event|0|||
49128792|NCT00427908|158310843|FG001|Primary Phase|Adverse Event|1|||
49128793|NCT00427908|158310844|FG002|Primary Phase|Adverse Event|0|||
49128794|NCT00427908|158310845|FG003|Primary Phase|Adverse Event|0|||
48815661|NCT04537897|157167373|FG004|Overall Study|Adverse Event|0|||
48720236|NCT03011892|156824942|FG011|Open Label (OL) Period|Withdrawal by Subject|2|||
48720237|NCT03011892|156824931|FG000|Open Label (OL) Period|Reason not specified|0|||
48720238|NCT03011892|156824932|FG001|Open Label (OL) Period|Reason not specified|0|||
48720239|NCT03011892|156824933|FG002|Open Label (OL) Period|Reason not specified|0|||
48720240|NCT03011892|156824934|FG003|Open Label (OL) Period|Reason not specified|0|||
48720241|NCT03011892|156824935|FG004|Open Label (OL) Period|Reason not specified|0|||
48720242|NCT03011892|156824936|FG005|Open Label (OL) Period|Reason not specified|0|||
48720243|NCT03011892|156824937|FG006|Open Label (OL) Period|Reason not specified|0|||
48720244|NCT03011892|156824938|FG007|Open Label (OL) Period|Reason not specified|1|||
48720245|NCT03011892|156824939|FG008|Open Label (OL) Period|Reason not specified|0|||
48720246|NCT03011892|156824940|FG009|Open Label (OL) Period|Reason not specified|0|||
48720247|NCT03011892|156824941|FG010|Open Label (OL) Period|Reason not specified|0|||
48720248|NCT03011892|156824942|FG011|Open Label (OL) Period|Reason not specified|0|||
48720249|NCT01470989|156824943|FG000|Overall Study|Participants did not entered extension studies 1, 2 and 3|103|||
48815662|NCT04537897|157167374|FG005|Overall Study|Adverse Event|0|||
48815663|NCT04537897|157167375|FG006|Overall Study|Adverse Event|0|||
48815664|NCT04537897|157167376|FG007|Overall Study|Adverse Event|0|||
48815665|NCT04537897|157167377|FG008|Overall Study|Adverse Event|0|||
48815666|NCT04537897|157167369|FG000|Overall Study|Withdrawal by Subject|0|||
48815667|NCT04537897|157167370|FG001|Overall Study|Withdrawal by Subject|1|||
48815668|NCT04537897|157167371|FG002|Overall Study|Withdrawal by Subject|0|||
48815669|NCT04537897|157167372|FG003|Overall Study|Withdrawal by Subject|0|||
48815670|NCT04537897|157167373|FG004|Overall Study|Withdrawal by Subject|0|||
48815671|NCT04537897|157167374|FG005|Overall Study|Withdrawal by Subject|0|||
48720250|NCT01470989|156824944|FG001|Overall Study|Participants did not entered extension studies 1, 2 and 3|136|||
48720251|NCT01470989|156824943|FG000|Overall Study|Adverse Event|2|||
48720252|NCT01470989|156824944|FG001|Overall Study|Adverse Event|5|||
48720253|NCT01470989|156824943|FG000|Overall Study|Abnormal laboratory value|1|||
48720254|NCT01470989|156824944|FG001|Overall Study|Abnormal laboratory value|1|||
48720255|NCT01470989|156824943|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
48720256|NCT01470989|156824944|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
48720257|NCT01470989|156824943|FG000|Overall Study|Withdrawal by Subject|19|||
48720258|NCT01470989|156824944|FG001|Overall Study|Withdrawal by Subject|17|||
48720259|NCT01470989|156824943|FG000|Overall Study|Lost to Follow-up|18|||
48720260|NCT01470989|156824944|FG001|Overall Study|Lost to Follow-up|13|||
48720261|NCT01470989|156824943|FG000|Overall Study|Administrative problems|2|||
48815672|NCT04537897|157167375|FG006|Overall Study|Withdrawal by Subject|0|||
48815673|NCT04537897|157167376|FG007|Overall Study|Withdrawal by Subject|0|||
48815674|NCT04537897|157167377|FG008|Overall Study|Withdrawal by Subject|0|||
48815675|NCT01130883|157167378|FG000|Overall Study|Patient Noncompliance|6|||
48815676|NCT01130883|157167378|FG000|Overall Study|Reason Unknown|1|||
48815677|NCT01130883|157167378|FG000|Overall Study|Adverse Event|3|||
48720262|NCT01470989|156824944|FG001|Overall Study|Administrative problems|4|||
48720263|NCT01470989|156824943|FG000|Overall Study|Death|2|||
48720264|NCT01470989|156824944|FG001|Overall Study|Death|2|||
48720265|NCT01470989|156824943|FG000|Overall Study|Protocol deviation|1|||
48720266|NCT01470989|156824944|FG001|Overall Study|Protocol deviation|2|||
48742997|NCT01086033|156910453|FG000|Overall Study|AE and Lack of Efficacy|4|||
48742998|NCT01086033|156910453|FG000|Overall Study|Death|1|||
48742999|NCT01086033|156910453|FG000|Overall Study|AE and Lost to Follow-up|1|||
48743000|NCT01086033|156910453|FG000|Overall Study|AE and Other Reason|1|||
48743001|NCT01086033|156910453|FG000|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1|||
48743002|NCT01921387|156910454|FG000|Overall Study|Adverse Event|1|||
48743003|NCT03727230|156910455|FG000|Overall Study|Lost to Follow-up|12|||
48743004|NCT02763462|156910456|FG000|Overall Study|Protocol Violation|6|||
48743005|NCT03600818|156910457|FG000|Overall Study|Adverse Event|4|||
48743006|NCT03600818|156910458|FG001|Overall Study|Adverse Event|7|||
48743007|NCT03600818|156910457|FG000|Overall Study|Lack of Efficacy|9|||
48815678|NCT04466618|157167384|FG000|Overall Study|Withdrawal by Subject|0|||
48815679|NCT04466618|157167385|FG001|Overall Study|Withdrawal by Subject|1|||
49011111|NCT00591253|157877395|FG000|Overall Study|Adverse Event|3|||
49011112|NCT00591253|157877396|FG001|Overall Study|Adverse Event|3|||
49011113|NCT00591253|157877397|FG002|Overall Study|Adverse Event|1|||
49011114|NCT00591253|157877395|FG000|Overall Study|Protocol Violation|2|||
49011115|NCT00591253|157877396|FG001|Overall Study|Protocol Violation|2|||
49011116|NCT00591253|157877397|FG002|Overall Study|Protocol Violation|2|||
49011117|NCT00591253|157877395|FG000|Overall Study|Lost to Follow-up|2|||
49011118|NCT00591253|157877396|FG001|Overall Study|Lost to Follow-up|4|||
49011119|NCT00591253|157877397|FG002|Overall Study|Lost to Follow-up|0|||
49011120|NCT00591253|157877395|FG000|Overall Study|Withdrawal by Subject|1|||
49011121|NCT00591253|157877396|FG001|Overall Study|Withdrawal by Subject|7|||
49011122|NCT00591253|157877397|FG002|Overall Study|Withdrawal by Subject|6|||
49011123|NCT00591253|157877395|FG000|Overall Study|Lack of Efficacy|1|||
49011124|NCT00591253|157877396|FG001|Overall Study|Lack of Efficacy|0|||
49011125|NCT00591253|157877397|FG002|Overall Study|Lack of Efficacy|3|||
49011126|NCT00591253|157877395|FG000|Overall Study|Other|5|||
48720267|NCT03860935|156826571|FG000|Overall Study|Withdrawal of Consent|15|||
48720268|NCT03860935|156826572|FG001|Overall Study|Withdrawal of Consent|6|||
48720269|NCT03860935|156826571|FG000|Overall Study|Death|75|||
48720270|NCT03860935|156826572|FG001|Overall Study|Death|51|||
48720271|NCT02661178|156826573|FG000|Part 1|Protocol Violation|1|||
48720272|NCT02661178|156826574|FG001|Part 1|Protocol Violation|0|||
48720273|NCT02661178|156826575|FG002|Part 1|Protocol Violation|0|||
48720274|NCT02661178|156826576|FG003|Part 1|Protocol Violation|0|||
48720275|NCT02661178|156826577|FG004|Part 1|Protocol Violation|0|||
48720276|NCT02661178|156826578|FG005|Part 1|Protocol Violation|0|||
48720277|NCT02661178|156826579|FG006|Part 1|Protocol Violation|0|||
48720278|NCT02661178|156826580|FG007|Part 1|Protocol Violation|0|||
48720279|NCT02661178|156826581|FG008|Part 1|Protocol Violation|0|||
48720280|NCT02661178|156826582|FG009|Part 1|Protocol Violation|0|||
48720281|NCT02661178|156826583|FG010|Part 1|Protocol Violation|0|||
48720282|NCT02661178|156826584|FG011|Part 1|Protocol Violation|0|||
48720283|NCT02661178|156826585|FG012|Part 1|Protocol Violation|0|||
48720284|NCT02661178|156826586|FG013|Part 1|Protocol Violation|0|||
48720285|NCT02661178|156826587|FG014|Part 1|Protocol Violation|0|||
48720286|NCT01437995|156826589|FG000|Overall Study|Lost to Follow-up|11|||
48720287|NCT01437995|156826590|FG001|Overall Study|Lost to Follow-up|18|||
48720288|NCT01437995|156826591|FG002|Overall Study|Lost to Follow-up|20|||
48720289|NCT00704522|156826594|FG000|Overall Study|Lack of Efficacy|65|||
49128795|NCT03040726|158310848|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|4|||
48720290|NCT00704522|156826595|FG001|Overall Study|Lack of Efficacy|17|||
48720291|NCT00704522|156826594|FG000|Overall Study|Failure to appear again at hospital|56|||
48720292|NCT00704522|156826595|FG001|Overall Study|Failure to appear again at hospital|10|||
48720293|NCT00704522|156826594|FG000|Overall Study|Withdrawal by Subject|17|||
48720294|NCT00704522|156826595|FG001|Overall Study|Withdrawal by Subject|8|||
48720295|NCT00704522|156826594|FG000|Overall Study|Adverse Event|9|||
48720296|NCT00704522|156826595|FG001|Overall Study|Adverse Event|1|||
48720297|NCT00704522|156826594|FG000|Overall Study|Undefined causes|9|||
48720298|NCT00704522|156826595|FG001|Overall Study|Undefined causes|7|||
48720299|NCT00704522|156826594|FG000|Overall Study|No information on therapy end|27|||
48720300|NCT00704522|156826595|FG001|Overall Study|No information on therapy end|2|||
48720301|NCT00775203|156826596|FG000|Overall Study|Adverse Event|25|||
48720302|NCT00775203|156826597|FG001|Overall Study|Adverse Event|6|||
48720303|NCT00775203|156826596|FG000|Overall Study|Lack of Efficacy|8|||
48720304|NCT00775203|156826597|FG001|Overall Study|Lack of Efficacy|9|||
48720305|NCT00775203|156826596|FG000|Overall Study|Withdrawal by Subject|11|||
48720306|NCT00775203|156826597|FG001|Overall Study|Withdrawal by Subject|9|||
48720307|NCT00775203|156826596|FG000|Overall Study|Lost to Follow-up|11|||
48720308|NCT00775203|156826597|FG001|Overall Study|Lost to Follow-up|15|||
48720309|NCT00775203|156826596|FG000|Overall Study|Administrative reason|2|||
48720310|NCT00775203|156826597|FG001|Overall Study|Administrative reason|0|||
48720311|NCT00775203|156826596|FG000|Overall Study|Noncompliance|4|||
48720312|NCT00775203|156826597|FG001|Overall Study|Noncompliance|2|||
48720313|NCT00775203|156826596|FG000|Overall Study|Protocol Violation|0|||
48720314|NCT00775203|156826597|FG001|Overall Study|Protocol Violation|1|||
48720315|NCT00775203|156826596|FG000|Overall Study|Entered other study|1|||
48720316|NCT00775203|156826597|FG001|Overall Study|Entered other study|0|||
48720317|NCT00775203|156826596|FG000|Overall Study|Physician Decision|0|||
48720318|NCT00775203|156826597|FG001|Overall Study|Physician Decision|1|||
48720319|NCT05458011|156826598|FG000|DB Period (12 Weeks)|Adverse Event|2|||
48720320|NCT05458011|156826599|FG001|DB Period (12 Weeks)|Adverse Event|1|||
48720321|NCT05458011|156826600|FG002|DB Period (12 Weeks)|Adverse Event|1|||
48720322|NCT05458011|156826598|FG000|DB Period (12 Weeks)|Withdrawal by Subject|4|||
48720323|NCT05458011|156826599|FG001|DB Period (12 Weeks)|Withdrawal by Subject|1|||
48720324|NCT05458011|156826600|FG002|DB Period (12 Weeks)|Withdrawal by Subject|1|||
49128796|NCT03040726|158310849|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|0|||
49128797|NCT03040726|158310848|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
49128798|NCT03040726|158310849|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
48720325|NCT05458011|156826598|FG000|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
48720326|NCT05458011|156826599|FG001|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
48720327|NCT05458011|156826600|FG002|DB Period (12 Weeks)|Non-compliance with trial drug|1|||
48720328|NCT05458011|156826598|FG000|DB Period (12 Weeks)|Protocol deviation|0|||
48720329|NCT05458011|156826599|FG001|DB Period (12 Weeks)|Protocol deviation|2|||
48720330|NCT05458011|156826600|FG002|DB Period (12 Weeks)|Protocol deviation|2|||
48720331|NCT05458011|156826598|FG000|OL Period (12 Weeks)|Adverse Event|1|||
48720332|NCT05458011|156826599|FG001|OL Period (12 Weeks)|Adverse Event|2|||
48720333|NCT05458011|156826600|FG002|OL Period (12 Weeks)|Adverse Event|1|||
48720334|NCT05458011|156826598|FG000|OL Period (12 Weeks)|Withdrawal by Subject|0|||
48720335|NCT05458011|156826599|FG001|OL Period (12 Weeks)|Withdrawal by Subject|3|||
48720336|NCT05458011|156826600|FG002|OL Period (12 Weeks)|Withdrawal by Subject|0|||
48720337|NCT01129024|156826602|FG000|Overall Study|Physician Decision|5|||
48720338|NCT01129024|156826602|FG000|Overall Study|Study Terminated by Sponsor|8|||
48720339|NCT01129024|156826602|FG000|Overall Study|Withdrawal by Subject|2|||
48720340|NCT01129024|156826602|FG000|Overall Study|Lack of Efficacy|3|||
48720341|NCT01129024|156826602|FG000|Overall Study|Needed a Platelet Transfusion|1|||
48720342|NCT00713310|156826604|FG000|Overall Study|Adverse Event|5|||
48720343|NCT00713310|156826605|FG001|Overall Study|Adverse Event|2|||
48720344|NCT00713310|156826604|FG000|Overall Study|Lack of Efficacy|0|||
48720345|NCT00713310|156826605|FG001|Overall Study|Lack of Efficacy|2|||
48720346|NCT00713310|156826604|FG000|Overall Study|Withdrawal by Subject|0|||
48720347|NCT00713310|156826605|FG001|Overall Study|Withdrawal by Subject|2|||
48720348|NCT03726996|156826607|FG000|Overall Study|Parent's decision|2|||
48720349|NCT03726996|156826607|FG000|Overall Study|Study early termination|2|||
48720350|NCT03499964|156826618|FG000|Overall Study|Lack of Efficacy|6|||
48720351|NCT03499964|156826619|FG001|Overall Study|Lack of Efficacy|26|||
48720352|NCT03499964|156826618|FG000|Overall Study|Adverse Event|1|||
48720353|NCT03499964|156826619|FG001|Overall Study|Adverse Event|0|||
48720354|NCT03499964|156826618|FG000|Overall Study|Death|1|||
48720355|NCT03499964|156826619|FG001|Overall Study|Death|0|||
48720356|NCT03499964|156826618|FG000|Overall Study|Withdrawal by Subject|2|||
48720357|NCT03499964|156826619|FG001|Overall Study|Withdrawal by Subject|1|||
48720358|NCT03499964|156826618|FG000|Overall Study|Lost to Follow-up|1|||
48720359|NCT03499964|156826619|FG001|Overall Study|Lost to Follow-up|0|||
48720360|NCT01673282|156826622|FG000|Overall Study|Adverse Drug Reaction - Vimpat|9|||
48720361|NCT01673282|156826623|FG001|Overall Study|Adverse Drug Reaction - Vimpat|5|||
48720362|NCT01673282|156826622|FG000|Overall Study|Lack of Efficacy|9|||
48720363|NCT01673282|156826623|FG001|Overall Study|Lack of Efficacy|2|||
48720364|NCT01673282|156826622|FG000|Overall Study|Lost to Follow-up|11|||
48720365|NCT01673282|156826623|FG001|Overall Study|Lost to Follow-up|10|||
48720366|NCT01673282|156826622|FG000|Overall Study|Withdrawal by Subject|3|||
48720367|NCT01673282|156826623|FG001|Overall Study|Withdrawal by Subject|3|||
48720368|NCT01673282|156826622|FG000|Overall Study|Other|1|||
48720369|NCT01673282|156826623|FG001|Overall Study|Other|6|||
48720370|NCT01534182|156826625|FG000|Overall Study|Administrative problems|1|||
48720371|NCT01534182|156826626|FG001|Overall Study|Administrative problems|0|||
48720372|NCT01534182|156826625|FG000|Overall Study|Withdrawal by Subject|4|||
48720373|NCT01534182|156826626|FG001|Overall Study|Withdrawal by Subject|7|||
48720374|NCT01534182|156826625|FG000|Overall Study|Adverse Event|7|||
48720375|NCT01534182|156826626|FG001|Overall Study|Adverse Event|3|||
48720376|NCT01323920|156826627|FG000|Overall Study|Death|5|||
48720377|NCT01323920|156826627|FG000|Overall Study|Withdrawal by Subject|1|||
48720378|NCT00816023|156826628|FG000|Overall Study|Lost to Follow-up|1|||
48720379|NCT00816023|156826629|FG001|Overall Study|Lost to Follow-up|1|||
48720380|NCT00816023|156826630|FG002|Overall Study|Lost to Follow-up|0|||
48720381|NCT00816023|156826631|FG003|Overall Study|Lost to Follow-up|0|||
48720382|NCT00816023|156826628|FG000|Overall Study|Withdrawal by Subject|1|||
48720383|NCT00816023|156826629|FG001|Overall Study|Withdrawal by Subject|0|||
48720384|NCT00816023|156826630|FG002|Overall Study|Withdrawal by Subject|0|||
48720385|NCT00816023|156826631|FG003|Overall Study|Withdrawal by Subject|0|||
48720386|NCT00816023|156826628|FG000|Overall Study|Physician Decision|0|||
48720387|NCT00816023|156826629|FG001|Overall Study|Physician Decision|0|||
48720388|NCT00816023|156826630|FG002|Overall Study|Physician Decision|1|||
48720389|NCT00816023|156826631|FG003|Overall Study|Physician Decision|0|||
48720390|NCT00816023|156826628|FG000|Overall Study|assessments complete prior to window|1|||
48815680|NCT04789577|157167392|FG000|Overall Study|Withdrawal by Subject|1|||
48815681|NCT04789577|157167393|FG001|Overall Study|Withdrawal by Subject|1|||
48815682|NCT04789577|157167394|FG002|Overall Study|Withdrawal by Subject|1|||
48815683|NCT04789577|157167395|FG003|Overall Study|Withdrawal by Subject|3|||
48815684|NCT04789577|157167396|FG004|Overall Study|Withdrawal by Subject|1|||
48815685|NCT04789577|157167397|FG005|Overall Study|Withdrawal by Subject|7|||
48815686|NCT04789577|157167398|FG006|Overall Study|Withdrawal by Subject|1|||
48815687|NCT04789577|157167392|FG000|Overall Study|Lost to Follow-up|7|||
48815688|NCT04789577|157167393|FG001|Overall Study|Lost to Follow-up|12|||
48720391|NCT00816023|156826629|FG001|Overall Study|assessments complete prior to window|1|||
48720392|NCT00816023|156826630|FG002|Overall Study|assessments complete prior to window|2|||
48720393|NCT00816023|156826631|FG003|Overall Study|assessments complete prior to window|1|||
48720394|NCT00816023|156826628|FG000|Overall Study|Randomized Not Treated|6|||
48720395|NCT00816023|156826629|FG001|Overall Study|Randomized Not Treated|4|||
48720396|NCT00816023|156826630|FG002|Overall Study|Randomized Not Treated|6|||
48720397|NCT00816023|156826631|FG003|Overall Study|Randomized Not Treated|11|||
48720398|NCT01224782|156826639|FG000|Overall Study|Lost to Follow-up|177|||
48720399|NCT01224782|156826639|FG000|Overall Study|Withdrawal by Subject|16|||
48720400|NCT01224782|156826639|FG000|Overall Study|Death|14|||
48720401|NCT01224782|156826639|FG000|Overall Study|Improvement|13|||
48720402|NCT01224782|156826639|FG000|Overall Study|Adverse Event|12|||
48720403|NCT01224782|156826639|FG000|Overall Study|Adverse Reaction|11|||
48720404|NCT01224782|156826639|FG000|Overall Study|Noncompliance|10|||
48720405|NCT01224782|156826639|FG000|Overall Study|Other|4|||
48720406|NCT01224782|156826639|FG000|Overall Study|Start of Dialysis|3|||
48815689|NCT04789577|157167394|FG002|Overall Study|Lost to Follow-up|7|||
48815690|NCT04789577|157167395|FG003|Overall Study|Lost to Follow-up|10|||
48815691|NCT04789577|157167396|FG004|Overall Study|Lost to Follow-up|8|||
48815692|NCT04789577|157167397|FG005|Overall Study|Lost to Follow-up|6|||
48815693|NCT04789577|157167398|FG006|Overall Study|Lost to Follow-up|10|||
48815694|NCT04789577|157167392|FG000|Overall Study|Migrated Or Moved From The Study Area|0|||
48815695|NCT04789577|157167393|FG001|Overall Study|Migrated Or Moved From The Study Area|0|||
48815696|NCT04789577|157167394|FG002|Overall Study|Migrated Or Moved From The Study Area|0|||
48815697|NCT04789577|157167395|FG003|Overall Study|Migrated Or Moved From The Study Area|1|||
48815698|NCT04789577|157167396|FG004|Overall Study|Migrated Or Moved From The Study Area|0|||
48815699|NCT04789577|157167397|FG005|Overall Study|Migrated Or Moved From The Study Area|0|||
48815700|NCT04789577|157167398|FG006|Overall Study|Migrated Or Moved From The Study Area|0|||
48815701|NCT04789577|157167392|FG000|Overall Study|AE Requiring Expedited Reporting|0|||
48815702|NCT04789577|157167393|FG001|Overall Study|AE Requiring Expedited Reporting|0|||
48815703|NCT04789577|157167394|FG002|Overall Study|AE Requiring Expedited Reporting|0|||
48815704|NCT04789577|157167395|FG003|Overall Study|AE Requiring Expedited Reporting|0|||
48815705|NCT04789577|157167396|FG004|Overall Study|AE Requiring Expedited Reporting|0|||
48815706|NCT04789577|157167397|FG005|Overall Study|AE Requiring Expedited Reporting|1|||
48815707|NCT04789577|157167398|FG006|Overall Study|AE Requiring Expedited Reporting|0|||
48815708|NCT02222896|157167404|FG000|Abdomen|Did not qualify|34|||
48815709|NCT02222896|157167405|FG001|Abdomen|Did not qualify|10|||
48815710|NCT02222896|157167406|FG002|Abdomen|Did not qualify|32|||
48815711|NCT02222896|157167404|FG000|Groin|Did not qualify|43|||
48815712|NCT02222896|157167405|FG001|Groin|Did not qualify|9|||
48815713|NCT02222896|157167406|FG002|Groin|Did not qualify|40|||
48815714|NCT02111213|157167408|FG000|Overall Study|Withdrawal by Subject|3|||
48815715|NCT02111213|157167409|FG001|Overall Study|Withdrawal by Subject|2|||
48815716|NCT02111213|157167408|FG000|Overall Study|Lost to Follow-up|3|||
48815717|NCT02111213|157167409|FG001|Overall Study|Lost to Follow-up|4|||
48815718|NCT03537261|157167414|FG000|Overall Study|Lost to Follow-up|4|||
48815719|NCT03537261|157167415|FG001|Overall Study|Lost to Follow-up|5|||
48815720|NCT03537261|157167414|FG000|Overall Study|Withdrawal by Subject|4|||
48815721|NCT03537261|157167415|FG001|Overall Study|Withdrawal by Subject|6|||
48815722|NCT03537261|157167414|FG000|Overall Study|Did not return study questionnaires|0|||
48815723|NCT03537261|157167415|FG001|Overall Study|Did not return study questionnaires|1|||
48815724|NCT03237013|157167417|FG000|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43|||
48720407|NCT01224782|156826639|FG000|Overall Study|Change of Treatment|1|||
48815725|NCT03237013|157167418|FG001|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30|||
48815726|NCT03237013|157167419|FG002|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37|||
48815727|NCT00287469|157167422|FG000|Overall Study|serious adverse event|1|||
48815728|NCT00287469|157167423|FG001|Overall Study|serious adverse event|6|||
48720408|NCT01224782|156826639|FG000|Overall Study|Financial Reasons|1|||
48720409|NCT01224782|156826639|FG000|Overall Study|Deterioration|1|||
48720410|NCT01224782|156826639|FG000|Overall Study|Transplantation|1|||
48720411|NCT01203852|156826644|FG000|Metoprolol 8 Weeks|Physician Decision|470|||
48720412|NCT01203852|156826644|FG000|Washout 2 Weeks|Physician Decision|46|||
48720413|NCT01238588|156826645|FG000|Overall Study|Withdrawal by Subject|1|||
48720414|NCT01238588|156826645|FG000|Overall Study|Physician Decision|2|||
48720415|NCT01903252|156826646|FG000|Double-Blind Induction|Adverse Event|20|||
48720416|NCT01903252|156826647|FG001|Double-Blind Induction|Adverse Event|18|||
48720417|NCT01903252|156826648|FG002|Double-Blind Induction|Adverse Event|0|||
48720418|NCT01903252|156826649|FG003|Double-Blind Induction|Adverse Event|0|||
48720419|NCT01903252|156826650|FG004|Double-Blind Induction|Adverse Event|0|||
48720420|NCT01903252|156826651|FG005|Double-Blind Induction|Adverse Event|0|||
48815729|NCT00287469|157167422|FG000|Overall Study|Adverse Event|1|||
48815730|NCT00287469|157167423|FG001|Overall Study|Adverse Event|1|||
48815731|NCT00287469|157167422|FG000|Overall Study|moved from area|144|||
48815732|NCT00287469|157167423|FG001|Overall Study|moved from area|138|||
48815733|NCT00287469|157167422|FG000|Overall Study|Lost to Follow-up|74|||
48815734|NCT00287469|157167423|FG001|Overall Study|Lost to Follow-up|69|||
48815735|NCT00967018|157167424|FG000|Overall Study|Adverse Event|2|||
48815736|NCT00967018|157167424|FG000|Overall Study|Physician Decision|7|||
48815737|NCT00967018|157167424|FG000|Overall Study|Lost to Follow-up|2|||
48720421|NCT01903252|156826646|FG000|Double-Blind Induction|Withdrawal by Subject|10|||
48720422|NCT01903252|156826647|FG001|Double-Blind Induction|Withdrawal by Subject|13|||
49011127|NCT00591253|157877396|FG001|Overall Study|Other|5|||
49011128|NCT00591253|157877397|FG002|Overall Study|Other|3|||
49011129|NCT00481247|157877398|FG000|Overall Study|Death|0|||
49011130|NCT00481247|157877399|FG001|Overall Study|Death|1|||
48720423|NCT01903252|156826648|FG002|Double-Blind Induction|Withdrawal by Subject|0|||
49011131|NCT00481247|157877398|FG000|Overall Study|Disease progression|18|||
49011132|NCT00481247|157877399|FG001|Overall Study|Disease progression|22|||
49011133|NCT00481247|157877398|FG000|Overall Study|Intolerance|42|||
49011134|NCT00481247|157877399|FG001|Overall Study|Intolerance|17|||
49011135|NCT00481247|157877398|FG000|Overall Study|Treatment failure|10|||
49011136|NCT00481247|157877399|FG001|Overall Study|Treatment failure|14|||
49011137|NCT00481247|157877398|FG000|Overall Study|AE unrelated to study drug|13|||
48720424|NCT01903252|156826649|FG003|Double-Blind Induction|Withdrawal by Subject|0|||
48720425|NCT01903252|156826650|FG004|Double-Blind Induction|Withdrawal by Subject|0|||
48720426|NCT01903252|156826651|FG005|Double-Blind Induction|Withdrawal by Subject|0|||
48720427|NCT01903252|156826646|FG000|Double-Blind Induction|Physician Decision|2|||
48720428|NCT01903252|156826647|FG001|Double-Blind Induction|Physician Decision|3|||
48720429|NCT01903252|156826648|FG002|Double-Blind Induction|Physician Decision|0|||
48720430|NCT01903252|156826649|FG003|Double-Blind Induction|Physician Decision|0|||
48720431|NCT01903252|156826650|FG004|Double-Blind Induction|Physician Decision|0|||
48720432|NCT01903252|156826651|FG005|Double-Blind Induction|Physician Decision|0|||
48720433|NCT01903252|156826646|FG000|Double-Blind Induction|non-compliance,|7|||
48720434|NCT01903252|156826647|FG001|Double-Blind Induction|non-compliance,|7|||
48720435|NCT01903252|156826648|FG002|Double-Blind Induction|non-compliance,|0|||
48720436|NCT01903252|156826649|FG003|Double-Blind Induction|non-compliance,|0|||
48720437|NCT01903252|156826650|FG004|Double-Blind Induction|non-compliance,|0|||
48720438|NCT01903252|156826651|FG005|Double-Blind Induction|non-compliance,|0|||
48720439|NCT01903252|156826646|FG000|Extended Induction, Open-Label|Adverse Event|0|||
48720440|NCT01903252|156826647|FG001|Extended Induction, Open-Label|Adverse Event|0|||
48720441|NCT01903252|156826648|FG002|Extended Induction, Open-Label|Adverse Event|17|||
48720442|NCT01903252|156826649|FG003|Extended Induction, Open-Label|Adverse Event|0|||
48720443|NCT01903252|156826650|FG004|Extended Induction, Open-Label|Adverse Event|0|||
48720444|NCT01903252|156826651|FG005|Extended Induction, Open-Label|Adverse Event|0|||
48720445|NCT01903252|156826646|FG000|Extended Induction, Open-Label|Withdrawal by Subject|0|||
48720446|NCT01903252|156826647|FG001|Extended Induction, Open-Label|Withdrawal by Subject|0|||
48720447|NCT01903252|156826648|FG002|Extended Induction, Open-Label|Withdrawal by Subject|5|||
48720448|NCT01903252|156826649|FG003|Extended Induction, Open-Label|Withdrawal by Subject|0|||
48720449|NCT01903252|156826650|FG004|Extended Induction, Open-Label|Withdrawal by Subject|0|||
48720450|NCT01903252|156826651|FG005|Extended Induction, Open-Label|Withdrawal by Subject|0|||
48720451|NCT01903252|156826646|FG000|Extended Induction, Open-Label|Physician Decision|0|||
48720452|NCT01903252|156826647|FG001|Extended Induction, Open-Label|Physician Decision|0|||
48720453|NCT01903252|156826648|FG002|Extended Induction, Open-Label|Physician Decision|1|||
48720454|NCT01903252|156826649|FG003|Extended Induction, Open-Label|Physician Decision|0|||
48720455|NCT01903252|156826650|FG004|Extended Induction, Open-Label|Physician Decision|0|||
48720456|NCT01903252|156826651|FG005|Extended Induction, Open-Label|Physician Decision|0|||
48720457|NCT01903252|156826646|FG000|Maintenance, Open-Label|Adverse Event|0|||
48720458|NCT01903252|156826647|FG001|Maintenance, Open-Label|Adverse Event|0|||
48720459|NCT01903252|156826648|FG002|Maintenance, Open-Label|Adverse Event|0|||
48720460|NCT01903252|156826649|FG003|Maintenance, Open-Label|Adverse Event|3|||
48720461|NCT01903252|156826650|FG004|Maintenance, Open-Label|Adverse Event|9|||
48720462|NCT01903252|156826651|FG005|Maintenance, Open-Label|Adverse Event|14|||
48720463|NCT01903252|156826646|FG000|Maintenance, Open-Label|Withdrawal by Subject|0|||
48720464|NCT01903252|156826647|FG001|Maintenance, Open-Label|Withdrawal by Subject|0|||
48720465|NCT01903252|156826648|FG002|Maintenance, Open-Label|Withdrawal by Subject|0|||
48720466|NCT01903252|156826649|FG003|Maintenance, Open-Label|Withdrawal by Subject|1|||
48720467|NCT01903252|156826650|FG004|Maintenance, Open-Label|Withdrawal by Subject|6|||
48720468|NCT01903252|156826651|FG005|Maintenance, Open-Label|Withdrawal by Subject|2|||
48720469|NCT01903252|156826646|FG000|Maintenance, Open-Label|Other|0|||
48720470|NCT01903252|156826647|FG001|Maintenance, Open-Label|Other|0|||
48720471|NCT01903252|156826648|FG002|Maintenance, Open-Label|Other|0|||
48720472|NCT01903252|156826649|FG003|Maintenance, Open-Label|Other|2|||
48720473|NCT01903252|156826650|FG004|Maintenance, Open-Label|Other|6|||
48720474|NCT01903252|156826651|FG005|Maintenance, Open-Label|Other|2|||
48720475|NCT00852371|156826652|FG000|Overall Study|Lost to Follow-up|2|||
48720476|NCT00852371|156826653|FG001|Overall Study|Lost to Follow-up|3|||
48720477|NCT00852371|156826654|FG002|Overall Study|Lost to Follow-up|4|||
48815738|NCT00967018|157167424|FG000|Overall Study|Withdrawal by Subject|1|||
48815739|NCT00967018|157167424|FG000|Overall Study|Miscellaneous Reasons|9|||
48815740|NCT04642469|157167427|FG000|Overall Study|Failure to meet inclusion/exclusion criteria|1|||
48815741|NCT04642469|157167428|FG001|Overall Study|Failure to meet inclusion/exclusion criteria|0|||
48815742|NCT04642469|157167427|FG000|Overall Study|Death|1|||
48815743|NCT04642469|157167428|FG001|Overall Study|Death|2|||
48815744|NCT04642469|157167427|FG000|Overall Study|Study/site closed following amendment 1|11|||
48815745|NCT04642469|157167428|FG001|Overall Study|Study/site closed following amendment 1|11|||
48815746|NCT04642469|157167427|FG000|Overall Study|Other|1|||
48920968|NCT04766021|157544799|FG000|Informed Consent/Screening Visit|Met exclusion criteria|10|||
48720478|NCT00852371|156826655|FG003|Overall Study|Lost to Follow-up|2|||
48720479|NCT01227824|156826659|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|12|||
48720480|NCT01227824|156826660|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|7|||
48720481|NCT01227824|156826661|FG002|Double-blind Phase: 96 Weeks Duration|Adverse Event|0|||
48720482|NCT01227824|156826659|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22|||
48720483|NCT01227824|156826660|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25|||
48720484|NCT01227824|156826661|FG002|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0|||
48815747|NCT04642469|157167428|FG001|Overall Study|Other|1|||
48720485|NCT01227824|156826659|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18|||
48720486|NCT01227824|156826660|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16|||
48720487|NCT01227824|156826661|FG002|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0|||
48720488|NCT01227824|156826659|FG000|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6|||
48720489|NCT01227824|156826660|FG001|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3|||
48720490|NCT01227824|156826661|FG002|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0|||
48720491|NCT01227824|156826659|FG000|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6|||
48720492|NCT01227824|156826660|FG001|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4|||
48720493|NCT01227824|156826661|FG002|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0|||
48720494|NCT01227824|156826659|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22|||
48720495|NCT01227824|156826660|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10|||
48720496|NCT01227824|156826661|FG002|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0|||
48720497|NCT01227824|156826659|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18|||
48720498|NCT01227824|156826660|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14|||
48720499|NCT01227824|156826661|FG002|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0|||
48720500|NCT01227824|156826659|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|3|||
48720501|NCT01227824|156826660|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
48920969|NCT01033734|157544800|FG000|Overall Study|Withdrawal by Subject|1|||
48720502|NCT01227824|156826661|FG002|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
48743008|NCT03600818|156910458|FG001|Overall Study|Lack of Efficacy|4|||
48743009|NCT03600818|156910457|FG000|Overall Study|Withdrawal by Subject|4|||
48743010|NCT03600818|156910458|FG001|Overall Study|Withdrawal by Subject|3|||
48743011|NCT03600818|156910457|FG000|Overall Study|Other-unspecified|5|||
48743012|NCT03600818|156910458|FG001|Overall Study|Other-unspecified|3|||
48743013|NCT03600818|156910457|FG000|Overall Study|Randomized and not treated|0|||
48743014|NCT03600818|156910458|FG001|Overall Study|Randomized and not treated|1|||
48743015|NCT04930965|156910459|FG000|Overall Study|Lost to Follow-up|7|||
48743016|NCT04930965|156910460|FG001|Overall Study|Lost to Follow-up|5|||
48743017|NCT03478930|156910461|FG000|Overall Study|Adverse Event|0|||
48743018|NCT03478930|156910462|FG001|Overall Study|Adverse Event|1|||
48743019|NCT03478930|156910461|FG000|Overall Study|Lack of Efficacy|3|||
48743020|NCT03478930|156910462|FG001|Overall Study|Lack of Efficacy|3|||
48743021|NCT03478930|156910461|FG000|Overall Study|Withdrawal by Subject|6|||
48743022|NCT03478930|156910462|FG001|Overall Study|Withdrawal by Subject|5|||
48743023|NCT02590003|156910480|FG000|Overall Study|Death|1|||
48743024|NCT02590003|156910481|FG001|Overall Study|Death|2|||
48743025|NCT01091974|156910482|FG000|Overall Study|Did not start intervention|3|||
48743026|NCT01091974|156910483|FG001|Overall Study|Did not start intervention|1|||
48743027|NCT01091974|156910484|FG002|Overall Study|Did not start intervention|3|||
48743028|NCT01091974|156910485|FG003|Overall Study|Did not start intervention|1|||
48743029|NCT01091974|156910482|FG000|Overall Study|resumed sleep medication|0|||
48743030|NCT01091974|156910483|FG001|Overall Study|resumed sleep medication|0|||
48743031|NCT01091974|156910484|FG002|Overall Study|resumed sleep medication|1|||
48743032|NCT01091974|156910485|FG003|Overall Study|resumed sleep medication|2|||
48743033|NCT01091974|156910482|FG000|Overall Study|Withdrawal by Subject|1|||
48743034|NCT01091974|156910483|FG001|Overall Study|Withdrawal by Subject|3|||
48743035|NCT01091974|156910484|FG002|Overall Study|Withdrawal by Subject|2|||
48743036|NCT01091974|156910485|FG003|Overall Study|Withdrawal by Subject|2|||
48743037|NCT01091974|156910482|FG000|Overall Study|side-effects|1|||
48743038|NCT01091974|156910483|FG001|Overall Study|side-effects|1|||
48743039|NCT01091974|156910484|FG002|Overall Study|side-effects|0|||
48743040|NCT01091974|156910485|FG003|Overall Study|side-effects|2|||
48743041|NCT00555971|156910486|FG000|Overall Study|Adverse Event|1|||
48743042|NCT00555971|156910487|FG001|Overall Study|Adverse Event|1|||
48743043|NCT03334539|156910491|FG000|Overall Study|Adverse Event|3|||
48743044|NCT03334539|156910492|FG001|Overall Study|Adverse Event|5|||
48743045|NCT03334539|156910493|FG002|Overall Study|Adverse Event|0|||
48743046|NCT03334539|156910491|FG000|Overall Study|Withdrawal by Subject|0|||
48743047|NCT03334539|156910492|FG001|Overall Study|Withdrawal by Subject|1|||
48743048|NCT03334539|156910493|FG002|Overall Study|Withdrawal by Subject|1|||
48743049|NCT03334539|156910491|FG000|Overall Study|Administrative Reasons|1|||
48743050|NCT03334539|156910492|FG001|Overall Study|Administrative Reasons|0|||
48743051|NCT03334539|156910493|FG002|Overall Study|Administrative Reasons|0|||
48743052|NCT03334539|156910491|FG000|Overall Study|Hypertension Not Controlled|0|||
48743053|NCT03334539|156910492|FG001|Overall Study|Hypertension Not Controlled|1|||
48743054|NCT03334539|156910493|FG002|Overall Study|Hypertension Not Controlled|0|||
48743055|NCT00968201|156910494|FG000|Base Study - (Period II)|Adverse Event|8|||
48743056|NCT00968201|156910495|FG001|Base Study - (Period II)|Adverse Event|0|||
48743057|NCT00968201|156910496|FG002|Base Study - (Period II)|Adverse Event|16|||
48743058|NCT00968201|156910494|FG000|Base Study - (Period II)|Lack of Efficacy|0|||
48720503|NCT01227824|156826659|FG000|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
48720504|NCT01227824|156826660|FG001|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
48720505|NCT01227824|156826661|FG002|Open-label Phase: Median of 1267 Days|Adverse Event|4|||
48720506|NCT01227824|156826659|FG000|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
48720507|NCT01227824|156826660|FG001|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
48720508|NCT01227824|156826661|FG002|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5|||
48720509|NCT01227824|156826659|FG000|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
48720510|NCT01227824|156826660|FG001|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
48720511|NCT01227824|156826661|FG002|Open-label Phase: Median of 1267 Days|Protocol Violation|5|||
48720512|NCT01227824|156826659|FG000|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
48720513|NCT01227824|156826660|FG001|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
48720514|NCT01227824|156826661|FG002|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4|||
48720515|NCT01227824|156826659|FG000|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
48720516|NCT01227824|156826660|FG001|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
48720517|NCT01227824|156826661|FG002|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15|||
48720518|NCT01227824|156826659|FG000|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
48720519|NCT01227824|156826660|FG001|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
48720520|NCT01227824|156826661|FG002|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8|||
48720521|NCT01227824|156826659|FG000|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
48720522|NCT01227824|156826660|FG001|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
48720523|NCT01227824|156826661|FG002|Open-label Phase: Median of 1267 Days|Physician Decision|3|||
48720524|NCT02694757|156826663|FG000|Overall Study|Lack of Efficacy|3|||
48720525|NCT00783302|156826666|FG000|Overall Study|Lost to Follow-up|17|||
48720526|NCT00783302|156826666|FG000|Overall Study|Technical Problems|11|||
48720527|NCT00783302|156826666|FG000|Overall Study|Protocol Violation|3|||
48720528|NCT00783302|156826666|FG000|Overall Study|Physician Decision|1|||
48720529|NCT00783302|156826666|FG000|Overall Study|Withdrawal by Subject|3|||
48720530|NCT03562767|156826670|FG000|Overall Study|Physician Decision|2|||
48720531|NCT03562767|156826671|FG001|Overall Study|Physician Decision|0|||
48720532|NCT03562767|156826672|FG002|Overall Study|Physician Decision|0|||
48720533|NCT03562767|156826670|FG000|Overall Study|Logistic Reason|1|||
48720534|NCT03562767|156826671|FG001|Overall Study|Logistic Reason|3|||
48720535|NCT03562767|156826672|FG002|Overall Study|Logistic Reason|0|||
48720536|NCT01589770|156826673|FG000|Overall Study|EGFR <60ml/min|6|||
48720537|NCT01589770|156826674|FG001|Overall Study|EGFR <60ml/min|4|||
48720538|NCT01589770|156826673|FG000|Overall Study|claustrophobic when entering cardiac MRI|2|||
48720539|NCT01589770|156826674|FG001|Overall Study|claustrophobic when entering cardiac MRI|1|||
48720540|NCT02048241|156826675|FG000|Overall Study|Withdrawal by Subject|0|||
48720541|NCT02048241|156826676|FG001|Overall Study|Withdrawal by Subject|1|||
48720542|NCT00402233|156826677|FG000|Overall Study|Adverse Event|1|||
48720543|NCT00402233|156826678|FG001|Overall Study|Adverse Event|7|||
48720544|NCT00402233|156826679|FG002|Overall Study|Adverse Event|9|||
48720545|NCT00402233|156826680|FG003|Overall Study|Adverse Event|9|||
48720546|NCT00402233|156826677|FG000|Overall Study|Protocol Violation|0|||
48920970|NCT01389752|157544802|FG000|Study Period 1|Sponsor decision|0|||
49128799|NCT03040726|158310848|FG000|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|4|||
49128800|NCT03040726|158310849|FG001|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|3|||
48720547|NCT00402233|156826678|FG001|Overall Study|Protocol Violation|1|||
48720548|NCT00402233|156826679|FG002|Overall Study|Protocol Violation|0|||
48720549|NCT00402233|156826680|FG003|Overall Study|Protocol Violation|0|||
48720550|NCT00402233|156826677|FG000|Overall Study|Withdrawal by Subject|2|||
48720551|NCT00402233|156826678|FG001|Overall Study|Withdrawal by Subject|1|||
48720552|NCT00402233|156826679|FG002|Overall Study|Withdrawal by Subject|2|||
48720553|NCT00402233|156826680|FG003|Overall Study|Withdrawal by Subject|2|||
48720554|NCT00402233|156826677|FG000|Overall Study|Worsening of disease under study|2|||
48720555|NCT00402233|156826678|FG001|Overall Study|Worsening of disease under study|0|||
48720556|NCT00402233|156826679|FG002|Overall Study|Worsening of disease under study|0|||
48720557|NCT00402233|156826680|FG003|Overall Study|Worsening of disease under study|0|||
48720558|NCT00402233|156826677|FG000|Overall Study|Worsening of other pre-existing disease|0|||
48720559|NCT00402233|156826678|FG001|Overall Study|Worsening of other pre-existing disease|1|||
48720560|NCT00402233|156826679|FG002|Overall Study|Worsening of other pre-existing disease|0|||
48720561|NCT00402233|156826680|FG003|Overall Study|Worsening of other pre-existing disease|0|||
48720562|NCT00927940|156826681|FG000|Overall Study|Death|1|||
48720563|NCT03007888|156826682|FG000|First Intervention (14 Days)|Adverse Event|1|||
48720564|NCT03007888|156826683|FG001|First Intervention (14 Days)|Adverse Event|0|||
48720565|NCT01658813|156826686|FG000|Overall Study|Disease progression|3|||
48720566|NCT02285062|156826692|FG000|Pre-Treatment Period|Protocol Violation|0|||
48720567|NCT02285062|156826693|FG001|Pre-Treatment Period|Protocol Violation|2|||
48720568|NCT02285062|156826692|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
48720569|NCT02285062|156826693|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
48720570|NCT01715129|156826694|FG000|Overall Study|Adverse Event, fatal|1|||
48720571|NCT01715129|156826694|FG000|Overall Study|Lack of Efficacy|3|||
48720572|NCT01715129|156826694|FG000|Overall Study|Protocol Violation|1|||
48720573|NCT01715129|156826694|FG000|Overall Study|Consent Withdrawn|2|||
48720574|NCT01715129|156826694|FG000|Overall Study|Lost to Follow-up|1|||
48720575|NCT01715129|156826694|FG000|Overall Study|Other|1|||
48720576|NCT01101191|156826697|FG000|Period 1|Withdrawal by Subject|1|||
48720577|NCT01101191|156826698|FG001|Period 1|Withdrawal by Subject|0|||
48720578|NCT01101191|156826697|FG000|Period 1|Adverse Event|1|||
48720579|NCT01101191|156826698|FG001|Period 1|Adverse Event|2|||
48720580|NCT03044574|156826699|FG000|Overall Study|Lost to Follow-up|37|||
48720581|NCT03044574|156826700|FG001|Overall Study|Lost to Follow-up|45|||
48720582|NCT00890045|156826701|FG000|Overall Study|Death|0|||
48720583|NCT00890045|156826702|FG001|Overall Study|Death|1|||
48720584|NCT00890045|156826701|FG000|Overall Study|Did not receive HeRO Graft|0|||
48720585|NCT00890045|156826702|FG001|Overall Study|Did not receive HeRO Graft|2|||
48720586|NCT00890045|156826701|FG000|Overall Study|Lost to Follow-up|5|||
48720587|NCT00890045|156826702|FG001|Overall Study|Lost to Follow-up|7|||
48720588|NCT03985878|156826715|FG000|Overall Study|Transitioned to Another Sarepta Study|2|||
48720589|NCT03985878|156826715|FG000|Overall Study|Study Terminated by Sponsor|12|||
48720590|NCT03985878|156826715|FG000|Overall Study|Withdrawal by Subject|1|||
48720591|NCT00591578|156826716|FG000|Double-Blind Treatment Phase|Adverse Event|20|||
48720592|NCT00591578|156826717|FG001|Double-Blind Treatment Phase|Adverse Event|26|||
48720593|NCT00591578|156826718|FG002|Double-Blind Treatment Phase|Adverse Event|19|||
48720594|NCT00591578|156826716|FG000|Double-Blind Treatment Phase|Protocol Violation|3|||
48720595|NCT00591578|156826717|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
48720596|NCT00591578|156826718|FG002|Double-Blind Treatment Phase|Protocol Violation|3|||
48720597|NCT00591578|156826716|FG000|Double-Blind Treatment Phase|Lost to Follow-up|12|||
49128801|NCT03040726|158310848|FG000|Overall Study|Reasons for not completing Blinded phase: Hospitalization|0|||
49128802|NCT03040726|158310849|FG001|Overall Study|Reasons for not completing Blinded phase: Hospitalization|2|||
49128803|NCT03040726|158310848|FG000|Overall Study|Reasons for not completing Blinded phase : Withdrawal|1|||
49128804|NCT03040726|158310849|FG001|Overall Study|Reasons for not completing Blinded phase : Withdrawal|0|||
49128805|NCT03805841|158310850|FG000|Overall Study|Clinical Progression|2|||
49128806|NCT03805841|158310851|FG001|Overall Study|Clinical Progression|0|||
49128807|NCT03805841|158310852|FG002|Overall Study|Clinical Progression|0|||
49128808|NCT03805841|158310850|FG000|Overall Study|Death|0|||
49128809|NCT03805841|158310851|FG001|Overall Study|Death|3|||
49128810|NCT03805841|158310852|FG002|Overall Study|Death|1|||
48815748|NCT04642469|157167427|FG000|Overall Study|Withdrawal by Subject|1|||
48815749|NCT04642469|157167428|FG001|Overall Study|Withdrawal by Subject|0|||
48815750|NCT03050398|157167429|FG000|Overall Study|Study terminated by sponsor|8|||
48815751|NCT02733042|157167430|FG000|Overall Study|Adverse Event|1|||
48815752|NCT02733042|157167431|FG001|Overall Study|Adverse Event|0|||
48815753|NCT02733042|157167432|FG002|Overall Study|Adverse Event|1|||
48815754|NCT02733042|157167433|FG003|Overall Study|Adverse Event|1|||
48815755|NCT02733042|157167434|FG004|Overall Study|Adverse Event|0|||
48815756|NCT02733042|157167435|FG005|Overall Study|Adverse Event|0|||
48815757|NCT02733042|157167436|FG006|Overall Study|Adverse Event|0|||
48815758|NCT02733042|157167437|FG007|Overall Study|Adverse Event|0|||
48815759|NCT02733042|157167438|FG008|Overall Study|Adverse Event|0|||
48815760|NCT02733042|157167439|FG009|Overall Study|Adverse Event|0|||
48815761|NCT02733042|157167440|FG010|Overall Study|Adverse Event|2|||
48815762|NCT02733042|157167441|FG011|Overall Study|Adverse Event|2|||
48815763|NCT02733042|157167442|FG012|Overall Study|Adverse Event|0|||
48815764|NCT02733042|157167443|FG013|Overall Study|Adverse Event|2|||
48815765|NCT02733042|157167444|FG014|Overall Study|Adverse Event|0|||
48815766|NCT02733042|157167445|FG015|Overall Study|Adverse Event|0|||
48815767|NCT02733042|157167446|FG016|Overall Study|Adverse Event|0|||
48815768|NCT02733042|157167447|FG017|Overall Study|Adverse Event|1|||
48815769|NCT02733042|157167448|FG018|Overall Study|Adverse Event|0|||
48815770|NCT02733042|157167430|FG000|Overall Study|Progressive Disease|2|||
48815771|NCT02733042|157167431|FG001|Overall Study|Progressive Disease|1|||
48720598|NCT00591578|156826717|FG001|Double-Blind Treatment Phase|Lost to Follow-up|12|||
48720599|NCT00591578|156826718|FG002|Double-Blind Treatment Phase|Lost to Follow-up|11|||
48720600|NCT00591578|156826716|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
49128811|NCT03805841|158310850|FG000|Overall Study|Lost to Follow-up|0|||
48720601|NCT00591578|156826717|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
48720602|NCT00591578|156826718|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
48720603|NCT00591578|156826716|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
48815772|NCT02733042|157167432|FG002|Overall Study|Progressive Disease|3|||
48815773|NCT02733042|157167433|FG003|Overall Study|Progressive Disease|1|||
48815774|NCT02733042|157167434|FG004|Overall Study|Progressive Disease|2|||
48720604|NCT00591578|156826717|FG001|Double-Blind Treatment Phase|Pregnancy|0|||
48815775|NCT02733042|157167435|FG005|Overall Study|Progressive Disease|3|||
48815776|NCT02733042|157167436|FG006|Overall Study|Progressive Disease|0|||
48720605|NCT00591578|156826718|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
48815777|NCT02733042|157167437|FG007|Overall Study|Progressive Disease|3|||
48815778|NCT02733042|157167438|FG008|Overall Study|Progressive Disease|3|||
49128812|NCT03805841|158310851|FG001|Overall Study|Lost to Follow-up|0|||
49128813|NCT03805841|158310852|FG002|Overall Study|Lost to Follow-up|1|||
49128814|NCT03805841|158310850|FG000|Overall Study|Withdrawal by Subject|2|||
49128815|NCT03805841|158310851|FG001|Overall Study|Withdrawal by Subject|3|||
49128816|NCT03805841|158310852|FG002|Overall Study|Withdrawal by Subject|0|||
49128817|NCT03805841|158310850|FG000|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
49128818|NCT03805841|158310851|FG001|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|4|||
49128819|NCT03805841|158310852|FG002|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
49128820|NCT00171249|158310860|FG000|Overall Study|Withdrawal by Subject|2|||
49128821|NCT00171249|158310861|FG001|Overall Study|Withdrawal by Subject|0|||
49128822|NCT00171249|158310862|FG002|Overall Study|Withdrawal by Subject|0|||
49128823|NCT00171249|158310863|FG003|Overall Study|Withdrawal by Subject|6|||
49128824|NCT00171249|158310864|FG004|Overall Study|Withdrawal by Subject|0|||
48720606|NCT00591578|156826716|FG000|Double-Blind Treatment Phase|Lack of Efficacy|16|||
48720607|NCT00591578|156826717|FG001|Double-Blind Treatment Phase|Lack of Efficacy|9|||
48720608|NCT00591578|156826718|FG002|Double-Blind Treatment Phase|Lack of Efficacy|25|||
48720609|NCT00591578|156826716|FG000|Double-Blind Treatment Phase|Other|4|||
48720610|NCT00591578|156826717|FG001|Double-Blind Treatment Phase|Other|9|||
48720611|NCT00591578|156826718|FG002|Double-Blind Treatment Phase|Other|4|||
48720612|NCT00591578|156826716|FG000|Open-Label Extension Phase|Adverse Event|3|||
48720613|NCT00591578|156826717|FG001|Open-Label Extension Phase|Adverse Event|5|||
48720614|NCT00591578|156826718|FG002|Open-Label Extension Phase|Adverse Event|0|||
48720615|NCT00591578|156826716|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
48720616|NCT00591578|156826717|FG001|Open-Label Extension Phase|Lost to Follow-up|4|||
48720617|NCT00591578|156826718|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
48720618|NCT00591578|156826716|FG000|Open-Label Extension Phase|Withdrawal by Subject|1|||
48720619|NCT00591578|156826717|FG001|Open-Label Extension Phase|Withdrawal by Subject|1|||
48720620|NCT00591578|156826718|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
48720621|NCT00591578|156826716|FG000|Open-Label Extension Phase|Other|1|||
48720622|NCT00591578|156826717|FG001|Open-Label Extension Phase|Other|0|||
48720623|NCT00591578|156826718|FG002|Open-Label Extension Phase|Other|0|||
48720624|NCT04738318|156826719|FG000|Overall Study|Protocol Violation|1|||
48720625|NCT04738318|156826720|FG001|Overall Study|Protocol Violation|0|||
48720626|NCT02119676|156826723|FG000|Overall Study|Adverse Event|9|||
49128825|NCT00171249|158310865|FG005|Overall Study|Withdrawal by Subject|0|||
49128826|NCT00171249|158310866|FG006|Overall Study|Withdrawal by Subject|0|||
49128827|NCT00171249|158310860|FG000|Overall Study|Unsatisfactory Therapeutic Effect|44|||
49128828|NCT00171249|158310861|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
49128829|NCT00171249|158310862|FG002|Overall Study|Unsatisfactory Therapeutic Effect|5|||
49128830|NCT00171249|158310863|FG003|Overall Study|Unsatisfactory Therapeutic Effect|70|||
49128831|NCT00171249|158310864|FG004|Overall Study|Unsatisfactory Therapeutic Effect|3|||
49128832|NCT00171249|158310865|FG005|Overall Study|Unsatisfactory Therapeutic Effect|31|||
49128833|NCT00171249|158310866|FG006|Overall Study|Unsatisfactory Therapeutic Effect|1|||
49128834|NCT00171249|158310860|FG000|Overall Study|Death|7|||
48720627|NCT02119676|156826724|FG001|Overall Study|Adverse Event|17|||
48720628|NCT02119676|156826725|FG002|Overall Study|Adverse Event|10|||
48720629|NCT02119676|156826726|FG003|Overall Study|Adverse Event|10|||
48720630|NCT02119676|156826723|FG000|Overall Study|Disease progression|53|||
48720631|NCT02119676|156826724|FG001|Overall Study|Disease progression|55|||
48720632|NCT02119676|156826725|FG002|Overall Study|Disease progression|68|||
48720633|NCT02119676|156826726|FG003|Overall Study|Disease progression|73|||
48720634|NCT02119676|156826723|FG000|Overall Study|Patient decision, inc. consent withdrawn|4|||
48720635|NCT02119676|156826724|FG001|Overall Study|Patient decision, inc. consent withdrawn|5|||
48720636|NCT02119676|156826725|FG002|Overall Study|Patient decision, inc. consent withdrawn|5|||
48720637|NCT02119676|156826726|FG003|Overall Study|Patient decision, inc. consent withdrawn|6|||
48720638|NCT02119676|156826723|FG000|Overall Study|Physician Decision|4|||
48720639|NCT02119676|156826724|FG001|Overall Study|Physician Decision|2|||
48720640|NCT02119676|156826725|FG002|Overall Study|Physician Decision|3|||
48720641|NCT02119676|156826726|FG003|Overall Study|Physician Decision|2|||
48720642|NCT02119676|156826723|FG000|Overall Study|Death|9|||
48720643|NCT02119676|156826724|FG001|Overall Study|Death|3|||
48720644|NCT02119676|156826725|FG002|Overall Study|Death|2|||
48720645|NCT02119676|156826726|FG003|Overall Study|Death|1|||
48720646|NCT02119676|156826723|FG000|Overall Study|Noncompliance|0|||
48720647|NCT02119676|156826724|FG001|Overall Study|Noncompliance|1|||
48720648|NCT02119676|156826725|FG002|Overall Study|Noncompliance|0|||
48720649|NCT02119676|156826726|FG003|Overall Study|Noncompliance|0|||
48720650|NCT02119676|156826723|FG000|Overall Study|Lost to Follow-up|0|||
48720651|NCT02119676|156826724|FG001|Overall Study|Lost to Follow-up|0|||
49128835|NCT00171249|158310861|FG001|Overall Study|Death|1|||
49128836|NCT00171249|158310862|FG002|Overall Study|Death|0|||
49128837|NCT00171249|158310863|FG003|Overall Study|Death|4|||
48720652|NCT02119676|156826725|FG002|Overall Study|Lost to Follow-up|1|||
48720653|NCT02119676|156826726|FG003|Overall Study|Lost to Follow-up|0|||
48720654|NCT02119676|156826723|FG000|Overall Study|Protocol deviation|0|||
48720655|NCT02119676|156826724|FG001|Overall Study|Protocol deviation|0|||
48720656|NCT02119676|156826725|FG002|Overall Study|Protocol deviation|1|||
48720657|NCT02119676|156826726|FG003|Overall Study|Protocol deviation|0|||
48720658|NCT02119676|156826723|FG000|Overall Study|Other, unspecified|2|||
48720659|NCT02119676|156826724|FG001|Overall Study|Other, unspecified|1|||
48720660|NCT02119676|156826725|FG002|Overall Study|Other, unspecified|3|||
48720661|NCT02119676|156826726|FG003|Overall Study|Other, unspecified|4|||
48720662|NCT02119676|156826723|FG000|Overall Study|Did not receive study med|2|||
48720663|NCT02119676|156826724|FG001|Overall Study|Did not receive study med|2|||
48720664|NCT02119676|156826725|FG002|Overall Study|Did not receive study med|4|||
48720665|NCT02119676|156826726|FG003|Overall Study|Did not receive study med|5|||
48720666|NCT01426789|156826729|FG000|Part 1|Protocol deviation|0|||
48720667|NCT01426789|156826730|FG001|Part 1|Protocol deviation|1|||
48720668|NCT01426789|156826731|FG002|Part 1|Protocol deviation|0|||
48720669|NCT01426789|156826732|FG003|Part 1|Protocol deviation|0|||
48720670|NCT01426789|156826733|FG004|Part 1|Protocol deviation|0|||
48815779|NCT02733042|157167439|FG009|Overall Study|Progressive Disease|2|||
48815780|NCT02733042|157167440|FG010|Overall Study|Progressive Disease|2|||
48815781|NCT02733042|157167441|FG011|Overall Study|Progressive Disease|2|||
48815782|NCT02733042|157167442|FG012|Overall Study|Progressive Disease|8|||
48815783|NCT02733042|157167443|FG013|Overall Study|Progressive Disease|1|||
48815784|NCT02733042|157167444|FG014|Overall Study|Progressive Disease|4|||
48815785|NCT02733042|157167445|FG015|Overall Study|Progressive Disease|7|||
48815786|NCT02733042|157167446|FG016|Overall Study|Progressive Disease|2|||
48815787|NCT02733042|157167447|FG017|Overall Study|Progressive Disease|3|||
48815788|NCT02733042|157167448|FG018|Overall Study|Progressive Disease|4|||
48815789|NCT02733042|157167430|FG000|Overall Study|Withdrawal by Subject|0|||
48815790|NCT02733042|157167431|FG001|Overall Study|Withdrawal by Subject|1|||
48815791|NCT02733042|157167432|FG002|Overall Study|Withdrawal by Subject|2|||
48815792|NCT02733042|157167433|FG003|Overall Study|Withdrawal by Subject|1|||
48815793|NCT02733042|157167434|FG004|Overall Study|Withdrawal by Subject|1|||
48815794|NCT02733042|157167435|FG005|Overall Study|Withdrawal by Subject|0|||
48815795|NCT02733042|157167436|FG006|Overall Study|Withdrawal by Subject|0|||
48815796|NCT02733042|157167437|FG007|Overall Study|Withdrawal by Subject|0|||
48815797|NCT02733042|157167438|FG008|Overall Study|Withdrawal by Subject|1|||
48815798|NCT02733042|157167439|FG009|Overall Study|Withdrawal by Subject|1|||
48815799|NCT02733042|157167440|FG010|Overall Study|Withdrawal by Subject|0|||
48815800|NCT02733042|157167441|FG011|Overall Study|Withdrawal by Subject|2|||
48815801|NCT02733042|157167442|FG012|Overall Study|Withdrawal by Subject|1|||
48815802|NCT02733042|157167443|FG013|Overall Study|Withdrawal by Subject|1|||
48815803|NCT02733042|157167444|FG014|Overall Study|Withdrawal by Subject|0|||
48815804|NCT02733042|157167445|FG015|Overall Study|Withdrawal by Subject|0|||
48815805|NCT02733042|157167446|FG016|Overall Study|Withdrawal by Subject|0|||
48815806|NCT02733042|157167447|FG017|Overall Study|Withdrawal by Subject|0|||
48815807|NCT02733042|157167448|FG018|Overall Study|Withdrawal by Subject|0|||
48815808|NCT02733042|157167430|FG000|Overall Study|Other Reasons|0|||
48815809|NCT02733042|157167431|FG001|Overall Study|Other Reasons|0|||
48815810|NCT02733042|157167432|FG002|Overall Study|Other Reasons|1|||
48815811|NCT02733042|157167433|FG003|Overall Study|Other Reasons|0|||
48815812|NCT02733042|157167434|FG004|Overall Study|Other Reasons|0|||
48815813|NCT02733042|157167435|FG005|Overall Study|Other Reasons|0|||
48815814|NCT02733042|157167436|FG006|Overall Study|Other Reasons|0|||
48815815|NCT02733042|157167437|FG007|Overall Study|Other Reasons|0|||
48815816|NCT02733042|157167438|FG008|Overall Study|Other Reasons|0|||
48815817|NCT02733042|157167439|FG009|Overall Study|Other Reasons|1|||
48815818|NCT02733042|157167440|FG010|Overall Study|Other Reasons|1|||
48815819|NCT02733042|157167441|FG011|Overall Study|Other Reasons|0|||
48815820|NCT02733042|157167442|FG012|Overall Study|Other Reasons|0|||
48815821|NCT02733042|157167443|FG013|Overall Study|Other Reasons|0|||
48815822|NCT02733042|157167444|FG014|Overall Study|Other Reasons|0|||
48815823|NCT02733042|157167445|FG015|Overall Study|Other Reasons|1|||
48815824|NCT02733042|157167446|FG016|Overall Study|Other Reasons|0|||
48815825|NCT02733042|157167447|FG017|Overall Study|Other Reasons|1|||
48815826|NCT02733042|157167448|FG018|Overall Study|Other Reasons|0|||
49128838|NCT00171249|158310864|FG004|Overall Study|Death|0|||
49128839|NCT00171249|158310865|FG005|Overall Study|Death|3|||
48720671|NCT01426789|156826734|FG005|Part 1|Protocol deviation|0|||
48720672|NCT01426789|156826729|FG000|Part 1|Lost to Follow-up|1|||
48815827|NCT02733042|157167430|FG000|Overall Study|Death|0|||
48720673|NCT01426789|156826730|FG001|Part 1|Lost to Follow-up|2|||
48720674|NCT01426789|156826731|FG002|Part 1|Lost to Follow-up|0|||
48720675|NCT01426789|156826732|FG003|Part 1|Lost to Follow-up|0|||
48720676|NCT01426789|156826733|FG004|Part 1|Lost to Follow-up|0|||
48720677|NCT01426789|156826734|FG005|Part 1|Lost to Follow-up|0|||
48920971|NCT01389752|157544803|FG001|Study Period 1|Sponsor decision|2|||
48815828|NCT02733042|157167431|FG001|Overall Study|Death|0|||
48815829|NCT02733042|157167432|FG002|Overall Study|Death|0|||
48815830|NCT02733042|157167433|FG003|Overall Study|Death|0|||
48815831|NCT02733042|157167434|FG004|Overall Study|Death|0|||
48815832|NCT02733042|157167435|FG005|Overall Study|Death|0|||
48815833|NCT02733042|157167436|FG006|Overall Study|Death|1|||
48720678|NCT01426789|156826729|FG000|Part 1|Lack of Efficacy|2|||
48720679|NCT01426789|156826730|FG001|Part 1|Lack of Efficacy|1|||
48720680|NCT01426789|156826731|FG002|Part 1|Lack of Efficacy|0|||
48720681|NCT01426789|156826732|FG003|Part 1|Lack of Efficacy|0|||
48720682|NCT01426789|156826733|FG004|Part 1|Lack of Efficacy|0|||
48720683|NCT01426789|156826734|FG005|Part 1|Lack of Efficacy|0|||
48720684|NCT01426789|156826729|FG000|Part 1|Adverse Event|3|||
48720685|NCT01426789|156826730|FG001|Part 1|Adverse Event|0|||
48720686|NCT01426789|156826731|FG002|Part 1|Adverse Event|0|||
48720687|NCT01426789|156826732|FG003|Part 1|Adverse Event|0|||
48720688|NCT01426789|156826733|FG004|Part 1|Adverse Event|0|||
48720689|NCT01426789|156826734|FG005|Part 1|Adverse Event|0|||
49128840|NCT00171249|158310866|FG006|Overall Study|Death|1|||
49128841|NCT00171249|158310860|FG000|Overall Study|Other|10|||
49128842|NCT00171249|158310861|FG001|Overall Study|Other|0|||
49128843|NCT00171249|158310862|FG002|Overall Study|Other|0|||
49128844|NCT00171249|158310863|FG003|Overall Study|Other|43|||
49128845|NCT00171249|158310864|FG004|Overall Study|Other|0|||
49128846|NCT00171249|158310865|FG005|Overall Study|Other|2|||
49128847|NCT00171249|158310866|FG006|Overall Study|Other|0|||
49128848|NCT00171249|158310860|FG000|Overall Study|No Longer Requires Study Drug|4|||
49128849|NCT00171249|158310861|FG001|Overall Study|No Longer Requires Study Drug|0|||
49128850|NCT00171249|158310862|FG002|Overall Study|No Longer Requires Study Drug|0|||
49128851|NCT00171249|158310863|FG003|Overall Study|No Longer Requires Study Drug|3|||
49128852|NCT00171249|158310864|FG004|Overall Study|No Longer Requires Study Drug|0|||
49128853|NCT00171249|158310865|FG005|Overall Study|No Longer Requires Study Drug|5|||
48815834|NCT02733042|157167437|FG007|Overall Study|Death|0|||
48815835|NCT02733042|157167438|FG008|Overall Study|Death|1|||
48815836|NCT02733042|157167439|FG009|Overall Study|Death|0|||
48815837|NCT02733042|157167440|FG010|Overall Study|Death|1|||
48815838|NCT02733042|157167441|FG011|Overall Study|Death|0|||
48815839|NCT02733042|157167442|FG012|Overall Study|Death|0|||
48815840|NCT02733042|157167443|FG013|Overall Study|Death|0|||
48815841|NCT02733042|157167444|FG014|Overall Study|Death|1|||
48815842|NCT02733042|157167445|FG015|Overall Study|Death|2|||
48815843|NCT02733042|157167446|FG016|Overall Study|Death|0|||
48815844|NCT02733042|157167447|FG017|Overall Study|Death|0|||
48815845|NCT02733042|157167448|FG018|Overall Study|Death|0|||
49128854|NCT00171249|158310866|FG006|Overall Study|No Longer Requires Study Drug|0|||
49128855|NCT00171249|158310860|FG000|Overall Study|Administrative Problems|1|||
48815846|NCT03688711|157167451|FG000|Overall Study|Withdrawal by Subject|0|||
48815847|NCT03688711|157167452|FG001|Overall Study|Withdrawal by Subject|1|||
48815848|NCT00873093|157167453|FG000|Overall Study|Adverse Event|0|||
48815849|NCT00873093|157167454|FG001|Overall Study|Adverse Event|2|||
48815850|NCT00873093|157167455|FG002|Overall Study|Adverse Event|0|||
48815851|NCT00873093|157167456|FG003|Overall Study|Adverse Event|0|||
48815852|NCT00873093|157167457|FG004|Overall Study|Adverse Event|0|||
48815853|NCT00873093|157167453|FG000|Overall Study|Death|0|||
48815854|NCT00873093|157167454|FG001|Overall Study|Death|3|||
48815855|NCT00873093|157167455|FG002|Overall Study|Death|2|||
48815856|NCT00873093|157167456|FG003|Overall Study|Death|0|||
48815857|NCT00873093|157167457|FG004|Overall Study|Death|0|||
48815858|NCT00873093|157167453|FG000|Overall Study|Physician Decision|0|||
48815859|NCT00873093|157167454|FG001|Overall Study|Physician Decision|17|||
48815860|NCT00873093|157167455|FG002|Overall Study|Physician Decision|10|||
48815861|NCT00873093|157167456|FG003|Overall Study|Physician Decision|10|||
48815862|NCT00873093|157167457|FG004|Overall Study|Physician Decision|2|||
49128856|NCT00171249|158310861|FG001|Overall Study|Administrative Problems|0|||
48720690|NCT01426789|156826729|FG000|Part 2|Protocol deviation|0|||
48720691|NCT01426789|156826730|FG001|Part 2|Protocol deviation|0|||
48720692|NCT01426789|156826731|FG002|Part 2|Protocol deviation|1|||
48720693|NCT01426789|156826732|FG003|Part 2|Protocol deviation|0|||
48815863|NCT00873093|157167453|FG000|Overall Study|Withdrawal by Subject|1|||
48815864|NCT00873093|157167454|FG001|Overall Study|Withdrawal by Subject|4|||
48815865|NCT00873093|157167455|FG002|Overall Study|Withdrawal by Subject|4|||
48815866|NCT00873093|157167456|FG003|Overall Study|Withdrawal by Subject|0|||
48920972|NCT01389752|157544802|FG000|Study Period 2|Sponsor decision|1|||
49128857|NCT00171249|158310862|FG002|Overall Study|Administrative Problems|0|||
49128858|NCT00171249|158310863|FG003|Overall Study|Administrative Problems|2|||
49128859|NCT00171249|158310864|FG004|Overall Study|Administrative Problems|0|||
49128860|NCT00171249|158310865|FG005|Overall Study|Administrative Problems|0|||
48720694|NCT01426789|156826733|FG004|Part 2|Protocol deviation|0|||
48720695|NCT01426789|156826734|FG005|Part 2|Protocol deviation|0|||
48720696|NCT01426789|156826729|FG000|Part 2|Death|0|||
48815867|NCT00873093|157167457|FG004|Overall Study|Withdrawal by Subject|0|||
48815868|NCT00873093|157167453|FG000|Overall Study|Ineligible|0|||
48815869|NCT00873093|157167454|FG001|Overall Study|Ineligible|1|||
48815870|NCT00873093|157167455|FG002|Overall Study|Ineligible|0|||
48815871|NCT00873093|157167456|FG003|Overall Study|Ineligible|1|||
48815872|NCT00873093|157167457|FG004|Overall Study|Ineligible|0|||
48815873|NCT01556763|157167465|FG000|Overall Study|Withdrawal by Subject|0|||
48815874|NCT01556763|157167466|FG001|Overall Study|Withdrawal by Subject|1|||
49128861|NCT00171249|158310866|FG006|Overall Study|Administrative Problems|0|||
48815875|NCT01556763|157167467|FG002|Overall Study|Withdrawal by Subject|0|||
48815876|NCT02243631|157168508|FG000|Overall Study|no synovial fluid on second aspirate|0|||
48815877|NCT02243631|157168509|FG001|Overall Study|no synovial fluid on second aspirate|1|||
48815878|NCT02105636|157168514|FG000|Pre-Treatment|Disease Progression|1|||
48815879|NCT02105636|157168515|FG001|Pre-Treatment|Disease Progression|0|||
48815880|NCT02105636|157168514|FG000|Pre-Treatment|Participant request to discontinue study treatment|1|||
48815881|NCT02105636|157168515|FG001|Pre-Treatment|Participant request to discontinue study treatment|2|||
48815882|NCT02105636|157168514|FG000|Pre-Treatment|Participant withdrew consent|0|||
48815883|NCT02105636|157168515|FG001|Pre-Treatment|Participant withdrew consent|6|||
48815884|NCT02105636|157168514|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
48815885|NCT02105636|157168515|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
48815886|NCT02105636|157168514|FG000|Treatment|Study Drug Toxicity|14|||
48815887|NCT02105636|157168515|FG001|Treatment|Study Drug Toxicity|10|||
48815888|NCT02105636|157168514|FG000|Treatment|Adverse event unrelated to study drug|19|||
48815889|NCT02105636|157168515|FG001|Treatment|Adverse event unrelated to study drug|3|||
48815890|NCT02105636|157168514|FG000|Treatment|Participant request to discontinue study treatment|8|||
48815891|NCT02105636|157168515|FG001|Treatment|Participant request to discontinue study treatment|6|||
48815892|NCT02105636|157168514|FG000|Treatment|Participant withdrew consent|5|||
48815893|NCT02105636|157168515|FG001|Treatment|Participant withdrew consent|1|||
48815894|NCT02105636|157168514|FG000|Treatment|Lost to Follow-up|1|||
48815895|NCT02105636|157168515|FG001|Treatment|Lost to Follow-up|0|||
48815896|NCT02105636|157168514|FG000|Treatment|Maximum Clinical Benefit|1|||
48815897|NCT02105636|157168515|FG001|Treatment|Maximum Clinical Benefit|3|||
48815898|NCT02105636|157168514|FG000|Treatment|Poor/Non-compliance|0|||
48815899|NCT02105636|157168515|FG001|Treatment|Poor/Non-compliance|1|||
48815900|NCT02105636|157168514|FG000|Treatment|Participant no longer meets study criteria|1|||
48815901|NCT02105636|157168515|FG001|Treatment|Participant no longer meets study criteria|0|||
48815902|NCT02105636|157168514|FG000|Treatment|Other reasons|1|||
48815903|NCT02105636|157168515|FG001|Treatment|Other reasons|0|||
48815904|NCT02105636|157168514|FG000|Treatment|Disease Progression|185|||
48815905|NCT02105636|157168515|FG001|Treatment|Disease Progression|87|||
48815906|NCT03722264|157168517|FG000|Overall Study|Physician Decision|3|||
48815907|NCT01995357|157168518|FG000|Period 5|Lack of Efficacy|1|||
48815908|NCT01995357|157168519|FG001|Period 5|Lack of Efficacy|0|||
48815909|NCT01995357|157168520|FG002|Period 5|Lack of Efficacy|0|||
48815910|NCT01995357|157168521|FG003|Period 5|Lack of Efficacy|0|||
48815911|NCT01995357|157168522|FG004|Period 5|Lack of Efficacy|0|||
48815912|NCT01995357|157168523|FG005|Period 5|Lack of Efficacy|0|||
48815913|NCT01995357|157168518|FG000|Period 5|Adverse Event|1|||
48815914|NCT01995357|157168519|FG001|Period 5|Adverse Event|0|||
48815915|NCT01995357|157168520|FG002|Period 5|Adverse Event|1|||
48815916|NCT01995357|157168521|FG003|Period 5|Adverse Event|0|||
48815917|NCT01995357|157168522|FG004|Period 5|Adverse Event|0|||
48815918|NCT01995357|157168523|FG005|Period 5|Adverse Event|0|||
48815919|NCT01807221|157168524|FG000|Overall Study|Progressive disease|1|||
48815920|NCT01807221|157168525|FG001|Overall Study|Progressive disease|0|||
48815921|NCT01807221|157168526|FG002|Overall Study|Progressive disease|1|||
48815922|NCT01807221|157168527|FG003|Overall Study|Progressive disease|0|||
48815923|NCT01807221|157168528|FG004|Overall Study|Progressive disease|0|||
48815924|NCT01807221|157168529|FG005|Overall Study|Progressive disease|0|||
48815925|NCT01807221|157168524|FG000|Overall Study|Death|7|||
48815926|NCT01807221|157168525|FG001|Overall Study|Death|9|||
48815927|NCT01807221|157168526|FG002|Overall Study|Death|4|||
48815928|NCT01807221|157168527|FG003|Overall Study|Death|2|||
48815929|NCT01807221|157168528|FG004|Overall Study|Death|1|||
48815930|NCT01807221|157168529|FG005|Overall Study|Death|6|||
48815931|NCT01807221|157168524|FG000|Overall Study|Physician Decision|2|||
48815932|NCT01807221|157168525|FG001|Overall Study|Physician Decision|1|||
48815933|NCT01807221|157168526|FG002|Overall Study|Physician Decision|0|||
48815934|NCT01807221|157168527|FG003|Overall Study|Physician Decision|0|||
48815935|NCT01807221|157168528|FG004|Overall Study|Physician Decision|0|||
48815936|NCT01807221|157168529|FG005|Overall Study|Physician Decision|0|||
48815937|NCT01807221|157168524|FG000|Overall Study|Adverse Event|33|||
48815938|NCT01807221|157168525|FG001|Overall Study|Adverse Event|22|||
48815939|NCT01807221|157168526|FG002|Overall Study|Adverse Event|26|||
48815940|NCT01807221|157168527|FG003|Overall Study|Adverse Event|25|||
48920973|NCT01389752|157544803|FG001|Study Period 2|Sponsor decision|0|||
48920974|NCT01318109|157544804|FG000|Overall Study|Adverse Event|0|||
48815941|NCT01807221|157168528|FG004|Overall Study|Adverse Event|18|||
48815942|NCT01807221|157168529|FG005|Overall Study|Adverse Event|21|||
48815943|NCT01807221|157168524|FG000|Overall Study|Protocol Violation|0|||
48815944|NCT01807221|157168525|FG001|Overall Study|Protocol Violation|2|||
48815945|NCT01807221|157168526|FG002|Overall Study|Protocol Violation|1|||
48815946|NCT01807221|157168527|FG003|Overall Study|Protocol Violation|2|||
48815947|NCT01807221|157168528|FG004|Overall Study|Protocol Violation|0|||
48815948|NCT01807221|157168529|FG005|Overall Study|Protocol Violation|1|||
48815949|NCT01807221|157168524|FG000|Overall Study|Non-compliance|1|||
48815950|NCT01807221|157168525|FG001|Overall Study|Non-compliance|2|||
48815951|NCT01807221|157168526|FG002|Overall Study|Non-compliance|0|||
48815952|NCT01807221|157168527|FG003|Overall Study|Non-compliance|1|||
48815953|NCT01807221|157168528|FG004|Overall Study|Non-compliance|0|||
48815954|NCT01807221|157168529|FG005|Overall Study|Non-compliance|0|||
49128862|NCT00171249|158310860|FG000|Overall Study|Adverse Event|3|||
49128863|NCT00171249|158310861|FG001|Overall Study|Adverse Event|1|||
49128864|NCT00171249|158310862|FG002|Overall Study|Adverse Event|0|||
48815955|NCT01807221|157168524|FG000|Overall Study|Logistical difficulties|0|||
48815956|NCT01807221|157168525|FG001|Overall Study|Logistical difficulties|1|||
48815957|NCT01807221|157168526|FG002|Overall Study|Logistical difficulties|0|||
48815958|NCT01807221|157168527|FG003|Overall Study|Logistical difficulties|0|||
48815959|NCT01807221|157168528|FG004|Overall Study|Logistical difficulties|1|||
48815960|NCT01807221|157168529|FG005|Overall Study|Logistical difficulties|0|||
48815961|NCT01807221|157168524|FG000|Overall Study|Withdrawal by Subject|33|||
48815962|NCT01807221|157168525|FG001|Overall Study|Withdrawal by Subject|15|||
48815963|NCT01807221|157168526|FG002|Overall Study|Withdrawal by Subject|8|||
48815964|NCT01807221|157168527|FG003|Overall Study|Withdrawal by Subject|14|||
48815965|NCT01807221|157168528|FG004|Overall Study|Withdrawal by Subject|16|||
48815966|NCT01807221|157168529|FG005|Overall Study|Withdrawal by Subject|13|||
48815967|NCT01807221|157168524|FG000|Overall Study|Sponsor decision|2|||
48815968|NCT01807221|157168525|FG001|Overall Study|Sponsor decision|0|||
48815969|NCT01807221|157168526|FG002|Overall Study|Sponsor decision|1|||
48815970|NCT01807221|157168527|FG003|Overall Study|Sponsor decision|1|||
48815971|NCT01807221|157168528|FG004|Overall Study|Sponsor decision|0|||
48815972|NCT01807221|157168529|FG005|Overall Study|Sponsor decision|0|||
48815973|NCT01807221|157168524|FG000|Overall Study|Lost to Follow-up|1|||
49128865|NCT00171249|158310863|FG003|Overall Study|Adverse Event|15|||
49128866|NCT00171249|158310864|FG004|Overall Study|Adverse Event|0|||
49128867|NCT00171249|158310865|FG005|Overall Study|Adverse Event|2|||
49128868|NCT00171249|158310866|FG006|Overall Study|Adverse Event|0|||
48815974|NCT01807221|157168525|FG001|Overall Study|Lost to Follow-up|0|||
48815975|NCT01807221|157168526|FG002|Overall Study|Lost to Follow-up|2|||
49128869|NCT00171249|158310860|FG000|Overall Study|Lost to Follow-up|5|||
49128870|NCT00171249|158310861|FG001|Overall Study|Lost to Follow-up|0|||
49128871|NCT00171249|158310862|FG002|Overall Study|Lost to Follow-up|0|||
49128872|NCT00171249|158310863|FG003|Overall Study|Lost to Follow-up|9|||
49128873|NCT00171249|158310864|FG004|Overall Study|Lost to Follow-up|0|||
49128874|NCT00171249|158310865|FG005|Overall Study|Lost to Follow-up|0|||
49128875|NCT00171249|158310866|FG006|Overall Study|Lost to Follow-up|0|||
49128876|NCT01776554|158310867|FG000|Overall Study|Adverse Event|1|||
49128877|NCT01776554|158310868|FG001|Overall Study|Adverse Event|0|||
49128878|NCT01776554|158310867|FG000|Overall Study|Withdrawal by Subject|3|||
49128879|NCT01776554|158310868|FG001|Overall Study|Withdrawal by Subject|8|||
49128880|NCT01776554|158310867|FG000|Overall Study|Lost to Follow-up|6|||
49128881|NCT01776554|158310868|FG001|Overall Study|Lost to Follow-up|9|||
49128882|NCT01776554|158310867|FG000|Overall Study|Administrative Reason|2|||
49128883|NCT01776554|158310868|FG001|Overall Study|Administrative Reason|5|||
49128884|NCT01776554|158310867|FG000|Overall Study|Protocol Violation|1|||
49128885|NCT01776554|158310868|FG001|Overall Study|Protocol Violation|0|||
49128886|NCT01776554|158310867|FG000|Overall Study|Unclassified|4|||
49128887|NCT01776554|158310868|FG001|Overall Study|Unclassified|1|||
49128888|NCT02668640|158310877|FG000|Overall Study|Lost to Follow-up|13|||
49128889|NCT02668640|158310877|FG000|Overall Study|Other, not specified|1|||
49128890|NCT02792504|158310878|FG000|Overall Study|Lost to Follow-up|24|||
49128891|NCT02792504|158310878|FG000|Overall Study|Violated inclusion/exclusion criteria|6|||
49128892|NCT02008526|158310879|FG000|Overall Study|Death|0|||
49128893|NCT02008526|158310880|FG001|Overall Study|Death|2|||
49128894|NCT02008526|158310881|FG002|Overall Study|Death|1|||
49128895|NCT02008526|158310879|FG000|Overall Study|Withdrawal by Subject|3|||
49128896|NCT02008526|158310880|FG001|Overall Study|Withdrawal by Subject|3|||
49128897|NCT02008526|158310881|FG002|Overall Study|Withdrawal by Subject|2|||
49128898|NCT02008526|158310879|FG000|Overall Study|Lost to Follow-up|5|||
49128899|NCT02008526|158310880|FG001|Overall Study|Lost to Follow-up|9|||
49128900|NCT02008526|158310881|FG002|Overall Study|Lost to Follow-up|6|||
49128901|NCT01811238|158310882|FG000|Overall Study|Withdrawal by Subject|42|||
49128902|NCT01811238|158310882|FG000|Overall Study|Adverse Event|25|||
49128903|NCT01811238|158310882|FG000|Overall Study|Protocol Violation|4|||
49128904|NCT01811238|158310882|FG000|Overall Study|Lack of Efficacy|4|||
49128905|NCT01811238|158310882|FG000|Overall Study|subject refused study medication|6|||
49128906|NCT00848497|158310883|FG000|Overall Study|Screen failure|2|||
49128907|NCT00848497|158310884|FG001|Overall Study|Screen failure|0|||
49128908|NCT00848497|158310883|FG000|Overall Study|Withdrawal by Subject|0|||
49128909|NCT00848497|158310884|FG001|Overall Study|Withdrawal by Subject|1|||
49128910|NCT00141817|158310886|FG000|Overall Study|Protocol Violation|0|||
49128911|NCT00141817|158310887|FG001|Overall Study|Protocol Violation|0|||
49128912|NCT00141817|158310888|FG002|Overall Study|Protocol Violation|1|||
49128913|NCT00141817|158310889|FG003|Overall Study|Protocol Violation|0|||
49128914|NCT00141817|158310886|FG000|Overall Study|Parent request|1|||
49128915|NCT00141817|158310887|FG001|Overall Study|Parent request|0|||
49128916|NCT00141817|158310888|FG002|Overall Study|Parent request|0|||
48720697|NCT01426789|156826730|FG001|Part 2|Death|0|||
48720698|NCT01426789|156826731|FG002|Part 2|Death|1|||
48720699|NCT01426789|156826732|FG003|Part 2|Death|0|||
48720700|NCT01426789|156826733|FG004|Part 2|Death|1|||
48720701|NCT01426789|156826734|FG005|Part 2|Death|0|||
48720702|NCT01426789|156826729|FG000|Part 2|Administrative problems|0|||
48720703|NCT01426789|156826730|FG001|Part 2|Administrative problems|0|||
48720704|NCT01426789|156826731|FG002|Part 2|Administrative problems|2|||
48720705|NCT01426789|156826732|FG003|Part 2|Administrative problems|0|||
48720706|NCT01426789|156826733|FG004|Part 2|Administrative problems|1|||
48720707|NCT01426789|156826734|FG005|Part 2|Administrative problems|0|||
48720708|NCT01426789|156826729|FG000|Part 2|Lost to Follow-up|0|||
48720709|NCT01426789|156826730|FG001|Part 2|Lost to Follow-up|0|||
48720710|NCT01426789|156826731|FG002|Part 2|Lost to Follow-up|4|||
48720711|NCT01426789|156826732|FG003|Part 2|Lost to Follow-up|0|||
48720712|NCT01426789|156826733|FG004|Part 2|Lost to Follow-up|1|||
48720713|NCT01426789|156826734|FG005|Part 2|Lost to Follow-up|0|||
48720714|NCT01426789|156826729|FG000|Part 2|Withdrawal by Subject|0|||
48720715|NCT01426789|156826730|FG001|Part 2|Withdrawal by Subject|0|||
48720716|NCT01426789|156826731|FG002|Part 2|Withdrawal by Subject|0|||
48720717|NCT01426789|156826732|FG003|Part 2|Withdrawal by Subject|1|||
48720718|NCT01426789|156826733|FG004|Part 2|Withdrawal by Subject|2|||
48720719|NCT01426789|156826734|FG005|Part 2|Withdrawal by Subject|0|||
48720720|NCT01426789|156826729|FG000|Part 2|Lack of Efficacy|0|||
48720721|NCT01426789|156826730|FG001|Part 2|Lack of Efficacy|0|||
48720722|NCT01426789|156826731|FG002|Part 2|Lack of Efficacy|5|||
48720723|NCT01426789|156826732|FG003|Part 2|Lack of Efficacy|0|||
48720724|NCT01426789|156826733|FG004|Part 2|Lack of Efficacy|2|||
48720725|NCT01426789|156826734|FG005|Part 2|Lack of Efficacy|0|||
48720726|NCT01426789|156826729|FG000|Part 2|Adverse Event|0|||
48720727|NCT01426789|156826730|FG001|Part 2|Adverse Event|0|||
48720728|NCT01426789|156826731|FG002|Part 2|Adverse Event|2|||
48720729|NCT01426789|156826732|FG003|Part 2|Adverse Event|0|||
48720730|NCT01426789|156826733|FG004|Part 2|Adverse Event|1|||
48720731|NCT01426789|156826734|FG005|Part 2|Adverse Event|0|||
48720732|NCT00362180|156828362|FG000|Treated Period|Withdrawal by Subject|1|||
48720733|NCT00362180|156828363|FG001|Treated Period|Withdrawal by Subject|0|||
48720734|NCT00362180|156828364|FG002|Treated Period|Withdrawal by Subject|0|||
48720735|NCT00362180|156828365|FG003|Treated Period|Withdrawal by Subject|0|||
48720736|NCT00362180|156828366|FG004|Treated Period|Withdrawal by Subject|0|||
48720737|NCT00362180|156828367|FG005|Treated Period|Withdrawal by Subject|0|||
48720738|NCT00362180|156828368|FG006|Treated Period|Withdrawal by Subject|0|||
48720739|NCT00362180|156828369|FG007|Treated Period|Withdrawal by Subject|0|||
48720740|NCT00362180|156828370|FG008|Treated Period|Withdrawal by Subject|0|||
48720741|NCT00362180|156828362|FG000|Treated Period|Adverse Event|0|||
48720742|NCT00362180|156828363|FG001|Treated Period|Adverse Event|0|||
48720743|NCT00362180|156828364|FG002|Treated Period|Adverse Event|0|||
48720744|NCT00362180|156828365|FG003|Treated Period|Adverse Event|0|||
48720745|NCT00362180|156828366|FG004|Treated Period|Adverse Event|0|||
48720746|NCT00362180|156828367|FG005|Treated Period|Adverse Event|1|||
48720747|NCT00362180|156828368|FG006|Treated Period|Adverse Event|0|||
48720748|NCT00362180|156828369|FG007|Treated Period|Adverse Event|1|||
48720749|NCT00362180|156828370|FG008|Treated Period|Adverse Event|0|||
48720756|NCT00745849|156828377|FG000|First Intervention|Withdrawal by Subject|0|||
48720757|NCT00745849|156828378|FG001|First Intervention|Withdrawal by Subject|1|||
48720758|NCT00745849|156828377|FG000|First Intervention|Lost to Follow-up|1|||
48720759|NCT00745849|156828378|FG001|First Intervention|Lost to Follow-up|1|||
48720760|NCT00745849|156828377|FG000|Second Intervention|Lost to Follow-up|2|||
48720761|NCT00745849|156828378|FG001|Second Intervention|Lost to Follow-up|1|||
48720762|NCT02656680|156828379|FG000|Overall Study|Lost to Follow-up|0|||
48720763|NCT02656680|156828380|FG001|Overall Study|Lost to Follow-up|1|||
48720764|NCT02656680|156828381|FG002|Overall Study|Lost to Follow-up|7|||
48720765|NCT01143389|156828382|FG000|Overall Study|Lost to Follow-up|26|||
48720766|NCT01143389|156828383|FG001|Overall Study|Lost to Follow-up|25|||
48720767|NCT04839562|156828384|FG000|Overall Study|Withdrawal by Subject|0|||
48720768|NCT04839562|156828385|FG001|Overall Study|Withdrawal by Subject|1|||
48720769|NCT04839562|156828384|FG000|Overall Study|Physician Decision|0|||
48720770|NCT04839562|156828385|FG001|Overall Study|Physician Decision|1|||
48720771|NCT03338959|156828386|FG000|Overall Study|Patients remain in Long-Term Follow-Up|17|||
48720772|NCT03338959|156828386|FG000|Overall Study|Physician Decision|1|||
48720773|NCT01904773|156828387|FG000|Screen|Screen failure|3|||
48720774|NCT01904773|156828388|FG001|Screen|Screen failure|0|||
48720775|NCT01904773|156828389|FG002|Screen|Screen failure|0|||
48720776|NCT01904773|156828390|FG003|Screen|Screen failure|0|||
48720777|NCT01904773|156828391|FG004|Screen|Screen failure|0|||
48720778|NCT01904773|156828392|FG005|Screen|Screen failure|0|||
49128917|NCT00141817|158310889|FG003|Overall Study|Parent request|0|||
49128918|NCT01981616|158310890|FG000|Overall Study|Adverse Event|0|||
49128919|NCT01981616|158310891|FG001|Overall Study|Adverse Event|1|||
49128920|NCT01981616|158310890|FG000|Overall Study|Protocol Violation|1|||
49128921|NCT01981616|158310891|FG001|Overall Study|Protocol Violation|0|||
49128922|NCT03642990|158310894|FG000|300 mg/Day for One Week|Withdrawal by Subject|1|||
49128923|NCT03642990|158310894|FG000|1000 mg/Day for Weeks 2-12|Physician Decision|4|||
49128924|NCT00094445|158310895|FG000|Overall Study|Withdrawal by Subject|3|||
49128925|NCT00094445|158310895|FG000|Overall Study|Lost to Follow-up|1|||
49128926|NCT00094445|158310895|FG000|Overall Study|Progressive Disease|2|||
49128927|NCT03087058|158310896|FG000|Overall Study|Withdrawal by Subject|2|||
49128928|NCT03087058|158310897|FG001|Overall Study|Withdrawal by Subject|0|||
49128929|NCT03087058|158310898|FG002|Overall Study|Withdrawal by Subject|0|||
49128930|NCT00855218|158310901|FG000|Overall Study|Adverse Event|43|||
49128931|NCT00855218|158310902|FG001|Overall Study|Adverse Event|27|||
49128932|NCT00855218|158310901|FG000|Overall Study|Withdrawal by Subject|10|||
49128933|NCT00855218|158310902|FG001|Overall Study|Withdrawal by Subject|6|||
49128934|NCT00855218|158310901|FG000|Overall Study|Physician Decision|18|||
49128935|NCT00855218|158310902|FG001|Overall Study|Physician Decision|11|||
49128936|NCT00855218|158310901|FG000|Overall Study|Lost to Follow-up|0|||
49128937|NCT00855218|158310902|FG001|Overall Study|Lost to Follow-up|1|||
49128938|NCT00855218|158310901|FG000|Overall Study|Protocol Violation|5|||
49128939|NCT00855218|158310902|FG001|Overall Study|Protocol Violation|9|||
49128940|NCT00855218|158310901|FG000|Overall Study|non-compliant with study drug|3|||
48720779|NCT01904773|156828393|FG006|Screen|Screen failure|0|||
48720780|NCT01904773|156828394|FG007|Screen|Screen failure|0|||
48720781|NCT01904773|156828395|FG008|Screen|Screen failure|0|||
48720782|NCT01904773|156828387|FG000|Screen|Withdrawal by Subject|1|||
48720783|NCT01904773|156828388|FG001|Screen|Withdrawal by Subject|0|||
48720784|NCT01904773|156828389|FG002|Screen|Withdrawal by Subject|0|||
48720785|NCT01904773|156828390|FG003|Screen|Withdrawal by Subject|0|||
48720786|NCT01904773|156828391|FG004|Screen|Withdrawal by Subject|0|||
48720787|NCT01904773|156828392|FG005|Screen|Withdrawal by Subject|0|||
48720788|NCT01904773|156828393|FG006|Screen|Withdrawal by Subject|0|||
48720789|NCT01904773|156828394|FG007|Screen|Withdrawal by Subject|0|||
48720790|NCT01904773|156828395|FG008|Screen|Withdrawal by Subject|0|||
48720791|NCT01904773|156828387|FG000|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1|||
48720792|NCT01904773|156828388|FG001|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
48720793|NCT01904773|156828389|FG002|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
48720794|NCT01904773|156828390|FG003|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
48720795|NCT01904773|156828391|FG004|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
48720796|NCT01904773|156828392|FG005|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
48720797|NCT01904773|156828393|FG006|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
48720798|NCT01904773|156828394|FG007|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
48720799|NCT01904773|156828395|FG008|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
48720800|NCT01904773|156828387|FG000|First Intervention|Adverse Event|0|||
48720801|NCT01904773|156828388|FG001|First Intervention|Adverse Event|0|||
48720802|NCT01904773|156828389|FG002|First Intervention|Adverse Event|0|||
48720803|NCT01904773|156828390|FG003|First Intervention|Adverse Event|0|||
48720804|NCT01904773|156828391|FG004|First Intervention|Adverse Event|0|||
48720805|NCT01904773|156828392|FG005|First Intervention|Adverse Event|0|||
48720806|NCT01904773|156828393|FG006|First Intervention|Adverse Event|1|||
48720807|NCT01904773|156828394|FG007|First Intervention|Adverse Event|0|||
48720808|NCT01904773|156828395|FG008|First Intervention|Adverse Event|0|||
48720809|NCT01904773|156828387|FG000|Placebo Washout First Intervention|Condition worsened|0|||
48720810|NCT01904773|156828388|FG001|Placebo Washout First Intervention|Condition worsened|1|||
48720811|NCT01904773|156828389|FG002|Placebo Washout First Intervention|Condition worsened|0|||
48720812|NCT01904773|156828390|FG003|Placebo Washout First Intervention|Condition worsened|0|||
48720813|NCT01904773|156828391|FG004|Placebo Washout First Intervention|Condition worsened|0|||
48720814|NCT01904773|156828392|FG005|Placebo Washout First Intervention|Condition worsened|0|||
48720815|NCT01904773|156828393|FG006|Placebo Washout First Intervention|Condition worsened|0|||
48720816|NCT01904773|156828394|FG007|Placebo Washout First Intervention|Condition worsened|0|||
48720817|NCT01904773|156828395|FG008|Placebo Washout First Intervention|Condition worsened|0|||
48720818|NCT01904773|156828387|FG000|Fifth Intervention|Adverse Event|0|||
48720819|NCT01904773|156828388|FG001|Fifth Intervention|Adverse Event|0|||
48720820|NCT01904773|156828389|FG002|Fifth Intervention|Adverse Event|0|||
48720821|NCT01904773|156828390|FG003|Fifth Intervention|Adverse Event|0|||
48720822|NCT01904773|156828391|FG004|Fifth Intervention|Adverse Event|0|||
48720823|NCT01904773|156828392|FG005|Fifth Intervention|Adverse Event|0|||
48720824|NCT01904773|156828393|FG006|Fifth Intervention|Adverse Event|0|||
48720825|NCT01904773|156828394|FG007|Fifth Intervention|Adverse Event|1|||
48720826|NCT01904773|156828395|FG008|Fifth Intervention|Adverse Event|0|||
49128941|NCT00855218|158310902|FG001|Overall Study|non-compliant with study drug|1|||
49128942|NCT00855218|158310901|FG000|Overall Study|patient convenience|2|||
48720827|NCT01904773|156828387|FG000|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
48720828|NCT01904773|156828388|FG001|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1|||
48720829|NCT01904773|156828389|FG002|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
48720830|NCT01904773|156828390|FG003|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
48720831|NCT01904773|156828391|FG004|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
48720832|NCT01904773|156828392|FG005|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
48720833|NCT01904773|156828393|FG006|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
48720834|NCT01904773|156828394|FG007|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
48720835|NCT01904773|156828395|FG008|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
48720836|NCT02276027|156828404|FG000|Overall Study|Death|1|||
48815976|NCT01807221|157168527|FG003|Overall Study|Lost to Follow-up|1|||
48815977|NCT01807221|157168528|FG004|Overall Study|Lost to Follow-up|0|||
48815978|NCT01807221|157168529|FG005|Overall Study|Lost to Follow-up|0|||
48720837|NCT02276027|156828405|FG001|Overall Study|Death|0|||
48720838|NCT02276027|156828406|FG002|Overall Study|Death|0|||
48720839|NCT02276027|156828407|FG003|Overall Study|Death|2|||
48815979|NCT03545113|157168530|FG000|Overall Study|Surgery Cancelled|1|||
48815980|NCT03545113|157168531|FG001|Overall Study|Surgery Cancelled|0|||
48815981|NCT03545113|157168530|FG000|Overall Study|Death|1|||
48815982|NCT03545113|157168531|FG001|Overall Study|Death|0|||
48815983|NCT03545113|157168530|FG000|Overall Study|Adverse Event|2|||
48815984|NCT03545113|157168531|FG001|Overall Study|Adverse Event|0|||
48815985|NCT03545113|157168530|FG000|Overall Study|Received different surgery|1|||
48815986|NCT03545113|157168531|FG001|Overall Study|Received different surgery|0|||
48815987|NCT00502996|157168544|FG000|Overall Study|Lost to Follow-up|9|||
48815988|NCT00502996|157168544|FG000|Overall Study|Protocol Violation|2|||
48815989|NCT00502996|157168544|FG000|Overall Study|Treatment failure|25|||
48815990|NCT00502996|157168544|FG000|Overall Study|Withdrawal Informed Consent|6|||
48815991|NCT00502996|157168544|FG000|Overall Study|Adverse Event|2|||
48815992|NCT00439179|157168545|FG000|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
48815993|NCT00439179|157168546|FG001|Overall Study|* 1 pt inelig, 1 pt numb not used|2|||
48815994|NCT00439179|157168547|FG002|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
48815995|NCT00439179|157168548|FG003|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
48815996|NCT00170573|157168555|FG000|Overall Study|Violation of inclusion criteria|13|||
48815997|NCT01375114|157168560|FG000|Overall Study|Lost to Follow-up|1|||
48815998|NCT01375114|157168561|FG001|Overall Study|Lost to Follow-up|0|||
48815999|NCT01375114|157168562|FG002|Overall Study|Lost to Follow-up|1|||
48816000|NCT01375114|157168560|FG000|Overall Study|Disease Progression|3|||
48816001|NCT01375114|157168561|FG001|Overall Study|Disease Progression|2|||
48816002|NCT01375114|157168562|FG002|Overall Study|Disease Progression|2|||
48816003|NCT01375114|157168560|FG000|Overall Study|Patient Changed Mind|0|||
48816004|NCT01375114|157168561|FG001|Overall Study|Patient Changed Mind|0|||
48816005|NCT01375114|157168562|FG002|Overall Study|Patient Changed Mind|2|||
48816006|NCT01375114|157168560|FG000|Overall Study|Pruritus|0|||
48816007|NCT01375114|157168561|FG001|Overall Study|Pruritus|0|||
48816008|NCT01375114|157168562|FG002|Overall Study|Pruritus|1|||
48816009|NCT01375114|157168560|FG000|Overall Study|Restlessness|0|||
48816010|NCT01375114|157168561|FG001|Overall Study|Restlessness|0|||
48816011|NCT01375114|157168562|FG002|Overall Study|Restlessness|1|||
48816012|NCT01375114|157168560|FG000|Overall Study|Diarrhea|0|||
48816013|NCT01375114|157168561|FG001|Overall Study|Diarrhea|0|||
48816014|NCT01375114|157168562|FG002|Overall Study|Diarrhea|1|||
48816015|NCT01375114|157168560|FG000|Overall Study|Pt enrolled in another clinical trial|0|||
48816016|NCT01375114|157168561|FG001|Overall Study|Pt enrolled in another clinical trial|1|||
48816017|NCT01375114|157168562|FG002|Overall Study|Pt enrolled in another clinical trial|0|||
48816018|NCT01375114|157168560|FG000|Overall Study|Nausea|0|||
48816019|NCT01375114|157168561|FG001|Overall Study|Nausea|1|||
48816020|NCT01375114|157168562|FG002|Overall Study|Nausea|0|||
48816021|NCT01375114|157168560|FG000|Overall Study|Increased AST/ALT|0|||
48720840|NCT02276027|156828404|FG000|Overall Study|Physician Decision|0|||
48816022|NCT01375114|157168561|FG001|Overall Study|Increased AST/ALT|1|||
48816023|NCT01375114|157168562|FG002|Overall Study|Increased AST/ALT|0|||
48816024|NCT01375114|157168560|FG000|Overall Study|Vaginal Hemorrhage|0|||
48816025|NCT01375114|157168561|FG001|Overall Study|Vaginal Hemorrhage|1|||
49128943|NCT00855218|158310902|FG001|Overall Study|patient convenience|0|||
49128944|NCT00855218|158310901|FG000|Overall Study|technical problems|2|||
48720841|NCT02276027|156828405|FG001|Overall Study|Physician Decision|0|||
48720842|NCT02276027|156828406|FG002|Overall Study|Physician Decision|0|||
48720843|NCT02276027|156828407|FG003|Overall Study|Physician Decision|1|||
48920975|NCT01318109|157544805|FG001|Overall Study|Adverse Event|2|||
48816026|NCT01375114|157168562|FG002|Overall Study|Vaginal Hemorrhage|0|||
48816027|NCT01375114|157168560|FG000|Overall Study|Family problem|0|||
48816028|NCT01375114|157168561|FG001|Overall Study|Family problem|1|||
48816029|NCT01375114|157168562|FG002|Overall Study|Family problem|0|||
48816030|NCT01375114|157168560|FG000|Overall Study|Protocol Violation|2|||
48816031|NCT01375114|157168561|FG001|Overall Study|Protocol Violation|0|||
48816032|NCT01375114|157168562|FG002|Overall Study|Protocol Violation|0|||
48720844|NCT02276027|156828404|FG000|Overall Study|Progressive disease|1|||
48720845|NCT02276027|156828405|FG001|Overall Study|Progressive disease|13|||
48720846|NCT02276027|156828406|FG002|Overall Study|Progressive disease|12|||
48720847|NCT02276027|156828407|FG003|Overall Study|Progressive disease|14|||
48720848|NCT02276027|156828404|FG000|Overall Study|Subject/guardian decision|0|||
48720849|NCT02276027|156828405|FG001|Overall Study|Subject/guardian decision|1|||
48720850|NCT02276027|156828406|FG002|Overall Study|Subject/guardian decision|0|||
48720851|NCT02276027|156828407|FG003|Overall Study|Subject/guardian decision|3|||
48720852|NCT02276027|156828404|FG000|Overall Study|Adverse Event|0|||
48720853|NCT02276027|156828405|FG001|Overall Study|Adverse Event|2|||
48720854|NCT02276027|156828406|FG002|Overall Study|Adverse Event|8|||
48720855|NCT02276027|156828407|FG003|Overall Study|Adverse Event|2|||
48720856|NCT00791076|156828410|FG000|Overall Study|Study was terminated,PI left institution|8|||
48720857|NCT00877773|156828411|FG000|Overall Study|Disease Progression|44|||
48720858|NCT05510232|156828418|FG000|Overall Study|Withdrawal by Subject|2|||
48720859|NCT05510232|156828419|FG001|Overall Study|Withdrawal by Subject|7|||
48720860|NCT05510232|156828420|FG002|Overall Study|Withdrawal by Subject|6|||
48720861|NCT01659554|156828422|FG000|Overall Study|Study Termination|4|||
48720862|NCT01328366|156828423|FG000|Overall Study|Death|1|||
48720863|NCT01328366|156828423|FG000|Overall Study|Withdrawal by Subject|2|||
48720864|NCT01328366|156828423|FG000|Overall Study|Lost to Follow-up|7|||
48720865|NCT02882152|156828424|FG000|Overall Study|Lost to Follow-up|1|||
48720866|NCT02882152|156828425|FG001|Overall Study|Lost to Follow-up|0|||
48720867|NCT03739242|156828428|FG000|Overall Study|Withdrawal by Subject|1|||
48720868|NCT03739242|156828429|FG001|Overall Study|Withdrawal by Subject|1|||
48720869|NCT03739242|156828428|FG000|Overall Study|Protocol Violation|0|||
48720870|NCT03739242|156828429|FG001|Overall Study|Protocol Violation|1|||
48720871|NCT00923364|156828436|FG000|Overall Study|Death|3|||
48720872|NCT00923364|156828437|FG001|Overall Study|Death|0|||
48720873|NCT00923364|156828436|FG000|Overall Study|Did not go to transplant|1|||
48720874|NCT00923364|156828437|FG001|Overall Study|Did not go to transplant|0|||
48720875|NCT02230527|156828438|FG000|Overall Study|Withdrawal by Subject|1|||
48720876|NCT02230527|156828439|FG001|Overall Study|Withdrawal by Subject|1|||
48720877|NCT02230527|156828438|FG000|Overall Study|Death|1|||
48720878|NCT02230527|156828439|FG001|Overall Study|Death|0|||
48720879|NCT02230527|156828438|FG000|Overall Study|Lost to Follow-up|2|||
48720880|NCT02230527|156828439|FG001|Overall Study|Lost to Follow-up|1|||
48720881|NCT02230527|156828438|FG000|Overall Study|Other|1|||
48720882|NCT02230527|156828439|FG001|Overall Study|Other|0|||
48720883|NCT04461600|156828440|FG000|Overall Study|Death|6|||
48720884|NCT04461600|156828441|FG001|Overall Study|Death|5|||
48720885|NCT04461600|156828440|FG000|Overall Study|Withdrawal by Subject|0|||
48720886|NCT04461600|156828441|FG001|Overall Study|Withdrawal by Subject|1|||
48720887|NCT02279407|156828442|FG000|Overall Study|Couldn't swallow IP; noncompliance|0|||
48720888|NCT02279407|156828443|FG001|Overall Study|Couldn't swallow IP; noncompliance|0|||
48720889|NCT02279407|156828444|FG002|Overall Study|Couldn't swallow IP; noncompliance|2|||
48720890|NCT02279407|156828445|FG003|Overall Study|Couldn't swallow IP; noncompliance|0|||
48720891|NCT02279407|156828442|FG000|Overall Study|Withdrawal by Subject|1|||
48720892|NCT02279407|156828443|FG001|Overall Study|Withdrawal by Subject|0|||
48720893|NCT02279407|156828444|FG002|Overall Study|Withdrawal by Subject|1|||
48720894|NCT02279407|156828445|FG003|Overall Study|Withdrawal by Subject|1|||
48720895|NCT02279407|156828442|FG000|Overall Study|Adverse Event|1|||
48720896|NCT02279407|156828443|FG001|Overall Study|Adverse Event|1|||
48720897|NCT02279407|156828444|FG002|Overall Study|Adverse Event|2|||
48720898|NCT02279407|156828445|FG003|Overall Study|Adverse Event|0|||
48720899|NCT00275821|156828446|FG000|Overall Study|Adverse Event|4|||
48720900|NCT00275821|156828447|FG001|Overall Study|Adverse Event|12|||
48720901|NCT00275821|156828448|FG002|Overall Study|Adverse Event|5|||
48720902|NCT00275821|156828446|FG000|Overall Study|Administrative problems|3|||
48720903|NCT00275821|156828447|FG001|Overall Study|Administrative problems|4|||
48720904|NCT00275821|156828448|FG002|Overall Study|Administrative problems|4|||
48720905|NCT00275821|156828446|FG000|Overall Study|Withdrawal by Subject|0|||
48720906|NCT00275821|156828447|FG001|Overall Study|Withdrawal by Subject|2|||
48720907|NCT00275821|156828448|FG002|Overall Study|Withdrawal by Subject|1|||
48720908|NCT00275821|156828446|FG000|Overall Study|Lost to Follow-up|0|||
48720909|NCT00275821|156828447|FG001|Overall Study|Lost to Follow-up|1|||
48720910|NCT00275821|156828448|FG002|Overall Study|Lost to Follow-up|1|||
48720911|NCT00275821|156828446|FG000|Overall Study|Death|0|||
48720912|NCT00275821|156828447|FG001|Overall Study|Death|2|||
48720913|NCT00275821|156828448|FG002|Overall Study|Death|1|||
48720914|NCT00275821|156828446|FG000|Overall Study|Lack of Efficacy|2|||
48720915|NCT00275821|156828447|FG001|Overall Study|Lack of Efficacy|1|||
48720916|NCT00275821|156828448|FG002|Overall Study|Lack of Efficacy|0|||
48720917|NCT00275821|156828446|FG000|Overall Study|Protocol Violation|5|||
48720918|NCT00275821|156828447|FG001|Overall Study|Protocol Violation|1|||
48720919|NCT00275821|156828448|FG002|Overall Study|Protocol Violation|0|||
48720920|NCT00045942|156828449|FG000|PKC412A2104 (Core)|Withdrawal by Subject|1|||
48720921|NCT00045942|156828450|FG001|PKC412A2104 (Core)|Withdrawal by Subject|0|||
48816033|NCT01208415|157168563|FG000|Overall Study|Death|1|||
48816034|NCT01208415|157168563|FG000|Overall Study|Lost to Follow-up|2|||
48816035|NCT01208415|157168563|FG000|Overall Study|Withdrawal by Subject|3|||
48816036|NCT01208415|157168563|FG000|Overall Study|Device not placed|1|||
48816037|NCT01208415|157168563|FG000|Overall Study|Still be eligible for follow-up|33|||
48816038|NCT02878213|157168564|FG000|Overall Study|Withdrawal by Subject|2|||
48816039|NCT02878213|157168564|FG000|Overall Study|Adverse Event|1|||
48816040|NCT03619174|157168577|FG000|Overall Study|Lost to Follow-up|3|||
48816041|NCT03619174|157168578|FG001|Overall Study|Lost to Follow-up|0|||
48816042|NCT03619174|157168577|FG000|Overall Study|Withdrawal by Subject|4|||
48816043|NCT03619174|157168578|FG001|Overall Study|Withdrawal by Subject|3|||
48816044|NCT03619174|157168577|FG000|Overall Study|Pregnancy|1|||
48816045|NCT03619174|157168578|FG001|Overall Study|Pregnancy|1|||
48816046|NCT03619174|157168577|FG000|Overall Study|Discomfort during treatment|1|||
48816047|NCT03619174|157168578|FG001|Overall Study|Discomfort during treatment|0|||
48816048|NCT03486899|157168579|FG000|Overall Study|Lost to Follow-up|4|||
48816049|NCT03486899|157168580|FG001|Overall Study|Lost to Follow-up|1|||
48816050|NCT03486899|157168581|FG002|Overall Study|Lost to Follow-up|4|||
48816051|NCT03486899|157168582|FG003|Overall Study|Lost to Follow-up|3|||
48816052|NCT03486899|157168579|FG000|Overall Study|Death|1|||
48816053|NCT03486899|157168580|FG001|Overall Study|Death|0|||
48816054|NCT03486899|157168581|FG002|Overall Study|Death|0|||
48816055|NCT03486899|157168582|FG003|Overall Study|Death|1|||
48816056|NCT03486899|157168579|FG000|Overall Study|Adverse Event|0|||
48816057|NCT03486899|157168580|FG001|Overall Study|Adverse Event|2|||
48816058|NCT03486899|157168581|FG002|Overall Study|Adverse Event|0|||
48816059|NCT03486899|157168582|FG003|Overall Study|Adverse Event|2|||
48816060|NCT03486899|157168579|FG000|Overall Study|Withdrawal by Subject|3|||
48816061|NCT03486899|157168580|FG001|Overall Study|Withdrawal by Subject|7|||
48816062|NCT03486899|157168581|FG002|Overall Study|Withdrawal by Subject|4|||
48816063|NCT03486899|157168582|FG003|Overall Study|Withdrawal by Subject|3|||
48816064|NCT03486899|157168579|FG000|Overall Study|Other Reasons|0|||
48816065|NCT03486899|157168580|FG001|Overall Study|Other Reasons|1|||
48816066|NCT03486899|157168581|FG002|Overall Study|Other Reasons|0|||
48816067|NCT03486899|157168582|FG003|Overall Study|Other Reasons|1|||
48816068|NCT01818700|157168583|FG000|Overall Study|Adverse Event|67|||
48816069|NCT01818700|157168583|FG000|Overall Study|Lack of Efficacy|2|||
48816070|NCT01818700|157168583|FG000|Overall Study|Lost to Follow-up|5|||
48816071|NCT01818700|157168583|FG000|Overall Study|Withdrawal by Subject|27|||
48816072|NCT01818700|157168583|FG000|Overall Study|Protocol Violation|2|||
48816073|NCT01818700|157168583|FG000|Overall Study|Other|1|||
48816074|NCT02213055|157168584|FG000|Overall Study|Protocol was not Followed at Enrollment|5|||
48816075|NCT02213055|157168585|FG001|Overall Study|Protocol was not Followed at Enrollment|0|||
48720922|NCT00045942|156828451|FG002|PKC412A2104 (Core)|Withdrawal by Subject|0|||
48720923|NCT00045942|156828452|FG003|PKC412A2104 (Core)|Withdrawal by Subject|0|||
48720924|NCT00045942|156828453|FG004|PKC412A2104 (Core)|Withdrawal by Subject|0|||
48720925|NCT00045942|156828454|FG005|PKC412A2104 (Core)|Withdrawal by Subject|0|||
48720926|NCT00045942|156828455|FG006|PKC412A2104 (Core)|Withdrawal by Subject|0|||
48720927|NCT00045942|156828456|FG007|PKC412A2104 (Core)|Withdrawal by Subject|0|||
48720928|NCT00045942|156828457|FG008|PKC412A2104 (Core)|Withdrawal by Subject|0|||
48720929|NCT00045942|156828449|FG000|PKC412A2104 (Core)|Adverse Event|5|||
48720930|NCT00045942|156828450|FG001|PKC412A2104 (Core)|Adverse Event|0|||
48720931|NCT00045942|156828451|FG002|PKC412A2104 (Core)|Adverse Event|0|||
48720932|NCT00045942|156828452|FG003|PKC412A2104 (Core)|Adverse Event|0|||
48720933|NCT00045942|156828453|FG004|PKC412A2104 (Core)|Adverse Event|0|||
48720934|NCT00045942|156828454|FG005|PKC412A2104 (Core)|Adverse Event|0|||
48720935|NCT00045942|156828455|FG006|PKC412A2104 (Core)|Adverse Event|0|||
48720936|NCT00045942|156828456|FG007|PKC412A2104 (Core)|Adverse Event|0|||
48720937|NCT00045942|156828457|FG008|PKC412A2104 (Core)|Adverse Event|0|||
48720938|NCT00045942|156828449|FG000|PKC412A2104 (Core)|Lack of Efficacy|13|||
48720939|NCT00045942|156828450|FG001|PKC412A2104 (Core)|Lack of Efficacy|0|||
48720940|NCT00045942|156828451|FG002|PKC412A2104 (Core)|Lack of Efficacy|0|||
48720941|NCT00045942|156828452|FG003|PKC412A2104 (Core)|Lack of Efficacy|0|||
48720942|NCT00045942|156828453|FG004|PKC412A2104 (Core)|Lack of Efficacy|0|||
48720943|NCT00045942|156828454|FG005|PKC412A2104 (Core)|Lack of Efficacy|0|||
48720944|NCT00045942|156828455|FG006|PKC412A2104 (Core)|Lack of Efficacy|0|||
48720945|NCT00045942|156828456|FG007|PKC412A2104 (Core)|Lack of Efficacy|0|||
48720946|NCT00045942|156828457|FG008|PKC412A2104 (Core)|Lack of Efficacy|0|||
48720947|NCT00045942|156828449|FG000|PKC412A2104 (Core)|Death|1|||
48720948|NCT00045942|156828450|FG001|PKC412A2104 (Core)|Death|0|||
48720949|NCT00045942|156828451|FG002|PKC412A2104 (Core)|Death|0|||
48720950|NCT00045942|156828452|FG003|PKC412A2104 (Core)|Death|0|||
48720951|NCT00045942|156828453|FG004|PKC412A2104 (Core)|Death|0|||
48720952|NCT00045942|156828454|FG005|PKC412A2104 (Core)|Death|0|||
48816076|NCT02213055|157168584|FG000|Overall Study|Protocol was not Followed during Study|1|||
48816077|NCT02213055|157168585|FG001|Overall Study|Protocol was not Followed during Study|0|||
48816078|NCT02213055|157168584|FG000|Overall Study|Documentation Issue at Enrollment|1|||
48816079|NCT02213055|157168585|FG001|Overall Study|Documentation Issue at Enrollment|0|||
48816080|NCT02213055|157168584|FG000|Overall Study|Documentation Issue during Study|10|||
48816081|NCT02213055|157168585|FG001|Overall Study|Documentation Issue during Study|0|||
48816082|NCT02213055|157168584|FG000|Overall Study|Did not have Live Lice|8|||
48816083|NCT02213055|157168585|FG001|Overall Study|Did not have Live Lice|0|||
48816084|NCT02213055|157168584|FG000|Overall Study|Had another Treatment during the Study|3|||
48816085|NCT02213055|157168585|FG001|Overall Study|Had another Treatment during the Study|0|||
48816086|NCT02213055|157168584|FG000|Overall Study|Did not meet Inclusion Criteria|6|||
48816087|NCT02213055|157168585|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
48816088|NCT02213055|157168584|FG000|Overall Study|Did not Return to School|5|||
48816089|NCT02213055|157168585|FG001|Overall Study|Did not Return to School|0|||
48816090|NCT03257995|157168588|FG000|Overall Study|Adverse Event|0|||
48816091|NCT03257995|157168589|FG001|Overall Study|Adverse Event|1|||
48816092|NCT03257995|157168590|FG002|Overall Study|Adverse Event|0|||
48816093|NCT03257995|157168591|FG003|Overall Study|Adverse Event|0|||
48816094|NCT03257995|157168592|FG004|Overall Study|Adverse Event|0|||
48816095|NCT03257995|157168593|FG005|Overall Study|Adverse Event|0|||
48816096|NCT03257995|157168588|FG000|Overall Study|Protocol deviation|0|||
48816097|NCT03257995|157168589|FG001|Overall Study|Protocol deviation|0|||
48816098|NCT03257995|157168590|FG002|Overall Study|Protocol deviation|0|||
48816099|NCT03257995|157168591|FG003|Overall Study|Protocol deviation|0|||
48816100|NCT03257995|157168592|FG004|Overall Study|Protocol deviation|0|||
48816101|NCT03257995|157168593|FG005|Overall Study|Protocol deviation|2|||
48816102|NCT01544114|157168594|FG000|Overall Study|Withdrawal by Subject|0|||
48816103|NCT01544114|157168595|FG001|Overall Study|Withdrawal by Subject|0|||
48816104|NCT01544114|157168596|FG002|Overall Study|Withdrawal by Subject|3|||
48816105|NCT01544114|157168594|FG000|Overall Study|Lost to Follow-up|0|||
48816106|NCT01544114|157168595|FG001|Overall Study|Lost to Follow-up|2|||
48816107|NCT01544114|157168596|FG002|Overall Study|Lost to Follow-up|0|||
48816108|NCT01544114|157168594|FG000|Overall Study|Adverse Event|1|||
48816109|NCT01544114|157168595|FG001|Overall Study|Adverse Event|1|||
48816110|NCT01544114|157168596|FG002|Overall Study|Adverse Event|2|||
48816111|NCT01544114|157168594|FG000|Overall Study|Protocol Violation|0|||
48816112|NCT01544114|157168595|FG001|Overall Study|Protocol Violation|1|||
48816113|NCT01544114|157168596|FG002|Overall Study|Protocol Violation|0|||
48816114|NCT02723591|157168599|FG000|Overall Study|Adverse Event|48|||
48816115|NCT02723591|157168600|FG001|Overall Study|Adverse Event|40|||
48816116|NCT02723591|157168599|FG000|Overall Study|Death|2|||
48816117|NCT02723591|157168600|FG001|Overall Study|Death|2|||
48816118|NCT02723591|157168599|FG000|Overall Study|Lack of Efficacy|4|||
48816119|NCT02723591|157168600|FG001|Overall Study|Lack of Efficacy|3|||
48816120|NCT02723591|157168599|FG000|Overall Study|Lost to Follow-up|1|||
48816121|NCT02723591|157168600|FG001|Overall Study|Lost to Follow-up|7|||
48816122|NCT02723591|157168599|FG000|Overall Study|Protocol Violation|20|||
48816123|NCT02723591|157168600|FG001|Overall Study|Protocol Violation|23|||
48816124|NCT02723591|157168599|FG000|Overall Study|Withdrawal by Subject|4|||
48816125|NCT02723591|157168600|FG001|Overall Study|Withdrawal by Subject|8|||
48816126|NCT02723591|157168599|FG000|Overall Study|Randomized but Never Received StudyDrug|12|||
48816127|NCT02723591|157168600|FG001|Overall Study|Randomized but Never Received StudyDrug|12|||
48816128|NCT02723591|157168599|FG000|Overall Study|Miscellaneous|5|||
48816129|NCT02723591|157168600|FG001|Overall Study|Miscellaneous|6|||
48816130|NCT01680458|157168607|FG000|Overall Study|Protocol Violation|3|||
49128945|NCT00855218|158310902|FG001|Overall Study|technical problems|1|||
48720953|NCT00045942|156828455|FG006|PKC412A2104 (Core)|Death|0|||
49128946|NCT00855218|158310901|FG000|Overall Study|Still treated with study medication|0|||
49128947|NCT00855218|158310902|FG001|Overall Study|Still treated with study medication|1|||
48720954|NCT00045942|156828456|FG007|PKC412A2104 (Core)|Death|0|||
48720955|NCT00045942|156828457|FG008|PKC412A2104 (Core)|Death|0|||
48720956|NCT00045942|156828449|FG000|PKC412A2104E1|Withdrawal by Subject|0|||
48720957|NCT00045942|156828450|FG001|PKC412A2104E1|Withdrawal by Subject|0|||
48720958|NCT00045942|156828451|FG002|PKC412A2104E1|Withdrawal by Subject|2|||
48720959|NCT00045942|156828452|FG003|PKC412A2104E1|Withdrawal by Subject|5|||
49128948|NCT00855218|158310901|FG000|Overall Study|Untreatable disease progression|54|||
48720960|NCT00045942|156828453|FG004|PKC412A2104E1|Withdrawal by Subject|2|||
48720961|NCT00045942|156828454|FG005|PKC412A2104E1|Withdrawal by Subject|0|||
48720962|NCT00045942|156828455|FG006|PKC412A2104E1|Withdrawal by Subject|0|||
48720963|NCT00045942|156828456|FG007|PKC412A2104E1|Withdrawal by Subject|0|||
48816131|NCT01923428|157168608|FG000|Overall Study|Adverse Event|8|||
48816132|NCT01923428|157168609|FG001|Overall Study|Adverse Event|6|||
48816133|NCT01923428|157168610|FG002|Overall Study|Adverse Event|3|||
48816134|NCT01923428|157168611|FG003|Overall Study|Adverse Event|3|||
48816135|NCT01923428|157168608|FG000|Overall Study|Withdrawal by Subject|5|||
48816136|NCT01923428|157168609|FG001|Overall Study|Withdrawal by Subject|3|||
49128949|NCT00855218|158310902|FG001|Overall Study|Untreatable disease progression|67|||
48720964|NCT00045942|156828457|FG008|PKC412A2104E1|Withdrawal by Subject|0|||
48816137|NCT01923428|157168610|FG002|Overall Study|Withdrawal by Subject|0|||
48816138|NCT01923428|157168611|FG003|Overall Study|Withdrawal by Subject|4|||
48920976|NCT01318109|157544806|FG002|Overall Study|Adverse Event|0|||
48816139|NCT01923428|157168608|FG000|Overall Study|Lost to Follow-up|2|||
48816140|NCT01923428|157168609|FG001|Overall Study|Lost to Follow-up|1|||
49128950|NCT00855218|158310901|FG000|Overall Study|Second malignancy|0|||
49128951|NCT00855218|158310902|FG001|Overall Study|Second malignancy|1|||
49128952|NCT00855218|158310901|FG000|Overall Study|Progression measurement proven|7|||
48720965|NCT00045942|156828449|FG000|PKC412A2104E1|Condition no longer requires study drug|0|||
48720966|NCT00045942|156828450|FG001|PKC412A2104E1|Condition no longer requires study drug|1|||
49128953|NCT00855218|158310902|FG001|Overall Study|Progression measurement proven|15|||
49128954|NCT00855218|158310901|FG000|Overall Study|Clinical endpoint reached|10|||
49128955|NCT00855218|158310902|FG001|Overall Study|Clinical endpoint reached|13|||
49128956|NCT01652690|158310906|FG000|Overall Study|Withdrawal by Subject|16|||
49128957|NCT01652690|158310907|FG001|Overall Study|Withdrawal by Subject|4|||
49128958|NCT01652690|158310906|FG000|Overall Study|Other|8|||
49128959|NCT01652690|158310907|FG001|Overall Study|Other|9|||
48720967|NCT00045942|156828451|FG002|PKC412A2104E1|Condition no longer requires study drug|1|||
48720968|NCT00045942|156828452|FG003|PKC412A2104E1|Condition no longer requires study drug|0|||
48720969|NCT00045942|156828453|FG004|PKC412A2104E1|Condition no longer requires study drug|1|||
48720970|NCT00045942|156828454|FG005|PKC412A2104E1|Condition no longer requires study drug|0|||
48720971|NCT00045942|156828455|FG006|PKC412A2104E1|Condition no longer requires study drug|0|||
48720972|NCT00045942|156828456|FG007|PKC412A2104E1|Condition no longer requires study drug|0|||
48720973|NCT00045942|156828457|FG008|PKC412A2104E1|Condition no longer requires study drug|0|||
48816141|NCT01923428|157168610|FG002|Overall Study|Lost to Follow-up|5|||
48816142|NCT01923428|157168611|FG003|Overall Study|Lost to Follow-up|0|||
48816143|NCT01923428|157168608|FG000|Overall Study|Protocol Violation|3|||
48816144|NCT01923428|157168609|FG001|Overall Study|Protocol Violation|0|||
48816145|NCT01923428|157168610|FG002|Overall Study|Protocol Violation|2|||
48816146|NCT01923428|157168611|FG003|Overall Study|Protocol Violation|1|||
48816147|NCT01923428|157168608|FG000|Overall Study|Non Compliance to treatment|1|||
48816148|NCT01923428|157168609|FG001|Overall Study|Non Compliance to treatment|2|||
48816149|NCT01923428|157168610|FG002|Overall Study|Non Compliance to treatment|0|||
48816150|NCT01923428|157168611|FG003|Overall Study|Non Compliance to treatment|1|||
48816151|NCT01923428|157168608|FG000|Overall Study|Lack of Efficacy|0|||
48816152|NCT01923428|157168609|FG001|Overall Study|Lack of Efficacy|0|||
48816153|NCT01923428|157168610|FG002|Overall Study|Lack of Efficacy|1|||
48816154|NCT01923428|157168611|FG003|Overall Study|Lack of Efficacy|1|||
48816155|NCT02337478|157168612|FG000|Overall Study|Lack of Efficacy|5|||
48816156|NCT00653263|157168613|FG000|Overall Study|Withdrawal by Subject|1|||
48816157|NCT00653263|157168613|FG000|Overall Study|Physician Decision|1|||
48816158|NCT01449721|157168617|FG000|Overall Study|Physician Decision|0|||
48816159|NCT01449721|157168618|FG001|Overall Study|Physician Decision|1|||
48816160|NCT01449721|157168617|FG000|Overall Study|Physician Decision|0|||
48816161|NCT01449721|157168618|FG001|Overall Study|Physician Decision|1|||
48816162|NCT03873246|157168622|FG000|Overall Study|Adverse Event|1|||
48816163|NCT03873246|157168623|FG001|Overall Study|Adverse Event|3|||
48816164|NCT03873246|157168624|FG002|Overall Study|Adverse Event|3|||
48816165|NCT03873246|157168622|FG000|Overall Study|Lost to Follow-up|4|||
48816166|NCT03873246|157168623|FG001|Overall Study|Lost to Follow-up|4|||
48816167|NCT03873246|157168624|FG002|Overall Study|Lost to Follow-up|5|||
48816168|NCT03873246|157168622|FG000|Overall Study|Protocol Violation|0|||
48816169|NCT03873246|157168623|FG001|Overall Study|Protocol Violation|1|||
48816170|NCT03873246|157168624|FG002|Overall Study|Protocol Violation|0|||
48720974|NCT00045942|156828449|FG000|PKC412A2104E1|Lack of Efficacy|0|||
48720975|NCT00045942|156828450|FG001|PKC412A2104E1|Lack of Efficacy|11|||
48720976|NCT00045942|156828451|FG002|PKC412A2104E1|Lack of Efficacy|11|||
48720977|NCT00045942|156828452|FG003|PKC412A2104E1|Lack of Efficacy|23|||
48720978|NCT00045942|156828453|FG004|PKC412A2104E1|Lack of Efficacy|17|||
48720979|NCT00045942|156828454|FG005|PKC412A2104E1|Lack of Efficacy|0|||
48720980|NCT00045942|156828455|FG006|PKC412A2104E1|Lack of Efficacy|0|||
48720981|NCT00045942|156828456|FG007|PKC412A2104E1|Lack of Efficacy|0|||
48720982|NCT00045942|156828457|FG008|PKC412A2104E1|Lack of Efficacy|0|||
48720983|NCT00045942|156828449|FG000|PKC412A2104E1|Abnormal laboratory value|0|||
48720984|NCT00045942|156828450|FG001|PKC412A2104E1|Abnormal laboratory value|1|||
48720985|NCT00045942|156828451|FG002|PKC412A2104E1|Abnormal laboratory value|0|||
48816171|NCT03873246|157168622|FG000|Overall Study|Withdrawal by Subject|0|||
48816172|NCT03873246|157168623|FG001|Overall Study|Withdrawal by Subject|4|||
48816173|NCT03873246|157168624|FG002|Overall Study|Withdrawal by Subject|1|||
49128960|NCT01652690|158310906|FG000|Overall Study|Lost to Follow-up|6|||
48816174|NCT01857323|157168625|FG000|Overall Study|Adverse Event|1|||
48816175|NCT01857323|157168625|FG000|Overall Study|Withdrawal by Subject|3|||
48816176|NCT01857323|157168625|FG000|Overall Study|Non-compliance|1|||
48816177|NCT01857323|157168625|FG000|Overall Study|Protocol Violation|6|||
48816178|NCT01857323|157168625|FG000|Overall Study|Lost to Follow-up|1|||
48816179|NCT01857323|157168625|FG000|Overall Study|Other|4|||
48816180|NCT01857323|157168625|FG000|Overall Study|Did not complete 180 doses|48|||
49128961|NCT01652690|158310907|FG001|Overall Study|Lost to Follow-up|6|||
48720986|NCT00045942|156828452|FG003|PKC412A2104E1|Abnormal laboratory value|0|||
48720987|NCT00045942|156828453|FG004|PKC412A2104E1|Abnormal laboratory value|0|||
48816181|NCT02593539|157170372|FG000|Overall Study|Adverse Event|1|||
48816182|NCT04838626|157170378|FG000|Overall Study|Adverse Event|2|||
49128962|NCT01652690|158310906|FG000|Overall Study|Death|5|||
49128963|NCT01652690|158310907|FG001|Overall Study|Death|2|||
49128964|NCT02273167|158310915|FG000|Overall Study|Adverse Event|1|||
49128965|NCT02273167|158310916|FG001|Overall Study|Adverse Event|0|||
49128966|NCT02273167|158310917|FG002|Overall Study|Adverse Event|0|||
49128967|NCT02273167|158310915|FG000|Overall Study|Protocol Violation|3|||
49128968|NCT02273167|158310916|FG001|Overall Study|Protocol Violation|1|||
48720988|NCT00045942|156828454|FG005|PKC412A2104E1|Abnormal laboratory value|0|||
48720989|NCT00045942|156828455|FG006|PKC412A2104E1|Abnormal laboratory value|0|||
48720990|NCT00045942|156828456|FG007|PKC412A2104E1|Abnormal laboratory value|0|||
48720991|NCT00045942|156828457|FG008|PKC412A2104E1|Abnormal laboratory value|0|||
48720992|NCT00045942|156828449|FG000|PKC412A2104E1|Adverse Event|0|||
48720993|NCT00045942|156828450|FG001|PKC412A2104E1|Adverse Event|1|||
48720994|NCT00045942|156828451|FG002|PKC412A2104E1|Adverse Event|1|||
48720995|NCT00045942|156828452|FG003|PKC412A2104E1|Adverse Event|3|||
48720996|NCT00045942|156828453|FG004|PKC412A2104E1|Adverse Event|6|||
48720997|NCT00045942|156828454|FG005|PKC412A2104E1|Adverse Event|0|||
48720998|NCT00045942|156828455|FG006|PKC412A2104E1|Adverse Event|0|||
48720999|NCT00045942|156828456|FG007|PKC412A2104E1|Adverse Event|0|||
48721000|NCT00045942|156828457|FG008|PKC412A2104E1|Adverse Event|0|||
49128969|NCT02273167|158310917|FG002|Overall Study|Protocol Violation|1|||
49128970|NCT02273167|158310915|FG000|Overall Study|Lost to Follow-up|0|||
49128971|NCT02273167|158310916|FG001|Overall Study|Lost to Follow-up|1|||
49128972|NCT02273167|158310917|FG002|Overall Study|Lost to Follow-up|1|||
49128973|NCT02273167|158310915|FG000|Overall Study|Withdrawal by Subject|10|||
49128974|NCT02273167|158310916|FG001|Overall Study|Withdrawal by Subject|12|||
49128975|NCT02273167|158310917|FG002|Overall Study|Withdrawal by Subject|11|||
49128976|NCT02273167|158310915|FG000|Overall Study|Various|10|||
49128977|NCT02273167|158310916|FG001|Overall Study|Various|9|||
48721001|NCT00045942|156828449|FG000|PKC412A2104E1|Death|0|||
49128978|NCT02273167|158310917|FG002|Overall Study|Various|8|||
49128979|NCT03311555|158310920|FG000|Overall Study|Adverse Event|1|||
48721002|NCT00045942|156828450|FG001|PKC412A2104E1|Death|4|||
48721003|NCT00045942|156828451|FG002|PKC412A2104E1|Death|1|||
49128980|NCT02160626|158310923|FG000|Overall Study|Adverse Event|1|||
49128981|NCT02160626|158310924|FG001|Overall Study|Adverse Event|0|||
49128982|NCT02160626|158310925|FG002|Overall Study|Adverse Event|0|||
49128983|NCT02160626|158310923|FG000|Overall Study|Schedule not conducive to study visits|0|||
49128984|NCT02160626|158310924|FG001|Overall Study|Schedule not conducive to study visits|0|||
49128985|NCT02160626|158310925|FG002|Overall Study|Schedule not conducive to study visits|1|||
49128986|NCT02160626|158310923|FG000|Overall Study|Withdrawal by Subject|0|||
49128987|NCT02160626|158310924|FG001|Overall Study|Withdrawal by Subject|1|||
49128988|NCT02160626|158310925|FG002|Overall Study|Withdrawal by Subject|0|||
49128989|NCT03074500|158310926|FG000|Overall Study|Lost to Follow-up|1|||
49128990|NCT03074500|158310927|FG001|Overall Study|Lost to Follow-up|0|||
49128991|NCT03074500|158310928|FG002|Overall Study|Lost to Follow-up|0|||
49128992|NCT03074500|158310926|FG000|Overall Study|Lack of Efficacy|0|||
49128993|NCT03074500|158310927|FG001|Overall Study|Lack of Efficacy|1|||
49128994|NCT03074500|158310928|FG002|Overall Study|Lack of Efficacy|0|||
49128995|NCT03074500|158310926|FG000|Overall Study|Adverse Event|0|||
49128996|NCT03074500|158310927|FG001|Overall Study|Adverse Event|0|||
49128997|NCT03074500|158310928|FG002|Overall Study|Adverse Event|1|||
49128998|NCT01248455|158312296|FG000|Overall Study|switched to alternate treatment|1|||
49128999|NCT00386334|158312299|FG000|Double Blind Period|Adverse Event|9|||
49129000|NCT00386334|158312300|FG001|Double Blind Period|Adverse Event|14|||
49129001|NCT00386334|158312299|FG000|Double Blind Period|Protocol Violation|1|||
49129002|NCT00386334|158312300|FG001|Double Blind Period|Protocol Violation|1|||
49129003|NCT00386334|158312299|FG000|Double Blind Period|Withdrawal by Subject|9|||
49129004|NCT00386334|158312300|FG001|Double Blind Period|Withdrawal by Subject|13|||
49129005|NCT00386334|158312299|FG000|Double Blind Period|Lack of Efficacy|20|||
49129006|NCT00386334|158312300|FG001|Double Blind Period|Lack of Efficacy|11|||
49129007|NCT00386334|158312299|FG000|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4|||
49129008|NCT00386334|158312300|FG001|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5|||
49129009|NCT00386334|158312299|FG000|Double Blind Period|Other|3|||
49129010|NCT00386334|158312300|FG001|Double Blind Period|Other|3|||
49129011|NCT00386334|158312299|FG000|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3|||
49129012|NCT00386334|158312300|FG001|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1|||
49129013|NCT01079780|158312301|FG000|Overall Study|Disease progression|43|||
49129014|NCT01079780|158312302|FG001|Overall Study|Disease progression|7|||
49129015|NCT01079780|158312303|FG002|Overall Study|Disease progression|31|||
48721004|NCT00045942|156828452|FG003|PKC412A2104E1|Death|1|||
48721005|NCT00045942|156828453|FG004|PKC412A2104E1|Death|1|||
48721006|NCT00045942|156828454|FG005|PKC412A2104E1|Death|0|||
48721007|NCT00045942|156828455|FG006|PKC412A2104E1|Death|0|||
48721008|NCT00045942|156828456|FG007|PKC412A2104E1|Death|0|||
48721009|NCT00045942|156828457|FG008|PKC412A2104E1|Death|0|||
48721010|NCT00045942|156828449|FG000|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
48721011|NCT00045942|156828450|FG001|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
48721012|NCT00045942|156828451|FG002|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
48721013|NCT00045942|156828452|FG003|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
48721014|NCT00045942|156828453|FG004|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
48721015|NCT00045942|156828454|FG005|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
48721016|NCT00045942|156828455|FG006|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
48721017|NCT00045942|156828456|FG007|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
48721018|NCT00045942|156828457|FG008|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
48721019|NCT00045942|156828449|FG000|PKC412A2104E2|Lost to Follow-up|0|||
48721020|NCT00045942|156828450|FG001|PKC412A2104E2|Lost to Follow-up|0|||
48721021|NCT00045942|156828451|FG002|PKC412A2104E2|Lost to Follow-up|0|||
48721022|NCT00045942|156828452|FG003|PKC412A2104E2|Lost to Follow-up|0|||
48721023|NCT00045942|156828453|FG004|PKC412A2104E2|Lost to Follow-up|0|||
48721024|NCT00045942|156828454|FG005|PKC412A2104E2|Lost to Follow-up|0|||
48721025|NCT00045942|156828455|FG006|PKC412A2104E2|Lost to Follow-up|0|||
48721026|NCT00045942|156828456|FG007|PKC412A2104E2|Lost to Follow-up|3|||
48721027|NCT00045942|156828457|FG008|PKC412A2104E2|Lost to Follow-up|0|||
48721028|NCT00045942|156828449|FG000|PKC412A2104E2|Withdrawal by Subject|0|||
48721029|NCT00045942|156828450|FG001|PKC412A2104E2|Withdrawal by Subject|0|||
48721030|NCT00045942|156828451|FG002|PKC412A2104E2|Withdrawal by Subject|0|||
48721031|NCT00045942|156828452|FG003|PKC412A2104E2|Withdrawal by Subject|0|||
48721032|NCT00045942|156828453|FG004|PKC412A2104E2|Withdrawal by Subject|0|||
48721033|NCT00045942|156828454|FG005|PKC412A2104E2|Withdrawal by Subject|1|||
48721034|NCT00045942|156828455|FG006|PKC412A2104E2|Withdrawal by Subject|0|||
48721035|NCT00045942|156828456|FG007|PKC412A2104E2|Withdrawal by Subject|1|||
48721036|NCT00045942|156828457|FG008|PKC412A2104E2|Withdrawal by Subject|0|||
48721037|NCT00045942|156828449|FG000|PKC412A2104E2|Lack of Efficacy|0|||
48721038|NCT00045942|156828450|FG001|PKC412A2104E2|Lack of Efficacy|0|||
48721039|NCT00045942|156828451|FG002|PKC412A2104E2|Lack of Efficacy|0|||
48721040|NCT00045942|156828452|FG003|PKC412A2104E2|Lack of Efficacy|0|||
48721041|NCT00045942|156828453|FG004|PKC412A2104E2|Lack of Efficacy|0|||
48721042|NCT00045942|156828454|FG005|PKC412A2104E2|Lack of Efficacy|3|||
48721043|NCT00045942|156828455|FG006|PKC412A2104E2|Lack of Efficacy|2|||
48721044|NCT00045942|156828456|FG007|PKC412A2104E2|Lack of Efficacy|2|||
48721045|NCT00045942|156828457|FG008|PKC412A2104E2|Lack of Efficacy|6|||
48721046|NCT00045942|156828449|FG000|PKC412A2104E2|Adverse Event|0|||
48721047|NCT00045942|156828450|FG001|PKC412A2104E2|Adverse Event|0|||
48721048|NCT00045942|156828451|FG002|PKC412A2104E2|Adverse Event|0|||
48721049|NCT00045942|156828452|FG003|PKC412A2104E2|Adverse Event|0|||
48721050|NCT00045942|156828453|FG004|PKC412A2104E2|Adverse Event|0|||
48721051|NCT00045942|156828454|FG005|PKC412A2104E2|Adverse Event|4|||
48721052|NCT00045942|156828455|FG006|PKC412A2104E2|Adverse Event|3|||
48721053|NCT00045942|156828456|FG007|PKC412A2104E2|Adverse Event|1|||
48721054|NCT00045942|156828457|FG008|PKC412A2104E2|Adverse Event|0|||
48721055|NCT00045942|156828449|FG000|PKC412A2104E2|Death|0|||
48721056|NCT00045942|156828450|FG001|PKC412A2104E2|Death|0|||
48721057|NCT00045942|156828451|FG002|PKC412A2104E2|Death|0|||
48721058|NCT00045942|156828452|FG003|PKC412A2104E2|Death|0|||
48721059|NCT00045942|156828453|FG004|PKC412A2104E2|Death|0|||
48721060|NCT00045942|156828454|FG005|PKC412A2104E2|Death|1|||
48721061|NCT00045942|156828455|FG006|PKC412A2104E2|Death|2|||
48721062|NCT00045942|156828456|FG007|PKC412A2104E2|Death|0|||
48721063|NCT00045942|156828457|FG008|PKC412A2104E2|Death|0|||
48721064|NCT03774823|156828458|FG000|Overall Study|Withdrawal by Subject|1|||
48721065|NCT03774823|156828459|FG001|Overall Study|Withdrawal by Subject|1|||
48721066|NCT04905498|156828466|FG000|Overall Study|Lost to Follow-up|0|||
48721067|NCT04905498|156828467|FG001|Overall Study|Lost to Follow-up|2|||
48721068|NCT04905498|156828466|FG000|Overall Study|COVID lockdown|1|||
48920977|NCT01318109|157544804|FG000|Overall Study|Withdrawal by Subject|1|||
49129016|NCT01079780|158312301|FG000|Overall Study|Adverse Event|13|||
49129017|NCT01079780|158312302|FG001|Overall Study|Adverse Event|5|||
49129018|NCT01079780|158312303|FG002|Overall Study|Adverse Event|7|||
49129019|NCT01079780|158312301|FG000|Overall Study|Death|2|||
49129020|NCT01079780|158312302|FG001|Overall Study|Death|0|||
49129021|NCT01079780|158312303|FG002|Overall Study|Death|2|||
49129022|NCT01079780|158312301|FG000|Overall Study|Withdrawal by Subject|6|||
49129023|NCT01079780|158312302|FG001|Overall Study|Withdrawal by Subject|4|||
49129024|NCT01079780|158312303|FG002|Overall Study|Withdrawal by Subject|4|||
49129025|NCT01079780|158312301|FG000|Overall Study|Alternative therapy|2|||
49129026|NCT01079780|158312302|FG001|Overall Study|Alternative therapy|0|||
49129027|NCT01079780|158312303|FG002|Overall Study|Alternative therapy|2|||
49129028|NCT01079780|158312301|FG000|Overall Study|Physician Decision|1|||
49129029|NCT01079780|158312302|FG001|Overall Study|Physician Decision|0|||
48721069|NCT04905498|156828467|FG001|Overall Study|COVID lockdown|0|||
48721070|NCT00409175|156828468|FG000|Overall Study|Adverse Event|4|||
48721071|NCT00409175|156828469|FG001|Overall Study|Adverse Event|3|||
48721072|NCT00409175|156828468|FG000|Overall Study|Withdrawal by Subject|1|||
49129030|NCT01079780|158312303|FG002|Overall Study|Physician Decision|1|||
49129031|NCT01079780|158312301|FG000|Overall Study|Error made in lesion measurement|1|||
48816183|NCT04838626|157170378|FG000|Overall Study|Physician Decision|6|||
48816184|NCT04838626|157170378|FG000|Overall Study|Protocol Violation|3|||
48816185|NCT04838626|157170378|FG000|Overall Study|Withdrawal by Subject|9|||
48816186|NCT04838626|157170378|FG000|Overall Study|Technical Problems|2|||
48816187|NCT00854295|157170381|FG000|Overall Study|Death|7|||
48816188|NCT00854295|157170382|FG001|Overall Study|Death|0|||
48816189|NCT00854295|157170383|FG002|Overall Study|Death|1|||
48816190|NCT00854295|157170384|FG003|Overall Study|Death|1|||
48816191|NCT00854295|157170381|FG000|Overall Study|Adverse Event|6|||
48816192|NCT00854295|157170382|FG001|Overall Study|Adverse Event|1|||
48816193|NCT00854295|157170383|FG002|Overall Study|Adverse Event|1|||
48816194|NCT00854295|157170384|FG003|Overall Study|Adverse Event|3|||
48816195|NCT00854295|157170381|FG000|Overall Study|Lost to Follow-up|18|||
48816196|NCT00854295|157170382|FG001|Overall Study|Lost to Follow-up|5|||
48816197|NCT00854295|157170383|FG002|Overall Study|Lost to Follow-up|21|||
48816198|NCT00854295|157170384|FG003|Overall Study|Lost to Follow-up|21|||
48816199|NCT00854295|157170381|FG000|Overall Study|Physician Decision|10|||
48816200|NCT00854295|157170382|FG001|Overall Study|Physician Decision|0|||
48816201|NCT00854295|157170383|FG002|Overall Study|Physician Decision|0|||
48816202|NCT00854295|157170384|FG003|Overall Study|Physician Decision|0|||
48816203|NCT00709592|157170385|FG000|Overall Study|Unable to proceed to transplant|0|||
48816204|NCT00709592|157170386|FG001|Overall Study|Unable to proceed to transplant|1|||
48816205|NCT02726399|157170387|FG000|Overall Study|Participant Non-Compliance|1|||
48816206|NCT02726399|157170387|FG000|Overall Study|Adverse Event|2|||
48816207|NCT02726399|157170387|FG000|Overall Study|Progression of disease|4|||
48816208|NCT01254305|157170388|FG000|Overall Study|Adverse Event|6|||
48816209|NCT01254305|157170389|FG001|Overall Study|Adverse Event|3|||
48816210|NCT01254305|157170390|FG002|Overall Study|Adverse Event|2|||
48816211|NCT01254305|157170388|FG000|Overall Study|Lack of Efficacy|1|||
48816212|NCT01254305|157170389|FG001|Overall Study|Lack of Efficacy|0|||
48816213|NCT01254305|157170390|FG002|Overall Study|Lack of Efficacy|1|||
48816214|NCT01254305|157170388|FG000|Overall Study|Protocol Violation|1|||
48816215|NCT01254305|157170389|FG001|Overall Study|Protocol Violation|7|||
48816216|NCT01254305|157170390|FG002|Overall Study|Protocol Violation|3|||
48816217|NCT01254305|157170388|FG000|Overall Study|Withdrawal by Subject|4|||
48816218|NCT01254305|157170389|FG001|Overall Study|Withdrawal by Subject|2|||
48816219|NCT01254305|157170390|FG002|Overall Study|Withdrawal by Subject|4|||
48721073|NCT00409175|156828469|FG001|Overall Study|Withdrawal by Subject|2|||
48721074|NCT00409175|156828468|FG000|Overall Study|Negative genotype|0|||
48721075|NCT00409175|156828469|FG001|Overall Study|Negative genotype|1|||
48721076|NCT00409175|156828468|FG000|Overall Study|Liver transplantation|13|||
48721077|NCT00409175|156828469|FG001|Overall Study|Liver transplantation|13|||
48721078|NCT00282464|156828470|FG000|Overall Study|Adverse Event|26|||
48721079|NCT00282464|156828471|FG001|Overall Study|Adverse Event|20|||
48721080|NCT00282464|156828470|FG000|Overall Study|Lack of Efficacy|8|||
48721081|NCT00282464|156828471|FG001|Overall Study|Lack of Efficacy|8|||
48721082|NCT00282464|156828470|FG000|Overall Study|Lost to Follow-up|10|||
48721083|NCT00282464|156828471|FG001|Overall Study|Lost to Follow-up|10|||
48721084|NCT00282464|156828470|FG000|Overall Study|Withdrawal by Subject|24|||
48721085|NCT00282464|156828471|FG001|Overall Study|Withdrawal by Subject|10|||
48721086|NCT00282464|156828470|FG000|Overall Study|laboratory abnormality|1|||
48721087|NCT00282464|156828471|FG001|Overall Study|laboratory abnormality|2|||
48721088|NCT00282464|156828470|FG000|Overall Study|Protocol Violation|0|||
48721089|NCT00282464|156828471|FG001|Overall Study|Protocol Violation|7|||
48721090|NCT00282464|156828470|FG000|Overall Study|Patient moved|1|||
48721091|NCT00282464|156828471|FG001|Overall Study|Patient moved|0|||
48721092|NCT00282464|156828470|FG000|Overall Study|patient non-compliant|3|||
48721093|NCT00282464|156828471|FG001|Overall Study|patient non-compliant|0|||
48721094|NCT00282464|156828470|FG000|Overall Study|patient no show|0|||
48721095|NCT00282464|156828471|FG001|Overall Study|patient no show|1|||
48721096|NCT00282464|156828470|FG000|Overall Study|patient incarcerated|0|||
48721097|NCT00282464|156828471|FG001|Overall Study|patient incarcerated|1|||
48721098|NCT00282464|156828470|FG000|Overall Study|family crisis|0|||
48721099|NCT00282464|156828471|FG001|Overall Study|family crisis|1|||
48721100|NCT00282464|156828470|FG000|Overall Study|dispensed wrong kit|0|||
48721101|NCT00282464|156828471|FG001|Overall Study|dispensed wrong kit|1|||
48721102|NCT00282464|156828470|FG000|Overall Study|dropped due to missed visits|0|||
48721103|NCT00282464|156828471|FG001|Overall Study|dropped due to missed visits|1|||
48816220|NCT01254305|157170388|FG000|Overall Study|Lost to Follow-up|10|||
48816221|NCT01254305|157170389|FG001|Overall Study|Lost to Follow-up|6|||
48816222|NCT01254305|157170390|FG002|Overall Study|Lost to Follow-up|5|||
48816223|NCT01254305|157170388|FG000|Overall Study|Other Reasons|0|||
48816224|NCT01254305|157170389|FG001|Overall Study|Other Reasons|0|||
48816225|NCT01254305|157170390|FG002|Overall Study|Other Reasons|2|||
48920978|NCT01318109|157544805|FG001|Overall Study|Withdrawal by Subject|0|||
48721104|NCT05463198|156828472|FG000|Overall Study|Withdrawal by Subject|19|||
48816226|NCT05033743|157170391|FG000|Overall Study|Lost to Follow-up|1|||
48816227|NCT05033743|157170391|FG000|Overall Study|Protocol Violation|2|||
48816228|NCT05033743|157170391|FG000|Overall Study|Withdrawal by Subject|1|||
49129032|NCT01079780|158312302|FG001|Overall Study|Error made in lesion measurement|0|||
49129033|NCT01079780|158312303|FG002|Overall Study|Error made in lesion measurement|0|||
49129034|NCT01079780|158312301|FG000|Overall Study|Patient had surgery|1|||
49129035|NCT01079780|158312302|FG001|Overall Study|Patient had surgery|0|||
48816229|NCT01592695|157170407|FG000|Overall Study|Lost to Follow-up|8|||
48816230|NCT01592695|157170408|FG001|Overall Study|Lost to Follow-up|4|||
48816231|NCT02564055|157170409|FG000|Overall Study|Adverse Event|1|||
48816232|NCT02564055|157170410|FG001|Overall Study|Adverse Event|0|||
48816233|NCT02564055|157170411|FG002|Overall Study|Adverse Event|4|||
48816234|NCT02564055|157170412|FG003|Overall Study|Adverse Event|1|||
48816235|NCT02564055|157170413|FG004|Overall Study|Adverse Event|4|||
48816236|NCT02564055|157170414|FG005|Overall Study|Adverse Event|1|||
48816237|NCT02564055|157170409|FG000|Overall Study|Protocol Violation|1|||
48816238|NCT02564055|157170410|FG001|Overall Study|Protocol Violation|0|||
48816239|NCT02564055|157170411|FG002|Overall Study|Protocol Violation|0|||
48816240|NCT02564055|157170412|FG003|Overall Study|Protocol Violation|0|||
48816241|NCT02564055|157170413|FG004|Overall Study|Protocol Violation|0|||
48816242|NCT02564055|157170414|FG005|Overall Study|Protocol Violation|0|||
48816243|NCT02564055|157170409|FG000|Overall Study|Reached stopping criteria|0|||
48816244|NCT02564055|157170410|FG001|Overall Study|Reached stopping criteria|0|||
48816245|NCT02564055|157170411|FG002|Overall Study|Reached stopping criteria|0|||
48816246|NCT02564055|157170412|FG003|Overall Study|Reached stopping criteria|0|||
48816247|NCT02564055|157170413|FG004|Overall Study|Reached stopping criteria|0|||
48816248|NCT02564055|157170414|FG005|Overall Study|Reached stopping criteria|1|||
48816249|NCT02564055|157170409|FG000|Overall Study|Lost to Follow-up|0|||
48816250|NCT02564055|157170410|FG001|Overall Study|Lost to Follow-up|1|||
48816251|NCT02564055|157170411|FG002|Overall Study|Lost to Follow-up|4|||
49129036|NCT01079780|158312303|FG002|Overall Study|Patient had surgery|0|||
49129037|NCT01079780|158312301|FG000|Overall Study|Treatment cycle delay|0|||
49129038|NCT01079780|158312302|FG001|Overall Study|Treatment cycle delay|0|||
49129039|NCT01079780|158312303|FG002|Overall Study|Treatment cycle delay|1|||
49129040|NCT01079780|158312301|FG000|Overall Study|Never started treatment|1|||
49129041|NCT01079780|158312302|FG001|Overall Study|Never started treatment|0|||
49129042|NCT01079780|158312303|FG002|Overall Study|Never started treatment|2|||
49129043|NCT01178294|158312309|FG000|Overall Study|Adverse Event|4|||
49129044|NCT01178294|158312309|FG000|Overall Study|Lost to Follow-up|2|||
49129045|NCT01178294|158312309|FG000|Overall Study|Lack of Efficacy|1|||
49129046|NCT01178294|158312309|FG000|Overall Study|Death|1|||
49129047|NCT01178294|158312309|FG000|Overall Study|Development of inhibitors to OBI-1|1|||
49129048|NCT01178294|158312309|FG000|Overall Study|Subject status is terminal|1|||
49129049|NCT01178294|158312309|FG000|Overall Study|Completion status could not be verified|1|||
49129050|NCT03435055|158312310|FG000|Screening|Physician Decision|2|||
49129051|NCT03435055|158312310|FG000|Received Intervention|Did not complete nitrous administration|3|||
49129052|NCT01239797|158312311|FG000|Randomized Participants|Participant no longer meets study criteria|1|||
49129053|NCT01239797|158312312|FG001|Randomized Participants|Participant no longer meets study criteria|1|||
49129054|NCT01239797|158312311|FG000|Randomized Participants|Participant withdrew consent|1|||
49129055|NCT01239797|158312312|FG001|Randomized Participants|Participant withdrew consent|7|||
49129056|NCT01239797|158312311|FG000|Randomized Participants|Adverse event unrelated to study drug|0|||
49129057|NCT01239797|158312312|FG001|Randomized Participants|Adverse event unrelated to study drug|1|||
49129058|NCT01239797|158312311|FG000|Treated Participants|Disease progression|185|||
49129059|NCT01239797|158312312|FG001|Treated Participants|Disease progression|185|||
49129060|NCT01239797|158312311|FG000|Treated Participants|Study drug toxicity|39|||
49129061|NCT01239797|158312312|FG001|Treated Participants|Study drug toxicity|45|||
49129062|NCT01239797|158312311|FG000|Treated Participants|Adverse event unrelated to study drug|31|||
49129063|NCT01239797|158312312|FG001|Treated Participants|Adverse event unrelated to study drug|37|||
49129064|NCT01239797|158312311|FG000|Treated Participants|Participants request to discontinue study treatment|28|||
49129065|NCT01239797|158312312|FG001|Treated Participants|Participants request to discontinue study treatment|18|||
49129066|NCT01239797|158312311|FG000|Treated Participants|Administrative reason by sponsor|13|||
49129067|NCT01239797|158312312|FG001|Treated Participants|Administrative reason by sponsor|4|||
49129068|NCT01239797|158312311|FG000|Treated Participants|Other reasons|14|||
49129069|NCT01239797|158312312|FG001|Treated Participants|Other reasons|14|||
49129070|NCT01239797|158312311|FG000|Treated Participants|Participant withdrew consent|6|||
48816252|NCT02564055|157170412|FG003|Overall Study|Lost to Follow-up|2|||
48816253|NCT02564055|157170413|FG004|Overall Study|Lost to Follow-up|1|||
48816254|NCT02564055|157170414|FG005|Overall Study|Lost to Follow-up|0|||
48816255|NCT02564055|157170409|FG000|Overall Study|Physician Decision|0|||
48816256|NCT02564055|157170410|FG001|Overall Study|Physician Decision|0|||
48816257|NCT02564055|157170411|FG002|Overall Study|Physician Decision|1|||
48816258|NCT02564055|157170412|FG003|Overall Study|Physician Decision|0|||
48816259|NCT02564055|157170413|FG004|Overall Study|Physician Decision|0|||
49129071|NCT01239797|158312312|FG001|Treated Participants|Participant withdrew consent|11|||
49129072|NCT01239797|158312311|FG000|Treated Participants|Death|1|||
48816260|NCT02564055|157170414|FG005|Overall Study|Physician Decision|0|||
48816261|NCT02564055|157170409|FG000|Overall Study|Withdrawal by Subject|4|||
48816262|NCT02564055|157170410|FG001|Overall Study|Withdrawal by Subject|4|||
48816263|NCT02564055|157170411|FG002|Overall Study|Withdrawal by Subject|3|||
48816264|NCT02564055|157170412|FG003|Overall Study|Withdrawal by Subject|3|||
48816265|NCT02564055|157170413|FG004|Overall Study|Withdrawal by Subject|10|||
49129073|NCT01239797|158312312|FG001|Treated Participants|Death|1|||
48721105|NCT05463198|156828472|FG000|Overall Study|Procedure Notes Missing|18|||
48721106|NCT02815280|156828475|FG000|Double-Blind Phase|Adverse Event|1|||
48721107|NCT02815280|156828476|FG001|Double-Blind Phase|Adverse Event|1|||
48721108|NCT02815280|156828475|FG000|Double-Blind Phase|Lost to Follow-up|10|||
48721109|NCT02815280|156828476|FG001|Double-Blind Phase|Lost to Follow-up|9|||
48721110|NCT02815280|156828475|FG000|Double-Blind Phase|Withdrawal by Subject|20|||
48721111|NCT02815280|156828476|FG001|Double-Blind Phase|Withdrawal by Subject|11|||
48721112|NCT02815280|156828475|FG000|Double-Blind Phase|Protocol Violation|2|||
48721113|NCT02815280|156828476|FG001|Double-Blind Phase|Protocol Violation|2|||
48721114|NCT02815280|156828475|FG000|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3|||
48721115|NCT02815280|156828476|FG001|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2|||
48721116|NCT02815280|156828475|FG000|Open-Label Phase|Adverse Event|2|||
48721117|NCT02815280|156828476|FG001|Open-Label Phase|Adverse Event|3|||
48721118|NCT02815280|156828475|FG000|Open-Label Phase|Lost to Follow-up|18|||
48721119|NCT02815280|156828476|FG001|Open-Label Phase|Lost to Follow-up|9|||
48721120|NCT02815280|156828475|FG000|Open-Label Phase|Withdrawal by Subject|33|||
48721121|NCT02815280|156828476|FG001|Open-Label Phase|Withdrawal by Subject|18|||
48721122|NCT02815280|156828475|FG000|Open-Label Phase|Protocol Violation|3|||
48721123|NCT02815280|156828476|FG001|Open-Label Phase|Protocol Violation|0|||
48721124|NCT02815280|156828475|FG000|Open-Label Phase|Administrative|26|||
48721125|NCT02815280|156828476|FG001|Open-Label Phase|Administrative|12|||
48721126|NCT02815280|156828475|FG000|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5|||
48721127|NCT02815280|156828476|FG001|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2|||
48721128|NCT02158364|156828488|FG000|Overall Study|Case report forms uncollected|10|||
48721129|NCT02158364|156828488|FG000|Overall Study|Protocol Deviation|50|||
48721130|NCT02412488|156828489|FG000|Overall Study|Lost to Follow-up|10|||
48721131|NCT02412488|156828489|FG000|Overall Study|Withdrawal by Subject|5|||
48721132|NCT02412488|156828489|FG000|Overall Study|Physician Decision|1|||
48721133|NCT02412488|156828489|FG000|Overall Study|No Reveal LINQ Insertion Attempt|1|||
48721134|NCT02412488|156828489|FG000|Overall Study|Reveal LINQ explant|1|||
48721135|NCT04381988|156828490|FG000|Overall Study|The study was terminated|4|||
48721136|NCT04381988|156828491|FG001|Overall Study|The study was terminated|0|||
48721137|NCT02915874|156828492|FG000|Overall Study|Lost to Follow-up|5|||
48721138|NCT02915874|156828493|FG001|Overall Study|Lost to Follow-up|4|||
48721139|NCT02915874|156828492|FG000|Overall Study|Withdrawal by Subject|1|||
48721140|NCT02915874|156828493|FG001|Overall Study|Withdrawal by Subject|1|||
48721141|NCT02915874|156828492|FG000|Overall Study|Started New Anxiety Medication|0|||
48721142|NCT02915874|156828493|FG001|Overall Study|Started New Anxiety Medication|1|||
48721143|NCT02195011|156828494|FG000|Overall Study|Adverse Event|4|||
48721144|NCT02195011|156828495|FG001|Overall Study|Adverse Event|0|||
48721145|NCT02195011|156828494|FG000|Overall Study|Progressive Disease|18|||
48721146|NCT02195011|156828495|FG001|Overall Study|Progressive Disease|1|||
48721147|NCT02195011|156828494|FG000|Overall Study|Withdrawal by Subject|3|||
48721148|NCT02195011|156828495|FG001|Overall Study|Withdrawal by Subject|0|||
48721149|NCT00674154|156828496|FG000|Overall Study|Withdrawal by Subject|3|||
48721150|NCT00674154|156828497|FG001|Overall Study|Withdrawal by Subject|1|||
48721151|NCT00674154|156828496|FG000|Overall Study|Did not want parathyroidectomy|0|||
48721152|NCT00674154|156828497|FG001|Overall Study|Did not want parathyroidectomy|2|||
48721153|NCT01107379|156828498|FG000|Overall Study|Withdrawal by Subject|18|||
48721154|NCT01107379|156828498|FG000|Overall Study|Lost to Follow-up|3|||
48721155|NCT05093790|156828501|FG000|Overall Study|Failure to meet continuation criteria|0|||
48721156|NCT05093790|156828502|FG001|Overall Study|Failure to meet continuation criteria|0|||
48721157|NCT05093790|156828503|FG002|Overall Study|Failure to meet continuation criteria|1|||
48721158|NCT05093790|156828504|FG003|Overall Study|Failure to meet continuation criteria|0|||
48721159|NCT05093790|156828501|FG000|Overall Study|Adverse Event|1|||
48721160|NCT05093790|156828502|FG001|Overall Study|Adverse Event|0|||
48721161|NCT05093790|156828503|FG002|Overall Study|Adverse Event|0|||
48721162|NCT05093790|156828504|FG003|Overall Study|Adverse Event|0|||
48721163|NCT00548405|156828505|FG000|Overall Study|Adverse Event|6|||
48721164|NCT00548405|156828506|FG001|Overall Study|Adverse Event|2|||
48721165|NCT00548405|156828507|FG002|Overall Study|Adverse Event|0|||
48721166|NCT00548405|156828505|FG000|Overall Study|Lack of Efficacy|6|||
48721167|NCT00548405|156828506|FG001|Overall Study|Lack of Efficacy|0|||
48721168|NCT00548405|156828507|FG002|Overall Study|Lack of Efficacy|0|||
48721169|NCT00548405|156828505|FG000|Overall Study|Physician Decision|3|||
49129074|NCT01239797|158312311|FG000|Treated Participants|Participant no longer meets study criteria|1|||
48721170|NCT00548405|156828506|FG001|Overall Study|Physician Decision|4|||
48816266|NCT02564055|157170414|FG005|Overall Study|Withdrawal by Subject|10|||
48816267|NCT01804816|157170421|FG000|No Acupuncture (Initial 5 Weeks)|Withdrawal by Subject|3|||
48816268|NCT01804816|157170421|FG000|Acupuncture (Second 5 Weeks)|Physician Decision|1|||
48816269|NCT00474175|157170422|FG000|Overall Study|Lack of Efficacy|0|||
48816270|NCT00474175|157170423|FG001|Overall Study|Lack of Efficacy|0|||
48816271|NCT00474175|157170424|FG002|Overall Study|Lack of Efficacy|1|||
48816272|NCT00474175|157170422|FG000|Overall Study|Withdrawal by Subject|0|||
49129075|NCT01239797|158312312|FG001|Treated Participants|Participant no longer meets study criteria|1|||
48721171|NCT00548405|156828507|FG002|Overall Study|Physician Decision|1|||
48721172|NCT00548405|156828505|FG000|Overall Study|Pregnancy|1|||
48721173|NCT00548405|156828506|FG001|Overall Study|Pregnancy|0|||
48721174|NCT00548405|156828507|FG002|Overall Study|Pregnancy|0|||
48721175|NCT00548405|156828505|FG000|Overall Study|Protocol Violation|1|||
48721176|NCT00548405|156828506|FG001|Overall Study|Protocol Violation|0|||
48721177|NCT00548405|156828507|FG002|Overall Study|Protocol Violation|0|||
48721178|NCT00548405|156828505|FG000|Overall Study|Withdrawal by Subject|36|||
48721179|NCT00548405|156828506|FG001|Overall Study|Withdrawal by Subject|12|||
48721180|NCT00548405|156828507|FG002|Overall Study|Withdrawal by Subject|5|||
48721181|NCT00548405|156828505|FG000|Overall Study|Lost to Follow-up|1|||
48721182|NCT00548405|156828506|FG001|Overall Study|Lost to Follow-up|1|||
48721183|NCT00548405|156828507|FG002|Overall Study|Lost to Follow-up|2|||
48721184|NCT00548405|156828505|FG000|Overall Study|Death|0|||
48721185|NCT00548405|156828506|FG001|Overall Study|Death|1|||
48721186|NCT00548405|156828507|FG002|Overall Study|Death|1|||
48721187|NCT00548405|156828505|FG000|Overall Study|Sponsor decision|1|||
48721188|NCT00548405|156828506|FG001|Overall Study|Sponsor decision|0|||
48721189|NCT00548405|156828507|FG002|Overall Study|Sponsor decision|0|||
48721190|NCT00548405|156828505|FG000|Overall Study|Randomized but not treated|1|||
48721191|NCT00548405|156828506|FG001|Overall Study|Randomized but not treated|0|||
48721192|NCT00548405|156828507|FG002|Overall Study|Randomized but not treated|0|||
48721193|NCT01609478|156828509|FG000|Overall Study|Adverse Event|3|||
48721194|NCT01609478|156828510|FG001|Overall Study|Adverse Event|1|||
48721195|NCT01609478|156828511|FG002|Overall Study|Adverse Event|5|||
48721196|NCT01609478|156828509|FG000|Overall Study|Protocol Deviation|0|||
48721197|NCT01609478|156828510|FG001|Overall Study|Protocol Deviation|1|||
48721198|NCT01609478|156828511|FG002|Overall Study|Protocol Deviation|1|||
48721199|NCT01609478|156828509|FG000|Overall Study|Non-Compliance with study treatment|1|||
48721200|NCT01609478|156828510|FG001|Overall Study|Non-Compliance with study treatment|0|||
48721201|NCT01609478|156828511|FG002|Overall Study|Non-Compliance with study treatment|0|||
48721202|NCT01609478|156828509|FG000|Overall Study|Physician Decision|1|||
48721203|NCT01609478|156828510|FG001|Overall Study|Physician Decision|0|||
48721204|NCT01609478|156828511|FG002|Overall Study|Physician Decision|1|||
48721205|NCT01609478|156828509|FG000|Overall Study|Withdrawal by Subject|2|||
48721206|NCT01609478|156828510|FG001|Overall Study|Withdrawal by Subject|0|||
48721207|NCT01609478|156828511|FG002|Overall Study|Withdrawal by Subject|2|||
48721208|NCT00459056|156828512|FG000|First Intervention (First Three Months)|Lost to Follow-up|1|||
48721209|NCT00459056|156828513|FG001|First Intervention (First Three Months)|Lost to Follow-up|1|||
48721210|NCT02793622|156828514|FG000|Overall Study|Lost to Follow-up|31|||
48721211|NCT02793622|156828515|FG001|Overall Study|Lost to Follow-up|19|||
48721212|NCT02793622|156828514|FG000|Overall Study|Withdrawal by Subject|21|||
48721213|NCT02793622|156828515|FG001|Overall Study|Withdrawal by Subject|17|||
48721214|NCT02793622|156828514|FG000|Overall Study|Adverse Event|0|||
48721215|NCT02793622|156828515|FG001|Overall Study|Adverse Event|1|||
48721216|NCT02793622|156828514|FG000|Overall Study|Protocol Violation|1|||
48721217|NCT02793622|156828515|FG001|Overall Study|Protocol Violation|5|||
48721218|NCT00492063|156828516|FG000|Overall Study|Death|0|||
48721219|NCT00492063|156828517|FG001|Overall Study|Death|0|||
48721220|NCT00492063|156828518|FG002|Overall Study|Death|1|||
48721221|NCT00492063|156828519|FG003|Overall Study|Death|2|||
48721222|NCT00492063|156828516|FG000|Overall Study|Withdrawal by Subject|4|||
48721223|NCT00492063|156828517|FG001|Overall Study|Withdrawal by Subject|3|||
48721224|NCT00492063|156828518|FG002|Overall Study|Withdrawal by Subject|5|||
48721225|NCT00492063|156828519|FG003|Overall Study|Withdrawal by Subject|4|||
48721226|NCT00492063|156828516|FG000|Overall Study|Lost to Follow-up|6|||
48721227|NCT00492063|156828517|FG001|Overall Study|Lost to Follow-up|11|||
48721228|NCT00492063|156828518|FG002|Overall Study|Lost to Follow-up|5|||
48721229|NCT00492063|156828519|FG003|Overall Study|Lost to Follow-up|3|||
48721230|NCT00492063|156828516|FG000|Overall Study|Protocol Violation|0|||
48721231|NCT00492063|156828517|FG001|Overall Study|Protocol Violation|0|||
48721232|NCT00492063|156828518|FG002|Overall Study|Protocol Violation|0|||
48721233|NCT00492063|156828519|FG003|Overall Study|Protocol Violation|1|||
48721234|NCT00592774|156828522|FG000|Overall Study|Adverse Event|5|||
48816273|NCT00474175|157170423|FG001|Overall Study|Withdrawal by Subject|1|||
48816274|NCT00474175|157170424|FG002|Overall Study|Withdrawal by Subject|1|||
49129076|NCT01239797|158312311|FG000|Treated Participants|Poor/non-compliance|0|||
48721235|NCT00592774|156828523|FG001|Overall Study|Adverse Event|19|||
48721236|NCT00592774|156828524|FG002|Overall Study|Adverse Event|2|||
48721237|NCT00592774|156828525|FG003|Overall Study|Adverse Event|14|||
48721238|NCT00592774|156828526|FG004|Overall Study|Adverse Event|8|||
48816275|NCT00474175|157170422|FG000|Overall Study|Ineligible|1|||
48816276|NCT00474175|157170423|FG001|Overall Study|Ineligible|3|||
48816277|NCT00474175|157170424|FG002|Overall Study|Ineligible|1|||
48816278|NCT00474175|157170422|FG000|Overall Study|Protocol Violation|0|||
48816279|NCT00474175|157170423|FG001|Overall Study|Protocol Violation|2|||
48721239|NCT00592774|156828522|FG000|Overall Study|Protocol Violation|0|||
48816280|NCT00474175|157170424|FG002|Overall Study|Protocol Violation|1|||
48816281|NCT00474175|157170422|FG000|Overall Study|Administrative|0|||
48816282|NCT00474175|157170423|FG001|Overall Study|Administrative|1|||
48816283|NCT00474175|157170424|FG002|Overall Study|Administrative|0|||
48816284|NCT00919893|157170427|FG000|Overall Study|Protocol Violation|19|||
48816285|NCT00919893|157170428|FG001|Overall Study|Protocol Violation|9|||
48816286|NCT00197028|157170429|FG000|Overall Study|Adverse Event|2|||
48816287|NCT00197028|157170430|FG001|Overall Study|Adverse Event|2|||
48816288|NCT00197028|157170429|FG000|Overall Study|Protocol Violation|2|||
48816289|NCT00197028|157170430|FG001|Overall Study|Protocol Violation|1|||
48816290|NCT00197028|157170429|FG000|Overall Study|Withdrawal by Subject|8|||
48816291|NCT00197028|157170430|FG001|Overall Study|Withdrawal by Subject|12|||
48816292|NCT00197028|157170429|FG000|Overall Study|Lost to Follow-up|1|||
48816293|NCT00197028|157170430|FG001|Overall Study|Lost to Follow-up|0|||
48816294|NCT00197028|157170429|FG000|Overall Study|Other|3|||
48816295|NCT00197028|157170430|FG001|Overall Study|Other|6|||
48816296|NCT02287610|157170431|FG000|Overall Study|Lost to Follow-up|3|||
48816297|NCT02287610|157170431|FG000|Overall Study|Withdrawal by Subject|8|||
48816298|NCT02287610|157170431|FG000|Overall Study|Excluded-investigator non-responsiveness|5|||
48816299|NCT02080520|157170432|FG000|Overall Study|Self-reported symptoms|5|||
48816300|NCT02080520|157170433|FG001|Overall Study|Self-reported symptoms|6|||
48816301|NCT02080520|157170432|FG000|Overall Study|Unable to contact|2|||
48816302|NCT02080520|157170433|FG001|Overall Study|Unable to contact|1|||
48816303|NCT02080520|157170432|FG000|Overall Study|Initiated aspirin|2|||
48816304|NCT02080520|157170433|FG001|Overall Study|Initiated aspirin|0|||
48816305|NCT02080520|157170432|FG000|Overall Study|Atrial fibrillation|1|||
48816306|NCT02080520|157170433|FG001|Overall Study|Atrial fibrillation|1|||
48816307|NCT02080520|157170432|FG000|Overall Study|Cancer|1|||
48816308|NCT02080520|157170433|FG001|Overall Study|Cancer|2|||
48816309|NCT02080520|157170432|FG000|Overall Study|Not interested in study|1|||
48816310|NCT02080520|157170433|FG001|Overall Study|Not interested in study|3|||
48816311|NCT02080520|157170432|FG000|Overall Study|Too busy|1|||
48816312|NCT02080520|157170433|FG001|Overall Study|Too busy|1|||
48816313|NCT02080520|157170432|FG000|Overall Study|Work-related injury|1|||
48816314|NCT02080520|157170433|FG001|Overall Study|Work-related injury|0|||
48816315|NCT02080520|157170432|FG000|Overall Study|Personal reasons|0|||
48816316|NCT02080520|157170433|FG001|Overall Study|Personal reasons|3|||
48816317|NCT00794820|157170434|FG000|Overall Study|Adverse Event|11|||
48816318|NCT00794820|157170434|FG000|Overall Study|Secondary Malignancies|2|||
48816319|NCT00794820|157170434|FG000|Overall Study|Resistant Disease|2|||
48816320|NCT00794820|157170434|FG000|Overall Study|Ineligible/Screen Failure|1|||
48816321|NCT00432679|157170440|FG000|Overall Study|Adverse Event|2|||
48816322|NCT00432679|157170441|FG001|Overall Study|Adverse Event|1|||
48816323|NCT00432679|157170440|FG000|Overall Study|Withdrawal by Subject|3|||
48816324|NCT00432679|157170441|FG001|Overall Study|Withdrawal by Subject|2|||
48816325|NCT01923389|157170446|FG000|Overall Study|Protocol Violation|1|||
48816326|NCT01923389|157170447|FG001|Overall Study|Protocol Violation|0|||
48816327|NCT04267614|157170451|FG000|Overall Study|Participants did not meet inclusion criteria|132|||
49129077|NCT01239797|158312312|FG001|Treated Participants|Poor/non-compliance|1|||
48721240|NCT00592774|156828523|FG001|Overall Study|Protocol Violation|1|||
48721241|NCT00592774|156828524|FG002|Overall Study|Protocol Violation|0|||
48721242|NCT00592774|156828525|FG003|Overall Study|Protocol Violation|0|||
48721243|NCT00592774|156828526|FG004|Overall Study|Protocol Violation|1|||
48721244|NCT00592774|156828522|FG000|Overall Study|Withdrawal by Subject|3|||
48721245|NCT00592774|156828523|FG001|Overall Study|Withdrawal by Subject|7|||
48721246|NCT00592774|156828524|FG002|Overall Study|Withdrawal by Subject|0|||
48721247|NCT00592774|156828525|FG003|Overall Study|Withdrawal by Subject|0|||
48721248|NCT00592774|156828526|FG004|Overall Study|Withdrawal by Subject|0|||
48721249|NCT00592774|156828522|FG000|Overall Study|Lack of Efficacy|3|||
48816328|NCT04267614|157170451|FG000|Overall Study|Lost to Follow-up|115|||
48816329|NCT00088205|157170452|FG000|Overall Study|Adverse Event|4|||
48816330|NCT00088205|157170452|FG000|Overall Study|Progressive Disease|51|||
48816331|NCT00088205|157170452|FG000|Overall Study|Physician Decision|1|||
48816332|NCT00088205|157170452|FG000|Overall Study|Death Due to Study Disease|4|||
49129078|NCT03712280|158312313|FG000|Overall Study|Randomized, but not treated due to Adverse Event|0|||
48816333|NCT00988351|157170453|FG000|Overall Study|Withdrawal by Subject|8|||
48816334|NCT00988351|157170454|FG001|Overall Study|Withdrawal by Subject|0|||
48816335|NCT00988351|157170453|FG000|Overall Study|Lost to Follow-up|6|||
48816336|NCT00988351|157170454|FG001|Overall Study|Lost to Follow-up|9|||
48816337|NCT00988351|157170453|FG000|Overall Study|not using CPAP|5|||
48816338|NCT00988351|157170454|FG001|Overall Study|not using CPAP|3|||
48816339|NCT01364727|157170455|FG000|Overall Study|Not Eligible|2|||
48816340|NCT01310868|157170459|FG000|Overall Study|Do not have histologically confirmed GBM|13|||
48816341|NCT01558674|157170460|FG000|Part 1|Study Terminated by Sponsor|10|||
48816342|NCT01558674|157170461|FG001|Part 1|Study Terminated by Sponsor|0|||
48816343|NCT01558674|157170460|FG000|Part 1|Withdrawal by Subject|1|||
48816344|NCT01558674|157170461|FG001|Part 1|Withdrawal by Subject|0|||
48816345|NCT04297241|157170464|FG000|Overall Study|Withdrawal by Subject|1|||
48816346|NCT04297241|157170464|FG000|Overall Study|Adverse Event|1|||
48816347|NCT04297241|157170464|FG000|Overall Study|Physician Decision|3|||
48816348|NCT02411591|157170465|FG000|Overall Study|Adverse Event|0|||
48816349|NCT02411591|157170466|FG001|Overall Study|Adverse Event|4|||
48816350|NCT02411591|157170467|FG002|Overall Study|Adverse Event|2|||
48816351|NCT02411591|157170465|FG000|Overall Study|Withdrawal by Subject|0|||
48816352|NCT02411591|157170466|FG001|Overall Study|Withdrawal by Subject|3|||
48816353|NCT02411591|157170467|FG002|Overall Study|Withdrawal by Subject|0|||
48816354|NCT02411591|157170465|FG000|Overall Study|Physician Decision|0|||
48816355|NCT02411591|157170466|FG001|Overall Study|Physician Decision|3|||
48816356|NCT02411591|157170467|FG002|Overall Study|Physician Decision|1|||
48816357|NCT03044353|157170468|FG000|Overall Study|Adverse Event|0|||
48816358|NCT03044353|157170469|FG001|Overall Study|Adverse Event|1|||
48816359|NCT03044353|157170470|FG002|Overall Study|Adverse Event|0|||
48816360|NCT02141659|157170471|FG000|Overall Study|Major Protocol Deviation|0|||
48816361|NCT02141659|157170472|FG001|Overall Study|Major Protocol Deviation|1|||
48816362|NCT02141659|157170473|FG002|Overall Study|Major Protocol Deviation|0|||
48816363|NCT02141659|157170474|FG003|Overall Study|Major Protocol Deviation|0|||
48816364|NCT02141659|157170475|FG004|Overall Study|Major Protocol Deviation|0|||
48816365|NCT02141659|157170476|FG005|Overall Study|Major Protocol Deviation|0|||
48816366|NCT02141659|157170471|FG000|Overall Study|Lack of Efficacy|0|||
48816367|NCT02141659|157170472|FG001|Overall Study|Lack of Efficacy|0|||
48816368|NCT02141659|157170473|FG002|Overall Study|Lack of Efficacy|0|||
48816369|NCT02141659|157170474|FG003|Overall Study|Lack of Efficacy|0|||
48816370|NCT02141659|157170475|FG004|Overall Study|Lack of Efficacy|0|||
48816371|NCT02141659|157170476|FG005|Overall Study|Lack of Efficacy|1|||
48816372|NCT02141659|157170471|FG000|Overall Study|Pretreatment Event/ Adverse Event|0|||
48816373|NCT02141659|157170472|FG001|Overall Study|Pretreatment Event/ Adverse Event|0|||
48816374|NCT02141659|157170473|FG002|Overall Study|Pretreatment Event/ Adverse Event|0|||
48816375|NCT02141659|157170474|FG003|Overall Study|Pretreatment Event/ Adverse Event|0|||
48816376|NCT02141659|157170475|FG004|Overall Study|Pretreatment Event/ Adverse Event|2|||
48816377|NCT02141659|157170476|FG005|Overall Study|Pretreatment Event/ Adverse Event|1|||
48816378|NCT02954575|157170477|FG000|Overall Study|Withdrawal by Subject|2|||
48816379|NCT02954575|157170477|FG000|Overall Study|Adverse Event|1|||
48816380|NCT03358329|157170479|FG000|Overall Study|Lost to Follow-up|2|||
48816381|NCT03358329|157170479|FG000|Overall Study|Withdrawal by Subject|2|||
48816382|NCT01313923|157170480|FG000|Overall Study|Physician Decision|3|||
48816383|NCT02836613|157170483|FG000|Overall Study|Accidental drowning|1|||
48816384|NCT02836613|157170484|FG001|Overall Study|Accidental drowning|0|||
48816385|NCT02836613|157170483|FG000|Overall Study|Lost to Follow-up|0|||
48816386|NCT02836613|157170484|FG001|Overall Study|Lost to Follow-up|1|||
48816387|NCT02836613|157170483|FG000|Overall Study|Withdrawal by Subject|0|||
48816388|NCT02836613|157170484|FG001|Overall Study|Withdrawal by Subject|2|||
48816389|NCT03824938|157170485|FG000|Overall Study|Withdrawal by Subject|2|||
48816390|NCT03824938|157170486|FG001|Overall Study|Withdrawal by Subject|1|||
48816391|NCT03824938|157170487|FG002|Overall Study|Withdrawal by Subject|0|||
48816392|NCT03824938|157170488|FG003|Overall Study|Withdrawal by Subject|2|||
48816393|NCT03824938|157170489|FG004|Overall Study|Withdrawal by Subject|0|||
48816394|NCT03824938|157170490|FG005|Overall Study|Withdrawal by Subject|1|||
48816395|NCT03824938|157170485|FG000|Overall Study|Lost to Follow-up|0|||
48816396|NCT03824938|157170486|FG001|Overall Study|Lost to Follow-up|1|||
48816397|NCT03824938|157170487|FG002|Overall Study|Lost to Follow-up|0|||
48816398|NCT03824938|157170488|FG003|Overall Study|Lost to Follow-up|0|||
48816399|NCT03824938|157170489|FG004|Overall Study|Lost to Follow-up|1|||
48816400|NCT03824938|157170490|FG005|Overall Study|Lost to Follow-up|0|||
48816401|NCT01990300|157170491|FG000|Overall Study|Case Report Forms Uncollected|89|||
48816402|NCT01990300|157170491|FG000|Overall Study|Protocol Deviation|53|||
48816403|NCT00065468|157170494|FG000|Overall Study|Death|172|||
48816404|NCT00065468|157170495|FG001|Overall Study|Death|169|||
49129079|NCT03712280|158312314|FG001|Overall Study|Randomized, but not treated due to Adverse Event|1|||
48816405|NCT00065468|157170496|FG002|Overall Study|Death|171|||
48816406|NCT00065468|157170494|FG000|Overall Study|Withdrawal by Subject|3|||
48816407|NCT00065468|157170495|FG001|Overall Study|Withdrawal by Subject|4|||
49129080|NCT03712280|158312315|FG002|Overall Study|Randomized, but not treated due to Adverse Event|0|||
48816408|NCT00065468|157170496|FG002|Overall Study|Withdrawal by Subject|5|||
48816409|NCT00065468|157170494|FG000|Overall Study|Lost to Follow-up|5|||
48816410|NCT00065468|157170495|FG001|Overall Study|Lost to Follow-up|3|||
48816411|NCT00065468|157170496|FG002|Overall Study|Lost to Follow-up|2|||
48816412|NCT00065468|157170494|FG000|Overall Study|Discontinuation of study by Sponsor|13|||
48816413|NCT00065468|157170495|FG001|Overall Study|Discontinuation of study by Sponsor|9|||
48816414|NCT00065468|157170496|FG002|Overall Study|Discontinuation of study by Sponsor|13|||
48816415|NCT00065468|157170494|FG000|Overall Study|Disease progression|0|||
48816416|NCT00065468|157170495|FG001|Overall Study|Disease progression|0|||
48816417|NCT00065468|157170496|FG002|Overall Study|Disease progression|1|||
48816418|NCT00065468|157170494|FG000|Overall Study|Other|14|||
48816419|NCT00065468|157170495|FG001|Overall Study|Other|24|||
48816420|NCT00065468|157170496|FG002|Overall Study|Other|18|||
48816421|NCT01225835|157170497|FG000|Overall Study|Completed protocol|2|||
48816422|NCT01225835|157170498|FG001|Overall Study|Completed protocol|1|||
48816423|NCT01225835|157170497|FG000|Overall Study|Did not meet hCG criterion|2|||
48816424|NCT01225835|157170498|FG001|Overall Study|Did not meet hCG criterion|0|||
48816425|NCT01225835|157170497|FG000|Overall Study|Adverse Event|2|||
48816426|NCT01225835|157170498|FG001|Overall Study|Adverse Event|1|||
48816427|NCT01225835|157170497|FG000|Overall Study|Other|1|||
48816428|NCT01225835|157170498|FG001|Overall Study|Other|1|||
48816429|NCT03443323|157170499|FG000|Overall Study|Lost to Follow-up|2|||
48816430|NCT03443323|157170500|FG001|Overall Study|Lost to Follow-up|2|||
48816431|NCT03443323|157170499|FG000|Overall Study|PI withdrawal|1|||
48816432|NCT03443323|157170500|FG001|Overall Study|PI withdrawal|0|||
48816433|NCT02589392|157170501|FG000|Overall Study|Adverse Event|1|||
48816434|NCT02589392|157170502|FG001|Overall Study|Adverse Event|1|||
48816435|NCT02589392|157170501|FG000|Overall Study|Withdrawal by Subject|1|||
48816436|NCT02589392|157170502|FG001|Overall Study|Withdrawal by Subject|2|||
48816437|NCT02589392|157170501|FG000|Overall Study|Protocol Violation|1|||
48816438|NCT02589392|157170502|FG001|Overall Study|Protocol Violation|1|||
48816439|NCT02589392|157170501|FG000|Overall Study|Lost to Follow-up|2|||
48816440|NCT02589392|157170502|FG001|Overall Study|Lost to Follow-up|2|||
48816441|NCT02589392|157170501|FG000|Overall Study|Sponsor decision to withdraw subject|1|||
48816442|NCT02589392|157170502|FG001|Overall Study|Sponsor decision to withdraw subject|0|||
48816443|NCT04927364|157170508|FG000|Overall Study|Withdrawal by Subject|3|||
48816444|NCT04927364|157170508|FG000|Overall Study|Unable to complete preassessment MRI|1|||
48816445|NCT04585815|157170514|FG000|Sub-study A- Treatment Phase|Adverse Event|0|||
48816446|NCT04585815|157170515|FG001|Sub-study A- Treatment Phase|Adverse Event|1|||
48816447|NCT04585815|157170516|FG002|Sub-study A- Treatment Phase|Adverse Event|0|||
48816448|NCT04585815|157170517|FG003|Sub-study A- Treatment Phase|Adverse Event|0|||
48816449|NCT04585815|157170518|FG004|Sub-study A- Treatment Phase|Adverse Event|0|||
48816450|NCT04585815|157170519|FG005|Sub-study A- Treatment Phase|Adverse Event|0|||
48816451|NCT04585815|157170520|FG006|Sub-study A- Treatment Phase|Adverse Event|0|||
48816452|NCT04585815|157170514|FG000|Sub-study A- Treatment Phase|Death|0|||
48816453|NCT04585815|157170515|FG001|Sub-study A- Treatment Phase|Death|1|||
48816454|NCT04585815|157170516|FG002|Sub-study A- Treatment Phase|Death|0|||
48816455|NCT04585815|157170517|FG003|Sub-study A- Treatment Phase|Death|0|||
48816456|NCT04585815|157170518|FG004|Sub-study A- Treatment Phase|Death|0|||
48816457|NCT04585815|157170519|FG005|Sub-study A- Treatment Phase|Death|0|||
48816458|NCT04585815|157170520|FG006|Sub-study A- Treatment Phase|Death|0|||
48816459|NCT04585815|157170514|FG000|Sub-study A- Treatment Phase|Withdrawal by Subject|1|||
48816460|NCT04585815|157170515|FG001|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
48816461|NCT04585815|157170516|FG002|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
48816462|NCT04585815|157170517|FG003|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
48816463|NCT04585815|157170518|FG004|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
48816464|NCT04585815|157170519|FG005|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
48816465|NCT04585815|157170520|FG006|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
48816466|NCT04585815|157170514|FG000|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
48816467|NCT04585815|157170515|FG001|Sub-study A- Treatment Phase|Global deterioration of health status|1|||
48816468|NCT04585815|157170516|FG002|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
48816469|NCT04585815|157170517|FG003|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
48816470|NCT04585815|157170518|FG004|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
48721250|NCT00592774|156828523|FG001|Overall Study|Lack of Efficacy|3|||
48721251|NCT00592774|156828524|FG002|Overall Study|Lack of Efficacy|0|||
48721252|NCT00592774|156828525|FG003|Overall Study|Lack of Efficacy|0|||
48721253|NCT00592774|156828526|FG004|Overall Study|Lack of Efficacy|2|||
48721254|NCT00592774|156828522|FG000|Overall Study|Physician Decision|0|||
48721255|NCT00592774|156828523|FG001|Overall Study|Physician Decision|1|||
48721256|NCT00592774|156828524|FG002|Overall Study|Physician Decision|1|||
48721257|NCT00592774|156828525|FG003|Overall Study|Physician Decision|0|||
48721258|NCT00592774|156828526|FG004|Overall Study|Physician Decision|1|||
48816471|NCT04585815|157170519|FG005|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
48816472|NCT04585815|157170520|FG006|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
48816473|NCT04585815|157170514|FG000|Sub-study A- Treatment Phase|Other|1|||
48816474|NCT04585815|157170515|FG001|Sub-study A- Treatment Phase|Other|0|||
48816475|NCT04585815|157170516|FG002|Sub-study A- Treatment Phase|Other|0|||
48816476|NCT04585815|157170517|FG003|Sub-study A- Treatment Phase|Other|0|||
48816477|NCT04585815|157170518|FG004|Sub-study A- Treatment Phase|Other|0|||
48816478|NCT04585815|157170519|FG005|Sub-study A- Treatment Phase|Other|0|||
48816479|NCT04585815|157170520|FG006|Sub-study A- Treatment Phase|Other|0|||
49129081|NCT03712280|158312316|FG003|Overall Study|Randomized, but not treated due to Adverse Event|1|||
49129082|NCT03712280|158312313|FG000|Overall Study|Withdrawal by Participant or Caregiver|1|||
48816480|NCT04585815|157170514|FG000|Sub-study A- Treatment Phase|Ongoing treatment|2|||
48816481|NCT04585815|157170515|FG001|Sub-study A- Treatment Phase|Ongoing treatment|6|||
48816482|NCT04585815|157170516|FG002|Sub-study A- Treatment Phase|Ongoing treatment|0|||
48816483|NCT04585815|157170517|FG003|Sub-study A- Treatment Phase|Ongoing treatment|0|||
48816484|NCT04585815|157170518|FG004|Sub-study A- Treatment Phase|Ongoing treatment|0|||
48816485|NCT04585815|157170519|FG005|Sub-study A- Treatment Phase|Ongoing treatment|0|||
48816486|NCT04585815|157170520|FG006|Sub-study A- Treatment Phase|Ongoing treatment|0|||
48816487|NCT04585815|157170514|FG000|Sub-study A- Follow-up Phase|Ongoing in study|0|||
48816488|NCT04585815|157170515|FG001|Sub-study A- Follow-up Phase|Ongoing in study|1|||
48816489|NCT04585815|157170516|FG002|Sub-study A- Follow-up Phase|Ongoing in study|0|||
48816490|NCT04585815|157170517|FG003|Sub-study A- Follow-up Phase|Ongoing in study|0|||
48816491|NCT04585815|157170518|FG004|Sub-study A- Follow-up Phase|Ongoing in study|0|||
48816492|NCT04585815|157170519|FG005|Sub-study A- Follow-up Phase|Ongoing in study|0|||
48816493|NCT04585815|157170520|FG006|Sub-study A- Follow-up Phase|Ongoing in study|0|||
48816494|NCT04585815|157170514|FG000|Sub-study B- Treatment Phase|Adverse Event|0|||
48816495|NCT04585815|157170515|FG001|Sub-study B- Treatment Phase|Adverse Event|0|||
48816496|NCT04585815|157170516|FG002|Sub-study B- Treatment Phase|Adverse Event|0|||
48816497|NCT04585815|157170517|FG003|Sub-study B- Treatment Phase|Adverse Event|0|||
48816498|NCT04585815|157170518|FG004|Sub-study B- Treatment Phase|Adverse Event|0|||
48816499|NCT04585815|157170519|FG005|Sub-study B- Treatment Phase|Adverse Event|0|||
48816500|NCT04585815|157170520|FG006|Sub-study B- Treatment Phase|Adverse Event|2|||
48816501|NCT04585815|157170514|FG000|Sub-study B- Treatment Phase|Death|0|||
48816502|NCT04585815|157170515|FG001|Sub-study B- Treatment Phase|Death|0|||
48816503|NCT04585815|157170516|FG002|Sub-study B- Treatment Phase|Death|0|||
48816504|NCT04585815|157170517|FG003|Sub-study B- Treatment Phase|Death|1|||
48816505|NCT04585815|157170518|FG004|Sub-study B- Treatment Phase|Death|0|||
48816506|NCT04585815|157170519|FG005|Sub-study B- Treatment Phase|Death|0|||
48816507|NCT04585815|157170520|FG006|Sub-study B- Treatment Phase|Death|0|||
48816508|NCT04585815|157170514|FG000|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
48816509|NCT04585815|157170515|FG001|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
48816510|NCT04585815|157170516|FG002|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
48816511|NCT04585815|157170517|FG003|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
48816512|NCT04585815|157170518|FG004|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
48816513|NCT04585815|157170519|FG005|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
48816514|NCT04585815|157170520|FG006|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
48816515|NCT04585815|157170514|FG000|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
48816516|NCT04585815|157170515|FG001|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
48816517|NCT04585815|157170516|FG002|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
48816518|NCT04585815|157170517|FG003|Sub-study B- Treatment Phase|Global deterioration of health status|1|||
48816519|NCT04585815|157170518|FG004|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
48816520|NCT04585815|157170519|FG005|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
48816521|NCT04585815|157170520|FG006|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
48816522|NCT04585815|157170514|FG000|Sub-study B- Treatment Phase|Ongoing treatment|0|||
48721259|NCT00592774|156828522|FG000|Overall Study|Other|0|||
48721260|NCT00592774|156828523|FG001|Overall Study|Other|1|||
48721261|NCT00592774|156828524|FG002|Overall Study|Other|1|||
48920979|NCT01318109|157544806|FG002|Overall Study|Withdrawal by Subject|0|||
48920980|NCT01318109|157544804|FG000|Overall Study|Schedule Conflict|0|||
48920981|NCT01318109|157544805|FG001|Overall Study|Schedule Conflict|1|||
48920982|NCT01318109|157544806|FG002|Overall Study|Schedule Conflict|0|||
48920983|NCT01181011|157544815|FG000|Overall Study|Adverse Event|2|||
48920984|NCT01181011|157544815|FG000|Overall Study|Lost to Follow-up|1|||
48920985|NCT00784654|157544818|FG000|Open-Label Period (Non-Randomized)|Adverse Event|44|||
48920986|NCT00784654|157544819|FG001|Open-Label Period (Non-Randomized)|Adverse Event|0|||
48920987|NCT00784654|157544820|FG002|Open-Label Period (Non-Randomized)|Adverse Event|0|||
48920988|NCT00784654|157544818|FG000|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22|||
48920989|NCT00784654|157544819|FG001|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
48920990|NCT00784654|157544820|FG002|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
48721262|NCT00592774|156828525|FG003|Overall Study|Other|0|||
48721263|NCT00592774|156828526|FG004|Overall Study|Other|2|||
48721264|NCT00278915|156828527|FG000|Overall Study|Disease progression|1|||
48721265|NCT00586664|156828528|FG000|Overall Study|Withdrawal by Subject|3|||
48721266|NCT00586664|156828529|FG001|Overall Study|Withdrawal by Subject|7|||
48816523|NCT04585815|157170515|FG001|Sub-study B- Treatment Phase|Ongoing treatment|0|||
48816524|NCT04585815|157170516|FG002|Sub-study B- Treatment Phase|Ongoing treatment|0|||
48816525|NCT04585815|157170517|FG003|Sub-study B- Treatment Phase|Ongoing treatment|0|||
48816526|NCT04585815|157170518|FG004|Sub-study B- Treatment Phase|Ongoing treatment|0|||
48721267|NCT00586664|156828530|FG002|Overall Study|Withdrawal by Subject|1|||
48721268|NCT00586664|156828528|FG000|Overall Study|Exclusion criteria met|2|||
48721269|NCT00586664|156828529|FG001|Overall Study|Exclusion criteria met|0|||
48721270|NCT00586664|156828530|FG002|Overall Study|Exclusion criteria met|0|||
48721271|NCT01037088|156828535|FG000|Overall Study|Withdrawal by Subject|3|||
48721272|NCT01585584|156828546|FG000|Overall Study|Lack of Efficacy|1|||
48721273|NCT01585584|156828546|FG000|Overall Study|Withdrawal by Subject|1|||
48721274|NCT01585584|156828546|FG000|Overall Study|Physician Decision|2|||
48721275|NCT00527488|156828547|FG000|Overall Study|Withdrawn prior to dosing|0|||
48721276|NCT00527488|156828548|FG001|Overall Study|Withdrawn prior to dosing|1|||
48721277|NCT00527488|156828549|FG002|Overall Study|Withdrawn prior to dosing|1|||
48721278|NCT00527488|156828550|FG003|Overall Study|Withdrawn prior to dosing|0|||
48721279|NCT00266864|156828551|FG000|Overall Study|Lost to Follow-up|4|||
48721280|NCT00266864|156828552|FG001|Overall Study|Lost to Follow-up|1|||
48721281|NCT00266864|156828551|FG000|Overall Study|Withdrawal by Subject|1|||
48721282|NCT00266864|156828552|FG001|Overall Study|Withdrawal by Subject|1|||
48721283|NCT01330017|156829955|FG000|Overall Study|Adverse Event|0|||
48721284|NCT01330017|156829956|FG001|Overall Study|Adverse Event|1|||
48721285|NCT01330017|156829957|FG002|Overall Study|Adverse Event|1|||
48721286|NCT01330017|156829958|FG003|Overall Study|Adverse Event|4|||
48721287|NCT01330017|156829959|FG004|Overall Study|Adverse Event|0|||
48721288|NCT01330017|156829955|FG000|Overall Study|Withdrawal by Subject|0|||
48721289|NCT01330017|156829956|FG001|Overall Study|Withdrawal by Subject|0|||
48721290|NCT01330017|156829957|FG002|Overall Study|Withdrawal by Subject|1|||
48721291|NCT01330017|156829958|FG003|Overall Study|Withdrawal by Subject|0|||
48721292|NCT01330017|156829959|FG004|Overall Study|Withdrawal by Subject|1|||
48721293|NCT01330017|156829955|FG000|Overall Study|Lost to Follow-up|0|||
48721294|NCT01330017|156829956|FG001|Overall Study|Lost to Follow-up|0|||
48721295|NCT01330017|156829957|FG002|Overall Study|Lost to Follow-up|1|||
48721296|NCT01330017|156829958|FG003|Overall Study|Lost to Follow-up|0|||
48721297|NCT01330017|156829959|FG004|Overall Study|Lost to Follow-up|0|||
48721298|NCT01330017|156829955|FG000|Overall Study|Protocol Violation|0|||
48721299|NCT01330017|156829956|FG001|Overall Study|Protocol Violation|0|||
48721300|NCT01330017|156829957|FG002|Overall Study|Protocol Violation|0|||
48721301|NCT01330017|156829958|FG003|Overall Study|Protocol Violation|1|||
48721302|NCT01330017|156829959|FG004|Overall Study|Protocol Violation|0|||
48721303|NCT01330017|156829955|FG000|Overall Study|Unknown Reason|5|||
48721304|NCT01330017|156829956|FG001|Overall Study|Unknown Reason|3|||
48721305|NCT01330017|156829957|FG002|Overall Study|Unknown Reason|5|||
48721306|NCT01330017|156829958|FG003|Overall Study|Unknown Reason|7|||
48721307|NCT01330017|156829959|FG004|Overall Study|Unknown Reason|2|||
48721308|NCT00814333|156829960|FG000|Enrollment|Lost to Follow-up|1|||
48721309|NCT00814333|156829961|FG001|Enrollment|Lost to Follow-up|0|||
48721310|NCT00830869|156829962|FG000|Period 1: Part 1|Symptomatic deterioration|0|||
48721311|NCT00830869|156829963|FG001|Period 1: Part 1|Symptomatic deterioration|0|||
48721312|NCT00830869|156829964|FG002|Period 1: Part 1|Symptomatic deterioration|0|||
48721313|NCT00830869|156829965|FG003|Period 1: Part 1|Symptomatic deterioration|1|||
48721314|NCT00830869|156829966|FG004|Period 1: Part 1|Symptomatic deterioration|0|||
48721315|NCT00830869|156829967|FG005|Period 1: Part 1|Symptomatic deterioration|1|||
48721316|NCT00830869|156829968|FG006|Period 1: Part 1|Symptomatic deterioration|1|||
48721317|NCT00830869|156829969|FG007|Period 1: Part 1|Symptomatic deterioration|0|||
48721318|NCT00830869|156829970|FG008|Period 1: Part 1|Symptomatic deterioration|0|||
48721319|NCT00830869|156829971|FG009|Period 1: Part 1|Symptomatic deterioration|0|||
48721320|NCT00830869|156829972|FG010|Period 1: Part 1|Symptomatic deterioration|0|||
48721321|NCT00830869|156829973|FG011|Period 1: Part 1|Symptomatic deterioration|0|||
48721322|NCT00830869|156829962|FG000|Period 1: Part 1|Withdrawal by Subject|0|||
48721323|NCT00830869|156829963|FG001|Period 1: Part 1|Withdrawal by Subject|1|||
48721324|NCT00830869|156829964|FG002|Period 1: Part 1|Withdrawal by Subject|0|||
48721325|NCT00830869|156829965|FG003|Period 1: Part 1|Withdrawal by Subject|0|||
48721326|NCT00830869|156829966|FG004|Period 1: Part 1|Withdrawal by Subject|0|||
48721327|NCT00830869|156829967|FG005|Period 1: Part 1|Withdrawal by Subject|0|||
48721328|NCT00830869|156829968|FG006|Period 1: Part 1|Withdrawal by Subject|0|||
48721329|NCT00830869|156829969|FG007|Period 1: Part 1|Withdrawal by Subject|0|||
48721330|NCT00830869|156829970|FG008|Period 1: Part 1|Withdrawal by Subject|0|||
48721331|NCT00830869|156829971|FG009|Period 1: Part 1|Withdrawal by Subject|0|||
48721332|NCT00830869|156829972|FG010|Period 1: Part 1|Withdrawal by Subject|0|||
48721333|NCT00830869|156829973|FG011|Period 1: Part 1|Withdrawal by Subject|0|||
48721334|NCT00830869|156829962|FG000|Period 1: Part 1|Adverse Event|0|||
48721335|NCT00830869|156829963|FG001|Period 1: Part 1|Adverse Event|0|||
48721336|NCT00830869|156829964|FG002|Period 1: Part 1|Adverse Event|0|||
48721337|NCT00830869|156829965|FG003|Period 1: Part 1|Adverse Event|0|||
48721338|NCT00830869|156829966|FG004|Period 1: Part 1|Adverse Event|0|||
48721339|NCT00830869|156829967|FG005|Period 1: Part 1|Adverse Event|1|||
48816527|NCT04585815|157170519|FG005|Sub-study B- Treatment Phase|Ongoing treatment|0|||
48816528|NCT04585815|157170520|FG006|Sub-study B- Treatment Phase|Ongoing treatment|1|||
48816529|NCT04585815|157170514|FG000|Sub-study B- Treatment Phase|Progressive disease|0|||
48816530|NCT04585815|157170515|FG001|Sub-study B- Treatment Phase|Progressive disease|0|||
48816531|NCT04585815|157170516|FG002|Sub-study B- Treatment Phase|Progressive disease|3|||
48816532|NCT04585815|157170517|FG003|Sub-study B- Treatment Phase|Progressive disease|2|||
48816533|NCT04585815|157170518|FG004|Sub-study B- Treatment Phase|Progressive disease|2|||
48816534|NCT04585815|157170519|FG005|Sub-study B- Treatment Phase|Progressive disease|0|||
48816535|NCT04585815|157170520|FG006|Sub-study B- Treatment Phase|Progressive disease|4|||
48816536|NCT04585815|157170514|FG000|Sub-study B- Treatment Phase|Physician Decision|0|||
48816537|NCT04585815|157170515|FG001|Sub-study B- Treatment Phase|Physician Decision|0|||
48816538|NCT04585815|157170516|FG002|Sub-study B- Treatment Phase|Physician Decision|0|||
48816539|NCT04585815|157170517|FG003|Sub-study B- Treatment Phase|Physician Decision|1|||
48816540|NCT04585815|157170518|FG004|Sub-study B- Treatment Phase|Physician Decision|1|||
48816541|NCT04585815|157170519|FG005|Sub-study B- Treatment Phase|Physician Decision|1|||
48816542|NCT04585815|157170520|FG006|Sub-study B- Treatment Phase|Physician Decision|0|||
48816543|NCT04585815|157170514|FG000|Sub-study B- Follow-up Phase|Ongoing in study|0|||
48816544|NCT04585815|157170515|FG001|Sub-study B- Follow-up Phase|Ongoing in study|0|||
48816545|NCT04585815|157170516|FG002|Sub-study B- Follow-up Phase|Ongoing in study|0|||
48816546|NCT04585815|157170517|FG003|Sub-study B- Follow-up Phase|Ongoing in study|0|||
48816547|NCT04585815|157170518|FG004|Sub-study B- Follow-up Phase|Ongoing in study|1|||
48816548|NCT04585815|157170519|FG005|Sub-study B- Follow-up Phase|Ongoing in study|1|||
48816549|NCT04585815|157170520|FG006|Sub-study B- Follow-up Phase|Ongoing in study|3|||
48816550|NCT04585815|157170514|FG000|Sub-study B- Follow-up Phase|Death|0|||
48816551|NCT04585815|157170515|FG001|Sub-study B- Follow-up Phase|Death|0|||
48816552|NCT04585815|157170516|FG002|Sub-study B- Follow-up Phase|Death|1|||
48816553|NCT04585815|157170517|FG003|Sub-study B- Follow-up Phase|Death|3|||
48816554|NCT04585815|157170518|FG004|Sub-study B- Follow-up Phase|Death|0|||
48816555|NCT04585815|157170519|FG005|Sub-study B- Follow-up Phase|Death|0|||
48816556|NCT04585815|157170520|FG006|Sub-study B- Follow-up Phase|Death|1|||
48816557|NCT02262260|157170521|FG000|Overall Study|Adverse Event|4|||
48816558|NCT02262260|157170522|FG001|Overall Study|Adverse Event|1|||
48816559|NCT02262260|157170521|FG000|Overall Study|Withdrawal of consent|4|||
48816560|NCT02262260|157170522|FG001|Overall Study|Withdrawal of consent|2|||
48816561|NCT02262260|157170521|FG000|Overall Study|Lost to Follow-up|1|||
48816562|NCT02262260|157170522|FG001|Overall Study|Lost to Follow-up|2|||
48816563|NCT02262260|157170521|FG000|Overall Study|Protocol deviation|2|||
48816564|NCT02262260|157170522|FG001|Overall Study|Protocol deviation|5|||
48816565|NCT02169219|157170523|FG000|Overall Study|Lack of Efficacy|6|||
48816566|NCT04158648|157170525|FG000|Overall Study|Ongoing in the Study|69|||
48816567|NCT04158648|157170525|FG000|Overall Study|Withdrawal by Subject|4|||
48816568|NCT00924560|157170526|FG000|Overall Study|Did Not Meet Protocol Requirements|4|||
48816569|NCT00924560|157170527|FG001|Overall Study|Did Not Meet Protocol Requirements|2|||
48816570|NCT00924560|157170528|FG002|Overall Study|Did Not Meet Protocol Requirements|1|||
49129083|NCT03712280|158312314|FG001|Overall Study|Withdrawal by Participant or Caregiver|0|||
49129084|NCT03712280|158312315|FG002|Overall Study|Withdrawal by Participant or Caregiver|0|||
49129085|NCT03712280|158312316|FG003|Overall Study|Withdrawal by Participant or Caregiver|0|||
49129086|NCT03712280|158312313|FG000|Overall Study|Adverse Event|0|||
49129087|NCT03712280|158312314|FG001|Overall Study|Adverse Event|0|||
49129088|NCT03712280|158312315|FG002|Overall Study|Adverse Event|1|||
49129089|NCT03712280|158312316|FG003|Overall Study|Adverse Event|0|||
49129090|NCT02133508|158312324|FG000|Overall Study|Decision of Investigator or Sponsor|1|||
49129091|NCT02133508|158312324|FG000|Overall Study|Death|12|||
49129092|NCT02133508|158312324|FG000|Overall Study|Lost to Follow-up|2|||
49129093|NCT02643693|158312325|FG000|Overall Study|Physician Decision|0|||
49129094|NCT02643693|158312326|FG001|Overall Study|Physician Decision|1|||
49129095|NCT02643693|158312327|FG002|Overall Study|Physician Decision|0|||
49129096|NCT02643693|158312328|FG003|Overall Study|Physician Decision|0|||
49129097|NCT02643693|158312329|FG004|Overall Study|Physician Decision|0|||
49129098|NCT02643693|158312330|FG005|Overall Study|Physician Decision|0|||
49129099|NCT02643693|158312325|FG000|Overall Study|Withdrawal by Subject|0|||
49129100|NCT02643693|158312326|FG001|Overall Study|Withdrawal by Subject|1|||
49129101|NCT02643693|158312327|FG002|Overall Study|Withdrawal by Subject|0|||
49129102|NCT02643693|158312328|FG003|Overall Study|Withdrawal by Subject|0|||
49129103|NCT02643693|158312329|FG004|Overall Study|Withdrawal by Subject|0|||
48721340|NCT00830869|156829968|FG006|Period 1: Part 1|Adverse Event|1|||
48721341|NCT00830869|156829969|FG007|Period 1: Part 1|Adverse Event|0|||
48721342|NCT00830869|156829970|FG008|Period 1: Part 1|Adverse Event|0|||
48721343|NCT00830869|156829971|FG009|Period 1: Part 1|Adverse Event|0|||
48721344|NCT00830869|156829972|FG010|Period 1: Part 1|Adverse Event|0|||
48721345|NCT00830869|156829973|FG011|Period 1: Part 1|Adverse Event|0|||
48721346|NCT00830869|156829962|FG000|Period 1: Part 1|Progressive disease|1|||
48721347|NCT00830869|156829963|FG001|Period 1: Part 1|Progressive disease|0|||
48721348|NCT00830869|156829964|FG002|Period 1: Part 1|Progressive disease|1|||
48721349|NCT00830869|156829965|FG003|Period 1: Part 1|Progressive disease|6|||
48721350|NCT00830869|156829966|FG004|Period 1: Part 1|Progressive disease|4|||
48721351|NCT00830869|156829967|FG005|Period 1: Part 1|Progressive disease|4|||
48721352|NCT00830869|156829968|FG006|Period 1: Part 1|Progressive disease|1|||
48721353|NCT00830869|156829969|FG007|Period 1: Part 1|Progressive disease|0|||
48721354|NCT00830869|156829970|FG008|Period 1: Part 1|Progressive disease|0|||
48721355|NCT00830869|156829971|FG009|Period 1: Part 1|Progressive disease|0|||
48721356|NCT00830869|156829972|FG010|Period 1: Part 1|Progressive disease|0|||
48721357|NCT00830869|156829973|FG011|Period 1: Part 1|Progressive disease|0|||
48721358|NCT00830869|156829962|FG000|Period 2: Part 2|Protocol Violation|0|||
48721359|NCT00830869|156829963|FG001|Period 2: Part 2|Protocol Violation|0|||
48721360|NCT00830869|156829964|FG002|Period 2: Part 2|Protocol Violation|0|||
48816571|NCT00924560|157170526|FG000|Overall Study|Non Compliance with the Protocol|20|||
48816572|NCT00924560|157170527|FG001|Overall Study|Non Compliance with the Protocol|15|||
48816573|NCT00924560|157170528|FG002|Overall Study|Non Compliance with the Protocol|4|||
48816574|NCT00924560|157170526|FG000|Overall Study|Physician Decision|2|||
48816575|NCT00924560|157170527|FG001|Overall Study|Physician Decision|3|||
48816576|NCT00924560|157170528|FG002|Overall Study|Physician Decision|4|||
48816577|NCT00924560|157170526|FG000|Overall Study|Withdrawal by Subject|50|||
48816578|NCT00924560|157170527|FG001|Overall Study|Withdrawal by Subject|44|||
48816579|NCT00924560|157170528|FG002|Overall Study|Withdrawal by Subject|18|||
48816580|NCT00924560|157170526|FG000|Overall Study|Adverse Event|39|||
48816581|NCT00924560|157170527|FG001|Overall Study|Adverse Event|33|||
48816582|NCT00924560|157170528|FG002|Overall Study|Adverse Event|0|||
48816583|NCT00924560|157170526|FG000|Overall Study|Pregnancy|5|||
48816584|NCT00924560|157170527|FG001|Overall Study|Pregnancy|7|||
48816585|NCT00924560|157170528|FG002|Overall Study|Pregnancy|1|||
48816586|NCT00924560|157170526|FG000|Overall Study|Lost to Follow-up|78|||
48816587|NCT00924560|157170527|FG001|Overall Study|Lost to Follow-up|94|||
48816588|NCT00924560|157170528|FG002|Overall Study|Lost to Follow-up|45|||
48816589|NCT00924560|157170526|FG000|Overall Study|Miscellaneous Reasons|13|||
48816590|NCT00924560|157170527|FG001|Overall Study|Miscellaneous Reasons|10|||
48816591|NCT00924560|157170528|FG002|Overall Study|Miscellaneous Reasons|10|||
48816592|NCT04426006|157170529|FG000|Inclusion|Protocol Violation|1|||
48816593|NCT04426006|157170529|FG000|Inclusion|Self-administered questionnaire at inclusion not completed|7|||
48816594|NCT04426006|157170529|FG000|Inclusion|Blood sample at inclusion not done|1|||
48816595|NCT04426006|157170529|FG000|3 Months|Lost to Follow-up|17|||
48816596|NCT04426006|157170529|FG000|12 Months|Lost to Follow-up|38|||
48816597|NCT00550173|157170533|FG000|Overall Study|Death|45|||
48816598|NCT00550173|157170534|FG001|Overall Study|Death|38|||
48721361|NCT00830869|156829965|FG003|Period 2: Part 2|Protocol Violation|0|||
48721362|NCT00830869|156829966|FG004|Period 2: Part 2|Protocol Violation|0|||
48721363|NCT00830869|156829967|FG005|Period 2: Part 2|Protocol Violation|0|||
48721364|NCT00830869|156829968|FG006|Period 2: Part 2|Protocol Violation|0|||
48721365|NCT00830869|156829969|FG007|Period 2: Part 2|Protocol Violation|1|||
48721366|NCT00830869|156829970|FG008|Period 2: Part 2|Protocol Violation|0|||
48721367|NCT00830869|156829971|FG009|Period 2: Part 2|Protocol Violation|1|||
48721368|NCT00830869|156829972|FG010|Period 2: Part 2|Protocol Violation|0|||
48721369|NCT00830869|156829973|FG011|Period 2: Part 2|Protocol Violation|0|||
48816599|NCT00550173|157170535|FG002|Overall Study|Death|50|||
48721370|NCT00830869|156829962|FG000|Period 2: Part 2|Withdrawal by Subject|0|||
48721371|NCT00830869|156829963|FG001|Period 2: Part 2|Withdrawal by Subject|0|||
48721372|NCT00830869|156829964|FG002|Period 2: Part 2|Withdrawal by Subject|0|||
48721373|NCT00830869|156829965|FG003|Period 2: Part 2|Withdrawal by Subject|0|||
48721374|NCT00830869|156829966|FG004|Period 2: Part 2|Withdrawal by Subject|0|||
48721375|NCT00830869|156829967|FG005|Period 2: Part 2|Withdrawal by Subject|0|||
48721376|NCT00830869|156829968|FG006|Period 2: Part 2|Withdrawal by Subject|0|||
48721377|NCT00830869|156829969|FG007|Period 2: Part 2|Withdrawal by Subject|1|||
48721378|NCT00830869|156829970|FG008|Period 2: Part 2|Withdrawal by Subject|2|||
48721379|NCT00830869|156829971|FG009|Period 2: Part 2|Withdrawal by Subject|1|||
48721380|NCT00830869|156829972|FG010|Period 2: Part 2|Withdrawal by Subject|0|||
48721381|NCT00830869|156829973|FG011|Period 2: Part 2|Withdrawal by Subject|1|||
48721382|NCT00830869|156829962|FG000|Period 2: Part 2|Adverse Event|0|||
48816600|NCT00550173|157170533|FG000|Overall Study|Physician Decision|1|||
48816601|NCT00550173|157170534|FG001|Overall Study|Physician Decision|2|||
48721383|NCT00830869|156829963|FG001|Period 2: Part 2|Adverse Event|0|||
48721384|NCT00830869|156829964|FG002|Period 2: Part 2|Adverse Event|0|||
48721385|NCT00830869|156829965|FG003|Period 2: Part 2|Adverse Event|0|||
48816602|NCT00550173|157170535|FG002|Overall Study|Physician Decision|2|||
48816603|NCT00550173|157170533|FG000|Overall Study|Withdrawal by Subject|9|||
48816604|NCT00550173|157170534|FG001|Overall Study|Withdrawal by Subject|12|||
48816605|NCT00550173|157170535|FG002|Overall Study|Withdrawal by Subject|17|||
48816606|NCT00550173|157170533|FG000|Overall Study|Sponsor Decision|13|||
48816607|NCT00550173|157170534|FG001|Overall Study|Sponsor Decision|7|||
48816608|NCT00550173|157170535|FG002|Overall Study|Sponsor Decision|1|||
48816609|NCT00550173|157170533|FG000|Overall Study|Lost to Follow-up|4|||
48816610|NCT00550173|157170534|FG001|Overall Study|Lost to Follow-up|4|||
48816611|NCT00550173|157170535|FG002|Overall Study|Lost to Follow-up|3|||
48816612|NCT00097370|157170536|FG000|Stage 1|Adverse Event|3|||
48816613|NCT00097370|157170536|FG000|Stage 1|Withdrawal by Subject|1|||
48816614|NCT00097370|157170536|FG000|Stage 1|Lack of Efficacy|2|||
48816615|NCT00097370|157170536|FG000|Stage 2|Adverse Event|5|||
48816616|NCT00097370|157170536|FG000|Stage 2|Withdrawal by Subject|1|||
48816617|NCT00097370|157170536|FG000|Stage 2|Lack of Efficacy|3|||
48816618|NCT00097370|157170536|FG000|Stage 2|Pregnancy|1|||
48816619|NCT00097370|157170536|FG000|Stage 2|Sponsor Terminated Study|2|||
48816620|NCT00097370|157170536|FG000|Stage 2|Lost to Follow-up|1|||
48816621|NCT00097370|157170536|FG000|Stage 3|Adverse Event|2|||
48816622|NCT00097370|157170536|FG000|Stage 3|Withdrawal by Subject|3|||
48816623|NCT00097370|157170536|FG000|Stage 3|Lack of Efficacy|1|||
48816624|NCT00097370|157170536|FG000|Stage 3|Sponsor Terminated Study|52|||
48816625|NCT00097370|157170536|FG000|Stage 3|Lost to Follow-up|1|||
48816626|NCT00802659|157171997|FG000|Overall Study|Physician Decision|0|||
48816627|NCT00802659|157171998|FG001|Overall Study|Physician Decision|1|||
48816628|NCT00802659|157171999|FG002|Overall Study|Physician Decision|0|||
48816629|NCT00802659|157172000|FG003|Overall Study|Physician Decision|0|||
48816630|NCT00289770|157172002|FG000|Year 15|Withdrawal by Subject|1|||
48816631|NCT00737061|157172003|FG000|Waiting Period|Lost to Follow-up|6|||
48816632|NCT00737061|157172003|FG000|Waiting Period|Withdrawal by Subject|1|||
48816633|NCT00737061|157172003|FG000|Waiting Period|Bilateral placement failure|34|||
48816634|NCT00737061|157172003|FG000|Waiting Period|Deemed patent following HSG|26|||
48816635|NCT00737061|157172003|FG000|Waiting Period|Alternative contraception failure|3|||
48816636|NCT00737061|157172003|FG000|Waiting Period|Elected surgical tubal ligation|5|||
48816637|NCT00737061|157172003|FG000|1 Year Wearing Period|Lost to Follow-up|11|||
48816638|NCT00737061|157172003|FG000|1 Year Wearing Period|Withdrawal by Subject|2|||
48816639|NCT00737061|157172003|FG000|1 Year Wearing Period|Discontinued reilance|3|||
48816640|NCT00737061|157172003|FG000|1 Year Wearing Period|Terminated for protocol non-compliance|1|||
48816641|NCT02761629|157172004|FG000|Overall Study|Adverse Event/Intercurrent Illness|7|||
48816642|NCT02761629|157172005|FG001|Overall Study|Adverse Event/Intercurrent Illness|5|||
48816643|NCT02761629|157172004|FG000|Overall Study|Insufficient Therapeutic Response|2|||
48816644|NCT02761629|157172005|FG001|Overall Study|Insufficient Therapeutic Response|7|||
48816645|NCT02761629|157172004|FG000|Overall Study|Failure to Return|2|||
48816646|NCT02761629|157172005|FG001|Overall Study|Failure to Return|4|||
48816647|NCT02761629|157172004|FG000|Overall Study|Did not Cooperate/Refused Treatment|2|||
48816648|NCT02761629|157172005|FG001|Overall Study|Did not Cooperate/Refused Treatment|4|||
48816649|NCT02761629|157172004|FG000|Overall Study|Protocol Violation|2|||
48816650|NCT02761629|157172005|FG001|Overall Study|Protocol Violation|2|||
48816651|NCT02761629|157172004|FG000|Overall Study|Withdrawal by Subject|0|||
48816652|NCT02761629|157172005|FG001|Overall Study|Withdrawal by Subject|3|||
48816653|NCT02761629|157172004|FG000|Overall Study|Other|0|||
48816654|NCT02761629|157172005|FG001|Overall Study|Other|2|||
48816655|NCT02761629|157172004|FG000|Overall Study|Lost to Follow-up|4|||
48816656|NCT02761629|157172005|FG001|Overall Study|Lost to Follow-up|1|||
48816657|NCT02761629|157172004|FG000|Overall Study|Randomized But Not Treated|8|||
48816658|NCT02761629|157172005|FG001|Overall Study|Randomized But Not Treated|4|||
48816659|NCT04581824|157172006|FG000|Overall Study|Ongoing|75|||
48816660|NCT04581824|157172007|FG001|Overall Study|Ongoing|69|||
48816661|NCT04581824|157172006|FG000|Overall Study|Withdrawal by Subject|3|||
48816662|NCT04581824|157172007|FG001|Overall Study|Withdrawal by Subject|5|||
48816663|NCT04581824|157172006|FG000|Overall Study|Lost to Follow-up|1|||
48816664|NCT04581824|157172007|FG001|Overall Study|Lost to Follow-up|0|||
48816665|NCT04716881|157172010|FG000|Overall Study|Adverse Event|1|||
48816666|NCT04716881|157172010|FG000|Overall Study|Lost to Follow-up|1|||
48816667|NCT04147260|157172011|FG000|Overall Study|Adverse Event|1|||
48816668|NCT04147260|157172012|FG001|Overall Study|Adverse Event|0|||
48816669|NCT04147260|157172013|FG002|Overall Study|Adverse Event|1|||
48816670|NCT04147260|157172014|FG003|Overall Study|Adverse Event|2|||
48816671|NCT04147260|157172015|FG004|Overall Study|Adverse Event|0|||
48816672|NCT04147260|157172011|FG000|Overall Study|Withdrawal by Subject|0|||
48816673|NCT04147260|157172012|FG001|Overall Study|Withdrawal by Subject|0|||
48816674|NCT04147260|157172013|FG002|Overall Study|Withdrawal by Subject|1|||
48816675|NCT04147260|157172014|FG003|Overall Study|Withdrawal by Subject|1|||
48816676|NCT04147260|157172015|FG004|Overall Study|Withdrawal by Subject|0|||
48816677|NCT01555021|157172016|FG000|Overall Study|Lost to Follow-up|1|||
48816678|NCT01555021|157172017|FG001|Overall Study|Lost to Follow-up|2|||
48816679|NCT01266993|157172026|FG000|Booster Phase (Month 68-69)|Lost to Follow-up|5|||
48816680|NCT01266993|157172027|FG001|Booster Phase (Month 68-69)|Lost to Follow-up|1|||
48816681|NCT01266993|157172026|FG000|Booster Phase (Month 68-69)|Withdrawal by Subject|0|||
48721386|NCT00830869|156829966|FG004|Period 2: Part 2|Adverse Event|0|||
48721387|NCT00830869|156829967|FG005|Period 2: Part 2|Adverse Event|0|||
48721388|NCT00830869|156829968|FG006|Period 2: Part 2|Adverse Event|0|||
48721389|NCT00830869|156829969|FG007|Period 2: Part 2|Adverse Event|4|||
48721390|NCT00830869|156829970|FG008|Period 2: Part 2|Adverse Event|3|||
48721391|NCT00830869|156829971|FG009|Period 2: Part 2|Adverse Event|2|||
48721392|NCT00830869|156829972|FG010|Period 2: Part 2|Adverse Event|2|||
48721393|NCT00830869|156829973|FG011|Period 2: Part 2|Adverse Event|0|||
48721394|NCT00830869|156829962|FG000|Period 2: Part 2|Symptomatic Deterioration|0|||
48721395|NCT00830869|156829963|FG001|Period 2: Part 2|Symptomatic Deterioration|0|||
48721396|NCT00830869|156829964|FG002|Period 2: Part 2|Symptomatic Deterioration|0|||
48721397|NCT00830869|156829965|FG003|Period 2: Part 2|Symptomatic Deterioration|0|||
49129104|NCT02643693|158312330|FG005|Overall Study|Withdrawal by Subject|0|||
49129105|NCT02643693|158312325|FG000|Overall Study|Protocol Adherence Issues|2|||
49129106|NCT02643693|158312326|FG001|Overall Study|Protocol Adherence Issues|0|||
49129107|NCT02643693|158312327|FG002|Overall Study|Protocol Adherence Issues|1|||
49129108|NCT02643693|158312328|FG003|Overall Study|Protocol Adherence Issues|0|||
49129109|NCT02643693|158312329|FG004|Overall Study|Protocol Adherence Issues|0|||
49129110|NCT02643693|158312330|FG005|Overall Study|Protocol Adherence Issues|1|||
49129111|NCT01670292|158312332|FG000|Overall Study|Lost to Follow-up|14|||
49129112|NCT03903172|158312333|FG000|Overall Study|screen fail|4|||
49129113|NCT03903172|158312334|FG001|Overall Study|screen fail|1|||
49129114|NCT01701245|158312335|FG000|Overall Study|Protocol Violation|1|||
49129115|NCT01701245|158312336|FG001|Overall Study|Protocol Violation|3|||
49129116|NCT01701245|158312335|FG000|Overall Study|Did not complete the open label period|11|||
49129117|NCT01701245|158312336|FG001|Overall Study|Did not complete the open label period|12|||
49129118|NCT01787552|158312340|FG000|Overall Study|Withdrawal by Subject|2|||
49129119|NCT01787552|158312341|FG001|Overall Study|Withdrawal by Subject|0|||
49129120|NCT01787552|158312342|FG002|Overall Study|Withdrawal by Subject|0|||
49129121|NCT01787552|158312343|FG003|Overall Study|Withdrawal by Subject|4|||
49129122|NCT01787552|158312340|FG000|Overall Study|Physician Decision|2|||
49129123|NCT01787552|158312341|FG001|Overall Study|Physician Decision|2|||
49129124|NCT01787552|158312342|FG002|Overall Study|Physician Decision|1|||
49129125|NCT01787552|158312343|FG003|Overall Study|Physician Decision|2|||
49129126|NCT01787552|158312340|FG000|Overall Study|Death|0|||
49129127|NCT01787552|158312341|FG001|Overall Study|Death|0|||
49129128|NCT01787552|158312342|FG002|Overall Study|Death|0|||
49129129|NCT01787552|158312343|FG003|Overall Study|Death|1|||
49129130|NCT01787552|158312340|FG000|Overall Study|Adverse Event|2|||
49129131|NCT01787552|158312341|FG001|Overall Study|Adverse Event|5|||
49129132|NCT01787552|158312342|FG002|Overall Study|Adverse Event|2|||
49129133|NCT01787552|158312343|FG003|Overall Study|Adverse Event|16|||
49129134|NCT01787552|158312340|FG000|Overall Study|Study terminated by Sponsor|0|||
49129135|NCT01787552|158312341|FG001|Overall Study|Study terminated by Sponsor|0|||
49129136|NCT01787552|158312342|FG002|Overall Study|Study terminated by Sponsor|1|||
49129137|NCT01787552|158312343|FG003|Overall Study|Study terminated by Sponsor|3|||
49129138|NCT01787552|158312340|FG000|Overall Study|Progressive Disease|2|||
49129139|NCT01787552|158312341|FG001|Overall Study|Progressive Disease|2|||
49129140|NCT01787552|158312342|FG002|Overall Study|Progressive Disease|1|||
49129141|NCT01787552|158312343|FG003|Overall Study|Progressive Disease|1|||
49129142|NCT00207740|158312346|FG000|Overall Study|Adverse Event|4|||
49129143|NCT00207740|158312347|FG001|Overall Study|Adverse Event|14|||
49129144|NCT00207740|158312348|FG002|Overall Study|Adverse Event|14|||
49129145|NCT00207740|158312349|FG003|Overall Study|Adverse Event|11|||
49129146|NCT00207740|158312346|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
49129147|NCT00207740|158312347|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
49129148|NCT00207740|158312348|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
49129149|NCT00207740|158312349|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
49129150|NCT00207740|158312346|FG000|Overall Study|Lost to Follow-up|0|||
49129151|NCT00207740|158312347|FG001|Overall Study|Lost to Follow-up|2|||
49129152|NCT00207740|158312348|FG002|Overall Study|Lost to Follow-up|1|||
49129153|NCT00207740|158312349|FG003|Overall Study|Lost to Follow-up|1|||
49129154|NCT00207740|158312346|FG000|Overall Study|Death|0|||
48721398|NCT00830869|156829966|FG004|Period 2: Part 2|Symptomatic Deterioration|0|||
48721399|NCT00830869|156829967|FG005|Period 2: Part 2|Symptomatic Deterioration|0|||
48721400|NCT00830869|156829968|FG006|Period 2: Part 2|Symptomatic Deterioration|0|||
48721401|NCT00830869|156829969|FG007|Period 2: Part 2|Symptomatic Deterioration|0|||
49129155|NCT00207740|158312347|FG001|Overall Study|Death|0|||
49129156|NCT00207740|158312348|FG002|Overall Study|Death|0|||
48721402|NCT00830869|156829970|FG008|Period 2: Part 2|Symptomatic Deterioration|6|||
48721403|NCT00830869|156829971|FG009|Period 2: Part 2|Symptomatic Deterioration|3|||
48721404|NCT00830869|156829972|FG010|Period 2: Part 2|Symptomatic Deterioration|1|||
48721405|NCT00830869|156829973|FG011|Period 2: Part 2|Symptomatic Deterioration|4|||
49129157|NCT00207740|158312349|FG003|Overall Study|Death|1|||
49129158|NCT00207740|158312346|FG000|Overall Study|Sponsor Directive|22|||
49129159|NCT00207740|158312347|FG001|Overall Study|Sponsor Directive|15|||
49129160|NCT00207740|158312348|FG002|Overall Study|Sponsor Directive|16|||
49129161|NCT00207740|158312349|FG003|Overall Study|Sponsor Directive|21|||
49129162|NCT00207740|158312346|FG000|Overall Study|Other|2|||
48816682|NCT01266993|157172027|FG001|Booster Phase (Month 68-69)|Withdrawal by Subject|1|||
48816683|NCT03285113|157172030|FG000|Overall Study|Unable to implant leads|2|||
48816684|NCT03382600|157172031|FG000|Overall Study|Adverse Event|3|||
48816685|NCT03382600|157172032|FG001|Overall Study|Adverse Event|3|||
49129163|NCT00207740|158312347|FG001|Overall Study|Other|10|||
48816686|NCT03382600|157172031|FG000|Overall Study|Clinical Disease Progression|2|||
48816687|NCT03382600|157172032|FG001|Overall Study|Clinical Disease Progression|4|||
48816688|NCT03382600|157172031|FG000|Overall Study|Radiological Progression|40|||
48816689|NCT03382600|157172032|FG001|Overall Study|Radiological Progression|31|||
48816690|NCT03382600|157172031|FG000|Overall Study|Withdrawal by Subject|0|||
48816691|NCT03382600|157172032|FG001|Overall Study|Withdrawal by Subject|1|||
48816692|NCT03382600|157172031|FG000|Overall Study|Other|9|||
48816693|NCT03382600|157172032|FG001|Overall Study|Other|7|||
48816694|NCT01000376|157172033|FG000|Cycle 1 Day 1|Adverse Event|1|||
48816695|NCT01000376|157172034|FG001|Cycle 1 Day 1|Adverse Event|0|||
48816696|NCT01000376|157172033|FG000|Cycle 1 Day 1|Progressive Disease|1|||
48816697|NCT01000376|157172034|FG001|Cycle 1 Day 1|Progressive Disease|0|||
48816698|NCT00507026|157172035|FG000|Overall Study|Lack of Efficacy|6|||
48816699|NCT00507026|157172036|FG001|Overall Study|Lack of Efficacy|4|||
48816700|NCT00507026|157172037|FG002|Overall Study|Lack of Efficacy|21|||
48816701|NCT00507026|157172035|FG000|Overall Study|Withdrawal by Subject|2|||
48816702|NCT00507026|157172036|FG001|Overall Study|Withdrawal by Subject|0|||
48816703|NCT00507026|157172037|FG002|Overall Study|Withdrawal by Subject|0|||
48816704|NCT00507026|157172035|FG000|Overall Study|Investigator Decision|1|||
48816705|NCT00507026|157172036|FG001|Overall Study|Investigator Decision|0|||
48816706|NCT00507026|157172037|FG002|Overall Study|Investigator Decision|0|||
48816707|NCT00507026|157172035|FG000|Overall Study|Adverse Event|2|||
48816708|NCT00507026|157172036|FG001|Overall Study|Adverse Event|0|||
48816709|NCT00507026|157172037|FG002|Overall Study|Adverse Event|0|||
48816710|NCT00507026|157172035|FG000|Overall Study|Protocol Violation|1|||
48816711|NCT00507026|157172036|FG001|Overall Study|Protocol Violation|0|||
48816712|NCT00507026|157172037|FG002|Overall Study|Protocol Violation|0|||
48816713|NCT00507026|157172035|FG000|Overall Study|Other|1|||
48816714|NCT00507026|157172036|FG001|Overall Study|Other|0|||
48816715|NCT00507026|157172037|FG002|Overall Study|Other|0|||
48816716|NCT01058863|157172038|FG000|Overall Study|Lost to Follow-up|1|||
48816717|NCT01058863|157172038|FG000|Overall Study|Withdrawal by Subject|1|||
48816718|NCT01058863|157172038|FG000|Overall Study|Sponsor requested withdrawal|1|||
48816719|NCT01058863|157172038|FG000|Overall Study|Randomized in error|1|||
48816720|NCT02269943|157172040|FG000|Treatment Period|Death|0|||
48816721|NCT02269943|157172041|FG001|Treatment Period|Death|1|||
49129164|NCT00207740|158312348|FG002|Overall Study|Other|7|||
49129165|NCT00207740|158312349|FG003|Overall Study|Other|5|||
48721406|NCT00830869|156829962|FG000|Period 2: Part 2|Progressive disease|0|||
48721407|NCT00830869|156829963|FG001|Period 2: Part 2|Progressive disease|0|||
48721408|NCT00830869|156829964|FG002|Period 2: Part 2|Progressive disease|0|||
48721409|NCT00830869|156829965|FG003|Period 2: Part 2|Progressive disease|0|||
48721410|NCT00830869|156829966|FG004|Period 2: Part 2|Progressive disease|0|||
48721411|NCT00830869|156829967|FG005|Period 2: Part 2|Progressive disease|0|||
48721412|NCT00830869|156829968|FG006|Period 2: Part 2|Progressive disease|0|||
48721413|NCT00830869|156829969|FG007|Period 2: Part 2|Progressive disease|14|||
48721414|NCT00830869|156829970|FG008|Period 2: Part 2|Progressive disease|11|||
48721415|NCT00830869|156829971|FG009|Period 2: Part 2|Progressive disease|12|||
48721416|NCT00830869|156829972|FG010|Period 2: Part 2|Progressive disease|8|||
48721417|NCT00830869|156829973|FG011|Period 2: Part 2|Progressive disease|15|||
48721418|NCT00830869|156829962|FG000|Period 2: Part 2|Other|0|||
48721419|NCT00830869|156829963|FG001|Period 2: Part 2|Other|0|||
48721420|NCT00830869|156829964|FG002|Period 2: Part 2|Other|0|||
48721421|NCT00830869|156829965|FG003|Period 2: Part 2|Other|0|||
48721422|NCT00830869|156829966|FG004|Period 2: Part 2|Other|0|||
48721423|NCT00830869|156829967|FG005|Period 2: Part 2|Other|0|||
48721424|NCT00830869|156829968|FG006|Period 2: Part 2|Other|0|||
48721425|NCT00830869|156829969|FG007|Period 2: Part 2|Other|0|||
48721426|NCT00830869|156829970|FG008|Period 2: Part 2|Other|0|||
48721427|NCT00830869|156829971|FG009|Period 2: Part 2|Other|1|||
48721428|NCT00830869|156829972|FG010|Period 2: Part 2|Other|0|||
48721429|NCT00830869|156829973|FG011|Period 2: Part 2|Other|0|||
48816722|NCT02269943|157172040|FG000|Treatment Period|Adverse Event|1|||
48816723|NCT02269943|157172041|FG001|Treatment Period|Adverse Event|10|||
48816724|NCT02269943|157172040|FG000|Treatment Period|Progressive Disease|5|||
48816725|NCT02269943|157172041|FG001|Treatment Period|Progressive Disease|17|||
48816726|NCT02269943|157172040|FG000|Treatment Period|Symptomatic Deterioration|0|||
49129166|NCT00323063|158312350|FG000|Overall Study|Adverse Event|1|||
48721430|NCT00617669|156829974|FG000|Overall Study|Withdrawal by Subject|71|||
48721431|NCT00617669|156829975|FG001|Overall Study|Withdrawal by Subject|77|||
48721432|NCT00617669|156829974|FG000|Overall Study|Lost to Follow-up|3|||
48721433|NCT00617669|156829975|FG001|Overall Study|Lost to Follow-up|2|||
48816727|NCT02269943|157172041|FG001|Treatment Period|Symptomatic Deterioration|2|||
49129167|NCT00323063|158312351|FG001|Overall Study|Adverse Event|0|||
49129168|NCT00323063|158312350|FG000|Overall Study|brain mets discovered prior to treatment|1|||
49129169|NCT00323063|158312351|FG001|Overall Study|brain mets discovered prior to treatment|0|||
49129170|NCT03055936|158312352|FG000|Overall Study|Adverse Event|0|||
49129171|NCT03055936|158312353|FG001|Overall Study|Adverse Event|1|||
49129172|NCT03055936|158312354|FG002|Overall Study|Adverse Event|1|||
49129173|NCT03055936|158312355|FG003|Overall Study|Adverse Event|1|||
49129174|NCT03055936|158312352|FG000|Overall Study|Personal reason|2|||
49129175|NCT03055936|158312353|FG001|Overall Study|Personal reason|0|||
49129176|NCT03055936|158312354|FG002|Overall Study|Personal reason|1|||
49129177|NCT03055936|158312355|FG003|Overall Study|Personal reason|0|||
49129178|NCT00983372|158312362|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
49129179|NCT00983372|158312362|FG000|Diltiazem ER Alone|missed diltiazem dose|2|||
49129180|NCT00983372|158312362|FG000|Diltiazem ER Alone|Adverse Event|1|||
49129181|NCT00111761|158312372|FG000|Part 1|Physician Decision|0|||
49129182|NCT00111761|158312373|FG001|Part 1|Physician Decision|1|||
49129183|NCT00111761|158312372|FG000|Part 1|Death|0|||
49129184|NCT00111761|158312373|FG001|Part 1|Death|2|||
49129185|NCT00111761|158312372|FG000|Part 1|Other|0|||
49129186|NCT00111761|158312373|FG001|Part 1|Other|1|||
49129187|NCT00111761|158312372|FG000|Part 1|Withdrawal by Subject|0|||
49129188|NCT00111761|158312373|FG001|Part 1|Withdrawal by Subject|1|||
49129189|NCT00111761|158312372|FG000|Part 2|Adverse Event|1|||
49129190|NCT00111761|158312373|FG001|Part 2|Adverse Event|0|||
49129191|NCT00111761|158312372|FG000|Part 2|Physician Decision|1|||
49129192|NCT00111761|158312373|FG001|Part 2|Physician Decision|0|||
49129193|NCT00111761|158312372|FG000|Part 2|Death|1|||
49129194|NCT00111761|158312373|FG001|Part 2|Death|0|||
49129195|NCT00111761|158312372|FG000|Part 2|Disease progression|3|||
49129196|NCT00111761|158312373|FG001|Part 2|Disease progression|0|||
48721434|NCT00617669|156829974|FG000|Overall Study|Adverse Event|87|||
48721435|NCT00617669|156829975|FG001|Overall Study|Adverse Event|76|||
48721436|NCT00617669|156829974|FG000|Overall Study|Protocol Violation|2|||
48721437|NCT00617669|156829975|FG001|Overall Study|Protocol Violation|3|||
48721438|NCT00617669|156829974|FG000|Overall Study|Reason not otherwise captured, eg; death|265|||
48721439|NCT00617669|156829975|FG001|Overall Study|Reason not otherwise captured, eg; death|290|||
48721440|NCT00617669|156829974|FG000|Overall Study|Patients randomized but not treated|2|||
48721441|NCT00617669|156829975|FG001|Overall Study|Patients randomized but not treated|3|||
48721442|NCT00507728|156829976|FG000|Randomization to Month 3|Lost to Follow-up|15|||
48721443|NCT00507728|156829977|FG001|Randomization to Month 3|Lost to Follow-up|14|||
48721444|NCT00507728|156829978|FG002|Randomization to Month 3|Lost to Follow-up|20|||
48721445|NCT00507728|156829976|FG000|From 3 Months to 6 Months|Lost to Follow-up|6|||
48721446|NCT00507728|156829977|FG001|From 3 Months to 6 Months|Lost to Follow-up|10|||
48721447|NCT00507728|156829978|FG002|From 3 Months to 6 Months|Lost to Follow-up|9|||
48721448|NCT04590248|156829979|FG000|Overall Study|Lost to Follow-up|1|||
48721449|NCT04590248|156829979|FG000|Overall Study|Withdrawal by Subject|16|||
48721450|NCT04590248|156829979|FG000|Overall Study|Other|2|||
48721451|NCT02292784|156829980|FG000|Overall Study|Lost to Follow-up|1|||
48721452|NCT02292784|156829981|FG001|Overall Study|Lost to Follow-up|17|||
48721453|NCT02292784|156829982|FG002|Overall Study|Lost to Follow-up|18|||
48721454|NCT02292784|156829980|FG000|Overall Study|Withdrawal by Subject|0|||
48721455|NCT02292784|156829981|FG001|Overall Study|Withdrawal by Subject|3|||
48721456|NCT02292784|156829982|FG002|Overall Study|Withdrawal by Subject|3|||
48721457|NCT00348933|156829983|FG000|Overall Study|Withdrawal by Subject|10|||
48721458|NCT00348933|156829983|FG000|Overall Study|Lost to Follow-up|6|||
48721459|NCT00348933|156829983|FG000|Overall Study|Protocol Violation|2|||
48721460|NCT00348933|156829983|FG000|Overall Study|Adverse Event|7|||
48721461|NCT05347147|156829990|FG000|Overall Study|Lost to Follow-up|0|||
48721462|NCT05347147|156829991|FG001|Overall Study|Lost to Follow-up|1|||
48721463|NCT05347147|156829990|FG000|Overall Study|Sponsor request|3|||
48721464|NCT05347147|156829991|FG001|Overall Study|Sponsor request|3|||
48721465|NCT05347147|156829990|FG000|Overall Study|Study termination|2|||
48721466|NCT05347147|156829991|FG001|Overall Study|Study termination|1|||
48721467|NCT01350544|156829992|FG000|Overall Study|Administrative Withdrawal|0|||
48721468|NCT01350544|156829993|FG001|Overall Study|Administrative Withdrawal|1|||
48721469|NCT01350544|156829992|FG000|Overall Study|Death|1|||
48721470|NCT01350544|156829993|FG001|Overall Study|Death|2|||
48721471|NCT01350544|156829992|FG000|Overall Study|Moved out of LA County|2|||
48721472|NCT01350544|156829993|FG001|Overall Study|Moved out of LA County|2|||
48721473|NCT01350544|156829992|FG000|Overall Study|Medical Issues|1|||
48721474|NCT01350544|156829993|FG001|Overall Study|Medical Issues|1|||
48721475|NCT01350544|156829992|FG000|Overall Study|Withdrawal by Subject|0|||
48721476|NCT01350544|156829993|FG001|Overall Study|Withdrawal by Subject|1|||
48721477|NCT01350544|156829992|FG000|Overall Study|Incarceration|1|||
48721478|NCT01350544|156829993|FG001|Overall Study|Incarceration|0|||
48721479|NCT01350544|156829992|FG000|Overall Study|Lost to Follow-up|18|||
48721480|NCT01350544|156829993|FG001|Overall Study|Lost to Follow-up|15|||
48721481|NCT01444092|156829994|FG000|Overall Study|Adverse Event|8|||
48721482|NCT01444092|156829994|FG000|Overall Study|Protocol Violation|1|||
48816728|NCT02269943|157172040|FG000|Follow-Up Survival Period|Death|3|||
48816729|NCT02269943|157172041|FG001|Follow-Up Survival Period|Death|16|||
48816730|NCT02269943|157172040|FG000|Follow-Up Survival Period|Lost to Follow-up|0|||
48816731|NCT02269943|157172041|FG001|Follow-Up Survival Period|Lost to Follow-up|2|||
48816732|NCT02269943|157172040|FG000|Follow-Up Survival Period|Alive|2|||
48816733|NCT02269943|157172041|FG001|Follow-Up Survival Period|Alive|8|||
48816734|NCT03541642|157172042|FG000|Overall Study|Withdrawal by Subject|1|||
48816735|NCT03541642|157172043|FG001|Overall Study|Withdrawal by Subject|2|||
48816736|NCT03541642|157172042|FG000|Overall Study|Lost to Follow-up|16|||
48816737|NCT03541642|157172043|FG001|Overall Study|Lost to Follow-up|12|||
48816738|NCT03541642|157172042|FG000|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
48816739|NCT03541642|157172043|FG001|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
48816740|NCT00598481|157172044|FG000|Treatment|Physician Decision|1|||
48816741|NCT01083160|157172045|FG000|Overall Study|Adverse Event|1|||
48816742|NCT00972179|157172046|FG000|Overall Study|Noncompliance|1|||
48816743|NCT00972179|157172047|FG001|Overall Study|Noncompliance|0|||
48816744|NCT00972179|157172048|FG002|Overall Study|Noncompliance|0|||
48816745|NCT00972179|157172049|FG003|Overall Study|Noncompliance|0|||
48816746|NCT00972179|157172050|FG004|Overall Study|Noncompliance|1|||
48816747|NCT00972179|157172051|FG005|Overall Study|Noncompliance|0|||
48816748|NCT00972179|157172052|FG006|Overall Study|Noncompliance|1|||
48816749|NCT00972179|157172046|FG000|Overall Study|Withdrawal by Subject|0|||
48816750|NCT00972179|157172047|FG001|Overall Study|Withdrawal by Subject|3|||
48816751|NCT00972179|157172048|FG002|Overall Study|Withdrawal by Subject|0|||
48816752|NCT00972179|157172049|FG003|Overall Study|Withdrawal by Subject|1|||
48816753|NCT00972179|157172050|FG004|Overall Study|Withdrawal by Subject|0|||
48816754|NCT00972179|157172051|FG005|Overall Study|Withdrawal by Subject|0|||
48816755|NCT00972179|157172052|FG006|Overall Study|Withdrawal by Subject|2|||
48816756|NCT00972179|157172046|FG000|Overall Study|Administrative Decision|0|||
48816757|NCT00972179|157172047|FG001|Overall Study|Administrative Decision|0|||
48816758|NCT00972179|157172048|FG002|Overall Study|Administrative Decision|0|||
48816759|NCT00972179|157172049|FG003|Overall Study|Administrative Decision|0|||
48816760|NCT00972179|157172050|FG004|Overall Study|Administrative Decision|1|||
48816761|NCT00972179|157172051|FG005|Overall Study|Administrative Decision|0|||
48816762|NCT00972179|157172052|FG006|Overall Study|Administrative Decision|0|||
48816763|NCT00972179|157172046|FG000|Overall Study|Lost to Follow-up|0|||
48816764|NCT00972179|157172047|FG001|Overall Study|Lost to Follow-up|0|||
48816765|NCT00972179|157172048|FG002|Overall Study|Lost to Follow-up|1|||
48816766|NCT00972179|157172049|FG003|Overall Study|Lost to Follow-up|0|||
48816767|NCT00972179|157172050|FG004|Overall Study|Lost to Follow-up|0|||
48816768|NCT00972179|157172051|FG005|Overall Study|Lost to Follow-up|3|||
48816769|NCT00972179|157172052|FG006|Overall Study|Lost to Follow-up|1|||
48816770|NCT03232138|157172055|FG000|Overall Study|Physician Decision|1|||
48816771|NCT03232138|157172056|FG001|Overall Study|Physician Decision|0|||
48816772|NCT03232138|157172055|FG000|Overall Study|Adverse Event|2|||
48816773|NCT03232138|157172056|FG001|Overall Study|Adverse Event|0|||
48816774|NCT03232138|157172055|FG000|Overall Study|Withdrawal by Subject|1|||
48816775|NCT03232138|157172056|FG001|Overall Study|Withdrawal by Subject|2|||
48816776|NCT01163149|157172059|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
48816777|NCT01163149|157172060|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
48816778|NCT01163149|157172061|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
48816779|NCT01163149|157172059|FG000|Extension Treatment Period|Adverse Event|0|||
48816780|NCT01163149|157172060|FG001|Extension Treatment Period|Adverse Event|1|||
48816781|NCT01163149|157172061|FG002|Extension Treatment Period|Adverse Event|0|||
48816782|NCT01163149|157172059|FG000|Extension Treatment Period|Noncompliance|0|||
48816783|NCT01163149|157172060|FG001|Extension Treatment Period|Noncompliance|0|||
48816784|NCT01163149|157172061|FG002|Extension Treatment Period|Noncompliance|1|||
48816785|NCT01932996|157172062|FG000|Overall Study|Protocol Violation|2|||
48816786|NCT01932996|157172063|FG001|Overall Study|Protocol Violation|0|||
48816787|NCT03008122|157172065|FG000|Overall Study|Physician Decision|3|||
48816788|NCT03008122|157172066|FG001|Overall Study|Physician Decision|2|||
48816789|NCT03008122|157172067|FG002|Overall Study|Physician Decision|0|||
48816790|NCT03008122|157172065|FG000|Overall Study|Withdrawal by Subject|1|||
48816791|NCT03008122|157172066|FG001|Overall Study|Withdrawal by Subject|3|||
48816792|NCT03008122|157172067|FG002|Overall Study|Withdrawal by Subject|0|||
48816793|NCT03008122|157172065|FG000|Overall Study|Lost to Follow-up|4|||
48816794|NCT03008122|157172066|FG001|Overall Study|Lost to Follow-up|8|||
48816795|NCT03008122|157172067|FG002|Overall Study|Lost to Follow-up|3|||
48816796|NCT03008122|157172065|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
48816797|NCT03008122|157172066|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
48816798|NCT03008122|157172067|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
48816799|NCT03008122|157172065|FG000|Overall Study|Subject Unable to Attend Clinical Visit|1|||
48816800|NCT03008122|157172066|FG001|Overall Study|Subject Unable to Attend Clinical Visit|0|||
48816801|NCT03008122|157172067|FG002|Overall Study|Subject Unable to Attend Clinical Visit|0|||
48816802|NCT03008122|157172065|FG000|Overall Study|Death|0|||
48816803|NCT03008122|157172066|FG001|Overall Study|Death|0|||
49129197|NCT00111761|158312372|FG000|Part 2|Protocol-specified criteria|1|||
49129198|NCT00111761|158312373|FG001|Part 2|Protocol-specified criteria|0|||
49129199|NCT00111761|158312372|FG000|Part 2|Other|1|||
49129200|NCT00111761|158312373|FG001|Part 2|Other|0|||
49129201|NCT00726609|158312374|FG000|Overall Study|Adverse Event|10|||
49129202|NCT00726609|158312374|FG000|Overall Study|Withdrawal by Subject|2|||
49129203|NCT00726609|158312374|FG000|Overall Study|Lack of Efficacy|25|||
49129204|NCT00726609|158312374|FG000|Overall Study|Other|16|||
49129205|NCT00726609|158312374|FG000|Overall Study|Missing|42|||
49129206|NCT00726609|158312374|FG000|Overall Study|Other|3|||
49129207|NCT01764841|158312377|FG000|Overall Study|Logistical Difficulties|0|||
49129208|NCT01764841|158312378|FG001|Overall Study|Logistical Difficulties|1|||
49129209|NCT01764841|158312379|FG002|Overall Study|Logistical Difficulties|0|||
49129210|NCT01764841|158312380|FG003|Overall Study|Logistical Difficulties|0|||
49129211|NCT01764841|158312377|FG000|Overall Study|Death|3|||
49129212|NCT01764841|158312378|FG001|Overall Study|Death|0|||
49129213|NCT01764841|158312379|FG002|Overall Study|Death|1|||
49129214|NCT01764841|158312380|FG003|Overall Study|Death|4|||
49129215|NCT01764841|158312377|FG000|Overall Study|No Follow Up|1|||
49129216|NCT01764841|158312378|FG001|Overall Study|No Follow Up|0|||
49129217|NCT01764841|158312379|FG002|Overall Study|No Follow Up|1|||
49129218|NCT01764841|158312380|FG003|Overall Study|No Follow Up|0|||
49129219|NCT01764841|158312377|FG000|Overall Study|Protocol Violation|0|||
49129220|NCT01764841|158312378|FG001|Overall Study|Protocol Violation|1|||
49129221|NCT01764841|158312379|FG002|Overall Study|Protocol Violation|0|||
49129222|NCT01764841|158312380|FG003|Overall Study|Protocol Violation|0|||
49129223|NCT01764841|158312377|FG000|Overall Study|Withdrawal by Subject|16|||
49129224|NCT01764841|158312378|FG001|Overall Study|Withdrawal by Subject|24|||
48721483|NCT01444092|156829994|FG000|Overall Study|Withdrawal by Subject|1|||
48721484|NCT01444092|156829994|FG000|Overall Study|Other Eligibility criteria|7|||
49129225|NCT01764841|158312379|FG002|Overall Study|Withdrawal by Subject|11|||
49129226|NCT01764841|158312380|FG003|Overall Study|Withdrawal by Subject|15|||
49129227|NCT01764841|158312377|FG000|Overall Study|Lost to Follow-up|3|||
49129228|NCT01764841|158312378|FG001|Overall Study|Lost to Follow-up|0|||
49129229|NCT01764841|158312379|FG002|Overall Study|Lost to Follow-up|1|||
48721485|NCT03188042|156829995|FG000|Overall Study|Withdrawal by Subject|1|||
48721486|NCT03188042|156829996|FG001|Overall Study|Withdrawal by Subject|1|||
48721487|NCT00870103|156829997|FG000|Overall Study|Physician Decision|2|||
48721488|NCT00870103|156829997|FG000|Overall Study|Lost to Follow-up|2|||
48721489|NCT01122394|156830004|FG000|Overall Study|Withdrawal by Subject|1|||
48721490|NCT01122394|156830005|FG001|Overall Study|Withdrawal by Subject|1|||
48721491|NCT01122394|156830004|FG000|Overall Study|Lost to Follow-up|2|||
48721492|NCT01122394|156830005|FG001|Overall Study|Lost to Follow-up|2|||
48721493|NCT01122394|156830004|FG000|Overall Study|Adverse Event|0|||
48721494|NCT01122394|156830005|FG001|Overall Study|Adverse Event|1|||
48721495|NCT01343823|156830006|FG000|Overall Study|Study Terminated|1|||
48721496|NCT01343823|156830007|FG001|Overall Study|Study Terminated|0|||
48721497|NCT01343823|156830008|FG002|Overall Study|Study Terminated|0|||
48721498|NCT01343823|156830009|FG003|Overall Study|Study Terminated|1|||
48721499|NCT01343823|156830006|FG000|Overall Study|Withdrawal by Subject|1|||
48721500|NCT01343823|156830007|FG001|Overall Study|Withdrawal by Subject|0|||
48721501|NCT01343823|156830008|FG002|Overall Study|Withdrawal by Subject|0|||
48721502|NCT01343823|156830009|FG003|Overall Study|Withdrawal by Subject|0|||
48721503|NCT01752036|156830011|FG000|Overall Study|Death|2|||
48721504|NCT04173663|156830012|FG000|Overall Study|Withdrawal by Subject|1|||
48721505|NCT04173663|156830013|FG001|Overall Study|Withdrawal by Subject|6|||
48721506|NCT04173663|156830012|FG000|Overall Study|Lost to Follow-up|17|||
48721507|NCT04173663|156830013|FG001|Overall Study|Lost to Follow-up|24|||
48721508|NCT03474107|156830014|FG000|Overall Study|Adverse Event|42|||
48721509|NCT03474107|156830015|FG001|Overall Study|Adverse Event|46|||
48721510|NCT03474107|156830014|FG000|Overall Study|Death|2|||
48721511|NCT03474107|156830015|FG001|Overall Study|Death|2|||
48721512|NCT03474107|156830014|FG000|Overall Study|Lost to Follow-up|0|||
48721513|NCT03474107|156830015|FG001|Overall Study|Lost to Follow-up|1|||
48721514|NCT03474107|156830014|FG000|Overall Study|Progressive Disease|177|||
48721515|NCT03474107|156830015|FG001|Overall Study|Progressive Disease|180|||
48721516|NCT03474107|156830014|FG000|Overall Study|Protocol Violation|1|||
48721517|NCT03474107|156830015|FG001|Overall Study|Protocol Violation|1|||
48721518|NCT03474107|156830014|FG000|Overall Study|Withdrawal by Subject|15|||
48721519|NCT03474107|156830015|FG001|Overall Study|Withdrawal by Subject|27|||
48721520|NCT03474107|156830014|FG000|Overall Study|Physician Decision|7|||
48721521|NCT03474107|156830015|FG001|Overall Study|Physician Decision|22|||
49129230|NCT01764841|158312380|FG003|Overall Study|Lost to Follow-up|0|||
49129231|NCT02144701|158312387|FG000|Overall Study|development of relapse, GVHD or death|9|||
49129232|NCT02144701|158312388|FG001|Overall Study|development of relapse, GVHD or death|3|||
48721522|NCT03474107|156830014|FG000|Overall Study|Miscellaneous|1|||
48721523|NCT03474107|156830015|FG001|Overall Study|Miscellaneous|6|||
48721524|NCT05070429|156830017|FG000|Overall Study|Death|0|||
48721525|NCT05070429|156830018|FG001|Overall Study|Death|4|||
49129233|NCT01041859|158312391|FG000|Open-Label Titration|Adverse Event|69|||
48721526|NCT05070429|156830017|FG000|Overall Study|Withdrawal by Subject|2|||
48816804|NCT03008122|157172067|FG002|Overall Study|Death|1|||
48816805|NCT01848834|157172068|FG000|Overall Study|Adverse Event|3|||
48816806|NCT01848834|157172069|FG001|Overall Study|Adverse Event|11|||
48816807|NCT01848834|157172070|FG002|Overall Study|Adverse Event|3|||
48816808|NCT01848834|157172071|FG003|Overall Study|Adverse Event|5|||
49129234|NCT01041859|158312392|FG001|Open-Label Titration|Adverse Event|0|||
49129235|NCT01041859|158312393|FG002|Open-Label Titration|Adverse Event|0|||
49129236|NCT01041859|158312391|FG000|Open-Label Titration|Lack of Efficacy|3|||
48721527|NCT05070429|156830018|FG001|Overall Study|Withdrawal by Subject|1|||
48721528|NCT05070429|156830017|FG000|Overall Study|Other|15|||
48721529|NCT05070429|156830018|FG001|Overall Study|Other|5|||
48721530|NCT03780400|156830025|FG000|Overall Study|Lost to Follow-up|5|||
48721531|NCT03780400|156830025|FG000|Overall Study|Withdrawal by Subject|2|||
48721532|NCT04559529|156830035|FG000|First Intervention (1 Day)|Adverse Event|0|||
48721533|NCT04559529|156830036|FG001|First Intervention (1 Day)|Adverse Event|0|||
48721534|NCT04559529|156830037|FG002|First Intervention (1 Day)|Adverse Event|0|||
48721535|NCT04559529|156830038|FG003|First Intervention (1 Day)|Adverse Event|1|||
48721536|NCT04559529|156830035|FG000|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
48721537|NCT04559529|156830036|FG001|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
48721538|NCT04559529|156830037|FG002|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|1|||
48721539|NCT04559529|156830038|FG003|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
48721540|NCT04559529|156830035|FG000|Second Intervention (1 Day)|Lost to Follow-up|0|||
48721541|NCT04559529|156830036|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
48721542|NCT04559529|156830037|FG002|Second Intervention (1 Day)|Lost to Follow-up|1|||
48721543|NCT04559529|156830038|FG003|Second Intervention (1 Day)|Lost to Follow-up|0|||
48721544|NCT00484185|156830040|FG000|Overall Study|Lost to Follow-up|44|||
48721545|NCT00484185|156830040|FG000|Overall Study|Other|20|||
48721546|NCT00484185|156830040|FG000|Overall Study|Randomized but not treated|5|||
48721547|NCT00484185|156830040|FG000|Overall Study|Death|2|||
48721548|NCT05615935|156830042|FG000|Overall Study|Lost to Follow-up|1|||
48721549|NCT05615935|156830043|FG001|Overall Study|Lost to Follow-up|1|||
48721550|NCT01092832|156830044|FG000|Overall Study|Other|1|||
48721551|NCT01092832|156830045|FG001|Overall Study|Other|0|||
48721552|NCT02635646|156830054|FG000|Overall Study|Lost to Follow-up|24|||
48721553|NCT02635646|156830055|FG001|Overall Study|Lost to Follow-up|25|||
48721554|NCT02635646|156830054|FG000|Overall Study|Pregnancy|1|||
48721555|NCT02635646|156830055|FG001|Overall Study|Pregnancy|1|||
48721556|NCT03189381|156830064|FG000|Overall Study|Death|1|||
48721557|NCT03189381|156830065|FG001|Overall Study|Death|0|||
48721558|NCT00251004|156830066|FG000|Overall Study|Withdrawal by Subject|23|||
48721559|NCT00251004|156830067|FG001|Overall Study|Withdrawal by Subject|16|||
48721560|NCT00251004|156830068|FG002|Overall Study|Withdrawal by Subject|14|||
48721561|NCT00251004|156830066|FG000|Overall Study|Death|9|||
48721562|NCT00251004|156830067|FG001|Overall Study|Death|10|||
48721563|NCT00251004|156830068|FG002|Overall Study|Death|8|||
48721564|NCT00251004|156830066|FG000|Overall Study|Lost to Follow-up|1|||
48721565|NCT00251004|156830067|FG001|Overall Study|Lost to Follow-up|2|||
48721566|NCT00251004|156830068|FG002|Overall Study|Lost to Follow-up|1|||
48721567|NCT00251004|156830066|FG000|Overall Study|Graft Loss|12|||
48721568|NCT00251004|156830067|FG001|Overall Study|Graft Loss|13|||
48721569|NCT00251004|156830068|FG002|Overall Study|Graft Loss|8|||
48721570|NCT01077375|156830069|FG000|Overall Study|Adverse Event|2|||
48721571|NCT01077375|156830070|FG001|Overall Study|Adverse Event|15|||
48721572|NCT01077375|156830069|FG000|Overall Study|Lack of Efficacy|6|||
48721573|NCT01077375|156830070|FG001|Overall Study|Lack of Efficacy|8|||
48721574|NCT01077375|156830069|FG000|Overall Study|Withdrawal by Subject|0|||
48721575|NCT01077375|156830070|FG001|Overall Study|Withdrawal by Subject|6|||
48721576|NCT01077375|156830069|FG000|Overall Study|Lost to Follow-up|2|||
48721577|NCT01077375|156830070|FG001|Overall Study|Lost to Follow-up|5|||
48721578|NCT01077375|156830069|FG000|Overall Study|Other Reason|0|||
48721579|NCT01077375|156830070|FG001|Overall Study|Other Reason|1|||
48721580|NCT01244490|156830071|FG000|Overall Study|Lack of Efficacy|14|||
48721581|NCT01244490|156830072|FG001|Overall Study|Lack of Efficacy|5|||
48816809|NCT01848834|157172072|FG004|Overall Study|Adverse Event|9|||
48816810|NCT01848834|157172068|FG000|Overall Study|Death|2|||
48816811|NCT01848834|157172069|FG001|Overall Study|Death|11|||
49129237|NCT01041859|158312392|FG001|Open-Label Titration|Lack of Efficacy|0|||
48721582|NCT01244490|156830073|FG002|Overall Study|Lack of Efficacy|5|||
48721583|NCT01244490|156830071|FG000|Overall Study|Withdrawal by Subject|4|||
48721584|NCT01244490|156830072|FG001|Overall Study|Withdrawal by Subject|4|||
48721585|NCT01244490|156830073|FG002|Overall Study|Withdrawal by Subject|9|||
48721586|NCT01244490|156830071|FG000|Overall Study|Adverse Event|1|||
48721587|NCT01244490|156830072|FG001|Overall Study|Adverse Event|9|||
48721588|NCT01244490|156830073|FG002|Overall Study|Adverse Event|5|||
48721589|NCT01244490|156830071|FG000|Overall Study|Lost to Follow-up|0|||
48721590|NCT01244490|156830072|FG001|Overall Study|Lost to Follow-up|6|||
48721591|NCT01244490|156830073|FG002|Overall Study|Lost to Follow-up|3|||
48816812|NCT01848834|157172070|FG002|Overall Study|Death|1|||
48816813|NCT01848834|157172071|FG003|Overall Study|Death|8|||
48721592|NCT01244490|156830071|FG000|Overall Study|Other|0|||
48721593|NCT01244490|156830072|FG001|Overall Study|Other|0|||
48816814|NCT01848834|157172072|FG004|Overall Study|Death|27|||
48816815|NCT01848834|157172068|FG000|Overall Study|Excluded Medication|5|||
48816816|NCT01848834|157172069|FG001|Overall Study|Excluded Medication|4|||
48816817|NCT01848834|157172070|FG002|Overall Study|Excluded Medication|3|||
48816818|NCT01848834|157172071|FG003|Overall Study|Excluded Medication|6|||
48816819|NCT01848834|157172072|FG004|Overall Study|Excluded Medication|6|||
48816820|NCT01848834|157172068|FG000|Overall Study|Lost to Follow-up|5|||
48816821|NCT01848834|157172069|FG001|Overall Study|Lost to Follow-up|5|||
48816822|NCT01848834|157172070|FG002|Overall Study|Lost to Follow-up|3|||
48816823|NCT01848834|157172071|FG003|Overall Study|Lost to Follow-up|0|||
48816824|NCT01848834|157172072|FG004|Overall Study|Lost to Follow-up|3|||
48721594|NCT01244490|156830073|FG002|Overall Study|Other|1|||
48721595|NCT04719832|156830078|FG000|Overall Study|Adverse Event|2|||
48721596|NCT04719832|156830079|FG001|Overall Study|Adverse Event|0|||
48721597|NCT04719832|156830078|FG000|Overall Study|Lack of Efficacy|2|||
48721598|NCT04719832|156830079|FG001|Overall Study|Lack of Efficacy|4|||
48721599|NCT04719832|156830078|FG000|Overall Study|Lost to Follow-up|0|||
48721600|NCT04719832|156830079|FG001|Overall Study|Lost to Follow-up|2|||
48721601|NCT04719832|156830078|FG000|Overall Study|Physician Decision|0|||
48721602|NCT04719832|156830079|FG001|Overall Study|Physician Decision|1|||
48721603|NCT04719832|156830078|FG000|Overall Study|Pregnancy|1|||
48721604|NCT04719832|156830079|FG001|Overall Study|Pregnancy|1|||
48721605|NCT04719832|156830078|FG000|Overall Study|Withdrawal by Subject|5|||
48721606|NCT04719832|156830079|FG001|Overall Study|Withdrawal by Subject|5|||
48721607|NCT04719832|156830078|FG000|Overall Study|Randomized, not treated|0|||
48721608|NCT04719832|156830079|FG001|Overall Study|Randomized, not treated|2|||
48721609|NCT04719832|156830078|FG000|Overall Study|GCP violations|4|||
48721610|NCT04719832|156830079|FG001|Overall Study|GCP violations|7|||
48721611|NCT01343901|156830080|FG000|Overall Study|Death|85|||
48721612|NCT01343901|156830080|FG000|Overall Study|Physician Decision|4|||
48721613|NCT01343901|156830080|FG000|Overall Study|Lost to Follow-up|12|||
48721614|NCT01343901|156830080|FG000|Overall Study|Management by another medical team|11|||
48721615|NCT01343901|156830080|FG000|Overall Study|Participant decision|1|||
48721616|NCT02232880|156830081|FG000|Overall Study|study stopped prior to randomization|1|||
48721617|NCT01958827|156830082|FG000|Overall Study|Adverse Event|3|||
48721618|NCT01958827|156830082|FG000|Overall Study|Lack of Efficacy|6|||
48721619|NCT01958827|156830082|FG000|Overall Study|Concomitant Prohibited Medicine for AE|1|||
48721620|NCT00604214|156830083|FG000|Baseline to Day 28|Death|223|||
48721621|NCT00604214|156830084|FG001|Baseline to Day 28|Death|202|||
48721622|NCT00604214|156830083|FG000|Baseline to Day 28|Lost to Follow-up|2|||
48721623|NCT00604214|156830084|FG001|Baseline to Day 28|Lost to Follow-up|4|||
48721624|NCT00604214|156830083|FG000|Baseline to Day 28|Withdrawal by Subject|3|||
48721625|NCT00604214|156830084|FG001|Baseline to Day 28|Withdrawal by Subject|7|||
48721626|NCT00604214|156830083|FG000|Day 29 to Day 90|Death|64|||
48721627|NCT00604214|156830084|FG001|Day 29 to Day 90|Death|67|||
48816825|NCT01848834|157172068|FG000|Overall Study|Physician Decision|1|||
48721628|NCT00604214|156830083|FG000|Day 29 to Day 90|Lost to Follow-up|4|||
48721629|NCT00604214|156830084|FG001|Day 29 to Day 90|Lost to Follow-up|6|||
48721630|NCT00604214|156830083|FG000|Day 29 to Day 90|Withdrawal by Subject|0|||
48721631|NCT00604214|156830084|FG001|Day 29 to Day 90|Withdrawal by Subject|6|||
48721632|NCT00604214|156830083|FG000|Day 91 to Day 180|Death|19|||
48721633|NCT00604214|156830084|FG001|Day 91 to Day 180|Death|23|||
48721634|NCT00604214|156830083|FG000|Day 91 to Day 180|Lost to Follow-up|6|||
48721635|NCT00604214|156830084|FG001|Day 91 to Day 180|Lost to Follow-up|8|||
48721636|NCT00604214|156830083|FG000|Day 91 to Day 180|Withdrawal by Subject|1|||
48721637|NCT00604214|156830084|FG001|Day 91 to Day 180|Withdrawal by Subject|1|||
48721638|NCT03505710|156830085|FG000|Overall Study|Progressive Disease|22|||
48721639|NCT03505710|156830086|FG001|Overall Study|Progressive Disease|9|||
48721640|NCT03505710|156830087|FG002|Overall Study|Progressive Disease|34|||
48721641|NCT03505710|156830085|FG000|Overall Study|Clinical Progression|6|||
48721642|NCT03505710|156830086|FG001|Overall Study|Clinical Progression|6|||
48721643|NCT03505710|156830087|FG002|Overall Study|Clinical Progression|3|||
48816826|NCT01848834|157172069|FG001|Overall Study|Physician Decision|3|||
48816827|NCT01848834|157172070|FG002|Overall Study|Physician Decision|4|||
49129238|NCT01041859|158312393|FG002|Open-Label Titration|Lack of Efficacy|0|||
48721644|NCT03505710|156830085|FG000|Overall Study|Adverse Event|12|||
48721645|NCT03505710|156830086|FG001|Overall Study|Adverse Event|5|||
49129239|NCT01041859|158312391|FG000|Open-Label Titration|Lost to Follow-up|1|||
48721646|NCT03505710|156830087|FG002|Overall Study|Adverse Event|27|||
48721647|NCT03505710|156830085|FG000|Overall Study|Withdrawal by Subject|1|||
48721648|NCT03505710|156830086|FG001|Overall Study|Withdrawal by Subject|3|||
48721649|NCT03505710|156830087|FG002|Overall Study|Withdrawal by Subject|3|||
48721650|NCT03505710|156830085|FG000|Overall Study|Physician Decision|1|||
48721651|NCT03505710|156830086|FG001|Overall Study|Physician Decision|0|||
48721652|NCT03505710|156830087|FG002|Overall Study|Physician Decision|2|||
48816828|NCT01848834|157172071|FG003|Overall Study|Physician Decision|0|||
48816829|NCT01848834|157172072|FG004|Overall Study|Physician Decision|11|||
48721653|NCT03505710|156830085|FG000|Overall Study|Death|4|||
48721654|NCT03505710|156830086|FG001|Overall Study|Death|3|||
48721655|NCT03505710|156830087|FG002|Overall Study|Death|6|||
48721656|NCT03505710|156830085|FG000|Overall Study|Other Reasons|1|||
48721657|NCT03505710|156830086|FG001|Overall Study|Other Reasons|1|||
48721658|NCT03505710|156830087|FG002|Overall Study|Other Reasons|1|||
48721659|NCT00817479|156830088|FG000|Overall Study|Physician Decision|1|||
48721660|NCT00817479|156830089|FG001|Overall Study|Physician Decision|1|||
49129240|NCT01041859|158312392|FG001|Open-Label Titration|Lost to Follow-up|0|||
49129241|NCT01041859|158312393|FG002|Open-Label Titration|Lost to Follow-up|0|||
48816830|NCT01848834|157172068|FG000|Overall Study|Protocol Violation|0|||
49129242|NCT01041859|158312391|FG000|Open-Label Titration|Physician Decision|1|||
49129243|NCT01041859|158312392|FG001|Open-Label Titration|Physician Decision|0|||
49129244|NCT01041859|158312393|FG002|Open-Label Titration|Physician Decision|0|||
49129245|NCT01041859|158312391|FG000|Open-Label Titration|Protocol Violation|1|||
48721661|NCT00282347|156830090|FG000|Treatment Period|Death|2|||
48721662|NCT00282347|156830091|FG001|Treatment Period|Death|0|||
48721663|NCT00282347|156830090|FG000|Treatment Period|Lost to Follow-up|2|||
48721664|NCT00282347|156830091|FG001|Treatment Period|Lost to Follow-up|5|||
48721665|NCT00282347|156830090|FG000|Treatment Period|Withdrawal by Subject|1|||
48721666|NCT00282347|156830091|FG001|Treatment Period|Withdrawal by Subject|3|||
48721667|NCT00282347|156830090|FG000|Treatment Period|Physician Decision|0|||
48721668|NCT00282347|156830091|FG001|Treatment Period|Physician Decision|1|||
48721669|NCT00282347|156830090|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
48721670|NCT00282347|156830091|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
48721671|NCT00282347|156830090|FG000|Safety Follow-up Period|Withdrawal by Subject|2|||
48721672|NCT00282347|156830091|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
48721673|NCT00282347|156830090|FG000|Safety Follow-up Period|Physician Decision|1|||
48721674|NCT00282347|156830091|FG001|Safety Follow-up Period|Physician Decision|1|||
48721675|NCT00282347|156830090|FG000|Safety Follow-up Period|Protocol Deviation|0|||
48721676|NCT00282347|156830091|FG001|Safety Follow-up Period|Protocol Deviation|2|||
48721677|NCT00282347|156830090|FG000|B Cell Follow-up Period|Withdrawal by Subject|2|||
48721678|NCT00282347|156830091|FG001|B Cell Follow-up Period|Withdrawal by Subject|0|||
48721679|NCT00282347|156830090|FG000|B Cell Follow-up Period|Physician Decision|1|||
48816831|NCT01848834|157172069|FG001|Overall Study|Protocol Violation|0|||
48816832|NCT01848834|157172070|FG002|Overall Study|Protocol Violation|0|||
48816833|NCT01848834|157172071|FG003|Overall Study|Protocol Violation|0|||
48816834|NCT01848834|157172072|FG004|Overall Study|Protocol Violation|1|||
48816835|NCT01848834|157172068|FG000|Overall Study|Sponsor Decision|1|||
48816836|NCT01848834|157172069|FG001|Overall Study|Sponsor Decision|1|||
48816837|NCT01848834|157172070|FG002|Overall Study|Sponsor Decision|0|||
48816838|NCT01848834|157172071|FG003|Overall Study|Sponsor Decision|1|||
48816839|NCT01848834|157172072|FG004|Overall Study|Sponsor Decision|1|||
48816840|NCT01848834|157172068|FG000|Overall Study|Withdrawal by Subject|2|||
48816841|NCT01848834|157172069|FG001|Overall Study|Withdrawal by Subject|13|||
48816842|NCT01848834|157172070|FG002|Overall Study|Withdrawal by Subject|10|||
48816843|NCT01848834|157172071|FG003|Overall Study|Withdrawal by Subject|6|||
48816844|NCT01848834|157172072|FG004|Overall Study|Withdrawal by Subject|36|||
48816845|NCT01406717|157172073|FG000|Overall Study|Subject non-compliance|4|||
48816846|NCT01406717|157172074|FG001|Overall Study|Subject non-compliance|3|||
48816847|NCT01406717|157172073|FG000|Overall Study|Protocol Violation|5|||
48816848|NCT01406717|157172074|FG001|Overall Study|Protocol Violation|1|||
48816849|NCT01406717|157172073|FG000|Overall Study|Lost to Follow-up|14|||
48816850|NCT01406717|157172074|FG001|Overall Study|Lost to Follow-up|8|||
48816851|NCT01406717|157172073|FG000|Overall Study|Withdrawal by Subject|19|||
48816852|NCT01406717|157172074|FG001|Overall Study|Withdrawal by Subject|15|||
48816853|NCT01406717|157172073|FG000|Overall Study|Adverse Event|1|||
48816854|NCT01406717|157172074|FG001|Overall Study|Adverse Event|2|||
48816855|NCT01406717|157172073|FG000|Overall Study|Lack of Efficacy|0|||
48816856|NCT01406717|157172074|FG001|Overall Study|Lack of Efficacy|1|||
49129246|NCT01041859|158312392|FG001|Open-Label Titration|Protocol Violation|0|||
48721680|NCT00282347|156830091|FG001|B Cell Follow-up Period|Physician Decision|0|||
48721681|NCT00282347|156830090|FG000|B Cell Follow-up Period|Reason Not Specified|2|||
48721682|NCT00282347|156830091|FG001|B Cell Follow-up Period|Reason Not Specified|0|||
48721683|NCT02125604|156830092|FG000|Overall Study|Other|4|||
48816857|NCT01406717|157172073|FG000|Overall Study|Non-completion of visit activity|0|||
48816858|NCT01406717|157172074|FG001|Overall Study|Non-completion of visit activity|1|||
48816859|NCT00655551|157172075|FG000|All Periods Combined|Adverse Event|0|||
48816860|NCT00655551|157172076|FG001|All Periods Combined|Adverse Event|3|||
48816861|NCT00655551|157172077|FG002|All Periods Combined|Adverse Event|4|||
48816862|NCT00655551|157172075|FG000|Period 2 (up to 7 Days)|Adverse Event|0|||
49129247|NCT01041859|158312393|FG002|Open-Label Titration|Protocol Violation|0|||
48920991|NCT00784654|157544818|FG000|Open-Label Period (Non-Randomized)|Lack of Efficacy|21|||
48721684|NCT02125604|156830092|FG000|Overall Study|Investigator Decision|1|||
48721685|NCT02125604|156830092|FG000|Overall Study|Lost to Follow-up|2|||
48721686|NCT02125604|156830092|FG000|Overall Study|Consent Withdrawn|4|||
48920992|NCT00784654|157544819|FG001|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
48816863|NCT00655551|157172076|FG001|Period 2 (up to 7 Days)|Adverse Event|1|||
48816864|NCT00655551|157172077|FG002|Period 2 (up to 7 Days)|Adverse Event|0|||
48816865|NCT00655551|157172075|FG000|Period 3 (up to 7 Days)|Adverse Event|0|||
48816866|NCT00655551|157172076|FG001|Period 3 (up to 7 Days)|Adverse Event|0|||
48816867|NCT00655551|157172077|FG002|Period 3 (up to 7 Days)|Adverse Event|4|||
48816868|NCT00655551|157172075|FG000|Period 4 (up to 7 Days)|Adverse Event|0|||
48816869|NCT00655551|157172076|FG001|Period 4 (up to 7 Days)|Adverse Event|2|||
48816870|NCT00655551|157172077|FG002|Period 4 (up to 7 Days)|Adverse Event|0|||
48816871|NCT00238420|157172078|FG000|Overall Study|Protocol Violation|1|||
48816872|NCT00238420|157172079|FG001|Overall Study|Protocol Violation|1|||
48816873|NCT02218489|157172082|FG000|Overall Study|Withdrawal by Subject|4|||
48816874|NCT02218489|157172083|FG001|Overall Study|Withdrawal by Subject|3|||
48816875|NCT02218489|157172082|FG000|Overall Study|Lost to Follow-up|1|||
48816876|NCT02218489|157172083|FG001|Overall Study|Lost to Follow-up|0|||
48816877|NCT02753530|157172084|FG000|Overall Study|Adverse Event|7|||
48816878|NCT02753530|157172085|FG001|Overall Study|Adverse Event|1|||
48816879|NCT02753530|157172084|FG000|Overall Study|Death|0|||
48816880|NCT02753530|157172085|FG001|Overall Study|Death|1|||
48816881|NCT02753530|157172084|FG000|Overall Study|Physician Decision|0|||
48816882|NCT02753530|157172085|FG001|Overall Study|Physician Decision|1|||
48816883|NCT02753530|157172084|FG000|Overall Study|Protocol Violation|1|||
48816884|NCT02753530|157172085|FG001|Overall Study|Protocol Violation|0|||
48816885|NCT02753530|157172084|FG000|Overall Study|Withdrawal by Subject|4|||
48816886|NCT02753530|157172085|FG001|Overall Study|Withdrawal by Subject|3|||
48816887|NCT03958630|157172086|FG000|Overall Study|Withdrawal by Subject|0|||
48816888|NCT03958630|157172087|FG001|Overall Study|Withdrawal by Subject|0|||
48816889|NCT03958630|157172088|FG002|Overall Study|Withdrawal by Subject|1|||
48816890|NCT03958630|157172086|FG000|Overall Study|Withdrawn due to the 2019 pandemic|0|||
48816891|NCT03958630|157172087|FG001|Overall Study|Withdrawn due to the 2019 pandemic|0|||
48816892|NCT03958630|157172088|FG002|Overall Study|Withdrawn due to the 2019 pandemic|1|||
48816893|NCT01824472|157172089|FG000|Overall Study|Lost to Follow-up|0|||
48816894|NCT01824472|157172090|FG001|Overall Study|Lost to Follow-up|0|||
48816895|NCT01824472|157172091|FG002|Overall Study|Lost to Follow-up|1|||
48816896|NCT01824472|157172089|FG000|Overall Study|Withdrawal by Subject|1|||
48816897|NCT01824472|157172090|FG001|Overall Study|Withdrawal by Subject|5|||
48816898|NCT01824472|157172091|FG002|Overall Study|Withdrawal by Subject|3|||
48816899|NCT01824472|157172089|FG000|Overall Study|Ineligible post randomization&screening|0|||
48816900|NCT01824472|157172090|FG001|Overall Study|Ineligible post randomization&screening|2|||
48816901|NCT01824472|157172091|FG002|Overall Study|Ineligible post randomization&screening|0|||
48816902|NCT01815736|157172092|FG000|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11|||
48816903|NCT01815736|157172093|FG001|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17|||
48816904|NCT01815736|157172092|FG000|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10|||
48816905|NCT01815736|157172093|FG001|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9|||
48816906|NCT01815736|157172092|FG000|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11|||
48816907|NCT01815736|157172093|FG001|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2|||
48816908|NCT01815736|157172092|FG000|Randomized Treatment Phase-Up to Week 96|Adverse Event|7|||
48816909|NCT01815736|157172093|FG001|Randomized Treatment Phase-Up to Week 96|Adverse Event|4|||
48816910|NCT01815736|157172092|FG000|Randomized Treatment Phase-Up to Week 96|Death|4|||
48816911|NCT01815736|157172093|FG001|Randomized Treatment Phase-Up to Week 96|Death|0|||
48816912|NCT01815736|157172092|FG000|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1|||
48816913|NCT01815736|157172093|FG001|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0|||
48816914|NCT01815736|157172092|FG000|Randomized Treatment Phase-Up to Week 96|Pregnancy|1|||
48816915|NCT01815736|157172093|FG001|Randomized Treatment Phase-Up to Week 96|Pregnancy|0|||
48816916|NCT01815736|157172092|FG000|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4|||
48816917|NCT01815736|157172093|FG001|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3|||
48816918|NCT01815736|157172092|FG000|Extension Treatment Phase- After Week 96|Investigator's Discretion|31|||
48721687|NCT02125604|156830092|FG000|Overall Study|Adverse Event|20|||
48721688|NCT01006603|156830093|FG000|Overall Study|Withdrawal by Subject|17|||
48721689|NCT01006603|156830094|FG001|Overall Study|Withdrawal by Subject|19|||
48721690|NCT01006603|156830093|FG000|Overall Study|Lost to Follow-up|0|||
48721691|NCT01006603|156830094|FG001|Overall Study|Lost to Follow-up|1|||
48721692|NCT01006603|156830093|FG000|Overall Study|Safety reason|1|||
48721693|NCT01006603|156830094|FG001|Overall Study|Safety reason|1|||
48721694|NCT01006603|156830093|FG000|Overall Study|Protocol Violation|1|||
48721695|NCT01006603|156830094|FG001|Overall Study|Protocol Violation|3|||
48721696|NCT01006603|156830093|FG000|Overall Study|Incorrect enrolment|0|||
48721697|NCT01006603|156830094|FG001|Overall Study|Incorrect enrolment|2|||
48816919|NCT01815736|157172093|FG001|Extension Treatment Phase- After Week 96|Investigator's Discretion|15|||
48920993|NCT00784654|157544820|FG002|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
48721698|NCT01006603|156830093|FG000|Overall Study|Adverse Event|15|||
48721699|NCT01006603|156830094|FG001|Overall Study|Adverse Event|7|||
48721700|NCT01006603|156830093|FG000|Overall Study|Death|1|||
48721701|NCT01006603|156830094|FG001|Overall Study|Death|1|||
49129248|NCT01041859|158312391|FG000|Open-Label Titration|Other|7|||
49129249|NCT01041859|158312392|FG001|Open-Label Titration|Other|0|||
49129250|NCT01041859|158312393|FG002|Open-Label Titration|Other|0|||
49129251|NCT01041859|158312391|FG000|Open-Label Titration|Noncompliance With Study Drug|8|||
49129252|NCT01041859|158312392|FG001|Open-Label Titration|Noncompliance With Study Drug|0|||
49129253|NCT01041859|158312393|FG002|Open-Label Titration|Noncompliance With Study Drug|0|||
49129254|NCT01041859|158312391|FG000|Open-Label Titration|Withdrawal by Subject|11|||
49129255|NCT01041859|158312392|FG001|Open-Label Titration|Withdrawal by Subject|0|||
49129256|NCT01041859|158312393|FG002|Open-Label Titration|Withdrawal by Subject|0|||
49129257|NCT01041859|158312391|FG000|Double-Blind Maintenance|Adverse Event|0|||
49129258|NCT01041859|158312392|FG001|Double-Blind Maintenance|Adverse Event|23|||
49129259|NCT01041859|158312393|FG002|Double-Blind Maintenance|Adverse Event|13|||
49129260|NCT01041859|158312391|FG000|Double-Blind Maintenance|Lack of Efficacy|0|||
49129261|NCT01041859|158312392|FG001|Double-Blind Maintenance|Lack of Efficacy|3|||
49129262|NCT01041859|158312393|FG002|Double-Blind Maintenance|Lack of Efficacy|11|||
49129263|NCT01041859|158312391|FG000|Double-Blind Maintenance|Lost to Follow-up|0|||
49129264|NCT01041859|158312392|FG001|Double-Blind Maintenance|Lost to Follow-up|1|||
49129265|NCT01041859|158312393|FG002|Double-Blind Maintenance|Lost to Follow-up|0|||
48816920|NCT01815736|157172092|FG000|Extension Treatment Phase- After Week 96|Lost to Follow-up|13|||
48816921|NCT01815736|157172093|FG001|Extension Treatment Phase- After Week 96|Lost to Follow-up|9|||
48816922|NCT01815736|157172092|FG000|Extension Treatment Phase- After Week 96|Withdrew Consent|5|||
48816923|NCT01815736|157172093|FG001|Extension Treatment Phase- After Week 96|Withdrew Consent|1|||
48816924|NCT01815736|157172092|FG000|Extension Treatment Phase- After Week 96|Adverse Event|1|||
48816925|NCT01815736|157172093|FG001|Extension Treatment Phase- After Week 96|Adverse Event|1|||
48816926|NCT01815736|157172092|FG000|Extension Treatment Phase- After Week 96|Death|1|||
48816927|NCT01815736|157172093|FG001|Extension Treatment Phase- After Week 96|Death|0|||
48816928|NCT01163747|157172094|FG000|Overall Study|Adverse Event|0|||
48816929|NCT01163747|157172095|FG001|Overall Study|Adverse Event|5|||
48816930|NCT01163747|157172094|FG000|Overall Study|Insufficient Therapeutic Response|0|||
48721702|NCT01006603|156830093|FG000|Overall Study|Study specific discontinuation criteria|33|||
48721703|NCT01006603|156830094|FG001|Overall Study|Study specific discontinuation criteria|34|||
48721704|NCT01006603|156830093|FG000|Overall Study|Other|3|||
48721705|NCT01006603|156830094|FG001|Overall Study|Other|7|||
48721706|NCT01974765|156831218|FG000|Overall Study|Withdrawal by Subject|1|||
48721707|NCT01974765|156831218|FG000|Overall Study|Death|1|||
48721708|NCT01974765|156831218|FG000|Overall Study|Adverse Event|2|||
48721709|NCT02519855|156831219|FG000|Overall Study|Adverse Event|0|||
48721710|NCT02519855|156831220|FG001|Overall Study|Adverse Event|1|||
48721711|NCT02519855|156831219|FG000|Overall Study|Lost to Follow-up|3|||
48721712|NCT02519855|156831220|FG001|Overall Study|Lost to Follow-up|3|||
48721713|NCT03699475|156831224|FG000|Overall Study|Death|1|||
48721714|NCT03055377|156831236|FG000|Treatment Phase|Lost to Follow-up|28|||
48721715|NCT03055377|156831237|FG001|Treatment Phase|Lost to Follow-up|24|||
48721716|NCT03055377|156831236|FG000|Post-Treatment Follow-Up|Lost to Follow-up|26|||
48816931|NCT01163747|157172095|FG001|Overall Study|Insufficient Therapeutic Response|1|||
48816932|NCT01163747|157172094|FG000|Overall Study|Protocol Violation|0|||
48816933|NCT01163747|157172095|FG001|Overall Study|Protocol Violation|1|||
48816934|NCT01163747|157172094|FG000|Overall Study|Refused Treatment|6|||
48816935|NCT01163747|157172095|FG001|Overall Study|Refused Treatment|4|||
48816936|NCT00604786|157172096|FG000|Overall Study|Lost to Follow-up|2|||
48816937|NCT00604786|157172097|FG001|Overall Study|Lost to Follow-up|0|||
48816938|NCT02698436|157172101|FG000|Overall Study|Adverse Event|1|||
49129266|NCT01041859|158312391|FG000|Double-Blind Maintenance|Physician Decision|0|||
49129267|NCT01041859|158312392|FG001|Double-Blind Maintenance|Physician Decision|2|||
48721717|NCT03055377|156831237|FG001|Post-Treatment Follow-Up|Lost to Follow-up|21|||
48721718|NCT03560739|156831238|FG000|Overall Study|Adverse Event|0|||
48816939|NCT02698436|157172102|FG001|Overall Study|Adverse Event|0|||
49129268|NCT01041859|158312393|FG002|Double-Blind Maintenance|Physician Decision|1|||
49129269|NCT01041859|158312391|FG000|Double-Blind Maintenance|Protocol Violation|0|||
49129270|NCT01041859|158312392|FG001|Double-Blind Maintenance|Protocol Violation|1|||
49129271|NCT01041859|158312393|FG002|Double-Blind Maintenance|Protocol Violation|3|||
49129272|NCT01041859|158312391|FG000|Double-Blind Maintenance|Other|0|||
49129273|NCT01041859|158312392|FG001|Double-Blind Maintenance|Other|6|||
48721719|NCT03560739|156831239|FG001|Overall Study|Adverse Event|1|||
48721720|NCT03560739|156831240|FG002|Overall Study|Adverse Event|0|||
48721721|NCT03560739|156831241|FG003|Overall Study|Adverse Event|0|||
48721722|NCT00636987|156831244|FG000|Overall Study|Death|44|||
48721723|NCT00636987|156831244|FG000|Overall Study|Explanted|13|||
48721724|NCT00636987|156831244|FG000|Overall Study|Lost to Follow-up|63|||
48721725|NCT00636987|156831244|FG000|Overall Study|5 year visit window not complete|69|||
48721726|NCT03192891|156831245|FG000|Overall Study|Lost to Follow-up|55|||
48816940|NCT02698436|157172101|FG000|Overall Study|Withdrawal by Subject|3|||
48816941|NCT02698436|157172102|FG001|Overall Study|Withdrawal by Subject|3|||
49129274|NCT01041859|158312393|FG002|Double-Blind Maintenance|Other|2|||
49129275|NCT01041859|158312391|FG000|Double-Blind Maintenance|Noncompliance With Study Drug|0|||
49129276|NCT01041859|158312392|FG001|Double-Blind Maintenance|Noncompliance With Study Drug|2|||
49129277|NCT01041859|158312393|FG002|Double-Blind Maintenance|Noncompliance With Study Drug|6|||
49129278|NCT01041859|158312391|FG000|Double-Blind Maintenance|Withdrawal by Subject|0|||
49129279|NCT01041859|158312392|FG001|Double-Blind Maintenance|Withdrawal by Subject|8|||
49129280|NCT01041859|158312393|FG002|Double-Blind Maintenance|Withdrawal by Subject|9|||
49129281|NCT02475369|158312394|FG000|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7|||
49129282|NCT02475369|158312395|FG001|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2|||
48721727|NCT05406921|156831246|FG000|Overall Study|Withdrawal by Subject|25|||
48721728|NCT05406921|156831247|FG001|Overall Study|Withdrawal by Subject|0|||
48721729|NCT05406921|156831248|FG002|Overall Study|Withdrawal by Subject|25|||
48721730|NCT05406921|156831246|FG000|Overall Study|Protocol Violation|0|||
48721731|NCT05406921|156831247|FG001|Overall Study|Protocol Violation|12|||
48721732|NCT05406921|156831248|FG002|Overall Study|Protocol Violation|0|||
48721733|NCT00075270|156831249|FG000|Overall Study|Withdrawal by Subject|28|||
48721734|NCT00075270|156831250|FG001|Overall Study|Withdrawal by Subject|21|||
48721735|NCT00075270|156831249|FG000|Overall Study|Lost to Follow-up|25|||
48721736|NCT00075270|156831250|FG001|Overall Study|Lost to Follow-up|28|||
48721737|NCT00075270|156831249|FG000|Overall Study|Protocol Violation|0|||
48721738|NCT00075270|156831250|FG001|Overall Study|Protocol Violation|2|||
48721739|NCT00075270|156831249|FG000|Overall Study|Death|198|||
48721740|NCT00075270|156831250|FG001|Overall Study|Death|215|||
48721741|NCT00075270|156831249|FG000|Overall Study|Other/Unknown|9|||
48721742|NCT00075270|156831250|FG001|Overall Study|Other/Unknown|5|||
48721743|NCT00075270|156831249|FG000|Overall Study|Missing|26|||
48721744|NCT00075270|156831250|FG001|Overall Study|Missing|13|||
48721745|NCT00246571|156831251|FG000|Overall Study|Adverse Event|7|||
48721746|NCT00246571|156831252|FG001|Overall Study|Adverse Event|0|||
48721747|NCT00246571|156831251|FG000|Overall Study|Protocol Violation|0|||
48721748|NCT00246571|156831252|FG001|Overall Study|Protocol Violation|1|||
48721749|NCT00246571|156831251|FG000|Overall Study|Withdrawal by Subject|2|||
48721750|NCT00246571|156831252|FG001|Overall Study|Withdrawal by Subject|3|||
48721751|NCT00246571|156831251|FG000|Overall Study|Lack of Efficacy|84|||
48721752|NCT00246571|156831252|FG001|Overall Study|Lack of Efficacy|21|||
48721753|NCT00246571|156831251|FG000|Overall Study|Death|17|||
48721754|NCT00246571|156831252|FG001|Overall Study|Death|3|||
48721755|NCT00246571|156831251|FG000|Overall Study|Sponsor|0|||
48721756|NCT00246571|156831252|FG001|Overall Study|Sponsor|1|||
48721757|NCT00246571|156831251|FG000|Overall Study|Did not meet entrance criteria|2|||
48721758|NCT00246571|156831252|FG001|Overall Study|Did not meet entrance criteria|1|||
48721759|NCT00246571|156831251|FG000|Overall Study|Laboratory abnormalities|1|||
48721760|NCT00246571|156831252|FG001|Overall Study|Laboratory abnormalities|0|||
48721761|NCT00246571|156831251|FG000|Overall Study|Crossover participants|0|||
48721762|NCT00246571|156831252|FG001|Overall Study|Crossover participants|74|||
48721763|NCT03924986|156831254|FG000|Overall Study|Death|57|||
48721764|NCT03924986|156831255|FG001|Overall Study|Death|66|||
48721765|NCT03924986|156831254|FG000|Overall Study|Study Concluded by Sponsor|51|||
48721766|NCT03924986|156831255|FG001|Overall Study|Study Concluded by Sponsor|41|||
48721767|NCT03924986|156831254|FG000|Overall Study|Withdrawal by Subject|15|||
48721768|NCT03924986|156831255|FG001|Overall Study|Withdrawal by Subject|20|||
48721769|NCT03924986|156831254|FG000|Overall Study|Lost to Follow-up|7|||
48721770|NCT03924986|156831255|FG001|Overall Study|Lost to Follow-up|5|||
48721771|NCT03924986|156831254|FG000|Overall Study|Miscellaneous|1|||
48721772|NCT03924986|156831255|FG001|Overall Study|Miscellaneous|0|||
48721773|NCT03920111|156831259|FG000|Overall Study|suspected covid - unable to attend study visit|0|||
48721774|NCT03920111|156831260|FG001|Overall Study|suspected covid - unable to attend study visit|0|||
48721775|NCT03920111|156831261|FG002|Overall Study|suspected covid - unable to attend study visit|1|||
48721776|NCT01133990|156831262|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|1|||
48721777|NCT01133990|156831263|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
48721778|NCT01133990|156831264|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
48721779|NCT01133990|156831265|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
48721780|NCT01133990|156831266|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
48721781|NCT01133990|156831267|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
48721782|NCT01133990|156831262|FG000|Phase 1b (Dose Escalation Phase)|Physician Decision|1|||
48721783|NCT01133990|156831263|FG001|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
48721784|NCT01133990|156831264|FG002|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
48721785|NCT01133990|156831265|FG003|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
48721786|NCT01133990|156831266|FG004|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
48721787|NCT01133990|156831267|FG005|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
48721788|NCT01133990|156831262|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
48721789|NCT01133990|156831263|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
48721790|NCT01133990|156831264|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
48721791|NCT01133990|156831265|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
48816942|NCT02698436|157172101|FG000|Overall Study|Lost to Follow-up|2|||
48816943|NCT02698436|157172102|FG001|Overall Study|Lost to Follow-up|4|||
48816944|NCT02698436|157172101|FG000|Overall Study|Non-compliance with study regimen|1|||
48816945|NCT02698436|157172102|FG001|Overall Study|Non-compliance with study regimen|0|||
48816946|NCT04163991|157172103|FG000|Overall Study|Adverse Event|0|||
48816947|NCT04163991|157172104|FG001|Overall Study|Adverse Event|0|||
48816948|NCT04163991|157172105|FG002|Overall Study|Adverse Event|0|||
48816949|NCT04163991|157172106|FG003|Overall Study|Adverse Event|1|||
48816950|NCT04163991|157172107|FG004|Overall Study|Adverse Event|0|||
49129283|NCT03608826|158312398|FG000|Overall Study|Death|3|||
49129284|NCT03608826|158312398|FG000|Overall Study|Heart Transplant|3|||
49129285|NCT03608826|158312398|FG000|Overall Study|Physician Decision|4|||
48816951|NCT04163991|157172103|FG000|Overall Study|Death|0|||
48816952|NCT04163991|157172104|FG001|Overall Study|Death|0|||
48816953|NCT04163991|157172105|FG002|Overall Study|Death|1|||
48816954|NCT04163991|157172106|FG003|Overall Study|Death|0|||
48816955|NCT04163991|157172107|FG004|Overall Study|Death|0|||
48816956|NCT04163991|157172103|FG000|Overall Study|Lost to Follow-up|0|||
48816957|NCT04163991|157172104|FG001|Overall Study|Lost to Follow-up|1|||
48816958|NCT04163991|157172105|FG002|Overall Study|Lost to Follow-up|0|||
49129286|NCT02121210|158312399|FG000|Overall Study|Adverse Event|5|||
49129287|NCT02121210|158312400|FG001|Overall Study|Adverse Event|7|||
49129288|NCT02121210|158312399|FG000|Overall Study|Lack of Efficacy|2|||
49129289|NCT02121210|158312400|FG001|Overall Study|Lack of Efficacy|0|||
49129290|NCT02121210|158312399|FG000|Overall Study|Other than specified above|0|||
49129291|NCT02121210|158312400|FG001|Overall Study|Other than specified above|2|||
49129292|NCT04609514|158312405|FG000|Overall Study|Lost to Follow-up|5|||
49129293|NCT04609514|158312406|FG001|Overall Study|Lost to Follow-up|4|||
49129294|NCT04609514|158312405|FG000|Overall Study|Withdrawal by PI|0|||
49129295|NCT04609514|158312406|FG001|Overall Study|Withdrawal by PI|2|||
49129296|NCT03122171|158312407|FG000|Overall Study|Withdrawal by Subject|1|||
49129297|NCT00671788|158312408|FG000|Overall Study|Adverse Event|8|||
49129298|NCT00671788|158312408|FG000|Overall Study|Refused further treatment|3|||
49129299|NCT00671788|158312408|FG000|Overall Study|Ineligible|1|||
49129300|NCT00671788|158312408|FG000|Overall Study|MD Decision|1|||
49129301|NCT00671788|158312408|FG000|Overall Study|Other|1|||
49129302|NCT02460289|158312415|FG000|Overall Study|Adverse Event|1|||
49129303|NCT02460289|158312415|FG000|Overall Study|Withdrawal by Subject|8|||
49129304|NCT02460289|158312415|FG000|Overall Study|Lost to Follow-up|1|||
49129305|NCT00720499|158312416|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|2|||
49129306|NCT00720499|158312417|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
49129307|NCT00720499|158312416|FG000|Treatment Period 1 (4 Weeks)|Protocol Violation|1|||
49129308|NCT00720499|158312417|FG001|Treatment Period 1 (4 Weeks)|Protocol Violation|2|||
49129309|NCT00720499|158312416|FG000|Treatment Period 2 (4 Weeks)|Adverse Event|2|||
49129310|NCT00720499|158312417|FG001|Treatment Period 2 (4 Weeks)|Adverse Event|3|||
49129311|NCT00296517|158312418|FG000|Dose Level 2 - Week 2|Adverse Event|1|||
49129312|NCT00296517|158312419|FG001|Dose Level 2 - Week 2|Adverse Event|5|||
48721792|NCT01133990|156831266|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
48721793|NCT01133990|156831267|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
48721794|NCT01133990|156831262|FG000|Phase 1b (Dose Escalation Phase)|Progression of disease|1|||
48721795|NCT01133990|156831263|FG001|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
48721796|NCT01133990|156831264|FG002|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
48721797|NCT01133990|156831265|FG003|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
49129313|NCT00296517|158312418|FG000|Dose Level 2 - Week 2|Withdrawal by Subject|1|||
49129314|NCT00296517|158312419|FG001|Dose Level 2 - Week 2|Withdrawal by Subject|0|||
48721798|NCT01133990|156831266|FG004|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
48721799|NCT01133990|156831267|FG005|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
48721800|NCT01185301|156831268|FG000|Overall Study|Adverse Event|3|||
48721801|NCT01185301|156831269|FG001|Overall Study|Adverse Event|0|||
48721802|NCT01185301|156831270|FG002|Overall Study|Adverse Event|2|||
48721803|NCT01185301|156831271|FG003|Overall Study|Adverse Event|3|||
48721804|NCT01185301|156831268|FG000|Overall Study|Withdrawal by Subject|7|||
49129315|NCT00296517|158312418|FG000|Dose Level 3 - Weeks 3-12|Adverse Event|30|||
49129316|NCT00296517|158312419|FG001|Dose Level 3 - Weeks 3-12|Adverse Event|34|||
48721805|NCT01185301|156831269|FG001|Overall Study|Withdrawal by Subject|5|||
48721806|NCT01185301|156831270|FG002|Overall Study|Withdrawal by Subject|2|||
48816959|NCT04163991|157172106|FG003|Overall Study|Lost to Follow-up|0|||
48816960|NCT04163991|157172107|FG004|Overall Study|Lost to Follow-up|0|||
49129317|NCT00296517|158312418|FG000|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3|||
49129318|NCT00296517|158312419|FG001|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6|||
49129319|NCT00296517|158312418|FG000|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3|||
49129320|NCT00296517|158312419|FG001|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2|||
48816961|NCT04163991|157172103|FG000|Overall Study|Withdrawal by Subject|1|||
49129321|NCT00296517|158312418|FG000|Dose Level 3 - Weeks 3-12|Protocol Violation|1|||
49129322|NCT00296517|158312419|FG001|Dose Level 3 - Weeks 3-12|Protocol Violation|0|||
48721807|NCT01185301|156831271|FG003|Overall Study|Withdrawal by Subject|3|||
48721808|NCT01185301|156831268|FG000|Overall Study|Lost to Follow-up|2|||
48721809|NCT01185301|156831269|FG001|Overall Study|Lost to Follow-up|0|||
48721810|NCT01185301|156831270|FG002|Overall Study|Lost to Follow-up|0|||
48721811|NCT01185301|156831271|FG003|Overall Study|Lost to Follow-up|1|||
48721812|NCT01185301|156831268|FG000|Overall Study|Other Reason|3|||
48721813|NCT01185301|156831269|FG001|Overall Study|Other Reason|2|||
48721814|NCT01185301|156831270|FG002|Overall Study|Other Reason|2|||
48721815|NCT01185301|156831271|FG003|Overall Study|Other Reason|2|||
48920994|NCT00784654|157544818|FG000|Open-Label Period (Non-Randomized)|Lost to Follow-up|11|||
49129323|NCT00296517|158312418|FG000|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7|||
49129324|NCT00296517|158312419|FG001|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18|||
49129325|NCT00296517|158312418|FG000|Dose Level 3 - Weeks 3-12|Non - Compliance|1|||
49129326|NCT00296517|158312419|FG001|Dose Level 3 - Weeks 3-12|Non - Compliance|0|||
49129327|NCT00296517|158312418|FG000|Dose Level 3 - Weeks 3-12|Other|0|||
49129328|NCT00296517|158312419|FG001|Dose Level 3 - Weeks 3-12|Other|2|||
49129329|NCT02814526|158312420|FG000|Overall Study|Adverse Event|4|||
49129330|NCT02814526|158312421|FG001|Overall Study|Adverse Event|3|||
49129331|NCT02814526|158312420|FG000|Overall Study|Death|1|||
49129332|NCT02814526|158312421|FG001|Overall Study|Death|1|||
49129333|NCT02814526|158312420|FG000|Overall Study|Lost to Follow-up|3|||
49129334|NCT02814526|158312421|FG001|Overall Study|Lost to Follow-up|4|||
49129335|NCT02814526|158312420|FG000|Overall Study|non site physician decision|1|||
49129336|NCT02814526|158312421|FG001|Overall Study|non site physician decision|0|||
49129337|NCT02814526|158312420|FG000|Overall Study|participant noncompliance|1|||
49129338|NCT02814526|158312421|FG001|Overall Study|participant noncompliance|1|||
49129339|NCT02814526|158312420|FG000|Overall Study|Withdrawal by Subject|20|||
49129340|NCT02814526|158312421|FG001|Overall Study|Withdrawal by Subject|14|||
49129341|NCT02814526|158312420|FG000|Overall Study|safety risk|2|||
49129342|NCT02814526|158312421|FG001|Overall Study|safety risk|1|||
49129343|NCT02814526|158312420|FG000|Overall Study|early termination-study terminated|1|||
49129344|NCT02814526|158312421|FG001|Overall Study|early termination-study terminated|2|||
49129345|NCT02814526|158312420|FG000|Overall Study|Other|0|||
49129346|NCT02814526|158312421|FG001|Overall Study|Other|4|||
49129347|NCT00161213|158313755|FG000|Overall Study|Withdrawal by Subject|1|||
49129348|NCT00161213|158313755|FG000|Overall Study|Evaluable for toxicity but not response|1|||
49129349|NCT03964207|158313758|FG000|First Treatment|Withdrawal by Subject|1|||
49129350|NCT03964207|158313759|FG001|First Treatment|Withdrawal by Subject|2|||
49129351|NCT03964207|158313758|FG000|First Treatment|Protocol Violation|1|||
49129352|NCT03964207|158313759|FG001|First Treatment|Protocol Violation|0|||
49129353|NCT03964207|158313758|FG000|First Treatment|Lost to Follow-up|1|||
49129354|NCT03964207|158313759|FG001|First Treatment|Lost to Follow-up|0|||
49129355|NCT03964207|158313758|FG000|Second Treatment|Lost to Follow-up|0|||
49129356|NCT03964207|158313759|FG001|Second Treatment|Lost to Follow-up|1|||
49129357|NCT03964207|158313758|FG000|Second Treatment|Adverse Event|1|||
49129358|NCT03964207|158313759|FG001|Second Treatment|Adverse Event|2|||
49129359|NCT02579629|158313761|FG000|Overall Study|Withdrawal by Subject|0|||
49129360|NCT02579629|158313762|FG001|Overall Study|Withdrawal by Subject|1|||
49129361|NCT02579629|158313763|FG002|Overall Study|Withdrawal by Subject|0|||
49129362|NCT02579629|158313761|FG000|Overall Study|Screen Failure|2|||
49129363|NCT02579629|158313762|FG001|Overall Study|Screen Failure|0|||
49129364|NCT02579629|158313763|FG002|Overall Study|Screen Failure|2|||
49129365|NCT00183430|158313766|FG000|Overall Study|Adverse Event|1|||
49129366|NCT00183430|158313767|FG001|Overall Study|Adverse Event|0|||
49129367|NCT00183430|158313766|FG000|Overall Study|Lost to Follow-up|3|||
49129368|NCT00183430|158313767|FG001|Overall Study|Lost to Follow-up|0|||
49129369|NCT00183430|158313766|FG000|Overall Study|did not meet inclusion criteria|1|||
49129370|NCT00183430|158313767|FG001|Overall Study|did not meet inclusion criteria|0|||
49129371|NCT00183430|158313766|FG000|Overall Study|Withdrawal by Subject|1|||
49129372|NCT00183430|158313767|FG001|Overall Study|Withdrawal by Subject|0|||
49129373|NCT02466399|158313768|FG000|Overall Study|Adverse Event|1|||
49129374|NCT02466399|158313769|FG001|Overall Study|Adverse Event|0|||
49129375|NCT02466399|158313768|FG000|Overall Study|Early exit due to family emergency|1|||
49129376|NCT02466399|158313769|FG001|Overall Study|Early exit due to family emergency|0|||
49129377|NCT01799941|158313770|FG000|Overall Study|Adverse Event|34|||
49129378|NCT01799941|158313770|FG000|Overall Study|Withdrawal by Subject|21|||
49129379|NCT01799941|158313770|FG000|Overall Study|Death|2|||
49129380|NCT01799941|158313770|FG000|Overall Study|Investigator Decision|4|||
49129381|NCT01799941|158313770|FG000|Overall Study|Lack of Efficacy|3|||
49129382|NCT01799941|158313770|FG000|Overall Study|Lost to Follow-up|17|||
49129383|NCT01799941|158313770|FG000|Overall Study|Other|15|||
49129384|NCT04889040|158313771|FG000|Overall Study|Withdrawal by Subject|3|||
48721816|NCT02047318|156831272|FG000|Core Study Period|Did not consent to 52-week follow- up|8|||
48920995|NCT00784654|157544819|FG001|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
48721817|NCT02047318|156831272|FG000|Core Study Period|Adverse Event|1|||
49129385|NCT04889040|158313772|FG001|Overall Study|Withdrawal by Subject|3|||
49129386|NCT04889040|158313771|FG000|Overall Study|Lost to Follow-up|0|||
48721818|NCT02047318|156831272|FG000|Core Study Period|Withdrawal by caregiver|3|||
48816962|NCT04163991|157172104|FG001|Overall Study|Withdrawal by Subject|1|||
48816963|NCT04163991|157172105|FG002|Overall Study|Withdrawal by Subject|3|||
48816964|NCT04163991|157172106|FG003|Overall Study|Withdrawal by Subject|1|||
48816965|NCT04163991|157172107|FG004|Overall Study|Withdrawal by Subject|1|||
48816966|NCT04163991|157172103|FG000|Overall Study|Other, Not Specified|0|||
48816967|NCT04163991|157172104|FG001|Overall Study|Other, Not Specified|1|||
48816968|NCT04163991|157172105|FG002|Overall Study|Other, Not Specified|1|||
48816969|NCT04163991|157172106|FG003|Overall Study|Other, Not Specified|1|||
48816970|NCT04163991|157172107|FG004|Overall Study|Other, Not Specified|0|||
48816971|NCT03390036|157173558|FG000|Overall Study|Lost to Follow-up|1|||
48816972|NCT03390036|157173559|FG001|Overall Study|Lost to Follow-up|0|||
48816973|NCT03390036|157173560|FG002|Overall Study|Lost to Follow-up|0|||
48816974|NCT03390036|157173558|FG000|Overall Study|Lack of Efficacy|1|||
49129387|NCT04889040|158313772|FG001|Overall Study|Lost to Follow-up|1|||
49129388|NCT04889040|158313771|FG000|Overall Study|Adverse Event|2|||
48721819|NCT02047318|156831272|FG000|Long-term Follow-up Treatment Period|consent withdrawn by subject|1|||
48721820|NCT00924781|156831273|FG000|Overall Study|Study terminated by sponsor|12|||
48721821|NCT00924781|156831274|FG001|Overall Study|Study terminated by sponsor|10|||
48721822|NCT02095132|156831276|FG000|Overall Study|Adverse Event|0|||
48721823|NCT02095132|156831277|FG001|Overall Study|Adverse Event|0|||
48721824|NCT02095132|156831278|FG002|Overall Study|Adverse Event|0|||
48721825|NCT02095132|156831279|FG003|Overall Study|Adverse Event|0|||
48721826|NCT02095132|156831280|FG004|Overall Study|Adverse Event|1|||
48721827|NCT02095132|156831281|FG005|Overall Study|Adverse Event|0|||
48721828|NCT02095132|156831282|FG006|Overall Study|Adverse Event|1|||
48721829|NCT02095132|156831283|FG007|Overall Study|Adverse Event|0|||
48721830|NCT02095132|156831284|FG008|Overall Study|Adverse Event|0|||
48721831|NCT02095132|156831276|FG000|Overall Study|Death|0|||
48721832|NCT02095132|156831277|FG001|Overall Study|Death|0|||
48721833|NCT02095132|156831278|FG002|Overall Study|Death|0|||
48721834|NCT02095132|156831279|FG003|Overall Study|Death|0|||
48721835|NCT02095132|156831280|FG004|Overall Study|Death|0|||
48721836|NCT02095132|156831281|FG005|Overall Study|Death|0|||
48721837|NCT02095132|156831282|FG006|Overall Study|Death|1|||
48721838|NCT02095132|156831283|FG007|Overall Study|Death|0|||
48721839|NCT02095132|156831284|FG008|Overall Study|Death|0|||
48721840|NCT02095132|156831276|FG000|Overall Study|Lack of Efficacy|3|||
48721841|NCT02095132|156831277|FG001|Overall Study|Lack of Efficacy|5|||
49129389|NCT04889040|158313772|FG001|Overall Study|Adverse Event|1|||
49129390|NCT04040439|158313775|FG000|Overall Study|Invalid registration|11|||
49129391|NCT04040439|158313775|FG000|Overall Study|No IC* on publication of study results|2|||
49129392|NCT00547339|158313776|FG000|Overall Study|Physician Decision|0|||
49129393|NCT00547339|158313777|FG001|Overall Study|Physician Decision|0|||
49129394|NCT00547339|158313778|FG002|Overall Study|Physician Decision|1|||
49129395|NCT00547339|158313779|FG003|Overall Study|Physician Decision|0|||
49129396|NCT01674725|158313783|FG000|Overall Study|Adverse Event|1|||
49129397|NCT01674725|158313784|FG001|Overall Study|Adverse Event|0|||
49129398|NCT01674725|158313783|FG000|Overall Study|Did not receive study drug|1|||
49129399|NCT01674725|158313784|FG001|Overall Study|Did not receive study drug|0|||
49129400|NCT01674725|158313783|FG000|Overall Study|Withdrawal by Subject|1|||
49129401|NCT01674725|158313784|FG001|Overall Study|Withdrawal by Subject|0|||
49129402|NCT01674725|158313783|FG000|Overall Study|Lost to Follow-up|0|||
49129403|NCT01674725|158313784|FG001|Overall Study|Lost to Follow-up|1|||
49129404|NCT02709746|158313785|FG000|Phase A (Single-blind Treatment Period)|Protocol Violation|4|||
49129405|NCT02709746|158313786|FG001|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
49129406|NCT02709746|158313787|FG002|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
49129407|NCT02709746|158313788|FG003|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
49129408|NCT02709746|158313789|FG004|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
49129409|NCT02709746|158313785|FG000|Phase A (Single-blind Treatment Period)|Not sepcified|14|||
49129410|NCT02709746|158313786|FG001|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
49129411|NCT02709746|158313787|FG002|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
48721842|NCT02095132|156831278|FG002|Overall Study|Lack of Efficacy|2|||
48721843|NCT02095132|156831279|FG003|Overall Study|Lack of Efficacy|8|||
48721844|NCT02095132|156831280|FG004|Overall Study|Lack of Efficacy|3|||
49129412|NCT02709746|158313788|FG003|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
49129413|NCT02709746|158313789|FG004|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
49129414|NCT02709746|158313785|FG000|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12|||
48721845|NCT02095132|156831281|FG005|Overall Study|Lack of Efficacy|6|||
48721846|NCT02095132|156831282|FG006|Overall Study|Lack of Efficacy|10|||
48816975|NCT03390036|157173559|FG001|Overall Study|Lack of Efficacy|0|||
48816976|NCT03390036|157173560|FG002|Overall Study|Lack of Efficacy|0|||
48816977|NCT00373295|157173561|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
48816978|NCT00373295|157173562|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
48816979|NCT00373295|157173563|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
48816980|NCT00373295|157173564|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
48816981|NCT00373295|157173565|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
48816982|NCT00373295|157173566|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
49129415|NCT02709746|158313786|FG001|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
49129416|NCT02709746|158313787|FG002|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
49129417|NCT02709746|158313788|FG003|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
49129418|NCT02709746|158313789|FG004|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
49129419|NCT02709746|158313785|FG000|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7|||
48816983|NCT05107401|157173567|FG000|Overall Study|Lost to Follow-up|13|||
48816984|NCT05107401|157173568|FG001|Overall Study|Lost to Follow-up|12|||
48816985|NCT00605319|157173571|FG000|Overall Study|Adverse Event|6|||
48816986|NCT01683994|157173589|FG000|Overall Study|Withdrawal by Subject|1|||
48816987|NCT01683994|157173590|FG001|Overall Study|Withdrawal by Subject|0|||
48816988|NCT01683994|157173591|FG002|Overall Study|Withdrawal by Subject|0|||
48816989|NCT01683994|157173592|FG003|Overall Study|Withdrawal by Subject|1|||
48816990|NCT01683994|157173593|FG004|Overall Study|Withdrawal by Subject|0|||
48816991|NCT01683994|157173589|FG000|Overall Study|Intercurrent illness|0|||
48816992|NCT01683994|157173590|FG001|Overall Study|Intercurrent illness|0|||
48816993|NCT01683994|157173591|FG002|Overall Study|Intercurrent illness|0|||
48816994|NCT01683994|157173592|FG003|Overall Study|Intercurrent illness|2|||
48721847|NCT02095132|156831283|FG007|Overall Study|Lack of Efficacy|9|||
48721848|NCT02095132|156831284|FG008|Overall Study|Lack of Efficacy|8|||
48721849|NCT02095132|156831276|FG000|Overall Study|Physician Decision|1|||
48721850|NCT02095132|156831277|FG001|Overall Study|Physician Decision|0|||
48721851|NCT02095132|156831278|FG002|Overall Study|Physician Decision|0|||
48721852|NCT02095132|156831279|FG003|Overall Study|Physician Decision|0|||
48721853|NCT02095132|156831280|FG004|Overall Study|Physician Decision|0|||
48721854|NCT02095132|156831281|FG005|Overall Study|Physician Decision|0|||
48721855|NCT02095132|156831282|FG006|Overall Study|Physician Decision|1|||
48721856|NCT02095132|156831283|FG007|Overall Study|Physician Decision|0|||
48721857|NCT02095132|156831284|FG008|Overall Study|Physician Decision|2|||
48721858|NCT02095132|156831276|FG000|Overall Study|Withdrawal by Subject|0|||
48721859|NCT02095132|156831277|FG001|Overall Study|Withdrawal by Subject|0|||
48721860|NCT02095132|156831278|FG002|Overall Study|Withdrawal by Subject|2|||
48721861|NCT02095132|156831279|FG003|Overall Study|Withdrawal by Subject|2|||
48721862|NCT02095132|156831280|FG004|Overall Study|Withdrawal by Subject|3|||
48721863|NCT02095132|156831281|FG005|Overall Study|Withdrawal by Subject|0|||
48721864|NCT02095132|156831282|FG006|Overall Study|Withdrawal by Subject|5|||
48721865|NCT02095132|156831283|FG007|Overall Study|Withdrawal by Subject|0|||
48721866|NCT02095132|156831284|FG008|Overall Study|Withdrawal by Subject|0|||
48721867|NCT02554279|156831291|FG000|Overall Study|Adverse Event|2|||
48721868|NCT02554279|156831292|FG001|Overall Study|Adverse Event|5|||
48721869|NCT02554279|156831291|FG000|Overall Study|Lost to Follow-up|3|||
48721870|NCT02554279|156831292|FG001|Overall Study|Lost to Follow-up|2|||
48721871|NCT02554279|156831291|FG000|Overall Study|Withdrawal by Subject|6|||
48721872|NCT02554279|156831292|FG001|Overall Study|Withdrawal by Subject|4|||
48721873|NCT02554279|156831291|FG000|Overall Study|Protocol Violation|2|||
48721874|NCT02554279|156831292|FG001|Overall Study|Protocol Violation|1|||
48721875|NCT02554279|156831291|FG000|Overall Study|Other reason|19|||
48721876|NCT02554279|156831292|FG001|Overall Study|Other reason|6|||
48721877|NCT02496676|156831299|FG000|Phase 1 - Period 1|Adverse Event|0|||
48721878|NCT02496676|156831300|FG001|Phase 1 - Period 1|Adverse Event|1|||
48721879|NCT02496676|156831299|FG000|Phase 2 - IV MgSO4|Adverse Event|0|||
48721880|NCT02496676|156831300|FG001|Phase 2 - IV MgSO4|Adverse Event|1|||
48721881|NCT01119937|156831301|FG000|Overall Study|Adverse Event|11|||
48721882|NCT01119937|156831302|FG001|Overall Study|Adverse Event|5|||
48721883|NCT01119937|156831301|FG000|Overall Study|Protocol deviation|3|||
48721884|NCT01119937|156831302|FG001|Overall Study|Protocol deviation|1|||
48816995|NCT01683994|157173593|FG004|Overall Study|Intercurrent illness|1|||
48816996|NCT01500226|157173595|FG000|Overall Study|Adverse Event|31|||
48816997|NCT01500226|157173596|FG001|Overall Study|Adverse Event|38|||
49129420|NCT02709746|158313786|FG001|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
49129421|NCT02709746|158313787|FG002|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
48721885|NCT01119937|156831301|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
48721886|NCT01119937|156831302|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
48721887|NCT01119937|156831301|FG000|Overall Study|Withdrawal by Subject|2|||
48721888|NCT01119937|156831302|FG001|Overall Study|Withdrawal by Subject|1|||
48721889|NCT02025556|156831303|FG000|Overall Study|Adverse Event|0|||
48721890|NCT02025556|156831304|FG001|Overall Study|Adverse Event|4|||
48721891|NCT02025556|156831305|FG002|Overall Study|Adverse Event|2|||
48721892|NCT02025556|156831303|FG000|Overall Study|Lack of Efficacy|2|||
48721893|NCT02025556|156831304|FG001|Overall Study|Lack of Efficacy|1|||
48721894|NCT02025556|156831305|FG002|Overall Study|Lack of Efficacy|0|||
48816998|NCT01500226|157173595|FG000|Overall Study|Chemo Completed or Change in Therapy|235|||
49129422|NCT02709746|158313788|FG003|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
49129423|NCT02709746|158313789|FG004|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
49129424|NCT02709746|158313785|FG000|Phase A (Single-blind Treatment Period)|Adverse Event|2|||
49129425|NCT02709746|158313786|FG001|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
49129426|NCT02709746|158313787|FG002|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
49129427|NCT02709746|158313788|FG003|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
49129428|NCT02709746|158313789|FG004|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
49129429|NCT02709746|158313785|FG000|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12|||
49129430|NCT02709746|158313786|FG001|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
49129431|NCT02709746|158313787|FG002|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
49129432|NCT02709746|158313788|FG003|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
49129433|NCT02709746|158313789|FG004|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
49129434|NCT02709746|158313785|FG000|Phase A (Single-blind Treatment Period)|Enrolled not treated|7|||
49129435|NCT02709746|158313786|FG001|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
49129436|NCT02709746|158313787|FG002|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
49129437|NCT02709746|158313788|FG003|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
49129438|NCT02709746|158313789|FG004|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
49129439|NCT02709746|158313785|FG000|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7|||
49129440|NCT02709746|158313786|FG001|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
49129441|NCT02709746|158313787|FG002|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
49129442|NCT02709746|158313788|FG003|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
49129443|NCT02709746|158313789|FG004|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
49129444|NCT02709746|158313785|FG000|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103|||
49129445|NCT02709746|158313786|FG001|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
49129446|NCT02709746|158313787|FG002|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
49129447|NCT02709746|158313788|FG003|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
49129448|NCT02709746|158313789|FG004|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
49129449|NCT02709746|158313785|FG000|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
49129450|NCT02709746|158313786|FG001|Phase B (Double-blind Treatment Period)|Protocol Violation|1|||
49129451|NCT02709746|158313787|FG002|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
49129452|NCT02709746|158313788|FG003|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
49129453|NCT02709746|158313789|FG004|Phase B (Double-blind Treatment Period)|Protocol Violation|2|||
49129454|NCT02709746|158313785|FG000|Phase B (Double-blind Treatment Period)|Other|0|||
49129455|NCT02709746|158313786|FG001|Phase B (Double-blind Treatment Period)|Other|6|||
49129456|NCT02709746|158313787|FG002|Phase B (Double-blind Treatment Period)|Other|5|||
49129457|NCT02709746|158313788|FG003|Phase B (Double-blind Treatment Period)|Other|6|||
49129458|NCT02709746|158313789|FG004|Phase B (Double-blind Treatment Period)|Other|7|||
49129459|NCT02709746|158313785|FG000|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
49129460|NCT02709746|158313786|FG001|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
49129461|NCT02709746|158313787|FG002|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4|||
49129462|NCT02709746|158313788|FG003|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
49129463|NCT02709746|158313789|FG004|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
49129464|NCT02709746|158313785|FG000|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
49129465|NCT02709746|158313786|FG001|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3|||
49129466|NCT02709746|158313787|FG002|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
49129467|NCT02709746|158313788|FG003|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1|||
49129468|NCT02709746|158313789|FG004|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2|||
49129469|NCT02709746|158313785|FG000|Phase B (Double-blind Treatment Period)|Adverse Event|0|||
49129470|NCT02709746|158313786|FG001|Phase B (Double-blind Treatment Period)|Adverse Event|4|||
49129471|NCT02709746|158313787|FG002|Phase B (Double-blind Treatment Period)|Adverse Event|8|||
49129472|NCT02709746|158313788|FG003|Phase B (Double-blind Treatment Period)|Adverse Event|5|||
49129473|NCT02709746|158313789|FG004|Phase B (Double-blind Treatment Period)|Adverse Event|2|||
49129474|NCT02709746|158313785|FG000|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0|||
49129475|NCT02709746|158313786|FG001|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
49129476|NCT02709746|158313787|FG002|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
49129477|NCT02709746|158313788|FG003|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
49129478|NCT02709746|158313789|FG004|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1|||
49129479|NCT02709746|158313785|FG000|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
49129480|NCT02709746|158313786|FG001|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
49129481|NCT02709746|158313787|FG002|Phase B (Double-blind Treatment Period)|enrolled not treated|1|||
49129482|NCT02709746|158313788|FG003|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
48721895|NCT02025556|156831303|FG000|Overall Study|Protocol Violation|2|||
48721896|NCT02025556|156831304|FG001|Overall Study|Protocol Violation|1|||
49129483|NCT02709746|158313789|FG004|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
49129484|NCT02709746|158313785|FG000|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
48721897|NCT02025556|156831305|FG002|Overall Study|Protocol Violation|0|||
48721898|NCT02025556|156831303|FG000|Overall Study|Withdrawal by Subject|0|||
48721899|NCT02025556|156831304|FG001|Overall Study|Withdrawal by Subject|3|||
48721900|NCT02025556|156831305|FG002|Overall Study|Withdrawal by Subject|6|||
48721901|NCT02025556|156831303|FG000|Overall Study|Lost to Follow-up|2|||
48721902|NCT02025556|156831304|FG001|Overall Study|Lost to Follow-up|4|||
49129485|NCT02709746|158313786|FG001|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4|||
49129486|NCT02709746|158313787|FG002|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
48721903|NCT02025556|156831305|FG002|Overall Study|Lost to Follow-up|0|||
48721904|NCT02025556|156831303|FG000|Overall Study|Reason not reported|0|||
48721905|NCT02025556|156831304|FG001|Overall Study|Reason not reported|0|||
48721906|NCT02025556|156831305|FG002|Overall Study|Reason not reported|1|||
48721907|NCT03946670|156831306|FG000|Overall Study|Progressive Disease|26|||
49129487|NCT02709746|158313788|FG003|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
49129488|NCT02709746|158313789|FG004|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
49129489|NCT03191799|158313794|FG000|Overall Study|Withdrawal by Subject|4|||
49129490|NCT03191799|158313794|FG000|Overall Study|Physician Decision|2|||
49129491|NCT03191799|158313794|FG000|Overall Study|Lost to Follow-up|1|||
48721908|NCT03946670|156831307|FG001|Overall Study|Progressive Disease|23|||
48721909|NCT03946670|156831306|FG000|Overall Study|Adverse Event|7|||
48721910|NCT03946670|156831307|FG001|Overall Study|Adverse Event|9|||
48721911|NCT03946670|156831306|FG000|Overall Study|Death|5|||
48721912|NCT03946670|156831307|FG001|Overall Study|Death|6|||
48721913|NCT03946670|156831306|FG000|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|5|||
48721914|NCT03946670|156831307|FG001|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|6|||
48721915|NCT03946670|156831306|FG000|Overall Study|Subject Decision|4|||
48721916|NCT03946670|156831307|FG001|Overall Study|Subject Decision|4|||
48721917|NCT03946670|156831306|FG000|Overall Study|Physician Decision|3|||
48721918|NCT03946670|156831307|FG001|Overall Study|Physician Decision|3|||
48721919|NCT03946670|156831306|FG000|Overall Study|New Therapy for Study Indication|1|||
48721920|NCT03946670|156831307|FG001|Overall Study|New Therapy for Study Indication|0|||
48721921|NCT03946670|156831306|FG000|Overall Study|Not treated|1|||
48721922|NCT03946670|156831307|FG001|Overall Study|Not treated|1|||
48721923|NCT02112045|156831308|FG000|Overall Study|Withdrawal by Subject|1|||
48721924|NCT02112045|156831309|FG001|Overall Study|Withdrawal by Subject|0|||
48721925|NCT01960907|156831310|FG000|Overall Study|Death|4|||
48721926|NCT01960907|156831311|FG001|Overall Study|Death|3|||
48721927|NCT01960907|156831310|FG000|Overall Study|Withdrawal by Subject|32|||
48721928|NCT01960907|156831311|FG001|Overall Study|Withdrawal by Subject|42|||
48721929|NCT00913692|156831317|FG000|Screening (4 Months)|Physician Decision|3|||
49129492|NCT03191799|158313794|FG000|Overall Study|Death|2|||
49129493|NCT04275336|158313795|FG000|Overall Study|First venipuncture failed|4|||
49129494|NCT04275336|158313796|FG001|Overall Study|First venipuncture failed|6|||
49129495|NCT04275336|158313797|FG002|Overall Study|First venipuncture failed|5|||
49129496|NCT04275336|158313795|FG000|Overall Study|Unscheduled venipuncture|9|||
49129497|NCT04275336|158313796|FG001|Overall Study|Unscheduled venipuncture|13|||
49129498|NCT04275336|158313797|FG002|Overall Study|Unscheduled venipuncture|7|||
49129499|NCT04275336|158313795|FG000|Overall Study|Failed specimen of saliva|4|||
49129500|NCT04275336|158313796|FG001|Overall Study|Failed specimen of saliva|3|||
49129501|NCT04275336|158313797|FG002|Overall Study|Failed specimen of saliva|4|||
49129502|NCT01483118|158313798|FG000|Overall Study|Lost to Follow-up|12|||
49129503|NCT01483118|158313799|FG001|Overall Study|Lost to Follow-up|16|||
49129504|NCT02000921|158313802|FG000|Overall Study|Withdrawal by Subject|3|||
49129505|NCT02000921|158313803|FG001|Overall Study|Withdrawal by Subject|10|||
49129506|NCT02000921|158313804|FG002|Overall Study|Withdrawal by Subject|5|||
49129507|NCT02000921|158313802|FG000|Overall Study|Lost to Follow-up|2|||
48721930|NCT00913692|156831317|FG000|Screening (4 Months)|Not eligible after screening phase.|6|||
48721931|NCT00913692|156831317|FG000|Treatment Phase 1 (5 Months)|Physician Decision|1|||
48721932|NCT00266877|156831320|FG000|Overall Study|Death|1|||
48721933|NCT00266877|156831321|FG001|Overall Study|Death|1|||
49129508|NCT02000921|158313803|FG001|Overall Study|Lost to Follow-up|4|||
49129509|NCT02000921|158313804|FG002|Overall Study|Lost to Follow-up|5|||
49129510|NCT02000921|158313802|FG000|Overall Study|Physician Decision|0|||
49129511|NCT02000921|158313803|FG001|Overall Study|Physician Decision|2|||
48721934|NCT00266877|156831322|FG002|Overall Study|Death|1|||
49129512|NCT02000921|158313804|FG002|Overall Study|Physician Decision|0|||
49129513|NCT02051296|158313811|FG000|Overall Study|Lost to Follow-up|1|||
49129514|NCT02051296|158313812|FG001|Overall Study|Lost to Follow-up|2|||
48721935|NCT00266877|156831320|FG000|Overall Study|Adverse Event|6|||
48721936|NCT00266877|156831321|FG001|Overall Study|Adverse Event|4|||
48721937|NCT00266877|156831322|FG002|Overall Study|Adverse Event|1|||
48721938|NCT00266877|156831320|FG000|Overall Study|Physician Decision|2|||
48721939|NCT00266877|156831321|FG001|Overall Study|Physician Decision|1|||
48721940|NCT00266877|156831322|FG002|Overall Study|Physician Decision|1|||
48721941|NCT00266877|156831320|FG000|Overall Study|Withdrawal by Subject|3|||
48721942|NCT00266877|156831321|FG001|Overall Study|Withdrawal by Subject|1|||
48721943|NCT00266877|156831322|FG002|Overall Study|Withdrawal by Subject|1|||
48721944|NCT00266877|156831320|FG000|Overall Study|Disease Progression|72|||
48721945|NCT00266877|156831321|FG001|Overall Study|Disease Progression|37|||
49129515|NCT02051296|158313811|FG000|Overall Study|withdraw prior to treatment|7|||
49129516|NCT02051296|158313812|FG001|Overall Study|withdraw prior to treatment|7|||
49129517|NCT00975416|158313813|FG000|Overall Study|early discharge from tx|3|||
49129518|NCT00975416|158313814|FG001|Overall Study|early discharge from tx|5|||
49129519|NCT03439137|158313815|FG000|Overall Study|Adverse Event|16|||
49129520|NCT03439137|158313816|FG001|Overall Study|Adverse Event|12|||
49129521|NCT03439137|158313815|FG000|Overall Study|Physician Decision|0|||
49129522|NCT03439137|158313816|FG001|Overall Study|Physician Decision|5|||
48721946|NCT00266877|156831322|FG002|Overall Study|Disease Progression|23|||
48721947|NCT00266877|156831320|FG000|Overall Study|Symptomatic Deterioration|6|||
48721948|NCT00266877|156831321|FG001|Overall Study|Symptomatic Deterioration|3|||
48721949|NCT00266877|156831322|FG002|Overall Study|Symptomatic Deterioration|1|||
48721950|NCT00266877|156831320|FG000|Overall Study|Hospitalization|1|||
48721951|NCT00266877|156831321|FG001|Overall Study|Hospitalization|0|||
48721952|NCT00266877|156831322|FG002|Overall Study|Hospitalization|0|||
48721953|NCT00266877|156831320|FG000|Overall Study|Concomitant Radiotherapy|0|||
48721954|NCT00266877|156831321|FG001|Overall Study|Concomitant Radiotherapy|1|||
48721955|NCT00266877|156831322|FG002|Overall Study|Concomitant Radiotherapy|0|||
48721956|NCT03945175|156831323|FG000|Overall Study|Did not meet inclusion criteria|31|||
48721957|NCT03945175|156831323|FG000|Overall Study|Withdrew consent|2|||
48721958|NCT03945175|156831323|FG000|Overall Study|Responded to Placebo Treatment and was not Allocated to Mydayis|1|||
48721959|NCT03945175|156831323|FG000|Overall Study|Early termination during Mydayis treatment|1|||
48721960|NCT01089361|156831325|FG000|Overall Study|Death|1|||
48721961|NCT01089361|156831326|FG001|Overall Study|Death|0|||
48721962|NCT01606878|156831327|FG000|Overall Study|Adverse Event|1|||
48721963|NCT01606878|156831328|FG001|Overall Study|Adverse Event|1|||
48721964|NCT01606878|156831329|FG002|Overall Study|Adverse Event|0|||
48721965|NCT01606878|156831330|FG003|Overall Study|Adverse Event|0|||
48721966|NCT01606878|156831331|FG004|Overall Study|Adverse Event|0|||
48721967|NCT01606878|156831332|FG005|Overall Study|Adverse Event|0|||
48721968|NCT01606878|156831333|FG006|Overall Study|Adverse Event|1|||
48721969|NCT01606878|156831334|FG007|Overall Study|Adverse Event|0|||
48721970|NCT01606878|156831335|FG008|Overall Study|Adverse Event|1|||
48721971|NCT01606878|156831336|FG009|Overall Study|Adverse Event|3|||
48721972|NCT01606878|156831337|FG010|Overall Study|Adverse Event|0|||
48721973|NCT01606878|156831327|FG000|Overall Study|Lack of Efficacy|1|||
48721974|NCT01606878|156831328|FG001|Overall Study|Lack of Efficacy|1|||
48816999|NCT01500226|157173596|FG001|Overall Study|Chemo Completed or Change in Therapy|237|||
48817000|NCT01500226|157173595|FG000|Overall Study|Withdrawal by Subject|93|||
48817001|NCT01500226|157173596|FG001|Overall Study|Withdrawal by Subject|96|||
48817002|NCT01500226|157173595|FG000|Overall Study|Death|12|||
48817003|NCT01500226|157173596|FG001|Overall Study|Death|4|||
48817004|NCT01500226|157173595|FG000|Overall Study|Disease Progression|16|||
48721975|NCT01606878|156831329|FG002|Overall Study|Lack of Efficacy|1|||
48721976|NCT01606878|156831330|FG003|Overall Study|Lack of Efficacy|2|||
48721977|NCT01606878|156831331|FG004|Overall Study|Lack of Efficacy|1|||
48721978|NCT01606878|156831332|FG005|Overall Study|Lack of Efficacy|2|||
48721979|NCT01606878|156831333|FG006|Overall Study|Lack of Efficacy|1|||
48721980|NCT01606878|156831334|FG007|Overall Study|Lack of Efficacy|2|||
48721981|NCT01606878|156831335|FG008|Overall Study|Lack of Efficacy|2|||
48721982|NCT01606878|156831336|FG009|Overall Study|Lack of Efficacy|0|||
48721983|NCT01606878|156831337|FG010|Overall Study|Lack of Efficacy|1|||
48721984|NCT01606878|156831327|FG000|Overall Study|Physician Decision|1|||
48721985|NCT01606878|156831328|FG001|Overall Study|Physician Decision|0|||
48721986|NCT01606878|156831329|FG002|Overall Study|Physician Decision|2|||
48721987|NCT01606878|156831330|FG003|Overall Study|Physician Decision|1|||
48817005|NCT01500226|157173596|FG001|Overall Study|Disease Progression|14|||
48817006|NCT01500226|157173595|FG000|Overall Study|Protocol Violation|53|||
49129523|NCT03439137|158313815|FG000|Overall Study|Withdrawal by Subject|14|||
48721988|NCT01606878|156831331|FG004|Overall Study|Physician Decision|1|||
48721989|NCT01606878|156831332|FG005|Overall Study|Physician Decision|1|||
48721990|NCT01606878|156831333|FG006|Overall Study|Physician Decision|2|||
48721991|NCT01606878|156831334|FG007|Overall Study|Physician Decision|0|||
48721992|NCT01606878|156831335|FG008|Overall Study|Physician Decision|1|||
48721993|NCT01606878|156831336|FG009|Overall Study|Physician Decision|0|||
48721994|NCT01606878|156831337|FG010|Overall Study|Physician Decision|0|||
48721995|NCT01606878|156831327|FG000|Overall Study|Withdrawal by Subject|3|||
48721996|NCT01606878|156831328|FG001|Overall Study|Withdrawal by Subject|2|||
48721997|NCT01606878|156831329|FG002|Overall Study|Withdrawal by Subject|2|||
48721998|NCT01606878|156831330|FG003|Overall Study|Withdrawal by Subject|0|||
48721999|NCT01606878|156831331|FG004|Overall Study|Withdrawal by Subject|1|||
49129524|NCT03439137|158313816|FG001|Overall Study|Withdrawal by Subject|4|||
49129525|NCT03439137|158313815|FG000|Overall Study|Conducting rescue therapy|2|||
48817007|NCT01500226|157173596|FG001|Overall Study|Protocol Violation|39|||
48817008|NCT01500226|157173595|FG000|Overall Study|Physician Decision|17|||
48817009|NCT01500226|157173596|FG001|Overall Study|Physician Decision|15|||
48817010|NCT01500226|157173595|FG000|Overall Study|Lack of Efficacy|14|||
48817011|NCT01500226|157173596|FG001|Overall Study|Lack of Efficacy|30|||
48817012|NCT01500226|157173595|FG000|Overall Study|Lost to Follow-up|9|||
48817013|NCT01500226|157173596|FG001|Overall Study|Lost to Follow-up|5|||
48722000|NCT01606878|156831332|FG005|Overall Study|Withdrawal by Subject|1|||
48722001|NCT01606878|156831333|FG006|Overall Study|Withdrawal by Subject|2|||
48722002|NCT01606878|156831334|FG007|Overall Study|Withdrawal by Subject|1|||
48722003|NCT01606878|156831335|FG008|Overall Study|Withdrawal by Subject|2|||
48722004|NCT01606878|156831336|FG009|Overall Study|Withdrawal by Subject|0|||
48722005|NCT01606878|156831337|FG010|Overall Study|Withdrawal by Subject|2|||
48722006|NCT00727532|156831338|FG000|Overall Study|Adverse Event|1|||
48722007|NCT00727532|156831338|FG000|Overall Study|Withdrawal by Subject|1|||
48722008|NCT02839265|156831343|FG000|Overall Study|Screen Failure|2|||
48722009|NCT02839265|156831343|FG000|Overall Study|Death|1|||
48722010|NCT02839265|156831343|FG000|Overall Study|Progression of SVC syndrome prior to treatment initiation|1|||
48722011|NCT03858517|156831344|FG000|Overall Study|Adverse Event|1|||
48722012|NCT03858517|156831344|FG000|Overall Study|Lost to Follow-up|1|||
48722013|NCT03858517|156831344|FG000|Overall Study|removed for being incarcerated|1|||
48722014|NCT03858517|156831344|FG000|Overall Study|Sponsor Closure|48|||
48722015|NCT01031836|156832578|FG000|Stage I|Adverse Event|1|||
48722016|NCT01031836|156832579|FG001|Stage I|Adverse Event|1|||
48722017|NCT01031836|156832580|FG002|Stage I|Adverse Event|0|||
48722018|NCT01031836|156832581|FG003|Stage I|Adverse Event|0|||
48722019|NCT01031836|156832582|FG004|Stage I|Adverse Event|0|||
48817014|NCT01500226|157173595|FG000|Overall Study|Other Reasons|19|||
48817015|NCT01500226|157173596|FG001|Overall Study|Other Reasons|16|||
48817016|NCT02718417|157173601|FG000|Chemotherapy Phase (CP)|Adverse Event|9|||
48817017|NCT02718417|157173602|FG001|Chemotherapy Phase (CP)|Adverse Event|14|||
48817018|NCT02718417|157173603|FG002|Chemotherapy Phase (CP)|Adverse Event|13|||
48817019|NCT02718417|157173601|FG000|Chemotherapy Phase (CP)|Death leading to discontinuation|5|||
48817020|NCT02718417|157173602|FG001|Chemotherapy Phase (CP)|Death leading to discontinuation|4|||
48817021|NCT02718417|157173603|FG002|Chemotherapy Phase (CP)|Death leading to discontinuation|1|||
48817022|NCT02718417|157173601|FG000|Chemotherapy Phase (CP)|Global deterioration of health status|3|||
48817023|NCT02718417|157173602|FG001|Chemotherapy Phase (CP)|Global deterioration of health status|2|||
48817024|NCT02718417|157173603|FG002|Chemotherapy Phase (CP)|Global deterioration of health status|1|||
48817025|NCT02718417|157173601|FG000|Chemotherapy Phase (CP)|No longer met eligibility criteria|4|||
48817026|NCT02718417|157173602|FG001|Chemotherapy Phase (CP)|No longer met eligibility criteria|2|||
48817027|NCT02718417|157173603|FG002|Chemotherapy Phase (CP)|No longer met eligibility criteria|1|||
48817028|NCT02718417|157173601|FG000|Chemotherapy Phase (CP)|Physician's decision|5|||
48817029|NCT02718417|157173602|FG001|Chemotherapy Phase (CP)|Physician's decision|0|||
49129526|NCT03439137|158313816|FG001|Overall Study|Conducting rescue therapy|1|||
49129527|NCT03439137|158313815|FG000|Overall Study|Difficult to control Hb|10|||
49129528|NCT03439137|158313816|FG001|Overall Study|Difficult to control Hb|2|||
49129529|NCT03439137|158313815|FG000|Overall Study|Initiation of a renal transplant|0|||
49129530|NCT03439137|158313816|FG001|Overall Study|Initiation of a renal transplant|2|||
49129531|NCT02251275|158313818|FG000|Overall Study|Adverse Event|23|||
49129532|NCT02251275|158313819|FG001|Overall Study|Adverse Event|60|||
49129533|NCT02251275|158313820|FG002|Overall Study|Adverse Event|28|||
49129534|NCT02251275|158313821|FG003|Overall Study|Adverse Event|0|||
48722020|NCT01031836|156832583|FG005|Stage I|Adverse Event|0|||
48722021|NCT01031836|156832578|FG000|Stage I|Other|0|||
48722022|NCT01031836|156832579|FG001|Stage I|Other|1|||
48722023|NCT01031836|156832580|FG002|Stage I|Other|0|||
48722024|NCT01031836|156832581|FG003|Stage I|Other|0|||
48722025|NCT01031836|156832582|FG004|Stage I|Other|0|||
49129535|NCT02251275|158313822|FG004|Overall Study|Adverse Event|0|||
48722026|NCT01031836|156832583|FG005|Stage I|Other|1|||
48722027|NCT01031836|156832578|FG000|Stage II|Adverse Event|0|||
48722028|NCT01031836|156832579|FG001|Stage II|Adverse Event|0|||
48722029|NCT01031836|156832580|FG002|Stage II|Adverse Event|2|||
48817030|NCT02718417|157173603|FG002|Chemotherapy Phase (CP)|Physician's decision|4|||
48817031|NCT02718417|157173601|FG000|Chemotherapy Phase (CP)|Progressive disease|11|||
49129536|NCT02251275|158313818|FG000|Overall Study|Lost to Follow-up|5|||
49129537|NCT02251275|158313819|FG001|Overall Study|Lost to Follow-up|6|||
48817032|NCT02718417|157173602|FG001|Chemotherapy Phase (CP)|Progressive disease|7|||
48817033|NCT02718417|157173603|FG002|Chemotherapy Phase (CP)|Progressive disease|10|||
48817034|NCT02718417|157173601|FG000|Chemotherapy Phase (CP)|Withdrawal by Subject|13|||
48817035|NCT02718417|157173602|FG001|Chemotherapy Phase (CP)|Withdrawal by Subject|8|||
48817036|NCT02718417|157173603|FG002|Chemotherapy Phase (CP)|Withdrawal by Subject|15|||
48817037|NCT02718417|157173601|FG000|Chemotherapy Phase (CP)|Other|2|||
48817038|NCT02718417|157173602|FG001|Chemotherapy Phase (CP)|Other|0|||
48817039|NCT02718417|157173603|FG002|Chemotherapy Phase (CP)|Other|1|||
48817040|NCT02718417|157173601|FG000|Maintenance Phase (MP)|Adverse Event|21|||
48817041|NCT02718417|157173602|FG001|Maintenance Phase (MP)|Adverse Event|26|||
48817042|NCT02718417|157173603|FG002|Maintenance Phase (MP)|Adverse Event|0|||
48817043|NCT02718417|157173601|FG000|Maintenance Phase (MP)|Death leading to discontinuation|1|||
48817044|NCT02718417|157173602|FG001|Maintenance Phase (MP)|Death leading to discontinuation|1|||
48817045|NCT02718417|157173603|FG002|Maintenance Phase (MP)|Death leading to discontinuation|0|||
48817046|NCT02718417|157173601|FG000|Maintenance Phase (MP)|Global deterioration of health status|5|||
48817047|NCT02718417|157173602|FG001|Maintenance Phase (MP)|Global deterioration of health status|3|||
48817048|NCT02718417|157173603|FG002|Maintenance Phase (MP)|Global deterioration of health status|0|||
48817049|NCT02718417|157173601|FG000|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
48817050|NCT02718417|157173602|FG001|Maintenance Phase (MP)|No longer met eligibility criteria|1|||
48817051|NCT02718417|157173603|FG002|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
48817052|NCT02718417|157173601|FG000|Maintenance Phase (MP)|Physician's decision|6|||
48817053|NCT02718417|157173602|FG001|Maintenance Phase (MP)|Physician's decision|7|||
48817054|NCT02718417|157173603|FG002|Maintenance Phase (MP)|Physician's decision|0|||
48817055|NCT02718417|157173601|FG000|Maintenance Phase (MP)|Progressive disease|100|||
48817056|NCT02718417|157173602|FG001|Maintenance Phase (MP)|Progressive disease|88|||
48817057|NCT02718417|157173603|FG002|Maintenance Phase (MP)|Progressive disease|0|||
48817058|NCT02718417|157173601|FG000|Maintenance Phase (MP)|Other|2|||
48817059|NCT02718417|157173602|FG001|Maintenance Phase (MP)|Other|1|||
48817060|NCT02718417|157173603|FG002|Maintenance Phase (MP)|Other|0|||
48817061|NCT02718417|157173601|FG000|Maintenance Phase (MP)|Withdrawal by Subject|17|||
48817062|NCT02718417|157173602|FG001|Maintenance Phase (MP)|Withdrawal by Subject|20|||
48817063|NCT02718417|157173603|FG002|Maintenance Phase (MP)|Withdrawal by Subject|0|||
48817064|NCT02718417|157173601|FG000|Maintenance Phase (MP)|Study terminated by sponsor|114|||
48817065|NCT02718417|157173602|FG001|Maintenance Phase (MP)|Study terminated by sponsor|140|||
48817066|NCT02718417|157173603|FG002|Maintenance Phase (MP)|Study terminated by sponsor|0|||
48817067|NCT02718417|157173601|FG000|Observation Phase (OP)|Adverse Event|0|||
48817068|NCT02718417|157173602|FG001|Observation Phase (OP)|Adverse Event|0|||
48817069|NCT02718417|157173603|FG002|Observation Phase (OP)|Adverse Event|1|||
48817070|NCT02718417|157173601|FG000|Observation Phase (OP)|Death leading to discontinuation|0|||
48817071|NCT02718417|157173602|FG001|Observation Phase (OP)|Death leading to discontinuation|0|||
48817072|NCT02718417|157173603|FG002|Observation Phase (OP)|Death leading to discontinuation|2|||
48817073|NCT02718417|157173601|FG000|Observation Phase (OP)|Lost to Follow-up|0|||
48817074|NCT02718417|157173602|FG001|Observation Phase (OP)|Lost to Follow-up|0|||
48817075|NCT02718417|157173603|FG002|Observation Phase (OP)|Lost to Follow-up|1|||
48817076|NCT02718417|157173601|FG000|Observation Phase (OP)|Physician Decision|0|||
48817077|NCT02718417|157173602|FG001|Observation Phase (OP)|Physician Decision|0|||
48817078|NCT02718417|157173603|FG002|Observation Phase (OP)|Physician Decision|9|||
48817079|NCT02718417|157173601|FG000|Observation Phase (OP)|Progressive disease|0|||
48817080|NCT02718417|157173602|FG001|Observation Phase (OP)|Progressive disease|0|||
48817081|NCT02718417|157173603|FG002|Observation Phase (OP)|Progressive disease|92|||
48817082|NCT02718417|157173601|FG000|Observation Phase (OP)|Study terminated by sponsor|0|||
48817083|NCT02718417|157173602|FG001|Observation Phase (OP)|Study terminated by sponsor|0|||
48817084|NCT02718417|157173603|FG002|Observation Phase (OP)|Study terminated by sponsor|135|||
48817085|NCT02718417|157173601|FG000|Observation Phase (OP)|Withdrawal by Subject|0|||
48722030|NCT01031836|156832581|FG003|Stage II|Adverse Event|2|||
48722031|NCT01031836|156832582|FG004|Stage II|Adverse Event|1|||
48722032|NCT01031836|156832583|FG005|Stage II|Adverse Event|1|||
48722033|NCT01031836|156832578|FG000|Stage II|Other|2|||
48722034|NCT01031836|156832579|FG001|Stage II|Other|0|||
48722035|NCT01031836|156832580|FG002|Stage II|Other|0|||
48722036|NCT01031836|156832581|FG003|Stage II|Other|1|||
48722037|NCT01031836|156832582|FG004|Stage II|Other|1|||
48722038|NCT01031836|156832583|FG005|Stage II|Other|0|||
48722039|NCT01925131|156832584|FG000|Overall Study|Death|0|||
48722040|NCT01925131|156832585|FG001|Overall Study|Death|0|||
48817086|NCT02718417|157173602|FG001|Observation Phase (OP)|Withdrawal by Subject|0|||
48920996|NCT00784654|157544820|FG002|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
48722041|NCT01925131|156832586|FG002|Overall Study|Death|1|||
48722042|NCT01925131|156832587|FG003|Overall Study|Death|0|||
48817087|NCT02718417|157173603|FG002|Observation Phase (OP)|Withdrawal by Subject|34|||
48817088|NCT02718417|157173601|FG000|Observation Phase (OP)|Global deterioration of health status|0|||
48722043|NCT01925131|156832588|FG004|Overall Study|Death|0|||
48722044|NCT01925131|156832589|FG005|Overall Study|Death|0|||
48817089|NCT02718417|157173602|FG001|Observation Phase (OP)|Global deterioration of health status|0|||
48817090|NCT02718417|157173603|FG002|Observation Phase (OP)|Global deterioration of health status|1|||
48817091|NCT02718417|157173601|FG000|Observation Phase (OP)|Other|0|||
48817092|NCT02718417|157173602|FG001|Observation Phase (OP)|Other|0|||
48817093|NCT02718417|157173603|FG002|Observation Phase (OP)|Other|7|||
48817094|NCT02718417|157173601|FG000|Follow-up Phase|Adverse Event|3|||
48817095|NCT02718417|157173602|FG001|Follow-up Phase|Adverse Event|1|||
48817096|NCT02718417|157173603|FG002|Follow-up Phase|Adverse Event|1|||
48817097|NCT02718417|157173601|FG000|Follow-up Phase|Other|4|||
48817098|NCT02718417|157173602|FG001|Follow-up Phase|Other|6|||
48817099|NCT02718417|157173603|FG002|Follow-up Phase|Other|4|||
48817100|NCT02718417|157173601|FG000|Follow-up Phase|Withdrawal by Subject|19|||
48817101|NCT02718417|157173602|FG001|Follow-up Phase|Withdrawal by Subject|17|||
48817102|NCT02718417|157173603|FG002|Follow-up Phase|Withdrawal by Subject|5|||
48817103|NCT02718417|157173601|FG000|Follow-up Phase|Study terminated by sponsor|100|||
48817104|NCT02718417|157173602|FG001|Follow-up Phase|Study terminated by sponsor|138|||
48817105|NCT02718417|157173603|FG002|Follow-up Phase|Study terminated by sponsor|6|||
48817106|NCT02718417|157173601|FG000|Follow-up Phase|Lost to Follow-up|2|||
48817107|NCT02718417|157173602|FG001|Follow-up Phase|Lost to Follow-up|3|||
48817108|NCT02718417|157173603|FG002|Follow-up Phase|Lost to Follow-up|0|||
48817109|NCT02718417|157173601|FG000|Follow-up Phase|Death leading to discontinuation|7|||
48817110|NCT02718417|157173602|FG001|Follow-up Phase|Death leading to discontinuation|7|||
48817111|NCT02718417|157173603|FG002|Follow-up Phase|Death leading to discontinuation|3|||
48817112|NCT02718417|157173601|FG000|Long-term Follow-up Phase|Death leading to discontinuation|20|||
48817113|NCT02718417|157173602|FG001|Long-term Follow-up Phase|Death leading to discontinuation|17|||
48817114|NCT02718417|157173603|FG002|Long-term Follow-up Phase|Death leading to discontinuation|11|||
48817115|NCT02718417|157173601|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
48817116|NCT02718417|157173602|FG001|Long-term Follow-up Phase|Lost to Follow-up|4|||
48817117|NCT02718417|157173603|FG002|Long-term Follow-up Phase|Lost to Follow-up|3|||
48817118|NCT02718417|157173601|FG000|Long-term Follow-up Phase|Study terminated by sponsor|105|||
48817119|NCT02718417|157173602|FG001|Long-term Follow-up Phase|Study terminated by sponsor|80|||
48817120|NCT02718417|157173603|FG002|Long-term Follow-up Phase|Study terminated by sponsor|112|||
48817121|NCT02718417|157173601|FG000|Long-term Follow-up Phase|Withdrawal by Subject|6|||
48817122|NCT02718417|157173602|FG001|Long-term Follow-up Phase|Withdrawal by Subject|9|||
48817123|NCT02718417|157173603|FG002|Long-term Follow-up Phase|Withdrawal by Subject|9|||
48817124|NCT02718417|157173601|FG000|Long-term Follow-up Phase|Other|0|||
48817125|NCT02718417|157173602|FG001|Long-term Follow-up Phase|Other|2|||
48817126|NCT02718417|157173603|FG002|Long-term Follow-up Phase|Other|0|||
48817127|NCT02163447|157173611|FG000|Overall Study|Withdrawal by Subject|2|||
48817128|NCT02163447|157173612|FG001|Overall Study|Withdrawal by Subject|0|||
48817129|NCT02163447|157173613|FG002|Overall Study|Withdrawal by Subject|1|||
48817130|NCT02163447|157173611|FG000|Overall Study|Lost to Follow-up|1|||
48817131|NCT02163447|157173612|FG001|Overall Study|Lost to Follow-up|3|||
48817132|NCT02163447|157173613|FG002|Overall Study|Lost to Follow-up|0|||
48817133|NCT02163447|157173611|FG000|Overall Study|Moved out of study area|2|||
48817134|NCT02163447|157173612|FG001|Overall Study|Moved out of study area|3|||
48817135|NCT02163447|157173613|FG002|Overall Study|Moved out of study area|2|||
48817136|NCT02163447|157173611|FG000|Overall Study|Became HIV infected at time of delivery|1|||
48817137|NCT02163447|157173612|FG001|Overall Study|Became HIV infected at time of delivery|0|||
48817138|NCT02163447|157173613|FG002|Overall Study|Became HIV infected at time of delivery|0|||
48817139|NCT03268590|157173620|FG000|Overall Study|Previously unknown exclusion criteria|1|||
48817140|NCT02771210|157173625|FG000|Period 1|Adverse Event|5|||
48817141|NCT02771210|157173626|FG001|Period 1|Adverse Event|3|||
48817142|NCT02771210|157173625|FG000|Period 1|Lack of Efficacy|3|||
48817143|NCT02771210|157173626|FG001|Period 1|Lack of Efficacy|6|||
48817144|NCT02771210|157173625|FG000|Period 1|Lost to Follow-up|2|||
48817145|NCT02771210|157173626|FG001|Period 1|Lost to Follow-up|0|||
49129538|NCT02251275|158313820|FG002|Overall Study|Lost to Follow-up|4|||
49129539|NCT02251275|158313821|FG003|Overall Study|Lost to Follow-up|0|||
49129540|NCT02251275|158313822|FG004|Overall Study|Lost to Follow-up|0|||
48817146|NCT02771210|157173625|FG000|Period 1|Physician Decision|0|||
49129541|NCT02251275|158313818|FG000|Overall Study|Physician Decision|19|||
48817147|NCT02771210|157173626|FG001|Period 1|Physician Decision|1|||
48817148|NCT02771210|157173625|FG000|Period 1|Withdrawal by Subject|0|||
48817149|NCT02771210|157173626|FG001|Period 1|Withdrawal by Subject|3|||
48817150|NCT02771210|157173625|FG000|Period 1|Withdrawal of informed consent|1|||
48817151|NCT02771210|157173626|FG001|Period 1|Withdrawal of informed consent|5|||
48817152|NCT02771210|157173625|FG000|Period 2|Adverse Event|1|||
48817153|NCT02771210|157173626|FG001|Period 2|Adverse Event|0|||
48817154|NCT02771210|157173625|FG000|Period 2|Lack of Efficacy|0|||
48817155|NCT02771210|157173626|FG001|Period 2|Lack of Efficacy|1|||
48817156|NCT02771210|157173625|FG000|Period 2|Withdrawal by Subject|1|||
48817157|NCT02771210|157173626|FG001|Period 2|Withdrawal by Subject|0|||
48817158|NCT02771210|157173625|FG000|Period 2|Withdrawal of informed consent|0|||
49129542|NCT02251275|158313819|FG001|Overall Study|Physician Decision|30|||
49129543|NCT02251275|158313820|FG002|Overall Study|Physician Decision|26|||
48817159|NCT02771210|157173626|FG001|Period 2|Withdrawal of informed consent|2|||
48817160|NCT00478608|157173627|FG000|Overall Study|Adverse Event|1|||
48817161|NCT00478608|157173627|FG000|Overall Study|Serious Adverse Event|14|||
48817162|NCT00478608|157173627|FG000|Overall Study|Withdrawal by Subject|2|||
48817163|NCT00478608|157173627|FG000|Overall Study|Protocol Violation|3|||
48817164|NCT01349907|157173629|FG000|Overall Study|Adverse Event|37|||
49129544|NCT02251275|158313821|FG003|Overall Study|Physician Decision|0|||
49129545|NCT02251275|158313822|FG004|Overall Study|Physician Decision|1|||
49129546|NCT02251275|158313818|FG000|Overall Study|Protocol Deviation|0|||
49129547|NCT02251275|158313819|FG001|Overall Study|Protocol Deviation|0|||
49129548|NCT02251275|158313820|FG002|Overall Study|Protocol Deviation|1|||
49129549|NCT02251275|158313821|FG003|Overall Study|Protocol Deviation|0|||
49129550|NCT02251275|158313822|FG004|Overall Study|Protocol Deviation|0|||
49129551|NCT02251275|158313818|FG000|Overall Study|Withdrawal by Subject|25|||
49129552|NCT02251275|158313819|FG001|Overall Study|Withdrawal by Subject|51|||
49129553|NCT02251275|158313820|FG002|Overall Study|Withdrawal by Subject|35|||
49129554|NCT02251275|158313821|FG003|Overall Study|Withdrawal by Subject|1|||
49129555|NCT02251275|158313822|FG004|Overall Study|Withdrawal by Subject|0|||
49129556|NCT04456686|158313824|FG000|Overall Study|Adverse Event|2|||
49129557|NCT04456686|158313825|FG001|Overall Study|Adverse Event|1|||
49129558|NCT04456686|158313824|FG000|Overall Study|Lack of Efficacy|3|||
49129559|NCT04456686|158313825|FG001|Overall Study|Lack of Efficacy|1|||
49129560|NCT04456686|158313824|FG000|Overall Study|Withdrew consent|3|||
49129561|NCT04456686|158313825|FG001|Overall Study|Withdrew consent|1|||
49129562|NCT04456686|158313824|FG000|Overall Study|Physician Decision|2|||
49129563|NCT04456686|158313825|FG001|Overall Study|Physician Decision|2|||
49129564|NCT04456686|158313824|FG000|Overall Study|Withdrawal by Subject|5|||
49129565|NCT04456686|158313825|FG001|Overall Study|Withdrawal by Subject|1|||
49129566|NCT04456686|158313824|FG000|Overall Study|Protocol Violation|0|||
49129567|NCT04456686|158313825|FG001|Overall Study|Protocol Violation|1|||
49129568|NCT03426345|158313833|FG000|Overall Study|Adverse Event|4|||
49129569|NCT03426345|158313834|FG001|Overall Study|Adverse Event|4|||
49129570|NCT03426345|158313833|FG000|Overall Study|Lack of Efficacy|1|||
49129571|NCT03426345|158313834|FG001|Overall Study|Lack of Efficacy|0|||
49129572|NCT03426345|158313833|FG000|Overall Study|Withdrawal by Subject|5|||
49129573|NCT03426345|158313834|FG001|Overall Study|Withdrawal by Subject|6|||
49129574|NCT03426345|158313833|FG000|Overall Study|Lost to Follow-up|3|||
49129575|NCT03426345|158313834|FG001|Overall Study|Lost to Follow-up|1|||
49129576|NCT03426345|158313833|FG000|Overall Study|Protocol Deviation|3|||
49129577|NCT03426345|158313834|FG001|Overall Study|Protocol Deviation|4|||
49129578|NCT03426345|158313833|FG000|Overall Study|Reason Not Specified|1|||
49129579|NCT03426345|158313834|FG001|Overall Study|Reason Not Specified|2|||
49129580|NCT03426345|158313833|FG000|Overall Study|Missing Completion Status|1|||
49129581|NCT03426345|158313834|FG001|Overall Study|Missing Completion Status|0|||
49129582|NCT00748241|158313835|FG000|Overall Study|Implant failure|1|||
49129583|NCT00748241|158313835|FG000|Overall Study|Lost to Follow-up|5|||
49129584|NCT00748241|158313835|FG000|Overall Study|Death|2|||
49129585|NCT01240382|158313836|FG000|Overall Study|Adverse Event|2|||
49129586|NCT01240382|158313837|FG001|Overall Study|Adverse Event|1|||
49129587|NCT01240382|158313836|FG000|Overall Study|Lack of Efficacy|0|||
49129588|NCT01240382|158313837|FG001|Overall Study|Lack of Efficacy|2|||
49129589|NCT01240382|158313836|FG000|Overall Study|Fear of adverse events|0|||
49129590|NCT01240382|158313837|FG001|Overall Study|Fear of adverse events|1|||
49129591|NCT02152007|158313838|FG000|Overall Study|Withdrawal by Subject|1|||
49129592|NCT01302899|158313843|FG000|Period 2 (Weeks 7 to 12)|Protocol Deviation|1|||
49129593|NCT01302899|158313844|FG001|Period 2 (Weeks 7 to 12)|Protocol Deviation|0|||
49129594|NCT01302899|158313843|FG000|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0|||
49129595|NCT01302899|158313844|FG001|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1|||
49129596|NCT02834975|158313845|FG000|Overall Study|Physician Decision|2|||
49129597|NCT02834975|158313845|FG000|Overall Study|Adverse Event|1|||
49129598|NCT02834975|158313845|FG000|Overall Study|Withdrawal by Subject|1|||
49129599|NCT02834975|158313845|FG000|Overall Study|Lack of Efficacy|1|||
49129600|NCT02497469|158313846|FG000|Overall Study|Randomized but not Treated|0|||
49129601|NCT02497469|158313847|FG001|Overall Study|Randomized but not Treated|2|||
49129602|NCT02497469|158313846|FG000|Overall Study|Pretreatment Event/Adverse Event|18|||
49129603|NCT02497469|158313847|FG001|Overall Study|Pretreatment Event/Adverse Event|16|||
49129604|NCT02497469|158313846|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
49129605|NCT02497469|158313847|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
49129606|NCT02497469|158313846|FG000|Overall Study|Significant Protocol Deviation|4|||
49129607|NCT02497469|158313847|FG001|Overall Study|Significant Protocol Deviation|5|||
49129608|NCT02497469|158313846|FG000|Overall Study|Lost to Follow-up|14|||
49129609|NCT02497469|158313847|FG001|Overall Study|Lost to Follow-up|4|||
48817165|NCT01349907|157173630|FG001|Overall Study|Adverse Event|11|||
49129610|NCT02497469|158313846|FG000|Overall Study|Voluntary Withdrawal|39|||
49129611|NCT02497469|158313847|FG001|Overall Study|Voluntary Withdrawal|41|||
49129612|NCT02497469|158313846|FG000|Overall Study|Pregnancy|1|||
49129613|NCT02497469|158313847|FG001|Overall Study|Pregnancy|1|||
49129614|NCT02497469|158313846|FG000|Overall Study|Lack of Efficacy|86|||
49129615|NCT02497469|158313847|FG001|Overall Study|Lack of Efficacy|40|||
48817166|NCT01349907|157173629|FG000|Overall Study|Treatment failure|13|||
48817167|NCT01349907|157173630|FG001|Overall Study|Treatment failure|4|||
49129616|NCT02497469|158313846|FG000|Overall Study|Reason not Specified|6|||
49129617|NCT02497469|158313847|FG001|Overall Study|Reason not Specified|6|||
48817168|NCT01349907|157173629|FG000|Overall Study|Lost to Follow-up|25|||
48817169|NCT01349907|157173630|FG001|Overall Study|Lost to Follow-up|6|||
48817170|NCT01349907|157173629|FG000|Overall Study|Withdrawal by Subject|30|||
48817171|NCT01349907|157173630|FG001|Overall Study|Withdrawal by Subject|8|||
48817172|NCT01349907|157173629|FG000|Overall Study|Protocol Violation|33|||
48817173|NCT01349907|157173630|FG001|Overall Study|Protocol Violation|13|||
48722045|NCT01925131|156832584|FG000|Overall Study|Progression/Relapse|1|||
48722046|NCT01925131|156832585|FG001|Overall Study|Progression/Relapse|1|||
48722047|NCT01925131|156832586|FG002|Overall Study|Progression/Relapse|4|||
48722048|NCT01925131|156832587|FG003|Overall Study|Progression/Relapse|0|||
48722049|NCT01925131|156832588|FG004|Overall Study|Progression/Relapse|0|||
48722050|NCT01925131|156832589|FG005|Overall Study|Progression/Relapse|1|||
48722051|NCT01925131|156832584|FG000|Overall Study|Patient Refusal|1|||
48722052|NCT01925131|156832585|FG001|Overall Study|Patient Refusal|0|||
48722053|NCT01925131|156832586|FG002|Overall Study|Patient Refusal|0|||
48722054|NCT01925131|156832587|FG003|Overall Study|Patient Refusal|0|||
48722055|NCT01925131|156832588|FG004|Overall Study|Patient Refusal|0|||
48722056|NCT01925131|156832589|FG005|Overall Study|Patient Refusal|0|||
48722057|NCT01925131|156832584|FG000|Overall Study|Adverse Event|0|||
48722058|NCT01925131|156832585|FG001|Overall Study|Adverse Event|0|||
48722059|NCT01925131|156832586|FG002|Overall Study|Adverse Event|2|||
48722060|NCT01925131|156832587|FG003|Overall Study|Adverse Event|0|||
48722061|NCT01925131|156832588|FG004|Overall Study|Adverse Event|1|||
48722062|NCT01925131|156832589|FG005|Overall Study|Adverse Event|3|||
48722063|NCT01925131|156832584|FG000|Overall Study|Other - Not Protocol Specified|3|||
48722064|NCT01925131|156832585|FG001|Overall Study|Other - Not Protocol Specified|1|||
48722065|NCT01925131|156832586|FG002|Overall Study|Other - Not Protocol Specified|2|||
48722066|NCT01925131|156832587|FG003|Overall Study|Other - Not Protocol Specified|5|||
48722067|NCT01925131|156832588|FG004|Overall Study|Other - Not Protocol Specified|10|||
48722068|NCT01925131|156832589|FG005|Overall Study|Other - Not Protocol Specified|6|||
48722069|NCT01696929|156832590|FG000|Overall Study|Physician Decision|1|||
48722070|NCT03811093|156832593|FG000|Overall Study|Lack of Efficacy, Withdrawal by Subject|0|||
48722071|NCT03811093|156832594|FG001|Overall Study|Lack of Efficacy, Withdrawal by Subject|4|||
48722072|NCT03811093|156832593|FG000|Overall Study|Unable to measure body fat percentage|2|||
48722073|NCT03811093|156832594|FG001|Overall Study|Unable to measure body fat percentage|0|||
48722074|NCT01673347|156832595|FG000|Overall Study|failure of allograft|7|||
48722075|NCT02186301|156832596|FG000|Overall Study|Progressive Disease|7|||
48722076|NCT02186301|156832597|FG001|Overall Study|Progressive Disease|22|||
48722077|NCT02186301|156832598|FG002|Overall Study|Progressive Disease|27|||
48722078|NCT02186301|156832596|FG000|Overall Study|Adverse Event|5|||
48722079|NCT02186301|156832597|FG001|Overall Study|Adverse Event|5|||
48722080|NCT02186301|156832598|FG002|Overall Study|Adverse Event|5|||
48722081|NCT02186301|156832596|FG000|Overall Study|Death|1|||
48722082|NCT02186301|156832597|FG001|Overall Study|Death|0|||
48722083|NCT02186301|156832598|FG002|Overall Study|Death|0|||
48817174|NCT01349907|157173629|FG000|Overall Study|Administrative|1|||
48817175|NCT01349907|157173630|FG001|Overall Study|Administrative|1|||
48817176|NCT03230864|157173633|FG000|Prospective Confirmation (PC) Period|Adverse Event|3|||
48817177|NCT03230864|157173634|FG001|Prospective Confirmation (PC) Period|Adverse Event|0|||
48722084|NCT02186301|156832596|FG000|Overall Study|Withdrawal by Subject|5|||
48722085|NCT02186301|156832597|FG001|Overall Study|Withdrawal by Subject|1|||
48722086|NCT02186301|156832598|FG002|Overall Study|Withdrawal by Subject|3|||
48722087|NCT02186301|156832596|FG000|Overall Study|Physician Decision|1|||
48722088|NCT02186301|156832597|FG001|Overall Study|Physician Decision|0|||
48722089|NCT02186301|156832598|FG002|Overall Study|Physician Decision|1|||
48722090|NCT02186301|156832596|FG000|Overall Study|Study Terminated by Sponsor|1|||
48722091|NCT02186301|156832597|FG001|Overall Study|Study Terminated by Sponsor|0|||
48722092|NCT02186301|156832598|FG002|Overall Study|Study Terminated by Sponsor|11|||
48722093|NCT02186301|156832596|FG000|Overall Study|Protocol Deviation|0|||
48722094|NCT02186301|156832597|FG001|Overall Study|Protocol Deviation|2|||
49129618|NCT03363906|158313852|FG000|Period 1 (Reference or Test)|Adverse Event|1|||
49129619|NCT03363906|158313853|FG001|Period 1 (Reference or Test)|Adverse Event|2|||
48722095|NCT02186301|156832598|FG002|Overall Study|Protocol Deviation|0|||
49129620|NCT03363906|158313852|FG000|Period 2 (Test or Reference)|Adverse Event|2|||
48722096|NCT02186301|156832596|FG000|Overall Study|Missing|0|||
48722097|NCT02186301|156832597|FG001|Overall Study|Missing|0|||
48722098|NCT02186301|156832598|FG002|Overall Study|Missing|2|||
48722099|NCT02186301|156832596|FG000|Overall Study|Other|0|||
48817178|NCT03230864|157173635|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
49129621|NCT03363906|158313853|FG001|Period 2 (Test or Reference)|Adverse Event|0|||
48722100|NCT02186301|156832597|FG001|Overall Study|Other|0|||
49129622|NCT03363906|158313852|FG000|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
49129623|NCT03363906|158313853|FG001|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
49129624|NCT03363906|158313852|FG000|Period 2 (Test or Reference)|Lost to Follow-up|1|||
49129625|NCT03363906|158313853|FG001|Period 2 (Test or Reference)|Lost to Follow-up|0|||
49129626|NCT02059239|158313854|FG000|Overall Study|Progressive Disease after Bendamustine|1|||
49129627|NCT02059239|158313855|FG001|Overall Study|Progressive Disease after Bendamustine|3|||
49129628|NCT02059239|158313854|FG000|Overall Study|Physician Decision|1|||
49129629|NCT02059239|158313855|FG001|Overall Study|Physician Decision|0|||
49129630|NCT00472420|158313857|FG000|Induction Treatment Period|Physician Decision|9|||
49129631|NCT00472420|158313857|FG000|Induction Treatment Period|Adverse Event|3|||
49129632|NCT00472420|158313857|FG000|Induction Treatment Period|Non-compliance|1|||
49129633|NCT00472420|158313857|FG000|Induction Treatment Period|Death|3|||
49129634|NCT00472420|158313857|FG000|Follow-up Period|Death|5|||
49129635|NCT00472420|158313857|FG000|Follow-up Period|Physician Decision|9|||
49129636|NCT00472420|158313857|FG000|Follow-up Period|Lost to Follow-up|2|||
49129637|NCT00472420|158313857|FG000|Follow-up Period|Protocol Violation|1|||
49129638|NCT01268267|158313858|FG000|Overall Study|Protocol Violation|1|||
49129639|NCT00686972|158313859|FG000|Overall Study|P.I, Left institution. Study terminated|51|||
49129640|NCT00113607|158313860|FG000|Overall Study|Adverse Event|40|||
49129641|NCT00113607|158313861|FG001|Overall Study|Adverse Event|71|||
49129642|NCT00113607|158313860|FG000|Overall Study|Death|8|||
49129643|NCT00113607|158313861|FG001|Overall Study|Death|8|||
49129644|NCT00113607|158313860|FG000|Overall Study|Withdrawal by Subject|50|||
49129645|NCT00113607|158313861|FG001|Overall Study|Withdrawal by Subject|58|||
49129646|NCT00113607|158313860|FG000|Overall Study|Lost to Follow-up|0|||
49129647|NCT00113607|158313861|FG001|Overall Study|Lost to Follow-up|2|||
49129648|NCT00113607|158313860|FG000|Overall Study|Disease Progression|180|||
49129649|NCT00113607|158313861|FG001|Overall Study|Disease Progression|142|||
49129650|NCT00113607|158313860|FG000|Overall Study|Complete Response (Confirmed)|14|||
49129651|NCT00113607|158313861|FG001|Overall Study|Complete Response (Confirmed)|24|||
49129652|NCT00113607|158313860|FG000|Overall Study|Other|43|||
49129653|NCT00113607|158313861|FG001|Overall Study|Other|32|||
49129654|NCT01901185|158313862|FG000|Overall Study|Withdrawal by Subject|2|||
49129655|NCT00909844|158313865|FG000|Overall Study|Adverse Event|1|||
49129656|NCT00909844|158313865|FG000|Overall Study|Withdrawal by Subject|1|||
49129657|NCT00909844|158313865|FG000|Overall Study|Lost to Follow-up|2|||
49129658|NCT04919317|158313866|FG000|Hospitalization and Wound Follow-up|Protocol Violation|0|||
49129659|NCT04919317|158313867|FG001|Hospitalization and Wound Follow-up|Protocol Violation|5|||
49129660|NCT04919317|158313866|FG000|SF-36 Quality of Life Survey Completion|Lost to Follow-up|12|||
49129661|NCT04919317|158313867|FG001|SF-36 Quality of Life Survey Completion|Lost to Follow-up|6|||
49129662|NCT02410629|158313868|FG000|Overall Study|Family cannot commit to the study|2|||
49129663|NCT02410629|158313869|FG001|Overall Study|Family cannot commit to the study|1|||
49129664|NCT02410629|158313868|FG000|Overall Study|Subject returned to work|1|||
49129665|NCT02410629|158313869|FG001|Overall Study|Subject returned to work|0|||
49129666|NCT02410629|158313868|FG000|Overall Study|Subject moved back to home country|0|||
49129667|NCT02410629|158313869|FG001|Overall Study|Subject moved back to home country|1|||
48722101|NCT02186301|156832598|FG002|Overall Study|Other|1|||
48722102|NCT03086967|156832599|FG000|Overall Study|Screen Failure|2|||
48722103|NCT03086967|156832600|FG001|Overall Study|Screen Failure|2|||
48722104|NCT04732494|156832601|FG000|Overall Study|Death|39|||
48722105|NCT04732494|156832602|FG001|Overall Study|Death|36|||
48722106|NCT04732494|156832601|FG000|Overall Study|Study Closed by Sponsor|20|||
48722107|NCT04732494|156832602|FG001|Overall Study|Study Closed by Sponsor|15|||
48722108|NCT04732494|156832601|FG000|Overall Study|Withdrawal by Subject|2|||
48722109|NCT04732494|156832602|FG001|Overall Study|Withdrawal by Subject|7|||
48722110|NCT04732494|156832601|FG000|Overall Study|Lost to Follow-up|1|||
48722111|NCT04732494|156832602|FG001|Overall Study|Lost to Follow-up|5|||
48722112|NCT01268579|156832606|FG000|Overall Study|Adverse Event|1|||
48722113|NCT01268579|156832606|FG000|Overall Study|Withdrawal by Subject|2|||
48722114|NCT00475423|156832607|FG000|Overall Study|Protocol Violation|5|||
48722115|NCT00475423|156832607|FG000|Overall Study|Adverse Event|4|||
48722116|NCT00475423|156832607|FG000|Overall Study|Withdrawal by Subject|6|||
48722117|NCT00475423|156832607|FG000|Overall Study|Lack of Efficacy|8|||
48722118|NCT00475423|156832607|FG000|Overall Study|Death|1|||
48722119|NCT00475423|156832607|FG000|Overall Study|Reason not specified|1|||
48722120|NCT00475423|156832607|FG000|Overall Study|Lost to Follow-up|7|||
48722121|NCT00868517|156832610|FG000|Overall Study|Withdrawal by Subject|3|||
48722122|NCT00868517|156832611|FG001|Overall Study|Withdrawal by Subject|3|||
48722123|NCT00868517|156832612|FG002|Overall Study|Withdrawal by Subject|2|||
48722124|NCT00868517|156832610|FG000|Overall Study|Protocol Violation|1|||
48722125|NCT00868517|156832611|FG001|Overall Study|Protocol Violation|1|||
48722126|NCT00868517|156832612|FG002|Overall Study|Protocol Violation|0|||
48722127|NCT00274924|156832614|FG000|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4|||
48722128|NCT00274924|156832615|FG001|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14|||
48722129|NCT00274924|156832616|FG002|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1|||
48722130|NCT00274924|156832614|FG000|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
48817179|NCT03230864|157173636|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
48722131|NCT00274924|156832615|FG001|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
48817180|NCT03230864|157173633|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
48817181|NCT03230864|157173634|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
48817182|NCT03230864|157173635|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
48817183|NCT03230864|157173636|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
48817184|NCT03230864|157173633|FG000|Prospective Confirmation (PC) Period|Protocol Violation|1|||
48817185|NCT03230864|157173634|FG001|Prospective Confirmation (PC) Period|Protocol Violation|2|||
48817186|NCT03230864|157173635|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
48817187|NCT03230864|157173636|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
48817188|NCT03230864|157173633|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|4|||
48817189|NCT03230864|157173634|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|1|||
48817190|NCT03230864|157173635|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
48817191|NCT03230864|157173636|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
48817192|NCT03230864|157173633|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14|||
48817193|NCT03230864|157173634|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5|||
48817194|NCT03230864|157173635|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
48817195|NCT03230864|157173636|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
48817196|NCT03230864|157173633|FG000|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
48817197|NCT03230864|157173634|FG001|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
48817198|NCT03230864|157173635|FG002|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
48817199|NCT03230864|157173636|FG003|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
48817200|NCT03230864|157173633|FG000|Prospective Confirmation (PC) Period|Study Personnel Decision|1|||
48817201|NCT03230864|157173634|FG001|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
48817202|NCT03230864|157173635|FG002|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
48817203|NCT03230864|157173636|FG003|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
48817204|NCT03230864|157173633|FG000|Double Blind Treatment (DBT) Period|Adverse Event|0|||
48817205|NCT03230864|157173634|FG001|Double Blind Treatment (DBT) Period|Adverse Event|0|||
48817206|NCT03230864|157173635|FG002|Double Blind Treatment (DBT) Period|Adverse Event|5|||
48817207|NCT03230864|157173636|FG003|Double Blind Treatment (DBT) Period|Adverse Event|1|||
49011138|NCT00481247|157877399|FG001|Overall Study|AE unrelated to study drug|4|||
48722132|NCT00274924|156832616|FG002|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1|||
49011139|NCT00481247|157877398|FG000|Overall Study|Withdrawal by Subject|8|||
49011140|NCT00481247|157877399|FG001|Overall Study|Withdrawal by Subject|13|||
49011141|NCT00481247|157877398|FG000|Overall Study|Pregnancy|2|||
48722133|NCT00274924|156832614|FG000|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
48722134|NCT00274924|156832615|FG001|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
48722135|NCT00274924|156832616|FG002|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1|||
48722136|NCT00274924|156832614|FG000|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
48722137|NCT00274924|156832615|FG001|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
48722138|NCT00274924|156832616|FG002|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1|||
48722139|NCT00274924|156832614|FG000|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
48722140|NCT00274924|156832615|FG001|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
48722141|NCT00274924|156832616|FG002|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1|||
48722142|NCT00274924|156832614|FG000|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
48722143|NCT00274924|156832615|FG001|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
48722144|NCT00274924|156832616|FG002|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1|||
48722145|NCT00274924|156832614|FG000|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4|||
48722146|NCT00274924|156832615|FG001|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15|||
48722147|NCT00274924|156832616|FG002|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0|||
48722148|NCT00274924|156832614|FG000|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1|||
48722149|NCT00274924|156832615|FG001|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
48722150|NCT00274924|156832616|FG002|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
48722151|NCT00274924|156832614|FG000|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1|||
48722152|NCT00274924|156832615|FG001|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
48722153|NCT00274924|156832616|FG002|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
48722154|NCT00274924|156832614|FG000|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1|||
48722155|NCT00274924|156832615|FG001|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
48722156|NCT00274924|156832616|FG002|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
48722157|NCT00274924|156832614|FG000|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
48722158|NCT00274924|156832615|FG001|Step 2 (Tx Based on Mid-treatment PET)|Death|1|||
48722159|NCT00274924|156832616|FG002|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
48722160|NCT00274924|156832614|FG000|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
48722161|NCT00274924|156832615|FG001|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1|||
48722162|NCT00274924|156832616|FG002|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
49011142|NCT00481247|157877399|FG001|Overall Study|Pregnancy|1|||
49129668|NCT02410629|158313868|FG000|Overall Study|Subject underwent heart surgery|0|||
49129669|NCT02410629|158313869|FG001|Overall Study|Subject underwent heart surgery|1|||
49129670|NCT03470922|158313872|FG000|Overall Study|Death|107|||
49129671|NCT03470922|158313873|FG001|Overall Study|Death|118|||
49129672|NCT03470922|158313872|FG000|Overall Study|Lost to Follow-up|5|||
49129673|NCT03470922|158313873|FG001|Overall Study|Lost to Follow-up|5|||
49129674|NCT03470922|158313872|FG000|Overall Study|Participant Withdrew Consent|4|||
49129675|NCT03470922|158313873|FG001|Overall Study|Participant Withdrew Consent|9|||
49129676|NCT03470922|158313872|FG000|Overall Study|Other reasons|1|||
49129677|NCT03470922|158313873|FG001|Overall Study|Other reasons|0|||
49129678|NCT03470922|158313872|FG000|Overall Study|Not reported|1|||
49129679|NCT03470922|158313873|FG001|Overall Study|Not reported|0|||
49129680|NCT03093181|158313876|FG000|Overall Study|Withdrawal by Subject|2|||
49129681|NCT03093181|158313877|FG001|Overall Study|Withdrawal by Subject|1|||
49129682|NCT03093181|158313878|FG002|Overall Study|Withdrawal by Subject|2|||
49129683|NCT03093181|158313876|FG000|Overall Study|Other (Not specified)|1|||
49129684|NCT03093181|158313877|FG001|Overall Study|Other (Not specified)|0|||
49129685|NCT03093181|158313878|FG002|Overall Study|Other (Not specified)|0|||
49129686|NCT03093181|158313876|FG000|Overall Study|Adverse Event|0|||
49129687|NCT03093181|158313877|FG001|Overall Study|Adverse Event|1|||
49129688|NCT03093181|158313878|FG002|Overall Study|Adverse Event|0|||
49129689|NCT03093181|158313876|FG000|Overall Study|Other (Protocol violation)|0|||
49129690|NCT03093181|158313877|FG001|Overall Study|Other (Protocol violation)|0|||
49129691|NCT03093181|158313878|FG002|Overall Study|Other (Protocol violation)|1|||
48722163|NCT00274924|156832614|FG000|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
48722164|NCT00274924|156832615|FG001|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1|||
48722165|NCT00274924|156832616|FG002|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
48722166|NCT00740051|156832617|FG000|Overall Study|Lack of Efficacy|2|||
48722167|NCT00740051|156832618|FG001|Overall Study|Lack of Efficacy|5|||
48722168|NCT00740051|156832617|FG000|Overall Study|Adverse Event|1|||
48722169|NCT00740051|156832618|FG001|Overall Study|Adverse Event|4|||
48722170|NCT00740051|156832617|FG000|Overall Study|Protocol Violation|2|||
48722171|NCT00740051|156832618|FG001|Overall Study|Protocol Violation|6|||
48722172|NCT00740051|156832617|FG000|Overall Study|Lost to Follow-up|3|||
48722173|NCT00740051|156832618|FG001|Overall Study|Lost to Follow-up|8|||
48722174|NCT00740051|156832617|FG000|Overall Study|Withdrawal by Subject|6|||
48722175|NCT00740051|156832618|FG001|Overall Study|Withdrawal by Subject|8|||
48722176|NCT00740051|156832617|FG000|Overall Study|Other reason (not specified)|4|||
48722177|NCT00740051|156832618|FG001|Overall Study|Other reason (not specified)|1|||
48722178|NCT00991952|156832619|FG000|Overall Study|Adverse Event|0|||
48722179|NCT00991952|156832620|FG001|Overall Study|Adverse Event|1|||
48722180|NCT04717492|156832621|FG000|Overall Study|Withdrawal by Subject|2|||
48722181|NCT04717492|156832622|FG001|Overall Study|Withdrawal by Subject|13|||
48722182|NCT04717492|156832621|FG000|Overall Study|Lost to Follow-up|2|||
48722183|NCT04717492|156832622|FG001|Overall Study|Lost to Follow-up|9|||
48817208|NCT03230864|157173633|FG000|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
48817209|NCT03230864|157173634|FG001|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
48817210|NCT03230864|157173635|FG002|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
48817211|NCT03230864|157173636|FG003|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
48817212|NCT03230864|157173633|FG000|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
48817213|NCT03230864|157173634|FG001|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
49129692|NCT00087178|158313879|FG000|Overall Study|No follow up data|5|||
49129693|NCT00087178|158313880|FG001|Overall Study|No follow up data|15|||
49129694|NCT00087178|158313879|FG000|Overall Study|No clinical assessment|1|||
49129695|NCT00087178|158313880|FG001|Overall Study|No clinical assessment|2|||
49129696|NCT00087178|158313879|FG000|Overall Study|Patient not at risk for primary endpoint|0|||
48722184|NCT03452527|156832625|FG000|Overall Study|Withdrawal by Subject|1|||
48722185|NCT03452527|156832626|FG001|Overall Study|Withdrawal by Subject|1|||
48722186|NCT03452527|156832625|FG000|Overall Study|Study Terminated|2|||
49129697|NCT00087178|158313880|FG001|Overall Study|Patient not at risk for primary endpoint|1|||
49129698|NCT02378662|158313881|FG000|Overall Study|Early Discontinuation|2|||
49129699|NCT02378662|158313882|FG001|Overall Study|Early Discontinuation|0|||
49129700|NCT02357459|158315750|FG000|Overall Study|Adverse Event|0|||
49129701|NCT02357459|158315751|FG001|Overall Study|Adverse Event|1|||
49129702|NCT02357459|158315752|FG002|Overall Study|Adverse Event|1|||
49129703|NCT02357459|158315750|FG000|Overall Study|Withdrawal by Subject|5|||
48722187|NCT03452527|156832626|FG001|Overall Study|Study Terminated|3|||
48722188|NCT01001299|156832629|FG000|Overall Study|Insufficient Therapeutic Response|20|||
48722189|NCT01001299|156832629|FG000|Overall Study|Adverse event or Intercurrent Illness|1|||
48722190|NCT01001299|156832629|FG000|Overall Study|Death|1|||
48722191|NCT01001299|156832629|FG000|Overall Study|Began Taking Commercially Available Drug|2|||
48722192|NCT01001299|156832629|FG000|Overall Study|Withdrew Consent|1|||
48722193|NCT02486627|156832630|FG000|Overall Study|Death|1|||
49129704|NCT02357459|158315751|FG001|Overall Study|Withdrawal by Subject|3|||
49129705|NCT02357459|158315752|FG002|Overall Study|Withdrawal by Subject|3|||
48722194|NCT02486627|156832631|FG001|Overall Study|Death|0|||
48722195|NCT02486627|156832630|FG000|Overall Study|Other Unspecified|0|||
48722196|NCT02486627|156832631|FG001|Overall Study|Other Unspecified|2|||
48722197|NCT02486627|156832630|FG000|Overall Study|Consent Withdrawn by Participant|4|||
48722198|NCT02486627|156832631|FG001|Overall Study|Consent Withdrawn by Participant|3|||
48722199|NCT02486627|156832630|FG000|Overall Study|Significant Participant Noncompliance|1|||
48722200|NCT02486627|156832631|FG001|Overall Study|Significant Participant Noncompliance|1|||
48722201|NCT02486627|156832630|FG000|Overall Study|Lost to Follow-up|1|||
48722202|NCT02486627|156832631|FG001|Overall Study|Lost to Follow-up|3|||
48722203|NCT01933932|156832632|FG000|Overall Study|Death|173|||
48722204|NCT01933932|156832633|FG001|Overall Study|Death|163|||
48722205|NCT01933932|156832632|FG000|Overall Study|Withdrawal by Subject|11|||
48722206|NCT01933932|156832633|FG001|Overall Study|Withdrawal by Subject|14|||
48722207|NCT01933932|156832632|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
48722208|NCT01933932|156832633|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
48722209|NCT04683744|156832634|FG000|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
48722210|NCT04683744|156832635|FG001|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
48722211|NCT04683744|156832636|FG002|Overall Study|withdrawn (determined not eligible after enrollment)|1|||
48722212|NCT02217527|156832637|FG000|Drug Condition 1: First Study Phase|Withdrawal by Subject|1|||
48722213|NCT02217527|156832638|FG001|Drug Condition 1: First Study Phase|Withdrawal by Subject|3|||
48722214|NCT02217527|156832637|FG000|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0|||
48722215|NCT02217527|156832638|FG001|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1|||
48722216|NCT05869383|156832639|FG000|Overall Study|Withdrawal by Subject|2|||
48722217|NCT05869383|156832640|FG001|Overall Study|Withdrawal by Subject|0|||
48722218|NCT02650921|156832647|FG000|Overall Study|Withdrawal by Subject|4|||
48722219|NCT02650921|156832647|FG000|Overall Study|Lost to Follow-up|2|||
48722220|NCT02650921|156832647|FG000|Overall Study|Adverse Event|1|||
48722221|NCT02650921|156832647|FG000|Overall Study|Due to Medical Condition|1|||
48722222|NCT02522871|156832648|FG000|Overall Study|Protocol Violation|1|||
48722223|NCT02522871|156832649|FG001|Overall Study|Protocol Violation|4|||
48722224|NCT02522871|156832648|FG000|Overall Study|Treated without randomization|1|||
48722225|NCT02522871|156832649|FG001|Overall Study|Treated without randomization|0|||
48722226|NCT02522871|156832648|FG000|Overall Study|Death|9|||
48722227|NCT02522871|156832649|FG001|Overall Study|Death|9|||
48722228|NCT02522871|156832648|FG000|Overall Study|Died in operating room prior to transplant|0|||
48722229|NCT02522871|156832649|FG001|Overall Study|Died in operating room prior to transplant|1|||
48722230|NCT02068768|156832650|FG000|Overall Study|Lost to Follow-up|5|||
48722231|NCT02068768|156832650|FG000|Overall Study|Early Termination by Sponsor|2|||
48722232|NCT02674854|156832651|FG000|Overall Study|Adverse Event|17|||
48722233|NCT02674854|156832652|FG001|Overall Study|Adverse Event|15|||
48722234|NCT02674854|156832653|FG002|Overall Study|Adverse Event|5|||
48722235|NCT02674854|156832651|FG000|Overall Study|Withdrawal by Subject|1|||
48722236|NCT02674854|156832652|FG001|Overall Study|Withdrawal by Subject|5|||
48722237|NCT02674854|156832653|FG002|Overall Study|Withdrawal by Subject|4|||
48722238|NCT02674854|156832651|FG000|Overall Study|No-compliant subject|1|||
48722239|NCT02674854|156832652|FG001|Overall Study|No-compliant subject|0|||
48722240|NCT02674854|156832653|FG002|Overall Study|No-compliant subject|1|||
48722241|NCT02674854|156832651|FG000|Overall Study|Lost to Follow-up|1|||
48817214|NCT03230864|157173635|FG002|Double Blind Treatment (DBT) Period|Sponsor Decision|2|||
48817215|NCT03230864|157173636|FG003|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
48817216|NCT00109928|157173645|FG000|Overall Study|Adverse Event|2|||
48817217|NCT00109928|157173645|FG000|Overall Study|Progression|6|||
48817218|NCT00109928|157173645|FG000|Overall Study|Death|2|||
48817219|NCT00109928|157173645|FG000|Overall Study|not protocol specified|2|||
48817220|NCT00109928|157173645|FG000|Overall Study|not eligible|1|||
48817221|NCT01196104|157173646|FG000|Overall Study|Lost to Follow-up|1|||
48817222|NCT01196104|157173647|FG001|Overall Study|Lost to Follow-up|0|||
48817223|NCT01196104|157173646|FG000|Overall Study|Physician Decision|0|||
48817224|NCT01196104|157173647|FG001|Overall Study|Physician Decision|1|||
48817225|NCT01196104|157173646|FG000|Overall Study|Withdrawal by Subject|3|||
48817226|NCT01196104|157173647|FG001|Overall Study|Withdrawal by Subject|3|||
48817227|NCT01196104|157173646|FG000|Overall Study|Various|0|||
48722242|NCT02674854|156832652|FG001|Overall Study|Lost to Follow-up|0|||
48722243|NCT02674854|156832653|FG002|Overall Study|Lost to Follow-up|2|||
48722244|NCT02674854|156832651|FG000|Overall Study|Lack of Efficacy|0|||
48722245|NCT02674854|156832652|FG001|Overall Study|Lack of Efficacy|3|||
48722246|NCT02674854|156832653|FG002|Overall Study|Lack of Efficacy|0|||
48722247|NCT02674854|156832651|FG000|Overall Study|Disallowed Concurrent Medication|2|||
48722248|NCT02674854|156832652|FG001|Overall Study|Disallowed Concurrent Medication|2|||
48722249|NCT02674854|156832653|FG002|Overall Study|Disallowed Concurrent Medication|0|||
48817228|NCT01196104|157173647|FG001|Overall Study|Various|1|||
48817229|NCT00610675|157173648|FG000|Overall Study|Untreated|4|||
48722250|NCT02674854|156832651|FG000|Overall Study|Protocol Violation|1|||
48722251|NCT02674854|156832652|FG001|Overall Study|Protocol Violation|1|||
48722252|NCT02674854|156832653|FG002|Overall Study|Protocol Violation|2|||
48722253|NCT02674854|156832651|FG000|Overall Study|Death|0|||
48722254|NCT02674854|156832652|FG001|Overall Study|Death|1|||
48722255|NCT02674854|156832653|FG002|Overall Study|Death|0|||
48722256|NCT02674854|156832651|FG000|Overall Study|Subject missed V6.2|1|||
48722257|NCT02674854|156832652|FG001|Overall Study|Subject missed V6.2|0|||
48722258|NCT02674854|156832653|FG002|Overall Study|Subject missed V6.2|0|||
48722259|NCT01185834|156832654|FG000|Overall Study|Lost to Follow-up|2|||
48722260|NCT01185834|156832654|FG000|Overall Study|Discomfort|4|||
48722261|NCT01185834|156832654|FG000|Overall Study|Biomicroscopy|4|||
48722262|NCT01185834|156832654|FG000|Overall Study|Time/Job Conflict|2|||
48722263|NCT01185834|156832654|FG000|Overall Study|Early exit - Site error|2|||
48722264|NCT00887744|156832655|FG000|Overall Study|Adverse Event|3|||
48722265|NCT00887744|156832655|FG000|Overall Study|Death|1|||
48722266|NCT00887744|156832655|FG000|Overall Study|Lost to Follow-up|3|||
48722267|NCT00887744|156832655|FG000|Overall Study|Withdrawal by Subject|18|||
48722268|NCT00887744|156832655|FG000|Overall Study|Various reasons|9|||
48722269|NCT00393042|156832658|FG000|First Intervention|Withdrawal by Subject|1|||
48722270|NCT00393042|156832659|FG001|First Intervention|Withdrawal by Subject|2|||
48722271|NCT00393042|156832658|FG000|First Intervention|Lost to Follow-up|3|||
48722272|NCT00393042|156832659|FG001|First Intervention|Lost to Follow-up|3|||
48722273|NCT00393042|156832658|FG000|First Intervention|Protocol Violation|1|||
48722274|NCT00393042|156832659|FG001|First Intervention|Protocol Violation|0|||
48722275|NCT00393042|156832658|FG000|First Intervention|Adverse Event|0|||
48722276|NCT00393042|156832659|FG001|First Intervention|Adverse Event|1|||
48722277|NCT00393042|156832658|FG000|Second Intervetion|Adverse Event|0|||
48722278|NCT00393042|156832659|FG001|Second Intervetion|Adverse Event|3|||
48722279|NCT00393042|156832658|FG000|Second Intervetion|Withdrawal by Subject|0|||
48722280|NCT00393042|156832659|FG001|Second Intervetion|Withdrawal by Subject|2|||
48722281|NCT00393042|156832658|FG000|Second Intervetion|Lack of Efficacy|1|||
48722282|NCT00393042|156832659|FG001|Second Intervetion|Lack of Efficacy|0|||
48722283|NCT00393042|156832658|FG000|Second Intervetion|Lost to Follow-up|0|||
48722284|NCT00393042|156832659|FG001|Second Intervetion|Lost to Follow-up|2|||
48722285|NCT00393042|156832658|FG000|Second Intervetion|Protocol Violation|1|||
48722286|NCT00393042|156832659|FG001|Second Intervetion|Protocol Violation|1|||
48722287|NCT02312687|156832660|FG000|Overall Study|Other, Not Specified|1|||
48722288|NCT02632838|156832661|FG000|Overall Study|Withdrawal by Subject|3|||
48722289|NCT02632838|156832662|FG001|Overall Study|Withdrawal by Subject|0|||
48722290|NCT02632838|156832661|FG000|Overall Study|Lost to Follow-up|0|||
48722291|NCT02632838|156832662|FG001|Overall Study|Lost to Follow-up|2|||
48722292|NCT01894568|156832663|FG000|Overall Study|Adverse Event|2|||
48722293|NCT01894568|156832664|FG001|Overall Study|Adverse Event|3|||
48722294|NCT01894568|156832663|FG000|Overall Study|Protocol required discontinuation|2|||
48722295|NCT01894568|156832664|FG001|Overall Study|Protocol required discontinuation|1|||
48722296|NCT01894568|156832663|FG000|Overall Study|Withdrawal by Subject|5|||
48722297|NCT01894568|156832664|FG001|Overall Study|Withdrawal by Subject|5|||
48722298|NCT01894568|156832663|FG000|Overall Study|Physician Decision|1|||
48722299|NCT01894568|156832664|FG001|Overall Study|Physician Decision|0|||
48722300|NCT01894568|156832663|FG000|Overall Study|Lost to Follow-up|0|||
48722301|NCT01894568|156832664|FG001|Overall Study|Lost to Follow-up|1|||
48722302|NCT03899259|156832665|FG000|Overall Study|Adverse Event|5|||
48722303|NCT03899259|156832666|FG001|Overall Study|Adverse Event|4|||
48722304|NCT03899259|156832667|FG002|Overall Study|Adverse Event|6|||
48722305|NCT03899259|156832665|FG000|Overall Study|Lack of Efficacy|5|||
48722306|NCT03899259|156832666|FG001|Overall Study|Lack of Efficacy|0|||
48722307|NCT03899259|156832667|FG002|Overall Study|Lack of Efficacy|2|||
48722308|NCT03899259|156832665|FG000|Overall Study|Pregnancy|3|||
48722309|NCT03899259|156832666|FG001|Overall Study|Pregnancy|0|||
48722310|NCT03899259|156832667|FG002|Overall Study|Pregnancy|1|||
48722311|NCT03899259|156832665|FG000|Overall Study|Physician Decision|0|||
48722312|NCT03899259|156832666|FG001|Overall Study|Physician Decision|1|||
48722313|NCT03899259|156832667|FG002|Overall Study|Physician Decision|0|||
48722314|NCT03899259|156832665|FG000|Overall Study|Protocol Deviation|1|||
48722315|NCT03899259|156832666|FG001|Overall Study|Protocol Deviation|1|||
48722316|NCT03899259|156832667|FG002|Overall Study|Protocol Deviation|1|||
48722317|NCT03899259|156832665|FG000|Overall Study|Withdrawal by Subject|8|||
48722318|NCT03899259|156832666|FG001|Overall Study|Withdrawal by Subject|10|||
48722319|NCT03899259|156832667|FG002|Overall Study|Withdrawal by Subject|12|||
48722320|NCT03899259|156832665|FG000|Overall Study|Lost to Follow-up|5|||
48722321|NCT03899259|156832666|FG001|Overall Study|Lost to Follow-up|6|||
48722322|NCT03899259|156832667|FG002|Overall Study|Lost to Follow-up|2|||
48722323|NCT03899259|156832665|FG000|Overall Study|Lack of Adherence|1|||
48722324|NCT03899259|156832666|FG001|Overall Study|Lack of Adherence|0|||
48722325|NCT03899259|156832667|FG002|Overall Study|Lack of Adherence|0|||
48722326|NCT03899259|156832665|FG000|Overall Study|Screen Failure|1|||
48722327|NCT03899259|156832666|FG001|Overall Study|Screen Failure|0|||
48722328|NCT03899259|156832667|FG002|Overall Study|Screen Failure|0|||
48722329|NCT03899259|156832665|FG000|Overall Study|Ongoing Study Participation|127|||
48722330|NCT03899259|156832666|FG001|Overall Study|Ongoing Study Participation|134|||
48722331|NCT03899259|156832667|FG002|Overall Study|Ongoing Study Participation|210|||
48722332|NCT02589795|156832669|FG000|Overall Study|Lost to Follow-up|1|||
48722333|NCT02589795|156832670|FG001|Overall Study|Lost to Follow-up|0|||
48722334|NCT02589795|156832671|FG002|Overall Study|Lost to Follow-up|0|||
48722335|NCT02589795|156832669|FG000|Overall Study|Withdrawal by Subject|0|||
48722336|NCT02589795|156832670|FG001|Overall Study|Withdrawal by Subject|0|||
48722337|NCT02589795|156832671|FG002|Overall Study|Withdrawal by Subject|2|||
48722338|NCT02589795|156832669|FG000|Overall Study|Protocol Violation|0|||
48722339|NCT02589795|156832670|FG001|Overall Study|Protocol Violation|0|||
48722340|NCT02589795|156832671|FG002|Overall Study|Protocol Violation|1|||
48722341|NCT03473548|156832672|FG000|Overall Study|Did not attempt HST testing|3|||
48722342|NCT03473548|156832673|FG001|Overall Study|Did not attempt HST testing|0|||
48722343|NCT01307020|156832674|FG000|Overall Study|Lost to Follow-up|0|||
48722344|NCT01307020|156832675|FG001|Overall Study|Lost to Follow-up|0|||
48722345|NCT01307020|156832676|FG002|Overall Study|Lost to Follow-up|1|||
48722346|NCT01307020|156832677|FG003|Overall Study|Lost to Follow-up|1|||
48722347|NCT01307020|156832678|FG004|Overall Study|Lost to Follow-up|0|||
48722348|NCT01307020|156832679|FG005|Overall Study|Lost to Follow-up|0|||
48722349|NCT01307020|156832680|FG006|Overall Study|Lost to Follow-up|1|||
48722350|NCT01307020|156832681|FG007|Overall Study|Lost to Follow-up|0|||
48722351|NCT01307020|156832682|FG008|Overall Study|Lost to Follow-up|0|||
48722352|NCT01307020|156832683|FG009|Overall Study|Lost to Follow-up|0|||
48722353|NCT01307020|156832674|FG000|Overall Study|Electronic data capture failure|0|||
48722354|NCT01307020|156832675|FG001|Overall Study|Electronic data capture failure|1|||
48722355|NCT01307020|156832676|FG002|Overall Study|Electronic data capture failure|0|||
48722356|NCT01307020|156832677|FG003|Overall Study|Electronic data capture failure|0|||
48722357|NCT01307020|156832678|FG004|Overall Study|Electronic data capture failure|0|||
48722358|NCT01307020|156832679|FG005|Overall Study|Electronic data capture failure|0|||
48722359|NCT01307020|156832680|FG006|Overall Study|Electronic data capture failure|0|||
48722360|NCT01307020|156832681|FG007|Overall Study|Electronic data capture failure|0|||
48722361|NCT01307020|156832682|FG008|Overall Study|Electronic data capture failure|0|||
48722362|NCT01307020|156832683|FG009|Overall Study|Electronic data capture failure|0|||
48722363|NCT03911843|156832684|FG000|Overall Study|Adverse Event|2|||
48722364|NCT03911843|156832685|FG001|Overall Study|Adverse Event|0|||
48722365|NCT03911843|156832684|FG000|Overall Study|Protocol Violation|2|||
48722366|NCT03911843|156832685|FG001|Overall Study|Protocol Violation|0|||
48722367|NCT03911843|156832684|FG000|Overall Study|Lost to Follow-up|0|||
48722368|NCT03911843|156832685|FG001|Overall Study|Lost to Follow-up|1|||
48722369|NCT00829933|156832686|FG000|Overall Study|Adverse Event|2|||
48722370|NCT00829933|156832687|FG001|Overall Study|Adverse Event|3|||
48722371|NCT00829933|156832688|FG002|Overall Study|Adverse Event|2|||
48722372|NCT00829933|156832689|FG003|Overall Study|Adverse Event|1|||
48722373|NCT00829933|156832686|FG000|Overall Study|Death|0|||
48722374|NCT00829933|156832687|FG001|Overall Study|Death|0|||
48722375|NCT00829933|156832688|FG002|Overall Study|Death|1|||
48722376|NCT00829933|156832689|FG003|Overall Study|Death|1|||
48722377|NCT00829933|156832686|FG000|Overall Study|Lack of Efficacy|0|||
48722378|NCT00829933|156832687|FG001|Overall Study|Lack of Efficacy|1|||
48722379|NCT00829933|156832688|FG002|Overall Study|Lack of Efficacy|0|||
48722380|NCT00829933|156832689|FG003|Overall Study|Lack of Efficacy|0|||
48722381|NCT00829933|156832686|FG000|Overall Study|Physician Decision|5|||
48722382|NCT00829933|156832687|FG001|Overall Study|Physician Decision|7|||
48722383|NCT00829933|156832688|FG002|Overall Study|Physician Decision|8|||
48722384|NCT00829933|156832689|FG003|Overall Study|Physician Decision|1|||
48722385|NCT00829933|156832686|FG000|Overall Study|Pregnancy|0|||
48722386|NCT00829933|156832687|FG001|Overall Study|Pregnancy|0|||
48722387|NCT00829933|156832688|FG002|Overall Study|Pregnancy|0|||
48722388|NCT00829933|156832689|FG003|Overall Study|Pregnancy|2|||
48722389|NCT00829933|156832686|FG000|Overall Study|Protocol Violation|2|||
48722390|NCT00829933|156832687|FG001|Overall Study|Protocol Violation|1|||
48722391|NCT00829933|156832688|FG002|Overall Study|Protocol Violation|0|||
48722392|NCT00829933|156832689|FG003|Overall Study|Protocol Violation|0|||
48722393|NCT00829933|156832686|FG000|Overall Study|withdrew before treatment started|5|||
49129706|NCT02357459|158315750|FG000|Overall Study|Physician Decision|0|||
49129707|NCT02357459|158315751|FG001|Overall Study|Physician Decision|2|||
48722394|NCT00829933|156832687|FG001|Overall Study|withdrew before treatment started|1|||
48722395|NCT00829933|156832688|FG002|Overall Study|withdrew before treatment started|2|||
48722396|NCT00829933|156832689|FG003|Overall Study|withdrew before treatment started|9|||
48722397|NCT05093842|156832695|FG000|Overall Study|Pregnancy loss|1|||
48722398|NCT05093842|156832696|FG001|Overall Study|Pregnancy loss|1|||
48722399|NCT05093842|156832695|FG000|Overall Study|Lost to Follow-up|6|||
48722400|NCT05093842|156832696|FG001|Overall Study|Lost to Follow-up|0|||
48722401|NCT05093842|156832695|FG000|Overall Study|Physician Decision|0|||
48722402|NCT05093842|156832696|FG001|Overall Study|Physician Decision|1|||
48722403|NCT00993044|156832709|FG000|Irinotecan 50 mg|Physician Decision|1|||
48722404|NCT04560179|156832715|FG000|Overall Study|Physician Decision|1|||
48722405|NCT04560179|156832716|FG001|Overall Study|Physician Decision|0|||
49129708|NCT02357459|158315752|FG002|Overall Study|Physician Decision|0|||
48722406|NCT04560179|156832717|FG002|Overall Study|Physician Decision|0|||
48722407|NCT04560179|156832718|FG003|Overall Study|Physician Decision|0|||
48817230|NCT00610675|157173648|FG000|Overall Study|Adverse Event|67|||
48817231|NCT00610675|157173648|FG000|Overall Study|Insufficient Effect|31|||
48817232|NCT00610675|157173648|FG000|Overall Study|Withdrawal by Subject|28|||
48817233|NCT00610675|157173648|FG000|Overall Study|Reasons unrelated to trial|27|||
48817234|NCT00610675|157173648|FG000|Overall Study|Lack of Compliance|7|||
48817235|NCT00610675|157173648|FG000|Overall Study|Lost to Follow-up|31|||
48817236|NCT00610675|157173648|FG000|Overall Study|Other reason (not specified)|25|||
48817237|NCT01734382|157173649|FG000|Part 1|Adverse Event|2|||
49129709|NCT02357459|158315750|FG000|Overall Study|Protocol Violation|1|||
49129710|NCT02357459|158315751|FG001|Overall Study|Protocol Violation|1|||
49129711|NCT02357459|158315752|FG002|Overall Study|Protocol Violation|0|||
49129712|NCT02357459|158315750|FG000|Overall Study|Lost to Follow-up|1|||
49129713|NCT02357459|158315751|FG001|Overall Study|Lost to Follow-up|3|||
49129714|NCT02357459|158315752|FG002|Overall Study|Lost to Follow-up|0|||
49129715|NCT02357459|158315750|FG000|Overall Study|Lack of Efficacy|7|||
49129716|NCT02357459|158315751|FG001|Overall Study|Lack of Efficacy|4|||
49129717|NCT02357459|158315752|FG002|Overall Study|Lack of Efficacy|4|||
49129718|NCT02357459|158315750|FG000|Overall Study|Patient Relocated|2|||
49129719|NCT02357459|158315751|FG001|Overall Study|Patient Relocated|0|||
49129720|NCT02357459|158315752|FG002|Overall Study|Patient Relocated|0|||
49129721|NCT02357459|158315750|FG000|Overall Study|Instruction from PCP|1|||
49129722|NCT02357459|158315751|FG001|Overall Study|Instruction from PCP|0|||
49129723|NCT02357459|158315752|FG002|Overall Study|Instruction from PCP|0|||
49129724|NCT02357459|158315750|FG000|Overall Study|Incarceration|0|||
49129725|NCT02357459|158315751|FG001|Overall Study|Incarceration|0|||
49129726|NCT02357459|158315752|FG002|Overall Study|Incarceration|1|||
49129727|NCT02357459|158315750|FG000|Overall Study|Pre-planned Knee surgery|0|||
49129728|NCT02357459|158315751|FG001|Overall Study|Pre-planned Knee surgery|0|||
49129729|NCT02357459|158315752|FG002|Overall Study|Pre-planned Knee surgery|2|||
49129730|NCT02357459|158315750|FG000|Overall Study|Job Commitments|0|||
49129731|NCT02357459|158315751|FG001|Overall Study|Job Commitments|0|||
49129732|NCT02357459|158315752|FG002|Overall Study|Job Commitments|1|||
49129733|NCT01548599|158315753|FG000|Overall Study|Lost to Follow-up|0|||
49129734|NCT01548599|158315754|FG001|Overall Study|Lost to Follow-up|1|||
49129735|NCT01548599|158315753|FG000|Overall Study|Withdrawal by Subject|4|||
49129736|NCT01548599|158315754|FG001|Overall Study|Withdrawal by Subject|0|||
49129737|NCT01548599|158315753|FG000|Overall Study|Death|2|||
49129738|NCT01548599|158315754|FG001|Overall Study|Death|1|||
49129739|NCT02873689|158315755|FG000|Overall Study|Lack of Efficacy|1|||
49129740|NCT02873689|158315756|FG001|Overall Study|Lack of Efficacy|0|||
49129741|NCT02873689|158315755|FG000|Overall Study|Withdrawal by Subject|2|||
49129742|NCT02873689|158315756|FG001|Overall Study|Withdrawal by Subject|2|||
49129743|NCT02873689|158315755|FG000|Overall Study|Protocol Violation|1|||
49129744|NCT02873689|158315756|FG001|Overall Study|Protocol Violation|0|||
49129745|NCT02873689|158315755|FG000|Overall Study|Adverse Event|2|||
49129746|NCT02873689|158315756|FG001|Overall Study|Adverse Event|2|||
49129747|NCT02873689|158315755|FG000|Overall Study|Randomized but not Treated|1|||
49129748|NCT02873689|158315756|FG001|Overall Study|Randomized but not Treated|1|||
49129749|NCT05630196|158315757|FG000|Overall Study|Adverse Event|2|||
49129750|NCT05630196|158315758|FG001|Overall Study|Adverse Event|1|||
49129751|NCT05630196|158315757|FG000|Overall Study|Lost to Follow-up|1|||
49129752|NCT05630196|158315758|FG001|Overall Study|Lost to Follow-up|1|||
49129753|NCT05630196|158315757|FG000|Overall Study|Protocol Violation|2|||
49129754|NCT05630196|158315758|FG001|Overall Study|Protocol Violation|3|||
49129755|NCT05630196|158315757|FG000|Overall Study|Physician Decision|1|||
49129756|NCT05630196|158315758|FG001|Overall Study|Physician Decision|0|||
49129757|NCT05630196|158315757|FG000|Overall Study|Withdrawal by Subject|3|||
49129758|NCT05630196|158315758|FG001|Overall Study|Withdrawal by Subject|4|||
49129759|NCT03250273|158315759|FG000|Overall Study|Disease Progression|2|||
49129760|NCT03250273|158315760|FG001|Overall Study|Disease Progression|11|||
48817238|NCT01734382|157173650|FG001|Part 1|Adverse Event|0|||
48817239|NCT01734382|157173651|FG002|Part 1|Adverse Event|0|||
48817240|NCT01734382|157173649|FG000|Part 2|Adverse Event|0|||
48817241|NCT01734382|157173650|FG001|Part 2|Adverse Event|0|||
49129761|NCT03250273|158315759|FG000|Overall Study|Death|0|||
49129762|NCT03250273|158315760|FG001|Overall Study|Death|1|||
49129763|NCT01317641|158315768|FG000|Overall Study|Not treated|0|||
49129764|NCT01317641|158315769|FG001|Overall Study|Not treated|0|||
48817242|NCT01734382|157173651|FG002|Part 2|Adverse Event|1|||
48817243|NCT01734382|157173649|FG000|Part 2|Lack of Efficacy|0|||
49129765|NCT01317641|158315770|FG002|Overall Study|Not treated|0|||
49129766|NCT01317641|158315771|FG003|Overall Study|Not treated|0|||
49129767|NCT01317641|158315772|FG004|Overall Study|Not treated|0|||
49129768|NCT01317641|158315773|FG005|Overall Study|Not treated|0|||
49129769|NCT01317641|158315774|FG006|Overall Study|Not treated|0|||
48817244|NCT01734382|157173650|FG001|Part 2|Lack of Efficacy|1|||
49129770|NCT01317641|158315775|FG007|Overall Study|Not treated|1|||
49129771|NCT01317641|158315776|FG008|Overall Study|Not treated|1|||
49129772|NCT01317641|158315768|FG000|Overall Study|Adverse Event|0|||
48722408|NCT04560179|156832719|FG004|Overall Study|Physician Decision|0|||
48722409|NCT04560179|156832715|FG000|Overall Study|Adverse Event|0|||
48722410|NCT04560179|156832716|FG001|Overall Study|Adverse Event|0|||
48722411|NCT04560179|156832717|FG002|Overall Study|Adverse Event|0|||
48722412|NCT04560179|156832718|FG003|Overall Study|Adverse Event|1|||
48722413|NCT04560179|156832719|FG004|Overall Study|Adverse Event|0|||
48722414|NCT04649047|156832720|FG000|Overall Study|Withdrawal by Subject|3|||
48722415|NCT04236141|156834557|FG000|Overall Study|Death|18|||
49129773|NCT01317641|158315769|FG001|Overall Study|Adverse Event|1|||
48817245|NCT01734382|157173651|FG002|Part 2|Lack of Efficacy|1|||
48722416|NCT04236141|156834558|FG001|Overall Study|Death|10|||
48722417|NCT04236141|156834557|FG000|Overall Study|Withdrawal by Participant|1|||
48722418|NCT04236141|156834558|FG001|Overall Study|Withdrawal by Participant|0|||
48722419|NCT04236141|156834557|FG000|Overall Study|Reason not Specified|1|||
48722420|NCT04236141|156834558|FG001|Overall Study|Reason not Specified|0|||
48817246|NCT01734382|157173649|FG000|Part 2|Other|0|||
48817247|NCT01734382|157173650|FG001|Part 2|Other|0|||
48817248|NCT01734382|157173651|FG002|Part 2|Other|1|||
48817249|NCT01734382|157173649|FG000|Part 2|Physician Decision|0|||
48817250|NCT01734382|157173650|FG001|Part 2|Physician Decision|0|||
49129774|NCT01317641|158315770|FG002|Overall Study|Adverse Event|0|||
48722421|NCT04236141|156834557|FG000|Overall Study|Study terminated by Sponsor|8|||
48722422|NCT04236141|156834558|FG001|Overall Study|Study terminated by Sponsor|4|||
48722423|NCT03865316|156834559|FG000|Overall Study|Procedure Cancelled|4|||
48722424|NCT03865316|156834559|FG000|Overall Study|Equipment failure|4|||
48722425|NCT01948193|156834564|FG000|Overall Study|Serious event|2|||
48722426|NCT01948193|156834564|FG000|Overall Study|Lost to Follow-up|7|||
48722427|NCT01258998|156834565|FG000|Overall Study|Ineligible|1|||
48722428|NCT00002931|156834568|FG000|Overall Study|rapidly progressing disease during|2|||
48722429|NCT03224598|156834572|FG000|Overall Study|Lost to Follow-up|0|||
48722430|NCT03224598|156834573|FG001|Overall Study|Lost to Follow-up|2|||
48722431|NCT03224598|156834574|FG002|Overall Study|Lost to Follow-up|0|||
48722432|NCT03224598|156834572|FG000|Overall Study|Other|0|||
48722433|NCT03224598|156834573|FG001|Overall Study|Other|1|||
48722434|NCT03224598|156834574|FG002|Overall Study|Other|0|||
48817251|NCT01734382|157173651|FG002|Part 2|Physician Decision|3|||
48817252|NCT01734382|157173649|FG000|Part 2|Protocol Violation|0|||
48817253|NCT01734382|157173650|FG001|Part 2|Protocol Violation|1|||
48817254|NCT01734382|157173651|FG002|Part 2|Protocol Violation|0|||
48817255|NCT01734382|157173649|FG000|Part 2|Withdrawal by Subject|0|||
48817256|NCT01734382|157173650|FG001|Part 2|Withdrawal by Subject|0|||
48817257|NCT01734382|157173651|FG002|Part 2|Withdrawal by Subject|1|||
48817258|NCT01439711|157173654|FG000|Overall Study|Ineligible|13|||
48817259|NCT01439711|157173654|FG000|Overall Study|Cancel|3|||
48817260|NCT01439711|157173654|FG000|Overall Study|Progression Prior to Beginning Tx|1|||
48817261|NCT01439711|157173654|FG000|Overall Study|Adverse Event|5|||
49129775|NCT01317641|158315771|FG003|Overall Study|Adverse Event|1|||
49129776|NCT01317641|158315772|FG004|Overall Study|Adverse Event|0|||
49129777|NCT01317641|158315773|FG005|Overall Study|Adverse Event|0|||
48722435|NCT02907892|156834578|FG000|Overall Study|Lost to Follow-up|27|||
48722436|NCT02907892|156834579|FG001|Overall Study|Lost to Follow-up|40|||
48722437|NCT04531462|156834580|FG000|Overall Study|Withdrawal by Subject|3|||
48722438|NCT04531462|156834581|FG001|Overall Study|Withdrawal by Subject|1|||
48722439|NCT04531462|156834580|FG000|Overall Study|Adverse Event|3|||
48722440|NCT04531462|156834581|FG001|Overall Study|Adverse Event|3|||
48722441|NCT01264081|156834582|FG000|Participants Screened|Screening failures|30|||
49129778|NCT01317641|158315774|FG006|Overall Study|Adverse Event|2|||
49129779|NCT01317641|158315775|FG007|Overall Study|Adverse Event|1|||
49129780|NCT01317641|158315776|FG008|Overall Study|Adverse Event|0|||
49129781|NCT01317641|158315768|FG000|Overall Study|Protocol Violation|1|||
48722442|NCT01264081|156834582|FG000|Started Treatment|Withdrawal by Subject|1|||
48722443|NCT01264081|156834582|FG000|Started Treatment|Not complete cycle 1 due to death|1|||
48722444|NCT00134784|156834585|FG000|Overall Study|Withdrawal by Subject|2|||
48722445|NCT00134784|156834586|FG001|Overall Study|Withdrawal by Subject|2|||
48722446|NCT00134784|156834587|FG002|Overall Study|Withdrawal by Subject|2|||
48722447|NCT00134784|156834588|FG003|Overall Study|Withdrawal by Subject|1|||
48722448|NCT00137839|156834592|FG000|Overall Study|Adverse Event|7|||
48722449|NCT00137839|156834592|FG000|Overall Study|Physician Decision|7|||
48817262|NCT01439711|157173654|FG000|Overall Study|Withdrawal by Subject|3|||
48817263|NCT01439711|157173654|FG000|Overall Study|Progression During Active Tx|3|||
49129782|NCT01317641|158315769|FG001|Overall Study|Protocol Violation|0|||
48722450|NCT00137839|156834592|FG000|Overall Study|Death|8|||
48722451|NCT00137839|156834592|FG000|Overall Study|Disease Progression|60|||
48722452|NCT00137839|156834592|FG000|Overall Study|Not Start Treatment|1|||
48722453|NCT00137839|156834592|FG000|Overall Study|Prolonged Treatment Delay|1|||
48722454|NCT03234881|156834593|FG000|Overall Study|Lost to Follow-up|9|||
48722455|NCT03234881|156834594|FG001|Overall Study|Lost to Follow-up|3|||
48817264|NCT01439711|157173654|FG000|Overall Study|Noncompliance|3|||
48817265|NCT01439711|157173654|FG000|Overall Study|No MRI|9|||
48817266|NCT00209027|157173655|FG000|Overall Study|study terminated|10|||
48722456|NCT01011478|156834597|FG000|Overall Study|No follow up data|12|||
48722457|NCT01011478|156834598|FG001|Overall Study|No follow up data|7|||
49129783|NCT01317641|158315770|FG002|Overall Study|Protocol Violation|0|||
49129784|NCT01317641|158315771|FG003|Overall Study|Protocol Violation|0|||
49129785|NCT01317641|158315772|FG004|Overall Study|Protocol Violation|0|||
49129786|NCT01317641|158315773|FG005|Overall Study|Protocol Violation|0|||
49129787|NCT01317641|158315774|FG006|Overall Study|Protocol Violation|0|||
49129788|NCT01317641|158315775|FG007|Overall Study|Protocol Violation|0|||
49129789|NCT01317641|158315776|FG008|Overall Study|Protocol Violation|0|||
49129790|NCT01317641|158315768|FG000|Overall Study|Disease progression|0|||
49129791|NCT01317641|158315769|FG001|Overall Study|Disease progression|0|||
49129792|NCT01317641|158315770|FG002|Overall Study|Disease progression|0|||
49129793|NCT01317641|158315771|FG003|Overall Study|Disease progression|0|||
49129794|NCT01317641|158315772|FG004|Overall Study|Disease progression|0|||
49129795|NCT01317641|158315773|FG005|Overall Study|Disease progression|0|||
49129796|NCT01317641|158315774|FG006|Overall Study|Disease progression|0|||
49129797|NCT01317641|158315775|FG007|Overall Study|Disease progression|3|||
49129798|NCT01317641|158315776|FG008|Overall Study|Disease progression|4|||
48722458|NCT00635024|156834602|FG000|Overall Study|Adverse Event|1|||
48722459|NCT04575597|156834603|FG000|Overall Study|Death|0|||
48722460|NCT04575597|156834604|FG001|Overall Study|Death|0|||
48722461|NCT04575597|156834605|FG002|Overall Study|Death|0|||
48722462|NCT04575597|156834606|FG003|Overall Study|Death|1|||
48722463|NCT04575597|156834607|FG004|Overall Study|Death|3|||
48722464|NCT04575597|156834608|FG005|Overall Study|Death|14|||
48722465|NCT04575597|156834603|FG000|Overall Study|Lost to Follow-up|2|||
48722466|NCT04575597|156834604|FG001|Overall Study|Lost to Follow-up|1|||
48722467|NCT04575597|156834605|FG002|Overall Study|Lost to Follow-up|1|||
48722468|NCT04575597|156834606|FG003|Overall Study|Lost to Follow-up|2|||
48722469|NCT04575597|156834607|FG004|Overall Study|Lost to Follow-up|10|||
48722470|NCT04575597|156834608|FG005|Overall Study|Lost to Follow-up|8|||
48722471|NCT04575597|156834603|FG000|Overall Study|Withdrawal by Subject|2|||
48722472|NCT04575597|156834604|FG001|Overall Study|Withdrawal by Subject|2|||
48722473|NCT04575597|156834605|FG002|Overall Study|Withdrawal by Subject|4|||
48722474|NCT04575597|156834606|FG003|Overall Study|Withdrawal by Subject|2|||
48722475|NCT04575597|156834607|FG004|Overall Study|Withdrawal by Subject|25|||
48722476|NCT04575597|156834608|FG005|Overall Study|Withdrawal by Subject|28|||
48722477|NCT04575597|156834603|FG000|Overall Study|Not Recorded|0|||
48722478|NCT04575597|156834604|FG001|Overall Study|Not Recorded|0|||
48722479|NCT04575597|156834605|FG002|Overall Study|Not Recorded|0|||
48722480|NCT04575597|156834606|FG003|Overall Study|Not Recorded|0|||
48722481|NCT04575597|156834607|FG004|Overall Study|Not Recorded|0|||
48722482|NCT04575597|156834608|FG005|Overall Study|Not Recorded|2|||
48722483|NCT04575597|156834603|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
48722484|NCT04575597|156834604|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
48722485|NCT04575597|156834605|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
48722486|NCT04575597|156834606|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
48722487|NCT04575597|156834607|FG004|Overall Study|Randomized By Mistake Without Study Treatment|3|||
48722488|NCT04575597|156834608|FG005|Overall Study|Randomized By Mistake Without Study Treatment|2|||
48722489|NCT01653132|156834609|FG000|First Intervention|Protocol Violation|1|||
48722490|NCT01653132|156834610|FG001|First Intervention|Protocol Violation|0|||
48722491|NCT01895361|156834615|FG000|Overall Study|Adverse Event|1|||
48722492|NCT01895361|156834616|FG001|Overall Study|Adverse Event|1|||
48722493|NCT01895361|156834617|FG002|Overall Study|Adverse Event|3|||
48722494|NCT01895361|156834615|FG000|Overall Study|Death|2|||
48722495|NCT01895361|156834616|FG001|Overall Study|Death|1|||
48722496|NCT01895361|156834617|FG002|Overall Study|Death|2|||
48722497|NCT01895361|156834615|FG000|Overall Study|Lost to Follow-up|4|||
48722498|NCT01895361|156834616|FG001|Overall Study|Lost to Follow-up|4|||
48722499|NCT01895361|156834617|FG002|Overall Study|Lost to Follow-up|6|||
48722500|NCT01895361|156834615|FG000|Overall Study|Non-compliance with study|1|||
48722501|NCT01895361|156834616|FG001|Overall Study|Non-compliance with study|3|||
48722502|NCT01895361|156834617|FG002|Overall Study|Non-compliance with study|1|||
48722503|NCT01895361|156834615|FG000|Overall Study|Physician Decision|2|||
48722504|NCT01895361|156834616|FG001|Overall Study|Physician Decision|2|||
48722505|NCT01895361|156834617|FG002|Overall Study|Physician Decision|2|||
48722506|NCT01895361|156834615|FG000|Overall Study|Withdrawal by Subject|7|||
48722507|NCT01895361|156834616|FG001|Overall Study|Withdrawal by Subject|6|||
48722508|NCT01895361|156834617|FG002|Overall Study|Withdrawal by Subject|6|||
48722509|NCT01895361|156834615|FG000|Overall Study|Lack of Efficacy|0|||
48722510|NCT01895361|156834616|FG001|Overall Study|Lack of Efficacy|1|||
49129799|NCT01317641|158315768|FG000|Overall Study|Withdrawal by Subject|0|||
48722511|NCT01895361|156834617|FG002|Overall Study|Lack of Efficacy|0|||
48722512|NCT01895361|156834615|FG000|Overall Study|Reasons different from categories above|7|||
48722513|NCT01895361|156834616|FG001|Overall Study|Reasons different from categories above|3|||
48722514|NCT01895361|156834617|FG002|Overall Study|Reasons different from categories above|4|||
49129800|NCT01317641|158315769|FG001|Overall Study|Withdrawal by Subject|0|||
49129801|NCT01317641|158315770|FG002|Overall Study|Withdrawal by Subject|0|||
49129802|NCT01317641|158315771|FG003|Overall Study|Withdrawal by Subject|0|||
49129803|NCT01317641|158315772|FG004|Overall Study|Withdrawal by Subject|0|||
49129804|NCT01317641|158315773|FG005|Overall Study|Withdrawal by Subject|0|||
49129805|NCT01317641|158315774|FG006|Overall Study|Withdrawal by Subject|1|||
49129806|NCT01317641|158315775|FG007|Overall Study|Withdrawal by Subject|0|||
49129807|NCT01317641|158315776|FG008|Overall Study|Withdrawal by Subject|0|||
49129808|NCT04006145|158315777|FG000|Overall Study|Lost to Follow-up|0|||
49129809|NCT04006145|158315778|FG001|Overall Study|Lost to Follow-up|1|||
49129810|NCT04006145|158315777|FG000|Overall Study|Other|1|||
49129811|NCT04006145|158315778|FG001|Overall Study|Other|2|||
49129812|NCT00830219|158315779|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
49129813|NCT00830219|158315780|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
49129814|NCT01145482|158315781|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
49129815|NCT01145482|158315782|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
49129816|NCT02351934|158315783|FG000|Allocation|POD weight<pre-op weight|3|||
49129817|NCT02351934|158315784|FG001|Allocation|POD weight<pre-op weight|0|||
49011143|NCT00481247|157877398|FG000|Overall Study|Lost to Follow-up|1|||
49129818|NCT02351934|158315783|FG000|Allocation|Hypotension preventing administration|2|||
49129819|NCT02351934|158315784|FG001|Allocation|Hypotension preventing administration|0|||
49129820|NCT02351934|158315783|FG000|Allocation|Acute Kidney Injury on Post Op Day 1|1|||
49129821|NCT02351934|158315784|FG001|Allocation|Acute Kidney Injury on Post Op Day 1|0|||
49129822|NCT02351934|158315783|FG000|Follow-Up|POD weight<pre-op weight|3|||
49129823|NCT02351934|158315784|FG001|Follow-Up|POD weight<pre-op weight|0|||
49129824|NCT02351934|158315783|FG000|Follow-Up|Acute Kidney Injury|1|||
49129825|NCT02351934|158315784|FG001|Follow-Up|Acute Kidney Injury|0|||
49129826|NCT02351934|158315783|FG000|Follow-Up|Early dismissal|3|||
49129827|NCT02351934|158315784|FG001|Follow-Up|Early dismissal|0|||
49129828|NCT02351934|158315783|FG000|Follow-Up|Hypotension|3|||
49129829|NCT02351934|158315784|FG001|Follow-Up|Hypotension|0|||
49129830|NCT02351934|158315783|FG000|Follow-Up|No documentation|2|||
49129831|NCT02351934|158315784|FG001|Follow-Up|No documentation|0|||
49129832|NCT02351934|158315783|FG000|Follow-Up|1 ERAS Component Noncompliant|0|||
49129833|NCT02351934|158315784|FG001|Follow-Up|1 ERAS Component Noncompliant|6|||
49129834|NCT02351934|158315783|FG000|Follow-Up|2 ERAS Components Noncompliant|0|||
49129835|NCT02351934|158315784|FG001|Follow-Up|2 ERAS Components Noncompliant|4|||
49129836|NCT01699750|158315785|FG000|Overall Study|Withdrew Consent|0|||
49129837|NCT01699750|158315786|FG001|Overall Study|Withdrew Consent|1|||
49129838|NCT01699750|158315785|FG000|Overall Study|Other|0|||
49129839|NCT01699750|158315786|FG001|Overall Study|Other|2|||
49129840|NCT04635839|158315787|FG000|Overall Study|Delivered prior to second dose of heparin|1|||
49129841|NCT04635839|158315788|FG001|Overall Study|Delivered prior to second dose of heparin|0|||
49129842|NCT02870868|158315789|FG000|Overall Study|Withdrawal by Subject|2|||
49129843|NCT02870868|158315790|FG001|Overall Study|Withdrawal by Subject|1|||
49129844|NCT00744939|158315791|FG000|Overall Study|Withdrawal by Subject|9|||
49129845|NCT00744939|158315791|FG000|Overall Study|Protocol Violation|13|||
49129846|NCT00744939|158315791|FG000|Overall Study|Death|24|||
49129847|NCT00744939|158315791|FG000|Overall Study|distance|4|||
49129848|NCT00744939|158315791|FG000|Overall Study|Lost to Follow-up|12|||
49129849|NCT00744939|158315791|FG000|Overall Study|Medical history exclusionary|1|||
49129850|NCT00744939|158315791|FG000|Overall Study|Did not receive Magnevist|7|||
48722515|NCT03490981|156834618|FG000|Overall Study|Lost to Follow-up|1|||
48722516|NCT03490981|156834619|FG001|Overall Study|Lost to Follow-up|2|||
48722517|NCT00812487|156834620|FG000|Overall Study|Lost to Follow-up|2|||
48722518|NCT00812487|156834621|FG001|Overall Study|Lost to Follow-up|0|||
48722519|NCT00812487|156834620|FG000|Overall Study|Withdrawal by Subject|3|||
48722520|NCT00812487|156834621|FG001|Overall Study|Withdrawal by Subject|2|||
48722521|NCT00812487|156834620|FG000|Overall Study|Transfer to ICU prior to intervention|1|||
48722522|NCT00812487|156834621|FG001|Overall Study|Transfer to ICU prior to intervention|0|||
48722523|NCT00812487|156834620|FG000|Overall Study|Protocol Violation|0|||
48722524|NCT00812487|156834621|FG001|Overall Study|Protocol Violation|1|||
48722525|NCT05498701|156834622|FG000|Period 3|Adverse Event|1|||
48722526|NCT05498701|156834623|FG001|Period 3|Adverse Event|0|||
48722527|NCT02129777|156834630|FG000|Double-Blind Period|Adverse Event|0|||
48722528|NCT02129777|156834631|FG001|Double-Blind Period|Adverse Event|0|||
48722529|NCT02129777|156834632|FG002|Double-Blind Period|Adverse Event|0|||
48722530|NCT02129777|156834633|FG003|Double-Blind Period|Adverse Event|0|||
48722531|NCT02129777|156834634|FG004|Double-Blind Period|Adverse Event|1|||
48722532|NCT02129777|156834635|FG005|Double-Blind Period|Adverse Event|0|||
48722533|NCT02129777|156834636|FG006|Double-Blind Period|Adverse Event|0|||
48722534|NCT02129777|156834630|FG000|Double-Blind Period|Lost to Follow-up|1|||
48722535|NCT02129777|156834631|FG001|Double-Blind Period|Lost to Follow-up|1|||
48722536|NCT02129777|156834632|FG002|Double-Blind Period|Lost to Follow-up|1|||
48722537|NCT02129777|156834633|FG003|Double-Blind Period|Lost to Follow-up|2|||
49129851|NCT00744939|158315791|FG000|Overall Study|Failed inclusion/exclusion criteria|19|||
49129852|NCT00744939|158315791|FG000|Overall Study|coma|1|||
49129853|NCT00744939|158315791|FG000|Overall Study|incorrect race|1|||
49129854|NCT01649765|158315793|FG000|Overall Study|Adverse Event|5|||
49129855|NCT01649765|158315794|FG001|Overall Study|Adverse Event|3|||
49129856|NCT01649765|158315793|FG000|Overall Study|Lack of Efficacy|1|||
49129857|NCT01649765|158315794|FG001|Overall Study|Lack of Efficacy|1|||
49129858|NCT01649765|158315793|FG000|Overall Study|Physician Decision|0|||
49129859|NCT01649765|158315794|FG001|Overall Study|Physician Decision|3|||
49129860|NCT01649765|158315793|FG000|Overall Study|Protocol Violation|1|||
49129861|NCT01649765|158315794|FG001|Overall Study|Protocol Violation|0|||
49129862|NCT01649765|158315793|FG000|Overall Study|Withdrawal by Subject|2|||
49129863|NCT01649765|158315794|FG001|Overall Study|Withdrawal by Subject|1|||
49129864|NCT02452047|158315795|FG000|Overall Study|Adverse Event|0|||
49129865|NCT02452047|158315796|FG001|Overall Study|Adverse Event|1|||
49129866|NCT02452047|158315797|FG002|Overall Study|Adverse Event|1|||
49129867|NCT02452047|158315795|FG000|Overall Study|Death|1|||
48722538|NCT02129777|156834634|FG004|Double-Blind Period|Lost to Follow-up|0|||
48722539|NCT02129777|156834635|FG005|Double-Blind Period|Lost to Follow-up|0|||
48722540|NCT02129777|156834636|FG006|Double-Blind Period|Lost to Follow-up|0|||
48722541|NCT02129777|156834630|FG000|Double-Blind Period|Withdrawal by Subject|2|||
48722542|NCT02129777|156834631|FG001|Double-Blind Period|Withdrawal by Subject|4|||
48722543|NCT02129777|156834632|FG002|Double-Blind Period|Withdrawal by Subject|3|||
48722544|NCT02129777|156834633|FG003|Double-Blind Period|Withdrawal by Subject|2|||
48722545|NCT02129777|156834634|FG004|Double-Blind Period|Withdrawal by Subject|3|||
48722546|NCT02129777|156834635|FG005|Double-Blind Period|Withdrawal by Subject|0|||
48722547|NCT02129777|156834636|FG006|Double-Blind Period|Withdrawal by Subject|0|||
48722548|NCT02129777|156834630|FG000|Double-Blind Period|Pregnancy|0|||
48722549|NCT02129777|156834631|FG001|Double-Blind Period|Pregnancy|0|||
48722550|NCT02129777|156834632|FG002|Double-Blind Period|Pregnancy|0|||
48722551|NCT02129777|156834633|FG003|Double-Blind Period|Pregnancy|0|||
48722552|NCT02129777|156834634|FG004|Double-Blind Period|Pregnancy|1|||
48722553|NCT02129777|156834635|FG005|Double-Blind Period|Pregnancy|0|||
48722554|NCT02129777|156834636|FG006|Double-Blind Period|Pregnancy|0|||
48722555|NCT02129777|156834630|FG000|Double-Blind Period|Lack of Efficacy|3|||
48722556|NCT02129777|156834631|FG001|Double-Blind Period|Lack of Efficacy|1|||
48722557|NCT02129777|156834632|FG002|Double-Blind Period|Lack of Efficacy|0|||
48722558|NCT02129777|156834633|FG003|Double-Blind Period|Lack of Efficacy|3|||
48722559|NCT02129777|156834634|FG004|Double-Blind Period|Lack of Efficacy|2|||
48722560|NCT02129777|156834635|FG005|Double-Blind Period|Lack of Efficacy|0|||
48722561|NCT02129777|156834636|FG006|Double-Blind Period|Lack of Efficacy|0|||
48722562|NCT02129777|156834630|FG000|Double-Blind Period|Other|1|||
48722563|NCT02129777|156834631|FG001|Double-Blind Period|Other|2|||
48722564|NCT02129777|156834632|FG002|Double-Blind Period|Other|0|||
48722565|NCT02129777|156834633|FG003|Double-Blind Period|Other|0|||
48722566|NCT02129777|156834634|FG004|Double-Blind Period|Other|0|||
48722567|NCT02129777|156834635|FG005|Double-Blind Period|Other|0|||
48722568|NCT02129777|156834636|FG006|Double-Blind Period|Other|0|||
48722569|NCT02129777|156834630|FG000|Open-Label Period|Lack of Efficacy|0|||
48722570|NCT02129777|156834631|FG001|Open-Label Period|Lack of Efficacy|0|||
48722571|NCT02129777|156834632|FG002|Open-Label Period|Lack of Efficacy|0|||
48722572|NCT02129777|156834633|FG003|Open-Label Period|Lack of Efficacy|0|||
48722573|NCT02129777|156834634|FG004|Open-Label Period|Lack of Efficacy|0|||
48722574|NCT02129777|156834635|FG005|Open-Label Period|Lack of Efficacy|0|||
48722575|NCT02129777|156834636|FG006|Open-Label Period|Lack of Efficacy|5|||
48722576|NCT02129777|156834630|FG000|Open-Label Period|Lost to Follow-up|0|||
48722577|NCT02129777|156834631|FG001|Open-Label Period|Lost to Follow-up|0|||
48722578|NCT02129777|156834632|FG002|Open-Label Period|Lost to Follow-up|0|||
48722579|NCT02129777|156834633|FG003|Open-Label Period|Lost to Follow-up|0|||
49129868|NCT02452047|158315796|FG001|Overall Study|Death|3|||
49129869|NCT02452047|158315797|FG002|Overall Study|Death|1|||
49129870|NCT02452047|158315795|FG000|Overall Study|Physician Decision|1|||
49129871|NCT02452047|158315796|FG001|Overall Study|Physician Decision|0|||
48722580|NCT02129777|156834634|FG004|Open-Label Period|Lost to Follow-up|0|||
48722581|NCT02129777|156834635|FG005|Open-Label Period|Lost to Follow-up|1|||
48722582|NCT02129777|156834636|FG006|Open-Label Period|Lost to Follow-up|1|||
48722583|NCT02129777|156834630|FG000|Open-Label Period|Withdrawal by Subject|0|||
48722584|NCT02129777|156834631|FG001|Open-Label Period|Withdrawal by Subject|0|||
48722585|NCT02129777|156834632|FG002|Open-Label Period|Withdrawal by Subject|0|||
48722586|NCT02129777|156834633|FG003|Open-Label Period|Withdrawal by Subject|0|||
48722587|NCT02129777|156834634|FG004|Open-Label Period|Withdrawal by Subject|0|||
48722588|NCT02129777|156834635|FG005|Open-Label Period|Withdrawal by Subject|1|||
48722589|NCT02129777|156834636|FG006|Open-Label Period|Withdrawal by Subject|3|||
48722590|NCT02129777|156834630|FG000|Open-Label Period|Study Termination|0|||
48722591|NCT02129777|156834631|FG001|Open-Label Period|Study Termination|0|||
48722592|NCT02129777|156834632|FG002|Open-Label Period|Study Termination|0|||
49129872|NCT02452047|158315797|FG002|Overall Study|Physician Decision|0|||
49129873|NCT02452047|158315795|FG000|Overall Study|Lost to Follow-up|1|||
49129874|NCT02452047|158315796|FG001|Overall Study|Lost to Follow-up|1|||
49129875|NCT02452047|158315797|FG002|Overall Study|Lost to Follow-up|0|||
49129876|NCT02452047|158315795|FG000|Overall Study|Withdrawal by Subject|1|||
49129877|NCT02452047|158315796|FG001|Overall Study|Withdrawal by Subject|0|||
49129878|NCT02452047|158315797|FG002|Overall Study|Withdrawal by Subject|0|||
49129879|NCT00499122|158315798|FG000|Overall Study|Withdrawal by Subject|2|||
49129880|NCT01739335|158315799|FG000|Overall Study|Lost to Follow-up|7|||
49129881|NCT01739335|158315800|FG001|Overall Study|Lost to Follow-up|4|||
49129882|NCT01739335|158315799|FG000|Overall Study|Ineligible patient randomized|0|||
49129883|NCT01739335|158315800|FG001|Overall Study|Ineligible patient randomized|1|||
49129884|NCT01715831|158315805|FG000|Overall Study|Adverse Event|1|||
49129885|NCT04748718|158315806|FG000|Overall Study|Lost to Follow-up|50|||
49129886|NCT03074695|158315808|FG000|Overall Study|Delivered with caesarean before request for analgesia|1|||
49129887|NCT03074695|158315809|FG001|Overall Study|Delivered with caesarean before request for analgesia|1|||
49129888|NCT03074695|158315808|FG000|Overall Study|Research staff not available|1|||
49129889|NCT03074695|158315809|FG001|Overall Study|Research staff not available|2|||
49129890|NCT03074695|158315808|FG000|Overall Study|Did not receive neuraxial block|2|||
49129891|NCT03074695|158315809|FG001|Overall Study|Did not receive neuraxial block|2|||
49129892|NCT03248037|158315810|FG000|Overall Study|Withdrawal by Subject|6|||
49129893|NCT03248037|158315811|FG001|Overall Study|Withdrawal by Subject|9|||
49129894|NCT03248037|158315810|FG000|Overall Study|Adverse Event|15|||
49129895|NCT03248037|158315811|FG001|Overall Study|Adverse Event|0|||
49129896|NCT02897349|158315812|FG000|Overall Study|Lost to Follow-up|2|||
49129897|NCT02897349|158315813|FG001|Overall Study|Lost to Follow-up|2|||
49129898|NCT02897349|158315812|FG000|Overall Study|Adverse Event|3|||
49129899|NCT02897349|158315813|FG001|Overall Study|Adverse Event|3|||
49129900|NCT02897349|158315812|FG000|Overall Study|Other than listed above|0|||
49129901|NCT02897349|158315813|FG001|Overall Study|Other than listed above|1|||
49129902|NCT03409744|158315814|FG000|Overall Study|Death|2|||
49129903|NCT03409744|158315814|FG000|Overall Study|Physician Decision|5|||
49129904|NCT03409744|158315814|FG000|Overall Study|Pregnancy|1|||
49129905|NCT03409744|158315814|FG000|Overall Study|Lost to Follow-up|1|||
49129906|NCT03409744|158315814|FG000|Overall Study|Protocol Violation|1|||
49129907|NCT02783066|158315815|FG000|Overall Study|Withdrawal by Subject|13|||
49129908|NCT00106002|158315826|FG000|Overall Study|Did not take any study drug|1|||
49129909|NCT00106002|158315826|FG000|Overall Study|Ineligible after Registration|1|||
49129910|NCT01663623|158315827|FG000|Overall Study|Adverse Event|3|||
49129911|NCT01663623|158315828|FG001|Overall Study|Adverse Event|7|||
49129912|NCT01663623|158315827|FG000|Overall Study|Lack of Efficacy|5|||
49129913|NCT01663623|158315828|FG001|Overall Study|Lack of Efficacy|6|||
49129914|NCT01663623|158315827|FG000|Overall Study|Protocol Violation|0|||
49129915|NCT01663623|158315828|FG001|Overall Study|Protocol Violation|1|||
49129916|NCT01663623|158315827|FG000|Overall Study|Other-Study closed/terminated|1|||
49129917|NCT01663623|158315828|FG001|Overall Study|Other-Study closed/terminated|1|||
49129918|NCT01663623|158315827|FG000|Overall Study|Physician Decision|1|||
49129919|NCT01663623|158315828|FG001|Overall Study|Physician Decision|4|||
49129920|NCT01663623|158315827|FG000|Overall Study|Withdrawal by Subject|2|||
49129921|NCT01663623|158315828|FG001|Overall Study|Withdrawal by Subject|1|||
49129922|NCT01033136|158315832|FG000|Follow-Up (3 Month)|Lost to Follow-up|2|||
49129923|NCT01033136|158315833|FG001|Follow-Up (3 Month)|Lost to Follow-up|2|||
49129924|NCT00465179|158315841|FG000|Overall Study|Adverse Event|4|||
49129925|NCT00465179|158315841|FG000|Overall Study|Withdrawal by Subject|2|||
49129926|NCT00465179|158315841|FG000|Overall Study|Progression of Disease|47|||
49129927|NCT00402831|158315842|FG000|Overall Study|Lost to Follow-up|1|||
49129928|NCT00402831|158315843|FG001|Overall Study|Lost to Follow-up|2|||
49129929|NCT00402831|158315842|FG000|Overall Study|Non-compliance with protocol|0|||
49129930|NCT00402831|158315843|FG001|Overall Study|Non-compliance with protocol|1|||
49129931|NCT01114724|158315855|FG000|Overall Study|Death|8|||
49129932|NCT01114724|158315855|FG000|Overall Study|Lost to Follow-up|1|||
49129933|NCT01114724|158315855|FG000|Overall Study|Withdrawal by Subject|1|||
49129934|NCT02966834|158315856|FG000|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
49129935|NCT02966834|158315857|FG001|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
49129936|NCT02966834|158315858|FG002|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
49129937|NCT02966834|158315859|FG003|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
49129938|NCT02966834|158315860|FG004|Main Study Period (Up to 12 Weeks)|Adverse Event|1|||
49129939|NCT02966834|158315861|FG005|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
49129940|NCT02966834|158315856|FG000|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1|||
49129941|NCT02966834|158315857|FG001|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
49129942|NCT02966834|158315858|FG002|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
49129943|NCT02966834|158315859|FG003|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
49129944|NCT02966834|158315860|FG004|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
49129945|NCT02966834|158315861|FG005|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
49129946|NCT02966834|158315856|FG000|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
49129947|NCT02966834|158315857|FG001|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
49129948|NCT02966834|158315858|FG002|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4|||
49129949|NCT02966834|158315859|FG003|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8|||
49129950|NCT02966834|158315860|FG004|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
49129951|NCT02966834|158315861|FG005|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5|||
49129952|NCT02966834|158315856|FG000|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
49129953|NCT02966834|158315857|FG001|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
49129954|NCT02966834|158315858|FG002|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
49129955|NCT02966834|158315859|FG003|Follow-up (Up to 4 Weeks)|Adverse Event|2|||
49129956|NCT02966834|158315860|FG004|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
49129957|NCT02966834|158315861|FG005|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
49129958|NCT02966834|158315856|FG000|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
49129959|NCT02966834|158315857|FG001|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
49129960|NCT02966834|158315858|FG002|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
49129961|NCT02966834|158315859|FG003|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2|||
49129962|NCT02966834|158315860|FG004|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
49129963|NCT02966834|158315861|FG005|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
49129964|NCT02966834|158315856|FG000|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
49129965|NCT02966834|158315857|FG001|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
49129966|NCT02966834|158315858|FG002|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
49129967|NCT02966834|158315859|FG003|Follow-up (Up to 4 Weeks)|Protocol Violation|1|||
49129968|NCT02966834|158315860|FG004|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
49129969|NCT02966834|158315861|FG005|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
49129970|NCT01922934|158315862|FG000|Eligible Patients|Death|0|||
49129971|NCT01922934|158315863|FG001|Eligible Patients|Death|7|||
49129972|NCT01922934|158315862|FG000|Eligible Patients|Physician Decision|17|||
49129973|NCT01922934|158315863|FG001|Eligible Patients|Physician Decision|0|||
49129974|NCT01922934|158315862|FG000|Eligible Patients|Did not meet inclusion criteria|36|||
49129975|NCT01922934|158315863|FG001|Eligible Patients|Did not meet inclusion criteria|81|||
49129976|NCT01922934|158315862|FG000|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169|||
49129977|NCT01922934|158315863|FG001|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0|||
49129978|NCT01922934|158315862|FG000|Visit 0 - Patient Contacted & Consented|No response or could not reach|66|||
49129979|NCT01922934|158315863|FG001|Visit 0 - Patient Contacted & Consented|No response or could not reach|0|||
49129980|NCT01922934|158315862|FG000|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21|||
49129981|NCT01922934|158315863|FG001|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284|||
49129982|NCT01326871|158315864|FG000|Overall Study|Major surgery|0|||
49129983|NCT01326871|158315865|FG001|Overall Study|Major surgery|1|||
49129984|NCT01326871|158315866|FG002|Overall Study|Major surgery|0|||
49129985|NCT01326871|158315864|FG000|Overall Study|SAE and death|0|||
49129986|NCT01326871|158315865|FG001|Overall Study|SAE and death|2|||
49129987|NCT01326871|158315866|FG002|Overall Study|SAE and death|0|||
49129988|NCT01326871|158315864|FG000|Overall Study|Physician decision and decreased performance status|0|||
49129989|NCT01326871|158315865|FG001|Overall Study|Physician decision and decreased performance status|1|||
49129990|NCT01326871|158315866|FG002|Overall Study|Physician decision and decreased performance status|0|||
49129991|NCT01326871|158315864|FG000|Overall Study|Disease progression|0|||
49129992|NCT01326871|158315865|FG001|Overall Study|Disease progression|11|||
49129993|NCT01326871|158315866|FG002|Overall Study|Disease progression|5|||
49129994|NCT01326871|158315864|FG000|Overall Study|Did not qualify or consent for repeat treatment|0|||
49129995|NCT01326871|158315865|FG001|Overall Study|Did not qualify or consent for repeat treatment|1|||
49129996|NCT01326871|158315866|FG002|Overall Study|Did not qualify or consent for repeat treatment|0|||
49129997|NCT01326871|158315864|FG000|Overall Study|Subject decision to continue survival follow-up only|0|||
49129998|NCT01326871|158315865|FG001|Overall Study|Subject decision to continue survival follow-up only|4|||
49129999|NCT01326871|158315866|FG002|Overall Study|Subject decision to continue survival follow-up only|1|||
49130000|NCT01326871|158315864|FG000|Overall Study|Withdrawal by Subject|0|||
49130001|NCT01326871|158315865|FG001|Overall Study|Withdrawal by Subject|1|||
49130002|NCT01326871|158315866|FG002|Overall Study|Withdrawal by Subject|0|||
49130003|NCT01326871|158315864|FG000|Overall Study|DLT|0|||
49130004|NCT01326871|158315865|FG001|Overall Study|DLT|2|||
49130005|NCT01326871|158315866|FG002|Overall Study|DLT|0|||
49130006|NCT01326871|158315864|FG000|Overall Study|SAE, disease progression and subject decision|0|||
49130007|NCT01326871|158315865|FG001|Overall Study|SAE, disease progression and subject decision|1|||
49130008|NCT01326871|158315866|FG002|Overall Study|SAE, disease progression and subject decision|0|||
49130009|NCT01326871|158315864|FG000|Overall Study|Death|0|||
49130010|NCT01326871|158315865|FG001|Overall Study|Death|1|||
49130011|NCT01326871|158315866|FG002|Overall Study|Death|0|||
48722593|NCT02129777|156834633|FG003|Open-Label Period|Study Termination|0|||
49130012|NCT01326871|158315864|FG000|Overall Study|Other|0|||
49130013|NCT01326871|158315865|FG001|Overall Study|Other|3|||
49130014|NCT01326871|158315866|FG002|Overall Study|Other|0|||
49130015|NCT01326871|158315864|FG000|Overall Study|SAE and disease progression|0|||
49130016|NCT01326871|158315865|FG001|Overall Study|SAE and disease progression|0|||
49130017|NCT01326871|158315866|FG002|Overall Study|SAE and disease progression|1|||
49130018|NCT01326871|158315864|FG000|Overall Study|SAE and physician decision|0|||
49130019|NCT01326871|158315865|FG001|Overall Study|SAE and physician decision|0|||
49130020|NCT01326871|158315866|FG002|Overall Study|SAE and physician decision|1|||
49130021|NCT01326871|158315864|FG000|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
49130022|NCT01326871|158315865|FG001|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
49130023|NCT01326871|158315866|FG002|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|1|||
49130024|NCT01326871|158315864|FG000|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
49130025|NCT01326871|158315865|FG001|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
49130026|NCT01326871|158315866|FG002|Overall Study|Did not qualify or consent for repeat treatment and disease progression|1|||
49130027|NCT01326871|158315864|FG000|Overall Study|Physician decision, AEs and subject compliance|0|||
49130028|NCT01326871|158315865|FG001|Overall Study|Physician decision, AEs and subject compliance|0|||
49130029|NCT01326871|158315866|FG002|Overall Study|Physician decision, AEs and subject compliance|1|||
49130030|NCT01326871|158315864|FG000|Overall Study|Physician Decision|0|||
49130031|NCT01326871|158315865|FG001|Overall Study|Physician Decision|0|||
49130032|NCT01326871|158315866|FG002|Overall Study|Physician Decision|1|||
49130033|NCT01326871|158315864|FG000|Overall Study|SAE|0|||
49130034|NCT01326871|158315865|FG001|Overall Study|SAE|0|||
49130035|NCT01326871|158315866|FG002|Overall Study|SAE|1|||
49130036|NCT01326871|158315864|FG000|Overall Study|Disease progression and death|0|||
49130037|NCT01326871|158315865|FG001|Overall Study|Disease progression and death|0|||
49130038|NCT01326871|158315866|FG002|Overall Study|Disease progression and death|1|||
49130039|NCT01326871|158315864|FG000|Overall Study|Subject decision|0|||
49130040|NCT01326871|158315865|FG001|Overall Study|Subject decision|0|||
49130041|NCT01326871|158315866|FG002|Overall Study|Subject decision|1|||
49130042|NCT00251758|158315867|FG000|Overall Study|Adverse Event|7|||
49130043|NCT00251758|158315868|FG001|Overall Study|Adverse Event|9|||
49130044|NCT00251758|158315869|FG002|Overall Study|Adverse Event|11|||
49130045|NCT00251758|158315867|FG000|Overall Study|Lost to Follow-up|4|||
49130046|NCT00251758|158315868|FG001|Overall Study|Lost to Follow-up|2|||
49130047|NCT00251758|158315869|FG002|Overall Study|Lost to Follow-up|5|||
49130048|NCT00251758|158315867|FG000|Overall Study|Withdrawal by Subject|13|||
49130049|NCT00251758|158315868|FG001|Overall Study|Withdrawal by Subject|7|||
49130050|NCT00251758|158315869|FG002|Overall Study|Withdrawal by Subject|3|||
49130051|NCT00251758|158315867|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
49130052|NCT00251758|158315868|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
49130053|NCT00251758|158315869|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
49130054|NCT00251758|158315867|FG000|Overall Study|Lack of Efficacy|3|||
49130055|NCT00251758|158315868|FG001|Overall Study|Lack of Efficacy|0|||
49130056|NCT00251758|158315869|FG002|Overall Study|Lack of Efficacy|0|||
49130057|NCT00251758|158315867|FG000|Overall Study|Noncompliant|0|||
49130058|NCT00251758|158315868|FG001|Overall Study|Noncompliant|2|||
49130059|NCT00251758|158315869|FG002|Overall Study|Noncompliant|2|||
49130060|NCT00251758|158315867|FG000|Overall Study|Pregnancy|0|||
49130061|NCT00251758|158315868|FG001|Overall Study|Pregnancy|1|||
49130062|NCT00251758|158315869|FG002|Overall Study|Pregnancy|0|||
49130063|NCT00251758|158315867|FG000|Overall Study|Per Subject Request|0|||
49130064|NCT00251758|158315868|FG001|Overall Study|Per Subject Request|0|||
49130065|NCT00251758|158315869|FG002|Overall Study|Per Subject Request|1|||
49130066|NCT00251758|158315867|FG000|Overall Study|Per Investigator Request|1|||
49130067|NCT00251758|158315868|FG001|Overall Study|Per Investigator Request|0|||
49130068|NCT00251758|158315869|FG002|Overall Study|Per Investigator Request|0|||
49130069|NCT01387269|158315873|FG000|Overall Study|Death|38|||
49130070|NCT01387269|158315874|FG001|Overall Study|Death|20|||
49130071|NCT01387269|158315873|FG000|Overall Study|Other|8|||
49130072|NCT01387269|158315874|FG001|Overall Study|Other|7|||
49130073|NCT01387269|158315873|FG000|Overall Study|Unrelated AE|12|||
49130074|NCT01387269|158315874|FG001|Overall Study|Unrelated AE|3|||
49130075|NCT01387269|158315873|FG000|Overall Study|Withdrawal by patient|32|||
49130076|NCT01387269|158315874|FG001|Overall Study|Withdrawal by patient|10|||
49130077|NCT01387269|158315873|FG000|Overall Study|Study drug-related AE|1|||
49130078|NCT01387269|158315874|FG001|Overall Study|Study drug-related AE|0|||
49130079|NCT01387269|158315873|FG000|Overall Study|Lost to Follow-up|1|||
49130080|NCT01387269|158315874|FG001|Overall Study|Lost to Follow-up|0|||
49130081|NCT02774889|158315879|FG000|Overall Study|Lost to Follow-up|2|||
49130082|NCT02774889|158315880|FG001|Overall Study|Lost to Follow-up|1|||
49130083|NCT01020123|158315882|FG000|Main Period|Withdrawal by Subject|6|||
49130084|NCT01020123|158315883|FG001|Main Period|Withdrawal by Subject|5|||
49130085|NCT01020123|158315884|FG002|Main Period|Withdrawal by Subject|3|||
49130086|NCT01020123|158315885|FG003|Main Period|Withdrawal by Subject|1|||
49130087|NCT01020123|158315886|FG004|Main Period|Withdrawal by Subject|6|||
49130088|NCT01020123|158315887|FG005|Main Period|Withdrawal by Subject|3|||
49130089|NCT01020123|158315888|FG006|Main Period|Withdrawal by Subject|2|||
49130090|NCT01020123|158315882|FG000|Main Period|Eligibility Criteria not fullfilled|0|||
49130091|NCT01020123|158315883|FG001|Main Period|Eligibility Criteria not fullfilled|1|||
49130092|NCT01020123|158315884|FG002|Main Period|Eligibility Criteria not fullfilled|0|||
49130093|NCT01020123|158315885|FG003|Main Period|Eligibility Criteria not fullfilled|0|||
49130094|NCT01020123|158315886|FG004|Main Period|Eligibility Criteria not fullfilled|1|||
49130095|NCT01020123|158315887|FG005|Main Period|Eligibility Criteria not fullfilled|0|||
49130096|NCT01020123|158315888|FG006|Main Period|Eligibility Criteria not fullfilled|0|||
49130097|NCT01020123|158315882|FG000|Main Period|Adverse Event|5|||
49130098|NCT01020123|158315883|FG001|Main Period|Adverse Event|2|||
49130099|NCT01020123|158315884|FG002|Main Period|Adverse Event|2|||
49130100|NCT01020123|158315885|FG003|Main Period|Adverse Event|1|||
49130101|NCT01020123|158315886|FG004|Main Period|Adverse Event|1|||
49130102|NCT01020123|158315887|FG005|Main Period|Adverse Event|2|||
49130103|NCT01020123|158315888|FG006|Main Period|Adverse Event|1|||
49130104|NCT01020123|158315882|FG000|Main Period|Protocol Violation|4|||
49130105|NCT01020123|158315883|FG001|Main Period|Protocol Violation|4|||
49130106|NCT01020123|158315884|FG002|Main Period|Protocol Violation|2|||
49130107|NCT01020123|158315885|FG003|Main Period|Protocol Violation|5|||
48722594|NCT02129777|156834634|FG004|Open-Label Period|Study Termination|0|||
48722595|NCT02129777|156834635|FG005|Open-Label Period|Study Termination|10|||
49130108|NCT01020123|158315886|FG004|Main Period|Protocol Violation|2|||
49130109|NCT01020123|158315887|FG005|Main Period|Protocol Violation|3|||
49130110|NCT01020123|158315888|FG006|Main Period|Protocol Violation|2|||
49130111|NCT01020123|158315882|FG000|Main Period|Lost to Follow-up|0|||
49130112|NCT01020123|158315883|FG001|Main Period|Lost to Follow-up|2|||
49130113|NCT01020123|158315884|FG002|Main Period|Lost to Follow-up|0|||
49130114|NCT01020123|158315885|FG003|Main Period|Lost to Follow-up|0|||
49130115|NCT01020123|158315886|FG004|Main Period|Lost to Follow-up|0|||
49130116|NCT01020123|158315887|FG005|Main Period|Lost to Follow-up|0|||
49130117|NCT01020123|158315888|FG006|Main Period|Lost to Follow-up|0|||
49130118|NCT01020123|158315882|FG000|Main Period|Unclasified|2|||
49130119|NCT01020123|158315883|FG001|Main Period|Unclasified|0|||
49130120|NCT01020123|158315884|FG002|Main Period|Unclasified|1|||
49130121|NCT01020123|158315885|FG003|Main Period|Unclasified|0|||
49130122|NCT01020123|158315886|FG004|Main Period|Unclasified|1|||
49130123|NCT01020123|158315887|FG005|Main Period|Unclasified|3|||
49130124|NCT01020123|158315888|FG006|Main Period|Unclasified|6|||
49130125|NCT01020123|158315882|FG000|Extention Period|Withdrawal by Subject|2|||
49130126|NCT01020123|158315883|FG001|Extention Period|Withdrawal by Subject|1|||
48722596|NCT02129777|156834636|FG006|Open-Label Period|Study Termination|39|||
48722597|NCT03485495|156834637|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
49130127|NCT01020123|158315884|FG002|Extention Period|Withdrawal by Subject|1|||
49130128|NCT01020123|158315885|FG003|Extention Period|Withdrawal by Subject|0|||
49130129|NCT01020123|158315886|FG004|Extention Period|Withdrawal by Subject|0|||
49130130|NCT01020123|158315887|FG005|Extention Period|Withdrawal by Subject|0|||
49130131|NCT01020123|158315888|FG006|Extention Period|Withdrawal by Subject|0|||
48722598|NCT03485495|156834638|FG001|Overall Study|Non-compliance with inclusion criteria|0|||
48722599|NCT00924170|156834639|FG000|Overall Study|Refused further treatment|0|||
48722600|NCT00924170|156834640|FG001|Overall Study|Refused further treatment|1|||
48722601|NCT00924170|156834639|FG000|Overall Study|Physician Decision|0|||
48722602|NCT00924170|156834640|FG001|Overall Study|Physician Decision|1|||
48722603|NCT00924170|156834639|FG000|Overall Study|Progressive disease|3|||
48722604|NCT00924170|156834640|FG001|Overall Study|Progressive disease|6|||
48722605|NCT00924170|156834639|FG000|Overall Study|Stopped due to neutralizing antibodies|3|||
48722606|NCT00924170|156834640|FG001|Overall Study|Stopped due to neutralizing antibodies|0|||
48722607|NCT00924170|156834639|FG000|Overall Study|Death|1|||
48722608|NCT00924170|156834640|FG001|Overall Study|Death|0|||
48722609|NCT05499377|156834641|FG000|Overall Study|Withdrawal by Subject|2|||
49130132|NCT01020123|158315882|FG000|Extention Period|Adverse Event|0|||
49130133|NCT01020123|158315883|FG001|Extention Period|Adverse Event|0|||
49130134|NCT01020123|158315884|FG002|Extention Period|Adverse Event|0|||
49130135|NCT01020123|158315885|FG003|Extention Period|Adverse Event|1|||
48722610|NCT05499377|156834642|FG001|Overall Study|Withdrawal by Subject|0|||
48722611|NCT05499377|156834641|FG000|Overall Study|Physician Decision|1|||
48722612|NCT05499377|156834642|FG001|Overall Study|Physician Decision|0|||
49130136|NCT01020123|158315886|FG004|Extention Period|Adverse Event|0|||
49130137|NCT01020123|158315887|FG005|Extention Period|Adverse Event|0|||
49130138|NCT01020123|158315888|FG006|Extention Period|Adverse Event|0|||
49130139|NCT01020123|158315882|FG000|Extention Period|Protocol Violation|1|||
49130140|NCT01020123|158315883|FG001|Extention Period|Protocol Violation|1|||
49130141|NCT01020123|158315884|FG002|Extention Period|Protocol Violation|1|||
49130142|NCT01020123|158315885|FG003|Extention Period|Protocol Violation|0|||
49130143|NCT01020123|158315886|FG004|Extention Period|Protocol Violation|0|||
49130144|NCT01020123|158315887|FG005|Extention Period|Protocol Violation|0|||
49130145|NCT01020123|158315888|FG006|Extention Period|Protocol Violation|1|||
49130146|NCT01020123|158315882|FG000|Extention Period|Lost to Follow-up|0|||
49130147|NCT01020123|158315883|FG001|Extention Period|Lost to Follow-up|0|||
49130148|NCT01020123|158315884|FG002|Extention Period|Lost to Follow-up|0|||
49130149|NCT01020123|158315885|FG003|Extention Period|Lost to Follow-up|0|||
49130150|NCT01020123|158315886|FG004|Extention Period|Lost to Follow-up|0|||
49130151|NCT01020123|158315887|FG005|Extention Period|Lost to Follow-up|2|||
49130152|NCT01020123|158315888|FG006|Extention Period|Lost to Follow-up|0|||
49130153|NCT00846365|158315889|FG000|Overall Study|Adverse Event|20|||
48722613|NCT04776317|156834643|FG000|Overall Study|Physician Decision|0|||
48722614|NCT04776317|156834644|FG001|Overall Study|Physician Decision|1|||
48722615|NCT04776317|156834645|FG002|Overall Study|Physician Decision|0|||
48722616|NCT04776317|156834646|FG003|Overall Study|Physician Decision|0|||
48722617|NCT04776317|156834647|FG004|Overall Study|Physician Decision|0|||
48722618|NCT04776317|156834648|FG005|Overall Study|Physician Decision|0|||
48722619|NCT04776317|156834649|FG006|Overall Study|Physician Decision|0|||
48722620|NCT04776317|156834650|FG007|Overall Study|Physician Decision|0|||
48817267|NCT00209027|157173656|FG001|Overall Study|study terminated|0|||
48817268|NCT05546411|157173657|FG000|Overall Study|Progressive Disease|1|||
48817269|NCT05546411|157173658|FG001|Overall Study|Progressive Disease|0|||
48817270|NCT05546411|157173657|FG000|Overall Study|Adverse Event|0|||
48817271|NCT05546411|157173658|FG001|Overall Study|Adverse Event|1|||
48817272|NCT05546411|157173657|FG000|Overall Study|Metastatic disease|1|||
48817273|NCT05546411|157173658|FG001|Overall Study|Metastatic disease|0|||
48817274|NCT00776100|157173659|FG000|Overall Study|Disease Progression|1|||
48817275|NCT00776100|157173660|FG001|Overall Study|Disease Progression|0|||
48817276|NCT02148718|157173661|FG000|Overall Study|Protocol Violation|26|||
48817277|NCT02148718|157173661|FG000|Overall Study|Discontinued Study Prematurely|5|||
48722621|NCT04776317|156834651|FG008|Overall Study|Physician Decision|0|||
48722622|NCT04776317|156834652|FG009|Overall Study|Physician Decision|0|||
48722623|NCT04776317|156834653|FG010|Overall Study|Physician Decision|0|||
48817278|NCT00003509|157173662|FG000|Overall Study|Not evaluable|5|||
48722624|NCT04776317|156834654|FG011|Overall Study|Physician Decision|0|||
48722625|NCT04776317|156834655|FG012|Overall Study|Physician Decision|0|||
48722626|NCT04776317|156834656|FG013|Overall Study|Physician Decision|0|||
48722627|NCT04776317|156834657|FG014|Overall Study|Physician Decision|0|||
48722628|NCT04776317|156834643|FG000|Overall Study|Protocol Violation|0|||
48722629|NCT04776317|156834644|FG001|Overall Study|Protocol Violation|0|||
48722630|NCT04776317|156834645|FG002|Overall Study|Protocol Violation|1|||
48722631|NCT04776317|156834646|FG003|Overall Study|Protocol Violation|0|||
48722632|NCT04776317|156834647|FG004|Overall Study|Protocol Violation|0|||
48722633|NCT04776317|156834648|FG005|Overall Study|Protocol Violation|0|||
48722634|NCT04776317|156834649|FG006|Overall Study|Protocol Violation|0|||
48722635|NCT04776317|156834650|FG007|Overall Study|Protocol Violation|0|||
48722636|NCT04776317|156834651|FG008|Overall Study|Protocol Violation|0|||
48722637|NCT04776317|156834652|FG009|Overall Study|Protocol Violation|0|||
48722638|NCT04776317|156834653|FG010|Overall Study|Protocol Violation|0|||
48722639|NCT04776317|156834654|FG011|Overall Study|Protocol Violation|0|||
48722640|NCT04776317|156834655|FG012|Overall Study|Protocol Violation|0|||
48722641|NCT04776317|156834656|FG013|Overall Study|Protocol Violation|0|||
49130154|NCT00846365|158315890|FG001|Overall Study|Adverse Event|30|||
49130155|NCT00846365|158315891|FG002|Overall Study|Adverse Event|11|||
48817279|NCT02107443|157173663|FG000|Overall Study|Death|42|||
49130156|NCT00846365|158315889|FG000|Overall Study|Protocol Violation|5|||
49130157|NCT00846365|158315890|FG001|Overall Study|Protocol Violation|4|||
49130158|NCT00846365|158315891|FG002|Overall Study|Protocol Violation|0|||
49130159|NCT00846365|158315889|FG000|Overall Study|Lost to Follow-up|8|||
49130160|NCT00846365|158315890|FG001|Overall Study|Lost to Follow-up|2|||
49130161|NCT00846365|158315891|FG002|Overall Study|Lost to Follow-up|5|||
49130162|NCT00846365|158315889|FG000|Overall Study|Withdrawal by Subject|11|||
49130163|NCT00846365|158315890|FG001|Overall Study|Withdrawal by Subject|11|||
49130164|NCT00846365|158315891|FG002|Overall Study|Withdrawal by Subject|9|||
49130165|NCT00846365|158315889|FG000|Overall Study|Pregnancy|1|||
49130166|NCT00846365|158315890|FG001|Overall Study|Pregnancy|0|||
49130167|NCT00846365|158315891|FG002|Overall Study|Pregnancy|0|||
48722642|NCT04776317|156834657|FG014|Overall Study|Protocol Violation|0|||
48722643|NCT04776317|156834643|FG000|Overall Study|Withdrawal by Subject|0|||
48722644|NCT04776317|156834644|FG001|Overall Study|Withdrawal by Subject|0|||
48722645|NCT04776317|156834645|FG002|Overall Study|Withdrawal by Subject|0|||
48817280|NCT02107443|157173664|FG001|Overall Study|Death|30|||
49130168|NCT00846365|158315889|FG000|Overall Study|Lack of Efficacy|1|||
48722646|NCT04776317|156834646|FG003|Overall Study|Withdrawal by Subject|0|||
48722647|NCT04776317|156834647|FG004|Overall Study|Withdrawal by Subject|1|||
49130169|NCT00846365|158315890|FG001|Overall Study|Lack of Efficacy|1|||
48817281|NCT02107443|157173663|FG000|Overall Study|Study Protocol Violation|3|||
49130170|NCT00846365|158315891|FG002|Overall Study|Lack of Efficacy|2|||
49130171|NCT00846365|158315889|FG000|Overall Study|Other|9|||
49130172|NCT00846365|158315890|FG001|Overall Study|Other|1|||
48817282|NCT02107443|157173664|FG001|Overall Study|Study Protocol Violation|1|||
48817283|NCT02107443|157173663|FG000|Overall Study|Registered but Not Eligible|0|||
48817284|NCT02107443|157173664|FG001|Overall Study|Registered but Not Eligible|1|||
48817285|NCT02107443|157173663|FG000|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
48817286|NCT02107443|157173664|FG001|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
48817287|NCT02107443|157173663|FG000|Overall Study|Withdrawal: Disliked Study Procedures|1|||
48817288|NCT02107443|157173664|FG001|Overall Study|Withdrawal: Disliked Study Procedures|2|||
48817289|NCT02107443|157173663|FG000|Overall Study|Withdrawal: Changed Mind|2|||
48817290|NCT02107443|157173664|FG001|Overall Study|Withdrawal: Changed Mind|0|||
48817291|NCT02107443|157173663|FG000|Overall Study|Withdrawal: Changed MD/Facility|1|||
48817292|NCT02107443|157173664|FG001|Overall Study|Withdrawal: Changed MD/Facility|3|||
48817293|NCT02107443|157173663|FG000|Overall Study|Withdrawal: Too Many Forms|3|||
48817294|NCT02107443|157173664|FG001|Overall Study|Withdrawal: Too Many Forms|1|||
48817295|NCT02107443|157173663|FG000|Overall Study|Withdrawal: Too Time Consuming|3|||
48817296|NCT02107443|157173664|FG001|Overall Study|Withdrawal: Too Time Consuming|6|||
48817297|NCT02107443|157173663|FG000|Overall Study|Withdrawal: Feeling Overwhelmed|2|||
48817298|NCT02107443|157173664|FG001|Overall Study|Withdrawal: Feeling Overwhelmed|1|||
48817299|NCT02107443|157173663|FG000|Overall Study|Withdrawal: Other Medical|9|||
48817300|NCT02107443|157173664|FG001|Overall Study|Withdrawal: Other Medical|5|||
48817301|NCT02107443|157173663|FG000|Overall Study|Withdrawal: Disease Progression|4|||
48817302|NCT02107443|157173664|FG001|Overall Study|Withdrawal: Disease Progression|2|||
48817303|NCT02107443|157173663|FG000|Overall Study|Withdrawal: Personal Issues|0|||
48817304|NCT02107443|157173664|FG001|Overall Study|Withdrawal: Personal Issues|3|||
48817305|NCT03428815|157173673|FG000|Overall Study|Lost to Follow-up|2|||
48817306|NCT03428815|157173674|FG001|Overall Study|Lost to Follow-up|2|||
48817307|NCT03428815|157173673|FG000|Overall Study|suspension of study activities due to Covid-19 pandemic|5|||
48817308|NCT03428815|157173674|FG001|Overall Study|suspension of study activities due to Covid-19 pandemic|2|||
48817309|NCT03428815|157173673|FG000|Overall Study|Intermittent fitting issues that affected reliability of data|3|||
48817310|NCT03428815|157173674|FG001|Overall Study|Intermittent fitting issues that affected reliability of data|1|||
48817311|NCT00209274|157173675|FG000|Overall Study|Missed visit|3|||
48817312|NCT00209274|157173676|FG001|Overall Study|Missed visit|2|||
48817313|NCT00209274|157173675|FG000|Overall Study|Death|32|||
48817314|NCT00209274|157173676|FG001|Overall Study|Death|15|||
48817315|NCT00209274|157173675|FG000|Overall Study|Withdrawal by Subject|30|||
48817316|NCT00209274|157173676|FG001|Overall Study|Withdrawal by Subject|15|||
48817317|NCT00209274|157173675|FG000|Overall Study|Randomized not treated (RNT)|6|||
48817318|NCT00209274|157173676|FG001|Overall Study|Randomized not treated (RNT)|15|||
48817319|NCT00386308|157175123|FG000|Overall Study|Adverse Event|3|||
48817320|NCT00386308|157175124|FG001|Overall Study|Adverse Event|3|||
48817321|NCT00386308|157175123|FG000|Overall Study|Protocol Violation|2|||
48817322|NCT00386308|157175124|FG001|Overall Study|Protocol Violation|5|||
48817323|NCT00386308|157175123|FG000|Overall Study|Lack of Efficacy|0|||
48817324|NCT00386308|157175124|FG001|Overall Study|Lack of Efficacy|2|||
48817325|NCT00386308|157175123|FG000|Overall Study|Lost to Follow-up|10|||
49130173|NCT00846365|158315891|FG002|Overall Study|Other|6|||
49130174|NCT02577029|158315892|FG000|Overall Study|Adverse Event|1|||
49130175|NCT02577029|158315893|FG001|Overall Study|Adverse Event|0|||
49130176|NCT02577029|158315894|FG002|Overall Study|Adverse Event|2|||
49130177|NCT02577029|158315895|FG003|Overall Study|Adverse Event|0|||
49130178|NCT02577029|158315896|FG004|Overall Study|Adverse Event|1|||
49130179|NCT02577029|158315897|FG005|Overall Study|Adverse Event|0|||
49130180|NCT02577029|158315898|FG006|Overall Study|Adverse Event|0|||
49130181|NCT02577029|158315899|FG007|Overall Study|Adverse Event|0|||
49130182|NCT02577029|158315892|FG000|Overall Study|Withdrawal by Subject|0|||
49130183|NCT02577029|158315893|FG001|Overall Study|Withdrawal by Subject|0|||
48817326|NCT00386308|157175124|FG001|Overall Study|Lost to Follow-up|6|||
49130184|NCT02577029|158315894|FG002|Overall Study|Withdrawal by Subject|0|||
49130185|NCT02577029|158315895|FG003|Overall Study|Withdrawal by Subject|0|||
49130186|NCT02577029|158315896|FG004|Overall Study|Withdrawal by Subject|0|||
49130187|NCT02577029|158315897|FG005|Overall Study|Withdrawal by Subject|1|||
49130188|NCT02577029|158315898|FG006|Overall Study|Withdrawal by Subject|0|||
49130189|NCT02577029|158315899|FG007|Overall Study|Withdrawal by Subject|0|||
49130190|NCT02577029|158315892|FG000|Overall Study|Sponsor Termination of the Study|9|||
49130191|NCT02577029|158315893|FG001|Overall Study|Sponsor Termination of the Study|2|||
48817327|NCT00386308|157175123|FG000|Overall Study|Withdrawal by Subject|6|||
48817328|NCT00386308|157175124|FG001|Overall Study|Withdrawal by Subject|2|||
48817329|NCT00386308|157175123|FG000|Overall Study|Other Event|8|||
48817330|NCT00386308|157175124|FG001|Overall Study|Other Event|1|||
48817331|NCT04814186|157175125|FG000|Treatment Phase|Adverse Event|1|||
49130192|NCT02577029|158315894|FG002|Overall Study|Sponsor Termination of the Study|5|||
49130193|NCT02577029|158315895|FG003|Overall Study|Sponsor Termination of the Study|12|||
48817332|NCT04814186|157175125|FG000|Treatment Phase|Death|6|||
48817333|NCT04814186|157175125|FG000|Treatment Phase|Withdrawal by Subject|2|||
48817334|NCT04814186|157175125|FG000|Treatment Phase|Other|1|||
48817335|NCT04814186|157175125|FG000|Follow-Up Phase|Adverse Event|1|||
48817336|NCT04814186|157175125|FG000|Follow-Up Phase|Death|6|||
48817337|NCT04814186|157175125|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
48817338|NCT04814186|157175125|FG000|Follow-Up Phase|Other|1|||
48817339|NCT03122886|157175133|FG000|Overall Study|Withdrawal by Subject|1|||
48817340|NCT03122886|157175134|FG001|Overall Study|Withdrawal by Subject|2|||
48817341|NCT01167179|157175139|FG000|Overall Study|disease recurrence|4|||
48817342|NCT01167179|157175140|FG001|Overall Study|disease recurrence|4|||
48817343|NCT01167179|157175139|FG000|Overall Study|Death|4|||
48817344|NCT01167179|157175140|FG001|Overall Study|Death|10|||
48817345|NCT01167179|157175139|FG000|Overall Study|Withdrawal by Subject|1|||
48817346|NCT01167179|157175140|FG001|Overall Study|Withdrawal by Subject|2|||
48817347|NCT01167179|157175139|FG000|Overall Study|diverse|6|||
49130194|NCT02577029|158315896|FG004|Overall Study|Sponsor Termination of the Study|10|||
49130195|NCT02577029|158315897|FG005|Overall Study|Sponsor Termination of the Study|12|||
49130196|NCT02577029|158315898|FG006|Overall Study|Sponsor Termination of the Study|12|||
49130197|NCT02577029|158315899|FG007|Overall Study|Sponsor Termination of the Study|12|||
49130198|NCT00721799|158315900|FG000|Overall Study|Withdrawal by Subject|7|||
49130199|NCT00721799|158315900|FG000|Overall Study|withdraw by subject after scan 1|1|||
49130200|NCT01047319|158315901|FG000|Overall Study|Teva requested participant withdrawal|3|||
49130201|NCT01047319|158315902|FG001|Overall Study|Teva requested participant withdrawal|0|||
49130202|NCT01047319|158315903|FG002|Overall Study|Teva requested participant withdrawal|1|||
49130203|NCT01047319|158315901|FG000|Overall Study|Protocol Violation|3|||
49130204|NCT01047319|158315902|FG001|Overall Study|Protocol Violation|2|||
49130205|NCT01047319|158315903|FG002|Overall Study|Protocol Violation|4|||
49130206|NCT01047319|158315901|FG000|Overall Study|Lack of Efficacy|4|||
49130207|NCT01047319|158315902|FG001|Overall Study|Lack of Efficacy|3|||
49130208|NCT01047319|158315903|FG002|Overall Study|Lack of Efficacy|3|||
49130209|NCT01047319|158315901|FG000|Overall Study|Death|5|||
48722648|NCT04776317|156834648|FG005|Overall Study|Withdrawal by Subject|0|||
48722649|NCT04776317|156834649|FG006|Overall Study|Withdrawal by Subject|0|||
49130210|NCT01047319|158315902|FG001|Overall Study|Death|1|||
49130211|NCT01047319|158315903|FG002|Overall Study|Death|5|||
49130212|NCT01047319|158315901|FG000|Overall Study|Pregnancy|13|||
49130213|NCT01047319|158315902|FG001|Overall Study|Pregnancy|8|||
49130214|NCT01047319|158315903|FG002|Overall Study|Pregnancy|8|||
49130215|NCT01047319|158315901|FG000|Overall Study|Physician Decision|12|||
49130216|NCT01047319|158315902|FG001|Overall Study|Physician Decision|9|||
49130217|NCT01047319|158315903|FG002|Overall Study|Physician Decision|10|||
49130218|NCT01047319|158315901|FG000|Overall Study|Lost to Follow-up|14|||
48722650|NCT04776317|156834650|FG007|Overall Study|Withdrawal by Subject|0|||
48722651|NCT04776317|156834651|FG008|Overall Study|Withdrawal by Subject|0|||
48722652|NCT04776317|156834652|FG009|Overall Study|Withdrawal by Subject|0|||
48722653|NCT04776317|156834653|FG010|Overall Study|Withdrawal by Subject|0|||
48722654|NCT04776317|156834654|FG011|Overall Study|Withdrawal by Subject|0|||
48722655|NCT04776317|156834655|FG012|Overall Study|Withdrawal by Subject|0|||
48722656|NCT04776317|156834656|FG013|Overall Study|Withdrawal by Subject|0|||
48722657|NCT04776317|156834657|FG014|Overall Study|Withdrawal by Subject|0|||
48722658|NCT04858451|156834658|FG000|Part 0 (Protocol Version 3.0)|Discontinued|4|||
48722659|NCT04858451|156834659|FG001|Part 0 (Protocol Version 3.0)|Discontinued|0|||
48722660|NCT04858451|156834660|FG002|Part 0 (Protocol Version 3.0)|Discontinued|0|||
48722661|NCT04858451|156834661|FG003|Part 0 (Protocol Version 3.0)|Discontinued|0|||
48722662|NCT04858451|156834662|FG004|Part 0 (Protocol Version 3.0)|Discontinued|0|||
48722663|NCT04858451|156834663|FG005|Part 0 (Protocol Version 3.0)|Discontinued|0|||
49130219|NCT01047319|158315902|FG001|Overall Study|Lost to Follow-up|10|||
49130220|NCT01047319|158315903|FG002|Overall Study|Lost to Follow-up|10|||
49130221|NCT01047319|158315901|FG000|Overall Study|Adverse Event|16|||
49130222|NCT01047319|158315902|FG001|Overall Study|Adverse Event|27|||
49130223|NCT01047319|158315903|FG002|Overall Study|Adverse Event|21|||
49130224|NCT01047319|158315901|FG000|Overall Study|Withdrawal by Subject|77|||
49130225|NCT01047319|158315902|FG001|Overall Study|Withdrawal by Subject|75|||
49130226|NCT01047319|158315903|FG002|Overall Study|Withdrawal by Subject|87|||
49130227|NCT01047319|158315901|FG000|Overall Study|Study terminated by Sponsor|198|||
48817348|NCT01167179|157175140|FG001|Overall Study|diverse|5|||
48817349|NCT00663117|157175141|FG000|Overall Study|Lack of Efficacy|1|||
48817350|NCT00663117|157175142|FG001|Overall Study|Lack of Efficacy|0|||
48817351|NCT02781506|157175143|FG000|Overall Study|Adverse Event|5|||
48817352|NCT01158378|157175144|FG000|Overall Study|Death|4|||
48817353|NCT01158378|157175145|FG001|Overall Study|Death|5|||
48817354|NCT01158378|157175144|FG000|Overall Study|Lost to Follow-up|2|||
49130228|NCT01047319|158315902|FG001|Overall Study|Study terminated by Sponsor|215|||
49130229|NCT01047319|158315903|FG002|Overall Study|Study terminated by Sponsor|203|||
49130230|NCT03573297|158315909|FG000|Open Label Treatment Period|Adverse Event|67|||
49130231|NCT03573297|158315910|FG001|Open Label Treatment Period|Adverse Event|0|||
48817355|NCT01158378|157175145|FG001|Overall Study|Lost to Follow-up|4|||
48817356|NCT01158378|157175144|FG000|Overall Study|Withdrawal by Subject|4|||
48817357|NCT01158378|157175145|FG001|Overall Study|Withdrawal by Subject|0|||
48817358|NCT00311155|157175146|FG000|Overall Study|Adverse Event|21|||
48817359|NCT00311155|157175146|FG000|Overall Study|Withdrawal by Subject|17|||
48817360|NCT00311155|157175146|FG000|Overall Study|Did not meet entry criteria|55|||
48817361|NCT00445601|157175147|FG000|Overall Study|Withdrawal by Subject|11|||
48817362|NCT00445601|157175148|FG001|Overall Study|Withdrawal by Subject|11|||
48817363|NCT00445601|157175147|FG000|Overall Study|TURBT Complication|12|||
48817364|NCT00445601|157175148|FG001|Overall Study|TURBT Complication|8|||
48817365|NCT00445601|157175147|FG000|Overall Study|Incorrect Disease Status|6|||
48817366|NCT00445601|157175148|FG001|Overall Study|Incorrect Disease Status|6|||
48817367|NCT00445601|157175147|FG000|Overall Study|Drug Delivery Issue|2|||
48817368|NCT00445601|157175148|FG001|Overall Study|Drug Delivery Issue|2|||
48817369|NCT00445601|157175147|FG000|Overall Study|Adverse Event|2|||
48817370|NCT00445601|157175148|FG001|Overall Study|Adverse Event|0|||
49130232|NCT03573297|158315911|FG002|Open Label Treatment Period|Adverse Event|0|||
49130233|NCT03573297|158315912|FG003|Open Label Treatment Period|Adverse Event|0|||
49130234|NCT03573297|158315909|FG000|Open Label Treatment Period|Lack of Efficacy|35|||
49130235|NCT03573297|158315910|FG001|Open Label Treatment Period|Lack of Efficacy|0|||
49130236|NCT03573297|158315911|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
49130237|NCT03573297|158315912|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
49130238|NCT03573297|158315909|FG000|Open Label Treatment Period|Withdrawal by Subject|104|||
49130239|NCT03573297|158315910|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
49130240|NCT03573297|158315911|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
49130241|NCT03573297|158315912|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
49130242|NCT03573297|158315909|FG000|Open Label Treatment Period|Lost to Follow-up|55|||
49130243|NCT03573297|158315910|FG001|Open Label Treatment Period|Lost to Follow-up|0|||
48722664|NCT04858451|156834664|FG006|Part 0 (Protocol Version 3.0)|Discontinued|0|||
48722665|NCT04858451|156834665|FG007|Part 0 (Protocol Version 3.0)|Discontinued|0|||
48722666|NCT04858451|156834666|FG008|Part 0 (Protocol Version 3.0)|Discontinued|0|||
48722667|NCT04858451|156834658|FG000|Part 2|Discontinued|0|||
48722668|NCT04858451|156834659|FG001|Part 2|Discontinued|0|||
48722669|NCT04858451|156834660|FG002|Part 2|Discontinued|0|||
48722670|NCT04858451|156834661|FG003|Part 2|Discontinued|0|||
48722671|NCT04858451|156834662|FG004|Part 2|Discontinued|0|||
48722672|NCT04858451|156834663|FG005|Part 2|Discontinued|0|||
48722673|NCT04858451|156834664|FG006|Part 2|Discontinued|0|||
48722674|NCT04858451|156834665|FG007|Part 2|Discontinued|0|||
48722675|NCT04858451|156834666|FG008|Part 2|Discontinued|63|||
48722676|NCT04992520|156834667|FG000|Part A: First Challenge|Withdrawal by Subject|1|||
48722677|NCT04992520|156834668|FG001|Part A: First Challenge|Withdrawal by Subject|0|||
48722678|NCT04992520|156834669|FG002|Part A: First Challenge|Withdrawal by Subject|0|||
48722679|NCT04992520|156834670|FG003|Part A: First Challenge|Withdrawal by Subject|1|||
48722680|NCT04992520|156834671|FG004|Part A: First Challenge|Withdrawal by Subject|0|||
48722681|NCT04992520|156834672|FG005|Part A: First Challenge|Withdrawal by Subject|0|||
48722682|NCT04992520|156834667|FG000|Part A: First Challenge|Non-compliance|0|||
48722683|NCT04992520|156834668|FG001|Part A: First Challenge|Non-compliance|0|||
48722684|NCT04992520|156834669|FG002|Part A: First Challenge|Non-compliance|0|||
48722685|NCT04992520|156834670|FG003|Part A: First Challenge|Non-compliance|1|||
48722686|NCT04992520|156834671|FG004|Part A: First Challenge|Non-compliance|0|||
48722687|NCT04992520|156834672|FG005|Part A: First Challenge|Non-compliance|0|||
48722688|NCT04992520|156834667|FG000|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
48722689|NCT04992520|156834668|FG001|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
48722690|NCT04992520|156834669|FG002|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
48722691|NCT04992520|156834670|FG003|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
48722692|NCT04992520|156834671|FG004|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
48722693|NCT04992520|156834672|FG005|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
48722694|NCT04992520|156834667|FG000|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
48722695|NCT04992520|156834668|FG001|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
48722696|NCT04992520|156834669|FG002|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|1|||
48722697|NCT04992520|156834670|FG003|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
48722698|NCT04992520|156834671|FG004|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
48722699|NCT04992520|156834672|FG005|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
48722700|NCT01146860|156834673|FG000|Overall Study|Withdrawal by Subject|0|||
48722701|NCT01146860|156834674|FG001|Overall Study|Withdrawal by Subject|1|||
48722702|NCT00718237|156834676|FG000|Overall Study|Adverse Event|1|||
48722703|NCT00718237|156834677|FG001|Overall Study|Adverse Event|3|||
48722704|NCT00718237|156834676|FG000|Overall Study|Lost to Follow-up|2|||
48722705|NCT00718237|156834677|FG001|Overall Study|Lost to Follow-up|2|||
48817371|NCT00445601|157175147|FG000|Overall Study|Death prior to TURBT|0|||
49130244|NCT03573297|158315911|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
49130245|NCT03573297|158315912|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
49130246|NCT03573297|158315909|FG000|Open Label Treatment Period|Pregnancy|1|||
49130247|NCT03573297|158315910|FG001|Open Label Treatment Period|Pregnancy|0|||
48722706|NCT00718237|156834676|FG000|Overall Study|Physician Decision|1|||
48722707|NCT00718237|156834677|FG001|Overall Study|Physician Decision|0|||
48722708|NCT00718237|156834676|FG000|Overall Study|Withdrawal by Subject|9|||
48722709|NCT00718237|156834677|FG001|Overall Study|Withdrawal by Subject|10|||
48722710|NCT03761797|156834678|FG000|Overall Study|Changing hospital|11|||
48722711|NCT03761797|156834678|FG000|Overall Study|Improvement/remission|6|||
48722712|NCT03761797|156834678|FG000|Overall Study|Withdrawal by Subject|19|||
48722713|NCT03761797|156834678|FG000|Overall Study|Lost to Follow-up|33|||
48722714|NCT03761797|156834678|FG000|Overall Study|Adverse Event|37|||
48722715|NCT03761797|156834678|FG000|Overall Study|Case report form (CRF) not collected|5|||
48722716|NCT03761797|156834678|FG000|Overall Study|No patient visit after entry|13|||
48722717|NCT03761797|156834678|FG000|Overall Study|Switch to other diabetes medication|10|||
48722718|NCT03761797|156834678|FG000|Overall Study|Prevention for recurrence of cystitis|1|||
48722719|NCT03761797|156834678|FG000|Overall Study|Postoperative therapy of esophageal cancer|1|||
48722720|NCT03761797|156834678|FG000|Overall Study|Insufficient effectives|2|||
48722721|NCT03761797|156834678|FG000|Overall Study|Excessive alcohol intake|1|||
48722722|NCT02694718|156834679|FG000|Overall Study|Death|1|||
48722723|NCT02694718|156834679|FG000|Overall Study|Withdrawal by Subject|1|||
48722724|NCT03785964|156834682|FG000|Overall Study|Adverse Event|14|||
48722725|NCT03785964|156834683|FG001|Overall Study|Adverse Event|1|||
48722726|NCT03785964|156834682|FG000|Overall Study|Unqualified Clinical Progression|1|||
48722727|NCT03785964|156834683|FG001|Overall Study|Unqualified Clinical Progression|1|||
48722728|NCT03785964|156834682|FG000|Overall Study|Participant non-compliance|1|||
48722729|NCT03785964|156834683|FG001|Overall Study|Participant non-compliance|1|||
48722730|NCT03785964|156834682|FG000|Overall Study|Not treated|1|||
48722731|NCT03785964|156834683|FG001|Overall Study|Not treated|0|||
48722732|NCT03785964|156834682|FG000|Overall Study|Other reason|5|||
48722733|NCT03785964|156834683|FG001|Overall Study|Other reason|11|||
48722734|NCT03785964|156834682|FG000|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|36|||
48722735|NCT03785964|156834683|FG001|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|23|||
48722736|NCT02055365|156836484|FG000|Overall Study|Prematurely Withdrawn|1|||
48722737|NCT00576420|156836485|FG000|Overall Study|Death|0|||
48722738|NCT00576420|156836486|FG001|Overall Study|Death|0|||
48722739|NCT00576420|156836487|FG002|Overall Study|Death|1|||
48722740|NCT01347580|156836493|FG000|Overall Study|Withdrawal by Subject|13|||
48722741|NCT01347580|156836494|FG001|Overall Study|Withdrawal by Subject|23|||
48722742|NCT01347580|156836493|FG000|Overall Study|Death|30|||
48722743|NCT01347580|156836494|FG001|Overall Study|Death|19|||
48722744|NCT01347580|156836493|FG000|Overall Study|Protocol Violation|10|||
48722745|NCT01347580|156836494|FG001|Overall Study|Protocol Violation|7|||
48722746|NCT01347580|156836493|FG000|Overall Study|Lost to Follow-up|3|||
48722747|NCT01347580|156836494|FG001|Overall Study|Lost to Follow-up|1|||
48722748|NCT01347580|156836493|FG000|Overall Study|Had other reason|9|||
48722749|NCT01347580|156836494|FG001|Overall Study|Had other reason|6|||
48722750|NCT02054481|156836495|FG000|Overall Study|Adverse Event|1|||
48722751|NCT02054481|156836496|FG001|Overall Study|Adverse Event|1|||
48722752|NCT02054481|156836497|FG002|Overall Study|Adverse Event|0|||
48722753|NCT02054481|156836498|FG003|Overall Study|Adverse Event|1|||
48722754|NCT02054481|156836495|FG000|Overall Study|Lost to Follow-up|1|||
48722755|NCT02054481|156836496|FG001|Overall Study|Lost to Follow-up|0|||
48722756|NCT02054481|156836497|FG002|Overall Study|Lost to Follow-up|0|||
48722757|NCT02054481|156836498|FG003|Overall Study|Lost to Follow-up|0|||
48722758|NCT02054481|156836495|FG000|Overall Study|Other reason|2|||
48722759|NCT02054481|156836496|FG001|Overall Study|Other reason|1|||
48722760|NCT02054481|156836497|FG002|Overall Study|Other reason|2|||
48722761|NCT02054481|156836498|FG003|Overall Study|Other reason|0|||
48722762|NCT01842633|156836501|FG000|Overall Study|Screen Failure|1|||
48722763|NCT01842633|156836502|FG001|Overall Study|Screen Failure|0|||
48722764|NCT01842633|156836503|FG002|Overall Study|Screen Failure|0|||
48722765|NCT01842633|156836501|FG000|Overall Study|Adverse Event|1|||
48722766|NCT01842633|156836502|FG001|Overall Study|Adverse Event|1|||
48722767|NCT01842633|156836503|FG002|Overall Study|Adverse Event|0|||
48722768|NCT01842633|156836501|FG000|Overall Study|Withdrawal by Subject|0|||
48722769|NCT01842633|156836502|FG001|Overall Study|Withdrawal by Subject|1|||
48722770|NCT01842633|156836503|FG002|Overall Study|Withdrawal by Subject|0|||
48722771|NCT01842633|156836501|FG000|Overall Study|Technical issues|1|||
48722772|NCT01842633|156836502|FG001|Overall Study|Technical issues|0|||
48722773|NCT01842633|156836503|FG002|Overall Study|Technical issues|0|||
48722774|NCT01547780|156836506|FG000|Baseline PET Scan|Physician Decision|1|||
48722775|NCT01547780|156836507|FG001|Baseline PET Scan|Physician Decision|0|||
48722776|NCT01547780|156836508|FG002|Baseline PET Scan|Physician Decision|1|||
48722777|NCT01547780|156836509|FG003|Baseline PET Scan|Physician Decision|0|||
48722778|NCT01547780|156836506|FG000|Baseline PET Scan|Withdrawal by Subject|2|||
48817372|NCT00445601|157175148|FG001|Overall Study|Death prior to TURBT|1|||
48817373|NCT01340482|157175149|FG000|Overall Study|Adverse Event|2|||
48817374|NCT01340482|157175150|FG001|Overall Study|Adverse Event|0|||
48817375|NCT01340482|157175151|FG002|Overall Study|Adverse Event|0|||
48817376|NCT01091428|157175158|FG000|Phase 1|Progressive Disease|24|||
48817377|NCT01091428|157175159|FG001|Phase 1|Progressive Disease|8|||
48817378|NCT01091428|157175160|FG002|Phase 1|Progressive Disease|0|||
48817379|NCT01091428|157175161|FG003|Phase 1|Progressive Disease|0|||
48817380|NCT01091428|157175158|FG000|Phase 1|Symptomatic Deterioration|3|||
48817381|NCT01091428|157175159|FG001|Phase 1|Symptomatic Deterioration|2|||
48817382|NCT01091428|157175160|FG002|Phase 1|Symptomatic Deterioration|0|||
48817383|NCT01091428|157175161|FG003|Phase 1|Symptomatic Deterioration|0|||
48817384|NCT01091428|157175158|FG000|Phase 1|Adverse Event|2|||
48817385|NCT01091428|157175159|FG001|Phase 1|Adverse Event|0|||
48817386|NCT01091428|157175160|FG002|Phase 1|Adverse Event|0|||
48817387|NCT01091428|157175161|FG003|Phase 1|Adverse Event|0|||
48817388|NCT01091428|157175158|FG000|Phase 1|Withdrawal by Subject|7|||
48817389|NCT01091428|157175159|FG001|Phase 1|Withdrawal by Subject|0|||
48817390|NCT01091428|157175160|FG002|Phase 1|Withdrawal by Subject|0|||
48817391|NCT01091428|157175161|FG003|Phase 1|Withdrawal by Subject|0|||
48817392|NCT01091428|157175158|FG000|Phase 1|Reason not specified|0|||
48817393|NCT01091428|157175159|FG001|Phase 1|Reason not specified|1|||
48817394|NCT01091428|157175160|FG002|Phase 1|Reason not specified|0|||
48817395|NCT01091428|157175161|FG003|Phase 1|Reason not specified|0|||
48817396|NCT01091428|157175158|FG000|Phase 1|Single-Patient IND|2|||
48817397|NCT01091428|157175159|FG001|Phase 1|Single-Patient IND|0|||
48817398|NCT01091428|157175160|FG002|Phase 1|Single-Patient IND|0|||
48817399|NCT01091428|157175161|FG003|Phase 1|Single-Patient IND|0|||
48817400|NCT01091428|157175158|FG000|Phase 2|Progressive Disease|0|||
48817401|NCT01091428|157175159|FG001|Phase 2|Progressive Disease|0|||
48817402|NCT01091428|157175160|FG002|Phase 2|Progressive Disease|44|||
48817403|NCT01091428|157175161|FG003|Phase 2|Progressive Disease|46|||
49130248|NCT03573297|158315911|FG002|Open Label Treatment Period|Pregnancy|0|||
49130249|NCT03573297|158315912|FG003|Open Label Treatment Period|Pregnancy|0|||
49130250|NCT03573297|158315909|FG000|Open Label Treatment Period|Protocol Violation|17|||
49130251|NCT03573297|158315910|FG001|Open Label Treatment Period|Protocol Violation|0|||
49130252|NCT03573297|158315911|FG002|Open Label Treatment Period|Protocol Violation|0|||
49130253|NCT03573297|158315912|FG003|Open Label Treatment Period|Protocol Violation|0|||
48817404|NCT01091428|157175158|FG000|Phase 2|Symptomatic Deterioration|0|||
48817405|NCT01091428|157175159|FG001|Phase 2|Symptomatic Deterioration|0|||
48817406|NCT01091428|157175160|FG002|Phase 2|Symptomatic Deterioration|1|||
48817407|NCT01091428|157175161|FG003|Phase 2|Symptomatic Deterioration|6|||
48817408|NCT01091428|157175158|FG000|Phase 2|Adverse Event|0|||
48817409|NCT01091428|157175159|FG001|Phase 2|Adverse Event|0|||
48817410|NCT01091428|157175160|FG002|Phase 2|Adverse Event|12|||
48817411|NCT01091428|157175161|FG003|Phase 2|Adverse Event|5|||
48817412|NCT01091428|157175158|FG000|Phase 2|Withdrawal by Subject|0|||
48817413|NCT01091428|157175159|FG001|Phase 2|Withdrawal by Subject|0|||
48817414|NCT01091428|157175160|FG002|Phase 2|Withdrawal by Subject|9|||
48817415|NCT01091428|157175161|FG003|Phase 2|Withdrawal by Subject|8|||
48817416|NCT01091428|157175158|FG000|Phase 2|Unsatisfactory Therapeutic Response|0|||
48817417|NCT01091428|157175159|FG001|Phase 2|Unsatisfactory Therapeutic Response|0|||
48817418|NCT01091428|157175160|FG002|Phase 2|Unsatisfactory Therapeutic Response|1|||
48817419|NCT01091428|157175161|FG003|Phase 2|Unsatisfactory Therapeutic Response|1|||
48817420|NCT01091428|157175158|FG000|Phase 2|Reason not specified|0|||
48817421|NCT01091428|157175159|FG001|Phase 2|Reason not specified|0|||
48817422|NCT01091428|157175160|FG002|Phase 2|Reason not specified|4|||
48817423|NCT01091428|157175161|FG003|Phase 2|Reason not specified|3|||
48817424|NCT01091428|157175158|FG000|Phase 2|Physician Decision|0|||
48817425|NCT01091428|157175159|FG001|Phase 2|Physician Decision|0|||
48817426|NCT01091428|157175160|FG002|Phase 2|Physician Decision|2|||
48817427|NCT01091428|157175161|FG003|Phase 2|Physician Decision|0|||
48817428|NCT01282476|157175162|FG000|Overall Study|Death|11|||
48817429|NCT00437125|157175168|FG000|Overall Study|Adverse Event|12|||
49130254|NCT03573297|158315909|FG000|Open Label Treatment Period|Non-Compliance With Study Drug|25|||
48817430|NCT00437125|157175168|FG000|Overall Study|Death|1|||
48817431|NCT00437125|157175168|FG000|Overall Study|Clinical Relapse|1|||
48817432|NCT00437125|157175168|FG000|Overall Study|Lack of Efficacy|1|||
48817433|NCT00437125|157175168|FG000|Overall Study|Lost to Follow-up|1|||
48817434|NCT00437125|157175168|FG000|Overall Study|Withdrawal by Subject|13|||
49130255|NCT03573297|158315910|FG001|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
48817435|NCT00437125|157175168|FG000|Overall Study|Withdrawal by Caregiver|2|||
48817436|NCT00437125|157175168|FG000|Overall Study|Physician Decision|1|||
49130256|NCT03573297|158315911|FG002|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
48817437|NCT03204695|157175169|FG000|Overall Study|Death|1|||
48817438|NCT03204695|157175169|FG000|Overall Study|Participant was treated with another device|1|||
48817439|NCT03204695|157175169|FG000|Overall Study|Physician Decision|2|||
49130257|NCT03573297|158315912|FG003|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
49130258|NCT03573297|158315909|FG000|Open Label Treatment Period|Study Terminated by Sponsor|2|||
49130259|NCT03573297|158315910|FG001|Open Label Treatment Period|Study Terminated by Sponsor|0|||
49130260|NCT03573297|158315911|FG002|Open Label Treatment Period|Study Terminated by Sponsor|0|||
49130261|NCT03573297|158315912|FG003|Open Label Treatment Period|Study Terminated by Sponsor|0|||
49130262|NCT03573297|158315909|FG000|Open Label Treatment Period|Failure to Meet Randomization Criteria|143|||
49130263|NCT03573297|158315910|FG001|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
49130264|NCT03573297|158315911|FG002|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
49130265|NCT03573297|158315912|FG003|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
49130266|NCT03573297|158315909|FG000|Open Label Treatment Period|Other, Not Specified|7|||
49130267|NCT03573297|158315910|FG001|Open Label Treatment Period|Other, Not Specified|0|||
49130268|NCT03573297|158315911|FG002|Open Label Treatment Period|Other, Not Specified|0|||
49130269|NCT03573297|158315912|FG003|Open Label Treatment Period|Other, Not Specified|0|||
49130270|NCT03573297|158315909|FG000|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|0|||
49130271|NCT03573297|158315910|FG001|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|29|||
49130272|NCT03573297|158315911|FG002|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|25|||
49130273|NCT03573297|158315912|FG003|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|26|||
49130274|NCT03573297|158315909|FG000|Double-Blind Treatment Period|Adverse Event|0|||
49130275|NCT03573297|158315910|FG001|Double-Blind Treatment Period|Adverse Event|1|||
49130276|NCT03573297|158315911|FG002|Double-Blind Treatment Period|Adverse Event|5|||
49130277|NCT03573297|158315912|FG003|Double-Blind Treatment Period|Adverse Event|1|||
49130278|NCT03573297|158315909|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
49130279|NCT03573297|158315910|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
49130280|NCT03573297|158315911|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
49130281|NCT03573297|158315912|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
49130282|NCT03573297|158315909|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
49130283|NCT03573297|158315910|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
49130284|NCT03573297|158315911|FG002|Double-Blind Treatment Period|Withdrawal by Subject|11|||
49130285|NCT03573297|158315912|FG003|Double-Blind Treatment Period|Withdrawal by Subject|14|||
49130286|NCT03573297|158315909|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
49130287|NCT03573297|158315910|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
49130288|NCT03573297|158315911|FG002|Double-Blind Treatment Period|Lost to Follow-up|4|||
49130289|NCT03573297|158315912|FG003|Double-Blind Treatment Period|Lost to Follow-up|9|||
49130290|NCT03573297|158315909|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
49130291|NCT03573297|158315910|FG001|Double-Blind Treatment Period|Protocol Violation|3|||
49130292|NCT03573297|158315911|FG002|Double-Blind Treatment Period|Protocol Violation|8|||
49130293|NCT03573297|158315912|FG003|Double-Blind Treatment Period|Protocol Violation|4|||
49130294|NCT03573297|158315909|FG000|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
48722779|NCT01547780|156836507|FG001|Baseline PET Scan|Withdrawal by Subject|0|||
48722780|NCT01547780|156836508|FG002|Baseline PET Scan|Withdrawal by Subject|1|||
48722781|NCT01547780|156836509|FG003|Baseline PET Scan|Withdrawal by Subject|0|||
48722782|NCT00895011|156836510|FG000|Overall Study|Withdrawal by Subject|14|||
48722783|NCT00895011|156836511|FG001|Overall Study|Withdrawal by Subject|7|||
48722784|NCT00895011|156836512|FG002|Overall Study|Withdrawal by Subject|2|||
48722785|NCT00895011|156836510|FG000|Overall Study|Lost to Follow-up|5|||
48722786|NCT00895011|156836511|FG001|Overall Study|Lost to Follow-up|4|||
48722787|NCT00895011|156836512|FG002|Overall Study|Lost to Follow-up|1|||
48722788|NCT00895011|156836510|FG000|Overall Study|Protocol Violation|3|||
48722789|NCT00895011|156836511|FG001|Overall Study|Protocol Violation|1|||
48722790|NCT00895011|156836512|FG002|Overall Study|Protocol Violation|3|||
48722791|NCT00895011|156836510|FG000|Overall Study|Adverse Event|1|||
48722792|NCT00895011|156836511|FG001|Overall Study|Adverse Event|2|||
48722793|NCT00895011|156836512|FG002|Overall Study|Adverse Event|2|||
48722794|NCT00895011|156836510|FG000|Overall Study|schedule conflict|1|||
48722795|NCT00895011|156836511|FG001|Overall Study|schedule conflict|0|||
48722796|NCT00895011|156836512|FG002|Overall Study|schedule conflict|0|||
48722797|NCT00959374|156836513|FG000|Overall Study|Withdrawal by Subject|2|||
48722798|NCT00959374|156836513|FG000|Overall Study|Lost to Follow-up|14|||
48722799|NCT00959374|156836513|FG000|Overall Study|Death|1|||
48722800|NCT00959374|156836513|FG000|Overall Study|Protocol Violation|1|||
48722801|NCT00959374|156836513|FG000|Overall Study|Implant Removed/Not Replaced|4|||
48722802|NCT00959374|156836513|FG000|Overall Study|Physician Decision|1|||
48722803|NCT01397825|156836515|FG000|Overall Study|Progressive Disease|10|||
48722804|NCT01397825|156836516|FG001|Overall Study|Progressive Disease|3|||
48722805|NCT01397825|156836517|FG002|Overall Study|Progressive Disease|11|||
48722806|NCT01397825|156836518|FG003|Overall Study|Progressive Disease|1|||
48722807|NCT01397825|156836519|FG004|Overall Study|Progressive Disease|0|||
48722808|NCT01397825|156836515|FG000|Overall Study|Symptomatic Deterioration|2|||
48722809|NCT01397825|156836516|FG001|Overall Study|Symptomatic Deterioration|0|||
48722810|NCT01397825|156836517|FG002|Overall Study|Symptomatic Deterioration|4|||
49130295|NCT03573297|158315910|FG001|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
49130296|NCT03573297|158315911|FG002|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
49130297|NCT03573297|158315912|FG003|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
49130298|NCT03573297|158315909|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
49130299|NCT03573297|158315910|FG001|Double-Blind Treatment Period|Other, Not Specified|5|||
49130300|NCT03573297|158315911|FG002|Double-Blind Treatment Period|Other, Not Specified|8|||
49130301|NCT03573297|158315912|FG003|Double-Blind Treatment Period|Other, Not Specified|6|||
49130302|NCT01094288|158318379|FG000|Overall Study|Adverse Event|0|||
49130303|NCT01094288|158318380|FG001|Overall Study|Adverse Event|3|||
49130304|NCT01094288|158318381|FG002|Overall Study|Adverse Event|1|||
49130305|NCT01094288|158318382|FG003|Overall Study|Adverse Event|1|||
49130306|NCT01094288|158318383|FG004|Overall Study|Adverse Event|0|||
49130307|NCT01094288|158318384|FG005|Overall Study|Adverse Event|0|||
49130308|NCT01094288|158318385|FG006|Overall Study|Adverse Event|0|||
49130309|NCT01094288|158318386|FG007|Overall Study|Adverse Event|0|||
49130310|NCT01094288|158318379|FG000|Overall Study|Withdrawal by Subject|0|||
49130311|NCT01094288|158318380|FG001|Overall Study|Withdrawal by Subject|1|||
49130312|NCT01094288|158318381|FG002|Overall Study|Withdrawal by Subject|2|||
49130313|NCT01094288|158318382|FG003|Overall Study|Withdrawal by Subject|0|||
49130314|NCT01094288|158318383|FG004|Overall Study|Withdrawal by Subject|0|||
49130315|NCT01094288|158318384|FG005|Overall Study|Withdrawal by Subject|0|||
49130316|NCT01094288|158318385|FG006|Overall Study|Withdrawal by Subject|0|||
49130317|NCT01094288|158318386|FG007|Overall Study|Withdrawal by Subject|2|||
49130318|NCT01094288|158318379|FG000|Overall Study|Initiation of Alternative Therapy|0|||
49130319|NCT01094288|158318380|FG001|Overall Study|Initiation of Alternative Therapy|0|||
49130320|NCT01094288|158318381|FG002|Overall Study|Initiation of Alternative Therapy|1|||
49130321|NCT01094288|158318382|FG003|Overall Study|Initiation of Alternative Therapy|0|||
49130322|NCT01094288|158318383|FG004|Overall Study|Initiation of Alternative Therapy|0|||
49130323|NCT01094288|158318384|FG005|Overall Study|Initiation of Alternative Therapy|0|||
49130324|NCT01094288|158318385|FG006|Overall Study|Initiation of Alternative Therapy|0|||
49130325|NCT01094288|158318386|FG007|Overall Study|Initiation of Alternative Therapy|0|||
49011144|NCT00481247|157877399|FG001|Overall Study|Lost to Follow-up|2|||
49130326|NCT01094288|158318379|FG000|Overall Study|Reason not Specified|2|||
49130327|NCT01094288|158318380|FG001|Overall Study|Reason not Specified|3|||
49130328|NCT01094288|158318381|FG002|Overall Study|Reason not Specified|0|||
49130329|NCT01094288|158318382|FG003|Overall Study|Reason not Specified|1|||
49130330|NCT01094288|158318383|FG004|Overall Study|Reason not Specified|0|||
49130331|NCT01094288|158318384|FG005|Overall Study|Reason not Specified|0|||
49130332|NCT01094288|158318385|FG006|Overall Study|Reason not Specified|0|||
49130333|NCT01094288|158318386|FG007|Overall Study|Reason not Specified|0|||
49130334|NCT01094288|158318379|FG000|Overall Study|Ongoing Participants|0|||
49130335|NCT01094288|158318380|FG001|Overall Study|Ongoing Participants|3|||
49130336|NCT01094288|158318381|FG002|Overall Study|Ongoing Participants|0|||
49130337|NCT01094288|158318382|FG003|Overall Study|Ongoing Participants|0|||
49130338|NCT01094288|158318383|FG004|Overall Study|Ongoing Participants|0|||
49130339|NCT01094288|158318384|FG005|Overall Study|Ongoing Participants|0|||
49130340|NCT01094288|158318385|FG006|Overall Study|Ongoing Participants|0|||
49130341|NCT01094288|158318386|FG007|Overall Study|Ongoing Participants|0|||
49130342|NCT01389232|158318387|FG000|Overall Study|Had scaffold removed|15|||
49130343|NCT01389232|158318387|FG000|Overall Study|Personal reasons|2|||
48722811|NCT01397825|156836518|FG003|Overall Study|Symptomatic Deterioration|0|||
48722812|NCT01397825|156836519|FG004|Overall Study|Symptomatic Deterioration|0|||
48722813|NCT01397825|156836515|FG000|Overall Study|Adverse Event|0|||
48722814|NCT01397825|156836516|FG001|Overall Study|Adverse Event|1|||
48722815|NCT01397825|156836517|FG002|Overall Study|Adverse Event|5|||
48722816|NCT01397825|156836518|FG003|Overall Study|Adverse Event|1|||
48722817|NCT01397825|156836519|FG004|Overall Study|Adverse Event|0|||
48722818|NCT01397825|156836515|FG000|Overall Study|Withdrawal by Subject|1|||
48722819|NCT01397825|156836516|FG001|Overall Study|Withdrawal by Subject|0|||
48722820|NCT01397825|156836517|FG002|Overall Study|Withdrawal by Subject|5|||
48722821|NCT01397825|156836518|FG003|Overall Study|Withdrawal by Subject|1|||
48722822|NCT01397825|156836519|FG004|Overall Study|Withdrawal by Subject|0|||
48722823|NCT03332017|156836523|FG000|Overall Study|Lost to Follow-up|1|||
48722824|NCT03332017|156836524|FG001|Overall Study|Lost to Follow-up|2|||
48722825|NCT03332017|156836523|FG000|Overall Study|Death|17|||
48722826|NCT03332017|156836524|FG001|Overall Study|Death|16|||
48722827|NCT03332017|156836523|FG000|Overall Study|Withdrawal by Subject|6|||
48722828|NCT03332017|156836524|FG001|Overall Study|Withdrawal by Subject|14|||
48722829|NCT03332017|156836523|FG000|Overall Study|Other|1|||
48722830|NCT03332017|156836524|FG001|Overall Study|Other|3|||
48722831|NCT03332017|156836523|FG000|Overall Study|Remained in Study (Ongoing)|47|||
48722832|NCT03332017|156836524|FG001|Overall Study|Remained in Study (Ongoing)|110|||
48722833|NCT03436290|156836525|FG000|Overall Study|Post-randomization Exclusion|1|||
48817440|NCT03095599|157175172|FG000|Overall Study|Withdrawal by Subject|1|||
48817441|NCT03095599|157175173|FG001|Overall Study|Withdrawal by Subject|0|||
48817442|NCT03095599|157175172|FG000|Overall Study|Lost to Follow-up|1|||
48817443|NCT03095599|157175173|FG001|Overall Study|Lost to Follow-up|0|||
48817444|NCT03095599|157175172|FG000|Overall Study|Withdrawal prior to vaccination|1|||
48817445|NCT03095599|157175173|FG001|Overall Study|Withdrawal prior to vaccination|0|||
48817446|NCT02391038|157175174|FG000|Overall Study|Progressive disease|3|||
48817447|NCT02391038|157175175|FG001|Overall Study|Progressive disease|3|||
48722834|NCT03436290|156836526|FG001|Overall Study|Post-randomization Exclusion|0|||
48722835|NCT03436290|156836525|FG000|Overall Study|Death|6|||
48817448|NCT02391038|157175176|FG002|Overall Study|Progressive disease|6|||
48722836|NCT03436290|156836526|FG001|Overall Study|Death|0|||
48722837|NCT03436290|156836525|FG000|Overall Study|Withdrawal by Subject|4|||
48722838|NCT03436290|156836526|FG001|Overall Study|Withdrawal by Subject|0|||
48722839|NCT03436290|156836525|FG000|Overall Study|Protocol Violation|30|||
48722840|NCT03436290|156836526|FG001|Overall Study|Protocol Violation|0|||
48722841|NCT00159822|156836527|FG000|Voriconazole Treatment Period|Lack of Efficacy|3|||
48722842|NCT00159822|156836527|FG000|Voriconazole Treatment Period|Adverse Event|9|||
48722843|NCT00159822|156836527|FG000|Voriconazole Treatment Period|Death|4|||
48722844|NCT00159822|156836527|FG000|Voriconazole Treatment Period|Protocol Violation|2|||
48722845|NCT00159822|156836527|FG000|Voriconazole Treatment Period|Lost to Follow-up|2|||
48817449|NCT02959138|157175177|FG000|Overall Study|Enrolled but Never Treated|0|||
48817450|NCT02959138|157175178|FG001|Overall Study|Enrolled but Never Treated|1|||
48817451|NCT02959138|157175179|FG002|Overall Study|Enrolled but Never Treated|0|||
48817452|NCT02531295|157175180|FG000|Overall Study|The study was terminated (Halted Prematurely).|0|||
48817453|NCT02531295|157175181|FG001|Overall Study|The study was terminated (Halted Prematurely).|0|||
48817454|NCT02531295|157175182|FG002|Overall Study|The study was terminated (Halted Prematurely).|0|||
48817455|NCT02531295|157175183|FG003|Overall Study|The study was terminated (Halted Prematurely).|0|||
48817456|NCT02531295|157175184|FG004|Overall Study|The study was terminated (Halted Prematurely).|0|||
48817457|NCT02531295|157175185|FG005|Overall Study|The study was terminated (Halted Prematurely).|1|||
48817458|NCT01811563|157175186|FG000|Overall Study|Lost to Follow-up|5|||
48722846|NCT00159822|156836527|FG000|Voriconazole Treatment Period|Withdrawal by Subject|2|||
48722847|NCT00159822|156836527|FG000|Post-treatment Follow-up Period|Death|1|||
48722848|NCT00159822|156836527|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|1|||
48817459|NCT01811563|157175187|FG001|Overall Study|Lost to Follow-up|2|||
48817460|NCT01811563|157175186|FG000|Overall Study|Incorrect Randomization procedure|0|||
48817461|NCT01811563|157175187|FG001|Overall Study|Incorrect Randomization procedure|1|||
48817462|NCT01755689|157175188|FG000|Overall Study|Withdrawal by Subject|1|||
48817463|NCT01755689|157175189|FG001|Overall Study|Withdrawal by Subject|3|||
48920997|NCT00784654|157544818|FG000|Open-Label Period (Non-Randomized)|Protocol Violation|7|||
48722849|NCT00159822|156836527|FG000|Post-treatment Follow-up Period|Reason unspecified|1|||
48817464|NCT01755689|157175190|FG002|Overall Study|Withdrawal by Subject|2|||
48817465|NCT01755689|157175191|FG003|Overall Study|Withdrawal by Subject|1|||
48817466|NCT01755689|157175192|FG004|Overall Study|Withdrawal by Subject|1|||
48817467|NCT01755689|157175188|FG000|Overall Study|Migrated/moved from study area|0|||
48817468|NCT01755689|157175189|FG001|Overall Study|Migrated/moved from study area|1|||
49130344|NCT01389232|158318387|FG000|Overall Study|Adverse Event|1|||
48722850|NCT02677324|156836533|FG000|Overall Study|Disease Progression|6|||
48722851|NCT02677324|156836533|FG000|Overall Study|Inability to Swallow pills|1|||
48722852|NCT02677324|156836533|FG000|Overall Study|Non-compliance|1|||
48722853|NCT02677324|156836533|FG000|Overall Study|Lack of Efficacy|1|||
48722854|NCT02677324|156836533|FG000|Overall Study|Medical insurance coverage|1|||
48722855|NCT02677324|156836533|FG000|Overall Study|Adverse Event|1|||
48722856|NCT02677324|156836533|FG000|Overall Study|IgM Myeloma diagnosis|1|||
48722857|NCT05134233|156836534|FG000|Overall Study|Pregnancy|1|||
48722858|NCT05134233|156836534|FG000|Overall Study|MEP value too low|2|||
48722859|NCT05134233|156836534|FG000|Overall Study|Lost to Follow-up|1|||
48722860|NCT04761627|156836535|FG000|Run-in Period|Death|1|||
48722861|NCT04761627|156836536|FG001|Run-in Period|Death|0|||
48722862|NCT04761627|156836537|FG002|Run-in Period|Death|0|||
48722863|NCT04761627|156836535|FG000|Run-in Period|Required alternative therapy|2|||
48722864|NCT04761627|156836536|FG001|Run-in Period|Required alternative therapy|0|||
48722865|NCT04761627|156836537|FG002|Run-in Period|Required alternative therapy|0|||
48722866|NCT04761627|156836535|FG000|Run-in Period|Lost to Follow-up|2|||
48722867|NCT04761627|156836536|FG001|Run-in Period|Lost to Follow-up|0|||
48722868|NCT04761627|156836537|FG002|Run-in Period|Lost to Follow-up|0|||
48722869|NCT04761627|156836535|FG000|Run-in Period|Protocol Violation|3|||
48722870|NCT04761627|156836536|FG001|Run-in Period|Protocol Violation|0|||
48722871|NCT04761627|156836537|FG002|Run-in Period|Protocol Violation|0|||
48722872|NCT04761627|156836535|FG000|Run-in Period|Abnormal liver function|1|||
48722873|NCT04761627|156836536|FG001|Run-in Period|Abnormal liver function|0|||
48722874|NCT04761627|156836537|FG002|Run-in Period|Abnormal liver function|0|||
48722875|NCT04761627|156836535|FG000|Run-in Period|Adverse Event|6|||
48722876|NCT04761627|156836536|FG001|Run-in Period|Adverse Event|0|||
48722877|NCT04761627|156836537|FG002|Run-in Period|Adverse Event|0|||
48722878|NCT04761627|156836535|FG000|Run-in Period|Withdrawal by Subject|7|||
48722879|NCT04761627|156836536|FG001|Run-in Period|Withdrawal by Subject|0|||
48722880|NCT04761627|156836537|FG002|Run-in Period|Withdrawal by Subject|0|||
48722881|NCT04761627|156836535|FG000|Run-in Period|Did not meet PASI 50|15|||
48722882|NCT04761627|156836536|FG001|Run-in Period|Did not meet PASI 50|0|||
48722883|NCT04761627|156836537|FG002|Run-in Period|Did not meet PASI 50|0|||
48722884|NCT04761627|156836535|FG000|Run-in Period|Study site closure|2|||
48722885|NCT04761627|156836536|FG001|Run-in Period|Study site closure|0|||
48722886|NCT04761627|156836537|FG002|Run-in Period|Study site closure|0|||
48722887|NCT04761627|156836535|FG000|Run-in Period|Pregnancy|2|||
48722888|NCT04761627|156836536|FG001|Run-in Period|Pregnancy|0|||
48722889|NCT04761627|156836537|FG002|Run-in Period|Pregnancy|0|||
48722890|NCT04761627|156836535|FG000|Post-randomization Period|Military service|0|||
48722891|NCT04761627|156836536|FG001|Post-randomization Period|Military service|1|||
48722892|NCT04761627|156836537|FG002|Post-randomization Period|Military service|0|||
48722893|NCT04761627|156836535|FG000|Post-randomization Period|Adverse Event|0|||
48722894|NCT04761627|156836536|FG001|Post-randomization Period|Adverse Event|4|||
48722895|NCT04761627|156836537|FG002|Post-randomization Period|Adverse Event|2|||
48722896|NCT04761627|156836535|FG000|Post-randomization Period|Lost to Follow-up|0|||
48722897|NCT04761627|156836536|FG001|Post-randomization Period|Lost to Follow-up|6|||
48722898|NCT04761627|156836537|FG002|Post-randomization Period|Lost to Follow-up|6|||
48722899|NCT04761627|156836535|FG000|Post-randomization Period|Withdrawal by Subject|0|||
48722900|NCT04761627|156836536|FG001|Post-randomization Period|Withdrawal by Subject|7|||
48722901|NCT04761627|156836537|FG002|Post-randomization Period|Withdrawal by Subject|6|||
48722902|NCT04761627|156836535|FG000|Post-randomization Period|Pregnancy|0|||
48722903|NCT04761627|156836536|FG001|Post-randomization Period|Pregnancy|0|||
48722904|NCT04761627|156836537|FG002|Post-randomization Period|Pregnancy|1|||
48722905|NCT04761627|156836535|FG000|Post-randomization Period|Study site closure|0|||
48722906|NCT04761627|156836536|FG001|Post-randomization Period|Study site closure|0|||
48722907|NCT04761627|156836537|FG002|Post-randomization Period|Study site closure|1|||
48722908|NCT04761627|156836535|FG000|Post-randomization Period|Family planning|0|||
48722909|NCT04761627|156836536|FG001|Post-randomization Period|Family planning|1|||
48722910|NCT04761627|156836537|FG002|Post-randomization Period|Family planning|0|||
48722911|NCT00466687|156836540|FG000|Overall Study|Adverse Event|1|||
48722912|NCT00466687|156836540|FG000|Overall Study|Other complicating illness|3|||
48722913|NCT00466687|156836540|FG000|Overall Study|Withdrawal by Subject|1|||
48722914|NCT00466687|156836540|FG000|Overall Study|Disease progression|29|||
48722915|NCT00420641|156836543|FG000|Overall Study|Adverse Event|3|||
48722916|NCT00420641|156836544|FG001|Overall Study|Adverse Event|25|||
48722917|NCT00420641|156836545|FG002|Overall Study|Adverse Event|10|||
48722918|NCT00420641|156836543|FG000|Overall Study|Lost to Follow-up|2|||
48722919|NCT00420641|156836544|FG001|Overall Study|Lost to Follow-up|4|||
48722920|NCT00420641|156836545|FG002|Overall Study|Lost to Follow-up|2|||
48722921|NCT00420641|156836543|FG000|Overall Study|Protocol Violation|8|||
48722922|NCT00420641|156836544|FG001|Overall Study|Protocol Violation|8|||
48722923|NCT00420641|156836545|FG002|Overall Study|Protocol Violation|7|||
48722924|NCT00420641|156836543|FG000|Overall Study|Withdrawal by Subject|15|||
48722925|NCT00420641|156836544|FG001|Overall Study|Withdrawal by Subject|21|||
48722926|NCT00420641|156836545|FG002|Overall Study|Withdrawal by Subject|14|||
48722927|NCT00420641|156836543|FG000|Overall Study|Lack of Efficacy|6|||
48722928|NCT00420641|156836544|FG001|Overall Study|Lack of Efficacy|5|||
48722929|NCT00420641|156836545|FG002|Overall Study|Lack of Efficacy|4|||
48722930|NCT00420641|156836543|FG000|Overall Study|Non-compliance|7|||
48722931|NCT00420641|156836544|FG001|Overall Study|Non-compliance|5|||
49130345|NCT01389232|158318387|FG000|Overall Study|Death|1|||
48817469|NCT01755689|157175190|FG002|Overall Study|Migrated/moved from study area|1|||
49130346|NCT00945243|158318388|FG000|Overall Study|Study Terminated: Subjects Dispositioned|3|||
49130347|NCT03255187|158318389|FG000|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1|||
49130348|NCT03255187|158318390|FG001|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3|||
49130349|NCT03255187|158318389|FG000|Period From First to Second Follow-up|Withdrawal by Subject|0|||
49130350|NCT03255187|158318390|FG001|Period From First to Second Follow-up|Withdrawal by Subject|1|||
49130351|NCT03256578|158318391|FG000|Overall Study|Excluded Post Randomization|66|||
49130352|NCT03256578|158318392|FG001|Overall Study|Excluded Post Randomization|56|||
49130353|NCT04969289|158318393|FG000|Overall Study|Lost to Follow-up|13|||
49130354|NCT04969289|158318394|FG001|Overall Study|Lost to Follow-up|9|||
49130355|NCT02787304|158318395|FG000|Overall Study|Adverse Event|9|||
49130356|NCT02787304|158318396|FG001|Overall Study|Adverse Event|3|||
49130357|NCT02787304|158318397|FG002|Overall Study|Adverse Event|8|||
49130358|NCT02787304|158318398|FG003|Overall Study|Adverse Event|1|||
48722932|NCT00420641|156836545|FG002|Overall Study|Non-compliance|4|||
48722933|NCT00420641|156836543|FG000|Overall Study|Other|4|||
48722934|NCT00420641|156836544|FG001|Overall Study|Other|4|||
48722935|NCT00420641|156836545|FG002|Overall Study|Other|3|||
48722936|NCT00247611|156836546|FG000|Baselined|Completed baseline, never placed on ARVs|8|||
48722937|NCT00247611|156836547|FG001|Baselined|Completed baseline, never placed on ARVs|5|||
48722938|NCT00247611|156836546|FG000|Baselined|Completed baseline only|9|||
48722939|NCT00247611|156836547|FG001|Baselined|Completed baseline only|8|||
48722940|NCT01878149|156836551|FG000|Overall Study|Did Not Meet Eligibility Criteria|2|||
48722941|NCT01878149|156836552|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
48722942|NCT04672252|156836553|FG000|Overall Study|Protocol Violation|1|||
48722943|NCT04672252|156836554|FG001|Overall Study|Protocol Violation|0|||
48817470|NCT01755689|157175191|FG003|Overall Study|Migrated/moved from study area|1|||
48817471|NCT01755689|157175192|FG004|Overall Study|Migrated/moved from study area|1|||
48817472|NCT01755689|157175188|FG000|Overall Study|Lost to Follow-up|1|||
48817473|NCT01755689|157175189|FG001|Overall Study|Lost to Follow-up|0|||
48817474|NCT01755689|157175190|FG002|Overall Study|Lost to Follow-up|1|||
48817475|NCT01755689|157175191|FG003|Overall Study|Lost to Follow-up|0|||
48817476|NCT01755689|157175192|FG004|Overall Study|Lost to Follow-up|2|||
48722944|NCT01582854|156836555|FG000|Overall Study|Death|8|||
48722945|NCT01582854|156836556|FG001|Overall Study|Death|5|||
48722946|NCT01582854|156836555|FG000|Overall Study|Adverse Event|2|||
48817477|NCT01755689|157175188|FG000|Overall Study|Pregnancy|1|||
48817478|NCT01755689|157175189|FG001|Overall Study|Pregnancy|1|||
48817479|NCT01755689|157175190|FG002|Overall Study|Pregnancy|2|||
48722947|NCT01582854|156836556|FG001|Overall Study|Adverse Event|3|||
48722948|NCT01582854|156836555|FG000|Overall Study|Withdrawal by Participant|8|||
48722949|NCT01582854|156836556|FG001|Overall Study|Withdrawal by Participant|11|||
48722950|NCT01582854|156836555|FG000|Overall Study|Lost to Follow-up|1|||
48722951|NCT01582854|156836556|FG001|Overall Study|Lost to Follow-up|2|||
48722952|NCT01582854|156836555|FG000|Overall Study|Physician Decision|0|||
48722953|NCT01582854|156836556|FG001|Overall Study|Physician Decision|1|||
48722954|NCT01582854|156836555|FG000|Overall Study|Recurrent Stroke|13|||
48722955|NCT01582854|156836556|FG001|Overall Study|Recurrent Stroke|8|||
48722956|NCT01582854|156836555|FG000|Overall Study|Disallowed Concomitant Medication|3|||
48722957|NCT01582854|156836556|FG001|Overall Study|Disallowed Concomitant Medication|2|||
48722958|NCT01582854|156836555|FG000|Overall Study|Carotid or Neurosurgery|0|||
48722959|NCT01582854|156836556|FG001|Overall Study|Carotid or Neurosurgery|1|||
48722960|NCT01582854|156836555|FG000|Overall Study|General Anaesthesia|0|||
48817480|NCT01755689|157175191|FG003|Overall Study|Pregnancy|4|||
48817481|NCT01755689|157175192|FG004|Overall Study|Pregnancy|2|||
48920998|NCT00784654|157544819|FG001|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
49130359|NCT02787304|158318395|FG000|Overall Study|Withdrawal by Subject|1|||
49130360|NCT02787304|158318396|FG001|Overall Study|Withdrawal by Subject|4|||
49130361|NCT02787304|158318397|FG002|Overall Study|Withdrawal by Subject|0|||
49130362|NCT02787304|158318398|FG003|Overall Study|Withdrawal by Subject|0|||
49130363|NCT02787304|158318395|FG000|Overall Study|Lost to Follow-up|1|||
49130364|NCT02787304|158318396|FG001|Overall Study|Lost to Follow-up|0|||
49130365|NCT02787304|158318397|FG002|Overall Study|Lost to Follow-up|0|||
49130366|NCT02787304|158318398|FG003|Overall Study|Lost to Follow-up|1|||
49130367|NCT02787304|158318395|FG000|Overall Study|Noncompliance with study drug|0|||
48722961|NCT01582854|156836556|FG001|Overall Study|General Anaesthesia|1|||
48722962|NCT01582854|156836555|FG000|Overall Study|Other Miscellaneous Reason|1|||
48722963|NCT01582854|156836556|FG001|Overall Study|Other Miscellaneous Reason|0|||
48722964|NCT02241889|156836564|FG000|Overall Study|device issues|0|||
48817482|NCT00329719|157175193|FG000|Overall Study|Lost to Follow-up|0|||
48817483|NCT00329719|157175194|FG001|Overall Study|Lost to Follow-up|0|||
48817484|NCT00329719|157175195|FG002|Overall Study|Lost to Follow-up|0|||
49130368|NCT02787304|158318396|FG001|Overall Study|Noncompliance with study drug|0|||
49130369|NCT02787304|158318397|FG002|Overall Study|Noncompliance with study drug|1|||
49130370|NCT02787304|158318398|FG003|Overall Study|Noncompliance with study drug|0|||
49130371|NCT02787304|158318395|FG000|Overall Study|Physician Decision|0|||
49130372|NCT02787304|158318396|FG001|Overall Study|Physician Decision|0|||
48817485|NCT00329719|157175196|FG003|Overall Study|Lost to Follow-up|1|||
48817486|NCT03918239|157175197|FG000|Overall Study|Lost to Follow-up|3|||
49130373|NCT02787304|158318397|FG002|Overall Study|Physician Decision|1|||
49130374|NCT02787304|158318398|FG003|Overall Study|Physician Decision|0|||
49130375|NCT02787304|158318395|FG000|Overall Study|Study terminated by sponsor|25|||
49130376|NCT02787304|158318396|FG001|Overall Study|Study terminated by sponsor|31|||
49130377|NCT02787304|158318397|FG002|Overall Study|Study terminated by sponsor|31|||
49130378|NCT02787304|158318398|FG003|Overall Study|Study terminated by sponsor|32|||
49130379|NCT01075048|158318404|FG000|Overall Study|Death|4|||
49130380|NCT01075048|158318405|FG001|Overall Study|Death|17|||
49130381|NCT01075048|158318406|FG002|Overall Study|Death|12|||
49130382|NCT01075048|158318404|FG000|Overall Study|Start of other or new therapy|4|||
49130383|NCT01075048|158318405|FG001|Overall Study|Start of other or new therapy|36|||
49130384|NCT01075048|158318406|FG002|Overall Study|Start of other or new therapy|46|||
49130385|NCT01075048|158318404|FG000|Overall Study|Withdrawal by Subject|1|||
49130386|NCT01075048|158318405|FG001|Overall Study|Withdrawal by Subject|6|||
49130387|NCT01075048|158318406|FG002|Overall Study|Withdrawal by Subject|3|||
49130388|NCT01075048|158318404|FG000|Overall Study|Lost to Follow-up|0|||
49130389|NCT01075048|158318405|FG001|Overall Study|Lost to Follow-up|1|||
49130390|NCT01075048|158318406|FG002|Overall Study|Lost to Follow-up|1|||
49130391|NCT01433159|158318407|FG000|Overall Study|Adverse Event|1|||
49130392|NCT01433159|158318408|FG001|Overall Study|Adverse Event|0|||
49130393|NCT01433159|158318407|FG000|Overall Study|Physician Decision|1|||
49130394|NCT01433159|158318408|FG001|Overall Study|Physician Decision|0|||
49130395|NCT01433159|158318407|FG000|Overall Study|Protocol Violation|0|||
49130396|NCT01433159|158318408|FG001|Overall Study|Protocol Violation|1|||
49130397|NCT04161391|158318409|FG000|Overall Study|Adverse Event|0|||
49130398|NCT04161391|158318410|FG001|Overall Study|Adverse Event|1|||
49130399|NCT04161391|158318411|FG002|Overall Study|Adverse Event|0|||
49130400|NCT04161391|158318412|FG003|Overall Study|Adverse Event|1|||
49130401|NCT04161391|158318413|FG004|Overall Study|Adverse Event|0|||
49130402|NCT04161391|158318414|FG005|Overall Study|Adverse Event|0|||
49130403|NCT04161391|158318415|FG006|Overall Study|Adverse Event|0|||
49130404|NCT04161391|158318416|FG007|Overall Study|Adverse Event|3|||
49130405|NCT04161391|158318417|FG008|Overall Study|Adverse Event|0|||
49130406|NCT04161391|158318409|FG000|Overall Study|Death|0|||
49130407|NCT04161391|158318410|FG001|Overall Study|Death|0|||
49130408|NCT04161391|158318411|FG002|Overall Study|Death|0|||
49130409|NCT04161391|158318412|FG003|Overall Study|Death|0|||
49130410|NCT04161391|158318413|FG004|Overall Study|Death|0|||
49130411|NCT04161391|158318414|FG005|Overall Study|Death|0|||
49130412|NCT04161391|158318415|FG006|Overall Study|Death|0|||
49130413|NCT04161391|158318416|FG007|Overall Study|Death|1|||
49130414|NCT04161391|158318417|FG008|Overall Study|Death|0|||
49130415|NCT04161391|158318409|FG000|Overall Study|Physician Decision|0|||
49130416|NCT04161391|158318410|FG001|Overall Study|Physician Decision|0|||
49130417|NCT04161391|158318411|FG002|Overall Study|Physician Decision|1|||
49130418|NCT04161391|158318412|FG003|Overall Study|Physician Decision|2|||
49130419|NCT04161391|158318413|FG004|Overall Study|Physician Decision|0|||
49130420|NCT04161391|158318414|FG005|Overall Study|Physician Decision|0|||
49130421|NCT04161391|158318415|FG006|Overall Study|Physician Decision|2|||
49130422|NCT04161391|158318416|FG007|Overall Study|Physician Decision|0|||
49130423|NCT04161391|158318417|FG008|Overall Study|Physician Decision|0|||
49130424|NCT04161391|158318409|FG000|Overall Study|Progressive Disease|4|||
49130425|NCT04161391|158318410|FG001|Overall Study|Progressive Disease|3|||
49130426|NCT04161391|158318411|FG002|Overall Study|Progressive Disease|3|||
49130427|NCT04161391|158318412|FG003|Overall Study|Progressive Disease|5|||
49130428|NCT04161391|158318413|FG004|Overall Study|Progressive Disease|3|||
49130429|NCT04161391|158318414|FG005|Overall Study|Progressive Disease|3|||
49130430|NCT04161391|158318415|FG006|Overall Study|Progressive Disease|5|||
49130431|NCT04161391|158318416|FG007|Overall Study|Progressive Disease|2|||
49130432|NCT04161391|158318417|FG008|Overall Study|Progressive Disease|2|||
49130433|NCT03630393|158318418|FG000|Overall Study|Death|1|||
48817487|NCT03918239|157175198|FG001|Overall Study|Lost to Follow-up|1|||
48817488|NCT03918239|157175197|FG000|Overall Study|Pregnancy|0|||
49130434|NCT03630393|158318419|FG001|Overall Study|Death|0|||
49130435|NCT01586195|158318420|FG000|Overall Study|Death|11|||
49130436|NCT01586195|158318420|FG000|Overall Study|Withdrawal of Consent|5|||
49130437|NCT01586195|158318420|FG000|Overall Study|Started new anti-melanoma therapy|1|||
49130438|NCT01586195|158318420|FG000|Overall Study|Reason not specified|9|||
49130439|NCT00266708|158318422|FG000|Overall Study|No renal function|1|||
49130440|NCT00266708|158318423|FG001|Overall Study|No renal function|1|||
49130441|NCT00266708|158318422|FG000|Overall Study|Refused biopsy|3|||
49130442|NCT00266708|158318423|FG001|Overall Study|Refused biopsy|6|||
49130443|NCT00266708|158318422|FG000|Overall Study|Asthma|0|||
49130444|NCT00266708|158318423|FG001|Overall Study|Asthma|2|||
49130445|NCT01548404|158318424|FG000|Overall Study|Adverse Event|3|||
49130446|NCT01548404|158318425|FG001|Overall Study|Adverse Event|1|||
49130447|NCT01548404|158318424|FG000|Overall Study|Physician Decision|2|||
49130448|NCT01548404|158318425|FG001|Overall Study|Physician Decision|1|||
49130449|NCT01548404|158318424|FG000|Overall Study|Inadequate response to study treatment|23|||
49130450|NCT01548404|158318425|FG001|Overall Study|Inadequate response to study treatment|7|||
49130451|NCT01548404|158318424|FG000|Overall Study|Lost to Follow-up|2|||
49130452|NCT01548404|158318425|FG001|Overall Study|Lost to Follow-up|0|||
49130453|NCT01548404|158318424|FG000|Overall Study|Withdrawal by Subject|0|||
49130454|NCT01548404|158318425|FG001|Overall Study|Withdrawal by Subject|3|||
49130455|NCT01548404|158318424|FG000|Overall Study|Other than specified above|0|||
49130456|NCT01548404|158318425|FG001|Overall Study|Other than specified above|2|||
49130457|NCT00427934|158318428|FG000|Overall Study|Adverse Event|1|||
49130458|NCT00427934|158318429|FG001|Overall Study|Adverse Event|0|||
49130459|NCT00427934|158318430|FG002|Overall Study|Adverse Event|5|||
49130460|NCT00427934|158318431|FG003|Overall Study|Adverse Event|4|||
49130461|NCT00427934|158318428|FG000|Overall Study|Lack of Efficacy|0|||
49130462|NCT00427934|158318429|FG001|Overall Study|Lack of Efficacy|0|||
49130463|NCT00427934|158318430|FG002|Overall Study|Lack of Efficacy|5|||
49130464|NCT00427934|158318431|FG003|Overall Study|Lack of Efficacy|2|||
49130465|NCT00427934|158318428|FG000|Overall Study|Randomized But Did Not Receive Treatment|0|||
49130466|NCT00427934|158318429|FG001|Overall Study|Randomized But Did Not Receive Treatment|0|||
49130467|NCT00427934|158318430|FG002|Overall Study|Randomized But Did Not Receive Treatment|1|||
49130468|NCT00427934|158318431|FG003|Overall Study|Randomized But Did Not Receive Treatment|1|||
49130469|NCT00427934|158318428|FG000|Overall Study|Other|0|||
49130470|NCT00427934|158318429|FG001|Overall Study|Other|0|||
49130471|NCT00427934|158318430|FG002|Overall Study|Other|11|||
49130472|NCT00427934|158318431|FG003|Overall Study|Other|5|||
48722965|NCT02241889|156836565|FG001|Overall Study|device issues|0|||
48722966|NCT02241889|156836566|FG002|Overall Study|device issues|1|||
48722967|NCT02241889|156836567|FG003|Overall Study|device issues|0|||
48722968|NCT02241889|156836568|FG004|Overall Study|device issues|0|||
48722969|NCT02241889|156836569|FG005|Overall Study|device issues|0|||
48722970|NCT02241889|156836564|FG000|Overall Study|Withdrawal by Subject|0|||
48722971|NCT02241889|156836565|FG001|Overall Study|Withdrawal by Subject|0|||
48722972|NCT02241889|156836566|FG002|Overall Study|Withdrawal by Subject|0|||
48722973|NCT02241889|156836567|FG003|Overall Study|Withdrawal by Subject|0|||
48722974|NCT02241889|156836568|FG004|Overall Study|Withdrawal by Subject|0|||
48722975|NCT02241889|156836569|FG005|Overall Study|Withdrawal by Subject|1|||
48722976|NCT00722371|156836575|FG000|Overall Study|Adverse Event|6|||
48722977|NCT00722371|156836576|FG001|Overall Study|Adverse Event|13|||
48722978|NCT00722371|156836577|FG002|Overall Study|Adverse Event|9|||
48722979|NCT00722371|156836578|FG003|Overall Study|Adverse Event|10|||
48722980|NCT00722371|156836579|FG004|Overall Study|Adverse Event|6|||
48722981|NCT00722371|156836580|FG005|Overall Study|Adverse Event|8|||
48722982|NCT00722371|156836581|FG006|Overall Study|Adverse Event|4|||
48722983|NCT00722371|156836575|FG000|Overall Study|Contraindication|0|||
48722984|NCT00722371|156836576|FG001|Overall Study|Contraindication|0|||
48722985|NCT00722371|156836577|FG002|Overall Study|Contraindication|1|||
48722986|NCT00722371|156836578|FG003|Overall Study|Contraindication|0|||
48722987|NCT00722371|156836579|FG004|Overall Study|Contraindication|0|||
48722988|NCT00722371|156836580|FG005|Overall Study|Contraindication|0|||
48722989|NCT00722371|156836581|FG006|Overall Study|Contraindication|0|||
48722990|NCT00722371|156836575|FG000|Overall Study|Creatinine / Creatinine clearance|2|||
48722991|NCT00722371|156836576|FG001|Overall Study|Creatinine / Creatinine clearance|1|||
48722992|NCT00722371|156836577|FG002|Overall Study|Creatinine / Creatinine clearance|2|||
48722993|NCT00722371|156836578|FG003|Overall Study|Creatinine / Creatinine clearance|3|||
48722994|NCT00722371|156836579|FG004|Overall Study|Creatinine / Creatinine clearance|2|||
48722995|NCT00722371|156836580|FG005|Overall Study|Creatinine / Creatinine clearance|1|||
48722996|NCT00722371|156836581|FG006|Overall Study|Creatinine / Creatinine clearance|1|||
48722997|NCT00722371|156836575|FG000|Overall Study|Excluded medication|0|||
48722998|NCT00722371|156836576|FG001|Overall Study|Excluded medication|1|||
48722999|NCT00722371|156836577|FG002|Overall Study|Excluded medication|1|||
48723000|NCT00722371|156836578|FG003|Overall Study|Excluded medication|0|||
48723001|NCT00722371|156836579|FG004|Overall Study|Excluded medication|0|||
49130473|NCT00427934|158318428|FG000|Overall Study|Withdrawal by Subject|0|||
49130474|NCT00427934|158318429|FG001|Overall Study|Withdrawal by Subject|0|||
49130475|NCT00427934|158318430|FG002|Overall Study|Withdrawal by Subject|1|||
49130476|NCT00427934|158318431|FG003|Overall Study|Withdrawal by Subject|3|||
49130477|NCT00288912|158318432|FG000|Overall Study|Developed exclusion criterion|4|||
49130478|NCT00288912|158318433|FG001|Overall Study|Developed exclusion criterion|6|||
49130479|NCT00288912|158318434|FG002|Overall Study|Developed exclusion criterion|7|||
49130480|NCT00288912|158318432|FG000|Overall Study|Lost to Follow-up|9|||
48920999|NCT00784654|157544820|FG002|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
48921000|NCT00784654|157544818|FG000|Open-Label Period (Non-Randomized)|Mother is a drug addict|1|||
48723002|NCT00722371|156836580|FG005|Overall Study|Excluded medication|0|||
48723003|NCT00722371|156836581|FG006|Overall Study|Excluded medication|1|||
48723004|NCT00722371|156836575|FG000|Overall Study|Hyperglycemia|2|||
48723005|NCT00722371|156836576|FG001|Overall Study|Hyperglycemia|6|||
48723006|NCT00722371|156836577|FG002|Overall Study|Hyperglycemia|4|||
49130481|NCT00288912|158318433|FG001|Overall Study|Lost to Follow-up|6|||
49130482|NCT00288912|158318434|FG002|Overall Study|Lost to Follow-up|9|||
49130483|NCT00288912|158318432|FG000|Overall Study|Withdrawal by Subject|4|||
49130484|NCT00288912|158318433|FG001|Overall Study|Withdrawal by Subject|5|||
49130485|NCT00288912|158318434|FG002|Overall Study|Withdrawal by Subject|12|||
49130486|NCT03312738|158318435|FG000|Overall Study|Progressive disease|58|||
49130487|NCT03312738|158318436|FG001|Overall Study|Progressive disease|67|||
49130488|NCT03312738|158318435|FG000|Overall Study|Patient/guardian decision|13|||
49130489|NCT03312738|158318436|FG001|Overall Study|Patient/guardian decision|5|||
49130490|NCT03312738|158318435|FG000|Overall Study|Adverse Event|5|||
49130491|NCT03312738|158318436|FG001|Overall Study|Adverse Event|3|||
49130492|NCT03312738|158318435|FG000|Overall Study|Protocol deviation|2|||
49130493|NCT03312738|158318436|FG001|Overall Study|Protocol deviation|0|||
49130494|NCT03312738|158318435|FG000|Overall Study|Technical problems|0|||
49130495|NCT03312738|158318436|FG001|Overall Study|Technical problems|1|||
49130496|NCT03312738|158318435|FG000|Overall Study|Physician Decision|2|||
49130497|NCT03312738|158318436|FG001|Overall Study|Physician Decision|3|||
49130498|NCT01316614|158318440|FG000|Overall Study|No solid lesion and FNA not indicated|25|||
49130499|NCT01316614|158318440|FG000|Overall Study|Cytology slides not available for review|4|||
49130500|NCT01316614|158318440|FG000|Overall Study|Cystic lesion|5|||
49130501|NCT01316614|158318440|FG000|Overall Study|Inadequate number of passes|2|||
49130502|NCT01316614|158318440|FG000|Overall Study|Medically unstable|1|||
49130503|NCT00076570|158318441|FG000|Overall Study|Drug intolerance|8|||
49130504|NCT00076570|158318442|FG001|Overall Study|Drug intolerance|8|||
49130505|NCT03427411|158318443|FG000|Overall Study|Screen failure - platelets too low|0|||
48723007|NCT00722371|156836578|FG003|Overall Study|Hyperglycemia|2|||
48723008|NCT00722371|156836579|FG004|Overall Study|Hyperglycemia|5|||
48723009|NCT00722371|156836580|FG005|Overall Study|Hyperglycemia|1|||
48723010|NCT00722371|156836581|FG006|Overall Study|Hyperglycemia|1|||
48723011|NCT00722371|156836575|FG000|Overall Study|Hypoglycemia|1|||
48723012|NCT00722371|156836576|FG001|Overall Study|Hypoglycemia|0|||
48723013|NCT00722371|156836577|FG002|Overall Study|Hypoglycemia|0|||
48723014|NCT00722371|156836578|FG003|Overall Study|Hypoglycemia|0|||
48723015|NCT00722371|156836579|FG004|Overall Study|Hypoglycemia|0|||
48723016|NCT00722371|156836580|FG005|Overall Study|Hypoglycemia|0|||
48723017|NCT00722371|156836581|FG006|Overall Study|Hypoglycemia|0|||
48723018|NCT00722371|156836575|FG000|Overall Study|Lack of Efficacy|4|||
48723019|NCT00722371|156836576|FG001|Overall Study|Lack of Efficacy|6|||
48723020|NCT00722371|156836577|FG002|Overall Study|Lack of Efficacy|6|||
48723021|NCT00722371|156836578|FG003|Overall Study|Lack of Efficacy|6|||
48723022|NCT00722371|156836579|FG004|Overall Study|Lack of Efficacy|2|||
48723023|NCT00722371|156836580|FG005|Overall Study|Lack of Efficacy|3|||
48723024|NCT00722371|156836581|FG006|Overall Study|Lack of Efficacy|0|||
48723025|NCT00722371|156836575|FG000|Overall Study|Lost to Follow-up|11|||
48723026|NCT00722371|156836576|FG001|Overall Study|Lost to Follow-up|14|||
48723027|NCT00722371|156836577|FG002|Overall Study|Lost to Follow-up|21|||
48723028|NCT00722371|156836578|FG003|Overall Study|Lost to Follow-up|13|||
48723029|NCT00722371|156836579|FG004|Overall Study|Lost to Follow-up|8|||
48723030|NCT00722371|156836580|FG005|Overall Study|Lost to Follow-up|16|||
48723031|NCT00722371|156836581|FG006|Overall Study|Lost to Follow-up|13|||
48723032|NCT00722371|156836575|FG000|Overall Study|Physician Decision|5|||
48723033|NCT00722371|156836576|FG001|Overall Study|Physician Decision|2|||
48723034|NCT00722371|156836577|FG002|Overall Study|Physician Decision|2|||
48723035|NCT00722371|156836578|FG003|Overall Study|Physician Decision|5|||
48723036|NCT00722371|156836579|FG004|Overall Study|Physician Decision|2|||
48723037|NCT00722371|156836580|FG005|Overall Study|Physician Decision|3|||
48723038|NCT00722371|156836581|FG006|Overall Study|Physician Decision|4|||
48723039|NCT00722371|156836575|FG000|Overall Study|Pregnancy|1|||
48723040|NCT00722371|156836576|FG001|Overall Study|Pregnancy|1|||
48723041|NCT00722371|156836577|FG002|Overall Study|Pregnancy|0|||
48723042|NCT00722371|156836578|FG003|Overall Study|Pregnancy|0|||
48723043|NCT00722371|156836579|FG004|Overall Study|Pregnancy|0|||
48723044|NCT00722371|156836580|FG005|Overall Study|Pregnancy|1|||
48723045|NCT00722371|156836581|FG006|Overall Study|Pregnancy|0|||
49130506|NCT03427411|158318444|FG001|Overall Study|Screen failure - platelets too low|1|||
48723046|NCT00722371|156836575|FG000|Overall Study|Protocol Violation|6|||
48723047|NCT00722371|156836576|FG001|Overall Study|Protocol Violation|1|||
48723048|NCT00722371|156836577|FG002|Overall Study|Protocol Violation|0|||
48723049|NCT00722371|156836578|FG003|Overall Study|Protocol Violation|1|||
49130507|NCT04539275|158318448|FG000|Overall Study|Death|2|||
49130508|NCT04539275|158318449|FG001|Overall Study|Death|4|||
49130509|NCT04539275|158318448|FG000|Overall Study|Lost to Follow-up|1|||
49130510|NCT04539275|158318449|FG001|Overall Study|Lost to Follow-up|1|||
49130511|NCT04539275|158318448|FG000|Overall Study|Withdrawal by Subject|3|||
49130512|NCT04539275|158318449|FG001|Overall Study|Withdrawal by Subject|0|||
49130513|NCT02669849|158318450|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
49130514|NCT02669849|158318451|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
49130515|NCT02669849|158318452|FG002|Overall Study|Withdrawal of Consent (not due to AE)|3|||
49130516|NCT02669849|158318450|FG000|Overall Study|Lost to Follow-up|1|||
49130517|NCT02669849|158318451|FG001|Overall Study|Lost to Follow-up|0|||
49130518|NCT02669849|158318452|FG002|Overall Study|Lost to Follow-up|3|||
49130519|NCT02669849|158318450|FG000|Overall Study|Death|1|||
49130520|NCT02669849|158318451|FG001|Overall Study|Death|1|||
49130521|NCT02669849|158318452|FG002|Overall Study|Death|2|||
49130522|NCT02669849|158318450|FG000|Overall Study|Study terminated by sponsor|16|||
49130523|NCT02669849|158318451|FG001|Overall Study|Study terminated by sponsor|1|||
49130524|NCT02669849|158318452|FG002|Overall Study|Study terminated by sponsor|14|||
49130525|NCT02669849|158318450|FG000|Overall Study|Other|0|||
49130526|NCT02669849|158318451|FG001|Overall Study|Other|0|||
49130527|NCT02669849|158318452|FG002|Overall Study|Other|2|||
49130528|NCT03257267|158318453|FG000|Overall Study|Adverse Event|17|||
49130529|NCT03257267|158318454|FG001|Overall Study|Adverse Event|7|||
49130530|NCT03257267|158318453|FG000|Overall Study|Death|96|||
49130531|NCT03257267|158318454|FG001|Overall Study|Death|98|||
49130532|NCT03257267|158318453|FG000|Overall Study|Lost to Follow-up|2|||
49130533|NCT03257267|158318454|FG001|Overall Study|Lost to Follow-up|2|||
49130534|NCT03257267|158318453|FG000|Overall Study|Non-compliance with Study Drug|0|||
49130535|NCT03257267|158318454|FG001|Overall Study|Non-compliance with Study Drug|2|||
49130536|NCT03257267|158318453|FG000|Overall Study|Participant Decision|35|||
49130537|NCT03257267|158318454|FG001|Overall Study|Participant Decision|43|||
49130538|NCT03257267|158318453|FG000|Overall Study|Sponsor Decision|1|||
49130539|NCT03257267|158318454|FG001|Overall Study|Sponsor Decision|0|||
49130540|NCT03257267|158318453|FG000|Overall Study|Physician Decision|1|||
49130541|NCT03257267|158318454|FG001|Overall Study|Physician Decision|3|||
49130542|NCT03257267|158318453|FG000|Overall Study|Disease Progression|109|||
49130543|NCT03257267|158318454|FG001|Overall Study|Disease Progression|121|||
49130544|NCT03257267|158318453|FG000|Overall Study|Withdrawal by Subject|8|||
49130545|NCT03257267|158318454|FG001|Overall Study|Withdrawal by Subject|26|||
49130546|NCT03257267|158318453|FG000|Overall Study|Other|0|||
49130547|NCT03257267|158318454|FG001|Overall Study|Other|2|||
49130548|NCT00606008|158318462|FG000|Overall Study|Adverse Event|1|||
49130549|NCT00606008|158318462|FG000|Overall Study|Withdrawal by Subject|4|||
49130550|NCT03183908|158318469|FG000|Overall Study|Missing Symptom Diary Data|0|||
49130551|NCT03183908|158318470|FG001|Overall Study|Missing Symptom Diary Data|2|||
49130552|NCT02014272|158318471|FG000|Intervention Period 1|Withdrawal by Subject|1|||
49130553|NCT02014272|158318472|FG001|Intervention Period 1|Withdrawal by Subject|0|||
49130554|NCT02014272|158318471|FG000|Intervention Period 1|Adverse Event|0|||
49130555|NCT02014272|158318472|FG001|Intervention Period 1|Adverse Event|1|||
49130556|NCT01240746|158318473|FG000|Overall Study|Adverse Event|2|||
49130557|NCT01240746|158318474|FG001|Overall Study|Adverse Event|0|||
49130558|NCT01240746|158318475|FG002|Overall Study|Adverse Event|10|||
49130559|NCT01240746|158318473|FG000|Overall Study|Lost to Follow-up|23|||
49130560|NCT01240746|158318474|FG001|Overall Study|Lost to Follow-up|20|||
49130561|NCT01240746|158318475|FG002|Overall Study|Lost to Follow-up|102|||
49130562|NCT01240746|158318473|FG000|Overall Study|Protocol Violation|24|||
49130563|NCT01240746|158318474|FG001|Overall Study|Protocol Violation|15|||
49130564|NCT01240746|158318475|FG002|Overall Study|Protocol Violation|72|||
49130565|NCT01240746|158318473|FG000|Overall Study|Withdrawal by Subject|10|||
49130566|NCT01240746|158318474|FG001|Overall Study|Withdrawal by Subject|13|||
49130567|NCT01240746|158318475|FG002|Overall Study|Withdrawal by Subject|59|||
49130568|NCT03636256|158318476|FG000|Overall Study|Lost to Follow-up|3|||
49130569|NCT03636256|158318477|FG001|Overall Study|Lost to Follow-up|0|||
49130570|NCT03636256|158318478|FG002|Overall Study|Lost to Follow-up|2|||
49130571|NCT03636256|158318479|FG003|Overall Study|Lost to Follow-up|1|||
49130572|NCT03636256|158318480|FG004|Overall Study|Lost to Follow-up|0|||
49130573|NCT03636256|158318481|FG005|Overall Study|Lost to Follow-up|4|||
49130574|NCT03636256|158318482|FG006|Overall Study|Lost to Follow-up|2|||
49130575|NCT03636256|158318483|FG007|Overall Study|Lost to Follow-up|0|||
49130576|NCT03636256|158318484|FG008|Overall Study|Lost to Follow-up|4|||
49130577|NCT03636256|158318476|FG000|Overall Study|Withdrawal by Subject|0|||
49130578|NCT03636256|158318477|FG001|Overall Study|Withdrawal by Subject|0|||
49130579|NCT03636256|158318478|FG002|Overall Study|Withdrawal by Subject|0|||
49130580|NCT03636256|158318479|FG003|Overall Study|Withdrawal by Subject|0|||
49130581|NCT03636256|158318480|FG004|Overall Study|Withdrawal by Subject|0|||
49130582|NCT03636256|158318481|FG005|Overall Study|Withdrawal by Subject|0|||
49130583|NCT03636256|158318482|FG006|Overall Study|Withdrawal by Subject|0|||
49130584|NCT03636256|158318483|FG007|Overall Study|Withdrawal by Subject|0|||
49130585|NCT03636256|158318484|FG008|Overall Study|Withdrawal by Subject|1|||
49130586|NCT05379920|158318485|FG000|Overall Study|Lost to Follow-up|0|||
49130587|NCT05379920|158318486|FG001|Overall Study|Lost to Follow-up|5|||
49130588|NCT05379920|158318487|FG002|Overall Study|Lost to Follow-up|0|||
49130589|NCT05379920|158318488|FG003|Overall Study|Lost to Follow-up|0|||
49130590|NCT03176771|158318489|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|3|||
49130591|NCT03176771|158318490|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|5|||
49130592|NCT03176771|158318491|FG002|Double-Blind Placebo-Controlled Period|Adverse Event|14|||
49130593|NCT03176771|158318492|FG003|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
49130594|NCT03176771|158318493|FG004|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
49130595|NCT03176771|158318489|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
49130596|NCT03176771|158318490|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|2|||
49130597|NCT03176771|158318491|FG002|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
49130598|NCT03176771|158318492|FG003|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
49130599|NCT03176771|158318493|FG004|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
49130600|NCT03176771|158318489|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|2|||
49130601|NCT03176771|158318490|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|8|||
49130602|NCT03176771|158318491|FG002|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|10|||
49130603|NCT03176771|158318492|FG003|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
49130604|NCT03176771|158318493|FG004|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
49130605|NCT03176771|158318489|FG000|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
49130606|NCT03176771|158318490|FG001|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
49130607|NCT03176771|158318491|FG002|Double-Blind Placebo-Controlled Period|Incorrect allocation|1|||
49130608|NCT03176771|158318492|FG003|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
49130609|NCT03176771|158318493|FG004|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
49130610|NCT03176771|158318489|FG000|Double-Blind Extension Period|Adverse Event|0|||
49130611|NCT03176771|158318490|FG001|Double-Blind Extension Period|Adverse Event|0|||
49130612|NCT03176771|158318491|FG002|Double-Blind Extension Period|Adverse Event|0|||
49130613|NCT03176771|158318492|FG003|Double-Blind Extension Period|Adverse Event|15|||
49130614|NCT03176771|158318493|FG004|Double-Blind Extension Period|Adverse Event|18|||
49130615|NCT03176771|158318489|FG000|Double-Blind Extension Period|Death|0|||
49130616|NCT03176771|158318490|FG001|Double-Blind Extension Period|Death|0|||
49130617|NCT03176771|158318491|FG002|Double-Blind Extension Period|Death|0|||
49130618|NCT03176771|158318492|FG003|Double-Blind Extension Period|Death|3|||
49130619|NCT03176771|158318493|FG004|Double-Blind Extension Period|Death|4|||
49130620|NCT03176771|158318489|FG000|Double-Blind Extension Period|Physician Decision|0|||
49130621|NCT03176771|158318490|FG001|Double-Blind Extension Period|Physician Decision|0|||
49130622|NCT03176771|158318491|FG002|Double-Blind Extension Period|Physician Decision|0|||
49130623|NCT03176771|158318492|FG003|Double-Blind Extension Period|Physician Decision|3|||
49130624|NCT03176771|158318493|FG004|Double-Blind Extension Period|Physician Decision|1|||
49130625|NCT03176771|158318489|FG000|Double-Blind Extension Period|Withdrawal by Subject|0|||
49130626|NCT03176771|158318490|FG001|Double-Blind Extension Period|Withdrawal by Subject|0|||
49130627|NCT03176771|158318491|FG002|Double-Blind Extension Period|Withdrawal by Subject|0|||
49130628|NCT03176771|158318492|FG003|Double-Blind Extension Period|Withdrawal by Subject|24|||
49130629|NCT03176771|158318493|FG004|Double-Blind Extension Period|Withdrawal by Subject|26|||
49130630|NCT02915835|158318509|FG000|Overall Study|Physician Decision|1|||
49130631|NCT02915835|158318510|FG001|Overall Study|Physician Decision|0|||
49130632|NCT02915835|158318509|FG000|Overall Study|Withdrawal by Subject|0|||
49130633|NCT02915835|158318510|FG001|Overall Study|Withdrawal by Subject|1|||
49130634|NCT01569022|158318511|FG000|First Intervention|Lost to Follow-up|2|||
49130635|NCT01569022|158318512|FG001|First Intervention|Lost to Follow-up|1|||
49130636|NCT01569022|158318511|FG000|Second Intervention|Lost to Follow-up|2|||
49130637|NCT01569022|158318512|FG001|Second Intervention|Lost to Follow-up|2|||
49130638|NCT00572832|158318513|FG000|Overall Study|Lost to Follow-up|0|||
49130639|NCT00572832|158318514|FG001|Overall Study|Lost to Follow-up|11|||
49130640|NCT00572832|158318513|FG000|Overall Study|Pregnancy|0|||
49130641|NCT00572832|158318514|FG001|Overall Study|Pregnancy|1|||
49130642|NCT00284856|158318515|FG000|Overall Study|Adverse Event|3|||
49130643|NCT00284856|158318516|FG001|Overall Study|Adverse Event|3|||
49130644|NCT00284856|158318517|FG002|Overall Study|Adverse Event|3|||
49130645|NCT00284856|158318515|FG000|Overall Study|Lack of Efficacy|2|||
49130646|NCT00284856|158318516|FG001|Overall Study|Lack of Efficacy|1|||
49130647|NCT00284856|158318517|FG002|Overall Study|Lack of Efficacy|8|||
49130648|NCT00284856|158318515|FG000|Overall Study|Lost to Follow-up|25|||
49130649|NCT00284856|158318516|FG001|Overall Study|Lost to Follow-up|21|||
49130650|NCT00284856|158318517|FG002|Overall Study|Lost to Follow-up|22|||
49130651|NCT00284856|158318515|FG000|Overall Study|Protocol Violation|5|||
49130652|NCT00284856|158318516|FG001|Overall Study|Protocol Violation|4|||
49130653|NCT00284856|158318517|FG002|Overall Study|Protocol Violation|5|||
49130654|NCT00284856|158318515|FG000|Overall Study|Withdrawal by Subject|12|||
49130655|NCT00284856|158318516|FG001|Overall Study|Withdrawal by Subject|16|||
49130656|NCT00284856|158318517|FG002|Overall Study|Withdrawal by Subject|18|||
49130657|NCT00284856|158318515|FG000|Overall Study|Other|4|||
49130658|NCT00284856|158318516|FG001|Overall Study|Other|5|||
49130659|NCT00284856|158318517|FG002|Overall Study|Other|4|||
49130660|NCT00423046|158318518|FG000|Overall Study|Other|340|||
49130661|NCT00423046|158318519|FG001|Overall Study|Other|345|||
49130662|NCT03704064|158318520|FG000|Overall Study|Lost to Follow-up|8|||
49130663|NCT03704064|158318521|FG001|Overall Study|Lost to Follow-up|4|||
49130664|NCT03704064|158318520|FG000|Overall Study|Withdrawal by Subject|1|||
49130665|NCT03704064|158318521|FG001|Overall Study|Withdrawal by Subject|1|||
49130666|NCT03704064|158318520|FG000|Overall Study|No longer available for study visits|0|||
49130667|NCT03704064|158318521|FG001|Overall Study|No longer available for study visits|1|||
49130668|NCT03704064|158318520|FG000|Overall Study|Censoring event|1|||
49130669|NCT03704064|158318521|FG001|Overall Study|Censoring event|0|||
49130670|NCT01286129|158318522|FG000|Overall Study|Withdrawal by Subject|4|||
49130671|NCT01286129|158318523|FG001|Overall Study|Withdrawal by Subject|1|||
49130672|NCT01286129|158318522|FG000|Overall Study|Could not comply with study requirements|4|||
49130673|NCT01286129|158318523|FG001|Overall Study|Could not comply with study requirements|4|||
49130674|NCT01604785|158318524|FG000|Overall Study|Repeat Visits Not Included in Analysis|7|||
49130675|NCT01604785|158318525|FG001|Overall Study|Repeat Visits Not Included in Analysis|1|||
49130676|NCT01285518|158318526|FG000|Overall Study|Lost to Follow-up|0|||
49130677|NCT01285518|158318527|FG001|Overall Study|Lost to Follow-up|0|||
49130678|NCT01285518|158318528|FG002|Overall Study|Lost to Follow-up|0|||
49130679|NCT01285518|158318529|FG003|Overall Study|Lost to Follow-up|0|||
49130680|NCT01285518|158318530|FG004|Overall Study|Lost to Follow-up|0|||
49130681|NCT01285518|158318531|FG005|Overall Study|Lost to Follow-up|1|||
49130682|NCT01285518|158318532|FG006|Overall Study|Lost to Follow-up|0|||
49130683|NCT01285518|158318533|FG007|Overall Study|Lost to Follow-up|0|||
49130684|NCT00879658|158318534|FG000|Overall Study|Abnormal laboratory value(s)|3|||
49130685|NCT00879658|158318535|FG001|Overall Study|Abnormal laboratory value(s)|0|||
49130686|NCT00879658|158318536|FG002|Overall Study|Abnormal laboratory value(s)|0|||
49130687|NCT00879658|158318537|FG003|Overall Study|Abnormal laboratory value(s)|1|||
49130688|NCT00879658|158318538|FG004|Overall Study|Abnormal laboratory value(s)|0|||
49130689|NCT00879658|158318539|FG005|Overall Study|Abnormal laboratory value(s)|0|||
49130690|NCT00879658|158318540|FG006|Overall Study|Abnormal laboratory value(s)|0|||
49130691|NCT00879658|158318534|FG000|Overall Study|Administrative problems|2|||
49130692|NCT00879658|158318535|FG001|Overall Study|Administrative problems|1|||
49130693|NCT00879658|158318536|FG002|Overall Study|Administrative problems|0|||
49130694|NCT00879658|158318537|FG003|Overall Study|Administrative problems|1|||
49130695|NCT00879658|158318538|FG004|Overall Study|Administrative problems|0|||
49130696|NCT00879658|158318539|FG005|Overall Study|Administrative problems|0|||
49130697|NCT00879658|158318540|FG006|Overall Study|Administrative problems|0|||
49130698|NCT00879658|158318534|FG000|Overall Study|Adverse Event|6|||
49130699|NCT00879658|158318535|FG001|Overall Study|Adverse Event|4|||
49130700|NCT00879658|158318536|FG002|Overall Study|Adverse Event|3|||
49130701|NCT00879658|158318537|FG003|Overall Study|Adverse Event|1|||
49130702|NCT00879658|158318538|FG004|Overall Study|Adverse Event|2|||
49130703|NCT00879658|158318539|FG005|Overall Study|Adverse Event|0|||
49130704|NCT00879658|158318540|FG006|Overall Study|Adverse Event|0|||
49130705|NCT00879658|158318534|FG000|Overall Study|Protocol Violation|1|||
49130706|NCT00879658|158318535|FG001|Overall Study|Protocol Violation|0|||
49130707|NCT00879658|158318536|FG002|Overall Study|Protocol Violation|0|||
49130708|NCT00879658|158318537|FG003|Overall Study|Protocol Violation|0|||
49130709|NCT00879658|158318538|FG004|Overall Study|Protocol Violation|0|||
49130710|NCT00879658|158318539|FG005|Overall Study|Protocol Violation|0|||
49130711|NCT00879658|158318540|FG006|Overall Study|Protocol Violation|0|||
49130712|NCT00879658|158318534|FG000|Overall Study|Withdrawal by Subject|3|||
49130713|NCT00879658|158318535|FG001|Overall Study|Withdrawal by Subject|0|||
49130714|NCT00879658|158318536|FG002|Overall Study|Withdrawal by Subject|2|||
49130715|NCT00879658|158318537|FG003|Overall Study|Withdrawal by Subject|0|||
49130716|NCT00879658|158318538|FG004|Overall Study|Withdrawal by Subject|0|||
49130717|NCT00879658|158318539|FG005|Overall Study|Withdrawal by Subject|1|||
48723050|NCT00722371|156836579|FG004|Overall Study|Protocol Violation|4|||
48723051|NCT00722371|156836580|FG005|Overall Study|Protocol Violation|2|||
48723052|NCT00722371|156836581|FG006|Overall Study|Protocol Violation|1|||
49130718|NCT00879658|158318540|FG006|Overall Study|Withdrawal by Subject|0|||
49130719|NCT00879658|158318534|FG000|Overall Study|Lack of Efficacy|0|||
49130720|NCT00879658|158318535|FG001|Overall Study|Lack of Efficacy|0|||
49130721|NCT00879658|158318536|FG002|Overall Study|Lack of Efficacy|2|||
49130722|NCT00879658|158318537|FG003|Overall Study|Lack of Efficacy|0|||
49130723|NCT00879658|158318538|FG004|Overall Study|Lack of Efficacy|0|||
49130724|NCT00879658|158318539|FG005|Overall Study|Lack of Efficacy|0|||
49130725|NCT00879658|158318540|FG006|Overall Study|Lack of Efficacy|0|||
49130726|NCT00879658|158318534|FG000|Overall Study|misrandomized (never received study med)|0|||
49130727|NCT00879658|158318535|FG001|Overall Study|misrandomized (never received study med)|0|||
49130728|NCT00879658|158318536|FG002|Overall Study|misrandomized (never received study med)|0|||
49130729|NCT00879658|158318537|FG003|Overall Study|misrandomized (never received study med)|1|||
48817489|NCT03918239|157175198|FG001|Overall Study|Pregnancy|2|||
48817490|NCT03918239|157175197|FG000|Overall Study|Withdrawal by Subject|3|||
48817491|NCT03918239|157175198|FG001|Overall Study|Withdrawal by Subject|3|||
48817492|NCT03918239|157175197|FG000|Overall Study|positive urine drug screening results|4|||
48817493|NCT03918239|157175198|FG001|Overall Study|positive urine drug screening results|1|||
48817494|NCT01681368|157175200|FG000|Overall Study|Refused further treatment|1|||
49130730|NCT00879658|158318538|FG004|Overall Study|misrandomized (never received study med)|0|||
49130731|NCT00879658|158318539|FG005|Overall Study|misrandomized (never received study med)|0|||
49130732|NCT00879658|158318540|FG006|Overall Study|misrandomized (never received study med)|0|||
49130733|NCT00833755|158318543|FG000|Overall Study|Physician Decision|4|||
49130734|NCT00833755|158318544|FG001|Overall Study|Physician Decision|4|||
49130735|NCT00833755|158318545|FG002|Overall Study|Physician Decision|2|||
48817495|NCT01681368|157175200|FG000|Overall Study|Refused further follow up|1|||
48817496|NCT01189890|157175201|FG000|Overall Study|Adverse Event|3|||
48817497|NCT01189890|157175202|FG001|Overall Study|Adverse Event|4|||
48817498|NCT01189890|157175201|FG000|Overall Study|Lack of Efficacy|7|||
49130736|NCT00833755|158318546|FG003|Overall Study|Physician Decision|6|||
49130737|NCT00833755|158318543|FG000|Overall Study|Subject had scheduling issues|0|||
49130738|NCT00833755|158318544|FG001|Overall Study|Subject had scheduling issues|1|||
49130739|NCT00833755|158318545|FG002|Overall Study|Subject had scheduling issues|0|||
49130740|NCT00833755|158318546|FG003|Overall Study|Subject had scheduling issues|0|||
49130741|NCT00471497|158318547|FG000|Core Treatment Phase|Abnormal Laboratory Values|3|||
49130742|NCT00471497|158318548|FG001|Core Treatment Phase|Abnormal Laboratory Values|9|||
49130743|NCT00471497|158318549|FG002|Core Treatment Phase|Abnormal Laboratory Values|9|||
49130744|NCT00471497|158318547|FG000|Core Treatment Phase|Abnormal Test Procedures|1|||
49130745|NCT00471497|158318548|FG001|Core Treatment Phase|Abnormal Test Procedures|0|||
49130746|NCT00471497|158318549|FG002|Core Treatment Phase|Abnormal Test Procedures|1|||
49130747|NCT00471497|158318547|FG000|Core Treatment Phase|Condition no longer requires study drug|0|||
49130748|NCT00471497|158318548|FG001|Core Treatment Phase|Condition no longer requires study drug|1|||
49130749|NCT00471497|158318549|FG002|Core Treatment Phase|Condition no longer requires study drug|0|||
49130750|NCT00471497|158318547|FG000|Core Treatment Phase|Withdrawal by Subject|31|||
49130751|NCT00471497|158318548|FG001|Core Treatment Phase|Withdrawal by Subject|29|||
49130752|NCT00471497|158318549|FG002|Core Treatment Phase|Withdrawal by Subject|34|||
49130753|NCT00471497|158318547|FG000|Core Treatment Phase|Lost to Follow-up|6|||
49130754|NCT00471497|158318548|FG001|Core Treatment Phase|Lost to Follow-up|6|||
49130755|NCT00471497|158318549|FG002|Core Treatment Phase|Lost to Follow-up|3|||
49130756|NCT00471497|158318547|FG000|Core Treatment Phase|Death|3|||
49130757|NCT00471497|158318548|FG001|Core Treatment Phase|Death|9|||
49130758|NCT00471497|158318549|FG002|Core Treatment Phase|Death|3|||
49130759|NCT00471497|158318547|FG000|Core Treatment Phase|Disease Progression|10|||
49130760|NCT00471497|158318548|FG001|Core Treatment Phase|Disease Progression|2|||
49130761|NCT00471497|158318549|FG002|Core Treatment Phase|Disease Progression|4|||
49130762|NCT00471497|158318547|FG000|Core Treatment Phase|Protocol Violation|6|||
49130763|NCT00471497|158318548|FG001|Core Treatment Phase|Protocol Violation|15|||
49130764|NCT00471497|158318549|FG002|Core Treatment Phase|Protocol Violation|11|||
49130765|NCT00471497|158318547|FG000|Core Treatment Phase|Sub optimal response or treat. failure|19|||
49130766|NCT00471497|158318548|FG001|Core Treatment Phase|Sub optimal response or treat. failure|11|||
49130767|NCT00471497|158318549|FG002|Core Treatment Phase|Sub optimal response or treat. failure|13|||
49130768|NCT00471497|158318547|FG000|Core Treatment Phase|Administrative problems|14|||
49130769|NCT00471497|158318548|FG001|Core Treatment Phase|Administrative problems|14|||
49130770|NCT00471497|158318549|FG002|Core Treatment Phase|Administrative problems|12|||
49130771|NCT00471497|158318547|FG000|Core Treatment Phase|Adverse Event|43|||
49130772|NCT00471497|158318548|FG001|Core Treatment Phase|Adverse Event|53|||
49130773|NCT00471497|158318549|FG002|Core Treatment Phase|Adverse Event|89|||
49130774|NCT00471497|158318547|FG000|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2|||
49130775|NCT00471497|158318548|FG001|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
48817499|NCT01189890|157175202|FG001|Overall Study|Lack of Efficacy|2|||
48817500|NCT01189890|157175201|FG000|Overall Study|Lost to Follow-up|1|||
48817501|NCT01189890|157175202|FG001|Overall Study|Lost to Follow-up|7|||
48817502|NCT01189890|157175201|FG000|Overall Study|Protocol Violation|1|||
49130776|NCT00471497|158318549|FG002|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
49130777|NCT00471497|158318547|FG000|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46|||
49130778|NCT00471497|158318548|FG001|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26|||
49130779|NCT00471497|158318549|FG002|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3|||
48817503|NCT01189890|157175202|FG001|Overall Study|Protocol Violation|5|||
48817504|NCT01189890|157175201|FG000|Overall Study|Withdrawal by Subject|15|||
48817505|NCT01189890|157175202|FG001|Overall Study|Withdrawal by Subject|11|||
49130780|NCT00471497|158318547|FG000|Extension Phase|Adverse Event|9|||
49130781|NCT00471497|158318548|FG001|Extension Phase|Adverse Event|5|||
49130782|NCT00471497|158318549|FG002|Extension Phase|Adverse Event|1|||
49130783|NCT00471497|158318547|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
49130784|NCT00471497|158318548|FG001|Extension Phase|Unsatisfactory therapeutic effect|6|||
49130785|NCT00471497|158318549|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
49130786|NCT00471497|158318547|FG000|Extension Phase|Withdrawal by Subject|3|||
49130787|NCT00471497|158318548|FG001|Extension Phase|Withdrawal by Subject|1|||
49130788|NCT00471497|158318549|FG002|Extension Phase|Withdrawal by Subject|0|||
49130789|NCT00471497|158318547|FG000|Extension Phase|Lost to Follow-up|2|||
48817506|NCT01189890|157175201|FG000|Overall Study|Non Compliance|0|||
48817507|NCT01189890|157175202|FG001|Overall Study|Non Compliance|1|||
48817508|NCT01189890|157175201|FG000|Overall Study|Physician Decision|5|||
49130790|NCT00471497|158318548|FG001|Extension Phase|Lost to Follow-up|0|||
49130791|NCT00471497|158318549|FG002|Extension Phase|Lost to Follow-up|0|||
49130792|NCT00471497|158318547|FG000|Extension Phase|Death|1|||
49130793|NCT00471497|158318548|FG001|Extension Phase|Death|0|||
49130794|NCT00471497|158318549|FG002|Extension Phase|Death|0|||
49130795|NCT00471497|158318547|FG000|Extension Phase|Disease progression|2|||
49130796|NCT00471497|158318548|FG001|Extension Phase|Disease progression|0|||
49130797|NCT00471497|158318549|FG002|Extension Phase|Disease progression|0|||
49130798|NCT00471497|158318547|FG000|Extension Phase|Protocol Violation|2|||
49130799|NCT00471497|158318548|FG001|Extension Phase|Protocol Violation|2|||
49130800|NCT00471497|158318549|FG002|Extension Phase|Protocol Violation|0|||
49130801|NCT03506477|158318550|FG000|Overall Study|Withdrawal by Subject|1|||
49130802|NCT03506477|158318551|FG001|Overall Study|Withdrawal by Subject|0|||
49130803|NCT01654276|158318552|FG000|Overall Study|Lack of Efficacy|1|||
49130804|NCT01654276|158318552|FG000|Overall Study|Lost to Follow-up|4|||
49130805|NCT01654276|158318552|FG000|Overall Study|Withdrawal by Subject|1|||
49130806|NCT00909870|158318561|FG000|Overall Study|Adverse Event|13|||
49130807|NCT00909870|158318562|FG001|Overall Study|Adverse Event|7|||
49130808|NCT00909870|158318561|FG000|Overall Study|Protocol Violation|1|||
49130809|NCT00909870|158318562|FG001|Overall Study|Protocol Violation|2|||
49130810|NCT00909870|158318561|FG000|Overall Study|Withdrawal by Subject|5|||
49130811|NCT00909870|158318562|FG001|Overall Study|Withdrawal by Subject|8|||
49130812|NCT00909870|158318561|FG000|Overall Study|Lost to Follow-up|3|||
49130813|NCT00909870|158318562|FG001|Overall Study|Lost to Follow-up|3|||
49130814|NCT00909870|158318561|FG000|Overall Study|Physician Decision|0|||
49130815|NCT00909870|158318562|FG001|Overall Study|Physician Decision|2|||
49130816|NCT00909870|158318561|FG000|Overall Study|Other|1|||
49130817|NCT00909870|158318562|FG001|Overall Study|Other|5|||
49130818|NCT02078817|158318576|FG000|Overall Study|Withdrawal by Subject|1|||
49130819|NCT03415178|158318577|FG000|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0|||
49130820|NCT03415178|158318578|FG001|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2|||
49130821|NCT03415178|158318577|FG000|Single Arm Period (up to Week 16)|Adverse Event|0|||
49130822|NCT03415178|158318578|FG001|Single Arm Period (up to Week 16)|Adverse Event|1|||
49130823|NCT00666237|158318585|FG000|Overall Study|Death|5|||
49130824|NCT00666237|158318586|FG001|Overall Study|Death|5|||
49130825|NCT00666237|158318585|FG000|Overall Study|Lost to Follow-up|29|||
49130826|NCT00666237|158318586|FG001|Overall Study|Lost to Follow-up|25|||
49130827|NCT03736967|158320325|FG000|Overall Study|Withdrawal by Subject|26|||
49130828|NCT03736967|158320326|FG001|Overall Study|Withdrawal by Subject|25|||
49130829|NCT03736967|158320327|FG002|Overall Study|Withdrawal by Subject|23|||
49130830|NCT03736967|158320328|FG003|Overall Study|Withdrawal by Subject|26|||
49130831|NCT03736967|158320325|FG000|Overall Study|Lost to Follow-up|3|||
49130832|NCT03736967|158320326|FG001|Overall Study|Lost to Follow-up|2|||
49130833|NCT03736967|158320327|FG002|Overall Study|Lost to Follow-up|1|||
49130834|NCT03736967|158320328|FG003|Overall Study|Lost to Follow-up|1|||
49130835|NCT03736967|158320325|FG000|Overall Study|Physician Decision|1|||
49130836|NCT03736967|158320326|FG001|Overall Study|Physician Decision|0|||
49130837|NCT03736967|158320327|FG002|Overall Study|Physician Decision|0|||
49130838|NCT03736967|158320328|FG003|Overall Study|Physician Decision|1|||
49130839|NCT03736967|158320325|FG000|Overall Study|Adverse Event|0|||
49130840|NCT03736967|158320326|FG001|Overall Study|Adverse Event|1|||
49130841|NCT03736967|158320327|FG002|Overall Study|Adverse Event|0|||
49130842|NCT03736967|158320328|FG003|Overall Study|Adverse Event|1|||
49130843|NCT03736967|158320325|FG000|Overall Study|Death|0|||
49130844|NCT03736967|158320326|FG001|Overall Study|Death|0|||
49130845|NCT03736967|158320327|FG002|Overall Study|Death|0|||
49130846|NCT03736967|158320328|FG003|Overall Study|Death|1|||
49130847|NCT03736967|158320325|FG000|Overall Study|Randomized but never treated|1|||
49130848|NCT03736967|158320326|FG001|Overall Study|Randomized but never treated|0|||
49130849|NCT03736967|158320327|FG002|Overall Study|Randomized but never treated|0|||
48817509|NCT01189890|157175202|FG001|Overall Study|Physician Decision|4|||
49130850|NCT03736967|158320328|FG003|Overall Study|Randomized but never treated|0|||
49130851|NCT02369653|158320329|FG000|Overall Study|Lost to Follow-up|0|||
49130852|NCT02369653|158320330|FG001|Overall Study|Lost to Follow-up|1|||
49130853|NCT02369653|158320329|FG000|Overall Study|Administrative reason by sponsor|0|||
48723053|NCT00722371|156836575|FG000|Overall Study|Withdrawal by Subject|18|||
48723054|NCT00722371|156836576|FG001|Overall Study|Withdrawal by Subject|27|||
48723055|NCT00722371|156836577|FG002|Overall Study|Withdrawal by Subject|19|||
48817510|NCT01189890|157175201|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
48817511|NCT01189890|157175202|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
48817512|NCT03398148|157175203|FG000|Substudy 1 Period 1|Adverse Event|5|||
48817513|NCT03398148|157175204|FG001|Substudy 1 Period 1|Adverse Event|2|||
48817514|NCT03398148|157175205|FG002|Substudy 1 Period 1|Adverse Event|2|||
48817515|NCT03398148|157175206|FG003|Substudy 1 Period 1|Adverse Event|0|||
48817516|NCT03398148|157175207|FG004|Substudy 1 Period 1|Adverse Event|8|||
48817517|NCT03398148|157175208|FG005|Substudy 1 Period 1|Adverse Event|0|||
48817518|NCT03398148|157175209|FG006|Substudy 1 Period 1|Adverse Event|0|||
48723056|NCT00722371|156836578|FG003|Overall Study|Withdrawal by Subject|23|||
48723057|NCT00722371|156836579|FG004|Overall Study|Withdrawal by Subject|19|||
48723058|NCT00722371|156836580|FG005|Overall Study|Withdrawal by Subject|18|||
48723059|NCT00722371|156836581|FG006|Overall Study|Withdrawal by Subject|26|||
48723060|NCT01423604|156836589|FG000|Safety Run-In|Adverse Event|3|||
48723061|NCT01423604|156836590|FG001|Safety Run-In|Adverse Event|0|||
48723062|NCT01423604|156836589|FG000|Safety Run-In|Death|1|||
48723063|NCT01423604|156836590|FG001|Safety Run-In|Death|0|||
48723064|NCT01423604|156836589|FG000|Safety Run-In|Physician Decision|1|||
48723065|NCT01423604|156836590|FG001|Safety Run-In|Physician Decision|0|||
48723066|NCT01423604|156836589|FG000|Safety Run-In|Disease progression|3|||
48723067|NCT01423604|156836590|FG001|Safety Run-In|Disease progression|0|||
48723068|NCT01423604|156836589|FG000|Safety Run-In|Patient decision|1|||
48723069|NCT01423604|156836590|FG001|Safety Run-In|Patient decision|0|||
48723070|NCT01423604|156836589|FG000|Randomized|Adverse Event|4|||
48723071|NCT01423604|156836590|FG001|Randomized|Adverse Event|10|||
48723072|NCT01423604|156836589|FG000|Randomized|Death|1|||
48723073|NCT01423604|156836590|FG001|Randomized|Death|0|||
48723074|NCT01423604|156836589|FG000|Randomized|Physician Decision|16|||
48723075|NCT01423604|156836590|FG001|Randomized|Physician Decision|13|||
48723076|NCT01423604|156836589|FG000|Randomized|Other - unspecified|37|||
48723077|NCT01423604|156836590|FG001|Randomized|Other - unspecified|31|||
48723078|NCT01423604|156836589|FG000|Randomized|Patient decision|5|||
48723079|NCT01423604|156836590|FG001|Randomized|Patient decision|9|||
48723080|NCT00424255|156836591|FG000|Overall Study|Death|115|||
48723081|NCT00424255|156836592|FG001|Overall Study|Death|111|||
48723082|NCT00424255|156836591|FG000|Overall Study|Lost to Follow-up|26|||
48723083|NCT00424255|156836592|FG001|Overall Study|Lost to Follow-up|20|||
48723084|NCT00424255|156836591|FG000|Overall Study|Protocol Violation|0|||
48723085|NCT00424255|156836592|FG001|Overall Study|Protocol Violation|1|||
48723086|NCT00424255|156836591|FG000|Overall Study|Withdrawal by Subject|34|||
48723087|NCT00424255|156836592|FG001|Overall Study|Withdrawal by Subject|38|||
48723088|NCT00424255|156836591|FG000|Overall Study|Physician Decision|3|||
48723089|NCT00424255|156836592|FG001|Overall Study|Physician Decision|7|||
48723090|NCT00424255|156836591|FG000|Overall Study|Cognitive Disturbance|1|||
48817519|NCT03398148|157175210|FG007|Substudy 1 Period 1|Adverse Event|0|||
48817520|NCT03398148|157175211|FG008|Substudy 1 Period 1|Adverse Event|0|||
48723091|NCT00424255|156836592|FG001|Overall Study|Cognitive Disturbance|0|||
48723092|NCT00424255|156836591|FG000|Overall Study|Non-compliance by Participants|1|||
48723093|NCT00424255|156836592|FG001|Overall Study|Non-compliance by Participants|0|||
48723094|NCT00424255|156836591|FG000|Overall Study|Fatigue|1|||
48723095|NCT00424255|156836592|FG001|Overall Study|Fatigue|0|||
48723096|NCT00424255|156836591|FG000|Overall Study|Disease Progression|0|||
48723097|NCT00424255|156836592|FG001|Overall Study|Disease Progression|2|||
48723098|NCT00424255|156836591|FG000|Overall Study|Sponsor Terminated Study|161|||
48723099|NCT00424255|156836592|FG001|Overall Study|Sponsor Terminated Study|167|||
48723100|NCT00256282|156836593|FG000|Overall Study|Disease progression, relapse during acti|12|||
48723101|NCT00256282|156836593|FG000|Overall Study|Adverse Event|3|||
48723102|NCT00256282|156836593|FG000|Overall Study|Physician Decision|1|||
48723103|NCT00969280|156836594|FG000|Overall Study|Protocol Violation|2|||
48723104|NCT00969280|156836595|FG001|Overall Study|Protocol Violation|1|||
48723105|NCT00969280|156836594|FG000|Overall Study|Withdrawal by Subject|0|||
48723106|NCT00969280|156836595|FG001|Overall Study|Withdrawal by Subject|1|||
48723107|NCT00969280|156836594|FG000|Overall Study|infection of influenza A(H1N1)|0|||
48723108|NCT00969280|156836595|FG001|Overall Study|infection of influenza A(H1N1)|1|||
48723109|NCT02290431|156836596|FG000|Overall Study|Adverse Event|20|||
49130854|NCT02369653|158320330|FG001|Overall Study|Administrative reason by sponsor|1|||
49130855|NCT02369653|158320329|FG000|Overall Study|Death|1|||
49130856|NCT02369653|158320330|FG001|Overall Study|Death|2|||
48723110|NCT02290431|156836596|FG000|Overall Study|Progressive disease|4|||
48723111|NCT02290431|156836596|FG000|Overall Study|Study terminated by Sponsor|1|||
48723112|NCT02290431|156836596|FG000|Overall Study|Physician Decision|2|||
48723113|NCT03963401|156836597|FG000|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
48723114|NCT03963401|156836598|FG001|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
48723115|NCT03963401|156836599|FG002|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
48723116|NCT03963401|156836600|FG003|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
48723117|NCT03963401|156836601|FG004|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
48723118|NCT03963401|156836602|FG005|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
48723119|NCT03963401|156836597|FG000|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
48723120|NCT03963401|156836598|FG001|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
48723121|NCT03963401|156836599|FG002|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
48723122|NCT03963401|156836600|FG003|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
48723123|NCT03963401|156836601|FG004|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
48723124|NCT03963401|156836602|FG005|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
48723125|NCT03963401|156836597|FG000|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
48723126|NCT03963401|156836598|FG001|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
48723127|NCT03963401|156836599|FG002|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
48723128|NCT03963401|156836600|FG003|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
48723129|NCT03963401|156836601|FG004|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
48723130|NCT03963401|156836602|FG005|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0|||
48723131|NCT03963401|156836597|FG000|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
48723132|NCT03963401|156836598|FG001|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1|||
48723133|NCT03963401|156836599|FG002|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
48723134|NCT03963401|156836600|FG003|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
48723135|NCT03963401|156836601|FG004|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
48723136|NCT03963401|156836602|FG005|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
48723137|NCT03963401|156836597|FG000|Extension Period (Week 17 - Week 52)|Adverse Event|6|||
48723138|NCT03963401|156836598|FG001|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
48817521|NCT03398148|157175212|FG009|Substudy 1 Period 1|Adverse Event|0|||
49130857|NCT02369653|158320329|FG000|Overall Study|Participant withdrew consent|13|||
49130858|NCT02369653|158320330|FG001|Overall Study|Participant withdrew consent|3|||
49130859|NCT03587636|158320335|FG000|Overall Study|Lost to Follow-up|2|||
49130860|NCT03587636|158320336|FG001|Overall Study|Lost to Follow-up|5|||
49130861|NCT01458587|158320337|FG000|Overall Study|Withdrawal by Subject|1|||
49130862|NCT01458587|158320338|FG001|Overall Study|Withdrawal by Subject|0|||
49130863|NCT00726453|158320339|FG000|Primary Enrollment Group|Death|18|||
49130864|NCT00726453|158320340|FG001|Primary Enrollment Group|Death|0|||
49130865|NCT00726453|158320339|FG000|Primary Enrollment Group|Withdrawal by Subject|13|||
49130866|NCT00726453|158320340|FG001|Primary Enrollment Group|Withdrawal by Subject|0|||
49130867|NCT00726453|158320339|FG000|38 mm Length Group|Death|0|||
49130868|NCT00726453|158320340|FG001|38 mm Length Group|Death|3|||
49130869|NCT00977197|158320341|FG000|Overall Study|Withdrawal by Subject|3|||
49130870|NCT00977197|158320342|FG001|Overall Study|Withdrawal by Subject|4|||
48723139|NCT03963401|156836599|FG002|Extension Period (Week 17 - Week 52)|Adverse Event|2|||
48723140|NCT03963401|156836600|FG003|Extension Period (Week 17 - Week 52)|Adverse Event|0|||
48723141|NCT03963401|156836601|FG004|Extension Period (Week 17 - Week 52)|Adverse Event|4|||
48817522|NCT03398148|157175213|FG010|Substudy 1 Period 1|Adverse Event|0|||
48817523|NCT03398148|157175214|FG011|Substudy 1 Period 1|Adverse Event|0|||
48817524|NCT03398148|157175215|FG012|Substudy 1 Period 1|Adverse Event|0|||
48817525|NCT03398148|157175216|FG013|Substudy 1 Period 1|Adverse Event|0|||
48817526|NCT03398148|157175217|FG014|Substudy 1 Period 1|Adverse Event|0|||
48817527|NCT03398148|157175203|FG000|Substudy 1 Period 1|WITHDREW CONSENT|1|||
48817528|NCT03398148|157175204|FG001|Substudy 1 Period 1|WITHDREW CONSENT|2|||
48817529|NCT03398148|157175205|FG002|Substudy 1 Period 1|WITHDREW CONSENT|0|||
48817530|NCT03398148|157175206|FG003|Substudy 1 Period 1|WITHDREW CONSENT|1|||
48817531|NCT03398148|157175207|FG004|Substudy 1 Period 1|WITHDREW CONSENT|3|||
48817532|NCT03398148|157175208|FG005|Substudy 1 Period 1|WITHDREW CONSENT|0|||
48817533|NCT03398148|157175209|FG006|Substudy 1 Period 1|WITHDREW CONSENT|0|||
48817534|NCT03398148|157175210|FG007|Substudy 1 Period 1|WITHDREW CONSENT|0|||
48817535|NCT03398148|157175211|FG008|Substudy 1 Period 1|WITHDREW CONSENT|0|||
48817536|NCT03398148|157175212|FG009|Substudy 1 Period 1|WITHDREW CONSENT|0|||
48817537|NCT03398148|157175213|FG010|Substudy 1 Period 1|WITHDREW CONSENT|0|||
48817538|NCT03398148|157175214|FG011|Substudy 1 Period 1|WITHDREW CONSENT|0|||
48817539|NCT03398148|157175215|FG012|Substudy 1 Period 1|WITHDREW CONSENT|0|||
48817540|NCT03398148|157175216|FG013|Substudy 1 Period 1|WITHDREW CONSENT|0|||
48817541|NCT03398148|157175217|FG014|Substudy 1 Period 1|WITHDREW CONSENT|0|||
48817542|NCT03398148|157175203|FG000|Substudy 1 Period 1|Lack of Efficacy|1|||
48817543|NCT03398148|157175204|FG001|Substudy 1 Period 1|Lack of Efficacy|1|||
48817544|NCT03398148|157175205|FG002|Substudy 1 Period 1|Lack of Efficacy|1|||
48817545|NCT03398148|157175206|FG003|Substudy 1 Period 1|Lack of Efficacy|0|||
48817546|NCT03398148|157175207|FG004|Substudy 1 Period 1|Lack of Efficacy|20|||
48817547|NCT03398148|157175208|FG005|Substudy 1 Period 1|Lack of Efficacy|0|||
48817548|NCT03398148|157175209|FG006|Substudy 1 Period 1|Lack of Efficacy|0|||
48817549|NCT03398148|157175210|FG007|Substudy 1 Period 1|Lack of Efficacy|0|||
48723142|NCT03963401|156836602|FG005|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
48723143|NCT03963401|156836597|FG000|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
48723144|NCT03963401|156836598|FG001|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
48723145|NCT03963401|156836599|FG002|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
48723146|NCT03963401|156836600|FG003|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
48723147|NCT03963401|156836601|FG004|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
48723148|NCT03963401|156836602|FG005|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
48723149|NCT03963401|156836597|FG000|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
48723150|NCT03963401|156836598|FG001|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
48723151|NCT03963401|156836599|FG002|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1|||
48723152|NCT03963401|156836600|FG003|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
48723153|NCT03963401|156836601|FG004|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
48723154|NCT03963401|156836602|FG005|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
48723155|NCT03963401|156836597|FG000|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1|||
48723156|NCT03963401|156836598|FG001|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
48723157|NCT03963401|156836599|FG002|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
48723158|NCT03963401|156836600|FG003|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
48723159|NCT03963401|156836601|FG004|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
48723160|NCT03963401|156836602|FG005|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
48723161|NCT03963401|156836597|FG000|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4|||
48723162|NCT03963401|156836598|FG001|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
48723163|NCT03963401|156836599|FG002|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
48723164|NCT03963401|156836600|FG003|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
48723165|NCT03963401|156836601|FG004|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
48723166|NCT03963401|156836602|FG005|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
48723167|NCT03963401|156836597|FG000|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1|||
48723168|NCT03963401|156836598|FG001|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
48723169|NCT03963401|156836599|FG002|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
48723170|NCT03963401|156836600|FG003|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
48723171|NCT03963401|156836601|FG004|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
48817550|NCT03398148|157175211|FG008|Substudy 1 Period 1|Lack of Efficacy|0|||
48817551|NCT03398148|157175212|FG009|Substudy 1 Period 1|Lack of Efficacy|0|||
48921001|NCT00784654|157544819|FG001|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
48723172|NCT03963401|156836602|FG005|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
48817552|NCT03398148|157175213|FG010|Substudy 1 Period 1|Lack of Efficacy|0|||
48817553|NCT03398148|157175214|FG011|Substudy 1 Period 1|Lack of Efficacy|0|||
48817554|NCT03398148|157175215|FG012|Substudy 1 Period 1|Lack of Efficacy|0|||
48817555|NCT03398148|157175216|FG013|Substudy 1 Period 1|Lack of Efficacy|0|||
48817556|NCT03398148|157175217|FG014|Substudy 1 Period 1|Lack of Efficacy|0|||
48817557|NCT03398148|157175203|FG000|Substudy 1 Period 1|Other|0|||
48817558|NCT03398148|157175204|FG001|Substudy 1 Period 1|Other|1|||
48817559|NCT03398148|157175205|FG002|Substudy 1 Period 1|Other|0|||
48817560|NCT03398148|157175206|FG003|Substudy 1 Period 1|Other|0|||
48817561|NCT03398148|157175207|FG004|Substudy 1 Period 1|Other|3|||
48817562|NCT03398148|157175208|FG005|Substudy 1 Period 1|Other|0|||
48817563|NCT03398148|157175209|FG006|Substudy 1 Period 1|Other|0|||
48817564|NCT03398148|157175210|FG007|Substudy 1 Period 1|Other|0|||
48817565|NCT03398148|157175211|FG008|Substudy 1 Period 1|Other|0|||
49130871|NCT00977197|158320341|FG000|Overall Study|Adverse Event|3|||
49130872|NCT00977197|158320342|FG001|Overall Study|Adverse Event|1|||
49130873|NCT00977197|158320341|FG000|Overall Study|Lack of Efficacy|1|||
49130874|NCT00977197|158320342|FG001|Overall Study|Lack of Efficacy|0|||
49130875|NCT00977197|158320341|FG000|Overall Study|Lost to Follow-up|1|||
49130876|NCT00977197|158320342|FG001|Overall Study|Lost to Follow-up|3|||
48723173|NCT03963401|156836597|FG000|Extension Period (Week 17 - Week 52)|Other|1|||
48723174|NCT03963401|156836598|FG001|Extension Period (Week 17 - Week 52)|Other|1|||
48723175|NCT03963401|156836599|FG002|Extension Period (Week 17 - Week 52)|Other|0|||
48723176|NCT03963401|156836600|FG003|Extension Period (Week 17 - Week 52)|Other|1|||
48723177|NCT03963401|156836601|FG004|Extension Period (Week 17 - Week 52)|Other|1|||
48723178|NCT03963401|156836602|FG005|Extension Period (Week 17 - Week 52)|Other|1|||
48723179|NCT00821327|156836605|FG000|Overall Study|Adverse Event|13|||
48723180|NCT00821327|156836605|FG000|Overall Study|Patient Request|1|||
48723181|NCT00821327|156836605|FG000|Overall Study|Investigator Request|2|||
48723182|NCT00821327|156836605|FG000|Overall Study|Sponsor Request|1|||
48723183|NCT00821327|156836605|FG000|Overall Study|Disease Progression|13|||
48723184|NCT00821327|156836605|FG000|Overall Study|Other/Unknown|5|||
48723185|NCT01514370|156836606|FG000|Overall Study|Protocol Violation|2|||
48723186|NCT01514370|156836607|FG001|Overall Study|Protocol Violation|3|||
48723187|NCT01514370|156836606|FG000|Overall Study|Lost to Follow-up|0|||
48723188|NCT01514370|156836607|FG001|Overall Study|Lost to Follow-up|2|||
48723189|NCT01514370|156836606|FG000|Overall Study|Withdrawal by Subject|2|||
48723190|NCT01514370|156836607|FG001|Overall Study|Withdrawal by Subject|1|||
48723191|NCT01514370|156836606|FG000|Overall Study|Adverse Event|1|||
48723192|NCT01514370|156836607|FG001|Overall Study|Adverse Event|3|||
48723193|NCT01514370|156836606|FG000|Overall Study|Other|6|||
48723194|NCT01514370|156836607|FG001|Overall Study|Other|7|||
48723195|NCT01551420|156836608|FG000|In-laboratory (Part A)|Lost to Follow-up|2|||
48723196|NCT01551420|156836609|FG001|In-laboratory (Part A)|Lost to Follow-up|1|||
48723197|NCT01551420|156836608|FG000|In-laboratory (Part A)|Withdrawal by Subject|2|||
48723198|NCT01551420|156836609|FG001|In-laboratory (Part A)|Withdrawal by Subject|0|||
48723199|NCT01551420|156836608|FG000|In-laboratory (Part A)|Scheduling conflict|2|||
48723200|NCT01551420|156836609|FG001|In-laboratory (Part A)|Scheduling conflict|1|||
48723201|NCT01551420|156836608|FG000|Screened for Part B Eligibility|Declined participation|8|||
48723202|NCT01551420|156836609|FG001|Screened for Part B Eligibility|Declined participation|1|||
48723203|NCT01551420|156836608|FG000|Screened for Part B Eligibility|Deemed ineligible by staff|1|||
48723204|NCT01551420|156836609|FG001|Screened for Part B Eligibility|Deemed ineligible by staff|2|||
48723205|NCT01551420|156836608|FG000|Home Use (Part B)|Withdrawal by Subject|6|||
48723206|NCT01551420|156836609|FG001|Home Use (Part B)|Withdrawal by Subject|0|||
48723207|NCT01551420|156836608|FG000|Home Use (Part B)|Withdrawal by staff|0|||
48723208|NCT01551420|156836609|FG001|Home Use (Part B)|Withdrawal by staff|1|||
48723209|NCT03612856|156836610|FG000|Pre-dose Period|Physician Decision|0|||
48723210|NCT03612856|156836611|FG001|Pre-dose Period|Physician Decision|1|||
48723211|NCT03612856|156836612|FG002|Pre-dose Period|Physician Decision|1|||
48723212|NCT03612856|156836610|FG000|Pre-dose Period|Withdrawal by Subject|0|||
48723213|NCT03612856|156836611|FG001|Pre-dose Period|Withdrawal by Subject|1|||
48723214|NCT03612856|156836612|FG002|Pre-dose Period|Withdrawal by Subject|0|||
48723215|NCT00219544|156836613|FG000|Single Blind Treatment Period|Lack of Efficacy|5|||
48723216|NCT00219544|156836614|FG001|Single Blind Treatment Period|Lack of Efficacy|0|||
48723217|NCT00219544|156836613|FG000|Single Blind Treatment Period|Adverse Event|9|||
48723218|NCT00219544|156836614|FG001|Single Blind Treatment Period|Adverse Event|0|||
48723219|NCT00219544|156836613|FG000|Single Blind Treatment Period|Protocol Violation|4|||
48817566|NCT03398148|157175212|FG009|Substudy 1 Period 1|Other|0|||
48817567|NCT03398148|157175213|FG010|Substudy 1 Period 1|Other|0|||
49130877|NCT00977197|158320341|FG000|Overall Study|Nonadherence|1|||
48723220|NCT00219544|156836614|FG001|Single Blind Treatment Period|Protocol Violation|0|||
48723221|NCT00219544|156836613|FG000|Single Blind Treatment Period|Lost to Follow-up|2|||
48723222|NCT00219544|156836614|FG001|Single Blind Treatment Period|Lost to Follow-up|0|||
48723223|NCT00219544|156836613|FG000|Single Blind Treatment Period|Investigator decision to withdraw|1|||
48817568|NCT03398148|157175214|FG011|Substudy 1 Period 1|Other|0|||
49130878|NCT00977197|158320342|FG001|Overall Study|Nonadherence|1|||
48723224|NCT00219544|156836614|FG001|Single Blind Treatment Period|Investigator decision to withdraw|0|||
48817569|NCT03398148|157175215|FG012|Substudy 1 Period 1|Other|0|||
48817570|NCT03398148|157175216|FG013|Substudy 1 Period 1|Other|0|||
48817571|NCT03398148|157175217|FG014|Substudy 1 Period 1|Other|0|||
48817572|NCT03398148|157175203|FG000|Substudy 1 Period 1|Enrolled but not Treated|0|||
48817573|NCT03398148|157175204|FG001|Substudy 1 Period 1|Enrolled but not Treated|0|||
48817574|NCT03398148|157175205|FG002|Substudy 1 Period 1|Enrolled but not Treated|0|||
48723225|NCT00219544|156836613|FG000|Single Blind Treatment Period|Withdrawal by Subject|1|||
48817575|NCT03398148|157175206|FG003|Substudy 1 Period 1|Enrolled but not Treated|0|||
48817576|NCT03398148|157175207|FG004|Substudy 1 Period 1|Enrolled but not Treated|1|||
48817577|NCT03398148|157175208|FG005|Substudy 1 Period 1|Enrolled but not Treated|0|||
48817578|NCT03398148|157175209|FG006|Substudy 1 Period 1|Enrolled but not Treated|0|||
48817579|NCT03398148|157175210|FG007|Substudy 1 Period 1|Enrolled but not Treated|0|||
48817580|NCT03398148|157175211|FG008|Substudy 1 Period 1|Enrolled but not Treated|0|||
48817581|NCT03398148|157175212|FG009|Substudy 1 Period 1|Enrolled but not Treated|0|||
48817582|NCT03398148|157175213|FG010|Substudy 1 Period 1|Enrolled but not Treated|0|||
48817583|NCT03398148|157175214|FG011|Substudy 1 Period 1|Enrolled but not Treated|0|||
48817584|NCT03398148|157175215|FG012|Substudy 1 Period 1|Enrolled but not Treated|0|||
48817585|NCT03398148|157175216|FG013|Substudy 1 Period 1|Enrolled but not Treated|0|||
48817586|NCT03398148|157175217|FG014|Substudy 1 Period 1|Enrolled but not Treated|0|||
48817587|NCT03398148|157175203|FG000|Substudy 1 Period 2|Adverse Event|0|||
49130879|NCT00551369|158320343|FG000|Overall Study|Protocol Violation|5|||
49130880|NCT00551369|158320343|FG000|Overall Study|Withdrawal by Subject|1|||
49130881|NCT00551369|158320343|FG000|Overall Study|Not treated per protocol and re|1|||
49130882|NCT02349386|158320347|FG000|24-Week Double-Blind Main Study|Adverse Event|0|||
49130883|NCT02349386|158320348|FG001|24-Week Double-Blind Main Study|Adverse Event|0|||
49130884|NCT02349386|158320349|FG002|24-Week Double-Blind Main Study|Adverse Event|1|||
49130885|NCT02349386|158320350|FG003|24-Week Double-Blind Main Study|Adverse Event|1|||
49130886|NCT02349386|158320347|FG000|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
48723226|NCT00219544|156836614|FG001|Single Blind Treatment Period|Withdrawal by Subject|0|||
48723227|NCT03800654|156836620|FG000|Overall Study|Time constraints|3|||
48723228|NCT03800654|156836621|FG001|Overall Study|Time constraints|3|||
48723229|NCT03800654|156836622|FG002|Overall Study|Time constraints|3|||
48723230|NCT03800654|156836620|FG000|Overall Study|Did Not Meet Inclusion Criteria|1|||
48723231|NCT03800654|156836621|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
48723232|NCT03800654|156836622|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
48723233|NCT03800654|156836620|FG000|Overall Study|Lost to Follow-up|2|||
48723234|NCT03800654|156836621|FG001|Overall Study|Lost to Follow-up|1|||
48723235|NCT03800654|156836622|FG002|Overall Study|Lost to Follow-up|6|||
48723236|NCT03800654|156836620|FG000|Overall Study|Medical Health Issue|0|||
48723237|NCT03800654|156836621|FG001|Overall Study|Medical Health Issue|0|||
48723238|NCT03800654|156836622|FG002|Overall Study|Medical Health Issue|1|||
48723239|NCT03800654|156836620|FG000|Overall Study|Personal Issues|0|||
48723240|NCT03800654|156836621|FG001|Overall Study|Personal Issues|2|||
48723241|NCT03800654|156836622|FG002|Overall Study|Personal Issues|0|||
48723242|NCT03800654|156836620|FG000|Overall Study|Protocol Violation|0|||
48723243|NCT03800654|156836621|FG001|Overall Study|Protocol Violation|1|||
48723244|NCT03800654|156836622|FG002|Overall Study|Protocol Violation|0|||
48723245|NCT02380690|156836626|FG000|Overall Study|Lost to Follow-up|14|||
48723246|NCT02380690|156836627|FG001|Overall Study|Lost to Follow-up|4|||
48723247|NCT02380690|156836626|FG000|Overall Study|Withdrawal by Subject|20|||
48723248|NCT02380690|156836627|FG001|Overall Study|Withdrawal by Subject|8|||
48723249|NCT01077154|156836628|FG000|Overall Study|Protocol-specified Criteria: Study Ended|1524|||
48723250|NCT01077154|156836629|FG001|Overall Study|Protocol-specified Criteria: Study Ended|1514|||
48723251|NCT01077154|156836628|FG000|Overall Study|Withdrawal by Subject|369|||
48723252|NCT01077154|156836629|FG001|Overall Study|Withdrawal by Subject|385|||
48723253|NCT01077154|156836628|FG000|Overall Study|Death|215|||
48723254|NCT01077154|156836629|FG001|Overall Study|Death|214|||
48723255|NCT01077154|156836628|FG000|Overall Study|Lost to Follow-up|43|||
48723256|NCT01077154|156836629|FG001|Overall Study|Lost to Follow-up|35|||
48723257|NCT01077154|156836628|FG000|Overall Study|Noncompliance|22|||
48723258|NCT01077154|156836629|FG001|Overall Study|Noncompliance|20|||
48723259|NCT01077154|156836628|FG000|Overall Study|Disease Progression|18|||
48723260|NCT01077154|156836629|FG001|Overall Study|Disease Progression|20|||
48723261|NCT01077154|156836628|FG000|Overall Study|Ineligibility Determined|10|||
48723262|NCT01077154|156836629|FG001|Overall Study|Ineligibility Determined|14|||
48723263|NCT01077154|156836628|FG000|Overall Study|Other|14|||
48723264|NCT01077154|156836629|FG001|Overall Study|Other|11|||
48723265|NCT01077154|156836628|FG000|Overall Study|Adverse Event|9|||
48817588|NCT03398148|157175204|FG001|Substudy 1 Period 2|Adverse Event|0|||
48723266|NCT01077154|156836629|FG001|Overall Study|Adverse Event|9|||
48723267|NCT01077154|156836628|FG000|Overall Study|Administrative Decision|1|||
48723268|NCT01077154|156836629|FG001|Overall Study|Administrative Decision|6|||
48723269|NCT01077154|156836628|FG000|Overall Study|Protocol Deviation|1|||
48723270|NCT01077154|156836629|FG001|Overall Study|Protocol Deviation|0|||
48723271|NCT02829944|156836630|FG000|Overall Study|Physician Decision|0|||
48723272|NCT02829944|156836631|FG001|Overall Study|Physician Decision|1|||
48723273|NCT02829944|156836630|FG000|Overall Study|Screen Failure|2|||
48723274|NCT02829944|156836631|FG001|Overall Study|Screen Failure|2|||
49130887|NCT02349386|158320348|FG001|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
49130888|NCT02349386|158320349|FG002|24-Week Double-Blind Main Study|Lack of Efficacy|2|||
49130889|NCT02349386|158320350|FG003|24-Week Double-Blind Main Study|Lack of Efficacy|7|||
49130890|NCT02349386|158320347|FG000|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
49130891|NCT02349386|158320348|FG001|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
49130892|NCT02349386|158320349|FG002|24-Week Double-Blind Main Study|Withdrawal by Subject|1|||
49130893|NCT02349386|158320350|FG003|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
49130894|NCT02349386|158320347|FG000|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
49130895|NCT02349386|158320348|FG001|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
49130896|NCT02349386|158320349|FG002|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|1|||
49130897|NCT02349386|158320350|FG003|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
49130898|NCT02349386|158320347|FG000|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
49130899|NCT02349386|158320348|FG001|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
49130900|NCT02349386|158320349|FG002|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
49130901|NCT02349386|158320350|FG003|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
49130902|NCT02349386|158320347|FG000|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
49130903|NCT02349386|158320348|FG001|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
49130904|NCT02349386|158320349|FG002|28-Week Double-Blind Optional Extension|Withdrawal by Subject|1|||
49130905|NCT02349386|158320350|FG003|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
49130906|NCT01496456|158320351|FG000|Overall Study|Protocol Violation|1|||
49130907|NCT01496456|158320351|FG000|Overall Study|Lost to Follow-up|7|||
49130908|NCT03451071|158320358|FG000|First Vaccine|Withdrawal by Subject|1|||
49130909|NCT03451071|158320358|FG000|Second Vaccine|Lost to Follow-up|19|||
49130910|NCT03451071|158320358|FG000|Third Vaccine|Lost to Follow-up|22|||
49130911|NCT03451071|158320358|FG000|Final Questionnaire and Blood Draw|Lost to Follow-up|4|||
49130912|NCT00297167|158320359|FG000|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
49130913|NCT00297167|158320360|FG001|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
49130914|NCT00297167|158320361|FG002|Open-label Dose Normalization Period 1|Withdrawal by Subject|1|||
49130915|NCT00297167|158320359|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
49130916|NCT00297167|158320360|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
49130917|NCT00297167|158320361|FG002|Second Double-blind Intervention Period|Protocol Violation|0|||
49130918|NCT03834350|158320362|FG000|Overall Study|Withdrawal by Subject|1|||
49130919|NCT01603277|158320363|FG000|Overall Study|Adverse Event|1|||
49130920|NCT01603277|158320364|FG001|Overall Study|Adverse Event|2|||
49130921|NCT01603277|158320363|FG000|Overall Study|Physician Decision|0|||
49130922|NCT01603277|158320364|FG001|Overall Study|Physician Decision|1|||
49130923|NCT01603277|158320363|FG000|Overall Study|Protocol Violation|6|||
49130924|NCT01603277|158320364|FG001|Overall Study|Protocol Violation|10|||
49130925|NCT01603277|158320363|FG000|Overall Study|Withdrawal by Subject|5|||
49130926|NCT01603277|158320364|FG001|Overall Study|Withdrawal by Subject|4|||
49130927|NCT01603277|158320363|FG000|Overall Study|Non-Compliance|2|||
49130928|NCT01603277|158320364|FG001|Overall Study|Non-Compliance|1|||
48817589|NCT03398148|157175205|FG002|Substudy 1 Period 2|Adverse Event|0|||
48817590|NCT03398148|157175206|FG003|Substudy 1 Period 2|Adverse Event|0|||
48817591|NCT03398148|157175207|FG004|Substudy 1 Period 2|Adverse Event|0|||
48817592|NCT03398148|157175208|FG005|Substudy 1 Period 2|Adverse Event|2|||
48817593|NCT03398148|157175209|FG006|Substudy 1 Period 2|Adverse Event|4|||
48817594|NCT03398148|157175210|FG007|Substudy 1 Period 2|Adverse Event|0|||
48817595|NCT03398148|157175211|FG008|Substudy 1 Period 2|Adverse Event|0|||
48817596|NCT03398148|157175212|FG009|Substudy 1 Period 2|Adverse Event|0|||
48817597|NCT03398148|157175213|FG010|Substudy 1 Period 2|Adverse Event|0|||
48817598|NCT03398148|157175214|FG011|Substudy 1 Period 2|Adverse Event|0|||
48817599|NCT03398148|157175215|FG012|Substudy 1 Period 2|Adverse Event|0|||
49130929|NCT01186770|158320365|FG000|Overall Study|Ineligibility|0|||
49130930|NCT01186770|158320366|FG001|Overall Study|Ineligibility|0|||
49130931|NCT01186770|158320367|FG002|Overall Study|Ineligibility|2|||
49130932|NCT01186770|158320368|FG003|Overall Study|Ineligibility|0|||
49130933|NCT01186770|158320365|FG000|Overall Study|Protocol Violation|7|||
49130934|NCT01186770|158320366|FG001|Overall Study|Protocol Violation|9|||
49130935|NCT01186770|158320367|FG002|Overall Study|Protocol Violation|12|||
49130936|NCT01186770|158320368|FG003|Overall Study|Protocol Violation|14|||
49130937|NCT01186770|158320365|FG000|Overall Study|Adverse Event|2|||
49130938|NCT01186770|158320366|FG001|Overall Study|Adverse Event|9|||
48817600|NCT03398148|157175216|FG013|Substudy 1 Period 2|Adverse Event|0|||
48817601|NCT03398148|157175217|FG014|Substudy 1 Period 2|Adverse Event|0|||
48817602|NCT03398148|157175203|FG000|Substudy 1 Period 2|WITHDREW CONSENT|0|||
48817603|NCT03398148|157175204|FG001|Substudy 1 Period 2|WITHDREW CONSENT|0|||
48817604|NCT03398148|157175205|FG002|Substudy 1 Period 2|WITHDREW CONSENT|0|||
48817605|NCT03398148|157175206|FG003|Substudy 1 Period 2|WITHDREW CONSENT|0|||
48817606|NCT03398148|157175207|FG004|Substudy 1 Period 2|WITHDREW CONSENT|0|||
48817607|NCT03398148|157175208|FG005|Substudy 1 Period 2|WITHDREW CONSENT|0|||
49130939|NCT01186770|158320367|FG002|Overall Study|Adverse Event|7|||
49130940|NCT01186770|158320368|FG003|Overall Study|Adverse Event|9|||
49130941|NCT01186770|158320365|FG000|Overall Study|Withdrawal by Subject|15|||
49130942|NCT01186770|158320366|FG001|Overall Study|Withdrawal by Subject|13|||
49130943|NCT01186770|158320367|FG002|Overall Study|Withdrawal by Subject|11|||
49130944|NCT01186770|158320368|FG003|Overall Study|Withdrawal by Subject|17|||
49130945|NCT01186770|158320365|FG000|Overall Study|Lost to Follow-up|10|||
49130946|NCT01186770|158320366|FG001|Overall Study|Lost to Follow-up|6|||
49130947|NCT01186770|158320367|FG002|Overall Study|Lost to Follow-up|14|||
49130948|NCT01186770|158320368|FG003|Overall Study|Lost to Follow-up|9|||
49130949|NCT01186770|158320365|FG000|Overall Study|Insufficient response to treatment|7|||
49130950|NCT01186770|158320366|FG001|Overall Study|Insufficient response to treatment|8|||
49130951|NCT01186770|158320367|FG002|Overall Study|Insufficient response to treatment|5|||
49130952|NCT01186770|158320368|FG003|Overall Study|Insufficient response to treatment|7|||
49130953|NCT01186770|158320365|FG000|Overall Study|Other than specified|0|||
49130954|NCT01186770|158320366|FG001|Overall Study|Other than specified|1|||
49130955|NCT01186770|158320367|FG002|Overall Study|Other than specified|1|||
49130956|NCT01186770|158320368|FG003|Overall Study|Other than specified|2|||
49130957|NCT01900444|158320372|FG000|Overall Study|Protocol Violation|2|||
49130958|NCT01900444|158320372|FG000|Overall Study|Lost to Follow-up|1|||
49130959|NCT00630916|158320373|FG000|Overall Study|Death|110|||
49130960|NCT00630916|158320373|FG000|Overall Study|Explant|8|||
49130961|NCT00630916|158320373|FG000|Overall Study|Lost to Follow-up|5|||
49130962|NCT00630916|158320373|FG000|Overall Study|Withdrawal by Subject|30|||
49130963|NCT00630916|158320373|FG000|Overall Study|Protocol Violation|7|||
49130964|NCT00630916|158320373|FG000|Overall Study|Physician Decision|47|||
49130965|NCT00630916|158320373|FG000|Overall Study|Lack of Efficacy|3|||
49130966|NCT02147626|158320377|FG000|Overall Study|Lost to Follow-up|4|||
49130967|NCT02147626|158320378|FG001|Overall Study|Lost to Follow-up|4|||
49130968|NCT02147626|158320377|FG000|Overall Study|Pregnancy|1|||
49130969|NCT02147626|158320378|FG001|Overall Study|Pregnancy|2|||
49130970|NCT02147626|158320377|FG000|Overall Study|Withdrawal by Subject|0|||
49130971|NCT02147626|158320378|FG001|Overall Study|Withdrawal by Subject|1|||
49130972|NCT04009837|158320381|FG000|Overall Study|Withdrawal by Subject|5|||
49130973|NCT04009837|158320382|FG001|Overall Study|Withdrawal by Subject|4|||
49130974|NCT04009837|158320381|FG000|Overall Study|Did not complete any aspect of of 8-week assessment|3|||
49130975|NCT04009837|158320382|FG001|Overall Study|Did not complete any aspect of of 8-week assessment|7|||
49130976|NCT01838876|158320385|FG000|Overall Study|Adverse Event|49|||
49130977|NCT01838876|158320385|FG000|Overall Study|Insufficient Therapeutic Response|10|||
49130978|NCT01838876|158320385|FG000|Overall Study|Protocol Violation|34|||
49130979|NCT01838876|158320385|FG000|Overall Study|Withdrawal of Consent|33|||
49130980|NCT01838876|158320385|FG000|Overall Study|Lost to Follow-up|21|||
49130981|NCT01838876|158320385|FG000|Overall Study|Study or Site Terminated by Sponsor|1|||
49130982|NCT01838876|158320385|FG000|Overall Study|Reason not Specified|7|||
49130983|NCT01838876|158320385|FG000|Overall Study|Did not meet eligibility criteria|78|||
49130984|NCT03101020|158320388|FG000|Overall Study|Lack of time to participate|1|||
49130985|NCT03101020|158320389|FG001|Overall Study|Lack of time to participate|0|||
49130986|NCT03101020|158320388|FG000|Overall Study|Ran over by a car|0|||
49130987|NCT03101020|158320389|FG001|Overall Study|Ran over by a car|1|||
49130988|NCT03101020|158320388|FG000|Overall Study|Withdrawal by Subject|0|||
49130989|NCT03101020|158320389|FG001|Overall Study|Withdrawal by Subject|2|||
49130990|NCT05412134|158320391|FG000|Overall Study|Lost to Follow-up|2|||
49130991|NCT05412134|158320392|FG001|Overall Study|Lost to Follow-up|0|||
49130992|NCT01192815|158320395|FG000|Overall Study|Withdrawal by Subject|1|||
49130993|NCT01192815|158320395|FG000|Overall Study|Lack of Efficacy|1|||
49130994|NCT03444584|158320399|FG000|Overall Study|Withdrawal by Subject|0|||
49130995|NCT03444584|158320400|FG001|Overall Study|Withdrawal by Subject|1|||
49130996|NCT03444584|158320399|FG000|Overall Study|Other|0|||
49130997|NCT03444584|158320400|FG001|Overall Study|Other|1|||
49130998|NCT02592824|158320406|FG000|Overall Study|Protocol Violation|5|||
49130999|NCT02592824|158320407|FG001|Overall Study|Protocol Violation|3|||
49131000|NCT02592824|158320406|FG000|Overall Study|Lost to Follow-up|2|||
49131001|NCT02592824|158320407|FG001|Overall Study|Lost to Follow-up|1|||
49131002|NCT01142336|158320408|FG000|Overall Study|Adverse Event|1|||
49131003|NCT01142336|158320409|FG001|Overall Study|Adverse Event|1|||
49131004|NCT01142336|158320408|FG000|Overall Study|Lost to Follow-up|0|||
49131005|NCT01142336|158320409|FG001|Overall Study|Lost to Follow-up|1|||
49131006|NCT01704261|158320410|FG000|Overall Study|Withdrawal by Subject|12|||
49131007|NCT01704261|158320411|FG001|Overall Study|Withdrawal by Subject|15|||
49131008|NCT01704261|158320410|FG000|Overall Study|Lost to Follow-up|1|||
49131009|NCT01704261|158320411|FG001|Overall Study|Lost to Follow-up|0|||
49131010|NCT00869960|158320412|FG000|Overall Study|Lost to Follow-up|2|||
49131011|NCT02153918|158320417|FG000|Overall Study|Refused further treatment|1|||
49131012|NCT02783911|158320420|FG000|Overall Study|Lost to Follow-up|3|||
49131013|NCT02783911|158320421|FG001|Overall Study|Lost to Follow-up|32|||
49131014|NCT01218802|158320425|FG000|Overall Study|Lost to Follow-up|5|||
49131015|NCT01218802|158320426|FG001|Overall Study|Lost to Follow-up|6|||
49131016|NCT01218802|158320425|FG000|Overall Study|Withdrawal by Subject|3|||
49131017|NCT01218802|158320426|FG001|Overall Study|Withdrawal by Subject|10|||
49131018|NCT01218802|158320425|FG000|Overall Study|Adverse Event|0|||
49131019|NCT01218802|158320426|FG001|Overall Study|Adverse Event|2|||
49131020|NCT01218802|158320425|FG000|Overall Study|Incarcerated|2|||
49131021|NCT01218802|158320426|FG001|Overall Study|Incarcerated|0|||
49131022|NCT01123655|158320427|FG000|Overall Study|Medication for RA had to be changed|1|||
49131023|NCT01123655|158320428|FG001|Overall Study|Medication for RA had to be changed|0|||
49131024|NCT01123655|158320429|FG002|Overall Study|Medication for RA had to be changed|0|||
49131025|NCT01123655|158320427|FG000|Overall Study|new illness|0|||
49131026|NCT01123655|158320428|FG001|Overall Study|new illness|1|||
49131027|NCT01123655|158320429|FG002|Overall Study|new illness|0|||
49131028|NCT01123655|158320427|FG000|Overall Study|began prohibitive drug|0|||
49131029|NCT01123655|158320428|FG001|Overall Study|began prohibitive drug|0|||
49131030|NCT01123655|158320429|FG002|Overall Study|began prohibitive drug|1|||
49131031|NCT00062166|158320430|FG000|Overall Study|Withdrawal by Subject|6|||
49131032|NCT00262119|158320432|FG000|Overall Study|Lost to Follow-up|38|||
49131033|NCT00262119|158320433|FG001|Overall Study|Lost to Follow-up|51|||
49131034|NCT00262119|158320434|FG002|Overall Study|Lost to Follow-up|42|||
49131035|NCT00262119|158320432|FG000|Overall Study|Death|20|||
48723275|NCT02829944|156836630|FG000|Overall Study|Inadequate Neuraxial Block|1|||
48817608|NCT03398148|157175209|FG006|Substudy 1 Period 2|WITHDREW CONSENT|1|||
48817609|NCT03398148|157175210|FG007|Substudy 1 Period 2|WITHDREW CONSENT|2|||
48817610|NCT03398148|157175211|FG008|Substudy 1 Period 2|WITHDREW CONSENT|0|||
48817611|NCT03398148|157175212|FG009|Substudy 1 Period 2|WITHDREW CONSENT|0|||
48817612|NCT03398148|157175213|FG010|Substudy 1 Period 2|WITHDREW CONSENT|0|||
48817613|NCT03398148|157175214|FG011|Substudy 1 Period 2|WITHDREW CONSENT|0|||
48817614|NCT03398148|157175215|FG012|Substudy 1 Period 2|WITHDREW CONSENT|0|||
48817615|NCT03398148|157175216|FG013|Substudy 1 Period 2|WITHDREW CONSENT|0|||
48817616|NCT03398148|157175217|FG014|Substudy 1 Period 2|WITHDREW CONSENT|0|||
48817617|NCT03398148|157175203|FG000|Substudy 1 Period 2|Lack of Efficacy|0|||
48817618|NCT03398148|157175204|FG001|Substudy 1 Period 2|Lack of Efficacy|0|||
48817619|NCT03398148|157175205|FG002|Substudy 1 Period 2|Lack of Efficacy|0|||
48817620|NCT03398148|157175206|FG003|Substudy 1 Period 2|Lack of Efficacy|0|||
48817621|NCT03398148|157175207|FG004|Substudy 1 Period 2|Lack of Efficacy|0|||
48817622|NCT03398148|157175208|FG005|Substudy 1 Period 2|Lack of Efficacy|5|||
48817623|NCT03398148|157175209|FG006|Substudy 1 Period 2|Lack of Efficacy|5|||
48817624|NCT03398148|157175210|FG007|Substudy 1 Period 2|Lack of Efficacy|0|||
48817625|NCT03398148|157175211|FG008|Substudy 1 Period 2|Lack of Efficacy|2|||
49131036|NCT00262119|158320433|FG001|Overall Study|Death|19|||
49131037|NCT00262119|158320434|FG002|Overall Study|Death|16|||
49131038|NCT04682301|158320435|FG000|Overall Study|Participant enrolled in Aim I only.|60|||
49131039|NCT04682301|158320435|FG000|Overall Study|Death|2|||
48723276|NCT02829944|156836631|FG001|Overall Study|Inadequate Neuraxial Block|1|||
48723277|NCT02829944|156836630|FG000|Overall Study|Withdrawal by Subject|2|||
48723278|NCT02829944|156836631|FG001|Overall Study|Withdrawal by Subject|1|||
48723279|NCT02829944|156836630|FG000|Overall Study|Catheter Displacement|1|||
48723280|NCT02829944|156836631|FG001|Overall Study|Catheter Displacement|0|||
48723281|NCT02829944|156836630|FG000|Overall Study|Catheter broke|0|||
48723282|NCT02829944|156836631|FG001|Overall Study|Catheter broke|1|||
48723283|NCT02829944|156836630|FG000|Overall Study|Staff unavailable|0|||
48723284|NCT02829944|156836631|FG001|Overall Study|Staff unavailable|1|||
48723285|NCT03640559|156836632|FG000|Overall Study|Physician Decision|1|||
48723286|NCT03640559|156836633|FG001|Overall Study|Physician Decision|1|||
48723287|NCT03640559|156836632|FG000|Overall Study|Withdrawal by Subject|1|||
48723288|NCT03640559|156836633|FG001|Overall Study|Withdrawal by Subject|0|||
48723289|NCT01340872|156837906|FG000|Double-blind Phase|Adverse Event|6|||
48723290|NCT01340872|156837907|FG001|Double-blind Phase|Adverse Event|4|||
48723291|NCT01340872|156837908|FG002|Double-blind Phase|Adverse Event|0|||
48723292|NCT01340872|156837909|FG003|Double-blind Phase|Adverse Event|0|||
48723293|NCT01340872|156837906|FG000|Double-blind Phase|Withdrawal by Subject|3|||
48723294|NCT01340872|156837907|FG001|Double-blind Phase|Withdrawal by Subject|5|||
48723295|NCT01340872|156837908|FG002|Double-blind Phase|Withdrawal by Subject|0|||
48723296|NCT01340872|156837909|FG003|Double-blind Phase|Withdrawal by Subject|0|||
48817626|NCT03398148|157175212|FG009|Substudy 1 Period 2|Lack of Efficacy|0|||
48817627|NCT03398148|157175213|FG010|Substudy 1 Period 2|Lack of Efficacy|0|||
48817628|NCT03398148|157175214|FG011|Substudy 1 Period 2|Lack of Efficacy|0|||
48817629|NCT03398148|157175215|FG012|Substudy 1 Period 2|Lack of Efficacy|0|||
48817630|NCT03398148|157175216|FG013|Substudy 1 Period 2|Lack of Efficacy|0|||
48817631|NCT03398148|157175217|FG014|Substudy 1 Period 2|Lack of Efficacy|0|||
48817632|NCT03398148|157175203|FG000|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
48817633|NCT03398148|157175204|FG001|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
49131040|NCT03462680|158320440|FG000|Overall Study|Withdrawal by Subject|3|||
49131041|NCT03462680|158320441|FG001|Overall Study|Withdrawal by Subject|5|||
49131042|NCT00392223|158320442|FG000|Overall Study|Adverse Event|5|||
49131043|NCT00392223|158320443|FG001|Overall Study|Adverse Event|4|||
49131044|NCT00392223|158320442|FG000|Overall Study|Lost to Follow-up|1|||
49131045|NCT00392223|158320443|FG001|Overall Study|Lost to Follow-up|4|||
48817634|NCT03398148|157175205|FG002|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
48817635|NCT03398148|157175206|FG003|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
48817636|NCT03398148|157175207|FG004|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
48817637|NCT03398148|157175208|FG005|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
48817638|NCT03398148|157175209|FG006|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|1|||
48817639|NCT03398148|157175210|FG007|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
49131046|NCT00392223|158320442|FG000|Overall Study|Protocol Violation|0|||
49131047|NCT00392223|158320443|FG001|Overall Study|Protocol Violation|3|||
49131048|NCT00392223|158320442|FG000|Overall Study|Withdrawal by Subject|3|||
48817640|NCT03398148|157175211|FG008|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
48817641|NCT03398148|157175212|FG009|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
48817642|NCT03398148|157175213|FG010|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
49131049|NCT00392223|158320443|FG001|Overall Study|Withdrawal by Subject|2|||
49131050|NCT01832766|158320444|FG000|Washout|Lost to Follow-up|0|||
48817643|NCT03398148|157175214|FG011|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
48817644|NCT03398148|157175215|FG012|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
49131051|NCT01832766|158320445|FG001|Washout|Lost to Follow-up|1|||
49131052|NCT01192178|158320446|FG000|Overall Study|Withdrawal by Subject|6|||
49131053|NCT01192178|158320447|FG001|Overall Study|Withdrawal by Subject|10|||
49131054|NCT01192178|158320446|FG000|Overall Study|Protocol Violation|10|||
48723297|NCT01340872|156837906|FG000|Double-blind Phase|Lost to Follow-up|0|||
48723298|NCT01340872|156837907|FG001|Double-blind Phase|Lost to Follow-up|1|||
48723299|NCT01340872|156837908|FG002|Double-blind Phase|Lost to Follow-up|0|||
48723300|NCT01340872|156837909|FG003|Double-blind Phase|Lost to Follow-up|0|||
48723301|NCT01340872|156837906|FG000|Double-blind Phase|Protocol Violation|0|||
48723302|NCT01340872|156837907|FG001|Double-blind Phase|Protocol Violation|1|||
48723303|NCT01340872|156837908|FG002|Double-blind Phase|Protocol Violation|0|||
48723304|NCT01340872|156837909|FG003|Double-blind Phase|Protocol Violation|0|||
48723305|NCT01340872|156837906|FG000|Open-label Phase|Physician Decision|0|||
48723306|NCT01340872|156837907|FG001|Open-label Phase|Physician Decision|0|||
48723307|NCT01340872|156837908|FG002|Open-label Phase|Physician Decision|2|||
49131055|NCT01192178|158320447|FG001|Overall Study|Protocol Violation|3|||
49131056|NCT01192178|158320446|FG000|Overall Study|Physician Decision|2|||
49131057|NCT01192178|158320447|FG001|Overall Study|Physician Decision|4|||
49131058|NCT01192178|158320446|FG000|Overall Study|Lost to Follow-up|3|||
49131059|NCT01192178|158320447|FG001|Overall Study|Lost to Follow-up|3|||
49131060|NCT01192178|158320446|FG000|Overall Study|Adverse Event|2|||
49131061|NCT01192178|158320447|FG001|Overall Study|Adverse Event|1|||
49131062|NCT01192178|158320446|FG000|Overall Study|Lack of Efficacy|1|||
49131063|NCT01192178|158320447|FG001|Overall Study|Lack of Efficacy|2|||
49131064|NCT01155570|158320448|FG000|Overall Study|Adverse Event|39|||
49131065|NCT01155570|158320448|FG000|Overall Study|Lack of Efficacy|46|||
49131066|NCT01155570|158320448|FG000|Overall Study|Participant's Economic Reasons|17|||
49131067|NCT01155570|158320448|FG000|Overall Study|No Hospital Visits|7|||
49131068|NCT01155570|158320448|FG000|Overall Study|Adverse Event + Lack of Efficacy|2|||
49131069|NCT01155570|158320448|FG000|Overall Study|Adverse Event + Other Reasons|7|||
49131070|NCT01155570|158320448|FG000|Overall Study|Participant's Economic Reasons + Other|1|||
49131071|NCT01155570|158320448|FG000|Overall Study|Other Reasons|23|||
49131072|NCT02324153|158320449|FG000|Overall Study|Withdrawal by Subject|4|||
49131073|NCT02324153|158320450|FG001|Overall Study|Withdrawal by Subject|1|||
49131074|NCT02324153|158320449|FG000|Overall Study|Surgery postponed after randomization|3|||
49131075|NCT02324153|158320450|FG001|Overall Study|Surgery postponed after randomization|0|||
49131076|NCT02324153|158320449|FG000|Overall Study|Developed delirium preoperatively|1|||
49131077|NCT02324153|158320450|FG001|Overall Study|Developed delirium preoperatively|0|||
49131078|NCT00700635|158320453|FG000|Overall Study|Adverse Event|1|||
49131079|NCT00700635|158320454|FG001|Overall Study|Adverse Event|0|||
49131080|NCT00700635|158320455|FG002|Overall Study|Adverse Event|0|||
49131081|NCT00700635|158320453|FG000|Overall Study|Lost to Follow-up|1|||
49131082|NCT00700635|158320454|FG001|Overall Study|Lost to Follow-up|3|||
49131083|NCT00700635|158320455|FG002|Overall Study|Lost to Follow-up|0|||
49131084|NCT00700635|158320453|FG000|Overall Study|Protocol Violation|2|||
49131085|NCT00700635|158320454|FG001|Overall Study|Protocol Violation|2|||
49131086|NCT00700635|158320455|FG002|Overall Study|Protocol Violation|0|||
48723308|NCT01340872|156837909|FG003|Open-label Phase|Physician Decision|1|||
48723309|NCT01340872|156837906|FG000|Open-label Phase|Pregnancy|0|||
48723310|NCT01340872|156837907|FG001|Open-label Phase|Pregnancy|0|||
48723311|NCT01340872|156837908|FG002|Open-label Phase|Pregnancy|1|||
48723312|NCT01340872|156837909|FG003|Open-label Phase|Pregnancy|0|||
48817645|NCT03398148|157175216|FG013|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
48817646|NCT03398148|157175217|FG014|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
48817647|NCT03398148|157175203|FG000|Substudy 1 Period 2|Other|0|||
49131087|NCT00700635|158320453|FG000|Overall Study|Withdrawal by Subject|7|||
49131088|NCT00700635|158320454|FG001|Overall Study|Withdrawal by Subject|3|||
49131089|NCT00700635|158320455|FG002|Overall Study|Withdrawal by Subject|1|||
49131090|NCT02394756|158320456|FG000|Period 1|Lens Discomfort|0|||
48723313|NCT01340872|156837906|FG000|Open-label Phase|Adverse Event|0|||
48723314|NCT01340872|156837907|FG001|Open-label Phase|Adverse Event|0|||
49131091|NCT02394756|158320457|FG001|Period 1|Lens Discomfort|0|||
49131092|NCT02394756|158320458|FG002|Period 1|Lens Discomfort|0|||
49131093|NCT02394756|158320459|FG003|Period 1|Lens Discomfort|0|||
49131094|NCT02394756|158320460|FG004|Period 1|Lens Discomfort|0|||
49131095|NCT02394756|158320461|FG005|Period 1|Lens Discomfort|1|||
49131096|NCT02394756|158320456|FG000|Period 1|Withdrawal by Subject|0|||
49131097|NCT02394756|158320457|FG001|Period 1|Withdrawal by Subject|1|||
49131098|NCT02394756|158320458|FG002|Period 1|Withdrawal by Subject|1|||
49131099|NCT02394756|158320459|FG003|Period 1|Withdrawal by Subject|1|||
49131100|NCT02394756|158320460|FG004|Period 1|Withdrawal by Subject|0|||
49131101|NCT02394756|158320461|FG005|Period 1|Withdrawal by Subject|0|||
49131102|NCT02394756|158320456|FG000|Period 2|Unsatisfactory Visual Response|0|||
49131103|NCT02394756|158320457|FG001|Period 2|Unsatisfactory Visual Response|0|||
49131104|NCT02394756|158320458|FG002|Period 2|Unsatisfactory Visual Response|0|||
49131105|NCT02394756|158320459|FG003|Period 2|Unsatisfactory Visual Response|0|||
49131106|NCT02394756|158320460|FG004|Period 2|Unsatisfactory Visual Response|1|||
49131107|NCT02394756|158320461|FG005|Period 2|Unsatisfactory Visual Response|0|||
49131108|NCT01525589|158320462|FG000|Overall Study|Non-treatment-related AE|1|||
49131109|NCT01525589|158320463|FG001|Overall Study|Non-treatment-related AE|0|||
49131110|NCT01525589|158320464|FG002|Overall Study|Non-treatment-related AE|0|||
49131111|NCT01525589|158320462|FG000|Overall Study|Progressive disease|48|||
49131112|NCT01525589|158320463|FG001|Overall Study|Progressive disease|15|||
49131113|NCT01525589|158320464|FG002|Overall Study|Progressive disease|29|||
49131114|NCT01525589|158320462|FG000|Overall Study|Never treated|2|||
49131115|NCT01525589|158320463|FG001|Overall Study|Never treated|0|||
49131116|NCT01525589|158320464|FG002|Overall Study|Never treated|0|||
49131117|NCT01525589|158320462|FG000|Overall Study|Physician Decision|4|||
49131118|NCT01525589|158320463|FG001|Overall Study|Physician Decision|2|||
49131119|NCT01525589|158320464|FG002|Overall Study|Physician Decision|2|||
49131120|NCT01525589|158320462|FG000|Overall Study|Death|0|||
49131121|NCT01525589|158320463|FG001|Overall Study|Death|0|||
49131122|NCT01525589|158320464|FG002|Overall Study|Death|2|||
49131123|NCT01525589|158320462|FG000|Overall Study|Treatment-related AE|1|||
49131124|NCT01525589|158320463|FG001|Overall Study|Treatment-related AE|1|||
49131125|NCT01525589|158320464|FG002|Overall Study|Treatment-related AE|2|||
49131126|NCT01525589|158320462|FG000|Overall Study|Other reasons|0|||
49131127|NCT01525589|158320463|FG001|Overall Study|Other reasons|1|||
49131128|NCT01525589|158320464|FG002|Overall Study|Other reasons|0|||
49131129|NCT01525589|158320462|FG000|Overall Study|Withdrawal by Subject|0|||
49131130|NCT01525589|158320463|FG001|Overall Study|Withdrawal by Subject|1|||
49131131|NCT01525589|158320464|FG002|Overall Study|Withdrawal by Subject|0|||
49131132|NCT04584788|158320467|FG000|Overall Study|Physician Decision|8|||
49131133|NCT04584788|158320467|FG000|Overall Study|Withdrawal by Subject|1|||
49131134|NCT04584788|158320467|FG000|Overall Study|Adverse Event|3|||
49131135|NCT00834041|158320468|FG000|Overall Study|Withdrawal by Subject|1|||
49131136|NCT00834041|158320469|FG001|Overall Study|Withdrawal by Subject|0|||
49131137|NCT00834041|158320468|FG000|Overall Study|Lost to Follow-up|0|||
49131138|NCT00834041|158320469|FG001|Overall Study|Lost to Follow-up|1|||
49131139|NCT03353220|158320470|FG000|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4|||
49131140|NCT03353220|158320471|FG001|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7|||
49131141|NCT02188160|158322099|FG000|Overall Study|Adverse Event|1|||
49131142|NCT02188160|158322100|FG001|Overall Study|Adverse Event|0|||
49131143|NCT02188160|158322099|FG000|Overall Study|Use of an excluded medication|0|||
49131144|NCT02188160|158322100|FG001|Overall Study|Use of an excluded medication|1|||
49131145|NCT03440320|158322101|FG000|Overall Study|Withdrawal by Subject|0|||
49131146|NCT03440320|158322102|FG001|Overall Study|Withdrawal by Subject|1|||
49131147|NCT04113694|158322103|FG000|Overall Study|Adverse Event|2|||
49131148|NCT04113694|158322103|FG000|Overall Study|Lost to Follow-up|2|||
49131149|NCT04113694|158322103|FG000|Overall Study|Withdrawal by Subject|6|||
49131150|NCT04113694|158322103|FG000|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1|||
49131151|NCT00352118|158322108|FG000|Overall Study|Physician Decision|4|||
49131152|NCT03427892|158322111|FG000|Overall Study|Lost to Follow-up|2|||
49131153|NCT01673386|158322116|FG000|Overall Study|Study terminated by sponsor|16|||
49131154|NCT01673386|158322117|FG001|Overall Study|Study terminated by sponsor|22|||
49131155|NCT01673386|158322116|FG000|Overall Study|Adverse Event|5|||
49131156|NCT01673386|158322117|FG001|Overall Study|Adverse Event|2|||
49131157|NCT01673386|158322116|FG000|Overall Study|Progressive disease|4|||
49131158|NCT01673386|158322117|FG001|Overall Study|Progressive disease|1|||
49131159|NCT01673386|158322116|FG000|Overall Study|Withdrawal by Subject|0|||
49131160|NCT01673386|158322117|FG001|Overall Study|Withdrawal by Subject|2|||
49131161|NCT00329108|158322119|FG000|Overall Study|Adverse Event|2|||
49131162|NCT00329108|158322120|FG001|Overall Study|Adverse Event|2|||
49131163|NCT00329108|158322119|FG000|Overall Study|Lack of Efficacy|3|||
49131164|NCT00329108|158322120|FG001|Overall Study|Lack of Efficacy|3|||
49131165|NCT00329108|158322119|FG000|Overall Study|Withdrawal by Subject|0|||
49131166|NCT00329108|158322120|FG001|Overall Study|Withdrawal by Subject|2|||
49131167|NCT00329108|158322119|FG000|Overall Study|symptomatic deterioration|1|||
48817648|NCT03398148|157175204|FG001|Substudy 1 Period 2|Other|0|||
48817649|NCT03398148|157175205|FG002|Substudy 1 Period 2|Other|0|||
49131168|NCT00329108|158322120|FG001|Overall Study|symptomatic deterioration|1|||
49131169|NCT00329108|158322119|FG000|Overall Study|Subject no longer willing to participate|2|||
49131170|NCT00329108|158322120|FG001|Overall Study|Subject no longer willing to participate|2|||
49131171|NCT00329108|158322119|FG000|Overall Study|study terminated by sponsor|1|||
49131172|NCT00329108|158322120|FG001|Overall Study|study terminated by sponsor|0|||
49131173|NCT00329108|158322119|FG000|Overall Study|withdrew patient after SAE resolved|1|||
49131174|NCT00329108|158322120|FG001|Overall Study|withdrew patient after SAE resolved|0|||
49131175|NCT00329108|158322119|FG000|Overall Study|Protocol Violation|0|||
49131176|NCT00329108|158322120|FG001|Overall Study|Protocol Violation|2|||
49131177|NCT01799889|158322126|FG000|Overall Study|Adverse Event|4|||
49131178|NCT01799889|158322127|FG001|Overall Study|Adverse Event|4|||
49131179|NCT01799889|158322128|FG002|Overall Study|Adverse Event|5|||
49131180|NCT01799889|158322129|FG003|Overall Study|Adverse Event|1|||
49131181|NCT01799889|158322130|FG004|Overall Study|Adverse Event|11|||
49131182|NCT01799889|158322131|FG005|Overall Study|Adverse Event|1|||
49131183|NCT01799889|158322132|FG006|Overall Study|Adverse Event|5|||
49131184|NCT01799889|158322133|FG007|Overall Study|Adverse Event|2|||
49131185|NCT01799889|158322134|FG008|Overall Study|Adverse Event|3|||
49131186|NCT01799889|158322135|FG009|Overall Study|Adverse Event|1|||
49131187|NCT01799889|158322136|FG010|Overall Study|Adverse Event|1|||
49131188|NCT01799889|158322137|FG011|Overall Study|Adverse Event|0|||
49131189|NCT01799889|158322126|FG000|Overall Study|Death|1|||
49131190|NCT01799889|158322127|FG001|Overall Study|Death|0|||
49131191|NCT01799889|158322128|FG002|Overall Study|Death|5|||
49131192|NCT01799889|158322129|FG003|Overall Study|Death|3|||
49131193|NCT01799889|158322130|FG004|Overall Study|Death|1|||
49131194|NCT01799889|158322131|FG005|Overall Study|Death|0|||
49131195|NCT01799889|158322132|FG006|Overall Study|Death|0|||
49131196|NCT01799889|158322133|FG007|Overall Study|Death|0|||
49131197|NCT01799889|158322134|FG008|Overall Study|Death|1|||
49131198|NCT01799889|158322135|FG009|Overall Study|Death|0|||
49131199|NCT01799889|158322136|FG010|Overall Study|Death|1|||
49131200|NCT01799889|158322137|FG011|Overall Study|Death|0|||
49131201|NCT01799889|158322126|FG000|Overall Study|Lack of Efficacy|1|||
49131202|NCT01799889|158322127|FG001|Overall Study|Lack of Efficacy|1|||
49131203|NCT01799889|158322128|FG002|Overall Study|Lack of Efficacy|0|||
49131204|NCT01799889|158322129|FG003|Overall Study|Lack of Efficacy|1|||
49131205|NCT01799889|158322130|FG004|Overall Study|Lack of Efficacy|2|||
49131206|NCT01799889|158322131|FG005|Overall Study|Lack of Efficacy|2|||
49131207|NCT01799889|158322132|FG006|Overall Study|Lack of Efficacy|0|||
49131208|NCT01799889|158322133|FG007|Overall Study|Lack of Efficacy|0|||
49131209|NCT01799889|158322134|FG008|Overall Study|Lack of Efficacy|2|||
49131210|NCT01799889|158322135|FG009|Overall Study|Lack of Efficacy|0|||
49131211|NCT01799889|158322136|FG010|Overall Study|Lack of Efficacy|1|||
49131212|NCT01799889|158322137|FG011|Overall Study|Lack of Efficacy|0|||
49131213|NCT01799889|158322126|FG000|Overall Study|Lost to Follow-up|0|||
49131214|NCT01799889|158322127|FG001|Overall Study|Lost to Follow-up|1|||
49131215|NCT01799889|158322128|FG002|Overall Study|Lost to Follow-up|0|||
49131216|NCT01799889|158322129|FG003|Overall Study|Lost to Follow-up|0|||
49131217|NCT01799889|158322130|FG004|Overall Study|Lost to Follow-up|0|||
49131218|NCT01799889|158322131|FG005|Overall Study|Lost to Follow-up|0|||
49131219|NCT01799889|158322132|FG006|Overall Study|Lost to Follow-up|0|||
49131220|NCT01799889|158322133|FG007|Overall Study|Lost to Follow-up|0|||
49131221|NCT01799889|158322134|FG008|Overall Study|Lost to Follow-up|0|||
49131222|NCT01799889|158322135|FG009|Overall Study|Lost to Follow-up|0|||
49131223|NCT01799889|158322136|FG010|Overall Study|Lost to Follow-up|0|||
49131224|NCT01799889|158322137|FG011|Overall Study|Lost to Follow-up|0|||
49131225|NCT01799889|158322126|FG000|Overall Study|Physician Decision|3|||
48817650|NCT03398148|157175206|FG003|Substudy 1 Period 2|Other|0|||
48817651|NCT03398148|157175207|FG004|Substudy 1 Period 2|Other|0|||
49131226|NCT01799889|158322127|FG001|Overall Study|Physician Decision|2|||
49131227|NCT01799889|158322128|FG002|Overall Study|Physician Decision|4|||
49131228|NCT01799889|158322129|FG003|Overall Study|Physician Decision|4|||
49131229|NCT01799889|158322130|FG004|Overall Study|Physician Decision|5|||
49131230|NCT01799889|158322131|FG005|Overall Study|Physician Decision|5|||
49131231|NCT01799889|158322132|FG006|Overall Study|Physician Decision|5|||
49131232|NCT01799889|158322133|FG007|Overall Study|Physician Decision|2|||
49131233|NCT01799889|158322134|FG008|Overall Study|Physician Decision|6|||
49131234|NCT01799889|158322135|FG009|Overall Study|Physician Decision|0|||
49131235|NCT01799889|158322136|FG010|Overall Study|Physician Decision|0|||
48817652|NCT03398148|157175208|FG005|Substudy 1 Period 2|Other|0|||
49131236|NCT01799889|158322137|FG011|Overall Study|Physician Decision|1|||
49131237|NCT01799889|158322126|FG000|Overall Study|Progressive Disease|30|||
49131238|NCT01799889|158322127|FG001|Overall Study|Progressive Disease|26|||
49131239|NCT01799889|158322128|FG002|Overall Study|Progressive Disease|25|||
49131240|NCT01799889|158322129|FG003|Overall Study|Progressive Disease|30|||
48817653|NCT03398148|157175209|FG006|Substudy 1 Period 2|Other|1|||
48817654|NCT03398148|157175210|FG007|Substudy 1 Period 2|Other|0|||
49131241|NCT01799889|158322130|FG004|Overall Study|Progressive Disease|23|||
49131242|NCT01799889|158322131|FG005|Overall Study|Progressive Disease|9|||
48723315|NCT01340872|156837908|FG002|Open-label Phase|Adverse Event|8|||
48723316|NCT01340872|156837909|FG003|Open-label Phase|Adverse Event|4|||
48723317|NCT01340872|156837906|FG000|Open-label Phase|Withdrawal by Subject|0|||
48723318|NCT01340872|156837907|FG001|Open-label Phase|Withdrawal by Subject|0|||
48723319|NCT01340872|156837908|FG002|Open-label Phase|Withdrawal by Subject|1|||
48723320|NCT01340872|156837909|FG003|Open-label Phase|Withdrawal by Subject|6|||
48723321|NCT01340872|156837906|FG000|Open-label Phase|Worsening of IBD|0|||
48723322|NCT01340872|156837907|FG001|Open-label Phase|Worsening of IBD|0|||
48723323|NCT01340872|156837908|FG002|Open-label Phase|Worsening of IBD|1|||
48723324|NCT01340872|156837909|FG003|Open-label Phase|Worsening of IBD|0|||
48723325|NCT03039621|156837912|FG000|Overall Study|Violation of inclusion criteria|3|||
48723326|NCT03039621|156837913|FG001|Overall Study|Violation of inclusion criteria|2|||
48723327|NCT03039621|156837912|FG000|Overall Study|Non-compliance with protocol requirement|4|||
48723328|NCT03039621|156837913|FG001|Overall Study|Non-compliance with protocol requirement|5|||
48723329|NCT03039621|156837912|FG000|Overall Study|Necessity to use drugs forbidden by pro|4|||
48723330|NCT03039621|156837913|FG001|Overall Study|Necessity to use drugs forbidden by pro|7|||
48723331|NCT03039621|156837912|FG000|Overall Study|Violation of non-inclusion criteria|1|||
48723332|NCT03039621|156837913|FG001|Overall Study|Violation of non-inclusion criteria|2|||
48723333|NCT03328182|156837917|FG000|Overall Study|Withdrawal by Subject|1|||
48723334|NCT03328182|156837917|FG000|Overall Study|Protocol Violation|2|||
48723335|NCT03328182|156837917|FG000|Overall Study|No Product Evaluated|1|||
48723336|NCT03274687|156837920|FG000|Overall Study|Protocol Violation|1|||
48723337|NCT03274687|156837921|FG001|Overall Study|Protocol Violation|1|||
48723338|NCT02919969|156837927|FG000|Overall Study|Lack of Efficacy|22|||
48723339|NCT02919969|156837927|FG000|Overall Study|Death|4|||
48723340|NCT02919969|156837927|FG000|Overall Study|Physician Decision|3|||
48723341|NCT02919969|156837927|FG000|Overall Study|Withdrawal by Subject|2|||
48723342|NCT00003830|156837928|FG000|Overall Study|No follow up data|3|||
48723343|NCT00003830|156837929|FG001|Overall Study|No follow up data|0|||
48817655|NCT03398148|157175211|FG008|Substudy 1 Period 2|Other|0|||
48817656|NCT03398148|157175212|FG009|Substudy 1 Period 2|Other|0|||
48817657|NCT03398148|157175213|FG010|Substudy 1 Period 2|Other|0|||
48817658|NCT03398148|157175214|FG011|Substudy 1 Period 2|Other|0|||
49131243|NCT01799889|158322132|FG006|Overall Study|Progressive Disease|8|||
49131244|NCT01799889|158322133|FG007|Overall Study|Progressive Disease|13|||
49131245|NCT01799889|158322134|FG008|Overall Study|Progressive Disease|18|||
49131246|NCT01799889|158322135|FG009|Overall Study|Progressive Disease|5|||
48723344|NCT00003830|156837928|FG000|Overall Study|Sentinel node positive patients|829|||
48817659|NCT03398148|157175215|FG012|Substudy 1 Period 2|Other|0|||
48817660|NCT03398148|157175216|FG013|Substudy 1 Period 2|Other|0|||
49131247|NCT01799889|158322136|FG010|Overall Study|Progressive Disease|3|||
49131248|NCT01799889|158322137|FG011|Overall Study|Progressive Disease|1|||
49131249|NCT01799889|158322126|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
49131250|NCT01799889|158322127|FG001|Overall Study|Specified Criteria for Withdrawal|1|||
49131251|NCT01799889|158322128|FG002|Overall Study|Specified Criteria for Withdrawal|1|||
49131252|NCT01799889|158322129|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
49131253|NCT01799889|158322130|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
49131254|NCT01799889|158322131|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
49131255|NCT01799889|158322132|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
49131256|NCT01799889|158322133|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
49131257|NCT01799889|158322134|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
49131258|NCT01799889|158322135|FG009|Overall Study|Specified Criteria for Withdrawal|0|||
49131259|NCT01799889|158322136|FG010|Overall Study|Specified Criteria for Withdrawal|0|||
49131260|NCT01799889|158322137|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
49131261|NCT01799889|158322126|FG000|Overall Study|Study Terminated By Sponsor|1|||
49131262|NCT01799889|158322127|FG001|Overall Study|Study Terminated By Sponsor|0|||
49131263|NCT01799889|158322128|FG002|Overall Study|Study Terminated By Sponsor|0|||
49131264|NCT01799889|158322129|FG003|Overall Study|Study Terminated By Sponsor|0|||
49131265|NCT01799889|158322130|FG004|Overall Study|Study Terminated By Sponsor|2|||
49131266|NCT01799889|158322131|FG005|Overall Study|Study Terminated By Sponsor|1|||
49131267|NCT01799889|158322132|FG006|Overall Study|Study Terminated By Sponsor|0|||
49131268|NCT01799889|158322133|FG007|Overall Study|Study Terminated By Sponsor|2|||
49131269|NCT01799889|158322134|FG008|Overall Study|Study Terminated By Sponsor|1|||
49131270|NCT01799889|158322135|FG009|Overall Study|Study Terminated By Sponsor|1|||
49131271|NCT01799889|158322136|FG010|Overall Study|Study Terminated By Sponsor|0|||
49131272|NCT01799889|158322137|FG011|Overall Study|Study Terminated By Sponsor|0|||
49131273|NCT01799889|158322126|FG000|Overall Study|Withdrawal by Subject|1|||
49131274|NCT01799889|158322127|FG001|Overall Study|Withdrawal by Subject|6|||
49131275|NCT01799889|158322128|FG002|Overall Study|Withdrawal by Subject|4|||
48723345|NCT00003830|156837929|FG001|Overall Study|Sentinel node positive patients|793|||
48723346|NCT00464490|156837930|FG000|Overall Study|Physician Decision|11|||
48723347|NCT00464490|156837931|FG001|Overall Study|Physician Decision|11|||
48723348|NCT00603590|156837932|FG000|Overall Study|Did not attend study clinic|39|||
48817661|NCT03398148|157175217|FG014|Substudy 1 Period 2|Other|0|||
49131276|NCT01799889|158322129|FG003|Overall Study|Withdrawal by Subject|0|||
49131277|NCT01799889|158322130|FG004|Overall Study|Withdrawal by Subject|5|||
48723349|NCT00603590|156837933|FG001|Overall Study|Did not attend study clinic|30|||
48723350|NCT00603590|156837932|FG000|Overall Study|Refused blood test|5|||
48723351|NCT00603590|156837933|FG001|Overall Study|Refused blood test|1|||
48817662|NCT03398148|157175203|FG000|Substudy 1 Period 2|Enrolled but not Treated|0|||
48817663|NCT03398148|157175204|FG001|Substudy 1 Period 2|Enrolled but not Treated|0|||
48817664|NCT03398148|157175205|FG002|Substudy 1 Period 2|Enrolled but not Treated|0|||
48817665|NCT03398148|157175206|FG003|Substudy 1 Period 2|Enrolled but not Treated|0|||
48817666|NCT03398148|157175207|FG004|Substudy 1 Period 2|Enrolled but not Treated|0|||
48817667|NCT03398148|157175208|FG005|Substudy 1 Period 2|Enrolled but not Treated|0|||
48817668|NCT03398148|157175209|FG006|Substudy 1 Period 2|Enrolled but not Treated|1|||
48817669|NCT03398148|157175210|FG007|Substudy 1 Period 2|Enrolled but not Treated|0|||
48817670|NCT03398148|157175211|FG008|Substudy 1 Period 2|Enrolled but not Treated|0|||
48817671|NCT03398148|157175212|FG009|Substudy 1 Period 2|Enrolled but not Treated|0|||
48817672|NCT03398148|157175213|FG010|Substudy 1 Period 2|Enrolled but not Treated|0|||
48817673|NCT03398148|157175214|FG011|Substudy 1 Period 2|Enrolled but not Treated|0|||
48723352|NCT00603590|156837932|FG000|Overall Study|Patient discontinued study drug|22|||
48723353|NCT00603590|156837933|FG001|Overall Study|Patient discontinued study drug|15|||
48723354|NCT00603590|156837932|FG000|Overall Study|Adverse Event|2|||
48723355|NCT00603590|156837933|FG001|Overall Study|Adverse Event|0|||
48723356|NCT00603590|156837932|FG000|Overall Study|Lost to Follow-up|8|||
48723357|NCT00603590|156837933|FG001|Overall Study|Lost to Follow-up|4|||
48817674|NCT03398148|157175215|FG012|Substudy 1 Period 2|Enrolled but not Treated|0|||
48817675|NCT03398148|157175216|FG013|Substudy 1 Period 2|Enrolled but not Treated|0|||
49131278|NCT01799889|158322131|FG005|Overall Study|Withdrawal by Subject|1|||
49131279|NCT01799889|158322132|FG006|Overall Study|Withdrawal by Subject|3|||
49131280|NCT01799889|158322133|FG007|Overall Study|Withdrawal by Subject|1|||
49131281|NCT01799889|158322134|FG008|Overall Study|Withdrawal by Subject|2|||
49131282|NCT01799889|158322135|FG009|Overall Study|Withdrawal by Subject|1|||
49131283|NCT01799889|158322136|FG010|Overall Study|Withdrawal by Subject|1|||
49131284|NCT01799889|158322137|FG011|Overall Study|Withdrawal by Subject|1|||
49131285|NCT01799889|158322126|FG000|Overall Study|Non-Compliance With Study Drug|0|||
49131286|NCT01799889|158322127|FG001|Overall Study|Non-Compliance With Study Drug|0|||
49131287|NCT01799889|158322128|FG002|Overall Study|Non-Compliance With Study Drug|0|||
49131288|NCT01799889|158322129|FG003|Overall Study|Non-Compliance With Study Drug|0|||
49131289|NCT01799889|158322130|FG004|Overall Study|Non-Compliance With Study Drug|0|||
49131290|NCT01799889|158322131|FG005|Overall Study|Non-Compliance With Study Drug|1|||
48723358|NCT00603590|156837932|FG000|Overall Study|Cardiovascular event|0|||
48723359|NCT00603590|156837933|FG001|Overall Study|Cardiovascular event|1|||
48723360|NCT01099709|156837936|FG000|Period 1|Withdrawal by Subject|0|||
48723361|NCT01099709|156837937|FG001|Period 1|Withdrawal by Subject|1|||
48723362|NCT01099709|156837936|FG000|Period 1|Positive cotinine test|0|||
48723363|NCT01099709|156837937|FG001|Period 1|Positive cotinine test|1|||
48723364|NCT01099709|156837936|FG000|Period 1|Adverse Event|1|||
48723365|NCT01099709|156837937|FG001|Period 1|Adverse Event|0|||
48723366|NCT01288976|156837938|FG000|Overall Study|Withdrawal by Subject|58|||
48723367|NCT01288976|156837939|FG001|Overall Study|Withdrawal by Subject|12|||
48723368|NCT01288976|156837940|FG002|Overall Study|Withdrawal by Subject|9|||
48723369|NCT01288976|156837938|FG000|Overall Study|Death|98|||
48723370|NCT01288976|156837939|FG001|Overall Study|Death|6|||
48723371|NCT01288976|156837940|FG002|Overall Study|Death|4|||
48723372|NCT01288976|156837938|FG000|Overall Study|Data unavailable|22|||
48723373|NCT01288976|156837939|FG001|Overall Study|Data unavailable|9|||
48723374|NCT01288976|156837940|FG002|Overall Study|Data unavailable|7|||
48723375|NCT01430754|156837945|FG000|Run-In Phase|Circadian Period Ineligible|24|||
48723376|NCT01430754|156837946|FG001|Run-In Phase|Circadian Period Ineligible|0|||
48723377|NCT01430754|156837945|FG000|Run-In Phase|Protocol Violation|6|||
48723378|NCT01430754|156837946|FG001|Run-In Phase|Protocol Violation|0|||
48723379|NCT01430754|156837945|FG000|Run-In Phase|Adverse Event|2|||
48723380|NCT01430754|156837946|FG001|Run-In Phase|Adverse Event|0|||
48723381|NCT01430754|156837945|FG000|Run-In Phase|Other|2|||
48723382|NCT01430754|156837946|FG001|Run-In Phase|Other|0|||
48723383|NCT01430754|156837945|FG000|Run-In Phase|Withdrawal by Subject|2|||
49131291|NCT01799889|158322132|FG006|Overall Study|Non-Compliance With Study Drug|0|||
48817676|NCT03398148|157175217|FG014|Substudy 1 Period 2|Enrolled but not Treated|0|||
49131292|NCT01799889|158322133|FG007|Overall Study|Non-Compliance With Study Drug|0|||
49131293|NCT01799889|158322134|FG008|Overall Study|Non-Compliance With Study Drug|0|||
48723384|NCT01430754|156837946|FG001|Run-In Phase|Withdrawal by Subject|0|||
48723385|NCT01430754|156837945|FG000|Run-In Phase|Lost to Follow-up|1|||
48723386|NCT01430754|156837946|FG001|Run-In Phase|Lost to Follow-up|0|||
48817677|NCT03398148|157175203|FG000|Substudy 2 Period 1|Adverse Event|0|||
48723387|NCT04179890|156837947|FG000|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|3|||
48723388|NCT04179890|156837948|FG001|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|0|||
48723389|NCT04179890|156837947|FG000|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|1|||
48723390|NCT04179890|156837948|FG001|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|0|||
48817678|NCT03398148|157175204|FG001|Substudy 2 Period 1|Adverse Event|0|||
48817679|NCT03398148|157175205|FG002|Substudy 2 Period 1|Adverse Event|0|||
48817680|NCT03398148|157175206|FG003|Substudy 2 Period 1|Adverse Event|0|||
48817681|NCT03398148|157175207|FG004|Substudy 2 Period 1|Adverse Event|0|||
48817682|NCT03398148|157175208|FG005|Substudy 2 Period 1|Adverse Event|0|||
48817683|NCT03398148|157175209|FG006|Substudy 2 Period 1|Adverse Event|0|||
48817684|NCT03398148|157175210|FG007|Substudy 2 Period 1|Adverse Event|0|||
48817685|NCT03398148|157175211|FG008|Substudy 2 Period 1|Adverse Event|0|||
48817686|NCT03398148|157175212|FG009|Substudy 2 Period 1|Adverse Event|12|||
48817687|NCT03398148|157175213|FG010|Substudy 2 Period 1|Adverse Event|2|||
48817688|NCT03398148|157175214|FG011|Substudy 2 Period 1|Adverse Event|0|||
48817689|NCT03398148|157175215|FG012|Substudy 2 Period 1|Adverse Event|0|||
48817690|NCT03398148|157175216|FG013|Substudy 2 Period 1|Adverse Event|0|||
48817691|NCT03398148|157175217|FG014|Substudy 2 Period 1|Adverse Event|0|||
48817692|NCT03398148|157175203|FG000|Substudy 2 Period 1|WITHDREW CONSENT|0|||
48817693|NCT03398148|157175204|FG001|Substudy 2 Period 1|WITHDREW CONSENT|0|||
48817694|NCT03398148|157175205|FG002|Substudy 2 Period 1|WITHDREW CONSENT|0|||
48817695|NCT03398148|157175206|FG003|Substudy 2 Period 1|WITHDREW CONSENT|0|||
48817696|NCT03398148|157175207|FG004|Substudy 2 Period 1|WITHDREW CONSENT|0|||
48817697|NCT03398148|157175208|FG005|Substudy 2 Period 1|WITHDREW CONSENT|0|||
48817698|NCT03398148|157175209|FG006|Substudy 2 Period 1|WITHDREW CONSENT|0|||
48817699|NCT03398148|157175210|FG007|Substudy 2 Period 1|WITHDREW CONSENT|0|||
48817700|NCT03398148|157175211|FG008|Substudy 2 Period 1|WITHDREW CONSENT|0|||
48817701|NCT03398148|157175212|FG009|Substudy 2 Period 1|WITHDREW CONSENT|6|||
48817702|NCT03398148|157175213|FG010|Substudy 2 Period 1|WITHDREW CONSENT|4|||
48723391|NCT04179890|156837947|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|3|||
48723392|NCT04179890|156837948|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|0|||
48723393|NCT04179890|156837947|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|2|||
48723394|NCT04179890|156837948|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|0|||
48817703|NCT03398148|157175214|FG011|Substudy 2 Period 1|WITHDREW CONSENT|0|||
48817704|NCT03398148|157175215|FG012|Substudy 2 Period 1|WITHDREW CONSENT|0|||
48817705|NCT03398148|157175216|FG013|Substudy 2 Period 1|WITHDREW CONSENT|0|||
48817706|NCT03398148|157175217|FG014|Substudy 2 Period 1|WITHDREW CONSENT|0|||
49131294|NCT01799889|158322135|FG009|Overall Study|Non-Compliance With Study Drug|0|||
49131295|NCT01799889|158322136|FG010|Overall Study|Non-Compliance With Study Drug|0|||
49131296|NCT01799889|158322137|FG011|Overall Study|Non-Compliance With Study Drug|0|||
49131297|NCT02308046|158322138|FG000|Overall Study|Negative yeast culture at Baseline|32|||
49131298|NCT02308046|158322139|FG001|Overall Study|Negative yeast culture at Baseline|33|||
49131299|NCT02308046|158322138|FG000|Overall Study|Positive for STD at Baseline|1|||
49131300|NCT02308046|158322139|FG001|Overall Study|Positive for STD at Baseline|2|||
49131301|NCT02308046|158322138|FG000|Overall Study|Lost to Follow-up|1|||
49131302|NCT02308046|158322139|FG001|Overall Study|Lost to Follow-up|3|||
48723395|NCT04179890|156837947|FG000|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|0|||
48817707|NCT03398148|157175203|FG000|Substudy 2 Period 1|Lack of Efficacy|0|||
48817708|NCT03398148|157175204|FG001|Substudy 2 Period 1|Lack of Efficacy|0|||
48817709|NCT03398148|157175205|FG002|Substudy 2 Period 1|Lack of Efficacy|0|||
48817710|NCT03398148|157175206|FG003|Substudy 2 Period 1|Lack of Efficacy|0|||
48817711|NCT03398148|157175207|FG004|Substudy 2 Period 1|Lack of Efficacy|0|||
48817712|NCT03398148|157175208|FG005|Substudy 2 Period 1|Lack of Efficacy|0|||
49131303|NCT01181167|158322140|FG000|Overall Study|Adverse Event|11|||
49131304|NCT01181167|158322141|FG001|Overall Study|Adverse Event|21|||
49131305|NCT01181167|158322140|FG000|Overall Study|Lost to Follow-up|1|||
49131306|NCT01181167|158322141|FG001|Overall Study|Lost to Follow-up|0|||
49131307|NCT01181167|158322140|FG000|Overall Study|Physician Decision|2|||
49131308|NCT01181167|158322141|FG001|Overall Study|Physician Decision|3|||
49131309|NCT01181167|158322140|FG000|Overall Study|Protocol Violation|3|||
49131310|NCT01181167|158322141|FG001|Overall Study|Protocol Violation|0|||
49131311|NCT01181167|158322140|FG000|Overall Study|Withdrawal by Subject|6|||
49131312|NCT01181167|158322141|FG001|Overall Study|Withdrawal by Subject|8|||
49131313|NCT01147822|158322142|FG000|Overall Study|Death|66|||
49131314|NCT01147822|158322143|FG001|Overall Study|Death|59|||
49131315|NCT01147822|158322142|FG000|Overall Study|Protocol Violation|0|||
49131316|NCT01147822|158322143|FG001|Overall Study|Protocol Violation|1|||
49131317|NCT01147822|158322142|FG000|Overall Study|Lost to Follow-up|3|||
49131318|NCT01147822|158322143|FG001|Overall Study|Lost to Follow-up|2|||
48817713|NCT03398148|157175209|FG006|Substudy 2 Period 1|Lack of Efficacy|0|||
48817714|NCT03398148|157175210|FG007|Substudy 2 Period 1|Lack of Efficacy|0|||
49131319|NCT01147822|158322142|FG000|Overall Study|Physician Decision|0|||
49131320|NCT01147822|158322143|FG001|Overall Study|Physician Decision|2|||
49131321|NCT01147822|158322142|FG000|Overall Study|Withdrawal by Subject|8|||
49131322|NCT01147822|158322143|FG001|Overall Study|Withdrawal by Subject|13|||
49131323|NCT01147822|158322142|FG000|Overall Study|Not Completed/Ongoing|111|||
49131324|NCT01147822|158322143|FG001|Overall Study|Not Completed/Ongoing|102|||
48817715|NCT03398148|157175211|FG008|Substudy 2 Period 1|Lack of Efficacy|0|||
48817716|NCT03398148|157175212|FG009|Substudy 2 Period 1|Lack of Efficacy|6|||
48817717|NCT03398148|157175213|FG010|Substudy 2 Period 1|Lack of Efficacy|1|||
48817718|NCT03398148|157175214|FG011|Substudy 2 Period 1|Lack of Efficacy|0|||
48817719|NCT03398148|157175215|FG012|Substudy 2 Period 1|Lack of Efficacy|0|||
48817720|NCT03398148|157175216|FG013|Substudy 2 Period 1|Lack of Efficacy|0|||
48817721|NCT03398148|157175217|FG014|Substudy 2 Period 1|Lack of Efficacy|0|||
48817722|NCT03398148|157175203|FG000|Substudy 2 Period 1|COVID-19 INFECTION|0|||
48817723|NCT03398148|157175204|FG001|Substudy 2 Period 1|COVID-19 INFECTION|0|||
48817724|NCT03398148|157175205|FG002|Substudy 2 Period 1|COVID-19 INFECTION|0|||
48817725|NCT03398148|157175206|FG003|Substudy 2 Period 1|COVID-19 INFECTION|0|||
48817726|NCT03398148|157175207|FG004|Substudy 2 Period 1|COVID-19 INFECTION|0|||
48817727|NCT03398148|157175208|FG005|Substudy 2 Period 1|COVID-19 INFECTION|0|||
48817728|NCT03398148|157175209|FG006|Substudy 2 Period 1|COVID-19 INFECTION|0|||
48817729|NCT03398148|157175210|FG007|Substudy 2 Period 1|COVID-19 INFECTION|0|||
48817730|NCT03398148|157175211|FG008|Substudy 2 Period 1|COVID-19 INFECTION|0|||
48817731|NCT03398148|157175212|FG009|Substudy 2 Period 1|COVID-19 INFECTION|0|||
48817732|NCT03398148|157175213|FG010|Substudy 2 Period 1|COVID-19 INFECTION|1|||
48817733|NCT03398148|157175214|FG011|Substudy 2 Period 1|COVID-19 INFECTION|0|||
48723396|NCT04179890|156837948|FG001|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|8|||
48723397|NCT04179890|156837947|FG000|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|0|||
48817734|NCT03398148|157175215|FG012|Substudy 2 Period 1|COVID-19 INFECTION|0|||
48817735|NCT03398148|157175216|FG013|Substudy 2 Period 1|COVID-19 INFECTION|0|||
48817736|NCT03398148|157175217|FG014|Substudy 2 Period 1|COVID-19 INFECTION|0|||
48817737|NCT03398148|157175203|FG000|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
48817738|NCT03398148|157175204|FG001|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
48817739|NCT03398148|157175205|FG002|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
48817740|NCT03398148|157175206|FG003|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
48817741|NCT03398148|157175207|FG004|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
48817742|NCT03398148|157175208|FG005|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
48817743|NCT03398148|157175209|FG006|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
48817744|NCT03398148|157175210|FG007|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
48817745|NCT03398148|157175211|FG008|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
48817746|NCT03398148|157175212|FG009|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
48817747|NCT03398148|157175213|FG010|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|1|||
48817748|NCT03398148|157175214|FG011|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
48817749|NCT03398148|157175215|FG012|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
48817750|NCT03398148|157175216|FG013|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
48723398|NCT04179890|156837948|FG001|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|4|||
48723399|NCT04179890|156837947|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|0|||
48723400|NCT04179890|156837948|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|2|||
48723401|NCT04179890|156837947|FG000|Overall Study|Patients without common EGFR mutations (Del19, L858R)|0|||
48723402|NCT04179890|156837948|FG001|Overall Study|Patients without common EGFR mutations (Del19, L858R)|1|||
48723403|NCT04179890|156837947|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|0|||
48723404|NCT04179890|156837948|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|1|||
48723405|NCT00095238|156837949|FG000|Overall Study|Lack of Efficacy|9|||
48723406|NCT00095238|156837950|FG001|Overall Study|Lack of Efficacy|9|||
48723407|NCT00095238|156837949|FG000|Overall Study|Adverse Event|331|||
48723408|NCT00095238|156837950|FG001|Overall Study|Adverse Event|287|||
48723409|NCT00095238|156837949|FG000|Overall Study|Subject Withdrew Consent|208|||
48723410|NCT00095238|156837950|FG001|Overall Study|Subject Withdrew Consent|223|||
48723411|NCT00095238|156837949|FG000|Overall Study|Death|154|||
48723412|NCT00095238|156837950|FG001|Overall Study|Death|170|||
48723413|NCT00095238|156837949|FG000|Overall Study|Lost to Follow-up|19|||
48817751|NCT03398148|157175217|FG014|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
48817752|NCT03398148|157175203|FG000|Substudy 2 Period 1|Other|0|||
48817753|NCT03398148|157175204|FG001|Substudy 2 Period 1|Other|0|||
49131325|NCT03103503|158322144|FG000|Overall Study|Death|64|||
49131326|NCT03103503|158322144|FG000|Overall Study|Physician Decision|57|||
49131327|NCT03103503|158322144|FG000|Overall Study|Withdrawal by Subject|10|||
48817754|NCT03398148|157175205|FG002|Substudy 2 Period 1|Other|0|||
49131328|NCT03103503|158322144|FG000|Overall Study|Plexa Lead or Pulse Generator Extraction|10|||
49131329|NCT03103503|158322144|FG000|Overall Study|Lost to Follow-up|3|||
49131330|NCT03103503|158322144|FG000|Overall Study|Study Closure|757|||
49131331|NCT01162343|158322148|FG000|Overall Study|Left ED prior to psychiatrist assessment|80|||
48817755|NCT03398148|157175206|FG003|Substudy 2 Period 1|Other|0|||
48817756|NCT03398148|157175207|FG004|Substudy 2 Period 1|Other|0|||
49131332|NCT01162343|158322148|FG000|Overall Study|Refused psychiatrist assessment|12|||
49131333|NCT00408499|158322149|FG000|Phase 1: Dose Levels 1-4|Adverse Event|0|||
48817757|NCT03398148|157175208|FG005|Substudy 2 Period 1|Other|0|||
49131334|NCT00408499|158322150|FG001|Phase 1: Dose Levels 1-4|Adverse Event|0|||
48817758|NCT03398148|157175209|FG006|Substudy 2 Period 1|Other|0|||
48817759|NCT03398148|157175210|FG007|Substudy 2 Period 1|Other|0|||
48817760|NCT03398148|157175211|FG008|Substudy 2 Period 1|Other|0|||
48817761|NCT03398148|157175212|FG009|Substudy 2 Period 1|Other|4|||
48817762|NCT03398148|157175213|FG010|Substudy 2 Period 1|Other|4|||
48817763|NCT03398148|157175214|FG011|Substudy 2 Period 1|Other|0|||
48817764|NCT03398148|157175215|FG012|Substudy 2 Period 1|Other|0|||
48817765|NCT03398148|157175216|FG013|Substudy 2 Period 1|Other|0|||
48817766|NCT03398148|157175217|FG014|Substudy 2 Period 1|Other|0|||
48817767|NCT03398148|157175203|FG000|Substudy 2 Period 1|Enrolled but not Treated|0|||
48817768|NCT03398148|157175204|FG001|Substudy 2 Period 1|Enrolled but not Treated|0|||
48817769|NCT03398148|157175205|FG002|Substudy 2 Period 1|Enrolled but not Treated|0|||
48817770|NCT03398148|157175206|FG003|Substudy 2 Period 1|Enrolled but not Treated|0|||
48817771|NCT03398148|157175207|FG004|Substudy 2 Period 1|Enrolled but not Treated|0|||
48817772|NCT03398148|157175208|FG005|Substudy 2 Period 1|Enrolled but not Treated|0|||
48817773|NCT03398148|157175209|FG006|Substudy 2 Period 1|Enrolled but not Treated|0|||
48817774|NCT03398148|157175210|FG007|Substudy 2 Period 1|Enrolled but not Treated|0|||
48817775|NCT03398148|157175211|FG008|Substudy 2 Period 1|Enrolled but not Treated|0|||
48817776|NCT03398148|157175212|FG009|Substudy 2 Period 1|Enrolled but not Treated|0|||
48817777|NCT03398148|157175213|FG010|Substudy 2 Period 1|Enrolled but not Treated|2|||
48817778|NCT03398148|157175214|FG011|Substudy 2 Period 1|Enrolled but not Treated|0|||
48817779|NCT03398148|157175215|FG012|Substudy 2 Period 1|Enrolled but not Treated|0|||
48817780|NCT03398148|157175216|FG013|Substudy 2 Period 1|Enrolled but not Treated|0|||
48817781|NCT03398148|157175217|FG014|Substudy 2 Period 1|Enrolled but not Treated|0|||
48817782|NCT03398148|157175203|FG000|Substudy 2 Period 2|Adverse Event|0|||
48817783|NCT03398148|157175204|FG001|Substudy 2 Period 2|Adverse Event|0|||
48817784|NCT03398148|157175205|FG002|Substudy 2 Period 2|Adverse Event|0|||
48817785|NCT03398148|157175206|FG003|Substudy 2 Period 2|Adverse Event|0|||
48817786|NCT03398148|157175207|FG004|Substudy 2 Period 2|Adverse Event|0|||
48817787|NCT03398148|157175208|FG005|Substudy 2 Period 2|Adverse Event|0|||
48723414|NCT00095238|156837950|FG001|Overall Study|Lost to Follow-up|24|||
48723415|NCT00095238|156837949|FG000|Overall Study|Noncompliance|44|||
48817788|NCT03398148|157175209|FG006|Substudy 2 Period 2|Adverse Event|0|||
48817789|NCT03398148|157175210|FG007|Substudy 2 Period 2|Adverse Event|0|||
48817790|NCT03398148|157175211|FG008|Substudy 2 Period 2|Adverse Event|0|||
48817791|NCT03398148|157175212|FG009|Substudy 2 Period 2|Adverse Event|0|||
48817792|NCT03398148|157175213|FG010|Substudy 2 Period 2|Adverse Event|0|||
48817793|NCT03398148|157175214|FG011|Substudy 2 Period 2|Adverse Event|0|||
48817794|NCT03398148|157175215|FG012|Substudy 2 Period 2|Adverse Event|0|||
48817795|NCT03398148|157175216|FG013|Substudy 2 Period 2|Adverse Event|1|||
48817796|NCT03398148|157175217|FG014|Substudy 2 Period 2|Adverse Event|3|||
48817797|NCT03398148|157175203|FG000|Substudy 2 Period 2|Lost to Follow-up|0|||
48817798|NCT03398148|157175204|FG001|Substudy 2 Period 2|Lost to Follow-up|0|||
48817799|NCT03398148|157175205|FG002|Substudy 2 Period 2|Lost to Follow-up|0|||
48817800|NCT03398148|157175206|FG003|Substudy 2 Period 2|Lost to Follow-up|0|||
48817801|NCT03398148|157175207|FG004|Substudy 2 Period 2|Lost to Follow-up|0|||
48817802|NCT03398148|157175208|FG005|Substudy 2 Period 2|Lost to Follow-up|0|||
48817803|NCT03398148|157175209|FG006|Substudy 2 Period 2|Lost to Follow-up|0|||
48817804|NCT03398148|157175210|FG007|Substudy 2 Period 2|Lost to Follow-up|0|||
49131335|NCT00408499|158322151|FG002|Phase 1: Dose Levels 1-4|Adverse Event|1|||
49131336|NCT00408499|158322152|FG003|Phase 1: Dose Levels 1-4|Adverse Event|0|||
49131337|NCT00408499|158322153|FG004|Phase 1: Dose Levels 1-4|Adverse Event|0|||
49131338|NCT00408499|158322149|FG000|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
49131339|NCT00408499|158322150|FG001|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
48723416|NCT00095238|156837950|FG001|Overall Study|Noncompliance|45|||
48723417|NCT00095238|156837949|FG000|Overall Study|No longer met study criteria|4|||
48723418|NCT00095238|156837950|FG001|Overall Study|No longer met study criteria|5|||
48723419|NCT00095238|156837949|FG000|Overall Study|Study terminated by sponsor|0|||
48723420|NCT00095238|156837950|FG001|Overall Study|Study terminated by sponsor|1|||
48723421|NCT00095238|156837949|FG000|Overall Study|Missing|1|||
48723422|NCT00095238|156837950|FG001|Overall Study|Missing|0|||
48723423|NCT00095238|156837949|FG000|Overall Study|Other Reasons|87|||
48723424|NCT00095238|156837950|FG001|Overall Study|Other Reasons|88|||
48817805|NCT03398148|157175211|FG008|Substudy 2 Period 2|Lost to Follow-up|0|||
48817806|NCT03398148|157175212|FG009|Substudy 2 Period 2|Lost to Follow-up|0|||
48817807|NCT03398148|157175213|FG010|Substudy 2 Period 2|Lost to Follow-up|0|||
48817808|NCT03398148|157175214|FG011|Substudy 2 Period 2|Lost to Follow-up|1|||
48817809|NCT03398148|157175215|FG012|Substudy 2 Period 2|Lost to Follow-up|1|||
48817810|NCT03398148|157175216|FG013|Substudy 2 Period 2|Lost to Follow-up|0|||
48817811|NCT03398148|157175217|FG014|Substudy 2 Period 2|Lost to Follow-up|0|||
48723425|NCT03263026|156837953|FG000|Overall Study|Withdrawal by Subject|1|||
48723426|NCT03263026|156837954|FG001|Overall Study|Withdrawal by Subject|0|||
48817812|NCT03398148|157175203|FG000|Substudy 2 Period 2|WITHDREW CONSENT|0|||
48817813|NCT03398148|157175204|FG001|Substudy 2 Period 2|WITHDREW CONSENT|0|||
48817814|NCT03398148|157175205|FG002|Substudy 2 Period 2|WITHDREW CONSENT|0|||
48817815|NCT03398148|157175206|FG003|Substudy 2 Period 2|WITHDREW CONSENT|0|||
48817816|NCT03398148|157175207|FG004|Substudy 2 Period 2|WITHDREW CONSENT|0|||
48817817|NCT03398148|157175208|FG005|Substudy 2 Period 2|WITHDREW CONSENT|0|||
48817818|NCT03398148|157175209|FG006|Substudy 2 Period 2|WITHDREW CONSENT|0|||
48817819|NCT03398148|157175210|FG007|Substudy 2 Period 2|WITHDREW CONSENT|0|||
48817820|NCT03398148|157175211|FG008|Substudy 2 Period 2|WITHDREW CONSENT|0|||
48817821|NCT03398148|157175212|FG009|Substudy 2 Period 2|WITHDREW CONSENT|0|||
48817822|NCT03398148|157175213|FG010|Substudy 2 Period 2|WITHDREW CONSENT|0|||
48817823|NCT03398148|157175214|FG011|Substudy 2 Period 2|WITHDREW CONSENT|4|||
48817824|NCT03398148|157175215|FG012|Substudy 2 Period 2|WITHDREW CONSENT|0|||
48817825|NCT03398148|157175216|FG013|Substudy 2 Period 2|WITHDREW CONSENT|2|||
48817826|NCT03398148|157175217|FG014|Substudy 2 Period 2|WITHDREW CONSENT|1|||
48817827|NCT03398148|157175203|FG000|Substudy 2 Period 2|Lack of Efficacy|0|||
48817828|NCT03398148|157175204|FG001|Substudy 2 Period 2|Lack of Efficacy|0|||
48817829|NCT03398148|157175205|FG002|Substudy 2 Period 2|Lack of Efficacy|0|||
48817830|NCT03398148|157175206|FG003|Substudy 2 Period 2|Lack of Efficacy|0|||
48817831|NCT03398148|157175207|FG004|Substudy 2 Period 2|Lack of Efficacy|0|||
48817832|NCT03398148|157175208|FG005|Substudy 2 Period 2|Lack of Efficacy|0|||
48817833|NCT03398148|157175209|FG006|Substudy 2 Period 2|Lack of Efficacy|0|||
48817834|NCT03398148|157175210|FG007|Substudy 2 Period 2|Lack of Efficacy|0|||
48817835|NCT03398148|157175211|FG008|Substudy 2 Period 2|Lack of Efficacy|0|||
48817836|NCT03398148|157175212|FG009|Substudy 2 Period 2|Lack of Efficacy|0|||
48817837|NCT03398148|157175213|FG010|Substudy 2 Period 2|Lack of Efficacy|0|||
48817838|NCT03398148|157175214|FG011|Substudy 2 Period 2|Lack of Efficacy|1|||
48817839|NCT03398148|157175215|FG012|Substudy 2 Period 2|Lack of Efficacy|4|||
48817840|NCT03398148|157175216|FG013|Substudy 2 Period 2|Lack of Efficacy|3|||
48817841|NCT03398148|157175217|FG014|Substudy 2 Period 2|Lack of Efficacy|4|||
48817842|NCT03398148|157175203|FG000|Substudy 2 Period 2|Other|0|||
48817843|NCT03398148|157175204|FG001|Substudy 2 Period 2|Other|0|||
48817844|NCT03398148|157175205|FG002|Substudy 2 Period 2|Other|0|||
48817845|NCT03398148|157175206|FG003|Substudy 2 Period 2|Other|0|||
48817846|NCT03398148|157175207|FG004|Substudy 2 Period 2|Other|0|||
48817847|NCT03398148|157175208|FG005|Substudy 2 Period 2|Other|0|||
48817848|NCT03398148|157175209|FG006|Substudy 2 Period 2|Other|0|||
48817849|NCT03398148|157175210|FG007|Substudy 2 Period 2|Other|0|||
48817850|NCT03398148|157175211|FG008|Substudy 2 Period 2|Other|0|||
48817851|NCT03398148|157175212|FG009|Substudy 2 Period 2|Other|0|||
48817852|NCT03398148|157175213|FG010|Substudy 2 Period 2|Other|0|||
48817853|NCT03398148|157175214|FG011|Substudy 2 Period 2|Other|0|||
48817854|NCT03398148|157175215|FG012|Substudy 2 Period 2|Other|0|||
48817855|NCT03398148|157175216|FG013|Substudy 2 Period 2|Other|1|||
48817856|NCT03398148|157175217|FG014|Substudy 2 Period 2|Other|1|||
48817857|NCT03398148|157175203|FG000|Substudy 2 Period 2|Enrolled but not Treated|0|||
48817858|NCT03398148|157175204|FG001|Substudy 2 Period 2|Enrolled but not Treated|0|||
48817859|NCT03398148|157175205|FG002|Substudy 2 Period 2|Enrolled but not Treated|0|||
48817860|NCT03398148|157175206|FG003|Substudy 2 Period 2|Enrolled but not Treated|0|||
48817861|NCT03398148|157175207|FG004|Substudy 2 Period 2|Enrolled but not Treated|0|||
48817862|NCT03398148|157175208|FG005|Substudy 2 Period 2|Enrolled but not Treated|0|||
48817863|NCT03398148|157175209|FG006|Substudy 2 Period 2|Enrolled but not Treated|0|||
48817864|NCT03398148|157175210|FG007|Substudy 2 Period 2|Enrolled but not Treated|0|||
48817865|NCT03398148|157175211|FG008|Substudy 2 Period 2|Enrolled but not Treated|0|||
48817866|NCT03398148|157175212|FG009|Substudy 2 Period 2|Enrolled but not Treated|0|||
48817867|NCT03398148|157175213|FG010|Substudy 2 Period 2|Enrolled but not Treated|0|||
48817868|NCT03398148|157175214|FG011|Substudy 2 Period 2|Enrolled but not Treated|0|||
48817869|NCT03398148|157175215|FG012|Substudy 2 Period 2|Enrolled but not Treated|1|||
48817870|NCT03398148|157175216|FG013|Substudy 2 Period 2|Enrolled but not Treated|0|||
48817871|NCT03398148|157175217|FG014|Substudy 2 Period 2|Enrolled but not Treated|1|||
48817872|NCT01155388|157175218|FG000|Overall Study|Adverse Event|1|||
48817873|NCT01155388|157175219|FG001|Overall Study|Adverse Event|0|||
48817874|NCT01023308|157175221|FG000|Overall Study|Abnormal test proceedure results|3|||
48817875|NCT01023308|157175222|FG001|Overall Study|Abnormal test proceedure results|8|||
49131340|NCT00408499|158322151|FG002|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
49131341|NCT00408499|158322152|FG003|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
49131342|NCT00408499|158322153|FG004|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
49131343|NCT00408499|158322149|FG000|Phase 1: Dose Levels 1-4|Physician Decision|1|||
49131344|NCT00408499|158322150|FG001|Phase 1: Dose Levels 1-4|Physician Decision|1|||
49131345|NCT00408499|158322151|FG002|Phase 1: Dose Levels 1-4|Physician Decision|0|||
48817876|NCT01023308|157175221|FG000|Overall Study|Administrative problems|2|||
48817877|NCT01023308|157175222|FG001|Overall Study|Administrative problems|1|||
48817878|NCT01023308|157175221|FG000|Overall Study|Adverse Event|130|||
48817879|NCT01023308|157175222|FG001|Overall Study|Adverse Event|66|||
48817880|NCT01023308|157175221|FG000|Overall Study|Death|21|||
48817881|NCT01023308|157175222|FG001|Overall Study|Death|17|||
48817882|NCT01023308|157175221|FG000|Overall Study|Disease progression|82|||
48817883|NCT01023308|157175222|FG001|Overall Study|Disease progression|153|||
48817884|NCT01023308|157175221|FG000|Overall Study|New Cancer therapy|4|||
49131346|NCT00408499|158322152|FG003|Phase 1: Dose Levels 1-4|Physician Decision|0|||
48817885|NCT01023308|157175222|FG001|Overall Study|New Cancer therapy|7|||
48817886|NCT01023308|157175221|FG000|Overall Study|Protocol Violation|3|||
48817887|NCT01023308|157175222|FG001|Overall Study|Protocol Violation|4|||
48817888|NCT01023308|157175221|FG000|Overall Study|Untreated|5|||
48817889|NCT01023308|157175222|FG001|Overall Study|Untreated|5|||
48817890|NCT01023308|157175221|FG000|Overall Study|Lost to Follow-up|1|||
48817891|NCT01023308|157175222|FG001|Overall Study|Lost to Follow-up|0|||
48817892|NCT01023308|157175221|FG000|Overall Study|Withdrawal by Subject|34|||
48817893|NCT01023308|157175222|FG001|Overall Study|Withdrawal by Subject|18|||
48817894|NCT01646320|157175223|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|3|||
49131347|NCT00408499|158322153|FG004|Phase 1: Dose Levels 1-4|Physician Decision|0|||
49131348|NCT00408499|158322149|FG000|Phase II- MTD Expansion|Adverse Event|0|||
48817895|NCT01646320|157175224|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|0|||
48817896|NCT01646320|157175223|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
48817897|NCT01646320|157175224|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1|||
48817898|NCT01646320|157175223|FG000|Short-term Period (Day 1 to Week 24)|Not reported|2|||
48723427|NCT03263026|156837953|FG000|Overall Study|Death|1|||
48723428|NCT03263026|156837954|FG001|Overall Study|Death|0|||
48723429|NCT03263026|156837953|FG000|Overall Study|Other/ Various|41|||
49131349|NCT00408499|158322150|FG001|Phase II- MTD Expansion|Adverse Event|0|||
49131350|NCT00408499|158322151|FG002|Phase II- MTD Expansion|Adverse Event|0|||
49131351|NCT00408499|158322152|FG003|Phase II- MTD Expansion|Adverse Event|0|||
49131352|NCT00408499|158322153|FG004|Phase II- MTD Expansion|Adverse Event|9|||
49131353|NCT00408499|158322149|FG000|Phase II- MTD Expansion|Death|0|||
49131354|NCT00408499|158322150|FG001|Phase II- MTD Expansion|Death|0|||
49131355|NCT00408499|158322151|FG002|Phase II- MTD Expansion|Death|0|||
49131356|NCT00408499|158322152|FG003|Phase II- MTD Expansion|Death|0|||
49131357|NCT00408499|158322153|FG004|Phase II- MTD Expansion|Death|2|||
49131358|NCT00408499|158322149|FG000|Phase II- MTD Expansion|Physician Decision|0|||
49131359|NCT00408499|158322150|FG001|Phase II- MTD Expansion|Physician Decision|0|||
49131360|NCT00408499|158322151|FG002|Phase II- MTD Expansion|Physician Decision|0|||
49131361|NCT00408499|158322152|FG003|Phase II- MTD Expansion|Physician Decision|0|||
49131362|NCT00408499|158322153|FG004|Phase II- MTD Expansion|Physician Decision|1|||
49131363|NCT00408499|158322149|FG000|Phase II- MTD Expansion|Withdrawal by Subject|0|||
49131364|NCT00408499|158322150|FG001|Phase II- MTD Expansion|Withdrawal by Subject|0|||
49131365|NCT00408499|158322151|FG002|Phase II- MTD Expansion|Withdrawal by Subject|0|||
49131366|NCT00408499|158322152|FG003|Phase II- MTD Expansion|Withdrawal by Subject|0|||
49131367|NCT00408499|158322153|FG004|Phase II- MTD Expansion|Withdrawal by Subject|5|||
49131368|NCT00408499|158322149|FG000|Phase II- MTD Expansion|treatment delay|0|||
49131369|NCT00408499|158322150|FG001|Phase II- MTD Expansion|treatment delay|0|||
49131370|NCT00408499|158322151|FG002|Phase II- MTD Expansion|treatment delay|0|||
48723430|NCT03263026|156837954|FG001|Overall Study|Other/ Various|29|||
48723431|NCT03285763|156837957|FG000|Overall Study|Death|470|||
48723432|NCT03285763|156837957|FG000|Overall Study|Lost to Follow-up|18|||
48817899|NCT01646320|157175224|FG001|Short-term Period (Day 1 to Week 24)|Not reported|2|||
48817900|NCT01646320|157175223|FG000|Short-term Period (Day 1 to Week 24)|Other|1|||
48817901|NCT01646320|157175224|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
48817902|NCT01646320|157175223|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
49131371|NCT00408499|158322152|FG003|Phase II- MTD Expansion|treatment delay|0|||
48723433|NCT03285763|156837957|FG000|Overall Study|Physician Decision|2|||
48723434|NCT03285763|156837957|FG000|Overall Study|Study Terminated By Sponsor|79|||
48723435|NCT03285763|156837957|FG000|Overall Study|Withdrawal by Subject|33|||
48723436|NCT01820260|156837958|FG000|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
48723437|NCT01820260|156837959|FG001|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
48723438|NCT01820260|156837960|FG002|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
48723439|NCT01820260|156837961|FG003|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
48723440|NCT01820260|156837962|FG004|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
48723441|NCT01820260|156837963|FG005|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
48723442|NCT01820260|156837964|FG006|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1|||
48723443|NCT01820260|156837965|FG007|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
48723444|NCT01820260|156837966|FG008|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
48723445|NCT01820260|156837967|FG009|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
48723446|NCT01820260|156837968|FG010|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
48723447|NCT01820260|156837969|FG011|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
48723448|NCT01820260|156837970|FG012|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
48723449|NCT01820260|156837971|FG013|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
48817903|NCT01646320|157175224|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
49131372|NCT00408499|158322153|FG004|Phase II- MTD Expansion|treatment delay|3|||
49131373|NCT00997334|158322154|FG000|Overall Study|still on therapy|12|||
49131374|NCT00997334|158322154|FG000|Overall Study|Adverse Event|3|||
49131375|NCT00997334|158322154|FG000|Overall Study|Patient non-compliance|1|||
48723450|NCT01820260|156837958|FG000|Phase 2 (Part 2)|Withdrawal by Subject|0|||
49131376|NCT00997334|158322154|FG000|Overall Study|Withdrawal by Subject|3|||
49131377|NCT00997334|158322154|FG000|Overall Study|Death|2|||
49131378|NCT00997334|158322154|FG000|Overall Study|Urgent Palliative Care|2|||
49131379|NCT00997334|158322154|FG000|Overall Study|No lesion amenable|1|||
49131380|NCT00997334|158322154|FG000|Overall Study|Ineligible|1|||
49131381|NCT01287936|158322155|FG000|Overall Study|Lost to Follow-up|0|||
49131382|NCT01287936|158322156|FG001|Overall Study|Lost to Follow-up|1|||
49131383|NCT01287936|158322157|FG002|Overall Study|Lost to Follow-up|1|||
49131384|NCT00296244|158322158|FG000|Overall Study|Underwent retransplant|0|||
49131385|NCT00296244|158322159|FG001|Overall Study|Underwent retransplant|1|||
49131386|NCT01140906|158322160|FG000|Overall Study|Adverse Event|7|||
49131387|NCT01140906|158322161|FG001|Overall Study|Adverse Event|10|||
49131388|NCT01140906|158322162|FG002|Overall Study|Adverse Event|17|||
49131389|NCT01140906|158322163|FG003|Overall Study|Adverse Event|7|||
49131390|NCT01140906|158322160|FG000|Overall Study|Lack of Efficacy|6|||
49131391|NCT01140906|158322161|FG001|Overall Study|Lack of Efficacy|8|||
49131392|NCT01140906|158322162|FG002|Overall Study|Lack of Efficacy|2|||
49131393|NCT01140906|158322163|FG003|Overall Study|Lack of Efficacy|1|||
49131394|NCT01140906|158322160|FG000|Overall Study|Non-compliance|0|||
49131395|NCT01140906|158322161|FG001|Overall Study|Non-compliance|1|||
49131396|NCT01140906|158322162|FG002|Overall Study|Non-compliance|0|||
49131397|NCT01140906|158322163|FG003|Overall Study|Non-compliance|1|||
49131398|NCT01140906|158322160|FG000|Overall Study|Protocol Violation|5|||
49131399|NCT01140906|158322161|FG001|Overall Study|Protocol Violation|3|||
49131400|NCT01140906|158322162|FG002|Overall Study|Protocol Violation|2|||
49131401|NCT01140906|158322163|FG003|Overall Study|Protocol Violation|1|||
49131402|NCT01140906|158322160|FG000|Overall Study|Withdrawal of consent|6|||
49131403|NCT01140906|158322161|FG001|Overall Study|Withdrawal of consent|6|||
49131404|NCT01140906|158322162|FG002|Overall Study|Withdrawal of consent|2|||
49131405|NCT01140906|158322163|FG003|Overall Study|Withdrawal of consent|2|||
49131406|NCT01140906|158322160|FG000|Overall Study|Lost to Follow-up|1|||
49131407|NCT01140906|158322161|FG001|Overall Study|Lost to Follow-up|1|||
49131408|NCT01140906|158322162|FG002|Overall Study|Lost to Follow-up|0|||
49131409|NCT01140906|158322163|FG003|Overall Study|Lost to Follow-up|2|||
49131410|NCT01140906|158322160|FG000|Overall Study|Administrative or other reason|0|||
49131411|NCT01140906|158322161|FG001|Overall Study|Administrative or other reason|5|||
49131412|NCT01140906|158322162|FG002|Overall Study|Administrative or other reason|3|||
49131413|NCT01140906|158322163|FG003|Overall Study|Administrative or other reason|2|||
49131414|NCT01130272|158322164|FG000|Overall Study|Adverse Event|2|||
49131415|NCT01130272|158322165|FG001|Overall Study|Adverse Event|5|||
49131416|NCT01130272|158322166|FG002|Overall Study|Adverse Event|6|||
49131417|NCT01130272|158322167|FG003|Overall Study|Adverse Event|22|||
49131418|NCT01130272|158322168|FG004|Overall Study|Adverse Event|7|||
49131419|NCT01130272|158322164|FG000|Overall Study|IVRS-confirmed constipation|0|||
49131420|NCT01130272|158322165|FG001|Overall Study|IVRS-confirmed constipation|1|||
49131421|NCT01130272|158322166|FG002|Overall Study|IVRS-confirmed constipation|1|||
49131422|NCT01130272|158322167|FG003|Overall Study|IVRS-confirmed constipation|2|||
49131423|NCT01130272|158322168|FG004|Overall Study|IVRS-confirmed constipation|0|||
49131424|NCT01130272|158322164|FG000|Overall Study|Rescue medications due to diarrhea|3|||
49131425|NCT01130272|158322165|FG001|Overall Study|Rescue medications due to diarrhea|5|||
49131426|NCT01130272|158322166|FG002|Overall Study|Rescue medications due to diarrhea|8|||
49131427|NCT01130272|158322167|FG003|Overall Study|Rescue medications due to diarrhea|8|||
49131428|NCT01130272|158322168|FG004|Overall Study|Rescue medications due to diarrhea|6|||
49131429|NCT01130272|158322164|FG000|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
49131430|NCT01130272|158322165|FG001|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
49131431|NCT01130272|158322166|FG002|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
49131432|NCT01130272|158322167|FG003|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
49131433|NCT01130272|158322168|FG004|Overall Study|Lack of efficacy- uncontrolled diarrhea|2|||
49131434|NCT01130272|158322164|FG000|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
48723451|NCT01820260|156837959|FG001|Phase 2 (Part 2)|Withdrawal by Subject|0|||
49131435|NCT01130272|158322165|FG001|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
49131436|NCT01130272|158322166|FG002|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
49131437|NCT01130272|158322167|FG003|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1|||
49131438|NCT01130272|158322168|FG004|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
49131439|NCT01130272|158322164|FG000|Overall Study|Protocol Violation|0|||
49131440|NCT01130272|158322165|FG001|Overall Study|Protocol Violation|0|||
49131441|NCT01130272|158322166|FG002|Overall Study|Protocol Violation|3|||
48723452|NCT01820260|156837960|FG002|Phase 2 (Part 2)|Withdrawal by Subject|0|||
49131442|NCT01130272|158322167|FG003|Overall Study|Protocol Violation|5|||
49131443|NCT01130272|158322168|FG004|Overall Study|Protocol Violation|5|||
49131444|NCT01130272|158322164|FG000|Overall Study|Lost to Follow-up|4|||
48723453|NCT01820260|156837961|FG003|Phase 2 (Part 2)|Withdrawal by Subject|0|||
48723454|NCT01820260|156837962|FG004|Phase 2 (Part 2)|Withdrawal by Subject|0|||
49131445|NCT01130272|158322165|FG001|Overall Study|Lost to Follow-up|3|||
49131446|NCT01130272|158322166|FG002|Overall Study|Lost to Follow-up|4|||
49131447|NCT01130272|158322167|FG003|Overall Study|Lost to Follow-up|7|||
49131448|NCT01130272|158322168|FG004|Overall Study|Lost to Follow-up|6|||
49131449|NCT01130272|158322164|FG000|Overall Study|Withdrawal by Subject|4|||
49131450|NCT01130272|158322165|FG001|Overall Study|Withdrawal by Subject|11|||
49131451|NCT01130272|158322166|FG002|Overall Study|Withdrawal by Subject|10|||
49131452|NCT01130272|158322167|FG003|Overall Study|Withdrawal by Subject|9|||
49131453|NCT01130272|158322168|FG004|Overall Study|Withdrawal by Subject|8|||
49131454|NCT01130272|158322164|FG000|Overall Study|Physician Decision|1|||
49131455|NCT01130272|158322165|FG001|Overall Study|Physician Decision|1|||
49131456|NCT01130272|158322166|FG002|Overall Study|Physician Decision|0|||
49131457|NCT01130272|158322167|FG003|Overall Study|Physician Decision|1|||
49131458|NCT01130272|158322168|FG004|Overall Study|Physician Decision|2|||
49131459|NCT01130272|158322164|FG000|Overall Study|Sponsor decision|6|||
49131460|NCT01130272|158322165|FG001|Overall Study|Sponsor decision|15|||
49131461|NCT01130272|158322166|FG002|Overall Study|Sponsor decision|16|||
49131462|NCT01130272|158322167|FG003|Overall Study|Sponsor decision|13|||
49131463|NCT01130272|158322168|FG004|Overall Study|Sponsor decision|16|||
49131464|NCT01130272|158322164|FG000|Overall Study|Study arm discontinued|38|||
49131465|NCT01130272|158322165|FG001|Overall Study|Study arm discontinued|0|||
49131466|NCT01130272|158322166|FG002|Overall Study|Study arm discontinued|0|||
49131467|NCT01130272|158322167|FG003|Overall Study|Study arm discontinued|0|||
49131468|NCT01130272|158322168|FG004|Overall Study|Study arm discontinued|0|||
49131469|NCT01294423|158322169|FG000|Overall Study|Adverse Event|1|||
49131470|NCT01294423|158322170|FG001|Overall Study|Adverse Event|2|||
49131471|NCT01294423|158322171|FG002|Overall Study|Adverse Event|3|||
49131472|NCT01294423|158322169|FG000|Overall Study|Withdrawal by Subject|1|||
49131473|NCT01294423|158322170|FG001|Overall Study|Withdrawal by Subject|2|||
49131474|NCT01294423|158322171|FG002|Overall Study|Withdrawal by Subject|2|||
49131475|NCT01294423|158322169|FG000|Overall Study|subject no longer meets study criteria|2|||
49131476|NCT01294423|158322170|FG001|Overall Study|subject no longer meets study criteria|5|||
49131477|NCT01294423|158322171|FG002|Overall Study|subject no longer meets study criteria|2|||
49131478|NCT01294423|158322169|FG000|Overall Study|poor/non-compliance|1|||
49131479|NCT01294423|158322170|FG001|Overall Study|poor/non-compliance|0|||
49131480|NCT01294423|158322171|FG002|Overall Study|poor/non-compliance|1|||
49131481|NCT00641056|158322172|FG000|Overall Study|Adverse Event|12|||
49131482|NCT00641056|158322173|FG001|Overall Study|Adverse Event|2|||
49131483|NCT00641056|158322172|FG000|Overall Study|Lost to Follow-up|2|||
49131484|NCT00641056|158322173|FG001|Overall Study|Lost to Follow-up|1|||
49131485|NCT00641056|158322172|FG000|Overall Study|Physician Decision|3|||
49131486|NCT00641056|158322173|FG001|Overall Study|Physician Decision|1|||
49131487|NCT00641056|158322172|FG000|Overall Study|Protocol Violation|2|||
49131488|NCT00641056|158322173|FG001|Overall Study|Protocol Violation|0|||
49131489|NCT00641056|158322172|FG000|Overall Study|Entry Criteria Not Met|3|||
49131490|NCT00641056|158322173|FG001|Overall Study|Entry Criteria Not Met|0|||
49131491|NCT00641056|158322172|FG000|Overall Study|Subject Decision|6|||
49131492|NCT00641056|158322173|FG001|Overall Study|Subject Decision|19|||
49131493|NCT00641056|158322172|FG000|Overall Study|Sponsor Decision|1|||
49131494|NCT00641056|158322173|FG001|Overall Study|Sponsor Decision|2|||
49131495|NCT01721798|158322176|FG000|Overall Study|Death|0|||
49131496|NCT01721798|158322177|FG001|Overall Study|Death|0|||
49131497|NCT01721798|158322178|FG002|Overall Study|Death|1|||
49131498|NCT01721798|158322179|FG003|Overall Study|Death|1|||
49131499|NCT01721798|158322176|FG000|Overall Study|Lost to Follow-up|2|||
49131500|NCT01721798|158322177|FG001|Overall Study|Lost to Follow-up|2|||
49131501|NCT01721798|158322178|FG002|Overall Study|Lost to Follow-up|9|||
49131502|NCT01721798|158322179|FG003|Overall Study|Lost to Follow-up|9|||
49131503|NCT01721798|158322176|FG000|Overall Study|Pregnancy|0|||
49131504|NCT01721798|158322177|FG001|Overall Study|Pregnancy|0|||
48723455|NCT01820260|156837963|FG005|Phase 2 (Part 2)|Withdrawal by Subject|0|||
48723456|NCT01820260|156837964|FG006|Phase 2 (Part 2)|Withdrawal by Subject|0|||
48723457|NCT01820260|156837965|FG007|Phase 2 (Part 2)|Withdrawal by Subject|0|||
49131505|NCT01721798|158322178|FG002|Overall Study|Pregnancy|1|||
49131506|NCT01721798|158322179|FG003|Overall Study|Pregnancy|1|||
49131507|NCT01721798|158322176|FG000|Overall Study|Withdrawal by Subject|1|||
49131508|NCT01721798|158322177|FG001|Overall Study|Withdrawal by Subject|0|||
49131509|NCT01721798|158322178|FG002|Overall Study|Withdrawal by Subject|2|||
48723458|NCT01820260|156837966|FG008|Phase 2 (Part 2)|Withdrawal by Subject|0|||
48723459|NCT01820260|156837967|FG009|Phase 2 (Part 2)|Withdrawal by Subject|1|||
48723460|NCT01820260|156837968|FG010|Phase 2 (Part 2)|Withdrawal by Subject|0|||
48723461|NCT01820260|156837969|FG011|Phase 2 (Part 2)|Withdrawal by Subject|0|||
48723462|NCT01820260|156837970|FG012|Phase 2 (Part 2)|Withdrawal by Subject|0|||
48723463|NCT01820260|156837971|FG013|Phase 2 (Part 2)|Withdrawal by Subject|0|||
48723464|NCT04088630|156837972|FG000|Overall Study|Lost to Follow-up|3|||
48723465|NCT04088630|156837973|FG001|Overall Study|Lost to Follow-up|2|||
48723466|NCT04088630|156837974|FG002|Overall Study|Lost to Follow-up|6|||
48723467|NCT04088630|156837972|FG000|Overall Study|Death|3|||
49131510|NCT01721798|158322179|FG003|Overall Study|Withdrawal by Subject|1|||
49131511|NCT01721798|158322176|FG000|Overall Study|Not eligible for 24 month visit|1|||
49131512|NCT01721798|158322177|FG001|Overall Study|Not eligible for 24 month visit|0|||
49131513|NCT01721798|158322178|FG002|Overall Study|Not eligible for 24 month visit|8|||
49131514|NCT01721798|158322179|FG003|Overall Study|Not eligible for 24 month visit|7|||
49131515|NCT00301834|158322180|FG000|Overall Study|Death|1|||
49131516|NCT00336544|158322183|FG000|Overall Study|Lack of Efficacy|8|||
49131517|NCT00336544|158322184|FG001|Overall Study|Lack of Efficacy|5|||
49131518|NCT00336544|158322183|FG000|Overall Study|Adverse Event|4|||
49131519|NCT00336544|158322184|FG001|Overall Study|Adverse Event|9|||
49131520|NCT00336544|158322183|FG000|Overall Study|Withdrawal by Subject|4|||
49131521|NCT00336544|158322184|FG001|Overall Study|Withdrawal by Subject|3|||
49131522|NCT00336544|158322183|FG000|Overall Study|Other|3|||
49131523|NCT00336544|158322184|FG001|Overall Study|Other|5|||
49131524|NCT02119299|158322185|FG000|Overall Study|Withdrawal by Subject|7|||
49131525|NCT02119299|158322185|FG000|Overall Study|Lack of Efficacy|1|||
49131526|NCT02119299|158322185|FG000|Overall Study|Pregnancy|1|||
49131527|NCT00486044|158322194|FG000|Overall Study|Withdrawal by Subject|2|||
49131528|NCT00486044|158322195|FG001|Overall Study|Withdrawal by Subject|1|||
48723468|NCT04088630|156837973|FG001|Overall Study|Death|1|||
48817904|NCT01646320|157175223|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2|||
48817905|NCT01646320|157175224|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
48817906|NCT01646320|157175223|FG000|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2|||
48817907|NCT01646320|157175224|FG001|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0|||
48817908|NCT01646320|157175223|FG000|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0|||
48817909|NCT01646320|157175224|FG001|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2|||
48817910|NCT01646320|157175223|FG000|Long-term Period (Weeks 24 to 52)|Adverse Event|4|||
48723469|NCT04088630|156837974|FG002|Overall Study|Death|1|||
48723470|NCT04088630|156837972|FG000|Overall Study|Physician Decision|0|||
48723471|NCT04088630|156837973|FG001|Overall Study|Physician Decision|1|||
48723472|NCT04088630|156837974|FG002|Overall Study|Physician Decision|1|||
48723473|NCT01265537|156837975|FG000|Overall Study|Adverse Event|2|||
48723474|NCT01265537|156837976|FG001|Overall Study|Adverse Event|1|||
48723475|NCT01265537|156837975|FG000|Overall Study|Physician Decision|0|||
48723476|NCT01265537|156837976|FG001|Overall Study|Physician Decision|1|||
48723477|NCT01944839|156837977|FG000|Overall Study|Physician Decision|2|||
48723478|NCT01944839|156837978|FG001|Overall Study|Physician Decision|2|||
48723479|NCT01944839|156837977|FG000|Overall Study|Protocol Violation|0|||
48723480|NCT01944839|156837978|FG001|Overall Study|Protocol Violation|1|||
48723481|NCT01944839|156837977|FG000|Overall Study|Adverse Event|10|||
48723482|NCT01944839|156837978|FG001|Overall Study|Adverse Event|5|||
48723483|NCT01944839|156837977|FG000|Overall Study|Withdrawal by Subject|9|||
48723484|NCT01944839|156837978|FG001|Overall Study|Withdrawal by Subject|17|||
48723485|NCT01944839|156837977|FG000|Overall Study|Lost to Follow-up|1|||
48723486|NCT01944839|156837978|FG001|Overall Study|Lost to Follow-up|0|||
48723487|NCT01944839|156837977|FG000|Overall Study|Subject non-compliance|0|||
48723488|NCT01944839|156837978|FG001|Overall Study|Subject non-compliance|3|||
48723489|NCT00627445|156837981|FG000|Overall Study|Adverse Event|3|||
48723490|NCT00627445|156837982|FG001|Overall Study|Adverse Event|3|||
48723491|NCT00627445|156837981|FG000|Overall Study|Lack of Efficacy|0|||
48723492|NCT00627445|156837982|FG001|Overall Study|Lack of Efficacy|1|||
48723493|NCT00627445|156837981|FG000|Overall Study|Other|6|||
48723494|NCT00627445|156837982|FG001|Overall Study|Other|8|||
48723495|NCT04505540|156837983|FG000|Baseline|Protocol Violation|10|||
48723496|NCT04505540|156837983|FG000|1 Week Eligible to Self-report|Incarcerated/Institutionalized|1|||
48723497|NCT04505540|156837983|FG000|1 Week Contacted for Self-report|Lost to Follow-up|27|||
48723498|NCT04505540|156837983|FG000|1 Week Eligible for Urinanalysis|COVID disruption of urine sampling|52|||
48723499|NCT04505540|156837983|FG000|1 Week Eligible for Urinanalysis|Incarcerated/Institutionalized|1|||
48723500|NCT04505540|156837983|FG000|1 Week Urine Sample Provided|Lost to Follow-up|13|||
48723501|NCT04505540|156837983|FG000|3 Months Eligible to Self-report|Incarcerated/Institutionalized|7|||
48723502|NCT04505540|156837983|FG000|3 Months Contacted for Self-report|Lost to Follow-up|22|||
48723503|NCT04505540|156837983|FG000|3 Months Eligible for Urinanalysis|COVID disruption of urine sampling|70|||
48723504|NCT04505540|156837983|FG000|3 Months Urine Sample Provided|Lost to Follow-up|13|||
48723505|NCT04505540|156837983|FG000|6 Months Eligible to Self-report|Incarcerated/Institutionalized|9|||
48723506|NCT04505540|156837983|FG000|6 Months Contacted for Self-report|Lost to Follow-up|17|||
48817911|NCT01646320|157175224|FG001|Long-term Period (Weeks 24 to 52)|Adverse Event|2|||
48817912|NCT01646320|157175223|FG000|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0|||
49131529|NCT00486044|158322194|FG000|Overall Study|Adverse Event|0|||
49131530|NCT00486044|158322195|FG001|Overall Study|Adverse Event|1|||
49131531|NCT00486044|158322194|FG000|Overall Study|Lost to Follow-up|0|||
48723507|NCT04505540|156837983|FG000|6 Months Eligible for Urinanalysis|COVID disruption of urine sampling|91|||
48723508|NCT00977080|156837984|FG000|Overall Study|Adverse Event|2|||
49131532|NCT00486044|158322195|FG001|Overall Study|Lost to Follow-up|1|||
49131533|NCT02737722|158322196|FG000|Overall Study|Physician Decision|0|||
48723509|NCT00977080|156837985|FG001|Overall Study|Adverse Event|7|||
48723510|NCT00977080|156837986|FG002|Overall Study|Adverse Event|7|||
48723511|NCT00977080|156837987|FG003|Overall Study|Adverse Event|7|||
48723512|NCT00977080|156837984|FG000|Overall Study|Withdrawal by Subject|1|||
48723513|NCT00977080|156837985|FG001|Overall Study|Withdrawal by Subject|5|||
48723514|NCT00977080|156837986|FG002|Overall Study|Withdrawal by Subject|1|||
48723515|NCT00977080|156837987|FG003|Overall Study|Withdrawal by Subject|5|||
48723516|NCT00977080|156837984|FG000|Overall Study|Protocol Violation|7|||
48723517|NCT00977080|156837985|FG001|Overall Study|Protocol Violation|3|||
48723518|NCT00977080|156837986|FG002|Overall Study|Protocol Violation|4|||
48723519|NCT00977080|156837987|FG003|Overall Study|Protocol Violation|3|||
48723520|NCT00977080|156837984|FG000|Overall Study|Noncompliance|0|||
48723521|NCT00977080|156837985|FG001|Overall Study|Noncompliance|2|||
48723522|NCT00977080|156837986|FG002|Overall Study|Noncompliance|1|||
48723523|NCT00977080|156837987|FG003|Overall Study|Noncompliance|0|||
48723524|NCT00977080|156837984|FG000|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
48817913|NCT01646320|157175224|FG001|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1|||
48817914|NCT01646320|157175223|FG000|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0|||
48817915|NCT01646320|157175224|FG001|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2|||
48817916|NCT01155726|157175225|FG000|Period 1, 3 Days (Masked)|Inconvenience|1|||
49131534|NCT02737722|158322197|FG001|Overall Study|Physician Decision|0|||
48723525|NCT00977080|156837985|FG001|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
49131535|NCT02737722|158322198|FG002|Overall Study|Physician Decision|1|||
49131536|NCT02737722|158322199|FG003|Overall Study|Physician Decision|0|||
49131537|NCT01026493|158322200|FG000|Overall Study|Protocol Violation|0|||
49131538|NCT01026493|158322201|FG001|Overall Study|Protocol Violation|1|||
49131539|NCT01026493|158322202|FG002|Overall Study|Protocol Violation|0|||
49131540|NCT01026493|158322203|FG003|Overall Study|Protocol Violation|0|||
49131541|NCT01026493|158322204|FG004|Overall Study|Protocol Violation|2|||
49131542|NCT01026493|158322205|FG005|Overall Study|Protocol Violation|3|||
49131543|NCT01026493|158322206|FG006|Overall Study|Protocol Violation|4|||
49131544|NCT01026493|158322207|FG007|Overall Study|Protocol Violation|1|||
49131545|NCT01206764|158322208|FG000|Overall Study|Adverse Event|20|||
49131546|NCT01206764|158322208|FG000|Overall Study|Abnormal laboratory value|2|||
49131547|NCT01206764|158322208|FG000|Overall Study|Abnormal test procedure result|1|||
49131548|NCT01206764|158322208|FG000|Overall Study|Patient withdrew consent|5|||
49131549|NCT01206764|158322208|FG000|Overall Study|Lost to Follow-up|6|||
49131550|NCT01206764|158322208|FG000|Overall Study|Death|11|||
49131551|NCT01206764|158322208|FG000|Overall Study|New cancer therapy|2|||
49131552|NCT01206764|158322208|FG000|Overall Study|Disease progression|88|||
49131553|NCT01206764|158322208|FG000|Overall Study|Protocol deviation|3|||
49131554|NCT00314145|158322209|FG000|Overall Study|Withdrawal by Subject|8|||
49131555|NCT00314145|158322210|FG001|Overall Study|Withdrawal by Subject|10|||
49131556|NCT00314145|158322209|FG000|Overall Study|Lost to Follow-up|5|||
49131557|NCT00314145|158322210|FG001|Overall Study|Lost to Follow-up|12|||
49131558|NCT00314145|158322209|FG000|Overall Study|Physician Decision|3|||
49131559|NCT00314145|158322210|FG001|Overall Study|Physician Decision|4|||
49131560|NCT00314145|158322209|FG000|Overall Study|Adverse Event|0|||
49131561|NCT00314145|158322210|FG001|Overall Study|Adverse Event|3|||
49131562|NCT00314145|158322209|FG000|Overall Study|Protocol Violation|3|||
49131563|NCT00314145|158322210|FG001|Overall Study|Protocol Violation|0|||
49131564|NCT00314145|158322209|FG000|Overall Study|Sponsor Decision|2|||
49131565|NCT00314145|158322210|FG001|Overall Study|Sponsor Decision|0|||
48817917|NCT01155726|157175226|FG001|Period 1, 3 Days (Masked)|Inconvenience|0|||
48817918|NCT01155726|157175227|FG002|Period 1, 3 Days (Masked)|Inconvenience|2|||
48817919|NCT01155726|157175228|FG003|Period 1, 3 Days (Masked)|Inconvenience|0|||
48817920|NCT01017120|157175229|FG000|Overall Study|Adverse Event|9|||
48817921|NCT01017120|157175230|FG001|Overall Study|Adverse Event|0|||
48817922|NCT01017120|157175229|FG000|Overall Study|Lost to Follow-up|13|||
48817923|NCT01017120|157175230|FG001|Overall Study|Lost to Follow-up|11|||
48921002|NCT00784654|157544820|FG002|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
49131566|NCT02029417|158322211|FG000|Overall Study|Death|1|||
49131567|NCT02029417|158322211|FG000|Overall Study|Adverse Event|1|||
49131568|NCT05259917|158322212|FG000|Overall Study|Protocol Violation|0|||
49131569|NCT05259917|158322213|FG001|Overall Study|Protocol Violation|0|||
48723526|NCT00977080|156837986|FG002|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
48723527|NCT00977080|156837987|FG003|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1|||
49131570|NCT05259917|158322214|FG002|Overall Study|Protocol Violation|1|||
49131571|NCT05259917|158322215|FG003|Overall Study|Protocol Violation|0|||
49131572|NCT05259917|158322216|FG004|Overall Study|Protocol Violation|0|||
49131573|NCT05259917|158322217|FG005|Overall Study|Protocol Violation|0|||
49131574|NCT05259917|158322212|FG000|Overall Study|Lost to Follow-up|0|||
48723528|NCT00977080|156837984|FG000|Overall Study|Required kidney transplantation|1|||
48723529|NCT00977080|156837985|FG001|Overall Study|Required kidney transplantation|3|||
48723530|NCT00977080|156837986|FG002|Overall Study|Required kidney transplantation|3|||
48723531|NCT00977080|156837987|FG003|Overall Study|Required kidney transplantation|1|||
48723532|NCT00977080|156837984|FG000|Overall Study|Travel for family reasons|1|||
48817924|NCT01017120|157175229|FG000|Overall Study|Lack of Efficacy|1|||
48817925|NCT01017120|157175230|FG001|Overall Study|Lack of Efficacy|0|||
49131575|NCT05259917|158322213|FG001|Overall Study|Lost to Follow-up|0|||
49131576|NCT05259917|158322214|FG002|Overall Study|Lost to Follow-up|1|||
49131577|NCT05259917|158322215|FG003|Overall Study|Lost to Follow-up|0|||
48723533|NCT00977080|156837985|FG001|Overall Study|Travel for family reasons|0|||
48723534|NCT00977080|156837986|FG002|Overall Study|Travel for family reasons|0|||
48723535|NCT00977080|156837987|FG003|Overall Study|Travel for family reasons|0|||
48723536|NCT00827931|156837991|FG000|Overall Study|Death|3|||
48723537|NCT00827931|156837992|FG001|Overall Study|Death|5|||
48723538|NCT00827931|156837991|FG000|Overall Study|Adverse Event|1|||
48723539|NCT00827931|156837992|FG001|Overall Study|Adverse Event|0|||
48723540|NCT00827931|156837991|FG000|Overall Study|Lost to Follow-up|1|||
48723541|NCT00827931|156837992|FG001|Overall Study|Lost to Follow-up|0|||
48723542|NCT00827931|156837991|FG000|Overall Study|Withdrawal by Subject|0|||
48723543|NCT00827931|156837992|FG001|Overall Study|Withdrawal by Subject|1|||
48723544|NCT00827931|156837991|FG000|Overall Study|Other|1|||
48723545|NCT00827931|156837992|FG001|Overall Study|Other|0|||
48723546|NCT01120067|156837997|FG000|Overall Study|Lost to Follow-up|3|||
48723547|NCT01120067|156837998|FG001|Overall Study|Lost to Follow-up|1|||
48723548|NCT01120067|156837997|FG000|Overall Study|fail to engage >3 sessions|2|||
48723549|NCT01120067|156837998|FG001|Overall Study|fail to engage >3 sessions|0|||
48723550|NCT01267955|156838001|FG000|Stage 1 (6 Months)|Death|3|||
48723551|NCT01267955|156838001|FG000|Stage 2 (6 Months)|Death|5|||
48723552|NCT01267955|156838001|FG000|Stage 2 (6 Months)|Protocol Violation|1|||
48723553|NCT00870233|156838002|FG000|Overall Study|Withdrawal by Subject|18|||
48723554|NCT00870233|156838002|FG000|Overall Study|Did not undergo laparotomy|3|||
48723555|NCT00870233|156838002|FG000|Overall Study|Incompatible internet browser|2|||
48723556|NCT00870233|156838002|FG000|Overall Study|Death|1|||
48723557|NCT02274038|156838006|FG000|Overall Study|Death|1|||
48723558|NCT01007253|156838013|FG000|Washout Period (2 Weeks) # 3|Physician Decision|1|||
48723559|NCT01007253|156838014|FG001|Washout Period (2 Weeks) # 3|Physician Decision|0|||
48723560|NCT01007253|156838015|FG002|Washout Period (2 Weeks) # 3|Physician Decision|0|||
48723561|NCT01007253|156838016|FG003|Washout Period (2 Weeks) # 3|Physician Decision|0|||
48723562|NCT02751931|156838017|FG000|Overall Study|Adverse Event|3|||
48723563|NCT02751931|156838018|FG001|Overall Study|Adverse Event|0|||
48723564|NCT02751931|156838017|FG000|Overall Study|Other: Miscelleneous|10|||
48723565|NCT02751931|156838018|FG001|Overall Study|Other: Miscelleneous|8|||
48723566|NCT05985980|156838020|FG000|Overall Study|Withdrawal by Subject|1|||
48723567|NCT05985980|156838020|FG000|Overall Study|Withdrawal by Subject|1|||
48723568|NCT05985980|156838020|FG000|Overall Study|Withdrawal by Subject|1|||
48723569|NCT05985980|156838020|FG000|Overall Study|Withdrawal by Subject|1|||
48723570|NCT01436162|156838021|FG000|Single-blind Lead-in Phase|Adverse Event|26|||
48723571|NCT01436162|156838022|FG001|Single-blind Lead-in Phase|Adverse Event|0|||
48723572|NCT01436162|156838023|FG002|Single-blind Lead-in Phase|Adverse Event|0|||
48723573|NCT01436162|156838021|FG000|Single-blind Lead-in Phase|Protocol Violation|24|||
48723574|NCT01436162|156838022|FG001|Single-blind Lead-in Phase|Protocol Violation|0|||
48723575|NCT01436162|156838023|FG002|Single-blind Lead-in Phase|Protocol Violation|0|||
48723576|NCT01436162|156838021|FG000|Single-blind Lead-in Phase|Withdrawal by Subject|69|||
48723577|NCT01436162|156838022|FG001|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
48723578|NCT01436162|156838023|FG002|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
48723579|NCT01436162|156838021|FG000|Single-blind Lead-in Phase|Lost to Follow-up|43|||
48723580|NCT01436162|156838022|FG001|Single-blind Lead-in Phase|Lost to Follow-up|0|||
48723581|NCT01436162|156838023|FG002|Single-blind Lead-in Phase|Lost to Follow-up|0|||
48723582|NCT01436162|156838021|FG000|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13|||
48723583|NCT01436162|156838022|FG001|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
48723584|NCT01436162|156838023|FG002|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
48723585|NCT01436162|156838021|FG000|Single-blind Lead-in Phase|Other|107|||
48723586|NCT01436162|156838022|FG001|Single-blind Lead-in Phase|Other|0|||
48723587|NCT01436162|156838023|FG002|Single-blind Lead-in Phase|Other|0|||
48723588|NCT01436162|156838021|FG000|Randomized Phase|Adverse Event|1|||
48723589|NCT01436162|156838022|FG001|Randomized Phase|Adverse Event|5|||
48723590|NCT01436162|156838023|FG002|Randomized Phase|Adverse Event|6|||
48723591|NCT01436162|156838021|FG000|Randomized Phase|Protocol Violation|4|||
48723592|NCT01436162|156838022|FG001|Randomized Phase|Protocol Violation|4|||
48723593|NCT01436162|156838023|FG002|Randomized Phase|Protocol Violation|2|||
48723594|NCT01436162|156838021|FG000|Randomized Phase|Withdrawal by Subject|16|||
48723595|NCT01436162|156838022|FG001|Randomized Phase|Withdrawal by Subject|9|||
48723596|NCT01436162|156838023|FG002|Randomized Phase|Withdrawal by Subject|8|||
48723597|NCT01436162|156838021|FG000|Randomized Phase|Lost to Follow-up|17|||
48723598|NCT01436162|156838022|FG001|Randomized Phase|Lost to Follow-up|5|||
48723599|NCT01436162|156838023|FG002|Randomized Phase|Lost to Follow-up|4|||
48723600|NCT01436162|156838021|FG000|Randomized Phase|Lack of Efficacy|0|||
48723601|NCT01436162|156838022|FG001|Randomized Phase|Lack of Efficacy|1|||
48723602|NCT01436162|156838023|FG002|Randomized Phase|Lack of Efficacy|1|||
48723603|NCT01436162|156838021|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4|||
48723604|NCT01436162|156838022|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
48723605|NCT01436162|156838023|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0|||
48817926|NCT01017120|157175229|FG000|Overall Study|Withdrawal by Subject|39|||
48817927|NCT01017120|157175230|FG001|Overall Study|Withdrawal by Subject|21|||
48723606|NCT01436162|156838021|FG000|Randomized Phase|Other|2|||
49131578|NCT05259917|158322216|FG004|Overall Study|Lost to Follow-up|0|||
49131579|NCT05259917|158322217|FG005|Overall Study|Lost to Follow-up|1|||
49131580|NCT05259917|158322212|FG000|Overall Study|Physician Decision|0|||
49131581|NCT05259917|158322213|FG001|Overall Study|Physician Decision|1|||
49131582|NCT05259917|158322214|FG002|Overall Study|Physician Decision|0|||
49131583|NCT05259917|158322215|FG003|Overall Study|Physician Decision|0|||
49131584|NCT05259917|158322216|FG004|Overall Study|Physician Decision|0|||
49131585|NCT05259917|158322217|FG005|Overall Study|Physician Decision|0|||
49131586|NCT05259917|158322212|FG000|Overall Study|Withdrawal by Subject|0|||
49131587|NCT05259917|158322213|FG001|Overall Study|Withdrawal by Subject|1|||
49131588|NCT05259917|158322214|FG002|Overall Study|Withdrawal by Subject|0|||
49131589|NCT05259917|158322215|FG003|Overall Study|Withdrawal by Subject|0|||
49131590|NCT05259917|158322216|FG004|Overall Study|Withdrawal by Subject|1|||
49131591|NCT05259917|158322217|FG005|Overall Study|Withdrawal by Subject|1|||
49131592|NCT05259917|158322212|FG000|Overall Study|Trial Termination by Sponsor|7|||
49131593|NCT05259917|158322213|FG001|Overall Study|Trial Termination by Sponsor|2|||
49131594|NCT05259917|158322214|FG002|Overall Study|Trial Termination by Sponsor|3|||
49131595|NCT05259917|158322215|FG003|Overall Study|Trial Termination by Sponsor|5|||
49131596|NCT05259917|158322216|FG004|Overall Study|Trial Termination by Sponsor|11|||
49131597|NCT05259917|158322217|FG005|Overall Study|Trial Termination by Sponsor|4|||
49131598|NCT05259917|158322212|FG000|Overall Study|Other|1|||
49131599|NCT05259917|158322213|FG001|Overall Study|Other|0|||
49131600|NCT05259917|158322214|FG002|Overall Study|Other|2|||
49131601|NCT05259917|158322215|FG003|Overall Study|Other|0|||
49131602|NCT05259917|158322216|FG004|Overall Study|Other|0|||
49131603|NCT05259917|158322217|FG005|Overall Study|Other|0|||
49131604|NCT01933594|158322219|FG000|Overall Study|Lost to Follow-up|1|||
49131605|NCT01933594|158322220|FG001|Overall Study|Lost to Follow-up|0|||
49131606|NCT01933594|158322221|FG002|Overall Study|Lost to Follow-up|0|||
49131607|NCT01933594|158322222|FG003|Overall Study|Lost to Follow-up|0|||
49131608|NCT01933594|158322223|FG004|Overall Study|Lost to Follow-up|1|||
49131609|NCT01933594|158322224|FG005|Overall Study|Lost to Follow-up|0|||
49131610|NCT01933594|158322219|FG000|Overall Study|Ineligible for subsequent study step|0|||
49131611|NCT01933594|158322220|FG001|Overall Study|Ineligible for subsequent study step|0|||
49131612|NCT01933594|158322221|FG002|Overall Study|Ineligible for subsequent study step|0|||
49131613|NCT01933594|158322222|FG003|Overall Study|Ineligible for subsequent study step|0|||
49131614|NCT01933594|158322223|FG004|Overall Study|Ineligible for subsequent study step|1|||
49131615|NCT01933594|158322224|FG005|Overall Study|Ineligible for subsequent study step|0|||
49131616|NCT03329885|158322230|FG000|Overall Study|Sponsor discontinued the study early|0|||
49131617|NCT03329885|158322231|FG001|Overall Study|Sponsor discontinued the study early|0|||
49131618|NCT03329885|158322232|FG002|Overall Study|Sponsor discontinued the study early|0|||
49131619|NCT03329885|158322233|FG003|Overall Study|Sponsor discontinued the study early|0|||
49131620|NCT03329885|158322234|FG004|Overall Study|Sponsor discontinued the study early|0|||
49131621|NCT03329885|158322235|FG005|Overall Study|Sponsor discontinued the study early|0|||
49131622|NCT03329885|158322236|FG006|Overall Study|Sponsor discontinued the study early|1|||
49131623|NCT03329885|158322237|FG007|Overall Study|Sponsor discontinued the study early|1|||
49131624|NCT03329885|158322238|FG008|Overall Study|Sponsor discontinued the study early|0|||
49131625|NCT02908347|158322239|FG000|Overall Study|Adverse Event|0|||
49131626|NCT02908347|158322240|FG001|Overall Study|Adverse Event|1|||
49131627|NCT02908347|158322239|FG000|Overall Study|Lost to Follow-up|1|||
49131628|NCT02908347|158322240|FG001|Overall Study|Lost to Follow-up|0|||
49131629|NCT03886272|158322241|FG000|Period 1|Withdrawal by Subject|0|||
49131630|NCT03886272|158322242|FG001|Period 1|Withdrawal by Subject|0|||
49131631|NCT03886272|158322243|FG002|Period 1|Withdrawal by Subject|0|||
49131632|NCT03886272|158322244|FG003|Period 1|Withdrawal by Subject|0|||
49131633|NCT03886272|158322245|FG004|Period 1|Withdrawal by Subject|0|||
49131634|NCT03886272|158322246|FG005|Period 1|Withdrawal by Subject|1|||
49131635|NCT03886272|158322247|FG006|Period 1|Withdrawal by Subject|0|||
49131636|NCT00325416|158322248|FG000|Phase I: Dose Escalation|Pre-transplant screen failure|8|||
49131637|NCT00325416|158322249|FG001|Phase I: Dose Escalation|Pre-transplant screen failure|9|||
49131638|NCT00325416|158322248|FG000|Phase I: Dose Escalation|Denial of insurance coverage|7|||
49131639|NCT00325416|158322249|FG001|Phase I: Dose Escalation|Denial of insurance coverage|4|||
49131640|NCT00325416|158322248|FG000|Phase I: Dose Escalation|Withdrawal by Subject|7|||
49131641|NCT00325416|158322249|FG001|Phase I: Dose Escalation|Withdrawal by Subject|2|||
49131642|NCT00325416|158322248|FG000|Phase I: Dose Escalation|Inability to collect adequate stem cells|0|||
49131643|NCT00325416|158322249|FG001|Phase I: Dose Escalation|Inability to collect adequate stem cells|1|||
49131644|NCT00325416|158322248|FG000|Phase II: Treatment at MTD|denial of insurance coverage|0|||
49131645|NCT00325416|158322249|FG001|Phase II: Treatment at MTD|denial of insurance coverage|1|||
49131646|NCT00325416|158322248|FG000|Phase II: Treatment at MTD|Withdrawal by Subject|0|||
49131647|NCT00325416|158322249|FG001|Phase II: Treatment at MTD|Withdrawal by Subject|1|||
49131648|NCT01299909|158322250|FG000|Overall Study|Lost to Follow-up|22|||
49131649|NCT01299909|158322251|FG001|Overall Study|Lost to Follow-up|18|||
49131650|NCT01299909|158322252|FG002|Overall Study|Lost to Follow-up|17|||
49131651|NCT02340949|158322253|FG000|Overall Study|Adverse Event|4|||
48723607|NCT01436162|156838022|FG001|Randomized Phase|Other|5|||
48723608|NCT01436162|156838023|FG002|Randomized Phase|Other|4|||
48723609|NCT03960463|156840362|FG000|Overall Study|Withdrawal by Subject|2|||
48723610|NCT03960463|156840363|FG001|Overall Study|Withdrawal by Subject|0|||
48723611|NCT02616146|156840366|FG000|Overall Study|Adverse Event|64|||
48723612|NCT02616146|156840367|FG001|Overall Study|Adverse Event|24|||
48723613|NCT02616146|156840366|FG000|Overall Study|Lost to Follow-up|23|||
48723614|NCT02616146|156840367|FG001|Overall Study|Lost to Follow-up|13|||
48723615|NCT02616146|156840366|FG000|Overall Study|Non-compliance with study protocol|2|||
48723616|NCT02616146|156840367|FG001|Overall Study|Non-compliance with study protocol|0|||
48723617|NCT02616146|156840366|FG000|Overall Study|Non-compliance with study drug|4|||
48723618|NCT02616146|156840367|FG001|Overall Study|Non-compliance with study drug|2|||
48723619|NCT02616146|156840366|FG000|Overall Study|Pregnancy|2|||
48723620|NCT02616146|156840367|FG001|Overall Study|Pregnancy|2|||
48723621|NCT02616146|156840366|FG000|Overall Study|Pregnancy wish|3|||
48723622|NCT02616146|156840367|FG001|Overall Study|Pregnancy wish|0|||
48723623|NCT02616146|156840366|FG000|Overall Study|Protocol Violation|6|||
48723624|NCT02616146|156840367|FG001|Overall Study|Protocol Violation|3|||
48723625|NCT02616146|156840366|FG000|Overall Study|Study terminated by sponsor|1372|||
48723626|NCT02616146|156840367|FG001|Overall Study|Study terminated by sponsor|432|||
48723627|NCT02616146|156840366|FG000|Overall Study|Participant moved|4|||
48723628|NCT02616146|156840367|FG001|Overall Study|Participant moved|3|||
48723629|NCT02616146|156840366|FG000|Overall Study|Withdrawal by Subject|30|||
48723630|NCT02616146|156840367|FG001|Overall Study|Withdrawal by Subject|24|||
48723631|NCT02616146|156840366|FG000|Overall Study|Physician Decision|2|||
48723632|NCT02616146|156840367|FG001|Overall Study|Physician Decision|1|||
48723633|NCT01221272|156840368|FG000|Period 1|Adverse Event|2|||
48723634|NCT01221272|156840369|FG001|Period 1|Adverse Event|0|||
48723635|NCT01221272|156840368|FG000|Period 1|Consent Withdrawal|0|||
48723636|NCT01221272|156840369|FG001|Period 1|Consent Withdrawal|1|||
48723637|NCT01221272|156840368|FG000|Period 1|Significant Dosing Noncompliance|0|||
48723638|NCT01221272|156840369|FG001|Period 1|Significant Dosing Noncompliance|1|||
48723639|NCT01221272|156840368|FG000|Period 2|Adverse Event|0|||
48723640|NCT01221272|156840369|FG001|Period 2|Adverse Event|2|||
48723641|NCT02320903|156840372|FG000|Overall Study|Withdrawal by Subject|0|||
48723642|NCT02320903|156840373|FG001|Overall Study|Withdrawal by Subject|9|||
48723643|NCT02320903|156840374|FG002|Overall Study|Withdrawal by Subject|9|||
48723644|NCT02320903|156840372|FG000|Overall Study|Exited therapy; no longer eligible|8|||
48723645|NCT02320903|156840373|FG001|Overall Study|Exited therapy; no longer eligible|2|||
48723646|NCT02320903|156840374|FG002|Overall Study|Exited therapy; no longer eligible|2|||
48723647|NCT02320903|156840372|FG000|Overall Study|Lost to Follow-up|0|||
48723648|NCT02320903|156840373|FG001|Overall Study|Lost to Follow-up|5|||
48723649|NCT02320903|156840374|FG002|Overall Study|Lost to Follow-up|5|||
48723650|NCT00730028|156840375|FG000|Overall Study|Adverse Event|23|||
48723651|NCT00730028|156840376|FG001|Overall Study|Adverse Event|26|||
48723652|NCT00730028|156840377|FG002|Overall Study|Adverse Event|16|||
48723653|NCT00730028|156840378|FG003|Overall Study|Adverse Event|20|||
48723654|NCT00730028|156840379|FG004|Overall Study|Adverse Event|43|||
48723655|NCT00730028|156840375|FG000|Overall Study|Lost to Follow-up|13|||
48723656|NCT00730028|156840376|FG001|Overall Study|Lost to Follow-up|26|||
48723657|NCT00730028|156840377|FG002|Overall Study|Lost to Follow-up|22|||
48723658|NCT00730028|156840378|FG003|Overall Study|Lost to Follow-up|26|||
48723659|NCT00730028|156840379|FG004|Overall Study|Lost to Follow-up|25|||
48723660|NCT00730028|156840375|FG000|Overall Study|Protocol Violation|6|||
48723661|NCT00730028|156840376|FG001|Overall Study|Protocol Violation|1|||
48723662|NCT00730028|156840377|FG002|Overall Study|Protocol Violation|1|||
48723663|NCT00730028|156840378|FG003|Overall Study|Protocol Violation|2|||
48723664|NCT00730028|156840379|FG004|Overall Study|Protocol Violation|0|||
48723665|NCT00730028|156840375|FG000|Overall Study|Withdrawal by Subject|9|||
48723666|NCT00730028|156840376|FG001|Overall Study|Withdrawal by Subject|5|||
48723667|NCT00730028|156840377|FG002|Overall Study|Withdrawal by Subject|4|||
48723668|NCT00730028|156840378|FG003|Overall Study|Withdrawal by Subject|5|||
48723669|NCT00730028|156840379|FG004|Overall Study|Withdrawal by Subject|9|||
48723670|NCT00730028|156840375|FG000|Overall Study|Physician Decision|3|||
48723671|NCT00730028|156840376|FG001|Overall Study|Physician Decision|3|||
48723672|NCT00730028|156840377|FG002|Overall Study|Physician Decision|2|||
48723673|NCT00730028|156840378|FG003|Overall Study|Physician Decision|3|||
48723674|NCT00730028|156840379|FG004|Overall Study|Physician Decision|2|||
48723675|NCT00730028|156840375|FG000|Overall Study|Treatment Failure|5|||
48723676|NCT00730028|156840376|FG001|Overall Study|Treatment Failure|5|||
48723677|NCT00730028|156840377|FG002|Overall Study|Treatment Failure|0|||
48723678|NCT00730028|156840378|FG003|Overall Study|Treatment Failure|0|||
48723679|NCT00730028|156840379|FG004|Overall Study|Treatment Failure|1|||
48723680|NCT00730028|156840375|FG000|Overall Study|Randomization Error|1|||
48723681|NCT00730028|156840376|FG001|Overall Study|Randomization Error|0|||
48723682|NCT00730028|156840377|FG002|Overall Study|Randomization Error|0|||
48723683|NCT00730028|156840378|FG003|Overall Study|Randomization Error|0|||
48723684|NCT00730028|156840379|FG004|Overall Study|Randomization Error|2|||
48723685|NCT01931670|156840385|FG000|Treatment Period|Exclusionary Medication Received|1|||
48723686|NCT01931670|156840386|FG001|Treatment Period|Exclusionary Medication Received|1|||
48723687|NCT01931670|156840387|FG002|Treatment Period|Exclusionary Medication Received|1|||
48723688|NCT01931670|156840385|FG000|Treatment Period|Surgery/Invasive Intervention|4|||
48723689|NCT01931670|156840386|FG001|Treatment Period|Surgery/Invasive Intervention|2|||
48723690|NCT01931670|156840387|FG002|Treatment Period|Surgery/Invasive Intervention|0|||
48723691|NCT01931670|156840385|FG000|Treatment Period|Subject Noncompliant|4|||
48723692|NCT01931670|156840386|FG001|Treatment Period|Subject Noncompliant|9|||
48817928|NCT01017120|157175229|FG000|Overall Study|Pregnancy|1|||
48817929|NCT01017120|157175230|FG001|Overall Study|Pregnancy|1|||
48817930|NCT01017120|157175229|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
48817931|NCT01017120|157175230|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
48817932|NCT01017120|157175229|FG000|Overall Study|Relocated Out of Town|0|||
48817933|NCT01017120|157175230|FG001|Overall Study|Relocated Out of Town|2|||
48817934|NCT01017120|157175229|FG000|Overall Study|Protocol Violation|1|||
48817935|NCT01017120|157175230|FG001|Overall Study|Protocol Violation|0|||
49131652|NCT02340949|158322254|FG001|Overall Study|Adverse Event|2|||
49131653|NCT02340949|158322253|FG000|Overall Study|Withdrawal by Subject|2|||
49131654|NCT02340949|158322254|FG001|Overall Study|Withdrawal by Subject|0|||
49131655|NCT02340949|158322253|FG000|Overall Study|Progression disease|6|||
49131656|NCT02340949|158322254|FG001|Overall Study|Progression disease|2|||
49131657|NCT02340949|158322253|FG000|Overall Study|Death|3|||
49131658|NCT02340949|158322254|FG001|Overall Study|Death|0|||
49131659|NCT02340949|158322253|FG000|Overall Study|Physician Decision|1|||
49131660|NCT02340949|158322254|FG001|Overall Study|Physician Decision|0|||
49131661|NCT01277861|158322257|FG000|Overall Study|Physician Decision|2|||
49131662|NCT01277861|158322258|FG001|Overall Study|Physician Decision|2|||
49131663|NCT01349595|158322270|FG000|Overall Study|Lack of funding|2|||
49131664|NCT01349595|158322271|FG001|Overall Study|Lack of funding|2|||
49131665|NCT01937299|158322272|FG000|Overall Study|Adverse Event|13|||
49131666|NCT01937299|158322273|FG001|Overall Study|Adverse Event|0|||
49131667|NCT01937299|158322272|FG000|Overall Study|Lack of Efficacy|0|||
49131668|NCT01937299|158322273|FG001|Overall Study|Lack of Efficacy|4|||
49131669|NCT01937299|158322272|FG000|Overall Study|Withdrawal by Subject|1|||
49131670|NCT01937299|158322273|FG001|Overall Study|Withdrawal by Subject|0|||
49131671|NCT00385840|158322274|FG000|Overall Study|Adverse Event|1|||
49131672|NCT00385840|158322275|FG001|Overall Study|Adverse Event|1|||
49131673|NCT00385840|158322274|FG000|Overall Study|Lost to Follow-up|3|||
49131674|NCT00385840|158322275|FG001|Overall Study|Lost to Follow-up|13|||
49131675|NCT00921024|158322277|FG000|Overall Study|Lost to Follow-up|2|||
49131676|NCT00921024|158322278|FG001|Overall Study|Lost to Follow-up|0|||
49131677|NCT00921024|158322277|FG000|Overall Study|Received concomittant therapy|2|||
49131678|NCT00921024|158322278|FG001|Overall Study|Received concomittant therapy|0|||
49131679|NCT00921024|158322277|FG000|Overall Study|Withdrawal by Subject|0|||
49131680|NCT00921024|158322278|FG001|Overall Study|Withdrawal by Subject|3|||
48723693|NCT01931670|156840387|FG002|Treatment Period|Subject Noncompliant|5|||
48723694|NCT01931670|156840385|FG000|Treatment Period|Adverse Event|19|||
48723695|NCT01931670|156840386|FG001|Treatment Period|Adverse Event|8|||
48723696|NCT01931670|156840387|FG002|Treatment Period|Adverse Event|21|||
48723697|NCT01931670|156840385|FG000|Treatment Period|Lack of Efficacy|11|||
48723698|NCT01931670|156840386|FG001|Treatment Period|Lack of Efficacy|2|||
48723699|NCT01931670|156840387|FG002|Treatment Period|Lack of Efficacy|2|||
48723700|NCT01931670|156840385|FG000|Treatment Period|Pregnancy|7|||
48723701|NCT01931670|156840386|FG001|Treatment Period|Pregnancy|2|||
48723702|NCT01931670|156840387|FG002|Treatment Period|Pregnancy|0|||
48723703|NCT01931670|156840385|FG000|Treatment Period|Other|8|||
48817936|NCT01017120|157175229|FG000|Overall Study|Parent Unable to Provide Transportation|1|||
49131681|NCT02074514|158322281|FG000|Overall Study|Lack of Efficacy|3|||
49131682|NCT02074514|158322282|FG001|Overall Study|Lack of Efficacy|2|||
48723704|NCT01931670|156840386|FG001|Treatment Period|Other|7|||
48723705|NCT01931670|156840387|FG002|Treatment Period|Other|2|||
48723706|NCT01931670|156840385|FG000|Treatment Period|Consent Withdrawn by Subject|17|||
48723707|NCT01931670|156840386|FG001|Treatment Period|Consent Withdrawn by Subject|12|||
48723708|NCT01931670|156840387|FG002|Treatment Period|Consent Withdrawn by Subject|7|||
48723709|NCT01931670|156840385|FG000|Treatment Period|Lost to Follow-up|19|||
48723710|NCT01931670|156840386|FG001|Treatment Period|Lost to Follow-up|5|||
48817937|NCT01017120|157175230|FG001|Overall Study|Parent Unable to Provide Transportation|0|||
49131683|NCT02074514|158322281|FG000|Overall Study|Lost to Follow-up|0|||
49131684|NCT02074514|158322282|FG001|Overall Study|Lost to Follow-up|1|||
49131685|NCT02074514|158322281|FG000|Overall Study|Withdrew Consent|0|||
48723711|NCT01931670|156840387|FG002|Treatment Period|Lost to Follow-up|7|||
48723712|NCT01931670|156840385|FG000|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3|||
48723713|NCT01931670|156840386|FG001|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
48723714|NCT01931670|156840387|FG002|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
49131686|NCT02074514|158322282|FG001|Overall Study|Withdrew Consent|1|||
48723715|NCT01931670|156840385|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0|||
49131687|NCT03069989|158322284|FG000|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1|||
48817938|NCT05038566|157175231|FG000|Overall Study|Technical Difficulties with the Device|0|||
48817939|NCT05038566|157175232|FG001|Overall Study|Technical Difficulties with the Device|1|||
48817940|NCT00806624|157175234|FG000|Overall Study|Adverse Event|2|||
48817941|NCT00806624|157175235|FG001|Overall Study|Adverse Event|8|||
48817942|NCT00806624|157175236|FG002|Overall Study|Adverse Event|0|||
48817943|NCT00806624|157175234|FG000|Overall Study|Death|0|||
48817944|NCT00806624|157175235|FG001|Overall Study|Death|1|||
48817945|NCT00806624|157175236|FG002|Overall Study|Death|1|||
48817946|NCT00806624|157175234|FG000|Overall Study|Lost to Follow-up|1|||
48817947|NCT00806624|157175235|FG001|Overall Study|Lost to Follow-up|0|||
48817948|NCT00806624|157175236|FG002|Overall Study|Lost to Follow-up|1|||
48817949|NCT00806624|157175234|FG000|Overall Study|Withdrawal by Subject|6|||
48817950|NCT00806624|157175235|FG001|Overall Study|Withdrawal by Subject|3|||
48817951|NCT00806624|157175236|FG002|Overall Study|Withdrawal by Subject|3|||
48817952|NCT00806624|157175234|FG000|Overall Study|discontinued before start of treatment|0|||
48817953|NCT00806624|157175235|FG001|Overall Study|discontinued before start of treatment|0|||
48817954|NCT00806624|157175236|FG002|Overall Study|discontinued before start of treatment|1|||
48817955|NCT01702428|157175237|FG000|Overall Study|Adverse Event|2|||
48817956|NCT01702428|157175238|FG001|Overall Study|Adverse Event|0|||
48817957|NCT01702428|157175239|FG002|Overall Study|Adverse Event|0|||
48817958|NCT01702428|157175240|FG003|Overall Study|Adverse Event|0|||
48817959|NCT01702428|157175237|FG000|Overall Study|Lost to Follow-up|33|||
48817960|NCT01702428|157175238|FG001|Overall Study|Lost to Follow-up|41|||
48817961|NCT01702428|157175239|FG002|Overall Study|Lost to Follow-up|37|||
48817962|NCT01702428|157175240|FG003|Overall Study|Lost to Follow-up|44|||
48817963|NCT01702428|157175237|FG000|Overall Study|Parents cannot assist to site|1|||
48817964|NCT01702428|157175238|FG001|Overall Study|Parents cannot assist to site|0|||
48817965|NCT01702428|157175239|FG002|Overall Study|Parents cannot assist to site|1|||
48817966|NCT01702428|157175240|FG003|Overall Study|Parents cannot assist to site|0|||
48817967|NCT01702428|157175237|FG000|Overall Study|Lost Coverage|0|||
48817968|NCT01702428|157175238|FG001|Overall Study|Lost Coverage|0|||
48817969|NCT01702428|157175239|FG002|Overall Study|Lost Coverage|0|||
48817970|NCT01702428|157175240|FG003|Overall Study|Lost Coverage|1|||
48817971|NCT01702428|157175237|FG000|Overall Study|Lost Health Plan|3|||
48817972|NCT01702428|157175238|FG001|Overall Study|Lost Health Plan|5|||
48817973|NCT01702428|157175239|FG002|Overall Study|Lost Health Plan|0|||
48817974|NCT01702428|157175240|FG003|Overall Study|Lost Health Plan|2|||
48817975|NCT01702428|157175237|FG000|Overall Study|Mother transferred care|0|||
48817976|NCT01702428|157175238|FG001|Overall Study|Mother transferred care|1|||
48817977|NCT01702428|157175239|FG002|Overall Study|Mother transferred care|0|||
48817978|NCT01702428|157175240|FG003|Overall Study|Mother transferred care|0|||
48817979|NCT01702428|157175237|FG000|Overall Study|Parents too busy|1|||
48817980|NCT01702428|157175238|FG001|Overall Study|Parents too busy|0|||
48817981|NCT01702428|157175239|FG002|Overall Study|Parents too busy|0|||
48817982|NCT01702428|157175240|FG003|Overall Study|Parents too busy|0|||
48817983|NCT01702428|157175237|FG000|Overall Study|Protocol Violation|3|||
48723716|NCT01931670|156840386|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2|||
48723717|NCT01931670|156840387|FG002|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1|||
48723718|NCT01931670|156840385|FG000|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
48817984|NCT01702428|157175238|FG001|Overall Study|Protocol Violation|0|||
48723719|NCT01931670|156840386|FG001|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
48723720|NCT01931670|156840387|FG002|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2|||
48723721|NCT01931670|156840385|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|6|||
48723722|NCT01931670|156840386|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
48723723|NCT01931670|156840387|FG002|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
48723724|NCT01931670|156840385|FG000|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6|||
48723725|NCT01931670|156840386|FG001|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3|||
48723726|NCT01931670|156840387|FG002|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13|||
48723727|NCT01931670|156840385|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
48723728|NCT01931670|156840386|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
48723729|NCT01931670|156840387|FG002|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2|||
48723730|NCT00976508|156840389|FG000|Overall Study|Death|7|||
48723731|NCT00976508|156840390|FG001|Overall Study|Death|1|||
48817985|NCT01702428|157175239|FG002|Overall Study|Protocol Violation|1|||
48817986|NCT01702428|157175240|FG003|Overall Study|Protocol Violation|0|||
48817987|NCT01702428|157175237|FG000|Overall Study|Withdrawal by Subject|21|||
48817988|NCT01702428|157175238|FG001|Overall Study|Withdrawal by Subject|23|||
48817989|NCT01702428|157175239|FG002|Overall Study|Withdrawal by Subject|14|||
49011145|NCT00481247|157877398|FG000|Overall Study|Poor compliance/noncompliance|1|||
49011146|NCT00481247|157877399|FG001|Overall Study|Poor compliance/noncompliance|7|||
48817990|NCT01702428|157175240|FG003|Overall Study|Withdrawal by Subject|10|||
48817991|NCT01804673|157175241|FG000|Overall Study|Adverse Event|4|||
48817992|NCT01804673|157175241|FG000|Overall Study|Withdrawal by Subject|1|||
48817993|NCT01804673|157175241|FG000|Overall Study|Lack of Efficacy|9|||
49131688|NCT03069989|158322285|FG001|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0|||
49131689|NCT01416571|158322286|FG000|Overall Study|Lost to Follow-up|2|||
49131690|NCT02371616|158324073|FG000|Overall Study|Protocol Violation|2|||
49131691|NCT02371616|158324074|FG001|Overall Study|Protocol Violation|1|||
49131692|NCT02371616|158324073|FG000|Overall Study|Adverse Event|0|||
49131693|NCT02371616|158324074|FG001|Overall Study|Adverse Event|1|||
49131694|NCT02371616|158324073|FG000|Overall Study|Withdrawal of Consent|1|||
49131695|NCT02371616|158324074|FG001|Overall Study|Withdrawal of Consent|0|||
48723732|NCT00976508|156840389|FG000|Overall Study|Lost to Follow-up|1|||
48723733|NCT00976508|156840390|FG001|Overall Study|Lost to Follow-up|0|||
48723734|NCT00976508|156840389|FG000|Overall Study|Withdrawal by Subject|1|||
48723735|NCT00976508|156840390|FG001|Overall Study|Withdrawal by Subject|0|||
48723736|NCT00976508|156840389|FG000|Overall Study|Disease Progression|4|||
48723737|NCT00976508|156840390|FG001|Overall Study|Disease Progression|4|||
48723738|NCT00976508|156840389|FG000|Overall Study|Subject Enrolled in Hospice|1|||
48723739|NCT00976508|156840390|FG001|Overall Study|Subject Enrolled in Hospice|0|||
48723740|NCT00976508|156840389|FG000|Overall Study|Terminated by the Sponsor|0|||
48723741|NCT00976508|156840390|FG001|Overall Study|Terminated by the Sponsor|1|||
48723742|NCT01992159|156840391|FG000|Overall Study|Withdrawal by Subject|4|||
48723743|NCT01992159|156840392|FG001|Overall Study|Withdrawal by Subject|7|||
48723744|NCT01992159|156840393|FG002|Overall Study|Withdrawal by Subject|0|||
48723745|NCT01992159|156840394|FG003|Overall Study|Withdrawal by Subject|3|||
48723746|NCT01992159|156840391|FG000|Overall Study|Adverse Event|0|||
48723747|NCT01992159|156840392|FG001|Overall Study|Adverse Event|1|||
48723748|NCT01992159|156840393|FG002|Overall Study|Adverse Event|0|||
48723749|NCT01992159|156840394|FG003|Overall Study|Adverse Event|1|||
48723750|NCT01992159|156840391|FG000|Overall Study|Death|0|||
48723751|NCT01992159|156840392|FG001|Overall Study|Death|0|||
48723752|NCT01992159|156840393|FG002|Overall Study|Death|1|||
48723753|NCT01992159|156840394|FG003|Overall Study|Death|0|||
48723754|NCT05058391|156840395|FG000|Overall Study|Adverse Event|1|||
48723755|NCT02742246|156840396|FG000|Overall Study|Never initiated treatment|5|||
48723756|NCT02742246|156840397|FG001|Overall Study|Never initiated treatment|3|||
48723757|NCT02742246|156840398|FG002|Overall Study|Never initiated treatment|1|||
48723758|NCT02742246|156840396|FG000|Overall Study|dropped out during treatment|7|||
48723759|NCT02742246|156840397|FG001|Overall Study|dropped out during treatment|13|||
48723760|NCT02742246|156840398|FG002|Overall Study|dropped out during treatment|10|||
48723761|NCT02742246|156840396|FG000|Overall Study|Death|1|||
48723762|NCT02742246|156840397|FG001|Overall Study|Death|0|||
48723763|NCT02742246|156840398|FG002|Overall Study|Death|0|||
48723764|NCT01261312|156840401|FG000|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|27|||
48723765|NCT01261312|156840402|FG001|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|26|||
48723766|NCT01261312|156840403|FG002|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|9|||
48723767|NCT01261312|156840404|FG003|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
48723768|NCT01261312|156840405|FG004|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
48723769|NCT01261312|156840406|FG005|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
48723770|NCT01261312|156840407|FG006|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
48723771|NCT01261312|156840408|FG007|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
48723772|NCT01261312|156840409|FG008|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
48723773|NCT01261312|156840410|FG009|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
48723774|NCT01261312|156840411|FG010|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
48723775|NCT01261312|156840412|FG011|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
48723776|NCT01261312|156840413|FG012|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
48723777|NCT01261312|156840401|FG000|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
48723778|NCT01261312|156840402|FG001|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
48723779|NCT01261312|156840403|FG002|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
48723780|NCT01261312|156840404|FG003|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
48723781|NCT01261312|156840405|FG004|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
48723782|NCT01261312|156840406|FG005|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
48723783|NCT01261312|156840407|FG006|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
48723784|NCT01261312|156840408|FG007|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
48723785|NCT01261312|156840409|FG008|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
48723786|NCT01261312|156840410|FG009|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
48723787|NCT01261312|156840411|FG010|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
48723788|NCT01261312|156840412|FG011|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
48723789|NCT01261312|156840413|FG012|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
48723790|NCT01261312|156840401|FG000|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|3|||
48723791|NCT01261312|156840402|FG001|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|2|||
48723792|NCT01261312|156840403|FG002|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
48723793|NCT01261312|156840404|FG003|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
49131696|NCT02371616|158324073|FG000|Overall Study|Other (Not specified)|1|||
48817994|NCT01804673|157175241|FG000|Overall Study|Change to Oral Therapy|37|||
48817995|NCT01804673|157175241|FG000|Overall Study|No Further Therapy Required|84|||
48817996|NCT01804673|157175241|FG000|Overall Study|Use of Prohibited Medication|1|||
48817997|NCT01804673|157175241|FG000|Overall Study|Other|4|||
48817998|NCT03685708|157175250|FG000|Overall Study|Withdrawal by Subject|0|||
48817999|NCT03685708|157175251|FG001|Overall Study|Withdrawal by Subject|0|||
48818000|NCT03685708|157175252|FG002|Overall Study|Withdrawal by Subject|1|||
49131697|NCT02371616|158324074|FG001|Overall Study|Other (Not specified)|5|||
49131698|NCT00593814|158324093|FG000|Overall Study|Death|7|||
49131699|NCT00593814|158324094|FG001|Overall Study|Death|0|||
49131700|NCT00593814|158324093|FG000|Overall Study|Withdrawal by Subject|7|||
49131701|NCT00593814|158324094|FG001|Overall Study|Withdrawal by Subject|0|||
49131702|NCT00593814|158324093|FG000|Overall Study|Lost to Follow-up|7|||
49131703|NCT00593814|158324094|FG001|Overall Study|Lost to Follow-up|0|||
49131704|NCT00593814|158324093|FG000|Overall Study|Physician Decision|3|||
49131705|NCT00593814|158324094|FG001|Overall Study|Physician Decision|0|||
49131706|NCT00557466|158324095|FG000|Overall Study|Adverse Event|3|||
48818001|NCT03685708|157175250|FG000|Overall Study|Screen Fail|0|||
48818002|NCT03685708|157175251|FG001|Overall Study|Screen Fail|1|||
48818003|NCT03685708|157175252|FG002|Overall Study|Screen Fail|1|||
48818004|NCT03685708|157175250|FG000|Overall Study|COVID 19 Pandemic|1|||
48818005|NCT03685708|157175251|FG001|Overall Study|COVID 19 Pandemic|1|||
48818006|NCT03685708|157175252|FG002|Overall Study|COVID 19 Pandemic|6|||
48818007|NCT03685708|157175250|FG000|Overall Study|Disease Progression|0|||
48818008|NCT03685708|157175251|FG001|Overall Study|Disease Progression|0|||
48818009|NCT03685708|157175252|FG002|Overall Study|Disease Progression|1|||
48818010|NCT04006366|157175255|FG000|Overall Study|Withdrawal by Subject|1|||
48818011|NCT04430335|157175256|FG000|Overall Study|Withdrawal by Subject|1|||
48818012|NCT00750893|157175259|FG000|Overall Study|Adverse Event|5|||
49131707|NCT00557466|158324096|FG001|Overall Study|Adverse Event|1|||
49131708|NCT00557466|158324097|FG002|Overall Study|Adverse Event|4|||
49131709|NCT00557466|158324098|FG003|Overall Study|Adverse Event|1|||
49131710|NCT00557466|158324099|FG004|Overall Study|Adverse Event|2|||
49131711|NCT00557466|158324100|FG005|Overall Study|Adverse Event|4|||
49131712|NCT00557466|158324095|FG000|Overall Study|Abnormal laboratory value(s)|1|||
49131713|NCT00557466|158324096|FG001|Overall Study|Abnormal laboratory value(s)|2|||
48818013|NCT00750893|157175259|FG000|Overall Study|Withdrawal by Subject|10|||
49131714|NCT00557466|158324097|FG002|Overall Study|Abnormal laboratory value(s)|0|||
49131715|NCT00557466|158324098|FG003|Overall Study|Abnormal laboratory value(s)|0|||
49131716|NCT00557466|158324099|FG004|Overall Study|Abnormal laboratory value(s)|0|||
49131717|NCT00557466|158324100|FG005|Overall Study|Abnormal laboratory value(s)|0|||
49131718|NCT00557466|158324095|FG000|Overall Study|Protocol deviation|0|||
49131719|NCT00557466|158324096|FG001|Overall Study|Protocol deviation|1|||
49131720|NCT00557466|158324097|FG002|Overall Study|Protocol deviation|0|||
49131721|NCT00557466|158324098|FG003|Overall Study|Protocol deviation|2|||
49131722|NCT00557466|158324099|FG004|Overall Study|Protocol deviation|0|||
49131723|NCT00557466|158324100|FG005|Overall Study|Protocol deviation|0|||
49131724|NCT00557466|158324095|FG000|Overall Study|Subject withdrew consent|0|||
49131725|NCT00557466|158324096|FG001|Overall Study|Subject withdrew consent|0|||
49131726|NCT00557466|158324097|FG002|Overall Study|Subject withdrew consent|0|||
49131727|NCT00557466|158324098|FG003|Overall Study|Subject withdrew consent|0|||
49131728|NCT00557466|158324099|FG004|Overall Study|Subject withdrew consent|1|||
49131729|NCT00557466|158324100|FG005|Overall Study|Subject withdrew consent|2|||
49131730|NCT00557466|158324095|FG000|Overall Study|Administrative problems|0|||
49131731|NCT00557466|158324096|FG001|Overall Study|Administrative problems|1|||
49131732|NCT00557466|158324097|FG002|Overall Study|Administrative problems|1|||
49131733|NCT00557466|158324098|FG003|Overall Study|Administrative problems|0|||
49131734|NCT00557466|158324099|FG004|Overall Study|Administrative problems|0|||
49131735|NCT00557466|158324100|FG005|Overall Study|Administrative problems|0|||
49131736|NCT00557466|158324095|FG000|Overall Study|Abnormal test procedure results|0|||
49131737|NCT00557466|158324096|FG001|Overall Study|Abnormal test procedure results|0|||
49131738|NCT00557466|158324097|FG002|Overall Study|Abnormal test procedure results|1|||
48818014|NCT00750893|157175259|FG000|Overall Study|Lost to Follow-up|510|||
48818015|NCT00750893|157175259|FG000|Overall Study|Other|17|||
48818016|NCT00531011|157176641|FG000|Overall Study|Withdrawal by Subject|2|||
48818017|NCT00531011|157176642|FG001|Overall Study|Withdrawal by Subject|4|||
49131739|NCT00557466|158324098|FG003|Overall Study|Abnormal test procedure results|0|||
49131740|NCT00557466|158324099|FG004|Overall Study|Abnormal test procedure results|0|||
49131741|NCT00557466|158324100|FG005|Overall Study|Abnormal test procedure results|0|||
49131742|NCT00557466|158324095|FG000|Overall Study|Lost to Follow-up|0|||
49131743|NCT00557466|158324096|FG001|Overall Study|Lost to Follow-up|0|||
48818018|NCT00531011|157176641|FG000|Overall Study|Death|1|||
48818019|NCT00531011|157176642|FG001|Overall Study|Death|0|||
48818020|NCT00531011|157176641|FG000|Overall Study|Lost to Follow-up|1|||
49131744|NCT00557466|158324097|FG002|Overall Study|Lost to Follow-up|0|||
48818021|NCT00531011|157176642|FG001|Overall Study|Lost to Follow-up|0|||
49131745|NCT00557466|158324098|FG003|Overall Study|Lost to Follow-up|1|||
49131746|NCT00557466|158324099|FG004|Overall Study|Lost to Follow-up|0|||
49131747|NCT00557466|158324100|FG005|Overall Study|Lost to Follow-up|0|||
49131748|NCT00947544|158324113|FG000|Safety-Extension Period (12 Months)|Withdrawal by Subject|1|||
49131749|NCT00947544|158324114|FG001|Safety-Extension Period (12 Months)|Withdrawal by Subject|0|||
49131750|NCT03408899|158324115|FG000|PC-1005 Gel: 4 mL Dose|Lost to Follow-up|1|||
49131751|NCT04745351|158324116|FG000|Overall Study|Death|51|||
49131752|NCT04745351|158324117|FG001|Overall Study|Death|25|||
49131753|NCT04745351|158324116|FG000|Overall Study|Lost to Follow-up|9|||
49131754|NCT04745351|158324117|FG001|Overall Study|Lost to Follow-up|3|||
49131755|NCT04745351|158324116|FG000|Overall Study|Randomized but Never Treated|3|||
49131756|NCT04745351|158324117|FG001|Overall Study|Randomized but Never Treated|3|||
49131757|NCT04745351|158324116|FG000|Overall Study|Adverse Event|4|||
49131758|NCT04745351|158324117|FG001|Overall Study|Adverse Event|0|||
49131759|NCT04745351|158324116|FG000|Overall Study|Withdrew Consent|1|||
49131760|NCT04745351|158324117|FG001|Overall Study|Withdrew Consent|2|||
49131761|NCT04745351|158324116|FG000|Overall Study|Investigator's Discretion|2|||
49131762|NCT04745351|158324117|FG001|Overall Study|Investigator's Discretion|0|||
49131763|NCT04745351|158324116|FG000|Overall Study|Protocol Violation|1|||
49131764|NCT04745351|158324117|FG001|Overall Study|Protocol Violation|0|||
49131765|NCT00900562|158324118|FG000|Overall Study|Progressive disease|9|||
49131766|NCT00900562|158324119|FG001|Overall Study|Progressive disease|5|||
49131767|NCT00900562|158324118|FG000|Overall Study|Toxicity|1|||
49131768|NCT00900562|158324119|FG001|Overall Study|Toxicity|0|||
49131769|NCT00900562|158324118|FG000|Overall Study|Death|1|||
49131770|NCT00900562|158324119|FG001|Overall Study|Death|1|||
49131771|NCT00900562|158324118|FG000|Overall Study|Withdrawal by Subject|0|||
49131772|NCT00900562|158324119|FG001|Overall Study|Withdrawal by Subject|1|||
49131773|NCT00900562|158324118|FG000|Overall Study|Unrelated adverse event|1|||
49131774|NCT00900562|158324119|FG001|Overall Study|Unrelated adverse event|0|||
49131775|NCT02426684|158324120|FG000|Overall Study|Physician Decision|1|||
49131776|NCT01715298|158324121|FG000|Overall Study|Lost to Follow-up|0|||
48921003|NCT00784654|157544818|FG000|Open-Label Period (Non-Randomized)|Decision of medical monitor|1|||
48921004|NCT00784654|157544819|FG001|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
48921005|NCT00784654|157544820|FG002|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
48921006|NCT00784654|157544818|FG000|Open-Label Period (Non-Randomized)|Home situation intolerable|1|||
48921007|NCT00784654|157544819|FG001|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
48921008|NCT00784654|157544820|FG002|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
48921009|NCT00784654|157544818|FG000|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1|||
48921010|NCT00784654|157544819|FG001|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
48921011|NCT00784654|157544820|FG002|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
48921012|NCT00784654|157544818|FG000|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1|||
48921013|NCT00784654|157544819|FG001|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
48921014|NCT00784654|157544820|FG002|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
48921015|NCT00784654|157544818|FG000|Open-Label Period (Non-Randomized)|Did not provide end of study page|1|||
48921016|NCT00784654|157544819|FG001|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
48921017|NCT00784654|157544820|FG002|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
48921018|NCT00784654|157544818|FG000|Randomized Withdrawal Period|Met relapse criteria per investigator|0|||
48921019|NCT00784654|157544819|FG001|Randomized Withdrawal Period|Met relapse criteria per investigator|8|||
48921020|NCT00784654|157544820|FG002|Randomized Withdrawal Period|Met relapse criteria per investigator|35|||
49131777|NCT01715298|158324122|FG001|Overall Study|Lost to Follow-up|2|||
49131778|NCT01715298|158324121|FG000|Overall Study|Patient/guardian decision|7|||
49131779|NCT01715298|158324122|FG001|Overall Study|Patient/guardian decision|9|||
48723794|NCT01261312|156840405|FG004|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
48723795|NCT01261312|156840406|FG005|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
48723796|NCT01261312|156840407|FG006|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
48723797|NCT01261312|156840408|FG007|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
48723798|NCT01261312|156840409|FG008|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
48723799|NCT01261312|156840410|FG009|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
48723800|NCT01261312|156840411|FG010|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
48723801|NCT01261312|156840412|FG011|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
48723802|NCT01261312|156840413|FG012|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
48723803|NCT01261312|156840401|FG000|Dose Escalation Phase (Day 0- Week 170)|Death|5|||
48723804|NCT01261312|156840402|FG001|Dose Escalation Phase (Day 0- Week 170)|Death|4|||
48723805|NCT01261312|156840403|FG002|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
48723806|NCT01261312|156840404|FG003|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
49131780|NCT01126424|158324123|FG000|Overall Study|Adverse Event|0|||
49131781|NCT01126424|158324124|FG001|Overall Study|Adverse Event|0|||
48723807|NCT01261312|156840405|FG004|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
48723808|NCT01261312|156840406|FG005|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
48818022|NCT00531011|157176641|FG000|Overall Study|Physician Decision|0|||
48818023|NCT00531011|157176642|FG001|Overall Study|Physician Decision|3|||
48818024|NCT02139982|157176643|FG000|Overall Study|Lack of Efficacy|0|||
48818025|NCT02139982|157176644|FG001|Overall Study|Lack of Efficacy|1|||
48818026|NCT02139982|157176645|FG002|Overall Study|Lack of Efficacy|0|||
48818027|NCT02139982|157176646|FG003|Overall Study|Lack of Efficacy|1|||
48818028|NCT02139982|157176647|FG004|Overall Study|Lack of Efficacy|0|||
48818029|NCT02139982|157176648|FG005|Overall Study|Lack of Efficacy|0|||
48818030|NCT02139982|157176649|FG006|Overall Study|Lack of Efficacy|0|||
48818031|NCT02139982|157176650|FG007|Overall Study|Lack of Efficacy|0|||
48818032|NCT02139982|157176651|FG008|Overall Study|Lack of Efficacy|0|||
48818033|NCT02139982|157176652|FG009|Overall Study|Lack of Efficacy|0|||
48818034|NCT00467142|157176653|FG000|Overall Study|Withdrawal by Subject|1|||
48818035|NCT00467142|157176653|FG000|Overall Study|Adverse Event|1|||
48818036|NCT00467142|157176653|FG000|Overall Study|Protocol Violation|1|||
48818037|NCT01619787|157176654|FG000|Overall Study|Lost to Follow-up|5|||
48818038|NCT03029780|157176680|FG000|Overall Study|Disease Progression|20|||
48723809|NCT01261312|156840407|FG006|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
48818039|NCT03029780|157176681|FG001|Overall Study|Disease Progression|22|||
48818040|NCT03029780|157176680|FG000|Overall Study|Study Drug Toxicity|15|||
48818041|NCT03029780|157176681|FG001|Overall Study|Study Drug Toxicity|11|||
48818042|NCT03029780|157176680|FG000|Overall Study|Adverse Event Unrelated to Study Drug|2|||
48818043|NCT03029780|157176681|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
48818044|NCT03029780|157176680|FG000|Overall Study|Participant request to discontinue study treatment|4|||
48818045|NCT03029780|157176681|FG001|Overall Study|Participant request to discontinue study treatment|1|||
48818046|NCT03029780|157176680|FG000|Overall Study|Maximum clinical benefit|1|||
48818047|NCT03029780|157176681|FG001|Overall Study|Maximum clinical benefit|0|||
48818048|NCT03029780|157176680|FG000|Overall Study|Participant no longer meets study criteria|0|||
48818049|NCT03029780|157176681|FG001|Overall Study|Participant no longer meets study criteria|1|||
48818050|NCT03029780|157176680|FG000|Overall Study|Other reasons|6|||
48818051|NCT03029780|157176681|FG001|Overall Study|Other reasons|6|||
48818052|NCT03029780|157176680|FG000|Overall Study|Not reported|1|||
48818053|NCT03029780|157176681|FG001|Overall Study|Not reported|1|||
48818054|NCT03029780|157176680|FG000|Overall Study|Death|2|||
48818055|NCT03029780|157176681|FG001|Overall Study|Death|6|||
48818056|NCT04012814|157176685|FG000|Overall Study|Lost to Follow-up|4|||
48818057|NCT04012814|157176685|FG000|Overall Study|Withdrawal by Subject|2|||
48818058|NCT04012814|157176685|FG000|Overall Study|Protocol Violation|1|||
48818059|NCT04012814|157176685|FG000|Overall Study|Adverse Event|1|||
48818060|NCT02942004|157176690|FG000|Overall Study|Withdrawal by Subject|0|||
48818061|NCT02942004|157176691|FG001|Overall Study|Withdrawal by Subject|2|||
48818062|NCT02942004|157176692|FG002|Overall Study|Withdrawal by Subject|3|||
48818063|NCT02942004|157176690|FG000|Overall Study|Lost to Follow-up|1|||
48818064|NCT02942004|157176691|FG001|Overall Study|Lost to Follow-up|1|||
48818065|NCT02942004|157176692|FG002|Overall Study|Lost to Follow-up|2|||
48818066|NCT02942004|157176690|FG000|Overall Study|Randomized but not dosed|3|||
48818067|NCT02942004|157176691|FG001|Overall Study|Randomized but not dosed|9|||
48818068|NCT02942004|157176692|FG002|Overall Study|Randomized but not dosed|4|||
48818069|NCT01544491|157176694|FG000|Overall Study|Withdrawal by Subject|3|||
48818070|NCT01544491|157176695|FG001|Overall Study|Withdrawal by Subject|2|||
48818071|NCT01544491|157176694|FG000|Overall Study|Lost to Follow-up|0|||
48818072|NCT01544491|157176695|FG001|Overall Study|Lost to Follow-up|1|||
48818073|NCT01544491|157176694|FG000|Overall Study|administrative problems|2|||
48818074|NCT01544491|157176695|FG001|Overall Study|administrative problems|0|||
48818075|NCT03653416|157176709|FG000|Overall Study|Protocol Violation|6|||
48818076|NCT03653416|157176710|FG001|Overall Study|Protocol Violation|1|||
48818077|NCT04230980|157176711|FG000|Overall Study|Lost to Follow-up|1|||
48818078|NCT04230980|157176712|FG001|Overall Study|Lost to Follow-up|2|||
48723810|NCT01261312|156840408|FG007|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
48723811|NCT01261312|156840409|FG008|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
48723812|NCT01261312|156840410|FG009|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
48723813|NCT01261312|156840411|FG010|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
48723814|NCT01261312|156840412|FG011|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
48723815|NCT01261312|156840413|FG012|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
48723816|NCT01261312|156840401|FG000|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|4|||
48723817|NCT01261312|156840402|FG001|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|1|||
48818079|NCT04230980|157176711|FG000|Overall Study|Adverse Event|0|||
48818080|NCT04230980|157176712|FG001|Overall Study|Adverse Event|1|||
48818081|NCT01461993|157176715|FG000|Overall Study|Withdrawal by Subject|60|||
48818082|NCT01461993|157176716|FG001|Overall Study|Withdrawal by Subject|53|||
48818083|NCT01461993|157176717|FG002|Overall Study|Withdrawal by Subject|16|||
48818084|NCT01461993|157176715|FG000|Overall Study|Lost to Follow-up|44|||
48818085|NCT01461993|157176716|FG001|Overall Study|Lost to Follow-up|48|||
48818086|NCT01461993|157176717|FG002|Overall Study|Lost to Follow-up|22|||
48818087|NCT01461993|157176715|FG000|Overall Study|Protocol Violation|10|||
48818088|NCT01461993|157176716|FG001|Overall Study|Protocol Violation|9|||
48818089|NCT01461993|157176717|FG002|Overall Study|Protocol Violation|7|||
48818090|NCT01461993|157176715|FG000|Overall Study|Adverse Event|9|||
48723818|NCT01261312|156840403|FG002|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|3|||
48723819|NCT01261312|156840404|FG003|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
48723820|NCT01261312|156840405|FG004|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
48723821|NCT01261312|156840406|FG005|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
48723822|NCT01261312|156840407|FG006|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
48723823|NCT01261312|156840408|FG007|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
48723824|NCT01261312|156840409|FG008|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
48723825|NCT01261312|156840410|FG009|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
48723826|NCT01261312|156840411|FG010|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
48723827|NCT01261312|156840412|FG011|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
48723828|NCT01261312|156840413|FG012|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
48723829|NCT01261312|156840401|FG000|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
48723830|NCT01261312|156840402|FG001|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
48723831|NCT01261312|156840403|FG002|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
48723832|NCT01261312|156840404|FG003|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
48723833|NCT01261312|156840405|FG004|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
48723834|NCT01261312|156840406|FG005|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
48723835|NCT01261312|156840407|FG006|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
48723836|NCT01261312|156840408|FG007|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
48723837|NCT01261312|156840409|FG008|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
48723838|NCT01261312|156840410|FG009|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
48723839|NCT01261312|156840411|FG010|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
48723840|NCT01261312|156840412|FG011|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
48723841|NCT01261312|156840413|FG012|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
48723842|NCT01261312|156840401|FG000|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|3|||
48723843|NCT01261312|156840402|FG001|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
48921021|NCT00784654|157544818|FG000|Randomized Withdrawal Period|Lack of Efficacy|0|||
48921022|NCT00784654|157544819|FG001|Randomized Withdrawal Period|Lack of Efficacy|5|||
48921023|NCT00784654|157544820|FG002|Randomized Withdrawal Period|Lack of Efficacy|18|||
48921024|NCT00784654|157544818|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
48921025|NCT00784654|157544819|FG001|Randomized Withdrawal Period|Withdrawal by Subject|1|||
48921026|NCT00784654|157544820|FG002|Randomized Withdrawal Period|Withdrawal by Subject|7|||
48921027|NCT00784654|157544818|FG000|Randomized Withdrawal Period|Protocol Violation|0|||
48921028|NCT00784654|157544819|FG001|Randomized Withdrawal Period|Protocol Violation|2|||
48921029|NCT00784654|157544820|FG002|Randomized Withdrawal Period|Protocol Violation|1|||
48921030|NCT00784654|157544818|FG000|Randomized Withdrawal Period|Adverse Event|0|||
49131782|NCT01126424|158324125|FG002|Overall Study|Adverse Event|0|||
49131783|NCT01126424|158324126|FG003|Overall Study|Adverse Event|0|||
49131784|NCT01126424|158324127|FG004|Overall Study|Adverse Event|1|||
49131785|NCT01126424|158324128|FG005|Overall Study|Adverse Event|0|||
49131786|NCT01126424|158324123|FG000|Overall Study|Withdrawal by Subject|0|||
49131787|NCT01126424|158324124|FG001|Overall Study|Withdrawal by Subject|0|||
49131788|NCT01126424|158324125|FG002|Overall Study|Withdrawal by Subject|1|||
49131789|NCT01126424|158324126|FG003|Overall Study|Withdrawal by Subject|3|||
49131790|NCT01126424|158324127|FG004|Overall Study|Withdrawal by Subject|1|||
49131791|NCT01126424|158324128|FG005|Overall Study|Withdrawal by Subject|0|||
49131792|NCT00426270|158324129|FG000|Overall Study|Incorrectly Enrolled in the Study|1|||
49131793|NCT00426270|158324129|FG000|Overall Study|Adverse Event|5|||
49131794|NCT01603602|158324130|FG000|Overall Study|Adverse Event|1|||
49131795|NCT01603602|158324131|FG001|Overall Study|Adverse Event|0|||
49131796|NCT01603602|158324132|FG002|Overall Study|Adverse Event|0|||
49131797|NCT01603602|158324130|FG000|Overall Study|Personal Reasons|1|||
49131798|NCT01603602|158324131|FG001|Overall Study|Personal Reasons|0|||
49131799|NCT01603602|158324132|FG002|Overall Study|Personal Reasons|1|||
49131800|NCT01117870|158324134|FG000|Overall Study|Inability to place needle|1|||
49131801|NCT01117870|158324135|FG001|Overall Study|Inability to place needle|0|||
49131802|NCT00083915|158324138|FG000|Overall Study|Death|6|||
49131803|NCT00083915|158324139|FG001|Overall Study|Death|3|||
49131804|NCT00083915|158324138|FG000|Overall Study|Physician Decision|11|||
49131805|NCT00083915|158324139|FG001|Overall Study|Physician Decision|6|||
49131806|NCT00083915|158324138|FG000|Overall Study|Withdrawal by Subject|8|||
49131807|NCT00083915|158324139|FG001|Overall Study|Withdrawal by Subject|3|||
49131808|NCT00083915|158324138|FG000|Overall Study|disease progression|18|||
49131809|NCT00083915|158324139|FG001|Overall Study|disease progression|23|||
49131810|NCT00083915|158324138|FG000|Overall Study|Failure to collect|3|||
49131811|NCT00083915|158324139|FG001|Overall Study|Failure to collect|0|||
49131812|NCT00083915|158324138|FG000|Overall Study|No response|3|||
49131813|NCT00083915|158324139|FG001|Overall Study|No response|1|||
49131814|NCT00083915|158324138|FG000|Overall Study|Insurance issues|1|||
49131815|NCT00083915|158324139|FG001|Overall Study|Insurance issues|1|||
49131816|NCT02089347|158324140|FG000|Overall Study|Protocol Violation|1|||
49131817|NCT02089347|158324141|FG001|Overall Study|Protocol Violation|0|||
49131818|NCT03530293|158324142|FG000|Pre-randomization|Adverse Event|12|||
49131819|NCT03530293|158324143|FG001|Pre-randomization|Adverse Event|0|||
49131820|NCT03530293|158324144|FG002|Pre-randomization|Adverse Event|0|||
49131821|NCT03530293|158324142|FG000|Pre-randomization|Protocol Violation|2|||
49131822|NCT03530293|158324143|FG001|Pre-randomization|Protocol Violation|0|||
49131823|NCT03530293|158324144|FG002|Pre-randomization|Protocol Violation|0|||
49131824|NCT03530293|158324142|FG000|Pre-randomization|Study Terminated by Sponsor|5|||
49131825|NCT03530293|158324143|FG001|Pre-randomization|Study Terminated by Sponsor|0|||
49131826|NCT03530293|158324144|FG002|Pre-randomization|Study Terminated by Sponsor|0|||
49131827|NCT03530293|158324142|FG000|Pre-randomization|Withdrawal by Subject|5|||
49131828|NCT03530293|158324143|FG001|Pre-randomization|Withdrawal by Subject|0|||
49131829|NCT03530293|158324144|FG002|Pre-randomization|Withdrawal by Subject|0|||
49131830|NCT03530293|158324142|FG000|Randomized Withdrawal Period / Follow-up|Adverse Event|0|||
49131831|NCT03530293|158324143|FG001|Randomized Withdrawal Period / Follow-up|Adverse Event|2|||
49131832|NCT03530293|158324144|FG002|Randomized Withdrawal Period / Follow-up|Adverse Event|4|||
49131833|NCT03530293|158324142|FG000|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
49131834|NCT03530293|158324143|FG001|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
49131835|NCT03530293|158324144|FG002|Randomized Withdrawal Period / Follow-up|Protocol Violation|1|||
49131836|NCT03530293|158324142|FG000|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|0|||
49131837|NCT03530293|158324143|FG001|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|3|||
49131838|NCT03530293|158324144|FG002|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|2|||
49131839|NCT03530293|158324142|FG000|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
49131840|NCT03530293|158324143|FG001|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|2|||
49131841|NCT03530293|158324144|FG002|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
49131842|NCT03530293|158324142|FG000|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|0|||
49131843|NCT03530293|158324143|FG001|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
49131844|NCT03530293|158324144|FG002|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
49131845|NCT00719901|158324145|FG000|Overall Study|Adverse Event|5|||
49131846|NCT00719901|158324145|FG000|Overall Study|Withdrawal by Subject|1|||
49131847|NCT00719901|158324145|FG000|Overall Study|Alternate Treatment|1|||
49131848|NCT00719901|158324145|FG000|Overall Study|Disease Progression|3|||
48818091|NCT01461993|157176716|FG001|Overall Study|Adverse Event|11|||
48818092|NCT01461993|157176717|FG002|Overall Study|Adverse Event|3|||
49131849|NCT00719901|158324145|FG000|Overall Study|Availability of Study Drug|1|||
49131850|NCT02765035|158324146|FG000|First Intervention (90 Days)|Adverse Event|1|||
49131851|NCT02765035|158324147|FG001|First Intervention (90 Days)|Adverse Event|1|||
49131852|NCT02765035|158324146|FG000|Second Intervention (30 Days)|Protocol Violation|2|||
49131853|NCT02765035|158324147|FG001|Second Intervention (30 Days)|Protocol Violation|2|||
49131854|NCT00891813|158324149|FG000|Overall Study|Adverse Event|3|||
49131855|NCT00891813|158324149|FG000|Overall Study|Withdrawal by Subject|1|||
49131856|NCT00891813|158324149|FG000|Overall Study|Patient Noncompliance|6|||
49131857|NCT00891813|158324149|FG000|Overall Study|Protocol Violation|2|||
49131858|NCT01712178|158324150|FG000|Overall Study|Withdrew consent due to an adverse event|1|||
49131859|NCT01712178|158324151|FG001|Overall Study|Withdrew consent due to an adverse event|1|||
49131860|NCT01712178|158324150|FG000|Overall Study|Serious adverse event/withdrew consent|0|||
48818093|NCT01461993|157176715|FG000|Overall Study|No longer met eligibility criteria|13|||
48818094|NCT01461993|157176716|FG001|Overall Study|No longer met eligibility criteria|18|||
48818095|NCT01461993|157176717|FG002|Overall Study|No longer met eligibility criteria|10|||
48818096|NCT01461993|157176715|FG000|Overall Study|Did not meet entrance criteria|2|||
48818097|NCT01461993|157176716|FG001|Overall Study|Did not meet entrance criteria|3|||
48818098|NCT01461993|157176717|FG002|Overall Study|Did not meet entrance criteria|0|||
48818099|NCT01461993|157176715|FG000|Overall Study|Other|13|||
48818100|NCT01461993|157176716|FG001|Overall Study|Other|15|||
48818101|NCT01461993|157176717|FG002|Overall Study|Other|6|||
48818102|NCT00680056|157176718|FG000|First Intervention|Mainly Exacerbation of COPD|1|||
48818103|NCT00680056|157176719|FG001|First Intervention|Mainly Exacerbation of COPD|2|||
48818104|NCT00680056|157176718|FG000|Second Intervention|Protocol Violation|3|||
48818105|NCT00680056|157176719|FG001|Second Intervention|Protocol Violation|1|||
48818106|NCT00219141|157176720|FG000|Overall Study|Adverse Event|4|||
48818107|NCT00219141|157176721|FG001|Overall Study|Adverse Event|10|||
48818108|NCT00219141|157176722|FG002|Overall Study|Adverse Event|5|||
49131861|NCT01712178|158324151|FG001|Overall Study|Serious adverse event/withdrew consent|1|||
49131862|NCT01712178|158324150|FG000|Overall Study|Lost to Follow-up|0|||
49131863|NCT01712178|158324151|FG001|Overall Study|Lost to Follow-up|1|||
49131864|NCT01122173|158324152|FG000|Overall Study|Lost to Follow-up|3|||
49131865|NCT01122173|158324152|FG000|Overall Study|Withdrawal by Subject|3|||
49131866|NCT01122173|158324152|FG000|Overall Study|Left study for other reasons|3|||
48818109|NCT00219141|157176720|FG000|Overall Study|Lack of Efficacy|3|||
49131867|NCT00856180|158324155|FG000|Overall Study|Adverse Event|4|||
49131868|NCT00856180|158324155|FG000|Overall Study|Progressive Disease|16|||
49131869|NCT02265510|158324156|FG000|Overall Study|Withdrawal by Subject|1|||
49131870|NCT02265510|158324157|FG001|Overall Study|Withdrawal by Subject|1|||
49131871|NCT02265510|158324158|FG002|Overall Study|Withdrawal by Subject|2|||
49131872|NCT02265510|158324159|FG003|Overall Study|Withdrawal by Subject|1|||
49131873|NCT02265510|158324160|FG004|Overall Study|Withdrawal by Subject|0|||
49131874|NCT02265510|158324161|FG005|Overall Study|Withdrawal by Subject|2|||
48818110|NCT00219141|157176721|FG001|Overall Study|Lack of Efficacy|2|||
48818111|NCT00219141|157176722|FG002|Overall Study|Lack of Efficacy|0|||
48818112|NCT00219141|157176720|FG000|Overall Study|Administrative problems|0|||
48818113|NCT00219141|157176721|FG001|Overall Study|Administrative problems|1|||
48818114|NCT00219141|157176722|FG002|Overall Study|Administrative problems|0|||
48818115|NCT00219141|157176720|FG000|Overall Study|Lost to Follow-up|2|||
48818116|NCT00219141|157176721|FG001|Overall Study|Lost to Follow-up|4|||
48818117|NCT00219141|157176722|FG002|Overall Study|Lost to Follow-up|1|||
48818118|NCT00219141|157176720|FG000|Overall Study|Protocol Violation|3|||
48818119|NCT00219141|157176721|FG001|Overall Study|Protocol Violation|1|||
48818120|NCT00219141|157176722|FG002|Overall Study|Protocol Violation|1|||
48818121|NCT00219141|157176720|FG000|Overall Study|Withdrawal by Subject|1|||
48818122|NCT00219141|157176721|FG001|Overall Study|Withdrawal by Subject|3|||
48818123|NCT00219141|157176722|FG002|Overall Study|Withdrawal by Subject|5|||
48818124|NCT00219141|157176720|FG000|Overall Study|Condition no longer requires study drug|1|||
48818125|NCT00219141|157176721|FG001|Overall Study|Condition no longer requires study drug|0|||
48818126|NCT00219141|157176722|FG002|Overall Study|Condition no longer requires study drug|0|||
48818127|NCT03055832|157176723|FG000|Week 2|Withdrawal by Subject|1|||
48818128|NCT03055832|157176724|FG001|Week 2|Withdrawal by Subject|0|||
48818129|NCT00479674|157176725|FG000|Overall Study|Adverse Event|18|||
48818130|NCT00479674|157176725|FG000|Overall Study|Withdrawal by Subject|6|||
48818131|NCT00479674|157176725|FG000|Overall Study|Physician Decision|14|||
48818132|NCT00479674|157176725|FG000|Overall Study|none provided|3|||
48818133|NCT02059161|157176727|FG000|Overall Study|Pregnancy|0|||
48818134|NCT02059161|157176728|FG001|Overall Study|Pregnancy|2|||
48818135|NCT02059161|157176727|FG000|Overall Study|Adverse Event|2|||
48818136|NCT02059161|157176728|FG001|Overall Study|Adverse Event|6|||
48818137|NCT02059161|157176727|FG000|Overall Study|Lost to Follow-up|20|||
48818138|NCT02059161|157176728|FG001|Overall Study|Lost to Follow-up|12|||
48818139|NCT02059161|157176727|FG000|Overall Study|Physician Decision|4|||
48818140|NCT02059161|157176728|FG001|Overall Study|Physician Decision|4|||
48818141|NCT02059161|157176727|FG000|Overall Study|Protocol Violation|1|||
48818142|NCT02059161|157176728|FG001|Overall Study|Protocol Violation|1|||
48818143|NCT02059161|157176727|FG000|Overall Study|Withdrawal by Subject|16|||
48818144|NCT02059161|157176728|FG001|Overall Study|Withdrawal by Subject|13|||
48818145|NCT02059161|157176727|FG000|Overall Study|Randomized in error, no study drug|0|||
48818146|NCT02059161|157176728|FG001|Overall Study|Randomized in error, no study drug|1|||
48818147|NCT02059161|157176727|FG000|Overall Study|Non-compliance with study drug|6|||
48818148|NCT02059161|157176728|FG001|Overall Study|Non-compliance with study drug|2|||
48818149|NCT00372528|157176729|FG000|Overall Study|Lack of Efficacy|1|||
48818150|NCT00372528|157176729|FG000|Overall Study|Adverse Event|1|||
48818151|NCT00372528|157176729|FG000|Overall Study|Study Terminated by Sponsor|18|||
48818152|NCT00372528|157176729|FG000|Overall Study|Other|1|||
48818153|NCT04242875|157176730|FG000|Overall Study|Adverse Event|2|||
48818154|NCT01012973|157176731|FG000|Overall Study|Adverse Event|5|||
48818155|NCT01012973|157176732|FG001|Overall Study|Adverse Event|5|||
48818156|NCT01012973|157176731|FG000|Overall Study|Lack of Efficacy|0|||
48818157|NCT01012973|157176732|FG001|Overall Study|Lack of Efficacy|5|||
48818158|NCT01012973|157176731|FG000|Overall Study|Lost to Follow-up|1|||
48818159|NCT01012973|157176732|FG001|Overall Study|Lost to Follow-up|0|||
48818160|NCT01012973|157176731|FG000|Overall Study|(Overseas travel - indefinite period)|1|||
48818161|NCT01012973|157176732|FG001|Overall Study|(Overseas travel - indefinite period)|0|||
48818162|NCT01012973|157176731|FG000|Overall Study|Increase in vis. acuity, never injected|0|||
48818163|NCT01012973|157176732|FG001|Overall Study|Increase in vis. acuity, never injected|1|||
48818164|NCT01012973|157176731|FG000|Overall Study|Protocol Violation|5|||
48818165|NCT01012973|157176732|FG001|Overall Study|Protocol Violation|2|||
48818166|NCT01012973|157176731|FG000|Overall Study|Withdrawal by Subject|4|||
48818167|NCT01012973|157176732|FG001|Overall Study|Withdrawal by Subject|6|||
48818168|NCT00231894|157176733|FG000|Overall Study|Withdrawal by Subject|1|||
48818169|NCT00231894|157176734|FG001|Overall Study|Withdrawal by Subject|1|||
48818170|NCT01024751|157176738|FG000|Enrolled Participants|Ineligible at baseline|3|||
48818171|NCT01024751|157176739|FG001|Enrolled Participants|Ineligible at baseline|4|||
48818172|NCT01024751|157176738|FG000|Eligible Participants|Withdrawal by Subject|0|||
48818173|NCT01024751|157176739|FG001|Eligible Participants|Withdrawal by Subject|1|||
48818174|NCT01024751|157176738|FG000|Eligible Participants|Lost to Follow-up|0|||
48818175|NCT01024751|157176739|FG001|Eligible Participants|Lost to Follow-up|1|||
48818176|NCT01024751|157176738|FG000|Eligible Participants|Ineligible|0|||
49131875|NCT02265510|158324162|FG006|Overall Study|Withdrawal by Subject|0|||
49131876|NCT02265510|158324163|FG007|Overall Study|Withdrawal by Subject|2|||
48818177|NCT01024751|157176739|FG001|Eligible Participants|Ineligible|1|||
48818178|NCT00577720|157176749|FG000|Overall Study|Adverse Event|2|||
48818179|NCT00577720|157176750|FG001|Overall Study|Adverse Event|1|||
48818180|NCT00577720|157176751|FG002|Overall Study|Adverse Event|0|||
48818181|NCT00577720|157176752|FG003|Overall Study|Adverse Event|4|||
48818182|NCT00577720|157176749|FG000|Overall Study|Lost to Follow-up|0|||
48818183|NCT00577720|157176750|FG001|Overall Study|Lost to Follow-up|0|||
48818184|NCT00577720|157176751|FG002|Overall Study|Lost to Follow-up|1|||
48818185|NCT00577720|157176752|FG003|Overall Study|Lost to Follow-up|0|||
48818186|NCT00577720|157176749|FG000|Overall Study|Protocol Violation|0|||
48818187|NCT00577720|157176750|FG001|Overall Study|Protocol Violation|0|||
48818188|NCT00577720|157176751|FG002|Overall Study|Protocol Violation|0|||
48818189|NCT00577720|157176752|FG003|Overall Study|Protocol Violation|1|||
48818190|NCT00577720|157176749|FG000|Overall Study|Withdrawal by Subject|2|||
48818191|NCT00577720|157176750|FG001|Overall Study|Withdrawal by Subject|0|||
48818192|NCT00577720|157176751|FG002|Overall Study|Withdrawal by Subject|0|||
48818193|NCT00577720|157176752|FG003|Overall Study|Withdrawal by Subject|2|||
48818194|NCT01628510|157176758|FG000|Overall Study|Withdrawal by Subject|0|||
48818195|NCT01628510|157176759|FG001|Overall Study|Withdrawal by Subject|4|||
48818196|NCT01628510|157176758|FG000|Overall Study|Death|3|||
48818197|NCT01628510|157176759|FG001|Overall Study|Death|1|||
48818198|NCT01653847|157176760|FG000|Overall Study|Withdrawal by Subject|1|||
48818199|NCT01653847|157176761|FG001|Overall Study|Withdrawal by Subject|0|||
48818200|NCT04707391|157176762|FG000|Overall Study|Adverse Event|5|||
48818201|NCT04707391|157176763|FG001|Overall Study|Adverse Event|8|||
48818202|NCT04707391|157176762|FG000|Overall Study|Lost to Follow-up|44|||
48818203|NCT04707391|157176763|FG001|Overall Study|Lost to Follow-up|31|||
48818204|NCT04707391|157176762|FG000|Overall Study|Protocol Violation|1|||
48818205|NCT04707391|157176763|FG001|Overall Study|Protocol Violation|5|||
48818206|NCT04707391|157176762|FG000|Overall Study|Withdrawal by Subject|27|||
48818207|NCT04707391|157176763|FG001|Overall Study|Withdrawal by Subject|25|||
48818208|NCT04707391|157176762|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
48818209|NCT04707391|157176763|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
48818210|NCT04707391|157176762|FG000|Overall Study|Other|0|||
48818211|NCT04707391|157176763|FG001|Overall Study|Other|2|||
48818212|NCT00131911|157176764|FG000|Overall Study|Withdrawal by Subject|1|||
48818213|NCT00131911|157176765|FG001|Overall Study|Withdrawal by Subject|0|||
48818214|NCT03519581|157176768|FG000|Overall Study|Lost to Follow-up|3|||
48818215|NCT03519581|157176769|FG001|Overall Study|Lost to Follow-up|2|||
48818216|NCT03519581|157176768|FG000|Overall Study|Adverse Event|5|||
48818217|NCT03519581|157176769|FG001|Overall Study|Adverse Event|2|||
48818218|NCT03519581|157176768|FG000|Overall Study|Withdrawal by Subject|2|||
48818219|NCT03519581|157176769|FG001|Overall Study|Withdrawal by Subject|0|||
48818220|NCT03519581|157176768|FG000|Overall Study|Change to insurance|2|||
48818221|NCT03519581|157176769|FG001|Overall Study|Change to insurance|1|||
48818222|NCT03519581|157176768|FG000|Overall Study|Other|2|||
48818223|NCT03519581|157176769|FG001|Overall Study|Other|4|||
48818224|NCT00388362|157176772|FG000|Enrolled|Ineligible|1|||
48818225|NCT00388362|157176772|FG000|Enrolled|Adverse Event|9|||
48818226|NCT00388362|157176772|FG000|Enrolled|Death|1|||
48818227|NCT00388362|157176772|FG000|Enrolled|Loss insurance|1|||
48818228|NCT00388362|157176772|FG000|Enrolled|Withdrawal by Subject|1|||
48818229|NCT00388362|157176772|FG000|Remained on Study Median of 514 Days|Death|2|||
48818230|NCT02035787|157176773|FG000|Overall Study- 12 Months|Adverse Event|3|||
48818231|NCT02035787|157176774|FG001|Overall Study- 12 Months|Adverse Event|0|||
48818232|NCT02035787|157176773|FG000|Overall Study- 12 Months|Complete response|4|||
49131877|NCT02265510|158324164|FG008|Overall Study|Withdrawal by Subject|0|||
48818233|NCT02035787|157176774|FG001|Overall Study- 12 Months|Complete response|1|||
48818234|NCT02035787|157176773|FG000|Overall Study- 12 Months|Protocol Violation|1|||
48818235|NCT02035787|157176774|FG001|Overall Study- 12 Months|Protocol Violation|1|||
48818236|NCT02323321|157176780|FG000|Overall Study|Re-Transplant|1|||
48818237|NCT02323321|157176780|FG000|Overall Study|Death|12|||
48818238|NCT02577835|157176781|FG000|Overall Study|Ambulatory blood pressure recordings were not valid for the analysis|142|||
48818239|NCT04516967|157176782|FG000|Core Phase|Adverse Event|2|||
49131878|NCT02265510|158324165|FG009|Overall Study|Withdrawal by Subject|0|||
49131879|NCT02265510|158324166|FG010|Overall Study|Withdrawal by Subject|0|||
49131880|NCT02265510|158324167|FG011|Overall Study|Withdrawal by Subject|0|||
48818240|NCT04516967|157176783|FG001|Core Phase|Adverse Event|1|||
48818241|NCT04516967|157176784|FG002|Core Phase|Adverse Event|0|||
48818242|NCT04516967|157176782|FG000|Core Phase|Physician Decision|1|||
48818243|NCT04516967|157176783|FG001|Core Phase|Physician Decision|1|||
48818244|NCT04516967|157176784|FG002|Core Phase|Physician Decision|0|||
48818245|NCT04516967|157176782|FG000|Core Phase|Lack of Efficacy|7|||
48818246|NCT04516967|157176783|FG001|Core Phase|Lack of Efficacy|18|||
48818247|NCT04516967|157176784|FG002|Core Phase|Lack of Efficacy|0|||
48818248|NCT00686335|157176785|FG000|Run-in Period|Adverse Event|1|||
48818249|NCT00686335|157176785|FG000|Run-in Period|asthma exacerbation|1|||
48818250|NCT00686335|157176785|FG000|Run-in Period|violation of inclusion/exclusion criteri|3|||
49131881|NCT02265510|158324168|FG012|Overall Study|Withdrawal by Subject|1|||
48818251|NCT01822353|157176790|FG000|Overall Study|Adverse Event|1|||
48818252|NCT01822353|157176791|FG001|Overall Study|Adverse Event|3|||
48818253|NCT01822353|157176792|FG002|Overall Study|Adverse Event|1|||
48818254|NCT01822353|157176790|FG000|Overall Study|Pregnancy|0|||
48818255|NCT01822353|157176791|FG001|Overall Study|Pregnancy|1|||
48818256|NCT01822353|157176792|FG002|Overall Study|Pregnancy|0|||
48818257|NCT01822353|157176790|FG000|Overall Study|Withdrawal by Subject|3|||
48818258|NCT01822353|157176791|FG001|Overall Study|Withdrawal by Subject|1|||
48818259|NCT01822353|157176792|FG002|Overall Study|Withdrawal by Subject|0|||
48818260|NCT02320721|157176793|FG000|Overall Study|Adverse Event|6|||
48818261|NCT02320721|157176794|FG001|Overall Study|Adverse Event|6|||
48818262|NCT02320721|157176793|FG000|Overall Study|Lack of Efficacy|2|||
48818263|NCT02320721|157176794|FG001|Overall Study|Lack of Efficacy|0|||
48818264|NCT02320721|157176793|FG000|Overall Study|Poor compliance to protocol|3|||
48818265|NCT02320721|157176794|FG001|Overall Study|Poor compliance to protocol|7|||
48818266|NCT02320721|157176793|FG000|Overall Study|Randomized but not treated|0|||
48818267|NCT02320721|157176794|FG001|Overall Study|Randomized but not treated|1|||
48818268|NCT02320721|157176793|FG000|Overall Study|Hypoglycemia|1|||
49131882|NCT02265510|158324169|FG013|Overall Study|Withdrawal by Subject|0|||
49131883|NCT02265510|158324156|FG000|Overall Study|Disease Progression|0|||
49131884|NCT02265510|158324157|FG001|Overall Study|Disease Progression|1|||
49131885|NCT02265510|158324158|FG002|Overall Study|Disease Progression|2|||
49131886|NCT02265510|158324159|FG003|Overall Study|Disease Progression|1|||
49131887|NCT02265510|158324160|FG004|Overall Study|Disease Progression|1|||
49131888|NCT02265510|158324161|FG005|Overall Study|Disease Progression|0|||
49131889|NCT02265510|158324162|FG006|Overall Study|Disease Progression|0|||
49131890|NCT02265510|158324163|FG007|Overall Study|Disease Progression|0|||
49131891|NCT02265510|158324164|FG008|Overall Study|Disease Progression|0|||
49131892|NCT02265510|158324165|FG009|Overall Study|Disease Progression|0|||
49131893|NCT02265510|158324166|FG010|Overall Study|Disease Progression|0|||
49131894|NCT02265510|158324167|FG011|Overall Study|Disease Progression|0|||
49131895|NCT02265510|158324168|FG012|Overall Study|Disease Progression|0|||
49131896|NCT02265510|158324169|FG013|Overall Study|Disease Progression|0|||
49131897|NCT02265510|158324156|FG000|Overall Study|Death|2|||
49131898|NCT02265510|158324157|FG001|Overall Study|Death|0|||
49131899|NCT02265510|158324158|FG002|Overall Study|Death|2|||
49131900|NCT02265510|158324159|FG003|Overall Study|Death|2|||
49131901|NCT02265510|158324160|FG004|Overall Study|Death|1|||
49131902|NCT02265510|158324161|FG005|Overall Study|Death|3|||
49131903|NCT02265510|158324162|FG006|Overall Study|Death|2|||
49131904|NCT02265510|158324163|FG007|Overall Study|Death|1|||
49131905|NCT02265510|158324164|FG008|Overall Study|Death|3|||
49131906|NCT02265510|158324165|FG009|Overall Study|Death|3|||
49131907|NCT02265510|158324166|FG010|Overall Study|Death|4|||
49131908|NCT02265510|158324167|FG011|Overall Study|Death|12|||
49131909|NCT02265510|158324168|FG012|Overall Study|Death|7|||
49131910|NCT02265510|158324169|FG013|Overall Study|Death|6|||
49131911|NCT02265510|158324156|FG000|Overall Study|Lost to Follow-up|0|||
49131912|NCT02265510|158324157|FG001|Overall Study|Lost to Follow-up|0|||
49131913|NCT02265510|158324158|FG002|Overall Study|Lost to Follow-up|0|||
49131914|NCT02265510|158324159|FG003|Overall Study|Lost to Follow-up|0|||
49131915|NCT02265510|158324160|FG004|Overall Study|Lost to Follow-up|1|||
49131916|NCT02265510|158324161|FG005|Overall Study|Lost to Follow-up|0|||
49131917|NCT02265510|158324162|FG006|Overall Study|Lost to Follow-up|0|||
49131918|NCT02265510|158324163|FG007|Overall Study|Lost to Follow-up|0|||
49131919|NCT02265510|158324164|FG008|Overall Study|Lost to Follow-up|0|||
49131920|NCT02265510|158324165|FG009|Overall Study|Lost to Follow-up|2|||
48818269|NCT02320721|157176794|FG001|Overall Study|Hypoglycemia|0|||
48818270|NCT02320721|157176793|FG000|Overall Study|Other than specified above|15|||
48818271|NCT02320721|157176794|FG001|Overall Study|Other than specified above|20|||
48818272|NCT04266795|157176810|FG000|Overall Study|Adverse Event|10|||
48818273|NCT04266795|157176811|FG001|Overall Study|Adverse Event|19|||
48818274|NCT04266795|157176810|FG000|Overall Study|Death|7|||
48818275|NCT04266795|157176811|FG001|Overall Study|Death|8|||
48818276|NCT04266795|157176810|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|6|||
49131921|NCT02265510|158324166|FG010|Overall Study|Lost to Follow-up|0|||
49131922|NCT02265510|158324167|FG011|Overall Study|Lost to Follow-up|0|||
49131923|NCT02265510|158324168|FG012|Overall Study|Lost to Follow-up|0|||
49131924|NCT02265510|158324169|FG013|Overall Study|Lost to Follow-up|2|||
49131925|NCT02265510|158324156|FG000|Overall Study|Other|0|||
49131926|NCT02265510|158324157|FG001|Overall Study|Other|1|||
49131927|NCT02265510|158324158|FG002|Overall Study|Other|0|||
49131928|NCT02265510|158324159|FG003|Overall Study|Other|0|||
49131929|NCT02265510|158324160|FG004|Overall Study|Other|0|||
49131930|NCT02265510|158324161|FG005|Overall Study|Other|0|||
49131931|NCT02265510|158324162|FG006|Overall Study|Other|0|||
49131932|NCT02265510|158324163|FG007|Overall Study|Other|0|||
49131933|NCT02265510|158324164|FG008|Overall Study|Other|0|||
49131934|NCT02265510|158324165|FG009|Overall Study|Other|0|||
49131935|NCT02265510|158324166|FG010|Overall Study|Other|0|||
49131936|NCT02265510|158324167|FG011|Overall Study|Other|0|||
49131937|NCT02265510|158324168|FG012|Overall Study|Other|0|||
49131938|NCT02265510|158324169|FG013|Overall Study|Other|0|||
49131939|NCT02265510|158324156|FG000|Overall Study|Study Terminated by Sponsor|0|||
49131940|NCT02265510|158324157|FG001|Overall Study|Study Terminated by Sponsor|0|||
49131941|NCT02265510|158324158|FG002|Overall Study|Study Terminated by Sponsor|0|||
49131942|NCT02265510|158324159|FG003|Overall Study|Study Terminated by Sponsor|0|||
49131943|NCT02265510|158324160|FG004|Overall Study|Study Terminated by Sponsor|0|||
49131944|NCT02265510|158324161|FG005|Overall Study|Study Terminated by Sponsor|1|||
49131945|NCT02265510|158324162|FG006|Overall Study|Study Terminated by Sponsor|1|||
49131946|NCT02265510|158324163|FG007|Overall Study|Study Terminated by Sponsor|1|||
49131947|NCT02265510|158324164|FG008|Overall Study|Study Terminated by Sponsor|1|||
49131948|NCT02265510|158324165|FG009|Overall Study|Study Terminated by Sponsor|2|||
48723844|NCT01261312|156840403|FG002|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|2|||
48723845|NCT01261312|156840404|FG003|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
48723846|NCT01261312|156840405|FG004|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
48723847|NCT01261312|156840406|FG005|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
48723848|NCT01261312|156840407|FG006|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
48723849|NCT01261312|156840408|FG007|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
48723850|NCT01261312|156840409|FG008|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
48723851|NCT01261312|156840410|FG009|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
48723852|NCT01261312|156840411|FG010|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
48723853|NCT01261312|156840412|FG011|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
48723854|NCT01261312|156840413|FG012|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
48723855|NCT01261312|156840401|FG000|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
48723856|NCT01261312|156840402|FG001|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
48723857|NCT01261312|156840403|FG002|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
48723858|NCT01261312|156840404|FG003|DE Phase: r/r AML (Week 75-242)|Progressive Disease|14|||
48723859|NCT01261312|156840405|FG004|DE Phase: r/r AML (Week 75-242)|Progressive Disease|16|||
48723860|NCT01261312|156840406|FG005|DE Phase: r/r AML (Week 75-242)|Progressive Disease|24|||
48921031|NCT00784654|157544819|FG001|Randomized Withdrawal Period|Adverse Event|1|||
49131949|NCT02265510|158324166|FG010|Overall Study|Study Terminated by Sponsor|1|||
49131950|NCT02265510|158324167|FG011|Overall Study|Study Terminated by Sponsor|4|||
49131951|NCT02265510|158324168|FG012|Overall Study|Study Terminated by Sponsor|1|||
49131952|NCT02265510|158324169|FG013|Overall Study|Study Terminated by Sponsor|2|||
49131953|NCT01668797|158324170|FG000|Phase A (Conversion Phase)|Lost to Follow-up|3|||
49131954|NCT01668797|158324171|FG001|Phase A (Conversion Phase)|Lost to Follow-up|0|||
49131955|NCT01668797|158324172|FG002|Phase A (Conversion Phase)|Lost to Follow-up|0|||
49131956|NCT01668797|158324173|FG003|Phase A (Conversion Phase)|Lost to Follow-up|0|||
49131957|NCT01668797|158324170|FG000|Phase A (Conversion Phase)|Met Withdrawal Criteria|3|||
49131958|NCT01668797|158324171|FG001|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
49131959|NCT01668797|158324172|FG002|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
49131960|NCT01668797|158324173|FG003|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
49131961|NCT01668797|158324170|FG000|Phase A (Conversion Phase)|Physician Decision|2|||
49131962|NCT01668797|158324171|FG001|Phase A (Conversion Phase)|Physician Decision|0|||
49131963|NCT01668797|158324172|FG002|Phase A (Conversion Phase)|Physician Decision|0|||
49131964|NCT01668797|158324173|FG003|Phase A (Conversion Phase)|Physician Decision|0|||
49131965|NCT01668797|158324170|FG000|Phase A (Conversion Phase)|Withdrawal by Subject|16|||
49131966|NCT01668797|158324171|FG001|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
49131967|NCT01668797|158324172|FG002|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
49131968|NCT01668797|158324173|FG003|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
49131969|NCT01668797|158324170|FG000|Phase A (Conversion Phase)|Protocol Violation|2|||
49131970|NCT01668797|158324171|FG001|Phase A (Conversion Phase)|Protocol Violation|0|||
49131971|NCT01668797|158324172|FG002|Phase A (Conversion Phase)|Protocol Violation|0|||
49131972|NCT01668797|158324173|FG003|Phase A (Conversion Phase)|Protocol Violation|0|||
49131973|NCT01668797|158324170|FG000|Phase A (Conversion Phase)|Lack of Efficacy|7|||
49131974|NCT01668797|158324171|FG001|Phase A (Conversion Phase)|Lack of Efficacy|0|||
49131975|NCT01668797|158324172|FG002|Phase A (Conversion Phase)|Lack of Efficacy|0|||
49131976|NCT01668797|158324173|FG003|Phase A (Conversion Phase)|Lack of Efficacy|0|||
49131977|NCT01668797|158324170|FG000|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8|||
49131978|NCT01668797|158324171|FG001|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
49131979|NCT01668797|158324172|FG002|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
48723861|NCT01261312|156840407|FG006|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
49131980|NCT01668797|158324173|FG003|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
49131981|NCT01668797|158324170|FG000|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19|||
49131982|NCT01668797|158324171|FG001|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
49131983|NCT01668797|158324172|FG002|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
49131984|NCT01668797|158324173|FG003|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
48818277|NCT04266795|157176811|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|2|||
48818278|NCT04266795|157176810|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
48818279|NCT04266795|157176811|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
48818280|NCT04266795|157176810|FG000|Overall Study|Progressive Disease|12|||
48818281|NCT04266795|157176811|FG001|Overall Study|Progressive Disease|9|||
48818282|NCT04266795|157176810|FG000|Overall Study|Withdrawal by Patient|5|||
48818283|NCT04266795|157176811|FG001|Overall Study|Withdrawal by Patient|6|||
48818284|NCT04266795|157176810|FG000|Overall Study|Disease Relapse|3|||
49131985|NCT01668797|158324170|FG000|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
49131986|NCT01668797|158324171|FG001|Phase B (Stabilization Phase)|Lost to Follow-up|16|||
49131987|NCT01668797|158324172|FG002|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
49131988|NCT01668797|158324173|FG003|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
49131989|NCT01668797|158324170|FG000|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
49131990|NCT01668797|158324171|FG001|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22|||
49131991|NCT01668797|158324172|FG002|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
49131992|NCT01668797|158324173|FG003|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
48818285|NCT04266795|157176811|FG001|Overall Study|Disease Relapse|6|||
48818286|NCT04266795|157176810|FG000|Overall Study|Reason not Specified|12|||
48818287|NCT04266795|157176811|FG001|Overall Study|Reason not Specified|10|||
48818288|NCT04266795|157176810|FG000|Overall Study|Participants Ongoing on Treatment|25|||
48818289|NCT04266795|157176811|FG001|Overall Study|Participants Ongoing on Treatment|23|||
48818290|NCT02764775|157178433|FG000|Overall Study|Death|1|||
48818291|NCT02764775|157178433|FG000|Overall Study|Lost to Follow-up|2|||
48818292|NCT02764775|157178433|FG000|Overall Study|Withdrawal by Subject|3|||
48818293|NCT00513019|157178437|FG000|Overall Study|Adverse Event|1|||
48818294|NCT00513019|157178438|FG001|Overall Study|Adverse Event|0|||
48818295|NCT00513019|157178437|FG000|Overall Study|Withdrawal by Subject|4|||
48818296|NCT00513019|157178438|FG001|Overall Study|Withdrawal by Subject|5|||
48818297|NCT00777803|157178439|FG000|Overall Study|Lost to Follow-up|12|||
48818298|NCT00777803|157178440|FG001|Overall Study|Lost to Follow-up|5|||
48818299|NCT00777803|157178439|FG000|Overall Study|Adverse Event|1|||
48818300|NCT00777803|157178440|FG001|Overall Study|Adverse Event|0|||
49131993|NCT01668797|158324170|FG000|Phase B (Stabilization Phase)|Physician Decision|0|||
49131994|NCT01668797|158324171|FG001|Phase B (Stabilization Phase)|Physician Decision|11|||
49131995|NCT01668797|158324172|FG002|Phase B (Stabilization Phase)|Physician Decision|0|||
49131996|NCT01668797|158324173|FG003|Phase B (Stabilization Phase)|Physician Decision|0|||
49131997|NCT01668797|158324170|FG000|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
49131998|NCT01668797|158324171|FG001|Phase B (Stabilization Phase)|Withdrawal by Subject|60|||
49131999|NCT01668797|158324172|FG002|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
49132000|NCT01668797|158324173|FG003|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
49132001|NCT01668797|158324170|FG000|Phase B (Stabilization Phase)|Protocol Violation|0|||
49132002|NCT01668797|158324171|FG001|Phase B (Stabilization Phase)|Protocol Violation|3|||
49132003|NCT01668797|158324172|FG002|Phase B (Stabilization Phase)|Protocol Violation|0|||
49132004|NCT01668797|158324173|FG003|Phase B (Stabilization Phase)|Protocol Violation|0|||
49132005|NCT01668797|158324170|FG000|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
49132006|NCT01668797|158324171|FG001|Phase B (Stabilization Phase)|Lack of Efficacy|21|||
49132007|NCT01668797|158324172|FG002|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
49132008|NCT01668797|158324173|FG003|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
49132009|NCT01668797|158324170|FG000|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
49132010|NCT01668797|158324171|FG001|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43|||
49132011|NCT01668797|158324172|FG002|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
49132012|NCT01668797|158324173|FG003|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
49132013|NCT01668797|158324170|FG000|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
49132014|NCT01668797|158324171|FG001|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86|||
49132015|NCT01668797|158324172|FG002|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
49132016|NCT01668797|158324173|FG003|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
48818301|NCT00777803|157178439|FG000|Overall Study|Non-compliance|2|||
48818302|NCT00777803|157178440|FG001|Overall Study|Non-compliance|2|||
48856506|NCT01159600|157312865|FG004|Overall Study|Patient refusal to continue,not due toAE|4|||
48818303|NCT02930122|157178442|FG000|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
48818304|NCT02930122|157178443|FG001|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
48818305|NCT00830947|157178444|FG000|Overall Study|Lost to Follow-up|4|||
48818306|NCT00830947|157178445|FG001|Overall Study|Lost to Follow-up|4|||
48818307|NCT00107380|157178449|FG000|Overall Study|Adverse Event|7|||
49132017|NCT01668797|158324170|FG000|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
48818308|NCT00107380|157178449|FG000|Overall Study|Refusal Unrelated to Adverse Event|7|||
48818309|NCT00107380|157178449|FG000|Overall Study|Progression/relapse|4|||
48818310|NCT00107380|157178449|FG000|Overall Study|Death|3|||
48818311|NCT00107380|157178449|FG000|Overall Study|Other - not protocol specified|7|||
48818312|NCT00107380|157178449|FG000|Overall Study|Ineligible|2|||
48818313|NCT04129528|157178462|FG000|Overall Study|Adverse Event|1|||
48818314|NCT04129528|157178463|FG001|Overall Study|Adverse Event|0|||
48818315|NCT04129528|157178462|FG000|Overall Study|Physician Decision|1|||
48818316|NCT04129528|157178463|FG001|Overall Study|Physician Decision|1|||
48818317|NCT04129528|157178462|FG000|Overall Study|Withdrawal by Subject|1|||
48818318|NCT04129528|157178463|FG001|Overall Study|Withdrawal by Subject|1|||
48818319|NCT01489020|157178464|FG000|Overall Study|Withdrawal by Subject|1|||
48818320|NCT01489020|157178465|FG001|Overall Study|Withdrawal by Subject|0|||
49132018|NCT01668797|158324171|FG001|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
49132019|NCT01668797|158324172|FG002|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4|||
48818321|NCT01489020|157178466|FG002|Overall Study|Withdrawal by Subject|0|||
49132020|NCT01668797|158324173|FG003|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6|||
49132021|NCT01668797|158324170|FG000|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
48818322|NCT01489020|157178467|FG003|Overall Study|Withdrawal by Subject|0|||
48818323|NCT01489020|157178468|FG004|Overall Study|Withdrawal by Subject|0|||
48818324|NCT01489020|157178469|FG005|Overall Study|Withdrawal by Subject|0|||
48818325|NCT01489020|157178464|FG000|Overall Study|Adverse Event|0|||
48818326|NCT01489020|157178465|FG001|Overall Study|Adverse Event|0|||
48818327|NCT01489020|157178466|FG002|Overall Study|Adverse Event|3|||
48818328|NCT01489020|157178467|FG003|Overall Study|Adverse Event|0|||
48818329|NCT01489020|157178468|FG004|Overall Study|Adverse Event|3|||
48818330|NCT01489020|157178469|FG005|Overall Study|Adverse Event|0|||
48818331|NCT01489020|157178464|FG000|Overall Study|Concomitant disease|0|||
48818332|NCT01489020|157178465|FG001|Overall Study|Concomitant disease|0|||
48818333|NCT01489020|157178466|FG002|Overall Study|Concomitant disease|0|||
49132022|NCT01668797|158324171|FG001|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
49132023|NCT01668797|158324172|FG002|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
49132024|NCT01668797|158324173|FG003|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
49132025|NCT01668797|158324170|FG000|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
49132026|NCT01668797|158324171|FG001|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
49132027|NCT01668797|158324172|FG002|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5|||
49132028|NCT01668797|158324173|FG003|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2|||
49132029|NCT01668797|158324170|FG000|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
49132030|NCT01668797|158324171|FG001|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
49132031|NCT01668797|158324172|FG002|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3|||
49132032|NCT01668797|158324173|FG003|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5|||
49132033|NCT01668797|158324170|FG000|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
49132034|NCT01668797|158324171|FG001|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
49132035|NCT01668797|158324172|FG002|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2|||
49132036|NCT01668797|158324173|FG003|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
49132037|NCT01668797|158324170|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
48818334|NCT01489020|157178467|FG003|Overall Study|Concomitant disease|0|||
48818335|NCT01489020|157178468|FG004|Overall Study|Concomitant disease|3|||
48818336|NCT01489020|157178469|FG005|Overall Study|Concomitant disease|0|||
49132038|NCT01668797|158324171|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
49132039|NCT01668797|158324172|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2|||
49132040|NCT01668797|158324173|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10|||
48818337|NCT01781611|157178475|FG000|Overall Study|Adverse Event|4|||
48818338|NCT01781611|157178476|FG001|Overall Study|Adverse Event|0|||
48818339|NCT04905290|157178477|FG000|Overall Study|Adverse Event|4|||
48818340|NCT04905290|157178477|FG000|Overall Study|Death|2|||
48818341|NCT04905290|157178477|FG000|Overall Study|Withdrawal by Subject|4|||
48818342|NCT04905290|157178477|FG000|Overall Study|Physician Decision|2|||
48818343|NCT04905290|157178477|FG000|Overall Study|Lost to Follow-up|2|||
48818344|NCT04905290|157178477|FG000|Overall Study|Screen Failure|2|||
48818345|NCT04905290|157178477|FG000|Overall Study|Unsuccessful Procedure|2|||
48818346|NCT00179010|157178480|FG000|Overall Study|Muscle probe defective|1|||
49132041|NCT01668797|158324170|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
49132042|NCT01668797|158324171|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
49132043|NCT01668797|158324172|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11|||
49132044|NCT01668797|158324173|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30|||
49132045|NCT01668797|158324170|FG000|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
49132046|NCT01668797|158324171|FG001|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
49132047|NCT01668797|158324172|FG002|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4|||
49132048|NCT01668797|158324173|FG003|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2|||
49132049|NCT01668797|158324170|FG000|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
49132050|NCT01668797|158324171|FG001|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
49132051|NCT01668797|158324172|FG002|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49|||
49132052|NCT01668797|158324173|FG003|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38|||
49132053|NCT01004614|158324174|FG000|Washout|Withdrawal by Subject|0|||
49132054|NCT01004614|158324175|FG001|Washout|Withdrawal by Subject|1|||
49132055|NCT01004614|158324176|FG002|Washout|Withdrawal by Subject|0|||
49132056|NCT01004614|158324177|FG003|Washout|Withdrawal by Subject|0|||
49132057|NCT02530385|158324178|FG000|Overall Study|Withdrawal by Subject|0|||
49132058|NCT02530385|158324179|FG001|Overall Study|Withdrawal by Subject|1|||
49132059|NCT00626639|158324184|FG000|Overall Study|Occurrence of grade 3 oral mucositis|2|||
49132060|NCT00626639|158324185|FG001|Overall Study|Occurrence of grade 3 oral mucositis|2|||
49132061|NCT00827567|158324186|FG000|Overall Study|Progression of Disease/Screen Failure|4|||
49132062|NCT00644059|158324187|FG000|Overall Study|Lost to Follow-up|37|||
49132063|NCT00644059|158324188|FG001|Overall Study|Lost to Follow-up|34|||
49132064|NCT00644059|158324189|FG002|Overall Study|Lost to Follow-up|16|||
49132065|NCT00644059|158324187|FG000|Overall Study|Withdrawal by Subject|52|||
49132066|NCT00644059|158324188|FG001|Overall Study|Withdrawal by Subject|60|||
49132067|NCT00644059|158324189|FG002|Overall Study|Withdrawal by Subject|30|||
49132068|NCT00644059|158324187|FG000|Overall Study|Adverse Event|8|||
49132069|NCT00644059|158324188|FG001|Overall Study|Adverse Event|5|||
49132070|NCT00644059|158324189|FG002|Overall Study|Adverse Event|1|||
49132071|NCT00644059|158324187|FG000|Overall Study|Inappropriate Enrollment|1|||
49132072|NCT00644059|158324188|FG001|Overall Study|Inappropriate Enrollment|3|||
49132073|NCT00644059|158324189|FG002|Overall Study|Inappropriate Enrollment|0|||
49132074|NCT00644059|158324187|FG000|Overall Study|Protocol Deviation/violation|20|||
49132075|NCT00644059|158324188|FG001|Overall Study|Protocol Deviation/violation|19|||
49132076|NCT00644059|158324189|FG002|Overall Study|Protocol Deviation/violation|15|||
49132077|NCT00644059|158324187|FG000|Overall Study|Unable to classify|6|||
49132078|NCT00644059|158324188|FG001|Overall Study|Unable to classify|2|||
49132079|NCT00644059|158324189|FG002|Overall Study|Unable to classify|3|||
49132080|NCT02020941|158324190|FG000|Overall Study|Adverse Event|1|||
49132081|NCT02020941|158324190|FG000|Overall Study|Physician Decision|2|||
49132082|NCT02020941|158324190|FG000|Overall Study|Withdrawal by Subject|1|||
49132083|NCT02020941|158324190|FG000|Overall Study|Disease Progression|4|||
49132084|NCT02736617|158324193|FG000|Treatment|Adverse Event|1|||
49132085|NCT02736617|158324193|FG000|Treatment|Lack of Efficacy|1|||
49132086|NCT02736617|158324193|FG000|Treatment|Withdrawal by Subject|1|||
49132087|NCT02736617|158324193|FG000|Maintenance|Lack of Efficacy|4|||
49132088|NCT02736617|158324193|FG000|Maintenance|Physician Decision|1|||
49132089|NCT00819039|158324194|FG000|Overall Study|Physician Decision|1|||
49132090|NCT00819039|158324195|FG001|Overall Study|Physician Decision|0|||
49132091|NCT00819039|158324196|FG002|Overall Study|Physician Decision|1|||
49132092|NCT00819039|158324194|FG000|Overall Study|Protocol Violation|1|||
48723862|NCT01261312|156840408|FG007|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
48723863|NCT01261312|156840409|FG008|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
48723864|NCT01261312|156840410|FG009|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
48723865|NCT01261312|156840411|FG010|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
48723866|NCT01261312|156840412|FG011|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
48723867|NCT01261312|156840413|FG012|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
48723868|NCT01261312|156840401|FG000|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
48723869|NCT01261312|156840402|FG001|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
48723870|NCT01261312|156840403|FG002|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
48723871|NCT01261312|156840404|FG003|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
48723872|NCT01261312|156840405|FG004|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
48723873|NCT01261312|156840406|FG005|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
48723874|NCT01261312|156840407|FG006|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
48723875|NCT01261312|156840408|FG007|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
49132093|NCT00819039|158324195|FG001|Overall Study|Protocol Violation|0|||
49132094|NCT00819039|158324196|FG002|Overall Study|Protocol Violation|0|||
49132095|NCT03502798|158324201|FG000|Overall Study|equipment failure|0|||
49132096|NCT03502798|158324202|FG001|Overall Study|equipment failure|7|||
49132097|NCT04076917|158324203|FG000|Overall Study|No AF episodes detected during Pre-Holter Observation period|49|||
49132098|NCT04076917|158324203|FG000|Overall Study|Study closure|13|||
49132099|NCT04076917|158324203|FG000|Overall Study|Physician Decision|3|||
49132100|NCT04076917|158324203|FG000|Overall Study|Death|1|||
49132101|NCT04076917|158324203|FG000|Overall Study|Lost to Follow-up|1|||
49132102|NCT04076917|158324203|FG000|Overall Study|Withdrawal by Subject|1|||
49132103|NCT04076917|158324203|FG000|Overall Study|Mean R-wave sensing is < 0.25 mV during Pre-Holter observation period|1|||
49132104|NCT00505921|158324204|FG000|Overall Study|Ineligible|1|||
49132105|NCT00505921|158324204|FG000|Overall Study|Failed to Mobilize|8|||
49132106|NCT04219189|158324205|FG000|Overall Study|Withdrawal by Subject|1|||
49132107|NCT04219189|158324206|FG001|Overall Study|Withdrawal by Subject|2|||
49132108|NCT04219189|158324205|FG000|Overall Study|Protocol Violation|0|||
49132109|NCT04219189|158324206|FG001|Overall Study|Protocol Violation|1|||
49132110|NCT04219189|158324205|FG000|Overall Study|Lost to Follow-up|0|||
49132111|NCT04219189|158324206|FG001|Overall Study|Lost to Follow-up|1|||
49132112|NCT04219189|158324205|FG000|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|0|||
49132113|NCT04219189|158324206|FG001|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|1|||
49132114|NCT00487188|158324207|FG000|Induction Phase|Abnormality of Laboratory Test|0|||
49132115|NCT00487188|158324208|FG001|Induction Phase|Abnormality of Laboratory Test|1|||
49132116|NCT00487188|158324209|FG002|Induction Phase|Abnormality of Laboratory Test|0|||
49132117|NCT00487188|158324207|FG000|Induction Phase|Adverse Event|5|||
49132118|NCT00487188|158324208|FG001|Induction Phase|Adverse Event|0|||
49132119|NCT00487188|158324209|FG002|Induction Phase|Adverse Event|0|||
49132120|NCT00487188|158324207|FG000|Induction Phase|Lack of Efficacy|0|||
49132121|NCT00487188|158324208|FG001|Induction Phase|Lack of Efficacy|1|||
49132122|NCT00487188|158324209|FG002|Induction Phase|Lack of Efficacy|0|||
49132123|NCT00487188|158324207|FG000|Induction Phase|Protocol Violation|1|||
49132124|NCT00487188|158324208|FG001|Induction Phase|Protocol Violation|0|||
49132125|NCT00487188|158324209|FG002|Induction Phase|Protocol Violation|0|||
49132126|NCT00487188|158324207|FG000|Induction Phase|Refused Treatment|1|||
49132127|NCT00487188|158324208|FG001|Induction Phase|Refused Treatment|2|||
49132128|NCT00487188|158324209|FG002|Induction Phase|Refused Treatment|0|||
49132129|NCT00487188|158324207|FG000|Induction Phase|Lost to Follow-up|2|||
49132130|NCT00487188|158324208|FG001|Induction Phase|Lost to Follow-up|2|||
49132131|NCT00487188|158324209|FG002|Induction Phase|Lost to Follow-up|0|||
49132132|NCT00487188|158324207|FG000|Induction Phase|Administrative|0|||
49132133|NCT00487188|158324208|FG001|Induction Phase|Administrative|1|||
49132134|NCT00487188|158324209|FG002|Induction Phase|Administrative|0|||
49132135|NCT00487188|158324207|FG000|Maintenance Phase|Adverse Event|1|||
49132136|NCT00487188|158324208|FG001|Maintenance Phase|Adverse Event|0|||
49132137|NCT00487188|158324209|FG002|Maintenance Phase|Adverse Event|0|||
49132138|NCT00487188|158324207|FG000|Maintenance Phase|Death|1|||
49132139|NCT00487188|158324208|FG001|Maintenance Phase|Death|0|||
49132140|NCT00487188|158324209|FG002|Maintenance Phase|Death|0|||
49132141|NCT00487188|158324207|FG000|Maintenance Phase|Lost to Follow-up|1|||
49132142|NCT00487188|158324208|FG001|Maintenance Phase|Lost to Follow-up|0|||
49132143|NCT00487188|158324209|FG002|Maintenance Phase|Lost to Follow-up|0|||
49132144|NCT00487188|158324207|FG000|Maintenance Phase|Administrative|0|||
49132145|NCT00487188|158324208|FG001|Maintenance Phase|Administrative|0|||
49132146|NCT00487188|158324209|FG002|Maintenance Phase|Administrative|1|||
49132147|NCT03530696|158324210|FG000|Overall Study|Excluded for not meeting eligibility criteria upon further review|1|||
49132148|NCT03530696|158324211|FG001|Overall Study|Excluded for not meeting eligibility criteria upon further review|2|||
49132149|NCT01299584|158324212|FG000|Overall Study|Protocol Violation|9|||
49132150|NCT03188822|158324216|FG000|Overall Study|Subjects chose not to attend the SOC 12 month follow up visit|6|||
49132151|NCT03188822|158324216|FG000|Overall Study|Clinic was closed due to COVID-19 for 12 month follow up visit|1|||
49132152|NCT00924898|158324217|FG000|Overall Study|Withdrawal by Subject|2|||
49132153|NCT01977846|158324223|FG000|Total Study - Prospective|Death|0|||
49132154|NCT01977846|158324224|FG001|Total Study - Prospective|Death|1|||
49132155|NCT01977846|158324223|FG000|Total Study - Prospective|Lost to Follow-up|0|||
49132156|NCT01977846|158324224|FG001|Total Study - Prospective|Lost to Follow-up|8|||
49132157|NCT01977846|158324223|FG000|Total Study - Prospective|Withdrawal by Subject|0|||
49132158|NCT01977846|158324224|FG001|Total Study - Prospective|Withdrawal by Subject|13|||
49132159|NCT01977846|158324223|FG000|Total Study - Prospective|Not available at time of visit|0|||
49132160|NCT01977846|158324224|FG001|Total Study - Prospective|Not available at time of visit|5|||
49132161|NCT01977846|158324223|FG000|Total Study - Prospective|No show|0|||
49132162|NCT01977846|158324224|FG001|Total Study - Prospective|No show|1|||
49132163|NCT01977846|158324223|FG000|Total Study - Prospective|Protocol Violation|0|||
49132164|NCT01977846|158324224|FG001|Total Study - Prospective|Protocol Violation|1|||
49132165|NCT02164916|158324225|FG000|Overall Study|Adverse Event|3|||
49132166|NCT02164916|158324226|FG001|Overall Study|Adverse Event|8|||
49132167|NCT02164916|158324225|FG000|Overall Study|Death|1|||
49132168|NCT02164916|158324226|FG001|Overall Study|Death|1|||
49132169|NCT02164916|158324225|FG000|Overall Study|Refusal unrelated to adverse event|3|||
49132170|NCT02164916|158324226|FG001|Overall Study|Refusal unrelated to adverse event|7|||
49132171|NCT02164916|158324225|FG000|Overall Study|Progression|37|||
49132172|NCT02164916|158324226|FG001|Overall Study|Progression|26|||
49132173|NCT02164916|158324225|FG000|Overall Study|Not protocol specified|5|||
49132174|NCT02164916|158324226|FG001|Overall Study|Not protocol specified|1|||
49132175|NCT02164916|158324225|FG000|Overall Study|Reason under review|1|||
49132176|NCT02164916|158324226|FG001|Overall Study|Reason under review|6|||
49132177|NCT02164916|158324225|FG000|Overall Study|Not eligible|2|||
49132178|NCT02164916|158324226|FG001|Overall Study|Not eligible|5|||
49132179|NCT02988661|158324227|FG000|Overall Study|Death|2|||
49132180|NCT02988661|158324228|FG001|Overall Study|Death|18|||
49132181|NCT02988661|158324227|FG000|Overall Study|Lost to Follow-up|0|||
49132182|NCT02988661|158324228|FG001|Overall Study|Lost to Follow-up|33|||
49132183|NCT02988661|158324227|FG000|Overall Study|Withdrawal by Subject|0|||
49132184|NCT02988661|158324228|FG001|Overall Study|Withdrawal by Subject|6|||
49132185|NCT02988661|158324227|FG000|Overall Study|Unable to complete the 18-month survey|1|||
49132186|NCT02988661|158324228|FG001|Overall Study|Unable to complete the 18-month survey|27|||
49132187|NCT03883386|158324231|FG000|First Assignment|Lost to Follow-up|1|||
49132188|NCT03883386|158324232|FG001|First Assignment|Lost to Follow-up|0|||
49132189|NCT03883386|158324231|FG000|First Assignment|Withdrawal by Subject|1|||
49132190|NCT03883386|158324232|FG001|First Assignment|Withdrawal by Subject|1|||
49132191|NCT00964782|158324233|FG000|Overall Study|Lost to Follow-up|1|||
49132192|NCT00964782|158324234|FG001|Overall Study|Lost to Follow-up|0|||
49132193|NCT03479905|158324243|FG000|Overall Study|Other airway method used|4|||
49132194|NCT03479905|158324244|FG001|Overall Study|Other airway method used|5|||
49132195|NCT03479905|158324245|FG002|Overall Study|Other airway method used|5|||
49132196|NCT05172570|158324246|FG000|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
49132197|NCT05172570|158324247|FG001|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|1|||
49132198|NCT05172570|158324248|FG002|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
49132199|NCT05172570|158324246|FG000|Overall Study|PI Decision due to equipment shortages|0|||
49132200|NCT05172570|158324247|FG001|Overall Study|PI Decision due to equipment shortages|0|||
49132201|NCT05172570|158324248|FG002|Overall Study|PI Decision due to equipment shortages|1|||
49132202|NCT00769561|158324249|FG000|Overall Study|Withdrawal by Subject|2|||
48723876|NCT01261312|156840409|FG008|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
48723877|NCT01261312|156840410|FG009|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
48723878|NCT01261312|156840411|FG010|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
48723879|NCT01261312|156840412|FG011|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
48723880|NCT01261312|156840413|FG012|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
48723881|NCT01261312|156840401|FG000|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
48723882|NCT01261312|156840402|FG001|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
48723883|NCT01261312|156840403|FG002|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
48723884|NCT01261312|156840404|FG003|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
48723885|NCT01261312|156840405|FG004|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|1|||
48723886|NCT01261312|156840406|FG005|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|2|||
48723887|NCT01261312|156840407|FG006|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
48723888|NCT01261312|156840408|FG007|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
48723889|NCT01261312|156840409|FG008|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
48723890|NCT01261312|156840410|FG009|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
48723891|NCT01261312|156840411|FG010|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
48723892|NCT01261312|156840412|FG011|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
48723893|NCT01261312|156840413|FG012|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
48723894|NCT01261312|156840401|FG000|DE Phase: r/r AML (Week 75-242)|Death|0|||
48723895|NCT01261312|156840402|FG001|DE Phase: r/r AML (Week 75-242)|Death|0|||
48723896|NCT01261312|156840403|FG002|DE Phase: r/r AML (Week 75-242)|Death|0|||
48723897|NCT01261312|156840404|FG003|DE Phase: r/r AML (Week 75-242)|Death|4|||
48723898|NCT01261312|156840405|FG004|DE Phase: r/r AML (Week 75-242)|Death|3|||
48723899|NCT01261312|156840406|FG005|DE Phase: r/r AML (Week 75-242)|Death|10|||
48723900|NCT01261312|156840407|FG006|DE Phase: r/r AML (Week 75-242)|Death|0|||
48723901|NCT01261312|156840408|FG007|DE Phase: r/r AML (Week 75-242)|Death|0|||
48723902|NCT01261312|156840409|FG008|DE Phase: r/r AML (Week 75-242)|Death|0|||
48723903|NCT01261312|156840410|FG009|DE Phase: r/r AML (Week 75-242)|Death|0|||
49132203|NCT00769561|158324250|FG001|Overall Study|Withdrawal by Subject|2|||
49132204|NCT00769561|158324249|FG000|Overall Study|Lost to Follow-up|1|||
49132205|NCT00769561|158324250|FG001|Overall Study|Lost to Follow-up|3|||
49132206|NCT01706328|158324258|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140|||
49132207|NCT01706328|158324259|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
49132208|NCT01706328|158324260|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
49132209|NCT01706328|158324258|FG000|2-week Run-in Period|Withdrawal by Subject|15|||
49132210|NCT01706328|158324259|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
49132211|NCT01706328|158324260|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
49132212|NCT01706328|158324258|FG000|2-week Run-in Period|Physician Decision|4|||
48723904|NCT01261312|156840411|FG010|DE Phase: r/r AML (Week 75-242)|Death|0|||
48723905|NCT01261312|156840412|FG011|DE Phase: r/r AML (Week 75-242)|Death|0|||
48723906|NCT01261312|156840413|FG012|DE Phase: r/r AML (Week 75-242)|Death|0|||
48723907|NCT01261312|156840401|FG000|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
48723908|NCT01261312|156840402|FG001|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
48723909|NCT01261312|156840403|FG002|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
48723910|NCT01261312|156840404|FG003|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
48723911|NCT01261312|156840405|FG004|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
48818347|NCT00179010|157178481|FG001|Overall Study|Muscle probe defective|1|||
48818348|NCT00179010|157178480|FG000|Overall Study|Failure to place arterial line|0|||
48818349|NCT00179010|157178481|FG001|Overall Study|Failure to place arterial line|1|||
48818350|NCT00178256|157178485|FG000|Overall Study|Adverse Event|2|||
48818351|NCT00178256|157178486|FG001|Overall Study|Adverse Event|0|||
48818352|NCT00178256|157178487|FG002|Overall Study|Adverse Event|0|||
48818353|NCT00178256|157178488|FG003|Overall Study|Adverse Event|0|||
48818354|NCT00178256|157178485|FG000|Overall Study|Death|0|||
48818355|NCT00178256|157178486|FG001|Overall Study|Death|1|||
48818356|NCT00178256|157178487|FG002|Overall Study|Death|0|||
48818357|NCT00178256|157178488|FG003|Overall Study|Death|1|||
48818358|NCT00178256|157178485|FG000|Overall Study|Cancer progression|2|||
48818359|NCT00178256|157178486|FG001|Overall Study|Cancer progression|0|||
48818360|NCT00178256|157178487|FG002|Overall Study|Cancer progression|0|||
49132213|NCT01706328|158324259|FG001|2-week Run-in Period|Physician Decision|0|||
49132214|NCT01706328|158324260|FG002|2-week Run-in Period|Physician Decision|0|||
49132215|NCT01706328|158324258|FG000|2-week Run-in Period|Adverse Event|4|||
49132216|NCT01706328|158324259|FG001|2-week Run-in Period|Adverse Event|0|||
49132217|NCT01706328|158324260|FG002|2-week Run-in Period|Adverse Event|0|||
49132218|NCT01706328|158324258|FG000|2-week Run-in Period|Lost to Follow-up|2|||
49132219|NCT01706328|158324259|FG001|2-week Run-in Period|Lost to Follow-up|0|||
49132220|NCT01706328|158324260|FG002|2-week Run-in Period|Lost to Follow-up|0|||
49132221|NCT01706328|158324258|FG000|12-week Double-blind Treatment Period|Adverse Event|0|||
49132222|NCT01706328|158324259|FG001|12-week Double-blind Treatment Period|Adverse Event|14|||
49132223|NCT01706328|158324260|FG002|12-week Double-blind Treatment Period|Adverse Event|16|||
49132224|NCT01706328|158324258|FG000|12-week Double-blind Treatment Period|Lack of Efficacy|0|||
49132225|NCT01706328|158324259|FG001|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
49132226|NCT01706328|158324260|FG002|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
49132227|NCT01706328|158324258|FG000|12-week Double-blind Treatment Period|Protocol Violation|0|||
49132228|NCT01706328|158324259|FG001|12-week Double-blind Treatment Period|Protocol Violation|4|||
49132229|NCT01706328|158324260|FG002|12-week Double-blind Treatment Period|Protocol Violation|2|||
49132230|NCT01706328|158324258|FG000|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0|||
49132231|NCT01706328|158324259|FG001|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11|||
49132232|NCT01706328|158324260|FG002|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9|||
49132233|NCT01706328|158324258|FG000|12-week Double-blind Treatment Period|Lost to Follow-up|0|||
49132234|NCT01706328|158324259|FG001|12-week Double-blind Treatment Period|Lost to Follow-up|3|||
49132235|NCT01706328|158324260|FG002|12-week Double-blind Treatment Period|Lost to Follow-up|1|||
49132236|NCT01706328|158324258|FG000|12-week Double-blind Treatment Period|Physician Decision|0|||
49132237|NCT01706328|158324259|FG001|12-week Double-blind Treatment Period|Physician Decision|2|||
49132238|NCT01706328|158324260|FG002|12-week Double-blind Treatment Period|Physician Decision|2|||
49132239|NCT01706328|158324258|FG000|12-week Double-blind Treatment Period|Withdrawal by Subject|0|||
49132240|NCT01706328|158324259|FG001|12-week Double-blind Treatment Period|Withdrawal by Subject|8|||
49132241|NCT01706328|158324260|FG002|12-week Double-blind Treatment Period|Withdrawal by Subject|11|||
49132242|NCT01928771|158324261|FG000|Overall Study|Adverse Event|6|||
49132243|NCT01928771|158324262|FG001|Overall Study|Adverse Event|5|||
49132244|NCT01928771|158324263|FG002|Overall Study|Adverse Event|1|||
49132245|NCT01928771|158324261|FG000|Overall Study|Death|2|||
49132246|NCT01928771|158324262|FG001|Overall Study|Death|2|||
49132247|NCT01928771|158324263|FG002|Overall Study|Death|2|||
49132248|NCT01928771|158324261|FG000|Overall Study|Lost to Follow-up|5|||
49132249|NCT01928771|158324262|FG001|Overall Study|Lost to Follow-up|6|||
49132250|NCT01928771|158324263|FG002|Overall Study|Lost to Follow-up|3|||
49132251|NCT01928771|158324261|FG000|Overall Study|Withdrawal by Subject|20|||
49132252|NCT01928771|158324262|FG001|Overall Study|Withdrawal by Subject|15|||
49132253|NCT01928771|158324263|FG002|Overall Study|Withdrawal by Subject|17|||
49132254|NCT01928771|158324261|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
49132255|NCT01928771|158324262|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
49132256|NCT01928771|158324263|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
49132257|NCT01928771|158324261|FG000|Overall Study|Other Reasons|9|||
49132258|NCT01928771|158324262|FG001|Overall Study|Other Reasons|9|||
49132259|NCT01928771|158324263|FG002|Overall Study|Other Reasons|14|||
49132260|NCT01928771|158324261|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
48723912|NCT01261312|156840406|FG005|DE Phase: r/r AML (Week 75-242)|Investigator Decision|6|||
48723913|NCT01261312|156840407|FG006|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
49132261|NCT01928771|158324262|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
49132262|NCT01928771|158324263|FG002|Overall Study|Severe Non-Compliance to Protocol|2|||
49132263|NCT04239924|158324266|FG000|Overall Study|Lost to Follow-up|2|||
49132264|NCT00350545|158325473|FG000|Overall Study|Withdrawal by Subject|2|||
49132265|NCT00916578|158325474|FG000|Overall Study|Physician Decision|2|||
49132266|NCT00916578|158325474|FG000|Overall Study|Withdrawal by Subject|3|||
49132267|NCT00916578|158325474|FG000|Overall Study|Insurance Denial|2|||
48723914|NCT01261312|156840408|FG007|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
48723915|NCT01261312|156840409|FG008|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
48723916|NCT01261312|156840410|FG009|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
48723917|NCT01261312|156840411|FG010|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
48723918|NCT01261312|156840412|FG011|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
48723919|NCT01261312|156840413|FG012|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
48723920|NCT01261312|156840401|FG000|DE Phase: r/r AML (Week 75-242)|HCT|0|||
48723921|NCT01261312|156840402|FG001|DE Phase: r/r AML (Week 75-242)|HCT|0|||
48723922|NCT01261312|156840403|FG002|DE Phase: r/r AML (Week 75-242)|HCT|0|||
48723923|NCT01261312|156840404|FG003|DE Phase: r/r AML (Week 75-242)|HCT|5|||
48818361|NCT00178256|157178488|FG003|Overall Study|Cancer progression|1|||
49132268|NCT00375752|158325476|FG000|Overall Study|Lack of Efficacy|4|||
49132269|NCT00375752|158325477|FG001|Overall Study|Lack of Efficacy|4|||
49132270|NCT00375752|158325476|FG000|Overall Study|Adverse Event|1|||
49132271|NCT00375752|158325477|FG001|Overall Study|Adverse Event|6|||
49132272|NCT00375752|158325476|FG000|Overall Study|Withdrawal by Subject|6|||
49132273|NCT00375752|158325477|FG001|Overall Study|Withdrawal by Subject|1|||
49132274|NCT00375752|158325476|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
49132275|NCT00375752|158325477|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
49132276|NCT00375752|158325476|FG000|Overall Study|Protocol Violation|0|||
49132277|NCT00375752|158325477|FG001|Overall Study|Protocol Violation|2|||
49132278|NCT00375752|158325476|FG000|Overall Study|Administrative Problems|0|||
49132279|NCT00375752|158325477|FG001|Overall Study|Administrative Problems|1|||
49132280|NCT00754741|158325478|FG000|Overall Study|Died or disenrolled|57|||
49132281|NCT00754741|158325479|FG001|Overall Study|Died or disenrolled|69|||
49132282|NCT00754741|158325480|FG002|Overall Study|Died or disenrolled|54|||
49132283|NCT01384877|158325481|FG000|Treatment 2|Lost to Follow-up|2|||
49132284|NCT01384877|158325482|FG001|Treatment 2|Lost to Follow-up|2|||
49132285|NCT00961064|158325483|FG000|Initial Treatment (Weeks 1 - 20)|No Response|11|||
49132286|NCT00961064|158325483|FG000|Initial Treatment (Weeks 1 - 20)|Disease Progression|3|||
49132287|NCT00961064|158325483|FG000|Initial Treatment (Weeks 1 - 20)|Death|1|||
49132288|NCT00961064|158325483|FG000|Initial Treatment (Weeks 1 - 20)|Withdrawal by Subject|1|||
49132289|NCT00961064|158325483|FG000|Extended Access: Week 20 to Up to Year 5|Disease Progression|3|||
49132290|NCT00961064|158325483|FG000|Extended Access: Week 20 to Up to Year 5|Lost Response|1|||
49132291|NCT00961064|158325483|FG000|Extended Access: Week 20 to Up to Year 5|Non-compliant|1|||
49132292|NCT00961064|158325483|FG000|Extended Access: Week 20 to Up to Year 5|Withdrawal by Subject|2|||
49132293|NCT00607893|158325486|FG000|Overall Study|Lost to Follow-up|4|||
49132294|NCT00607893|158325487|FG001|Overall Study|Lost to Follow-up|0|||
49132295|NCT00607893|158325486|FG000|Overall Study|withdrew due to loss of interest|0|||
49132296|NCT00607893|158325487|FG001|Overall Study|withdrew due to loss of interest|1|||
49132297|NCT00607893|158325486|FG000|Overall Study|Withdrew due to osteomyelitis surgery|0|||
49132298|NCT00607893|158325487|FG001|Overall Study|Withdrew due to osteomyelitis surgery|1|||
49132299|NCT00607893|158325486|FG000|Overall Study|withdrew could not tolerate CPAP|0|||
49132300|NCT00607893|158325487|FG001|Overall Study|withdrew could not tolerate CPAP|1|||
49132301|NCT00607893|158325486|FG000|Overall Study|Declined to be treated|1|||
49132302|NCT00607893|158325487|FG001|Overall Study|Declined to be treated|0|||
49132303|NCT00607893|158325486|FG000|Overall Study|Withdrew due to hypertensive urgency|1|||
49132304|NCT00607893|158325487|FG001|Overall Study|Withdrew due to hypertensive urgency|1|||
49132305|NCT03979313|158325492|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|3|||
49132306|NCT03979313|158325493|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|9|||
49132307|NCT03979313|158325492|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|3|||
49132308|NCT03979313|158325493|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|4|||
49132309|NCT03979313|158325492|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Death|0|||
49132310|NCT03979313|158325493|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Death|4|||
49132311|NCT03979313|158325492|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|14|||
49132312|NCT03979313|158325493|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|20|||
49132313|NCT03979313|158325492|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|1|||
49132314|NCT03979313|158325493|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|3|||
48723924|NCT01261312|156840405|FG004|DE Phase: r/r AML (Week 75-242)|HCT|3|||
49132315|NCT03979313|158325492|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|432|||
49132316|NCT03979313|158325493|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|865|||
49132317|NCT03979313|158325492|FG000|All Subjects|Any Other Reason|16|||
49132318|NCT03979313|158325493|FG001|All Subjects|Any Other Reason|23|||
49132319|NCT03979313|158325492|FG000|All Subjects|Covid-19|1|||
49132320|NCT03979313|158325493|FG001|All Subjects|Covid-19|3|||
48818362|NCT04102540|157178491|FG000|Overall Study|Withdrawn by PI|2|||
48818363|NCT04102540|157178491|FG000|Overall Study|Lost to Follow-up|6|||
48818364|NCT04467840|157178492|FG000|Overall Study|Death|35|||
48818365|NCT04467840|157178493|FG001|Overall Study|Death|39|||
48818366|NCT04467840|157178492|FG000|Overall Study|Withdrawal by Subject|8|||
48818367|NCT04467840|157178493|FG001|Overall Study|Withdrawal by Subject|4|||
48818368|NCT04467840|157178492|FG000|Overall Study|Adverse Event|2|||
48818369|NCT04467840|157178493|FG001|Overall Study|Adverse Event|0|||
48818370|NCT04467840|157178492|FG000|Overall Study|Lost to Follow-up|1|||
48818371|NCT04467840|157178493|FG001|Overall Study|Lost to Follow-up|3|||
48818372|NCT04467840|157178492|FG000|Overall Study|Physician Decision|1|||
48818373|NCT04467840|157178493|FG001|Overall Study|Physician Decision|0|||
48818374|NCT04467840|157178492|FG000|Overall Study|Other|1|||
48818375|NCT04467840|157178493|FG001|Overall Study|Other|5|||
48818376|NCT04467840|157178492|FG000|Overall Study|Missing study completion status|3|||
48818377|NCT04467840|157178493|FG001|Overall Study|Missing study completion status|1|||
48818378|NCT00280293|157178494|FG000|Overall Study|Protocol Violation|3|||
48818379|NCT00280293|157178495|FG001|Overall Study|Protocol Violation|0|||
48818380|NCT00280293|157178494|FG000|Overall Study|Physician Decision|5|||
48818381|NCT00280293|157178495|FG001|Overall Study|Physician Decision|4|||
49132321|NCT03979313|158325492|FG000|All Subjects|Withdrawal by Subject|35|||
49132322|NCT03979313|158325493|FG001|All Subjects|Withdrawal by Subject|44|||
49132323|NCT03979313|158325492|FG000|All Subjects|Death|0|||
49132324|NCT03979313|158325493|FG001|All Subjects|Death|5|||
49132325|NCT03979313|158325492|FG000|All Subjects|Lost to Follow-up|28|||
49132326|NCT03979313|158325493|FG001|All Subjects|Lost to Follow-up|61|||
49132327|NCT00089648|158325494|FG000|Overall Study|Adverse Event|7|||
49132328|NCT00089648|158325494|FG000|Overall Study|Withdrawal by Subject|1|||
49132329|NCT00089648|158325494|FG000|Overall Study|Lack of Efficacy|33|||
49132330|NCT00300053|158325495|FG000|Overall Study|Patient/Caregiver Preference|2|||
49132331|NCT00300053|158325496|FG001|Overall Study|Patient/Caregiver Preference|2|||
49132332|NCT00300053|158325497|FG002|Overall Study|Patient/Caregiver Preference|3|||
49132333|NCT00300053|158325495|FG000|Overall Study|Death|0|||
49132334|NCT00300053|158325496|FG001|Overall Study|Death|0|||
49132335|NCT00300053|158325497|FG002|Overall Study|Death|3|||
49132336|NCT00300053|158325495|FG000|Overall Study|Lost to Follow-up|0|||
49132337|NCT00300053|158325496|FG001|Overall Study|Lost to Follow-up|1|||
49132338|NCT00300053|158325497|FG002|Overall Study|Lost to Follow-up|0|||
49132339|NCT01125930|158325498|FG000|Overall Study|Adverse Event|0|||
49132340|NCT01125930|158325499|FG001|Overall Study|Adverse Event|1|||
49132341|NCT01125930|158325498|FG000|Overall Study|Withdrawal by Subject|1|||
49132342|NCT01125930|158325499|FG001|Overall Study|Withdrawal by Subject|6|||
49132343|NCT01125930|158325498|FG000|Overall Study|Protocol Violation|0|||
49132344|NCT01125930|158325499|FG001|Overall Study|Protocol Violation|1|||
49132345|NCT01125930|158325498|FG000|Overall Study|Lost to Follow-up|0|||
49132346|NCT01125930|158325499|FG001|Overall Study|Lost to Follow-up|2|||
49132347|NCT04400318|158325500|FG000|Overall Study|Adverse Event|1|||
49132348|NCT04400318|158325501|FG001|Overall Study|Adverse Event|0|||
49132349|NCT04400318|158325500|FG000|Overall Study|Withdrawal by Subject|1|||
49132350|NCT04400318|158325501|FG001|Overall Study|Withdrawal by Subject|1|||
49132351|NCT04400318|158325500|FG000|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|0|||
49132352|NCT04400318|158325501|FG001|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|3|||
49132353|NCT02026141|158325502|FG000|Overall Study|Protocol Violation|0|||
48818382|NCT00280293|157178494|FG000|Overall Study|Lost to Follow-up|14|||
48818383|NCT00280293|157178495|FG001|Overall Study|Lost to Follow-up|12|||
48818384|NCT00280293|157178494|FG000|Overall Study|Withdrawal by Subject|3|||
49132354|NCT02026141|158325503|FG001|Overall Study|Protocol Violation|1|||
48818385|NCT00280293|157178495|FG001|Overall Study|Withdrawal by Subject|5|||
48818386|NCT00280293|157178494|FG000|Overall Study|Incarceration/Legal Reasons|1|||
48818387|NCT00280293|157178495|FG001|Overall Study|Incarceration/Legal Reasons|1|||
48818388|NCT00280293|157178494|FG000|Overall Study|Adverse Event|0|||
48818389|NCT00280293|157178495|FG001|Overall Study|Adverse Event|1|||
48818390|NCT01720797|157178498|FG000|Overall Study|Withdrawal by Subject|3|||
49132355|NCT01991314|158325504|FG000|Overall Study|Adverse Event|5|||
49132356|NCT01991314|158325505|FG001|Overall Study|Adverse Event|1|||
49132357|NCT01991314|158325504|FG000|Overall Study|Lost to Follow-up|6|||
48818391|NCT01720797|157178499|FG001|Overall Study|Withdrawal by Subject|0|||
48818392|NCT01880554|157178506|FG000|Overall Study|Protocol Violation|14|||
48818393|NCT01880554|157178506|FG000|Overall Study|Simon's design requirements|2|||
48818394|NCT04227340|157178507|FG000|Overall Study|Withdrawal by Subject|3|||
48818395|NCT00570661|157178508|FG000|Overall Study|Disease worsening|5|||
49132358|NCT01991314|158325505|FG001|Overall Study|Lost to Follow-up|10|||
49132359|NCT00883181|158325506|FG000|Overall Study|Hematological Adverse Event|26|||
49132360|NCT00883181|158325506|FG000|Overall Study|Non-hematological Adverse Event|55|||
49132361|NCT00883181|158325506|FG000|Overall Study|Disease Progression|94|||
49132362|NCT00883181|158325506|FG000|Overall Study|Administrative Reason|24|||
49132363|NCT00883181|158325506|FG000|Overall Study|Withdrawal by Subject|4|||
49132364|NCT00883181|158325506|FG000|Overall Study|Death|31|||
49132365|NCT00883181|158325506|FG000|Overall Study|Other|38|||
48723925|NCT01261312|156840406|FG005|DE Phase: r/r AML (Week 75-242)|HCT|9|||
48723926|NCT01261312|156840407|FG006|DE Phase: r/r AML (Week 75-242)|HCT|0|||
48723927|NCT01261312|156840408|FG007|DE Phase: r/r AML (Week 75-242)|HCT|0|||
48723928|NCT01261312|156840409|FG008|DE Phase: r/r AML (Week 75-242)|HCT|0|||
48723929|NCT01261312|156840410|FG009|DE Phase: r/r AML (Week 75-242)|HCT|0|||
48723930|NCT01261312|156840411|FG010|DE Phase: r/r AML (Week 75-242)|HCT|0|||
48723931|NCT01261312|156840412|FG011|DE Phase: r/r AML (Week 75-242)|HCT|0|||
48723932|NCT01261312|156840413|FG012|DE Phase: r/r AML (Week 75-242)|HCT|0|||
48723933|NCT01261312|156840401|FG000|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
48723934|NCT01261312|156840402|FG001|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
48723935|NCT01261312|156840403|FG002|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
48723936|NCT01261312|156840404|FG003|DE Phase: r/r AML (Week 75-242)|Reason not Specified|1|||
48723937|NCT01261312|156840405|FG004|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
48723938|NCT01261312|156840406|FG005|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
48723939|NCT01261312|156840407|FG006|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
48723940|NCT01261312|156840408|FG007|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
48723941|NCT01261312|156840409|FG008|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
48723942|NCT01261312|156840410|FG009|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
48723943|NCT01261312|156840411|FG010|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
48723944|NCT01261312|156840412|FG011|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
48723945|NCT01261312|156840413|FG012|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
48723946|NCT01261312|156840401|FG000|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
48723947|NCT01261312|156840402|FG001|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
48723948|NCT01261312|156840403|FG002|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
48723949|NCT01261312|156840404|FG003|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
48723950|NCT01261312|156840405|FG004|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
48723951|NCT01261312|156840406|FG005|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
48723952|NCT01261312|156840407|FG006|DE Phase: TN AML (Week 85-283)|Progressive Disease|9|||
48723953|NCT01261312|156840408|FG007|DE Phase: TN AML (Week 85-283)|Progressive Disease|11|||
48723954|NCT01261312|156840409|FG008|DE Phase: TN AML (Week 85-283)|Progressive Disease|17|||
48723955|NCT01261312|156840410|FG009|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
48723956|NCT01261312|156840411|FG010|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
48723957|NCT01261312|156840412|FG011|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
48723958|NCT01261312|156840413|FG012|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
48723959|NCT01261312|156840401|FG000|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
48723960|NCT01261312|156840402|FG001|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
48723961|NCT01261312|156840403|FG002|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
48723962|NCT01261312|156840404|FG003|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
48723963|NCT01261312|156840405|FG004|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
48723964|NCT01261312|156840406|FG005|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
48723965|NCT01261312|156840407|FG006|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
48723966|NCT01261312|156840408|FG007|DE Phase: TN AML (Week 85-283)|Adverse Event|1|||
48723967|NCT01261312|156840409|FG008|DE Phase: TN AML (Week 85-283)|Adverse Event|2|||
48723968|NCT01261312|156840410|FG009|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
48723969|NCT01261312|156840411|FG010|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
48723970|NCT01261312|156840412|FG011|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
48723971|NCT01261312|156840413|FG012|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
48818396|NCT00570661|157178508|FG000|Overall Study|Unmet criterion of sufficient therapeutic response|1|||
49132366|NCT00883181|158325506|FG000|Overall Study|Protocol Deviation|3|||
49132367|NCT00883181|158325506|FG000|Overall Study|Noncompliance|3|||
49132368|NCT02472405|158325507|FG000|Overall Study|Lost to Follow-up|9|||
49132369|NCT02472405|158325507|FG000|Overall Study|Adverse Event|1|||
49132370|NCT03617588|158325508|FG000|Overall Study|Withdrawal by Subject|1|||
49132371|NCT03617588|158325509|FG001|Overall Study|Withdrawal by Subject|0|||
49132372|NCT01118299|158325510|FG000|Overall Study|Death|7|||
49132373|NCT01118299|158325511|FG001|Overall Study|Death|5|||
49132374|NCT01118299|158325510|FG000|Overall Study|Withdrawal by Subject|8|||
49132375|NCT01118299|158325511|FG001|Overall Study|Withdrawal by Subject|8|||
49132376|NCT01118299|158325510|FG000|Overall Study|Lost to Follow-up|2|||
49132377|NCT01118299|158325511|FG001|Overall Study|Lost to Follow-up|1|||
49132378|NCT01118299|158325510|FG000|Overall Study|Enrollment Closure, Protocol Amendment|6|||
49132379|NCT01118299|158325511|FG001|Overall Study|Enrollment Closure, Protocol Amendment|15|||
49132380|NCT04459338|158325512|FG000|Overall Study|Loss of IV during study|1|||
49132381|NCT04459338|158325513|FG001|Overall Study|Loss of IV during study|0|||
49132382|NCT02690727|158325514|FG000|Overall Study|Adverse Event|2|||
49132383|NCT02690727|158325515|FG001|Overall Study|Adverse Event|2|||
49132384|NCT03157089|158325516|FG000|Overall Study|Treated only with pembrolizumab|1|||
49132385|NCT03157089|158325517|FG001|Overall Study|Treated only with pembrolizumab|0|||
48723972|NCT01261312|156840401|FG000|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
49132386|NCT03157089|158325516|FG000|Overall Study|Adverse Event|5|||
49132387|NCT03157089|158325517|FG001|Overall Study|Adverse Event|4|||
48818397|NCT00570661|157178508|FG000|Overall Study|Adverse Event|1|||
48818398|NCT01076088|157178511|FG000|Overall Study|Adverse Event|1|||
48818399|NCT01076088|157178512|FG001|Overall Study|Adverse Event|6|||
48818400|NCT01076088|157178513|FG002|Overall Study|Adverse Event|3|||
48818401|NCT01076088|157178514|FG003|Overall Study|Adverse Event|2|||
48818402|NCT01076088|157178515|FG004|Overall Study|Adverse Event|3|||
48818403|NCT01076088|157178516|FG005|Overall Study|Adverse Event|3|||
48818404|NCT01076088|157178511|FG000|Overall Study|Lost to Follow-up|1|||
48818405|NCT01076088|157178512|FG001|Overall Study|Lost to Follow-up|1|||
48818406|NCT01076088|157178513|FG002|Overall Study|Lost to Follow-up|0|||
48818407|NCT01076088|157178514|FG003|Overall Study|Lost to Follow-up|1|||
48818408|NCT01076088|157178515|FG004|Overall Study|Lost to Follow-up|1|||
48818409|NCT01076088|157178516|FG005|Overall Study|Lost to Follow-up|2|||
48818410|NCT01076088|157178511|FG000|Overall Study|Non-compliance with study drug|0|||
48818411|NCT01076088|157178512|FG001|Overall Study|Non-compliance with study drug|0|||
48818412|NCT01076088|157178513|FG002|Overall Study|Non-compliance with study drug|0|||
48818413|NCT01076088|157178514|FG003|Overall Study|Non-compliance with study drug|1|||
48818414|NCT01076088|157178515|FG004|Overall Study|Non-compliance with study drug|0|||
48818415|NCT01076088|157178516|FG005|Overall Study|Non-compliance with study drug|0|||
48818416|NCT01076088|157178511|FG000|Overall Study|Physician Decision|1|||
48818417|NCT01076088|157178512|FG001|Overall Study|Physician Decision|3|||
48818418|NCT01076088|157178513|FG002|Overall Study|Physician Decision|0|||
48818419|NCT01076088|157178514|FG003|Overall Study|Physician Decision|1|||
48818420|NCT01076088|157178515|FG004|Overall Study|Physician Decision|1|||
48818421|NCT01076088|157178516|FG005|Overall Study|Physician Decision|0|||
48818422|NCT01076088|157178511|FG000|Overall Study|Withdrawal by Subject|8|||
48818423|NCT01076088|157178512|FG001|Overall Study|Withdrawal by Subject|8|||
48818424|NCT01076088|157178513|FG002|Overall Study|Withdrawal by Subject|14|||
48818425|NCT01076088|157178514|FG003|Overall Study|Withdrawal by Subject|10|||
48818426|NCT01076088|157178515|FG004|Overall Study|Withdrawal by Subject|11|||
48818427|NCT01076088|157178516|FG005|Overall Study|Withdrawal by Subject|17|||
48818428|NCT01076088|157178511|FG000|Overall Study|Other protocol specified criteria|0|||
48818429|NCT01076088|157178512|FG001|Overall Study|Other protocol specified criteria|0|||
48818430|NCT01076088|157178513|FG002|Overall Study|Other protocol specified criteria|0|||
48818431|NCT01076088|157178514|FG003|Overall Study|Other protocol specified criteria|0|||
48818432|NCT01076088|157178515|FG004|Overall Study|Other protocol specified criteria|0|||
48818433|NCT01076088|157178516|FG005|Overall Study|Other protocol specified criteria|1|||
48818434|NCT03053492|157178517|FG000|Overall Study|Adverse Event|1|||
48818435|NCT03053492|157178518|FG001|Overall Study|Adverse Event|1|||
48818436|NCT03053492|157178517|FG000|Overall Study|Withdrawal by Subject|7|||
48818437|NCT03053492|157178518|FG001|Overall Study|Withdrawal by Subject|5|||
48818438|NCT04537949|157178523|FG000|Treatment Phase|personal reasons not related to the IMP|1|||
48818439|NCT04537949|157178524|FG001|Treatment Phase|personal reasons not related to the IMP|0|||
48818440|NCT04537949|157178525|FG002|Treatment Phase|personal reasons not related to the IMP|0|||
48818441|NCT04537949|157178526|FG003|Treatment Phase|personal reasons not related to the IMP|0|||
48818442|NCT04537949|157178527|FG004|Treatment Phase|personal reasons not related to the IMP|0|||
48818443|NCT04537949|157178528|FG005|Treatment Phase|personal reasons not related to the IMP|0|||
48818444|NCT04537949|157178529|FG006|Treatment Phase|personal reasons not related to the IMP|0|||
48818445|NCT04537949|157178530|FG007|Treatment Phase|personal reasons not related to the IMP|0|||
48818446|NCT04537949|157178523|FG000|Follow-up Phase|Roll-over into trial BNT162-14|3|||
48818447|NCT04537949|157178524|FG001|Follow-up Phase|Roll-over into trial BNT162-14|1|||
48818448|NCT04537949|157178525|FG002|Follow-up Phase|Roll-over into trial BNT162-14|0|||
48818449|NCT04537949|157178526|FG003|Follow-up Phase|Roll-over into trial BNT162-14|2|||
48818450|NCT04537949|157178527|FG004|Follow-up Phase|Roll-over into trial BNT162-14|1|||
48818451|NCT04537949|157178528|FG005|Follow-up Phase|Roll-over into trial BNT162-14|1|||
48818452|NCT04537949|157178529|FG006|Follow-up Phase|Roll-over into trial BNT162-14|5|||
48818453|NCT04537949|157178530|FG007|Follow-up Phase|Roll-over into trial BNT162-14|6|||
48818454|NCT04537949|157178523|FG000|Follow-up Phase|Lost to Follow-up|0|||
48723973|NCT01261312|156840402|FG001|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
48723974|NCT01261312|156840403|FG002|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
48723975|NCT01261312|156840404|FG003|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
48723976|NCT01261312|156840405|FG004|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
48723977|NCT01261312|156840406|FG005|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
48723978|NCT01261312|156840407|FG006|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
48723979|NCT01261312|156840408|FG007|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
48723980|NCT01261312|156840409|FG008|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
49132388|NCT03157089|158325516|FG000|Overall Study|Progressive disease|6|||
48723981|NCT01261312|156840410|FG009|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
48818455|NCT04537949|157178524|FG001|Follow-up Phase|Lost to Follow-up|3|||
49132389|NCT03157089|158325517|FG001|Overall Study|Progressive disease|8|||
48723982|NCT01261312|156840411|FG010|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
48818456|NCT04537949|157178525|FG002|Follow-up Phase|Lost to Follow-up|0|||
48818457|NCT04537949|157178526|FG003|Follow-up Phase|Lost to Follow-up|0|||
48818458|NCT04537949|157178527|FG004|Follow-up Phase|Lost to Follow-up|0|||
48818459|NCT04537949|157178528|FG005|Follow-up Phase|Lost to Follow-up|0|||
48818460|NCT04537949|157178529|FG006|Follow-up Phase|Lost to Follow-up|0|||
48818461|NCT04537949|157178530|FG007|Follow-up Phase|Lost to Follow-up|0|||
48818462|NCT04537949|157178523|FG000|Follow-up Phase|personal reasons|0|||
48818463|NCT04537949|157178524|FG001|Follow-up Phase|personal reasons|0|||
48818464|NCT04537949|157178525|FG002|Follow-up Phase|personal reasons|0|||
48818465|NCT04537949|157178526|FG003|Follow-up Phase|personal reasons|1|||
48818466|NCT04537949|157178527|FG004|Follow-up Phase|personal reasons|1|||
48818467|NCT04537949|157178528|FG005|Follow-up Phase|personal reasons|0|||
48818468|NCT04537949|157178529|FG006|Follow-up Phase|personal reasons|0|||
48818469|NCT04537949|157178530|FG007|Follow-up Phase|personal reasons|0|||
49132390|NCT04018066|158325520|FG000|Overall Study|participants started taking medications during the study period|3|||
49132391|NCT04018066|158325520|FG000|Overall Study|participant dropped out due to schedule conflicts.|1|||
49132392|NCT03817528|158325521|FG000|Overall Study|Withdrawal by Subject|1|||
49132393|NCT03817528|158325521|FG000|Overall Study|Adverse Event|2|||
49132394|NCT00091819|158325525|FG000|Overall Study|Adverse Event|1|||
49132395|NCT00091819|158325526|FG001|Overall Study|Adverse Event|1|||
49132396|NCT00091819|158325525|FG000|Overall Study|Death|4|||
49132397|NCT00091819|158325526|FG001|Overall Study|Death|5|||
48818470|NCT04537949|157178523|FG000|Follow-up Phase|Withdrawal by Subject|0|||
48818471|NCT04537949|157178524|FG001|Follow-up Phase|Withdrawal by Subject|0|||
48818472|NCT04537949|157178525|FG002|Follow-up Phase|Withdrawal by Subject|0|||
48818473|NCT04537949|157178526|FG003|Follow-up Phase|Withdrawal by Subject|0|||
48818474|NCT04537949|157178527|FG004|Follow-up Phase|Withdrawal by Subject|1|||
48818475|NCT04537949|157178528|FG005|Follow-up Phase|Withdrawal by Subject|0|||
48818476|NCT04537949|157178529|FG006|Follow-up Phase|Withdrawal by Subject|0|||
48818477|NCT04537949|157178530|FG007|Follow-up Phase|Withdrawal by Subject|0|||
48818478|NCT00322374|157178531|FG000|Starting Dose|Physician Decision|2|||
48818479|NCT00322374|157178532|FG001|Starting Dose|Physician Decision|0|||
48818480|NCT00322374|157178533|FG002|Starting Dose|Physician Decision|0|||
48818481|NCT00322374|157178534|FG003|Starting Dose|Physician Decision|0|||
48818482|NCT00322374|157178531|FG000|Starting Dose|Study Drug Toxicity|4|||
48818483|NCT00322374|157178532|FG001|Starting Dose|Study Drug Toxicity|0|||
48818484|NCT00322374|157178533|FG002|Starting Dose|Study Drug Toxicity|0|||
48818485|NCT00322374|157178534|FG003|Starting Dose|Study Drug Toxicity|0|||
48818486|NCT00322374|157178531|FG000|First Escalation|Documented Disease Progression|0|||
48818487|NCT00322374|157178532|FG001|First Escalation|Documented Disease Progression|6|||
48818488|NCT00322374|157178533|FG002|First Escalation|Documented Disease Progression|0|||
48818489|NCT00322374|157178534|FG003|First Escalation|Documented Disease Progression|0|||
48818490|NCT00322374|157178531|FG000|First Escalation|Physician Decision|0|||
48818491|NCT00322374|157178532|FG001|First Escalation|Physician Decision|12|||
48818492|NCT00322374|157178533|FG002|First Escalation|Physician Decision|0|||
48818493|NCT00322374|157178534|FG003|First Escalation|Physician Decision|0|||
48818494|NCT00322374|157178531|FG000|First Escalation|Study Drug Toxicity|0|||
48818495|NCT00322374|157178532|FG001|First Escalation|Study Drug Toxicity|11|||
48818496|NCT00322374|157178533|FG002|First Escalation|Study Drug Toxicity|0|||
48818497|NCT00322374|157178534|FG003|First Escalation|Study Drug Toxicity|0|||
48818498|NCT00322374|157178531|FG000|First Escalation|Participant Request|0|||
48818499|NCT00322374|157178532|FG001|First Escalation|Participant Request|1|||
48818500|NCT00322374|157178533|FG002|First Escalation|Participant Request|0|||
48818501|NCT00322374|157178534|FG003|First Escalation|Participant Request|0|||
48818502|NCT00322374|157178531|FG000|Second Escalation|Physician Decision|0|||
48818503|NCT00322374|157178532|FG001|Second Escalation|Physician Decision|0|||
48818504|NCT00322374|157178533|FG002|Second Escalation|Physician Decision|5|||
48818505|NCT00322374|157178534|FG003|Second Escalation|Physician Decision|0|||
48818506|NCT00322374|157178531|FG000|Second Escalation|Study Drug Toxicity|0|||
48818507|NCT00322374|157178532|FG001|Second Escalation|Study Drug Toxicity|0|||
48818508|NCT00322374|157178533|FG002|Second Escalation|Study Drug Toxicity|1|||
48818509|NCT00322374|157178534|FG003|Second Escalation|Study Drug Toxicity|0|||
48818510|NCT00681187|157178537|FG000|Overall Study|Withdrawal by Subject|1|||
48818511|NCT00681187|157178538|FG001|Overall Study|Withdrawal by Subject|0|||
48818512|NCT00681187|157178537|FG000|Overall Study|Death|0|||
48818513|NCT00681187|157178538|FG001|Overall Study|Death|1|||
48818514|NCT00681187|157178537|FG000|Overall Study|Adverse Event|0|||
48818515|NCT00681187|157178538|FG001|Overall Study|Adverse Event|1|||
48818516|NCT01708187|157178539|FG000|Overall Study|Lost to Follow-up|0|||
48818517|NCT01708187|157178540|FG001|Overall Study|Lost to Follow-up|1|||
48818518|NCT02117544|157178541|FG000|Period 1|Lost to follow-up (prior to treatment)|2|||
48818519|NCT02117544|157178542|FG001|Period 1|Lost to follow-up (prior to treatment)|0|||
48818520|NCT01991197|157178543|FG000|Overall Study|Lost to Follow-up|1|||
48818521|NCT01991197|157178544|FG001|Overall Study|Lost to Follow-up|1|||
48818522|NCT01991197|157178543|FG000|Overall Study|Physician Decision|0|||
48818523|NCT01991197|157178544|FG001|Overall Study|Physician Decision|2|||
48818524|NCT01991197|157178543|FG000|Overall Study|Withdrawal by Subject|2|||
48818525|NCT01991197|157178544|FG001|Overall Study|Withdrawal by Subject|0|||
48818526|NCT03293485|157178545|FG000|Overall Study|Death|1|||
49132398|NCT00091819|158325525|FG000|Overall Study|Lost to Follow-up|26|||
48818527|NCT03293485|157178545|FG000|Overall Study|Screen Failure|2|||
48818528|NCT03293485|157178545|FG000|Overall Study|Withdrawal by Subject|2|||
48818529|NCT01010217|157178546|FG000|Overall Study|Lost to Follow-up|4|||
48818530|NCT01010217|157178547|FG001|Overall Study|Lost to Follow-up|5|||
48818531|NCT01010217|157178548|FG002|Overall Study|Lost to Follow-up|1|||
48818532|NCT01010217|157178549|FG003|Overall Study|Lost to Follow-up|0|||
48818533|NCT01010217|157178550|FG004|Overall Study|Lost to Follow-up|0|||
48818534|NCT01010217|157178546|FG000|Overall Study|Withdrawal by Subject|1|||
48818535|NCT01010217|157178547|FG001|Overall Study|Withdrawal by Subject|0|||
48818536|NCT01010217|157178548|FG002|Overall Study|Withdrawal by Subject|0|||
48818537|NCT01010217|157178549|FG003|Overall Study|Withdrawal by Subject|0|||
48818538|NCT01010217|157178550|FG004|Overall Study|Withdrawal by Subject|0|||
48818539|NCT01010217|157178546|FG000|Overall Study|Physician Decision|0|||
48818540|NCT01010217|157178547|FG001|Overall Study|Physician Decision|0|||
48818541|NCT01010217|157178548|FG002|Overall Study|Physician Decision|0|||
48818542|NCT01010217|157178549|FG003|Overall Study|Physician Decision|6|||
48818543|NCT01010217|157178550|FG004|Overall Study|Physician Decision|3|||
48818544|NCT01767129|157178551|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
48818545|NCT01767129|157178552|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
48818546|NCT03785340|157178556|FG000|Overall Study|Lost to Follow-up|2|||
48818547|NCT03785340|157178557|FG001|Overall Study|Lost to Follow-up|0|||
48818548|NCT03785340|157178556|FG000|Overall Study|Adverse Event|1|||
48818549|NCT03785340|157178557|FG001|Overall Study|Adverse Event|0|||
48818550|NCT02274662|157178558|FG000|Overall Study|Death|1|||
48818551|NCT02274662|157178558|FG000|Overall Study|Lost to Follow-up|3|||
48818552|NCT05459688|157178561|FG000|Overall Study|Lost to Follow-up|6|||
48818553|NCT05459688|157178561|FG000|Overall Study|Physician Decision|1|||
48818554|NCT05459688|157178561|FG000|Overall Study|Withdrawal by Subject|19|||
48818555|NCT05459688|157178561|FG000|Overall Study|Noncompliance, Subject unable to complete last visit.|3|||
48818556|NCT04640571|157178562|FG000|Overall Study|Withdrawal by Subject|0|||
48818557|NCT04640571|157178563|FG001|Overall Study|Withdrawal by Subject|0|||
48818558|NCT04640571|157178564|FG002|Overall Study|Withdrawal by Subject|0|||
48818559|NCT04640571|157178565|FG003|Overall Study|Withdrawal by Subject|0|||
48818560|NCT04640571|157178566|FG004|Overall Study|Withdrawal by Subject|0|||
48818561|NCT04640571|157178567|FG005|Overall Study|Withdrawal by Subject|2|||
48818562|NCT02844465|157178573|FG000|Overall Study|Screen Failure|36|||
48818563|NCT02844465|157178573|FG000|Overall Study|Withdrawal Prior to Procedure|17|||
48818564|NCT02844465|157178573|FG000|Overall Study|Withdrawal by Subject|5|||
48818565|NCT02844465|157178573|FG000|Overall Study|Lost to Follow-up|1|||
48818566|NCT02844465|157178573|FG000|Overall Study|Retreatment|1|||
48818567|NCT01828099|157178574|FG000|Treatment Period|Adverse Event|24|||
48818568|NCT01828099|157178575|FG001|Treatment Period|Adverse Event|23|||
48818569|NCT01828099|157178574|FG000|Treatment Period|Death|10|||
48818570|NCT01828099|157178575|FG001|Treatment Period|Death|12|||
48818571|NCT01828099|157178574|FG000|Treatment Period|Lost to Follow-up|2|||
48818572|NCT01828099|157178575|FG001|Treatment Period|Lost to Follow-up|1|||
48818573|NCT01828099|157178574|FG000|Treatment Period|Non-compliance with study treatment|1|||
48818574|NCT01828099|157178575|FG001|Treatment Period|Non-compliance with study treatment|0|||
48818575|NCT01828099|157178574|FG000|Treatment Period|Physician Decision|17|||
48818576|NCT01828099|157178575|FG001|Treatment Period|Physician Decision|16|||
48818577|NCT01828099|157178574|FG000|Treatment Period|Progressive disease|99|||
48818578|NCT01828099|157178575|FG001|Treatment Period|Progressive disease|107|||
48723983|NCT01261312|156840412|FG011|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
48818579|NCT01828099|157178574|FG000|Treatment Period|Subject/guardian decision|22|||
48818580|NCT01828099|157178575|FG001|Treatment Period|Subject/guardian decision|26|||
48818581|NCT01828099|157178574|FG000|Treatment Period|Study terminated by Sponsor|13|||
48818582|NCT01828099|157178575|FG001|Treatment Period|Study terminated by Sponsor|1|||
48818583|NCT01828099|157178574|FG000|Treatment Period|Protocol deviation|1|||
48818584|NCT01828099|157178575|FG001|Treatment Period|Protocol deviation|0|||
48818585|NCT01828099|157178574|FG000|Treatment Period|No longer requires treatment|0|||
48818586|NCT01828099|157178575|FG001|Treatment Period|No longer requires treatment|1|||
48723984|NCT01261312|156840413|FG012|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
48723985|NCT01261312|156840401|FG000|DE Phase: TN AML (Week 85-283)|Death|0|||
48723986|NCT01261312|156840402|FG001|DE Phase: TN AML (Week 85-283)|Death|0|||
48723987|NCT01261312|156840403|FG002|DE Phase: TN AML (Week 85-283)|Death|0|||
48723988|NCT01261312|156840404|FG003|DE Phase: TN AML (Week 85-283)|Death|0|||
48723989|NCT01261312|156840405|FG004|DE Phase: TN AML (Week 85-283)|Death|0|||
48723990|NCT01261312|156840406|FG005|DE Phase: TN AML (Week 85-283)|Death|0|||
48723991|NCT01261312|156840407|FG006|DE Phase: TN AML (Week 85-283)|Death|4|||
48723992|NCT01261312|156840408|FG007|DE Phase: TN AML (Week 85-283)|Death|7|||
48818587|NCT01828099|157178574|FG000|Extension-treatment Phase|Adverse Event|0|||
48723993|NCT01261312|156840409|FG008|DE Phase: TN AML (Week 85-283)|Death|11|||
48818588|NCT01828099|157178575|FG001|Extension-treatment Phase|Adverse Event|17|||
48723994|NCT01261312|156840410|FG009|DE Phase: TN AML (Week 85-283)|Death|0|||
48723995|NCT01261312|156840411|FG010|DE Phase: TN AML (Week 85-283)|Death|0|||
48723996|NCT01261312|156840412|FG011|DE Phase: TN AML (Week 85-283)|Death|0|||
48818589|NCT01828099|157178574|FG000|Extension-treatment Phase|Death|0|||
48818590|NCT01828099|157178575|FG001|Extension-treatment Phase|Death|11|||
48818591|NCT01828099|157178574|FG000|Extension-treatment Phase|Physician Decision|0|||
48818592|NCT01828099|157178575|FG001|Extension-treatment Phase|Physician Decision|5|||
48818593|NCT01828099|157178574|FG000|Extension-treatment Phase|Progressive disease|0|||
48818594|NCT01828099|157178575|FG001|Extension-treatment Phase|Progressive disease|54|||
48818595|NCT01828099|157178574|FG000|Extension-treatment Phase|Study terminated by sponsor|0|||
48818596|NCT01828099|157178575|FG001|Extension-treatment Phase|Study terminated by sponsor|5|||
48818597|NCT01828099|157178574|FG000|Extension-treatment Phase|Subject/guardian decision|0|||
48818598|NCT01828099|157178575|FG001|Extension-treatment Phase|Subject/guardian decision|10|||
48818599|NCT05446870|157178576|FG000|Overall Study|Death|6|||
48818600|NCT05446870|157178577|FG001|Overall Study|Death|2|||
48818601|NCT05446870|157178576|FG000|Overall Study|Lost to Follow-up|0|||
48818602|NCT05446870|157178577|FG001|Overall Study|Lost to Follow-up|1|||
48818603|NCT05446870|157178576|FG000|Overall Study|Physician Decision|27|||
48818604|NCT05446870|157178577|FG001|Overall Study|Physician Decision|25|||
48818605|NCT05446870|157178576|FG000|Overall Study|Withdrawal by Subject|3|||
49132399|NCT00091819|158325526|FG001|Overall Study|Lost to Follow-up|23|||
49132400|NCT00091819|158325525|FG000|Overall Study|Withdrawal by Subject|5|||
49132401|NCT00091819|158325526|FG001|Overall Study|Withdrawal by Subject|8|||
49132402|NCT00091819|158325525|FG000|Overall Study|Protocol Violation|1|||
49132403|NCT00091819|158325526|FG001|Overall Study|Protocol Violation|2|||
49132404|NCT00091819|158325525|FG000|Overall Study|Other|2|||
49132405|NCT00091819|158325526|FG001|Overall Study|Other|3|||
49132406|NCT00091819|158325525|FG000|Overall Study|Never received study treatment|3|||
49132407|NCT00091819|158325526|FG001|Overall Study|Never received study treatment|4|||
49132408|NCT00116142|158325528|FG000|Overall Study|Adverse Event|8|||
49132409|NCT00116142|158325529|FG001|Overall Study|Adverse Event|7|||
49132410|NCT00116142|158325528|FG000|Overall Study|Protocol Violation|2|||
49132411|NCT00116142|158325529|FG001|Overall Study|Protocol Violation|1|||
49132412|NCT00116142|158325528|FG000|Overall Study|Withdrawal by Subject|5|||
49132413|NCT00116142|158325529|FG001|Overall Study|Withdrawal by Subject|5|||
49132414|NCT00116142|158325528|FG000|Overall Study|Physician Decision|3|||
49132415|NCT00116142|158325529|FG001|Overall Study|Physician Decision|1|||
49132416|NCT00116142|158325528|FG000|Overall Study|Delayed Radiation Therapy|1|||
49132417|NCT00116142|158325529|FG001|Overall Study|Delayed Radiation Therapy|0|||
49132418|NCT00116142|158325528|FG000|Overall Study|Patient could not tolerate docetaxel|0|||
49132419|NCT00116142|158325529|FG001|Overall Study|Patient could not tolerate docetaxel|2|||
49132420|NCT00116142|158325528|FG000|Overall Study|Patient stopped due to depression|0|||
49132421|NCT00116142|158325529|FG001|Overall Study|Patient stopped due to depression|1|||
49132422|NCT00116142|158325528|FG000|Overall Study|Patient stopped due to bilateral ruptured tendons|0|||
49132423|NCT00116142|158325529|FG001|Overall Study|Patient stopped due to bilateral ruptured tendons|1|||
49132424|NCT00116142|158325528|FG000|Overall Study|Patient didn't start due to diagnosis of colon cancer|0|||
49132425|NCT00116142|158325529|FG001|Overall Study|Patient didn't start due to diagnosis of colon cancer|1|||
49132426|NCT00116142|158325528|FG000|Overall Study|Patient didn't start due to low platelet counts|0|||
49132427|NCT00116142|158325529|FG001|Overall Study|Patient didn't start due to low platelet counts|1|||
49132428|NCT00433836|158325530|FG000|Overall Study|Adverse Event|7|||
49132429|NCT00433836|158325531|FG001|Overall Study|Adverse Event|0|||
49132430|NCT00433836|158325530|FG000|Overall Study|Lost to Follow-up|3|||
49132431|NCT00433836|158325531|FG001|Overall Study|Lost to Follow-up|0|||
49132432|NCT00433836|158325530|FG000|Overall Study|Withdrawal by Subject|2|||
49132433|NCT00433836|158325531|FG001|Overall Study|Withdrawal by Subject|1|||
49132434|NCT00433836|158325530|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
49132435|NCT00433836|158325531|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
49132436|NCT00433836|158325530|FG000|Overall Study|Protocol Violation|0|||
49132437|NCT00433836|158325531|FG001|Overall Study|Protocol Violation|2|||
49132438|NCT00433836|158325530|FG000|Overall Study|Condition no longer requires study drug|0|||
49132439|NCT00433836|158325531|FG001|Overall Study|Condition no longer requires study drug|1|||
49132440|NCT00433836|158325530|FG000|Overall Study|Abnormal laboratory values|0|||
49132441|NCT00433836|158325531|FG001|Overall Study|Abnormal laboratory values|1|||
49132442|NCT00851591|158325534|FG000|Overall Study|Withdrawal by Subject|2|||
49132443|NCT00851591|158325535|FG001|Overall Study|Withdrawal by Subject|0|||
49132444|NCT03558516|158325536|FG000|Overall Study|Protocol Violation|2|||
48818606|NCT05446870|157178577|FG001|Overall Study|Withdrawal by Subject|2|||
48818607|NCT05446870|157178576|FG000|Overall Study|Study Ongoing|37|||
48818608|NCT05446870|157178577|FG001|Overall Study|Study Ongoing|43|||
49132445|NCT03558516|158325537|FG001|Overall Study|Protocol Violation|2|||
49132446|NCT02469857|158325538|FG000|Overall Study|Death|24|||
48818609|NCT03030261|157178580|FG000|Overall Study|Still receiving continuation therapy|5|||
48818610|NCT04793464|157178581|FG000|Overall Study|Lost to Follow-up|458|||
49132447|NCT02469857|158325539|FG001|Overall Study|Death|29|||
49132448|NCT02469857|158325538|FG000|Overall Study|Discontinuation|1|||
49132449|NCT02469857|158325539|FG001|Overall Study|Discontinuation|3|||
49132450|NCT00142415|158325540|FG000|Overall Study|Physician Decision|0|||
49132451|NCT00142415|158325541|FG001|Overall Study|Physician Decision|0|||
49132452|NCT00142415|158325542|FG002|Overall Study|Physician Decision|0|||
48723997|NCT01261312|156840413|FG012|DE Phase: TN AML (Week 85-283)|Death|0|||
48723998|NCT01261312|156840401|FG000|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
48723999|NCT01261312|156840402|FG001|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
48724000|NCT01261312|156840403|FG002|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
48724001|NCT01261312|156840404|FG003|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
48724002|NCT01261312|156840405|FG004|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
48724003|NCT01261312|156840406|FG005|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
48724004|NCT01261312|156840407|FG006|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
48724005|NCT01261312|156840408|FG007|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
48724006|NCT01261312|156840409|FG008|DE Phase: TN AML (Week 85-283)|Investigator Decision|9|||
48724007|NCT01261312|156840410|FG009|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
48724008|NCT01261312|156840411|FG010|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
48724009|NCT01261312|156840412|FG011|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
48724010|NCT01261312|156840413|FG012|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
48724011|NCT01261312|156840401|FG000|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
48724012|NCT01261312|156840402|FG001|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
48724013|NCT01261312|156840403|FG002|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
48724014|NCT01261312|156840404|FG003|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
48724015|NCT01261312|156840405|FG004|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
48724016|NCT01261312|156840406|FG005|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
48724017|NCT01261312|156840407|FG006|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
48724018|NCT01261312|156840408|FG007|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|1|||
48724019|NCT01261312|156840409|FG008|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
48724020|NCT01261312|156840410|FG009|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
48724021|NCT01261312|156840411|FG010|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
48724022|NCT01261312|156840412|FG011|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
48724023|NCT01261312|156840413|FG012|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
48724024|NCT01261312|156840401|FG000|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
48724025|NCT01261312|156840402|FG001|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
48724026|NCT01261312|156840403|FG002|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
48724027|NCT01261312|156840404|FG003|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
48724028|NCT01261312|156840405|FG004|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
48724029|NCT01261312|156840406|FG005|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
48724030|NCT01261312|156840407|FG006|DE Phase: TN AML (Week 85-283)|Reason not Specified|5|||
48724031|NCT01261312|156840408|FG007|DE Phase: TN AML (Week 85-283)|Reason not Specified|1|||
48724032|NCT01261312|156840409|FG008|DE Phase: TN AML (Week 85-283)|Reason not Specified|6|||
48724033|NCT01261312|156840410|FG009|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
48724034|NCT01261312|156840411|FG010|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
48724035|NCT01261312|156840412|FG011|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
48724036|NCT01261312|156840413|FG012|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
49132453|NCT00142415|158325543|FG003|Overall Study|Physician Decision|0|||
49132454|NCT00142415|158325544|FG004|Overall Study|Physician Decision|1|||
49132455|NCT00142415|158325545|FG005|Overall Study|Physician Decision|2|||
49132456|NCT01553851|158325549|FG000|Overall Study|Adverse Event|2|||
49132457|NCT01553851|158325549|FG000|Overall Study|constipation|1|||
49132458|NCT02472353|158325551|FG000|Overall Study|Lost to Follow-up|1|||
49132459|NCT02472353|158325552|FG001|Overall Study|Lost to Follow-up|1|||
49132460|NCT02472353|158325551|FG000|Overall Study|Withdrawal by Subject|2|||
49132461|NCT02472353|158325552|FG001|Overall Study|Withdrawal by Subject|1|||
49132462|NCT02472353|158325551|FG000|Overall Study|Study Termination|1|||
49132463|NCT02472353|158325552|FG001|Overall Study|Study Termination|4|||
49132464|NCT00797563|158325553|FG000|Overall Study|Adverse Event|1|||
49132465|NCT00701363|158325554|FG000|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4|||
49132466|NCT00701363|158325555|FG001|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
49132467|NCT00701363|158325556|FG002|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
49132468|NCT00701363|158325557|FG003|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
49132469|NCT00701363|158325554|FG000|Treatment Phase 1|Does not meet entry Criteria|1|||
49132470|NCT00701363|158325555|FG001|Treatment Phase 1|Does not meet entry Criteria|0|||
49132471|NCT00701363|158325556|FG002|Treatment Phase 1|Does not meet entry Criteria|0|||
49132472|NCT00701363|158325557|FG003|Treatment Phase 1|Does not meet entry Criteria|0|||
49132473|NCT00701363|158325554|FG000|Treatment Phase 1|Adverse Event|7|||
49132474|NCT00701363|158325555|FG001|Treatment Phase 1|Adverse Event|0|||
49132475|NCT00701363|158325556|FG002|Treatment Phase 1|Adverse Event|0|||
49132476|NCT00701363|158325557|FG003|Treatment Phase 1|Adverse Event|0|||
49132477|NCT00701363|158325554|FG000|Treatment Phase 1|Protocol Violation|1|||
49132478|NCT00701363|158325555|FG001|Treatment Phase 1|Protocol Violation|0|||
49132479|NCT00701363|158325556|FG002|Treatment Phase 1|Protocol Violation|0|||
48818611|NCT04793464|157178582|FG001|Overall Study|Lost to Follow-up|168|||
48818612|NCT04793464|157178583|FG002|Overall Study|Lost to Follow-up|5|||
48818613|NCT04793464|157178581|FG000|Overall Study|Withdrawal by Subject|43|||
48818614|NCT04793464|157178582|FG001|Overall Study|Withdrawal by Subject|15|||
49132480|NCT00701363|158325557|FG003|Treatment Phase 1|Protocol Violation|0|||
49132481|NCT00701363|158325554|FG000|Treatment Phase 1|Withdrawal by Subject|5|||
49132482|NCT00701363|158325555|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
49132483|NCT00701363|158325556|FG002|Treatment Phase 1|Withdrawal by Subject|0|||
49132484|NCT00701363|158325557|FG003|Treatment Phase 1|Withdrawal by Subject|0|||
49132485|NCT00701363|158325554|FG000|Treatment Phase 1|Lack of Efficacy|1|||
49132486|NCT00701363|158325555|FG001|Treatment Phase 1|Lack of Efficacy|0|||
49132487|NCT00701363|158325556|FG002|Treatment Phase 1|Lack of Efficacy|0|||
49132488|NCT00701363|158325557|FG003|Treatment Phase 1|Lack of Efficacy|0|||
49132489|NCT00701363|158325554|FG000|Treatment Phase 2|Adverse Event|0|||
49132490|NCT00701363|158325555|FG001|Treatment Phase 2|Adverse Event|0|||
49132491|NCT00701363|158325556|FG002|Treatment Phase 2|Adverse Event|1|||
49132492|NCT00701363|158325557|FG003|Treatment Phase 2|Adverse Event|0|||
49132493|NCT00701363|158325554|FG000|Treatment Phase 2|Withdrawal by Subject|0|||
49132494|NCT00701363|158325555|FG001|Treatment Phase 2|Withdrawal by Subject|0|||
49132495|NCT00701363|158325556|FG002|Treatment Phase 2|Withdrawal by Subject|1|||
49132496|NCT00701363|158325557|FG003|Treatment Phase 2|Withdrawal by Subject|0|||
49132497|NCT02722967|158325561|FG000|Overall Study|Adverse Event|1|||
49132498|NCT02722967|158325562|FG001|Overall Study|Adverse Event|0|||
49132499|NCT02722967|158325563|FG002|Overall Study|Adverse Event|0|||
49132500|NCT02722967|158325561|FG000|Overall Study|Lost to Follow-up|0|||
49132501|NCT02722967|158325562|FG001|Overall Study|Lost to Follow-up|1|||
48818615|NCT04793464|157178583|FG002|Overall Study|Withdrawal by Subject|0|||
48818616|NCT02234310|157178586|FG000|Overall Study|Physician Decision|1|||
49132502|NCT02722967|158325563|FG002|Overall Study|Lost to Follow-up|0|||
49132503|NCT02722967|158325561|FG000|Overall Study|Non-compliance with patch wearing|2|||
49132504|NCT02722967|158325562|FG001|Overall Study|Non-compliance with patch wearing|1|||
49132505|NCT02722967|158325563|FG002|Overall Study|Non-compliance with patch wearing|1|||
49132506|NCT02722967|158325561|FG000|Overall Study|Withdrawal by Subject|1|||
49132507|NCT02722967|158325562|FG001|Overall Study|Withdrawal by Subject|0|||
49132508|NCT02722967|158325563|FG002|Overall Study|Withdrawal by Subject|1|||
49132509|NCT02722967|158325561|FG000|Overall Study|Physician Decision|1|||
49132510|NCT02722967|158325562|FG001|Overall Study|Physician Decision|0|||
49132511|NCT02722967|158325563|FG002|Overall Study|Physician Decision|0|||
49132512|NCT02722967|158325561|FG000|Overall Study|Non-adherence of the patch to the skin|0|||
49132513|NCT02722967|158325562|FG001|Overall Study|Non-adherence of the patch to the skin|0|||
49132514|NCT02722967|158325563|FG002|Overall Study|Non-adherence of the patch to the skin|2|||
49132515|NCT00695019|158325564|FG000|Overall Study|Withdrawal by Subject|8|||
48818617|NCT02234310|157178586|FG000|Overall Study|Adverse Event|1|||
48818618|NCT02234310|157178586|FG000|Overall Study|Eligibility Criteria not fulfilled|2|||
48818619|NCT02234310|157178586|FG000|Overall Study|Withdrawal by Subject|2|||
48818620|NCT02487446|157178587|FG000|Period 1|Physician Decision|0|||
49132516|NCT00695019|158325565|FG001|Overall Study|Withdrawal by Subject|6|||
49132517|NCT00695019|158325566|FG002|Overall Study|Withdrawal by Subject|4|||
49132518|NCT00695019|158325564|FG000|Overall Study|Protocol Violation|1|||
49132519|NCT00695019|158325565|FG001|Overall Study|Protocol Violation|3|||
48818621|NCT02487446|157178588|FG001|Period 1|Physician Decision|1|||
48818622|NCT02487446|157178587|FG000|Period 1|Lack of Efficacy|1|||
49132520|NCT00695019|158325566|FG002|Overall Study|Protocol Violation|1|||
49132521|NCT00695019|158325564|FG000|Overall Study|Lack of Efficacy|0|||
49132522|NCT00695019|158325565|FG001|Overall Study|Lack of Efficacy|0|||
49132523|NCT00695019|158325566|FG002|Overall Study|Lack of Efficacy|1|||
49132524|NCT00695019|158325564|FG000|Overall Study|Various|4|||
49132525|NCT00695019|158325565|FG001|Overall Study|Various|5|||
49132526|NCT00695019|158325566|FG002|Overall Study|Various|4|||
49132527|NCT00639509|158325567|FG000|Overall Study|Death|1|||
48818623|NCT02487446|157178588|FG001|Period 1|Lack of Efficacy|0|||
48818624|NCT02487446|157178587|FG000|Period 1|Protocol deviation|3|||
48818625|NCT02487446|157178588|FG001|Period 1|Protocol deviation|2|||
48818626|NCT02487446|157178587|FG000|Period 1|Lost to Follow-up|2|||
48818627|NCT02487446|157178588|FG001|Period 1|Lost to Follow-up|0|||
48818628|NCT02487446|157178587|FG000|Period 1|Withdrawal by Subject|2|||
48818629|NCT02487446|157178588|FG001|Period 1|Withdrawal by Subject|0|||
48818630|NCT02487446|157178587|FG000|Period 1|Adverse Event|5|||
48818631|NCT02487446|157178588|FG001|Period 1|Adverse Event|5|||
48818632|NCT02487446|157178587|FG000|Washout|Lost to Follow-up|0|||
48818633|NCT02487446|157178588|FG001|Washout|Lost to Follow-up|2|||
48818634|NCT02487446|157178587|FG000|Washout|Withdrawal by Subject|1|||
48818635|NCT02487446|157178588|FG001|Washout|Withdrawal by Subject|4|||
49132528|NCT03122106|158325568|FG000|Overall Study|Not enough tissue|1|||
49132529|NCT03122106|158325568|FG000|Overall Study|Disease progression during screening|2|||
49132530|NCT03122106|158325568|FG000|Overall Study|Poor RNA quality for vaccine|1|||
49132531|NCT01143324|158325569|FG000|Overall Study|Lost to Follow-up|11|||
49132532|NCT01143324|158325569|FG000|Overall Study|Withdrawal by Subject|4|||
49132533|NCT01143324|158325569|FG000|Overall Study|Explant of the device|4|||
48818636|NCT02487446|157178587|FG000|Washout|Adverse Event|2|||
48818637|NCT02487446|157178588|FG001|Washout|Adverse Event|2|||
48818638|NCT02487446|157178587|FG000|Period 2|Protocol deviation|0|||
48818639|NCT02487446|157178588|FG001|Period 2|Protocol deviation|1|||
48818640|NCT02487446|157178587|FG000|Period 2|Lost to Follow-up|1|||
48818641|NCT02487446|157178588|FG001|Period 2|Lost to Follow-up|1|||
48818642|NCT02487446|157178587|FG000|Period 2|Withdrawal by Subject|1|||
48818643|NCT02487446|157178588|FG001|Period 2|Withdrawal by Subject|1|||
48818644|NCT02487446|157178587|FG000|Period 2|Adverse Event|6|||
48818645|NCT02487446|157178588|FG001|Period 2|Adverse Event|2|||
48818646|NCT00946647|157178589|FG000|Phase 1 Part|Adverse Event|2|||
48818647|NCT00946647|157178590|FG001|Phase 1 Part|Adverse Event|5|||
48818648|NCT00946647|157178591|FG002|Phase 1 Part|Adverse Event|3|||
48818649|NCT00946647|157178592|FG003|Phase 1 Part|Adverse Event|0|||
48818650|NCT00946647|157178593|FG004|Phase 1 Part|Adverse Event|0|||
48818651|NCT00946647|157178589|FG000|Phase 1 Part|Disease progression|3|||
48818652|NCT00946647|157178590|FG001|Phase 1 Part|Disease progression|6|||
48818653|NCT00946647|157178591|FG002|Phase 1 Part|Disease progression|1|||
48818654|NCT00946647|157178592|FG003|Phase 1 Part|Disease progression|0|||
49132534|NCT00434252|158326959|FG000|Overall Study|Lack of Efficacy|50|||
49132535|NCT00434252|158326960|FG001|Overall Study|Lack of Efficacy|100|||
49132536|NCT00434252|158326959|FG000|Overall Study|Adverse Event|6|||
49132537|NCT00434252|158326960|FG001|Overall Study|Adverse Event|13|||
49132538|NCT00434252|158326959|FG000|Overall Study|Death|1|||
49132539|NCT00434252|158326960|FG001|Overall Study|Death|2|||
49132540|NCT00434252|158326959|FG000|Overall Study|Lost to Follow-up|0|||
49132541|NCT00434252|158326960|FG001|Overall Study|Lost to Follow-up|1|||
49132542|NCT00434252|158326959|FG000|Overall Study|Physician Decision|4|||
49132543|NCT00434252|158326960|FG001|Overall Study|Physician Decision|8|||
49132544|NCT00434252|158326959|FG000|Overall Study|Withdrawal by Subject|3|||
49132545|NCT00434252|158326960|FG001|Overall Study|Withdrawal by Subject|7|||
49132546|NCT01655901|158326961|FG000|Third Intervention (Hour 3)|Lost to Follow-up|1|||
49132547|NCT01655901|158326962|FG001|Third Intervention (Hour 3)|Lost to Follow-up|1|||
49132548|NCT01655901|158326963|FG002|Third Intervention (Hour 3)|Lost to Follow-up|1|||
49132549|NCT01655901|158326964|FG003|Third Intervention (Hour 3)|Lost to Follow-up|0|||
49132550|NCT01655901|158326965|FG004|Third Intervention (Hour 3)|Lost to Follow-up|1|||
49132551|NCT01655901|158326966|FG005|Third Intervention (Hour 3)|Lost to Follow-up|0|||
49132552|NCT03861039|158326969|FG000|Overall Study|Adverse Event|2|||
48818655|NCT00946647|157178593|FG004|Phase 1 Part|Disease progression|0|||
48818656|NCT00946647|157178589|FG000|Phase 1 Part|Withdrawal by Subject|1|||
48818657|NCT00946647|157178590|FG001|Phase 1 Part|Withdrawal by Subject|4|||
48818658|NCT00946647|157178591|FG002|Phase 1 Part|Withdrawal by Subject|3|||
49132553|NCT03861039|158326970|FG001|Overall Study|Adverse Event|5|||
48818659|NCT00946647|157178592|FG003|Phase 1 Part|Withdrawal by Subject|0|||
48818660|NCT00946647|157178593|FG004|Phase 1 Part|Withdrawal by Subject|0|||
48818661|NCT00946647|157178589|FG000|Phase 1 Part|Abnormal values|0|||
48818662|NCT00946647|157178590|FG001|Phase 1 Part|Abnormal values|2|||
48818663|NCT00946647|157178591|FG002|Phase 1 Part|Abnormal values|0|||
49132554|NCT03861039|158326971|FG002|Overall Study|Adverse Event|11|||
49132555|NCT03861039|158326969|FG000|Overall Study|Withdrawal by Subject|1|||
49132556|NCT03861039|158326970|FG001|Overall Study|Withdrawal by Subject|3|||
48818664|NCT00946647|157178592|FG003|Phase 1 Part|Abnormal values|0|||
48818665|NCT00946647|157178593|FG004|Phase 1 Part|Abnormal values|0|||
48818666|NCT00946647|157178589|FG000|Phase 1 Part|Reason missing|0|||
48818667|NCT00946647|157178590|FG001|Phase 1 Part|Reason missing|1|||
48818668|NCT00946647|157178591|FG002|Phase 1 Part|Reason missing|0|||
49132557|NCT03861039|158326971|FG002|Overall Study|Withdrawal by Subject|4|||
48818669|NCT00946647|157178592|FG003|Phase 1 Part|Reason missing|0|||
49132558|NCT00849056|158326972|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|13|||
49132559|NCT00849056|158326973|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
49132560|NCT00849056|158326972|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|3|||
49132561|NCT00849056|158326973|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|6|||
49132562|NCT00849056|158326972|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
49132563|NCT00849056|158326973|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
49132564|NCT00849056|158326972|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
49132565|NCT00849056|158326973|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5|||
49132566|NCT00849056|158326972|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31|||
49132567|NCT00849056|158326973|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18|||
49132568|NCT00849056|158326972|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
49132569|NCT00849056|158326973|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
49132570|NCT00849056|158326972|FG000|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1|||
49132571|NCT00849056|158326973|FG001|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4|||
49132572|NCT00849056|158326972|FG000|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1|||
49132573|NCT00849056|158326973|FG001|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0|||
49132574|NCT00849056|158326972|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
48724037|NCT01261312|156840401|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
48818670|NCT00946647|157178593|FG004|Phase 1 Part|Reason missing|0|||
48818671|NCT00946647|157178589|FG000|Phase ll Part|Untreated|0|||
48818672|NCT00946647|157178590|FG001|Phase ll Part|Untreated|0|||
48818673|NCT00946647|157178591|FG002|Phase ll Part|Untreated|0|||
48818674|NCT00946647|157178592|FG003|Phase ll Part|Untreated|0|||
48818675|NCT00946647|157178593|FG004|Phase ll Part|Untreated|2|||
49132575|NCT00849056|158326973|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
49132576|NCT00849056|158326972|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
49132577|NCT00849056|158326973|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3|||
49132578|NCT00849056|158326972|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
49132579|NCT00849056|158326973|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
49132580|NCT00849056|158326972|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14|||
49132581|NCT00849056|158326973|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9|||
49132582|NCT00849056|158326972|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9|||
49132583|NCT00849056|158326973|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7|||
49132584|NCT00849056|158326972|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
48818676|NCT00946647|157178589|FG000|Phase ll Part|Adverse Event|0|||
48818677|NCT00946647|157178590|FG001|Phase ll Part|Adverse Event|0|||
49132585|NCT00849056|158326973|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
48724038|NCT01261312|156840402|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
48724039|NCT01261312|156840403|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
48724040|NCT01261312|156840404|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
48724041|NCT01261312|156840405|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
48724042|NCT01261312|156840406|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
48724043|NCT01261312|156840407|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
48724044|NCT01261312|156840408|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
48724045|NCT01261312|156840409|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
48724046|NCT01261312|156840410|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
48724047|NCT01261312|156840411|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
48724048|NCT01261312|156840412|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|9|||
48724049|NCT01261312|156840413|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|2|||
48724050|NCT01261312|156840401|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
48724051|NCT01261312|156840402|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
48724052|NCT01261312|156840403|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
48724053|NCT01261312|156840404|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
48724054|NCT01261312|156840405|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
48724055|NCT01261312|156840406|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
48724056|NCT01261312|156840407|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
48724057|NCT01261312|156840408|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
48724058|NCT01261312|156840409|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
48724059|NCT01261312|156840410|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|2|||
48724060|NCT01261312|156840411|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
48818678|NCT00946647|157178591|FG002|Phase ll Part|Adverse Event|0|||
49132586|NCT00849056|158326972|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1|||
48818679|NCT00946647|157178592|FG003|Phase ll Part|Adverse Event|10|||
49132587|NCT00849056|158326973|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4|||
49132588|NCT00849056|158326972|FG000|Follow-up Period (FUP) (8 Weeks)|Early Termination|1|||
48818680|NCT00946647|157178593|FG004|Phase ll Part|Adverse Event|6|||
48818681|NCT00946647|157178589|FG000|Phase ll Part|Withdrawal by Subject|0|||
48818682|NCT00946647|157178590|FG001|Phase ll Part|Withdrawal by Subject|0|||
48818683|NCT00946647|157178591|FG002|Phase ll Part|Withdrawal by Subject|0|||
48818684|NCT00946647|157178592|FG003|Phase ll Part|Withdrawal by Subject|8|||
48818685|NCT00946647|157178593|FG004|Phase ll Part|Withdrawal by Subject|6|||
48818686|NCT00946647|157178589|FG000|Phase ll Part|Administrative problems|0|||
48818687|NCT00946647|157178590|FG001|Phase ll Part|Administrative problems|0|||
48818688|NCT00946647|157178591|FG002|Phase ll Part|Administrative problems|0|||
48818689|NCT00946647|157178592|FG003|Phase ll Part|Administrative problems|3|||
48818690|NCT00946647|157178593|FG004|Phase ll Part|Administrative problems|8|||
48818691|NCT00946647|157178589|FG000|Phase ll Part|Death|0|||
48818692|NCT00946647|157178590|FG001|Phase ll Part|Death|0|||
48818693|NCT00946647|157178591|FG002|Phase ll Part|Death|0|||
48818694|NCT00946647|157178592|FG003|Phase ll Part|Death|7|||
48818695|NCT00946647|157178593|FG004|Phase ll Part|Death|4|||
48818696|NCT00946647|157178589|FG000|Phase ll Part|Disease progression|0|||
48818697|NCT00946647|157178590|FG001|Phase ll Part|Disease progression|0|||
48818698|NCT00946647|157178591|FG002|Phase ll Part|Disease progression|0|||
48818699|NCT00946647|157178592|FG003|Phase ll Part|Disease progression|6|||
48818700|NCT00946647|157178593|FG004|Phase ll Part|Disease progression|14|||
49132589|NCT00849056|158326973|FG001|Follow-up Period (FUP) (8 Weeks)|Early Termination|0|||
49132590|NCT00548327|158326978|FG000|Overall Study|Adverse Event|0|||
49132591|NCT00548327|158326979|FG001|Overall Study|Adverse Event|1|||
48724061|NCT01261312|156840412|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
49132592|NCT02997163|158326982|FG000|Overall Study|Adverse Event|1|||
48724062|NCT01261312|156840413|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
48724063|NCT01261312|156840401|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
48724064|NCT01261312|156840402|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
48724065|NCT01261312|156840403|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
48724066|NCT01261312|156840404|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
48724067|NCT01261312|156840405|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
48724068|NCT01261312|156840406|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
48724069|NCT01261312|156840407|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
48724070|NCT01261312|156840408|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
48724071|NCT01261312|156840409|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
48724072|NCT01261312|156840410|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|4|||
48724073|NCT01261312|156840411|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|5|||
48724074|NCT01261312|156840412|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
48724075|NCT01261312|156840413|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
48724076|NCT01261312|156840401|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
48724077|NCT01261312|156840402|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
48724078|NCT01261312|156840403|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
48724079|NCT01261312|156840404|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
48724080|NCT01261312|156840405|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
48724081|NCT01261312|156840406|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
48724082|NCT01261312|156840407|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
48724083|NCT01261312|156840408|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
48724084|NCT01261312|156840409|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
48724085|NCT01261312|156840410|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
48724086|NCT01261312|156840411|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|4|||
48724087|NCT01261312|156840412|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|1|||
48724088|NCT01261312|156840413|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
48724089|NCT01261312|156840401|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
48724090|NCT01261312|156840402|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
48724091|NCT01261312|156840403|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
48724092|NCT01261312|156840404|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
48724093|NCT01261312|156840405|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
48724094|NCT01261312|156840406|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
48724095|NCT01261312|156840407|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
48724096|NCT01261312|156840408|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
48724097|NCT01261312|156840409|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
48724098|NCT01261312|156840410|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
48724099|NCT01261312|156840411|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|6|||
48724100|NCT01261312|156840412|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|3|||
48724101|NCT01261312|156840413|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
48818701|NCT00946647|157178589|FG000|Phase ll Part|Protocol Violation|0|||
48818702|NCT00946647|157178590|FG001|Phase ll Part|Protocol Violation|0|||
48818703|NCT00946647|157178591|FG002|Phase ll Part|Protocol Violation|0|||
48818704|NCT00946647|157178592|FG003|Phase ll Part|Protocol Violation|4|||
48818705|NCT00946647|157178593|FG004|Phase ll Part|Protocol Violation|2|||
49132593|NCT02997163|158326983|FG001|Overall Study|Adverse Event|0|||
49132594|NCT02997163|158326984|FG002|Overall Study|Adverse Event|0|||
49132595|NCT02997163|158326985|FG003|Overall Study|Adverse Event|1|||
49132596|NCT00903201|158326986|FG000|Overall Study|Adverse Event|1|||
49132597|NCT00903201|158326987|FG001|Overall Study|Adverse Event|4|||
49132598|NCT00903201|158326988|FG002|Overall Study|Adverse Event|0|||
49132599|NCT00903201|158326986|FG000|Overall Study|Protocol Violation|2|||
49132600|NCT00903201|158326987|FG001|Overall Study|Protocol Violation|1|||
49132601|NCT00903201|158326988|FG002|Overall Study|Protocol Violation|0|||
49132602|NCT00903201|158326986|FG000|Overall Study|Lost to Follow-up|0|||
49132603|NCT00903201|158326987|FG001|Overall Study|Lost to Follow-up|1|||
49132604|NCT00903201|158326988|FG002|Overall Study|Lost to Follow-up|0|||
49132605|NCT00903201|158326986|FG000|Overall Study|Physician Decision|1|||
49132606|NCT00903201|158326987|FG001|Overall Study|Physician Decision|0|||
49132607|NCT00903201|158326988|FG002|Overall Study|Physician Decision|1|||
49132608|NCT00903201|158326986|FG000|Overall Study|Withdrawal by Subject|1|||
49132609|NCT00903201|158326987|FG001|Overall Study|Withdrawal by Subject|0|||
49132610|NCT00903201|158326988|FG002|Overall Study|Withdrawal by Subject|1|||
49132611|NCT02337764|158326989|FG000|Overall Study|Pretreatment Event/Adverse Event|46|||
49132612|NCT02337764|158326989|FG000|Overall Study|Voluntary Withdrawal|12|||
49132613|NCT02337764|158326989|FG000|Overall Study|Lack of Efficacy|2|||
49132614|NCT01787838|158326990|FG000|Overall Study|refused|1413|||
49132615|NCT01516216|158326991|FG000|Overall Study|Adverse Event|2|||
49132616|NCT01516216|158326992|FG001|Overall Study|Adverse Event|4|||
49132617|NCT01516216|158326991|FG000|Overall Study|Disease Progression|38|||
49132618|NCT01516216|158326992|FG001|Overall Study|Disease Progression|34|||
49132619|NCT01516216|158326991|FG000|Overall Study|Withdrawal by Subject|9|||
49132620|NCT01516216|158326992|FG001|Overall Study|Withdrawal by Subject|11|||
49132621|NCT01516216|158326991|FG000|Overall Study|Potentially Curative Resection|6|||
49132622|NCT01516216|158326992|FG001|Overall Study|Potentially Curative Resection|12|||
49132623|NCT01516216|158326991|FG000|Overall Study|Nonadherence|2|||
49132624|NCT01516216|158326992|FG001|Overall Study|Nonadherence|3|||
49132625|NCT01516216|158326991|FG000|Overall Study|Physician Decision|6|||
49132626|NCT01516216|158326992|FG001|Overall Study|Physician Decision|3|||
49132627|NCT01516216|158326991|FG000|Overall Study|Prolonged Treatment Delay|5|||
49132628|NCT01516216|158326992|FG001|Overall Study|Prolonged Treatment Delay|1|||
49132629|NCT01516216|158326991|FG000|Overall Study|Intercurrent Illness|1|||
49132630|NCT01516216|158326992|FG001|Overall Study|Intercurrent Illness|0|||
49132631|NCT01516216|158326991|FG000|Overall Study|Death|1|||
49132632|NCT01516216|158326992|FG001|Overall Study|Death|1|||
49132633|NCT03098979|158326993|FG000|Overall Study|Adverse Event|1|||
49132634|NCT03098979|158326994|FG001|Overall Study|Adverse Event|0|||
49132635|NCT03098979|158326995|FG002|Overall Study|Adverse Event|1|||
49132636|NCT03098979|158326996|FG003|Overall Study|Adverse Event|4|||
49132637|NCT03098979|158326997|FG004|Overall Study|Adverse Event|6|||
49132638|NCT03098979|158326998|FG005|Overall Study|Adverse Event|1|||
49132639|NCT03098979|158326993|FG000|Overall Study|Withdrawal by Subject|2|||
49132640|NCT03098979|158326994|FG001|Overall Study|Withdrawal by Subject|1|||
48724102|NCT01261312|156840401|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
48724103|NCT01261312|156840402|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
48818706|NCT00946647|157178589|FG000|Phase ll Part|Subj cond no longer required study drug|0|||
48818707|NCT00946647|157178590|FG001|Phase ll Part|Subj cond no longer required study drug|0|||
48818708|NCT00946647|157178591|FG002|Phase ll Part|Subj cond no longer required study drug|0|||
48818709|NCT00946647|157178592|FG003|Phase ll Part|Subj cond no longer required study drug|2|||
48818710|NCT00946647|157178593|FG004|Phase ll Part|Subj cond no longer required study drug|0|||
48818711|NCT00333788|157178594|FG000|Overall Study|Adverse Event|44|||
49132641|NCT03098979|158326995|FG002|Overall Study|Withdrawal by Subject|1|||
49132642|NCT03098979|158326996|FG003|Overall Study|Withdrawal by Subject|1|||
49132643|NCT03098979|158326997|FG004|Overall Study|Withdrawal by Subject|2|||
49132644|NCT03098979|158326998|FG005|Overall Study|Withdrawal by Subject|1|||
49132645|NCT03098979|158326993|FG000|Overall Study|Death|1|||
48724104|NCT01261312|156840403|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
48724105|NCT01261312|156840404|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
48724106|NCT01261312|156840405|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
48724107|NCT01261312|156840406|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
48724108|NCT01261312|156840407|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
48818712|NCT00333788|157178594|FG000|Overall Study|Lack of Efficacy|80|||
48818713|NCT00333788|157178594|FG000|Overall Study|Lost to Follow-up|2|||
48818714|NCT00333788|157178594|FG000|Overall Study|Withdrawal by Subject|24|||
49132646|NCT03098979|158326994|FG001|Overall Study|Death|0|||
49132647|NCT03098979|158326995|FG002|Overall Study|Death|2|||
49132648|NCT03098979|158326996|FG003|Overall Study|Death|0|||
49132649|NCT03098979|158326997|FG004|Overall Study|Death|1|||
49132650|NCT03098979|158326998|FG005|Overall Study|Death|0|||
49132651|NCT03098979|158326993|FG000|Overall Study|Physician Decision|2|||
49132652|NCT03098979|158326994|FG001|Overall Study|Physician Decision|1|||
49132653|NCT03098979|158326995|FG002|Overall Study|Physician Decision|0|||
49132654|NCT03098979|158326996|FG003|Overall Study|Physician Decision|0|||
48724109|NCT01261312|156840408|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
49132655|NCT03098979|158326997|FG004|Overall Study|Physician Decision|0|||
49132656|NCT03098979|158326998|FG005|Overall Study|Physician Decision|0|||
49132657|NCT03098979|158326993|FG000|Overall Study|Non-compliance|0|||
49132658|NCT03098979|158326994|FG001|Overall Study|Non-compliance|0|||
49132659|NCT03098979|158326995|FG002|Overall Study|Non-compliance|0|||
49132660|NCT03098979|158326996|FG003|Overall Study|Non-compliance|0|||
49132661|NCT03098979|158326997|FG004|Overall Study|Non-compliance|0|||
49132662|NCT03098979|158326998|FG005|Overall Study|Non-compliance|1|||
49132663|NCT03098979|158326993|FG000|Overall Study|Protocol Violation|0|||
49132664|NCT03098979|158326994|FG001|Overall Study|Protocol Violation|0|||
49132665|NCT03098979|158326995|FG002|Overall Study|Protocol Violation|0|||
49132666|NCT03098979|158326996|FG003|Overall Study|Protocol Violation|0|||
49132667|NCT03098979|158326997|FG004|Overall Study|Protocol Violation|0|||
49132668|NCT03098979|158326998|FG005|Overall Study|Protocol Violation|1|||
49132669|NCT00941928|158327003|FG000|Overall Study|Withdrawal by Subject|1|||
49132670|NCT00941928|158327003|FG000|Overall Study|Disease Progression|1|||
49132671|NCT01829347|158327006|FG000|VTI-210|Death|5|||
49132672|NCT01829347|158327007|FG001|VTI-210|Death|3|||
49132673|NCT01829347|158327006|FG000|VTI-210|Withdrawal by Subject|1|||
49132674|NCT01829347|158327007|FG001|VTI-210|Withdrawal by Subject|0|||
49132675|NCT01829347|158327006|FG000|VTI-210E|Death|2|||
49132676|NCT01829347|158327007|FG001|VTI-210E|Death|1|||
49132677|NCT01829347|158327006|FG000|VTI-210E|Study terminated prematurely|1|||
49132678|NCT01829347|158327007|FG001|VTI-210E|Study terminated prematurely|5|||
49132679|NCT02471339|158327012|FG000|Overall Study|Did not provide follow-up data|2|||
49132680|NCT02471339|158327013|FG001|Overall Study|Did not provide follow-up data|0|||
49132681|NCT00984867|158327014|FG000|Overall Study|Adverse Event|3|||
49132682|NCT00984867|158327015|FG001|Overall Study|Adverse Event|7|||
49132683|NCT00984867|158327014|FG000|Overall Study|Death|1|||
49132684|NCT00984867|158327015|FG001|Overall Study|Death|0|||
49132685|NCT00984867|158327014|FG000|Overall Study|Withdrawal by Subject|13|||
49132686|NCT00984867|158327015|FG001|Overall Study|Withdrawal by Subject|4|||
49132687|NCT00984867|158327014|FG000|Overall Study|Lost to Follow-up|3|||
49132688|NCT00984867|158327015|FG001|Overall Study|Lost to Follow-up|4|||
49132689|NCT00984867|158327014|FG000|Overall Study|Poor/non-compliance|0|||
49132690|NCT00984867|158327015|FG001|Overall Study|Poor/non-compliance|1|||
49132691|NCT00984867|158327014|FG000|Overall Study|Subject no longer meets study criteria|1|||
49132692|NCT00984867|158327015|FG001|Overall Study|Subject no longer meets study criteria|1|||
49132693|NCT00984867|158327014|FG000|Overall Study|site closing|1|||
49132694|NCT00984867|158327015|FG001|Overall Study|site closing|0|||
49132695|NCT00984867|158327014|FG000|Overall Study|lack of efficacy and subject compliance|1|||
49132696|NCT00984867|158327015|FG001|Overall Study|lack of efficacy and subject compliance|0|||
49132697|NCT00407511|158327016|FG000|Overall Study|Adverse Event|9|||
49132698|NCT00407511|158327016|FG000|Overall Study|Lost to Follow-up|4|||
49132699|NCT00407511|158327016|FG000|Overall Study|Other|5|||
49132700|NCT00407511|158327016|FG000|Overall Study|Withdrawal by Subject|4|||
49132701|NCT01184872|158327017|FG000|Overall Study|Adverse Event|3|||
49132702|NCT01184872|158327018|FG001|Overall Study|Adverse Event|4|||
49132703|NCT01184872|158327017|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
49132704|NCT01184872|158327018|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
49132705|NCT01184872|158327017|FG000|Overall Study|Withdrawal by Subject|2|||
49132706|NCT01184872|158327018|FG001|Overall Study|Withdrawal by Subject|0|||
49132707|NCT01184872|158327017|FG000|Overall Study|Lost to Follow-up|0|||
49132708|NCT01184872|158327018|FG001|Overall Study|Lost to Follow-up|1|||
49132709|NCT01184872|158327017|FG000|Overall Study|Administrative problems|1|||
49132710|NCT01184872|158327018|FG001|Overall Study|Administrative problems|1|||
49132711|NCT01184872|158327017|FG000|Overall Study|Protocol deviation|1|||
48724110|NCT01261312|156840409|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
49132712|NCT01184872|158327018|FG001|Overall Study|Protocol deviation|0|||
49132713|NCT03722576|158327019|FG000|Overall Study|Withdrawal by Subject|3|||
49132714|NCT03722576|158327019|FG000|Overall Study|Adverse Event|2|||
49132715|NCT03722576|158327019|FG000|Overall Study|Physician Decision|1|||
48724111|NCT01261312|156840410|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|3|||
48724112|NCT01261312|156840411|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|1|||
48724113|NCT01261312|156840412|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|6|||
48724114|NCT01261312|156840413|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|4|||
48724115|NCT01261312|156840401|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
48724116|NCT01261312|156840402|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
48724117|NCT01261312|156840403|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
48724118|NCT01261312|156840404|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
48818715|NCT00333788|157178594|FG000|Overall Study|Other: Non-compliance|2|||
49132716|NCT03722576|158327019|FG000|Overall Study|Lost to Follow-up|1|||
49132717|NCT03329989|158327024|FG000|Overall Study|Withdrawal by Subject|9|||
49132718|NCT03329989|158327024|FG000|Overall Study|Lost to Follow-up|8|||
49132719|NCT03329989|158327024|FG000|Overall Study|Adverse Event|5|||
49132720|NCT03329989|158327024|FG000|Overall Study|Protocol Violation|1|||
49132721|NCT00706797|158327027|FG000|Overall Study|Lack of Efficacy|3|||
49132722|NCT00706797|158327028|FG001|Overall Study|Lack of Efficacy|0|||
49132723|NCT00706797|158327027|FG000|Overall Study|Adverse Event|0|||
49132724|NCT00706797|158327028|FG001|Overall Study|Adverse Event|3|||
49132725|NCT00706797|158327027|FG000|Overall Study|Withdrawal by Subject|8|||
49132726|NCT00706797|158327028|FG001|Overall Study|Withdrawal by Subject|1|||
49132727|NCT00706797|158327027|FG000|Overall Study|Death|1|||
49132728|NCT00706797|158327028|FG001|Overall Study|Death|0|||
49132729|NCT00706797|158327027|FG000|Overall Study|Discontinuation of study by sponsor|52|||
49132730|NCT00706797|158327028|FG001|Overall Study|Discontinuation of study by sponsor|63|||
49132731|NCT00706797|158327027|FG000|Overall Study|Protocol Violation|3|||
49132732|NCT00706797|158327028|FG001|Overall Study|Protocol Violation|2|||
49132733|NCT00706797|158327027|FG000|Overall Study|Lost to Follow-up|1|||
49132734|NCT00706797|158327028|FG001|Overall Study|Lost to Follow-up|2|||
49132735|NCT00706797|158327027|FG000|Overall Study|Other|1|||
49132736|NCT00706797|158327028|FG001|Overall Study|Other|0|||
49132737|NCT00537277|158327036|FG000|Overall Study|Adverse Event|1|||
49132738|NCT00537277|158327036|FG000|Overall Study|Lack of Efficacy|2|||
49132739|NCT00537277|158327036|FG000|Overall Study|Lost to Follow-up|12|||
49132740|NCT00537277|158327036|FG000|Overall Study|Protocol Violation|11|||
49132741|NCT00537277|158327036|FG000|Overall Study|Unclassified|4|||
49132742|NCT00537277|158327036|FG000|Overall Study|Inability to tolerate trial medication|4|||
49132743|NCT00537277|158327036|FG000|Overall Study|Non-compliance with trial procedures|15|||
49132744|NCT00997893|158327039|FG000|Overall Study|Adverse Event|1|||
49132745|NCT00997893|158327040|FG001|Overall Study|Adverse Event|0|||
49132746|NCT00997893|158327041|FG002|Overall Study|Adverse Event|0|||
49132747|NCT00997893|158327039|FG000|Overall Study|Unable to meet study timelines|1|||
49132748|NCT00997893|158327040|FG001|Overall Study|Unable to meet study timelines|0|||
49132749|NCT00997893|158327041|FG002|Overall Study|Unable to meet study timelines|0|||
49132750|NCT00997893|158327039|FG000|Overall Study|Pain/pain meds during Visit 4|0|||
49132751|NCT00997893|158327040|FG001|Overall Study|Pain/pain meds during Visit 4|1|||
49132752|NCT00997893|158327041|FG002|Overall Study|Pain/pain meds during Visit 4|0|||
49132753|NCT03620162|158327042|FG000|Overall Study|Physician Decision|4|||
49132754|NCT03620162|158327043|FG001|Overall Study|Physician Decision|0|||
49132755|NCT03620162|158327044|FG002|Overall Study|Physician Decision|1|||
49132756|NCT03620162|158327045|FG003|Overall Study|Physician Decision|0|||
49132757|NCT03620162|158327046|FG004|Overall Study|Physician Decision|2|||
48724119|NCT01261312|156840405|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
48724120|NCT01261312|156840406|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
48724121|NCT01261312|156840407|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
48724122|NCT01261312|156840408|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
48724123|NCT01261312|156840409|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
48724124|NCT01261312|156840410|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
48724125|NCT01261312|156840411|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
48724126|NCT01261312|156840412|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
48724127|NCT01261312|156840413|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|1|||
48724128|NCT01993836|156840416|FG000|Overall Study|Surgery Cancelled|3|||
48724129|NCT01993836|156840417|FG001|Overall Study|Surgery Cancelled|0|||
48724130|NCT01993836|156840418|FG002|Overall Study|Surgery Cancelled|0|||
48724131|NCT01993836|156840416|FG000|Overall Study|Physician Decision|2|||
48724132|NCT01993836|156840417|FG001|Overall Study|Physician Decision|1|||
48724133|NCT01993836|156840418|FG002|Overall Study|Physician Decision|0|||
48724134|NCT01993836|156840416|FG000|Overall Study|Death|0|||
48724135|NCT01993836|156840417|FG001|Overall Study|Death|2|||
48724136|NCT01993836|156840418|FG002|Overall Study|Death|0|||
48724137|NCT01993836|156840416|FG000|Overall Study|Withdrawal by Subject|12|||
48724138|NCT01993836|156840417|FG001|Overall Study|Withdrawal by Subject|10|||
48724139|NCT01993836|156840418|FG002|Overall Study|Withdrawal by Subject|5|||
48724140|NCT00584740|156840425|FG000|Overall Study|Adverse Event|1|||
48724141|NCT00584740|156840426|FG001|Overall Study|Adverse Event|1|||
48724142|NCT00584740|156840425|FG000|Overall Study|Lack of Efficacy|8|||
48724143|NCT00584740|156840426|FG001|Overall Study|Lack of Efficacy|2|||
48724144|NCT00584740|156840425|FG000|Overall Study|Withdrawal by Subject|3|||
49132758|NCT03620162|158327042|FG000|Overall Study|Lost to Follow-up|2|||
49132759|NCT03620162|158327043|FG001|Overall Study|Lost to Follow-up|6|||
49132760|NCT03620162|158327044|FG002|Overall Study|Lost to Follow-up|7|||
49132761|NCT03620162|158327045|FG003|Overall Study|Lost to Follow-up|3|||
49132762|NCT03620162|158327046|FG004|Overall Study|Lost to Follow-up|2|||
48724145|NCT00584740|156840426|FG001|Overall Study|Withdrawal by Subject|2|||
48724146|NCT00584740|156840425|FG000|Overall Study|Lost to Follow-up|0|||
49132763|NCT03620162|158327042|FG000|Overall Study|Consent withdrawn by parent/guardian|9|||
49132764|NCT03620162|158327043|FG001|Overall Study|Consent withdrawn by parent/guardian|8|||
49132765|NCT03620162|158327044|FG002|Overall Study|Consent withdrawn by parent/guardian|25|||
49132766|NCT03620162|158327045|FG003|Overall Study|Consent withdrawn by parent/guardian|17|||
49132767|NCT03620162|158327046|FG004|Overall Study|Consent withdrawn by parent/guardian|9|||
49132768|NCT00717886|158327048|FG000|Overall Study|Withdrawal by Subject|3|||
49132769|NCT00717886|158327048|FG000|Overall Study|Treatment Failure|1|||
49132770|NCT00390689|158327049|FG000|Overall Study|Adverse Event|2|||
48724147|NCT00584740|156840426|FG001|Overall Study|Lost to Follow-up|1|||
48724148|NCT00582816|156840427|FG000|Overall Study|Engraftment Failure|3|||
48724149|NCT02514473|156840428|FG000|Overall Study|Adverse Event|0|||
48724150|NCT02514473|156840429|FG001|Overall Study|Adverse Event|2|||
48724151|NCT02514473|156840428|FG000|Overall Study|Withdrawal by Subject|2|||
48724152|NCT02514473|156840429|FG001|Overall Study|Withdrawal by Subject|1|||
49132771|NCT00390689|158327050|FG001|Overall Study|Adverse Event|5|||
49132772|NCT00390689|158327051|FG002|Overall Study|Adverse Event|2|||
49132773|NCT00390689|158327049|FG000|Overall Study|Lack of Efficacy|0|||
49132774|NCT00390689|158327050|FG001|Overall Study|Lack of Efficacy|0|||
49132775|NCT00390689|158327051|FG002|Overall Study|Lack of Efficacy|1|||
49132776|NCT00390689|158327049|FG000|Overall Study|Protocol Violation|1|||
49132777|NCT00390689|158327050|FG001|Overall Study|Protocol Violation|0|||
49132778|NCT00390689|158327051|FG002|Overall Study|Protocol Violation|0|||
49132779|NCT00390689|158327049|FG000|Overall Study|Investigator's judgement|2|||
49132780|NCT00390689|158327050|FG001|Overall Study|Investigator's judgement|0|||
49132781|NCT00390689|158327051|FG002|Overall Study|Investigator's judgement|0|||
49132782|NCT02747927|158327052|FG000|Overall Study|Adverse Event|5|||
49132783|NCT02747927|158327053|FG001|Overall Study|Adverse Event|14|||
49132784|NCT02747927|158327052|FG000|Overall Study|Lost to Follow-up|22|||
49132785|NCT02747927|158327053|FG001|Overall Study|Lost to Follow-up|43|||
49132786|NCT02747927|158327052|FG000|Overall Study|Pregnancy|34|||
49132787|NCT02747927|158327053|FG001|Overall Study|Pregnancy|66|||
49132788|NCT02747927|158327052|FG000|Overall Study|Protocol Violation|2|||
49132789|NCT02747927|158327053|FG001|Overall Study|Protocol Violation|4|||
49132790|NCT02747927|158327052|FG000|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|147|||
48724153|NCT02514473|156840428|FG000|Overall Study|Lost to Follow-up|0|||
48724154|NCT02514473|156840429|FG001|Overall Study|Lost to Follow-up|1|||
48724155|NCT02514473|156840428|FG000|Overall Study|Other|1|||
48724156|NCT02514473|156840429|FG001|Overall Study|Other|1|||
48724157|NCT02106923|156840430|FG000|Overall Study|Protocol Violation|0|||
48724158|NCT02106923|156840431|FG001|Overall Study|Protocol Violation|0|||
48724159|NCT02106923|156840432|FG002|Overall Study|Protocol Violation|0|||
48818716|NCT00333788|157178594|FG000|Overall Study|Other: Moved|2|||
48818717|NCT00333788|157178594|FG000|Overall Study|Other: Recurrent squamaous cell cancer|1|||
48818718|NCT00333788|157178594|FG000|Overall Study|Other: Investigator decision|1|||
48818719|NCT00333788|157178594|FG000|Overall Study|Other: Quality of life concern|1|||
48818720|NCT00333788|157178594|FG000|Overall Study|Other: Sponsor decision|1|||
48818721|NCT00333788|157178594|FG000|Overall Study|Other: Subject in need of an Entocort|1|||
48818722|NCT00333788|157178594|FG000|Overall Study|Other: Medical monitor decision|1|||
49132791|NCT02747927|158327053|FG001|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|304|||
49132792|NCT02747927|158327052|FG000|Overall Study|Reason not Specified|11|||
49132793|NCT02747927|158327053|FG001|Overall Study|Reason not Specified|27|||
49132794|NCT03451045|158327054|FG000|Overall Study|Lack of Efficacy|3|||
49132795|NCT03451045|158327055|FG001|Overall Study|Lack of Efficacy|2|||
49132796|NCT03451045|158327056|FG002|Overall Study|Lack of Efficacy|2|||
49132797|NCT03451045|158327054|FG000|Overall Study|Physician Decision|1|||
49132798|NCT03451045|158327055|FG001|Overall Study|Physician Decision|1|||
48724160|NCT02106923|156840433|FG003|Overall Study|Protocol Violation|0|||
48724161|NCT02106923|156840434|FG004|Overall Study|Protocol Violation|0|||
48724162|NCT02106923|156840435|FG005|Overall Study|Protocol Violation|1|||
49132799|NCT03451045|158327056|FG002|Overall Study|Physician Decision|1|||
49132800|NCT03451045|158327054|FG000|Overall Study|Withdrawal by Subject|4|||
49132801|NCT03451045|158327055|FG001|Overall Study|Withdrawal by Subject|0|||
48818723|NCT00333788|157178594|FG000|Overall Study|Other: Physician decision|1|||
48921032|NCT00784654|157544820|FG002|Randomized Withdrawal Period|Adverse Event|1|||
48724163|NCT03222492|156840438|FG000|Overall Study|Withdrawal by Subject|0|||
48724164|NCT03222492|156840439|FG001|Overall Study|Withdrawal by Subject|0|||
48724165|NCT03222492|156840440|FG002|Overall Study|Withdrawal by Subject|1|||
48724166|NCT03222492|156840441|FG003|Overall Study|Withdrawal by Subject|0|||
48724167|NCT03222492|156840438|FG000|Overall Study|COVID-19 related|0|||
48724168|NCT03222492|156840439|FG001|Overall Study|COVID-19 related|0|||
48724169|NCT03222492|156840440|FG002|Overall Study|COVID-19 related|1|||
48724170|NCT03222492|156840441|FG003|Overall Study|COVID-19 related|0|||
48724171|NCT01624870|156840442|FG000|Overall Study|Death|19|||
48724172|NCT01624870|156840442|FG000|Overall Study|Withdrawal by Subject|1|||
48724173|NCT01624870|156840442|FG000|Overall Study|CoreValve not implanted|6|||
48724174|NCT01624870|156840442|FG000|Overall Study|Lost to follow up|1|||
48724175|NCT00984568|156840444|FG000|Overall Study|Withdrawal by Subject|1|||
48724176|NCT00984568|156840445|FG001|Overall Study|Withdrawal by Subject|2|||
48724177|NCT00984568|156840444|FG000|Overall Study|Lack of Efficacy|2|||
48724178|NCT00984568|156840445|FG001|Overall Study|Lack of Efficacy|0|||
48724179|NCT00984568|156840444|FG000|Overall Study|Adverse Event|2|||
48724180|NCT00984568|156840445|FG001|Overall Study|Adverse Event|0|||
48724181|NCT00984568|156840444|FG000|Overall Study|Did Not Meet Randomization Criteria|1|||
48724182|NCT00984568|156840445|FG001|Overall Study|Did Not Meet Randomization Criteria|0|||
48724183|NCT00984568|156840444|FG000|Overall Study|Lost to Follow-up|0|||
48724184|NCT00984568|156840445|FG001|Overall Study|Lost to Follow-up|1|||
48724185|NCT00984568|156840444|FG000|Overall Study|Opportunistic Infection|1|||
48724186|NCT00984568|156840445|FG001|Overall Study|Opportunistic Infection|0|||
48724187|NCT00984568|156840444|FG000|Overall Study|Unknown Reason|1|||
48724188|NCT00984568|156840445|FG001|Overall Study|Unknown Reason|3|||
49132802|NCT03451045|158327056|FG002|Overall Study|Withdrawal by Subject|5|||
49132803|NCT03451045|158327054|FG000|Overall Study|Pregnancy|0|||
49132804|NCT03451045|158327055|FG001|Overall Study|Pregnancy|0|||
48724189|NCT02964507|156840447|FG000|Overall Study|Protocol specified Withdrawal criteria met|0|||
48724190|NCT02964507|156840448|FG001|Overall Study|Protocol specified Withdrawal criteria met|1|||
48724191|NCT02964507|156840449|FG002|Overall Study|Protocol specified Withdrawal criteria met|0|||
48818724|NCT00333788|157178594|FG000|Overall Study|Other: Signed consent for another study|1|||
48818725|NCT01007552|157178595|FG000|Overall Study|Withdrawal by Subject|1|||
48818726|NCT02507219|157178602|FG000|Overall Study|Physician Decision|1|||
48818727|NCT02507219|157178603|FG001|Overall Study|Physician Decision|0|||
48818728|NCT02507219|157178604|FG002|Overall Study|Physician Decision|0|||
48724192|NCT02964507|156840450|FG003|Overall Study|Protocol specified Withdrawal criteria met|0|||
48724193|NCT02964507|156840451|FG004|Overall Study|Protocol specified Withdrawal criteria met|1|||
48724194|NCT02964507|156840452|FG005|Overall Study|Protocol specified Withdrawal criteria met|0|||
48724195|NCT02964507|156840453|FG006|Overall Study|Protocol specified Withdrawal criteria met|0|||
48724196|NCT02964507|156840454|FG007|Overall Study|Protocol specified Withdrawal criteria met|0|||
48724197|NCT02964507|156840447|FG000|Overall Study|Study terminated by Sponsor|9|||
48724198|NCT02964507|156840448|FG001|Overall Study|Study terminated by Sponsor|1|||
48724199|NCT02964507|156840449|FG002|Overall Study|Study terminated by Sponsor|9|||
48724200|NCT02964507|156840450|FG003|Overall Study|Study terminated by Sponsor|3|||
48724201|NCT02964507|156840451|FG004|Overall Study|Study terminated by Sponsor|3|||
48724202|NCT02964507|156840452|FG005|Overall Study|Study terminated by Sponsor|2|||
48724203|NCT02964507|156840453|FG006|Overall Study|Study terminated by Sponsor|0|||
48724204|NCT02964507|156840454|FG007|Overall Study|Study terminated by Sponsor|0|||
48724205|NCT02964507|156840447|FG000|Overall Study|Other|3|||
48818729|NCT02507219|157178605|FG003|Overall Study|Physician Decision|0|||
48818730|NCT02507219|157178606|FG004|Overall Study|Physician Decision|0|||
48818731|NCT02507219|157178607|FG005|Overall Study|Physician Decision|0|||
48724206|NCT02964507|156840448|FG001|Overall Study|Other|0|||
48724207|NCT02964507|156840449|FG002|Overall Study|Other|0|||
48724208|NCT02964507|156840450|FG003|Overall Study|Other|0|||
49132805|NCT03451045|158327056|FG002|Overall Study|Pregnancy|2|||
49132806|NCT03451045|158327054|FG000|Overall Study|Adverse Event|7|||
49132807|NCT03451045|158327055|FG001|Overall Study|Adverse Event|1|||
49132808|NCT03451045|158327056|FG002|Overall Study|Adverse Event|3|||
48724209|NCT02964507|156840451|FG004|Overall Study|Other|1|||
48818732|NCT02507219|157178602|FG000|Overall Study|Withdrawal by Subject|0|||
49132809|NCT03451045|158327054|FG000|Overall Study|Non-compliance with study|2|||
49132810|NCT03451045|158327055|FG001|Overall Study|Non-compliance with study|0|||
49132811|NCT03451045|158327056|FG002|Overall Study|Non-compliance with study|1|||
49132812|NCT03451045|158327054|FG000|Overall Study|any other reason|10|||
49132813|NCT03451045|158327055|FG001|Overall Study|any other reason|2|||
49132814|NCT03451045|158327056|FG002|Overall Study|any other reason|13|||
48724210|NCT02964507|156840452|FG005|Overall Study|Other|0|||
48724211|NCT02964507|156840453|FG006|Overall Study|Other|0|||
48724212|NCT02964507|156840454|FG007|Overall Study|Other|0|||
48724213|NCT02964507|156840447|FG000|Overall Study|Death|11|||
48724214|NCT02964507|156840448|FG001|Overall Study|Death|9|||
48818733|NCT02507219|157178603|FG001|Overall Study|Withdrawal by Subject|0|||
48818734|NCT02507219|157178604|FG002|Overall Study|Withdrawal by Subject|0|||
49132815|NCT02550795|158327061|FG000|Overall Study|Physician Decision|0|||
49132816|NCT02550795|158327062|FG001|Overall Study|Physician Decision|1|||
49132817|NCT02550795|158327063|FG002|Overall Study|Physician Decision|0|||
48818735|NCT02507219|157178605|FG003|Overall Study|Withdrawal by Subject|0|||
48818736|NCT02507219|157178606|FG004|Overall Study|Withdrawal by Subject|1|||
48818737|NCT02507219|157178607|FG005|Overall Study|Withdrawal by Subject|0|||
48818738|NCT02291289|157179826|FG000|Induction Treatment|Withdrawal by Subject|0|||
48818739|NCT02291289|157179827|FG001|Induction Treatment|Withdrawal by Subject|0|||
48818740|NCT02291289|157179828|FG002|Induction Treatment|Withdrawal by Subject|0|||
48818741|NCT02291289|157179829|FG003|Induction Treatment|Withdrawal by Subject|24|||
48818742|NCT02291289|157179830|FG004|Induction Treatment|Withdrawal by Subject|0|||
48818743|NCT02291289|157179831|FG005|Induction Treatment|Withdrawal by Subject|0|||
48818744|NCT02291289|157179832|FG006|Induction Treatment|Withdrawal by Subject|0|||
48818745|NCT02291289|157179833|FG007|Induction Treatment|Withdrawal by Subject|0|||
48818746|NCT02291289|157179834|FG008|Induction Treatment|Withdrawal by Subject|0|||
48818747|NCT02291289|157179835|FG009|Induction Treatment|Withdrawal by Subject|18|||
48818748|NCT02291289|157179836|FG010|Induction Treatment|Withdrawal by Subject|0|||
48818749|NCT02291289|157179837|FG011|Induction Treatment|Withdrawal by Subject|0|||
48818750|NCT02291289|157179838|FG012|Induction Treatment|Withdrawal by Subject|0|||
48818751|NCT02291289|157179826|FG000|Induction Treatment|Adverse Event|0|||
48818752|NCT02291289|157179827|FG001|Induction Treatment|Adverse Event|0|||
48818753|NCT02291289|157179828|FG002|Induction Treatment|Adverse Event|0|||
48818754|NCT02291289|157179829|FG003|Induction Treatment|Adverse Event|3|||
48818755|NCT02291289|157179830|FG004|Induction Treatment|Adverse Event|0|||
48818756|NCT02291289|157179831|FG005|Induction Treatment|Adverse Event|0|||
48818757|NCT02291289|157179832|FG006|Induction Treatment|Adverse Event|0|||
48818758|NCT02291289|157179833|FG007|Induction Treatment|Adverse Event|0|||
48818759|NCT02291289|157179834|FG008|Induction Treatment|Adverse Event|0|||
48818760|NCT02291289|157179835|FG009|Induction Treatment|Adverse Event|1|||
48818761|NCT02291289|157179836|FG010|Induction Treatment|Adverse Event|0|||
48818762|NCT02291289|157179837|FG011|Induction Treatment|Adverse Event|0|||
48818763|NCT02291289|157179838|FG012|Induction Treatment|Adverse Event|0|||
48818764|NCT02291289|157179826|FG000|Induction Treatment|Death|25|||
48818765|NCT02291289|157179827|FG001|Induction Treatment|Death|0|||
48818766|NCT02291289|157179828|FG002|Induction Treatment|Death|0|||
48818767|NCT02291289|157179829|FG003|Induction Treatment|Death|111|||
48818768|NCT02291289|157179830|FG004|Induction Treatment|Death|0|||
48818769|NCT02291289|157179831|FG005|Induction Treatment|Death|0|||
48818770|NCT02291289|157179832|FG006|Induction Treatment|Death|1|||
48818771|NCT02291289|157179833|FG007|Induction Treatment|Death|0|||
48818772|NCT02291289|157179834|FG008|Induction Treatment|Death|0|||
48818773|NCT02291289|157179835|FG009|Induction Treatment|Death|82|||
48818774|NCT02291289|157179836|FG010|Induction Treatment|Death|0|||
48818775|NCT02291289|157179837|FG011|Induction Treatment|Death|0|||
48818776|NCT02291289|157179838|FG012|Induction Treatment|Death|0|||
48818777|NCT02291289|157179826|FG000|Induction Treatment|Lost to Follow-up|1|||
48818778|NCT02291289|157179827|FG001|Induction Treatment|Lost to Follow-up|0|||
48818779|NCT02291289|157179828|FG002|Induction Treatment|Lost to Follow-up|0|||
48818780|NCT02291289|157179829|FG003|Induction Treatment|Lost to Follow-up|12|||
48818781|NCT02291289|157179830|FG004|Induction Treatment|Lost to Follow-up|0|||
48818782|NCT02291289|157179831|FG005|Induction Treatment|Lost to Follow-up|0|||
48818783|NCT02291289|157179832|FG006|Induction Treatment|Lost to Follow-up|0|||
48818784|NCT02291289|157179833|FG007|Induction Treatment|Lost to Follow-up|0|||
48818785|NCT02291289|157179834|FG008|Induction Treatment|Lost to Follow-up|0|||
48818786|NCT02291289|157179835|FG009|Induction Treatment|Lost to Follow-up|9|||
48818787|NCT02291289|157179836|FG010|Induction Treatment|Lost to Follow-up|0|||
48818788|NCT02291289|157179837|FG011|Induction Treatment|Lost to Follow-up|0|||
48818789|NCT02291289|157179838|FG012|Induction Treatment|Lost to Follow-up|0|||
48818790|NCT02291289|157179826|FG000|Induction Treatment|Non-Compliance|0|||
48818791|NCT02291289|157179827|FG001|Induction Treatment|Non-Compliance|0|||
48818792|NCT02291289|157179828|FG002|Induction Treatment|Non-Compliance|0|||
48818793|NCT02291289|157179829|FG003|Induction Treatment|Non-Compliance|1|||
48818794|NCT02291289|157179830|FG004|Induction Treatment|Non-Compliance|0|||
48818795|NCT02291289|157179831|FG005|Induction Treatment|Non-Compliance|0|||
48818796|NCT02291289|157179832|FG006|Induction Treatment|Non-Compliance|0|||
48818797|NCT02291289|157179833|FG007|Induction Treatment|Non-Compliance|0|||
48818798|NCT02291289|157179834|FG008|Induction Treatment|Non-Compliance|0|||
48818799|NCT02291289|157179835|FG009|Induction Treatment|Non-Compliance|1|||
48818800|NCT02291289|157179836|FG010|Induction Treatment|Non-Compliance|0|||
48818801|NCT02291289|157179837|FG011|Induction Treatment|Non-Compliance|0|||
48818802|NCT02291289|157179838|FG012|Induction Treatment|Non-Compliance|0|||
48818803|NCT02291289|157179826|FG000|Induction Treatment|Reason Not Specified|0|||
48818804|NCT02291289|157179827|FG001|Induction Treatment|Reason Not Specified|0|||
48818805|NCT02291289|157179828|FG002|Induction Treatment|Reason Not Specified|0|||
48818806|NCT02291289|157179829|FG003|Induction Treatment|Reason Not Specified|4|||
48818807|NCT02291289|157179830|FG004|Induction Treatment|Reason Not Specified|0|||
49011147|NCT00481247|157877398|FG000|Overall Study|Administrative reason by sponsor|157|||
49011148|NCT00481247|157877399|FG001|Overall Study|Administrative reason by sponsor|162|||
49011149|NCT00481247|157877398|FG000|Overall Study|Varied|6|||
49011150|NCT00481247|157877399|FG001|Overall Study|Varied|15|||
49011151|NCT00481247|157877398|FG000|Overall Study|Did not receive treatment|1|||
48818808|NCT02291289|157179831|FG005|Induction Treatment|Reason Not Specified|0|||
48818809|NCT02291289|157179832|FG006|Induction Treatment|Reason Not Specified|0|||
48818810|NCT02291289|157179833|FG007|Induction Treatment|Reason Not Specified|0|||
48818811|NCT02291289|157179834|FG008|Induction Treatment|Reason Not Specified|0|||
48724215|NCT02964507|156840449|FG002|Overall Study|Death|12|||
48818812|NCT02291289|157179835|FG009|Induction Treatment|Reason Not Specified|7|||
48818813|NCT02291289|157179836|FG010|Induction Treatment|Reason Not Specified|0|||
48818814|NCT02291289|157179837|FG011|Induction Treatment|Reason Not Specified|0|||
48818815|NCT02291289|157179838|FG012|Induction Treatment|Reason Not Specified|0|||
48818816|NCT02291289|157179826|FG000|Induction Treatment|Physician Decision|0|||
48818817|NCT02291289|157179827|FG001|Induction Treatment|Physician Decision|0|||
48818818|NCT02291289|157179828|FG002|Induction Treatment|Physician Decision|0|||
48818819|NCT02291289|157179829|FG003|Induction Treatment|Physician Decision|3|||
48818820|NCT02291289|157179830|FG004|Induction Treatment|Physician Decision|0|||
48818821|NCT02291289|157179831|FG005|Induction Treatment|Physician Decision|0|||
48818822|NCT02291289|157179832|FG006|Induction Treatment|Physician Decision|0|||
48818823|NCT02291289|157179833|FG007|Induction Treatment|Physician Decision|0|||
48818824|NCT02291289|157179834|FG008|Induction Treatment|Physician Decision|0|||
48818825|NCT02291289|157179835|FG009|Induction Treatment|Physician Decision|1|||
48818826|NCT02291289|157179836|FG010|Induction Treatment|Physician Decision|0|||
48818827|NCT02291289|157179837|FG011|Induction Treatment|Physician Decision|0|||
48818828|NCT02291289|157179838|FG012|Induction Treatment|Physician Decision|0|||
48818829|NCT02291289|157179826|FG000|Induction Treatment|Protocol Violation|0|||
48818830|NCT02291289|157179827|FG001|Induction Treatment|Protocol Violation|0|||
48818831|NCT02291289|157179828|FG002|Induction Treatment|Protocol Violation|0|||
48818832|NCT02291289|157179829|FG003|Induction Treatment|Protocol Violation|3|||
48818833|NCT02291289|157179830|FG004|Induction Treatment|Protocol Violation|0|||
48818834|NCT02291289|157179831|FG005|Induction Treatment|Protocol Violation|0|||
48818835|NCT02291289|157179832|FG006|Induction Treatment|Protocol Violation|0|||
48818836|NCT02291289|157179833|FG007|Induction Treatment|Protocol Violation|0|||
48818837|NCT02291289|157179834|FG008|Induction Treatment|Protocol Violation|0|||
48818838|NCT02291289|157179835|FG009|Induction Treatment|Protocol Violation|2|||
48818839|NCT02291289|157179836|FG010|Induction Treatment|Protocol Violation|0|||
48818840|NCT02291289|157179837|FG011|Induction Treatment|Protocol Violation|0|||
48818841|NCT02291289|157179838|FG012|Induction Treatment|Protocol Violation|0|||
48818842|NCT02291289|157179826|FG000|Induction Treatment|Missing|4|||
48818843|NCT02291289|157179827|FG001|Induction Treatment|Missing|0|||
48818844|NCT02291289|157179828|FG002|Induction Treatment|Missing|0|||
48818845|NCT02291289|157179829|FG003|Induction Treatment|Missing|14|||
48818846|NCT02291289|157179830|FG004|Induction Treatment|Missing|0|||
48818847|NCT02291289|157179831|FG005|Induction Treatment|Missing|0|||
48818848|NCT02291289|157179832|FG006|Induction Treatment|Missing|0|||
48818849|NCT02291289|157179833|FG007|Induction Treatment|Missing|0|||
48818850|NCT02291289|157179834|FG008|Induction Treatment|Missing|0|||
48818851|NCT02291289|157179835|FG009|Induction Treatment|Missing|54|||
48818852|NCT02291289|157179836|FG010|Induction Treatment|Missing|0|||
48818853|NCT02291289|157179837|FG011|Induction Treatment|Missing|0|||
48818854|NCT02291289|157179838|FG012|Induction Treatment|Missing|0|||
48818855|NCT02291289|157179826|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
48818856|NCT02291289|157179827|FG001|Maintenance Treatment Phase|Withdrawal by Subject|0|||
48818857|NCT02291289|157179828|FG002|Maintenance Treatment Phase|Withdrawal by Subject|0|||
48724216|NCT02964507|156840450|FG003|Overall Study|Death|2|||
48724217|NCT02964507|156840451|FG004|Overall Study|Death|10|||
48724218|NCT02964507|156840452|FG005|Overall Study|Death|5|||
48724219|NCT02964507|156840453|FG006|Overall Study|Death|0|||
48724220|NCT02964507|156840454|FG007|Overall Study|Death|0|||
48724221|NCT02964507|156840447|FG000|Overall Study|Withdrawal by Subject|1|||
48724222|NCT02964507|156840448|FG001|Overall Study|Withdrawal by Subject|0|||
48724223|NCT02964507|156840449|FG002|Overall Study|Withdrawal by Subject|1|||
48724224|NCT02964507|156840450|FG003|Overall Study|Withdrawal by Subject|1|||
48724225|NCT02964507|156840451|FG004|Overall Study|Withdrawal by Subject|0|||
48724226|NCT02964507|156840452|FG005|Overall Study|Withdrawal by Subject|1|||
48724227|NCT02964507|156840453|FG006|Overall Study|Withdrawal by Subject|0|||
48724228|NCT02964507|156840454|FG007|Overall Study|Withdrawal by Subject|0|||
48724229|NCT02964507|156840447|FG000|Overall Study|Physician Decision|2|||
48724230|NCT02964507|156840448|FG001|Overall Study|Physician Decision|0|||
48724231|NCT02964507|156840449|FG002|Overall Study|Physician Decision|3|||
48724232|NCT02964507|156840450|FG003|Overall Study|Physician Decision|0|||
48724233|NCT02964507|156840451|FG004|Overall Study|Physician Decision|1|||
48724234|NCT02964507|156840452|FG005|Overall Study|Physician Decision|0|||
48818858|NCT02291289|157179829|FG003|Maintenance Treatment Phase|Withdrawal by Subject|0|||
48818859|NCT02291289|157179830|FG004|Maintenance Treatment Phase|Withdrawal by Subject|15|||
48818860|NCT02291289|157179831|FG005|Maintenance Treatment Phase|Withdrawal by Subject|12|||
48724235|NCT02964507|156840453|FG006|Overall Study|Physician Decision|0|||
48724236|NCT02964507|156840454|FG007|Overall Study|Physician Decision|0|||
48724237|NCT02582684|156840455|FG000|Overall Study|Unable to contact subject/parent|4|||
48818861|NCT02291289|157179832|FG006|Maintenance Treatment Phase|Withdrawal by Subject|0|||
48818862|NCT02291289|157179833|FG007|Maintenance Treatment Phase|Withdrawal by Subject|0|||
48818863|NCT02291289|157179834|FG008|Maintenance Treatment Phase|Withdrawal by Subject|0|||
48818864|NCT02291289|157179835|FG009|Maintenance Treatment Phase|Withdrawal by Subject|0|||
48818865|NCT02291289|157179836|FG010|Maintenance Treatment Phase|Withdrawal by Subject|2|||
48818866|NCT02291289|157179837|FG011|Maintenance Treatment Phase|Withdrawal by Subject|3|||
48818867|NCT02291289|157179838|FG012|Maintenance Treatment Phase|Withdrawal by Subject|0|||
48818868|NCT02291289|157179826|FG000|Maintenance Treatment Phase|Death|0|||
48818869|NCT02291289|157179827|FG001|Maintenance Treatment Phase|Death|29|||
48818870|NCT02291289|157179828|FG002|Maintenance Treatment Phase|Death|16|||
48818871|NCT02291289|157179829|FG003|Maintenance Treatment Phase|Death|0|||
48818872|NCT02291289|157179830|FG004|Maintenance Treatment Phase|Death|188|||
48818873|NCT02291289|157179831|FG005|Maintenance Treatment Phase|Death|107|||
48818874|NCT02291289|157179832|FG006|Maintenance Treatment Phase|Death|0|||
48818875|NCT02291289|157179833|FG007|Maintenance Treatment Phase|Death|1|||
48818876|NCT02291289|157179834|FG008|Maintenance Treatment Phase|Death|1|||
48818877|NCT02291289|157179835|FG009|Maintenance Treatment Phase|Death|0|||
48818878|NCT02291289|157179836|FG010|Maintenance Treatment Phase|Death|46|||
48818879|NCT02291289|157179837|FG011|Maintenance Treatment Phase|Death|19|||
48818880|NCT02291289|157179838|FG012|Maintenance Treatment Phase|Death|0|||
48818881|NCT02291289|157179826|FG000|Maintenance Treatment Phase|Adverse Event|0|||
48818882|NCT02291289|157179827|FG001|Maintenance Treatment Phase|Adverse Event|0|||
48818883|NCT02291289|157179828|FG002|Maintenance Treatment Phase|Adverse Event|0|||
48818884|NCT02291289|157179829|FG003|Maintenance Treatment Phase|Adverse Event|0|||
48818885|NCT02291289|157179830|FG004|Maintenance Treatment Phase|Adverse Event|1|||
48818886|NCT02291289|157179831|FG005|Maintenance Treatment Phase|Adverse Event|1|||
48818887|NCT02291289|157179832|FG006|Maintenance Treatment Phase|Adverse Event|0|||
48818888|NCT02291289|157179833|FG007|Maintenance Treatment Phase|Adverse Event|0|||
48818889|NCT02291289|157179834|FG008|Maintenance Treatment Phase|Adverse Event|0|||
48818890|NCT02291289|157179835|FG009|Maintenance Treatment Phase|Adverse Event|0|||
48818891|NCT02291289|157179836|FG010|Maintenance Treatment Phase|Adverse Event|0|||
48818892|NCT02291289|157179837|FG011|Maintenance Treatment Phase|Adverse Event|0|||
48818893|NCT02291289|157179838|FG012|Maintenance Treatment Phase|Adverse Event|0|||
48818894|NCT02291289|157179826|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
48818895|NCT02291289|157179827|FG001|Maintenance Treatment Phase|Lost to Follow-up|1|||
48818896|NCT02291289|157179828|FG002|Maintenance Treatment Phase|Lost to Follow-up|0|||
48818897|NCT02291289|157179829|FG003|Maintenance Treatment Phase|Lost to Follow-up|0|||
48818898|NCT02291289|157179830|FG004|Maintenance Treatment Phase|Lost to Follow-up|15|||
48818899|NCT02291289|157179831|FG005|Maintenance Treatment Phase|Lost to Follow-up|4|||
48818900|NCT02291289|157179832|FG006|Maintenance Treatment Phase|Lost to Follow-up|0|||
48818901|NCT02291289|157179833|FG007|Maintenance Treatment Phase|Lost to Follow-up|1|||
48818902|NCT02291289|157179834|FG008|Maintenance Treatment Phase|Lost to Follow-up|0|||
48818903|NCT02291289|157179835|FG009|Maintenance Treatment Phase|Lost to Follow-up|0|||
48818904|NCT02291289|157179836|FG010|Maintenance Treatment Phase|Lost to Follow-up|3|||
48818905|NCT02291289|157179837|FG011|Maintenance Treatment Phase|Lost to Follow-up|3|||
48818906|NCT02291289|157179838|FG012|Maintenance Treatment Phase|Lost to Follow-up|0|||
48818907|NCT02291289|157179826|FG000|Maintenance Treatment Phase|Reason Not Specified|0|||
48818908|NCT02291289|157179827|FG001|Maintenance Treatment Phase|Reason Not Specified|0|||
48818909|NCT02291289|157179828|FG002|Maintenance Treatment Phase|Reason Not Specified|0|||
48818910|NCT02291289|157179829|FG003|Maintenance Treatment Phase|Reason Not Specified|0|||
48818911|NCT02291289|157179830|FG004|Maintenance Treatment Phase|Reason Not Specified|7|||
48818912|NCT02291289|157179831|FG005|Maintenance Treatment Phase|Reason Not Specified|2|||
48818913|NCT02291289|157179832|FG006|Maintenance Treatment Phase|Reason Not Specified|0|||
48818914|NCT02291289|157179833|FG007|Maintenance Treatment Phase|Reason Not Specified|1|||
48818915|NCT02291289|157179834|FG008|Maintenance Treatment Phase|Reason Not Specified|0|||
48818916|NCT02291289|157179835|FG009|Maintenance Treatment Phase|Reason Not Specified|0|||
48818917|NCT02291289|157179836|FG010|Maintenance Treatment Phase|Reason Not Specified|1|||
48818918|NCT02291289|157179837|FG011|Maintenance Treatment Phase|Reason Not Specified|0|||
48818919|NCT02291289|157179838|FG012|Maintenance Treatment Phase|Reason Not Specified|0|||
48818920|NCT02291289|157179826|FG000|Maintenance Treatment Phase|Physician Decision|0|||
48818921|NCT02291289|157179827|FG001|Maintenance Treatment Phase|Physician Decision|2|||
48818922|NCT02291289|157179828|FG002|Maintenance Treatment Phase|Physician Decision|0|||
48818923|NCT02291289|157179829|FG003|Maintenance Treatment Phase|Physician Decision|0|||
48818924|NCT02291289|157179830|FG004|Maintenance Treatment Phase|Physician Decision|3|||
48818925|NCT02291289|157179831|FG005|Maintenance Treatment Phase|Physician Decision|0|||
48818926|NCT02291289|157179832|FG006|Maintenance Treatment Phase|Physician Decision|0|||
48818927|NCT02291289|157179833|FG007|Maintenance Treatment Phase|Physician Decision|0|||
48818928|NCT02291289|157179834|FG008|Maintenance Treatment Phase|Physician Decision|0|||
49132818|NCT03197129|158327066|FG000|Overall Study|did not answer the VPT: shyness|4|||
49132819|NCT03197129|158327067|FG001|Overall Study|did not answer the VPT: shyness|5|||
48818929|NCT02291289|157179835|FG009|Maintenance Treatment Phase|Physician Decision|0|||
48818930|NCT02291289|157179836|FG010|Maintenance Treatment Phase|Physician Decision|1|||
48818931|NCT02291289|157179837|FG011|Maintenance Treatment Phase|Physician Decision|3|||
48818932|NCT02291289|157179838|FG012|Maintenance Treatment Phase|Physician Decision|0|||
48818933|NCT02291289|157179826|FG000|Maintenance Treatment Phase|Not Treated|0|||
48818934|NCT02291289|157179827|FG001|Maintenance Treatment Phase|Not Treated|0|||
48818935|NCT02291289|157179828|FG002|Maintenance Treatment Phase|Not Treated|2|||
48818936|NCT02291289|157179829|FG003|Maintenance Treatment Phase|Not Treated|0|||
48818937|NCT02291289|157179830|FG004|Maintenance Treatment Phase|Not Treated|0|||
48818938|NCT02291289|157179831|FG005|Maintenance Treatment Phase|Not Treated|0|||
48818939|NCT02291289|157179832|FG006|Maintenance Treatment Phase|Not Treated|0|||
48818940|NCT02291289|157179833|FG007|Maintenance Treatment Phase|Not Treated|0|||
48818941|NCT02291289|157179834|FG008|Maintenance Treatment Phase|Not Treated|0|||
48818942|NCT02291289|157179835|FG009|Maintenance Treatment Phase|Not Treated|0|||
48818943|NCT02291289|157179836|FG010|Maintenance Treatment Phase|Not Treated|0|||
48724238|NCT02582684|156840455|FG000|Overall Study|Subject not able to get to clinic|10|||
48724239|NCT02582684|156840455|FG000|Overall Study|Subject withdrew consent|1|||
48724240|NCT02582684|156840455|FG000|Overall Study|Found to be ineligible after enrollment|2|||
48724241|NCT04074759|156840461|FG000|Overall Study|Withdrawal by Subject|0|||
48724242|NCT04074759|156840462|FG001|Overall Study|Withdrawal by Subject|0|||
48724243|NCT04074759|156840463|FG002|Overall Study|Withdrawal by Subject|0|||
48724244|NCT04074759|156840464|FG003|Overall Study|Withdrawal by Subject|0|||
48724245|NCT04074759|156840465|FG004|Overall Study|Withdrawal by Subject|0|||
48724246|NCT04074759|156840466|FG005|Overall Study|Withdrawal by Subject|2|||
48724247|NCT04074759|156840467|FG006|Overall Study|Withdrawal by Subject|0|||
48724248|NCT04074759|156840468|FG007|Overall Study|Withdrawal by Subject|2|||
48724249|NCT04074759|156840469|FG008|Overall Study|Withdrawal by Subject|1|||
48724250|NCT04074759|156840470|FG009|Overall Study|Withdrawal by Subject|2|||
48724251|NCT04074759|156840471|FG010|Overall Study|Withdrawal by Subject|9|||
48724252|NCT04074759|156840472|FG011|Overall Study|Withdrawal by Subject|2|||
48724253|NCT04074759|156840473|FG012|Overall Study|Withdrawal by Subject|1|||
48724254|NCT04074759|156840474|FG013|Overall Study|Withdrawal by Subject|3|||
48724255|NCT04074759|156840475|FG014|Overall Study|Withdrawal by Subject|2|||
48724256|NCT04074759|156840476|FG015|Overall Study|Withdrawal by Subject|0|||
48724257|NCT04074759|156840477|FG016|Overall Study|Withdrawal by Subject|0|||
48724258|NCT04074759|156840478|FG017|Overall Study|Withdrawal by Subject|3|||
48724259|NCT04074759|156840479|FG018|Overall Study|Withdrawal by Subject|1|||
48724260|NCT04074759|156840461|FG000|Overall Study|Death|1|||
48724261|NCT04074759|156840462|FG001|Overall Study|Death|0|||
48724262|NCT04074759|156840463|FG002|Overall Study|Death|1|||
48724263|NCT04074759|156840464|FG003|Overall Study|Death|1|||
48724264|NCT04074759|156840465|FG004|Overall Study|Death|2|||
48724265|NCT04074759|156840466|FG005|Overall Study|Death|0|||
48724266|NCT04074759|156840467|FG006|Overall Study|Death|1|||
48724267|NCT04074759|156840468|FG007|Overall Study|Death|0|||
48724268|NCT04074759|156840469|FG008|Overall Study|Death|3|||
48724269|NCT04074759|156840470|FG009|Overall Study|Death|2|||
48724270|NCT04074759|156840471|FG010|Overall Study|Death|4|||
48724271|NCT04074759|156840472|FG011|Overall Study|Death|1|||
48724272|NCT04074759|156840473|FG012|Overall Study|Death|0|||
48724273|NCT04074759|156840474|FG013|Overall Study|Death|2|||
48724274|NCT04074759|156840475|FG014|Overall Study|Death|1|||
48724275|NCT04074759|156840476|FG015|Overall Study|Death|0|||
48724276|NCT04074759|156840477|FG016|Overall Study|Death|1|||
48724277|NCT04074759|156840478|FG017|Overall Study|Death|0|||
48724278|NCT04074759|156840479|FG018|Overall Study|Death|1|||
48724279|NCT04074759|156840461|FG000|Overall Study|Lost to Follow-up|0|||
48724280|NCT04074759|156840462|FG001|Overall Study|Lost to Follow-up|0|||
48724281|NCT04074759|156840463|FG002|Overall Study|Lost to Follow-up|0|||
48724282|NCT04074759|156840464|FG003|Overall Study|Lost to Follow-up|0|||
48724283|NCT04074759|156840465|FG004|Overall Study|Lost to Follow-up|0|||
48724284|NCT04074759|156840466|FG005|Overall Study|Lost to Follow-up|0|||
48724285|NCT04074759|156840467|FG006|Overall Study|Lost to Follow-up|0|||
48724286|NCT04074759|156840468|FG007|Overall Study|Lost to Follow-up|0|||
48724287|NCT04074759|156840469|FG008|Overall Study|Lost to Follow-up|0|||
48724288|NCT04074759|156840470|FG009|Overall Study|Lost to Follow-up|0|||
48724289|NCT04074759|156840471|FG010|Overall Study|Lost to Follow-up|1|||
48724290|NCT04074759|156840472|FG011|Overall Study|Lost to Follow-up|0|||
48724291|NCT04074759|156840473|FG012|Overall Study|Lost to Follow-up|0|||
48724292|NCT04074759|156840474|FG013|Overall Study|Lost to Follow-up|0|||
48724293|NCT04074759|156840475|FG014|Overall Study|Lost to Follow-up|0|||
48724294|NCT04074759|156840476|FG015|Overall Study|Lost to Follow-up|0|||
48724295|NCT04074759|156840477|FG016|Overall Study|Lost to Follow-up|1|||
48724296|NCT04074759|156840478|FG017|Overall Study|Lost to Follow-up|0|||
48724297|NCT04074759|156840479|FG018|Overall Study|Lost to Follow-up|1|||
48724298|NCT04074759|156840461|FG000|Overall Study|Other|0|||
48724299|NCT04074759|156840462|FG001|Overall Study|Other|1|||
48724300|NCT04074759|156840463|FG002|Overall Study|Other|1|||
48724301|NCT04074759|156840464|FG003|Overall Study|Other|0|||
48724302|NCT04074759|156840465|FG004|Overall Study|Other|2|||
48724303|NCT04074759|156840466|FG005|Overall Study|Other|1|||
48724304|NCT04074759|156840467|FG006|Overall Study|Other|2|||
48724305|NCT04074759|156840468|FG007|Overall Study|Other|1|||
48818944|NCT02291289|157179837|FG011|Maintenance Treatment Phase|Not Treated|0|||
48818945|NCT02291289|157179838|FG012|Maintenance Treatment Phase|Not Treated|0|||
48818946|NCT02291289|157179826|FG000|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
48818947|NCT02291289|157179827|FG001|Maintenance Treatment Phase|Study Ended by Sponsor|1|||
48818948|NCT02291289|157179828|FG002|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
48818949|NCT02291289|157179829|FG003|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
48818950|NCT02291289|157179830|FG004|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
48818951|NCT02291289|157179831|FG005|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
48818952|NCT02291289|157179832|FG006|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
48818953|NCT02291289|157179833|FG007|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
48818954|NCT02291289|157179834|FG008|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
48818955|NCT02291289|157179835|FG009|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
48818956|NCT02291289|157179836|FG010|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
48818957|NCT02291289|157179837|FG011|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
48818958|NCT02291289|157179838|FG012|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
48818959|NCT02291289|157179826|FG000|Maintenance Treatment Phase|Non-Compliance|0|||
48818960|NCT02291289|157179827|FG001|Maintenance Treatment Phase|Non-Compliance|1|||
48818961|NCT02291289|157179828|FG002|Maintenance Treatment Phase|Non-Compliance|0|||
48818962|NCT02291289|157179829|FG003|Maintenance Treatment Phase|Non-Compliance|0|||
48818963|NCT02291289|157179830|FG004|Maintenance Treatment Phase|Non-Compliance|2|||
48818964|NCT02291289|157179831|FG005|Maintenance Treatment Phase|Non-Compliance|1|||
48818965|NCT02291289|157179832|FG006|Maintenance Treatment Phase|Non-Compliance|0|||
48818966|NCT02291289|157179833|FG007|Maintenance Treatment Phase|Non-Compliance|0|||
48818967|NCT02291289|157179834|FG008|Maintenance Treatment Phase|Non-Compliance|0|||
48818968|NCT02291289|157179835|FG009|Maintenance Treatment Phase|Non-Compliance|0|||
48818969|NCT02291289|157179836|FG010|Maintenance Treatment Phase|Non-Compliance|0|||
48818970|NCT02291289|157179837|FG011|Maintenance Treatment Phase|Non-Compliance|0|||
48818971|NCT02291289|157179838|FG012|Maintenance Treatment Phase|Non-Compliance|0|||
48818972|NCT02291289|157179826|FG000|Early Disease Progression|Death|0|||
48818973|NCT02291289|157179827|FG001|Early Disease Progression|Death|0|||
48818974|NCT02291289|157179828|FG002|Early Disease Progression|Death|0|||
48818975|NCT02291289|157179829|FG003|Early Disease Progression|Death|0|||
48818976|NCT02291289|157179830|FG004|Early Disease Progression|Death|0|||
48818977|NCT02291289|157179831|FG005|Early Disease Progression|Death|0|||
48818978|NCT02291289|157179832|FG006|Early Disease Progression|Death|0|||
48724306|NCT04074759|156840469|FG008|Overall Study|Other|1|||
49132820|NCT00071981|158327070|FG000|Overall Study|Lack of Efficacy|37|||
48724307|NCT04074759|156840470|FG009|Overall Study|Other|4|||
48724308|NCT04074759|156840471|FG010|Overall Study|Other|4|||
48724309|NCT04074759|156840472|FG011|Overall Study|Other|2|||
48724310|NCT04074759|156840473|FG012|Overall Study|Other|0|||
48724311|NCT04074759|156840474|FG013|Overall Study|Other|0|||
48724312|NCT04074759|156840475|FG014|Overall Study|Other|0|||
48724313|NCT04074759|156840476|FG015|Overall Study|Other|1|||
48724314|NCT04074759|156840477|FG016|Overall Study|Other|0|||
48818979|NCT02291289|157179833|FG007|Early Disease Progression|Death|0|||
48818980|NCT02291289|157179834|FG008|Early Disease Progression|Death|0|||
48818981|NCT02291289|157179835|FG009|Early Disease Progression|Death|0|||
48818982|NCT02291289|157179836|FG010|Early Disease Progression|Death|0|||
48818983|NCT02291289|157179837|FG011|Early Disease Progression|Death|0|||
48818984|NCT02291289|157179838|FG012|Early Disease Progression|Death|10|||
48818985|NCT02291289|157179826|FG000|Early Disease Progression|Lost to Follow-up|0|||
48818986|NCT02291289|157179827|FG001|Early Disease Progression|Lost to Follow-up|0|||
48818987|NCT02291289|157179828|FG002|Early Disease Progression|Lost to Follow-up|0|||
48818988|NCT02291289|157179829|FG003|Early Disease Progression|Lost to Follow-up|0|||
48818989|NCT02291289|157179830|FG004|Early Disease Progression|Lost to Follow-up|0|||
49132821|NCT00071981|158327071|FG001|Overall Study|Lack of Efficacy|29|||
49132822|NCT00071981|158327072|FG002|Overall Study|Lack of Efficacy|30|||
49132823|NCT00071981|158327073|FG003|Overall Study|Lack of Efficacy|43|||
48818990|NCT02291289|157179831|FG005|Early Disease Progression|Lost to Follow-up|0|||
48818991|NCT02291289|157179832|FG006|Early Disease Progression|Lost to Follow-up|0|||
49132824|NCT00071981|158327070|FG000|Overall Study|Adverse Event|4|||
49132825|NCT00071981|158327071|FG001|Overall Study|Adverse Event|4|||
49132826|NCT00071981|158327072|FG002|Overall Study|Adverse Event|3|||
49132827|NCT00071981|158327073|FG003|Overall Study|Adverse Event|1|||
49132828|NCT00071981|158327070|FG000|Overall Study|Death|0|||
49132829|NCT00071981|158327071|FG001|Overall Study|Death|0|||
49132830|NCT00071981|158327072|FG002|Overall Study|Death|1|||
49132831|NCT00071981|158327073|FG003|Overall Study|Death|1|||
48724315|NCT04074759|156840478|FG017|Overall Study|Other|0|||
48724316|NCT04074759|156840479|FG018|Overall Study|Other|0|||
48724317|NCT04074759|156840461|FG000|Overall Study|Missing end of study status|0|||
48724318|NCT04074759|156840462|FG001|Overall Study|Missing end of study status|0|||
48724319|NCT04074759|156840463|FG002|Overall Study|Missing end of study status|0|||
48724320|NCT04074759|156840464|FG003|Overall Study|Missing end of study status|0|||
48724321|NCT04074759|156840465|FG004|Overall Study|Missing end of study status|0|||
48724322|NCT04074759|156840466|FG005|Overall Study|Missing end of study status|0|||
48724323|NCT04074759|156840467|FG006|Overall Study|Missing end of study status|0|||
48724324|NCT04074759|156840468|FG007|Overall Study|Missing end of study status|0|||
49132832|NCT00071981|158327070|FG000|Overall Study|Withdrawal by Subject|3|||
49132833|NCT00071981|158327071|FG001|Overall Study|Withdrawal by Subject|1|||
48724325|NCT04074759|156840469|FG008|Overall Study|Missing end of study status|0|||
48724326|NCT04074759|156840470|FG009|Overall Study|Missing end of study status|0|||
48724327|NCT04074759|156840471|FG010|Overall Study|Missing end of study status|2|||
48724328|NCT04074759|156840472|FG011|Overall Study|Missing end of study status|0|||
48724329|NCT04074759|156840473|FG012|Overall Study|Missing end of study status|0|||
48724330|NCT04074759|156840474|FG013|Overall Study|Missing end of study status|0|||
48724331|NCT04074759|156840475|FG014|Overall Study|Missing end of study status|0|||
48724332|NCT04074759|156840476|FG015|Overall Study|Missing end of study status|0|||
48724333|NCT04074759|156840477|FG016|Overall Study|Missing end of study status|1|||
48724334|NCT04074759|156840478|FG017|Overall Study|Missing end of study status|0|||
48724335|NCT04074759|156840479|FG018|Overall Study|Missing end of study status|0|||
48724336|NCT00555425|156840480|FG000|Overall Study|Missed Medication > 1 wk|34|||
48724337|NCT00555425|156840481|FG001|Overall Study|Missed Medication > 1 wk|15|||
48724338|NCT00555425|156840480|FG000|Overall Study|Missed 3 physician management visits|1|||
48724339|NCT00555425|156840481|FG001|Overall Study|Missed 3 physician management visits|0|||
48724340|NCT00555425|156840480|FG000|Overall Study|Met criteria for protective transfer|16|||
48724341|NCT00555425|156840481|FG001|Overall Study|Met criteria for protective transfer|3|||
48724342|NCT00555425|156840480|FG000|Overall Study|Became pregnant and transferred care|0|||
48724343|NCT00555425|156840481|FG001|Overall Study|Became pregnant and transferred care|1|||
48724344|NCT01262352|156840482|FG000|Period 1|Illness after randomization|1|||
48724345|NCT01262352|156840483|FG001|Period 1|Illness after randomization|0|||
48724346|NCT01262352|156840482|FG000|Washout|Adverse Event|1|||
48724347|NCT01262352|156840483|FG001|Washout|Adverse Event|1|||
48724348|NCT01262352|156840482|FG000|Washout|Extended Washout|0|||
48724349|NCT01262352|156840483|FG001|Washout|Extended Washout|1|||
48724350|NCT00450385|156840484|FG000|Overall Study|Death|3|||
48724351|NCT00450385|156840484|FG000|Overall Study|Protocol Violation|1|||
48724352|NCT00450385|156840484|FG000|Overall Study|Withdrawal by Subject|2|||
48724353|NCT00450385|156840484|FG000|Overall Study|Lack of Efficacy|2|||
48724354|NCT00450385|156840484|FG000|Overall Study|Adverse Event|1|||
48724355|NCT00450385|156840484|FG000|Overall Study|Physician Decision|1|||
48724356|NCT00450385|156840484|FG000|Overall Study|Other|3|||
48724357|NCT00645788|156840485|FG000|Overall Study|Did not receive study drug|1|||
48724358|NCT00645788|156840486|FG001|Overall Study|Did not receive study drug|1|||
48724359|NCT00645788|156840487|FG002|Overall Study|Did not receive study drug|0|||
48724360|NCT00645788|156840488|FG003|Overall Study|Did not receive study drug|0|||
48724361|NCT00645788|156840485|FG000|Overall Study|Adverse Event|4|||
48724362|NCT00645788|156840486|FG001|Overall Study|Adverse Event|9|||
48724363|NCT00645788|156840487|FG002|Overall Study|Adverse Event|5|||
48724364|NCT00645788|156840488|FG003|Overall Study|Adverse Event|3|||
48724365|NCT00645788|156840485|FG000|Overall Study|Lost to Follow-up|1|||
48724366|NCT00645788|156840486|FG001|Overall Study|Lost to Follow-up|0|||
48724367|NCT00645788|156840487|FG002|Overall Study|Lost to Follow-up|0|||
48724368|NCT00645788|156840488|FG003|Overall Study|Lost to Follow-up|0|||
48724369|NCT00645788|156840485|FG000|Overall Study|Protocol Violation|1|||
48724370|NCT00645788|156840486|FG001|Overall Study|Protocol Violation|0|||
48724371|NCT00645788|156840487|FG002|Overall Study|Protocol Violation|2|||
48724372|NCT00645788|156840488|FG003|Overall Study|Protocol Violation|0|||
48724373|NCT00645788|156840485|FG000|Overall Study|Withdrawal by Subject|0|||
48724374|NCT00645788|156840486|FG001|Overall Study|Withdrawal by Subject|1|||
48724375|NCT00645788|156840487|FG002|Overall Study|Withdrawal by Subject|0|||
48724376|NCT00645788|156840488|FG003|Overall Study|Withdrawal by Subject|2|||
48724377|NCT00645788|156840485|FG000|Overall Study|Pulmonary exacerbation|13|||
48724378|NCT00645788|156840486|FG001|Overall Study|Pulmonary exacerbation|16|||
49132834|NCT00071981|158327072|FG002|Overall Study|Withdrawal by Subject|0|||
49132835|NCT00071981|158327073|FG003|Overall Study|Withdrawal by Subject|0|||
48724379|NCT00645788|156840487|FG002|Overall Study|Pulmonary exacerbation|11|||
48724380|NCT00645788|156840488|FG003|Overall Study|Pulmonary exacerbation|9|||
48724381|NCT00400153|156840489|FG000|Overall Study|AE due to study disease worsening|14|||
48724382|NCT00400153|156840490|FG001|Overall Study|AE due to study disease worsening|19|||
48724383|NCT00400153|156840491|FG002|Overall Study|AE due to study disease worsening|20|||
48724384|NCT00400153|156840489|FG000|Overall Study|AE due to other disease worsening|2|||
48724385|NCT00400153|156840490|FG001|Overall Study|AE due to other disease worsening|1|||
48724386|NCT00400153|156840491|FG002|Overall Study|AE due to other disease worsening|0|||
48724387|NCT00400153|156840489|FG000|Overall Study|AE due to other condition|3|||
48724388|NCT00400153|156840490|FG001|Overall Study|AE due to other condition|14|||
48724389|NCT00400153|156840491|FG002|Overall Study|AE due to other condition|15|||
48724390|NCT00400153|156840489|FG000|Overall Study|Protocol Violation|7|||
48724391|NCT00400153|156840490|FG001|Overall Study|Protocol Violation|4|||
48724392|NCT00400153|156840491|FG002|Overall Study|Protocol Violation|9|||
48818992|NCT02291289|157179833|FG007|Early Disease Progression|Lost to Follow-up|0|||
48818993|NCT02291289|157179834|FG008|Early Disease Progression|Lost to Follow-up|0|||
48818994|NCT02291289|157179835|FG009|Early Disease Progression|Lost to Follow-up|0|||
48818995|NCT02291289|157179836|FG010|Early Disease Progression|Lost to Follow-up|0|||
48818996|NCT02291289|157179837|FG011|Early Disease Progression|Lost to Follow-up|0|||
48818997|NCT02291289|157179838|FG012|Early Disease Progression|Lost to Follow-up|1|||
48818998|NCT03615482|157179839|FG000|Overall Study|Death|1|||
48818999|NCT03615482|157179840|FG001|Overall Study|Death|0|||
48819000|NCT03615482|157179839|FG000|Overall Study|Lost to Follow-up|7|||
48819001|NCT03615482|157179840|FG001|Overall Study|Lost to Follow-up|7|||
48819002|NCT03615482|157179839|FG000|Overall Study|Physician Decision|2|||
48819003|NCT03615482|157179840|FG001|Overall Study|Physician Decision|3|||
48819004|NCT03615482|157179839|FG000|Overall Study|Withdrawal by Subject|7|||
48819005|NCT03615482|157179840|FG001|Overall Study|Withdrawal by Subject|7|||
48819006|NCT00163215|157179841|FG000|Overall Study|Lack of Efficacy|3|||
48819007|NCT00163215|157179841|FG000|Overall Study|Withdrawal by Subject|5|||
48819008|NCT00163215|157179841|FG000|Overall Study|Other|7|||
48819009|NCT00504348|157179842|FG000|Overall Study|Adverse Event|3|||
48819010|NCT00504348|157179842|FG000|Overall Study|Lack of Efficacy|4|||
48819011|NCT00504348|157179842|FG000|Overall Study|Physician Decision|1|||
48819012|NCT00999661|157179846|FG000|Overall Study|Lost to Follow-up|59|||
48819013|NCT00999661|157179846|FG000|Overall Study|Adverse Event|1|||
48819014|NCT00999661|157179846|FG000|Overall Study|Withdrawal by Subject|1|||
48819015|NCT00999661|157179846|FG000|Overall Study|Not meeting eligibility criteria|9|||
48819016|NCT00506285|157179847|FG000|3 Week Screening Phase|Withdrawal by Subject|17|||
48819017|NCT00506285|157179848|FG001|3 Week Screening Phase|Withdrawal by Subject|10|||
48819018|NCT00506285|157179847|FG000|Double Blind Cross-Over Phase|Withdrawal by Subject|4|||
48819019|NCT00506285|157179848|FG001|Double Blind Cross-Over Phase|Withdrawal by Subject|3|||
48819020|NCT00506285|157179847|FG000|Double Blind Cross-Over Phase|Lost to Follow-up|5|||
48819021|NCT00506285|157179848|FG001|Double Blind Cross-Over Phase|Lost to Follow-up|2|||
48819022|NCT00506285|157179847|FG000|6-month Open Label Phase|Lost to Follow-up|1|||
48819023|NCT00506285|157179848|FG001|6-month Open Label Phase|Lost to Follow-up|7|||
48819024|NCT00506285|157179847|FG000|6-month Open Label Phase|Withdrawal by Subject|9|||
48819025|NCT00506285|157179848|FG001|6-month Open Label Phase|Withdrawal by Subject|5|||
48819026|NCT01238575|157179849|FG000|Overall Study|Lack of Efficacy|2|||
48819027|NCT01238575|157179850|FG001|Overall Study|Lack of Efficacy|4|||
48819028|NCT01238575|157179849|FG000|Overall Study|Adverse Event|2|||
48819029|NCT01238575|157179850|FG001|Overall Study|Adverse Event|0|||
48819030|NCT00593554|157179851|FG000|Overall Study|Death|1|||
48819031|NCT00593554|157179852|FG001|Overall Study|Death|2|||
48819032|NCT00593554|157179851|FG000|Overall Study|Physician Decision|0|||
48819033|NCT00593554|157179852|FG001|Overall Study|Physician Decision|1|||
48819034|NCT00593554|157179851|FG000|Overall Study|Withdrawal by Subject|1|||
48819035|NCT00593554|157179852|FG001|Overall Study|Withdrawal by Subject|0|||
48819036|NCT00593554|157179851|FG000|Overall Study|Disease Progression|1|||
48819037|NCT00593554|157179852|FG001|Overall Study|Disease Progression|2|||
48819038|NCT04668989|157179859|FG000|First Intervention|Covid-19 related self-isolation|0|||
48819039|NCT04668989|157179860|FG001|First Intervention|Covid-19 related self-isolation|1|||
48819040|NCT04668989|157179859|FG000|Second Intervention|Adverse Event|0|||
48819041|NCT04668989|157179860|FG001|Second Intervention|Adverse Event|1|||
48819042|NCT01375959|157179861|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
48819043|NCT01375959|157179862|FG001|First Intervention (6 Weeks)|Adverse Event|3|||
48819044|NCT01375959|157179861|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
48819045|NCT01375959|157179862|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
48819046|NCT01375959|157179861|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
48819047|NCT01375959|157179862|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
48819048|NCT02206152|157179873|FG000|Pre-Randomization|Withdrawal by Subject|2|||
48819049|NCT02420327|157179875|FG000|Overall Study|Adverse Event|7|||
48819050|NCT02420327|157179875|FG000|Overall Study|Pregnancy|1|||
48819051|NCT02420327|157179875|FG000|Overall Study|Withdrawal by Subject|6|||
49132836|NCT00071981|158327070|FG000|Overall Study|No protocol therapy|2|||
49132837|NCT00071981|158327071|FG001|Overall Study|No protocol therapy|5|||
49132838|NCT00071981|158327072|FG002|Overall Study|No protocol therapy|1|||
49132839|NCT00071981|158327073|FG003|Overall Study|No protocol therapy|0|||
49132840|NCT00071981|158327070|FG000|Overall Study|others (not specified in the study)|0|||
49132841|NCT00071981|158327071|FG001|Overall Study|others (not specified in the study)|2|||
49132842|NCT00071981|158327072|FG002|Overall Study|others (not specified in the study)|2|||
49132843|NCT00071981|158327073|FG003|Overall Study|others (not specified in the study)|0|||
49132844|NCT00317369|158327074|FG000|Overall Study|Adverse Event|2|||
48819052|NCT02420327|157179875|FG000|Overall Study|Lost to Follow-up|1|||
48819053|NCT02420327|157179875|FG000|Overall Study|Protocol Violation|1|||
48819054|NCT04496167|157179877|FG000|Overall Study|Adverse Event|6|||
48819055|NCT04496167|157179878|FG001|Overall Study|Adverse Event|2|||
48819056|NCT04496167|157179877|FG000|Overall Study|Withdrawal by Subject|7|||
48819057|NCT04496167|157179878|FG001|Overall Study|Withdrawal by Subject|6|||
48819058|NCT04496167|157179877|FG000|Overall Study|Lost to Follow-up|3|||
48819059|NCT04496167|157179878|FG001|Overall Study|Lost to Follow-up|5|||
48819060|NCT04496167|157179877|FG000|Overall Study|Not Treated|1|||
48819061|NCT04496167|157179878|FG001|Overall Study|Not Treated|2|||
48819062|NCT04496167|157179877|FG000|Overall Study|Other Than Specified|1|||
48819063|NCT04496167|157179878|FG001|Overall Study|Other Than Specified|1|||
48819064|NCT00683449|157179879|FG000|Overall Study|Lost to Follow-up|0|||
48819065|NCT00683449|157179880|FG001|Overall Study|Lost to Follow-up|1|||
48819066|NCT00683449|157179881|FG002|Overall Study|Lost to Follow-up|0|||
48819067|NCT00683449|157179882|FG003|Overall Study|Lost to Follow-up|0|||
48819068|NCT00683449|157179883|FG004|Overall Study|Lost to Follow-up|0|||
48819069|NCT02322775|157179885|FG000|Overall Study|Adverse Event|1|||
48819070|NCT02322775|157179886|FG001|Overall Study|Adverse Event|0|||
48819071|NCT02322775|157179885|FG000|Overall Study|Lost to Follow-up|0|||
48819072|NCT02322775|157179886|FG001|Overall Study|Lost to Follow-up|1|||
48819073|NCT02322775|157179885|FG000|Overall Study|Protocol Violation|1|||
48819074|NCT02322775|157179886|FG001|Overall Study|Protocol Violation|0|||
48819075|NCT02322775|157179885|FG000|Overall Study|Withdrawal by Subject|3|||
48819076|NCT02322775|157179886|FG001|Overall Study|Withdrawal by Subject|4|||
48819077|NCT02322775|157179885|FG000|Overall Study|Not willing to perform all FU visits|0|||
48819078|NCT02322775|157179886|FG001|Overall Study|Not willing to perform all FU visits|1|||
48819079|NCT03590743|157179892|FG000|Overall Study|Withdrawal by Subject|0|||
48819080|NCT03590743|157179893|FG001|Overall Study|Withdrawal by Subject|1|||
48819081|NCT01190176|157179894|FG000|Overall Study|Withdrawal by Subject|1|||
48819082|NCT01190176|157179894|FG000|Overall Study|Lost to Follow-up|1|||
48819083|NCT02696226|157179895|FG000|Overall Study|Study terminated - lack of enrollment|1|||
48819084|NCT02696226|157179896|FG001|Overall Study|Study terminated - lack of enrollment|0|||
48819085|NCT02696226|157179897|FG002|Overall Study|Study terminated - lack of enrollment|2|||
48819086|NCT02696226|157179898|FG003|Overall Study|Study terminated - lack of enrollment|0|||
48819087|NCT02909101|157179906|FG000|Overall Study|Lost to Follow-up|1|||
48819088|NCT02909101|157179907|FG001|Overall Study|Lost to Follow-up|1|||
48819089|NCT01836458|157179908|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
48819090|NCT01836458|157179909|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
48819091|NCT01836458|157179910|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
48819092|NCT01836458|157179911|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
48819093|NCT01221181|157179916|FG000|Overall Study|Lost to Follow-up|1|||
48819094|NCT02189863|157179917|FG000|First 2 Weeks|Motion Sickness|4|||
48819095|NCT02189863|157179918|FG001|First 2 Weeks|Motion Sickness|2|||
48819096|NCT02427646|157179923|FG000|Overall Study|Lack of Efficacy|2|||
48819097|NCT02427646|157179924|FG001|Overall Study|Lack of Efficacy|3|||
48819098|NCT02427646|157179923|FG000|Overall Study|Physician Decision|1|||
48819099|NCT02427646|157179924|FG001|Overall Study|Physician Decision|4|||
48819100|NCT02427646|157179923|FG000|Overall Study|Protocol Violation|3|||
48819101|NCT02427646|157179924|FG001|Overall Study|Protocol Violation|3|||
48819102|NCT02427646|157179923|FG000|Overall Study|Bothersome hand weakness|2|||
48724393|NCT00400153|156840489|FG000|Overall Study|Lost to Follow-up|2|||
48724394|NCT00400153|156840490|FG001|Overall Study|Lost to Follow-up|1|||
48724395|NCT00400153|156840491|FG002|Overall Study|Lost to Follow-up|4|||
48724396|NCT00400153|156840489|FG000|Overall Study|Withdrawal by Subject|12|||
48724397|NCT00400153|156840490|FG001|Overall Study|Withdrawal by Subject|11|||
48819103|NCT02427646|157179924|FG001|Overall Study|Bothersome hand weakness|4|||
48819104|NCT02990338|157179937|FG000|Overall Study|Randomized and not treated|4|||
48819105|NCT02990338|157179938|FG001|Overall Study|Randomized and not treated|2|||
48819106|NCT02990338|157179937|FG000|Overall Study|Adverse Event|23|||
48724398|NCT00400153|156840491|FG002|Overall Study|Withdrawal by Subject|10|||
48724399|NCT00400153|156840489|FG000|Overall Study|Other reasons - not mentioned above|8|||
48724400|NCT00400153|156840490|FG001|Overall Study|Other reasons - not mentioned above|5|||
48819107|NCT02990338|157179938|FG001|Overall Study|Adverse Event|22|||
48819108|NCT02990338|157179937|FG000|Overall Study|Progressive disease|118|||
48724401|NCT00400153|156840491|FG002|Overall Study|Other reasons - not mentioned above|3|||
48724402|NCT01150474|156840492|FG000|Overall Study|Withdrawal by Subject|5|||
48819109|NCT02990338|157179938|FG001|Overall Study|Progressive disease|107|||
48819110|NCT02990338|157179937|FG000|Overall Study|Poor compliance to protocol|0|||
48819111|NCT02990338|157179938|FG001|Overall Study|Poor compliance to protocol|1|||
48819112|NCT02990338|157179937|FG000|Overall Study|Withdrawal by Subject|6|||
48819113|NCT02990338|157179938|FG001|Overall Study|Withdrawal by Subject|8|||
48819114|NCT02990338|157179937|FG000|Overall Study|Physician's decision|2|||
48819115|NCT02990338|157179938|FG001|Overall Study|Physician's decision|6|||
48819116|NCT02990338|157179937|FG000|Overall Study|Treatment extension study|0|||
49011152|NCT00481247|157877399|FG001|Overall Study|Did not receive treatment|2|||
49011153|NCT03811249|157877401|FG000|Overall Study|Withdrawal by Subject|44|||
49011154|NCT03811249|157877401|FG000|Overall Study|Missed Visit|24|||
49011155|NCT00124449|157877402|FG000|6-month Double-Blind Treatment Period|Adverse Event|1|||
49011156|NCT00124449|157877403|FG001|6-month Double-Blind Treatment Period|Adverse Event|0|||
49011157|NCT00124449|157877402|FG000|6-month Double-Blind Treatment Period|Lack of Efficacy|3|||
49011158|NCT00124449|157877403|FG001|6-month Double-Blind Treatment Period|Lack of Efficacy|8|||
48819117|NCT02990338|157179938|FG001|Overall Study|Treatment extension study|6|||
48819118|NCT02990338|157179937|FG000|Overall Study|Unconfirmed disease progression per investigator|0|||
48819119|NCT02990338|157179938|FG001|Overall Study|Unconfirmed disease progression per investigator|1|||
48819120|NCT02990338|157179937|FG000|Overall Study|Continue with therapy available commercially|0|||
48819121|NCT02990338|157179938|FG001|Overall Study|Continue with therapy available commercially|1|||
48819122|NCT03675737|157179939|FG000|Overall Study|Death|593|||
48819123|NCT03675737|157179940|FG001|Overall Study|Death|660|||
48819124|NCT03675737|157179939|FG000|Overall Study|Lost to Follow-up|1|||
48819125|NCT03675737|157179940|FG001|Overall Study|Lost to Follow-up|5|||
48819126|NCT03675737|157179939|FG000|Overall Study|Physician Decision|1|||
48819127|NCT03675737|157179940|FG001|Overall Study|Physician Decision|0|||
48819128|NCT03675737|157179939|FG000|Overall Study|Withdrawal by Subject|14|||
48819129|NCT03675737|157179940|FG001|Overall Study|Withdrawal by Subject|12|||
48819130|NCT03675737|157179939|FG000|Overall Study|Ongoing in Study|181|||
48819131|NCT03675737|157179940|FG001|Overall Study|Ongoing in Study|112|||
48819132|NCT02169830|157181751|FG000|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
48819133|NCT02169830|157181752|FG001|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
48819134|NCT02169830|157181753|FG002|Diet Intervention (4 Weeks)|Lost to Follow-up|1|||
48819135|NCT02169830|157181751|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
48819136|NCT02169830|157181752|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
48819137|NCT02169830|157181753|FG002|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
48819138|NCT02169830|157181751|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
48819139|NCT02169830|157181752|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|5|||
48819140|NCT02169830|157181753|FG002|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
48819141|NCT02169830|157181751|FG000|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
48819142|NCT02169830|157181752|FG001|Third Intervention (8 Weeks)|Lost to Follow-up|1|||
48819143|NCT02169830|157181753|FG002|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
48819144|NCT02169830|157181751|FG000|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
48819145|NCT02169830|157181752|FG001|Third Intervention (8 Weeks)|Withdrawal by Subject|1|||
48819146|NCT02169830|157181753|FG002|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
48819147|NCT02555371|157181754|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1|||
48819148|NCT02555371|157181755|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
48819149|NCT02555371|157181756|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
48819150|NCT02555371|157181757|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
48819151|NCT02555371|157181758|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
48819152|NCT02555371|157181754|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2|||
48819153|NCT02555371|157181755|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
49132845|NCT00317369|158327075|FG001|Overall Study|Adverse Event|1|||
49132846|NCT00317369|158327076|FG002|Overall Study|Adverse Event|0|||
49132847|NCT00317369|158327074|FG000|Overall Study|Lack of Efficacy|0|||
48724403|NCT01150474|156840493|FG001|Overall Study|Withdrawal by Subject|2|||
48819154|NCT02555371|157181756|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
48819155|NCT02555371|157181757|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
48819156|NCT02555371|157181758|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
48819157|NCT02555371|157181754|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5|||
48819158|NCT02555371|157181755|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
48819159|NCT02555371|157181756|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
48819160|NCT02555371|157181757|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
48819161|NCT02555371|157181758|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
48819162|NCT02555371|157181754|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1|||
48819163|NCT02555371|157181755|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
48819164|NCT02555371|157181756|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
48819165|NCT02555371|157181757|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
48819166|NCT02555371|157181758|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
48724404|NCT01150474|156840492|FG000|Overall Study|Cancer found|1|||
48724405|NCT01150474|156840493|FG001|Overall Study|Cancer found|0|||
48724406|NCT01150474|156840492|FG000|Overall Study|Multiple Studies|0|||
48724407|NCT01150474|156840493|FG001|Overall Study|Multiple Studies|1|||
48724408|NCT01150474|156840492|FG000|Overall Study|Rectotomy|1|||
48724409|NCT01150474|156840493|FG001|Overall Study|Rectotomy|0|||
48724410|NCT01150474|156840492|FG000|Overall Study|Drug did not arrive in time|1|||
48819167|NCT02555371|157181754|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2|||
48819168|NCT02555371|157181755|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
48819169|NCT02555371|157181756|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
48724411|NCT01150474|156840493|FG001|Overall Study|Drug did not arrive in time|0|||
48819170|NCT02555371|157181757|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
48819171|NCT02555371|157181758|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
48819172|NCT02555371|157181754|FG000|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
48724412|NCT01150474|156840492|FG000|Overall Study|Drug not administered|1|||
48724413|NCT01150474|156840493|FG001|Overall Study|Drug not administered|0|||
48819173|NCT02555371|157181755|FG001|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84|||
48819174|NCT02555371|157181756|FG002|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45|||
48819175|NCT02555371|157181757|FG003|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
48819176|NCT02555371|157181758|FG004|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
48819177|NCT02555371|157181754|FG000|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
48819178|NCT02555371|157181755|FG001|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
48819179|NCT02555371|157181756|FG002|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
48819180|NCT02555371|157181757|FG003|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
48819181|NCT02555371|157181758|FG004|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
48819182|NCT02555371|157181754|FG000|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
48819183|NCT02555371|157181755|FG001|Part C (DB Period: Up to 52W)|Lack of Efficacy|1|||
48819184|NCT02555371|157181756|FG002|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
48819185|NCT02555371|157181757|FG003|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
48819186|NCT02555371|157181758|FG004|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
48819187|NCT02555371|157181754|FG000|Part C (DB Period: Up to 52W)|Adverse Event|0|||
48819188|NCT02555371|157181755|FG001|Part C (DB Period: Up to 52W)|Adverse Event|2|||
48819189|NCT02555371|157181756|FG002|Part C (DB Period: Up to 52W)|Adverse Event|1|||
48819190|NCT02555371|157181757|FG003|Part C (DB Period: Up to 52W)|Adverse Event|0|||
48819191|NCT02555371|157181758|FG004|Part C (DB Period: Up to 52W)|Adverse Event|0|||
48819192|NCT02555371|157181754|FG000|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
48819193|NCT02555371|157181755|FG001|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
48819194|NCT02555371|157181756|FG002|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
48819195|NCT02555371|157181757|FG003|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1|||
48819196|NCT02555371|157181758|FG004|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
48819197|NCT02555371|157181754|FG000|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
48819198|NCT02555371|157181755|FG001|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
48819199|NCT02555371|157181756|FG002|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
48819200|NCT02555371|157181757|FG003|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2|||
48819201|NCT02555371|157181758|FG004|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
48819202|NCT02555371|157181754|FG000|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
48819203|NCT02555371|157181755|FG001|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
48819204|NCT02555371|157181756|FG002|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
48819205|NCT02555371|157181757|FG003|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
48819206|NCT02555371|157181758|FG004|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2|||
48819207|NCT02555371|157181754|FG000|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
48819208|NCT02555371|157181755|FG001|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
48819209|NCT02555371|157181756|FG002|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
48819210|NCT02555371|157181757|FG003|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
48819211|NCT02555371|157181758|FG004|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1|||
48819212|NCT02555371|157181754|FG000|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
48819213|NCT02555371|157181755|FG001|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
48819214|NCT02555371|157181756|FG002|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
48819215|NCT02555371|157181757|FG003|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1|||
48819216|NCT02555371|157181758|FG004|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
48819217|NCT01853254|157181759|FG000|Overall Study|Abnormal Laboratory Test|1|||
48819218|NCT01853254|157181759|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
48819219|NCT01853254|157181759|FG000|Overall Study|Death|1|||
48819220|NCT01853254|157181759|FG000|Overall Study|Failure to Return|43|||
48819221|NCT01853254|157181759|FG000|Overall Study|Insufficient Therapeutic Response|22|||
48819222|NCT01853254|157181759|FG000|Overall Study|Refusal of Treatment|1|||
48819223|NCT01853254|157181759|FG000|Overall Study|Other Protocol Violation|1|||
48819224|NCT01853254|157181759|FG000|Overall Study|Withdrawal of Consent|16|||
48819225|NCT01853254|157181759|FG000|Overall Study|Administrative/Other|16|||
48819226|NCT00900627|157181760|FG000|Overall Study|Condition under investigation worsened|4|||
48819227|NCT00900627|157181761|FG001|Overall Study|Condition under investigation worsened|0|||
48819228|NCT00900627|157181762|FG002|Overall Study|Condition under investigation worsened|5|||
48819229|NCT00900627|157181763|FG003|Overall Study|Condition under investigation worsened|3|||
48819230|NCT00900627|157181764|FG004|Overall Study|Condition under investigation worsened|0|||
48819231|NCT00900627|157181765|FG005|Overall Study|Condition under investigation worsened|0|||
48819232|NCT00900627|157181760|FG000|Overall Study|Withdrawal by Subject|1|||
48819233|NCT00900627|157181761|FG001|Overall Study|Withdrawal by Subject|0|||
48819234|NCT00900627|157181762|FG002|Overall Study|Withdrawal by Subject|1|||
48921033|NCT00784654|157544818|FG000|Randomized Withdrawal Period|Did not complete a visit|0|||
48819235|NCT00900627|157181763|FG003|Overall Study|Withdrawal by Subject|0|||
48819236|NCT00900627|157181764|FG004|Overall Study|Withdrawal by Subject|1|||
48819237|NCT00900627|157181765|FG005|Overall Study|Withdrawal by Subject|2|||
48819238|NCT00900627|157181760|FG000|Overall Study|Adverse Event|1|||
48819239|NCT00900627|157181761|FG001|Overall Study|Adverse Event|2|||
48819240|NCT00900627|157181762|FG002|Overall Study|Adverse Event|0|||
48819241|NCT00900627|157181763|FG003|Overall Study|Adverse Event|3|||
48819242|NCT00900627|157181764|FG004|Overall Study|Adverse Event|0|||
48819243|NCT00900627|157181765|FG005|Overall Study|Adverse Event|0|||
48819244|NCT00900627|157181760|FG000|Overall Study|Death|0|||
48819245|NCT00900627|157181761|FG001|Overall Study|Death|0|||
48819246|NCT00900627|157181762|FG002|Overall Study|Death|0|||
48819247|NCT00900627|157181763|FG003|Overall Study|Death|0|||
49132848|NCT00317369|158327075|FG001|Overall Study|Lack of Efficacy|1|||
49132849|NCT00317369|158327076|FG002|Overall Study|Lack of Efficacy|1|||
49132850|NCT00317369|158327074|FG000|Overall Study|Withdrawal by Subject|0|||
49132851|NCT00317369|158327075|FG001|Overall Study|Withdrawal by Subject|0|||
49132852|NCT00317369|158327076|FG002|Overall Study|Withdrawal by Subject|1|||
49132853|NCT00157755|158327077|FG000|Overall Study|Death|2|||
49132854|NCT00157755|158327078|FG001|Overall Study|Death|3|||
48724414|NCT01150474|156840492|FG000|Overall Study|Surgery Changed|1|||
48724415|NCT01150474|156840493|FG001|Overall Study|Surgery Changed|0|||
48724416|NCT03533686|156840494|FG000|Overall Study|Withdrawal by Subject|1|||
48724417|NCT03533686|156840495|FG001|Overall Study|Withdrawal by Subject|0|||
48724418|NCT03533686|156840496|FG002|Overall Study|Withdrawal by Subject|0|||
48724419|NCT03533686|156840497|FG003|Overall Study|Withdrawal by Subject|3|||
48724420|NCT03533686|156840498|FG004|Overall Study|Withdrawal by Subject|5|||
48724421|NCT03533686|156840499|FG005|Overall Study|Withdrawal by Subject|1|||
48724422|NCT03533686|156840494|FG000|Overall Study|Lost to Follow-up|0|||
48724423|NCT03533686|156840495|FG001|Overall Study|Lost to Follow-up|1|||
48724424|NCT03533686|156840496|FG002|Overall Study|Lost to Follow-up|0|||
48724425|NCT03533686|156840497|FG003|Overall Study|Lost to Follow-up|0|||
48724426|NCT03533686|156840498|FG004|Overall Study|Lost to Follow-up|2|||
48724427|NCT03533686|156840499|FG005|Overall Study|Lost to Follow-up|0|||
48724428|NCT03533686|156840494|FG000|Overall Study|Screen Failure|0|||
48724429|NCT03533686|156840495|FG001|Overall Study|Screen Failure|0|||
48724430|NCT03533686|156840496|FG002|Overall Study|Screen Failure|0|||
48724431|NCT03533686|156840497|FG003|Overall Study|Screen Failure|2|||
48724432|NCT03533686|156840498|FG004|Overall Study|Screen Failure|0|||
48724433|NCT03533686|156840499|FG005|Overall Study|Screen Failure|0|||
48724434|NCT01856023|156840500|FG000|Overall Study|Death|1|||
48724435|NCT01856023|156840501|FG001|Overall Study|Death|2|||
48819248|NCT00900627|157181764|FG004|Overall Study|Death|28|||
48819249|NCT00900627|157181765|FG005|Overall Study|Death|24|||
48819250|NCT01625338|157181766|FG000|Overall Study|Enrolled but not Treated|0|||
48819251|NCT01625338|157181767|FG001|Overall Study|Enrolled but not Treated|0|||
48819252|NCT01625338|157181768|FG002|Overall Study|Enrolled but not Treated|1|||
48819253|NCT01625338|157181766|FG000|Overall Study|Efficacy Failure|27|||
48819254|NCT01625338|157181767|FG001|Overall Study|Efficacy Failure|39|||
48819255|NCT01625338|157181768|FG002|Overall Study|Efficacy Failure|31|||
48819256|NCT01625338|157181766|FG000|Overall Study|Lost to Follow-up|3|||
48819257|NCT01625338|157181767|FG001|Overall Study|Lost to Follow-up|3|||
48819258|NCT01625338|157181768|FG002|Overall Study|Lost to Follow-up|2|||
48819259|NCT01625338|157181766|FG000|Overall Study|Investigator Decision|0|||
48819260|NCT01625338|157181767|FG001|Overall Study|Investigator Decision|2|||
48819261|NCT01625338|157181768|FG002|Overall Study|Investigator Decision|1|||
48819262|NCT01625338|157181766|FG000|Overall Study|Subject Withdrew Consent|1|||
48724436|NCT01856023|156840500|FG000|Overall Study|Adverse Event|2|||
48724437|NCT01856023|156840501|FG001|Overall Study|Adverse Event|1|||
48724438|NCT01856023|156840500|FG000|Overall Study|Lack of Efficacy|5|||
48724439|NCT01856023|156840501|FG001|Overall Study|Lack of Efficacy|5|||
48724440|NCT01856023|156840500|FG000|Overall Study|non compliance, study closure|1|||
48724441|NCT01856023|156840501|FG001|Overall Study|non compliance, study closure|3|||
48724442|NCT01856023|156840500|FG000|Overall Study|Withdrawal by Subject|1|||
48724443|NCT01856023|156840501|FG001|Overall Study|Withdrawal by Subject|1|||
49132855|NCT00157755|158327079|FG002|Overall Study|Death|3|||
49132856|NCT00157755|158327080|FG003|Overall Study|Death|2|||
48724444|NCT00384111|156840502|FG000|Overall Study|Disease Progression|3|||
48724445|NCT00384111|156840502|FG000|Overall Study|Adverse Event|1|||
48724446|NCT00384111|156840502|FG000|Overall Study|Investigator Decision|3|||
48724447|NCT00384111|156840502|FG000|Overall Study|Study Terminated by the Sponsor|19|||
48724448|NCT02273739|156840503|FG000|Overall Study|Progression of Disease|3|||
48724449|NCT02273739|156840504|FG001|Overall Study|Progression of Disease|4|||
48819263|NCT01625338|157181767|FG001|Overall Study|Subject Withdrew Consent|0|||
48819264|NCT01625338|157181768|FG002|Overall Study|Subject Withdrew Consent|2|||
48819265|NCT01625338|157181766|FG000|Overall Study|Adverse Event|1|||
48819266|NCT01625338|157181767|FG001|Overall Study|Adverse Event|0|||
48819267|NCT01625338|157181768|FG002|Overall Study|Adverse Event|1|||
48819268|NCT01625338|157181766|FG000|Overall Study|Study Discontinued by Sponsor|0|||
48819269|NCT01625338|157181767|FG001|Overall Study|Study Discontinued by Sponsor|0|||
49132857|NCT00157755|158327081|FG004|Overall Study|Death|0|||
49132858|NCT00157755|158327082|FG005|Overall Study|Death|0|||
49132859|NCT00157755|158327077|FG000|Overall Study|Lost to Follow-up|0|||
49132860|NCT00157755|158327078|FG001|Overall Study|Lost to Follow-up|0|||
49132861|NCT00157755|158327079|FG002|Overall Study|Lost to Follow-up|1|||
49132862|NCT00157755|158327080|FG003|Overall Study|Lost to Follow-up|0|||
49132863|NCT00157755|158327081|FG004|Overall Study|Lost to Follow-up|0|||
49132864|NCT00157755|158327082|FG005|Overall Study|Lost to Follow-up|0|||
49132865|NCT00157755|158327077|FG000|Overall Study|Withdrawal by Subject|0|||
48724450|NCT02273739|156840505|FG002|Overall Study|Progression of Disease|5|||
48724451|NCT02273739|156840506|FG003|Overall Study|Progression of Disease|2|||
48724452|NCT02273739|156840503|FG000|Overall Study|Death|0|||
48724453|NCT02273739|156840504|FG001|Overall Study|Death|0|||
48724454|NCT02273739|156840505|FG002|Overall Study|Death|0|||
48724455|NCT02273739|156840506|FG003|Overall Study|Death|2|||
48724456|NCT02273739|156840503|FG000|Overall Study|Adverse Event|0|||
48724457|NCT02273739|156840504|FG001|Overall Study|Adverse Event|0|||
48724458|NCT02273739|156840505|FG002|Overall Study|Adverse Event|0|||
48724459|NCT02273739|156840506|FG003|Overall Study|Adverse Event|1|||
48724460|NCT02273739|156840503|FG000|Overall Study|Withdrawal by Subject|0|||
48724461|NCT02273739|156840504|FG001|Overall Study|Withdrawal by Subject|0|||
48724462|NCT02273739|156840505|FG002|Overall Study|Withdrawal by Subject|2|||
48724463|NCT02273739|156840506|FG003|Overall Study|Withdrawal by Subject|1|||
48724464|NCT02273739|156840503|FG000|Overall Study|Physician Decision|0|||
48724465|NCT02273739|156840504|FG001|Overall Study|Physician Decision|0|||
48724466|NCT02273739|156840505|FG002|Overall Study|Physician Decision|0|||
48724467|NCT02273739|156840506|FG003|Overall Study|Physician Decision|1|||
48724468|NCT00327470|156840508|FG000|Overall Study|Randomized, but not treated|0|||
48724469|NCT00327470|156840509|FG001|Overall Study|Randomized, but not treated|2|||
48724470|NCT00327470|156840508|FG000|Overall Study|Adverse Event|9|||
48724471|NCT00327470|156840509|FG001|Overall Study|Adverse Event|14|||
48724472|NCT00327470|156840508|FG000|Overall Study|Lack of Efficacy|7|||
48724473|NCT00327470|156840509|FG001|Overall Study|Lack of Efficacy|19|||
48724474|NCT00327470|156840508|FG000|Overall Study|Other|5|||
48724475|NCT00327470|156840509|FG001|Overall Study|Other|9|||
48724476|NCT00327470|156840508|FG000|Overall Study|Lost to Follow-up|1|||
48724477|NCT00327470|156840509|FG001|Overall Study|Lost to Follow-up|3|||
48724478|NCT00327470|156840508|FG000|Overall Study|Withdrawal by Subject|6|||
48724479|NCT00327470|156840509|FG001|Overall Study|Withdrawal by Subject|12|||
48724480|NCT00327470|156840508|FG000|Overall Study|Death|1|||
48724481|NCT00327470|156840509|FG001|Overall Study|Death|4|||
48724482|NCT00309985|156840512|FG000|Overall Study|Disease progression|12|||
48724483|NCT00309985|156840513|FG001|Overall Study|Disease progression|0|||
48724484|NCT00309985|156840512|FG000|Overall Study|Adverse Event|30|||
48724485|NCT00309985|156840513|FG001|Overall Study|Adverse Event|0|||
48724486|NCT00309985|156840512|FG000|Overall Study|Death|2|||
48724487|NCT00309985|156840513|FG001|Overall Study|Death|0|||
48724488|NCT00309985|156840512|FG000|Overall Study|Withdrawal by Subject|5|||
48724489|NCT00309985|156840513|FG001|Overall Study|Withdrawal by Subject|1|||
48724490|NCT00309985|156840512|FG000|Overall Study|Physician Decision|3|||
48724491|NCT00309985|156840513|FG001|Overall Study|Physician Decision|0|||
48724492|NCT00309985|156840512|FG000|Overall Study|Never started treatment|7|||
48724493|NCT00309985|156840513|FG001|Overall Study|Never started treatment|0|||
48724494|NCT00309985|156840512|FG000|Overall Study|Complicating disease|1|||
48724495|NCT00309985|156840513|FG001|Overall Study|Complicating disease|0|||
48724496|NCT00309985|156840512|FG000|Overall Study|Non-compliance|1|||
48724497|NCT00309985|156840513|FG001|Overall Study|Non-compliance|0|||
48724498|NCT00309985|156840512|FG000|Overall Study|Chemotherapy discontinued only|1|||
48724499|NCT00309985|156840513|FG001|Overall Study|Chemotherapy discontinued only|0|||
48724500|NCT05104463|156840514|FG000|Overall Study|Adverse Event|1|||
48724501|NCT05104463|156840515|FG001|Overall Study|Adverse Event|1|||
48724502|NCT05104463|156840514|FG000|Overall Study|Lost to Follow-up|1|||
48724503|NCT05104463|156840515|FG001|Overall Study|Lost to Follow-up|1|||
48724504|NCT05104463|156840514|FG000|Overall Study|Physician Decision|1|||
48724505|NCT05104463|156840515|FG001|Overall Study|Physician Decision|0|||
48724506|NCT05104463|156840514|FG000|Overall Study|Protocol Violation|0|||
48724507|NCT05104463|156840515|FG001|Overall Study|Protocol Violation|2|||
48724508|NCT05104463|156840514|FG000|Overall Study|Withdrawal by Subject|1|||
48724509|NCT05104463|156840515|FG001|Overall Study|Withdrawal by Subject|1|||
48724510|NCT01876810|156840516|FG000|Overall Study|Physician Decision|0|||
48724511|NCT01876810|156840517|FG001|Overall Study|Physician Decision|1|||
48724512|NCT00491556|156840520|FG000|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1|||
48724513|NCT00491556|156840521|FG001|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0|||
48724514|NCT00491556|156840520|FG000|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1|||
48724515|NCT00491556|156840521|FG001|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0|||
48724516|NCT00491556|156840520|FG000|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1|||
48724517|NCT00491556|156840521|FG001|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0|||
48724518|NCT00491556|156840520|FG000|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2|||
48724519|NCT00491556|156840521|FG001|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0|||
48724520|NCT00491556|156840520|FG000|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11|||
49132866|NCT00157755|158327078|FG001|Overall Study|Withdrawal by Subject|0|||
49132867|NCT00157755|158327079|FG002|Overall Study|Withdrawal by Subject|1|||
49132868|NCT00157755|158327080|FG003|Overall Study|Withdrawal by Subject|1|||
48819270|NCT01625338|157181768|FG002|Overall Study|Study Discontinued by Sponsor|1|||
48819271|NCT04421378|157181770|FG000|Overall Study|Adverse Event|2|||
49132869|NCT00157755|158327081|FG004|Overall Study|Withdrawal by Subject|1|||
49132870|NCT00157755|158327082|FG005|Overall Study|Withdrawal by Subject|2|||
49132871|NCT00157755|158327077|FG000|Overall Study|Explant due to infection|0|||
49132872|NCT00157755|158327078|FG001|Overall Study|Explant due to infection|0|||
49132873|NCT00157755|158327079|FG002|Overall Study|Explant due to infection|1|||
49132874|NCT00157755|158327080|FG003|Overall Study|Explant due to infection|0|||
49132875|NCT00157755|158327081|FG004|Overall Study|Explant due to infection|0|||
49132876|NCT00157755|158327082|FG005|Overall Study|Explant due to infection|0|||
49132877|NCT00157755|158327077|FG000|Overall Study|Medical reason|0|||
49132878|NCT00157755|158327078|FG001|Overall Study|Medical reason|0|||
49132879|NCT00157755|158327079|FG002|Overall Study|Medical reason|1|||
49132880|NCT00157755|158327080|FG003|Overall Study|Medical reason|1|||
49132881|NCT00157755|158327081|FG004|Overall Study|Medical reason|0|||
49132882|NCT00157755|158327082|FG005|Overall Study|Medical reason|0|||
49132883|NCT00157755|158327077|FG000|Overall Study|Study site closure|0|||
49132884|NCT00157755|158327078|FG001|Overall Study|Study site closure|1|||
49132885|NCT00157755|158327079|FG002|Overall Study|Study site closure|0|||
49132886|NCT00157755|158327080|FG003|Overall Study|Study site closure|0|||
49132887|NCT00157755|158327081|FG004|Overall Study|Study site closure|0|||
49132888|NCT00157755|158327082|FG005|Overall Study|Study site closure|0|||
49132889|NCT00157755|158327077|FG000|Overall Study|Subject non-compliance|0|||
49132890|NCT00157755|158327078|FG001|Overall Study|Subject non-compliance|0|||
49132891|NCT00157755|158327079|FG002|Overall Study|Subject non-compliance|0|||
49132892|NCT00157755|158327080|FG003|Overall Study|Subject non-compliance|0|||
49132893|NCT00157755|158327081|FG004|Overall Study|Subject non-compliance|0|||
49132894|NCT00157755|158327082|FG005|Overall Study|Subject non-compliance|1|||
49132895|NCT00157755|158327077|FG000|Overall Study|Study completion|0|||
49132896|NCT00157755|158327078|FG001|Overall Study|Study completion|0|||
49132897|NCT00157755|158327079|FG002|Overall Study|Study completion|0|||
49132898|NCT00157755|158327080|FG003|Overall Study|Study completion|0|||
49132899|NCT00157755|158327081|FG004|Overall Study|Study completion|1|||
49132900|NCT00157755|158327082|FG005|Overall Study|Study completion|2|||
49132901|NCT02696798|158327087|FG000|Blinded Treatment Dosing Period|Adverse Event|2|||
49132902|NCT02696798|158327088|FG001|Blinded Treatment Dosing Period|Adverse Event|9|||
49132903|NCT02696798|158327089|FG002|Blinded Treatment Dosing Period|Adverse Event|2|||
49132904|NCT02696798|158327087|FG000|Blinded Treatment Dosing Period|Death|0|||
49132905|NCT02696798|158327088|FG001|Blinded Treatment Dosing Period|Death|0|||
49132906|NCT02696798|158327089|FG002|Blinded Treatment Dosing Period|Death|1|||
49132907|NCT02696798|158327087|FG000|Blinded Treatment Dosing Period|Lack of Efficacy|2|||
49132908|NCT02696798|158327088|FG001|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
49132909|NCT02696798|158327089|FG002|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
49132910|NCT02696798|158327087|FG000|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
49132911|NCT02696798|158327088|FG001|Blinded Treatment Dosing Period|Lost to Follow-up|1|||
49132912|NCT02696798|158327089|FG002|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
49132913|NCT02696798|158327087|FG000|Blinded Treatment Dosing Period|Physician Decision|0|||
49132914|NCT02696798|158327088|FG001|Blinded Treatment Dosing Period|Physician Decision|1|||
49132915|NCT02696798|158327089|FG002|Blinded Treatment Dosing Period|Physician Decision|0|||
49132916|NCT02696798|158327087|FG000|Blinded Treatment Dosing Period|Withdrawal by Subject|7|||
49132917|NCT02696798|158327088|FG001|Blinded Treatment Dosing Period|Withdrawal by Subject|3|||
48819272|NCT04421378|157181771|FG001|Overall Study|Adverse Event|7|||
49132918|NCT02696798|158327089|FG002|Blinded Treatment Dosing Period|Withdrawal by Subject|4|||
49132919|NCT02696798|158327087|FG000|Extended Treatment Period|Adverse Event|1|||
49132920|NCT02696798|158327088|FG001|Extended Treatment Period|Adverse Event|4|||
49132921|NCT02696798|158327089|FG002|Extended Treatment Period|Adverse Event|5|||
49132922|NCT02696798|158327087|FG000|Extended Treatment Period|Lack of Efficacy|7|||
48724521|NCT00491556|156840521|FG001|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0|||
48724522|NCT00491556|156840520|FG000|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2|||
48724523|NCT00491556|156840521|FG001|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0|||
48724524|NCT00491556|156840520|FG000|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2|||
48724525|NCT00491556|156840521|FG001|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0|||
48724526|NCT00491556|156840520|FG000|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3|||
48724527|NCT00491556|156840521|FG001|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0|||
48724528|NCT00491556|156840520|FG000|Entry-Week (WK) 48: EXP/Standard Care|Other|3|||
49132923|NCT02696798|158327088|FG001|Extended Treatment Period|Lack of Efficacy|2|||
49132924|NCT02696798|158327089|FG002|Extended Treatment Period|Lack of Efficacy|2|||
49132925|NCT02696798|158327087|FG000|Extended Treatment Period|Lost to Follow-up|1|||
49132926|NCT02696798|158327088|FG001|Extended Treatment Period|Lost to Follow-up|0|||
49132927|NCT02696798|158327089|FG002|Extended Treatment Period|Lost to Follow-up|0|||
49132928|NCT02696798|158327087|FG000|Extended Treatment Period|Physician Decision|0|||
49132929|NCT02696798|158327088|FG001|Extended Treatment Period|Physician Decision|1|||
49132930|NCT02696798|158327089|FG002|Extended Treatment Period|Physician Decision|0|||
49132931|NCT02696798|158327087|FG000|Extended Treatment Period|Withdrawal by Subject|3|||
49132932|NCT02696798|158327088|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
49132933|NCT02696798|158327089|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
48724529|NCT00491556|156840521|FG001|Entry-Week (WK) 48: EXP/Standard Care|Other|0|||
48724530|NCT00491556|156840520|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
49132934|NCT02696798|158327087|FG000|Post-treatment Follow-up Period|Adverse Event|2|||
49132935|NCT02696798|158327088|FG001|Post-treatment Follow-up Period|Adverse Event|12|||
49132936|NCT02696798|158327089|FG002|Post-treatment Follow-up Period|Adverse Event|6|||
49132937|NCT02696798|158327087|FG000|Post-treatment Follow-up Period|Lost to Follow-up|0|||
49132938|NCT02696798|158327088|FG001|Post-treatment Follow-up Period|Lost to Follow-up|1|||
49132939|NCT02696798|158327089|FG002|Post-treatment Follow-up Period|Lost to Follow-up|1|||
49132940|NCT02696798|158327087|FG000|Post-treatment Follow-up Period|Lack of Efficacy|1|||
49132941|NCT02696798|158327088|FG001|Post-treatment Follow-up Period|Lack of Efficacy|2|||
49132942|NCT02696798|158327089|FG002|Post-treatment Follow-up Period|Lack of Efficacy|0|||
49132943|NCT02696798|158327087|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|2|||
49132944|NCT02696798|158327088|FG001|Post-treatment Follow-up Period|Withdrawal by Subject|8|||
49132945|NCT02696798|158327089|FG002|Post-treatment Follow-up Period|Withdrawal by Subject|12|||
49132946|NCT02696798|158327087|FG000|Post-treatment Follow-up Period|Physician Decision|0|||
49132947|NCT02696798|158327088|FG001|Post-treatment Follow-up Period|Physician Decision|2|||
49132948|NCT02696798|158327089|FG002|Post-treatment Follow-up Period|Physician Decision|0|||
49132949|NCT02696798|158327087|FG000|Post-treatment Follow-up Period|No progressive improvement|0|||
49132950|NCT02696798|158327088|FG001|Post-treatment Follow-up Period|No progressive improvement|1|||
49132951|NCT02696798|158327089|FG002|Post-treatment Follow-up Period|No progressive improvement|0|||
49132952|NCT01101178|158327091|FG000|Period 1|Withdrawal by Subject|1|||
49132953|NCT01101178|158327092|FG001|Period 1|Withdrawal by Subject|2|||
49132954|NCT01101178|158327091|FG000|Period 1|Positive drug screen|1|||
49132955|NCT01101178|158327092|FG001|Period 1|Positive drug screen|1|||
49132956|NCT01101178|158327091|FG000|Period 1|Adverse Event|2|||
49132957|NCT01101178|158327092|FG001|Period 1|Adverse Event|1|||
49132958|NCT01101178|158327091|FG000|Period 2|Withdrawal by Subject|0|||
49132959|NCT01101178|158327092|FG001|Period 2|Withdrawal by Subject|1|||
49132960|NCT00655889|158327093|FG000|Overall Study|Inadequate cell growth|1|||
49132961|NCT00655889|158327093|FG000|Overall Study|Protocol Violation|1|||
49132962|NCT00862992|158327098|FG000|Overall Study|Adverse Event|2|||
49132963|NCT00862992|158327099|FG001|Overall Study|Adverse Event|1|||
49132964|NCT00862992|158327100|FG002|Overall Study|Adverse Event|1|||
49132965|NCT00862992|158327098|FG000|Overall Study|Physician Decision|1|||
49132966|NCT00862992|158327099|FG001|Overall Study|Physician Decision|0|||
49132967|NCT00862992|158327100|FG002|Overall Study|Physician Decision|0|||
49132968|NCT00862992|158327098|FG000|Overall Study|Withdrawal by Subject|0|||
49132969|NCT00862992|158327099|FG001|Overall Study|Withdrawal by Subject|0|||
49132970|NCT00862992|158327100|FG002|Overall Study|Withdrawal by Subject|2|||
49132971|NCT01147458|158327101|FG000|First Intervention|Study terminated by sponsor|8|||
49132972|NCT01147458|158327102|FG001|First Intervention|Study terminated by sponsor|8|||
49132973|NCT01147458|158327103|FG002|First Intervention|Study terminated by sponsor|7|||
49132974|NCT01147458|158327104|FG003|First Intervention|Study terminated by sponsor|8|||
49132975|NCT01147458|158327101|FG000|First Intervention|Protocol Violation|2|||
49132976|NCT01147458|158327102|FG001|First Intervention|Protocol Violation|3|||
49132977|NCT01147458|158327103|FG002|First Intervention|Protocol Violation|2|||
49132978|NCT01147458|158327104|FG003|First Intervention|Protocol Violation|3|||
49132979|NCT01147458|158327101|FG000|First Intervention|Withdrawal by Subject|3|||
49132980|NCT01147458|158327102|FG001|First Intervention|Withdrawal by Subject|0|||
49132981|NCT01147458|158327103|FG002|First Intervention|Withdrawal by Subject|1|||
49132982|NCT01147458|158327104|FG003|First Intervention|Withdrawal by Subject|0|||
49132983|NCT01147458|158327101|FG000|First Intervention|Adverse Event|0|||
49132984|NCT01147458|158327102|FG001|First Intervention|Adverse Event|3|||
49132985|NCT01147458|158327103|FG002|First Intervention|Adverse Event|2|||
49132986|NCT01147458|158327104|FG003|First Intervention|Adverse Event|3|||
49132987|NCT01147458|158327101|FG000|First Intervention|Other|1|||
49132988|NCT01147458|158327102|FG001|First Intervention|Other|2|||
49132989|NCT01147458|158327103|FG002|First Intervention|Other|0|||
49132990|NCT01147458|158327104|FG003|First Intervention|Other|0|||
49132991|NCT01147458|158327101|FG000|Second Intervention|Study terminated by sponsor|7|||
49132992|NCT01147458|158327102|FG001|Second Intervention|Study terminated by sponsor|5|||
49132993|NCT01147458|158327103|FG002|Second Intervention|Study terminated by sponsor|5|||
48819273|NCT04421378|157181772|FG002|Overall Study|Adverse Event|0|||
49132994|NCT01147458|158327104|FG003|Second Intervention|Study terminated by sponsor|3|||
49132995|NCT01147458|158327101|FG000|Second Intervention|Protocol Violation|0|||
49132996|NCT01147458|158327102|FG001|Second Intervention|Protocol Violation|1|||
49132997|NCT01147458|158327103|FG002|Second Intervention|Protocol Violation|1|||
49132998|NCT01147458|158327104|FG003|Second Intervention|Protocol Violation|0|||
48819274|NCT04421378|157181773|FG003|Overall Study|Adverse Event|1|||
48819275|NCT04421378|157181774|FG004|Overall Study|Adverse Event|0|||
48819276|NCT04421378|157181770|FG000|Overall Study|Physician Decision|1|||
48819277|NCT04421378|157181771|FG001|Overall Study|Physician Decision|2|||
48819278|NCT04421378|157181772|FG002|Overall Study|Physician Decision|0|||
48819279|NCT04421378|157181773|FG003|Overall Study|Physician Decision|0|||
48819280|NCT04421378|157181774|FG004|Overall Study|Physician Decision|0|||
48819281|NCT04421378|157181770|FG000|Overall Study|Progressive Disease|16|||
48819282|NCT04421378|157181771|FG001|Overall Study|Progressive Disease|4|||
48819283|NCT04421378|157181772|FG002|Overall Study|Progressive Disease|18|||
48819284|NCT04421378|157181773|FG003|Overall Study|Progressive Disease|11|||
48819285|NCT04421378|157181774|FG004|Overall Study|Progressive Disease|3|||
48819286|NCT04421378|157181770|FG000|Overall Study|Study Terminated by Sponsor|0|||
48819287|NCT04421378|157181771|FG001|Overall Study|Study Terminated by Sponsor|1|||
48819288|NCT04421378|157181772|FG002|Overall Study|Study Terminated by Sponsor|1|||
48819289|NCT04421378|157181773|FG003|Overall Study|Study Terminated by Sponsor|0|||
48819290|NCT04421378|157181774|FG004|Overall Study|Study Terminated by Sponsor|0|||
48819291|NCT04421378|157181770|FG000|Overall Study|Withdrawal by Subject|3|||
48819292|NCT04421378|157181771|FG001|Overall Study|Withdrawal by Subject|1|||
48819293|NCT04421378|157181772|FG002|Overall Study|Withdrawal by Subject|0|||
48819294|NCT04421378|157181773|FG003|Overall Study|Withdrawal by Subject|2|||
48819295|NCT04421378|157181774|FG004|Overall Study|Withdrawal by Subject|0|||
48819296|NCT04421378|157181770|FG000|Overall Study|Other|1|||
48819297|NCT04421378|157181771|FG001|Overall Study|Other|0|||
48819298|NCT04421378|157181772|FG002|Overall Study|Other|0|||
48819299|NCT04421378|157181773|FG003|Overall Study|Other|0|||
48819300|NCT04421378|157181774|FG004|Overall Study|Other|0|||
48819301|NCT00765362|157181775|FG000|Overall Study|Death|9|||
48819302|NCT00765362|157181775|FG000|Overall Study|Adverse Event|2|||
48819303|NCT00765362|157181775|FG000|Overall Study|Protocol Violation|18|||
48819304|NCT00765362|157181775|FG000|Overall Study|Withdrawal by Subject|13|||
48819305|NCT00765362|157181775|FG000|Overall Study|Lost to Follow-up|95|||
48819306|NCT03019458|157181776|FG000|Overall Study|Death|0|||
48819307|NCT03019458|157181777|FG001|Overall Study|Death|1|||
48819308|NCT03302910|157181785|FG000|Overall Study|Protocol Violation|1|||
48819309|NCT03302910|157181786|FG001|Overall Study|Protocol Violation|0|||
48819310|NCT05862870|157181787|FG000|Overall Study|Lost to Follow-up|3|||
48819311|NCT01477749|157181790|FG000|Overall Study|Physician Decision|4|||
48819312|NCT01567163|157181793|FG000|Overall Study|Progressive Disease|2|||
48819313|NCT01567163|157181793|FG000|Overall Study|Lost to Follow-up|2|||
48819314|NCT03405662|157181796|FG000|Overall Study|COVID-19 restriction|1|||
48819315|NCT03405662|157181797|FG001|Overall Study|COVID-19 restriction|0|||
48819316|NCT03405662|157181796|FG000|Overall Study|unblinding|0|||
48819317|NCT03405662|157181797|FG001|Overall Study|unblinding|1|||
48819318|NCT03405662|157181796|FG000|Overall Study|placement in memory care facility|0|||
48819319|NCT03405662|157181797|FG001|Overall Study|placement in memory care facility|2|||
48819320|NCT01177813|157181798|FG000|Overall Study|Adverse Event|8|||
48819321|NCT01177813|157181799|FG001|Overall Study|Adverse Event|2|||
48819322|NCT01177813|157181800|FG002|Overall Study|Adverse Event|4|||
48819323|NCT01177813|157181801|FG003|Overall Study|Adverse Event|6|||
49132999|NCT01147458|158327101|FG000|Second Intervention|Withdrawal by Subject|0|||
49133000|NCT01147458|158327102|FG001|Second Intervention|Withdrawal by Subject|1|||
49133001|NCT01147458|158327103|FG002|Second Intervention|Withdrawal by Subject|0|||
49133002|NCT01147458|158327104|FG003|Second Intervention|Withdrawal by Subject|0|||
49133003|NCT01147458|158327101|FG000|Second Intervention|Adverse Event|2|||
49133004|NCT01147458|158327102|FG001|Second Intervention|Adverse Event|0|||
49133005|NCT01147458|158327103|FG002|Second Intervention|Adverse Event|1|||
49133006|NCT01147458|158327104|FG003|Second Intervention|Adverse Event|1|||
49133007|NCT01147458|158327101|FG000|Second Intervention|Other|0|||
49133008|NCT01147458|158327102|FG001|Second Intervention|Other|0|||
49133009|NCT01147458|158327103|FG002|Second Intervention|Other|1|||
48819324|NCT01177813|157181802|FG004|Overall Study|Adverse Event|3|||
48819325|NCT01177813|157181798|FG000|Overall Study|Lack of Efficacy|1|||
48819326|NCT01177813|157181799|FG001|Overall Study|Lack of Efficacy|0|||
48819327|NCT01177813|157181800|FG002|Overall Study|Lack of Efficacy|0|||
48819328|NCT01177813|157181801|FG003|Overall Study|Lack of Efficacy|0|||
48819329|NCT01177813|157181802|FG004|Overall Study|Lack of Efficacy|0|||
48819330|NCT01177813|157181798|FG000|Overall Study|Protocol Violation|3|||
48819331|NCT01177813|157181799|FG001|Overall Study|Protocol Violation|2|||
48819332|NCT01177813|157181800|FG002|Overall Study|Protocol Violation|2|||
48819333|NCT01177813|157181801|FG003|Overall Study|Protocol Violation|0|||
48819334|NCT01177813|157181802|FG004|Overall Study|Protocol Violation|1|||
49133010|NCT01147458|158327104|FG003|Second Intervention|Other|0|||
49133011|NCT00720759|158327105|FG000|Overall Study|Lost to Follow-up|0|||
49133012|NCT00720759|158327106|FG001|Overall Study|Lost to Follow-up|1|||
49133013|NCT00720759|158327107|FG002|Overall Study|Lost to Follow-up|1|||
48819335|NCT01177813|157181798|FG000|Overall Study|Lost to Follow-up|12|||
49133014|NCT00720759|158327108|FG003|Overall Study|Lost to Follow-up|0|||
49133015|NCT00640289|158327115|FG000|Overall Study|Death|3|||
49133016|NCT00640289|158327115|FG000|Overall Study|Withdrawal by Subject|1|||
49133017|NCT00640289|158327115|FG000|Overall Study|Lost to Follow-up|1|||
49133018|NCT00640289|158327115|FG000|Overall Study|Data collected under different amendment|2|||
49133019|NCT00640289|158327115|FG000|Overall Study|Transferred to another center|1|||
49133020|NCT00640289|158327115|FG000|Overall Study|Missing status|5|||
49133021|NCT01288430|158328756|FG000|Part 1|Progressive disease|2|||
49133022|NCT01288430|158328757|FG001|Part 1|Progressive disease|1|||
49133023|NCT01288430|158328758|FG002|Part 1|Progressive disease|1|||
49133024|NCT01288430|158328759|FG003|Part 1|Progressive disease|6|||
49133025|NCT01288430|158328760|FG004|Part 1|Progressive disease|2|||
49133026|NCT01288430|158328761|FG005|Part 1|Progressive disease|4|||
49133027|NCT01288430|158328762|FG006|Part 1|Progressive disease|2|||
49133028|NCT01288430|158328763|FG007|Part 1|Progressive disease|0|||
49133029|NCT01288430|158328764|FG008|Part 1|Progressive disease|0|||
49133030|NCT01288430|158328765|FG009|Part 1|Progressive disease|0|||
49133031|NCT01288430|158328756|FG000|Part 1|Clinical disease progression|0|||
49133032|NCT01288430|158328757|FG001|Part 1|Clinical disease progression|0|||
49133033|NCT01288430|158328758|FG002|Part 1|Clinical disease progression|1|||
49133034|NCT01288430|158328759|FG003|Part 1|Clinical disease progression|0|||
48724531|NCT00491556|156840521|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
49011159|NCT00124449|157877402|FG000|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
48724532|NCT00491556|156840520|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2|||
48724533|NCT00491556|156840521|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0|||
48724534|NCT00491556|156840520|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2|||
48724535|NCT00491556|156840521|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1|||
48724536|NCT00491556|156840520|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5|||
48724537|NCT00491556|156840521|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0|||
48724538|NCT00491556|156840520|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2|||
48724539|NCT00491556|156840521|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0|||
48724540|NCT00491556|156840520|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5|||
48724541|NCT00491556|156840521|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0|||
48724542|NCT00491556|156840520|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2|||
48724543|NCT00491556|156840521|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0|||
48724544|NCT00491556|156840520|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2|||
48724545|NCT00491556|156840521|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0|||
48724546|NCT00491556|156840520|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2|||
48724547|NCT00491556|156840521|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0|||
48724548|NCT00491556|156840520|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0|||
48724549|NCT00491556|156840521|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1|||
48724550|NCT00491556|156840520|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0|||
48724551|NCT00491556|156840521|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1|||
48724552|NCT02361346|156840522|FG000|Part 1 and 2 ( Up to Day 112)|Death|0|||
48724553|NCT02361346|156840523|FG001|Part 1 and 2 ( Up to Day 112)|Death|0|||
48724554|NCT02361346|156840524|FG002|Part 1 and 2 ( Up to Day 112)|Death|0|||
49011160|NCT00124449|157877403|FG001|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
49011161|NCT00124449|157877402|FG000|6-month Double-Blind Treatment Period|Poor/Noncompliance|1|||
49011162|NCT00124449|157877403|FG001|6-month Double-Blind Treatment Period|Poor/Noncompliance|0|||
49011163|NCT00124449|157877402|FG000|6-month Double-Blind Treatment Period|Sponsor request|0|||
49011164|NCT00124449|157877403|FG001|6-month Double-Blind Treatment Period|Sponsor request|1|||
49011165|NCT00124449|157877402|FG000|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0|||
49011166|NCT00124449|157877403|FG001|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1|||
49011167|NCT00124449|157877402|FG000|18-Month Untreated Observation Period|Adverse Event|0|||
49011168|NCT00124449|157877403|FG001|18-Month Untreated Observation Period|Adverse Event|1|||
49011169|NCT00124449|157877402|FG000|18-Month Untreated Observation Period|Lack of Efficacy|11|||
49011170|NCT00124449|157877403|FG001|18-Month Untreated Observation Period|Lack of Efficacy|12|||
49011171|NCT00124449|157877402|FG000|18-Month Untreated Observation Period|Lost to Follow-up|1|||
49011172|NCT00124449|157877403|FG001|18-Month Untreated Observation Period|Lost to Follow-up|0|||
49011173|NCT00124449|157877402|FG000|18-Month Untreated Observation Period|Pregnancy|1|||
49011174|NCT00124449|157877403|FG001|18-Month Untreated Observation Period|Pregnancy|0|||
49011175|NCT00124449|157877402|FG000|18-Month Untreated Observation Period|Poor/Noncompliance|1|||
49011176|NCT00124449|157877403|FG001|18-Month Untreated Observation Period|Poor/Noncompliance|0|||
49011177|NCT00124449|157877402|FG000|18-Month Untreated Observation Period|Relocated|1|||
49011178|NCT00124449|157877403|FG001|18-Month Untreated Observation Period|Relocated|0|||
49011179|NCT04317781|157877407|FG000|Overall Study|Adverse Event|1|||
49011180|NCT04317781|157877407|FG000|Overall Study|Disease relapse|1|||
49133035|NCT01288430|158328760|FG004|Part 1|Clinical disease progression|0|||
49133036|NCT01288430|158328761|FG005|Part 1|Clinical disease progression|2|||
49133037|NCT01288430|158328762|FG006|Part 1|Clinical disease progression|2|||
49133038|NCT01288430|158328763|FG007|Part 1|Clinical disease progression|0|||
49133039|NCT01288430|158328764|FG008|Part 1|Clinical disease progression|0|||
49133040|NCT01288430|158328765|FG009|Part 1|Clinical disease progression|0|||
49133041|NCT01288430|158328756|FG000|Part 1|Death due to disease progression|0|||
49133042|NCT01288430|158328757|FG001|Part 1|Death due to disease progression|0|||
49133043|NCT01288430|158328758|FG002|Part 1|Death due to disease progression|0|||
49133044|NCT01288430|158328759|FG003|Part 1|Death due to disease progression|0|||
49133045|NCT01288430|158328760|FG004|Part 1|Death due to disease progression|1|||
49133046|NCT01288430|158328761|FG005|Part 1|Death due to disease progression|0|||
49133047|NCT01288430|158328762|FG006|Part 1|Death due to disease progression|0|||
49133048|NCT01288430|158328763|FG007|Part 1|Death due to disease progression|0|||
49133049|NCT01288430|158328764|FG008|Part 1|Death due to disease progression|0|||
49133050|NCT01288430|158328765|FG009|Part 1|Death due to disease progression|0|||
49133051|NCT01288430|158328756|FG000|Part 1|Adverse Event|0|||
49133052|NCT01288430|158328757|FG001|Part 1|Adverse Event|0|||
49133053|NCT01288430|158328758|FG002|Part 1|Adverse Event|3|||
49133054|NCT01288430|158328759|FG003|Part 1|Adverse Event|1|||
48819336|NCT01177813|157181799|FG001|Overall Study|Lost to Follow-up|5|||
48819337|NCT01177813|157181800|FG002|Overall Study|Lost to Follow-up|6|||
48819338|NCT01177813|157181801|FG003|Overall Study|Lost to Follow-up|3|||
48819339|NCT01177813|157181802|FG004|Overall Study|Lost to Follow-up|0|||
49133055|NCT01288430|158328760|FG004|Part 1|Adverse Event|0|||
49133056|NCT01288430|158328761|FG005|Part 1|Adverse Event|0|||
49133057|NCT01288430|158328762|FG006|Part 1|Adverse Event|2|||
49133058|NCT01288430|158328763|FG007|Part 1|Adverse Event|0|||
49133059|NCT01288430|158328764|FG008|Part 1|Adverse Event|0|||
49133060|NCT01288430|158328765|FG009|Part 1|Adverse Event|0|||
49133061|NCT01288430|158328756|FG000|Part 1|Other|0|||
49133062|NCT01288430|158328757|FG001|Part 1|Other|2|||
49133063|NCT01288430|158328758|FG002|Part 1|Other|0|||
49133064|NCT01288430|158328759|FG003|Part 1|Other|0|||
49133065|NCT01288430|158328760|FG004|Part 1|Other|0|||
49133066|NCT01288430|158328761|FG005|Part 1|Other|0|||
49133067|NCT01288430|158328762|FG006|Part 1|Other|1|||
49133068|NCT01288430|158328763|FG007|Part 1|Other|0|||
49133069|NCT01288430|158328764|FG008|Part 1|Other|0|||
49133070|NCT01288430|158328765|FG009|Part 1|Other|0|||
49133071|NCT01288430|158328756|FG000|Part 2|Progressive disease|0|||
49133072|NCT01288430|158328757|FG001|Part 2|Progressive disease|0|||
49133073|NCT01288430|158328758|FG002|Part 2|Progressive disease|0|||
49133074|NCT01288430|158328759|FG003|Part 2|Progressive disease|0|||
49133075|NCT01288430|158328760|FG004|Part 2|Progressive disease|0|||
49133076|NCT01288430|158328761|FG005|Part 2|Progressive disease|0|||
49133077|NCT01288430|158328762|FG006|Part 2|Progressive disease|0|||
49133078|NCT01288430|158328763|FG007|Part 2|Progressive disease|8|||
49133079|NCT01288430|158328764|FG008|Part 2|Progressive disease|7|||
49133080|NCT01288430|158328765|FG009|Part 2|Progressive disease|2|||
49133081|NCT01288430|158328756|FG000|Part 2|Clinical disease progression|0|||
49133082|NCT01288430|158328757|FG001|Part 2|Clinical disease progression|0|||
49133083|NCT01288430|158328758|FG002|Part 2|Clinical disease progression|0|||
49133084|NCT01288430|158328759|FG003|Part 2|Clinical disease progression|0|||
49133085|NCT01288430|158328760|FG004|Part 2|Clinical disease progression|0|||
49133086|NCT01288430|158328761|FG005|Part 2|Clinical disease progression|0|||
49133087|NCT01288430|158328762|FG006|Part 2|Clinical disease progression|0|||
49133088|NCT01288430|158328763|FG007|Part 2|Clinical disease progression|2|||
49133089|NCT01288430|158328764|FG008|Part 2|Clinical disease progression|0|||
49133090|NCT01288430|158328765|FG009|Part 2|Clinical disease progression|0|||
49133091|NCT01288430|158328756|FG000|Part 2|Withdrawal by Subject|0|||
49133092|NCT01288430|158328757|FG001|Part 2|Withdrawal by Subject|0|||
49133093|NCT01288430|158328758|FG002|Part 2|Withdrawal by Subject|0|||
49133094|NCT01288430|158328759|FG003|Part 2|Withdrawal by Subject|0|||
49133095|NCT01288430|158328760|FG004|Part 2|Withdrawal by Subject|0|||
49133096|NCT01288430|158328761|FG005|Part 2|Withdrawal by Subject|0|||
49133097|NCT01288430|158328762|FG006|Part 2|Withdrawal by Subject|0|||
49133098|NCT01288430|158328763|FG007|Part 2|Withdrawal by Subject|1|||
49133099|NCT01288430|158328764|FG008|Part 2|Withdrawal by Subject|4|||
49133100|NCT01288430|158328765|FG009|Part 2|Withdrawal by Subject|0|||
49133101|NCT01288430|158328756|FG000|Part 2|Adverse Event|0|||
49133102|NCT01288430|158328757|FG001|Part 2|Adverse Event|0|||
49133103|NCT01288430|158328758|FG002|Part 2|Adverse Event|0|||
49133104|NCT01288430|158328759|FG003|Part 2|Adverse Event|0|||
48819340|NCT01177813|157181798|FG000|Overall Study|Withdrawal by Subject|12|||
49133105|NCT01288430|158328760|FG004|Part 2|Adverse Event|0|||
49133106|NCT01288430|158328761|FG005|Part 2|Adverse Event|0|||
49133107|NCT01288430|158328762|FG006|Part 2|Adverse Event|0|||
49133108|NCT01288430|158328763|FG007|Part 2|Adverse Event|1|||
49133109|NCT01288430|158328764|FG008|Part 2|Adverse Event|1|||
49133110|NCT01288430|158328765|FG009|Part 2|Adverse Event|0|||
49133111|NCT01288430|158328756|FG000|Part 2|Other|0|||
49133112|NCT01288430|158328757|FG001|Part 2|Other|0|||
49133113|NCT01288430|158328758|FG002|Part 2|Other|0|||
49133114|NCT01288430|158328759|FG003|Part 2|Other|0|||
49133115|NCT01288430|158328760|FG004|Part 2|Other|0|||
49133116|NCT01288430|158328761|FG005|Part 2|Other|0|||
49133117|NCT01288430|158328762|FG006|Part 2|Other|0|||
49133118|NCT01288430|158328763|FG007|Part 2|Other|0|||
49133119|NCT01288430|158328764|FG008|Part 2|Other|0|||
49133120|NCT01288430|158328765|FG009|Part 2|Other|1|||
49133121|NCT00549055|158328766|FG000|Overall Study|Adverse Event|4|||
49133122|NCT00549055|158328766|FG000|Overall Study|Lack of Efficacy|18|||
49133123|NCT00549055|158328766|FG000|Overall Study|Stabilization|5|||
49133124|NCT00549055|158328766|FG000|Overall Study|Progression to fibrosis|2|||
49133125|NCT00549055|158328766|FG000|Overall Study|Decrease of size|1|||
49133126|NCT00549055|158328766|FG000|Overall Study|Active choroidal neovascula increased|1|||
49133127|NCT00549055|158328766|FG000|Overall Study|Vitreous hemorrhage|1|||
49133128|NCT00549055|158328766|FG000|Overall Study|Growth choroidal neovascularisation|1|||
49133129|NCT00549055|158328766|FG000|Overall Study|Choroidal neovascularization|1|||
49133130|NCT00549055|158328766|FG000|Overall Study|Very low visual acuity (VA)|1|||
49133131|NCT02807259|158328776|FG000|Baseline (3 Months)|migration, refusal, not available|77|||
49133132|NCT02807259|158328777|FG001|Baseline (3 Months)|migration, refusal, not available|112|||
49133133|NCT02807259|158328776|FG000|Midline (3 Months)|migration, refusal, not available|30|||
49133134|NCT02807259|158328777|FG001|Midline (3 Months)|migration, refusal, not available|34|||
49133135|NCT02807259|158328776|FG000|Endline (3 Months)|migration, refusal, not available|35|||
49133136|NCT02807259|158328777|FG001|Endline (3 Months)|migration, refusal, not available|87|||
49133137|NCT00362232|158328778|FG000|Treatment (12 +/- 2 Days)|Adverse Event|62|||
49133138|NCT00362232|158328779|FG001|Treatment (12 +/- 2 Days)|Adverse Event|56|||
49133139|NCT00362232|158328778|FG000|Treatment (12 +/- 2 Days)|Death|1|||
49133140|NCT00362232|158328779|FG001|Treatment (12 +/- 2 Days)|Death|3|||
49133141|NCT00362232|158328778|FG000|Treatment (12 +/- 2 Days)|Lost to Follow-up|3|||
49133142|NCT00362232|158328779|FG001|Treatment (12 +/- 2 Days)|Lost to Follow-up|1|||
49133143|NCT00362232|158328778|FG000|Treatment (12 +/- 2 Days)|Physician Decision|2|||
49133144|NCT00362232|158328779|FG001|Treatment (12 +/- 2 Days)|Physician Decision|5|||
49133145|NCT00362232|158328778|FG000|Treatment (12 +/- 2 Days)|Protocol Violation|22|||
49133146|NCT00362232|158328779|FG001|Treatment (12 +/- 2 Days)|Protocol Violation|21|||
49133147|NCT00362232|158328778|FG000|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49|||
49133148|NCT00362232|158328779|FG001|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47|||
49133149|NCT00362232|158328778|FG000|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9|||
49133150|NCT00362232|158328779|FG001|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0|||
49133151|NCT00362232|158328778|FG000|Treatment (12 +/- 2 Days)|Technical Problems|1|||
49133152|NCT00362232|158328779|FG001|Treatment (12 +/- 2 Days)|Technical Problems|0|||
49133153|NCT00362232|158328778|FG000|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10|||
49133154|NCT00362232|158328779|FG001|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18|||
49133155|NCT00362232|158328778|FG000|Follow-up (30 (+ 5) Days)|Adverse Event|2|||
49133156|NCT00362232|158328779|FG001|Follow-up (30 (+ 5) Days)|Adverse Event|3|||
49133157|NCT00362232|158328778|FG000|Follow-up (30 (+ 5) Days)|Death|1|||
49133158|NCT00362232|158328779|FG001|Follow-up (30 (+ 5) Days)|Death|1|||
49133159|NCT00362232|158328778|FG000|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27|||
49133160|NCT00362232|158328779|FG001|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28|||
49133161|NCT00362232|158328778|FG000|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8|||
49133162|NCT00362232|158328779|FG001|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7|||
49133163|NCT00109343|158328783|FG000|Overall Study|Adverse Event|1|||
49133164|NCT00109343|158328784|FG001|Overall Study|Adverse Event|0|||
49133165|NCT00109343|158328785|FG002|Overall Study|Adverse Event|2|||
49133166|NCT00109343|158328783|FG000|Overall Study|Lack of Efficacy|1|||
49133167|NCT00109343|158328784|FG001|Overall Study|Lack of Efficacy|0|||
49133168|NCT00109343|158328785|FG002|Overall Study|Lack of Efficacy|0|||
49133169|NCT00109343|158328783|FG000|Overall Study|Lost to Follow-up|35|||
49133170|NCT00109343|158328784|FG001|Overall Study|Lost to Follow-up|20|||
49133171|NCT00109343|158328785|FG002|Overall Study|Lost to Follow-up|14|||
49133172|NCT00109343|158328783|FG000|Overall Study|Protocol Violation|1|||
49133173|NCT00109343|158328784|FG001|Overall Study|Protocol Violation|2|||
49133174|NCT00109343|158328785|FG002|Overall Study|Protocol Violation|2|||
49133175|NCT00109343|158328783|FG000|Overall Study|Withdrawal by Subject|15|||
49133176|NCT00109343|158328784|FG001|Overall Study|Withdrawal by Subject|11|||
49133177|NCT00109343|158328785|FG002|Overall Study|Withdrawal by Subject|10|||
49133178|NCT00109343|158328783|FG000|Overall Study|Subject Moved|6|||
49133179|NCT00109343|158328784|FG001|Overall Study|Subject Moved|2|||
49133180|NCT00109343|158328785|FG002|Overall Study|Subject Moved|1|||
49133181|NCT00109343|158328783|FG000|Overall Study|Other|5|||
49133182|NCT00109343|158328784|FG001|Overall Study|Other|2|||
49133183|NCT00109343|158328785|FG002|Overall Study|Other|1|||
49133184|NCT00750269|158328786|FG000|Overall Study|Protocol Violation|0|||
49133185|NCT00750269|158328787|FG001|Overall Study|Protocol Violation|1|||
49133186|NCT00750269|158328788|FG002|Overall Study|Protocol Violation|1|||
49133187|NCT00750269|158328789|FG003|Overall Study|Protocol Violation|2|||
49133188|NCT00750269|158328790|FG004|Overall Study|Protocol Violation|4|||
49133189|NCT00750269|158328786|FG000|Overall Study|Withdrawal by Subject|0|||
49133190|NCT00750269|158328787|FG001|Overall Study|Withdrawal by Subject|0|||
49133191|NCT00750269|158328788|FG002|Overall Study|Withdrawal by Subject|2|||
48724555|NCT02361346|156840525|FG003|Part 1 and 2 ( Up to Day 112)|Death|1|||
48819341|NCT01177813|157181799|FG001|Overall Study|Withdrawal by Subject|7|||
48819342|NCT01177813|157181800|FG002|Overall Study|Withdrawal by Subject|6|||
48819343|NCT01177813|157181801|FG003|Overall Study|Withdrawal by Subject|5|||
48819344|NCT01177813|157181802|FG004|Overall Study|Withdrawal by Subject|3|||
48819345|NCT01177813|157181798|FG000|Overall Study|Other reason not defined above|5|||
48819346|NCT01177813|157181799|FG001|Overall Study|Other reason not defined above|2|||
48819347|NCT01177813|157181800|FG002|Overall Study|Other reason not defined above|2|||
48819348|NCT01177813|157181801|FG003|Overall Study|Other reason not defined above|3|||
48819349|NCT01177813|157181802|FG004|Overall Study|Other reason not defined above|2|||
48819350|NCT02886728|157181804|FG000|Overall Study|Withdrew Consent|31|||
48819351|NCT02886728|157181805|FG001|Overall Study|Withdrew Consent|13|||
48819352|NCT02886728|157181806|FG002|Overall Study|Withdrew Consent|11|||
48819353|NCT02886728|157181807|FG003|Overall Study|Withdrew Consent|47|||
48819354|NCT02886728|157181804|FG000|Overall Study|Lost to Follow-up|12|||
48819355|NCT02886728|157181805|FG001|Overall Study|Lost to Follow-up|6|||
48819356|NCT02886728|157181806|FG002|Overall Study|Lost to Follow-up|13|||
48724556|NCT02361346|156840526|FG004|Part 1 and 2 ( Up to Day 112)|Death|0|||
48724557|NCT02361346|156840527|FG005|Part 1 and 2 ( Up to Day 112)|Death|0|||
48724558|NCT02361346|156840528|FG006|Part 1 and 2 ( Up to Day 112)|Death|0|||
48724559|NCT02361346|156840529|FG007|Part 1 and 2 ( Up to Day 112)|Death|0|||
48724560|NCT02361346|156840530|FG008|Part 1 and 2 ( Up to Day 112)|Death|0|||
48724561|NCT02361346|156840522|FG000|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
48724562|NCT02361346|156840523|FG001|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
48724563|NCT02361346|156840524|FG002|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
48724564|NCT02361346|156840525|FG003|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
48724565|NCT02361346|156840526|FG004|Part 1 and 2 ( Up to Day 112)|Adverse Event|2|||
48724566|NCT02361346|156840527|FG005|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
48724567|NCT02361346|156840528|FG006|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
48724568|NCT02361346|156840529|FG007|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
48724569|NCT02361346|156840530|FG008|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
48724570|NCT02361346|156840522|FG000|Part 3 (Up to Day 112)|Adverse Event|0|||
48724571|NCT02361346|156840523|FG001|Part 3 (Up to Day 112)|Adverse Event|0|||
48724572|NCT02361346|156840524|FG002|Part 3 (Up to Day 112)|Adverse Event|0|||
48724573|NCT02361346|156840525|FG003|Part 3 (Up to Day 112)|Adverse Event|0|||
48724574|NCT02361346|156840526|FG004|Part 3 (Up to Day 112)|Adverse Event|0|||
48724575|NCT02361346|156840527|FG005|Part 3 (Up to Day 112)|Adverse Event|0|||
48724576|NCT02361346|156840528|FG006|Part 3 (Up to Day 112)|Adverse Event|0|||
48724577|NCT02361346|156840529|FG007|Part 3 (Up to Day 112)|Adverse Event|1|||
48724578|NCT02361346|156840530|FG008|Part 3 (Up to Day 112)|Adverse Event|0|||
48724579|NCT02361346|156840522|FG000|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
48724580|NCT02361346|156840523|FG001|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
48724581|NCT02361346|156840524|FG002|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
48724582|NCT02361346|156840525|FG003|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
48724583|NCT02361346|156840526|FG004|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
48724584|NCT02361346|156840527|FG005|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
48724585|NCT02361346|156840528|FG006|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
48724586|NCT02361346|156840529|FG007|Part 3 (Up to Day 112)|Withdrawal by Subject|1|||
48724587|NCT02361346|156840530|FG008|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
48724588|NCT02361346|156840522|FG000|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
48724589|NCT02361346|156840523|FG001|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
48724590|NCT02361346|156840524|FG002|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
48724591|NCT02361346|156840525|FG003|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
48724592|NCT02361346|156840526|FG004|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
48724593|NCT02361346|156840527|FG005|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
48724594|NCT02361346|156840528|FG006|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
48724595|NCT02361346|156840529|FG007|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|7|||
48724596|NCT02361346|156840530|FG008|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
48724597|NCT02361346|156840522|FG000|Part 3 (Up to Day 112)|Clinical disease progression|0|||
48724598|NCT02361346|156840523|FG001|Part 3 (Up to Day 112)|Clinical disease progression|0|||
48724599|NCT02361346|156840524|FG002|Part 3 (Up to Day 112)|Clinical disease progression|0|||
48724600|NCT02361346|156840525|FG003|Part 3 (Up to Day 112)|Clinical disease progression|0|||
48724601|NCT02361346|156840526|FG004|Part 3 (Up to Day 112)|Clinical disease progression|0|||
48724602|NCT02361346|156840527|FG005|Part 3 (Up to Day 112)|Clinical disease progression|0|||
48819357|NCT02886728|157181807|FG003|Overall Study|Lost to Follow-up|12|||
48819358|NCT02886728|157181804|FG000|Overall Study|Adverse Event|13|||
48819359|NCT02886728|157181805|FG001|Overall Study|Adverse Event|5|||
48819360|NCT02886728|157181806|FG002|Overall Study|Adverse Event|5|||
49133192|NCT00750269|158328789|FG003|Overall Study|Withdrawal by Subject|2|||
49133193|NCT00750269|158328790|FG004|Overall Study|Withdrawal by Subject|2|||
49133194|NCT00750269|158328786|FG000|Overall Study|Physician Decision|0|||
49133195|NCT00750269|158328787|FG001|Overall Study|Physician Decision|0|||
49133196|NCT00750269|158328788|FG002|Overall Study|Physician Decision|0|||
49133197|NCT00750269|158328789|FG003|Overall Study|Physician Decision|0|||
49133198|NCT00750269|158328790|FG004|Overall Study|Physician Decision|2|||
49133199|NCT00750269|158328786|FG000|Overall Study|Patient too large for positioning|0|||
49133200|NCT00750269|158328787|FG001|Overall Study|Patient too large for positioning|0|||
49133201|NCT00750269|158328788|FG002|Overall Study|Patient too large for positioning|1|||
49133202|NCT00750269|158328789|FG003|Overall Study|Patient too large for positioning|0|||
49133203|NCT00750269|158328790|FG004|Overall Study|Patient too large for positioning|0|||
49133204|NCT00750269|158328786|FG000|Overall Study|Site error|0|||
49133205|NCT00750269|158328787|FG001|Overall Study|Site error|0|||
49133206|NCT00750269|158328788|FG002|Overall Study|Site error|0|||
49133207|NCT00750269|158328789|FG003|Overall Study|Site error|1|||
49133208|NCT00750269|158328790|FG004|Overall Study|Site error|0|||
49133209|NCT00750269|158328786|FG000|Overall Study|SBRT plan could not be drawn|0|||
49133210|NCT00750269|158328787|FG001|Overall Study|SBRT plan could not be drawn|0|||
49133211|NCT00750269|158328788|FG002|Overall Study|SBRT plan could not be drawn|0|||
49133212|NCT00750269|158328789|FG003|Overall Study|SBRT plan could not be drawn|0|||
49133213|NCT00750269|158328790|FG004|Overall Study|SBRT plan could not be drawn|1|||
49133214|NCT00750269|158328786|FG000|Overall Study|Fiducials could not be placed|0|||
49133215|NCT00750269|158328787|FG001|Overall Study|Fiducials could not be placed|0|||
49133216|NCT00750269|158328788|FG002|Overall Study|Fiducials could not be placed|0|||
49133217|NCT00750269|158328789|FG003|Overall Study|Fiducials could not be placed|0|||
49133218|NCT00750269|158328790|FG004|Overall Study|Fiducials could not be placed|1|||
49133219|NCT02934178|158328793|FG000|Received Vaccination 2|Death|0|||
49133220|NCT02934178|158328794|FG001|Received Vaccination 2|Death|1|||
49133221|NCT02934178|158328793|FG000|Received Vaccination 3|Withdrawal by Subject|1|||
49133222|NCT02934178|158328794|FG001|Received Vaccination 3|Withdrawal by Subject|0|||
49133223|NCT00870727|158328797|FG000|Overall Study|Lost to Follow-up|0|||
49133224|NCT00870727|158328798|FG001|Overall Study|Lost to Follow-up|1|||
49133225|NCT00870727|158328797|FG000|Overall Study|Lack of Efficacy|1|||
49133226|NCT00870727|158328798|FG001|Overall Study|Lack of Efficacy|3|||
49133227|NCT00870727|158328797|FG000|Overall Study|Adverse Event|0|||
49133228|NCT00870727|158328798|FG001|Overall Study|Adverse Event|1|||
49133229|NCT00720278|158328799|FG000|Overall Study|Adverse Event|5|||
49133230|NCT00720278|158328800|FG001|Overall Study|Adverse Event|3|||
49133231|NCT00720278|158328801|FG002|Overall Study|Adverse Event|4|||
49133232|NCT00720278|158328799|FG000|Overall Study|Withdrawal by Subject|0|||
49133233|NCT00720278|158328800|FG001|Overall Study|Withdrawal by Subject|1|||
49133234|NCT00720278|158328801|FG002|Overall Study|Withdrawal by Subject|0|||
49133235|NCT00720278|158328799|FG000|Overall Study|Lost to Follow-up|0|||
49133236|NCT00720278|158328800|FG001|Overall Study|Lost to Follow-up|0|||
49133237|NCT00720278|158328801|FG002|Overall Study|Lost to Follow-up|1|||
49133238|NCT00720278|158328799|FG000|Overall Study|Non-compliance|1|||
49133239|NCT00720278|158328800|FG001|Overall Study|Non-compliance|0|||
49133240|NCT00720278|158328801|FG002|Overall Study|Non-compliance|0|||
49133241|NCT00720278|158328799|FG000|Overall Study|eligibility criteria violation|1|||
49133242|NCT00720278|158328800|FG001|Overall Study|eligibility criteria violation|0|||
49133243|NCT00720278|158328801|FG002|Overall Study|eligibility criteria violation|1|||
49133244|NCT00737048|158328804|FG000|Overall Study|Physician Decision|0|||
49133245|NCT00737048|158328805|FG001|Overall Study|Physician Decision|0|||
49133246|NCT00737048|158328806|FG002|Overall Study|Physician Decision|1|||
49133247|NCT00737048|158328804|FG000|Overall Study|Adverse Event|0|||
49133248|NCT00737048|158328805|FG001|Overall Study|Adverse Event|1|||
49133249|NCT00737048|158328806|FG002|Overall Study|Adverse Event|0|||
49133250|NCT00737048|158328804|FG000|Overall Study|Worsening of the symptoms|3|||
49133251|NCT00737048|158328805|FG001|Overall Study|Worsening of the symptoms|5|||
49133252|NCT00737048|158328806|FG002|Overall Study|Worsening of the symptoms|3|||
49133253|NCT01294046|158328807|FG000|Overall Study|Infection and surgical explant|1|||
49133254|NCT01294046|158328807|FG000|Overall Study|Eligibility criteria expanded|1|||
49133255|NCT01294046|158328807|FG000|Overall Study|Stimulation response inadqequate|1|||
49133256|NCT01373164|158328812|FG000|Overall Study|Lost to Follow-up|0|||
49133257|NCT01373164|158328813|FG001|Overall Study|Lost to Follow-up|0|||
49133258|NCT01373164|158328814|FG002|Overall Study|Lost to Follow-up|1|||
49133259|NCT01373164|158328815|FG003|Overall Study|Lost to Follow-up|2|||
49133260|NCT01373164|158328816|FG004|Overall Study|Lost to Follow-up|0|||
49133261|NCT01373164|158328812|FG000|Overall Study|Withdrawal by Subject|0|||
49133262|NCT01373164|158328813|FG001|Overall Study|Withdrawal by Subject|1|||
49133263|NCT01373164|158328814|FG002|Overall Study|Withdrawal by Subject|0|||
49133264|NCT01373164|158328815|FG003|Overall Study|Withdrawal by Subject|10|||
49133265|NCT01373164|158328816|FG004|Overall Study|Withdrawal by Subject|2|||
49133266|NCT00420745|158328817|FG000|Overall Study|Adverse Event|2|||
49133267|NCT00420745|158328818|FG001|Overall Study|Adverse Event|2|||
49133268|NCT00420745|158328817|FG000|Overall Study|Lost to Follow-up|10|||
49133269|NCT00420745|158328818|FG001|Overall Study|Lost to Follow-up|2|||
49133270|NCT00420745|158328817|FG000|Overall Study|Protocol Violation|1|||
49133271|NCT00420745|158328818|FG001|Overall Study|Protocol Violation|0|||
49133272|NCT00420745|158328817|FG000|Overall Study|Physician Decision|1|||
49133273|NCT00420745|158328818|FG001|Overall Study|Physician Decision|1|||
49133274|NCT00420745|158328817|FG000|Overall Study|Recurrent pneumonia & bronchitis|0|||
49133275|NCT00420745|158328818|FG001|Overall Study|Recurrent pneumonia & bronchitis|1|||
49133276|NCT00420745|158328817|FG000|Overall Study|Age limit exceeded for Dose 2|1|||
49133277|NCT00420745|158328818|FG001|Overall Study|Age limit exceeded for Dose 2|0|||
49133278|NCT01963611|158328819|FG000|Overall Study|Adverse Event|1|||
48724603|NCT02361346|156840528|FG006|Part 3 (Up to Day 112)|Clinical disease progression|0|||
48724604|NCT02361346|156840529|FG007|Part 3 (Up to Day 112)|Clinical disease progression|2|||
48724605|NCT02361346|156840530|FG008|Part 3 (Up to Day 112)|Clinical disease progression|0|||
48724606|NCT03571386|156840531|FG000|Overall Study|scheduling conflict|4|||
48724607|NCT03571386|156840532|FG001|Overall Study|scheduling conflict|0|||
48724608|NCT03571386|156840531|FG000|Overall Study|Withdrawal by Subject|15|||
48724609|NCT03571386|156840532|FG001|Overall Study|Withdrawal by Subject|5|||
48724610|NCT04571515|156840533|FG000|Overall Study|Physician Decision|0|||
48724611|NCT04571515|156840534|FG001|Overall Study|Physician Decision|0|||
48724612|NCT04571515|156840535|FG002|Overall Study|Physician Decision|0|||
48724613|NCT04571515|156840536|FG003|Overall Study|Physician Decision|0|||
48724614|NCT04571515|156840537|FG004|Overall Study|Physician Decision|1|||
48724615|NCT04571515|156840533|FG000|Overall Study|Withdrawal by Subject|0|||
48724616|NCT04571515|156840534|FG001|Overall Study|Withdrawal by Subject|0|||
48724617|NCT04571515|156840535|FG002|Overall Study|Withdrawal by Subject|0|||
48724618|NCT04571515|156840536|FG003|Overall Study|Withdrawal by Subject|0|||
48724619|NCT04571515|156840537|FG004|Overall Study|Withdrawal by Subject|1|||
48724620|NCT04571515|156840533|FG000|Overall Study|insufficient pain|1|||
48724621|NCT04571515|156840534|FG001|Overall Study|insufficient pain|0|||
48724622|NCT04571515|156840535|FG002|Overall Study|insufficient pain|0|||
48724623|NCT04571515|156840536|FG003|Overall Study|insufficient pain|0|||
48724624|NCT04571515|156840537|FG004|Overall Study|insufficient pain|1|||
48724625|NCT03670836|156840545|FG000|Intent-to-treat Population (ITT)|Withdrawal by Subject|1|||
48724626|NCT03670836|156840546|FG001|Intent-to-treat Population (ITT)|Withdrawal by Subject|3|||
48724627|NCT03670836|156840545|FG000|Per Protocol Population (PP)|Physician Decision|9|||
49133279|NCT01963611|158328820|FG001|Overall Study|Adverse Event|1|||
49133280|NCT01963611|158328821|FG002|Overall Study|Adverse Event|3|||
49133281|NCT01963611|158328822|FG003|Overall Study|Adverse Event|4|||
49133282|NCT01963611|158328823|FG004|Overall Study|Adverse Event|3|||
49133283|NCT01963611|158328819|FG000|Overall Study|Protocol Violation|0|||
49133284|NCT01963611|158328820|FG001|Overall Study|Protocol Violation|0|||
49133285|NCT01963611|158328821|FG002|Overall Study|Protocol Violation|0|||
49133286|NCT01963611|158328822|FG003|Overall Study|Protocol Violation|1|||
49133287|NCT01963611|158328823|FG004|Overall Study|Protocol Violation|0|||
49133288|NCT01963611|158328819|FG000|Overall Study|Lack of Efficacy|0|||
49133289|NCT01963611|158328820|FG001|Overall Study|Lack of Efficacy|0|||
49133290|NCT01963611|158328821|FG002|Overall Study|Lack of Efficacy|0|||
49133291|NCT01963611|158328822|FG003|Overall Study|Lack of Efficacy|1|||
48724628|NCT03670836|156840546|FG001|Per Protocol Population (PP)|Physician Decision|10|||
48724629|NCT03670836|156840545|FG000|Per Protocol Population (PP)|Physician Decision|4|||
48724630|NCT03670836|156840546|FG001|Per Protocol Population (PP)|Physician Decision|6|||
48724631|NCT03670836|156840545|FG000|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
48724632|NCT03670836|156840546|FG001|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
48724633|NCT00718081|156842000|FG000|Overall Study|Adverse Event|0|||
48724634|NCT00718081|156842001|FG001|Overall Study|Adverse Event|1|||
48724635|NCT00718081|156842002|FG002|Overall Study|Adverse Event|0|||
48724636|NCT00718081|156842000|FG000|Overall Study|Lack of Efficacy|7|||
48724637|NCT00718081|156842001|FG001|Overall Study|Lack of Efficacy|3|||
48724638|NCT00718081|156842002|FG002|Overall Study|Lack of Efficacy|21|||
48724639|NCT03281291|156842004|FG000|Overall Study|Serious Adverse Event And/Or pIMD|2|||
48724640|NCT03281291|156842005|FG001|Overall Study|Serious Adverse Event And/Or pIMD|1|||
48724641|NCT03281291|156842006|FG002|Overall Study|Serious Adverse Event And/Or pIMD|0|||
48724642|NCT03281291|156842007|FG003|Overall Study|Serious Adverse Event And/Or pIMD|4|||
48724643|NCT03281291|156842008|FG004|Overall Study|Serious Adverse Event And/Or pIMD|1|||
48724644|NCT03281291|156842004|FG000|Overall Study|Protocol Deviation|2|||
48724645|NCT03281291|156842005|FG001|Overall Study|Protocol Deviation|0|||
48724646|NCT03281291|156842006|FG002|Overall Study|Protocol Deviation|1|||
48724647|NCT03281291|156842007|FG003|Overall Study|Protocol Deviation|2|||
48724648|NCT03281291|156842008|FG004|Overall Study|Protocol Deviation|1|||
48724649|NCT03281291|156842004|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
49133292|NCT01963611|158328823|FG004|Overall Study|Lack of Efficacy|0|||
49133293|NCT01963611|158328819|FG000|Overall Study|Withdrawal by Subject|3|||
49133294|NCT01963611|158328820|FG001|Overall Study|Withdrawal by Subject|2|||
49133295|NCT01963611|158328821|FG002|Overall Study|Withdrawal by Subject|1|||
49133296|NCT01963611|158328822|FG003|Overall Study|Withdrawal by Subject|1|||
48819361|NCT02886728|157181807|FG003|Overall Study|Adverse Event|11|||
48819362|NCT02886728|157181804|FG000|Overall Study|Investigator's Discretion|11|||
48819363|NCT02886728|157181805|FG001|Overall Study|Investigator's Discretion|7|||
48819364|NCT02886728|157181806|FG002|Overall Study|Investigator's Discretion|5|||
49133297|NCT01963611|158328823|FG004|Overall Study|Withdrawal by Subject|3|||
49133298|NCT01963611|158328819|FG000|Overall Study|Other|47|||
49133299|NCT01963611|158328820|FG001|Overall Study|Other|46|||
49133300|NCT01963611|158328821|FG002|Overall Study|Other|48|||
49133301|NCT01963611|158328822|FG003|Overall Study|Other|45|||
49133302|NCT01963611|158328823|FG004|Overall Study|Other|45|||
49133303|NCT02058095|158328824|FG000|Overall Study|Adverse Event|1|||
49133304|NCT02058095|158328825|FG001|Overall Study|Adverse Event|0|||
49133305|NCT00958074|158328831|FG000|Overall Study|Withdrawal by Subject|0|||
49133306|NCT00958074|158328832|FG001|Overall Study|Withdrawal by Subject|1|||
49133307|NCT02842866|158328835|FG000|Overall Study|Serious Adverse Event|0|||
49133308|NCT02842866|158328836|FG001|Overall Study|Serious Adverse Event|1|||
49133309|NCT02842866|158328835|FG000|Overall Study|Protocol Violation|4|||
49133310|NCT02842866|158328836|FG001|Overall Study|Protocol Violation|2|||
49133311|NCT02842866|158328835|FG000|Overall Study|Lost to Follow-up|2|||
49133312|NCT02842866|158328836|FG001|Overall Study|Lost to Follow-up|0|||
49133313|NCT02842866|158328835|FG000|Overall Study|Withdrawal by Subject|1|||
49133314|NCT02842866|158328836|FG001|Overall Study|Withdrawal by Subject|0|||
49133315|NCT02300610|158328837|FG000|Overall Study|Withdrawal by Subject|1|||
49133316|NCT02300610|158328838|FG001|Overall Study|Withdrawal by Subject|0|||
49133317|NCT02300610|158328839|FG002|Overall Study|Withdrawal by Subject|1|||
49133318|NCT00577408|158328840|FG000|Overall Study|Stopped attending study visits|9|||
49133319|NCT00577408|158328841|FG001|Overall Study|Stopped attending study visits|11|||
49133320|NCT00577408|158328840|FG000|Overall Study|Continued opioid use|3|||
49133321|NCT00577408|158328841|FG001|Overall Study|Continued opioid use|2|||
49133322|NCT00577408|158328840|FG000|Overall Study|Non-compliance with study meds|0|||
49133323|NCT00577408|158328841|FG001|Overall Study|Non-compliance with study meds|3|||
49133324|NCT00577408|158328840|FG000|Overall Study|Refused Oral Naltrexone|0|||
49133325|NCT00577408|158328841|FG001|Overall Study|Refused Oral Naltrexone|1|||
49133326|NCT00577408|158328840|FG000|Overall Study|Moved out of state|0|||
49133327|NCT00577408|158328841|FG001|Overall Study|Moved out of state|1|||
49133328|NCT00577408|158328840|FG000|Overall Study|Scheduling Issues|0|||
49133329|NCT00577408|158328841|FG001|Overall Study|Scheduling Issues|3|||
49133330|NCT00577408|158328840|FG000|Overall Study|Death|0|||
49133331|NCT00577408|158328841|FG001|Overall Study|Death|1|||
49133332|NCT00577408|158328840|FG000|Overall Study|Psychiatric hospitalization|0|||
49133333|NCT00577408|158328841|FG001|Overall Study|Psychiatric hospitalization|1|||
49133334|NCT03743194|158328842|FG000|Overall Study|Protocol Violation|7|||
49133335|NCT03743194|158328843|FG001|Overall Study|Protocol Violation|7|||
49133336|NCT03743194|158328842|FG000|Overall Study|Physician Decision|0|||
49133337|NCT03743194|158328843|FG001|Overall Study|Physician Decision|2|||
49133338|NCT02030600|158328845|FG000|Treatment Period 1|Adverse Event|5|||
49133339|NCT02030600|158328846|FG001|Treatment Period 1|Adverse Event|7|||
49133340|NCT02030600|158328845|FG000|Treatment Period 1|Lack of Efficacy|0|||
49133341|NCT02030600|158328846|FG001|Treatment Period 1|Lack of Efficacy|1|||
49133342|NCT02030600|158328845|FG000|Treatment Period 1|Lost to Follow-up|11|||
49133343|NCT02030600|158328846|FG001|Treatment Period 1|Lost to Follow-up|3|||
49133344|NCT02030600|158328845|FG000|Treatment Period 1|Protocol Violation|22|||
49133345|NCT02030600|158328846|FG001|Treatment Period 1|Protocol Violation|17|||
49133346|NCT02030600|158328845|FG000|Treatment Period 1|Withdrawal by Subject|13|||
49133347|NCT02030600|158328846|FG001|Treatment Period 1|Withdrawal by Subject|17|||
49133348|NCT02030600|158328845|FG000|Treatment Period 1|Casebook Unsigned|1|||
49133349|NCT02030600|158328846|FG001|Treatment Period 1|Casebook Unsigned|0|||
49133350|NCT02030600|158328845|FG000|Treatment Period 1|Unclassified|1|||
49133351|NCT02030600|158328846|FG001|Treatment Period 1|Unclassified|0|||
49133352|NCT02030600|158328845|FG000|Treatment Period 2|Adverse Event|4|||
49133353|NCT02030600|158328846|FG001|Treatment Period 2|Adverse Event|4|||
49133354|NCT02030600|158328845|FG000|Treatment Period 2|Lack of Efficacy|2|||
49133355|NCT02030600|158328846|FG001|Treatment Period 2|Lack of Efficacy|1|||
49133356|NCT02030600|158328845|FG000|Treatment Period 2|Lost to Follow-up|4|||
49133357|NCT02030600|158328846|FG001|Treatment Period 2|Lost to Follow-up|2|||
49133358|NCT02030600|158328845|FG000|Treatment Period 2|Protocol Violation|1|||
49133359|NCT02030600|158328846|FG001|Treatment Period 2|Protocol Violation|2|||
49133360|NCT02030600|158328845|FG000|Treatment Period 2|Withdrawal by Subject|13|||
49133361|NCT02030600|158328846|FG001|Treatment Period 2|Withdrawal by Subject|9|||
49133362|NCT02030600|158328845|FG000|Treatment Period 2|Unclassified|1|||
49133363|NCT02030600|158328846|FG001|Treatment Period 2|Unclassified|0|||
49133364|NCT01541748|158328848|FG000|Overall Study|Lost to Follow-up|17|||
49133365|NCT01541748|158328848|FG000|Overall Study|Moved out of state|1|||
48724650|NCT03281291|156842005|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
48724651|NCT03281291|156842006|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
49133366|NCT01541748|158328848|FG000|Overall Study|Withdrawal by Subject|7|||
49133367|NCT01541748|158328848|FG000|Overall Study|Screen failure|5|||
49133368|NCT01541748|158328848|FG000|Overall Study|Did not receive study device|1|||
49133369|NCT02111083|158328850|FG000|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
48724652|NCT03281291|156842007|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
48724653|NCT03281291|156842008|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
48724654|NCT03281291|156842004|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
48724655|NCT03281291|156842005|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
48724656|NCT03281291|156842006|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
48724657|NCT03281291|156842007|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
48724658|NCT03281291|156842008|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
48724659|NCT03281291|156842004|FG000|Overall Study|Lost to Follow-up|10|||
48724660|NCT03281291|156842005|FG001|Overall Study|Lost to Follow-up|10|||
48724661|NCT03281291|156842006|FG002|Overall Study|Lost to Follow-up|4|||
48724662|NCT03281291|156842007|FG003|Overall Study|Lost to Follow-up|6|||
48724663|NCT03281291|156842008|FG004|Overall Study|Lost to Follow-up|10|||
48724664|NCT03281291|156842004|FG000|Overall Study|Other|0|||
48724665|NCT03281291|156842005|FG001|Overall Study|Other|2|||
48724666|NCT03281291|156842006|FG002|Overall Study|Other|0|||
48724667|NCT03281291|156842007|FG003|Overall Study|Other|2|||
48724668|NCT03281291|156842008|FG004|Overall Study|Other|1|||
48724669|NCT04956861|156842009|FG000|Overall Study|Withdrawal by Subject|4|||
48724670|NCT04956861|156842010|FG001|Overall Study|Withdrawal by Subject|4|||
48724671|NCT04956861|156842011|FG002|Overall Study|Withdrawal by Subject|2|||
48724672|NCT04956861|156842009|FG000|Overall Study|Physician Decision|4|||
48724673|NCT04956861|156842010|FG001|Overall Study|Physician Decision|5|||
48724674|NCT04956861|156842011|FG002|Overall Study|Physician Decision|1|||
48819365|NCT02886728|157181807|FG003|Overall Study|Investigator's Discretion|11|||
48819366|NCT02886728|157181804|FG000|Overall Study|Death|3|||
48819367|NCT02886728|157181805|FG001|Overall Study|Death|1|||
48819368|NCT02886728|157181806|FG002|Overall Study|Death|0|||
48819369|NCT02886728|157181807|FG003|Overall Study|Death|0|||
48819370|NCT02886728|157181804|FG000|Overall Study|Protocol Violation|0|||
48819371|NCT02886728|157181805|FG001|Overall Study|Protocol Violation|0|||
48819372|NCT02886728|157181806|FG002|Overall Study|Protocol Violation|0|||
48819373|NCT02886728|157181807|FG003|Overall Study|Protocol Violation|4|||
48819374|NCT02886728|157181804|FG000|Overall Study|Non-Compliance with Study Drug|1|||
48819375|NCT02886728|157181805|FG001|Overall Study|Non-Compliance with Study Drug|0|||
48819376|NCT02886728|157181806|FG002|Overall Study|Non-Compliance with Study Drug|1|||
49133370|NCT02111083|158328851|FG001|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
49133371|NCT01259245|158328852|FG000|Overall Study|Withdrawal by Subject|27|||
49133372|NCT01259245|158328853|FG001|Overall Study|Withdrawal by Subject|24|||
49133373|NCT01259245|158328852|FG000|Overall Study|Death|1|||
48724675|NCT03355664|156842012|FG000|Overall Study|Adverse Event|1|||
48724676|NCT03355664|156842013|FG001|Overall Study|Adverse Event|2|||
48724677|NCT03355664|156842012|FG000|Overall Study|Lost to Follow-up|11|||
48724678|NCT03355664|156842013|FG001|Overall Study|Lost to Follow-up|7|||
48819377|NCT02886728|157181807|FG003|Overall Study|Non-Compliance with Study Drug|0|||
48819378|NCT02886728|157181804|FG000|Overall Study|Pregnancy|0|||
48724679|NCT03355664|156842012|FG000|Overall Study|Protocol Violation|1|||
48724680|NCT03355664|156842013|FG001|Overall Study|Protocol Violation|2|||
48724681|NCT03355664|156842012|FG000|Overall Study|Withdrawal by Subject|2|||
48724682|NCT03355664|156842013|FG001|Overall Study|Withdrawal by Subject|1|||
48819379|NCT02886728|157181805|FG001|Overall Study|Pregnancy|0|||
48819380|NCT02886728|157181806|FG002|Overall Study|Pregnancy|1|||
48819381|NCT02886728|157181807|FG003|Overall Study|Pregnancy|0|||
49133374|NCT01259245|158328853|FG001|Overall Study|Death|2|||
49133375|NCT02832037|158328854|FG000|Overall Study|Administrative reasons|0|||
48724683|NCT00290407|156842014|FG000|Overall Study|Physician Decision|2|||
48819382|NCT02886728|157181804|FG000|Overall Study|Randomized but Not Dosed|1|||
48724684|NCT03915860|156842017|FG000|Overall Study|Adverse Event|3|||
49011181|NCT04317781|157877407|FG000|Overall Study|Withdrawal by Subject|1|||
49011182|NCT01504867|157877408|FG000|Overall Study|Inclusion criteria not met|2|||
49011183|NCT01504867|157877409|FG001|Overall Study|Inclusion criteria not met|2|||
49011184|NCT01504867|157877408|FG000|Overall Study|Consent revoked|5|||
49011185|NCT01504867|157877409|FG001|Overall Study|Consent revoked|1|||
49011186|NCT00571922|157877410|FG000|Overall Study|Completion unknown|36|||
49011187|NCT00571922|157877411|FG001|Overall Study|Completion unknown|36|||
49011188|NCT03124381|157877435|FG000|Overall Study|Lost to Follow-up|1|||
49011189|NCT03124381|157877436|FG001|Overall Study|Lost to Follow-up|1|||
49011190|NCT03124381|157877435|FG000|Overall Study|Withdrawal by Subject|6|||
49011191|NCT03124381|157877436|FG001|Overall Study|Withdrawal by Subject|3|||
49011192|NCT03124381|157877435|FG000|Overall Study|Protocol Violation|0|||
49011193|NCT03124381|157877436|FG001|Overall Study|Protocol Violation|1|||
49011194|NCT03124381|157877435|FG000|Overall Study|Adverse Event|1|||
49011195|NCT03124381|157877436|FG001|Overall Study|Adverse Event|1|||
49011196|NCT03124381|157877435|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
49011197|NCT03124381|157877436|FG001|Overall Study|Non-Compliance with Study Treatment|0|||
49011198|NCT01337050|157877448|FG000|Overall Study|Death|0|||
49011199|NCT01337050|157877449|FG001|Overall Study|Death|0|||
49011200|NCT01337050|157877450|FG002|Overall Study|Death|4|||
49011201|NCT01337050|157877448|FG000|Overall Study|Other|4|||
49011202|NCT01337050|157877449|FG001|Overall Study|Other|6|||
49011203|NCT01337050|157877450|FG002|Overall Study|Other|8|||
49011204|NCT01337050|157877448|FG000|Overall Study|Participants refused further follow-up|0|||
49011205|NCT01337050|157877449|FG001|Overall Study|Participants refused further follow-up|7|||
49011206|NCT01337050|157877450|FG002|Overall Study|Participants refused further follow-up|7|||
49011207|NCT00003102|157877451|FG000|Overall Study|Physician Decision|1|||
49011208|NCT00003102|157877452|FG001|Overall Study|Physician Decision|1|||
49011209|NCT00003102|157877453|FG002|Overall Study|Physician Decision|0|||
49011210|NCT00003102|157877451|FG000|Overall Study|Progressive Disease|0|||
49011211|NCT00003102|157877452|FG001|Overall Study|Progressive Disease|1|||
49011212|NCT00003102|157877453|FG002|Overall Study|Progressive Disease|0|||
49011213|NCT00003102|157877451|FG000|Overall Study|Adverse Event|0|||
49011214|NCT00003102|157877452|FG001|Overall Study|Adverse Event|1|||
49011215|NCT00003102|157877453|FG002|Overall Study|Adverse Event|1|||
49011216|NCT00003102|157877451|FG000|Overall Study|Death|0|||
49011217|NCT00003102|157877452|FG001|Overall Study|Death|0|||
49011218|NCT00003102|157877453|FG002|Overall Study|Death|1|||
49011219|NCT00583596|157877454|FG000|Overall Study|Lost to Follow-up|110|||
49011220|NCT00583596|157877454|FG000|Overall Study|Excluded due to Hurricane Katrina|30|||
49011221|NCT00583596|157877454|FG000|Overall Study|Death|2|||
49011222|NCT00583596|157877454|FG000|Overall Study|Withdrawal by Subject|6|||
49011223|NCT00583596|157877454|FG000|Overall Study|Lost to Follow-up|94|||
49011224|NCT00583596|157877454|FG000|Overall Study|Data not complete|1|||
49011225|NCT00583596|157877454|FG000|Overall Study|Not consented|15|||
49011226|NCT00583596|157877454|FG000|Overall Study|Outside f-up window|26|||
49011227|NCT00616928|157877455|FG000|Overall Study|Adverse Event|6|||
49011228|NCT00616928|157877456|FG001|Overall Study|Adverse Event|3|||
49011229|NCT00616928|157877457|FG002|Overall Study|Adverse Event|2|||
49011230|NCT00616928|157877458|FG003|Overall Study|Adverse Event|2|||
49011231|NCT00616928|157877455|FG000|Overall Study|Other|51|||
49011232|NCT00616928|157877456|FG001|Overall Study|Other|8|||
49011233|NCT00616928|157877457|FG002|Overall Study|Other|15|||
49011234|NCT00616928|157877458|FG003|Overall Study|Other|5|||
49011235|NCT00616928|157877455|FG000|Overall Study|Lost to Follow-up|5|||
49011236|NCT00616928|157877456|FG001|Overall Study|Lost to Follow-up|7|||
49133376|NCT02832037|158328855|FG001|Overall Study|Administrative reasons|0|||
49133377|NCT02832037|158328856|FG002|Overall Study|Administrative reasons|1|||
49133378|NCT02832037|158328857|FG003|Overall Study|Administrative reasons|0|||
49133379|NCT02832037|158328858|FG004|Overall Study|Administrative reasons|0|||
49133380|NCT02832037|158328854|FG000|Overall Study|Protocol Violation|3|||
49133381|NCT02832037|158328855|FG001|Overall Study|Protocol Violation|0|||
49133382|NCT02832037|158328856|FG002|Overall Study|Protocol Violation|4|||
49133383|NCT02832037|158328857|FG003|Overall Study|Protocol Violation|1|||
49133384|NCT02832037|158328858|FG004|Overall Study|Protocol Violation|2|||
49133385|NCT02832037|158328854|FG000|Overall Study|Lost to Follow-up|2|||
49133386|NCT02832037|158328855|FG001|Overall Study|Lost to Follow-up|0|||
49133387|NCT02832037|158328856|FG002|Overall Study|Lost to Follow-up|3|||
49133388|NCT02832037|158328857|FG003|Overall Study|Lost to Follow-up|0|||
49133389|NCT02832037|158328858|FG004|Overall Study|Lost to Follow-up|5|||
49133390|NCT02832037|158328854|FG000|Overall Study|Withdrawal by Subject|9|||
49133391|NCT02832037|158328855|FG001|Overall Study|Withdrawal by Subject|8|||
49133392|NCT02832037|158328856|FG002|Overall Study|Withdrawal by Subject|0|||
49133393|NCT02832037|158328857|FG003|Overall Study|Withdrawal by Subject|4|||
49133394|NCT02832037|158328858|FG004|Overall Study|Withdrawal by Subject|8|||
49133395|NCT02832037|158328854|FG000|Overall Study|Adverse Event|5|||
49133396|NCT02832037|158328855|FG001|Overall Study|Adverse Event|4|||
49133397|NCT02832037|158328856|FG002|Overall Study|Adverse Event|0|||
49133398|NCT02832037|158328857|FG003|Overall Study|Adverse Event|2|||
49133399|NCT02832037|158328858|FG004|Overall Study|Adverse Event|4|||
49133400|NCT01369433|158328859|FG000|Overall Study|Adverse Event|31|||
49133401|NCT01369433|158328860|FG001|Overall Study|Adverse Event|1|||
49133402|NCT01369433|158328859|FG000|Overall Study|Required significant surgical procedure|1|||
49133403|NCT01369433|158328860|FG001|Overall Study|Required significant surgical procedure|0|||
49133404|NCT01369433|158328859|FG000|Overall Study|Non-compliance|1|||
49133405|NCT01369433|158328860|FG001|Overall Study|Non-compliance|0|||
49133406|NCT01369433|158328859|FG000|Overall Study|Withdrawal by Subject|5|||
49133407|NCT01369433|158328860|FG001|Overall Study|Withdrawal by Subject|2|||
49133408|NCT01369433|158328859|FG000|Overall Study|Study terminated by Sponsor|67|||
49133409|NCT01369433|158328860|FG001|Overall Study|Study terminated by Sponsor|0|||
49133410|NCT01369433|158328859|FG000|Overall Study|Lost to Follow-up|1|||
49133411|NCT01369433|158328860|FG001|Overall Study|Lost to Follow-up|0|||
49133412|NCT01369433|158328859|FG000|Overall Study|Death|5|||
49133413|NCT01369433|158328860|FG001|Overall Study|Death|0|||
49133414|NCT01369433|158328859|FG000|Overall Study|Investigator discretion|6|||
49133415|NCT01369433|158328860|FG001|Overall Study|Investigator discretion|1|||
49133416|NCT01369433|158328859|FG000|Overall Study|Progressive Disease|92|||
49133417|NCT01369433|158328860|FG001|Overall Study|Progressive Disease|12|||
49133418|NCT00963235|158328861|FG000|Overall Study|Withdrawal by Subject|22|||
49133419|NCT00963235|158328861|FG000|Overall Study|Lost to Follow-up|14|||
49133420|NCT00963235|158328861|FG000|Overall Study|Failed to return|9|||
49133421|NCT00963235|158328861|FG000|Overall Study|Protocol Violation|7|||
49133422|NCT00963235|158328861|FG000|Overall Study|Adverse Event|5|||
49133423|NCT00963235|158328861|FG000|Overall Study|Physician Decision|2|||
49133424|NCT00963235|158328861|FG000|Overall Study|Other|1|||
49133425|NCT01697579|158328862|FG000|Base Study-Cycle 1|Adverse Event|1|||
49133426|NCT01697579|158328863|FG001|Base Study-Cycle 1|Adverse Event|0|||
49133427|NCT01697579|158328864|FG002|Base Study-Cycle 1|Adverse Event|0|||
49133428|NCT01697579|158328865|FG003|Base Study-Cycle 1|Adverse Event|0|||
48724685|NCT03915860|156842017|FG000|Overall Study|Withdrawal by Subject|6|||
48724686|NCT03915860|156842017|FG000|Overall Study|Lost to Follow-up|2|||
48724687|NCT03915860|156842017|FG000|Overall Study|Other than specified|3|||
49133429|NCT01697579|158328866|FG004|Base Study-Cycle 1|Adverse Event|0|||
49133430|NCT01697579|158328867|FG005|Base Study-Cycle 1|Adverse Event|0|||
49133431|NCT01697579|158328868|FG006|Base Study-Cycle 1|Adverse Event|0|||
49133432|NCT01697579|158328862|FG000|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1|||
49133433|NCT01697579|158328863|FG001|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
49133434|NCT01697579|158328864|FG002|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
49133435|NCT01697579|158328865|FG003|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
49133436|NCT01697579|158328866|FG004|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
49133437|NCT01697579|158328867|FG005|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
48724688|NCT00768469|156842018|FG000|Overall Study|Adverse Event|0|||
49133438|NCT01697579|158328868|FG006|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
49133439|NCT01697579|158328862|FG000|Base Study-Cycle 1|Protocol Violation|0|||
49133440|NCT01697579|158328863|FG001|Base Study-Cycle 1|Protocol Violation|0|||
49133441|NCT01697579|158328864|FG002|Base Study-Cycle 1|Protocol Violation|0|||
49133442|NCT01697579|158328865|FG003|Base Study-Cycle 1|Protocol Violation|0|||
49133443|NCT01697579|158328866|FG004|Base Study-Cycle 1|Protocol Violation|3|||
49133444|NCT01697579|158328867|FG005|Base Study-Cycle 1|Protocol Violation|0|||
49133445|NCT01697579|158328868|FG006|Base Study-Cycle 1|Protocol Violation|0|||
49133446|NCT01697579|158328862|FG000|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
49133447|NCT01697579|158328863|FG001|Base Study-Cycle 1|Consent Withdrawn by Participant|1|||
49133448|NCT01697579|158328864|FG002|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
49133449|NCT01697579|158328865|FG003|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
49133450|NCT01697579|158328866|FG004|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
49133451|NCT01697579|158328867|FG005|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
49133452|NCT01697579|158328868|FG006|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
49133453|NCT01697579|158328862|FG000|Base Study-Cycle 1|Technical Problems|0|||
49133454|NCT01697579|158328863|FG001|Base Study-Cycle 1|Technical Problems|0|||
49133455|NCT01697579|158328864|FG002|Base Study-Cycle 1|Technical Problems|1|||
49133456|NCT01697579|158328865|FG003|Base Study-Cycle 1|Technical Problems|1|||
49133457|NCT01697579|158328866|FG004|Base Study-Cycle 1|Technical Problems|0|||
49133458|NCT01697579|158328867|FG005|Base Study-Cycle 1|Technical Problems|0|||
49133459|NCT01697579|158328868|FG006|Base Study-Cycle 1|Technical Problems|0|||
49133460|NCT01697579|158328862|FG000|Optional Extension-Cycles 2-6|Death|0|||
49133461|NCT01697579|158328863|FG001|Optional Extension-Cycles 2-6|Death|0|||
49133462|NCT01697579|158328864|FG002|Optional Extension-Cycles 2-6|Death|0|||
49133463|NCT01697579|158328865|FG003|Optional Extension-Cycles 2-6|Death|0|||
49133464|NCT01697579|158328866|FG004|Optional Extension-Cycles 2-6|Death|0|||
49133465|NCT01697579|158328867|FG005|Optional Extension-Cycles 2-6|Death|0|||
48724689|NCT00768469|156842019|FG001|Overall Study|Adverse Event|2|||
48724690|NCT00768469|156842018|FG000|Overall Study|Disease Progression|3|||
48724691|NCT00768469|156842019|FG001|Overall Study|Disease Progression|4|||
48724692|NCT00768469|156842018|FG000|Overall Study|Withdrawal by Subject|0|||
48724693|NCT00768469|156842019|FG001|Overall Study|Withdrawal by Subject|1|||
48724694|NCT03180684|156842022|FG000|Overall Study|Withdrawal by Subject (Not Related to AE)|5|||
48724695|NCT03180684|156842023|FG001|Overall Study|Withdrawal by Subject (Not Related to AE)|0|||
49133466|NCT01697579|158328868|FG006|Optional Extension-Cycles 2-6|Death|2|||
49133467|NCT01697579|158328862|FG000|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
49133468|NCT01697579|158328863|FG001|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
49133469|NCT01697579|158328864|FG002|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
48724696|NCT03180684|156842022|FG000|Overall Study|Physician Decision|1|||
48724697|NCT03180684|156842023|FG001|Overall Study|Physician Decision|0|||
48724698|NCT03180684|156842022|FG000|Overall Study|Lost to Follow-up|1|||
48724699|NCT03180684|156842023|FG001|Overall Study|Lost to Follow-up|0|||
48724700|NCT03180684|156842022|FG000|Overall Study|Progressive Disease|1|||
48724701|NCT03180684|156842023|FG001|Overall Study|Progressive Disease|0|||
48724702|NCT00136604|156842024|FG000|Overall Study|Lost to Follow-up|1|||
48724703|NCT00136604|156842025|FG001|Overall Study|Lost to Follow-up|0|||
48724704|NCT00136604|156842026|FG002|Overall Study|Lost to Follow-up|0|||
48724705|NCT00136604|156842027|FG003|Overall Study|Lost to Follow-up|0|||
48724706|NCT00136604|156842028|FG004|Overall Study|Lost to Follow-up|1|||
48724707|NCT00136604|156842024|FG000|Overall Study|Migrated/moved from study area|0|||
48724708|NCT00136604|156842025|FG001|Overall Study|Migrated/moved from study area|1|||
48724709|NCT00136604|156842026|FG002|Overall Study|Migrated/moved from study area|0|||
48724710|NCT00136604|156842027|FG003|Overall Study|Migrated/moved from study area|0|||
48724711|NCT00136604|156842028|FG004|Overall Study|Migrated/moved from study area|0|||
48724712|NCT02942576|156842031|FG000|Overall Study|Adverse Event|28|||
48724713|NCT02942576|156842032|FG001|Overall Study|Adverse Event|6|||
48724714|NCT02942576|156842031|FG000|Overall Study|Withdrawal by Subject|7|||
48724715|NCT02942576|156842032|FG001|Overall Study|Withdrawal by Subject|5|||
49133470|NCT01697579|158328865|FG003|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
49133471|NCT01697579|158328866|FG004|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
49133472|NCT01697579|158328867|FG005|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1|||
49133473|NCT01697579|158328868|FG006|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5|||
49133474|NCT01697579|158328862|FG000|Optional Extension-Cycles 2-6|Physician Decision|0|||
49133475|NCT01697579|158328863|FG001|Optional Extension-Cycles 2-6|Physician Decision|0|||
49133476|NCT01697579|158328864|FG002|Optional Extension-Cycles 2-6|Physician Decision|0|||
49133477|NCT01697579|158328865|FG003|Optional Extension-Cycles 2-6|Physician Decision|0|||
49133478|NCT01697579|158328866|FG004|Optional Extension-Cycles 2-6|Physician Decision|0|||
49133479|NCT01697579|158328867|FG005|Optional Extension-Cycles 2-6|Physician Decision|7|||
49133480|NCT01697579|158328868|FG006|Optional Extension-Cycles 2-6|Physician Decision|11|||
49133481|NCT01697579|158328862|FG000|Optional Extension-Cycles 2-6|Protocol Violation|0|||
49133482|NCT01697579|158328863|FG001|Optional Extension-Cycles 2-6|Protocol Violation|0|||
49133483|NCT01697579|158328864|FG002|Optional Extension-Cycles 2-6|Protocol Violation|0|||
49133484|NCT01697579|158328865|FG003|Optional Extension-Cycles 2-6|Protocol Violation|0|||
49133485|NCT01697579|158328866|FG004|Optional Extension-Cycles 2-6|Protocol Violation|0|||
49133486|NCT01697579|158328867|FG005|Optional Extension-Cycles 2-6|Protocol Violation|0|||
49133487|NCT01697579|158328868|FG006|Optional Extension-Cycles 2-6|Protocol Violation|4|||
49133488|NCT01697579|158328862|FG000|Optional Extension-Cycles 2-6|Excluded Medication|0|||
49133489|NCT01697579|158328863|FG001|Optional Extension-Cycles 2-6|Excluded Medication|0|||
49133490|NCT01697579|158328864|FG002|Optional Extension-Cycles 2-6|Excluded Medication|0|||
49133491|NCT01697579|158328865|FG003|Optional Extension-Cycles 2-6|Excluded Medication|0|||
48724716|NCT02942576|156842031|FG000|Overall Study|Physician Decision|1|||
49133492|NCT01697579|158328866|FG004|Optional Extension-Cycles 2-6|Excluded Medication|0|||
48724717|NCT02942576|156842032|FG001|Overall Study|Physician Decision|4|||
48724718|NCT02942576|156842031|FG000|Overall Study|Other|10|||
48724719|NCT02942576|156842032|FG001|Overall Study|Other|8|||
49133493|NCT01697579|158328867|FG005|Optional Extension-Cycles 2-6|Excluded Medication|1|||
49133494|NCT01697579|158328868|FG006|Optional Extension-Cycles 2-6|Excluded Medication|2|||
49133495|NCT01697579|158328862|FG000|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
49133496|NCT01697579|158328863|FG001|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
49133497|NCT01697579|158328864|FG002|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
49133498|NCT01697579|158328865|FG003|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
49133499|NCT01697579|158328866|FG004|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
49133500|NCT01697579|158328867|FG005|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1|||
49133501|NCT01697579|158328868|FG006|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
49133502|NCT01697579|158328862|FG000|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
49133503|NCT01697579|158328863|FG001|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
49133504|NCT01697579|158328864|FG002|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
49133505|NCT01697579|158328865|FG003|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
48724720|NCT01017575|156842051|FG000|Overall Study|Lack of Efficacy|0|||
48724721|NCT01017575|156842052|FG001|Overall Study|Lack of Efficacy|1|||
48724722|NCT01017575|156842053|FG002|Overall Study|Lack of Efficacy|0|||
48724723|NCT01017575|156842054|FG003|Overall Study|Lack of Efficacy|1|||
48724724|NCT01017575|156842055|FG004|Overall Study|Lack of Efficacy|1|||
48724725|NCT01017575|156842051|FG000|Overall Study|Adverse Event|0|||
48724726|NCT01017575|156842052|FG001|Overall Study|Adverse Event|1|||
48724727|NCT01017575|156842053|FG002|Overall Study|Adverse Event|0|||
48724728|NCT01017575|156842054|FG003|Overall Study|Adverse Event|0|||
48724729|NCT01017575|156842055|FG004|Overall Study|Adverse Event|2|||
48724730|NCT01017575|156842051|FG000|Overall Study|Withdrawal by Subject|1|||
48724731|NCT01017575|156842052|FG001|Overall Study|Withdrawal by Subject|0|||
48724732|NCT01017575|156842053|FG002|Overall Study|Withdrawal by Subject|0|||
48724733|NCT01017575|156842054|FG003|Overall Study|Withdrawal by Subject|0|||
48724734|NCT01017575|156842055|FG004|Overall Study|Withdrawal by Subject|0|||
48724735|NCT03500679|156842056|FG000|Overall Study|Lost to Follow-up|6|||
48724736|NCT03500679|156842057|FG001|Overall Study|Lost to Follow-up|3|||
48724737|NCT03500679|156842056|FG000|Overall Study|Withdrawal by Subject|3|||
48724738|NCT03500679|156842057|FG001|Overall Study|Withdrawal by Subject|0|||
48724739|NCT05446168|156842062|FG000|Overall Study|Physician Decision|0|||
48724740|NCT05446168|156842063|FG001|Overall Study|Physician Decision|1|||
48724741|NCT01986933|156842064|FG000|Placebo-controlled (Part A)|Adverse Event|1|||
48724742|NCT01986933|156842065|FG001|Placebo-controlled (Part A)|Adverse Event|5|||
48724743|NCT01986933|156842066|FG002|Placebo-controlled (Part A)|Adverse Event|2|||
48724744|NCT01986933|156842067|FG003|Placebo-controlled (Part A)|Adverse Event|2|||
48724745|NCT01986933|156842068|FG004|Placebo-controlled (Part A)|Adverse Event|4|||
48724746|NCT01986933|156842064|FG000|Placebo-controlled (Part A)|Lack of Efficacy|3|||
48724747|NCT01986933|156842065|FG001|Placebo-controlled (Part A)|Lack of Efficacy|1|||
48724748|NCT01986933|156842066|FG002|Placebo-controlled (Part A)|Lack of Efficacy|1|||
49133506|NCT01697579|158328866|FG004|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
49133507|NCT01697579|158328867|FG005|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15|||
49133508|NCT01697579|158328868|FG006|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24|||
49133509|NCT01697579|158328862|FG000|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
49133510|NCT01697579|158328863|FG001|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
49133511|NCT01697579|158328864|FG002|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
49133512|NCT01697579|158328865|FG003|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
49133513|NCT01697579|158328866|FG004|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
49133514|NCT01697579|158328867|FG005|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4|||
49133515|NCT01697579|158328868|FG006|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11|||
49133516|NCT01697579|158328862|FG000|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
49133517|NCT01697579|158328863|FG001|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
49133518|NCT01697579|158328864|FG002|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
49133519|NCT01697579|158328865|FG003|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
49133520|NCT01697579|158328866|FG004|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
49133521|NCT01697579|158328867|FG005|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
49133522|NCT01697579|158328868|FG006|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2|||
49133523|NCT01697579|158328862|FG000|Optional Extension-Cycles 2-6|Technical Problems|0|||
49133524|NCT01697579|158328863|FG001|Optional Extension-Cycles 2-6|Technical Problems|0|||
49133525|NCT01697579|158328864|FG002|Optional Extension-Cycles 2-6|Technical Problems|0|||
49133526|NCT01697579|158328865|FG003|Optional Extension-Cycles 2-6|Technical Problems|0|||
49133527|NCT01697579|158328866|FG004|Optional Extension-Cycles 2-6|Technical Problems|0|||
49133528|NCT01697579|158328867|FG005|Optional Extension-Cycles 2-6|Technical Problems|0|||
49133529|NCT01697579|158328868|FG006|Optional Extension-Cycles 2-6|Technical Problems|1|||
49133530|NCT01697579|158328862|FG000|Optional Extension-Cycles 2-6|Participant Moved|0|||
49133531|NCT01697579|158328863|FG001|Optional Extension-Cycles 2-6|Participant Moved|0|||
49133532|NCT01697579|158328864|FG002|Optional Extension-Cycles 2-6|Participant Moved|0|||
49133533|NCT01697579|158328865|FG003|Optional Extension-Cycles 2-6|Participant Moved|0|||
49133534|NCT01697579|158328866|FG004|Optional Extension-Cycles 2-6|Participant Moved|0|||
49133535|NCT01697579|158328867|FG005|Optional Extension-Cycles 2-6|Participant Moved|0|||
49133536|NCT01697579|158328868|FG006|Optional Extension-Cycles 2-6|Participant Moved|2|||
49133537|NCT01697579|158328862|FG000|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
49133538|NCT01697579|158328863|FG001|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
49133539|NCT01697579|158328864|FG002|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
49133540|NCT01697579|158328865|FG003|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
49133541|NCT01697579|158328866|FG004|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
49133542|NCT01697579|158328867|FG005|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6|||
49133543|NCT01697579|158328868|FG006|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4|||
49133544|NCT01697579|158328862|FG000|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
49133545|NCT01697579|158328863|FG001|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
49133546|NCT01697579|158328864|FG002|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
49133547|NCT01697579|158328865|FG003|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
49133548|NCT01697579|158328866|FG004|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
49133549|NCT01697579|158328867|FG005|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
49133550|NCT01697579|158328868|FG006|Optional Extension-Cycles 2-6|Lost to Follow-up|1|||
49133551|NCT03034967|158328869|FG000|Overall Study|Withdrawal by Subject|9|||
49133552|NCT03034967|158328870|FG001|Overall Study|Withdrawal by Subject|2|||
49133553|NCT03034967|158328871|FG002|Overall Study|Withdrawal by Subject|6|||
49133554|NCT03034967|158328872|FG003|Overall Study|Withdrawal by Subject|6|||
49133555|NCT03034967|158328873|FG004|Overall Study|Withdrawal by Subject|9|||
49133556|NCT03034967|158328874|FG005|Overall Study|Withdrawal by Subject|2|||
49133557|NCT03034967|158328869|FG000|Overall Study|Physician Decision|1|||
49133558|NCT03034967|158328870|FG001|Overall Study|Physician Decision|0|||
49133559|NCT03034967|158328871|FG002|Overall Study|Physician Decision|1|||
49133560|NCT03034967|158328872|FG003|Overall Study|Physician Decision|1|||
49133561|NCT03034967|158328873|FG004|Overall Study|Physician Decision|1|||
49133562|NCT03034967|158328874|FG005|Overall Study|Physician Decision|0|||
49133563|NCT03034967|158328869|FG000|Overall Study|Lost to Follow-up|0|||
49133564|NCT03034967|158328870|FG001|Overall Study|Lost to Follow-up|0|||
49133565|NCT03034967|158328871|FG002|Overall Study|Lost to Follow-up|0|||
49133566|NCT03034967|158328872|FG003|Overall Study|Lost to Follow-up|1|||
49133567|NCT03034967|158328873|FG004|Overall Study|Lost to Follow-up|0|||
49133568|NCT03034967|158328874|FG005|Overall Study|Lost to Follow-up|2|||
48819383|NCT02886728|157181805|FG001|Overall Study|Randomized but Not Dosed|0|||
48819384|NCT02886728|157181806|FG002|Overall Study|Randomized but Not Dosed|0|||
48819385|NCT02886728|157181807|FG003|Overall Study|Randomized but Not Dosed|2|||
48819386|NCT00884286|157181808|FG000|Overall Study|Progressive disease|21|||
48819387|NCT00884286|157181809|FG001|Overall Study|Progressive disease|28|||
48819388|NCT00884286|157181808|FG000|Overall Study|Toxicity|4|||
49133569|NCT03034967|158328869|FG000|Overall Study|Liver function test abnormality|0|||
49133570|NCT03034967|158328870|FG001|Overall Study|Liver function test abnormality|0|||
49133571|NCT03034967|158328871|FG002|Overall Study|Liver function test abnormality|1|||
49133572|NCT03034967|158328872|FG003|Overall Study|Liver function test abnormality|0|||
49133573|NCT03034967|158328873|FG004|Overall Study|Liver function test abnormality|0|||
49133574|NCT03034967|158328874|FG005|Overall Study|Liver function test abnormality|0|||
49133575|NCT03034967|158328869|FG000|Overall Study|Protocol Violation|1|||
49133576|NCT03034967|158328870|FG001|Overall Study|Protocol Violation|0|||
49133577|NCT03034967|158328871|FG002|Overall Study|Protocol Violation|0|||
49133578|NCT03034967|158328872|FG003|Overall Study|Protocol Violation|0|||
49133579|NCT03034967|158328873|FG004|Overall Study|Protocol Violation|0|||
49133580|NCT03034967|158328874|FG005|Overall Study|Protocol Violation|2|||
49133581|NCT03034967|158328869|FG000|Overall Study|Lack of Efficacy|0|||
49133582|NCT03034967|158328870|FG001|Overall Study|Lack of Efficacy|1|||
49133583|NCT03034967|158328871|FG002|Overall Study|Lack of Efficacy|2|||
49133584|NCT03034967|158328872|FG003|Overall Study|Lack of Efficacy|1|||
49133585|NCT03034967|158328873|FG004|Overall Study|Lack of Efficacy|1|||
49133586|NCT03034967|158328874|FG005|Overall Study|Lack of Efficacy|0|||
49133587|NCT03034967|158328869|FG000|Overall Study|Adverse Event, non-fatal|3|||
49133588|NCT03034967|158328870|FG001|Overall Study|Adverse Event, non-fatal|1|||
49133589|NCT03034967|158328871|FG002|Overall Study|Adverse Event, non-fatal|2|||
49133590|NCT03034967|158328872|FG003|Overall Study|Adverse Event, non-fatal|0|||
49133591|NCT03034967|158328873|FG004|Overall Study|Adverse Event, non-fatal|2|||
49133592|NCT03034967|158328874|FG005|Overall Study|Adverse Event, non-fatal|8|||
49133593|NCT03034967|158328869|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
49133594|NCT03034967|158328870|FG001|Overall Study|Adverse Event, Serious Fatal|1|||
49133595|NCT03034967|158328871|FG002|Overall Study|Adverse Event, Serious Fatal|1|||
49133596|NCT03034967|158328872|FG003|Overall Study|Adverse Event, Serious Fatal|2|||
49133597|NCT03034967|158328873|FG004|Overall Study|Adverse Event, Serious Fatal|1|||
49133598|NCT03034967|158328874|FG005|Overall Study|Adverse Event, Serious Fatal|1|||
49133599|NCT01991795|158328876|FG000|Overall Study|Lost to Follow-up|6|||
49133600|NCT01991795|158328877|FG001|Overall Study|Lost to Follow-up|4|||
49133601|NCT01991795|158328876|FG000|Overall Study|Withdrawal by Subject|117|||
49133602|NCT01991795|158328877|FG001|Overall Study|Withdrawal by Subject|94|||
49133603|NCT01991795|158328876|FG000|Overall Study|Site prematurely closed by sponsor|26|||
49133604|NCT01991795|158328877|FG001|Overall Study|Site prematurely closed by sponsor|25|||
49133605|NCT02246777|158328878|FG000|Overall Study|Adverse Event|2|||
49133606|NCT02246777|158328878|FG000|Overall Study|Change of residence|1|||
49133607|NCT03980223|158328879|FG000|Overall Study|Lost to Follow-up|3|||
49133608|NCT03980223|158328880|FG001|Overall Study|Lost to Follow-up|7|||
49133609|NCT03980223|158328881|FG002|Overall Study|Lost to Follow-up|10|||
49133610|NCT03980223|158328882|FG003|Overall Study|Lost to Follow-up|8|||
49133611|NCT03980223|158328879|FG000|Overall Study|Withdrawal by Subject|0|||
49133612|NCT03980223|158328880|FG001|Overall Study|Withdrawal by Subject|0|||
49133613|NCT03980223|158328881|FG002|Overall Study|Withdrawal by Subject|1|||
49133614|NCT03980223|158328882|FG003|Overall Study|Withdrawal by Subject|2|||
49133615|NCT03980223|158328879|FG000|Overall Study|Physician Decision|0|||
49133616|NCT03980223|158328880|FG001|Overall Study|Physician Decision|0|||
49133617|NCT03980223|158328881|FG002|Overall Study|Physician Decision|1|||
49133618|NCT03980223|158328882|FG003|Overall Study|Physician Decision|0|||
49133619|NCT03980223|158328879|FG000|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|72|||
49133620|NCT03980223|158328880|FG001|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|33|||
49133621|NCT03980223|158328881|FG002|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|20|||
48724749|NCT01986933|156842067|FG003|Placebo-controlled (Part A)|Lack of Efficacy|2|||
48724750|NCT01986933|156842068|FG004|Placebo-controlled (Part A)|Lack of Efficacy|1|||
48724751|NCT01986933|156842064|FG000|Placebo-controlled (Part A)|Withdrawal by Subject|5|||
49133622|NCT03980223|158328882|FG003|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|11|||
49133623|NCT03091439|158328883|FG000|Overall Study|Study Terminated by the Sponsor|1|||
49133624|NCT03091439|158328884|FG001|Overall Study|Study Terminated by the Sponsor|0|||
49133625|NCT00596635|158328887|FG000|Overall Study|Lost to Follow-up|0|||
49133626|NCT00596635|158328888|FG001|Overall Study|Lost to Follow-up|2|||
49133627|NCT00596635|158328889|FG002|Overall Study|Lost to Follow-up|0|||
49133628|NCT00596635|158328887|FG000|Overall Study|Treatment for symptomatic UTI|4|||
49133629|NCT00596635|158328888|FG001|Overall Study|Treatment for symptomatic UTI|6|||
49133630|NCT00596635|158328889|FG002|Overall Study|Treatment for symptomatic UTI|3|||
49133631|NCT00596635|158328887|FG000|Overall Study|Hip fracture|2|||
49133632|NCT00596635|158328888|FG001|Overall Study|Hip fracture|3|||
49133633|NCT00596635|158328889|FG002|Overall Study|Hip fracture|3|||
49133634|NCT00596635|158328887|FG000|Overall Study|Could not provide urine specimen|1|||
49133635|NCT00596635|158328888|FG001|Overall Study|Could not provide urine specimen|2|||
49133636|NCT00596635|158328889|FG002|Overall Study|Could not provide urine specimen|2|||
49133637|NCT01860989|158328892|FG000|Overall Study|Unsatisfactory therapeutic|5|||
49133638|NCT02916927|158328895|FG000|Overall Study|Discharged prior to study drug receipt|0|||
49133639|NCT02916927|158328896|FG001|Overall Study|Discharged prior to study drug receipt|2|||
49133640|NCT02916927|158328895|FG000|Overall Study|At radiology for 45 & 60 min time points|0|||
49133641|NCT02916927|158328896|FG001|Overall Study|At radiology for 45 & 60 min time points|1|||
49133642|NCT02916927|158328895|FG000|Overall Study|Withdrawal before first time point|1|||
49133643|NCT02916927|158328896|FG001|Overall Study|Withdrawal before first time point|0|||
49133644|NCT00858988|158328897|FG000|Analysis|Lactulose unable to be detected in urine|2|||
49133645|NCT00858988|158328898|FG001|Analysis|Lactulose unable to be detected in urine|1|||
49133646|NCT02145390|158328899|FG000|Overall Study|Withdrawal by Subject|1|||
49133647|NCT01260948|158328900|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
49133648|NCT01260948|158328901|FG001|Washout of 28 Days|Withdrawal by Subject|3|||
49133649|NCT01260948|158328900|FG000|Second Intervention|Emesis|0|||
49133650|NCT01260948|158328901|FG001|Second Intervention|Emesis|1|||
49133651|NCT02318940|158328902|FG000|Overall Study|lost the record|1|||
49133652|NCT02318940|158328903|FG001|Overall Study|lost the record|0|||
49133653|NCT01163617|158328904|FG000|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
49133654|NCT01163617|158328905|FG001|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1|||
49133655|NCT01163617|158328906|FG002|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
49133656|NCT01163617|158328907|FG003|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
49133657|NCT01163617|158328908|FG004|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
49133658|NCT01163617|158328909|FG005|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
49133659|NCT01163617|158328910|FG006|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
49133660|NCT01163617|158328911|FG007|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
49133661|NCT01163617|158328904|FG000|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
49133662|NCT01163617|158328905|FG001|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1|||
49133663|NCT01163617|158328906|FG002|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
49133664|NCT01163617|158328907|FG003|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
49133665|NCT01163617|158328908|FG004|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
49133666|NCT01163617|158328909|FG005|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
49133667|NCT01163617|158328910|FG006|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
49133668|NCT01163617|158328911|FG007|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
49133669|NCT01163617|158328904|FG000|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
49133670|NCT01163617|158328905|FG001|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
49133671|NCT01163617|158328906|FG002|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1|||
49133672|NCT01163617|158328907|FG003|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
49133673|NCT01163617|158328908|FG004|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
49133674|NCT01163617|158328909|FG005|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
49133675|NCT01163617|158328910|FG006|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
49133676|NCT01163617|158328911|FG007|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
49133677|NCT04711005|158328912|FG000|Overall Study|Withdrawal by Subject|0|||
49133678|NCT04711005|158328913|FG001|Overall Study|Withdrawal by Subject|0|||
48724752|NCT01986933|156842065|FG001|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
49133679|NCT04711005|158328914|FG002|Overall Study|Withdrawal by Subject|0|||
49133680|NCT04711005|158328915|FG003|Overall Study|Withdrawal by Subject|0|||
49133681|NCT04711005|158328916|FG004|Overall Study|Withdrawal by Subject|0|||
49133682|NCT04711005|158328917|FG005|Overall Study|Withdrawal by Subject|0|||
49133683|NCT04711005|158328918|FG006|Overall Study|Withdrawal by Subject|0|||
49133684|NCT04711005|158328919|FG007|Overall Study|Withdrawal by Subject|1|||
49133685|NCT04711005|158328920|FG008|Overall Study|Withdrawal by Subject|0|||
49133686|NCT04711005|158328921|FG009|Overall Study|Withdrawal by Subject|0|||
49133687|NCT04711005|158328912|FG000|Overall Study|Physician Decision|0|||
49133688|NCT04711005|158328913|FG001|Overall Study|Physician Decision|0|||
49133689|NCT04711005|158328914|FG002|Overall Study|Physician Decision|0|||
49133690|NCT04711005|158328915|FG003|Overall Study|Physician Decision|0|||
49133691|NCT04711005|158328916|FG004|Overall Study|Physician Decision|0|||
49133692|NCT04711005|158328917|FG005|Overall Study|Physician Decision|0|||
49133693|NCT04711005|158328918|FG006|Overall Study|Physician Decision|0|||
49133694|NCT04711005|158328919|FG007|Overall Study|Physician Decision|2|||
49133695|NCT04711005|158328920|FG008|Overall Study|Physician Decision|1|||
49133696|NCT04711005|158328921|FG009|Overall Study|Physician Decision|0|||
49133697|NCT02034006|158330467|FG000|Overall Study|Withdrawal by Subject|7|||
49133698|NCT02034006|158330467|FG000|Overall Study|Lost to Follow-up|5|||
49133699|NCT02034006|158330467|FG000|Overall Study|Death|1|||
49133700|NCT02034006|158330467|FG000|Overall Study|Pregnancy|1|||
49133701|NCT00587457|158330468|FG000|Overall Study|Adverse Event|1|||
49133702|NCT00587457|158330469|FG001|Overall Study|Adverse Event|2|||
49133703|NCT00587457|158330470|FG002|Overall Study|Adverse Event|1|||
49133704|NCT00587457|158330468|FG000|Overall Study|Disease progression|2|||
49133705|NCT00587457|158330469|FG001|Overall Study|Disease progression|0|||
49133706|NCT00587457|158330470|FG002|Overall Study|Disease progression|2|||
49133707|NCT00587457|158330468|FG000|Overall Study|Initiation of alternative therapy|0|||
49133708|NCT00587457|158330469|FG001|Overall Study|Initiation of alternative therapy|1|||
49133709|NCT00587457|158330470|FG002|Overall Study|Initiation of alternative therapy|0|||
49133710|NCT00587457|158330468|FG000|Overall Study|Undefined|0|||
49133711|NCT00587457|158330469|FG001|Overall Study|Undefined|0|||
49133712|NCT00587457|158330470|FG002|Overall Study|Undefined|1|||
49133713|NCT00587457|158330468|FG000|Overall Study|Development of neutralizing Abs|0|||
49133714|NCT00587457|158330469|FG001|Overall Study|Development of neutralizing Abs|0|||
49133715|NCT00587457|158330470|FG002|Overall Study|Development of neutralizing Abs|1|||
49133716|NCT01712516|158330471|FG000|Overall Study|Technical problems|0|||
49133717|NCT01712516|158330472|FG001|Overall Study|Technical problems|0|||
49133718|NCT01712516|158330473|FG002|Overall Study|Technical problems|0|||
49133719|NCT01712516|158330474|FG003|Overall Study|Technical problems|2|||
49133720|NCT01712516|158330471|FG000|Overall Study|Lost to Follow-up|0|||
49133721|NCT01712516|158330472|FG001|Overall Study|Lost to Follow-up|0|||
49133722|NCT01712516|158330473|FG002|Overall Study|Lost to Follow-up|2|||
49133723|NCT01712516|158330474|FG003|Overall Study|Lost to Follow-up|1|||
49133724|NCT01712516|158330471|FG000|Overall Study|Death|0|||
49133725|NCT01712516|158330472|FG001|Overall Study|Death|1|||
49133726|NCT01712516|158330473|FG002|Overall Study|Death|0|||
49133727|NCT01712516|158330474|FG003|Overall Study|Death|0|||
49133728|NCT01712516|158330471|FG000|Overall Study|Protocol deviation|1|||
49133729|NCT01712516|158330472|FG001|Overall Study|Protocol deviation|0|||
49133730|NCT01712516|158330473|FG002|Overall Study|Protocol deviation|1|||
49133731|NCT01712516|158330474|FG003|Overall Study|Protocol deviation|0|||
49133732|NCT01712516|158330471|FG000|Overall Study|Physician Decision|2|||
49133733|NCT01712516|158330472|FG001|Overall Study|Physician Decision|0|||
49133734|NCT01712516|158330473|FG002|Overall Study|Physician Decision|0|||
49133735|NCT01712516|158330474|FG003|Overall Study|Physician Decision|1|||
49133736|NCT01712516|158330471|FG000|Overall Study|Withdrawal by Subject|3|||
49133737|NCT01712516|158330472|FG001|Overall Study|Withdrawal by Subject|9|||
49133738|NCT01712516|158330473|FG002|Overall Study|Withdrawal by Subject|3|||
49133739|NCT01712516|158330474|FG003|Overall Study|Withdrawal by Subject|9|||
49133740|NCT00715208|158330477|FG000|Overall Study|Withdrawal by Subject|1|||
49133741|NCT00715208|158330478|FG001|Overall Study|Withdrawal by Subject|1|||
49133742|NCT00715208|158330477|FG000|Overall Study|Adverse Event|0|||
49133743|NCT00715208|158330478|FG001|Overall Study|Adverse Event|6|||
49133744|NCT00715208|158330477|FG000|Overall Study|Lack of Efficacy|0|||
49133745|NCT00715208|158330478|FG001|Overall Study|Lack of Efficacy|2|||
48819389|NCT00884286|157181809|FG001|Overall Study|Toxicity|1|||
48819390|NCT00884286|157181808|FG000|Overall Study|Death|2|||
48819391|NCT00884286|157181809|FG001|Overall Study|Death|2|||
48819392|NCT00884286|157181808|FG000|Overall Study|Physician Decision|1|||
48819393|NCT00884286|157181809|FG001|Overall Study|Physician Decision|0|||
48819394|NCT00884286|157181808|FG000|Overall Study|Septic shock|1|||
49133746|NCT01648764|158330479|FG000|Overall Study|Progressive Disease|0|||
49133747|NCT01648764|158330480|FG001|Overall Study|Progressive Disease|1|||
49133748|NCT01648764|158330481|FG002|Overall Study|Progressive Disease|0|||
49133749|NCT01648764|158330482|FG003|Overall Study|Progressive Disease|0|||
49133750|NCT01648764|158330483|FG004|Overall Study|Progressive Disease|0|||
49133751|NCT01648764|158330484|FG005|Overall Study|Progressive Disease|1|||
48724753|NCT01986933|156842066|FG002|Placebo-controlled (Part A)|Withdrawal by Subject|6|||
48819395|NCT00884286|157181809|FG001|Overall Study|Septic shock|0|||
48819396|NCT00884286|157181808|FG000|Overall Study|Thrombus in right auricle|1|||
48819397|NCT00884286|157181809|FG001|Overall Study|Thrombus in right auricle|0|||
49133752|NCT01648764|158330485|FG006|Overall Study|Progressive Disease|1|||
48724754|NCT01986933|156842067|FG003|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
48724755|NCT01986933|156842068|FG004|Placebo-controlled (Part A)|Withdrawal by Subject|7|||
48724756|NCT01986933|156842064|FG000|Placebo-controlled (Part A)|Lost to Follow-up|0|||
48724757|NCT01986933|156842065|FG001|Placebo-controlled (Part A)|Lost to Follow-up|1|||
48724758|NCT01986933|156842066|FG002|Placebo-controlled (Part A)|Lost to Follow-up|0|||
48724759|NCT01986933|156842067|FG003|Placebo-controlled (Part A)|Lost to Follow-up|1|||
48724760|NCT01986933|156842068|FG004|Placebo-controlled (Part A)|Lost to Follow-up|0|||
48724761|NCT01986933|156842064|FG000|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
48724762|NCT01986933|156842065|FG001|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
48724763|NCT01986933|156842066|FG002|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
48724764|NCT01986933|156842067|FG003|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
48724765|NCT01986933|156842068|FG004|Placebo-controlled (Part A)|Others (not classified above reasons)|2|||
48724766|NCT01986933|156842064|FG000|Active-to-active (Part B)|Adverse Event|0|||
48724767|NCT01986933|156842065|FG001|Active-to-active (Part B)|Adverse Event|2|||
48724768|NCT01986933|156842066|FG002|Active-to-active (Part B)|Adverse Event|0|||
48724769|NCT01986933|156842067|FG003|Active-to-active (Part B)|Adverse Event|1|||
48724770|NCT01986933|156842068|FG004|Active-to-active (Part B)|Adverse Event|3|||
48724771|NCT01986933|156842064|FG000|Active-to-active (Part B)|Lack of Efficacy|0|||
48724772|NCT01986933|156842065|FG001|Active-to-active (Part B)|Lack of Efficacy|3|||
48724773|NCT01986933|156842066|FG002|Active-to-active (Part B)|Lack of Efficacy|2|||
48724774|NCT01986933|156842067|FG003|Active-to-active (Part B)|Lack of Efficacy|0|||
48724775|NCT01986933|156842068|FG004|Active-to-active (Part B)|Lack of Efficacy|4|||
48724776|NCT01986933|156842064|FG000|Active-to-active (Part B)|Pregnancy|0|||
48724777|NCT01986933|156842065|FG001|Active-to-active (Part B)|Pregnancy|0|||
48724778|NCT01986933|156842066|FG002|Active-to-active (Part B)|Pregnancy|0|||
48724779|NCT01986933|156842067|FG003|Active-to-active (Part B)|Pregnancy|0|||
48724780|NCT01986933|156842068|FG004|Active-to-active (Part B)|Pregnancy|1|||
48724781|NCT01986933|156842064|FG000|Active-to-active (Part B)|Physician Decision|0|||
48724782|NCT01986933|156842065|FG001|Active-to-active (Part B)|Physician Decision|0|||
48724783|NCT01986933|156842066|FG002|Active-to-active (Part B)|Physician Decision|1|||
48724784|NCT01986933|156842067|FG003|Active-to-active (Part B)|Physician Decision|1|||
48724785|NCT01986933|156842068|FG004|Active-to-active (Part B)|Physician Decision|0|||
48724786|NCT01986933|156842064|FG000|Active-to-active (Part B)|Withdrawal by Subject|0|||
48724787|NCT01986933|156842065|FG001|Active-to-active (Part B)|Withdrawal by Subject|4|||
48724788|NCT01986933|156842066|FG002|Active-to-active (Part B)|Withdrawal by Subject|7|||
48724789|NCT01986933|156842067|FG003|Active-to-active (Part B)|Withdrawal by Subject|6|||
48724790|NCT01986933|156842068|FG004|Active-to-active (Part B)|Withdrawal by Subject|6|||
48724791|NCT01986933|156842064|FG000|Active-to-active (Part B)|Lost to Follow-up|0|||
48724792|NCT01986933|156842065|FG001|Active-to-active (Part B)|Lost to Follow-up|0|||
48724793|NCT01986933|156842066|FG002|Active-to-active (Part B)|Lost to Follow-up|0|||
48724794|NCT01986933|156842067|FG003|Active-to-active (Part B)|Lost to Follow-up|0|||
48724795|NCT01986933|156842068|FG004|Active-to-active (Part B)|Lost to Follow-up|1|||
48724796|NCT01986933|156842064|FG000|Active-to-active (Part B)|Others (not classified above reasons)|0|||
48724797|NCT01986933|156842065|FG001|Active-to-active (Part B)|Others (not classified above reasons)|1|||
48724798|NCT01986933|156842066|FG002|Active-to-active (Part B)|Others (not classified above reasons)|0|||
48724799|NCT01986933|156842067|FG003|Active-to-active (Part B)|Others (not classified above reasons)|1|||
48724800|NCT01986933|156842068|FG004|Active-to-active (Part B)|Others (not classified above reasons)|1|||
48724801|NCT01986933|156842064|FG000|Placebo-to-active (Part B)|Adverse Event|0|||
48724802|NCT01986933|156842065|FG001|Placebo-to-active (Part B)|Adverse Event|1|||
48819398|NCT00884286|157181808|FG000|Overall Study|Not treated|2|||
48819399|NCT00884286|157181809|FG001|Overall Study|Not treated|1|||
48921034|NCT00784654|157544819|FG001|Randomized Withdrawal Period|Did not complete a visit|1|||
49133753|NCT01648764|158330486|FG007|Overall Study|Progressive Disease|0|||
49133754|NCT01648764|158330487|FG008|Overall Study|Progressive Disease|0|||
49133755|NCT01648764|158330488|FG009|Overall Study|Progressive Disease|2|||
49133756|NCT01648764|158330489|FG010|Overall Study|Progressive Disease|0|||
49133757|NCT01648764|158330490|FG011|Overall Study|Progressive Disease|1|||
49133758|NCT01648764|158330491|FG012|Overall Study|Progressive Disease|2|||
49133759|NCT01648764|158330492|FG013|Overall Study|Progressive Disease|1|||
49133760|NCT01648764|158330479|FG000|Overall Study|Adverse Event|0|||
49133761|NCT01648764|158330480|FG001|Overall Study|Adverse Event|0|||
49133762|NCT01648764|158330481|FG002|Overall Study|Adverse Event|0|||
49133763|NCT01648764|158330482|FG003|Overall Study|Adverse Event|0|||
49133764|NCT01648764|158330483|FG004|Overall Study|Adverse Event|0|||
49133765|NCT01648764|158330484|FG005|Overall Study|Adverse Event|1|||
49133766|NCT01648764|158330485|FG006|Overall Study|Adverse Event|0|||
49133767|NCT01648764|158330486|FG007|Overall Study|Adverse Event|0|||
49133768|NCT01648764|158330487|FG008|Overall Study|Adverse Event|0|||
49133769|NCT01648764|158330488|FG009|Overall Study|Adverse Event|1|||
49133770|NCT01648764|158330489|FG010|Overall Study|Adverse Event|0|||
49133771|NCT01648764|158330490|FG011|Overall Study|Adverse Event|3|||
49133772|NCT01648764|158330491|FG012|Overall Study|Adverse Event|1|||
49133773|NCT01648764|158330492|FG013|Overall Study|Adverse Event|1|||
49133774|NCT01648764|158330479|FG000|Overall Study|Death|0|||
49133775|NCT01648764|158330480|FG001|Overall Study|Death|0|||
49133776|NCT01648764|158330481|FG002|Overall Study|Death|0|||
49133777|NCT01648764|158330482|FG003|Overall Study|Death|0|||
49133778|NCT01648764|158330483|FG004|Overall Study|Death|0|||
49133779|NCT01648764|158330484|FG005|Overall Study|Death|0|||
49133780|NCT01648764|158330485|FG006|Overall Study|Death|1|||
49133781|NCT01648764|158330486|FG007|Overall Study|Death|0|||
49133782|NCT01648764|158330487|FG008|Overall Study|Death|0|||
49133783|NCT01648764|158330488|FG009|Overall Study|Death|0|||
49133784|NCT01648764|158330489|FG010|Overall Study|Death|0|||
49133785|NCT01648764|158330490|FG011|Overall Study|Death|0|||
49133786|NCT01648764|158330491|FG012|Overall Study|Death|0|||
49133787|NCT01648764|158330492|FG013|Overall Study|Death|1|||
49133788|NCT01648764|158330479|FG000|Overall Study|Withdrawal by Subject|0|||
49133789|NCT01648764|158330480|FG001|Overall Study|Withdrawal by Subject|0|||
48724803|NCT01986933|156842066|FG002|Placebo-to-active (Part B)|Adverse Event|0|||
48724804|NCT01986933|156842067|FG003|Placebo-to-active (Part B)|Adverse Event|1|||
49133790|NCT01648764|158330481|FG002|Overall Study|Withdrawal by Subject|0|||
49133791|NCT01648764|158330482|FG003|Overall Study|Withdrawal by Subject|0|||
49133792|NCT01648764|158330483|FG004|Overall Study|Withdrawal by Subject|0|||
49133793|NCT01648764|158330484|FG005|Overall Study|Withdrawal by Subject|0|||
48724805|NCT01986933|156842068|FG004|Placebo-to-active (Part B)|Adverse Event|0|||
48724806|NCT01986933|156842064|FG000|Placebo-to-active (Part B)|Lack of Efficacy|0|||
48724807|NCT01986933|156842065|FG001|Placebo-to-active (Part B)|Lack of Efficacy|0|||
48724808|NCT01986933|156842066|FG002|Placebo-to-active (Part B)|Lack of Efficacy|0|||
48724809|NCT01986933|156842067|FG003|Placebo-to-active (Part B)|Lack of Efficacy|1|||
48724810|NCT01986933|156842068|FG004|Placebo-to-active (Part B)|Lack of Efficacy|0|||
48724811|NCT01986933|156842064|FG000|Placebo-to-active (Part B)|Protocol Violation|0|||
48819400|NCT00884286|157181808|FG000|Overall Study|Comprised lung carcinoma|0|||
48819401|NCT00884286|157181809|FG001|Overall Study|Comprised lung carcinoma|1|||
48819402|NCT03712098|157181813|FG000|Overall Study|Lost to Follow-up|3|||
48819403|NCT03712098|157181814|FG001|Overall Study|Lost to Follow-up|7|||
48819404|NCT03712098|157181813|FG000|Overall Study|Withdrawal by Subject|9|||
48819405|NCT03712098|157181814|FG001|Overall Study|Withdrawal by Subject|4|||
49133794|NCT01648764|158330485|FG006|Overall Study|Withdrawal by Subject|2|||
49133795|NCT01648764|158330486|FG007|Overall Study|Withdrawal by Subject|0|||
49133796|NCT01648764|158330487|FG008|Overall Study|Withdrawal by Subject|0|||
49133797|NCT01648764|158330488|FG009|Overall Study|Withdrawal by Subject|0|||
49133798|NCT01648764|158330489|FG010|Overall Study|Withdrawal by Subject|0|||
49133799|NCT01648764|158330490|FG011|Overall Study|Withdrawal by Subject|0|||
48819406|NCT03712098|157181813|FG000|Overall Study|Protocol Violation|2|||
49133800|NCT01648764|158330491|FG012|Overall Study|Withdrawal by Subject|1|||
49133801|NCT01648764|158330492|FG013|Overall Study|Withdrawal by Subject|0|||
49133802|NCT01648764|158330479|FG000|Overall Study|Investigator Decision|0|||
48819407|NCT03712098|157181814|FG001|Overall Study|Protocol Violation|1|||
49133803|NCT01648764|158330480|FG001|Overall Study|Investigator Decision|0|||
49133804|NCT01648764|158330481|FG002|Overall Study|Investigator Decision|0|||
49133805|NCT01648764|158330482|FG003|Overall Study|Investigator Decision|0|||
49133806|NCT01648764|158330483|FG004|Overall Study|Investigator Decision|0|||
49133807|NCT01648764|158330484|FG005|Overall Study|Investigator Decision|0|||
49133808|NCT01648764|158330485|FG006|Overall Study|Investigator Decision|1|||
49133809|NCT01648764|158330486|FG007|Overall Study|Investigator Decision|0|||
49133810|NCT01648764|158330487|FG008|Overall Study|Investigator Decision|0|||
49133811|NCT01648764|158330488|FG009|Overall Study|Investigator Decision|0|||
49133812|NCT01648764|158330489|FG010|Overall Study|Investigator Decision|0|||
49133813|NCT01648764|158330490|FG011|Overall Study|Investigator Decision|1|||
49133814|NCT01648764|158330491|FG012|Overall Study|Investigator Decision|0|||
49133815|NCT01648764|158330492|FG013|Overall Study|Investigator Decision|0|||
49133816|NCT00656617|158330496|FG000|Overall Study|Adverse Event|1|||
49133817|NCT00656617|158330496|FG000|Overall Study|Death|2|||
49133818|NCT00656617|158330496|FG000|Overall Study|Insurance Issues|2|||
49133819|NCT00656617|158330496|FG000|Overall Study|Move to different clinical trial|2|||
49133820|NCT03482024|158330500|FG000|Overall Study|Physician Decision|1|||
49133821|NCT03482024|158330501|FG001|Overall Study|Physician Decision|0|||
49133822|NCT03482024|158330502|FG002|Overall Study|Physician Decision|0|||
49133823|NCT03482024|158330503|FG003|Overall Study|Physician Decision|0|||
49133824|NCT03482024|158330504|FG004|Overall Study|Physician Decision|0|||
49133825|NCT00634504|158330505|FG000|Overall Study|Protocol Violation|1|||
49133826|NCT00634504|158330506|FG001|Overall Study|Protocol Violation|0|||
49133827|NCT02453048|158330513|FG000|Overall Study|Only part of initial 6 mo. study|0|||
49133828|NCT02453048|158330514|FG001|Overall Study|Only part of initial 6 mo. study|0|||
49133829|NCT02453048|158330515|FG002|Overall Study|Only part of initial 6 mo. study|0|||
49133830|NCT02453048|158330516|FG003|Overall Study|Only part of initial 6 mo. study|0|||
49133831|NCT02453048|158330517|FG004|Overall Study|Only part of initial 6 mo. study|6|||
49133832|NCT02453048|158330513|FG000|Overall Study|Lost to Follow-up|0|||
49133833|NCT02453048|158330514|FG001|Overall Study|Lost to Follow-up|1|||
49133834|NCT02453048|158330515|FG002|Overall Study|Lost to Follow-up|2|||
49133835|NCT02453048|158330516|FG003|Overall Study|Lost to Follow-up|0|||
49133836|NCT02453048|158330517|FG004|Overall Study|Lost to Follow-up|0|||
49133837|NCT00676143|158330518|FG000|Overall Study|Adverse Event|34|||
49133838|NCT00676143|158330519|FG001|Overall Study|Adverse Event|60|||
49133839|NCT00676143|158330518|FG000|Overall Study|Death|4|||
49133840|NCT00676143|158330519|FG001|Overall Study|Death|4|||
49133841|NCT00676143|158330518|FG000|Overall Study|Lack of Efficacy|0|||
49133842|NCT00676143|158330519|FG001|Overall Study|Lack of Efficacy|6|||
48724812|NCT01986933|156842065|FG001|Placebo-to-active (Part B)|Protocol Violation|0|||
48724813|NCT01986933|156842066|FG002|Placebo-to-active (Part B)|Protocol Violation|1|||
48724814|NCT01986933|156842067|FG003|Placebo-to-active (Part B)|Protocol Violation|0|||
48724815|NCT01986933|156842068|FG004|Placebo-to-active (Part B)|Protocol Violation|0|||
48724816|NCT01986933|156842064|FG000|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
48724817|NCT01986933|156842065|FG001|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
48724818|NCT01986933|156842066|FG002|Placebo-to-active (Part B)|Withdrawal by Subject|4|||
48724819|NCT01986933|156842067|FG003|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
48724820|NCT01986933|156842068|FG004|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
48724821|NCT01986933|156842064|FG000|Placebo-to-active (Part B)|Lost to Follow-up|0|||
48724822|NCT01986933|156842065|FG001|Placebo-to-active (Part B)|Lost to Follow-up|1|||
48724823|NCT01986933|156842066|FG002|Placebo-to-active (Part B)|Lost to Follow-up|0|||
48724824|NCT01986933|156842067|FG003|Placebo-to-active (Part B)|Lost to Follow-up|0|||
48724825|NCT01986933|156842068|FG004|Placebo-to-active (Part B)|Lost to Follow-up|0|||
48724826|NCT00686998|156842069|FG000|Overall Study|Adverse Event|3|||
48724827|NCT00686998|156842070|FG001|Overall Study|Adverse Event|2|||
48724828|NCT00686998|156842071|FG002|Overall Study|Adverse Event|1|||
48724829|NCT00686998|156842069|FG000|Overall Study|Withdrawal by Subject|2|||
48724830|NCT00686998|156842070|FG001|Overall Study|Withdrawal by Subject|1|||
48724831|NCT00686998|156842071|FG002|Overall Study|Withdrawal by Subject|2|||
48724832|NCT00686998|156842069|FG000|Overall Study|Lack of Efficacy|7|||
48724833|NCT00686998|156842070|FG001|Overall Study|Lack of Efficacy|5|||
48724834|NCT00686998|156842071|FG002|Overall Study|Lack of Efficacy|0|||
48724835|NCT00686998|156842069|FG000|Overall Study|Other|0|||
48724836|NCT00686998|156842070|FG001|Overall Study|Other|0|||
48724837|NCT00686998|156842071|FG002|Overall Study|Other|1|||
48724838|NCT00686998|156842069|FG000|Overall Study|Safety Reasons|1|||
48724839|NCT00686998|156842070|FG001|Overall Study|Safety Reasons|0|||
48724840|NCT00686998|156842071|FG002|Overall Study|Safety Reasons|0|||
48724841|NCT01758289|156842072|FG000|Overall Study|Premature Study Termination|44|||
48724842|NCT01758289|156842072|FG000|Overall Study|Adverse Event|9|||
49133843|NCT00676143|158330518|FG000|Overall Study|Lost to Follow-up|0|||
49133844|NCT00676143|158330519|FG001|Overall Study|Lost to Follow-up|13|||
49133845|NCT00676143|158330518|FG000|Overall Study|Physician Decision|5|||
49133846|NCT00676143|158330519|FG001|Overall Study|Physician Decision|8|||
49133847|NCT00676143|158330518|FG000|Overall Study|Protocol Violation|4|||
49133848|NCT00676143|158330519|FG001|Overall Study|Protocol Violation|8|||
49133849|NCT00676143|158330518|FG000|Overall Study|Withdrawal by Subject|24|||
49133850|NCT00676143|158330519|FG001|Overall Study|Withdrawal by Subject|42|||
49133851|NCT00676143|158330518|FG000|Overall Study|Discontinuation of study by sponsor|65|||
49133852|NCT00676143|158330519|FG001|Overall Study|Discontinuation of study by sponsor|88|||
49133853|NCT00676143|158330518|FG000|Overall Study|Failed to return|2|||
49133854|NCT00676143|158330519|FG001|Overall Study|Failed to return|1|||
49133855|NCT00676143|158330518|FG000|Overall Study|Loss of caregiver|5|||
49133856|NCT00676143|158330519|FG001|Overall Study|Loss of caregiver|3|||
49133857|NCT00676143|158330518|FG000|Overall Study|Other|11|||
49133858|NCT00676143|158330519|FG001|Overall Study|Other|20|||
49133859|NCT00676143|158330518|FG000|Overall Study|Participant participation unknown|1|||
49133860|NCT00676143|158330519|FG001|Overall Study|Participant participation unknown|4|||
49133861|NCT00676143|158330518|FG000|Overall Study|Vasogenic edema recurrence|1|||
49133862|NCT00676143|158330519|FG001|Overall Study|Vasogenic edema recurrence|3|||
49133863|NCT02696616|158330520|FG000|Overall Study|Adverse Event|0|||
49133864|NCT02696616|158330521|FG001|Overall Study|Adverse Event|1|||
49133865|NCT02696616|158330522|FG002|Overall Study|Adverse Event|0|||
49133866|NCT02696616|158330523|FG003|Overall Study|Adverse Event|0|||
49133867|NCT02696616|158330524|FG004|Overall Study|Adverse Event|0|||
49133868|NCT02696616|158330525|FG005|Overall Study|Adverse Event|0|||
49133869|NCT02696616|158330526|FG006|Overall Study|Adverse Event|0|||
49133870|NCT03937778|158330529|FG000|Overall Study|Withdrawal by Subject|1|||
49133871|NCT03937778|158330529|FG000|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1|||
49133872|NCT04796415|158330530|FG000|Overall Study|not interested|12|||
49133873|NCT04796415|158330530|FG000|Overall Study|health issue|8|||
49133874|NCT04796415|158330530|FG000|Overall Study|Other|4|||
49133875|NCT04796415|158330530|FG000|Overall Study|discharged from home health service|3|||
49133876|NCT04796415|158330530|FG000|Overall Study|re-hospitalization|2|||
49133877|NCT04796415|158330530|FG000|Overall Study|moving to nursing home|1|||
48724843|NCT02793128|156842077|FG000|Overall Study|Death|4|||
48724844|NCT02793128|156842077|FG000|Overall Study|Withdrawal by Subject|2|||
48724845|NCT02793128|156842077|FG000|Overall Study|Physician Decision|1|||
48724846|NCT02793128|156842077|FG000|Overall Study|Comorbid conditions and noncompliance|1|||
48724847|NCT02793128|156842077|FG000|Overall Study|Patient elected nephroureterectomy|1|||
48724848|NCT04024020|156842083|FG000|Overall Study|Withdrawal by Subject|2|||
48724849|NCT04024020|156842084|FG001|Overall Study|Withdrawal by Subject|2|||
48724850|NCT00356122|156842087|FG000|TREATMENT|Lack of Efficacy|26|||
48724851|NCT00356122|156842087|FG000|TREATMENT|Adverse Event|10|||
48724852|NCT00356122|156842087|FG000|TREATMENT|Subject's request|4|||
48724853|NCT00356122|156842087|FG000|TREATMENT|Other|4|||
48724854|NCT00356122|156842087|FG000|TREATMENT|Did not receive study medication|1|||
48724855|NCT00356122|156842087|FG000|FOLLOW-UP|Death|37|||
48724856|NCT00356122|156842087|FG000|FOLLOW-UP|Lost to Follow-up|2|||
48724857|NCT00356122|156842087|FG000|FOLLOW-UP|Other|2|||
48724858|NCT00782795|156842088|FG000|Overall Study|Withdrawal by Subject|1|||
49133878|NCT04796415|158330530|FG000|Overall Study|lost contact|1|||
49133879|NCT02065557|158330533|FG000|Induction Period|Withdrawal by Subject|2|||
49133880|NCT02065557|158330534|FG001|Induction Period|Withdrawal by Subject|1|||
49133881|NCT02065557|158330535|FG002|Induction Period|Withdrawal by Subject|0|||
49133882|NCT02065557|158330536|FG003|Induction Period|Withdrawal by Subject|0|||
49133883|NCT02065557|158330537|FG004|Induction Period|Withdrawal by Subject|0|||
49133884|NCT02065557|158330538|FG005|Induction Period|Withdrawal by Subject|0|||
49133885|NCT02065557|158330533|FG000|Induction Period|Lack of Efficacy|2|||
49133886|NCT02065557|158330534|FG001|Induction Period|Lack of Efficacy|1|||
49133887|NCT02065557|158330535|FG002|Induction Period|Lack of Efficacy|1|||
49133888|NCT02065557|158330536|FG003|Induction Period|Lack of Efficacy|0|||
49133889|NCT02065557|158330537|FG004|Induction Period|Lack of Efficacy|0|||
49133890|NCT02065557|158330538|FG005|Induction Period|Lack of Efficacy|0|||
49133891|NCT02065557|158330533|FG000|Induction Period|Requires Alternative/Prohibited Therapy|1|||
49133892|NCT02065557|158330534|FG001|Induction Period|Requires Alternative/Prohibited Therapy|1|||
49133893|NCT02065557|158330535|FG002|Induction Period|Requires Alternative/Prohibited Therapy|1|||
49133894|NCT02065557|158330536|FG003|Induction Period|Requires Alternative/Prohibited Therapy|0|||
49133895|NCT02065557|158330537|FG004|Induction Period|Requires Alternative/Prohibited Therapy|0|||
49133896|NCT02065557|158330538|FG005|Induction Period|Requires Alternative/Prohibited Therapy|0|||
48724859|NCT00782795|156842089|FG001|Overall Study|Withdrawal by Subject|2|||
48724860|NCT01015131|156842090|FG000|Overall Study|Physician Decision|1|||
48724861|NCT01015131|156842090|FG000|Overall Study|Protocol Violation|1|||
48724862|NCT01015131|156842090|FG000|Overall Study|Withdrawal by Subject|2|||
48724863|NCT01015131|156842090|FG000|Overall Study|Other Protocol Specified Criteria|4|||
48724864|NCT04480424|156842091|FG000|Overall Study|Withdrawal by Subject|0|||
48724865|NCT04480424|156842092|FG001|Overall Study|Withdrawal by Subject|2|||
48724866|NCT04480424|156842091|FG000|Overall Study|Lost to Follow-up|3|||
48724867|NCT04480424|156842092|FG001|Overall Study|Lost to Follow-up|3|||
48724868|NCT04480424|156842091|FG000|Overall Study|Death|14|||
49133897|NCT02065557|158330533|FG000|Induction Period|Non-Responder at Week 8|4|||
49133898|NCT02065557|158330534|FG001|Induction Period|Non-Responder at Week 8|4|||
49133899|NCT02065557|158330535|FG002|Induction Period|Non-Responder at Week 8|0|||
49133900|NCT02065557|158330536|FG003|Induction Period|Non-Responder at Week 8|0|||
49133901|NCT02065557|158330537|FG004|Induction Period|Non-Responder at Week 8|0|||
49133902|NCT02065557|158330538|FG005|Induction Period|Non-Responder at Week 8|0|||
49133903|NCT02065557|158330533|FG000|Induction Period|Adverse Event|1|||
49133904|NCT02065557|158330534|FG001|Induction Period|Adverse Event|1|||
49133905|NCT02065557|158330535|FG002|Induction Period|Adverse Event|0|||
49133906|NCT02065557|158330536|FG003|Induction Period|Adverse Event|0|||
49133907|NCT02065557|158330537|FG004|Induction Period|Adverse Event|0|||
49133908|NCT02065557|158330538|FG005|Induction Period|Adverse Event|0|||
49133909|NCT02065557|158330533|FG000|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
49133910|NCT02065557|158330534|FG001|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
49133911|NCT02065557|158330535|FG002|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
49133912|NCT02065557|158330536|FG003|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
49133913|NCT02065557|158330537|FG004|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
49133914|NCT02065557|158330538|FG005|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
49133915|NCT02065557|158330533|FG000|Maintenance Period|Withdrawal by Subject|0|||
48724869|NCT04480424|156842092|FG001|Overall Study|Death|16|||
48724870|NCT04480424|156842091|FG000|Overall Study|Reason not Specified|5|||
48724871|NCT04480424|156842092|FG001|Overall Study|Reason not Specified|5|||
48724872|NCT01857583|156842093|FG000|Overall Study|Adverse Event|0|||
48724873|NCT01857583|156842094|FG001|Overall Study|Adverse Event|0|||
48724874|NCT01857583|156842095|FG002|Overall Study|Adverse Event|1|||
48724875|NCT01857583|156842096|FG003|Overall Study|Adverse Event|1|||
48724876|NCT01857583|156842093|FG000|Overall Study|Death|0|||
48724877|NCT01857583|156842094|FG001|Overall Study|Death|1|||
48724878|NCT01857583|156842095|FG002|Overall Study|Death|1|||
48724879|NCT01857583|156842096|FG003|Overall Study|Death|0|||
48724880|NCT01857583|156842093|FG000|Overall Study|Physician Decision|0|||
48724881|NCT01857583|156842094|FG001|Overall Study|Physician Decision|0|||
48724882|NCT01857583|156842095|FG002|Overall Study|Physician Decision|0|||
48724883|NCT01857583|156842096|FG003|Overall Study|Physician Decision|1|||
48724884|NCT01857583|156842093|FG000|Overall Study|Withdrawal by Subject|1|||
48724885|NCT01857583|156842094|FG001|Overall Study|Withdrawal by Subject|0|||
48724886|NCT01857583|156842095|FG002|Overall Study|Withdrawal by Subject|1|||
48724887|NCT01857583|156842096|FG003|Overall Study|Withdrawal by Subject|2|||
48724888|NCT02211638|156842097|FG000|Overall Study|Case Report Forms Uncollected|291|||
48724889|NCT02211638|156842097|FG000|Overall Study|Protocol Violation|692|||
48724890|NCT04382755|156842098|FG000|Overall Study|Withdrawal by Subject|1|||
48724891|NCT04382755|156842099|FG001|Overall Study|Withdrawal by Subject|0|||
48724892|NCT04382755|156842098|FG000|Overall Study|did not receive allocated intervention due to clinical error|0|||
48724893|NCT04382755|156842099|FG001|Overall Study|did not receive allocated intervention due to clinical error|1|||
48724894|NCT04382755|156842098|FG000|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|0|||
48724895|NCT04382755|156842099|FG001|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|1|||
48724896|NCT02867592|156842104|FG000|Overall Study|Adverse Event|3|||
48724897|NCT02867592|156842105|FG001|Overall Study|Adverse Event|0|||
48724898|NCT02867592|156842106|FG002|Overall Study|Adverse Event|2|||
48724899|NCT02867592|156842107|FG003|Overall Study|Adverse Event|1|||
48724900|NCT02867592|156842108|FG004|Overall Study|Adverse Event|1|||
48724901|NCT02867592|156842109|FG005|Overall Study|Adverse Event|5|||
48724902|NCT02867592|156842104|FG000|Overall Study|Death|0|||
48724903|NCT02867592|156842105|FG001|Overall Study|Death|0|||
48724904|NCT02867592|156842106|FG002|Overall Study|Death|0|||
48724905|NCT02867592|156842107|FG003|Overall Study|Death|1|||
48724906|NCT02867592|156842108|FG004|Overall Study|Death|0|||
48724907|NCT02867592|156842109|FG005|Overall Study|Death|1|||
48724908|NCT02867592|156842104|FG000|Overall Study|Lack of Efficacy|8|||
48724909|NCT02867592|156842105|FG001|Overall Study|Lack of Efficacy|10|||
48724910|NCT02867592|156842106|FG002|Overall Study|Lack of Efficacy|8|||
48724911|NCT02867592|156842107|FG003|Overall Study|Lack of Efficacy|8|||
48724912|NCT02867592|156842108|FG004|Overall Study|Lack of Efficacy|12|||
48724913|NCT02867592|156842109|FG005|Overall Study|Lack of Efficacy|17|||
48724914|NCT02867592|156842104|FG000|Overall Study|Physician Decision|1|||
48724915|NCT02867592|156842105|FG001|Overall Study|Physician Decision|2|||
48724916|NCT02867592|156842106|FG002|Overall Study|Physician Decision|2|||
48724917|NCT02867592|156842107|FG003|Overall Study|Physician Decision|0|||
48724918|NCT02867592|156842108|FG004|Overall Study|Physician Decision|5|||
48724919|NCT02867592|156842109|FG005|Overall Study|Physician Decision|1|||
48724920|NCT02867592|156842104|FG000|Overall Study|Protocol Violation|0|||
48724921|NCT02867592|156842105|FG001|Overall Study|Protocol Violation|0|||
48724922|NCT02867592|156842106|FG002|Overall Study|Protocol Violation|0|||
48724923|NCT02867592|156842107|FG003|Overall Study|Protocol Violation|0|||
48724924|NCT02867592|156842108|FG004|Overall Study|Protocol Violation|1|||
48724925|NCT02867592|156842109|FG005|Overall Study|Protocol Violation|1|||
48724926|NCT02867592|156842104|FG000|Overall Study|Withdrawal by Subject|0|||
48724927|NCT02867592|156842105|FG001|Overall Study|Withdrawal by Subject|1|||
48724928|NCT02867592|156842106|FG002|Overall Study|Withdrawal by Subject|0|||
48724929|NCT02867592|156842107|FG003|Overall Study|Withdrawal by Subject|1|||
48724930|NCT02867592|156842108|FG004|Overall Study|Withdrawal by Subject|3|||
48724931|NCT02867592|156842109|FG005|Overall Study|Withdrawal by Subject|3|||
49133916|NCT02065557|158330534|FG001|Maintenance Period|Withdrawal by Subject|0|||
49133917|NCT02065557|158330535|FG002|Maintenance Period|Withdrawal by Subject|0|||
49133918|NCT02065557|158330536|FG003|Maintenance Period|Withdrawal by Subject|0|||
49133919|NCT02065557|158330537|FG004|Maintenance Period|Withdrawal by Subject|2|||
49133920|NCT02065557|158330538|FG005|Maintenance Period|Withdrawal by Subject|1|||
49133921|NCT02065557|158330533|FG000|Maintenance Period|Lack of Efficacy|0|||
49133922|NCT02065557|158330534|FG001|Maintenance Period|Lack of Efficacy|0|||
49133923|NCT02065557|158330535|FG002|Maintenance Period|Lack of Efficacy|0|||
49133924|NCT02065557|158330536|FG003|Maintenance Period|Lack of Efficacy|0|||
49133925|NCT02065557|158330537|FG004|Maintenance Period|Lack of Efficacy|5|||
49133926|NCT02065557|158330538|FG005|Maintenance Period|Lack of Efficacy|2|||
49133927|NCT02065557|158330533|FG000|Maintenance Period|Subject Non-Compliance|0|||
49133928|NCT02065557|158330534|FG001|Maintenance Period|Subject Non-Compliance|0|||
49133929|NCT02065557|158330535|FG002|Maintenance Period|Subject Non-Compliance|0|||
49133930|NCT02065557|158330536|FG003|Maintenance Period|Subject Non-Compliance|0|||
49133931|NCT02065557|158330537|FG004|Maintenance Period|Subject Non-Compliance|0|||
49133932|NCT02065557|158330538|FG005|Maintenance Period|Subject Non-Compliance|1|||
49133933|NCT00250588|158330541|FG000|Overall Study|Withdrawal by Subject|3|||
49133934|NCT00250588|158330542|FG001|Overall Study|Withdrawal by Subject|6|||
49133935|NCT00250588|158330543|FG002|Overall Study|Withdrawal by Subject|0|||
49133936|NCT00250588|158330541|FG000|Overall Study|Lost to Follow-up|6|||
49133937|NCT00250588|158330542|FG001|Overall Study|Lost to Follow-up|13|||
49133938|NCT00250588|158330543|FG002|Overall Study|Lost to Follow-up|13|||
49133939|NCT04810962|158330545|FG000|Overall Study|Adverse Event|0|||
49133940|NCT04810962|158330546|FG001|Overall Study|Adverse Event|1|||
49133941|NCT04810962|158330545|FG000|Overall Study|Lost to Follow-up|2|||
49133942|NCT04810962|158330546|FG001|Overall Study|Lost to Follow-up|1|||
49133943|NCT04810962|158330545|FG000|Overall Study|Physician Decision|1|||
49133944|NCT04810962|158330546|FG001|Overall Study|Physician Decision|0|||
49133945|NCT04810962|158330545|FG000|Overall Study|Withdrawal by Subject|1|||
49133946|NCT04810962|158330546|FG001|Overall Study|Withdrawal by Subject|3|||
49133947|NCT04810962|158330545|FG000|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|2|||
49133948|NCT04810962|158330546|FG001|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|1|||
49133949|NCT02378181|158330550|FG000|Overall Study|Lost to Follow-up|2|||
49133950|NCT02378181|158330551|FG001|Overall Study|Lost to Follow-up|5|||
49133951|NCT02378181|158330550|FG000|Overall Study|Withdrawal by Subject|1|||
49133952|NCT02378181|158330551|FG001|Overall Study|Withdrawal by Subject|1|||
49133953|NCT02378181|158330550|FG000|Overall Study|Incarcerated|0|||
49133954|NCT02378181|158330551|FG001|Overall Study|Incarcerated|1|||
49133955|NCT01462942|158330552|FG000|Overall Study|Adverse Event|7|||
49133956|NCT01462942|158330553|FG001|Overall Study|Adverse Event|12|||
49133957|NCT01462942|158330554|FG002|Overall Study|Adverse Event|10|||
49133958|NCT01462942|158330555|FG003|Overall Study|Adverse Event|11|||
49133959|NCT01462942|158330556|FG004|Overall Study|Adverse Event|11|||
49133960|NCT01462942|158330552|FG000|Overall Study|Other, including COPD exacerbation|3|||
49133961|NCT01462942|158330553|FG001|Overall Study|Other, including COPD exacerbation|5|||
49133962|NCT01462942|158330554|FG002|Overall Study|Other, including COPD exacerbation|2|||
49133963|NCT01462942|158330555|FG003|Overall Study|Other, including COPD exacerbation|8|||
49133964|NCT01462942|158330556|FG004|Overall Study|Other, including COPD exacerbation|5|||
49133965|NCT01462942|158330552|FG000|Overall Study|Withdrawal by Subject|14|||
49133966|NCT01462942|158330553|FG001|Overall Study|Withdrawal by Subject|10|||
49133967|NCT01462942|158330554|FG002|Overall Study|Withdrawal by Subject|14|||
49133968|NCT01462942|158330555|FG003|Overall Study|Withdrawal by Subject|16|||
49133969|NCT01462942|158330556|FG004|Overall Study|Withdrawal by Subject|19|||
49133970|NCT01462942|158330552|FG000|Overall Study|Lack of Efficacy|6|||
49133971|NCT01462942|158330553|FG001|Overall Study|Lack of Efficacy|0|||
49133972|NCT01462942|158330554|FG002|Overall Study|Lack of Efficacy|4|||
49133973|NCT01462942|158330555|FG003|Overall Study|Lack of Efficacy|5|||
49133974|NCT01462942|158330556|FG004|Overall Study|Lack of Efficacy|3|||
49133975|NCT01462942|158330552|FG000|Overall Study|Lost to Follow-up|0|||
49133976|NCT01462942|158330553|FG001|Overall Study|Lost to Follow-up|1|||
49133977|NCT01462942|158330554|FG002|Overall Study|Lost to Follow-up|1|||
49133978|NCT01462942|158330555|FG003|Overall Study|Lost to Follow-up|1|||
49133979|NCT01462942|158330556|FG004|Overall Study|Lost to Follow-up|1|||
49133980|NCT01462942|158330552|FG000|Overall Study|Protocol Violation|4|||
49133981|NCT01462942|158330553|FG001|Overall Study|Protocol Violation|6|||
49133982|NCT01462942|158330554|FG002|Overall Study|Protocol Violation|9|||
49133983|NCT01462942|158330555|FG003|Overall Study|Protocol Violation|9|||
49133984|NCT01462942|158330556|FG004|Overall Study|Protocol Violation|6|||
49133985|NCT00296335|158330557|FG000|Overall Study|Recurrence|3|||
49133986|NCT00296335|158330558|FG001|Overall Study|Recurrence|51|||
49133987|NCT00296335|158330557|FG000|Overall Study|Adverse Event|17|||
49133988|NCT00296335|158330558|FG001|Overall Study|Adverse Event|27|||
49133989|NCT00296335|158330557|FG000|Overall Study|Lost to Follow-up|7|||
49133990|NCT00296335|158330558|FG001|Overall Study|Lost to Follow-up|33|||
49133991|NCT00296335|158330557|FG000|Overall Study|Physician Decision|3|||
49133992|NCT00296335|158330558|FG001|Overall Study|Physician Decision|11|||
49133993|NCT01027845|158330560|FG000|Primary Vaccination Phase|Serious Adverse Event|2|||
49133994|NCT01027845|158330561|FG001|Primary Vaccination Phase|Serious Adverse Event|0|||
49133995|NCT01027845|158330562|FG002|Primary Vaccination Phase|Serious Adverse Event|0|||
49133996|NCT01027845|158330563|FG003|Primary Vaccination Phase|Serious Adverse Event|0|||
49133997|NCT01027845|158330560|FG000|Primary Vaccination Phase|Adverse Event|1|||
49133998|NCT01027845|158330561|FG001|Primary Vaccination Phase|Adverse Event|0|||
49133999|NCT01027845|158330562|FG002|Primary Vaccination Phase|Adverse Event|0|||
49134000|NCT01027845|158330563|FG003|Primary Vaccination Phase|Adverse Event|0|||
49134001|NCT01027845|158330560|FG000|Primary Vaccination Phase|Protocol Violation|1|||
49134002|NCT01027845|158330561|FG001|Primary Vaccination Phase|Protocol Violation|0|||
49134003|NCT01027845|158330562|FG002|Primary Vaccination Phase|Protocol Violation|0|||
49134004|NCT01027845|158330563|FG003|Primary Vaccination Phase|Protocol Violation|0|||
49134005|NCT01027845|158330560|FG000|Primary Vaccination Phase|Migrated/moved from study area|0|||
49134006|NCT01027845|158330561|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
49134007|NCT01027845|158330562|FG002|Primary Vaccination Phase|Migrated/moved from study area|0|||
49134008|NCT01027845|158330563|FG003|Primary Vaccination Phase|Migrated/moved from study area|0|||
49134009|NCT01027845|158330560|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
49134010|NCT01027845|158330561|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
49134011|NCT01027845|158330562|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
49134012|NCT01027845|158330563|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
49134013|NCT01027845|158330560|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
49134014|NCT01027845|158330561|FG001|Booster Vaccination Phase|Migrated/moved from study area|0|||
49134015|NCT01027845|158330562|FG002|Booster Vaccination Phase|Migrated/moved from study area|0|||
49134016|NCT01027845|158330563|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
49134017|NCT02701634|158330564|FG000|Overall Study|Adverse Event|2|||
49134018|NCT02701634|158330565|FG001|Overall Study|Adverse Event|3|||
49134019|NCT02701634|158330564|FG000|Overall Study|Death|1|||
49134020|NCT02701634|158330565|FG001|Overall Study|Death|0|||
49134021|NCT02701634|158330564|FG000|Overall Study|Investigator's Discretion|7|||
49134022|NCT02701634|158330565|FG001|Overall Study|Investigator's Discretion|4|||
49134023|NCT02701634|158330564|FG000|Overall Study|Study terminated by Sponsor|15|||
49134024|NCT02701634|158330565|FG001|Overall Study|Study terminated by Sponsor|17|||
49134025|NCT02701634|158330564|FG000|Overall Study|Withdrew Consent|6|||
49134026|NCT02701634|158330565|FG001|Overall Study|Withdrew Consent|7|||
49134027|NCT02701634|158330564|FG000|Overall Study|Randomized but not treated|1|||
49134028|NCT02701634|158330565|FG001|Overall Study|Randomized but not treated|0|||
49134029|NCT02765165|158330566|FG000|Treatment Period|Progressive disease|3|||
49134030|NCT02765165|158330567|FG001|Treatment Period|Progressive disease|2|||
49134031|NCT02765165|158330568|FG002|Treatment Period|Progressive disease|3|||
49134032|NCT02765165|158330569|FG003|Treatment Period|Progressive disease|3|||
49134033|NCT02765165|158330570|FG004|Treatment Period|Progressive disease|4|||
49134034|NCT02765165|158330571|FG005|Treatment Period|Progressive disease|2|||
49134035|NCT02765165|158330572|FG006|Treatment Period|Progressive disease|2|||
49134036|NCT02765165|158330566|FG000|Treatment Period|Physician Decision|0|||
49134037|NCT02765165|158330567|FG001|Treatment Period|Physician Decision|1|||
49134038|NCT02765165|158330568|FG002|Treatment Period|Physician Decision|0|||
49134039|NCT02765165|158330569|FG003|Treatment Period|Physician Decision|0|||
49134040|NCT02765165|158330570|FG004|Treatment Period|Physician Decision|0|||
49134041|NCT02765165|158330571|FG005|Treatment Period|Physician Decision|0|||
49134042|NCT02765165|158330572|FG006|Treatment Period|Physician Decision|0|||
49134043|NCT02765165|158330566|FG000|Treatment Period|Adverse Event|0|||
49134044|NCT02765165|158330567|FG001|Treatment Period|Adverse Event|1|||
49134045|NCT02765165|158330568|FG002|Treatment Period|Adverse Event|0|||
49134046|NCT02765165|158330569|FG003|Treatment Period|Adverse Event|0|||
49134047|NCT02765165|158330570|FG004|Treatment Period|Adverse Event|0|||
49134048|NCT02765165|158330571|FG005|Treatment Period|Adverse Event|0|||
49134049|NCT02765165|158330572|FG006|Treatment Period|Adverse Event|0|||
49134050|NCT02765165|158330566|FG000|Treatment Period|Withdrawal by Subject|0|||
49134051|NCT02765165|158330567|FG001|Treatment Period|Withdrawal by Subject|0|||
49134052|NCT02765165|158330568|FG002|Treatment Period|Withdrawal by Subject|0|||
49134053|NCT02765165|158330569|FG003|Treatment Period|Withdrawal by Subject|0|||
49134054|NCT02765165|158330570|FG004|Treatment Period|Withdrawal by Subject|2|||
49134055|NCT02765165|158330571|FG005|Treatment Period|Withdrawal by Subject|0|||
49134056|NCT02765165|158330572|FG006|Treatment Period|Withdrawal by Subject|0|||
49134057|NCT02765165|158330566|FG000|Treatment Period|Study terminated|0|||
49134058|NCT02765165|158330567|FG001|Treatment Period|Study terminated|0|||
49134059|NCT02765165|158330568|FG002|Treatment Period|Study terminated|0|||
49134060|NCT02765165|158330569|FG003|Treatment Period|Study terminated|0|||
49134061|NCT02765165|158330570|FG004|Treatment Period|Study terminated|0|||
49134062|NCT02765165|158330571|FG005|Treatment Period|Study terminated|1|||
49134063|NCT02765165|158330572|FG006|Treatment Period|Study terminated|2|||
49134064|NCT02765165|158330566|FG000|Post-treatment Follow-up|Death|1|||
49134065|NCT02765165|158330567|FG001|Post-treatment Follow-up|Death|2|||
49134066|NCT02765165|158330568|FG002|Post-treatment Follow-up|Death|1|||
49134067|NCT02765165|158330569|FG003|Post-treatment Follow-up|Death|1|||
49134068|NCT02765165|158330570|FG004|Post-treatment Follow-up|Death|1|||
49134069|NCT02765165|158330571|FG005|Post-treatment Follow-up|Death|1|||
49134070|NCT02765165|158330572|FG006|Post-treatment Follow-up|Death|0|||
49134071|NCT02765165|158330566|FG000|Post-treatment Follow-up|Lost to Follow-up|0|||
49134072|NCT02765165|158330567|FG001|Post-treatment Follow-up|Lost to Follow-up|0|||
49134073|NCT02765165|158330568|FG002|Post-treatment Follow-up|Lost to Follow-up|0|||
49134074|NCT02765165|158330569|FG003|Post-treatment Follow-up|Lost to Follow-up|1|||
49134075|NCT02765165|158330570|FG004|Post-treatment Follow-up|Lost to Follow-up|0|||
49134076|NCT02765165|158330571|FG005|Post-treatment Follow-up|Lost to Follow-up|0|||
49134077|NCT02765165|158330572|FG006|Post-treatment Follow-up|Lost to Follow-up|0|||
49134078|NCT02765165|158330566|FG000|Post-treatment Follow-up|Site terminated by sponsor|0|||
49134079|NCT02765165|158330567|FG001|Post-treatment Follow-up|Site terminated by sponsor|0|||
49134080|NCT02765165|158330568|FG002|Post-treatment Follow-up|Site terminated by sponsor|1|||
49134081|NCT02765165|158330569|FG003|Post-treatment Follow-up|Site terminated by sponsor|0|||
49134082|NCT02765165|158330570|FG004|Post-treatment Follow-up|Site terminated by sponsor|0|||
49134083|NCT02765165|158330571|FG005|Post-treatment Follow-up|Site terminated by sponsor|0|||
49134084|NCT02765165|158330572|FG006|Post-treatment Follow-up|Site terminated by sponsor|0|||
49134085|NCT02765165|158330566|FG000|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
49134086|NCT02765165|158330567|FG001|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
49134087|NCT02765165|158330568|FG002|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
49134088|NCT02765165|158330569|FG003|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
49134089|NCT02765165|158330570|FG004|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
49134090|NCT02765165|158330571|FG005|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
49134091|NCT02765165|158330572|FG006|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
49134092|NCT02765165|158330566|FG000|Post-treatment Follow-up|Withdrawal by Subject|0|||
49134093|NCT02765165|158330567|FG001|Post-treatment Follow-up|Withdrawal by Subject|1|||
49134094|NCT02765165|158330568|FG002|Post-treatment Follow-up|Withdrawal by Subject|0|||
49134095|NCT02765165|158330569|FG003|Post-treatment Follow-up|Withdrawal by Subject|0|||
49134096|NCT02765165|158330570|FG004|Post-treatment Follow-up|Withdrawal by Subject|0|||
49134097|NCT02765165|158330571|FG005|Post-treatment Follow-up|Withdrawal by Subject|0|||
49134098|NCT02765165|158330572|FG006|Post-treatment Follow-up|Withdrawal by Subject|0|||
49134099|NCT02765165|158330566|FG000|Post-treatment Follow-up|Study terminated by the sponsor|0|||
49134100|NCT02765165|158330567|FG001|Post-treatment Follow-up|Study terminated by the sponsor|0|||
49134101|NCT02765165|158330568|FG002|Post-treatment Follow-up|Study terminated by the sponsor|0|||
49134102|NCT02765165|158330569|FG003|Post-treatment Follow-up|Study terminated by the sponsor|0|||
49134103|NCT02765165|158330570|FG004|Post-treatment Follow-up|Study terminated by the sponsor|2|||
49134104|NCT02765165|158330571|FG005|Post-treatment Follow-up|Study terminated by the sponsor|2|||
49134105|NCT02765165|158330572|FG006|Post-treatment Follow-up|Study terminated by the sponsor|1|||
49134106|NCT04465422|158330575|FG000|Overall Study|Lost to Follow-up|0|||
49134107|NCT04465422|158330576|FG001|Overall Study|Lost to Follow-up|2|||
49134108|NCT00630292|158330577|FG000|Overall Study|Withdrawal by Subject|1|||
49134109|NCT01189266|158330580|FG000|Overall Study|Adverse Event|1|||
49134110|NCT01189266|158330581|FG001|Overall Study|Adverse Event|0|||
49134111|NCT01189266|158330582|FG002|Overall Study|Adverse Event|5|||
49134112|NCT01189266|158330580|FG000|Overall Study|Death|0|||
49134113|NCT01189266|158330581|FG001|Overall Study|Death|0|||
49134114|NCT01189266|158330582|FG002|Overall Study|Death|5|||
49134115|NCT01189266|158330580|FG000|Overall Study|Lack of Efficacy|4|||
49134116|NCT01189266|158330581|FG001|Overall Study|Lack of Efficacy|5|||
49134117|NCT01189266|158330582|FG002|Overall Study|Lack of Efficacy|44|||
49134118|NCT01189266|158330580|FG000|Overall Study|Physician Decision|0|||
49134119|NCT01189266|158330581|FG001|Overall Study|Physician Decision|0|||
49134120|NCT01189266|158330582|FG002|Overall Study|Physician Decision|1|||
49134121|NCT01189266|158330580|FG000|Overall Study|Protocol Violation|0|||
49134122|NCT01189266|158330581|FG001|Overall Study|Protocol Violation|1|||
49134123|NCT01189266|158330582|FG002|Overall Study|Protocol Violation|1|||
49134124|NCT01189266|158330580|FG000|Overall Study|Withdrawal by Subject|0|||
49134125|NCT01189266|158330581|FG001|Overall Study|Withdrawal by Subject|0|||
49134126|NCT01189266|158330582|FG002|Overall Study|Withdrawal by Subject|1|||
49134127|NCT01189266|158330580|FG000|Overall Study|Patient refuses further therapy|1|||
49134128|NCT01189266|158330581|FG001|Overall Study|Patient refuses further therapy|0|||
49134129|NCT01189266|158330582|FG002|Overall Study|Patient refuses further therapy|7|||
49134130|NCT01189266|158330580|FG000|Overall Study|No treatment|0|||
49134131|NCT01189266|158330581|FG001|Overall Study|No treatment|0|||
49134132|NCT01189266|158330582|FG002|Overall Study|No treatment|1|||
49134133|NCT00410163|158330583|FG000|Treatment and Follow-up Phase (2 Years)|Adverse Event|4|||
49134134|NCT00410163|158330584|FG001|Treatment and Follow-up Phase (2 Years)|Adverse Event|2|||
48819408|NCT03366649|157181815|FG000|Overall Study|Failed preoperative screening|4|||
48819409|NCT03366649|157181816|FG001|Overall Study|Failed preoperative screening|0|||
48819410|NCT03366649|157181817|FG002|Overall Study|Failed preoperative screening|0|||
48819411|NCT03366649|157181815|FG000|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|4|||
48819412|NCT03366649|157181816|FG001|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
48819413|NCT03366649|157181817|FG002|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
48819414|NCT01676220|157181819|FG000|Overall Study|Randomized But Not Treated|4|||
48819415|NCT01676220|157181820|FG001|Overall Study|Randomized But Not Treated|1|||
48819416|NCT01676220|157181819|FG000|Overall Study|Adverse Event|10|||
48819417|NCT01676220|157181820|FG001|Overall Study|Adverse Event|8|||
48819418|NCT01676220|157181819|FG000|Overall Study|Lack of Efficacy|2|||
48819419|NCT01676220|157181820|FG001|Overall Study|Lack of Efficacy|5|||
48819420|NCT01676220|157181819|FG000|Overall Study|Protocol Violation|11|||
48819421|NCT01676220|157181820|FG001|Overall Study|Protocol Violation|12|||
48819422|NCT01676220|157181819|FG000|Overall Study|Received Rescue Therapy|14|||
48819423|NCT01676220|157181820|FG001|Overall Study|Received Rescue Therapy|22|||
48819424|NCT01676220|157181819|FG000|Overall Study|Personal Reason|34|||
48819425|NCT01676220|157181820|FG001|Overall Study|Personal Reason|45|||
48819426|NCT01676220|157181819|FG000|Overall Study|Lost to Follow-up|11|||
48819427|NCT01676220|157181820|FG001|Overall Study|Lost to Follow-up|18|||
48819428|NCT01676220|157181819|FG000|Overall Study|Selection Criterion/Protocol Violation|9|||
48819429|NCT01676220|157181820|FG001|Overall Study|Selection Criterion/Protocol Violation|9|||
48819430|NCT01676220|157181819|FG000|Overall Study|Site Closure/Site Withdrawal|1|||
48819431|NCT01676220|157181820|FG001|Overall Study|Site Closure/Site Withdrawal|4|||
48819432|NCT01676220|157181819|FG000|Overall Study|Perceived Lack of Efficacy|3|||
48819433|NCT01676220|157181820|FG001|Overall Study|Perceived Lack of Efficacy|1|||
48819434|NCT01676220|157181819|FG000|Overall Study|Non Serious Hypoglycemia|2|||
48819435|NCT01676220|157181820|FG001|Overall Study|Non Serious Hypoglycemia|0|||
48819436|NCT01676220|157181819|FG000|Overall Study|No More Need of Insulin|1|||
48819437|NCT01676220|157181820|FG001|Overall Study|No More Need of Insulin|0|||
48819438|NCT04347161|157181821|FG000|Overall Study|Death|0|||
48819439|NCT04347161|157181822|FG001|Overall Study|Death|2|||
48819440|NCT04347161|157181821|FG000|Overall Study|Withdrawal by Subject|1|||
48819441|NCT04347161|157181822|FG001|Overall Study|Withdrawal by Subject|0|||
48819442|NCT04347161|157181821|FG000|Overall Study|Lost to Follow-up|0|||
48819443|NCT04347161|157181822|FG001|Overall Study|Lost to Follow-up|1|||
48819444|NCT04347161|157181821|FG000|Overall Study|No longer on study medication|1|||
48819445|NCT04347161|157181822|FG001|Overall Study|No longer on study medication|1|||
48819446|NCT00896454|157181823|FG000|Overall Study|Death|10|||
48819447|NCT00896454|157181823|FG000|Overall Study|Adverse Event|8|||
48819448|NCT00896454|157181823|FG000|Overall Study|Disease Progression|5|||
48819449|NCT00896454|157181823|FG000|Overall Study|Other|4|||
48819450|NCT00896454|157181823|FG000|Overall Study|Requirement for alternative therapy|3|||
48819451|NCT00896454|157181823|FG000|Overall Study|Ongoing in study|2|||
48819452|NCT00896454|157181823|FG000|Overall Study|Withdrawal by Subject|1|||
48819453|NCT01712789|157181824|FG000|Overall Study|Lack of Efficacy|2|||
48819454|NCT01712789|157181824|FG000|Overall Study|Lost to Follow-up|1|||
48819455|NCT01712789|157181824|FG000|Overall Study|Progressive Disease|504|||
48819456|NCT01712789|157181824|FG000|Overall Study|Death|57|||
48819457|NCT01712789|157181824|FG000|Overall Study|Adverse Event|52|||
48819458|NCT01712789|157181824|FG000|Overall Study|Miscellaneous|31|||
49134135|NCT00410163|158330583|FG000|Treatment and Follow-up Phase (2 Years)|Death|1|||
49134136|NCT00410163|158330584|FG001|Treatment and Follow-up Phase (2 Years)|Death|1|||
49134137|NCT00410163|158330583|FG000|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2|||
49134138|NCT00410163|158330584|FG001|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1|||
49134139|NCT00410163|158330583|FG000|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0|||
49134140|NCT00410163|158330584|FG001|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4|||
49134141|NCT00410163|158330583|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2|||
49134142|NCT00410163|158330584|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1|||
49134143|NCT00410163|158330583|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1|||
49134144|NCT00410163|158330584|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0|||
49134145|NCT00410163|158330583|FG000|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
49134146|NCT00410163|158330584|FG001|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
49134147|NCT00410163|158330583|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1|||
48819459|NCT01712789|157181824|FG000|Overall Study|Withdrawal by Subject|21|||
48819460|NCT01712789|157181824|FG000|Overall Study|Transition to Commercial Treatment|8|||
48819461|NCT01712789|157181824|FG000|Overall Study|Participants Did Not Receive Study Drug|6|||
48819462|NCT03018106|157181825|FG000|Overall Study|Lost to Follow-up|0|||
48819463|NCT03018106|157181826|FG001|Overall Study|Lost to Follow-up|1|||
48819464|NCT01994720|157181827|FG000|Overall Study|Withdrawal by Subject|46|||
48819465|NCT01994720|157181828|FG001|Overall Study|Withdrawal by Subject|56|||
49134148|NCT00410163|158330584|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0|||
49134149|NCT00410163|158330583|FG000|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0|||
49134150|NCT00410163|158330584|FG001|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1|||
49134151|NCT00410163|158330583|FG000|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3|||
49134152|NCT00410163|158330584|FG001|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1|||
49134153|NCT00410163|158330583|FG000|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
49134154|NCT00410163|158330584|FG001|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
49134155|NCT00410163|158330583|FG000|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1|||
49134156|NCT00410163|158330584|FG001|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0|||
49134157|NCT00410163|158330583|FG000|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4|||
49134158|NCT00410163|158330584|FG001|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8|||
49134159|NCT00410163|158330583|FG000|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1|||
49134160|NCT00410163|158330584|FG001|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0|||
48724932|NCT02867592|156842104|FG000|Overall Study|Ineligible|1|||
48724933|NCT02867592|156842105|FG001|Overall Study|Ineligible|1|||
48724934|NCT02867592|156842106|FG002|Overall Study|Ineligible|0|||
48724935|NCT02867592|156842107|FG003|Overall Study|Ineligible|0|||
48724936|NCT02867592|156842108|FG004|Overall Study|Ineligible|2|||
48724937|NCT02867592|156842109|FG005|Overall Study|Ineligible|0|||
48724938|NCT02867592|156842104|FG000|Overall Study|No Treatment|1|||
48724939|NCT02867592|156842105|FG001|Overall Study|No Treatment|0|||
48724940|NCT02867592|156842106|FG002|Overall Study|No Treatment|0|||
48724941|NCT02867592|156842107|FG003|Overall Study|No Treatment|0|||
48724942|NCT02867592|156842108|FG004|Overall Study|No Treatment|0|||
48724943|NCT02867592|156842109|FG005|Overall Study|No Treatment|0|||
48724944|NCT02867592|156842104|FG000|Overall Study|Still on Therapy|0|||
48724945|NCT02867592|156842105|FG001|Overall Study|Still on Therapy|0|||
48724946|NCT02867592|156842106|FG002|Overall Study|Still on Therapy|0|||
48724947|NCT02867592|156842107|FG003|Overall Study|Still on Therapy|0|||
48724948|NCT02867592|156842108|FG004|Overall Study|Still on Therapy|1|||
48724949|NCT02867592|156842109|FG005|Overall Study|Still on Therapy|0|||
48724950|NCT02867592|156842104|FG000|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
48724951|NCT02867592|156842105|FG001|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
48724952|NCT02867592|156842106|FG002|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
48724953|NCT02867592|156842107|FG003|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
48724954|NCT02867592|156842108|FG004|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
48724955|NCT02867592|156842109|FG005|Overall Study|Patient received concurrent anticancer or investigational therapy|1|||
48724956|NCT02867592|156842104|FG000|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
48724957|NCT02867592|156842105|FG001|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
48724958|NCT02867592|156842106|FG002|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
48724959|NCT02867592|156842107|FG003|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|2|||
48724960|NCT02867592|156842108|FG004|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
48724961|NCT02867592|156842109|FG005|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
48724962|NCT02418156|156842110|FG000|Overall Study|Lost to Follow-up|12|||
48724963|NCT02418156|156842110|FG000|Overall Study|Death|2|||
48724964|NCT02418156|156842110|FG000|Overall Study|Physician Decision|1|||
48724965|NCT02418156|156842110|FG000|Overall Study|Withdrawal by Subject|1|||
48724966|NCT02418156|156842110|FG000|Overall Study|Subject refused to return|1|||
48724967|NCT00458536|156842111|FG000|Overall Study|Disease progression prior to treatment|7|||
48724968|NCT00458536|156842111|FG000|Overall Study|Unable to make vaccine|3|||
48724969|NCT00458536|156842111|FG000|Overall Study|No measurable disease after surgery|2|||
48724970|NCT00458536|156842111|FG000|Overall Study|Did not have renal cell carcinoma|2|||
48724971|NCT00458536|156842111|FG000|Overall Study|Patient did not have surgery|1|||
48724972|NCT00458536|156842111|FG000|Overall Study|Ineligible due to toxicity|1|||
48724973|NCT00458536|156842111|FG000|Overall Study|Withdrawal by Subject|1|||
48724974|NCT00458536|156842111|FG000|Overall Study|Progressive disease during treatment|2|||
48724975|NCT00285207|156842113|FG000|Overall Study|Lost to Follow-up|3|||
48724976|NCT00285207|156842114|FG001|Overall Study|Lost to Follow-up|2|||
48724977|NCT00285207|156842113|FG000|Overall Study|Withdrawal by Subject|5|||
48724978|NCT00285207|156842114|FG001|Overall Study|Withdrawal by Subject|2|||
48724979|NCT00285207|156842113|FG000|Overall Study|Pregnancy|1|||
48724980|NCT00285207|156842114|FG001|Overall Study|Pregnancy|1|||
48724981|NCT00285207|156842113|FG000|Overall Study|non-compliance|0|||
48724982|NCT00285207|156842114|FG001|Overall Study|non-compliance|1|||
48724983|NCT05140382|156842117|FG000|Overall Study|Death|3|||
48724984|NCT05140382|156842118|FG001|Overall Study|Death|0|||
48724985|NCT05140382|156842119|FG002|Overall Study|Death|0|||
48724986|NCT05140382|156842117|FG000|Overall Study|Investigator decision|1|||
48724987|NCT05140382|156842118|FG001|Overall Study|Investigator decision|0|||
48819466|NCT00146640|157181829|FG000|Overall Study|Adverse Event|12|||
48819467|NCT00146640|157181830|FG001|Overall Study|Adverse Event|10|||
48819468|NCT00146640|157181829|FG000|Overall Study|Medical Reasons|3|||
48819469|NCT00146640|157181830|FG001|Overall Study|Medical Reasons|0|||
48819470|NCT00146640|157181829|FG000|Overall Study|Non-Medical Reasons|8|||
48819471|NCT00146640|157181830|FG001|Overall Study|Non-Medical Reasons|4|||
48819472|NCT03867500|157181838|FG000|Saline Infustion Intervention|Withdrawal by Subject|1|||
48819473|NCT05894577|157181839|FG000|Overall Study|No receipt of study drug|14|||
48819474|NCT05894577|157181840|FG001|Overall Study|No receipt of study drug|13|||
49134161|NCT00324155|158330587|FG000|Enrolled and Randomized|No longer met study criteria|3|||
49134162|NCT00324155|158330588|FG001|Enrolled and Randomized|No longer met study criteria|0|||
49134163|NCT00324155|158330587|FG000|Enrolled and Randomized|Lost to Follow-up|0|||
49134164|NCT00324155|158330588|FG001|Enrolled and Randomized|Lost to Follow-up|1|||
49134165|NCT00324155|158330587|FG000|Received Treatment in Induction Phase|Disease Progression|88|||
49134166|NCT00324155|158330588|FG001|Received Treatment in Induction Phase|Disease Progression|152|||
49134167|NCT00324155|158330587|FG000|Received Treatment in Induction Phase|Study Drug Toxicity|83|||
49134168|NCT00324155|158330588|FG001|Received Treatment in Induction Phase|Study Drug Toxicity|10|||
49134169|NCT00324155|158330587|FG000|Received Treatment in Induction Phase|Death|8|||
49134170|NCT00324155|158330588|FG001|Received Treatment in Induction Phase|Death|15|||
49134171|NCT00324155|158330587|FG000|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9|||
49134172|NCT00324155|158330588|FG001|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8|||
49134173|NCT00324155|158330587|FG000|Received Treatment in Induction Phase|Adverse Event|6|||
49134174|NCT00324155|158330588|FG001|Received Treatment in Induction Phase|Adverse Event|7|||
49134175|NCT00324155|158330587|FG000|Received Treatment in Induction Phase|Withdrawal by Subject|6|||
49134176|NCT00324155|158330588|FG001|Received Treatment in Induction Phase|Withdrawal by Subject|5|||
49134177|NCT00324155|158330587|FG000|Received Treatment in Induction Phase|Physician Decision|2|||
49134178|NCT00324155|158330588|FG001|Received Treatment in Induction Phase|Physician Decision|0|||
49134179|NCT00324155|158330587|FG000|Received Treatment in Maintenance Phase|Disease Progression|26|||
49134180|NCT00324155|158330588|FG001|Received Treatment in Maintenance Phase|Disease Progression|41|||
49134181|NCT00324155|158330587|FG000|Received Treatment in Maintenance Phase|Study Drug Toxicity|4|||
49134182|NCT00324155|158330588|FG001|Received Treatment in Maintenance Phase|Study Drug Toxicity|0|||
49134183|NCT00324155|158330587|FG000|Received Treatment in Maintenance Phase|Withdrawal by Subject|1|||
49134184|NCT00324155|158330588|FG001|Received Treatment in Maintenance Phase|Withdrawal by Subject|3|||
49134185|NCT00324155|158330587|FG000|Received Treatment in Maintenance Phase|Adverse Event|0|||
49134186|NCT00324155|158330588|FG001|Received Treatment in Maintenance Phase|Adverse Event|3|||
49134187|NCT00324155|158330587|FG000|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1|||
49134188|NCT00324155|158330588|FG001|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0|||
49134189|NCT00324155|158330587|FG000|Follow-up Phase|On-going participants still on drug|11|||
49134190|NCT00324155|158330588|FG001|Follow-up Phase|On-going participants still on drug|6|||
49134191|NCT02309359|158330591|FG000|Overall Study|Adverse Event|4|||
49134192|NCT02309359|158330592|FG001|Overall Study|Adverse Event|5|||
49134193|NCT02309359|158330593|FG002|Overall Study|Adverse Event|5|||
49134194|NCT02309359|158330594|FG003|Overall Study|Adverse Event|4|||
49134195|NCT02309359|158330595|FG004|Overall Study|Adverse Event|4|||
49134196|NCT02309359|158330591|FG000|Overall Study|Death|1|||
49134197|NCT02309359|158330592|FG001|Overall Study|Death|0|||
49134198|NCT02309359|158330593|FG002|Overall Study|Death|0|||
49134199|NCT02309359|158330594|FG003|Overall Study|Death|0|||
49134200|NCT02309359|158330595|FG004|Overall Study|Death|0|||
49134201|NCT02309359|158330591|FG000|Overall Study|Withdrawal by Subject|2|||
49134202|NCT02309359|158330592|FG001|Overall Study|Withdrawal by Subject|2|||
49134203|NCT02309359|158330593|FG002|Overall Study|Withdrawal by Subject|4|||
49134204|NCT02309359|158330594|FG003|Overall Study|Withdrawal by Subject|4|||
49134205|NCT02309359|158330595|FG004|Overall Study|Withdrawal by Subject|0|||
49134206|NCT02309359|158330591|FG000|Overall Study|Lack of Efficacy|3|||
49134207|NCT02309359|158330592|FG001|Overall Study|Lack of Efficacy|1|||
49134208|NCT02309359|158330593|FG002|Overall Study|Lack of Efficacy|0|||
49134209|NCT02309359|158330594|FG003|Overall Study|Lack of Efficacy|0|||
49134210|NCT02309359|158330595|FG004|Overall Study|Lack of Efficacy|3|||
49134211|NCT02309359|158330591|FG000|Overall Study|Lost to Follow-up|0|||
49134212|NCT02309359|158330592|FG001|Overall Study|Lost to Follow-up|0|||
49134213|NCT02309359|158330593|FG002|Overall Study|Lost to Follow-up|0|||
49134214|NCT02309359|158330594|FG003|Overall Study|Lost to Follow-up|1|||
49134215|NCT02309359|158330595|FG004|Overall Study|Lost to Follow-up|0|||
49134216|NCT02309359|158330591|FG000|Overall Study|Other|2|||
49134217|NCT02309359|158330592|FG001|Overall Study|Other|0|||
48819475|NCT05894577|157181839|FG000|Overall Study|Randomized not enrolled (Drug not received)|11|||
49134218|NCT02309359|158330593|FG002|Overall Study|Other|2|||
49134219|NCT02309359|158330594|FG003|Overall Study|Other|3|||
49134220|NCT02309359|158330595|FG004|Overall Study|Other|2|||
49134221|NCT02836769|158330597|FG000|Overall Study|Lost to Follow-up|10|||
48819476|NCT05894577|157181840|FG001|Overall Study|Randomized not enrolled (Drug not received)|14|||
48819477|NCT05894577|157181839|FG000|Overall Study|Screen Fail|2|||
48819478|NCT05894577|157181840|FG001|Overall Study|Screen Fail|0|||
48819479|NCT05894577|157181839|FG000|Overall Study|Study drug recall|86|||
48819480|NCT05894577|157181840|FG001|Overall Study|Study drug recall|63|||
48819481|NCT01919554|157181841|FG000|Overall Study|Withdrawal by Subject|0|||
48819482|NCT01919554|157181842|FG001|Overall Study|Withdrawal by Subject|0|||
48819483|NCT01919554|157181843|FG002|Overall Study|Withdrawal by Subject|1|||
48819484|NCT01919554|157181844|FG003|Overall Study|Withdrawal by Subject|1|||
48819485|NCT06182033|157181845|FG000|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
48819486|NCT06182033|157181846|FG001|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
48819487|NCT06182033|157181845|FG000|Overall Study|Target child relocation|1|||
48819488|NCT06182033|157181846|FG001|Overall Study|Target child relocation|1|||
48819489|NCT06182033|157181845|FG000|Overall Study|Withdrawal by Subject|1|||
48819490|NCT06182033|157181846|FG001|Overall Study|Withdrawal by Subject|0|||
48819491|NCT00442286|157181858|FG000|Overall Study|Death|2|||
48819492|NCT00442286|157181859|FG001|Overall Study|Death|2|||
48819493|NCT00442286|157181858|FG000|Overall Study|Lost to Follow-up|1|||
48819494|NCT00442286|157181859|FG001|Overall Study|Lost to Follow-up|0|||
48819495|NCT00442286|157181858|FG000|Overall Study|Withdrawal by Subject|2|||
48819496|NCT00442286|157181859|FG001|Overall Study|Withdrawal by Subject|0|||
48819497|NCT00442286|157181858|FG000|Overall Study|System explanted|1|||
48819498|NCT00442286|157181859|FG001|Overall Study|System explanted|0|||
48819499|NCT00442286|157181858|FG000|Overall Study|Patient Injury|1|||
48819500|NCT00442286|157181859|FG001|Overall Study|Patient Injury|0|||
48819501|NCT05114590|157181860|FG000|Overall Study|Adverse Event|1|||
48819502|NCT05114590|157181860|FG000|Overall Study|Investigator decision|1|||
48819503|NCT05114590|157181860|FG000|Overall Study|Lost to Follow-up|5|||
48819504|NCT05114590|157181860|FG000|Overall Study|Withdrawal by Subject|5|||
48819505|NCT05114590|157181860|FG000|Overall Study|Other|2|||
48819506|NCT00429793|157181863|FG000|Overall Study|Improper pre-protocol treatment|3|||
48819507|NCT00429793|157181863|FG000|Overall Study|Required test not done|1|||
48819508|NCT00429793|157181863|FG000|Overall Study|Never treated|1|||
48819509|NCT00429793|157181863|FG000|Overall Study|Non-measurable|1|||
48819510|NCT01394991|157181864|FG000|Overall Study|Adverse Event|0|||
48819511|NCT01394991|157181865|FG001|Overall Study|Adverse Event|4|||
48819512|NCT01394991|157181864|FG000|Overall Study|Lack of Efficacy|5|||
48819513|NCT01394991|157181865|FG001|Overall Study|Lack of Efficacy|7|||
48819514|NCT01394991|157181864|FG000|Overall Study|Lost to Follow-up|6|||
48819515|NCT01394991|157181865|FG001|Overall Study|Lost to Follow-up|8|||
48819516|NCT01394991|157181864|FG000|Overall Study|Physician Decision|1|||
48819517|NCT01394991|157181865|FG001|Overall Study|Physician Decision|3|||
48819518|NCT01394991|157181864|FG000|Overall Study|Protocol Violation|1|||
48819519|NCT01394991|157181865|FG001|Overall Study|Protocol Violation|1|||
48819520|NCT01394991|157181864|FG000|Overall Study|Withdrawal by Subject|20|||
48819521|NCT01394991|157181865|FG001|Overall Study|Withdrawal by Subject|17|||
48819522|NCT01394991|157181864|FG000|Overall Study|Chemotherapy Termination|10|||
48819523|NCT01394991|157181865|FG001|Overall Study|Chemotherapy Termination|15|||
48819524|NCT01394991|157181864|FG000|Overall Study|Disease Progression|7|||
48819525|NCT01394991|157181865|FG001|Overall Study|Disease Progression|7|||
48819526|NCT01394991|157181864|FG000|Overall Study|Prematurely Termination of Trial|9|||
48819527|NCT01394991|157181865|FG001|Overall Study|Prematurely Termination of Trial|10|||
48819528|NCT02337361|157181866|FG000|3-month Follow-up|Lost to Follow-up|19|||
48819529|NCT02337361|157181867|FG001|3-month Follow-up|Lost to Follow-up|14|||
48819530|NCT02337361|157181866|FG000|6-month Follow-up|Lost to Follow-up|2|||
48819531|NCT02337361|157181867|FG001|6-month Follow-up|Lost to Follow-up|4|||
48819532|NCT03073005|157181868|FG000|Overall Study|Death|6|||
48819533|NCT03073005|157181869|FG001|Overall Study|Death|0|||
48819534|NCT03073005|157181870|FG002|Overall Study|Death|7|||
48819535|NCT03073005|157181871|FG003|Overall Study|Death|0|||
49134222|NCT02836769|158330597|FG000|Overall Study|Medical withdrawal|2|||
49134223|NCT02836769|158330597|FG000|Overall Study|Withdrawal by Subject|3|||
49134224|NCT02452190|158330602|FG000|Overall Study|Withdrawal by Sponsor|1|||
48819536|NCT03073005|157181868|FG000|Overall Study|caregiver withdrew bc of pt death|0|||
48819537|NCT03073005|157181869|FG001|Overall Study|caregiver withdrew bc of pt death|6|||
48819538|NCT03073005|157181870|FG002|Overall Study|caregiver withdrew bc of pt death|0|||
48819539|NCT03073005|157181871|FG003|Overall Study|caregiver withdrew bc of pt death|7|||
48819540|NCT03073005|157181868|FG000|Overall Study|Lost to Follow-up|2|||
48819541|NCT03073005|157181869|FG001|Overall Study|Lost to Follow-up|2|||
48819542|NCT03073005|157181870|FG002|Overall Study|Lost to Follow-up|1|||
48819543|NCT03073005|157181871|FG003|Overall Study|Lost to Follow-up|2|||
48819544|NCT03073005|157181868|FG000|Overall Study|Withdrawal by Subject|0|||
48819545|NCT03073005|157181869|FG001|Overall Study|Withdrawal by Subject|4|||
48819546|NCT03073005|157181870|FG002|Overall Study|Withdrawal by Subject|4|||
48819547|NCT03073005|157181871|FG003|Overall Study|Withdrawal by Subject|4|||
48819548|NCT00725010|157181879|FG000|Overall Study|Toxicity|9|||
48819549|NCT00725010|157181879|FG000|Overall Study|Tumor Progression|7|||
48819550|NCT00725010|157181879|FG000|Overall Study|Withdrawal by Subject|2|||
48819551|NCT00725010|157181879|FG000|Overall Study|Death|1|||
48819552|NCT00725010|157181879|FG000|Overall Study|Lost to Follow-up|1|||
48819553|NCT00725010|157181879|FG000|Overall Study|Hepatopathy probably not Temodal-related|1|||
48819554|NCT00725010|157181879|FG000|Overall Study|Suspect lymph nodes neck thorax abdomen|1|||
48819555|NCT00725010|157181879|FG000|Overall Study|No further documentation|1|||
48819556|NCT00725010|157181879|FG000|Overall Study|Intensified treatment scheme: 3 on 1 off|2|||
48819557|NCT02414828|157181880|FG000|Overall Study|Lost to Follow-up|0|||
48819558|NCT02414828|157181881|FG001|Overall Study|Lost to Follow-up|1|||
48819559|NCT02414828|157181882|FG002|Overall Study|Lost to Follow-up|1|||
48819560|NCT02414828|157181883|FG003|Overall Study|Lost to Follow-up|2|||
48819561|NCT00434837|157181884|FG000|Overall Study|Lost to Follow-up|20|||
48819562|NCT00434837|157181885|FG001|Overall Study|Lost to Follow-up|23|||
48819563|NCT00434837|157181886|FG002|Overall Study|Lost to Follow-up|30|||
48819564|NCT02499328|157181888|FG000|Overall Study|Withdrawal by Subject|1|||
48819565|NCT02499328|157181889|FG001|Overall Study|Withdrawal by Subject|1|||
48819566|NCT02499328|157181890|FG002|Overall Study|Withdrawal by Subject|5|||
48819567|NCT02499328|157181891|FG003|Overall Study|Withdrawal by Subject|3|||
48819568|NCT02499328|157181892|FG004|Overall Study|Withdrawal by Subject|5|||
48819569|NCT02499328|157181893|FG005|Overall Study|Withdrawal by Subject|0|||
48819570|NCT02499328|157181894|FG006|Overall Study|Withdrawal by Subject|0|||
48819571|NCT02499328|157181895|FG007|Overall Study|Withdrawal by Subject|0|||
48819572|NCT02499328|157181896|FG008|Overall Study|Withdrawal by Subject|2|||
48819573|NCT02499328|157181897|FG009|Overall Study|Withdrawal by Subject|2|||
48819574|NCT02499328|157181898|FG010|Overall Study|Withdrawal by Subject|0|||
48819575|NCT02499328|157181899|FG011|Overall Study|Withdrawal by Subject|3|||
48819576|NCT02499328|157181900|FG012|Overall Study|Withdrawal by Subject|7|||
48819577|NCT02499328|157181901|FG013|Overall Study|Withdrawal by Subject|3|||
48819578|NCT02499328|157181902|FG014|Overall Study|Withdrawal by Subject|1|||
48819579|NCT02499328|157181903|FG015|Overall Study|Withdrawal by Subject|0|||
48819580|NCT02499328|157181904|FG016|Overall Study|Withdrawal by Subject|0|||
48819581|NCT02499328|157181905|FG017|Overall Study|Withdrawal by Subject|3|||
48819582|NCT02499328|157181906|FG018|Overall Study|Withdrawal by Subject|0|||
48819583|NCT02499328|157181888|FG000|Overall Study|Lost to Follow-up|0|||
48819584|NCT02499328|157181889|FG001|Overall Study|Lost to Follow-up|1|||
48819585|NCT02499328|157181890|FG002|Overall Study|Lost to Follow-up|1|||
48819586|NCT02499328|157181891|FG003|Overall Study|Lost to Follow-up|2|||
48819587|NCT02499328|157181892|FG004|Overall Study|Lost to Follow-up|0|||
48819588|NCT02499328|157181893|FG005|Overall Study|Lost to Follow-up|0|||
48819589|NCT02499328|157181894|FG006|Overall Study|Lost to Follow-up|0|||
48819590|NCT02499328|157181895|FG007|Overall Study|Lost to Follow-up|2|||
48819591|NCT02499328|157181896|FG008|Overall Study|Lost to Follow-up|3|||
48819592|NCT02499328|157181897|FG009|Overall Study|Lost to Follow-up|0|||
48819593|NCT02499328|157181898|FG010|Overall Study|Lost to Follow-up|0|||
48819594|NCT02499328|157181899|FG011|Overall Study|Lost to Follow-up|0|||
48819595|NCT02499328|157181900|FG012|Overall Study|Lost to Follow-up|0|||
48819596|NCT02499328|157181901|FG013|Overall Study|Lost to Follow-up|0|||
48819597|NCT02499328|157181902|FG014|Overall Study|Lost to Follow-up|0|||
48819598|NCT02499328|157181903|FG015|Overall Study|Lost to Follow-up|0|||
48819599|NCT02499328|157181904|FG016|Overall Study|Lost to Follow-up|0|||
49134225|NCT02452190|158330603|FG001|Overall Study|Withdrawal by Sponsor|3|||
49134226|NCT02452190|158330602|FG000|Overall Study|Pregnancy|1|||
49134227|NCT02452190|158330603|FG001|Overall Study|Pregnancy|0|||
48819600|NCT02499328|157181905|FG017|Overall Study|Lost to Follow-up|0|||
48819601|NCT02499328|157181906|FG018|Overall Study|Lost to Follow-up|1|||
48819602|NCT02499328|157181888|FG000|Overall Study|Death|0|||
48819603|NCT02499328|157181889|FG001|Overall Study|Death|3|||
48819604|NCT02499328|157181890|FG002|Overall Study|Death|3|||
49134228|NCT02452190|158330602|FG000|Overall Study|Investigator's Decision|2|||
49134229|NCT02452190|158330603|FG001|Overall Study|Investigator's Decision|0|||
49134230|NCT02452190|158330602|FG000|Overall Study|Lack of Efficacy|3|||
49134231|NCT02452190|158330603|FG001|Overall Study|Lack of Efficacy|1|||
49134232|NCT02452190|158330602|FG000|Overall Study|Lost to Follow-up|4|||
48819605|NCT02499328|157181891|FG003|Overall Study|Death|2|||
48819606|NCT02499328|157181892|FG004|Overall Study|Death|4|||
48819607|NCT02499328|157181893|FG005|Overall Study|Death|7|||
48819608|NCT02499328|157181894|FG006|Overall Study|Death|3|||
48819609|NCT02499328|157181895|FG007|Overall Study|Death|0|||
48819610|NCT02499328|157181896|FG008|Overall Study|Death|2|||
48819611|NCT02499328|157181897|FG009|Overall Study|Death|6|||
48819612|NCT02499328|157181898|FG010|Overall Study|Death|6|||
48819613|NCT02499328|157181899|FG011|Overall Study|Death|20|||
48819614|NCT02499328|157181900|FG012|Overall Study|Death|9|||
48819615|NCT02499328|157181901|FG013|Overall Study|Death|7|||
48819616|NCT02499328|157181902|FG014|Overall Study|Death|3|||
48819617|NCT02499328|157181903|FG015|Overall Study|Death|1|||
48819618|NCT02499328|157181904|FG016|Overall Study|Death|1|||
48819619|NCT02499328|157181905|FG017|Overall Study|Death|16|||
49134233|NCT02452190|158330603|FG001|Overall Study|Lost to Follow-up|3|||
49134234|NCT02452190|158330602|FG000|Overall Study|Adverse Event|2|||
49134235|NCT02452190|158330603|FG001|Overall Study|Adverse Event|5|||
49134236|NCT02452190|158330602|FG000|Overall Study|Withdrawal by Subject|20|||
49134237|NCT02452190|158330603|FG001|Overall Study|Withdrawal by Subject|11|||
49134238|NCT02452190|158330602|FG000|Overall Study|Noncompliance with study drug|1|||
49134239|NCT02452190|158330603|FG001|Overall Study|Noncompliance with study drug|0|||
49134240|NCT02452190|158330602|FG000|Overall Study|Participant traveled abroad|1|||
48819620|NCT02499328|157181906|FG018|Overall Study|Death|5|||
48819621|NCT02499328|157181888|FG000|Overall Study|"Other"|2|||
48819622|NCT02499328|157181889|FG001|Overall Study|"Other"|2|||
48819623|NCT02499328|157181890|FG002|Overall Study|"Other"|1|||
48819624|NCT02499328|157181891|FG003|Overall Study|"Other"|3|||
48819625|NCT02499328|157181892|FG004|Overall Study|"Other"|6|||
48819626|NCT02499328|157181893|FG005|Overall Study|"Other"|2|||
48819627|NCT02499328|157181894|FG006|Overall Study|"Other"|3|||
48819628|NCT02499328|157181895|FG007|Overall Study|"Other"|4|||
48819629|NCT02499328|157181896|FG008|Overall Study|"Other"|6|||
48819630|NCT02499328|157181897|FG009|Overall Study|"Other"|16|||
48819631|NCT02499328|157181898|FG010|Overall Study|"Other"|13|||
48819632|NCT02499328|157181899|FG011|Overall Study|"Other"|31|||
48819633|NCT02499328|157181900|FG012|Overall Study|"Other"|8|||
48819634|NCT02499328|157181901|FG013|Overall Study|"Other"|7|||
48819635|NCT02499328|157181902|FG014|Overall Study|"Other"|6|||
48819636|NCT02499328|157181903|FG015|Overall Study|"Other"|0|||
48819637|NCT02499328|157181904|FG016|Overall Study|"Other"|0|||
48819638|NCT02499328|157181905|FG017|Overall Study|"Other"|34|||
48819639|NCT02499328|157181906|FG018|Overall Study|"Other"|43|||
48819640|NCT02499328|157181888|FG000|Overall Study|Disease Progression|0|||
48819641|NCT02499328|157181889|FG001|Overall Study|Disease Progression|0|||
48819642|NCT02499328|157181890|FG002|Overall Study|Disease Progression|0|||
48819643|NCT02499328|157181891|FG003|Overall Study|Disease Progression|0|||
49134241|NCT02452190|158330603|FG001|Overall Study|Participant traveled abroad|0|||
49134242|NCT02452190|158330602|FG000|Overall Study|Death|0|||
49134243|NCT02452190|158330603|FG001|Overall Study|Death|1|||
49134244|NCT03839641|158330604|FG000|Overall Study|Withdrawal by Subject|1|||
48819644|NCT02499328|157181892|FG004|Overall Study|Disease Progression|0|||
48819645|NCT02499328|157181893|FG005|Overall Study|Disease Progression|0|||
48819646|NCT02499328|157181894|FG006|Overall Study|Disease Progression|1|||
48819647|NCT02499328|157181895|FG007|Overall Study|Disease Progression|0|||
48819648|NCT02499328|157181896|FG008|Overall Study|Disease Progression|1|||
48819649|NCT02499328|157181897|FG009|Overall Study|Disease Progression|0|||
48819650|NCT02499328|157181898|FG010|Overall Study|Disease Progression|1|||
49134245|NCT03839641|158330605|FG001|Overall Study|Withdrawal by Subject|1|||
49134246|NCT00390013|158330606|FG000|Phase 1|tired|0|||
49134247|NCT00390013|158330607|FG001|Phase 1|tired|0|||
49134248|NCT00390013|158330608|FG002|Phase 1|tired|0|||
49134249|NCT00390013|158330609|FG003|Phase 1|tired|1|||
49134250|NCT00390013|158330606|FG000|Phase 2 First Treatment|tired|1|||
49134251|NCT00390013|158330607|FG001|Phase 2 First Treatment|tired|0|||
49134252|NCT00390013|158330608|FG002|Phase 2 First Treatment|tired|0|||
49134253|NCT00390013|158330609|FG003|Phase 2 First Treatment|tired|0|||
49134254|NCT00390013|158330606|FG000|Phase 2 First Treatment|Withdrawal by Subject|0|||
49134255|NCT00390013|158330607|FG001|Phase 2 First Treatment|Withdrawal by Subject|1|||
49134256|NCT00390013|158330608|FG002|Phase 2 First Treatment|Withdrawal by Subject|0|||
49134257|NCT00390013|158330609|FG003|Phase 2 First Treatment|Withdrawal by Subject|0|||
49134258|NCT00374868|158330610|FG000|Overall Study|Adverse Event|12|||
49134259|NCT00374868|158330610|FG000|Overall Study|Progressive Disease|7|||
49134260|NCT00374868|158330610|FG000|Overall Study|Physician Decision|13|||
49134261|NCT00374868|158330610|FG000|Overall Study|Lost to Follow-up|1|||
49134262|NCT00374868|158330610|FG000|Overall Study|Death|2|||
49134263|NCT00374868|158330610|FG000|Overall Study|Other - Not Specified|1|||
49134264|NCT04470427|158330611|FG000|Part A: Blinded|Discontinued from Study in Part A|831|||
49134265|NCT04470427|158330612|FG001|Part A: Blinded|Discontinued from Study in Part A|548|||
49134266|NCT04470427|158330613|FG002|Part A: Blinded|Discontinued from Study in Part A|0|||
49134267|NCT04470427|158330614|FG003|Part A: Blinded|Discontinued from Study in Part A|0|||
49134268|NCT04470427|158330615|FG004|Part A: Blinded|Discontinued from Study in Part A|0|||
49134269|NCT04470427|158330616|FG005|Part A: Blinded|Discontinued from Study in Part A|0|||
48819651|NCT02499328|157181899|FG011|Overall Study|Disease Progression|0|||
48819652|NCT02499328|157181900|FG012|Overall Study|Disease Progression|0|||
48819653|NCT02499328|157181901|FG013|Overall Study|Disease Progression|0|||
48819654|NCT02499328|157181902|FG014|Overall Study|Disease Progression|0|||
49134270|NCT04470427|158330611|FG000|Part B :Open-label|Other than specified|0|||
48819655|NCT02499328|157181903|FG015|Overall Study|Disease Progression|0|||
48819656|NCT02499328|157181904|FG016|Overall Study|Disease Progression|0|||
48819657|NCT02499328|157181905|FG017|Overall Study|Disease Progression|2|||
48819658|NCT02499328|157181906|FG018|Overall Study|Disease Progression|0|||
48819659|NCT02499328|157181888|FG000|Overall Study|Adverse Event|1|||
48819660|NCT02499328|157181889|FG001|Overall Study|Adverse Event|0|||
48819661|NCT02499328|157181890|FG002|Overall Study|Adverse Event|0|||
49134271|NCT04470427|158330612|FG001|Part B :Open-label|Other than specified|0|||
49134272|NCT04470427|158330613|FG002|Part B :Open-label|Other than specified|788|||
49134273|NCT04470427|158330614|FG003|Part B :Open-label|Other than specified|0|||
49134274|NCT04470427|158330615|FG004|Part B :Open-label|Other than specified|523|||
49134275|NCT04470427|158330616|FG005|Part B :Open-label|Other than specified|0|||
49134276|NCT04470427|158330611|FG000|Part B :Open-label|Discontinued from Study in Part B|0|||
49134277|NCT04470427|158330612|FG001|Part B :Open-label|Discontinued from Study in Part B|0|||
49134278|NCT04470427|158330613|FG002|Part B :Open-label|Discontinued from Study in Part B|1576|||
49134279|NCT04470427|158330614|FG003|Part B :Open-label|Discontinued from Study in Part B|2185|||
49134280|NCT04470427|158330615|FG004|Part B :Open-label|Discontinued from Study in Part B|4490|||
49134281|NCT04470427|158330616|FG005|Part B :Open-label|Discontinued from Study in Part B|0|||
49134282|NCT04470427|158330611|FG000|Part C: Booster|Discontinued from Study in Part C|0|||
49134283|NCT04470427|158330612|FG001|Part C: Booster|Discontinued from Study in Part C|0|||
49134284|NCT04470427|158330613|FG002|Part C: Booster|Discontinued from Study in Part C|0|||
49134285|NCT04470427|158330614|FG003|Part C: Booster|Discontinued from Study in Part C|0|||
49134286|NCT04470427|158330615|FG004|Part C: Booster|Discontinued from Study in Part C|0|||
49134287|NCT04470427|158330616|FG005|Part C: Booster|Discontinued from Study in Part C|2918|||
49134288|NCT02802228|158330617|FG000|Overall Study|Withdrawal by Subject|2|||
49134289|NCT02802228|158330618|FG001|Overall Study|Withdrawal by Subject|0|||
49134290|NCT02802228|158330617|FG000|Overall Study|Lost to Follow-up|1|||
49134291|NCT02802228|158330618|FG001|Overall Study|Lost to Follow-up|0|||
49134292|NCT02802228|158330617|FG000|Overall Study|Adverse Event|1|||
49134293|NCT02802228|158330618|FG001|Overall Study|Adverse Event|0|||
49134294|NCT02802228|158330617|FG000|Overall Study|Physician Decision|1|||
49134295|NCT02802228|158330618|FG001|Overall Study|Physician Decision|0|||
49134296|NCT00724945|158330620|FG000|Period 1|non-compliance|1|||
49134297|NCT00724945|158330621|FG001|Period 1|non-compliance|0|||
49134298|NCT00724945|158330620|FG000|Period 1|Adverse Event|1|||
49134299|NCT00724945|158330621|FG001|Period 1|Adverse Event|1|||
49134300|NCT00724945|158330620|FG000|Period 1|Lost to Follow-up|1|||
49134301|NCT00724945|158330621|FG001|Period 1|Lost to Follow-up|0|||
49134302|NCT00724945|158330620|FG000|Period 2|lens comfort issue|3|||
49134303|NCT00724945|158330621|FG001|Period 2|lens comfort issue|0|||
49134304|NCT00724945|158330620|FG000|Period 2|lens physiology issue|1|||
49134305|NCT00724945|158330621|FG001|Period 2|lens physiology issue|0|||
49134306|NCT02207608|158330623|FG000|Overall Study|Adverse Event|1|||
49134307|NCT02207608|158330624|FG001|Overall Study|Adverse Event|0|||
49134308|NCT01030900|158330625|FG000|Overall Study|Not treated due to congestive heart failure|1|||
49134309|NCT01030900|158330625|FG000|Overall Study|Not treated due to rapid disease|1|||
49134310|NCT03334175|158330626|FG000|Overall Study|Lost to Follow-up|0|||
49134311|NCT03334175|158330627|FG001|Overall Study|Lost to Follow-up|1|||
49134312|NCT00632359|158330628|FG000|Overall Study|Withdrawal by Subject|2|||
49134313|NCT01695772|158330629|FG000|Overall Study|Withdrawal by Subject|18|||
49134314|NCT01695772|158330629|FG000|Overall Study|Progressive Disease|8|||
49134315|NCT01695772|158330629|FG000|Overall Study|Investigator Decision|5|||
49134316|NCT01695772|158330629|FG000|Overall Study|Lost to Follow-up|4|||
49134317|NCT01695772|158330629|FG000|Overall Study|Protocol Violation|2|||
49134318|NCT01695772|158330629|FG000|Overall Study|Unspecified Reason|1|||
49134319|NCT00753519|158332050|FG000|Overall Study|Withdrawal by Subject|0|||
49134320|NCT00753519|158332051|FG001|Overall Study|Withdrawal by Subject|2|||
49134321|NCT04591015|158332054|FG000|Overall Study|Death|6|||
49134322|NCT04591015|158332055|FG001|Overall Study|Death|4|||
49134323|NCT04591015|158332054|FG000|Overall Study|Withdrawal by Subject|6|||
49134324|NCT04591015|158332055|FG001|Overall Study|Withdrawal by Subject|3|||
49134325|NCT04591015|158332054|FG000|Overall Study|Lost to Follow-up|16|||
49134326|NCT04591015|158332055|FG001|Overall Study|Lost to Follow-up|11|||
49134327|NCT02194465|158332056|FG000|Overall Study|Adverse Event|6|||
49134328|NCT02194465|158332057|FG001|Overall Study|Adverse Event|1|||
49134329|NCT02194465|158332058|FG002|Overall Study|Adverse Event|4|||
49134330|NCT02194465|158332059|FG003|Overall Study|Adverse Event|4|||
49134331|NCT02194465|158332060|FG004|Overall Study|Adverse Event|4|||
49134332|NCT02194465|158332061|FG005|Overall Study|Adverse Event|2|||
49134333|NCT02194465|158332062|FG006|Overall Study|Adverse Event|0|||
49134334|NCT02194465|158332056|FG000|Overall Study|Lost to Follow-up|0|||
49134335|NCT02194465|158332057|FG001|Overall Study|Lost to Follow-up|0|||
49134336|NCT02194465|158332058|FG002|Overall Study|Lost to Follow-up|0|||
49134337|NCT02194465|158332059|FG003|Overall Study|Lost to Follow-up|1|||
49134338|NCT02194465|158332060|FG004|Overall Study|Lost to Follow-up|0|||
49134339|NCT02194465|158332061|FG005|Overall Study|Lost to Follow-up|1|||
49134340|NCT02194465|158332062|FG006|Overall Study|Lost to Follow-up|0|||
49134341|NCT02194465|158332056|FG000|Overall Study|Physician Decision|1|||
49134342|NCT02194465|158332057|FG001|Overall Study|Physician Decision|0|||
49134343|NCT02194465|158332058|FG002|Overall Study|Physician Decision|0|||
49134344|NCT02194465|158332059|FG003|Overall Study|Physician Decision|0|||
49134345|NCT02194465|158332060|FG004|Overall Study|Physician Decision|0|||
49134346|NCT02194465|158332061|FG005|Overall Study|Physician Decision|0|||
49134347|NCT02194465|158332062|FG006|Overall Study|Physician Decision|0|||
48819662|NCT02499328|157181891|FG003|Overall Study|Adverse Event|1|||
48819663|NCT02499328|157181892|FG004|Overall Study|Adverse Event|0|||
48819664|NCT02499328|157181893|FG005|Overall Study|Adverse Event|0|||
48819665|NCT02499328|157181894|FG006|Overall Study|Adverse Event|0|||
49134348|NCT02194465|158332056|FG000|Overall Study|Protocol Violation|1|||
49134349|NCT02194465|158332057|FG001|Overall Study|Protocol Violation|1|||
49134350|NCT02194465|158332058|FG002|Overall Study|Protocol Violation|2|||
49134351|NCT02194465|158332059|FG003|Overall Study|Protocol Violation|1|||
49134352|NCT02194465|158332060|FG004|Overall Study|Protocol Violation|1|||
49134353|NCT02194465|158332061|FG005|Overall Study|Protocol Violation|0|||
49134354|NCT02194465|158332062|FG006|Overall Study|Protocol Violation|0|||
49134355|NCT02194465|158332056|FG000|Overall Study|Withdrawal by Subject|1|||
49134356|NCT02194465|158332057|FG001|Overall Study|Withdrawal by Subject|3|||
49134357|NCT02194465|158332058|FG002|Overall Study|Withdrawal by Subject|1|||
49134358|NCT02194465|158332059|FG003|Overall Study|Withdrawal by Subject|2|||
49134359|NCT02194465|158332060|FG004|Overall Study|Withdrawal by Subject|2|||
49134360|NCT02194465|158332061|FG005|Overall Study|Withdrawal by Subject|1|||
49134361|NCT02194465|158332062|FG006|Overall Study|Withdrawal by Subject|2|||
49134362|NCT02194465|158332056|FG000|Overall Study|Discontinued follow-up period|0|||
49134363|NCT02194465|158332057|FG001|Overall Study|Discontinued follow-up period|2|||
49134364|NCT02194465|158332058|FG002|Overall Study|Discontinued follow-up period|1|||
49134365|NCT02194465|158332059|FG003|Overall Study|Discontinued follow-up period|0|||
49134366|NCT02194465|158332060|FG004|Overall Study|Discontinued follow-up period|2|||
49134367|NCT02194465|158332061|FG005|Overall Study|Discontinued follow-up period|0|||
49134368|NCT02194465|158332062|FG006|Overall Study|Discontinued follow-up period|0|||
49134369|NCT00903968|158332063|FG000|Overall Study|Adverse Event|0|||
49134370|NCT00903968|158332064|FG001|Overall Study|Adverse Event|0|||
49134371|NCT00903968|158332065|FG002|Overall Study|Adverse Event|0|||
49134372|NCT00903968|158332066|FG003|Overall Study|Adverse Event|0|||
49134373|NCT00903968|158332067|FG004|Overall Study|Adverse Event|0|||
49134374|NCT00903968|158332068|FG005|Overall Study|Adverse Event|0|||
49134375|NCT00903968|158332069|FG006|Overall Study|Adverse Event|1|||
49134376|NCT00903968|158332070|FG007|Overall Study|Adverse Event|8|||
49134377|NCT00903968|158332063|FG000|Overall Study|DLT|0|||
49134378|NCT00903968|158332064|FG001|Overall Study|DLT|0|||
49134379|NCT00903968|158332065|FG002|Overall Study|DLT|0|||
49134380|NCT00903968|158332066|FG003|Overall Study|DLT|0|||
49134381|NCT00903968|158332067|FG004|Overall Study|DLT|0|||
49134382|NCT00903968|158332068|FG005|Overall Study|DLT|0|||
49134383|NCT00903968|158332069|FG006|Overall Study|DLT|2|||
49134384|NCT00903968|158332070|FG007|Overall Study|DLT|0|||
49134385|NCT00903968|158332063|FG000|Overall Study|Withdrawal by Subject|1|||
49134386|NCT00903968|158332064|FG001|Overall Study|Withdrawal by Subject|0|||
49134387|NCT00903968|158332065|FG002|Overall Study|Withdrawal by Subject|1|||
49134388|NCT00903968|158332066|FG003|Overall Study|Withdrawal by Subject|0|||
49134389|NCT00903968|158332067|FG004|Overall Study|Withdrawal by Subject|1|||
49134390|NCT00903968|158332068|FG005|Overall Study|Withdrawal by Subject|1|||
49134391|NCT00903968|158332069|FG006|Overall Study|Withdrawal by Subject|0|||
49134392|NCT00903968|158332070|FG007|Overall Study|Withdrawal by Subject|4|||
49134393|NCT00903968|158332063|FG000|Overall Study|Non-Compliance|0|||
49134394|NCT00903968|158332064|FG001|Overall Study|Non-Compliance|0|||
49134395|NCT00903968|158332065|FG002|Overall Study|Non-Compliance|0|||
49134396|NCT00903968|158332066|FG003|Overall Study|Non-Compliance|0|||
49134397|NCT00903968|158332067|FG004|Overall Study|Non-Compliance|0|||
49134398|NCT00903968|158332068|FG005|Overall Study|Non-Compliance|1|||
49134399|NCT00903968|158332069|FG006|Overall Study|Non-Compliance|0|||
49134400|NCT00903968|158332070|FG007|Overall Study|Non-Compliance|0|||
49134401|NCT00903968|158332063|FG000|Overall Study|Physician Decision|0|||
49134402|NCT00903968|158332064|FG001|Overall Study|Physician Decision|0|||
49134403|NCT00903968|158332065|FG002|Overall Study|Physician Decision|0|||
49134404|NCT00903968|158332066|FG003|Overall Study|Physician Decision|0|||
49134405|NCT00903968|158332067|FG004|Overall Study|Physician Decision|0|||
49134406|NCT00903968|158332068|FG005|Overall Study|Physician Decision|1|||
49134407|NCT00903968|158332069|FG006|Overall Study|Physician Decision|0|||
49134408|NCT00903968|158332070|FG007|Overall Study|Physician Decision|0|||
49134409|NCT00903968|158332063|FG000|Overall Study|Progressive Disease|2|||
49134410|NCT00903968|158332064|FG001|Overall Study|Progressive Disease|3|||
49134411|NCT00903968|158332065|FG002|Overall Study|Progressive Disease|2|||
49134412|NCT00903968|158332066|FG003|Overall Study|Progressive Disease|3|||
49134413|NCT00903968|158332067|FG004|Overall Study|Progressive Disease|3|||
49134414|NCT00903968|158332068|FG005|Overall Study|Progressive Disease|3|||
49134415|NCT00903968|158332069|FG006|Overall Study|Progressive Disease|0|||
48819666|NCT02499328|157181895|FG007|Overall Study|Adverse Event|0|||
49134416|NCT00903968|158332070|FG007|Overall Study|Progressive Disease|18|||
49134417|NCT00903968|158332063|FG000|Overall Study|Lack of Efficacy|0|||
49134418|NCT00903968|158332064|FG001|Overall Study|Lack of Efficacy|0|||
49134419|NCT00903968|158332065|FG002|Overall Study|Lack of Efficacy|0|||
49134420|NCT00903968|158332066|FG003|Overall Study|Lack of Efficacy|0|||
49134421|NCT00903968|158332067|FG004|Overall Study|Lack of Efficacy|0|||
49134422|NCT00903968|158332068|FG005|Overall Study|Lack of Efficacy|0|||
48819667|NCT02499328|157181896|FG008|Overall Study|Adverse Event|0|||
48819668|NCT02499328|157181897|FG009|Overall Study|Adverse Event|0|||
48819669|NCT02499328|157181898|FG010|Overall Study|Adverse Event|0|||
48819670|NCT02499328|157181899|FG011|Overall Study|Adverse Event|0|||
49134423|NCT00903968|158332069|FG006|Overall Study|Lack of Efficacy|0|||
49134424|NCT00903968|158332070|FG007|Overall Study|Lack of Efficacy|3|||
49134425|NCT03738696|158332071|FG000|Overall Study|Withdrawal by Subject|0|||
49134426|NCT03738696|158332072|FG001|Overall Study|Withdrawal by Subject|1|||
49134427|NCT03738696|158332071|FG000|Overall Study|Lost to Follow-up|8|||
49134428|NCT03738696|158332072|FG001|Overall Study|Lost to Follow-up|14|||
49134429|NCT01294514|158332075|FG000|Overall Study|Excluded due to Arrhythmia|1|||
49134430|NCT01572792|158332078|FG000|Lead-in Study|Lost to Follow-up|5|||
48819671|NCT02499328|157181900|FG012|Overall Study|Adverse Event|1|||
48819672|NCT02499328|157181901|FG013|Overall Study|Adverse Event|0|||
48819673|NCT02499328|157181902|FG014|Overall Study|Adverse Event|0|||
48819674|NCT02499328|157181903|FG015|Overall Study|Adverse Event|0|||
48819675|NCT02499328|157181904|FG016|Overall Study|Adverse Event|0|||
49134431|NCT01572792|158332079|FG001|Lead-in Study|Lost to Follow-up|9|||
49134432|NCT01572792|158332080|FG002|Lead-in Study|Lost to Follow-up|4|||
49134433|NCT01572792|158332081|FG003|Lead-in Study|Lost to Follow-up|2|||
49134434|NCT01572792|158332082|FG004|Lead-in Study|Lost to Follow-up|4|||
49134435|NCT01572792|158332078|FG000|Lead-in Study|Withdrawal by Subject|22|||
49134436|NCT01572792|158332079|FG001|Lead-in Study|Withdrawal by Subject|11|||
49134437|NCT01572792|158332080|FG002|Lead-in Study|Withdrawal by Subject|12|||
49134438|NCT01572792|158332081|FG003|Lead-in Study|Withdrawal by Subject|24|||
49134439|NCT01572792|158332082|FG004|Lead-in Study|Withdrawal by Subject|11|||
49134440|NCT01572792|158332078|FG000|Lead-in Study|Protocol Violation|19|||
49134441|NCT01572792|158332079|FG001|Lead-in Study|Protocol Violation|10|||
49134442|NCT01572792|158332080|FG002|Lead-in Study|Protocol Violation|12|||
49134443|NCT01572792|158332081|FG003|Lead-in Study|Protocol Violation|13|||
49134444|NCT01572792|158332082|FG004|Lead-in Study|Protocol Violation|21|||
49134445|NCT01572792|158332078|FG000|Lead-in Study|Lack of Efficacy|20|||
49134446|NCT01572792|158332079|FG001|Lead-in Study|Lack of Efficacy|5|||
49134447|NCT01572792|158332080|FG002|Lead-in Study|Lack of Efficacy|4|||
49134448|NCT01572792|158332081|FG003|Lead-in Study|Lack of Efficacy|8|||
49134449|NCT01572792|158332082|FG004|Lead-in Study|Lack of Efficacy|10|||
49134450|NCT01572792|158332078|FG000|Lead-in Study|Adverse Event|21|||
49134451|NCT01572792|158332079|FG001|Lead-in Study|Adverse Event|21|||
49134452|NCT01572792|158332080|FG002|Lead-in Study|Adverse Event|22|||
49134453|NCT01572792|158332081|FG003|Lead-in Study|Adverse Event|16|||
49134454|NCT01572792|158332082|FG004|Lead-in Study|Adverse Event|14|||
49134455|NCT01572792|158332078|FG000|Lead-in Study|Site termination/COPD exacerbation/other|14|||
49134456|NCT01572792|158332079|FG001|Lead-in Study|Site termination/COPD exacerbation/other|10|||
49134457|NCT01572792|158332080|FG002|Lead-in Study|Site termination/COPD exacerbation/other|8|||
49134458|NCT01572792|158332081|FG003|Lead-in Study|Site termination/COPD exacerbation/other|9|||
49134459|NCT01572792|158332082|FG004|Lead-in Study|Site termination/COPD exacerbation/other|9|||
49134460|NCT01572792|158332078|FG000|Extension Study|Lost to Follow-up|6|||
49134461|NCT01572792|158332079|FG001|Extension Study|Lost to Follow-up|2|||
49134462|NCT01572792|158332080|FG002|Extension Study|Lost to Follow-up|0|||
49134463|NCT01572792|158332081|FG003|Extension Study|Lost to Follow-up|3|||
49134464|NCT01572792|158332082|FG004|Extension Study|Lost to Follow-up|3|||
49134465|NCT01572792|158332078|FG000|Extension Study|Withdrawal by Subject|7|||
49134466|NCT01572792|158332079|FG001|Extension Study|Withdrawal by Subject|6|||
49134467|NCT01572792|158332080|FG002|Extension Study|Withdrawal by Subject|11|||
49134468|NCT01572792|158332081|FG003|Extension Study|Withdrawal by Subject|8|||
49134469|NCT01572792|158332082|FG004|Extension Study|Withdrawal by Subject|14|||
49134470|NCT01572792|158332078|FG000|Extension Study|Protocol Violation|0|||
49134471|NCT01572792|158332079|FG001|Extension Study|Protocol Violation|4|||
49134472|NCT01572792|158332080|FG002|Extension Study|Protocol Violation|3|||
49134473|NCT01572792|158332081|FG003|Extension Study|Protocol Violation|4|||
49134474|NCT01572792|158332082|FG004|Extension Study|Protocol Violation|3|||
49134475|NCT01572792|158332078|FG000|Extension Study|Lack of Efficacy|2|||
49134476|NCT01572792|158332079|FG001|Extension Study|Lack of Efficacy|3|||
49134477|NCT01572792|158332080|FG002|Extension Study|Lack of Efficacy|3|||
49134478|NCT01572792|158332081|FG003|Extension Study|Lack of Efficacy|2|||
49134479|NCT01572792|158332082|FG004|Extension Study|Lack of Efficacy|2|||
49134480|NCT01572792|158332078|FG000|Extension Study|Adverse Event|7|||
49134481|NCT01572792|158332079|FG001|Extension Study|Adverse Event|6|||
49134482|NCT01572792|158332080|FG002|Extension Study|Adverse Event|5|||
49134483|NCT01572792|158332081|FG003|Extension Study|Adverse Event|6|||
49134484|NCT01572792|158332082|FG004|Extension Study|Adverse Event|4|||
48819676|NCT02499328|157181905|FG017|Overall Study|Adverse Event|0|||
48819677|NCT02499328|157181906|FG018|Overall Study|Adverse Event|0|||
49134485|NCT01572792|158332078|FG000|Extension Study|Site termination/COPD exacerbation/other|3|||
49134486|NCT01572792|158332079|FG001|Extension Study|Site termination/COPD exacerbation/other|8|||
49134487|NCT01572792|158332080|FG002|Extension Study|Site termination/COPD exacerbation/other|4|||
49134488|NCT01572792|158332081|FG003|Extension Study|Site termination/COPD exacerbation/other|6|||
48819678|NCT04214418|157181932|FG000|Overall Study|Withdrawal by Subject|1|||
48819679|NCT04214418|157181933|FG001|Overall Study|Withdrawal by Subject|0|||
48819680|NCT04214418|157181934|FG002|Overall Study|Withdrawal by Subject|0|||
48819681|NCT04214418|157181935|FG003|Overall Study|Withdrawal by Subject|0|||
48819682|NCT04214418|157181936|FG004|Overall Study|Withdrawal by Subject|0|||
48819683|NCT04214418|157181937|FG005|Overall Study|Withdrawal by Subject|0|||
48819684|NCT04214418|157181932|FG000|Overall Study|Adverse Event|0|||
48819685|NCT04214418|157181933|FG001|Overall Study|Adverse Event|2|||
48819686|NCT04214418|157181934|FG002|Overall Study|Adverse Event|0|||
48819687|NCT04214418|157181935|FG003|Overall Study|Adverse Event|0|||
48819688|NCT04214418|157181936|FG004|Overall Study|Adverse Event|0|||
48819689|NCT04214418|157181937|FG005|Overall Study|Adverse Event|0|||
48819690|NCT04214418|157181932|FG000|Overall Study|Death|1|||
48819691|NCT04214418|157181933|FG001|Overall Study|Death|0|||
48819692|NCT04214418|157181934|FG002|Overall Study|Death|0|||
48819693|NCT04214418|157181935|FG003|Overall Study|Death|0|||
48819694|NCT04214418|157181936|FG004|Overall Study|Death|0|||
48819695|NCT04214418|157181937|FG005|Overall Study|Death|0|||
48819696|NCT00802737|157183570|FG000|Overall Study|Withdrawn due to Disease Progression|9|||
48819697|NCT00802737|157183571|FG001|Overall Study|Withdrawn due to Disease Progression|3|||
48819698|NCT00802737|157183572|FG002|Overall Study|Withdrawn due to Disease Progression|0|||
49134489|NCT01572792|158332082|FG004|Extension Study|Site termination/COPD exacerbation/other|6|||
49134490|NCT02101294|158332083|FG000|Overall Study|Withdrawal by Subject|5|||
49134491|NCT02101294|158332083|FG000|Overall Study|Lost to Follow-up|6|||
49134492|NCT03416179|158332084|FG000|Overall Study|Death|90|||
49134493|NCT03416179|158332085|FG001|Overall Study|Death|87|||
49134494|NCT03416179|158332086|FG002|Overall Study|Death|117|||
49134495|NCT03416179|158332087|FG003|Overall Study|Death|113|||
49134496|NCT03416179|158332084|FG000|Overall Study|Withdrawal by Subject|15|||
49134497|NCT03416179|158332085|FG001|Overall Study|Withdrawal by Subject|20|||
49134498|NCT03416179|158332086|FG002|Overall Study|Withdrawal by Subject|6|||
49134499|NCT03416179|158332087|FG003|Overall Study|Withdrawal by Subject|9|||
49134500|NCT03416179|158332084|FG000|Overall Study|Lost to Follow-up|1|||
49134501|NCT03416179|158332085|FG001|Overall Study|Lost to Follow-up|1|||
49134502|NCT03416179|158332086|FG002|Overall Study|Lost to Follow-up|0|||
49134503|NCT03416179|158332087|FG003|Overall Study|Lost to Follow-up|3|||
49134504|NCT03416179|158332084|FG000|Overall Study|Study participation terminated by Sponsor|93|||
49134505|NCT03416179|158332085|FG001|Overall Study|Study participation terminated by Sponsor|91|||
49134506|NCT03416179|158332086|FG002|Overall Study|Study participation terminated by Sponsor|26|||
49134507|NCT03416179|158332087|FG003|Overall Study|Study participation terminated by Sponsor|31|||
49134508|NCT03416179|158332084|FG000|Overall Study|Other|2|||
49134509|NCT03416179|158332085|FG001|Overall Study|Other|3|||
49134510|NCT03416179|158332086|FG002|Overall Study|Other|1|||
49134511|NCT03416179|158332087|FG003|Overall Study|Other|0|||
49134512|NCT02311478|158332091|FG000|Overall Study|Withdrawal by Subject|1|||
49134513|NCT02311478|158332091|FG000|Overall Study|Lost to Follow-up|5|||
49134514|NCT02311478|158332091|FG000|Overall Study|Failed IUD Insertion|1|||
49134515|NCT02225587|158332094|FG000|Overall Study|Adverse Event|5|||
49134516|NCT02225587|158332095|FG001|Overall Study|Adverse Event|5|||
49134517|NCT02225587|158332094|FG000|Overall Study|Lost to Follow-up|5|||
49134518|NCT02225587|158332095|FG001|Overall Study|Lost to Follow-up|5|||
49134519|NCT02225587|158332094|FG000|Overall Study|Non-Compliance With Study Drug|1|||
49134520|NCT02225587|158332095|FG001|Overall Study|Non-Compliance With Study Drug|0|||
49134521|NCT02225587|158332094|FG000|Overall Study|Physician Decision|2|||
49134522|NCT02225587|158332095|FG001|Overall Study|Physician Decision|0|||
49134523|NCT02225587|158332094|FG000|Overall Study|Protocol Violation|1|||
49134524|NCT02225587|158332095|FG001|Overall Study|Protocol Violation|0|||
49134525|NCT02225587|158332094|FG000|Overall Study|Participant Moved|1|||
49134526|NCT02225587|158332095|FG001|Overall Study|Participant Moved|0|||
49134527|NCT02225587|158332094|FG000|Overall Study|Withdrawal by Subject|13|||
49134528|NCT02225587|158332095|FG001|Overall Study|Withdrawal by Subject|28|||
49134529|NCT01925794|158332098|FG000|180 Days|Death|2|||
49134530|NCT01925794|158332098|FG000|180 Days|Withdrawal by Subject|2|||
49134531|NCT01925794|158332098|FG000|270 Days|Death|2|||
49134532|NCT01925794|158332098|FG000|270 Days|Protocol Violation|3|||
48819699|NCT00802737|157183570|FG000|Overall Study|Death|6|||
48819700|NCT00802737|157183571|FG001|Overall Study|Death|5|||
48819701|NCT00802737|157183572|FG002|Overall Study|Death|1|||
48819702|NCT00802737|157183570|FG000|Overall Study|Adverse Event|1|||
48819703|NCT00802737|157183571|FG001|Overall Study|Adverse Event|0|||
49134533|NCT05073315|158332101|FG000|Period 1 (Lead-in Period)|Adverse Event|6|||
49134534|NCT05073315|158332102|FG001|Period 1 (Lead-in Period)|Adverse Event|0|||
49134535|NCT05073315|158332103|FG002|Period 1 (Lead-in Period)|Adverse Event|0|||
48819704|NCT00802737|157183572|FG002|Overall Study|Adverse Event|0|||
48819705|NCT00802737|157183570|FG000|Overall Study|Received Prohibited Therapy|1|||
49134536|NCT05073315|158332101|FG000|Period 1 (Lead-in Period)|Death|1|||
49134537|NCT05073315|158332102|FG001|Period 1 (Lead-in Period)|Death|0|||
49134538|NCT05073315|158332103|FG002|Period 1 (Lead-in Period)|Death|0|||
49134539|NCT05073315|158332101|FG000|Period 1 (Lead-in Period)|Withdrawal by Subject|6|||
49134540|NCT05073315|158332102|FG001|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
49134541|NCT05073315|158332103|FG002|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
49134542|NCT05073315|158332101|FG000|Period 1 (Lead-in Period)|Lost to Follow-up|3|||
49134543|NCT05073315|158332102|FG001|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
49134544|NCT05073315|158332103|FG002|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
49134545|NCT05073315|158332101|FG000|Period 1 (Lead-in Period)|Protocol Violation|5|||
49134546|NCT05073315|158332102|FG001|Period 1 (Lead-in Period)|Protocol Violation|0|||
48724988|NCT05140382|156842119|FG002|Overall Study|Investigator decision|0|||
48724989|NCT05140382|156842117|FG000|Overall Study|Other|4|||
48724990|NCT05140382|156842118|FG001|Overall Study|Other|0|||
48724991|NCT05140382|156842119|FG002|Overall Study|Other|1|||
48724992|NCT05140382|156842117|FG000|Overall Study|Progressive disease|20|||
48724993|NCT05140382|156842118|FG001|Overall Study|Progressive disease|1|||
48724994|NCT05140382|156842119|FG002|Overall Study|Progressive disease|12|||
48724995|NCT05140382|156842117|FG000|Overall Study|Subjective disease progression|2|||
48724996|NCT05140382|156842118|FG001|Overall Study|Subjective disease progression|1|||
48724997|NCT05140382|156842119|FG002|Overall Study|Subjective disease progression|0|||
48724998|NCT05140382|156842117|FG000|Overall Study|Unknown at data cut-off|0|||
48724999|NCT05140382|156842118|FG001|Overall Study|Unknown at data cut-off|0|||
48725000|NCT05140382|156842119|FG002|Overall Study|Unknown at data cut-off|1|||
48725001|NCT05140382|156842117|FG000|Overall Study|Withdrawal by Subject|1|||
48725002|NCT05140382|156842118|FG001|Overall Study|Withdrawal by Subject|0|||
48725003|NCT05140382|156842119|FG002|Overall Study|Withdrawal by Subject|4|||
48725004|NCT05140382|156842117|FG000|Overall Study|Withdrawal of consent|0|||
48725005|NCT05140382|156842118|FG001|Overall Study|Withdrawal of consent|0|||
48725006|NCT05140382|156842119|FG002|Overall Study|Withdrawal of consent|1|||
48725007|NCT02782949|156842120|FG000|Overall Study|Protocol Violation|1|||
48725008|NCT02782949|156842121|FG001|Overall Study|Protocol Violation|0|||
48725009|NCT02782949|156842120|FG000|Overall Study|Withdrawal by Subject|0|||
48725010|NCT02782949|156842121|FG001|Overall Study|Withdrawal by Subject|1|||
48725011|NCT03287635|156842123|FG000|Overall Study|Lost to Follow-up|5|||
48725012|NCT03287635|156842123|FG000|Overall Study|Withdrawal by Subject|1|||
48725013|NCT03287635|156842123|FG000|Overall Study|Physician Decision|1|||
48725014|NCT03641560|156842124|FG000|Overall Study|Withdrawal by Subject|6|||
48725015|NCT03641560|156842124|FG000|Overall Study|Progressive disease|40|||
48725016|NCT03641560|156842124|FG000|Overall Study|Death|6|||
48725017|NCT03269552|156843128|FG000|Overall Study|Adverse Event|2|||
48725018|NCT02616601|156843129|FG000|Overall Study|Withdrawal by Subject|4|||
48725019|NCT02616601|156843130|FG001|Overall Study|Withdrawal by Subject|4|||
48725020|NCT02616601|156843131|FG002|Overall Study|Withdrawal by Subject|3|||
48725021|NCT02616601|156843129|FG000|Overall Study|Adverse Event|2|||
48725022|NCT02616601|156843130|FG001|Overall Study|Adverse Event|0|||
48725023|NCT02616601|156843131|FG002|Overall Study|Adverse Event|2|||
48725024|NCT02616601|156843129|FG000|Overall Study|Death|1|||
48725025|NCT02616601|156843130|FG001|Overall Study|Death|0|||
48725026|NCT02616601|156843131|FG002|Overall Study|Death|0|||
48725027|NCT02616601|156843129|FG000|Overall Study|Lost to Follow-up|1|||
48725028|NCT02616601|156843130|FG001|Overall Study|Lost to Follow-up|0|||
48725029|NCT02616601|156843131|FG002|Overall Study|Lost to Follow-up|1|||
48725030|NCT02616601|156843129|FG000|Overall Study|Non-Compliance with Test Article|1|||
48725031|NCT02616601|156843130|FG001|Overall Study|Non-Compliance with Test Article|0|||
48725032|NCT02616601|156843131|FG002|Overall Study|Non-Compliance with Test Article|1|||
48725033|NCT02446743|156843132|FG000|Overall Study|Withdrawal by Subject|1|||
48725034|NCT02446743|156843133|FG001|Overall Study|Withdrawal by Subject|1|||
48725035|NCT02446743|156843132|FG000|Overall Study|Lost to Follow-up|1|||
48725036|NCT02446743|156843133|FG001|Overall Study|Lost to Follow-up|0|||
48725037|NCT02446743|156843132|FG000|Overall Study|Adverse Event|1|||
48725038|NCT02446743|156843133|FG001|Overall Study|Adverse Event|1|||
48725039|NCT02446743|156843132|FG000|Overall Study|Other|2|||
48725040|NCT02446743|156843133|FG001|Overall Study|Other|3|||
48725041|NCT00371761|156843134|FG000|Overall Study|Adverse Event|1|||
48725042|NCT00371761|156843135|FG001|Overall Study|Adverse Event|1|||
48725043|NCT00371761|156843134|FG000|Overall Study|Withdrawal by Subject|1|||
48725044|NCT00371761|156843135|FG001|Overall Study|Withdrawal by Subject|3|||
48921035|NCT00784654|157544820|FG002|Randomized Withdrawal Period|Did not complete a visit|0|||
48921036|NCT00784654|157544818|FG000|Randomized Withdrawal Period|Family reasons|0|||
49134547|NCT05073315|158332103|FG002|Period 1 (Lead-in Period)|Protocol Violation|0|||
49134548|NCT05073315|158332101|FG000|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|23|||
49134549|NCT05073315|158332102|FG001|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
49134550|NCT05073315|158332103|FG002|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
49134551|NCT05073315|158332101|FG000|Period 1 (Lead-in Period)|Lack of Efficacy|1|||
49134552|NCT05073315|158332102|FG001|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
49134553|NCT05073315|158332103|FG002|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
49134554|NCT05073315|158332101|FG000|Period 2|Adverse Event|0|||
49134555|NCT05073315|158332102|FG001|Period 2|Adverse Event|3|||
49134556|NCT05073315|158332103|FG002|Period 2|Adverse Event|6|||
49134557|NCT05073315|158332101|FG000|Period 2|Lost to Follow-up|0|||
48725045|NCT00371761|156843134|FG000|Overall Study|Investigator Judgment|2|||
48725046|NCT00371761|156843135|FG001|Overall Study|Investigator Judgment|3|||
48725047|NCT00371761|156843134|FG000|Overall Study|Study termination|4|||
48725048|NCT00371761|156843135|FG001|Overall Study|Study termination|3|||
48725049|NCT02478398|156843136|FG000|Overall Study|Adverse Event|20|||
48725050|NCT02478398|156843137|FG001|Overall Study|Adverse Event|5|||
48725051|NCT02478398|156843136|FG000|Overall Study|Lost to Follow-up|5|||
48725052|NCT02478398|156843137|FG001|Overall Study|Lost to Follow-up|4|||
48725053|NCT02478398|156843136|FG000|Overall Study|Non-Compliance With Study Drug|5|||
48725054|NCT02478398|156843137|FG001|Overall Study|Non-Compliance With Study Drug|1|||
48725055|NCT02478398|156843136|FG000|Overall Study|Protocol Violation|3|||
48725056|NCT02478398|156843137|FG001|Overall Study|Protocol Violation|1|||
48725057|NCT02478398|156843136|FG000|Overall Study|Withdrawal By Parent/Guardian|9|||
48725058|NCT02478398|156843137|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
48725059|NCT02478398|156843136|FG000|Overall Study|Withdrawal By Participant|10|||
48725060|NCT02478398|156843137|FG001|Overall Study|Withdrawal By Participant|4|||
48725061|NCT03828370|156843138|FG000|3 Month Follow-up|Lost to Follow-up|4|||
48725062|NCT03828370|156843139|FG001|3 Month Follow-up|Lost to Follow-up|12|||
48725063|NCT03828370|156843138|FG000|9 Month Follow up|Lost to Follow-up|12|||
48725064|NCT03828370|156843139|FG001|9 Month Follow up|Lost to Follow-up|20|||
48725065|NCT01155479|156843142|FG000|Part I|Adverse Event|13|||
48725066|NCT01155479|156843143|FG001|Part I|Adverse Event|8|||
48725067|NCT01155479|156843144|FG002|Part I|Adverse Event|18|||
48725068|NCT01155479|156843145|FG003|Part I|Adverse Event|7|||
48725069|NCT01155479|156843146|FG004|Part I|Adverse Event|6|||
48725070|NCT01155479|156843142|FG000|Part I|Administrative|2|||
48725071|NCT01155479|156843143|FG001|Part I|Administrative|2|||
48725072|NCT01155479|156843144|FG002|Part I|Administrative|2|||
48725073|NCT01155479|156843145|FG003|Part I|Administrative|0|||
48725074|NCT01155479|156843146|FG004|Part I|Administrative|0|||
48725075|NCT01155479|156843142|FG000|Part I|Did Not Meet Protocol Eligibility|3|||
48725076|NCT01155479|156843143|FG001|Part I|Did Not Meet Protocol Eligibility|1|||
48725077|NCT01155479|156843144|FG002|Part I|Did Not Meet Protocol Eligibility|2|||
48725078|NCT01155479|156843145|FG003|Part I|Did Not Meet Protocol Eligibility|1|||
48725079|NCT01155479|156843146|FG004|Part I|Did Not Meet Protocol Eligibility|3|||
48725080|NCT01155479|156843142|FG000|Part I|Withdrawal by Subject|11|||
48725081|NCT01155479|156843143|FG001|Part I|Withdrawal by Subject|13|||
48725082|NCT01155479|156843144|FG002|Part I|Withdrawal by Subject|8|||
48725083|NCT01155479|156843145|FG003|Part I|Withdrawal by Subject|8|||
48725084|NCT01155479|156843146|FG004|Part I|Withdrawal by Subject|9|||
48725085|NCT01155479|156843142|FG000|Part I|Lost to Follow-up|0|||
48725086|NCT01155479|156843143|FG001|Part I|Lost to Follow-up|0|||
48725087|NCT01155479|156843144|FG002|Part I|Lost to Follow-up|1|||
48725088|NCT01155479|156843145|FG003|Part I|Lost to Follow-up|1|||
48725089|NCT01155479|156843146|FG004|Part I|Lost to Follow-up|0|||
48819706|NCT00802737|157183571|FG001|Overall Study|Received Prohibited Therapy|0|||
48819707|NCT00802737|157183572|FG002|Overall Study|Received Prohibited Therapy|0|||
48819708|NCT00802737|157183570|FG000|Overall Study|Ongoing CLL-Treatment|0|||
48819709|NCT00802737|157183571|FG001|Overall Study|Ongoing CLL-Treatment|1|||
48819710|NCT00802737|157183572|FG002|Overall Study|Ongoing CLL-Treatment|0|||
48819711|NCT00802737|157183570|FG000|Overall Study|Participant too Unwell|0|||
48725090|NCT01155479|156843142|FG000|Part I|Treatment Failure|3|||
48725091|NCT01155479|156843143|FG001|Part I|Treatment Failure|0|||
48725092|NCT01155479|156843144|FG002|Part I|Treatment Failure|3|||
48725093|NCT01155479|156843145|FG003|Part I|Treatment Failure|1|||
48725094|NCT01155479|156843146|FG004|Part I|Treatment Failure|2|||
48725095|NCT01155479|156843142|FG000|Part I|Did Not Receive Treatment|4|||
48725096|NCT01155479|156843143|FG001|Part I|Did Not Receive Treatment|2|||
48725097|NCT01155479|156843144|FG002|Part I|Did Not Receive Treatment|2|||
48725098|NCT01155479|156843145|FG003|Part I|Did Not Receive Treatment|6|||
48725099|NCT01155479|156843146|FG004|Part I|Did Not Receive Treatment|1|||
48725100|NCT01155479|156843142|FG000|Part I|Non-Compliance with Protocol|2|||
48725101|NCT01155479|156843143|FG001|Part I|Non-Compliance with Protocol|1|||
48725102|NCT01155479|156843144|FG002|Part I|Non-Compliance with Protocol|3|||
48725103|NCT01155479|156843145|FG003|Part I|Non-Compliance with Protocol|3|||
48725104|NCT01155479|156843146|FG004|Part I|Non-Compliance with Protocol|2|||
48725105|NCT01155479|156843142|FG000|Part II|Adverse Event|7|||
48725106|NCT01155479|156843143|FG001|Part II|Adverse Event|6|||
48819712|NCT00802737|157183571|FG001|Overall Study|Participant too Unwell|2|||
48819713|NCT00802737|157183572|FG002|Overall Study|Participant too Unwell|0|||
48819714|NCT04714216|157183573|FG000|Overall Study|Did not initiate AID due to CGM inaccuracies|2|||
48819715|NCT04714216|157183573|FG000|Overall Study|Discharged prior to 48 hours of AID|2|||
48819716|NCT01625910|157183575|FG000|Overall Study|Lost to Follow-up|3|||
48819717|NCT01625910|157183576|FG001|Overall Study|Lost to Follow-up|4|||
48819718|NCT02176928|157183577|FG000|Overall Study|Lost to Follow-up|2|||
48819719|NCT02176928|157183578|FG001|Overall Study|Lost to Follow-up|4|||
48819720|NCT02268396|157183583|FG000|Overall Study|Adverse Event|3|||
48819721|NCT02268396|157183583|FG000|Overall Study|Administrative|2|||
48819722|NCT02268396|157183583|FG000|Overall Study|Withdrawal by Subject|1|||
48819723|NCT02268396|157183583|FG000|Overall Study|Lost to Follow-up|2|||
48819724|NCT02268396|157183583|FG000|Overall Study|Protocol-Specified Criteria|2|||
48819725|NCT02268396|157183583|FG000|Overall Study|2 Subjects no Day 29 Assessment|2|||
48819726|NCT03699124|157183585|FG000|Overall Study|Adverse Event|6|||
48819727|NCT03699124|157183586|FG001|Overall Study|Adverse Event|5|||
48819728|NCT03699124|157183587|FG002|Overall Study|Adverse Event|2|||
48819729|NCT03699124|157183585|FG000|Overall Study|Death|0|||
48819730|NCT03699124|157183586|FG001|Overall Study|Death|2|||
48819731|NCT03699124|157183587|FG002|Overall Study|Death|0|||
48819732|NCT03699124|157183585|FG000|Overall Study|Lost to Follow-up|20|||
48819733|NCT03699124|157183586|FG001|Overall Study|Lost to Follow-up|16|||
48819734|NCT03699124|157183587|FG002|Overall Study|Lost to Follow-up|15|||
48819735|NCT03699124|157183585|FG000|Overall Study|Protocol Violation|1|||
48819736|NCT03699124|157183586|FG001|Overall Study|Protocol Violation|0|||
48819737|NCT03699124|157183587|FG002|Overall Study|Protocol Violation|0|||
48819738|NCT03699124|157183585|FG000|Overall Study|Withdrawal by Subject|13|||
48819739|NCT03699124|157183586|FG001|Overall Study|Withdrawal by Subject|14|||
48819740|NCT03699124|157183587|FG002|Overall Study|Withdrawal by Subject|13|||
48819741|NCT03699124|157183585|FG000|Overall Study|Other reasons|5|||
48819742|NCT03699124|157183586|FG001|Overall Study|Other reasons|3|||
48819743|NCT03699124|157183587|FG002|Overall Study|Other reasons|10|||
48819744|NCT01333943|157183588|FG000|Overall Study|Known neuropathy|1|||
48819745|NCT01333943|157183589|FG001|Overall Study|Known neuropathy|0|||
48819746|NCT01244763|157183590|FG000|Overall Study|Adverse Event|1|||
48819747|NCT01244763|157183591|FG001|Overall Study|Adverse Event|0|||
48819748|NCT01244763|157183592|FG002|Overall Study|Adverse Event|0|||
48819749|NCT01244763|157183593|FG003|Overall Study|Adverse Event|0|||
48819750|NCT01244763|157183594|FG004|Overall Study|Adverse Event|0|||
48819751|NCT01244763|157183595|FG005|Overall Study|Adverse Event|1|||
48819752|NCT01244763|157183590|FG000|Overall Study|Death|1|||
48819753|NCT01244763|157183591|FG001|Overall Study|Death|0|||
48819754|NCT01244763|157183592|FG002|Overall Study|Death|1|||
48819755|NCT01244763|157183593|FG003|Overall Study|Death|0|||
48819756|NCT01244763|157183594|FG004|Overall Study|Death|2|||
48819757|NCT01244763|157183595|FG005|Overall Study|Death|0|||
48819758|NCT01244763|157183590|FG000|Overall Study|Physician Decision|0|||
48819759|NCT01244763|157183591|FG001|Overall Study|Physician Decision|0|||
48819760|NCT01244763|157183592|FG002|Overall Study|Physician Decision|1|||
48819761|NCT01244763|157183593|FG003|Overall Study|Physician Decision|0|||
48819762|NCT01244763|157183594|FG004|Overall Study|Physician Decision|0|||
48819763|NCT01244763|157183595|FG005|Overall Study|Physician Decision|0|||
48819764|NCT01244763|157183590|FG000|Overall Study|Withdrawal by Subject|1|||
48819765|NCT01244763|157183591|FG001|Overall Study|Withdrawal by Subject|2|||
48819766|NCT01244763|157183592|FG002|Overall Study|Withdrawal by Subject|0|||
48819767|NCT01244763|157183593|FG003|Overall Study|Withdrawal by Subject|1|||
48819768|NCT01244763|157183594|FG004|Overall Study|Withdrawal by Subject|1|||
48819769|NCT01244763|157183595|FG005|Overall Study|Withdrawal by Subject|2|||
48819770|NCT01244763|157183590|FG000|Overall Study|Lost to Follow-up|0|||
48819771|NCT01244763|157183591|FG001|Overall Study|Lost to Follow-up|1|||
48819772|NCT01244763|157183592|FG002|Overall Study|Lost to Follow-up|0|||
48819773|NCT01244763|157183593|FG003|Overall Study|Lost to Follow-up|0|||
48819774|NCT01244763|157183594|FG004|Overall Study|Lost to Follow-up|0|||
48819775|NCT01244763|157183595|FG005|Overall Study|Lost to Follow-up|0|||
49134558|NCT05073315|158332102|FG001|Period 2|Lost to Follow-up|5|||
48819776|NCT01244763|157183590|FG000|Overall Study|Enrolled into the Extension Study|0|||
49134559|NCT05073315|158332103|FG002|Period 2|Lost to Follow-up|5|||
49134560|NCT05073315|158332101|FG000|Period 2|Withdrawal by Subject|0|||
48819777|NCT01244763|157183591|FG001|Overall Study|Enrolled into the Extension Study|0|||
48819778|NCT01244763|157183592|FG002|Overall Study|Enrolled into the Extension Study|0|||
48819779|NCT01244763|157183593|FG003|Overall Study|Enrolled into the Extension Study|0|||
48819780|NCT01244763|157183594|FG004|Overall Study|Enrolled into the Extension Study|0|||
48819781|NCT01244763|157183595|FG005|Overall Study|Enrolled into the Extension Study|1|||
48819782|NCT00997243|157183596|FG000|Overall Study|Early termination of study by sponsor|7|||
48819783|NCT03220737|157183600|FG000|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
48819784|NCT03220737|157183601|FG001|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
48819785|NCT03220737|157183602|FG002|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
48819786|NCT03220737|157183603|FG003|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
48819787|NCT03220737|157183604|FG004|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
48725107|NCT01155479|156843144|FG002|Part II|Adverse Event|8|||
48725108|NCT01155479|156843145|FG003|Part II|Adverse Event|3|||
48725109|NCT01155479|156843146|FG004|Part II|Adverse Event|4|||
48725110|NCT01155479|156843142|FG000|Part II|Administrative|43|||
48725111|NCT01155479|156843143|FG001|Part II|Administrative|49|||
48725112|NCT01155479|156843144|FG002|Part II|Administrative|36|||
48725113|NCT01155479|156843145|FG003|Part II|Administrative|38|||
48725114|NCT01155479|156843146|FG004|Part II|Administrative|46|||
48725115|NCT01155479|156843142|FG000|Part II|Withdrawal by Subject|8|||
48725116|NCT01155479|156843143|FG001|Part II|Withdrawal by Subject|4|||
48725117|NCT01155479|156843144|FG002|Part II|Withdrawal by Subject|12|||
48725118|NCT01155479|156843145|FG003|Part II|Withdrawal by Subject|7|||
48725119|NCT01155479|156843146|FG004|Part II|Withdrawal by Subject|3|||
48725120|NCT01155479|156843142|FG000|Part II|Lost to Follow-up|1|||
48725121|NCT01155479|156843143|FG001|Part II|Lost to Follow-up|0|||
48725122|NCT01155479|156843144|FG002|Part II|Lost to Follow-up|0|||
48725123|NCT01155479|156843145|FG003|Part II|Lost to Follow-up|0|||
48725124|NCT01155479|156843146|FG004|Part II|Lost to Follow-up|1|||
48725125|NCT01155479|156843142|FG000|Part II|Treatment Failure|0|||
48725126|NCT01155479|156843143|FG001|Part II|Treatment Failure|1|||
48725127|NCT01155479|156843144|FG002|Part II|Treatment Failure|2|||
48725128|NCT01155479|156843145|FG003|Part II|Treatment Failure|0|||
48725129|NCT01155479|156843146|FG004|Part II|Treatment Failure|1|||
48725130|NCT01155479|156843142|FG000|Part II|Non-Compliance with Protocol|0|||
48725131|NCT01155479|156843143|FG001|Part II|Non-Compliance with Protocol|1|||
48725132|NCT01155479|156843144|FG002|Part II|Non-Compliance with Protocol|0|||
48725133|NCT01155479|156843145|FG003|Part II|Non-Compliance with Protocol|2|||
48725134|NCT01155479|156843146|FG004|Part II|Non-Compliance with Protocol|0|||
48725135|NCT01634178|156843147|FG000|Treatment Period 1|Adverse Event|0|||
48725136|NCT01634178|156843148|FG001|Treatment Period 1|Adverse Event|1|||
48725137|NCT01634178|156843147|FG000|Treatment Period 2|Adverse Event|1|||
48725138|NCT01634178|156843148|FG001|Treatment Period 2|Adverse Event|0|||
48725139|NCT00609362|156843151|FG000|Overall Study|Withdrawal by Subject|2|||
48725140|NCT00609362|156843152|FG001|Overall Study|Withdrawal by Subject|1|||
48725141|NCT00609362|156843151|FG000|Overall Study|Adverse Event|1|||
48725142|NCT00609362|156843152|FG001|Overall Study|Adverse Event|0|||
48725143|NCT02283177|156843153|FG000|Overall Study|Withdrawal by Subject|1|||
48725144|NCT02283177|156843154|FG001|Overall Study|Withdrawal by Subject|1|||
48725145|NCT02045303|156843158|FG000|Overall Study|Protocol Violation|2|||
48725146|NCT02045303|156843159|FG001|Overall Study|Protocol Violation|1|||
48725147|NCT02045303|156843160|FG002|Overall Study|Protocol Violation|0|||
48725148|NCT02045303|156843158|FG000|Overall Study|Withdrawal by Subject|0|||
48725149|NCT02045303|156843159|FG001|Overall Study|Withdrawal by Subject|2|||
48725150|NCT02045303|156843160|FG002|Overall Study|Withdrawal by Subject|0|||
48725151|NCT00245583|156843163|FG000|Overall Study|Lost to Follow-up|1|||
48725152|NCT00245583|156843164|FG001|Overall Study|Lost to Follow-up|5|||
48725153|NCT00245583|156843163|FG000|Overall Study|Adverse Event|2|||
48725154|NCT00245583|156843164|FG001|Overall Study|Adverse Event|1|||
48725155|NCT00245583|156843163|FG000|Overall Study|Lack of Efficacy|1|||
48725156|NCT00245583|156843164|FG001|Overall Study|Lack of Efficacy|0|||
48725157|NCT00245583|156843163|FG000|Overall Study|Withdrawal by Subject|2|||
48725158|NCT00245583|156843164|FG001|Overall Study|Withdrawal by Subject|3|||
48725159|NCT00667446|156843165|FG000|Treatment Period (36 Months)|Ready to enter puberty based on age|13|||
48725160|NCT00667446|156843166|FG001|Treatment Period (36 Months)|Ready to enter puberty based on age|15|||
48725161|NCT00667446|156843165|FG000|Treatment Period (36 Months)|Other|2|||
48725162|NCT00667446|156843166|FG001|Treatment Period (36 Months)|Other|2|||
48725163|NCT00667446|156843165|FG000|Treatment Period (36 Months)|Personal reasons|2|||
48725164|NCT00667446|156843166|FG001|Treatment Period (36 Months)|Personal reasons|2|||
48725165|NCT00667446|156843165|FG000|Treatment Period (36 Months)|Withdrawal by Subject|0|||
48725166|NCT00667446|156843166|FG001|Treatment Period (36 Months)|Withdrawal by Subject|4|||
48725167|NCT00667446|156843165|FG000|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3|||
48725168|NCT00667446|156843166|FG001|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0|||
48725169|NCT00667446|156843165|FG000|Treatment Period (36 Months)|Lost to Follow-up|1|||
48725170|NCT00667446|156843166|FG001|Treatment Period (36 Months)|Lost to Follow-up|0|||
48725171|NCT00667446|156843165|FG000|Treatment Period (36 Months)|Protocol Violation|1|||
48725172|NCT00667446|156843166|FG001|Treatment Period (36 Months)|Protocol Violation|1|||
48725173|NCT00667446|156843165|FG000|Treatment Period (36 Months)|Therapeutic Failure|1|||
48725174|NCT00667446|156843166|FG001|Treatment Period (36 Months)|Therapeutic Failure|1|||
48725175|NCT00667446|156843165|FG000|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0|||
48725176|NCT00667446|156843166|FG001|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1|||
48725177|NCT01309893|156843167|FG000|Week 2 - Crossover Intervention|Lost to Follow-up|1|||
48725178|NCT01309893|156843168|FG001|Week 2 - Crossover Intervention|Lost to Follow-up|0|||
48725179|NCT01309893|156843167|FG000|Week 2 - Crossover Intervention|Missed crossover visit|0|||
48725180|NCT01309893|156843168|FG001|Week 2 - Crossover Intervention|Missed crossover visit|1|||
48725181|NCT02314143|156843174|FG000|Overall Study|Adverse Event|0|||
48819788|NCT03220737|157183605|FG005|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
48819789|NCT03220737|157183606|FG006|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
48819790|NCT03220737|157183600|FG000|Main Study (Day 1 - 181)|Lost to Follow-up|2|||
48819791|NCT03220737|157183601|FG001|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
48819792|NCT03220737|157183602|FG002|Main Study (Day 1 - 181)|Lost to Follow-up|6|||
48819793|NCT03220737|157183603|FG003|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
48819794|NCT03220737|157183604|FG004|Main Study (Day 1 - 181)|Lost to Follow-up|13|||
48819795|NCT03220737|157183605|FG005|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
48819796|NCT03220737|157183606|FG006|Main Study (Day 1 - 181)|Lost to Follow-up|0|||
48819797|NCT03220737|157183600|FG000|Main Study (Day 1 - 181)|Protocol Violation|0|||
48819798|NCT03220737|157183601|FG001|Main Study (Day 1 - 181)|Protocol Violation|0|||
48819799|NCT03220737|157183602|FG002|Main Study (Day 1 - 181)|Protocol Violation|1|||
48819800|NCT03220737|157183603|FG003|Main Study (Day 1 - 181)|Protocol Violation|1|||
48819801|NCT03220737|157183604|FG004|Main Study (Day 1 - 181)|Protocol Violation|3|||
48819802|NCT03220737|157183605|FG005|Main Study (Day 1 - 181)|Protocol Violation|0|||
48819803|NCT03220737|157183606|FG006|Main Study (Day 1 - 181)|Protocol Violation|1|||
48819804|NCT03220737|157183600|FG000|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
48819805|NCT03220737|157183601|FG001|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
48819806|NCT03220737|157183602|FG002|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1|||
48819807|NCT03220737|157183603|FG003|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
48819808|NCT03220737|157183604|FG004|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
48819809|NCT03220737|157183605|FG005|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
48819810|NCT03220737|157183606|FG006|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
48819811|NCT03220737|157183600|FG000|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
48819812|NCT03220737|157183601|FG001|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
48819813|NCT03220737|157183602|FG002|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
48819814|NCT03220737|157183603|FG003|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
48819815|NCT03220737|157183604|FG004|Placebo Crossover (Day 181-365)|Lost to Follow-up|2|||
48819816|NCT03220737|157183605|FG005|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
48819817|NCT03220737|157183606|FG006|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
48819818|NCT03220737|157183600|FG000|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1|||
48819819|NCT03220737|157183601|FG001|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
48819820|NCT03220737|157183602|FG002|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
48819821|NCT03220737|157183603|FG003|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
48819822|NCT03220737|157183604|FG004|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
48819823|NCT03220737|157183605|FG005|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
48819824|NCT03220737|157183606|FG006|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
48819825|NCT03220737|157183600|FG000|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9|||
48819826|NCT03220737|157183601|FG001|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
48819827|NCT03220737|157183602|FG002|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
48819828|NCT03220737|157183603|FG003|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
48725182|NCT02314143|156843175|FG001|Overall Study|Adverse Event|6|||
48725183|NCT02314143|156843176|FG002|Overall Study|Adverse Event|4|||
48725184|NCT02314143|156843174|FG000|Overall Study|Other (Study Closed/Terminated)|5|||
48725185|NCT02314143|156843175|FG001|Overall Study|Other (Study Closed/Terminated)|3|||
48725186|NCT02314143|156843176|FG002|Overall Study|Other (Study Closed/Terminated)|4|||
48819829|NCT03220737|157183604|FG004|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
48819830|NCT03220737|157183605|FG005|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
48819831|NCT03220737|157183606|FG006|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
48819832|NCT03220737|157183600|FG000|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1|||
48819833|NCT03220737|157183601|FG001|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
48819834|NCT03220737|157183602|FG002|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
48819835|NCT03220737|157183603|FG003|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
48819836|NCT03220737|157183604|FG004|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
48819837|NCT03220737|157183605|FG005|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
48819838|NCT03220737|157183606|FG006|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
48819839|NCT00983619|157183609|FG000|Overall Study|Lost to Follow-up|0|||
48819840|NCT00983619|157183610|FG001|Overall Study|Lost to Follow-up|1|||
48819841|NCT00983619|157183611|FG002|Overall Study|Lost to Follow-up|0|||
48819842|NCT00983619|157183612|FG003|Overall Study|Lost to Follow-up|0|||
48819843|NCT00983619|157183613|FG004|Overall Study|Lost to Follow-up|0|||
49134561|NCT05073315|158332102|FG001|Period 2|Withdrawal by Subject|4|||
48725187|NCT02314143|156843174|FG000|Overall Study|Physician Decision|2|||
48725188|NCT02314143|156843175|FG001|Overall Study|Physician Decision|1|||
48725189|NCT02314143|156843176|FG002|Overall Study|Physician Decision|0|||
48725190|NCT02314143|156843174|FG000|Overall Study|Withdrawal by Subject|1|||
48725191|NCT02314143|156843175|FG001|Overall Study|Withdrawal by Subject|0|||
49134562|NCT05073315|158332103|FG002|Period 2|Withdrawal by Subject|9|||
48725192|NCT02314143|156843176|FG002|Overall Study|Withdrawal by Subject|1|||
48819844|NCT00983619|157183614|FG005|Overall Study|Lost to Follow-up|2|||
48819845|NCT00983619|157183615|FG006|Overall Study|Lost to Follow-up|0|||
48819846|NCT00983619|157183616|FG007|Overall Study|Lost to Follow-up|0|||
48819847|NCT00983619|157183617|FG008|Overall Study|Lost to Follow-up|0|||
48819848|NCT00983619|157183618|FG009|Overall Study|Lost to Follow-up|0|||
48819849|NCT00983619|157183619|FG010|Overall Study|Lost to Follow-up|0|||
48819850|NCT00983619|157183620|FG011|Overall Study|Lost to Follow-up|2|||
48819851|NCT00983619|157183609|FG000|Overall Study|Withdrawal by Subject|2|||
48819852|NCT00983619|157183610|FG001|Overall Study|Withdrawal by Subject|1|||
48819853|NCT00983619|157183611|FG002|Overall Study|Withdrawal by Subject|1|||
48819854|NCT00983619|157183612|FG003|Overall Study|Withdrawal by Subject|3|||
48819855|NCT00983619|157183613|FG004|Overall Study|Withdrawal by Subject|1|||
48819856|NCT00983619|157183614|FG005|Overall Study|Withdrawal by Subject|23|||
48819857|NCT00983619|157183615|FG006|Overall Study|Withdrawal by Subject|0|||
48819858|NCT00983619|157183616|FG007|Overall Study|Withdrawal by Subject|0|||
48819859|NCT00983619|157183617|FG008|Overall Study|Withdrawal by Subject|0|||
48819860|NCT00983619|157183618|FG009|Overall Study|Withdrawal by Subject|0|||
48819861|NCT00983619|157183619|FG010|Overall Study|Withdrawal by Subject|1|||
48819862|NCT00983619|157183620|FG011|Overall Study|Withdrawal by Subject|1|||
48819863|NCT00983619|157183609|FG000|Overall Study|Death|0|||
48819864|NCT00983619|157183610|FG001|Overall Study|Death|2|||
48819865|NCT00983619|157183611|FG002|Overall Study|Death|2|||
48819866|NCT00983619|157183612|FG003|Overall Study|Death|1|||
48819867|NCT00983619|157183613|FG004|Overall Study|Death|2|||
48819868|NCT00983619|157183614|FG005|Overall Study|Death|30|||
48819869|NCT00983619|157183615|FG006|Overall Study|Death|1|||
48819870|NCT00983619|157183616|FG007|Overall Study|Death|0|||
48819871|NCT00983619|157183617|FG008|Overall Study|Death|1|||
48819872|NCT00983619|157183618|FG009|Overall Study|Death|2|||
48819873|NCT00983619|157183619|FG010|Overall Study|Death|9|||
48819874|NCT00983619|157183620|FG011|Overall Study|Death|8|||
48819875|NCT00983619|157183609|FG000|Overall Study|Other|1|||
48819876|NCT00983619|157183610|FG001|Overall Study|Other|0|||
48819877|NCT00983619|157183611|FG002|Overall Study|Other|0|||
48819878|NCT00983619|157183612|FG003|Overall Study|Other|1|||
48819879|NCT00983619|157183613|FG004|Overall Study|Other|0|||
48819880|NCT00983619|157183614|FG005|Overall Study|Other|12|||
48819881|NCT00983619|157183615|FG006|Overall Study|Other|2|||
48819882|NCT00983619|157183616|FG007|Overall Study|Other|2|||
48819883|NCT00983619|157183617|FG008|Overall Study|Other|0|||
48819884|NCT00983619|157183618|FG009|Overall Study|Other|1|||
48819885|NCT00983619|157183619|FG010|Overall Study|Other|1|||
48819886|NCT00983619|157183620|FG011|Overall Study|Other|0|||
48819887|NCT00691028|157183621|FG000|Open-label Period|Adverse Event|0|||
48819888|NCT00691028|157183622|FG001|Open-label Period|Adverse Event|0|||
48819889|NCT00691028|157183623|FG002|Open-label Period|Adverse Event|0|||
48819890|NCT00691028|157183624|FG003|Open-label Period|Adverse Event|16|||
48819891|NCT00691028|157183621|FG000|Open-label Period|Withdrawal by Subject|0|||
48819892|NCT00691028|157183622|FG001|Open-label Period|Withdrawal by Subject|0|||
48819893|NCT00691028|157183623|FG002|Open-label Period|Withdrawal by Subject|0|||
48819894|NCT00691028|157183624|FG003|Open-label Period|Withdrawal by Subject|3|||
48819895|NCT00691028|157183621|FG000|Open-label Period|not come to a hospital|0|||
48819896|NCT00691028|157183622|FG001|Open-label Period|not come to a hospital|0|||
48819897|NCT00691028|157183623|FG002|Open-label Period|not come to a hospital|0|||
48819898|NCT00691028|157183624|FG003|Open-label Period|not come to a hospital|1|||
48819899|NCT00691028|157183621|FG000|Double-blind Period|Adverse Event|8|||
48819900|NCT00691028|157183622|FG001|Double-blind Period|Adverse Event|9|||
48819901|NCT00691028|157183623|FG002|Double-blind Period|Adverse Event|6|||
48819902|NCT00691028|157183624|FG003|Double-blind Period|Adverse Event|0|||
48819903|NCT00691028|157183621|FG000|Double-blind Period|Lack of Efficacy|4|||
48819904|NCT00691028|157183622|FG001|Double-blind Period|Lack of Efficacy|3|||
48819905|NCT00691028|157183623|FG002|Double-blind Period|Lack of Efficacy|2|||
48819906|NCT00691028|157183624|FG003|Double-blind Period|Lack of Efficacy|0|||
48819907|NCT00691028|157183621|FG000|Double-blind Period|Withdrawal by Subject|1|||
48819908|NCT00691028|157183622|FG001|Double-blind Period|Withdrawal by Subject|0|||
48819909|NCT00691028|157183623|FG002|Double-blind Period|Withdrawal by Subject|1|||
48819910|NCT00691028|157183624|FG003|Double-blind Period|Withdrawal by Subject|0|||
48819911|NCT00691028|157183621|FG000|Double-blind Period|not come to a hospital.|0|||
48819912|NCT00691028|157183622|FG001|Double-blind Period|not come to a hospital.|1|||
48819913|NCT00691028|157183623|FG002|Double-blind Period|not come to a hospital.|0|||
48819914|NCT00691028|157183624|FG003|Double-blind Period|not come to a hospital.|0|||
48819915|NCT00972543|157183627|FG000|Overall Study|Adverse Event|1|||
48819916|NCT00972543|157183628|FG001|Overall Study|Adverse Event|0|||
48819917|NCT00972543|157183627|FG000|Overall Study|Early study termination by sponsor|4|||
48819918|NCT00972543|157183628|FG001|Overall Study|Early study termination by sponsor|1|||
48819919|NCT01066156|157183631|FG000|Overall Study|ineligible|2|||
48819920|NCT01066156|157183631|FG000|Overall Study|Lost to Follow-up|7|||
48819921|NCT01066156|157183631|FG000|Overall Study|Withdrawal by Subject|1|||
48819922|NCT03135548|157183634|FG000|Overall Study|Lost to Follow-up|3|||
48819923|NCT03135548|157183635|FG001|Overall Study|Lost to Follow-up|0|||
48819924|NCT03135548|157183636|FG002|Overall Study|Lost to Follow-up|0|||
48819925|NCT03135548|157183634|FG000|Overall Study|Withdrawal by Subject|2|||
48819926|NCT03135548|157183635|FG001|Overall Study|Withdrawal by Subject|2|||
48819927|NCT03135548|157183636|FG002|Overall Study|Withdrawal by Subject|1|||
48819928|NCT03135548|157183634|FG000|Overall Study|Other than listed|0|||
48819929|NCT03135548|157183635|FG001|Overall Study|Other than listed|2|||
48819930|NCT03135548|157183636|FG002|Overall Study|Other than listed|2|||
48819931|NCT00918749|157183637|FG000|Overall Study|Adverse Event|1|||
48819932|NCT00918749|157183638|FG001|Overall Study|Adverse Event|0|||
48819933|NCT00918749|157183639|FG002|Overall Study|Adverse Event|1|||
48819934|NCT00918749|157183637|FG000|Overall Study|Lost to Follow-up|0|||
48819935|NCT00918749|157183638|FG001|Overall Study|Lost to Follow-up|0|||
48819936|NCT00918749|157183639|FG002|Overall Study|Lost to Follow-up|1|||
48819937|NCT00918749|157183637|FG000|Overall Study|Withdrawal by Subject|5|||
48819938|NCT00918749|157183638|FG001|Overall Study|Withdrawal by Subject|3|||
48819939|NCT00918749|157183639|FG002|Overall Study|Withdrawal by Subject|5|||
48819940|NCT00918749|157183637|FG000|Overall Study|No Study Medication Taken|1|||
48819941|NCT00918749|157183638|FG001|Overall Study|No Study Medication Taken|0|||
48819942|NCT00918749|157183639|FG002|Overall Study|No Study Medication Taken|0|||
48819943|NCT01152554|157183640|FG000|Overall Study|Withdrawal by Subject|73|||
48819944|NCT01152554|157183641|FG001|Overall Study|Withdrawal by Subject|28|||
48819945|NCT01152554|157183640|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
48819946|NCT01152554|157183641|FG001|Overall Study|Eligiblity criteria not fulfilled|1|||
48819947|NCT01152554|157183640|FG000|Overall Study|Adverse Event|67|||
48819948|NCT01152554|157183641|FG001|Overall Study|Adverse Event|14|||
48819949|NCT01152554|157183640|FG000|Overall Study|Severe non-compliance to protocol|36|||
48819950|NCT01152554|157183641|FG001|Overall Study|Severe non-compliance to protocol|14|||
48819951|NCT01152554|157183640|FG000|Overall Study|Condition under investigation worsened|5|||
48819952|NCT01152554|157183641|FG001|Overall Study|Condition under investigation worsened|2|||
48819953|NCT01152554|157183640|FG000|Overall Study|Lack of Efficacy|20|||
48819954|NCT01152554|157183641|FG001|Overall Study|Lack of Efficacy|3|||
48819955|NCT01152554|157183640|FG000|Overall Study|Study-specific withdrawal criteria|17|||
48819956|NCT01152554|157183641|FG001|Overall Study|Study-specific withdrawal criteria|8|||
48819957|NCT01152554|157183640|FG000|Overall Study|Lost to Follow-up|87|||
48819958|NCT01152554|157183641|FG001|Overall Study|Lost to Follow-up|32|||
48819959|NCT01152554|157183640|FG000|Overall Study|Other|28|||
48819960|NCT01152554|157183641|FG001|Overall Study|Other|8|||
48819961|NCT01152554|157183640|FG000|Overall Study|Death|1|||
48819962|NCT01152554|157183641|FG001|Overall Study|Death|1|||
48819963|NCT02025205|157183643|FG000|Overall Study|Withdrawal by Subject|1|||
48819964|NCT02025205|157183644|FG001|Overall Study|Withdrawal by Subject|1|||
48819965|NCT02025205|157183643|FG000|Overall Study|Protocol Violation|2|||
48819966|NCT02025205|157183644|FG001|Overall Study|Protocol Violation|1|||
48819967|NCT02025205|157183643|FG000|Overall Study|Death|0|||
48819968|NCT02025205|157183644|FG001|Overall Study|Death|1|||
48819969|NCT03389893|157183645|FG000|Randomized Double Blind Period|Withdrawal by Subject|1|||
48819970|NCT03389893|157183646|FG001|Randomized Double Blind Period|Withdrawal by Subject|0|||
48819971|NCT03389893|157183647|FG002|Randomized Double Blind Period|Withdrawal by Subject|0|||
48819972|NCT03389893|157183648|FG003|Randomized Double Blind Period|Withdrawal by Subject|0|||
48819973|NCT03389893|157183645|FG000|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
48819974|NCT03389893|157183646|FG001|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
48819975|NCT03389893|157183647|FG002|Open Label Extension and Follow-Up|Lost to Follow-up|2|||
48819976|NCT03389893|157183648|FG003|Open Label Extension and Follow-Up|Lost to Follow-up|1|||
48819977|NCT03389893|157183645|FG000|Open Label Extension and Follow-Up|Physician Decision|0|||
48819978|NCT03389893|157183646|FG001|Open Label Extension and Follow-Up|Physician Decision|0|||
48819979|NCT03389893|157183647|FG002|Open Label Extension and Follow-Up|Physician Decision|1|||
48819980|NCT03389893|157183648|FG003|Open Label Extension and Follow-Up|Physician Decision|0|||
48819981|NCT03389893|157183645|FG000|Open Label Extension and Follow-Up|Participant Moved|0|||
48819982|NCT03389893|157183646|FG001|Open Label Extension and Follow-Up|Participant Moved|0|||
48819983|NCT03389893|157183647|FG002|Open Label Extension and Follow-Up|Participant Moved|1|||
48819984|NCT03389893|157183648|FG003|Open Label Extension and Follow-Up|Participant Moved|0|||
48819985|NCT01318811|157183650|FG000|Overall Study|Physician Decision|1|||
48819986|NCT01318811|157183651|FG001|Overall Study|Physician Decision|1|||
48819987|NCT01318811|157183650|FG000|Overall Study|CRRT stopped for head CT|0|||
48819988|NCT01318811|157183651|FG001|Overall Study|CRRT stopped for head CT|1|||
48819989|NCT01318811|157183650|FG000|Overall Study|Death|0|||
48819990|NCT01318811|157183651|FG001|Overall Study|Death|1|||
48819991|NCT01318811|157183650|FG000|Overall Study|CRRT stopped for head MRI|0|||
48819992|NCT01318811|157183651|FG001|Overall Study|CRRT stopped for head MRI|1|||
48819993|NCT02554513|157183652|FG000|First Treatment Phase (7 Weeks)|Withdrawal by Subject|0|||
48819994|NCT02554513|157183653|FG001|First Treatment Phase (7 Weeks)|Withdrawal by Subject|1|||
48820027|NCT04529538|157183662|FG000|Overall Study|Lost to Follow-up|3|||
48820028|NCT04529538|157183663|FG001|Overall Study|Lost to Follow-up|2|||
48820029|NCT04529538|157183664|FG002|Overall Study|Lost to Follow-up|1|||
48820030|NCT04529538|157183665|FG003|Overall Study|Lost to Follow-up|0|||
48820031|NCT04529538|157183666|FG004|Overall Study|Lost to Follow-up|1|||
48820032|NCT04529538|157183667|FG005|Overall Study|Lost to Follow-up|1|||
48820033|NCT04529538|157183668|FG006|Overall Study|Lost to Follow-up|2|||
48820034|NCT04529538|157183669|FG007|Overall Study|Lost to Follow-up|0|||
48820035|NCT04529538|157183662|FG000|Overall Study|Not eligible at enrollment|0|||
48820036|NCT04529538|157183663|FG001|Overall Study|Not eligible at enrollment|1|||
48820037|NCT04529538|157183664|FG002|Overall Study|Not eligible at enrollment|2|||
48820038|NCT04529538|157183665|FG003|Overall Study|Not eligible at enrollment|1|||
48820039|NCT04529538|157183666|FG004|Overall Study|Not eligible at enrollment|0|||
48820040|NCT04529538|157183667|FG005|Overall Study|Not eligible at enrollment|0|||
48820041|NCT04529538|157183668|FG006|Overall Study|Not eligible at enrollment|0|||
48820042|NCT04529538|157183669|FG007|Overall Study|Not eligible at enrollment|1|||
48820043|NCT04529538|157183662|FG000|Overall Study|Withdrawal by Subject|0|||
48820044|NCT04529538|157183663|FG001|Overall Study|Withdrawal by Subject|1|||
48820045|NCT04529538|157183664|FG002|Overall Study|Withdrawal by Subject|1|||
48820046|NCT04529538|157183665|FG003|Overall Study|Withdrawal by Subject|2|||
48820047|NCT04529538|157183666|FG004|Overall Study|Withdrawal by Subject|0|||
48820048|NCT04529538|157183667|FG005|Overall Study|Withdrawal by Subject|2|||
48820049|NCT04529538|157183668|FG006|Overall Study|Withdrawal by Subject|3|||
48820050|NCT04529538|157183669|FG007|Overall Study|Withdrawal by Subject|0|||
48820051|NCT04529538|157183662|FG000|Overall Study|Other|0|||
48820052|NCT04529538|157183663|FG001|Overall Study|Other|1|||
48820053|NCT04529538|157183664|FG002|Overall Study|Other|0|||
48820054|NCT04529538|157183665|FG003|Overall Study|Other|0|||
48820055|NCT04529538|157183666|FG004|Overall Study|Other|0|||
48820056|NCT04529538|157183667|FG005|Overall Study|Other|0|||
48820057|NCT04529538|157183668|FG006|Overall Study|Other|0|||
48820058|NCT04529538|157183669|FG007|Overall Study|Other|0|||
48820059|NCT04529538|157183662|FG000|Overall Study|Adverse Event|0|||
48820060|NCT04529538|157183663|FG001|Overall Study|Adverse Event|0|||
48820061|NCT04529538|157183664|FG002|Overall Study|Adverse Event|0|||
48820062|NCT04529538|157183665|FG003|Overall Study|Adverse Event|1|||
48820063|NCT04529538|157183666|FG004|Overall Study|Adverse Event|0|||
48820064|NCT04529538|157183667|FG005|Overall Study|Adverse Event|0|||
48820065|NCT04529538|157183668|FG006|Overall Study|Adverse Event|0|||
48820066|NCT04529538|157183669|FG007|Overall Study|Adverse Event|0|||
48820067|NCT04529538|157183662|FG000|Overall Study|Protocol Deviation|0|||
48820068|NCT04529538|157183663|FG001|Overall Study|Protocol Deviation|0|||
48820069|NCT04529538|157183664|FG002|Overall Study|Protocol Deviation|0|||
48820070|NCT04529538|157183665|FG003|Overall Study|Protocol Deviation|1|||
48820071|NCT04529538|157183666|FG004|Overall Study|Protocol Deviation|0|||
48820072|NCT04529538|157183667|FG005|Overall Study|Protocol Deviation|0|||
48820073|NCT04529538|157183668|FG006|Overall Study|Protocol Deviation|0|||
48820074|NCT04529538|157183669|FG007|Overall Study|Protocol Deviation|0|||
48820075|NCT04529538|157183662|FG000|Overall Study|Physician Decision|0|||
48820076|NCT04529538|157183663|FG001|Overall Study|Physician Decision|0|||
48820077|NCT04529538|157183664|FG002|Overall Study|Physician Decision|0|||
48820078|NCT04529538|157183665|FG003|Overall Study|Physician Decision|0|||
48820079|NCT04529538|157183666|FG004|Overall Study|Physician Decision|0|||
48820080|NCT04529538|157183667|FG005|Overall Study|Physician Decision|1|||
48820081|NCT04529538|157183668|FG006|Overall Study|Physician Decision|0|||
48820082|NCT04529538|157183669|FG007|Overall Study|Physician Decision|1|||
48820083|NCT04963062|157183670|FG000|Overall Study|withdrew by the study team|4|||
48820084|NCT04963062|157183671|FG001|Overall Study|withdrew by the study team|2|||
48820085|NCT02431533|157183672|FG000|Overall Study|Withdrawal by Subject|1|||
48820086|NCT02431533|157183673|FG001|Overall Study|Withdrawal by Subject|3|||
48820087|NCT02431533|157183672|FG000|Overall Study|Developed Exclusionary criteria|1|||
48820088|NCT02431533|157183673|FG001|Overall Study|Developed Exclusionary criteria|0|||
48820089|NCT00885495|157183678|FG000|Overall Study|Adverse Event|1|||
48820090|NCT00885495|157183679|FG001|Overall Study|Adverse Event|2|||
48820091|NCT00885495|157183678|FG000|Overall Study|Protocol Violation|0|||
48820092|NCT00885495|157183679|FG001|Overall Study|Protocol Violation|1|||
48820093|NCT00885495|157183678|FG000|Overall Study|Withdrawal by Subject|1|||
48820094|NCT00885495|157183679|FG001|Overall Study|Withdrawal by Subject|0|||
48820095|NCT01400893|157183680|FG000|Overall Study|Death|27|||
48820096|NCT01400893|157183681|FG001|Overall Study|Death|21|||
48820097|NCT01400893|157183680|FG000|Overall Study|Lost to Follow-up|0|||
48820098|NCT01400893|157183681|FG001|Overall Study|Lost to Follow-up|6|||
48820099|NCT02453282|157183684|FG000|Overall Study|Death|275|||
48820100|NCT02453282|157183685|FG001|Overall Study|Death|277|||
48820101|NCT02453282|157183686|FG002|Overall Study|Death|296|||
48820102|NCT02453282|157183684|FG000|Overall Study|Lost to Follow-up|1|||
48820103|NCT02453282|157183685|FG001|Overall Study|Lost to Follow-up|0|||
48820104|NCT02453282|157183686|FG002|Overall Study|Lost to Follow-up|2|||
48820105|NCT02453282|157183684|FG000|Overall Study|Withdrawal by Subject|12|||
48820106|NCT02453282|157183685|FG001|Overall Study|Withdrawal by Subject|10|||
48820107|NCT02453282|157183686|FG002|Overall Study|Withdrawal by Subject|11|||
48820108|NCT02453282|157183684|FG000|Overall Study|Participants ongoing at data cut-off|85|||
48820109|NCT02453282|157183685|FG001|Overall Study|Participants ongoing at data cut-off|84|||
48820110|NCT02453282|157183686|FG002|Overall Study|Participants ongoing at data cut-off|62|||
48820111|NCT02453282|157183684|FG000|Overall Study|Other|1|||
48820112|NCT02453282|157183685|FG001|Overall Study|Other|1|||
48820113|NCT02453282|157183686|FG002|Overall Study|Other|1|||
48820114|NCT04562779|157183690|FG000|Overall Study|Lost to Follow-up|7|||
48820115|NCT04562779|157183691|FG001|Overall Study|Lost to Follow-up|5|||
48820116|NCT04562779|157183692|FG002|Overall Study|Lost to Follow-up|10|||
48820117|NCT04562779|157183690|FG000|Overall Study|Protocol Violation|2|||
48820118|NCT04562779|157183691|FG001|Overall Study|Protocol Violation|2|||
48820119|NCT04562779|157183692|FG002|Overall Study|Protocol Violation|0|||
48820120|NCT00333138|157183693|FG000|Core Study (6 Months)|Adverse Event|4|||
48820121|NCT00333138|157183694|FG001|Core Study (6 Months)|Adverse Event|5|||
48820122|NCT00333138|157183695|FG002|Core Study (6 Months)|Adverse Event|8|||
48820123|NCT00333138|157183693|FG000|Core Study (6 Months)|Withdrawal by Subject|1|||
48820124|NCT00333138|157183694|FG001|Core Study (6 Months)|Withdrawal by Subject|1|||
48820125|NCT00333138|157183695|FG002|Core Study (6 Months)|Withdrawal by Subject|2|||
48820126|NCT00333138|157183693|FG000|Core Study (6 Months)|Lack of Efficacy|1|||
48820127|NCT00333138|157183694|FG001|Core Study (6 Months)|Lack of Efficacy|0|||
48820128|NCT00333138|157183695|FG002|Core Study (6 Months)|Lack of Efficacy|0|||
48820129|NCT00333138|157183693|FG000|Core Study (6 Months)|Protocol Violation|1|||
48820130|NCT00333138|157183694|FG001|Core Study (6 Months)|Protocol Violation|0|||
48820131|NCT00333138|157183695|FG002|Core Study (6 Months)|Protocol Violation|1|||
48820132|NCT00333138|157183693|FG000|Core Study (6 Months)|Laboratory abnormality|0|||
48820133|NCT00333138|157183694|FG001|Core Study (6 Months)|Laboratory abnormality|0|||
48820134|NCT00333138|157183695|FG002|Core Study (6 Months)|Laboratory abnormality|1|||
48820135|NCT00333138|157183693|FG000|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3|||
48820136|NCT00333138|157183694|FG001|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
48820137|NCT00333138|157183695|FG002|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
48820138|NCT00333138|157183693|FG000|Extension Study (Month6 to End of Study)|Administrative problems|1|||
48820139|NCT00333138|157183694|FG001|Extension Study (Month6 to End of Study)|Administrative problems|1|||
48820140|NCT00333138|157183695|FG002|Extension Study (Month6 to End of Study)|Administrative problems|2|||
48820141|NCT00333138|157183693|FG000|Extension Study (Month6 to End of Study)|Adverse Event|15|||
48820142|NCT00333138|157183694|FG001|Extension Study (Month6 to End of Study)|Adverse Event|19|||
48820143|NCT00333138|157183695|FG002|Extension Study (Month6 to End of Study)|Adverse Event|15|||
48820144|NCT00333138|157183693|FG000|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
48820145|NCT00333138|157183694|FG001|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
48820146|NCT00333138|157183695|FG002|Extension Study (Month6 to End of Study)|Protocol Violation|3|||
48820147|NCT00333138|157183693|FG000|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
48820148|NCT00333138|157183694|FG001|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13|||
48820149|NCT00333138|157183695|FG002|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
48820150|NCT00333138|157183693|FG000|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
48820151|NCT00333138|157183694|FG001|Extension Study (Month6 to End of Study)|Lack of Efficacy|4|||
48820152|NCT00333138|157183695|FG002|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
48820153|NCT00333138|157183693|FG000|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2|||
48820154|NCT00333138|157183694|FG001|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1|||
48820155|NCT00333138|157183695|FG002|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0|||
48820156|NCT00333138|157183693|FG000|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
48820157|NCT00333138|157183694|FG001|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
48820158|NCT00333138|157183695|FG002|Extension Study (Month6 to End of Study)|Lost to Follow-up|0|||
48820159|NCT00333138|157183693|FG000|Extension Study (Month6 to End of Study)|Death|0|||
48820160|NCT00333138|157183694|FG001|Extension Study (Month6 to End of Study)|Death|1|||
48820161|NCT00333138|157183695|FG002|Extension Study (Month6 to End of Study)|Death|0|||
48820162|NCT03499600|157183702|FG000|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|21|||
49134563|NCT05073315|158332101|FG000|Period 2|Protocol Violation|0|||
49134564|NCT05073315|158332102|FG001|Period 2|Protocol Violation|0|||
49134565|NCT05073315|158332103|FG002|Period 2|Protocol Violation|1|||
49134566|NCT00294658|158332104|FG000|Overall Study|Death|0|||
49134567|NCT00294658|158332105|FG001|Overall Study|Death|1|||
49134568|NCT00294658|158332104|FG000|Overall Study|Lost to Follow-up|4|||
49134569|NCT00294658|158332105|FG001|Overall Study|Lost to Follow-up|0|||
49134570|NCT00294658|158332104|FG000|Overall Study|Physician Decision|1|||
49134571|NCT00294658|158332105|FG001|Overall Study|Physician Decision|2|||
49134572|NCT00294658|158332104|FG000|Overall Study|Pregnancy|0|||
49134573|NCT00294658|158332105|FG001|Overall Study|Pregnancy|1|||
49134574|NCT00294658|158332104|FG000|Overall Study|Withdrawal by Subject|0|||
49134575|NCT00294658|158332105|FG001|Overall Study|Withdrawal by Subject|4|||
49134576|NCT00294658|158332104|FG000|Overall Study|Found to have invasive thymoma|1|||
49134577|NCT00294658|158332105|FG001|Overall Study|Found to have invasive thymoma|0|||
49134578|NCT00294658|158332104|FG000|Overall Study|Patient and family were not satisfied|0|||
49134579|NCT00294658|158332105|FG001|Overall Study|Patient and family were not satisfied|1|||
49134580|NCT00976027|158332107|FG000|Overall Study|Serious Adverse Event|36|||
49134581|NCT00976027|158332108|FG001|Overall Study|Serious Adverse Event|17|||
49134582|NCT00976027|158332107|FG000|Overall Study|Adverse Event|0|||
49134583|NCT00976027|158332108|FG001|Overall Study|Adverse Event|2|||
49134584|NCT00976027|158332107|FG000|Overall Study|Protocol Violation|60|||
49134585|NCT00976027|158332108|FG001|Overall Study|Protocol Violation|27|||
49134586|NCT00976027|158332107|FG000|Overall Study|Lost to Follow-up|208|||
49134587|NCT00976027|158332108|FG001|Overall Study|Lost to Follow-up|103|||
49134588|NCT00976027|158332107|FG000|Overall Study|Withdrawal by Subject|107|||
49134589|NCT00976027|158332108|FG001|Overall Study|Withdrawal by Subject|66|||
49134590|NCT00927472|158332121|FG000|Overall Study|Withdrawal by Subject|10|||
49134591|NCT00927472|158332122|FG001|Overall Study|Withdrawal by Subject|11|||
49134592|NCT00927472|158332121|FG000|Overall Study|Lost to Follow-up|1|||
49134593|NCT00927472|158332122|FG001|Overall Study|Lost to Follow-up|6|||
49134594|NCT00927472|158332121|FG000|Overall Study|Protocol Violation|0|||
49134595|NCT00927472|158332122|FG001|Overall Study|Protocol Violation|1|||
49134596|NCT00927472|158332121|FG000|Overall Study|Post treatment Assessment out of window|0|||
49134597|NCT00927472|158332122|FG001|Overall Study|Post treatment Assessment out of window|4|||
49134598|NCT02691572|158332123|FG000|Overall Study|Withdrawal by Subject|1|||
49134599|NCT02691572|158332124|FG001|Overall Study|Withdrawal by Subject|0|||
49134600|NCT02691572|158332123|FG000|Overall Study|Protocol Violation|0|||
49134601|NCT02691572|158332124|FG001|Overall Study|Protocol Violation|1|||
49134602|NCT02401230|158332126|FG000|Overall Study|Adverse Event|3|||
49134603|NCT02401230|158332127|FG001|Overall Study|Adverse Event|2|||
49134604|NCT02401230|158332128|FG002|Overall Study|Adverse Event|0|||
49134605|NCT02401230|158332126|FG000|Overall Study|Withdrawal by Subject|2|||
49134606|NCT02401230|158332127|FG001|Overall Study|Withdrawal by Subject|1|||
49134607|NCT02401230|158332128|FG002|Overall Study|Withdrawal by Subject|1|||
49134608|NCT02401230|158332126|FG000|Overall Study|Lost to Follow-up|1|||
48820163|NCT03499600|157183703|FG001|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|30|||
48820164|NCT01290094|157183704|FG000|Overall Study|Withdrawal by Subject|1|||
49134609|NCT02401230|158332127|FG001|Overall Study|Lost to Follow-up|3|||
49134610|NCT02401230|158332128|FG002|Overall Study|Lost to Follow-up|3|||
49134611|NCT01925417|158332140|FG000|Overall Study|Withdrawal by Subject|2|||
49134612|NCT01925417|158332140|FG000|Overall Study|Death|1|||
49134613|NCT03550209|158332143|FG000|Overall Study|Lost to Follow-up|1|||
49134614|NCT03550209|158332144|FG001|Overall Study|Lost to Follow-up|0|||
49134615|NCT03550209|158332145|FG002|Overall Study|Lost to Follow-up|1|||
49134616|NCT03550209|158332146|FG003|Overall Study|Lost to Follow-up|0|||
49134617|NCT03550209|158332143|FG000|Overall Study|Withdrawal by Subject|0|||
48725193|NCT00089674|156843177|FG000|Overall Study|Physician Decision|4|||
48725194|NCT00089674|156843178|FG001|Overall Study|Physician Decision|2|||
48725195|NCT00089674|156843177|FG000|Overall Study|Adverse Event|23|||
48725196|NCT00089674|156843178|FG001|Overall Study|Adverse Event|29|||
48725197|NCT00089674|156843177|FG000|Overall Study|Withdrawal by Subject|143|||
48725198|NCT00089674|156843178|FG001|Overall Study|Withdrawal by Subject|127|||
48725199|NCT00089674|156843177|FG000|Overall Study|Death|43|||
48725200|NCT00089674|156843178|FG001|Overall Study|Death|43|||
48725201|NCT00089674|156843177|FG000|Overall Study|Disease progression|21|||
48725202|NCT00089674|156843178|FG001|Overall Study|Disease progression|23|||
48725203|NCT00089674|156843177|FG000|Overall Study|Ineligibility determined|8|||
48725204|NCT00089674|156843178|FG001|Overall Study|Ineligibility determined|10|||
48725205|NCT00089674|156843177|FG000|Overall Study|Lost to Follow-up|21|||
48725206|NCT00089674|156843178|FG001|Overall Study|Lost to Follow-up|17|||
48725207|NCT00089674|156843177|FG000|Overall Study|Noncompliance|7|||
48725208|NCT00089674|156843178|FG001|Overall Study|Noncompliance|3|||
48725209|NCT00089674|156843177|FG000|Overall Study|Other|5|||
48725210|NCT00089674|156843178|FG001|Overall Study|Other|9|||
48725211|NCT00089674|156843177|FG000|Overall Study|Requirement for alternative therapy|14|||
48725212|NCT00089674|156843178|FG001|Overall Study|Requirement for alternative therapy|4|||
48725213|NCT03324581|156843179|FG000|Overall Study|Adverse Event|18|||
48725214|NCT03324581|156843180|FG001|Overall Study|Adverse Event|11|||
48725215|NCT03324581|156843181|FG002|Overall Study|Adverse Event|7|||
48725216|NCT03324581|156843179|FG000|Overall Study|Lack of Efficacy|0|||
48725217|NCT03324581|156843180|FG001|Overall Study|Lack of Efficacy|1|||
48725218|NCT03324581|156843181|FG002|Overall Study|Lack of Efficacy|0|||
48725219|NCT03324581|156843179|FG000|Overall Study|Lost to Follow-up|5|||
48725220|NCT03324581|156843180|FG001|Overall Study|Lost to Follow-up|3|||
48725221|NCT03324581|156843181|FG002|Overall Study|Lost to Follow-up|6|||
48725222|NCT03324581|156843179|FG000|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
48725223|NCT03324581|156843180|FG001|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
48725224|NCT03324581|156843181|FG002|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0|||
49134618|NCT03550209|158332144|FG001|Overall Study|Withdrawal by Subject|3|||
49134619|NCT03550209|158332145|FG002|Overall Study|Withdrawal by Subject|1|||
49134620|NCT03550209|158332146|FG003|Overall Study|Withdrawal by Subject|2|||
48725225|NCT03324581|156843179|FG000|Overall Study|Physician Decision|0|||
48725226|NCT03324581|156843180|FG001|Overall Study|Physician Decision|1|||
48725227|NCT03324581|156843181|FG002|Overall Study|Physician Decision|2|||
48725228|NCT03324581|156843179|FG000|Overall Study|Protocol Deviation|8|||
48725229|NCT03324581|156843180|FG001|Overall Study|Protocol Deviation|9|||
48725230|NCT03324581|156843181|FG002|Overall Study|Protocol Deviation|4|||
48725231|NCT03324581|156843179|FG000|Overall Study|Withdrawal by Subject|6|||
48725232|NCT03324581|156843180|FG001|Overall Study|Withdrawal by Subject|8|||
48725233|NCT03324581|156843181|FG002|Overall Study|Withdrawal by Subject|6|||
48725234|NCT03324581|156843179|FG000|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
48921037|NCT00784654|157544819|FG001|Randomized Withdrawal Period|Family reasons|0|||
49134621|NCT03550209|158332143|FG000|Overall Study|Excluded due to ineligibility after randomization|0|||
49134622|NCT03550209|158332144|FG001|Overall Study|Excluded due to ineligibility after randomization|0|||
49134623|NCT03550209|158332145|FG002|Overall Study|Excluded due to ineligibility after randomization|0|||
49134624|NCT03550209|158332146|FG003|Overall Study|Excluded due to ineligibility after randomization|2|||
49134625|NCT02555878|158332147|FG000|Overall Study|Lost to Follow-up|2|||
49134626|NCT02555878|158332148|FG001|Overall Study|Lost to Follow-up|3|||
49134627|NCT02555878|158332147|FG000|Overall Study|Withdrawal by Subject|48|||
49134628|NCT02555878|158332148|FG001|Overall Study|Withdrawal by Subject|48|||
49134629|NCT02555878|158332147|FG000|Overall Study|Adverse Event|12|||
49134630|NCT02555878|158332148|FG001|Overall Study|Adverse Event|8|||
49134631|NCT02555878|158332147|FG000|Overall Study|Death|74|||
49134632|NCT02555878|158332148|FG001|Overall Study|Death|59|||
49134633|NCT02555878|158332147|FG000|Overall Study|Protocol Violation|1|||
49134634|NCT02555878|158332148|FG001|Overall Study|Protocol Violation|2|||
49134635|NCT02555878|158332147|FG000|Overall Study|Physician Decision|12|||
49134636|NCT02555878|158332148|FG001|Overall Study|Physician Decision|13|||
48725235|NCT03324581|156843180|FG001|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1|||
48725236|NCT03324581|156843181|FG002|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
48725237|NCT04271280|156843183|FG000|Overall Study|Lost to Follow-up|300|||
48725238|NCT04271280|156843183|FG000|Overall Study|Death|153|||
48725239|NCT04271280|156843183|FG000|Overall Study|Withdrawal of consent by patient|59|||
49134637|NCT02555878|158332147|FG000|Overall Study|Other|17|||
49134638|NCT02555878|158332148|FG001|Overall Study|Other|17|||
48725240|NCT04271280|156843183|FG000|Overall Study|Other|51|||
48725241|NCT04271280|156843183|FG000|Overall Study|No end of study information|42|||
48725242|NCT00510952|156843187|FG000|Overall Study|Adverse Event|1|||
48725243|NCT00510952|156843188|FG001|Overall Study|Adverse Event|0|||
48725244|NCT00510952|156843187|FG000|Overall Study|Entry Criteria Not Met|3|||
48725245|NCT00510952|156843188|FG001|Overall Study|Entry Criteria Not Met|1|||
48725246|NCT00510952|156843187|FG000|Overall Study|Lost to Follow-up|5|||
49134639|NCT00765076|158332149|FG000|Overall Study|Adverse Event|1|||
48820165|NCT01290094|157183704|FG000|Overall Study|Lost to Follow-up|5|||
48820166|NCT02367040|157183705|FG000|Overall Study|Lost to Follow-up|1|||
48820167|NCT02367040|157183706|FG001|Overall Study|Lost to Follow-up|1|||
48820168|NCT02367040|157183705|FG000|Overall Study|Lack of Efficacy|1|||
48820169|NCT02367040|157183706|FG001|Overall Study|Lack of Efficacy|0|||
48820170|NCT02367040|157183705|FG000|Overall Study|Additional primary malignancy|0|||
48820171|NCT02367040|157183706|FG001|Overall Study|Additional primary malignancy|1|||
48820172|NCT02367040|157183705|FG000|Overall Study|AE not associated with clinical disease progression|114|||
48820173|NCT02367040|157183706|FG001|Overall Study|AE not associated with clinical disease progression|11|||
48820174|NCT02367040|157183705|FG000|Overall Study|AE associated with clinical disease progression|1|||
48820175|NCT02367040|157183706|FG001|Overall Study|AE associated with clinical disease progression|3|||
48820176|NCT02367040|157183705|FG000|Overall Study|Physician Decision|2|||
48820177|NCT02367040|157183706|FG001|Overall Study|Physician Decision|8|||
48820178|NCT02367040|157183705|FG000|Overall Study|Non-compliance with study drug|1|||
48820179|NCT02367040|157183706|FG001|Overall Study|Non-compliance with study drug|0|||
48820180|NCT02367040|157183705|FG000|Overall Study|Failure to meet continuation criteria|1|||
48820181|NCT02367040|157183706|FG001|Overall Study|Failure to meet continuation criteria|0|||
48820182|NCT02367040|157183705|FG000|Overall Study|Switching to other therapy|2|||
48820183|NCT02367040|157183706|FG001|Overall Study|Switching to other therapy|0|||
48820184|NCT02367040|157183705|FG000|Overall Study|Withdrawal by Subject|46|||
48820185|NCT02367040|157183706|FG001|Overall Study|Withdrawal by Subject|16|||
48820186|NCT02367040|157183705|FG000|Overall Study|Patient decision: COVID-19 pandemic related|1|||
48820187|NCT02367040|157183706|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
48820188|NCT02367040|157183705|FG000|Overall Study|Patient decision|39|||
48820189|NCT02367040|157183706|FG001|Overall Study|Patient decision|14|||
48820190|NCT02367040|157183705|FG000|Overall Study|Required procedure failed|1|||
48820191|NCT02367040|157183706|FG001|Overall Study|Required procedure failed|0|||
48820192|NCT02367040|157183705|FG000|Overall Study|Randomized by mistake with study treatment|1|||
48820193|NCT02367040|157183706|FG001|Overall Study|Randomized by mistake with study treatment|0|||
48820194|NCT02367040|157183705|FG000|Overall Study|Protocol Violation|1|||
48820195|NCT02367040|157183706|FG001|Overall Study|Protocol Violation|0|||
48820196|NCT02367040|157183705|FG000|Overall Study|Progressive disease - radiological progression|51|||
48820197|NCT02367040|157183706|FG001|Overall Study|Progressive disease - radiological progression|78|||
48820198|NCT02367040|157183705|FG000|Overall Study|Progressive disease - clinical progression|6|||
49011237|NCT00616928|157877457|FG002|Overall Study|Lost to Follow-up|0|||
49011238|NCT00616928|157877458|FG003|Overall Study|Lost to Follow-up|0|||
49011239|NCT01606137|157877499|FG000|Overall Study|Adverse Event|85|||
49011240|NCT01606137|157877499|FG000|Overall Study|Withdrawal by Subject|74|||
49011241|NCT01606137|157877499|FG000|Overall Study|Lack of Efficacy|56|||
48820199|NCT02367040|157183706|FG001|Overall Study|Progressive disease - clinical progression|6|||
48820200|NCT02367040|157183705|FG000|Overall Study|Drug not administered|3|||
49011242|NCT01606137|157877499|FG000|Overall Study|Lost to Follow-up|15|||
49011243|NCT01606137|157877499|FG000|Overall Study|Protocol Violation|1|||
49011244|NCT01606137|157877499|FG000|Overall Study|Patient non-compliance|9|||
49011245|NCT01606137|157877499|FG000|Overall Study|Death|1|||
49011246|NCT01606137|157877499|FG000|Overall Study|Decreased/no pain|4|||
49011247|NCT01606137|157877499|FG000|Overall Study|Issues with driving|4|||
49011248|NCT01606137|157877499|FG000|Overall Study|multiple sclerosis less stable|1|||
49011249|NCT01606137|157877499|FG000|Overall Study|Increased bilirubin|1|||
49011250|NCT01606137|157877499|FG000|Overall Study|Spray causes nausea|1|||
49011251|NCT01606137|157877499|FG000|Overall Study|Not enough improvement|4|||
49011252|NCT01606137|157877499|FG000|Overall Study|Wanted to try another treatment|1|||
49011253|NCT01606137|157877499|FG000|Overall Study|Patient leaving country|1|||
48725247|NCT00510952|156843188|FG001|Overall Study|Lost to Follow-up|3|||
48725248|NCT00510952|156843187|FG000|Overall Study|Physician Decision|1|||
48725249|NCT00510952|156843188|FG001|Overall Study|Physician Decision|1|||
48725250|NCT00510952|156843187|FG000|Overall Study|Protocol Violation|7|||
48725251|NCT00510952|156843188|FG001|Overall Study|Protocol Violation|4|||
48725252|NCT00510952|156843187|FG000|Overall Study|Sponsor Decision|1|||
48725253|NCT00510952|156843188|FG001|Overall Study|Sponsor Decision|0|||
48725254|NCT00510952|156843187|FG000|Overall Study|Withdrawal by Subject|6|||
48725255|NCT00510952|156843188|FG001|Overall Study|Withdrawal by Subject|7|||
48725256|NCT00510952|156843187|FG000|Overall Study|Did Not Receive Study Drug|2|||
48725257|NCT00510952|156843188|FG001|Overall Study|Did Not Receive Study Drug|0|||
48725258|NCT03119701|156843189|FG000|6-day Dosing|Death|4|||
48725259|NCT03119701|156843190|FG001|6-day Dosing|Death|1|||
48725260|NCT03119701|156843189|FG000|6-day Dosing|Adverse Event|3|||
48725261|NCT03119701|156843190|FG001|6-day Dosing|Adverse Event|0|||
48725262|NCT03119701|156843189|FG000|6-day Dosing|Physician Decision|0|||
48725263|NCT03119701|156843190|FG001|6-day Dosing|Physician Decision|1|||
48725264|NCT03119701|156843189|FG000|6-day Dosing|Withdrawal by Subject|0|||
49011254|NCT01606137|157877499|FG000|Overall Study|Personal reasons|1|||
49011255|NCT01606137|157877499|FG000|Overall Study|Unable to tolerate study med. taste|1|||
48725265|NCT03119701|156843190|FG001|6-day Dosing|Withdrawal by Subject|1|||
48725266|NCT03119701|156843189|FG000|Mid-term (Final) Follow-up at D90|Death|3|||
48725267|NCT03119701|156843190|FG001|Mid-term (Final) Follow-up at D90|Death|1|||
48725268|NCT02603887|156843197|FG000|Stage 1|Adverse Event|4|||
48725269|NCT02603887|156843197|FG000|Stage 1|Disease progression|1|||
48725270|NCT02603887|156843197|FG000|Stage 2|FDA guidance|1|||
48725271|NCT01074047|156843198|FG000|Treatment Phase|Adverse Event|89|||
48725272|NCT01074047|156843199|FG001|Treatment Phase|Adverse Event|66|||
48725273|NCT01074047|156843198|FG000|Treatment Phase|Disease Progression|16|||
48725274|NCT01074047|156843199|FG001|Treatment Phase|Disease Progression|21|||
48725275|NCT01074047|156843198|FG000|Treatment Phase|Withdrawal by Subject|27|||
49134640|NCT00765076|158332150|FG001|Overall Study|Adverse Event|0|||
49134641|NCT00765076|158332151|FG002|Overall Study|Adverse Event|0|||
49134642|NCT00765076|158332149|FG000|Overall Study|Withdrawal by Subject|0|||
49134643|NCT00765076|158332150|FG001|Overall Study|Withdrawal by Subject|0|||
49134644|NCT00765076|158332151|FG002|Overall Study|Withdrawal by Subject|1|||
49134645|NCT01164475|158332152|FG000|Overall Study|Lack of Efficacy|1|||
48725276|NCT01074047|156843199|FG001|Treatment Phase|Withdrawal by Subject|48|||
48725277|NCT01074047|156843198|FG000|Treatment Phase|Death|53|||
48725278|NCT01074047|156843199|FG001|Treatment Phase|Death|58|||
48725279|NCT01074047|156843198|FG000|Treatment Phase|Lost to Follow-up|0|||
48725280|NCT01074047|156843199|FG001|Treatment Phase|Lost to Follow-up|1|||
48725281|NCT01074047|156843198|FG000|Treatment Phase|Protocol Violation|0|||
48725282|NCT01074047|156843199|FG001|Treatment Phase|Protocol Violation|1|||
48725283|NCT01074047|156843198|FG000|Treatment Phase|Miscellaneous|32|||
48725284|NCT01074047|156843199|FG001|Treatment Phase|Miscellaneous|39|||
48725285|NCT01074047|156843198|FG000|Survival Follow-Up Phase|Withdrawal by Subject|5|||
48725286|NCT01074047|156843199|FG001|Survival Follow-Up Phase|Withdrawal by Subject|8|||
48725287|NCT01074047|156843198|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
48725288|NCT01074047|156843199|FG001|Survival Follow-Up Phase|Lost to Follow-up|1|||
48725289|NCT01074047|156843198|FG000|Survival Follow-Up Phase|Death|116|||
48725290|NCT01074047|156843199|FG001|Survival Follow-Up Phase|Death|124|||
48725291|NCT01074047|156843198|FG000|Survival Follow-Up Phase|Alive at study closure|1|||
48725292|NCT01074047|156843199|FG001|Survival Follow-Up Phase|Alive at study closure|3|||
48725293|NCT01074047|156843198|FG000|Extension Phase|Physician Decision|1|||
48725294|NCT01074047|156843199|FG001|Extension Phase|Physician Decision|0|||
48725295|NCT01074047|156843198|FG000|Extension Phase|Adverse Event|5|||
48725296|NCT01074047|156843199|FG001|Extension Phase|Adverse Event|0|||
48725297|NCT01074047|156843198|FG000|Extension Phase|Disease Progression|9|||
48725298|NCT01074047|156843199|FG001|Extension Phase|Disease Progression|0|||
48725299|NCT01074047|156843198|FG000|Extension Phase|Withdrawal by Subject|2|||
48725300|NCT01074047|156843199|FG001|Extension Phase|Withdrawal by Subject|0|||
48725301|NCT01074047|156843198|FG000|Extension Phase|Death|5|||
48725302|NCT01074047|156843199|FG001|Extension Phase|Death|0|||
48725303|NCT00395538|156843202|FG000|Overall Study|Did not re-consent to revised protocol|1|||
48725304|NCT00395538|156843203|FG001|Overall Study|Did not re-consent to revised protocol|10|||
48725305|NCT00395538|156843204|FG002|Overall Study|Did not re-consent to revised protocol|0|||
48725306|NCT00395538|156843202|FG000|Overall Study|FDA partial hold on PTH|0|||
48725307|NCT00395538|156843203|FG001|Overall Study|FDA partial hold on PTH|0|||
48725308|NCT00395538|156843204|FG002|Overall Study|FDA partial hold on PTH|11|||
48725309|NCT00395538|156843202|FG000|Overall Study|Failed screening|0|||
48725310|NCT00395538|156843203|FG001|Overall Study|Failed screening|0|||
48725311|NCT00395538|156843204|FG002|Overall Study|Failed screening|4|||
48725312|NCT00395538|156843202|FG000|Overall Study|Switch to Natpara|0|||
48725313|NCT00395538|156843203|FG001|Overall Study|Switch to Natpara|0|||
48725314|NCT00395538|156843204|FG002|Overall Study|Switch to Natpara|3|||
48725315|NCT00395538|156843202|FG000|Overall Study|Adverse Event|1|||
48725316|NCT00395538|156843203|FG001|Overall Study|Adverse Event|0|||
48725317|NCT00395538|156843204|FG002|Overall Study|Adverse Event|2|||
48725318|NCT00395538|156843202|FG000|Overall Study|DXA or QCT z-score or t-score<-2|0|||
48725319|NCT00395538|156843203|FG001|Overall Study|DXA or QCT z-score or t-score<-2|2|||
48725320|NCT00395538|156843204|FG002|Overall Study|DXA or QCT z-score or t-score<-2|0|||
48725321|NCT00395538|156843202|FG000|Overall Study|Non-compliance with study protocol|0|||
48725322|NCT00395538|156843203|FG001|Overall Study|Non-compliance with study protocol|1|||
48725323|NCT00395538|156843204|FG002|Overall Study|Non-compliance with study protocol|0|||
48725324|NCT00395538|156843202|FG000|Overall Study|PTH resistance|0|||
48725325|NCT00395538|156843203|FG001|Overall Study|PTH resistance|0|||
48725326|NCT00395538|156843204|FG002|Overall Study|PTH resistance|1|||
48725327|NCT00395538|156843202|FG000|Overall Study|Pregnancy|1|||
48725328|NCT00395538|156843203|FG001|Overall Study|Pregnancy|0|||
48725329|NCT00395538|156843204|FG002|Overall Study|Pregnancy|0|||
48725330|NCT00395538|156843202|FG000|Overall Study|Partial recovery of parathyroid function|0|||
48725331|NCT00395538|156843203|FG001|Overall Study|Partial recovery of parathyroid function|0|||
48725332|NCT00395538|156843204|FG002|Overall Study|Partial recovery of parathyroid function|1|||
48725333|NCT00395538|156843202|FG000|Overall Study|Participant elected to discontinue|0|||
48725334|NCT00395538|156843203|FG001|Overall Study|Participant elected to discontinue|0|||
48725335|NCT00395538|156843204|FG002|Overall Study|Participant elected to discontinue|1|||
48725336|NCT02782923|156843206|FG000|Overall Study|Lost to Follow-up|15|||
48725337|NCT01163318|156843207|FG000|Overall Study|Off-Label Use of Adalimumab|8|||
48725338|NCT01163318|156843207|FG000|Overall Study|Did Not Continue Use of Adalimumab|26|||
48725339|NCT01163318|156843207|FG000|Overall Study|History/comorbidity of malignant tumor|3|||
49134646|NCT01164475|158332153|FG001|Overall Study|Lack of Efficacy|0|||
48725340|NCT01163318|156843207|FG000|Overall Study|Participants Without Case Report Form|7|||
48725341|NCT01163318|156843207|FG000|Overall Study|Multiple Reasons Per Participant|224|||
48725342|NCT03484819|156843208|FG000|Overall Study|Death|2|||
49134647|NCT01164475|158332152|FG000|Overall Study|Other|0|||
49134648|NCT01164475|158332153|FG001|Overall Study|Other|1|||
48820201|NCT02367040|157183706|FG001|Overall Study|Drug not administered|2|||
48820202|NCT02367040|157183705|FG000|Overall Study|Progressive disease|0|||
48820203|NCT02367040|157183706|FG001|Overall Study|Progressive disease|1|||
48820204|NCT02367040|157183705|FG000|Overall Study|Other reason: Covid-19 pandemic related|1|||
48820205|NCT02367040|157183706|FG001|Overall Study|Other reason: Covid-19 pandemic related|0|||
48820206|NCT02367040|157183705|FG000|Overall Study|Death|2|||
48820207|NCT02367040|157183706|FG001|Overall Study|Death|0|||
48820208|NCT00742885|157185419|FG000|Overall Study|Lost to Follow-up|1|||
48820209|NCT00742885|157185420|FG001|Overall Study|Lost to Follow-up|0|||
48820210|NCT00802841|157185428|FG000|Overall Study|Administrative problems|1|||
48820211|NCT00802841|157185429|FG001|Overall Study|Administrative problems|0|||
48820212|NCT00802841|157185428|FG000|Overall Study|Lost to Follow-up|2|||
48820213|NCT00802841|157185429|FG001|Overall Study|Lost to Follow-up|1|||
48820214|NCT00802841|157185428|FG000|Overall Study|Death|1|||
48820215|NCT00802841|157185429|FG001|Overall Study|Death|2|||
48820216|NCT00802841|157185428|FG000|Overall Study|Adverse Event|8|||
48820217|NCT00802841|157185429|FG001|Overall Study|Adverse Event|2|||
48820218|NCT00802841|157185428|FG000|Overall Study|Disease progression|7|||
48820219|NCT00802841|157185429|FG001|Overall Study|Disease progression|3|||
48820220|NCT00802841|157185428|FG000|Overall Study|Withdrawal by Subject|9|||
48820221|NCT00802841|157185429|FG001|Overall Study|Withdrawal by Subject|5|||
48820222|NCT00802841|157185428|FG000|Overall Study|Protocol deviation|2|||
48820223|NCT00802841|157185429|FG001|Overall Study|Protocol deviation|6|||
48820224|NCT00802841|157185428|FG000|Overall Study|Treatment duration completed|66|||
48820225|NCT00802841|157185429|FG001|Overall Study|Treatment duration completed|76|||
48820226|NCT02955277|157185432|FG000|Pre-Post Intervention|Withdrawal by Subject|5|||
48820227|NCT02955277|157185433|FG001|Pre-Post Intervention|Withdrawal by Subject|6|||
48820228|NCT02955277|157185432|FG000|Post to Follow-up|Lost to Follow-up|8|||
48820229|NCT02955277|157185433|FG001|Post to Follow-up|Lost to Follow-up|11|||
48820230|NCT01668147|157185434|FG000|Overall Study|Withdrawal by Subject|6|||
48820231|NCT02459587|157185444|FG000|3-Month Follow-up Assessment|Death|0|||
48820232|NCT02459587|157185445|FG001|3-Month Follow-up Assessment|Death|2|||
48820233|NCT02459587|157185444|FG000|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
48820234|NCT02459587|157185445|FG001|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
48820235|NCT02459587|157185444|FG000|3-Month Follow-up Assessment|Lost to Follow-up|27|||
48820236|NCT02459587|157185445|FG001|3-Month Follow-up Assessment|Lost to Follow-up|22|||
48820237|NCT02459587|157185444|FG000|3-Month Follow-up Assessment|Researcher withdrew|2|||
48820238|NCT02459587|157185445|FG001|3-Month Follow-up Assessment|Researcher withdrew|4|||
48820239|NCT02459587|157185444|FG000|6-month Follow-up Assessment|Death|2|||
48820240|NCT02459587|157185445|FG001|6-month Follow-up Assessment|Death|1|||
48820241|NCT02459587|157185444|FG000|6-month Follow-up Assessment|Withdrawal by Subject|1|||
48820242|NCT02459587|157185445|FG001|6-month Follow-up Assessment|Withdrawal by Subject|2|||
48820243|NCT02459587|157185444|FG000|6-month Follow-up Assessment|Lost to Follow-up|21|||
48820244|NCT02459587|157185445|FG001|6-month Follow-up Assessment|Lost to Follow-up|22|||
48820245|NCT02459587|157185444|FG000|12-month Follow-up Assessment|Death|2|||
48820246|NCT02459587|157185445|FG001|12-month Follow-up Assessment|Death|0|||
48820247|NCT02459587|157185444|FG000|12-month Follow-up Assessment|Withdrawal by Subject|2|||
48820248|NCT02459587|157185445|FG001|12-month Follow-up Assessment|Withdrawal by Subject|4|||
48820249|NCT02459587|157185444|FG000|12-month Follow-up Assessment|Lost to Follow-up|18|||
48820250|NCT02459587|157185445|FG001|12-month Follow-up Assessment|Lost to Follow-up|22|||
48820251|NCT02459587|157185444|FG000|12-month Follow-up Assessment|Researcher withdrew|0|||
48820252|NCT02459587|157185445|FG001|12-month Follow-up Assessment|Researcher withdrew|1|||
48820253|NCT01744496|157185454|FG000|Titration Period|Adverse Event|2|||
48820254|NCT01744496|157185455|FG001|Titration Period|Adverse Event|1|||
48820255|NCT01744496|157185454|FG000|Titration Period|Personal reasons|0|||
48820256|NCT01744496|157185455|FG001|Titration Period|Personal reasons|1|||
48820257|NCT01744496|157185454|FG000|Maintenance Period|Adverse Event|1|||
48820258|NCT01744496|157185455|FG001|Maintenance Period|Adverse Event|3|||
48820259|NCT01744496|157185454|FG000|Maintenance Period|Protocol Violation|1|||
48820260|NCT01744496|157185455|FG001|Maintenance Period|Protocol Violation|0|||
48820261|NCT01744496|157185454|FG000|Maintenance Period|Withdrawal by Subject|1|||
48820262|NCT01744496|157185455|FG001|Maintenance Period|Withdrawal by Subject|1|||
48820263|NCT01744496|157185454|FG000|Maintenance Period|Subject left town|1|||
48820264|NCT01744496|157185455|FG001|Maintenance Period|Subject left town|0|||
48820265|NCT00372567|157185464|FG000|Phase 3 Study|Adverse Event|5|||
48820266|NCT00372567|157185465|FG001|Phase 3 Study|Adverse Event|1|||
49011256|NCT01606137|157877499|FG000|Overall Study|Patient moving|1|||
48820267|NCT00372567|157185466|FG002|Phase 3 Study|Adverse Event|1|||
48820268|NCT00372567|157185464|FG000|Phase 3 Study|Death|1|||
48820269|NCT00372567|157185465|FG001|Phase 3 Study|Death|1|||
48820270|NCT00372567|157185466|FG002|Phase 3 Study|Death|0|||
48820271|NCT00372567|157185464|FG000|Phase 3 Study|Protocol Violation|0|||
48820272|NCT00372567|157185465|FG001|Phase 3 Study|Protocol Violation|0|||
48820273|NCT00372567|157185466|FG002|Phase 3 Study|Protocol Violation|1|||
48820274|NCT00372567|157185464|FG000|Phase 3 Study|Objective progression or relapse|10|||
48820275|NCT00372567|157185465|FG001|Phase 3 Study|Objective progression or relapse|13|||
48820276|NCT00372567|157185466|FG002|Phase 3 Study|Objective progression or relapse|4|||
48820277|NCT00372567|157185464|FG000|Phase 3 Study|Global deterioration of health status|0|||
48820278|NCT00372567|157185465|FG001|Phase 3 Study|Global deterioration of health status|1|||
48820279|NCT00372567|157185466|FG002|Phase 3 Study|Global deterioration of health status|0|||
48820280|NCT00372567|157185464|FG000|Phase 3 Study|Other|2|||
48820281|NCT00372567|157185465|FG001|Phase 3 Study|Other|2|||
48820282|NCT00372567|157185466|FG002|Phase 3 Study|Other|1|||
48820283|NCT00372567|157185464|FG000|Phase 3 Study|study terminated by sponsor|13|||
48820284|NCT00372567|157185465|FG001|Phase 3 Study|study terminated by sponsor|8|||
48820285|NCT00372567|157185466|FG002|Phase 3 Study|study terminated by sponsor|5|||
48725343|NCT03484819|156843208|FG000|Overall Study|Adverse Event|2|||
48725344|NCT03484819|156843208|FG000|Overall Study|Physician Decision|1|||
48725345|NCT03484819|156843208|FG000|Overall Study|Withdrawal by Subject|2|||
48725346|NCT03484819|156843208|FG000|Overall Study|Disease Progression|4|||
48725347|NCT03484819|156843208|FG000|Overall Study|Complicating Condition|1|||
48725348|NCT01121588|156843212|FG000|Overall Study|Death|5|||
48725349|NCT01121588|156843213|FG001|Overall Study|Death|3|||
48725350|NCT01121588|156843214|FG002|Overall Study|Death|13|||
48725351|NCT01121588|156843212|FG000|Overall Study|Study Terminated by Sponsor|1|||
48725352|NCT01121588|156843213|FG001|Overall Study|Study Terminated by Sponsor|1|||
48725353|NCT01121588|156843214|FG002|Overall Study|Study Terminated by Sponsor|0|||
48725354|NCT01121588|156843212|FG000|Overall Study|Participant Refused Further Followup|2|||
48725355|NCT01121588|156843213|FG001|Overall Study|Participant Refused Further Followup|0|||
48725356|NCT01121588|156843214|FG002|Overall Study|Participant Refused Further Followup|2|||
48725357|NCT01121588|156843212|FG000|Overall Study|Lost to Follow-up|0|||
48725358|NCT01121588|156843213|FG001|Overall Study|Lost to Follow-up|1|||
48725359|NCT01121588|156843214|FG002|Overall Study|Lost to Follow-up|1|||
48725360|NCT01121588|156843212|FG000|Overall Study|Non-Specified Reasons|9|||
48725361|NCT01121588|156843213|FG001|Overall Study|Non-Specified Reasons|4|||
48725362|NCT01121588|156843214|FG002|Overall Study|Non-Specified Reasons|2|||
48725363|NCT00130442|156845021|FG000|Overall Study|Withdrawal by Subject|0|||
48725364|NCT00130442|156845022|FG001|Overall Study|Withdrawal by Subject|1|||
48725365|NCT00130442|156845021|FG000|Overall Study|did not meet criteria|1|||
48725366|NCT00130442|156845022|FG001|Overall Study|did not meet criteria|1|||
48725367|NCT01142089|156845024|FG000|Overall Study|Physician Decision|1|||
48725368|NCT01142089|156845025|FG001|Overall Study|Physician Decision|0|||
48725369|NCT01142089|156845024|FG000|Overall Study|Withdrawal by Subject|1|||
48725370|NCT01142089|156845025|FG001|Overall Study|Withdrawal by Subject|2|||
48820286|NCT03890120|157185467|FG000|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|119|||
48820287|NCT03890120|157185468|FG001|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|57|||
48820288|NCT03890120|157185469|FG002|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
48820289|NCT03890120|157185470|FG003|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
48820290|NCT03890120|157185467|FG000|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|17|||
48820291|NCT03890120|157185468|FG001|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|7|||
48820292|NCT03890120|157185469|FG002|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
48820293|NCT03890120|157185470|FG003|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
49134649|NCT01164475|158332152|FG000|Overall Study|Progressive disease|0|||
48725371|NCT01142089|156845024|FG000|Overall Study|Use of prohibited medications|0|||
48725372|NCT01142089|156845025|FG001|Overall Study|Use of prohibited medications|1|||
48725373|NCT01142089|156845024|FG000|Overall Study|Noncompliance with study procedures|2|||
48725374|NCT01142089|156845025|FG001|Overall Study|Noncompliance with study procedures|1|||
48725375|NCT01142089|156845024|FG000|Overall Study|Patient required rescue medication|8|||
49134650|NCT01164475|158332153|FG001|Overall Study|Progressive disease|1|||
48725376|NCT01142089|156845025|FG001|Overall Study|Patient required rescue medication|17|||
49134651|NCT01164475|158332152|FG000|Overall Study|Protocol Violation|1|||
49134652|NCT01164475|158332153|FG001|Overall Study|Protocol Violation|0|||
49134653|NCT02335944|158332154|FG000|Treatment Phase|Progressive Disease|2|||
49134654|NCT02335944|158332155|FG001|Treatment Phase|Progressive Disease|5|||
49134655|NCT02335944|158332156|FG002|Treatment Phase|Progressive Disease|2|||
49134656|NCT02335944|158332157|FG003|Treatment Phase|Progressive Disease|11|||
49134657|NCT02335944|158332158|FG004|Treatment Phase|Progressive Disease|4|||
49134658|NCT02335944|158332159|FG005|Treatment Phase|Progressive Disease|25|||
49134659|NCT02335944|158332160|FG006|Treatment Phase|Progressive Disease|2|||
49134660|NCT02335944|158332161|FG007|Treatment Phase|Progressive Disease|30|||
49134661|NCT02335944|158332162|FG008|Treatment Phase|Progressive Disease|27|||
49134662|NCT02335944|158332163|FG009|Treatment Phase|Progressive Disease|0|||
49134663|NCT02335944|158332154|FG000|Treatment Phase|Adverse Event|2|||
49134664|NCT02335944|158332155|FG001|Treatment Phase|Adverse Event|0|||
49134665|NCT02335944|158332156|FG002|Treatment Phase|Adverse Event|0|||
49134666|NCT02335944|158332157|FG003|Treatment Phase|Adverse Event|2|||
49134667|NCT02335944|158332158|FG004|Treatment Phase|Adverse Event|1|||
49134668|NCT02335944|158332159|FG005|Treatment Phase|Adverse Event|15|||
49134669|NCT02335944|158332160|FG006|Treatment Phase|Adverse Event|0|||
49134670|NCT02335944|158332161|FG007|Treatment Phase|Adverse Event|5|||
49134671|NCT02335944|158332162|FG008|Treatment Phase|Adverse Event|7|||
49134672|NCT02335944|158332163|FG009|Treatment Phase|Adverse Event|0|||
49134673|NCT02335944|158332154|FG000|Treatment Phase|Physician Decision|0|||
49134674|NCT02335944|158332155|FG001|Treatment Phase|Physician Decision|0|||
49134675|NCT02335944|158332156|FG002|Treatment Phase|Physician Decision|0|||
49134676|NCT02335944|158332157|FG003|Treatment Phase|Physician Decision|1|||
49134677|NCT02335944|158332158|FG004|Treatment Phase|Physician Decision|0|||
49134678|NCT02335944|158332159|FG005|Treatment Phase|Physician Decision|6|||
49134679|NCT02335944|158332160|FG006|Treatment Phase|Physician Decision|1|||
49134680|NCT02335944|158332161|FG007|Treatment Phase|Physician Decision|2|||
49134681|NCT02335944|158332162|FG008|Treatment Phase|Physician Decision|1|||
49134682|NCT02335944|158332163|FG009|Treatment Phase|Physician Decision|0|||
49134683|NCT02335944|158332154|FG000|Treatment Phase|Study Terminated By Sponsor|0|||
49134684|NCT02335944|158332155|FG001|Treatment Phase|Study Terminated By Sponsor|0|||
49134685|NCT02335944|158332156|FG002|Treatment Phase|Study Terminated By Sponsor|0|||
49134686|NCT02335944|158332157|FG003|Treatment Phase|Study Terminated By Sponsor|1|||
49134687|NCT02335944|158332158|FG004|Treatment Phase|Study Terminated By Sponsor|0|||
49134688|NCT02335944|158332159|FG005|Treatment Phase|Study Terminated By Sponsor|3|||
49134689|NCT02335944|158332160|FG006|Treatment Phase|Study Terminated By Sponsor|0|||
49134690|NCT02335944|158332161|FG007|Treatment Phase|Study Terminated By Sponsor|1|||
49134691|NCT02335944|158332162|FG008|Treatment Phase|Study Terminated By Sponsor|1|||
49134692|NCT02335944|158332163|FG009|Treatment Phase|Study Terminated By Sponsor|0|||
49134693|NCT02335944|158332154|FG000|Treatment Phase|Subject/Guardian Decision|0|||
49134694|NCT02335944|158332155|FG001|Treatment Phase|Subject/Guardian Decision|0|||
49134695|NCT02335944|158332156|FG002|Treatment Phase|Subject/Guardian Decision|1|||
49134696|NCT02335944|158332157|FG003|Treatment Phase|Subject/Guardian Decision|0|||
49134697|NCT02335944|158332158|FG004|Treatment Phase|Subject/Guardian Decision|0|||
49134698|NCT02335944|158332159|FG005|Treatment Phase|Subject/Guardian Decision|1|||
49134699|NCT02335944|158332160|FG006|Treatment Phase|Subject/Guardian Decision|0|||
49134700|NCT02335944|158332161|FG007|Treatment Phase|Subject/Guardian Decision|4|||
49134701|NCT02335944|158332162|FG008|Treatment Phase|Subject/Guardian Decision|0|||
49134702|NCT02335944|158332163|FG009|Treatment Phase|Subject/Guardian Decision|0|||
49134703|NCT02335944|158332154|FG000|Post-treatment Follow-up|Progressive Disease|0|||
49134704|NCT02335944|158332155|FG001|Post-treatment Follow-up|Progressive Disease|0|||
49134705|NCT02335944|158332156|FG002|Post-treatment Follow-up|Progressive Disease|0|||
49134706|NCT02335944|158332157|FG003|Post-treatment Follow-up|Progressive Disease|1|||
49134707|NCT02335944|158332158|FG004|Post-treatment Follow-up|Progressive Disease|0|||
49134708|NCT02335944|158332159|FG005|Post-treatment Follow-up|Progressive Disease|9|||
49134709|NCT02335944|158332160|FG006|Post-treatment Follow-up|Progressive Disease|0|||
49134710|NCT02335944|158332161|FG007|Post-treatment Follow-up|Progressive Disease|2|||
49134711|NCT02335944|158332162|FG008|Post-treatment Follow-up|Progressive Disease|3|||
49134712|NCT02335944|158332163|FG009|Post-treatment Follow-up|Progressive Disease|0|||
48725377|NCT02582255|156845026|FG000|Overall Study|Protocol Violation|0|||
48725378|NCT02582255|156845027|FG001|Overall Study|Protocol Violation|3|||
48725379|NCT01879579|156845028|FG000|Overall Study|Phone incompatible with texting platform|3|||
48725380|NCT01879579|156845029|FG001|Overall Study|Phone incompatible with texting platform|0|||
48725381|NCT01879579|156845028|FG000|Overall Study|Did not enroll in texting platform|1|||
48725382|NCT01879579|156845029|FG001|Overall Study|Did not enroll in texting platform|0|||
48725383|NCT01879579|156845028|FG000|Overall Study|Did not initiate insulin treatment|1|||
48725384|NCT01879579|156845029|FG001|Overall Study|Did not initiate insulin treatment|0|||
48725385|NCT01879579|156845028|FG000|Overall Study|Phenotypic type 1 diabetes|0|||
48725386|NCT01879579|156845029|FG001|Overall Study|Phenotypic type 1 diabetes|1|||
48725387|NCT01879579|156845028|FG000|Overall Study|Discontinued insulin - possible allergy|0|||
48725388|NCT01879579|156845029|FG001|Overall Study|Discontinued insulin - possible allergy|1|||
48725389|NCT02093351|156845031|FG000|Part A|Adverse Event|0|||
48725390|NCT02093351|156845032|FG001|Part A|Adverse Event|1|||
48725391|NCT02093351|156845033|FG002|Part A|Adverse Event|1|||
48725392|NCT02093351|156845034|FG003|Part A|Adverse Event|0|||
48725393|NCT02093351|156845031|FG000|Part A|Condition under investigation worsened|2|||
48725394|NCT02093351|156845032|FG001|Part A|Condition under investigation worsened|0|||
48725395|NCT02093351|156845033|FG002|Part A|Condition under investigation worsened|2|||
48725396|NCT02093351|156845034|FG003|Part A|Condition under investigation worsened|0|||
48725397|NCT02093351|156845031|FG000|Part A|Death|0|||
48725398|NCT02093351|156845032|FG001|Part A|Death|1|||
49134713|NCT02335944|158332154|FG000|Post-treatment Follow-up|Subject/Guardian Decision|0|||
49134714|NCT02335944|158332155|FG001|Post-treatment Follow-up|Subject/Guardian Decision|0|||
49134715|NCT02335944|158332156|FG002|Post-treatment Follow-up|Subject/Guardian Decision|0|||
49134716|NCT02335944|158332157|FG003|Post-treatment Follow-up|Subject/Guardian Decision|0|||
49134717|NCT02335944|158332158|FG004|Post-treatment Follow-up|Subject/Guardian Decision|0|||
48725399|NCT02093351|156845033|FG002|Part A|Death|0|||
48725400|NCT02093351|156845034|FG003|Part A|Death|0|||
48725401|NCT02093351|156845031|FG000|Part B|Patient decision|0|||
48725402|NCT02093351|156845032|FG001|Part B|Patient decision|0|||
48820294|NCT03890120|157185467|FG000|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|12|||
48820295|NCT03890120|157185468|FG001|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|4|||
48820296|NCT03890120|157185469|FG002|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
48820297|NCT03890120|157185470|FG003|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
48820298|NCT03890120|157185467|FG000|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|4|||
48820299|NCT03890120|157185468|FG001|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|1|||
48820300|NCT03890120|157185469|FG002|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
48820301|NCT03890120|157185470|FG003|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
48820302|NCT03890120|157185467|FG000|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|1|||
48820303|NCT03890120|157185468|FG001|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|2|||
48820304|NCT03890120|157185469|FG002|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
48820305|NCT03890120|157185470|FG003|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
48820306|NCT03890120|157185467|FG000|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|1|||
48820307|NCT03890120|157185468|FG001|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|2|||
48820308|NCT03890120|157185469|FG002|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
48820309|NCT03890120|157185470|FG003|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
48820310|NCT03890120|157185467|FG000|Blinded Treatment Phase (100.3 Weeks)|Death|1|||
48820311|NCT03890120|157185468|FG001|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
48820312|NCT03890120|157185469|FG002|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
48820313|NCT03890120|157185470|FG003|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
48820314|NCT03890120|157185467|FG000|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
48820315|NCT03890120|157185468|FG001|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|1|||
48820316|NCT03890120|157185469|FG002|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
48820317|NCT03890120|157185470|FG003|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
48820318|NCT03890120|157185467|FG000|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
48820319|NCT03890120|157185468|FG001|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|1|||
48820320|NCT03890120|157185469|FG002|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
48820321|NCT03890120|157185470|FG003|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
48820322|NCT03890120|157185467|FG000|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
48820323|NCT03890120|157185468|FG001|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
48820324|NCT03890120|157185469|FG002|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|76|||
48820325|NCT03890120|157185470|FG003|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|42|||
48820326|NCT03890120|157185467|FG000|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
48820327|NCT03890120|157185468|FG001|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
48820328|NCT03890120|157185469|FG002|Open-Label Extension Phase (45 Weeks)|Adverse Event|3|||
48820329|NCT03890120|157185470|FG003|Open-Label Extension Phase (45 Weeks)|Adverse Event|1|||
48820330|NCT03890120|157185467|FG000|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
48820331|NCT03890120|157185468|FG001|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
48820332|NCT03890120|157185469|FG002|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
48820333|NCT03890120|157185470|FG003|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|2|||
48820334|NCT03890120|157185467|FG000|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
48820335|NCT03890120|157185468|FG001|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
48820336|NCT03890120|157185469|FG002|Open-Label Extension Phase (45 Weeks)|Withdrew consent|1|||
48820337|NCT03890120|157185470|FG003|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
48820338|NCT02400307|157185477|FG000|Overall Study|Enrolled and Never Dosed|1|||
48820339|NCT02400307|157185478|FG001|Overall Study|Enrolled and Never Dosed|0|||
48820340|NCT03101592|157185485|FG000|Overall Study|participant files could not be located|111|||
48820341|NCT03101592|157185486|FG001|Overall Study|participant files could not be located|170|||
48820342|NCT03101592|157185487|FG002|Overall Study|participant files could not be located|118|||
48820343|NCT03255941|157185488|FG000|Overall Study|Not eligible or refused injection|37|||
48820344|NCT03255941|157185489|FG001|Overall Study|Not eligible or refused injection|44|||
48820345|NCT03255941|157185490|FG002|Overall Study|Not eligible or refused injection|5|||
48820346|NCT03255941|157185491|FG003|Overall Study|Not eligible or refused injection|6|||
48820347|NCT03255941|157185488|FG000|Overall Study|Did not complete exit interview|1|||
48820348|NCT03255941|157185489|FG001|Overall Study|Did not complete exit interview|2|||
48820349|NCT03255941|157185490|FG002|Overall Study|Did not complete exit interview|0|||
48820350|NCT03255941|157185491|FG003|Overall Study|Did not complete exit interview|0|||
48820351|NCT01052662|157185492|FG000|Overall Study|Lost to Follow-up|15|||
48820352|NCT01052662|157185493|FG001|Overall Study|Lost to Follow-up|13|||
49134718|NCT02335944|158332159|FG005|Post-treatment Follow-up|Subject/Guardian Decision|2|||
49134719|NCT02335944|158332160|FG006|Post-treatment Follow-up|Subject/Guardian Decision|0|||
49134720|NCT02335944|158332161|FG007|Post-treatment Follow-up|Subject/Guardian Decision|0|||
49134721|NCT02335944|158332162|FG008|Post-treatment Follow-up|Subject/Guardian Decision|0|||
49134722|NCT02335944|158332163|FG009|Post-treatment Follow-up|Subject/Guardian Decision|0|||
49134723|NCT02335944|158332154|FG000|Post-treatment Follow-up|Terminated by Sponsor|0|||
49134724|NCT02335944|158332155|FG001|Post-treatment Follow-up|Terminated by Sponsor|0|||
49134725|NCT02335944|158332156|FG002|Post-treatment Follow-up|Terminated by Sponsor|0|||
49134726|NCT02335944|158332157|FG003|Post-treatment Follow-up|Terminated by Sponsor|0|||
49134727|NCT02335944|158332158|FG004|Post-treatment Follow-up|Terminated by Sponsor|0|||
49134728|NCT02335944|158332159|FG005|Post-treatment Follow-up|Terminated by Sponsor|0|||
48725403|NCT02093351|156845033|FG002|Part B|Patient decision|0|||
48725404|NCT02093351|156845034|FG003|Part B|Patient decision|3|||
48725405|NCT02093351|156845031|FG000|Part B|Disease progression|0|||
48725406|NCT02093351|156845032|FG001|Part B|Disease progression|0|||
48725407|NCT02093351|156845033|FG002|Part B|Disease progression|0|||
49134729|NCT02335944|158332160|FG006|Post-treatment Follow-up|Terminated by Sponsor|0|||
49134730|NCT02335944|158332161|FG007|Post-treatment Follow-up|Terminated by Sponsor|2|||
49134731|NCT02335944|158332162|FG008|Post-treatment Follow-up|Terminated by Sponsor|0|||
49134732|NCT02335944|158332163|FG009|Post-treatment Follow-up|Terminated by Sponsor|0|||
49134733|NCT02335944|158332154|FG000|Post-treatment Follow-up|Adverse Event|0|||
49134734|NCT02335944|158332155|FG001|Post-treatment Follow-up|Adverse Event|0|||
49134735|NCT02335944|158332156|FG002|Post-treatment Follow-up|Adverse Event|0|||
49134736|NCT02335944|158332157|FG003|Post-treatment Follow-up|Adverse Event|0|||
49134737|NCT02335944|158332158|FG004|Post-treatment Follow-up|Adverse Event|0|||
49134738|NCT02335944|158332159|FG005|Post-treatment Follow-up|Adverse Event|1|||
49134739|NCT02335944|158332160|FG006|Post-treatment Follow-up|Adverse Event|0|||
49134740|NCT02335944|158332161|FG007|Post-treatment Follow-up|Adverse Event|0|||
49134741|NCT02335944|158332162|FG008|Post-treatment Follow-up|Adverse Event|0|||
49134742|NCT02335944|158332163|FG009|Post-treatment Follow-up|Adverse Event|0|||
49134743|NCT02335944|158332154|FG000|Post-treatment Follow-up|Death|0|||
49134744|NCT02335944|158332155|FG001|Post-treatment Follow-up|Death|0|||
49134745|NCT02335944|158332156|FG002|Post-treatment Follow-up|Death|0|||
49134746|NCT02335944|158332157|FG003|Post-treatment Follow-up|Death|1|||
49134747|NCT02335944|158332158|FG004|Post-treatment Follow-up|Death|0|||
49134748|NCT02335944|158332159|FG005|Post-treatment Follow-up|Death|1|||
49134749|NCT02335944|158332160|FG006|Post-treatment Follow-up|Death|0|||
49134750|NCT02335944|158332161|FG007|Post-treatment Follow-up|Death|0|||
49134751|NCT02335944|158332162|FG008|Post-treatment Follow-up|Death|0|||
49134752|NCT02335944|158332163|FG009|Post-treatment Follow-up|Death|0|||
49134753|NCT02335944|158332154|FG000|Post-treatment Follow-up|Physician Decision|1|||
49134754|NCT02335944|158332155|FG001|Post-treatment Follow-up|Physician Decision|0|||
49134755|NCT02335944|158332156|FG002|Post-treatment Follow-up|Physician Decision|0|||
49134756|NCT02335944|158332157|FG003|Post-treatment Follow-up|Physician Decision|0|||
49134757|NCT02335944|158332158|FG004|Post-treatment Follow-up|Physician Decision|0|||
49134758|NCT02335944|158332159|FG005|Post-treatment Follow-up|Physician Decision|0|||
49134759|NCT02335944|158332160|FG006|Post-treatment Follow-up|Physician Decision|0|||
49134760|NCT02335944|158332161|FG007|Post-treatment Follow-up|Physician Decision|1|||
49134761|NCT02335944|158332162|FG008|Post-treatment Follow-up|Physician Decision|0|||
49134762|NCT02335944|158332163|FG009|Post-treatment Follow-up|Physician Decision|0|||
49134763|NCT01202591|158332164|FG000|Overall Study|Adverse Event|2|||
49134764|NCT01202591|158332165|FG001|Overall Study|Adverse Event|1|||
49134765|NCT01202591|158332166|FG002|Overall Study|Adverse Event|4|||
49134766|NCT01202591|158332167|FG003|Overall Study|Adverse Event|4|||
49134767|NCT01202591|158332168|FG004|Overall Study|Adverse Event|0|||
49134768|NCT01202591|158332169|FG005|Overall Study|Adverse Event|0|||
49134769|NCT01202591|158332164|FG000|Overall Study|Other reason as per investigator|3|||
49134770|NCT01202591|158332165|FG001|Overall Study|Other reason as per investigator|4|||
49134771|NCT01202591|158332166|FG002|Overall Study|Other reason as per investigator|7|||
49134772|NCT01202591|158332167|FG003|Overall Study|Other reason as per investigator|3|||
49134773|NCT01202591|158332168|FG004|Overall Study|Other reason as per investigator|1|||
49134774|NCT01202591|158332169|FG005|Overall Study|Other reason as per investigator|3|||
49134775|NCT01202591|158332164|FG000|Overall Study|Withdrawal by Subject|0|||
49134776|NCT01202591|158332165|FG001|Overall Study|Withdrawal by Subject|0|||
49134777|NCT01202591|158332166|FG002|Overall Study|Withdrawal by Subject|0|||
49134778|NCT01202591|158332167|FG003|Overall Study|Withdrawal by Subject|0|||
49134779|NCT01202591|158332168|FG004|Overall Study|Withdrawal by Subject|2|||
49134780|NCT01202591|158332169|FG005|Overall Study|Withdrawal by Subject|1|||
49134781|NCT01202591|158332164|FG000|Overall Study|Objective Disease Progression|0|||
48725408|NCT02093351|156845034|FG003|Part B|Disease progression|4|||
48725409|NCT02093351|156845031|FG000|Part B|Complete response|0|||
48725410|NCT02093351|156845032|FG001|Part B|Complete response|0|||
48725411|NCT02093351|156845033|FG002|Part B|Complete response|0|||
48725412|NCT02093351|156845034|FG003|Part B|Complete response|1|||
48725413|NCT02093351|156845031|FG000|Part B|Adverse event + disease progression|0|||
49134782|NCT01202591|158332165|FG001|Overall Study|Objective Disease Progression|0|||
48725414|NCT02093351|156845032|FG001|Part B|Adverse event + disease progression|0|||
48725415|NCT02093351|156845033|FG002|Part B|Adverse event + disease progression|0|||
48725416|NCT02093351|156845034|FG003|Part B|Adverse event + disease progression|1|||
48820353|NCT01052662|157185494|FG002|Overall Study|Lost to Follow-up|18|||
49134783|NCT01202591|158332166|FG002|Overall Study|Objective Disease Progression|0|||
49134784|NCT01202591|158332167|FG003|Overall Study|Objective Disease Progression|0|||
49134785|NCT01202591|158332168|FG004|Overall Study|Objective Disease Progression|2|||
49134786|NCT01202591|158332169|FG005|Overall Study|Objective Disease Progression|0|||
49134787|NCT02406612|158332174|FG000|Overall Study|Screening Failure|3|||
49134788|NCT02406612|158332175|FG001|Overall Study|Screening Failure|0|||
49134789|NCT02406612|158332174|FG000|Overall Study|Intra-procedural Exclusion|1|||
49134790|NCT02406612|158332175|FG001|Overall Study|Intra-procedural Exclusion|3|||
49134791|NCT02406612|158332174|FG000|Overall Study|Guidewire Failure|0|||
49134792|NCT02406612|158332175|FG001|Overall Study|Guidewire Failure|1|||
49134793|NCT00959751|158333214|FG000|Overall Study|Lost to Follow-up|2|||
49134794|NCT00959751|158333215|FG001|Overall Study|Lost to Follow-up|3|||
49134795|NCT00959751|158333214|FG000|Overall Study|Consent Withdrawn|0|||
49134796|NCT00959751|158333215|FG001|Overall Study|Consent Withdrawn|1|||
49134797|NCT00959751|158333214|FG000|Overall Study|Non-compliance to Study Procedures|0|||
48725417|NCT02093351|156845031|FG000|Part B|Lack of therapeutic response|0|||
48725418|NCT02093351|156845032|FG001|Part B|Lack of therapeutic response|0|||
48725419|NCT02093351|156845033|FG002|Part B|Lack of therapeutic response|0|||
48725420|NCT02093351|156845034|FG003|Part B|Lack of therapeutic response|12|||
48725421|NCT02093351|156845031|FG000|Part B|Condition under investigation worsened|0|||
48725422|NCT02093351|156845032|FG001|Part B|Condition under investigation worsened|0|||
48725423|NCT02093351|156845033|FG002|Part B|Condition under investigation worsened|0|||
48725424|NCT02093351|156845034|FG003|Part B|Condition under investigation worsened|39|||
48725425|NCT02093351|156845031|FG000|Part B|Adverse Event|0|||
48725426|NCT02093351|156845032|FG001|Part B|Adverse Event|0|||
48725427|NCT02093351|156845033|FG002|Part B|Adverse Event|0|||
48725428|NCT02093351|156845034|FG003|Part B|Adverse Event|2|||
48725429|NCT02093351|156845031|FG000|Part B|Death|0|||
48725430|NCT02093351|156845032|FG001|Part B|Death|0|||
48725431|NCT02093351|156845033|FG002|Part B|Death|0|||
48725432|NCT02093351|156845034|FG003|Part B|Death|1|||
48725433|NCT00706849|156845041|FG000|Treatment Period|Adverse Event|0|||
48725434|NCT00706849|156845042|FG001|Treatment Period|Adverse Event|9|||
48725435|NCT00706849|156845041|FG000|Treatment Period|Other|0|||
48725436|NCT00706849|156845042|FG001|Treatment Period|Other|1|||
48725437|NCT00706849|156845041|FG000|Follow-up Period|Withdrawal by Subject|0|||
48725438|NCT00706849|156845042|FG001|Follow-up Period|Withdrawal by Subject|2|||
48725439|NCT00706849|156845041|FG000|Follow-up Period|Protocol non-compliance|0|||
48725440|NCT00706849|156845042|FG001|Follow-up Period|Protocol non-compliance|1|||
48725441|NCT00588952|156845043|FG000|Overall Study|Adverse Event|0|||
48725442|NCT00588952|156845044|FG001|Overall Study|Adverse Event|2|||
48725443|NCT00588952|156845043|FG000|Overall Study|Withdrawal by Subject|3|||
48725444|NCT00588952|156845044|FG001|Overall Study|Withdrawal by Subject|5|||
48725445|NCT01461057|156845045|FG000|Overall Study|Death|10|||
48725446|NCT01461057|156845046|FG001|Overall Study|Death|9|||
48725447|NCT01461057|156845045|FG000|Overall Study|Withdrawal by Subject|2|||
48725448|NCT01461057|156845046|FG001|Overall Study|Withdrawal by Subject|3|||
48725449|NCT01461057|156845045|FG000|Overall Study|Physician Decision|0|||
48725450|NCT01461057|156845046|FG001|Overall Study|Physician Decision|2|||
48725451|NCT01461057|156845045|FG000|Overall Study|Adverse Event|0|||
48725452|NCT01461057|156845046|FG001|Overall Study|Adverse Event|1|||
48725453|NCT01461057|156845045|FG000|Overall Study|Progression of Disease|1|||
48725454|NCT01461057|156845046|FG001|Overall Study|Progression of Disease|0|||
48725455|NCT01461057|156845045|FG000|Overall Study|Study Terminated by Sponsor|2|||
48725456|NCT01461057|156845046|FG001|Overall Study|Study Terminated by Sponsor|0|||
48725457|NCT00039871|156845047|FG000|Overall Study|Adverse Event|165|||
48725458|NCT00039871|156845047|FG000|Overall Study|Lost to Follow-up|18|||
48725459|NCT00039871|156845047|FG000|Overall Study|Protocol Violation|24|||
48725460|NCT00039871|156845047|FG000|Overall Study|Withdrawal by Subject|97|||
48725461|NCT00039871|156845047|FG000|Overall Study|Did not meet eligibility criteria|11|||
48725462|NCT00039871|156845047|FG000|Overall Study|Administrative|1|||
48725463|NCT00039871|156845047|FG000|Overall Study|Discontinued at Week 12 per protocol|1061|||
48725464|NCT00039871|156845047|FG000|Overall Study|Never entered follow-up|7|||
48725465|NCT03361176|156845052|FG000|Overall Study|Lost to Follow-up|1|||
48725466|NCT03361176|156845053|FG001|Overall Study|Lost to Follow-up|2|||
48725467|NCT03361176|156845052|FG000|Overall Study|Adverse Event|0|||
48725468|NCT03361176|156845053|FG001|Overall Study|Adverse Event|2|||
48725469|NCT03361176|156845052|FG000|Overall Study|Withdrawal by Subject|0|||
48725470|NCT03361176|156845053|FG001|Overall Study|Withdrawal by Subject|1|||
48725471|NCT03718299|156845054|FG000|Overall Study|Adverse Event|1|||
48725472|NCT03718299|156845054|FG000|Overall Study|Withdrawal by Subject|6|||
48725473|NCT03718299|156845054|FG000|Overall Study|Physician Decision|2|||
48725474|NCT03718299|156845054|FG000|Overall Study|Lost to Follow-up|1|||
48725475|NCT03123185|156845055|FG000|Overall Study|Withdrawal by Subject|0|||
48725476|NCT03123185|156845056|FG001|Overall Study|Withdrawal by Subject|0|||
48725477|NCT03123185|156845057|FG002|Overall Study|Withdrawal by Subject|0|||
48725478|NCT03123185|156845058|FG003|Overall Study|Withdrawal by Subject|0|||
49134798|NCT00959751|158333215|FG001|Overall Study|Non-compliance to Study Procedures|1|||
49134799|NCT00959751|158333214|FG000|Overall Study|No migraine headache without aura|7|||
49134800|NCT00959751|158333215|FG001|Overall Study|No migraine headache without aura|7|||
49134801|NCT03846479|158333216|FG000|Overall Study|Death|8|||
49134802|NCT03846479|158333216|FG000|Overall Study|Lost to Follow-up|1|||
49134803|NCT05177094|158333217|FG000|Overall Study|Adverse Event|5|||
49134804|NCT05177094|158333218|FG001|Overall Study|Adverse Event|5|||
49134805|NCT05177094|158333217|FG000|Overall Study|Non-compliance With Study Drug and Procedures|0|||
49134806|NCT05177094|158333218|FG001|Overall Study|Non-compliance With Study Drug and Procedures|1|||
48725479|NCT03123185|156845059|FG004|Overall Study|Withdrawal by Subject|0|||
48725480|NCT03123185|156845060|FG005|Overall Study|Withdrawal by Subject|0|||
48725481|NCT03123185|156845061|FG006|Overall Study|Withdrawal by Subject|0|||
48725482|NCT03123185|156845062|FG007|Overall Study|Withdrawal by Subject|0|||
48725483|NCT03123185|156845063|FG008|Overall Study|Withdrawal by Subject|0|||
48725484|NCT03123185|156845064|FG009|Overall Study|Withdrawal by Subject|0|||
48725485|NCT03123185|156845065|FG010|Overall Study|Withdrawal by Subject|0|||
48725486|NCT03123185|156845066|FG011|Overall Study|Withdrawal by Subject|0|||
48725487|NCT03123185|156845067|FG012|Overall Study|Withdrawal by Subject|1|||
48725488|NCT03123185|156845068|FG013|Overall Study|Withdrawal by Subject|0|||
48725489|NCT04352127|156845075|FG000|Overall Study|Unable to obtain readings|4|||
48725490|NCT04352127|156845076|FG001|Overall Study|Unable to obtain readings|1|||
48725491|NCT04535167|156845079|FG000|Treatment|Adverse Event|0|||
48725492|NCT04535167|156845080|FG001|Treatment|Adverse Event|0|||
48725493|NCT04535167|156845081|FG002|Treatment|Adverse Event|0|||
48725494|NCT04535167|156845082|FG003|Treatment|Adverse Event|0|||
48725495|NCT04535167|156845083|FG004|Treatment|Adverse Event|0|||
48725496|NCT04535167|156845084|FG005|Treatment|Adverse Event|0|||
48725497|NCT04535167|156845085|FG006|Treatment|Adverse Event|1|||
48725498|NCT04535167|156845079|FG000|Follow-Up|Death|0|||
48725499|NCT04535167|156845080|FG001|Follow-Up|Death|0|||
48725500|NCT04535167|156845081|FG002|Follow-Up|Death|0|||
48725501|NCT04535167|156845082|FG003|Follow-Up|Death|0|||
48725502|NCT04535167|156845083|FG004|Follow-Up|Death|0|||
48725503|NCT04535167|156845084|FG005|Follow-Up|Death|0|||
48725504|NCT04535167|156845085|FG006|Follow-Up|Death|1|||
48725505|NCT04535167|156845079|FG000|Follow-Up|Lost to Follow-up|0|||
48725506|NCT04535167|156845080|FG001|Follow-Up|Lost to Follow-up|0|||
48725507|NCT04535167|156845081|FG002|Follow-Up|Lost to Follow-up|0|||
48725508|NCT04535167|156845082|FG003|Follow-Up|Lost to Follow-up|1|||
48725509|NCT04535167|156845083|FG004|Follow-Up|Lost to Follow-up|0|||
48725510|NCT04535167|156845084|FG005|Follow-Up|Lost to Follow-up|0|||
48725511|NCT04535167|156845085|FG006|Follow-Up|Lost to Follow-up|0|||
48725512|NCT03584373|156845088|FG000|Overall Study|Lost to Follow-up|7|||
48725513|NCT03584373|156845089|FG001|Overall Study|Lost to Follow-up|8|||
48725514|NCT01487577|156845090|FG000|Overall Study|Became ineligible after signing consent|1|||
48725515|NCT04369924|156845091|FG000|Overall Study|Lost to Follow-up|302|||
48725516|NCT04369924|156845092|FG001|Overall Study|Lost to Follow-up|339|||
48725517|NCT01850602|156845094|FG000|Overall Study|Adverse Event|7|||
48725518|NCT01850602|156845095|FG001|Overall Study|Adverse Event|10|||
48725519|NCT01850602|156845094|FG000|Overall Study|Physician Decision|2|||
48725520|NCT01850602|156845095|FG001|Overall Study|Physician Decision|1|||
48725521|NCT01850602|156845094|FG000|Overall Study|Withdrawal by Subject|2|||
48725522|NCT01850602|156845095|FG001|Overall Study|Withdrawal by Subject|4|||
48725523|NCT01850602|156845094|FG000|Overall Study|Decrease in serum calcium|2|||
48725524|NCT01850602|156845095|FG001|Overall Study|Decrease in serum calcium|3|||
48725525|NCT01850602|156845094|FG000|Overall Study|Increase in serum ferritin|1|||
48725526|NCT01850602|156845095|FG001|Overall Study|Increase in serum ferritin|0|||
48725527|NCT01209832|156845096|FG000|Period 1|Sponsor Decision and was not dosed|1|||
48725528|NCT01209832|156845096|FG000|Period 2|Sponsor Decision|1|||
48725529|NCT02360605|156845098|FG000|Overall Study|Withdrawal by Subject|4|||
48725530|NCT02360605|156845099|FG001|Overall Study|Withdrawal by Subject|9|||
48725531|NCT02360605|156845098|FG000|Overall Study|Lost to Follow-up|7|||
48725532|NCT02360605|156845099|FG001|Overall Study|Lost to Follow-up|8|||
48725533|NCT02360605|156845098|FG000|Overall Study|Death|0|||
48725534|NCT02360605|156845099|FG001|Overall Study|Death|1|||
48725535|NCT01933789|156845100|FG000|Overall Study|Death|0|||
48725536|NCT01933789|156845101|FG001|Overall Study|Death|0|||
48725537|NCT01933789|156845102|FG002|Overall Study|Death|0|||
48725538|NCT01933789|156845103|FG003|Overall Study|Death|0|||
48725539|NCT01933789|156845104|FG004|Overall Study|Death|21|||
48725540|NCT01933789|156845105|FG005|Overall Study|Death|32|||
48725541|NCT01933789|156845106|FG006|Overall Study|Death|0|||
48725542|NCT01933789|156845107|FG007|Overall Study|Death|0|||
48725543|NCT01933789|156845108|FG008|Overall Study|Death|0|||
48725544|NCT01933789|156845100|FG000|Overall Study|Lost to Follow-up|0|||
48725545|NCT01933789|156845101|FG001|Overall Study|Lost to Follow-up|0|||
48725546|NCT01933789|156845102|FG002|Overall Study|Lost to Follow-up|0|||
48725547|NCT01933789|156845103|FG003|Overall Study|Lost to Follow-up|1|||
48725548|NCT01933789|156845104|FG004|Overall Study|Lost to Follow-up|8|||
48725549|NCT01933789|156845105|FG005|Overall Study|Lost to Follow-up|9|||
48725550|NCT01933789|156845106|FG006|Overall Study|Lost to Follow-up|1|||
48725551|NCT01933789|156845107|FG007|Overall Study|Lost to Follow-up|4|||
48725552|NCT01933789|156845108|FG008|Overall Study|Lost to Follow-up|0|||
48725553|NCT01933789|156845100|FG000|Overall Study|Withdrawal by Subject|2|||
48725554|NCT01933789|156845101|FG001|Overall Study|Withdrawal by Subject|1|||
48725555|NCT01933789|156845102|FG002|Overall Study|Withdrawal by Subject|0|||
48725556|NCT01933789|156845103|FG003|Overall Study|Withdrawal by Subject|0|||
48725557|NCT01933789|156845104|FG004|Overall Study|Withdrawal by Subject|17|||
48725558|NCT01933789|156845105|FG005|Overall Study|Withdrawal by Subject|16|||
48725559|NCT01933789|156845106|FG006|Overall Study|Withdrawal by Subject|1|||
48725560|NCT01933789|156845107|FG007|Overall Study|Withdrawal by Subject|4|||
48725561|NCT01933789|156845108|FG008|Overall Study|Withdrawal by Subject|0|||
48725562|NCT01933789|156845100|FG000|Overall Study|Became Ineligible|4|||
48725563|NCT01933789|156845101|FG001|Overall Study|Became Ineligible|0|||
48725564|NCT01933789|156845102|FG002|Overall Study|Became Ineligible|0|||
48725565|NCT01933789|156845103|FG003|Overall Study|Became Ineligible|0|||
48725566|NCT01933789|156845104|FG004|Overall Study|Became Ineligible|13|||
48725567|NCT01933789|156845105|FG005|Overall Study|Became Ineligible|10|||
48725568|NCT01933789|156845106|FG006|Overall Study|Became Ineligible|13|||
48725569|NCT01933789|156845107|FG007|Overall Study|Became Ineligible|6|||
48725570|NCT01933789|156845108|FG008|Overall Study|Became Ineligible|0|||
48725571|NCT01525901|156845114|FG000|Period 2: 12 Weeks|Adverse Event|0|||
48725572|NCT01525901|156845115|FG001|Period 2: 12 Weeks|Adverse Event|1|||
48725573|NCT01525901|156845116|FG002|Period 2: 12 Weeks|Adverse Event|0|||
48725574|NCT01525901|156845117|FG003|Period 2: 12 Weeks|Adverse Event|0|||
48725575|NCT04449029|156845118|FG000|Overall Study|Adverse Event|0|||
48725576|NCT04449029|156845119|FG001|Overall Study|Adverse Event|1|||
48725577|NCT04449029|156845120|FG002|Overall Study|Adverse Event|1|||
48725578|NCT04449029|156845121|FG003|Overall Study|Adverse Event|0|||
48725579|NCT04449029|156845122|FG004|Overall Study|Adverse Event|1|||
48725580|NCT04449029|156845123|FG005|Overall Study|Adverse Event|0|||
48725581|NCT04449029|156845124|FG006|Overall Study|Adverse Event|1|||
48725582|NCT04449029|156845125|FG007|Overall Study|Adverse Event|0|||
48725583|NCT04449029|156845118|FG000|Overall Study|Lost to Follow-up|0|||
48725584|NCT04449029|156845119|FG001|Overall Study|Lost to Follow-up|1|||
48725585|NCT04449029|156845120|FG002|Overall Study|Lost to Follow-up|0|||
48725586|NCT04449029|156845121|FG003|Overall Study|Lost to Follow-up|0|||
48725587|NCT04449029|156845122|FG004|Overall Study|Lost to Follow-up|0|||
48725588|NCT04449029|156845123|FG005|Overall Study|Lost to Follow-up|0|||
48725589|NCT04449029|156845124|FG006|Overall Study|Lost to Follow-up|0|||
48725590|NCT04449029|156845125|FG007|Overall Study|Lost to Follow-up|0|||
48725591|NCT04449029|156845118|FG000|Overall Study|Protocol Violation|0|||
48725592|NCT04449029|156845119|FG001|Overall Study|Protocol Violation|1|||
48725593|NCT04449029|156845120|FG002|Overall Study|Protocol Violation|0|||
48725594|NCT04449029|156845121|FG003|Overall Study|Protocol Violation|0|||
48725595|NCT04449029|156845122|FG004|Overall Study|Protocol Violation|0|||
48725596|NCT04449029|156845123|FG005|Overall Study|Protocol Violation|0|||
48725597|NCT04449029|156845124|FG006|Overall Study|Protocol Violation|0|||
48725598|NCT04449029|156845125|FG007|Overall Study|Protocol Violation|0|||
48725599|NCT04449029|156845118|FG000|Overall Study|Physician Decision|0|||
48725600|NCT04449029|156845119|FG001|Overall Study|Physician Decision|0|||
48725601|NCT04449029|156845120|FG002|Overall Study|Physician Decision|0|||
48725602|NCT04449029|156845121|FG003|Overall Study|Physician Decision|0|||
48725603|NCT04449029|156845122|FG004|Overall Study|Physician Decision|0|||
48725604|NCT04449029|156845123|FG005|Overall Study|Physician Decision|1|||
48725605|NCT04449029|156845124|FG006|Overall Study|Physician Decision|0|||
48725606|NCT04449029|156845125|FG007|Overall Study|Physician Decision|0|||
48725607|NCT04449029|156845118|FG000|Overall Study|Withdrawal by Subject|3|||
48725608|NCT04449029|156845119|FG001|Overall Study|Withdrawal by Subject|0|||
48725609|NCT04449029|156845120|FG002|Overall Study|Withdrawal by Subject|1|||
48725610|NCT04449029|156845121|FG003|Overall Study|Withdrawal by Subject|1|||
48725611|NCT04449029|156845122|FG004|Overall Study|Withdrawal by Subject|5|||
48725612|NCT04449029|156845123|FG005|Overall Study|Withdrawal by Subject|1|||
48725613|NCT04449029|156845124|FG006|Overall Study|Withdrawal by Subject|4|||
48725614|NCT04449029|156845125|FG007|Overall Study|Withdrawal by Subject|0|||
48725615|NCT03901456|156845126|FG000|Overall Study|Withdrawal by Subject|0|||
48725616|NCT03901456|156845127|FG001|Overall Study|Withdrawal by Subject|0|||
48725617|NCT03901456|156845128|FG002|Overall Study|Withdrawal by Subject|1|||
48725618|NCT03901456|156845126|FG000|Overall Study|Lost to Follow-up|0|||
48725619|NCT03901456|156845127|FG001|Overall Study|Lost to Follow-up|1|||
48725620|NCT03901456|156845128|FG002|Overall Study|Lost to Follow-up|0|||
48725621|NCT00814801|156845137|FG000|Overall Study|Adverse Event|15|||
49134807|NCT05177094|158333217|FG000|Overall Study|Protocol Deviation|3|||
49134808|NCT05177094|158333218|FG001|Overall Study|Protocol Deviation|0|||
48820354|NCT01052662|157185492|FG000|Overall Study|Withdrawal by Subject|3|||
48820355|NCT01052662|157185493|FG001|Overall Study|Withdrawal by Subject|2|||
48820356|NCT01052662|157185494|FG002|Overall Study|Withdrawal by Subject|1|||
48820357|NCT01052662|157185492|FG000|Overall Study|Pharmacy issue|1|||
48820358|NCT01052662|157185493|FG001|Overall Study|Pharmacy issue|3|||
48820359|NCT01052662|157185494|FG002|Overall Study|Pharmacy issue|3|||
48820360|NCT01052662|157185492|FG000|Overall Study|Adverse Event|1|||
48820361|NCT01052662|157185493|FG001|Overall Study|Adverse Event|1|||
48820362|NCT01052662|157185494|FG002|Overall Study|Adverse Event|0|||
48820363|NCT01052662|157185492|FG000|Overall Study|Legal Problem|2|||
48820364|NCT01052662|157185493|FG001|Overall Study|Legal Problem|0|||
48820365|NCT01052662|157185494|FG002|Overall Study|Legal Problem|0|||
48820366|NCT01052662|157185492|FG000|Overall Study|Administrative|0|||
48820367|NCT01052662|157185493|FG001|Overall Study|Administrative|3|||
48820368|NCT01052662|157185494|FG002|Overall Study|Administrative|0|||
48820369|NCT03523871|157185495|FG000|Overall Study|Death|1|||
48820370|NCT00372060|157185496|FG000|Period I - Double-blind (Weeks 0-12)|Adverse Event|2|||
48820371|NCT00372060|157185497|FG001|Period I - Double-blind (Weeks 0-12)|Adverse Event|0|||
48820372|NCT00372060|157185496|FG000|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0|||
48820373|NCT00372060|157185497|FG001|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1|||
48820374|NCT00372060|157185496|FG000|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1|||
48820375|NCT00372060|157185497|FG001|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0|||
48820376|NCT00372060|157185496|FG000|Period II - Open-label (Weeks 12-52)|Adverse Event|3|||
48820377|NCT00372060|157185497|FG001|Period II - Open-label (Weeks 12-52)|Adverse Event|0|||
48820378|NCT00372060|157185496|FG000|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9|||
48820379|NCT00372060|157185497|FG001|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8|||
48820380|NCT00372060|157185496|FG000|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2|||
49134809|NCT05177094|158333217|FG000|Overall Study|Withdrawal by Subject|6|||
49134810|NCT05177094|158333218|FG001|Overall Study|Withdrawal by Subject|3|||
48820381|NCT00372060|157185497|FG001|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0|||
48820382|NCT01579578|157185500|FG000|Overall Study|Death|4|||
48820383|NCT01579578|157185501|FG001|Overall Study|Death|1|||
48820384|NCT01579578|157185500|FG000|Overall Study|Lost to Follow-up|1|||
48820385|NCT01579578|157185501|FG001|Overall Study|Lost to Follow-up|1|||
48820386|NCT01579578|157185500|FG000|Overall Study|Withdrawal by Subject|2|||
48820387|NCT01579578|157185501|FG001|Overall Study|Withdrawal by Subject|1|||
48820388|NCT01579578|157185500|FG000|Overall Study|Eligibility criteria|3|||
48820389|NCT01579578|157185501|FG001|Overall Study|Eligibility criteria|9|||
49134811|NCT05177094|158333217|FG000|Overall Study|Participant could not tolerate long study visits|1|||
49134812|NCT05177094|158333218|FG001|Overall Study|Participant could not tolerate long study visits|0|||
49134813|NCT03600350|158333219|FG000|Overall Study|Death|1|||
49134814|NCT03600350|158333219|FG000|Overall Study|On Follow Up|18|||
49134815|NCT01006629|158333220|FG000|Overall Study|Adverse Event|1|||
49134816|NCT01006629|158333220|FG000|Overall Study|Parent refused to continue participation|1|||
49134817|NCT01006629|158333220|FG000|Overall Study|Parent unable to perform site visit|4|||
49134818|NCT00782067|158333225|FG000|Overall Study|Adverse Event|35|||
49134819|NCT00782067|158333225|FG000|Overall Study|Subject withdrew consent|11|||
49134820|NCT00782067|158333225|FG000|Overall Study|Lost to Follow-up|2|||
49134821|NCT00782067|158333225|FG000|Overall Study|Administrative problems|14|||
49134822|NCT00782067|158333225|FG000|Overall Study|Death|9|||
49134823|NCT00782067|158333225|FG000|Overall Study|Disease progression|43|||
49134824|NCT00782067|158333225|FG000|Overall Study|Protocol deviation|2|||
48820390|NCT01579578|157185500|FG000|Overall Study|Ongoing|3|||
48820391|NCT01579578|157185501|FG001|Overall Study|Ongoing|0|||
48820392|NCT02015663|157185503|FG000|Overall Study|unsatisfactory therapeutic effect|1|||
48820393|NCT02015663|157185504|FG001|Overall Study|unsatisfactory therapeutic effect|0|||
48820394|NCT02015663|157185503|FG000|Overall Study|Withdrawal by Subject|1|||
49134825|NCT01134042|158333226|FG000|Overall Study|Adverse Event|3|||
49134826|NCT01134042|158333227|FG001|Overall Study|Adverse Event|7|||
49134827|NCT01134042|158333228|FG002|Overall Study|Adverse Event|2|||
49134828|NCT01134042|158333226|FG000|Overall Study|Lack of Efficacy|21|||
48820395|NCT02015663|157185504|FG001|Overall Study|Withdrawal by Subject|0|||
48820396|NCT02015663|157185503|FG000|Overall Study|Protocol Violation|0|||
48820397|NCT02015663|157185504|FG001|Overall Study|Protocol Violation|1|||
48820398|NCT02015663|157185503|FG000|Overall Study|Adverse Event|3|||
48820399|NCT02015663|157185504|FG001|Overall Study|Adverse Event|0|||
48820400|NCT02015663|157185503|FG000|Overall Study|Administrative problems|10|||
48820401|NCT02015663|157185504|FG001|Overall Study|Administrative problems|11|||
49134829|NCT01134042|158333227|FG001|Overall Study|Lack of Efficacy|6|||
49134830|NCT01134042|158333228|FG002|Overall Study|Lack of Efficacy|18|||
48820402|NCT01113463|157185507|FG000|Overall Study|Physician Decision|5|||
48820403|NCT00136916|157185508|FG000|Overall Study|Never received study treatment|3|||
49134831|NCT01134042|158333226|FG000|Overall Study|Protocol Violation|5|||
49134832|NCT01134042|158333227|FG001|Overall Study|Protocol Violation|3|||
48820404|NCT00136916|157185509|FG001|Overall Study|Never received study treatment|5|||
48820405|NCT00136916|157185508|FG000|Overall Study|Death|1|||
48820406|NCT00136916|157185509|FG001|Overall Study|Death|3|||
48820407|NCT00136916|157185508|FG000|Overall Study|Adverse Event|27|||
48820408|NCT00136916|157185509|FG001|Overall Study|Adverse Event|8|||
48820409|NCT00136916|157185508|FG000|Overall Study|Laboratory abnormality|0|||
48820410|NCT00136916|157185509|FG001|Overall Study|Laboratory abnormality|1|||
48820411|NCT00136916|157185508|FG000|Overall Study|Lack of Efficacy|13|||
49134833|NCT01134042|158333228|FG002|Overall Study|Protocol Violation|5|||
49134834|NCT01134042|158333226|FG000|Overall Study|Lost to Follow-up|2|||
49134835|NCT01134042|158333227|FG001|Overall Study|Lost to Follow-up|0|||
49134836|NCT01134042|158333228|FG002|Overall Study|Lost to Follow-up|1|||
49134837|NCT01134042|158333226|FG000|Overall Study|Physician Decision|4|||
49134838|NCT01134042|158333227|FG001|Overall Study|Physician Decision|8|||
49134839|NCT01134042|158333228|FG002|Overall Study|Physician Decision|1|||
49134840|NCT01134042|158333226|FG000|Overall Study|Withdrawal by Subject|13|||
49134841|NCT01134042|158333227|FG001|Overall Study|Withdrawal by Subject|4|||
49134842|NCT01134042|158333228|FG002|Overall Study|Withdrawal by Subject|7|||
49134843|NCT01454284|158333234|FG000|Overall Study|Adverse Event|20|||
49134844|NCT01454284|158333235|FG001|Overall Study|Adverse Event|7|||
49134845|NCT01454284|158333234|FG000|Overall Study|Death|0|||
49134846|NCT01454284|158333235|FG001|Overall Study|Death|3|||
49134847|NCT01454284|158333234|FG000|Overall Study|Lost to Follow-up|13|||
49134848|NCT01454284|158333235|FG001|Overall Study|Lost to Follow-up|8|||
49134849|NCT01454284|158333234|FG000|Overall Study|Protocol Violation|9|||
49134850|NCT01454284|158333235|FG001|Overall Study|Protocol Violation|6|||
49134851|NCT01454284|158333234|FG000|Overall Study|Withdrawal by Subject|58|||
49134852|NCT01454284|158333235|FG001|Overall Study|Withdrawal by Subject|36|||
49134853|NCT01454284|158333234|FG000|Overall Study|Physician Decision|16|||
49134854|NCT01454284|158333235|FG001|Overall Study|Physician Decision|11|||
49134855|NCT01454284|158333234|FG000|Overall Study|Sponsor Decision|0|||
49134856|NCT01454284|158333235|FG001|Overall Study|Sponsor Decision|2|||
49134857|NCT02665117|158333236|FG000|Overall Study|Physician Decision|1|||
49134858|NCT02665117|158333237|FG001|Overall Study|Physician Decision|0|||
49134859|NCT00764517|158333242|FG000|Overall Study|Adverse Event|9|||
49134860|NCT00764517|158333243|FG001|Overall Study|Adverse Event|3|||
49134861|NCT00764517|158333242|FG000|Overall Study|Death|3|||
49134862|NCT00764517|158333243|FG001|Overall Study|Death|11|||
49134863|NCT00764517|158333242|FG000|Overall Study|Physician Decision|3|||
49134864|NCT00764517|158333243|FG001|Overall Study|Physician Decision|0|||
49134865|NCT00141921|158333244|FG000|Overall Study|Remain on Study|28|||
49134866|NCT00141921|158333244|FG000|Overall Study|Withdrawal by Subject|42|||
49134867|NCT00141921|158333244|FG000|Overall Study|Lost to Follow-up|19|||
49134868|NCT00141921|158333244|FG000|Overall Study|Noncompliance|17|||
49134869|NCT00141921|158333244|FG000|Overall Study|Disease Progression|7|||
49134870|NCT00141921|158333244|FG000|Overall Study|Protocol Deviation|7|||
49134871|NCT00141921|158333244|FG000|Overall Study|Adverse Event|5|||
49134872|NCT00141921|158333244|FG000|Overall Study|Administrative Decision|2|||
49134873|NCT00141921|158333244|FG000|Overall Study|Pregnancy|4|||
49134874|NCT00141921|158333244|FG000|Overall Study|Ineligibility Determined|2|||
49134875|NCT00141921|158333244|FG000|Overall Study|Other|8|||
49134876|NCT01091259|158333245|FG000|Overall Study|Adverse Event|3|||
49134877|NCT01091259|158333245|FG000|Overall Study|Lack of Efficacy|2|||
49134878|NCT04307394|158333247|FG000|Overall Study|Lost to Follow-up|3|||
49134879|NCT04307394|158333247|FG000|Overall Study|Withdrawal by Subject|2|||
49134880|NCT01027949|158333248|FG000|Overall Study|Death|174|||
48725622|NCT00814801|156845138|FG001|Overall Study|Adverse Event|16|||
49134881|NCT01027949|158333248|FG000|Overall Study|Progressive Disease|163|||
49134882|NCT01027949|158333248|FG000|Overall Study|Adverse Event|172|||
49134883|NCT01027949|158333248|FG000|Overall Study|Withdrawal by Subject|113|||
49134884|NCT01027949|158333248|FG000|Overall Study|Lost to Follow-up|17|||
49134885|NCT01027949|158333248|FG000|Overall Study|Protocol Violation|13|||
49134886|NCT01027949|158333248|FG000|Overall Study|PI Decision|8|||
49134887|NCT01027949|158333248|FG000|Overall Study|Limited Study Drug Effectiveness|7|||
49134888|NCT01027949|158333248|FG000|Overall Study|Non-compliance with Study Procedures|7|||
48725623|NCT00814801|156845139|FG002|Overall Study|Adverse Event|19|||
48725624|NCT00814801|156845137|FG000|Overall Study|Withdrawal by Subject|9|||
48725625|NCT00814801|156845138|FG001|Overall Study|Withdrawal by Subject|11|||
48725626|NCT00814801|156845139|FG002|Overall Study|Withdrawal by Subject|14|||
48725627|NCT00814801|156845137|FG000|Overall Study|Inappropriate as a subject|1|||
48725628|NCT00814801|156845138|FG001|Overall Study|Inappropriate as a subject|1|||
48725629|NCT00814801|156845139|FG002|Overall Study|Inappropriate as a subject|1|||
48725630|NCT00814801|156845137|FG000|Overall Study|Change of patients for CIBIC plus-J|1|||
48725631|NCT00814801|156845138|FG001|Overall Study|Change of patients for CIBIC plus-J|1|||
48725632|NCT00814801|156845139|FG002|Overall Study|Change of patients for CIBIC plus-J|0|||
48820412|NCT00136916|157185509|FG001|Overall Study|Lack of Efficacy|3|||
49134889|NCT01027949|158333248|FG000|Overall Study|Lung Transplant|5|||
49134890|NCT01027949|158333248|FG000|Overall Study|Unable to Tolerate Study Drug|2|||
49134891|NCT01027949|158333248|FG000|Overall Study|Use of Excluded Medication|2|||
48820413|NCT00136916|157185508|FG000|Overall Study|Lost to Follow-up|12|||
48820414|NCT00136916|157185509|FG001|Overall Study|Lost to Follow-up|14|||
49134892|NCT01027949|158333248|FG000|Overall Study|Patient Self-discontinuation|1|||
49134893|NCT01027949|158333248|FG000|Overall Study|Pregnancy|1|||
49134894|NCT01027949|158333248|FG000|Overall Study|Surgery|1|||
49134895|NCT00898807|158333259|FG000|Overall Study|Withdrawal by Subject|5|||
49134896|NCT00898807|158333260|FG001|Overall Study|Withdrawal by Subject|3|||
49134897|NCT00898807|158333259|FG000|Overall Study|Family pressure to discontinue|2|||
49134898|NCT00898807|158333260|FG001|Overall Study|Family pressure to discontinue|2|||
49134899|NCT00898807|158333259|FG000|Overall Study|Lost to Follow-up|1|||
48820415|NCT00136916|157185508|FG000|Overall Study|Withdrawal by Subject|44|||
48820416|NCT00136916|157185509|FG001|Overall Study|Withdrawal by Subject|46|||
48820417|NCT00136916|157185508|FG000|Overall Study|Other|22|||
48820418|NCT00136916|157185509|FG001|Overall Study|Other|24|||
48820419|NCT00136916|157185508|FG000|Overall Study|Discontinued in follow up period|3|||
48820420|NCT00136916|157185509|FG001|Overall Study|Discontinued in follow up period|0|||
48820421|NCT04285229|157185516|FG000|Double-Blind Treatment Period|Withdrawal by Subject|2|||
48820422|NCT04285229|157185517|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
48820423|NCT04285229|157185518|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
48820424|NCT04285229|157185519|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
48820425|NCT04285229|157185520|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
48820426|NCT04285229|157185521|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
48820427|NCT04285229|157185516|FG000|Extended Treatment Period|Withdrawal by Subject|0|||
48820428|NCT04285229|157185517|FG001|Extended Treatment Period|Withdrawal by Subject|0|||
48820429|NCT04285229|157185518|FG002|Extended Treatment Period|Withdrawal by Subject|0|||
48820430|NCT04285229|157185519|FG003|Extended Treatment Period|Withdrawal by Subject|7|||
48820431|NCT04285229|157185520|FG004|Extended Treatment Period|Withdrawal by Subject|0|||
49134900|NCT00898807|158333260|FG001|Overall Study|Lost to Follow-up|3|||
49134901|NCT00898807|158333259|FG000|Overall Study|Death|0|||
49134902|NCT00898807|158333260|FG001|Overall Study|Death|1|||
49134903|NCT00817063|158333261|FG000|Overall Study|Adverse Event|32|||
49134904|NCT00817063|158333262|FG001|Overall Study|Adverse Event|13|||
49134905|NCT00817063|158333261|FG000|Overall Study|Death|1|||
49134906|NCT00817063|158333262|FG001|Overall Study|Death|1|||
49134907|NCT00817063|158333261|FG000|Overall Study|Lack of Efficacy|33|||
49134908|NCT00817063|158333262|FG001|Overall Study|Lack of Efficacy|86|||
49134909|NCT00817063|158333261|FG000|Overall Study|Failure to Return|13|||
49134910|NCT00817063|158333262|FG001|Overall Study|Failure to Return|12|||
49134911|NCT00817063|158333261|FG000|Overall Study|Violation of Selection at Entry|7|||
49134912|NCT00817063|158333262|FG001|Overall Study|Violation of Selection at Entry|4|||
49134913|NCT00817063|158333261|FG000|Overall Study|Protocol Violation|3|||
49134914|NCT00817063|158333262|FG001|Overall Study|Protocol Violation|8|||
49134915|NCT00817063|158333261|FG000|Overall Study|Withdrawal by Subject|17|||
49134916|NCT00817063|158333262|FG001|Overall Study|Withdrawal by Subject|37|||
49134917|NCT00817063|158333261|FG000|Overall Study|Early Improvement|19|||
49134918|NCT00817063|158333262|FG001|Overall Study|Early Improvement|4|||
49134919|NCT00817063|158333261|FG000|Overall Study|Administrative|10|||
49134920|NCT00817063|158333262|FG001|Overall Study|Administrative|4|||
49134921|NCT00817063|158333261|FG000|Overall Study|Abnormality of Laboratory Test|2|||
49134922|NCT00817063|158333262|FG001|Overall Study|Abnormality of Laboratory Test|1|||
49134923|NCT00671060|158333263|FG000|Overall Study|Protocol Violation|1|||
49134924|NCT00671060|158333264|FG001|Overall Study|Protocol Violation|0|||
49134925|NCT00671060|158333263|FG000|Overall Study|Physician Decision|0|||
49134926|NCT00671060|158333264|FG001|Overall Study|Physician Decision|1|||
49134927|NCT00671749|158333265|FG000|Overall Study|Adverse Event|2|||
49134928|NCT00671749|158333265|FG000|Overall Study|Withdrawal by Subject|4|||
49134929|NCT00671749|158333265|FG000|Overall Study|Protocol Violation|1|||
49134930|NCT00671749|158333265|FG000|Overall Study|Lost to Follow-up|1|||
49134931|NCT00529035|158333266|FG000|Overall Study|Withdrawal by Subject|1|||
49134932|NCT02515227|158333267|FG000|Overall Study|Adverse Event|0|||
49134933|NCT02515227|158333268|FG001|Overall Study|Adverse Event|2|||
49134934|NCT02515227|158333267|FG000|Overall Study|Progressive disease|2|||
49134935|NCT02515227|158333268|FG001|Overall Study|Progressive disease|9|||
49134936|NCT01461551|158333269|FG000|Overall Study|Physician Decision|2|||
49134937|NCT01461551|158333270|FG001|Overall Study|Physician Decision|1|||
49134938|NCT01461551|158333271|FG002|Overall Study|Physician Decision|2|||
49134939|NCT00303186|158333272|FG000|Overall Study|Other|52|||
49134940|NCT00712920|158333273|FG000|Overall Study|Adverse Event|3|||
49134941|NCT00712920|158333274|FG001|Overall Study|Adverse Event|4|||
49134942|NCT00712920|158333275|FG002|Overall Study|Adverse Event|7|||
49134943|NCT00712920|158333273|FG000|Overall Study|Withdrawal by Subject|4|||
49134944|NCT00712920|158333274|FG001|Overall Study|Withdrawal by Subject|2|||
49134945|NCT00712920|158333275|FG002|Overall Study|Withdrawal by Subject|1|||
49134946|NCT00712920|158333273|FG000|Overall Study|Lost to Follow-up|1|||
49134947|NCT00712920|158333274|FG001|Overall Study|Lost to Follow-up|4|||
49134948|NCT00712920|158333275|FG002|Overall Study|Lost to Follow-up|0|||
49134949|NCT00712920|158333273|FG000|Overall Study|Lack of Efficacy|1|||
48820432|NCT04285229|157185521|FG005|Extended Treatment Period|Withdrawal by Subject|0|||
48820433|NCT04285229|157185516|FG000|Extended Treatment Period|Adverse Event|0|||
48820434|NCT04285229|157185517|FG001|Extended Treatment Period|Adverse Event|0|||
48820435|NCT04285229|157185518|FG002|Extended Treatment Period|Adverse Event|0|||
48820436|NCT04285229|157185519|FG003|Extended Treatment Period|Adverse Event|1|||
48820437|NCT04285229|157185520|FG004|Extended Treatment Period|Adverse Event|0|||
48820438|NCT04285229|157185521|FG005|Extended Treatment Period|Adverse Event|0|||
48820439|NCT04285229|157185516|FG000|Extended Treatment Period|Physician Decision|0|||
48820440|NCT04285229|157185517|FG001|Extended Treatment Period|Physician Decision|0|||
48820441|NCT04285229|157185518|FG002|Extended Treatment Period|Physician Decision|1|||
48820442|NCT04285229|157185519|FG003|Extended Treatment Period|Physician Decision|0|||
48820443|NCT04285229|157185520|FG004|Extended Treatment Period|Physician Decision|0|||
48820444|NCT04285229|157185521|FG005|Extended Treatment Period|Physician Decision|0|||
48820445|NCT04285229|157185516|FG000|Follow-up Period|Adverse Event|0|||
48820446|NCT04285229|157185517|FG001|Follow-up Period|Adverse Event|0|||
48820447|NCT04285229|157185518|FG002|Follow-up Period|Adverse Event|0|||
48820448|NCT04285229|157185519|FG003|Follow-up Period|Adverse Event|0|||
48820449|NCT04285229|157185520|FG004|Follow-up Period|Adverse Event|1|||
48820450|NCT04285229|157185521|FG005|Follow-up Period|Adverse Event|4|||
48820451|NCT04285229|157185516|FG000|Follow-up Period|Withdrawal by Subject|0|||
48820452|NCT04285229|157185517|FG001|Follow-up Period|Withdrawal by Subject|0|||
48820453|NCT04285229|157185518|FG002|Follow-up Period|Withdrawal by Subject|0|||
48820454|NCT04285229|157185519|FG003|Follow-up Period|Withdrawal by Subject|0|||
48820455|NCT04285229|157185520|FG004|Follow-up Period|Withdrawal by Subject|0|||
48820456|NCT04285229|157185521|FG005|Follow-up Period|Withdrawal by Subject|5|||
48820457|NCT04285229|157185516|FG000|Follow-up Period|Covid-19|0|||
48820458|NCT04285229|157185517|FG001|Follow-up Period|Covid-19|0|||
48820459|NCT04285229|157185518|FG002|Follow-up Period|Covid-19|0|||
48820460|NCT04285229|157185519|FG003|Follow-up Period|Covid-19|0|||
48820461|NCT04285229|157185520|FG004|Follow-up Period|Covid-19|0|||
48820462|NCT04285229|157185521|FG005|Follow-up Period|Covid-19|2|||
48820463|NCT04285229|157185516|FG000|Follow-up Period|Physician Decision|0|||
48820464|NCT04285229|157185517|FG001|Follow-up Period|Physician Decision|0|||
48820465|NCT04285229|157185518|FG002|Follow-up Period|Physician Decision|0|||
48820466|NCT04285229|157185519|FG003|Follow-up Period|Physician Decision|0|||
48820467|NCT04285229|157185520|FG004|Follow-up Period|Physician Decision|0|||
48820468|NCT04285229|157185521|FG005|Follow-up Period|Physician Decision|1|||
48820469|NCT01723826|157185522|FG000|Overall Study|Adverse Event|4|||
48820470|NCT01723826|157185523|FG001|Overall Study|Adverse Event|1|||
48820471|NCT01723826|157185524|FG002|Overall Study|Adverse Event|4|||
48820472|NCT01723826|157185525|FG003|Overall Study|Adverse Event|5|||
48820473|NCT01723826|157185522|FG000|Overall Study|Death according to AE eCRF|2|||
48820474|NCT01723826|157185523|FG001|Overall Study|Death according to AE eCRF|3|||
48820475|NCT01723826|157185524|FG002|Overall Study|Death according to AE eCRF|3|||
48820476|NCT01723826|157185525|FG003|Overall Study|Death according to AE eCRF|7|||
48820477|NCT01723826|157185522|FG000|Overall Study|Lost to Follow-up|1|||
48820478|NCT01723826|157185523|FG001|Overall Study|Lost to Follow-up|3|||
48820479|NCT01723826|157185524|FG002|Overall Study|Lost to Follow-up|1|||
48820480|NCT01723826|157185525|FG003|Overall Study|Lost to Follow-up|1|||
48820481|NCT01723826|157185522|FG000|Overall Study|Non-compliance|0|||
48820482|NCT01723826|157185523|FG001|Overall Study|Non-compliance|1|||
48820483|NCT01723826|157185524|FG002|Overall Study|Non-compliance|3|||
48820484|NCT01723826|157185525|FG003|Overall Study|Non-compliance|3|||
49134950|NCT00712920|158333274|FG001|Overall Study|Lack of Efficacy|0|||
49134951|NCT00712920|158333275|FG002|Overall Study|Lack of Efficacy|1|||
49134952|NCT00712920|158333273|FG000|Overall Study|Other|5|||
49134953|NCT00712920|158333274|FG001|Overall Study|Other|7|||
49134954|NCT00712920|158333275|FG002|Overall Study|Other|3|||
49134955|NCT00712920|158333273|FG000|Overall Study|Non-compliance|3|||
49134956|NCT00712920|158333274|FG001|Overall Study|Non-compliance|0|||
49134957|NCT00712920|158333275|FG002|Overall Study|Non-compliance|0|||
49134958|NCT02326883|158333276|FG000|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84|||
48820485|NCT01723826|157185522|FG000|Overall Study|Non-compliance With Study Drug|0|||
48820486|NCT01723826|157185523|FG001|Overall Study|Non-compliance With Study Drug|1|||
48820487|NCT01723826|157185524|FG002|Overall Study|Non-compliance With Study Drug|0|||
48820488|NCT01723826|157185525|FG003|Overall Study|Non-compliance With Study Drug|0|||
48820489|NCT01723826|157185522|FG000|Overall Study|Other Reason|8|||
48820490|NCT01723826|157185523|FG001|Overall Study|Other Reason|6|||
48820491|NCT01723826|157185524|FG002|Overall Study|Other Reason|12|||
48820492|NCT01723826|157185525|FG003|Overall Study|Other Reason|14|||
48820493|NCT01723826|157185522|FG000|Overall Study|Physician Decision|1|||
49134959|NCT02326883|158333277|FG001|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85|||
48820494|NCT01723826|157185523|FG001|Overall Study|Physician Decision|3|||
48820495|NCT01723826|157185524|FG002|Overall Study|Physician Decision|4|||
48820496|NCT01723826|157185525|FG003|Overall Study|Physician Decision|11|||
48820497|NCT01723826|157185522|FG000|Overall Study|Protocol Violation|1|||
49134960|NCT02326883|158333278|FG002|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69|||
49134961|NCT00481676|158333285|FG000|Overall Study|Adverse Event|0|||
49134962|NCT00481676|158333286|FG001|Overall Study|Adverse Event|1|||
49134963|NCT00481676|158333285|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
49134964|NCT00481676|158333286|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
49134965|NCT00481676|158333285|FG000|Overall Study|Administrative problem|1|||
49134966|NCT00481676|158333286|FG001|Overall Study|Administrative problem|0|||
49134967|NCT01513590|158333287|FG000|Overall Study|Adverse Event|2|||
49134968|NCT01513590|158333288|FG001|Overall Study|Adverse Event|3|||
49134969|NCT01513590|158333287|FG000|Overall Study|Withdrawal Criteria|3|||
49134970|NCT01513590|158333288|FG001|Overall Study|Withdrawal Criteria|0|||
49134971|NCT01513590|158333287|FG000|Overall Study|Unclassified|5|||
49134972|NCT01513590|158333288|FG001|Overall Study|Unclassified|10|||
49134973|NCT00844519|158333297|FG000|Overall Study|Withdrawal by Subject|1|||
49134974|NCT00844519|158333298|FG001|Overall Study|Withdrawal by Subject|1|||
49134975|NCT00844519|158333297|FG000|Overall Study|Adverse Event|1|||
49134976|NCT00844519|158333298|FG001|Overall Study|Adverse Event|0|||
49134977|NCT02948400|158333301|FG000|Overall Study|Withdrawal by Subject|17|||
49134978|NCT02948400|158333302|FG001|Overall Study|Withdrawal by Subject|10|||
49134979|NCT02948400|158333301|FG000|Overall Study|failed to attend appointments|47|||
49134980|NCT02948400|158333302|FG001|Overall Study|failed to attend appointments|34|||
49134981|NCT02948400|158333301|FG000|Overall Study|COVID-related closure|6|||
49134982|NCT02948400|158333302|FG001|Overall Study|COVID-related closure|2|||
49134983|NCT02948400|158333301|FG000|Overall Study|sibling discovered to be in study so participant ineligible|1|||
49134984|NCT02948400|158333302|FG001|Overall Study|sibling discovered to be in study so participant ineligible|0|||
49134985|NCT02948400|158333301|FG000|Overall Study|motion sickness in virtual reality|2|||
49134986|NCT02948400|158333302|FG001|Overall Study|motion sickness in virtual reality|0|||
49134987|NCT03325439|158333303|FG000|Overall Study|Ineligibility|3|||
49134988|NCT03301714|158333304|FG000|Overall Study|Lost to Follow-up|10|||
49134989|NCT03301714|158333305|FG001|Overall Study|Lost to Follow-up|4|||
49134990|NCT03301714|158333306|FG002|Overall Study|Lost to Follow-up|4|||
49134991|NCT03301714|158333304|FG000|Overall Study|Did not receive allocated intervention|0|||
49134992|NCT03301714|158333305|FG001|Overall Study|Did not receive allocated intervention|2|||
49134993|NCT03301714|158333306|FG002|Overall Study|Did not receive allocated intervention|3|||
49134994|NCT01179516|158333307|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
49134995|NCT01179516|158333308|FG001|Overall Study|Pretreatment Event or Adverse Event|8|||
49134996|NCT01179516|158333309|FG002|Overall Study|Pretreatment Event or Adverse Event|12|||
49134997|NCT01179516|158333307|FG000|Overall Study|Lack of Efficacy|4|||
49134998|NCT01179516|158333308|FG001|Overall Study|Lack of Efficacy|2|||
49134999|NCT01179516|158333309|FG002|Overall Study|Lack of Efficacy|0|||
49135000|NCT01179516|158333307|FG000|Overall Study|Noncompliance with Study Drug|2|||
49135001|NCT01179516|158333308|FG001|Overall Study|Noncompliance with Study Drug|0|||
49135002|NCT01179516|158333309|FG002|Overall Study|Noncompliance with Study Drug|1|||
49135003|NCT01179516|158333307|FG000|Overall Study|Protocol Deviations|4|||
49135004|NCT01179516|158333308|FG001|Overall Study|Protocol Deviations|3|||
49135005|NCT01179516|158333309|FG002|Overall Study|Protocol Deviations|3|||
49135006|NCT01179516|158333307|FG000|Overall Study|Withdrawal of Consent|2|||
49135007|NCT01179516|158333308|FG001|Overall Study|Withdrawal of Consent|6|||
49135008|NCT01179516|158333309|FG002|Overall Study|Withdrawal of Consent|10|||
49135009|NCT01179516|158333307|FG000|Overall Study|Lost to Follow-up|7|||
49135010|NCT01179516|158333308|FG001|Overall Study|Lost to Follow-up|7|||
49135011|NCT01179516|158333309|FG002|Overall Study|Lost to Follow-up|3|||
49135012|NCT01179516|158333307|FG000|Overall Study|Other|2|||
49135013|NCT01179516|158333308|FG001|Overall Study|Other|0|||
49135014|NCT01179516|158333309|FG002|Overall Study|Other|2|||
49135015|NCT02572167|158333310|FG000|Overall Study|Withdrawal by Subject|0|||
49135016|NCT02572167|158333311|FG001|Overall Study|Withdrawal by Subject|3|||
49135017|NCT02572167|158333312|FG002|Overall Study|Withdrawal by Subject|0|||
49135018|NCT02572167|158333310|FG000|Overall Study|Lost to Follow-up|2|||
49135019|NCT02572167|158333311|FG001|Overall Study|Lost to Follow-up|5|||
49135020|NCT02572167|158333312|FG002|Overall Study|Lost to Follow-up|3|||
49135021|NCT02572167|158333310|FG000|Overall Study|Death|0|||
49135022|NCT02572167|158333311|FG001|Overall Study|Death|8|||
49135023|NCT02572167|158333312|FG002|Overall Study|Death|3|||
49135024|NCT02572167|158333310|FG000|Overall Study|Did not meet inclusion criteria|0|||
49135025|NCT02572167|158333311|FG001|Overall Study|Did not meet inclusion criteria|0|||
49135026|NCT02572167|158333312|FG002|Overall Study|Did not meet inclusion criteria|1|||
48820498|NCT01723826|157185523|FG001|Overall Study|Protocol Violation|1|||
49135027|NCT02572167|158333310|FG000|Overall Study|Study closure by Sponsor|4|||
49135028|NCT02572167|158333311|FG001|Overall Study|Study closure by Sponsor|40|||
49135029|NCT02572167|158333312|FG002|Overall Study|Study closure by Sponsor|24|||
49135030|NCT01551173|158333313|FG000|Overall Study|Withdrawal by Subject|11|||
49135031|NCT01551173|158333314|FG001|Overall Study|Withdrawal by Subject|16|||
49135032|NCT01551173|158333313|FG000|Overall Study|Adverse Event|7|||
49135033|NCT01551173|158333314|FG001|Overall Study|Adverse Event|6|||
48820499|NCT01723826|157185524|FG002|Overall Study|Protocol Violation|3|||
48820500|NCT01723826|157185525|FG003|Overall Study|Protocol Violation|1|||
48820501|NCT01723826|157185522|FG000|Overall Study|Withdrawal by Subject|10|||
48820502|NCT01723826|157185523|FG001|Overall Study|Withdrawal by Subject|17|||
48820503|NCT01723826|157185524|FG002|Overall Study|Withdrawal by Subject|27|||
48725633|NCT00814801|156845137|FG000|Overall Study|Missing or change of caregiver|6|||
48725634|NCT00814801|156845138|FG001|Overall Study|Missing or change of caregiver|2|||
48725635|NCT00814801|156845139|FG002|Overall Study|Missing or change of caregiver|4|||
48725636|NCT00814801|156845137|FG000|Overall Study|Non-compliance|0|||
48725637|NCT00814801|156845138|FG001|Overall Study|Non-compliance|1|||
48725638|NCT00814801|156845139|FG002|Overall Study|Non-compliance|1|||
48725639|NCT00814801|156845137|FG000|Overall Study|Other|2|||
48725640|NCT00814801|156845138|FG001|Overall Study|Other|6|||
48725641|NCT00814801|156845139|FG002|Overall Study|Other|4|||
48725642|NCT02117427|156845140|FG000|Overall Study|Permanent need for exogenous EPO Tx|2|||
48725643|NCT02117427|156845141|FG001|Overall Study|Permanent need for exogenous EPO Tx|0|||
48725644|NCT02117427|156845142|FG002|Overall Study|Permanent need for exogenous EPO Tx|0|||
48725645|NCT02117427|156845140|FG000|Overall Study|Permanent need for exogenous ESA Tx|3|||
48725646|NCT02117427|156845141|FG001|Overall Study|Permanent need for exogenous ESA Tx|1|||
48725647|NCT02117427|156845142|FG002|Overall Study|Permanent need for exogenous ESA Tx|0|||
48725648|NCT02117427|156845140|FG000|Overall Study|Physician Decision|0|||
48725649|NCT02117427|156845141|FG001|Overall Study|Physician Decision|2|||
48725650|NCT02117427|156845142|FG002|Overall Study|Physician Decision|0|||
48725651|NCT02117427|156845140|FG000|Overall Study|No longer meets inclusion criteria|0|||
48725652|NCT02117427|156845141|FG001|Overall Study|No longer meets inclusion criteria|1|||
48725653|NCT02117427|156845142|FG002|Overall Study|No longer meets inclusion criteria|0|||
48725654|NCT02117427|156845140|FG000|Overall Study|Death|0|||
48725655|NCT02117427|156845141|FG001|Overall Study|Death|1|||
48725656|NCT02117427|156845142|FG002|Overall Study|Death|0|||
48725657|NCT03036800|156845143|FG000|Overall Study|Protocol Violation|1|||
48725658|NCT03036800|156845144|FG001|Overall Study|Protocol Violation|0|||
48725659|NCT03036800|156845143|FG000|Overall Study|Non-compliance|1|||
48725660|NCT03036800|156845144|FG001|Overall Study|Non-compliance|0|||
48725661|NCT03036800|156845143|FG000|Overall Study|Lost to Follow-up|1|||
48820504|NCT01723826|157185525|FG003|Overall Study|Withdrawal by Subject|48|||
48820505|NCT03023332|157185526|FG000|Overall Study|Withdrawal by Subject|10|||
48820506|NCT03023332|157185527|FG001|Overall Study|Withdrawal by Subject|5|||
48820507|NCT03023332|157185528|FG002|Overall Study|Withdrawal by Subject|4|||
48820508|NCT03023332|157185529|FG003|Overall Study|Withdrawal by Subject|7|||
48820509|NCT03023332|157185526|FG000|Overall Study|Lost to Follow-up|13|||
48820510|NCT03023332|157185527|FG001|Overall Study|Lost to Follow-up|16|||
48820511|NCT03023332|157185528|FG002|Overall Study|Lost to Follow-up|8|||
48820512|NCT03023332|157185529|FG003|Overall Study|Lost to Follow-up|13|||
48820513|NCT03023332|157185526|FG000|Overall Study|Death|1|||
48820514|NCT03023332|157185527|FG001|Overall Study|Death|0|||
48820515|NCT03023332|157185528|FG002|Overall Study|Death|0|||
49135034|NCT01551173|158333313|FG000|Overall Study|Lost to Follow-up|5|||
48820516|NCT03023332|157185529|FG003|Overall Study|Death|0|||
48820517|NCT04179461|157185532|FG000|Overall Study|Lost to Follow-up|4|||
48820518|NCT03100838|157185533|FG000|Overall Study|Adverse Event|1|||
49135035|NCT01551173|158333314|FG001|Overall Study|Lost to Follow-up|7|||
49135036|NCT01551173|158333313|FG000|Overall Study|Other|5|||
49135037|NCT01551173|158333314|FG001|Overall Study|Other|3|||
49135038|NCT02393755|158333315|FG000|Overall Study|Withdrawal by Subject|0|||
49135039|NCT02393755|158333316|FG001|Overall Study|Withdrawal by Subject|3|||
49135040|NCT02393755|158333315|FG000|Overall Study|Adverse Event|0|||
49135041|NCT02393755|158333316|FG001|Overall Study|Adverse Event|2|||
49135042|NCT02393755|158333315|FG000|Overall Study|Physician Decision|0|||
49135043|NCT02393755|158333316|FG001|Overall Study|Physician Decision|2|||
49135044|NCT00262925|158333317|FG000|Overall Study|Lack of Efficacy|3|||
49135045|NCT00262925|158333317|FG000|Overall Study|Adverse Event|4|||
49135046|NCT00262925|158333317|FG000|Overall Study|Death|2|||
49135047|NCT00262925|158333317|FG000|Overall Study|alternative therapy|1|||
49135048|NCT00262925|158333317|FG000|Overall Study|Other|1|||
49135049|NCT00544882|158333322|FG000|Cycle 1: Run-in Cycle|Withdrawal by Subject|2|||
48820519|NCT03100838|157185534|FG001|Overall Study|Adverse Event|0|||
48820520|NCT03100838|157185535|FG002|Overall Study|Adverse Event|0|||
49135050|NCT00544882|158333323|FG001|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
49135051|NCT00544882|158333324|FG002|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
48820521|NCT03100838|157185536|FG003|Overall Study|Adverse Event|0|||
48820522|NCT03100838|157185533|FG000|Overall Study|Physician Decision|1|||
48820523|NCT03100838|157185534|FG001|Overall Study|Physician Decision|1|||
48820524|NCT03100838|157185535|FG002|Overall Study|Physician Decision|1|||
48820525|NCT03100838|157185536|FG003|Overall Study|Physician Decision|1|||
48820526|NCT03100838|157185533|FG000|Overall Study|Pregnancy|0|||
48725662|NCT03036800|156845144|FG001|Overall Study|Lost to Follow-up|0|||
48725663|NCT03036800|156845143|FG000|Overall Study|Death|1|||
48725664|NCT03036800|156845144|FG001|Overall Study|Death|0|||
48725665|NCT03036800|156845143|FG000|Overall Study|Tolerance|5|||
48725666|NCT03036800|156845144|FG001|Overall Study|Tolerance|0|||
48725667|NCT03036800|156845143|FG000|Overall Study|Unknown/no reason given|50|||
48725668|NCT03036800|156845144|FG001|Overall Study|Unknown/no reason given|39|||
48725669|NCT01505647|156845145|FG000|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1|||
48725670|NCT01505647|156845146|FG001|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0|||
48725671|NCT01505647|156845145|FG000|Day 1 Through Day 42 Follow-up|Physician Decision|1|||
48725672|NCT01505647|156845146|FG001|Day 1 Through Day 42 Follow-up|Physician Decision|0|||
48725673|NCT01505647|156845145|FG000|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1|||
48725674|NCT01505647|156845146|FG001|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0|||
48725675|NCT01505647|156845145|FG000|Day 43 Through Day 182 Follow-up|Death|0|||
48725676|NCT01505647|156845146|FG001|Day 43 Through Day 182 Follow-up|Death|1|||
48725677|NCT01505647|156845145|FG000|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1|||
48820527|NCT03100838|157185534|FG001|Overall Study|Pregnancy|1|||
48820528|NCT03100838|157185535|FG002|Overall Study|Pregnancy|0|||
48725678|NCT01505647|156845146|FG001|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2|||
48725679|NCT00596362|156845148|FG000|Overall Study|Progressive Disease|1|||
48725680|NCT03112590|156845149|FG000|Overall Study|Adverse Event|0|||
48725681|NCT03112590|156845150|FG001|Overall Study|Adverse Event|1|||
48725682|NCT03112590|156845151|FG002|Overall Study|Adverse Event|0|||
48725683|NCT01574079|156845152|FG000|Overall Study|Physician Decision|0|||
48725684|NCT01574079|156845153|FG001|Overall Study|Physician Decision|2|||
48820529|NCT03100838|157185536|FG003|Overall Study|Pregnancy|0|||
48820530|NCT03100838|157185533|FG000|Overall Study|Lost to Follow-up|0|||
48820531|NCT03100838|157185534|FG001|Overall Study|Lost to Follow-up|0|||
48820532|NCT03100838|157185535|FG002|Overall Study|Lost to Follow-up|1|||
48820533|NCT03100838|157185536|FG003|Overall Study|Lost to Follow-up|0|||
48820534|NCT00619151|157185540|FG000|Overall Study|Study terminated prior to followup|1|||
49135052|NCT00544882|158333322|FG000|Cycle 1: Run-in Cycle|Adverse Event|1|||
49135053|NCT00544882|158333323|FG001|Cycle 1: Run-in Cycle|Adverse Event|0|||
48820535|NCT00619151|157185541|FG001|Overall Study|Study terminated prior to followup|0|||
48820536|NCT02015195|157185543|FG000|Overall Study|Adverse Event|0|||
48820537|NCT02015195|157185544|FG001|Overall Study|Adverse Event|0|||
48820538|NCT02015195|157185545|FG002|Overall Study|Adverse Event|0|||
48820539|NCT02015195|157185546|FG003|Overall Study|Adverse Event|1|||
48820540|NCT02015195|157185547|FG004|Overall Study|Adverse Event|0|||
48820541|NCT02015195|157185548|FG005|Overall Study|Adverse Event|0|||
48820542|NCT02015195|157185549|FG006|Overall Study|Adverse Event|0|||
48820543|NCT02303574|157185556|FG000|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
48820544|NCT02303574|157185557|FG001|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
48820545|NCT02303574|157185558|FG002|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1|||
49135054|NCT00544882|158333324|FG002|Cycle 1: Run-in Cycle|Adverse Event|0|||
49135055|NCT00544882|158333322|FG000|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
49135056|NCT00544882|158333323|FG001|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1|||
49135057|NCT00544882|158333324|FG002|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
49135058|NCT00544882|158333322|FG000|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
49135059|NCT00544882|158333323|FG001|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
49135060|NCT00544882|158333324|FG002|Cycle 2: Randomized Treatment Cycle|Noncompliance|1|||
49135061|NCT00544882|158333322|FG000|Cycle 3: Follow-up|Noncompliance|0|||
49135062|NCT00544882|158333323|FG001|Cycle 3: Follow-up|Noncompliance|1|||
48725685|NCT01574079|156845152|FG000|Overall Study|Lost to Follow-up|1|||
48820546|NCT02303574|157185559|FG003|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
48820547|NCT02303574|157185560|FG004|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
48820548|NCT02303574|157185561|FG005|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
48820549|NCT02303574|157185562|FG006|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
48820550|NCT02303574|157185563|FG007|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
49135063|NCT00544882|158333324|FG002|Cycle 3: Follow-up|Noncompliance|0|||
49135064|NCT00544882|158333322|FG000|Cycle 3: Follow-up|Pregnancy|0|||
48725686|NCT01574079|156845153|FG001|Overall Study|Lost to Follow-up|0|||
48725687|NCT02059005|156845156|FG000|Overall Study|Death|1|||
48725688|NCT02059005|156845157|FG001|Overall Study|Death|3|||
48725689|NCT02059005|156845156|FG000|Overall Study|Lost to Follow-up|19|||
48725690|NCT02059005|156845157|FG001|Overall Study|Lost to Follow-up|19|||
48725691|NCT02059005|156845156|FG000|Overall Study|Incarceration|0|||
49135065|NCT00544882|158333323|FG001|Cycle 3: Follow-up|Pregnancy|1|||
49135066|NCT00544882|158333324|FG002|Cycle 3: Follow-up|Pregnancy|0|||
49135067|NCT02583269|158333325|FG000|Overall Study|Patient hospitalized prior to start|1|||
48725692|NCT02059005|156845157|FG001|Overall Study|Incarceration|1|||
48820551|NCT02303574|157185564|FG008|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
48820552|NCT02303574|157185565|FG009|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
48820553|NCT02303574|157185556|FG000|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
48820554|NCT02303574|157185557|FG001|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
48820555|NCT02303574|157185558|FG002|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
48820556|NCT02303574|157185559|FG003|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
48820557|NCT02303574|157185560|FG004|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
48820558|NCT02303574|157185561|FG005|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
48820559|NCT02303574|157185562|FG006|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
48820560|NCT02303574|157185563|FG007|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1|||
48820561|NCT02303574|157185564|FG008|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
48725693|NCT02059005|156845156|FG000|Overall Study|Inpatient|0|||
48725694|NCT02059005|156845157|FG001|Overall Study|Inpatient|1|||
48725695|NCT00760084|156845162|FG000|Overall Study|Physician Decision|5|||
48725696|NCT00760084|156845162|FG000|Overall Study|Withdrawal by Subject|2|||
48725697|NCT00760084|156845162|FG000|Overall Study|Progressive Disease|3|||
48725698|NCT00973349|156845163|FG000|Overall Study|Adverse Event|0|||
48820562|NCT02303574|157185565|FG009|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
48820563|NCT01347645|157185566|FG000|Overall Study|Death|1|||
48820564|NCT01347645|157185567|FG001|Overall Study|Death|5|||
48820565|NCT01347645|157185568|FG002|Overall Study|Death|2|||
48820566|NCT01347645|157185569|FG003|Overall Study|Death|7|||
48820567|NCT01347645|157185570|FG004|Overall Study|Death|7|||
48820568|NCT01347645|157185566|FG000|Overall Study|Lost to Follow-up|1|||
48820569|NCT01347645|157185567|FG001|Overall Study|Lost to Follow-up|1|||
48820570|NCT01347645|157185568|FG002|Overall Study|Lost to Follow-up|0|||
48820571|NCT01347645|157185569|FG003|Overall Study|Lost to Follow-up|1|||
48820572|NCT01347645|157185570|FG004|Overall Study|Lost to Follow-up|1|||
48820573|NCT01347645|157185566|FG000|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|0|||
48820574|NCT01347645|157185567|FG001|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|2|||
48820575|NCT01347645|157185568|FG002|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|1|||
48820576|NCT01347645|157185569|FG003|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|22|||
48820577|NCT01347645|157185570|FG004|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|20|||
48820578|NCT01347645|157185566|FG000|Overall Study|Other|1|||
48820579|NCT01347645|157185567|FG001|Overall Study|Other|0|||
48820580|NCT01347645|157185568|FG002|Overall Study|Other|0|||
48820581|NCT01347645|157185569|FG003|Overall Study|Other|0|||
48820582|NCT01347645|157185570|FG004|Overall Study|Other|1|||
48820583|NCT01347645|157185566|FG000|Overall Study|Withdrawal by Subject|0|||
48820584|NCT01347645|157185567|FG001|Overall Study|Withdrawal by Subject|0|||
48820585|NCT01347645|157185568|FG002|Overall Study|Withdrawal by Subject|0|||
48820586|NCT01347645|157185569|FG003|Overall Study|Withdrawal by Subject|3|||
48820587|NCT01347645|157185570|FG004|Overall Study|Withdrawal by Subject|3|||
48820588|NCT01347645|157185566|FG000|Overall Study|Physician Decision|0|||
48725699|NCT00973349|156845164|FG001|Overall Study|Adverse Event|0|||
48820589|NCT01347645|157185567|FG001|Overall Study|Physician Decision|0|||
48820590|NCT01347645|157185568|FG002|Overall Study|Physician Decision|0|||
48820591|NCT01347645|157185569|FG003|Overall Study|Physician Decision|0|||
48820592|NCT01347645|157185570|FG004|Overall Study|Physician Decision|1|||
48820593|NCT01347645|157185566|FG000|Overall Study|Adverse Event|0|||
48820594|NCT01347645|157185567|FG001|Overall Study|Adverse Event|0|||
48820595|NCT01347645|157185568|FG002|Overall Study|Adverse Event|0|||
48820596|NCT01347645|157185569|FG003|Overall Study|Adverse Event|1|||
48820597|NCT01347645|157185570|FG004|Overall Study|Adverse Event|1|||
48820598|NCT00783718|157185571|FG000|Induction Phase|Adverse Event|4|||
48820599|NCT00783718|157185572|FG001|Induction Phase|Adverse Event|0|||
48820600|NCT00783718|157185573|FG002|Induction Phase|Adverse Event|7|||
48820601|NCT00783718|157185574|FG003|Induction Phase|Adverse Event|0|||
48820602|NCT00783718|157185575|FG004|Induction Phase|Adverse Event|0|||
48820603|NCT00783718|157185576|FG005|Induction Phase|Adverse Event|0|||
48820604|NCT00783718|157185577|FG006|Induction Phase|Adverse Event|0|||
48820605|NCT00783718|157185571|FG000|Induction Phase|Protocol Violation|1|||
48725700|NCT00973349|156845165|FG002|Overall Study|Adverse Event|0|||
48725701|NCT00973349|156845166|FG003|Overall Study|Adverse Event|0|||
48725702|NCT00973349|156845167|FG004|Overall Study|Adverse Event|1|||
48820606|NCT00783718|157185572|FG001|Induction Phase|Protocol Violation|1|||
48820607|NCT00783718|157185573|FG002|Induction Phase|Protocol Violation|6|||
48820608|NCT00783718|157185574|FG003|Induction Phase|Protocol Violation|0|||
48820609|NCT00783718|157185575|FG004|Induction Phase|Protocol Violation|0|||
48725703|NCT00973349|156845168|FG005|Overall Study|Adverse Event|0|||
48725704|NCT00973349|156845169|FG006|Overall Study|Adverse Event|0|||
48725705|NCT00973349|156845170|FG007|Overall Study|Adverse Event|0|||
48820610|NCT00783718|157185576|FG005|Induction Phase|Protocol Violation|0|||
48725706|NCT00973349|156845171|FG008|Overall Study|Adverse Event|1|||
48725707|NCT00973349|156845172|FG009|Overall Study|Adverse Event|0|||
48725708|NCT00973349|156845173|FG010|Overall Study|Adverse Event|0|||
48725709|NCT00973349|156845174|FG011|Overall Study|Adverse Event|0|||
48725710|NCT00973349|156845175|FG012|Overall Study|Adverse Event|0|||
48725711|NCT00973349|156845176|FG013|Overall Study|Adverse Event|0|||
48725712|NCT00973349|156845177|FG014|Overall Study|Adverse Event|1|||
48725713|NCT00973349|156845178|FG015|Overall Study|Adverse Event|0|||
48725714|NCT00973349|156845163|FG000|Overall Study|Withdrawal by Subject|1|||
48725715|NCT00973349|156845164|FG001|Overall Study|Withdrawal by Subject|2|||
48725716|NCT00973349|156845165|FG002|Overall Study|Withdrawal by Subject|2|||
48725717|NCT00973349|156845166|FG003|Overall Study|Withdrawal by Subject|3|||
48725718|NCT00973349|156845167|FG004|Overall Study|Withdrawal by Subject|2|||
48725719|NCT00973349|156845168|FG005|Overall Study|Withdrawal by Subject|0|||
48725720|NCT00973349|156845169|FG006|Overall Study|Withdrawal by Subject|2|||
48725721|NCT00973349|156845170|FG007|Overall Study|Withdrawal by Subject|2|||
48725722|NCT00973349|156845171|FG008|Overall Study|Withdrawal by Subject|0|||
48725723|NCT00973349|156845172|FG009|Overall Study|Withdrawal by Subject|2|||
48725724|NCT00973349|156845173|FG010|Overall Study|Withdrawal by Subject|0|||
48725725|NCT00973349|156845174|FG011|Overall Study|Withdrawal by Subject|1|||
48725726|NCT00973349|156845175|FG012|Overall Study|Withdrawal by Subject|0|||
48725727|NCT00973349|156845176|FG013|Overall Study|Withdrawal by Subject|0|||
48725728|NCT00973349|156845177|FG014|Overall Study|Withdrawal by Subject|0|||
48725729|NCT00973349|156845178|FG015|Overall Study|Withdrawal by Subject|0|||
48725730|NCT00973349|156845163|FG000|Overall Study|Lost to Follow-up|3|||
48725731|NCT00973349|156845164|FG001|Overall Study|Lost to Follow-up|1|||
48725732|NCT00973349|156845165|FG002|Overall Study|Lost to Follow-up|2|||
48725733|NCT00973349|156845166|FG003|Overall Study|Lost to Follow-up|2|||
48725734|NCT00973349|156845167|FG004|Overall Study|Lost to Follow-up|1|||
48725735|NCT00973349|156845168|FG005|Overall Study|Lost to Follow-up|3|||
48725736|NCT00973349|156845169|FG006|Overall Study|Lost to Follow-up|0|||
48725737|NCT00973349|156845170|FG007|Overall Study|Lost to Follow-up|1|||
48725738|NCT00973349|156845171|FG008|Overall Study|Lost to Follow-up|2|||
48725739|NCT00973349|156845172|FG009|Overall Study|Lost to Follow-up|1|||
48725740|NCT00973349|156845173|FG010|Overall Study|Lost to Follow-up|0|||
48725741|NCT00973349|156845174|FG011|Overall Study|Lost to Follow-up|1|||
48725742|NCT00973349|156845175|FG012|Overall Study|Lost to Follow-up|0|||
48725743|NCT00973349|156845176|FG013|Overall Study|Lost to Follow-up|0|||
48725744|NCT00973349|156845177|FG014|Overall Study|Lost to Follow-up|0|||
48725745|NCT00973349|156845178|FG015|Overall Study|Lost to Follow-up|1|||
48725746|NCT00973349|156845163|FG000|Overall Study|Inappropriate enrolment|0|||
48725747|NCT00973349|156845164|FG001|Overall Study|Inappropriate enrolment|0|||
48725748|NCT00973349|156845165|FG002|Overall Study|Inappropriate enrolment|1|||
48725749|NCT00973349|156845166|FG003|Overall Study|Inappropriate enrolment|0|||
48725750|NCT00973349|156845167|FG004|Overall Study|Inappropriate enrolment|0|||
48725751|NCT00973349|156845168|FG005|Overall Study|Inappropriate enrolment|0|||
48725752|NCT00973349|156845169|FG006|Overall Study|Inappropriate enrolment|0|||
48725753|NCT00973349|156845170|FG007|Overall Study|Inappropriate enrolment|0|||
48725754|NCT00973349|156845171|FG008|Overall Study|Inappropriate enrolment|0|||
48725755|NCT00973349|156845172|FG009|Overall Study|Inappropriate enrolment|2|||
48725756|NCT00973349|156845173|FG010|Overall Study|Inappropriate enrolment|0|||
48725757|NCT00973349|156845174|FG011|Overall Study|Inappropriate enrolment|0|||
48725758|NCT00973349|156845175|FG012|Overall Study|Inappropriate enrolment|1|||
48725759|NCT00973349|156845176|FG013|Overall Study|Inappropriate enrolment|0|||
48725760|NCT00973349|156845177|FG014|Overall Study|Inappropriate enrolment|1|||
48725761|NCT00973349|156845178|FG015|Overall Study|Inappropriate enrolment|1|||
48725762|NCT00973349|156845163|FG000|Overall Study|Protocol Violation|0|||
48725763|NCT00973349|156845164|FG001|Overall Study|Protocol Violation|0|||
48725764|NCT00973349|156845165|FG002|Overall Study|Protocol Violation|0|||
48725765|NCT00973349|156845166|FG003|Overall Study|Protocol Violation|0|||
48725766|NCT00973349|156845167|FG004|Overall Study|Protocol Violation|0|||
48725767|NCT00973349|156845168|FG005|Overall Study|Protocol Violation|0|||
49135068|NCT02583269|158333326|FG001|Overall Study|Patient hospitalized prior to start|0|||
49135069|NCT02583269|158333327|FG002|Overall Study|Patient hospitalized prior to start|0|||
49135070|NCT02583269|158333328|FG003|Overall Study|Patient hospitalized prior to start|0|||
49135071|NCT02583269|158333329|FG004|Overall Study|Patient hospitalized prior to start|0|||
49135072|NCT01171534|158334666|FG000|Overall Study|Lost to Follow-up|0|||
49135073|NCT01171534|158334667|FG001|Overall Study|Lost to Follow-up|2|||
49135074|NCT01171534|158334666|FG000|Overall Study|screen failure|0|||
49135075|NCT01171534|158334667|FG001|Overall Study|screen failure|1|||
49135076|NCT02332707|158334668|FG000|Overall Study|Adverse Event|0|||
49135077|NCT02332707|158334669|FG001|Overall Study|Adverse Event|0|||
49135078|NCT02332707|158334670|FG002|Overall Study|Adverse Event|0|||
49135079|NCT02332707|158334671|FG003|Overall Study|Adverse Event|0|||
49135080|NCT02332707|158334672|FG004|Overall Study|Adverse Event|0|||
49135081|NCT02332707|158334673|FG005|Overall Study|Adverse Event|0|||
48725768|NCT00973349|156845169|FG006|Overall Study|Protocol Violation|0|||
48725769|NCT00973349|156845170|FG007|Overall Study|Protocol Violation|0|||
48725770|NCT00973349|156845171|FG008|Overall Study|Protocol Violation|1|||
48725771|NCT00973349|156845172|FG009|Overall Study|Protocol Violation|0|||
48725772|NCT00973349|156845173|FG010|Overall Study|Protocol Violation|0|||
48725773|NCT00973349|156845174|FG011|Overall Study|Protocol Violation|0|||
48725774|NCT00973349|156845175|FG012|Overall Study|Protocol Violation|0|||
48725775|NCT00973349|156845176|FG013|Overall Study|Protocol Violation|0|||
48725776|NCT00973349|156845177|FG014|Overall Study|Protocol Violation|0|||
48725777|NCT00973349|156845178|FG015|Overall Study|Protocol Violation|0|||
48725778|NCT00973349|156845163|FG000|Overall Study|Unable to classify|0|||
48725779|NCT00973349|156845164|FG001|Overall Study|Unable to classify|0|||
48725780|NCT00973349|156845165|FG002|Overall Study|Unable to classify|0|||
48725781|NCT00973349|156845166|FG003|Overall Study|Unable to classify|0|||
48725782|NCT00973349|156845167|FG004|Overall Study|Unable to classify|1|||
48725783|NCT00973349|156845168|FG005|Overall Study|Unable to classify|1|||
48725784|NCT00973349|156845169|FG006|Overall Study|Unable to classify|0|||
48725785|NCT00973349|156845170|FG007|Overall Study|Unable to classify|0|||
48725786|NCT00973349|156845171|FG008|Overall Study|Unable to classify|0|||
48725787|NCT00973349|156845172|FG009|Overall Study|Unable to classify|1|||
48725788|NCT00973349|156845173|FG010|Overall Study|Unable to classify|0|||
48725789|NCT00973349|156845174|FG011|Overall Study|Unable to classify|0|||
48725790|NCT00973349|156845175|FG012|Overall Study|Unable to classify|0|||
48725791|NCT00973349|156845176|FG013|Overall Study|Unable to classify|0|||
48725792|NCT00973349|156845177|FG014|Overall Study|Unable to classify|0|||
48725793|NCT00973349|156845178|FG015|Overall Study|Unable to classify|0|||
48725794|NCT02101112|156845181|FG000|Overall Study|Adverse Event|0|||
48725795|NCT02101112|156845182|FG001|Overall Study|Adverse Event|0|||
48725796|NCT02101112|156845183|FG002|Overall Study|Adverse Event|1|||
48725797|NCT02101112|156845184|FG003|Overall Study|Adverse Event|0|||
48725798|NCT02101112|156845185|FG004|Overall Study|Adverse Event|0|||
48725799|NCT02101112|156845186|FG005|Overall Study|Adverse Event|0|||
48725800|NCT02101112|156845181|FG000|Overall Study|Withdrawal by Subject|0|||
48725801|NCT02101112|156845182|FG001|Overall Study|Withdrawal by Subject|0|||
48725802|NCT02101112|156845183|FG002|Overall Study|Withdrawal by Subject|0|||
48725803|NCT02101112|156845184|FG003|Overall Study|Withdrawal by Subject|0|||
48725804|NCT02101112|156845185|FG004|Overall Study|Withdrawal by Subject|1|||
48725805|NCT02101112|156845186|FG005|Overall Study|Withdrawal by Subject|0|||
48725806|NCT02628769|156845187|FG000|First Intervention|Adverse Event|1|||
49011257|NCT01606137|157877499|FG000|Overall Study|Unable to collect consistent data|1|||
49011258|NCT00830063|157878904|FG000|Overall Study|Adverse Event|7|||
49011259|NCT00830063|157878905|FG001|Overall Study|Adverse Event|13|||
49011260|NCT00830063|157878906|FG002|Overall Study|Adverse Event|16|||
49011261|NCT00830063|157878907|FG003|Overall Study|Adverse Event|13|||
49011262|NCT00830063|157878904|FG000|Overall Study|Death|1|||
49011263|NCT00830063|157878905|FG001|Overall Study|Death|0|||
49011264|NCT00830063|157878906|FG002|Overall Study|Death|0|||
49011265|NCT00830063|157878907|FG003|Overall Study|Death|0|||
49011266|NCT00830063|157878904|FG000|Overall Study|Lost to Follow-up|0|||
49011267|NCT00830063|157878905|FG001|Overall Study|Lost to Follow-up|0|||
49011268|NCT00830063|157878906|FG002|Overall Study|Lost to Follow-up|3|||
49011269|NCT00830063|157878907|FG003|Overall Study|Lost to Follow-up|1|||
49011270|NCT00830063|157878904|FG000|Overall Study|Preferred Time Entry in Extension Study|119|||
49011271|NCT00830063|157878905|FG001|Overall Study|Preferred Time Entry in Extension Study|139|||
49011272|NCT00830063|157878906|FG002|Overall Study|Preferred Time Entry in Extension Study|127|||
49011273|NCT00830063|157878907|FG003|Overall Study|Preferred Time Entry in Extension Study|126|||
49011274|NCT00830063|157878904|FG000|Overall Study|Lack of Efficacy|51|||
49011275|NCT00830063|157878905|FG001|Overall Study|Lack of Efficacy|23|||
49135082|NCT02332707|158334674|FG006|Overall Study|Adverse Event|0|||
48921038|NCT00784654|157544820|FG002|Randomized Withdrawal Period|Family reasons|1|||
48921039|NCT01079182|157544821|FG000|Overall Study|Lost to Follow-up|1634|||
48921040|NCT01079182|157544821|FG000|Overall Study|Adverse Drug Reaction (ADR)|261|||
48921041|NCT01079182|157544821|FG000|Overall Study|Lack of Efficacy|514|||
48921042|NCT01079182|157544821|FG000|Overall Study|ADR and Lack of Effectiveness|39|||
49135083|NCT02332707|158334675|FG007|Overall Study|Adverse Event|0|||
49135084|NCT02332707|158334676|FG008|Overall Study|Adverse Event|0|||
49135085|NCT02332707|158334677|FG009|Overall Study|Adverse Event|0|||
49135086|NCT02332707|158334678|FG010|Overall Study|Adverse Event|0|||
49135087|NCT02332707|158334679|FG011|Overall Study|Adverse Event|0|||
49135088|NCT02332707|158334680|FG012|Overall Study|Adverse Event|1|||
49135089|NCT02332707|158334681|FG013|Overall Study|Adverse Event|0|||
49135090|NCT02332707|158334682|FG014|Overall Study|Adverse Event|0|||
49135091|NCT02332707|158334683|FG015|Overall Study|Adverse Event|0|||
49135092|NCT02332707|158334684|FG016|Overall Study|Adverse Event|0|||
49135093|NCT02332707|158334685|FG017|Overall Study|Adverse Event|0|||
49135094|NCT02332707|158334668|FG000|Overall Study|Lost to Follow-up|0|||
49135095|NCT02332707|158334669|FG001|Overall Study|Lost to Follow-up|0|||
49135096|NCT02332707|158334670|FG002|Overall Study|Lost to Follow-up|0|||
49135097|NCT02332707|158334671|FG003|Overall Study|Lost to Follow-up|0|||
49135098|NCT02332707|158334672|FG004|Overall Study|Lost to Follow-up|0|||
49135099|NCT02332707|158334673|FG005|Overall Study|Lost to Follow-up|1|||
49135100|NCT02332707|158334674|FG006|Overall Study|Lost to Follow-up|0|||
49135101|NCT02332707|158334675|FG007|Overall Study|Lost to Follow-up|0|||
49135102|NCT02332707|158334676|FG008|Overall Study|Lost to Follow-up|0|||
49135103|NCT02332707|158334677|FG009|Overall Study|Lost to Follow-up|0|||
49135104|NCT02332707|158334678|FG010|Overall Study|Lost to Follow-up|2|||
49135105|NCT02332707|158334679|FG011|Overall Study|Lost to Follow-up|0|||
48725807|NCT02628769|156845188|FG001|First Intervention|Adverse Event|0|||
48725808|NCT02628769|156845187|FG000|First Intervention|Withdrawal by Subject|0|||
48725809|NCT02628769|156845188|FG001|First Intervention|Withdrawal by Subject|1|||
48725810|NCT02628769|156845187|FG000|Second Intervention|Adverse Event|2|||
48725811|NCT02628769|156845188|FG001|Second Intervention|Adverse Event|0|||
48725812|NCT02628769|156845187|FG000|Second Intervention|Physician Decision|0|||
48725813|NCT02628769|156845188|FG001|Second Intervention|Physician Decision|1|||
48725814|NCT00543855|156846505|FG000|Overall Study|Adverse Event|3|||
48725815|NCT00543855|156846506|FG001|Overall Study|Adverse Event|1|||
48725816|NCT00543855|156846507|FG002|Overall Study|Adverse Event|3|||
48725817|NCT00543855|156846508|FG003|Overall Study|Adverse Event|4|||
48725818|NCT00543855|156846505|FG000|Overall Study|Lost to Follow-up|0|||
48725819|NCT00543855|156846506|FG001|Overall Study|Lost to Follow-up|0|||
48725820|NCT00543855|156846507|FG002|Overall Study|Lost to Follow-up|1|||
48725821|NCT00543855|156846508|FG003|Overall Study|Lost to Follow-up|0|||
48725822|NCT00543855|156846505|FG000|Overall Study|Withdrawal by Subject|0|||
48725823|NCT00543855|156846506|FG001|Overall Study|Withdrawal by Subject|1|||
48725824|NCT00543855|156846507|FG002|Overall Study|Withdrawal by Subject|2|||
48725825|NCT00543855|156846508|FG003|Overall Study|Withdrawal by Subject|0|||
48725826|NCT00543855|156846505|FG000|Overall Study|Protocol Violation|1|||
48725827|NCT00543855|156846506|FG001|Overall Study|Protocol Violation|0|||
48725828|NCT00543855|156846507|FG002|Overall Study|Protocol Violation|0|||
48725829|NCT00543855|156846508|FG003|Overall Study|Protocol Violation|0|||
48725830|NCT03603509|156846509|FG000|Overall Study|Lost to Follow-up|3|||
48725831|NCT03603509|156846510|FG001|Overall Study|Lost to Follow-up|4|||
48725832|NCT00910247|156846515|FG000|Overall Study|Adverse Event|15|||
48725833|NCT00910247|156846515|FG000|Overall Study|Death|2|||
48725834|NCT00910247|156846515|FG000|Overall Study|Lost to Follow-up|10|||
48725835|NCT00910247|156846515|FG000|Overall Study|Physician Decision|3|||
48725836|NCT00910247|156846515|FG000|Overall Study|Protocol Violation|10|||
48725837|NCT00910247|156846515|FG000|Overall Study|Withdrawal by Subject|25|||
48725838|NCT00910247|156846515|FG000|Overall Study|Not collected|4|||
48725839|NCT04285580|156846516|FG000|Overall Study|Protocol Violation|0|||
48725840|NCT04285580|156846517|FG001|Overall Study|Protocol Violation|1|||
48725841|NCT02927067|156846518|FG000|Overall Study|Withdrawn Consent|20|||
48725842|NCT02927067|156846519|FG001|Overall Study|Withdrawn Consent|12|||
48725843|NCT02927067|156846518|FG000|Overall Study|Death|18|||
48725844|NCT02927067|156846519|FG001|Overall Study|Death|31|||
49135106|NCT02332707|158334680|FG012|Overall Study|Lost to Follow-up|3|||
49135107|NCT02332707|158334681|FG013|Overall Study|Lost to Follow-up|0|||
48725845|NCT02927067|156846518|FG000|Overall Study|Adverse Event|13|||
48725846|NCT02927067|156846519|FG001|Overall Study|Adverse Event|10|||
49135108|NCT02332707|158334682|FG014|Overall Study|Lost to Follow-up|0|||
48725847|NCT02927067|156846518|FG000|Overall Study|Noncompliance|5|||
48725848|NCT02927067|156846519|FG001|Overall Study|Noncompliance|2|||
48725849|NCT02927067|156846518|FG000|Overall Study|Reason not Specified|4|||
48725850|NCT02927067|156846519|FG001|Overall Study|Reason not Specified|6|||
49135109|NCT02332707|158334683|FG015|Overall Study|Lost to Follow-up|0|||
49135110|NCT02332707|158334684|FG016|Overall Study|Lost to Follow-up|0|||
49135111|NCT02332707|158334685|FG017|Overall Study|Lost to Follow-up|0|||
49135112|NCT02332707|158334668|FG000|Overall Study|Physician Decision|0|||
49135113|NCT02332707|158334669|FG001|Overall Study|Physician Decision|0|||
49135114|NCT02332707|158334670|FG002|Overall Study|Physician Decision|0|||
49135115|NCT02332707|158334671|FG003|Overall Study|Physician Decision|1|||
49135116|NCT02332707|158334672|FG004|Overall Study|Physician Decision|0|||
49135117|NCT02332707|158334673|FG005|Overall Study|Physician Decision|0|||
49135118|NCT02332707|158334674|FG006|Overall Study|Physician Decision|0|||
49135119|NCT02332707|158334675|FG007|Overall Study|Physician Decision|0|||
49135120|NCT02332707|158334676|FG008|Overall Study|Physician Decision|0|||
49135121|NCT02332707|158334677|FG009|Overall Study|Physician Decision|0|||
49135122|NCT02332707|158334678|FG010|Overall Study|Physician Decision|0|||
49135123|NCT02332707|158334679|FG011|Overall Study|Physician Decision|0|||
49135124|NCT02332707|158334680|FG012|Overall Study|Physician Decision|1|||
49135125|NCT02332707|158334681|FG013|Overall Study|Physician Decision|0|||
49135126|NCT02332707|158334682|FG014|Overall Study|Physician Decision|0|||
49135127|NCT02332707|158334683|FG015|Overall Study|Physician Decision|0|||
49135128|NCT02332707|158334684|FG016|Overall Study|Physician Decision|0|||
49135129|NCT02332707|158334685|FG017|Overall Study|Physician Decision|0|||
49135130|NCT02332707|158334668|FG000|Overall Study|Withdrawal by Subject|0|||
49135131|NCT02332707|158334669|FG001|Overall Study|Withdrawal by Subject|0|||
49135132|NCT02332707|158334670|FG002|Overall Study|Withdrawal by Subject|1|||
49135133|NCT02332707|158334671|FG003|Overall Study|Withdrawal by Subject|0|||
49135134|NCT02332707|158334672|FG004|Overall Study|Withdrawal by Subject|0|||
49135135|NCT02332707|158334673|FG005|Overall Study|Withdrawal by Subject|0|||
49135136|NCT02332707|158334674|FG006|Overall Study|Withdrawal by Subject|0|||
49135137|NCT02332707|158334675|FG007|Overall Study|Withdrawal by Subject|0|||
49135138|NCT02332707|158334676|FG008|Overall Study|Withdrawal by Subject|0|||
49135139|NCT02332707|158334677|FG009|Overall Study|Withdrawal by Subject|3|||
49135140|NCT02332707|158334678|FG010|Overall Study|Withdrawal by Subject|0|||
49135141|NCT02332707|158334679|FG011|Overall Study|Withdrawal by Subject|0|||
49135142|NCT02332707|158334680|FG012|Overall Study|Withdrawal by Subject|0|||
49135143|NCT02332707|158334681|FG013|Overall Study|Withdrawal by Subject|0|||
49135144|NCT02332707|158334682|FG014|Overall Study|Withdrawal by Subject|0|||
49135145|NCT02332707|158334683|FG015|Overall Study|Withdrawal by Subject|0|||
49135146|NCT02332707|158334684|FG016|Overall Study|Withdrawal by Subject|0|||
49135147|NCT02332707|158334685|FG017|Overall Study|Withdrawal by Subject|0|||
49135148|NCT00274456|158334686|FG000|Overall Study|Still on treatment|2|||
49135149|NCT00274456|158334687|FG001|Overall Study|Still on treatment|3|||
49135150|NCT00274456|158334688|FG002|Overall Study|Still on treatment|5|||
49135151|NCT00274456|158334689|FG003|Overall Study|Still on treatment|1|||
49135152|NCT00274456|158334686|FG000|Overall Study|Unacceptable toxicity|10|||
49135153|NCT00274456|158334687|FG001|Overall Study|Unacceptable toxicity|5|||
49135154|NCT00274456|158334688|FG002|Overall Study|Unacceptable toxicity|12|||
49135155|NCT00274456|158334689|FG003|Overall Study|Unacceptable toxicity|16|||
49135156|NCT00274456|158334686|FG000|Overall Study|Adverse Event|0|||
49135157|NCT00274456|158334687|FG001|Overall Study|Adverse Event|1|||
49135158|NCT00274456|158334688|FG002|Overall Study|Adverse Event|2|||
49135159|NCT00274456|158334689|FG003|Overall Study|Adverse Event|2|||
49135160|NCT00274456|158334686|FG000|Overall Study|Physician Decision|7|||
49135161|NCT00274456|158334687|FG001|Overall Study|Physician Decision|5|||
49135162|NCT00274456|158334688|FG002|Overall Study|Physician Decision|6|||
49135163|NCT00274456|158334689|FG003|Overall Study|Physician Decision|13|||
49135164|NCT00274456|158334686|FG000|Overall Study|Lost to Follow-up|0|||
49135165|NCT00274456|158334687|FG001|Overall Study|Lost to Follow-up|0|||
49135166|NCT00274456|158334688|FG002|Overall Study|Lost to Follow-up|1|||
49135167|NCT00274456|158334689|FG003|Overall Study|Lost to Follow-up|0|||
48725851|NCT00622739|156846522|FG000|Overall Study|Physician Decision|1|||
48725852|NCT00622739|156846523|FG001|Overall Study|Physician Decision|0|||
48725853|NCT00622739|156846522|FG000|Overall Study|Adverse Event|1|||
48725854|NCT00622739|156846523|FG001|Overall Study|Adverse Event|2|||
48725855|NCT00622739|156846522|FG000|Overall Study|Lack of Efficacy|0|||
48725856|NCT00622739|156846523|FG001|Overall Study|Lack of Efficacy|2|||
48725857|NCT00622739|156846522|FG000|Overall Study|Withdrawal by Subject|0|||
48725858|NCT00622739|156846523|FG001|Overall Study|Withdrawal by Subject|1|||
48725859|NCT00622739|156846522|FG000|Overall Study|Lost to Follow-up|0|||
48725860|NCT00622739|156846523|FG001|Overall Study|Lost to Follow-up|1|||
48725861|NCT01314911|156846528|FG000|Overall Study|Lost to Follow-up|3|||
48725862|NCT01314911|156846529|FG001|Overall Study|Lost to Follow-up|2|||
48725863|NCT01314911|156846528|FG000|Overall Study|Withdrawal by Subject|1|||
48725864|NCT01314911|156846529|FG001|Overall Study|Withdrawal by Subject|3|||
48725865|NCT01314911|156846528|FG000|Overall Study|Received Non-randomized Study Drug|0|||
48725866|NCT01314911|156846529|FG001|Overall Study|Received Non-randomized Study Drug|1|||
48725867|NCT01314911|156846528|FG000|Overall Study|Never Started Treatment|1|||
48725868|NCT01314911|156846529|FG001|Overall Study|Never Started Treatment|0|||
48725869|NCT00773383|156846533|FG000|Overall Study|Adverse Event|4|||
48725870|NCT00773383|156846533|FG000|Overall Study|Death|1|||
48725871|NCT00773383|156846533|FG000|Overall Study|Progression of Disease|23|||
49135168|NCT00274456|158334686|FG000|Overall Study|Withdrawal by Subject|18|||
49135169|NCT00274456|158334687|FG001|Overall Study|Withdrawal by Subject|13|||
49135170|NCT00274456|158334688|FG002|Overall Study|Withdrawal by Subject|9|||
49135171|NCT00274456|158334689|FG003|Overall Study|Withdrawal by Subject|13|||
49135172|NCT00090103|158334690|FG000|Four-Year Double-Blind Treatment Period|Adverse Event|211|||
49135173|NCT00090103|158334691|FG001|Four-Year Double-Blind Treatment Period|Adverse Event|185|||
49135174|NCT00090103|158334692|FG002|Four-Year Double-Blind Treatment Period|Adverse Event|210|||
49135175|NCT00090103|158334690|FG000|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114|||
49135176|NCT00090103|158334691|FG001|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160|||
49135177|NCT00090103|158334692|FG002|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148|||
49135178|NCT00090103|158334690|FG000|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53|||
49135179|NCT00090103|158334691|FG001|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48|||
49135180|NCT00090103|158334692|FG002|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58|||
49135181|NCT00090103|158334690|FG000|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
49135182|NCT00090103|158334691|FG001|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
49135183|NCT00090103|158334692|FG002|Four-Year Double-Blind Treatment Period|Protocol Violation|34|||
49135184|NCT00090103|158334690|FG000|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53|||
49135185|NCT00090103|158334691|FG001|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71|||
49135186|NCT00090103|158334692|FG002|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104|||
49135187|NCT00090103|158334690|FG000|Four-Year Double-Blind Treatment Period|Participant Relocated|7|||
49135188|NCT00090103|158334691|FG001|Four-Year Double-Blind Treatment Period|Participant Relocated|2|||
49135189|NCT00090103|158334692|FG002|Four-Year Double-Blind Treatment Period|Participant Relocated|8|||
48725872|NCT00773383|156846533|FG000|Overall Study|Other|2|||
48725873|NCT00773383|156846533|FG000|Overall Study|No study dose received|1|||
48725874|NCT01611454|156846534|FG000|Overall Study|Lack of Efficacy|18|||
48725875|NCT01611454|156846535|FG001|Overall Study|Lack of Efficacy|10|||
48725876|NCT02987660|156846537|FG000|Overall Study|Study terminated by sponsor|10|||
48725877|NCT02987660|156846538|FG001|Overall Study|Study terminated by sponsor|10|||
48725878|NCT02361580|156846540|FG000|Overall Study|Lost to Follow-up|6|||
48725879|NCT02361580|156846541|FG001|Overall Study|Lost to Follow-up|3|||
48725880|NCT01653782|156846542|FG000|Overall Study|Withdrawal by Subject|9|||
48725881|NCT01653782|156846543|FG001|Overall Study|Withdrawal by Subject|15|||
48725882|NCT01653782|156846544|FG002|Overall Study|Withdrawal by Subject|4|||
48725883|NCT01653782|156846542|FG000|Overall Study|Lost to Follow-up|7|||
48725884|NCT01653782|156846543|FG001|Overall Study|Lost to Follow-up|3|||
48725885|NCT01653782|156846544|FG002|Overall Study|Lost to Follow-up|2|||
48725886|NCT03312751|156846546|FG000|Overall Study|Death|7|||
48725887|NCT03312751|156846547|FG001|Overall Study|Death|9|||
48725888|NCT03312751|156846546|FG000|Overall Study|Study discontinuation due to other reason|0|||
48725889|NCT03312751|156846547|FG001|Overall Study|Study discontinuation due to other reason|1|||
48725890|NCT01857310|156846548|FG000|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315|||
48725891|NCT01857310|156846549|FG001|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282|||
48725892|NCT01117792|156846550|FG000|Overall Study|Death|1|||
48725893|NCT01117792|156846550|FG000|Overall Study|Adverse Event|3|||
48725894|NCT01966432|156846551|FG000|Overall Study|Lost to Follow-up|3|||
48725895|NCT01966432|156846552|FG001|Overall Study|Lost to Follow-up|2|||
48725896|NCT01966432|156846553|FG002|Overall Study|Lost to Follow-up|5|||
48725897|NCT01966432|156846551|FG000|Overall Study|Withdrawal by Subject|1|||
48725898|NCT01966432|156846552|FG001|Overall Study|Withdrawal by Subject|3|||
48725899|NCT01966432|156846553|FG002|Overall Study|Withdrawal by Subject|0|||
48725900|NCT01966432|156846551|FG000|Overall Study|Subject Incarcerated|0|||
48725901|NCT01966432|156846552|FG001|Overall Study|Subject Incarcerated|0|||
48725902|NCT01966432|156846553|FG002|Overall Study|Subject Incarcerated|1|||
48725903|NCT01966432|156846551|FG000|Overall Study|SBIRT program ended|1|||
48725904|NCT01966432|156846552|FG001|Overall Study|SBIRT program ended|8|||
48725905|NCT01966432|156846553|FG002|Overall Study|SBIRT program ended|20|||
48725906|NCT03170232|156846554|FG000|Overall Study|Adverse Event|0|||
48725907|NCT03170232|156846555|FG001|Overall Study|Adverse Event|1|||
48725908|NCT03170232|156846554|FG000|Overall Study|Protocol Violation|0|||
48725909|NCT03170232|156846555|FG001|Overall Study|Protocol Violation|1|||
48725910|NCT03170232|156846554|FG000|Overall Study|Lack of Efficacy|0|||
48725911|NCT03170232|156846555|FG001|Overall Study|Lack of Efficacy|1|||
48725912|NCT03170232|156846554|FG000|Overall Study|Study closed/terminated|26|||
48725913|NCT03170232|156846555|FG001|Overall Study|Study closed/terminated|23|||
48725914|NCT03170232|156846554|FG000|Overall Study|Lost to Follow-up|1|||
48725915|NCT03170232|156846555|FG001|Overall Study|Lost to Follow-up|0|||
48725916|NCT03170232|156846554|FG000|Overall Study|Withdrawal by Subject|0|||
48725917|NCT03170232|156846555|FG001|Overall Study|Withdrawal by Subject|1|||
48725918|NCT01439347|156846556|FG000|Overall Study|Death|10|||
48725919|NCT01439347|156846557|FG001|Overall Study|Death|9|||
48725920|NCT01439347|156846556|FG000|Overall Study|Withdrawal by Subject|0|||
48725921|NCT01439347|156846557|FG001|Overall Study|Withdrawal by Subject|1|||
48725922|NCT01439347|156846556|FG000|Overall Study|Physician Decision|1|||
49135190|NCT00090103|158334690|FG000|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
49135191|NCT00090103|158334691|FG001|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
49135192|NCT00090103|158334692|FG002|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4|||
49135193|NCT00090103|158334690|FG000|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6|||
49135194|NCT00090103|158334691|FG001|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4|||
49135195|NCT00090103|158334692|FG002|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7|||
49135196|NCT00090103|158334690|FG000|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3|||
49135197|NCT00090103|158334691|FG001|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7|||
49135198|NCT00090103|158334692|FG002|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19|||
49135199|NCT00090103|158334690|FG000|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2|||
49135200|NCT00090103|158334691|FG001|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0|||
49135201|NCT00090103|158334692|FG002|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4|||
49135202|NCT00090103|158334690|FG000|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2|||
49135203|NCT00090103|158334691|FG001|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3|||
49135204|NCT00090103|158334692|FG002|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6|||
49135205|NCT00090103|158334690|FG000|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
49135206|NCT00090103|158334691|FG001|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
49135207|NCT00090103|158334692|FG002|Four-Year Double-Blind Treatment Period|Prohibited Medication|8|||
49135208|NCT00090103|158334690|FG000|Four-Year Double-Blind Treatment Period|Investigator Departure|2|||
49135209|NCT00090103|158334691|FG001|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
49135210|NCT00090103|158334692|FG002|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
49135211|NCT00090103|158334690|FG000|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1|||
49135212|NCT00090103|158334691|FG001|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
49135213|NCT00090103|158334692|FG002|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
49135214|NCT00090103|158334690|FG000|Four-Year Double-Blind Treatment Period|Screen Failure|1|||
49135215|NCT00090103|158334691|FG001|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
49135216|NCT00090103|158334692|FG002|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
49135217|NCT00090103|158334690|FG000|Four-Year Double-Blind Treatment Period|No Improvement|1|||
49135218|NCT00090103|158334691|FG001|Four-Year Double-Blind Treatment Period|No Improvement|0|||
49135219|NCT00090103|158334692|FG002|Four-Year Double-Blind Treatment Period|No Improvement|0|||
49135220|NCT00090103|158334690|FG000|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1|||
49135221|NCT00090103|158334691|FG001|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0|||
49135222|NCT00090103|158334692|FG002|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5|||
49135223|NCT00090103|158334690|FG000|Four-Year Double-Blind Treatment Period|Financial Problems|1|||
49135224|NCT00090103|158334691|FG001|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
49135225|NCT00090103|158334692|FG002|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
49135226|NCT00090103|158334690|FG000|Four-Year Double-Blind Treatment Period|Loss of Libido|1|||
49135227|NCT00090103|158334691|FG001|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
49135228|NCT00090103|158334692|FG002|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
49135229|NCT00090103|158334690|FG000|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
49135230|NCT00090103|158334691|FG001|Four-Year Double-Blind Treatment Period|Angina Pectoris|2|||
49135231|NCT00090103|158334692|FG002|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
49135232|NCT00090103|158334690|FG000|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
49135233|NCT00090103|158334691|FG001|Four-Year Double-Blind Treatment Period|Loss of Contact|1|||
48725923|NCT01439347|156846557|FG001|Overall Study|Physician Decision|0|||
48725924|NCT01439347|156846556|FG000|Overall Study|Sponsor Terminated Study|2|||
48725925|NCT01439347|156846557|FG001|Overall Study|Sponsor Terminated Study|3|||
48725926|NCT03101267|156846558|FG000|Primary Study Period|Withdrawal by Subject|1|||
48725927|NCT03101267|156846559|FG001|Primary Study Period|Withdrawal by Subject|2|||
48725928|NCT03101267|156846560|FG002|Primary Study Period|Withdrawal by Subject|3|||
48725929|NCT03101267|156846558|FG000|Primary Study Period|Miscellaneous|2|||
48725930|NCT03101267|156846559|FG001|Primary Study Period|Miscellaneous|0|||
48725931|NCT03101267|156846560|FG002|Primary Study Period|Miscellaneous|0|||
48725932|NCT04322539|156846561|FG000|Overall Study|Withdrawal of consent|14|||
48725933|NCT04322539|156846562|FG001|Overall Study|Withdrawal of consent|8|||
48725934|NCT04322539|156846561|FG000|Overall Study|Death|317|||
48725935|NCT04322539|156846562|FG001|Overall Study|Death|173|||
48725936|NCT04322539|156846561|FG000|Overall Study|Adverse Event|1|||
48725937|NCT04322539|156846562|FG001|Overall Study|Adverse Event|0|||
48725938|NCT04322539|156846561|FG000|Overall Study|Lost to Follow-up|3|||
48725939|NCT04322539|156846562|FG001|Overall Study|Lost to Follow-up|0|||
48725940|NCT04322539|156846561|FG000|Overall Study|Other|2|||
48725941|NCT04322539|156846562|FG001|Overall Study|Other|3|||
48725942|NCT04322539|156846561|FG000|Overall Study|Ongoing|124|||
48725943|NCT04322539|156846562|FG001|Overall Study|Ongoing|46|||
49135234|NCT00090103|158334692|FG002|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
49135235|NCT00090103|158334690|FG000|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0|||
49135236|NCT00090103|158334691|FG001|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
49135237|NCT00090103|158334692|FG002|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
49135238|NCT00090103|158334690|FG000|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
49135239|NCT00090103|158334691|FG001|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2|||
49135240|NCT00090103|158334692|FG002|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
49135241|NCT00090103|158334690|FG000|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
49135242|NCT00090103|158334691|FG001|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1|||
49135243|NCT00090103|158334692|FG002|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
49135244|NCT00090103|158334690|FG000|Four-Year Double-Blind Treatment Period|Back Pain|0|||
49135245|NCT00090103|158334691|FG001|Four-Year Double-Blind Treatment Period|Back Pain|1|||
49135246|NCT00090103|158334692|FG002|Four-Year Double-Blind Treatment Period|Back Pain|0|||
49135247|NCT00090103|158334690|FG000|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
49135248|NCT00090103|158334691|FG001|Four-Year Double-Blind Treatment Period|Scheduling Issues|1|||
49135249|NCT00090103|158334692|FG002|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
49135250|NCT00090103|158334690|FG000|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
49135251|NCT00090103|158334691|FG001|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1|||
49135252|NCT00090103|158334692|FG002|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
49135253|NCT00090103|158334690|FG000|Four-Year Double-Blind Treatment Period|Investigator Decision|0|||
49135254|NCT00090103|158334691|FG001|Four-Year Double-Blind Treatment Period|Investigator Decision|1|||
49135255|NCT00090103|158334692|FG002|Four-Year Double-Blind Treatment Period|Investigator Decision|3|||
49135256|NCT00090103|158334690|FG000|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
49135257|NCT00090103|158334691|FG001|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
49135258|NCT00090103|158334692|FG002|Four-Year Double-Blind Treatment Period|Enrollment Error|2|||
49135259|NCT00090103|158334690|FG000|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
49135260|NCT00090103|158334691|FG001|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
49135261|NCT00090103|158334692|FG002|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1|||
49135262|NCT00090103|158334690|FG000|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
49135263|NCT00090103|158334691|FG001|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1|||
49135264|NCT00090103|158334692|FG002|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
49135265|NCT00090103|158334690|FG000|16-Week Safety Follow-up Period|Adverse Event|34|||
48725944|NCT01401959|156846563|FG000|Enrolled|Withdrawal by Subject|1|||
48725945|NCT01401959|156846564|FG001|Enrolled|Withdrawal by Subject|0|||
48725946|NCT01401959|156846565|FG002|Enrolled|Withdrawal by Subject|0|||
48725947|NCT01401959|156846563|FG000|Treated|Disease Progression|2|||
48725948|NCT01401959|156846564|FG001|Treated|Disease Progression|2|||
48725949|NCT01401959|156846565|FG002|Treated|Disease Progression|1|||
48725950|NCT01401959|156846563|FG000|Treated|Adverse Event|4|||
48725951|NCT01401959|156846564|FG001|Treated|Adverse Event|3|||
48725952|NCT01401959|156846565|FG002|Treated|Adverse Event|2|||
48725953|NCT01401959|156846563|FG000|Treated|Withdrawal by Subject|1|||
48725954|NCT01401959|156846564|FG001|Treated|Withdrawal by Subject|2|||
48725955|NCT01401959|156846565|FG002|Treated|Withdrawal by Subject|2|||
48725956|NCT01401959|156846563|FG000|Treated|Protocol Violation|0|||
48725957|NCT01401959|156846564|FG001|Treated|Protocol Violation|1|||
48725958|NCT01401959|156846565|FG002|Treated|Protocol Violation|0|||
48725959|NCT02925793|156846566|FG000|Overall Study|Adverse Event|3|||
48725960|NCT02925793|156846567|FG001|Overall Study|Adverse Event|3|||
48725961|NCT02925793|156846568|FG002|Overall Study|Adverse Event|6|||
48725962|NCT02925793|156846566|FG000|Overall Study|Withdrawal by Subject|16|||
48725963|NCT02925793|156846567|FG001|Overall Study|Withdrawal by Subject|15|||
48725964|NCT02925793|156846568|FG002|Overall Study|Withdrawal by Subject|13|||
48725965|NCT02925793|156846566|FG000|Overall Study|Investigator Discretion|0|||
48725966|NCT02925793|156846567|FG001|Overall Study|Investigator Discretion|1|||
48725967|NCT02925793|156846568|FG002|Overall Study|Investigator Discretion|1|||
48725968|NCT02925793|156846566|FG000|Overall Study|Lost to Follow-up|2|||
48725969|NCT02925793|156846567|FG001|Overall Study|Lost to Follow-up|3|||
48725970|NCT02925793|156846568|FG002|Overall Study|Lost to Follow-up|1|||
48725971|NCT02925793|156846566|FG000|Overall Study|Lack of Efficacy|2|||
48725972|NCT02925793|156846567|FG001|Overall Study|Lack of Efficacy|6|||
48725973|NCT02925793|156846568|FG002|Overall Study|Lack of Efficacy|4|||
48725974|NCT02925793|156846566|FG000|Overall Study|Other:|2|||
48725975|NCT02925793|156846567|FG001|Overall Study|Other:|1|||
48725976|NCT02925793|156846568|FG002|Overall Study|Other:|3|||
48725977|NCT01390220|156846570|FG000|Test Dose Phase|Adverse Event|17|||
48725978|NCT01390220|156846571|FG001|Test Dose Phase|Adverse Event|0|||
48725979|NCT01390220|156846572|FG002|Test Dose Phase|Adverse Event|0|||
48725980|NCT01390220|156846570|FG000|Test Dose Phase|Withdrawal by Subject|8|||
48725981|NCT01390220|156846571|FG001|Test Dose Phase|Withdrawal by Subject|0|||
49135266|NCT00090103|158334691|FG001|16-Week Safety Follow-up Period|Adverse Event|39|||
49135267|NCT00090103|158334692|FG002|16-Week Safety Follow-up Period|Adverse Event|44|||
49135268|NCT00090103|158334690|FG000|16-Week Safety Follow-up Period|Withdrawal by Subject|185|||
49135269|NCT00090103|158334691|FG001|16-Week Safety Follow-up Period|Withdrawal by Subject|212|||
49135270|NCT00090103|158334692|FG002|16-Week Safety Follow-up Period|Withdrawal by Subject|229|||
49135271|NCT00090103|158334690|FG000|16-Week Safety Follow-up Period|Lost to Follow-up|101|||
49135272|NCT00090103|158334691|FG001|16-Week Safety Follow-up Period|Lost to Follow-up|97|||
49135273|NCT00090103|158334692|FG002|16-Week Safety Follow-up Period|Lost to Follow-up|111|||
49135274|NCT00090103|158334690|FG000|16-Week Safety Follow-up Period|Protocol Violation|18|||
49135275|NCT00090103|158334691|FG001|16-Week Safety Follow-up Period|Protocol Violation|18|||
49135276|NCT00090103|158334692|FG002|16-Week Safety Follow-up Period|Protocol Violation|17|||
49135277|NCT00090103|158334690|FG000|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8|||
49135278|NCT00090103|158334691|FG001|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5|||
49135279|NCT00090103|158334692|FG002|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4|||
49135280|NCT00090103|158334690|FG000|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8|||
49135281|NCT00090103|158334691|FG001|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6|||
49135282|NCT00090103|158334692|FG002|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4|||
49135283|NCT00090103|158334690|FG000|16-Week Safety Follow-up Period|Loss of Contact|4|||
49135284|NCT00090103|158334691|FG001|16-Week Safety Follow-up Period|Loss of Contact|0|||
49135285|NCT00090103|158334692|FG002|16-Week Safety Follow-up Period|Loss of Contact|2|||
49135286|NCT00090103|158334690|FG000|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3|||
49135287|NCT00090103|158334691|FG001|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
49135288|NCT00090103|158334692|FG002|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
49135289|NCT00090103|158334690|FG000|16-Week Safety Follow-up Period|Participant relocated|2|||
49135290|NCT00090103|158334691|FG001|16-Week Safety Follow-up Period|Participant relocated|3|||
49135291|NCT00090103|158334692|FG002|16-Week Safety Follow-up Period|Participant relocated|1|||
49135292|NCT00090103|158334690|FG000|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
49135293|NCT00090103|158334691|FG001|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1|||
49135294|NCT00090103|158334692|FG002|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
49135295|NCT00090103|158334690|FG000|16-Week Safety Follow-up Period|Prohibited Medication|2|||
49135296|NCT00090103|158334691|FG001|16-Week Safety Follow-up Period|Prohibited Medication|3|||
49135297|NCT00090103|158334692|FG002|16-Week Safety Follow-up Period|Prohibited Medication|5|||
48725982|NCT01390220|156846572|FG002|Test Dose Phase|Withdrawal by Subject|0|||
48725983|NCT01390220|156846570|FG000|Test Dose Phase|Lost to Follow-up|2|||
48725984|NCT01390220|156846571|FG001|Test Dose Phase|Lost to Follow-up|0|||
48725985|NCT01390220|156846572|FG002|Test Dose Phase|Lost to Follow-up|0|||
48725986|NCT01390220|156846570|FG000|Test Dose Phase|Protocol Violation|8|||
48725987|NCT01390220|156846571|FG001|Test Dose Phase|Protocol Violation|0|||
48725988|NCT01390220|156846572|FG002|Test Dose Phase|Protocol Violation|0|||
48725989|NCT01390220|156846570|FG000|Test Dose Phase|No treated seizure cluster episode|37|||
48725990|NCT01390220|156846571|FG001|Test Dose Phase|No treated seizure cluster episode|0|||
48725991|NCT01390220|156846572|FG002|Test Dose Phase|No treated seizure cluster episode|0|||
48725992|NCT01390220|156846570|FG000|Test Dose Phase|Study/Site closure|6|||
48725993|NCT01390220|156846571|FG001|Test Dose Phase|Study/Site closure|0|||
48725994|NCT01390220|156846572|FG002|Test Dose Phase|Study/Site closure|0|||
48725995|NCT01390220|156846570|FG000|Test Dose Phase|Caregiver no longer available|5|||
48725996|NCT01390220|156846571|FG001|Test Dose Phase|Caregiver no longer available|0|||
48725997|NCT01390220|156846572|FG002|Test Dose Phase|Caregiver no longer available|0|||
48725998|NCT01390220|156846570|FG000|Test Dose Phase|Noncompliance|2|||
48725999|NCT01390220|156846571|FG001|Test Dose Phase|Noncompliance|0|||
48726000|NCT01390220|156846572|FG002|Test Dose Phase|Noncompliance|0|||
48726001|NCT01390220|156846570|FG000|Test Dose Phase|Logistical|6|||
48726002|NCT01390220|156846571|FG001|Test Dose Phase|Logistical|0|||
48726003|NCT01390220|156846572|FG002|Test Dose Phase|Logistical|0|||
48726004|NCT01390220|156846570|FG000|Comparative Phase|Withdrawal by Subject|0|||
48726005|NCT01390220|156846571|FG001|Comparative Phase|Withdrawal by Subject|1|||
48726006|NCT01390220|156846572|FG002|Comparative Phase|Withdrawal by Subject|0|||
48726007|NCT00249288|156846573|FG000|Overall Study|Lost to Follow-up|3|||
48726008|NCT00249288|156846574|FG001|Overall Study|Lost to Follow-up|3|||
48726009|NCT00249288|156846573|FG000|Overall Study|Withdrawal by Subject|2|||
48726010|NCT00249288|156846574|FG001|Overall Study|Withdrawal by Subject|2|||
48726011|NCT00829283|156846575|FG000|Overall Study|Lost to Follow-up|7|||
48726012|NCT00829283|156846576|FG001|Overall Study|Lost to Follow-up|25|||
48726013|NCT02414139|156846577|FG000|Treatment Period|Adverse Event|11|||
48726014|NCT02414139|156846578|FG001|Treatment Period|Adverse Event|6|||
48726015|NCT02414139|156846579|FG002|Treatment Period|Adverse Event|8|||
48726016|NCT02414139|156846580|FG003|Treatment Period|Adverse Event|5|||
48726017|NCT02414139|156846581|FG004|Treatment Period|Adverse Event|14|||
48726018|NCT02414139|156846582|FG005|Treatment Period|Adverse Event|3|||
48726019|NCT02414139|156846583|FG006|Treatment Period|Adverse Event|6|||
49135298|NCT00090103|158334690|FG000|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
49135299|NCT00090103|158334691|FG001|16-Week Safety Follow-up Period|Alcohol Dependent|0|||
49135300|NCT00090103|158334692|FG002|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
49135301|NCT00090103|158334690|FG000|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1|||
49135302|NCT00090103|158334691|FG001|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5|||
49135303|NCT00090103|158334692|FG002|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13|||
49135304|NCT00090103|158334690|FG000|16-Week Safety Follow-up Period|Loss of Libido|1|||
49135305|NCT00090103|158334691|FG001|16-Week Safety Follow-up Period|Loss of Libido|0|||
49135306|NCT00090103|158334692|FG002|16-Week Safety Follow-up Period|Loss of Libido|0|||
49135307|NCT00090103|158334690|FG000|16-Week Safety Follow-up Period|Enrollment Error|1|||
49135308|NCT00090103|158334691|FG001|16-Week Safety Follow-up Period|Enrollment Error|0|||
49135309|NCT00090103|158334692|FG002|16-Week Safety Follow-up Period|Enrollment Error|2|||
49135310|NCT00090103|158334690|FG000|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1|||
49135311|NCT00090103|158334691|FG001|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3|||
49135312|NCT00090103|158334692|FG002|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6|||
49135313|NCT00090103|158334690|FG000|16-Week Safety Follow-up Period|Death|1|||
48726020|NCT02414139|156846584|FG007|Treatment Period|Adverse Event|1|||
48726021|NCT02414139|156846585|FG008|Treatment Period|Adverse Event|6|||
48726022|NCT02414139|156846586|FG009|Treatment Period|Adverse Event|8|||
48726023|NCT02414139|156846577|FG000|Treatment Period|Death|0|||
48726024|NCT02414139|156846578|FG001|Treatment Period|Death|0|||
48726025|NCT02414139|156846579|FG002|Treatment Period|Death|1|||
48726026|NCT02414139|156846580|FG003|Treatment Period|Death|1|||
48726027|NCT02414139|156846581|FG004|Treatment Period|Death|0|||
48726028|NCT02414139|156846582|FG005|Treatment Period|Death|0|||
48726029|NCT02414139|156846583|FG006|Treatment Period|Death|0|||
48726030|NCT02414139|156846584|FG007|Treatment Period|Death|0|||
48726031|NCT02414139|156846585|FG008|Treatment Period|Death|0|||
48726032|NCT02414139|156846586|FG009|Treatment Period|Death|1|||
48726033|NCT02414139|156846577|FG000|Treatment Period|Physician Decision|5|||
48726034|NCT02414139|156846578|FG001|Treatment Period|Physician Decision|4|||
48726035|NCT02414139|156846579|FG002|Treatment Period|Physician Decision|6|||
48726036|NCT02414139|156846580|FG003|Treatment Period|Physician Decision|1|||
48726037|NCT02414139|156846581|FG004|Treatment Period|Physician Decision|4|||
48726038|NCT02414139|156846582|FG005|Treatment Period|Physician Decision|0|||
48726039|NCT02414139|156846583|FG006|Treatment Period|Physician Decision|2|||
48726040|NCT02414139|156846584|FG007|Treatment Period|Physician Decision|0|||
48726041|NCT02414139|156846585|FG008|Treatment Period|Physician Decision|1|||
48726042|NCT02414139|156846586|FG009|Treatment Period|Physician Decision|4|||
48726043|NCT02414139|156846577|FG000|Treatment Period|Progressive disease|48|||
48726044|NCT02414139|156846578|FG001|Treatment Period|Progressive disease|31|||
48726045|NCT02414139|156846579|FG002|Treatment Period|Progressive disease|37|||
48726046|NCT02414139|156846580|FG003|Treatment Period|Progressive disease|21|||
48726047|NCT02414139|156846581|FG004|Treatment Period|Progressive disease|43|||
48726048|NCT02414139|156846582|FG005|Treatment Period|Progressive disease|12|||
48726049|NCT02414139|156846583|FG006|Treatment Period|Progressive disease|16|||
48726050|NCT02414139|156846584|FG007|Treatment Period|Progressive disease|2|||
48726051|NCT02414139|156846585|FG008|Treatment Period|Progressive disease|20|||
48726052|NCT02414139|156846586|FG009|Treatment Period|Progressive disease|14|||
48726053|NCT02414139|156846577|FG000|Treatment Period|Protocol deviation|0|||
48726054|NCT02414139|156846578|FG001|Treatment Period|Protocol deviation|0|||
48726055|NCT02414139|156846579|FG002|Treatment Period|Protocol deviation|1|||
48726056|NCT02414139|156846580|FG003|Treatment Period|Protocol deviation|0|||
48726057|NCT02414139|156846581|FG004|Treatment Period|Protocol deviation|0|||
48726058|NCT02414139|156846582|FG005|Treatment Period|Protocol deviation|0|||
48726059|NCT02414139|156846583|FG006|Treatment Period|Protocol deviation|0|||
48726060|NCT02414139|156846584|FG007|Treatment Period|Protocol deviation|0|||
48726061|NCT02414139|156846585|FG008|Treatment Period|Protocol deviation|0|||
48726062|NCT02414139|156846586|FG009|Treatment Period|Protocol deviation|0|||
48726063|NCT02414139|156846577|FG000|Treatment Period|Subject/Guardian decision|5|||
48726064|NCT02414139|156846578|FG001|Treatment Period|Subject/Guardian decision|1|||
48726065|NCT02414139|156846579|FG002|Treatment Period|Subject/Guardian decision|1|||
48726066|NCT02414139|156846580|FG003|Treatment Period|Subject/Guardian decision|2|||
48820611|NCT00783718|157185577|FG006|Induction Phase|Protocol Violation|0|||
48820612|NCT00783718|157185571|FG000|Induction Phase|Lack of Efficacy|5|||
48820613|NCT00783718|157185572|FG001|Induction Phase|Lack of Efficacy|2|||
48820614|NCT00783718|157185573|FG002|Induction Phase|Lack of Efficacy|14|||
48820615|NCT00783718|157185574|FG003|Induction Phase|Lack of Efficacy|0|||
48820616|NCT00783718|157185575|FG004|Induction Phase|Lack of Efficacy|0|||
48820617|NCT00783718|157185576|FG005|Induction Phase|Lack of Efficacy|0|||
48820618|NCT00783718|157185577|FG006|Induction Phase|Lack of Efficacy|0|||
48820619|NCT00783718|157185571|FG000|Induction Phase|Withdrawal by Subject|3|||
48820620|NCT00783718|157185572|FG001|Induction Phase|Withdrawal by Subject|4|||
49135314|NCT00090103|158334691|FG001|16-Week Safety Follow-up Period|Death|0|||
49135315|NCT00090103|158334692|FG002|16-Week Safety Follow-up Period|Death|1|||
49135316|NCT00090103|158334690|FG000|16-Week Safety Follow-up Period|Gyneomastia|1|||
49135317|NCT00090103|158334691|FG001|16-Week Safety Follow-up Period|Gyneomastia|0|||
49135318|NCT00090103|158334692|FG002|16-Week Safety Follow-up Period|Gyneomastia|0|||
49135319|NCT00090103|158334690|FG000|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0|||
49135320|NCT00090103|158334691|FG001|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5|||
49135321|NCT00090103|158334692|FG002|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4|||
49135322|NCT00090103|158334690|FG000|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0|||
49135323|NCT00090103|158334691|FG001|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2|||
49135324|NCT00090103|158334692|FG002|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3|||
49135325|NCT00090103|158334690|FG000|16-Week Safety Follow-up Period|Angina Pectoris|0|||
49135326|NCT00090103|158334691|FG001|16-Week Safety Follow-up Period|Angina Pectoris|1|||
49135327|NCT00090103|158334692|FG002|16-Week Safety Follow-up Period|Angina Pectoris|0|||
49135328|NCT00090103|158334690|FG000|16-Week Safety Follow-up Period|Back Pain|0|||
49135329|NCT00090103|158334691|FG001|16-Week Safety Follow-up Period|Back Pain|1|||
49135330|NCT00090103|158334692|FG002|16-Week Safety Follow-up Period|Back Pain|0|||
49135331|NCT00090103|158334690|FG000|16-Week Safety Follow-up Period|Scheduling Issues|0|||
48820621|NCT00783718|157185573|FG002|Induction Phase|Withdrawal by Subject|8|||
49135332|NCT00090103|158334691|FG001|16-Week Safety Follow-up Period|Scheduling Issues|2|||
49135333|NCT00090103|158334692|FG002|16-Week Safety Follow-up Period|Scheduling Issues|4|||
49135334|NCT00090103|158334690|FG000|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0|||
49135335|NCT00090103|158334691|FG001|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2|||
49135336|NCT00090103|158334692|FG002|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3|||
49135337|NCT00090103|158334690|FG000|16-Week Safety Follow-up Period|Depression|0|||
49135338|NCT00090103|158334691|FG001|16-Week Safety Follow-up Period|Depression|1|||
49135339|NCT00090103|158334692|FG002|16-Week Safety Follow-up Period|Depression|0|||
49135340|NCT00090103|158334690|FG000|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
49135341|NCT00090103|158334691|FG001|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1|||
49135342|NCT00090103|158334692|FG002|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
49135343|NCT00090103|158334690|FG000|16-Week Safety Follow-up Period|Jailed|0|||
49135344|NCT00090103|158334691|FG001|16-Week Safety Follow-up Period|Jailed|1|||
49135345|NCT00090103|158334692|FG002|16-Week Safety Follow-up Period|Jailed|0|||
49135346|NCT00090103|158334690|FG000|16-Week Safety Follow-up Period|Other|0|||
49135347|NCT00090103|158334691|FG001|16-Week Safety Follow-up Period|Other|1|||
49135348|NCT00090103|158334692|FG002|16-Week Safety Follow-up Period|Other|0|||
49135349|NCT04766333|158334693|FG000|Overall Study|Lost to Follow-up|40|||
49135350|NCT04766333|158334694|FG001|Overall Study|Lost to Follow-up|826|||
49135351|NCT01898078|158334695|FG000|Overall Study|Progressive Disease|1|||
49135352|NCT01898078|158334696|FG001|Overall Study|Progressive Disease|5|||
49135353|NCT01898078|158334695|FG000|Overall Study|Adverse Event|2|||
49135354|NCT01898078|158334696|FG001|Overall Study|Adverse Event|1|||
49135355|NCT01898078|158334695|FG000|Overall Study|Withdrawal by Subject|1|||
49135356|NCT01898078|158334696|FG001|Overall Study|Withdrawal by Subject|1|||
49135357|NCT01898078|158334695|FG000|Overall Study|Symptomatic Deterioration|2|||
49135358|NCT01898078|158334696|FG001|Overall Study|Symptomatic Deterioration|0|||
49135359|NCT01898078|158334695|FG000|Overall Study|Reason not Specified|0|||
49135360|NCT01898078|158334696|FG001|Overall Study|Reason not Specified|1|||
49135361|NCT00541229|158334697|FG000|Treatment Period I (Week 1)|Physician Decision|0|||
49135362|NCT00541229|158334698|FG001|Treatment Period I (Week 1)|Physician Decision|0|||
49135363|NCT00541229|158334699|FG002|Treatment Period I (Week 1)|Physician Decision|1|||
49135364|NCT00541229|158334700|FG003|Treatment Period I (Week 1)|Physician Decision|0|||
49135365|NCT00541229|158334701|FG004|Treatment Period I (Week 1)|Physician Decision|0|||
49135366|NCT00541229|158334702|FG005|Treatment Period I (Week 1)|Physician Decision|0|||
49135367|NCT00541229|158334697|FG000|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
49135368|NCT00541229|158334698|FG001|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
49135369|NCT00541229|158334699|FG002|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
49135370|NCT00541229|158334700|FG003|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
48820622|NCT00783718|157185574|FG003|Induction Phase|Withdrawal by Subject|0|||
48820623|NCT00783718|157185575|FG004|Induction Phase|Withdrawal by Subject|0|||
48820624|NCT00783718|157185576|FG005|Induction Phase|Withdrawal by Subject|0|||
48820625|NCT00783718|157185577|FG006|Induction Phase|Withdrawal by Subject|0|||
48820626|NCT00783718|157185571|FG000|Induction Phase|Lost to Follow-up|1|||
48820627|NCT00783718|157185572|FG001|Induction Phase|Lost to Follow-up|0|||
48820628|NCT00783718|157185573|FG002|Induction Phase|Lost to Follow-up|1|||
48820629|NCT00783718|157185574|FG003|Induction Phase|Lost to Follow-up|0|||
48820630|NCT00783718|157185575|FG004|Induction Phase|Lost to Follow-up|0|||
49135371|NCT00541229|158334701|FG004|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
49135372|NCT00541229|158334702|FG005|Treatment Period I (Week 1)|Withdrawal by Subject|1|||
49135373|NCT00541229|158334697|FG000|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
49135374|NCT00541229|158334698|FG001|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
49135375|NCT00541229|158334699|FG002|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
49135376|NCT00541229|158334700|FG003|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
49135377|NCT00541229|158334701|FG004|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
49135378|NCT00541229|158334702|FG005|Treatment Period I (Week 1)|Protocol Specified Criteria|1|||
49135379|NCT00541229|158334697|FG000|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
49135380|NCT00541229|158334698|FG001|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
49135381|NCT00541229|158334699|FG002|Treatment Period I (Week 1)|Study Terminated by Sponsor|2|||
49135382|NCT00541229|158334700|FG003|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
49135383|NCT00541229|158334701|FG004|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
49135384|NCT00541229|158334702|FG005|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
49135385|NCT00541229|158334697|FG000|Washout Period I (Week 2-5)|Adverse Event|1|||
49135386|NCT00541229|158334698|FG001|Washout Period I (Week 2-5)|Adverse Event|0|||
49135387|NCT00541229|158334699|FG002|Washout Period I (Week 2-5)|Adverse Event|1|||
49135388|NCT00541229|158334700|FG003|Washout Period I (Week 2-5)|Adverse Event|0|||
49135389|NCT00541229|158334701|FG004|Washout Period I (Week 2-5)|Adverse Event|0|||
49135390|NCT00541229|158334702|FG005|Washout Period I (Week 2-5)|Adverse Event|0|||
49135391|NCT00541229|158334697|FG000|Washout Period I (Week 2-5)|Physician Decision|0|||
49135392|NCT00541229|158334698|FG001|Washout Period I (Week 2-5)|Physician Decision|0|||
49135393|NCT00541229|158334699|FG002|Washout Period I (Week 2-5)|Physician Decision|0|||
49135394|NCT00541229|158334700|FG003|Washout Period I (Week 2-5)|Physician Decision|1|||
48820631|NCT00783718|157185576|FG005|Induction Phase|Lost to Follow-up|0|||
48820632|NCT00783718|157185577|FG006|Induction Phase|Lost to Follow-up|0|||
48820633|NCT00783718|157185571|FG000|Maintenance Phase|Adverse Event|12|||
49135395|NCT00541229|158334701|FG004|Washout Period I (Week 2-5)|Physician Decision|0|||
49135396|NCT00541229|158334702|FG005|Washout Period I (Week 2-5)|Physician Decision|0|||
49135397|NCT00541229|158334697|FG000|Washout Period I (Week 2-5)|Protocol Violation|0|||
49135398|NCT00541229|158334698|FG001|Washout Period I (Week 2-5)|Protocol Violation|0|||
49135399|NCT00541229|158334699|FG002|Washout Period I (Week 2-5)|Protocol Violation|0|||
49135400|NCT00541229|158334700|FG003|Washout Period I (Week 2-5)|Protocol Violation|0|||
49135401|NCT00541229|158334701|FG004|Washout Period I (Week 2-5)|Protocol Violation|0|||
49135402|NCT00541229|158334702|FG005|Washout Period I (Week 2-5)|Protocol Violation|1|||
49135403|NCT00541229|158334697|FG000|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
49135404|NCT00541229|158334698|FG001|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2|||
49135405|NCT00541229|158334699|FG002|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
49135406|NCT00541229|158334700|FG003|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
49135407|NCT00541229|158334701|FG004|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1|||
49135408|NCT00541229|158334702|FG005|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4|||
49135409|NCT00541229|158334697|FG000|Treatment Period II (Week 6)|Protocol Violation|0|||
49135410|NCT00541229|158334698|FG001|Treatment Period II (Week 6)|Protocol Violation|0|||
49135411|NCT00541229|158334699|FG002|Treatment Period II (Week 6)|Protocol Violation|0|||
49135412|NCT00541229|158334700|FG003|Treatment Period II (Week 6)|Protocol Violation|0|||
49135413|NCT00541229|158334701|FG004|Treatment Period II (Week 6)|Protocol Violation|1|||
49135414|NCT00541229|158334702|FG005|Treatment Period II (Week 6)|Protocol Violation|1|||
49135415|NCT00541229|158334697|FG000|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
49135416|NCT00541229|158334698|FG001|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
49135417|NCT00541229|158334699|FG002|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
49135418|NCT00541229|158334700|FG003|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
49135419|NCT00541229|158334701|FG004|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
48820634|NCT00783718|157185572|FG001|Maintenance Phase|Adverse Event|0|||
49135420|NCT00541229|158334702|FG005|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
49135421|NCT00541229|158334697|FG000|Washout Period II (Week 7-10)|Protocol Violation|1|||
49135422|NCT00541229|158334698|FG001|Washout Period II (Week 7-10)|Protocol Violation|0|||
49135423|NCT00541229|158334699|FG002|Washout Period II (Week 7-10)|Protocol Violation|0|||
49135424|NCT00541229|158334700|FG003|Washout Period II (Week 7-10)|Protocol Violation|0|||
49135425|NCT00541229|158334701|FG004|Washout Period II (Week 7-10)|Protocol Violation|0|||
49135426|NCT00541229|158334702|FG005|Washout Period II (Week 7-10)|Protocol Violation|0|||
49135427|NCT00541229|158334697|FG000|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
48820635|NCT00783718|157185573|FG002|Maintenance Phase|Adverse Event|0|||
49135428|NCT00541229|158334698|FG001|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
49135429|NCT00541229|158334699|FG002|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
49135430|NCT00541229|158334700|FG003|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
49135431|NCT00541229|158334701|FG004|Washout Period II (Week 7-10)|Withdrawal by Subject|1|||
49135432|NCT00541229|158334702|FG005|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
49135433|NCT00541229|158334697|FG000|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
49135434|NCT00541229|158334698|FG001|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
49135435|NCT00541229|158334699|FG002|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2|||
49135436|NCT00541229|158334700|FG003|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
49135437|NCT00541229|158334701|FG004|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
49135438|NCT00541229|158334702|FG005|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
49135439|NCT00541229|158334697|FG000|Treatment Period III (Week 11)|Adverse Event|0|||
49135440|NCT00541229|158334698|FG001|Treatment Period III (Week 11)|Adverse Event|0|||
49135441|NCT00541229|158334699|FG002|Treatment Period III (Week 11)|Adverse Event|0|||
49135442|NCT00541229|158334700|FG003|Treatment Period III (Week 11)|Adverse Event|0|||
49135443|NCT00541229|158334701|FG004|Treatment Period III (Week 11)|Adverse Event|1|||
49135444|NCT00541229|158334702|FG005|Treatment Period III (Week 11)|Adverse Event|0|||
49135445|NCT00541229|158334697|FG000|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
49135446|NCT00541229|158334698|FG001|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
49135447|NCT00541229|158334699|FG002|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
49135448|NCT00541229|158334700|FG003|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
49135449|NCT00541229|158334701|FG004|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
49135450|NCT00541229|158334702|FG005|Treatment Period III (Week 11)|Protocol Specified Criteria|1|||
49135451|NCT00541229|158334697|FG000|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
49135452|NCT00541229|158334698|FG001|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
49135453|NCT00541229|158334699|FG002|Treatment Period III (Week 11)|Study Terminated by Sponsor|1|||
49135454|NCT00541229|158334700|FG003|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
49135455|NCT00541229|158334701|FG004|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
49135456|NCT00541229|158334702|FG005|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
49135457|NCT02017717|158334705|FG000|Before Treatment Period|Adverse Event unrelated to study drug|0|||
49135458|NCT02017717|158334706|FG001|Before Treatment Period|Adverse Event unrelated to study drug|0|||
49135459|NCT02017717|158334707|FG002|Before Treatment Period|Adverse Event unrelated to study drug|0|||
49135460|NCT02017717|158334708|FG003|Before Treatment Period|Adverse Event unrelated to study drug|1|||
49135461|NCT02017717|158334709|FG004|Before Treatment Period|Adverse Event unrelated to study drug|0|||
49135462|NCT02017717|158334710|FG005|Before Treatment Period|Adverse Event unrelated to study drug|0|||
49135463|NCT02017717|158334711|FG006|Before Treatment Period|Adverse Event unrelated to study drug|0|||
49135464|NCT02017717|158334712|FG007|Before Treatment Period|Adverse Event unrelated to study drug|0|||
49135465|NCT02017717|158334713|FG008|Before Treatment Period|Adverse Event unrelated to study drug|0|||
49135466|NCT02017717|158334705|FG000|Before Treatment Period|Participant request to stop therapy|0|||
49135467|NCT02017717|158334706|FG001|Before Treatment Period|Participant request to stop therapy|0|||
49135468|NCT02017717|158334707|FG002|Before Treatment Period|Participant request to stop therapy|0|||
49135469|NCT02017717|158334708|FG003|Before Treatment Period|Participant request to stop therapy|0|||
49135470|NCT02017717|158334709|FG004|Before Treatment Period|Participant request to stop therapy|5|||
49135471|NCT02017717|158334710|FG005|Before Treatment Period|Participant request to stop therapy|0|||
49135472|NCT02017717|158334711|FG006|Before Treatment Period|Participant request to stop therapy|0|||
49135473|NCT02017717|158334712|FG007|Before Treatment Period|Participant request to stop therapy|0|||
49135474|NCT02017717|158334713|FG008|Before Treatment Period|Participant request to stop therapy|0|||
49135475|NCT02017717|158334705|FG000|Before Treatment Period|Participant withdrew consent|0|||
49135476|NCT02017717|158334706|FG001|Before Treatment Period|Participant withdrew consent|0|||
49135477|NCT02017717|158334707|FG002|Before Treatment Period|Participant withdrew consent|0|||
49135478|NCT02017717|158334708|FG003|Before Treatment Period|Participant withdrew consent|0|||
49135479|NCT02017717|158334709|FG004|Before Treatment Period|Participant withdrew consent|11|||
49135480|NCT02017717|158334710|FG005|Before Treatment Period|Participant withdrew consent|0|||
49135481|NCT02017717|158334711|FG006|Before Treatment Period|Participant withdrew consent|0|||
49135482|NCT02017717|158334712|FG007|Before Treatment Period|Participant withdrew consent|0|||
49135483|NCT02017717|158334713|FG008|Before Treatment Period|Participant withdrew consent|2|||
49135484|NCT02017717|158334705|FG000|Before Treatment Period|Lost to Follow-up|0|||
49135485|NCT02017717|158334706|FG001|Before Treatment Period|Lost to Follow-up|0|||
48820636|NCT00783718|157185574|FG003|Maintenance Phase|Adverse Event|15|||
49135486|NCT02017717|158334707|FG002|Before Treatment Period|Lost to Follow-up|0|||
49135487|NCT02017717|158334708|FG003|Before Treatment Period|Lost to Follow-up|0|||
49135488|NCT02017717|158334709|FG004|Before Treatment Period|Lost to Follow-up|1|||
49135489|NCT02017717|158334710|FG005|Before Treatment Period|Lost to Follow-up|0|||
49135490|NCT02017717|158334711|FG006|Before Treatment Period|Lost to Follow-up|0|||
49135491|NCT02017717|158334712|FG007|Before Treatment Period|Lost to Follow-up|0|||
49135492|NCT02017717|158334713|FG008|Before Treatment Period|Lost to Follow-up|0|||
49135493|NCT02017717|158334705|FG000|Before Treatment Period|Participant no longer met criteria|0|||
49135494|NCT02017717|158334706|FG001|Before Treatment Period|Participant no longer met criteria|0|||
49135495|NCT02017717|158334707|FG002|Before Treatment Period|Participant no longer met criteria|0|||
49135496|NCT02017717|158334708|FG003|Before Treatment Period|Participant no longer met criteria|1|||
48726067|NCT02414139|156846581|FG004|Treatment Period|Subject/Guardian decision|5|||
48726068|NCT02414139|156846582|FG005|Treatment Period|Subject/Guardian decision|0|||
48726069|NCT02414139|156846583|FG006|Treatment Period|Subject/Guardian decision|2|||
48726070|NCT02414139|156846584|FG007|Treatment Period|Subject/Guardian decision|0|||
48726071|NCT02414139|156846585|FG008|Treatment Period|Subject/Guardian decision|1|||
48726072|NCT02414139|156846586|FG009|Treatment Period|Subject/Guardian decision|1|||
48726073|NCT02414139|156846577|FG000|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
48726074|NCT02414139|156846578|FG001|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
48726075|NCT02414139|156846579|FG002|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
48726076|NCT02414139|156846580|FG003|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
48726077|NCT02414139|156846581|FG004|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
48726078|NCT02414139|156846582|FG005|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
48726079|NCT02414139|156846583|FG006|Treatment Period|Study terminated (as per protocol) by Sponsor|2|||
48726080|NCT02414139|156846584|FG007|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
48726081|NCT02414139|156846585|FG008|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
48726082|NCT02414139|156846586|FG009|Treatment Period|Study terminated (as per protocol) by Sponsor|4|||
48726083|NCT02414139|156846577|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
48726084|NCT02414139|156846578|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
48726085|NCT02414139|156846579|FG002|Post-treatment Efficacy Follow-up|Adverse Event|0|||
48726086|NCT02414139|156846580|FG003|Post-treatment Efficacy Follow-up|Adverse Event|0|||
48726087|NCT02414139|156846581|FG004|Post-treatment Efficacy Follow-up|Adverse Event|2|||
48726088|NCT02414139|156846582|FG005|Post-treatment Efficacy Follow-up|Adverse Event|0|||
48726089|NCT02414139|156846583|FG006|Post-treatment Efficacy Follow-up|Adverse Event|0|||
48726090|NCT02414139|156846584|FG007|Post-treatment Efficacy Follow-up|Adverse Event|0|||
48726091|NCT02414139|156846585|FG008|Post-treatment Efficacy Follow-up|Adverse Event|0|||
48726092|NCT02414139|156846586|FG009|Post-treatment Efficacy Follow-up|Adverse Event|0|||
48726093|NCT02414139|156846577|FG000|Post-treatment Efficacy Follow-up|Death|0|||
48726094|NCT02414139|156846578|FG001|Post-treatment Efficacy Follow-up|Death|1|||
48726095|NCT02414139|156846579|FG002|Post-treatment Efficacy Follow-up|Death|0|||
48726096|NCT02414139|156846580|FG003|Post-treatment Efficacy Follow-up|Death|0|||
48726097|NCT02414139|156846581|FG004|Post-treatment Efficacy Follow-up|Death|1|||
48726098|NCT02414139|156846582|FG005|Post-treatment Efficacy Follow-up|Death|0|||
48726099|NCT02414139|156846583|FG006|Post-treatment Efficacy Follow-up|Death|0|||
48726100|NCT02414139|156846584|FG007|Post-treatment Efficacy Follow-up|Death|0|||
48726101|NCT02414139|156846585|FG008|Post-treatment Efficacy Follow-up|Death|0|||
48726102|NCT02414139|156846586|FG009|Post-treatment Efficacy Follow-up|Death|1|||
48726103|NCT02414139|156846577|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
48726104|NCT02414139|156846578|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
48726105|NCT02414139|156846579|FG002|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
48726106|NCT02414139|156846580|FG003|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
48726107|NCT02414139|156846581|FG004|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
48726108|NCT02414139|156846582|FG005|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
48726109|NCT02414139|156846583|FG006|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
48726110|NCT02414139|156846584|FG007|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
48726111|NCT02414139|156846585|FG008|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
48726112|NCT02414139|156846586|FG009|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
48726113|NCT02414139|156846577|FG000|Post-treatment Efficacy Follow-up|Physician Decision|4|||
48726114|NCT02414139|156846578|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
48726115|NCT02414139|156846579|FG002|Post-treatment Efficacy Follow-up|Physician Decision|4|||
48726116|NCT02414139|156846580|FG003|Post-treatment Efficacy Follow-up|Physician Decision|2|||
48726117|NCT02414139|156846581|FG004|Post-treatment Efficacy Follow-up|Physician Decision|4|||
48726118|NCT02414139|156846582|FG005|Post-treatment Efficacy Follow-up|Physician Decision|0|||
48726119|NCT02414139|156846583|FG006|Post-treatment Efficacy Follow-up|Physician Decision|1|||
48726120|NCT02414139|156846584|FG007|Post-treatment Efficacy Follow-up|Physician Decision|0|||
48726121|NCT02414139|156846585|FG008|Post-treatment Efficacy Follow-up|Physician Decision|0|||
48726122|NCT02414139|156846586|FG009|Post-treatment Efficacy Follow-up|Physician Decision|1|||
48726123|NCT02414139|156846577|FG000|Post-treatment Efficacy Follow-up|Progressive disease|6|||
48820637|NCT00783718|157185575|FG004|Maintenance Phase|Adverse Event|7|||
48820638|NCT00783718|157185576|FG005|Maintenance Phase|Adverse Event|6|||
48820639|NCT00783718|157185577|FG006|Maintenance Phase|Adverse Event|16|||
48820640|NCT00783718|157185571|FG000|Maintenance Phase|Protocol Violation|1|||
48820641|NCT00783718|157185572|FG001|Maintenance Phase|Protocol Violation|0|||
48820642|NCT00783718|157185573|FG002|Maintenance Phase|Protocol Violation|0|||
48820643|NCT00783718|157185574|FG003|Maintenance Phase|Protocol Violation|0|||
48820644|NCT00783718|157185575|FG004|Maintenance Phase|Protocol Violation|0|||
48820645|NCT00783718|157185576|FG005|Maintenance Phase|Protocol Violation|0|||
48820646|NCT00783718|157185577|FG006|Maintenance Phase|Protocol Violation|2|||
48820647|NCT00783718|157185571|FG000|Maintenance Phase|Lack of Efficacy|83|||
48820648|NCT00783718|157185572|FG001|Maintenance Phase|Lack of Efficacy|0|||
48820649|NCT00783718|157185573|FG002|Maintenance Phase|Lack of Efficacy|0|||
48820650|NCT00783718|157185574|FG003|Maintenance Phase|Lack of Efficacy|61|||
48820651|NCT00783718|157185575|FG004|Maintenance Phase|Lack of Efficacy|31|||
48820652|NCT00783718|157185576|FG005|Maintenance Phase|Lack of Efficacy|33|||
48820653|NCT00783718|157185577|FG006|Maintenance Phase|Lack of Efficacy|155|||
48820654|NCT00783718|157185571|FG000|Maintenance Phase|Withdrawal by Subject|6|||
48820655|NCT00783718|157185572|FG001|Maintenance Phase|Withdrawal by Subject|0|||
48820656|NCT00783718|157185573|FG002|Maintenance Phase|Withdrawal by Subject|0|||
48820657|NCT00783718|157185574|FG003|Maintenance Phase|Withdrawal by Subject|2|||
48820658|NCT00783718|157185575|FG004|Maintenance Phase|Withdrawal by Subject|5|||
48820659|NCT00783718|157185576|FG005|Maintenance Phase|Withdrawal by Subject|2|||
48820660|NCT00783718|157185577|FG006|Maintenance Phase|Withdrawal by Subject|20|||
48820661|NCT00783718|157185571|FG000|Maintenance Phase|Lost to Follow-up|3|||
48820662|NCT00783718|157185572|FG001|Maintenance Phase|Lost to Follow-up|0|||
48820663|NCT00783718|157185573|FG002|Maintenance Phase|Lost to Follow-up|0|||
48820664|NCT00783718|157185574|FG003|Maintenance Phase|Lost to Follow-up|0|||
48820665|NCT00783718|157185575|FG004|Maintenance Phase|Lost to Follow-up|2|||
48820666|NCT00783718|157185576|FG005|Maintenance Phase|Lost to Follow-up|0|||
48820667|NCT00783718|157185577|FG006|Maintenance Phase|Lost to Follow-up|2|||
48820668|NCT04668144|157185587|FG000|Overall Study|Protocol Violation|0|||
49135497|NCT02017717|158334709|FG004|Before Treatment Period|Participant no longer met criteria|2|||
49135498|NCT02017717|158334710|FG005|Before Treatment Period|Participant no longer met criteria|0|||
49135499|NCT02017717|158334711|FG006|Before Treatment Period|Participant no longer met criteria|0|||
49135500|NCT02017717|158334712|FG007|Before Treatment Period|Participant no longer met criteria|1|||
49135501|NCT02017717|158334713|FG008|Before Treatment Period|Participant no longer met criteria|0|||
49135502|NCT02017717|158334705|FG000|Before Treatment Period|other reason|0|||
49135503|NCT02017717|158334706|FG001|Before Treatment Period|other reason|0|||
49135504|NCT02017717|158334707|FG002|Before Treatment Period|other reason|0|||
49135505|NCT02017717|158334708|FG003|Before Treatment Period|other reason|0|||
49135506|NCT02017717|158334709|FG004|Before Treatment Period|other reason|1|||
49135507|NCT02017717|158334710|FG005|Before Treatment Period|other reason|0|||
49135508|NCT02017717|158334711|FG006|Before Treatment Period|other reason|0|||
49135509|NCT02017717|158334712|FG007|Before Treatment Period|other reason|0|||
49135510|NCT02017717|158334713|FG008|Before Treatment Period|other reason|0|||
49135511|NCT02017717|158334705|FG000|Treatment Period|Disease progression|7|||
49135512|NCT02017717|158334706|FG001|Treatment Period|Disease progression|9|||
49135513|NCT02017717|158334707|FG002|Treatment Period|Disease progression|12|||
49135514|NCT02017717|158334708|FG003|Treatment Period|Disease progression|165|||
49135515|NCT02017717|158334709|FG004|Treatment Period|Disease progression|134|||
49135516|NCT02017717|158334710|FG005|Treatment Period|Disease progression|20|||
49135517|NCT02017717|158334711|FG006|Treatment Period|Disease progression|26|||
49135518|NCT02017717|158334712|FG007|Treatment Period|Disease progression|17|||
49135519|NCT02017717|158334713|FG008|Treatment Period|Disease progression|22|||
49135520|NCT02017717|158334705|FG000|Treatment Period|Study drug toxicity|3|||
49135521|NCT02017717|158334706|FG001|Treatment Period|Study drug toxicity|0|||
49135522|NCT02017717|158334707|FG002|Treatment Period|Study drug toxicity|1|||
48820669|NCT04668144|157185588|FG001|Overall Study|Protocol Violation|1|||
48820670|NCT04668144|157185589|FG002|Overall Study|Protocol Violation|2|||
48820671|NCT03909165|157185590|FG000|Overall Study|Physician Decision|0|||
48820672|NCT03909165|157185591|FG001|Overall Study|Physician Decision|1|||
48820673|NCT03909165|157185592|FG002|Overall Study|Physician Decision|0|||
48820674|NCT03909165|157185593|FG003|Overall Study|Physician Decision|0|||
48820675|NCT03909165|157185594|FG004|Overall Study|Physician Decision|0|||
49011276|NCT00830063|157878906|FG002|Overall Study|Lack of Efficacy|25|||
48726124|NCT02414139|156846578|FG001|Post-treatment Efficacy Follow-up|Progressive disease|5|||
48726125|NCT02414139|156846579|FG002|Post-treatment Efficacy Follow-up|Progressive disease|9|||
48726126|NCT02414139|156846580|FG003|Post-treatment Efficacy Follow-up|Progressive disease|5|||
48726127|NCT02414139|156846581|FG004|Post-treatment Efficacy Follow-up|Progressive disease|15|||
48726128|NCT02414139|156846582|FG005|Post-treatment Efficacy Follow-up|Progressive disease|4|||
49135523|NCT02017717|158334708|FG003|Treatment Period|Study drug toxicity|7|||
49135524|NCT02017717|158334709|FG004|Treatment Period|Study drug toxicity|11|||
49135525|NCT02017717|158334710|FG005|Treatment Period|Study drug toxicity|4|||
49135526|NCT02017717|158334711|FG006|Treatment Period|Study drug toxicity|4|||
49135527|NCT02017717|158334712|FG007|Treatment Period|Study drug toxicity|5|||
49135528|NCT02017717|158334713|FG008|Treatment Period|Study drug toxicity|3|||
49135529|NCT02017717|158334705|FG000|Treatment Period|Death|0|||
49135530|NCT02017717|158334706|FG001|Treatment Period|Death|0|||
48726129|NCT02414139|156846583|FG006|Post-treatment Efficacy Follow-up|Progressive disease|5|||
49011277|NCT00830063|157878907|FG003|Overall Study|Lack of Efficacy|32|||
49135531|NCT02017717|158334707|FG002|Treatment Period|Death|1|||
49135532|NCT02017717|158334708|FG003|Treatment Period|Death|0|||
49135533|NCT02017717|158334709|FG004|Treatment Period|Death|0|||
49135534|NCT02017717|158334710|FG005|Treatment Period|Death|0|||
49135535|NCT02017717|158334711|FG006|Treatment Period|Death|0|||
49135536|NCT02017717|158334712|FG007|Treatment Period|Death|1|||
49135537|NCT02017717|158334713|FG008|Treatment Period|Death|0|||
49135538|NCT02017717|158334705|FG000|Treatment Period|Adverse event unrelated to study drug|0|||
49135539|NCT02017717|158334706|FG001|Treatment Period|Adverse event unrelated to study drug|0|||
49135540|NCT02017717|158334707|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
49135541|NCT02017717|158334708|FG003|Treatment Period|Adverse event unrelated to study drug|4|||
49135542|NCT02017717|158334709|FG004|Treatment Period|Adverse event unrelated to study drug|5|||
49135543|NCT02017717|158334710|FG005|Treatment Period|Adverse event unrelated to study drug|0|||
49135544|NCT02017717|158334711|FG006|Treatment Period|Adverse event unrelated to study drug|0|||
49135545|NCT02017717|158334712|FG007|Treatment Period|Adverse event unrelated to study drug|0|||
49135546|NCT02017717|158334713|FG008|Treatment Period|Adverse event unrelated to study drug|1|||
49135547|NCT02017717|158334705|FG000|Treatment Period|Participant request to stop therapy|0|||
49135548|NCT02017717|158334706|FG001|Treatment Period|Participant request to stop therapy|0|||
49135549|NCT02017717|158334707|FG002|Treatment Period|Participant request to stop therapy|3|||
49135550|NCT02017717|158334708|FG003|Treatment Period|Participant request to stop therapy|4|||
49135551|NCT02017717|158334709|FG004|Treatment Period|Participant request to stop therapy|7|||
49135552|NCT02017717|158334710|FG005|Treatment Period|Participant request to stop therapy|5|||
49135553|NCT02017717|158334711|FG006|Treatment Period|Participant request to stop therapy|0|||
49135554|NCT02017717|158334712|FG007|Treatment Period|Participant request to stop therapy|2|||
49135555|NCT02017717|158334713|FG008|Treatment Period|Participant request to stop therapy|1|||
49135556|NCT02017717|158334705|FG000|Treatment Period|Participant withdrew consent|0|||
49135557|NCT02017717|158334706|FG001|Treatment Period|Participant withdrew consent|0|||
49135558|NCT02017717|158334707|FG002|Treatment Period|Participant withdrew consent|1|||
49135559|NCT02017717|158334708|FG003|Treatment Period|Participant withdrew consent|1|||
49135560|NCT02017717|158334709|FG004|Treatment Period|Participant withdrew consent|4|||
49135561|NCT02017717|158334710|FG005|Treatment Period|Participant withdrew consent|0|||
49135562|NCT02017717|158334711|FG006|Treatment Period|Participant withdrew consent|0|||
49135563|NCT02017717|158334712|FG007|Treatment Period|Participant withdrew consent|2|||
49135564|NCT02017717|158334713|FG008|Treatment Period|Participant withdrew consent|0|||
49135565|NCT02017717|158334705|FG000|Treatment Period|Participant no longer met criteria|0|||
49135566|NCT02017717|158334706|FG001|Treatment Period|Participant no longer met criteria|0|||
49135567|NCT02017717|158334707|FG002|Treatment Period|Participant no longer met criteria|0|||
49135568|NCT02017717|158334708|FG003|Treatment Period|Participant no longer met criteria|0|||
49135569|NCT02017717|158334709|FG004|Treatment Period|Participant no longer met criteria|1|||
49135570|NCT02017717|158334710|FG005|Treatment Period|Participant no longer met criteria|0|||
49135571|NCT02017717|158334711|FG006|Treatment Period|Participant no longer met criteria|0|||
48726130|NCT02414139|156846584|FG007|Post-treatment Efficacy Follow-up|Progressive disease|1|||
48726131|NCT02414139|156846585|FG008|Post-treatment Efficacy Follow-up|Progressive disease|3|||
48726132|NCT02414139|156846586|FG009|Post-treatment Efficacy Follow-up|Progressive disease|3|||
48726133|NCT02414139|156846577|FG000|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
48726134|NCT02414139|156846578|FG001|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
48726135|NCT02414139|156846579|FG002|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
48726136|NCT02414139|156846580|FG003|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
48726137|NCT02414139|156846581|FG004|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
48726138|NCT02414139|156846582|FG005|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
48726139|NCT02414139|156846583|FG006|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
48726140|NCT02414139|156846584|FG007|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
48726141|NCT02414139|156846585|FG008|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
49135572|NCT02017717|158334712|FG007|Treatment Period|Participant no longer met criteria|0|||
49135573|NCT02017717|158334713|FG008|Treatment Period|Participant no longer met criteria|0|||
49135574|NCT02017717|158334705|FG000|Treatment Period|other reasons|0|||
49135575|NCT02017717|158334706|FG001|Treatment Period|other reasons|0|||
48820676|NCT03909165|157185590|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
48820677|NCT03909165|157185591|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
48820678|NCT03909165|157185592|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
48820679|NCT03909165|157185593|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
48820680|NCT03909165|157185594|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
48820681|NCT03909165|157185590|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
48820682|NCT03909165|157185591|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
48820683|NCT03909165|157185592|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
48820684|NCT03909165|157185593|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
48820685|NCT03909165|157185594|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
48820686|NCT03909165|157185590|FG000|Overall Study|Previous Drug Exposure|0|||
48820687|NCT03909165|157185591|FG001|Overall Study|Previous Drug Exposure|0|||
48820688|NCT03909165|157185592|FG002|Overall Study|Previous Drug Exposure|1|||
48820689|NCT03909165|157185593|FG003|Overall Study|Previous Drug Exposure|0|||
48820690|NCT03909165|157185594|FG004|Overall Study|Previous Drug Exposure|0|||
48820691|NCT03909165|157185590|FG000|Overall Study|Early Discharge|1|||
48820692|NCT03909165|157185591|FG001|Overall Study|Early Discharge|0|||
48820693|NCT03909165|157185592|FG002|Overall Study|Early Discharge|0|||
48820694|NCT03909165|157185593|FG003|Overall Study|Early Discharge|0|||
48820695|NCT03909165|157185594|FG004|Overall Study|Early Discharge|0|||
48820696|NCT04159896|157185595|FG000|Overall Study|Lack of Efficacy|7|||
48820697|NCT04159896|157185595|FG000|Overall Study|Withdrawal by Subject|1|||
48820698|NCT04159896|157185595|FG000|Overall Study|Adverse Event|1|||
48820699|NCT04159896|157185595|FG000|Overall Study|A transient ischaemic attack|1|||
48820700|NCT04515849|157185606|FG000|Overall Study|Adverse Event|0|||
48820701|NCT04515849|157185607|FG001|Overall Study|Adverse Event|0|||
48820702|NCT04515849|157185608|FG002|Overall Study|Adverse Event|0|||
48820703|NCT04515849|157185609|FG003|Overall Study|Adverse Event|1|||
48820704|NCT04515849|157185610|FG004|Overall Study|Adverse Event|2|||
48820705|NCT04515849|157185606|FG000|Overall Study|Death|2|||
48820706|NCT04515849|157185607|FG001|Overall Study|Death|0|||
48820707|NCT04515849|157185608|FG002|Overall Study|Death|0|||
48820708|NCT04515849|157185609|FG003|Overall Study|Death|0|||
48820709|NCT04515849|157185610|FG004|Overall Study|Death|0|||
48820710|NCT04515849|157185606|FG000|Overall Study|Other:family emergency|0|||
48820711|NCT04515849|157185607|FG001|Overall Study|Other:family emergency|0|||
48820712|NCT04515849|157185608|FG002|Overall Study|Other:family emergency|0|||
48820713|NCT04515849|157185609|FG003|Overall Study|Other:family emergency|1|||
48820714|NCT04515849|157185610|FG004|Overall Study|Other:family emergency|0|||
48820715|NCT04515849|157185606|FG000|Overall Study|Other:randomised by error|0|||
48820716|NCT04515849|157185607|FG001|Overall Study|Other:randomised by error|1|||
48820717|NCT04515849|157185608|FG002|Overall Study|Other:randomised by error|0|||
48820718|NCT04515849|157185609|FG003|Overall Study|Other:randomised by error|0|||
48820719|NCT04515849|157185610|FG004|Overall Study|Other:randomised by error|0|||
48820720|NCT04515849|157185606|FG000|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
48820721|NCT04515849|157185607|FG001|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
48820722|NCT04515849|157185608|FG002|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
48820723|NCT04515849|157185609|FG003|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|1|||
48820724|NCT04515849|157185610|FG004|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
48820725|NCT04515849|157185606|FG000|Overall Study|Physician Decision|0|||
48820726|NCT04515849|157185607|FG001|Overall Study|Physician Decision|1|||
48820727|NCT04515849|157185608|FG002|Overall Study|Physician Decision|0|||
48820728|NCT04515849|157185609|FG003|Overall Study|Physician Decision|0|||
48820729|NCT04515849|157185610|FG004|Overall Study|Physician Decision|0|||
48820730|NCT04515849|157185606|FG000|Overall Study|Withdrawal by Subject|1|||
48820731|NCT04515849|157185607|FG001|Overall Study|Withdrawal by Subject|2|||
49135576|NCT02017717|158334707|FG002|Treatment Period|other reasons|0|||
49135577|NCT02017717|158334708|FG003|Treatment Period|other reasons|0|||
49135578|NCT02017717|158334709|FG004|Treatment Period|other reasons|1|||
49135579|NCT02017717|158334710|FG005|Treatment Period|other reasons|0|||
48820732|NCT04515849|157185608|FG002|Overall Study|Withdrawal by Subject|1|||
48820733|NCT04515849|157185609|FG003|Overall Study|Withdrawal by Subject|0|||
48820734|NCT04515849|157185610|FG004|Overall Study|Withdrawal by Subject|0|||
48820735|NCT03658811|157185613|FG000|Overall Study|Lost to Follow-up|3|||
48820736|NCT00235495|157185614|FG000|Overall Study|Death|52|||
48820737|NCT00235495|157185615|FG001|Overall Study|Death|42|||
48820738|NCT00235495|157185614|FG000|Overall Study|Withdrawal by Subject|5|||
49011278|NCT00830063|157878904|FG000|Overall Study|Other|5|||
49135580|NCT02017717|158334711|FG006|Treatment Period|other reasons|0|||
49135581|NCT02017717|158334712|FG007|Treatment Period|other reasons|1|||
49135582|NCT02017717|158334713|FG008|Treatment Period|other reasons|1|||
49135583|NCT02017717|158334705|FG000|Treatment Period|Maximum clinical benefit|0|||
49135584|NCT02017717|158334706|FG001|Treatment Period|Maximum clinical benefit|0|||
49135585|NCT02017717|158334707|FG002|Treatment Period|Maximum clinical benefit|0|||
49135586|NCT02017717|158334708|FG003|Treatment Period|Maximum clinical benefit|0|||
49135587|NCT02017717|158334709|FG004|Treatment Period|Maximum clinical benefit|1|||
49135588|NCT02017717|158334710|FG005|Treatment Period|Maximum clinical benefit|0|||
49135589|NCT02017717|158334711|FG006|Treatment Period|Maximum clinical benefit|0|||
49135590|NCT02017717|158334712|FG007|Treatment Period|Maximum clinical benefit|0|||
49135591|NCT02017717|158334713|FG008|Treatment Period|Maximum clinical benefit|0|||
49135592|NCT00703534|158334714|FG000|Overall Study|Adverse Event|14|||
49135593|NCT00703534|158334715|FG001|Overall Study|Adverse Event|3|||
49135594|NCT00703534|158334714|FG000|Overall Study|Withdrawal by Subject|8|||
49135595|NCT00703534|158334715|FG001|Overall Study|Withdrawal by Subject|7|||
49135596|NCT00703534|158334714|FG000|Overall Study|Incorrect Enrollment|6|||
49135597|NCT00703534|158334715|FG001|Overall Study|Incorrect Enrollment|6|||
49135598|NCT00703534|158334714|FG000|Overall Study|Lost to Follow-up|1|||
49135599|NCT00703534|158334715|FG001|Overall Study|Lost to Follow-up|4|||
49135600|NCT00703534|158334714|FG000|Overall Study|Severe Non Compliance|1|||
49135601|NCT00703534|158334715|FG001|Overall Study|Severe Non Compliance|5|||
49135602|NCT00761319|158334716|FG000|Overall Study|Protocol Violation|21|||
49135603|NCT00761319|158334717|FG001|Overall Study|Protocol Violation|14|||
49135604|NCT00761319|158334716|FG000|Overall Study|Adverse Event|11|||
49135605|NCT00761319|158334717|FG001|Overall Study|Adverse Event|7|||
49135606|NCT00761319|158334716|FG000|Overall Study|Withdrawal by Subject|8|||
49135607|NCT00761319|158334717|FG001|Overall Study|Withdrawal by Subject|7|||
49135608|NCT00761319|158334716|FG000|Overall Study|Noncompliance|4|||
49135609|NCT00761319|158334717|FG001|Overall Study|Noncompliance|3|||
49135610|NCT00761319|158334716|FG000|Overall Study|Lost to Follow-up|1|||
49135611|NCT00761319|158334717|FG001|Overall Study|Lost to Follow-up|1|||
49135612|NCT00761319|158334716|FG000|Overall Study|Nonspecified|2|||
49135613|NCT00761319|158334717|FG001|Overall Study|Nonspecified|2|||
49135614|NCT00761319|158334716|FG000|Overall Study|Missing|1|||
49135615|NCT00761319|158334717|FG001|Overall Study|Missing|0|||
49135616|NCT00423605|158334723|FG000|Overall Study|Adverse Event|129|||
49135617|NCT00423605|158334723|FG000|Overall Study|Withdrawal by Subject|36|||
49135618|NCT00423605|158334723|FG000|Overall Study|Lost to Follow-up|15|||
49135619|NCT00423605|158334723|FG000|Overall Study|Lack of Efficacy|38|||
49135620|NCT00423605|158334723|FG000|Overall Study|Sponsor Decision|3|||
49135621|NCT00423605|158334723|FG000|Overall Study|Physician Decision|8|||
49135622|NCT00423605|158334723|FG000|Overall Study|Protocol Violation|7|||
49135623|NCT00423605|158334723|FG000|Overall Study|Not one of the pre-specified options|5|||
49135624|NCT02566005|158334728|FG000|Overall Study|vaginal bleeding|0|||
49135625|NCT02566005|158334729|FG001|Overall Study|vaginal bleeding|1|||
49135626|NCT02566005|158334728|FG000|Overall Study|received foley|8|||
49135627|NCT02566005|158334729|FG001|Overall Study|received foley|0|||
49135628|NCT02566005|158334728|FG000|Overall Study|did not receive foley|0|||
49135629|NCT02566005|158334729|FG001|Overall Study|did not receive foley|1|||
49135630|NCT02566005|158334728|FG000|Overall Study|labor after randomization|0|||
49135631|NCT02566005|158334729|FG001|Overall Study|labor after randomization|4|||
49135632|NCT03095287|158334730|FG000|Overall Study|Treatment Failure|1|||
49135633|NCT03095287|158334730|FG000|Overall Study|Adverse Event|1|||
49135634|NCT02107898|158334731|FG000|Overall Study|Adverse Event|4|||
49135635|NCT02107898|158334732|FG001|Overall Study|Adverse Event|7|||
49135636|NCT02107898|158334731|FG000|Overall Study|Poor compliance to protocol|0|||
49135637|NCT02107898|158334732|FG001|Overall Study|Poor compliance to protocol|1|||
49135638|NCT02107898|158334731|FG000|Overall Study|Participant moved|0|||
49135639|NCT02107898|158334732|FG001|Overall Study|Participant moved|2|||
49135640|NCT02107898|158334731|FG000|Overall Study|Consent withdrawn by participant|2|||
49135641|NCT02107898|158334732|FG001|Overall Study|Consent withdrawn by participant|1|||
49135642|NCT02107898|158334731|FG000|Overall Study|Randomized but not treated|0|||
49135643|NCT02107898|158334732|FG001|Overall Study|Randomized but not treated|1|||
49135644|NCT05001620|158334733|FG000|Overall Study|Didn't complete the telehealth Palliative Care Consultation|1|||
49135645|NCT05001620|158334734|FG001|Overall Study|Didn't complete the telehealth Palliative Care Consultation|0|||
49135646|NCT02115386|158334735|FG000|Overall Study|Protocol Violation|1|||
49135647|NCT02115386|158334735|FG000|Overall Study|Administrative - trial was terminated|6|||
49135648|NCT01240694|158334736|FG000|Overall Study|Adverse Event|9|||
49135649|NCT01240694|158334736|FG000|Overall Study|Lack of Efficacy|6|||
49135650|NCT01240694|158334736|FG000|Overall Study|Withdrawal by Subject|6|||
49135651|NCT01240694|158334736|FG000|Overall Study|Protocol Violation|2|||
49135652|NCT01240694|158334736|FG000|Overall Study|Lost to Follow-up|2|||
49135653|NCT01240694|158334736|FG000|Overall Study|Other than specified|3|||
49135654|NCT01240694|158334736|FG000|Overall Study|Withdrawn due to early study termination|107|||
49135655|NCT02714153|158334737|FG000|Overall Study|Death|1|||
49135656|NCT01137786|158334739|FG000|Overall Study|Lost to Follow-up|0|||
49135657|NCT01137786|158334740|FG001|Overall Study|Lost to Follow-up|2|||
49135658|NCT01137786|158334739|FG000|Overall Study|Withdrawal by Subject|1|||
49135659|NCT01137786|158334740|FG001|Overall Study|Withdrawal by Subject|1|||
49135660|NCT00147238|158334741|FG000|Overall Study|Inevaluable|8|||
49135661|NCT01348269|158334744|FG000|Follow-up (Until Week 12)|Surgical intervention - not study related|1|||
49135662|NCT01348269|158334745|FG001|Follow-up (Until Week 12)|Surgical intervention - not study related|0|||
49135663|NCT01348269|158334744|FG000|Follow-up (Until Week 12)|Subsequent follow-up treatment required|0|||
49135664|NCT01348269|158334745|FG001|Follow-up (Until Week 12)|Subsequent follow-up treatment required|1|||
49135665|NCT01348269|158334744|FG000|Follow-up (Until Week 12)|Adverse Event|1|||
49135666|NCT01348269|158334745|FG001|Follow-up (Until Week 12)|Adverse Event|0|||
49135667|NCT00800540|158334746|FG000|Period One: 6 Weeks|Noncompliance|1|||
49135668|NCT00800540|158334747|FG001|Period One: 6 Weeks|Noncompliance|0|||
49135669|NCT00800540|158334746|FG000|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0|||
49135670|NCT00800540|158334747|FG001|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1|||
49135671|NCT00800540|158334746|FG000|Period 2: 6 Weeks|Adverse Event|0|||
49135672|NCT00800540|158334747|FG001|Period 2: 6 Weeks|Adverse Event|1|||
49135673|NCT00805532|158334751|FG000|Overall Study|invalid data|0|||
49135674|NCT00805532|158334752|FG001|Overall Study|invalid data|1|||
49135675|NCT00460798|158334755|FG000|Overall Study|Death|59|||
49135676|NCT00460798|158334755|FG000|Overall Study|Adverse Event|27|||
49135677|NCT00460798|158334755|FG000|Overall Study|Lost to Follow-up|19|||
49135678|NCT00460798|158334755|FG000|Overall Study|Progressive Disease|99|||
49135679|NCT00460798|158334755|FG000|Overall Study|Other|27|||
49135680|NCT00460798|158334755|FG000|Overall Study|Ongoing at Date of Cut-Off|82|||
49135681|NCT00460798|158334755|FG000|Overall Study|Missing/Incomplete Dosing Information|27|||
48820739|NCT00235495|157185615|FG001|Overall Study|Withdrawal by Subject|3|||
48820740|NCT00235495|157185614|FG000|Overall Study|Lost to Follow-up|11|||
48820741|NCT00235495|157185615|FG001|Overall Study|Lost to Follow-up|13|||
48820742|NCT00235495|157185614|FG000|Overall Study|Visit/assessmen outside window/missing|0|||
48820743|NCT00235495|157185615|FG001|Overall Study|Visit/assessmen outside window/missing|10|||
48820744|NCT05259033|157185616|FG000|Overall Study|Withdrawal by Subject|10|||
48820745|NCT05259033|157185617|FG001|Overall Study|Withdrawal by Subject|5|||
49135682|NCT00920816|158334756|FG000|Overall Study|Death|116|||
49135683|NCT00920816|158334757|FG001|Overall Study|Death|63|||
49135684|NCT00920816|158334758|FG002|Overall Study|Death|8|||
49135685|NCT00920816|158334759|FG003|Overall Study|Death|3|||
49135686|NCT00920816|158334756|FG000|Overall Study|Participant refused continued treatment for reason other than adverse events|11|||
49135687|NCT00920816|158334757|FG001|Overall Study|Participant refused continued treatment for reason other than adverse events|5|||
49135688|NCT00920816|158334758|FG002|Overall Study|Participant refused continued treatment for reason other than adverse events|1|||
49135689|NCT00920816|158334759|FG003|Overall Study|Participant refused continued treatment for reason other than adverse events|0|||
49135690|NCT00920816|158334756|FG000|Overall Study|Global deterioration of health status|2|||
49135691|NCT00920816|158334757|FG001|Overall Study|Global deterioration of health status|0|||
49135692|NCT00920816|158334758|FG002|Overall Study|Global deterioration of health status|0|||
49135693|NCT00920816|158334759|FG003|Overall Study|Global deterioration of health status|0|||
49135694|NCT00920816|158334756|FG000|Overall Study|Objective progression or relapse|6|||
49135695|NCT00920816|158334757|FG001|Overall Study|Objective progression or relapse|2|||
49135696|NCT00920816|158334758|FG002|Overall Study|Objective progression or relapse|0|||
49135697|NCT00920816|158334759|FG003|Overall Study|Objective progression or relapse|0|||
49135698|NCT00920816|158334756|FG000|Overall Study|Other|26|||
49135699|NCT00920816|158334757|FG001|Overall Study|Other|15|||
49135700|NCT00920816|158334758|FG002|Overall Study|Other|1|||
49135701|NCT00920816|158334759|FG003|Overall Study|Other|2|||
48820746|NCT05259033|157185616|FG000|Overall Study|Lost to Follow-up|1|||
48820747|NCT05259033|157185617|FG001|Overall Study|Lost to Follow-up|0|||
48820748|NCT05259033|157185616|FG000|Overall Study|Death|2|||
48820749|NCT05259033|157185617|FG001|Overall Study|Death|0|||
48820750|NCT01513967|157185618|FG000|Overall Study|Pregnancy|0|||
48820751|NCT01513967|157185619|FG001|Overall Study|Pregnancy|0|||
48820752|NCT01513967|157185620|FG002|Overall Study|Pregnancy|0|||
48820753|NCT01513967|157185621|FG003|Overall Study|Pregnancy|0|||
48820754|NCT01513967|157185622|FG004|Overall Study|Pregnancy|0|||
48820755|NCT01513967|157185623|FG005|Overall Study|Pregnancy|0|||
48820756|NCT01513967|157185624|FG006|Overall Study|Pregnancy|1|||
48820757|NCT01513967|157185625|FG007|Overall Study|Pregnancy|0|||
48820758|NCT01513967|157185618|FG000|Overall Study|missed a study visit|0|||
48820759|NCT01513967|157185619|FG001|Overall Study|missed a study visit|0|||
48820760|NCT01513967|157185620|FG002|Overall Study|missed a study visit|0|||
49135702|NCT00920816|158334756|FG000|Overall Study|Lost to Follow-up|11|||
49135703|NCT00920816|158334757|FG001|Overall Study|Lost to Follow-up|2|||
48726142|NCT02414139|156846586|FG009|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
48726143|NCT02414139|156846577|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|4|||
48726144|NCT02414139|156846578|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
48726145|NCT02414139|156846579|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|3|||
49135704|NCT00920816|158334758|FG002|Overall Study|Lost to Follow-up|0|||
49135705|NCT00920816|158334759|FG003|Overall Study|Lost to Follow-up|0|||
49135706|NCT00920816|158334756|FG000|Overall Study|Adverse Event|1|||
49135707|NCT00920816|158334757|FG001|Overall Study|Adverse Event|1|||
49135708|NCT00920816|158334758|FG002|Overall Study|Adverse Event|1|||
49135709|NCT00920816|158334759|FG003|Overall Study|Adverse Event|0|||
49135710|NCT00920816|158334756|FG000|Overall Study|Data not disclosed due to lack of HGRAC filings|16|||
49135711|NCT00920816|158334757|FG001|Overall Study|Data not disclosed due to lack of HGRAC filings|8|||
49135712|NCT00920816|158334758|FG002|Overall Study|Data not disclosed due to lack of HGRAC filings|124|||
49135713|NCT00920816|158334759|FG003|Overall Study|Data not disclosed due to lack of HGRAC filings|64|||
49135714|NCT00920816|158334756|FG000|Overall Study|Randomized but not treated|3|||
49135715|NCT00920816|158334757|FG001|Overall Study|Randomized but not treated|0|||
49135716|NCT00920816|158334758|FG002|Overall Study|Randomized but not treated|0|||
49135717|NCT00920816|158334759|FG003|Overall Study|Randomized but not treated|0|||
49135718|NCT04115059|158334760|FG000|Overall Study|Withdrawal by Subject|1|||
49135719|NCT04115059|158334760|FG000|Overall Study|Lack of Efficacy|2|||
49135720|NCT00368550|158334761|FG000|Overall Study|Adverse Event|7|||
49135721|NCT00368550|158334762|FG001|Overall Study|Adverse Event|4|||
49135722|NCT00368550|158334761|FG000|Overall Study|Lack of Efficacy|4|||
49135723|NCT00368550|158334762|FG001|Overall Study|Lack of Efficacy|9|||
48726146|NCT02414139|156846580|FG003|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
48726147|NCT02414139|156846581|FG004|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
48726148|NCT02414139|156846582|FG005|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
48726149|NCT02414139|156846583|FG006|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
48726150|NCT02414139|156846584|FG007|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
48726151|NCT02414139|156846585|FG008|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
48726152|NCT02414139|156846586|FG009|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
48726153|NCT03631355|156846587|FG000|Overall Study|Lost to Follow-up|1|||
48726154|NCT03631355|156846588|FG001|Overall Study|Lost to Follow-up|2|||
48726155|NCT00378079|156846589|FG000|Overall Study|Lost to Follow-up|6|||
48726156|NCT00378079|156846590|FG001|Overall Study|Lost to Follow-up|1|||
48726157|NCT00378079|156846591|FG002|Overall Study|Lost to Follow-up|0|||
48726158|NCT04473482|156846593|FG000|Overall Study|Death|0|||
48726159|NCT04473482|156846594|FG001|Overall Study|Death|3|||
48726160|NCT04473482|156846593|FG000|Overall Study|Lost to Follow-up|9|||
48726161|NCT04473482|156846594|FG001|Overall Study|Lost to Follow-up|7|||
48726162|NCT04473482|156846593|FG000|Overall Study|Withdrawal by Subject|2|||
48726163|NCT04473482|156846594|FG001|Overall Study|Withdrawal by Subject|1|||
48726164|NCT02021656|156846601|FG000|Overall Study|Adverse Event|1|||
48726165|NCT02021656|156846601|FG000|Overall Study|Lack of Efficacy|2|||
48726166|NCT02021656|156846601|FG000|Overall Study|Lost to Follow-up|1|||
48726167|NCT02021656|156846601|FG000|Overall Study|Withdrew Consent|2|||
48726168|NCT02286089|156846604|FG000|Overall Study|Ongoing in Study|1|||
48726169|NCT02286089|156846605|FG001|Overall Study|Ongoing in Study|1|||
48726170|NCT02286089|156846606|FG002|Overall Study|Ongoing in Study|4|||
48820761|NCT01513967|157185621|FG003|Overall Study|missed a study visit|0|||
48820762|NCT01513967|157185622|FG004|Overall Study|missed a study visit|0|||
48820763|NCT01513967|157185623|FG005|Overall Study|missed a study visit|0|||
48820764|NCT01513967|157185624|FG006|Overall Study|missed a study visit|1|||
48820765|NCT01513967|157185625|FG007|Overall Study|missed a study visit|0|||
48820766|NCT01513967|157185618|FG000|Overall Study|excluded due to positive drug screen|0|||
48820767|NCT01513967|157185619|FG001|Overall Study|excluded due to positive drug screen|0|||
49135724|NCT00368550|158334761|FG000|Overall Study|Withdrawal by Subject|17|||
49135725|NCT00368550|158334762|FG001|Overall Study|Withdrawal by Subject|10|||
49135726|NCT01582451|158334763|FG000|Overall Study|Adverse Event|1|||
49135727|NCT01582451|158334764|FG001|Overall Study|Adverse Event|3|||
49135728|NCT01582451|158334763|FG000|Overall Study|Death|3|||
49135729|NCT01582451|158334764|FG001|Overall Study|Death|3|||
49135730|NCT01582451|158334763|FG000|Overall Study|Lost to Follow-up|0|||
49135731|NCT01582451|158334764|FG001|Overall Study|Lost to Follow-up|2|||
49135732|NCT01582451|158334763|FG000|Overall Study|Protocol Violation|11|||
49135733|NCT01582451|158334764|FG001|Overall Study|Protocol Violation|3|||
49135734|NCT01582451|158334763|FG000|Overall Study|Withdrawal by Subject|13|||
49135735|NCT01582451|158334764|FG001|Overall Study|Withdrawal by Subject|9|||
49135736|NCT01582451|158334763|FG000|Overall Study|Physician Decision|3|||
49135737|NCT01582451|158334764|FG001|Overall Study|Physician Decision|0|||
49135738|NCT01582451|158334763|FG000|Overall Study|Sponsor Decision|1|||
49135739|NCT01582451|158334764|FG001|Overall Study|Sponsor Decision|0|||
49135740|NCT02178956|158334774|FG000|Overall Study|Lost to Follow-up|4|||
49135741|NCT02178956|158334775|FG001|Overall Study|Lost to Follow-up|4|||
49135742|NCT02178956|158334774|FG000|Overall Study|Sponsor terminated study|49|||
49135743|NCT02178956|158334775|FG001|Overall Study|Sponsor terminated study|58|||
49135744|NCT02178956|158334774|FG000|Overall Study|Withdrawal by Subject|15|||
49135745|NCT02178956|158334775|FG001|Overall Study|Withdrawal by Subject|11|||
49135746|NCT02178956|158334774|FG000|Overall Study|Various Reasons|3|||
49135747|NCT02178956|158334775|FG001|Overall Study|Various Reasons|5|||
49135748|NCT02989389|158334778|FG000|Period 1|Lost to Follow-up|0|||
49135749|NCT02989389|158334779|FG001|Period 1|Lost to Follow-up|1|||
49135750|NCT02989389|158334780|FG002|Period 1|Lost to Follow-up|0|||
49135751|NCT02989389|158334781|FG003|Period 1|Lost to Follow-up|0|||
49135752|NCT02989389|158334782|FG004|Period 1|Lost to Follow-up|0|||
49135753|NCT02989389|158334783|FG005|Period 1|Lost to Follow-up|0|||
49135754|NCT02989389|158334784|FG006|Period 1|Lost to Follow-up|0|||
49135755|NCT02989389|158334785|FG007|Period 1|Lost to Follow-up|0|||
49135756|NCT02989389|158334786|FG008|Period 1|Lost to Follow-up|0|||
49135757|NCT02989389|158334787|FG009|Period 1|Lost to Follow-up|0|||
49135758|NCT02989389|158334778|FG000|Period 1|Physician Decision|0|||
49135759|NCT02989389|158334779|FG001|Period 1|Physician Decision|0|||
49135760|NCT02989389|158334780|FG002|Period 1|Physician Decision|0|||
49135761|NCT02989389|158334781|FG003|Period 1|Physician Decision|0|||
49135762|NCT02989389|158334782|FG004|Period 1|Physician Decision|0|||
49135763|NCT02989389|158334783|FG005|Period 1|Physician Decision|0|||
49135764|NCT02989389|158334784|FG006|Period 1|Physician Decision|0|||
49135765|NCT02989389|158334785|FG007|Period 1|Physician Decision|0|||
49135766|NCT02989389|158334786|FG008|Period 1|Physician Decision|1|||
49135767|NCT02989389|158334787|FG009|Period 1|Physician Decision|0|||
49135768|NCT04615507|158334790|FG000|Period 1|Covid-19 exposure|2|||
49135769|NCT04615507|158334791|FG001|Period 1|Covid-19 exposure|1|||
48820768|NCT01513967|157185620|FG002|Overall Study|excluded due to positive drug screen|0|||
49135770|NCT04615507|158334790|FG000|Period 2|Covid-19 exposure|0|||
49135771|NCT04615507|158334791|FG001|Period 2|Covid-19 exposure|1|||
48820769|NCT01513967|157185621|FG003|Overall Study|excluded due to positive drug screen|0|||
48820770|NCT01513967|157185622|FG004|Overall Study|excluded due to positive drug screen|0|||
48820771|NCT01513967|157185623|FG005|Overall Study|excluded due to positive drug screen|0|||
48820772|NCT01513967|157185624|FG006|Overall Study|excluded due to positive drug screen|0|||
48820773|NCT01513967|157185625|FG007|Overall Study|excluded due to positive drug screen|2|||
49135772|NCT04615507|158334790|FG000|Period 2|Protocol Violation|1|||
49135773|NCT04615507|158334791|FG001|Period 2|Protocol Violation|0|||
49135774|NCT04615507|158334790|FG000|Period 2|Withdrawal by Subject|1|||
49135775|NCT04615507|158334791|FG001|Period 2|Withdrawal by Subject|0|||
49135776|NCT04615507|158334790|FG000|Period 2|Adverse Event|0|||
49135777|NCT04615507|158334791|FG001|Period 2|Adverse Event|1|||
49135778|NCT04615507|158334790|FG000|Period 3|Covid-19 exposure|0|||
49135779|NCT04615507|158334791|FG001|Period 3|Covid-19 exposure|1|||
49135780|NCT00699751|158334792|FG000|Period 1: Without/Before Drug Switch|Investigator Request|27|||
49135781|NCT00699751|158334793|FG001|Period 1: Without/Before Drug Switch|Investigator Request|27|||
49135782|NCT00699751|158334792|FG000|Period 1: Without/Before Drug Switch|Death|28|||
49135783|NCT00699751|158334793|FG001|Period 1: Without/Before Drug Switch|Death|29|||
48820774|NCT01513967|157185618|FG000|Overall Study|Physician Decision|0|||
48820775|NCT01513967|157185619|FG001|Overall Study|Physician Decision|0|||
48820776|NCT01513967|157185620|FG002|Overall Study|Physician Decision|0|||
49135784|NCT00699751|158334792|FG000|Period 1: Without/Before Drug Switch|Subject Request|43|||
49135785|NCT00699751|158334793|FG001|Period 1: Without/Before Drug Switch|Subject Request|23|||
49135786|NCT00699751|158334792|FG000|Period 1: Without/Before Drug Switch|Other|30|||
48820777|NCT01513967|157185621|FG003|Overall Study|Physician Decision|0|||
48820778|NCT01513967|157185622|FG004|Overall Study|Physician Decision|0|||
49135787|NCT00699751|158334793|FG001|Period 1: Without/Before Drug Switch|Other|20|||
49135788|NCT00699751|158334792|FG000|Period 1: Without/Before Drug Switch|Adverse Event|97|||
49135789|NCT00699751|158334793|FG001|Period 1: Without/Before Drug Switch|Adverse Event|63|||
49135790|NCT00699751|158334792|FG000|Period 2:Switched From Placebo to Xofigo|Adverse Event|0|||
49135791|NCT00699751|158334793|FG001|Period 2:Switched From Placebo to Xofigo|Adverse Event|4|||
49135792|NCT00699751|158334792|FG000|Period 2:Switched From Placebo to Xofigo|Investigator Request|0|||
49135793|NCT00699751|158334793|FG001|Period 2:Switched From Placebo to Xofigo|Investigator Request|1|||
49135794|NCT00699751|158334792|FG000|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0|||
49135795|NCT00699751|158334793|FG001|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4|||
48726171|NCT02286089|156846607|FG003|Overall Study|Ongoing in Study|10|||
48726172|NCT02286089|156846604|FG000|Overall Study|Withdrawal by Subject|0|||
48726173|NCT02286089|156846605|FG001|Overall Study|Withdrawal by Subject|0|||
48726174|NCT02286089|156846606|FG002|Overall Study|Withdrawal by Subject|2|||
48726175|NCT02286089|156846607|FG003|Overall Study|Withdrawal by Subject|2|||
48726176|NCT00336583|156847856|FG000|Overall Study|Lost to Follow-up|1|||
48726177|NCT00336583|156847856|FG000|Overall Study|Death|1|||
48726178|NCT01527357|156847857|FG000|Overall Study|Death|8|||
49135796|NCT01947933|158334794|FG000|Overall Study|Withdrawal by Subject|0|||
49135797|NCT01947933|158334795|FG001|Overall Study|Withdrawal by Subject|0|||
48726179|NCT01527357|156847858|FG001|Overall Study|Death|2|||
49135798|NCT01947933|158334796|FG002|Overall Study|Withdrawal by Subject|1|||
49135799|NCT01947933|158334797|FG003|Overall Study|Withdrawal by Subject|0|||
49135800|NCT01947933|158334798|FG004|Overall Study|Withdrawal by Subject|0|||
49135801|NCT01947933|158334799|FG005|Overall Study|Withdrawal by Subject|0|||
49135802|NCT01947933|158334800|FG006|Overall Study|Withdrawal by Subject|0|||
49135803|NCT01947933|158334801|FG007|Overall Study|Withdrawal by Subject|0|||
49135804|NCT01947933|158334802|FG008|Overall Study|Withdrawal by Subject|0|||
49135805|NCT01947933|158334794|FG000|Overall Study|Lost to Follow-up|0|||
49135806|NCT01947933|158334795|FG001|Overall Study|Lost to Follow-up|0|||
49135807|NCT01947933|158334796|FG002|Overall Study|Lost to Follow-up|0|||
49135808|NCT01947933|158334797|FG003|Overall Study|Lost to Follow-up|0|||
48726180|NCT01527357|156847857|FG000|Overall Study|Lost to Follow-up|6|||
49135809|NCT01947933|158334798|FG004|Overall Study|Lost to Follow-up|0|||
49135810|NCT01947933|158334799|FG005|Overall Study|Lost to Follow-up|0|||
49135811|NCT01947933|158334800|FG006|Overall Study|Lost to Follow-up|0|||
49135812|NCT01947933|158334801|FG007|Overall Study|Lost to Follow-up|0|||
49135813|NCT01947933|158334802|FG008|Overall Study|Lost to Follow-up|1|||
49135814|NCT00831844|158334803|FG000|Overall Study|Adverse Event|2|||
49135815|NCT00831844|158334804|FG001|Overall Study|Adverse Event|0|||
49135816|NCT00831844|158334805|FG002|Overall Study|Adverse Event|0|||
49135817|NCT00831844|158334806|FG003|Overall Study|Adverse Event|0|||
49135818|NCT00831844|158334807|FG004|Overall Study|Adverse Event|1|||
49135819|NCT00831844|158334808|FG005|Overall Study|Adverse Event|1|||
49135820|NCT00831844|158334809|FG006|Overall Study|Adverse Event|2|||
49135821|NCT00831844|158334810|FG007|Overall Study|Adverse Event|0|||
49135822|NCT00831844|158334811|FG008|Overall Study|Adverse Event|0|||
49135823|NCT00831844|158334812|FG009|Overall Study|Adverse Event|0|||
49135824|NCT00831844|158334803|FG000|Overall Study|Death|0|||
49135825|NCT00831844|158334804|FG001|Overall Study|Death|0|||
49135826|NCT00831844|158334805|FG002|Overall Study|Death|0|||
49135827|NCT00831844|158334806|FG003|Overall Study|Death|1|||
49135828|NCT00831844|158334807|FG004|Overall Study|Death|0|||
49135829|NCT00831844|158334808|FG005|Overall Study|Death|0|||
49135830|NCT00831844|158334809|FG006|Overall Study|Death|0|||
49135831|NCT00831844|158334810|FG007|Overall Study|Death|0|||
49135832|NCT00831844|158334811|FG008|Overall Study|Death|0|||
49135833|NCT00831844|158334812|FG009|Overall Study|Death|0|||
49135834|NCT00831844|158334803|FG000|Overall Study|Lack of Efficacy|8|||
49135835|NCT00831844|158334804|FG001|Overall Study|Lack of Efficacy|10|||
49135836|NCT00831844|158334805|FG002|Overall Study|Lack of Efficacy|15|||
49135837|NCT00831844|158334806|FG003|Overall Study|Lack of Efficacy|8|||
49135838|NCT00831844|158334807|FG004|Overall Study|Lack of Efficacy|11|||
49135839|NCT00831844|158334808|FG005|Overall Study|Lack of Efficacy|17|||
49135840|NCT00831844|158334809|FG006|Overall Study|Lack of Efficacy|8|||
49135841|NCT00831844|158334810|FG007|Overall Study|Lack of Efficacy|9|||
49135842|NCT00831844|158334811|FG008|Overall Study|Lack of Efficacy|7|||
49135843|NCT00831844|158334812|FG009|Overall Study|Lack of Efficacy|0|||
49135844|NCT00831844|158334803|FG000|Overall Study|Physician Decision|0|||
49135845|NCT00831844|158334804|FG001|Overall Study|Physician Decision|1|||
49135846|NCT00831844|158334805|FG002|Overall Study|Physician Decision|3|||
49135847|NCT00831844|158334806|FG003|Overall Study|Physician Decision|1|||
49135848|NCT00831844|158334807|FG004|Overall Study|Physician Decision|1|||
49135849|NCT00831844|158334808|FG005|Overall Study|Physician Decision|1|||
48726181|NCT01527357|156847858|FG001|Overall Study|Lost to Follow-up|4|||
48726182|NCT01527357|156847857|FG000|Overall Study|Withdrew Consent|1|||
49135850|NCT00831844|158334809|FG006|Overall Study|Physician Decision|0|||
48726183|NCT01527357|156847858|FG001|Overall Study|Withdrew Consent|1|||
48726184|NCT01527357|156847857|FG000|Overall Study|Non-compliance|0|||
48726185|NCT01527357|156847858|FG001|Overall Study|Non-compliance|1|||
48726186|NCT01527357|156847857|FG000|Overall Study|No Day 29 Visit|0|||
48726187|NCT01527357|156847858|FG001|Overall Study|No Day 29 Visit|1|||
48726188|NCT01527357|156847857|FG000|Overall Study|Did Not Receive Treatment|2|||
48726189|NCT01527357|156847858|FG001|Overall Study|Did Not Receive Treatment|0|||
48726190|NCT02716896|156847864|FG000|Overall Study|Physician Decision|0|||
48726191|NCT02716896|156847865|FG001|Overall Study|Physician Decision|1|||
48726192|NCT01727700|156847866|FG000|Overall Study|Adverse Event|0|||
48726193|NCT01727700|156847867|FG001|Overall Study|Adverse Event|7|||
48726194|NCT01727700|156847868|FG002|Overall Study|Adverse Event|1|||
49135851|NCT00831844|158334810|FG007|Overall Study|Physician Decision|0|||
49135852|NCT00831844|158334811|FG008|Overall Study|Physician Decision|1|||
49135853|NCT00831844|158334812|FG009|Overall Study|Physician Decision|0|||
49135854|NCT00831844|158334803|FG000|Overall Study|Withdrawal by Subject|0|||
49135855|NCT00831844|158334804|FG001|Overall Study|Withdrawal by Subject|0|||
49135856|NCT00831844|158334805|FG002|Overall Study|Withdrawal by Subject|1|||
49135857|NCT00831844|158334806|FG003|Overall Study|Withdrawal by Subject|0|||
49135858|NCT00831844|158334807|FG004|Overall Study|Withdrawal by Subject|0|||
49135859|NCT00831844|158334808|FG005|Overall Study|Withdrawal by Subject|0|||
49135860|NCT00831844|158334809|FG006|Overall Study|Withdrawal by Subject|0|||
49135861|NCT00831844|158334810|FG007|Overall Study|Withdrawal by Subject|1|||
49135862|NCT00831844|158334811|FG008|Overall Study|Withdrawal by Subject|1|||
49135863|NCT00831844|158334812|FG009|Overall Study|Withdrawal by Subject|0|||
49135864|NCT00831844|158334803|FG000|Overall Study|Ineligible|0|||
49135865|NCT00831844|158334804|FG001|Overall Study|Ineligible|1|||
49135866|NCT00831844|158334805|FG002|Overall Study|Ineligible|1|||
49135867|NCT00831844|158334806|FG003|Overall Study|Ineligible|0|||
49135868|NCT00831844|158334807|FG004|Overall Study|Ineligible|1|||
49135869|NCT00831844|158334808|FG005|Overall Study|Ineligible|0|||
49135870|NCT00831844|158334809|FG006|Overall Study|Ineligible|0|||
49135871|NCT00831844|158334810|FG007|Overall Study|Ineligible|0|||
49135872|NCT00831844|158334811|FG008|Overall Study|Ineligible|0|||
49135873|NCT00831844|158334812|FG009|Overall Study|Ineligible|0|||
49135874|NCT00127803|158334815|FG000|Overall Study|Adverse Event|2|||
49135875|NCT00127803|158334816|FG001|Overall Study|Adverse Event|0|||
49135876|NCT00127803|158334817|FG002|Overall Study|Adverse Event|0|||
49135877|NCT00127803|158334818|FG003|Overall Study|Adverse Event|0|||
49135878|NCT00127803|158334815|FG000|Overall Study|Withdrawal by Subject|1|||
49135879|NCT00127803|158334816|FG001|Overall Study|Withdrawal by Subject|0|||
49135880|NCT00127803|158334817|FG002|Overall Study|Withdrawal by Subject|0|||
49135881|NCT00127803|158334818|FG003|Overall Study|Withdrawal by Subject|0|||
49135882|NCT00127803|158334815|FG000|Overall Study|Lost to Follow-up|0|||
49135883|NCT00127803|158334816|FG001|Overall Study|Lost to Follow-up|0|||
49135884|NCT00127803|158334817|FG002|Overall Study|Lost to Follow-up|0|||
49135885|NCT00127803|158334818|FG003|Overall Study|Lost to Follow-up|1|||
49135886|NCT05166876|158334821|FG000|Overall Study|Withdrawal by Subject|1|||
49135887|NCT05166876|158334822|FG001|Overall Study|Withdrawal by Subject|0|||
49135888|NCT05166876|158334823|FG002|Overall Study|Withdrawal by Subject|0|||
49135889|NCT00658528|158334824|FG000|Overall Study|Adverse Event|5|||
49135890|NCT00658528|158334825|FG001|Overall Study|Adverse Event|7|||
49135891|NCT00658528|158334824|FG000|Overall Study|Lost to Follow-up|14|||
49135892|NCT00658528|158334825|FG001|Overall Study|Lost to Follow-up|22|||
49135893|NCT00658528|158334824|FG000|Overall Study|Withdrawal by Subject|8|||
49135894|NCT00658528|158334825|FG001|Overall Study|Withdrawal by Subject|6|||
49135895|NCT00658528|158334824|FG000|Overall Study|Withdrawal of consent|5|||
49135896|NCT00658528|158334825|FG001|Overall Study|Withdrawal of consent|6|||
49135897|NCT00658528|158334824|FG000|Overall Study|Other|8|||
48726195|NCT01727700|156847866|FG000|Overall Study|Particpant withdrew consent|0|||
48726196|NCT01727700|156847867|FG001|Overall Study|Particpant withdrew consent|3|||
49135898|NCT00658528|158334825|FG001|Overall Study|Other|4|||
49135899|NCT00832975|158334829|FG000|Overall Study|Lost to Follow-up|7|||
49135900|NCT00832975|158334829|FG000|Overall Study|Protocol Violation|6|||
49135901|NCT00832975|158334829|FG000|Overall Study|Death|5|||
49135902|NCT00832975|158334829|FG000|Overall Study|Physician Decision|4|||
49135903|NCT00832975|158334829|FG000|Overall Study|Withdrawal by Subject|3|||
49135904|NCT00832975|158334829|FG000|Overall Study|Other reasons|14|||
49135905|NCT02811159|158334833|FG000|Treatment Course 1|Lost to Follow-up|1|||
49135906|NCT00433290|158334840|FG000|Overall Study|Adverse Event|24|||
49135907|NCT00433290|158334841|FG001|Overall Study|Adverse Event|7|||
49135908|NCT00433290|158334840|FG000|Overall Study|Lack of Efficacy|1|||
48726197|NCT01727700|156847868|FG002|Overall Study|Particpant withdrew consent|1|||
49135909|NCT00433290|158334841|FG001|Overall Study|Lack of Efficacy|5|||
49135910|NCT00433290|158334840|FG000|Overall Study|Withdrawal by Subject|4|||
49135911|NCT00433290|158334841|FG001|Overall Study|Withdrawal by Subject|2|||
49135912|NCT00433290|158334840|FG000|Overall Study|Protocol Violation|3|||
49135913|NCT00433290|158334841|FG001|Overall Study|Protocol Violation|2|||
49135914|NCT00433290|158334840|FG000|Overall Study|Physician Decision|2|||
49135915|NCT00433290|158334841|FG001|Overall Study|Physician Decision|0|||
49135916|NCT00433290|158334840|FG000|Overall Study|Entry Criteria Not Met|0|||
49135917|NCT00433290|158334841|FG001|Overall Study|Entry Criteria Not Met|1|||
49135918|NCT00433290|158334840|FG000|Overall Study|Lost to Follow-up|1|||
48726198|NCT01727700|156847866|FG000|Overall Study|Protocol Violation|2|||
49135919|NCT00433290|158334841|FG001|Overall Study|Lost to Follow-up|0|||
49135920|NCT00857389|158334842|FG000|Overall Study|Did not proceed to transplant|2|||
49135921|NCT01113749|158336592|FG000|Overall Study|Lost to Follow-up|1|||
49135922|NCT01113749|158336593|FG001|Overall Study|Lost to Follow-up|2|||
49135923|NCT03439839|158336594|FG000|Overall Study|Death|3|||
49135924|NCT03439839|158336595|FG001|Overall Study|Death|0|||
49135925|NCT02100631|158336598|FG000|Overall Study|Withdrawal by Subject|1|||
49135926|NCT02100631|158336599|FG001|Overall Study|Withdrawal by Subject|0|||
49135927|NCT02100631|158336600|FG002|Overall Study|Withdrawal by Subject|0|||
49135928|NCT02100631|158336598|FG000|Overall Study|Lost to Follow-up|3|||
49135929|NCT02100631|158336599|FG001|Overall Study|Lost to Follow-up|4|||
49135930|NCT02100631|158336600|FG002|Overall Study|Lost to Follow-up|0|||
49135931|NCT02100631|158336598|FG000|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3|||
49135932|NCT02100631|158336599|FG001|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
49135933|NCT02100631|158336600|FG002|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
49135934|NCT01847209|158336601|FG000|Overall Study|Withdrawal by Subject|1|||
49135935|NCT01847209|158336601|FG000|Overall Study|No lung nodule found on intraop CT scan|1|||
49135936|NCT01408641|158336602|FG000|Overall Study|Physician Decision|1|||
49135937|NCT01408641|158336603|FG001|Overall Study|Physician Decision|0|||
49135938|NCT00576758|158336604|FG000|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
49135939|NCT00576758|158336605|FG001|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
49135940|NCT00576758|158336604|FG000|Induction Treatment Period|Insufficient therapeutic response|2|||
49135941|NCT00576758|158336605|FG001|Induction Treatment Period|Insufficient therapeutic response|0|||
49135942|NCT00576758|158336604|FG000|Induction Treatment Period|Violation of selection criteria at entry|1|||
49135943|NCT00576758|158336605|FG001|Induction Treatment Period|Violation of selection criteria at entry|1|||
49135944|NCT00576758|158336604|FG000|Induction Treatment Period|Death|1|||
49135945|NCT00576758|158336605|FG001|Induction Treatment Period|Death|0|||
49135946|NCT00576758|158336604|FG000|Induction Treatment Period|Refused treatment/ Did not Cooperate|0|||
49135947|NCT00576758|158336605|FG001|Induction Treatment Period|Refused treatment/ Did not Cooperate|1|||
49135948|NCT00576758|158336604|FG000|Induction Treatment Period|Withdrew consent|1|||
49135949|NCT00576758|158336605|FG001|Induction Treatment Period|Withdrew consent|0|||
49135950|NCT00576758|158336604|FG000|Extension Treatment Period|Adverse event or Intercurrent illness|6|||
49135951|NCT00576758|158336605|FG001|Extension Treatment Period|Adverse event or Intercurrent illness|7|||
49135952|NCT00576758|158336604|FG000|Extension Treatment Period|Death|1|||
49135953|NCT00576758|158336605|FG001|Extension Treatment Period|Death|1|||
49135954|NCT00576758|158336604|FG000|Extension Treatment Period|Refused treatment/did not cooperate|2|||
49135955|NCT00576758|158336605|FG001|Extension Treatment Period|Refused treatment/did not cooperate|1|||
49135956|NCT00576758|158336604|FG000|Extension Treatment Period|Insufficient therapeutic response|30|||
49135957|NCT00576758|158336605|FG001|Extension Treatment Period|Insufficient therapeutic response|33|||
49135958|NCT00576758|158336604|FG000|Extension Treatment Period|Administrative/Other|3|||
49135959|NCT00576758|158336605|FG001|Extension Treatment Period|Administrative/Other|1|||
49135960|NCT00576758|158336604|FG000|Follow-up Period|Administrative/Other|6|||
49135961|NCT00576758|158336605|FG001|Follow-up Period|Administrative/Other|8|||
49135962|NCT00576758|158336604|FG000|Follow-up Period|Death|3|||
49135963|NCT00576758|158336605|FG001|Follow-up Period|Death|3|||
49135964|NCT00576758|158336604|FG000|Follow-up Period|Insufficient therapeutic response|16|||
49135965|NCT00576758|158336605|FG001|Follow-up Period|Insufficient therapeutic response|5|||
49135966|NCT00576758|158336604|FG000|Follow-up Period|Withdrew consent|2|||
49135967|NCT00576758|158336605|FG001|Follow-up Period|Withdrew consent|1|||
49135968|NCT01136954|158336624|FG000|Overall Study|Adverse Event|3|||
49135969|NCT01136954|158336625|FG001|Overall Study|Adverse Event|2|||
49135970|NCT01136954|158336624|FG000|Overall Study|Withdrawal by Subject|6|||
49135971|NCT01136954|158336625|FG001|Overall Study|Withdrawal by Subject|2|||
49135972|NCT01136954|158336624|FG000|Overall Study|Lack of Efficacy|14|||
49135973|NCT01136954|158336625|FG001|Overall Study|Lack of Efficacy|13|||
49135974|NCT01136954|158336624|FG000|Overall Study|Physician Decision|0|||
49135975|NCT01136954|158336625|FG001|Overall Study|Physician Decision|1|||
49135976|NCT01136954|158336624|FG000|Overall Study|Other|1|||
49135977|NCT01136954|158336625|FG001|Overall Study|Other|3|||
49135978|NCT03801252|158336628|FG000|Overall Study|Protocol Violation|1|||
49135979|NCT03801252|158336629|FG001|Overall Study|Protocol Violation|2|||
49135980|NCT02471183|158336634|FG000|Main Treatment Period|Adverse Event|1|||
49135981|NCT02471183|158336634|FG000|Main Treatment Period|Withdrawal by Subject|1|||
49135982|NCT02471183|158336634|FG000|Extended Treatment Period|Lack of Efficacy|1|||
49135983|NCT02328105|158336638|FG000|Overall Study|Death|6|||
49135984|NCT02328105|158336638|FG000|Overall Study|Withdrawal by Subject|1|||
49135985|NCT02328105|158336638|FG000|Overall Study|Still On Study in Follow-Up|4|||
49135986|NCT01588509|158336641|FG000|Overall Study|Lost to Follow-up|1|||
49135987|NCT01588509|158336642|FG001|Overall Study|Lost to Follow-up|0|||
49135988|NCT03345004|158336643|FG000|Overall Study|Physician Decision|1|||
49135989|NCT03345004|158336644|FG001|Overall Study|Physician Decision|0|||
48726199|NCT01727700|156847867|FG001|Overall Study|Protocol Violation|0|||
49135990|NCT03345004|158336643|FG000|Overall Study|Withdrawal by Subject|0|||
49135991|NCT03345004|158336644|FG001|Overall Study|Withdrawal by Subject|1|||
49135992|NCT02932943|158336645|FG000|Overall Study|Lost to Follow-up|0|||
49135993|NCT02932943|158336646|FG001|Overall Study|Lost to Follow-up|2|||
49135994|NCT02932943|158336645|FG000|Overall Study|Adverse Event|2|||
49135995|NCT02932943|158336646|FG001|Overall Study|Adverse Event|2|||
49135996|NCT02932943|158336645|FG000|Overall Study|Withdrawal by Subject|3|||
49135997|NCT02932943|158336646|FG001|Overall Study|Withdrawal by Subject|3|||
49135998|NCT01983930|158336647|FG000|Overall Study|Withdrawal by Subject|9|||
49135999|NCT01983930|158336648|FG001|Overall Study|Withdrawal by Subject|8|||
49136000|NCT01983930|158336647|FG000|Overall Study|Adverse Event|0|||
49136001|NCT01983930|158336648|FG001|Overall Study|Adverse Event|1|||
49136002|NCT03286504|158336655|FG000|Overall Study|Lost to Follow-up|19|||
49136003|NCT03286504|158336656|FG001|Overall Study|Lost to Follow-up|16|||
49136004|NCT01732692|158336668|FG000|Overall Study|Adverse Event|0|||
49136005|NCT01732692|158336669|FG001|Overall Study|Adverse Event|1|||
49136006|NCT00929669|158336672|FG000|Overall Study|elevated glucose levels|1|||
49136007|NCT01056276|158336673|FG000|Treatment Period-Cycles 1-8|Toxicity|2|||
49136008|NCT01056276|158336674|FG001|Treatment Period-Cycles 1-8|Toxicity|1|||
49136009|NCT01056276|158336673|FG000|Treatment Period-Cycles 1-8|Withdrawal by Subject|1|||
49136010|NCT01056276|158336674|FG001|Treatment Period-Cycles 1-8|Withdrawal by Subject|2|||
49136011|NCT01056276|158336673|FG000|Treatment Period-Cycles 1-8|Disease Progression|2|||
49136012|NCT01056276|158336674|FG001|Treatment Period-Cycles 1-8|Disease Progression|2|||
49136013|NCT01056276|158336673|FG000|Treatment Period-Cycles 1-8|Intercurrent Illness|1|||
49136014|NCT01056276|158336674|FG001|Treatment Period-Cycles 1-8|Intercurrent Illness|2|||
49136015|NCT01056276|158336673|FG000|Treatment Period-Cycles 1-8|Physician Decision|3|||
49136016|NCT01056276|158336674|FG001|Treatment Period-Cycles 1-8|Physician Decision|0|||
49136017|NCT01056276|158336673|FG000|Treatment Period-Cycles 1-8|Death|3|||
49136018|NCT01056276|158336674|FG001|Treatment Period-Cycles 1-8|Death|1|||
49136019|NCT01056276|158336673|FG000|Treatment Period-Cycles 1-8|Lost to Follow-up|1|||
49136020|NCT01056276|158336674|FG001|Treatment Period-Cycles 1-8|Lost to Follow-up|0|||
49136021|NCT01056276|158336673|FG000|Maintenance Therapy|Toxicity|0|||
49136022|NCT01056276|158336674|FG001|Maintenance Therapy|Toxicity|2|||
49136023|NCT01056276|158336673|FG000|Maintenance Therapy|Progressive Disease|0|||
49136024|NCT01056276|158336674|FG001|Maintenance Therapy|Progressive Disease|9|||
49136025|NCT01056276|158336673|FG000|Maintenance Therapy|Physician Decision|0|||
49136026|NCT01056276|158336674|FG001|Maintenance Therapy|Physician Decision|1|||
49136027|NCT01056276|158336673|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
49136028|NCT01056276|158336674|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
49136029|NCT01056276|158336673|FG000|Maintenance Therapy|Intercurrent Illness|0|||
49136030|NCT01056276|158336674|FG001|Maintenance Therapy|Intercurrent Illness|1|||
49136031|NCT01056276|158336673|FG000|Maintenance Therapy|Continuing maintenance therapy|0|||
49136032|NCT01056276|158336674|FG001|Maintenance Therapy|Continuing maintenance therapy|14|||
49136033|NCT01881425|158336675|FG000|Overall Study|Death|5|||
49136034|NCT01881425|158336676|FG001|Overall Study|Death|1|||
49136035|NCT01881425|158336675|FG000|Overall Study|Withdrawal by Subject|8|||
49136036|NCT01881425|158336676|FG001|Overall Study|Withdrawal by Subject|3|||
49136037|NCT01881425|158336675|FG000|Overall Study|Physician Decision|2|||
49136038|NCT01881425|158336676|FG001|Overall Study|Physician Decision|1|||
49136039|NCT01881425|158336675|FG000|Overall Study|Adverse Event|3|||
49136040|NCT01881425|158336676|FG001|Overall Study|Adverse Event|0|||
49136041|NCT01881425|158336675|FG000|Overall Study|General Anesthesia panic attack|0|||
49136042|NCT01881425|158336676|FG001|Overall Study|General Anesthesia panic attack|1|||
49136043|NCT01881425|158336675|FG000|Overall Study|Subject randomized after study treatment cut off|0|||
49136044|NCT01881425|158336676|FG001|Overall Study|Subject randomized after study treatment cut off|1|||
49136045|NCT01881425|158336675|FG000|Overall Study|Lost to Follow-up|7|||
49136046|NCT01881425|158336676|FG001|Overall Study|Lost to Follow-up|2|||
49136047|NCT04900272|158336677|FG000|Overall Study|Lost to Follow-up|2|||
48820779|NCT01513967|157185623|FG005|Overall Study|Physician Decision|1|||
49136048|NCT04900272|158336677|FG000|Overall Study|Withdrawal due to technical difficulties (see above)|3|||
49136049|NCT04900272|158336677|FG000|Overall Study|Withdrawal by Subject|1|||
49136050|NCT00937950|158336678|FG000|Overall Study|Withdrawal by Subject|23|||
49136051|NCT00937950|158336678|FG000|Overall Study|Migrated/moved from study area|27|||
49136052|NCT00937950|158336678|FG000|Overall Study|Lost to Follow-up|144|||
49136053|NCT00937950|158336678|FG000|Overall Study|Missing confirmed|4|||
49136054|NCT00937950|158336678|FG000|Overall Study|Other|18|||
49136055|NCT00485303|158336679|FG000|Overall Study|Adverse Event|5|||
49136056|NCT00485303|158336679|FG000|Overall Study|Progressive Disease|44|||
49136057|NCT00485303|158336679|FG000|Overall Study|Other|3|||
49136058|NCT00485303|158336679|FG000|Overall Study|Initiation of new anti-cancer treatment|2|||
49136059|NCT00485303|158336679|FG000|Overall Study|Treatment ongoing at cutoff date|2|||
49136060|NCT00741611|158336680|FG000|Overall Study|Death|0|||
49136061|NCT00741611|158336681|FG001|Overall Study|Death|0|||
49136062|NCT00741611|158336682|FG002|Overall Study|Death|1|||
49136063|NCT00741611|158336680|FG000|Overall Study|Withdrawal by Subject|0|||
49136064|NCT00741611|158336681|FG001|Overall Study|Withdrawal by Subject|2|||
49136065|NCT00741611|158336682|FG002|Overall Study|Withdrawal by Subject|2|||
49136066|NCT04424901|158336683|FG000|Overall Study|patients were discharged prior to Hospital Day 9|17|||
49136067|NCT04424901|158336684|FG001|Overall Study|patients were discharged prior to Hospital Day 9|16|||
49136068|NCT01970371|158336685|FG000|Overall Study|Death|8|||
49136069|NCT01970371|158336686|FG001|Overall Study|Death|13|||
49136070|NCT01970371|158336687|FG002|Overall Study|Death|12|||
49136071|NCT01970371|158336685|FG000|Overall Study|Lost to Follow-up|0|||
49136072|NCT01970371|158336686|FG001|Overall Study|Lost to Follow-up|0|||
49136073|NCT01970371|158336687|FG002|Overall Study|Lost to Follow-up|1|||
49136074|NCT02239328|158336688|FG000|Overall Study|Benign disease noted at time of surgery|6|||
49136075|NCT02239328|158336688|FG000|Overall Study|Equipment or website malfunction|2|||
49136076|NCT00770367|158336689|FG000|First Intervention|Withdrawal by Subject|0|||
49136077|NCT00770367|158336690|FG001|First Intervention|Withdrawal by Subject|2|||
49136078|NCT00770367|158336689|FG000|Washout Period of 4 Weeks|Withdrawal by Subject|0|||
49136079|NCT00770367|158336690|FG001|Washout Period of 4 Weeks|Withdrawal by Subject|1|||
49136080|NCT00770367|158336689|FG000|Second Intervention|Lost to Follow-up|2|||
49136081|NCT00770367|158336690|FG001|Second Intervention|Lost to Follow-up|0|||
49136082|NCT00435942|158336691|FG000|Overall Study|Death|17|||
49136083|NCT00435942|158336692|FG001|Overall Study|Death|10|||
49136084|NCT00435942|158336691|FG000|Overall Study|Withdrawal by Subject|2|||
49136085|NCT00435942|158336692|FG001|Overall Study|Withdrawal by Subject|0|||
49136086|NCT00435942|158336691|FG000|Overall Study|Lost to Follow-up|0|||
49136087|NCT00435942|158336692|FG001|Overall Study|Lost to Follow-up|16|||
49136088|NCT00435942|158336691|FG000|Overall Study|Conversion to Open Repair|1|||
49136089|NCT00435942|158336692|FG001|Overall Study|Conversion to Open Repair|0|||
49136090|NCT00435942|158336691|FG000|Overall Study|Technical Failure|3|||
49136091|NCT00435942|158336692|FG001|Overall Study|Technical Failure|0|||
49136092|NCT00435942|158336691|FG000|Overall Study|Other|0|||
49136093|NCT00435942|158336692|FG001|Overall Study|Other|1|||
49136094|NCT01875237|158336694|FG000|Overall Study|GVDH before DLI|1|||
49136095|NCT01875237|158336695|FG001|Overall Study|GVDH before DLI|0|||
49136096|NCT01875237|158336694|FG000|Overall Study|DLI cells could not be produced|1|||
49136097|NCT01875237|158336695|FG001|Overall Study|DLI cells could not be produced|0|||
49136098|NCT04871113|158336696|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
49136099|NCT04871113|158336697|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
49136100|NCT04871113|158336698|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
49136101|NCT04871113|158336699|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
49136102|NCT04871113|158336700|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
49136103|NCT04871113|158336701|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|1|||
49136104|NCT04871113|158336702|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
49136105|NCT04871113|158336703|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
49136106|NCT04871113|158336704|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
49136107|NCT04871113|158336705|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
49136108|NCT04871113|158336696|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
49136109|NCT04871113|158336697|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
49136110|NCT04871113|158336698|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
49136111|NCT04871113|158336699|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
49136112|NCT04871113|158336700|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
49136113|NCT04871113|158336701|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
49136114|NCT04871113|158336702|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|1|||
49136115|NCT04871113|158336703|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|2|||
49136116|NCT04871113|158336704|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
49136117|NCT04871113|158336705|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
49136118|NCT02412657|158336709|FG000|Overall Study|Lost to Follow-up|1|||
49136119|NCT02412657|158336710|FG001|Overall Study|Lost to Follow-up|0|||
49136120|NCT02412657|158336711|FG002|Overall Study|Lost to Follow-up|0|||
48726200|NCT01727700|156847868|FG002|Overall Study|Protocol Violation|0|||
48726201|NCT00084838|156847869|FG000|Overall Study|Death|1|||
49136121|NCT02412657|158336709|FG000|Overall Study|Protocol Violation|0|||
49136122|NCT02412657|158336710|FG001|Overall Study|Protocol Violation|2|||
49136123|NCT02412657|158336711|FG002|Overall Study|Protocol Violation|3|||
49136124|NCT02382939|158336713|FG000|Overall Study|Adverse Event|1|||
49136125|NCT02382939|158336714|FG001|Overall Study|Adverse Event|1|||
49136126|NCT02382939|158336713|FG000|Overall Study|Withdrawal by Subject|2|||
49136127|NCT02382939|158336714|FG001|Overall Study|Withdrawal by Subject|2|||
49136128|NCT00689936|158336716|FG000|Active Treatment Phase|Adverse Event|68|||
49136129|NCT00689936|158336717|FG001|Active Treatment Phase|Adverse Event|71|||
49136130|NCT00689936|158336718|FG002|Active Treatment Phase|Adverse Event|76|||
49136131|NCT00689936|158336716|FG000|Active Treatment Phase|Disease Progression|273|||
49136132|NCT00689936|158336717|FG001|Active Treatment Phase|Disease Progression|362|||
49136133|NCT00689936|158336718|FG002|Active Treatment Phase|Disease Progression|339|||
49136134|NCT00689936|158336716|FG000|Active Treatment Phase|Withdrawal by Subject|16|||
49136135|NCT00689936|158336717|FG001|Active Treatment Phase|Withdrawal by Subject|16|||
49136136|NCT00689936|158336718|FG002|Active Treatment Phase|Withdrawal by Subject|21|||
49136137|NCT00689936|158336716|FG000|Active Treatment Phase|Death|60|||
49136138|NCT00689936|158336717|FG001|Active Treatment Phase|Death|28|||
49136139|NCT00689936|158336718|FG002|Active Treatment Phase|Death|37|||
49136140|NCT00689936|158336716|FG000|Active Treatment Phase|Lost to Follow-up|0|||
49136141|NCT00689936|158336717|FG001|Active Treatment Phase|Lost to Follow-up|2|||
49136142|NCT00689936|158336718|FG002|Active Treatment Phase|Lost to Follow-up|2|||
49136143|NCT00689936|158336716|FG000|Active Treatment Phase|Protocol Violation|2|||
49136144|NCT00689936|158336717|FG001|Active Treatment Phase|Protocol Violation|2|||
48820780|NCT01513967|157185624|FG006|Overall Study|Physician Decision|0|||
49136145|NCT00689936|158336718|FG002|Active Treatment Phase|Protocol Violation|4|||
49136146|NCT00689936|158336716|FG000|Active Treatment Phase|Study Close Out|64|||
48820781|NCT01513967|157185625|FG007|Overall Study|Physician Decision|0|||
49136147|NCT00689936|158336717|FG001|Active Treatment Phase|Study Close Out|26|||
49136148|NCT00689936|158336718|FG002|Active Treatment Phase|Study Close Out|21|||
49136149|NCT00689936|158336716|FG000|Active Treatment Phase|Miscellaneous|52|||
49136150|NCT00689936|158336717|FG001|Active Treatment Phase|Miscellaneous|34|||
49136151|NCT00689936|158336718|FG002|Active Treatment Phase|Miscellaneous|47|||
49136152|NCT00689936|158336716|FG000|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127|||
49136153|NCT00689936|158336717|FG001|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188|||
49136154|NCT00689936|158336718|FG002|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144|||
49136155|NCT01682031|158336719|FG000|Overall Study|Withdrawal by Subject|0|||
49136156|NCT01682031|158336720|FG001|Overall Study|Withdrawal by Subject|1|||
49136157|NCT01682031|158336719|FG000|Overall Study|Adverse Event|0|||
49136158|NCT01682031|158336720|FG001|Overall Study|Adverse Event|2|||
49136159|NCT01682031|158336719|FG000|Overall Study|MRI results indicate increased nodul|0|||
49136160|NCT01682031|158336720|FG001|Overall Study|MRI results indicate increased nodul|1|||
49136161|NCT01682031|158336719|FG000|Overall Study|Patient could not swallow tablets|1|||
49136162|NCT01682031|158336720|FG001|Overall Study|Patient could not swallow tablets|0|||
49136163|NCT01682031|158336719|FG000|Overall Study|Patient stopped selenium on his own|0|||
49136164|NCT01682031|158336720|FG001|Overall Study|Patient stopped selenium on his own|1|||
49136165|NCT03881371|158336722|FG000|Overall Study|Adverse Event|8|||
49136166|NCT03881371|158336723|FG001|Overall Study|Adverse Event|9|||
49136167|NCT03881371|158336722|FG000|Overall Study|Death|1|||
49136168|NCT03881371|158336723|FG001|Overall Study|Death|0|||
49136169|NCT03881371|158336722|FG000|Overall Study|Lost to Follow-up|1|||
49136170|NCT03881371|158336723|FG001|Overall Study|Lost to Follow-up|0|||
49011279|NCT00830063|157878905|FG001|Overall Study|Other|5|||
49136171|NCT03881371|158336722|FG000|Overall Study|Non-Compliance with Study Drug|0|||
49136172|NCT03881371|158336723|FG001|Overall Study|Non-Compliance with Study Drug|2|||
49136173|NCT03881371|158336722|FG000|Overall Study|Physician Decision|3|||
49136174|NCT03881371|158336723|FG001|Overall Study|Physician Decision|3|||
49136175|NCT03881371|158336722|FG000|Overall Study|Withdrawal by Subject|2|||
49136176|NCT03881371|158336723|FG001|Overall Study|Withdrawal by Subject|10|||
49136177|NCT03881371|158336722|FG000|Overall Study|Discontinuation from Study|1|||
49136178|NCT03881371|158336723|FG001|Overall Study|Discontinuation from Study|0|||
49136179|NCT01303419|158336724|FG000|Overall Study|Discontinuation of study|60|||
49136180|NCT01303419|158336724|FG000|Overall Study|Did not complete both imaging methods|5|||
49136181|NCT01303419|158336724|FG000|Overall Study|Did not meet all I/E after screening|31|||
49136182|NCT02709369|158336729|FG000|Overall Study|Lost to Follow-up|15|||
49136183|NCT02709369|158336729|FG000|Overall Study|Withdrawal by Subject|10|||
49136184|NCT02709369|158336729|FG000|Overall Study|Did not received intervention|2|||
49136185|NCT01056536|158336732|FG000|Overall Study|Lost to Follow-up|202|||
49136186|NCT01056536|158336733|FG001|Overall Study|Lost to Follow-up|116|||
49136187|NCT01056536|158336734|FG002|Overall Study|Lost to Follow-up|248|||
49136188|NCT00975923|158336739|FG000|Overall Study|Withdrawal by Subject|0|||
49136189|NCT00975923|158336740|FG001|Overall Study|Withdrawal by Subject|1|||
49136190|NCT01564407|158336756|FG000|Overall Study|Lost to Follow-up|0|||
49136191|NCT01564407|158336757|FG001|Overall Study|Lost to Follow-up|1|||
49136192|NCT01564407|158336758|FG002|Overall Study|Lost to Follow-up|0|||
49136193|NCT01564407|158336759|FG003|Overall Study|Lost to Follow-up|0|||
49136194|NCT01564407|158336760|FG004|Overall Study|Lost to Follow-up|0|||
49136195|NCT01564407|158336756|FG000|Overall Study|Withdrawal by Subject|0|||
49136196|NCT01564407|158336757|FG001|Overall Study|Withdrawal by Subject|1|||
49136197|NCT01564407|158336758|FG002|Overall Study|Withdrawal by Subject|0|||
49136198|NCT01564407|158336759|FG003|Overall Study|Withdrawal by Subject|0|||
49136199|NCT01564407|158336760|FG004|Overall Study|Withdrawal by Subject|0|||
49136200|NCT01564407|158336756|FG000|Overall Study|funding lost, study ended|0|||
49136201|NCT01564407|158336757|FG001|Overall Study|funding lost, study ended|0|||
49136202|NCT01564407|158336758|FG002|Overall Study|funding lost, study ended|0|||
49136203|NCT01564407|158336759|FG003|Overall Study|funding lost, study ended|1|||
49136204|NCT01564407|158336760|FG004|Overall Study|funding lost, study ended|0|||
49136205|NCT01160614|158336761|FG000|Overall Study|Withdrawal by Subject|0|||
49136206|NCT01160614|158336762|FG001|Overall Study|Withdrawal by Subject|2|||
49136207|NCT00768053|158336764|FG000|Overall Study|Adverse Event|10|||
49136208|NCT00768053|158336764|FG000|Overall Study|Lost to Follow-up|1|||
49136209|NCT01452347|158336765|FG000|Overall Study|Adverse Event|2|||
49136210|NCT01452347|158336766|FG001|Overall Study|Adverse Event|1|||
49136211|NCT01452347|158336765|FG000|Overall Study|Non compliance protocol|2|||
49136212|NCT01452347|158336766|FG001|Overall Study|Non compliance protocol|0|||
49136213|NCT01452347|158336765|FG000|Overall Study|Lost to Follow-up|2|||
49136214|NCT01452347|158336766|FG001|Overall Study|Lost to Follow-up|0|||
49136215|NCT01452347|158336765|FG000|Overall Study|Withdrawal by Subject|3|||
49136216|NCT01452347|158336766|FG001|Overall Study|Withdrawal by Subject|3|||
49136217|NCT01452347|158336765|FG000|Overall Study|Not treated|6|||
49136218|NCT01452347|158336766|FG001|Overall Study|Not treated|3|||
49136219|NCT01452347|158336765|FG000|Overall Study|Other reason not defined above|2|||
49136220|NCT01452347|158336766|FG001|Overall Study|Other reason not defined above|0|||
49136221|NCT01179399|158336770|FG000|Overall Study|Adverse Event|1|||
49136222|NCT01179399|158336770|FG000|Overall Study|Lack of Efficacy|30|||
49136223|NCT01179399|158336770|FG000|Overall Study|Withdrawal by Subject|1|||
49136224|NCT03704688|158338572|FG000|Overall Study|Adverse Event|0|||
49136225|NCT03704688|158338573|FG001|Overall Study|Adverse Event|0|||
49136226|NCT03704688|158338574|FG002|Overall Study|Adverse Event|0|||
49136227|NCT03704688|158338575|FG003|Overall Study|Adverse Event|4|||
49136228|NCT03704688|158338576|FG004|Overall Study|Adverse Event|1|||
49136229|NCT03704688|158338577|FG005|Overall Study|Adverse Event|0|||
49136230|NCT03704688|158338572|FG000|Overall Study|Disease Progression|0|||
49136231|NCT03704688|158338573|FG001|Overall Study|Disease Progression|0|||
49136232|NCT03704688|158338574|FG002|Overall Study|Disease Progression|0|||
49136233|NCT03704688|158338575|FG003|Overall Study|Disease Progression|3|||
49136234|NCT03704688|158338576|FG004|Overall Study|Disease Progression|1|||
49136235|NCT03704688|158338577|FG005|Overall Study|Disease Progression|0|||
49136236|NCT03704688|158338572|FG000|Overall Study|Death|0|||
49136237|NCT03704688|158338573|FG001|Overall Study|Death|0|||
49136238|NCT03704688|158338574|FG002|Overall Study|Death|0|||
49136239|NCT03704688|158338575|FG003|Overall Study|Death|0|||
49136240|NCT03704688|158338576|FG004|Overall Study|Death|3|||
49136241|NCT03704688|158338577|FG005|Overall Study|Death|0|||
49136242|NCT00620542|158338578|FG000|Part A (Run-in - 2 Weeks)|Adverse Event|12|||
49136243|NCT00620542|158338579|FG001|Part A (Run-in - 2 Weeks)|Adverse Event|15|||
49136244|NCT00620542|158338580|FG002|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
49136245|NCT00620542|158338581|FG003|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
49136246|NCT00620542|158338578|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|406|||
48820782|NCT01458275|157185628|FG000|Overall Study|Adverse Event|3|||
48820783|NCT01458275|157185629|FG001|Overall Study|Adverse Event|4|||
48820784|NCT01458275|157185630|FG002|Overall Study|Adverse Event|1|||
48820785|NCT01458275|157185628|FG000|Overall Study|Lost to Follow-up|3|||
48820786|NCT01458275|157185629|FG001|Overall Study|Lost to Follow-up|2|||
48820787|NCT01458275|157185630|FG002|Overall Study|Lost to Follow-up|5|||
49136247|NCT00620542|158338579|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|409|||
49136248|NCT00620542|158338580|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
49136249|NCT00620542|158338581|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
49136250|NCT00620542|158338578|FG000|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43|||
49136251|NCT00620542|158338579|FG001|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40|||
49136252|NCT00620542|158338580|FG002|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
49136253|NCT00620542|158338581|FG003|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
49136254|NCT00620542|158338578|FG000|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7|||
49136255|NCT00620542|158338579|FG001|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6|||
48820788|NCT01458275|157185628|FG000|Overall Study|Protocol Violation|5|||
48820789|NCT01458275|157185629|FG001|Overall Study|Protocol Violation|5|||
48820790|NCT01458275|157185630|FG002|Overall Study|Protocol Violation|2|||
49136256|NCT00620542|158338580|FG002|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
49136257|NCT00620542|158338581|FG003|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
49136258|NCT00620542|158338578|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
49136259|NCT00620542|158338579|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|1|||
49136260|NCT00620542|158338580|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
49136261|NCT00620542|158338581|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
49136262|NCT00620542|158338578|FG000|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
49136263|NCT00620542|158338579|FG001|Part A (Run-in - 2 Weeks)|Safety reasons|1|||
49136264|NCT00620542|158338580|FG002|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
49136265|NCT00620542|158338581|FG003|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
49136266|NCT00620542|158338578|FG000|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
49136267|NCT00620542|158338579|FG001|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
49136268|NCT00620542|158338580|FG002|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
49136269|NCT00620542|158338581|FG003|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
49136270|NCT00620542|158338578|FG000|Part B (2 Year Core Study)|Adverse Event|0|||
49136271|NCT00620542|158338579|FG001|Part B (2 Year Core Study)|Adverse Event|0|||
49136272|NCT00620542|158338580|FG002|Part B (2 Year Core Study)|Adverse Event|46|||
49136273|NCT00620542|158338581|FG003|Part B (2 Year Core Study)|Adverse Event|49|||
49136274|NCT00620542|158338578|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
49136275|NCT00620542|158338579|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
49136276|NCT00620542|158338580|FG002|Part B (2 Year Core Study)|Protocol Violation|3|||
49136277|NCT00620542|158338581|FG003|Part B (2 Year Core Study)|Protocol Violation|5|||
49136278|NCT00620542|158338578|FG000|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
49136279|NCT00620542|158338579|FG001|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
49136280|NCT00620542|158338580|FG002|Part B (2 Year Core Study)|Withdrawal by Subject|55|||
49136281|NCT00620542|158338581|FG003|Part B (2 Year Core Study)|Withdrawal by Subject|54|||
49136282|NCT00620542|158338578|FG000|Part B (2 Year Core Study)|Lost to Follow-up|0|||
49136283|NCT00620542|158338579|FG001|Part B (2 Year Core Study)|Lost to Follow-up|0|||
49136284|NCT00620542|158338580|FG002|Part B (2 Year Core Study)|Lost to Follow-up|20|||
49136285|NCT00620542|158338581|FG003|Part B (2 Year Core Study)|Lost to Follow-up|9|||
49136286|NCT00620542|158338578|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
49136287|NCT00620542|158338579|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
49136288|NCT00620542|158338580|FG002|Part B (2 Year Core Study)|Protocol Violation|13|||
49136289|NCT00620542|158338581|FG003|Part B (2 Year Core Study)|Protocol Violation|16|||
49136290|NCT00620542|158338578|FG000|Part B (2 Year Core Study)|Safety reasons|0|||
49136291|NCT00620542|158338579|FG001|Part B (2 Year Core Study)|Safety reasons|0|||
49136292|NCT00620542|158338580|FG002|Part B (2 Year Core Study)|Safety reasons|2|||
49136293|NCT00620542|158338581|FG003|Part B (2 Year Core Study)|Safety reasons|3|||
49136294|NCT00620542|158338578|FG000|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
49136295|NCT00620542|158338579|FG001|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
49136296|NCT00620542|158338580|FG002|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
49136297|NCT00620542|158338581|FG003|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
49136298|NCT00620542|158338578|FG000|Part B (2 Year Core Study)|IVUS not available|0|||
49136299|NCT00620542|158338579|FG001|Part B (2 Year Core Study)|IVUS not available|0|||
49136300|NCT00620542|158338580|FG002|Part B (2 Year Core Study)|IVUS not available|3|||
49136301|NCT00620542|158338581|FG003|Part B (2 Year Core Study)|IVUS not available|2|||
49136302|NCT02911116|158338586|FG000|Overall Study|Insufficient Therapeutic Response|1|||
49136303|NCT02911116|158338587|FG001|Overall Study|Insufficient Therapeutic Response|0|||
49136304|NCT02911116|158338586|FG000|Overall Study|Lost to Follow-up|0|||
49136305|NCT02911116|158338587|FG001|Overall Study|Lost to Follow-up|1|||
49136306|NCT01482221|158338588|FG000|Overall Study|Lack of Efficacy|1|||
49136307|NCT01482221|158338589|FG001|Overall Study|Lack of Efficacy|0|||
49136308|NCT01482221|158338590|FG002|Overall Study|Lack of Efficacy|1|||
48820791|NCT01458275|157185628|FG000|Overall Study|Withdrawal by Subject|3|||
48820792|NCT01458275|157185629|FG001|Overall Study|Withdrawal by Subject|2|||
49136309|NCT01482221|158338588|FG000|Overall Study|Lost to Follow-up|3|||
49136310|NCT01482221|158338589|FG001|Overall Study|Lost to Follow-up|2|||
49136311|NCT01482221|158338590|FG002|Overall Study|Lost to Follow-up|1|||
49136312|NCT01482221|158338588|FG000|Overall Study|Study-Specific Withdrawal Criteria|2|||
49136313|NCT01482221|158338589|FG001|Overall Study|Study-Specific Withdrawal Criteria|0|||
49136314|NCT01482221|158338590|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
49136315|NCT01482221|158338588|FG000|Overall Study|Condition under Investigation Worsened|3|||
49136316|NCT01482221|158338589|FG001|Overall Study|Condition under Investigation Worsened|2|||
49136317|NCT01482221|158338590|FG002|Overall Study|Condition under Investigation Worsened|4|||
49136318|NCT01482221|158338588|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
48820793|NCT01458275|157185630|FG002|Overall Study|Withdrawal by Subject|1|||
49136319|NCT01482221|158338589|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
49136320|NCT01482221|158338590|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
49136321|NCT01482221|158338588|FG000|Overall Study|Adverse Event|1|||
49136322|NCT01482221|158338589|FG001|Overall Study|Adverse Event|7|||
49136323|NCT01482221|158338590|FG002|Overall Study|Adverse Event|3|||
49136324|NCT01482221|158338588|FG000|Overall Study|Withdrawal by Subject|10|||
49136325|NCT01482221|158338589|FG001|Overall Study|Withdrawal by Subject|7|||
49136326|NCT01482221|158338590|FG002|Overall Study|Withdrawal by Subject|12|||
49136327|NCT01482221|158338588|FG000|Overall Study|Incorrect randomization|0|||
49136328|NCT01482221|158338589|FG001|Overall Study|Incorrect randomization|1|||
49136329|NCT01482221|158338590|FG002|Overall Study|Incorrect randomization|0|||
49136330|NCT01482221|158338588|FG000|Overall Study|Physician Decision|0|||
49136331|NCT01482221|158338589|FG001|Overall Study|Physician Decision|1|||
49136332|NCT01482221|158338590|FG002|Overall Study|Physician Decision|0|||
49136333|NCT03677401|158338591|FG000|Overall Study|Adverse Event|4|||
49136334|NCT03677401|158338592|FG001|Overall Study|Adverse Event|14|||
49136335|NCT03677401|158338591|FG000|Overall Study|Lack of Efficacy|3|||
49136336|NCT03677401|158338592|FG001|Overall Study|Lack of Efficacy|1|||
49136337|NCT03677401|158338591|FG000|Overall Study|Withdrawal by Subject|2|||
49136338|NCT03677401|158338592|FG001|Overall Study|Withdrawal by Subject|2|||
49136339|NCT03677401|158338591|FG000|Overall Study|Sponsor decision|0|||
49136340|NCT03677401|158338592|FG001|Overall Study|Sponsor decision|1|||
49136341|NCT03677401|158338591|FG000|Overall Study|Reason Unspecified|1|||
49136342|NCT03677401|158338592|FG001|Overall Study|Reason Unspecified|0|||
49136343|NCT01510756|158338593|FG000|Overall Study|Death|1|||
49136344|NCT01510756|158338593|FG000|Overall Study|Lack of Efficacy|2|||
49136345|NCT01510756|158338593|FG000|Overall Study|Physician Decision|1|||
49136346|NCT02299167|158338596|FG000|Overall Study|patients were excluded from the study|11|||
49136347|NCT02320396|158338597|FG000|Overall Study|Adverse Event|2|||
48820794|NCT02419755|157185632|FG000|Overall Study|Death|1|||
49136348|NCT02320396|158338598|FG001|Overall Study|Adverse Event|2|||
49136349|NCT02320396|158338597|FG000|Overall Study|Pregnancy|0|||
49136350|NCT02320396|158338598|FG001|Overall Study|Pregnancy|1|||
49136351|NCT02320396|158338597|FG000|Overall Study|Protocol Violation|0|||
49136352|NCT02320396|158338598|FG001|Overall Study|Protocol Violation|1|||
49136353|NCT02320396|158338597|FG000|Overall Study|Withdrawal by Subject|2|||
49136354|NCT02320396|158338598|FG001|Overall Study|Withdrawal by Subject|0|||
49136355|NCT02606253|158338599|FG000|Overall Study|Adverse Event|2|||
49136356|NCT02606253|158338600|FG001|Overall Study|Adverse Event|0|||
49136357|NCT02606253|158338601|FG002|Overall Study|Adverse Event|0|||
49136358|NCT02606253|158338599|FG000|Overall Study|Protocol Violation|2|||
49136359|NCT02606253|158338600|FG001|Overall Study|Protocol Violation|1|||
49136360|NCT02606253|158338601|FG002|Overall Study|Protocol Violation|0|||
49136361|NCT02606253|158338599|FG000|Overall Study|Physician Decision|1|||
49136362|NCT02606253|158338600|FG001|Overall Study|Physician Decision|1|||
49136363|NCT02606253|158338601|FG002|Overall Study|Physician Decision|0|||
49136364|NCT02969018|158338607|FG000|Overall Study|Adverse Event|2|||
49136365|NCT02969018|158338608|FG001|Overall Study|Adverse Event|4|||
49136366|NCT02969018|158338609|FG002|Overall Study|Adverse Event|1|||
49136367|NCT02969018|158338610|FG003|Overall Study|Adverse Event|2|||
49136368|NCT02969018|158338611|FG004|Overall Study|Adverse Event|0|||
49136369|NCT02969018|158338612|FG005|Overall Study|Adverse Event|1|||
49136370|NCT02969018|158338613|FG006|Overall Study|Adverse Event|2|||
49136371|NCT02969018|158338614|FG007|Overall Study|Adverse Event|0|||
49136372|NCT02969018|158338607|FG000|Overall Study|Lack of Efficacy|0|||
49136373|NCT02969018|158338608|FG001|Overall Study|Lack of Efficacy|1|||
49136374|NCT02969018|158338609|FG002|Overall Study|Lack of Efficacy|0|||
49136375|NCT02969018|158338610|FG003|Overall Study|Lack of Efficacy|0|||
49136376|NCT02969018|158338611|FG004|Overall Study|Lack of Efficacy|1|||
49136377|NCT02969018|158338612|FG005|Overall Study|Lack of Efficacy|1|||
49136378|NCT02969018|158338613|FG006|Overall Study|Lack of Efficacy|1|||
49136379|NCT02969018|158338614|FG007|Overall Study|Lack of Efficacy|1|||
49136380|NCT02969018|158338607|FG000|Overall Study|Lost to Follow-up|1|||
49136381|NCT02969018|158338608|FG001|Overall Study|Lost to Follow-up|2|||
49136382|NCT02969018|158338609|FG002|Overall Study|Lost to Follow-up|2|||
49136383|NCT02969018|158338610|FG003|Overall Study|Lost to Follow-up|0|||
49136384|NCT02969018|158338611|FG004|Overall Study|Lost to Follow-up|1|||
49136385|NCT02969018|158338612|FG005|Overall Study|Lost to Follow-up|1|||
49136386|NCT02969018|158338613|FG006|Overall Study|Lost to Follow-up|0|||
49136387|NCT02969018|158338614|FG007|Overall Study|Lost to Follow-up|1|||
49136388|NCT02969018|158338607|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
49136389|NCT02969018|158338608|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
49136390|NCT02969018|158338609|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
49136391|NCT02969018|158338610|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
49136392|NCT02969018|158338611|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
49136393|NCT02969018|158338612|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
49136394|NCT02969018|158338613|FG006|Overall Study|No Longer Meets Eligibility Criteria|1|||
49136395|NCT02969018|158338614|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
49136396|NCT02969018|158338607|FG000|Overall Study|Non-Compliance With Study Drug|1|||
49136397|NCT02969018|158338608|FG001|Overall Study|Non-Compliance With Study Drug|0|||
49136398|NCT02969018|158338609|FG002|Overall Study|Non-Compliance With Study Drug|0|||
49136399|NCT02969018|158338610|FG003|Overall Study|Non-Compliance With Study Drug|0|||
49136400|NCT02969018|158338611|FG004|Overall Study|Non-Compliance With Study Drug|0|||
49136401|NCT02969018|158338612|FG005|Overall Study|Non-Compliance With Study Drug|0|||
49136402|NCT02969018|158338613|FG006|Overall Study|Non-Compliance With Study Drug|0|||
49136403|NCT02969018|158338614|FG007|Overall Study|Non-Compliance With Study Drug|0|||
49136404|NCT02969018|158338607|FG000|Overall Study|Other|0|||
49136405|NCT02969018|158338608|FG001|Overall Study|Other|0|||
49136406|NCT02969018|158338609|FG002|Overall Study|Other|0|||
49136407|NCT02969018|158338610|FG003|Overall Study|Other|1|||
49136408|NCT02969018|158338611|FG004|Overall Study|Other|0|||
49136409|NCT02969018|158338612|FG005|Overall Study|Other|0|||
49136410|NCT02969018|158338613|FG006|Overall Study|Other|0|||
49136411|NCT02969018|158338614|FG007|Overall Study|Other|2|||
49136412|NCT02969018|158338607|FG000|Overall Study|Pregnancy|0|||
49136413|NCT02969018|158338608|FG001|Overall Study|Pregnancy|0|||
49136414|NCT02969018|158338609|FG002|Overall Study|Pregnancy|0|||
49136415|NCT02969018|158338610|FG003|Overall Study|Pregnancy|0|||
49136416|NCT02969018|158338611|FG004|Overall Study|Pregnancy|0|||
49136417|NCT02969018|158338612|FG005|Overall Study|Pregnancy|1|||
49136418|NCT02969018|158338613|FG006|Overall Study|Pregnancy|0|||
49136419|NCT02969018|158338614|FG007|Overall Study|Pregnancy|0|||
49136420|NCT02969018|158338607|FG000|Overall Study|Protocol Violation|0|||
49136421|NCT02969018|158338608|FG001|Overall Study|Protocol Violation|0|||
49136422|NCT02969018|158338609|FG002|Overall Study|Protocol Violation|1|||
49136423|NCT02969018|158338610|FG003|Overall Study|Protocol Violation|1|||
49136424|NCT02969018|158338611|FG004|Overall Study|Protocol Violation|0|||
49136425|NCT02969018|158338612|FG005|Overall Study|Protocol Violation|0|||
49136426|NCT02969018|158338613|FG006|Overall Study|Protocol Violation|0|||
49136427|NCT02969018|158338614|FG007|Overall Study|Protocol Violation|0|||
49136428|NCT02969018|158338607|FG000|Overall Study|Withdrawal by Subject|0|||
49136429|NCT02969018|158338608|FG001|Overall Study|Withdrawal by Subject|1|||
49136430|NCT02969018|158338609|FG002|Overall Study|Withdrawal by Subject|2|||
49136431|NCT02969018|158338610|FG003|Overall Study|Withdrawal by Subject|1|||
49136432|NCT02969018|158338611|FG004|Overall Study|Withdrawal by Subject|0|||
48726202|NCT00084838|156847869|FG000|Overall Study|Adverse Event|2|||
48726203|NCT00084838|156847869|FG000|Overall Study|Withdrawal by Subject|1|||
48820795|NCT02419755|157185633|FG001|Overall Study|Death|3|||
48820796|NCT02419755|157185632|FG000|Overall Study|Relapse|0|||
48820797|NCT02419755|157185633|FG001|Overall Study|Relapse|1|||
48820798|NCT02419755|157185632|FG000|Overall Study|Ineligible|1|||
48820799|NCT02419755|157185633|FG001|Overall Study|Ineligible|0|||
48820800|NCT02419755|157185632|FG000|Overall Study|Withdrawal by Subject|1|||
48820801|NCT02419755|157185633|FG001|Overall Study|Withdrawal by Subject|0|||
48820802|NCT01959880|157185635|FG000|Overall Study|Withdrawal by Subject|11|||
48820803|NCT01959880|157185636|FG001|Overall Study|Withdrawal by Subject|13|||
48820804|NCT01959880|157185637|FG002|Overall Study|Withdrawal by Subject|8|||
48820805|NCT01959880|157185638|FG003|Overall Study|Withdrawal by Subject|7|||
48820806|NCT01959880|157185635|FG000|Overall Study|Death|1|||
48820807|NCT01959880|157185636|FG001|Overall Study|Death|10|||
48820808|NCT01959880|157185637|FG002|Overall Study|Death|1|||
48820809|NCT01959880|157185638|FG003|Overall Study|Death|2|||
48820810|NCT01959880|157185635|FG000|Overall Study|Lost to Follow-up|95|||
48820811|NCT01959880|157185636|FG001|Overall Study|Lost to Follow-up|18|||
48820812|NCT01959880|157185637|FG002|Overall Study|Lost to Follow-up|15|||
48820813|NCT01959880|157185638|FG003|Overall Study|Lost to Follow-up|8|||
48820814|NCT01959880|157185635|FG000|Overall Study|Explantation w/o study device reimplant.|22|||
48820815|NCT01959880|157185636|FG001|Overall Study|Explantation w/o study device reimplant.|17|||
48820816|NCT01959880|157185637|FG002|Overall Study|Explantation w/o study device reimplant.|5|||
48820817|NCT01959880|157185638|FG003|Overall Study|Explantation w/o study device reimplant.|12|||
48820818|NCT01959880|157185635|FG000|Overall Study|Study completed early-FDA approved|1003|||
48726204|NCT00084838|156847869|FG000|Overall Study|Progressive Disease|4|||
48726205|NCT00084838|156847869|FG000|Overall Study|Pt Non-Compliance|1|||
48726206|NCT00084838|156847869|FG000|Overall Study|Ineligible|4|||
48726207|NCT01757691|156847870|FG000|Overall Study|Administrative problems|2|||
48726208|NCT01757691|156847871|FG001|Overall Study|Administrative problems|0|||
48726209|NCT00400946|156847878|FG000|Overall Study|Ineligible|0|||
48726210|NCT00400946|156847879|FG001|Overall Study|Ineligible|0|||
48726211|NCT00400946|156847880|FG002|Overall Study|Ineligible|0|||
48726212|NCT00400946|156847881|FG003|Overall Study|Ineligible|5|||
48820819|NCT01959880|157185636|FG001|Overall Study|Study completed early-FDA approved|311|||
48820820|NCT01959880|157185637|FG002|Overall Study|Study completed early-FDA approved|179|||
48820821|NCT01959880|157185638|FG003|Overall Study|Study completed early-FDA approved|152|||
48820822|NCT03418740|157185639|FG000|Overall Study|Lost to Follow-up|13|||
48820823|NCT03418740|157185639|FG000|Overall Study|Scheduling Issues|7|||
48726213|NCT00400946|156847882|FG004|Overall Study|Ineligible|1|||
48820824|NCT03418740|157185639|FG000|Overall Study|Withdrawal by Subject|2|||
48820825|NCT03418740|157185639|FG000|Overall Study|Unable to Continue Consent|1|||
48820826|NCT04535414|157185640|FG000|Overall Study|Taken off study due to principal investigator (PI) discretion.|1|||
49011280|NCT00830063|157878906|FG002|Overall Study|Other|8|||
49011281|NCT00830063|157878907|FG003|Overall Study|Other|6|||
49011282|NCT00830063|157878904|FG000|Overall Study|Withdrawal by Subject|16|||
49011283|NCT00830063|157878905|FG001|Overall Study|Withdrawal by Subject|10|||
49011284|NCT00830063|157878906|FG002|Overall Study|Withdrawal by Subject|16|||
49011285|NCT00830063|157878907|FG003|Overall Study|Withdrawal by Subject|13|||
49011286|NCT00830063|157878904|FG000|Overall Study|Protocol Violation|1|||
49011287|NCT00830063|157878905|FG001|Overall Study|Protocol Violation|0|||
49011288|NCT00830063|157878906|FG002|Overall Study|Protocol Violation|3|||
49011289|NCT00830063|157878907|FG003|Overall Study|Protocol Violation|2|||
49011290|NCT00830063|157878904|FG000|Overall Study|Randomized But Not Treated|0|||
49011291|NCT00830063|157878905|FG001|Overall Study|Randomized But Not Treated|2|||
49136433|NCT02969018|158338612|FG005|Overall Study|Withdrawal by Subject|4|||
49136434|NCT02969018|158338613|FG006|Overall Study|Withdrawal by Subject|4|||
49136435|NCT02969018|158338614|FG007|Overall Study|Withdrawal by Subject|3|||
49136436|NCT00112957|158338615|FG000|Overall Study|Progressive disease|18|||
49136437|NCT00112957|158338615|FG000|Overall Study|Physician Decision|1|||
49136438|NCT02313155|158338621|FG000|Overall Study|Lost to Follow-up|0|||
49136439|NCT02313155|158338622|FG001|Overall Study|Lost to Follow-up|1|||
49136440|NCT01044498|158338626|FG000|Overall Study|Withdrew consent|1|||
49136441|NCT01044498|158338627|FG001|Overall Study|Withdrew consent|1|||
49136442|NCT01044498|158338626|FG000|Overall Study|Adverse Event|1|||
49136443|NCT01044498|158338627|FG001|Overall Study|Adverse Event|1|||
49136444|NCT01044498|158338626|FG000|Overall Study|Other|1|||
49136445|NCT01044498|158338627|FG001|Overall Study|Other|0|||
49136446|NCT00724893|158338628|FG000|Overall Study|Adverse Event|76|||
49136447|NCT00724893|158338629|FG001|Overall Study|Adverse Event|142|||
49136448|NCT00724893|158338628|FG000|Overall Study|Withdrawal by Subject|0|||
49136449|NCT00724893|158338629|FG001|Overall Study|Withdrawal by Subject|1|||
49136450|NCT00724893|158338628|FG000|Overall Study|Lack of virologic response|94|||
49136451|NCT00724893|158338629|FG001|Overall Study|Lack of virologic response|202|||
49136452|NCT00724893|158338628|FG000|Overall Study|Reason not specified|193|||
49136453|NCT00724893|158338629|FG001|Overall Study|Reason not specified|7|||
49136454|NCT00724893|158338628|FG000|Overall Study|Patient choice|0|||
49136455|NCT00724893|158338629|FG001|Overall Study|Patient choice|26|||
49136456|NCT00724893|158338628|FG000|Overall Study|Geographic reasons|0|||
49136457|NCT00724893|158338629|FG001|Overall Study|Geographic reasons|11|||
49136458|NCT00724893|158338628|FG000|Overall Study|Incarceration|0|||
49136459|NCT00724893|158338629|FG001|Overall Study|Incarceration|9|||
49136460|NCT00724893|158338628|FG000|Overall Study|Substance abuse|0|||
49136461|NCT00724893|158338629|FG001|Overall Study|Substance abuse|3|||
49136462|NCT00724893|158338628|FG000|Overall Study|Financial reasons|0|||
49136463|NCT00724893|158338629|FG001|Overall Study|Financial reasons|2|||
49136464|NCT00724893|158338628|FG000|Overall Study|Assigned shorter treatment|0|||
49136465|NCT00724893|158338629|FG001|Overall Study|Assigned shorter treatment|2|||
49136466|NCT00724893|158338628|FG000|Overall Study|Lost to Follow-up|0|||
49136467|NCT00724893|158338629|FG001|Overall Study|Lost to Follow-up|52|||
49136468|NCT00724893|158338628|FG000|Overall Study|Unknown, missing data|1|||
49136469|NCT00724893|158338629|FG001|Overall Study|Unknown, missing data|1|||
49136470|NCT01860404|158338630|FG000|Overall Study|Lost to Follow-up|3|||
49136471|NCT01860404|158338631|FG001|Overall Study|Lost to Follow-up|4|||
49136472|NCT01860404|158338632|FG002|Overall Study|Lost to Follow-up|1|||
49136473|NCT01860404|158338633|FG003|Overall Study|Lost to Follow-up|6|||
49136474|NCT01860404|158338634|FG004|Overall Study|Lost to Follow-up|4|||
49136475|NCT01860404|158338630|FG000|Overall Study|Withdrawal by Subject|0|||
49136476|NCT01860404|158338631|FG001|Overall Study|Withdrawal by Subject|0|||
49136477|NCT01860404|158338632|FG002|Overall Study|Withdrawal by Subject|4|||
49136478|NCT01860404|158338633|FG003|Overall Study|Withdrawal by Subject|0|||
48820827|NCT04535414|157185641|FG001|Overall Study|Taken off study due to principal investigator (PI) discretion.|0|||
48820828|NCT04535414|157185640|FG000|Overall Study|Cancelled appointment|1|||
48820829|NCT04535414|157185641|FG001|Overall Study|Cancelled appointment|0|||
48820830|NCT04535414|157185640|FG000|Overall Study|cancelled - food in stomach|2|||
48820831|NCT04535414|157185641|FG001|Overall Study|cancelled - food in stomach|0|||
48820832|NCT04535414|157185640|FG000|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
48820833|NCT04535414|157185641|FG001|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
48820834|NCT04535414|157185640|FG000|Overall Study|Withdrawal by Subject|0|||
48820835|NCT04535414|157185641|FG001|Overall Study|Withdrawal by Subject|1|||
48820836|NCT00619476|157187304|FG000|Overall Study|Adverse Event|12|||
48820837|NCT00619476|157187305|FG001|Overall Study|Adverse Event|6|||
48820838|NCT00619476|157187306|FG002|Overall Study|Adverse Event|12|||
48820839|NCT00619476|157187307|FG003|Overall Study|Adverse Event|16|||
49136479|NCT01860404|158338634|FG004|Overall Study|Withdrawal by Subject|0|||
49136480|NCT01910441|158338635|FG000|Overall Study|Sponsor decision|0|||
49136481|NCT01910441|158338636|FG001|Overall Study|Sponsor decision|2|||
48820840|NCT00619476|157187304|FG000|Overall Study|Lack of Efficacy|6|||
49136482|NCT01910441|158338635|FG000|Overall Study|Lost to Follow-up|6|||
49136483|NCT01910441|158338636|FG001|Overall Study|Lost to Follow-up|5|||
49136484|NCT01910441|158338635|FG000|Overall Study|Withdrawal by Subject|0|||
49136485|NCT01910441|158338636|FG001|Overall Study|Withdrawal by Subject|1|||
49136486|NCT01910441|158338635|FG000|Overall Study|Non-compliance|0|||
49136487|NCT01910441|158338636|FG001|Overall Study|Non-compliance|1|||
49136488|NCT01910441|158338635|FG000|Overall Study|Adverse Event|1|||
49136489|NCT01910441|158338636|FG001|Overall Study|Adverse Event|0|||
48820841|NCT00619476|157187305|FG001|Overall Study|Lack of Efficacy|1|||
48820842|NCT00619476|157187306|FG002|Overall Study|Lack of Efficacy|1|||
49136490|NCT01910441|158338635|FG000|Overall Study|Physician Decision|0|||
49136491|NCT01910441|158338636|FG001|Overall Study|Physician Decision|1|||
49136492|NCT02949934|158338641|FG000|Natural Drinking Period|Adverse Event|1|||
49136493|NCT02949934|158338642|FG001|Natural Drinking Period|Adverse Event|0|||
49136494|NCT02949934|158338643|FG002|Natural Drinking Period|Adverse Event|0|||
48820843|NCT00619476|157187307|FG003|Overall Study|Lack of Efficacy|4|||
48820844|NCT00619476|157187304|FG000|Overall Study|Protocol Violation|5|||
48820845|NCT00619476|157187305|FG001|Overall Study|Protocol Violation|4|||
48820846|NCT00619476|157187306|FG002|Overall Study|Protocol Violation|4|||
48820847|NCT00619476|157187307|FG003|Overall Study|Protocol Violation|9|||
48820848|NCT00619476|157187304|FG000|Overall Study|Lost to Follow-up|1|||
48820849|NCT00619476|157187305|FG001|Overall Study|Lost to Follow-up|2|||
48820850|NCT00619476|157187306|FG002|Overall Study|Lost to Follow-up|0|||
48820851|NCT00619476|157187307|FG003|Overall Study|Lost to Follow-up|1|||
48820852|NCT00619476|157187304|FG000|Overall Study|Investigator Discretion|2|||
48820853|NCT00619476|157187305|FG001|Overall Study|Investigator Discretion|2|||
48820854|NCT00619476|157187306|FG002|Overall Study|Investigator Discretion|2|||
48820855|NCT00619476|157187307|FG003|Overall Study|Investigator Discretion|0|||
48820856|NCT00619476|157187304|FG000|Overall Study|Withdrawal by Subject|5|||
48820857|NCT00619476|157187305|FG001|Overall Study|Withdrawal by Subject|7|||
48820858|NCT00619476|157187306|FG002|Overall Study|Withdrawal by Subject|5|||
48820859|NCT00619476|157187307|FG003|Overall Study|Withdrawal by Subject|4|||
48820860|NCT00795132|157187310|FG000|Overall Study|Death|1|||
48820861|NCT00795132|157187310|FG000|Overall Study|Relapse|2|||
48820862|NCT02403674|157187311|FG000|Base Study|Death|1|||
48820863|NCT02403674|157187312|FG001|Base Study|Death|4|||
48820864|NCT02403674|157187311|FG000|Base Study|Adverse Event|11|||
48820865|NCT02403674|157187312|FG001|Base Study|Adverse Event|26|||
48820866|NCT02403674|157187311|FG000|Base Study|Lack of Efficacy|31|||
48820867|NCT02403674|157187312|FG001|Base Study|Lack of Efficacy|23|||
48820868|NCT02403674|157187311|FG000|Base Study|Lost to Follow-up|6|||
48820869|NCT02403674|157187312|FG001|Base Study|Lost to Follow-up|8|||
48820870|NCT02403674|157187311|FG000|Base Study|Withdrawal by Subject|10|||
48820871|NCT02403674|157187312|FG001|Base Study|Withdrawal by Subject|17|||
48820872|NCT02403674|157187311|FG000|Base Study|Physician Decision|2|||
49136495|NCT02949934|158338644|FG003|Natural Drinking Period|Adverse Event|1|||
49136496|NCT02949934|158338645|FG004|Natural Drinking Period|Adverse Event|0|||
49136497|NCT02949934|158338646|FG005|Natural Drinking Period|Adverse Event|0|||
49136498|NCT02949934|158338641|FG000|Natural Drinking Period|Lost to Follow-up|0|||
49136499|NCT02949934|158338642|FG001|Natural Drinking Period|Lost to Follow-up|0|||
49136500|NCT02949934|158338643|FG002|Natural Drinking Period|Lost to Follow-up|0|||
49136501|NCT02949934|158338644|FG003|Natural Drinking Period|Lost to Follow-up|0|||
49136502|NCT02949934|158338645|FG004|Natural Drinking Period|Lost to Follow-up|1|||
49136503|NCT02949934|158338646|FG005|Natural Drinking Period|Lost to Follow-up|0|||
49136504|NCT02949934|158338641|FG000|Neuroimaging|Protocol Violation|2|||
49136505|NCT02949934|158338642|FG001|Neuroimaging|Protocol Violation|0|||
49136506|NCT02949934|158338643|FG002|Neuroimaging|Protocol Violation|0|||
49136507|NCT02949934|158338644|FG003|Neuroimaging|Protocol Violation|0|||
49136508|NCT02949934|158338645|FG004|Neuroimaging|Protocol Violation|1|||
49136509|NCT02949934|158338646|FG005|Neuroimaging|Protocol Violation|0|||
49136510|NCT02949934|158338641|FG000|Neuroimaging|Motion artifacts in imaging data|1|||
49136511|NCT02949934|158338642|FG001|Neuroimaging|Motion artifacts in imaging data|0|||
49136512|NCT02949934|158338643|FG002|Neuroimaging|Motion artifacts in imaging data|1|||
49136513|NCT02949934|158338644|FG003|Neuroimaging|Motion artifacts in imaging data|0|||
49136514|NCT02949934|158338645|FG004|Neuroimaging|Motion artifacts in imaging data|1|||
49136515|NCT02949934|158338646|FG005|Neuroimaging|Motion artifacts in imaging data|0|||
49136516|NCT02949934|158338641|FG000|Neuroimaging|Not scanned|0|||
48820873|NCT02403674|157187312|FG001|Base Study|Physician Decision|2|||
48820874|NCT02403674|157187311|FG000|Base Study|Pregnancy|2|||
48820875|NCT02403674|157187312|FG001|Base Study|Pregnancy|2|||
48820876|NCT02403674|157187311|FG000|Base Study|Protocol Violation|8|||
48820877|NCT02403674|157187312|FG001|Base Study|Protocol Violation|4|||
48820878|NCT02403674|157187311|FG000|Base Study|Non-Compliance with study drug|1|||
48820879|NCT02403674|157187312|FG001|Base Study|Non-Compliance with study drug|4|||
48820880|NCT02403674|157187311|FG000|Study Extension 1 (Open-Label)|Adverse Event|1|||
49136517|NCT02949934|158338642|FG001|Neuroimaging|Not scanned|0|||
49136518|NCT02949934|158338643|FG002|Neuroimaging|Not scanned|1|||
48820881|NCT02403674|157187312|FG001|Study Extension 1 (Open-Label)|Adverse Event|4|||
48820882|NCT02403674|157187311|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|10|||
48921043|NCT01079182|157544821|FG000|Overall Study|Reasons not Evaluated|271|||
49136519|NCT02949934|158338644|FG003|Neuroimaging|Not scanned|0|||
49136520|NCT02949934|158338645|FG004|Neuroimaging|Not scanned|0|||
49136521|NCT02949934|158338646|FG005|Neuroimaging|Not scanned|2|||
49136522|NCT02949934|158338641|FG000|Bar Laboratory|Procedure not done due to COVID-19 pandemic|0|||
48820883|NCT02403674|157187312|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|13|||
48820884|NCT02403674|157187311|FG000|Study Extension 1 (Open-Label)|Lost to Follow-up|8|||
48820885|NCT02403674|157187312|FG001|Study Extension 1 (Open-Label)|Lost to Follow-up|5|||
48820886|NCT02403674|157187311|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|11|||
48820887|NCT02403674|157187312|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|13|||
49136523|NCT02949934|158338642|FG001|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
48820888|NCT02403674|157187311|FG000|Study Extension 1 (Open-Label)|Physician Decision|2|||
48820889|NCT02403674|157187312|FG001|Study Extension 1 (Open-Label)|Physician Decision|5|||
48726214|NCT00400946|156847878|FG000|Overall Study|Induction Failure|0|||
48726215|NCT00400946|156847879|FG001|Overall Study|Induction Failure|0|||
48726216|NCT00400946|156847880|FG002|Overall Study|Induction Failure|0|||
48726217|NCT00400946|156847881|FG003|Overall Study|Induction Failure|11|||
48726218|NCT00400946|156847882|FG004|Overall Study|Induction Failure|8|||
48726219|NCT00400946|156847878|FG000|Overall Study|Induction Death|0|||
48726220|NCT00400946|156847879|FG001|Overall Study|Induction Death|0|||
48726221|NCT00400946|156847880|FG002|Overall Study|Induction Death|0|||
48726222|NCT00400946|156847881|FG003|Overall Study|Induction Death|13|||
48726223|NCT00400946|156847882|FG004|Overall Study|Induction Death|3|||
49136524|NCT02949934|158338643|FG002|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
49136525|NCT02949934|158338644|FG003|Bar Laboratory|Procedure not done due to COVID-19 pandemic|3|||
48726224|NCT00400946|156847878|FG000|Overall Study|Lost to Follow-up|1|||
48726225|NCT00400946|156847879|FG001|Overall Study|Lost to Follow-up|1|||
48726226|NCT00400946|156847880|FG002|Overall Study|Lost to Follow-up|0|||
48726227|NCT00400946|156847881|FG003|Overall Study|Lost to Follow-up|0|||
48820890|NCT02403674|157187311|FG000|Study Extension 1 (Open-Label)|Pregnancy|4|||
48820891|NCT02403674|157187312|FG001|Study Extension 1 (Open-Label)|Pregnancy|2|||
48820892|NCT02403674|157187311|FG000|Study Extension 1 (Open-Label)|Death|1|||
48820893|NCT02403674|157187312|FG001|Study Extension 1 (Open-Label)|Death|0|||
48820894|NCT02403674|157187311|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|22|||
48820895|NCT02403674|157187312|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|19|||
48820896|NCT02403674|157187311|FG000|Study Extension 1 (Open-Label)|Non-Compliance|2|||
48820897|NCT02403674|157187312|FG001|Study Extension 1 (Open-Label)|Non-Compliance|3|||
48726228|NCT00400946|156847882|FG004|Overall Study|Lost to Follow-up|1|||
48726229|NCT00400946|156847878|FG000|Overall Study|Remission Death|1|||
48726230|NCT00400946|156847879|FG001|Overall Study|Remission Death|1|||
48726231|NCT00400946|156847880|FG002|Overall Study|Remission Death|0|||
48726232|NCT00400946|156847881|FG003|Overall Study|Remission Death|0|||
48726233|NCT00400946|156847882|FG004|Overall Study|Remission Death|1|||
48726234|NCT00400946|156847878|FG000|Overall Study|Relapse|9|||
48726235|NCT00400946|156847879|FG001|Overall Study|Relapse|2|||
48726236|NCT00400946|156847880|FG002|Overall Study|Relapse|1|||
48726237|NCT00400946|156847881|FG003|Overall Study|Relapse|1|||
48726238|NCT00400946|156847882|FG004|Overall Study|Relapse|5|||
48726239|NCT00400946|156847878|FG000|Overall Study|Transplant in CR1|0|||
48726240|NCT00400946|156847879|FG001|Overall Study|Transplant in CR1|0|||
48726241|NCT00400946|156847880|FG002|Overall Study|Transplant in CR1|0|||
48726242|NCT00400946|156847881|FG003|Overall Study|Transplant in CR1|10|||
48726243|NCT00400946|156847882|FG004|Overall Study|Transplant in CR1|1|||
48726244|NCT00400946|156847878|FG000|Overall Study|Withdrawal by Subject|2|||
48726245|NCT00400946|156847879|FG001|Overall Study|Withdrawal by Subject|5|||
48726246|NCT00400946|156847880|FG002|Overall Study|Withdrawal by Subject|1|||
48726247|NCT00400946|156847881|FG003|Overall Study|Withdrawal by Subject|5|||
48726248|NCT00400946|156847882|FG004|Overall Study|Withdrawal by Subject|8|||
48726249|NCT00400946|156847878|FG000|Overall Study|Clinical|1|||
48726250|NCT00400946|156847879|FG001|Overall Study|Clinical|2|||
48726251|NCT00400946|156847880|FG002|Overall Study|Clinical|0|||
48726252|NCT00400946|156847881|FG003|Overall Study|Clinical|2|||
48726253|NCT00400946|156847882|FG004|Overall Study|Clinical|9|||
48726254|NCT00400946|156847878|FG000|Overall Study|Other|0|||
48726255|NCT00400946|156847879|FG001|Overall Study|Other|0|||
48726256|NCT00400946|156847880|FG002|Overall Study|Other|0|||
48726257|NCT00400946|156847881|FG003|Overall Study|Other|0|||
48726258|NCT00400946|156847882|FG004|Overall Study|Other|1|||
48820898|NCT02403674|157187311|FG000|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
48820899|NCT02403674|157187312|FG001|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
48820900|NCT02403674|157187311|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
48726259|NCT00814879|156847884|FG000|By Week 24|Cancer Diagnosis|1|||
48726260|NCT00814879|156847885|FG001|By Week 24|Cancer Diagnosis|0|||
48726261|NCT00814879|156847884|FG000|By Week 24|Incarceration|0|||
48726262|NCT00814879|156847885|FG001|By Week 24|Incarceration|1|||
48726263|NCT00814879|156847884|FG000|By Week 48|Lost to Follow-up|2|||
48820901|NCT02403674|157187312|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|7|||
48820902|NCT02403674|157187311|FG000|Study Extension 2 (Open-Label)|Withdrawal by Subject|8|||
48921044|NCT01026831|157544822|FG000|Overall Study|Adverse Event|4|||
48726264|NCT00814879|156847885|FG001|By Week 48|Lost to Follow-up|2|||
48726265|NCT00814879|156847884|FG000|By Week 48|Death|0|||
48726266|NCT00814879|156847885|FG001|By Week 48|Death|1|||
48726267|NCT00920907|156847886|FG000|Induction Period|Adverse Event|0|||
48726268|NCT00920907|156847887|FG001|Induction Period|Adverse Event|2|||
48726269|NCT00920907|156847886|FG000|Induction Period|Death|1|||
48726270|NCT00920907|156847887|FG001|Induction Period|Death|1|||
48726271|NCT00920907|156847886|FG000|Induction Period|Disease Progression|12|||
48726272|NCT00920907|156847887|FG001|Induction Period|Disease Progression|11|||
48726273|NCT00920907|156847886|FG000|Induction Period|Study Drug Toxicity|8|||
48820903|NCT02403674|157187312|FG001|Study Extension 2 (Open-Label)|Withdrawal by Subject|6|||
48726274|NCT00920907|156847887|FG001|Induction Period|Study Drug Toxicity|6|||
48726275|NCT00920907|156847886|FG000|Induction Period|No longer meets study criteria|0|||
48726276|NCT00920907|156847887|FG001|Induction Period|No longer meets study criteria|1|||
48726277|NCT00920907|156847886|FG000|Induction Period|Withdrawal by Subject|1|||
48726278|NCT00920907|156847887|FG001|Induction Period|Withdrawal by Subject|1|||
48726279|NCT00920907|156847886|FG000|Maintenance Period|Disease Progression|3|||
48726280|NCT00920907|156847887|FG001|Maintenance Period|Disease Progression|7|||
48726281|NCT00920907|156847886|FG000|Maintenance Period|Administrative (study closure)|7|||
48726282|NCT00920907|156847887|FG001|Maintenance Period|Administrative (study closure)|2|||
48726283|NCT00920907|156847886|FG000|Maintenance Period|Study Drug Toxicity|0|||
48726284|NCT00920907|156847887|FG001|Maintenance Period|Study Drug Toxicity|2|||
48726285|NCT00920907|156847886|FG000|Maintenance Period|Death|1|||
48726286|NCT00920907|156847887|FG001|Maintenance Period|Death|1|||
48726287|NCT00920907|156847886|FG000|Maintenance Period|Withdrawal by Subject|1|||
48726288|NCT00920907|156847887|FG001|Maintenance Period|Withdrawal by Subject|0|||
48726289|NCT00920907|156847886|FG000|Maintenance Period|Adverse Event|0|||
48726290|NCT00920907|156847887|FG001|Maintenance Period|Adverse Event|1|||
48726291|NCT01275339|156847890|FG000|Overall Study|Referred for surgery for AS symptoms|1|||
48726292|NCT01275339|156847891|FG001|Overall Study|Referred for surgery for AS symptoms|0|||
48726293|NCT01275339|156847892|FG002|Overall Study|Referred for surgery for AS symptoms|0|||
48726294|NCT01275339|156847893|FG003|Overall Study|Referred for surgery for AS symptoms|0|||
48726295|NCT01275339|156847890|FG000|Overall Study|Withdrawal by Subject|0|||
48726296|NCT01275339|156847891|FG001|Overall Study|Withdrawal by Subject|0|||
48726297|NCT01275339|156847892|FG002|Overall Study|Withdrawal by Subject|1|||
48726298|NCT01275339|156847893|FG003|Overall Study|Withdrawal by Subject|0|||
48726299|NCT01362595|156847894|FG000|Overall Study|Screen failure|10|||
48726300|NCT01362595|156847894|FG000|Overall Study|Withdrawal by Subject|2|||
48726301|NCT01475071|156847895|FG000|Overall Study|Physician Decision|1|||
48726302|NCT01475071|156847895|FG000|Overall Study|Withdrawal by Subject|6|||
48726303|NCT01475071|156847895|FG000|Overall Study|Lost to Follow-up|1|||
48726304|NCT01736657|156847898|FG000|Overall Study|insufficient vascular access|1|||
48726305|NCT01205581|156847899|FG000|Overall Study|Withdrawal by Subject|1|||
48726306|NCT01205581|156847900|FG001|Overall Study|Withdrawal by Subject|0|||
48726307|NCT01205581|156847901|FG002|Overall Study|Withdrawal by Subject|0|||
48726308|NCT01205581|156847902|FG003|Overall Study|Withdrawal by Subject|0|||
48726309|NCT01205581|156847903|FG004|Overall Study|Withdrawal by Subject|0|||
48726310|NCT01205581|156847904|FG005|Overall Study|Withdrawal by Subject|0|||
48726311|NCT03468543|156847905|FG000|Overall Study|Protocol stopping rules met|3|||
48726312|NCT01236118|156847907|FG000|Overall Study|Adverse Event|2|||
48726313|NCT01236118|156847908|FG001|Overall Study|Adverse Event|0|||
48726314|NCT01236118|156847909|FG002|Overall Study|Adverse Event|2|||
48726315|NCT01236118|156847907|FG000|Overall Study|Physician Decision|0|||
48726316|NCT01236118|156847908|FG001|Overall Study|Physician Decision|1|||
48726317|NCT01236118|156847909|FG002|Overall Study|Physician Decision|0|||
48726318|NCT01236118|156847907|FG000|Overall Study|Withdrawal by Subject|0|||
48726319|NCT01236118|156847908|FG001|Overall Study|Withdrawal by Subject|0|||
48726320|NCT01236118|156847909|FG002|Overall Study|Withdrawal by Subject|1|||
48726321|NCT04972630|156847914|FG000|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
48726322|NCT04972630|156847915|FG001|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
48726323|NCT04972630|156847916|FG002|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|0|||
48726324|NCT00397943|156847917|FG000|Overall Study|Unspecified reasons|12|||
48726325|NCT00397943|156847918|FG001|Overall Study|Unspecified reasons|9|||
48726326|NCT00397943|156847919|FG002|Overall Study|Unspecified reasons|0|||
48726327|NCT00397943|156847920|FG003|Overall Study|Unspecified reasons|0|||
48726328|NCT00397943|156847921|FG004|Overall Study|Unspecified reasons|0|||
49136526|NCT02949934|158338645|FG004|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
48726329|NCT04251156|156847923|FG000|Overall Study|Lost to Follow-up|1|||
48726330|NCT04251156|156847924|FG001|Overall Study|Lost to Follow-up|1|||
48726331|NCT04251156|156847923|FG000|Overall Study|Withdrawal by Subject|4|||
48726332|NCT04251156|156847924|FG001|Overall Study|Withdrawal by Subject|4|||
48726333|NCT04626310|156847925|FG000|Overall Study|4-miss from treatment|6|||
48726334|NCT04626310|156847926|FG001|Overall Study|4-miss from treatment|5|||
48726335|NCT04626310|156847927|FG002|Overall Study|4-miss from treatment|5|||
48726336|NCT04626310|156847925|FG000|Overall Study|Withdrawal by Subject|1|||
48726337|NCT04626310|156847926|FG001|Overall Study|Withdrawal by Subject|0|||
48726338|NCT04626310|156847927|FG002|Overall Study|Withdrawal by Subject|3|||
48726339|NCT02604017|156847929|FG000|Overall Study|Withdrew Consent|0|||
48726340|NCT02604017|156847930|FG001|Overall Study|Withdrew Consent|2|||
48726341|NCT02604017|156847929|FG000|Overall Study|Lost to Follow-up|5|||
48726342|NCT02604017|156847930|FG001|Overall Study|Lost to Follow-up|6|||
48726343|NCT02604017|156847929|FG000|Overall Study|Other|1|||
48726344|NCT02604017|156847930|FG001|Overall Study|Other|0|||
48726345|NCT02195687|156847933|FG000|Overall Study|Personal Reasons|1|||
49136527|NCT02949934|158338646|FG005|Bar Laboratory|Procedure not done due to COVID-19 pandemic|1|||
49136528|NCT02949934|158338641|FG000|Bar Laboratory|Adverse Event|1|||
48820904|NCT02403674|157187311|FG000|Study Extension 2 (Open-Label)|Physician Decision|1|||
48820905|NCT02403674|157187312|FG001|Study Extension 2 (Open-Label)|Physician Decision|1|||
48820906|NCT02403674|157187311|FG000|Study Extension 2 (Open-Label)|Pregnancy|0|||
48820907|NCT02403674|157187312|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
48820908|NCT02403674|157187311|FG000|Study Extension 2 (Open-Label)|Death|2|||
48820909|NCT02403674|157187312|FG001|Study Extension 2 (Open-Label)|Death|2|||
48820910|NCT02403674|157187311|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|27|||
48820911|NCT02403674|157187312|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|23|||
48820912|NCT02403674|157187311|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|2|||
48820913|NCT02403674|157187312|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
48820914|NCT02403674|157187311|FG000|Study Extension 3 (Open-Label)|Lost to Follow-up|5|||
48820915|NCT02403674|157187312|FG001|Study Extension 3 (Open-Label)|Lost to Follow-up|4|||
48820916|NCT02403674|157187311|FG000|Study Extension 3 (Open-Label)|Withdrawal by Subject|1|||
48820917|NCT02403674|157187312|FG001|Study Extension 3 (Open-Label)|Withdrawal by Subject|3|||
49136529|NCT02949934|158338642|FG001|Bar Laboratory|Adverse Event|0|||
49136530|NCT02949934|158338643|FG002|Bar Laboratory|Adverse Event|2|||
49136531|NCT02949934|158338644|FG003|Bar Laboratory|Adverse Event|0|||
49136532|NCT02949934|158338645|FG004|Bar Laboratory|Adverse Event|1|||
48820918|NCT02403674|157187311|FG000|Study Extension 3 (Open-Label)|Physician Decision|1|||
48820919|NCT02403674|157187312|FG001|Study Extension 3 (Open-Label)|Physician Decision|5|||
49136533|NCT02949934|158338646|FG005|Bar Laboratory|Adverse Event|0|||
49136534|NCT02949934|158338641|FG000|Bar Laboratory|Protocol Violation|0|||
49136535|NCT02949934|158338642|FG001|Bar Laboratory|Protocol Violation|0|||
49136536|NCT02949934|158338643|FG002|Bar Laboratory|Protocol Violation|0|||
49136537|NCT02949934|158338644|FG003|Bar Laboratory|Protocol Violation|1|||
49136538|NCT02949934|158338645|FG004|Bar Laboratory|Protocol Violation|0|||
49136539|NCT02949934|158338646|FG005|Bar Laboratory|Protocol Violation|0|||
48726346|NCT02195687|156847934|FG001|Overall Study|Personal Reasons|1|||
48726347|NCT02195687|156847933|FG000|Overall Study|Lost to Follow-up|4|||
48726348|NCT02195687|156847934|FG001|Overall Study|Lost to Follow-up|1|||
48726349|NCT01142128|156847937|FG000|Overall Study|Physician Decision|1|||
48726350|NCT01142128|156847937|FG000|Overall Study|Lost to Follow-up|1|||
48726351|NCT01142128|156847937|FG000|Overall Study|Withdrawal by Subject|2|||
48726352|NCT00761748|156847938|FG000|First Intervention (21 +/- 3 Days)|Adverse Event|3|||
48726353|NCT00761748|156847939|FG001|First Intervention (21 +/- 3 Days)|Adverse Event|0|||
48726354|NCT00761748|156847938|FG000|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0|||
48726355|NCT00761748|156847939|FG001|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3|||
48726356|NCT01214174|156847940|FG000|Overall Study|Withdrawal by Subject|0|||
48820920|NCT02403674|157187311|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
48820921|NCT02403674|157187312|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
48820922|NCT02403674|157187311|FG000|Study Extension 3 (Open-Label)|Availability of study drug locally|14|||
48820923|NCT02403674|157187312|FG001|Study Extension 3 (Open-Label)|Availability of study drug locally|13|||
48820924|NCT03930186|157187314|FG000|Weeks 0 to 16|Adverse Event|6|||
48820925|NCT03930186|157187314|FG000|Weeks 0 to 16|Withdrawal by Subject|6|||
48820926|NCT03930186|157187314|FG000|Weeks 16 to 32|Adverse Event|1|||
48820927|NCT03930186|157187314|FG000|Weeks 16 to 32|Withdrawal by Subject|3|||
48726357|NCT01214174|156847941|FG001|Overall Study|Withdrawal by Subject|0|||
48726358|NCT01214174|156847942|FG002|Overall Study|Withdrawal by Subject|1|||
48726359|NCT00046891|156847946|FG000|Overall Study|Cancels|5|||
48726360|NCT00046891|156847947|FG001|Overall Study|Cancels|9|||
48726361|NCT00046891|156847946|FG000|Overall Study|Ineligible|1|||
48726362|NCT00046891|156847947|FG001|Overall Study|Ineligible|1|||
48726363|NCT00046891|156847946|FG000|Overall Study|Withdrawal by Subject|18|||
48726364|NCT00046891|156847947|FG001|Overall Study|Withdrawal by Subject|15|||
48820928|NCT04254679|157187315|FG000|Overall Study|Protocol Violation|1|||
49136540|NCT00294398|158338650|FG000|Overall Study|Lost to Follow-up|21|||
49136541|NCT00294398|158338651|FG001|Overall Study|Lost to Follow-up|26|||
49136542|NCT03407482|158338654|FG000|Overall Study|Adverse Event|12|||
49136543|NCT03407482|158338654|FG000|Overall Study|Disease Relapse|1|||
48726365|NCT00046891|156847946|FG000|Overall Study|Adverse Event|5|||
48726366|NCT00046891|156847947|FG001|Overall Study|Adverse Event|5|||
48726367|NCT01055496|156847952|FG000|Overall Study|Withdrawal by Subject|2|||
48726368|NCT01055496|156847953|FG001|Overall Study|Withdrawal by Subject|4|||
48726369|NCT01055496|156847952|FG000|Overall Study|Death|13|||
48726370|NCT01055496|156847953|FG001|Overall Study|Death|23|||
48820929|NCT04254679|157187316|FG001|Overall Study|Protocol Violation|1|||
48726371|NCT01055496|156847952|FG000|Overall Study|Lost to Follow-up|0|||
48726372|NCT01055496|156847953|FG001|Overall Study|Lost to Follow-up|2|||
48726373|NCT01055496|156847952|FG000|Overall Study|Other - Unspecified|0|||
48820930|NCT04254679|157187315|FG000|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|2|||
48820931|NCT04254679|157187316|FG001|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|1|||
48820932|NCT04004208|157187323|FG000|Overall Study|Withdrawal by parent/guardian|1|||
49136544|NCT03407482|158338654|FG000|Overall Study|Lost to Follow-up|1|||
49136545|NCT03407482|158338654|FG000|Overall Study|Non-Compliance With Study Drug|1|||
49136546|NCT03407482|158338654|FG000|Overall Study|Pregnancy|2|||
49136547|NCT03407482|158338654|FG000|Overall Study|Protocol Violation|1|||
49136548|NCT03407482|158338654|FG000|Overall Study|Study Terminated By Sponsor|106|||
49136549|NCT03407482|158338654|FG000|Overall Study|Withdrawal by Subject|6|||
49136550|NCT03407482|158338654|FG000|Overall Study|Data Entry Error|1|||
49136551|NCT00424008|158338657|FG000|Overall Study|Adverse Event|8|||
49136552|NCT00424008|158338658|FG001|Overall Study|Adverse Event|6|||
49136553|NCT00424008|158338657|FG000|Overall Study|Lack of Efficacy|40|||
49136554|NCT00424008|158338658|FG001|Overall Study|Lack of Efficacy|34|||
49136555|NCT00424008|158338657|FG000|Overall Study|Lost to Follow-up|1|||
49136556|NCT00424008|158338658|FG001|Overall Study|Lost to Follow-up|2|||
49136557|NCT00424008|158338657|FG000|Overall Study|Withdrawal by Subject|5|||
49136558|NCT00424008|158338658|FG001|Overall Study|Withdrawal by Subject|8|||
49136559|NCT00424008|158338657|FG000|Overall Study|Noncompliance with protocol|13|||
49136560|NCT00424008|158338658|FG001|Overall Study|Noncompliance with protocol|7|||
49136561|NCT00424008|158338657|FG000|Overall Study|Did not meet protocol eligibility|16|||
49136562|NCT00424008|158338658|FG001|Overall Study|Did not meet protocol eligibility|21|||
49136563|NCT00424008|158338657|FG000|Overall Study|Administrative|266|||
49136564|NCT00424008|158338658|FG001|Overall Study|Administrative|257|||
49136565|NCT02593864|158338660|FG000|Overall Study|Withdrawal by Subject|3|||
49136566|NCT02593864|158338660|FG000|Overall Study|Lost to Follow-up|3|||
49136567|NCT04739709|158338661|FG000|Overall Study|Physician Decision|1|||
49136568|NCT04739709|158338662|FG001|Overall Study|Physician Decision|0|||
49136569|NCT01069939|158338663|FG000|Randomised and Included in the Analyses|Adverse Event|17|||
49136570|NCT01069939|158338664|FG001|Randomised and Included in the Analyses|Adverse Event|22|||
49136571|NCT01069939|158338663|FG000|Randomised and Included in the Analyses|Withdrawal by Subject|15|||
49136572|NCT01069939|158338664|FG001|Randomised and Included in the Analyses|Withdrawal by Subject|12|||
49136573|NCT01069939|158338663|FG000|Randomised and Included in the Analyses|Lost to Follow-up|1|||
49136574|NCT01069939|158338664|FG001|Randomised and Included in the Analyses|Lost to Follow-up|1|||
49136575|NCT01069939|158338663|FG000|Randomised and Included in the Analyses|Protocol Violation|0|||
49136576|NCT01069939|158338664|FG001|Randomised and Included in the Analyses|Protocol Violation|1|||
49136577|NCT01069939|158338663|FG000|Randomised and Included in the Analyses|Lack of Efficacy|0|||
49136578|NCT01069939|158338664|FG001|Randomised and Included in the Analyses|Lack of Efficacy|1|||
49136579|NCT01069939|158338663|FG000|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7|||
49136580|NCT01069939|158338664|FG001|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33|||
49136581|NCT01069939|158338663|FG000|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4|||
49136582|NCT01069939|158338664|FG001|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3|||
49136583|NCT01069939|158338663|FG000|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4|||
49136584|NCT01069939|158338664|FG001|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2|||
49136585|NCT01069939|158338663|FG000|Randomised and Included in the Analyses|Physician Decision|0|||
49136586|NCT01069939|158338664|FG001|Randomised and Included in the Analyses|Physician Decision|2|||
49136587|NCT01069939|158338663|FG000|Randomised and Included in the Analyses|Removal|1|||
49136588|NCT01069939|158338664|FG001|Randomised and Included in the Analyses|Removal|0|||
49136589|NCT01913353|158338665|FG000|Overall Study|Adverse Event|2|||
49136590|NCT01913353|158338666|FG001|Overall Study|Adverse Event|0|||
49136591|NCT01913353|158338665|FG000|Overall Study|Physician Decision|0|||
49136592|NCT01913353|158338666|FG001|Overall Study|Physician Decision|2|||
49136593|NCT01913353|158338665|FG000|Overall Study|Withdrawal by Subject|20|||
49136594|NCT01913353|158338666|FG001|Overall Study|Withdrawal by Subject|6|||
49136595|NCT01913353|158338665|FG000|Overall Study|multiple reasons|10|||
49136596|NCT01913353|158338666|FG001|Overall Study|multiple reasons|7|||
49136597|NCT00462462|158338670|FG000|Overall Study|Physician Decision|0|||
49136598|NCT00462462|158338671|FG001|Overall Study|Physician Decision|1|||
49136599|NCT01685437|158338673|FG000|Overall Study|Withdrawal by Subject|22|||
49136600|NCT01685437|158338673|FG000|Overall Study|Lost to Follow-up|3|||
49136601|NCT01685437|158338673|FG000|Overall Study|Adverse Event|1|||
49136602|NCT01685437|158338673|FG000|Overall Study|Protocol Violation|4|||
49136603|NCT01685437|158338673|FG000|Overall Study|Unable to make visits due to work|1|||
49136604|NCT02875080|158338674|FG000|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2|||
49136605|NCT02875080|158338675|FG001|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
49136606|NCT02875080|158338676|FG002|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
49136607|NCT02114684|158338677|FG000|Overall Study|Death|6|||
49136608|NCT02114684|158338678|FG001|Overall Study|Death|4|||
49136609|NCT02114684|158338677|FG000|Overall Study|Lost to Follow-up|1|||
48726374|NCT01055496|156847953|FG001|Overall Study|Other - Unspecified|1|||
49136610|NCT02114684|158338678|FG001|Overall Study|Lost to Follow-up|2|||
48726375|NCT01289782|156847954|FG000|Overall Study|Lost to Follow-up|14|||
48726376|NCT01289782|156847955|FG001|Overall Study|Lost to Follow-up|7|||
48726377|NCT01289782|156847954|FG000|Overall Study|Protocol Violation|1|||
48726378|NCT01289782|156847955|FG001|Overall Study|Protocol Violation|1|||
49136611|NCT02114684|158338677|FG000|Overall Study|Withdrawal by Subject|1|||
48726379|NCT01289782|156847954|FG000|Overall Study|Withdrawal by Subject|8|||
48726380|NCT01289782|156847955|FG001|Overall Study|Withdrawal by Subject|2|||
48726381|NCT01289782|156847954|FG000|Overall Study|Sponsor's Decision|1|||
48726382|NCT01289782|156847955|FG001|Overall Study|Sponsor's Decision|0|||
49011292|NCT00830063|157878906|FG002|Overall Study|Randomized But Not Treated|0|||
49011293|NCT00830063|157878907|FG003|Overall Study|Randomized But Not Treated|2|||
49011294|NCT01377233|157878916|FG000|Open-label|Adverse Event|1|||
49011295|NCT01377233|157878917|FG001|Open-label|Adverse Event|0|||
49011296|NCT01377233|157878918|FG002|Open-label|Adverse Event|0|||
49011297|NCT01377233|157878919|FG003|Open-label|Adverse Event|0|||
49011298|NCT01377233|157878920|FG004|Open-label|Adverse Event|0|||
49011299|NCT01377233|157878916|FG000|Open-label|Withdrawal by Subject|3|||
49011300|NCT01377233|157878917|FG001|Open-label|Withdrawal by Subject|0|||
49011301|NCT01377233|157878918|FG002|Open-label|Withdrawal by Subject|0|||
49011302|NCT01377233|157878919|FG003|Open-label|Withdrawal by Subject|0|||
49011303|NCT01377233|157878920|FG004|Open-label|Withdrawal by Subject|0|||
49011304|NCT01377233|157878916|FG000|Double-blind|Adverse Event|0|||
49011305|NCT01377233|157878917|FG001|Double-blind|Adverse Event|1|||
49011306|NCT01377233|157878918|FG002|Double-blind|Adverse Event|2|||
49011307|NCT01377233|157878919|FG003|Double-blind|Adverse Event|2|||
49011308|NCT01377233|157878920|FG004|Double-blind|Adverse Event|0|||
49011309|NCT01377233|157878916|FG000|Double-blind|Protocol Violation|0|||
49011310|NCT01377233|157878917|FG001|Double-blind|Protocol Violation|0|||
49011311|NCT01377233|157878918|FG002|Double-blind|Protocol Violation|0|||
49011312|NCT01377233|157878919|FG003|Double-blind|Protocol Violation|0|||
49011313|NCT01377233|157878920|FG004|Double-blind|Protocol Violation|1|||
49011314|NCT01377233|157878916|FG000|Double-blind|Withdrawal by Subject|0|||
49011315|NCT01377233|157878917|FG001|Double-blind|Withdrawal by Subject|0|||
49011316|NCT01377233|157878918|FG002|Double-blind|Withdrawal by Subject|0|||
49011317|NCT01377233|157878919|FG003|Double-blind|Withdrawal by Subject|1|||
49011318|NCT01377233|157878920|FG004|Double-blind|Withdrawal by Subject|0|||
49011319|NCT01377233|157878916|FG000|Double-blind|Administrative or other|0|||
49011320|NCT01377233|157878917|FG001|Double-blind|Administrative or other|0|||
49011321|NCT01377233|157878918|FG002|Double-blind|Administrative or other|0|||
49011322|NCT01377233|157878919|FG003|Double-blind|Administrative or other|1|||
49011323|NCT01377233|157878920|FG004|Double-blind|Administrative or other|1|||
49011324|NCT01814761|157878923|FG000|Overall Study|Other Reasons|1|||
49011325|NCT01814761|157878924|FG001|Overall Study|Other Reasons|10|||
49011326|NCT01814761|157878923|FG000|Overall Study|Ocular Adverse Event|6|||
49011327|NCT01814761|157878924|FG001|Overall Study|Ocular Adverse Event|15|||
49011328|NCT01814761|157878923|FG000|Overall Study|Lost to Follow-up|1|||
49011329|NCT01814761|157878924|FG001|Overall Study|Lost to Follow-up|5|||
49011330|NCT03137082|157878925|FG000|Overall Study|Withdrawal by Subject|1|||
49011331|NCT03137082|157878926|FG001|Overall Study|Withdrawal by Subject|1|||
49011332|NCT03137082|157878925|FG000|Overall Study|Lost to Follow-up|1|||
49011333|NCT03137082|157878926|FG001|Overall Study|Lost to Follow-up|0|||
49011334|NCT00417027|157878927|FG000|Overall Study|Protocol Violation|0|||
49011335|NCT00417027|157878928|FG001|Overall Study|Protocol Violation|5|||
49011336|NCT00417027|157878929|FG002|Overall Study|Protocol Violation|5|||
49011337|NCT01155063|157878930|FG000|Overall Study|Adverse Event|1|||
49011338|NCT01155063|157878930|FG000|Overall Study|Withdrawal by Subject|1|||
49011339|NCT01155063|157878930|FG000|Overall Study|Study terminated by sponsor|87|||
49011340|NCT00936884|157878931|FG000|Double-blind|Withdrawal by Subject|6|||
49011341|NCT00936884|157878932|FG001|Double-blind|Withdrawal by Subject|4|||
49011342|NCT00936884|157878933|FG002|Double-blind|Withdrawal by Subject|0|||
49136612|NCT02114684|158338678|FG001|Overall Study|Withdrawal by Subject|2|||
49136613|NCT02114684|158338677|FG000|Overall Study|Relocation|3|||
49136614|NCT02114684|158338678|FG001|Overall Study|Relocation|1|||
49136615|NCT02114684|158338677|FG000|Overall Study|Rifampicin resistant on culture|0|||
49136616|NCT02114684|158338678|FG001|Overall Study|Rifampicin resistant on culture|1|||
49136617|NCT02114684|158338677|FG000|Overall Study|Patient Incarcerated|1|||
49136618|NCT02114684|158338678|FG001|Overall Study|Patient Incarcerated|0|||
49136619|NCT00283959|158338679|FG000|Extension Period|Low Compliance|1|||
49136620|NCT00191100|158338680|FG000|Overall Study|Adverse Event|18|||
49136621|NCT00191100|158338681|FG001|Overall Study|Adverse Event|1|||
49136622|NCT00191100|158338680|FG000|Overall Study|Lost to Follow-up|2|||
49136623|NCT00191100|158338681|FG001|Overall Study|Lost to Follow-up|0|||
49136624|NCT00191100|158338680|FG000|Overall Study|Patient Moved|0|||
49136625|NCT00191100|158338681|FG001|Overall Study|Patient Moved|1|||
49136626|NCT00191100|158338680|FG000|Overall Study|Withdrawal by Subject|9|||
49136627|NCT00191100|158338681|FG001|Overall Study|Withdrawal by Subject|3|||
49136628|NCT00191100|158338680|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
49136629|NCT00191100|158338681|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
49136630|NCT00191100|158338680|FG000|Overall Study|Clinical Relapse|2|||
49136631|NCT00191100|158338681|FG001|Overall Study|Clinical Relapse|1|||
49136632|NCT00191100|158338680|FG000|Overall Study|Lack of Efficacy, Progressive Disease|1|||
49136633|NCT00191100|158338681|FG001|Overall Study|Lack of Efficacy, Progressive Disease|2|||
49136634|NCT00191100|158338680|FG000|Overall Study|Lack of Efficacy, Stable Disease|1|||
49136635|NCT00191100|158338681|FG001|Overall Study|Lack of Efficacy, Stable Disease|0|||
49136636|NCT00191100|158338680|FG000|Overall Study|Physician Decision|3|||
49136637|NCT00191100|158338681|FG001|Overall Study|Physician Decision|1|||
49136638|NCT00191100|158338680|FG000|Overall Study|Death from Study Drug Toxicity|2|||
49136639|NCT00191100|158338681|FG001|Overall Study|Death from Study Drug Toxicity|0|||
49136640|NCT00191100|158338680|FG000|Overall Study|Protocol Violation|1|||
49136641|NCT00191100|158338681|FG001|Overall Study|Protocol Violation|1|||
49136642|NCT00191100|158338680|FG000|Overall Study|Death from Other Cause|1|||
49136643|NCT00191100|158338681|FG001|Overall Study|Death from Other Cause|0|||
49136644|NCT00191100|158338680|FG000|Overall Study|Reason Not Specified|0|||
49136645|NCT00191100|158338681|FG001|Overall Study|Reason Not Specified|1|||
49136646|NCT00165698|158338685|FG000|Overall Study|Adverse Event|2|||
49136647|NCT00165698|158338686|FG001|Overall Study|Adverse Event|10|||
49136648|NCT00165698|158338685|FG000|Overall Study|Lost to Follow-up|2|||
49136649|NCT00165698|158338686|FG001|Overall Study|Lost to Follow-up|2|||
49136650|NCT00165698|158338685|FG000|Overall Study|Withdrawal by Subject|2|||
49136651|NCT00165698|158338686|FG001|Overall Study|Withdrawal by Subject|1|||
49136652|NCT00165698|158338685|FG000|Overall Study|Protocol Violation|1|||
49136653|NCT00165698|158338686|FG001|Overall Study|Protocol Violation|0|||
49136654|NCT00165698|158338685|FG000|Overall Study|Not Taken/Lost the medicine|1|||
49136655|NCT00165698|158338686|FG001|Overall Study|Not Taken/Lost the medicine|2|||
49136656|NCT01026038|158338687|FG000|Overall Study|Lost to Follow-up|1|||
49136657|NCT01026038|158338688|FG001|Overall Study|Lost to Follow-up|1|||
49136658|NCT01026038|158338689|FG002|Overall Study|Lost to Follow-up|0|||
49136659|NCT01397747|158338698|FG000|Overall Study|Multitarget DNA test excluded|689|||
49136660|NCT01397747|158338698|FG000|Overall Study|Colonoscopy excluded|304|||
49136661|NCT01397747|158338698|FG000|Overall Study|FIT excluded|34|||
49136662|NCT02547935|158338699|FG000|Overall Study|Other|0|||
49136663|NCT02547935|158338700|FG001|Overall Study|Other|1|||
49136664|NCT02547935|158338701|FG002|Overall Study|Other|0|||
49136665|NCT02547935|158338699|FG000|Overall Study|Withdrawal by Subject|2|||
49136666|NCT02547935|158338700|FG001|Overall Study|Withdrawal by Subject|3|||
49136667|NCT02547935|158338701|FG002|Overall Study|Withdrawal by Subject|4|||
49136668|NCT02547935|158338699|FG000|Overall Study|Screen Failure|2|||
49136669|NCT02547935|158338700|FG001|Overall Study|Screen Failure|0|||
49136670|NCT02547935|158338701|FG002|Overall Study|Screen Failure|0|||
49136671|NCT02547935|158338699|FG000|Overall Study|Physician Decision|0|||
49136672|NCT02547935|158338700|FG001|Overall Study|Physician Decision|1|||
49136673|NCT02547935|158338701|FG002|Overall Study|Physician Decision|0|||
49136674|NCT02547935|158338699|FG000|Overall Study|Lost to Follow-up|0|||
49136675|NCT02547935|158338700|FG001|Overall Study|Lost to Follow-up|2|||
48726383|NCT01289782|156847954|FG000|Overall Study|Reason not specified|1|||
49136676|NCT02547935|158338701|FG002|Overall Study|Lost to Follow-up|1|||
48726384|NCT01289782|156847955|FG001|Overall Study|Reason not specified|2|||
48726385|NCT01009281|156847961|FG000|Overall Study|Administrative problems|7|||
48726386|NCT02398227|156847963|FG000|Overall Study|Lost to Follow-up|21|||
49136677|NCT02547935|158338699|FG000|Overall Study|Death|1|||
49136678|NCT02547935|158338700|FG001|Overall Study|Death|1|||
49136679|NCT02547935|158338701|FG002|Overall Study|Death|0|||
49136680|NCT03770455|158338708|FG000|Overall Study|Screen failures|3|||
49136681|NCT03572218|158338713|FG000|Overall Study|Lost to Follow-up|3|||
49136682|NCT03572218|158338714|FG001|Overall Study|Lost to Follow-up|2|||
49136683|NCT03572218|158338713|FG000|Overall Study|No longer available for study visits|2|||
49136684|NCT03572218|158338714|FG001|Overall Study|No longer available for study visits|1|||
49136685|NCT03572218|158338713|FG000|Overall Study|No longer interested|1|||
49136686|NCT03572218|158338714|FG001|Overall Study|No longer interested|2|||
49136687|NCT01350973|158338718|FG000|Overall Study|Adverse Event|4|||
49136688|NCT01350973|158338719|FG001|Overall Study|Adverse Event|7|||
49136689|NCT01350973|158338720|FG002|Overall Study|Adverse Event|7|||
49136690|NCT01350973|158338718|FG000|Overall Study|Voluntary Withdrawal|2|||
49136691|NCT01350973|158338719|FG001|Overall Study|Voluntary Withdrawal|1|||
49136692|NCT01350973|158338720|FG002|Overall Study|Voluntary Withdrawal|1|||
49136693|NCT02638493|158338721|FG000|Overall Study|Inability to provide semen samples|2|||
49136694|NCT02638493|158338722|FG001|Overall Study|Inability to provide semen samples|0|||
49136695|NCT02638493|158338723|FG002|Overall Study|Inability to provide semen samples|0|||
49136696|NCT02711137|158340771|FG000|Overall Study|Death|1|||
49136697|NCT02711137|158340772|FG001|Overall Study|Death|4|||
49136698|NCT02711137|158340773|FG002|Overall Study|Death|5|||
49136699|NCT02711137|158340774|FG003|Overall Study|Death|5|||
49136700|NCT02711137|158340775|FG004|Overall Study|Death|3|||
49136701|NCT02711137|158340776|FG005|Overall Study|Death|1|||
49136702|NCT02711137|158340777|FG006|Overall Study|Death|61|||
49136703|NCT02711137|158340778|FG007|Overall Study|Death|3|||
49136704|NCT02711137|158340779|FG008|Overall Study|Death|0|||
48726387|NCT02398227|156847964|FG001|Overall Study|Lost to Follow-up|12|||
48726388|NCT02398227|156847963|FG000|Overall Study|Withdrawal by Subject|5|||
48726389|NCT02398227|156847964|FG001|Overall Study|Withdrawal by Subject|6|||
48726390|NCT02398227|156847963|FG000|Overall Study|Removed from treatment and dropped out|1|||
48726391|NCT02398227|156847964|FG001|Overall Study|Removed from treatment and dropped out|0|||
48726392|NCT00879879|156847965|FG000|Overall Study|Death|1|||
48726393|NCT00879879|156847965|FG000|Overall Study|Withdrawal by Subject|1|||
48726394|NCT00879879|156847965|FG000|Overall Study|Physician Decision|1|||
48726395|NCT00064298|156847966|FG000|Overall Study|Withdrawal by Subject|2|||
48820933|NCT04004208|157187324|FG001|Overall Study|Withdrawal by parent/guardian|1|||
48820934|NCT04004208|157187323|FG000|Overall Study|Death|3|||
48820935|NCT04004208|157187324|FG001|Overall Study|Death|0|||
48820936|NCT04004208|157187323|FG000|Overall Study|COVID-19 pandemic|1|||
48820937|NCT04004208|157187324|FG001|Overall Study|COVID-19 pandemic|0|||
48820938|NCT04004208|157187323|FG000|Overall Study|Physician Decision|1|||
48820939|NCT04004208|157187324|FG001|Overall Study|Physician Decision|0|||
49136705|NCT02711137|158340780|FG009|Overall Study|Death|1|||
49136706|NCT02711137|158340781|FG010|Overall Study|Death|1|||
49136707|NCT02711137|158340782|FG011|Overall Study|Death|1|||
49136708|NCT02711137|158340783|FG012|Overall Study|Death|0|||
49136709|NCT02711137|158340784|FG013|Overall Study|Death|0|||
49136710|NCT02711137|158340785|FG014|Overall Study|Death|0|||
48726396|NCT00064298|156847967|FG001|Overall Study|Withdrawal by Subject|1|||
49136711|NCT02711137|158340771|FG000|Overall Study|Study Terminated by Sponsor|0|||
49136712|NCT02711137|158340772|FG001|Overall Study|Study Terminated by Sponsor|0|||
48726397|NCT00064298|156847966|FG000|Overall Study|Lost to Follow-up|2|||
48820940|NCT04004208|157187323|FG000|Overall Study|Adverse Event|1|||
48726398|NCT00064298|156847967|FG001|Overall Study|Lost to Follow-up|2|||
48726399|NCT00064298|156847966|FG000|Overall Study|Death|0|||
48726400|NCT00064298|156847967|FG001|Overall Study|Death|1|||
49136713|NCT02711137|158340773|FG002|Overall Study|Study Terminated by Sponsor|1|||
49136714|NCT02711137|158340774|FG003|Overall Study|Study Terminated by Sponsor|0|||
49136715|NCT02711137|158340775|FG004|Overall Study|Study Terminated by Sponsor|0|||
49136716|NCT02711137|158340776|FG005|Overall Study|Study Terminated by Sponsor|0|||
49136717|NCT02711137|158340777|FG006|Overall Study|Study Terminated by Sponsor|1|||
49136718|NCT02711137|158340778|FG007|Overall Study|Study Terminated by Sponsor|0|||
49136719|NCT02711137|158340779|FG008|Overall Study|Study Terminated by Sponsor|0|||
49136720|NCT02711137|158340780|FG009|Overall Study|Study Terminated by Sponsor|0|||
49136721|NCT02711137|158340781|FG010|Overall Study|Study Terminated by Sponsor|0|||
49136722|NCT02711137|158340782|FG011|Overall Study|Study Terminated by Sponsor|0|||
49136723|NCT02711137|158340783|FG012|Overall Study|Study Terminated by Sponsor|0|||
49136724|NCT02711137|158340784|FG013|Overall Study|Study Terminated by Sponsor|0|||
49136725|NCT02711137|158340785|FG014|Overall Study|Study Terminated by Sponsor|0|||
49136726|NCT02711137|158340771|FG000|Overall Study|Physician Decision|1|||
49136727|NCT02711137|158340772|FG001|Overall Study|Physician Decision|0|||
49136728|NCT02711137|158340773|FG002|Overall Study|Physician Decision|2|||
49136729|NCT02711137|158340774|FG003|Overall Study|Physician Decision|1|||
49136730|NCT02711137|158340775|FG004|Overall Study|Physician Decision|1|||
49136731|NCT02711137|158340776|FG005|Overall Study|Physician Decision|0|||
49136732|NCT02711137|158340777|FG006|Overall Study|Physician Decision|12|||
49136733|NCT02711137|158340778|FG007|Overall Study|Physician Decision|2|||
49136734|NCT02711137|158340779|FG008|Overall Study|Physician Decision|1|||
49136735|NCT02711137|158340780|FG009|Overall Study|Physician Decision|1|||
49136736|NCT02711137|158340781|FG010|Overall Study|Physician Decision|3|||
49136737|NCT02711137|158340782|FG011|Overall Study|Physician Decision|2|||
49136738|NCT02711137|158340783|FG012|Overall Study|Physician Decision|1|||
49136739|NCT02711137|158340784|FG013|Overall Study|Physician Decision|1|||
49136740|NCT02711137|158340785|FG014|Overall Study|Physician Decision|2|||
49136741|NCT02711137|158340771|FG000|Overall Study|Other|0|||
49136742|NCT02711137|158340772|FG001|Overall Study|Other|1|||
49136743|NCT02711137|158340773|FG002|Overall Study|Other|0|||
49136744|NCT02711137|158340774|FG003|Overall Study|Other|0|||
49136745|NCT02711137|158340775|FG004|Overall Study|Other|0|||
49136746|NCT02711137|158340776|FG005|Overall Study|Other|0|||
49136747|NCT02711137|158340777|FG006|Overall Study|Other|3|||
49136748|NCT02711137|158340778|FG007|Overall Study|Other|0|||
49136749|NCT02711137|158340779|FG008|Overall Study|Other|0|||
49136750|NCT02711137|158340780|FG009|Overall Study|Other|0|||
49136751|NCT02711137|158340781|FG010|Overall Study|Other|0|||
49136752|NCT02711137|158340782|FG011|Overall Study|Other|0|||
49136753|NCT02711137|158340783|FG012|Overall Study|Other|0|||
49136754|NCT02711137|158340784|FG013|Overall Study|Other|0|||
49136755|NCT02711137|158340785|FG014|Overall Study|Other|1|||
49136756|NCT02711137|158340771|FG000|Overall Study|Withdrawal by Subject|1|||
49136757|NCT02711137|158340772|FG001|Overall Study|Withdrawal by Subject|0|||
49136758|NCT02711137|158340773|FG002|Overall Study|Withdrawal by Subject|0|||
49136759|NCT02711137|158340774|FG003|Overall Study|Withdrawal by Subject|1|||
49136760|NCT02711137|158340775|FG004|Overall Study|Withdrawal by Subject|1|||
49136761|NCT02711137|158340776|FG005|Overall Study|Withdrawal by Subject|0|||
49136762|NCT02711137|158340777|FG006|Overall Study|Withdrawal by Subject|7|||
49136763|NCT02711137|158340778|FG007|Overall Study|Withdrawal by Subject|0|||
49136764|NCT02711137|158340779|FG008|Overall Study|Withdrawal by Subject|0|||
49136765|NCT02711137|158340780|FG009|Overall Study|Withdrawal by Subject|0|||
49136766|NCT02711137|158340781|FG010|Overall Study|Withdrawal by Subject|0|||
49136767|NCT02711137|158340782|FG011|Overall Study|Withdrawal by Subject|0|||
49136768|NCT02711137|158340783|FG012|Overall Study|Withdrawal by Subject|0|||
49136769|NCT02711137|158340784|FG013|Overall Study|Withdrawal by Subject|1|||
49136770|NCT02711137|158340785|FG014|Overall Study|Withdrawal by Subject|0|||
49136771|NCT02711137|158340771|FG000|Overall Study|Lost to Follow-up|1|||
49136772|NCT02711137|158340772|FG001|Overall Study|Lost to Follow-up|0|||
49136773|NCT02711137|158340773|FG002|Overall Study|Lost to Follow-up|0|||
49136774|NCT02711137|158340774|FG003|Overall Study|Lost to Follow-up|0|||
49136775|NCT02711137|158340775|FG004|Overall Study|Lost to Follow-up|0|||
49136776|NCT02711137|158340776|FG005|Overall Study|Lost to Follow-up|0|||
49136777|NCT02711137|158340777|FG006|Overall Study|Lost to Follow-up|2|||
49136778|NCT02711137|158340778|FG007|Overall Study|Lost to Follow-up|0|||
49136779|NCT02711137|158340779|FG008|Overall Study|Lost to Follow-up|0|||
49136780|NCT02711137|158340780|FG009|Overall Study|Lost to Follow-up|0|||
49136781|NCT02711137|158340781|FG010|Overall Study|Lost to Follow-up|0|||
49136782|NCT02711137|158340782|FG011|Overall Study|Lost to Follow-up|0|||
49136783|NCT02711137|158340783|FG012|Overall Study|Lost to Follow-up|0|||
49136784|NCT02711137|158340784|FG013|Overall Study|Lost to Follow-up|0|||
49136785|NCT02711137|158340785|FG014|Overall Study|Lost to Follow-up|0|||
49136786|NCT05399771|158340786|FG000|Overall Study|Physician Decision|3|||
49136787|NCT05399771|158340786|FG000|Overall Study|Adverse Event|1|||
49136788|NCT02233413|158340787|FG000|Overall Study|Lost to Follow-up|7|||
49136789|NCT02233413|158340788|FG001|Overall Study|Lost to Follow-up|9|||
49136790|NCT02233413|158340787|FG000|Overall Study|Withdrawal by Subject|4|||
49136791|NCT02233413|158340788|FG001|Overall Study|Withdrawal by Subject|5|||
48820941|NCT04004208|157187324|FG001|Overall Study|Adverse Event|1|||
49136792|NCT00134719|158340789|FG000|Primary Vaccination Phase|Adverse Event|4|||
49136793|NCT00134719|158340790|FG001|Primary Vaccination Phase|Adverse Event|0|||
49136794|NCT00134719|158340791|FG002|Primary Vaccination Phase|Adverse Event|0|||
49136795|NCT00134719|158340789|FG000|Primary Vaccination Phase|Protocol Violation|1|||
49136796|NCT00134719|158340790|FG001|Primary Vaccination Phase|Protocol Violation|0|||
49136797|NCT00134719|158340791|FG002|Primary Vaccination Phase|Protocol Violation|0|||
49136798|NCT00134719|158340789|FG000|Primary Vaccination Phase|Withdrawal by Subject|2|||
49136799|NCT00134719|158340790|FG001|Primary Vaccination Phase|Withdrawal by Subject|3|||
49136800|NCT00134719|158340791|FG002|Primary Vaccination Phase|Withdrawal by Subject|2|||
49136801|NCT00134719|158340789|FG000|Primary Vaccination Phase|Lost to Follow-up|7|||
49136802|NCT00134719|158340790|FG001|Primary Vaccination Phase|Lost to Follow-up|3|||
49136803|NCT00134719|158340791|FG002|Primary Vaccination Phase|Lost to Follow-up|3|||
49136804|NCT00134719|158340789|FG000|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
49136805|NCT00134719|158340790|FG001|Fourth Dose Vaccination Phase|Lost to Follow-up|3|||
48820942|NCT01316692|157187325|FG000|Overall Study|Adverse Event|5|||
48820943|NCT01316692|157187325|FG000|Overall Study|Disease Progression|7|||
48820944|NCT03772314|157187329|FG000|Overall Study|Adverse Event|7|||
49136806|NCT00134719|158340791|FG002|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
49136807|NCT00134719|158340789|FG000|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1|||
49136808|NCT00134719|158340790|FG001|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
49136809|NCT00134719|158340791|FG002|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
49136810|NCT00876395|158340792|FG000|Overall Study|Untreated|8|||
49136811|NCT00876395|158340793|FG001|Overall Study|Untreated|1|||
49136812|NCT00876395|158340792|FG000|Overall Study|Adverse Event|63|||
49136813|NCT00876395|158340793|FG001|Overall Study|Adverse Event|11|||
49136814|NCT00876395|158340792|FG000|Overall Study|Abnormal test procedure result(s)|1|||
48820945|NCT03772314|157187330|FG001|Overall Study|Adverse Event|2|||
48820946|NCT03138512|157187331|FG000|Randomization|Participants withdrew consent|0|||
48820947|NCT03138512|157187332|FG001|Randomization|Participants withdrew consent|1|||
48820948|NCT03138512|157187333|FG002|Randomization|Participants withdrew consent|1|||
48820949|NCT03138512|157187334|FG003|Randomization|Participants withdrew consent|0|||
48820950|NCT03138512|157187335|FG004|Randomization|Participants withdrew consent|0|||
48820951|NCT03138512|157187331|FG000|Randomization|Participant no longer meets study criteria|0|||
48820952|NCT03138512|157187332|FG001|Randomization|Participant no longer meets study criteria|3|||
48820953|NCT03138512|157187333|FG002|Randomization|Participant no longer meets study criteria|1|||
48820954|NCT03138512|157187334|FG003|Randomization|Participant no longer meets study criteria|1|||
48820955|NCT03138512|157187335|FG004|Randomization|Participant no longer meets study criteria|3|||
48820956|NCT03138512|157187331|FG000|Randomization|Other reasons|1|||
48820957|NCT03138512|157187332|FG001|Randomization|Other reasons|0|||
48820958|NCT03138512|157187333|FG002|Randomization|Other reasons|0|||
48820959|NCT03138512|157187334|FG003|Randomization|Other reasons|0|||
48820960|NCT03138512|157187335|FG004|Randomization|Other reasons|0|||
48820961|NCT03138512|157187331|FG000|Treatment Part A|Disease recurrence|10|||
48820962|NCT03138512|157187332|FG001|Treatment Part A|Disease recurrence|20|||
48820963|NCT03138512|157187333|FG002|Treatment Part A|Disease recurrence|0|||
48820964|NCT03138512|157187334|FG003|Treatment Part A|Disease recurrence|0|||
48820965|NCT03138512|157187335|FG004|Treatment Part A|Disease recurrence|0|||
48820966|NCT03138512|157187331|FG000|Treatment Part A|Study Drug Toxicity|132|||
48820967|NCT03138512|157187332|FG001|Treatment Part A|Study Drug Toxicity|5|||
49136815|NCT00876395|158340793|FG001|Overall Study|Abnormal test procedure result(s)|0|||
48820968|NCT03138512|157187333|FG002|Treatment Part A|Study Drug Toxicity|0|||
48820969|NCT03138512|157187334|FG003|Treatment Part A|Study Drug Toxicity|0|||
48820970|NCT03138512|157187335|FG004|Treatment Part A|Study Drug Toxicity|0|||
49136816|NCT00876395|158340792|FG000|Overall Study|Disease progression|259|||
49136817|NCT00876395|158340793|FG001|Overall Study|Disease progression|162|||
49136818|NCT00876395|158340792|FG000|Overall Study|New cancer therapy|25|||
49136819|NCT00876395|158340793|FG001|Overall Study|New cancer therapy|7|||
49136820|NCT00876395|158340792|FG000|Overall Study|Protocol Violation|5|||
49136821|NCT00876395|158340793|FG001|Overall Study|Protocol Violation|2|||
48820971|NCT03138512|157187331|FG000|Treatment Part A|Death|1|||
48820972|NCT03138512|157187332|FG001|Treatment Part A|Death|0|||
49136822|NCT00876395|158340792|FG000|Overall Study|Withdrawal by Subject|66|||
49136823|NCT00876395|158340793|FG001|Overall Study|Withdrawal by Subject|33|||
49136824|NCT00876395|158340792|FG000|Overall Study|Lost to Follow-up|2|||
49136825|NCT00876395|158340793|FG001|Overall Study|Lost to Follow-up|0|||
48820973|NCT03138512|157187333|FG002|Treatment Part A|Death|0|||
48820974|NCT03138512|157187334|FG003|Treatment Part A|Death|0|||
48820975|NCT03138512|157187335|FG004|Treatment Part A|Death|0|||
48820976|NCT03138512|157187331|FG000|Treatment Part A|Adverse event unrelated to study drug|9|||
48820977|NCT03138512|157187332|FG001|Treatment Part A|Adverse event unrelated to study drug|4|||
48820978|NCT03138512|157187333|FG002|Treatment Part A|Adverse event unrelated to study drug|0|||
49136826|NCT00876395|158340792|FG000|Overall Study|Administrative problems|39|||
49136827|NCT00876395|158340793|FG001|Overall Study|Administrative problems|23|||
48820979|NCT03138512|157187334|FG003|Treatment Part A|Adverse event unrelated to study drug|0|||
48820980|NCT03138512|157187335|FG004|Treatment Part A|Adverse event unrelated to study drug|0|||
48820981|NCT03138512|157187331|FG000|Treatment Part A|Participant request to discontinue treatment|9|||
48820982|NCT03138512|157187332|FG001|Treatment Part A|Participant request to discontinue treatment|4|||
48820983|NCT03138512|157187333|FG002|Treatment Part A|Participant request to discontinue treatment|0|||
48820984|NCT03138512|157187334|FG003|Treatment Part A|Participant request to discontinue treatment|0|||
48820985|NCT03138512|157187335|FG004|Treatment Part A|Participant request to discontinue treatment|0|||
48820986|NCT03138512|157187331|FG000|Treatment Part A|Participant withdrew consent|2|||
48820987|NCT03138512|157187332|FG001|Treatment Part A|Participant withdrew consent|4|||
48820988|NCT03138512|157187333|FG002|Treatment Part A|Participant withdrew consent|0|||
48820989|NCT03138512|157187334|FG003|Treatment Part A|Participant withdrew consent|0|||
48820990|NCT03138512|157187335|FG004|Treatment Part A|Participant withdrew consent|0|||
48820991|NCT03138512|157187331|FG000|Treatment Part A|Lost to Follow-up|0|||
48820992|NCT03138512|157187332|FG001|Treatment Part A|Lost to Follow-up|1|||
48820993|NCT03138512|157187333|FG002|Treatment Part A|Lost to Follow-up|0|||
49136828|NCT00876395|158340792|FG000|Overall Study|Death|12|||
49136829|NCT00876395|158340793|FG001|Overall Study|Death|0|||
49136830|NCT03261401|158340794|FG000|Overall Study|Withdrawal by Subject|0|||
49136831|NCT03261401|158340795|FG001|Overall Study|Withdrawal by Subject|0|||
49136832|NCT03261401|158340796|FG002|Overall Study|Withdrawal by Subject|0|||
49136833|NCT03261401|158340797|FG003|Overall Study|Withdrawal by Subject|0|||
49136834|NCT03261401|158340798|FG004|Overall Study|Withdrawal by Subject|0|||
49136835|NCT03261401|158340799|FG005|Overall Study|Withdrawal by Subject|1|||
49136836|NCT03261401|158340800|FG006|Overall Study|Withdrawal by Subject|0|||
49136837|NCT03261401|158340801|FG007|Overall Study|Withdrawal by Subject|0|||
49136838|NCT03261401|158340802|FG008|Overall Study|Withdrawal by Subject|0|||
49136839|NCT03261401|158340803|FG009|Overall Study|Withdrawal by Subject|0|||
49136840|NCT03261401|158340804|FG010|Overall Study|Withdrawal by Subject|0|||
49136841|NCT03261401|158340805|FG011|Overall Study|Withdrawal by Subject|0|||
49136842|NCT03261401|158340806|FG012|Overall Study|Withdrawal by Subject|0|||
49136843|NCT03261401|158340794|FG000|Overall Study|Participant Unable To Attend Final Visit|0|||
49136844|NCT03261401|158340795|FG001|Overall Study|Participant Unable To Attend Final Visit|0|||
49136845|NCT03261401|158340796|FG002|Overall Study|Participant Unable To Attend Final Visit|0|||
49136846|NCT03261401|158340797|FG003|Overall Study|Participant Unable To Attend Final Visit|0|||
49136847|NCT03261401|158340798|FG004|Overall Study|Participant Unable To Attend Final Visit|0|||
49136848|NCT03261401|158340799|FG005|Overall Study|Participant Unable To Attend Final Visit|0|||
49136849|NCT03261401|158340800|FG006|Overall Study|Participant Unable To Attend Final Visit|0|||
49136850|NCT03261401|158340801|FG007|Overall Study|Participant Unable To Attend Final Visit|0|||
49136851|NCT03261401|158340802|FG008|Overall Study|Participant Unable To Attend Final Visit|0|||
49136852|NCT03261401|158340803|FG009|Overall Study|Participant Unable To Attend Final Visit|0|||
49136853|NCT03261401|158340804|FG010|Overall Study|Participant Unable To Attend Final Visit|0|||
49136854|NCT03261401|158340805|FG011|Overall Study|Participant Unable To Attend Final Visit|0|||
49136855|NCT03261401|158340806|FG012|Overall Study|Participant Unable To Attend Final Visit|1|||
49136856|NCT00970944|158340807|FG000|Overall Study|Death|1|||
49136857|NCT00970944|158340808|FG001|Overall Study|Death|0|||
48820994|NCT03138512|157187334|FG003|Treatment Part A|Lost to Follow-up|0|||
49136858|NCT00970944|158340807|FG000|Overall Study|Physician Decision|0|||
49136859|NCT00970944|158340808|FG001|Overall Study|Physician Decision|2|||
49136860|NCT02008370|158340809|FG000|Overall Study|Lost to Follow-up|7|||
49136861|NCT00662259|158340810|FG000|Overall Study|Adverse Event|2|||
49136862|NCT00662259|158340811|FG001|Overall Study|Adverse Event|0|||
49136863|NCT02394275|158340815|FG000|Overall Study|Adverse Event|22|||
49136864|NCT02394275|158340815|FG000|Overall Study|Lost to Follow-up|7|||
49136865|NCT01499511|158340816|FG000|Overall Study|Death|1|||
49136866|NCT01499511|158340817|FG001|Overall Study|Death|0|||
49011343|NCT00936884|157878931|FG000|Double-blind|Death|2|||
49011344|NCT00936884|157878932|FG001|Double-blind|Death|1|||
49011345|NCT00936884|157878933|FG002|Double-blind|Death|0|||
49011346|NCT00936884|157878931|FG000|Double-blind|Lack of Efficacy|1|||
49011347|NCT00936884|157878932|FG001|Double-blind|Lack of Efficacy|1|||
49011348|NCT00936884|157878933|FG002|Double-blind|Lack of Efficacy|0|||
49011349|NCT00936884|157878931|FG000|Double-blind|Adverse Event|1|||
49011350|NCT00936884|157878932|FG001|Double-blind|Adverse Event|0|||
49011351|NCT00936884|157878933|FG002|Double-blind|Adverse Event|0|||
49011352|NCT00936884|157878931|FG000|Double-blind|Physician Decision|1|||
49011353|NCT00936884|157878932|FG001|Double-blind|Physician Decision|0|||
49011354|NCT00936884|157878933|FG002|Double-blind|Physician Decision|0|||
49011355|NCT00936884|157878931|FG000|Double-blind|No post baseline diary entry|1|||
49011356|NCT00936884|157878932|FG001|Double-blind|No post baseline diary entry|0|||
49011357|NCT00936884|157878933|FG002|Double-blind|No post baseline diary entry|0|||
49136867|NCT00998946|158340818|FG000|Overall Study|Lost to Follow-up|1|||
49136868|NCT00998946|158340818|FG000|Overall Study|Withdrawal by Subject|1|||
49011358|NCT00936884|157878931|FG000|Double-blind|Did not receive study drug|0|||
49136869|NCT00998946|158340818|FG000|Overall Study|Death|2|||
49136870|NCT00998946|158340818|FG000|Overall Study|Reason Unspecified|3|||
49136871|NCT00998946|158340818|FG000|Overall Study|Enrolled but not Dosed|2|||
49136872|NCT03915067|158340819|FG000|Overall Study|Adverse Event|0|||
49136873|NCT03915067|158340820|FG001|Overall Study|Adverse Event|0|||
49136874|NCT03915067|158340821|FG002|Overall Study|Adverse Event|1|||
49136875|NCT03915067|158340819|FG000|Overall Study|Withdrawal by Subject|4|||
49136876|NCT03915067|158340820|FG001|Overall Study|Withdrawal by Subject|3|||
49011359|NCT00936884|157878932|FG001|Double-blind|Did not receive study drug|1|||
49136877|NCT03915067|158340821|FG002|Overall Study|Withdrawal by Subject|0|||
49136878|NCT03915067|158340819|FG000|Overall Study|Lost to Follow-up|3|||
49136879|NCT03915067|158340820|FG001|Overall Study|Lost to Follow-up|2|||
49136880|NCT03915067|158340821|FG002|Overall Study|Lost to Follow-up|0|||
49136881|NCT03915067|158340819|FG000|Overall Study|Protocol Deviation|0|||
49136882|NCT03915067|158340820|FG001|Overall Study|Protocol Deviation|0|||
49136883|NCT03915067|158340821|FG002|Overall Study|Protocol Deviation|1|||
49136884|NCT03915067|158340819|FG000|Overall Study|Covid-19 Related Issues|2|||
49136885|NCT03915067|158340820|FG001|Overall Study|Covid-19 Related Issues|4|||
49136886|NCT03915067|158340821|FG002|Overall Study|Covid-19 Related Issues|4|||
49136887|NCT03915067|158340819|FG000|Overall Study|Randomized With Incorrect C-APPS|1|||
49136888|NCT03915067|158340820|FG001|Overall Study|Randomized With Incorrect C-APPS|0|||
49136889|NCT03915067|158340821|FG002|Overall Study|Randomized With Incorrect C-APPS|0|||
49136890|NCT03317496|158340823|FG000|Phase 1b Lead-in: Treatment|Adverse Event|3|||
49136891|NCT03317496|158340824|FG001|Phase 1b Lead-in: Treatment|Adverse Event|4|||
49136892|NCT03317496|158340825|FG002|Phase 1b Lead-in: Treatment|Adverse Event|1|||
49136893|NCT03317496|158340826|FG003|Phase 1b Lead-in: Treatment|Adverse Event|1|||
49136894|NCT03317496|158340827|FG004|Phase 1b Lead-in: Treatment|Adverse Event|0|||
49136895|NCT03317496|158340823|FG000|Phase 1b Lead-in: Treatment|Physician Decision|0|||
49136896|NCT03317496|158340824|FG001|Phase 1b Lead-in: Treatment|Physician Decision|1|||
49136897|NCT03317496|158340825|FG002|Phase 1b Lead-in: Treatment|Physician Decision|0|||
49136898|NCT03317496|158340826|FG003|Phase 1b Lead-in: Treatment|Physician Decision|0|||
49136899|NCT03317496|158340827|FG004|Phase 1b Lead-in: Treatment|Physician Decision|0|||
49136900|NCT03317496|158340823|FG000|Phase 1b Lead-in: Treatment|Death|0|||
49136901|NCT03317496|158340824|FG001|Phase 1b Lead-in: Treatment|Death|0|||
49136902|NCT03317496|158340825|FG002|Phase 1b Lead-in: Treatment|Death|1|||
49136903|NCT03317496|158340826|FG003|Phase 1b Lead-in: Treatment|Death|0|||
49136904|NCT03317496|158340827|FG004|Phase 1b Lead-in: Treatment|Death|0|||
49136905|NCT03317496|158340823|FG000|Phase 1b Lead-in: Treatment|Progressive Disease|1|||
49136906|NCT03317496|158340824|FG001|Phase 1b Lead-in: Treatment|Progressive Disease|6|||
49136907|NCT03317496|158340825|FG002|Phase 1b Lead-in: Treatment|Progressive Disease|3|||
49136908|NCT03317496|158340826|FG003|Phase 1b Lead-in: Treatment|Progressive Disease|4|||
49136909|NCT03317496|158340827|FG004|Phase 1b Lead-in: Treatment|Progressive Disease|0|||
49011360|NCT00936884|157878933|FG002|Double-blind|Did not receive study drug|0|||
49011361|NCT01314703|157878934|FG000|Overall Study|screen failure and closed enrollment|8|||
49011362|NCT00461500|157878937|FG000|Overall Study|Adverse Event|1|||
49011363|NCT00461500|157878938|FG001|Overall Study|Adverse Event|0|||
49011364|NCT00461500|157878937|FG000|Overall Study|Lack of Efficacy|0|||
49011365|NCT00461500|157878938|FG001|Overall Study|Lack of Efficacy|1|||
49011366|NCT00461500|157878937|FG000|Overall Study|Expired Drug Treatment|1|||
49011367|NCT00461500|157878938|FG001|Overall Study|Expired Drug Treatment|1|||
49011368|NCT00461500|157878937|FG000|Overall Study|Study Stopped|1|||
49011369|NCT00461500|157878938|FG001|Overall Study|Study Stopped|2|||
49011370|NCT00461500|157878937|FG000|Overall Study|Drug Treatment Misuse|1|||
49011371|NCT00461500|157878938|FG001|Overall Study|Drug Treatment Misuse|0|||
49011372|NCT00461500|157878937|FG000|Overall Study|No Longer Willing to Take Part in Study|1|||
49011373|NCT00461500|157878938|FG001|Overall Study|No Longer Willing to Take Part in Study|0|||
49011374|NCT00461500|157878937|FG000|Overall Study|Lost to Follow-up|2|||
49011375|NCT00461500|157878938|FG001|Overall Study|Lost to Follow-up|2|||
49011376|NCT01462695|157878941|FG000|Overall Study|Adverse Event|1|||
49011377|NCT01462695|157878942|FG001|Overall Study|Adverse Event|1|||
49011378|NCT01462695|157878941|FG000|Overall Study|Death|2|||
49011379|NCT01462695|157878942|FG001|Overall Study|Death|0|||
49011380|NCT01462695|157878941|FG000|Overall Study|Lack of Efficacy|6|||
49011381|NCT01462695|157878942|FG001|Overall Study|Lack of Efficacy|12|||
49011382|NCT01462695|157878941|FG000|Overall Study|Physician Decision|5|||
49011383|NCT01462695|157878942|FG001|Overall Study|Physician Decision|0|||
49011384|NCT01462695|157878941|FG000|Overall Study|Withdrawal by Subject|2|||
49011385|NCT01462695|157878942|FG001|Overall Study|Withdrawal by Subject|0|||
49011386|NCT01462695|157878941|FG000|Overall Study|Inevaluable (did not receive study drug)|1|||
49011387|NCT01462695|157878942|FG001|Overall Study|Inevaluable (did not receive study drug)|0|||
49011388|NCT01507831|157878943|FG000|Overall Study|Randomized but not treated|0|||
49011389|NCT01507831|157878944|FG001|Overall Study|Randomized but not treated|3|||
49011390|NCT01507831|157878943|FG000|Overall Study|Adverse Event|48|||
49011391|NCT01507831|157878944|FG001|Overall Study|Adverse Event|113|||
49011392|NCT01507831|157878943|FG000|Overall Study|Death|6|||
49011393|NCT01507831|157878944|FG001|Overall Study|Death|2|||
49011394|NCT01507831|157878943|FG000|Overall Study|Poor compliance to protocol|38|||
49011395|NCT01507831|157878944|FG001|Overall Study|Poor compliance to protocol|60|||
49011396|NCT01507831|157878943|FG000|Overall Study|Physician Decision|0|||
49011397|NCT01507831|157878944|FG001|Overall Study|Physician Decision|4|||
49011398|NCT01507831|157878943|FG000|Overall Study|Participant moved|5|||
49011399|NCT01507831|157878944|FG001|Overall Study|Participant moved|19|||
49011400|NCT01507831|157878943|FG000|Overall Study|Consent withdrawn by participant|34|||
49136910|NCT03317496|158340823|FG000|Phase 1b Lead-in: Treatment|Other|2|||
48820995|NCT03138512|157187335|FG004|Treatment Part A|Lost to Follow-up|0|||
49136911|NCT03317496|158340824|FG001|Phase 1b Lead-in: Treatment|Other|1|||
49136912|NCT03317496|158340825|FG002|Phase 1b Lead-in: Treatment|Other|0|||
49136913|NCT03317496|158340826|FG003|Phase 1b Lead-in: Treatment|Other|0|||
49136914|NCT03317496|158340827|FG004|Phase 1b Lead-in: Treatment|Other|0|||
49136915|NCT03317496|158340823|FG000|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
49136916|NCT03317496|158340824|FG001|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
49136917|NCT03317496|158340825|FG002|Phase 1b Lead-in: Treatment|Global deterioration of health status|1|||
49136918|NCT03317496|158340826|FG003|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
49136919|NCT03317496|158340827|FG004|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
49136920|NCT03317496|158340823|FG000|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
49136921|NCT03317496|158340824|FG001|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
49136922|NCT03317496|158340825|FG002|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
49136923|NCT03317496|158340826|FG003|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
49136924|NCT03317496|158340827|FG004|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
49136925|NCT03317496|158340823|FG000|Phase 1b Lead-in: Follow-up|Death|3|||
49136926|NCT03317496|158340824|FG001|Phase 1b Lead-in: Follow-up|Death|8|||
49136927|NCT03317496|158340825|FG002|Phase 1b Lead-in: Follow-up|Death|4|||
49136928|NCT03317496|158340826|FG003|Phase 1b Lead-in: Follow-up|Death|4|||
49136929|NCT03317496|158340827|FG004|Phase 1b Lead-in: Follow-up|Death|0|||
49136930|NCT03317496|158340823|FG000|Phase 1b Lead-in: Follow-up|Lost to Follow-up|1|||
49136931|NCT03317496|158340824|FG001|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
49136932|NCT03317496|158340825|FG002|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
49136933|NCT03317496|158340826|FG003|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
49136934|NCT03317496|158340827|FG004|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
49136935|NCT03317496|158340823|FG000|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
49136936|NCT03317496|158340824|FG001|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
49136937|NCT03317496|158340825|FG002|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|1|||
49136938|NCT03317496|158340826|FG003|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
49136939|NCT03317496|158340827|FG004|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
49136940|NCT03317496|158340823|FG000|Phase 1b Lead-in: Follow-up|Other|0|||
49136941|NCT03317496|158340824|FG001|Phase 1b Lead-in: Follow-up|Other|1|||
49136942|NCT03317496|158340825|FG002|Phase 1b Lead-in: Follow-up|Other|0|||
48820996|NCT03138512|157187331|FG000|Treatment Part A|Poor/non-compliance|1|||
49011401|NCT01507831|157878944|FG001|Overall Study|Consent withdrawn by participant|72|||
49011402|NCT01507831|157878943|FG000|Overall Study|Related to study drug administration|5|||
49136943|NCT03317496|158340826|FG003|Phase 1b Lead-in: Follow-up|Other|1|||
49136944|NCT03317496|158340827|FG004|Phase 1b Lead-in: Follow-up|Other|0|||
49136945|NCT03317496|158340823|FG000|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|2|||
49136946|NCT03317496|158340824|FG001|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|3|||
49136947|NCT03317496|158340825|FG002|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
49136948|NCT03317496|158340826|FG003|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|1|||
49136949|NCT03317496|158340827|FG004|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
49136950|NCT03317496|158340823|FG000|Phase 2: Treatment|Adverse Event|0|||
49136951|NCT03317496|158340824|FG001|Phase 2: Treatment|Adverse Event|0|||
49136952|NCT03317496|158340825|FG002|Phase 2: Treatment|Adverse Event|0|||
49136953|NCT03317496|158340826|FG003|Phase 2: Treatment|Adverse Event|0|||
49136954|NCT03317496|158340827|FG004|Phase 2: Treatment|Adverse Event|6|||
49136955|NCT03317496|158340823|FG000|Phase 2: Treatment|Progressive disease|0|||
49136956|NCT03317496|158340824|FG001|Phase 2: Treatment|Progressive disease|0|||
49136957|NCT03317496|158340825|FG002|Phase 2: Treatment|Progressive disease|0|||
49136958|NCT03317496|158340826|FG003|Phase 2: Treatment|Progressive disease|0|||
49136959|NCT03317496|158340827|FG004|Phase 2: Treatment|Progressive disease|22|||
49136960|NCT03317496|158340823|FG000|Phase 2: Treatment|Other|0|||
49136961|NCT03317496|158340824|FG001|Phase 2: Treatment|Other|0|||
49136962|NCT03317496|158340825|FG002|Phase 2: Treatment|Other|0|||
49136963|NCT03317496|158340826|FG003|Phase 2: Treatment|Other|0|||
49136964|NCT03317496|158340827|FG004|Phase 2: Treatment|Other|4|||
49136965|NCT03317496|158340823|FG000|Phase 2: Treatment|Withdrawal by Subject|0|||
49136966|NCT03317496|158340824|FG001|Phase 2: Treatment|Withdrawal by Subject|0|||
49136967|NCT03317496|158340825|FG002|Phase 2: Treatment|Withdrawal by Subject|0|||
49136968|NCT03317496|158340826|FG003|Phase 2: Treatment|Withdrawal by Subject|0|||
49136969|NCT03317496|158340827|FG004|Phase 2: Treatment|Withdrawal by Subject|1|||
49136970|NCT03317496|158340823|FG000|Phase 2: Treatment|Physician Decision|0|||
49136971|NCT03317496|158340824|FG001|Phase 2: Treatment|Physician Decision|0|||
48820997|NCT03138512|157187332|FG001|Treatment Part A|Poor/non-compliance|0|||
49136972|NCT03317496|158340825|FG002|Phase 2: Treatment|Physician Decision|0|||
49136973|NCT03317496|158340826|FG003|Phase 2: Treatment|Physician Decision|0|||
49136974|NCT03317496|158340827|FG004|Phase 2: Treatment|Physician Decision|1|||
49136975|NCT03317496|158340823|FG000|Phase 2: Treatment|Death|0|||
49136976|NCT03317496|158340824|FG001|Phase 2: Treatment|Death|0|||
49136977|NCT03317496|158340825|FG002|Phase 2: Treatment|Death|0|||
49136978|NCT03317496|158340826|FG003|Phase 2: Treatment|Death|0|||
49136979|NCT03317496|158340827|FG004|Phase 2: Treatment|Death|1|||
49136980|NCT03317496|158340823|FG000|Phase 2: Follow-up|Death|0|||
49136981|NCT03317496|158340824|FG001|Phase 2: Follow-up|Death|0|||
49136982|NCT03317496|158340825|FG002|Phase 2: Follow-up|Death|0|||
49136983|NCT03317496|158340826|FG003|Phase 2: Follow-up|Death|0|||
49136984|NCT03317496|158340827|FG004|Phase 2: Follow-up|Death|24|||
49136985|NCT03317496|158340823|FG000|Phase 2: Follow-up|Lost to Follow-up|0|||
49136986|NCT03317496|158340824|FG001|Phase 2: Follow-up|Lost to Follow-up|0|||
49136987|NCT03317496|158340825|FG002|Phase 2: Follow-up|Lost to Follow-up|0|||
49136988|NCT03317496|158340826|FG003|Phase 2: Follow-up|Lost to Follow-up|0|||
49136989|NCT03317496|158340827|FG004|Phase 2: Follow-up|Lost to Follow-up|1|||
49136990|NCT03317496|158340823|FG000|Phase 2: Follow-up|Other|0|||
49136991|NCT03317496|158340824|FG001|Phase 2: Follow-up|Other|0|||
49136992|NCT03317496|158340825|FG002|Phase 2: Follow-up|Other|0|||
49136993|NCT03317496|158340826|FG003|Phase 2: Follow-up|Other|0|||
49136994|NCT03317496|158340827|FG004|Phase 2: Follow-up|Other|1|||
49136995|NCT03317496|158340823|FG000|Phase 2: Follow-up|Study terminated by sponsor|0|||
49136996|NCT03317496|158340824|FG001|Phase 2: Follow-up|Study terminated by sponsor|0|||
49136997|NCT03317496|158340825|FG002|Phase 2: Follow-up|Study terminated by sponsor|0|||
49136998|NCT03317496|158340826|FG003|Phase 2: Follow-up|Study terminated by sponsor|0|||
49136999|NCT03317496|158340827|FG004|Phase 2: Follow-up|Study terminated by sponsor|7|||
49137000|NCT00316004|158340828|FG000|Overall Study|Subject was not given study fluid.|14|||
49137001|NCT00316004|158340829|FG001|Overall Study|Subject was not given study fluid.|14|||
49137002|NCT00316004|158340830|FG002|Overall Study|Subject was not given study fluid.|21|||
49137003|NCT01750346|158340832|FG000|Overall Study|Adverse Event|1|||
49137004|NCT01750346|158340833|FG001|Overall Study|Adverse Event|0|||
49137005|NCT01750346|158340834|FG002|Overall Study|Adverse Event|0|||
49137006|NCT00784875|158340835|FG000|Period A - Baseline|Entry Criteria Not Met|0|||
49137007|NCT00784875|158340836|FG001|Period A - Baseline|Entry Criteria Not Met|0|||
49137008|NCT00784875|158340837|FG002|Period A - Baseline|Entry Criteria Not Met|0|||
49137009|NCT00784875|158340838|FG003|Period A - Baseline|Entry Criteria Not Met|5|||
49137010|NCT00784875|158340835|FG000|Period A - Baseline|Adverse Event|0|||
49137011|NCT00784875|158340836|FG001|Period A - Baseline|Adverse Event|0|||
49137012|NCT00784875|158340837|FG002|Period A - Baseline|Adverse Event|0|||
49137013|NCT00784875|158340838|FG003|Period A - Baseline|Adverse Event|8|||
49137014|NCT00784875|158340835|FG000|Period A - Baseline|Protocol Violation|0|||
49137015|NCT00784875|158340836|FG001|Period A - Baseline|Protocol Violation|0|||
49137016|NCT00784875|158340837|FG002|Period A - Baseline|Protocol Violation|0|||
49137017|NCT00784875|158340838|FG003|Period A - Baseline|Protocol Violation|25|||
49137018|NCT00784875|158340835|FG000|Period A - Baseline|Withdrawal by Subject|0|||
49137019|NCT00784875|158340836|FG001|Period A - Baseline|Withdrawal by Subject|0|||
49137020|NCT00784875|158340837|FG002|Period A - Baseline|Withdrawal by Subject|0|||
49137021|NCT00784875|158340838|FG003|Period A - Baseline|Withdrawal by Subject|27|||
49137022|NCT00784875|158340835|FG000|Period A - Baseline|Physician Decision|0|||
49137023|NCT00784875|158340836|FG001|Period A - Baseline|Physician Decision|0|||
49137024|NCT00784875|158340837|FG002|Period A - Baseline|Physician Decision|0|||
49137025|NCT00784875|158340838|FG003|Period A - Baseline|Physician Decision|2|||
49137026|NCT00784875|158340835|FG000|Period A - Baseline|Sponsor Decision|0|||
49137027|NCT00784875|158340836|FG001|Period A - Baseline|Sponsor Decision|0|||
49137028|NCT00784875|158340837|FG002|Period A - Baseline|Sponsor Decision|0|||
49137029|NCT00784875|158340838|FG003|Period A - Baseline|Sponsor Decision|113|||
49137030|NCT00784875|158340835|FG000|Period A - Baseline|Lost to Follow-up|0|||
49137031|NCT00784875|158340836|FG001|Period A - Baseline|Lost to Follow-up|0|||
49137032|NCT00784875|158340837|FG002|Period A - Baseline|Lost to Follow-up|0|||
49137033|NCT00784875|158340838|FG003|Period A - Baseline|Lost to Follow-up|2|||
49137034|NCT00784875|158340835|FG000|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
49137035|NCT00784875|158340836|FG001|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
49137036|NCT00784875|158340837|FG002|Period B - Efficacy Endpoint|Entry Criteria Not Met|2|||
49137037|NCT00784875|158340838|FG003|Period B - Efficacy Endpoint|Entry Criteria Not Met|1|||
49137038|NCT00784875|158340835|FG000|Period B - Efficacy Endpoint|Adverse Event|0|||
49137039|NCT00784875|158340836|FG001|Period B - Efficacy Endpoint|Adverse Event|3|||
49137040|NCT00784875|158340837|FG002|Period B - Efficacy Endpoint|Adverse Event|2|||
49137041|NCT00784875|158340838|FG003|Period B - Efficacy Endpoint|Adverse Event|1|||
49137042|NCT00784875|158340835|FG000|Period B - Efficacy Endpoint|Protocol Violation|1|||
49137043|NCT00784875|158340836|FG001|Period B - Efficacy Endpoint|Protocol Violation|1|||
49137044|NCT00784875|158340837|FG002|Period B - Efficacy Endpoint|Protocol Violation|2|||
49137045|NCT00784875|158340838|FG003|Period B - Efficacy Endpoint|Protocol Violation|3|||
49137046|NCT00784875|158340835|FG000|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
49137047|NCT00784875|158340836|FG001|Period B - Efficacy Endpoint|Lack of Efficacy|1|||
49137048|NCT00784875|158340837|FG002|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
49137049|NCT00784875|158340838|FG003|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
49137050|NCT00784875|158340835|FG000|Period B - Efficacy Endpoint|Withdrawal by Subject|4|||
49137051|NCT00784875|158340836|FG001|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
49137052|NCT00784875|158340837|FG002|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
49137053|NCT00784875|158340838|FG003|Period B - Efficacy Endpoint|Withdrawal by Subject|2|||
49137054|NCT00784875|158340835|FG000|Period B - Efficacy Endpoint|Physician Decision|0|||
49137055|NCT00784875|158340836|FG001|Period B - Efficacy Endpoint|Physician Decision|0|||
49137056|NCT00784875|158340837|FG002|Period B - Efficacy Endpoint|Physician Decision|1|||
49137057|NCT00784875|158340838|FG003|Period B - Efficacy Endpoint|Physician Decision|0|||
49137058|NCT00784875|158340835|FG000|Period B - Efficacy Endpoint|Sponsor Decision|9|||
49137059|NCT00784875|158340836|FG001|Period B - Efficacy Endpoint|Sponsor Decision|6|||
49137060|NCT00784875|158340837|FG002|Period B - Efficacy Endpoint|Sponsor Decision|12|||
49137061|NCT00784875|158340838|FG003|Period B - Efficacy Endpoint|Sponsor Decision|12|||
49137062|NCT00784875|158340835|FG000|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
49137063|NCT00784875|158340836|FG001|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
49137064|NCT00784875|158340837|FG002|Period B - Efficacy Endpoint|Lost to Follow-up|1|||
49137065|NCT00784875|158340838|FG003|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
49137066|NCT00784875|158340835|FG000|Period C|Adverse Event|1|||
49137067|NCT00784875|158340836|FG001|Period C|Adverse Event|0|||
49137068|NCT00784875|158340837|FG002|Period C|Adverse Event|4|||
49137069|NCT00784875|158340838|FG003|Period C|Adverse Event|2|||
49137070|NCT00784875|158340835|FG000|Period C|Protocol Violation|0|||
49137071|NCT00784875|158340836|FG001|Period C|Protocol Violation|0|||
49137072|NCT00784875|158340837|FG002|Period C|Protocol Violation|1|||
49137073|NCT00784875|158340838|FG003|Period C|Protocol Violation|2|||
49137074|NCT00784875|158340835|FG000|Period C|Lack of Efficacy|0|||
49137075|NCT00784875|158340836|FG001|Period C|Lack of Efficacy|0|||
49137076|NCT00784875|158340837|FG002|Period C|Lack of Efficacy|1|||
49137077|NCT00784875|158340838|FG003|Period C|Lack of Efficacy|0|||
49137078|NCT00784875|158340835|FG000|Period C|Withdrawal by Subject|1|||
49137079|NCT00784875|158340836|FG001|Period C|Withdrawal by Subject|1|||
49137080|NCT00784875|158340837|FG002|Period C|Withdrawal by Subject|2|||
49137081|NCT00784875|158340838|FG003|Period C|Withdrawal by Subject|0|||
49137082|NCT00784875|158340835|FG000|Period C|Physician Decision|0|||
49137083|NCT00784875|158340836|FG001|Period C|Physician Decision|0|||
49137084|NCT00784875|158340837|FG002|Period C|Physician Decision|1|||
49137085|NCT00784875|158340838|FG003|Period C|Physician Decision|1|||
49137086|NCT00784875|158340835|FG000|Period C|Sponsor Decision|5|||
49137087|NCT00784875|158340836|FG001|Period C|Sponsor Decision|5|||
49137088|NCT00784875|158340837|FG002|Period C|Sponsor Decision|4|||
49137089|NCT00784875|158340838|FG003|Period C|Sponsor Decision|2|||
49137090|NCT00784875|158340835|FG000|Period D|Adverse Event|0|||
49137091|NCT00784875|158340836|FG001|Period D|Adverse Event|2|||
49137092|NCT00784875|158340837|FG002|Period D|Adverse Event|2|||
49137093|NCT00784875|158340838|FG003|Period D|Adverse Event|0|||
49137094|NCT00784875|158340835|FG000|Period D|Protocol Violation|1|||
49137095|NCT00784875|158340836|FG001|Period D|Protocol Violation|0|||
49137096|NCT00784875|158340837|FG002|Period D|Protocol Violation|0|||
49137097|NCT00784875|158340838|FG003|Period D|Protocol Violation|0|||
49137098|NCT00784875|158340835|FG000|Period D|Withdrawal by Subject|2|||
49137099|NCT00784875|158340836|FG001|Period D|Withdrawal by Subject|0|||
49137100|NCT00784875|158340837|FG002|Period D|Withdrawal by Subject|2|||
49137101|NCT00784875|158340838|FG003|Period D|Withdrawal by Subject|0|||
49137102|NCT00784875|158340835|FG000|Period D|Physician Decision|0|||
49137103|NCT00784875|158340836|FG001|Period D|Physician Decision|1|||
49137104|NCT00784875|158340837|FG002|Period D|Physician Decision|0|||
49137105|NCT00784875|158340838|FG003|Period D|Physician Decision|0|||
49137106|NCT00784875|158340835|FG000|Period D|Sponsor Decision|1|||
49137107|NCT00784875|158340836|FG001|Period D|Sponsor Decision|1|||
49137108|NCT00784875|158340837|FG002|Period D|Sponsor Decision|1|||
49137109|NCT00784875|158340838|FG003|Period D|Sponsor Decision|0|||
49137110|NCT00784875|158340835|FG000|Period D|Lost to Follow-up|1|||
49137111|NCT00784875|158340836|FG001|Period D|Lost to Follow-up|0|||
49137112|NCT00784875|158340837|FG002|Period D|Lost to Follow-up|1|||
49137113|NCT00784875|158340838|FG003|Period D|Lost to Follow-up|1|||
49137114|NCT02782468|158340839|FG000|Overall Study|Progressive Disease|2|||
49137115|NCT02782468|158340840|FG001|Overall Study|Progressive Disease|5|||
49137116|NCT02782468|158340841|FG002|Overall Study|Progressive Disease|0|||
49137117|NCT02782468|158340842|FG003|Overall Study|Progressive Disease|4|||
49137118|NCT02782468|158340839|FG000|Overall Study|Adverse Event|0|||
49137119|NCT02782468|158340840|FG001|Overall Study|Adverse Event|2|||
49137120|NCT02782468|158340841|FG002|Overall Study|Adverse Event|2|||
49137121|NCT02782468|158340842|FG003|Overall Study|Adverse Event|3|||
49137122|NCT02782468|158340839|FG000|Overall Study|Other|0|||
49137123|NCT02782468|158340840|FG001|Overall Study|Other|0|||
49137124|NCT02782468|158340841|FG002|Overall Study|Other|1|||
49137125|NCT02782468|158340842|FG003|Overall Study|Other|1|||
49137126|NCT02782468|158340839|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
49137127|NCT02782468|158340840|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
49137128|NCT02782468|158340841|FG002|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
49137129|NCT02782468|158340842|FG003|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|1|||
49137130|NCT02782468|158340839|FG000|Overall Study|Symptomatic Deterioration|0|||
49137131|NCT02782468|158340840|FG001|Overall Study|Symptomatic Deterioration|0|||
49137132|NCT02782468|158340841|FG002|Overall Study|Symptomatic Deterioration|0|||
49137133|NCT02782468|158340842|FG003|Overall Study|Symptomatic Deterioration|1|||
49137134|NCT02782468|158340839|FG000|Overall Study|Withdrawal by Subject|1|||
49137135|NCT02782468|158340840|FG001|Overall Study|Withdrawal by Subject|0|||
49137136|NCT02782468|158340841|FG002|Overall Study|Withdrawal by Subject|0|||
49137137|NCT02782468|158340842|FG003|Overall Study|Withdrawal by Subject|0|||
49137138|NCT00313170|158340843|FG000|Overall Study|Death|2|||
49137139|NCT00313170|158340844|FG001|Overall Study|Death|4|||
49137140|NCT00313170|158340845|FG002|Overall Study|Death|2|||
48921045|NCT01026831|157544823|FG001|Overall Study|Adverse Event|3|||
49137141|NCT00313170|158340843|FG000|Overall Study|Adverse Event|1|||
49137142|NCT00313170|158340844|FG001|Overall Study|Adverse Event|2|||
49137143|NCT00313170|158340845|FG002|Overall Study|Adverse Event|0|||
49137144|NCT00313170|158340843|FG000|Overall Study|Disease progression|31|||
49137145|NCT00313170|158340844|FG001|Overall Study|Disease progression|26|||
49137146|NCT00313170|158340845|FG002|Overall Study|Disease progression|27|||
49137147|NCT00313170|158340843|FG000|Overall Study|Withdrawal by Subject|1|||
49137148|NCT00313170|158340844|FG001|Overall Study|Withdrawal by Subject|0|||
49137149|NCT00313170|158340845|FG002|Overall Study|Withdrawal by Subject|1|||
49137150|NCT00313170|158340843|FG000|Overall Study|Incorrect enrollment|0|||
49137151|NCT00313170|158340844|FG001|Overall Study|Incorrect enrollment|2|||
49137152|NCT00313170|158340845|FG002|Overall Study|Incorrect enrollment|1|||
49137153|NCT00313170|158340843|FG000|Overall Study|Lost to Follow-up|0|||
49137154|NCT00313170|158340844|FG001|Overall Study|Lost to Follow-up|0|||
49137155|NCT00313170|158340845|FG002|Overall Study|Lost to Follow-up|1|||
49137156|NCT00313170|158340843|FG000|Overall Study|Progression (investigators opinion)|1|||
49137157|NCT00313170|158340844|FG001|Overall Study|Progression (investigators opinion)|0|||
49137158|NCT00313170|158340845|FG002|Overall Study|Progression (investigators opinion)|0|||
49137159|NCT01155141|158340857|FG000|Overall Study|Withdrawal by Subject|1|||
49137160|NCT01155141|158340857|FG000|Overall Study|Screen Failure|1|||
49137161|NCT03473197|158340858|FG000|Overall Study|Adverse Event|4|||
49137162|NCT03473197|158340858|FG000|Overall Study|Lost to Follow-up|1|||
49137163|NCT03473197|158340858|FG000|Overall Study|Withdrawal by Subject|5|||
49137164|NCT00785629|158340859|FG000|Overall Study|Adverse Event|2|||
49137165|NCT00785629|158340860|FG001|Overall Study|Adverse Event|1|||
49137166|NCT00785629|158340861|FG002|Overall Study|Adverse Event|1|||
49137167|NCT00785629|158340862|FG003|Overall Study|Adverse Event|5|||
49137168|NCT00785629|158340859|FG000|Overall Study|Protocol Violation|1|||
49137169|NCT00785629|158340860|FG001|Overall Study|Protocol Violation|2|||
49137170|NCT00785629|158340861|FG002|Overall Study|Protocol Violation|4|||
49137171|NCT00785629|158340862|FG003|Overall Study|Protocol Violation|5|||
49137172|NCT00785629|158340859|FG000|Overall Study|administrative decision|5|||
49137173|NCT00785629|158340860|FG001|Overall Study|administrative decision|1|||
49137174|NCT00785629|158340861|FG002|Overall Study|administrative decision|3|||
49137175|NCT00785629|158340862|FG003|Overall Study|administrative decision|4|||
49137176|NCT00785629|158340859|FG000|Overall Study|Withdrawal by Subject|0|||
49137177|NCT00785629|158340860|FG001|Overall Study|Withdrawal by Subject|1|||
49137178|NCT00785629|158340861|FG002|Overall Study|Withdrawal by Subject|2|||
49137179|NCT00785629|158340862|FG003|Overall Study|Withdrawal by Subject|2|||
49137180|NCT04919161|158340865|FG000|Overall Study|Early participant discharge from rehabilitation program after session 4|1|||
49137181|NCT04919161|158340866|FG001|Overall Study|Early participant discharge from rehabilitation program after session 4|0|||
49137182|NCT04919161|158340865|FG000|Overall Study|Flare-up of existing orthopedic condition after session 4|0|||
49137183|NCT04919161|158340866|FG001|Overall Study|Flare-up of existing orthopedic condition after session 4|1|||
49137184|NCT04919161|158340865|FG000|Overall Study|Acute ankle sprain after session 1|0|||
49137185|NCT04919161|158340866|FG001|Overall Study|Acute ankle sprain after session 1|1|||
49137186|NCT02110693|158340872|FG000|Overall Study|Withdrawal by Subject|6|||
49137187|NCT02110693|158340873|FG001|Overall Study|Withdrawal by Subject|7|||
49137188|NCT02110693|158340872|FG000|Overall Study|skipped assessment|15|||
49137189|NCT02110693|158340873|FG001|Overall Study|skipped assessment|18|||
49137190|NCT02110693|158340872|FG000|Overall Study|technical difficulties|6|||
49137191|NCT02110693|158340873|FG001|Overall Study|technical difficulties|4|||
49137192|NCT02110693|158340872|FG000|Overall Study|Other|1|||
49137193|NCT02110693|158340873|FG001|Overall Study|Other|0|||
49137194|NCT00447278|158340874|FG000|Period II (6 Month Open-Label)|Adverse Event|7|||
49137195|NCT00447278|158340875|FG001|Period II (6 Month Open-Label)|Adverse Event|3|||
49137196|NCT00447278|158340874|FG000|Period II (6 Month Open-Label)|Lost to Follow-up|0|||
49137197|NCT00447278|158340875|FG001|Period II (6 Month Open-Label)|Lost to Follow-up|4|||
49137198|NCT00447278|158340874|FG000|Period II (6 Month Open-Label)|Protocol Violation|10|||
49137199|NCT00447278|158340875|FG001|Period II (6 Month Open-Label)|Protocol Violation|7|||
49137200|NCT00447278|158340874|FG000|Period II (6 Month Open-Label)|Withdrawal by Subject|1|||
48921046|NCT01026831|157544822|FG000|Overall Study|Lost to Follow-up|2|||
49137201|NCT00447278|158340875|FG001|Period II (6 Month Open-Label)|Withdrawal by Subject|3|||
49137202|NCT00447278|158340874|FG000|Period II (6 Month Open-Label)|Physician Decision|4|||
49137203|NCT00447278|158340875|FG001|Period II (6 Month Open-Label)|Physician Decision|1|||
49137204|NCT00447278|158340874|FG000|Period II (6 Month Open-Label)|Lack of Efficacy|11|||
49137205|NCT00447278|158340875|FG001|Period II (6 Month Open-Label)|Lack of Efficacy|1|||
49137206|NCT00447278|158340874|FG000|Period II (6 Month Open-Label)|Parent/Guardian Decision|9|||
49137207|NCT00447278|158340875|FG001|Period II (6 Month Open-Label)|Parent/Guardian Decision|10|||
49137208|NCT00447278|158340874|FG000|Period III (Optional 6 Month Extension)|Adverse Event|2|||
49137209|NCT00447278|158340875|FG001|Period III (Optional 6 Month Extension)|Adverse Event|2|||
49137210|NCT00447278|158340874|FG000|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
49137211|NCT00447278|158340875|FG001|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
49137212|NCT00447278|158340874|FG000|Period III (Optional 6 Month Extension)|Protocol Violation|6|||
49137213|NCT00447278|158340875|FG001|Period III (Optional 6 Month Extension)|Protocol Violation|1|||
49137214|NCT00447278|158340874|FG000|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4|||
49137215|NCT00447278|158340875|FG001|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1|||
49137216|NCT00447278|158340874|FG000|Period III (Optional 6 Month Extension)|Physician Decision|1|||
49137217|NCT00447278|158340875|FG001|Period III (Optional 6 Month Extension)|Physician Decision|1|||
49137218|NCT00447278|158340874|FG000|Period III (Optional 6 Month Extension)|Lack of Efficacy|4|||
49137219|NCT00447278|158340875|FG001|Period III (Optional 6 Month Extension)|Lack of Efficacy|0|||
49137220|NCT00447278|158340874|FG000|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11|||
49137221|NCT00447278|158340875|FG001|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8|||
49137222|NCT02595749|158340876|FG000|Overall Study|Withdrawal by Subject|12|||
49137223|NCT02595749|158340877|FG001|Overall Study|Withdrawal by Subject|7|||
49137224|NCT01047501|158340878|FG000|Overall Study|Adverse Event|7|||
49137225|NCT01047501|158340879|FG001|Overall Study|Adverse Event|8|||
49137226|NCT01047501|158340880|FG002|Overall Study|Adverse Event|5|||
49137227|NCT01047501|158340878|FG000|Overall Study|Withdrew Consent|6|||
49137228|NCT01047501|158340879|FG001|Overall Study|Withdrew Consent|2|||
49137229|NCT01047501|158340880|FG002|Overall Study|Withdrew Consent|4|||
49137230|NCT01047501|158340878|FG000|Overall Study|Lost to Follow-up|0|||
49137231|NCT01047501|158340879|FG001|Overall Study|Lost to Follow-up|1|||
49137232|NCT01047501|158340880|FG002|Overall Study|Lost to Follow-up|1|||
49137233|NCT01047501|158340878|FG000|Overall Study|Triglycerides >800 mg/dL|1|||
49137234|NCT01047501|158340879|FG001|Overall Study|Triglycerides >800 mg/dL|0|||
49137235|NCT01047501|158340880|FG002|Overall Study|Triglycerides >800 mg/dL|0|||
49137236|NCT01047501|158340878|FG000|Overall Study|Death|1|||
49137237|NCT01047501|158340879|FG001|Overall Study|Death|0|||
49137238|NCT01047501|158340880|FG002|Overall Study|Death|0|||
49137239|NCT01047501|158340878|FG000|Overall Study|Other discontinuation|1|||
49137240|NCT01047501|158340879|FG001|Overall Study|Other discontinuation|0|||
49137241|NCT01047501|158340880|FG002|Overall Study|Other discontinuation|1|||
49137242|NCT01047501|158340878|FG000|Overall Study|Investigator judgement|0|||
49137243|NCT01047501|158340879|FG001|Overall Study|Investigator judgement|0|||
49137244|NCT01047501|158340880|FG002|Overall Study|Investigator judgement|1|||
49137245|NCT01039675|158340881|FG000|Overall Study|Adverse Event|0|||
49137246|NCT01039675|158340882|FG001|Overall Study|Adverse Event|2|||
49137247|NCT01039675|158340881|FG000|Overall Study|Lack of Efficacy|0|||
49137248|NCT01039675|158340882|FG001|Overall Study|Lack of Efficacy|2|||
49137249|NCT01039675|158340881|FG000|Overall Study|Withdrawal by Subject|0|||
49137250|NCT01039675|158340882|FG001|Overall Study|Withdrawal by Subject|1|||
49137251|NCT01039675|158340881|FG000|Overall Study|Lost to Follow-up|0|||
49137252|NCT01039675|158340882|FG001|Overall Study|Lost to Follow-up|1|||
49137253|NCT01039675|158340881|FG000|Overall Study|Physician Decision|0|||
49137254|NCT01039675|158340882|FG001|Overall Study|Physician Decision|1|||
49137255|NCT01562444|158340883|FG000|Overall Study|Did not meet entry criteria|2|||
49137256|NCT01562444|158340884|FG001|Overall Study|Did not meet entry criteria|0|||
49137257|NCT01562444|158340885|FG002|Overall Study|Did not meet entry criteria|3|||
49137258|NCT01562444|158340883|FG000|Overall Study|Did not comply with blood draw schedule|1|||
49137259|NCT01562444|158340884|FG001|Overall Study|Did not comply with blood draw schedule|0|||
49137260|NCT01562444|158340885|FG002|Overall Study|Did not comply with blood draw schedule|1|||
49137261|NCT01562444|158340883|FG000|Overall Study|Unavailable serological results|0|||
49137262|NCT01562444|158340884|FG001|Overall Study|Unavailable serological results|2|||
49137263|NCT01562444|158340885|FG002|Overall Study|Unavailable serological results|2|||
49137264|NCT01562444|158340883|FG000|Overall Study|Protocol forbidden concomitant vaccine|1|||
49137265|NCT01562444|158340884|FG001|Overall Study|Protocol forbidden concomitant vaccine|0|||
49137266|NCT01562444|158340885|FG002|Overall Study|Protocol forbidden concomitant vaccine|1|||
49137267|NCT01562444|158340883|FG000|Overall Study|Protocol forbidden medication|1|||
49137268|NCT01562444|158340884|FG001|Overall Study|Protocol forbidden medication|0|||
49137269|NCT01562444|158340885|FG002|Overall Study|Protocol forbidden medication|0|||
49137270|NCT01177410|158340886|FG000|Overall Study|Adverse Event|0|||
49137271|NCT01177410|158340887|FG001|Overall Study|Adverse Event|2|||
49137272|NCT01177410|158340888|FG002|Overall Study|Adverse Event|2|||
48726401|NCT00064298|156847966|FG000|Overall Study|Disease Progression|2|||
48726402|NCT00064298|156847967|FG001|Overall Study|Disease Progression|1|||
48726403|NCT01569464|156847968|FG000|Overall Study|Adverse Event|4|||
48726404|NCT01569464|156847969|FG001|Overall Study|Adverse Event|0|||
48726405|NCT01569464|156847968|FG000|Overall Study|Lack of Efficacy|1|||
48726406|NCT01569464|156847969|FG001|Overall Study|Lack of Efficacy|0|||
48820998|NCT03138512|157187333|FG002|Treatment Part A|Poor/non-compliance|0|||
48820999|NCT03138512|157187334|FG003|Treatment Part A|Poor/non-compliance|0|||
48821000|NCT03138512|157187335|FG004|Treatment Part A|Poor/non-compliance|0|||
48821001|NCT03138512|157187331|FG000|Treatment Part A|Pregnancy|0|||
48821002|NCT03138512|157187332|FG001|Treatment Part A|Pregnancy|1|||
49137273|NCT01177410|158340886|FG000|Overall Study|Withdrawal by Subject|1|||
49137274|NCT01177410|158340887|FG001|Overall Study|Withdrawal by Subject|4|||
49137275|NCT01177410|158340888|FG002|Overall Study|Withdrawal by Subject|3|||
49137276|NCT01177410|158340886|FG000|Overall Study|Lost to Follow-up|0|||
48726407|NCT01569464|156847968|FG000|Overall Study|Protocol Violation|1|||
48726408|NCT01569464|156847969|FG001|Overall Study|Protocol Violation|0|||
48726409|NCT01569464|156847968|FG000|Overall Study|Lost to Follow-up|2|||
48726410|NCT01569464|156847969|FG001|Overall Study|Lost to Follow-up|3|||
49137277|NCT01177410|158340887|FG001|Overall Study|Lost to Follow-up|1|||
49137278|NCT01177410|158340888|FG002|Overall Study|Lost to Follow-up|0|||
49137279|NCT03483103|158340889|FG000|Pre-Treatment Phase|Other reasons|1|||
49137280|NCT03483103|158340889|FG000|Pre-Treatment Phase|No longer meets eligibility criteria|4|||
49137281|NCT03483103|158340889|FG000|Pre-Treatment Phase|Disease-related complications|1|||
49137282|NCT03483103|158340889|FG000|Pre-Treatment Phase|Death|5|||
49137283|NCT03483103|158340889|FG000|Treatment Phase|Withdrawal by Subject|7|||
49137284|NCT03483103|158340889|FG000|Treatment Phase|Other reasons|1|||
49137285|NCT03483103|158340889|FG000|Treatment Phase|Death|23|||
49137286|NCT03483103|158340889|FG000|Treatment Phase|Did not receive either JAR017 or nonconforming product|1|||
49137287|NCT03483103|158340889|FG000|Treatment Phase|Received nonconforming product|1|||
49137288|NCT04727749|158340890|FG000|Overall Study|Lost to Follow-up|10|||
49137289|NCT04727749|158340891|FG001|Overall Study|Lost to Follow-up|3|||
49137290|NCT01555931|158340892|FG000|Overall Study|Lost to Follow-up|2|||
49137291|NCT01555931|158340893|FG001|Overall Study|Lost to Follow-up|5|||
49137292|NCT00429299|158340894|FG000|Overall Study|Disease Progression|1|||
49137293|NCT00429299|158340895|FG001|Overall Study|Disease Progression|1|||
49137294|NCT00429299|158340896|FG002|Overall Study|Disease Progression|0|||
49137295|NCT00429299|158340894|FG000|Overall Study|Adverse Event|2|||
49137296|NCT00429299|158340895|FG001|Overall Study|Adverse Event|5|||
49137297|NCT00429299|158340896|FG002|Overall Study|Adverse Event|1|||
49137298|NCT00429299|158340894|FG000|Overall Study|Protocol Violation|1|||
49137299|NCT00429299|158340895|FG001|Overall Study|Protocol Violation|0|||
49137300|NCT00429299|158340896|FG002|Overall Study|Protocol Violation|0|||
49137301|NCT00429299|158340894|FG000|Overall Study|Withdrawal by Subject|0|||
49137302|NCT00429299|158340895|FG001|Overall Study|Withdrawal by Subject|1|||
49137303|NCT00429299|158340896|FG002|Overall Study|Withdrawal by Subject|3|||
49137304|NCT01180777|158340902|FG000|Overall Study|Protocol Violation|6|||
49137305|NCT01180777|158340902|FG000|Overall Study|Poor lens fit|4|||
49137306|NCT01180777|158340902|FG000|Overall Study|Lost to Follow-up|1|||
49137307|NCT01180777|158340902|FG000|Overall Study|Adverse Event|1|||
49137308|NCT02441283|158340906|FG000|Overall Study|Withdrew consent|15|||
49137309|NCT02441283|158340906|FG000|Overall Study|Lost to Follow-up|42|||
49137310|NCT02441283|158340906|FG000|Overall Study|Death|1|||
49137311|NCT02441283|158340906|FG000|Overall Study|Other, not specified|32|||
49137312|NCT03880565|158340907|FG000|Overall Study|Withdrawal by Subject|1|||
49137313|NCT03880565|158340908|FG001|Overall Study|Withdrawal by Subject|0|||
49137314|NCT00226655|158340910|FG000|Overall Study|Death|13|||
49137315|NCT00226655|158340910|FG000|Overall Study|Withdrawal by Subject|15|||
49137316|NCT00226655|158340910|FG000|Overall Study|Adverse Event|35|||
49137317|NCT00226655|158340910|FG000|Overall Study|Physician Decision|6|||
49137318|NCT00226655|158340910|FG000|Overall Study|Clinical deterioration|10|||
49137319|NCT03329001|158340911|FG000|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
49137320|NCT03329001|158340912|FG001|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
49137321|NCT03329001|158340913|FG002|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|5|||
49137322|NCT03329001|158340914|FG003|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|6|||
49137323|NCT03329001|158340915|FG004|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
49137324|NCT03329001|158340916|FG005|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
49137325|NCT03329001|158340917|FG006|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
49137326|NCT03329001|158340918|FG007|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
49137327|NCT03329001|158340911|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
49137328|NCT03329001|158340912|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
48821003|NCT03138512|157187333|FG002|Treatment Part A|Pregnancy|0|||
48726411|NCT01569464|156847968|FG000|Overall Study|Withdrawal by Subject|1|||
48726412|NCT01569464|156847969|FG001|Overall Study|Withdrawal by Subject|1|||
49137329|NCT03329001|158340913|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
49137330|NCT03329001|158340914|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|1|||
49137331|NCT03329001|158340915|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
49137332|NCT03329001|158340916|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
49137333|NCT03329001|158340917|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
49137334|NCT03329001|158340918|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
49137335|NCT03329001|158340911|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
49137336|NCT03329001|158340912|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
49137337|NCT03329001|158340913|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
49137338|NCT03329001|158340914|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|1|||
49137339|NCT03329001|158340915|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
49137340|NCT03329001|158340916|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
49137341|NCT03329001|158340917|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
49137342|NCT03329001|158340918|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
49137343|NCT03329001|158340911|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
49137344|NCT03329001|158340912|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
49137345|NCT03329001|158340913|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
49137346|NCT03329001|158340914|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|1|||
49137347|NCT03329001|158340915|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
49137348|NCT03329001|158340916|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
49137349|NCT03329001|158340917|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
49137350|NCT03329001|158340918|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
49137351|NCT03329001|158340911|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
49137352|NCT03329001|158340912|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
49137353|NCT03329001|158340913|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|1|||
49137354|NCT03329001|158340914|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
49137355|NCT03329001|158340915|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
49137356|NCT03329001|158340916|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
49137357|NCT03329001|158340917|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
49137358|NCT03329001|158340918|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
49137359|NCT03329001|158340911|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
49137360|NCT03329001|158340912|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
49137361|NCT03329001|158340913|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|1|||
49137362|NCT03329001|158340914|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
49137363|NCT03329001|158340915|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
49137364|NCT03329001|158340916|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
49137365|NCT03329001|158340917|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
49137366|NCT03329001|158340918|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
49137367|NCT03329001|158340911|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
49137368|NCT03329001|158340912|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
49137369|NCT03329001|158340913|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|1|||
49137370|NCT03329001|158340914|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
49137371|NCT03329001|158340915|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
49137372|NCT03329001|158340916|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
49137373|NCT03329001|158340917|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
49137374|NCT03329001|158340918|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
49137375|NCT03329001|158340911|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
48726413|NCT01569464|156847968|FG000|Overall Study|Other|1|||
48726414|NCT01569464|156847969|FG001|Overall Study|Other|1|||
48726415|NCT04010539|156847970|FG000|Overall Study|Withdrawal by Subject|4|||
48726416|NCT04010539|156847971|FG001|Overall Study|Withdrawal by Subject|1|||
48726417|NCT04010539|156847970|FG000|Overall Study|Physician Decision|0|||
48726418|NCT04010539|156847971|FG001|Overall Study|Physician Decision|2|||
48921047|NCT01026831|157544823|FG001|Overall Study|Lost to Follow-up|0|||
49137376|NCT03329001|158340912|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
49137377|NCT03329001|158340913|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|1|||
49137378|NCT03329001|158340914|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
49137379|NCT03329001|158340915|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
49137380|NCT03329001|158340916|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
49137381|NCT03329001|158340917|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
49137382|NCT03329001|158340918|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
49137383|NCT03329001|158340911|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
49137384|NCT03329001|158340912|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
49137385|NCT03329001|158340913|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
48726419|NCT04010539|156847970|FG000|Overall Study|Lost to Follow-up|10|||
48726420|NCT04010539|156847971|FG001|Overall Study|Lost to Follow-up|14|||
49137386|NCT03329001|158340914|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
49137387|NCT03329001|158340915|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
48726421|NCT04010539|156847970|FG000|Overall Study|Adverse Event|3|||
48726422|NCT04010539|156847971|FG001|Overall Study|Adverse Event|0|||
48726423|NCT04010539|156847970|FG000|Overall Study|Participant Did Not Receive IP|0|||
48726424|NCT04010539|156847971|FG001|Overall Study|Participant Did Not Receive IP|1|||
48726425|NCT04010539|156847970|FG000|Overall Study|Protocol Deviation|0|||
48821004|NCT03138512|157187334|FG003|Treatment Part A|Pregnancy|0|||
48821005|NCT03138512|157187335|FG004|Treatment Part A|Pregnancy|0|||
48821006|NCT03138512|157187331|FG000|Treatment Part A|Other reasons|11|||
48821007|NCT03138512|157187332|FG001|Treatment Part A|Other reasons|8|||
48821008|NCT03138512|157187333|FG002|Treatment Part A|Other reasons|0|||
48821009|NCT03138512|157187334|FG003|Treatment Part A|Other reasons|0|||
48821010|NCT03138512|157187335|FG004|Treatment Part A|Other reasons|0|||
48821011|NCT03138512|157187331|FG000|Treatment Part B|Disease recurrence|0|||
48821012|NCT03138512|157187332|FG001|Treatment Part B|Disease recurrence|0|||
48821013|NCT03138512|157187333|FG002|Treatment Part B|Disease recurrence|6|||
48821014|NCT03138512|157187334|FG003|Treatment Part B|Disease recurrence|12|||
48726426|NCT04010539|156847971|FG001|Overall Study|Protocol Deviation|1|||
49137388|NCT03329001|158340916|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
49137389|NCT03329001|158340917|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
49137390|NCT03329001|158340918|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
48726427|NCT04010539|156847970|FG000|Overall Study|Randomized in Error/ Mistake|2|||
48726428|NCT04010539|156847971|FG001|Overall Study|Randomized in Error/ Mistake|0|||
48726429|NCT04010539|156847970|FG000|Overall Study|Eligibility Criteria Unable to Evaluate|1|||
48726430|NCT04010539|156847971|FG001|Overall Study|Eligibility Criteria Unable to Evaluate|0|||
48726431|NCT00322153|156847972|FG000|Overall Study|Adverse Event|21|||
48726432|NCT00322153|156847973|FG001|Overall Study|Adverse Event|34|||
48821015|NCT03138512|157187335|FG004|Treatment Part B|Disease recurrence|10|||
49137391|NCT03329001|158340911|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
49137392|NCT03329001|158340912|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
49137393|NCT03329001|158340913|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|1|||
49137394|NCT03329001|158340914|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
49137395|NCT03329001|158340915|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
49137396|NCT03329001|158340916|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
49137397|NCT03329001|158340917|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
49137398|NCT03329001|158340918|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
49137399|NCT03329001|158340911|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
49137400|NCT03329001|158340912|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
49137401|NCT03329001|158340913|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
49137402|NCT03329001|158340914|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
49137403|NCT03329001|158340915|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
49137404|NCT03329001|158340916|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
49137405|NCT03329001|158340917|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
49137406|NCT03329001|158340918|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
49137407|NCT03329001|158340911|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
49137408|NCT03329001|158340912|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
49137409|NCT03329001|158340913|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|5|||
49137410|NCT03329001|158340914|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|2|||
49137411|NCT03329001|158340915|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
48726433|NCT00322153|156847972|FG000|Overall Study|Protocol Violation|6|||
48821016|NCT03138512|157187331|FG000|Treatment Part B|Study drug toxicity|0|||
48921048|NCT01026831|157544822|FG000|Overall Study|Physician Decision|1|||
49137412|NCT03329001|158340916|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
48726434|NCT00322153|156847973|FG001|Overall Study|Protocol Violation|14|||
48726435|NCT00322153|156847972|FG000|Overall Study|Withdrawal by Subject|18|||
49137413|NCT03329001|158340917|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
49137414|NCT03329001|158340918|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
49137415|NCT03329001|158340911|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
49137416|NCT03329001|158340912|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
49137417|NCT03329001|158340913|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Death|1|||
49137418|NCT03329001|158340914|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Death|2|||
49137419|NCT03329001|158340915|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
49137420|NCT03329001|158340916|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
49137421|NCT03329001|158340917|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
49137422|NCT03329001|158340918|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
49137423|NCT03329001|158340911|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
49137424|NCT03329001|158340912|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
49137425|NCT03329001|158340913|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
49137426|NCT03329001|158340914|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|1|||
49137427|NCT03329001|158340915|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
49137428|NCT03329001|158340916|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
49137429|NCT03329001|158340917|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
49137430|NCT03329001|158340918|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
49137431|NCT03329001|158340911|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
49137432|NCT03329001|158340912|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
49137433|NCT03329001|158340913|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
49137434|NCT03329001|158340914|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|1|||
49137435|NCT03329001|158340915|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
49137436|NCT03329001|158340916|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
49137437|NCT03329001|158340917|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
49137438|NCT03329001|158340918|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
49137439|NCT03329001|158340911|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
49137440|NCT03329001|158340912|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
49137441|NCT03329001|158340913|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|1|||
49137442|NCT03329001|158340914|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
49137443|NCT03329001|158340915|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
49137444|NCT03329001|158340916|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
49137445|NCT03329001|158340917|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
49137446|NCT03329001|158340918|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
49137447|NCT03329001|158340911|FG000|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
49137448|NCT03329001|158340912|FG001|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
49137449|NCT03329001|158340913|FG002|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
49137450|NCT03329001|158340914|FG003|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
49137451|NCT03329001|158340915|FG004|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
49137452|NCT03329001|158340916|FG005|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
49137453|NCT03329001|158340917|FG006|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
49137454|NCT03329001|158340918|FG007|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
49137455|NCT03329001|158340911|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
49137456|NCT03329001|158340912|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
49137457|NCT03329001|158340913|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|1|||
49137458|NCT03329001|158340914|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
49137459|NCT03329001|158340915|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
49137460|NCT03329001|158340916|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
49137461|NCT03329001|158340917|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
49137462|NCT03329001|158340918|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
48726436|NCT00322153|156847973|FG001|Overall Study|Withdrawal by Subject|10|||
48726437|NCT00322153|156847972|FG000|Overall Study|Lack of Efficacy|8|||
48726438|NCT00322153|156847973|FG001|Overall Study|Lack of Efficacy|3|||
49137463|NCT03329001|158340911|FG000|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
49137464|NCT03329001|158340912|FG001|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
49137465|NCT03329001|158340913|FG002|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|2|||
49137466|NCT03329001|158340914|FG003|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
49137467|NCT03329001|158340915|FG004|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
49137468|NCT03329001|158340916|FG005|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
49137469|NCT03329001|158340917|FG006|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
49137470|NCT03329001|158340918|FG007|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
49137471|NCT03329001|158340911|FG000|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
49137472|NCT03329001|158340912|FG001|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
49137473|NCT03329001|158340913|FG002|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
49137474|NCT03329001|158340914|FG003|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|2|||
49137475|NCT03329001|158340915|FG004|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
49137476|NCT03329001|158340916|FG005|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
49137477|NCT03329001|158340917|FG006|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
48821017|NCT03138512|157187332|FG001|Treatment Part B|Study drug toxicity|0|||
48821018|NCT03138512|157187333|FG002|Treatment Part B|Study drug toxicity|63|||
49011403|NCT01507831|157878944|FG001|Overall Study|Related to study drug administration|14|||
49011404|NCT01507831|157878943|FG000|Overall Study|Last visit outside protocol visit window|51|||
49011405|NCT01507831|157878944|FG001|Overall Study|Last visit outside protocol visit window|143|||
49011406|NCT01507831|157878943|FG000|Overall Study|Selection criteria finally not met|0|||
48821019|NCT03138512|157187334|FG003|Treatment Part B|Study drug toxicity|3|||
48821020|NCT03138512|157187335|FG004|Treatment Part B|Study drug toxicity|45|||
48821021|NCT03138512|157187331|FG000|Treatment Part B|Death|0|||
49137478|NCT03329001|158340918|FG007|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
49137479|NCT03329001|158340911|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
49137480|NCT03329001|158340912|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
49137481|NCT03329001|158340913|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
49137482|NCT03329001|158340914|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
49137483|NCT03329001|158340915|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
49137484|NCT03329001|158340916|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|1|||
49137485|NCT03329001|158340917|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
49137486|NCT03329001|158340918|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
49137487|NCT03329001|158340911|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
49137488|NCT03329001|158340912|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
49137489|NCT03329001|158340913|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
49137490|NCT03329001|158340914|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
49137491|NCT03329001|158340915|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|1|||
49137492|NCT03329001|158340916|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
49137493|NCT03329001|158340917|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
49137494|NCT03329001|158340918|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
49137495|NCT03329001|158340911|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
48821022|NCT03138512|157187332|FG001|Treatment Part B|Death|0|||
48821023|NCT03138512|157187333|FG002|Treatment Part B|Death|1|||
48821024|NCT03138512|157187334|FG003|Treatment Part B|Death|0|||
48821025|NCT03138512|157187335|FG004|Treatment Part B|Death|0|||
48821026|NCT03138512|157187331|FG000|Treatment Part B|Adverse event unrelated to study drug|0|||
48821027|NCT03138512|157187332|FG001|Treatment Part B|Adverse event unrelated to study drug|0|||
49011407|NCT01507831|157878944|FG001|Overall Study|Selection criteria finally not met|1|||
49137496|NCT03329001|158340912|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
49137497|NCT03329001|158340913|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
49011408|NCT01507831|157878943|FG000|Overall Study|Site closure|0|||
49011409|NCT01507831|157878944|FG001|Overall Study|Site closure|3|||
49011410|NCT01507831|157878943|FG000|Overall Study|Potential lost to follow-up|3|||
48726439|NCT00322153|156847972|FG000|Overall Study|Lost to Follow-up|5|||
48726440|NCT00322153|156847973|FG001|Overall Study|Lost to Follow-up|4|||
48726441|NCT00322153|156847972|FG000|Overall Study|Withdrawn for other reasons|5|||
48726442|NCT00322153|156847973|FG001|Overall Study|Withdrawn for other reasons|4|||
48726443|NCT03091777|156847975|FG000|Overall Study|Pregnancy|2|||
49137498|NCT03329001|158340914|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
49137499|NCT03329001|158340915|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
49137500|NCT03329001|158340916|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
49137501|NCT03329001|158340917|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
49137502|NCT03329001|158340918|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
49137503|NCT03329001|158340911|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
49137504|NCT03329001|158340912|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
49137505|NCT03329001|158340913|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
49137506|NCT03329001|158340914|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
49137507|NCT03329001|158340915|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|1|||
49137508|NCT03329001|158340916|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
49137509|NCT03329001|158340917|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
49137510|NCT03329001|158340918|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
49137511|NCT03329001|158340911|FG000|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
48726444|NCT03091777|156847976|FG001|Overall Study|Pregnancy|1|||
48726445|NCT03091777|156847977|FG002|Overall Study|Pregnancy|0|||
48726446|NCT03091777|156847975|FG000|Overall Study|Adverse Event|2|||
48726447|NCT03091777|156847976|FG001|Overall Study|Adverse Event|1|||
48726448|NCT03091777|156847977|FG002|Overall Study|Adverse Event|4|||
48921049|NCT01026831|157544823|FG001|Overall Study|Physician Decision|1|||
49137512|NCT03329001|158340912|FG001|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
49137513|NCT03329001|158340913|FG002|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
49137514|NCT03329001|158340914|FG003|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
49137515|NCT03329001|158340915|FG004|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
49137516|NCT03329001|158340916|FG005|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
49137517|NCT03329001|158340917|FG006|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
49137518|NCT03329001|158340918|FG007|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
49137519|NCT03329001|158340911|FG000|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
49137520|NCT03329001|158340912|FG001|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
49137521|NCT03329001|158340913|FG002|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
49137522|NCT03329001|158340914|FG003|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
49137523|NCT03329001|158340915|FG004|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
49137524|NCT03329001|158340916|FG005|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
49137525|NCT03329001|158340917|FG006|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|22|||
49137526|NCT03329001|158340918|FG007|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|14|||
49137527|NCT03329001|158340911|FG000|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
49137528|NCT03329001|158340912|FG001|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
49137529|NCT03329001|158340913|FG002|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
49137530|NCT03329001|158340914|FG003|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
49137531|NCT03329001|158340915|FG004|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
49137532|NCT03329001|158340916|FG005|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
49137533|NCT03329001|158340917|FG006|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|4|||
49137534|NCT03329001|158340918|FG007|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
49137535|NCT03329001|158340911|FG000|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
49137536|NCT03329001|158340912|FG001|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
49137537|NCT03329001|158340913|FG002|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
49137538|NCT03329001|158340914|FG003|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
49137539|NCT03329001|158340915|FG004|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
49137540|NCT03329001|158340916|FG005|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
49137541|NCT03329001|158340917|FG006|Extension Phase(Approx 5 Years 5 Months)|Death|15|||
49137542|NCT03329001|158340918|FG007|Extension Phase(Approx 5 Years 5 Months)|Death|3|||
49137543|NCT03329001|158340911|FG000|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
49137544|NCT03329001|158340912|FG001|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
49137545|NCT03329001|158340913|FG002|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
49137546|NCT03329001|158340914|FG003|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
49137547|NCT03329001|158340915|FG004|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
48726449|NCT03091777|156847975|FG000|Overall Study|Withdrawal by Subject|4|||
48726450|NCT03091777|156847976|FG001|Overall Study|Withdrawal by Subject|2|||
48726451|NCT03091777|156847977|FG002|Overall Study|Withdrawal by Subject|6|||
49137548|NCT03329001|158340916|FG005|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
49137549|NCT03329001|158340917|FG006|Extension Phase(Approx 5 Years 5 Months)|Other reasons|30|||
49137550|NCT03329001|158340918|FG007|Extension Phase(Approx 5 Years 5 Months)|Other reasons|13|||
49137551|NCT04327271|158340921|FG000|Overall Study|Death|1|||
49137552|NCT04327271|158340922|FG001|Overall Study|Death|0|||
49137553|NCT04327271|158340921|FG000|Overall Study|Withdrawal by Subject|1|||
49137554|NCT04327271|158340922|FG001|Overall Study|Withdrawal by Subject|0|||
49137555|NCT04327271|158340921|FG000|Overall Study|randomization error (data capture)|4|||
49137556|NCT04327271|158340922|FG001|Overall Study|randomization error (data capture)|3|||
49137557|NCT03637374|158340923|FG000|Overall Study|Death|2|||
49137558|NCT03637374|158340924|FG001|Overall Study|Death|0|||
49137559|NCT01900314|158340925|FG000|Overall Study|Lost to Follow-up|1|||
49137560|NCT01900314|158340926|FG001|Overall Study|Lost to Follow-up|0|||
49137561|NCT01900314|158340925|FG000|Overall Study|Protocol Violation|0|||
49137562|NCT01900314|158340926|FG001|Overall Study|Protocol Violation|1|||
49137563|NCT01900314|158340925|FG000|Overall Study|Withdrawal by Subject|3|||
49137564|NCT01900314|158340926|FG001|Overall Study|Withdrawal by Subject|3|||
49137565|NCT01136915|158340929|FG000|Overall Study|Lost to Follow-up|2|||
49137566|NCT01136915|158340930|FG001|Overall Study|Lost to Follow-up|0|||
49137567|NCT01136915|158340929|FG000|Overall Study|Exclusion criterion met|0|||
49137568|NCT01136915|158340930|FG001|Overall Study|Exclusion criterion met|1|||
49137569|NCT01756235|158340931|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
49137570|NCT00376506|158340934|FG000|Overall Study|Death|0|||
49137571|NCT00376506|158340935|FG001|Overall Study|Death|2|||
49137572|NCT02403271|158340936|FG000|Period 1|Other varied reasons|1|||
49137573|NCT02403271|158340937|FG001|Period 1|Other varied reasons|0|||
49137574|NCT02403271|158340936|FG000|Period 2|Withdrawal by Subject|0|||
49137575|NCT02403271|158340937|FG001|Period 2|Withdrawal by Subject|14|||
49137576|NCT02403271|158340936|FG000|Period 2|Death|0|||
49137577|NCT02403271|158340937|FG001|Period 2|Death|84|||
48726452|NCT03091777|156847975|FG000|Overall Study|Protocol Violation|2|||
48726453|NCT03091777|156847976|FG001|Overall Study|Protocol Violation|1|||
48726454|NCT03091777|156847977|FG002|Overall Study|Protocol Violation|1|||
48726455|NCT03091777|156847975|FG000|Overall Study|Lost to Follow-up|12|||
48726456|NCT03091777|156847976|FG001|Overall Study|Lost to Follow-up|14|||
48726457|NCT03091777|156847977|FG002|Overall Study|Lost to Follow-up|7|||
48726458|NCT03091777|156847975|FG000|Overall Study|Lack of Efficacy|0|||
48726459|NCT03091777|156847976|FG001|Overall Study|Lack of Efficacy|0|||
48726460|NCT03091777|156847977|FG002|Overall Study|Lack of Efficacy|5|||
48726461|NCT03091777|156847975|FG000|Overall Study|Noncompliance with study drug|2|||
48726462|NCT03091777|156847976|FG001|Overall Study|Noncompliance with study drug|3|||
49137578|NCT02403271|158340936|FG000|Period 2|Lost to Follow-up|0|||
49137579|NCT02403271|158340937|FG001|Period 2|Lost to Follow-up|2|||
49137580|NCT02403271|158340936|FG000|Period 2|Study Terminated by Sponsor|0|||
49137581|NCT02403271|158340937|FG001|Period 2|Study Terminated by Sponsor|14|||
49137582|NCT02403271|158340936|FG000|Period 2|Other varied reasons|0|||
49137583|NCT02403271|158340937|FG001|Period 2|Other varied reasons|10|||
49137584|NCT01695746|158340942|FG000|Overall Study|Adverse Event|1|||
49137585|NCT01695746|158340942|FG000|Overall Study|Non-compliance by the participant|3|||
49137586|NCT01695746|158340942|FG000|Overall Study|Protocol Violation|5|||
49137587|NCT01695746|158340942|FG000|Overall Study|Participant not willing to participate|3|||
49137588|NCT01125748|158340945|FG000|Overall Study|Adverse Event|0|||
49137589|NCT01125748|158340946|FG001|Overall Study|Adverse Event|2|||
49137590|NCT01125748|158340945|FG000|Overall Study|Lost to Follow-up|0|||
48921050|NCT01026831|157544822|FG000|Overall Study|Protocol Violation|0|||
48921051|NCT01026831|157544823|FG001|Overall Study|Protocol Violation|2|||
48921052|NCT01026831|157544822|FG000|Overall Study|Withdrawal by Subject|7|||
48921053|NCT01026831|157544823|FG001|Overall Study|Withdrawal by Subject|5|||
48921054|NCT02255422|157544824|FG000|Overall Study|Withdrawal by Subject|0|||
48921055|NCT02255422|157544825|FG001|Overall Study|Withdrawal by Subject|0|||
49137591|NCT01125748|158340946|FG001|Overall Study|Lost to Follow-up|1|||
49137592|NCT01125748|158340945|FG000|Overall Study|Physician Decision|8|||
49137593|NCT01125748|158340946|FG001|Overall Study|Physician Decision|7|||
49137594|NCT01125748|158340945|FG000|Overall Study|Patient Decision to Withdraw|2|||
49137595|NCT01125748|158340946|FG001|Overall Study|Patient Decision to Withdraw|4|||
49137596|NCT04167670|158342577|FG000|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|1|||
49137597|NCT04167670|158342578|FG001|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|7|||
49137598|NCT04167670|158342579|FG002|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|4|||
49137599|NCT04167670|158342577|FG000|Overall Study|Significant protocol deviation|3|||
49137600|NCT04167670|158342578|FG001|Overall Study|Significant protocol deviation|1|||
49137601|NCT04167670|158342579|FG002|Overall Study|Significant protocol deviation|0|||
49137602|NCT04167670|158342577|FG000|Overall Study|Lost to Follow-up|0|||
49137603|NCT04167670|158342578|FG001|Overall Study|Lost to Follow-up|3|||
49137604|NCT04167670|158342579|FG002|Overall Study|Lost to Follow-up|3|||
49137605|NCT04167670|158342577|FG000|Overall Study|Voluntary Withdrawal|0|||
49137606|NCT04167670|158342578|FG001|Overall Study|Voluntary Withdrawal|1|||
48726463|NCT03091777|156847977|FG002|Overall Study|Noncompliance with study drug|1|||
48726464|NCT03091777|156847975|FG000|Overall Study|Physician Decision|1|||
48726465|NCT03091777|156847976|FG001|Overall Study|Physician Decision|0|||
48821028|NCT03138512|157187333|FG002|Treatment Part B|Adverse event unrelated to study drug|5|||
48821029|NCT03138512|157187334|FG003|Treatment Part B|Adverse event unrelated to study drug|2|||
48821030|NCT03138512|157187335|FG004|Treatment Part B|Adverse event unrelated to study drug|12|||
48821031|NCT03138512|157187331|FG000|Treatment Part B|Participants request to discontinue study treatment|0|||
48821032|NCT03138512|157187332|FG001|Treatment Part B|Participants request to discontinue study treatment|0|||
48821033|NCT03138512|157187333|FG002|Treatment Part B|Participants request to discontinue study treatment|6|||
48821034|NCT03138512|157187334|FG003|Treatment Part B|Participants request to discontinue study treatment|4|||
48821035|NCT03138512|157187335|FG004|Treatment Part B|Participants request to discontinue study treatment|6|||
48726466|NCT03091777|156847977|FG002|Overall Study|Physician Decision|1|||
48726467|NCT03091777|156847975|FG000|Overall Study|Abnormal Laboratory Value|7|||
48726468|NCT03091777|156847976|FG001|Overall Study|Abnormal Laboratory Value|11|||
48726469|NCT03091777|156847977|FG002|Overall Study|Abnormal Laboratory Value|12|||
48726470|NCT03021564|156847978|FG000|Overall Study|Death|84|||
48726471|NCT03021564|156847979|FG001|Overall Study|Death|466|||
48726472|NCT03021564|156847978|FG000|Overall Study|Lost to Follow-up|0|||
48726473|NCT03021564|156847979|FG001|Overall Study|Lost to Follow-up|2|||
48726474|NCT02469038|156849775|FG000|Overall Study|Physician Decision|4|||
48726475|NCT02469038|156849776|FG001|Overall Study|Physician Decision|5|||
48726476|NCT01251146|156849779|FG000|Overall Study|Lost to Follow-up|3|||
48726477|NCT01251146|156849780|FG001|Overall Study|Lost to Follow-up|10|||
48726478|NCT00815516|156849781|FG000|Overall Study|Death|3|||
48726479|NCT00815516|156849782|FG001|Overall Study|Death|1|||
48726480|NCT00815516|156849781|FG000|Overall Study|Physician Decision|1|||
48726481|NCT00815516|156849782|FG001|Overall Study|Physician Decision|0|||
48726482|NCT03350984|156849783|FG000|Overall Study|Death|1|||
48726483|NCT03350984|156849784|FG001|Overall Study|Death|0|||
48726484|NCT03350984|156849783|FG000|Overall Study|Lost to Follow-up|5|||
48726485|NCT03350984|156849784|FG001|Overall Study|Lost to Follow-up|6|||
48726486|NCT03350984|156849783|FG000|Overall Study|Protocol Violation|1|||
48726487|NCT03350984|156849784|FG001|Overall Study|Protocol Violation|2|||
48726488|NCT03350984|156849783|FG000|Overall Study|Physician Decision|1|||
48726489|NCT03350984|156849784|FG001|Overall Study|Physician Decision|0|||
48726490|NCT02278471|156849793|FG000|Overall Study|Lost to Follow-up|6|||
48726491|NCT02278471|156849794|FG001|Overall Study|Lost to Follow-up|15|||
48726492|NCT02278471|156849793|FG000|Overall Study|Death|2|||
48726493|NCT02278471|156849794|FG001|Overall Study|Death|2|||
48726494|NCT02278471|156849793|FG000|Overall Study|Withdrawal by Subject|0|||
48726495|NCT02278471|156849794|FG001|Overall Study|Withdrawal by Subject|3|||
48726496|NCT00640835|156849795|FG000|Overall Study|Adverse Event|5|||
48726497|NCT00640835|156849796|FG001|Overall Study|Adverse Event|3|||
48726498|NCT00640835|156849795|FG000|Overall Study|Withdrawal by Subject|12|||
48726499|NCT00640835|156849796|FG001|Overall Study|Withdrawal by Subject|14|||
48726500|NCT00640835|156849795|FG000|Overall Study|Physician Decision|10|||
48726501|NCT00640835|156849796|FG001|Overall Study|Physician Decision|14|||
48726502|NCT00640835|156849795|FG000|Overall Study|Sponsor's Decision|11|||
48726503|NCT00640835|156849796|FG001|Overall Study|Sponsor's Decision|7|||
48726504|NCT00640835|156849795|FG000|Overall Study|Protocol Violation|2|||
48726505|NCT00640835|156849796|FG001|Overall Study|Protocol Violation|2|||
48726506|NCT00640835|156849795|FG000|Overall Study|Lost to Follow-up|17|||
48726507|NCT00640835|156849796|FG001|Overall Study|Lost to Follow-up|13|||
48726508|NCT00640835|156849795|FG000|Overall Study|Other Reason|19|||
48726509|NCT00640835|156849796|FG001|Overall Study|Other Reason|4|||
48726510|NCT01249118|156849797|FG000|First Washout Period|Physician Decision|0|||
48726511|NCT01249118|156849798|FG001|First Washout Period|Physician Decision|1|||
48726512|NCT01249118|156849799|FG002|First Washout Period|Physician Decision|0|||
48726513|NCT00997438|156849800|FG000|Overall Study|Blood draw difficulty|2|||
48726514|NCT00997438|156849801|FG001|Overall Study|Blood draw difficulty|0|||
48726515|NCT00997438|156849802|FG002|Overall Study|Blood draw difficulty|1|||
48726516|NCT00997438|156849800|FG000|Overall Study|Withdrawal by Subject|1|||
48726517|NCT00997438|156849801|FG001|Overall Study|Withdrawal by Subject|1|||
48726518|NCT00997438|156849802|FG002|Overall Study|Withdrawal by Subject|0|||
48726519|NCT00997438|156849800|FG000|Overall Study|Exclusion criteria at visit 1|2|||
48726520|NCT00997438|156849801|FG001|Overall Study|Exclusion criteria at visit 1|2|||
48726521|NCT00997438|156849802|FG002|Overall Study|Exclusion criteria at visit 1|3|||
48726522|NCT04618770|156849808|FG000|Overall Study|Censored from Analysis|12|||
48726523|NCT04618770|156849808|FG000|Overall Study|Early Termination|25|||
48726524|NCT02579928|156849809|FG000|Overall Study|Withdrawal by Subject|1|||
48726525|NCT02579928|156849810|FG001|Overall Study|Withdrawal by Subject|0|||
48726526|NCT00737464|156849811|FG000|Overall Study|Adverse Event|1|||
48726527|NCT00737464|156849811|FG000|Overall Study|Death|6|||
48726528|NCT00737464|156849811|FG000|Overall Study|Other - Failure to Return|1|||
48726529|NCT00737464|156849811|FG000|Overall Study|Refused Treatment / Withdrew Consent|6|||
48726530|NCT00737464|156849811|FG000|Overall Study|Other reasons|4|||
48726531|NCT03410823|156849812|FG000|Overall Study|Death|1|||
48726532|NCT03410823|156849812|FG000|Overall Study|Withdrawal by Subject|2|||
48726533|NCT03410823|156849812|FG000|Overall Study|Withdraw due to COVID-19 shutdown|2|||
48726534|NCT00206076|156849818|FG000|Overall Study|Physician Decision|2|||
48726535|NCT00206076|156849819|FG001|Overall Study|Physician Decision|0|||
48726536|NCT00206076|156849818|FG000|Overall Study|Withdrawal by Subject|1|||
48726537|NCT00206076|156849819|FG001|Overall Study|Withdrawal by Subject|1|||
48726538|NCT00366340|156849820|FG000|Infant Series|Protocol Violation|3|||
48726539|NCT00366340|156849821|FG001|Infant Series|Protocol Violation|4|||
48726540|NCT00366340|156849820|FG000|Infant Series|Withdrawal by Subject|3|||
48726541|NCT00366340|156849821|FG001|Infant Series|Withdrawal by Subject|3|||
48726542|NCT00366340|156849820|FG000|Infant Series|Adverse Event|0|||
48726543|NCT00366340|156849821|FG001|Infant Series|Adverse Event|2|||
48726544|NCT00366340|156849820|FG000|Infant Series|Lost to Follow-up|1|||
48726545|NCT00366340|156849821|FG001|Infant Series|Lost to Follow-up|1|||
48726546|NCT00366340|156849820|FG000|Infant Series|Failure to return|1|||
48726547|NCT00366340|156849821|FG001|Infant Series|Failure to return|0|||
48726548|NCT00366340|156849820|FG000|After the Infant Series|Parent/legal guardian request|1|||
48726549|NCT00366340|156849821|FG001|After the Infant Series|Parent/legal guardian request|1|||
48726550|NCT00366340|156849820|FG000|After the Infant Series|Failed to return|0|||
48726551|NCT00366340|156849821|FG001|After the Infant Series|Failed to return|1|||
48726552|NCT00366340|156849820|FG000|After the Infant Series|Protocol Violation|2|||
48726553|NCT00366340|156849821|FG001|After the Infant Series|Protocol Violation|2|||
48726554|NCT00366340|156849820|FG000|After the Infant Series|Adverse Event|0|||
48726555|NCT00366340|156849821|FG001|After the Infant Series|Adverse Event|1|||
48726556|NCT00366340|156849820|FG000|After the Infant Series|Lost to Follow-up|0|||
48726557|NCT00366340|156849821|FG001|After the Infant Series|Lost to Follow-up|1|||
48726558|NCT00366340|156849820|FG000|Toddler Dose|Failed to return|1|||
48726559|NCT00366340|156849821|FG001|Toddler Dose|Failed to return|0|||
48726560|NCT00366340|156849820|FG000|Toddler Dose|Parent/legal guardian request|0|||
48726561|NCT00366340|156849821|FG001|Toddler Dose|Parent/legal guardian request|1|||
48726562|NCT00761150|156849822|FG000|Open-label Period|Adverse Event|36|||
48726563|NCT00761150|156849823|FG001|Open-label Period|Adverse Event|0|||
48726564|NCT00761150|156849824|FG002|Open-label Period|Adverse Event|0|||
48726565|NCT00761150|156849822|FG000|Open-label Period|Did not meet DB randomization criteria|11|||
48726566|NCT00761150|156849823|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
48726567|NCT00761150|156849824|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
48726568|NCT00761150|156849822|FG000|Open-label Period|Lost to Follow-up|7|||
48726569|NCT00761150|156849823|FG001|Open-label Period|Lost to Follow-up|0|||
48726570|NCT00761150|156849824|FG002|Open-label Period|Lost to Follow-up|0|||
48726571|NCT00761150|156849822|FG000|Open-label Period|Lack of Efficacy|4|||
48726572|NCT00761150|156849823|FG001|Open-label Period|Lack of Efficacy|0|||
48726573|NCT00761150|156849824|FG002|Open-label Period|Lack of Efficacy|0|||
48726574|NCT00761150|156849822|FG000|Open-label Period|Withdrawal by Subject|5|||
48726575|NCT00761150|156849823|FG001|Open-label Period|Withdrawal by Subject|0|||
48726576|NCT00761150|156849824|FG002|Open-label Period|Withdrawal by Subject|0|||
48726577|NCT00761150|156849822|FG000|Open-label Period|Noncompliance|2|||
48726578|NCT00761150|156849823|FG001|Open-label Period|Noncompliance|0|||
48726579|NCT00761150|156849824|FG002|Open-label Period|Noncompliance|0|||
48726580|NCT00761150|156849822|FG000|Open-label Period|Other|5|||
48726581|NCT00761150|156849823|FG001|Open-label Period|Other|0|||
48821036|NCT03138512|157187331|FG000|Treatment Part B|Participant withdrew consent|0|||
48821037|NCT03138512|157187332|FG001|Treatment Part B|Participant withdrew consent|0|||
48726582|NCT00761150|156849824|FG002|Open-label Period|Other|0|||
48726583|NCT00761150|156849822|FG000|Double-blind Period|Lack of Efficacy|0|||
48726584|NCT00761150|156849823|FG001|Double-blind Period|Lack of Efficacy|2|||
48726585|NCT00761150|156849824|FG002|Double-blind Period|Lack of Efficacy|19|||
48726586|NCT00761150|156849822|FG000|Double-blind Period|Adverse Event|0|||
48726587|NCT00761150|156849823|FG001|Double-blind Period|Adverse Event|3|||
48821038|NCT03138512|157187333|FG002|Treatment Part B|Participant withdrew consent|1|||
48726588|NCT00761150|156849824|FG002|Double-blind Period|Adverse Event|3|||
48726589|NCT00761150|156849822|FG000|Double-blind Period|Withdrawal by Subject|0|||
48726590|NCT00761150|156849823|FG001|Double-blind Period|Withdrawal by Subject|3|||
48726591|NCT00761150|156849824|FG002|Double-blind Period|Withdrawal by Subject|2|||
48821039|NCT03138512|157187334|FG003|Treatment Part B|Participant withdrew consent|1|||
48726592|NCT00761150|156849822|FG000|Double-blind Period|Lost to Follow-up|0|||
48726593|NCT00761150|156849823|FG001|Double-blind Period|Lost to Follow-up|2|||
48726594|NCT00761150|156849824|FG002|Double-blind Period|Lost to Follow-up|1|||
48726595|NCT00761150|156849822|FG000|Double-blind Period|Did not meet DB randomization criteria|0|||
48726596|NCT00761150|156849823|FG001|Double-blind Period|Did not meet DB randomization criteria|0|||
48726597|NCT00761150|156849824|FG002|Double-blind Period|Did not meet DB randomization criteria|1|||
48726598|NCT00761150|156849822|FG000|Double-blind Period|Noncompliance|0|||
48726599|NCT00761150|156849823|FG001|Double-blind Period|Noncompliance|1|||
48726600|NCT00761150|156849824|FG002|Double-blind Period|Noncompliance|0|||
48726601|NCT00761150|156849822|FG000|Double-blind Period|Other|0|||
48726602|NCT00761150|156849823|FG001|Double-blind Period|Other|3|||
48726603|NCT00761150|156849824|FG002|Double-blind Period|Other|3|||
48726604|NCT03823378|156849825|FG000|Overall Study|Adverse Event|2|||
48821040|NCT03138512|157187335|FG004|Treatment Part B|Participant withdrew consent|2|||
48821041|NCT03138512|157187331|FG000|Treatment Part B|Lost to Follow-up|0|||
49137607|NCT04167670|158342579|FG002|Overall Study|Voluntary Withdrawal|1|||
49137608|NCT04167670|158342577|FG000|Overall Study|Withdrawal of Consent|4|||
49137609|NCT04167670|158342578|FG001|Overall Study|Withdrawal of Consent|1|||
49137610|NCT04167670|158342579|FG002|Overall Study|Withdrawal of Consent|3|||
49137611|NCT04167670|158342577|FG000|Overall Study|Miscellaneous|7|||
49137612|NCT04167670|158342578|FG001|Overall Study|Miscellaneous|5|||
49137613|NCT04167670|158342579|FG002|Overall Study|Miscellaneous|3|||
49137614|NCT02293499|158342588|FG000|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
49137615|NCT02293499|158342589|FG001|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
49137616|NCT02293499|158342590|FG002|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10|||
49137617|NCT02293499|158342588|FG000|Intervention - Camp|Withdrawal by Subject|3|||
49137618|NCT02293499|158342589|FG001|Intervention - Camp|Withdrawal by Subject|6|||
49137619|NCT02293499|158342590|FG002|Intervention - Camp|Withdrawal by Subject|2|||
49137620|NCT02293499|158342588|FG000|Intervention - Camp|these are those not showing up at camp|24|||
49137621|NCT02293499|158342589|FG001|Intervention - Camp|these are those not showing up at camp|28|||
49137622|NCT02293499|158342590|FG002|Intervention - Camp|these are those not showing up at camp|4|||
49137623|NCT02293499|158342588|FG000|3 Month Follow Up|Withdrawal by Subject|1|||
49137624|NCT02293499|158342589|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
49137625|NCT02293499|158342590|FG002|3 Month Follow Up|Withdrawal by Subject|4|||
49137626|NCT02293499|158342588|FG000|3 Month Follow Up|Lost to Follow-up|14|||
49137627|NCT02293499|158342589|FG001|3 Month Follow Up|Lost to Follow-up|15|||
49137628|NCT02293499|158342590|FG002|3 Month Follow Up|Lost to Follow-up|6|||
49137629|NCT02293499|158342588|FG000|6 Month Follow Up|Lost to Follow-up|17|||
49137630|NCT02293499|158342589|FG001|6 Month Follow Up|Lost to Follow-up|27|||
49137631|NCT02293499|158342590|FG002|6 Month Follow Up|Lost to Follow-up|6|||
48821042|NCT03138512|157187332|FG001|Treatment Part B|Lost to Follow-up|0|||
48821043|NCT03138512|157187333|FG002|Treatment Part B|Lost to Follow-up|0|||
48821044|NCT03138512|157187334|FG003|Treatment Part B|Lost to Follow-up|1|||
48821045|NCT03138512|157187335|FG004|Treatment Part B|Lost to Follow-up|0|||
48821046|NCT03138512|157187331|FG000|Treatment Part B|Poor/non-compliance|0|||
48821047|NCT03138512|157187332|FG001|Treatment Part B|Poor/non-compliance|0|||
48821048|NCT03138512|157187333|FG002|Treatment Part B|Poor/non-compliance|1|||
48821049|NCT03138512|157187334|FG003|Treatment Part B|Poor/non-compliance|1|||
48821050|NCT03138512|157187335|FG004|Treatment Part B|Poor/non-compliance|1|||
48821051|NCT03138512|157187331|FG000|Treatment Part B|Other reasons|0|||
48821052|NCT03138512|157187332|FG001|Treatment Part B|Other reasons|0|||
48821053|NCT03138512|157187333|FG002|Treatment Part B|Other reasons|3|||
48821054|NCT03138512|157187334|FG003|Treatment Part B|Other reasons|1|||
48821055|NCT03138512|157187335|FG004|Treatment Part B|Other reasons|5|||
49137632|NCT02293499|158342588|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
49137633|NCT02293499|158342589|FG001|6 Month Follow Up|Withdrawal by Subject|0|||
49137634|NCT02293499|158342590|FG002|6 Month Follow Up|Withdrawal by Subject|1|||
49137635|NCT02293499|158342588|FG000|9 Month Follow Up|Withdrawal by Subject|2|||
49137636|NCT02293499|158342589|FG001|9 Month Follow Up|Withdrawal by Subject|0|||
49137637|NCT02293499|158342590|FG002|9 Month Follow Up|Withdrawal by Subject|0|||
49137638|NCT02293499|158342588|FG000|9 Month Follow Up|Lost to Follow-up|24|||
49137639|NCT02293499|158342589|FG001|9 Month Follow Up|Lost to Follow-up|28|||
49137640|NCT02293499|158342590|FG002|9 Month Follow Up|Lost to Follow-up|4|||
49137641|NCT02293499|158342588|FG000|12 Month Follow Up|Lost to Follow-up|26|||
49137642|NCT02293499|158342589|FG001|12 Month Follow Up|Lost to Follow-up|25|||
49137643|NCT02293499|158342590|FG002|12 Month Follow Up|Lost to Follow-up|6|||
49137644|NCT02293499|158342588|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
48726605|NCT03823378|156849826|FG001|Overall Study|Adverse Event|2|||
48821056|NCT02118714|157187336|FG000|Overall Study|Lost to Follow-up|2|||
49137645|NCT02293499|158342589|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
49137646|NCT02293499|158342590|FG002|12 Month Follow Up|Withdrawal by Subject|0|||
49137647|NCT02293499|158342588|FG000|15 Month Follow Up|Lost to Follow-up|22|||
49137648|NCT02293499|158342589|FG001|15 Month Follow Up|Lost to Follow-up|22|||
49137649|NCT02293499|158342590|FG002|15 Month Follow Up|Lost to Follow-up|7|||
49137650|NCT05417113|158342591|FG000|Overall Study|Lost to Follow-up|2|||
48821057|NCT02118714|157187336|FG000|Overall Study|Protocol Violation|1|||
48821058|NCT01004263|157187338|FG000|Overall Study|Adverse Event|15|||
48921056|NCT02255422|157544826|FG002|Overall Study|Withdrawal by Subject|0|||
48726606|NCT03823378|156849827|FG002|Overall Study|Adverse Event|0|||
49137651|NCT05417113|158342592|FG001|Overall Study|Lost to Follow-up|2|||
49137652|NCT01022580|158342593|FG000|Overall Study|Death|18|||
49137653|NCT01022580|158342594|FG001|Overall Study|Death|22|||
49137654|NCT01239680|158342597|FG000|Overall Study|Withdrawal by Subject|2|||
49137655|NCT01239680|158342598|FG001|Overall Study|Withdrawal by Subject|0|||
49137656|NCT01631188|158342599|FG000|Overall Study|Physician Decision|75|||
49137657|NCT01431976|158342600|FG000|Overall Study|Adverse Event|6|||
49137658|NCT01431976|158342600|FG000|Overall Study|Lack of Efficacy|2|||
49137659|NCT01431976|158342600|FG000|Overall Study|Met Protocol-defined Stopping Criteria|4|||
49137660|NCT01431976|158342600|FG000|Overall Study|Physician Decision|1|||
49137661|NCT01431976|158342600|FG000|Overall Study|Withdrawal by Subject|1|||
49137662|NCT01033942|158342611|FG000|Overall Study|Withdrawal by Subject|1|||
49137663|NCT01033942|158342612|FG001|Overall Study|Withdrawal by Subject|1|||
49137664|NCT01033942|158342613|FG002|Overall Study|Withdrawal by Subject|1|||
49137665|NCT01033942|158342611|FG000|Overall Study|Lost to Follow-up|1|||
49137666|NCT01033942|158342612|FG001|Overall Study|Lost to Follow-up|0|||
49137667|NCT01033942|158342613|FG002|Overall Study|Lost to Follow-up|0|||
49137668|NCT01033942|158342611|FG000|Overall Study|Enrolled in Extension Study|0|||
49137669|NCT01033942|158342612|FG001|Overall Study|Enrolled in Extension Study|3|||
49137670|NCT01033942|158342613|FG002|Overall Study|Enrolled in Extension Study|0|||
49137671|NCT02693418|158342614|FG000|Overall Study|Lost to Follow-up|1|||
49137672|NCT02693418|158342615|FG001|Overall Study|Lost to Follow-up|2|||
49137673|NCT02693418|158342616|FG002|Overall Study|Lost to Follow-up|0|||
49137674|NCT02693418|158342617|FG003|Overall Study|Lost to Follow-up|0|||
49137675|NCT02693418|158342618|FG004|Overall Study|Lost to Follow-up|0|||
49137676|NCT02693418|158342614|FG000|Overall Study|Menses during study period|0|||
49137677|NCT02693418|158342615|FG001|Overall Study|Menses during study period|0|||
49137678|NCT02693418|158342616|FG002|Overall Study|Menses during study period|2|||
49137679|NCT02693418|158342617|FG003|Overall Study|Menses during study period|0|||
49137680|NCT02693418|158342618|FG004|Overall Study|Menses during study period|0|||
49137681|NCT02737618|158342619|FG000|Overall Study|Withdrawal by Subject|9|||
49137682|NCT00393367|158342623|FG000|Overall Study|Protocol Violation|2|||
49137683|NCT00393367|158342624|FG001|Overall Study|Protocol Violation|5|||
49137684|NCT00393367|158342623|FG000|Overall Study|Withdrawal by Subject|0|||
49137685|NCT00393367|158342624|FG001|Overall Study|Withdrawal by Subject|2|||
49137686|NCT01432951|158342625|FG000|Treatment Phase (Day 1 to 30)|Never Treated|1|||
49137687|NCT05350423|158342628|FG000|Overall Study|Lost to Follow-up|3|||
49137688|NCT05350423|158342629|FG001|Overall Study|Lost to Follow-up|3|||
49137689|NCT05350423|158342628|FG000|Overall Study|screen failure|5|||
49137690|NCT05350423|158342629|FG001|Overall Study|screen failure|6|||
49137691|NCT01018979|158342630|FG000|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3|||
49137692|NCT01018979|158342631|FG001|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9|||
48726607|NCT03823378|156849828|FG003|Overall Study|Adverse Event|0|||
49137693|NCT01018979|158342630|FG000|Overall Study|Not received at least one dose|0|||
49137694|NCT01018979|158342631|FG001|Overall Study|Not received at least one dose|1|||
49137695|NCT02278354|158342632|FG000|Overall Study|Lost to Follow-up|2|||
49137696|NCT02278354|158342633|FG001|Overall Study|Lost to Follow-up|2|||
49137697|NCT02278354|158342632|FG000|Overall Study|Withdrawal by Subject|0|||
49137698|NCT02278354|158342633|FG001|Overall Study|Withdrawal by Subject|1|||
49137699|NCT02278354|158342632|FG000|Overall Study|<10 professional fights|2|||
49137700|NCT02278354|158342633|FG001|Overall Study|<10 professional fights|0|||
49137701|NCT03188185|158342637|FG000|Stage 1|Adverse Event|4|||
49137702|NCT03188185|158342638|FG001|Stage 1|Adverse Event|12|||
49137703|NCT03188185|158342639|FG002|Stage 1|Adverse Event|0|||
49137704|NCT03188185|158342640|FG003|Stage 1|Adverse Event|0|||
49137705|NCT03188185|158342637|FG000|Stage 1|Lack of Efficacy|0|||
49137706|NCT03188185|158342638|FG001|Stage 1|Lack of Efficacy|2|||
49137707|NCT03188185|158342639|FG002|Stage 1|Lack of Efficacy|0|||
49137708|NCT03188185|158342640|FG003|Stage 1|Lack of Efficacy|0|||
49137709|NCT03188185|158342637|FG000|Stage 1|Lost to Follow-up|6|||
49137710|NCT03188185|158342638|FG001|Stage 1|Lost to Follow-up|1|||
49137711|NCT03188185|158342639|FG002|Stage 1|Lost to Follow-up|0|||
48726608|NCT03823378|156849829|FG004|Overall Study|Adverse Event|0|||
49137712|NCT03188185|158342640|FG003|Stage 1|Lost to Follow-up|0|||
49137713|NCT03188185|158342637|FG000|Stage 1|Withdrawal by Subject|9|||
49137714|NCT03188185|158342638|FG001|Stage 1|Withdrawal by Subject|0|||
49137715|NCT03188185|158342639|FG002|Stage 1|Withdrawal by Subject|0|||
49137716|NCT03188185|158342640|FG003|Stage 1|Withdrawal by Subject|0|||
49137717|NCT03188185|158342637|FG000|Stage 1|Identified as a professional patient|0|||
49137718|NCT03188185|158342638|FG001|Stage 1|Identified as a professional patient|1|||
49137719|NCT03188185|158342639|FG002|Stage 1|Identified as a professional patient|0|||
48726609|NCT03823378|156849830|FG005|Overall Study|Adverse Event|0|||
48726610|NCT03823378|156849825|FG000|Overall Study|Lost to Follow-up|0|||
48726611|NCT03823378|156849826|FG001|Overall Study|Lost to Follow-up|1|||
48726612|NCT03823378|156849827|FG002|Overall Study|Lost to Follow-up|0|||
48726613|NCT03823378|156849828|FG003|Overall Study|Lost to Follow-up|0|||
48726614|NCT03823378|156849829|FG004|Overall Study|Lost to Follow-up|1|||
48726615|NCT03823378|156849830|FG005|Overall Study|Lost to Follow-up|0|||
48726616|NCT03823378|156849825|FG000|Overall Study|Withdrawal by Subject|0|||
48726617|NCT03823378|156849826|FG001|Overall Study|Withdrawal by Subject|1|||
48726618|NCT03823378|156849827|FG002|Overall Study|Withdrawal by Subject|4|||
48726619|NCT03823378|156849828|FG003|Overall Study|Withdrawal by Subject|2|||
48726620|NCT03823378|156849829|FG004|Overall Study|Withdrawal by Subject|0|||
48726621|NCT03823378|156849830|FG005|Overall Study|Withdrawal by Subject|1|||
48726622|NCT03823378|156849825|FG000|Overall Study|Other, not specified|19|||
48726623|NCT03823378|156849826|FG001|Overall Study|Other, not specified|12|||
48726624|NCT03823378|156849827|FG002|Overall Study|Other, not specified|6|||
48726625|NCT03823378|156849828|FG003|Overall Study|Other, not specified|8|||
48726626|NCT03823378|156849829|FG004|Overall Study|Other, not specified|17|||
48726627|NCT03823378|156849830|FG005|Overall Study|Other, not specified|7|||
48726628|NCT02497976|156849831|FG000|Overall Study|Withdrawal by Subject|2|||
48726629|NCT02497976|156849832|FG001|Overall Study|Withdrawal by Subject|0|||
48726630|NCT02497976|156849831|FG000|Overall Study|Moved out of area|0|||
48726631|NCT02497976|156849832|FG001|Overall Study|Moved out of area|1|||
48726632|NCT05442775|156849833|FG000|Overall Study|Trial terminated|61|||
48726633|NCT05442775|156849833|FG000|Overall Study|Lack of Efficacy|4|||
48726634|NCT05442775|156849833|FG000|Overall Study|Withdrawal by Subject|4|||
48726635|NCT05442775|156849833|FG000|Overall Study|Death|1|||
48726636|NCT05442775|156849833|FG000|Overall Study|Participant removed at Sponsor request|1|||
48726637|NCT00058539|156849834|FG000|Overall Study|Disease progression|24|||
48726638|NCT00058539|156849834|FG000|Overall Study|Adverse Event|3|||
48726639|NCT00058539|156849834|FG000|Overall Study|Withdrawal by Subject|5|||
48726640|NCT00058539|156849834|FG000|Overall Study|Physician Decision|9|||
48726641|NCT00058539|156849834|FG000|Overall Study|Death|1|||
48726642|NCT00930982|156849840|FG000|Overall Study|Adverse Event|19|||
48726643|NCT00930982|156849841|FG001|Overall Study|Adverse Event|23|||
48726644|NCT00930982|156849840|FG000|Overall Study|Protocol Violation|1|||
48726645|NCT00930982|156849841|FG001|Overall Study|Protocol Violation|5|||
48726646|NCT00930982|156849840|FG000|Overall Study|Withdrawal by Subject|1|||
48726647|NCT00930982|156849841|FG001|Overall Study|Withdrawal by Subject|1|||
48726648|NCT02093026|156849842|FG000|Overall Study|Adverse Event|26|||
48726649|NCT02093026|156849842|FG000|Overall Study|Death|10|||
48726650|NCT02093026|156849842|FG000|Overall Study|Other|157|||
48726651|NCT02483533|156849843|FG000|Overall Study|Lack of Efficacy|50|||
48726652|NCT02483533|156849844|FG001|Overall Study|Lack of Efficacy|50|||
48726653|NCT01565499|156849847|FG000|Overall Study|Physician Decision|1|||
48726654|NCT01565499|156849847|FG000|Overall Study|Adverse Event|5|||
48726655|NCT01565499|156849847|FG000|Overall Study|Withdrawal by Subject|2|||
48726656|NCT01923168|156849851|FG000|Overall Study|Protocol Violation|1|||
48726657|NCT01923168|156849852|FG001|Overall Study|Protocol Violation|1|||
48726658|NCT01923168|156849853|FG002|Overall Study|Protocol Violation|0|||
48726659|NCT01923168|156849851|FG000|Overall Study|Subject/guardian decision|14|||
49137720|NCT03188185|158342640|FG003|Stage 1|Identified as a professional patient|0|||
49137721|NCT03188185|158342637|FG000|Stage 2|Adverse Event|0|||
49137722|NCT03188185|158342638|FG001|Stage 2|Adverse Event|0|||
48726660|NCT01923168|156849852|FG001|Overall Study|Subject/guardian decision|14|||
49137723|NCT03188185|158342639|FG002|Stage 2|Adverse Event|2|||
48726661|NCT01923168|156849853|FG002|Overall Study|Subject/guardian decision|4|||
48921057|NCT02255422|157544827|FG003|Overall Study|Withdrawal by Subject|0|||
48726662|NCT01923168|156849851|FG000|Overall Study|Adverse Event|12|||
48726663|NCT01923168|156849852|FG001|Overall Study|Adverse Event|12|||
48726664|NCT01923168|156849853|FG002|Overall Study|Adverse Event|0|||
48921058|NCT02255422|157544828|FG004|Overall Study|Withdrawal by Subject|0|||
48921059|NCT02255422|157544829|FG005|Overall Study|Withdrawal by Subject|0|||
48726665|NCT01923168|156849851|FG000|Overall Study|Physician Decision|6|||
48726666|NCT01923168|156849852|FG001|Overall Study|Physician Decision|9|||
48726667|NCT01923168|156849853|FG002|Overall Study|Physician Decision|5|||
48726668|NCT01923168|156849851|FG000|Overall Study|Progressive disease|4|||
48726669|NCT01923168|156849852|FG001|Overall Study|Progressive disease|3|||
48726670|NCT01923168|156849853|FG002|Overall Study|Progressive disease|7|||
48726671|NCT01923168|156849851|FG000|Overall Study|Death|0|||
48726672|NCT01923168|156849852|FG001|Overall Study|Death|0|||
48921060|NCT02255422|157544830|FG006|Overall Study|Withdrawal by Subject|2|||
48726673|NCT01923168|156849853|FG002|Overall Study|Death|1|||
48726674|NCT01466595|156849854|FG000|Overall Study|Withdrawal by Subject|0|||
49137724|NCT03188185|158342640|FG003|Stage 2|Adverse Event|4|||
48726675|NCT01466595|156849855|FG001|Overall Study|Withdrawal by Subject|1|||
48726676|NCT00450112|156849858|FG000|Overall Study|Other Treatment Required|5|||
48726677|NCT00450112|156849859|FG001|Overall Study|Other Treatment Required|1|||
48726678|NCT00450112|156849858|FG000|Overall Study|Withdrawal by Subject|4|||
48726679|NCT00450112|156849859|FG001|Overall Study|Withdrawal by Subject|1|||
48726680|NCT00450112|156849858|FG000|Overall Study|Lost to Follow-up|2|||
48726681|NCT00450112|156849859|FG001|Overall Study|Lost to Follow-up|1|||
48726682|NCT00450112|156849858|FG000|Overall Study|Others|2|||
48726683|NCT00450112|156849859|FG001|Overall Study|Others|3|||
48726684|NCT03418571|156849860|FG000|Overall Study|Consent withdrawn by legal guardian|1|||
48726685|NCT03418571|156849861|FG001|Overall Study|Consent withdrawn by legal guardian|0|||
48726686|NCT01255787|156849865|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
48726687|NCT01255787|156849866|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|2|||
48726688|NCT01255787|156849867|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
48726689|NCT01255787|156849868|FG003|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
48726690|NCT01255787|156849865|FG000|Overall Study|Major Protocol Deviation|1|||
48726691|NCT01255787|156849866|FG001|Overall Study|Major Protocol Deviation|1|||
48726692|NCT01255787|156849867|FG002|Overall Study|Major Protocol Deviation|0|||
48726693|NCT01255787|156849868|FG003|Overall Study|Major Protocol Deviation|4|||
48726694|NCT01255787|156849865|FG000|Overall Study|Lost to Follow-up|1|||
48726695|NCT01255787|156849866|FG001|Overall Study|Lost to Follow-up|2|||
48726696|NCT01255787|156849867|FG002|Overall Study|Lost to Follow-up|4|||
48726697|NCT01255787|156849868|FG003|Overall Study|Lost to Follow-up|2|||
48726698|NCT01255787|156849865|FG000|Overall Study|Withdrawal of Consent|3|||
48726699|NCT01255787|156849866|FG001|Overall Study|Withdrawal of Consent|9|||
48726700|NCT01255787|156849867|FG002|Overall Study|Withdrawal of Consent|3|||
48726701|NCT01255787|156849868|FG003|Overall Study|Withdrawal of Consent|4|||
48726702|NCT01255787|156849865|FG000|Overall Study|Pregnancy|0|||
48726703|NCT01255787|156849866|FG001|Overall Study|Pregnancy|0|||
48726704|NCT01255787|156849867|FG002|Overall Study|Pregnancy|0|||
48726705|NCT01255787|156849868|FG003|Overall Study|Pregnancy|1|||
48726706|NCT01255787|156849865|FG000|Overall Study|Lack of Efficacy|2|||
48726707|NCT01255787|156849866|FG001|Overall Study|Lack of Efficacy|2|||
48726708|NCT01255787|156849867|FG002|Overall Study|Lack of Efficacy|2|||
48726709|NCT01255787|156849868|FG003|Overall Study|Lack of Efficacy|2|||
48726710|NCT01255787|156849865|FG000|Overall Study|Noncompliance with Study Drug|3|||
48726711|NCT01255787|156849866|FG001|Overall Study|Noncompliance with Study Drug|1|||
48726712|NCT01255787|156849867|FG002|Overall Study|Noncompliance with Study Drug|0|||
48726713|NCT01255787|156849868|FG003|Overall Study|Noncompliance with Study Drug|0|||
48726714|NCT00214500|156849869|FG000|Treatment Period|Adverse Event|1|||
48726715|NCT00214500|156849869|FG000|Extension Period|Withdrawal by Subject|2|||
48726716|NCT00476047|156849870|FG000|Overall Study|Lost to Follow-up|1|||
48726717|NCT01056380|156849871|FG000|Overall Study|Lost to Follow-up|2|||
48726718|NCT01056380|156849872|FG001|Overall Study|Lost to Follow-up|3|||
48726719|NCT00586326|156849873|FG000|Enrollment to Device Placement-Enrolled|Skin Distance|6|||
48726720|NCT00586326|156849873|FG000|Enrollment to Device Placement-Enrolled|Cavity Conformance|4|||
48726721|NCT00586326|156849873|FG000|Enrollment to Device Placement-Enrolled|Microinvasion|2|||
48726722|NCT00586326|156849873|FG000|Enrollment to Device Placement-Enrolled|Physician Decision|1|||
48726723|NCT00586326|156849873|FG000|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1|||
48726724|NCT00586326|156849873|FG000|Enrollment to Device Placement-Enrolled|Other|1|||
48726725|NCT00586326|156849873|FG000|Device Placed toTreatment-ITT|Skin Distance|7|||
48726726|NCT00586326|156849873|FG000|Device Placed toTreatment-ITT|Cavity Conformance|6|||
48726727|NCT00586326|156849873|FG000|Device Placed toTreatment-ITT|Microinvasion|1|||
48726728|NCT00586326|156849873|FG000|Device Placed toTreatment-ITT|Positive Margins|3|||
48726729|NCT00586326|156849873|FG000|Device Placed toTreatment-ITT|Physician Decision|1|||
48726730|NCT00586326|156849873|FG000|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1|||
49137725|NCT03188185|158342637|FG000|Stage 2|Lack of Efficacy|0|||
49137726|NCT03188185|158342638|FG001|Stage 2|Lack of Efficacy|0|||
48726731|NCT00586326|156849873|FG000|Treated Through 5-yr Follow Up-Treated|Death|2|||
48726732|NCT00586326|156849873|FG000|Treated Through 5-yr Follow Up-Treated|Medical Reason|2|||
48726733|NCT00586326|156849873|FG000|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5|||
48726734|NCT00586326|156849873|FG000|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14|||
48726735|NCT00586326|156849873|FG000|Treated Through 5-yr Follow Up-Treated|Other|2|||
48726736|NCT00542451|156849874|FG000|Overall Study|Adverse Event|31|||
48726737|NCT00542451|156849874|FG000|Overall Study|Withdrawal by Subject|30|||
48726738|NCT00542451|156849874|FG000|Overall Study|Physician Decision|4|||
48726739|NCT00542451|156849874|FG000|Overall Study|Recurrent disease|1|||
49011411|NCT01507831|157878944|FG001|Overall Study|Potential lost to follow-up|0|||
49137727|NCT03188185|158342639|FG002|Stage 2|Lack of Efficacy|3|||
48726740|NCT00542451|156849874|FG000|Overall Study|unknown reason|1|||
48726741|NCT00542451|156849874|FG000|Overall Study|Death|2|||
48726742|NCT00542451|156849874|FG000|Overall Study|Lost to Follow-up|10|||
48726743|NCT05342532|156849876|FG000|Overall Study|Adverse Event|5|||
48726744|NCT05342532|156849877|FG001|Overall Study|Adverse Event|20|||
48726745|NCT05342532|156849876|FG000|Overall Study|Lost to Follow-up|10|||
48726746|NCT05342532|156849877|FG001|Overall Study|Lost to Follow-up|15|||
48726747|NCT02652767|156849879|FG000|Overall Study|Death|2|||
48726748|NCT02652767|156849879|FG000|Overall Study|Lost to Follow-up|1|||
48726749|NCT02652767|156849879|FG000|Overall Study|Withdrawal by Subject|1|||
48726750|NCT02220998|156849880|FG000|Overall Study|Randomized but Never Treated|1|||
48726751|NCT02220998|156849881|FG001|Overall Study|Randomized but Never Treated|2|||
48726752|NCT02220998|156849880|FG000|Overall Study|Death|2|||
48726753|NCT02220998|156849881|FG001|Overall Study|Death|0|||
48726754|NCT02220998|156849880|FG000|Overall Study|Lack of Efficacy|0|||
48726755|NCT02220998|156849881|FG001|Overall Study|Lack of Efficacy|5|||
48726756|NCT02220998|156849880|FG000|Overall Study|Lost to Follow-up|4|||
48726757|NCT02220998|156849881|FG001|Overall Study|Lost to Follow-up|4|||
48726758|NCT02764190|156849882|FG000|Overall Study|Lost to Follow-up|17|||
49137728|NCT03188185|158342640|FG003|Stage 2|Lack of Efficacy|0|||
49137729|NCT03188185|158342637|FG000|Stage 2|Lost to Follow-up|0|||
49137730|NCT03188185|158342638|FG001|Stage 2|Lost to Follow-up|0|||
49137731|NCT03188185|158342639|FG002|Stage 2|Lost to Follow-up|1|||
49137732|NCT03188185|158342640|FG003|Stage 2|Lost to Follow-up|0|||
49137733|NCT03188185|158342637|FG000|Stage 2|Physician Decision|0|||
48726759|NCT02764190|156849883|FG001|Overall Study|Lost to Follow-up|13|||
48726760|NCT01233687|156849884|FG000|Phase II AMG 102 + Erlotinib|Death|1|||
48726761|NCT01233687|156849884|FG000|Phase II AMG 102 + Erlotinib|Physician Decision|2|||
48726762|NCT01233687|156849884|FG000|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1|||
48726763|NCT00938964|156849889|FG000|Overall Study|Death|3|||
48821059|NCT01004263|157187338|FG000|Overall Study|Withdrawal by Subject|58|||
48821060|NCT01004263|157187338|FG000|Overall Study|Protocol Violation|10|||
48821061|NCT01004263|157187338|FG000|Overall Study|Lost to Follow-up|64|||
48821062|NCT01004263|157187338|FG000|Overall Study|Lack of Efficacy|13|||
48821063|NCT01004263|157187338|FG000|Overall Study|Pregnancy|2|||
48821064|NCT01004263|157187338|FG000|Overall Study|Physician Decision|15|||
48821065|NCT01004263|157187338|FG000|Overall Study|Lack of Qualifying Event|2|||
48821066|NCT04545619|157187341|FG000|Overall Study|due to equipment challenges|1|||
48821067|NCT02013687|157187342|FG000|Overall Study|Lost to Follow-up|0|||
48821068|NCT02013687|157187343|FG001|Overall Study|Lost to Follow-up|0|||
48821069|NCT02013687|157187344|FG002|Overall Study|Lost to Follow-up|1|||
48821070|NCT02013687|157187345|FG003|Overall Study|Lost to Follow-up|0|||
48821071|NCT02013687|157187342|FG000|Overall Study|Protocol Violation|0|||
48821072|NCT02013687|157187343|FG001|Overall Study|Protocol Violation|0|||
48821073|NCT02013687|157187344|FG002|Overall Study|Protocol Violation|0|||
49137734|NCT03188185|158342638|FG001|Stage 2|Physician Decision|0|||
49137735|NCT03188185|158342639|FG002|Stage 2|Physician Decision|0|||
49137736|NCT03188185|158342640|FG003|Stage 2|Physician Decision|1|||
49137737|NCT03188185|158342637|FG000|Stage 2|Withdrawal by Subject|0|||
49137738|NCT03188185|158342638|FG001|Stage 2|Withdrawal by Subject|0|||
49137739|NCT03188185|158342639|FG002|Stage 2|Withdrawal by Subject|3|||
49137740|NCT03188185|158342640|FG003|Stage 2|Withdrawal by Subject|1|||
49137741|NCT00790036|158342641|FG000|Overall Study|Abnormal lab values|3|||
49137742|NCT00790036|158342642|FG001|Overall Study|Abnormal lab values|2|||
49137743|NCT00790036|158342641|FG000|Overall Study|Administrative problems|5|||
49137744|NCT00790036|158342642|FG001|Overall Study|Administrative problems|9|||
49137745|NCT00790036|158342641|FG000|Overall Study|Adverse Event|113|||
49137746|NCT00790036|158342642|FG001|Overall Study|Adverse Event|44|||
49137747|NCT00790036|158342641|FG000|Overall Study|Death|1|||
49137748|NCT00790036|158342642|FG001|Overall Study|Death|0|||
49137749|NCT00790036|158342641|FG000|Overall Study|Disease progression|24|||
49137750|NCT00790036|158342642|FG001|Overall Study|Disease progression|48|||
49137751|NCT00790036|158342641|FG000|Overall Study|Lost to Follow-up|1|||
49137752|NCT00790036|158342642|FG001|Overall Study|Lost to Follow-up|2|||
49137753|NCT00790036|158342641|FG000|Overall Study|Protocol Violation|10|||
49137754|NCT00790036|158342642|FG001|Overall Study|Protocol Violation|2|||
49137755|NCT00790036|158342641|FG000|Overall Study|Withdrawal by Subject|18|||
49137756|NCT00790036|158342642|FG001|Overall Study|Withdrawal by Subject|7|||
49137757|NCT00790036|158342641|FG000|Overall Study|Subject/guardian decision|20|||
49137758|NCT00790036|158342642|FG001|Overall Study|Subject/guardian decision|7|||
49137759|NCT02612155|158342643|FG000|Overall Study|Death|1|||
49137760|NCT02612155|158342644|FG001|Overall Study|Death|1|||
49137761|NCT02612155|158342643|FG000|Overall Study|Lost to Follow-up|2|||
49137762|NCT02612155|158342644|FG001|Overall Study|Lost to Follow-up|2|||
49137763|NCT00866320|158342645|FG000|Overall Study|Withdrawal by Subject|4|||
48726764|NCT00938964|156849890|FG001|Overall Study|Death|3|||
48726765|NCT00938964|156849889|FG000|Overall Study|Lost to Follow-up|2|||
48726766|NCT00938964|156849890|FG001|Overall Study|Lost to Follow-up|3|||
48726767|NCT00938964|156849889|FG000|Overall Study|Withdrawal by Subject|22|||
48726768|NCT00938964|156849890|FG001|Overall Study|Withdrawal by Subject|18|||
48726769|NCT00938964|156849889|FG000|Overall Study|Found to Meet Exclusion Criteria|3|||
48821074|NCT02013687|157187345|FG003|Overall Study|Protocol Violation|1|||
48821075|NCT02013687|157187342|FG000|Overall Study|Withdrawal by Subject|0|||
48821076|NCT02013687|157187343|FG001|Overall Study|Withdrawal by Subject|0|||
48921061|NCT02255422|157544824|FG000|Overall Study|Lost to Follow-up|0|||
48921062|NCT02255422|157544825|FG001|Overall Study|Lost to Follow-up|0|||
49137764|NCT00866320|158342645|FG000|Overall Study|Death|2|||
49137765|NCT00580840|158342648|FG000|Run-in|Adverse Event|17|||
49137766|NCT00580840|158342649|FG001|Run-in|Adverse Event|0|||
49137767|NCT00580840|158342650|FG002|Run-in|Adverse Event|0|||
49137768|NCT00580840|158342651|FG003|Run-in|Adverse Event|0|||
49137769|NCT00580840|158342648|FG000|Run-in|Lack of Efficacy|93|||
49137770|NCT00580840|158342649|FG001|Run-in|Lack of Efficacy|0|||
49137771|NCT00580840|158342650|FG002|Run-in|Lack of Efficacy|0|||
49137772|NCT00580840|158342651|FG003|Run-in|Lack of Efficacy|0|||
49137773|NCT00580840|158342648|FG000|Run-in|Loss of Efficacy|1|||
49137774|NCT00580840|158342649|FG001|Run-in|Loss of Efficacy|0|||
49137775|NCT00580840|158342650|FG002|Run-in|Loss of Efficacy|0|||
49137776|NCT00580840|158342651|FG003|Run-in|Loss of Efficacy|0|||
49137777|NCT00580840|158342648|FG000|Run-in|Lost to Follow-up|4|||
49137778|NCT00580840|158342649|FG001|Run-in|Lost to Follow-up|0|||
49137779|NCT00580840|158342650|FG002|Run-in|Lost to Follow-up|0|||
49137780|NCT00580840|158342651|FG003|Run-in|Lost to Follow-up|0|||
49137781|NCT00580840|158342648|FG000|Run-in|Withdrawal by Subject|5|||
49137782|NCT00580840|158342649|FG001|Run-in|Withdrawal by Subject|0|||
49137783|NCT00580840|158342650|FG002|Run-in|Withdrawal by Subject|0|||
49137784|NCT00580840|158342651|FG003|Run-in|Withdrawal by Subject|0|||
49137785|NCT00580840|158342648|FG000|Run-in|Other: Per Sponsor Request|2|||
49137786|NCT00580840|158342649|FG001|Run-in|Other: Per Sponsor Request|0|||
49137787|NCT00580840|158342650|FG002|Run-in|Other: Per Sponsor Request|0|||
49137788|NCT00580840|158342651|FG003|Run-in|Other: Per Sponsor Request|0|||
49137789|NCT00580840|158342648|FG000|Run-in|Other: Did Not Meet Joint Count Criteria|1|||
48921063|NCT02255422|157544826|FG002|Overall Study|Lost to Follow-up|1|||
48921064|NCT02255422|157544827|FG003|Overall Study|Lost to Follow-up|0|||
48921065|NCT02255422|157544828|FG004|Overall Study|Lost to Follow-up|0|||
48921066|NCT02255422|157544829|FG005|Overall Study|Lost to Follow-up|0|||
48921067|NCT02255422|157544830|FG006|Overall Study|Lost to Follow-up|0|||
48921068|NCT03652662|157544831|FG000|Overall Study|Withdrawal by Subject|2|||
49137790|NCT00580840|158342649|FG001|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
49137791|NCT00580840|158342650|FG002|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
49137792|NCT00580840|158342651|FG003|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
49137793|NCT00580840|158342648|FG000|Run-in|Other: Exclusionary Lab Value|1|||
48921069|NCT03652662|157544832|FG001|Overall Study|Withdrawal by Subject|1|||
48921070|NCT03652662|157544831|FG000|Overall Study|Lost to Follow-up|1|||
49137794|NCT00580840|158342649|FG001|Run-in|Other: Exclusionary Lab Value|0|||
49137795|NCT00580840|158342650|FG002|Run-in|Other: Exclusionary Lab Value|0|||
49137796|NCT00580840|158342651|FG003|Run-in|Other: Exclusionary Lab Value|0|||
49137797|NCT00580840|158342648|FG000|Double-Blind|Adverse Event|0|||
49137798|NCT00580840|158342649|FG001|Double-Blind|Adverse Event|3|||
49137799|NCT00580840|158342650|FG002|Double-Blind|Adverse Event|4|||
49137800|NCT00580840|158342651|FG003|Double-Blind|Adverse Event|1|||
49137801|NCT00580840|158342648|FG000|Double-Blind|Loss of Efficacy|0|||
49137802|NCT00580840|158342649|FG001|Double-Blind|Loss of Efficacy|1|||
49137803|NCT00580840|158342650|FG002|Double-Blind|Loss of Efficacy|2|||
49137804|NCT00580840|158342651|FG003|Double-Blind|Loss of Efficacy|10|||
48921071|NCT03652662|157544832|FG001|Overall Study|Lost to Follow-up|0|||
48921072|NCT00993928|157544835|FG000|Overall Study|Withdrawal by Subject|4|||
48921073|NCT00993928|157544836|FG001|Overall Study|Withdrawal by Subject|7|||
48921074|NCT00993928|157544835|FG000|Overall Study|ineligible|1|||
48921075|NCT00993928|157544836|FG001|Overall Study|ineligible|0|||
49137805|NCT00580840|158342648|FG000|Double-Blind|Lost to Follow-up|0|||
49137806|NCT00580840|158342649|FG001|Double-Blind|Lost to Follow-up|1|||
49137807|NCT00580840|158342650|FG002|Double-Blind|Lost to Follow-up|0|||
49137808|NCT00580840|158342651|FG003|Double-Blind|Lost to Follow-up|2|||
49137809|NCT00580840|158342648|FG000|Double-Blind|Withdrawal by Subject|0|||
49137810|NCT00580840|158342649|FG001|Double-Blind|Withdrawal by Subject|1|||
49137811|NCT00580840|158342650|FG002|Double-Blind|Withdrawal by Subject|2|||
49137812|NCT00580840|158342651|FG003|Double-Blind|Withdrawal by Subject|2|||
49137813|NCT00580840|158342648|FG000|Double-Blind|Other: Discontinued Methotrexate|0|||
49137814|NCT00580840|158342649|FG001|Double-Blind|Other: Discontinued Methotrexate|1|||
49137815|NCT00580840|158342650|FG002|Double-Blind|Other: Discontinued Methotrexate|0|||
49137816|NCT00580840|158342651|FG003|Double-Blind|Other: Discontinued Methotrexate|0|||
49137817|NCT00580840|158342648|FG000|Double-Blind|Other: Forbidden Medication|0|||
49137818|NCT00580840|158342649|FG001|Double-Blind|Other: Forbidden Medication|0|||
49137819|NCT00580840|158342650|FG002|Double-Blind|Other: Forbidden Medication|1|||
48921076|NCT02751502|157544837|FG000|Overall Study|Lack of funding|4|||
49137820|NCT00580840|158342651|FG003|Double-Blind|Other: Forbidden Medication|0|||
49137821|NCT02315625|158342654|FG000|First Intervention|Disease Progression|1|||
49137822|NCT02315625|158342655|FG001|First Intervention|Disease Progression|0|||
49137823|NCT02315625|158342654|FG000|Second Intervention|Physician Decision|2|||
49137824|NCT02315625|158342655|FG001|Second Intervention|Physician Decision|1|||
49137825|NCT02315625|158342654|FG000|Second Intervention|Study closure|1|||
49137826|NCT02315625|158342655|FG001|Second Intervention|Study closure|0|||
49137827|NCT02315625|158342654|FG000|Second Intervention|Disease Progression|1|||
49137828|NCT02315625|158342655|FG001|Second Intervention|Disease Progression|0|||
49137829|NCT01402700|158342656|FG000|Overall Study|Death|3|||
48921077|NCT00088374|157544838|FG000|Overall Study|patient did not receive any 17AAG|1|||
48921078|NCT00088374|157544838|FG000|Overall Study|patient received <1 cycle only of 17AAG|1|||
48921079|NCT00852995|157544839|FG000|Overall Study|Adverse Event|1|||
48921080|NCT00852995|157544840|FG001|Overall Study|Adverse Event|0|||
48921081|NCT00852995|157544841|FG002|Overall Study|Adverse Event|4|||
48921082|NCT00852995|157544842|FG003|Overall Study|Adverse Event|0|||
48921083|NCT00852995|157544843|FG004|Overall Study|Adverse Event|0|||
48921084|NCT00852995|157544839|FG000|Overall Study|Lost to Follow-up|0|||
48921085|NCT00852995|157544840|FG001|Overall Study|Lost to Follow-up|1|||
48921086|NCT00852995|157544841|FG002|Overall Study|Lost to Follow-up|1|||
48921087|NCT00852995|157544842|FG003|Overall Study|Lost to Follow-up|0|||
48921088|NCT00852995|157544843|FG004|Overall Study|Lost to Follow-up|0|||
48921089|NCT00852995|157544839|FG000|Overall Study|Withdrawal by Subject|4|||
48921090|NCT00852995|157544840|FG001|Overall Study|Withdrawal by Subject|0|||
48921091|NCT00852995|157544841|FG002|Overall Study|Withdrawal by Subject|0|||
48921092|NCT00852995|157544842|FG003|Overall Study|Withdrawal by Subject|1|||
48921093|NCT00852995|157544843|FG004|Overall Study|Withdrawal by Subject|2|||
48921094|NCT00852995|157544839|FG000|Overall Study|Non-Compliance|0|||
48921095|NCT00852995|157544840|FG001|Overall Study|Non-Compliance|0|||
48921096|NCT00852995|157544841|FG002|Overall Study|Non-Compliance|0|||
48921097|NCT00852995|157544842|FG003|Overall Study|Non-Compliance|2|||
48921098|NCT00852995|157544843|FG004|Overall Study|Non-Compliance|0|||
48921099|NCT00852995|157544839|FG000|Overall Study|Progressive Disease|1|||
48921100|NCT00852995|157544840|FG001|Overall Study|Progressive Disease|0|||
49011412|NCT01507831|157878943|FG000|Overall Study|Other|3|||
49011413|NCT01507831|157878944|FG001|Overall Study|Other|6|||
49011414|NCT03263819|157878945|FG000|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|1|||
49011415|NCT03263819|157878946|FG001|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|0|||
49011416|NCT03412019|157878947|FG000|Overall Study|Withdrawal by Subject|1|||
49011417|NCT03412019|157878948|FG001|Overall Study|Withdrawal by Subject|1|||
49011418|NCT00415532|157878961|FG000|Treatment Period|Adverse Event|2|||
49011419|NCT00415532|157878962|FG001|Treatment Period|Adverse Event|3|||
49011420|NCT00415532|157878961|FG000|Treatment Period|Death|2|||
49011421|NCT00415532|157878962|FG001|Treatment Period|Death|1|||
49011422|NCT00415532|157878961|FG000|Treatment Period|Lost to Follow-up|1|||
49011423|NCT00415532|157878962|FG001|Treatment Period|Lost to Follow-up|1|||
49011424|NCT00415532|157878961|FG000|Treatment Period|Protocol Violation|1|||
48726770|NCT00938964|156849890|FG001|Overall Study|Found to Meet Exclusion Criteria|4|||
48921101|NCT00852995|157544841|FG002|Overall Study|Progressive Disease|0|||
48921102|NCT00852995|157544842|FG003|Overall Study|Progressive Disease|2|||
48921103|NCT00852995|157544843|FG004|Overall Study|Progressive Disease|1|||
48921104|NCT00852995|157544839|FG000|Overall Study|Physician Decision|1|||
48921105|NCT00852995|157544840|FG001|Overall Study|Physician Decision|0|||
48921106|NCT00852995|157544841|FG002|Overall Study|Physician Decision|0|||
48921107|NCT00852995|157544842|FG003|Overall Study|Physician Decision|0|||
48921108|NCT00852995|157544843|FG004|Overall Study|Physician Decision|0|||
48921109|NCT00852995|157544839|FG000|Overall Study|Protocol Violation|0|||
48921110|NCT00852995|157544840|FG001|Overall Study|Protocol Violation|0|||
48921111|NCT00852995|157544841|FG002|Overall Study|Protocol Violation|0|||
48921112|NCT00852995|157544842|FG003|Overall Study|Protocol Violation|0|||
48921113|NCT00852995|157544843|FG004|Overall Study|Protocol Violation|1|||
48921114|NCT00852995|157544839|FG000|Overall Study|Moved Out of Area|1|||
48921115|NCT00852995|157544840|FG001|Overall Study|Moved Out of Area|0|||
48921116|NCT00852995|157544841|FG002|Overall Study|Moved Out of Area|0|||
48726771|NCT02862600|156849894|FG000|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9|||
48726772|NCT02862600|156849894|FG000|Period 1--Perhexiline-low Target Range|Protocol Violation|3|||
48921117|NCT00852995|157544842|FG003|Overall Study|Moved Out of Area|0|||
48921118|NCT00852995|157544843|FG004|Overall Study|Moved Out of Area|0|||
48921119|NCT02286947|157544845|FG000|Overall Study|Withdrawal by Subject|2|||
48726773|NCT02862600|156849894|FG000|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1|||
48726774|NCT02862600|156849894|FG000|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7|||
48726775|NCT00570232|156849908|FG000|Overall Study|Adverse Event|10|||
48726776|NCT00570232|156849908|FG000|Overall Study|discontinued due to medical condition|3|||
48726777|NCT00570232|156849908|FG000|Overall Study|discontinued due to recurrence|8|||
48726778|NCT00570232|156849908|FG000|Overall Study|discontinued due to noncompliance|2|||
48726779|NCT01076075|156849909|FG000|Overall Study|Adverse Event|3|||
48726780|NCT01076075|156849910|FG001|Overall Study|Adverse Event|9|||
48726781|NCT01076075|156849909|FG000|Overall Study|Lack of Efficacy|5|||
48726782|NCT01076075|156849910|FG001|Overall Study|Lack of Efficacy|4|||
48726783|NCT01076075|156849909|FG000|Overall Study|Lost to Follow-up|6|||
48726784|NCT01076075|156849910|FG001|Overall Study|Lost to Follow-up|5|||
48921120|NCT00730639|157544846|FG000|Overall Study|Adverse Event|3|||
48921121|NCT00730639|157544847|FG001|Overall Study|Adverse Event|0|||
48921122|NCT00730639|157544848|FG002|Overall Study|Adverse Event|9|||
48921123|NCT00730639|157544849|FG003|Overall Study|Adverse Event|8|||
48921124|NCT00730639|157544850|FG004|Overall Study|Adverse Event|23|||
48921125|NCT00730639|157544846|FG000|Overall Study|Complete Response|0|||
48921126|NCT00730639|157544847|FG001|Overall Study|Complete Response|0|||
48921127|NCT00730639|157544848|FG002|Overall Study|Complete Response|2|||
48726785|NCT01076075|156849909|FG000|Overall Study|other|19|||
48921128|NCT00730639|157544849|FG003|Overall Study|Complete Response|2|||
49137830|NCT01402700|158342656|FG000|Overall Study|Withdrawal by Subject|3|||
49137831|NCT01402700|158342656|FG000|Overall Study|Missed Visit|1|||
49137832|NCT02187055|158342659|FG000|Overall Study|Lack of Efficacy|10|||
49137833|NCT02187055|158342660|FG001|Overall Study|Lack of Efficacy|3|||
49137834|NCT02187055|158342661|FG002|Overall Study|Lack of Efficacy|7|||
49137835|NCT02187055|158342659|FG000|Overall Study|Lost to Follow-up|2|||
49137836|NCT02187055|158342660|FG001|Overall Study|Lost to Follow-up|7|||
49137837|NCT02187055|158342661|FG002|Overall Study|Lost to Follow-up|3|||
49137838|NCT02187055|158342659|FG000|Overall Study|No longer meets eligibility criteria|0|||
49137839|NCT02187055|158342660|FG001|Overall Study|No longer meets eligibility criteria|2|||
49137840|NCT02187055|158342661|FG002|Overall Study|No longer meets eligibility criteria|0|||
49137841|NCT02187055|158342659|FG000|Overall Study|No longer willing to participate|6|||
49137842|NCT02187055|158342660|FG001|Overall Study|No longer willing to participate|8|||
49137843|NCT02187055|158342661|FG002|Overall Study|No longer willing to participate|10|||
49137844|NCT02187055|158342659|FG000|Overall Study|Other|5|||
49137845|NCT02187055|158342660|FG001|Overall Study|Other|6|||
49137846|NCT02187055|158342661|FG002|Overall Study|Other|3|||
49137847|NCT02187055|158342659|FG000|Overall Study|Protocol Violation|9|||
49137848|NCT02187055|158342660|FG001|Overall Study|Protocol Violation|9|||
49137849|NCT02187055|158342661|FG002|Overall Study|Protocol Violation|4|||
49137850|NCT02187055|158342659|FG000|Overall Study|Pregnancy|3|||
49137851|NCT02187055|158342660|FG001|Overall Study|Pregnancy|1|||
49137852|NCT02187055|158342661|FG002|Overall Study|Pregnancy|0|||
49137853|NCT02187055|158342659|FG000|Overall Study|Withdrawal by Subject|11|||
49137854|NCT02187055|158342660|FG001|Overall Study|Withdrawal by Subject|11|||
49137855|NCT02187055|158342661|FG002|Overall Study|Withdrawal by Subject|11|||
49137856|NCT02187055|158342659|FG000|Overall Study|Adverse Event|21|||
49137857|NCT02187055|158342660|FG001|Overall Study|Adverse Event|26|||
49137858|NCT02187055|158342661|FG002|Overall Study|Adverse Event|36|||
49137859|NCT02187055|158342659|FG000|Overall Study|Death|2|||
49137860|NCT02187055|158342660|FG001|Overall Study|Death|0|||
49137861|NCT02187055|158342661|FG002|Overall Study|Death|0|||
49137862|NCT02965833|158342664|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
49137863|NCT02965833|158342665|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
49137864|NCT02965833|158342664|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
49137865|NCT02965833|158342665|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
49137866|NCT02965833|158342664|FG000|Period 1, First 30 Days of Wear|Protocol Violation|1|||
49137867|NCT02965833|158342665|FG001|Period 1, First 30 Days of Wear|Protocol Violation|0|||
49137868|NCT02965833|158342664|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
49137869|NCT02965833|158342665|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
49137870|NCT02965833|158342664|FG000|Period 2, Second 30 Days of Wear|Protocol Violation|2|||
48726786|NCT01076075|156849910|FG001|Overall Study|other|9|||
48726787|NCT01076075|156849909|FG000|Overall Study|Protocol Violation|0|||
48726788|NCT01076075|156849910|FG001|Overall Study|Protocol Violation|1|||
49137871|NCT02965833|158342665|FG001|Period 2, Second 30 Days of Wear|Protocol Violation|0|||
49137872|NCT03010501|158342667|FG000|Study Week 1|Withdrawal by Subject|2|||
49137873|NCT03010501|158342668|FG001|Study Week 1|Withdrawal by Subject|1|||
49137874|NCT03010501|158342669|FG002|Study Week 1|Withdrawal by Subject|0|||
49137875|NCT03010501|158342670|FG003|Study Week 1|Withdrawal by Subject|2|||
49137876|NCT03010501|158342671|FG004|Study Week 1|Withdrawal by Subject|0|||
48726789|NCT01076075|156849909|FG000|Overall Study|Withdrawal by Subject|8|||
48726790|NCT01076075|156849910|FG001|Overall Study|Withdrawal by Subject|19|||
48726791|NCT01285960|156849911|FG000|Overall Study|Withdrawal by Subject|2|||
48726792|NCT01285960|156849911|FG000|Overall Study|Lost to Follow-up|2|||
48726793|NCT01285960|156849911|FG000|Overall Study|2 subjects received less 10 sonications|2|||
48726794|NCT00667420|156849913|FG000|Overall Study|Adverse Event|2|||
48726795|NCT00667420|156849913|FG000|Overall Study|Lack of Efficacy|5|||
48726796|NCT00667420|156849913|FG000|Overall Study|Physician Decision|1|||
48726797|NCT00667420|156849913|FG000|Overall Study|Withdrawal by Subject|2|||
48726798|NCT03194490|156849920|FG000|Overall Study|Lost to Follow-up|1|||
48726799|NCT03194490|156849921|FG001|Overall Study|Lost to Follow-up|3|||
48921129|NCT00730639|157544850|FG004|Overall Study|Complete Response|1|||
49137877|NCT03010501|158342672|FG005|Study Week 1|Withdrawal by Subject|0|||
48726800|NCT03194490|156849920|FG000|Overall Study|participant developed specific neck pain|1|||
48726801|NCT03194490|156849921|FG001|Overall Study|participant developed specific neck pain|0|||
48726802|NCT01931202|156849922|FG000|Overall Study|Withdrawal by Subject|0|||
48921130|NCT00730639|157544846|FG000|Overall Study|Completed Maximum Cycles|0|||
49137878|NCT03010501|158342667|FG000|Study Week 3|Withdrawal by Subject|0|||
49137879|NCT03010501|158342668|FG001|Study Week 3|Withdrawal by Subject|0|||
49137880|NCT03010501|158342669|FG002|Study Week 3|Withdrawal by Subject|0|||
49137881|NCT03010501|158342670|FG003|Study Week 3|Withdrawal by Subject|1|||
49137882|NCT03010501|158342671|FG004|Study Week 3|Withdrawal by Subject|0|||
48821077|NCT02013687|157187344|FG002|Overall Study|Withdrawal by Subject|0|||
48821078|NCT02013687|157187345|FG003|Overall Study|Withdrawal by Subject|1|||
48821079|NCT02013687|157187342|FG000|Overall Study|Missed visits due to patient travel|0|||
48821080|NCT02013687|157187343|FG001|Overall Study|Missed visits due to patient travel|0|||
48821081|NCT02013687|157187344|FG002|Overall Study|Missed visits due to patient travel|1|||
48821082|NCT02013687|157187345|FG003|Overall Study|Missed visits due to patient travel|0|||
48821083|NCT01782326|157187346|FG000|Planned Treatment Epoch|Subject/guardian decision|149|||
48821084|NCT01782326|157187347|FG001|Planned Treatment Epoch|Subject/guardian decision|151|||
48821085|NCT01782326|157187346|FG000|Planned Treatment Epoch|Death|29|||
48821086|NCT01782326|157187347|FG001|Planned Treatment Epoch|Death|30|||
48821087|NCT01782326|157187346|FG000|Planned Treatment Epoch|Physician Decision|18|||
48821088|NCT01782326|157187347|FG001|Planned Treatment Epoch|Physician Decision|16|||
48821089|NCT01782326|157187346|FG000|Planned Treatment Epoch|Protocol deviation|2|||
48821090|NCT01782326|157187347|FG001|Planned Treatment Epoch|Protocol deviation|3|||
48821091|NCT01782326|157187346|FG000|Planned Treatment Epoch|Lost to Follow-up|4|||
48821092|NCT01782326|157187347|FG001|Planned Treatment Epoch|Lost to Follow-up|4|||
48821093|NCT01782326|157187346|FG000|Planned Treatment Epoch|Technical problems|0|||
48821094|NCT01782326|157187347|FG001|Planned Treatment Epoch|Technical problems|4|||
48821095|NCT01782326|157187346|FG000|Double-blind Treatment|Adverse Event|129|||
48821096|NCT01782326|157187347|FG001|Double-blind Treatment|Adverse Event|145|||
48821097|NCT01782326|157187346|FG000|Double-blind Treatment|Subject/guardian decision|111|||
49137883|NCT03010501|158342672|FG005|Study Week 3|Withdrawal by Subject|0|||
49137884|NCT02184156|158342673|FG000|Phase 2 20 Week Efficacy|Protocol Violation|0|||
49137885|NCT02184156|158342674|FG001|Phase 2 20 Week Efficacy|Protocol Violation|1|||
49137886|NCT02184156|158342673|FG000|Phase 2 20 Week Efficacy|Withdrawal by Subject|1|||
49137887|NCT02184156|158342674|FG001|Phase 2 20 Week Efficacy|Withdrawal by Subject|0|||
49137888|NCT03003468|158342680|FG000|Overall Study|Withdrawal by Subject|0|||
49137889|NCT03003468|158342681|FG001|Overall Study|Withdrawal by Subject|0|||
49137890|NCT03003468|158342682|FG002|Overall Study|Withdrawal by Subject|1|||
49137891|NCT03003468|158342680|FG000|Overall Study|No measurable lesions|0|||
49137892|NCT03003468|158342681|FG001|Overall Study|No measurable lesions|0|||
49137893|NCT03003468|158342682|FG002|Overall Study|No measurable lesions|1|||
49137894|NCT00421993|158342687|FG000|Overall Study|Withdrawal by Subject|22|||
49137895|NCT00421993|158342688|FG001|Overall Study|Withdrawal by Subject|23|||
49137896|NCT00421993|158342689|FG002|Overall Study|Withdrawal by Subject|23|||
49137897|NCT00421993|158342690|FG003|Overall Study|Withdrawal by Subject|24|||
49137898|NCT00421993|158342687|FG000|Overall Study|Lost to Follow-up|18|||
49137899|NCT00421993|158342688|FG001|Overall Study|Lost to Follow-up|19|||
49137900|NCT00421993|158342689|FG002|Overall Study|Lost to Follow-up|22|||
49137901|NCT00421993|158342690|FG003|Overall Study|Lost to Follow-up|20|||
49137902|NCT00421993|158342687|FG000|Overall Study|Adverse Event|11|||
49137903|NCT00421993|158342688|FG001|Overall Study|Adverse Event|1|||
49137904|NCT00421993|158342689|FG002|Overall Study|Adverse Event|6|||
49137905|NCT00421993|158342690|FG003|Overall Study|Adverse Event|4|||
49137906|NCT00421993|158342687|FG000|Overall Study|Protocol Violation|2|||
49137907|NCT00421993|158342688|FG001|Overall Study|Protocol Violation|2|||
49137908|NCT00421993|158342689|FG002|Overall Study|Protocol Violation|0|||
49137909|NCT00421993|158342690|FG003|Overall Study|Protocol Violation|1|||
49137910|NCT00421993|158342687|FG000|Overall Study|Lack of Efficacy|0|||
49137911|NCT00421993|158342688|FG001|Overall Study|Lack of Efficacy|3|||
49137912|NCT00421993|158342689|FG002|Overall Study|Lack of Efficacy|0|||
49137913|NCT00421993|158342690|FG003|Overall Study|Lack of Efficacy|5|||
49137914|NCT00421993|158342687|FG000|Overall Study|Pregnancy|0|||
49137915|NCT00421993|158342688|FG001|Overall Study|Pregnancy|1|||
49137916|NCT00421993|158342689|FG002|Overall Study|Pregnancy|1|||
49137917|NCT00421993|158342690|FG003|Overall Study|Pregnancy|2|||
49137918|NCT00421993|158342687|FG000|Overall Study|Subject transportation issues|0|||
49137919|NCT00421993|158342688|FG001|Overall Study|Subject transportation issues|0|||
49137920|NCT00421993|158342689|FG002|Overall Study|Subject transportation issues|0|||
49137921|NCT00421993|158342690|FG003|Overall Study|Subject transportation issues|1|||
49137922|NCT01214720|158342700|FG000|Overall Study|Alive and still on treatment|34|||
49137923|NCT01214720|158342701|FG001|Overall Study|Alive and still on treatment|18|||
49137924|NCT01214720|158342700|FG000|Overall Study|Alive and in follow-up|45|||
49137925|NCT01214720|158342701|FG001|Overall Study|Alive and in follow-up|48|||
49137926|NCT01214720|158342700|FG000|Overall Study|Lost to Follow-up|6|||
49137927|NCT01214720|158342701|FG001|Overall Study|Lost to Follow-up|2|||
49137928|NCT02347787|158342703|FG000|6 Month Follow-Up|Lost to Follow-up|63|||
49137929|NCT02347787|158342704|FG001|6 Month Follow-Up|Lost to Follow-up|47|||
49137930|NCT02347787|158342703|FG000|6 Month Follow-Up|Withdrawal by Subject|3|||
49137931|NCT02347787|158342704|FG001|6 Month Follow-Up|Withdrawal by Subject|9|||
49137932|NCT02347787|158342703|FG000|9 Month Follow-Up|Lost to Follow-up|52|||
49137933|NCT02347787|158342704|FG001|9 Month Follow-Up|Lost to Follow-up|59|||
49137934|NCT02347787|158342703|FG000|9 Month Follow-Up|Withdrawal by Subject|9|||
49137935|NCT02347787|158342704|FG001|9 Month Follow-Up|Withdrawal by Subject|12|||
49137936|NCT01980888|158342705|FG000|Overall Study|Study Terminated by Sponsor|116|||
49137937|NCT01980888|158342706|FG001|Overall Study|Study Terminated by Sponsor|122|||
49137938|NCT01980888|158342705|FG000|Overall Study|Withdrew Consent|17|||
49137939|NCT01980888|158342706|FG001|Overall Study|Withdrew Consent|6|||
49137940|NCT01980888|158342705|FG000|Overall Study|Investigator's Discretion|8|||
49137941|NCT01980888|158342706|FG001|Overall Study|Investigator's Discretion|3|||
49137942|NCT01980888|158342705|FG000|Overall Study|Non-Compliance with Study Drug|3|||
49137943|NCT01980888|158342706|FG001|Overall Study|Non-Compliance with Study Drug|2|||
49137944|NCT01751685|158342707|FG000|6-mo Followup|Missed study visit|1|||
49137945|NCT01751685|158342708|FG001|6-mo Followup|Missed study visit|0|||
49137946|NCT01751685|158342707|FG000|6-mo Followup|Withdrawal by Subject|2|||
49137947|NCT01751685|158342708|FG001|6-mo Followup|Withdrawal by Subject|2|||
49137948|NCT01751685|158342707|FG000|6-mo Followup|Lost to Follow-up|0|||
49137949|NCT01751685|158342708|FG001|6-mo Followup|Lost to Follow-up|1|||
49137950|NCT01751685|158342707|FG000|12-mo Followup|Lost to Follow-up|5|||
49137951|NCT01751685|158342708|FG001|12-mo Followup|Lost to Follow-up|0|||
49137952|NCT04625972|158342710|FG000|Overall Study|Death|3|||
49137953|NCT04625972|158342711|FG001|Overall Study|Death|2|||
49137954|NCT04625972|158342710|FG000|Overall Study|Lost to Follow-up|82|||
49137955|NCT04625972|158342711|FG001|Overall Study|Lost to Follow-up|38|||
49137956|NCT04625972|158342710|FG000|Overall Study|Physician Decision|2|||
49137957|NCT04625972|158342711|FG001|Overall Study|Physician Decision|0|||
49137958|NCT04625972|158342710|FG000|Overall Study|Protocol Violation|0|||
49137959|NCT04625972|158342711|FG001|Overall Study|Protocol Violation|1|||
49137960|NCT04625972|158342710|FG000|Overall Study|Withdrawal by Subject|37|||
49137961|NCT04625972|158342711|FG001|Overall Study|Withdrawal by Subject|24|||
49137962|NCT04625972|158342710|FG000|Overall Study|Not specified elsewhere|8|||
49137963|NCT04625972|158342711|FG001|Overall Study|Not specified elsewhere|6|||
49137964|NCT01107457|158342715|FG000|Part A|Adverse Event|1|||
49137965|NCT01107457|158342716|FG001|Part A|Adverse Event|2|||
49137966|NCT01107457|158342717|FG002|Part A|Adverse Event|1|||
49137967|NCT01107457|158342718|FG003|Part A|Adverse Event|0|||
49137968|NCT01107457|158342719|FG004|Part A|Adverse Event|0|||
49137969|NCT01107457|158342720|FG005|Part A|Adverse Event|0|||
49137970|NCT01107457|158342715|FG000|Part A|Withdrawal by Subject|3|||
49137971|NCT01107457|158342716|FG001|Part A|Withdrawal by Subject|3|||
49137972|NCT01107457|158342717|FG002|Part A|Withdrawal by Subject|0|||
49137973|NCT01107457|158342718|FG003|Part A|Withdrawal by Subject|3|||
49137974|NCT01107457|158342719|FG004|Part A|Withdrawal by Subject|1|||
49137975|NCT01107457|158342720|FG005|Part A|Withdrawal by Subject|0|||
49137976|NCT01107457|158342715|FG000|Part A|Lost to Follow-up|0|||
49137977|NCT01107457|158342716|FG001|Part A|Lost to Follow-up|1|||
49137978|NCT01107457|158342717|FG002|Part A|Lost to Follow-up|0|||
49137979|NCT01107457|158342718|FG003|Part A|Lost to Follow-up|0|||
49137980|NCT01107457|158342719|FG004|Part A|Lost to Follow-up|0|||
49137981|NCT01107457|158342720|FG005|Part A|Lost to Follow-up|0|||
49137982|NCT01107457|158342715|FG000|Part A|Lack of Efficacy|1|||
49137983|NCT01107457|158342716|FG001|Part A|Lack of Efficacy|0|||
49137984|NCT01107457|158342717|FG002|Part A|Lack of Efficacy|0|||
49137985|NCT01107457|158342718|FG003|Part A|Lack of Efficacy|0|||
49137986|NCT01107457|158342719|FG004|Part A|Lack of Efficacy|0|||
49137987|NCT01107457|158342720|FG005|Part A|Lack of Efficacy|0|||
49137988|NCT01107457|158342715|FG000|Part A|Protocol Violation|0|||
49137989|NCT01107457|158342716|FG001|Part A|Protocol Violation|1|||
49137990|NCT01107457|158342717|FG002|Part A|Protocol Violation|0|||
49137991|NCT01107457|158342718|FG003|Part A|Protocol Violation|0|||
49137992|NCT01107457|158342719|FG004|Part A|Protocol Violation|0|||
49137993|NCT01107457|158342720|FG005|Part A|Protocol Violation|0|||
49137994|NCT01107457|158342715|FG000|Part B and C|Adverse Event|0|||
49137995|NCT01107457|158342716|FG001|Part B and C|Adverse Event|0|||
49137996|NCT01107457|158342717|FG002|Part B and C|Adverse Event|0|||
49137997|NCT01107457|158342718|FG003|Part B and C|Adverse Event|0|||
49137998|NCT01107457|158342719|FG004|Part B and C|Adverse Event|0|||
49137999|NCT01107457|158342720|FG005|Part B and C|Adverse Event|12|||
49138000|NCT01107457|158342715|FG000|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
49138001|NCT01107457|158342716|FG001|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
49138002|NCT01107457|158342717|FG002|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
49138003|NCT01107457|158342718|FG003|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
49138004|NCT01107457|158342719|FG004|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
49138005|NCT01107457|158342720|FG005|Part B and C|Inclusion/Exclusion Criteria Not Met|1|||
49138006|NCT01107457|158342715|FG000|Part B and C|Physician Decision|0|||
49138007|NCT01107457|158342716|FG001|Part B and C|Physician Decision|0|||
49138008|NCT01107457|158342717|FG002|Part B and C|Physician Decision|0|||
49138009|NCT01107457|158342718|FG003|Part B and C|Physician Decision|0|||
49138010|NCT01107457|158342719|FG004|Part B and C|Physician Decision|0|||
49138011|NCT01107457|158342720|FG005|Part B and C|Physician Decision|3|||
49138012|NCT01107457|158342715|FG000|Part B and C|Lack of Efficacy|0|||
49138013|NCT01107457|158342716|FG001|Part B and C|Lack of Efficacy|0|||
49138014|NCT01107457|158342717|FG002|Part B and C|Lack of Efficacy|0|||
49138015|NCT01107457|158342718|FG003|Part B and C|Lack of Efficacy|0|||
49138016|NCT01107457|158342719|FG004|Part B and C|Lack of Efficacy|0|||
48726803|NCT01931202|156849923|FG001|Overall Study|Withdrawal by Subject|0|||
48921131|NCT00730639|157544847|FG001|Overall Study|Completed Maximum Cycles|0|||
49138017|NCT01107457|158342720|FG005|Part B and C|Lack of Efficacy|7|||
49138018|NCT01107457|158342715|FG000|Part B and C|Lost to Follow-up|0|||
49138019|NCT01107457|158342716|FG001|Part B and C|Lost to Follow-up|0|||
49138020|NCT01107457|158342717|FG002|Part B and C|Lost to Follow-up|0|||
49138021|NCT01107457|158342718|FG003|Part B and C|Lost to Follow-up|0|||
49138022|NCT01107457|158342719|FG004|Part B and C|Lost to Follow-up|0|||
49138023|NCT01107457|158342720|FG005|Part B and C|Lost to Follow-up|10|||
49138024|NCT01107457|158342715|FG000|Part B and C|Protocol Violation|0|||
49138025|NCT01107457|158342716|FG001|Part B and C|Protocol Violation|0|||
49138026|NCT01107457|158342717|FG002|Part B and C|Protocol Violation|0|||
49138027|NCT01107457|158342718|FG003|Part B and C|Protocol Violation|0|||
49138028|NCT01107457|158342719|FG004|Part B and C|Protocol Violation|0|||
49138029|NCT01107457|158342720|FG005|Part B and C|Protocol Violation|1|||
49138030|NCT01107457|158342715|FG000|Part B and C|Sponsor Decision|0|||
49138031|NCT01107457|158342716|FG001|Part B and C|Sponsor Decision|0|||
49138032|NCT01107457|158342717|FG002|Part B and C|Sponsor Decision|0|||
49138033|NCT01107457|158342718|FG003|Part B and C|Sponsor Decision|0|||
49138034|NCT01107457|158342719|FG004|Part B and C|Sponsor Decision|0|||
49138035|NCT01107457|158342720|FG005|Part B and C|Sponsor Decision|66|||
49138036|NCT01107457|158342715|FG000|Part B and C|Withdrawal by Subject|0|||
49138037|NCT01107457|158342716|FG001|Part B and C|Withdrawal by Subject|0|||
49138038|NCT01107457|158342717|FG002|Part B and C|Withdrawal by Subject|0|||
49138039|NCT01107457|158342718|FG003|Part B and C|Withdrawal by Subject|0|||
49138040|NCT01107457|158342719|FG004|Part B and C|Withdrawal by Subject|0|||
49138041|NCT01107457|158342720|FG005|Part B and C|Withdrawal by Subject|16|||
49138042|NCT01107457|158342715|FG000|Part B and C|Clinical Relapse|0|||
49138043|NCT01107457|158342716|FG001|Part B and C|Clinical Relapse|0|||
49138044|NCT01107457|158342717|FG002|Part B and C|Clinical Relapse|0|||
49138045|NCT01107457|158342718|FG003|Part B and C|Clinical Relapse|0|||
49138046|NCT01107457|158342719|FG004|Part B and C|Clinical Relapse|0|||
49138047|NCT01107457|158342720|FG005|Part B and C|Clinical Relapse|4|||
49138048|NCT03738215|158342736|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
49138049|NCT03738215|158342737|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|1|||
49138050|NCT03738215|158342738|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
49138051|NCT03738215|158342736|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
49138052|NCT03738215|158342737|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
49138053|NCT03738215|158342738|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
49138054|NCT03738215|158342736|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
49138055|NCT03738215|158342737|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
49138056|NCT03738215|158342738|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|18|||
49138057|NCT03738215|158342736|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|13|||
49138058|NCT03738215|158342737|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|11|||
49138059|NCT03738215|158342738|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|9|||
49138060|NCT03738215|158342736|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
49138061|NCT03738215|158342737|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
49138062|NCT03738215|158342738|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
49138063|NCT03738215|158342736|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
49138064|NCT03738215|158342737|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
49138065|NCT03738215|158342738|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|5|||
49138066|NCT03738215|158342736|FG000|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
49138067|NCT03738215|158342737|FG001|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
49138068|NCT03738215|158342738|FG002|Safety Follow Up Period (4 Weeks)|Adverse Event|1|||
49138069|NCT03738215|158342736|FG000|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
49138070|NCT03738215|158342737|FG001|Safety Follow Up Period (4 Weeks)|Reason Not Specified|2|||
49138071|NCT03738215|158342738|FG002|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
49138072|NCT03738215|158342736|FG000|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
49138073|NCT03738215|158342737|FG001|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
49138074|NCT03738215|158342738|FG002|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|3|||
49138075|NCT03738215|158342736|FG000|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
49138076|NCT03738215|158342737|FG001|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
49138077|NCT03738215|158342738|FG002|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|4|||
49138078|NCT04073407|158342741|FG000|Part 1|Withdrawal by Subject|1|||
49138079|NCT04073407|158342742|FG001|Part 1|Withdrawal by Subject|0|||
49138080|NCT04073407|158342741|FG000|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4|||
49138081|NCT04073407|158342742|FG001|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1|||
49138082|NCT04073407|158342741|FG000|Part 2|Withdrawal by Subject|0|||
49138083|NCT04073407|158342742|FG001|Part 2|Withdrawal by Subject|1|||
49138084|NCT02034591|158343865|FG000|Overall Study|Withdrawal by Subject|0|||
49138085|NCT02034591|158343866|FG001|Overall Study|Withdrawal by Subject|0|||
48921132|NCT00730639|157544848|FG002|Overall Study|Completed Maximum Cycles|11|||
48921133|NCT00730639|157544849|FG003|Overall Study|Completed Maximum Cycles|3|||
49138086|NCT02034591|158343867|FG002|Overall Study|Withdrawal by Subject|0|||
49138087|NCT02034591|158343868|FG003|Overall Study|Withdrawal by Subject|0|||
49138088|NCT02034591|158343869|FG004|Overall Study|Withdrawal by Subject|1|||
49138089|NCT02034591|158343870|FG005|Overall Study|Withdrawal by Subject|0|||
49138090|NCT02536794|158343875|FG000|Reached 1st Response Assessment|Adverse Event|2|||
49138091|NCT02536794|158343875|FG000|Reached 1st Response Assessment|Progressive Disease|2|||
49138092|NCT02536794|158343875|FG000|Reached 1st Response Assessment|Withdrawal by Subject|1|||
49138093|NCT02536794|158343875|FG000|Reached 1st Response Assessment|Protocol Violation|1|||
49138094|NCT02536794|158343875|FG000|Continued Treatment After 1st Response|Progressive disease|7|||
49138095|NCT02536794|158343875|FG000|Continued Treatment After 1st Response|Adverse Event|1|||
49138096|NCT02316613|158343876|FG000|Overall Study|Death|63|||
49138097|NCT02316613|158343876|FG000|Overall Study|Lost to Follow-up|9|||
49138098|NCT02316613|158343876|FG000|Overall Study|Lymphoma transformation|2|||
49138099|NCT02316613|158343876|FG000|Overall Study|Participant moved/changed medical team|11|||
49138100|NCT02316613|158343876|FG000|Overall Study|No data and duplicate cases|5|||
49138101|NCT02316613|158343876|FG000|Overall Study|Did not met selection criteria|14|||
49138102|NCT00973973|158343877|FG000|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1|||
49138103|NCT00973973|158343878|FG001|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3|||
49138104|NCT00973973|158343877|FG000|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1|||
49138105|NCT00973973|158343878|FG001|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0|||
49138106|NCT00973973|158343877|FG000|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1|||
49138107|NCT00973973|158343878|FG001|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3|||
49138108|NCT00973973|158343877|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1|||
49138109|NCT00973973|158343878|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0|||
49138110|NCT00973973|158343877|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
48726804|NCT01931202|156849924|FG002|Overall Study|Withdrawal by Subject|2|||
48726805|NCT01931202|156849922|FG000|Overall Study|Lost to Follow-up|0|||
49138111|NCT00973973|158343878|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
49138112|NCT00973973|158343877|FG000|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
49138113|NCT00973973|158343878|FG001|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
49138114|NCT00973973|158343877|FG000|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1|||
49138115|NCT00973973|158343878|FG001|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2|||
48726806|NCT01931202|156849923|FG001|Overall Study|Lost to Follow-up|5|||
48726807|NCT01931202|156849924|FG002|Overall Study|Lost to Follow-up|2|||
48921134|NCT00730639|157544850|FG004|Overall Study|Completed Maximum Cycles|6|||
48921135|NCT00730639|157544846|FG000|Overall Study|Death|0|||
48921136|NCT00730639|157544847|FG001|Overall Study|Death|0|||
48921137|NCT00730639|157544848|FG002|Overall Study|Death|0|||
48921138|NCT00730639|157544849|FG003|Overall Study|Death|0|||
48921139|NCT00730639|157544850|FG004|Overall Study|Death|2|||
48921140|NCT00730639|157544846|FG000|Overall Study|Disease Progression|12|||
48921141|NCT00730639|157544847|FG001|Overall Study|Disease Progression|13|||
48921142|NCT00730639|157544848|FG002|Overall Study|Disease Progression|48|||
48921143|NCT00730639|157544849|FG003|Overall Study|Disease Progression|32|||
48921144|NCT00730639|157544850|FG004|Overall Study|Disease Progression|88|||
48921145|NCT00730639|157544846|FG000|Overall Study|non-specified|0|||
48921146|NCT00730639|157544847|FG001|Overall Study|non-specified|0|||
48921147|NCT00730639|157544848|FG002|Overall Study|non-specified|4|||
48921148|NCT00730639|157544849|FG003|Overall Study|non-specified|2|||
48921149|NCT00730639|157544850|FG004|Overall Study|non-specified|3|||
48921150|NCT00730639|157544846|FG000|Overall Study|Protocol Violation|0|||
48921151|NCT00730639|157544847|FG001|Overall Study|Protocol Violation|0|||
48921152|NCT00730639|157544848|FG002|Overall Study|Protocol Violation|1|||
48921153|NCT00730639|157544849|FG003|Overall Study|Protocol Violation|0|||
48921154|NCT00730639|157544850|FG004|Overall Study|Protocol Violation|0|||
48921155|NCT00730639|157544846|FG000|Overall Study|Withdrawal by Subject|0|||
48921156|NCT00730639|157544847|FG001|Overall Study|Withdrawal by Subject|0|||
48921157|NCT00730639|157544848|FG002|Overall Study|Withdrawal by Subject|6|||
48921158|NCT00730639|157544849|FG003|Overall Study|Withdrawal by Subject|3|||
48921159|NCT00730639|157544850|FG004|Overall Study|Withdrawal by Subject|4|||
48921160|NCT00730639|157544846|FG000|Overall Study|Treatment on-going|2|||
48921161|NCT00730639|157544847|FG001|Overall Study|Treatment on-going|5|||
48921162|NCT00730639|157544848|FG002|Overall Study|Treatment on-going|5|||
48921163|NCT00730639|157544849|FG003|Overall Study|Treatment on-going|4|||
48921164|NCT00730639|157544850|FG004|Overall Study|Treatment on-going|4|||
48921165|NCT01836783|157544853|FG000|Overall Study|Withdrawal by Subject|0|||
48921166|NCT01836783|157544854|FG001|Overall Study|Withdrawal by Subject|2|||
48921167|NCT04942925|157544857|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
48921168|NCT04942925|157544858|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
48921169|NCT04942925|157544857|FG000|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
48921170|NCT04942925|157544858|FG001|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
48726808|NCT04597918|156849925|FG000|Overall Study|Withdrawal by Subject|6|||
48726809|NCT04597918|156849925|FG000|Overall Study|Lost to Follow-up|3|||
48726810|NCT04597918|156849925|FG000|Overall Study|Death|1|||
48726811|NCT00171054|156849926|FG000|Overall Study|Protocol Violation|1|||
48726812|NCT00171054|156849927|FG001|Overall Study|Protocol Violation|2|||
48726813|NCT00171054|156849926|FG000|Overall Study|Patient withdrew consent|1|||
48726814|NCT00171054|156849927|FG001|Overall Study|Patient withdrew consent|0|||
48726815|NCT00171054|156849926|FG000|Overall Study|Lost to Follow-up|0|||
48726816|NCT00171054|156849927|FG001|Overall Study|Lost to Follow-up|1|||
48726817|NCT00171054|156849926|FG000|Overall Study|Adverse Event|8|||
48726818|NCT00171054|156849927|FG001|Overall Study|Adverse Event|8|||
48726819|NCT00171054|156849926|FG000|Overall Study|Condition no longer required study drug|0|||
48726820|NCT00171054|156849927|FG001|Overall Study|Condition no longer required study drug|1|||
48726821|NCT02775903|156849928|FG000|Overall Study|Death|7|||
48726822|NCT02775903|156849929|FG001|Overall Study|Death|11|||
48726823|NCT02775903|156849930|FG002|Overall Study|Death|12|||
48726824|NCT02775903|156849931|FG003|Overall Study|Death|11|||
48726825|NCT02775903|156849928|FG000|Overall Study|Adverse Event|0|||
48726826|NCT02775903|156849929|FG001|Overall Study|Adverse Event|1|||
48726827|NCT02775903|156849930|FG002|Overall Study|Adverse Event|12|||
48726828|NCT02775903|156849931|FG003|Overall Study|Adverse Event|3|||
48726829|NCT02775903|156849928|FG000|Overall Study|Progressive disease|15|||
48726830|NCT02775903|156849929|FG001|Overall Study|Progressive disease|14|||
48726831|NCT02775903|156849930|FG002|Overall Study|Progressive disease|30|||
48726832|NCT02775903|156849931|FG003|Overall Study|Progressive disease|20|||
48726833|NCT02775903|156849928|FG000|Overall Study|Lack of Efficacy|2|||
48726834|NCT02775903|156849929|FG001|Overall Study|Lack of Efficacy|2|||
48726835|NCT02775903|156849930|FG002|Overall Study|Lack of Efficacy|2|||
48726836|NCT02775903|156849931|FG003|Overall Study|Lack of Efficacy|6|||
48726837|NCT02775903|156849928|FG000|Overall Study|Withdrawal by Subject|7|||
48726838|NCT02775903|156849929|FG001|Overall Study|Withdrawal by Subject|5|||
48726839|NCT02775903|156849930|FG002|Overall Study|Withdrawal by Subject|5|||
48726840|NCT02775903|156849931|FG003|Overall Study|Withdrawal by Subject|8|||
48726841|NCT02775903|156849928|FG000|Overall Study|Other reasons|7|||
48726842|NCT02775903|156849929|FG001|Overall Study|Other reasons|8|||
48726843|NCT02775903|156849930|FG002|Overall Study|Other reasons|2|||
48726844|NCT02775903|156849931|FG003|Overall Study|Other reasons|12|||
48726845|NCT02718300|156849934|FG000|Overall Study|Death|4|||
48726846|NCT02718300|156849935|FG001|Overall Study|Death|5|||
48726847|NCT02718300|156849936|FG002|Overall Study|Death|17|||
48726848|NCT02718300|156849934|FG000|Overall Study|Lost to Follow-up|1|||
48726849|NCT02718300|156849935|FG001|Overall Study|Lost to Follow-up|0|||
48726850|NCT02718300|156849936|FG002|Overall Study|Lost to Follow-up|2|||
49138116|NCT00973973|158343877|FG000|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1|||
49138117|NCT00973973|158343878|FG001|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0|||
49138118|NCT00973973|158343877|FG000|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1|||
49138119|NCT00973973|158343878|FG001|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0|||
49138120|NCT00973973|158343877|FG000|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1|||
49138121|NCT00973973|158343878|FG001|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3|||
48726851|NCT02718300|156849934|FG000|Overall Study|Physician Decision|1|||
49011425|NCT00415532|157878962|FG001|Treatment Period|Protocol Violation|0|||
49011426|NCT00415532|157878961|FG000|Treatment Period|Withdrawal by Subject|6|||
49011427|NCT00415532|157878962|FG001|Treatment Period|Withdrawal by Subject|6|||
49011428|NCT00415532|157878961|FG000|Treatment Period|Other|2|||
49011429|NCT00415532|157878962|FG001|Treatment Period|Other|2|||
49011430|NCT00415532|157878961|FG000|Treatment Period|Ineligibility determined|1|||
49011431|NCT00415532|157878962|FG001|Treatment Period|Ineligibility determined|1|||
49011432|NCT00415532|157878961|FG000|Treatment Period|Noncompliance|1|||
49011433|NCT00415532|157878962|FG001|Treatment Period|Noncompliance|1|||
49011434|NCT00415532|157878961|FG000|Treatment Period|Requirement for alternative therapy|1|||
49011435|NCT00415532|157878962|FG001|Treatment Period|Requirement for alternative therapy|0|||
49011436|NCT00415532|157878961|FG000|Safety Follow Up Period|Adverse Event|1|||
48726852|NCT02718300|156849935|FG001|Overall Study|Physician Decision|0|||
48726853|NCT02718300|156849936|FG002|Overall Study|Physician Decision|2|||
49011437|NCT00415532|157878962|FG001|Safety Follow Up Period|Adverse Event|3|||
49011438|NCT00415532|157878961|FG000|Safety Follow Up Period|Death|3|||
49011439|NCT00415532|157878962|FG001|Safety Follow Up Period|Death|0|||
48726854|NCT02718300|156849934|FG000|Overall Study|Study Terminated by Sponsor|6|||
49011440|NCT00415532|157878961|FG000|Safety Follow Up Period|Withdrawal by Subject|2|||
49011441|NCT00415532|157878962|FG001|Safety Follow Up Period|Withdrawal by Subject|3|||
48726855|NCT02718300|156849935|FG001|Overall Study|Study Terminated by Sponsor|3|||
48726856|NCT02718300|156849936|FG002|Overall Study|Study Terminated by Sponsor|4|||
48726857|NCT02718300|156849934|FG000|Overall Study|Withdrawal by Subject|0|||
48726858|NCT02718300|156849935|FG001|Overall Study|Withdrawal by Subject|4|||
48726859|NCT02718300|156849936|FG002|Overall Study|Withdrawal by Subject|3|||
48726860|NCT02718300|156849934|FG000|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
48743059|NCT00968201|156910495|FG001|Base Study - (Period II)|Lack of Efficacy|0|||
48726861|NCT02718300|156849935|FG001|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
48726862|NCT02718300|156849936|FG002|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|4|||
49138122|NCT00973973|158343877|FG000|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1|||
49138123|NCT00973973|158343878|FG001|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0|||
49138124|NCT00973973|158343877|FG000|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1|||
49138125|NCT00973973|158343878|FG001|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0|||
49138126|NCT02362451|158343880|FG000|Overall Study|Withdrawal by Subject|0|||
49138127|NCT02362451|158343881|FG001|Overall Study|Withdrawal by Subject|1|||
49138128|NCT02362451|158343880|FG000|Overall Study|Lack of Efficacy|2|||
49138129|NCT02362451|158343881|FG001|Overall Study|Lack of Efficacy|0|||
49138130|NCT02362451|158343880|FG000|Overall Study|Progression|1|||
49138131|NCT02362451|158343881|FG001|Overall Study|Progression|0|||
49138132|NCT02362451|158343880|FG000|Overall Study|Participant chose other therapy.|1|||
49138133|NCT02362451|158343881|FG001|Overall Study|Participant chose other therapy.|0|||
49138134|NCT01245751|158343882|FG000|Part 1: Day 1 to Week 52 (1 Year)|Death|2|||
49138135|NCT01245751|158343883|FG001|Part 1: Day 1 to Week 52 (1 Year)|Death|1|||
49138136|NCT01245751|158343884|FG002|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
49138137|NCT01245751|158343885|FG003|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
49138138|NCT01245751|158343882|FG000|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
49138139|NCT01245751|158343883|FG001|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
49138140|NCT01245751|158343884|FG002|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
49138141|NCT01245751|158343885|FG003|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2|||
49138142|NCT01245751|158343882|FG000|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
49138143|NCT01245751|158343883|FG001|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4|||
49138144|NCT01245751|158343884|FG002|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
49138145|NCT01245751|158343885|FG003|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
49138146|NCT00845182|158343894|FG000|Overall Study|Lost to Follow-up|3|||
49138147|NCT00845182|158343895|FG001|Overall Study|Lost to Follow-up|3|||
49138148|NCT00845182|158343896|FG002|Overall Study|Lost to Follow-up|4|||
49138149|NCT00845182|158343894|FG000|Overall Study|Adverse Event|0|||
49138150|NCT00845182|158343895|FG001|Overall Study|Adverse Event|1|||
49138151|NCT00845182|158343896|FG002|Overall Study|Adverse Event|1|||
49138152|NCT00845182|158343894|FG000|Overall Study|Physician Decision|0|||
49138153|NCT00845182|158343895|FG001|Overall Study|Physician Decision|0|||
49138154|NCT00845182|158343896|FG002|Overall Study|Physician Decision|1|||
49138155|NCT00762788|158343898|FG000|Overall Study|Lost to Follow-up|26|||
49138156|NCT00762788|158343899|FG001|Overall Study|Lost to Follow-up|37|||
49138157|NCT00762788|158343900|FG002|Overall Study|Lost to Follow-up|21|||
49138158|NCT00762788|158343901|FG003|Overall Study|Lost to Follow-up|26|||
49138159|NCT00762788|158343902|FG004|Overall Study|Lost to Follow-up|13|||
49138160|NCT00762788|158343903|FG005|Overall Study|Lost to Follow-up|21|||
49138161|NCT01625182|158343904|FG000|Overall Study|Administrative problems|1|||
49138162|NCT01625182|158343905|FG001|Overall Study|Administrative problems|0|||
49138163|NCT01625182|158343904|FG000|Overall Study|Protocol deviation|0|||
49138164|NCT01625182|158343905|FG001|Overall Study|Protocol deviation|2|||
49138165|NCT01625182|158343904|FG000|Overall Study|Adverse Event|2|||
49138166|NCT01625182|158343905|FG001|Overall Study|Adverse Event|0|||
49138167|NCT01625182|158343904|FG000|Overall Study|Withdrawal by Subject|5|||
49138168|NCT01625182|158343905|FG001|Overall Study|Withdrawal by Subject|1|||
49138169|NCT01625182|158343904|FG000|Overall Study|Lack of Efficacy|12|||
49138170|NCT01625182|158343905|FG001|Overall Study|Lack of Efficacy|8|||
49138171|NCT01348698|158343910|FG000|Overall Study|Does not meet lesion size criteria|1|||
49138172|NCT01348698|158343910|FG000|Overall Study|Death|3|||
49138173|NCT01348698|158343910|FG000|Overall Study|PI decision to close study|68|||
49138174|NCT01500083|158343911|FG000|Overall Study|Adverse Event|4|||
48726863|NCT03729362|156851480|FG000|Overall Study|Withdrawal by Subject|2|||
49138175|NCT01500083|158343912|FG001|Overall Study|Adverse Event|17|||
49138176|NCT01500083|158343911|FG000|Overall Study|Death|0|||
49138177|NCT01500083|158343912|FG001|Overall Study|Death|2|||
49138178|NCT01500083|158343911|FG000|Overall Study|Lost to Follow-up|1|||
49138179|NCT01500083|158343912|FG001|Overall Study|Lost to Follow-up|0|||
48726864|NCT03729362|156851481|FG001|Overall Study|Withdrawal by Subject|0|||
48726865|NCT03729362|156851480|FG000|Overall Study|Physician Decision|1|||
48726866|NCT03729362|156851481|FG001|Overall Study|Physician Decision|0|||
49138180|NCT01500083|158343911|FG000|Overall Study|Withdrawal of Consent|0|||
49138181|NCT01500083|158343912|FG001|Overall Study|Withdrawal of Consent|1|||
49138182|NCT01500083|158343911|FG000|Overall Study|Disease Progression|2|||
49138183|NCT01500083|158343912|FG001|Overall Study|Disease Progression|10|||
49138184|NCT01500083|158343911|FG000|Overall Study|Investigator Discretion|3|||
49138185|NCT01500083|158343912|FG001|Overall Study|Investigator Discretion|8|||
49138186|NCT01500083|158343911|FG000|Overall Study|Other Reasons|2|||
49138187|NCT01500083|158343912|FG001|Overall Study|Other Reasons|5|||
49138188|NCT01200355|158343913|FG000|Overall Study|Death|7|||
49138189|NCT01200355|158343914|FG001|Overall Study|Death|2|||
49138190|NCT05607043|158343917|FG000|Overall Study|Lost to Follow-up|2|||
49138191|NCT00471354|158343921|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
48821098|NCT01782326|157187347|FG001|Double-blind Treatment|Subject/guardian decision|125|||
48821099|NCT01782326|157187346|FG000|Double-blind Treatment|Lack of Efficacy|17|||
48821100|NCT01782326|157187347|FG001|Double-blind Treatment|Lack of Efficacy|22|||
48821101|NCT01782326|157187346|FG000|Double-blind Treatment|Physician Decision|13|||
48821102|NCT01782326|157187347|FG001|Double-blind Treatment|Physician Decision|16|||
48821103|NCT01782326|157187346|FG000|Double-blind Treatment|Protocol deviation|8|||
49138192|NCT00471354|158343921|FG000|Overall Study|Adverse Event|13|||
49138193|NCT00471354|158343921|FG000|Overall Study|Protocol Violation|12|||
49138194|NCT00471354|158343921|FG000|Overall Study|Withdrawal by Subject|1|||
49138195|NCT00471354|158343921|FG000|Overall Study|Physician Decision|4|||
49138196|NCT00471354|158343921|FG000|Overall Study|Sponsor Decision|1|||
49138197|NCT00471354|158343921|FG000|Overall Study|Lost to Follow-up|3|||
49138198|NCT00471354|158343921|FG000|Overall Study|Lack of Efficacy|5|||
49138199|NCT00471354|158343921|FG000|Overall Study|Patient/Caregiver Decision|12|||
49138200|NCT01481779|158343922|FG000|Overall Study|Adverse Event|23|||
49138201|NCT01481779|158343923|FG001|Overall Study|Adverse Event|5|||
49138202|NCT01481779|158343922|FG000|Overall Study|Lost to Follow-up|3|||
48821104|NCT01782326|157187347|FG001|Double-blind Treatment|Protocol deviation|7|||
48821105|NCT01782326|157187346|FG000|Double-blind Treatment|Technical problems|0|||
49011442|NCT00415532|157878961|FG000|Safety Follow Up Period|Other|1|||
49011443|NCT00415532|157878962|FG001|Safety Follow Up Period|Other|4|||
49011444|NCT00415532|157878961|FG000|Safety Follow Up Period|Ineligibility determined|1|||
49011445|NCT00415532|157878962|FG001|Safety Follow Up Period|Ineligibility determined|1|||
49011446|NCT00415532|157878961|FG000|Safety Follow Up Period|Noncompliance|1|||
49011447|NCT00415532|157878962|FG001|Safety Follow Up Period|Noncompliance|0|||
49011448|NCT00415532|157878961|FG000|Safety Follow Up Period|Requirement for alternative therapy|0|||
49011449|NCT00415532|157878962|FG001|Safety Follow Up Period|Requirement for alternative therapy|1|||
49011450|NCT01783730|157878968|FG000|Overall Study|Failed to meet inclusion criteria|6|||
49011451|NCT01841359|157878969|FG000|Overall Study|Underwent reversal of Roux-en-Y gastric bypass (RYGB)|2|||
49011452|NCT01841359|157878969|FG000|Overall Study|Concommitant medical issues|2|||
49011453|NCT01841359|157878969|FG000|Overall Study|Adverse Event|3|||
49011454|NCT01841359|157878969|FG000|Overall Study|Did not receive study drug at visit 4 prior to mixed meal testing|1|||
49011455|NCT02151461|157878973|FG000|Overall Study|Adverse Event|5|||
49011456|NCT02151461|157878974|FG001|Overall Study|Adverse Event|1|||
49011457|NCT02151461|157878975|FG002|Overall Study|Adverse Event|0|||
49011458|NCT02151461|157878976|FG003|Overall Study|Adverse Event|2|||
49011459|NCT02151461|157878973|FG000|Overall Study|Lost to Follow-up|0|||
49011460|NCT02151461|157878974|FG001|Overall Study|Lost to Follow-up|0|||
49011461|NCT02151461|157878975|FG002|Overall Study|Lost to Follow-up|1|||
49011462|NCT02151461|157878976|FG003|Overall Study|Lost to Follow-up|1|||
49011463|NCT02151461|157878973|FG000|Overall Study|Withdrawal by Subject|1|||
49011464|NCT02151461|157878974|FG001|Overall Study|Withdrawal by Subject|0|||
49011465|NCT02151461|157878975|FG002|Overall Study|Withdrawal by Subject|1|||
49011466|NCT02151461|157878976|FG003|Overall Study|Withdrawal by Subject|1|||
49011467|NCT02151461|157878973|FG000|Overall Study|Treatment discontinuation|0|||
49011468|NCT02151461|157878974|FG001|Overall Study|Treatment discontinuation|0|||
49011469|NCT02151461|157878975|FG002|Overall Study|Treatment discontinuation|1|||
49011470|NCT02151461|157878976|FG003|Overall Study|Treatment discontinuation|0|||
49011471|NCT01254045|157878977|FG000|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1|||
49011472|NCT01254045|157878978|FG001|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
49011473|NCT01254045|157878979|FG002|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
49011474|NCT01254045|157878980|FG003|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
49011475|NCT01254045|157878981|FG004|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
49011476|NCT01254045|157878982|FG005|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
49011477|NCT02533999|157878984|FG000|Overall Study|Lost to Follow-up|3|||
49011478|NCT02533999|157878985|FG001|Overall Study|Lost to Follow-up|5|||
49011479|NCT02533999|157878984|FG000|Overall Study|Protocol Violation|3|||
49011480|NCT02533999|157878985|FG001|Overall Study|Protocol Violation|0|||
49011481|NCT02533999|157878984|FG000|Overall Study|Adverse Event|0|||
49011482|NCT02533999|157878985|FG001|Overall Study|Adverse Event|1|||
49011483|NCT02533999|157878984|FG000|Overall Study|Randomized but intervention not received|0|||
49011484|NCT02533999|157878985|FG001|Overall Study|Randomized but intervention not received|1|||
49011485|NCT03210259|157878986|FG000|12-Week Run-in Period|Adverse Event|1|||
49011486|NCT03210259|157878987|FG001|12-Week Run-in Period|Adverse Event|0|||
49011487|NCT03210259|157878988|FG002|12-Week Run-in Period|Adverse Event|0|||
49011488|NCT03210259|157878986|FG000|12-Week Run-in Period|Death|1|||
49011489|NCT03210259|157878987|FG001|12-Week Run-in Period|Death|0|||
49011490|NCT03210259|157878988|FG002|12-Week Run-in Period|Death|0|||
49011491|NCT03210259|157878986|FG000|12-Week Run-in Period|Withdrawal by Subject|9|||
49011492|NCT03210259|157878987|FG001|12-Week Run-in Period|Withdrawal by Subject|0|||
49011493|NCT03210259|157878988|FG002|12-Week Run-in Period|Withdrawal by Subject|0|||
49138203|NCT01481779|158343923|FG001|Overall Study|Lost to Follow-up|2|||
49138204|NCT01481779|158343922|FG000|Overall Study|Protocol Violation|2|||
49138205|NCT01481779|158343923|FG001|Overall Study|Protocol Violation|3|||
49138206|NCT01481779|158343922|FG000|Overall Study|Withdrawal by Subject|26|||
48821106|NCT01782326|157187347|FG001|Double-blind Treatment|Technical problems|5|||
48821107|NCT00647348|157187348|FG000|Overall Study|Lost to Follow-up|3|||
48821108|NCT00647348|157187349|FG001|Overall Study|Lost to Follow-up|6|||
48821109|NCT01719861|157187350|FG000|Cycle 1|Death|4|||
48821110|NCT01719861|157187350|FG000|Cycle 2|Death|1|||
48821111|NCT02448719|157187351|FG000|Overall Study|Withdrawal by Subject|0|||
48821112|NCT02448719|157187352|FG001|Overall Study|Withdrawal by Subject|0|||
48821113|NCT02448719|157187353|FG002|Overall Study|Withdrawal by Subject|0|||
48821114|NCT02448719|157187354|FG003|Overall Study|Withdrawal by Subject|0|||
48821115|NCT02448719|157187355|FG004|Overall Study|Withdrawal by Subject|1|||
48821116|NCT02448719|157187356|FG005|Overall Study|Withdrawal by Subject|0|||
48821117|NCT02448719|157187357|FG006|Overall Study|Withdrawal by Subject|0|||
48821118|NCT02448719|157187358|FG007|Overall Study|Withdrawal by Subject|0|||
48821119|NCT02448719|157187359|FG008|Overall Study|Withdrawal by Subject|0|||
48821120|NCT02448719|157187360|FG009|Overall Study|Withdrawal by Subject|0|||
48821121|NCT02448719|157187361|FG010|Overall Study|Withdrawal by Subject|0|||
48821122|NCT01232556|157187362|FG000|Overall Study|Withdrawal by Subject|21|||
48821123|NCT01232556|157187363|FG001|Overall Study|Withdrawal by Subject|17|||
48821124|NCT01232556|157187362|FG000|Overall Study|Death|97|||
48821125|NCT01232556|157187363|FG001|Overall Study|Death|97|||
48821126|NCT01232556|157187362|FG000|Overall Study|Lost to Follow-up|0|||
48821127|NCT01232556|157187363|FG001|Overall Study|Lost to Follow-up|2|||
48821128|NCT01232556|157187362|FG000|Overall Study|Terminated by Sponsor|35|||
48821129|NCT01232556|157187363|FG001|Overall Study|Terminated by Sponsor|51|||
48821130|NCT01232556|157187362|FG000|Overall Study|Other|6|||
48821131|NCT01232556|157187363|FG001|Overall Study|Other|4|||
48821132|NCT01925170|157187377|FG000|Overall Study|Unverified cancer status|53|||
48821133|NCT00848211|157187378|FG000|Overall Study|Protocol Violation|0|||
48821134|NCT00848211|157187379|FG001|Overall Study|Protocol Violation|1|||
48821135|NCT00848211|157187380|FG002|Overall Study|Protocol Violation|1|||
48821136|NCT00848211|157187381|FG003|Overall Study|Protocol Violation|0|||
48821137|NCT00848211|157187378|FG000|Overall Study|Adverse Event|0|||
48821138|NCT00848211|157187379|FG001|Overall Study|Adverse Event|0|||
48821139|NCT00848211|157187380|FG002|Overall Study|Adverse Event|0|||
48821140|NCT00848211|157187381|FG003|Overall Study|Adverse Event|0|||
48821141|NCT00801242|157187384|FG000|Overall Study|Adverse Event|10|||
48821142|NCT00801242|157187384|FG000|Overall Study|Withdrawal by Subject|13|||
48726867|NCT03729362|156851480|FG000|Overall Study|COVID-19 Pandemic|1|||
48726868|NCT03729362|156851481|FG001|Overall Study|COVID-19 Pandemic|0|||
48726869|NCT03729362|156851480|FG000|Overall Study|Discontinued due to COVID-19 related pneumonia|1|||
48726870|NCT03729362|156851481|FG001|Overall Study|Discontinued due to COVID-19 related pneumonia|0|||
48726871|NCT03729362|156851480|FG000|Overall Study|Adverse Event|0|||
48726872|NCT03729362|156851481|FG001|Overall Study|Adverse Event|1|||
48726873|NCT03729362|156851480|FG000|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|0|||
48726874|NCT03729362|156851481|FG001|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|2|||
48726875|NCT00504582|156851482|FG000|Overall Study|Lost to Follow-up|1|||
48726876|NCT00504582|156851483|FG001|Overall Study|Lost to Follow-up|0|||
49138207|NCT01481779|158343923|FG001|Overall Study|Withdrawal by Subject|13|||
49138208|NCT01481779|158343922|FG000|Overall Study|Physician Decision|13|||
49138209|NCT01481779|158343923|FG001|Overall Study|Physician Decision|4|||
49138210|NCT01481779|158343922|FG000|Overall Study|Sponsor Decision|3|||
49138211|NCT01481779|158343923|FG001|Overall Study|Sponsor Decision|1|||
49138212|NCT01922011|158343924|FG000|Overall Study|Protocol Violation|0|||
48726877|NCT00504582|156851484|FG002|Overall Study|Lost to Follow-up|0|||
48821143|NCT00801242|157187384|FG000|Overall Study|Protocol Violation|5|||
48821144|NCT00801242|157187384|FG000|Overall Study|Physician Decision|3|||
49011494|NCT03210259|157878986|FG000|12-Week Run-in Period|Lost to Follow-up|4|||
49011495|NCT03210259|157878987|FG001|12-Week Run-in Period|Lost to Follow-up|0|||
49011496|NCT03210259|157878988|FG002|12-Week Run-in Period|Lost to Follow-up|0|||
48821145|NCT00801242|157187384|FG000|Overall Study|Lost to Follow-up|1|||
48821146|NCT00801242|157187384|FG000|Overall Study|Miscellaneous reasons|20|||
48821147|NCT04319094|157187387|FG000|Baseline|Lost to Follow-up|4|||
48821148|NCT04319094|157187388|FG001|Baseline|Lost to Follow-up|5|||
48821149|NCT04319094|157187387|FG000|Baseline|Protocol Violation|0|||
48821150|NCT04319094|157187388|FG001|Baseline|Protocol Violation|3|||
48821151|NCT04319094|157187387|FG000|Baseline|Withdrawal by Subject|2|||
48821152|NCT04319094|157187388|FG001|Baseline|Withdrawal by Subject|1|||
48821153|NCT04319094|157187387|FG000|Post-Intervention|Death|0|||
48821154|NCT04319094|157187388|FG001|Post-Intervention|Death|1|||
48821155|NCT04319094|157187387|FG000|Post-Intervention|Lost to Follow-up|4|||
48821156|NCT04319094|157187388|FG001|Post-Intervention|Lost to Follow-up|4|||
48821157|NCT04319094|157187387|FG000|Post-Intervention|Withdrawal by Subject|8|||
48821158|NCT04319094|157187388|FG001|Post-Intervention|Withdrawal by Subject|5|||
48821159|NCT04319094|157187387|FG000|Post-Intervention|Incomplete Data Collection|1|||
49011497|NCT03210259|157878986|FG000|12-Week Run-in Period|Lack of Efficacy|6|||
49138213|NCT01922011|158343925|FG001|Overall Study|Protocol Violation|1|||
49138214|NCT01922011|158343924|FG000|Overall Study|Physician Decision|0|||
49138215|NCT01922011|158343925|FG001|Overall Study|Physician Decision|1|||
49011498|NCT03210259|157878987|FG001|12-Week Run-in Period|Lack of Efficacy|0|||
48726878|NCT00076024|156851486|FG000|Phase 1, Lead-in|Lack of Efficacy|4|||
48726879|NCT00076024|156851487|FG001|Phase 1, Lead-in|Lack of Efficacy|0|||
48726880|NCT00076024|156851488|FG002|Phase 1, Lead-in|Lack of Efficacy|0|||
48726881|NCT00076024|156851489|FG003|Phase 1, Lead-in|Lack of Efficacy|0|||
48726882|NCT00076024|156851486|FG000|Phase 1, Lead-in|Adverse Event|1|||
48821160|NCT04319094|157187388|FG001|Post-Intervention|Incomplete Data Collection|3|||
48821161|NCT04319094|157187387|FG000|3-month|Death|1|||
48821162|NCT04319094|157187388|FG001|3-month|Death|0|||
48821163|NCT04319094|157187387|FG000|3-month|Lost to Follow-up|2|||
49011499|NCT03210259|157878988|FG002|12-Week Run-in Period|Lack of Efficacy|0|||
49011500|NCT03210259|157878986|FG000|48-Week Randomized Responder Period|Missed study visit|0|||
48726883|NCT00076024|156851487|FG001|Phase 1, Lead-in|Adverse Event|0|||
48726884|NCT00076024|156851488|FG002|Phase 1, Lead-in|Adverse Event|0|||
48726885|NCT00076024|156851489|FG003|Phase 1, Lead-in|Adverse Event|0|||
48726886|NCT00076024|156851486|FG000|Phase 1, Lead-in|Clinical progression|1|||
48726887|NCT00076024|156851487|FG001|Phase 1, Lead-in|Clinical progression|0|||
48726888|NCT00076024|156851488|FG002|Phase 1, Lead-in|Clinical progression|0|||
48726889|NCT00076024|156851489|FG003|Phase 1, Lead-in|Clinical progression|0|||
48726890|NCT00076024|156851486|FG000|Phase 2, Double-blind|Lack of Efficacy|0|||
48726891|NCT00076024|156851487|FG001|Phase 2, Double-blind|Lack of Efficacy|59|||
48726892|NCT00076024|156851488|FG002|Phase 2, Double-blind|Lack of Efficacy|40|||
48726893|NCT00076024|156851489|FG003|Phase 2, Double-blind|Lack of Efficacy|0|||
48726894|NCT00076024|156851486|FG000|Phase 2, Double-blind|Withdrawal by Subject|0|||
48726895|NCT00076024|156851487|FG001|Phase 2, Double-blind|Withdrawal by Subject|13|||
48726896|NCT00076024|156851488|FG002|Phase 2, Double-blind|Withdrawal by Subject|4|||
48726897|NCT00076024|156851489|FG003|Phase 2, Double-blind|Withdrawal by Subject|0|||
48726898|NCT00076024|156851486|FG000|Phase 2, Double-blind|Adverse Event|0|||
48726899|NCT00076024|156851487|FG001|Phase 2, Double-blind|Adverse Event|25|||
48726900|NCT00076024|156851488|FG002|Phase 2, Double-blind|Adverse Event|6|||
48726901|NCT00076024|156851489|FG003|Phase 2, Double-blind|Adverse Event|0|||
48726902|NCT00076024|156851486|FG000|Phase 2, Double-blind|Un-specified|0|||
48821164|NCT04319094|157187388|FG001|3-month|Lost to Follow-up|2|||
48821165|NCT04319094|157187387|FG000|3-month|Withdrawal by Subject|0|||
48821166|NCT04319094|157187388|FG001|3-month|Withdrawal by Subject|3|||
48821167|NCT04319094|157187387|FG000|3-month|Incomplete data collection|9|||
48821168|NCT04319094|157187388|FG001|3-month|Incomplete data collection|7|||
48821169|NCT04319094|157187387|FG000|6-month|Lost to Follow-up|1|||
48821170|NCT04319094|157187388|FG001|6-month|Lost to Follow-up|1|||
48726903|NCT00076024|156851487|FG001|Phase 2, Double-blind|Un-specified|14|||
48726904|NCT00076024|156851488|FG002|Phase 2, Double-blind|Un-specified|6|||
48726905|NCT00076024|156851489|FG003|Phase 2, Double-blind|Un-specified|0|||
48726906|NCT00076024|156851486|FG000|Phase 2, Double-blind|Randomized but not treated|0|||
48726907|NCT00076024|156851487|FG001|Phase 2, Double-blind|Randomized but not treated|1|||
48726908|NCT00076024|156851488|FG002|Phase 2, Double-blind|Randomized but not treated|0|||
48726909|NCT00076024|156851489|FG003|Phase 2, Double-blind|Randomized but not treated|0|||
48726910|NCT00076024|156851486|FG000|Phase 2, Open-label|Adverse Event|0|||
48726911|NCT00076024|156851487|FG001|Phase 2, Open-label|Adverse Event|0|||
48726912|NCT00076024|156851488|FG002|Phase 2, Open-label|Adverse Event|0|||
48726913|NCT00076024|156851489|FG003|Phase 2, Open-label|Adverse Event|2|||
48726914|NCT00076024|156851486|FG000|Phase 2, Open-label|Lack of Efficacy|0|||
48726915|NCT00076024|156851487|FG001|Phase 2, Open-label|Lack of Efficacy|0|||
48726916|NCT00076024|156851488|FG002|Phase 2, Open-label|Lack of Efficacy|0|||
48726917|NCT00076024|156851489|FG003|Phase 2, Open-label|Lack of Efficacy|11|||
48726918|NCT00076024|156851486|FG000|Phase 2, Open-label|Withdrawal by Subject|0|||
48726919|NCT00076024|156851487|FG001|Phase 2, Open-label|Withdrawal by Subject|0|||
48726920|NCT00076024|156851488|FG002|Phase 2, Open-label|Withdrawal by Subject|0|||
48726921|NCT00076024|156851489|FG003|Phase 2, Open-label|Withdrawal by Subject|1|||
48726922|NCT00076024|156851486|FG000|Phase 2, Open-label|Other|0|||
48726923|NCT00076024|156851487|FG001|Phase 2, Open-label|Other|0|||
48726924|NCT00076024|156851488|FG002|Phase 2, Open-label|Other|0|||
48821171|NCT04319094|157187387|FG000|6-month|Withdrawal by Subject|0|||
48821172|NCT04319094|157187388|FG001|6-month|Withdrawal by Subject|3|||
48821173|NCT04319094|157187387|FG000|6-month|Incomplete data collection|14|||
49011501|NCT03210259|157878987|FG001|48-Week Randomized Responder Period|Missed study visit|1|||
49011502|NCT03210259|157878988|FG002|48-Week Randomized Responder Period|Missed study visit|2|||
48726925|NCT00076024|156851489|FG003|Phase 2, Open-label|Other|2|||
48726926|NCT00301821|156851490|FG000|Overall Study|Ineligible|25|||
48821174|NCT04319094|157187388|FG001|6-month|Incomplete data collection|9|||
48821175|NCT04319094|157187387|FG000|9-month|Lost to Follow-up|8|||
49011503|NCT03210259|157878986|FG000|48-Week Randomized Responder Period|Lost to Follow-up|0|||
48726927|NCT00301821|156851490|FG000|Overall Study|Cancel|1|||
48726928|NCT03206073|156851491|FG000|Overall Study|Participant Noncompliance|0|||
48726929|NCT03206073|156851492|FG001|Overall Study|Participant Noncompliance|1|||
48726930|NCT03206073|156851493|FG002|Overall Study|Participant Noncompliance|0|||
48726931|NCT03206073|156851494|FG003|Overall Study|Participant Noncompliance|0|||
48726932|NCT03206073|156851491|FG000|Overall Study|Unable to complete the dose limiting toxicity period|1|||
49138216|NCT01922011|158343924|FG000|Overall Study|Parent/Guardian Decision|3|||
49138217|NCT01922011|158343925|FG001|Overall Study|Parent/Guardian Decision|0|||
49138218|NCT01922011|158343924|FG000|Overall Study|Lost to Follow-up|0|||
48726933|NCT03206073|156851492|FG001|Overall Study|Unable to complete the dose limiting toxicity period|0|||
48726934|NCT03206073|156851493|FG002|Overall Study|Unable to complete the dose limiting toxicity period|0|||
48726935|NCT03206073|156851494|FG003|Overall Study|Unable to complete the dose limiting toxicity period|0|||
48726936|NCT03206073|156851491|FG000|Overall Study|Death|0|||
48726937|NCT03206073|156851492|FG001|Overall Study|Death|0|||
48726938|NCT03206073|156851493|FG002|Overall Study|Death|1|||
48726939|NCT03206073|156851494|FG003|Overall Study|Death|0|||
48726940|NCT03206073|156851491|FG000|Overall Study|Taken off active treatment|0|||
48726941|NCT03206073|156851492|FG001|Overall Study|Taken off active treatment|0|||
48726942|NCT03206073|156851493|FG002|Overall Study|Taken off active treatment|3|||
48821176|NCT04319094|157187388|FG001|9-month|Lost to Follow-up|4|||
48821177|NCT04319094|157187387|FG000|9-month|Withdrawal by Subject|0|||
48821178|NCT04319094|157187388|FG001|9-month|Withdrawal by Subject|1|||
48726943|NCT03206073|156851494|FG003|Overall Study|Taken off active treatment|0|||
48821179|NCT04319094|157187387|FG000|9-month|Incomplete data collection|8|||
48821180|NCT04319094|157187388|FG001|9-month|Incomplete data collection|5|||
48821181|NCT04319094|157187387|FG000|12-month|Lost to Follow-up|11|||
48821182|NCT04319094|157187388|FG001|12-month|Lost to Follow-up|8|||
48821183|NCT02956967|157187391|FG000|Overall Study|Adverse Event|3|||
48821184|NCT02956967|157187391|FG000|Overall Study|Reason non-related to neutropenia|10|||
48821185|NCT02956967|157187391|FG000|Overall Study|Lost to Follow-up|5|||
48821186|NCT02956967|157187391|FG000|Overall Study|Missing|1|||
48821187|NCT02956967|157187391|FG000|Overall Study|Termination of Nivestim administration|29|||
48821188|NCT00057811|157187392|FG000|Overall Study|Lack of Efficacy|1|||
48821189|NCT00057811|157187393|FG001|Overall Study|Lack of Efficacy|4|||
48821190|NCT00057811|157187392|FG000|Overall Study|Physician Decision|1|||
48821191|NCT00057811|157187393|FG001|Overall Study|Physician Decision|0|||
48821192|NCT00057811|157187392|FG000|Overall Study|Withdrawal by Subject|3|||
48821193|NCT00057811|157187393|FG001|Overall Study|Withdrawal by Subject|4|||
48821194|NCT00057811|157187392|FG000|Overall Study|Ineligible|4|||
48821195|NCT00057811|157187393|FG001|Overall Study|Ineligible|2|||
48821196|NCT00057811|157187392|FG000|Overall Study|Inevaluable|1|||
48821197|NCT00057811|157187393|FG001|Overall Study|Inevaluable|2|||
48821198|NCT04482855|157187394|FG000|Overall Study|Lost to Follow-up|1|||
48821199|NCT04482855|157187395|FG001|Overall Study|Lost to Follow-up|0|||
48821200|NCT04482855|157187394|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|1|||
48821201|NCT04482855|157187395|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|0|||
48821202|NCT04482855|157187394|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|1|||
48821203|NCT04482855|157187395|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|0|||
48821204|NCT00701311|157187398|FG000|Overall Study|Lack of Efficacy|3|||
48821205|NCT00701311|157187398|FG000|Overall Study|Adverse Event|3|||
48726944|NCT03442764|156851495|FG000|Overall Study|Adverse Event|1|||
48726945|NCT03442764|156851496|FG001|Overall Study|Adverse Event|0|||
48726946|NCT03442764|156851497|FG002|Overall Study|Adverse Event|0|||
48726947|NCT00719264|156851498|FG000|Overall Study|Adverse Event|41|||
48726948|NCT00719264|156851499|FG001|Overall Study|Adverse Event|49|||
48726949|NCT00719264|156851498|FG000|Overall Study|Death|13|||
48726950|NCT00719264|156851499|FG001|Overall Study|Death|10|||
48726951|NCT00719264|156851498|FG000|Overall Study|Administrative Problems|6|||
48726952|NCT00719264|156851499|FG001|Overall Study|Administrative Problems|4|||
48726953|NCT00719264|156851498|FG000|Overall Study|Lost to Follow-up|1|||
48726954|NCT00719264|156851499|FG001|Overall Study|Lost to Follow-up|1|||
48726955|NCT00719264|156851498|FG000|Overall Study|Withdrawal by Subject|12|||
48726956|NCT00719264|156851499|FG001|Overall Study|Withdrawal by Subject|7|||
48726957|NCT00719264|156851498|FG000|Overall Study|Protocol Deviation|1|||
48726958|NCT00719264|156851499|FG001|Overall Study|Protocol Deviation|3|||
48726959|NCT00719264|156851498|FG000|Overall Study|New Cancer Therapy|4|||
48726960|NCT00719264|156851499|FG001|Overall Study|New Cancer Therapy|2|||
48821206|NCT00701311|157187398|FG000|Overall Study|Withdrawal by Subject|2|||
48821207|NCT02501811|157187399|FG000|Overall Study|Death|1|||
48821208|NCT02501811|157187400|FG001|Overall Study|Death|3|||
48821209|NCT02501811|157187401|FG002|Overall Study|Death|2|||
49138219|NCT01922011|158343925|FG001|Overall Study|Lost to Follow-up|1|||
49138220|NCT01922011|158343924|FG000|Overall Study|Missed Test-of-Cure Visit|0|||
49138221|NCT01922011|158343925|FG001|Overall Study|Missed Test-of-Cure Visit|2|||
49138222|NCT01922011|158343924|FG000|Overall Study|Not Treated|1|||
49138223|NCT01922011|158343925|FG001|Overall Study|Not Treated|0|||
49138224|NCT01922011|158343924|FG000|Overall Study|Lack of willing home health agency|1|||
49138225|NCT01922011|158343925|FG001|Overall Study|Lack of willing home health agency|0|||
49138226|NCT01922011|158343924|FG000|Overall Study|Randomized in error|1|||
49138227|NCT01922011|158343925|FG001|Overall Study|Randomized in error|0|||
49138228|NCT01859741|158343926|FG000|Overall Study|Death|3|||
49138229|NCT01859741|158343927|FG001|Overall Study|Death|2|||
49138230|NCT01859741|158343928|FG002|Overall Study|Death|4|||
49138231|NCT01859741|158343929|FG003|Overall Study|Death|3|||
49138232|NCT01859741|158343930|FG004|Overall Study|Death|5|||
49138233|NCT01859741|158343931|FG005|Overall Study|Death|4|||
49138234|NCT01859741|158343932|FG006|Overall Study|Death|51|||
49138235|NCT01859741|158343933|FG007|Overall Study|Death|51|||
48726961|NCT00719264|156851498|FG000|Overall Study|Disease Progression|104|||
48726962|NCT00719264|156851499|FG001|Overall Study|Disease Progression|107|||
48821210|NCT02501811|157187402|FG003|Overall Study|Death|3|||
48821211|NCT02501811|157187399|FG000|Overall Study|Withdrawal by Subject|3|||
48821212|NCT02501811|157187400|FG001|Overall Study|Withdrawal by Subject|3|||
48821213|NCT02501811|157187401|FG002|Overall Study|Withdrawal by Subject|2|||
48821214|NCT02501811|157187402|FG003|Overall Study|Withdrawal by Subject|3|||
48821215|NCT02501811|157187399|FG000|Overall Study|Lost to Follow-up|0|||
48821216|NCT02501811|157187400|FG001|Overall Study|Lost to Follow-up|0|||
48726963|NCT01277042|156851500|FG000|Overall Study|Adverse Event|4|||
48726964|NCT01277042|156851501|FG001|Overall Study|Adverse Event|3|||
48726965|NCT01277042|156851500|FG000|Overall Study|Lost to Follow-up|2|||
48726966|NCT01277042|156851501|FG001|Overall Study|Lost to Follow-up|2|||
48726967|NCT01277042|156851500|FG000|Overall Study|Withdrawal by Subject|2|||
48726968|NCT01277042|156851501|FG001|Overall Study|Withdrawal by Subject|0|||
48726969|NCT04389970|156851502|FG000|Overall Study|Lost to Follow-up|1|||
48726970|NCT01739400|156851503|FG000|Overall Study|Physician Decision|3|||
48726971|NCT01739400|156851504|FG001|Overall Study|Physician Decision|0|||
48726972|NCT01739400|156851503|FG000|Overall Study|Lost to Follow-up|2|||
48726973|NCT01739400|156851504|FG001|Overall Study|Lost to Follow-up|0|||
48726974|NCT01739400|156851503|FG000|Overall Study|Death|5|||
48726975|NCT01739400|156851504|FG001|Overall Study|Death|2|||
48726976|NCT01739400|156851503|FG000|Overall Study|Withdrawal by Subject|7|||
48726977|NCT01739400|156851504|FG001|Overall Study|Withdrawal by Subject|7|||
48726978|NCT00470158|156851507|FG000|Overall Study|Death|0|||
48726979|NCT00470158|156851508|FG001|Overall Study|Death|0|||
48726980|NCT00470158|156851509|FG002|Overall Study|Death|0|||
48726981|NCT00470158|156851510|FG003|Overall Study|Death|0|||
48726982|NCT00470158|156851511|FG004|Overall Study|Death|2|||
48726983|NCT00470158|156851507|FG000|Overall Study|Lost to Follow-up|7|||
48726984|NCT00470158|156851508|FG001|Overall Study|Lost to Follow-up|8|||
48726985|NCT00470158|156851509|FG002|Overall Study|Lost to Follow-up|8|||
48726986|NCT00470158|156851510|FG003|Overall Study|Lost to Follow-up|5|||
48726987|NCT00470158|156851511|FG004|Overall Study|Lost to Follow-up|4|||
48726988|NCT00470158|156851507|FG000|Overall Study|Protocol Violation|1|||
48726989|NCT00470158|156851508|FG001|Overall Study|Protocol Violation|0|||
48726990|NCT00470158|156851509|FG002|Overall Study|Protocol Violation|0|||
48726991|NCT00470158|156851510|FG003|Overall Study|Protocol Violation|0|||
48726992|NCT00470158|156851511|FG004|Overall Study|Protocol Violation|0|||
48726993|NCT02038829|156851512|FG000|Washout Period 1|Death|0|||
48726994|NCT02038829|156851513|FG001|Washout Period 1|Death|0|||
48726995|NCT02038829|156851514|FG002|Washout Period 1|Death|0|||
48726996|NCT02038829|156851515|FG003|Washout Period 1|Death|0|||
48726997|NCT02038829|156851516|FG004|Washout Period 1|Death|1|||
48726998|NCT02038829|156851517|FG005|Washout Period 1|Death|0|||
48726999|NCT02038829|156851518|FG006|Washout Period 1|Death|0|||
48727000|NCT02038829|156851519|FG007|Washout Period 1|Death|0|||
48727001|NCT02038829|156851520|FG008|Washout Period 1|Death|0|||
48727002|NCT02038829|156851521|FG009|Washout Period 1|Death|0|||
48727003|NCT02038829|156851522|FG010|Washout Period 1|Death|0|||
48727004|NCT02038829|156851523|FG011|Washout Period 1|Death|0|||
48727005|NCT02038829|156851512|FG000|Treatment Period 2|Adverse Event|0|||
48727006|NCT02038829|156851513|FG001|Treatment Period 2|Adverse Event|0|||
48727007|NCT02038829|156851514|FG002|Treatment Period 2|Adverse Event|0|||
48727008|NCT02038829|156851515|FG003|Treatment Period 2|Adverse Event|0|||
48727009|NCT02038829|156851516|FG004|Treatment Period 2|Adverse Event|0|||
48727010|NCT02038829|156851517|FG005|Treatment Period 2|Adverse Event|0|||
48727011|NCT02038829|156851518|FG006|Treatment Period 2|Adverse Event|0|||
48727012|NCT02038829|156851519|FG007|Treatment Period 2|Adverse Event|0|||
48821217|NCT02501811|157187401|FG002|Overall Study|Lost to Follow-up|2|||
48727013|NCT02038829|156851520|FG008|Treatment Period 2|Adverse Event|0|||
48727014|NCT02038829|156851521|FG009|Treatment Period 2|Adverse Event|0|||
48727015|NCT02038829|156851522|FG010|Treatment Period 2|Adverse Event|1|||
48727016|NCT02038829|156851523|FG011|Treatment Period 2|Adverse Event|0|||
48727017|NCT02038829|156851512|FG000|Treatment Period 2|Withdrawal by Subject|1|||
48727018|NCT02038829|156851513|FG001|Treatment Period 2|Withdrawal by Subject|0|||
48727019|NCT02038829|156851514|FG002|Treatment Period 2|Withdrawal by Subject|0|||
48727020|NCT02038829|156851515|FG003|Treatment Period 2|Withdrawal by Subject|0|||
48727021|NCT02038829|156851516|FG004|Treatment Period 2|Withdrawal by Subject|0|||
48727022|NCT02038829|156851517|FG005|Treatment Period 2|Withdrawal by Subject|0|||
48821218|NCT02501811|157187402|FG003|Overall Study|Lost to Follow-up|1|||
49138236|NCT01859741|158343926|FG000|Overall Study|Lost to Follow-up|0|||
49138237|NCT01859741|158343927|FG001|Overall Study|Lost to Follow-up|0|||
48821219|NCT02997202|157187403|FG000|Overall Study|Miscellaneous|2|||
48821220|NCT02997202|157187404|FG001|Overall Study|Miscellaneous|2|||
48821221|NCT02997202|157187403|FG000|Overall Study|Withdrawal by Subject|8|||
48821222|NCT02997202|157187404|FG001|Overall Study|Withdrawal by Subject|12|||
48821223|NCT02997202|157187403|FG000|Overall Study|Lost to Follow-up|5|||
48821224|NCT02997202|157187404|FG001|Overall Study|Lost to Follow-up|3|||
48821225|NCT02997202|157187403|FG000|Overall Study|Death|41|||
48821226|NCT02997202|157187404|FG001|Overall Study|Death|45|||
48821227|NCT03248479|157187405|FG000|Overall Study|Death|12|||
48821228|NCT03248479|157187406|FG001|Overall Study|Death|44|||
48821229|NCT03248479|157187407|FG002|Overall Study|Death|1|||
48821230|NCT03248479|157187408|FG003|Overall Study|Death|72|||
48821231|NCT03248479|157187409|FG004|Overall Study|Death|17|||
48821232|NCT03248479|157187410|FG005|Overall Study|Death|6|||
48821233|NCT03248479|157187411|FG006|Overall Study|Death|1|||
48821234|NCT03248479|157187412|FG007|Overall Study|Death|14|||
48821235|NCT03248479|157187413|FG008|Overall Study|Death|3|||
48821236|NCT03248479|157187414|FG009|Overall Study|Death|7|||
48821237|NCT03248479|157187415|FG010|Overall Study|Death|3|||
48821238|NCT03248479|157187416|FG011|Overall Study|Death|1|||
48727023|NCT02038829|156851518|FG006|Treatment Period 2|Withdrawal by Subject|0|||
48821239|NCT03248479|157187417|FG012|Overall Study|Death|1|||
49011504|NCT03210259|157878987|FG001|48-Week Randomized Responder Period|Lost to Follow-up|3|||
49011505|NCT03210259|157878988|FG002|48-Week Randomized Responder Period|Lost to Follow-up|8|||
49011506|NCT03210259|157878986|FG000|48-Week Randomized Responder Period|Pregnancy|0|||
49011507|NCT03210259|157878987|FG001|48-Week Randomized Responder Period|Pregnancy|1|||
49011508|NCT03210259|157878988|FG002|48-Week Randomized Responder Period|Pregnancy|0|||
49011509|NCT03210259|157878986|FG000|48-Week Randomized Responder Period|Physician Decision|0|||
48727024|NCT02038829|156851519|FG007|Treatment Period 2|Withdrawal by Subject|0|||
48727025|NCT02038829|156851520|FG008|Treatment Period 2|Withdrawal by Subject|0|||
48727026|NCT02038829|156851521|FG009|Treatment Period 2|Withdrawal by Subject|0|||
48727027|NCT02038829|156851522|FG010|Treatment Period 2|Withdrawal by Subject|0|||
48727028|NCT02038829|156851523|FG011|Treatment Period 2|Withdrawal by Subject|0|||
48727029|NCT02038829|156851512|FG000|Washout Period 2|Adverse Event|0|||
48727030|NCT02038829|156851513|FG001|Washout Period 2|Adverse Event|0|||
48727031|NCT02038829|156851514|FG002|Washout Period 2|Adverse Event|0|||
48727032|NCT02038829|156851515|FG003|Washout Period 2|Adverse Event|0|||
48727033|NCT02038829|156851516|FG004|Washout Period 2|Adverse Event|0|||
48727034|NCT02038829|156851517|FG005|Washout Period 2|Adverse Event|0|||
48727035|NCT02038829|156851518|FG006|Washout Period 2|Adverse Event|0|||
48727036|NCT02038829|156851519|FG007|Washout Period 2|Adverse Event|0|||
48727037|NCT02038829|156851520|FG008|Washout Period 2|Adverse Event|1|||
48727038|NCT02038829|156851521|FG009|Washout Period 2|Adverse Event|0|||
48727039|NCT02038829|156851522|FG010|Washout Period 2|Adverse Event|0|||
48727040|NCT02038829|156851523|FG011|Washout Period 2|Adverse Event|0|||
48727041|NCT02038829|156851512|FG000|Washout Period 2|Withdrawal by Subject|0|||
48727042|NCT02038829|156851513|FG001|Washout Period 2|Withdrawal by Subject|0|||
48727043|NCT02038829|156851514|FG002|Washout Period 2|Withdrawal by Subject|0|||
48727044|NCT02038829|156851515|FG003|Washout Period 2|Withdrawal by Subject|0|||
48727045|NCT02038829|156851516|FG004|Washout Period 2|Withdrawal by Subject|0|||
48727046|NCT02038829|156851517|FG005|Washout Period 2|Withdrawal by Subject|1|||
48727047|NCT02038829|156851518|FG006|Washout Period 2|Withdrawal by Subject|0|||
48727048|NCT02038829|156851519|FG007|Washout Period 2|Withdrawal by Subject|0|||
48727049|NCT02038829|156851520|FG008|Washout Period 2|Withdrawal by Subject|0|||
48727050|NCT02038829|156851521|FG009|Washout Period 2|Withdrawal by Subject|0|||
48727051|NCT02038829|156851522|FG010|Washout Period 2|Withdrawal by Subject|0|||
48727052|NCT02038829|156851523|FG011|Washout Period 2|Withdrawal by Subject|0|||
48727053|NCT02038829|156851512|FG000|Treatment Period 4|Adverse Event|0|||
48727054|NCT02038829|156851513|FG001|Treatment Period 4|Adverse Event|1|||
48727055|NCT02038829|156851514|FG002|Treatment Period 4|Adverse Event|0|||
48727056|NCT02038829|156851515|FG003|Treatment Period 4|Adverse Event|0|||
48727057|NCT02038829|156851516|FG004|Treatment Period 4|Adverse Event|0|||
48727058|NCT02038829|156851517|FG005|Treatment Period 4|Adverse Event|0|||
48727059|NCT02038829|156851518|FG006|Treatment Period 4|Adverse Event|0|||
48727060|NCT02038829|156851519|FG007|Treatment Period 4|Adverse Event|0|||
48727061|NCT02038829|156851520|FG008|Treatment Period 4|Adverse Event|0|||
48727062|NCT02038829|156851521|FG009|Treatment Period 4|Adverse Event|0|||
48821240|NCT03248479|157187405|FG000|Overall Study|Study terminated by sponsor|12|||
48821241|NCT03248479|157187406|FG001|Overall Study|Study terminated by sponsor|15|||
48821242|NCT03248479|157187407|FG002|Overall Study|Study terminated by sponsor|0|||
48821243|NCT03248479|157187408|FG003|Overall Study|Study terminated by sponsor|5|||
48727063|NCT02038829|156851522|FG010|Treatment Period 4|Adverse Event|0|||
48727064|NCT02038829|156851523|FG011|Treatment Period 4|Adverse Event|0|||
48727065|NCT02038829|156851512|FG000|Washout Period 4|Adverse Event|0|||
48727066|NCT02038829|156851513|FG001|Washout Period 4|Adverse Event|0|||
48727067|NCT02038829|156851514|FG002|Washout Period 4|Adverse Event|0|||
48821244|NCT03248479|157187409|FG004|Overall Study|Study terminated by sponsor|0|||
48727068|NCT02038829|156851515|FG003|Washout Period 4|Adverse Event|0|||
48821245|NCT03248479|157187410|FG005|Overall Study|Study terminated by sponsor|0|||
48727069|NCT02038829|156851516|FG004|Washout Period 4|Adverse Event|0|||
48727070|NCT02038829|156851517|FG005|Washout Period 4|Adverse Event|0|||
48727071|NCT02038829|156851518|FG006|Washout Period 4|Adverse Event|1|||
48727072|NCT02038829|156851519|FG007|Washout Period 4|Adverse Event|0|||
48727073|NCT02038829|156851520|FG008|Washout Period 4|Adverse Event|0|||
48727074|NCT02038829|156851521|FG009|Washout Period 4|Adverse Event|0|||
48821246|NCT03248479|157187411|FG006|Overall Study|Study terminated by sponsor|0|||
48727075|NCT02038829|156851522|FG010|Washout Period 4|Adverse Event|0|||
48727076|NCT02038829|156851523|FG011|Washout Period 4|Adverse Event|0|||
48821247|NCT03248479|157187412|FG007|Overall Study|Study terminated by sponsor|1|||
48821248|NCT03248479|157187413|FG008|Overall Study|Study terminated by sponsor|1|||
48821249|NCT03248479|157187414|FG009|Overall Study|Study terminated by sponsor|0|||
48821250|NCT03248479|157187415|FG010|Overall Study|Study terminated by sponsor|5|||
48821251|NCT03248479|157187416|FG011|Overall Study|Study terminated by sponsor|4|||
48821252|NCT03248479|157187417|FG012|Overall Study|Study terminated by sponsor|0|||
48821253|NCT03248479|157187405|FG000|Overall Study|Consent withdrawn|6|||
48821254|NCT03248479|157187406|FG001|Overall Study|Consent withdrawn|3|||
48821255|NCT03248479|157187407|FG002|Overall Study|Consent withdrawn|0|||
48821256|NCT03248479|157187408|FG003|Overall Study|Consent withdrawn|9|||
48821257|NCT03248479|157187409|FG004|Overall Study|Consent withdrawn|1|||
48821258|NCT03248479|157187410|FG005|Overall Study|Consent withdrawn|0|||
48821259|NCT03248479|157187411|FG006|Overall Study|Consent withdrawn|0|||
48821260|NCT03248479|157187412|FG007|Overall Study|Consent withdrawn|1|||
48821261|NCT03248479|157187413|FG008|Overall Study|Consent withdrawn|0|||
48821262|NCT03248479|157187414|FG009|Overall Study|Consent withdrawn|3|||
48821263|NCT03248479|157187415|FG010|Overall Study|Consent withdrawn|1|||
48821264|NCT03248479|157187416|FG011|Overall Study|Consent withdrawn|0|||
48821265|NCT03248479|157187417|FG012|Overall Study|Consent withdrawn|1|||
48821266|NCT03248479|157187405|FG000|Overall Study|Lost to Follow-up|2|||
48821267|NCT03248479|157187406|FG001|Overall Study|Lost to Follow-up|1|||
48821268|NCT03248479|157187407|FG002|Overall Study|Lost to Follow-up|0|||
48821269|NCT03248479|157187408|FG003|Overall Study|Lost to Follow-up|0|||
48821270|NCT03248479|157187409|FG004|Overall Study|Lost to Follow-up|0|||
48821271|NCT03248479|157187410|FG005|Overall Study|Lost to Follow-up|0|||
48821272|NCT03248479|157187411|FG006|Overall Study|Lost to Follow-up|0|||
48821273|NCT03248479|157187412|FG007|Overall Study|Lost to Follow-up|0|||
48821274|NCT03248479|157187413|FG008|Overall Study|Lost to Follow-up|0|||
48821275|NCT03248479|157187414|FG009|Overall Study|Lost to Follow-up|0|||
48821276|NCT03248479|157187415|FG010|Overall Study|Lost to Follow-up|0|||
48821277|NCT03248479|157187416|FG011|Overall Study|Lost to Follow-up|0|||
48821278|NCT03248479|157187417|FG012|Overall Study|Lost to Follow-up|1|||
48821279|NCT03248479|157187405|FG000|Overall Study|Not reported|0|||
48821280|NCT03248479|157187406|FG001|Overall Study|Not reported|0|||
48821281|NCT03248479|157187407|FG002|Overall Study|Not reported|0|||
48821282|NCT03248479|157187408|FG003|Overall Study|Not reported|1|||
48821283|NCT03248479|157187409|FG004|Overall Study|Not reported|1|||
48821284|NCT03248479|157187410|FG005|Overall Study|Not reported|0|||
48821285|NCT03248479|157187411|FG006|Overall Study|Not reported|0|||
48821286|NCT03248479|157187412|FG007|Overall Study|Not reported|1|||
48821287|NCT03248479|157187413|FG008|Overall Study|Not reported|1|||
48821288|NCT03248479|157187414|FG009|Overall Study|Not reported|0|||
48821289|NCT03248479|157187415|FG010|Overall Study|Not reported|0|||
48821290|NCT03248479|157187416|FG011|Overall Study|Not reported|0|||
48821291|NCT03248479|157187417|FG012|Overall Study|Not reported|0|||
48821292|NCT04626427|157187418|FG000|Overall Study|Death|1|||
48821293|NCT04626427|157187418|FG000|Overall Study|Withdrawal by Subject|1|||
48821294|NCT04626427|157187418|FG000|Overall Study|Investigation Early Termination by Sponsor|11|||
48821295|NCT04626427|157187418|FG000|Overall Study|Participant Permanently Moved Abroad|1|||
48821296|NCT01349829|157188638|FG000|Overall Study|Lost to Follow-up|4|||
48821297|NCT01349829|157188639|FG001|Overall Study|Lost to Follow-up|8|||
48821298|NCT01349829|157188638|FG000|Overall Study|Consent withdrawal|3|||
48921171|NCT00159861|157544860|FG000|Core Study - 16 Weeks|Death|3|||
49138238|NCT01859741|158343928|FG002|Overall Study|Lost to Follow-up|0|||
49138239|NCT01859741|158343929|FG003|Overall Study|Lost to Follow-up|0|||
49138240|NCT01859741|158343930|FG004|Overall Study|Lost to Follow-up|0|||
49138241|NCT01859741|158343931|FG005|Overall Study|Lost to Follow-up|1|||
49138242|NCT01859741|158343932|FG006|Overall Study|Lost to Follow-up|0|||
49138243|NCT01859741|158343933|FG007|Overall Study|Lost to Follow-up|4|||
48727077|NCT02038829|156851512|FG000|Treatment Period 6|Adverse Event|0|||
48727078|NCT02038829|156851513|FG001|Treatment Period 6|Adverse Event|0|||
48821299|NCT01349829|157188639|FG001|Overall Study|Consent withdrawal|8|||
48821300|NCT01349829|157188638|FG000|Overall Study|Migrated/moved|2|||
48821301|NCT01349829|157188639|FG001|Overall Study|Migrated/moved|7|||
48821302|NCT00231179|157188642|FG000|Overall Study|Lost to Follow-up|21|||
48821303|NCT00231179|157188643|FG001|Overall Study|Lost to Follow-up|21|||
48821304|NCT00231179|157188642|FG000|Overall Study|Withdrawal by Subject|3|||
48821305|NCT00231179|157188643|FG001|Overall Study|Withdrawal by Subject|3|||
48821306|NCT00262743|157188644|FG000|Overall Study|Adverse Event|0|||
49138244|NCT01859741|158343926|FG000|Overall Study|Withdrawal by Subject|0|||
49138245|NCT01859741|158343927|FG001|Overall Study|Withdrawal by Subject|1|||
49011510|NCT03210259|157878987|FG001|48-Week Randomized Responder Period|Physician Decision|0|||
49011511|NCT03210259|157878988|FG002|48-Week Randomized Responder Period|Physician Decision|1|||
49011512|NCT03210259|157878986|FG000|48-Week Randomized Responder Period|Withdrawal by Subject|0|||
49011513|NCT03210259|157878987|FG001|48-Week Randomized Responder Period|Withdrawal by Subject|5|||
49011514|NCT03210259|157878988|FG002|48-Week Randomized Responder Period|Withdrawal by Subject|17|||
49011515|NCT03210259|157878986|FG000|48-Week Randomized Responder Period|Adverse Event|0|||
49011516|NCT03210259|157878987|FG001|48-Week Randomized Responder Period|Adverse Event|1|||
49011517|NCT03210259|157878988|FG002|48-Week Randomized Responder Period|Adverse Event|1|||
49011518|NCT02087059|157878989|FG000|Overall Study|Disease Progression|1|||
49138246|NCT01859741|158343928|FG002|Overall Study|Withdrawal by Subject|2|||
49138247|NCT01859741|158343929|FG003|Overall Study|Withdrawal by Subject|0|||
49138248|NCT01859741|158343930|FG004|Overall Study|Withdrawal by Subject|0|||
48727079|NCT02038829|156851514|FG002|Treatment Period 6|Adverse Event|1|||
48727080|NCT02038829|156851515|FG003|Treatment Period 6|Adverse Event|0|||
48727081|NCT02038829|156851516|FG004|Treatment Period 6|Adverse Event|0|||
48727082|NCT02038829|156851517|FG005|Treatment Period 6|Adverse Event|0|||
48727083|NCT02038829|156851518|FG006|Treatment Period 6|Adverse Event|0|||
48727084|NCT02038829|156851519|FG007|Treatment Period 6|Adverse Event|0|||
48727085|NCT02038829|156851520|FG008|Treatment Period 6|Adverse Event|0|||
48727086|NCT02038829|156851521|FG009|Treatment Period 6|Adverse Event|0|||
48727087|NCT02038829|156851522|FG010|Treatment Period 6|Adverse Event|0|||
48727088|NCT02038829|156851523|FG011|Treatment Period 6|Adverse Event|0|||
48727089|NCT01117051|156851528|FG000|Overall Study|Withdrawal by Subject|5|||
48727090|NCT01117051|156851529|FG001|Overall Study|Withdrawal by Subject|3|||
48727091|NCT01117051|156851528|FG000|Overall Study|Adverse Event|4|||
48727092|NCT01117051|156851529|FG001|Overall Study|Adverse Event|3|||
48727093|NCT01117051|156851528|FG000|Overall Study|Lost to Follow-up|0|||
48727094|NCT01117051|156851529|FG001|Overall Study|Lost to Follow-up|1|||
48727095|NCT01117051|156851528|FG000|Overall Study|Did not meet in-/exclusion criteria|0|||
48727096|NCT01117051|156851529|FG001|Overall Study|Did not meet in-/exclusion criteria|1|||
48727097|NCT01117051|156851528|FG000|Overall Study|Sponsor's decision|3|||
48727098|NCT01117051|156851529|FG001|Overall Study|Sponsor's decision|1|||
48727099|NCT01117051|156851528|FG000|Overall Study|Surgical procedure|0|||
48727100|NCT01117051|156851529|FG001|Overall Study|Surgical procedure|1|||
48727101|NCT01117051|156851528|FG000|Overall Study|Randomized by mistake|0|||
48727102|NCT01117051|156851529|FG001|Overall Study|Randomized by mistake|1|||
48727103|NCT01117051|156851528|FG000|Overall Study|Convenience issue|1|||
48727104|NCT01117051|156851529|FG001|Overall Study|Convenience issue|0|||
48727105|NCT01479985|156851530|FG000|Overall Study|Tablet malfunction, no data saved|1|||
48727106|NCT01479985|156851531|FG001|Overall Study|Tablet malfunction, no data saved|1|||
48727107|NCT01479985|156851530|FG000|Overall Study|No decisional conflict scale responses|0|||
48727108|NCT01479985|156851531|FG001|Overall Study|No decisional conflict scale responses|2|||
48727109|NCT01479985|156851530|FG000|Overall Study|No post-visit survey|5|||
48727110|NCT01479985|156851531|FG001|Overall Study|No post-visit survey|3|||
48727111|NCT00367770|156851532|FG000|Overall Study|Adverse Event|1|||
48727112|NCT00367770|156851532|FG000|Overall Study|Withdrawal by Subject|1|||
48727113|NCT02480712|156851533|FG000|Overall Study|Enrolled but Never Treated|1|||
48727114|NCT02480712|156851533|FG000|Overall Study|Lost to Follow-up|5|||
48727115|NCT02480712|156851533|FG000|Overall Study|Withdrew Consent|3|||
48727116|NCT02480712|156851533|FG000|Overall Study|Death|1|||
48727117|NCT02480712|156851533|FG000|Overall Study|Lack of Efficacy|1|||
48727118|NCT01751802|156851534|FG000|Overall Study|Adverse Event|4|||
48727119|NCT01751802|156851535|FG001|Overall Study|Adverse Event|2|||
48727120|NCT00442468|156851536|FG000|Overall Study|Adverse Event|4|||
48727121|NCT00442468|156851536|FG000|Overall Study|Withdrawal by Subject|91|||
49138249|NCT01859741|158343931|FG005|Overall Study|Withdrawal by Subject|1|||
49138250|NCT01859741|158343932|FG006|Overall Study|Withdrawal by Subject|1|||
49138251|NCT01859741|158343933|FG007|Overall Study|Withdrawal by Subject|1|||
49138252|NCT01859741|158343926|FG000|Overall Study|Study Terminated by Sponsor|0|||
49138253|NCT01859741|158343927|FG001|Overall Study|Study Terminated by Sponsor|0|||
49138254|NCT01859741|158343928|FG002|Overall Study|Study Terminated by Sponsor|0|||
49138255|NCT01859741|158343929|FG003|Overall Study|Study Terminated by Sponsor|0|||
49138256|NCT01859741|158343930|FG004|Overall Study|Study Terminated by Sponsor|1|||
49138257|NCT01859741|158343931|FG005|Overall Study|Study Terminated by Sponsor|0|||
49138258|NCT01859741|158343932|FG006|Overall Study|Study Terminated by Sponsor|16|||
49138259|NCT01859741|158343933|FG007|Overall Study|Study Terminated by Sponsor|14|||
49138260|NCT01859741|158343926|FG000|Overall Study|Other|0|||
48727122|NCT00442468|156851536|FG000|Overall Study|Did not complete all study procedures|88|||
48727123|NCT01721577|156851543|FG000|Overall Study|Lack of Efficacy|1|||
48727124|NCT01721577|156851544|FG001|Overall Study|Lack of Efficacy|0|||
48727125|NCT01721577|156851543|FG000|Overall Study|Death|1|||
48727126|NCT01721577|156851544|FG001|Overall Study|Death|0|||
48727127|NCT01721577|156851543|FG000|Overall Study|Dose Escalation to 400mg BID|0|||
49138261|NCT01859741|158343927|FG001|Overall Study|Other|0|||
49138262|NCT01859741|158343928|FG002|Overall Study|Other|0|||
49138263|NCT01859741|158343929|FG003|Overall Study|Other|0|||
49138264|NCT01859741|158343930|FG004|Overall Study|Other|0|||
49138265|NCT01859741|158343931|FG005|Overall Study|Other|0|||
49138266|NCT01859741|158343932|FG006|Overall Study|Other|2|||
48727128|NCT01721577|156851544|FG001|Overall Study|Dose Escalation to 400mg BID|1|||
48727129|NCT01721577|156851543|FG000|Overall Study|Adverse Event|0|||
48727130|NCT01721577|156851544|FG001|Overall Study|Adverse Event|2|||
48727131|NCT01151098|156851545|FG000|Overall Study|Adverse Event|82|||
48727132|NCT01151098|156851545|FG000|Overall Study|Lost to Follow-up|6|||
48727133|NCT01151098|156851545|FG000|Overall Study|Lack of Efficacy|15|||
48727134|NCT01151098|156851545|FG000|Overall Study|Protocol Violation|1|||
48727135|NCT01151098|156851545|FG000|Overall Study|Miscellaneous|13|||
48727136|NCT02325791|156851553|FG000|Overall Study|Adverse Event|0|||
48727137|NCT02325791|156851554|FG001|Overall Study|Adverse Event|1|||
48727138|NCT02325791|156851555|FG002|Overall Study|Adverse Event|1|||
48727139|NCT02325791|156851556|FG003|Overall Study|Adverse Event|0|||
48727140|NCT02325791|156851553|FG000|Overall Study|Death|0|||
48727141|NCT02325791|156851554|FG001|Overall Study|Death|3|||
48727142|NCT02325791|156851555|FG002|Overall Study|Death|0|||
48727143|NCT02325791|156851556|FG003|Overall Study|Death|1|||
48727144|NCT02325791|156851553|FG000|Overall Study|Lost to Follow-up|0|||
48727145|NCT02325791|156851554|FG001|Overall Study|Lost to Follow-up|15|||
48727146|NCT02325791|156851555|FG002|Overall Study|Lost to Follow-up|14|||
48727147|NCT02325791|156851556|FG003|Overall Study|Lost to Follow-up|9|||
48727148|NCT02325791|156851553|FG000|Overall Study|Physician Decision|0|||
48727149|NCT02325791|156851554|FG001|Overall Study|Physician Decision|1|||
48727150|NCT02325791|156851555|FG002|Overall Study|Physician Decision|1|||
48727151|NCT02325791|156851556|FG003|Overall Study|Physician Decision|0|||
48727152|NCT02325791|156851553|FG000|Overall Study|Protocol Violation|0|||
48727153|NCT02325791|156851554|FG001|Overall Study|Protocol Violation|0|||
48727154|NCT02325791|156851555|FG002|Overall Study|Protocol Violation|1|||
48727155|NCT02325791|156851556|FG003|Overall Study|Protocol Violation|0|||
48727156|NCT02325791|156851553|FG000|Overall Study|Withdrawal by Subject|0|||
48727157|NCT02325791|156851554|FG001|Overall Study|Withdrawal by Subject|5|||
48727158|NCT02325791|156851555|FG002|Overall Study|Withdrawal by Subject|8|||
48727159|NCT02325791|156851556|FG003|Overall Study|Withdrawal by Subject|16|||
48727160|NCT02456103|156851558|FG000|Overall Study|Study Closure|207|||
48727161|NCT02456103|156851558|FG000|Overall Study|Physician Decision|1|||
48727162|NCT02456103|156851558|FG000|Overall Study|Required prohibited medications|5|||
48727163|NCT02456103|156851558|FG000|Overall Study|Protocol Violation|1|||
48727164|NCT02456103|156851558|FG000|Overall Study|Adverse Event|5|||
48727165|NCT02456103|156851558|FG000|Overall Study|Abnormal Laboratory Value|2|||
48727166|NCT02456103|156851558|FG000|Overall Study|Lost to Follow-up|1|||
48727167|NCT02456103|156851558|FG000|Overall Study|Withdrawal by Subject|24|||
48727168|NCT01975831|156851559|FG000|Overall Study|Adverse Event|1|||
48727169|NCT01975831|156851560|FG001|Overall Study|Adverse Event|2|||
48727170|NCT01975831|156851561|FG002|Overall Study|Adverse Event|2|||
48727171|NCT01975831|156851562|FG003|Overall Study|Adverse Event|0|||
48727172|NCT01975831|156851563|FG004|Overall Study|Adverse Event|1|||
48727173|NCT01975831|156851564|FG005|Overall Study|Adverse Event|1|||
48727174|NCT01975831|156851565|FG006|Overall Study|Adverse Event|3|||
48727175|NCT01975831|156851566|FG007|Overall Study|Adverse Event|4|||
48727176|NCT01975831|156851567|FG008|Overall Study|Adverse Event|1|||
48727177|NCT01975831|156851559|FG000|Overall Study|Death|1|||
48727178|NCT01975831|156851560|FG001|Overall Study|Death|1|||
48727179|NCT01975831|156851561|FG002|Overall Study|Death|0|||
48727180|NCT01975831|156851562|FG003|Overall Study|Death|0|||
48727181|NCT01975831|156851563|FG004|Overall Study|Death|1|||
48727182|NCT01975831|156851564|FG005|Overall Study|Death|0|||
48727183|NCT01975831|156851565|FG006|Overall Study|Death|1|||
48727184|NCT01975831|156851566|FG007|Overall Study|Death|0|||
48727185|NCT01975831|156851567|FG008|Overall Study|Death|0|||
48727186|NCT01975831|156851559|FG000|Overall Study|Progressive Disease|1|||
48727187|NCT01975831|156851560|FG001|Overall Study|Progressive Disease|3|||
48727188|NCT01975831|156851561|FG002|Overall Study|Progressive Disease|2|||
48727189|NCT01975831|156851562|FG003|Overall Study|Progressive Disease|4|||
48727190|NCT01975831|156851563|FG004|Overall Study|Progressive Disease|13|||
48727191|NCT01975831|156851564|FG005|Overall Study|Progressive Disease|9|||
48727192|NCT01975831|156851565|FG006|Overall Study|Progressive Disease|10|||
48727193|NCT01975831|156851566|FG007|Overall Study|Progressive Disease|8|||
48727194|NCT01975831|156851567|FG008|Overall Study|Progressive Disease|10|||
48727195|NCT01975831|156851559|FG000|Overall Study|Withdrawal by Subject|0|||
48727196|NCT01975831|156851560|FG001|Overall Study|Withdrawal by Subject|3|||
48727197|NCT01975831|156851561|FG002|Overall Study|Withdrawal by Subject|0|||
48727198|NCT01975831|156851562|FG003|Overall Study|Withdrawal by Subject|0|||
48727199|NCT01975831|156851563|FG004|Overall Study|Withdrawal by Subject|3|||
48727200|NCT01975831|156851564|FG005|Overall Study|Withdrawal by Subject|1|||
48727201|NCT01975831|156851565|FG006|Overall Study|Withdrawal by Subject|1|||
48727202|NCT01975831|156851566|FG007|Overall Study|Withdrawal by Subject|0|||
48727203|NCT01975831|156851567|FG008|Overall Study|Withdrawal by Subject|0|||
48727204|NCT01975831|156851559|FG000|Overall Study|Physician Decision|0|||
49138267|NCT01859741|158343933|FG007|Overall Study|Other|0|||
49138268|NCT02568423|158343934|FG000|Overall Study|Lost to Follow-up|0|||
49138269|NCT02568423|158343935|FG001|Overall Study|Lost to Follow-up|2|||
49138270|NCT02568423|158343936|FG002|Overall Study|Lost to Follow-up|0|||
49138271|NCT02568423|158343937|FG003|Overall Study|Lost to Follow-up|0|||
49138272|NCT02568423|158343938|FG004|Overall Study|Lost to Follow-up|0|||
49138273|NCT02568423|158343939|FG005|Overall Study|Lost to Follow-up|0|||
49138274|NCT02568423|158343940|FG006|Overall Study|Lost to Follow-up|0|||
49138275|NCT02568423|158343941|FG007|Overall Study|Lost to Follow-up|0|||
49138276|NCT02568423|158343934|FG000|Overall Study|Physician Decision|0|||
48727205|NCT01975831|156851560|FG001|Overall Study|Physician Decision|0|||
48727206|NCT01975831|156851561|FG002|Overall Study|Physician Decision|0|||
48727207|NCT01975831|156851562|FG003|Overall Study|Physician Decision|0|||
48727208|NCT01975831|156851563|FG004|Overall Study|Physician Decision|0|||
48727209|NCT01975831|156851564|FG005|Overall Study|Physician Decision|1|||
48727210|NCT01975831|156851565|FG006|Overall Study|Physician Decision|0|||
48727211|NCT01975831|156851566|FG007|Overall Study|Physician Decision|1|||
48727212|NCT01975831|156851567|FG008|Overall Study|Physician Decision|0|||
48727213|NCT01975831|156851559|FG000|Overall Study|Initiation of Subsequent Therapy|0|||
48727214|NCT01975831|156851560|FG001|Overall Study|Initiation of Subsequent Therapy|0|||
48727215|NCT01975831|156851561|FG002|Overall Study|Initiation of Subsequent Therapy|0|||
48727216|NCT01975831|156851562|FG003|Overall Study|Initiation of Subsequent Therapy|0|||
48727217|NCT01975831|156851563|FG004|Overall Study|Initiation of Subsequent Therapy|0|||
48727218|NCT01975831|156851564|FG005|Overall Study|Initiation of Subsequent Therapy|1|||
48727219|NCT01975831|156851565|FG006|Overall Study|Initiation of Subsequent Therapy|0|||
48727220|NCT01975831|156851566|FG007|Overall Study|Initiation of Subsequent Therapy|2|||
48727221|NCT01975831|156851567|FG008|Overall Study|Initiation of Subsequent Therapy|0|||
48727222|NCT01975831|156851559|FG000|Overall Study|Entered Hospice|0|||
48727223|NCT01975831|156851560|FG001|Overall Study|Entered Hospice|0|||
48727224|NCT01975831|156851561|FG002|Overall Study|Entered Hospice|0|||
48727225|NCT01975831|156851562|FG003|Overall Study|Entered Hospice|0|||
48727226|NCT01975831|156851563|FG004|Overall Study|Entered Hospice|0|||
48727227|NCT01975831|156851564|FG005|Overall Study|Entered Hospice|1|||
48727228|NCT01975831|156851565|FG006|Overall Study|Entered Hospice|0|||
48727229|NCT01975831|156851566|FG007|Overall Study|Entered Hospice|0|||
48727230|NCT01975831|156851567|FG008|Overall Study|Entered Hospice|0|||
48727231|NCT01975831|156851559|FG000|Overall Study|Unable to Treat Within Protocol Windows|0|||
48727232|NCT01975831|156851560|FG001|Overall Study|Unable to Treat Within Protocol Windows|0|||
48727233|NCT01975831|156851561|FG002|Overall Study|Unable to Treat Within Protocol Windows|0|||
48727234|NCT01975831|156851562|FG003|Overall Study|Unable to Treat Within Protocol Windows|0|||
48727235|NCT01975831|156851563|FG004|Overall Study|Unable to Treat Within Protocol Windows|0|||
48727236|NCT01975831|156851564|FG005|Overall Study|Unable to Treat Within Protocol Windows|0|||
48727237|NCT01975831|156851565|FG006|Overall Study|Unable to Treat Within Protocol Windows|1|||
48727238|NCT01975831|156851566|FG007|Overall Study|Unable to Treat Within Protocol Windows|0|||
48727239|NCT01975831|156851567|FG008|Overall Study|Unable to Treat Within Protocol Windows|1|||
48727240|NCT03614975|156851568|FG000|Overall Study|Physician Decision|7|||
48727241|NCT03614975|156851569|FG001|Overall Study|Physician Decision|5|||
48727242|NCT03614975|156851568|FG000|Overall Study|Withdrawal by Subject|2|||
48727243|NCT03614975|156851569|FG001|Overall Study|Withdrawal by Subject|2|||
48727244|NCT03614975|156851568|FG000|Overall Study|Specimens not in lab batch shipment|1|||
48727245|NCT03614975|156851569|FG001|Overall Study|Specimens not in lab batch shipment|1|||
48727246|NCT02581943|156851570|FG000|Overall Study|Death|5|||
48727247|NCT02581943|156851571|FG001|Overall Study|Death|2|||
48727248|NCT02581943|156851570|FG000|Overall Study|Disease Progression|12|||
48727249|NCT02581943|156851571|FG001|Overall Study|Disease Progression|15|||
48727250|NCT02581943|156851570|FG000|Overall Study|Withdrawal by Subject|1|||
48727251|NCT02581943|156851571|FG001|Overall Study|Withdrawal by Subject|2|||
48727252|NCT02536833|156851574|FG000|Overall Study|Discontinued Before Treatment|0|||
48727253|NCT02536833|156851575|FG001|Overall Study|Discontinued Before Treatment|0|||
48727254|NCT02536833|156851576|FG002|Overall Study|Discontinued Before Treatment|1|||
48727255|NCT02536833|156851577|FG003|Overall Study|Discontinued Before Treatment|2|||
48727256|NCT02536833|156851574|FG000|Overall Study|Adverse Event|1|||
48727257|NCT02536833|156851575|FG001|Overall Study|Adverse Event|3|||
48921172|NCT00159861|157544861|FG001|Core Study - 16 Weeks|Death|0|||
48727258|NCT02536833|156851576|FG002|Overall Study|Adverse Event|4|||
48727259|NCT02536833|156851577|FG003|Overall Study|Adverse Event|1|||
48727260|NCT02536833|156851574|FG000|Overall Study|Lost to Follow-up|2|||
48727261|NCT02536833|156851575|FG001|Overall Study|Lost to Follow-up|1|||
48727262|NCT02536833|156851576|FG002|Overall Study|Lost to Follow-up|2|||
48727263|NCT02536833|156851577|FG003|Overall Study|Lost to Follow-up|2|||
49138277|NCT02568423|158343935|FG001|Overall Study|Physician Decision|0|||
49138278|NCT02568423|158343936|FG002|Overall Study|Physician Decision|0|||
49138279|NCT02568423|158343937|FG003|Overall Study|Physician Decision|0|||
49138280|NCT02568423|158343938|FG004|Overall Study|Physician Decision|0|||
49138281|NCT02568423|158343939|FG005|Overall Study|Physician Decision|1|||
49138282|NCT02568423|158343940|FG006|Overall Study|Physician Decision|0|||
49138283|NCT02568423|158343941|FG007|Overall Study|Physician Decision|0|||
49138284|NCT00081458|158343944|FG000|Overall Study|Adverse Event|1|||
49138285|NCT00081458|158343945|FG001|Overall Study|Adverse Event|5|||
49138286|NCT00081458|158343946|FG002|Overall Study|Adverse Event|2|||
49138287|NCT00081458|158343944|FG000|Overall Study|Withdrawal by Subject|0|||
49138288|NCT00081458|158343945|FG001|Overall Study|Withdrawal by Subject|3|||
49138289|NCT00081458|158343946|FG002|Overall Study|Withdrawal by Subject|1|||
49138290|NCT00081458|158343944|FG000|Overall Study|Randomized but not dosed|0|||
49138291|NCT00081458|158343945|FG001|Overall Study|Randomized but not dosed|0|||
49138292|NCT00081458|158343946|FG002|Overall Study|Randomized but not dosed|1|||
49138293|NCT01995201|158343947|FG000|From Baseline Until Week 24|Adverse Event|4|||
49138294|NCT01995201|158343948|FG001|From Baseline Until Week 24|Adverse Event|15|||
49138295|NCT01995201|158343949|FG002|From Baseline Until Week 24|Adverse Event|0|||
49138296|NCT01995201|158343950|FG003|From Baseline Until Week 24|Adverse Event|0|||
49138297|NCT01995201|158343951|FG004|From Baseline Until Week 24|Adverse Event|0|||
49138298|NCT01995201|158343952|FG005|From Baseline Until Week 24|Adverse Event|0|||
49138299|NCT01995201|158343953|FG006|From Baseline Until Week 24|Adverse Event|0|||
49138300|NCT01995201|158343947|FG000|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
49138301|NCT01995201|158343948|FG001|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3|||
49138302|NCT01995201|158343949|FG002|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
49138303|NCT01995201|158343950|FG003|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
49138304|NCT01995201|158343951|FG004|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
49138305|NCT01995201|158343952|FG005|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
49138306|NCT01995201|158343953|FG006|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
49138307|NCT01995201|158343947|FG000|From Baseline Until Week 24|Death|0|||
49138308|NCT01995201|158343948|FG001|From Baseline Until Week 24|Death|1|||
49138309|NCT01995201|158343949|FG002|From Baseline Until Week 24|Death|0|||
49138310|NCT01995201|158343950|FG003|From Baseline Until Week 24|Death|0|||
49138311|NCT01995201|158343951|FG004|From Baseline Until Week 24|Death|0|||
49138312|NCT01995201|158343952|FG005|From Baseline Until Week 24|Death|0|||
49138313|NCT01995201|158343953|FG006|From Baseline Until Week 24|Death|0|||
49138314|NCT01995201|158343947|FG000|From Baseline Until Week 24|Lack of Efficacy|2|||
49138315|NCT01995201|158343948|FG001|From Baseline Until Week 24|Lack of Efficacy|5|||
49138316|NCT01995201|158343949|FG002|From Baseline Until Week 24|Lack of Efficacy|0|||
49138317|NCT01995201|158343950|FG003|From Baseline Until Week 24|Lack of Efficacy|0|||
49138318|NCT01995201|158343951|FG004|From Baseline Until Week 24|Lack of Efficacy|0|||
49138319|NCT01995201|158343952|FG005|From Baseline Until Week 24|Lack of Efficacy|0|||
49138320|NCT01995201|158343953|FG006|From Baseline Until Week 24|Lack of Efficacy|0|||
49138321|NCT01995201|158343947|FG000|From Baseline Until Week 24|Lost to Follow-up|2|||
49138322|NCT01995201|158343948|FG001|From Baseline Until Week 24|Lost to Follow-up|3|||
49138323|NCT01995201|158343949|FG002|From Baseline Until Week 24|Lost to Follow-up|0|||
49138324|NCT01995201|158343950|FG003|From Baseline Until Week 24|Lost to Follow-up|0|||
49138325|NCT01995201|158343951|FG004|From Baseline Until Week 24|Lost to Follow-up|0|||
49138326|NCT01995201|158343952|FG005|From Baseline Until Week 24|Lost to Follow-up|0|||
49138327|NCT01995201|158343953|FG006|From Baseline Until Week 24|Lost to Follow-up|0|||
49138328|NCT01995201|158343947|FG000|From Baseline Until Week 24|Withdrawal by Subject|2|||
49138329|NCT01995201|158343948|FG001|From Baseline Until Week 24|Withdrawal by Subject|8|||
49138330|NCT01995201|158343949|FG002|From Baseline Until Week 24|Withdrawal by Subject|0|||
49138331|NCT01995201|158343950|FG003|From Baseline Until Week 24|Withdrawal by Subject|0|||
49138332|NCT01995201|158343951|FG004|From Baseline Until Week 24|Withdrawal by Subject|0|||
49138333|NCT01995201|158343952|FG005|From Baseline Until Week 24|Withdrawal by Subject|0|||
49138334|NCT01995201|158343953|FG006|From Baseline Until Week 24|Withdrawal by Subject|0|||
49138335|NCT01995201|158343947|FG000|From Baseline Until Week 24|Physician Decision|0|||
49138336|NCT01995201|158343948|FG001|From Baseline Until Week 24|Physician Decision|2|||
48727264|NCT02536833|156851574|FG000|Overall Study|Physician Decision|0|||
48727265|NCT02536833|156851575|FG001|Overall Study|Physician Decision|0|||
48727266|NCT02536833|156851576|FG002|Overall Study|Physician Decision|0|||
48727267|NCT02536833|156851577|FG003|Overall Study|Physician Decision|1|||
48727268|NCT02536833|156851574|FG000|Overall Study|Site Terminated by Sponsor|2|||
48727269|NCT02536833|156851575|FG001|Overall Study|Site Terminated by Sponsor|2|||
48727270|NCT02536833|156851576|FG002|Overall Study|Site Terminated by Sponsor|2|||
48727271|NCT02536833|156851577|FG003|Overall Study|Site Terminated by Sponsor|2|||
48727272|NCT02536833|156851574|FG000|Overall Study|Subject Non-Compliance|0|||
48727273|NCT02536833|156851575|FG001|Overall Study|Subject Non-Compliance|1|||
48727274|NCT02536833|156851576|FG002|Overall Study|Subject Non-Compliance|1|||
48727275|NCT02536833|156851577|FG003|Overall Study|Subject Non-Compliance|0|||
48727276|NCT02536833|156851574|FG000|Overall Study|Withdrawal by Subject|4|||
48727277|NCT02536833|156851575|FG001|Overall Study|Withdrawal by Subject|3|||
48727278|NCT02536833|156851576|FG002|Overall Study|Withdrawal by Subject|5|||
48821307|NCT00262743|157188645|FG001|Overall Study|Adverse Event|9|||
48821308|NCT00262743|157188644|FG000|Overall Study|Disease progression|0|||
48821309|NCT00262743|157188645|FG001|Overall Study|Disease progression|3|||
48821310|NCT02297503|157188650|FG000|Overall Study|Withdrawal by Subject|1|||
48821311|NCT02297503|157188651|FG001|Overall Study|Withdrawal by Subject|1|||
48821312|NCT02297503|157188650|FG000|Overall Study|Protocol Violation|1|||
48821313|NCT02297503|157188651|FG001|Overall Study|Protocol Violation|0|||
48821314|NCT02297503|157188650|FG000|Overall Study|Pregnancy|0|||
48821315|NCT02297503|157188651|FG001|Overall Study|Pregnancy|1|||
48821316|NCT02297503|157188650|FG000|Overall Study|Lost to Follow-up|0|||
48821317|NCT02297503|157188651|FG001|Overall Study|Lost to Follow-up|1|||
48821318|NCT02297503|157188650|FG000|Overall Study|Medical reason|0|||
48727279|NCT02536833|156851577|FG003|Overall Study|Withdrawal by Subject|11|||
48727280|NCT02889562|156851578|FG000|Overall Study|Physician Decision|0|||
49138337|NCT01995201|158343949|FG002|From Baseline Until Week 24|Physician Decision|0|||
49138338|NCT01995201|158343950|FG003|From Baseline Until Week 24|Physician Decision|0|||
49138339|NCT01995201|158343951|FG004|From Baseline Until Week 24|Physician Decision|0|||
49138340|NCT01995201|158343952|FG005|From Baseline Until Week 24|Physician Decision|0|||
49138341|NCT01995201|158343953|FG006|From Baseline Until Week 24|Physician Decision|0|||
49138342|NCT01995201|158343947|FG000|From Baseline Until Week 24|Protocol Violation|0|||
49138343|NCT01995201|158343948|FG001|From Baseline Until Week 24|Protocol Violation|9|||
49138344|NCT01995201|158343949|FG002|From Baseline Until Week 24|Protocol Violation|0|||
49138345|NCT01995201|158343950|FG003|From Baseline Until Week 24|Protocol Violation|0|||
49138346|NCT01995201|158343951|FG004|From Baseline Until Week 24|Protocol Violation|0|||
49138347|NCT01995201|158343952|FG005|From Baseline Until Week 24|Protocol Violation|0|||
49138348|NCT01995201|158343953|FG006|From Baseline Until Week 24|Protocol Violation|0|||
49138349|NCT01995201|158343947|FG000|From Week 24 Until Week 48|Adverse Event|0|||
49138350|NCT01995201|158343948|FG001|From Week 24 Until Week 48|Adverse Event|0|||
49138351|NCT01995201|158343949|FG002|From Week 24 Until Week 48|Adverse Event|2|||
49138352|NCT01995201|158343950|FG003|From Week 24 Until Week 48|Adverse Event|1|||
49138353|NCT01995201|158343951|FG004|From Week 24 Until Week 48|Adverse Event|1|||
49138354|NCT01995201|158343952|FG005|From Week 24 Until Week 48|Adverse Event|3|||
49138355|NCT01995201|158343953|FG006|From Week 24 Until Week 48|Adverse Event|1|||
49138356|NCT01995201|158343947|FG000|From Week 24 Until Week 48|Death|0|||
49138357|NCT01995201|158343948|FG001|From Week 24 Until Week 48|Death|0|||
49138358|NCT01995201|158343949|FG002|From Week 24 Until Week 48|Death|0|||
49138359|NCT01995201|158343950|FG003|From Week 24 Until Week 48|Death|0|||
49138360|NCT01995201|158343951|FG004|From Week 24 Until Week 48|Death|0|||
49138361|NCT01995201|158343952|FG005|From Week 24 Until Week 48|Death|2|||
49138362|NCT01995201|158343953|FG006|From Week 24 Until Week 48|Death|0|||
49138363|NCT01995201|158343947|FG000|From Week 24 Until Week 48|Lack of Efficacy|0|||
49138364|NCT01995201|158343948|FG001|From Week 24 Until Week 48|Lack of Efficacy|0|||
49138365|NCT01995201|158343949|FG002|From Week 24 Until Week 48|Lack of Efficacy|1|||
48727281|NCT02889562|156851579|FG001|Overall Study|Physician Decision|1|||
48727282|NCT02889562|156851578|FG000|Overall Study|Withdrawal by Subject|0|||
48821319|NCT02297503|157188651|FG001|Overall Study|Medical reason|1|||
48727283|NCT02889562|156851579|FG001|Overall Study|Withdrawal by Subject|1|||
48727284|NCT00873860|156851580|FG000|Overall Study|Lost to Follow-up|1|||
48727285|NCT00873860|156851581|FG001|Overall Study|Lost to Follow-up|0|||
48727286|NCT00873860|156851582|FG002|Overall Study|Lost to Follow-up|0|||
48727287|NCT00873860|156851583|FG003|Overall Study|Lost to Follow-up|1|||
48727288|NCT00873860|156851580|FG000|Overall Study|Withdrawal by Subject|1|||
48727289|NCT00873860|156851581|FG001|Overall Study|Withdrawal by Subject|0|||
48727290|NCT00873860|156851582|FG002|Overall Study|Withdrawal by Subject|2|||
48727291|NCT00873860|156851583|FG003|Overall Study|Withdrawal by Subject|0|||
48727292|NCT00873860|156851580|FG000|Overall Study|Death|1|||
48821320|NCT01154036|157188652|FG000|Phase I|Physician Decision|0|||
48821321|NCT01154036|157188653|FG001|Phase I|Physician Decision|1|||
48821322|NCT01154036|157188654|FG002|Phase I|Physician Decision|0|||
48821323|NCT01154036|157188655|FG003|Phase I|Physician Decision|0|||
49138366|NCT01995201|158343950|FG003|From Week 24 Until Week 48|Lack of Efficacy|0|||
49138367|NCT01995201|158343951|FG004|From Week 24 Until Week 48|Lack of Efficacy|0|||
49138368|NCT01995201|158343952|FG005|From Week 24 Until Week 48|Lack of Efficacy|2|||
49138369|NCT01995201|158343953|FG006|From Week 24 Until Week 48|Lack of Efficacy|1|||
49138370|NCT01995201|158343947|FG000|From Week 24 Until Week 48|Lost to Follow-up|0|||
48727293|NCT00873860|156851581|FG001|Overall Study|Death|0|||
49138371|NCT01995201|158343948|FG001|From Week 24 Until Week 48|Lost to Follow-up|0|||
49138372|NCT01995201|158343949|FG002|From Week 24 Until Week 48|Lost to Follow-up|0|||
49138373|NCT01995201|158343950|FG003|From Week 24 Until Week 48|Lost to Follow-up|0|||
49138374|NCT01995201|158343951|FG004|From Week 24 Until Week 48|Lost to Follow-up|1|||
49138375|NCT01995201|158343952|FG005|From Week 24 Until Week 48|Lost to Follow-up|1|||
49138376|NCT01995201|158343953|FG006|From Week 24 Until Week 48|Lost to Follow-up|0|||
49138377|NCT01995201|158343947|FG000|From Week 24 Until Week 48|Withdrawal by Subject|0|||
49138378|NCT01995201|158343948|FG001|From Week 24 Until Week 48|Withdrawal by Subject|0|||
49138379|NCT01995201|158343949|FG002|From Week 24 Until Week 48|Withdrawal by Subject|1|||
49138380|NCT01995201|158343950|FG003|From Week 24 Until Week 48|Withdrawal by Subject|0|||
49138381|NCT01995201|158343951|FG004|From Week 24 Until Week 48|Withdrawal by Subject|1|||
49138382|NCT01995201|158343952|FG005|From Week 24 Until Week 48|Withdrawal by Subject|0|||
49138383|NCT01995201|158343953|FG006|From Week 24 Until Week 48|Withdrawal by Subject|0|||
49138384|NCT01995201|158343947|FG000|From Week 24 Until Week 48|Physician Decision|0|||
49138385|NCT01995201|158343948|FG001|From Week 24 Until Week 48|Physician Decision|0|||
49138386|NCT01995201|158343949|FG002|From Week 24 Until Week 48|Physician Decision|0|||
49138387|NCT01995201|158343950|FG003|From Week 24 Until Week 48|Physician Decision|0|||
49138388|NCT01995201|158343951|FG004|From Week 24 Until Week 48|Physician Decision|1|||
49138389|NCT01995201|158343952|FG005|From Week 24 Until Week 48|Physician Decision|0|||
49138390|NCT01995201|158343953|FG006|From Week 24 Until Week 48|Physician Decision|0|||
49138391|NCT01995201|158343947|FG000|From Week 24 Until Week 48|Protocol Violation|0|||
49138392|NCT01995201|158343948|FG001|From Week 24 Until Week 48|Protocol Violation|0|||
49138393|NCT01995201|158343949|FG002|From Week 24 Until Week 48|Protocol Violation|1|||
49138394|NCT01995201|158343950|FG003|From Week 24 Until Week 48|Protocol Violation|0|||
49138395|NCT01995201|158343951|FG004|From Week 24 Until Week 48|Protocol Violation|2|||
49138396|NCT01995201|158343952|FG005|From Week 24 Until Week 48|Protocol Violation|0|||
49138397|NCT01995201|158343953|FG006|From Week 24 Until Week 48|Protocol Violation|0|||
49138398|NCT01104766|158343955|FG000|Overall Study|Did not meet inc/exc criteria|1|||
49138399|NCT01104766|158343956|FG001|Overall Study|Did not meet inc/exc criteria|0|||
49138400|NCT01104766|158343957|FG002|Overall Study|Did not meet inc/exc criteria|0|||
49138401|NCT01104766|158343958|FG003|Overall Study|Did not meet inc/exc criteria|0|||
49138402|NCT01104766|158343955|FG000|Overall Study|Adverse Event|17|||
49138403|NCT01104766|158343956|FG001|Overall Study|Adverse Event|15|||
49138404|NCT01104766|158343957|FG002|Overall Study|Adverse Event|20|||
49138405|NCT01104766|158343958|FG003|Overall Study|Adverse Event|14|||
49138406|NCT01104766|158343955|FG000|Overall Study|Lack of Efficacy|20|||
49138407|NCT01104766|158343956|FG001|Overall Study|Lack of Efficacy|15|||
49138408|NCT01104766|158343957|FG002|Overall Study|Lack of Efficacy|14|||
49138409|NCT01104766|158343958|FG003|Overall Study|Lack of Efficacy|8|||
49138410|NCT01104766|158343955|FG000|Overall Study|Protocol Violation|2|||
49138411|NCT01104766|158343956|FG001|Overall Study|Protocol Violation|0|||
49138412|NCT01104766|158343957|FG002|Overall Study|Protocol Violation|0|||
49138413|NCT01104766|158343958|FG003|Overall Study|Protocol Violation|0|||
49138414|NCT01104766|158343955|FG000|Overall Study|Withdrawal by Subject|17|||
49138415|NCT01104766|158343956|FG001|Overall Study|Withdrawal by Subject|19|||
49138416|NCT01104766|158343957|FG002|Overall Study|Withdrawal by Subject|25|||
49138417|NCT01104766|158343958|FG003|Overall Study|Withdrawal by Subject|15|||
49138418|NCT01104766|158343955|FG000|Overall Study|Lost to Follow-up|1|||
49138419|NCT01104766|158343956|FG001|Overall Study|Lost to Follow-up|2|||
49138420|NCT01104766|158343957|FG002|Overall Study|Lost to Follow-up|1|||
48727294|NCT00873860|156851582|FG002|Overall Study|Death|0|||
48727295|NCT00873860|156851583|FG003|Overall Study|Death|0|||
48727296|NCT00873860|156851580|FG000|Overall Study|Other|1|||
48727297|NCT00873860|156851581|FG001|Overall Study|Other|0|||
48727298|NCT00873860|156851582|FG002|Overall Study|Other|1|||
48727299|NCT00873860|156851583|FG003|Overall Study|Other|0|||
48727300|NCT00321893|156851586|FG000|Overall Study|Non-Compliance/Refusal|16|||
48727301|NCT00321893|156851587|FG001|Overall Study|Non-Compliance/Refusal|10|||
48727302|NCT00321893|156851586|FG000|Overall Study|Lost to Follow-up|2|||
48727303|NCT00321893|156851587|FG001|Overall Study|Lost to Follow-up|1|||
48727304|NCT00321893|156851586|FG000|Overall Study|Adverse Event|6|||
48727305|NCT00321893|156851587|FG001|Overall Study|Adverse Event|3|||
48727306|NCT00769483|156851588|FG000|Overall Study|Withdrawal by Subject|0|||
48727307|NCT00769483|156851589|FG001|Overall Study|Withdrawal by Subject|1|||
48727308|NCT00769483|156851590|FG002|Overall Study|Withdrawal by Subject|0|||
48727309|NCT00769483|156851591|FG003|Overall Study|Withdrawal by Subject|0|||
48821324|NCT01154036|157188656|FG004|Phase I|Physician Decision|0|||
48821325|NCT01154036|157188657|FG005|Phase I|Physician Decision|0|||
49138421|NCT01104766|158343958|FG003|Overall Study|Lost to Follow-up|1|||
49138422|NCT01341470|158343959|FG000|Overall Study|Sponsor decision|0|||
49138423|NCT01341470|158343960|FG001|Overall Study|Sponsor decision|0|||
49138424|NCT01341470|158343961|FG002|Overall Study|Sponsor decision|1|||
49138425|NCT01341470|158343962|FG003|Overall Study|Sponsor decision|1|||
49138426|NCT01341470|158343963|FG004|Overall Study|Sponsor decision|0|||
49138427|NCT01341470|158343964|FG005|Overall Study|Sponsor decision|1|||
48727310|NCT00769483|156851592|FG004|Overall Study|Withdrawal by Subject|1|||
48727311|NCT00769483|156851593|FG005|Overall Study|Withdrawal by Subject|0|||
48727312|NCT03455764|156851594|FG000|Overall Study|Adverse Event|1|||
48727313|NCT03455764|156851595|FG001|Overall Study|Adverse Event|0|||
48727314|NCT03455764|156851596|FG002|Overall Study|Adverse Event|0|||
48727315|NCT03455764|156851597|FG003|Overall Study|Adverse Event|0|||
48727316|NCT03455764|156851598|FG004|Overall Study|Adverse Event|0|||
48727317|NCT03455764|156851594|FG000|Overall Study|Disease Progression|4|||
48727318|NCT03455764|156851595|FG001|Overall Study|Disease Progression|0|||
48727319|NCT03455764|156851596|FG002|Overall Study|Disease Progression|0|||
48727320|NCT03455764|156851597|FG003|Overall Study|Disease Progression|0|||
48727321|NCT03455764|156851598|FG004|Overall Study|Disease Progression|0|||
48727322|NCT03455764|156851594|FG000|Overall Study|On Treatment|1|||
48727323|NCT03455764|156851595|FG001|Overall Study|On Treatment|0|||
48727324|NCT03455764|156851596|FG002|Overall Study|On Treatment|0|||
48727325|NCT03455764|156851597|FG003|Overall Study|On Treatment|0|||
48727326|NCT03455764|156851598|FG004|Overall Study|On Treatment|0|||
48727327|NCT01172275|156851599|FG000|Overall Study|Lost to Follow-up|1|||
48727328|NCT01172275|156851600|FG001|Overall Study|Lost to Follow-up|0|||
48727329|NCT01172275|156851599|FG000|Overall Study|Protocol Violation|1|||
48727330|NCT01172275|156851600|FG001|Overall Study|Protocol Violation|0|||
48727331|NCT00194675|156851611|FG000|Overall Study|Lost to Follow-up|1|||
48727332|NCT00194675|156851612|FG001|Overall Study|Lost to Follow-up|1|||
49138428|NCT00997126|158343966|FG000|Overall Study|Physician Decision|7|||
49138429|NCT00997126|158343967|FG001|Overall Study|Physician Decision|11|||
48727333|NCT00194675|156851611|FG000|Overall Study|lack of interest|1|||
48727334|NCT00194675|156851612|FG001|Overall Study|lack of interest|1|||
48727335|NCT00194675|156851611|FG000|Overall Study|"withdrew due to edgy feeling"|1|||
48727336|NCT00194675|156851612|FG001|Overall Study|"withdrew due to edgy feeling"|0|||
48821326|NCT01154036|157188658|FG006|Phase I|Physician Decision|0|||
48821327|NCT01154036|157188659|FG007|Phase I|Physician Decision|0|||
49138430|NCT00303628|158343969|FG000|Overall Study|Disease progression|0|||
49138431|NCT00303628|158343970|FG001|Overall Study|Disease progression|1|||
49138432|NCT00303628|158343969|FG000|Overall Study|Adverse Event|26|||
49138433|NCT00303628|158343970|FG001|Overall Study|Adverse Event|36|||
49138434|NCT00303628|158343969|FG000|Overall Study|Death|0|||
49138435|NCT00303628|158343970|FG001|Overall Study|Death|1|||
49138436|NCT00303628|158343969|FG000|Overall Study|Withdrawal by Subject|11|||
49138437|NCT00303628|158343970|FG001|Overall Study|Withdrawal by Subject|20|||
48821328|NCT01154036|157188652|FG000|Phase I|Lost to Follow-up|0|||
48821329|NCT01154036|157188653|FG001|Phase I|Lost to Follow-up|3|||
48821330|NCT01154036|157188654|FG002|Phase I|Lost to Follow-up|6|||
48821331|NCT01154036|157188655|FG003|Phase I|Lost to Follow-up|0|||
48821332|NCT01154036|157188656|FG004|Phase I|Lost to Follow-up|0|||
48821333|NCT01154036|157188657|FG005|Phase I|Lost to Follow-up|0|||
48821334|NCT01154036|157188658|FG006|Phase I|Lost to Follow-up|0|||
48821335|NCT01154036|157188659|FG007|Phase I|Lost to Follow-up|0|||
49138438|NCT00303628|158343969|FG000|Overall Study|Alternative therapy|2|||
49138439|NCT00303628|158343970|FG001|Overall Study|Alternative therapy|0|||
49138440|NCT00303628|158343969|FG000|Overall Study|Other complicating disease|0|||
49138441|NCT00303628|158343970|FG001|Overall Study|Other complicating disease|1|||
49138442|NCT00303628|158343969|FG000|Overall Study|Not start protocol therapy|3|||
49138443|NCT00303628|158343970|FG001|Overall Study|Not start protocol therapy|5|||
49138444|NCT00303628|158343969|FG000|Overall Study|Other|8|||
48821336|NCT01154036|157188652|FG000|Phase I|Protocol Violation|0|||
49138445|NCT00303628|158343970|FG001|Overall Study|Other|9|||
49138446|NCT00005047|158343980|FG000|Overall Study|Withdrawal by Subject|12|||
49138447|NCT00005047|158343981|FG001|Overall Study|Withdrawal by Subject|0|||
49138448|NCT00005047|158343982|FG002|Overall Study|Withdrawal by Subject|0|||
49138449|NCT00005047|158343983|FG003|Overall Study|Withdrawal by Subject|0|||
49138450|NCT00005047|158343980|FG000|Overall Study|Adverse Event|5|||
49138451|NCT00005047|158343981|FG001|Overall Study|Adverse Event|0|||
48727337|NCT00194675|156851611|FG000|Overall Study|Protocol Violation|1|||
48821337|NCT01154036|157188653|FG001|Phase I|Protocol Violation|3|||
49138452|NCT00005047|158343982|FG002|Overall Study|Adverse Event|0|||
49138453|NCT00005047|158343983|FG003|Overall Study|Adverse Event|0|||
48727338|NCT00194675|156851612|FG001|Overall Study|Protocol Violation|0|||
48821338|NCT01154036|157188654|FG002|Phase I|Protocol Violation|9|||
48727339|NCT00194675|156851611|FG000|Overall Study|Death|1|||
48727340|NCT00194675|156851612|FG001|Overall Study|Death|0|||
48727341|NCT00473746|156851613|FG000|Period 1 (Phase 1)|Adverse Event|1|||
48727342|NCT00473746|156851614|FG001|Period 1 (Phase 1)|Adverse Event|0|||
48821339|NCT01154036|157188655|FG003|Phase I|Protocol Violation|0|||
48821340|NCT01154036|157188656|FG004|Phase I|Protocol Violation|0|||
48821341|NCT01154036|157188657|FG005|Phase I|Protocol Violation|0|||
49138454|NCT00005047|158343980|FG000|Overall Study|Lost to Follow-up|1|||
49138455|NCT00005047|158343981|FG001|Overall Study|Lost to Follow-up|0|||
49138456|NCT00005047|158343982|FG002|Overall Study|Lost to Follow-up|0|||
49138457|NCT00005047|158343983|FG003|Overall Study|Lost to Follow-up|0|||
49138458|NCT00005047|158343980|FG000|Overall Study|Lack of Efficacy|1|||
49138459|NCT00005047|158343981|FG001|Overall Study|Lack of Efficacy|0|||
48727343|NCT00473746|156851615|FG002|Period 1 (Phase 1)|Adverse Event|0|||
48727344|NCT00473746|156851616|FG003|Period 1 (Phase 1)|Adverse Event|0|||
48727345|NCT00473746|156851617|FG004|Period 1 (Phase 1)|Adverse Event|0|||
48727346|NCT00473746|156851613|FG000|Period 1 (Phase 1)|Withdrawal by Subject|0|||
48727347|NCT00473746|156851614|FG001|Period 1 (Phase 1)|Withdrawal by Subject|1|||
48727348|NCT00473746|156851615|FG002|Period 1 (Phase 1)|Withdrawal by Subject|0|||
48727349|NCT00473746|156851616|FG003|Period 1 (Phase 1)|Withdrawal by Subject|0|||
48727350|NCT00473746|156851617|FG004|Period 1 (Phase 1)|Withdrawal by Subject|0|||
48821342|NCT01154036|157188658|FG006|Phase I|Protocol Violation|0|||
48821343|NCT01154036|157188659|FG007|Phase I|Protocol Violation|0|||
48821344|NCT01154036|157188652|FG000|Phase I|Withdrawal by Subject|2|||
49138460|NCT00005047|158343982|FG002|Overall Study|Lack of Efficacy|0|||
49138461|NCT00005047|158343983|FG003|Overall Study|Lack of Efficacy|0|||
49138462|NCT00303953|158343984|FG000|Overall Study|Ineligible|1|||
49138463|NCT00303953|158343984|FG000|Overall Study|Death|1|||
49138464|NCT00303953|158343984|FG000|Overall Study|Adverse Event|4|||
49138465|NCT00303953|158343984|FG000|Overall Study|Lack of Efficacy|12|||
49138466|NCT00303953|158343984|FG000|Overall Study|Physician Decision|1|||
49138467|NCT00021255|158343985|FG000|Overall Study|Death|1|||
49138468|NCT00021255|158343986|FG001|Overall Study|Death|0|||
49138469|NCT00021255|158343987|FG002|Overall Study|Death|2|||
49138470|NCT00021255|158343985|FG000|Overall Study|Breast cancer relapse|5|||
49138471|NCT00021255|158343986|FG001|Overall Study|Breast cancer relapse|18|||
49138472|NCT00021255|158343987|FG002|Overall Study|Breast cancer relapse|11|||
49138473|NCT00021255|158343985|FG000|Overall Study|Second primary malignancy|0|||
49138474|NCT00021255|158343986|FG001|Overall Study|Second primary malignancy|4|||
49138475|NCT00021255|158343987|FG002|Overall Study|Second primary malignancy|1|||
49138476|NCT00021255|158343985|FG000|Overall Study|Withdrawal by Subject|41|||
49138477|NCT00021255|158343986|FG001|Overall Study|Withdrawal by Subject|64|||
49138478|NCT00021255|158343987|FG002|Overall Study|Withdrawal by Subject|26|||
49138479|NCT00021255|158343985|FG000|Overall Study|Lost to Follow-up|0|||
49138480|NCT00021255|158343986|FG001|Overall Study|Lost to Follow-up|2|||
49138481|NCT00021255|158343987|FG002|Overall Study|Lost to Follow-up|3|||
49138482|NCT00021255|158343985|FG000|Overall Study|Cardiac toxicity|0|||
48727351|NCT00473746|156851613|FG000|Period 1 (Phase 1)|Progressive Disease|5|||
48821345|NCT01154036|157188653|FG001|Phase I|Withdrawal by Subject|10|||
48821346|NCT01154036|157188654|FG002|Phase I|Withdrawal by Subject|29|||
48821347|NCT01154036|157188655|FG003|Phase I|Withdrawal by Subject|0|||
48821348|NCT01154036|157188656|FG004|Phase I|Withdrawal by Subject|0|||
48821349|NCT01154036|157188657|FG005|Phase I|Withdrawal by Subject|0|||
48821350|NCT01154036|157188658|FG006|Phase I|Withdrawal by Subject|0|||
48821351|NCT01154036|157188659|FG007|Phase I|Withdrawal by Subject|0|||
48821352|NCT01154036|157188652|FG000|Phase I|Adverse Event|1|||
48821353|NCT01154036|157188653|FG001|Phase I|Adverse Event|11|||
48821354|NCT01154036|157188654|FG002|Phase I|Adverse Event|12|||
48821355|NCT01154036|157188655|FG003|Phase I|Adverse Event|0|||
48821356|NCT01154036|157188656|FG004|Phase I|Adverse Event|0|||
48821357|NCT01154036|157188657|FG005|Phase I|Adverse Event|0|||
48821358|NCT01154036|157188658|FG006|Phase I|Adverse Event|0|||
48821359|NCT01154036|157188659|FG007|Phase I|Adverse Event|0|||
48821360|NCT01154036|157188652|FG000|Phase II|Adverse Event|0|||
48821361|NCT01154036|157188653|FG001|Phase II|Adverse Event|0|||
48821362|NCT01154036|157188654|FG002|Phase II|Adverse Event|0|||
48821363|NCT01154036|157188655|FG003|Phase II|Adverse Event|0|||
48821364|NCT01154036|157188656|FG004|Phase II|Adverse Event|1|||
48821365|NCT01154036|157188657|FG005|Phase II|Adverse Event|1|||
48821366|NCT01154036|157188658|FG006|Phase II|Adverse Event|1|||
48821367|NCT01154036|157188659|FG007|Phase II|Adverse Event|1|||
49138483|NCT00021255|158343986|FG001|Overall Study|Cardiac toxicity|61|||
49138484|NCT00021255|158343987|FG002|Overall Study|Cardiac toxicity|32|||
49138485|NCT00021255|158343985|FG000|Overall Study|Herceptin toxicity|0|||
49138486|NCT00021255|158343986|FG001|Overall Study|Herceptin toxicity|22|||
49138487|NCT00021255|158343987|FG002|Overall Study|Herceptin toxicity|6|||
48921173|NCT00159861|157544860|FG000|Core Study - 16 Weeks|Adverse Event|12|||
48921174|NCT00159861|157544861|FG001|Core Study - 16 Weeks|Adverse Event|6|||
48921175|NCT00159861|157544860|FG000|Core Study - 16 Weeks|Lack of Efficacy|2|||
48921176|NCT00159861|157544861|FG001|Core Study - 16 Weeks|Lack of Efficacy|3|||
48727352|NCT00473746|156851614|FG001|Period 1 (Phase 1)|Progressive Disease|6|||
48727353|NCT00473746|156851615|FG002|Period 1 (Phase 1)|Progressive Disease|6|||
48727354|NCT00473746|156851616|FG003|Period 1 (Phase 1)|Progressive Disease|10|||
48727355|NCT00473746|156851617|FG004|Period 1 (Phase 1)|Progressive Disease|0|||
48727356|NCT00473746|156851613|FG000|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
48727357|NCT00473746|156851614|FG001|Period 1 (Phase 1)|Symptomatic Deterioration|1|||
48727358|NCT00473746|156851615|FG002|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
48727359|NCT00473746|156851616|FG003|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
48727360|NCT00473746|156851617|FG004|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
48727361|NCT00473746|156851613|FG000|Period 1 (Phase 1)|Reason not specified|0|||
48727362|NCT00473746|156851614|FG001|Period 1 (Phase 1)|Reason not specified|1|||
48727363|NCT00473746|156851615|FG002|Period 1 (Phase 1)|Reason not specified|0|||
48727364|NCT00473746|156851616|FG003|Period 1 (Phase 1)|Reason not specified|0|||
48727365|NCT00473746|156851617|FG004|Period 1 (Phase 1)|Reason not specified|0|||
48727366|NCT00473746|156851613|FG000|Period 2 (Phase 2)|Adverse Event|0|||
48727367|NCT00473746|156851614|FG001|Period 2 (Phase 2)|Adverse Event|0|||
48727368|NCT00473746|156851615|FG002|Period 2 (Phase 2)|Adverse Event|0|||
48727369|NCT00473746|156851616|FG003|Period 2 (Phase 2)|Adverse Event|0|||
48727370|NCT00473746|156851617|FG004|Period 2 (Phase 2)|Adverse Event|3|||
48727371|NCT00473746|156851613|FG000|Period 2 (Phase 2)|Death|0|||
48727372|NCT00473746|156851614|FG001|Period 2 (Phase 2)|Death|0|||
48727373|NCT00473746|156851615|FG002|Period 2 (Phase 2)|Death|0|||
48727374|NCT00473746|156851616|FG003|Period 2 (Phase 2)|Death|0|||
48727375|NCT00473746|156851617|FG004|Period 2 (Phase 2)|Death|1|||
48727376|NCT00473746|156851613|FG000|Period 2 (Phase 2)|Progressive Disease|0|||
48727377|NCT00473746|156851614|FG001|Period 2 (Phase 2)|Progressive Disease|0|||
48727378|NCT00473746|156851615|FG002|Period 2 (Phase 2)|Progressive Disease|0|||
48727379|NCT00473746|156851616|FG003|Period 2 (Phase 2)|Progressive Disease|0|||
48727380|NCT00473746|156851617|FG004|Period 2 (Phase 2)|Progressive Disease|20|||
48727381|NCT00473746|156851613|FG000|Period 2 (Phase 2)|Reason not specified|0|||
48727382|NCT00473746|156851614|FG001|Period 2 (Phase 2)|Reason not specified|0|||
48727383|NCT00473746|156851615|FG002|Period 2 (Phase 2)|Reason not specified|0|||
48727384|NCT00473746|156851616|FG003|Period 2 (Phase 2)|Reason not specified|0|||
48727385|NCT00473746|156851617|FG004|Period 2 (Phase 2)|Reason not specified|3|||
48727386|NCT01445886|156851618|FG000|Overall Study|Lost to Follow-up|2|||
48727387|NCT01445886|156851618|FG000|Overall Study|Protocol Violation|3|||
48727388|NCT03224546|156851619|FG000|Overall Study|Lost to Follow-up|9|||
48727389|NCT03224546|156851620|FG001|Overall Study|Lost to Follow-up|8|||
48727390|NCT03224546|156851621|FG002|Overall Study|Lost to Follow-up|3|||
48727391|NCT03224546|156851619|FG000|Overall Study|Withdrawal by Subject|7|||
48727392|NCT03224546|156851620|FG001|Overall Study|Withdrawal by Subject|14|||
48727393|NCT03224546|156851621|FG002|Overall Study|Withdrawal by Subject|12|||
48727394|NCT00976573|156851624|FG000|Overall Study|Ineligible|0|||
48727395|NCT00976573|156851625|FG001|Overall Study|Ineligible|1|||
48727396|NCT00976573|156851624|FG000|Overall Study|Cancel prior to receiving treatment|4|||
48727397|NCT00976573|156851625|FG001|Overall Study|Cancel prior to receiving treatment|2|||
48727398|NCT00937391|156851626|FG000|Stage 2|Withdrawal by Subject|1|||
48727399|NCT00880165|156851635|FG000|Overall Study|Withdrawal by Subject|27|||
48727400|NCT00880165|156851636|FG001|Overall Study|Withdrawal by Subject|23|||
48727401|NCT00880165|156851635|FG000|Overall Study|Not diagnosed with OSA|14|||
48727402|NCT00880165|156851636|FG001|Overall Study|Not diagnosed with OSA|8|||
48727403|NCT00880165|156851635|FG000|Overall Study|Required BIPAP or oxygen treatment|12|||
48727404|NCT00880165|156851636|FG001|Overall Study|Required BIPAP or oxygen treatment|4|||
48727405|NCT00880165|156851635|FG000|Overall Study|Lost to follow|9|||
48727406|NCT00880165|156851636|FG001|Overall Study|Lost to follow|15|||
48727407|NCT02359851|156851639|FG000|Overall Study|Death|1|||
48727408|NCT02359851|156851639|FG000|Overall Study|Disease progression|1|||
48727409|NCT01854944|156851640|FG000|Overall Study|Withdrawal by Subject|0|||
48727410|NCT01854944|156851641|FG001|Overall Study|Withdrawal by Subject|0|||
48727411|NCT01854944|156851642|FG002|Overall Study|Withdrawal by Subject|1|||
48727412|NCT00323869|156851643|FG000|Overall Study|Death|1|||
48727413|NCT06106022|156851649|FG000|Overall Study|Lost to Follow-up|1|||
48727414|NCT06106022|156851650|FG001|Overall Study|Lost to Follow-up|0|||
48727415|NCT06106022|156851649|FG000|Overall Study|Voluntary Withdrawal|0|||
48727416|NCT06106022|156851650|FG001|Overall Study|Voluntary Withdrawal|2|||
48727417|NCT04085367|156853289|FG000|Overall Study|Adverse Event|1|||
48727418|NCT04085367|156853290|FG001|Overall Study|Adverse Event|1|||
48727419|NCT04085367|156853289|FG000|Overall Study|Withdrawal by Subject|13|||
48727420|NCT04085367|156853290|FG001|Overall Study|Withdrawal by Subject|4|||
48921177|NCT00159861|157544860|FG000|Core Study - 16 Weeks|Reason Unspecified|5|||
48727421|NCT04085367|156853289|FG000|Overall Study|Lost to Follow-up|3|||
48727422|NCT04085367|156853290|FG001|Overall Study|Lost to Follow-up|1|||
48727423|NCT04085367|156853289|FG000|Overall Study|Other unspecified|2|||
48821368|NCT01154036|157188652|FG000|Phase II|Physician Decision|0|||
48821369|NCT01154036|157188653|FG001|Phase II|Physician Decision|0|||
48821370|NCT01154036|157188654|FG002|Phase II|Physician Decision|0|||
48821371|NCT01154036|157188655|FG003|Phase II|Physician Decision|0|||
48821372|NCT01154036|157188656|FG004|Phase II|Physician Decision|0|||
48821373|NCT01154036|157188657|FG005|Phase II|Physician Decision|0|||
48727424|NCT04085367|156853290|FG001|Overall Study|Other unspecified|1|||
48727425|NCT04085367|156853289|FG000|Overall Study|Status Unknown|1|||
48727426|NCT04085367|156853290|FG001|Overall Study|Status Unknown|1|||
48727427|NCT00510874|156853291|FG000|Overall Study|Withdrawal by Subject|1|||
48727428|NCT00510874|156853292|FG001|Overall Study|Withdrawal by Subject|1|||
48727429|NCT00510874|156853293|FG002|Overall Study|Withdrawal by Subject|0|||
48727430|NCT00510874|156853294|FG003|Overall Study|Withdrawal by Subject|0|||
48727431|NCT00510874|156853295|FG004|Overall Study|Withdrawal by Subject|3|||
48727432|NCT00510874|156853296|FG005|Overall Study|Withdrawal by Subject|0|||
48727433|NCT00510874|156853297|FG006|Overall Study|Withdrawal by Subject|0|||
48727434|NCT00510874|156853291|FG000|Overall Study|Lost to Follow-up|2|||
48727435|NCT00510874|156853292|FG001|Overall Study|Lost to Follow-up|3|||
48727436|NCT00510874|156853293|FG002|Overall Study|Lost to Follow-up|1|||
48727437|NCT00510874|156853294|FG003|Overall Study|Lost to Follow-up|3|||
48727438|NCT00510874|156853295|FG004|Overall Study|Lost to Follow-up|4|||
48727439|NCT00510874|156853296|FG005|Overall Study|Lost to Follow-up|0|||
48727440|NCT00510874|156853297|FG006|Overall Study|Lost to Follow-up|1|||
48727441|NCT03023046|156853300|FG000|Overall Study|Withdrawal by Subject|1|||
48727442|NCT05691309|156853303|FG000|Overall Study|vancomycin discontinued by clinical team|2|||
48727443|NCT05691309|156853303|FG000|Overall Study|vancomycin levels not evaluable|2|||
48821374|NCT01154036|157188658|FG006|Phase II|Physician Decision|1|||
48821375|NCT01154036|157188659|FG007|Phase II|Physician Decision|0|||
48727444|NCT00708201|156853304|FG000|Overall Study|Adverse Event|4|||
48727445|NCT00708201|156853305|FG001|Overall Study|Adverse Event|4|||
48727446|NCT00708201|156853304|FG000|Overall Study|Withdrawal by Subject|1|||
48727447|NCT00708201|156853305|FG001|Overall Study|Withdrawal by Subject|1|||
48727448|NCT00708201|156853304|FG000|Overall Study|Lost to Follow-up|2|||
48727449|NCT00708201|156853305|FG001|Overall Study|Lost to Follow-up|0|||
48727450|NCT00708201|156853304|FG000|Overall Study|Protocol Violation|0|||
48727451|NCT00708201|156853305|FG001|Overall Study|Protocol Violation|1|||
48727452|NCT01860846|156853311|FG000|Overall Study|Lost to Follow-up|33|||
48727453|NCT00998764|156853315|FG000|Overall Study|Lack of Efficacy|3|||
48727454|NCT00998764|156853316|FG001|Overall Study|Lack of Efficacy|6|||
48727455|NCT00998764|156853315|FG000|Overall Study|Adverse Event|17|||
48821376|NCT01154036|157188652|FG000|Phase II|Lost to Follow-up|0|||
48821377|NCT01154036|157188653|FG001|Phase II|Lost to Follow-up|0|||
48821378|NCT01154036|157188654|FG002|Phase II|Lost to Follow-up|0|||
49138488|NCT00021255|158343985|FG000|Overall Study|Adverse Event|46|||
49138489|NCT00021255|158343986|FG001|Overall Study|Adverse Event|30|||
49138490|NCT00021255|158343987|FG002|Overall Study|Adverse Event|18|||
49138491|NCT00021255|158343985|FG000|Overall Study|Protocol Violation|0|||
49138492|NCT00021255|158343986|FG001|Overall Study|Protocol Violation|2|||
49138493|NCT00021255|158343987|FG002|Overall Study|Protocol Violation|0|||
49138494|NCT00021255|158343985|FG000|Overall Study|Other than specified above|0|||
48821379|NCT01154036|157188655|FG003|Phase II|Lost to Follow-up|1|||
48821380|NCT01154036|157188656|FG004|Phase II|Lost to Follow-up|2|||
49138495|NCT00021255|158343986|FG001|Overall Study|Other than specified above|38|||
49138496|NCT00021255|158343987|FG002|Overall Study|Other than specified above|19|||
49138497|NCT00021255|158343985|FG000|Overall Study|Missing|0|||
49138498|NCT00021255|158343986|FG001|Overall Study|Missing|27|||
48821381|NCT01154036|157188657|FG005|Phase II|Lost to Follow-up|0|||
48821382|NCT01154036|157188658|FG006|Phase II|Lost to Follow-up|2|||
48821383|NCT01154036|157188659|FG007|Phase II|Lost to Follow-up|1|||
48821384|NCT01154036|157188652|FG000|Phase II|Protocol Violation|0|||
48821385|NCT01154036|157188653|FG001|Phase II|Protocol Violation|0|||
49011519|NCT02087059|157878989|FG000|Overall Study|Adverse Event|5|||
49138499|NCT00021255|158343987|FG002|Overall Study|Missing|13|||
48727456|NCT00998764|156853316|FG001|Overall Study|Adverse Event|12|||
48727457|NCT00998764|156853315|FG000|Overall Study|Withdrawal by Subject|19|||
48727458|NCT00998764|156853316|FG001|Overall Study|Withdrawal by Subject|25|||
48727459|NCT00998764|156853315|FG000|Overall Study|Physician Decision|3|||
48727460|NCT00998764|156853316|FG001|Overall Study|Physician Decision|3|||
48727461|NCT00998764|156853315|FG000|Overall Study|Death|3|||
48727462|NCT00998764|156853316|FG001|Overall Study|Death|1|||
48727463|NCT00998764|156853315|FG000|Overall Study|Discontinuation of Study by Sponsor|164|||
48821386|NCT01154036|157188654|FG002|Phase II|Protocol Violation|0|||
48821387|NCT01154036|157188655|FG003|Phase II|Protocol Violation|0|||
48821388|NCT01154036|157188656|FG004|Phase II|Protocol Violation|1|||
48821389|NCT01154036|157188657|FG005|Phase II|Protocol Violation|2|||
48727464|NCT00998764|156853316|FG001|Overall Study|Discontinuation of Study by Sponsor|217|||
48821390|NCT01154036|157188658|FG006|Phase II|Protocol Violation|0|||
49138500|NCT00021255|158343985|FG000|Overall Study|Randomized but not treated|28|||
49138501|NCT00021255|158343986|FG001|Overall Study|Randomized but not treated|2|||
48727465|NCT00998764|156853315|FG000|Overall Study|Protocol Violation|0|||
48727466|NCT00998764|156853316|FG001|Overall Study|Protocol Violation|1|||
48727467|NCT00998764|156853315|FG000|Overall Study|Failed to Return|1|||
48727468|NCT00998764|156853316|FG001|Overall Study|Failed to Return|1|||
48727469|NCT00998764|156853315|FG000|Overall Study|Lost to Follow-up|1|||
48727470|NCT00998764|156853316|FG001|Overall Study|Lost to Follow-up|1|||
48727471|NCT00998764|156853315|FG000|Overall Study|Loss of Caregiver|0|||
48727472|NCT00998764|156853316|FG001|Overall Study|Loss of Caregiver|3|||
48727473|NCT00998764|156853315|FG000|Overall Study|Other|4|||
48727474|NCT00998764|156853316|FG001|Overall Study|Other|4|||
48727475|NCT00998764|156853315|FG000|Overall Study|Recurrent Episode of vasogenic edema|1|||
48727476|NCT00998764|156853316|FG001|Overall Study|Recurrent Episode of vasogenic edema|0|||
48727477|NCT01315236|156853317|FG000|Double-blind Phase|Death|1|||
48727478|NCT01315236|156853318|FG001|Double-blind Phase|Death|0|||
48727479|NCT01315236|156853317|FG000|Double-blind Phase|Adverse Event|1|||
48727480|NCT01315236|156853318|FG001|Double-blind Phase|Adverse Event|0|||
48727481|NCT01315236|156853317|FG000|Double-blind Phase|Withdrawal of Consent|1|||
49138502|NCT00021255|158343987|FG002|Overall Study|Randomized but not treated|18|||
49138503|NCT03370302|158343991|FG000|Dose Escalation Phase|Other|0|||
49138504|NCT03370302|158343992|FG001|Dose Escalation Phase|Other|1|||
49138505|NCT03370302|158343993|FG002|Dose Escalation Phase|Other|1|||
49138506|NCT03370302|158343994|FG003|Dose Escalation Phase|Other|0|||
49138507|NCT03370302|158343995|FG004|Dose Escalation Phase|Other|0|||
49138508|NCT03370302|158343996|FG005|Dose Escalation Phase|Other|0|||
49138509|NCT03370302|158343991|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
49138510|NCT03370302|158343992|FG001|Dose Escalation Phase|Withdrawal by Subject|1|||
49138511|NCT03370302|158343993|FG002|Dose Escalation Phase|Withdrawal by Subject|2|||
48727482|NCT01315236|156853318|FG001|Double-blind Phase|Withdrawal of Consent|0|||
48727483|NCT01315236|156853317|FG000|Double-blind Phase|Lost to Follow-up|1|||
48727484|NCT01315236|156853318|FG001|Double-blind Phase|Lost to Follow-up|0|||
48727485|NCT01315236|156853317|FG000|Open-label Phase|Death|1|||
48727486|NCT01315236|156853318|FG001|Open-label Phase|Death|0|||
48727487|NCT01315236|156853317|FG000|Open-label Phase|Adverse Event|0|||
48727488|NCT01315236|156853318|FG001|Open-label Phase|Adverse Event|1|||
48727489|NCT01315236|156853317|FG000|Open-label Phase|Other|0|||
48727490|NCT01315236|156853318|FG001|Open-label Phase|Other|1|||
48727491|NCT01315236|156853317|FG000|12-Month Follow-up Period|Death|0|||
48727492|NCT01315236|156853318|FG001|12-Month Follow-up Period|Death|1|||
48727493|NCT01315236|156853317|FG000|12-Month Follow-up Period|Did not return to the site for Month 12|1|||
48727494|NCT01315236|156853318|FG001|12-Month Follow-up Period|Did not return to the site for Month 12|0|||
48727495|NCT00521001|156853327|FG000|Overall Study|Ineligible|1|||
48727496|NCT00470184|156853330|FG000|Overall Study|Not Treated(became ineligible)|4|||
48727497|NCT00470184|156853330|FG000|Overall Study|Not treated (other)|1|||
48727498|NCT00470184|156853330|FG000|Overall Study|disease Progression|4|||
48727499|NCT00470184|156853330|FG000|Overall Study|Adverse Event|3|||
48727500|NCT00470184|156853330|FG000|Overall Study|Withdrawal by Subject|4|||
48727501|NCT00470184|156853330|FG000|Overall Study|other|5|||
48727502|NCT00470184|156853330|FG000|Overall Study|recurrence|1|||
48727503|NCT01082640|156853331|FG000|Overall Study|Adverse Event|9|||
48727504|NCT01082640|156853332|FG001|Overall Study|Adverse Event|5|||
49138512|NCT03370302|158343994|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
49138513|NCT03370302|158343995|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
49138514|NCT03370302|158343996|FG005|Dose Escalation Phase|Withdrawal by Subject|2|||
49138515|NCT03370302|158343991|FG000|Dose Escalation Phase|Adverse Event|1|||
49138516|NCT03370302|158343992|FG001|Dose Escalation Phase|Adverse Event|0|||
49138517|NCT03370302|158343993|FG002|Dose Escalation Phase|Adverse Event|2|||
49138518|NCT03370302|158343994|FG003|Dose Escalation Phase|Adverse Event|0|||
49138519|NCT03370302|158343995|FG004|Dose Escalation Phase|Adverse Event|0|||
49138520|NCT03370302|158343996|FG005|Dose Escalation Phase|Adverse Event|0|||
49138521|NCT03370302|158343991|FG000|Dose Escalation Phase|Progressive Disease|2|||
49138522|NCT03370302|158343992|FG001|Dose Escalation Phase|Progressive Disease|4|||
49138523|NCT03370302|158343993|FG002|Dose Escalation Phase|Progressive Disease|2|||
49138524|NCT03370302|158343994|FG003|Dose Escalation Phase|Progressive Disease|0|||
49138525|NCT03370302|158343995|FG004|Dose Escalation Phase|Progressive Disease|3|||
49138526|NCT03370302|158343996|FG005|Dose Escalation Phase|Progressive Disease|1|||
49138527|NCT03370302|158343991|FG000|Dose Expansion Phase|Progressive Disease|0|||
49138528|NCT03370302|158343992|FG001|Dose Expansion Phase|Progressive Disease|0|||
49138529|NCT03370302|158343993|FG002|Dose Expansion Phase|Progressive Disease|0|||
48727505|NCT01082640|156853333|FG002|Overall Study|Adverse Event|3|||
48727506|NCT01082640|156853331|FG000|Overall Study|Withdrawal by Subject|3|||
48727507|NCT01082640|156853332|FG001|Overall Study|Withdrawal by Subject|3|||
48727508|NCT01082640|156853333|FG002|Overall Study|Withdrawal by Subject|2|||
49138530|NCT03370302|158343994|FG003|Dose Expansion Phase|Progressive Disease|6|||
49138531|NCT03370302|158343995|FG004|Dose Expansion Phase|Progressive Disease|0|||
49138532|NCT03370302|158343996|FG005|Dose Expansion Phase|Progressive Disease|0|||
49138533|NCT00118287|158343997|FG000|Overall Study|Intracranial haemorrhage|1|||
49138534|NCT00118287|158343997|FG000|Overall Study|Muscle pain|1|||
48821391|NCT01154036|157188659|FG007|Phase II|Protocol Violation|0|||
48821392|NCT01154036|157188652|FG000|Phase II|Withdrawal by Subject|0|||
48821393|NCT01154036|157188653|FG001|Phase II|Withdrawal by Subject|0|||
48821394|NCT01154036|157188654|FG002|Phase II|Withdrawal by Subject|0|||
48821395|NCT01154036|157188655|FG003|Phase II|Withdrawal by Subject|0|||
48821396|NCT01154036|157188656|FG004|Phase II|Withdrawal by Subject|4|||
48821397|NCT01154036|157188657|FG005|Phase II|Withdrawal by Subject|2|||
48821398|NCT01154036|157188658|FG006|Phase II|Withdrawal by Subject|5|||
48821399|NCT01154036|157188659|FG007|Phase II|Withdrawal by Subject|4|||
48727509|NCT01082640|156853331|FG000|Overall Study|Major protocol deviation|3|||
48727510|NCT01082640|156853332|FG001|Overall Study|Major protocol deviation|3|||
48727511|NCT01082640|156853333|FG002|Overall Study|Major protocol deviation|0|||
48821400|NCT03330119|157188664|FG000|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166|||
48821401|NCT03330119|157188665|FG001|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282|||
48821402|NCT03929302|157188666|FG000|Intervention - myTAP Mouth Shield|Withdrawal by Subject|5|||
48821403|NCT03929302|157188667|FG001|Intervention - myTAP Mouth Shield|Withdrawal by Subject|8|||
48821404|NCT03929302|157188668|FG002|Intervention - myTAP Mouth Shield|Withdrawal by Subject|4|||
48821405|NCT03929302|157188666|FG000|Intervention - myTAP Mouth Shield|Time constraints|3|||
48821406|NCT03929302|157188667|FG001|Intervention - myTAP Mouth Shield|Time constraints|0|||
48821407|NCT03929302|157188668|FG002|Intervention - myTAP Mouth Shield|Time constraints|0|||
48821408|NCT03929302|157188666|FG000|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
48821409|NCT03929302|157188667|FG001|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
48821410|NCT03929302|157188668|FG002|Intervention - myTAP Mouth Shield|Device didnot fit|1|||
48821411|NCT02800928|157188670|FG000|Overall Study|Withdrawal by Subject|1|||
48821412|NCT02800928|157188671|FG001|Overall Study|Withdrawal by Subject|1|||
48821413|NCT02800928|157188670|FG000|Overall Study|Protocol Violation|1|||
48821414|NCT02800928|157188671|FG001|Overall Study|Protocol Violation|1|||
48821415|NCT00278564|157188672|FG000|Overall Study|Lack of Efficacy|4|||
48821416|NCT01458249|157188675|FG000|Overall Study|Not treated|1|||
48821417|NCT01458249|157188675|FG000|Overall Study|Adverse Event|4|||
48821418|NCT01458249|157188675|FG000|Overall Study|Other|2|||
48821419|NCT01458249|157188675|FG000|Overall Study|Ongoing|1|||
48821420|NCT03606460|157188676|FG000|Overall Study|Lost to Follow-up|1|||
48821421|NCT03606460|157188677|FG001|Overall Study|Lost to Follow-up|8|||
48821422|NCT04990440|157188678|FG000|Overall Study|Sponsor's Decision|0|||
48821423|NCT04990440|157188679|FG001|Overall Study|Sponsor's Decision|0|||
48821424|NCT04990440|157188680|FG002|Overall Study|Sponsor's Decision|1|||
48821425|NCT02408549|157188684|FG000|Overall Study|Adverse Event|15|||
48821426|NCT02408549|157188684|FG000|Overall Study|Death|4|||
48821427|NCT02408549|157188684|FG000|Overall Study|Lack of Efficacy|17|||
48821428|NCT02408549|157188684|FG000|Overall Study|Protocol Violation|4|||
48821429|NCT02408549|157188684|FG000|Overall Study|Lost to Follow-up|6|||
48821430|NCT02408549|157188684|FG000|Overall Study|Consent withdrawn|30|||
48821431|NCT02408549|157188684|FG000|Overall Study|Neurology research program closing at site|1|||
48821432|NCT02408549|157188684|FG000|Overall Study|Site closure|1|||
48821433|NCT02408549|157188684|FG000|Overall Study|Pregnancy|1|||
48727512|NCT01082640|156853331|FG000|Overall Study|Lost to Follow-up|0|||
48727513|NCT01082640|156853332|FG001|Overall Study|Lost to Follow-up|3|||
48727514|NCT01082640|156853333|FG002|Overall Study|Lost to Follow-up|0|||
48727515|NCT01082640|156853331|FG000|Overall Study|Other|2|||
48727516|NCT01082640|156853332|FG001|Overall Study|Other|1|||
48727517|NCT01082640|156853333|FG002|Overall Study|Other|3|||
48727518|NCT02011893|156853339|FG000|Enrollment to Randomization|Adverse Event|2|||
48727519|NCT02011893|156853340|FG001|Enrollment to Randomization|Adverse Event|0|||
48727520|NCT02011893|156853341|FG002|Enrollment to Randomization|Adverse Event|0|||
48727521|NCT02011893|156853339|FG000|Enrollment to Randomization|Physician Decision|10|||
48727522|NCT02011893|156853340|FG001|Enrollment to Randomization|Physician Decision|0|||
48727523|NCT02011893|156853341|FG002|Enrollment to Randomization|Physician Decision|0|||
48821434|NCT02408549|157188684|FG000|Overall Study|Withdrawal of consent due to business trip|1|||
48821435|NCT02408549|157188684|FG000|Overall Study|Subject moved to another place, far from site|1|||
48821436|NCT02408549|157188684|FG000|Overall Study|Study terminated at site|1|||
48921178|NCT00159861|157544861|FG001|Core Study - 16 Weeks|Reason Unspecified|3|||
48921179|NCT00159861|157544860|FG000|Core Study - 16 Weeks|Subject Defaulted|1|||
48727524|NCT02011893|156853339|FG000|Enrollment to Randomization|Withdrawal by Subject|21|||
48821437|NCT01657032|157188685|FG000|Overall Study|Lost to Follow-up|0|||
48821438|NCT01657032|157188686|FG001|Overall Study|Lost to Follow-up|7|||
48821439|NCT02696785|157188687|FG000|Blinded Treatment Period|Adverse Event|0|||
48821440|NCT02696785|157188688|FG001|Blinded Treatment Period|Adverse Event|1|||
48821441|NCT02696785|157188689|FG002|Blinded Treatment Period|Adverse Event|3|||
48821442|NCT02696785|157188690|FG003|Blinded Treatment Period|Adverse Event|0|||
48821443|NCT02696785|157188687|FG000|Blinded Treatment Period|Withdrawal by Subject|0|||
48921180|NCT00159861|157544861|FG001|Core Study - 16 Weeks|Subject Defaulted|0|||
48727525|NCT02011893|156853340|FG001|Enrollment to Randomization|Withdrawal by Subject|0|||
48727526|NCT02011893|156853341|FG002|Enrollment to Randomization|Withdrawal by Subject|0|||
48727527|NCT02011893|156853339|FG000|Enrollment to Randomization|Screening Failure|29|||
49138535|NCT02530242|158343999|FG000|Overall Study|excluded due to asthma and oxcarbazepine|0|||
49138536|NCT02530242|158344000|FG001|Overall Study|excluded due to asthma and oxcarbazepine|1|||
49138537|NCT01727154|158344002|FG000|Overall Study|Death|17|||
49138538|NCT01727154|158344002|FG000|Overall Study|Withdrawal by Subject|14|||
49138539|NCT01727154|158344002|FG000|Overall Study|Subject Withdrew Consent|18|||
49138540|NCT01727154|158344002|FG000|Overall Study|Study Terminated|6|||
49138541|NCT01727154|158344002|FG000|Overall Study|No Discontinuation Documentation|4|||
49138542|NCT01407367|158344004|FG000|Overall Study|Death|24|||
49138543|NCT01407367|158344005|FG001|Overall Study|Death|32|||
49138544|NCT01407367|158344004|FG000|Overall Study|Renal Replacement Therapy (RRT)|12|||
49138545|NCT01407367|158344005|FG001|Overall Study|Renal Replacement Therapy (RRT)|29|||
49138546|NCT01407367|158344004|FG000|Overall Study|Withdrawal by Subject|4|||
49138547|NCT01407367|158344005|FG001|Overall Study|Withdrawal by Subject|15|||
49138548|NCT01407367|158344004|FG000|Overall Study|Lost to Follow-up|0|||
49138549|NCT01407367|158344005|FG001|Overall Study|Lost to Follow-up|2|||
49138550|NCT04333498|158345812|FG000|Overall Study|Lost to Follow-up|1|||
49138551|NCT04333498|158345813|FG001|Overall Study|Lost to Follow-up|0|||
48921181|NCT00159861|157544860|FG000|Core Study - 16 Weeks|Randomized but not Treated|2|||
48727528|NCT02011893|156853340|FG001|Enrollment to Randomization|Screening Failure|0|||
48727529|NCT02011893|156853341|FG002|Enrollment to Randomization|Screening Failure|0|||
48727530|NCT02011893|156853339|FG000|Enrollment to Randomization|Temporary Trial Stimulation Failure|9|||
48727531|NCT02011893|156853340|FG001|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
48727532|NCT02011893|156853341|FG002|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
48727533|NCT02011893|156853339|FG000|Enrollment to Randomization|Insurance/Financial Reasons|2|||
48727534|NCT02011893|156853340|FG001|Enrollment to Randomization|Insurance/Financial Reasons|0|||
48727535|NCT02011893|156853341|FG002|Enrollment to Randomization|Insurance/Financial Reasons|0|||
48727536|NCT02011893|156853339|FG000|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
48727537|NCT02011893|156853340|FG001|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
48727538|NCT02011893|156853341|FG002|Period 1 (Randomization to 12 Weeks)|Physician Decision|1|||
48727539|NCT02011893|156853339|FG000|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
48727540|NCT02011893|156853340|FG001|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
48727541|NCT02011893|156853341|FG002|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2|||
48727542|NCT02011893|156853339|FG000|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
48727543|NCT02011893|156853340|FG001|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
48727544|NCT02011893|156853341|FG002|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1|||
48727545|NCT03739840|156853342|FG000|Treatment Period: Wk0-16|Adverse Event|2|||
48727546|NCT03739840|156853343|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
48727547|NCT03739840|156853344|FG002|Treatment Period: Wk0-16|Adverse Event|6|||
48727548|NCT03739840|156853345|FG003|Treatment Period: Wk0-16|Adverse Event|12|||
48727549|NCT03739840|156853342|FG000|Treatment Period: Wk0-16|Lack of Efficacy|0|||
48727550|NCT03739840|156853343|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
48727551|NCT03739840|156853344|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
49138552|NCT04333498|158345812|FG000|Overall Study|Lost to Follow-up|0|||
49138553|NCT04333498|158345813|FG001|Overall Study|Lost to Follow-up|1|||
49138554|NCT00143507|158345819|FG000|Overall Study|Death|572|||
49138555|NCT00143507|158345820|FG001|Overall Study|Death|547|||
49138556|NCT00143507|158345819|FG000|Overall Study|Withdrawal by Subject|114|||
49138557|NCT00143507|158345820|FG001|Overall Study|Withdrawal by Subject|102|||
49138558|NCT00143507|158345819|FG000|Overall Study|Lost to Follow-up|1|||
49138559|NCT00143507|158345820|FG001|Overall Study|Lost to Follow-up|0|||
49138560|NCT00143507|158345819|FG000|Overall Study|Withdrawn by sponsor's decision|0|||
49138561|NCT00143507|158345820|FG001|Overall Study|Withdrawn by sponsor's decision|3|||
49138562|NCT00484159|158345821|FG000|Overall Study|Lost to Follow-up|1|||
49138563|NCT00484159|158345822|FG001|Overall Study|Lost to Follow-up|1|||
48727552|NCT03739840|156853345|FG003|Treatment Period: Wk0-16|Lack of Efficacy|3|||
48727553|NCT03739840|156853342|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
48727554|NCT03739840|156853343|FG001|Treatment Period: Wk0-16|Protocol Violation|0|||
48727555|NCT03739840|156853344|FG002|Treatment Period: Wk0-16|Protocol Violation|1|||
48727556|NCT03739840|156853345|FG003|Treatment Period: Wk0-16|Protocol Violation|0|||
48727557|NCT03739840|156853342|FG000|Treatment Period: Wk0-16|Consent Withdrawn|1|||
48727558|NCT03739840|156853343|FG001|Treatment Period: Wk0-16|Consent Withdrawn|3|||
48727559|NCT03739840|156853344|FG002|Treatment Period: Wk0-16|Consent Withdrawn|1|||
48727560|NCT03739840|156853345|FG003|Treatment Period: Wk0-16|Consent Withdrawn|1|||
49138564|NCT00484159|158345823|FG002|Overall Study|Lost to Follow-up|0|||
49138565|NCT00177671|158345824|FG000|Overall Study|Withdrawal by Subject|5|||
48727561|NCT03739840|156853342|FG000|Treatment Period: Wk0-16|Program Termination|3|||
48727562|NCT03739840|156853343|FG001|Treatment Period: Wk0-16|Program Termination|0|||
49138566|NCT00177671|158345825|FG001|Overall Study|Withdrawal by Subject|6|||
49138567|NCT00177671|158345824|FG000|Overall Study|medical complications|2|||
49138568|NCT00177671|158345825|FG001|Overall Study|medical complications|0|||
49138569|NCT00177671|158345824|FG000|Overall Study|Adverse Event|6|||
49138570|NCT00177671|158345825|FG001|Overall Study|Adverse Event|0|||
49138571|NCT00177671|158345824|FG000|Overall Study|Physician Decision|12|||
49138572|NCT00177671|158345825|FG001|Overall Study|Physician Decision|8|||
49138573|NCT00327171|158345831|FG000|Overall Study|Did not receive study medication|3|||
49138574|NCT00327171|158345832|FG001|Overall Study|Did not receive study medication|0|||
49138575|NCT00327171|158345831|FG000|Overall Study|Adverse Event|23|||
49138576|NCT00327171|158345832|FG001|Overall Study|Adverse Event|23|||
49138577|NCT00327171|158345831|FG000|Overall Study|Disease progression/lack of efficacy|68|||
49138578|NCT00327171|158345832|FG001|Overall Study|Disease progression/lack of efficacy|69|||
48821444|NCT02696785|157188688|FG001|Blinded Treatment Period|Withdrawal by Subject|1|||
48821445|NCT02696785|157188689|FG002|Blinded Treatment Period|Withdrawal by Subject|1|||
48821446|NCT02696785|157188690|FG003|Blinded Treatment Period|Withdrawal by Subject|2|||
48821447|NCT02696785|157188687|FG000|Blinded Treatment Period|Lack of Efficacy|0|||
49138579|NCT00327171|158345831|FG000|Overall Study|Investigator/participant request|1|||
49138580|NCT00327171|158345832|FG001|Overall Study|Investigator/participant request|8|||
49138581|NCT00327171|158345831|FG000|Overall Study|Clinical progression|12|||
49138582|NCT00327171|158345832|FG001|Overall Study|Clinical progression|8|||
49138583|NCT00327171|158345831|FG000|Overall Study|Undisclosed history of ischemia|0|||
49138584|NCT00327171|158345832|FG001|Overall Study|Undisclosed history of ischemia|1|||
49138585|NCT00327171|158345831|FG000|Overall Study|Other|1|||
49138586|NCT00327171|158345832|FG001|Overall Study|Other|0|||
49138587|NCT01363440|158345833|FG000|Overall Study|Adverse Event|5|||
49138588|NCT01363440|158345834|FG001|Overall Study|Adverse Event|4|||
49138589|NCT01363440|158345835|FG002|Overall Study|Adverse Event|4|||
49138590|NCT01363440|158345833|FG000|Overall Study|Death|3|||
49138591|NCT01363440|158345834|FG001|Overall Study|Death|7|||
49138592|NCT01363440|158345835|FG002|Overall Study|Death|5|||
49138593|NCT01363440|158345833|FG000|Overall Study|Withdrawal by Subject|9|||
48821448|NCT02696785|157188688|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
48821449|NCT02696785|157188689|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
48821450|NCT02696785|157188690|FG003|Blinded Treatment Period|Lack of Efficacy|1|||
48821451|NCT02696785|157188687|FG000|Blinded Treatment Period|Screen Failure|1|||
48821452|NCT02696785|157188688|FG001|Blinded Treatment Period|Screen Failure|0|||
48821453|NCT02696785|157188689|FG002|Blinded Treatment Period|Screen Failure|0|||
48821454|NCT02696785|157188690|FG003|Blinded Treatment Period|Screen Failure|0|||
48821455|NCT02696785|157188687|FG000|Washout Period|Withdrawal by Subject|0|||
48727563|NCT03739840|156853344|FG002|Treatment Period: Wk0-16|Program Termination|1|||
48727564|NCT03739840|156853345|FG003|Treatment Period: Wk0-16|Program Termination|1|||
48727565|NCT03739840|156853342|FG000|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1|||
48727566|NCT03739840|156853343|FG001|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
48727567|NCT03739840|156853344|FG002|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
48727568|NCT03739840|156853345|FG003|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
48727569|NCT03739840|156853342|FG000|Treatment Period: Wk0-16|Sponsors Decision|3|||
49138594|NCT01363440|158345834|FG001|Overall Study|Withdrawal by Subject|11|||
48821456|NCT02696785|157188688|FG001|Washout Period|Withdrawal by Subject|1|||
48821457|NCT02696785|157188689|FG002|Washout Period|Withdrawal by Subject|0|||
48821458|NCT02696785|157188690|FG003|Washout Period|Withdrawal by Subject|0|||
48821459|NCT02696785|157188687|FG000|Washout Period|Lack of Efficacy|0|||
48821460|NCT02696785|157188688|FG001|Washout Period|Lack of Efficacy|1|||
48821461|NCT02696785|157188689|FG002|Washout Period|Lack of Efficacy|0|||
48821462|NCT02696785|157188690|FG003|Washout Period|Lack of Efficacy|0|||
48821463|NCT02696785|157188687|FG000|Extended Treatment Period|Adverse Event|2|||
48821464|NCT02696785|157188688|FG001|Extended Treatment Period|Adverse Event|3|||
48821465|NCT02696785|157188689|FG002|Extended Treatment Period|Adverse Event|2|||
48821466|NCT02696785|157188690|FG003|Extended Treatment Period|Adverse Event|1|||
49138595|NCT01363440|158345835|FG002|Overall Study|Withdrawal by Subject|11|||
49138596|NCT01363440|158345833|FG000|Overall Study|Lost to Follow-up|2|||
49138597|NCT01363440|158345834|FG001|Overall Study|Lost to Follow-up|4|||
49138598|NCT01363440|158345835|FG002|Overall Study|Lost to Follow-up|5|||
49138599|NCT01363440|158345833|FG000|Overall Study|Other|4|||
49138600|NCT01363440|158345834|FG001|Overall Study|Other|5|||
49138601|NCT01363440|158345835|FG002|Overall Study|Other|2|||
49138602|NCT01771913|158345836|FG000|Overall Study|Withdrawal by Subject|1|||
49138603|NCT01771913|158345837|FG001|Overall Study|Withdrawal by Subject|0|||
48727570|NCT03739840|156853343|FG001|Treatment Period: Wk0-16|Sponsors Decision|2|||
48821467|NCT02696785|157188687|FG000|Extended Treatment Period|Lack of Efficacy|0|||
48821468|NCT02696785|157188688|FG001|Extended Treatment Period|Lack of Efficacy|1|||
48821469|NCT02696785|157188689|FG002|Extended Treatment Period|Lack of Efficacy|0|||
48821470|NCT02696785|157188690|FG003|Extended Treatment Period|Lack of Efficacy|0|||
49011520|NCT02087059|157878989|FG000|Overall Study|Lost to Follow-up|1|||
49138604|NCT00266812|158345838|FG000|Overall Study|Disease Progression|9|||
49138605|NCT00266812|158345839|FG001|Overall Study|Disease Progression|3|||
49138606|NCT00266812|158345838|FG000|Overall Study|Death|5|||
49138607|NCT00266812|158345839|FG001|Overall Study|Death|4|||
49138608|NCT00266812|158345838|FG000|Overall Study|Adverse Event|3|||
49138609|NCT00266812|158345839|FG001|Overall Study|Adverse Event|1|||
49138610|NCT00266812|158345838|FG000|Overall Study|Protocol Violation|0|||
48727571|NCT03739840|156853344|FG002|Treatment Period: Wk0-16|Sponsors Decision|1|||
48727572|NCT03739840|156853345|FG003|Treatment Period: Wk0-16|Sponsors Decision|3|||
48727573|NCT03739840|156853342|FG000|Treatment Period: Wk0-16|Promotor Decision|0|||
48727574|NCT03739840|156853343|FG001|Treatment Period: Wk0-16|Promotor Decision|1|||
48727575|NCT03739840|156853344|FG002|Treatment Period: Wk0-16|Promotor Decision|0|||
48727576|NCT03739840|156853345|FG003|Treatment Period: Wk0-16|Promotor Decision|0|||
48727577|NCT03739840|156853342|FG000|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
48727578|NCT03739840|156853343|FG001|Treatment Period: Wk0-16|Per Sponsor Study Closed|1|||
48727579|NCT03739840|156853344|FG002|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
48727580|NCT03739840|156853345|FG003|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
48727581|NCT03739840|156853342|FG000|Treatment Period: Wk0-16|Premature Program Termination|0|||
48727582|NCT03739840|156853343|FG001|Treatment Period: Wk0-16|Premature Program Termination|1|||
48727583|NCT03739840|156853344|FG002|Treatment Period: Wk0-16|Premature Program Termination|0|||
48727584|NCT03739840|156853345|FG003|Treatment Period: Wk0-16|Premature Program Termination|0|||
48727585|NCT03739840|156853342|FG000|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
48727586|NCT03739840|156853343|FG001|Treatment Period: Wk0-16|Trial Closed By Sponsor|1|||
48727587|NCT03739840|156853344|FG002|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
48727588|NCT03739840|156853345|FG003|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
48727589|NCT03739840|156853342|FG000|Treatment Period: Wk0-16|Study Early Closure|0|||
48727590|NCT03739840|156853343|FG001|Treatment Period: Wk0-16|Study Early Closure|0|||
48727591|NCT03739840|156853344|FG002|Treatment Period: Wk0-16|Study Early Closure|1|||
48727592|NCT03739840|156853345|FG003|Treatment Period: Wk0-16|Study Early Closure|0|||
48727593|NCT03739840|156853342|FG000|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
48727594|NCT03739840|156853343|FG001|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
48727595|NCT03739840|156853344|FG002|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1|||
48727596|NCT03739840|156853345|FG003|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
48727597|NCT03739840|156853342|FG000|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
48727598|NCT03739840|156853343|FG001|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
48727599|NCT03739840|156853344|FG002|Treatment Period: Wk0-16|Premature Closure Of The Study|1|||
48727600|NCT03739840|156853345|FG003|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
48727601|NCT03739840|156853342|FG000|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
48727602|NCT03739840|156853343|FG001|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
48727603|NCT03739840|156853344|FG002|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
48727604|NCT03739840|156853345|FG003|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1|||
48727605|NCT03739840|156853342|FG000|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
48727606|NCT03739840|156853343|FG001|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
48727607|NCT03739840|156853344|FG002|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
48727608|NCT03739840|156853345|FG003|Treatment Period: Wk0-16|Due To Sponsor Instruction|1|||
48727609|NCT03739840|156853342|FG000|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
48727610|NCT03739840|156853343|FG001|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
48727611|NCT03739840|156853344|FG002|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
48727612|NCT03739840|156853345|FG003|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1|||
48727613|NCT03739840|156853342|FG000|Post-Treatment Period: Wk16-23|Adverse Event|3|||
48727614|NCT03739840|156853343|FG001|Post-Treatment Period: Wk16-23|Adverse Event|0|||
48727615|NCT03739840|156853344|FG002|Post-Treatment Period: Wk16-23|Adverse Event|0|||
48727616|NCT03739840|156853345|FG003|Post-Treatment Period: Wk16-23|Adverse Event|0|||
48727617|NCT03739840|156853342|FG000|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
48727618|NCT03739840|156853343|FG001|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
48727619|NCT03739840|156853344|FG002|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
48727620|NCT03739840|156853345|FG003|Post-Treatment Period: Wk16-23|Consent Withdrawn|1|||
48727621|NCT03739840|156853342|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1|||
48727622|NCT03739840|156853343|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
48727623|NCT03739840|156853344|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
48727624|NCT03739840|156853345|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
48727625|NCT03739840|156853342|FG000|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
48727626|NCT03739840|156853343|FG001|Post-Treatment Period: Wk16-23|Sponsor's Decision|1|||
48727627|NCT03739840|156853344|FG002|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
48727628|NCT03739840|156853345|FG003|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
48727629|NCT03739840|156853342|FG000|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
48727630|NCT03739840|156853343|FG001|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1|||
48727631|NCT03739840|156853344|FG002|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
48727632|NCT03739840|156853345|FG003|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
48727633|NCT03739840|156853342|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
48727634|NCT03739840|156853343|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
48727635|NCT03739840|156853344|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1|||
49011521|NCT00597207|157878990|FG000|Overall Study|Lost to Follow-up|5|||
48821471|NCT02696785|157188687|FG000|Extended Treatment Period|Withdrawal by Subject|1|||
48821472|NCT02696785|157188688|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
48821473|NCT02696785|157188689|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
48821474|NCT02696785|157188690|FG003|Extended Treatment Period|Withdrawal by Subject|5|||
48821475|NCT02696785|157188687|FG000|Follow-up Period|Adverse Event|0|||
48821476|NCT02696785|157188688|FG001|Follow-up Period|Adverse Event|0|||
48821477|NCT02696785|157188689|FG002|Follow-up Period|Adverse Event|8|||
48821478|NCT02696785|157188690|FG003|Follow-up Period|Adverse Event|2|||
48821479|NCT02696785|157188687|FG000|Follow-up Period|Lost to Follow-up|0|||
48821480|NCT02696785|157188688|FG001|Follow-up Period|Lost to Follow-up|0|||
48821481|NCT02696785|157188689|FG002|Follow-up Period|Lost to Follow-up|0|||
48821482|NCT02696785|157188690|FG003|Follow-up Period|Lost to Follow-up|1|||
48821483|NCT02696785|157188687|FG000|Follow-up Period|Lack of Efficacy|0|||
48821484|NCT02696785|157188688|FG001|Follow-up Period|Lack of Efficacy|0|||
48821485|NCT02696785|157188689|FG002|Follow-up Period|Lack of Efficacy|0|||
48821486|NCT02696785|157188690|FG003|Follow-up Period|Lack of Efficacy|1|||
48821487|NCT02696785|157188687|FG000|Follow-up Period|Withdrawal by Subject|1|||
48821488|NCT02696785|157188688|FG001|Follow-up Period|Withdrawal by Subject|0|||
48821489|NCT02696785|157188689|FG002|Follow-up Period|Withdrawal by Subject|5|||
48821490|NCT02696785|157188690|FG003|Follow-up Period|Withdrawal by Subject|4|||
48821491|NCT01880515|157188693|FG000|Overall Study|Lost to Follow-up|3|||
48821492|NCT01880515|157188694|FG001|Overall Study|Lost to Follow-up|2|||
48821493|NCT01880515|157188693|FG000|Overall Study|Disease Progression|5|||
48821494|NCT01880515|157188694|FG001|Overall Study|Disease Progression|7|||
48821495|NCT02061761|157188695|FG000|Overall Study|Disease progression|2|||
48821496|NCT02061761|157188696|FG001|Overall Study|Disease progression|8|||
48821497|NCT02061761|157188697|FG002|Overall Study|Disease progression|4|||
48821498|NCT02061761|157188698|FG003|Overall Study|Disease progression|5|||
48821499|NCT02061761|157188699|FG004|Overall Study|Disease progression|9|||
48821500|NCT02061761|157188700|FG005|Overall Study|Disease progression|3|||
48821501|NCT02061761|157188701|FG006|Overall Study|Disease progression|1|||
48821502|NCT02061761|157188702|FG007|Overall Study|Disease progression|2|||
48821503|NCT02061761|157188703|FG008|Overall Study|Disease progression|28|||
48821504|NCT02061761|157188695|FG000|Overall Study|Study Drug toxicity|0|||
48821505|NCT02061761|157188696|FG001|Overall Study|Study Drug toxicity|0|||
48821506|NCT02061761|157188697|FG002|Overall Study|Study Drug toxicity|0|||
48821507|NCT02061761|157188698|FG003|Overall Study|Study Drug toxicity|0|||
48821508|NCT02061761|157188699|FG004|Overall Study|Study Drug toxicity|0|||
48821509|NCT02061761|157188700|FG005|Overall Study|Study Drug toxicity|1|||
48821510|NCT02061761|157188701|FG006|Overall Study|Study Drug toxicity|0|||
48821511|NCT02061761|157188702|FG007|Overall Study|Study Drug toxicity|2|||
48821512|NCT02061761|157188703|FG008|Overall Study|Study Drug toxicity|6|||
48821513|NCT02061761|157188695|FG000|Overall Study|Adverse event unrelated to study Drug|1|||
49138611|NCT00266812|158345839|FG001|Overall Study|Protocol Violation|1|||
48821514|NCT02061761|157188696|FG001|Overall Study|Adverse event unrelated to study Drug|0|||
48821515|NCT02061761|157188697|FG002|Overall Study|Adverse event unrelated to study Drug|0|||
48821516|NCT02061761|157188698|FG003|Overall Study|Adverse event unrelated to study Drug|1|||
48821517|NCT02061761|157188699|FG004|Overall Study|Adverse event unrelated to study Drug|0|||
48821518|NCT02061761|157188700|FG005|Overall Study|Adverse event unrelated to study Drug|0|||
48821519|NCT02061761|157188701|FG006|Overall Study|Adverse event unrelated to study Drug|0|||
49138612|NCT00266812|158345838|FG000|Overall Study|Withdrawal by Subject|0|||
49138613|NCT00266812|158345839|FG001|Overall Study|Withdrawal by Subject|2|||
49138614|NCT00266812|158345838|FG000|Overall Study|Discontinued before starting study drug|4|||
49138615|NCT00266812|158345839|FG001|Overall Study|Discontinued before starting study drug|0|||
49138616|NCT03695094|158345841|FG000|Overall Study|Adverse Event|1|||
49138617|NCT03695094|158345842|FG001|Overall Study|Adverse Event|1|||
49138618|NCT03695094|158345841|FG000|Overall Study|Withdrawal by Subject|1|||
49138619|NCT03695094|158345842|FG001|Overall Study|Withdrawal by Subject|0|||
49138620|NCT02323334|158345843|FG000|Period 3|Lost to Follow-up|0|||
49138621|NCT02323334|158345844|FG001|Period 3|Lost to Follow-up|0|||
49138622|NCT02323334|158345845|FG002|Period 3|Lost to Follow-up|1|||
49138623|NCT02323334|158345846|FG003|Period 3|Lost to Follow-up|0|||
49138624|NCT02323334|158345847|FG004|Period 3|Lost to Follow-up|0|||
49138625|NCT02323334|158345848|FG005|Period 3|Lost to Follow-up|0|||
49138626|NCT02323334|158345849|FG006|Period 3|Lost to Follow-up|0|||
49138627|NCT02323334|158345850|FG007|Period 3|Lost to Follow-up|0|||
49138628|NCT02323334|158345851|FG008|Period 3|Lost to Follow-up|0|||
49138629|NCT02323334|158345852|FG009|Period 3|Lost to Follow-up|0|||
49138630|NCT02323334|158345853|FG010|Period 3|Lost to Follow-up|0|||
49138631|NCT02323334|158345854|FG011|Period 3|Lost to Follow-up|0|||
48821520|NCT02061761|157188702|FG007|Overall Study|Adverse event unrelated to study Drug|0|||
49011522|NCT00597207|157878991|FG001|Overall Study|Lost to Follow-up|7|||
49138632|NCT02323334|158345855|FG012|Period 3|Lost to Follow-up|0|||
49138633|NCT02323334|158345856|FG013|Period 3|Lost to Follow-up|0|||
49138634|NCT02323334|158345857|FG014|Period 3|Lost to Follow-up|0|||
49138635|NCT02323334|158345858|FG015|Period 3|Lost to Follow-up|0|||
49138636|NCT02323334|158345859|FG016|Period 3|Lost to Follow-up|0|||
48727636|NCT03739840|156853345|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
48727637|NCT03739840|156853342|FG000|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
48727638|NCT03739840|156853343|FG001|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
48727639|NCT03739840|156853344|FG002|Post-Treatment Period: Wk16-23|Early Study Closure|1|||
48727640|NCT03739840|156853345|FG003|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
48727641|NCT03739840|156853342|FG000|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
48727642|NCT03739840|156853343|FG001|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
48727643|NCT03739840|156853344|FG002|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1|||
48727644|NCT03739840|156853345|FG003|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
48727645|NCT01028378|156853346|FG000|Overall Study|Lost to Follow-up|12|||
48727646|NCT01028378|156853346|FG000|Overall Study|Withdrawal by Subject|1|||
48727647|NCT01028378|156853346|FG000|Overall Study|Adminstrative Reasons|4|||
48727648|NCT01298193|156853347|FG000|Observational Phase (First Cycle)|Withdrawal by Subject|2|||
48727649|NCT01298193|156853347|FG000|Observational Phase (First Cycle)|Received TC at a different dose|16|||
48727650|NCT01298193|156853347|FG000|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9|||
48727651|NCT01298193|156853347|FG000|Efficacy Phase (Second Cycle)|Death|1|||
48727652|NCT01115803|156853348|FG000|Overall Study|Withdrawal by Subject|0|||
48727653|NCT01115803|156853349|FG001|Overall Study|Withdrawal by Subject|0|||
48727654|NCT01115803|156853350|FG002|Overall Study|Withdrawal by Subject|0|||
48727655|NCT01115803|156853351|FG003|Overall Study|Withdrawal by Subject|0|||
48727656|NCT01115803|156853352|FG004|Overall Study|Withdrawal by Subject|0|||
48727657|NCT01115803|156853353|FG005|Overall Study|Withdrawal by Subject|0|||
48727658|NCT01115803|156853354|FG006|Overall Study|Withdrawal by Subject|1|||
48727659|NCT01115803|156853348|FG000|Overall Study|Lost to Follow-up|0|||
48727660|NCT01115803|156853349|FG001|Overall Study|Lost to Follow-up|0|||
48727661|NCT01115803|156853350|FG002|Overall Study|Lost to Follow-up|1|||
48727662|NCT01115803|156853351|FG003|Overall Study|Lost to Follow-up|0|||
48727663|NCT01115803|156853352|FG004|Overall Study|Lost to Follow-up|0|||
48727664|NCT01115803|156853353|FG005|Overall Study|Lost to Follow-up|0|||
48727665|NCT01115803|156853354|FG006|Overall Study|Lost to Follow-up|0|||
48727666|NCT01115803|156853348|FG000|Overall Study|Progressive Disease during Cycle1|0|||
48727667|NCT01115803|156853349|FG001|Overall Study|Progressive Disease during Cycle1|0|||
48727668|NCT01115803|156853350|FG002|Overall Study|Progressive Disease during Cycle1|0|||
48727669|NCT01115803|156853351|FG003|Overall Study|Progressive Disease during Cycle1|0|||
48727670|NCT01115803|156853352|FG004|Overall Study|Progressive Disease during Cycle1|0|||
48727671|NCT01115803|156853353|FG005|Overall Study|Progressive Disease during Cycle1|0|||
48727672|NCT01115803|156853354|FG006|Overall Study|Progressive Disease during Cycle1|1|||
48727673|NCT03475875|156853356|FG000|Period 1|Lost to Follow-up|1|||
48727674|NCT03475875|156853357|FG001|Period 1|Lost to Follow-up|0|||
48727675|NCT03475875|156853356|FG000|Period 1|Adverse Event|2|||
48727676|NCT03475875|156853357|FG001|Period 1|Adverse Event|1|||
48727677|NCT03475875|156853356|FG000|Period 2|Adverse Event|3|||
48727678|NCT03475875|156853357|FG001|Period 2|Adverse Event|0|||
48727679|NCT03475875|156853356|FG000|Period 2|Protocol Violation|0|||
48727680|NCT03475875|156853357|FG001|Period 2|Protocol Violation|1|||
48727681|NCT03059446|156853358|FG000|Overall Study|Adverse Event|11|||
48727682|NCT03059446|156853358|FG000|Overall Study|Withdrawal of Consent|16|||
48727683|NCT03059446|156853358|FG000|Overall Study|Lost to Follow-up|3|||
48727684|NCT03059446|156853358|FG000|Overall Study|Protocol Violation|1|||
48727685|NCT03059446|156853358|FG000|Overall Study|Study Terminated by Sponsor|131|||
48727686|NCT03059446|156853358|FG000|Overall Study|Reason not Specified|5|||
48821521|NCT02061761|157188703|FG008|Overall Study|Adverse event unrelated to study Drug|0|||
48821522|NCT02061761|157188695|FG000|Overall Study|Participant request to discontinue study treatment|0|||
48821523|NCT02061761|157188696|FG001|Overall Study|Participant request to discontinue study treatment|0|||
48821524|NCT02061761|157188697|FG002|Overall Study|Participant request to discontinue study treatment|2|||
48821525|NCT02061761|157188698|FG003|Overall Study|Participant request to discontinue study treatment|2|||
48821526|NCT02061761|157188699|FG004|Overall Study|Participant request to discontinue study treatment|0|||
48821527|NCT02061761|157188700|FG005|Overall Study|Participant request to discontinue study treatment|1|||
48821528|NCT02061761|157188701|FG006|Overall Study|Participant request to discontinue study treatment|0|||
48727687|NCT02992132|156853359|FG000|Overall Study|Adverse Event|4|||
48727688|NCT02992132|156853360|FG001|Overall Study|Adverse Event|1|||
48727689|NCT02992132|156853361|FG002|Overall Study|Adverse Event|3|||
48727690|NCT02992132|156853359|FG000|Overall Study|Lack of Efficacy|2|||
48727691|NCT02992132|156853360|FG001|Overall Study|Lack of Efficacy|0|||
48727692|NCT02992132|156853361|FG002|Overall Study|Lack of Efficacy|0|||
48727693|NCT02992132|156853359|FG000|Overall Study|Non-compliance with study drug|2|||
48727694|NCT02992132|156853360|FG001|Overall Study|Non-compliance with study drug|0|||
48727695|NCT02992132|156853361|FG002|Overall Study|Non-compliance with study drug|0|||
48727696|NCT02992132|156853359|FG000|Overall Study|Progressive disease|1|||
48727697|NCT02992132|156853360|FG001|Overall Study|Progressive disease|0|||
48727698|NCT02992132|156853361|FG002|Overall Study|Progressive disease|0|||
48727699|NCT02992132|156853359|FG000|Overall Study|Protocol Violation|2|||
48727700|NCT02992132|156853360|FG001|Overall Study|Protocol Violation|2|||
49138637|NCT02323334|158345843|FG000|Period 3|Withdrawal by Subject|1|||
49138638|NCT02323334|158345844|FG001|Period 3|Withdrawal by Subject|0|||
49138639|NCT02323334|158345845|FG002|Period 3|Withdrawal by Subject|0|||
49138640|NCT02323334|158345846|FG003|Period 3|Withdrawal by Subject|0|||
49138641|NCT02323334|158345847|FG004|Period 3|Withdrawal by Subject|0|||
49138642|NCT02323334|158345848|FG005|Period 3|Withdrawal by Subject|0|||
49138643|NCT02323334|158345849|FG006|Period 3|Withdrawal by Subject|0|||
49138644|NCT02323334|158345850|FG007|Period 3|Withdrawal by Subject|0|||
49138645|NCT02323334|158345851|FG008|Period 3|Withdrawal by Subject|0|||
49138646|NCT02323334|158345852|FG009|Period 3|Withdrawal by Subject|0|||
49138647|NCT02323334|158345853|FG010|Period 3|Withdrawal by Subject|0|||
49138648|NCT02323334|158345854|FG011|Period 3|Withdrawal by Subject|0|||
49138649|NCT02323334|158345855|FG012|Period 3|Withdrawal by Subject|0|||
49138650|NCT02323334|158345856|FG013|Period 3|Withdrawal by Subject|0|||
49138651|NCT02323334|158345857|FG014|Period 3|Withdrawal by Subject|0|||
49138652|NCT02323334|158345858|FG015|Period 3|Withdrawal by Subject|0|||
49138653|NCT02323334|158345859|FG016|Period 3|Withdrawal by Subject|0|||
49138654|NCT01617967|158345861|FG000|Overall Study|Protocol Violation|0|||
49138655|NCT01617967|158345862|FG001|Overall Study|Protocol Violation|0|||
49138656|NCT01617967|158345863|FG002|Overall Study|Protocol Violation|0|||
49138657|NCT01617967|158345864|FG003|Overall Study|Protocol Violation|1|||
49138658|NCT01617967|158345865|FG004|Overall Study|Protocol Violation|0|||
49138659|NCT01617967|158345866|FG005|Overall Study|Protocol Violation|0|||
49138660|NCT01617967|158345861|FG000|Overall Study|Withdrawal by Subject|0|||
49138661|NCT01617967|158345862|FG001|Overall Study|Withdrawal by Subject|0|||
49138662|NCT01617967|158345863|FG002|Overall Study|Withdrawal by Subject|0|||
49138663|NCT01617967|158345864|FG003|Overall Study|Withdrawal by Subject|0|||
49138664|NCT01617967|158345865|FG004|Overall Study|Withdrawal by Subject|0|||
49138665|NCT01617967|158345866|FG005|Overall Study|Withdrawal by Subject|1|||
48727701|NCT02992132|156853361|FG002|Overall Study|Protocol Violation|0|||
48727702|NCT02992132|156853359|FG000|Overall Study|Caregiver withdrew consent|2|||
48727703|NCT02992132|156853360|FG001|Overall Study|Caregiver withdrew consent|3|||
48727704|NCT02992132|156853361|FG002|Overall Study|Caregiver withdrew consent|2|||
48727705|NCT02992132|156853359|FG000|Overall Study|Withdrawal by Subject|0|||
48727706|NCT02992132|156853360|FG001|Overall Study|Withdrawal by Subject|2|||
48727707|NCT02992132|156853361|FG002|Overall Study|Withdrawal by Subject|1|||
48821529|NCT02061761|157188702|FG007|Overall Study|Participant request to discontinue study treatment|0|||
48821530|NCT02061761|157188703|FG008|Overall Study|Participant request to discontinue study treatment|2|||
48821531|NCT02061761|157188695|FG000|Overall Study|Withdrawal by Subject|0|||
48821532|NCT02061761|157188696|FG001|Overall Study|Withdrawal by Subject|0|||
48821533|NCT02061761|157188697|FG002|Overall Study|Withdrawal by Subject|0|||
48821534|NCT02061761|157188698|FG003|Overall Study|Withdrawal by Subject|0|||
48821535|NCT02061761|157188699|FG004|Overall Study|Withdrawal by Subject|0|||
48821536|NCT02061761|157188700|FG005|Overall Study|Withdrawal by Subject|0|||
48727708|NCT02992132|156853359|FG000|Overall Study|Physician Decision|0|||
49138666|NCT01617967|158345861|FG000|Overall Study|Dosing Suspended by Sponsor|1|||
49138667|NCT01617967|158345862|FG001|Overall Study|Dosing Suspended by Sponsor|0|||
49138668|NCT01617967|158345863|FG002|Overall Study|Dosing Suspended by Sponsor|0|||
48727709|NCT02992132|156853360|FG001|Overall Study|Physician Decision|0|||
48727710|NCT02992132|156853361|FG002|Overall Study|Physician Decision|1|||
49138669|NCT01617967|158345864|FG003|Overall Study|Dosing Suspended by Sponsor|0|||
49138670|NCT01617967|158345865|FG004|Overall Study|Dosing Suspended by Sponsor|0|||
49138671|NCT01617967|158345866|FG005|Overall Study|Dosing Suspended by Sponsor|0|||
49138672|NCT01732783|158345871|FG000|Overall Study|Discontinued Panitumumab Treatment|106|||
49138673|NCT01732783|158345872|FG001|Overall Study|Discontinued Panitumumab Treatment|25|||
49138674|NCT01732783|158345873|FG002|Overall Study|Discontinued Panitumumab Treatment|7|||
48727711|NCT02431247|156853362|FG000|BL to EOE-Test and BL to Switch- Control|Other|11|||
48727712|NCT02431247|156853363|FG001|BL to EOE-Test and BL to Switch- Control|Other|2|||
48727713|NCT02431247|156853364|FG002|BL to EOE-Test and BL to Switch- Control|Other|0|||
48727714|NCT02431247|156853362|FG000|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|17|||
48727715|NCT02431247|156853363|FG001|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|8|||
48727716|NCT02431247|156853364|FG002|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|0|||
48821537|NCT02061761|157188701|FG006|Overall Study|Withdrawal by Subject|0|||
48821538|NCT02061761|157188702|FG007|Overall Study|Withdrawal by Subject|0|||
48821539|NCT02061761|157188703|FG008|Overall Study|Withdrawal by Subject|2|||
48821540|NCT02061761|157188695|FG000|Overall Study|Maximum clinical benefit|0|||
49138675|NCT01732783|158345871|FG000|Overall Study|Death|13|||
49138676|NCT01732783|158345872|FG001|Overall Study|Death|4|||
49138677|NCT01732783|158345873|FG002|Overall Study|Death|1|||
49138678|NCT01732783|158345871|FG000|Overall Study|Lost to Follow-up|7|||
49138679|NCT01732783|158345872|FG001|Overall Study|Lost to Follow-up|1|||
49138680|NCT01732783|158345873|FG002|Overall Study|Lost to Follow-up|1|||
49138681|NCT01732783|158345871|FG000|Overall Study|Administrative Decision|8|||
49138682|NCT01732783|158345872|FG001|Overall Study|Administrative Decision|2|||
49138683|NCT01732783|158345873|FG002|Overall Study|Administrative Decision|1|||
49138684|NCT01732783|158345871|FG000|Overall Study|Withdrawal by Subject|1|||
48727717|NCT02431247|156853362|FG000|BL to EOE-Test and BL to Switch- Control|Physician Decision|9|||
48727718|NCT02431247|156853363|FG001|BL to EOE-Test and BL to Switch- Control|Physician Decision|4|||
48727719|NCT02431247|156853364|FG002|BL to EOE-Test and BL to Switch- Control|Physician Decision|0|||
48727720|NCT02431247|156853362|FG000|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
48727721|NCT02431247|156853363|FG001|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
48727722|NCT02431247|156853364|FG002|BL to EOE-Test and BL to Switch- Control|Pregnancy|0|||
48727723|NCT02431247|156853362|FG000|BL to EOE-Test and BL to Switch- Control|Adverse Event|12|||
48727724|NCT02431247|156853363|FG001|BL to EOE-Test and BL to Switch- Control|Adverse Event|16|||
48821541|NCT02061761|157188696|FG001|Overall Study|Maximum clinical benefit|0|||
48821542|NCT02061761|157188697|FG002|Overall Study|Maximum clinical benefit|0|||
48821543|NCT02061761|157188698|FG003|Overall Study|Maximum clinical benefit|1|||
48821544|NCT02061761|157188699|FG004|Overall Study|Maximum clinical benefit|0|||
48727725|NCT02431247|156853364|FG002|BL to EOE-Test and BL to Switch- Control|Adverse Event|0|||
48727726|NCT02431247|156853362|FG000|BL to EOE-Test and BL to Switch- Control|Death|0|||
48727727|NCT02431247|156853363|FG001|BL to EOE-Test and BL to Switch- Control|Death|1|||
49138685|NCT01732783|158345872|FG001|Overall Study|Withdrawal by Subject|0|||
48821545|NCT02061761|157188700|FG005|Overall Study|Maximum clinical benefit|0|||
48821546|NCT02061761|157188701|FG006|Overall Study|Maximum clinical benefit|0|||
48821547|NCT02061761|157188702|FG007|Overall Study|Maximum clinical benefit|0|||
48821548|NCT02061761|157188703|FG008|Overall Study|Maximum clinical benefit|6|||
48727728|NCT02431247|156853364|FG002|BL to EOE-Test and BL to Switch- Control|Death|0|||
49138686|NCT01732783|158345873|FG002|Overall Study|Withdrawal by Subject|0|||
49138687|NCT03086343|158345874|FG000|Period 1|Adverse Event|7|||
48727729|NCT02431247|156853362|FG000|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|14|||
48821549|NCT02061761|157188695|FG000|Overall Study|Participant no longer meets study criteria|0|||
48821550|NCT02061761|157188696|FG001|Overall Study|Participant no longer meets study criteria|0|||
48821551|NCT02061761|157188697|FG002|Overall Study|Participant no longer meets study criteria|0|||
48821552|NCT02061761|157188698|FG003|Overall Study|Participant no longer meets study criteria|0|||
48821553|NCT02061761|157188699|FG004|Overall Study|Participant no longer meets study criteria|0|||
48821554|NCT02061761|157188700|FG005|Overall Study|Participant no longer meets study criteria|0|||
48821555|NCT02061761|157188701|FG006|Overall Study|Participant no longer meets study criteria|0|||
49138688|NCT03086343|158345875|FG001|Period 1|Adverse Event|7|||
49138689|NCT03086343|158345876|FG002|Period 1|Adverse Event|0|||
49138690|NCT03086343|158345877|FG003|Period 1|Adverse Event|1|||
49138691|NCT03086343|158345874|FG000|Period 1|Withdrawal by Subject|6|||
49138692|NCT03086343|158345875|FG001|Period 1|Withdrawal by Subject|10|||
49138693|NCT03086343|158345876|FG002|Period 1|Withdrawal by Subject|0|||
49138694|NCT03086343|158345877|FG003|Period 1|Withdrawal by Subject|0|||
49138695|NCT03086343|158345874|FG000|Period 1|Lost to Follow-up|1|||
49138696|NCT03086343|158345875|FG001|Period 1|Lost to Follow-up|3|||
49138697|NCT03086343|158345876|FG002|Period 1|Lost to Follow-up|1|||
49138698|NCT03086343|158345877|FG003|Period 1|Lost to Follow-up|0|||
49138699|NCT03086343|158345874|FG000|Period 1|Other, Not Specified|10|||
49138700|NCT03086343|158345875|FG001|Period 1|Other, Not Specified|12|||
49138701|NCT03086343|158345876|FG002|Period 1|Other, Not Specified|2|||
49138702|NCT03086343|158345877|FG003|Period 1|Other, Not Specified|1|||
49138703|NCT03086343|158345874|FG000|Period 1|Missing|1|||
49138704|NCT03086343|158345875|FG001|Period 1|Missing|0|||
49138705|NCT03086343|158345876|FG002|Period 1|Missing|0|||
49138706|NCT03086343|158345877|FG003|Period 1|Missing|0|||
49138707|NCT03086343|158345874|FG000|Period 2|Adverse Event|20|||
49138708|NCT03086343|158345875|FG001|Period 2|Adverse Event|11|||
49138709|NCT03086343|158345876|FG002|Period 2|Adverse Event|1|||
49138710|NCT03086343|158345877|FG003|Period 2|Adverse Event|2|||
49138711|NCT03086343|158345874|FG000|Period 2|Withdrawal by Subject|15|||
49138712|NCT03086343|158345875|FG001|Period 2|Withdrawal by Subject|25|||
49138713|NCT03086343|158345876|FG002|Period 2|Withdrawal by Subject|2|||
49138714|NCT03086343|158345877|FG003|Period 2|Withdrawal by Subject|2|||
49138715|NCT03086343|158345874|FG000|Period 2|Lost to Follow-up|6|||
49138716|NCT03086343|158345875|FG001|Period 2|Lost to Follow-up|11|||
49138717|NCT03086343|158345876|FG002|Period 2|Lost to Follow-up|1|||
49138718|NCT03086343|158345877|FG003|Period 2|Lost to Follow-up|0|||
49138719|NCT03086343|158345874|FG000|Period 2|COVID-19 Infection|5|||
49138720|NCT03086343|158345875|FG001|Period 2|COVID-19 Infection|0|||
49138721|NCT03086343|158345876|FG002|Period 2|COVID-19 Infection|0|||
49138722|NCT03086343|158345877|FG003|Period 2|COVID-19 Infection|0|||
49138723|NCT03086343|158345874|FG000|Period 2|COVID-19 Logistical Restrictions|1|||
49138724|NCT03086343|158345875|FG001|Period 2|COVID-19 Logistical Restrictions|0|||
49138725|NCT03086343|158345876|FG002|Period 2|COVID-19 Logistical Restrictions|0|||
49138726|NCT03086343|158345877|FG003|Period 2|COVID-19 Logistical Restrictions|0|||
49138727|NCT03086343|158345874|FG000|Period 2|Other, Not Specified|23|||
49138728|NCT03086343|158345875|FG001|Period 2|Other, Not Specified|22|||
49138729|NCT03086343|158345876|FG002|Period 2|Other, Not Specified|2|||
49138730|NCT03086343|158345877|FG003|Period 2|Other, Not Specified|4|||
49138731|NCT02447029|158345880|FG000|Overall Study|Withdrawal by Subject|3|||
49138732|NCT02447029|158345881|FG001|Overall Study|Withdrawal by Subject|2|||
49138733|NCT00726557|158345882|FG000|Overall Study|Screening failure|4|||
49138734|NCT00726557|158345882|FG000|Overall Study|No end of treatment documentation|37|||
49138735|NCT00726557|158345882|FG000|Overall Study|No follow-up documentation available|55|||
49138736|NCT00726557|158345882|FG000|Overall Study|Treatment less than 3 months|17|||
49138737|NCT00726557|158345882|FG000|Overall Study|Inclusion criteria not met|15|||
49138738|NCT03147287|158345885|FG000|Overall Study|Randomized Not Treated|2|||
49138739|NCT03147287|158345886|FG001|Overall Study|Randomized Not Treated|1|||
49138740|NCT03147287|158345887|FG002|Overall Study|Randomized Not Treated|1|||
49138741|NCT03147287|158345885|FG000|Overall Study|Progressive Disease RECIST|31|||
49138742|NCT03147287|158345886|FG001|Overall Study|Progressive Disease RECIST|72|||
49138743|NCT03147287|158345887|FG002|Overall Study|Progressive Disease RECIST|32|||
49138744|NCT03147287|158345885|FG000|Overall Study|Progressive Disease not RECIST|13|||
49138745|NCT03147287|158345886|FG001|Overall Study|Progressive Disease not RECIST|21|||
49138746|NCT03147287|158345887|FG002|Overall Study|Progressive Disease not RECIST|13|||
49138747|NCT03147287|158345885|FG000|Overall Study|Physician Decision|1|||
49138748|NCT03147287|158345886|FG001|Overall Study|Physician Decision|2|||
49138749|NCT03147287|158345887|FG002|Overall Study|Physician Decision|1|||
49138750|NCT03147287|158345885|FG000|Overall Study|Intercurrent illness|0|||
49138751|NCT03147287|158345886|FG001|Overall Study|Intercurrent illness|1|||
49138752|NCT03147287|158345887|FG002|Overall Study|Intercurrent illness|0|||
49138753|NCT03147287|158345885|FG000|Overall Study|Withdrawal by Subject|2|||
49138754|NCT03147287|158345886|FG001|Overall Study|Withdrawal by Subject|3|||
49138755|NCT03147287|158345887|FG002|Overall Study|Withdrawal by Subject|2|||
49138756|NCT03147287|158345885|FG000|Overall Study|Patient Non-Compliance|0|||
49138757|NCT03147287|158345886|FG001|Overall Study|Patient Non-Compliance|2|||
49138758|NCT03147287|158345887|FG002|Overall Study|Patient Non-Compliance|0|||
49138759|NCT03147287|158345885|FG000|Overall Study|Patient moved|0|||
49138760|NCT03147287|158345886|FG001|Overall Study|Patient moved|1|||
49138761|NCT03147287|158345887|FG002|Overall Study|Patient moved|0|||
49138762|NCT03147287|158345885|FG000|Overall Study|Arm A crossover without PD|1|||
49138763|NCT03147287|158345886|FG001|Overall Study|Arm A crossover without PD|0|||
49138764|NCT03147287|158345887|FG002|Overall Study|Arm A crossover without PD|0|||
49138765|NCT03147287|158345885|FG000|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
49138766|NCT03147287|158345886|FG001|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|8|||
49138767|NCT03147287|158345887|FG002|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
49138768|NCT01898130|158345888|FG000|Treatment|Withdrawal by Subject|2|||
49138769|NCT01898130|158345888|FG000|Treatment|Progressive Disease|4|||
49138770|NCT01898130|158345888|FG000|Follow up Until PD or Death|Lost to Follow-up|1|||
49138771|NCT02930941|158345893|FG000|Overall Study|Lost to Follow-up|1|||
49138772|NCT02930941|158345894|FG001|Overall Study|Lost to Follow-up|2|||
49138773|NCT04398134|158345897|FG000|Overall Study|Adverse Event|0|||
49138774|NCT04398134|158345898|FG001|Overall Study|Adverse Event|0|||
49138775|NCT04398134|158345899|FG002|Overall Study|Adverse Event|1|||
48821556|NCT02061761|157188702|FG007|Overall Study|Participant no longer meets study criteria|0|||
48821557|NCT02061761|157188703|FG008|Overall Study|Participant no longer meets study criteria|1|||
48821558|NCT02061761|157188695|FG000|Overall Study|Other reasons|0|||
48821559|NCT02061761|157188696|FG001|Overall Study|Other reasons|0|||
48821560|NCT02061761|157188697|FG002|Overall Study|Other reasons|0|||
49138776|NCT04398134|158345900|FG003|Overall Study|Adverse Event|0|||
49138777|NCT04398134|158345897|FG000|Overall Study|Withdrawal by Subject|2|||
49138778|NCT04398134|158345898|FG001|Overall Study|Withdrawal by Subject|0|||
48821561|NCT02061761|157188698|FG003|Overall Study|Other reasons|0|||
49138779|NCT04398134|158345899|FG002|Overall Study|Withdrawal by Subject|0|||
49138780|NCT04398134|158345900|FG003|Overall Study|Withdrawal by Subject|1|||
49138781|NCT04398134|158345897|FG000|Overall Study|Study Terminated by Sponsor|30|||
49138782|NCT04398134|158345898|FG001|Overall Study|Study Terminated by Sponsor|11|||
49138783|NCT04398134|158345899|FG002|Overall Study|Study Terminated by Sponsor|32|||
49138784|NCT04398134|158345900|FG003|Overall Study|Study Terminated by Sponsor|11|||
49138785|NCT00976898|158345901|FG000|Overall Study|Protocol Violation|1|||
49138786|NCT00976898|158345901|FG000|Overall Study|Adverse Event|1|||
49138787|NCT00976898|158345901|FG000|Overall Study|Physician Decision|1|||
49138788|NCT00976898|158345901|FG000|Overall Study|Liver Transplant|1|||
49138789|NCT00976898|158345901|FG000|Overall Study|Progressive Disease|1|||
49138790|NCT00103506|158345904|FG000|Overall Study|Study closed by sponsor|34|||
49138791|NCT00103506|158345905|FG001|Overall Study|Study closed by sponsor|37|||
49138792|NCT00103506|158345904|FG000|Overall Study|Death|257|||
49138793|NCT00103506|158345905|FG001|Overall Study|Death|253|||
49138794|NCT00103506|158345904|FG000|Overall Study|Lost to Follow-up|13|||
49138795|NCT00103506|158345905|FG001|Overall Study|Lost to Follow-up|13|||
49138796|NCT00103506|158345904|FG000|Overall Study|Withdrawal by Subject|18|||
49138797|NCT00103506|158345905|FG001|Overall Study|Withdrawal by Subject|21|||
49138798|NCT02153827|158345906|FG000|Overall Study|Lost to Follow-up|3|||
49138799|NCT02153827|158345907|FG001|Overall Study|Lost to Follow-up|9|||
49138800|NCT04167462|158345908|FG000|Overall Study|Other reasons|3|||
49138801|NCT04167462|158345909|FG001|Overall Study|Other reasons|2|||
49138802|NCT04167462|158345908|FG000|Overall Study|Withdrawal by Subject|6|||
49138803|NCT04167462|158345909|FG001|Overall Study|Withdrawal by Subject|7|||
49138804|NCT04167462|158345908|FG000|Overall Study|Adverse Event|4|||
49138805|NCT04167462|158345909|FG001|Overall Study|Adverse Event|0|||
49138806|NCT04167462|158345908|FG000|Overall Study|Pregnancy|1|||
49138807|NCT04167462|158345909|FG001|Overall Study|Pregnancy|0|||
49138808|NCT04167462|158345908|FG000|Overall Study|Lack of Efficacy|0|||
49138809|NCT04167462|158345909|FG001|Overall Study|Lack of Efficacy|1|||
49138810|NCT03331562|158345912|FG000|Overall Study|Adverse Event|2|||
49138811|NCT03331562|158345913|FG001|Overall Study|Adverse Event|0|||
49138812|NCT03331562|158345912|FG000|Overall Study|Death|1|||
49138813|NCT03331562|158345913|FG001|Overall Study|Death|0|||
49138814|NCT03718000|158345914|FG000|Overall Study|Relocation|2|||
49138815|NCT03718000|158345915|FG001|Overall Study|Relocation|4|||
49138816|NCT03718000|158345914|FG000|Overall Study|Pregnancy|0|||
49138817|NCT03718000|158345915|FG001|Overall Study|Pregnancy|1|||
49138818|NCT02202616|158345922|FG000|Overall Study|Screen failed|24|||
49138819|NCT02202616|158345922|FG000|Overall Study|Adverse Event|32|||
49138820|NCT02202616|158345922|FG000|Overall Study|Protocol deviation|18|||
49138821|NCT02202616|158345922|FG000|Overall Study|Patient withdrew consent|12|||
49138822|NCT02202616|158345922|FG000|Overall Study|Lost to Follow-up|6|||
49138823|NCT02202616|158345922|FG000|Overall Study|Administrative problems|6|||
49138824|NCT02202616|158345922|FG000|Overall Study|Abnormal test procedure result|1|||
49138825|NCT02202616|158345922|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
49138826|NCT00367458|158345923|FG000|First Intervention - 8 Weeks|Adverse Event|2|||
49138827|NCT00367458|158345924|FG001|First Intervention - 8 Weeks|Adverse Event|0|||
49138828|NCT01129128|158345927|FG000|Overall Study|Lost to Follow-up|2|||
49138829|NCT01129128|158345928|FG001|Overall Study|Lost to Follow-up|2|||
49138830|NCT01129128|158345929|FG002|Overall Study|Lost to Follow-up|1|||
49138831|NCT01129128|158345927|FG000|Overall Study|Protocol Violation|0|||
49138832|NCT01129128|158345928|FG001|Overall Study|Protocol Violation|1|||
49138833|NCT01129128|158345929|FG002|Overall Study|Protocol Violation|0|||
49138834|NCT01129128|158345927|FG000|Overall Study|Withdrawal by Subject|0|||
49138835|NCT01129128|158345928|FG001|Overall Study|Withdrawal by Subject|1|||
49138836|NCT01129128|158345929|FG002|Overall Study|Withdrawal by Subject|3|||
49138837|NCT01129128|158345927|FG000|Overall Study|Physician Decision|1|||
49138838|NCT01129128|158345928|FG001|Overall Study|Physician Decision|0|||
49138839|NCT01129128|158345929|FG002|Overall Study|Physician Decision|0|||
49138840|NCT00961415|158345930|FG000|Induction Treatment Phase|Withdrawal by Subject|11|||
49138841|NCT00961415|158345931|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
49138842|NCT00961415|158345932|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
49138843|NCT00961415|158345930|FG000|Induction Treatment Phase|Death|77|||
49138844|NCT00961415|158345931|FG001|Induction Treatment Phase|Death|0|||
49138845|NCT00961415|158345932|FG002|Induction Treatment Phase|Death|0|||
49138846|NCT00961415|158345930|FG000|Induction Treatment Phase|Protocol Violation|1|||
49138847|NCT00961415|158345931|FG001|Induction Treatment Phase|Protocol Violation|0|||
49138848|NCT00961415|158345932|FG002|Induction Treatment Phase|Protocol Violation|0|||
49138849|NCT00961415|158345930|FG000|Induction Treatment Phase|Physician Decision|2|||
49138850|NCT00961415|158345931|FG001|Induction Treatment Phase|Physician Decision|0|||
49138851|NCT00961415|158345932|FG002|Induction Treatment Phase|Physician Decision|0|||
49138852|NCT00961415|158345930|FG000|Induction Treatment Phase|Didn't meet maintenance phase criteria|27|||
49138853|NCT00961415|158345931|FG001|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
48727730|NCT02431247|156853363|FG001|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|9|||
49138854|NCT00961415|158345932|FG002|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
49138855|NCT00961415|158345930|FG000|Induction Treatment Phase|Other Reason|5|||
49138856|NCT00961415|158345931|FG001|Induction Treatment Phase|Other Reason|0|||
49138857|NCT00961415|158345932|FG002|Induction Treatment Phase|Other Reason|0|||
49138858|NCT00961415|158345930|FG000|Maintenance Treatment Phase|Death|0|||
49138859|NCT00961415|158345931|FG001|Maintenance Treatment Phase|Death|42|||
49138860|NCT00961415|158345932|FG002|Maintenance Treatment Phase|Death|34|||
49138861|NCT00961415|158345930|FG000|Maintenance Treatment Phase|Investigators decision|0|||
49138862|NCT00961415|158345931|FG001|Maintenance Treatment Phase|Investigators decision|2|||
49138863|NCT00961415|158345932|FG002|Maintenance Treatment Phase|Investigators decision|0|||
49138864|NCT00961415|158345930|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
49138865|NCT00961415|158345931|FG001|Maintenance Treatment Phase|Withdrawal by Subject|3|||
49138866|NCT00961415|158345932|FG002|Maintenance Treatment Phase|Withdrawal by Subject|8|||
49138867|NCT00961415|158345930|FG000|Maintenance Treatment Phase|Other reason|0|||
49138868|NCT00961415|158345931|FG001|Maintenance Treatment Phase|Other reason|1|||
49138869|NCT00961415|158345932|FG002|Maintenance Treatment Phase|Other reason|3|||
48727731|NCT02431247|156853364|FG002|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|0|||
48727732|NCT02431247|156853362|FG000|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|2|||
48727733|NCT02431247|156853363|FG001|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
49138870|NCT04666298|158345933|FG000|Overall Study|Subject decision|1|||
49138871|NCT04666298|158345934|FG001|Overall Study|Subject decision|0|||
49138872|NCT04666298|158345935|FG002|Overall Study|Subject decision|0|||
49138873|NCT04666298|158345936|FG003|Overall Study|Subject decision|2|||
48727734|NCT02431247|156853364|FG002|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
48727735|NCT02431247|156853362|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
48821562|NCT02061761|157188699|FG004|Overall Study|Other reasons|2|||
48821563|NCT02061761|157188700|FG005|Overall Study|Other reasons|0|||
48821564|NCT02061761|157188701|FG006|Overall Study|Other reasons|0|||
48821565|NCT02061761|157188702|FG007|Overall Study|Other reasons|0|||
49138874|NCT04666298|158345933|FG000|Overall Study|Death|1|||
49138875|NCT04666298|158345934|FG001|Overall Study|Death|0|||
48727736|NCT02431247|156853363|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
48727737|NCT02431247|156853364|FG002|Switch to D/C/F/TAF (Until EOE)|Other|4|||
48727738|NCT02431247|156853362|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
48727739|NCT02431247|156853363|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
48727740|NCT02431247|156853364|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|12|||
48727741|NCT02431247|156853362|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
48727742|NCT02431247|156853363|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
48727743|NCT02431247|156853364|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
48727744|NCT02431247|156853362|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
48727745|NCT02431247|156853363|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
48727746|NCT02431247|156853364|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|5|||
48727747|NCT02431247|156853362|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
48727748|NCT02431247|156853363|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
48727749|NCT02431247|156853364|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
48727750|NCT02431247|156853362|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
48727751|NCT02431247|156853363|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
48727752|NCT02431247|156853364|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|10|||
48727753|NCT01562873|156853365|FG000|Overall Study|Disease Progression per RECIST|10|||
48727754|NCT01562873|156853366|FG001|Overall Study|Disease Progression per RECIST|0|||
48727755|NCT01562873|156853365|FG000|Overall Study|Adverse Event|1|||
48727756|NCT01562873|156853366|FG001|Overall Study|Adverse Event|0|||
48727757|NCT01562873|156853365|FG000|Overall Study|Clinical Disease Progression|9|||
48727758|NCT01562873|156853366|FG001|Overall Study|Clinical Disease Progression|0|||
48727759|NCT01562873|156853365|FG000|Overall Study|Clinical PD and adverse event|1|||
48727760|NCT01562873|156853366|FG001|Overall Study|Clinical PD and adverse event|0|||
48727761|NCT01369485|156853367|FG000|Randomized Phase (Day 0 to Week 12)|Adverse Event|7|||
48727762|NCT01369485|156853368|FG001|Randomized Phase (Day 0 to Week 12)|Adverse Event|5|||
48727763|NCT01369485|156853367|FG000|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12|||
48727764|NCT01369485|156853368|FG001|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8|||
48727765|NCT01369485|156853367|FG000|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2|||
48727766|NCT01369485|156853368|FG001|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4|||
48727767|NCT01369485|156853367|FG000|Randomized Phase (Day 0 to Week 12)|expired patches|2|||
48727768|NCT01369485|156853368|FG001|Randomized Phase (Day 0 to Week 12)|expired patches|0|||
48727769|NCT01369485|156853367|FG000|Open Label Phase (Week 12 to Month 12)|Adverse Event|11|||
48727770|NCT01369485|156853368|FG001|Open Label Phase (Week 12 to Month 12)|Adverse Event|9|||
48727771|NCT01369485|156853367|FG000|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2|||
48727772|NCT01369485|156853368|FG001|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3|||
48727773|NCT01369485|156853367|FG000|Open Label Phase (Week 12 to Month 12)|Physician Decision|3|||
48727774|NCT01369485|156853368|FG001|Open Label Phase (Week 12 to Month 12)|Physician Decision|4|||
48727775|NCT01369485|156853367|FG000|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17|||
48821566|NCT02061761|157188703|FG008|Overall Study|Other reasons|6|||
48821567|NCT01473420|157188704|FG000|Titration Period (18 Weeks)|Adverse Event|4|||
49138876|NCT04666298|158345935|FG002|Overall Study|Death|0|||
49138877|NCT04666298|158345936|FG003|Overall Study|Death|0|||
49138878|NCT04666298|158345933|FG000|Overall Study|Lost to Follow-up|0|||
49138879|NCT04666298|158345934|FG001|Overall Study|Lost to Follow-up|0|||
49138880|NCT04666298|158345935|FG002|Overall Study|Lost to Follow-up|0|||
49138881|NCT04666298|158345936|FG003|Overall Study|Lost to Follow-up|1|||
49138882|NCT04666298|158345933|FG000|Overall Study|Physician Decision|0|||
49138883|NCT04666298|158345934|FG001|Overall Study|Physician Decision|0|||
49138884|NCT04666298|158345935|FG002|Overall Study|Physician Decision|0|||
49138885|NCT04666298|158345936|FG003|Overall Study|Physician Decision|1|||
49138886|NCT04666298|158345933|FG000|Overall Study|Protocol deviation|0|||
49138887|NCT04666298|158345934|FG001|Overall Study|Protocol deviation|0|||
49138888|NCT04666298|158345935|FG002|Overall Study|Protocol deviation|1|||
49138889|NCT04666298|158345936|FG003|Overall Study|Protocol deviation|0|||
49138890|NCT01334515|158345939|FG000|Overall Study|Adverse Event|1|||
49138891|NCT01334515|158345940|FG001|Overall Study|Adverse Event|6|||
49138892|NCT01334515|158345939|FG000|Overall Study|Death|1|||
49138893|NCT01334515|158345940|FG001|Overall Study|Death|0|||
49138894|NCT01334515|158345939|FG000|Overall Study|Lack of Efficacy|8|||
49138895|NCT01334515|158345940|FG001|Overall Study|Lack of Efficacy|21|||
49138896|NCT01334515|158345939|FG000|Overall Study|Physician Decision|1|||
49138897|NCT01334515|158345940|FG001|Overall Study|Physician Decision|1|||
49138898|NCT01334515|158345939|FG000|Overall Study|Withdrawal by Subject|1|||
49138899|NCT01334515|158345940|FG001|Overall Study|Withdrawal by Subject|1|||
48727776|NCT01369485|156853368|FG001|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20|||
48727777|NCT01369485|156853367|FG000|Open Label Phase (Week 12 to Month 12)|Death|0|||
48727778|NCT01369485|156853368|FG001|Open Label Phase (Week 12 to Month 12)|Death|1|||
48727779|NCT01369485|156853367|FG000|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0|||
48727780|NCT01369485|156853368|FG001|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3|||
48727781|NCT02140775|156853369|FG000|Overall Study|Withdrawal by Subject|30|||
48727782|NCT02140775|156853370|FG001|Overall Study|Withdrawal by Subject|7|||
48727783|NCT03783702|156853371|FG000|Overall Study|Lost to Follow-up|6|||
48727784|NCT03783702|156853372|FG001|Overall Study|Lost to Follow-up|8|||
48727785|NCT03783702|156853371|FG000|Overall Study|Protocol Violation|1|||
48727786|NCT03783702|156853372|FG001|Overall Study|Protocol Violation|3|||
48727787|NCT01306877|156853373|FG000|Overall Study|Lost to Follow-up|3|||
48727788|NCT01306877|156853374|FG001|Overall Study|Lost to Follow-up|3|||
48727789|NCT01306877|156853373|FG000|Overall Study|Physician Decision|0|||
48727790|NCT01306877|156853374|FG001|Overall Study|Physician Decision|1|||
48727791|NCT00459979|156853375|FG000|Overall Study|Withdrawal by Subject|1|||
48727792|NCT00459979|156853375|FG000|Overall Study|Protocol Violation|1|||
48727793|NCT00381381|156853376|FG000|Overall Study|Adverse Event|3|||
48727794|NCT00381381|156853376|FG000|Overall Study|Lost to Follow-up|52|||
48727795|NCT00381381|156853376|FG000|Overall Study|Withdrawal by Subject|9|||
48727796|NCT01227564|156853378|FG000|Overall Study|No Longer Willing to Participate|4|||
48727797|NCT01227564|156853379|FG001|Overall Study|No Longer Willing to Participate|2|||
48727798|NCT01227564|156853380|FG002|Overall Study|No Longer Willing to Participate|5|||
48727799|NCT01227564|156853378|FG000|Overall Study|Participant moved to another town|0|||
48727800|NCT01227564|156853379|FG001|Overall Study|Participant moved to another town|0|||
48821568|NCT01473420|157188705|FG001|Titration Period (18 Weeks)|Adverse Event|6|||
48821569|NCT01473420|157188704|FG000|Titration Period (18 Weeks)|Did not meet criteria|32|||
49138900|NCT01311661|158345941|FG000|Overall Study|Adverse Event|2|||
49138901|NCT01311661|158345941|FG000|Overall Study|Protocol Violation|3|||
49138902|NCT01311661|158345941|FG000|Overall Study|Withdrawal by Subject|2|||
49138903|NCT00604383|158345942|FG000|Overall Study|Withdrawal by Subject|33|||
49138904|NCT00604383|158345943|FG001|Overall Study|Withdrawal by Subject|31|||
49138905|NCT00604383|158345942|FG000|Overall Study|Lost to Follow-up|24|||
49138906|NCT00604383|158345943|FG001|Overall Study|Lost to Follow-up|19|||
49138907|NCT00604383|158345942|FG000|Overall Study|Death|14|||
48821570|NCT01473420|157188705|FG001|Titration Period (18 Weeks)|Did not meet criteria|32|||
49138908|NCT00604383|158345943|FG001|Overall Study|Death|22|||
49138909|NCT00604383|158345942|FG000|Overall Study|Adverse Event|16|||
49138910|NCT00604383|158345943|FG001|Overall Study|Adverse Event|9|||
49138911|NCT00604383|158345942|FG000|Overall Study|Physician Decision|0|||
49138912|NCT00604383|158345943|FG001|Overall Study|Physician Decision|3|||
49138913|NCT02287025|158345944|FG000|Overall Study|Not treated|2|||
49138914|NCT02287025|158345945|FG001|Overall Study|Not treated|0|||
49138915|NCT02287025|158345944|FG000|Overall Study|Progression of disease|3|||
48727801|NCT01227564|156853380|FG002|Overall Study|Participant moved to another town|1|||
48727802|NCT00745615|156853387|FG000|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3|||
48727803|NCT00745615|156853388|FG001|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1|||
48821571|NCT01473420|157188704|FG000|Maintenance Period (16 Weeks)|Adverse Event|3|||
49011523|NCT00252187|157878994|FG000|Overall Study|Adverse Event|3|||
49138916|NCT02287025|158345945|FG001|Overall Study|Progression of disease|2|||
49138917|NCT02287025|158345944|FG000|Overall Study|Adverse Event|2|||
49138918|NCT02287025|158345945|FG001|Overall Study|Adverse Event|4|||
48727804|NCT00745615|156853389|FG002|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
49138919|NCT02287025|158345944|FG000|Overall Study|Withdrawal by Subject|2|||
49138920|NCT02287025|158345945|FG001|Overall Study|Withdrawal by Subject|2|||
49138921|NCT02287025|158345944|FG000|Overall Study|Screening failed|1|||
49138922|NCT02287025|158345945|FG001|Overall Study|Screening failed|1|||
49138923|NCT00899847|158345946|FG000|Overall Study|Lack of suitable allogeneic donor|2|||
49138924|NCT00221104|158345955|FG000|Overall Study|Adverse Event|1|||
49138925|NCT00221104|158345956|FG001|Overall Study|Adverse Event|0|||
49138926|NCT00221104|158345955|FG000|Overall Study|Physician Decision|1|||
49138927|NCT00221104|158345956|FG001|Overall Study|Physician Decision|0|||
49138928|NCT00221104|158345955|FG000|Overall Study|Protocol Violation|2|||
49138929|NCT00221104|158345956|FG001|Overall Study|Protocol Violation|0|||
49138930|NCT00221104|158345955|FG000|Overall Study|Withdrawal by Subject|42|||
49138931|NCT00221104|158345956|FG001|Overall Study|Withdrawal by Subject|29|||
49138932|NCT00221104|158345955|FG000|Overall Study|Others|37|||
49138933|NCT00221104|158345956|FG001|Overall Study|Others|47|||
49138934|NCT00876343|158345957|FG000|Overall Study|Adverse Event|7|||
49138935|NCT00876343|158345958|FG001|Overall Study|Adverse Event|8|||
49138936|NCT00876343|158345959|FG002|Overall Study|Adverse Event|2|||
49138937|NCT00876343|158345957|FG000|Overall Study|Withdrawal by Subject|4|||
49138938|NCT00876343|158345958|FG001|Overall Study|Withdrawal by Subject|4|||
49138939|NCT00876343|158345959|FG002|Overall Study|Withdrawal by Subject|3|||
49138940|NCT00876343|158345957|FG000|Overall Study|Lack of Efficacy|0|||
49138941|NCT00876343|158345958|FG001|Overall Study|Lack of Efficacy|0|||
49138942|NCT00876343|158345959|FG002|Overall Study|Lack of Efficacy|1|||
49138943|NCT00876343|158345957|FG000|Overall Study|Protocol Violation|4|||
48727805|NCT00745615|156853390|FG003|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4|||
48727806|NCT00745615|156853391|FG004|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
48727807|NCT00745615|156853392|FG005|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
49138944|NCT00876343|158345958|FG001|Overall Study|Protocol Violation|1|||
49138945|NCT00876343|158345959|FG002|Overall Study|Protocol Violation|1|||
49138946|NCT00876343|158345957|FG000|Overall Study|Physician Decision|0|||
49138947|NCT00876343|158345958|FG001|Overall Study|Physician Decision|1|||
49138948|NCT00876343|158345959|FG002|Overall Study|Physician Decision|1|||
49138949|NCT00876343|158345957|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
49138950|NCT00876343|158345958|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
49138951|NCT00876343|158345959|FG002|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
49138952|NCT00876343|158345957|FG000|Overall Study|Change of residence or other commitments|2|||
49138953|NCT00876343|158345958|FG001|Overall Study|Change of residence or other commitments|2|||
49138954|NCT00876343|158345959|FG002|Overall Study|Change of residence or other commitments|3|||
48727808|NCT00745615|156853387|FG000|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
48727809|NCT00745615|156853388|FG001|Double-Blind Extension (36 Weeks)|Physician Decision|1|||
48921182|NCT00159861|157544861|FG001|Core Study - 16 Weeks|Randomized but not Treated|0|||
49138955|NCT01279200|158345962|FG000|Overall Study|Withdrawal by Subject|1|||
49138956|NCT01279200|158345963|FG001|Overall Study|Withdrawal by Subject|3|||
49138957|NCT01279200|158345962|FG000|Overall Study|Patient withdrawal due to high cost|0|||
49138958|NCT01279200|158345963|FG001|Overall Study|Patient withdrawal due to high cost|1|||
49138959|NCT01279200|158345962|FG000|Overall Study|Inconvenience of ultrasound visit|0|||
48727810|NCT00745615|156853389|FG002|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
48727811|NCT00745615|156853390|FG003|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
48727812|NCT00745615|156853391|FG004|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
48727813|NCT00745615|156853392|FG005|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
48727814|NCT00745615|156853387|FG000|Double-Blind Extension (36 Weeks)|Adverse Event|2|||
48727815|NCT00745615|156853388|FG001|Double-Blind Extension (36 Weeks)|Adverse Event|3|||
48727816|NCT00745615|156853389|FG002|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
48727817|NCT00745615|156853390|FG003|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
48727818|NCT00745615|156853391|FG004|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
48727819|NCT00745615|156853392|FG005|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
48727820|NCT00745615|156853387|FG000|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
48727821|NCT00745615|156853388|FG001|Double-Blind Extension (36 Weeks)|Pregnancy|1|||
48727822|NCT00745615|156853389|FG002|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
48727823|NCT00745615|156853390|FG003|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
48921183|NCT00159861|157544860|FG000|Extension Study - up to 3 Years|Death|24|||
48727824|NCT00745615|156853391|FG004|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
48727825|NCT00745615|156853392|FG005|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
48727826|NCT00745615|156853387|FG000|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
48727827|NCT00745615|156853388|FG001|Double-Blind Extension (36 Weeks)|Other Than Specified|1|||
48727828|NCT00745615|156853389|FG002|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
48727829|NCT00745615|156853390|FG003|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
48727830|NCT00745615|156853391|FG004|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
48727831|NCT00745615|156853392|FG005|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
48727832|NCT00745615|156853387|FG000|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
48727833|NCT00745615|156853388|FG001|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
48727834|NCT00745615|156853389|FG002|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
49138960|NCT01279200|158345963|FG001|Overall Study|Inconvenience of ultrasound visit|1|||
49138961|NCT01279200|158345962|FG000|Overall Study|ultrasound screening failure|0|||
49138962|NCT01279200|158345963|FG001|Overall Study|ultrasound screening failure|1|||
49138963|NCT01279200|158345962|FG000|Overall Study|Lost to Follow-up|0|||
49138964|NCT01279200|158345963|FG001|Overall Study|Lost to Follow-up|1|||
49138965|NCT01279200|158345962|FG000|Overall Study|Adverse Event|1|||
49138966|NCT01279200|158345963|FG001|Overall Study|Adverse Event|0|||
49138967|NCT01901562|158345965|FG000|Overall Study|Protocol Violation|5|||
49138968|NCT01901562|158345965|FG000|Overall Study|Excluded intraoperatively|4|||
49138969|NCT02112552|158345966|FG000|Overall Study|Withdrawal by Subject|1|||
49138970|NCT02112552|158345966|FG000|Overall Study|Adverse Event|1|||
48727835|NCT00745615|156853390|FG003|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
48727836|NCT00745615|156853391|FG004|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
48727837|NCT00745615|156853392|FG005|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
48727838|NCT00745615|156853387|FG000|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
48727839|NCT00745615|156853388|FG001|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
48727840|NCT00745615|156853389|FG002|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
48727841|NCT00745615|156853390|FG003|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
48727842|NCT00745615|156853391|FG004|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
48727843|NCT00745615|156853392|FG005|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
48727844|NCT00745615|156853387|FG000|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
48727845|NCT00745615|156853388|FG001|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
48727846|NCT00745615|156853389|FG002|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
48727847|NCT00745615|156853390|FG003|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
48727848|NCT00745615|156853391|FG004|Open-Label (up to Approx 10.5 Years)|Physician Decision|9|||
48727849|NCT00745615|156853392|FG005|Open-Label (up to Approx 10.5 Years)|Physician Decision|11|||
48727850|NCT00745615|156853387|FG000|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
48727851|NCT00745615|156853388|FG001|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
48727852|NCT00745615|156853389|FG002|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
48727853|NCT00745615|156853390|FG003|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
48727854|NCT00745615|156853391|FG004|Open-Label (up to Approx 10.5 Years)|Adverse Event|2|||
48727855|NCT00745615|156853392|FG005|Open-Label (up to Approx 10.5 Years)|Adverse Event|8|||
48727856|NCT00745615|156853387|FG000|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
48727857|NCT00745615|156853388|FG001|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
48727858|NCT00745615|156853389|FG002|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
48727859|NCT00745615|156853390|FG003|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
48727860|NCT00745615|156853391|FG004|Open-Label (up to Approx 10.5 Years)|Pregnancy|2|||
48727861|NCT00745615|156853392|FG005|Open-Label (up to Approx 10.5 Years)|Pregnancy|5|||
49138971|NCT00774748|158345967|FG000|Overall Study|Lost to Follow-up|3|||
49138972|NCT03349515|158345970|FG000|Overall Study|Lack of Efficacy|2|||
49138973|NCT03349515|158345971|FG001|Overall Study|Lack of Efficacy|0|||
49138974|NCT03349515|158345970|FG000|Overall Study|Physician Decision|3|||
48727862|NCT00745615|156853387|FG000|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
48727863|NCT00745615|156853388|FG001|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
48727864|NCT00745615|156853389|FG002|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
48727865|NCT00745615|156853390|FG003|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
48727866|NCT00745615|156853391|FG004|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1|||
48727867|NCT00745615|156853392|FG005|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3|||
49138975|NCT03349515|158345971|FG001|Overall Study|Physician Decision|1|||
49138976|NCT02336503|158345972|FG000|Overall Study|Lost to Follow-up|0|||
49138977|NCT02336503|158345973|FG001|Overall Study|Lost to Follow-up|3|||
48727868|NCT00745615|156853387|FG000|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
49011524|NCT00252187|157878995|FG001|Overall Study|Adverse Event|1|||
49138978|NCT02336503|158345974|FG002|Overall Study|Lost to Follow-up|0|||
49138979|NCT02336503|158345975|FG003|Overall Study|Lost to Follow-up|2|||
49138980|NCT02336503|158345972|FG000|Overall Study|Withdrawal by Subject|2|||
49138981|NCT02336503|158345973|FG001|Overall Study|Withdrawal by Subject|0|||
49138982|NCT02336503|158345974|FG002|Overall Study|Withdrawal by Subject|0|||
49138983|NCT02336503|158345975|FG003|Overall Study|Withdrawal by Subject|4|||
49138984|NCT02336503|158345972|FG000|Overall Study|Adverse Event|0|||
49138985|NCT02336503|158345973|FG001|Overall Study|Adverse Event|0|||
49138986|NCT02336503|158345974|FG002|Overall Study|Adverse Event|1|||
49138987|NCT02336503|158345975|FG003|Overall Study|Adverse Event|0|||
49138988|NCT00896233|158345976|FG000|Overall Study|Claustrophobia during MRI|1|||
49138989|NCT00088153|158345977|FG000|Overall Study|Physician Decision|3|||
49138990|NCT00088153|158345978|FG001|Overall Study|Physician Decision|3|||
49138991|NCT00088153|158345977|FG000|Overall Study|Withdrawal by Subject|10|||
49138992|NCT00088153|158345978|FG001|Overall Study|Withdrawal by Subject|10|||
48727869|NCT00745615|156853388|FG001|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
48727870|NCT00745615|156853389|FG002|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
48727871|NCT00745615|156853390|FG003|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
48727872|NCT00745615|156853391|FG004|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
48727873|NCT00745615|156853392|FG005|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1|||
48727874|NCT00745615|156853387|FG000|Open-Label (up to Approx 10.5 Years)|Death|0|||
48727875|NCT00745615|156853388|FG001|Open-Label (up to Approx 10.5 Years)|Death|0|||
48727876|NCT00745615|156853389|FG002|Open-Label (up to Approx 10.5 Years)|Death|0|||
48727877|NCT00745615|156853390|FG003|Open-Label (up to Approx 10.5 Years)|Death|0|||
48727878|NCT00745615|156853391|FG004|Open-Label (up to Approx 10.5 Years)|Death|0|||
48727879|NCT00745615|156853392|FG005|Open-Label (up to Approx 10.5 Years)|Death|1|||
48727880|NCT00745615|156853387|FG000|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
48727881|NCT00745615|156853388|FG001|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
48727882|NCT00745615|156853389|FG002|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
48727883|NCT00745615|156853390|FG003|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
48727884|NCT00745615|156853391|FG004|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8|||
48727885|NCT00745615|156853392|FG005|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10|||
48727886|NCT00772070|156853395|FG000|Overall Study|Lost to Follow-up|0|||
48727887|NCT00772070|156853396|FG001|Overall Study|Lost to Follow-up|8|||
48727888|NCT00772070|156853395|FG000|Overall Study|Withdrawal by Subject|0|||
48727889|NCT00772070|156853396|FG001|Overall Study|Withdrawal by Subject|2|||
48727890|NCT00772070|156853395|FG000|Overall Study|Vaccination error-wrong dose/expired lot|2|||
48727891|NCT00772070|156853396|FG001|Overall Study|Vaccination error-wrong dose/expired lot|0|||
48727892|NCT01982331|156853397|FG000|Received Vaccination 2|Adverse Event|1|||
48727893|NCT01982331|156853398|FG001|Received Vaccination 2|Adverse Event|2|||
48727894|NCT01982331|156853397|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
48727895|NCT01982331|156853398|FG001|Received Vaccination 2|Withdrawal by Subject|1|||
48727896|NCT01982331|156853397|FG000|Completed Study (Day 112)|Withdrawal by Subject|2|||
48727897|NCT01982331|156853398|FG001|Completed Study (Day 112)|Withdrawal by Subject|0|||
48727898|NCT01962922|156853405|FG000|PK Portion Day 7|Withdrawal by Subject|3|||
48727899|NCT01962922|156853406|FG001|PK Portion Day 7|Withdrawal by Subject|0|||
48727900|NCT01962922|156853405|FG000|PK Portion Day 7|non-compliance|1|||
48727901|NCT01962922|156853406|FG001|PK Portion Day 7|non-compliance|0|||
48727902|NCT01962922|156853405|FG000|Extendion Portion (up to Month 6)|no longer wished to participate in study|4|||
48727903|NCT01962922|156853406|FG001|Extendion Portion (up to Month 6)|no longer wished to participate in study|3|||
48727904|NCT01962922|156853405|FG000|Extendion Portion (up to Month 6)|Physician Decision|1|||
48727905|NCT01962922|156853406|FG001|Extendion Portion (up to Month 6)|Physician Decision|0|||
48727906|NCT00568685|156853407|FG000|Overall Study|Adverse Event|2|||
49138993|NCT00088153|158345977|FG000|Overall Study|Lost to Follow-up|11|||
49138994|NCT00088153|158345978|FG001|Overall Study|Lost to Follow-up|12|||
49138995|NCT02232698|158345981|FG000|Overall Study|Pregnancy|1|||
49138996|NCT02232698|158345982|FG001|Overall Study|Pregnancy|1|||
49138997|NCT02232698|158345981|FG000|Overall Study|Met exclusion criteria|1|||
48727907|NCT00568685|156853408|FG001|Overall Study|Adverse Event|3|||
48727908|NCT00568685|156853409|FG002|Overall Study|Adverse Event|3|||
48727909|NCT00568685|156853407|FG000|Overall Study|Withdrawal by Subject|7|||
48727910|NCT00568685|156853408|FG001|Overall Study|Withdrawal by Subject|2|||
48727911|NCT00568685|156853409|FG002|Overall Study|Withdrawal by Subject|2|||
48727912|NCT00568685|156853407|FG000|Overall Study|Protocol Violation|1|||
48727913|NCT00568685|156853408|FG001|Overall Study|Protocol Violation|0|||
48727914|NCT00568685|156853409|FG002|Overall Study|Protocol Violation|0|||
49138998|NCT02232698|158345982|FG001|Overall Study|Met exclusion criteria|1|||
49138999|NCT02232698|158345981|FG000|Overall Study|Had device-associated symptoms|7|||
49139000|NCT02232698|158345982|FG001|Overall Study|Had device-associated symptoms|0|||
49139001|NCT02232698|158345981|FG000|Overall Study|Non-compliance with study device|1|||
49139002|NCT02232698|158345982|FG001|Overall Study|Non-compliance with study device|4|||
49139003|NCT02232698|158345981|FG000|Overall Study|Allocated to control group|0|||
49139004|NCT02232698|158345982|FG001|Overall Study|Allocated to control group|3|||
48727915|NCT01163032|156853410|FG000|Randomization Phase|Withdrawal by Subject|2|||
48727916|NCT01163032|156853411|FG001|Randomization Phase|Withdrawal by Subject|3|||
48727917|NCT01163032|156853412|FG002|Randomization Phase|Withdrawal by Subject|0|||
49139005|NCT02232698|158345981|FG000|Overall Study|Withdrawal by Subject|0|||
49139006|NCT02232698|158345982|FG001|Overall Study|Withdrawal by Subject|11|||
49139007|NCT01327703|158345983|FG000|Second Treatment Period|Adverse Event|1|||
49139008|NCT01327703|158345984|FG001|Second Treatment Period|Adverse Event|1|||
49139009|NCT01327703|158345983|FG000|Second Treatment Period|Protocol Violation|0|||
49139010|NCT01327703|158345984|FG001|Second Treatment Period|Protocol Violation|1|||
49139011|NCT00977561|158345985|FG000|Overall Study|Death|3|||
48727918|NCT01163032|156853410|FG000|Randomization Phase|Adverse Event|3|||
48727919|NCT01163032|156853411|FG001|Randomization Phase|Adverse Event|3|||
48727920|NCT01163032|156853412|FG002|Randomization Phase|Adverse Event|0|||
48727921|NCT01163032|156853410|FG000|Randomization Phase|Protocol Violation|0|||
49139012|NCT00977561|158345986|FG001|Overall Study|Death|2|||
49139013|NCT00977561|158345985|FG000|Overall Study|Study terminated|0|||
49139014|NCT00977561|158345986|FG001|Overall Study|Study terminated|2|||
49139015|NCT00977561|158345985|FG000|Overall Study|Other|2|||
49139016|NCT00977561|158345986|FG001|Overall Study|Other|0|||
49139017|NCT00433537|158345987|FG000|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
49139018|NCT00433537|158345988|FG001|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0|||
49139019|NCT00433537|158345989|FG002|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
49139020|NCT00433537|158345987|FG000|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
49139021|NCT00433537|158345988|FG001|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
49139022|NCT00433537|158345989|FG002|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2|||
49139023|NCT00433537|158345987|FG000|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
49139024|NCT00433537|158345988|FG001|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
49139025|NCT00433537|158345989|FG002|Step 1 - VcR-CVAD Induction|Adverse Event|4|||
49139026|NCT00433537|158345987|FG000|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
49139027|NCT00433537|158345988|FG001|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
49139028|NCT00433537|158345989|FG002|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2|||
49139029|NCT00433537|158345987|FG000|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1|||
49139030|NCT00433537|158345988|FG001|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
49139031|NCT00433537|158345989|FG002|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
49139032|NCT00433537|158345987|FG000|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8|||
49139033|NCT00433537|158345988|FG001|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
49139034|NCT00433537|158345989|FG002|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
49139035|NCT00433537|158345987|FG000|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2|||
49139036|NCT00433537|158345988|FG001|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
49139037|NCT00433537|158345989|FG002|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
49139038|NCT00433537|158345987|FG000|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4|||
49139039|NCT00433537|158345988|FG001|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
49139040|NCT00433537|158345989|FG002|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
49139041|NCT00433537|158345987|FG000|Step 2 - Maintenance Rituximab or ASCT|Other|1|||
49139042|NCT00433537|158345988|FG001|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
49139043|NCT00433537|158345989|FG002|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
49139044|NCT01428128|158345990|FG000|Overall Study|Withdrawal by Subject|4|||
49139045|NCT01428128|158345990|FG000|Overall Study|Screen failure by p53|10|||
49139046|NCT01428128|158345990|FG000|Overall Study|Received Neulasta in one cycle|2|||
49139047|NCT01428128|158345990|FG000|Overall Study|Adverse Event|1|||
49139048|NCT04124965|158345991|FG000|Overall Study|Adverse event, non-fatal|3|||
49139049|NCT04124965|158345992|FG001|Overall Study|Adverse event, non-fatal|1|||
49139050|NCT04124965|158345991|FG000|Overall Study|Withdrawal by Subject|1|||
49139051|NCT04124965|158345992|FG001|Overall Study|Withdrawal by Subject|1|||
49139052|NCT04124965|158345991|FG000|Overall Study|Rolled Over To MG0007 Study|25|||
49139053|NCT04124965|158345992|FG001|Overall Study|Rolled Over To MG0007 Study|28|||
49139054|NCT04124965|158345991|FG000|Overall Study|Pregnancy|1|||
49139055|NCT04124965|158345992|FG001|Overall Study|Pregnancy|0|||
49139056|NCT04124965|158345991|FG000|Overall Study|Sponsor and participant decision|0|||
49139057|NCT04124965|158345992|FG001|Overall Study|Sponsor and participant decision|1|||
49139058|NCT04124965|158345991|FG000|Overall Study|Personal surgery|0|||
49139059|NCT04124965|158345992|FG001|Overall Study|Personal surgery|1|||
49139060|NCT04124965|158345991|FG000|Overall Study|Physician Decision|0|||
49139061|NCT04124965|158345992|FG001|Overall Study|Physician Decision|1|||
49139062|NCT01033071|158345997|FG000|Overall Study|Adverse Event|28|||
49139063|NCT01033071|158345998|FG001|Overall Study|Adverse Event|51|||
49139064|NCT01033071|158345999|FG002|Overall Study|Adverse Event|26|||
49139065|NCT01033071|158345997|FG000|Overall Study|Protocol Violation|0|||
49139066|NCT01033071|158345998|FG001|Overall Study|Protocol Violation|2|||
49139067|NCT01033071|158345999|FG002|Overall Study|Protocol Violation|1|||
49139068|NCT01033071|158345997|FG000|Overall Study|Lost to Follow-up|4|||
49139069|NCT01033071|158345998|FG001|Overall Study|Lost to Follow-up|5|||
49139070|NCT01033071|158345999|FG002|Overall Study|Lost to Follow-up|5|||
49139071|NCT01033071|158345997|FG000|Overall Study|Withdrawal by Subject|17|||
49139072|NCT01033071|158345998|FG001|Overall Study|Withdrawal by Subject|14|||
49139073|NCT01033071|158345999|FG002|Overall Study|Withdrawal by Subject|11|||
48727922|NCT01163032|156853411|FG001|Randomization Phase|Protocol Violation|1|||
48727923|NCT01163032|156853412|FG002|Randomization Phase|Protocol Violation|0|||
48727924|NCT01163032|156853410|FG000|Randomization Phase|Various*|5|||
48727925|NCT01163032|156853411|FG001|Randomization Phase|Various*|4|||
49139074|NCT01033071|158345997|FG000|Overall Study|Lack of Efficacy|0|||
49139075|NCT01033071|158345998|FG001|Overall Study|Lack of Efficacy|1|||
49139076|NCT01033071|158345999|FG002|Overall Study|Lack of Efficacy|1|||
49139077|NCT01033071|158345997|FG000|Overall Study|Other|6|||
48921184|NCT00159861|157544861|FG001|Extension Study - up to 3 Years|Death|28|||
48921185|NCT00159861|157544860|FG000|Extension Study - up to 3 Years|Adverse Event|14|||
48921186|NCT00159861|157544861|FG001|Extension Study - up to 3 Years|Adverse Event|14|||
48921187|NCT00159861|157544860|FG000|Extension Study - up to 3 Years|Lack of Efficacy|5|||
48727926|NCT01163032|156853412|FG002|Randomization Phase|Various*|0|||
48727927|NCT01163032|156853410|FG000|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
48921188|NCT00159861|157544861|FG001|Extension Study - up to 3 Years|Lack of Efficacy|1|||
48921189|NCT00159861|157544860|FG000|Extension Study - up to 3 Years|Reason Unspecified|12|||
48921190|NCT00159861|157544861|FG001|Extension Study - up to 3 Years|Reason Unspecified|19|||
48921191|NCT00159861|157544860|FG000|Extension Study - up to 3 Years|Withdrawal by Subject|7|||
48921192|NCT00159861|157544861|FG001|Extension Study - up to 3 Years|Withdrawal by Subject|9|||
48921193|NCT01632566|157544863|FG000|Overall Study|Withdrawal by Subject|0|||
48921194|NCT01632566|157544864|FG001|Overall Study|Withdrawal by Subject|1|||
48921195|NCT01632566|157544865|FG002|Overall Study|Withdrawal by Subject|0|||
48921196|NCT01632566|157544866|FG003|Overall Study|Withdrawal by Subject|0|||
48921197|NCT01632566|157544867|FG004|Overall Study|Withdrawal by Subject|0|||
48921198|NCT01632566|157544863|FG000|Overall Study|Sponsor Decision|0|||
48921199|NCT01632566|157544864|FG001|Overall Study|Sponsor Decision|2|||
48921200|NCT01632566|157544865|FG002|Overall Study|Sponsor Decision|9|||
48921201|NCT01632566|157544866|FG003|Overall Study|Sponsor Decision|2|||
48921202|NCT01632566|157544867|FG004|Overall Study|Sponsor Decision|2|||
48921203|NCT01100437|157544870|FG000|Titration/Stabilization|Adverse Event|0|||
48921204|NCT01100437|157544871|FG001|Titration/Stabilization|Adverse Event|0|||
48921205|NCT01100437|157544872|FG002|Titration/Stabilization|Adverse Event|4|||
48921206|NCT01100437|157544870|FG000|Titration/Stabilization|Non-compliance|0|||
48921207|NCT01100437|157544871|FG001|Titration/Stabilization|Non-compliance|0|||
48921208|NCT01100437|157544872|FG002|Titration/Stabilization|Non-compliance|1|||
48921209|NCT01100437|157544870|FG000|Titration/Stabilization|Sponsor canceled study|0|||
48921210|NCT01100437|157544871|FG001|Titration/Stabilization|Sponsor canceled study|0|||
48921211|NCT01100437|157544872|FG002|Titration/Stabilization|Sponsor canceled study|1|||
48921212|NCT01100437|157544870|FG000|Maintenance|Withdrawal by Subject|0|||
48921213|NCT01100437|157544871|FG001|Maintenance|Withdrawal by Subject|0|||
48921214|NCT01100437|157544872|FG002|Maintenance|Withdrawal by Subject|1|||
48921215|NCT01100437|157544870|FG000|Maintenance|Sponsor termination of study|0|||
49139078|NCT01033071|158345998|FG001|Overall Study|Other|4|||
49139079|NCT01033071|158345999|FG002|Overall Study|Other|3|||
49139080|NCT01127061|158348215|FG000|Overall Study|Lost to Follow-up|7|||
49139081|NCT01127061|158348216|FG001|Overall Study|Lost to Follow-up|10|||
49139082|NCT01127061|158348215|FG000|Overall Study|Physician Decision|3|||
49139083|NCT01127061|158348216|FG001|Overall Study|Physician Decision|3|||
49139084|NCT03595748|158348219|FG000|Overall Study|Death|11|||
49139085|NCT03595748|158348220|FG001|Overall Study|Death|12|||
49139086|NCT03595748|158348219|FG000|Overall Study|Withdrawal by Subject|28|||
49139087|NCT03595748|158348220|FG001|Overall Study|Withdrawal by Subject|29|||
49139088|NCT03595748|158348219|FG000|Overall Study|Protocol Violation|0|||
49139089|NCT03595748|158348220|FG001|Overall Study|Protocol Violation|1|||
49139090|NCT00479232|158348223|FG000|Overall Study|Adverse Event|0|||
49139091|NCT00479232|158348224|FG001|Overall Study|Adverse Event|0|||
49139092|NCT00479232|158348225|FG002|Overall Study|Adverse Event|5|||
49139093|NCT00479232|158348226|FG003|Overall Study|Adverse Event|0|||
49139094|NCT00479232|158348227|FG004|Overall Study|Adverse Event|0|||
49139095|NCT00479232|158348228|FG005|Overall Study|Adverse Event|10|||
49139096|NCT00479232|158348223|FG000|Overall Study|Deviation from Protocol|0|||
49139097|NCT00479232|158348224|FG001|Overall Study|Deviation from Protocol|0|||
49139098|NCT00479232|158348225|FG002|Overall Study|Deviation from Protocol|1|||
49139099|NCT00479232|158348226|FG003|Overall Study|Deviation from Protocol|0|||
49139100|NCT00479232|158348227|FG004|Overall Study|Deviation from Protocol|0|||
49139101|NCT00479232|158348228|FG005|Overall Study|Deviation from Protocol|0|||
49139102|NCT00479232|158348223|FG000|Overall Study|Lack of Efficacy|0|||
49139103|NCT00479232|158348224|FG001|Overall Study|Lack of Efficacy|0|||
49139104|NCT00479232|158348225|FG002|Overall Study|Lack of Efficacy|2|||
49139105|NCT00479232|158348226|FG003|Overall Study|Lack of Efficacy|0|||
49139106|NCT00479232|158348227|FG004|Overall Study|Lack of Efficacy|0|||
49139107|NCT00479232|158348228|FG005|Overall Study|Lack of Efficacy|4|||
49139108|NCT00479232|158348223|FG000|Overall Study|Physician Decision|0|||
49139109|NCT00479232|158348224|FG001|Overall Study|Physician Decision|0|||
49139110|NCT00479232|158348225|FG002|Overall Study|Physician Decision|2|||
49139111|NCT00479232|158348226|FG003|Overall Study|Physician Decision|0|||
49139112|NCT00479232|158348227|FG004|Overall Study|Physician Decision|0|||
49139113|NCT00479232|158348228|FG005|Overall Study|Physician Decision|1|||
49139114|NCT00479232|158348223|FG000|Overall Study|Progressive Disease|3|||
49139115|NCT00479232|158348224|FG001|Overall Study|Progressive Disease|1|||
49139116|NCT00479232|158348225|FG002|Overall Study|Progressive Disease|12|||
49139117|NCT00479232|158348226|FG003|Overall Study|Progressive Disease|3|||
49139118|NCT00479232|158348227|FG004|Overall Study|Progressive Disease|3|||
49139119|NCT00479232|158348228|FG005|Overall Study|Progressive Disease|12|||
48727928|NCT01163032|156853411|FG001|Randomization Phase|Unsatisfactory Therapeutic Effect|1|||
48727929|NCT01163032|156853412|FG002|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
48727930|NCT01163032|156853410|FG000|Open Label Extension Phase|Adverse Event|0|||
48727931|NCT01163032|156853411|FG001|Open Label Extension Phase|Adverse Event|0|||
48727932|NCT01163032|156853412|FG002|Open Label Extension Phase|Adverse Event|3|||
48727933|NCT01163032|156853410|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
48727934|NCT01163032|156853411|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
48727935|NCT01163032|156853412|FG002|Open Label Extension Phase|Withdrawal by Subject|3|||
48727936|NCT01163032|156853410|FG000|Open Label Extension Phase|Protocol Violation|0|||
48727937|NCT01163032|156853411|FG001|Open Label Extension Phase|Protocol Violation|0|||
48727938|NCT01163032|156853412|FG002|Open Label Extension Phase|Protocol Violation|1|||
48727939|NCT01163032|156853410|FG000|Open Label Extension Phase|Study Termination|0|||
48727940|NCT01163032|156853411|FG001|Open Label Extension Phase|Study Termination|0|||
48727941|NCT01163032|156853412|FG002|Open Label Extension Phase|Study Termination|7|||
48727942|NCT01163032|156853410|FG000|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
48727943|NCT01163032|156853411|FG001|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
48727944|NCT01163032|156853412|FG002|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2|||
48727945|NCT03687970|156853413|FG000|Overall Study|visit scheduling conflicts|2|||
48727946|NCT03687970|156853414|FG001|Overall Study|visit scheduling conflicts|0|||
48821572|NCT01473420|157188705|FG001|Maintenance Period (16 Weeks)|Adverse Event|2|||
48821573|NCT01473420|157188704|FG000|Maintenance Period (16 Weeks)|Physician Decision|1|||
48821574|NCT01473420|157188705|FG001|Maintenance Period (16 Weeks)|Physician Decision|2|||
48821575|NCT01473420|157188704|FG000|Maintenance Period (16 Weeks)|Did not meet criteria|0|||
48821576|NCT01473420|157188705|FG001|Maintenance Period (16 Weeks)|Did not meet criteria|2|||
48821577|NCT01473420|157188704|FG000|Maintenance Period (16 Weeks)|Kidney transplant|3|||
48821578|NCT01473420|157188705|FG001|Maintenance Period (16 Weeks)|Kidney transplant|1|||
49139120|NCT00479232|158348223|FG000|Overall Study|Withdrew Consent|0|||
49139121|NCT00479232|158348224|FG001|Overall Study|Withdrew Consent|2|||
49139122|NCT00479232|158348225|FG002|Overall Study|Withdrew Consent|6|||
49139123|NCT00479232|158348226|FG003|Overall Study|Withdrew Consent|0|||
49139124|NCT00479232|158348227|FG004|Overall Study|Withdrew Consent|1|||
49139125|NCT00479232|158348228|FG005|Overall Study|Withdrew Consent|3|||
49139126|NCT00690898|158348230|FG000|SCREENING|Screen failure|18|||
49139127|NCT00690898|158348230|FG000|TREATMENT|Adverse Event|3|||
49139128|NCT00690898|158348230|FG000|TREATMENT|Lack of Efficacy|18|||
49139129|NCT00690898|158348230|FG000|TREATMENT|Withdrawal by Subject|4|||
49139130|NCT00690898|158348230|FG000|TREATMENT|Other (not otherwise specified)|1|||
49139131|NCT03807843|158348233|FG000|Overall Study|Lost to Follow-up|1|||
49139132|NCT03807843|158348234|FG001|Overall Study|Lost to Follow-up|0|||
49139133|NCT01312129|158348235|FG000|Second Intervention (24 Hours)|Lost to Follow-up|0|||
49139134|NCT01312129|158348236|FG001|Second Intervention (24 Hours)|Lost to Follow-up|1|||
49139135|NCT03720847|158348237|FG000|Washout|Physician Decision|1|||
49139136|NCT03720847|158348238|FG001|Washout|Physician Decision|2|||
49139137|NCT03022630|158348239|FG000|Overall Study|Death|9|||
49139138|NCT03022630|158348240|FG001|Overall Study|Death|7|||
49139139|NCT03022630|158348239|FG000|Overall Study|Withdrawal by Subject|0|||
49139140|NCT03022630|158348240|FG001|Overall Study|Withdrawal by Subject|5|||
49139141|NCT00884949|158348241|FG000|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1|||
49139142|NCT00884949|158348241|FG000|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1|||
49139143|NCT01807520|158348242|FG000|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
49139144|NCT01807520|158348243|FG001|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1|||
49139145|NCT01807520|158348244|FG002|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3|||
49139146|NCT01807520|158348245|FG003|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
49139147|NCT01807520|158348246|FG004|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
49139148|NCT01807520|158348247|FG005|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
49139149|NCT01807520|158348248|FG006|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
49139150|NCT01807520|158348242|FG000|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
49139151|NCT01807520|158348243|FG001|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
49139152|NCT01807520|158348244|FG002|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
48821579|NCT01473420|157188704|FG000|Maintenance Period (16 Weeks)|Lost to Follow-up|1|||
49139153|NCT01807520|158348245|FG003|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
48727947|NCT02711345|156853415|FG000|Overall Study|Adverse Event|0|||
48727948|NCT02711345|156853416|FG001|Overall Study|Adverse Event|0|||
48727949|NCT02711345|156853417|FG002|Overall Study|Adverse Event|0|||
48727950|NCT02711345|156853418|FG003|Overall Study|Adverse Event|1|||
48727951|NCT02711345|156853419|FG004|Overall Study|Adverse Event|1|||
49139154|NCT01807520|158348246|FG004|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
49139155|NCT01807520|158348247|FG005|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
48727952|NCT02711345|156853420|FG005|Overall Study|Adverse Event|2|||
48727953|NCT02711345|156853421|FG006|Overall Study|Adverse Event|1|||
48727954|NCT02711345|156853422|FG007|Overall Study|Adverse Event|0|||
48727955|NCT02711345|156853423|FG008|Overall Study|Adverse Event|0|||
48727956|NCT02711345|156853424|FG009|Overall Study|Adverse Event|2|||
48727957|NCT02711345|156853415|FG000|Overall Study|Physician Decision|0|||
48727958|NCT02711345|156853416|FG001|Overall Study|Physician Decision|0|||
48727959|NCT02711345|156853417|FG002|Overall Study|Physician Decision|1|||
48727960|NCT02711345|156853418|FG003|Overall Study|Physician Decision|0|||
48727961|NCT02711345|156853419|FG004|Overall Study|Physician Decision|0|||
48727962|NCT02711345|156853420|FG005|Overall Study|Physician Decision|0|||
48727963|NCT02711345|156853421|FG006|Overall Study|Physician Decision|0|||
48727964|NCT02711345|156853422|FG007|Overall Study|Physician Decision|0|||
48727965|NCT02711345|156853423|FG008|Overall Study|Physician Decision|1|||
48727966|NCT02711345|156853424|FG009|Overall Study|Physician Decision|0|||
48727967|NCT02711345|156853415|FG000|Overall Study|Progressive disease|1|||
48727968|NCT02711345|156853416|FG001|Overall Study|Progressive disease|3|||
48727969|NCT02711345|156853417|FG002|Overall Study|Progressive disease|5|||
48727970|NCT02711345|156853418|FG003|Overall Study|Progressive disease|3|||
48727971|NCT02711345|156853419|FG004|Overall Study|Progressive disease|7|||
48727972|NCT02711345|156853420|FG005|Overall Study|Progressive disease|2|||
48727973|NCT02711345|156853421|FG006|Overall Study|Progressive disease|8|||
48727974|NCT02711345|156853422|FG007|Overall Study|Progressive disease|4|||
48727975|NCT02711345|156853423|FG008|Overall Study|Progressive disease|5|||
48727976|NCT02711345|156853424|FG009|Overall Study|Progressive disease|6|||
48727977|NCT02711345|156853415|FG000|Overall Study|Subject/guardian decision|0|||
48727978|NCT02711345|156853416|FG001|Overall Study|Subject/guardian decision|0|||
48727979|NCT02711345|156853417|FG002|Overall Study|Subject/guardian decision|0|||
48727980|NCT02711345|156853418|FG003|Overall Study|Subject/guardian decision|0|||
48727981|NCT02711345|156853419|FG004|Overall Study|Subject/guardian decision|0|||
48727982|NCT02711345|156853420|FG005|Overall Study|Subject/guardian decision|2|||
48727983|NCT02711345|156853421|FG006|Overall Study|Subject/guardian decision|3|||
48727984|NCT02711345|156853422|FG007|Overall Study|Subject/guardian decision|1|||
48727985|NCT02711345|156853423|FG008|Overall Study|Subject/guardian decision|0|||
48727986|NCT02711345|156853424|FG009|Overall Study|Subject/guardian decision|4|||
48727987|NCT02711345|156853415|FG000|Overall Study|Death|1|||
48727988|NCT02711345|156853416|FG001|Overall Study|Death|0|||
48727989|NCT02711345|156853417|FG002|Overall Study|Death|0|||
48727990|NCT02711345|156853418|FG003|Overall Study|Death|0|||
48727991|NCT02711345|156853419|FG004|Overall Study|Death|0|||
48727992|NCT02711345|156853420|FG005|Overall Study|Death|0|||
48727993|NCT02711345|156853421|FG006|Overall Study|Death|0|||
48727994|NCT02711345|156853422|FG007|Overall Study|Death|1|||
48727995|NCT02711345|156853423|FG008|Overall Study|Death|0|||
48727996|NCT02711345|156853424|FG009|Overall Study|Death|0|||
48727997|NCT00739596|156853425|FG000|Overall Study|Adverse Event|12|||
48727998|NCT00739596|156853426|FG001|Overall Study|Adverse Event|6|||
48727999|NCT00739596|156853425|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
48728000|NCT00739596|156853426|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
48728001|NCT00739596|156853425|FG000|Overall Study|Patient Withdrew Consent|8|||
48728002|NCT00739596|156853426|FG001|Overall Study|Patient Withdrew Consent|8|||
48728003|NCT00739596|156853425|FG000|Overall Study|Lost to Follow-up|0|||
48728004|NCT00739596|156853426|FG001|Overall Study|Lost to Follow-up|2|||
48728005|NCT00739596|156853425|FG000|Overall Study|Protocol Deviation|1|||
48728006|NCT00739596|156853426|FG001|Overall Study|Protocol Deviation|1|||
48728007|NCT01888003|156853429|FG000|Overall Study|Study Terminated|5|||
48728008|NCT01888003|156853430|FG001|Overall Study|Study Terminated|6|||
48728009|NCT01888003|156853431|FG002|Overall Study|Study Terminated|40|||
48821580|NCT01473420|157188705|FG001|Maintenance Period (16 Weeks)|Lost to Follow-up|2|||
48821581|NCT01473420|157188704|FG000|Maintenance Period (16 Weeks)|Withdrawal by Subject|4|||
48821582|NCT01473420|157188705|FG001|Maintenance Period (16 Weeks)|Withdrawal by Subject|6|||
48821583|NCT01473420|157188704|FG000|Maintenance Period (16 Weeks)|Site closure|3|||
48728010|NCT02734433|156853436|FG000|Overall Study|Disease progression|1|||
48728011|NCT02734433|156853437|FG001|Overall Study|Disease progression|5|||
48821584|NCT01473420|157188705|FG001|Maintenance Period (16 Weeks)|Site closure|1|||
48821585|NCT01473420|157188704|FG000|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1|||
48821586|NCT01473420|157188705|FG001|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0|||
48728012|NCT02734433|156853436|FG000|Overall Study|Clinical progression|0|||
48728013|NCT02734433|156853437|FG001|Overall Study|Clinical progression|1|||
48728014|NCT02734433|156853436|FG000|Overall Study|Withdrawal by Subject|1|||
48728015|NCT02734433|156853437|FG001|Overall Study|Withdrawal by Subject|2|||
48728016|NCT03505671|156854308|FG000|Overall Study|Withdrawal by Subject|2|||
48728017|NCT03505671|156854309|FG001|Overall Study|Withdrawal by Subject|1|||
48728018|NCT03505671|156854308|FG000|Overall Study|Lost to Follow-up|1|||
48728019|NCT03505671|156854309|FG001|Overall Study|Lost to Follow-up|0|||
48728020|NCT04423939|156854312|FG000|Overall Study|Still on study (but completed primary endpoint)|8|||
48728021|NCT04423939|156854313|FG001|Overall Study|Still on study (but completed primary endpoint)|8|||
48728022|NCT04423939|156854312|FG000|Overall Study|Death|3|||
48728023|NCT04423939|156854313|FG001|Overall Study|Death|0|||
48728024|NCT04423939|156854312|FG000|Overall Study|Withdrawal by Subject|3|||
48728025|NCT04423939|156854313|FG001|Overall Study|Withdrawal by Subject|0|||
48728026|NCT04423939|156854312|FG000|Overall Study|Caregiver to patient who died|0|||
48728027|NCT04423939|156854313|FG001|Overall Study|Caregiver to patient who died|3|||
48728028|NCT04423939|156854312|FG000|Overall Study|Caregiver to patient who withdrew|0|||
49139156|NCT01807520|158348248|FG006|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
49139157|NCT01807520|158348242|FG000|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
49139158|NCT01807520|158348243|FG001|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
49139159|NCT01807520|158348244|FG002|Treatment Period 1 (0-16 Weeks)|Physician Decision|1|||
49139160|NCT01807520|158348245|FG003|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
49139161|NCT01807520|158348246|FG004|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
49139162|NCT01807520|158348247|FG005|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
49139163|NCT01807520|158348248|FG006|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
49139164|NCT01807520|158348242|FG000|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1|||
49139165|NCT01807520|158348243|FG001|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
49139166|NCT01807520|158348244|FG002|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
49139167|NCT01807520|158348245|FG003|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
49139168|NCT01807520|158348246|FG004|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
49139169|NCT01807520|158348247|FG005|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
49139170|NCT01807520|158348248|FG006|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
49139171|NCT01807520|158348242|FG000|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
49139172|NCT01807520|158348243|FG001|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
49139173|NCT01807520|158348244|FG002|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2|||
49139174|NCT01807520|158348245|FG003|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
49139175|NCT01807520|158348246|FG004|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
49139176|NCT01807520|158348247|FG005|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
49139177|NCT01807520|158348248|FG006|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
49139178|NCT01807520|158348242|FG000|Treatment Period 1 (0-16 Weeks)|Adverse Event|2|||
49139179|NCT01807520|158348243|FG001|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
49139180|NCT01807520|158348244|FG002|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
49139181|NCT01807520|158348245|FG003|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
49139182|NCT01807520|158348246|FG004|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
49139183|NCT01807520|158348247|FG005|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
49139184|NCT01807520|158348248|FG006|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
49139185|NCT01807520|158348242|FG000|Treatment Period 2 (16-132 Weeks)|Study terminated|7|||
49139186|NCT01807520|158348243|FG001|Treatment Period 2 (16-132 Weeks)|Study terminated|4|||
49139187|NCT01807520|158348244|FG002|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
49139188|NCT01807520|158348245|FG003|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
49139189|NCT01807520|158348246|FG004|Treatment Period 2 (16-132 Weeks)|Study terminated|2|||
49139190|NCT01807520|158348247|FG005|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
49139191|NCT01807520|158348248|FG006|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
49139192|NCT01807520|158348242|FG000|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
49139193|NCT01807520|158348243|FG001|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
49139194|NCT01807520|158348244|FG002|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
48728029|NCT04423939|156854313|FG001|Overall Study|Caregiver to patient who withdrew|3|||
48728030|NCT04711135|156854314|FG000|Overall Study|Physician Decision|0|||
48728031|NCT04711135|156854315|FG001|Overall Study|Physician Decision|1|||
48728032|NCT04711135|156854314|FG000|Overall Study|Ongoing treatment|0|||
48728033|NCT04711135|156854315|FG001|Overall Study|Ongoing treatment|1|||
48728034|NCT01903525|156854322|FG000|Overall Study|Lost to Follow-up|5|||
48728035|NCT01903525|156854323|FG001|Overall Study|Lost to Follow-up|9|||
48728036|NCT01903525|156854322|FG000|Overall Study|Adverse Event|0|||
48728037|NCT01903525|156854323|FG001|Overall Study|Adverse Event|1|||
48728038|NCT02537574|156854324|FG000|Overall Study|Adverse Event|1|||
48728039|NCT02537574|156854325|FG001|Overall Study|Adverse Event|3|||
48728040|NCT02537574|156854326|FG002|Overall Study|Adverse Event|2|||
48728041|NCT02537574|156854324|FG000|Overall Study|Lost to Follow-up|40|||
49139195|NCT01807520|158348245|FG003|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1|||
49139196|NCT01807520|158348246|FG004|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
49139197|NCT01807520|158348247|FG005|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
49139198|NCT01807520|158348248|FG006|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
49139199|NCT01807520|158348242|FG000|Treatment Period 2 (16-132 Weeks)|Pregnancy|1|||
49139200|NCT01807520|158348243|FG001|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
49139201|NCT01807520|158348244|FG002|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
48728042|NCT02537574|156854325|FG001|Overall Study|Lost to Follow-up|51|||
48921216|NCT01100437|157544871|FG001|Maintenance|Sponsor termination of study|0|||
49139202|NCT01807520|158348245|FG003|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
49139203|NCT01807520|158348246|FG004|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
48728043|NCT02537574|156854326|FG002|Overall Study|Lost to Follow-up|55|||
48728044|NCT02537574|156854324|FG000|Overall Study|Noncompliance with study drug|0|||
48728045|NCT02537574|156854325|FG001|Overall Study|Noncompliance with study drug|1|||
48728046|NCT02537574|156854326|FG002|Overall Study|Noncompliance with study drug|1|||
48728047|NCT02537574|156854324|FG000|Overall Study|Physician Decision|2|||
48728048|NCT02537574|156854325|FG001|Overall Study|Physician Decision|0|||
48728049|NCT02537574|156854326|FG002|Overall Study|Physician Decision|0|||
48728050|NCT02537574|156854324|FG000|Overall Study|Protocol Violation|4|||
48728051|NCT02537574|156854325|FG001|Overall Study|Protocol Violation|2|||
48728052|NCT02537574|156854326|FG002|Overall Study|Protocol Violation|3|||
48728053|NCT02537574|156854324|FG000|Overall Study|Withdrawal by Subject|37|||
48728054|NCT02537574|156854325|FG001|Overall Study|Withdrawal by Subject|27|||
48728055|NCT02537574|156854326|FG002|Overall Study|Withdrawal by Subject|29|||
48728056|NCT02537574|156854324|FG000|Overall Study|Lack of Efficacy|14|||
48728057|NCT02537574|156854325|FG001|Overall Study|Lack of Efficacy|16|||
48728058|NCT02537574|156854326|FG002|Overall Study|Lack of Efficacy|15|||
48728059|NCT02537574|156854324|FG000|Overall Study|Duplicate Patient|1|||
48728060|NCT02537574|156854325|FG001|Overall Study|Duplicate Patient|0|||
48728061|NCT02537574|156854326|FG002|Overall Study|Duplicate Patient|0|||
48728062|NCT02537574|156854324|FG000|Overall Study|Patient not Stable|0|||
48728063|NCT02537574|156854325|FG001|Overall Study|Patient not Stable|1|||
48728064|NCT02537574|156854326|FG002|Overall Study|Patient not Stable|0|||
48728065|NCT02537574|156854324|FG000|Overall Study|Incarceration|0|||
48728066|NCT02537574|156854325|FG001|Overall Study|Incarceration|1|||
48728067|NCT02537574|156854326|FG002|Overall Study|Incarceration|0|||
48728068|NCT02537574|156854324|FG000|Overall Study|Failed Naloxone Challenge|0|||
48728069|NCT02537574|156854325|FG001|Overall Study|Failed Naloxone Challenge|1|||
48728070|NCT02537574|156854326|FG002|Overall Study|Failed Naloxone Challenge|0|||
48728071|NCT02537574|156854324|FG000|Overall Study|Transportation Issues|0|||
48728072|NCT02537574|156854325|FG001|Overall Study|Transportation Issues|0|||
48728073|NCT02537574|156854326|FG002|Overall Study|Transportation Issues|1|||
48728074|NCT02537574|156854324|FG000|Overall Study|Subject did not want last Vivitrol Injec|0|||
48728075|NCT02537574|156854325|FG001|Overall Study|Subject did not want last Vivitrol Injec|0|||
48728076|NCT02537574|156854326|FG002|Overall Study|Subject did not want last Vivitrol Injec|1|||
48728077|NCT02537574|156854324|FG000|Overall Study|Noncompliance with Protocol|0|||
48728078|NCT02537574|156854325|FG001|Overall Study|Noncompliance with Protocol|0|||
48728079|NCT02537574|156854326|FG002|Overall Study|Noncompliance with Protocol|1|||
48728080|NCT00433654|156854327|FG000|Overall Study|Death|4|||
48728081|NCT00433654|156854328|FG001|Overall Study|Death|0|||
48728082|NCT00433654|156854327|FG000|Overall Study|Missed visit|6|||
48728083|NCT00433654|156854328|FG001|Overall Study|Missed visit|3|||
48728084|NCT00433654|156854327|FG000|Overall Study|Subject not yet due for visit|4|||
48728085|NCT00433654|156854328|FG001|Overall Study|Subject not yet due for visit|0|||
48728086|NCT00433654|156854327|FG000|Overall Study|Withdrawal by Subject|1|||
48728087|NCT00433654|156854328|FG001|Overall Study|Withdrawal by Subject|2|||
48728088|NCT02663687|156854329|FG000|Overall Study|Adverse Event|1|||
48728089|NCT02663687|156854330|FG001|Overall Study|Adverse Event|0|||
48728090|NCT02663687|156854331|FG002|Overall Study|Adverse Event|0|||
48728091|NCT02663687|156854332|FG003|Overall Study|Adverse Event|0|||
48728092|NCT02663687|156854333|FG004|Overall Study|Adverse Event|0|||
48728093|NCT02663687|156854329|FG000|Overall Study|Other|1|||
48728094|NCT02663687|156854330|FG001|Overall Study|Other|0|||
48728095|NCT02663687|156854331|FG002|Overall Study|Other|1|||
48728096|NCT02663687|156854332|FG003|Overall Study|Other|0|||
48728097|NCT02663687|156854333|FG004|Overall Study|Other|0|||
48728098|NCT00679055|156854337|FG000|Overall Study|Adverse Event|0|||
48728099|NCT00679055|156854338|FG001|Overall Study|Adverse Event|1|||
48728100|NCT00679055|156854337|FG000|Overall Study|Other|0|||
48728101|NCT00679055|156854338|FG001|Overall Study|Other|3|||
48728102|NCT00679055|156854337|FG000|Overall Study|Study Terminated|2|||
48728103|NCT00679055|156854338|FG001|Overall Study|Study Terminated|1|||
48728104|NCT05291689|156854339|FG000|Overall Study|Adverse Event|3|||
48728105|NCT05291689|156854339|FG000|Overall Study|Lack of Efficacy|10|||
48821587|NCT01473420|157188704|FG000|Maintenance Period (16 Weeks)|Long term hospitalization|0|||
48821588|NCT01473420|157188705|FG001|Maintenance Period (16 Weeks)|Long term hospitalization|1|||
48821589|NCT01473420|157188704|FG000|Maintenance Period (16 Weeks)|Sponsor's Decision|1|||
48821590|NCT01473420|157188705|FG001|Maintenance Period (16 Weeks)|Sponsor's Decision|0|||
48821591|NCT01473420|157188704|FG000|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1|||
48821592|NCT01473420|157188705|FG001|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0|||
48821593|NCT00761774|157188706|FG000|Overall Study|Adverse Event|17|||
48821594|NCT00761774|157188706|FG000|Overall Study|Lack of Efficacy|37|||
48821595|NCT00761774|157188706|FG000|Overall Study|Lost to Follow-up|2|||
48821596|NCT00761774|157188706|FG000|Overall Study|Withdrawal by Subject|9|||
48821597|NCT00761774|157188706|FG000|Overall Study|Non-compliance|4|||
48821598|NCT00761774|157188706|FG000|Overall Study|End of study|2|||
48821599|NCT00761774|157188706|FG000|Overall Study|Reclassification of seizures|1|||
48821600|NCT00761774|157188706|FG000|Overall Study|Medical decision to read SUSAR reports|1|||
48821601|NCT00761774|157188706|FG000|Overall Study|Sponsor decision|1|||
48821602|NCT00761774|157188706|FG000|Overall Study|Investigator clinical judgement|1|||
48821603|NCT00761774|157188706|FG000|Overall Study|Patient moved out of study area|1|||
48728106|NCT05291689|156854339|FG000|Overall Study|Withdrawal by Subject|4|||
48728107|NCT01222403|156854340|FG000|Overall Study|Inappropriate enrollment|0|||
48728108|NCT01222403|156854341|FG001|Overall Study|Inappropriate enrollment|2|||
48728109|NCT02017171|156854346|FG000|Overall Study|Death|10|||
48728110|NCT02017171|156854347|FG001|Overall Study|Death|4|||
48821604|NCT00761774|157188706|FG000|Overall Study|Coordinator leaving site|1|||
48821605|NCT00761774|157188706|FG000|Overall Study|Subject IP non-compliance|1|||
48821606|NCT00761774|157188706|FG000|Overall Study|IP stopped by hospital physician|1|||
48821607|NCT01077024|157188707|FG000|Overall Study|Lost to Follow-up|20|||
48821608|NCT01077024|157188708|FG001|Overall Study|Lost to Follow-up|14|||
48821609|NCT01077024|157188707|FG000|Overall Study|Withdrawal by Subject|0|||
48821610|NCT01077024|157188708|FG001|Overall Study|Withdrawal by Subject|2|||
48821611|NCT01077024|157188707|FG000|Overall Study|Incarcerated|7|||
48821612|NCT01077024|157188708|FG001|Overall Study|Incarcerated|8|||
48821613|NCT01077024|157188707|FG000|Overall Study|Other|4|||
48821614|NCT01077024|157188708|FG001|Overall Study|Other|4|||
48821615|NCT03379233|157188709|FG000|Overall Study|Technical issues with Concept 2 inhalers|1|||
48821616|NCT03379233|157188710|FG001|Overall Study|Technical issues with Concept 2 inhalers|6|||
48821617|NCT00965484|157188711|FG000|Overall Study|Protocol Violation|1|||
48821618|NCT00965484|157188711|FG000|Overall Study|Withdrawal by Subject|1|||
48821619|NCT01603121|157188712|FG000|Second Intervention, 10 Hours|Adverse Event|1|||
48821620|NCT01603121|157188713|FG001|Second Intervention, 10 Hours|Adverse Event|0|||
48821621|NCT02839681|157188719|FG000|Overall Study|Death|2|||
48821622|NCT00738530|157188720|FG000|Overall Study|Death|220|||
48821623|NCT00738530|157188721|FG001|Overall Study|Death|224|||
48728111|NCT02017171|156854346|FG000|Overall Study|Withdrawal by Subject|23|||
48821624|NCT00738530|157188720|FG000|Overall Study|Lost to Follow-up|8|||
48821625|NCT00738530|157188721|FG001|Overall Study|Lost to Follow-up|6|||
48821626|NCT00738530|157188720|FG000|Overall Study|Withdrawal by Subject|6|||
48821627|NCT00738530|157188721|FG001|Overall Study|Withdrawal by Subject|8|||
48821628|NCT01656759|157188722|FG000|Overall Study|Protocol Violation|2|||
48821629|NCT01656759|157188723|FG001|Overall Study|Protocol Violation|3|||
48821630|NCT00772928|157188724|FG000|Overall Study|Lost to Follow-up|9|||
48821631|NCT00772928|157188725|FG001|Overall Study|Lost to Follow-up|6|||
48821632|NCT00772928|157188724|FG000|Overall Study|Protocol Violation|10|||
48821633|NCT00772928|157188725|FG001|Overall Study|Protocol Violation|12|||
48821634|NCT00772928|157188724|FG000|Overall Study|Withdrawal by Subject|25|||
48821635|NCT00772928|157188725|FG001|Overall Study|Withdrawal by Subject|22|||
48821636|NCT00772928|157188724|FG000|Overall Study|Did not receive vaccine|0|||
48821637|NCT00772928|157188725|FG001|Overall Study|Did not receive vaccine|1|||
48821638|NCT01582243|157188727|FG000|Overall Study|Withdrawal by Subject|1|||
48821639|NCT01582243|157188727|FG000|Overall Study|Adverse Event|1|||
48821640|NCT01582243|157188727|FG000|Overall Study|Lost to Follow-up|1|||
48821641|NCT00994279|157188728|FG000|Overall Study|Withdrawal by Subject|2|||
48821642|NCT00994279|157188729|FG001|Overall Study|Withdrawal by Subject|2|||
48821643|NCT00994279|157188728|FG000|Overall Study|Toxicity|1|||
48821644|NCT00994279|157188729|FG001|Overall Study|Toxicity|0|||
48821645|NCT00994279|157188728|FG000|Overall Study|Multiple reasons|1|||
48821646|NCT00994279|157188729|FG001|Overall Study|Multiple reasons|3|||
48728112|NCT02017171|156854347|FG001|Overall Study|Withdrawal by Subject|17|||
48728113|NCT02017171|156854346|FG000|Overall Study|Lost to Follow-up|21|||
48728114|NCT02017171|156854347|FG001|Overall Study|Lost to Follow-up|20|||
48728115|NCT02017171|156854346|FG000|Overall Study|ESKD|6|||
48728116|NCT02017171|156854347|FG001|Overall Study|ESKD|2|||
48728117|NCT02017171|156854346|FG000|Overall Study|Miscellaneous|2|||
48728118|NCT02017171|156854347|FG001|Overall Study|Miscellaneous|3|||
48728119|NCT03370289|156854348|FG000|Overall Study|Screen Failure|1|||
48728120|NCT03370289|156854348|FG000|Overall Study|Sample Size Sufficient|4|||
48728121|NCT03309046|156854349|FG000|Overall Study|Withdrawal by Subject|4|||
48728122|NCT03309046|156854350|FG001|Overall Study|Withdrawal by Subject|17|||
48728123|NCT01484938|156854352|FG000|Overall Study|Adverse Event|2|||
48728124|NCT01484938|156854352|FG000|Overall Study|Lost to Follow-up|1|||
48728125|NCT01484938|156854352|FG000|Overall Study|Noncompliance|1|||
48728126|NCT01858636|156854357|FG000|Overall Study|No Device Deployment Attempted|24|||
48728127|NCT01858636|156854357|FG000|Overall Study|Physician Decision|1|||
48921217|NCT01100437|157544872|FG002|Maintenance|Sponsor termination of study|1|||
48728128|NCT01858636|156854357|FG000|Overall Study|Death|1|||
48728129|NCT01858636|156854357|FG000|Overall Study|Lost to Follow-up|1|||
48728130|NCT01858636|156854357|FG000|Overall Study|Withdrawal by Subject|1|||
48728131|NCT03523000|156854360|FG000|Overall Study|Withdrawal by Subject|3|||
48728132|NCT03523000|156854361|FG001|Overall Study|Withdrawal by Subject|0|||
48821647|NCT01253200|157188732|FG000|Overall Study|Death|1|||
48821648|NCT01253200|157188733|FG001|Overall Study|Death|0|||
48821649|NCT01253200|157188734|FG002|Overall Study|Death|0|||
48821650|NCT01253200|157188735|FG003|Overall Study|Death|0|||
48821651|NCT01253200|157188736|FG004|Overall Study|Death|0|||
48821652|NCT01253200|157188732|FG000|Overall Study|Lost to Follow-up|1|||
48821653|NCT01253200|157188733|FG001|Overall Study|Lost to Follow-up|1|||
48821654|NCT01253200|157188734|FG002|Overall Study|Lost to Follow-up|0|||
49139204|NCT01807520|158348247|FG005|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
49139205|NCT01807520|158348248|FG006|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
49139206|NCT01807520|158348242|FG000|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
49139207|NCT01807520|158348243|FG001|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2|||
49139208|NCT01807520|158348244|FG002|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
49139209|NCT01807520|158348245|FG003|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
49139210|NCT01807520|158348246|FG004|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
49139211|NCT01807520|158348247|FG005|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
49139212|NCT01807520|158348248|FG006|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
49139213|NCT01807520|158348242|FG000|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4|||
49139214|NCT01807520|158348243|FG001|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
49139215|NCT01807520|158348244|FG002|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
49139216|NCT01807520|158348245|FG003|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1|||
49139217|NCT01807520|158348246|FG004|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
49139218|NCT01807520|158348247|FG005|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
49139219|NCT01807520|158348248|FG006|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
49139220|NCT01807520|158348242|FG000|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5|||
49139221|NCT01807520|158348243|FG001|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3|||
49139222|NCT01807520|158348244|FG002|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
49139223|NCT01807520|158348245|FG003|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
49139224|NCT01807520|158348246|FG004|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1|||
49139225|NCT01807520|158348247|FG005|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
48728133|NCT03523000|156854360|FG000|Overall Study|Unsuccessful trial|2|||
48728134|NCT03523000|156854361|FG001|Overall Study|Unsuccessful trial|0|||
48728135|NCT00999921|156854364|FG000|Overall Study|Lost to Follow-up|10|||
48728136|NCT00999921|156854365|FG001|Overall Study|Lost to Follow-up|19|||
48728137|NCT01912963|156854373|FG000|Overall Study|Disease Progression (RECIST1.1)|6|||
48728138|NCT01912963|156854374|FG001|Overall Study|Disease Progression (RECIST1.1)|9|||
48728139|NCT01912963|156854375|FG002|Overall Study|Disease Progression (RECIST1.1)|5|||
48728140|NCT01912963|156854373|FG000|Overall Study|Disease Progression (not RECIST1.1)|0|||
48728141|NCT01912963|156854374|FG001|Overall Study|Disease Progression (not RECIST1.1)|7|||
48728142|NCT01912963|156854375|FG002|Overall Study|Disease Progression (not RECIST1.1)|1|||
48728143|NCT01912963|156854373|FG000|Overall Study|Adverse Event|0|||
48728144|NCT01912963|156854374|FG001|Overall Study|Adverse Event|1|||
48728145|NCT01912963|156854375|FG002|Overall Study|Adverse Event|1|||
48728146|NCT01912963|156854373|FG000|Overall Study|Withdrawal by Subject|0|||
48728147|NCT01912963|156854374|FG001|Overall Study|Withdrawal by Subject|1|||
48728148|NCT01912963|156854375|FG002|Overall Study|Withdrawal by Subject|0|||
48728149|NCT01912963|156854373|FG000|Overall Study|Sought treatment locally|0|||
48728150|NCT01912963|156854374|FG001|Overall Study|Sought treatment locally|1|||
48728151|NCT01912963|156854375|FG002|Overall Study|Sought treatment locally|0|||
48728152|NCT00144027|156854381|FG000|Overall Study|Lost to Follow-up|1|||
48728153|NCT00144027|156854382|FG001|Overall Study|Lost to Follow-up|3|||
48728154|NCT00144027|156854381|FG000|Overall Study|Withdrawal by Subject|2|||
48728155|NCT00144027|156854382|FG001|Overall Study|Withdrawal by Subject|2|||
48728156|NCT00144027|156854381|FG000|Overall Study|did not complete baseline assessment|0|||
48728157|NCT00144027|156854382|FG001|Overall Study|did not complete baseline assessment|6|||
48728158|NCT01226043|156854383|FG000|4-week Crossover Phase - Period 1|Protocol Violation|1|||
48728159|NCT01226043|156854384|FG001|4-week Crossover Phase - Period 1|Protocol Violation|2|||
48728160|NCT01226043|156854385|FG002|4-week Crossover Phase - Period 1|Protocol Violation|0|||
48728161|NCT01226043|156854386|FG003|4-week Crossover Phase - Period 1|Protocol Violation|0|||
48728162|NCT01226043|156854383|FG000|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
48728163|NCT01226043|156854384|FG001|4-week Crossover Phase - Period 1|Lost to Follow-up|1|||
48728164|NCT01226043|156854385|FG002|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
48728165|NCT01226043|156854386|FG003|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
48728166|NCT01226043|156854383|FG000|4-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
48728167|NCT01226043|156854384|FG001|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
48728168|NCT01226043|156854385|FG002|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
48728169|NCT01226043|156854386|FG003|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
48728170|NCT01226043|156854383|FG000|4-week Crossover Phase - Period 1|Physician Decision|0|||
49139226|NCT01807520|158348248|FG006|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
49139227|NCT01807520|158348242|FG000|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
49139228|NCT01807520|158348243|FG001|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
49139229|NCT01807520|158348244|FG002|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
48728171|NCT01226043|156854384|FG001|4-week Crossover Phase - Period 1|Physician Decision|6|||
48728172|NCT01226043|156854385|FG002|4-week Crossover Phase - Period 1|Physician Decision|0|||
48728173|NCT01226043|156854386|FG003|4-week Crossover Phase - Period 1|Physician Decision|0|||
48728174|NCT01226043|156854383|FG000|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
48728175|NCT01226043|156854384|FG001|4-week Crossover Phase - Period 2|Withdrawal by Subject|1|||
48728176|NCT01226043|156854385|FG002|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
48728177|NCT01226043|156854386|FG003|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
48728178|NCT01226043|156854383|FG000|4-week Crossover Phase - Period 2|Physician Decision|4|||
48728179|NCT01226043|156854384|FG001|4-week Crossover Phase - Period 2|Physician Decision|5|||
48728180|NCT01226043|156854385|FG002|4-week Crossover Phase - Period 2|Physician Decision|0|||
48728181|NCT01226043|156854386|FG003|4-week Crossover Phase - Period 2|Physician Decision|0|||
48728182|NCT01226043|156854383|FG000|6-week Re-randomization Phase|Adverse Event|0|||
48728183|NCT01226043|156854384|FG001|6-week Re-randomization Phase|Adverse Event|0|||
48728184|NCT01226043|156854385|FG002|6-week Re-randomization Phase|Adverse Event|1|||
48728185|NCT01226043|156854386|FG003|6-week Re-randomization Phase|Adverse Event|1|||
48728186|NCT01226043|156854383|FG000|6-week Re-randomization Phase|Protocol Violation|0|||
48728187|NCT01226043|156854384|FG001|6-week Re-randomization Phase|Protocol Violation|0|||
48728188|NCT01226043|156854385|FG002|6-week Re-randomization Phase|Protocol Violation|1|||
48728189|NCT01226043|156854386|FG003|6-week Re-randomization Phase|Protocol Violation|1|||
48728190|NCT01226043|156854383|FG000|6-week Re-randomization Phase|Lost to Follow-up|0|||
48728191|NCT01226043|156854384|FG001|6-week Re-randomization Phase|Lost to Follow-up|0|||
48728192|NCT01226043|156854385|FG002|6-week Re-randomization Phase|Lost to Follow-up|1|||
48728193|NCT01226043|156854386|FG003|6-week Re-randomization Phase|Lost to Follow-up|3|||
48728194|NCT01226043|156854383|FG000|6-week Re-randomization Phase|Withdrawal by Subject|0|||
48728195|NCT01226043|156854384|FG001|6-week Re-randomization Phase|Withdrawal by Subject|0|||
48728196|NCT01226043|156854385|FG002|6-week Re-randomization Phase|Withdrawal by Subject|1|||
48728197|NCT01226043|156854386|FG003|6-week Re-randomization Phase|Withdrawal by Subject|3|||
48728198|NCT01226043|156854383|FG000|6-week Re-randomization Phase|Physician Decision|0|||
48728199|NCT01226043|156854384|FG001|6-week Re-randomization Phase|Physician Decision|0|||
48728200|NCT01226043|156854385|FG002|6-week Re-randomization Phase|Physician Decision|3|||
48728201|NCT01226043|156854386|FG003|6-week Re-randomization Phase|Physician Decision|2|||
48728202|NCT01226043|156854383|FG000|6-week Re-randomization Phase|completed in error|0|||
48728203|NCT01226043|156854384|FG001|6-week Re-randomization Phase|completed in error|0|||
48728204|NCT01226043|156854385|FG002|6-week Re-randomization Phase|completed in error|0|||
48728205|NCT01226043|156854386|FG003|6-week Re-randomization Phase|completed in error|1|||
49139230|NCT01807520|158348245|FG003|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
49139231|NCT01807520|158348246|FG004|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
49139232|NCT01807520|158348247|FG005|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
49139233|NCT01807520|158348248|FG006|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
49139234|NCT01807520|158348242|FG000|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5|||
49139235|NCT01807520|158348243|FG001|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6|||
48921218|NCT01358864|157544873|FG000|Overall Study|Adverse Event|0|||
48921219|NCT01358864|157544874|FG001|Overall Study|Adverse Event|6|||
48921220|NCT01358864|157544875|FG002|Overall Study|Adverse Event|9|||
48921221|NCT01358864|157544876|FG003|Overall Study|Adverse Event|0|||
48921222|NCT01358864|157544877|FG004|Overall Study|Adverse Event|4|||
48921223|NCT01358864|157544878|FG005|Overall Study|Adverse Event|8|||
48921224|NCT01358864|157544879|FG006|Overall Study|Adverse Event|12|||
48921225|NCT01358864|157544880|FG007|Overall Study|Adverse Event|7|||
48921226|NCT01358864|157544873|FG000|Overall Study|Lack of Efficacy|26|||
48921227|NCT01358864|157544874|FG001|Overall Study|Lack of Efficacy|3|||
48921228|NCT01358864|157544875|FG002|Overall Study|Lack of Efficacy|4|||
48921229|NCT01358864|157544876|FG003|Overall Study|Lack of Efficacy|19|||
48921230|NCT01358864|157544877|FG004|Overall Study|Lack of Efficacy|7|||
48921231|NCT01358864|157544878|FG005|Overall Study|Lack of Efficacy|4|||
48921232|NCT01358864|157544879|FG006|Overall Study|Lack of Efficacy|49|||
48921233|NCT01358864|157544880|FG007|Overall Study|Lack of Efficacy|44|||
48921234|NCT01358864|157544873|FG000|Overall Study|Lost to Follow-up|0|||
48921235|NCT01358864|157544874|FG001|Overall Study|Lost to Follow-up|0|||
48921236|NCT01358864|157544875|FG002|Overall Study|Lost to Follow-up|1|||
48921237|NCT01358864|157544876|FG003|Overall Study|Lost to Follow-up|0|||
48921238|NCT01358864|157544877|FG004|Overall Study|Lost to Follow-up|0|||
48921239|NCT01358864|157544878|FG005|Overall Study|Lost to Follow-up|0|||
48921240|NCT01358864|157544879|FG006|Overall Study|Lost to Follow-up|0|||
48921241|NCT01358864|157544880|FG007|Overall Study|Lost to Follow-up|1|||
48921242|NCT01358864|157544873|FG000|Overall Study|Withdrawal by Subject|3|||
48921243|NCT01358864|157544874|FG001|Overall Study|Withdrawal by Subject|4|||
49139236|NCT01807520|158348244|FG002|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
49139237|NCT01807520|158348245|FG003|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
49139238|NCT01807520|158348246|FG004|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
48921244|NCT01358864|157544875|FG002|Overall Study|Withdrawal by Subject|2|||
48728206|NCT01226043|156854383|FG000|30-week Observational Phase|Adverse Event|0|||
48921245|NCT01358864|157544876|FG003|Overall Study|Withdrawal by Subject|0|||
48921246|NCT01358864|157544877|FG004|Overall Study|Withdrawal by Subject|0|||
48921247|NCT01358864|157544878|FG005|Overall Study|Withdrawal by Subject|1|||
48921248|NCT01358864|157544879|FG006|Overall Study|Withdrawal by Subject|1|||
49139239|NCT01807520|158348247|FG005|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
49139240|NCT01807520|158348248|FG006|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
48728207|NCT01226043|156854384|FG001|30-week Observational Phase|Adverse Event|0|||
48728208|NCT01226043|156854385|FG002|30-week Observational Phase|Adverse Event|1|||
48728209|NCT01226043|156854386|FG003|30-week Observational Phase|Adverse Event|1|||
49139241|NCT01807520|158348242|FG000|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
49139242|NCT01807520|158348243|FG001|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
49139243|NCT01807520|158348244|FG002|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
49139244|NCT01807520|158348245|FG003|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
49139245|NCT01807520|158348246|FG004|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
49139246|NCT01807520|158348247|FG005|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1|||
49139247|NCT01807520|158348248|FG006|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
49139248|NCT01807520|158348242|FG000|Follow-up Period (132-140 Weeks)|Study terminated|0|||
48728210|NCT01226043|156854383|FG000|30-week Observational Phase|Protocol Violation|0|||
48728211|NCT01226043|156854384|FG001|30-week Observational Phase|Protocol Violation|0|||
48728212|NCT01226043|156854385|FG002|30-week Observational Phase|Protocol Violation|0|||
48728213|NCT01226043|156854386|FG003|30-week Observational Phase|Protocol Violation|1|||
48728214|NCT01226043|156854383|FG000|30-week Observational Phase|Lost to Follow-up|0|||
48728215|NCT01226043|156854384|FG001|30-week Observational Phase|Lost to Follow-up|0|||
48728216|NCT01226043|156854385|FG002|30-week Observational Phase|Lost to Follow-up|2|||
48728217|NCT01226043|156854386|FG003|30-week Observational Phase|Lost to Follow-up|2|||
48728218|NCT01226043|156854383|FG000|30-week Observational Phase|Withdrawal by Subject|0|||
48728219|NCT01226043|156854384|FG001|30-week Observational Phase|Withdrawal by Subject|0|||
49139249|NCT01807520|158348243|FG001|Follow-up Period (132-140 Weeks)|Study terminated|0|||
49139250|NCT01807520|158348244|FG002|Follow-up Period (132-140 Weeks)|Study terminated|0|||
49139251|NCT01807520|158348245|FG003|Follow-up Period (132-140 Weeks)|Study terminated|0|||
49139252|NCT01807520|158348246|FG004|Follow-up Period (132-140 Weeks)|Study terminated|0|||
49139253|NCT01807520|158348247|FG005|Follow-up Period (132-140 Weeks)|Study terminated|1|||
49139254|NCT01807520|158348248|FG006|Follow-up Period (132-140 Weeks)|Study terminated|0|||
49139255|NCT01807520|158348242|FG000|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
49139256|NCT01807520|158348243|FG001|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
49139257|NCT01807520|158348244|FG002|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
49139258|NCT01807520|158348245|FG003|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
49139259|NCT01807520|158348246|FG004|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
49139260|NCT01807520|158348247|FG005|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2|||
49139261|NCT01807520|158348248|FG006|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1|||
49139262|NCT00639379|158348251|FG000|Period 1 - 2 Weeks|Lost to Follow-up|2|||
49139263|NCT00639379|158348252|FG001|Period 1 - 2 Weeks|Lost to Follow-up|0|||
49139264|NCT00639379|158348251|FG000|Period 1 - 2 Weeks|lens issue|3|||
49139265|NCT00639379|158348252|FG001|Period 1 - 2 Weeks|lens issue|0|||
49139266|NCT00924651|158348255|FG000|Overall Study|Chemo started too soon|2|||
49139267|NCT00924651|158348256|FG001|Overall Study|Chemo started too soon|3|||
49139268|NCT00924651|158348255|FG000|Overall Study|No Reason|3|||
49139269|NCT00924651|158348256|FG001|Overall Study|No Reason|7|||
49139270|NCT00924651|158348255|FG000|Overall Study|Overwhelmed|6|||
49139271|NCT00924651|158348256|FG001|Overall Study|Overwhelmed|6|||
49139272|NCT00924651|158348255|FG000|Overall Study|Noncompliant|1|||
49139273|NCT00924651|158348256|FG001|Overall Study|Noncompliant|4|||
49139274|NCT00924651|158348255|FG000|Overall Study|Medical|1|||
49139275|NCT00924651|158348256|FG001|Overall Study|Medical|3|||
49139276|NCT00924651|158348255|FG000|Overall Study|Changed Mind|10|||
49139277|NCT00924651|158348256|FG001|Overall Study|Changed Mind|1|||
49139278|NCT00924651|158348255|FG000|Overall Study|Incomplete Form|2|||
49139279|NCT00924651|158348256|FG001|Overall Study|Incomplete Form|1|||
49139280|NCT00729586|158348257|FG000|Overall Study|Ineligible|0|||
49139281|NCT00729586|158348258|FG001|Overall Study|Ineligible|1|||
49139282|NCT00729586|158348257|FG000|Overall Study|never treated|1|||
49139283|NCT00729586|158348258|FG001|Overall Study|never treated|0|||
49139284|NCT00972738|158348264|FG000|Overall Study|Adverse Event|7|||
49139285|NCT00972738|158348265|FG001|Overall Study|Adverse Event|1|||
49139286|NCT00972738|158348266|FG002|Overall Study|Adverse Event|8|||
49139287|NCT00972738|158348264|FG000|Overall Study|Protocol Violation|2|||
49139288|NCT00972738|158348265|FG001|Overall Study|Protocol Violation|1|||
49139289|NCT00972738|158348266|FG002|Overall Study|Protocol Violation|3|||
48728220|NCT01226043|156854385|FG002|30-week Observational Phase|Withdrawal by Subject|1|||
49139290|NCT00972738|158348264|FG000|Overall Study|Lost to Follow-up|1|||
49139291|NCT00972738|158348265|FG001|Overall Study|Lost to Follow-up|0|||
49139292|NCT00972738|158348266|FG002|Overall Study|Lost to Follow-up|1|||
49139293|NCT00972738|158348264|FG000|Overall Study|Lack of Efficacy|5|||
49139294|NCT00972738|158348265|FG001|Overall Study|Lack of Efficacy|1|||
48728221|NCT01226043|156854386|FG003|30-week Observational Phase|Withdrawal by Subject|7|||
48728222|NCT01226043|156854383|FG000|30-week Observational Phase|Physician Decision|0|||
48821655|NCT01253200|157188735|FG003|Overall Study|Lost to Follow-up|0|||
49139295|NCT00972738|158348266|FG002|Overall Study|Lack of Efficacy|11|||
49139296|NCT00972738|158348264|FG000|Overall Study|Withdrawal by Subject|5|||
49139297|NCT00972738|158348265|FG001|Overall Study|Withdrawal by Subject|1|||
49139298|NCT00972738|158348266|FG002|Overall Study|Withdrawal by Subject|4|||
49139299|NCT00972738|158348264|FG000|Overall Study|Moved|0|||
49139300|NCT00972738|158348265|FG001|Overall Study|Moved|0|||
49139301|NCT00972738|158348266|FG002|Overall Study|Moved|1|||
49139302|NCT00972738|158348264|FG000|Overall Study|Other|1|||
48728223|NCT01226043|156854384|FG001|30-week Observational Phase|Physician Decision|0|||
48728224|NCT01226043|156854385|FG002|30-week Observational Phase|Physician Decision|2|||
48728225|NCT01226043|156854386|FG003|30-week Observational Phase|Physician Decision|2|||
49139303|NCT00972738|158348265|FG001|Overall Study|Other|2|||
48728226|NCT01278160|156854389|FG000|Overall Study|Adverse Event|1|||
48728227|NCT01278160|156854390|FG001|Overall Study|Adverse Event|1|||
48728228|NCT01278160|156854389|FG000|Overall Study|Lost to Follow-up|0|||
49139304|NCT00972738|158348266|FG002|Overall Study|Other|1|||
48728229|NCT01278160|156854390|FG001|Overall Study|Lost to Follow-up|1|||
48728230|NCT01278160|156854389|FG000|Overall Study|Withdrawal by Subject|3|||
49139305|NCT02513199|158348267|FG000|Treatment|Death|1|||
49139306|NCT02513199|158348267|FG000|Treatment|Lost to Follow-up|1|||
49139307|NCT02513199|158348267|FG000|Follow-Up|Death|11|||
49139308|NCT00614393|158348268|FG000|Overall Study|Adverse Event|20|||
48821656|NCT01253200|157188736|FG004|Overall Study|Lost to Follow-up|0|||
48821657|NCT01253200|157188732|FG000|Overall Study|Withdrawal by Subject|2|||
48821658|NCT01253200|157188733|FG001|Overall Study|Withdrawal by Subject|0|||
48821659|NCT01253200|157188734|FG002|Overall Study|Withdrawal by Subject|0|||
48821660|NCT01253200|157188735|FG003|Overall Study|Withdrawal by Subject|0|||
48821661|NCT01253200|157188736|FG004|Overall Study|Withdrawal by Subject|0|||
48821662|NCT01253200|157188732|FG000|Overall Study|Protocol Violation|1|||
49139309|NCT00614393|158348269|FG001|Overall Study|Adverse Event|2|||
49139310|NCT00614393|158348270|FG002|Overall Study|Adverse Event|3|||
48728231|NCT01278160|156854390|FG001|Overall Study|Withdrawal by Subject|2|||
48728232|NCT01278160|156854389|FG000|Overall Study|Unclassified|1|||
49139311|NCT00614393|158348271|FG003|Overall Study|Adverse Event|13|||
49139312|NCT00614393|158348272|FG004|Overall Study|Adverse Event|21|||
49139313|NCT00614393|158348268|FG000|Overall Study|Lost to Follow-up|0|||
49139314|NCT00614393|158348269|FG001|Overall Study|Lost to Follow-up|0|||
49139315|NCT00614393|158348270|FG002|Overall Study|Lost to Follow-up|0|||
49139316|NCT00614393|158348271|FG003|Overall Study|Lost to Follow-up|1|||
49139317|NCT00614393|158348272|FG004|Overall Study|Lost to Follow-up|2|||
49139318|NCT00614393|158348268|FG000|Overall Study|Physician Decision|17|||
49139319|NCT00614393|158348269|FG001|Overall Study|Physician Decision|0|||
49139320|NCT00614393|158348270|FG002|Overall Study|Physician Decision|1|||
49139321|NCT00614393|158348271|FG003|Overall Study|Physician Decision|8|||
49139322|NCT00614393|158348272|FG004|Overall Study|Physician Decision|9|||
49139323|NCT00614393|158348268|FG000|Overall Study|Progressive Disease|118|||
49139324|NCT00614393|158348269|FG001|Overall Study|Progressive Disease|5|||
49139325|NCT00614393|158348270|FG002|Overall Study|Progressive Disease|5|||
49139326|NCT00614393|158348271|FG003|Overall Study|Progressive Disease|138|||
49139327|NCT00614393|158348272|FG004|Overall Study|Progressive Disease|130|||
49139328|NCT00614393|158348268|FG000|Overall Study|Protocol Violation|1|||
49139329|NCT00614393|158348269|FG001|Overall Study|Protocol Violation|0|||
49139330|NCT00614393|158348270|FG002|Overall Study|Protocol Violation|0|||
49139331|NCT00614393|158348271|FG003|Overall Study|Protocol Violation|0|||
49139332|NCT00614393|158348272|FG004|Overall Study|Protocol Violation|0|||
49139333|NCT00614393|158348268|FG000|Overall Study|Terminated by Sponsor|0|||
49139334|NCT00614393|158348269|FG001|Overall Study|Terminated by Sponsor|0|||
48728233|NCT01278160|156854390|FG001|Overall Study|Unclassified|2|||
48728234|NCT03187756|156854391|FG000|Overall Study|Termination of study|4|||
48728235|NCT04041700|156854395|FG000|Overall Study|Pregnancy|1|||
49139335|NCT00614393|158348270|FG002|Overall Study|Terminated by Sponsor|0|||
49139336|NCT00614393|158348271|FG003|Overall Study|Terminated by Sponsor|0|||
49139337|NCT00614393|158348272|FG004|Overall Study|Terminated by Sponsor|1|||
49139338|NCT00614393|158348268|FG000|Overall Study|Withdrawal by Subject|20|||
49139339|NCT00614393|158348269|FG001|Overall Study|Withdrawal by Subject|1|||
49139340|NCT00614393|158348270|FG002|Overall Study|Withdrawal by Subject|1|||
49139341|NCT00614393|158348271|FG003|Overall Study|Withdrawal by Subject|16|||
49139342|NCT00614393|158348272|FG004|Overall Study|Withdrawal by Subject|13|||
49139343|NCT00614393|158348268|FG000|Overall Study|Other|4|||
49139344|NCT00614393|158348269|FG001|Overall Study|Other|0|||
49139345|NCT00614393|158348270|FG002|Overall Study|Other|0|||
49139346|NCT00614393|158348271|FG003|Overall Study|Other|4|||
49139347|NCT00614393|158348272|FG004|Overall Study|Other|2|||
49139348|NCT00614393|158348268|FG000|Overall Study|Not Treated|0|||
49139349|NCT00614393|158348269|FG001|Overall Study|Not Treated|0|||
49139350|NCT00614393|158348270|FG002|Overall Study|Not Treated|0|||
49139351|NCT00614393|158348271|FG003|Overall Study|Not Treated|0|||
49139352|NCT00614393|158348272|FG004|Overall Study|Not Treated|2|||
48728236|NCT04041700|156854395|FG000|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1|||
48728237|NCT00560885|156854397|FG000|Overall Study|Death|7|||
48728238|NCT00560885|156854397|FG000|Overall Study|Withdrawal by Subject|1|||
48821663|NCT01253200|157188733|FG001|Overall Study|Protocol Violation|4|||
48821664|NCT01253200|157188734|FG002|Overall Study|Protocol Violation|0|||
49139353|NCT02260986|158348274|FG000|Overall Study|Adverse Event|24|||
49139354|NCT02260986|158348275|FG001|Overall Study|Adverse Event|0|||
49139355|NCT02260986|158348276|FG002|Overall Study|Adverse Event|11|||
49139356|NCT02260986|158348274|FG000|Overall Study|Lack of Efficacy|27|||
49139357|NCT02260986|158348275|FG001|Overall Study|Lack of Efficacy|3|||
49139358|NCT02260986|158348276|FG002|Overall Study|Lack of Efficacy|0|||
49139359|NCT02260986|158348274|FG000|Overall Study|Protocol Violation|14|||
49139360|NCT02260986|158348275|FG001|Overall Study|Protocol Violation|5|||
49139361|NCT02260986|158348276|FG002|Overall Study|Protocol Violation|16|||
49139362|NCT02260986|158348274|FG000|Overall Study|Car accident|0|||
49139363|NCT02260986|158348275|FG001|Overall Study|Car accident|0|||
49139364|NCT02260986|158348276|FG002|Overall Study|Car accident|1|||
49139365|NCT02260986|158348274|FG000|Overall Study|Withdrawal by Subject|17|||
49139366|NCT02260986|158348275|FG001|Overall Study|Withdrawal by Subject|4|||
49139367|NCT02260986|158348276|FG002|Overall Study|Withdrawal by Subject|9|||
49139368|NCT02260986|158348274|FG000|Overall Study|Incorrect randomization|0|||
49139369|NCT02260986|158348275|FG001|Overall Study|Incorrect randomization|1|||
49139370|NCT02260986|158348276|FG002|Overall Study|Incorrect randomization|0|||
49139371|NCT02260986|158348274|FG000|Overall Study|Lack of investigation product supply|2|||
49139372|NCT02260986|158348275|FG001|Overall Study|Lack of investigation product supply|0|||
49139373|NCT02260986|158348276|FG002|Overall Study|Lack of investigation product supply|1|||
49139374|NCT02260986|158348274|FG000|Overall Study|Lost to Follow-up|4|||
49139375|NCT02260986|158348275|FG001|Overall Study|Lost to Follow-up|0|||
49139376|NCT02260986|158348276|FG002|Overall Study|Lost to Follow-up|3|||
49139377|NCT02260986|158348274|FG000|Overall Study|Pregnancy|2|||
49139378|NCT02260986|158348275|FG001|Overall Study|Pregnancy|0|||
49139379|NCT02260986|158348276|FG002|Overall Study|Pregnancy|0|||
49139380|NCT00853385|158348277|FG000|Overall Study|Death|0|||
49139381|NCT00853385|158348278|FG001|Overall Study|Death|0|||
49139382|NCT00853385|158348279|FG002|Overall Study|Death|0|||
49139383|NCT00853385|158348280|FG003|Overall Study|Death|0|||
49139384|NCT00853385|158348281|FG004|Overall Study|Death|1|||
49139385|NCT00853385|158348277|FG000|Overall Study|Adverse Event|24|||
49139386|NCT00853385|158348278|FG001|Overall Study|Adverse Event|24|||
49139387|NCT00853385|158348279|FG002|Overall Study|Adverse Event|2|||
49139388|NCT00853385|158348280|FG003|Overall Study|Adverse Event|5|||
49139389|NCT00853385|158348281|FG004|Overall Study|Adverse Event|22|||
49139390|NCT00853385|158348277|FG000|Overall Study|Lack of Efficacy|6|||
49139391|NCT00853385|158348278|FG001|Overall Study|Lack of Efficacy|7|||
49139392|NCT00853385|158348279|FG002|Overall Study|Lack of Efficacy|3|||
49139393|NCT00853385|158348280|FG003|Overall Study|Lack of Efficacy|3|||
49139394|NCT00853385|158348281|FG004|Overall Study|Lack of Efficacy|6|||
49139395|NCT00853385|158348277|FG000|Overall Study|Lost to Follow-up|2|||
49139396|NCT00853385|158348278|FG001|Overall Study|Lost to Follow-up|1|||
49139397|NCT00853385|158348279|FG002|Overall Study|Lost to Follow-up|0|||
49139398|NCT00853385|158348280|FG003|Overall Study|Lost to Follow-up|0|||
49139399|NCT00853385|158348281|FG004|Overall Study|Lost to Follow-up|0|||
49139400|NCT00853385|158348277|FG000|Overall Study|Withdrawal by Subject|4|||
49139401|NCT00853385|158348278|FG001|Overall Study|Withdrawal by Subject|2|||
49139402|NCT00853385|158348279|FG002|Overall Study|Withdrawal by Subject|0|||
49139403|NCT00853385|158348280|FG003|Overall Study|Withdrawal by Subject|1|||
49139404|NCT00853385|158348281|FG004|Overall Study|Withdrawal by Subject|1|||
48921249|NCT01358864|157544880|FG007|Overall Study|Withdrawal by Subject|3|||
48921250|NCT01358864|157544873|FG000|Overall Study|Other reason not defined above|2|||
48921251|NCT01358864|157544874|FG001|Overall Study|Other reason not defined above|0|||
48921252|NCT01358864|157544875|FG002|Overall Study|Other reason not defined above|0|||
49139405|NCT00853385|158348277|FG000|Overall Study|Other|18|||
49139406|NCT00853385|158348278|FG001|Overall Study|Other|9|||
49139407|NCT00853385|158348279|FG002|Overall Study|Other|4|||
49139408|NCT00853385|158348280|FG003|Overall Study|Other|4|||
49139409|NCT00853385|158348281|FG004|Overall Study|Other|12|||
49139410|NCT00915525|158348282|FG000|Overall Study|Protocol Violation|9|||
49139411|NCT00915525|158348283|FG001|Overall Study|Protocol Violation|4|||
49139412|NCT00915525|158348282|FG000|Overall Study|Withdrawal by Subject|59|||
49139413|NCT00915525|158348283|FG001|Overall Study|Withdrawal by Subject|21|||
49139414|NCT00915525|158348282|FG000|Overall Study|Lost to Follow-up|27|||
49139415|NCT00915525|158348283|FG001|Overall Study|Lost to Follow-up|16|||
49139416|NCT00915525|158348282|FG000|Overall Study|Pregnancy|2|||
49139417|NCT00915525|158348283|FG001|Overall Study|Pregnancy|0|||
49139418|NCT00915525|158348282|FG000|Overall Study|Lack of Efficacy|15|||
49139419|NCT00915525|158348283|FG001|Overall Study|Lack of Efficacy|32|||
49139420|NCT00915525|158348282|FG000|Overall Study|Adverse Event|29|||
49139421|NCT00915525|158348283|FG001|Overall Study|Adverse Event|13|||
49139422|NCT00915525|158348282|FG000|Overall Study|Missing|12|||
49139423|NCT00915525|158348283|FG001|Overall Study|Missing|1|||
49139424|NCT00915525|158348282|FG000|Overall Study|Other Reason|35|||
49139425|NCT00915525|158348283|FG001|Overall Study|Other Reason|12|||
49139426|NCT00915525|158348282|FG000|Overall Study|Site Closed|27|||
49139427|NCT00915525|158348283|FG001|Overall Study|Site Closed|9|||
49139428|NCT00915525|158348282|FG000|Overall Study|Retreat Request >Wk 144 (exclusionary)|4|||
49139429|NCT00915525|158348283|FG001|Overall Study|Retreat Request >Wk 144 (exclusionary)|5|||
49139430|NCT00915525|158348282|FG000|Overall Study|Study Burden|28|||
49139431|NCT00915525|158348283|FG001|Overall Study|Study Burden|12|||
49139432|NCT00915525|158348282|FG000|Overall Study|Non-Compliance|3|||
49139433|NCT00915525|158348283|FG001|Overall Study|Non-Compliance|1|||
49139434|NCT00915525|158348282|FG000|Overall Study|Patient Moved|15|||
49139435|NCT00915525|158348283|FG001|Overall Study|Patient Moved|9|||
49139436|NCT01432327|158348286|FG000|Posttest 3 Months|depression|3|||
49139437|NCT01432327|158348287|FG001|Posttest 3 Months|depression|0|||
49139438|NCT01432327|158348288|FG002|Posttest 3 Months|depression|0|||
49139439|NCT01432327|158348289|FG003|Posttest 3 Months|depression|0|||
49139440|NCT01432327|158348286|FG000|Posttest 3 Months|Lost to Follow-up|1|||
49139441|NCT01432327|158348287|FG001|Posttest 3 Months|Lost to Follow-up|0|||
49139442|NCT01432327|158348288|FG002|Posttest 3 Months|Lost to Follow-up|2|||
49139443|NCT01432327|158348289|FG003|Posttest 3 Months|Lost to Follow-up|1|||
49139444|NCT01432327|158348286|FG000|Posttest 3 Months|Allergic reaction|0|||
49139445|NCT01432327|158348287|FG001|Posttest 3 Months|Allergic reaction|2|||
49139446|NCT01432327|158348288|FG002|Posttest 3 Months|Allergic reaction|0|||
49139447|NCT01432327|158348289|FG003|Posttest 3 Months|Allergic reaction|0|||
49139448|NCT01432327|158348286|FG000|Posttest 6 Months|Lost to Follow-up|0|||
49139449|NCT01432327|158348287|FG001|Posttest 6 Months|Lost to Follow-up|0|||
49139450|NCT01432327|158348288|FG002|Posttest 6 Months|Lost to Follow-up|3|||
49139451|NCT01432327|158348289|FG003|Posttest 6 Months|Lost to Follow-up|2|||
49139452|NCT01432327|158348286|FG000|Posttest 6 Months|Allergic reaction|0|||
49139453|NCT01432327|158348287|FG001|Posttest 6 Months|Allergic reaction|0|||
49139454|NCT01432327|158348288|FG002|Posttest 6 Months|Allergic reaction|1|||
49139455|NCT01432327|158348289|FG003|Posttest 6 Months|Allergic reaction|0|||
49139456|NCT01432327|158348286|FG000|Posttest 6 Months|Withdrawal by Subject|0|||
49139457|NCT01432327|158348287|FG001|Posttest 6 Months|Withdrawal by Subject|0|||
49139458|NCT01432327|158348288|FG002|Posttest 6 Months|Withdrawal by Subject|1|||
49139459|NCT01432327|158348289|FG003|Posttest 6 Months|Withdrawal by Subject|0|||
49139460|NCT01432327|158348286|FG000|Posttest 1 Year|Measurement have to take place in future|24|||
49139461|NCT01432327|158348287|FG001|Posttest 1 Year|Measurement have to take place in future|28|||
49139462|NCT01432327|158348288|FG002|Posttest 1 Year|Measurement have to take place in future|15|||
49139463|NCT01432327|158348289|FG003|Posttest 1 Year|Measurement have to take place in future|20|||
49139464|NCT01432327|158348286|FG000|Posttest 1 Year|Lost to Follow-up|0|||
49139465|NCT01432327|158348287|FG001|Posttest 1 Year|Lost to Follow-up|0|||
49139466|NCT01432327|158348288|FG002|Posttest 1 Year|Lost to Follow-up|4|||
49139467|NCT01432327|158348289|FG003|Posttest 1 Year|Lost to Follow-up|2|||
49139468|NCT01432327|158348286|FG000|Posttest 1 Year|Allergic reaction|0|||
49139469|NCT01432327|158348287|FG001|Posttest 1 Year|Allergic reaction|0|||
48921253|NCT01358864|157544876|FG003|Overall Study|Other reason not defined above|0|||
48921254|NCT01358864|157544877|FG004|Overall Study|Other reason not defined above|0|||
48921255|NCT01358864|157544878|FG005|Overall Study|Other reason not defined above|0|||
48921256|NCT01358864|157544879|FG006|Overall Study|Other reason not defined above|2|||
48921257|NCT01358864|157544880|FG007|Overall Study|Other reason not defined above|0|||
48921258|NCT01358864|157544873|FG000|Overall Study|Not treated|0|||
48921259|NCT01358864|157544874|FG001|Overall Study|Not treated|0|||
48921260|NCT01358864|157544875|FG002|Overall Study|Not treated|0|||
48921261|NCT01358864|157544876|FG003|Overall Study|Not treated|0|||
48921262|NCT01358864|157544877|FG004|Overall Study|Not treated|0|||
48921263|NCT01358864|157544878|FG005|Overall Study|Not treated|0|||
48921264|NCT01358864|157544879|FG006|Overall Study|Not treated|1|||
48921265|NCT01358864|157544880|FG007|Overall Study|Not treated|0|||
48921266|NCT00278993|157544887|FG000|Overall Study|Adverse Event|24|||
48921267|NCT00278993|157544887|FG000|Overall Study|Withdrawal by Subject|5|||
48921268|NCT00278993|157544887|FG000|Overall Study|Progressive Disease|65|||
48921269|NCT00278993|157544887|FG000|Overall Study|Physician Decision|9|||
48921270|NCT00278993|157544887|FG000|Overall Study|Not Otherwise Specified|4|||
48921271|NCT01250379|157544888|FG000|Overall Study|Death|141|||
48921272|NCT01250379|157544889|FG001|Overall Study|Death|148|||
48921273|NCT01250379|157544888|FG000|Overall Study|Withdrawal by Subject|32|||
48921274|NCT01250379|157544889|FG001|Overall Study|Withdrawal by Subject|20|||
48921275|NCT01250379|157544888|FG000|Overall Study|Physician Decision|11|||
48921276|NCT01250379|157544889|FG001|Overall Study|Physician Decision|3|||
48921277|NCT01250379|157544888|FG000|Overall Study|Protocol Violation|2|||
48921278|NCT01250379|157544889|FG001|Overall Study|Protocol Violation|8|||
48921279|NCT01250379|157544888|FG000|Overall Study|Lost to Follow-up|9|||
48728239|NCT04551066|156854398|FG000|Overall Study|Death|5|||
48921280|NCT01250379|157544889|FG001|Overall Study|Lost to Follow-up|6|||
48921281|NCT01250379|157544888|FG000|Overall Study|Adverse Event|5|||
48921282|NCT01250379|157544889|FG001|Overall Study|Adverse Event|4|||
49139470|NCT01432327|158348288|FG002|Posttest 1 Year|Allergic reaction|1|||
49139471|NCT01432327|158348289|FG003|Posttest 1 Year|Allergic reaction|1|||
49139472|NCT01001104|158348290|FG000|Overall Study|Adverse Event|2|||
49139473|NCT01001104|158348291|FG001|Overall Study|Adverse Event|1|||
48921283|NCT01250379|157544888|FG000|Overall Study|Other|0|||
48728240|NCT04551066|156854399|FG001|Overall Study|Death|3|||
48821665|NCT01253200|157188735|FG003|Overall Study|Protocol Violation|0|||
48821666|NCT01253200|157188736|FG004|Overall Study|Protocol Violation|5|||
48821667|NCT01253200|157188732|FG000|Overall Study|intents|10|||
48821668|NCT01253200|157188733|FG001|Overall Study|intents|10|||
49139474|NCT01001104|158348292|FG002|Overall Study|Adverse Event|0|||
48821669|NCT01253200|157188734|FG002|Overall Study|intents|1|||
48821670|NCT01253200|157188735|FG003|Overall Study|intents|3|||
48821671|NCT01253200|157188736|FG004|Overall Study|intents|0|||
48821672|NCT01253200|157188732|FG000|Overall Study|Attempts|6|||
48821673|NCT01253200|157188733|FG001|Overall Study|Attempts|4|||
48728241|NCT04551066|156854398|FG000|Overall Study|Lost to Follow-up|1|||
48728242|NCT04551066|156854399|FG001|Overall Study|Lost to Follow-up|0|||
48728243|NCT04551066|156854398|FG000|Overall Study|Sponsor Decision|103|||
48728244|NCT04551066|156854399|FG001|Overall Study|Sponsor Decision|117|||
48728245|NCT04551066|156854398|FG000|Overall Study|Withdrawal by Subject|8|||
48728246|NCT04551066|156854399|FG001|Overall Study|Withdrawal by Subject|2|||
48728247|NCT04551066|156854398|FG000|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
48728248|NCT04551066|156854399|FG001|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
48728249|NCT04551066|156854398|FG000|Overall Study|Adverse Event|2|||
48728250|NCT04551066|156854399|FG001|Overall Study|Adverse Event|0|||
48728251|NCT04551066|156854398|FG000|Overall Study|Physician Decision|2|||
48728252|NCT04551066|156854399|FG001|Overall Study|Physician Decision|0|||
48728253|NCT04551066|156854398|FG000|Overall Study|Protocol Violation|1|||
48728254|NCT04551066|156854399|FG001|Overall Study|Protocol Violation|0|||
48728255|NCT04551066|156854398|FG000|Overall Study|Lack of Efficacy|0|||
48728256|NCT04551066|156854399|FG001|Overall Study|Lack of Efficacy|1|||
48728257|NCT04551066|156854398|FG000|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|0|||
48728258|NCT04551066|156854399|FG001|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|1|||
48728259|NCT03387150|156855479|FG000|Overall Study|Withdrawal by Subject|3|||
48728260|NCT03387150|156855480|FG001|Overall Study|Withdrawal by Subject|0|||
48728261|NCT03387150|156855481|FG002|Overall Study|Withdrawal by Subject|3|||
48728262|NCT03387150|156855482|FG003|Overall Study|Withdrawal by Subject|4|||
48728263|NCT03387150|156855483|FG004|Overall Study|Withdrawal by Subject|1|||
48728264|NCT03387150|156855484|FG005|Overall Study|Withdrawal by Subject|2|||
48728265|NCT03387150|156855485|FG006|Overall Study|Withdrawal by Subject|0|||
48728266|NCT03387150|156855479|FG000|Overall Study|Lost to Follow-up|3|||
48728267|NCT03387150|156855480|FG001|Overall Study|Lost to Follow-up|2|||
48728268|NCT03387150|156855481|FG002|Overall Study|Lost to Follow-up|2|||
48728269|NCT03387150|156855482|FG003|Overall Study|Lost to Follow-up|3|||
48728270|NCT03387150|156855483|FG004|Overall Study|Lost to Follow-up|3|||
48728271|NCT03387150|156855484|FG005|Overall Study|Lost to Follow-up|3|||
48728272|NCT03387150|156855485|FG006|Overall Study|Lost to Follow-up|0|||
48728273|NCT03387150|156855479|FG000|Overall Study|Participant unable to adhere to visit|0|||
48728274|NCT03387150|156855480|FG001|Overall Study|Participant unable to adhere to visit|1|||
48728275|NCT03387150|156855481|FG002|Overall Study|Participant unable to adhere to visit|0|||
48728276|NCT03387150|156855482|FG003|Overall Study|Participant unable to adhere to visit|0|||
48728277|NCT03387150|156855483|FG004|Overall Study|Participant unable to adhere to visit|2|||
48728278|NCT03387150|156855484|FG005|Overall Study|Participant unable to adhere to visit|2|||
48728279|NCT03387150|156855485|FG006|Overall Study|Participant unable to adhere to visit|0|||
48728280|NCT02425644|156855491|FG000|Overall Study|Lost to Follow-up|2|||
48728281|NCT02425644|156855492|FG001|Overall Study|Lost to Follow-up|3|||
48728282|NCT02425644|156855491|FG000|Overall Study|Withdrawal by Subject|41|||
48728283|NCT02425644|156855492|FG001|Overall Study|Withdrawal by Subject|36|||
48728284|NCT02425644|156855491|FG000|Overall Study|Lack of Efficacy|3|||
48728285|NCT02425644|156855492|FG001|Overall Study|Lack of Efficacy|10|||
48728286|NCT02425644|156855491|FG000|Overall Study|Adverse Event|13|||
48728287|NCT02425644|156855492|FG001|Overall Study|Adverse Event|3|||
48728288|NCT02425644|156855491|FG000|Overall Study|Death|0|||
48728289|NCT02425644|156855492|FG001|Overall Study|Death|2|||
48728290|NCT02425644|156855491|FG000|Overall Study|Other|18|||
48728291|NCT02425644|156855492|FG001|Overall Study|Other|17|||
48728292|NCT02448680|156855495|FG000|Overall Study|Physician Decision|1|||
48728293|NCT02448680|156855496|FG001|Overall Study|Physician Decision|1|||
48728294|NCT02448680|156855495|FG000|Overall Study|Withdrawal by Subject|0|||
48728295|NCT02448680|156855496|FG001|Overall Study|Withdrawal by Subject|2|||
48728296|NCT03435640|156855497|FG000|Overall Study|Withdrawal by Subject|0|||
48728297|NCT03435640|156855498|FG001|Overall Study|Withdrawal by Subject|1|||
48728298|NCT03435640|156855499|FG002|Overall Study|Withdrawal by Subject|0|||
48728299|NCT03435640|156855500|FG003|Overall Study|Withdrawal by Subject|2|||
48728300|NCT03435640|156855501|FG004|Overall Study|Withdrawal by Subject|0|||
48728301|NCT03435640|156855502|FG005|Overall Study|Withdrawal by Subject|0|||
48728302|NCT03435640|156855503|FG006|Overall Study|Withdrawal by Subject|3|||
48728303|NCT03435640|156855504|FG007|Overall Study|Withdrawal by Subject|0|||
48821674|NCT01253200|157188734|FG002|Overall Study|Attempts|1|||
48821675|NCT01253200|157188735|FG003|Overall Study|Attempts|2|||
48821676|NCT01253200|157188736|FG004|Overall Study|Attempts|0|||
48821677|NCT03285711|157188741|FG000|Blinded Phase (Up to Week 16)|Adverse Event|2|||
49139475|NCT01001104|158348293|FG003|Overall Study|Adverse Event|0|||
49139476|NCT01001104|158348290|FG000|Overall Study|Lost to Follow-up|0|||
49139477|NCT01001104|158348291|FG001|Overall Study|Lost to Follow-up|0|||
49139478|NCT01001104|158348292|FG002|Overall Study|Lost to Follow-up|1|||
49139479|NCT01001104|158348293|FG003|Overall Study|Lost to Follow-up|0|||
49139480|NCT01001104|158348290|FG000|Overall Study|Entry Criteria Not Met|0|||
49139481|NCT01001104|158348291|FG001|Overall Study|Entry Criteria Not Met|0|||
49139482|NCT01001104|158348292|FG002|Overall Study|Entry Criteria Not Met|0|||
49139483|NCT01001104|158348293|FG003|Overall Study|Entry Criteria Not Met|1|||
49139484|NCT01001104|158348290|FG000|Overall Study|Withdrawal by Subject|0|||
49139485|NCT01001104|158348291|FG001|Overall Study|Withdrawal by Subject|0|||
49139486|NCT01001104|158348292|FG002|Overall Study|Withdrawal by Subject|0|||
49139487|NCT01001104|158348293|FG003|Overall Study|Withdrawal by Subject|2|||
49139488|NCT02397837|158348298|FG000|Overall Study|Withdrawal by Subject|6|||
49139489|NCT02397837|158348299|FG001|Overall Study|Withdrawal by Subject|5|||
48921284|NCT01250379|157544889|FG001|Overall Study|Other|4|||
48921285|NCT01250379|157544888|FG000|Overall Study|Participant noncompliance|2|||
48921286|NCT01250379|157544889|FG001|Overall Study|Participant noncompliance|0|||
48921287|NCT02270242|157544892|FG000|Overall Study|Withdrawal by Subject|18|||
48921288|NCT02270242|157544893|FG001|Overall Study|Withdrawal by Subject|25|||
49139490|NCT02397837|158348298|FG000|Overall Study|Physician Decision|1|||
49139491|NCT02397837|158348299|FG001|Overall Study|Physician Decision|1|||
49139492|NCT03320369|158348300|FG000|Overall Study|Adverse Event|1|||
48728304|NCT03435640|156855505|FG008|Overall Study|Withdrawal by Subject|0|||
48728305|NCT03435640|156855506|FG009|Overall Study|Withdrawal by Subject|2|||
48728306|NCT03435640|156855507|FG010|Overall Study|Withdrawal by Subject|3|||
48728307|NCT03435640|156855497|FG000|Overall Study|Lost to Follow-up|0|||
48728308|NCT03435640|156855498|FG001|Overall Study|Lost to Follow-up|0|||
48728309|NCT03435640|156855499|FG002|Overall Study|Lost to Follow-up|1|||
48728310|NCT03435640|156855500|FG003|Overall Study|Lost to Follow-up|0|||
48728311|NCT03435640|156855501|FG004|Overall Study|Lost to Follow-up|0|||
48728312|NCT03435640|156855502|FG005|Overall Study|Lost to Follow-up|0|||
48728313|NCT03435640|156855503|FG006|Overall Study|Lost to Follow-up|0|||
48728314|NCT03435640|156855504|FG007|Overall Study|Lost to Follow-up|0|||
48728315|NCT03435640|156855505|FG008|Overall Study|Lost to Follow-up|0|||
48728316|NCT03435640|156855506|FG009|Overall Study|Lost to Follow-up|0|||
48728317|NCT03435640|156855507|FG010|Overall Study|Lost to Follow-up|0|||
48728318|NCT01920555|156855508|FG000|Overall Study|Physician Decision|1|||
49139493|NCT03320369|158348300|FG000|Overall Study|Withdrawal by Subject|2|||
49139494|NCT01002105|158348301|FG000|Overall Study|Lost to Follow-up|10|||
48728319|NCT01920555|156855509|FG001|Overall Study|Physician Decision|2|||
48728320|NCT01920555|156855510|FG002|Overall Study|Physician Decision|1|||
48728321|NCT01920555|156855511|FG003|Overall Study|Physician Decision|2|||
48728322|NCT01920555|156855512|FG004|Overall Study|Physician Decision|0|||
48728323|NCT01920555|156855508|FG000|Overall Study|Lack of Efficacy|2|||
48728324|NCT01920555|156855509|FG001|Overall Study|Lack of Efficacy|0|||
48728325|NCT01920555|156855510|FG002|Overall Study|Lack of Efficacy|0|||
48728326|NCT01920555|156855511|FG003|Overall Study|Lack of Efficacy|0|||
48728327|NCT01920555|156855512|FG004|Overall Study|Lack of Efficacy|0|||
48728328|NCT01920555|156855508|FG000|Overall Study|Travel Difficulties|1|||
48728329|NCT01920555|156855509|FG001|Overall Study|Travel Difficulties|1|||
48728330|NCT01920555|156855510|FG002|Overall Study|Travel Difficulties|0|||
48728331|NCT01920555|156855511|FG003|Overall Study|Travel Difficulties|0|||
48728332|NCT01920555|156855512|FG004|Overall Study|Travel Difficulties|1|||
48728333|NCT01920555|156855508|FG000|Overall Study|Lost to Follow-up|0|||
48728334|NCT01920555|156855509|FG001|Overall Study|Lost to Follow-up|1|||
48728335|NCT01920555|156855510|FG002|Overall Study|Lost to Follow-up|0|||
48728336|NCT01920555|156855511|FG003|Overall Study|Lost to Follow-up|1|||
48728337|NCT01920555|156855512|FG004|Overall Study|Lost to Follow-up|0|||
48728338|NCT01741012|156855515|FG000|Overall Study|Lost to Follow-up|1|||
48728339|NCT01741012|156855515|FG000|Overall Study|Withdrawal by Subject|2|||
48728340|NCT00880685|156855518|FG000|Memantine 10mg|Lost to Follow-up|2|||
48728341|NCT00880685|156855518|FG000|Memantine 20mg|Withdrawal by Subject|1|||
48728342|NCT01711879|156855519|FG000|Overall Study|Death|1|||
48728343|NCT01711879|156855520|FG001|Overall Study|Death|0|||
48728344|NCT03845296|156855524|FG000|Overall Study|On Treatment|2|||
48728345|NCT03845296|156855525|FG001|Overall Study|On Treatment|1|||
48728346|NCT03845296|156855524|FG000|Overall Study|Adverse Event|4|||
48728347|NCT03845296|156855525|FG001|Overall Study|Adverse Event|11|||
48728348|NCT03845296|156855524|FG000|Overall Study|Refusal unrelated to adverse event|0|||
48728349|NCT03845296|156855525|FG001|Overall Study|Refusal unrelated to adverse event|1|||
48921289|NCT02270242|157544892|FG000|Overall Study|Lost to Follow-up|41|||
48728350|NCT03845296|156855524|FG000|Overall Study|Progression/relapse|14|||
48921290|NCT02270242|157544893|FG001|Overall Study|Lost to Follow-up|27|||
48728351|NCT03845296|156855525|FG001|Overall Study|Progression/relapse|18|||
48728352|NCT03845296|156855524|FG000|Overall Study|Death|4|||
48728353|NCT03845296|156855525|FG001|Overall Study|Death|0|||
48728354|NCT03845296|156855524|FG000|Overall Study|Other - not protocol specified|1|||
48728355|NCT03845296|156855525|FG001|Overall Study|Other - not protocol specified|3|||
49139495|NCT01002105|158348302|FG001|Overall Study|Lost to Follow-up|16|||
49139496|NCT01002105|158348301|FG000|Overall Study|non compliance|5|||
49139497|NCT01002105|158348302|FG001|Overall Study|non compliance|3|||
48728356|NCT00589784|156855531|FG000|Overall Study|Withdrawal by Subject|0|||
49139498|NCT01002105|158348301|FG000|Overall Study|condition worsened|4|||
49139499|NCT01002105|158348302|FG001|Overall Study|condition worsened|2|||
49139500|NCT01793935|158348303|FG000|Overall Study|Pregnancy|1|||
49139501|NCT01793935|158348304|FG001|Overall Study|Pregnancy|0|||
49139502|NCT01793935|158348303|FG000|Overall Study|Protocol Violation|2|||
49139503|NCT01793935|158348304|FG001|Overall Study|Protocol Violation|1|||
49139504|NCT01793935|158348303|FG000|Overall Study|Adverse Event|2|||
49139505|NCT01793935|158348304|FG001|Overall Study|Adverse Event|0|||
49139506|NCT01793935|158348303|FG000|Overall Study|Patient did not take study medication|1|||
49139507|NCT01793935|158348304|FG001|Overall Study|Patient did not take study medication|1|||
49139508|NCT01793935|158348303|FG000|Overall Study|Lost to Follow-up|0|||
49139509|NCT01793935|158348304|FG001|Overall Study|Lost to Follow-up|1|||
49139510|NCT02506036|158348305|FG000|First Intervention (4-6 Weeks)|Death|1|||
49139511|NCT02506036|158348306|FG001|First Intervention (4-6 Weeks)|Death|0|||
49139512|NCT02506036|158348305|FG000|First Intervention (4-6 Weeks)|Lost to Follow-up|0|||
49139513|NCT02506036|158348306|FG001|First Intervention (4-6 Weeks)|Lost to Follow-up|1|||
49139514|NCT02506036|158348305|FG000|First Intervention (4-6 Weeks)|Withdrawal by Subject|0|||
49139515|NCT02506036|158348306|FG001|First Intervention (4-6 Weeks)|Withdrawal by Subject|1|||
49139516|NCT02265744|158348318|FG000|Overall Study|Poor/Non-compliance|1|||
49139517|NCT02265744|158348319|FG001|Overall Study|Poor/Non-compliance|1|||
49139518|NCT02265744|158348320|FG002|Overall Study|Poor/Non-compliance|0|||
49139519|NCT02265744|158348321|FG003|Overall Study|Poor/Non-compliance|0|||
49139520|NCT02265744|158348322|FG004|Overall Study|Poor/Non-compliance|2|||
49139521|NCT02265744|158348318|FG000|Overall Study|Lost to Follow-up|0|||
49139522|NCT02265744|158348319|FG001|Overall Study|Lost to Follow-up|0|||
49139523|NCT02265744|158348320|FG002|Overall Study|Lost to Follow-up|0|||
49139524|NCT02265744|158348321|FG003|Overall Study|Lost to Follow-up|1|||
49139525|NCT02265744|158348322|FG004|Overall Study|Lost to Follow-up|0|||
49139526|NCT02265744|158348318|FG000|Overall Study|Death|0|||
49139527|NCT02265744|158348319|FG001|Overall Study|Death|0|||
49139528|NCT02265744|158348320|FG002|Overall Study|Death|0|||
49139529|NCT02265744|158348321|FG003|Overall Study|Death|2|||
49139530|NCT02265744|158348322|FG004|Overall Study|Death|0|||
49139531|NCT02265744|158348318|FG000|Overall Study|Withdrawal by Subject|2|||
49139532|NCT02265744|158348319|FG001|Overall Study|Withdrawal by Subject|0|||
49139533|NCT02265744|158348320|FG002|Overall Study|Withdrawal by Subject|0|||
49139534|NCT02265744|158348321|FG003|Overall Study|Withdrawal by Subject|2|||
49139535|NCT02265744|158348322|FG004|Overall Study|Withdrawal by Subject|0|||
49139536|NCT02265744|158348318|FG000|Overall Study|Participant request to discontinue|2|||
49139537|NCT02265744|158348319|FG001|Overall Study|Participant request to discontinue|2|||
49139538|NCT02265744|158348320|FG002|Overall Study|Participant request to discontinue|2|||
49139539|NCT02265744|158348321|FG003|Overall Study|Participant request to discontinue|0|||
49139540|NCT02265744|158348322|FG004|Overall Study|Participant request to discontinue|0|||
49139541|NCT02265744|158348318|FG000|Overall Study|Adverse Event|8|||
49139542|NCT02265744|158348319|FG001|Overall Study|Adverse Event|4|||
49139543|NCT02265744|158348320|FG002|Overall Study|Adverse Event|9|||
49139544|NCT02265744|158348321|FG003|Overall Study|Adverse Event|8|||
49139545|NCT02265744|158348322|FG004|Overall Study|Adverse Event|2|||
49139546|NCT02265744|158348318|FG000|Overall Study|Lack of Efficacy|2|||
49139547|NCT02265744|158348319|FG001|Overall Study|Lack of Efficacy|4|||
49139548|NCT02265744|158348320|FG002|Overall Study|Lack of Efficacy|3|||
49139549|NCT02265744|158348321|FG003|Overall Study|Lack of Efficacy|4|||
49139550|NCT02265744|158348322|FG004|Overall Study|Lack of Efficacy|5|||
49139551|NCT02265744|158348318|FG000|Overall Study|Reason not provided by Investigator|1|||
49139552|NCT02265744|158348319|FG001|Overall Study|Reason not provided by Investigator|0|||
48728357|NCT00589784|156855532|FG001|Overall Study|Withdrawal by Subject|6|||
49139553|NCT02265744|158348320|FG002|Overall Study|Reason not provided by Investigator|0|||
49139554|NCT02265744|158348321|FG003|Overall Study|Reason not provided by Investigator|2|||
49139555|NCT02265744|158348322|FG004|Overall Study|Reason not provided by Investigator|0|||
49139556|NCT02265744|158348318|FG000|Overall Study|Administrative reason by sponsor|3|||
48728358|NCT00589784|156855531|FG000|Overall Study|Patient inevaluable|1|||
49139557|NCT02265744|158348319|FG001|Overall Study|Administrative reason by sponsor|2|||
49139558|NCT02265744|158348320|FG002|Overall Study|Administrative reason by sponsor|2|||
48728359|NCT00589784|156855532|FG001|Overall Study|Patient inevaluable|0|||
49139559|NCT02265744|158348321|FG003|Overall Study|Administrative reason by sponsor|3|||
49139560|NCT02265744|158348322|FG004|Overall Study|Administrative reason by sponsor|3|||
49139561|NCT02265744|158348318|FG000|Overall Study|Subject no longer meets study criteria|0|||
49139562|NCT02265744|158348319|FG001|Overall Study|Subject no longer meets study criteria|0|||
49139563|NCT02265744|158348320|FG002|Overall Study|Subject no longer meets study criteria|0|||
49139564|NCT02265744|158348321|FG003|Overall Study|Subject no longer meets study criteria|0|||
49139565|NCT02265744|158348322|FG004|Overall Study|Subject no longer meets study criteria|1|||
49139566|NCT02265744|158348318|FG000|Overall Study|Pregnancy|1|||
49139567|NCT02265744|158348319|FG001|Overall Study|Pregnancy|2|||
49139568|NCT02265744|158348320|FG002|Overall Study|Pregnancy|1|||
49139569|NCT02265744|158348321|FG003|Overall Study|Pregnancy|1|||
49139570|NCT02265744|158348322|FG004|Overall Study|Pregnancy|0|||
49139571|NCT03097315|158348329|FG000|Overall Study|Withdrawal by Subject|1|||
49139572|NCT05161936|158348330|FG000|Overall Study|Study terminated by Sponsor|1|||
49139573|NCT05161936|158348331|FG001|Overall Study|Study terminated by Sponsor|0|||
49139574|NCT05161936|158348332|FG002|Overall Study|Study terminated by Sponsor|0|||
49139575|NCT05161936|158348330|FG000|Overall Study|Withdrawal by Subject|0|||
49139576|NCT05161936|158348331|FG001|Overall Study|Withdrawal by Subject|0|||
49139577|NCT05161936|158348332|FG002|Overall Study|Withdrawal by Subject|1|||
49139578|NCT01560988|158348335|FG000|First Intervention (Six Weeks)|Lost to Follow-up|7|||
49139579|NCT01560988|158348336|FG001|First Intervention (Six Weeks)|Lost to Follow-up|4|||
49139580|NCT01560988|158348335|FG000|First Intervention (Six Weeks)|Withdrawal by Subject|3|||
49139581|NCT01560988|158348336|FG001|First Intervention (Six Weeks)|Withdrawal by Subject|0|||
49139582|NCT01560988|158348335|FG000|Washout (Six Weeks)|Lost to Follow-up|2|||
49139583|NCT01560988|158348336|FG001|Washout (Six Weeks)|Lost to Follow-up|2|||
49139584|NCT02541903|158348337|FG000|Overall Study|Death|1|||
49139585|NCT02421510|158348338|FG000|Overall Study|Other|4|||
49139586|NCT02421510|158348339|FG001|Overall Study|Other|2|||
49139587|NCT02421510|158348340|FG002|Overall Study|Other|3|||
49139588|NCT02421510|158348338|FG000|Overall Study|Protocol Violation|1|||
49139589|NCT02421510|158348339|FG001|Overall Study|Protocol Violation|2|||
48921291|NCT02270242|157544892|FG000|Overall Study|Physician Decision|0|||
48921292|NCT02270242|157544893|FG001|Overall Study|Physician Decision|1|||
48921293|NCT00644787|157544896|FG000|Period 1: Titration Phase|Adverse Event|11|||
49139590|NCT02421510|158348340|FG002|Overall Study|Protocol Violation|0|||
49139591|NCT02421510|158348338|FG000|Overall Study|Death|1|||
49139592|NCT02421510|158348339|FG001|Overall Study|Death|0|||
49139593|NCT02421510|158348340|FG002|Overall Study|Death|0|||
49139594|NCT02421510|158348338|FG000|Overall Study|Noncompliance with study drug|1|||
49139595|NCT02421510|158348339|FG001|Overall Study|Noncompliance with study drug|0|||
49139596|NCT02421510|158348340|FG002|Overall Study|Noncompliance with study drug|0|||
49139597|NCT02421510|158348338|FG000|Overall Study|Physician Decision|1|||
49139598|NCT02421510|158348339|FG001|Overall Study|Physician Decision|1|||
49139599|NCT02421510|158348340|FG002|Overall Study|Physician Decision|3|||
49139600|NCT02421510|158348338|FG000|Overall Study|Adverse Event|9|||
49139601|NCT02421510|158348339|FG001|Overall Study|Adverse Event|10|||
48921294|NCT00644787|157544897|FG001|Period 1: Titration Phase|Adverse Event|0|||
48921295|NCT00644787|157544898|FG002|Period 1: Titration Phase|Adverse Event|0|||
48921296|NCT00644787|157544896|FG000|Period 1: Titration Phase|Withdrawal by Subject|2|||
48921297|NCT00644787|157544897|FG001|Period 1: Titration Phase|Withdrawal by Subject|0|||
48921298|NCT00644787|157544898|FG002|Period 1: Titration Phase|Withdrawal by Subject|0|||
49139602|NCT02421510|158348340|FG002|Overall Study|Adverse Event|18|||
49139603|NCT02421510|158348338|FG000|Overall Study|Pregnancy|1|||
49139604|NCT02421510|158348339|FG001|Overall Study|Pregnancy|1|||
49139605|NCT02421510|158348340|FG002|Overall Study|Pregnancy|0|||
49139606|NCT02421510|158348338|FG000|Overall Study|Withdrawal by Subject|14|||
49139607|NCT02421510|158348339|FG001|Overall Study|Withdrawal by Subject|18|||
48728360|NCT00589784|156855531|FG000|Overall Study|Adverse Event|0|||
48728361|NCT00589784|156855532|FG001|Overall Study|Adverse Event|4|||
48728362|NCT01058265|156855541|FG000|Overall Study|Lost to Follow-up|11|||
48728363|NCT01058265|156855542|FG001|Overall Study|Lost to Follow-up|12|||
48728364|NCT00566501|156855543|FG000|Overall Study|Adverse Event|68|||
48728365|NCT00566501|156855544|FG001|Overall Study|Adverse Event|59|||
48728366|NCT00566501|156855543|FG000|Overall Study|Medication Non-compliance|5|||
48728367|NCT00566501|156855544|FG001|Overall Study|Medication Non-compliance|0|||
48728368|NCT00566501|156855543|FG000|Overall Study|Protocol Violation|2|||
48728369|NCT00566501|156855544|FG001|Overall Study|Protocol Violation|2|||
48728370|NCT00566501|156855543|FG000|Overall Study|Request of Investigator or Sponsor|6|||
48728371|NCT00566501|156855544|FG001|Overall Study|Request of Investigator or Sponsor|7|||
48728372|NCT00566501|156855543|FG000|Overall Study|Withdrawal by Subject|33|||
48728373|NCT00566501|156855544|FG001|Overall Study|Withdrawal by Subject|30|||
48728374|NCT00566501|156855543|FG000|Overall Study|Lack of Efficacy|8|||
48728375|NCT00566501|156855544|FG001|Overall Study|Lack of Efficacy|3|||
48728376|NCT00566501|156855543|FG000|Overall Study|Other|25|||
48728377|NCT00566501|156855544|FG001|Overall Study|Other|21|||
48728378|NCT01367119|156855545|FG000|Overall Study|Adverse Event|1|||
48728379|NCT01367119|156855546|FG001|Overall Study|Adverse Event|0|||
48728380|NCT01367119|156855545|FG000|Overall Study|Withdrawal by Subject|1|||
48728381|NCT01367119|156855546|FG001|Overall Study|Withdrawal by Subject|1|||
48728382|NCT02310321|156855547|FG000|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|1|||
48728383|NCT02310321|156855548|FG001|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
48728384|NCT02310321|156855549|FG002|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
48728385|NCT02310321|156855547|FG000|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|1|||
48728386|NCT02310321|156855548|FG001|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
48921299|NCT00644787|157544896|FG000|Period 1: Titration Phase|Physician Decision|1|||
48921300|NCT00644787|157544897|FG001|Period 1: Titration Phase|Physician Decision|0|||
48921301|NCT00644787|157544898|FG002|Period 1: Titration Phase|Physician Decision|0|||
48921302|NCT00644787|157544896|FG000|Period 1: Titration Phase|Worsening of underlying disease|5|||
48921303|NCT00644787|157544897|FG001|Period 1: Titration Phase|Worsening of underlying disease|0|||
48728387|NCT02310321|156855549|FG002|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
48728388|NCT02310321|156855547|FG000|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|1|||
48821678|NCT03285711|157188742|FG001|Blinded Phase (Up to Week 16)|Adverse Event|1|||
48821679|NCT03285711|157188743|FG002|Blinded Phase (Up to Week 16)|Adverse Event|0|||
48821680|NCT03285711|157188744|FG003|Blinded Phase (Up to Week 16)|Adverse Event|0|||
48821681|NCT03285711|157188741|FG000|Blinded Phase (Up to Week 16)|Protocol Violation|1|||
48821682|NCT03285711|157188742|FG001|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
48821683|NCT03285711|157188743|FG002|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
49139608|NCT02421510|158348340|FG002|Overall Study|Withdrawal by Subject|12|||
49139609|NCT02421510|158348338|FG000|Overall Study|Lost to Follow-up|1|||
49139610|NCT02421510|158348339|FG001|Overall Study|Lost to Follow-up|1|||
49139611|NCT02421510|158348340|FG002|Overall Study|Lost to Follow-up|0|||
49139612|NCT02691663|158348341|FG000|Overall Study|Screen failure after baseline|2|||
49139613|NCT02691663|158348342|FG001|Overall Study|Screen failure after baseline|2|||
49139614|NCT02691663|158348341|FG000|Overall Study|withdrawn after Follow up 1 visit|2|||
49139615|NCT02691663|158348342|FG001|Overall Study|withdrawn after Follow up 1 visit|2|||
49139616|NCT02691663|158348341|FG000|Overall Study|Withdrawn after Follow up 2|1|||
49139617|NCT02691663|158348342|FG001|Overall Study|Withdrawn after Follow up 2|1|||
49139618|NCT02691663|158348341|FG000|Overall Study|Lost to Follow-up|3|||
49139619|NCT02691663|158348342|FG001|Overall Study|Lost to Follow-up|2|||
49139620|NCT04925934|158348343|FG000|Overall Study|Adverse Event|1|||
49139621|NCT04925934|158348344|FG001|Overall Study|Adverse Event|0|||
49139622|NCT04925934|158348345|FG002|Overall Study|Adverse Event|0|||
49139623|NCT04925934|158348343|FG000|Overall Study|Lost to Follow-up|2|||
49139624|NCT04925934|158348344|FG001|Overall Study|Lost to Follow-up|0|||
49139625|NCT04925934|158348345|FG002|Overall Study|Lost to Follow-up|1|||
49139626|NCT04925934|158348343|FG000|Overall Study|Death|0|||
49139627|NCT04925934|158348344|FG001|Overall Study|Death|1|||
48728389|NCT02310321|156855548|FG001|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
48921304|NCT00644787|157544898|FG002|Period 1: Titration Phase|Worsening of underlying disease|0|||
48921305|NCT00644787|157544896|FG000|Period 1: Titration Phase|Worsening of complications|1|||
48728390|NCT02310321|156855549|FG002|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
48728391|NCT02310321|156855547|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
48728392|NCT02310321|156855548|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|1|||
48728393|NCT02310321|156855549|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
48728394|NCT02310321|156855547|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
48728395|NCT02310321|156855548|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|4|||
48728396|NCT02310321|156855549|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
48728397|NCT02310321|156855547|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
48728398|NCT02310321|156855548|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|1|||
48728399|NCT02310321|156855549|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
48728400|NCT02310321|156855547|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
48728401|NCT02310321|156855548|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|1|||
48821684|NCT03285711|157188744|FG003|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
48821685|NCT03285711|157188741|FG000|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
48821686|NCT03285711|157188742|FG001|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
48821687|NCT03285711|157188743|FG002|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1|||
48821688|NCT03285711|157188744|FG003|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
48921306|NCT00644787|157544897|FG001|Period 1: Titration Phase|Worsening of complications|0|||
49139628|NCT04925934|158348345|FG002|Overall Study|Death|0|||
49139629|NCT04925934|158348343|FG000|Overall Study|Withdrawal by Subject|8|||
48821689|NCT03285711|157188741|FG000|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
49139630|NCT04925934|158348344|FG001|Overall Study|Withdrawal by Subject|5|||
49139631|NCT04925934|158348345|FG002|Overall Study|Withdrawal by Subject|9|||
49139632|NCT04925934|158348343|FG000|Overall Study|Other|2|||
49139633|NCT04925934|158348344|FG001|Overall Study|Other|2|||
49139634|NCT04925934|158348345|FG002|Overall Study|Other|2|||
49139635|NCT04925934|158348343|FG000|Overall Study|Eastern European Conflict|7|||
49139636|NCT04925934|158348344|FG001|Overall Study|Eastern European Conflict|3|||
49139637|NCT04925934|158348345|FG002|Overall Study|Eastern European Conflict|2|||
49139638|NCT01149538|158348347|FG000|Overall Study|Lost to Follow-up|0|||
49139639|NCT01149538|158348348|FG001|Overall Study|Lost to Follow-up|1|||
49139640|NCT01149538|158348347|FG000|Overall Study|Withdrawal by Subject|5|||
49139641|NCT01149538|158348348|FG001|Overall Study|Withdrawal by Subject|3|||
49139642|NCT01529268|158348351|FG000|Overall Study|Lost to Follow-up|9|||
49139643|NCT01529268|158348352|FG001|Overall Study|Lost to Follow-up|3|||
49139644|NCT01529268|158348351|FG000|Overall Study|Moved|3|||
48921307|NCT00644787|157544898|FG002|Period 1: Titration Phase|Worsening of complications|0|||
48921308|NCT00644787|157544896|FG000|Period 1: Titration Phase|Worsening of symptoms|1|||
48921309|NCT00644787|157544897|FG001|Period 1: Titration Phase|Worsening of symptoms|0|||
48921310|NCT00644787|157544898|FG002|Period 1: Titration Phase|Worsening of symptoms|0|||
48921311|NCT00644787|157544896|FG000|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3|||
48921312|NCT00644787|157544897|FG001|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
48921313|NCT00644787|157544898|FG002|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
48921314|NCT00644787|157544896|FG000|Period 1: Titration Phase|Participant was judged as ineligible|3|||
48921315|NCT00644787|157544897|FG001|Period 1: Titration Phase|Participant was judged as ineligible|0|||
48921316|NCT00644787|157544898|FG002|Period 1: Titration Phase|Participant was judged as ineligible|0|||
48921317|NCT00644787|157544896|FG000|Period 2: Double Blind Phase|Adverse Event|0|||
48921318|NCT00644787|157544897|FG001|Period 2: Double Blind Phase|Adverse Event|2|||
48921319|NCT00644787|157544898|FG002|Period 2: Double Blind Phase|Adverse Event|4|||
48921320|NCT00644787|157544896|FG000|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
48921321|NCT00644787|157544897|FG001|Period 2: Double Blind Phase|Withdrawal by Subject|1|||
48921322|NCT00644787|157544898|FG002|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
48921323|NCT00644787|157544896|FG000|Period 2: Double Blind Phase|Worsening of underlying disease|0|||
48921324|NCT00644787|157544897|FG001|Period 2: Double Blind Phase|Worsening of underlying disease|6|||
48921325|NCT00644787|157544898|FG002|Period 2: Double Blind Phase|Worsening of underlying disease|2|||
48921326|NCT00644787|157544896|FG000|Period 2: Double Blind Phase|Worsening of symptoms|0|||
48921327|NCT00644787|157544897|FG001|Period 2: Double Blind Phase|Worsening of symptoms|0|||
48921328|NCT00644787|157544898|FG002|Period 2: Double Blind Phase|Worsening of symptoms|1|||
48921329|NCT00861744|157544899|FG000|Overall Study|Adverse Event|0|||
48921330|NCT00861744|157544900|FG001|Overall Study|Adverse Event|0|||
48921331|NCT00861744|157544901|FG002|Overall Study|Adverse Event|0|||
48921332|NCT00861744|157544902|FG003|Overall Study|Adverse Event|1|||
48921333|NCT00861744|157544899|FG000|Overall Study|Lost to Follow-up|7|||
48921334|NCT00861744|157544900|FG001|Overall Study|Lost to Follow-up|19|||
48921335|NCT00861744|157544901|FG002|Overall Study|Lost to Follow-up|17|||
48921336|NCT00861744|157544902|FG003|Overall Study|Lost to Follow-up|12|||
48921337|NCT00861744|157544899|FG000|Overall Study|Withdrawal by Subject|10|||
48921338|NCT00861744|157544900|FG001|Overall Study|Withdrawal by Subject|6|||
48921339|NCT00861744|157544901|FG002|Overall Study|Withdrawal by Subject|6|||
48921340|NCT00861744|157544902|FG003|Overall Study|Withdrawal by Subject|19|||
48921341|NCT00861744|157544899|FG000|Overall Study|Protocol Violation|0|||
48921342|NCT00861744|157544900|FG001|Overall Study|Protocol Violation|1|||
49139645|NCT01529268|158348352|FG001|Overall Study|Moved|0|||
49139646|NCT00387127|158348353|FG000|Overall Study|Lost to Follow-up|0|||
49139647|NCT00387127|158348354|FG001|Overall Study|Lost to Follow-up|4|||
49139648|NCT00387127|158348353|FG000|Overall Study|Death|16|||
49139649|NCT00387127|158348354|FG001|Overall Study|Death|16|||
49139650|NCT00387127|158348353|FG000|Overall Study|Physician Decision|0|||
49139651|NCT00387127|158348354|FG001|Overall Study|Physician Decision|1|||
49139652|NCT00387127|158348353|FG000|Overall Study|Withdrawal by Subject|3|||
49139653|NCT00387127|158348354|FG001|Overall Study|Withdrawal by Subject|2|||
49139654|NCT00387127|158348353|FG000|Overall Study|Required by Protocol Amendment #4|12|||
49139655|NCT00387127|158348354|FG001|Overall Study|Required by Protocol Amendment #4|10|||
48728402|NCT02310321|156855549|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
48728403|NCT02310321|156855547|FG000|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
48728404|NCT02310321|156855548|FG001|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|3|||
48728405|NCT02310321|156855549|FG002|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
48728406|NCT02310321|156855547|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
49139656|NCT00387127|158348353|FG000|Overall Study|Serious Adverse Event|1|||
49139657|NCT00387127|158348354|FG001|Overall Study|Serious Adverse Event|1|||
49139658|NCT00387127|158348353|FG000|Overall Study|Sponsor Unblinded|1|||
49139659|NCT00387127|158348354|FG001|Overall Study|Sponsor Unblinded|0|||
49139660|NCT00927082|158348357|FG000|Overall Study|Lost to Follow-up|9|||
49139661|NCT00927082|158348358|FG001|Overall Study|Lost to Follow-up|8|||
49139662|NCT00927082|158348359|FG002|Overall Study|Lost to Follow-up|12|||
49139663|NCT00927082|158348360|FG003|Overall Study|Lost to Follow-up|16|||
48921343|NCT00861744|157544901|FG002|Overall Study|Protocol Violation|0|||
48921344|NCT00861744|157544902|FG003|Overall Study|Protocol Violation|0|||
49139664|NCT00927082|158348357|FG000|Overall Study|Withdrawal by Subject|3|||
49139665|NCT00927082|158348358|FG001|Overall Study|Withdrawal by Subject|2|||
49139666|NCT00927082|158348359|FG002|Overall Study|Withdrawal by Subject|7|||
49139667|NCT00927082|158348360|FG003|Overall Study|Withdrawal by Subject|2|||
49139668|NCT00927082|158348357|FG000|Overall Study|Death|0|||
48728407|NCT02310321|156855548|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
48728408|NCT02310321|156855549|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|2|||
48728409|NCT02310321|156855547|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
48921345|NCT00861744|157544899|FG000|Overall Study|Migration from study area|0|||
48921346|NCT00861744|157544900|FG001|Overall Study|Migration from study area|3|||
48921347|NCT00861744|157544901|FG002|Overall Study|Migration from study area|1|||
48821690|NCT03285711|157188742|FG001|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1|||
48821691|NCT03285711|157188743|FG002|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
48821692|NCT03285711|157188744|FG003|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
48821693|NCT00877851|157188745|FG000|Overall Study|Lost to Follow-up|5|||
48821694|NCT00877851|157188746|FG001|Overall Study|Lost to Follow-up|5|||
48921348|NCT00861744|157544902|FG003|Overall Study|Migration from study area|0|||
48728410|NCT02310321|156855548|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
48728411|NCT02310321|156855549|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|2|||
48728412|NCT02310321|156855547|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
48728413|NCT02310321|156855548|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
48728414|NCT02310321|156855549|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|6|||
48728415|NCT02310321|156855547|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
48728416|NCT02310321|156855548|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
48728417|NCT02310321|156855549|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|4|||
48821695|NCT00877851|157188745|FG000|Overall Study|computer problem|3|||
48821696|NCT00877851|157188746|FG001|Overall Study|computer problem|0|||
48821697|NCT00877851|157188745|FG000|Overall Study|no longer interested in participating|1|||
48821698|NCT00877851|157188746|FG001|Overall Study|no longer interested in participating|0|||
48821699|NCT01871285|157188747|FG000|First Intervention (1 Day)|Adverse Event|1|||
48821700|NCT01871285|157188748|FG001|First Intervention (1 Day)|Adverse Event|0|||
48821701|NCT01871285|157188749|FG002|First Intervention (1 Day)|Adverse Event|0|||
48821702|NCT01871285|157188750|FG003|First Intervention (1 Day)|Adverse Event|0|||
48821703|NCT01871285|157188747|FG000|First Intervention (1 Day)|Lost to Follow-up|0|||
48821704|NCT01871285|157188748|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
48821705|NCT01871285|157188749|FG002|First Intervention (1 Day)|Lost to Follow-up|1|||
48821706|NCT01871285|157188750|FG003|First Intervention (1 Day)|Lost to Follow-up|0|||
48821707|NCT00114959|157188751|FG000|Overall Study|Lack of Efficacy|6|||
48821708|NCT00114959|157188751|FG000|Overall Study|Physician Decision|1|||
48821709|NCT00114959|157188751|FG000|Overall Study|Death|1|||
48821710|NCT01866917|157188759|FG000|Overall Study|Pharmacist stopped dispensing treatment|4|||
48821711|NCT01866917|157188760|FG001|Overall Study|Pharmacist stopped dispensing treatment|6|||
48821712|NCT01515319|157188761|FG000|Overall Study|Withdrawal by Subject|0|||
48821713|NCT01515319|157188762|FG001|Overall Study|Withdrawal by Subject|0|||
48921349|NCT00861744|157544899|FG000|Overall Study|Blood draws|0|||
48921350|NCT00861744|157544900|FG001|Overall Study|Blood draws|0|||
48921351|NCT00861744|157544901|FG002|Overall Study|Blood draws|0|||
48921352|NCT00861744|157544902|FG003|Overall Study|Blood draws|1|||
48921353|NCT00562588|157544906|FG000|Overall Study|Adverse Event|40|||
48921354|NCT00562588|157544907|FG001|Overall Study|Adverse Event|58|||
48921355|NCT00562588|157544906|FG000|Overall Study|Protocol Violation|30|||
48921356|NCT00562588|157544907|FG001|Overall Study|Protocol Violation|26|||
48921357|NCT00562588|157544906|FG000|Overall Study|Lost to Follow-up|12|||
48921358|NCT00562588|157544907|FG001|Overall Study|Lost to Follow-up|4|||
48921359|NCT00562588|157544906|FG000|Overall Study|Withdrawal by Subject|10|||
48921360|NCT00562588|157544907|FG001|Overall Study|Withdrawal by Subject|9|||
48921361|NCT00562588|157544906|FG000|Overall Study|Other|0|||
48921362|NCT00562588|157544907|FG001|Overall Study|Other|2|||
48921363|NCT03809611|157544908|FG000|Overall Study|Withdrawal by Subject|1|||
48921364|NCT03809611|157544909|FG001|Overall Study|Withdrawal by Subject|1|||
48921365|NCT00879229|157546354|FG000|Overall Study|Study terminated by Sponsor|13|||
48921366|NCT00879229|157546355|FG001|Overall Study|Study terminated by Sponsor|12|||
48921367|NCT00879229|157546354|FG000|Overall Study|Death|4|||
48921368|NCT00879229|157546355|FG001|Overall Study|Death|2|||
48921369|NCT00879229|157546354|FG000|Overall Study|Adverse Event|2|||
48921370|NCT00879229|157546355|FG001|Overall Study|Adverse Event|0|||
48921371|NCT00879229|157546354|FG000|Overall Study|Withdrawal by Subject|1|||
48921372|NCT00879229|157546355|FG001|Overall Study|Withdrawal by Subject|0|||
48921373|NCT00879229|157546354|FG000|Overall Study|Clinical status did not improve|1|||
48921374|NCT00879229|157546355|FG001|Overall Study|Clinical status did not improve|0|||
48921375|NCT00879229|157546354|FG000|Overall Study|Other|1|||
48921376|NCT00879229|157546355|FG001|Overall Study|Other|0|||
48921377|NCT00925015|157546358|FG000|Overall Study|Adverse Event|1|||
48921378|NCT00925015|157546359|FG001|Overall Study|Adverse Event|2|||
48921379|NCT00925015|157546360|FG002|Overall Study|Adverse Event|1|||
48921380|NCT00925015|157546358|FG000|Overall Study|Physician Decision|0|||
48921381|NCT00925015|157546359|FG001|Overall Study|Physician Decision|1|||
48921382|NCT00925015|157546360|FG002|Overall Study|Physician Decision|0|||
48921383|NCT00925015|157546358|FG000|Overall Study|Progressive Disease|7|||
48921384|NCT00925015|157546359|FG001|Overall Study|Progressive Disease|3|||
48921385|NCT00925015|157546360|FG002|Overall Study|Progressive Disease|4|||
48921386|NCT00925015|157546358|FG000|Overall Study|Withdrawal by Subject|0|||
48921387|NCT00925015|157546359|FG001|Overall Study|Withdrawal by Subject|0|||
48728418|NCT02310321|156855547|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
48728419|NCT02310321|156855548|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
48728420|NCT02310321|156855549|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|3|||
48728421|NCT02310321|156855547|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
48728422|NCT02310321|156855548|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
48728423|NCT02310321|156855549|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|3|||
49139669|NCT00927082|158348358|FG001|Overall Study|Death|0|||
49139670|NCT00927082|158348359|FG002|Overall Study|Death|1|||
49139671|NCT00927082|158348360|FG003|Overall Study|Death|0|||
49139672|NCT00927082|158348357|FG000|Overall Study|Screen fail,Participant migrated,Unknown|0|||
49139673|NCT00927082|158348358|FG001|Overall Study|Screen fail,Participant migrated,Unknown|0|||
49139674|NCT00927082|158348359|FG002|Overall Study|Screen fail,Participant migrated,Unknown|2|||
49139675|NCT00927082|158348360|FG003|Overall Study|Screen fail,Participant migrated,Unknown|1|||
49139676|NCT03983109|158348361|FG000|Overall Study|Operational Hurdles Linked to Usage Methodologies|12|||
49139677|NCT03983109|158348362|FG001|Overall Study|Operational Hurdles Linked to Usage Methodologies|0|||
49139678|NCT01786109|158348363|FG000|Overall Study|fail manometry barostat tube placement|1|||
49139679|NCT01786109|158348364|FG001|Overall Study|fail manometry barostat tube placement|0|||
49139680|NCT01786109|158348365|FG002|Overall Study|fail manometry barostat tube placement|0|||
49139681|NCT01786109|158348363|FG000|Overall Study|unrelated illness|0|||
49139682|NCT01786109|158348364|FG001|Overall Study|unrelated illness|0|||
49139683|NCT01786109|158348365|FG002|Overall Study|unrelated illness|1|||
49139684|NCT01786109|158348363|FG000|Overall Study|adverse effects colon preparation|0|||
49139685|NCT01786109|158348364|FG001|Overall Study|adverse effects colon preparation|0|||
49139686|NCT01786109|158348365|FG002|Overall Study|adverse effects colon preparation|1|||
49139687|NCT04149353|158348366|FG000|Overall Study|Study terminated|1|||
49139688|NCT00849472|158348367|FG000|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2|||
49139689|NCT00849472|158348367|FG000|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1|||
49139690|NCT00849472|158348367|FG000|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1|||
49139691|NCT00849472|158348367|FG000|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1|||
49139692|NCT00849472|158348367|FG000|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1|||
49139693|NCT00849472|158348367|FG000|Weekly Paclitaxel|Disease Progression|1|||
49139694|NCT00849472|158348367|FG000|Weekly Paclitaxel|Adverse Event|11|||
49139695|NCT00849472|158348367|FG000|Weekly Paclitaxel|Withdrawal by Subject|1|||
49139696|NCT00849472|158348367|FG000|Weekly Paclitaxel|Physician Decision|3|||
49139697|NCT00849472|158348367|FG000|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52|||
49139698|NCT00849472|158348367|FG000|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4|||
49139699|NCT00849472|158348367|FG000|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1|||
49139700|NCT00849472|158348367|FG000|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1|||
49139701|NCT00849472|158348367|FG000|Pazopanib Postsurgery Treatment|Adverse Event|19|||
49139702|NCT00849472|158348367|FG000|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5|||
49139703|NCT00849472|158348367|FG000|Pazopanib Postsurgery Treatment|Moved|1|||
49139704|NCT00849472|158348367|FG000|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1|||
49139705|NCT02068599|158348368|FG000|Overall Study|Adverse Event|4|||
49139706|NCT02068599|158348369|FG001|Overall Study|Adverse Event|1|||
49139707|NCT02068599|158348370|FG002|Overall Study|Adverse Event|1|||
49139708|NCT02068599|158348368|FG000|Overall Study|Withdrawal by Subject|2|||
49139709|NCT02068599|158348369|FG001|Overall Study|Withdrawal by Subject|7|||
49139710|NCT02068599|158348370|FG002|Overall Study|Withdrawal by Subject|5|||
49139711|NCT02068599|158348368|FG000|Overall Study|Protocol Violation|4|||
49139712|NCT02068599|158348369|FG001|Overall Study|Protocol Violation|2|||
49139713|NCT02068599|158348370|FG002|Overall Study|Protocol Violation|3|||
49139714|NCT02068599|158348368|FG000|Overall Study|Lost to Follow-up|1|||
49139715|NCT02068599|158348369|FG001|Overall Study|Lost to Follow-up|0|||
49139716|NCT02068599|158348370|FG002|Overall Study|Lost to Follow-up|0|||
49139717|NCT02068599|158348368|FG000|Overall Study|Lack of Efficacy|0|||
49139718|NCT02068599|158348369|FG001|Overall Study|Lack of Efficacy|0|||
49139719|NCT02068599|158348370|FG002|Overall Study|Lack of Efficacy|3|||
49139720|NCT02068599|158348368|FG000|Overall Study|Noncompliance|0|||
49139721|NCT02068599|158348369|FG001|Overall Study|Noncompliance|0|||
49139722|NCT02068599|158348370|FG002|Overall Study|Noncompliance|1|||
49139723|NCT02762604|158348371|FG000|Overall Study|Lost to Follow-up|2|||
49139724|NCT02762604|158348372|FG001|Overall Study|Lost to Follow-up|7|||
48728424|NCT02310321|156855547|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
48728425|NCT02310321|156855548|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
49139725|NCT02762604|158348371|FG000|Overall Study|Study Suspension due to COVID pandemic|1|||
49139726|NCT02762604|158348372|FG001|Overall Study|Study Suspension due to COVID pandemic|3|||
49139727|NCT01405911|158348373|FG000|Overall Study|Pre-treatment lab AE|0|||
49139728|NCT01405911|158348374|FG001|Overall Study|Pre-treatment lab AE|1|||
49139729|NCT01405911|158348375|FG002|Overall Study|Pre-treatment lab AE|0|||
49139730|NCT01405911|158348373|FG000|Overall Study|Lost to Follow-up|0|||
49139731|NCT01405911|158348374|FG001|Overall Study|Lost to Follow-up|1|||
49139732|NCT01405911|158348375|FG002|Overall Study|Lost to Follow-up|0|||
49139733|NCT01405911|158348373|FG000|Overall Study|Protocol Violation|1|||
49139734|NCT01405911|158348374|FG001|Overall Study|Protocol Violation|0|||
49139735|NCT01405911|158348375|FG002|Overall Study|Protocol Violation|0|||
49139736|NCT01405911|158348373|FG000|Overall Study|Withdrawal by Subject|3|||
48728426|NCT02310321|156855549|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|2|||
48728427|NCT02310321|156855547|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Missing|0|||
49139737|NCT01405911|158348374|FG001|Overall Study|Withdrawal by Subject|1|||
49139738|NCT01405911|158348375|FG002|Overall Study|Withdrawal by Subject|1|||
49139739|NCT00004859|158348386|FG000|Overall Study|Lack of Efficacy|43|||
49139740|NCT00004859|158348387|FG001|Overall Study|Lack of Efficacy|113|||
49139741|NCT00004859|158348386|FG000|Overall Study|Adverse Event|31|||
49139742|NCT00004859|158348387|FG001|Overall Study|Adverse Event|93|||
49139743|NCT00004859|158348386|FG000|Overall Study|Death|5|||
49139744|NCT00004859|158348387|FG001|Overall Study|Death|5|||
49139745|NCT00004859|158348386|FG000|Overall Study|Withdrawal by Subject|7|||
49139746|NCT00004859|158348387|FG001|Overall Study|Withdrawal by Subject|33|||
49139747|NCT00004859|158348386|FG000|Overall Study|Protocol Violation|2|||
49139748|NCT00004859|158348387|FG001|Overall Study|Protocol Violation|2|||
49139749|NCT00004859|158348386|FG000|Overall Study|other disease|0|||
49139750|NCT00004859|158348387|FG001|Overall Study|other disease|3|||
49139751|NCT00004859|158348386|FG000|Overall Study|error|3|||
49139752|NCT00004859|158348387|FG001|Overall Study|error|1|||
49139753|NCT00004859|158348386|FG000|Overall Study|missing data|14|||
49139754|NCT00004859|158348387|FG001|Overall Study|missing data|11|||
49139755|NCT00004859|158348386|FG000|Overall Study|Other|13|||
49139756|NCT00004859|158348387|FG001|Overall Study|Other|21|||
48728428|NCT02310321|156855548|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Missing|0|||
48728429|NCT02310321|156855549|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Missing|16|||
48728430|NCT02310321|156855547|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
48728431|NCT02310321|156855548|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
48728432|NCT02310321|156855549|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|3|||
49011525|NCT00252187|157878994|FG000|Overall Study|Withdrawal by Subject|1|||
48728433|NCT02310321|156855547|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
48728434|NCT02310321|156855548|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
48728435|NCT02310321|156855549|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|3|||
48728436|NCT02310321|156855547|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
48728437|NCT02310321|156855548|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
48728438|NCT02310321|156855549|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|3|||
48728439|NCT02310321|156855547|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Missing|0|||
48728440|NCT02310321|156855548|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Missing|0|||
48728441|NCT02310321|156855549|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Missing|26|||
48728442|NCT02310321|156855547|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
48728443|NCT02310321|156855548|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
48728444|NCT02310321|156855549|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|1|||
48728445|NCT02310321|156855547|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
48728446|NCT02310321|156855548|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
48728447|NCT02310321|156855549|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|1|||
48728448|NCT02495233|156855550|FG000|Overall Study|Miscellaneous|0|||
48728449|NCT02495233|156855551|FG001|Overall Study|Miscellaneous|1|||
48728450|NCT03953183|156855554|FG000|Overall Study|Physician Decision|0|||
48728451|NCT03953183|156855555|FG001|Overall Study|Physician Decision|1|||
48728452|NCT03953183|156855554|FG000|Overall Study|Withdrawal by Subject|0|||
48728453|NCT03953183|156855555|FG001|Overall Study|Withdrawal by Subject|1|||
48728454|NCT00107952|156855559|FG000|Overall Study|Death|75|||
48728455|NCT00107952|156855560|FG001|Overall Study|Death|61|||
48728456|NCT00107952|156855559|FG000|Overall Study|Lost to Follow-up|0|||
48728457|NCT00107952|156855560|FG001|Overall Study|Lost to Follow-up|3|||
48728458|NCT00107952|156855559|FG000|Overall Study|Withdrawal by Subject|9|||
48728459|NCT00107952|156855560|FG001|Overall Study|Withdrawal by Subject|6|||
48728460|NCT00107952|156855559|FG000|Overall Study|Other|2|||
48728461|NCT00107952|156855560|FG001|Overall Study|Other|5|||
48728462|NCT00107952|156855559|FG000|Overall Study|Never received study treatment|9|||
48728463|NCT00107952|156855560|FG001|Overall Study|Never received study treatment|6|||
48821714|NCT01515319|157188763|FG002|Overall Study|Withdrawal by Subject|0|||
48821715|NCT01515319|157188764|FG003|Overall Study|Withdrawal by Subject|0|||
48821716|NCT01515319|157188765|FG004|Overall Study|Withdrawal by Subject|0|||
48821717|NCT01515319|157188766|FG005|Overall Study|Withdrawal by Subject|0|||
48821718|NCT01515319|157188767|FG006|Overall Study|Withdrawal by Subject|1|||
48821719|NCT01515319|157188768|FG007|Overall Study|Withdrawal by Subject|0|||
48821720|NCT01515319|157188769|FG008|Overall Study|Withdrawal by Subject|0|||
48821721|NCT01515319|157188770|FG009|Overall Study|Withdrawal by Subject|0|||
48821722|NCT01515319|157188761|FG000|Overall Study|Adverse Event|0|||
48821723|NCT01515319|157188762|FG001|Overall Study|Adverse Event|0|||
48821724|NCT01515319|157188763|FG002|Overall Study|Adverse Event|0|||
48821725|NCT01515319|157188764|FG003|Overall Study|Adverse Event|0|||
48821726|NCT01515319|157188765|FG004|Overall Study|Adverse Event|0|||
48821727|NCT01515319|157188766|FG005|Overall Study|Adverse Event|0|||
48821728|NCT01515319|157188767|FG006|Overall Study|Adverse Event|0|||
48821729|NCT01515319|157188768|FG007|Overall Study|Adverse Event|0|||
48821730|NCT01515319|157188769|FG008|Overall Study|Adverse Event|3|||
48821731|NCT01515319|157188770|FG009|Overall Study|Adverse Event|0|||
48821732|NCT01515319|157188761|FG000|Overall Study|Protocol Violation|0|||
48821733|NCT01515319|157188762|FG001|Overall Study|Protocol Violation|0|||
48821734|NCT01515319|157188763|FG002|Overall Study|Protocol Violation|0|||
48821735|NCT01515319|157188764|FG003|Overall Study|Protocol Violation|0|||
48821736|NCT01515319|157188765|FG004|Overall Study|Protocol Violation|0|||
48728464|NCT02280473|156855566|FG000|Overall Study|Adverse Event|1|||
48728465|NCT02280473|156855567|FG001|Overall Study|Adverse Event|1|||
48728466|NCT02280473|156855566|FG000|Overall Study|Lack of Efficacy|0|||
48728467|NCT02280473|156855567|FG001|Overall Study|Lack of Efficacy|1|||
48728468|NCT02280473|156855566|FG000|Overall Study|Lost to Follow-up|0|||
48728469|NCT02280473|156855567|FG001|Overall Study|Lost to Follow-up|1|||
48728470|NCT04706416|156855570|FG000|Overall Study|Lost to Follow-up|2|||
48728471|NCT04706416|156855571|FG001|Overall Study|Lost to Follow-up|0|||
48728472|NCT00995865|156855575|FG000|Overall Study|Protocol Violation|2|||
48728473|NCT00995865|156855576|FG001|Overall Study|Protocol Violation|0|||
48728474|NCT00995865|156855577|FG002|Overall Study|Protocol Violation|0|||
48728475|NCT00995865|156855575|FG000|Overall Study|Lost to Follow-up|0|||
48728476|NCT00995865|156855576|FG001|Overall Study|Lost to Follow-up|0|||
48728477|NCT00995865|156855577|FG002|Overall Study|Lost to Follow-up|1|||
48728478|NCT03131453|156855591|FG000|Overall Study|Study terminated by Sponsor|424|||
48728479|NCT03131453|156855592|FG001|Overall Study|Study terminated by Sponsor|222|||
48728480|NCT03131453|156855593|FG002|Overall Study|Study terminated by Sponsor|438|||
48728481|NCT03131453|156855591|FG000|Overall Study|Withdrawal by Subject|18|||
48728482|NCT03131453|156855592|FG001|Overall Study|Withdrawal by Subject|7|||
48728483|NCT03131453|156855593|FG002|Overall Study|Withdrawal by Subject|13|||
48728484|NCT03131453|156855591|FG000|Overall Study|Adverse Event|10|||
48728485|NCT03131453|156855592|FG001|Overall Study|Adverse Event|3|||
48728486|NCT03131453|156855593|FG002|Overall Study|Adverse Event|3|||
48728487|NCT03131453|156855591|FG000|Overall Study|Lost to Follow-up|1|||
48728488|NCT03131453|156855592|FG001|Overall Study|Lost to Follow-up|0|||
48728489|NCT03131453|156855593|FG002|Overall Study|Lost to Follow-up|1|||
48728490|NCT03131453|156855591|FG000|Overall Study|Physician Decision|1|||
48728491|NCT03131453|156855592|FG001|Overall Study|Physician Decision|0|||
48728492|NCT03131453|156855593|FG002|Overall Study|Physician Decision|1|||
48728493|NCT03131453|156855591|FG000|Overall Study|Non-compliance with study treatment|1|||
48728494|NCT03131453|156855592|FG001|Overall Study|Non-compliance with study treatment|0|||
48821737|NCT01515319|157188766|FG005|Overall Study|Protocol Violation|0|||
48821738|NCT01515319|157188767|FG006|Overall Study|Protocol Violation|0|||
48821739|NCT01515319|157188768|FG007|Overall Study|Protocol Violation|0|||
48821740|NCT01515319|157188769|FG008|Overall Study|Protocol Violation|2|||
48821741|NCT01515319|157188770|FG009|Overall Study|Protocol Violation|0|||
48821742|NCT04174560|157188772|FG000|Overall Study|Lost to Follow-up|1|||
48821743|NCT04174560|157188773|FG001|Overall Study|Lost to Follow-up|0|||
48821744|NCT04174560|157188774|FG002|Overall Study|Lost to Follow-up|0|||
48821745|NCT04174560|157188775|FG003|Overall Study|Lost to Follow-up|0|||
48821746|NCT04174560|157188772|FG000|Overall Study|Withdrawal by Subject|0|||
48821747|NCT04174560|157188773|FG001|Overall Study|Withdrawal by Subject|0|||
48821748|NCT04174560|157188774|FG002|Overall Study|Withdrawal by Subject|2|||
48821749|NCT04174560|157188775|FG003|Overall Study|Withdrawal by Subject|0|||
48821750|NCT04834362|157190438|FG000|Overall Study|Death|1|||
48821751|NCT04834362|157190439|FG001|Overall Study|Death|2|||
48821752|NCT04922021|157190442|FG000|Overall Study|Withdrawal by Subject|4|||
48821753|NCT04922021|157190443|FG001|Overall Study|Withdrawal by Subject|10|||
48728495|NCT03131453|156855593|FG002|Overall Study|Non-compliance with study treatment|0|||
48728496|NCT03131453|156855591|FG000|Overall Study|Technical problems|1|||
48728497|NCT03131453|156855592|FG001|Overall Study|Technical problems|0|||
48728498|NCT03131453|156855593|FG002|Overall Study|Technical problems|0|||
48821754|NCT04922021|157190442|FG000|Overall Study|Adverse Event|2|||
48821755|NCT04922021|157190443|FG001|Overall Study|Adverse Event|2|||
48821756|NCT04922021|157190442|FG000|Overall Study|Lack of Efficacy|0|||
48821757|NCT04922021|157190443|FG001|Overall Study|Lack of Efficacy|1|||
49139757|NCT00855582|158351430|FG000|Overall Study|Adverse Event|2|||
49139758|NCT00855582|158351431|FG001|Overall Study|Adverse Event|6|||
49139759|NCT00855582|158351432|FG002|Overall Study|Adverse Event|3|||
49139760|NCT00855582|158351430|FG000|Overall Study|Death|1|||
49139761|NCT00855582|158351431|FG001|Overall Study|Death|0|||
49139762|NCT00855582|158351432|FG002|Overall Study|Death|0|||
49139763|NCT00855582|158351430|FG000|Overall Study|Lack of Efficacy|1|||
49139764|NCT00855582|158351431|FG001|Overall Study|Lack of Efficacy|3|||
49139765|NCT00855582|158351432|FG002|Overall Study|Lack of Efficacy|8|||
49139766|NCT00855582|158351430|FG000|Overall Study|Lost to Follow-up|1|||
49139767|NCT00855582|158351431|FG001|Overall Study|Lost to Follow-up|3|||
49139768|NCT00855582|158351432|FG002|Overall Study|Lost to Follow-up|1|||
49139769|NCT00855582|158351430|FG000|Overall Study|Physician Decision|0|||
49139770|NCT00855582|158351431|FG001|Overall Study|Physician Decision|0|||
49139771|NCT00855582|158351432|FG002|Overall Study|Physician Decision|1|||
49139772|NCT00855582|158351430|FG000|Overall Study|Protocol Violation|6|||
49139773|NCT00855582|158351431|FG001|Overall Study|Protocol Violation|2|||
49139774|NCT00855582|158351432|FG002|Overall Study|Protocol Violation|6|||
49139775|NCT00855582|158351430|FG000|Overall Study|Entry Criteria Not Met|8|||
49139776|NCT00855582|158351431|FG001|Overall Study|Entry Criteria Not Met|6|||
49139777|NCT00855582|158351432|FG002|Overall Study|Entry Criteria Not Met|3|||
49139778|NCT00855582|158351430|FG000|Overall Study|Withdrawal by Subject|7|||
49139779|NCT00855582|158351431|FG001|Overall Study|Withdrawal by Subject|4|||
49139780|NCT00855582|158351432|FG002|Overall Study|Withdrawal by Subject|8|||
49139781|NCT00835978|158351433|FG000|Overall Study|Death|33|||
49139782|NCT00835978|158351434|FG001|Overall Study|Death|40|||
49139783|NCT00835978|158351435|FG002|Overall Study|Death|49|||
49139784|NCT00835978|158351436|FG003|Overall Study|Death|4|||
49139785|NCT00835978|158351433|FG000|Overall Study|Lost to Follow-up|3|||
49139786|NCT00835978|158351434|FG001|Overall Study|Lost to Follow-up|4|||
49139787|NCT00835978|158351435|FG002|Overall Study|Lost to Follow-up|2|||
49139788|NCT00835978|158351436|FG003|Overall Study|Lost to Follow-up|1|||
49139789|NCT00835978|158351433|FG000|Overall Study|Other|5|||
49139790|NCT00835978|158351434|FG001|Overall Study|Other|1|||
49139791|NCT00835978|158351435|FG002|Overall Study|Other|8|||
49139792|NCT00835978|158351436|FG003|Overall Study|Other|0|||
49139793|NCT00835978|158351433|FG000|Overall Study|Objective progression or relapse|2|||
49139794|NCT00835978|158351434|FG001|Overall Study|Objective progression or relapse|0|||
49139795|NCT00835978|158351435|FG002|Overall Study|Objective progression or relapse|1|||
49139796|NCT00835978|158351436|FG003|Overall Study|Objective progression or relapse|0|||
49139797|NCT00835978|158351433|FG000|Overall Study|Adverse Event|1|||
49139798|NCT00835978|158351434|FG001|Overall Study|Adverse Event|0|||
49139799|NCT00835978|158351435|FG002|Overall Study|Adverse Event|1|||
49139800|NCT00835978|158351436|FG003|Overall Study|Adverse Event|0|||
49139801|NCT00835978|158351433|FG000|Overall Study|Withdrawal by Subject|0|||
49139802|NCT00835978|158351434|FG001|Overall Study|Withdrawal by Subject|3|||
49139803|NCT00835978|158351435|FG002|Overall Study|Withdrawal by Subject|0|||
49139804|NCT00835978|158351436|FG003|Overall Study|Withdrawal by Subject|5|||
49139805|NCT00835978|158351433|FG000|Overall Study|Study terminated by sponsor|12|||
49139806|NCT00835978|158351434|FG001|Overall Study|Study terminated by sponsor|8|||
49139807|NCT00835978|158351435|FG002|Overall Study|Study terminated by sponsor|30|||
49139808|NCT00835978|158351436|FG003|Overall Study|Study terminated by sponsor|0|||
49139809|NCT01013753|158351437|FG000|Overall Study|Adverse Event|8|||
49139810|NCT01013753|158351437|FG000|Overall Study|Protocol Violation|3|||
49139811|NCT01013753|158351437|FG000|Overall Study|Lost to Follow-up|1|||
49139812|NCT01013753|158351437|FG000|Overall Study|Withdrawal by Subject|2|||
49139813|NCT01013753|158351437|FG000|Overall Study|Other|2|||
49139814|NCT04575324|158351438|FG000|Overall Study|Lost to Follow-up|29|||
49139815|NCT04575324|158351439|FG001|Overall Study|Lost to Follow-up|25|||
49139816|NCT04575324|158351438|FG000|Overall Study|Death|1|||
49139817|NCT04575324|158351439|FG001|Overall Study|Death|2|||
49139818|NCT04575324|158351438|FG000|Overall Study|Withdrawn: Did not meet eligibility criteria|0|||
49139819|NCT04575324|158351439|FG001|Overall Study|Withdrawn: Did not meet eligibility criteria|1|||
49139820|NCT02097277|158351440|FG000|Overall Study|Subject no longer meets study criteria|0|||
49139821|NCT02097277|158351441|FG001|Overall Study|Subject no longer meets study criteria|1|||
49139822|NCT02097277|158351442|FG002|Overall Study|Subject no longer meets study criteria|0|||
49139823|NCT02097277|158351443|FG003|Overall Study|Subject no longer meets study criteria|1|||
49139824|NCT02097277|158351444|FG004|Overall Study|Subject no longer meets study criteria|0|||
49139825|NCT02097277|158351440|FG000|Overall Study|Subject request to discontinue treatment|0|||
49139826|NCT02097277|158351441|FG001|Overall Study|Subject request to discontinue treatment|0|||
49139827|NCT02097277|158351442|FG002|Overall Study|Subject request to discontinue treatment|0|||
49139828|NCT02097277|158351443|FG003|Overall Study|Subject request to discontinue treatment|0|||
49139829|NCT02097277|158351444|FG004|Overall Study|Subject request to discontinue treatment|1|||
49139830|NCT02097277|158351440|FG000|Overall Study|Lost to Follow-up|0|||
49139831|NCT02097277|158351441|FG001|Overall Study|Lost to Follow-up|1|||
49139832|NCT02097277|158351442|FG002|Overall Study|Lost to Follow-up|1|||
49139833|NCT02097277|158351443|FG003|Overall Study|Lost to Follow-up|0|||
49139834|NCT02097277|158351444|FG004|Overall Study|Lost to Follow-up|0|||
49139835|NCT02097277|158351440|FG000|Overall Study|Withdrawal by Subject|2|||
49139836|NCT02097277|158351441|FG001|Overall Study|Withdrawal by Subject|1|||
49139837|NCT02097277|158351442|FG002|Overall Study|Withdrawal by Subject|0|||
49139838|NCT02097277|158351443|FG003|Overall Study|Withdrawal by Subject|1|||
49139839|NCT02097277|158351444|FG004|Overall Study|Withdrawal by Subject|0|||
49139840|NCT02097277|158351440|FG000|Overall Study|Adverse Event|0|||
48821758|NCT04922021|157190442|FG000|Overall Study|Multiple reasons|1|||
48821759|NCT04922021|157190443|FG001|Overall Study|Multiple reasons|0|||
48821760|NCT01327547|157190444|FG000|Overall Study|Adverse Event|4|||
48821761|NCT01327547|157190445|FG001|Overall Study|Adverse Event|1|||
48821762|NCT01327547|157190444|FG000|Overall Study|Death|1|||
48821763|NCT01327547|157190445|FG001|Overall Study|Death|2|||
48821764|NCT01327547|157190444|FG000|Overall Study|Lost to Follow-up|6|||
48821765|NCT01327547|157190445|FG001|Overall Study|Lost to Follow-up|6|||
48821766|NCT01327547|157190444|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
48821767|NCT01327547|157190445|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
48821768|NCT01327547|157190444|FG000|Overall Study|Withdrawal by Subject|3|||
48821769|NCT01327547|157190445|FG001|Overall Study|Withdrawal by Subject|7|||
48821770|NCT01327547|157190444|FG000|Overall Study|Does Not Meet Entrance Criteria|2|||
48821771|NCT01327547|157190445|FG001|Overall Study|Does Not Meet Entrance Criteria|2|||
48821772|NCT01327547|157190444|FG000|Overall Study|Protocol Violation|1|||
48821773|NCT01327547|157190445|FG001|Overall Study|Protocol Violation|0|||
49139841|NCT02097277|158351441|FG001|Overall Study|Adverse Event|0|||
49139842|NCT02097277|158351442|FG002|Overall Study|Adverse Event|1|||
49139843|NCT02097277|158351443|FG003|Overall Study|Adverse Event|2|||
49139844|NCT02097277|158351444|FG004|Overall Study|Adverse Event|0|||
49139845|NCT02582632|158351446|FG000|Overall Study|Other|1|||
49139846|NCT05427916|158351447|FG000|Overall Study|Adverse Event|3|||
49139847|NCT05427916|158351448|FG001|Overall Study|Adverse Event|0|||
49139848|NCT05427916|158351447|FG000|Overall Study|Lack of Efficacy|6|||
49139849|NCT05427916|158351448|FG001|Overall Study|Lack of Efficacy|0|||
49139850|NCT05427916|158351447|FG000|Overall Study|Active arm terminated; trial was ended.|3|||
49139851|NCT05427916|158351448|FG001|Overall Study|Active arm terminated; trial was ended.|8|||
49139852|NCT01257542|158351451|FG000|Overall Study|Protocol Violation|3|||
49139853|NCT01257542|158351452|FG001|Overall Study|Protocol Violation|5|||
49139854|NCT01257542|158351451|FG000|Overall Study|Withdrawal by Subject|0|||
49139855|NCT01257542|158351452|FG001|Overall Study|Withdrawal by Subject|2|||
49139856|NCT00790933|158351453|FG000|Overall Study|Adverse Event|94|||
49139857|NCT00790933|158351454|FG001|Overall Study|Adverse Event|119|||
49139858|NCT00790933|158351455|FG002|Overall Study|Adverse Event|65|||
49139859|NCT00790933|158351456|FG003|Overall Study|Adverse Event|5|||
49139860|NCT00790933|158351457|FG004|Overall Study|Adverse Event|69|||
49139861|NCT00790933|158351453|FG000|Overall Study|Protocol Violation(s)|8|||
49139862|NCT00790933|158351454|FG001|Overall Study|Protocol Violation(s)|18|||
49139863|NCT00790933|158351455|FG002|Overall Study|Protocol Violation(s)|7|||
49139864|NCT00790933|158351456|FG003|Overall Study|Protocol Violation(s)|0|||
49139865|NCT00790933|158351457|FG004|Overall Study|Protocol Violation(s)|12|||
48821774|NCT01327547|157190444|FG000|Overall Study|Non-compliance due to alcohol intake|0|||
48821775|NCT01327547|157190445|FG001|Overall Study|Non-compliance due to alcohol intake|1|||
48821776|NCT01327547|157190444|FG000|Overall Study|Required prohibited medication|2|||
48821777|NCT01327547|157190445|FG001|Overall Study|Required prohibited medication|0|||
48821778|NCT01327547|157190444|FG000|Overall Study|Non-compliance with study procedures|1|||
48821779|NCT01327547|157190445|FG001|Overall Study|Non-compliance with study procedures|0|||
49139866|NCT00790933|158351453|FG000|Overall Study|Lack of Efficacy|192|||
49139867|NCT00790933|158351454|FG001|Overall Study|Lack of Efficacy|176|||
49139868|NCT00790933|158351455|FG002|Overall Study|Lack of Efficacy|130|||
49139869|NCT00790933|158351456|FG003|Overall Study|Lack of Efficacy|1|||
49139870|NCT00790933|158351457|FG004|Overall Study|Lack of Efficacy|121|||
49139871|NCT00790933|158351453|FG000|Overall Study|Study Terminated by Sponsor|0|||
48821780|NCT01327547|157190444|FG000|Overall Study|By investigator in subject's interest|0|||
48821781|NCT01327547|157190445|FG001|Overall Study|By investigator in subject's interest|1|||
49139872|NCT00790933|158351454|FG001|Overall Study|Study Terminated by Sponsor|0|||
49139873|NCT00790933|158351455|FG002|Overall Study|Study Terminated by Sponsor|1|||
48821782|NCT02462083|157190446|FG000|Overall Study|Sponsor request|39|||
48821783|NCT02462083|157190446|FG000|Overall Study|Withdrawal by Subject|87|||
48821784|NCT02462083|157190446|FG000|Overall Study|Lost to Follow-up|41|||
48821785|NCT02462083|157190446|FG000|Overall Study|Lack of Efficacy|151|||
49139874|NCT00790933|158351456|FG003|Overall Study|Study Terminated by Sponsor|0|||
49139875|NCT00790933|158351457|FG004|Overall Study|Study Terminated by Sponsor|0|||
49139876|NCT00790933|158351453|FG000|Overall Study|Withdrawal by Subject|123|||
49139877|NCT00790933|158351454|FG001|Overall Study|Withdrawal by Subject|120|||
49139878|NCT00790933|158351455|FG002|Overall Study|Withdrawal by Subject|52|||
49139879|NCT00790933|158351456|FG003|Overall Study|Withdrawal by Subject|6|||
49139880|NCT00790933|158351457|FG004|Overall Study|Withdrawal by Subject|50|||
48821786|NCT02462083|157190446|FG000|Overall Study|Pregnancy|1|||
48821787|NCT02462083|157190446|FG000|Overall Study|Protocol Violation|6|||
49139881|NCT00790933|158351453|FG000|Overall Study|Lost to Follow-up|13|||
49139882|NCT00790933|158351454|FG001|Overall Study|Lost to Follow-up|31|||
49139883|NCT00790933|158351455|FG002|Overall Study|Lost to Follow-up|10|||
49139884|NCT00790933|158351456|FG003|Overall Study|Lost to Follow-up|1|||
49139885|NCT00790933|158351457|FG004|Overall Study|Lost to Follow-up|15|||
49139886|NCT00790933|158351453|FG000|Overall Study|Reason Not Specified|8|||
49139887|NCT00790933|158351454|FG001|Overall Study|Reason Not Specified|16|||
49139888|NCT00790933|158351455|FG002|Overall Study|Reason Not Specified|4|||
49139889|NCT00790933|158351456|FG003|Overall Study|Reason Not Specified|1|||
49139890|NCT00790933|158351457|FG004|Overall Study|Reason Not Specified|9|||
49139891|NCT04491994|158351459|FG000|Overall Study|Withdrawal by Subject|10|||
49139892|NCT04491994|158351460|FG001|Overall Study|Withdrawal by Subject|5|||
49139893|NCT04491994|158351459|FG000|Overall Study|developed fever > 3 days|4|||
49139894|NCT04491994|158351460|FG001|Overall Study|developed fever > 3 days|1|||
49139895|NCT04491994|158351459|FG000|Overall Study|Protocol Violation|11|||
48728499|NCT03131453|156855591|FG000|Overall Study|Protocol deviation|0|||
49139896|NCT04491994|158351460|FG001|Overall Study|Protocol Violation|2|||
49139897|NCT04491994|158351459|FG000|Overall Study|Lost to Follow-up|4|||
49139898|NCT04491994|158351460|FG001|Overall Study|Lost to Follow-up|3|||
49139899|NCT02448043|158351469|FG000|Overall Study|Withdrawal by Subject|2|||
49139900|NCT02448043|158351470|FG001|Overall Study|Withdrawal by Subject|2|||
49139901|NCT02448043|158351469|FG000|Overall Study|Protocol Violation|1|||
49139902|NCT02448043|158351470|FG001|Overall Study|Protocol Violation|2|||
49139903|NCT01138046|158351471|FG000|Overall Study|Withdrawal due to death|6|||
49139904|NCT00827242|158351472|FG000|Overall Study|Withdrawal by Subject|2|||
49139905|NCT00827242|158351473|FG001|Overall Study|Withdrawal by Subject|4|||
49139906|NCT00827242|158351472|FG000|Overall Study|Protocol Violation|1|||
49139907|NCT00827242|158351473|FG001|Overall Study|Protocol Violation|3|||
49139908|NCT00827242|158351472|FG000|Overall Study|Lost to Follow-up|0|||
49139909|NCT00827242|158351473|FG001|Overall Study|Lost to Follow-up|3|||
49139910|NCT00827242|158351472|FG000|Overall Study|Adverse Event Excluding Death|2|||
49139911|NCT00827242|158351473|FG001|Overall Study|Adverse Event Excluding Death|1|||
49139912|NCT00827242|158351472|FG000|Overall Study|Entry Criteria Not Met|4|||
49139913|NCT00827242|158351473|FG001|Overall Study|Entry Criteria Not Met|1|||
49139914|NCT00827242|158351472|FG000|Overall Study|Physician Decision|2|||
49139915|NCT00827242|158351473|FG001|Overall Study|Physician Decision|0|||
49139916|NCT00827242|158351472|FG000|Overall Study|Death|1|||
49139917|NCT00827242|158351473|FG001|Overall Study|Death|0|||
49139918|NCT00827242|158351472|FG000|Overall Study|Lack of Efficacy|1|||
49139919|NCT00827242|158351473|FG001|Overall Study|Lack of Efficacy|0|||
49139920|NCT04790201|158351474|FG000|Overall Study|Lost to Follow-up|0|||
49139921|NCT04790201|158351475|FG001|Overall Study|Lost to Follow-up|0|||
49139922|NCT04790201|158351476|FG002|Overall Study|Lost to Follow-up|2|||
49139923|NCT04790201|158351474|FG000|Overall Study|Death|0|||
49139924|NCT04790201|158351475|FG001|Overall Study|Death|1|||
49139925|NCT04790201|158351476|FG002|Overall Study|Death|0|||
49139926|NCT04790201|158351474|FG000|Overall Study|Protocol Violation|1|||
49139927|NCT04790201|158351475|FG001|Overall Study|Protocol Violation|0|||
49139928|NCT04790201|158351476|FG002|Overall Study|Protocol Violation|1|||
49139929|NCT03670628|158351477|FG000|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|8|||
49139930|NCT03670628|158351478|FG001|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|3|||
49139931|NCT03670628|158351477|FG000|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|4|||
49139932|NCT03670628|158351478|FG001|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|6|||
49139933|NCT01479530|158351479|FG000|Overall Study|Adverse Event|5|||
48728500|NCT03131453|156855592|FG001|Overall Study|Protocol deviation|1|||
48728501|NCT03131453|156855593|FG002|Overall Study|Protocol deviation|0|||
49139934|NCT01479530|158351480|FG001|Overall Study|Adverse Event|6|||
49139935|NCT01479530|158351479|FG000|Overall Study|Lack of Efficacy|0|||
49139936|NCT01479530|158351480|FG001|Overall Study|Lack of Efficacy|1|||
49139937|NCT01479530|158351479|FG000|Overall Study|Protocol Violation|2|||
48728502|NCT00908011|156855594|FG000|Overall Study|Withdrawal by Subject|2|||
48728503|NCT00908011|156855595|FG001|Overall Study|Withdrawal by Subject|2|||
48728504|NCT02567552|156855598|FG000|Overall Study|Adverse Event|0|||
48728505|NCT02567552|156855599|FG001|Overall Study|Adverse Event|1|||
48728506|NCT00055471|156855600|FG000|Period 1: Dose Escalation Period|Adverse Event|0|||
48728507|NCT00055471|156855601|FG001|Period 1: Dose Escalation Period|Adverse Event|1|||
48728508|NCT00055471|156855602|FG002|Period 1: Dose Escalation Period|Adverse Event|2|||
48728509|NCT00055471|156855600|FG000|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
48728510|NCT00055471|156855601|FG001|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
48728511|NCT00055471|156855602|FG002|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1|||
48728512|NCT00055471|156855600|FG000|Period 1: Dose Escalation Period|Disease progression|0|||
48728513|NCT00055471|156855601|FG001|Period 1: Dose Escalation Period|Disease progression|1|||
48728514|NCT00055471|156855602|FG002|Period 1: Dose Escalation Period|Disease progression|0|||
48728515|NCT02301988|156855603|FG000|Overall Study|Withdrawal by Subject|2|||
49139938|NCT01479530|158351480|FG001|Overall Study|Protocol Violation|3|||
49139939|NCT01479530|158351479|FG000|Overall Study|Withdrawal of Consent|3|||
49139940|NCT01479530|158351480|FG001|Overall Study|Withdrawal of Consent|2|||
49139941|NCT04795323|158351481|FG000|Overall Study|Did not interact with TARA|1|||
49139942|NCT04795323|158351482|FG001|Overall Study|Did not interact with TARA|0|||
49139943|NCT00514917|158351490|FG000|Overall Study|Death|4|||
49139944|NCT00514917|158351491|FG001|Overall Study|Death|10|||
49139945|NCT00514917|158351490|FG000|Overall Study|Protocol Violation|1|||
49139946|NCT00514917|158351491|FG001|Overall Study|Protocol Violation|0|||
49139947|NCT00514917|158351490|FG000|Overall Study|Lost to Follow-up|4|||
49139948|NCT00514917|158351491|FG001|Overall Study|Lost to Follow-up|3|||
49139949|NCT00514917|158351490|FG000|Overall Study|Withdrawal by Subject|18|||
49139950|NCT00514917|158351491|FG001|Overall Study|Withdrawal by Subject|16|||
49139951|NCT00514917|158351490|FG000|Overall Study|Discontinued due to study closure|88|||
49139952|NCT00514917|158351491|FG001|Overall Study|Discontinued due to study closure|81|||
49139953|NCT00514917|158351490|FG000|Overall Study|Undefined|11|||
49139954|NCT00514917|158351491|FG001|Overall Study|Undefined|5|||
49139955|NCT01132755|158351492|FG000|Overall Study|Procedure not done due to medical reason|23|||
49139956|NCT01132755|158351492|FG000|Overall Study|Protocol Violation|15|||
49139957|NCT01132755|158351492|FG000|Overall Study|Withdrawal by Subject|4|||
49139958|NCT02697422|158351493|FG000|Overall Study|Declined exit survey|9|||
49139959|NCT02697422|158351494|FG001|Overall Study|Declined exit survey|2|||
49139960|NCT02697422|158351493|FG000|Overall Study|Lost to Follow-up|13|||
49139961|NCT02697422|158351494|FG001|Overall Study|Lost to Follow-up|8|||
49139962|NCT02697422|158351493|FG000|Overall Study|Death|2|||
49139963|NCT02697422|158351494|FG001|Overall Study|Death|1|||
49139964|NCT02697422|158351493|FG000|Overall Study|Withdrawal by Subject|0|||
49139965|NCT02697422|158351494|FG001|Overall Study|Withdrawal by Subject|1|||
49139966|NCT02697422|158351493|FG000|Overall Study|Physician Decision|1|||
49139967|NCT02697422|158351494|FG001|Overall Study|Physician Decision|1|||
49139968|NCT02697422|158351493|FG000|Overall Study|Exit survey data lost|1|||
49139969|NCT02697422|158351494|FG001|Overall Study|Exit survey data lost|0|||
49139970|NCT00407030|158351495|FG000|Main Period - 8 to 20 Weeks|Adverse Event|2|||
49139971|NCT00407030|158351496|FG001|Main Period - 8 to 20 Weeks|Adverse Event|1|||
49139972|NCT00407030|158351497|FG002|Main Period - 8 to 20 Weeks|Adverse Event|0|||
49139973|NCT00407030|158351495|FG000|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
49139974|NCT00407030|158351496|FG001|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
49139975|NCT00407030|158351497|FG002|Main Period - 8 to 20 Weeks|Lack of Efficacy|3|||
49139976|NCT00407030|158351495|FG000|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
49139977|NCT00407030|158351496|FG001|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
49139978|NCT00407030|158351497|FG002|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
49139979|NCT00407030|158351495|FG000|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
49139980|NCT00407030|158351496|FG001|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
49139981|NCT00407030|158351497|FG002|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
49139982|NCT00407030|158351495|FG000|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
49139983|NCT00407030|158351496|FG001|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
49139984|NCT00407030|158351497|FG002|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1|||
48728516|NCT02301988|156855604|FG001|Overall Study|Withdrawal by Subject|1|||
48728517|NCT02301988|156855603|FG000|Overall Study|Physician Decision|2|||
48728518|NCT02301988|156855604|FG001|Overall Study|Physician Decision|2|||
48728519|NCT02301988|156855603|FG000|Overall Study|Unknown Reason|1|||
48728520|NCT02301988|156855604|FG001|Overall Study|Unknown Reason|3|||
48728521|NCT02301988|156855603|FG000|Overall Study|Lack of Efficacy|3|||
48728522|NCT02301988|156855604|FG001|Overall Study|Lack of Efficacy|2|||
48728523|NCT02301988|156855603|FG000|Overall Study|Death|1|||
48728524|NCT02301988|156855604|FG001|Overall Study|Death|0|||
48728525|NCT02301988|156855603|FG000|Overall Study|Adverse Event|1|||
48728526|NCT02301988|156855604|FG001|Overall Study|Adverse Event|1|||
48728527|NCT06010836|156855605|FG000|Overall Study|Lost to Follow-up|2|||
48728528|NCT06010836|156855606|FG001|Overall Study|Lost to Follow-up|2|||
48728529|NCT06010836|156855605|FG000|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|8|||
48728530|NCT06010836|156855606|FG001|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|2|||
48728531|NCT06010836|156855605|FG000|Overall Study|Poor or absent audio recording for data collection|1|||
48728532|NCT06010836|156855606|FG001|Overall Study|Poor or absent audio recording for data collection|4|||
48728533|NCT06010836|156855605|FG000|Overall Study|Did not receive intervention discussion|0|||
48728534|NCT06010836|156855606|FG001|Overall Study|Did not receive intervention discussion|4|||
49139985|NCT00407030|158351495|FG000|Main Period - 8 to 20 Weeks|Patient Decision|1|||
49139986|NCT00407030|158351496|FG001|Main Period - 8 to 20 Weeks|Patient Decision|0|||
49139987|NCT00407030|158351497|FG002|Main Period - 8 to 20 Weeks|Patient Decision|0|||
49139988|NCT00407030|158351495|FG000|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
49139989|NCT00407030|158351496|FG001|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5|||
49139990|NCT00407030|158351497|FG002|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
49139991|NCT00407030|158351495|FG000|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
49139992|NCT00407030|158351496|FG001|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
49139993|NCT00407030|158351497|FG002|Extension Period - up to 68 Weeks|Lack of Efficacy|0|||
49139994|NCT00407030|158351495|FG000|Extension Period - up to 68 Weeks|Adverse Event|1|||
49139995|NCT00407030|158351496|FG001|Extension Period - up to 68 Weeks|Adverse Event|0|||
49139996|NCT00407030|158351497|FG002|Extension Period - up to 68 Weeks|Adverse Event|0|||
49139997|NCT00407030|158351495|FG000|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
49139998|NCT00407030|158351496|FG001|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
49139999|NCT00407030|158351497|FG002|Extension Period - up to 68 Weeks|Consent Withdrawn|0|||
49140000|NCT00407030|158351495|FG000|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
48821788|NCT02462083|157190446|FG000|Overall Study|Adverse Event|33|||
48821789|NCT02462083|157190446|FG000|Overall Study|Worsening condition|16|||
48821790|NCT02462083|157190446|FG000|Overall Study|Other than specified|45|||
48821791|NCT02711995|157190447|FG000|Washout (90 Days)|Conflicting medication|1|||
48821792|NCT00322868|157190448|FG000|Overall Study|disease progression|1|||
48821793|NCT01852162|157190449|FG000|Overall Study|Adverse Event|1|||
48821794|NCT01852162|157190450|FG001|Overall Study|Adverse Event|0|||
48821795|NCT01852162|157190449|FG000|Overall Study|Withdrawal by Subject|3|||
49140001|NCT00407030|158351496|FG001|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
49140002|NCT00407030|158351497|FG002|Extension Period - up to 68 Weeks|Lost to Follow-up|0|||
49140003|NCT00407030|158351495|FG000|Extension Period - up to 68 Weeks|Patient Decision|1|||
49140004|NCT00407030|158351496|FG001|Extension Period - up to 68 Weeks|Patient Decision|2|||
49140005|NCT00407030|158351497|FG002|Extension Period - up to 68 Weeks|Patient Decision|0|||
49140006|NCT00407030|158351495|FG000|Extension Period - up to 68 Weeks|Physician Decision|1|||
49140007|NCT00407030|158351496|FG001|Extension Period - up to 68 Weeks|Physician Decision|2|||
49140008|NCT00407030|158351497|FG002|Extension Period - up to 68 Weeks|Physician Decision|0|||
49140009|NCT04243837|158351498|FG000|Overall Study|Adverse Event|2|||
49140010|NCT04243837|158351499|FG001|Overall Study|Adverse Event|1|||
49140011|NCT04243837|158351498|FG000|Overall Study|Withdrawal by Subject|4|||
49140012|NCT04243837|158351499|FG001|Overall Study|Withdrawal by Subject|2|||
49140013|NCT04243837|158351498|FG000|Overall Study|Covid-19 lock down|1|||
49140014|NCT04243837|158351499|FG001|Overall Study|Covid-19 lock down|0|||
49140015|NCT04243837|158351498|FG000|Overall Study|Study Terminated by Sponsor|11|||
49140016|NCT04243837|158351499|FG001|Overall Study|Study Terminated by Sponsor|12|||
49140017|NCT02337946|158351502|FG000|Protocol Treatment 1 Period|Adverse Event|7|||
49140018|NCT02337946|158351503|FG001|Protocol Treatment 1 Period|Adverse Event|0|||
49140019|NCT02337946|158351504|FG002|Protocol Treatment 1 Period|Adverse Event|0|||
49140020|NCT02337946|158351502|FG000|Protocol Treatment 1 Period|Major Protocol Deviation|1|||
49140021|NCT02337946|158351503|FG001|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
49140022|NCT02337946|158351504|FG002|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
49140023|NCT02337946|158351502|FG000|Protocol Treatment 1 Period|Voluntary Withdrawal|6|||
49140024|NCT02337946|158351503|FG001|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
48821796|NCT01852162|157190450|FG001|Overall Study|Withdrawal by Subject|1|||
48821797|NCT04212169|157190451|FG000|Overall Study|Adverse Event|0|||
48821798|NCT04212169|157190452|FG001|Overall Study|Adverse Event|0|||
48821799|NCT04212169|157190453|FG002|Overall Study|Adverse Event|0|||
49140025|NCT02337946|158351504|FG002|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
49140026|NCT02337946|158351502|FG000|Protocol Treatment 1 Period|Lack of Efficacy|15|||
48821800|NCT04212169|157190454|FG003|Overall Study|Adverse Event|2|||
48821801|NCT04212169|157190451|FG000|Overall Study|Lost to Follow-up|1|||
48821802|NCT04212169|157190452|FG001|Overall Study|Lost to Follow-up|0|||
48821803|NCT04212169|157190453|FG002|Overall Study|Lost to Follow-up|0|||
49140027|NCT02337946|158351503|FG001|Protocol Treatment 1 Period|Lack of Efficacy|0|||
49140028|NCT02337946|158351504|FG002|Protocol Treatment 1 Period|Lack of Efficacy|0|||
49140029|NCT02337946|158351502|FG000|Protocol Treatment 1 Period|Death During Protocol Treatment|3|||
48821804|NCT04212169|157190454|FG003|Overall Study|Lost to Follow-up|2|||
49140030|NCT02337946|158351503|FG001|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
49140031|NCT02337946|158351504|FG002|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
49140032|NCT02337946|158351502|FG000|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9|||
49140033|NCT02337946|158351503|FG001|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
49140034|NCT02337946|158351504|FG002|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
49140035|NCT02337946|158351502|FG000|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1|||
49140036|NCT02337946|158351503|FG001|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
49140037|NCT02337946|158351504|FG002|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
49140038|NCT02337946|158351502|FG000|Protocol Treatment 1 Period|Reason not specified|8|||
49140039|NCT02337946|158351503|FG001|Protocol Treatment 1 Period|Reason not specified|0|||
49140040|NCT02337946|158351504|FG002|Protocol Treatment 1 Period|Reason not specified|0|||
49140041|NCT02337946|158351502|FG000|In-between Period|Without Informed Consent|1|||
49140042|NCT02337946|158351503|FG001|In-between Period|Without Informed Consent|0|||
49140043|NCT02337946|158351504|FG002|In-between Period|Without Informed Consent|0|||
49140044|NCT02337946|158351502|FG000|Protocol Treatment 2 Period|Adverse Event|0|||
49140045|NCT02337946|158351503|FG001|Protocol Treatment 2 Period|Adverse Event|9|||
49140046|NCT02337946|158351504|FG002|Protocol Treatment 2 Period|Adverse Event|9|||
49140047|NCT02337946|158351502|FG000|Protocol Treatment 2 Period|Voluntary Withdrawal|0|||
49140048|NCT02337946|158351503|FG001|Protocol Treatment 2 Period|Voluntary Withdrawal|3|||
49140049|NCT02337946|158351504|FG002|Protocol Treatment 2 Period|Voluntary Withdrawal|1|||
49140050|NCT02337946|158351502|FG000|Protocol Treatment 2 Period|Lack of Efficacy|0|||
49140051|NCT02337946|158351503|FG001|Protocol Treatment 2 Period|Lack of Efficacy|29|||
49140052|NCT02337946|158351504|FG002|Protocol Treatment 2 Period|Lack of Efficacy|29|||
49140053|NCT02337946|158351502|FG000|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
49140054|NCT02337946|158351503|FG001|Protocol Treatment 2 Period|Death During Protocol Treatment|1|||
49140055|NCT02337946|158351504|FG002|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
49140056|NCT02337946|158351502|FG000|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0|||
49140057|NCT02337946|158351503|FG001|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5|||
49140058|NCT02337946|158351504|FG002|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7|||
49140059|NCT02337946|158351502|FG000|Protocol Treatment 2 Period|Reason not specified|0|||
49140060|NCT02337946|158351503|FG001|Protocol Treatment 2 Period|Reason not specified|4|||
49140061|NCT02337946|158351504|FG002|Protocol Treatment 2 Period|Reason not specified|4|||
49140062|NCT02280499|158351505|FG000|Overall Study|Death|14|||
49140063|NCT02280499|158351505|FG000|Overall Study|Lost to Follow-up|42|||
49140064|NCT02280499|158351505|FG000|Overall Study|Adverse Event|5|||
49140065|NCT01873833|158351510|FG000|Overall Study|Withdrawal by Subject|1|||
49140066|NCT01968785|158351511|FG000|Overall Study|Withdrawal by Subject|1|||
49140067|NCT01968785|158351512|FG001|Overall Study|Withdrawal by Subject|0|||
49140068|NCT01663987|158351514|FG000|Overall Study|Adverse Event|7|||
49140069|NCT01663987|158351515|FG001|Overall Study|Adverse Event|2|||
49140070|NCT01663987|158351514|FG000|Overall Study|Lost to Follow-up|1|||
49140071|NCT01663987|158351515|FG001|Overall Study|Lost to Follow-up|1|||
49140072|NCT01663987|158351514|FG000|Overall Study|Withdrawal by Subject|2|||
49140073|NCT01663987|158351515|FG001|Overall Study|Withdrawal by Subject|3|||
49140074|NCT01663987|158351514|FG000|Overall Study|Other reason not defined above|3|||
49140075|NCT01663987|158351515|FG001|Overall Study|Other reason not defined above|0|||
49140076|NCT04000724|158351516|FG000|Overall Study|Withdrawal by Subject|5|||
49140077|NCT04000724|158351517|FG001|Overall Study|Withdrawal by Subject|3|||
48821805|NCT04212169|157190451|FG000|Overall Study|Withdrawal by Subject|10|||
48821806|NCT04212169|157190452|FG001|Overall Study|Withdrawal by Subject|2|||
49011526|NCT00252187|157878995|FG001|Overall Study|Withdrawal by Subject|0|||
49011527|NCT04896385|157878996|FG000|24-Week Double-Blind Period|Lost to Follow-up|2|||
49011528|NCT04896385|157878997|FG001|24-Week Double-Blind Period|Lost to Follow-up|3|||
49011529|NCT04896385|157878998|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
49011530|NCT04896385|157878999|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
49140078|NCT04000724|158351518|FG002|Overall Study|Withdrawal by Subject|4|||
49140079|NCT04000724|158351516|FG000|Overall Study|Lost to Follow-up|11|||
49140080|NCT04000724|158351517|FG001|Overall Study|Lost to Follow-up|7|||
49140081|NCT04000724|158351518|FG002|Overall Study|Lost to Follow-up|13|||
49140082|NCT00455455|158351519|FG000|Washout|Withdrawal by Subject|0|||
49140083|NCT00455455|158351520|FG001|Washout|Withdrawal by Subject|1|||
49140084|NCT00455455|158351519|FG000|Washout|Withdrawal by Subject|1|||
49140085|NCT00455455|158351520|FG001|Washout|Withdrawal by Subject|0|||
49140086|NCT02006654|158351521|FG000|Overall Study|Withdrawal before treatment|4|||
49140087|NCT02006654|158351522|FG001|Overall Study|Withdrawal before treatment|2|||
49140088|NCT02006654|158351521|FG000|Overall Study|Adverse Event|16|||
49140089|NCT02006654|158351522|FG001|Overall Study|Adverse Event|17|||
49140090|NCT02006654|158351521|FG000|Overall Study|Death|1|||
49140091|NCT02006654|158351522|FG001|Overall Study|Death|0|||
49140092|NCT02006654|158351521|FG000|Overall Study|Withdrawal by Subject|14|||
49140093|NCT02006654|158351522|FG001|Overall Study|Withdrawal by Subject|12|||
49140094|NCT02006654|158351521|FG000|Overall Study|Protocol Violation|5|||
49140095|NCT02006654|158351522|FG001|Overall Study|Protocol Violation|8|||
49140096|NCT02006654|158351521|FG000|Overall Study|Lost to Follow-up|1|||
49140097|NCT02006654|158351522|FG001|Overall Study|Lost to Follow-up|0|||
49140098|NCT02006654|158351521|FG000|Overall Study|patient's will|2|||
49140099|NCT02006654|158351522|FG001|Overall Study|patient's will|1|||
49140100|NCT02006654|158351521|FG000|Overall Study|insufficient compliance|1|||
49140101|NCT02006654|158351522|FG001|Overall Study|insufficient compliance|0|||
49140102|NCT02006654|158351521|FG000|Overall Study|worsening cognitive condition|0|||
49140103|NCT02006654|158351522|FG001|Overall Study|worsening cognitive condition|1|||
49140104|NCT02006654|158351521|FG000|Overall Study|faecal incontinence|0|||
49140105|NCT02006654|158351522|FG001|Overall Study|faecal incontinence|1|||
48821807|NCT04212169|157190453|FG002|Overall Study|Withdrawal by Subject|5|||
48821808|NCT04212169|157190454|FG003|Overall Study|Withdrawal by Subject|7|||
48821809|NCT04212169|157190451|FG000|Overall Study|Other reason, unspecified|3|||
48821810|NCT04212169|157190452|FG001|Overall Study|Other reason, unspecified|1|||
48821811|NCT04212169|157190453|FG002|Overall Study|Other reason, unspecified|0|||
48821812|NCT04212169|157190454|FG003|Overall Study|Other reason, unspecified|2|||
49140106|NCT02006654|158351521|FG000|Overall Study|mood disorder|0|||
49140107|NCT02006654|158351522|FG001|Overall Study|mood disorder|1|||
49140108|NCT02006654|158351521|FG000|Overall Study|disallowed medication|1|||
48821813|NCT01809210|157190463|FG000|Overall Study|Withdrawal by Subject|0|||
49011531|NCT04896385|157878996|FG000|24-Week Double-Blind Period|Withdrawal by Subject|2|||
49140109|NCT02006654|158351522|FG001|Overall Study|disallowed medication|0|||
49140110|NCT02006654|158351521|FG000|Overall Study|moving out of state|0|||
49140111|NCT02006654|158351522|FG001|Overall Study|moving out of state|1|||
49140112|NCT01370538|158351527|FG000|Overall Study|Voluntary Discontinuation by Subject|3|||
49140113|NCT01370538|158351528|FG001|Overall Study|Voluntary Discontinuation by Subject|2|||
49140114|NCT01370538|158351527|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
49140115|NCT01370538|158351528|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
49140116|NCT01370538|158351527|FG000|Overall Study|Adverse Event|1|||
49140117|NCT01370538|158351528|FG001|Overall Study|Adverse Event|0|||
49140118|NCT01370538|158351527|FG000|Overall Study|Protocol Violation|8|||
49140119|NCT01370538|158351528|FG001|Overall Study|Protocol Violation|5|||
49140120|NCT01370538|158351527|FG000|Overall Study|Development of study specific withdrawal|1|||
49140121|NCT01370538|158351528|FG001|Overall Study|Development of study specific withdrawal|1|||
49140122|NCT01370538|158351527|FG000|Overall Study|Lost to follow up|6|||
49140123|NCT01370538|158351528|FG001|Overall Study|Lost to follow up|10|||
49140124|NCT01757847|158351534|FG000|Overall Study|Withdrawal by Subject|3|||
49140125|NCT01757847|158351535|FG001|Overall Study|Withdrawal by Subject|4|||
49140126|NCT03520387|158351536|FG000|Pre-Randomization|Withdrawal by Subject|1|||
49140127|NCT03520387|158351537|FG001|Pre-Randomization|Withdrawal by Subject|0|||
49140128|NCT03520387|158351538|FG002|Pre-Randomization|Withdrawal by Subject|0|||
49140129|NCT03520387|158351539|FG003|Pre-Randomization|Withdrawal by Subject|0|||
49140130|NCT03520387|158351540|FG004|Pre-Randomization|Withdrawal by Subject|0|||
49140131|NCT03520387|158351536|FG000|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2|||
49140132|NCT03520387|158351537|FG001|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
48821814|NCT01809210|157190464|FG001|Overall Study|Withdrawal by Subject|0|||
48821815|NCT01809210|157190465|FG002|Overall Study|Withdrawal by Subject|1|||
48821816|NCT01809210|157190466|FG003|Overall Study|Withdrawal by Subject|1|||
48821817|NCT01809210|157190467|FG004|Overall Study|Withdrawal by Subject|1|||
48821818|NCT01809210|157190468|FG005|Overall Study|Withdrawal by Subject|0|||
48821819|NCT01809210|157190469|FG006|Overall Study|Withdrawal by Subject|4|||
48821820|NCT01809210|157190463|FG000|Overall Study|Death|1|||
48821821|NCT01809210|157190464|FG001|Overall Study|Death|1|||
48821822|NCT01809210|157190465|FG002|Overall Study|Death|2|||
48821823|NCT01809210|157190466|FG003|Overall Study|Death|0|||
48821824|NCT01809210|157190467|FG004|Overall Study|Death|1|||
48821825|NCT01809210|157190468|FG005|Overall Study|Death|3|||
48821826|NCT01809210|157190469|FG006|Overall Study|Death|1|||
48821827|NCT01115998|157190471|FG000|Overall Study|Lost to Follow-up|6|||
48821828|NCT01115998|157190472|FG001|Overall Study|Lost to Follow-up|6|||
48821829|NCT00590980|157190473|FG000|Overall Study|Did not meet all inclusion criteria|10|||
49140133|NCT03520387|158351538|FG002|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
49140134|NCT03520387|158351539|FG003|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
48728605|NCT00920829|156857113|FG000|Allocation|No post randomization data|3|||
48728606|NCT00920829|156857114|FG001|Allocation|No post randomization data|1|||
48728607|NCT00920829|156857115|FG002|Allocation|No post randomization data|0|||
48728608|NCT00920829|156857116|FG003|Allocation|No post randomization data|2|||
48728609|NCT00920829|156857113|FG000|Available for Analysis|Withdrawal by Subject|6|||
48728610|NCT00920829|156857114|FG001|Available for Analysis|Withdrawal by Subject|6|||
48728611|NCT00920829|156857115|FG002|Available for Analysis|Withdrawal by Subject|6|||
48728612|NCT00920829|156857116|FG003|Available for Analysis|Withdrawal by Subject|10|||
48728613|NCT00920829|156857113|FG000|Available for Analysis|Required Medical Treatment|0|||
48728614|NCT00920829|156857114|FG001|Available for Analysis|Required Medical Treatment|1|||
48728615|NCT00920829|156857115|FG002|Available for Analysis|Required Medical Treatment|2|||
48728616|NCT00920829|156857116|FG003|Available for Analysis|Required Medical Treatment|0|||
48728617|NCT00920829|156857113|FG000|Available for Analysis|Adverse Event|1|||
48728618|NCT00920829|156857114|FG001|Available for Analysis|Adverse Event|2|||
48728619|NCT00920829|156857115|FG002|Available for Analysis|Adverse Event|1|||
48728620|NCT00920829|156857116|FG003|Available for Analysis|Adverse Event|0|||
48728621|NCT00920829|156857113|FG000|Available for Analysis|Death|1|||
48728622|NCT00920829|156857114|FG001|Available for Analysis|Death|0|||
48728623|NCT00920829|156857115|FG002|Available for Analysis|Death|0|||
48728624|NCT00920829|156857116|FG003|Available for Analysis|Death|0|||
48728625|NCT00920829|156857113|FG000|Available for Analysis|Protocol Violation|0|||
48821830|NCT02819479|157190474|FG000|Overall Study|Adverse Event|2|||
48821831|NCT03850444|157190475|FG000|Overall Study|Adverse Event|16|||
48821832|NCT03850444|157190476|FG001|Overall Study|Adverse Event|10|||
48821833|NCT03850444|157190475|FG000|Overall Study|Death|87|||
48821834|NCT03850444|157190476|FG001|Overall Study|Death|107|||
48821835|NCT03850444|157190475|FG000|Overall Study|Lost to Follow-up|1|||
49140135|NCT03520387|158351540|FG004|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
49140136|NCT03336866|158351541|FG000|Overall Study|Lost to Follow-up|2|||
49140137|NCT03336866|158351542|FG001|Overall Study|Lost to Follow-up|0|||
49140138|NCT03336866|158351543|FG002|Overall Study|Lost to Follow-up|3|||
49140139|NCT03336866|158351541|FG000|Overall Study|Withdrawal by Subject|1|||
48728626|NCT00920829|156857114|FG001|Available for Analysis|Protocol Violation|0|||
48728627|NCT00920829|156857115|FG002|Available for Analysis|Protocol Violation|1|||
48728628|NCT00920829|156857116|FG003|Available for Analysis|Protocol Violation|0|||
48728629|NCT00920829|156857113|FG000|Available for Analysis|Required more treatment|0|||
48728630|NCT00920829|156857114|FG001|Available for Analysis|Required more treatment|2|||
48728631|NCT00920829|156857115|FG002|Available for Analysis|Required more treatment|0|||
48728632|NCT00920829|156857116|FG003|Available for Analysis|Required more treatment|1|||
48728633|NCT02284178|156857120|FG000|Overall Study|Met exclusion criteria|49|||
48728634|NCT02284178|156857121|FG001|Overall Study|Met exclusion criteria|54|||
48728635|NCT00978432|156857122|FG000|Overall Study|Withdrawal by Subject|0|||
48728636|NCT00978432|156857123|FG001|Overall Study|Withdrawal by Subject|0|||
48728637|NCT00978432|156857124|FG002|Overall Study|Withdrawal by Subject|1|||
48728638|NCT00978432|156857122|FG000|Overall Study|Lack of Efficacy|1|||
48728639|NCT00978432|156857123|FG001|Overall Study|Lack of Efficacy|1|||
48728640|NCT00978432|156857124|FG002|Overall Study|Lack of Efficacy|3|||
48728641|NCT00978432|156857122|FG000|Overall Study|Adverse Event|2|||
48728642|NCT00978432|156857123|FG001|Overall Study|Adverse Event|0|||
48728643|NCT00978432|156857124|FG002|Overall Study|Adverse Event|1|||
48821836|NCT03850444|157190476|FG001|Overall Study|Lost to Follow-up|1|||
48728644|NCT02910583|156857125|FG000|Overall Study|Death|7|||
48728645|NCT02910583|156857126|FG001|Overall Study|Death|3|||
48728646|NCT02910583|156857125|FG000|Overall Study|Lost to Follow-up|1|||
48728647|NCT02910583|156857126|FG001|Overall Study|Lost to Follow-up|0|||
48821837|NCT03850444|157190475|FG000|Overall Study|Withdrawal by Subject|1|||
48728648|NCT02910583|156857125|FG000|Overall Study|Withdrawal by Subject|12|||
48728649|NCT02910583|156857126|FG001|Overall Study|Withdrawal by Subject|8|||
48728650|NCT02910583|156857125|FG000|Overall Study|Other, Not Specified|6|||
48728651|NCT02910583|156857126|FG001|Overall Study|Other, Not Specified|3|||
48728652|NCT01385176|156857127|FG000|Randomization Phase|Death|1|||
48728653|NCT01385176|156857128|FG001|Randomization Phase|Death|2|||
48728654|NCT01385176|156857127|FG000|6-18 Month All VNS Active|Death|1|||
48728655|NCT01385176|156857128|FG001|6-18 Month All VNS Active|Death|2|||
48728656|NCT01385176|156857127|FG000|6-18 Month All VNS Active|Physician Decision|0|||
48728657|NCT01385176|156857128|FG001|6-18 Month All VNS Active|Physician Decision|1|||
48728658|NCT01385176|156857127|FG000|6-18 Month All VNS Active|Withdrawal by Subject|2|||
48728659|NCT01385176|156857128|FG001|6-18 Month All VNS Active|Withdrawal by Subject|0|||
48728660|NCT01385176|156857127|FG000|6-18 Month All VNS Active|Heart Transplant|1|||
48728661|NCT01385176|156857128|FG001|6-18 Month All VNS Active|Heart Transplant|0|||
48728662|NCT04656275|156857129|FG000|Overall Study|Study terminated by sponsor|2|||
48728663|NCT04656275|156857130|FG001|Overall Study|Study terminated by sponsor|4|||
48728664|NCT04902326|156857131|FG000|Overall Study|Withdrawal by Subject|1|||
48728665|NCT04902326|156857132|FG001|Overall Study|Withdrawal by Subject|3|||
48728666|NCT04902326|156857133|FG002|Overall Study|Withdrawal by Subject|0|||
48728667|NCT04902326|156857134|FG003|Overall Study|Withdrawal by Subject|1|||
48728668|NCT04902326|156857131|FG000|Overall Study|Lost to Follow-up|14|||
48728669|NCT04902326|156857132|FG001|Overall Study|Lost to Follow-up|14|||
48728670|NCT04902326|156857133|FG002|Overall Study|Lost to Follow-up|14|||
48728671|NCT04902326|156857134|FG003|Overall Study|Lost to Follow-up|6|||
48728672|NCT02821910|156857137|FG000|Overall Study|Withdrawal by Subject|0|||
48728673|NCT02821910|156857138|FG001|Overall Study|Withdrawal by Subject|0|||
48728674|NCT02821910|156857139|FG002|Overall Study|Withdrawal by Subject|1|||
48728675|NCT02821910|156857140|FG003|Overall Study|Withdrawal by Subject|0|||
48728676|NCT02821910|156857141|FG004|Overall Study|Withdrawal by Subject|0|||
48728677|NCT02821910|156857142|FG005|Overall Study|Withdrawal by Subject|1|||
48728678|NCT02821910|156857137|FG000|Overall Study|Other than specified|1|||
48821838|NCT03850444|157190476|FG001|Overall Study|Withdrawal by Subject|5|||
48728679|NCT02821910|156857138|FG001|Overall Study|Other than specified|0|||
48728680|NCT02821910|156857139|FG002|Overall Study|Other than specified|1|||
48728681|NCT02821910|156857140|FG003|Overall Study|Other than specified|0|||
48728682|NCT02821910|156857141|FG004|Overall Study|Other than specified|0|||
48821839|NCT03850444|157190475|FG000|Overall Study|Participation in study terminated by Sponsor|23|||
48821840|NCT03850444|157190476|FG001|Overall Study|Participation in study terminated by Sponsor|11|||
48728683|NCT02821910|156857142|FG005|Overall Study|Other than specified|0|||
48728684|NCT05867342|156857143|FG000|Overall Study|Investigator Decision|3|||
48728685|NCT05867342|156857144|FG001|Overall Study|Investigator Decision|3|||
48728686|NCT00287079|156857145|FG000|Overall Study|Qualifying relapse|12|||
48728687|NCT00287079|156857146|FG001|Overall Study|Qualifying relapse|1|||
48728688|NCT00287079|156857145|FG000|Overall Study|Non-qualifying relapse|1|||
48728689|NCT00287079|156857146|FG001|Overall Study|Non-qualifying relapse|0|||
48728690|NCT00287079|156857145|FG000|Overall Study|Adverse Event|5|||
48728691|NCT00287079|156857146|FG001|Overall Study|Adverse Event|0|||
48728692|NCT00287079|156857145|FG000|Overall Study|Protocol Violation|1|||
49140140|NCT03336866|158351542|FG001|Overall Study|Withdrawal by Subject|1|||
49140141|NCT03336866|158351543|FG002|Overall Study|Withdrawal by Subject|0|||
49140142|NCT03336866|158351541|FG000|Overall Study|Noncompliance with clinic house rules|0|||
49140143|NCT03336866|158351542|FG001|Overall Study|Noncompliance with clinic house rules|0|||
49140144|NCT03336866|158351543|FG002|Overall Study|Noncompliance with clinic house rules|1|||
49140145|NCT00985790|158351545|FG000|Overall Study|Withdrawal by Subject|1|||
49140146|NCT00985790|158351546|FG001|Overall Study|Withdrawal by Subject|1|||
48728693|NCT00287079|156857146|FG001|Overall Study|Protocol Violation|0|||
48728694|NCT00287079|156857145|FG000|Overall Study|Other|3|||
48728695|NCT00287079|156857146|FG001|Overall Study|Other|0|||
49140147|NCT00985790|158351545|FG000|Overall Study|Lost to Follow-up|6|||
49140148|NCT00985790|158351546|FG001|Overall Study|Lost to Follow-up|7|||
49140149|NCT00250718|158351547|FG000|Overall Study|Death|1|||
49140150|NCT00250718|158351547|FG000|Overall Study|Adverse Event|1|||
49140151|NCT00250718|158351547|FG000|Overall Study|Withdrawal by Subject|1|||
49140152|NCT04518410|158351552|FG000|Overall Study|Lost to Follow-up|1|||
49140153|NCT04518410|158351553|FG001|Overall Study|Lost to Follow-up|1|||
49140154|NCT04518410|158351554|FG002|Overall Study|Lost to Follow-up|8|||
49140155|NCT04518410|158351555|FG003|Overall Study|Lost to Follow-up|5|||
49140156|NCT04518410|158351556|FG004|Overall Study|Lost to Follow-up|92|||
49140157|NCT04518410|158351557|FG005|Overall Study|Lost to Follow-up|25|||
49140158|NCT04518410|158351558|FG006|Overall Study|Lost to Follow-up|25|||
49140159|NCT04518410|158351559|FG007|Overall Study|Lost to Follow-up|3|||
49140160|NCT04518410|158351560|FG008|Overall Study|Lost to Follow-up|2|||
49140161|NCT04518410|158351561|FG009|Overall Study|Lost to Follow-up|13|||
49140162|NCT04518410|158351562|FG010|Overall Study|Lost to Follow-up|9|||
49140163|NCT04518410|158351563|FG011|Overall Study|Lost to Follow-up|13|||
49140164|NCT04518410|158351564|FG012|Overall Study|Lost to Follow-up|9|||
49140165|NCT04518410|158351565|FG013|Overall Study|Lost to Follow-up|13|||
49140166|NCT04518410|158351566|FG014|Overall Study|Lost to Follow-up|8|||
49140167|NCT04518410|158351567|FG015|Overall Study|Lost to Follow-up|10|||
49140168|NCT04518410|158351568|FG016|Overall Study|Lost to Follow-up|6|||
49140169|NCT04518410|158351569|FG017|Overall Study|Lost to Follow-up|13|||
49140170|NCT04518410|158351570|FG018|Overall Study|Lost to Follow-up|21|||
49140171|NCT04518410|158351571|FG019|Overall Study|Lost to Follow-up|6|||
49140172|NCT04518410|158351572|FG020|Overall Study|Lost to Follow-up|7|||
49140173|NCT04518410|158351573|FG021|Overall Study|Lost to Follow-up|21|||
49140174|NCT04518410|158351574|FG022|Overall Study|Lost to Follow-up|1|||
49140175|NCT04518410|158351575|FG023|Overall Study|Lost to Follow-up|7|||
49140176|NCT04518410|158351576|FG024|Overall Study|Lost to Follow-up|6|||
49140177|NCT04518410|158351552|FG000|Overall Study|Withdrawal by Subject|1|||
49140178|NCT04518410|158351553|FG001|Overall Study|Withdrawal by Subject|2|||
49140179|NCT04518410|158351554|FG002|Overall Study|Withdrawal by Subject|2|||
49140180|NCT04518410|158351555|FG003|Overall Study|Withdrawal by Subject|3|||
49140181|NCT04518410|158351556|FG004|Overall Study|Withdrawal by Subject|20|||
49140182|NCT04518410|158351557|FG005|Overall Study|Withdrawal by Subject|20|||
49140183|NCT04518410|158351558|FG006|Overall Study|Withdrawal by Subject|25|||
49140184|NCT04518410|158351559|FG007|Overall Study|Withdrawal by Subject|6|||
49140185|NCT04518410|158351560|FG008|Overall Study|Withdrawal by Subject|1|||
49140186|NCT04518410|158351561|FG009|Overall Study|Withdrawal by Subject|12|||
49140187|NCT04518410|158351562|FG010|Overall Study|Withdrawal by Subject|5|||
49140188|NCT04518410|158351563|FG011|Overall Study|Withdrawal by Subject|7|||
49140189|NCT04518410|158351564|FG012|Overall Study|Withdrawal by Subject|2|||
49140190|NCT04518410|158351565|FG013|Overall Study|Withdrawal by Subject|13|||
49140191|NCT04518410|158351566|FG014|Overall Study|Withdrawal by Subject|4|||
49140192|NCT04518410|158351567|FG015|Overall Study|Withdrawal by Subject|9|||
49140193|NCT04518410|158351568|FG016|Overall Study|Withdrawal by Subject|0|||
49140194|NCT04518410|158351569|FG017|Overall Study|Withdrawal by Subject|15|||
49140195|NCT04518410|158351570|FG018|Overall Study|Withdrawal by Subject|12|||
49140196|NCT04518410|158351571|FG019|Overall Study|Withdrawal by Subject|9|||
49140197|NCT04518410|158351572|FG020|Overall Study|Withdrawal by Subject|14|||
49140198|NCT04518410|158351573|FG021|Overall Study|Withdrawal by Subject|3|||
48728696|NCT00723203|156857147|FG000|Overall Study|Withdrawal by Subject|3|||
48728697|NCT03416374|156857150|FG000|Between Treatment Period I and II|Other|0|||
48728698|NCT03416374|156857151|FG001|Between Treatment Period I and II|Other|9|||
48728699|NCT03416374|156857150|FG000|Treatment Period II|Lack of Efficacy|3|||
48728700|NCT03416374|156857151|FG001|Treatment Period II|Lack of Efficacy|11|||
48728701|NCT03416374|156857150|FG000|Treatment Period II|Adverse Event|1|||
48728702|NCT03416374|156857151|FG001|Treatment Period II|Adverse Event|4|||
48728703|NCT03416374|156857150|FG000|Treatment Period II|Death|0|||
48728704|NCT03416374|156857151|FG001|Treatment Period II|Death|1|||
48728705|NCT03416374|156857150|FG000|Treatment Period II|Other|0|||
48728706|NCT03416374|156857151|FG001|Treatment Period II|Other|2|||
48728707|NCT03463031|156857154|FG000|Overall Study|Withdrawal by Subject|4|||
48728708|NCT03463031|156857155|FG001|Overall Study|Withdrawal by Subject|2|||
48728709|NCT03463031|156857154|FG000|Overall Study|Investigator/Sponsor Decision|0|||
48728710|NCT03463031|156857155|FG001|Overall Study|Investigator/Sponsor Decision|1|||
48728711|NCT03463031|156857154|FG000|Overall Study|Lost to Follow-up|1|||
48821841|NCT00224133|157190477|FG000|Overall Study|Adverse Event|93|||
48821842|NCT00224133|157190477|FG000|Overall Study|Protocol Violation|6|||
48821843|NCT00224133|157190477|FG000|Overall Study|Withdrawal by Subject|33|||
48821844|NCT00224133|157190477|FG000|Overall Study|Lack of Efficacy|58|||
48821845|NCT00224133|157190477|FG000|Overall Study|Lost to Follow-up|21|||
48821846|NCT00224133|157190477|FG000|Overall Study|Physician Decision|1|||
48821847|NCT00224133|157190477|FG000|Overall Study|Other|14|||
48821848|NCT04096365|157190480|FG000|Overall Study|Adverse Event|1|||
48821849|NCT02401529|157190481|FG000|Overall Study|Lost to Follow-up|2|||
48821850|NCT02401529|157190482|FG001|Overall Study|Lost to Follow-up|1|||
49140199|NCT04518410|158351574|FG022|Overall Study|Withdrawal by Subject|2|||
49140200|NCT04518410|158351575|FG023|Overall Study|Withdrawal by Subject|9|||
49140201|NCT04518410|158351576|FG024|Overall Study|Withdrawal by Subject|8|||
49140202|NCT04518410|158351552|FG000|Overall Study|Other|1|||
49140203|NCT04518410|158351553|FG001|Overall Study|Other|0|||
49140204|NCT04518410|158351554|FG002|Overall Study|Other|0|||
49011532|NCT04896385|157878997|FG001|24-Week Double-Blind Period|Withdrawal by Subject|2|||
49011533|NCT04896385|157878998|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
49011534|NCT04896385|157878999|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
49011535|NCT04896385|157878996|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
49011536|NCT04896385|157878997|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
49011537|NCT04896385|157878998|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
49011538|NCT04896385|157878999|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|2|||
48728712|NCT03463031|156857155|FG001|Overall Study|Lost to Follow-up|1|||
48728713|NCT03463031|156857154|FG000|Overall Study|Adverse Event|4|||
48728714|NCT03463031|156857155|FG001|Overall Study|Adverse Event|1|||
48728715|NCT03463031|156857154|FG000|Overall Study|Use of prohibited medication by subject|1|||
48728716|NCT03463031|156857155|FG001|Overall Study|Use of prohibited medication by subject|0|||
48728717|NCT03116347|156857156|FG000|Overall Study|Withdrawal by Subject|1|||
49140205|NCT04518410|158351555|FG003|Overall Study|Other|1|||
49140206|NCT04518410|158351556|FG004|Overall Study|Other|6|||
49140207|NCT04518410|158351557|FG005|Overall Study|Other|6|||
49140208|NCT04518410|158351558|FG006|Overall Study|Other|5|||
49140209|NCT04518410|158351559|FG007|Overall Study|Other|2|||
49140210|NCT04518410|158351560|FG008|Overall Study|Other|0|||
49140211|NCT04518410|158351561|FG009|Overall Study|Other|1|||
49140212|NCT04518410|158351562|FG010|Overall Study|Other|0|||
49140213|NCT04518410|158351563|FG011|Overall Study|Other|2|||
49140214|NCT04518410|158351564|FG012|Overall Study|Other|0|||
49140215|NCT04518410|158351565|FG013|Overall Study|Other|0|||
49140216|NCT04518410|158351566|FG014|Overall Study|Other|0|||
49140217|NCT04518410|158351567|FG015|Overall Study|Other|3|||
49140218|NCT04518410|158351568|FG016|Overall Study|Other|1|||
49140219|NCT04518410|158351569|FG017|Overall Study|Other|1|||
49140220|NCT04518410|158351570|FG018|Overall Study|Other|1|||
49140221|NCT04518410|158351571|FG019|Overall Study|Other|0|||
49140222|NCT04518410|158351572|FG020|Overall Study|Other|1|||
49140223|NCT04518410|158351573|FG021|Overall Study|Other|0|||
49140224|NCT04518410|158351574|FG022|Overall Study|Other|1|||
49140225|NCT04518410|158351575|FG023|Overall Study|Other|2|||
49140226|NCT04518410|158351576|FG024|Overall Study|Other|2|||
49140227|NCT04518410|158351552|FG000|Overall Study|Protocol Violation|0|||
49140228|NCT04518410|158351553|FG001|Overall Study|Protocol Violation|0|||
49140229|NCT04518410|158351554|FG002|Overall Study|Protocol Violation|0|||
49140230|NCT04518410|158351555|FG003|Overall Study|Protocol Violation|2|||
49140231|NCT04518410|158351556|FG004|Overall Study|Protocol Violation|17|||
49140232|NCT04518410|158351557|FG005|Overall Study|Protocol Violation|1|||
49140233|NCT04518410|158351558|FG006|Overall Study|Protocol Violation|2|||
49140234|NCT04518410|158351559|FG007|Overall Study|Protocol Violation|1|||
49140235|NCT04518410|158351560|FG008|Overall Study|Protocol Violation|0|||
49140236|NCT04518410|158351561|FG009|Overall Study|Protocol Violation|0|||
49140237|NCT04518410|158351562|FG010|Overall Study|Protocol Violation|0|||
49140238|NCT04518410|158351563|FG011|Overall Study|Protocol Violation|0|||
49140239|NCT04518410|158351564|FG012|Overall Study|Protocol Violation|0|||
49011539|NCT04896385|157878996|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
49140240|NCT04518410|158351565|FG013|Overall Study|Protocol Violation|0|||
49140241|NCT04518410|158351566|FG014|Overall Study|Protocol Violation|0|||
48728718|NCT03116347|156857157|FG001|Overall Study|Withdrawal by Subject|2|||
49140242|NCT04518410|158351567|FG015|Overall Study|Protocol Violation|0|||
49140243|NCT04518410|158351568|FG016|Overall Study|Protocol Violation|1|||
48821851|NCT02401529|157190481|FG000|Overall Study|Physician Decision|2|||
48821852|NCT02401529|157190482|FG001|Overall Study|Physician Decision|6|||
48728719|NCT01629706|156857158|FG000|Phase 1 PureVision|Screen Failure|4|||
48821853|NCT02401529|157190481|FG000|Overall Study|Protocol Violation|5|||
49140244|NCT04518410|158351569|FG017|Overall Study|Protocol Violation|1|||
49140245|NCT04518410|158351570|FG018|Overall Study|Protocol Violation|0|||
49140246|NCT04518410|158351571|FG019|Overall Study|Protocol Violation|0|||
49140247|NCT04518410|158351572|FG020|Overall Study|Protocol Violation|1|||
49140248|NCT04518410|158351573|FG021|Overall Study|Protocol Violation|2|||
49140249|NCT04518410|158351574|FG022|Overall Study|Protocol Violation|0|||
49140250|NCT04518410|158351575|FG023|Overall Study|Protocol Violation|3|||
48821854|NCT02401529|157190482|FG001|Overall Study|Protocol Violation|0|||
48821855|NCT01474512|157190483|FG000|Induction Period|Adverse Event|6|||
48821856|NCT01474512|157190484|FG001|Induction Period|Adverse Event|10|||
48821857|NCT01474512|157190485|FG002|Induction Period|Adverse Event|10|||
48821858|NCT01474512|157190486|FG003|Induction Period|Adverse Event|0|||
48821859|NCT01474512|157190487|FG004|Induction Period|Adverse Event|0|||
48821860|NCT01474512|157190488|FG005|Induction Period|Adverse Event|0|||
48821861|NCT01474512|157190489|FG006|Induction Period|Adverse Event|0|||
48821862|NCT01474512|157190490|FG007|Induction Period|Adverse Event|0|||
48821863|NCT01474512|157190491|FG008|Induction Period|Adverse Event|0|||
48821864|NCT01474512|157190492|FG009|Induction Period|Adverse Event|0|||
48821865|NCT01474512|157190493|FG010|Induction Period|Adverse Event|0|||
48821866|NCT01474512|157190494|FG011|Induction Period|Adverse Event|0|||
49140251|NCT04518410|158351576|FG024|Overall Study|Protocol Violation|0|||
49140252|NCT04518410|158351552|FG000|Overall Study|Death|0|||
49140253|NCT04518410|158351553|FG001|Overall Study|Death|0|||
49140254|NCT04518410|158351554|FG002|Overall Study|Death|0|||
49140255|NCT04518410|158351555|FG003|Overall Study|Death|0|||
49140256|NCT04518410|158351556|FG004|Overall Study|Death|12|||
49140257|NCT04518410|158351557|FG005|Overall Study|Death|2|||
49140258|NCT04518410|158351558|FG006|Overall Study|Death|11|||
49140259|NCT04518410|158351559|FG007|Overall Study|Death|0|||
49140260|NCT04518410|158351560|FG008|Overall Study|Death|1|||
49140261|NCT04518410|158351561|FG009|Overall Study|Death|0|||
49140262|NCT04518410|158351562|FG010|Overall Study|Death|0|||
49140263|NCT04518410|158351563|FG011|Overall Study|Death|0|||
49140264|NCT04518410|158351564|FG012|Overall Study|Death|0|||
48728720|NCT01629706|156857158|FG000|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1|||
48728721|NCT01629706|156857158|FG000|Phase 1 PureVision|Inconvenience prior to Dispense|1|||
48728722|NCT01629706|156857158|FG000|Phase 1 PureVision|No Solution-Induced Corneal Staining|3|||
48728723|NCT01629706|156857158|FG000|Phase 2 Habitual|Screen Failure|6|||
48728724|NCT01629706|156857158|FG000|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1|||
48728725|NCT01629706|156857158|FG000|Phase 2 Habitual|Relocation prior to Dispense|1|||
48728726|NCT01629706|156857158|FG000|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1|||
48728727|NCT01629706|156857158|FG000|Phase 2 Habitual|Lost to Follow Up after Dispense|1|||
49140265|NCT04518410|158351565|FG013|Overall Study|Death|1|||
49140266|NCT04518410|158351566|FG014|Overall Study|Death|1|||
49140267|NCT04518410|158351567|FG015|Overall Study|Death|0|||
49140268|NCT04518410|158351568|FG016|Overall Study|Death|0|||
49140269|NCT04518410|158351569|FG017|Overall Study|Death|1|||
49140270|NCT04518410|158351570|FG018|Overall Study|Death|4|||
49140271|NCT04518410|158351571|FG019|Overall Study|Death|4|||
49140272|NCT04518410|158351572|FG020|Overall Study|Death|1|||
49140273|NCT04518410|158351573|FG021|Overall Study|Death|0|||
49140274|NCT04518410|158351574|FG022|Overall Study|Death|0|||
49140275|NCT04518410|158351575|FG023|Overall Study|Death|0|||
49140276|NCT04518410|158351576|FG024|Overall Study|Death|0|||
49140277|NCT04518410|158351552|FG000|Overall Study|Requirement to start alternative therapy|0|||
49140278|NCT04518410|158351553|FG001|Overall Study|Requirement to start alternative therapy|0|||
49140279|NCT04518410|158351554|FG002|Overall Study|Requirement to start alternative therapy|1|||
49140280|NCT04518410|158351555|FG003|Overall Study|Requirement to start alternative therapy|0|||
49140281|NCT04518410|158351556|FG004|Overall Study|Requirement to start alternative therapy|0|||
49140282|NCT04518410|158351557|FG005|Overall Study|Requirement to start alternative therapy|0|||
49140283|NCT04518410|158351558|FG006|Overall Study|Requirement to start alternative therapy|0|||
49140284|NCT04518410|158351559|FG007|Overall Study|Requirement to start alternative therapy|0|||
48728728|NCT02117414|156857159|FG000|Overall Study|Death|5|||
48728729|NCT02117414|156857160|FG001|Overall Study|Death|2|||
48728730|NCT02117414|156857159|FG000|Overall Study|Withdrawal by Subject|10|||
48728731|NCT02117414|156857160|FG001|Overall Study|Withdrawal by Subject|4|||
48728732|NCT00417482|156857165|FG000|Phase B 1st 16 Weeks|Lack of Efficacy|14|||
48728733|NCT00417482|156857166|FG001|Phase B 1st 16 Weeks|Lack of Efficacy|8|||
48728734|NCT00417482|156857167|FG002|Phase B 1st 16 Weeks|Lack of Efficacy|24|||
49140285|NCT04518410|158351560|FG008|Overall Study|Requirement to start alternative therapy|0|||
49140286|NCT04518410|158351561|FG009|Overall Study|Requirement to start alternative therapy|0|||
49140287|NCT04518410|158351562|FG010|Overall Study|Requirement to start alternative therapy|0|||
49140288|NCT04518410|158351563|FG011|Overall Study|Requirement to start alternative therapy|0|||
48728735|NCT00417482|156857165|FG000|Phase B 1st 16 Weeks|Adverse Event|2|||
48728736|NCT00417482|156857166|FG001|Phase B 1st 16 Weeks|Adverse Event|0|||
48821867|NCT01474512|157190495|FG012|Induction Period|Adverse Event|0|||
48821868|NCT01474512|157190496|FG013|Induction Period|Adverse Event|0|||
48821869|NCT01474512|157190497|FG014|Induction Period|Adverse Event|0|||
48821870|NCT01474512|157190498|FG015|Induction Period|Adverse Event|0|||
48821871|NCT01474512|157190499|FG016|Induction Period|Adverse Event|0|||
49140289|NCT04518410|158351564|FG012|Overall Study|Requirement to start alternative therapy|0|||
49140290|NCT04518410|158351565|FG013|Overall Study|Requirement to start alternative therapy|0|||
49140291|NCT04518410|158351566|FG014|Overall Study|Requirement to start alternative therapy|0|||
49140292|NCT04518410|158351567|FG015|Overall Study|Requirement to start alternative therapy|0|||
49140293|NCT04518410|158351568|FG016|Overall Study|Requirement to start alternative therapy|0|||
49140294|NCT04518410|158351569|FG017|Overall Study|Requirement to start alternative therapy|0|||
49140295|NCT04518410|158351570|FG018|Overall Study|Requirement to start alternative therapy|0|||
49140296|NCT04518410|158351571|FG019|Overall Study|Requirement to start alternative therapy|0|||
49140297|NCT04518410|158351572|FG020|Overall Study|Requirement to start alternative therapy|0|||
49140298|NCT04518410|158351573|FG021|Overall Study|Requirement to start alternative therapy|0|||
49140299|NCT04518410|158351574|FG022|Overall Study|Requirement to start alternative therapy|0|||
49140300|NCT04518410|158351575|FG023|Overall Study|Requirement to start alternative therapy|0|||
49140301|NCT04518410|158351576|FG024|Overall Study|Requirement to start alternative therapy|0|||
49140302|NCT04518410|158351552|FG000|Overall Study|Randomized but not treated|0|||
49140303|NCT04518410|158351553|FG001|Overall Study|Randomized but not treated|0|||
49011540|NCT04896385|157878997|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
49140304|NCT04518410|158351554|FG002|Overall Study|Randomized but not treated|0|||
48821872|NCT01474512|157190500|FG017|Induction Period|Adverse Event|0|||
48821873|NCT01474512|157190483|FG000|Induction Period|Lack of Efficacy|7|||
48821874|NCT01474512|157190484|FG001|Induction Period|Lack of Efficacy|1|||
48821875|NCT01474512|157190485|FG002|Induction Period|Lack of Efficacy|0|||
48821876|NCT01474512|157190486|FG003|Induction Period|Lack of Efficacy|0|||
48821877|NCT01474512|157190487|FG004|Induction Period|Lack of Efficacy|0|||
48821878|NCT01474512|157190488|FG005|Induction Period|Lack of Efficacy|0|||
48821879|NCT01474512|157190489|FG006|Induction Period|Lack of Efficacy|0|||
48821880|NCT01474512|157190490|FG007|Induction Period|Lack of Efficacy|0|||
48821881|NCT01474512|157190491|FG008|Induction Period|Lack of Efficacy|0|||
48821882|NCT01474512|157190492|FG009|Induction Period|Lack of Efficacy|0|||
48821883|NCT01474512|157190493|FG010|Induction Period|Lack of Efficacy|0|||
48821884|NCT01474512|157190494|FG011|Induction Period|Lack of Efficacy|0|||
48821885|NCT01474512|157190495|FG012|Induction Period|Lack of Efficacy|0|||
48821886|NCT01474512|157190496|FG013|Induction Period|Lack of Efficacy|0|||
48821887|NCT01474512|157190497|FG014|Induction Period|Lack of Efficacy|0|||
48821888|NCT01474512|157190498|FG015|Induction Period|Lack of Efficacy|0|||
48821889|NCT01474512|157190499|FG016|Induction Period|Lack of Efficacy|0|||
48821890|NCT01474512|157190500|FG017|Induction Period|Lack of Efficacy|0|||
48821891|NCT01474512|157190483|FG000|Induction Period|Withdrawal by Subject|6|||
48821892|NCT01474512|157190484|FG001|Induction Period|Withdrawal by Subject|6|||
48821893|NCT01474512|157190485|FG002|Induction Period|Withdrawal by Subject|5|||
48821894|NCT01474512|157190486|FG003|Induction Period|Withdrawal by Subject|0|||
48821895|NCT01474512|157190487|FG004|Induction Period|Withdrawal by Subject|0|||
48821896|NCT01474512|157190488|FG005|Induction Period|Withdrawal by Subject|0|||
48821897|NCT01474512|157190489|FG006|Induction Period|Withdrawal by Subject|0|||
48821898|NCT01474512|157190490|FG007|Induction Period|Withdrawal by Subject|0|||
48821899|NCT01474512|157190491|FG008|Induction Period|Withdrawal by Subject|0|||
48821900|NCT01474512|157190492|FG009|Induction Period|Withdrawal by Subject|0|||
48821901|NCT01474512|157190493|FG010|Induction Period|Withdrawal by Subject|0|||
48821902|NCT01474512|157190494|FG011|Induction Period|Withdrawal by Subject|0|||
48821903|NCT01474512|157190495|FG012|Induction Period|Withdrawal by Subject|0|||
48821904|NCT01474512|157190496|FG013|Induction Period|Withdrawal by Subject|0|||
48821905|NCT01474512|157190497|FG014|Induction Period|Withdrawal by Subject|0|||
48821906|NCT01474512|157190498|FG015|Induction Period|Withdrawal by Subject|0|||
48821907|NCT01474512|157190499|FG016|Induction Period|Withdrawal by Subject|0|||
48821908|NCT01474512|157190500|FG017|Induction Period|Withdrawal by Subject|0|||
48821909|NCT01474512|157190483|FG000|Induction Period|Protocol Violation|3|||
48821910|NCT01474512|157190484|FG001|Induction Period|Protocol Violation|6|||
48821911|NCT01474512|157190485|FG002|Induction Period|Protocol Violation|0|||
48821912|NCT01474512|157190486|FG003|Induction Period|Protocol Violation|0|||
48821913|NCT01474512|157190487|FG004|Induction Period|Protocol Violation|0|||
48821914|NCT01474512|157190488|FG005|Induction Period|Protocol Violation|0|||
48821915|NCT01474512|157190489|FG006|Induction Period|Protocol Violation|0|||
48821916|NCT01474512|157190490|FG007|Induction Period|Protocol Violation|0|||
48821917|NCT01474512|157190491|FG008|Induction Period|Protocol Violation|0|||
48821918|NCT01474512|157190492|FG009|Induction Period|Protocol Violation|0|||
48821919|NCT01474512|157190493|FG010|Induction Period|Protocol Violation|0|||
48821920|NCT01474512|157190494|FG011|Induction Period|Protocol Violation|0|||
48821921|NCT01474512|157190495|FG012|Induction Period|Protocol Violation|0|||
49140305|NCT04518410|158351555|FG003|Overall Study|Randomized but not treated|2|||
48821922|NCT01474512|157190496|FG013|Induction Period|Protocol Violation|0|||
48821923|NCT01474512|157190497|FG014|Induction Period|Protocol Violation|0|||
48821924|NCT01474512|157190498|FG015|Induction Period|Protocol Violation|0|||
48821925|NCT01474512|157190499|FG016|Induction Period|Protocol Violation|0|||
48821926|NCT01474512|157190500|FG017|Induction Period|Protocol Violation|0|||
48821927|NCT01474512|157190483|FG000|Induction Period|Sponsor Decision|1|||
48821928|NCT01474512|157190484|FG001|Induction Period|Sponsor Decision|1|||
48821929|NCT01474512|157190485|FG002|Induction Period|Sponsor Decision|1|||
48821930|NCT01474512|157190486|FG003|Induction Period|Sponsor Decision|0|||
48821931|NCT01474512|157190487|FG004|Induction Period|Sponsor Decision|0|||
48821932|NCT01474512|157190488|FG005|Induction Period|Sponsor Decision|0|||
49140306|NCT04518410|158351556|FG004|Overall Study|Randomized but not treated|6|||
49140307|NCT04518410|158351557|FG005|Overall Study|Randomized but not treated|4|||
49140308|NCT04518410|158351558|FG006|Overall Study|Randomized but not treated|3|||
49140309|NCT04518410|158351559|FG007|Overall Study|Randomized but not treated|3|||
49140310|NCT04518410|158351560|FG008|Overall Study|Randomized but not treated|0|||
49140311|NCT04518410|158351561|FG009|Overall Study|Randomized but not treated|4|||
49140312|NCT04518410|158351562|FG010|Overall Study|Randomized but not treated|0|||
49140313|NCT04518410|158351563|FG011|Overall Study|Randomized but not treated|0|||
49140314|NCT04518410|158351564|FG012|Overall Study|Randomized but not treated|1|||
49140315|NCT04518410|158351565|FG013|Overall Study|Randomized but not treated|3|||
49140316|NCT04518410|158351566|FG014|Overall Study|Randomized but not treated|3|||
49140317|NCT04518410|158351567|FG015|Overall Study|Randomized but not treated|3|||
49140318|NCT04518410|158351568|FG016|Overall Study|Randomized but not treated|4|||
49140319|NCT04518410|158351569|FG017|Overall Study|Randomized but not treated|5|||
49140320|NCT04518410|158351570|FG018|Overall Study|Randomized but not treated|4|||
49140321|NCT04518410|158351571|FG019|Overall Study|Randomized but not treated|0|||
49140322|NCT04518410|158351572|FG020|Overall Study|Randomized but not treated|0|||
49140323|NCT04518410|158351573|FG021|Overall Study|Randomized but not treated|5|||
49140324|NCT04518410|158351574|FG022|Overall Study|Randomized but not treated|0|||
49140325|NCT04518410|158351575|FG023|Overall Study|Randomized but not treated|3|||
49140326|NCT04518410|158351576|FG024|Overall Study|Randomized but not treated|1|||
49140327|NCT04518410|158351552|FG000|Overall Study|Screen Fail but Randomized|0|||
49140328|NCT04518410|158351553|FG001|Overall Study|Screen Fail but Randomized|0|||
49140329|NCT04518410|158351554|FG002|Overall Study|Screen Fail but Randomized|0|||
49140330|NCT04518410|158351555|FG003|Overall Study|Screen Fail but Randomized|0|||
49140331|NCT04518410|158351556|FG004|Overall Study|Screen Fail but Randomized|2|||
49140332|NCT04518410|158351557|FG005|Overall Study|Screen Fail but Randomized|0|||
49140333|NCT04518410|158351558|FG006|Overall Study|Screen Fail but Randomized|0|||
49140334|NCT04518410|158351559|FG007|Overall Study|Screen Fail but Randomized|0|||
49140335|NCT04518410|158351560|FG008|Overall Study|Screen Fail but Randomized|0|||
49140336|NCT04518410|158351561|FG009|Overall Study|Screen Fail but Randomized|0|||
49140337|NCT04518410|158351562|FG010|Overall Study|Screen Fail but Randomized|0|||
49140338|NCT04518410|158351563|FG011|Overall Study|Screen Fail but Randomized|0|||
49140339|NCT04518410|158351564|FG012|Overall Study|Screen Fail but Randomized|0|||
49140340|NCT04518410|158351565|FG013|Overall Study|Screen Fail but Randomized|0|||
48821933|NCT01474512|157190489|FG006|Induction Period|Sponsor Decision|0|||
48821934|NCT01474512|157190490|FG007|Induction Period|Sponsor Decision|0|||
48821935|NCT01474512|157190491|FG008|Induction Period|Sponsor Decision|0|||
48821936|NCT01474512|157190492|FG009|Induction Period|Sponsor Decision|0|||
48821937|NCT01474512|157190493|FG010|Induction Period|Sponsor Decision|0|||
49140341|NCT04518410|158351566|FG014|Overall Study|Screen Fail but Randomized|0|||
49140342|NCT04518410|158351567|FG015|Overall Study|Screen Fail but Randomized|0|||
49140343|NCT04518410|158351568|FG016|Overall Study|Screen Fail but Randomized|0|||
49140344|NCT04518410|158351569|FG017|Overall Study|Screen Fail but Randomized|0|||
48821938|NCT01474512|157190494|FG011|Induction Period|Sponsor Decision|0|||
48821939|NCT01474512|157190495|FG012|Induction Period|Sponsor Decision|0|||
48821940|NCT01474512|157190496|FG013|Induction Period|Sponsor Decision|0|||
48821941|NCT01474512|157190497|FG014|Induction Period|Sponsor Decision|0|||
48821942|NCT01474512|157190498|FG015|Induction Period|Sponsor Decision|0|||
48821943|NCT01474512|157190499|FG016|Induction Period|Sponsor Decision|0|||
48821944|NCT01474512|157190500|FG017|Induction Period|Sponsor Decision|0|||
48821945|NCT01474512|157190483|FG000|Induction Period|Lost to Follow-up|1|||
48821946|NCT01474512|157190484|FG001|Induction Period|Lost to Follow-up|0|||
48821947|NCT01474512|157190485|FG002|Induction Period|Lost to Follow-up|2|||
48821948|NCT01474512|157190486|FG003|Induction Period|Lost to Follow-up|0|||
48821949|NCT01474512|157190487|FG004|Induction Period|Lost to Follow-up|0|||
48821950|NCT01474512|157190488|FG005|Induction Period|Lost to Follow-up|0|||
48821951|NCT01474512|157190489|FG006|Induction Period|Lost to Follow-up|0|||
48821952|NCT01474512|157190490|FG007|Induction Period|Lost to Follow-up|0|||
48821953|NCT01474512|157190491|FG008|Induction Period|Lost to Follow-up|0|||
48821954|NCT01474512|157190492|FG009|Induction Period|Lost to Follow-up|0|||
48821955|NCT01474512|157190493|FG010|Induction Period|Lost to Follow-up|0|||
48821956|NCT01474512|157190494|FG011|Induction Period|Lost to Follow-up|0|||
49140345|NCT04518410|158351570|FG018|Overall Study|Screen Fail but Randomized|0|||
49140346|NCT04518410|158351571|FG019|Overall Study|Screen Fail but Randomized|0|||
49140347|NCT04518410|158351572|FG020|Overall Study|Screen Fail but Randomized|0|||
49140348|NCT04518410|158351573|FG021|Overall Study|Screen Fail but Randomized|0|||
49140349|NCT04518410|158351574|FG022|Overall Study|Screen Fail but Randomized|0|||
48821957|NCT01474512|157190495|FG012|Induction Period|Lost to Follow-up|0|||
48821958|NCT01474512|157190496|FG013|Induction Period|Lost to Follow-up|0|||
48821959|NCT01474512|157190497|FG014|Induction Period|Lost to Follow-up|0|||
48821960|NCT01474512|157190498|FG015|Induction Period|Lost to Follow-up|0|||
49140350|NCT04518410|158351575|FG023|Overall Study|Screen Fail but Randomized|0|||
48821961|NCT01474512|157190499|FG016|Induction Period|Lost to Follow-up|0|||
49140351|NCT04518410|158351576|FG024|Overall Study|Screen Fail but Randomized|0|||
48728737|NCT00417482|156857167|FG002|Phase B 1st 16 Weeks|Adverse Event|1|||
48728738|NCT00417482|156857165|FG000|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
48821962|NCT01474512|157190500|FG017|Induction Period|Lost to Follow-up|0|||
48821963|NCT01474512|157190483|FG000|Maintenance Period|Relapsed (sPGA ≥3)|0|||
48821964|NCT01474512|157190484|FG001|Maintenance Period|Relapsed (sPGA ≥3)|0|||
48821965|NCT01474512|157190485|FG002|Maintenance Period|Relapsed (sPGA ≥3)|0|||
48821966|NCT01474512|157190486|FG003|Maintenance Period|Relapsed (sPGA ≥3)|186|||
48821967|NCT01474512|157190487|FG004|Maintenance Period|Relapsed (sPGA ≥3)|111|||
48821968|NCT01474512|157190488|FG005|Maintenance Period|Relapsed (sPGA ≥3)|39|||
48821969|NCT01474512|157190489|FG006|Maintenance Period|Relapsed (sPGA ≥3)|9|||
48821970|NCT01474512|157190490|FG007|Maintenance Period|Relapsed (sPGA ≥3)|0|||
48821971|NCT01474512|157190491|FG008|Maintenance Period|Relapsed (sPGA ≥3)|0|||
48821972|NCT01474512|157190492|FG009|Maintenance Period|Relapsed (sPGA ≥3)|0|||
48821973|NCT01474512|157190493|FG010|Maintenance Period|Relapsed (sPGA ≥3)|0|||
48821974|NCT01474512|157190494|FG011|Maintenance Period|Relapsed (sPGA ≥3)|0|||
48821975|NCT01474512|157190495|FG012|Maintenance Period|Relapsed (sPGA ≥3)|0|||
48728739|NCT00417482|156857166|FG001|Phase B 1st 16 Weeks|Moved, Unclear reasons|3|||
48728740|NCT00417482|156857167|FG002|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
49011541|NCT04896385|157878998|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
49011542|NCT04896385|157878999|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
49011543|NCT04896385|157878996|FG000|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
48821976|NCT01474512|157190496|FG013|Maintenance Period|Relapsed (sPGA ≥3)|0|||
48728741|NCT00417482|156857165|FG000|Phase B 1st 16 Weeks|Death|1|||
48728742|NCT00417482|156857166|FG001|Phase B 1st 16 Weeks|Death|0|||
48728743|NCT00417482|156857167|FG002|Phase B 1st 16 Weeks|Death|0|||
48728744|NCT00417482|156857165|FG000|Phase B 2nd 16 Weeks|Lack of Efficacy|1|||
48728745|NCT00417482|156857166|FG001|Phase B 2nd 16 Weeks|Lack of Efficacy|12|||
48728746|NCT00417482|156857167|FG002|Phase B 2nd 16 Weeks|Lack of Efficacy|2|||
48728747|NCT00417482|156857165|FG000|Phase B 2nd 16 Weeks|Adverse Event|0|||
48728748|NCT00417482|156857166|FG001|Phase B 2nd 16 Weeks|Adverse Event|0|||
48728749|NCT00417482|156857167|FG002|Phase B 2nd 16 Weeks|Adverse Event|1|||
48728750|NCT00417482|156857165|FG000|Phase B 2nd 16 Weeks|Moved; unclear reason|1|||
48728751|NCT00417482|156857166|FG001|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
48821977|NCT01474512|157190497|FG014|Maintenance Period|Relapsed (sPGA ≥3)|0|||
48728752|NCT00417482|156857167|FG002|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
48728753|NCT00417482|156857165|FG000|Phase B 2nd 16 Weeks|Death|1|||
48728754|NCT00417482|156857166|FG001|Phase B 2nd 16 Weeks|Death|1|||
48728755|NCT00417482|156857167|FG002|Phase B 2nd 16 Weeks|Death|0|||
48728756|NCT01465191|156857168|FG000|Overall Study|Protocol Violation|6|||
48728757|NCT01465191|156857169|FG001|Overall Study|Protocol Violation|3|||
48728758|NCT01465191|156857170|FG002|Overall Study|Protocol Violation|3|||
48728759|NCT01465191|156857168|FG000|Overall Study|Lost to Follow-up|3|||
48728760|NCT01465191|156857169|FG001|Overall Study|Lost to Follow-up|6|||
48728761|NCT01465191|156857170|FG002|Overall Study|Lost to Follow-up|4|||
48728762|NCT01152450|156857173|FG000|Period 1 (4 Weeks)|Adverse Event|0|||
49140352|NCT04518410|158351552|FG000|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
49140353|NCT04518410|158351553|FG001|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
49140354|NCT04518410|158351554|FG002|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
49140355|NCT04518410|158351555|FG003|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
49140356|NCT04518410|158351556|FG004|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|81|||
49140357|NCT04518410|158351557|FG005|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|37|||
49140358|NCT04518410|158351558|FG006|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|23|||
49140359|NCT04518410|158351559|FG007|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
48821978|NCT01474512|157190498|FG015|Maintenance Period|Relapsed (sPGA ≥3)|0|||
48728763|NCT01152450|156857174|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
48728764|NCT01152450|156857175|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
48728765|NCT01152450|156857176|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
48728766|NCT01152450|156857177|FG004|Period 1 (4 Weeks)|Adverse Event|1|||
48728767|NCT01152450|156857178|FG005|Period 1 (4 Weeks)|Adverse Event|1|||
48728768|NCT01152450|156857173|FG000|Period 1 (4 Weeks)|Protocol Violation|0|||
48728769|NCT01152450|156857174|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
48821979|NCT01474512|157190499|FG016|Maintenance Period|Relapsed (sPGA ≥3)|0|||
48821980|NCT01474512|157190500|FG017|Maintenance Period|Relapsed (sPGA ≥3)|0|||
49011544|NCT04896385|157878997|FG001|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
48728770|NCT01152450|156857175|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
48728771|NCT01152450|156857176|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
48728772|NCT01152450|156857177|FG004|Period 1 (4 Weeks)|Protocol Violation|1|||
48728773|NCT01152450|156857178|FG005|Period 1 (4 Weeks)|Protocol Violation|0|||
48728774|NCT01152450|156857173|FG000|Period 1 (4 Weeks)|Lost to Follow-up|0|||
49140360|NCT04518410|158351560|FG008|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|6|||
49140361|NCT04518410|158351561|FG009|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
49140362|NCT04518410|158351562|FG010|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
49140363|NCT04518410|158351563|FG011|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
49140364|NCT04518410|158351564|FG012|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
49140365|NCT04518410|158351565|FG013|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
49140366|NCT04518410|158351566|FG014|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
49140367|NCT04518410|158351567|FG015|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
49140368|NCT04518410|158351568|FG016|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
49140369|NCT04518410|158351569|FG017|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
49140370|NCT04518410|158351570|FG018|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|16|||
49140371|NCT04518410|158351571|FG019|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
49140372|NCT04518410|158351572|FG020|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|19|||
49140373|NCT04518410|158351573|FG021|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
49140374|NCT04518410|158351574|FG022|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
49140375|NCT04518410|158351575|FG023|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
49140376|NCT04518410|158351576|FG024|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
49140377|NCT04518410|158351552|FG000|Overall Study|Dual Enrolled Subject|0|||
48821981|NCT01474512|157190483|FG000|Maintenance Period|Adverse Event|0|||
48821982|NCT01474512|157190484|FG001|Maintenance Period|Adverse Event|0|||
48821983|NCT01474512|157190485|FG002|Maintenance Period|Adverse Event|0|||
48821984|NCT01474512|157190486|FG003|Maintenance Period|Adverse Event|4|||
48821985|NCT01474512|157190487|FG004|Maintenance Period|Adverse Event|2|||
48821986|NCT01474512|157190488|FG005|Maintenance Period|Adverse Event|7|||
48821987|NCT01474512|157190489|FG006|Maintenance Period|Adverse Event|0|||
48821988|NCT01474512|157190490|FG007|Maintenance Period|Adverse Event|19|||
48821989|NCT01474512|157190491|FG008|Maintenance Period|Adverse Event|1|||
48821990|NCT01474512|157190492|FG009|Maintenance Period|Adverse Event|3|||
48821991|NCT01474512|157190493|FG010|Maintenance Period|Adverse Event|0|||
48821992|NCT01474512|157190494|FG011|Maintenance Period|Adverse Event|0|||
48821993|NCT01474512|157190495|FG012|Maintenance Period|Adverse Event|0|||
48821994|NCT01474512|157190496|FG013|Maintenance Period|Adverse Event|0|||
48821995|NCT01474512|157190497|FG014|Maintenance Period|Adverse Event|0|||
48821996|NCT01474512|157190498|FG015|Maintenance Period|Adverse Event|0|||
48821997|NCT01474512|157190499|FG016|Maintenance Period|Adverse Event|0|||
48821998|NCT01474512|157190500|FG017|Maintenance Period|Adverse Event|0|||
48821999|NCT01474512|157190483|FG000|Maintenance Period|Withdrawal by Subject|0|||
48822000|NCT01474512|157190484|FG001|Maintenance Period|Withdrawal by Subject|0|||
48822001|NCT01474512|157190485|FG002|Maintenance Period|Withdrawal by Subject|0|||
48822002|NCT01474512|157190486|FG003|Maintenance Period|Withdrawal by Subject|6|||
48822003|NCT01474512|157190487|FG004|Maintenance Period|Withdrawal by Subject|2|||
48822004|NCT01474512|157190488|FG005|Maintenance Period|Withdrawal by Subject|3|||
48822005|NCT01474512|157190489|FG006|Maintenance Period|Withdrawal by Subject|1|||
48822006|NCT01474512|157190490|FG007|Maintenance Period|Withdrawal by Subject|6|||
48822007|NCT01474512|157190491|FG008|Maintenance Period|Withdrawal by Subject|3|||
48822008|NCT01474512|157190492|FG009|Maintenance Period|Withdrawal by Subject|1|||
48822009|NCT01474512|157190493|FG010|Maintenance Period|Withdrawal by Subject|0|||
48822010|NCT01474512|157190494|FG011|Maintenance Period|Withdrawal by Subject|0|||
48822011|NCT01474512|157190495|FG012|Maintenance Period|Withdrawal by Subject|0|||
48822012|NCT01474512|157190496|FG013|Maintenance Period|Withdrawal by Subject|0|||
48822013|NCT01474512|157190497|FG014|Maintenance Period|Withdrawal by Subject|0|||
48822014|NCT01474512|157190498|FG015|Maintenance Period|Withdrawal by Subject|0|||
48822015|NCT01474512|157190499|FG016|Maintenance Period|Withdrawal by Subject|0|||
48822016|NCT01474512|157190500|FG017|Maintenance Period|Withdrawal by Subject|0|||
48822017|NCT01474512|157190483|FG000|Maintenance Period|Lost to Follow-up|0|||
48822018|NCT01474512|157190484|FG001|Maintenance Period|Lost to Follow-up|0|||
48822019|NCT01474512|157190485|FG002|Maintenance Period|Lost to Follow-up|0|||
48822020|NCT01474512|157190486|FG003|Maintenance Period|Lost to Follow-up|3|||
48822021|NCT01474512|157190487|FG004|Maintenance Period|Lost to Follow-up|3|||
48822022|NCT01474512|157190488|FG005|Maintenance Period|Lost to Follow-up|0|||
48822023|NCT01474512|157190489|FG006|Maintenance Period|Lost to Follow-up|0|||
48822024|NCT01474512|157190490|FG007|Maintenance Period|Lost to Follow-up|2|||
48822025|NCT01474512|157190491|FG008|Maintenance Period|Lost to Follow-up|1|||
48822026|NCT01474512|157190492|FG009|Maintenance Period|Lost to Follow-up|1|||
48822027|NCT01474512|157190493|FG010|Maintenance Period|Lost to Follow-up|0|||
48728775|NCT01152450|156857174|FG001|Period 1 (4 Weeks)|Lost to Follow-up|1|||
48728776|NCT01152450|156857175|FG002|Period 1 (4 Weeks)|Lost to Follow-up|1|||
48728777|NCT01152450|156857176|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
48728778|NCT01152450|156857177|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
48728779|NCT01152450|156857178|FG005|Period 1 (4 Weeks)|Lost to Follow-up|0|||
48728780|NCT04764162|156857182|FG000|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|0|||
48728781|NCT04764162|156857183|FG001|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|1|||
48728782|NCT00704808|156857184|FG000|Overall Study|Discontinued prior to starting treatment|14|||
48728783|NCT00704808|156857184|FG000|Overall Study|Death|7|||
48728784|NCT00704808|156857184|FG000|Overall Study|Tumor progression|80|||
48728785|NCT00704808|156857184|FG000|Overall Study|Patient's decision|11|||
48728786|NCT00704808|156857184|FG000|Overall Study|Early therapy discontinuation|16|||
48728787|NCT00704808|156857184|FG000|Overall Study|Adverse Event|1|||
48728788|NCT00704808|156857184|FG000|Overall Study|Lost to Follow-up|1|||
49140378|NCT04518410|158351553|FG001|Overall Study|Dual Enrolled Subject|0|||
49140379|NCT04518410|158351554|FG002|Overall Study|Dual Enrolled Subject|0|||
49140380|NCT04518410|158351555|FG003|Overall Study|Dual Enrolled Subject|0|||
49140381|NCT04518410|158351556|FG004|Overall Study|Dual Enrolled Subject|0|||
49140382|NCT04518410|158351557|FG005|Overall Study|Dual Enrolled Subject|0|||
48728789|NCT00704808|156857184|FG000|Overall Study|Treatment change|1|||
48728790|NCT01476644|156857185|FG000|Overall Study|Death|5|||
48728791|NCT01476644|156857185|FG000|Overall Study|moved to another state|2|||
48728792|NCT01476644|156857185|FG000|Overall Study|Lost to Follow-up|19|||
48728793|NCT01476644|156857185|FG000|Overall Study|Withdrawal by Subject|13|||
48728794|NCT00095628|156857186|FG000|Overall Study|Disease progression prior to treatment|1|||
48728795|NCT00495131|156857188|FG000|Overall Study|Adverse Event|6|||
48728796|NCT00495131|156857189|FG001|Overall Study|Adverse Event|2|||
48728797|NCT00495131|156857188|FG000|Overall Study|Lack of Efficacy|0|||
48728798|NCT00495131|156857189|FG001|Overall Study|Lack of Efficacy|2|||
48728799|NCT00495131|156857188|FG000|Overall Study|Lost to Follow-up|0|||
48728800|NCT00495131|156857189|FG001|Overall Study|Lost to Follow-up|2|||
48728801|NCT00495131|156857188|FG000|Overall Study|Withdrawal by Subject|1|||
48728802|NCT00495131|156857189|FG001|Overall Study|Withdrawal by Subject|0|||
49140383|NCT04518410|158351558|FG006|Overall Study|Dual Enrolled Subject|0|||
49140384|NCT04518410|158351559|FG007|Overall Study|Dual Enrolled Subject|0|||
49140385|NCT04518410|158351560|FG008|Overall Study|Dual Enrolled Subject|0|||
49140386|NCT04518410|158351561|FG009|Overall Study|Dual Enrolled Subject|0|||
49140387|NCT04518410|158351562|FG010|Overall Study|Dual Enrolled Subject|0|||
49140388|NCT04518410|158351563|FG011|Overall Study|Dual Enrolled Subject|0|||
49140389|NCT04518410|158351564|FG012|Overall Study|Dual Enrolled Subject|0|||
49140390|NCT04518410|158351565|FG013|Overall Study|Dual Enrolled Subject|0|||
49140391|NCT04518410|158351566|FG014|Overall Study|Dual Enrolled Subject|0|||
49140392|NCT04518410|158351567|FG015|Overall Study|Dual Enrolled Subject|0|||
49140393|NCT04518410|158351568|FG016|Overall Study|Dual Enrolled Subject|0|||
49140394|NCT04518410|158351569|FG017|Overall Study|Dual Enrolled Subject|1|||
49140395|NCT04518410|158351570|FG018|Overall Study|Dual Enrolled Subject|0|||
49140396|NCT04518410|158351571|FG019|Overall Study|Dual Enrolled Subject|0|||
49140397|NCT04518410|158351572|FG020|Overall Study|Dual Enrolled Subject|0|||
49140398|NCT04518410|158351573|FG021|Overall Study|Dual Enrolled Subject|0|||
49140399|NCT04518410|158351574|FG022|Overall Study|Dual Enrolled Subject|0|||
49140400|NCT04518410|158351575|FG023|Overall Study|Dual Enrolled Subject|0|||
49140401|NCT04518410|158351576|FG024|Overall Study|Dual Enrolled Subject|0|||
49140402|NCT00002874|158351577|FG000|Overall Study|Withdrawal by Subject|1|||
49140403|NCT00002874|158351578|FG001|Overall Study|Withdrawal by Subject|1|||
49140404|NCT00002874|158351577|FG000|Overall Study|Protocol Violation|44|||
49140405|NCT00002874|158351578|FG001|Overall Study|Protocol Violation|34|||
49140406|NCT03018938|158351579|FG000|Overall Study|Death|0|||
49140407|NCT03018938|158351580|FG001|Overall Study|Death|1|||
49140408|NCT03018938|158351579|FG000|Overall Study|Lost to Follow-up|21|||
49140409|NCT03018938|158351580|FG001|Overall Study|Lost to Follow-up|32|||
49140410|NCT03018938|158351579|FG000|Overall Study|Withdrawal by Subject|38|||
49140411|NCT03018938|158351580|FG001|Overall Study|Withdrawal by Subject|45|||
49140412|NCT03018938|158351579|FG000|Overall Study|Physician Decision|3|||
49140413|NCT03018938|158351580|FG001|Overall Study|Physician Decision|2|||
49140414|NCT03018938|158351579|FG000|Overall Study|Sponsor Decision|0|||
49140415|NCT03018938|158351580|FG001|Overall Study|Sponsor Decision|1|||
49140416|NCT03018938|158351579|FG000|Overall Study|Screen failure-After randomization|4|||
49140417|NCT03018938|158351580|FG001|Overall Study|Screen failure-After randomization|2|||
49140418|NCT03018938|158351579|FG000|Overall Study|Not recorded|0|||
49140419|NCT03018938|158351580|FG001|Overall Study|Not recorded|2|||
48728803|NCT00744471|156857190|FG000|Overall Study|Randomized but not treated|1|||
48728804|NCT00744471|156857191|FG001|Overall Study|Randomized but not treated|1|||
48728805|NCT00744471|156857192|FG002|Overall Study|Randomized but not treated|4|||
48728806|NCT00744471|156857193|FG003|Overall Study|Randomized but not treated|0|||
48728807|NCT00744471|156857190|FG000|Overall Study|Death|0|||
49140420|NCT03828383|158351593|FG000|Overall Study|Lost to Follow-up|3|||
49140421|NCT03828383|158351594|FG001|Overall Study|Lost to Follow-up|2|||
49140422|NCT03828383|158351593|FG000|Overall Study|Withdrawal by Subject|4|||
49140423|NCT03828383|158351594|FG001|Overall Study|Withdrawal by Subject|5|||
49140424|NCT00504309|158351595|FG000|Overall Study|Death|0|||
49140425|NCT00504309|158351596|FG001|Overall Study|Death|0|||
49140426|NCT00504309|158351597|FG002|Overall Study|Death|0|||
49140427|NCT00504309|158351598|FG003|Overall Study|Death|0|||
49140428|NCT00504309|158351599|FG004|Overall Study|Death|1|||
49140429|NCT00504309|158351600|FG005|Overall Study|Death|0|||
49140430|NCT00504309|158351595|FG000|Overall Study|Withdrawal by Subject|0|||
49140431|NCT00504309|158351596|FG001|Overall Study|Withdrawal by Subject|0|||
49140432|NCT00504309|158351597|FG002|Overall Study|Withdrawal by Subject|1|||
49140433|NCT00504309|158351598|FG003|Overall Study|Withdrawal by Subject|0|||
49140434|NCT00504309|158351599|FG004|Overall Study|Withdrawal by Subject|0|||
49140435|NCT00504309|158351600|FG005|Overall Study|Withdrawal by Subject|0|||
49140436|NCT00086307|158351601|FG000|Overall Study|Lack of Efficacy|1|||
49140437|NCT00086307|158351602|FG001|Overall Study|Lack of Efficacy|1|||
49140438|NCT00086307|158351603|FG002|Overall Study|Lack of Efficacy|2|||
49140439|NCT00086307|158351601|FG000|Overall Study|Shortness of breath and muscle spasms|1|||
49140440|NCT00086307|158351602|FG001|Overall Study|Shortness of breath and muscle spasms|0|||
49140441|NCT00086307|158351603|FG002|Overall Study|Shortness of breath and muscle spasms|0|||
49140442|NCT00086307|158351601|FG000|Overall Study|Nausea and headaches|0|||
49140443|NCT00086307|158351602|FG001|Overall Study|Nausea and headaches|0|||
49140444|NCT00086307|158351603|FG002|Overall Study|Nausea and headaches|1|||
49140445|NCT00086307|158351601|FG000|Overall Study|Constipation and sleepiness|0|||
49140446|NCT00086307|158351602|FG001|Overall Study|Constipation and sleepiness|0|||
49140447|NCT00086307|158351603|FG002|Overall Study|Constipation and sleepiness|1|||
49140448|NCT00086307|158351601|FG000|Overall Study|Suicidal ideation|0|||
49140449|NCT00086307|158351602|FG001|Overall Study|Suicidal ideation|0|||
49140450|NCT00086307|158351603|FG002|Overall Study|Suicidal ideation|1|||
49140451|NCT00086307|158351601|FG000|Overall Study|Fatigue and difficulty falling asleep|0|||
49140452|NCT00086307|158351602|FG001|Overall Study|Fatigue and difficulty falling asleep|0|||
49140453|NCT00086307|158351603|FG002|Overall Study|Fatigue and difficulty falling asleep|1|||
49140454|NCT00086307|158351601|FG000|Overall Study|Withdrawal by Subject|0|||
49140455|NCT00086307|158351602|FG001|Overall Study|Withdrawal by Subject|0|||
49140456|NCT00086307|158351603|FG002|Overall Study|Withdrawal by Subject|2|||
49140457|NCT00683384|158351604|FG000|Overall Study|Death|1|||
49140458|NCT00683384|158351604|FG000|Overall Study|Adverse Event|1|||
49140459|NCT00120874|158351605|FG000|Overall Study|Death|0|||
49140460|NCT00120874|158351606|FG001|Overall Study|Death|1|||
49140461|NCT00441896|158351609|FG000|Overall Study|Withdrawal by Subject|0|||
49140462|NCT00441896|158351610|FG001|Overall Study|Withdrawal by Subject|0|||
49140463|NCT00441896|158351611|FG002|Overall Study|Withdrawal by Subject|0|||
49140464|NCT00441896|158351612|FG003|Overall Study|Withdrawal by Subject|1|||
49140465|NCT00441896|158351613|FG004|Overall Study|Withdrawal by Subject|0|||
49140466|NCT00441896|158351614|FG005|Overall Study|Withdrawal by Subject|0|||
49140467|NCT00441896|158351615|FG006|Overall Study|Withdrawal by Subject|0|||
49140468|NCT00441896|158351616|FG007|Overall Study|Withdrawal by Subject|0|||
49140469|NCT00441896|158351617|FG008|Overall Study|Withdrawal by Subject|0|||
49011545|NCT04896385|157878998|FG002|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|3|||
48822028|NCT01474512|157190494|FG011|Maintenance Period|Lost to Follow-up|0|||
48822029|NCT01474512|157190495|FG012|Maintenance Period|Lost to Follow-up|0|||
48822030|NCT01474512|157190496|FG013|Maintenance Period|Lost to Follow-up|0|||
48822031|NCT01474512|157190497|FG014|Maintenance Period|Lost to Follow-up|0|||
48822032|NCT01474512|157190498|FG015|Maintenance Period|Lost to Follow-up|0|||
48822033|NCT01474512|157190499|FG016|Maintenance Period|Lost to Follow-up|0|||
48822034|NCT01474512|157190500|FG017|Maintenance Period|Lost to Follow-up|0|||
48822035|NCT01474512|157190483|FG000|Maintenance Period|Death|0|||
48822036|NCT01474512|157190484|FG001|Maintenance Period|Death|0|||
48822037|NCT01474512|157190485|FG002|Maintenance Period|Death|0|||
48822038|NCT01474512|157190486|FG003|Maintenance Period|Death|0|||
48822039|NCT01474512|157190487|FG004|Maintenance Period|Death|0|||
48822040|NCT01474512|157190488|FG005|Maintenance Period|Death|2|||
48822041|NCT01474512|157190489|FG006|Maintenance Period|Death|0|||
48822042|NCT01474512|157190490|FG007|Maintenance Period|Death|0|||
48822043|NCT01474512|157190491|FG008|Maintenance Period|Death|0|||
49140470|NCT00441896|158351618|FG009|Overall Study|Withdrawal by Subject|0|||
49140471|NCT00441896|158351609|FG000|Overall Study|Other|0|||
49140472|NCT00441896|158351610|FG001|Overall Study|Other|0|||
49140473|NCT00441896|158351611|FG002|Overall Study|Other|0|||
49140474|NCT00441896|158351612|FG003|Overall Study|Other|0|||
49140475|NCT00441896|158351613|FG004|Overall Study|Other|1|||
49140476|NCT00441896|158351614|FG005|Overall Study|Other|0|||
49140477|NCT00441896|158351615|FG006|Overall Study|Other|0|||
48822044|NCT01474512|157190492|FG009|Maintenance Period|Death|0|||
48822045|NCT01474512|157190493|FG010|Maintenance Period|Death|0|||
49011546|NCT04896385|157878999|FG003|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|2|||
49140478|NCT00441896|158351616|FG007|Overall Study|Other|0|||
49140479|NCT00441896|158351617|FG008|Overall Study|Other|0|||
49140480|NCT00441896|158351618|FG009|Overall Study|Other|0|||
49140481|NCT01301092|158351619|FG000|Overall Study|Lost to Follow-up|0|||
49140482|NCT01301092|158351620|FG001|Overall Study|Lost to Follow-up|0|||
49140483|NCT01301092|158351621|FG002|Overall Study|Lost to Follow-up|1|||
49140484|NCT01363076|158353047|FG000|Overall Study|Withdrawal by Subject|0|||
49140485|NCT01363076|158353048|FG001|Overall Study|Withdrawal by Subject|1|||
49140486|NCT01373229|158353049|FG000|Overall Study|Death|3|||
49140487|NCT01373229|158353049|FG000|Overall Study|Physician Decision|3|||
49140488|NCT02724644|158353050|FG000|Overall Study|Adverse Event|7|||
49140489|NCT02724644|158353051|FG001|Overall Study|Adverse Event|1|||
49140490|NCT02724644|158353050|FG000|Overall Study|Lost to Follow-up|6|||
48728808|NCT00744471|156857191|FG001|Overall Study|Death|0|||
48728809|NCT00744471|156857192|FG002|Overall Study|Death|0|||
48728810|NCT00744471|156857193|FG003|Overall Study|Death|1|||
48728811|NCT00744471|156857190|FG000|Overall Study|Adverse Event|6|||
48728812|NCT00744471|156857191|FG001|Overall Study|Adverse Event|7|||
48728813|NCT00744471|156857192|FG002|Overall Study|Adverse Event|5|||
48728814|NCT00744471|156857193|FG003|Overall Study|Adverse Event|9|||
48728815|NCT00744471|156857190|FG000|Overall Study|Withdrawal by Subject|9|||
48728816|NCT00744471|156857191|FG001|Overall Study|Withdrawal by Subject|9|||
48728817|NCT00744471|156857192|FG002|Overall Study|Withdrawal by Subject|15|||
48728818|NCT00744471|156857193|FG003|Overall Study|Withdrawal by Subject|12|||
48728819|NCT00744471|156857190|FG000|Overall Study|Protocol Violation|1|||
48728820|NCT00744471|156857191|FG001|Overall Study|Protocol Violation|4|||
48728821|NCT00744471|156857192|FG002|Overall Study|Protocol Violation|1|||
48728822|NCT00744471|156857193|FG003|Overall Study|Protocol Violation|2|||
48728823|NCT00744471|156857190|FG000|Overall Study|Entered extension study|41|||
48728824|NCT00744471|156857191|FG001|Overall Study|Entered extension study|84|||
48728825|NCT00744471|156857192|FG002|Overall Study|Entered extension study|100|||
48728826|NCT00744471|156857193|FG003|Overall Study|Entered extension study|91|||
48728827|NCT00744471|156857190|FG000|Overall Study|Other|2|||
48728828|NCT00744471|156857191|FG001|Overall Study|Other|3|||
48728829|NCT00744471|156857192|FG002|Overall Study|Other|6|||
48728830|NCT00744471|156857193|FG003|Overall Study|Other|2|||
48728831|NCT00744471|156857190|FG000|Overall Study|Lack of Efficacy|83|||
48728832|NCT00744471|156857191|FG001|Overall Study|Lack of Efficacy|37|||
48728833|NCT00744471|156857192|FG002|Overall Study|Lack of Efficacy|19|||
48728834|NCT00744471|156857193|FG003|Overall Study|Lack of Efficacy|31|||
48728835|NCT00744471|156857190|FG000|Overall Study|Lost to Follow-up|0|||
48728836|NCT00744471|156857191|FG001|Overall Study|Lost to Follow-up|0|||
48728837|NCT00744471|156857192|FG002|Overall Study|Lost to Follow-up|2|||
48728838|NCT00744471|156857193|FG003|Overall Study|Lost to Follow-up|0|||
48728839|NCT01280955|156857196|FG000|Overall Study|Death|2|||
48728840|NCT01280955|156857196|FG000|Overall Study|Withdrawal by Subject|1|||
48728841|NCT01539317|156857197|FG000|Overall Study|Screening Error. Deleted from analysis.|1|||
48728842|NCT01539317|156857198|FG001|Overall Study|Screening Error. Deleted from analysis.|0|||
48728843|NCT02730208|156857199|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
48728844|NCT02730208|156857200|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
48728845|NCT00364130|156857201|FG000|Intervention Period|Lost to Follow-up|4|||
48728846|NCT00364130|156857202|FG001|Intervention Period|Lost to Follow-up|3|||
48728847|NCT00364130|156857201|FG000|Intervention Period|Pregnancy|1|||
48728848|NCT00364130|156857202|FG001|Intervention Period|Pregnancy|0|||
48728849|NCT00364130|156857201|FG000|Intervention Period|Withdrawal by Subject|4|||
48728850|NCT00364130|156857202|FG001|Intervention Period|Withdrawal by Subject|5|||
48728851|NCT00364130|156857201|FG000|Post Intervention Follow-up Period|Lost to Follow-up|5|||
48728852|NCT00364130|156857202|FG001|Post Intervention Follow-up Period|Lost to Follow-up|11|||
48728853|NCT01638819|156857211|FG000|Overall Study|Lost to Follow-up|1|||
48728854|NCT01638819|156857212|FG001|Overall Study|Lost to Follow-up|0|||
48728855|NCT01336569|156857213|FG000|Overall Study|Lost to Follow-up|4|||
48728856|NCT04263454|156857214|FG000|Overall Study|Adverse Event|0|||
48728857|NCT04263454|156857215|FG001|Overall Study|Adverse Event|2|||
48728858|NCT04263454|156857214|FG000|Overall Study|Physician Decision|3|||
48728859|NCT04263454|156857215|FG001|Overall Study|Physician Decision|5|||
48728860|NCT04263454|156857214|FG000|Overall Study|Poor Data Quality|0|||
48728861|NCT04263454|156857215|FG001|Overall Study|Poor Data Quality|1|||
48822046|NCT01474512|157190494|FG011|Maintenance Period|Death|0|||
48822047|NCT01474512|157190495|FG012|Maintenance Period|Death|0|||
48728862|NCT02898116|156857217|FG000|Overall Study|Adverse Event|1|||
48728863|NCT02898116|156857217|FG000|Overall Study|Progressive disease|1|||
48728864|NCT04059185|156857219|FG000|Longitudinal Assessment-Adults Only|Lost to Follow-up|187|||
48728865|NCT04059185|156857220|FG001|Longitudinal Assessment-Adults Only|Lost to Follow-up|195|||
48728866|NCT04059185|156857221|FG002|Longitudinal Assessment-Adults Only|Lost to Follow-up|177|||
48728867|NCT04059185|156857219|FG000|Longitudinal Assessment-Adults Only|Protocol Violation|11|||
48728868|NCT04059185|156857220|FG001|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
48728869|NCT04059185|156857221|FG002|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
49140491|NCT02724644|158353051|FG001|Overall Study|Lost to Follow-up|2|||
48822048|NCT01474512|157190496|FG013|Maintenance Period|Death|0|||
49140492|NCT02724644|158353050|FG000|Overall Study|Withdrawal by Subject|7|||
48728870|NCT04059185|156857219|FG000|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
48728871|NCT04059185|156857220|FG001|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
48728872|NCT04059185|156857221|FG002|Longitudinal Assessment-Adults Only|Withdrawal by Subject|1|||
48728873|NCT04059185|156857219|FG000|Longitudinal Assessment-Adults Only|Baseline survey incomplete|4|||
48728874|NCT04059185|156857220|FG001|Longitudinal Assessment-Adults Only|Baseline survey incomplete|8|||
48728875|NCT04059185|156857221|FG002|Longitudinal Assessment-Adults Only|Baseline survey incomplete|3|||
48728876|NCT04059185|156857219|FG000|Longitudinal Assessment-Adults Only|Death|4|||
48728877|NCT04059185|156857220|FG001|Longitudinal Assessment-Adults Only|Death|4|||
48728878|NCT04059185|156857221|FG002|Longitudinal Assessment-Adults Only|Death|3|||
48728879|NCT03805646|156857222|FG000|Overall Study|Death|40|||
48728880|NCT03805646|156857223|FG001|Overall Study|Death|49|||
48728881|NCT03805646|156857222|FG000|Overall Study|Not reached on phone/ Did not consent|614|||
48728882|NCT03805646|156857223|FG001|Overall Study|Not reached on phone/ Did not consent|936|||
49140493|NCT02724644|158353051|FG001|Overall Study|Withdrawal by Subject|1|||
49140494|NCT02724644|158353050|FG000|Overall Study|Administrative|1|||
49140495|NCT02724644|158353051|FG001|Overall Study|Administrative|0|||
49140496|NCT01500096|158353052|FG000|Overall Study|Lost to Follow-up|1|||
49140497|NCT01500096|158353053|FG001|Overall Study|Lost to Follow-up|0|||
49140498|NCT01500096|158353054|FG002|Overall Study|Lost to Follow-up|0|||
49140499|NCT01500096|158353055|FG003|Overall Study|Lost to Follow-up|2|||
49140500|NCT00382070|158353058|FG000|Overall Study|No follow up data mapped to Other|17|||
48728883|NCT04544956|156857224|FG000|Overall Study|Withdrawal by Subject|1|||
48728884|NCT01554397|156857226|FG000|Overall Study|Withdrawal by Subject|1|||
48728885|NCT01554397|156857227|FG001|Overall Study|Withdrawal by Subject|0|||
48728886|NCT01554397|156857226|FG000|Overall Study|Ineligible|7|||
48728887|NCT01554397|156857227|FG001|Overall Study|Ineligible|0|||
48728888|NCT02233946|156858243|FG000|Baseline|Withdrawal by Subject|2|||
48728889|NCT02233946|156858244|FG001|Baseline|Withdrawal by Subject|0|||
48728890|NCT02233946|156858243|FG000|3-months Follow-up|Lost to Follow-up|53|||
48728891|NCT02233946|156858244|FG001|3-months Follow-up|Lost to Follow-up|29|||
48728892|NCT02233946|156858243|FG000|6-months Follow-up|Lost to Follow-up|21|||
48728893|NCT02233946|156858244|FG001|6-months Follow-up|Lost to Follow-up|2|||
48728894|NCT02233946|156858243|FG000|9-month Follow-up|Lost to Follow-up|20|||
48728895|NCT02233946|156858244|FG001|9-month Follow-up|Lost to Follow-up|11|||
49140501|NCT00382070|158353059|FG001|Overall Study|No follow up data mapped to Other|19|||
49140502|NCT00382070|158353058|FG000|Overall Study|Patient not at risk for primary endpoint mapped to Other|7|||
49140503|NCT00382070|158353059|FG001|Overall Study|Patient not at risk for primary endpoint mapped to Other|0|||
49140504|NCT00382070|158353058|FG000|Overall Study|No clinical assessment|9|||
49140505|NCT00382070|158353059|FG001|Overall Study|No clinical assessment|11|||
49140506|NCT03033901|158353060|FG000|Overall Study|Ineligible for Polysomnography (PSG)|59|||
49140507|NCT03033901|158353060|FG000|Overall Study|Refused PSG|23|||
49140508|NCT03033901|158353060|FG000|Overall Study|Total Sleep Time < 2 hours|12|||
48728896|NCT02233946|156858243|FG000|12-month Follow-up|Lost to Follow-up|28|||
48822049|NCT01474512|157190497|FG014|Maintenance Period|Death|0|||
48822050|NCT01474512|157190498|FG015|Maintenance Period|Death|0|||
48822051|NCT01474512|157190499|FG016|Maintenance Period|Death|0|||
48822052|NCT01474512|157190500|FG017|Maintenance Period|Death|0|||
48822053|NCT01474512|157190483|FG000|Maintenance Period|Physician Decision|0|||
48822054|NCT01474512|157190484|FG001|Maintenance Period|Physician Decision|0|||
48822055|NCT01474512|157190485|FG002|Maintenance Period|Physician Decision|0|||
48822056|NCT01474512|157190486|FG003|Maintenance Period|Physician Decision|0|||
48822057|NCT01474512|157190487|FG004|Maintenance Period|Physician Decision|0|||
48822058|NCT01474512|157190488|FG005|Maintenance Period|Physician Decision|1|||
48822059|NCT01474512|157190489|FG006|Maintenance Period|Physician Decision|0|||
48822060|NCT01474512|157190490|FG007|Maintenance Period|Physician Decision|2|||
48822061|NCT01474512|157190491|FG008|Maintenance Period|Physician Decision|0|||
48822062|NCT01474512|157190492|FG009|Maintenance Period|Physician Decision|0|||
48822063|NCT01474512|157190493|FG010|Maintenance Period|Physician Decision|0|||
48822064|NCT01474512|157190494|FG011|Maintenance Period|Physician Decision|0|||
48822065|NCT01474512|157190495|FG012|Maintenance Period|Physician Decision|0|||
48822066|NCT01474512|157190496|FG013|Maintenance Period|Physician Decision|0|||
48822067|NCT01474512|157190497|FG014|Maintenance Period|Physician Decision|0|||
48822068|NCT01474512|157190498|FG015|Maintenance Period|Physician Decision|0|||
49140509|NCT03033901|158353060|FG000|Overall Study|Missing Oximetry Data|3|||
49140510|NCT01567085|158353061|FG000|Overall Study|Death|6|||
49140511|NCT01567085|158353061|FG000|Overall Study|Adverse Event|6|||
49140512|NCT01567085|158353061|FG000|Overall Study|Lost to Follow-up|3|||
49140513|NCT01567085|158353061|FG000|Overall Study|Graft loss|2|||
48728897|NCT02233946|156858244|FG001|12-month Follow-up|Lost to Follow-up|11|||
48728898|NCT00625742|156858246|FG000|Overall Study|Disease Progression|2|||
48822069|NCT01474512|157190499|FG016|Maintenance Period|Physician Decision|0|||
49140514|NCT01567085|158353061|FG000|Overall Study|Renal transplantectomy|1|||
49140515|NCT01567085|158353061|FG000|Overall Study|Returned to chronic dialysis|1|||
48822070|NCT01474512|157190500|FG017|Maintenance Period|Physician Decision|0|||
48822071|NCT01474512|157190483|FG000|Maintenance Period|Clinical Relapse|0|||
48728899|NCT00625742|156858246|FG000|Overall Study|Withdrawal by Subject|1|||
48728900|NCT00625742|156858246|FG000|Overall Study|Adverse Event|4|||
48728901|NCT00625742|156858246|FG000|Overall Study|Lost to Follow-up|4|||
48728902|NCT00625742|156858246|FG000|Overall Study|Ineligible|1|||
48728903|NCT04099251|156858247|FG000|Pre-Treatment|Other reasons|1|||
48728904|NCT04099251|156858248|FG001|Pre-Treatment|Other reasons|0|||
48728905|NCT04099251|156858247|FG000|Pre-Treatment|Participant no longer meets study criteria|1|||
48728906|NCT04099251|156858248|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
48728907|NCT04099251|156858247|FG000|Blinded Treatment Phase|Other reasons|16|||
48728908|NCT04099251|156858248|FG001|Blinded Treatment Phase|Other reasons|7|||
48728909|NCT04099251|156858247|FG000|Blinded Treatment Phase|Disease recurrence|26|||
48728910|NCT04099251|156858248|FG001|Blinded Treatment Phase|Disease recurrence|41|||
48728911|NCT04099251|156858247|FG000|Blinded Treatment Phase|Adverse event unrelated to study drug|11|||
48728912|NCT04099251|156858248|FG001|Blinded Treatment Phase|Adverse event unrelated to study drug|1|||
48728913|NCT04099251|156858247|FG000|Blinded Treatment Phase|Study drug toxicity|94|||
48728914|NCT04099251|156858248|FG001|Blinded Treatment Phase|Study drug toxicity|7|||
48728915|NCT04099251|156858247|FG000|Blinded Treatment Phase|Participant no longer meets study criteria|1|||
48728916|NCT04099251|156858248|FG001|Blinded Treatment Phase|Participant no longer meets study criteria|0|||
48728917|NCT04099251|156858247|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
48728918|NCT04099251|156858248|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
48728919|NCT04099251|156858247|FG000|Blinded Treatment Phase|Death|6|||
48728920|NCT04099251|156858248|FG001|Blinded Treatment Phase|Death|2|||
48728921|NCT04099251|156858247|FG000|Blinded Treatment Phase|Withdrawal by Subject|18|||
48728922|NCT04099251|156858248|FG001|Blinded Treatment Phase|Withdrawal by Subject|7|||
48728923|NCT04099251|156858247|FG000|Blinded Treatment Phase|Participant request to discontinue study treatment|29|||
48728924|NCT04099251|156858248|FG001|Blinded Treatment Phase|Participant request to discontinue study treatment|0|||
48728925|NCT04099251|156858247|FG000|Blinded Treatment Phase|Ongoing treatment|64|||
48728926|NCT04099251|156858248|FG001|Blinded Treatment Phase|Ongoing treatment|39|||
48728927|NCT04099251|156858247|FG000|Blinded Treatment Phase|Maximum clinical benefit|1|||
48728928|NCT04099251|156858248|FG001|Blinded Treatment Phase|Maximum clinical benefit|2|||
48728929|NCT04099251|156858247|FG000|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|0|||
48728930|NCT04099251|156858248|FG001|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|2|||
48728931|NCT04099251|156858247|FG000|Optional Open-Label Phase Treatment|Disease progression/recurrence|0|||
48728932|NCT04099251|156858248|FG001|Optional Open-Label Phase Treatment|Disease progression/recurrence|5|||
48728933|NCT04099251|156858247|FG000|Optional Open-Label Phase Treatment|Decision by Principal Investigator|0|||
48728934|NCT04099251|156858248|FG001|Optional Open-Label Phase Treatment|Decision by Principal Investigator|1|||
48728935|NCT04099251|156858247|FG000|Optional Open-Label Phase Treatment|Study drug toxicity|0|||
48728936|NCT04099251|156858248|FG001|Optional Open-Label Phase Treatment|Study drug toxicity|2|||
48728937|NCT04099251|156858247|FG000|Optional Open-Label Phase Treatment|Ongoing treatment|2|||
48728938|NCT04099251|156858248|FG001|Optional Open-Label Phase Treatment|Ongoing treatment|17|||
48728939|NCT03052764|156858252|FG000|Double-Blind Treatment Period|Adverse Event|2|||
48728940|NCT03052764|156858253|FG001|Double-Blind Treatment Period|Adverse Event|0|||
48728941|NCT03052764|156858252|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
48728942|NCT03052764|156858253|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
48728943|NCT03052764|156858252|FG000|Double-Blind Treatment Period|Protocol Violation|2|||
48728944|NCT03052764|156858253|FG001|Double-Blind Treatment Period|Protocol Violation|1|||
48728945|NCT03052764|156858252|FG000|Double-Blind Treatment Period|Withdrawal by Subject|3|||
48728946|NCT03052764|156858253|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
48728947|NCT03052764|156858252|FG000|Double-Blind Treatment Period|Reason not Specified|2|||
48728948|NCT03052764|156858253|FG001|Double-Blind Treatment Period|Reason not Specified|1|||
48728949|NCT04850313|156858255|FG000|Overall Study|Withdrawal by Subject|0|||
48728950|NCT04850313|156858256|FG001|Overall Study|Withdrawal by Subject|1|||
48728951|NCT02316548|156858257|FG000|Overall Study|Protocol Violation|0|||
48728952|NCT02316548|156858258|FG001|Overall Study|Protocol Violation|1|||
48728953|NCT04123665|156858259|FG000|Overall Study|Withdrawal by Subject|7|||
48728954|NCT04123665|156858260|FG001|Overall Study|Withdrawal by Subject|0|||
48728955|NCT04123665|156858259|FG000|Overall Study|Lost to Follow-up|1|||
48728956|NCT04123665|156858260|FG001|Overall Study|Lost to Follow-up|0|||
48728957|NCT01483690|156858261|FG000|Overall Study|Adverse Event|1|||
48728958|NCT01483690|156858262|FG001|Overall Study|Adverse Event|2|||
48728959|NCT01483690|156858261|FG000|Overall Study|clinical deterioration|1|||
48822072|NCT01474512|157190484|FG001|Maintenance Period|Clinical Relapse|0|||
49011547|NCT04896385|157878996|FG000|28-Week Treatment-Extension Period|Pregnancy|0|||
48728960|NCT01483690|156858262|FG001|Overall Study|clinical deterioration|0|||
48728961|NCT01483690|156858261|FG000|Overall Study|Physician Decision|0|||
48728962|NCT01483690|156858262|FG001|Overall Study|Physician Decision|2|||
48728963|NCT01483690|156858261|FG000|Overall Study|exclusionary procedure|0|||
48728964|NCT01483690|156858262|FG001|Overall Study|exclusionary procedure|1|||
48728965|NCT03422627|156858268|FG000|Overall Study|Protocol-specified Criteria|1|||
48728966|NCT03422627|156858269|FG001|Overall Study|Protocol-specified Criteria|1|||
48728967|NCT03422627|156858270|FG002|Overall Study|Protocol-specified Criteria|0|||
48728968|NCT03422627|156858271|FG003|Overall Study|Protocol-specified Criteria|0|||
48728969|NCT03422627|156858272|FG004|Overall Study|Protocol-specified Criteria|2|||
48728970|NCT03422627|156858268|FG000|Overall Study|Requirement for Alternative Therapy|1|||
48728971|NCT03422627|156858269|FG001|Overall Study|Requirement for Alternative Therapy|1|||
48728972|NCT03422627|156858270|FG002|Overall Study|Requirement for Alternative Therapy|2|||
48728973|NCT03422627|156858271|FG003|Overall Study|Requirement for Alternative Therapy|0|||
48728974|NCT03422627|156858272|FG004|Overall Study|Requirement for Alternative Therapy|0|||
48728975|NCT03422627|156858268|FG000|Overall Study|Disease Progression|1|||
48728976|NCT03422627|156858269|FG001|Overall Study|Disease Progression|0|||
48728977|NCT03422627|156858270|FG002|Overall Study|Disease Progression|1|||
48728978|NCT03422627|156858271|FG003|Overall Study|Disease Progression|2|||
48728979|NCT03422627|156858272|FG004|Overall Study|Disease Progression|0|||
48728980|NCT03422627|156858268|FG000|Overall Study|Adverse Event|2|||
48728981|NCT03422627|156858269|FG001|Overall Study|Adverse Event|1|||
48728982|NCT03422627|156858270|FG002|Overall Study|Adverse Event|0|||
48728983|NCT03422627|156858271|FG003|Overall Study|Adverse Event|0|||
48728984|NCT03422627|156858272|FG004|Overall Study|Adverse Event|2|||
48728985|NCT03422627|156858268|FG000|Overall Study|Ineligibility Determined|0|||
48728986|NCT03422627|156858269|FG001|Overall Study|Ineligibility Determined|1|||
48728987|NCT03422627|156858270|FG002|Overall Study|Ineligibility Determined|0|||
48728988|NCT03422627|156858271|FG003|Overall Study|Ineligibility Determined|0|||
48728989|NCT03422627|156858272|FG004|Overall Study|Ineligibility Determined|0|||
48728990|NCT03422627|156858268|FG000|Overall Study|Death|0|||
48728991|NCT03422627|156858269|FG001|Overall Study|Death|1|||
48728992|NCT03422627|156858270|FG002|Overall Study|Death|1|||
48728993|NCT03422627|156858271|FG003|Overall Study|Death|0|||
48728994|NCT03422627|156858272|FG004|Overall Study|Death|0|||
48728995|NCT03422627|156858268|FG000|Overall Study|Withdrawal by Subject|0|||
48728996|NCT03422627|156858269|FG001|Overall Study|Withdrawal by Subject|0|||
48728997|NCT03422627|156858270|FG002|Overall Study|Withdrawal by Subject|0|||
48728998|NCT03422627|156858271|FG003|Overall Study|Withdrawal by Subject|1|||
48728999|NCT03422627|156858272|FG004|Overall Study|Withdrawal by Subject|0|||
48729000|NCT03707184|156858273|FG000|Overall Study|Withdrawal by Subject|2|||
48729001|NCT04982588|156858274|FG000|Overall Study|Withdrawal by Subject|2|||
48729002|NCT02923427|156858275|FG000|Overall Study|convert to laparatomy|2|||
48729003|NCT02923427|156858276|FG001|Overall Study|convert to laparatomy|2|||
48729004|NCT02923427|156858275|FG000|Overall Study|destaturation|1|||
48729005|NCT02923427|156858276|FG001|Overall Study|destaturation|0|||
48729006|NCT02923427|156858275|FG000|Overall Study|can not replace LMA|1|||
48729007|NCT02923427|156858276|FG001|Overall Study|can not replace LMA|0|||
48729008|NCT01229397|156858277|FG000|Overall Study|Withdrawal by Subject|3|||
48729009|NCT01229397|156858278|FG001|Overall Study|Withdrawal by Subject|3|||
48729010|NCT01229397|156858277|FG000|Overall Study|Lost to Follow-up|7|||
48729011|NCT01229397|156858278|FG001|Overall Study|Lost to Follow-up|6|||
48729012|NCT01229397|156858277|FG000|Overall Study|Migrated/moved from study area|1|||
48729013|NCT01229397|156858278|FG001|Overall Study|Migrated/moved from study area|0|||
48729014|NCT03026088|156858279|FG000|Overall Study|Study termination|20|||
48729015|NCT04163718|156858283|FG000|Overall Study|Study terminated|12|||
48729016|NCT01606254|156858284|FG000|Overall Study|Withdrawal by Subject|1|||
48729017|NCT01606254|156858285|FG001|Overall Study|Withdrawal by Subject|3|||
48729018|NCT01606254|156858286|FG002|Overall Study|Withdrawal by Subject|0|||
48729019|NCT01606254|156858287|FG003|Overall Study|Withdrawal by Subject|2|||
48729020|NCT01606254|156858284|FG000|Overall Study|Adverse Event|1|||
48729021|NCT01606254|156858285|FG001|Overall Study|Adverse Event|1|||
48729022|NCT01606254|156858286|FG002|Overall Study|Adverse Event|0|||
48729023|NCT01606254|156858287|FG003|Overall Study|Adverse Event|1|||
48729024|NCT02131532|156858288|FG000|Overall Study|Withdrawal by Subject|1|||
48729025|NCT02131532|156858288|FG000|Overall Study|Physician Decision|1|||
48729026|NCT02131532|156858288|FG000|Overall Study|Other health conditions|2|||
48729027|NCT02376829|156858291|FG000|Overall Study|Withdrawal by Subject|27|||
48729028|NCT02376829|156858292|FG001|Overall Study|Withdrawal by Subject|44|||
49140516|NCT01567085|158353061|FG000|Overall Study|Terminal chronic kidney dysfunction|1|||
49140517|NCT03298061|158353066|FG000|Overall Study|Adverse Event|3|||
49140518|NCT03298061|158353066|FG000|Overall Study|Lack of Efficacy|6|||
49140519|NCT03298061|158353066|FG000|Overall Study|Protocol Violation|1|||
49140520|NCT03298061|158353066|FG000|Overall Study|Physician Decision|7|||
48729029|NCT05153473|156858293|FG000|Overall Study|Death|46|||
49140521|NCT03298061|158353066|FG000|Overall Study|Withdrawal by Subject|10|||
49140522|NCT02827708|158353069|FG000|Overall Study|Lost to Follow-up|3|||
48729030|NCT05153473|156858293|FG000|Overall Study|Lost to Follow-up|3|||
48729031|NCT02788474|156858294|FG000|Double Blind Treatment Period|Not treated|1|||
48729032|NCT02788474|156858295|FG001|Double Blind Treatment Period|Not treated|0|||
48729033|NCT02788474|156858294|FG000|Double Blind Treatment Period|Patient's refusal|3|||
48729034|NCT02788474|156858295|FG001|Double Blind Treatment Period|Patient's refusal|0|||
48729035|NCT02788474|156858294|FG000|Double Blind Treatment Period|Adverse Event|6|||
48729036|NCT02788474|156858295|FG001|Double Blind Treatment Period|Adverse Event|4|||
49011548|NCT04896385|157878997|FG001|28-Week Treatment-Extension Period|Pregnancy|0|||
49011549|NCT04896385|157878998|FG002|28-Week Treatment-Extension Period|Pregnancy|1|||
49011550|NCT04896385|157878999|FG003|28-Week Treatment-Extension Period|Pregnancy|0|||
49011551|NCT01306253|157879000|FG000|Overall Study|Lost to Follow-up|1|||
49011552|NCT01306253|157879001|FG001|Overall Study|Lost to Follow-up|1|||
49011553|NCT01086215|157879002|FG000|Overall Study|Death|14|||
49011554|NCT01086215|157879003|FG001|Overall Study|Death|8|||
49011555|NCT01086215|157879004|FG002|Overall Study|Death|8|||
49011556|NCT01086215|157879005|FG003|Overall Study|Death|1|||
49011557|NCT01086215|157879002|FG000|Overall Study|Lost to Follow-up|22|||
48921388|NCT00925015|157546360|FG002|Overall Study|Withdrawal by Subject|1|||
48921389|NCT04962022|157546361|FG000|Period 1|Withdrawal by Subject|1|||
49011558|NCT01086215|157879003|FG001|Overall Study|Lost to Follow-up|39|||
49011559|NCT01086215|157879004|FG002|Overall Study|Lost to Follow-up|18|||
49011560|NCT01086215|157879005|FG003|Overall Study|Lost to Follow-up|2|||
49011561|NCT02472977|157879006|FG000|Overall Study|Disease progression|4|||
49011562|NCT02472977|157879007|FG001|Overall Study|Disease progression|25|||
49011563|NCT02472977|157879008|FG002|Overall Study|Disease progression|6|||
49011564|NCT02472977|157879006|FG000|Overall Study|Withdrawal by Subject|0|||
49011565|NCT02472977|157879007|FG001|Overall Study|Withdrawal by Subject|1|||
49011566|NCT02472977|157879008|FG002|Overall Study|Withdrawal by Subject|0|||
49011567|NCT02472977|157879006|FG000|Overall Study|Study drug toxicity|2|||
49011568|NCT02472977|157879007|FG001|Overall Study|Study drug toxicity|0|||
49011569|NCT02472977|157879008|FG002|Overall Study|Study drug toxicity|2|||
49011570|NCT02472977|157879006|FG000|Overall Study|Subject request to discontinue treatment|0|||
49011571|NCT02472977|157879007|FG001|Overall Study|Subject request to discontinue treatment|1|||
49011572|NCT02472977|157879008|FG002|Overall Study|Subject request to discontinue treatment|0|||
49011573|NCT01193517|157879009|FG000|Overall Study|Early Progression|1|||
49011574|NCT01193517|157879010|FG001|Overall Study|Early Progression|0|||
49011575|NCT01193517|157879011|FG002|Overall Study|Early Progression|0|||
49011576|NCT01199601|157879012|FG000|Overall Study|Lost to Follow-up|47|||
49011577|NCT01199601|157879013|FG001|Overall Study|Lost to Follow-up|66|||
49011578|NCT01199601|157879012|FG000|Overall Study|Withdrawal by Subject|15|||
49011579|NCT01199601|157879013|FG001|Overall Study|Withdrawal by Subject|3|||
49011580|NCT01199601|157879012|FG000|Overall Study|Insecurity prevented staff interviewing.|7|||
49011581|NCT01199601|157879013|FG001|Overall Study|Insecurity prevented staff interviewing.|9|||
49011582|NCT00146770|157879014|FG000|Overall Study|Adverse Event|2|||
49011583|NCT00146770|157879015|FG001|Overall Study|Adverse Event|0|||
49011584|NCT00146770|157879014|FG000|Overall Study|Pregnancy|1|||
49011585|NCT00146770|157879015|FG001|Overall Study|Pregnancy|0|||
49011586|NCT00146770|157879014|FG000|Overall Study|Withdrawal by Subject|2|||
49011587|NCT00146770|157879015|FG001|Overall Study|Withdrawal by Subject|0|||
49011588|NCT00299728|157879022|FG000|Overall Study|Lost to Follow-up|0|||
49011589|NCT00299728|157879023|FG001|Overall Study|Lost to Follow-up|1|||
49011590|NCT00299728|157879022|FG000|Overall Study|Withdrawal by Subject|0|||
49011591|NCT00299728|157879023|FG001|Overall Study|Withdrawal by Subject|1|||
49011592|NCT00299728|157879022|FG000|Overall Study|Progressive disease|0|||
49011593|NCT00299728|157879023|FG001|Overall Study|Progressive disease|1|||
49011594|NCT02826603|157879024|FG000|Overall Study|Adverse Event|17|||
49011595|NCT02826603|157879025|FG001|Overall Study|Adverse Event|9|||
49011596|NCT02826603|157879024|FG000|Overall Study|Lack of Efficacy|4|||
48729037|NCT02788474|156858294|FG000|Open Label Treatment Period|Adverse Event|29|||
48729038|NCT02788474|156858295|FG001|Open Label Treatment Period|Adverse Event|9|||
48921390|NCT04962022|157546362|FG001|Period 1|Withdrawal by Subject|0|||
48921391|NCT02590588|157546370|FG000|Overall Study|Adverse Event|1|||
48921392|NCT00732303|157546371|FG000|Overall Study|Study Terminated|2|||
48921393|NCT00763815|157546376|FG000|Overall Study|Adverse Event|14|||
48921394|NCT00763815|157546377|FG001|Overall Study|Adverse Event|29|||
48921395|NCT00763815|157546376|FG000|Overall Study|Lack of Efficacy|10|||
48921396|NCT00763815|157546377|FG001|Overall Study|Lack of Efficacy|11|||
48921397|NCT00763815|157546376|FG000|Overall Study|Poor Compliance to Protocol|6|||
48921398|NCT00763815|157546377|FG001|Overall Study|Poor Compliance to Protocol|6|||
48921399|NCT00763815|157546376|FG000|Overall Study|Lost to Follow-up|2|||
49011597|NCT02826603|157879025|FG001|Overall Study|Lack of Efficacy|9|||
49011598|NCT02826603|157879024|FG000|Overall Study|Lost to Follow-up|13|||
49011599|NCT02826603|157879025|FG001|Overall Study|Lost to Follow-up|12|||
49011600|NCT02826603|157879024|FG000|Overall Study|Noncompliance with treatment|0|||
49011601|NCT02826603|157879025|FG001|Overall Study|Noncompliance with treatment|2|||
49011602|NCT02826603|157879024|FG000|Overall Study|Physician Decision|1|||
49011603|NCT02826603|157879025|FG001|Overall Study|Physician Decision|7|||
49011604|NCT02826603|157879024|FG000|Overall Study|Pregnancy|1|||
48921400|NCT00763815|157546377|FG001|Overall Study|Lost to Follow-up|4|||
48921401|NCT00763815|157546376|FG000|Overall Study|Early Termination|1|||
48921402|NCT00763815|157546377|FG001|Overall Study|Early Termination|0|||
48921403|NCT00763815|157546376|FG000|Overall Study|Familial and Personal Reasons|9|||
49011605|NCT02826603|157879025|FG001|Overall Study|Pregnancy|2|||
49011606|NCT02826603|157879024|FG000|Overall Study|Protocol Violation|3|||
49011607|NCT02826603|157879025|FG001|Overall Study|Protocol Violation|3|||
49140523|NCT02827708|158353070|FG001|Overall Study|Lost to Follow-up|1|||
49140524|NCT02827708|158353069|FG000|Overall Study|Withdrawal by Subject|1|||
49140525|NCT02827708|158353070|FG001|Overall Study|Withdrawal by Subject|2|||
49140526|NCT02827708|158353069|FG000|Overall Study|Death|1|||
49140527|NCT02827708|158353070|FG001|Overall Study|Death|2|||
49140528|NCT02082483|158353073|FG000|Overall Study|Lost to Follow-up|1|||
49140529|NCT02082483|158353074|FG001|Overall Study|Lost to Follow-up|1|||
49140530|NCT02082483|158353073|FG000|Overall Study|Withdrawal by Subject|2|||
49140531|NCT02082483|158353074|FG001|Overall Study|Withdrawal by Subject|1|||
49140532|NCT02082483|158353073|FG000|Overall Study|Physician Decision|1|||
49140533|NCT02082483|158353074|FG001|Overall Study|Physician Decision|1|||
49140534|NCT02082483|158353073|FG000|Overall Study|Death|2|||
49140535|NCT02082483|158353074|FG001|Overall Study|Death|3|||
49140536|NCT03055195|158353076|FG000|Overall Study|Lack of Efficacy|1|||
49140537|NCT03055195|158353077|FG001|Overall Study|Lack of Efficacy|0|||
49140538|NCT03055195|158353076|FG000|Overall Study|Withdrawal by Subject|6|||
49140539|NCT03055195|158353077|FG001|Overall Study|Withdrawal by Subject|7|||
49140540|NCT03055195|158353076|FG000|Overall Study|Study Terminated by Sponsor|2|||
49140541|NCT03055195|158353077|FG001|Overall Study|Study Terminated by Sponsor|6|||
49140542|NCT03055195|158353076|FG000|Overall Study|Protocol Violation|2|||
49140543|NCT03055195|158353077|FG001|Overall Study|Protocol Violation|1|||
49140544|NCT03055195|158353076|FG000|Overall Study|Physician Decision|1|||
49140545|NCT03055195|158353077|FG001|Overall Study|Physician Decision|0|||
49140546|NCT00875667|158353085|FG000|Overall Study|Adverse Event|29|||
49140547|NCT00875667|158353086|FG001|Overall Study|Adverse Event|10|||
49140548|NCT00875667|158353085|FG000|Overall Study|Withdrawal by Subject|17|||
49140549|NCT00875667|158353086|FG001|Overall Study|Withdrawal by Subject|5|||
49140550|NCT00875667|158353085|FG000|Overall Study|Death|7|||
49140551|NCT00875667|158353086|FG001|Overall Study|Death|2|||
49140552|NCT00875667|158353085|FG000|Overall Study|Protocol Violation|2|||
49140553|NCT00875667|158353086|FG001|Overall Study|Protocol Violation|0|||
49140554|NCT00875667|158353085|FG000|Overall Study|Disease Progression|100|||
49140555|NCT00875667|158353086|FG001|Overall Study|Disease Progression|49|||
49140556|NCT00875667|158353085|FG000|Overall Study|Miscellaneous|12|||
49140557|NCT00875667|158353086|FG001|Overall Study|Miscellaneous|6|||
49140558|NCT00875667|158353085|FG000|Overall Study|Randomized but no Study Drug Given|3|||
49140559|NCT00875667|158353086|FG001|Overall Study|Randomized but no Study Drug Given|1|||
49140560|NCT00549328|158353089|FG000|Overall Study|Adverse Event|2|||
49140561|NCT00549328|158353089|FG000|Overall Study|Disease Progression|10|||
49140562|NCT00549328|158353089|FG000|Overall Study|Death|1|||
49140563|NCT00549328|158353089|FG000|Overall Study|Use of Prohibited Medication|1|||
49140564|NCT00770484|158353090|FG000|Overall Study|Withdrawal by Subject|1|||
49140565|NCT00770484|158353091|FG001|Overall Study|Withdrawal by Subject|0|||
49140566|NCT00894647|158353092|FG000|Overall Study|Adverse Event|5|||
49140567|NCT00894647|158353093|FG001|Overall Study|Adverse Event|4|||
49140568|NCT00894647|158353092|FG000|Overall Study|Withdrawal by Subject|4|||
49140569|NCT00894647|158353093|FG001|Overall Study|Withdrawal by Subject|4|||
49140570|NCT00894647|158353092|FG000|Overall Study|Lost to Follow-up|0|||
49140571|NCT00894647|158353093|FG001|Overall Study|Lost to Follow-up|2|||
49140572|NCT00894647|158353092|FG000|Overall Study|Non-compliance with study procedures|0|||
49140573|NCT00894647|158353093|FG001|Overall Study|Non-compliance with study procedures|2|||
49140574|NCT00894647|158353092|FG000|Overall Study|Other, not due to AE|1|||
49140575|NCT00894647|158353093|FG001|Overall Study|Other, not due to AE|2|||
49140576|NCT01967277|158353094|FG000|Overall Study|Lost to Follow-up|1|||
49140577|NCT01967277|158353095|FG001|Overall Study|Lost to Follow-up|2|||
49140578|NCT01967277|158353094|FG000|Overall Study|Unrelated illness|0|||
49140579|NCT01967277|158353095|FG001|Overall Study|Unrelated illness|1|||
49140580|NCT01281306|158353096|FG000|Overall Study|Lack of Efficacy|0|||
49140581|NCT01281306|158353097|FG001|Overall Study|Lack of Efficacy|1|||
49140582|NCT01281306|158353098|FG002|Overall Study|Lack of Efficacy|3|||
49140583|NCT01281306|158353099|FG003|Overall Study|Lack of Efficacy|0|||
49140584|NCT01281306|158353100|FG004|Overall Study|Lack of Efficacy|2|||
49140585|NCT01281306|158353101|FG005|Overall Study|Lack of Efficacy|0|||
49140586|NCT01281306|158353102|FG006|Overall Study|Lack of Efficacy|1|||
49140587|NCT01281306|158353096|FG000|Overall Study|Withdrawal by Subject|1|||
49140588|NCT01281306|158353097|FG001|Overall Study|Withdrawal by Subject|0|||
49140589|NCT01281306|158353098|FG002|Overall Study|Withdrawal by Subject|2|||
49140590|NCT01281306|158353099|FG003|Overall Study|Withdrawal by Subject|4|||
49140591|NCT01281306|158353100|FG004|Overall Study|Withdrawal by Subject|1|||
49140592|NCT01281306|158353101|FG005|Overall Study|Withdrawal by Subject|3|||
49140593|NCT01281306|158353102|FG006|Overall Study|Withdrawal by Subject|1|||
49140594|NCT01281306|158353096|FG000|Overall Study|Protocol deviation|0|||
49140595|NCT01281306|158353097|FG001|Overall Study|Protocol deviation|1|||
49140596|NCT01281306|158353098|FG002|Overall Study|Protocol deviation|1|||
49140597|NCT01281306|158353099|FG003|Overall Study|Protocol deviation|1|||
49140598|NCT01281306|158353100|FG004|Overall Study|Protocol deviation|1|||
49140599|NCT01281306|158353101|FG005|Overall Study|Protocol deviation|0|||
49140600|NCT01281306|158353102|FG006|Overall Study|Protocol deviation|0|||
49140601|NCT01281306|158353096|FG000|Overall Study|Condition no longer requires study drug|1|||
48822073|NCT01474512|157190485|FG002|Maintenance Period|Clinical Relapse|0|||
48822074|NCT01474512|157190486|FG003|Maintenance Period|Clinical Relapse|1|||
48822075|NCT01474512|157190487|FG004|Maintenance Period|Clinical Relapse|0|||
49140602|NCT01281306|158353097|FG001|Overall Study|Condition no longer requires study drug|0|||
49140603|NCT01281306|158353098|FG002|Overall Study|Condition no longer requires study drug|0|||
49140604|NCT01281306|158353099|FG003|Overall Study|Condition no longer requires study drug|0|||
49140605|NCT01281306|158353100|FG004|Overall Study|Condition no longer requires study drug|0|||
49140606|NCT01281306|158353101|FG005|Overall Study|Condition no longer requires study drug|1|||
49140607|NCT01281306|158353102|FG006|Overall Study|Condition no longer requires study drug|1|||
49140608|NCT01281306|158353096|FG000|Overall Study|Lost to Follow-up|1|||
49011608|NCT02826603|157879024|FG000|Overall Study|Withdrawal by Subject|20|||
49011609|NCT02826603|157879025|FG001|Overall Study|Withdrawal by Subject|19|||
49011610|NCT02826603|157879024|FG000|Overall Study|Death|2|||
49011611|NCT02826603|157879025|FG001|Overall Study|Death|0|||
49011612|NCT02826603|157879024|FG000|Overall Study|New therapy for study indication|0|||
49011613|NCT02826603|157879025|FG001|Overall Study|New therapy for study indication|1|||
49011614|NCT02139306|157879032|FG000|Overall Study|Withdrawal by Subject|4|||
49011615|NCT02139306|157879033|FG001|Overall Study|Withdrawal by Subject|6|||
49140609|NCT01281306|158353097|FG001|Overall Study|Lost to Follow-up|0|||
49140610|NCT01281306|158353098|FG002|Overall Study|Lost to Follow-up|0|||
49011616|NCT02139306|157879032|FG000|Overall Study|Adverse Event|3|||
49011617|NCT02139306|157879033|FG001|Overall Study|Adverse Event|4|||
49011618|NCT02139306|157879032|FG000|Overall Study|Physician Decision|0|||
49011619|NCT02139306|157879033|FG001|Overall Study|Physician Decision|1|||
49011620|NCT02139306|157879032|FG000|Overall Study|Other Unspecified|2|||
49011621|NCT02139306|157879033|FG001|Overall Study|Other Unspecified|3|||
49011622|NCT02139306|157879032|FG000|Overall Study|Protocol Violation|4|||
49011623|NCT02139306|157879033|FG001|Overall Study|Protocol Violation|0|||
49140611|NCT01281306|158353099|FG003|Overall Study|Lost to Follow-up|2|||
49011624|NCT01512979|157879034|FG000|Overall Study|Adverse Event|2|||
49011625|NCT01512979|157879035|FG001|Overall Study|Adverse Event|2|||
49011626|NCT01512979|157879034|FG000|Overall Study|Protocol Violation|1|||
49011627|NCT01512979|157879035|FG001|Overall Study|Protocol Violation|4|||
48822076|NCT01474512|157190488|FG005|Maintenance Period|Clinical Relapse|0|||
48822077|NCT01474512|157190489|FG006|Maintenance Period|Clinical Relapse|0|||
48822078|NCT01474512|157190490|FG007|Maintenance Period|Clinical Relapse|0|||
48822079|NCT01474512|157190491|FG008|Maintenance Period|Clinical Relapse|0|||
49140612|NCT01281306|158353100|FG004|Overall Study|Lost to Follow-up|0|||
49011628|NCT01512979|157879034|FG000|Overall Study|Lost to Follow-up|2|||
49011629|NCT01512979|157879035|FG001|Overall Study|Lost to Follow-up|5|||
49011630|NCT01512979|157879034|FG000|Overall Study|Withdrawal by Subject|1|||
49011631|NCT01512979|157879035|FG001|Overall Study|Withdrawal by Subject|2|||
49011632|NCT01512979|157879034|FG000|Overall Study|Reason other than stated above|13|||
49011633|NCT01512979|157879035|FG001|Overall Study|Reason other than stated above|9|||
49011634|NCT02789111|157879036|FG000|Overall Study|Withdrawal by Subject|1|||
49011635|NCT02789111|157879037|FG001|Overall Study|Withdrawal by Subject|4|||
49011636|NCT03111147|157879040|FG000|Overall Study|Lost to Follow-up|2|||
49011637|NCT03111147|157879041|FG001|Overall Study|Lost to Follow-up|5|||
49011638|NCT03111147|157879040|FG000|Overall Study|Withdrawal by Subject|4|||
49011639|NCT03111147|157879041|FG001|Overall Study|Withdrawal by Subject|3|||
49011640|NCT03111147|157879040|FG000|Overall Study|Protocol Violation|2|||
49011641|NCT03111147|157879041|FG001|Overall Study|Protocol Violation|1|||
49011642|NCT03111147|157879040|FG000|Overall Study|Death|1|||
49011643|NCT03111147|157879041|FG001|Overall Study|Death|1|||
49011644|NCT04409002|157879045|FG000|Overall Study|Disease progression prior to starting study treatment|3|||
48822080|NCT01474512|157190492|FG009|Maintenance Period|Clinical Relapse|0|||
48822081|NCT01474512|157190493|FG010|Maintenance Period|Clinical Relapse|0|||
49140613|NCT01281306|158353101|FG005|Overall Study|Lost to Follow-up|0|||
48822082|NCT01474512|157190494|FG011|Maintenance Period|Clinical Relapse|0|||
48822083|NCT01474512|157190495|FG012|Maintenance Period|Clinical Relapse|0|||
49011645|NCT03740100|157879047|FG000|Overall Study|Adverse Event|1|||
49140614|NCT01281306|158353102|FG006|Overall Study|Lost to Follow-up|1|||
49140615|NCT01281306|158353096|FG000|Overall Study|Death|1|||
49140616|NCT01281306|158353097|FG001|Overall Study|Death|0|||
49140617|NCT01281306|158353098|FG002|Overall Study|Death|0|||
49140618|NCT01281306|158353099|FG003|Overall Study|Death|0|||
49011646|NCT03740100|157879047|FG000|Overall Study|Death|1|||
49011647|NCT00319449|157879048|FG000|Overall Study|Subject did not wish to continue|1|||
49011648|NCT00319449|157879049|FG001|Overall Study|Subject did not wish to continue|0|||
49011649|NCT00319449|157879048|FG000|Overall Study|Noncompliance with the protocol|1|||
49011650|NCT00319449|157879049|FG001|Overall Study|Noncompliance with the protocol|0|||
49140619|NCT01281306|158353100|FG004|Overall Study|Death|0|||
49140620|NCT01281306|158353101|FG005|Overall Study|Death|0|||
49011651|NCT01025193|157879050|FG000|Overall Study|Protocol Violation|1|||
49011652|NCT01025193|157879050|FG000|Overall Study|Adverse Event|3|||
48822084|NCT01474512|157190496|FG013|Maintenance Period|Clinical Relapse|0|||
49011653|NCT00455533|157879051|FG000|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1|||
49011654|NCT00455533|157879052|FG001|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
49011655|NCT00455533|157879053|FG002|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
49011656|NCT00455533|157879051|FG000|Period One: Initial Chemotherapy|Disease Progression|5|||
49011657|NCT00455533|157879052|FG001|Period One: Initial Chemotherapy|Disease Progression|0|||
49011658|NCT00455533|157879053|FG002|Period One: Initial Chemotherapy|Disease Progression|0|||
49011659|NCT00455533|157879051|FG000|Period One: Initial Chemotherapy|Lost to Follow-up|2|||
49011660|NCT00455533|157879052|FG001|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
49011661|NCT00455533|157879053|FG002|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
49011662|NCT00455533|157879051|FG000|Period One: Initial Chemotherapy|Not Reported|1|||
49011663|NCT00455533|157879052|FG001|Period One: Initial Chemotherapy|Not Reported|0|||
49011664|NCT00455533|157879053|FG002|Period One: Initial Chemotherapy|Not Reported|0|||
49011665|NCT00455533|157879051|FG000|Period One: Initial Chemotherapy|Other--Need Reasons|2|||
49011666|NCT00455533|157879052|FG001|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
49011667|NCT00455533|157879053|FG002|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
49011668|NCT00455533|157879051|FG000|Period One: Initial Chemotherapy|Study Drug Toxicity|2|||
49011669|NCT00455533|157879052|FG001|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
49011670|NCT00455533|157879053|FG002|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
49011671|NCT00455533|157879051|FG000|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1|||
49011672|NCT00455533|157879052|FG001|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
49011673|NCT00455533|157879053|FG002|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
49011674|NCT00455533|157879051|FG000|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2|||
49011675|NCT00455533|157879052|FG001|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
49011676|NCT00455533|157879053|FG002|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
49011677|NCT00455533|157879051|FG000|Period One: Initial Chemotherapy|Subject Withdrew Consent|2|||
49011678|NCT00455533|157879052|FG001|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
49011679|NCT00455533|157879053|FG002|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
49011680|NCT00455533|157879051|FG000|Period Two: Randomized Period|Death|0|||
49011681|NCT00455533|157879052|FG001|Period Two: Randomized Period|Death|0|||
49011682|NCT00455533|157879053|FG002|Period Two: Randomized Period|Death|3|||
49011683|NCT00455533|157879051|FG000|Period Two: Randomized Period|Disease Progression|0|||
49011684|NCT00455533|157879052|FG001|Period Two: Randomized Period|Disease Progression|1|||
49011685|NCT00455533|157879053|FG002|Period Two: Randomized Period|Disease Progression|1|||
49011686|NCT00455533|157879051|FG000|Period Two: Randomized Period|Lost to Follow-up|0|||
49011687|NCT00455533|157879052|FG001|Period Two: Randomized Period|Lost to Follow-up|0|||
49011688|NCT00455533|157879053|FG002|Period Two: Randomized Period|Lost to Follow-up|1|||
49011689|NCT00455533|157879051|FG000|Period Two: Randomized Period|Other - need reasons|0|||
49011690|NCT00455533|157879052|FG001|Period Two: Randomized Period|Other - need reasons|1|||
49011691|NCT00455533|157879053|FG002|Period Two: Randomized Period|Other - need reasons|0|||
49011692|NCT00455533|157879051|FG000|Period Two: Randomized Period|Study Drug Toxicity|0|||
49011693|NCT00455533|157879052|FG001|Period Two: Randomized Period|Study Drug Toxicity|2|||
49011694|NCT00455533|157879053|FG002|Period Two: Randomized Period|Study Drug Toxicity|0|||
49011695|NCT00455533|157879051|FG000|Period Two: Randomized Period|Subject Withdrew Consent|0|||
49011696|NCT00455533|157879052|FG001|Period Two: Randomized Period|Subject Withdrew Consent|2|||
49011697|NCT00455533|157879053|FG002|Period Two: Randomized Period|Subject Withdrew Consent|1|||
49011698|NCT02904200|157879054|FG000|Overall Study|Withdrawal by Subject|1|||
49011699|NCT02904200|157879055|FG001|Overall Study|Withdrawal by Subject|0|||
49011700|NCT03280537|157879057|FG000|Overall Study|Withdrawal by Subject|2|||
49011701|NCT03280537|157879058|FG001|Overall Study|Withdrawal by Subject|4|||
49011702|NCT01588106|157879059|FG000|Overall Study|Withdrawal by Subject|5|||
49011703|NCT01588106|157879060|FG001|Overall Study|Withdrawal by Subject|4|||
49011704|NCT03862625|157881530|FG000|Overall Study|Lost to Follow-up|0|||
49011705|NCT03862625|157881531|FG001|Overall Study|Lost to Follow-up|1|||
49011706|NCT03769181|157881536|FG000|Overall Study|Adverse Event|1|||
49011707|NCT03769181|157881537|FG001|Overall Study|Adverse Event|0|||
48729039|NCT02788474|156858294|FG000|Open Label Treatment Period|Other than reason specified|1|||
49011708|NCT03769181|157881538|FG002|Overall Study|Adverse Event|2|||
49011709|NCT03769181|157881539|FG003|Overall Study|Adverse Event|4|||
49011710|NCT03769181|157881536|FG000|Overall Study|Withdrawal by Subject|1|||
49011711|NCT03769181|157881537|FG001|Overall Study|Withdrawal by Subject|0|||
49011712|NCT03769181|157881538|FG002|Overall Study|Withdrawal by Subject|2|||
49011713|NCT03769181|157881539|FG003|Overall Study|Withdrawal by Subject|1|||
49011714|NCT03769181|157881536|FG000|Overall Study|Progressive disease|9|||
49011715|NCT03769181|157881537|FG001|Overall Study|Progressive disease|7|||
49011716|NCT03769181|157881538|FG002|Overall Study|Progressive disease|13|||
49011717|NCT03769181|157881539|FG003|Overall Study|Progressive disease|6|||
49011718|NCT03769181|157881536|FG000|Overall Study|Other - Unspecified|2|||
49011719|NCT03769181|157881537|FG001|Overall Study|Other - Unspecified|1|||
49011720|NCT03769181|157881538|FG002|Overall Study|Other - Unspecified|0|||
49011721|NCT03769181|157881539|FG003|Overall Study|Other - Unspecified|0|||
49011722|NCT04378010|157881540|FG000|Overall Study|Adverse Event|8|||
49011723|NCT04378010|157881541|FG001|Overall Study|Adverse Event|14|||
49011724|NCT04378010|157881542|FG002|Overall Study|Adverse Event|4|||
49011725|NCT04378010|157881540|FG000|Overall Study|Withdrawal by Subject|0|||
49011726|NCT04378010|157881541|FG001|Overall Study|Withdrawal by Subject|2|||
49011727|NCT04378010|157881542|FG002|Overall Study|Withdrawal by Subject|1|||
49011728|NCT04378010|157881540|FG000|Overall Study|Protocol Violation|2|||
49011729|NCT04378010|157881541|FG001|Overall Study|Protocol Violation|1|||
49011730|NCT04378010|157881542|FG002|Overall Study|Protocol Violation|4|||
49011731|NCT04378010|157881540|FG000|Overall Study|Study terminated by Sponsor|22|||
49011732|NCT04378010|157881541|FG001|Overall Study|Study terminated by Sponsor|16|||
49011733|NCT04378010|157881542|FG002|Overall Study|Study terminated by Sponsor|22|||
49011734|NCT04378010|157881540|FG000|Overall Study|Subject inability to complete study visit|0|||
49011735|NCT04378010|157881541|FG001|Overall Study|Subject inability to complete study visit|0|||
49011736|NCT04378010|157881542|FG002|Overall Study|Subject inability to complete study visit|1|||
49011737|NCT04378010|157881540|FG000|Overall Study|Subject never dosed|0|||
49011738|NCT04378010|157881541|FG001|Overall Study|Subject never dosed|1|||
49011739|NCT04378010|157881542|FG002|Overall Study|Subject never dosed|0|||
49011740|NCT01792284|157881543|FG000|Lead-in Period|Adverse Event|15|||
49011741|NCT01792284|157881544|FG001|Lead-in Period|Adverse Event|0|||
49011742|NCT01792284|157881545|FG002|Lead-in Period|Adverse Event|0|||
49011743|NCT01792284|157881543|FG000|Lead-in Period|Lost to Follow-up|2|||
49011744|NCT01792284|157881544|FG001|Lead-in Period|Lost to Follow-up|0|||
49011745|NCT01792284|157881545|FG002|Lead-in Period|Lost to Follow-up|0|||
49011746|NCT01792284|157881543|FG000|Lead-in Period|Protocol Violation|1|||
49011747|NCT01792284|157881544|FG001|Lead-in Period|Protocol Violation|0|||
49011748|NCT01792284|157881545|FG002|Lead-in Period|Protocol Violation|0|||
49011749|NCT01792284|157881543|FG000|Lead-in Period|Withdrawal by Subject|10|||
49011750|NCT01792284|157881544|FG001|Lead-in Period|Withdrawal by Subject|0|||
49011751|NCT01792284|157881545|FG002|Lead-in Period|Withdrawal by Subject|0|||
49011752|NCT01792284|157881543|FG000|Lead-in Period|Physician Decision|1|||
49011753|NCT01792284|157881544|FG001|Lead-in Period|Physician Decision|0|||
49011754|NCT01792284|157881545|FG002|Lead-in Period|Physician Decision|0|||
49011755|NCT01792284|157881543|FG000|Lead-in Period|Protocol Required Discontinuation|1|||
49011756|NCT01792284|157881544|FG001|Lead-in Period|Protocol Required Discontinuation|0|||
49011757|NCT01792284|157881545|FG002|Lead-in Period|Protocol Required Discontinuation|0|||
49011758|NCT01792284|157881543|FG000|Randomization Period 1|Withdrawal by Subject|0|||
49011759|NCT01792284|157881544|FG001|Randomization Period 1|Withdrawal by Subject|1|||
49011760|NCT01792284|157881545|FG002|Randomization Period 1|Withdrawal by Subject|1|||
49011761|NCT01792284|157881543|FG000|Randomization Period 1|Physician Decision|0|||
49011762|NCT01792284|157881544|FG001|Randomization Period 1|Physician Decision|1|||
49011763|NCT01792284|157881545|FG002|Randomization Period 1|Physician Decision|1|||
49011764|NCT01792284|157881543|FG000|Randomization Period 1|Adverse Event|0|||
49011765|NCT01792284|157881544|FG001|Randomization Period 1|Adverse Event|0|||
49011766|NCT01792284|157881545|FG002|Randomization Period 1|Adverse Event|2|||
49011767|NCT01792284|157881543|FG000|Randomization Period 1|Lost to Follow-up|0|||
49011768|NCT01792284|157881544|FG001|Randomization Period 1|Lost to Follow-up|0|||
49011769|NCT01792284|157881545|FG002|Randomization Period 1|Lost to Follow-up|1|||
49011770|NCT01792284|157881543|FG000|Randomization Period 2|Protocol Violation|0|||
49011771|NCT01792284|157881544|FG001|Randomization Period 2|Protocol Violation|1|||
49011772|NCT01792284|157881545|FG002|Randomization Period 2|Protocol Violation|0|||
49011773|NCT01792284|157881543|FG000|Randomization Period 2|Withdrawal by Subject|0|||
49011774|NCT01792284|157881544|FG001|Randomization Period 2|Withdrawal by Subject|2|||
49011775|NCT01792284|157881545|FG002|Randomization Period 2|Withdrawal by Subject|0|||
49011776|NCT04023994|157881551|FG000|Overall Study|Lost to Follow-up|0|||
49011777|NCT04023994|157881552|FG001|Overall Study|Lost to Follow-up|1|||
49011778|NCT04023994|157881553|FG002|Overall Study|Lost to Follow-up|2|||
49011779|NCT04023994|157881554|FG003|Overall Study|Lost to Follow-up|0|||
49011780|NCT04023994|157881555|FG004|Overall Study|Lost to Follow-up|0|||
49011781|NCT04023994|157881556|FG005|Overall Study|Lost to Follow-up|0|||
49140621|NCT01281306|158353102|FG006|Overall Study|Death|0|||
49140622|NCT01281306|158353096|FG000|Overall Study|Adverse Event|3|||
49140623|NCT01281306|158353097|FG001|Overall Study|Adverse Event|2|||
49140624|NCT01281306|158353098|FG002|Overall Study|Adverse Event|2|||
49140625|NCT01281306|158353099|FG003|Overall Study|Adverse Event|3|||
49140626|NCT01281306|158353100|FG004|Overall Study|Adverse Event|5|||
49140627|NCT01281306|158353101|FG005|Overall Study|Adverse Event|3|||
49140628|NCT01281306|158353102|FG006|Overall Study|Adverse Event|3|||
49140629|NCT01281306|158353096|FG000|Overall Study|Randomized in error|1|||
49140630|NCT01281306|158353097|FG001|Overall Study|Randomized in error|0|||
49140631|NCT01281306|158353098|FG002|Overall Study|Randomized in error|0|||
49140632|NCT01281306|158353099|FG003|Overall Study|Randomized in error|1|||
49140633|NCT01281306|158353100|FG004|Overall Study|Randomized in error|0|||
49140634|NCT01281306|158353101|FG005|Overall Study|Randomized in error|0|||
49140635|NCT01281306|158353102|FG006|Overall Study|Randomized in error|0|||
49140636|NCT01946802|158353107|FG000|Overall Study|Death|1|||
49140637|NCT01946802|158353107|FG000|Overall Study|Withdrawal by Subject|2|||
49140638|NCT01946802|158353107|FG000|Overall Study|Combined septic shock|1|||
49140639|NCT01946802|158353107|FG000|Overall Study|Protocol Violation|1|||
49140640|NCT00923702|158353108|FG000|Overall Study|Ongoing enrollment|0|||
49140641|NCT00923702|158353109|FG001|Overall Study|Ongoing enrollment|0|||
49140642|NCT00923702|158353110|FG002|Overall Study|Ongoing enrollment|0|||
49140643|NCT00923702|158353111|FG003|Overall Study|Ongoing enrollment|0|||
49140644|NCT00923702|158353112|FG004|Overall Study|Ongoing enrollment|354|||
49140645|NCT02755090|158353113|FG000|Overall Study|equipment malfunction|1|||
49140646|NCT02755090|158353114|FG001|Overall Study|equipment malfunction|0|||
49140647|NCT01186419|158353117|FG000|Overall Study|Withdrawal by Subject|5|||
49140648|NCT01186419|158353118|FG001|Overall Study|Withdrawal by Subject|3|||
49140649|NCT01186419|158353117|FG000|Overall Study|Adverse Event|1|||
49140650|NCT01186419|158353118|FG001|Overall Study|Adverse Event|2|||
49140651|NCT01186419|158353117|FG000|Overall Study|Physician Decision|0|||
49140652|NCT01186419|158353118|FG001|Overall Study|Physician Decision|3|||
49140653|NCT01186419|158353117|FG000|Overall Study|Other|1|||
49011782|NCT04023994|157881551|FG000|Overall Study|Withdrawal by Subject|0|||
49140654|NCT01186419|158353118|FG001|Overall Study|Other|1|||
49140655|NCT01078545|158353119|FG000|Overall Study|Lost to Follow-up|13|||
49140656|NCT01078545|158353119|FG000|Overall Study|Physician Decision|6|||
49140657|NCT01078545|158353119|FG000|Overall Study|Withdrawal by Subject|3|||
49140658|NCT01078545|158353119|FG000|Overall Study|Death|3|||
49140659|NCT01078545|158353119|FG000|Overall Study|Participant moved to another physician|1|||
49140660|NCT04401293|158353122|FG000|Overall Study|Withdrawal by Subject|1|||
49140661|NCT04401293|158353123|FG001|Overall Study|Withdrawal by Subject|3|||
49140662|NCT03679884|158353124|FG000|Overall Study|Other|12|||
49140663|NCT03679884|158353125|FG001|Overall Study|Other|12|||
49140664|NCT03679884|158353126|FG002|Overall Study|Other|12|||
49140665|NCT03679884|158353127|FG003|Overall Study|Other|7|||
49140666|NCT03679884|158353128|FG004|Overall Study|Other|8|||
49140667|NCT03679884|158353124|FG000|Overall Study|Lack of Efficacy|15|||
49140668|NCT03679884|158353125|FG001|Overall Study|Lack of Efficacy|29|||
49140669|NCT03679884|158353126|FG002|Overall Study|Lack of Efficacy|13|||
48822085|NCT01474512|157190497|FG014|Maintenance Period|Clinical Relapse|0|||
48822086|NCT01474512|157190498|FG015|Maintenance Period|Clinical Relapse|0|||
48822087|NCT01474512|157190499|FG016|Maintenance Period|Clinical Relapse|0|||
48822088|NCT01474512|157190500|FG017|Maintenance Period|Clinical Relapse|0|||
49140670|NCT03679884|158353127|FG003|Overall Study|Lack of Efficacy|29|||
49140671|NCT03679884|158353128|FG004|Overall Study|Lack of Efficacy|10|||
49140672|NCT03679884|158353124|FG000|Overall Study|Death|1|||
49140673|NCT03679884|158353125|FG001|Overall Study|Death|0|||
48822089|NCT01474512|157190483|FG000|Maintenance Period|Lack of Efficacy|0|||
48822090|NCT01474512|157190484|FG001|Maintenance Period|Lack of Efficacy|0|||
48822091|NCT01474512|157190485|FG002|Maintenance Period|Lack of Efficacy|0|||
48822092|NCT01474512|157190486|FG003|Maintenance Period|Lack of Efficacy|1|||
48822093|NCT01474512|157190487|FG004|Maintenance Period|Lack of Efficacy|0|||
48822094|NCT01474512|157190488|FG005|Maintenance Period|Lack of Efficacy|0|||
48822095|NCT01474512|157190489|FG006|Maintenance Period|Lack of Efficacy|0|||
48822096|NCT01474512|157190490|FG007|Maintenance Period|Lack of Efficacy|11|||
48822097|NCT01474512|157190491|FG008|Maintenance Period|Lack of Efficacy|11|||
48822098|NCT01474512|157190492|FG009|Maintenance Period|Lack of Efficacy|12|||
48822099|NCT01474512|157190493|FG010|Maintenance Period|Lack of Efficacy|0|||
48822100|NCT01474512|157190494|FG011|Maintenance Period|Lack of Efficacy|0|||
48822101|NCT01474512|157190495|FG012|Maintenance Period|Lack of Efficacy|0|||
48822102|NCT01474512|157190496|FG013|Maintenance Period|Lack of Efficacy|0|||
48822103|NCT01474512|157190497|FG014|Maintenance Period|Lack of Efficacy|0|||
48822104|NCT01474512|157190498|FG015|Maintenance Period|Lack of Efficacy|0|||
48822105|NCT01474512|157190499|FG016|Maintenance Period|Lack of Efficacy|0|||
48822106|NCT01474512|157190500|FG017|Maintenance Period|Lack of Efficacy|0|||
48822107|NCT01474512|157190483|FG000|Maintenance Period|Protocol Violation|0|||
48822108|NCT01474512|157190484|FG001|Maintenance Period|Protocol Violation|0|||
49140674|NCT03679884|158353126|FG002|Overall Study|Death|0|||
49011783|NCT04023994|157881552|FG001|Overall Study|Withdrawal by Subject|0|||
49011784|NCT04023994|157881553|FG002|Overall Study|Withdrawal by Subject|0|||
49011785|NCT04023994|157881554|FG003|Overall Study|Withdrawal by Subject|1|||
49011786|NCT04023994|157881555|FG004|Overall Study|Withdrawal by Subject|0|||
49011787|NCT04023994|157881556|FG005|Overall Study|Withdrawal by Subject|0|||
49011788|NCT00923195|157881557|FG000|Overall Study|Death|0|||
49011789|NCT00923195|157881558|FG001|Overall Study|Death|1|||
49011790|NCT00525031|157881559|FG000|Overall Study|Disease Progression|1|||
49011791|NCT00525031|157881560|FG001|Overall Study|Disease Progression|1|||
49011792|NCT02323295|157881565|FG000|Overall Study|Adverse Event|0|||
48729040|NCT02788474|156858295|FG001|Open Label Treatment Period|Other than reason specified|0|||
49140675|NCT03679884|158353127|FG003|Overall Study|Death|0|||
49140676|NCT03679884|158353128|FG004|Overall Study|Death|0|||
49140677|NCT03679884|158353124|FG000|Overall Study|Adverse Event|2|||
49140678|NCT03679884|158353125|FG001|Overall Study|Adverse Event|10|||
49140679|NCT03679884|158353126|FG002|Overall Study|Adverse Event|9|||
49140680|NCT03679884|158353127|FG003|Overall Study|Adverse Event|6|||
49140681|NCT03679884|158353128|FG004|Overall Study|Adverse Event|6|||
49140682|NCT03679884|158353124|FG000|Overall Study|Withdrawal by Subject|12|||
49140683|NCT03679884|158353125|FG001|Overall Study|Withdrawal by Subject|23|||
49140684|NCT03679884|158353126|FG002|Overall Study|Withdrawal by Subject|8|||
49140685|NCT03679884|158353127|FG003|Overall Study|Withdrawal by Subject|8|||
49140686|NCT03679884|158353128|FG004|Overall Study|Withdrawal by Subject|9|||
49140687|NCT03679884|158353124|FG000|Overall Study|Lost to Follow-up|1|||
49140688|NCT03679884|158353125|FG001|Overall Study|Lost to Follow-up|4|||
49140689|NCT03679884|158353126|FG002|Overall Study|Lost to Follow-up|2|||
49140690|NCT03679884|158353127|FG003|Overall Study|Lost to Follow-up|0|||
49140691|NCT03679884|158353128|FG004|Overall Study|Lost to Follow-up|3|||
49140692|NCT00694161|158353129|FG000|Part 2 (After Week 6 up to Month 12)|Adverse Event|1|||
49140693|NCT00694161|158353129|FG000|Part 2 (After Week 6 up to Month 12)|Physician Decision|1|||
49140694|NCT00694161|158353129|FG000|Part 2 (After Week 6 up to Month 12)|Death|1|||
49140695|NCT03601052|158353130|FG000|Overall Study|Lost to Follow-up|2|||
49140696|NCT01483651|158353131|FG000|Overall Study|Withdrawal by Subject|0|||
49140697|NCT01483651|158353132|FG001|Overall Study|Withdrawal by Subject|1|||
49140698|NCT01483651|158353133|FG002|Overall Study|Withdrawal by Subject|1|||
49140699|NCT01483651|158353134|FG003|Overall Study|Withdrawal by Subject|0|||
49140700|NCT01483651|158353135|FG004|Overall Study|Withdrawal by Subject|0|||
49140701|NCT01483651|158353136|FG005|Overall Study|Withdrawal by Subject|1|||
49140702|NCT00837330|158353137|FG000|Overall Study|Lost to Follow-up|1|||
49140703|NCT00837330|158353138|FG001|Overall Study|Lost to Follow-up|3|||
49140704|NCT01227395|158353139|FG000|Overall Study|Protocol Violation|0|||
49140705|NCT01227395|158353140|FG001|Overall Study|Protocol Violation|1|||
49140706|NCT00694122|158353144|FG000|First Intervention (3-4 Weeks)|Withdrawal by Subject|7|||
49140707|NCT00694122|158353145|FG001|First Intervention (3-4 Weeks)|Withdrawal by Subject|0|||
49140708|NCT00694122|158353144|FG000|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
48822109|NCT01474512|157190485|FG002|Maintenance Period|Protocol Violation|0|||
48822110|NCT01474512|157190486|FG003|Maintenance Period|Protocol Violation|1|||
48822111|NCT01474512|157190487|FG004|Maintenance Period|Protocol Violation|0|||
48822112|NCT01474512|157190488|FG005|Maintenance Period|Protocol Violation|0|||
49140709|NCT00694122|158353145|FG001|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
49140710|NCT00694122|158353144|FG000|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2|||
49140711|NCT00694122|158353145|FG001|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1|||
49140712|NCT00308685|158353146|FG000|Overall Study|Lost to Follow-up|1|||
49140713|NCT00308685|158353147|FG001|Overall Study|Lost to Follow-up|0|||
49140714|NCT00308685|158353146|FG000|Overall Study|Need to administer prohibited medication|1|||
49140715|NCT00308685|158353147|FG001|Overall Study|Need to administer prohibited medication|2|||
49140716|NCT00308685|158353146|FG000|Overall Study|Other than specified|1|||
49140717|NCT00308685|158353147|FG001|Overall Study|Other than specified|3|||
49140718|NCT01018953|158353148|FG000|Overall Study|Adverse Event|2|||
49140719|NCT01018953|158353148|FG000|Overall Study|Withdrawal by Subject|1|||
49140720|NCT01018953|158353148|FG000|Overall Study|Study termination by sponsor|5|||
49140721|NCT02665455|158353149|FG000|Overall Study|Withdrawal by Subject|6|||
49140722|NCT02665455|158353149|FG000|Overall Study|Lost to Follow-up|1|||
49140723|NCT02665455|158353149|FG000|Overall Study|Adverse Event|1|||
49140724|NCT02665455|158353149|FG000|Overall Study|Protocol Violation|1|||
49140725|NCT02830087|158353150|FG000|Overall Study|No study staff to follow-up patients|4|||
49140726|NCT02830087|158353151|FG001|Overall Study|No study staff to follow-up patients|4|||
49140727|NCT02830087|158353152|FG002|Overall Study|No study staff to follow-up patients|4|||
49140728|NCT02830087|158353153|FG003|Overall Study|No study staff to follow-up patients|3|||
49140729|NCT02830087|158353154|FG004|Overall Study|No study staff to follow-up patients|3|||
49140730|NCT02830087|158353155|FG005|Overall Study|No study staff to follow-up patients|3|||
49140731|NCT00724503|158353156|FG000|Overall Study|Lost to Follow-up|4|||
49140732|NCT00724503|158353157|FG001|Overall Study|Lost to Follow-up|8|||
49140733|NCT00724503|158353156|FG000|Overall Study|Withdrawal by Subject|11|||
49140734|NCT00724503|158353157|FG001|Overall Study|Withdrawal by Subject|23|||
49140735|NCT00724503|158353156|FG000|Overall Study|Death|190|||
49140736|NCT00724503|158353157|FG001|Overall Study|Death|182|||
49140737|NCT00724503|158353156|FG000|Overall Study|Adverse Event|1|||
49140738|NCT00724503|158353157|FG001|Overall Study|Adverse Event|0|||
49140739|NCT00724503|158353156|FG000|Overall Study|Not otherwise specified|4|||
49140740|NCT00724503|158353157|FG001|Overall Study|Not otherwise specified|7|||
49140741|NCT01198548|158353164|FG000|Overall Study|Disease Progression|9|||
49140742|NCT01198548|158353164|FG000|Overall Study|Administrative Decision|1|||
49140743|NCT01049828|158353165|FG000|Overall Study|Claustrophibia and Frustration|2|||
49140744|NCT01245062|158353167|FG000|Randomization and Crossover Phase|Lost to Follow-up|4|||
49140745|NCT01245062|158353168|FG001|Randomization and Crossover Phase|Lost to Follow-up|2|||
49140746|NCT01245062|158353169|FG002|Randomization and Crossover Phase|Lost to Follow-up|0|||
49140747|NCT01245062|158353167|FG000|Randomization and Crossover Phase|Physician Decision|2|||
49140748|NCT01245062|158353168|FG001|Randomization and Crossover Phase|Physician Decision|4|||
49140749|NCT01245062|158353169|FG002|Randomization and Crossover Phase|Physician Decision|0|||
49140750|NCT01245062|158353167|FG000|Randomization and Crossover Phase|Withdrew Consent|12|||
49140751|NCT01245062|158353168|FG001|Randomization and Crossover Phase|Withdrew Consent|11|||
49140752|NCT01245062|158353169|FG002|Randomization and Crossover Phase|Withdrew Consent|0|||
49140753|NCT01245062|158353167|FG000|Randomization and Crossover Phase|Study closed/ terminated|23|||
49140754|NCT01245062|158353168|FG001|Randomization and Crossover Phase|Study closed/ terminated|14|||
49140755|NCT01245062|158353169|FG002|Randomization and Crossover Phase|Study closed/ terminated|0|||
49140756|NCT01245062|158353167|FG000|Cross-over Phase|Lost to Follow-up|0|||
49140757|NCT01245062|158353168|FG001|Cross-over Phase|Lost to Follow-up|0|||
49140758|NCT01245062|158353169|FG002|Cross-over Phase|Lost to Follow-up|1|||
49140759|NCT01245062|158353167|FG000|Cross-over Phase|Physician Decision|0|||
49140760|NCT01245062|158353168|FG001|Cross-over Phase|Physician Decision|0|||
49140761|NCT01245062|158353169|FG002|Cross-over Phase|Physician Decision|1|||
49140762|NCT01245062|158353167|FG000|Cross-over Phase|Withdrew Consent|0|||
49140763|NCT01245062|158353168|FG001|Cross-over Phase|Withdrew Consent|0|||
49140764|NCT01245062|158353169|FG002|Cross-over Phase|Withdrew Consent|4|||
49140765|NCT01245062|158353167|FG000|Cross-over Phase|Study closed/ terminated|0|||
49140766|NCT01245062|158353168|FG001|Cross-over Phase|Study closed/ terminated|0|||
49140767|NCT01245062|158353169|FG002|Cross-over Phase|Study closed/ terminated|11|||
49140768|NCT03723070|158353171|FG000|Overall Study|Lost to Follow-up|2|||
49140769|NCT03723070|158353171|FG000|Overall Study|Physician Decision|1|||
49140770|NCT03723070|158353171|FG000|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6|||
49140771|NCT00286455|158353172|FG000|Overall Study|Hyperglycemia rescue|19|||
49140772|NCT00286455|158353173|FG001|Overall Study|Hyperglycemia rescue|13|||
49140773|NCT00286455|158353174|FG002|Overall Study|Hyperglycemia rescue|10|||
49140774|NCT00286455|158353172|FG000|Overall Study|Adverse Event|1|||
49140775|NCT00286455|158353173|FG001|Overall Study|Adverse Event|3|||
48822113|NCT01474512|157190489|FG006|Maintenance Period|Protocol Violation|0|||
49140776|NCT00286455|158353174|FG002|Overall Study|Adverse Event|2|||
49140777|NCT00286455|158353172|FG000|Overall Study|Lost to Follow-up|0|||
49140778|NCT00286455|158353173|FG001|Overall Study|Lost to Follow-up|3|||
49140779|NCT00286455|158353174|FG002|Overall Study|Lost to Follow-up|3|||
49140780|NCT00286455|158353172|FG000|Overall Study|Physician Decision|3|||
49140781|NCT00286455|158353173|FG001|Overall Study|Physician Decision|0|||
49140782|NCT00286455|158353174|FG002|Overall Study|Physician Decision|2|||
49140783|NCT00286455|158353172|FG000|Overall Study|Protocol Violation|1|||
49140784|NCT00286455|158353173|FG001|Overall Study|Protocol Violation|1|||
49140785|NCT00286455|158353174|FG002|Overall Study|Protocol Violation|0|||
49140786|NCT00286455|158353172|FG000|Overall Study|Participant Non-compliance|1|||
49140787|NCT00286455|158353173|FG001|Overall Study|Participant Non-compliance|0|||
49140788|NCT00286455|158353174|FG002|Overall Study|Participant Non-compliance|0|||
49140789|NCT00286455|158353172|FG000|Overall Study|Withdrawal by Subject|0|||
49140790|NCT00286455|158353173|FG001|Overall Study|Withdrawal by Subject|8|||
49140791|NCT00286455|158353174|FG002|Overall Study|Withdrawal by Subject|7|||
49140792|NCT02487199|158353175|FG000|Overall Study|Withdrew Consent|0|||
49011793|NCT02323295|157881566|FG001|Overall Study|Adverse Event|1|||
49011794|NCT02323295|157881565|FG000|Overall Study|Withdrawal by Subject|0|||
49011795|NCT02323295|157881566|FG001|Overall Study|Withdrawal by Subject|1|||
48729041|NCT02788474|156858294|FG000|Open Label Treatment Period|Patient's refusal|1|||
48729042|NCT02788474|156858295|FG001|Open Label Treatment Period|Patient's refusal|3|||
49140793|NCT02487199|158353176|FG001|Overall Study|Withdrew Consent|1|||
49140794|NCT04706403|158354525|FG000|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
49140795|NCT04706403|158354526|FG001|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
49140796|NCT04706403|158354527|FG002|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
49140797|NCT04706403|158354528|FG003|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
49140798|NCT04706403|158354529|FG004|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|2|||
49140799|NCT01797185|158354530|FG000|Overall Study|Adverse Event|5|||
49140800|NCT01797185|158354531|FG001|Overall Study|Adverse Event|15|||
49140801|NCT01797185|158354532|FG002|Overall Study|Adverse Event|6|||
49140802|NCT01797185|158354530|FG000|Overall Study|Withdrawal by Subject|6|||
49140803|NCT01797185|158354531|FG001|Overall Study|Withdrawal by Subject|9|||
49140804|NCT01797185|158354532|FG002|Overall Study|Withdrawal by Subject|5|||
49140805|NCT01797185|158354530|FG000|Overall Study|Site terminated|8|||
49140806|NCT01797185|158354531|FG001|Overall Study|Site terminated|4|||
49140807|NCT01797185|158354532|FG002|Overall Study|Site terminated|0|||
49140808|NCT01797185|158354530|FG000|Overall Study|Lost to Follow-up|2|||
49140809|NCT01797185|158354531|FG001|Overall Study|Lost to Follow-up|6|||
48729043|NCT02788474|156858294|FG000|Open Label Treatment Period|Non-compliance|1|||
48729044|NCT02788474|156858295|FG001|Open Label Treatment Period|Non-compliance|0|||
48729045|NCT03053271|156858297|FG000|Overall Study|Did not meet randomization criteria|3|||
48729046|NCT03053271|156858297|FG000|Overall Study|Withdrawal by Subject|1|||
48729047|NCT02694523|156858298|FG000|Part A|Adverse Event|7|||
48729048|NCT02694523|156858299|FG001|Part A|Adverse Event|3|||
48729049|NCT02694523|156858300|FG002|Part A|Adverse Event|0|||
48729050|NCT02694523|156858301|FG003|Part A|Adverse Event|0|||
48729051|NCT02694523|156858302|FG004|Part A|Adverse Event|0|||
48729052|NCT02694523|156858303|FG005|Part A|Adverse Event|0|||
48729053|NCT02694523|156858304|FG006|Part A|Adverse Event|0|||
48729054|NCT02694523|156858298|FG000|Part A|Protocol Violation|1|||
48729055|NCT02694523|156858299|FG001|Part A|Protocol Violation|0|||
48729056|NCT02694523|156858300|FG002|Part A|Protocol Violation|0|||
48729057|NCT02694523|156858301|FG003|Part A|Protocol Violation|0|||
48729058|NCT02694523|156858302|FG004|Part A|Protocol Violation|0|||
48729059|NCT02694523|156858303|FG005|Part A|Protocol Violation|0|||
48729060|NCT02694523|156858304|FG006|Part A|Protocol Violation|0|||
48729061|NCT02694523|156858298|FG000|Part A|Lost to Follow-up|1|||
48729062|NCT02694523|156858299|FG001|Part A|Lost to Follow-up|2|||
48729063|NCT02694523|156858300|FG002|Part A|Lost to Follow-up|0|||
48729064|NCT02694523|156858301|FG003|Part A|Lost to Follow-up|0|||
48729065|NCT02694523|156858302|FG004|Part A|Lost to Follow-up|0|||
49011796|NCT02323295|157881565|FG000|Overall Study|Patient did not have surgery as planned.|0|||
49140810|NCT01797185|158354532|FG002|Overall Study|Lost to Follow-up|1|||
49140811|NCT01797185|158354530|FG000|Overall Study|Withdrawn per sponsor|5|||
49140812|NCT01797185|158354531|FG001|Overall Study|Withdrawn per sponsor|0|||
48729066|NCT02694523|156858303|FG005|Part A|Lost to Follow-up|0|||
49011797|NCT02323295|157881566|FG001|Overall Study|Patient did not have surgery as planned.|1|||
48729067|NCT02694523|156858304|FG006|Part A|Lost to Follow-up|0|||
48729068|NCT02694523|156858298|FG000|Part A|Withdrawal by Subject|3|||
49140813|NCT01797185|158354532|FG002|Overall Study|Withdrawn per sponsor|0|||
49140814|NCT01797185|158354530|FG000|Overall Study|Physician Decision|1|||
49140815|NCT01797185|158354531|FG001|Overall Study|Physician Decision|3|||
49140816|NCT01797185|158354532|FG002|Overall Study|Physician Decision|0|||
49140817|NCT01797185|158354530|FG000|Overall Study|Protocol Violation|1|||
49140818|NCT01797185|158354531|FG001|Overall Study|Protocol Violation|1|||
49140819|NCT01797185|158354532|FG002|Overall Study|Protocol Violation|0|||
49140820|NCT00992836|158354534|FG000|Overall Study|Lost to Follow-up|1|||
49140821|NCT00992836|158354534|FG000|Overall Study|Withdrawal by Subject|2|||
49140822|NCT00992836|158354534|FG000|Overall Study|Protocol Violation|2|||
49140823|NCT01121926|158354535|FG000|First Intervention Period|Adverse Event|1|||
49140824|NCT01121926|158354536|FG001|First Intervention Period|Adverse Event|0|||
49140825|NCT01121926|158354535|FG000|Washout Period|Adverse Event|0|||
49140826|NCT01121926|158354536|FG001|Washout Period|Adverse Event|1|||
49140827|NCT01121926|158354535|FG000|Washout Period|Positive pregnancy test|0|||
49140828|NCT01121926|158354536|FG001|Washout Period|Positive pregnancy test|1|||
49140829|NCT04137887|158354537|FG000|Overall Study|Death|102|||
49140830|NCT04137887|158354538|FG001|Overall Study|Death|92|||
49140831|NCT04137887|158354537|FG000|Overall Study|Withdrawal by Subject|2|||
49140832|NCT04137887|158354538|FG001|Overall Study|Withdrawal by Subject|3|||
49140833|NCT04137887|158354537|FG000|Overall Study|Randomized but not treated|0|||
49140834|NCT04137887|158354538|FG001|Overall Study|Randomized but not treated|1|||
49140835|NCT00416949|158354541|FG000|Overall Study|Patients refused to participate|5|||
49140836|NCT01158404|158354546|FG000|Overall Study|Withdrawal by Subject|0|||
49140837|NCT01158404|158354547|FG001|Overall Study|Withdrawal by Subject|1|||
49140838|NCT01158404|158354548|FG002|Overall Study|Withdrawal by Subject|0|||
49140839|NCT01158404|158354549|FG003|Overall Study|Withdrawal by Subject|0|||
49140840|NCT01158404|158354550|FG004|Overall Study|Withdrawal by Subject|3|||
49140841|NCT01158404|158354551|FG005|Overall Study|Withdrawal by Subject|1|||
49140842|NCT01158404|158354552|FG006|Overall Study|Withdrawal by Subject|0|||
49140843|NCT01158404|158354553|FG007|Overall Study|Withdrawal by Subject|1|||
49140844|NCT01158404|158354546|FG000|Overall Study|Physician Decision|0|||
49140845|NCT01158404|158354547|FG001|Overall Study|Physician Decision|0|||
49140846|NCT01158404|158354548|FG002|Overall Study|Physician Decision|0|||
49140847|NCT01158404|158354549|FG003|Overall Study|Physician Decision|0|||
49140848|NCT01158404|158354550|FG004|Overall Study|Physician Decision|0|||
49140849|NCT01158404|158354551|FG005|Overall Study|Physician Decision|0|||
49140850|NCT01158404|158354552|FG006|Overall Study|Physician Decision|0|||
49140851|NCT01158404|158354553|FG007|Overall Study|Physician Decision|1|||
49140852|NCT01158404|158354546|FG000|Overall Study|Progressive Disease|0|||
49140853|NCT01158404|158354547|FG001|Overall Study|Progressive Disease|0|||
49140854|NCT01158404|158354548|FG002|Overall Study|Progressive Disease|0|||
49140855|NCT01158404|158354549|FG003|Overall Study|Progressive Disease|0|||
49140856|NCT01158404|158354550|FG004|Overall Study|Progressive Disease|0|||
49140857|NCT01158404|158354551|FG005|Overall Study|Progressive Disease|0|||
49140858|NCT01158404|158354552|FG006|Overall Study|Progressive Disease|1|||
49140859|NCT01158404|158354553|FG007|Overall Study|Progressive Disease|0|||
49140860|NCT02384460|158354554|FG000|Overall Study|Protocol Violation|0|||
49140861|NCT02384460|158354555|FG001|Overall Study|Protocol Violation|1|||
49140862|NCT02384460|158354554|FG000|Overall Study|Returned to previous therapeutic regimen|0|||
49140863|NCT02384460|158354555|FG001|Overall Study|Returned to previous therapeutic regimen|1|||
49140864|NCT02384460|158354554|FG000|Overall Study|Adverse Event|5|||
49140865|NCT02384460|158354555|FG001|Overall Study|Adverse Event|2|||
49140866|NCT02384460|158354554|FG000|Overall Study|Withdrawal by Subject|0|||
49140867|NCT02384460|158354555|FG001|Overall Study|Withdrawal by Subject|3|||
49140868|NCT02384460|158354554|FG000|Overall Study|Elective medical treatment|1|||
49140869|NCT02384460|158354555|FG001|Overall Study|Elective medical treatment|0|||
49140870|NCT02384460|158354554|FG000|Overall Study|Non-compliance|1|||
49140871|NCT02384460|158354555|FG001|Overall Study|Non-compliance|0|||
49140872|NCT02400580|158354556|FG000|Overall Study|Withdrawal by Subject|1|||
49140873|NCT02400580|158354557|FG001|Overall Study|Withdrawal by Subject|1|||
49140874|NCT02400580|158354556|FG000|Overall Study|Adverse Event|1|||
49140875|NCT02400580|158354557|FG001|Overall Study|Adverse Event|0|||
49140876|NCT01441414|158354558|FG000|Overall Study|Participant died|9|||
49140877|NCT01441414|158354558|FG000|Overall Study|Other reasons|3|||
49140878|NCT01441414|158354558|FG000|Overall Study|Study terminated by sponsor|2|||
49140879|NCT01441414|158354558|FG000|Overall Study|Subject refused further follow-up|1|||
49140880|NCT03822416|158354561|FG000|Overall Study|Lost to Follow-up|1|||
49140881|NCT03822416|158354562|FG001|Overall Study|Lost to Follow-up|0|||
49140882|NCT03822416|158354561|FG000|Overall Study|Withdrawal by Subject|0|||
49140883|NCT03822416|158354562|FG001|Overall Study|Withdrawal by Subject|1|||
49140884|NCT04339972|158354563|FG000|Overall Study|Scheduling Issues|3|||
49140885|NCT04339972|158354564|FG001|Overall Study|Scheduling Issues|3|||
49140886|NCT04339972|158354563|FG000|Overall Study|dropout|1|||
49140887|NCT04339972|158354564|FG001|Overall Study|dropout|1|||
49140888|NCT04339972|158354563|FG000|Overall Study|Technical issues|1|||
49140889|NCT04339972|158354564|FG001|Overall Study|Technical issues|0|||
49140890|NCT04339972|158354563|FG000|Overall Study|Claustraphobia|0|||
49140891|NCT04339972|158354564|FG001|Overall Study|Claustraphobia|1|||
49140892|NCT01011283|158354573|FG000|Overall Study|Adverse Event|4|||
49140893|NCT01011283|158354574|FG001|Overall Study|Adverse Event|2|||
49140894|NCT01011283|158354573|FG000|Overall Study|Progressive Disease|0|||
49140895|NCT01011283|158354574|FG001|Overall Study|Progressive Disease|2|||
48729069|NCT02694523|156858299|FG001|Part A|Withdrawal by Subject|1|||
49140896|NCT01011283|158354573|FG000|Overall Study|Terminated by Sponsor|5|||
49140897|NCT01011283|158354574|FG001|Overall Study|Terminated by Sponsor|5|||
49140898|NCT01011283|158354573|FG000|Overall Study|Other|2|||
49140899|NCT01011283|158354574|FG001|Overall Study|Other|2|||
49140900|NCT01717859|158354575|FG000|Overall Study|Adverse Event|5|||
49140901|NCT01717859|158354575|FG000|Overall Study|Moved out of state|1|||
49140902|NCT01717859|158354575|FG000|Overall Study|Patient concerned about mental health|1|||
49140903|NCT01717859|158354575|FG000|Overall Study|Lost to Follow-up|1|||
49140904|NCT01717859|158354575|FG000|Overall Study|Withdrawal by Subject|2|||
49140905|NCT04964388|158354576|FG000|Overall Study|Lost to Follow-up|3|||
49140906|NCT04964388|158354577|FG001|Overall Study|Lost to Follow-up|2|||
49140907|NCT01755637|158354578|FG000|Period 1|Adverse Event|0|||
49140908|NCT01755637|158354579|FG001|Period 1|Adverse Event|1|||
49140909|NCT03142750|158354580|FG000|Overall Study|Lost to Follow-up|4|||
49140910|NCT03142750|158354581|FG001|Overall Study|Lost to Follow-up|1|||
49140911|NCT00474968|158354582|FG000|Overall Study|Withdrawal by Subject|8|||
49140912|NCT00474968|158354583|FG001|Overall Study|Withdrawal by Subject|7|||
49140913|NCT00474968|158354582|FG000|Overall Study|Protocol Violation|9|||
49140914|NCT00474968|158354583|FG001|Overall Study|Protocol Violation|8|||
49140915|NCT00474968|158354582|FG000|Overall Study|Sample not collected|1|||
49140916|NCT00474968|158354583|FG001|Overall Study|Sample not collected|1|||
49140917|NCT01111292|158354584|FG000|Treatment|Physician Decision|1|||
49140918|NCT01111292|158354585|FG001|Treatment|Physician Decision|1|||
49140919|NCT04914000|158354586|FG000|Overall Study|Lost to Follow-up|8|||
49140920|NCT04914000|158354586|FG000|Overall Study|Withdrawal by Subject|1|||
49140921|NCT00471107|158354587|FG000|Overall Study|Technical problems/data loss|3|||
49140922|NCT00471107|158354588|FG001|Overall Study|Technical problems/data loss|1|||
49140923|NCT00471107|158354589|FG002|Overall Study|Technical problems/data loss|3|||
49140924|NCT01769443|158354593|FG000|Overall Study|Study closure|1|||
49140925|NCT01769443|158354594|FG001|Overall Study|Study closure|0|||
49140926|NCT02346370|158354595|FG000|Overall Study|Not treated|1|||
49140927|NCT02346370|158354596|FG001|Overall Study|Not treated|0|||
49140928|NCT02346370|158354597|FG002|Overall Study|Not treated|0|||
49140929|NCT02346370|158354595|FG000|Overall Study|Withdrawal of consent|1|||
49140930|NCT02346370|158354596|FG001|Overall Study|Withdrawal of consent|0|||
49140931|NCT02346370|158354597|FG002|Overall Study|Withdrawal of consent|0|||
49140932|NCT02346370|158354595|FG000|Overall Study|Death|1|||
49140933|NCT02346370|158354596|FG001|Overall Study|Death|3|||
49140934|NCT02346370|158354597|FG002|Overall Study|Death|1|||
49140935|NCT02346370|158354595|FG000|Overall Study|Sponsor discontinued study|5|||
49140936|NCT02346370|158354596|FG001|Overall Study|Sponsor discontinued study|0|||
49140937|NCT02346370|158354597|FG002|Overall Study|Sponsor discontinued study|2|||
49140938|NCT02346370|158354595|FG000|Overall Study|Radiologic progression|0|||
49140939|NCT02346370|158354596|FG001|Overall Study|Radiologic progression|0|||
49140940|NCT02346370|158354597|FG002|Overall Study|Radiologic progression|1|||
49140941|NCT02346370|158354595|FG000|Overall Study|Physician Decision|0|||
49140942|NCT02346370|158354596|FG001|Overall Study|Physician Decision|1|||
49140943|NCT02346370|158354597|FG002|Overall Study|Physician Decision|0|||
49140944|NCT01668537|158354600|FG000|Overall Study|Request to Discontinue Prematurely|1|||
49140945|NCT01668537|158354601|FG001|Overall Study|Request to Discontinue Prematurely|1|||
49140946|NCT01668537|158354600|FG000|Overall Study|Subject unwilling/unable to comply|5|||
49140947|NCT01668537|158354601|FG001|Overall Study|Subject unwilling/unable to comply|0|||
49140948|NCT01668537|158354600|FG000|Overall Study|Reason Precludes Participation|1|||
49140949|NCT01668537|158354601|FG001|Overall Study|Reason Precludes Participation|0|||
49140950|NCT01668537|158354600|FG000|Overall Study|Lost to Follow-up|13|||
49140951|NCT01668537|158354601|FG001|Overall Study|Lost to Follow-up|6|||
49140952|NCT01668537|158354600|FG000|Overall Study|Other|2|||
49140953|NCT01668537|158354601|FG001|Overall Study|Other|3|||
49140954|NCT00114777|158354602|FG000|Randomization to Month 36|Death|10|||
48729070|NCT02694523|156858300|FG002|Part A|Withdrawal by Subject|0|||
48729071|NCT02694523|156858301|FG003|Part A|Withdrawal by Subject|0|||
48729072|NCT02694523|156858302|FG004|Part A|Withdrawal by Subject|0|||
48729073|NCT02694523|156858303|FG005|Part A|Withdrawal by Subject|0|||
48729074|NCT02694523|156858304|FG006|Part A|Withdrawal by Subject|0|||
48729075|NCT02694523|156858298|FG000|Part A|Other|1|||
49011798|NCT01847313|157881567|FG000|Overall Study|Death|0|||
49140955|NCT00114777|158354603|FG001|Randomization to Month 36|Death|4|||
49140956|NCT00114777|158354604|FG002|Randomization to Month 36|Death|3|||
49140957|NCT00114777|158354602|FG000|Randomization to Month 36|No Longer Met Study Criteria|0|||
49140958|NCT00114777|158354603|FG001|Randomization to Month 36|No Longer Met Study Criteria|0|||
48729076|NCT02694523|156858299|FG001|Part A|Other|1|||
48729077|NCT02694523|156858300|FG002|Part A|Other|0|||
48822114|NCT01474512|157190490|FG007|Maintenance Period|Protocol Violation|1|||
48822115|NCT01474512|157190491|FG008|Maintenance Period|Protocol Violation|0|||
48822116|NCT01474512|157190492|FG009|Maintenance Period|Protocol Violation|1|||
48822117|NCT01474512|157190493|FG010|Maintenance Period|Protocol Violation|0|||
48822118|NCT01474512|157190494|FG011|Maintenance Period|Protocol Violation|0|||
48822119|NCT01474512|157190495|FG012|Maintenance Period|Protocol Violation|0|||
48822120|NCT01474512|157190496|FG013|Maintenance Period|Protocol Violation|0|||
48822121|NCT01474512|157190497|FG014|Maintenance Period|Protocol Violation|0|||
48822122|NCT01474512|157190498|FG015|Maintenance Period|Protocol Violation|0|||
48822123|NCT01474512|157190499|FG016|Maintenance Period|Protocol Violation|0|||
48822124|NCT01474512|157190500|FG017|Maintenance Period|Protocol Violation|0|||
49140959|NCT00114777|158354604|FG002|Randomization to Month 36|No Longer Met Study Criteria|2|||
49140960|NCT00114777|158354602|FG000|Randomization to Month 36|Lack of Efficacy|19|||
48729078|NCT02694523|156858301|FG003|Part A|Other|0|||
48729079|NCT02694523|156858302|FG004|Part A|Other|0|||
48729080|NCT02694523|156858303|FG005|Part A|Other|0|||
49140961|NCT00114777|158354603|FG001|Randomization to Month 36|Lack of Efficacy|15|||
49140962|NCT00114777|158354604|FG002|Randomization to Month 36|Lack of Efficacy|17|||
48822125|NCT01474512|157190483|FG000|Maintenance Period|Treated but Discontinued in Induction|0|||
48822126|NCT01474512|157190484|FG001|Maintenance Period|Treated but Discontinued in Induction|0|||
48822127|NCT01474512|157190485|FG002|Maintenance Period|Treated but Discontinued in Induction|0|||
48822128|NCT01474512|157190486|FG003|Maintenance Period|Treated but Discontinued in Induction|0|||
48822129|NCT01474512|157190487|FG004|Maintenance Period|Treated but Discontinued in Induction|1|||
48822130|NCT01474512|157190488|FG005|Maintenance Period|Treated but Discontinued in Induction|0|||
48822131|NCT01474512|157190489|FG006|Maintenance Period|Treated but Discontinued in Induction|0|||
48822132|NCT01474512|157190490|FG007|Maintenance Period|Treated but Discontinued in Induction|0|||
48729081|NCT02694523|156858304|FG006|Part A|Other|0|||
48729082|NCT02694523|156858298|FG000|Part B|Adverse Event|0|||
48822133|NCT01474512|157190491|FG008|Maintenance Period|Treated but Discontinued in Induction|0|||
48729083|NCT02694523|156858299|FG001|Part B|Adverse Event|0|||
49140963|NCT00114777|158354602|FG000|Randomization to Month 36|Poor or Non-Compliance|0|||
49140964|NCT00114777|158354603|FG001|Randomization to Month 36|Poor or Non-Compliance|0|||
49140965|NCT00114777|158354604|FG002|Randomization to Month 36|Poor or Non-Compliance|1|||
49140966|NCT00114777|158354602|FG000|Randomization to Month 36|Adverse Event|34|||
49140967|NCT00114777|158354603|FG001|Randomization to Month 36|Adverse Event|35|||
49140968|NCT00114777|158354604|FG002|Randomization to Month 36|Adverse Event|44|||
48729084|NCT02694523|156858300|FG002|Part B|Adverse Event|7|||
48729085|NCT02694523|156858301|FG003|Part B|Adverse Event|1|||
48729086|NCT02694523|156858302|FG004|Part B|Adverse Event|1|||
48729087|NCT02694523|156858303|FG005|Part B|Adverse Event|2|||
48729088|NCT02694523|156858304|FG006|Part B|Adverse Event|0|||
48729089|NCT02694523|156858298|FG000|Part B|Protocol Violation|0|||
48729090|NCT02694523|156858299|FG001|Part B|Protocol Violation|0|||
48729091|NCT02694523|156858300|FG002|Part B|Protocol Violation|1|||
48729092|NCT02694523|156858301|FG003|Part B|Protocol Violation|0|||
49140969|NCT00114777|158354602|FG000|Randomization to Month 36|Withdrawal by Subject|3|||
49140970|NCT00114777|158354603|FG001|Randomization to Month 36|Withdrawal by Subject|4|||
49140971|NCT00114777|158354604|FG002|Randomization to Month 36|Withdrawal by Subject|5|||
48729093|NCT02694523|156858302|FG004|Part B|Protocol Violation|0|||
48822134|NCT01474512|157190492|FG009|Maintenance Period|Treated but Discontinued in Induction|0|||
48822135|NCT01474512|157190493|FG010|Maintenance Period|Treated but Discontinued in Induction|0|||
48822136|NCT01474512|157190494|FG011|Maintenance Period|Treated but Discontinued in Induction|0|||
48822137|NCT01474512|157190495|FG012|Maintenance Period|Treated but Discontinued in Induction|0|||
48729094|NCT02694523|156858303|FG005|Part B|Protocol Violation|0|||
48729095|NCT02694523|156858304|FG006|Part B|Protocol Violation|0|||
48729096|NCT02694523|156858298|FG000|Part B|Lost to Follow-up|0|||
48729097|NCT02694523|156858299|FG001|Part B|Lost to Follow-up|0|||
48729098|NCT02694523|156858300|FG002|Part B|Lost to Follow-up|2|||
48822138|NCT01474512|157190496|FG013|Maintenance Period|Treated but Discontinued in Induction|0|||
48822139|NCT01474512|157190497|FG014|Maintenance Period|Treated but Discontinued in Induction|0|||
49140972|NCT00114777|158354602|FG000|Randomization to Month 36|Other|9|||
49140973|NCT00114777|158354603|FG001|Randomization to Month 36|Other|3|||
49140974|NCT00114777|158354604|FG002|Randomization to Month 36|Other|12|||
49140975|NCT00114777|158354602|FG000|Long-Term Extension to Month 84|Death|8|||
49140976|NCT00114777|158354603|FG001|Long-Term Extension to Month 84|Death|13|||
48822140|NCT01474512|157190498|FG015|Maintenance Period|Treated but Discontinued in Induction|0|||
49140977|NCT00114777|158354604|FG002|Long-Term Extension to Month 84|Death|7|||
49140978|NCT00114777|158354602|FG000|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
48822141|NCT01474512|157190499|FG016|Maintenance Period|Treated but Discontinued in Induction|0|||
49140979|NCT00114777|158354603|FG001|Long-Term Extension to Month 84|No Longer Met Study Criteria|0|||
48729099|NCT02694523|156858301|FG003|Part B|Lost to Follow-up|3|||
48729100|NCT02694523|156858302|FG004|Part B|Lost to Follow-up|2|||
48729101|NCT02694523|156858303|FG005|Part B|Lost to Follow-up|0|||
48729102|NCT02694523|156858304|FG006|Part B|Lost to Follow-up|1|||
48729103|NCT02694523|156858298|FG000|Part B|Withdrawal by Subject|0|||
48729104|NCT02694523|156858299|FG001|Part B|Withdrawal by Subject|0|||
48729105|NCT02694523|156858300|FG002|Part B|Withdrawal by Subject|9|||
48729106|NCT02694523|156858301|FG003|Part B|Withdrawal by Subject|0|||
48729107|NCT02694523|156858302|FG004|Part B|Withdrawal by Subject|1|||
48729108|NCT02694523|156858303|FG005|Part B|Withdrawal by Subject|3|||
48729109|NCT02694523|156858304|FG006|Part B|Withdrawal by Subject|0|||
48729110|NCT02694523|156858298|FG000|Part B|Other|0|||
48729111|NCT02694523|156858299|FG001|Part B|Other|0|||
48729112|NCT02694523|156858300|FG002|Part B|Other|1|||
48729113|NCT02694523|156858301|FG003|Part B|Other|0|||
48729114|NCT02694523|156858302|FG004|Part B|Other|0|||
48729115|NCT02694523|156858303|FG005|Part B|Other|0|||
48729116|NCT02694523|156858304|FG006|Part B|Other|1|||
48729117|NCT01272661|156858305|FG000|Overall Study|lost to followup/case closed/ no birth|126|||
48729118|NCT01272661|156858306|FG001|Overall Study|lost to followup/case closed/ no birth|209|||
48729119|NCT01272661|156858307|FG002|Overall Study|lost to followup/case closed/ no birth|72|||
48729120|NCT02962765|156858308|FG000|Overall Study|Protocol Violation|9|||
48729121|NCT02962765|156858308|FG000|Overall Study|Withdrawal by Subject|3|||
48729122|NCT02962765|156858308|FG000|Overall Study|Lost to Follow-up|1|||
48729123|NCT02962765|156858308|FG000|Overall Study|Death|1|||
48729124|NCT02962765|156858308|FG000|Overall Study|Limited access to study medication|3|||
48729125|NCT05409183|156858314|FG000|Complete Study|Adverse Event|1|||
48729126|NCT05409183|156858315|FG001|Complete Study|Adverse Event|2|||
48729127|NCT05409183|156858314|FG000|Complete Study|Withdrawal by Subject|3|||
48729128|NCT05409183|156858315|FG001|Complete Study|Withdrawal by Subject|0|||
48729129|NCT04654468|156858317|FG000|Overall Study|Death|1|||
48729130|NCT04654468|156858317|FG000|Overall Study|Ongoing in the Study|50|||
48729131|NCT00764504|156858319|FG000|Overall Study|Death|12|||
48729132|NCT00764504|156858320|FG001|Overall Study|Death|6|||
48729133|NCT00764504|156858321|FG002|Overall Study|Death|13|||
48729134|NCT00764504|156858319|FG000|Overall Study|Revision of Device|12|||
48729135|NCT00764504|156858320|FG001|Overall Study|Revision of Device|23|||
48729136|NCT00764504|156858321|FG002|Overall Study|Revision of Device|14|||
48729137|NCT00764504|156858319|FG000|Overall Study|Physician Decision|1|||
48729138|NCT00764504|156858320|FG001|Overall Study|Physician Decision|0|||
48729139|NCT00764504|156858321|FG002|Overall Study|Physician Decision|0|||
48729140|NCT00764504|156858319|FG000|Overall Study|Withdrawal by Subject|1|||
48729141|NCT00764504|156858320|FG001|Overall Study|Withdrawal by Subject|7|||
48729142|NCT00764504|156858321|FG002|Overall Study|Withdrawal by Subject|4|||
48822142|NCT01474512|157190500|FG017|Maintenance Period|Treated but Discontinued in Induction|0|||
48822143|NCT01474512|157190483|FG000|Long-Term Extension Period|Withdrawal by Subject|0|||
48822144|NCT01474512|157190484|FG001|Long-Term Extension Period|Withdrawal by Subject|0|||
48822145|NCT01474512|157190485|FG002|Long-Term Extension Period|Withdrawal by Subject|0|||
48822146|NCT01474512|157190486|FG003|Long-Term Extension Period|Withdrawal by Subject|0|||
48822147|NCT01474512|157190487|FG004|Long-Term Extension Period|Withdrawal by Subject|0|||
48822148|NCT01474512|157190488|FG005|Long-Term Extension Period|Withdrawal by Subject|0|||
48822149|NCT01474512|157190489|FG006|Long-Term Extension Period|Withdrawal by Subject|0|||
48822150|NCT01474512|157190490|FG007|Long-Term Extension Period|Withdrawal by Subject|0|||
48822151|NCT01474512|157190491|FG008|Long-Term Extension Period|Withdrawal by Subject|0|||
48822152|NCT01474512|157190492|FG009|Long-Term Extension Period|Withdrawal by Subject|0|||
48822153|NCT01474512|157190493|FG010|Long-Term Extension Period|Withdrawal by Subject|0|||
48822154|NCT01474512|157190494|FG011|Long-Term Extension Period|Withdrawal by Subject|3|||
48822155|NCT01474512|157190495|FG012|Long-Term Extension Period|Withdrawal by Subject|61|||
48822156|NCT01474512|157190496|FG013|Long-Term Extension Period|Withdrawal by Subject|61|||
48822157|NCT01474512|157190497|FG014|Long-Term Extension Period|Withdrawal by Subject|0|||
48822158|NCT01474512|157190498|FG015|Long-Term Extension Period|Withdrawal by Subject|0|||
48822159|NCT01474512|157190499|FG016|Long-Term Extension Period|Withdrawal by Subject|0|||
48822160|NCT01474512|157190500|FG017|Long-Term Extension Period|Withdrawal by Subject|0|||
48822161|NCT01474512|157190483|FG000|Long-Term Extension Period|Adverse Event|0|||
48729143|NCT00764504|156858319|FG000|Overall Study|Lost to Follow-up|40|||
48822162|NCT01474512|157190484|FG001|Long-Term Extension Period|Adverse Event|0|||
48822163|NCT01474512|157190485|FG002|Long-Term Extension Period|Adverse Event|0|||
48822164|NCT01474512|157190486|FG003|Long-Term Extension Period|Adverse Event|0|||
49011799|NCT01847313|157881568|FG001|Overall Study|Death|1|||
49011800|NCT01847313|157881567|FG000|Overall Study|Withdrawal by Subject|0|||
49011801|NCT01847313|157881568|FG001|Overall Study|Withdrawal by Subject|1|||
49011802|NCT02370784|157881569|FG000|Overall Study|Patient started prohibited medication|0|||
49011803|NCT02370784|157881570|FG001|Overall Study|Patient started prohibited medication|1|||
49011804|NCT02140164|157881573|FG000|Overall Study|Cystoid Macular Edema (CME) resolved|2|||
49011805|NCT02962882|157881574|FG000|Overall Study|Adverse Event|2|||
49011806|NCT02962882|157881574|FG000|Overall Study|Withdrawal by Subject|2|||
49011807|NCT02962882|157881574|FG000|Overall Study|Transfer from ICU|32|||
49011808|NCT00707174|157881575|FG000|Overall Study|Adverse Event|1|||
49011809|NCT00707174|157881576|FG001|Overall Study|Adverse Event|6|||
49011810|NCT00707174|157881575|FG000|Overall Study|Withdrawal by Subject|4|||
49011811|NCT00707174|157881576|FG001|Overall Study|Withdrawal by Subject|1|||
49011812|NCT00544557|157881577|FG000|Overall Study|Adverse Event|140|||
49140980|NCT00114777|158354604|FG002|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
49140981|NCT00114777|158354602|FG000|Long-Term Extension to Month 84|Lack of Efficacy|1|||
49140982|NCT00114777|158354603|FG001|Long-Term Extension to Month 84|Lack of Efficacy|0|||
49140983|NCT00114777|158354604|FG002|Long-Term Extension to Month 84|Lack of Efficacy|1|||
49140984|NCT00114777|158354602|FG000|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
48729144|NCT00764504|156858320|FG001|Overall Study|Lost to Follow-up|34|||
48729145|NCT00764504|156858321|FG002|Overall Study|Lost to Follow-up|72|||
48729146|NCT02028871|156858322|FG000|Overall Study|Positive urine drug screen|1|||
48729147|NCT02028871|156858323|FG001|Overall Study|Positive urine drug screen|1|||
48729148|NCT02028871|156858322|FG000|Overall Study|Withdrawal by Subject|1|||
48729149|NCT02028871|156858323|FG001|Overall Study|Withdrawal by Subject|2|||
48729150|NCT02028871|156858322|FG000|Overall Study|IV placement difficulty|1|||
48729151|NCT02028871|156858323|FG001|Overall Study|IV placement difficulty|0|||
48729152|NCT02028871|156858322|FG000|Overall Study|Current Illness|1|||
48729153|NCT02028871|156858323|FG001|Overall Study|Current Illness|0|||
48729154|NCT00006389|156858329|FG000|Overall Study|Adverse Event|1|||
48729155|NCT00989573|156858340|FG000|Overall Study|Adverse Event|8|||
48729156|NCT00989573|156858341|FG001|Overall Study|Adverse Event|12|||
48729157|NCT00989573|156858342|FG002|Overall Study|Adverse Event|4|||
48729158|NCT00989573|156858340|FG000|Overall Study|Physician Decision|0|||
48729159|NCT00989573|156858341|FG001|Overall Study|Physician Decision|2|||
48729160|NCT00989573|156858342|FG002|Overall Study|Physician Decision|0|||
48729161|NCT00989573|156858340|FG000|Overall Study|Protocol Violation|1|||
48729162|NCT00989573|156858341|FG001|Overall Study|Protocol Violation|1|||
48729163|NCT00989573|156858342|FG002|Overall Study|Protocol Violation|1|||
48729164|NCT00989573|156858340|FG000|Overall Study|Withdrawal by Subject|4|||
48729165|NCT00989573|156858341|FG001|Overall Study|Withdrawal by Subject|7|||
48729166|NCT00989573|156858342|FG002|Overall Study|Withdrawal by Subject|3|||
48729167|NCT01674634|156858354|FG000|Overall Study|Withdrawal by Subject|3|||
48729168|NCT01674634|156858354|FG000|Overall Study|Lost to Follow-up|3|||
48729169|NCT04690582|156858359|FG000|Overall Study|Withdrawal by Subject|6|||
48729170|NCT04690582|156858360|FG001|Overall Study|Withdrawal by Subject|4|||
48729171|NCT05736224|156858361|FG000|Overall Study|Excluded from analysis because processed biopsy sample was inadequate for analysis|1|||
48729172|NCT02452697|156858362|FG000|Overall Study|Physician Decision|4|||
48729173|NCT02452697|156858363|FG001|Overall Study|Physician Decision|4|||
48729174|NCT02452697|156858364|FG002|Overall Study|Physician Decision|3|||
48729175|NCT02452697|156858365|FG003|Overall Study|Physician Decision|2|||
48729176|NCT02452697|156858362|FG000|Overall Study|Withdrawal by Subject|1|||
48729177|NCT02452697|156858363|FG001|Overall Study|Withdrawal by Subject|0|||
48729178|NCT02452697|156858364|FG002|Overall Study|Withdrawal by Subject|0|||
48729179|NCT02452697|156858365|FG003|Overall Study|Withdrawal by Subject|0|||
48729180|NCT02452697|156858362|FG000|Overall Study|still in follow-up|2|||
48729181|NCT02452697|156858363|FG001|Overall Study|still in follow-up|2|||
48729182|NCT02452697|156858364|FG002|Overall Study|still in follow-up|1|||
48729183|NCT02452697|156858365|FG003|Overall Study|still in follow-up|3|||
48729184|NCT03803683|156858368|FG000|Overall Study|Lost to Follow-up|41|||
48729185|NCT03803683|156858369|FG001|Overall Study|Lost to Follow-up|18|||
48729186|NCT03803683|156858370|FG002|Overall Study|Lost to Follow-up|12|||
48729187|NCT03803683|156858368|FG000|Overall Study|Withdrawal by Subject|9|||
48729188|NCT03803683|156858369|FG001|Overall Study|Withdrawal by Subject|1|||
48729189|NCT03803683|156858370|FG002|Overall Study|Withdrawal by Subject|4|||
48729190|NCT01709578|156859686|FG000|Overall Study|Rescued and entered in long term safety|63|||
48729191|NCT01709578|156859687|FG001|Overall Study|Rescued and entered in long term safety|25|||
48729192|NCT01709578|156859688|FG002|Overall Study|Rescued and entered in long term safety|26|||
48729193|NCT01709578|156859686|FG000|Overall Study|Adverse Event|9|||
48729194|NCT01709578|156859687|FG001|Overall Study|Adverse Event|18|||
48729195|NCT01709578|156859688|FG002|Overall Study|Adverse Event|17|||
48729196|NCT01709578|156859686|FG000|Overall Study|Lack of Efficacy|5|||
48729197|NCT01709578|156859687|FG001|Overall Study|Lack of Efficacy|4|||
48729198|NCT01709578|156859688|FG002|Overall Study|Lack of Efficacy|2|||
48729199|NCT01709578|156859686|FG000|Overall Study|Poor compliance to protocol|1|||
48729200|NCT01709578|156859687|FG001|Overall Study|Poor compliance to protocol|2|||
48729201|NCT01709578|156859688|FG002|Overall Study|Poor compliance to protocol|1|||
48729202|NCT01709578|156859686|FG000|Overall Study|Other, not related to safety or efficacy|2|||
48729203|NCT01709578|156859687|FG001|Overall Study|Other, not related to safety or efficacy|7|||
48729204|NCT01709578|156859688|FG002|Overall Study|Other, not related to safety or efficacy|5|||
48729205|NCT04050371|156859689|FG000|Overall Study|Withdrawal by Subject|1|||
48729206|NCT04050371|156859690|FG001|Overall Study|Withdrawal by Subject|0|||
48729207|NCT02294773|156859691|FG000|Overall Study|Withdrawal by Subject|0|||
48729208|NCT02294773|156859692|FG001|Overall Study|Withdrawal by Subject|2|||
48729209|NCT05108922|156859693|FG000|Overall Study|Adverse Event|2|||
48729210|NCT05108922|156859694|FG001|Overall Study|Adverse Event|3|||
48729211|NCT05108922|156859693|FG000|Overall Study|Lost to Follow-up|2|||
48729212|NCT05108922|156859694|FG001|Overall Study|Lost to Follow-up|1|||
48729213|NCT05108922|156859693|FG000|Overall Study|Inadvertent enrollment|0|||
49011813|NCT00544557|157881577|FG000|Overall Study|Lack of Efficacy|196|||
49140985|NCT00114777|158354603|FG001|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
49140986|NCT00114777|158354604|FG002|Long-Term Extension to Month 84|Poor or Non-Compliance|3|||
49140987|NCT00114777|158354602|FG000|Long-Term Extension to Month 84|Adverse Event|15|||
49140988|NCT00114777|158354603|FG001|Long-Term Extension to Month 84|Adverse Event|14|||
49140989|NCT00114777|158354604|FG002|Long-Term Extension to Month 84|Adverse Event|7|||
49140990|NCT00114777|158354602|FG000|Long-Term Extension to Month 84|Withdrawal by Subject|2|||
49140991|NCT00114777|158354603|FG001|Long-Term Extension to Month 84|Withdrawal by Subject|1|||
49140992|NCT00114777|158354604|FG002|Long-Term Extension to Month 84|Withdrawal by Subject|6|||
49140993|NCT00114777|158354602|FG000|Long-Term Extension to Month 84|Lost to Follow-up|0|||
49140994|NCT00114777|158354603|FG001|Long-Term Extension to Month 84|Lost to Follow-up|0|||
49140995|NCT00114777|158354604|FG002|Long-Term Extension to Month 84|Lost to Follow-up|2|||
49140996|NCT00114777|158354602|FG000|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
49140997|NCT00114777|158354603|FG001|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
48729214|NCT05108922|156859694|FG001|Overall Study|Inadvertent enrollment|1|||
48729215|NCT05108922|156859693|FG000|Overall Study|Physician Decision|2|||
48729216|NCT05108922|156859694|FG001|Overall Study|Physician Decision|3|||
48729217|NCT05108922|156859693|FG000|Overall Study|Protocol deviation|1|||
48729218|NCT05108922|156859694|FG001|Overall Study|Protocol deviation|0|||
48729219|NCT05108922|156859693|FG000|Overall Study|Screen failure|1|||
48729220|NCT05108922|156859694|FG001|Overall Study|Screen failure|0|||
48729221|NCT05108922|156859693|FG000|Overall Study|Withdrawal by Subject|11|||
48729222|NCT05108922|156859694|FG001|Overall Study|Withdrawal by Subject|8|||
48729223|NCT03183778|156859698|FG000|Overall Study|Withdrawn by Investigator (potassium in normal range)|1|||
48729224|NCT00749580|156859699|FG000|Overall Study|Lost to Follow-up|4|||
48729225|NCT00749580|156859700|FG001|Overall Study|Lost to Follow-up|8|||
49011814|NCT00544557|157881577|FG000|Overall Study|Other|98|||
49011815|NCT03763331|157881578|FG000|Overall Study|Lost to Follow-up|1|||
49011816|NCT03763331|157881579|FG001|Overall Study|Lost to Follow-up|0|||
48729226|NCT00749580|156859699|FG000|Overall Study|Adverse Event|0|||
48729227|NCT00749580|156859700|FG001|Overall Study|Adverse Event|1|||
48729228|NCT01083173|156859701|FG000|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
48729229|NCT01083173|156859702|FG001|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
48729230|NCT01083173|156859701|FG000|Main Surveillance: Safety Group|Violation of the use/dosage|1|||
48729231|NCT01083173|156859702|FG001|Main Surveillance: Safety Group|Violation of the use/dosage|0|||
48729232|NCT01083173|156859701|FG000|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201|||
48729233|NCT01083173|156859702|FG001|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0|||
48729234|NCT01083173|156859701|FG000|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168|||
48729235|NCT01083173|156859702|FG001|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0|||
48729236|NCT01083173|156859701|FG000|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13|||
48729237|NCT01083173|156859702|FG001|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0|||
48729238|NCT01083173|156859701|FG000|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
48729239|NCT01083173|156859702|FG001|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
48729240|NCT01083173|156859701|FG000|Long-term Surveillance: Safety Group|Violation of the dosage|0|||
48729241|NCT01083173|156859702|FG001|Long-term Surveillance: Safety Group|Violation of the dosage|1|||
48729242|NCT01083173|156859701|FG000|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0|||
48729243|NCT01083173|156859702|FG001|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101|||
48729244|NCT01083173|156859701|FG000|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0|||
48729245|NCT01083173|156859702|FG001|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195|||
48729246|NCT01083173|156859701|FG000|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0|||
48729247|NCT01083173|156859702|FG001|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136|||
48729248|NCT01083173|156859701|FG000|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0|||
48729249|NCT01083173|156859702|FG001|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46|||
49011817|NCT03763331|157881578|FG000|Overall Study|Withdrawal by Subject|1|||
49011818|NCT03763331|157881579|FG001|Overall Study|Withdrawal by Subject|0|||
49011819|NCT03763331|157881578|FG000|Overall Study|Non-compliance|0|||
49011820|NCT03763331|157881579|FG001|Overall Study|Non-compliance|3|||
49011821|NCT01312779|157881580|FG000|Overall Study|Withdrawal by Subject|2|||
49011822|NCT01312779|157881580|FG000|Overall Study|Death|3|||
49011823|NCT01312779|157881580|FG000|Overall Study|Not Implanted with Device|27|||
49011824|NCT04741503|157881581|FG000|Initial Enrollment|Failed to meet screening criteria|0|||
49011825|NCT04741503|157881582|FG001|Initial Enrollment|Failed to meet screening criteria|0|||
49011826|NCT04741503|157881583|FG002|Initial Enrollment|Failed to meet screening criteria|767|||
49011827|NCT04741503|157881581|FG000|Initial Enrollment|Overquotas removed|0|||
49011828|NCT04741503|157881582|FG001|Initial Enrollment|Overquotas removed|0|||
49011829|NCT04741503|157881583|FG002|Initial Enrollment|Overquotas removed|186|||
49015358|NCT00717756|157892155|FG000|Overall Study|Withdrawal by Subject|1|||
48822165|NCT01474512|157190487|FG004|Long-Term Extension Period|Adverse Event|0|||
48822166|NCT01474512|157190488|FG005|Long-Term Extension Period|Adverse Event|0|||
48822167|NCT01474512|157190489|FG006|Long-Term Extension Period|Adverse Event|0|||
48822168|NCT01474512|157190490|FG007|Long-Term Extension Period|Adverse Event|0|||
48822169|NCT01474512|157190491|FG008|Long-Term Extension Period|Adverse Event|0|||
49140998|NCT00114777|158354604|FG002|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1|||
49140999|NCT00114777|158354602|FG000|Long-Term Extension to Month 84|Other|2|||
49141000|NCT00114777|158354603|FG001|Long-Term Extension to Month 84|Other|0|||
49141001|NCT00114777|158354604|FG002|Long-Term Extension to Month 84|Other|2|||
49141002|NCT05064800|158354605|FG000|Period 3|Withdrawal by Subject|0|||
49141003|NCT05064800|158354606|FG001|Period 3|Withdrawal by Subject|0|||
49141004|NCT05064800|158354607|FG002|Period 3|Withdrawal by Subject|0|||
49141005|NCT05064800|158354608|FG003|Period 3|Withdrawal by Subject|0|||
49141006|NCT05064800|158354609|FG004|Period 3|Withdrawal by Subject|1|||
49141007|NCT05064800|158354610|FG005|Period 3|Withdrawal by Subject|0|||
49141008|NCT00629239|158354611|FG000|Overall Study|Adverse Event|7|||
49141009|NCT00629239|158354612|FG001|Overall Study|Adverse Event|4|||
49141010|NCT00629239|158354611|FG000|Overall Study|Physician Decision|1|||
49011830|NCT04741503|157881581|FG000|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|23|||
49011831|NCT04741503|157881582|FG001|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|17|||
49011832|NCT04741503|157881583|FG002|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|0|||
49011833|NCT02280421|157881584|FG000|Washout (2 Weeks)|Adverse Event|0|||
49011834|NCT02280421|157881585|FG001|Washout (2 Weeks)|Adverse Event|1|||
49011835|NCT02280421|157881584|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
49011836|NCT02280421|157881585|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
49011837|NCT00597584|157881586|FG000|Overall Study|Adverse Event|4|||
49011838|NCT00597584|157881587|FG001|Overall Study|Adverse Event|2|||
49011839|NCT00597584|157881586|FG000|Overall Study|Death|53|||
49011840|NCT00597584|157881587|FG001|Overall Study|Death|30|||
49011841|NCT00597584|157881586|FG000|Overall Study|Lack of Efficacy|1|||
49011842|NCT00597584|157881587|FG001|Overall Study|Lack of Efficacy|0|||
49011843|NCT00597584|157881586|FG000|Overall Study|Lost to Follow-up|2|||
49011844|NCT00597584|157881587|FG001|Overall Study|Lost to Follow-up|4|||
49011845|NCT00597584|157881586|FG000|Overall Study|Physician Decision|3|||
49011846|NCT00597584|157881587|FG001|Overall Study|Physician Decision|0|||
49011847|NCT00597584|157881586|FG000|Overall Study|Pregnancy|2|||
49011848|NCT00597584|157881587|FG001|Overall Study|Pregnancy|0|||
49011849|NCT00597584|157881586|FG000|Overall Study|Withdrawal by Subject|44|||
49011850|NCT00597584|157881587|FG001|Overall Study|Withdrawal by Subject|12|||
49011851|NCT00597584|157881586|FG000|Overall Study|Discontinued Dialysis|0|||
49011852|NCT00597584|157881587|FG001|Overall Study|Discontinued Dialysis|1|||
49011853|NCT00597584|157881586|FG000|Overall Study|Lost ability to consent|1|||
49011854|NCT00597584|157881587|FG001|Overall Study|Lost ability to consent|1|||
49011855|NCT00597584|157881586|FG000|Overall Study|Never dosed|1|||
49011856|NCT00597584|157881587|FG001|Overall Study|Never dosed|0|||
49011857|NCT00597584|157881586|FG000|Overall Study|Relocation|8|||
49011858|NCT00597584|157881587|FG001|Overall Study|Relocation|6|||
49011859|NCT00597584|157881586|FG000|Overall Study|Renal transplant|9|||
49011860|NCT00597584|157881587|FG001|Overall Study|Renal transplant|7|||
49011861|NCT01859390|157881588|FG000|Overall Study|Insufficient Sputum Collected|1|||
49011862|NCT01859390|157881589|FG001|Overall Study|Insufficient Sputum Collected|3|||
49141011|NCT00629239|158354612|FG001|Overall Study|Physician Decision|0|||
49141012|NCT01851369|158354617|FG000|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
49141013|NCT01851369|158354618|FG001|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
49141014|NCT01851369|158354619|FG002|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
49141015|NCT01851369|158354620|FG003|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
49141016|NCT01851369|158354621|FG004|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
49141017|NCT01851369|158354622|FG005|Phase I Dose Escalation|Declined to participate (before treatment started)|1|||
49141018|NCT01851369|158354623|FG006|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
49141019|NCT01851369|158354624|FG007|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
49141020|NCT01851369|158354625|FG008|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
49141021|NCT01851369|158354626|FG009|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
49141022|NCT01851369|158354627|FG010|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
49011863|NCT01859390|157881588|FG000|Overall Study|Sample Missing Collection Date|0|||
49011864|NCT01859390|157881589|FG001|Overall Study|Sample Missing Collection Date|1|||
49011865|NCT01859390|157881588|FG000|Overall Study|Tube Cracked|0|||
49011866|NCT01859390|157881589|FG001|Overall Study|Tube Cracked|2|||
49011867|NCT01859390|157881588|FG000|Overall Study|Shipment Error|0|||
48822170|NCT01474512|157190492|FG009|Long-Term Extension Period|Adverse Event|0|||
49011868|NCT01859390|157881589|FG001|Overall Study|Shipment Error|1|||
48729250|NCT03954041|156859703|FG000|Overall Study|Lost to Follow-up|3|||
48729251|NCT03954041|156859704|FG001|Overall Study|Lost to Follow-up|3|||
48729252|NCT03954041|156859705|FG002|Overall Study|Lost to Follow-up|6|||
48729253|NCT03954041|156859703|FG000|Overall Study|Death|4|||
48729254|NCT03954041|156859704|FG001|Overall Study|Death|0|||
48729255|NCT03954041|156859705|FG002|Overall Study|Death|1|||
48729256|NCT03954041|156859703|FG000|Overall Study|Death by neurologic criteria|0|||
48729257|NCT03954041|156859704|FG001|Overall Study|Death by neurologic criteria|0|||
48729258|NCT03954041|156859705|FG002|Overall Study|Death by neurologic criteria|1|||
48729259|NCT03954041|156859703|FG000|Overall Study|Reason not specified|7|||
48729260|NCT03954041|156859704|FG001|Overall Study|Reason not specified|4|||
48729261|NCT03954041|156859705|FG002|Overall Study|Reason not specified|2|||
48729262|NCT03954041|156859703|FG000|Overall Study|Withdrew prior to dosing|4|||
48729263|NCT03954041|156859704|FG001|Overall Study|Withdrew prior to dosing|2|||
48729264|NCT03954041|156859705|FG002|Overall Study|Withdrew prior to dosing|0|||
48729265|NCT03868124|156859706|FG000|Overall Study|Withdrawal by Subject|4|||
48729266|NCT03868124|156859707|FG001|Overall Study|Withdrawal by Subject|0|||
49011869|NCT02482805|157881599|FG000|Overall Study|Lost to Follow-up|4|||
49011870|NCT02482805|157881600|FG001|Overall Study|Lost to Follow-up|4|||
49011871|NCT02482805|157881601|FG002|Overall Study|Lost to Follow-up|0|||
49011872|NCT01806597|157881602|FG000|Period 1 (Baseline to Week 16)|Adverse Event|1|||
49011873|NCT01806597|157881603|FG001|Period 1 (Baseline to Week 16)|Adverse Event|1|||
49011874|NCT01806597|157881604|FG002|Period 1 (Baseline to Week 16)|Adverse Event|0|||
49011875|NCT01806597|157881605|FG003|Period 1 (Baseline to Week 16)|Adverse Event|0|||
49011876|NCT01806597|157881606|FG004|Period 1 (Baseline to Week 16)|Adverse Event|2|||
49011877|NCT01806597|157881607|FG005|Period 1 (Baseline to Week 16)|Adverse Event|0|||
49011878|NCT01806597|157881602|FG000|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
49011879|NCT01806597|157881603|FG001|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
49011880|NCT01806597|157881604|FG002|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
49011881|NCT01806597|157881605|FG003|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
49011882|NCT01806597|157881606|FG004|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
49011883|NCT01806597|157881607|FG005|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
49011884|NCT01806597|157881602|FG000|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
49011885|NCT01806597|157881603|FG001|Period 1 (Baseline to Week 16)|Protocol Violation|1|||
49011886|NCT01806597|157881604|FG002|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
49011887|NCT01806597|157881605|FG003|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
49011888|NCT01806597|157881606|FG004|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
49011889|NCT01806597|157881607|FG005|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
49011890|NCT01806597|157881602|FG000|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3|||
49011891|NCT01806597|157881603|FG001|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
49011892|NCT01806597|157881604|FG002|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
49011893|NCT01806597|157881605|FG003|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
49011894|NCT01806597|157881606|FG004|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
49011895|NCT01806597|157881607|FG005|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
49011896|NCT01806597|157881602|FG000|Period 1 (Baseline to Week 16)|Physician Decision|0|||
49011897|NCT01806597|157881603|FG001|Period 1 (Baseline to Week 16)|Physician Decision|1|||
49011898|NCT01806597|157881604|FG002|Period 1 (Baseline to Week 16)|Physician Decision|0|||
49011899|NCT01806597|157881605|FG003|Period 1 (Baseline to Week 16)|Physician Decision|0|||
49011900|NCT01806597|157881606|FG004|Period 1 (Baseline to Week 16)|Physician Decision|0|||
49011901|NCT01806597|157881607|FG005|Period 1 (Baseline to Week 16)|Physician Decision|0|||
49011902|NCT01806597|157881602|FG000|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9|||
49011903|NCT01806597|157881603|FG001|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6|||
49011904|NCT01806597|157881604|FG002|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4|||
49011905|NCT01806597|157881605|FG003|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3|||
49011906|NCT01806597|157881606|FG004|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1|||
49011907|NCT01806597|157881607|FG005|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0|||
49011908|NCT01806597|157881602|FG000|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12|||
49011909|NCT01806597|157881603|FG001|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5|||
49011910|NCT01806597|157881604|FG002|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3|||
49011911|NCT01806597|157881605|FG003|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1|||
49011912|NCT01806597|157881606|FG004|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
49011913|NCT01806597|157881607|FG005|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
49011914|NCT01806597|157881602|FG000|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2|||
49011915|NCT01806597|157881603|FG001|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
49011916|NCT01806597|157881604|FG002|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
49011917|NCT01806597|157881605|FG003|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
49011918|NCT01806597|157881606|FG004|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
49011919|NCT01806597|157881607|FG005|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
49011920|NCT01806597|157881602|FG000|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
49011921|NCT01806597|157881603|FG001|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
49141023|NCT01851369|158354628|FG011|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
49141024|NCT01851369|158354629|FG012|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
49141025|NCT01691482|158354631|FG000|Treatment Period 2|Adverse Event|0|||
49011922|NCT01806597|157881604|FG002|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
49011923|NCT01806597|157881605|FG003|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
49011924|NCT01806597|157881606|FG004|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
49011925|NCT01806597|157881607|FG005|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
49011926|NCT01806597|157881602|FG000|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2|||
49011927|NCT01806597|157881603|FG001|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
49011928|NCT01806597|157881604|FG002|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
49011929|NCT01806597|157881605|FG003|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
49011930|NCT01806597|157881606|FG004|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
49011931|NCT01806597|157881607|FG005|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
49011932|NCT01806597|157881602|FG000|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
49011933|NCT01806597|157881603|FG001|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
49011934|NCT01806597|157881604|FG002|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
49011935|NCT01806597|157881605|FG003|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
49011936|NCT01806597|157881606|FG004|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
49011937|NCT01806597|157881607|FG005|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
48822171|NCT01474512|157190493|FG010|Long-Term Extension Period|Adverse Event|0|||
48822172|NCT01474512|157190494|FG011|Long-Term Extension Period|Adverse Event|1|||
48822173|NCT01474512|157190495|FG012|Long-Term Extension Period|Adverse Event|57|||
48822174|NCT01474512|157190496|FG013|Long-Term Extension Period|Adverse Event|58|||
48822175|NCT01474512|157190497|FG014|Long-Term Extension Period|Adverse Event|0|||
48822176|NCT01474512|157190498|FG015|Long-Term Extension Period|Adverse Event|0|||
48822177|NCT01474512|157190499|FG016|Long-Term Extension Period|Adverse Event|0|||
49141026|NCT01691482|158354632|FG001|Treatment Period 2|Adverse Event|1|||
49141027|NCT01691482|158354631|FG000|Treatment Period 2|Protocol Violation|1|||
49141028|NCT01691482|158354632|FG001|Treatment Period 2|Protocol Violation|1|||
49141029|NCT02460380|158354633|FG000|Overall Study|Withdrawal by Subject|10|||
49141030|NCT02460380|158354634|FG001|Overall Study|Withdrawal by Subject|5|||
49141031|NCT05436288|158354639|FG000|Overall Study|Lost to Follow-up|1|||
49141032|NCT05436288|158354639|FG000|Overall Study|Adverse Event|1|||
49141033|NCT03501277|158354644|FG000|Intervention Period 1 (4 Days)|Other|0|||
49141034|NCT03501277|158354645|FG001|Intervention Period 1 (4 Days)|Other|0|||
49141035|NCT03501277|158354646|FG002|Intervention Period 1 (4 Days)|Other|1|||
49141036|NCT03501277|158354647|FG003|Intervention Period 1 (4 Days)|Other|0|||
49141037|NCT03501277|158354644|FG000|Intervention Period 1 (4 Days)|Adverse Event|0|||
49141038|NCT03501277|158354645|FG001|Intervention Period 1 (4 Days)|Adverse Event|0|||
49141039|NCT03501277|158354646|FG002|Intervention Period 1 (4 Days)|Adverse Event|0|||
49141040|NCT03501277|158354647|FG003|Intervention Period 1 (4 Days)|Adverse Event|1|||
49141041|NCT03501277|158354644|FG000|Intervention Period 2 (4 Days)|Adverse Event|0|||
49141042|NCT03501277|158354645|FG001|Intervention Period 2 (4 Days)|Adverse Event|0|||
49141043|NCT03501277|158354646|FG002|Intervention Period 2 (4 Days)|Adverse Event|0|||
49141044|NCT03501277|158354647|FG003|Intervention Period 2 (4 Days)|Adverse Event|1|||
49141045|NCT03501277|158354644|FG000|Intervention Period 3 (4 Days)|Adverse Event|0|||
49141046|NCT03501277|158354645|FG001|Intervention Period 3 (4 Days)|Adverse Event|0|||
49141047|NCT03501277|158354646|FG002|Intervention Period 3 (4 Days)|Adverse Event|0|||
49141048|NCT03501277|158354647|FG003|Intervention Period 3 (4 Days)|Adverse Event|1|||
49141049|NCT00066170|158354648|FG000|Overall Study|Adverse Event|2|||
49141050|NCT00066170|158354649|FG001|Overall Study|Adverse Event|4|||
49141051|NCT00066170|158354650|FG002|Overall Study|Adverse Event|1|||
49141052|NCT00066170|158354651|FG003|Overall Study|Adverse Event|7|||
49141053|NCT00066170|158354648|FG000|Overall Study|Serious Adverse Event|0|||
49141054|NCT00066170|158354649|FG001|Overall Study|Serious Adverse Event|0|||
49141055|NCT00066170|158354650|FG002|Overall Study|Serious Adverse Event|1|||
49141056|NCT00066170|158354651|FG003|Overall Study|Serious Adverse Event|1|||
49141057|NCT00066170|158354648|FG000|Overall Study|Lost to Follow-up|0|||
49141058|NCT00066170|158354649|FG001|Overall Study|Lost to Follow-up|1|||
49141059|NCT00066170|158354650|FG002|Overall Study|Lost to Follow-up|0|||
49141060|NCT00066170|158354651|FG003|Overall Study|Lost to Follow-up|0|||
49141061|NCT00066170|158354648|FG000|Overall Study|Non-Compliance with Trial Medicine|1|||
48822178|NCT01474512|157190500|FG017|Long-Term Extension Period|Adverse Event|0|||
48822179|NCT01474512|157190483|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
49141062|NCT00066170|158354649|FG001|Overall Study|Non-Compliance with Trial Medicine|0|||
49141063|NCT00066170|158354650|FG002|Overall Study|Non-Compliance with Trial Medicine|0|||
49141064|NCT00066170|158354651|FG003|Overall Study|Non-Compliance with Trial Medicine|1|||
49141065|NCT00066170|158354648|FG000|Overall Study|Protocol Violation|3|||
49141066|NCT00066170|158354649|FG001|Overall Study|Protocol Violation|0|||
49141067|NCT00066170|158354650|FG002|Overall Study|Protocol Violation|0|||
48729267|NCT03868124|156859708|FG002|Overall Study|Withdrawal by Subject|1|||
49141068|NCT00066170|158354651|FG003|Overall Study|Protocol Violation|0|||
49141069|NCT00066170|158354648|FG000|Overall Study|Other|1|||
49141070|NCT00066170|158354649|FG001|Overall Study|Other|5|||
49141071|NCT00066170|158354650|FG002|Overall Study|Other|2|||
49141072|NCT00066170|158354651|FG003|Overall Study|Other|0|||
49141073|NCT00812097|158354652|FG000|Overall Study|Death|3|||
49141074|NCT00812097|158354653|FG001|Overall Study|Death|10|||
49141075|NCT00812097|158354654|FG002|Overall Study|Death|3|||
49141076|NCT00812097|158354655|FG003|Overall Study|Death|3|||
49141077|NCT00812097|158354652|FG000|Overall Study|Withdrawal by Subject|14|||
49141078|NCT00812097|158354653|FG001|Overall Study|Withdrawal by Subject|12|||
49141079|NCT00812097|158354654|FG002|Overall Study|Withdrawal by Subject|8|||
49141080|NCT00812097|158354655|FG003|Overall Study|Withdrawal by Subject|2|||
49141081|NCT00812097|158354652|FG000|Overall Study|Lost to Follow-up|90|||
49141082|NCT00812097|158354653|FG001|Overall Study|Lost to Follow-up|14|||
49141083|NCT00812097|158354654|FG002|Overall Study|Lost to Follow-up|17|||
49141084|NCT00812097|158354655|FG003|Overall Study|Lost to Follow-up|5|||
49141085|NCT00812097|158354652|FG000|Overall Study|Explantation of study device(s)|27|||
49141086|NCT00812097|158354653|FG001|Overall Study|Explantation of study device(s)|29|||
49141087|NCT00812097|158354654|FG002|Overall Study|Explantation of study device(s)|14|||
49141088|NCT00812097|158354655|FG003|Overall Study|Explantation of study device(s)|20|||
49141089|NCT00812097|158354652|FG000|Overall Study|Unknown reasons and patient/doctor moves|111|||
49141090|NCT00812097|158354653|FG001|Overall Study|Unknown reasons and patient/doctor moves|24|||
49141091|NCT00812097|158354654|FG002|Overall Study|Unknown reasons and patient/doctor moves|15|||
49141092|NCT00812097|158354655|FG003|Overall Study|Unknown reasons and patient/doctor moves|5|||
49141093|NCT04069520|158354657|FG000|Overall Study|Lost to Follow-up|0|||
49141094|NCT04069520|158354658|FG001|Overall Study|Lost to Follow-up|2|||
49141095|NCT04069520|158354657|FG000|Overall Study|Withdrawal by Subject|0|||
49141096|NCT04069520|158354658|FG001|Overall Study|Withdrawal by Subject|1|||
49141097|NCT04069520|158354657|FG000|Overall Study|Prior Injury|1|||
49141098|NCT04069520|158354658|FG001|Overall Study|Prior Injury|0|||
49141099|NCT04069520|158354657|FG000|Overall Study|Orthodontia|1|||
49141100|NCT04069520|158354658|FG001|Overall Study|Orthodontia|0|||
49141101|NCT04069520|158354657|FG000|Overall Study|Cut from team|0|||
49141102|NCT04069520|158354658|FG001|Overall Study|Cut from team|2|||
49141103|NCT01068912|158354659|FG000|Overall Study|Adverse Event|2|||
49141104|NCT01068912|158354660|FG001|Overall Study|Adverse Event|3|||
49141105|NCT01068912|158354661|FG002|Overall Study|Adverse Event|2|||
49141106|NCT01068912|158354659|FG000|Overall Study|Withdrawal by Subject|5|||
49141107|NCT01068912|158354660|FG001|Overall Study|Withdrawal by Subject|6|||
49141108|NCT01068912|158354661|FG002|Overall Study|Withdrawal by Subject|6|||
49141109|NCT01068912|158354659|FG000|Overall Study|Lost to Follow-up|3|||
49141110|NCT01068912|158354660|FG001|Overall Study|Lost to Follow-up|7|||
49141111|NCT01068912|158354661|FG002|Overall Study|Lost to Follow-up|3|||
49141112|NCT01068912|158354659|FG000|Overall Study|Protocol Violation|0|||
49141113|NCT01068912|158354660|FG001|Overall Study|Protocol Violation|2|||
49141114|NCT01068912|158354661|FG002|Overall Study|Protocol Violation|0|||
49141115|NCT01068912|158354659|FG000|Overall Study|aggravation influenza|1|||
49141116|NCT01068912|158354660|FG001|Overall Study|aggravation influenza|1|||
49141117|NCT01068912|158354661|FG002|Overall Study|aggravation influenza|1|||
49141118|NCT01068912|158354659|FG000|Overall Study|other underlying illness|0|||
49141119|NCT01068912|158354660|FG001|Overall Study|other underlying illness|3|||
49141120|NCT01068912|158354661|FG002|Overall Study|other underlying illness|3|||
49141121|NCT03528577|158354666|FG000|Sequence 1|Failed Spirometry|1|||
49141122|NCT03528577|158354666|FG000|Sequence 1|Restricted medication|1|||
49141123|NCT03528577|158354666|FG000|Sequence 2|Adverse Event|1|||
49141124|NCT03528577|158354666|FG000|Sequence 2|Withdrawal by Subject|1|||
48729268|NCT03868124|156859706|FG000|Overall Study|Physician Decision|1|||
48729269|NCT03868124|156859707|FG001|Overall Study|Physician Decision|0|||
48729270|NCT03868124|156859708|FG002|Overall Study|Physician Decision|1|||
48729271|NCT03868124|156859706|FG000|Overall Study|Lost to Follow-up|1|||
48729272|NCT03868124|156859707|FG001|Overall Study|Lost to Follow-up|1|||
48729273|NCT03868124|156859708|FG002|Overall Study|Lost to Follow-up|2|||
48729274|NCT03868124|156859706|FG000|Overall Study|Death|1|||
49141125|NCT03528577|158354666|FG000|Sequence 2|Failed Spirometry|1|||
49141126|NCT03528577|158354666|FG000|Sequence 3|Failed Spirometry|1|||
49141127|NCT03528577|158354666|FG000|Sequence 4|Failed Spirometry|2|||
49141128|NCT03528577|158354666|FG000|Sequence 4|Adverse Event|1|||
49141129|NCT02939781|158354667|FG000|Overall Study|Protocol Violation|8|||
49141130|NCT02939781|158354667|FG000|Overall Study|Withdrawal by Subject|1|||
49141131|NCT00541775|158354668|FG000|Overall Study|Adverse Event|3|||
49141132|NCT00541775|158354669|FG001|Overall Study|Adverse Event|2|||
49141133|NCT00541775|158354670|FG002|Overall Study|Adverse Event|1|||
49141134|NCT00541775|158354668|FG000|Overall Study|Lack of Efficacy|0|||
49141135|NCT00541775|158354669|FG001|Overall Study|Lack of Efficacy|0|||
49141136|NCT00541775|158354670|FG002|Overall Study|Lack of Efficacy|3|||
49141137|NCT00541775|158354668|FG000|Overall Study|Lost to Follow-up|0|||
48729275|NCT03868124|156859707|FG001|Overall Study|Death|1|||
48729276|NCT03868124|156859708|FG002|Overall Study|Death|2|||
48729277|NCT03868124|156859706|FG000|Overall Study|Adverse Event|0|||
48729278|NCT03868124|156859707|FG001|Overall Study|Adverse Event|0|||
48729279|NCT03868124|156859708|FG002|Overall Study|Adverse Event|3|||
48729280|NCT03868124|156859706|FG000|Overall Study|Explanted|2|||
48729281|NCT03868124|156859707|FG001|Overall Study|Explanted|1|||
48729282|NCT03868124|156859708|FG002|Overall Study|Explanted|0|||
48729283|NCT03868124|156859706|FG000|Overall Study|Ongoing in study|176|||
48729284|NCT03868124|156859707|FG001|Overall Study|Ongoing in study|180|||
48729285|NCT03868124|156859708|FG002|Overall Study|Ongoing in study|183|||
48729286|NCT04024462|156859711|FG000|Overall Study|Withdrawal by Subject|6|||
48729287|NCT04024462|156859712|FG001|Overall Study|Withdrawal by Subject|7|||
48729288|NCT04024462|156859711|FG000|Overall Study|Progressive Disease|0|||
48729289|NCT04024462|156859712|FG001|Overall Study|Progressive Disease|1|||
48729290|NCT04024462|156859711|FG000|Overall Study|Adverse Event|0|||
48729291|NCT04024462|156859712|FG001|Overall Study|Adverse Event|1|||
48729292|NCT04024462|156859711|FG000|Overall Study|Death|0|||
48729293|NCT04024462|156859712|FG001|Overall Study|Death|1|||
48729294|NCT04024462|156859711|FG000|Overall Study|Lost to Follow-up|1|||
48729295|NCT04024462|156859712|FG001|Overall Study|Lost to Follow-up|0|||
48729296|NCT04024462|156859711|FG000|Overall Study|Ongoing in the Study|94|||
48729297|NCT04024462|156859712|FG001|Overall Study|Ongoing in the Study|89|||
48822180|NCT01474512|157190484|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
48822181|NCT01474512|157190485|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
48822182|NCT01474512|157190486|FG003|Long-Term Extension Period|Lost to Follow-up|0|||
49141138|NCT00541775|158354669|FG001|Overall Study|Lost to Follow-up|0|||
49141139|NCT00541775|158354670|FG002|Overall Study|Lost to Follow-up|2|||
49141140|NCT00541775|158354668|FG000|Overall Study|Protocol Violation|1|||
49141141|NCT00541775|158354669|FG001|Overall Study|Protocol Violation|0|||
49141142|NCT00541775|158354670|FG002|Overall Study|Protocol Violation|0|||
49141143|NCT00541775|158354668|FG000|Overall Study|Withdrawal by Subject and Other|5|||
49141144|NCT00541775|158354669|FG001|Overall Study|Withdrawal by Subject and Other|0|||
49141145|NCT00541775|158354670|FG002|Overall Study|Withdrawal by Subject and Other|2|||
49141146|NCT00032487|158354671|FG000|Overall Study|Withdrawal by Subject|67|||
49141147|NCT00032487|158354672|FG001|Overall Study|Withdrawal by Subject|43|||
49141148|NCT00032487|158354671|FG000|Overall Study|Adverse Event|3|||
49141149|NCT00032487|158354672|FG001|Overall Study|Adverse Event|7|||
49141150|NCT00032487|158354671|FG000|Overall Study|Lost to Follow-up|57|||
49141151|NCT00032487|158354672|FG001|Overall Study|Lost to Follow-up|58|||
49141152|NCT00032487|158354671|FG000|Overall Study|Had other reason|12|||
49141153|NCT00032487|158354672|FG001|Overall Study|Had other reason|12|||
49141154|NCT03753542|158354673|FG000|Overall Study|Lost to Follow-up|9|||
49141155|NCT03753542|158354674|FG001|Overall Study|Lost to Follow-up|14|||
49141156|NCT01028391|158354675|FG000|Overall Study|Adverse Event|4|||
49141157|NCT01028391|158354676|FG001|Overall Study|Adverse Event|0|||
49141158|NCT01028391|158354675|FG000|Overall Study|Lack of Efficacy|0|||
49141159|NCT01028391|158354676|FG001|Overall Study|Lack of Efficacy|2|||
49141160|NCT01028391|158354675|FG000|Overall Study|Lost to Follow-up|3|||
49141161|NCT01028391|158354676|FG001|Overall Study|Lost to Follow-up|4|||
49141162|NCT01028391|158354675|FG000|Overall Study|Physician Decision|0|||
49141163|NCT01028391|158354676|FG001|Overall Study|Physician Decision|1|||
49141164|NCT01028391|158354675|FG000|Overall Study|Withdrawal by Subject|6|||
49141165|NCT01028391|158354676|FG001|Overall Study|Withdrawal by Subject|3|||
49141166|NCT01028391|158354675|FG000|Overall Study|Needed excluded medication|1|||
49141167|NCT01028391|158354676|FG001|Overall Study|Needed excluded medication|1|||
49141168|NCT03259308|158354677|FG000|Overall Study|Adverse Event|5|||
49141169|NCT03259308|158354678|FG001|Overall Study|Adverse Event|4|||
49141170|NCT03259308|158354679|FG002|Overall Study|Adverse Event|1|||
49141171|NCT03259308|158354677|FG000|Overall Study|Withdrawal by Subject|2|||
49141172|NCT03259308|158354678|FG001|Overall Study|Withdrawal by Subject|1|||
48729298|NCT05128929|156859715|FG000|Overall Study|Adverse Event|0|||
48729299|NCT05128929|156859716|FG001|Overall Study|Adverse Event|1|||
48729300|NCT04622735|156859717|FG000|Overall Study|Lost to Follow-up|1|||
48729301|NCT04622735|156859718|FG001|Overall Study|Lost to Follow-up|2|||
48729302|NCT04622735|156859719|FG002|Overall Study|Lost to Follow-up|1|||
48729303|NCT04622735|156859717|FG000|Overall Study|Adverse Event|0|||
48729304|NCT04622735|156859718|FG001|Overall Study|Adverse Event|0|||
48822183|NCT01474512|157190487|FG004|Long-Term Extension Period|Lost to Follow-up|0|||
48822184|NCT01474512|157190488|FG005|Long-Term Extension Period|Lost to Follow-up|0|||
49141173|NCT03259308|158354679|FG002|Overall Study|Withdrawal by Subject|3|||
49141174|NCT03259308|158354677|FG000|Overall Study|Lost to Follow-up|0|||
49141175|NCT03259308|158354678|FG001|Overall Study|Lost to Follow-up|0|||
49141176|NCT03259308|158354679|FG002|Overall Study|Lost to Follow-up|1|||
49141177|NCT03259308|158354677|FG000|Overall Study|Pregnancy|0|||
48729305|NCT04622735|156859719|FG002|Overall Study|Adverse Event|1|||
49141178|NCT03259308|158354678|FG001|Overall Study|Pregnancy|0|||
49141179|NCT03259308|158354679|FG002|Overall Study|Pregnancy|1|||
49141180|NCT03259308|158354677|FG000|Overall Study|Protocol Deviation|0|||
49141181|NCT03259308|158354678|FG001|Overall Study|Protocol Deviation|3|||
48822185|NCT01474512|157190489|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
48729306|NCT04622735|156859717|FG000|Overall Study|Protocol Violation|1|||
48729307|NCT04622735|156859718|FG001|Overall Study|Protocol Violation|0|||
48729308|NCT04622735|156859719|FG002|Overall Study|Protocol Violation|0|||
48729309|NCT01809691|156859720|FG000|Overall Study|Currently on Treatment|192|||
48729310|NCT01809691|156859721|FG001|Overall Study|Currently on Treatment|100|||
48729311|NCT01809691|156859720|FG000|Overall Study|No Protocol Treatment|10|||
48729312|NCT01809691|156859721|FG001|Overall Study|No Protocol Treatment|11|||
48729313|NCT01809691|156859720|FG000|Overall Study|Adverse Event|80|||
48729314|NCT01809691|156859721|FG001|Overall Study|Adverse Event|21|||
48729315|NCT01809691|156859720|FG000|Overall Study|Disease Progression|226|||
48822186|NCT01474512|157190490|FG007|Long-Term Extension Period|Lost to Follow-up|0|||
48822187|NCT01474512|157190491|FG008|Long-Term Extension Period|Lost to Follow-up|0|||
48729316|NCT01809691|156859721|FG001|Overall Study|Disease Progression|372|||
48729317|NCT01809691|156859720|FG000|Overall Study|Death|26|||
48729318|NCT01809691|156859721|FG001|Overall Study|Death|13|||
48822188|NCT01474512|157190492|FG009|Long-Term Extension Period|Lost to Follow-up|0|||
48822189|NCT01474512|157190493|FG010|Long-Term Extension Period|Lost to Follow-up|0|||
48822190|NCT01474512|157190494|FG011|Long-Term Extension Period|Lost to Follow-up|0|||
48822191|NCT01474512|157190495|FG012|Long-Term Extension Period|Lost to Follow-up|25|||
48822192|NCT01474512|157190496|FG013|Long-Term Extension Period|Lost to Follow-up|25|||
48822193|NCT01474512|157190497|FG014|Long-Term Extension Period|Lost to Follow-up|0|||
48822194|NCT01474512|157190498|FG015|Long-Term Extension Period|Lost to Follow-up|0|||
48822195|NCT01474512|157190499|FG016|Long-Term Extension Period|Lost to Follow-up|0|||
48822196|NCT01474512|157190500|FG017|Long-Term Extension Period|Lost to Follow-up|0|||
48822197|NCT01474512|157190483|FG000|Long-Term Extension Period|Lack of Efficacy|0|||
48822198|NCT01474512|157190484|FG001|Long-Term Extension Period|Lack of Efficacy|0|||
48822199|NCT01474512|157190485|FG002|Long-Term Extension Period|Lack of Efficacy|0|||
48822200|NCT01474512|157190486|FG003|Long-Term Extension Period|Lack of Efficacy|0|||
48822201|NCT01474512|157190487|FG004|Long-Term Extension Period|Lack of Efficacy|0|||
48822202|NCT01474512|157190488|FG005|Long-Term Extension Period|Lack of Efficacy|0|||
48822203|NCT01474512|157190489|FG006|Long-Term Extension Period|Lack of Efficacy|0|||
48822204|NCT01474512|157190490|FG007|Long-Term Extension Period|Lack of Efficacy|0|||
48822205|NCT01474512|157190491|FG008|Long-Term Extension Period|Lack of Efficacy|0|||
48822206|NCT01474512|157190492|FG009|Long-Term Extension Period|Lack of Efficacy|0|||
48822207|NCT01474512|157190493|FG010|Long-Term Extension Period|Lack of Efficacy|0|||
48822208|NCT01474512|157190494|FG011|Long-Term Extension Period|Lack of Efficacy|1|||
48822209|NCT01474512|157190495|FG012|Long-Term Extension Period|Lack of Efficacy|24|||
48822210|NCT01474512|157190496|FG013|Long-Term Extension Period|Lack of Efficacy|25|||
48822211|NCT01474512|157190497|FG014|Long-Term Extension Period|Lack of Efficacy|0|||
48822212|NCT01474512|157190498|FG015|Long-Term Extension Period|Lack of Efficacy|0|||
48822213|NCT01474512|157190499|FG016|Long-Term Extension Period|Lack of Efficacy|0|||
48822214|NCT01474512|157190500|FG017|Long-Term Extension Period|Lack of Efficacy|0|||
48822215|NCT01474512|157190483|FG000|Long-Term Extension Period|Physician Decision|0|||
48822216|NCT01474512|157190484|FG001|Long-Term Extension Period|Physician Decision|0|||
48822217|NCT01474512|157190485|FG002|Long-Term Extension Period|Physician Decision|0|||
48822218|NCT01474512|157190486|FG003|Long-Term Extension Period|Physician Decision|0|||
48822219|NCT01474512|157190487|FG004|Long-Term Extension Period|Physician Decision|0|||
48822220|NCT01474512|157190488|FG005|Long-Term Extension Period|Physician Decision|0|||
48822221|NCT01474512|157190489|FG006|Long-Term Extension Period|Physician Decision|0|||
48822222|NCT01474512|157190490|FG007|Long-Term Extension Period|Physician Decision|0|||
48822223|NCT01474512|157190491|FG008|Long-Term Extension Period|Physician Decision|0|||
48822224|NCT01474512|157190492|FG009|Long-Term Extension Period|Physician Decision|0|||
48822225|NCT01474512|157190493|FG010|Long-Term Extension Period|Physician Decision|0|||
48822226|NCT01474512|157190494|FG011|Long-Term Extension Period|Physician Decision|0|||
49011938|NCT01806597|157881602|FG000|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10|||
49011939|NCT01806597|157881603|FG001|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
49011940|NCT01806597|157881604|FG002|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6|||
49011941|NCT01806597|157881605|FG003|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
49011942|NCT01806597|157881606|FG004|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
49011943|NCT01806597|157881607|FG005|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
49011944|NCT01806597|157881602|FG000|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
49011945|NCT01806597|157881603|FG001|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
49011946|NCT01806597|157881604|FG002|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
49011947|NCT01806597|157881605|FG003|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
49011948|NCT01806597|157881606|FG004|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
49011949|NCT01806597|157881607|FG005|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
49011950|NCT01806597|157881602|FG000|Treatment Period 2 (Week 16 to Week 132)|Death|1|||
49011951|NCT01806597|157881603|FG001|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
49011952|NCT01806597|157881604|FG002|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
49011953|NCT01806597|157881605|FG003|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
49141182|NCT03259308|158354679|FG002|Overall Study|Protocol Deviation|0|||
49141183|NCT03259308|158354677|FG000|Overall Study|Lack of Efficacy|0|||
49141184|NCT03259308|158354678|FG001|Overall Study|Lack of Efficacy|0|||
49141185|NCT03259308|158354679|FG002|Overall Study|Lack of Efficacy|1|||
49141186|NCT01108055|158354680|FG000|Overall Study|Ineligible|11|||
49141187|NCT01108055|158354680|FG000|Overall Study|Not evaluable- didn't complete treatment|4|||
49141188|NCT03339453|158354683|FG000|First Visit of Glucagon Treatment|Adverse Event|0|||
49141189|NCT03339453|158354684|FG001|First Visit of Glucagon Treatment|Adverse Event|1|||
49141190|NCT03158311|158354687|FG000|Overall Study|Subject/Guardian Decision|10|||
49141191|NCT03158311|158354688|FG001|Overall Study|Subject/Guardian Decision|6|||
49141192|NCT03158311|158354689|FG002|Overall Study|Subject/Guardian Decision|11|||
49141193|NCT03158311|158354687|FG000|Overall Study|Adverse Event|5|||
49141194|NCT03158311|158354688|FG001|Overall Study|Adverse Event|3|||
49141195|NCT03158311|158354689|FG002|Overall Study|Adverse Event|3|||
49141196|NCT03158311|158354687|FG000|Overall Study|Techinical Problems|3|||
49141197|NCT03158311|158354688|FG001|Overall Study|Techinical Problems|1|||
49141198|NCT03158311|158354689|FG002|Overall Study|Techinical Problems|5|||
49141199|NCT03158311|158354687|FG000|Overall Study|Physician Decision|2|||
49141200|NCT03158311|158354688|FG001|Overall Study|Physician Decision|3|||
49141201|NCT03158311|158354689|FG002|Overall Study|Physician Decision|7|||
49141202|NCT03158311|158354687|FG000|Overall Study|Lost to Follow-up|1|||
49141203|NCT03158311|158354688|FG001|Overall Study|Lost to Follow-up|1|||
49141204|NCT03158311|158354689|FG002|Overall Study|Lost to Follow-up|1|||
49141205|NCT03158311|158354687|FG000|Overall Study|Sponsor decision|1|||
49141206|NCT03158311|158354688|FG001|Overall Study|Sponsor decision|0|||
49141207|NCT03158311|158354689|FG002|Overall Study|Sponsor decision|0|||
49141208|NCT03158311|158354687|FG000|Overall Study|Pregnancy|0|||
49141209|NCT03158311|158354688|FG001|Overall Study|Pregnancy|2|||
49141210|NCT03158311|158354689|FG002|Overall Study|Pregnancy|0|||
49141211|NCT03158311|158354687|FG000|Overall Study|Randomized in error|0|||
49141212|NCT03158311|158354688|FG001|Overall Study|Randomized in error|0|||
49141213|NCT03158311|158354689|FG002|Overall Study|Randomized in error|1|||
49141214|NCT01800058|158354694|FG000|Overall Study|Lost to Follow-up|1|||
49141215|NCT00290238|158354695|FG000|Overall Study|Study terminated|27|||
49141216|NCT00290238|158354696|FG001|Overall Study|Study terminated|27|||
49141217|NCT00290238|158354695|FG000|Overall Study|Lost to Follow-up|0|||
49141218|NCT00290238|158354696|FG001|Overall Study|Lost to Follow-up|1|||
49141219|NCT00290238|158354695|FG000|Overall Study|Withdrawal by Subject|15|||
49141220|NCT00290238|158354696|FG001|Overall Study|Withdrawal by Subject|13|||
49141221|NCT01671059|158354697|FG000|Overall Study|Adverse Event|4|||
49141222|NCT01671059|158354697|FG000|Overall Study|Lack of Efficacy|1|||
49141223|NCT00954538|158354703|FG000|Part III|Withdrawal by Subject|0|||
49141224|NCT00954538|158354704|FG001|Part III|Withdrawal by Subject|0|||
48729319|NCT01809691|156859720|FG000|Overall Study|Participant Refusal|70|||
48729320|NCT01809691|156859721|FG001|Overall Study|Participant Refusal|72|||
48729321|NCT01809691|156859720|FG000|Overall Study|Other, Not Specified|34|||
48729322|NCT01809691|156859721|FG001|Overall Study|Other, Not Specified|52|||
48729323|NCT03834493|156859722|FG000|Overall Study|Participants Ongoing|311|||
48729324|NCT03834493|156859723|FG001|Overall Study|Participants Ongoing|324|||
48729325|NCT03834493|156859722|FG000|Overall Study|Withdrawal by Subject|20|||
48729326|NCT03834493|156859723|FG001|Overall Study|Withdrawal by Subject|17|||
48729327|NCT03834493|156859722|FG000|Overall Study|Physician Decision|1|||
48729328|NCT03834493|156859723|FG001|Overall Study|Physician Decision|0|||
48729329|NCT03834493|156859722|FG000|Overall Study|Death|289|||
48729330|NCT03834493|156859723|FG001|Overall Study|Death|282|||
48729331|NCT02278341|156859725|FG000|Overall Study|Randomized but never received study drug|1|||
48729332|NCT02278341|156859726|FG001|Overall Study|Randomized but never received study drug|1|||
48729333|NCT02278341|156859725|FG000|Overall Study|Adverse Event|3|||
48729334|NCT02278341|156859726|FG001|Overall Study|Adverse Event|0|||
48729335|NCT02278341|156859725|FG000|Overall Study|Death|68|||
48729336|NCT02278341|156859726|FG001|Overall Study|Death|56|||
48729337|NCT02278341|156859725|FG000|Overall Study|Withdrawal by Subject|30|||
48729338|NCT02278341|156859726|FG001|Overall Study|Withdrawal by Subject|19|||
48729339|NCT02278341|156859725|FG000|Overall Study|Lost to Follow-up|0|||
48729340|NCT02278341|156859726|FG001|Overall Study|Lost to Follow-up|1|||
48729341|NCT02278341|156859725|FG000|Overall Study|Physician Decision|1|||
48729342|NCT02278341|156859726|FG001|Overall Study|Physician Decision|1|||
48729343|NCT02278341|156859725|FG000|Overall Study|Miscellaneous|15|||
48729344|NCT02278341|156859726|FG001|Overall Study|Miscellaneous|14|||
48729345|NCT05710107|156859727|FG000|Overall Study|Withdrawal by Subject|1|||
48729346|NCT05710107|156859728|FG001|Overall Study|Withdrawal by Subject|1|||
48729347|NCT05710107|156859727|FG000|Overall Study|Lost to Follow-up|8|||
48729348|NCT05710107|156859728|FG001|Overall Study|Lost to Follow-up|9|||
48729349|NCT05710107|156859727|FG000|Overall Study|Unable to place assigned block|2|||
48729350|NCT05710107|156859728|FG001|Overall Study|Unable to place assigned block|0|||
49011954|NCT01806597|157881606|FG004|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
49141225|NCT00954538|158354705|FG002|Part III|Withdrawal by Subject|0|||
48822227|NCT01474512|157190495|FG012|Long-Term Extension Period|Physician Decision|21|||
48822228|NCT01474512|157190496|FG013|Long-Term Extension Period|Physician Decision|21|||
48822229|NCT01474512|157190497|FG014|Long-Term Extension Period|Physician Decision|0|||
48822230|NCT01474512|157190498|FG015|Long-Term Extension Period|Physician Decision|0|||
48822231|NCT01474512|157190499|FG016|Long-Term Extension Period|Physician Decision|0|||
48822232|NCT01474512|157190500|FG017|Long-Term Extension Period|Physician Decision|0|||
48822233|NCT01474512|157190483|FG000|Long-Term Extension Period|Clinical Relapse|0|||
48822234|NCT01474512|157190484|FG001|Long-Term Extension Period|Clinical Relapse|0|||
48822235|NCT01474512|157190485|FG002|Long-Term Extension Period|Clinical Relapse|0|||
48822236|NCT01474512|157190486|FG003|Long-Term Extension Period|Clinical Relapse|0|||
48822237|NCT01474512|157190487|FG004|Long-Term Extension Period|Clinical Relapse|0|||
48822238|NCT01474512|157190488|FG005|Long-Term Extension Period|Clinical Relapse|0|||
48822239|NCT01474512|157190489|FG006|Long-Term Extension Period|Clinical Relapse|0|||
49141226|NCT00954538|158354706|FG003|Part III|Withdrawal by Subject|0|||
49141227|NCT00954538|158354707|FG004|Part III|Withdrawal by Subject|1|||
49141228|NCT00954538|158354708|FG005|Part III|Withdrawal by Subject|0|||
49141229|NCT02400736|158356581|FG000|Overall Study|Lost to Follow-up|6|||
49141230|NCT02400736|158356582|FG001|Overall Study|Lost to Follow-up|6|||
49141231|NCT02400736|158356581|FG000|Overall Study|Withdrawal by Subject|2|||
49141232|NCT02400736|158356582|FG001|Overall Study|Withdrawal by Subject|1|||
49141233|NCT02400736|158356581|FG000|Overall Study|Moved from the area|3|||
49141234|NCT02400736|158356582|FG001|Overall Study|Moved from the area|1|||
49141235|NCT02370394|158356583|FG000|Overall Study|Lost to Follow-up|2|||
49141236|NCT02370394|158356584|FG001|Overall Study|Lost to Follow-up|1|||
49141237|NCT02370394|158356583|FG000|Overall Study|Withdrawal by Subject|0|||
49141238|NCT02370394|158356584|FG001|Overall Study|Withdrawal by Subject|1|||
49141239|NCT01105130|158356585|FG000|Overall Study|Withdrawal by Subject|4|||
49141240|NCT01105130|158356586|FG001|Overall Study|Withdrawal by Subject|6|||
49141241|NCT01105130|158356587|FG002|Overall Study|Withdrawal by Subject|2|||
49141242|NCT01105130|158356585|FG000|Overall Study|Never Started|2|||
49141243|NCT01105130|158356586|FG001|Overall Study|Never Started|2|||
49141244|NCT01105130|158356587|FG002|Overall Study|Never Started|4|||
49141245|NCT01105130|158356585|FG000|Overall Study|Toxicity|1|||
49141246|NCT01105130|158356586|FG001|Overall Study|Toxicity|3|||
48729351|NCT05710107|156859727|FG000|Overall Study|Withdrawn by study team|0|||
48729352|NCT05710107|156859728|FG001|Overall Study|Withdrawn by study team|1|||
48729353|NCT00145600|156859729|FG000|Overall Study|Death|1|||
48729354|NCT00145600|156859730|FG001|Overall Study|Death|2|||
48729355|NCT00145600|156859731|FG002|Overall Study|Death|2|||
48729356|NCT00145600|156859732|FG003|Overall Study|Death|6|||
48729357|NCT00145600|156859729|FG000|Overall Study|Ineligible|3|||
48729358|NCT00145600|156859730|FG001|Overall Study|Ineligible|0|||
48729359|NCT00145600|156859731|FG002|Overall Study|Ineligible|1|||
48729360|NCT00145600|156859732|FG003|Overall Study|Ineligible|5|||
48729361|NCT00145600|156859729|FG000|Overall Study|Lost to Follow-up|2|||
48729362|NCT00145600|156859730|FG001|Overall Study|Lost to Follow-up|6|||
48729363|NCT00145600|156859731|FG002|Overall Study|Lost to Follow-up|2|||
48729364|NCT00145600|156859732|FG003|Overall Study|Lost to Follow-up|4|||
48729365|NCT00145600|156859729|FG000|Overall Study|Noncompliance|1|||
48729366|NCT00145600|156859730|FG001|Overall Study|Noncompliance|0|||
48729367|NCT00145600|156859731|FG002|Overall Study|Noncompliance|0|||
48729368|NCT00145600|156859732|FG003|Overall Study|Noncompliance|0|||
48729369|NCT00145600|156859729|FG000|Overall Study|Withdrawal by Subject|1|||
48729370|NCT00145600|156859730|FG001|Overall Study|Withdrawal by Subject|2|||
48729371|NCT00145600|156859731|FG002|Overall Study|Withdrawal by Subject|0|||
48729372|NCT00145600|156859732|FG003|Overall Study|Withdrawal by Subject|1|||
48729373|NCT05128773|156859737|FG000|Overall Study|Sponsor decision to terminate study|3|||
48729374|NCT04543409|156859738|FG000|Double-Blind Treatment Period|Withdrawal by Subject|1|||
48729375|NCT04543409|156859739|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
48729376|NCT04543409|156859738|FG000|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|1|||
48729377|NCT04543409|156859739|FG001|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|0|||
48729378|NCT04543409|156859738|FG000|Open-Label Treatment Period|Lost to Follow-up|0|||
48729379|NCT04543409|156859739|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
48729380|NCT04543409|156859738|FG000|Open-Label Treatment Period|Study terminated by sponsor|17|||
48729381|NCT04543409|156859739|FG001|Open-Label Treatment Period|Study terminated by sponsor|19|||
48822240|NCT01474512|157190490|FG007|Long-Term Extension Period|Clinical Relapse|0|||
48822241|NCT01474512|157190491|FG008|Long-Term Extension Period|Clinical Relapse|0|||
48822242|NCT01474512|157190492|FG009|Long-Term Extension Period|Clinical Relapse|0|||
49011955|NCT01806597|157881607|FG005|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
49015359|NCT00306384|157892156|FG000|Overall Study|Adverse Event|103|||
49141247|NCT01105130|158356587|FG002|Overall Study|Toxicity|2|||
49141248|NCT01105130|158356585|FG000|Overall Study|Multiple Reasons|3|||
49141249|NCT01105130|158356586|FG001|Overall Study|Multiple Reasons|0|||
49141250|NCT01105130|158356587|FG002|Overall Study|Multiple Reasons|2|||
49141251|NCT02927145|158356592|FG000|Initial Recruitment|Withdrawal by Subject|0|||
49141252|NCT02927145|158356593|FG001|Initial Recruitment|Withdrawal by Subject|1|||
49141253|NCT02927145|158356594|FG002|Initial Recruitment|Withdrawal by Subject|1|||
49141254|NCT02927145|158356595|FG003|Initial Recruitment|Withdrawal by Subject|4|||
49141255|NCT02927145|158356596|FG004|Initial Recruitment|Withdrawal by Subject|1|||
49141256|NCT02927145|158356597|FG005|Initial Recruitment|Withdrawal by Subject|1|||
49141257|NCT02927145|158356598|FG006|Initial Recruitment|Withdrawal by Subject|0|||
49141258|NCT02927145|158356599|FG007|Initial Recruitment|Withdrawal by Subject|0|||
49141259|NCT02927145|158356600|FG008|Initial Recruitment|Withdrawal by Subject|2|||
48822243|NCT01474512|157190493|FG010|Long-Term Extension Period|Clinical Relapse|0|||
49011956|NCT01806597|157881602|FG000|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
49011957|NCT01806597|157881603|FG001|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
49141260|NCT02927145|158356592|FG000|Initial Recruitment|Adverse Event|0|||
48822244|NCT01474512|157190494|FG011|Long-Term Extension Period|Clinical Relapse|0|||
49141261|NCT02927145|158356593|FG001|Initial Recruitment|Adverse Event|0|||
49141262|NCT02927145|158356594|FG002|Initial Recruitment|Adverse Event|0|||
49141263|NCT02927145|158356595|FG003|Initial Recruitment|Adverse Event|0|||
49141264|NCT02927145|158356596|FG004|Initial Recruitment|Adverse Event|2|||
49141265|NCT02927145|158356597|FG005|Initial Recruitment|Adverse Event|0|||
49141266|NCT02927145|158356598|FG006|Initial Recruitment|Adverse Event|0|||
49141267|NCT02927145|158356599|FG007|Initial Recruitment|Adverse Event|0|||
49141268|NCT02927145|158356600|FG008|Initial Recruitment|Adverse Event|0|||
49141269|NCT02927145|158356592|FG000|Invitation for Additional Challenge|Pregnancy|0|||
49141270|NCT02927145|158356593|FG001|Invitation for Additional Challenge|Pregnancy|0|||
49141271|NCT02927145|158356594|FG002|Invitation for Additional Challenge|Pregnancy|0|||
49141272|NCT02927145|158356595|FG003|Invitation for Additional Challenge|Pregnancy|0|||
49141273|NCT02927145|158356596|FG004|Invitation for Additional Challenge|Pregnancy|0|||
49141274|NCT02927145|158356597|FG005|Invitation for Additional Challenge|Pregnancy|0|||
48822245|NCT01474512|157190495|FG012|Long-Term Extension Period|Clinical Relapse|9|||
48822246|NCT01474512|157190496|FG013|Long-Term Extension Period|Clinical Relapse|9|||
48822247|NCT01474512|157190497|FG014|Long-Term Extension Period|Clinical Relapse|0|||
48822248|NCT01474512|157190498|FG015|Long-Term Extension Period|Clinical Relapse|0|||
48822249|NCT01474512|157190499|FG016|Long-Term Extension Period|Clinical Relapse|0|||
48822250|NCT01474512|157190500|FG017|Long-Term Extension Period|Clinical Relapse|0|||
49141275|NCT02927145|158356598|FG006|Invitation for Additional Challenge|Pregnancy|1|||
48729382|NCT04543409|156859738|FG000|Open-Label Treatment Period|Withdrawal by Subject|4|||
48729383|NCT04543409|156859739|FG001|Open-Label Treatment Period|Withdrawal by Subject|3|||
49141276|NCT02927145|158356599|FG007|Invitation for Additional Challenge|Pregnancy|0|||
49141277|NCT02927145|158356600|FG008|Invitation for Additional Challenge|Pregnancy|0|||
49141278|NCT00599313|158356604|FG000|Overall Study|Adverse Event|19|||
49141279|NCT00599313|158356604|FG000|Overall Study|Disease Progression|12|||
49141280|NCT00599313|158356604|FG000|Overall Study|Patient Request|4|||
49141281|NCT00599313|158356604|FG000|Overall Study|Ineligible|1|||
49141282|NCT00456612|158356609|FG000|Overall Study|Withdrawal by Subject|3|||
49141283|NCT00356590|158356614|FG000|Overall Study|Adverse Event|54|||
49141284|NCT00356590|158356614|FG000|Overall Study|Death|10|||
49141285|NCT00356590|158356614|FG000|Overall Study|Lost to Follow-up|35|||
48729384|NCT04543409|156859738|FG000|Open-Label Extension Treatment Period|Adverse Event|0|||
48729385|NCT04543409|156859739|FG001|Open-Label Extension Treatment Period|Adverse Event|1|||
48729386|NCT04543409|156859738|FG000|Open-Label Extension Treatment Period|Lost to Follow-up|1|||
48729387|NCT04543409|156859739|FG001|Open-Label Extension Treatment Period|Lost to Follow-up|0|||
48729388|NCT04543409|156859738|FG000|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
48729389|NCT04543409|156859739|FG001|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
48729390|NCT04543409|156859738|FG000|Open-Label Extension Treatment Period|Withdrawal by Subject|0|||
48822251|NCT01474512|157190483|FG000|Long-Term Extension Period|Death|0|||
48822252|NCT01474512|157190484|FG001|Long-Term Extension Period|Death|0|||
48822253|NCT01474512|157190485|FG002|Long-Term Extension Period|Death|0|||
48822254|NCT01474512|157190486|FG003|Long-Term Extension Period|Death|0|||
49011958|NCT01806597|157881604|FG002|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
49011959|NCT01806597|157881605|FG003|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
49011960|NCT01806597|157881606|FG004|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
49011961|NCT01806597|157881607|FG005|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5|||
49011962|NCT01806597|157881602|FG000|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
49011963|NCT01806597|157881603|FG001|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
49011964|NCT01806597|157881604|FG002|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
49011965|NCT01806597|157881605|FG003|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
49011966|NCT01806597|157881606|FG004|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
49011967|NCT01806597|157881607|FG005|Follow-up Period (Week 132 to Week 140)|Adverse Event|2|||
49011968|NCT01806597|157881602|FG000|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
49011969|NCT01806597|157881603|FG001|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
49011970|NCT01806597|157881604|FG002|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
48822255|NCT01474512|157190487|FG004|Long-Term Extension Period|Death|0|||
48822256|NCT01474512|157190488|FG005|Long-Term Extension Period|Death|0|||
48822257|NCT01474512|157190489|FG006|Long-Term Extension Period|Death|0|||
48729391|NCT04543409|156859739|FG001|Open-Label Extension Treatment Period|Withdrawal by Subject|1|||
48729392|NCT04543409|156859738|FG000|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|0|||
48729393|NCT04543409|156859739|FG001|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|1|||
48729394|NCT04543409|156859738|FG000|Open-Label Extension Treatment Period|No study/treatment discontinuation information|0|||
48729395|NCT04543409|156859739|FG001|Open-Label Extension Treatment Period|No study/treatment discontinuation information|1|||
48729396|NCT03977454|156859740|FG000|Overall Study|immediate postoperative revision|2|||
48729397|NCT03977454|156859741|FG001|Overall Study|immediate postoperative revision|2|||
48822258|NCT01474512|157190490|FG007|Long-Term Extension Period|Death|0|||
48822259|NCT01474512|157190491|FG008|Long-Term Extension Period|Death|0|||
48822260|NCT01474512|157190492|FG009|Long-Term Extension Period|Death|0|||
48822261|NCT01474512|157190493|FG010|Long-Term Extension Period|Death|0|||
48822262|NCT01474512|157190494|FG011|Long-Term Extension Period|Death|0|||
48822263|NCT01474512|157190495|FG012|Long-Term Extension Period|Death|9|||
48822264|NCT01474512|157190496|FG013|Long-Term Extension Period|Death|9|||
48822265|NCT01474512|157190497|FG014|Long-Term Extension Period|Death|0|||
48822266|NCT01474512|157190498|FG015|Long-Term Extension Period|Death|0|||
48822267|NCT01474512|157190499|FG016|Long-Term Extension Period|Death|0|||
48822268|NCT01474512|157190500|FG017|Long-Term Extension Period|Death|0|||
49011971|NCT01806597|157881605|FG003|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
49011972|NCT01806597|157881606|FG004|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
49011973|NCT01806597|157881607|FG005|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2|||
49011974|NCT01806597|157881602|FG000|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
49011975|NCT01806597|157881603|FG001|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
49011976|NCT01806597|157881604|FG002|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
49011977|NCT01806597|157881605|FG003|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
49011978|NCT01806597|157881606|FG004|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
49011979|NCT01806597|157881607|FG005|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2|||
49011980|NCT01806597|157881602|FG000|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
49011981|NCT01806597|157881603|FG001|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
49011982|NCT01806597|157881604|FG002|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
49011983|NCT01806597|157881605|FG003|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
49011984|NCT01806597|157881606|FG004|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
49011985|NCT01806597|157881607|FG005|Follow-up Period (Week 132 to Week 140)|Physician Decision|1|||
49011986|NCT01020305|157881608|FG000|Overall Study|Adverse Event|2|||
49011987|NCT00467818|157881609|FG000|Overall Study|Adverse Event|1|||
49011988|NCT00467818|157881610|FG001|Overall Study|Adverse Event|0|||
49011989|NCT00467818|157881609|FG000|Overall Study|Lost to Follow-up|2|||
49011990|NCT00467818|157881610|FG001|Overall Study|Lost to Follow-up|2|||
49011991|NCT00881959|157881617|FG000|Overall Study|Lost to Follow-up|2|||
49011992|NCT00881959|157881618|FG001|Overall Study|Lost to Follow-up|4|||
49011993|NCT02791659|157881619|FG000|Overall Study|Protocol Violation|0|||
49011994|NCT02791659|157881620|FG001|Overall Study|Protocol Violation|1|||
49011995|NCT01456052|157881621|FG000|Overall Study|Adverse Event|1|||
49011996|NCT01456052|157881622|FG001|Overall Study|Adverse Event|1|||
49011997|NCT01456052|157881623|FG002|Overall Study|Adverse Event|2|||
49011998|NCT01456052|157881621|FG000|Overall Study|Consent withdrawn|0|||
49011999|NCT01456052|157881622|FG001|Overall Study|Consent withdrawn|2|||
49012000|NCT01456052|157881623|FG002|Overall Study|Consent withdrawn|1|||
49012001|NCT01456052|157881621|FG000|Overall Study|Protocol Violation|0|||
49012002|NCT01456052|157881622|FG001|Overall Study|Protocol Violation|1|||
49012003|NCT01456052|157881623|FG002|Overall Study|Protocol Violation|0|||
49012004|NCT01456052|157881621|FG000|Overall Study|Physician Decision|1|||
49012005|NCT01456052|157881622|FG001|Overall Study|Physician Decision|0|||
49012006|NCT01456052|157881623|FG002|Overall Study|Physician Decision|1|||
49012007|NCT01456052|157881621|FG000|Overall Study|Treatment Failure|0|||
49012008|NCT01456052|157881622|FG001|Overall Study|Treatment Failure|1|||
49012009|NCT01456052|157881623|FG002|Overall Study|Treatment Failure|1|||
49012010|NCT00618774|157881626|FG000|Overall Study|Adverse Event|5|||
49012011|NCT00618774|157881627|FG001|Overall Study|Adverse Event|3|||
49012012|NCT00618774|157881626|FG000|Overall Study|Withdrawal by Subject|1|||
49012013|NCT00618774|157881627|FG001|Overall Study|Withdrawal by Subject|0|||
49012014|NCT02753400|157881628|FG000|Overall Study|Adverse Event|3|||
49012015|NCT02753400|157881629|FG001|Overall Study|Adverse Event|0|||
49012016|NCT02753400|157881628|FG000|Overall Study|Withdrawal by Subject|2|||
49012017|NCT02753400|157881629|FG001|Overall Study|Withdrawal by Subject|1|||
49012018|NCT02622074|157881630|FG000|Overall Study|Death|4|||
49012019|NCT02622074|157881631|FG001|Overall Study|Death|0|||
49012020|NCT02622074|157881632|FG002|Overall Study|Death|0|||
49012021|NCT02622074|157881633|FG003|Overall Study|Death|1|||
49012022|NCT02622074|157881634|FG004|Overall Study|Death|1|||
49012023|NCT02622074|157881635|FG005|Overall Study|Death|0|||
49012024|NCT02622074|157881630|FG000|Overall Study|Withdrawal by Subject|0|||
49141286|NCT00356590|158356614|FG000|Overall Study|Physician Decision|46|||
49141287|NCT00356590|158356614|FG000|Overall Study|Withdrawal by Subject|41|||
49141288|NCT00356590|158356614|FG000|Overall Study|Completed month 12 only|2|||
49141289|NCT00356590|158356614|FG000|Overall Study|Protocol issues|6|||
49141290|NCT00356590|158356614|FG000|Overall Study|Response status|28|||
49141291|NCT00356590|158356614|FG000|Overall Study|Other|52|||
49141292|NCT03422718|158356617|FG000|12 Month Interventional Trial Period|Lost to Follow-up|26|||
49141293|NCT03422718|158356618|FG001|12 Month Interventional Trial Period|Lost to Follow-up|16|||
49141294|NCT03422718|158356619|FG002|12 Month Interventional Trial Period|Lost to Follow-up|23|||
49141295|NCT03422718|158356620|FG003|12 Month Interventional Trial Period|Lost to Follow-up|27|||
49141296|NCT03422718|158356621|FG004|12 Month Interventional Trial Period|Lost to Follow-up|21|||
49141297|NCT03422718|158356622|FG005|12 Month Interventional Trial Period|Lost to Follow-up|22|||
49141298|NCT03422718|158356623|FG006|12 Month Interventional Trial Period|Lost to Follow-up|36|||
49141299|NCT03422718|158356624|FG007|12 Month Interventional Trial Period|Lost to Follow-up|25|||
49141300|NCT03422718|158356617|FG000|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
49141301|NCT03422718|158356618|FG001|12 Month Interventional Trial Period|Withdrawal by Subject|13|||
49141302|NCT03422718|158356619|FG002|12 Month Interventional Trial Period|Withdrawal by Subject|15|||
49141303|NCT03422718|158356620|FG003|12 Month Interventional Trial Period|Withdrawal by Subject|12|||
49141304|NCT03422718|158356621|FG004|12 Month Interventional Trial Period|Withdrawal by Subject|7|||
49141305|NCT03422718|158356622|FG005|12 Month Interventional Trial Period|Withdrawal by Subject|8|||
49141306|NCT03422718|158356623|FG006|12 Month Interventional Trial Period|Withdrawal by Subject|4|||
49141307|NCT03422718|158356624|FG007|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
49141308|NCT03422718|158356617|FG000|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|8|||
49141309|NCT03422718|158356618|FG001|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|11|||
49141310|NCT03422718|158356619|FG002|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|16|||
49141311|NCT03422718|158356620|FG003|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
49141312|NCT03422718|158356621|FG004|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|17|||
49141313|NCT03422718|158356622|FG005|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
49141314|NCT03422718|158356623|FG006|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
49141315|NCT03422718|158356624|FG007|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|10|||
49141316|NCT03422718|158356617|FG000|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
49141317|NCT03422718|158356618|FG001|Optional Six Month Follow-Up Period|Withdrawal by Subject|3|||
49141318|NCT03422718|158356619|FG002|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
49141319|NCT03422718|158356620|FG003|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
49141320|NCT03422718|158356621|FG004|Optional Six Month Follow-Up Period|Withdrawal by Subject|1|||
49141321|NCT03422718|158356622|FG005|Optional Six Month Follow-Up Period|Withdrawal by Subject|2|||
49141322|NCT03422718|158356623|FG006|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
49141323|NCT03422718|158356624|FG007|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
49141324|NCT03422718|158356617|FG000|Optional Six Month Follow-Up Period|ineligible|8|||
49141325|NCT03422718|158356618|FG001|Optional Six Month Follow-Up Period|ineligible|5|||
49141326|NCT03422718|158356619|FG002|Optional Six Month Follow-Up Period|ineligible|2|||
49141327|NCT03422718|158356620|FG003|Optional Six Month Follow-Up Period|ineligible|2|||
48729398|NCT01052844|156859742|FG000|Overall Study|Adverse Event|0|||
48729399|NCT01052844|156859743|FG001|Overall Study|Adverse Event|1|||
48729400|NCT04250714|156859744|FG000|Overall Study|Treatment - withdrawal by subject|14|||
48729401|NCT04250714|156859744|FG000|Overall Study|Treatment - Lost to Follow-up|11|||
48729402|NCT04250714|156859744|FG000|Overall Study|Treatment - End of study due to logistical reasons|2|||
48729403|NCT04250714|156859744|FG000|Overall Study|Treatment - End of study due to refusing testing COVID|1|||
48729404|NCT04250714|156859744|FG000|Overall Study|Treatment - Death|1|||
48729405|NCT04250714|156859744|FG000|Overall Study|Treatment - Withdrawn due to unknown reason|2|||
48729406|NCT04250714|156859744|FG000|Overall Study|Consent Ineligible - Does not meet eligibility criteria|1|||
48729407|NCT04250714|156859744|FG000|Overall Study|Attempt|2|||
48729408|NCT04250714|156859744|FG000|Overall Study|Intent|7|||
48729409|NCT03960554|156859745|FG000|Overall Study|Due to the pandemic, this study was terminated early|4|||
48729410|NCT03960554|156859746|FG001|Overall Study|Due to the pandemic, this study was terminated early|4|||
48729411|NCT03882008|156859764|FG000|Overall Study|Withdrawal by Subject|1|||
48729412|NCT03882008|156859764|FG000|Overall Study|Lost to Follow-up|1|||
48729413|NCT00048061|156859765|FG000|Overall Study|Adverse Event|41|||
48729414|NCT00048061|156859766|FG001|Overall Study|Adverse Event|32|||
48729415|NCT00048061|156859767|FG002|Overall Study|Adverse Event|44|||
48729416|NCT00048061|156859768|FG003|Overall Study|Adverse Event|37|||
48729417|NCT00048061|156859765|FG000|Overall Study|Lost to Follow-up|3|||
48729418|NCT00048061|156859766|FG001|Overall Study|Lost to Follow-up|2|||
48729419|NCT00048061|156859767|FG002|Overall Study|Lost to Follow-up|4|||
48729420|NCT00048061|156859768|FG003|Overall Study|Lost to Follow-up|5|||
48729421|NCT00048061|156859765|FG000|Overall Study|Withdrawal by Subject|20|||
48729422|NCT00048061|156859766|FG001|Overall Study|Withdrawal by Subject|29|||
48729423|NCT00048061|156859767|FG002|Overall Study|Withdrawal by Subject|29|||
49141328|NCT03422718|158356621|FG004|Optional Six Month Follow-Up Period|ineligible|1|||
49141329|NCT03422718|158356622|FG005|Optional Six Month Follow-Up Period|ineligible|5|||
49141330|NCT03422718|158356623|FG006|Optional Six Month Follow-Up Period|ineligible|2|||
49141331|NCT03422718|158356624|FG007|Optional Six Month Follow-Up Period|ineligible|4|||
49141332|NCT03422718|158356617|FG000|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
49141333|NCT03422718|158356618|FG001|Optional Six Month Follow-Up Period|Lost to Follow-up|11|||
49141334|NCT03422718|158356619|FG002|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
49141335|NCT03422718|158356620|FG003|Optional Six Month Follow-Up Period|Lost to Follow-up|4|||
49141336|NCT03422718|158356621|FG004|Optional Six Month Follow-Up Period|Lost to Follow-up|9|||
49141337|NCT03422718|158356622|FG005|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
49141338|NCT03422718|158356623|FG006|Optional Six Month Follow-Up Period|Lost to Follow-up|3|||
49141339|NCT03422718|158356624|FG007|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
49141340|NCT04602000|158356627|FG000|Overall Study|Withdrawal by Subject|3|||
49141341|NCT04602000|158356628|FG001|Overall Study|Withdrawal by Subject|6|||
49141342|NCT04602000|158356629|FG002|Overall Study|Withdrawal by Subject|3|||
49141343|NCT04602000|158356630|FG003|Overall Study|Withdrawal by Subject|27|||
49141344|NCT04602000|158356631|FG004|Overall Study|Withdrawal by Subject|39|||
49141345|NCT04602000|158356627|FG000|Overall Study|Physician Decision|1|||
49141346|NCT04602000|158356628|FG001|Overall Study|Physician Decision|0|||
49141347|NCT04602000|158356629|FG002|Overall Study|Physician Decision|0|||
49141348|NCT04602000|158356630|FG003|Overall Study|Physician Decision|2|||
49141349|NCT04602000|158356631|FG004|Overall Study|Physician Decision|2|||
49141350|NCT04602000|158356627|FG000|Overall Study|Death|0|||
49141351|NCT04602000|158356628|FG001|Overall Study|Death|1|||
49141352|NCT04602000|158356629|FG002|Overall Study|Death|0|||
49141353|NCT04602000|158356630|FG003|Overall Study|Death|1|||
49141354|NCT04602000|158356631|FG004|Overall Study|Death|2|||
49141355|NCT04602000|158356627|FG000|Overall Study|Lost to Follow-up|0|||
49141356|NCT04602000|158356628|FG001|Overall Study|Lost to Follow-up|0|||
49141357|NCT04602000|158356629|FG002|Overall Study|Lost to Follow-up|0|||
49141358|NCT04602000|158356630|FG003|Overall Study|Lost to Follow-up|3|||
49141359|NCT04602000|158356631|FG004|Overall Study|Lost to Follow-up|4|||
49141360|NCT04602000|158356627|FG000|Overall Study|Other|4|||
49141361|NCT04602000|158356628|FG001|Overall Study|Other|1|||
49141362|NCT04602000|158356629|FG002|Overall Study|Other|2|||
49141363|NCT04602000|158356630|FG003|Overall Study|Other|5|||
49141364|NCT04602000|158356631|FG004|Overall Study|Other|4|||
49141365|NCT04602000|158356627|FG000|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
49141366|NCT04602000|158356628|FG001|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
49141367|NCT04602000|158356629|FG002|Overall Study|Completed Treatment Period but not entered into Follow-up Period|1|||
49141368|NCT04602000|158356630|FG003|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
49141369|NCT04602000|158356631|FG004|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
48729424|NCT00048061|156859768|FG003|Overall Study|Withdrawal by Subject|32|||
48729425|NCT00048061|156859765|FG000|Overall Study|Did not follow-up|5|||
48729426|NCT00048061|156859766|FG001|Overall Study|Did not follow-up|5|||
49141370|NCT03055221|158356633|FG000|Overall Study|Adverse Event|2|||
49141371|NCT03055221|158356633|FG000|Overall Study|Withdrawal by Subject|4|||
49141372|NCT03055221|158356633|FG000|Overall Study|Death|6|||
49141373|NCT03055221|158356633|FG000|Overall Study|Physician Decision|1|||
49141374|NCT03055221|158356633|FG000|Overall Study|Study terminated by Sponsor|3|||
49141375|NCT03055221|158356633|FG000|Overall Study|Lost to Follow-up|4|||
49141376|NCT01243424|158356634|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49|||
49141377|NCT01243424|158356635|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37|||
49141378|NCT01243424|158356634|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14|||
49141379|NCT01243424|158356635|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12|||
49141380|NCT01243424|158356634|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15|||
49141381|NCT01243424|158356635|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22|||
49141382|NCT01243424|158356634|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0|||
49141383|NCT01243424|158356635|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1|||
49141384|NCT01243424|158356634|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38|||
49141385|NCT01243424|158356635|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35|||
49141386|NCT01243424|158356634|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
49141387|NCT01243424|158356635|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
49141388|NCT01243424|158356634|FG000|Discontinuation From Study (Treated Set)|Not treated|5|||
49141389|NCT01243424|158356635|FG001|Discontinuation From Study (Treated Set)|Not treated|4|||
49141390|NCT01243424|158356634|FG000|Discontinuation From Treatment|Not treated|5|||
49141391|NCT01243424|158356635|FG001|Discontinuation From Treatment|Not treated|4|||
49141392|NCT01243424|158356634|FG000|Discontinuation From Treatment|Adverse Event|457|||
49141393|NCT01243424|158356635|FG001|Discontinuation From Treatment|Adverse Event|523|||
49141394|NCT01243424|158356634|FG000|Discontinuation From Treatment|Lack of Efficacy|61|||
49141395|NCT01243424|158356635|FG001|Discontinuation From Treatment|Lack of Efficacy|41|||
49141396|NCT01243424|158356634|FG000|Discontinuation From Treatment|Protocol Violation|46|||
49141397|NCT01243424|158356635|FG001|Discontinuation From Treatment|Protocol Violation|47|||
49141398|NCT01243424|158356634|FG000|Discontinuation From Treatment|Lost to Follow-up|24|||
49141399|NCT01243424|158356635|FG001|Discontinuation From Treatment|Lost to Follow-up|28|||
49141400|NCT01243424|158356634|FG000|Discontinuation From Treatment|Withdrawal by Subject|309|||
49141401|NCT01243424|158356635|FG001|Discontinuation From Treatment|Withdrawal by Subject|328|||
49141402|NCT01243424|158356634|FG000|Discontinuation From Treatment|Other than listed above|230|||
49141403|NCT01243424|158356635|FG001|Discontinuation From Treatment|Other than listed above|211|||
49141404|NCT01960842|158356642|FG000|Overall Study|Adverse Event|1|||
49141405|NCT01960842|158356642|FG000|Overall Study|Withdrawal by Subject|2|||
49141406|NCT01160744|158356656|FG000|Overall Study|Withdrawal by Subject|11|||
49141407|NCT01160744|158356657|FG001|Overall Study|Withdrawal by Subject|5|||
49141408|NCT01160744|158356658|FG002|Overall Study|Withdrawal by Subject|6|||
49141409|NCT01160744|158356659|FG003|Overall Study|Withdrawal by Subject|4|||
49141410|NCT01160744|158356656|FG000|Overall Study|Not meet inclusion/exclusion criteria|0|||
49141411|NCT01160744|158356657|FG001|Overall Study|Not meet inclusion/exclusion criteria|0|||
49141412|NCT01160744|158356658|FG002|Overall Study|Not meet inclusion/exclusion criteria|1|||
49141413|NCT01160744|158356659|FG003|Overall Study|Not meet inclusion/exclusion criteria|0|||
48822269|NCT01474512|157190483|FG000|Long-Term Extension Period|Sponsor Decision|0|||
48822270|NCT01474512|157190484|FG001|Long-Term Extension Period|Sponsor Decision|0|||
48822271|NCT01474512|157190485|FG002|Long-Term Extension Period|Sponsor Decision|0|||
48822272|NCT01474512|157190486|FG003|Long-Term Extension Period|Sponsor Decision|0|||
48822273|NCT01474512|157190487|FG004|Long-Term Extension Period|Sponsor Decision|0|||
48822274|NCT01474512|157190488|FG005|Long-Term Extension Period|Sponsor Decision|0|||
48822275|NCT01474512|157190489|FG006|Long-Term Extension Period|Sponsor Decision|0|||
49141414|NCT00195429|158356660|FG000|Overall Study|Adverse Event|2|||
49141415|NCT00195429|158356661|FG001|Overall Study|Adverse Event|4|||
49141416|NCT00195429|158356660|FG000|Overall Study|Lack of Efficacy|2|||
49141417|NCT00195429|158356661|FG001|Overall Study|Lack of Efficacy|1|||
49141418|NCT00195429|158356660|FG000|Overall Study|Lost to Follow-up|1|||
49141419|NCT00195429|158356661|FG001|Overall Study|Lost to Follow-up|0|||
49141420|NCT04233580|158356664|FG000|Overall Study|Adverse Event|3|||
49141421|NCT04233580|158356665|FG001|Overall Study|Adverse Event|3|||
49141422|NCT04233580|158356664|FG000|Overall Study|Withdrawal by Subject|2|||
49141423|NCT04233580|158356665|FG001|Overall Study|Withdrawal by Subject|1|||
49141424|NCT02070991|158356668|FG000|Overall Study|Death|2|||
49141425|NCT02070991|158356669|FG001|Overall Study|Death|0|||
49141426|NCT02070991|158356668|FG000|Overall Study|Withdrawal by Subject|1|||
49141427|NCT02070991|158356669|FG001|Overall Study|Withdrawal by Subject|0|||
49141428|NCT00933933|158356673|FG000|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
49141429|NCT00933933|158356674|FG001|General Population From 16 to 89 Years|Did not meet criteria for analysis|20|||
49141430|NCT00933933|158356675|FG002|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
49141431|NCT00933933|158356673|FG000|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
49141432|NCT00933933|158356674|FG001|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2|||
49141433|NCT00933933|158356675|FG002|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
49141434|NCT01145222|158356683|FG000|Overall Study|Procedure not done (no anesthesiologist)|0|||
49141435|NCT01145222|158356684|FG001|Overall Study|Procedure not done (no anesthesiologist)|0|||
49141436|NCT01145222|158356685|FG002|Overall Study|Procedure not done (no anesthesiologist)|1|||
49141437|NCT01145222|158356686|FG003|Overall Study|Procedure not done (no anesthesiologist)|0|||
49141438|NCT01145222|158356683|FG000|Overall Study|Poor bowel preparation|0|||
49141439|NCT01145222|158356684|FG001|Overall Study|Poor bowel preparation|0|||
49141440|NCT01145222|158356685|FG002|Overall Study|Poor bowel preparation|0|||
49141441|NCT01145222|158356686|FG003|Overall Study|Poor bowel preparation|1|||
49141442|NCT01623752|158356691|FG000|Phase 1 (78 Weeks)|No Data|249|||
49141443|NCT01623752|158356692|FG001|Phase 1 (78 Weeks)|No Data|66|||
49141444|NCT01623752|158356693|FG002|Phase 1 (78 Weeks)|No Data|2|||
49141445|NCT01623752|158356691|FG000|Phase 1 (78 Weeks)|Other|33|||
49141446|NCT01623752|158356692|FG001|Phase 1 (78 Weeks)|Other|20|||
49141447|NCT01623752|158356693|FG002|Phase 1 (78 Weeks)|Other|0|||
49141448|NCT01623752|158356691|FG000|Phase 1 (78 Weeks)|Adverse Event|122|||
49141449|NCT01623752|158356692|FG001|Phase 1 (78 Weeks)|Adverse Event|39|||
49141450|NCT01623752|158356693|FG002|Phase 1 (78 Weeks)|Adverse Event|0|||
49141451|NCT01623752|158356691|FG000|Phase 1 (78 Weeks)|Lack of Efficacy|227|||
49141452|NCT01623752|158356692|FG001|Phase 1 (78 Weeks)|Lack of Efficacy|82|||
48822276|NCT01474512|157190490|FG007|Long-Term Extension Period|Sponsor Decision|0|||
49141453|NCT01623752|158356693|FG002|Phase 1 (78 Weeks)|Lack of Efficacy|0|||
49141454|NCT01623752|158356691|FG000|Phase 2 (78 Weeks)|Lack of Efficacy|14|||
49141455|NCT01623752|158356692|FG001|Phase 2 (78 Weeks)|Lack of Efficacy|2|||
49141456|NCT01623752|158356693|FG002|Phase 2 (78 Weeks)|Lack of Efficacy|0|||
49141457|NCT01623752|158356691|FG000|Phase 2 (78 Weeks)|Other|5|||
49141458|NCT01623752|158356692|FG001|Phase 2 (78 Weeks)|Other|1|||
48822277|NCT01474512|157190491|FG008|Long-Term Extension Period|Sponsor Decision|0|||
49141459|NCT01623752|158356693|FG002|Phase 2 (78 Weeks)|Other|0|||
49141460|NCT01623752|158356691|FG000|Phase 2 (78 Weeks)|No Data|43|||
49141461|NCT01623752|158356692|FG001|Phase 2 (78 Weeks)|No Data|11|||
49141462|NCT01623752|158356693|FG002|Phase 2 (78 Weeks)|No Data|0|||
49141463|NCT01623752|158356691|FG000|Phase 2 (78 Weeks)|Adverse Event|4|||
49141464|NCT01623752|158356692|FG001|Phase 2 (78 Weeks)|Adverse Event|4|||
49141465|NCT01623752|158356693|FG002|Phase 2 (78 Weeks)|Adverse Event|0|||
49141466|NCT01814332|158356694|FG000|Overall Study|Adverse Event|8|||
49141467|NCT01814332|158356695|FG001|Overall Study|Adverse Event|3|||
49141468|NCT01814332|158356694|FG000|Overall Study|Withdrawal by Subject|3|||
49141469|NCT01814332|158356695|FG001|Overall Study|Withdrawal by Subject|8|||
49141470|NCT01814332|158356694|FG000|Overall Study|Protocol Violation|0|||
49141471|NCT01814332|158356695|FG001|Overall Study|Protocol Violation|4|||
49141472|NCT01814332|158356694|FG000|Overall Study|Lost to Follow-up|5|||
49141473|NCT01814332|158356695|FG001|Overall Study|Lost to Follow-up|1|||
49141474|NCT02942407|158356697|FG000|Overall Study|Lost to Follow-up|3|||
49141475|NCT02942407|158356698|FG001|Overall Study|Lost to Follow-up|2|||
49141476|NCT02942407|158356697|FG000|Overall Study|Withdrawal by Subject|7|||
49141477|NCT02942407|158356698|FG001|Overall Study|Withdrawal by Subject|9|||
49141478|NCT02942407|158356697|FG000|Overall Study|Death|16|||
49141479|NCT02942407|158356698|FG001|Overall Study|Death|13|||
49141480|NCT02061592|158356699|FG000|Period 1|Withdrawal by Subject|1|||
49141481|NCT02061592|158356700|FG001|Period 1|Withdrawal by Subject|0|||
49141482|NCT02061592|158356699|FG000|Period 1|Protocol Violation|1|||
49141483|NCT02061592|158356700|FG001|Period 1|Protocol Violation|0|||
49141484|NCT02061592|158356699|FG000|Period 2|Lost to Follow-up|0|||
49012025|NCT02622074|157881631|FG001|Overall Study|Withdrawal by Subject|1|||
49012026|NCT02622074|157881632|FG002|Overall Study|Withdrawal by Subject|0|||
49012027|NCT02622074|157881633|FG003|Overall Study|Withdrawal by Subject|0|||
49012028|NCT02622074|157881634|FG004|Overall Study|Withdrawal by Subject|0|||
49012029|NCT02622074|157881635|FG005|Overall Study|Withdrawal by Subject|0|||
49012030|NCT02629133|157881636|FG000|Overall Study|Lost to Follow-up|3|||
49012031|NCT02629133|157881637|FG001|Overall Study|Lost to Follow-up|1|||
49012032|NCT02629133|157881636|FG000|Overall Study|Withdrawal by Subject|1|||
49012033|NCT02629133|157881637|FG001|Overall Study|Withdrawal by Subject|1|||
49012034|NCT00863057|157881638|FG000|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
49012035|NCT00863057|157881639|FG001|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
49012036|NCT00863057|157881640|FG002|Milestones Period 1 (Weeks 0-5)|Adverse Event|0|||
49012037|NCT00863057|157881641|FG003|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
49012038|NCT00863057|157881638|FG000|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
49141485|NCT02061592|158356700|FG001|Period 2|Lost to Follow-up|1|||
49141486|NCT03338023|158356701|FG000|Overall Study|Withdrawal by Subject|3|||
49141487|NCT03338023|158356702|FG001|Overall Study|Withdrawal by Subject|4|||
49141488|NCT03338023|158356701|FG000|Overall Study|Protocol Violation|3|||
49141489|NCT03338023|158356702|FG001|Overall Study|Protocol Violation|3|||
49141490|NCT03338023|158356701|FG000|Overall Study|Lost to Follow-up|2|||
49141491|NCT03338023|158356702|FG001|Overall Study|Lost to Follow-up|1|||
49141492|NCT03338023|158356701|FG000|Overall Study|Physician Decision|1|||
49141493|NCT03338023|158356702|FG001|Overall Study|Physician Decision|2|||
49141494|NCT01716156|158356703|FG000|Overall Study|Protocol Violation|1|||
49141495|NCT01716156|158356704|FG001|Overall Study|Protocol Violation|0|||
49141496|NCT01716156|158356705|FG002|Overall Study|Protocol Violation|0|||
49141497|NCT01716156|158356703|FG000|Overall Study|Withdrawal by Subject|0|||
49141498|NCT01716156|158356704|FG001|Overall Study|Withdrawal by Subject|1|||
49141499|NCT01716156|158356705|FG002|Overall Study|Withdrawal by Subject|2|||
49141500|NCT01716156|158356703|FG000|Overall Study|Lost to Follow-up|1|||
49141501|NCT01716156|158356704|FG001|Overall Study|Lost to Follow-up|0|||
49141502|NCT01716156|158356705|FG002|Overall Study|Lost to Follow-up|0|||
49141503|NCT02318277|158356708|FG000|Overall Study|Physician Decision|0|||
49141504|NCT02318277|158356709|FG001|Overall Study|Physician Decision|0|||
49012039|NCT00863057|157881639|FG001|Milestones Period 1 (Weeks 0-5)|Physician Decision|1|||
49012040|NCT00863057|157881640|FG002|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
49012041|NCT00863057|157881641|FG003|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
49012042|NCT00863057|157881638|FG000|Period 2 (Weeks 6-10)|Adverse Event|0|||
49012043|NCT00863057|157881639|FG001|Period 2 (Weeks 6-10)|Adverse Event|1|||
49141505|NCT02318277|158356710|FG002|Overall Study|Physician Decision|0|||
49141506|NCT02318277|158356711|FG003|Overall Study|Physician Decision|0|||
49141507|NCT02318277|158356712|FG004|Overall Study|Physician Decision|0|||
49012044|NCT00863057|157881640|FG002|Period 2 (Weeks 6-10)|Adverse Event|1|||
49012045|NCT00863057|157881641|FG003|Period 2 (Weeks 6-10)|Adverse Event|0|||
49012046|NCT00863057|157881638|FG000|Period 2 (Weeks 6-10)|Physician Decision|0|||
49141508|NCT02318277|158356713|FG005|Overall Study|Physician Decision|0|||
49141509|NCT02318277|158356714|FG006|Overall Study|Physician Decision|0|||
49141510|NCT02318277|158356715|FG007|Overall Study|Physician Decision|1|||
49141511|NCT02318277|158356708|FG000|Overall Study|Other|0|||
49141512|NCT02318277|158356709|FG001|Overall Study|Other|0|||
49141513|NCT02318277|158356710|FG002|Overall Study|Other|0|||
49141514|NCT02318277|158356711|FG003|Overall Study|Other|0|||
49141515|NCT02318277|158356712|FG004|Overall Study|Other|0|||
49141516|NCT02318277|158356713|FG005|Overall Study|Other|0|||
49141517|NCT02318277|158356714|FG006|Overall Study|Other|1|||
49141518|NCT02318277|158356715|FG007|Overall Study|Other|0|||
49141519|NCT02318277|158356708|FG000|Overall Study|Withdrawal by Subject|0|||
49141520|NCT02318277|158356709|FG001|Overall Study|Withdrawal by Subject|0|||
49141521|NCT02318277|158356710|FG002|Overall Study|Withdrawal by Subject|1|||
49141522|NCT02318277|158356711|FG003|Overall Study|Withdrawal by Subject|0|||
49141523|NCT02318277|158356712|FG004|Overall Study|Withdrawal by Subject|1|||
49141524|NCT02318277|158356713|FG005|Overall Study|Withdrawal by Subject|1|||
49141525|NCT02318277|158356714|FG006|Overall Study|Withdrawal by Subject|6|||
49141526|NCT02318277|158356715|FG007|Overall Study|Withdrawal by Subject|14|||
49141527|NCT02318277|158356708|FG000|Overall Study|Participant trial terminated by sponsor|0|||
49141528|NCT02318277|158356709|FG001|Overall Study|Participant trial terminated by sponsor|0|||
49141529|NCT02318277|158356710|FG002|Overall Study|Participant trial terminated by sponsor|1|||
49141530|NCT02318277|158356711|FG003|Overall Study|Participant trial terminated by sponsor|0|||
49141531|NCT02318277|158356712|FG004|Overall Study|Participant trial terminated by sponsor|1|||
49141532|NCT02318277|158356713|FG005|Overall Study|Participant trial terminated by sponsor|2|||
49141533|NCT02318277|158356714|FG006|Overall Study|Participant trial terminated by sponsor|5|||
49141534|NCT02318277|158356715|FG007|Overall Study|Participant trial terminated by sponsor|16|||
49141535|NCT02318277|158356708|FG000|Overall Study|Lost to Follow-up|1|||
49012047|NCT00863057|157881639|FG001|Period 2 (Weeks 6-10)|Physician Decision|0|||
49012048|NCT00863057|157881640|FG002|Period 2 (Weeks 6-10)|Physician Decision|0|||
49012049|NCT00863057|157881641|FG003|Period 2 (Weeks 6-10)|Physician Decision|1|||
49012050|NCT00770315|157881642|FG000|Overall Study|Adverse Event|11|||
49141536|NCT02318277|158356709|FG001|Overall Study|Lost to Follow-up|0|||
49141537|NCT02318277|158356710|FG002|Overall Study|Lost to Follow-up|1|||
49141538|NCT02318277|158356711|FG003|Overall Study|Lost to Follow-up|0|||
49141539|NCT02318277|158356712|FG004|Overall Study|Lost to Follow-up|0|||
49141540|NCT02318277|158356713|FG005|Overall Study|Lost to Follow-up|0|||
49141541|NCT02318277|158356714|FG006|Overall Study|Lost to Follow-up|3|||
49012051|NCT00770315|157881643|FG001|Overall Study|Adverse Event|17|||
49012052|NCT00770315|157881644|FG002|Overall Study|Adverse Event|16|||
49012053|NCT00770315|157881645|FG003|Overall Study|Adverse Event|6|||
49012054|NCT00770315|157881642|FG000|Overall Study|Lost to Follow-up|9|||
49012055|NCT00770315|157881643|FG001|Overall Study|Lost to Follow-up|5|||
49012056|NCT00770315|157881644|FG002|Overall Study|Lost to Follow-up|10|||
49012057|NCT00770315|157881645|FG003|Overall Study|Lost to Follow-up|3|||
49012058|NCT00770315|157881642|FG000|Overall Study|Withdrawal by Subject|13|||
49012059|NCT00770315|157881643|FG001|Overall Study|Withdrawal by Subject|17|||
49012060|NCT00770315|157881644|FG002|Overall Study|Withdrawal by Subject|24|||
49012061|NCT00770315|157881645|FG003|Overall Study|Withdrawal by Subject|20|||
49012062|NCT00770315|157881642|FG000|Overall Study|Noncompliance with Protocol|7|||
49012063|NCT00770315|157881643|FG001|Overall Study|Noncompliance with Protocol|4|||
48729427|NCT00048061|156859767|FG002|Overall Study|Did not follow-up|4|||
48729428|NCT00048061|156859768|FG003|Overall Study|Did not follow-up|5|||
49141542|NCT02318277|158356715|FG007|Overall Study|Lost to Follow-up|4|||
49012064|NCT00770315|157881644|FG002|Overall Study|Noncompliance with Protocol|7|||
49012065|NCT00770315|157881645|FG003|Overall Study|Noncompliance with Protocol|9|||
49012066|NCT03652961|157881646|FG000|Overall Study|Lost to Follow-up|3|||
49012067|NCT03652961|157881646|FG000|Overall Study|Screen Failure|1|||
49012068|NCT00373685|157881647|FG000|Overall Study|Death|2|||
49012069|NCT00373685|157881648|FG001|Overall Study|Death|1|||
49012070|NCT00373685|157881647|FG000|Overall Study|Adverse Event|278|||
49012071|NCT00373685|157881648|FG001|Overall Study|Adverse Event|253|||
49141543|NCT02318277|158356708|FG000|Overall Study|Death|5|||
49141544|NCT02318277|158356709|FG001|Overall Study|Death|3|||
49141545|NCT02318277|158356710|FG002|Overall Study|Death|1|||
49141546|NCT02318277|158356711|FG003|Overall Study|Death|4|||
49141547|NCT02318277|158356712|FG004|Overall Study|Death|6|||
49141548|NCT02318277|158356713|FG005|Overall Study|Death|5|||
49141549|NCT02318277|158356714|FG006|Overall Study|Death|34|||
49141550|NCT02318277|158356715|FG007|Overall Study|Death|58|||
49141551|NCT02318277|158356708|FG000|Overall Study|Transitioned to Hospice|0|||
49141552|NCT02318277|158356709|FG001|Overall Study|Transitioned to Hospice|0|||
48729429|NCT00048061|156859765|FG000|Overall Study|Early improvement|6|||
49012072|NCT00373685|157881647|FG000|Overall Study|Insufficient clinical response|169|||
49012073|NCT00373685|157881648|FG001|Overall Study|Insufficient clinical response|119|||
49012074|NCT00373685|157881647|FG000|Overall Study|Did not meet entrance criteria|167|||
49012075|NCT00373685|157881648|FG001|Overall Study|Did not meet entrance criteria|184|||
49012076|NCT00373685|157881647|FG000|Overall Study|Lost to follow up|83|||
49141553|NCT02318277|158356710|FG002|Overall Study|Transitioned to Hospice|0|||
49141554|NCT02318277|158356711|FG003|Overall Study|Transitioned to Hospice|0|||
49141555|NCT02318277|158356712|FG004|Overall Study|Transitioned to Hospice|0|||
49141556|NCT02318277|158356713|FG005|Overall Study|Transitioned to Hospice|1|||
49141557|NCT02318277|158356714|FG006|Overall Study|Transitioned to Hospice|0|||
49141558|NCT02318277|158356715|FG007|Overall Study|Transitioned to Hospice|0|||
48729430|NCT00048061|156859766|FG001|Overall Study|Early improvement|5|||
49141559|NCT02503865|158356716|FG000|Overall Study|Moved out of area|1|||
49141560|NCT02503865|158356717|FG001|Overall Study|Moved out of area|8|||
49141561|NCT02503865|158356718|FG002|Overall Study|Moved out of area|0|||
49141562|NCT02503865|158356716|FG000|Overall Study|Refused treatment|4|||
49141563|NCT02503865|158356717|FG001|Overall Study|Refused treatment|39|||
49141564|NCT02503865|158356718|FG002|Overall Study|Refused treatment|2|||
49141565|NCT01210443|158356719|FG000|Overall Study|Study terminated by sponsor|2|||
49141566|NCT04584554|158356720|FG000|Overall Study|Withdrawal by Subject|2|||
49141567|NCT04584554|158356721|FG001|Overall Study|Withdrawal by Subject|2|||
49141568|NCT02497755|158356722|FG000|Overall Study|Protocol Violation|1|||
49141569|NCT02497755|158356723|FG001|Overall Study|Protocol Violation|0|||
49141570|NCT01774370|158356724|FG000|Overall Study|Never taken the PRADAXA during the study|4|||
49141571|NCT01774370|158356724|FG000|Overall Study|Administered prior to the contract date|4|||
49141572|NCT01774370|158356724|FG000|Overall Study|Subjects of contraindications|34|||
49141573|NCT01774370|158356724|FG000|Overall Study|Violated inclusion/exclusion criteria|53|||
49141574|NCT01774370|158356724|FG000|Overall Study|Follow-up failure|34|||
49141575|NCT00501085|158356732|FG000|Overall Study|Lost to Follow-up|195|||
49141576|NCT00501085|158356732|FG000|Overall Study|Withdrawal by Subject|34|||
49141577|NCT00501085|158356732|FG000|Overall Study|Subject Decision|1|||
49141578|NCT00501085|158356732|FG000|Overall Study|Revision Surgery|7|||
49141579|NCT00501085|158356732|FG000|Overall Study|Explantation Surgery|26|||
49141580|NCT00501085|158356732|FG000|Overall Study|Adverse Event|4|||
49141581|NCT00501085|158356732|FG000|Overall Study|Non-Compliance|24|||
49141582|NCT00501085|158356732|FG000|Overall Study|Study closed by sponsor|109|||
49141583|NCT00501085|158356732|FG000|Overall Study|Other loss to follow-up|32|||
49141584|NCT02958527|158356737|FG000|Overall Study|Not collected CRFs|12|||
49141585|NCT02366130|158356738|FG000|Overall Study|Withdrawal by Subject|3|||
49141586|NCT02366130|158356738|FG000|Overall Study|Ineligible|6|||
49141587|NCT03467945|158356739|FG000|Treatment Period 2|Withdrawal by Subject|0|||
49141588|NCT03467945|158356740|FG001|Treatment Period 2|Withdrawal by Subject|1|||
49012077|NCT00373685|157881648|FG001|Overall Study|Lost to follow up|103|||
49012078|NCT00373685|157881647|FG000|Overall Study|No longer willing to participate|337|||
49012079|NCT00373685|157881648|FG001|Overall Study|No longer willing to participate|352|||
49012080|NCT00373685|157881647|FG000|Overall Study|Other|149|||
49012081|NCT00373685|157881648|FG001|Overall Study|Other|146|||
49012082|NCT00373685|157881647|FG000|Overall Study|Protocol Violation|191|||
49012083|NCT00373685|157881648|FG001|Overall Study|Protocol Violation|182|||
49012084|NCT00373685|157881647|FG000|Overall Study|Final Status Unknown|12|||
49012085|NCT00373685|157881648|FG001|Overall Study|Final Status Unknown|4|||
49012086|NCT00373685|157881647|FG000|Overall Study|Randomized, not treated|51|||
49012087|NCT00373685|157881648|FG001|Overall Study|Randomized, not treated|77|||
49012088|NCT01953783|157881649|FG000|Overall Study|Progressive disease|2|||
49012089|NCT01620489|157881652|FG000|Overall Study|Adverse Event|17|||
49012090|NCT01620489|157881653|FG001|Overall Study|Adverse Event|4|||
49012091|NCT01620489|157881652|FG000|Overall Study|Protocol Violation|0|||
49012092|NCT01620489|157881653|FG001|Overall Study|Protocol Violation|3|||
49012093|NCT01620489|157881652|FG000|Overall Study|Withdrawal Criteria|17|||
49012094|NCT01620489|157881653|FG001|Overall Study|Withdrawal Criteria|25|||
49012095|NCT01620489|157881652|FG000|Overall Study|Unclassified|1|||
49012096|NCT01620489|157881653|FG001|Overall Study|Unclassified|2|||
49012097|NCT00871169|157881654|FG000|Overall Study|Protocol Violation|1|||
49012098|NCT00871169|157881654|FG000|Overall Study|Patient did not receive study treatment|2|||
49012099|NCT02168270|157881655|FG000|Overall Study|Lack of Efficacy|4|||
49012100|NCT02971605|157881659|FG000|Overall Study|Withdrawal by Subject|1|||
48822278|NCT01474512|157190492|FG009|Long-Term Extension Period|Sponsor Decision|0|||
49141589|NCT03467945|158356741|FG002|Treatment Period 2|Withdrawal by Subject|0|||
49141590|NCT03467945|158356742|FG003|Treatment Period 2|Withdrawal by Subject|0|||
49141591|NCT03467945|158356739|FG000|Treatment Period 3|Withdrawal by Subject|1|||
49141592|NCT03467945|158356740|FG001|Treatment Period 3|Withdrawal by Subject|0|||
49141593|NCT03467945|158356741|FG002|Treatment Period 3|Withdrawal by Subject|2|||
49141594|NCT03467945|158356742|FG003|Treatment Period 3|Withdrawal by Subject|1|||
49141595|NCT01666314|158356743|FG000|Overall Study|Adverse Event|3|||
49141596|NCT01666314|158356744|FG001|Overall Study|Adverse Event|13|||
49141597|NCT01666314|158356745|FG002|Overall Study|Adverse Event|7|||
49141598|NCT01666314|158356746|FG003|Overall Study|Adverse Event|7|||
49141599|NCT01666314|158356743|FG000|Overall Study|Progressive Disease|11|||
49141600|NCT01666314|158356744|FG001|Overall Study|Progressive Disease|9|||
49141601|NCT01666314|158356745|FG002|Overall Study|Progressive Disease|19|||
48822279|NCT01474512|157190493|FG010|Long-Term Extension Period|Sponsor Decision|0|||
49012101|NCT02649231|157881662|FG000|Overall Study|Adverse Event|0|||
49141602|NCT01666314|158356746|FG003|Overall Study|Progressive Disease|20|||
49141603|NCT01666314|158356743|FG000|Overall Study|Symptomatic Deterioration|1|||
49141604|NCT01666314|158356744|FG001|Overall Study|Symptomatic Deterioration|0|||
49141605|NCT01666314|158356745|FG002|Overall Study|Symptomatic Deterioration|2|||
49141606|NCT01666314|158356746|FG003|Overall Study|Symptomatic Deterioration|0|||
49012102|NCT02649231|157881663|FG001|Overall Study|Adverse Event|0|||
49012103|NCT02649231|157881664|FG002|Overall Study|Adverse Event|0|||
49012104|NCT02649231|157881665|FG003|Overall Study|Adverse Event|1|||
48729431|NCT00048061|156859767|FG002|Overall Study|Early improvement|3|||
48729432|NCT00048061|156859768|FG003|Overall Study|Early improvement|0|||
48729433|NCT00901927|156859772|FG000|Overall Study|Lack of Efficacy|1|||
49141607|NCT01666314|158356743|FG000|Overall Study|Unsatisfactory Therapeutic Response|7|||
49141608|NCT01666314|158356744|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
49141609|NCT01666314|158356745|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
49141610|NCT01666314|158356746|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
49141611|NCT01666314|158356743|FG000|Overall Study|Withdrawal by Subject|1|||
49141612|NCT01666314|158356744|FG001|Overall Study|Withdrawal by Subject|1|||
49141613|NCT01666314|158356745|FG002|Overall Study|Withdrawal by Subject|2|||
49141614|NCT01666314|158356746|FG003|Overall Study|Withdrawal by Subject|3|||
49141615|NCT01666314|158356743|FG000|Overall Study|Reason not Specified|10|||
49141616|NCT01666314|158356744|FG001|Overall Study|Reason not Specified|7|||
49141617|NCT01666314|158356745|FG002|Overall Study|Reason not Specified|5|||
49141618|NCT01666314|158356746|FG003|Overall Study|Reason not Specified|5|||
49141619|NCT01945242|158356747|FG000|Overall Study|Physician Decision|3|||
49141620|NCT01945242|158356748|FG001|Overall Study|Physician Decision|3|||
49141621|NCT02405962|158356750|FG000|Overall Study|Lost to Follow-up|1|||
49141622|NCT02405962|158356751|FG001|Overall Study|Lost to Follow-up|4|||
49141623|NCT02405962|158356750|FG000|Overall Study|A participant has moved to another place|0|||
49141624|NCT02405962|158356751|FG001|Overall Study|A participant has moved to another place|1|||
49141625|NCT00962650|158356752|FG000|Overall Study|Transgastric DP was not completed|2|||
49141626|NCT00105508|158356754|FG000|Overall Study|Prephase Dropout|1|||
49141627|NCT00105508|158356755|FG001|Overall Study|Prephase Dropout|0|||
49141628|NCT00105508|158356754|FG000|Overall Study|Adverse Event|16|||
49141629|NCT00105508|158356755|FG001|Overall Study|Adverse Event|19|||
49141630|NCT00105508|158356754|FG000|Overall Study|Insufficient Efficacy|1|||
49141631|NCT00105508|158356755|FG001|Overall Study|Insufficient Efficacy|0|||
49141632|NCT00105508|158356754|FG000|Overall Study|Withdrawal by Subject|10|||
49141633|NCT00105508|158356755|FG001|Overall Study|Withdrawal by Subject|6|||
49141634|NCT00105508|158356754|FG000|Overall Study|Lost to Follow-up|3|||
49141635|NCT00105508|158356755|FG001|Overall Study|Lost to Follow-up|0|||
49141636|NCT00105508|158356754|FG000|Overall Study|Protocol Violation|1|||
49141637|NCT00105508|158356755|FG001|Overall Study|Protocol Violation|2|||
49141638|NCT00105508|158356754|FG000|Overall Study|Other|8|||
49141639|NCT00105508|158356755|FG001|Overall Study|Other|9|||
49141640|NCT03684057|158358687|FG000|Overall Study|Withdrawal by Subject|4|||
49141641|NCT03684057|158358688|FG001|Overall Study|Withdrawal by Subject|5|||
49141642|NCT00368849|158358696|FG000|Overall Study|Withdrawal by Subject|0|||
49141643|NCT00368849|158358697|FG001|Overall Study|Withdrawal by Subject|1|||
49141644|NCT00368849|158358696|FG000|Overall Study|Physician Decision|0|||
49141645|NCT00368849|158358697|FG001|Overall Study|Physician Decision|1|||
49141646|NCT01155323|158358698|FG000|First Intervention|exclusion criteria|1|||
49141647|NCT01155323|158358699|FG001|First Intervention|exclusion criteria|1|||
49141648|NCT01155323|158358698|FG000|Second Intervention|Lost to Follow-up|1|||
49141649|NCT01155323|158358699|FG001|Second Intervention|Lost to Follow-up|1|||
49141650|NCT01410604|158358700|FG000|Overall Study|Adverse Event|2|||
49141651|NCT01410604|158358701|FG001|Overall Study|Adverse Event|1|||
49141652|NCT01410604|158358700|FG000|Overall Study|Lost to Follow-up|1|||
49141653|NCT01410604|158358701|FG001|Overall Study|Lost to Follow-up|0|||
49141654|NCT01410604|158358700|FG000|Overall Study|Physician Decision|0|||
49141655|NCT01410604|158358701|FG001|Overall Study|Physician Decision|1|||
49141656|NCT01521364|158358703|FG000|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1|||
49141657|NCT01521364|158358703|FG000|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1|||
49141658|NCT02175758|158358704|FG000|Treatment Phase|Lost to Follow-up|0|||
49141659|NCT02175758|158358705|FG001|Treatment Phase|Lost to Follow-up|1|||
49141660|NCT02175758|158358706|FG002|Treatment Phase|Lost to Follow-up|0|||
49141661|NCT02175758|158358707|FG003|Treatment Phase|Lost to Follow-up|0|||
49141662|NCT02175758|158358708|FG004|Treatment Phase|Lost to Follow-up|0|||
49141663|NCT02175758|158358709|FG005|Treatment Phase|Lost to Follow-up|0|||
49141664|NCT02175758|158358704|FG000|Treatment Phase|Adverse Event|0|||
49141665|NCT02175758|158358705|FG001|Treatment Phase|Adverse Event|0|||
49141666|NCT02175758|158358706|FG002|Treatment Phase|Adverse Event|0|||
49141667|NCT02175758|158358707|FG003|Treatment Phase|Adverse Event|0|||
48729434|NCT00901927|156859772|FG000|Overall Study|Protocol Violation|3|||
48729435|NCT00901927|156859772|FG000|Overall Study|Withdrawal by Subject|2|||
48729436|NCT00072176|156859783|FG000|Overall Study|Withdrawal by Subject|1|||
49141668|NCT02175758|158358708|FG004|Treatment Phase|Adverse Event|1|||
49141669|NCT02175758|158358709|FG005|Treatment Phase|Adverse Event|0|||
49141670|NCT02636283|158358712|FG000|Overall Study|Adverse Event|2|||
49141671|NCT02636283|158358713|FG001|Overall Study|Adverse Event|0|||
49141672|NCT02636283|158358712|FG000|Overall Study|Trial Terminated Prematurely|0|||
49141673|NCT02636283|158358713|FG001|Overall Study|Trial Terminated Prematurely|3|||
49141674|NCT01178411|158358714|FG000|Overall Study|Adverse Event|5|||
49141675|NCT01178411|158358714|FG000|Overall Study|Withdrawal by Subject|4|||
49141676|NCT01178411|158358714|FG000|Overall Study|Protocol Violation|1|||
49141677|NCT01178411|158358714|FG000|Overall Study|Progressive disease per RECIST|32|||
48822280|NCT01474512|157190494|FG011|Long-Term Extension Period|Sponsor Decision|0|||
48822281|NCT01474512|157190495|FG012|Long-Term Extension Period|Sponsor Decision|6|||
48822282|NCT01474512|157190496|FG013|Long-Term Extension Period|Sponsor Decision|6|||
48822283|NCT01474512|157190497|FG014|Long-Term Extension Period|Sponsor Decision|0|||
48822284|NCT01474512|157190498|FG015|Long-Term Extension Period|Sponsor Decision|0|||
49141678|NCT01178411|158358714|FG000|Overall Study|Progressive disease per clinician|9|||
49141679|NCT01178411|158358714|FG000|Overall Study|Physician Decision|6|||
49141680|NCT01178411|158358714|FG000|Overall Study|Death|1|||
49141681|NCT01178411|158358714|FG000|Overall Study|No reason provided|1|||
49141682|NCT01178411|158358714|FG000|Overall Study|Drug manufacturing ended|1|||
49141683|NCT03309605|158358715|FG000|Overall Study|Adverse Event|0|||
49141684|NCT03309605|158358716|FG001|Overall Study|Adverse Event|0|||
49141685|NCT03309605|158358717|FG002|Overall Study|Adverse Event|0|||
49141686|NCT03309605|158358718|FG003|Overall Study|Adverse Event|1|||
49141687|NCT03309605|158358719|FG004|Overall Study|Adverse Event|0|||
49141688|NCT03309605|158358720|FG005|Overall Study|Adverse Event|0|||
49141689|NCT03309605|158358721|FG006|Overall Study|Adverse Event|2|||
49141690|NCT03309605|158358722|FG007|Overall Study|Adverse Event|1|||
49141691|NCT03309605|158358715|FG000|Overall Study|Withdrawal by Subject|0|||
49141692|NCT03309605|158358716|FG001|Overall Study|Withdrawal by Subject|0|||
49141693|NCT03309605|158358717|FG002|Overall Study|Withdrawal by Subject|0|||
49141694|NCT03309605|158358718|FG003|Overall Study|Withdrawal by Subject|0|||
49141695|NCT03309605|158358719|FG004|Overall Study|Withdrawal by Subject|1|||
49141696|NCT03309605|158358720|FG005|Overall Study|Withdrawal by Subject|0|||
49141697|NCT03309605|158358721|FG006|Overall Study|Withdrawal by Subject|1|||
49141698|NCT03309605|158358722|FG007|Overall Study|Withdrawal by Subject|1|||
49141699|NCT00394472|158358726|FG000|Overall Study|Protocol Violation|1|||
49141700|NCT00394472|158358727|FG001|Overall Study|Protocol Violation|3|||
49141701|NCT00394472|158358726|FG000|Overall Study|incorrect enrolment|4|||
49141702|NCT00394472|158358727|FG001|Overall Study|incorrect enrolment|2|||
49141703|NCT00394472|158358726|FG000|Overall Study|Adverse Event|4|||
49141704|NCT00394472|158358727|FG001|Overall Study|Adverse Event|2|||
49141705|NCT00394472|158358726|FG000|Overall Study|Withdrawal by Subject|0|||
49141706|NCT00394472|158358727|FG001|Overall Study|Withdrawal by Subject|2|||
49141707|NCT00394472|158358726|FG000|Overall Study|Physician Decision|0|||
49141708|NCT00394472|158358727|FG001|Overall Study|Physician Decision|1|||
49141709|NCT00394472|158358726|FG000|Overall Study|Lost to Follow-up|0|||
49141710|NCT00394472|158358727|FG001|Overall Study|Lost to Follow-up|1|||
49141711|NCT01879852|158358728|FG000|Overall Study|Withdrawal by Subject|2|||
49141712|NCT01879852|158358729|FG001|Overall Study|Withdrawal by Subject|0|||
49141713|NCT00145327|158358735|FG000|Overall Study|Withdrawal by Subject|77|||
49141714|NCT00145327|158358736|FG001|Overall Study|Withdrawal by Subject|72|||
49141715|NCT00145327|158358737|FG002|Overall Study|Withdrawal by Subject|164|||
49141716|NCT00145327|158358735|FG000|Overall Study|Death|26|||
49141717|NCT00145327|158358736|FG001|Overall Study|Death|18|||
49141718|NCT00145327|158358737|FG002|Overall Study|Death|30|||
49141719|NCT00145327|158358735|FG000|Overall Study|Adverse Event|14|||
49141720|NCT00145327|158358736|FG001|Overall Study|Adverse Event|11|||
49141721|NCT00145327|158358737|FG002|Overall Study|Adverse Event|22|||
49141722|NCT00145327|158358735|FG000|Overall Study|Lost to Follow-up|9|||
49141723|NCT00145327|158358736|FG001|Overall Study|Lost to Follow-up|14|||
49141724|NCT00145327|158358737|FG002|Overall Study|Lost to Follow-up|14|||
49141725|NCT00145327|158358735|FG000|Overall Study|Administrative problems|12|||
49141726|NCT00145327|158358736|FG001|Overall Study|Administrative problems|9|||
49141727|NCT00145327|158358737|FG002|Overall Study|Administrative problems|13|||
49141728|NCT00145327|158358735|FG000|Overall Study|Protocol Violation|2|||
49141729|NCT00145327|158358736|FG001|Overall Study|Protocol Violation|0|||
49141730|NCT00145327|158358737|FG002|Overall Study|Protocol Violation|2|||
49141731|NCT00145327|158358735|FG000|Overall Study|Abnormal laboratory value(s)|1|||
49141732|NCT00145327|158358736|FG001|Overall Study|Abnormal laboratory value(s)|0|||
49141733|NCT00145327|158358737|FG002|Overall Study|Abnormal laboratory value(s)|2|||
49141734|NCT00145327|158358735|FG000|Overall Study|Missing - not stated|1|||
49141735|NCT00145327|158358736|FG001|Overall Study|Missing - not stated|0|||
49141736|NCT00145327|158358737|FG002|Overall Study|Missing - not stated|1|||
49141737|NCT01137812|158358740|FG000|Overall Study|Adverse Event|21|||
49141738|NCT01137812|158358741|FG001|Overall Study|Adverse Event|14|||
49141739|NCT01137812|158358740|FG000|Overall Study|Lost to Follow-up|6|||
49141740|NCT01137812|158358741|FG001|Overall Study|Lost to Follow-up|8|||
49141741|NCT01137812|158358740|FG000|Overall Study|Physician Decision|25|||
49141742|NCT01137812|158358741|FG001|Overall Study|Physician Decision|17|||
49141743|NCT01137812|158358740|FG000|Overall Study|Protocol Violation|5|||
49141744|NCT01137812|158358741|FG001|Overall Study|Protocol Violation|4|||
49141745|NCT01137812|158358740|FG000|Overall Study|Withdrawal by Subject|5|||
49141746|NCT01137812|158358741|FG001|Overall Study|Withdrawal by Subject|13|||
49141747|NCT01137812|158358740|FG000|Overall Study|Death|2|||
49141748|NCT01137812|158358741|FG001|Overall Study|Death|0|||
49141749|NCT01137812|158358740|FG000|Overall Study|Patient met glycemic withdrawal criteria|40|||
49141750|NCT01137812|158358741|FG001|Overall Study|Patient met glycemic withdrawal criteria|85|||
49012105|NCT02649231|157881662|FG000|Overall Study|Lost to Follow-up|2|||
49012106|NCT02649231|157881663|FG001|Overall Study|Lost to Follow-up|1|||
49012107|NCT02649231|157881664|FG002|Overall Study|Lost to Follow-up|1|||
49012108|NCT02649231|157881665|FG003|Overall Study|Lost to Follow-up|0|||
49012109|NCT02649231|157881662|FG000|Overall Study|Withdrawal by Subject|0|||
49012110|NCT02649231|157881663|FG001|Overall Study|Withdrawal by Subject|1|||
49012111|NCT02649231|157881664|FG002|Overall Study|Withdrawal by Subject|0|||
49012112|NCT02649231|157881665|FG003|Overall Study|Withdrawal by Subject|1|||
49012113|NCT02649231|157881662|FG000|Overall Study|Protocol Violation|2|||
49012114|NCT02649231|157881663|FG001|Overall Study|Protocol Violation|1|||
49012115|NCT02649231|157881664|FG002|Overall Study|Protocol Violation|1|||
49012116|NCT02649231|157881665|FG003|Overall Study|Protocol Violation|0|||
49012117|NCT00638157|157881666|FG000|Overall Study|Adverse Event|0|||
49012118|NCT00638157|157881667|FG001|Overall Study|Adverse Event|1|||
49012119|NCT00638157|157881666|FG000|Overall Study|Clinical (symptomatic) failure|1|||
49012120|NCT00638157|157881667|FG001|Overall Study|Clinical (symptomatic) failure|1|||
49012121|NCT00638157|157881666|FG000|Overall Study|Microbiological failure|1|||
49012122|NCT00638157|157881667|FG001|Overall Study|Microbiological failure|0|||
49012123|NCT00638157|157881666|FG000|Overall Study|Lost to Follow-up|1|||
49012124|NCT00638157|157881667|FG001|Overall Study|Lost to Follow-up|0|||
49012125|NCT00638157|157881666|FG000|Overall Study|Physician Decision|1|||
49012126|NCT00638157|157881667|FG001|Overall Study|Physician Decision|0|||
49012127|NCT00638157|157881666|FG000|Overall Study|Other|1|||
49012128|NCT00638157|157881667|FG001|Overall Study|Other|2|||
49012129|NCT00638157|157881666|FG000|Overall Study|Randomized, not treated|2|||
49012130|NCT00638157|157881667|FG001|Overall Study|Randomized, not treated|0|||
49012131|NCT00437281|157881668|FG000|Overall Study|Adverse Event|0|||
49012132|NCT00437281|157881669|FG001|Overall Study|Adverse Event|0|||
49141751|NCT01137812|158358740|FG000|Overall Study|Other|19|||
49141752|NCT01137812|158358741|FG001|Overall Study|Other|27|||
49141753|NCT01283386|158358742|FG000|Overall Study|Death|2|||
49141754|NCT01283386|158358743|FG001|Overall Study|Death|0|||
49141755|NCT01283386|158358742|FG000|Overall Study|Withdrawal by Subject|2|||
49141756|NCT01283386|158358743|FG001|Overall Study|Withdrawal by Subject|1|||
49141757|NCT01283386|158358742|FG000|Overall Study|Relapse of underlying disease|1|||
49141758|NCT01283386|158358743|FG001|Overall Study|Relapse of underlying disease|3|||
49141759|NCT01283386|158358742|FG000|Overall Study|Progression of underlying disease|2|||
49141760|NCT01283386|158358743|FG001|Overall Study|Progression of underlying disease|7|||
49141761|NCT01283386|158358742|FG000|Overall Study|Reason not specified|1|||
49141762|NCT01283386|158358743|FG001|Overall Study|Reason not specified|0|||
49141763|NCT01283386|158358742|FG000|Overall Study|Protocol Violation|0|||
49141764|NCT01283386|158358743|FG001|Overall Study|Protocol Violation|1|||
49012133|NCT00437281|157881670|FG002|Overall Study|Adverse Event|0|||
49012134|NCT00437281|157881671|FG003|Overall Study|Adverse Event|1|||
49012135|NCT00437281|157881672|FG004|Overall Study|Adverse Event|0|||
49012136|NCT00437281|157881673|FG005|Overall Study|Adverse Event|1|||
49012137|NCT00437281|157881674|FG006|Overall Study|Adverse Event|0|||
49012138|NCT00437281|157881675|FG007|Overall Study|Adverse Event|0|||
49012139|NCT00437281|157881676|FG008|Overall Study|Adverse Event|0|||
49012140|NCT00437281|157881677|FG009|Overall Study|Adverse Event|1|||
49012141|NCT00437281|157881678|FG010|Overall Study|Adverse Event|0|||
49012142|NCT00437281|157881679|FG011|Overall Study|Adverse Event|0|||
49012143|NCT00437281|157881680|FG012|Overall Study|Adverse Event|0|||
49012144|NCT00437281|157881681|FG013|Overall Study|Adverse Event|1|||
49012145|NCT00437281|157881682|FG014|Overall Study|Adverse Event|1|||
49012146|NCT00437281|157881683|FG015|Overall Study|Adverse Event|0|||
49012147|NCT00437281|157881684|FG016|Overall Study|Adverse Event|0|||
49012148|NCT00437281|157881685|FG017|Overall Study|Adverse Event|0|||
49012149|NCT00437281|157881686|FG018|Overall Study|Adverse Event|1|||
49012150|NCT00437281|157881687|FG019|Overall Study|Adverse Event|0|||
49012151|NCT00437281|157881668|FG000|Overall Study|Lost to Follow-up|0|||
49012152|NCT00437281|157881669|FG001|Overall Study|Lost to Follow-up|0|||
49012153|NCT00437281|157881670|FG002|Overall Study|Lost to Follow-up|0|||
49012154|NCT00437281|157881671|FG003|Overall Study|Lost to Follow-up|0|||
49012155|NCT00437281|157881672|FG004|Overall Study|Lost to Follow-up|0|||
49012156|NCT00437281|157881673|FG005|Overall Study|Lost to Follow-up|0|||
49012157|NCT00437281|157881674|FG006|Overall Study|Lost to Follow-up|0|||
49012158|NCT00437281|157881675|FG007|Overall Study|Lost to Follow-up|0|||
49012159|NCT00437281|157881676|FG008|Overall Study|Lost to Follow-up|0|||
49012160|NCT00437281|157881677|FG009|Overall Study|Lost to Follow-up|0|||
49012161|NCT00437281|157881678|FG010|Overall Study|Lost to Follow-up|0|||
49012162|NCT00437281|157881679|FG011|Overall Study|Lost to Follow-up|0|||
49141765|NCT04027946|158358744|FG000|Overall Study|Screen failures|3|||
49012163|NCT00437281|157881680|FG012|Overall Study|Lost to Follow-up|0|||
49012164|NCT00437281|157881681|FG013|Overall Study|Lost to Follow-up|0|||
49141766|NCT01028053|158358748|FG000|Overall Study|Screen Failure|113|||
49012165|NCT00437281|157881682|FG014|Overall Study|Lost to Follow-up|0|||
49012166|NCT00437281|157881683|FG015|Overall Study|Lost to Follow-up|0|||
49012167|NCT00437281|157881684|FG016|Overall Study|Lost to Follow-up|0|||
49141767|NCT01028053|158358748|FG000|Overall Study|Patient Request|11|||
49012168|NCT00437281|157881685|FG017|Overall Study|Lost to Follow-up|0|||
49012169|NCT00437281|157881686|FG018|Overall Study|Lost to Follow-up|0|||
49012170|NCT00437281|157881687|FG019|Overall Study|Lost to Follow-up|1|||
49012171|NCT02110706|157881688|FG000|Overall Study|Adverse Event|2|||
49012172|NCT02110706|157881689|FG001|Overall Study|Adverse Event|3|||
49012173|NCT02110706|157881688|FG000|Overall Study|Patients who didn't receive 2nd infusion|3|||
49012174|NCT02110706|157881689|FG001|Overall Study|Patients who didn't receive 2nd infusion|1|||
49012175|NCT00520351|157881692|FG000|First Intervention|Withdrawal by Subject|1|||
49012176|NCT00520351|157881693|FG001|First Intervention|Withdrawal by Subject|1|||
49012177|NCT01875445|157881694|FG000|Overall Study|Lost to Follow-up|5|||
49012178|NCT01875445|157881695|FG001|Overall Study|Lost to Follow-up|0|||
49012179|NCT01875445|157881694|FG000|Overall Study|Withdrawal by Subject|2|||
49012180|NCT01875445|157881695|FG001|Overall Study|Withdrawal by Subject|0|||
49012181|NCT01102777|157881696|FG000|Overall Study|Death|2|||
49012182|NCT01102777|157881697|FG001|Overall Study|Death|6|||
49012183|NCT01102777|157881696|FG000|Overall Study|Lost to Follow-up|7|||
49012184|NCT01102777|157881697|FG001|Overall Study|Lost to Follow-up|10|||
49012185|NCT00706706|157881698|FG000|Overall Study|Death|53|||
49012186|NCT00706706|157881698|FG000|Overall Study|Lost to Follow-up|7|||
49012187|NCT00706706|157881698|FG000|Overall Study|Study endpoint had reached|45|||
49012188|NCT00593333|157881699|FG000|Overall Study|Lost to Follow-up|10|||
49012189|NCT00593333|157881700|FG001|Overall Study|Lost to Follow-up|11|||
49012190|NCT05476679|157881701|FG000|Overall Study|Withdrawal by Subject|0|||
49012191|NCT05476679|157881702|FG001|Overall Study|Withdrawal by Subject|0|||
49012192|NCT05476679|157881703|FG002|Overall Study|Withdrawal by Subject|0|||
49012193|NCT05476679|157881704|FG003|Overall Study|Withdrawal by Subject|1|||
49012194|NCT05476679|157881705|FG004|Overall Study|Withdrawal by Subject|0|||
49012195|NCT05476679|157881701|FG000|Overall Study|Lost to Follow-up|0|||
49012196|NCT05476679|157881702|FG001|Overall Study|Lost to Follow-up|0|||
49012197|NCT05476679|157881703|FG002|Overall Study|Lost to Follow-up|0|||
49012198|NCT05476679|157881704|FG003|Overall Study|Lost to Follow-up|1|||
49141768|NCT01028053|158358748|FG000|Overall Study|Protocol Violation|1|||
49141769|NCT01028053|158358748|FG000|Overall Study|Physician Decision|2|||
49141770|NCT01028053|158358748|FG000|Overall Study|Technical Problem|1|||
48729437|NCT00072176|156859784|FG001|Overall Study|Withdrawal by Subject|0|||
48729438|NCT00072176|156859783|FG000|Overall Study|Protocol Violation|0|||
48729439|NCT00072176|156859784|FG001|Overall Study|Protocol Violation|1|||
48729440|NCT04567615|156859796|FG000|Randomization|Participant withdrew consent|1|||
48729441|NCT04567615|156859797|FG001|Randomization|Participant withdrew consent|0|||
48729442|NCT04567615|156859798|FG002|Randomization|Participant withdrew consent|0|||
48729443|NCT04567615|156859796|FG000|Randomization|Adverse event unrelated to study drug|0|||
48729444|NCT04567615|156859797|FG001|Randomization|Adverse event unrelated to study drug|1|||
48729445|NCT04567615|156859798|FG002|Randomization|Adverse event unrelated to study drug|0|||
48729446|NCT04567615|156859796|FG000|Treatment Period|Participant Withdrew Consent|2|||
49141771|NCT01028053|158358748|FG000|Overall Study|Terminated by Sponsor|1|||
48729447|NCT04567615|156859797|FG001|Treatment Period|Participant Withdrew Consent|5|||
49141772|NCT01028053|158358748|FG000|Overall Study|Various reasons|4|||
49141773|NCT03315689|158358749|FG000|Double-blind Period = 28 Days|Withdrawal by Subject|1|||
49141774|NCT03315689|158358750|FG001|Double-blind Period = 28 Days|Withdrawal by Subject|0|||
49141775|NCT03315689|158358749|FG000|Open Label Extension = 52 Weeks|Withdrawal by Subject|0|||
49141776|NCT03315689|158358750|FG001|Open Label Extension = 52 Weeks|Withdrawal by Subject|2|||
49141777|NCT03315689|158358749|FG000|Open Label Extension = 52 Weeks|Lost to Follow-up|0|||
49141778|NCT03315689|158358750|FG001|Open Label Extension = 52 Weeks|Lost to Follow-up|1|||
49141779|NCT01297244|158358755|FG000|Overall Study|Progressive disease|22|||
49141780|NCT01297244|158358756|FG001|Overall Study|Progressive disease|3|||
49141781|NCT01297244|158358755|FG000|Overall Study|Adverse Event|9|||
49141782|NCT01297244|158358756|FG001|Overall Study|Adverse Event|1|||
49141783|NCT01297244|158358755|FG000|Overall Study|Death|1|||
49141784|NCT01297244|158358756|FG001|Overall Study|Death|1|||
49141785|NCT01297244|158358755|FG000|Overall Study|Clinical progression|1|||
49141786|NCT01297244|158358756|FG001|Overall Study|Clinical progression|1|||
49141787|NCT01297244|158358755|FG000|Overall Study|Withdrawal by Subject|2|||
49141788|NCT01297244|158358756|FG001|Overall Study|Withdrawal by Subject|0|||
49141789|NCT00263562|158358757|FG000|Overall Study|Protocol Violation|3|||
49141790|NCT00263562|158358758|FG001|Overall Study|Protocol Violation|0|||
49141791|NCT03387046|158358761|FG000|Overall Study|Adverse Event|1|||
49141792|NCT03387046|158358762|FG001|Overall Study|Adverse Event|1|||
49141793|NCT00986232|158358763|FG000|Overall Study|Adverse Event|1|||
49141794|NCT00986232|158358764|FG001|Overall Study|Adverse Event|2|||
49141795|NCT00986232|158358765|FG002|Overall Study|Adverse Event|3|||
49141796|NCT00986232|158358766|FG003|Overall Study|Adverse Event|0|||
49141797|NCT00986232|158358763|FG000|Overall Study|Lost to Follow-up|19|||
49141798|NCT00986232|158358764|FG001|Overall Study|Lost to Follow-up|12|||
49141799|NCT00986232|158358765|FG002|Overall Study|Lost to Follow-up|12|||
49141800|NCT00986232|158358766|FG003|Overall Study|Lost to Follow-up|7|||
49141801|NCT00986232|158358763|FG000|Overall Study|Protocol Violation|2|||
49141802|NCT00986232|158358764|FG001|Overall Study|Protocol Violation|3|||
49141803|NCT00986232|158358765|FG002|Overall Study|Protocol Violation|0|||
49141804|NCT00986232|158358766|FG003|Overall Study|Protocol Violation|1|||
49141805|NCT00986232|158358763|FG000|Overall Study|Withdrawal by Subject|13|||
49141806|NCT00986232|158358764|FG001|Overall Study|Withdrawal by Subject|16|||
49012199|NCT05476679|157881705|FG004|Overall Study|Lost to Follow-up|0|||
49012200|NCT01965652|157881707|FG000|Overall Study|Adverse Event|40|||
49141807|NCT00986232|158358765|FG002|Overall Study|Withdrawal by Subject|12|||
49141808|NCT00986232|158358766|FG003|Overall Study|Withdrawal by Subject|3|||
49141809|NCT00986232|158358763|FG000|Overall Study|Missed one or more bleeds|13|||
49012201|NCT01965652|157881708|FG001|Overall Study|Adverse Event|37|||
49012202|NCT01965652|157881707|FG000|Overall Study|Withdrawal by Subject|62|||
49012203|NCT01965652|157881708|FG001|Overall Study|Withdrawal by Subject|69|||
49012204|NCT01965652|157881707|FG000|Overall Study|Lost to Follow-up|53|||
49012205|NCT01965652|157881708|FG001|Overall Study|Lost to Follow-up|40|||
49012206|NCT01965652|157881707|FG000|Overall Study|Protocol Violation|34|||
49012207|NCT01965652|157881708|FG001|Overall Study|Protocol Violation|38|||
48729448|NCT04567615|156859798|FG002|Treatment Period|Participant Withdrew Consent|1|||
48729449|NCT04567615|156859796|FG000|Treatment Period|Death|1|||
48729450|NCT04567615|156859797|FG001|Treatment Period|Death|2|||
48822285|NCT01474512|157190499|FG016|Long-Term Extension Period|Sponsor Decision|0|||
48822286|NCT01474512|157190500|FG017|Long-Term Extension Period|Sponsor Decision|0|||
48822287|NCT01474512|157190483|FG000|Long-Term Extension Period|Protocol Violation|0|||
48822288|NCT01474512|157190484|FG001|Long-Term Extension Period|Protocol Violation|0|||
48822289|NCT01474512|157190485|FG002|Long-Term Extension Period|Protocol Violation|0|||
48822290|NCT01474512|157190486|FG003|Long-Term Extension Period|Protocol Violation|0|||
48822291|NCT01474512|157190487|FG004|Long-Term Extension Period|Protocol Violation|0|||
49141810|NCT00986232|158358764|FG001|Overall Study|Missed one or more bleeds|10|||
49141811|NCT00986232|158358765|FG002|Overall Study|Missed one or more bleeds|6|||
49141812|NCT00986232|158358766|FG003|Overall Study|Missed one or more bleeds|7|||
49141813|NCT00986232|158358763|FG000|Overall Study|Incomplete safety follow-up|3|||
49141814|NCT00986232|158358764|FG001|Overall Study|Incomplete safety follow-up|7|||
49141815|NCT00986232|158358765|FG002|Overall Study|Incomplete safety follow-up|2|||
49141816|NCT00986232|158358766|FG003|Overall Study|Incomplete safety follow-up|2|||
49141817|NCT01027416|158358767|FG000|Overall Study|Withdrawal by Subject|0|||
49141818|NCT01027416|158358768|FG001|Overall Study|Withdrawal by Subject|1|||
49141819|NCT01027416|158358767|FG000|Overall Study|Physician Decision|1|||
49141820|NCT01027416|158358768|FG001|Overall Study|Physician Decision|4|||
49141821|NCT00676052|158358769|FG000|Overall Study|Adverse Event|0|||
49141822|NCT00676052|158358770|FG001|Overall Study|Adverse Event|1|||
49141823|NCT00676052|158358771|FG002|Overall Study|Adverse Event|1|||
49141824|NCT00676052|158358772|FG003|Overall Study|Adverse Event|2|||
49141825|NCT00676052|158358773|FG004|Overall Study|Adverse Event|2|||
48729451|NCT04567615|156859798|FG002|Treatment Period|Death|0|||
48729452|NCT04567615|156859796|FG000|Treatment Period|Lost to Follow-up|0|||
48729453|NCT04567615|156859797|FG001|Treatment Period|Lost to Follow-up|1|||
48729454|NCT04567615|156859798|FG002|Treatment Period|Lost to Follow-up|0|||
48729455|NCT04567615|156859796|FG000|Treatment Period|Participant No Longer Meets Study Criteria|0|||
48729456|NCT04567615|156859797|FG001|Treatment Period|Participant No Longer Meets Study Criteria|1|||
48729457|NCT04567615|156859798|FG002|Treatment Period|Participant No Longer Meets Study Criteria|0|||
48729458|NCT04567615|156859796|FG000|Treatment Period|Disease Progression|85|||
48729459|NCT04567615|156859797|FG001|Treatment Period|Disease Progression|63|||
48729460|NCT04567615|156859798|FG002|Treatment Period|Disease Progression|16|||
48729461|NCT04567615|156859796|FG000|Treatment Period|Study Drug Toxicity|3|||
48729462|NCT04567615|156859797|FG001|Treatment Period|Study Drug Toxicity|10|||
48729463|NCT04567615|156859798|FG002|Treatment Period|Study Drug Toxicity|4|||
48729464|NCT04567615|156859796|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|11|||
48729465|NCT04567615|156859797|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|6|||
48729466|NCT04567615|156859798|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|1|||
48729467|NCT04567615|156859796|FG000|Treatment Period|Other Reasons|1|||
48729468|NCT04567615|156859797|FG001|Treatment Period|Other Reasons|2|||
49141826|NCT00676052|158358774|FG005|Overall Study|Adverse Event|2|||
48729469|NCT04567615|156859798|FG002|Treatment Period|Other Reasons|0|||
48729470|NCT04567615|156859796|FG000|Treatment Period|Still On-going Treatment|21|||
48729471|NCT04567615|156859797|FG001|Treatment Period|Still On-going Treatment|22|||
48822292|NCT01474512|157190488|FG005|Long-Term Extension Period|Protocol Violation|0|||
48822293|NCT01474512|157190489|FG006|Long-Term Extension Period|Protocol Violation|0|||
48822294|NCT01474512|157190490|FG007|Long-Term Extension Period|Protocol Violation|0|||
49012208|NCT01965652|157881707|FG000|Overall Study|Death|3|||
49141827|NCT00676052|158358769|FG000|Overall Study|Lack of Efficacy|2|||
49012209|NCT01965652|157881708|FG001|Overall Study|Death|4|||
49141828|NCT00676052|158358770|FG001|Overall Study|Lack of Efficacy|2|||
49141829|NCT00676052|158358771|FG002|Overall Study|Lack of Efficacy|1|||
49141830|NCT00676052|158358772|FG003|Overall Study|Lack of Efficacy|1|||
49141831|NCT00676052|158358773|FG004|Overall Study|Lack of Efficacy|2|||
49141832|NCT00676052|158358774|FG005|Overall Study|Lack of Efficacy|1|||
49141833|NCT00676052|158358769|FG000|Overall Study|Protocol Violation|5|||
49141834|NCT00676052|158358770|FG001|Overall Study|Protocol Violation|3|||
49141835|NCT00676052|158358771|FG002|Overall Study|Protocol Violation|2|||
49141836|NCT00676052|158358772|FG003|Overall Study|Protocol Violation|2|||
49141837|NCT00676052|158358773|FG004|Overall Study|Protocol Violation|1|||
49141838|NCT00676052|158358774|FG005|Overall Study|Protocol Violation|2|||
49141839|NCT00676052|158358769|FG000|Overall Study|Lost to Follow-up|0|||
49141840|NCT00676052|158358770|FG001|Overall Study|Lost to Follow-up|0|||
49141841|NCT00676052|158358771|FG002|Overall Study|Lost to Follow-up|0|||
49141842|NCT00676052|158358772|FG003|Overall Study|Lost to Follow-up|0|||
49141843|NCT00676052|158358773|FG004|Overall Study|Lost to Follow-up|1|||
49141844|NCT00676052|158358774|FG005|Overall Study|Lost to Follow-up|0|||
49141845|NCT00676052|158358769|FG000|Overall Study|Physician Decision|1|||
49141846|NCT00676052|158358770|FG001|Overall Study|Physician Decision|1|||
49141847|NCT00676052|158358771|FG002|Overall Study|Physician Decision|1|||
49141848|NCT00676052|158358772|FG003|Overall Study|Physician Decision|0|||
49141849|NCT00676052|158358773|FG004|Overall Study|Physician Decision|0|||
49141850|NCT00676052|158358774|FG005|Overall Study|Physician Decision|1|||
49141851|NCT00676052|158358769|FG000|Overall Study|Withdrawal by Subject|1|||
48729472|NCT04567615|156859798|FG002|Treatment Period|Still On-going Treatment|2|||
48822295|NCT01474512|157190491|FG008|Long-Term Extension Period|Protocol Violation|0|||
48822296|NCT01474512|157190492|FG009|Long-Term Extension Period|Protocol Violation|0|||
48822297|NCT01474512|157190493|FG010|Long-Term Extension Period|Protocol Violation|0|||
48822298|NCT01474512|157190494|FG011|Long-Term Extension Period|Protocol Violation|0|||
48729473|NCT04854642|156861228|FG000|Overall Study|Adverse Event|1|||
48729474|NCT04854642|156861229|FG001|Overall Study|Adverse Event|2|||
48729475|NCT04854642|156861228|FG000|Overall Study|Withdrawal by Subject|0|||
48729476|NCT04854642|156861229|FG001|Overall Study|Withdrawal by Subject|1|||
48729477|NCT00597701|156861230|FG000|Overall Study|Withdrawal by Subject|5|||
48729478|NCT00597701|156861231|FG001|Overall Study|Withdrawal by Subject|5|||
48729479|NCT00597701|156861230|FG000|Overall Study|Death|0|||
48729480|NCT00597701|156861231|FG001|Overall Study|Death|1|||
48729481|NCT00597701|156861230|FG000|Overall Study|Physician Decision|2|||
48729482|NCT00597701|156861231|FG001|Overall Study|Physician Decision|0|||
48729483|NCT00597701|156861230|FG000|Overall Study|Did not start intervention (pharmacy er)|0|||
49141852|NCT00676052|158358770|FG001|Overall Study|Withdrawal by Subject|0|||
48822299|NCT01474512|157190495|FG012|Long-Term Extension Period|Protocol Violation|5|||
48822300|NCT01474512|157190496|FG013|Long-Term Extension Period|Protocol Violation|5|||
48822301|NCT01474512|157190497|FG014|Long-Term Extension Period|Protocol Violation|0|||
48822302|NCT01474512|157190498|FG015|Long-Term Extension Period|Protocol Violation|0|||
48822303|NCT01474512|157190499|FG016|Long-Term Extension Period|Protocol Violation|0|||
48822304|NCT01474512|157190500|FG017|Long-Term Extension Period|Protocol Violation|0|||
48822305|NCT01474512|157190483|FG000|Long-Term Extension Period|Parent/Caregiver Decision|0|||
48822306|NCT01474512|157190484|FG001|Long-Term Extension Period|Parent/Caregiver Decision|0|||
48822307|NCT01474512|157190485|FG002|Long-Term Extension Period|Parent/Caregiver Decision|0|||
48822308|NCT01474512|157190486|FG003|Long-Term Extension Period|Parent/Caregiver Decision|0|||
48822309|NCT01474512|157190487|FG004|Long-Term Extension Period|Parent/Caregiver Decision|0|||
48822310|NCT01474512|157190488|FG005|Long-Term Extension Period|Parent/Caregiver Decision|0|||
48822311|NCT01474512|157190489|FG006|Long-Term Extension Period|Parent/Caregiver Decision|0|||
48822312|NCT01474512|157190490|FG007|Long-Term Extension Period|Parent/Caregiver Decision|0|||
48822313|NCT01474512|157190491|FG008|Long-Term Extension Period|Parent/Caregiver Decision|0|||
48822314|NCT01474512|157190492|FG009|Long-Term Extension Period|Parent/Caregiver Decision|0|||
48822315|NCT01474512|157190493|FG010|Long-Term Extension Period|Parent/Caregiver Decision|0|||
48822316|NCT01474512|157190494|FG011|Long-Term Extension Period|Parent/Caregiver Decision|0|||
48822317|NCT01474512|157190495|FG012|Long-Term Extension Period|Parent/Caregiver Decision|1|||
48822318|NCT01474512|157190496|FG013|Long-Term Extension Period|Parent/Caregiver Decision|1|||
48822319|NCT01474512|157190497|FG014|Long-Term Extension Period|Parent/Caregiver Decision|0|||
48822320|NCT01474512|157190498|FG015|Long-Term Extension Period|Parent/Caregiver Decision|0|||
48822321|NCT01474512|157190499|FG016|Long-Term Extension Period|Parent/Caregiver Decision|0|||
48822322|NCT01474512|157190500|FG017|Long-Term Extension Period|Parent/Caregiver Decision|0|||
48822323|NCT01474512|157190483|FG000|Long-Term Extension Period|Switched From PBO to Ixe|0|||
48729484|NCT00597701|156861231|FG001|Overall Study|Did not start intervention (pharmacy er)|2|||
48729485|NCT01107418|156861232|FG000|Overall Study|Disease Progression|45|||
49141853|NCT00676052|158358771|FG002|Overall Study|Withdrawal by Subject|1|||
48822324|NCT01474512|157190484|FG001|Long-Term Extension Period|Switched From PBO to Ixe|0|||
49141854|NCT00676052|158358772|FG003|Overall Study|Withdrawal by Subject|0|||
49141855|NCT00676052|158358773|FG004|Overall Study|Withdrawal by Subject|0|||
49141856|NCT00676052|158358774|FG005|Overall Study|Withdrawal by Subject|0|||
48729486|NCT01107418|156861232|FG000|Overall Study|Adverse Event|3|||
48729487|NCT01107418|156861232|FG000|Overall Study|Withdrawal by Subject|1|||
48729488|NCT01107418|156861232|FG000|Overall Study|Study Closing|1|||
48729489|NCT01107418|156861232|FG000|Overall Study|Started Other Therapy|1|||
48729490|NCT01107418|156861232|FG000|Overall Study|Entered Extension Study|1|||
49141857|NCT01913470|158358775|FG000|Overall Study|Lost to Follow-up|0|||
49141858|NCT01913470|158358776|FG001|Overall Study|Lost to Follow-up|1|||
49141859|NCT01913470|158358775|FG000|Overall Study|Physician Decision|0|||
49141860|NCT01913470|158358776|FG001|Overall Study|Physician Decision|1|||
49141861|NCT01913470|158358775|FG000|Overall Study|Withdrawal by Subject|0|||
49141862|NCT01913470|158358776|FG001|Overall Study|Withdrawal by Subject|1|||
49141863|NCT02573467|158358777|FG000|Double-blind Treatment Epoch|Lack of Efficacy|0|||
49141864|NCT02573467|158358778|FG001|Double-blind Treatment Epoch|Lack of Efficacy|0|||
49141865|NCT02573467|158358779|FG002|Double-blind Treatment Epoch|Lack of Efficacy|1|||
49141866|NCT02573467|158358780|FG003|Double-blind Treatment Epoch|Lack of Efficacy|0|||
49141867|NCT02573467|158358777|FG000|Double-blind Treatment Epoch|Adverse Event|1|||
49141868|NCT02573467|158358778|FG001|Double-blind Treatment Epoch|Adverse Event|0|||
49141869|NCT02573467|158358779|FG002|Double-blind Treatment Epoch|Adverse Event|1|||
49141870|NCT02573467|158358780|FG003|Double-blind Treatment Epoch|Adverse Event|0|||
48822325|NCT01474512|157190485|FG002|Long-Term Extension Period|Switched From PBO to Ixe|0|||
48822326|NCT01474512|157190486|FG003|Long-Term Extension Period|Switched From PBO to Ixe|0|||
48822327|NCT01474512|157190487|FG004|Long-Term Extension Period|Switched From PBO to Ixe|0|||
48822328|NCT01474512|157190488|FG005|Long-Term Extension Period|Switched From PBO to Ixe|0|||
48822329|NCT01474512|157190489|FG006|Long-Term Extension Period|Switched From PBO to Ixe|0|||
48822330|NCT01474512|157190490|FG007|Long-Term Extension Period|Switched From PBO to Ixe|0|||
48822331|NCT01474512|157190491|FG008|Long-Term Extension Period|Switched From PBO to Ixe|0|||
48822332|NCT01474512|157190492|FG009|Long-Term Extension Period|Switched From PBO to Ixe|0|||
48822333|NCT01474512|157190493|FG010|Long-Term Extension Period|Switched From PBO to Ixe|0|||
48822334|NCT01474512|157190494|FG011|Long-Term Extension Period|Switched From PBO to Ixe|21|||
48822335|NCT01474512|157190495|FG012|Long-Term Extension Period|Switched From PBO to Ixe|0|||
48822336|NCT01474512|157190496|FG013|Long-Term Extension Period|Switched From PBO to Ixe|0|||
48822337|NCT01474512|157190497|FG014|Long-Term Extension Period|Switched From PBO to Ixe|0|||
48822338|NCT01474512|157190498|FG015|Long-Term Extension Period|Switched From PBO to Ixe|0|||
48822339|NCT01474512|157190499|FG016|Long-Term Extension Period|Switched From PBO to Ixe|0|||
48822340|NCT01474512|157190500|FG017|Long-Term Extension Period|Switched From PBO to Ixe|0|||
49141871|NCT02573467|158358777|FG000|Double-blind Treatment Epoch|Withdrawal by Subject|2|||
49141872|NCT02573467|158358778|FG001|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
49141873|NCT02573467|158358779|FG002|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
49141874|NCT02573467|158358780|FG003|Double-blind Treatment Epoch|Withdrawal by Subject|0|||
49141875|NCT02573467|158358777|FG000|Double-blind Treatment Epoch|Study Terminated by sponsor|50|||
49141876|NCT02573467|158358778|FG001|Double-blind Treatment Epoch|Study Terminated by sponsor|51|||
49141877|NCT02573467|158358779|FG002|Double-blind Treatment Epoch|Study Terminated by sponsor|48|||
48822341|NCT01474512|157190483|FG000|Post-Treatment Follow-Up|Adverse Event|0|||
48822342|NCT01474512|157190484|FG001|Post-Treatment Follow-Up|Adverse Event|0|||
48822343|NCT01474512|157190485|FG002|Post-Treatment Follow-Up|Adverse Event|0|||
48822344|NCT01474512|157190486|FG003|Post-Treatment Follow-Up|Adverse Event|0|||
48822345|NCT01474512|157190487|FG004|Post-Treatment Follow-Up|Adverse Event|0|||
48822346|NCT01474512|157190488|FG005|Post-Treatment Follow-Up|Adverse Event|0|||
48822347|NCT01474512|157190489|FG006|Post-Treatment Follow-Up|Adverse Event|0|||
48822348|NCT01474512|157190490|FG007|Post-Treatment Follow-Up|Adverse Event|0|||
48822349|NCT01474512|157190491|FG008|Post-Treatment Follow-Up|Adverse Event|0|||
48822350|NCT01474512|157190492|FG009|Post-Treatment Follow-Up|Adverse Event|0|||
48822351|NCT01474512|157190493|FG010|Post-Treatment Follow-Up|Adverse Event|0|||
48822352|NCT01474512|157190494|FG011|Post-Treatment Follow-Up|Adverse Event|0|||
48822353|NCT01474512|157190495|FG012|Post-Treatment Follow-Up|Adverse Event|0|||
48822354|NCT01474512|157190496|FG013|Post-Treatment Follow-Up|Adverse Event|0|||
48822355|NCT01474512|157190497|FG014|Post-Treatment Follow-Up|Adverse Event|8|||
48822356|NCT01474512|157190498|FG015|Post-Treatment Follow-Up|Adverse Event|2|||
48822357|NCT01474512|157190499|FG016|Post-Treatment Follow-Up|Adverse Event|58|||
48822358|NCT01474512|157190500|FG017|Post-Treatment Follow-Up|Adverse Event|11|||
48822359|NCT01474512|157190483|FG000|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
48822360|NCT01474512|157190484|FG001|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
48822361|NCT01474512|157190485|FG002|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
48822362|NCT01474512|157190486|FG003|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
48822363|NCT01474512|157190487|FG004|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
48822364|NCT01474512|157190488|FG005|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
48822365|NCT01474512|157190489|FG006|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
48822366|NCT01474512|157190490|FG007|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
48822367|NCT01474512|157190491|FG008|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
49141878|NCT02573467|158358780|FG003|Double-blind Treatment Epoch|Study Terminated by sponsor|55|||
48822368|NCT01474512|157190492|FG009|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
49141879|NCT02573467|158358777|FG000|Post-treatment Follow up Epoch|Death|1|||
49141880|NCT02573467|158358778|FG001|Post-treatment Follow up Epoch|Death|1|||
49141881|NCT02573467|158358779|FG002|Post-treatment Follow up Epoch|Death|0|||
49141882|NCT02573467|158358780|FG003|Post-treatment Follow up Epoch|Death|1|||
48822369|NCT01474512|157190493|FG010|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
49141883|NCT02573467|158358777|FG000|Post-treatment Follow up Epoch|Withdrawal by Subject|5|||
49141884|NCT02573467|158358778|FG001|Post-treatment Follow up Epoch|Withdrawal by Subject|4|||
49141885|NCT02573467|158358779|FG002|Post-treatment Follow up Epoch|Withdrawal by Subject|9|||
49141886|NCT02573467|158358780|FG003|Post-treatment Follow up Epoch|Withdrawal by Subject|2|||
49141887|NCT02573467|158358777|FG000|Post-treatment Follow up Epoch|Technical problems|0|||
49141888|NCT02573467|158358778|FG001|Post-treatment Follow up Epoch|Technical problems|0|||
49141889|NCT02573467|158358779|FG002|Post-treatment Follow up Epoch|Technical problems|1|||
49141890|NCT02573467|158358780|FG003|Post-treatment Follow up Epoch|Technical problems|0|||
49141891|NCT01331005|158358783|FG000|Overall Study|Lost to Follow-up|2|||
49141892|NCT01331005|158358784|FG001|Overall Study|Lost to Follow-up|1|||
49141893|NCT01331005|158358783|FG000|Overall Study|Withdrawal by Subject|2|||
49141894|NCT01331005|158358784|FG001|Overall Study|Withdrawal by Subject|3|||
49141895|NCT02639559|158358790|FG000|Overall Study|Mobilization failure|0|||
49141896|NCT02639559|158358791|FG001|Overall Study|Mobilization failure|3|||
49141897|NCT02639559|158358790|FG000|Overall Study|Issues with vascular acess|1|||
49141898|NCT02639559|158358791|FG001|Overall Study|Issues with vascular acess|0|||
49141899|NCT01058005|158358797|FG000|Overall Study|Adverse Event|0|||
49141900|NCT01058005|158358798|FG001|Overall Study|Adverse Event|2|||
49141901|NCT01058005|158358799|FG002|Overall Study|Adverse Event|1|||
49141902|NCT01058005|158358797|FG000|Overall Study|Physician Decision|2|||
49141903|NCT01058005|158358798|FG001|Overall Study|Physician Decision|2|||
49141904|NCT01058005|158358799|FG002|Overall Study|Physician Decision|0|||
49141905|NCT01058005|158358797|FG000|Overall Study|Withdrawal by Subject|4|||
49141906|NCT01058005|158358798|FG001|Overall Study|Withdrawal by Subject|5|||
49141907|NCT01058005|158358799|FG002|Overall Study|Withdrawal by Subject|11|||
49141908|NCT01058005|158358797|FG000|Overall Study|Withdrawn Due to Study Termination|27|||
49141909|NCT01058005|158358798|FG001|Overall Study|Withdrawn Due to Study Termination|13|||
49141910|NCT01058005|158358799|FG002|Overall Study|Withdrawn Due to Study Termination|7|||
49141911|NCT01058005|158358797|FG000|Overall Study|Reason Missing|5|||
49141912|NCT01058005|158358798|FG001|Overall Study|Reason Missing|3|||
49141913|NCT01058005|158358799|FG002|Overall Study|Reason Missing|1|||
49141914|NCT01896986|158358803|FG000|Overall Study|samples lost|14|||
49141915|NCT01896986|158358804|FG001|Overall Study|samples lost|23|||
49141916|NCT01750281|158358805|FG000|Overall Study|Discontinued Selumetinib/Placebo|37|||
49141917|NCT01750281|158358806|FG001|Overall Study|Discontinued Selumetinib/Placebo|77|||
49141918|NCT01750281|158358807|FG002|Overall Study|Discontinued Selumetinib/Placebo|75|||
49141919|NCT01750281|158358805|FG000|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6|||
49141920|NCT01750281|158358806|FG001|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7|||
49141921|NCT01750281|158358807|FG002|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9|||
49141922|NCT01750281|158358805|FG000|Overall Study|Did not receive treatment|0|||
49141923|NCT01750281|158358806|FG001|Overall Study|Did not receive treatment|1|||
49141924|NCT01750281|158358807|FG002|Overall Study|Did not receive treatment|0|||
49141925|NCT01421134|158358808|FG000|Overall Study|Adverse Event|3|||
49141926|NCT01421134|158358809|FG001|Overall Study|Adverse Event|5|||
49141927|NCT01421134|158358808|FG000|Overall Study|Lack of Efficacy|2|||
49141928|NCT01421134|158358809|FG001|Overall Study|Lack of Efficacy|4|||
49141929|NCT01421134|158358808|FG000|Overall Study|Protocol Violation|0|||
49141930|NCT01421134|158358809|FG001|Overall Study|Protocol Violation|3|||
49141931|NCT01421134|158358808|FG000|Overall Study|Withdrawal by Subject|1|||
49141932|NCT01421134|158358809|FG001|Overall Study|Withdrawal by Subject|1|||
49141933|NCT01421134|158358808|FG000|Overall Study|Administrative|0|||
49141934|NCT01421134|158358809|FG001|Overall Study|Administrative|1|||
49141935|NCT01421134|158358808|FG000|Overall Study|Lost to Follow-up|1|||
49141936|NCT01421134|158358809|FG001|Overall Study|Lost to Follow-up|1|||
49141937|NCT02959892|158358810|FG000|Overall Study|PET tracer synthesis failure|1|||
49141938|NCT02959892|158358811|FG001|Overall Study|PET tracer synthesis failure|0|||
49141939|NCT02959892|158358810|FG000|Overall Study|Study termination|0|||
49141940|NCT02959892|158358811|FG001|Overall Study|Study termination|1|||
49141941|NCT00281580|158358812|FG000|Overall Study|Adverse Event|2|||
49141942|NCT00281580|158358813|FG001|Overall Study|Adverse Event|0|||
49141943|NCT00281580|158358814|FG002|Overall Study|Adverse Event|2|||
49141944|NCT00281580|158358815|FG003|Overall Study|Adverse Event|4|||
49141945|NCT00281580|158358816|FG004|Overall Study|Adverse Event|1|||
49141946|NCT00281580|158358817|FG005|Overall Study|Adverse Event|0|||
48729491|NCT01002482|156861233|FG000|Overall Study|Withdrawal by Subject|14|||
49141947|NCT00281580|158358818|FG006|Overall Study|Adverse Event|1|||
48729492|NCT01002482|156861234|FG001|Overall Study|Withdrawal by Subject|21|||
48729493|NCT01002482|156861233|FG000|Overall Study|Included twice|1|||
48729494|NCT01002482|156861234|FG001|Overall Study|Included twice|0|||
48729495|NCT03150485|156861235|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
48729496|NCT03150485|156861236|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
48729497|NCT03150485|156861237|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
48729498|NCT03150485|156861238|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
48729499|NCT03150485|156861239|FG004|Overall Study|Unsatisfactory Lens Fitting|0|||
48729500|NCT03150485|156861240|FG005|Overall Study|Unsatisfactory Lens Fitting|0|||
49141948|NCT00281580|158358819|FG007|Overall Study|Adverse Event|0|||
48729501|NCT00697073|156861246|FG000|Overall Study|Withdrawal by Subject|2|||
48729502|NCT00697073|156861246|FG000|Overall Study|Pregnancy|1|||
48729503|NCT00697073|156861246|FG000|Overall Study|non compliance and other|6|||
49141949|NCT00281580|158358820|FG008|Overall Study|Adverse Event|1|||
49141950|NCT00281580|158358821|FG009|Overall Study|Adverse Event|6|||
49012210|NCT01965652|157881707|FG000|Overall Study|Other - Miscellaneous|18|||
48822370|NCT01474512|157190494|FG011|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
48822371|NCT01474512|157190495|FG012|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
48822372|NCT01474512|157190496|FG013|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
48822373|NCT01474512|157190497|FG014|Post-Treatment Follow-Up|Withdrawal by Subject|3|||
48822374|NCT01474512|157190498|FG015|Post-Treatment Follow-Up|Withdrawal by Subject|2|||
48822375|NCT01474512|157190499|FG016|Post-Treatment Follow-Up|Withdrawal by Subject|36|||
48822376|NCT01474512|157190500|FG017|Post-Treatment Follow-Up|Withdrawal by Subject|17|||
48822377|NCT01474512|157190483|FG000|Post-Treatment Follow-Up|Lack of Efficacy|0|||
48822378|NCT01474512|157190484|FG001|Post-Treatment Follow-Up|Lack of Efficacy|0|||
48822379|NCT01474512|157190485|FG002|Post-Treatment Follow-Up|Lack of Efficacy|0|||
48822380|NCT01474512|157190486|FG003|Post-Treatment Follow-Up|Lack of Efficacy|0|||
48822381|NCT01474512|157190487|FG004|Post-Treatment Follow-Up|Lack of Efficacy|0|||
48822382|NCT01474512|157190488|FG005|Post-Treatment Follow-Up|Lack of Efficacy|0|||
48822383|NCT01474512|157190489|FG006|Post-Treatment Follow-Up|Lack of Efficacy|0|||
48822384|NCT01474512|157190490|FG007|Post-Treatment Follow-Up|Lack of Efficacy|0|||
48822385|NCT01474512|157190491|FG008|Post-Treatment Follow-Up|Lack of Efficacy|0|||
48822386|NCT01474512|157190492|FG009|Post-Treatment Follow-Up|Lack of Efficacy|0|||
48822387|NCT01474512|157190493|FG010|Post-Treatment Follow-Up|Lack of Efficacy|0|||
48822388|NCT01474512|157190494|FG011|Post-Treatment Follow-Up|Lack of Efficacy|0|||
48822389|NCT01474512|157190495|FG012|Post-Treatment Follow-Up|Lack of Efficacy|0|||
48822390|NCT01474512|157190496|FG013|Post-Treatment Follow-Up|Lack of Efficacy|0|||
48822391|NCT01474512|157190497|FG014|Post-Treatment Follow-Up|Lack of Efficacy|3|||
48822392|NCT01474512|157190498|FG015|Post-Treatment Follow-Up|Lack of Efficacy|2|||
48822393|NCT01474512|157190499|FG016|Post-Treatment Follow-Up|Lack of Efficacy|31|||
48822394|NCT01474512|157190500|FG017|Post-Treatment Follow-Up|Lack of Efficacy|3|||
48822395|NCT01474512|157190483|FG000|Post-Treatment Follow-Up|Lost to Follow-up|0|||
48822396|NCT01474512|157190484|FG001|Post-Treatment Follow-Up|Lost to Follow-up|0|||
48822397|NCT01474512|157190485|FG002|Post-Treatment Follow-Up|Lost to Follow-up|0|||
48822398|NCT01474512|157190486|FG003|Post-Treatment Follow-Up|Lost to Follow-up|0|||
48822399|NCT01474512|157190487|FG004|Post-Treatment Follow-Up|Lost to Follow-up|0|||
48822400|NCT01474512|157190488|FG005|Post-Treatment Follow-Up|Lost to Follow-up|0|||
48822401|NCT01474512|157190489|FG006|Post-Treatment Follow-Up|Lost to Follow-up|0|||
48822402|NCT01474512|157190490|FG007|Post-Treatment Follow-Up|Lost to Follow-up|0|||
48822403|NCT01474512|157190491|FG008|Post-Treatment Follow-Up|Lost to Follow-up|0|||
48822404|NCT01474512|157190492|FG009|Post-Treatment Follow-Up|Lost to Follow-up|0|||
48822405|NCT01474512|157190493|FG010|Post-Treatment Follow-Up|Lost to Follow-up|0|||
48822406|NCT01474512|157190494|FG011|Post-Treatment Follow-Up|Lost to Follow-up|0|||
48729504|NCT03981822|156861247|FG000|Overall Study|Lost to Follow-up|0|||
48729505|NCT03981822|156861248|FG001|Overall Study|Lost to Follow-up|1|||
49141951|NCT00281580|158358822|FG010|Overall Study|Adverse Event|0|||
49141952|NCT00281580|158358823|FG011|Overall Study|Adverse Event|5|||
49141953|NCT00281580|158358824|FG012|Overall Study|Adverse Event|8|||
49141954|NCT00281580|158358825|FG013|Overall Study|Adverse Event|2|||
49141955|NCT00281580|158358826|FG014|Overall Study|Adverse Event|3|||
49141956|NCT00281580|158358827|FG015|Overall Study|Adverse Event|3|||
49141957|NCT00281580|158358812|FG000|Overall Study|Protocol Violation|0|||
49141958|NCT00281580|158358813|FG001|Overall Study|Protocol Violation|0|||
49141959|NCT00281580|158358814|FG002|Overall Study|Protocol Violation|1|||
49141960|NCT00281580|158358815|FG003|Overall Study|Protocol Violation|1|||
49141961|NCT00281580|158358816|FG004|Overall Study|Protocol Violation|0|||
49141962|NCT00281580|158358817|FG005|Overall Study|Protocol Violation|0|||
49141963|NCT00281580|158358818|FG006|Overall Study|Protocol Violation|1|||
49141964|NCT00281580|158358819|FG007|Overall Study|Protocol Violation|0|||
49141965|NCT00281580|158358820|FG008|Overall Study|Protocol Violation|2|||
49141966|NCT00281580|158358821|FG009|Overall Study|Protocol Violation|0|||
49141967|NCT00281580|158358822|FG010|Overall Study|Protocol Violation|1|||
48822407|NCT01474512|157190495|FG012|Post-Treatment Follow-Up|Lost to Follow-up|0|||
49141968|NCT00281580|158358823|FG011|Overall Study|Protocol Violation|2|||
49141969|NCT00281580|158358824|FG012|Overall Study|Protocol Violation|0|||
49141970|NCT00281580|158358825|FG013|Overall Study|Protocol Violation|1|||
48729506|NCT03981822|156861249|FG002|Overall Study|Lost to Follow-up|1|||
48822408|NCT01474512|157190496|FG013|Post-Treatment Follow-Up|Lost to Follow-up|0|||
48822409|NCT01474512|157190497|FG014|Post-Treatment Follow-Up|Lost to Follow-up|0|||
48729507|NCT03981822|156861250|FG003|Overall Study|Lost to Follow-up|0|||
48729508|NCT03981822|156861251|FG004|Overall Study|Lost to Follow-up|6|||
49012211|NCT01965652|157881708|FG001|Overall Study|Other - Miscellaneous|21|||
49012212|NCT01965652|157881707|FG000|Overall Study|Pregnancy|0|||
49141971|NCT00281580|158358826|FG014|Overall Study|Protocol Violation|1|||
49141972|NCT00281580|158358827|FG015|Overall Study|Protocol Violation|3|||
49141973|NCT00281580|158358812|FG000|Overall Study|Withdrawal by Subject|3|||
49141974|NCT00281580|158358813|FG001|Overall Study|Withdrawal by Subject|0|||
49141975|NCT00281580|158358814|FG002|Overall Study|Withdrawal by Subject|1|||
49141976|NCT00281580|158358815|FG003|Overall Study|Withdrawal by Subject|1|||
49141977|NCT00281580|158358816|FG004|Overall Study|Withdrawal by Subject|1|||
49141978|NCT00281580|158358817|FG005|Overall Study|Withdrawal by Subject|2|||
49141979|NCT00281580|158358818|FG006|Overall Study|Withdrawal by Subject|2|||
49141980|NCT00281580|158358819|FG007|Overall Study|Withdrawal by Subject|0|||
49141981|NCT00281580|158358820|FG008|Overall Study|Withdrawal by Subject|1|||
49141982|NCT00281580|158358821|FG009|Overall Study|Withdrawal by Subject|4|||
49141983|NCT00281580|158358822|FG010|Overall Study|Withdrawal by Subject|1|||
49141984|NCT00281580|158358823|FG011|Overall Study|Withdrawal by Subject|1|||
49141985|NCT00281580|158358824|FG012|Overall Study|Withdrawal by Subject|2|||
49141986|NCT00281580|158358825|FG013|Overall Study|Withdrawal by Subject|2|||
49141987|NCT00281580|158358826|FG014|Overall Study|Withdrawal by Subject|1|||
49141988|NCT00281580|158358827|FG015|Overall Study|Withdrawal by Subject|5|||
49141989|NCT00281580|158358812|FG000|Overall Study|Lack of Efficacy|2|||
49141990|NCT00281580|158358813|FG001|Overall Study|Lack of Efficacy|1|||
49141991|NCT00281580|158358814|FG002|Overall Study|Lack of Efficacy|1|||
49141992|NCT00281580|158358815|FG003|Overall Study|Lack of Efficacy|6|||
49141993|NCT00281580|158358816|FG004|Overall Study|Lack of Efficacy|2|||
49141994|NCT00281580|158358817|FG005|Overall Study|Lack of Efficacy|0|||
49141995|NCT00281580|158358818|FG006|Overall Study|Lack of Efficacy|0|||
49141996|NCT00281580|158358819|FG007|Overall Study|Lack of Efficacy|0|||
49141997|NCT00281580|158358820|FG008|Overall Study|Lack of Efficacy|0|||
49141998|NCT00281580|158358821|FG009|Overall Study|Lack of Efficacy|0|||
48729509|NCT03981822|156861252|FG005|Overall Study|Lost to Follow-up|4|||
48729510|NCT03981822|156861253|FG006|Overall Study|Lost to Follow-up|4|||
49141999|NCT00281580|158358822|FG010|Overall Study|Lack of Efficacy|0|||
49142000|NCT00281580|158358823|FG011|Overall Study|Lack of Efficacy|1|||
49142001|NCT00281580|158358824|FG012|Overall Study|Lack of Efficacy|0|||
49142002|NCT00281580|158358825|FG013|Overall Study|Lack of Efficacy|2|||
49142003|NCT00281580|158358826|FG014|Overall Study|Lack of Efficacy|1|||
49142004|NCT00281580|158358827|FG015|Overall Study|Lack of Efficacy|0|||
49142005|NCT00281580|158358812|FG000|Overall Study|Lost to Follow-up|0|||
49142006|NCT00281580|158358813|FG001|Overall Study|Lost to Follow-up|0|||
49142007|NCT00281580|158358814|FG002|Overall Study|Lost to Follow-up|0|||
49142008|NCT00281580|158358815|FG003|Overall Study|Lost to Follow-up|3|||
49142009|NCT00281580|158358816|FG004|Overall Study|Lost to Follow-up|0|||
49142010|NCT00281580|158358817|FG005|Overall Study|Lost to Follow-up|1|||
49142011|NCT00281580|158358818|FG006|Overall Study|Lost to Follow-up|0|||
49142012|NCT00281580|158358819|FG007|Overall Study|Lost to Follow-up|1|||
49142013|NCT00281580|158358820|FG008|Overall Study|Lost to Follow-up|2|||
49142014|NCT00281580|158358821|FG009|Overall Study|Lost to Follow-up|1|||
49142015|NCT00281580|158358822|FG010|Overall Study|Lost to Follow-up|1|||
49142016|NCT00281580|158358823|FG011|Overall Study|Lost to Follow-up|0|||
49142017|NCT00281580|158358824|FG012|Overall Study|Lost to Follow-up|1|||
48729511|NCT03981822|156861254|FG007|Overall Study|Lost to Follow-up|2|||
48729512|NCT03981822|156861247|FG000|Overall Study|Withdrawal by Subject|0|||
48729513|NCT03981822|156861248|FG001|Overall Study|Withdrawal by Subject|1|||
48729514|NCT03981822|156861249|FG002|Overall Study|Withdrawal by Subject|0|||
48729515|NCT03981822|156861250|FG003|Overall Study|Withdrawal by Subject|0|||
48729516|NCT03981822|156861251|FG004|Overall Study|Withdrawal by Subject|0|||
48729517|NCT03981822|156861252|FG005|Overall Study|Withdrawal by Subject|1|||
48729518|NCT03981822|156861253|FG006|Overall Study|Withdrawal by Subject|0|||
48729519|NCT03981822|156861254|FG007|Overall Study|Withdrawal by Subject|2|||
48729520|NCT03981822|156861247|FG000|Overall Study|COVID-19 Related|0|||
48729521|NCT03981822|156861248|FG001|Overall Study|COVID-19 Related|0|||
48729522|NCT03981822|156861249|FG002|Overall Study|COVID-19 Related|0|||
48729523|NCT03981822|156861250|FG003|Overall Study|COVID-19 Related|0|||
48729524|NCT03981822|156861251|FG004|Overall Study|COVID-19 Related|2|||
48729525|NCT03981822|156861252|FG005|Overall Study|COVID-19 Related|1|||
48729526|NCT03981822|156861253|FG006|Overall Study|COVID-19 Related|2|||
48729527|NCT03981822|156861254|FG007|Overall Study|COVID-19 Related|1|||
48729528|NCT03646643|156861255|FG000|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
48729529|NCT03646643|156861256|FG001|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
49142018|NCT00281580|158358825|FG013|Overall Study|Lost to Follow-up|0|||
49142019|NCT00281580|158358826|FG014|Overall Study|Lost to Follow-up|0|||
49142020|NCT00281580|158358827|FG015|Overall Study|Lost to Follow-up|0|||
49142021|NCT00281580|158358812|FG000|Overall Study|Randomised in error; pregnancy; moving|0|||
49142022|NCT00281580|158358813|FG001|Overall Study|Randomised in error; pregnancy; moving|0|||
49142023|NCT00281580|158358814|FG002|Overall Study|Randomised in error; pregnancy; moving|0|||
49142024|NCT00281580|158358815|FG003|Overall Study|Randomised in error; pregnancy; moving|2|||
49142025|NCT00281580|158358816|FG004|Overall Study|Randomised in error; pregnancy; moving|0|||
49142026|NCT00281580|158358817|FG005|Overall Study|Randomised in error; pregnancy; moving|0|||
48729530|NCT03646643|156861255|FG000|Overall Study|Lost to Follow-up|0|||
49142027|NCT00281580|158358818|FG006|Overall Study|Randomised in error; pregnancy; moving|1|||
48822410|NCT01474512|157190498|FG015|Post-Treatment Follow-Up|Lost to Follow-up|0|||
48822411|NCT01474512|157190499|FG016|Post-Treatment Follow-Up|Lost to Follow-up|12|||
48822412|NCT01474512|157190500|FG017|Post-Treatment Follow-Up|Lost to Follow-up|7|||
48822413|NCT01474512|157190483|FG000|Post-Treatment Follow-Up|Physician Decision|0|||
48822414|NCT01474512|157190484|FG001|Post-Treatment Follow-Up|Physician Decision|0|||
48822415|NCT01474512|157190485|FG002|Post-Treatment Follow-Up|Physician Decision|0|||
49142028|NCT00281580|158358819|FG007|Overall Study|Randomised in error; pregnancy; moving|0|||
49142029|NCT00281580|158358820|FG008|Overall Study|Randomised in error; pregnancy; moving|2|||
49142030|NCT00281580|158358821|FG009|Overall Study|Randomised in error; pregnancy; moving|1|||
49142031|NCT00281580|158358822|FG010|Overall Study|Randomised in error; pregnancy; moving|1|||
49142032|NCT00281580|158358823|FG011|Overall Study|Randomised in error; pregnancy; moving|1|||
49142033|NCT00281580|158358824|FG012|Overall Study|Randomised in error; pregnancy; moving|2|||
49142034|NCT00281580|158358825|FG013|Overall Study|Randomised in error; pregnancy; moving|0|||
49142035|NCT00281580|158358826|FG014|Overall Study|Randomised in error; pregnancy; moving|1|||
49142036|NCT00281580|158358827|FG015|Overall Study|Randomised in error; pregnancy; moving|2|||
49142037|NCT00776997|158358828|FG000|Overall Study|Adverse Event|2|||
49142038|NCT00225758|158358829|FG000|Overall Study|Adverse Event|4|||
49142039|NCT01259024|158358830|FG000|Overall Study|Physician Decision|1|||
49142040|NCT00933166|158358831|FG000|Overall Study|Lost to Follow-up|4|||
49142041|NCT00933166|158358831|FG000|Overall Study|Lack of Efficacy|9|||
49142042|NCT00933166|158358831|FG000|Overall Study|Unavailable|4|||
49142043|NCT00933166|158358831|FG000|Overall Study|Withdrawal by Subject|1|||
49142044|NCT05029362|158358832|FG000|Overall Study|Lost to Follow-up|9|||
49142045|NCT01290731|158358834|FG000|Overall Study|Withdrawal by Subject|1|||
49142046|NCT00601107|158358835|FG000|Overall Study|Adverse Event|0|||
49142047|NCT00601107|158358836|FG001|Overall Study|Adverse Event|1|||
49142048|NCT00601107|158358837|FG002|Overall Study|Adverse Event|3|||
49142049|NCT00601107|158358838|FG003|Overall Study|Adverse Event|0|||
49142050|NCT00601107|158358835|FG000|Overall Study|Withdrawal by Subject|5|||
49142051|NCT00601107|158358836|FG001|Overall Study|Withdrawal by Subject|4|||
49142052|NCT00601107|158358837|FG002|Overall Study|Withdrawal by Subject|7|||
49142053|NCT00601107|158358838|FG003|Overall Study|Withdrawal by Subject|4|||
49142054|NCT00601107|158358835|FG000|Overall Study|Lost to Follow-up|3|||
49142055|NCT00601107|158358836|FG001|Overall Study|Lost to Follow-up|3|||
49142056|NCT00601107|158358837|FG002|Overall Study|Lost to Follow-up|0|||
49142057|NCT00601107|158358838|FG003|Overall Study|Lost to Follow-up|3|||
49142058|NCT00601107|158358835|FG000|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
49142059|NCT00601107|158358836|FG001|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
49142060|NCT00601107|158358837|FG002|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
49142061|NCT00601107|158358838|FG003|Overall Study|Serum Calcium >11.5 milligram/deciliter|1|||
49142062|NCT00601107|158358835|FG000|Overall Study|Worsening of Psoriasis|4|||
49142063|NCT00601107|158358836|FG001|Overall Study|Worsening of Psoriasis|1|||
49142064|NCT00601107|158358837|FG002|Overall Study|Worsening of Psoriasis|1|||
49142065|NCT00601107|158358838|FG003|Overall Study|Worsening of Psoriasis|4|||
49142066|NCT00601107|158358835|FG000|Overall Study|Undefined|1|||
48822416|NCT01474512|157190486|FG003|Post-Treatment Follow-Up|Physician Decision|0|||
48822417|NCT01474512|157190487|FG004|Post-Treatment Follow-Up|Physician Decision|0|||
48822418|NCT01474512|157190488|FG005|Post-Treatment Follow-Up|Physician Decision|0|||
48822419|NCT01474512|157190489|FG006|Post-Treatment Follow-Up|Physician Decision|0|||
48822420|NCT01474512|157190490|FG007|Post-Treatment Follow-Up|Physician Decision|0|||
48822421|NCT01474512|157190491|FG008|Post-Treatment Follow-Up|Physician Decision|0|||
48822422|NCT01474512|157190492|FG009|Post-Treatment Follow-Up|Physician Decision|0|||
49012213|NCT01965652|157881708|FG001|Overall Study|Pregnancy|1|||
49012214|NCT03469271|157881709|FG000|Overall Study|Withdrawal by Subject|2|||
48822423|NCT01474512|157190493|FG010|Post-Treatment Follow-Up|Physician Decision|0|||
49142067|NCT00601107|158358836|FG001|Overall Study|Undefined|0|||
49142068|NCT00601107|158358837|FG002|Overall Study|Undefined|1|||
49142069|NCT00601107|158358838|FG003|Overall Study|Undefined|0|||
49012215|NCT03469271|157881710|FG001|Overall Study|Withdrawal by Subject|0|||
48822424|NCT01474512|157190494|FG011|Post-Treatment Follow-Up|Physician Decision|0|||
48822425|NCT01474512|157190495|FG012|Post-Treatment Follow-Up|Physician Decision|0|||
48822426|NCT01474512|157190496|FG013|Post-Treatment Follow-Up|Physician Decision|0|||
49012216|NCT03469271|157881711|FG002|Overall Study|Withdrawal by Subject|0|||
49012217|NCT03469271|157881712|FG003|Overall Study|Withdrawal by Subject|1|||
49012218|NCT00395083|157881713|FG000|Overall Study|Withdrawal by Subject|6|||
49142070|NCT02181738|158358841|FG000|Overall Study|Participant Withdrew Consent|2|||
49142071|NCT02181738|158358842|FG001|Overall Study|Participant Withdrew Consent|1|||
49142072|NCT02181738|158358843|FG002|Overall Study|Participant Withdrew Consent|1|||
49142073|NCT02181738|158358844|FG003|Overall Study|Participant Withdrew Consent|1|||
49142074|NCT02181738|158358841|FG000|Overall Study|Lost to Follow-up|1|||
49142075|NCT02181738|158358842|FG001|Overall Study|Lost to Follow-up|2|||
49142076|NCT02181738|158358843|FG002|Overall Study|Lost to Follow-up|1|||
49142077|NCT02181738|158358844|FG003|Overall Study|Lost to Follow-up|1|||
49142078|NCT02181738|158358841|FG000|Overall Study|Participant no Longer Meets Study Criteria|0|||
49142079|NCT02181738|158358842|FG001|Overall Study|Participant no Longer Meets Study Criteria|0|||
49142080|NCT02181738|158358843|FG002|Overall Study|Participant no Longer Meets Study Criteria|0|||
49142081|NCT02181738|158358844|FG003|Overall Study|Participant no Longer Meets Study Criteria|1|||
49142082|NCT02181738|158358841|FG000|Overall Study|Poor/Non-Compliance|1|||
49142083|NCT02181738|158358842|FG001|Overall Study|Poor/Non-Compliance|0|||
49142084|NCT02181738|158358843|FG002|Overall Study|Poor/Non-Compliance|2|||
49142085|NCT02181738|158358844|FG003|Overall Study|Poor/Non-Compliance|1|||
49142086|NCT02181738|158358841|FG000|Overall Study|Disease Progression|28|||
49142087|NCT02181738|158358842|FG001|Overall Study|Disease Progression|35|||
49142088|NCT02181738|158358843|FG002|Overall Study|Disease Progression|40|||
49142089|NCT02181738|158358844|FG003|Overall Study|Disease Progression|0|||
49142090|NCT02181738|158358841|FG000|Overall Study|Participant Request to Discontinue Study Treatment|5|||
49142091|NCT02181738|158358842|FG001|Overall Study|Participant Request to Discontinue Study Treatment|12|||
49142092|NCT02181738|158358843|FG002|Overall Study|Participant Request to Discontinue Study Treatment|5|||
49142093|NCT02181738|158358844|FG003|Overall Study|Participant Request to Discontinue Study Treatment|1|||
49142094|NCT02181738|158358841|FG000|Overall Study|Study Drug Toxicity|6|||
49142095|NCT02181738|158358842|FG001|Overall Study|Study Drug Toxicity|11|||
49142096|NCT02181738|158358843|FG002|Overall Study|Study Drug Toxicity|8|||
49142097|NCT02181738|158358844|FG003|Overall Study|Study Drug Toxicity|1|||
49142098|NCT02181738|158358841|FG000|Overall Study|Other Reasons|14|||
49142099|NCT02181738|158358842|FG001|Overall Study|Other Reasons|16|||
49142100|NCT02181738|158358843|FG002|Overall Study|Other Reasons|28|||
49142101|NCT02181738|158358844|FG003|Overall Study|Other Reasons|0|||
48729531|NCT03646643|156861256|FG001|Overall Study|Lost to Follow-up|1|||
48729532|NCT03489551|156861257|FG000|Overall Study|Withdrawal by Subject|2|||
48729533|NCT04541706|156861258|FG000|Overall Study|Withdrawal by Subject|3|||
48729534|NCT04541706|156861258|FG000|Overall Study|Progressive disease|33|||
48729535|NCT04541706|156861258|FG000|Overall Study|Physician Decision|1|||
48729536|NCT04541706|156861258|FG000|Overall Study|Lost to Follow-up|2|||
48729537|NCT04541706|156861258|FG000|Overall Study|Death|5|||
48729538|NCT04541706|156861258|FG000|Overall Study|Adverse Event|1|||
48729539|NCT03150810|156861259|FG000|Overall Study|Death|4|||
48729540|NCT03150810|156861260|FG001|Overall Study|Death|8|||
48729541|NCT03150810|156861261|FG002|Overall Study|Death|7|||
48729542|NCT03150810|156861262|FG003|Overall Study|Death|2|||
48729543|NCT03150810|156861263|FG004|Overall Study|Death|2|||
48729544|NCT03150810|156861264|FG005|Overall Study|Death|10|||
48729545|NCT03150810|156861265|FG006|Overall Study|Death|8|||
48729546|NCT03150810|156861266|FG007|Overall Study|Death|6|||
48729547|NCT03150810|156861267|FG008|Overall Study|Death|18|||
48729548|NCT03150810|156861268|FG009|Overall Study|Death|3|||
48729549|NCT03150810|156861269|FG010|Overall Study|Death|19|||
48729550|NCT03150810|156861270|FG011|Overall Study|Death|1|||
48729551|NCT03150810|156861271|FG012|Overall Study|Death|19|||
48729552|NCT03150810|156861259|FG000|Overall Study|Withdrawal by Subject|0|||
48729553|NCT03150810|156861260|FG001|Overall Study|Withdrawal by Subject|1|||
48729554|NCT03150810|156861261|FG002|Overall Study|Withdrawal by Subject|1|||
48729555|NCT03150810|156861262|FG003|Overall Study|Withdrawal by Subject|1|||
48729556|NCT03150810|156861263|FG004|Overall Study|Withdrawal by Subject|0|||
48729557|NCT03150810|156861264|FG005|Overall Study|Withdrawal by Subject|0|||
48729558|NCT03150810|156861265|FG006|Overall Study|Withdrawal by Subject|2|||
48729559|NCT03150810|156861266|FG007|Overall Study|Withdrawal by Subject|0|||
48729560|NCT03150810|156861267|FG008|Overall Study|Withdrawal by Subject|2|||
48729561|NCT03150810|156861268|FG009|Overall Study|Withdrawal by Subject|0|||
48729562|NCT03150810|156861269|FG010|Overall Study|Withdrawal by Subject|1|||
49142102|NCT02181738|158358841|FG000|Overall Study|Maximum Clinical Benefit|3|||
49142103|NCT02181738|158358842|FG001|Overall Study|Maximum Clinical Benefit|0|||
49142104|NCT02181738|158358843|FG002|Overall Study|Maximum Clinical Benefit|1|||
49142105|NCT02181738|158358844|FG003|Overall Study|Maximum Clinical Benefit|0|||
49142106|NCT02181738|158358841|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
49142107|NCT02181738|158358842|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
49142108|NCT02181738|158358843|FG002|Overall Study|Adverse Event Unrelated to Study Drug|1|||
49142109|NCT02181738|158358844|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
48729563|NCT03150810|156861270|FG011|Overall Study|Withdrawal by Subject|0|||
49142110|NCT00888849|158358845|FG000|Overall Study|Death|4|||
49142111|NCT00888849|158358846|FG001|Overall Study|Death|7|||
49142112|NCT00888849|158358845|FG000|Overall Study|Lost to Follow-up|1|||
49142113|NCT00888849|158358846|FG001|Overall Study|Lost to Follow-up|2|||
49142114|NCT01181128|158358847|FG000|Overall Study|Withdrawal by Subject|2|||
48729564|NCT03150810|156861271|FG012|Overall Study|Withdrawal by Subject|1|||
48729565|NCT03150810|156861259|FG000|Overall Study|Sponsor Decision|0|||
48729566|NCT03150810|156861260|FG001|Overall Study|Sponsor Decision|2|||
48729567|NCT03150810|156861261|FG002|Overall Study|Sponsor Decision|0|||
48729568|NCT03150810|156861262|FG003|Overall Study|Sponsor Decision|0|||
48729569|NCT03150810|156861263|FG004|Overall Study|Sponsor Decision|1|||
48729570|NCT03150810|156861264|FG005|Overall Study|Sponsor Decision|1|||
48729571|NCT03150810|156861265|FG006|Overall Study|Sponsor Decision|0|||
48729572|NCT03150810|156861266|FG007|Overall Study|Sponsor Decision|0|||
48729573|NCT03150810|156861267|FG008|Overall Study|Sponsor Decision|1|||
48822427|NCT01474512|157190497|FG014|Post-Treatment Follow-Up|Physician Decision|0|||
48822428|NCT01474512|157190498|FG015|Post-Treatment Follow-Up|Physician Decision|0|||
48822429|NCT01474512|157190499|FG016|Post-Treatment Follow-Up|Physician Decision|4|||
48822430|NCT01474512|157190500|FG017|Post-Treatment Follow-Up|Physician Decision|5|||
48822431|NCT01474512|157190483|FG000|Post-Treatment Follow-Up|Clinical Relapse|0|||
48822432|NCT01474512|157190484|FG001|Post-Treatment Follow-Up|Clinical Relapse|0|||
48822433|NCT01474512|157190485|FG002|Post-Treatment Follow-Up|Clinical Relapse|0|||
48822434|NCT01474512|157190486|FG003|Post-Treatment Follow-Up|Clinical Relapse|0|||
48822435|NCT01474512|157190487|FG004|Post-Treatment Follow-Up|Clinical Relapse|0|||
48729574|NCT03150810|156861268|FG009|Overall Study|Sponsor Decision|0|||
48729575|NCT03150810|156861269|FG010|Overall Study|Sponsor Decision|0|||
48729576|NCT03150810|156861270|FG011|Overall Study|Sponsor Decision|0|||
48729577|NCT03150810|156861271|FG012|Overall Study|Sponsor Decision|5|||
48729578|NCT03150810|156861259|FG000|Overall Study|Lost to Follow-up|0|||
48729579|NCT03150810|156861260|FG001|Overall Study|Lost to Follow-up|1|||
48729580|NCT03150810|156861261|FG002|Overall Study|Lost to Follow-up|1|||
48729581|NCT03150810|156861262|FG003|Overall Study|Lost to Follow-up|0|||
48729582|NCT03150810|156861263|FG004|Overall Study|Lost to Follow-up|0|||
48729583|NCT03150810|156861264|FG005|Overall Study|Lost to Follow-up|0|||
48729584|NCT03150810|156861265|FG006|Overall Study|Lost to Follow-up|1|||
48729585|NCT03150810|156861266|FG007|Overall Study|Lost to Follow-up|0|||
48729586|NCT03150810|156861267|FG008|Overall Study|Lost to Follow-up|0|||
48729587|NCT03150810|156861268|FG009|Overall Study|Lost to Follow-up|0|||
48729588|NCT03150810|156861269|FG010|Overall Study|Lost to Follow-up|1|||
48729589|NCT03150810|156861270|FG011|Overall Study|Lost to Follow-up|0|||
48729590|NCT03150810|156861271|FG012|Overall Study|Lost to Follow-up|0|||
48729591|NCT03150810|156861259|FG000|Overall Study|Physician Decision|0|||
48729592|NCT03150810|156861260|FG001|Overall Study|Physician Decision|0|||
48729593|NCT03150810|156861261|FG002|Overall Study|Physician Decision|0|||
48729594|NCT03150810|156861262|FG003|Overall Study|Physician Decision|0|||
48729595|NCT03150810|156861263|FG004|Overall Study|Physician Decision|0|||
48729596|NCT03150810|156861264|FG005|Overall Study|Physician Decision|1|||
48729597|NCT03150810|156861265|FG006|Overall Study|Physician Decision|1|||
48729598|NCT03150810|156861266|FG007|Overall Study|Physician Decision|0|||
48729599|NCT03150810|156861267|FG008|Overall Study|Physician Decision|0|||
48729600|NCT03150810|156861268|FG009|Overall Study|Physician Decision|0|||
48729601|NCT03150810|156861269|FG010|Overall Study|Physician Decision|0|||
48729602|NCT03150810|156861270|FG011|Overall Study|Physician Decision|0|||
48729603|NCT03150810|156861271|FG012|Overall Study|Physician Decision|0|||
48729604|NCT03150810|156861259|FG000|Overall Study|Site withdrawal from study|0|||
48729605|NCT03150810|156861260|FG001|Overall Study|Site withdrawal from study|1|||
48822436|NCT01474512|157190488|FG005|Post-Treatment Follow-Up|Clinical Relapse|0|||
49012219|NCT00395083|157881714|FG001|Overall Study|Withdrawal by Subject|5|||
49012220|NCT00395083|157881713|FG000|Overall Study|Developed another disease|4|||
49012221|NCT00395083|157881714|FG001|Overall Study|Developed another disease|3|||
49012222|NCT04147715|157881717|FG000|Overall Study|Adverse Event|0|||
49012223|NCT04147715|157881718|FG001|Overall Study|Adverse Event|0|||
49012224|NCT04147715|157881719|FG002|Overall Study|Adverse Event|0|||
49012225|NCT04147715|157881720|FG003|Overall Study|Adverse Event|0|||
49012226|NCT04147715|157881721|FG004|Overall Study|Adverse Event|0|||
49012227|NCT04147715|157881722|FG005|Overall Study|Adverse Event|0|||
49012228|NCT04147715|157881723|FG006|Overall Study|Adverse Event|0|||
49012229|NCT04147715|157881724|FG007|Overall Study|Adverse Event|2|||
49012230|NCT04147715|157881725|FG008|Overall Study|Adverse Event|1|||
49012231|NCT04147715|157881726|FG009|Overall Study|Adverse Event|0|||
49012232|NCT04147715|157881727|FG010|Overall Study|Adverse Event|0|||
49012233|NCT04147715|157881728|FG011|Overall Study|Adverse Event|0|||
49012234|NCT02418910|157881729|FG000|Overall Study|Lost to Follow-up|3|||
49012235|NCT02418910|157881729|FG000|Overall Study|Withdrawal by Subject|4|||
49012236|NCT00254397|157881758|FG000|Overall Study|Disease Progression|4|||
49012237|NCT00254397|157881759|FG001|Overall Study|Disease Progression|1|||
49012238|NCT00254397|157881760|FG002|Overall Study|Disease Progression|16|||
49012239|NCT00254397|157881761|FG003|Overall Study|Disease Progression|23|||
49012240|NCT00254397|157881758|FG000|Overall Study|Non-Compliant|0|||
49012241|NCT00254397|157881759|FG001|Overall Study|Non-Compliant|0|||
49012242|NCT00254397|157881760|FG002|Overall Study|Non-Compliant|0|||
49012243|NCT00254397|157881761|FG003|Overall Study|Non-Compliant|1|||
49012244|NCT00254397|157881758|FG000|Overall Study|Adverse Event|2|||
49012245|NCT00254397|157881759|FG001|Overall Study|Adverse Event|0|||
49012246|NCT00254397|157881760|FG002|Overall Study|Adverse Event|3|||
49012247|NCT00254397|157881761|FG003|Overall Study|Adverse Event|1|||
49012248|NCT01098240|157881762|FG000|Open-Label Phase|Study Terminated by Sponsor|27|||
49012249|NCT01098240|157881763|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
49012250|NCT01098240|157881764|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
49012251|NCT01098240|157881762|FG000|Open-Label Phase|Protocol Violation|4|||
49012252|NCT01098240|157881763|FG001|Open-Label Phase|Protocol Violation|0|||
49012253|NCT01098240|157881764|FG002|Open-Label Phase|Protocol Violation|0|||
49012254|NCT01098240|157881762|FG000|Open-Label Phase|Lost to Follow-up|13|||
48729606|NCT03150810|156861261|FG002|Overall Study|Site withdrawal from study|0|||
48729607|NCT03150810|156861262|FG003|Overall Study|Site withdrawal from study|0|||
48729608|NCT03150810|156861263|FG004|Overall Study|Site withdrawal from study|0|||
48729609|NCT03150810|156861264|FG005|Overall Study|Site withdrawal from study|0|||
48729610|NCT03150810|156861265|FG006|Overall Study|Site withdrawal from study|0|||
48729611|NCT03150810|156861266|FG007|Overall Study|Site withdrawal from study|0|||
48729612|NCT03150810|156861267|FG008|Overall Study|Site withdrawal from study|0|||
49012255|NCT01098240|157881763|FG001|Open-Label Phase|Lost to Follow-up|0|||
49012256|NCT01098240|157881764|FG002|Open-Label Phase|Lost to Follow-up|0|||
49012257|NCT01098240|157881762|FG000|Open-Label Phase|Other|19|||
49012258|NCT01098240|157881763|FG001|Open-Label Phase|Other|0|||
49012259|NCT01098240|157881764|FG002|Open-Label Phase|Other|0|||
49012260|NCT01098240|157881762|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|50|||
49012261|NCT01098240|157881763|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
49012262|NCT01098240|157881764|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
49012263|NCT01098240|157881762|FG000|Open-Label Phase|Pregnancy|1|||
49012264|NCT01098240|157881763|FG001|Open-Label Phase|Pregnancy|0|||
49012265|NCT01098240|157881764|FG002|Open-Label Phase|Pregnancy|0|||
49012266|NCT01098240|157881762|FG000|Open-Label Phase|Withdrawal by Subject|9|||
49012267|NCT01098240|157881763|FG001|Open-Label Phase|Withdrawal by Subject|0|||
49012268|NCT01098240|157881764|FG002|Open-Label Phase|Withdrawal by Subject|0|||
49012269|NCT01098240|157881762|FG000|Open-Label Phase|Adverse Event|12|||
49012270|NCT01098240|157881763|FG001|Open-Label Phase|Adverse Event|0|||
49012271|NCT01098240|157881764|FG002|Open-Label Phase|Adverse Event|0|||
49012272|NCT01098240|157881762|FG000|Double-Blind Phase|Study Terminated by Sponsor|0|||
49012273|NCT01098240|157881763|FG001|Double-Blind Phase|Study Terminated by Sponsor|5|||
49012274|NCT01098240|157881764|FG002|Double-Blind Phase|Study Terminated by Sponsor|8|||
49012275|NCT01098240|157881762|FG000|Double-Blind Phase|Protocol Violation|0|||
49012276|NCT01098240|157881763|FG001|Double-Blind Phase|Protocol Violation|2|||
49012277|NCT01098240|157881764|FG002|Double-Blind Phase|Protocol Violation|4|||
49012278|NCT01098240|157881762|FG000|Double-Blind Phase|Lost to Follow-up|0|||
49012279|NCT01098240|157881763|FG001|Double-Blind Phase|Lost to Follow-up|2|||
49012280|NCT01098240|157881764|FG002|Double-Blind Phase|Lost to Follow-up|0|||
49012281|NCT01098240|157881762|FG000|Double-Blind Phase|Other|0|||
49012282|NCT01098240|157881763|FG001|Double-Blind Phase|Other|2|||
49012283|NCT01098240|157881764|FG002|Double-Blind Phase|Other|2|||
49012284|NCT01098240|157881762|FG000|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
49012285|NCT01098240|157881763|FG001|Double-Blind Phase|Did Not Meet Entrance Criteria|1|||
49012286|NCT01098240|157881764|FG002|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
49012287|NCT01098240|157881762|FG000|Double-Blind Phase|Insufficient Clinical Response|0|||
49012288|NCT01098240|157881763|FG001|Double-Blind Phase|Insufficient Clinical Response|1|||
49012289|NCT01098240|157881764|FG002|Double-Blind Phase|Insufficient Clinical Response|2|||
49012290|NCT01098240|157881762|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
49012291|NCT01098240|157881763|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
49012292|NCT01098240|157881764|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
49012293|NCT01098240|157881762|FG000|Double-Blind Phase|Adverse Event|0|||
49012294|NCT01098240|157881763|FG001|Double-Blind Phase|Adverse Event|3|||
49012295|NCT01098240|157881764|FG002|Double-Blind Phase|Adverse Event|3|||
49012296|NCT01133392|157881765|FG000|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0|||
49012297|NCT01133392|157881766|FG001|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1|||
49012298|NCT01133392|157881765|FG000|Interval Between Dosing (4-7 Days)|Protocol Violation|0|||
49012299|NCT01133392|157881766|FG001|Interval Between Dosing (4-7 Days)|Protocol Violation|1|||
49012300|NCT01759537|157881767|FG000|Overall Study|Death|1|||
49012301|NCT01759537|157881768|FG001|Overall Study|Death|1|||
49012302|NCT01759537|157881767|FG000|Overall Study|Pregnancy|1|||
49012303|NCT01759537|157881768|FG001|Overall Study|Pregnancy|1|||
49012304|NCT01759537|157881767|FG000|Overall Study|Lost to Follow-up|9|||
49012305|NCT01759537|157881768|FG001|Overall Study|Lost to Follow-up|9|||
49012306|NCT01759537|157881767|FG000|Overall Study|Accident involving jaw fracture|1|||
49012307|NCT01759537|157881768|FG001|Overall Study|Accident involving jaw fracture|1|||
49012308|NCT01759537|157881767|FG000|Overall Study|Subcrestal implant too coronal|1|||
49012309|NCT01759537|157881768|FG001|Overall Study|Subcrestal implant too coronal|1|||
49012310|NCT00003782|157881769|FG000|Overall Study|No follow up data|30|||
49012311|NCT00003782|157881770|FG001|Overall Study|No follow up data|31|||
49012312|NCT00003782|157881771|FG002|Overall Study|No follow up data|26|||
49012313|NCT04603937|157881773|FG000|Overall Study|Adverse Event|9|||
49012314|NCT04603937|157881774|FG001|Overall Study|Adverse Event|10|||
49012315|NCT04603937|157881773|FG000|Overall Study|Withdrawal by Subject|7|||
49012316|NCT04603937|157881774|FG001|Overall Study|Withdrawal by Subject|6|||
49012317|NCT04603937|157881773|FG000|Overall Study|Lost to Follow-up|5|||
49012318|NCT04603937|157881774|FG001|Overall Study|Lost to Follow-up|6|||
49012319|NCT04603937|157881773|FG000|Overall Study|Physician Decision|0|||
49012320|NCT04603937|157881774|FG001|Overall Study|Physician Decision|1|||
49012321|NCT04603937|157881773|FG000|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|0|||
49012322|NCT04603937|157881774|FG001|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|1|||
49012323|NCT01625845|157883444|FG000|Overall Study|Adverse Event|1|||
49142115|NCT01181128|158358848|FG001|Overall Study|Withdrawal by Subject|2|||
49142116|NCT01181128|158358849|FG002|Overall Study|Withdrawal by Subject|0|||
49142117|NCT01181128|158358847|FG000|Overall Study|Death|1|||
49142118|NCT01181128|158358848|FG001|Overall Study|Death|0|||
49142119|NCT01181128|158358849|FG002|Overall Study|Death|0|||
49142120|NCT01181128|158358847|FG000|Overall Study|Physician Decision|2|||
49142121|NCT01181128|158358848|FG001|Overall Study|Physician Decision|0|||
49142122|NCT01181128|158358849|FG002|Overall Study|Physician Decision|0|||
49142123|NCT01181128|158358847|FG000|Overall Study|Adverse Event|0|||
49142124|NCT01181128|158358848|FG001|Overall Study|Adverse Event|2|||
49142125|NCT01181128|158358849|FG002|Overall Study|Adverse Event|0|||
49142126|NCT01181128|158358847|FG000|Overall Study|Other|1|||
49142127|NCT01181128|158358848|FG001|Overall Study|Other|1|||
49142128|NCT01181128|158358849|FG002|Overall Study|Other|1|||
49142129|NCT01827943|158358850|FG000|Overall Study|Protocol Violation|8|||
49142130|NCT01827943|158358850|FG000|Overall Study|Never treated because of an rapid progression|1|||
49142131|NCT01653262|158360479|FG000|Overall Study|Lack of Efficacy|1|||
49142132|NCT01653262|158360479|FG000|Overall Study|SAE, non-fatal|1|||
49142133|NCT01653262|158360479|FG000|Overall Study|AE, non-serious non-fatal|1|||
49142134|NCT01778985|158360481|FG000|Overall Study|Lost to Follow-up|1|||
49142135|NCT01778985|158360482|FG001|Overall Study|Lost to Follow-up|0|||
49142136|NCT01778985|158360481|FG000|Overall Study|Physician Decision|2|||
49142137|NCT01778985|158360482|FG001|Overall Study|Physician Decision|2|||
49142138|NCT01778985|158360481|FG000|Overall Study|Protocol Violation|4|||
49142139|NCT01778985|158360482|FG001|Overall Study|Protocol Violation|1|||
49142140|NCT00723944|158360483|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
49142141|NCT00723944|158360484|FG001|Permanent Prosthesis Placement|Adverse Event|7|||
49142142|NCT00723944|158360483|FG000|Permanent Prosthesis Placement|Lost to Follow-up|2|||
49142143|NCT00723944|158360484|FG001|Permanent Prosthesis Placement|Lost to Follow-up|2|||
49142144|NCT00723944|158360483|FG000|One Year Post Placement Follow-up|Lost to Follow-up|1|||
49142145|NCT00723944|158360484|FG001|One Year Post Placement Follow-up|Lost to Follow-up|4|||
48729613|NCT03150810|156861268|FG009|Overall Study|Site withdrawal from study|1|||
48729614|NCT03150810|156861269|FG010|Overall Study|Site withdrawal from study|1|||
48729615|NCT03150810|156861270|FG011|Overall Study|Site withdrawal from study|0|||
49142146|NCT00530075|158360486|FG000|Overall Study|Adverse Event|1|||
49012324|NCT01625845|157883445|FG001|Overall Study|Adverse Event|2|||
49012325|NCT01625845|157883444|FG000|Overall Study|Lost to Follow-up|2|||
49012326|NCT01625845|157883445|FG001|Overall Study|Lost to Follow-up|1|||
49012327|NCT01625845|157883444|FG000|Overall Study|Withdrawal by Subject|2|||
49012328|NCT01625845|157883445|FG001|Overall Study|Withdrawal by Subject|0|||
49012329|NCT00686374|157883447|FG000|Overall Study|Lack of Efficacy|10|||
49012330|NCT00686374|157883447|FG000|Overall Study|Adverse Event|8|||
49012331|NCT00686374|157883447|FG000|Overall Study|Withdrew consent|5|||
49142147|NCT00530075|158360486|FG000|Overall Study|Death|1|||
49142148|NCT00530075|158360486|FG000|Overall Study|Lack of Efficacy|3|||
49142149|NCT00530075|158360486|FG000|Overall Study|Protocol Violation|1|||
49142150|NCT00530075|158360486|FG000|Overall Study|Withdrawal by Subject|1|||
49142151|NCT00552058|158360489|FG000|Overall Study|Adverse Event|8|||
49142152|NCT00552058|158360490|FG001|Overall Study|Adverse Event|7|||
49142153|NCT00552058|158360489|FG000|Overall Study|Lack of Efficacy|1|||
49142154|NCT00552058|158360490|FG001|Overall Study|Lack of Efficacy|5|||
49142155|NCT00552058|158360489|FG000|Overall Study|Lost to Follow-up|1|||
49142156|NCT00552058|158360490|FG001|Overall Study|Lost to Follow-up|0|||
49142157|NCT00552058|158360489|FG000|Overall Study|Withdrawal by Subject|4|||
49142158|NCT00552058|158360490|FG001|Overall Study|Withdrawal by Subject|4|||
49012332|NCT00686374|157883447|FG000|Overall Study|Lost to Follow-up|1|||
49012333|NCT00686374|157883447|FG000|Overall Study|Missing reason|33|||
49012334|NCT00686374|157883447|FG000|Overall Study|Other, not specified|4|||
49012335|NCT01294592|157883450|FG000|Overall Study|Adverse Event|28|||
49012336|NCT01294592|157883451|FG001|Overall Study|Adverse Event|13|||
49142159|NCT00552058|158360489|FG000|Overall Study|Other: Protocol Violation|0|||
49142160|NCT00552058|158360490|FG001|Overall Study|Other: Protocol Violation|1|||
49142161|NCT00552058|158360489|FG000|Overall Study|Other: Non Compliance|1|||
49142162|NCT00552058|158360490|FG001|Overall Study|Other: Non Compliance|2|||
49142163|NCT00552058|158360489|FG000|Overall Study|Other: Crossed Over to a Follow-up Study|0|||
49142164|NCT00552058|158360490|FG001|Overall Study|Other: Crossed Over to a Follow-up Study|1|||
49012337|NCT01294592|157883450|FG000|Overall Study|Lack of Efficacy|7|||
49142165|NCT00552058|158360489|FG000|Overall Study|Other: Low CDAI score, entry violation|0|||
48729616|NCT03150810|156861271|FG012|Overall Study|Site withdrawal from study|0|||
49142166|NCT00552058|158360490|FG001|Overall Study|Other: Low CDAI score, entry violation|1|||
49142167|NCT00552058|158360489|FG000|Overall Study|Other: Positive Stool Result|0|||
49142168|NCT00552058|158360490|FG001|Overall Study|Other: Positive Stool Result|1|||
49012338|NCT01294592|157883451|FG001|Overall Study|Lack of Efficacy|5|||
49012339|NCT01294592|157883450|FG000|Overall Study|Protocol Violation|1|||
49142169|NCT00552058|158360489|FG000|Overall Study|Other: Randomized in error|0|||
49142170|NCT00552058|158360490|FG001|Overall Study|Other: Randomized in error|1|||
49142171|NCT00552058|158360489|FG000|Overall Study|Other: Sponsors Decision|0|||
48822437|NCT01474512|157190489|FG006|Post-Treatment Follow-Up|Clinical Relapse|0|||
48822438|NCT01474512|157190490|FG007|Post-Treatment Follow-Up|Clinical Relapse|0|||
48822439|NCT01474512|157190491|FG008|Post-Treatment Follow-Up|Clinical Relapse|0|||
49142172|NCT00552058|158360490|FG001|Overall Study|Other: Sponsors Decision|1|||
49142173|NCT00552058|158360489|FG000|Overall Study|Other: Early Roll Over|1|||
49142174|NCT00552058|158360490|FG001|Overall Study|Other: Early Roll Over|0|||
49142175|NCT03439514|158360491|FG000|Double-Blind Treatment Period|Other|4|||
49142176|NCT03439514|158360492|FG001|Double-Blind Treatment Period|Other|1|||
49142177|NCT03439514|158360491|FG000|Double-Blind Treatment Period|Withdrawal by Subject|4|||
49142178|NCT03439514|158360492|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
49142179|NCT03439514|158360491|FG000|Double-Blind Treatment Period|Study Termination by Sponsor|29|||
49012340|NCT01294592|157883451|FG001|Overall Study|Protocol Violation|7|||
49012341|NCT01294592|157883450|FG000|Overall Study|Lost to Follow-up|7|||
49012342|NCT01294592|157883451|FG001|Overall Study|Lost to Follow-up|9|||
49012343|NCT01294592|157883450|FG000|Overall Study|Physician Decision|6|||
49012344|NCT01294592|157883451|FG001|Overall Study|Physician Decision|11|||
49012345|NCT01294592|157883450|FG000|Overall Study|Withdrawal by Subject|28|||
49012346|NCT01294592|157883451|FG001|Overall Study|Withdrawal by Subject|28|||
49012347|NCT02762565|157883452|FG000|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11|||
49012348|NCT03549130|157883453|FG000|Overall Study|Adverse Event|0|||
49012349|NCT03549130|157883454|FG001|Overall Study|Adverse Event|1|||
49012350|NCT03549130|157883453|FG000|Overall Study|Lost to Follow-up|0|||
49012351|NCT03549130|157883454|FG001|Overall Study|Lost to Follow-up|1|||
49012352|NCT02038634|157883456|FG000|Overall Study|Lost to Follow-up|0|||
49012353|NCT02038634|157883457|FG001|Overall Study|Lost to Follow-up|1|||
49012354|NCT01113710|157883458|FG000|Overall Study|Adverse Event|64|||
49012355|NCT01113710|157883458|FG000|Overall Study|Lack of Efficacy|41|||
49012356|NCT01113710|157883458|FG000|Overall Study|No Information Available|40|||
49012357|NCT01113710|157883458|FG000|Overall Study|Withdrawal by Subject|28|||
49012358|NCT01113710|157883458|FG000|Overall Study|Lost to Follow-up|20|||
49012359|NCT01113710|157883458|FG000|Overall Study|Lack of Efficacy/Withdrawal by Subject|13|||
49012360|NCT01113710|157883458|FG000|Overall Study|Withdrawal by Subject/Adverse Event|11|||
49012361|NCT01113710|157883458|FG000|Overall Study|Lack of Patient's Compliance|8|||
49012362|NCT01113710|157883458|FG000|Overall Study|Other|7|||
49012363|NCT01113710|157883458|FG000|Overall Study|Adverse Event/Other|5|||
49012364|NCT01113710|157883458|FG000|Overall Study|Patient's Compliance/Lost to Follow up|5|||
49012365|NCT01113710|157883458|FG000|Overall Study|Lack of Efficacy/Other|4|||
49012366|NCT01113710|157883458|FG000|Overall Study|Patient Compliance/Withdrawal by Subject|4|||
49012367|NCT01113710|157883458|FG000|Overall Study|Lack of Efficacy/Adverse Event|3|||
49012368|NCT01113710|157883458|FG000|Overall Study|Efficacy/Subject Withdrawal/AE|2|||
49012369|NCT01113710|157883458|FG000|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2|||
49012370|NCT01113710|157883458|FG000|Overall Study|Lost to Follow up/Withdrawal by Subject|2|||
49012371|NCT01113710|157883458|FG000|Overall Study|Efficacy/Withdrawal by Subject/Other|1|||
49012372|NCT01113710|157883458|FG000|Overall Study|Compliance/Efficacy/Adverse Event|1|||
49012373|NCT01113710|157883458|FG000|Overall Study|Compliance/Efficacy/AE/Other|1|||
49012374|NCT01113710|157883458|FG000|Overall Study|Compliance/Efficacy/Subject Withdrawal|1|||
49012375|NCT01113710|157883458|FG000|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1|||
49012376|NCT01113710|157883458|FG000|Overall Study|Lack of Patient's Compliance/Other|1|||
49012377|NCT01113710|157883458|FG000|Overall Study|Compliance/Subject Withdrawal/AE|1|||
49012378|NCT01113710|157883458|FG000|Overall Study|Subject Did Not Receive Neupro|3|||
49012379|NCT02742181|157883459|FG000|Overall Study|Physician Decision|1|||
49012380|NCT02742181|157883460|FG001|Overall Study|Physician Decision|0|||
49012381|NCT02770716|157883462|FG000|Overall Study|Death|101|||
49012382|NCT02770716|157883463|FG001|Overall Study|Death|45|||
49012383|NCT02770716|157883462|FG000|Overall Study|Withdrawal by Subject|4|||
49012384|NCT02770716|157883463|FG001|Overall Study|Withdrawal by Subject|2|||
49012385|NCT02770716|157883462|FG000|Overall Study|Lost to Follow-up|1|||
49012386|NCT02770716|157883463|FG001|Overall Study|Lost to Follow-up|0|||
49012387|NCT02770716|157883462|FG000|Overall Study|Various reasons|6|||
49012388|NCT02770716|157883463|FG001|Overall Study|Various reasons|2|||
49012389|NCT01078623|157883464|FG000|Treatment Period 1|Adverse Event|1|||
49012390|NCT01078623|157883465|FG001|Treatment Period 1|Adverse Event|1|||
49012391|NCT01078623|157883466|FG002|Treatment Period 1|Adverse Event|1|||
49012392|NCT01078623|157883467|FG003|Treatment Period 1|Adverse Event|0|||
49012393|NCT01078623|157883468|FG004|Treatment Period 1|Adverse Event|0|||
49012394|NCT01078623|157883469|FG005|Treatment Period 1|Adverse Event|0|||
49012395|NCT01078623|157883470|FG006|Treatment Period 1|Adverse Event|1|||
49012396|NCT01078623|157883471|FG007|Treatment Period 1|Adverse Event|0|||
49012397|NCT01078623|157883472|FG008|Treatment Period 1|Adverse Event|1|||
49012398|NCT01078623|157883473|FG009|Treatment Period 1|Adverse Event|1|||
49012399|NCT01078623|157883474|FG010|Treatment Period 1|Adverse Event|0|||
49012400|NCT01078623|157883475|FG011|Treatment Period 1|Adverse Event|0|||
49012401|NCT01078623|157883476|FG012|Treatment Period 1|Adverse Event|0|||
49012402|NCT01078623|157883477|FG013|Treatment Period 1|Adverse Event|0|||
49012403|NCT01078623|157883478|FG014|Treatment Period 1|Adverse Event|0|||
49012404|NCT01078623|157883479|FG015|Treatment Period 1|Adverse Event|0|||
48729617|NCT03150810|156861259|FG000|Overall Study|Hospice|0|||
48729618|NCT03150810|156861260|FG001|Overall Study|Hospice|0|||
48729619|NCT03150810|156861261|FG002|Overall Study|Hospice|0|||
49142180|NCT03439514|158360492|FG001|Double-Blind Treatment Period|Study Termination by Sponsor|32|||
49142181|NCT03439514|158360491|FG000|Double-Blind Treatment Period|Lost to Follow-up|2|||
49142182|NCT03439514|158360492|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
49142183|NCT03439514|158360491|FG000|Double-Blind Treatment Period|Death|1|||
49142184|NCT03439514|158360492|FG001|Double-Blind Treatment Period|Death|2|||
49142185|NCT03520569|158360496|FG000|Overall Study|Withdrawal by Subject|1|||
49142186|NCT02489773|158360497|FG000|Overall Study|Lost to Follow-up|4|||
49142187|NCT02489773|158360498|FG001|Overall Study|Lost to Follow-up|1|||
49142188|NCT02489773|158360497|FG000|Overall Study|Physician Decision|1|||
49142189|NCT02489773|158360498|FG001|Overall Study|Physician Decision|0|||
49142190|NCT02489773|158360497|FG000|Overall Study|Withdrawal by Subject|1|||
49142191|NCT02489773|158360498|FG001|Overall Study|Withdrawal by Subject|0|||
49142192|NCT02489773|158360497|FG000|Overall Study|Leave the country or the state|1|||
49142193|NCT02489773|158360498|FG001|Overall Study|Leave the country or the state|1|||
49142194|NCT02383173|158360501|FG000|Overall Study|Palliative Care Team withdrew|0|||
49142195|NCT02383173|158360502|FG001|Overall Study|Palliative Care Team withdrew|2|||
49142196|NCT03073109|158360503|FG000|Overall Study|Adverse Event|0|||
49142197|NCT03073109|158360504|FG001|Overall Study|Adverse Event|1|||
49142198|NCT03073109|158360503|FG000|Overall Study|Other|2|||
49142199|NCT03073109|158360504|FG001|Overall Study|Other|0|||
49142200|NCT03073109|158360503|FG000|Overall Study|Lost to Follow-up|8|||
49142201|NCT03073109|158360504|FG001|Overall Study|Lost to Follow-up|1|||
49142202|NCT04621760|158360505|FG000|Overall Study|Lost to Follow-up|2|||
49142203|NCT04621760|158360506|FG001|Overall Study|Lost to Follow-up|4|||
49142204|NCT04621760|158360505|FG000|Overall Study|Withdrawal by Subject|1|||
49142205|NCT04621760|158360506|FG001|Overall Study|Withdrawal by Subject|0|||
49142206|NCT00669331|158360507|FG000|Randomisation to First Dose|Adverse Event|1|||
49142207|NCT00669331|158360508|FG001|Randomisation to First Dose|Adverse Event|0|||
49142208|NCT00669331|158360507|FG000|Randomisation to First Dose|Protocol Violation|1|||
49142209|NCT00669331|158360508|FG001|Randomisation to First Dose|Protocol Violation|0|||
49142210|NCT00669331|158360507|FG000|Randomisation to First Dose|Withdrawal by Subject|3|||
49142211|NCT00669331|158360508|FG001|Randomisation to First Dose|Withdrawal by Subject|2|||
49142212|NCT00669331|158360507|FG000|Randomisation to First Dose|Lost to Follow-up|2|||
49142213|NCT00669331|158360508|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
49142214|NCT00669331|158360507|FG000|Randomisation to First Dose|Death|1|||
49142215|NCT00669331|158360508|FG001|Randomisation to First Dose|Death|0|||
49142216|NCT00669331|158360507|FG000|Randomisation to First Dose|Sponsor decision|0|||
49142217|NCT00669331|158360508|FG001|Randomisation to First Dose|Sponsor decision|1|||
49142218|NCT00669331|158360507|FG000|Randomisation to First Dose|Randomised in error|3|||
49142219|NCT00669331|158360508|FG001|Randomisation to First Dose|Randomised in error|10|||
49142220|NCT00669331|158360507|FG000|Blinded Treatment Period|Adverse Event|16|||
49142221|NCT00669331|158360508|FG001|Blinded Treatment Period|Adverse Event|10|||
49142222|NCT00669331|158360507|FG000|Blinded Treatment Period|Protocol Violation|1|||
49142223|NCT00669331|158360508|FG001|Blinded Treatment Period|Protocol Violation|1|||
49142224|NCT00669331|158360507|FG000|Blinded Treatment Period|Withdrawal by Subject|17|||
49142225|NCT00669331|158360508|FG001|Blinded Treatment Period|Withdrawal by Subject|19|||
49142226|NCT00669331|158360507|FG000|Blinded Treatment Period|Lost to Follow-up|3|||
49142227|NCT00669331|158360508|FG001|Blinded Treatment Period|Lost to Follow-up|2|||
49142228|NCT00669331|158360507|FG000|Blinded Treatment Period|Death|0|||
49142229|NCT00669331|158360508|FG001|Blinded Treatment Period|Death|2|||
49142230|NCT00669331|158360507|FG000|Blinded Treatment Period|Physician Decision|3|||
49142231|NCT00669331|158360508|FG001|Blinded Treatment Period|Physician Decision|3|||
49142232|NCT00669331|158360507|FG000|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
49142233|NCT00669331|158360508|FG001|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
49142234|NCT01531153|158360509|FG000|Overall Study|Withdrawal by Subject|10|||
49142235|NCT01531153|158360510|FG001|Overall Study|Withdrawal by Subject|9|||
49142236|NCT01531153|158360511|FG002|Overall Study|Withdrawal by Subject|15|||
49142237|NCT01239745|158360514|FG000|Overall Study|Study terminated by sponsor|45|||
48729620|NCT03150810|156861262|FG003|Overall Study|Hospice|0|||
48729621|NCT03150810|156861263|FG004|Overall Study|Hospice|0|||
48921404|NCT00763815|157546377|FG001|Overall Study|Familial and Personal Reasons|16|||
48921405|NCT00763815|157546376|FG000|Overall Study|Physician Decision|1|||
49142238|NCT01239745|158360514|FG000|Overall Study|Adverse Event|1|||
49142239|NCT03600428|158360515|FG000|Overall Study|Not eligible|0|||
49142240|NCT03600428|158360516|FG001|Overall Study|Not eligible|1|||
49142241|NCT03600428|158360515|FG000|Overall Study|Lost to Follow-up|5|||
49142242|NCT03600428|158360516|FG001|Overall Study|Lost to Follow-up|4|||
49142243|NCT00363467|158360517|FG000|Overall Study|Physician Decision|1|||
49142244|NCT00245570|158360518|FG000|Washout Between Periods III and IV|Adverse Event|0|||
49142245|NCT00245570|158360519|FG001|Washout Between Periods III and IV|Adverse Event|1|||
49142246|NCT00245570|158360520|FG002|Washout Between Periods III and IV|Adverse Event|0|||
48729622|NCT03150810|156861264|FG005|Overall Study|Hospice|1|||
49142247|NCT00245570|158360521|FG003|Washout Between Periods III and IV|Adverse Event|0|||
49142248|NCT00245570|158360522|FG004|Washout Between Periods III and IV|Adverse Event|0|||
49142249|NCT00245570|158360523|FG005|Washout Between Periods III and IV|Adverse Event|0|||
49142250|NCT00397930|158360544|FG000|Overall Study|Personal reasons|14|||
49142251|NCT00397930|158360545|FG001|Overall Study|Personal reasons|8|||
49142252|NCT00397930|158360544|FG000|Overall Study|Other medical|9|||
49142253|NCT00397930|158360545|FG001|Overall Study|Other medical|4|||
49142254|NCT00397930|158360544|FG000|Overall Study|Unknown reasons|9|||
49142255|NCT00397930|158360545|FG001|Overall Study|Unknown reasons|14|||
49142256|NCT00397930|158360544|FG000|Overall Study|Noncompliant|3|||
49142257|NCT00397930|158360545|FG001|Overall Study|Noncompliant|2|||
49142258|NCT00397930|158360544|FG000|Overall Study|Too time-consuming|2|||
49142259|NCT00397930|158360545|FG001|Overall Study|Too time-consuming|9|||
49142260|NCT00397930|158360544|FG000|Overall Study|Started own yoga program|1|||
49142261|NCT00397930|158360545|FG001|Overall Study|Started own yoga program|1|||
49142262|NCT00397930|158360544|FG000|Overall Study|Did not want to be in control group|0|||
49142263|NCT00397930|158360545|FG001|Overall Study|Did not want to be in control group|1|||
49142264|NCT00397930|158360544|FG000|Overall Study|Withdrawal by Subject|0|||
49142265|NCT00397930|158360545|FG001|Overall Study|Withdrawal by Subject|8|||
49012405|NCT01078623|157883480|FG016|Treatment Period 1|Adverse Event|0|||
49012406|NCT01078623|157883481|FG017|Treatment Period 1|Adverse Event|0|||
48729623|NCT03150810|156861265|FG006|Overall Study|Hospice|0|||
48729624|NCT03150810|156861266|FG007|Overall Study|Hospice|0|||
48729625|NCT03150810|156861267|FG008|Overall Study|Hospice|0|||
49142266|NCT00397930|158360544|FG000|Overall Study|Missing data|0|||
49142267|NCT00397930|158360545|FG001|Overall Study|Missing data|4|||
49142268|NCT00710554|158360553|FG000|Overall Study|Adverse Event|24|||
49142269|NCT00710554|158360554|FG001|Overall Study|Adverse Event|7|||
49142270|NCT00710554|158360553|FG000|Overall Study|Withdrawal by Subject|7|||
49142271|NCT00710554|158360554|FG001|Overall Study|Withdrawal by Subject|3|||
49142272|NCT00710554|158360553|FG000|Overall Study|Lost to Follow-up|7|||
49142273|NCT00710554|158360554|FG001|Overall Study|Lost to Follow-up|1|||
48729626|NCT03150810|156861268|FG009|Overall Study|Hospice|0|||
48729627|NCT03150810|156861269|FG010|Overall Study|Hospice|0|||
48729628|NCT03150810|156861270|FG011|Overall Study|Hospice|0|||
48729629|NCT03150810|156861271|FG012|Overall Study|Hospice|0|||
48729630|NCT03150810|156861259|FG000|Overall Study|Participant relocated abroad.|0|||
48729631|NCT03150810|156861260|FG001|Overall Study|Participant relocated abroad.|0|||
48729632|NCT03150810|156861261|FG002|Overall Study|Participant relocated abroad.|0|||
48729633|NCT03150810|156861262|FG003|Overall Study|Participant relocated abroad.|0|||
48729634|NCT03150810|156861263|FG004|Overall Study|Participant relocated abroad.|0|||
48729635|NCT03150810|156861264|FG005|Overall Study|Participant relocated abroad.|1|||
48729636|NCT03150810|156861265|FG006|Overall Study|Participant relocated abroad.|0|||
49142274|NCT00710554|158360553|FG000|Overall Study|Lack of Efficacy|11|||
49142275|NCT00710554|158360554|FG001|Overall Study|Lack of Efficacy|12|||
49142276|NCT00710554|158360553|FG000|Overall Study|Receiving radiotherapy - prostate cancer|0|||
49142277|NCT00710554|158360554|FG001|Overall Study|Receiving radiotherapy - prostate cancer|1|||
49142278|NCT02056288|158360555|FG000|In-Hospital Data|Surgery cancelled|1|||
49142279|NCT02056288|158360556|FG001|In-Hospital Data|Surgery cancelled|0|||
49142280|NCT02056288|158360555|FG000|In-Hospital Data|Protocol Violation|3|||
49142281|NCT02056288|158360556|FG001|In-Hospital Data|Protocol Violation|0|||
49012407|NCT01078623|157883482|FG018|Treatment Period 1|Adverse Event|0|||
49012408|NCT01078623|157883483|FG019|Treatment Period 1|Adverse Event|0|||
49012409|NCT01078623|157883464|FG000|Treatment Period 1|Withdrawal by Subject|0|||
49012410|NCT01078623|157883465|FG001|Treatment Period 1|Withdrawal by Subject|0|||
49012411|NCT01078623|157883466|FG002|Treatment Period 1|Withdrawal by Subject|0|||
49012412|NCT01078623|157883467|FG003|Treatment Period 1|Withdrawal by Subject|0|||
49012413|NCT01078623|157883468|FG004|Treatment Period 1|Withdrawal by Subject|0|||
49012414|NCT01078623|157883469|FG005|Treatment Period 1|Withdrawal by Subject|0|||
49012415|NCT01078623|157883470|FG006|Treatment Period 1|Withdrawal by Subject|0|||
49012416|NCT01078623|157883471|FG007|Treatment Period 1|Withdrawal by Subject|1|||
49012417|NCT01078623|157883472|FG008|Treatment Period 1|Withdrawal by Subject|0|||
49012418|NCT01078623|157883473|FG009|Treatment Period 1|Withdrawal by Subject|0|||
49012419|NCT01078623|157883474|FG010|Treatment Period 1|Withdrawal by Subject|1|||
49012420|NCT01078623|157883475|FG011|Treatment Period 1|Withdrawal by Subject|0|||
49142282|NCT02056288|158360555|FG000|In-Hospital Data|Physician Decision|1|||
49142283|NCT02056288|158360556|FG001|In-Hospital Data|Physician Decision|0|||
48729637|NCT03150810|156861266|FG007|Overall Study|Participant relocated abroad.|0|||
49012421|NCT01078623|157883476|FG012|Treatment Period 1|Withdrawal by Subject|0|||
49012422|NCT01078623|157883477|FG013|Treatment Period 1|Withdrawal by Subject|0|||
49012423|NCT01078623|157883478|FG014|Treatment Period 1|Withdrawal by Subject|0|||
49142284|NCT02056288|158360555|FG000|48-Hour Post-Discharge Data|Did not return diary|14|||
48822440|NCT01474512|157190492|FG009|Post-Treatment Follow-Up|Clinical Relapse|0|||
49142285|NCT02056288|158360556|FG001|48-Hour Post-Discharge Data|Did not return diary|20|||
48729638|NCT03150810|156861267|FG008|Overall Study|Participant relocated abroad.|0|||
48729639|NCT03150810|156861268|FG009|Overall Study|Participant relocated abroad.|0|||
48729640|NCT03150810|156861269|FG010|Overall Study|Participant relocated abroad.|0|||
48729641|NCT03150810|156861270|FG011|Overall Study|Participant relocated abroad.|0|||
48729642|NCT03150810|156861271|FG012|Overall Study|Participant relocated abroad.|0|||
48729643|NCT03150810|156861259|FG000|Overall Study|Transferred care to oncologist|0|||
48729644|NCT03150810|156861260|FG001|Overall Study|Transferred care to oncologist|0|||
48729645|NCT03150810|156861261|FG002|Overall Study|Transferred care to oncologist|0|||
48729646|NCT03150810|156861262|FG003|Overall Study|Transferred care to oncologist|0|||
48729647|NCT03150810|156861263|FG004|Overall Study|Transferred care to oncologist|0|||
48729648|NCT03150810|156861264|FG005|Overall Study|Transferred care to oncologist|0|||
48729649|NCT03150810|156861265|FG006|Overall Study|Transferred care to oncologist|2|||
48729650|NCT03150810|156861266|FG007|Overall Study|Transferred care to oncologist|0|||
48729651|NCT03150810|156861267|FG008|Overall Study|Transferred care to oncologist|0|||
48729652|NCT03150810|156861268|FG009|Overall Study|Transferred care to oncologist|0|||
48729653|NCT03150810|156861269|FG010|Overall Study|Transferred care to oncologist|0|||
48729654|NCT03150810|156861270|FG011|Overall Study|Transferred care to oncologist|0|||
48729655|NCT03150810|156861271|FG012|Overall Study|Transferred care to oncologist|0|||
48729656|NCT01323946|156861272|FG000|Overall Study|Lost to Follow-up|0|||
48729657|NCT01323946|156861273|FG001|Overall Study|Lost to Follow-up|1|||
48729658|NCT01323946|156861274|FG002|Overall Study|Lost to Follow-up|0|||
48729659|NCT01323946|156861272|FG000|Overall Study|Parents refused the last blood draw|1|||
48729660|NCT01323946|156861273|FG001|Overall Study|Parents refused the last blood draw|0|||
48729661|NCT01323946|156861274|FG002|Overall Study|Parents refused the last blood draw|0|||
48729662|NCT01323946|156861272|FG000|Overall Study|Withdrawal by Subject|2|||
48729663|NCT01323946|156861273|FG001|Overall Study|Withdrawal by Subject|2|||
48729664|NCT01323946|156861274|FG002|Overall Study|Withdrawal by Subject|0|||
48822441|NCT01474512|157190493|FG010|Post-Treatment Follow-Up|Clinical Relapse|0|||
48822442|NCT01474512|157190494|FG011|Post-Treatment Follow-Up|Clinical Relapse|0|||
48822443|NCT01474512|157190495|FG012|Post-Treatment Follow-Up|Clinical Relapse|0|||
49142286|NCT01060111|158360559|FG000|Overall Study|Adverse Event|9|||
49142287|NCT01060111|158360560|FG001|Overall Study|Adverse Event|5|||
48822444|NCT01474512|157190496|FG013|Post-Treatment Follow-Up|Clinical Relapse|0|||
48822445|NCT01474512|157190497|FG014|Post-Treatment Follow-Up|Clinical Relapse|0|||
48822446|NCT01474512|157190498|FG015|Post-Treatment Follow-Up|Clinical Relapse|0|||
49142288|NCT01060111|158360561|FG002|Overall Study|Adverse Event|18|||
49142289|NCT01060111|158360559|FG000|Overall Study|Lack of Efficacy|2|||
49142290|NCT01060111|158360560|FG001|Overall Study|Lack of Efficacy|1|||
49142291|NCT01060111|158360561|FG002|Overall Study|Lack of Efficacy|0|||
49142292|NCT01060111|158360559|FG000|Overall Study|Inappropriate participant|5|||
49142293|NCT01060111|158360560|FG001|Overall Study|Inappropriate participant|4|||
49142294|NCT01060111|158360561|FG002|Overall Study|Inappropriate participant|5|||
49142295|NCT01060111|158360559|FG000|Overall Study|Participants' evasion for hospital visit|0|||
49142296|NCT01060111|158360560|FG001|Overall Study|Participants' evasion for hospital visit|3|||
49142297|NCT01060111|158360561|FG002|Overall Study|Participants' evasion for hospital visit|2|||
48729665|NCT03711266|156861275|FG000|Overall Study|Lost to Follow-up|10|||
48822447|NCT01474512|157190499|FG016|Post-Treatment Follow-Up|Clinical Relapse|6|||
48822448|NCT01474512|157190500|FG017|Post-Treatment Follow-Up|Clinical Relapse|2|||
48822449|NCT01474512|157190483|FG000|Post-Treatment Follow-Up|Protocol Violation|0|||
48822450|NCT01474512|157190484|FG001|Post-Treatment Follow-Up|Protocol Violation|0|||
48822451|NCT01474512|157190485|FG002|Post-Treatment Follow-Up|Protocol Violation|0|||
48822452|NCT01474512|157190486|FG003|Post-Treatment Follow-Up|Protocol Violation|0|||
48822453|NCT01474512|157190487|FG004|Post-Treatment Follow-Up|Protocol Violation|0|||
48822454|NCT01474512|157190488|FG005|Post-Treatment Follow-Up|Protocol Violation|0|||
48822455|NCT01474512|157190489|FG006|Post-Treatment Follow-Up|Protocol Violation|0|||
48822456|NCT01474512|157190490|FG007|Post-Treatment Follow-Up|Protocol Violation|0|||
48921406|NCT00763815|157546377|FG001|Overall Study|Physician Decision|0|||
49142298|NCT01060111|158360559|FG000|Overall Study|Participants' non-cooperation|8|||
49142299|NCT01060111|158360560|FG001|Overall Study|Participants' non-cooperation|6|||
49142300|NCT01060111|158360561|FG002|Overall Study|Participants' non-cooperation|6|||
49142301|NCT01060111|158360559|FG000|Overall Study|Adverse event and insufficient effect|0|||
49142302|NCT01060111|158360560|FG001|Overall Study|Adverse event and insufficient effect|1|||
49142303|NCT01060111|158360561|FG002|Overall Study|Adverse event and insufficient effect|0|||
49142304|NCT01060111|158360559|FG000|Overall Study|Participants' non-cooperation|1|||
49142305|NCT01060111|158360560|FG001|Overall Study|Participants' non-cooperation|0|||
49142306|NCT01060111|158360561|FG002|Overall Study|Participants' non-cooperation|0|||
49142307|NCT01060111|158360559|FG000|Overall Study|Other|2|||
49142308|NCT01060111|158360560|FG001|Overall Study|Other|3|||
49142309|NCT01060111|158360561|FG002|Overall Study|Other|4|||
49142310|NCT02441114|158360562|FG000|Washout2|Withdrawal by Subject|4|||
49142311|NCT00625378|158360565|FG000|Overall Study|Adverse Event|22|||
49142312|NCT00625378|158360566|FG001|Overall Study|Adverse Event|0|||
49142313|NCT00625378|158360565|FG000|Overall Study|Withdrawal by Subject|16|||
49142314|NCT00625378|158360566|FG001|Overall Study|Withdrawal by Subject|0|||
49142315|NCT00625378|158360565|FG000|Overall Study|Death|38|||
49142316|NCT00625378|158360566|FG001|Overall Study|Death|0|||
49142317|NCT00625378|158360565|FG000|Overall Study|Disease progression, recurrence or relapse|88|||
49142318|NCT00625378|158360566|FG001|Overall Study|Disease progression, recurrence or relapse|0|||
49142319|NCT00625378|158360565|FG000|Overall Study|Lost to Follow-up|17|||
49142320|NCT00625378|158360566|FG001|Overall Study|Lost to Follow-up|0|||
49142321|NCT00625378|158360565|FG000|Overall Study|Non-compliant with study medication|3|||
49142322|NCT00625378|158360566|FG001|Overall Study|Non-compliant with study medication|0|||
49142323|NCT00625378|158360565|FG000|Overall Study|Investigator's judgement (no need to continue treatment)|1|||
49142324|NCT00625378|158360566|FG001|Overall Study|Investigator's judgement (no need to continue treatment)|0|||
49142325|NCT00625378|158360565|FG000|Overall Study|Medical decision|1|||
49142326|NCT00625378|158360566|FG001|Overall Study|Medical decision|0|||
49142327|NCT00625378|158360565|FG000|Overall Study|Multiple toxicities|1|||
49142328|NCT00625378|158360566|FG001|Overall Study|Multiple toxicities|0|||
49142329|NCT00625378|158360565|FG000|Overall Study|New cancer|1|||
49142330|NCT00625378|158360566|FG001|Overall Study|New cancer|0|||
49142331|NCT00625378|158360565|FG000|Overall Study|PTA program|2|||
49142332|NCT00625378|158360566|FG001|Overall Study|PTA program|0|||
49142333|NCT00625378|158360565|FG000|Overall Study|Recurrent rise in amylase and lipase|1|||
49142334|NCT00625378|158360566|FG001|Overall Study|Recurrent rise in amylase and lipase|0|||
49142335|NCT00625378|158360565|FG000|Overall Study|Sponsor decision|1|||
49142336|NCT00625378|158360566|FG001|Overall Study|Sponsor decision|0|||
49142337|NCT00625378|158360565|FG000|Overall Study|Sponsor's decision to stop the trial|1|||
49142338|NCT00625378|158360566|FG001|Overall Study|Sponsor's decision to stop the trial|0|||
49142339|NCT00625378|158360565|FG000|Overall Study|Switch to commercial drug|6|||
49142340|NCT00625378|158360566|FG001|Overall Study|Switch to commercial drug|1|||
49142341|NCT00625378|158360565|FG000|Overall Study|Missing|2|||
49142342|NCT00625378|158360566|FG001|Overall Study|Missing|0|||
49142343|NCT00625378|158360565|FG000|Overall Study|End of treatment not available|2|||
49142344|NCT00625378|158360566|FG001|Overall Study|End of treatment not available|0|||
49142345|NCT00625378|158360565|FG000|Overall Study|Never treated|2|||
49142346|NCT00625378|158360566|FG001|Overall Study|Never treated|0|||
49142347|NCT00122187|158360576|FG000|Overall Study|Withdrew because of resource limitations|2|||
49142348|NCT00122187|158360577|FG001|Overall Study|Withdrew because of resource limitations|2|||
49142349|NCT00564070|158360578|FG000|Overall Study|Lost to Follow-up|9|||
49142350|NCT00564070|158360579|FG001|Overall Study|Lost to Follow-up|7|||
49142351|NCT00564070|158360578|FG000|Overall Study|Worsening depression, referred to care|3|||
49142352|NCT00564070|158360579|FG001|Overall Study|Worsening depression, referred to care|0|||
49142353|NCT02583477|158360580|FG000|Overall Study|Adverse Event|0|||
49142354|NCT02583477|158360581|FG001|Overall Study|Adverse Event|2|||
49142355|NCT02583477|158360580|FG000|Overall Study|Death|1|||
49142356|NCT02583477|158360581|FG001|Overall Study|Death|16|||
49142357|NCT02583477|158360580|FG000|Overall Study|Study terminated|2|||
49142358|NCT02583477|158360581|FG001|Overall Study|Study terminated|2|||
49142359|NCT00567112|158360582|FG000|Treatment Period 2 (3 Days)|Protocol Violation|0|||
49142360|NCT00567112|158360583|FG001|Treatment Period 2 (3 Days)|Protocol Violation|1|||
49142361|NCT00567112|158360584|FG002|Treatment Period 2 (3 Days)|Protocol Violation|0|||
49142362|NCT00567112|158360582|FG000|Washout Period 3 (3 Days)|Lost to Follow-up|2|||
49142363|NCT00567112|158360583|FG001|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
49142364|NCT00567112|158360584|FG002|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
49142365|NCT00567112|158360582|FG000|Washout Period 3 (3 Days)|Protocol Violation|1|||
49142366|NCT00567112|158360583|FG001|Washout Period 3 (3 Days)|Protocol Violation|0|||
49142367|NCT00567112|158360584|FG002|Washout Period 3 (3 Days)|Protocol Violation|0|||
49142368|NCT02945046|158360585|FG000|Overall Study|Adverse Event|1|||
49142369|NCT02945046|158360586|FG001|Overall Study|Adverse Event|0|||
49142370|NCT02945046|158360587|FG002|Overall Study|Adverse Event|2|||
49142371|NCT02945046|158360585|FG000|Overall Study|Withdrawal by Subject|3|||
49142372|NCT02945046|158360586|FG001|Overall Study|Withdrawal by Subject|3|||
49142373|NCT02945046|158360587|FG002|Overall Study|Withdrawal by Subject|3|||
49142374|NCT02945046|158360585|FG000|Overall Study|Protocol Violation|2|||
49142375|NCT02945046|158360586|FG001|Overall Study|Protocol Violation|3|||
49142376|NCT02945046|158360587|FG002|Overall Study|Protocol Violation|2|||
48822457|NCT01474512|157190491|FG008|Post-Treatment Follow-Up|Protocol Violation|0|||
49142377|NCT02945046|158360585|FG000|Overall Study|Lost to Follow-up|1|||
49142378|NCT02945046|158360586|FG001|Overall Study|Lost to Follow-up|1|||
49142379|NCT02945046|158360587|FG002|Overall Study|Lost to Follow-up|0|||
49142380|NCT02945046|158360585|FG000|Overall Study|Lack of Efficacy|1|||
49142381|NCT02945046|158360586|FG001|Overall Study|Lack of Efficacy|2|||
49142382|NCT02945046|158360587|FG002|Overall Study|Lack of Efficacy|1|||
49142383|NCT02945046|158360585|FG000|Overall Study|Other than specified|5|||
49142384|NCT02945046|158360586|FG001|Overall Study|Other than specified|4|||
49142385|NCT02945046|158360587|FG002|Overall Study|Other than specified|7|||
49142386|NCT03072875|158360590|FG000|Overall Study|Lost to Follow-up|1|||
49142387|NCT03111732|158360591|FG000|Overall Study|Enrolled in different study|1|||
49142388|NCT03111732|158360591|FG000|Overall Study|Progressive disease|3|||
49142389|NCT03111732|158360591|FG000|Overall Study|Withdrawal by Subject|1|||
49142390|NCT03478787|158360592|FG000|Overall Study|Adverse Event|5|||
49142391|NCT03478787|158360593|FG001|Overall Study|Adverse Event|1|||
49142392|NCT03478787|158360592|FG000|Overall Study|Protocol Violation|3|||
49142393|NCT03478787|158360593|FG001|Overall Study|Protocol Violation|0|||
49142394|NCT03478787|158360592|FG000|Overall Study|Lack of Efficacy|7|||
49142395|NCT03478787|158360593|FG001|Overall Study|Lack of Efficacy|1|||
49142396|NCT03478787|158360592|FG000|Overall Study|Lost to Follow-up|9|||
49142397|NCT03478787|158360593|FG001|Overall Study|Lost to Follow-up|5|||
49142398|NCT03478787|158360592|FG000|Overall Study|Withdrawal by Subject|2|||
49142399|NCT03478787|158360593|FG001|Overall Study|Withdrawal by Subject|6|||
49142400|NCT03478787|158360592|FG000|Overall Study|Other, Not Specified|3|||
49142401|NCT03478787|158360593|FG001|Overall Study|Other, Not Specified|0|||
49142402|NCT01121575|158360596|FG000|Overall Study|Participant Refused Further Follow-Up|0|||
49142403|NCT01121575|158360597|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
49142404|NCT01121575|158360598|FG002|Overall Study|Participant Refused Further Follow-Up|0|||
49142405|NCT01121575|158360599|FG003|Overall Study|Participant Refused Further Follow-Up|0|||
48729666|NCT01954342|156861276|FG000|Overall Study|Missing data from 13-16week study visit|0|||
48729667|NCT01954342|156861277|FG001|Overall Study|Missing data from 13-16week study visit|0|||
48729668|NCT01954342|156861278|FG002|Overall Study|Missing data from 13-16week study visit|0|||
48729669|NCT01954342|156861279|FG003|Overall Study|Missing data from 13-16week study visit|1|||
48729670|NCT01954342|156861276|FG000|Overall Study|Miscarriage|0|||
48729671|NCT01954342|156861277|FG001|Overall Study|Miscarriage|0|||
48729672|NCT01954342|156861278|FG002|Overall Study|Miscarriage|0|||
48729673|NCT01954342|156861279|FG003|Overall Study|Miscarriage|3|||
48729674|NCT01954342|156861276|FG000|Overall Study|Lost to Follow-up|0|||
48729675|NCT01954342|156861277|FG001|Overall Study|Lost to Follow-up|0|||
48729676|NCT01954342|156861278|FG002|Overall Study|Lost to Follow-up|0|||
48729677|NCT01954342|156861279|FG003|Overall Study|Lost to Follow-up|5|||
49142406|NCT01121575|158360600|FG004|Overall Study|Participant Refused Further Follow-Up|5|||
49142407|NCT01121575|158360601|FG005|Overall Study|Participant Refused Further Follow-Up|1|||
49142408|NCT01121575|158360596|FG000|Overall Study|Unspecified Reasons|8|||
49142409|NCT01121575|158360597|FG001|Overall Study|Unspecified Reasons|6|||
48729678|NCT01954342|156861276|FG000|Overall Study|Preterm delivery|0|||
48729679|NCT01954342|156861277|FG001|Overall Study|Preterm delivery|0|||
48729680|NCT01954342|156861278|FG002|Overall Study|Preterm delivery|0|||
48729681|NCT01954342|156861279|FG003|Overall Study|Preterm delivery|3|||
48729682|NCT01954342|156861276|FG000|Overall Study|Pre-eclampsia|0|||
48729683|NCT01954342|156861277|FG001|Overall Study|Pre-eclampsia|0|||
48729684|NCT01954342|156861278|FG002|Overall Study|Pre-eclampsia|0|||
49142410|NCT01121575|158360598|FG002|Overall Study|Unspecified Reasons|7|||
49142411|NCT01121575|158360599|FG003|Overall Study|Unspecified Reasons|5|||
49142412|NCT01121575|158360600|FG004|Overall Study|Unspecified Reasons|13|||
49142413|NCT01121575|158360601|FG005|Overall Study|Unspecified Reasons|10|||
49142414|NCT01121575|158360596|FG000|Overall Study|Death|6|||
49142415|NCT01121575|158360597|FG001|Overall Study|Death|0|||
49142416|NCT01121575|158360598|FG002|Overall Study|Death|0|||
49142417|NCT01121575|158360599|FG003|Overall Study|Death|1|||
49142418|NCT01121575|158360600|FG004|Overall Study|Death|7|||
49142419|NCT01121575|158360601|FG005|Overall Study|Death|1|||
49142420|NCT00452400|158360602|FG000|Overall Study|Adverse Event|1|||
49142421|NCT00452400|158360603|FG001|Overall Study|Adverse Event|1|||
48729685|NCT01954342|156861279|FG003|Overall Study|Pre-eclampsia|4|||
48729686|NCT01954342|156861276|FG000|Overall Study|Unreliable Data|0|||
48729687|NCT01954342|156861277|FG001|Overall Study|Unreliable Data|0|||
48729688|NCT01954342|156861278|FG002|Overall Study|Unreliable Data|0|||
48729689|NCT01954342|156861279|FG003|Overall Study|Unreliable Data|2|||
48729690|NCT00057876|156861280|FG000|Overall Study|Adverse Event|8|||
48729691|NCT00057876|156861281|FG001|Overall Study|Adverse Event|8|||
48729692|NCT00057876|156861280|FG000|Overall Study|Death|2|||
48729693|NCT00057876|156861281|FG001|Overall Study|Death|1|||
48729694|NCT00057876|156861280|FG000|Overall Study|Withdrawal by Subject|5|||
48729695|NCT00057876|156861281|FG001|Overall Study|Withdrawal by Subject|6|||
48729696|NCT00057876|156861280|FG000|Overall Study|Lack of Efficacy|10|||
48729697|NCT00057876|156861281|FG001|Overall Study|Lack of Efficacy|8|||
48729698|NCT00057876|156861280|FG000|Overall Study|Ineligible|1|||
48729699|NCT00057876|156861281|FG001|Overall Study|Ineligible|2|||
48729700|NCT00057876|156861280|FG000|Overall Study|other reason|2|||
48729701|NCT00057876|156861281|FG001|Overall Study|other reason|2|||
48729702|NCT00057876|156861280|FG000|Overall Study|other complicating disease|1|||
48729703|NCT00057876|156861281|FG001|Overall Study|other complicating disease|0|||
48729704|NCT00750880|156861282|FG000|Overall Study|Adverse Event|76|||
48729705|NCT00750880|156861282|FG000|Overall Study|Death|4|||
48729706|NCT00750880|156861282|FG000|Overall Study|Lack of Efficacy|46|||
49142422|NCT00452400|158360604|FG002|Overall Study|Adverse Event|5|||
49142423|NCT00452400|158360605|FG003|Overall Study|Adverse Event|0|||
49142424|NCT00452400|158360606|FG004|Overall Study|Adverse Event|2|||
48729707|NCT00750880|156861282|FG000|Overall Study|Lost to Follow-up|10|||
48729708|NCT00750880|156861282|FG000|Overall Study|Protocol Violation|15|||
48729709|NCT00750880|156861282|FG000|Overall Study|Withdrawal by Subject|33|||
48729710|NCT00750880|156861282|FG000|Overall Study|Physician Decision|20|||
48729711|NCT00750880|156861282|FG000|Overall Study|Administrative|11|||
49012424|NCT01078623|157883479|FG015|Treatment Period 1|Withdrawal by Subject|0|||
49012425|NCT01078623|157883480|FG016|Treatment Period 1|Withdrawal by Subject|0|||
48729712|NCT02105766|156861283|FG000|Overall Study|Physician Decision|1|||
48729713|NCT02105766|156861284|FG001|Overall Study|Physician Decision|1|||
48729714|NCT02105766|156861285|FG002|Overall Study|Physician Decision|0|||
48729715|NCT02105766|156861283|FG000|Overall Study|Lost to Follow-up|2|||
48729716|NCT02105766|156861284|FG001|Overall Study|Lost to Follow-up|0|||
48729717|NCT02105766|156861285|FG002|Overall Study|Lost to Follow-up|0|||
48729718|NCT02105766|156861283|FG000|Overall Study|Death|1|||
48729719|NCT02105766|156861284|FG001|Overall Study|Death|1|||
48729720|NCT02105766|156861285|FG002|Overall Study|Death|0|||
48729721|NCT00925990|156861286|FG000|Overall Study|Adverse Event|1|||
48729722|NCT00925990|156861287|FG001|Overall Study|Adverse Event|3|||
48729723|NCT00925990|156861286|FG000|Overall Study|Withdrawal by Subject|2|||
48729724|NCT00925990|156861287|FG001|Overall Study|Withdrawal by Subject|2|||
48729725|NCT00925990|156861286|FG000|Overall Study|Lost to Follow-up|1|||
48729726|NCT00925990|156861287|FG001|Overall Study|Lost to Follow-up|3|||
48729727|NCT00925990|156861286|FG000|Overall Study|Physician Decision|1|||
48729728|NCT00925990|156861287|FG001|Overall Study|Physician Decision|1|||
48729729|NCT00925990|156861286|FG000|Overall Study|moved out of state, missed medication|0|||
48729730|NCT00925990|156861287|FG001|Overall Study|moved out of state, missed medication|2|||
48729731|NCT00853073|156861288|FG000|Overall Study|Withdrawal by Subject|3|||
49142425|NCT00452400|158360602|FG000|Overall Study|Protocol Violation|0|||
49142426|NCT00452400|158360603|FG001|Overall Study|Protocol Violation|0|||
49142427|NCT00452400|158360604|FG002|Overall Study|Protocol Violation|1|||
49142428|NCT00452400|158360605|FG003|Overall Study|Protocol Violation|0|||
49142429|NCT00452400|158360606|FG004|Overall Study|Protocol Violation|0|||
49142430|NCT00452400|158360602|FG000|Overall Study|Lost to Follow-up|1|||
49142431|NCT00452400|158360603|FG001|Overall Study|Lost to Follow-up|0|||
49142432|NCT00452400|158360604|FG002|Overall Study|Lost to Follow-up|0|||
49142433|NCT00452400|158360605|FG003|Overall Study|Lost to Follow-up|0|||
49142434|NCT00452400|158360606|FG004|Overall Study|Lost to Follow-up|0|||
49142435|NCT00452400|158360602|FG000|Overall Study|Withdrawal by Subject|1|||
49142436|NCT00452400|158360603|FG001|Overall Study|Withdrawal by Subject|0|||
49142437|NCT00452400|158360604|FG002|Overall Study|Withdrawal by Subject|1|||
49142438|NCT00452400|158360605|FG003|Overall Study|Withdrawal by Subject|0|||
49142439|NCT00452400|158360606|FG004|Overall Study|Withdrawal by Subject|0|||
49142440|NCT00452400|158360602|FG000|Overall Study|Lack of Efficacy|2|||
49142441|NCT00452400|158360603|FG001|Overall Study|Lack of Efficacy|0|||
49142442|NCT00452400|158360604|FG002|Overall Study|Lack of Efficacy|0|||
49142443|NCT00452400|158360605|FG003|Overall Study|Lack of Efficacy|0|||
49142444|NCT00452400|158360606|FG004|Overall Study|Lack of Efficacy|0|||
49142445|NCT00452400|158360602|FG000|Overall Study|Other reasons not listed above|0|||
49142446|NCT00452400|158360603|FG001|Overall Study|Other reasons not listed above|0|||
49142447|NCT00452400|158360604|FG002|Overall Study|Other reasons not listed above|0|||
49142448|NCT00452400|158360605|FG003|Overall Study|Other reasons not listed above|1|||
49142449|NCT00452400|158360606|FG004|Overall Study|Other reasons not listed above|1|||
49142450|NCT00003474|158360608|FG000|Overall Study|Not Evaluable|14|||
49142451|NCT01712074|158360609|FG000|Placebo Run-in Period|Adverse Event|2|||
49142452|NCT01712074|158360610|FG001|Placebo Run-in Period|Adverse Event|0|||
49142453|NCT01712074|158360611|FG002|Placebo Run-in Period|Adverse Event|0|||
49142454|NCT01712074|158360609|FG000|Placebo Run-in Period|Lost to Follow-up|1|||
49142455|NCT01712074|158360610|FG001|Placebo Run-in Period|Lost to Follow-up|0|||
49142456|NCT01712074|158360611|FG002|Placebo Run-in Period|Lost to Follow-up|0|||
49142457|NCT01712074|158360609|FG000|Placebo Run-in Period|No longer meets eligibility criteria|5|||
49142458|NCT01712074|158360610|FG001|Placebo Run-in Period|No longer meets eligibility criteria|0|||
49012426|NCT01078623|157883481|FG017|Treatment Period 1|Withdrawal by Subject|0|||
48729732|NCT00853073|156861289|FG001|Overall Study|Withdrawal by Subject|2|||
48729733|NCT03381274|156861290|FG000|Overall Study|Death|2|||
48729734|NCT03381274|156861291|FG001|Overall Study|Death|9|||
48729735|NCT03381274|156861292|FG002|Overall Study|Death|3|||
48729736|NCT03381274|156861293|FG003|Overall Study|Death|2|||
48729737|NCT03381274|156861294|FG004|Overall Study|Death|3|||
48729738|NCT03381274|156861290|FG000|Overall Study|Lost to Follow-up|0|||
49142459|NCT01712074|158360611|FG002|Placebo Run-in Period|No longer meets eligibility criteria|0|||
49142460|NCT01712074|158360609|FG000|Placebo Run-in Period|Other|1|||
49142461|NCT01712074|158360610|FG001|Placebo Run-in Period|Other|0|||
49142462|NCT01712074|158360611|FG002|Placebo Run-in Period|Other|0|||
49142463|NCT01712074|158360609|FG000|Placebo Run-in Period|No longer willing to participate|1|||
49142464|NCT01712074|158360610|FG001|Placebo Run-in Period|No longer willing to participate|0|||
48729739|NCT03381274|156861291|FG001|Overall Study|Lost to Follow-up|0|||
48729740|NCT03381274|156861292|FG002|Overall Study|Lost to Follow-up|0|||
48729741|NCT03381274|156861293|FG003|Overall Study|Lost to Follow-up|1|||
48729742|NCT03381274|156861294|FG004|Overall Study|Lost to Follow-up|0|||
48729743|NCT03381274|156861290|FG000|Overall Study|Withdrawal by Subject|2|||
48729744|NCT03381274|156861291|FG001|Overall Study|Withdrawal by Subject|1|||
49012427|NCT01078623|157883482|FG018|Treatment Period 1|Withdrawal by Subject|0|||
48729745|NCT03381274|156861292|FG002|Overall Study|Withdrawal by Subject|3|||
48729746|NCT03381274|156861293|FG003|Overall Study|Withdrawal by Subject|1|||
48729747|NCT03381274|156861294|FG004|Overall Study|Withdrawal by Subject|0|||
48729748|NCT03381274|156861290|FG000|Overall Study|Other|1|||
48729749|NCT03381274|156861291|FG001|Overall Study|Other|11|||
48729750|NCT03381274|156861292|FG002|Overall Study|Other|0|||
48729751|NCT03381274|156861293|FG003|Overall Study|Other|2|||
48729752|NCT03381274|156861294|FG004|Overall Study|Other|2|||
48729753|NCT04966741|156861295|FG000|Overall Study|Lost to Follow-up|1|||
48729754|NCT04966741|156861296|FG001|Overall Study|Lost to Follow-up|0|||
48729755|NCT02675231|156861297|FG000|Overall Study|Withdrawal by Subject|2|||
48729756|NCT02675231|156861298|FG001|Overall Study|Withdrawal by Subject|4|||
48729757|NCT02675231|156861299|FG002|Overall Study|Withdrawal by Subject|2|||
48729758|NCT02675231|156861297|FG000|Overall Study|Lost to Follow-up|3|||
48729759|NCT02675231|156861298|FG001|Overall Study|Lost to Follow-up|4|||
48729760|NCT02675231|156861299|FG002|Overall Study|Lost to Follow-up|3|||
48729761|NCT02810340|156861300|FG000|Overall Study|Withdrawal by Subject|1|||
48729762|NCT02810340|156861301|FG001|Overall Study|Withdrawal by Subject|0|||
48729763|NCT02810340|156861302|FG002|Overall Study|Withdrawal by Subject|0|||
48729764|NCT02810340|156861300|FG000|Overall Study|Incarceration|0|||
48729765|NCT02810340|156861301|FG001|Overall Study|Incarceration|1|||
48729766|NCT02810340|156861302|FG002|Overall Study|Incarceration|0|||
48729767|NCT02810340|156861300|FG000|Overall Study|Lost to Follow-up|0|||
48729768|NCT02810340|156861301|FG001|Overall Study|Lost to Follow-up|0|||
48729769|NCT02810340|156861302|FG002|Overall Study|Lost to Follow-up|1|||
48729770|NCT01484054|156861310|FG000|Period 1|Withdrawal by Subject|0|||
48729771|NCT01484054|156861311|FG001|Period 1|Withdrawal by Subject|1|||
48729772|NCT01610271|156861312|FG000|Overall Study|Surgery not complete|0|||
48729773|NCT01610271|156861313|FG001|Overall Study|Surgery not complete|1|||
48729774|NCT01610271|156861312|FG000|Overall Study|Prosthesis not implanted|2|||
48729775|NCT01610271|156861313|FG001|Overall Study|Prosthesis not implanted|3|||
48729776|NCT02961218|156861314|FG000|Overall Study|Lost to Follow-up|0|||
48729777|NCT02961218|156861315|FG001|Overall Study|Lost to Follow-up|2|||
48729778|NCT02961218|156861314|FG000|Overall Study|Physician Decision|0|||
48729779|NCT02961218|156861315|FG001|Overall Study|Physician Decision|2|||
48729780|NCT02961218|156861314|FG000|Overall Study|Subject/Guardian Decision|3|||
48729781|NCT02961218|156861315|FG001|Overall Study|Subject/Guardian Decision|1|||
48729782|NCT02393690|156861316|FG000|Overall Study|Ineligible|0|||
48729783|NCT02393690|156861317|FG001|Overall Study|Ineligible|1|||
48729784|NCT00586846|156861318|FG000|Overall Study|Physician Decision|1|||
48729785|NCT00586846|156861318|FG000|Overall Study|Death|1|||
48729786|NCT00586846|156861318|FG000|Overall Study|Evaluable for Toxicity Only|4|||
48729787|NCT05080660|156861319|FG000|Overall Study|Adverse Event|4|||
48729788|NCT05080660|156861320|FG001|Overall Study|Adverse Event|0|||
48729789|NCT05080660|156861319|FG000|Overall Study|Non-compliance With Study Drug and Procedures|1|||
48729790|NCT05080660|156861320|FG001|Overall Study|Non-compliance With Study Drug and Procedures|0|||
48729791|NCT05080660|156861319|FG000|Overall Study|Physician Decision|1|||
48729792|NCT05080660|156861320|FG001|Overall Study|Physician Decision|0|||
48729793|NCT05080660|156861319|FG000|Overall Study|Protocol Deviation|2|||
48729794|NCT05080660|156861320|FG001|Overall Study|Protocol Deviation|0|||
48729795|NCT05080660|156861319|FG000|Overall Study|Withdrawal by Subject|5|||
48729796|NCT05080660|156861320|FG001|Overall Study|Withdrawal by Subject|2|||
48729797|NCT01721070|156861321|FG000|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1|||
48729798|NCT02204007|156861331|FG000|Overall Study|Surgery Canceled|1|||
48729799|NCT02204007|156861332|FG001|Overall Study|Surgery Canceled|1|||
48729800|NCT05070728|156861335|FG000|Overall Study|Sponsor decided to stop study enrollment and terminate the study|0|||
48729801|NCT05070728|156861336|FG001|Overall Study|Sponsor decided to stop study enrollment and terminate the study|6|||
48729802|NCT00292318|156861341|FG000|Overall Study|Study terminated by officials|2|||
48729803|NCT00292318|156861342|FG001|Overall Study|Study terminated by officials|1|||
48729804|NCT03438383|156861345|FG000|Overall Study|Protocol Violation|9|||
48729805|NCT03438383|156861346|FG001|Overall Study|Protocol Violation|3|||
48729806|NCT02819518|156861347|FG000|Overall Study|Death|9|||
49142465|NCT01712074|158360611|FG002|Placebo Run-in Period|No longer willing to participate|0|||
48729807|NCT02819518|156861348|FG001|Overall Study|Death|12|||
48729808|NCT02819518|156861349|FG002|Overall Study|Death|9|||
48729809|NCT02819518|156861350|FG003|Overall Study|Death|475|||
48729810|NCT02819518|156861351|FG004|Overall Study|Death|244|||
48729811|NCT02819518|156861347|FG000|Overall Study|Withdrawal by Subject|0|||
49142466|NCT01712074|158360609|FG000|Double Blind Period|Adverse Event|0|||
48729812|NCT02819518|156861348|FG001|Overall Study|Withdrawal by Subject|0|||
48729813|NCT02819518|156861349|FG002|Overall Study|Withdrawal by Subject|0|||
48729814|NCT02819518|156861350|FG003|Overall Study|Withdrawal by Subject|25|||
48729815|NCT02819518|156861351|FG004|Overall Study|Withdrawal by Subject|8|||
48729816|NCT02819518|156861347|FG000|Overall Study|Lost to Follow-up|0|||
48729817|NCT02819518|156861348|FG001|Overall Study|Lost to Follow-up|0|||
48729818|NCT02819518|156861349|FG002|Overall Study|Lost to Follow-up|0|||
48729819|NCT02819518|156861350|FG003|Overall Study|Lost to Follow-up|0|||
49142467|NCT01712074|158360610|FG001|Double Blind Period|Adverse Event|2|||
48729820|NCT02819518|156861351|FG004|Overall Study|Lost to Follow-up|1|||
48729821|NCT02819518|156861347|FG000|Overall Study|Sponsor Decision|1|||
48729822|NCT02819518|156861348|FG001|Overall Study|Sponsor Decision|1|||
48729823|NCT02819518|156861349|FG002|Overall Study|Sponsor Decision|0|||
49142468|NCT01712074|158360611|FG002|Double Blind Period|Adverse Event|1|||
49142469|NCT01712074|158360609|FG000|Double Blind Period|No longer willing to participate|0|||
49142470|NCT01712074|158360610|FG001|Double Blind Period|No longer willing to participate|2|||
49142471|NCT01712074|158360611|FG002|Double Blind Period|No longer willing to participate|4|||
49142472|NCT01712074|158360609|FG000|Double Blind Period|Death|0|||
49142473|NCT01712074|158360610|FG001|Double Blind Period|Death|1|||
49142474|NCT01712074|158360611|FG002|Double Blind Period|Death|0|||
49142475|NCT01712074|158360609|FG000|Double Blind Period|Lost to Follow-up|0|||
49142476|NCT01712074|158360610|FG001|Double Blind Period|Lost to Follow-up|2|||
49142477|NCT01712074|158360611|FG002|Double Blind Period|Lost to Follow-up|1|||
48729824|NCT02819518|156861350|FG003|Overall Study|Sponsor Decision|34|||
48729825|NCT02819518|156861351|FG004|Overall Study|Sponsor Decision|17|||
48729826|NCT02819518|156861347|FG000|Overall Study|Transferred to extension study|1|||
48729827|NCT02819518|156861348|FG001|Overall Study|Transferred to extension study|1|||
48729828|NCT02819518|156861349|FG002|Overall Study|Transferred to extension study|1|||
48729829|NCT02819518|156861350|FG003|Overall Study|Transferred to extension study|32|||
48729830|NCT02819518|156861351|FG004|Overall Study|Transferred to extension study|11|||
48729831|NCT02435069|156861352|FG000|Dose Response - First Intervention|Adverse Event|0|||
48729832|NCT02435069|156861353|FG001|Dose Response - First Intervention|Adverse Event|1|||
48729833|NCT02435069|156861354|FG002|Dose Response - First Intervention|Adverse Event|1|||
48729834|NCT02435069|156861355|FG003|Dose Response - First Intervention|Adverse Event|0|||
48729835|NCT02435069|156861356|FG004|Dose Response - First Intervention|Adverse Event|0|||
48729836|NCT02435069|156861352|FG000|Effectiveness - Second Intervention|Lack of Efficacy|0|||
48729837|NCT02435069|156861353|FG001|Effectiveness - Second Intervention|Lack of Efficacy|0|||
48729838|NCT02435069|156861354|FG002|Effectiveness - Second Intervention|Lack of Efficacy|0|||
48729839|NCT02435069|156861355|FG003|Effectiveness - Second Intervention|Lack of Efficacy|0|||
48729840|NCT02435069|156861356|FG004|Effectiveness - Second Intervention|Lack of Efficacy|1|||
48729841|NCT00843726|156861358|FG000|Overall Study|Death|1|||
48729842|NCT00843726|156861359|FG001|Overall Study|Death|0|||
48729843|NCT00843726|156861358|FG000|Overall Study|Withdrawal by Subject|0|||
48729844|NCT00843726|156861359|FG001|Overall Study|Withdrawal by Subject|1|||
48729845|NCT00667602|156861360|FG000|Overall Study|Withdrawal by Subject|4|||
48729846|NCT00667602|156861361|FG001|Overall Study|Withdrawal by Subject|9|||
48729847|NCT00667602|156861362|FG002|Overall Study|Withdrawal by Subject|10|||
48729848|NCT00667602|156861360|FG000|Overall Study|Lost to Follow-up|4|||
48729849|NCT00667602|156861361|FG001|Overall Study|Lost to Follow-up|5|||
48729850|NCT00667602|156861362|FG002|Overall Study|Lost to Follow-up|6|||
48729851|NCT00667602|156861360|FG000|Overall Study|Administrative reason|0|||
48729852|NCT00667602|156861361|FG001|Overall Study|Administrative reason|0|||
48729853|NCT00667602|156861362|FG002|Overall Study|Administrative reason|2|||
48729854|NCT00667602|156861360|FG000|Overall Study|Protocol Violation|0|||
48729855|NCT00667602|156861361|FG001|Overall Study|Protocol Violation|1|||
48729856|NCT00667602|156861362|FG002|Overall Study|Protocol Violation|0|||
48729857|NCT03035409|156861363|FG000|Overall Study|Adverse Event|5|||
48729858|NCT03035409|156861363|FG000|Overall Study|Death|2|||
48729859|NCT03035409|156861363|FG000|Overall Study|Withdrawal by Subject|2|||
48729860|NCT03035409|156861363|FG000|Overall Study|Non compliance|4|||
48729861|NCT03035409|156861363|FG000|Overall Study|Patient was jittery|1|||
48729862|NCT03035409|156861363|FG000|Overall Study|Did not like Questionnaire|1|||
48729863|NCT03035409|156861363|FG000|Overall Study|Aspartate Aminotransferase increased|1|||
48729864|NCT03035409|156861363|FG000|Overall Study|Did not like taking drugs|1|||
48729865|NCT02750943|156861364|FG000|Overall Study|Lost to Follow-up|1|||
48729866|NCT02750943|156861365|FG001|Overall Study|Lost to Follow-up|2|||
48729867|NCT02750943|156861364|FG000|Overall Study|Withdrawal by Subject|5|||
48729868|NCT02750943|156861365|FG001|Overall Study|Withdrawal by Subject|7|||
49142478|NCT01712074|158360609|FG000|Double Blind Period|Other|0|||
49142479|NCT01712074|158360610|FG001|Double Blind Period|Other|4|||
48729869|NCT01467583|156861366|FG000|Overall Study|Death|1|||
48729870|NCT01467583|156861367|FG001|Overall Study|Death|1|||
48729871|NCT01467583|156861368|FG002|Overall Study|Death|0|||
48729872|NCT01467583|156861366|FG000|Overall Study|Withdrawal by Subject|1|||
48729873|NCT01467583|156861367|FG001|Overall Study|Withdrawal by Subject|0|||
48729874|NCT01467583|156861368|FG002|Overall Study|Withdrawal by Subject|0|||
48729875|NCT01467583|156861366|FG000|Overall Study|Protocol Violation|0|||
48729876|NCT01467583|156861367|FG001|Overall Study|Protocol Violation|0|||
48729877|NCT01467583|156861368|FG002|Overall Study|Protocol Violation|2|||
49142480|NCT01712074|158360611|FG002|Double Blind Period|Other|1|||
49142481|NCT01712074|158360609|FG000|Double Blind Period|Protocol Violation|0|||
48729878|NCT05868382|156861369|FG000|Overall Study|Lost to Follow-up|5|||
48729879|NCT05868382|156861370|FG001|Overall Study|Lost to Follow-up|0|||
48729880|NCT05868382|156861371|FG002|Overall Study|Lost to Follow-up|6|||
48729881|NCT05868382|156861372|FG003|Overall Study|Lost to Follow-up|4|||
48729882|NCT05868382|156861373|FG004|Overall Study|Lost to Follow-up|2|||
48729883|NCT05868382|156861374|FG005|Overall Study|Lost to Follow-up|6|||
48729884|NCT05868382|156861369|FG000|Overall Study|Withdrawal by Subject|1|||
48729885|NCT05868382|156861370|FG001|Overall Study|Withdrawal by Subject|0|||
49012428|NCT01078623|157883483|FG019|Treatment Period 1|Withdrawal by Subject|0|||
49012429|NCT01078623|157883464|FG000|Treatment Period 1|Protocol Violation|0|||
49012430|NCT01078623|157883465|FG001|Treatment Period 1|Protocol Violation|0|||
49012431|NCT01078623|157883466|FG002|Treatment Period 1|Protocol Violation|0|||
49012432|NCT01078623|157883467|FG003|Treatment Period 1|Protocol Violation|0|||
49012433|NCT01078623|157883468|FG004|Treatment Period 1|Protocol Violation|0|||
49012434|NCT01078623|157883469|FG005|Treatment Period 1|Protocol Violation|1|||
49012435|NCT01078623|157883470|FG006|Treatment Period 1|Protocol Violation|0|||
48729886|NCT05868382|156861371|FG002|Overall Study|Withdrawal by Subject|0|||
48729887|NCT05868382|156861372|FG003|Overall Study|Withdrawal by Subject|0|||
48729888|NCT05868382|156861373|FG004|Overall Study|Withdrawal by Subject|1|||
49142482|NCT01712074|158360610|FG001|Double Blind Period|Protocol Violation|0|||
49142483|NCT01712074|158360611|FG002|Double Blind Period|Protocol Violation|1|||
49142484|NCT01712074|158360609|FG000|Double Blind Period|No longer met eligibility criteria|0|||
49142485|NCT01712074|158360610|FG001|Double Blind Period|No longer met eligibility criteria|3|||
49142486|NCT01712074|158360611|FG002|Double Blind Period|No longer met eligibility criteria|0|||
49142487|NCT01472835|158360616|FG000|Overall Study|Lost to Follow-up|2|||
49142488|NCT01472835|158360617|FG001|Overall Study|Lost to Follow-up|0|||
49012436|NCT01078623|157883471|FG007|Treatment Period 1|Protocol Violation|0|||
49012437|NCT01078623|157883472|FG008|Treatment Period 1|Protocol Violation|0|||
49142489|NCT02413346|158360618|FG000|Overall Study|Adverse Event|6|||
49142490|NCT02413346|158360619|FG001|Overall Study|Adverse Event|6|||
49142491|NCT02413346|158360618|FG000|Overall Study|Withdrawal by Subject|30|||
49142492|NCT02413346|158360619|FG001|Overall Study|Withdrawal by Subject|40|||
49142493|NCT02413346|158360618|FG000|Overall Study|Lost to Follow-up|17|||
49142494|NCT02413346|158360619|FG001|Overall Study|Lost to Follow-up|21|||
49142495|NCT02413346|158360618|FG000|Overall Study|Protocol Violation|2|||
49142496|NCT02413346|158360619|FG001|Overall Study|Protocol Violation|0|||
49142497|NCT02413346|158360618|FG000|Overall Study|Other Miscellaneous Reasons|4|||
49142498|NCT02413346|158360619|FG001|Overall Study|Other Miscellaneous Reasons|3|||
49142499|NCT01316900|158360622|FG000|Overall Study|Adverse Event|10|||
49142500|NCT01316900|158360623|FG001|Overall Study|Adverse Event|10|||
49142501|NCT01316900|158360624|FG002|Overall Study|Adverse Event|15|||
49142502|NCT01316900|158360625|FG003|Overall Study|Adverse Event|9|||
49142503|NCT01316900|158360622|FG000|Overall Study|Lack of Efficacy|17|||
49142504|NCT01316900|158360623|FG001|Overall Study|Lack of Efficacy|9|||
48729889|NCT05868382|156861374|FG005|Overall Study|Withdrawal by Subject|0|||
48729890|NCT02445391|156861377|FG000|Overall Study|No active protocol treatment|3|||
49142505|NCT01316900|158360624|FG002|Overall Study|Lack of Efficacy|5|||
49142506|NCT01316900|158360625|FG003|Overall Study|Lack of Efficacy|7|||
48729891|NCT02445391|156861378|FG001|Overall Study|No active protocol treatment|0|||
48729892|NCT02445391|156861379|FG002|Overall Study|No active protocol treatment|0|||
48729893|NCT02445391|156861377|FG000|Overall Study|Adverse Event|0|||
48729894|NCT02445391|156861378|FG001|Overall Study|Adverse Event|21|||
48729895|NCT02445391|156861379|FG002|Overall Study|Adverse Event|12|||
48729896|NCT02445391|156861377|FG000|Overall Study|Alternative therapy|0|||
48729897|NCT02445391|156861378|FG001|Overall Study|Alternative therapy|0|||
48729898|NCT02445391|156861379|FG002|Overall Study|Alternative therapy|1|||
48729899|NCT02445391|156861377|FG000|Overall Study|Disease progression|0|||
48729900|NCT02445391|156861378|FG001|Overall Study|Disease progression|7|||
48729901|NCT02445391|156861379|FG002|Overall Study|Disease progression|22|||
48729902|NCT02445391|156861377|FG000|Overall Study|Complicating disease|0|||
48729903|NCT02445391|156861378|FG001|Overall Study|Complicating disease|2|||
48729904|NCT02445391|156861379|FG002|Overall Study|Complicating disease|1|||
48729905|NCT02445391|156861377|FG000|Overall Study|Withdrawal by Subject|0|||
48729906|NCT02445391|156861378|FG001|Overall Study|Withdrawal by Subject|4|||
48729907|NCT02445391|156861379|FG002|Overall Study|Withdrawal by Subject|9|||
48729908|NCT02445391|156861377|FG000|Overall Study|Financial issue|0|||
48729909|NCT02445391|156861378|FG001|Overall Study|Financial issue|0|||
48729910|NCT02445391|156861379|FG002|Overall Study|Financial issue|2|||
48729911|NCT02445391|156861377|FG000|Overall Study|Still on treatment|0|||
48729912|NCT02445391|156861378|FG001|Overall Study|Still on treatment|7|||
48729913|NCT02445391|156861379|FG002|Overall Study|Still on treatment|16|||
48729914|NCT02445391|156861377|FG000|Overall Study|Not start protocol therapy|0|||
48729915|NCT02445391|156861378|FG001|Overall Study|Not start protocol therapy|12|||
48729916|NCT02445391|156861379|FG002|Overall Study|Not start protocol therapy|9|||
48729917|NCT01155219|156862914|FG000|Overall Study|Adverse Event|3|||
48729918|NCT01155219|156862915|FG001|Overall Study|Adverse Event|1|||
49142507|NCT01316900|158360622|FG000|Overall Study|Protocol Violation|7|||
48729919|NCT01155219|156862914|FG000|Overall Study|non-medical reason|1|||
48729920|NCT01155219|156862915|FG001|Overall Study|non-medical reason|2|||
48729921|NCT01865084|156862916|FG000|Double Blind Period (DB)|Adverse Event|2|||
48729922|NCT01865084|156862917|FG001|Double Blind Period (DB)|Adverse Event|2|||
48729923|NCT01865084|156862918|FG002|Double Blind Period (DB)|Adverse Event|1|||
49142508|NCT01316900|158360623|FG001|Overall Study|Protocol Violation|1|||
49142509|NCT01316900|158360624|FG002|Overall Study|Protocol Violation|4|||
49142510|NCT01316900|158360625|FG003|Overall Study|Protocol Violation|0|||
49142511|NCT01316900|158360622|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
48729924|NCT01865084|156862916|FG000|Double Blind Period (DB)|Protocol Violation|0|||
48729925|NCT01865084|156862917|FG001|Double Blind Period (DB)|Protocol Violation|0|||
48729926|NCT01865084|156862918|FG002|Double Blind Period (DB)|Protocol Violation|1|||
48729927|NCT01865084|156862916|FG000|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
49142512|NCT01316900|158360623|FG001|Overall Study|Protocol-defined Stopping Criteria|3|||
49142513|NCT01316900|158360624|FG002|Overall Study|Protocol-defined Stopping Criteria|10|||
49142514|NCT01316900|158360625|FG003|Overall Study|Protocol-defined Stopping Criteria|5|||
49142515|NCT01316900|158360622|FG000|Overall Study|Lost to Follow-up|1|||
48729928|NCT01865084|156862917|FG001|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
48729929|NCT01865084|156862918|FG002|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4|||
48729930|NCT01865084|156862916|FG000|Double Blind Period (DB)|Withdrawal by Subject|1|||
48729931|NCT01865084|156862917|FG001|Double Blind Period (DB)|Withdrawal by Subject|0|||
48729932|NCT01865084|156862918|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
48729933|NCT01865084|156862916|FG000|Open Label Extension (OLE) Period|Adverse Event|0|||
48729934|NCT01865084|156862917|FG001|Open Label Extension (OLE) Period|Adverse Event|0|||
48729935|NCT01865084|156862918|FG002|Open Label Extension (OLE) Period|Adverse Event|1|||
48729936|NCT01865084|156862916|FG000|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
48729937|NCT01865084|156862917|FG001|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
48729938|NCT01865084|156862918|FG002|Open Label Extension (OLE) Period|Lack of Efficacy|2|||
48729939|NCT01865084|156862916|FG000|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
48729940|NCT01865084|156862917|FG001|Open Label Extension (OLE) Period|Lost to Follow-up|1|||
48729941|NCT01865084|156862918|FG002|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
48729942|NCT01865084|156862916|FG000|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0|||
48729943|NCT01865084|156862917|FG001|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8|||
48729944|NCT01865084|156862918|FG002|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2|||
48729945|NCT01865084|156862916|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
48729946|NCT01865084|156862917|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
48729947|NCT01865084|156862918|FG002|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
48729948|NCT00096954|156862919|FG000|Overall Study|Adverse Event|3|||
48729949|NCT00096954|156862920|FG001|Overall Study|Adverse Event|1|||
48729950|NCT00096954|156862919|FG000|Overall Study|Withdrawal by Subject|9|||
48729951|NCT00096954|156862920|FG001|Overall Study|Withdrawal by Subject|8|||
48729952|NCT00096954|156862919|FG000|Overall Study|Physician Decision|1|||
48729953|NCT00096954|156862920|FG001|Overall Study|Physician Decision|1|||
48729954|NCT00096954|156862919|FG000|Overall Study|Sponsors Decision|1|||
48729955|NCT00096954|156862920|FG001|Overall Study|Sponsors Decision|1|||
48729956|NCT00096954|156862919|FG000|Overall Study|Pregnancy|1|||
48729957|NCT00096954|156862920|FG001|Overall Study|Pregnancy|1|||
48729958|NCT00096954|156862919|FG000|Overall Study|Initiation of immunotherapy|1|||
48729959|NCT00096954|156862920|FG001|Overall Study|Initiation of immunotherapy|0|||
48729960|NCT00096954|156862919|FG000|Overall Study|Non-compliance|0|||
48729961|NCT00096954|156862920|FG001|Overall Study|Non-compliance|3|||
48729962|NCT00096954|156862919|FG000|Overall Study|Lost to Follow-up|8|||
48729963|NCT00096954|156862920|FG001|Overall Study|Lost to Follow-up|5|||
48729964|NCT04478123|156862921|FG000|Overall Study|Pt withdrawal or refusal before begin prot txt|2|||
48729965|NCT04478123|156862921|FG000|Overall Study|NE|1|||
48729966|NCT03034200|156862922|FG000|Overall Study|Disease progression|8|||
48729967|NCT03034200|156862923|FG001|Overall Study|Disease progression|10|||
48729968|NCT03034200|156862924|FG002|Overall Study|Disease progression|4|||
48729969|NCT03034200|156862922|FG000|Overall Study|Physician Decision|2|||
48729970|NCT03034200|156862923|FG001|Overall Study|Physician Decision|0|||
48729971|NCT03034200|156862924|FG002|Overall Study|Physician Decision|3|||
48729972|NCT03034200|156862922|FG000|Overall Study|Patient off treatment for other complicating disease|0|||
48729973|NCT03034200|156862923|FG001|Overall Study|Patient off treatment for other complicating disease|1|||
48729974|NCT03034200|156862924|FG002|Overall Study|Patient off treatment for other complicating disease|0|||
48729975|NCT03034200|156862922|FG000|Overall Study|Adjuvant Therapy|0|||
48729976|NCT03034200|156862923|FG001|Overall Study|Adjuvant Therapy|0|||
48729977|NCT03034200|156862924|FG002|Overall Study|Adjuvant Therapy|1|||
48729978|NCT00642473|156862925|FG000|Overall Study|Withdrawal by Subject|0|||
48729979|NCT00642473|156862926|FG001|Overall Study|Withdrawal by Subject|5|||
48729980|NCT00642473|156862925|FG000|Overall Study|Progression or death|2|||
48729981|NCT00642473|156862926|FG001|Overall Study|Progression or death|4|||
48729982|NCT00642473|156862925|FG000|Overall Study|Other|2|||
48729983|NCT00642473|156862926|FG001|Overall Study|Other|2|||
48729984|NCT03213457|156862929|FG000|Screening Period|Withdrawal by Subject|0|||
48729985|NCT03213457|156862930|FG001|Screening Period|Withdrawal by Subject|1|||
48729986|NCT03213457|156862931|FG002|Screening Period|Withdrawal by Subject|0|||
48729987|NCT03213457|156862929|FG000|Screening Period|Other|1|||
49142516|NCT01316900|158360623|FG001|Overall Study|Lost to Follow-up|0|||
49142517|NCT01316900|158360624|FG002|Overall Study|Lost to Follow-up|1|||
49142518|NCT01316900|158360625|FG003|Overall Study|Lost to Follow-up|1|||
49142519|NCT01316900|158360622|FG000|Overall Study|Withdrawal by Subject|7|||
49142520|NCT01316900|158360623|FG001|Overall Study|Withdrawal by Subject|8|||
49142521|NCT01316900|158360624|FG002|Overall Study|Withdrawal by Subject|6|||
49142522|NCT01316900|158360625|FG003|Overall Study|Withdrawal by Subject|9|||
49142523|NCT02205359|158360626|FG000|Overall Study|Death|293|||
49142524|NCT02205359|158360627|FG001|Overall Study|Death|327|||
49142525|NCT02205359|158360626|FG000|Overall Study|Lost to Follow-up|182|||
49142526|NCT02205359|158360627|FG001|Overall Study|Lost to Follow-up|162|||
49142527|NCT02205359|158360626|FG000|Overall Study|Physician Decision|51|||
49142528|NCT02205359|158360627|FG001|Overall Study|Physician Decision|53|||
49142529|NCT02205359|158360626|FG000|Overall Study|Withdrawal by Subject|167|||
49142530|NCT02205359|158360627|FG001|Overall Study|Withdrawal by Subject|169|||
49142531|NCT01905683|158360630|FG000|Overall Study|Protocol Violation|1|||
49142532|NCT01905683|158360630|FG000|Overall Study|Re-injection criteria not met; others|13|||
49142533|NCT01905683|158360630|FG000|Overall Study|Physician Decision|1|||
49142534|NCT01905683|158360630|FG000|Overall Study|Lack of Efficacy|8|||
49142535|NCT01905683|158360630|FG000|Overall Study|Withdrawal by Subject|20|||
49142536|NCT01905683|158360630|FG000|Overall Study|Adverse Event|4|||
49142537|NCT01905683|158360630|FG000|Overall Study|Lost to Follow-up|4|||
49142538|NCT02151604|158360634|FG000|Overall Study|Lost to Follow-up|3|||
49142539|NCT02151604|158360634|FG000|Overall Study|Withdrawal by Subject|2|||
49142540|NCT02151604|158360634|FG000|Overall Study|Physician Decision|3|||
49142541|NCT02151604|158360634|FG000|Overall Study|Death|1|||
49142542|NCT00182637|158362257|FG000|Overall Study|Adverse Event|2|||
49142543|NCT00182637|158362257|FG000|Overall Study|Disease Progression|1|||
49142544|NCT04289298|158362260|FG000|Overall Study|Lost to Follow-up|5|||
49142545|NCT04289298|158362261|FG001|Overall Study|Lost to Follow-up|0|||
49142546|NCT04289298|158362260|FG000|Overall Study|Withdrawal by Subject|2|||
49142547|NCT04289298|158362261|FG001|Overall Study|Withdrawal by Subject|0|||
49142548|NCT03418675|158362262|FG000|Overall Study|Lost to Follow-up|13|||
49142549|NCT03418675|158362263|FG001|Overall Study|Lost to Follow-up|10|||
49142550|NCT03418675|158362262|FG000|Overall Study|Adverse Event|2|||
49142551|NCT03418675|158362263|FG001|Overall Study|Adverse Event|0|||
49142552|NCT03197935|158362264|FG000|Overall Study|Death due to any cause|26|||
49142553|NCT03197935|158362265|FG001|Overall Study|Death due to any cause|15|||
49142554|NCT03197935|158362264|FG000|Overall Study|Lost to Follow-up|3|||
49142555|NCT03197935|158362265|FG001|Overall Study|Lost to Follow-up|5|||
49142556|NCT03197935|158362264|FG000|Overall Study|Physician Decision|2|||
49142557|NCT03197935|158362265|FG001|Overall Study|Physician Decision|1|||
49142558|NCT03197935|158362264|FG000|Overall Study|Withdrawal by Subject|16|||
49142559|NCT03197935|158362265|FG001|Overall Study|Withdrawal by Subject|8|||
49142560|NCT05059080|158362266|FG000|Overall Study|Withdrawal by Subject|3|||
49142561|NCT05059080|158362266|FG000|Overall Study|Study Terminated by Sponsor|64|||
49142562|NCT02255279|158362267|FG000|Overall Study|Lost to Follow-up|2|||
49142563|NCT02255279|158362268|FG001|Overall Study|Lost to Follow-up|2|||
49142564|NCT02255279|158362267|FG000|Overall Study|Protocol Violation|0|||
49142565|NCT02255279|158362268|FG001|Overall Study|Protocol Violation|1|||
49142566|NCT02255279|158362267|FG000|Overall Study|Withdrawal by Subject|3|||
49142567|NCT02255279|158362268|FG001|Overall Study|Withdrawal by Subject|6|||
49142568|NCT00509600|158362269|FG000|Overall Study|Adverse Event|1|||
49142569|NCT01829165|158362272|FG000|Overall Study|Did not complete intervention|2|||
49142570|NCT01829165|158362273|FG001|Overall Study|Did not complete intervention|0|||
49142571|NCT00090402|158362274|FG000|Overall Study|Death|1|||
49142572|NCT00090402|158362275|FG001|Overall Study|Death|1|||
49142573|NCT00090402|158362276|FG002|Overall Study|Death|0|||
49142574|NCT00090402|158362274|FG000|Overall Study|subject moved|0|||
49142575|NCT00090402|158362275|FG001|Overall Study|subject moved|1|||
49142576|NCT00090402|158362276|FG002|Overall Study|subject moved|0|||
49142577|NCT00090402|158362274|FG000|Overall Study|stopped taking study medication|1|||
49142578|NCT00090402|158362275|FG001|Overall Study|stopped taking study medication|0|||
49142579|NCT00090402|158362276|FG002|Overall Study|stopped taking study medication|1|||
48729988|NCT03213457|156862930|FG001|Screening Period|Other|0|||
48729989|NCT03213457|156862931|FG002|Screening Period|Other|0|||
48729990|NCT03213457|156862929|FG000|Double-Blind Period|Adverse Event|3|||
49142580|NCT00965094|158362278|FG000|Overall Study|Adverse Event|5|||
49142581|NCT00965094|158362279|FG001|Overall Study|Adverse Event|0|||
49142582|NCT00965094|158362278|FG000|Overall Study|Lost to Follow-up|0|||
49142583|NCT00965094|158362279|FG001|Overall Study|Lost to Follow-up|1|||
49142584|NCT00927186|158362280|FG000|12 Months Primary Study|Adverse Event|5|||
49142585|NCT00927186|158362281|FG001|12 Months Primary Study|Adverse Event|2|||
49142586|NCT00927186|158362280|FG000|12 Months Primary Study|Lost to Follow-up|1|||
49142587|NCT00927186|158362281|FG001|12 Months Primary Study|Lost to Follow-up|0|||
49142588|NCT00927186|158362280|FG000|12 Months Primary Study|Protocol Violation|0|||
49142589|NCT00927186|158362281|FG001|12 Months Primary Study|Protocol Violation|1|||
48729991|NCT03213457|156862930|FG001|Double-Blind Period|Adverse Event|2|||
49142590|NCT00927186|158362280|FG000|12 Months Primary Study|Withdrawal by Subject|1|||
49142591|NCT00927186|158362281|FG001|12 Months Primary Study|Withdrawal by Subject|1|||
49142592|NCT01658735|158362285|FG000|Overall Study|Lack of Efficacy|1|||
49142593|NCT01658735|158362286|FG001|Overall Study|Lack of Efficacy|0|||
49142594|NCT01658735|158362287|FG002|Overall Study|Lack of Efficacy|1|||
49142595|NCT01658735|158362285|FG000|Overall Study|Lost to Follow-up|1|||
49142596|NCT01658735|158362286|FG001|Overall Study|Lost to Follow-up|1|||
49142597|NCT01658735|158362287|FG002|Overall Study|Lost to Follow-up|0|||
49142598|NCT01658735|158362285|FG000|Overall Study|Protocol Violation|0|||
49142599|NCT01658735|158362286|FG001|Overall Study|Protocol Violation|1|||
49142600|NCT01658735|158362287|FG002|Overall Study|Protocol Violation|0|||
49142601|NCT01658735|158362285|FG000|Overall Study|Withdrawal by Subject|3|||
49142602|NCT01658735|158362286|FG001|Overall Study|Withdrawal by Subject|5|||
49142603|NCT01658735|158362287|FG002|Overall Study|Withdrawal by Subject|3|||
49142604|NCT05463705|158362291|FG000|Overall Study|Did not complete a visit during study intervention period|103|||
49142605|NCT05463705|158362292|FG001|Overall Study|Did not complete a visit during study intervention period|107|||
49142606|NCT05463705|158362293|FG002|Overall Study|Did not complete a visit during study intervention period|100|||
49142607|NCT05463705|158362294|FG003|Overall Study|Did not complete a visit during study intervention period|4|||
49142608|NCT05463705|158362295|FG004|Overall Study|Did not complete a visit during study intervention period|8|||
49142609|NCT05463705|158362296|FG005|Overall Study|Did not complete a visit during study intervention period|4|||
49142610|NCT00311168|158362297|FG000|First Intervention|Withdrawal by Subject|2|||
49142611|NCT00311168|158362298|FG001|First Intervention|Withdrawal by Subject|2|||
49142612|NCT00311168|158362297|FG000|First Intervention|Lost to Follow-up|1|||
49142613|NCT00311168|158362298|FG001|First Intervention|Lost to Follow-up|1|||
49142614|NCT00311168|158362297|FG000|First Intervention|Protocol Violation|1|||
49142615|NCT00311168|158362298|FG001|First Intervention|Protocol Violation|1|||
49142616|NCT00311168|158362297|FG000|First Intervention|Adverse Event|1|||
49142617|NCT00311168|158362298|FG001|First Intervention|Adverse Event|0|||
49142618|NCT00311168|158362297|FG000|First Intervention|Other|2|||
49142619|NCT00311168|158362298|FG001|First Intervention|Other|2|||
49142620|NCT00311168|158362297|FG000|Second Intervention|Lost to Follow-up|9|||
49142621|NCT00311168|158362298|FG001|Second Intervention|Lost to Follow-up|2|||
49142622|NCT00311168|158362297|FG000|Second Intervention|Withdrawal by Subject|0|||
49142623|NCT00311168|158362298|FG001|Second Intervention|Withdrawal by Subject|1|||
49142624|NCT00311168|158362297|FG000|Second Intervention|Other|1|||
49142625|NCT00311168|158362298|FG001|Second Intervention|Other|1|||
49142626|NCT01666652|158362301|FG000|Overall Study|Serious Adverse Event|0|||
49142627|NCT01666652|158362302|FG001|Overall Study|Serious Adverse Event|0|||
49142628|NCT01666652|158362303|FG002|Overall Study|Serious Adverse Event|0|||
49142629|NCT01666652|158362304|FG003|Overall Study|Serious Adverse Event|1|||
49142630|NCT01666652|158362305|FG004|Overall Study|Serious Adverse Event|0|||
49142631|NCT01666652|158362301|FG000|Overall Study|Withdrawal by Subject|0|||
49142632|NCT01666652|158362302|FG001|Overall Study|Withdrawal by Subject|0|||
49142633|NCT01666652|158362303|FG002|Overall Study|Withdrawal by Subject|0|||
49142634|NCT01666652|158362304|FG003|Overall Study|Withdrawal by Subject|0|||
49142635|NCT01666652|158362305|FG004|Overall Study|Withdrawal by Subject|1|||
49142636|NCT01666652|158362301|FG000|Overall Study|Moved from study area|1|||
49142637|NCT01666652|158362302|FG001|Overall Study|Moved from study area|0|||
49142638|NCT01666652|158362303|FG002|Overall Study|Moved from study area|0|||
49142639|NCT01666652|158362304|FG003|Overall Study|Moved from study area|2|||
49142640|NCT01666652|158362305|FG004|Overall Study|Moved from study area|0|||
49142641|NCT01666652|158362301|FG000|Overall Study|Lost to Follow-up|1|||
49142642|NCT01666652|158362302|FG001|Overall Study|Lost to Follow-up|1|||
49142643|NCT01666652|158362303|FG002|Overall Study|Lost to Follow-up|1|||
49142644|NCT01666652|158362304|FG003|Overall Study|Lost to Follow-up|1|||
49142645|NCT01666652|158362305|FG004|Overall Study|Lost to Follow-up|0|||
49142646|NCT00609973|158362306|FG000|Overall Study|Adverse Event|2|||
49142647|NCT00609973|158362307|FG001|Overall Study|Adverse Event|1|||
49142648|NCT00609973|158362306|FG000|Overall Study|Protocol Violation|4|||
49142649|NCT00609973|158362307|FG001|Overall Study|Protocol Violation|3|||
49142650|NCT00609973|158362306|FG000|Overall Study|Lost to Follow-up|2|||
49142651|NCT00609973|158362307|FG001|Overall Study|Lost to Follow-up|1|||
49142652|NCT00609973|158362306|FG000|Overall Study|Withdrawal by Subject|0|||
49142653|NCT00609973|158362307|FG001|Overall Study|Withdrawal by Subject|1|||
49142654|NCT02453191|158362310|FG000|Overall Study|Withdrawal by Subject|1|||
49142655|NCT03412890|158362311|FG000|Overall Study|Adverse Event|5|||
49142656|NCT03412890|158362312|FG001|Overall Study|Adverse Event|5|||
49142657|NCT03412890|158362313|FG002|Overall Study|Adverse Event|9|||
48729992|NCT03213457|156862931|FG002|Double-Blind Period|Adverse Event|7|||
48729993|NCT03213457|156862929|FG000|Double-Blind Period|Withdrawal by Subject|14|||
49142658|NCT03412890|158362311|FG000|Overall Study|Protocol deviation|2|||
49142659|NCT03412890|158362312|FG001|Overall Study|Protocol deviation|1|||
49142660|NCT03412890|158362313|FG002|Overall Study|Protocol deviation|2|||
49142661|NCT03412890|158362311|FG000|Overall Study|Lost to Follow-up|7|||
49142662|NCT03412890|158362312|FG001|Overall Study|Lost to Follow-up|10|||
49142663|NCT03412890|158362313|FG002|Overall Study|Lost to Follow-up|10|||
49142664|NCT03412890|158362311|FG000|Overall Study|Withdrawal by Subject|9|||
49142665|NCT03412890|158362312|FG001|Overall Study|Withdrawal by Subject|12|||
49142666|NCT03412890|158362313|FG002|Overall Study|Withdrawal by Subject|11|||
49142667|NCT03412890|158362311|FG000|Overall Study|Lack of Efficacy|2|||
49142668|NCT03412890|158362312|FG001|Overall Study|Lack of Efficacy|7|||
49142669|NCT03412890|158362313|FG002|Overall Study|Lack of Efficacy|5|||
49142670|NCT03412890|158362311|FG000|Overall Study|Other|5|||
49142671|NCT03412890|158362312|FG001|Overall Study|Other|6|||
49142672|NCT03412890|158362313|FG002|Overall Study|Other|5|||
49142673|NCT03412890|158362311|FG000|Overall Study|Participants who did not receive any study drug|0|||
49142674|NCT03412890|158362312|FG001|Overall Study|Participants who did not receive any study drug|1|||
49142675|NCT03412890|158362313|FG002|Overall Study|Participants who did not receive any study drug|0|||
49142676|NCT01696214|158362319|FG000|Overall Study|Lost to Follow-up|1|||
49142677|NCT01696214|158362320|FG001|Overall Study|Lost to Follow-up|0|||
49142678|NCT01696214|158362321|FG002|Overall Study|Lost to Follow-up|0|||
49142679|NCT01696214|158362322|FG003|Overall Study|Lost to Follow-up|0|||
49142680|NCT02965976|158362323|FG000|Overall Study|Withdrawal by Subject|2|||
49142681|NCT02965976|158362324|FG001|Overall Study|Withdrawal by Subject|0|||
49142682|NCT02134028|158362325|FG000|Overall Study|Lack of Efficacy|1|||
49012438|NCT01078623|157883473|FG009|Treatment Period 1|Protocol Violation|0|||
49012439|NCT01078623|157883474|FG010|Treatment Period 1|Protocol Violation|0|||
49012440|NCT01078623|157883475|FG011|Treatment Period 1|Protocol Violation|0|||
49012441|NCT01078623|157883476|FG012|Treatment Period 1|Protocol Violation|0|||
49012442|NCT01078623|157883477|FG013|Treatment Period 1|Protocol Violation|0|||
49012443|NCT01078623|157883478|FG014|Treatment Period 1|Protocol Violation|0|||
49142683|NCT02134028|158362326|FG001|Overall Study|Lack of Efficacy|0|||
49142684|NCT02134028|158362327|FG002|Overall Study|Lack of Efficacy|3|||
49142685|NCT02134028|158362328|FG003|Overall Study|Lack of Efficacy|2|||
49142686|NCT02134028|158362329|FG004|Overall Study|Lack of Efficacy|1|||
49012444|NCT01078623|157883479|FG015|Treatment Period 1|Protocol Violation|0|||
49012445|NCT01078623|157883480|FG016|Treatment Period 1|Protocol Violation|0|||
49012446|NCT01078623|157883481|FG017|Treatment Period 1|Protocol Violation|0|||
49012447|NCT01078623|157883482|FG018|Treatment Period 1|Protocol Violation|0|||
49012448|NCT01078623|157883483|FG019|Treatment Period 1|Protocol Violation|0|||
49012449|NCT01078623|157883464|FG000|Treatment Period 2|Adverse Event|0|||
49012450|NCT01078623|157883465|FG001|Treatment Period 2|Adverse Event|0|||
48729994|NCT03213457|156862930|FG001|Double-Blind Period|Withdrawal by Subject|2|||
48729995|NCT03213457|156862931|FG002|Double-Blind Period|Withdrawal by Subject|14|||
48729996|NCT03213457|156862929|FG000|Double-Blind Period|Lost to Follow-up|2|||
49142687|NCT02134028|158362330|FG005|Overall Study|Lack of Efficacy|2|||
49142688|NCT02134028|158362331|FG006|Overall Study|Lack of Efficacy|1|||
49142689|NCT02134028|158362332|FG007|Overall Study|Lack of Efficacy|0|||
49142690|NCT02134028|158362325|FG000|Overall Study|Poor compliance to protocol|1|||
49142691|NCT02134028|158362326|FG001|Overall Study|Poor compliance to protocol|1|||
49142692|NCT02134028|158362327|FG002|Overall Study|Poor compliance to protocol|3|||
49142693|NCT02134028|158362328|FG003|Overall Study|Poor compliance to protocol|7|||
49142694|NCT02134028|158362329|FG004|Overall Study|Poor compliance to protocol|1|||
49142695|NCT02134028|158362330|FG005|Overall Study|Poor compliance to protocol|1|||
49142696|NCT02134028|158362331|FG006|Overall Study|Poor compliance to protocol|0|||
49142697|NCT02134028|158362332|FG007|Overall Study|Poor compliance to protocol|0|||
49142698|NCT02134028|158362325|FG000|Overall Study|Other unspecified|4|||
49142699|NCT02134028|158362326|FG001|Overall Study|Other unspecified|22|||
49142700|NCT02134028|158362327|FG002|Overall Study|Other unspecified|33|||
49142701|NCT02134028|158362328|FG003|Overall Study|Other unspecified|64|||
49142702|NCT02134028|158362329|FG004|Overall Study|Other unspecified|8|||
49142703|NCT02134028|158362330|FG005|Overall Study|Other unspecified|6|||
49142704|NCT02134028|158362331|FG006|Overall Study|Other unspecified|2|||
49142705|NCT02134028|158362332|FG007|Overall Study|Other unspecified|1|||
49142706|NCT02134028|158362325|FG000|Overall Study|Adverse Event|3|||
49142707|NCT02134028|158362326|FG001|Overall Study|Adverse Event|19|||
49142708|NCT02134028|158362327|FG002|Overall Study|Adverse Event|13|||
49142709|NCT02134028|158362328|FG003|Overall Study|Adverse Event|32|||
49012451|NCT01078623|157883466|FG002|Treatment Period 2|Adverse Event|0|||
49012452|NCT01078623|157883467|FG003|Treatment Period 2|Adverse Event|0|||
49012453|NCT01078623|157883468|FG004|Treatment Period 2|Adverse Event|0|||
48729997|NCT03213457|156862930|FG001|Double-Blind Period|Lost to Follow-up|3|||
48729998|NCT03213457|156862931|FG002|Double-Blind Period|Lost to Follow-up|9|||
49012454|NCT01078623|157883469|FG005|Treatment Period 2|Adverse Event|0|||
49142710|NCT02134028|158362329|FG004|Overall Study|Adverse Event|4|||
49142711|NCT02134028|158362330|FG005|Overall Study|Adverse Event|5|||
48729999|NCT03213457|156862929|FG000|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
48730000|NCT03213457|156862930|FG001|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
49012455|NCT01078623|157883470|FG006|Treatment Period 2|Adverse Event|1|||
49142712|NCT02134028|158362331|FG006|Overall Study|Adverse Event|1|||
49142713|NCT02134028|158362332|FG007|Overall Study|Adverse Event|2|||
49142714|NCT00806026|158362333|FG000|Overall Study|Death|0|||
49142715|NCT00806026|158362334|FG001|Overall Study|Death|0|||
49142716|NCT00806026|158362335|FG002|Overall Study|Death|0|||
49012456|NCT01078623|157883471|FG007|Treatment Period 2|Adverse Event|0|||
49012457|NCT01078623|157883472|FG008|Treatment Period 2|Adverse Event|0|||
49012458|NCT01078623|157883473|FG009|Treatment Period 2|Adverse Event|0|||
49012459|NCT01078623|157883474|FG010|Treatment Period 2|Adverse Event|0|||
49012460|NCT01078623|157883475|FG011|Treatment Period 2|Adverse Event|0|||
48730001|NCT03213457|156862931|FG002|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
48730002|NCT03213457|156862929|FG000|Double-Blind Period|Non-compliance with study procedures|0|||
48730003|NCT03213457|156862930|FG001|Double-Blind Period|Non-compliance with study procedures|2|||
48730004|NCT03213457|156862931|FG002|Double-Blind Period|Non-compliance with study procedures|4|||
48730005|NCT03213457|156862929|FG000|Double-Blind Period|Pregnancy|5|||
48730006|NCT03213457|156862930|FG001|Double-Blind Period|Pregnancy|0|||
48730007|NCT03213457|156862931|FG002|Double-Blind Period|Pregnancy|0|||
48730008|NCT03213457|156862929|FG000|Double-Blind Period|Other|10|||
48730009|NCT03213457|156862930|FG001|Double-Blind Period|Other|3|||
48730010|NCT03213457|156862931|FG002|Double-Blind Period|Other|17|||
48730011|NCT03213457|156862929|FG000|Open-Label Period|Adverse Event|1|||
48730012|NCT03213457|156862930|FG001|Open-Label Period|Adverse Event|2|||
48730013|NCT03213457|156862931|FG002|Open-Label Period|Adverse Event|2|||
48822458|NCT01474512|157190492|FG009|Post-Treatment Follow-Up|Protocol Violation|0|||
48822459|NCT01474512|157190493|FG010|Post-Treatment Follow-Up|Protocol Violation|0|||
48822460|NCT01474512|157190494|FG011|Post-Treatment Follow-Up|Protocol Violation|0|||
48822461|NCT01474512|157190495|FG012|Post-Treatment Follow-Up|Protocol Violation|0|||
48822462|NCT01474512|157190496|FG013|Post-Treatment Follow-Up|Protocol Violation|0|||
48822463|NCT01474512|157190497|FG014|Post-Treatment Follow-Up|Protocol Violation|2|||
48822464|NCT01474512|157190498|FG015|Post-Treatment Follow-Up|Protocol Violation|2|||
48822465|NCT01474512|157190499|FG016|Post-Treatment Follow-Up|Protocol Violation|4|||
48822466|NCT01474512|157190500|FG017|Post-Treatment Follow-Up|Protocol Violation|0|||
48822467|NCT01474512|157190483|FG000|Post-Treatment Follow-Up|Sponsor Decision|0|||
48822468|NCT01474512|157190484|FG001|Post-Treatment Follow-Up|Sponsor Decision|0|||
48822469|NCT01474512|157190485|FG002|Post-Treatment Follow-Up|Sponsor Decision|0|||
48822470|NCT01474512|157190486|FG003|Post-Treatment Follow-Up|Sponsor Decision|0|||
49012461|NCT01078623|157883476|FG012|Treatment Period 2|Adverse Event|0|||
49012462|NCT01078623|157883477|FG013|Treatment Period 2|Adverse Event|0|||
49012463|NCT01078623|157883478|FG014|Treatment Period 2|Adverse Event|0|||
49012464|NCT01078623|157883479|FG015|Treatment Period 2|Adverse Event|0|||
49012465|NCT01078623|157883480|FG016|Treatment Period 2|Adverse Event|0|||
49012466|NCT01078623|157883481|FG017|Treatment Period 2|Adverse Event|0|||
49012467|NCT01078623|157883482|FG018|Treatment Period 2|Adverse Event|1|||
49012468|NCT01078623|157883483|FG019|Treatment Period 2|Adverse Event|0|||
49012469|NCT01078623|157883464|FG000|Treatment Period 2|Withdrawal by Subject|0|||
49012470|NCT01078623|157883465|FG001|Treatment Period 2|Withdrawal by Subject|0|||
49012471|NCT01078623|157883466|FG002|Treatment Period 2|Withdrawal by Subject|0|||
49012472|NCT01078623|157883467|FG003|Treatment Period 2|Withdrawal by Subject|0|||
49012473|NCT01078623|157883468|FG004|Treatment Period 2|Withdrawal by Subject|0|||
49012474|NCT01078623|157883469|FG005|Treatment Period 2|Withdrawal by Subject|1|||
49012475|NCT01078623|157883470|FG006|Treatment Period 2|Withdrawal by Subject|0|||
49012476|NCT01078623|157883471|FG007|Treatment Period 2|Withdrawal by Subject|0|||
49012477|NCT01078623|157883472|FG008|Treatment Period 2|Withdrawal by Subject|0|||
49012478|NCT01078623|157883473|FG009|Treatment Period 2|Withdrawal by Subject|0|||
49012479|NCT01078623|157883474|FG010|Treatment Period 2|Withdrawal by Subject|0|||
49012480|NCT01078623|157883475|FG011|Treatment Period 2|Withdrawal by Subject|0|||
49012481|NCT01078623|157883476|FG012|Treatment Period 2|Withdrawal by Subject|0|||
49012482|NCT01078623|157883477|FG013|Treatment Period 2|Withdrawal by Subject|0|||
49012483|NCT01078623|157883478|FG014|Treatment Period 2|Withdrawal by Subject|0|||
49012484|NCT01078623|157883479|FG015|Treatment Period 2|Withdrawal by Subject|0|||
49012485|NCT01078623|157883480|FG016|Treatment Period 2|Withdrawal by Subject|0|||
49012486|NCT01078623|157883481|FG017|Treatment Period 2|Withdrawal by Subject|0|||
49012487|NCT01078623|157883482|FG018|Treatment Period 2|Withdrawal by Subject|0|||
49012488|NCT01078623|157883483|FG019|Treatment Period 2|Withdrawal by Subject|0|||
49012489|NCT01078623|157883464|FG000|Treatment Period 3|Adverse Event|0|||
49012490|NCT01078623|157883465|FG001|Treatment Period 3|Adverse Event|0|||
49012491|NCT01078623|157883466|FG002|Treatment Period 3|Adverse Event|0|||
49012492|NCT01078623|157883467|FG003|Treatment Period 3|Adverse Event|0|||
49012493|NCT01078623|157883468|FG004|Treatment Period 3|Adverse Event|1|||
49012494|NCT01078623|157883469|FG005|Treatment Period 3|Adverse Event|0|||
49012495|NCT01078623|157883470|FG006|Treatment Period 3|Adverse Event|0|||
49012496|NCT01078623|157883471|FG007|Treatment Period 3|Adverse Event|0|||
49012497|NCT01078623|157883472|FG008|Treatment Period 3|Adverse Event|0|||
49012498|NCT01078623|157883473|FG009|Treatment Period 3|Adverse Event|0|||
49012499|NCT01078623|157883474|FG010|Treatment Period 3|Adverse Event|0|||
49012500|NCT01078623|157883475|FG011|Treatment Period 3|Adverse Event|0|||
49012501|NCT01078623|157883476|FG012|Treatment Period 3|Adverse Event|0|||
49012502|NCT01078623|157883477|FG013|Treatment Period 3|Adverse Event|1|||
49012503|NCT01078623|157883478|FG014|Treatment Period 3|Adverse Event|0|||
49012504|NCT01078623|157883479|FG015|Treatment Period 3|Adverse Event|0|||
49012505|NCT01078623|157883480|FG016|Treatment Period 3|Adverse Event|0|||
49012506|NCT01078623|157883481|FG017|Treatment Period 3|Adverse Event|0|||
49142717|NCT00806026|158362336|FG003|Overall Study|Death|1|||
49142718|NCT00806026|158362337|FG004|Overall Study|Death|0|||
49142719|NCT00806026|158362338|FG005|Overall Study|Death|0|||
49142720|NCT00806026|158362333|FG000|Overall Study|Did not meet entrance criteria|4|||
49142721|NCT00806026|158362334|FG001|Overall Study|Did not meet entrance criteria|1|||
49142722|NCT00806026|158362335|FG002|Overall Study|Did not meet entrance criteria|2|||
49142723|NCT00806026|158362336|FG003|Overall Study|Did not meet entrance criteria|1|||
49142724|NCT00806026|158362337|FG004|Overall Study|Did not meet entrance criteria|0|||
49142725|NCT00806026|158362338|FG005|Overall Study|Did not meet entrance criteria|0|||
49142726|NCT00806026|158362333|FG000|Overall Study|Lack of Efficacy|5|||
48730014|NCT03213457|156862929|FG000|Open-Label Period|Withdrawal by Subject|12|||
48730015|NCT03213457|156862930|FG001|Open-Label Period|Withdrawal by Subject|5|||
48730016|NCT03213457|156862931|FG002|Open-Label Period|Withdrawal by Subject|24|||
48730017|NCT03213457|156862929|FG000|Open-Label Period|Lost to Follow-up|1|||
48730018|NCT03213457|156862930|FG001|Open-Label Period|Lost to Follow-up|2|||
48730019|NCT03213457|156862931|FG002|Open-Label Period|Lost to Follow-up|8|||
48730020|NCT03213457|156862929|FG000|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
48730021|NCT03213457|156862930|FG001|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
48730022|NCT03213457|156862931|FG002|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
48730023|NCT03213457|156862929|FG000|Open-Label Period|Non-compliance with study procedures|1|||
48730024|NCT03213457|156862930|FG001|Open-Label Period|Non-compliance with study procedures|1|||
48730025|NCT03213457|156862931|FG002|Open-Label Period|Non-compliance with study procedures|2|||
48730026|NCT03213457|156862929|FG000|Open-Label Period|Exclusionary medications|0|||
48730027|NCT03213457|156862930|FG001|Open-Label Period|Exclusionary medications|0|||
48730028|NCT03213457|156862931|FG002|Open-Label Period|Exclusionary medications|1|||
48730029|NCT03213457|156862929|FG000|Open-Label Period|Other|1|||
48730030|NCT03213457|156862930|FG001|Open-Label Period|Other|1|||
48730031|NCT03213457|156862931|FG002|Open-Label Period|Other|6|||
48730032|NCT03213457|156862929|FG000|Follow-Up Period|Adverse Event|16|||
48730033|NCT03213457|156862930|FG001|Follow-Up Period|Adverse Event|8|||
48730034|NCT03213457|156862931|FG002|Follow-Up Period|Adverse Event|37|||
48730035|NCT03213457|156862929|FG000|Follow-Up Period|Withdrawal by Subject|18|||
48730036|NCT03213457|156862930|FG001|Follow-Up Period|Withdrawal by Subject|11|||
48730037|NCT03213457|156862931|FG002|Follow-Up Period|Withdrawal by Subject|55|||
48730038|NCT03213457|156862929|FG000|Follow-Up Period|Lost to Follow-up|28|||
48730039|NCT03213457|156862930|FG001|Follow-Up Period|Lost to Follow-up|15|||
48730040|NCT03213457|156862931|FG002|Follow-Up Period|Lost to Follow-up|50|||
48730041|NCT03213457|156862929|FG000|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|3|||
48730042|NCT03213457|156862930|FG001|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
48730043|NCT03213457|156862931|FG002|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
48730044|NCT03213457|156862929|FG000|Follow-Up Period|Non-compliance with study procedures|4|||
48730045|NCT03213457|156862930|FG001|Follow-Up Period|Non-compliance with study procedures|1|||
48730046|NCT03213457|156862931|FG002|Follow-Up Period|Non-compliance with study procedures|6|||
49142727|NCT00806026|158362334|FG001|Overall Study|Lack of Efficacy|18|||
49142728|NCT00806026|158362335|FG002|Overall Study|Lack of Efficacy|13|||
49142729|NCT00806026|158362336|FG003|Overall Study|Lack of Efficacy|4|||
49142730|NCT00806026|158362337|FG004|Overall Study|Lack of Efficacy|8|||
49142731|NCT00806026|158362338|FG005|Overall Study|Lack of Efficacy|7|||
49142732|NCT00806026|158362333|FG000|Overall Study|Lost to Follow-up|8|||
49142733|NCT00806026|158362334|FG001|Overall Study|Lost to Follow-up|15|||
49142734|NCT00806026|158362335|FG002|Overall Study|Lost to Follow-up|8|||
49142735|NCT00806026|158362336|FG003|Overall Study|Lost to Follow-up|2|||
49142736|NCT00806026|158362337|FG004|Overall Study|Lost to Follow-up|6|||
49142737|NCT00806026|158362338|FG005|Overall Study|Lost to Follow-up|6|||
49142738|NCT00806026|158362333|FG000|Overall Study|Withdrawal by Subject|14|||
49142739|NCT00806026|158362334|FG001|Overall Study|Withdrawal by Subject|17|||
49142740|NCT00806026|158362335|FG002|Overall Study|Withdrawal by Subject|9|||
49142741|NCT00806026|158362336|FG003|Overall Study|Withdrawal by Subject|2|||
49142742|NCT00806026|158362337|FG004|Overall Study|Withdrawal by Subject|5|||
49142743|NCT00806026|158362338|FG005|Overall Study|Withdrawal by Subject|3|||
49142744|NCT00806026|158362333|FG000|Overall Study|Other|3|||
49142745|NCT00806026|158362334|FG001|Overall Study|Other|6|||
49142746|NCT00806026|158362335|FG002|Overall Study|Other|8|||
49142747|NCT00806026|158362336|FG003|Overall Study|Other|2|||
49142748|NCT00806026|158362337|FG004|Overall Study|Other|0|||
49142749|NCT00806026|158362338|FG005|Overall Study|Other|4|||
48730047|NCT03213457|156862929|FG000|Follow-Up Period|Pregnancy|7|||
48730048|NCT03213457|156862930|FG001|Follow-Up Period|Pregnancy|0|||
48730049|NCT03213457|156862931|FG002|Follow-Up Period|Pregnancy|18|||
48730050|NCT03213457|156862929|FG000|Follow-Up Period|Exclusionary medications|1|||
48730051|NCT03213457|156862930|FG001|Follow-Up Period|Exclusionary medications|1|||
49142750|NCT00806026|158362333|FG000|Overall Study|Protocol Violation|6|||
48730052|NCT03213457|156862931|FG002|Follow-Up Period|Exclusionary medications|5|||
49142751|NCT00806026|158362334|FG001|Overall Study|Protocol Violation|9|||
49142752|NCT00806026|158362335|FG002|Overall Study|Protocol Violation|9|||
49142753|NCT00806026|158362336|FG003|Overall Study|Protocol Violation|0|||
49142754|NCT00806026|158362337|FG004|Overall Study|Protocol Violation|2|||
49142755|NCT00806026|158362338|FG005|Overall Study|Protocol Violation|3|||
49142756|NCT00806026|158362333|FG000|Overall Study|Adverse Event|52|||
49142757|NCT00806026|158362334|FG001|Overall Study|Adverse Event|35|||
49142758|NCT00806026|158362335|FG002|Overall Study|Adverse Event|44|||
49142759|NCT00806026|158362336|FG003|Overall Study|Adverse Event|17|||
49142760|NCT00806026|158362337|FG004|Overall Study|Adverse Event|9|||
49142761|NCT00806026|158362338|FG005|Overall Study|Adverse Event|9|||
49142762|NCT00819832|158362341|FG000|Overall Study|Sponsor Termination of Study|3|||
49142763|NCT00819832|158362342|FG001|Overall Study|Sponsor Termination of Study|0|||
49142764|NCT00819832|158362343|FG002|Overall Study|Sponsor Termination of Study|0|||
49142765|NCT00819832|158362344|FG003|Overall Study|Sponsor Termination of Study|0|||
49142766|NCT00819832|158362345|FG004|Overall Study|Sponsor Termination of Study|0|||
49142767|NCT00819832|158362346|FG005|Overall Study|Sponsor Termination of Study|0|||
49142768|NCT03767894|158362350|FG000|Overall Study|Withdrawal by Subject|1|||
49142769|NCT01452789|158362351|FG000|Overall Study|Withdrawal by Subject|3|||
49142770|NCT01452789|158362352|FG001|Overall Study|Withdrawal by Subject|2|||
49142771|NCT01436500|158362353|FG000|Overall Study|Death|1|||
49142772|NCT01436500|158362354|FG001|Overall Study|Death|0|||
49142773|NCT01436500|158362355|FG002|Overall Study|Death|0|||
49142774|NCT01436500|158362356|FG003|Overall Study|Death|0|||
49142775|NCT01436500|158362357|FG004|Overall Study|Death|0|||
48730053|NCT03213457|156862929|FG000|Follow-Up Period|COVID-19 logistical restrictions|1|||
48730054|NCT03213457|156862930|FG001|Follow-Up Period|COVID-19 logistical restrictions|0|||
48730055|NCT03213457|156862931|FG002|Follow-Up Period|COVID-19 logistical restrictions|0|||
48730056|NCT03213457|156862929|FG000|Follow-Up Period|Other|14|||
48730057|NCT03213457|156862930|FG001|Follow-Up Period|Other|10|||
48730058|NCT03213457|156862931|FG002|Follow-Up Period|Other|31|||
48730059|NCT00054717|156862937|FG000|Overall Study|Randomized but not treated|2|||
48730060|NCT00054717|156862938|FG001|Overall Study|Randomized but not treated|8|||
48730061|NCT00054717|156862937|FG000|Overall Study|Adverse Event|70|||
48730062|NCT00054717|156862938|FG001|Overall Study|Adverse Event|22|||
48730063|NCT00054717|156862937|FG000|Overall Study|Protocol Violation|18|||
48730064|NCT00054717|156862938|FG001|Overall Study|Protocol Violation|19|||
48730065|NCT00054717|156862937|FG000|Overall Study|Lost to Follow-up|23|||
48730066|NCT00054717|156862938|FG001|Overall Study|Lost to Follow-up|13|||
48730067|NCT00054717|156862937|FG000|Overall Study|Withdrawal by Subject|32|||
48730068|NCT00054717|156862938|FG001|Overall Study|Withdrawal by Subject|20|||
48730069|NCT00054717|156862937|FG000|Overall Study|Other reason not defined above|117|||
48730070|NCT00054717|156862938|FG001|Overall Study|Other reason not defined above|217|||
48730071|NCT05007717|156862941|FG000|Overall Study|Death|3|||
48730072|NCT05007717|156862942|FG001|Overall Study|Death|2|||
48730073|NCT03553836|156862943|FG000|Overall Study|Ongoing in Study|460|||
48730074|NCT03553836|156862944|FG001|Overall Study|Ongoing in Study|459|||
48730075|NCT03553836|156862943|FG000|Overall Study|Withdrawal by Subject|9|||
48730076|NCT03553836|156862944|FG001|Overall Study|Withdrawal by Subject|10|||
48730077|NCT03553836|156862943|FG000|Overall Study|Lost to Follow-up|1|||
48730078|NCT03553836|156862944|FG001|Overall Study|Lost to Follow-up|3|||
48730079|NCT03553836|156862943|FG000|Overall Study|Death|17|||
48730080|NCT03553836|156862944|FG001|Overall Study|Death|17|||
48730081|NCT01041495|156862948|FG000|Overall Study|Withdrawal by Subject|2|||
48730082|NCT01041495|156862949|FG001|Overall Study|Withdrawal by Subject|5|||
48730083|NCT01041495|156862948|FG000|Overall Study|Adverse Event|2|||
48730084|NCT01041495|156862949|FG001|Overall Study|Adverse Event|1|||
48730085|NCT01041495|156862948|FG000|Overall Study|Lost to Follow-up|0|||
48730086|NCT01041495|156862949|FG001|Overall Study|Lost to Follow-up|1|||
48730087|NCT00846742|156862950|FG000|Overall Study|Withdrawal by Subject|1|||
48730088|NCT00427960|156862951|FG000|Overall Study|Adverse Event|2|||
48730089|NCT00427960|156862952|FG001|Overall Study|Adverse Event|0|||
49142776|NCT01436500|158362353|FG000|Overall Study|Adverse Event|0|||
49142777|NCT01436500|158362354|FG001|Overall Study|Adverse Event|2|||
49142778|NCT01436500|158362355|FG002|Overall Study|Adverse Event|2|||
48730090|NCT00427960|156862951|FG000|Overall Study|Withdrawal by Subject|0|||
48730091|NCT00427960|156862952|FG001|Overall Study|Withdrawal by Subject|3|||
48730092|NCT00427960|156862951|FG000|Overall Study|Other|0|||
48730093|NCT00427960|156862952|FG001|Overall Study|Other|1|||
48730094|NCT01325623|156862955|FG000|Overall Study|Withdrawal by Subject|3|||
49142779|NCT01436500|158362356|FG003|Overall Study|Adverse Event|0|||
49142780|NCT01436500|158362357|FG004|Overall Study|Adverse Event|1|||
49142781|NCT01436500|158362353|FG000|Overall Study|Withdrawal by Subject|0|||
49142782|NCT01436500|158362354|FG001|Overall Study|Withdrawal by Subject|0|||
49142783|NCT01436500|158362355|FG002|Overall Study|Withdrawal by Subject|2|||
48730095|NCT01539642|156862956|FG000|Overall Study|Lack of Efficacy|20|||
48730096|NCT01539642|156862957|FG001|Overall Study|Lack of Efficacy|18|||
48730097|NCT01539642|156862956|FG000|Overall Study|Patient ready for early discharge|8|||
48730098|NCT01539642|156862957|FG001|Overall Study|Patient ready for early discharge|7|||
48730099|NCT01539642|156862956|FG000|Overall Study|Adverse Event|6|||
49142784|NCT01436500|158362356|FG003|Overall Study|Withdrawal by Subject|0|||
49142785|NCT01436500|158362357|FG004|Overall Study|Withdrawal by Subject|2|||
49142786|NCT01436500|158362353|FG000|Overall Study|Physician Decision|0|||
49142787|NCT01436500|158362354|FG001|Overall Study|Physician Decision|0|||
49142788|NCT01436500|158362355|FG002|Overall Study|Physician Decision|1|||
49142789|NCT01436500|158362356|FG003|Overall Study|Physician Decision|0|||
49142790|NCT01436500|158362357|FG004|Overall Study|Physician Decision|0|||
49142791|NCT01436500|158362353|FG000|Overall Study|liver transplant|1|||
49142792|NCT01436500|158362354|FG001|Overall Study|liver transplant|0|||
49142793|NCT01436500|158362355|FG002|Overall Study|liver transplant|0|||
49142794|NCT01436500|158362356|FG003|Overall Study|liver transplant|0|||
49142795|NCT01436500|158362357|FG004|Overall Study|liver transplant|0|||
49142796|NCT01436500|158362353|FG000|Overall Study|initiation of dialysis|0|||
49142797|NCT01436500|158362354|FG001|Overall Study|initiation of dialysis|0|||
49142798|NCT01436500|158362355|FG002|Overall Study|initiation of dialysis|0|||
49142799|NCT01436500|158362356|FG003|Overall Study|initiation of dialysis|0|||
49142800|NCT01436500|158362357|FG004|Overall Study|initiation of dialysis|1|||
49142801|NCT01436500|158362353|FG000|Overall Study|discontinued study drug|1|||
49142802|NCT01436500|158362354|FG001|Overall Study|discontinued study drug|0|||
49142803|NCT01436500|158362355|FG002|Overall Study|discontinued study drug|0|||
49142804|NCT01436500|158362356|FG003|Overall Study|discontinued study drug|0|||
49142805|NCT01436500|158362357|FG004|Overall Study|discontinued study drug|0|||
49142806|NCT01436500|158362353|FG000|Overall Study|Other|0|||
49142807|NCT01436500|158362354|FG001|Overall Study|Other|1|||
49142808|NCT01436500|158362355|FG002|Overall Study|Other|0|||
49142809|NCT01436500|158362356|FG003|Overall Study|Other|1|||
49142810|NCT01436500|158362357|FG004|Overall Study|Other|0|||
49142811|NCT01489358|158362358|FG000|Overall Study|Lost to Follow-up|0|||
49142812|NCT01489358|158362359|FG001|Overall Study|Lost to Follow-up|0|||
49142813|NCT01489358|158362360|FG002|Overall Study|Lost to Follow-up|2|||
49142814|NCT01131585|158362361|FG000|Overall Study|Adverse Event|0|||
49142815|NCT01131585|158362362|FG001|Overall Study|Adverse Event|2|||
49142816|NCT01131585|158362361|FG000|Overall Study|Abnormal laboratory value|1|||
49142817|NCT01131585|158362362|FG001|Overall Study|Abnormal laboratory value|0|||
49142818|NCT01131585|158362361|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
49142819|NCT01131585|158362362|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
49142820|NCT01131585|158362361|FG000|Overall Study|Protocol Violation|2|||
49142821|NCT01131585|158362362|FG001|Overall Study|Protocol Violation|1|||
48822471|NCT01474512|157190487|FG004|Post-Treatment Follow-Up|Sponsor Decision|0|||
48822472|NCT01474512|157190488|FG005|Post-Treatment Follow-Up|Sponsor Decision|0|||
49142822|NCT01131585|158362361|FG000|Overall Study|Withdrawal by Subject|3|||
49142823|NCT01131585|158362362|FG001|Overall Study|Withdrawal by Subject|3|||
49142824|NCT01131585|158362361|FG000|Overall Study|Lost to Follow-up|0|||
49142825|NCT01131585|158362362|FG001|Overall Study|Lost to Follow-up|1|||
49142826|NCT01131585|158362361|FG000|Overall Study|Administrative problems|1|||
49142827|NCT01131585|158362362|FG001|Overall Study|Administrative problems|1|||
49142828|NCT01131585|158362361|FG000|Overall Study|Study termination|78|||
49142829|NCT01131585|158362362|FG001|Overall Study|Study termination|32|||
49142830|NCT01370642|158362363|FG000|Overall Study|Adverse Event|2|||
49142831|NCT01370642|158362364|FG001|Overall Study|Adverse Event|1|||
49142832|NCT01370642|158362365|FG002|Overall Study|Adverse Event|1|||
49142833|NCT01370642|158362363|FG000|Overall Study|Detectable HCV RNA|0|||
49142834|NCT01370642|158362364|FG001|Overall Study|Detectable HCV RNA|0|||
49142835|NCT01370642|158362365|FG002|Overall Study|Detectable HCV RNA|22|||
49142836|NCT01370642|158362363|FG000|Overall Study|Lost to Follow-up|0|||
49142837|NCT01370642|158362364|FG001|Overall Study|Lost to Follow-up|0|||
49142838|NCT01370642|158362365|FG002|Overall Study|Lost to Follow-up|1|||
49142839|NCT01370642|158362363|FG000|Overall Study|Physician Decision|4|||
49142840|NCT01370642|158362364|FG001|Overall Study|Physician Decision|1|||
49142841|NCT01370642|158362365|FG002|Overall Study|Physician Decision|2|||
49142842|NCT01370642|158362363|FG000|Overall Study|Withdrawal by Subject|2|||
49142843|NCT01370642|158362364|FG001|Overall Study|Withdrawal by Subject|4|||
49142844|NCT01370642|158362365|FG002|Overall Study|Withdrawal by Subject|3|||
49142845|NCT00728182|158362370|FG000|Overall Study|Adverse Event|1|||
49142846|NCT00728182|158362371|FG001|Overall Study|Adverse Event|0|||
48822473|NCT01474512|157190489|FG006|Post-Treatment Follow-Up|Sponsor Decision|0|||
49142847|NCT00728182|158362370|FG000|Overall Study|Lost to Follow-up|2|||
49142848|NCT00728182|158362371|FG001|Overall Study|Lost to Follow-up|0|||
49142849|NCT00728182|158362370|FG000|Overall Study|Death|0|||
49142850|NCT00728182|158362371|FG001|Overall Study|Death|2|||
49142851|NCT00728182|158362370|FG000|Overall Study|Protocol Noncompliance|0|||
49142852|NCT00728182|158362371|FG001|Overall Study|Protocol Noncompliance|1|||
49142853|NCT00560404|158362374|FG000|Overall Study|Adverse Event|2|||
49142854|NCT00560404|158362375|FG001|Overall Study|Adverse Event|3|||
49142855|NCT00560404|158362374|FG000|Overall Study|Death|3|||
49142856|NCT00560404|158362375|FG001|Overall Study|Death|3|||
49142857|NCT00560404|158362374|FG000|Overall Study|Protocol Violation|12|||
49142858|NCT00560404|158362375|FG001|Overall Study|Protocol Violation|7|||
49142859|NCT00560404|158362374|FG000|Overall Study|Administrative Reasons|1|||
49142860|NCT00560404|158362375|FG001|Overall Study|Administrative Reasons|1|||
49142861|NCT00560404|158362374|FG000|Overall Study|Withdrew Consent|4|||
49142862|NCT00560404|158362375|FG001|Overall Study|Withdrew Consent|0|||
49142863|NCT00560404|158362374|FG000|Overall Study|Failure to return|1|||
49142864|NCT00560404|158362375|FG001|Overall Study|Failure to return|2|||
49142865|NCT00560404|158362374|FG000|Overall Study|Other withdrawal reason|13|||
49142866|NCT00560404|158362375|FG001|Overall Study|Other withdrawal reason|5|||
49142867|NCT00676689|158362376|FG000|Overall Study|Screen Failure|2|||
49142868|NCT00676689|158362376|FG000|Overall Study|Death|2|||
49142869|NCT00676689|158362376|FG000|Overall Study|Lost to Follow-up|4|||
49142870|NCT00676689|158362376|FG000|Overall Study|Physician Decision|1|||
49142871|NCT00676689|158362376|FG000|Overall Study|Withdrawal by Subject|3|||
49142872|NCT00676689|158362376|FG000|Overall Study|Continuing FU|49|||
49142873|NCT01618708|158362377|FG000|Overall Study|Adverse Event|10|||
49142874|NCT01618708|158362378|FG001|Overall Study|Adverse Event|10|||
49142875|NCT01618708|158362377|FG000|Overall Study|Lost to Follow-up|3|||
49142876|NCT01618708|158362378|FG001|Overall Study|Lost to Follow-up|3|||
49142877|NCT01618708|158362377|FG000|Overall Study|Withdrawal by Subject|17|||
49142878|NCT01618708|158362378|FG001|Overall Study|Withdrawal by Subject|22|||
49142879|NCT01618708|158362377|FG000|Overall Study|Lack of Efficacy|8|||
49142880|NCT01618708|158362378|FG001|Overall Study|Lack of Efficacy|8|||
49142881|NCT01618708|158362377|FG000|Overall Study|Technical problems|2|||
49142882|NCT01618708|158362378|FG001|Overall Study|Technical problems|0|||
49142883|NCT01618708|158362377|FG000|Overall Study|Other than specified above|1|||
49142884|NCT01618708|158362378|FG001|Overall Study|Other than specified above|1|||
49142885|NCT01618708|158362377|FG000|Overall Study|Randomized but not treated|3|||
49142886|NCT01618708|158362378|FG001|Overall Study|Randomized but not treated|2|||
49142887|NCT00356421|158362379|FG000|Overall Study|Lack of Efficacy|3|||
49142888|NCT00356421|158362380|FG001|Overall Study|Lack of Efficacy|0|||
49142889|NCT00356421|158362379|FG000|Overall Study|Withdrawal by Subject|9|||
49142890|NCT00356421|158362380|FG001|Overall Study|Withdrawal by Subject|2|||
49142891|NCT00356421|158362379|FG000|Overall Study|Related to study drug|15|||
49142892|NCT00356421|158362380|FG001|Overall Study|Related to study drug|12|||
49142893|NCT00356421|158362379|FG000|Overall Study|Not related to study drug|5|||
49142894|NCT00356421|158362380|FG001|Overall Study|Not related to study drug|3|||
49142895|NCT00663351|158362381|FG000|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|10|||
49142896|NCT00663351|158362382|FG001|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|19|||
48730100|NCT01539642|156862957|FG001|Overall Study|Adverse Event|4|||
48730101|NCT01539642|156862956|FG000|Overall Study|Withdrawal by Subject|2|||
48730102|NCT01539642|156862957|FG001|Overall Study|Withdrawal by Subject|2|||
48730103|NCT00608543|156862958|FG000|Overall Study|Adverse Event|4|||
48730104|NCT04365257|156862959|FG000|Overall Study|Physician Decision|1|||
48730105|NCT04365257|156862960|FG001|Overall Study|Physician Decision|0|||
48730106|NCT04365257|156862959|FG000|Overall Study|Patient Noncompliance|1|||
48730107|NCT04365257|156862960|FG001|Overall Study|Patient Noncompliance|0|||
48730108|NCT04365257|156862959|FG000|Overall Study|Withdrawal by Subject|0|||
48730109|NCT04365257|156862960|FG001|Overall Study|Withdrawal by Subject|1|||
48730110|NCT00174291|156862961|FG000|Overall Study|Lost to Follow-up|1|||
48730111|NCT00174291|156862962|FG001|Overall Study|Lost to Follow-up|1|||
48730112|NCT00174291|156862961|FG000|Overall Study|Protocol Violation|0|||
48822474|NCT01474512|157190490|FG007|Post-Treatment Follow-Up|Sponsor Decision|0|||
48822475|NCT01474512|157190491|FG008|Post-Treatment Follow-Up|Sponsor Decision|0|||
48822476|NCT01474512|157190492|FG009|Post-Treatment Follow-Up|Sponsor Decision|0|||
48822477|NCT01474512|157190493|FG010|Post-Treatment Follow-Up|Sponsor Decision|0|||
48822478|NCT01474512|157190494|FG011|Post-Treatment Follow-Up|Sponsor Decision|0|||
48822479|NCT01474512|157190495|FG012|Post-Treatment Follow-Up|Sponsor Decision|0|||
48822480|NCT01474512|157190496|FG013|Post-Treatment Follow-Up|Sponsor Decision|0|||
48822481|NCT01474512|157190497|FG014|Post-Treatment Follow-Up|Sponsor Decision|1|||
48822482|NCT01474512|157190498|FG015|Post-Treatment Follow-Up|Sponsor Decision|0|||
48822483|NCT01474512|157190499|FG016|Post-Treatment Follow-Up|Sponsor Decision|4|||
48822484|NCT01474512|157190500|FG017|Post-Treatment Follow-Up|Sponsor Decision|0|||
48822485|NCT01474512|157190483|FG000|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
48822486|NCT01474512|157190484|FG001|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
48822487|NCT01474512|157190485|FG002|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
48822488|NCT01474512|157190486|FG003|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
48822489|NCT01474512|157190487|FG004|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
48822490|NCT01474512|157190488|FG005|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
48822491|NCT01474512|157190489|FG006|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
49142897|NCT00663351|158362381|FG000|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|29|||
49142898|NCT00663351|158362382|FG001|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|10|||
48730113|NCT00174291|156862962|FG001|Overall Study|Protocol Violation|2|||
49142899|NCT00663351|158362381|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|8|||
49142900|NCT00663351|158362382|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|15|||
49142901|NCT00663351|158362381|FG000|Post-Approval Study (Year 6 to Year 10)|Death|18|||
49142902|NCT00663351|158362382|FG001|Post-Approval Study (Year 6 to Year 10)|Death|7|||
48730114|NCT00174291|156862961|FG000|Overall Study|Study terminated by sponsor|1|||
48730115|NCT00174291|156862962|FG001|Overall Study|Study terminated by sponsor|0|||
48822492|NCT01474512|157190490|FG007|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
49142903|NCT00663351|158362381|FG000|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|13|||
49142904|NCT00663351|158362382|FG001|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|7|||
49142905|NCT00663351|158362381|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|44|||
49142906|NCT00663351|158362382|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|32|||
49142907|NCT03211832|158362383|FG000|Overall Study|No longer with agency|32|||
49142908|NCT03211832|158362384|FG001|Overall Study|No longer with agency|49|||
49142909|NCT03211832|158362385|FG002|Overall Study|No longer with agency|30|||
49142910|NCT03211832|158362383|FG000|Overall Study|Declined survey|3|||
49142911|NCT03211832|158362384|FG001|Overall Study|Declined survey|3|||
49142912|NCT03211832|158362385|FG002|Overall Study|Declined survey|2|||
49142913|NCT03211832|158362383|FG000|Overall Study|Not available during data collection|1|||
49142914|NCT03211832|158362384|FG001|Overall Study|Not available during data collection|0|||
49142915|NCT03211832|158362385|FG002|Overall Study|Not available during data collection|2|||
49142916|NCT03721965|158362386|FG000|Overall Study|Death|1|||
49142917|NCT03721965|158362386|FG000|Overall Study|Study Terminated by Sponsor|1|||
49142918|NCT02657551|158362390|FG000|Overall Study|Adverse Event|2|||
49142919|NCT02657551|158362390|FG000|Overall Study|Withdrawal by Subject|1|||
49142920|NCT02657551|158362390|FG000|Overall Study|Non-Compliance|1|||
48822493|NCT01474512|157190491|FG008|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
48822494|NCT01474512|157190492|FG009|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
48822495|NCT01474512|157190493|FG010|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
48822496|NCT01474512|157190494|FG011|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
49142921|NCT02657551|158362390|FG000|Overall Study|Progression / Relapse|4|||
49142922|NCT00025233|158362391|FG000|Overall Study|Ineligible: wrong cell type|1|||
49142923|NCT00025233|158362391|FG000|Overall Study|Ineligible: wrong primary|1|||
49142924|NCT00025233|158362391|FG000|Overall Study|Ineligible: improper prior treatment|1|||
49142925|NCT00025233|158362391|FG000|Overall Study|Never treated|1|||
48730116|NCT00174291|156862961|FG000|Overall Study|Withdrawal by Subject|3|||
48730117|NCT00174291|156862962|FG001|Overall Study|Withdrawal by Subject|3|||
48730118|NCT01439568|156862963|FG000|Overall Study|Lost to Follow-up|1|||
48730119|NCT01439568|156862964|FG001|Overall Study|Lost to Follow-up|0|||
48730120|NCT01439568|156862963|FG000|Overall Study|Withdrawal by Subject|2|||
48730121|NCT01439568|156862964|FG001|Overall Study|Withdrawal by Subject|2|||
49142926|NCT01184118|158362392|FG000|Overall Study|Only asthma step 1 - screen fail|1|||
49142927|NCT01184118|158362392|FG000|Overall Study|No physiologic confirmation of asthma|8|||
49142928|NCT01184118|158362392|FG000|Overall Study|FEV1 <60% predicted|2|||
49142929|NCT01184118|158362392|FG000|Overall Study|Exclusionary medical condition|2|||
49142930|NCT01184118|158362392|FG000|Overall Study|Withdrawal by Subject|5|||
49142931|NCT00682435|158362397|FG000|Overall Study|Insufficient data|5|||
49142932|NCT00682435|158362397|FG000|Overall Study|Erroneously enrolled twice|2|||
49142933|NCT02916433|158362398|FG000|Overall Study|Withdrawal by Subject|1|||
49142934|NCT02916433|158362399|FG001|Overall Study|Withdrawal by Subject|0|||
49142935|NCT02916433|158362398|FG000|Overall Study|Physician Decision|1|||
48822497|NCT01474512|157190495|FG012|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
48822498|NCT01474512|157190496|FG013|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
48822499|NCT01474512|157190497|FG014|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
48822500|NCT01474512|157190498|FG015|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
48822501|NCT01474512|157190499|FG016|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
48822502|NCT01474512|157190500|FG017|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
48822503|NCT01474512|157190483|FG000|Post-Treatment Follow-Up|Death|0|||
48822504|NCT01474512|157190484|FG001|Post-Treatment Follow-Up|Death|0|||
48822505|NCT01474512|157190485|FG002|Post-Treatment Follow-Up|Death|0|||
48822506|NCT01474512|157190486|FG003|Post-Treatment Follow-Up|Death|0|||
48730122|NCT00117286|156862965|FG000|Overall Study|Adverse Event|12|||
49142936|NCT02916433|158362399|FG001|Overall Study|Physician Decision|0|||
49142937|NCT00800384|158362400|FG000|Overall Study|Withdrawal by Subject|24|||
49142938|NCT00800384|158362401|FG001|Overall Study|Withdrawal by Subject|17|||
49142939|NCT00800384|158362400|FG000|Overall Study|Lost to Follow-up|17|||
49142940|NCT00800384|158362401|FG001|Overall Study|Lost to Follow-up|26|||
49142941|NCT00853047|158362402|FG000|Core Phase|Participant Request|0|||
49142942|NCT00853047|158362403|FG001|Core Phase|Participant Request|0|||
49142943|NCT00853047|158362404|FG002|Core Phase|Participant Request|0|||
48730123|NCT00117286|156862966|FG001|Overall Study|Adverse Event|6|||
48730124|NCT00117286|156862965|FG000|Overall Study|Lost to Follow-up|2|||
49142944|NCT00853047|158362405|FG003|Core Phase|Participant Request|1|||
49142945|NCT00853047|158362406|FG004|Core Phase|Participant Request|0|||
49142946|NCT00853047|158362407|FG005|Core Phase|Participant Request|0|||
48822507|NCT01474512|157190487|FG004|Post-Treatment Follow-Up|Death|0|||
48822508|NCT01474512|157190488|FG005|Post-Treatment Follow-Up|Death|0|||
49142947|NCT00853047|158362402|FG000|Open-Label Extension Phase|Participant Request|0|||
49142948|NCT00853047|158362403|FG001|Open-Label Extension Phase|Participant Request|0|||
48822509|NCT01474512|157190489|FG006|Post-Treatment Follow-Up|Death|0|||
49142949|NCT00853047|158362404|FG002|Open-Label Extension Phase|Participant Request|0|||
49142950|NCT00853047|158362405|FG003|Open-Label Extension Phase|Participant Request|0|||
49142951|NCT00853047|158362406|FG004|Open-Label Extension Phase|Participant Request|0|||
49142952|NCT00853047|158362407|FG005|Open-Label Extension Phase|Participant Request|7|||
49142953|NCT00853047|158362402|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
49142954|NCT00853047|158362403|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
49142955|NCT00853047|158362404|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
49142956|NCT00853047|158362405|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
49142957|NCT00853047|158362406|FG004|Open-Label Extension Phase|Lost to Follow-up|0|||
49142958|NCT00853047|158362407|FG005|Open-Label Extension Phase|Lost to Follow-up|1|||
49142959|NCT00853047|158362402|FG000|Open-Label Extension Phase|Transfer to LX1606-302|0|||
49142960|NCT00853047|158362403|FG001|Open-Label Extension Phase|Transfer to LX1606-302|0|||
49142961|NCT00853047|158362404|FG002|Open-Label Extension Phase|Transfer to LX1606-302|0|||
49142962|NCT00853047|158362405|FG003|Open-Label Extension Phase|Transfer to LX1606-302|0|||
49142963|NCT00853047|158362406|FG004|Open-Label Extension Phase|Transfer to LX1606-302|0|||
49142964|NCT00853047|158362407|FG005|Open-Label Extension Phase|Transfer to LX1606-302|2|||
49142965|NCT00853047|158362402|FG000|Open-Label Extension Phase|Investigator Decision|0|||
49142966|NCT00853047|158362403|FG001|Open-Label Extension Phase|Investigator Decision|0|||
49142967|NCT00853047|158362404|FG002|Open-Label Extension Phase|Investigator Decision|0|||
49142968|NCT00853047|158362405|FG003|Open-Label Extension Phase|Investigator Decision|0|||
49142969|NCT00853047|158362406|FG004|Open-Label Extension Phase|Investigator Decision|0|||
49142970|NCT00853047|158362407|FG005|Open-Label Extension Phase|Investigator Decision|1|||
49142971|NCT00853047|158362402|FG000|Open-Label Extension Phase|Reason Not Specified|0|||
49142972|NCT00853047|158362403|FG001|Open-Label Extension Phase|Reason Not Specified|0|||
49142973|NCT00853047|158362404|FG002|Open-Label Extension Phase|Reason Not Specified|0|||
49142974|NCT00853047|158362405|FG003|Open-Label Extension Phase|Reason Not Specified|0|||
49142975|NCT00853047|158362406|FG004|Open-Label Extension Phase|Reason Not Specified|0|||
49142976|NCT00853047|158362407|FG005|Open-Label Extension Phase|Reason Not Specified|6|||
49142977|NCT00450749|158362408|FG000|Overall Study|Withdrawal by Subject|0|||
49142978|NCT00450749|158362409|FG001|Overall Study|Withdrawal by Subject|0|||
48822510|NCT01474512|157190490|FG007|Post-Treatment Follow-Up|Death|0|||
48822511|NCT01474512|157190491|FG008|Post-Treatment Follow-Up|Death|0|||
48822512|NCT01474512|157190492|FG009|Post-Treatment Follow-Up|Death|0|||
48822513|NCT01474512|157190493|FG010|Post-Treatment Follow-Up|Death|0|||
48822514|NCT01474512|157190494|FG011|Post-Treatment Follow-Up|Death|0|||
48822515|NCT01474512|157190495|FG012|Post-Treatment Follow-Up|Death|0|||
48822516|NCT01474512|157190496|FG013|Post-Treatment Follow-Up|Death|0|||
48822517|NCT01474512|157190497|FG014|Post-Treatment Follow-Up|Death|0|||
48822518|NCT01474512|157190498|FG015|Post-Treatment Follow-Up|Death|0|||
49142979|NCT00450749|158362410|FG002|Overall Study|Withdrawal by Subject|2|||
49142980|NCT00450749|158362408|FG000|Overall Study|Noncompliant|0|||
49142981|NCT00450749|158362409|FG001|Overall Study|Noncompliant|1|||
49142982|NCT00450749|158362410|FG002|Overall Study|Noncompliant|0|||
49142983|NCT00537082|158362411|FG000|Overall Study|Adverse Event|6|||
48822519|NCT01474512|157190499|FG016|Post-Treatment Follow-Up|Death|1|||
48822520|NCT01474512|157190500|FG017|Post-Treatment Follow-Up|Death|0|||
48822521|NCT01118962|157190501|FG000|Overall Study|Adverse Event|2|||
48822522|NCT01118962|157190501|FG000|Overall Study|Lack of Efficacy|1|||
48822523|NCT01118962|157190501|FG000|Overall Study|Protocol Violation|1|||
48822524|NCT01118962|157190501|FG000|Overall Study|Withdrawal by Subject|4|||
48822525|NCT01118962|157190501|FG000|Overall Study|Pregnancy|1|||
48822526|NCT01118962|157190501|FG000|Overall Study|Non-compliance with Medicinal Product|1|||
48822527|NCT01536262|157190509|FG000|Overall Study|Adverse Event|6|||
48822528|NCT01536262|157190510|FG001|Overall Study|Adverse Event|1|||
48822529|NCT01536262|157190511|FG002|Overall Study|Adverse Event|2|||
49142984|NCT00537082|158362412|FG001|Overall Study|Adverse Event|6|||
49142985|NCT00537082|158362413|FG002|Overall Study|Adverse Event|3|||
49142986|NCT00537082|158362411|FG000|Overall Study|Protocol Violation|0|||
49142987|NCT00537082|158362412|FG001|Overall Study|Protocol Violation|2|||
49142988|NCT00537082|158362413|FG002|Overall Study|Protocol Violation|1|||
49142989|NCT00537082|158362411|FG000|Overall Study|Lack of Efficacy|0|||
49142990|NCT00537082|158362412|FG001|Overall Study|Lack of Efficacy|0|||
49142991|NCT00537082|158362413|FG002|Overall Study|Lack of Efficacy|2|||
49142992|NCT00537082|158362411|FG000|Overall Study|Withdrawal by Subject|0|||
48822530|NCT01536262|157190509|FG000|Overall Study|Withdrawal by Subject|1|||
48822531|NCT01536262|157190510|FG001|Overall Study|Withdrawal by Subject|1|||
48822532|NCT01536262|157190511|FG002|Overall Study|Withdrawal by Subject|0|||
48822533|NCT01536262|157190509|FG000|Overall Study|Other than stated above|1|||
48822534|NCT01536262|157190510|FG001|Overall Study|Other than stated above|0|||
48822535|NCT01536262|157190511|FG002|Overall Study|Other than stated above|0|||
48822536|NCT01440049|157190515|FG000|Overall Study|Adverse Event|5|||
48822537|NCT03738241|157190518|FG000|Overall Study|Withdrawal by Subject|0|||
48822538|NCT03738241|157190519|FG001|Overall Study|Withdrawal by Subject|0|||
48822539|NCT03738241|157190520|FG002|Overall Study|Withdrawal by Subject|0|||
49142993|NCT00537082|158362412|FG001|Overall Study|Withdrawal by Subject|1|||
49142994|NCT00537082|158362413|FG002|Overall Study|Withdrawal by Subject|0|||
49142995|NCT00537082|158362411|FG000|Overall Study|Discontinued before initiating treatment|3|||
49012507|NCT01078623|157883482|FG018|Treatment Period 3|Adverse Event|0|||
49012508|NCT01078623|157883483|FG019|Treatment Period 3|Adverse Event|0|||
49012509|NCT01078623|157883464|FG000|Treatment Period 4|Adverse Event|0|||
49012510|NCT01078623|157883465|FG001|Treatment Period 4|Adverse Event|0|||
49012511|NCT01078623|157883466|FG002|Treatment Period 4|Adverse Event|1|||
49012512|NCT01078623|157883467|FG003|Treatment Period 4|Adverse Event|0|||
49012513|NCT01078623|157883468|FG004|Treatment Period 4|Adverse Event|0|||
49012514|NCT01078623|157883469|FG005|Treatment Period 4|Adverse Event|0|||
49012515|NCT01078623|157883470|FG006|Treatment Period 4|Adverse Event|0|||
49012516|NCT01078623|157883471|FG007|Treatment Period 4|Adverse Event|0|||
49012517|NCT01078623|157883472|FG008|Treatment Period 4|Adverse Event|0|||
49012518|NCT01078623|157883473|FG009|Treatment Period 4|Adverse Event|0|||
49012519|NCT01078623|157883474|FG010|Treatment Period 4|Adverse Event|0|||
49012520|NCT01078623|157883475|FG011|Treatment Period 4|Adverse Event|0|||
49012521|NCT01078623|157883476|FG012|Treatment Period 4|Adverse Event|0|||
49012522|NCT01078623|157883477|FG013|Treatment Period 4|Adverse Event|0|||
49012523|NCT01078623|157883478|FG014|Treatment Period 4|Adverse Event|0|||
49012524|NCT01078623|157883479|FG015|Treatment Period 4|Adverse Event|0|||
49012525|NCT01078623|157883480|FG016|Treatment Period 4|Adverse Event|0|||
49012526|NCT01078623|157883481|FG017|Treatment Period 4|Adverse Event|0|||
49012527|NCT01078623|157883482|FG018|Treatment Period 4|Adverse Event|0|||
49012528|NCT01078623|157883483|FG019|Treatment Period 4|Adverse Event|0|||
49012529|NCT01078623|157883464|FG000|Treatment Period 4|Withdrawal by Subject|0|||
49012530|NCT01078623|157883465|FG001|Treatment Period 4|Withdrawal by Subject|0|||
49012531|NCT01078623|157883466|FG002|Treatment Period 4|Withdrawal by Subject|0|||
49012532|NCT01078623|157883467|FG003|Treatment Period 4|Withdrawal by Subject|0|||
49012533|NCT01078623|157883468|FG004|Treatment Period 4|Withdrawal by Subject|0|||
49012534|NCT01078623|157883469|FG005|Treatment Period 4|Withdrawal by Subject|0|||
49012535|NCT01078623|157883470|FG006|Treatment Period 4|Withdrawal by Subject|0|||
49012536|NCT01078623|157883471|FG007|Treatment Period 4|Withdrawal by Subject|0|||
49012537|NCT01078623|157883472|FG008|Treatment Period 4|Withdrawal by Subject|0|||
49012538|NCT01078623|157883473|FG009|Treatment Period 4|Withdrawal by Subject|0|||
49012539|NCT01078623|157883474|FG010|Treatment Period 4|Withdrawal by Subject|0|||
49012540|NCT01078623|157883475|FG011|Treatment Period 4|Withdrawal by Subject|0|||
49012541|NCT01078623|157883476|FG012|Treatment Period 4|Withdrawal by Subject|0|||
49012542|NCT01078623|157883477|FG013|Treatment Period 4|Withdrawal by Subject|0|||
49012543|NCT01078623|157883478|FG014|Treatment Period 4|Withdrawal by Subject|0|||
49012544|NCT01078623|157883479|FG015|Treatment Period 4|Withdrawal by Subject|1|||
49012545|NCT01078623|157883480|FG016|Treatment Period 4|Withdrawal by Subject|0|||
49012546|NCT01078623|157883481|FG017|Treatment Period 4|Withdrawal by Subject|0|||
49012547|NCT01078623|157883482|FG018|Treatment Period 4|Withdrawal by Subject|0|||
49012548|NCT01078623|157883483|FG019|Treatment Period 4|Withdrawal by Subject|0|||
49012549|NCT00623623|157883484|FG000|Overall Study|Previous enrolment into this study|1|||
49012550|NCT00623623|157883485|FG001|Overall Study|Previous enrolment into this study|1|||
49012551|NCT01725113|157883486|FG000|Overall Study|Kidney Transplant|1|||
49012552|NCT01725113|157883487|FG001|Overall Study|Kidney Transplant|1|||
49012553|NCT01725113|157883486|FG000|Overall Study|Withdrawal by Subject|0|||
49012554|NCT01725113|157883487|FG001|Overall Study|Withdrawal by Subject|1|||
49012555|NCT00463866|157883488|FG000|Overall Study|Adverse Event|70|||
49012556|NCT00463866|157883489|FG001|Overall Study|Adverse Event|93|||
49012557|NCT00463866|157883488|FG000|Overall Study|Withdrawal by Subject|81|||
49012558|NCT00463866|157883489|FG001|Overall Study|Withdrawal by Subject|79|||
49012559|NCT00463866|157883488|FG000|Overall Study|Lost to Follow-up|46|||
49012560|NCT00463866|157883489|FG001|Overall Study|Lost to Follow-up|55|||
49012561|NCT00463866|157883488|FG000|Overall Study|Incorrect Enrolment|64|||
49012562|NCT00463866|157883489|FG001|Overall Study|Incorrect Enrolment|66|||
49012563|NCT00463866|157883488|FG000|Overall Study|Severe Non-Compliance to Protocol|25|||
49012564|NCT00463866|157883489|FG001|Overall Study|Severe Non-Compliance to Protocol|21|||
49012565|NCT00463866|157883488|FG000|Overall Study|Safety Reason|1|||
49012566|NCT00463866|157883489|FG001|Overall Study|Safety Reason|3|||
49012567|NCT00463866|157883488|FG000|Overall Study|Mis-Randomization of subject|0|||
49012568|NCT00463866|157883489|FG001|Overall Study|Mis-Randomization of subject|1|||
49012569|NCT00463866|157883488|FG000|Overall Study|Other|22|||
49012570|NCT00463866|157883489|FG001|Overall Study|Other|22|||
49012571|NCT02265952|157883490|FG000|Open Label Extension (OLE) Period|Physician Decision|0|||
49012572|NCT02265952|157883491|FG001|Open Label Extension (OLE) Period|Physician Decision|7|||
49012573|NCT02265952|157883490|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
49012574|NCT02265952|157883491|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|1|||
49012575|NCT03989115|157883494|FG000|Overall Study|Withdrawal by Subject|2|||
49012576|NCT03989115|157883495|FG001|Overall Study|Withdrawal by Subject|1|||
49012577|NCT03989115|157883496|FG002|Overall Study|Withdrawal by Subject|3|||
49142996|NCT00537082|158362412|FG001|Overall Study|Discontinued before initiating treatment|0|||
49142997|NCT00537082|158362413|FG002|Overall Study|Discontinued before initiating treatment|0|||
49142998|NCT01691092|158362414|FG000|Overall Study|Lost to Follow-up|10|||
49142999|NCT01691092|158362414|FG000|Overall Study|Physician Decision|4|||
49143000|NCT01691092|158362414|FG000|Overall Study|Withdrawal by Subject|3|||
49143001|NCT01691092|158362414|FG000|Overall Study|non-compliance|3|||
49143002|NCT01691092|158362414|FG000|Overall Study|used for different study|2|||
49143003|NCT01691092|158362414|FG000|Overall Study|screen fail|19|||
49143004|NCT00655746|158362415|FG000|Overall Study|Withdrawal by Subject|1|||
49143005|NCT02931539|158362416|FG000|Period 1: Treatment Phase|Investigator discretion|1|||
49143006|NCT02931539|158362417|FG001|Period 1: Treatment Phase|Investigator discretion|1|||
49143007|NCT02931539|158362418|FG002|Period 1: Treatment Phase|Investigator discretion|0|||
49143008|NCT02931539|158362416|FG000|Period 1: Treatment Phase|Adverse Event|5|||
49143009|NCT02931539|158362417|FG001|Period 1: Treatment Phase|Adverse Event|1|||
49143010|NCT02931539|158362418|FG002|Period 1: Treatment Phase|Adverse Event|0|||
49143011|NCT02931539|158362416|FG000|Period 1: Treatment Phase|Lost to Follow-up|1|||
49143012|NCT02931539|158362417|FG001|Period 1: Treatment Phase|Lost to Follow-up|2|||
49143013|NCT02931539|158362418|FG002|Period 1: Treatment Phase|Lost to Follow-up|0|||
49143014|NCT02931539|158362416|FG000|Period 1: Treatment Phase|Death|8|||
49143015|NCT02931539|158362417|FG001|Period 1: Treatment Phase|Death|24|||
49143016|NCT02931539|158362418|FG002|Period 1: Treatment Phase|Death|0|||
49143017|NCT02931539|158362416|FG000|Period 1: Treatment Phase|Withdrawal by Subject|16|||
49143018|NCT02931539|158362417|FG001|Period 1: Treatment Phase|Withdrawal by Subject|8|||
49143019|NCT02931539|158362418|FG002|Period 1: Treatment Phase|Withdrawal by Subject|0|||
49143020|NCT02931539|158362416|FG000|Period 1: Treatment Phase|Protocol Violation|6|||
48730125|NCT00117286|156862966|FG001|Overall Study|Lost to Follow-up|0|||
48730126|NCT00117286|156862965|FG000|Overall Study|Protocol Violation|3|||
48730127|NCT00117286|156862966|FG001|Overall Study|Protocol Violation|3|||
48730128|NCT00117286|156862965|FG000|Overall Study|Withdrawal by Subject|6|||
48730129|NCT00117286|156862966|FG001|Overall Study|Withdrawal by Subject|2|||
48730130|NCT00117286|156862965|FG000|Overall Study|Physician Decision|3|||
48730131|NCT00117286|156862966|FG001|Overall Study|Physician Decision|7|||
48730132|NCT00117286|156862965|FG000|Overall Study|Lack of Efficacy|2|||
48730133|NCT00117286|156862966|FG001|Overall Study|Lack of Efficacy|1|||
48730134|NCT00117286|156862965|FG000|Overall Study|Research site closing|0|||
48730135|NCT00117286|156862966|FG001|Overall Study|Research site closing|2|||
48730136|NCT02057393|156862969|FG000|Overall Study|Withdrawal by Subject|1|||
48730137|NCT02057393|156862969|FG000|Overall Study|Patient did not meet criteria|1|||
48730138|NCT05896748|156862972|FG000|Screening Phase (Week -4 up to Day 1)|Passed away due to unknown reasons|1|||
48730139|NCT05896748|156862972|FG000|SC Injection Phase (Day 1 up to Week 12)|Adverse Event|2|||
48730140|NCT05896748|156862972|FG000|SC Injection Phase (Day 1 up to Week 12)|Protocol Violation|1|||
48730141|NCT05896748|156862972|FG000|SC Injection Phase (Day 1 up to Week 12)|Withdrawal by Subject|3|||
48822540|NCT03738241|157190521|FG003|Overall Study|Withdrawal by Subject|0|||
48730142|NCT05896748|156862972|FG000|Return to IM Glu Inj Phase(Week12-Week20|Protocol Violation|1|||
48730143|NCT04508140|156862973|FG000|Overall Study|Adverse Event|2|||
48730144|NCT04508140|156862974|FG001|Overall Study|Adverse Event|2|||
48730145|NCT04508140|156862973|FG000|Overall Study|Withdrawal by Subject|0|||
48730146|NCT04508140|156862974|FG001|Overall Study|Withdrawal by Subject|2|||
48730147|NCT04508140|156862973|FG000|Overall Study|progressive disease|9|||
48730148|NCT04508140|156862974|FG001|Overall Study|progressive disease|3|||
48730149|NCT05298306|156862975|FG000|Overall Study|Physician Decision|0|||
48730150|NCT05298306|156862976|FG001|Overall Study|Physician Decision|0|||
48730151|NCT05298306|156862977|FG002|Overall Study|Physician Decision|0|||
48730152|NCT05298306|156862978|FG003|Overall Study|Physician Decision|1|||
48730153|NCT05298306|156862979|FG004|Overall Study|Physician Decision|0|||
48730154|NCT05298306|156862980|FG005|Overall Study|Physician Decision|0|||
48730155|NCT00467610|156862981|FG000|Overall Study|Withdrawal by Subject|1|||
48730156|NCT01917929|156862984|FG000|Overall Study|Death|5|||
48730157|NCT01917929|156862984|FG000|Overall Study|Lost to Follow-up|19|||
48730158|NCT01917929|156862984|FG000|Overall Study|Withdrawal by Subject|31|||
48730159|NCT01917929|156862984|FG000|Overall Study|Adverse Event|6|||
48730160|NCT01917929|156862984|FG000|Overall Study|Investigative Site Terminated|11|||
48730161|NCT01917929|156862984|FG000|Overall Study|Censored because study device not implanted|6|||
48730162|NCT01917929|156862984|FG000|Overall Study|Censored because surgery not performed|3|||
48730163|NCT01917929|156862984|FG000|Overall Study|Censored because of inclusion exclusion violation|3|||
48730164|NCT01917929|156862984|FG000|Overall Study|No 5 year data|70|||
48730165|NCT01917929|156862984|FG000|Overall Study|Sponsor terminated study|26|||
48730166|NCT03971071|156862987|FG000|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
48730167|NCT03971071|156862988|FG001|Double-blind Treatment Period (DBTP)|Sponsor decision|1|||
48822541|NCT03738241|157190522|FG004|Overall Study|Withdrawal by Subject|0|||
48730168|NCT03971071|156862989|FG002|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
48730169|NCT03971071|156862990|FG003|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
49143021|NCT02931539|158362417|FG001|Period 1: Treatment Phase|Protocol Violation|0|||
49143022|NCT02931539|158362418|FG002|Period 1: Treatment Phase|Protocol Violation|0|||
48730170|NCT03971071|156862991|FG004|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
48822542|NCT03738241|157190523|FG005|Overall Study|Withdrawal by Subject|0|||
48822543|NCT03738241|157190524|FG006|Overall Study|Withdrawal by Subject|0|||
48822544|NCT03738241|157190525|FG007|Overall Study|Withdrawal by Subject|0|||
48822545|NCT03738241|157190526|FG008|Overall Study|Withdrawal by Subject|0|||
48822546|NCT03738241|157190527|FG009|Overall Study|Withdrawal by Subject|1|||
48822547|NCT03738241|157190518|FG000|Overall Study|Physician Decision|0|||
48822548|NCT03738241|157190519|FG001|Overall Study|Physician Decision|0|||
48822549|NCT03738241|157190520|FG002|Overall Study|Physician Decision|0|||
48822550|NCT03738241|157190521|FG003|Overall Study|Physician Decision|0|||
48822551|NCT03738241|157190522|FG004|Overall Study|Physician Decision|0|||
48822552|NCT03738241|157190523|FG005|Overall Study|Physician Decision|0|||
48822553|NCT03738241|157190524|FG006|Overall Study|Physician Decision|0|||
48822554|NCT03738241|157190525|FG007|Overall Study|Physician Decision|0|||
48822555|NCT03738241|157190526|FG008|Overall Study|Physician Decision|1|||
48822556|NCT03738241|157190527|FG009|Overall Study|Physician Decision|0|||
48822557|NCT03738241|157190518|FG000|Overall Study|Adverse Event|1|||
48822558|NCT03738241|157190519|FG001|Overall Study|Adverse Event|0|||
48822559|NCT03738241|157190520|FG002|Overall Study|Adverse Event|0|||
48822560|NCT03738241|157190521|FG003|Overall Study|Adverse Event|0|||
48822561|NCT03738241|157190522|FG004|Overall Study|Adverse Event|0|||
48822562|NCT03738241|157190523|FG005|Overall Study|Adverse Event|0|||
48822563|NCT03738241|157190524|FG006|Overall Study|Adverse Event|0|||
48822564|NCT03738241|157190525|FG007|Overall Study|Adverse Event|0|||
48822565|NCT03738241|157190526|FG008|Overall Study|Adverse Event|0|||
48822566|NCT03738241|157190527|FG009|Overall Study|Adverse Event|0|||
48822567|NCT01106976|157190528|FG000|Overall Study|Lost to Follow-up|8|||
48822568|NCT02559817|157190529|FG000|Treatment Period|Adverse Event|1|||
48822569|NCT02559817|157190530|FG001|Treatment Period|Adverse Event|0|||
48822570|NCT02559817|157190531|FG002|Treatment Period|Adverse Event|1|||
48822571|NCT02559817|157190532|FG003|Treatment Period|Adverse Event|0|||
48822572|NCT02559817|157190533|FG004|Treatment Period|Adverse Event|0|||
48822573|NCT02559817|157190529|FG000|Treatment Period|Lack of Efficacy|0|||
48822574|NCT02559817|157190530|FG001|Treatment Period|Lack of Efficacy|1|||
48822575|NCT02559817|157190531|FG002|Treatment Period|Lack of Efficacy|0|||
48822576|NCT02559817|157190532|FG003|Treatment Period|Lack of Efficacy|0|||
48822577|NCT02559817|157190533|FG004|Treatment Period|Lack of Efficacy|0|||
48822578|NCT02559817|157190529|FG000|Treatment Period|Lost to Follow-up|0|||
48822579|NCT02559817|157190530|FG001|Treatment Period|Lost to Follow-up|1|||
48822580|NCT02559817|157190531|FG002|Treatment Period|Lost to Follow-up|0|||
48822581|NCT02559817|157190532|FG003|Treatment Period|Lost to Follow-up|1|||
48822582|NCT02559817|157190533|FG004|Treatment Period|Lost to Follow-up|0|||
48822583|NCT02559817|157190529|FG000|Treatment Period|Non-Compliance With Study Drug|0|||
48822584|NCT02559817|157190530|FG001|Treatment Period|Non-Compliance With Study Drug|0|||
48822585|NCT02559817|157190531|FG002|Treatment Period|Non-Compliance With Study Drug|1|||
48822586|NCT02559817|157190532|FG003|Treatment Period|Non-Compliance With Study Drug|0|||
48822587|NCT02559817|157190533|FG004|Treatment Period|Non-Compliance With Study Drug|0|||
48822588|NCT02559817|157190529|FG000|Treatment Period|Protocol Violation|0|||
48822589|NCT02559817|157190530|FG001|Treatment Period|Protocol Violation|0|||
48822590|NCT02559817|157190531|FG002|Treatment Period|Protocol Violation|0|||
48822591|NCT02559817|157190532|FG003|Treatment Period|Protocol Violation|1|||
48822592|NCT02559817|157190533|FG004|Treatment Period|Protocol Violation|0|||
49143023|NCT02931539|158362416|FG000|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22|||
49143024|NCT02931539|158362417|FG001|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
48822593|NCT04172987|157190534|FG000|Lead In Period|Adverse Event|1|||
48822594|NCT04172987|157190534|FG000|Lead In Period|Protocol Violation|1|||
48822595|NCT04172987|157190534|FG000|Period 1|Physician Decision|1|||
48822596|NCT04172987|157190534|FG000|Period 2|Adverse Event|5|||
48822597|NCT04172987|157190534|FG000|Period 2|Dosing Termination by Sponsor|4|||
48822598|NCT02687919|157190535|FG000|Overall Study|Withdrawal by Subject|6|||
48822599|NCT02687919|157190536|FG001|Overall Study|Withdrawal by Subject|6|||
48822600|NCT02687919|157190535|FG000|Overall Study|Protocol Violation|2|||
48822601|NCT02687919|157190536|FG001|Overall Study|Protocol Violation|0|||
48822602|NCT00419003|157190537|FG000|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
48822603|NCT00419003|157190538|FG001|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
48822604|NCT00419003|157190537|FG000|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1|||
48822605|NCT00419003|157190538|FG001|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0|||
48822606|NCT01813422|157190539|FG000|Overall Study|Withdrawal by Subject|14|||
48822607|NCT01813422|157190540|FG001|Overall Study|Withdrawal by Subject|8|||
48822608|NCT01813422|157190539|FG000|Overall Study|Death|2|||
48822609|NCT01813422|157190540|FG001|Overall Study|Death|3|||
48822610|NCT01813422|157190539|FG000|Overall Study|Sponsor Decision|2|||
48822611|NCT01813422|157190540|FG001|Overall Study|Sponsor Decision|1|||
48822612|NCT01813422|157190539|FG000|Overall Study|Lost to Follow-up|2|||
48822613|NCT01813422|157190540|FG001|Overall Study|Lost to Follow-up|4|||
48822614|NCT01167023|157190544|FG000|Overall Study|Lost to Follow-up|0|||
48822615|NCT01167023|157190545|FG001|Overall Study|Lost to Follow-up|1|||
48822616|NCT01167023|157190546|FG002|Overall Study|Lost to Follow-up|1|||
49143025|NCT02931539|158362418|FG002|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
49143026|NCT02931539|158362416|FG000|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
49143027|NCT02931539|158362417|FG001|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
49143028|NCT02931539|158362418|FG002|Period 2: Maribavir Rescue Therapy|Sponsor decision|2|||
49143029|NCT00003456|158364344|FG000|Overall Study|Not evaluable|8|||
49143030|NCT00284934|158364345|FG000|Overall Study|Adverse Event|1|||
49143031|NCT00284934|158364346|FG001|Overall Study|Adverse Event|2|||
49143032|NCT00284934|158364345|FG000|Overall Study|Other reasons|3|||
49143033|NCT00284934|158364346|FG001|Overall Study|Other reasons|1|||
49143034|NCT01108796|158364347|FG000|Overall Study|Adverse Event|0|||
49143035|NCT01108796|158364348|FG001|Overall Study|Adverse Event|1|||
49143036|NCT01108796|158364347|FG000|Overall Study|Lost to Follow-up|7|||
49143037|NCT01108796|158364348|FG001|Overall Study|Lost to Follow-up|6|||
49143038|NCT01208051|158364349|FG000|Total Enrollment|Withdrawal by Subject|0|||
49143039|NCT01208051|158364350|FG001|Total Enrollment|Withdrawal by Subject|1|||
49143040|NCT01208051|158364351|FG002|Total Enrollment|Withdrawal by Subject|0|||
49143041|NCT01208051|158364352|FG003|Total Enrollment|Withdrawal by Subject|0|||
49143042|NCT01208051|158364353|FG004|Total Enrollment|Withdrawal by Subject|2|||
49143043|NCT01208051|158364349|FG000|Total Enrollment|Brain metastases|0|||
49143044|NCT01208051|158364350|FG001|Total Enrollment|Brain metastases|0|||
49012578|NCT03989115|157883497|FG003|Overall Study|Withdrawal by Subject|0|||
49012579|NCT03989115|157883498|FG004|Overall Study|Withdrawal by Subject|17|||
49143045|NCT01208051|158364351|FG002|Total Enrollment|Brain metastases|1|||
49143046|NCT01208051|158364352|FG003|Total Enrollment|Brain metastases|0|||
49143047|NCT01208051|158364353|FG004|Total Enrollment|Brain metastases|0|||
49143048|NCT00326495|158364354|FG000|Overall Study|Switched to alternative treatment|1|||
49143049|NCT00326495|158364354|FG000|Overall Study|Disease progression before treatment|1|||
49143050|NCT00326495|158364354|FG000|Overall Study|Refused further treatment|2|||
49143051|NCT00326495|158364354|FG000|Overall Study|Subject off study before assessment|1|||
49143052|NCT00864513|158364358|FG000|Overall Study|Withdrawal by Subject|3|||
49143053|NCT03548415|158364359|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
49143054|NCT03548415|158364360|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
49143055|NCT03548415|158364361|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
49143056|NCT03548415|158364362|FG003|Overall Study|Adverse Event or Serious Adverse Event|0|||
49143057|NCT03548415|158364363|FG004|Overall Study|Adverse Event or Serious Adverse Event|1|||
49143058|NCT00621322|158364364|FG000|Overall Study|Lost to Follow-up|0|||
49143059|NCT00621322|158364365|FG001|Overall Study|Lost to Follow-up|0|||
49143060|NCT00621322|158364366|FG002|Overall Study|Lost to Follow-up|0|||
49143061|NCT00621322|158364367|FG003|Overall Study|Lost to Follow-up|0|||
49143062|NCT00621322|158364368|FG004|Overall Study|Lost to Follow-up|1|||
49143063|NCT00621322|158364369|FG005|Overall Study|Lost to Follow-up|0|||
49143064|NCT00621322|158364364|FG000|Overall Study|Physician Decision|0|||
49143065|NCT00621322|158364365|FG001|Overall Study|Physician Decision|0|||
49143066|NCT00621322|158364366|FG002|Overall Study|Physician Decision|1|||
49143067|NCT00621322|158364367|FG003|Overall Study|Physician Decision|1|||
49143068|NCT00621322|158364368|FG004|Overall Study|Physician Decision|0|||
49143069|NCT00621322|158364369|FG005|Overall Study|Physician Decision|0|||
49143070|NCT00621322|158364364|FG000|Overall Study|Withdrawal by Subject|0|||
49143071|NCT00621322|158364365|FG001|Overall Study|Withdrawal by Subject|0|||
49143072|NCT00621322|158364366|FG002|Overall Study|Withdrawal by Subject|0|||
49143073|NCT00621322|158364367|FG003|Overall Study|Withdrawal by Subject|1|||
49143074|NCT00621322|158364368|FG004|Overall Study|Withdrawal by Subject|0|||
49143075|NCT00621322|158364369|FG005|Overall Study|Withdrawal by Subject|2|||
49143076|NCT00621322|158364364|FG000|Overall Study|Migrated/moved from study area|1|||
49143077|NCT00621322|158364365|FG001|Overall Study|Migrated/moved from study area|0|||
49143078|NCT00621322|158364366|FG002|Overall Study|Migrated/moved from study area|1|||
49143079|NCT00621322|158364367|FG003|Overall Study|Migrated/moved from study area|1|||
49143080|NCT00621322|158364368|FG004|Overall Study|Migrated/moved from study area|0|||
49143081|NCT00621322|158364369|FG005|Overall Study|Migrated/moved from study area|2|||
49143082|NCT00756444|158364370|FG000|Overall Study|Adverse Event|1|||
49143083|NCT00756444|158364371|FG001|Overall Study|Adverse Event|1|||
49143084|NCT00756444|158364370|FG000|Overall Study|Withdrawal by Subject|6|||
49143085|NCT00756444|158364371|FG001|Overall Study|Withdrawal by Subject|8|||
49143086|NCT00756444|158364370|FG000|Overall Study|Lost to Follow-up|0|||
49143087|NCT00756444|158364371|FG001|Overall Study|Lost to Follow-up|1|||
49143088|NCT00756444|158364370|FG000|Overall Study|Death|5|||
49143089|NCT00756444|158364371|FG001|Overall Study|Death|4|||
49143090|NCT00756444|158364370|FG000|Overall Study|Disease Progression|2|||
49143091|NCT00756444|158364371|FG001|Overall Study|Disease Progression|7|||
49143092|NCT00756444|158364370|FG000|Overall Study|Ineligibility Determined|1|||
49143093|NCT00756444|158364371|FG001|Overall Study|Ineligibility Determined|0|||
49143094|NCT04882215|158364375|FG000|Overall Study|Withdrawal by Subject|5|||
49143095|NCT04882215|158364376|FG001|Overall Study|Withdrawal by Subject|0|||
48822617|NCT01167023|157190544|FG000|Overall Study|Screen Failure|0|||
48822618|NCT01167023|157190545|FG001|Overall Study|Screen Failure|1|||
49012580|NCT03989115|157883499|FG005|Overall Study|Withdrawal by Subject|1|||
48730171|NCT03971071|156862987|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|7|||
48822619|NCT01167023|157190546|FG002|Overall Study|Screen Failure|0|||
49143096|NCT01399099|158364377|FG000|Overall Study|Lost to Follow-up|14|||
49143097|NCT01399099|158364377|FG000|Overall Study|Physician Decision|1|||
49143098|NCT01399099|158364377|FG000|Overall Study|Protocol Violation|1|||
49143099|NCT01399099|158364377|FG000|Overall Study|Skin Irritation|13|||
49143100|NCT01399099|158364377|FG000|Overall Study|Infection|1|||
49143101|NCT01399099|158364377|FG000|Overall Study|Miscellaneous|4|||
49143102|NCT01362270|158364378|FG000|Overall Study|Withdrawal by Subject|1|||
49143103|NCT01362270|158364379|FG001|Overall Study|Withdrawal by Subject|0|||
49143104|NCT01362270|158364378|FG000|Overall Study|Met exclusion criteria after 1st session|0|||
49143105|NCT01362270|158364379|FG001|Overall Study|Met exclusion criteria after 1st session|1|||
49143106|NCT01362270|158364378|FG000|Overall Study|Met excl. criteria before 1st session|1|||
49143107|NCT01362270|158364379|FG001|Overall Study|Met excl. criteria before 1st session|1|||
48730172|NCT03971071|156862988|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|11|||
48730173|NCT03971071|156862989|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
48730174|NCT03971071|156862990|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
48822620|NCT01167023|157190544|FG000|Overall Study|Sponsor Decision|0|||
48822621|NCT01167023|157190545|FG001|Overall Study|Sponsor Decision|1|||
48822622|NCT01167023|157190546|FG002|Overall Study|Sponsor Decision|0|||
48822623|NCT01167023|157190544|FG000|Overall Study|Withdrawal by Subject|0|||
48822624|NCT01167023|157190545|FG001|Overall Study|Withdrawal by Subject|0|||
48822625|NCT01167023|157190546|FG002|Overall Study|Withdrawal by Subject|1|||
48822626|NCT01700530|157190547|FG000|Overall Study|Withdrawal by Subject|0|||
48822627|NCT01700530|157190548|FG001|Overall Study|Withdrawal by Subject|3|||
48822628|NCT01700530|157190549|FG002|Overall Study|Withdrawal by Subject|1|||
48822629|NCT03251378|157190554|FG000|Overall Study|Death|3|||
48822630|NCT03251378|157190555|FG001|Overall Study|Death|2|||
48822631|NCT03251378|157190556|FG002|Overall Study|Death|3|||
48822632|NCT03251378|157190557|FG003|Overall Study|Death|30|||
48822633|NCT03251378|157190558|FG004|Overall Study|Death|24|||
48822634|NCT03251378|157190559|FG005|Overall Study|Death|12|||
48822635|NCT03251378|157190560|FG006|Overall Study|Death|12|||
48822636|NCT03251378|157190554|FG000|Overall Study|Lost to Follow-up|0|||
48822637|NCT03251378|157190555|FG001|Overall Study|Lost to Follow-up|0|||
48822638|NCT03251378|157190556|FG002|Overall Study|Lost to Follow-up|1|||
48822639|NCT03251378|157190557|FG003|Overall Study|Lost to Follow-up|3|||
48822640|NCT03251378|157190558|FG004|Overall Study|Lost to Follow-up|0|||
48822641|NCT03251378|157190559|FG005|Overall Study|Lost to Follow-up|0|||
48822642|NCT03251378|157190560|FG006|Overall Study|Lost to Follow-up|0|||
48822643|NCT03251378|157190554|FG000|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
48822644|NCT03251378|157190555|FG001|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
48822645|NCT03251378|157190556|FG002|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
48822646|NCT03251378|157190557|FG003|Overall Study|Patient withdrew consent and refused to provide follow-up information|3|||
48822647|NCT03251378|157190558|FG004|Overall Study|Patient withdrew consent and refused to provide follow-up information|2|||
49143108|NCT04341662|158364380|FG000|Overall Study|Did not have source-verified blood loss data|423|||
49143109|NCT04341662|158364381|FG001|Overall Study|Did not have source-verified blood loss data|514|||
49143110|NCT02571244|158364385|FG000|Overall Study|Lost to Follow-up|0|||
49143111|NCT02571244|158364386|FG001|Overall Study|Lost to Follow-up|1|||
49143112|NCT02571244|158364385|FG000|Overall Study|Unable to reach out post discharge|3|||
49143113|NCT02571244|158364386|FG001|Overall Study|Unable to reach out post discharge|0|||
49143114|NCT01543503|158364387|FG000|Overall Study|Lost to Follow-up|32|||
49143115|NCT01543503|158364388|FG001|Overall Study|Lost to Follow-up|36|||
49143116|NCT01543503|158364387|FG000|Overall Study|Adverse Event|9|||
49143117|NCT01543503|158364388|FG001|Overall Study|Adverse Event|13|||
49143118|NCT01543503|158364387|FG000|Overall Study|Lack of Efficacy|4|||
49143119|NCT01543503|158364388|FG001|Overall Study|Lack of Efficacy|16|||
49143120|NCT01543503|158364387|FG000|Overall Study|Participant withdrew informed consent|8|||
49012581|NCT03989115|157883500|FG006|Overall Study|Withdrawal by Subject|0|||
49012582|NCT03989115|157883501|FG007|Overall Study|Withdrawal by Subject|0|||
49012583|NCT03989115|157883494|FG000|Overall Study|Sponsor decision to terminate the study|1|||
49143121|NCT01543503|158364388|FG001|Overall Study|Participant withdrew informed consent|10|||
49143122|NCT01543503|158364387|FG000|Overall Study|Change of jobs|0|||
48730175|NCT03971071|156862991|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
49012584|NCT03989115|157883495|FG001|Overall Study|Sponsor decision to terminate the study|1|||
49012585|NCT03989115|157883496|FG002|Overall Study|Sponsor decision to terminate the study|0|||
49143123|NCT01543503|158364388|FG001|Overall Study|Change of jobs|1|||
48730176|NCT03971071|156862987|FG000|Double-blind Treatment Period (DBTP)|Other|2|||
48822648|NCT03251378|157190559|FG005|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
48822649|NCT03251378|157190560|FG006|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
49143124|NCT01543503|158364387|FG000|Overall Study|Intolerance to the biologic treatment|0|||
48822650|NCT03251378|157190554|FG000|Overall Study|Progressive disease|2|||
48822651|NCT03251378|157190555|FG001|Overall Study|Progressive disease|0|||
48822652|NCT03251378|157190556|FG002|Overall Study|Progressive disease|0|||
48822653|NCT03251378|157190557|FG003|Overall Study|Progressive disease|1|||
48822654|NCT03251378|157190558|FG004|Overall Study|Progressive disease|0|||
48822655|NCT03251378|157190559|FG005|Overall Study|Progressive disease|0|||
48822656|NCT03251378|157190560|FG006|Overall Study|Progressive disease|0|||
48822657|NCT03251378|157190554|FG000|Overall Study|Physician Decision|0|||
48822658|NCT03251378|157190555|FG001|Overall Study|Physician Decision|2|||
48822659|NCT03251378|157190556|FG002|Overall Study|Physician Decision|0|||
48822660|NCT03251378|157190557|FG003|Overall Study|Physician Decision|0|||
48822661|NCT03251378|157190558|FG004|Overall Study|Physician Decision|0|||
48822662|NCT03251378|157190559|FG005|Overall Study|Physician Decision|0|||
48822663|NCT03251378|157190560|FG006|Overall Study|Physician Decision|0|||
48822664|NCT03251378|157190554|FG000|Overall Study|Other|2|||
48822665|NCT03251378|157190555|FG001|Overall Study|Other|3|||
48822666|NCT03251378|157190556|FG002|Overall Study|Other|2|||
48822667|NCT03251378|157190557|FG003|Overall Study|Other|0|||
48822668|NCT03251378|157190558|FG004|Overall Study|Other|1|||
48822669|NCT03251378|157190559|FG005|Overall Study|Other|1|||
48822670|NCT03251378|157190560|FG006|Overall Study|Other|1|||
48822671|NCT03251378|157190554|FG000|Overall Study|Other|0|||
48822672|NCT03251378|157190555|FG001|Overall Study|Other|0|||
48822673|NCT03251378|157190556|FG002|Overall Study|Other|0|||
48822674|NCT03251378|157190557|FG003|Overall Study|Other|4|||
48822675|NCT03251378|157190558|FG004|Overall Study|Other|13|||
48822676|NCT03251378|157190559|FG005|Overall Study|Other|0|||
48822677|NCT03251378|157190560|FG006|Overall Study|Other|0|||
49143125|NCT01543503|158364388|FG001|Overall Study|Intolerance to the biologic treatment|1|||
49143126|NCT01543503|158364387|FG000|Overall Study|Probable overlap of RA with fibromyalgia|1|||
48730177|NCT03971071|156862988|FG001|Double-blind Treatment Period (DBTP)|Other|2|||
48822678|NCT04060680|157190563|FG000|Overall Study|Unsuccessful implant|17|||
48822679|NCT04060680|157190564|FG001|Overall Study|Unsuccessful implant|2|||
48822680|NCT04060680|157190563|FG000|Overall Study|Adverse Event|3|||
48822681|NCT04060680|157190564|FG001|Overall Study|Adverse Event|0|||
48822682|NCT04060680|157190563|FG000|Overall Study|Death|2|||
48822683|NCT04060680|157190564|FG001|Overall Study|Death|0|||
49012586|NCT03989115|157883497|FG003|Overall Study|Sponsor decision to terminate the study|1|||
48730178|NCT03971071|156862989|FG002|Double-blind Treatment Period (DBTP)|Other|0|||
48730179|NCT03971071|156862990|FG003|Double-blind Treatment Period (DBTP)|Other|0|||
48730180|NCT03971071|156862991|FG004|Double-blind Treatment Period (DBTP)|Other|0|||
48730181|NCT03971071|156862987|FG000|Open-label Treatment Period|Sponsor decision|0|||
48730182|NCT03971071|156862988|FG001|Open-label Treatment Period|Sponsor decision|0|||
48730183|NCT03971071|156862989|FG002|Open-label Treatment Period|Sponsor decision|0|||
48730184|NCT03971071|156862990|FG003|Open-label Treatment Period|Sponsor decision|0|||
48730185|NCT03971071|156862991|FG004|Open-label Treatment Period|Sponsor decision|1|||
48730186|NCT03971071|156862987|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
48730187|NCT03971071|156862988|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
48730188|NCT03971071|156862989|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
48730189|NCT03971071|156862990|FG003|Open-label Treatment Period|Withdrawal by Subject|10|||
48730190|NCT03971071|156862991|FG004|Open-label Treatment Period|Withdrawal by Subject|13|||
48730191|NCT03971071|156862987|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
48730192|NCT03971071|156862988|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
48730193|NCT03971071|156862989|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
48730194|NCT03971071|156862990|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
48730195|NCT03971071|156862991|FG004|Open-label Treatment Period|Lost to Follow-up|1|||
48730196|NCT00602667|156862995|FG000|Overall Study|Still on Therapy|0|||
48730197|NCT00602667|156862996|FG001|Overall Study|Still on Therapy|2|||
48730198|NCT00602667|156862997|FG002|Overall Study|Still on Therapy|2|||
48730199|NCT00602667|156862995|FG000|Overall Study|Death|0|||
48730200|NCT00602667|156862996|FG001|Overall Study|Death|1|||
48822684|NCT04060680|157190563|FG000|Overall Study|Study product no longer in use|1|||
48822685|NCT04060680|157190564|FG001|Overall Study|Study product no longer in use|0|||
48822686|NCT04060680|157190563|FG000|Overall Study|Withdrawal by Subject|1|||
48822687|NCT04060680|157190564|FG001|Overall Study|Withdrawal by Subject|0|||
48822688|NCT01661881|157190565|FG000|Overall Study|Disease Progression|1|||
48822689|NCT02886936|157190566|FG000|Overall Study|Lost to Follow-up|4|||
48822690|NCT02886936|157190567|FG001|Overall Study|Lost to Follow-up|3|||
48822691|NCT02886936|157190568|FG002|Overall Study|Lost to Follow-up|0|||
48822692|NCT02081391|157190573|FG000|12-hour Treatment|Withdrawal by Subject|3|||
48822693|NCT02081391|157190574|FG001|12-hour Treatment|Withdrawal by Subject|2|||
48822694|NCT02081391|157190575|FG002|12-hour Treatment|Withdrawal by Subject|0|||
48822695|NCT02081391|157190576|FG003|12-hour Treatment|Withdrawal by Subject|0|||
48822696|NCT02081391|157190573|FG000|12-hour Treatment|Physician Decision|4|||
48822697|NCT02081391|157190574|FG001|12-hour Treatment|Physician Decision|1|||
48822698|NCT02081391|157190575|FG002|12-hour Treatment|Physician Decision|0|||
48822699|NCT02081391|157190576|FG003|12-hour Treatment|Physician Decision|0|||
48822700|NCT02081391|157190573|FG000|12-hour Treatment|Lack of Efficacy|3|||
49143127|NCT01543503|158364388|FG001|Overall Study|Probable overlap of RA with fibromyalgia|0|||
49143128|NCT01543503|158364387|FG000|Overall Study|Participant did not complete last visit|0|||
49143129|NCT01543503|158364388|FG001|Overall Study|Participant did not complete last visit|2|||
49143130|NCT01543503|158364387|FG000|Overall Study|Refused to continue treatment|7|||
49143131|NCT01543503|158364388|FG001|Overall Study|Refused to continue treatment|0|||
49143132|NCT01543503|158364387|FG000|Overall Study|Incorrect medication received|1|||
49143133|NCT01543503|158364388|FG001|Overall Study|Incorrect medication received|0|||
49143134|NCT01543503|158364387|FG000|Overall Study|Participant moved to another city|2|||
49143135|NCT01543503|158364388|FG001|Overall Study|Participant moved to another city|0|||
49143136|NCT01543503|158364387|FG000|Overall Study|Participant will not return for visits|0|||
49143137|NCT01543503|158364388|FG001|Overall Study|Participant will not return for visits|2|||
49143138|NCT01543503|158364387|FG000|Overall Study|Participant transferred to another city|1|||
49143139|NCT01543503|158364388|FG001|Overall Study|Participant transferred to another city|0|||
49143140|NCT01543503|158364387|FG000|Overall Study|Participant moved to Scotland|1|||
49143141|NCT01543503|158364388|FG001|Overall Study|Participant moved to Scotland|0|||
49143142|NCT01543503|158364387|FG000|Overall Study|Participant decision to stop treatment|1|||
49143143|NCT01543503|158364388|FG001|Overall Study|Participant decision to stop treatment|0|||
49143144|NCT01543503|158364387|FG000|Overall Study|Investigator did not wish to participate|1|||
49143145|NCT01543503|158364388|FG001|Overall Study|Investigator did not wish to participate|1|||
49143146|NCT01543503|158364387|FG000|Overall Study|Participant recruited after closing date|0|||
49143147|NCT01543503|158364388|FG001|Overall Study|Participant recruited after closing date|1|||
49143148|NCT01543503|158364387|FG000|Overall Study|Site stopped participation|5|||
49143149|NCT01543503|158364388|FG001|Overall Study|Site stopped participation|1|||
49143150|NCT01543503|158364387|FG000|Overall Study|Participant did not attend a visit|1|||
49143151|NCT01543503|158364388|FG001|Overall Study|Participant did not attend a visit|0|||
49012587|NCT03989115|157883498|FG004|Overall Study|Sponsor decision to terminate the study|11|||
48822701|NCT02081391|157190574|FG001|12-hour Treatment|Lack of Efficacy|0|||
49143152|NCT01543503|158364387|FG000|Overall Study|Moved to other rheumatologic site|0|||
49012588|NCT03989115|157883499|FG005|Overall Study|Sponsor decision to terminate the study|0|||
49143153|NCT01543503|158364388|FG001|Overall Study|Moved to other rheumatologic site|1|||
49143154|NCT01543503|158364387|FG000|Overall Study|Participant consented to another study|0|||
49143155|NCT01543503|158364388|FG001|Overall Study|Participant consented to another study|2|||
49143156|NCT01543503|158364387|FG000|Overall Study|Participant went to United States|1|||
49143157|NCT01543503|158364388|FG001|Overall Study|Participant went to United States|0|||
49143158|NCT01543503|158364387|FG000|Overall Study|Screen failure|1|||
49143159|NCT01543503|158364388|FG001|Overall Study|Screen failure|0|||
49143160|NCT00052715|158364397|FG000|Overall Study|wrong histology|1|||
49143161|NCT01936974|158364398|FG000|Overall Study|Physician Decision|2|||
49143162|NCT01936974|158364399|FG001|Overall Study|Physician Decision|5|||
49143163|NCT01646216|158364402|FG000|Overall Study|Baseline step length difference (<5cm)|10|||
48730201|NCT00602667|156862997|FG002|Overall Study|Death|1|||
48730202|NCT00602667|156862995|FG000|Overall Study|Family request|3|||
48730203|NCT00602667|156862996|FG001|Overall Study|Family request|25|||
48730204|NCT00602667|156862997|FG002|Overall Study|Family request|6|||
48730205|NCT00602667|156862995|FG000|Overall Study|Excessive toxicity|1|||
48730206|NCT00602667|156862996|FG001|Overall Study|Excessive toxicity|1|||
48730207|NCT00602667|156862997|FG002|Overall Study|Excessive toxicity|0|||
48730208|NCT00602667|156862995|FG000|Overall Study|Second malignancy|0|||
48730209|NCT00602667|156862996|FG001|Overall Study|Second malignancy|1|||
48730210|NCT00602667|156862997|FG002|Overall Study|Second malignancy|0|||
48822702|NCT02081391|157190575|FG002|12-hour Treatment|Lack of Efficacy|0|||
48822703|NCT02081391|157190576|FG003|12-hour Treatment|Lack of Efficacy|0|||
48822704|NCT02081391|157190573|FG000|12-hour Treatment|Adverse Event|4|||
48822705|NCT02081391|157190574|FG001|12-hour Treatment|Adverse Event|2|||
48822706|NCT02081391|157190575|FG002|12-hour Treatment|Adverse Event|0|||
48822707|NCT02081391|157190576|FG003|12-hour Treatment|Adverse Event|0|||
49143164|NCT01646216|158364403|FG001|Overall Study|Baseline step length difference (<5cm)|10|||
49143165|NCT01646216|158364402|FG000|Overall Study|Did not complete training|0|||
49143166|NCT01646216|158364403|FG001|Overall Study|Did not complete training|2|||
49012589|NCT03989115|157883500|FG006|Overall Study|Sponsor decision to terminate the study|2|||
49012590|NCT03989115|157883501|FG007|Overall Study|Sponsor decision to terminate the study|1|||
49012591|NCT03989115|157883494|FG000|Overall Study|Lost to Follow-up|2|||
49012592|NCT03989115|157883495|FG001|Overall Study|Lost to Follow-up|0|||
49012593|NCT03989115|157883496|FG002|Overall Study|Lost to Follow-up|0|||
49012594|NCT03989115|157883497|FG003|Overall Study|Lost to Follow-up|0|||
48822708|NCT02081391|157190573|FG000|12-hour Treatment|Recovery (opioid no longer needed)|2|||
48822709|NCT02081391|157190574|FG001|12-hour Treatment|Recovery (opioid no longer needed)|0|||
49143167|NCT01646216|158364402|FG000|Overall Study|Investigator decision|1|||
49012595|NCT03989115|157883498|FG004|Overall Study|Lost to Follow-up|1|||
48730211|NCT00602667|156862995|FG000|Overall Study|Physician Decision|2|||
48730212|NCT00602667|156862996|FG001|Overall Study|Physician Decision|3|||
48822710|NCT02081391|157190575|FG002|12-hour Treatment|Recovery (opioid no longer needed)|1|||
49143168|NCT01646216|158364403|FG001|Overall Study|Investigator decision|1|||
49012596|NCT03989115|157883499|FG005|Overall Study|Lost to Follow-up|0|||
49012597|NCT03989115|157883500|FG006|Overall Study|Lost to Follow-up|0|||
49012598|NCT03989115|157883501|FG007|Overall Study|Lost to Follow-up|0|||
49012599|NCT03989115|157883494|FG000|Overall Study|Death|2|||
48730213|NCT00602667|156862997|FG002|Overall Study|Physician Decision|8|||
48730214|NCT00602667|156862995|FG000|Overall Study|Progressive disease|13|||
48730215|NCT00602667|156862996|FG001|Overall Study|Progressive disease|48|||
48730216|NCT00602667|156862997|FG002|Overall Study|Progressive disease|45|||
48730217|NCT00602667|156862995|FG000|Overall Study|Progressive disease prior to therapy|0|||
48730218|NCT00602667|156862996|FG001|Overall Study|Progressive disease prior to therapy|0|||
48730219|NCT00602667|156862997|FG002|Overall Study|Progressive disease prior to therapy|1|||
48730220|NCT00445978|156862998|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1|||
48730221|NCT00445978|156862998|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1|||
48730222|NCT00445978|156862998|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1|||
48730223|NCT00445978|156862998|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1|||
48730224|NCT00445978|156862998|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1|||
48730225|NCT00445978|156862998|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1|||
48730226|NCT00445978|156862998|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1|||
48730227|NCT00445978|156862998|FG000|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1|||
48730228|NCT00445978|156862998|FG000|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1|||
48730229|NCT01822496|156862999|FG000|Overall Study|Protocol Violation|2|||
48730230|NCT01822496|156863000|FG001|Overall Study|Protocol Violation|2|||
48730231|NCT01822496|156863001|FG002|Overall Study|Protocol Violation|0|||
48730232|NCT01822496|156863002|FG003|Overall Study|Protocol Violation|1|||
48730233|NCT01822496|156862999|FG000|Overall Study|Withdrawal by Subject|0|||
48730234|NCT01822496|156863000|FG001|Overall Study|Withdrawal by Subject|0|||
48730235|NCT01822496|156863001|FG002|Overall Study|Withdrawal by Subject|0|||
48730236|NCT01822496|156863002|FG003|Overall Study|Withdrawal by Subject|3|||
48730237|NCT01011738|156863003|FG000|Overall Study|Death|12|||
48730238|NCT01011738|156863004|FG001|Overall Study|Death|3|||
48730239|NCT01011738|156863005|FG002|Overall Study|Death|0|||
48730240|NCT01011738|156863003|FG000|Overall Study|Unknown reasons|312|||
48730241|NCT01011738|156863004|FG001|Overall Study|Unknown reasons|291|||
48730242|NCT01011738|156863005|FG002|Overall Study|Unknown reasons|17|||
48730243|NCT01163266|156863008|FG000|Overall Study|Pretreatment Event or Adverse Event|2|||
48730244|NCT01163266|156863009|FG001|Overall Study|Pretreatment Event or Adverse Event|9|||
48730245|NCT01163266|156863010|FG002|Overall Study|Pretreatment Event or Adverse Event|7|||
48730246|NCT01163266|156863008|FG000|Overall Study|Lack of Efficacy|1|||
48730247|NCT01163266|156863009|FG001|Overall Study|Lack of Efficacy|3|||
48730248|NCT01163266|156863010|FG002|Overall Study|Lack of Efficacy|1|||
48730249|NCT01163266|156863008|FG000|Overall Study|Noncompliance with Study Drug|0|||
48730250|NCT01163266|156863009|FG001|Overall Study|Noncompliance with Study Drug|2|||
48730251|NCT01163266|156863010|FG002|Overall Study|Noncompliance with Study Drug|0|||
48730252|NCT01163266|156863008|FG000|Overall Study|Protocol Deviations|2|||
48730253|NCT01163266|156863009|FG001|Overall Study|Protocol Deviations|2|||
48730254|NCT01163266|156863010|FG002|Overall Study|Protocol Deviations|5|||
48730255|NCT01163266|156863008|FG000|Overall Study|Withdrawal of Consent|5|||
48730256|NCT01163266|156863009|FG001|Overall Study|Withdrawal of Consent|7|||
48730257|NCT01163266|156863010|FG002|Overall Study|Withdrawal of Consent|3|||
48730258|NCT01163266|156863008|FG000|Overall Study|Lost to Follow-up|7|||
48730259|NCT01163266|156863009|FG001|Overall Study|Lost to Follow-up|7|||
48730260|NCT01163266|156863010|FG002|Overall Study|Lost to Follow-up|10|||
48730261|NCT01163266|156863008|FG000|Overall Study|Other|1|||
48730262|NCT01163266|156863009|FG001|Overall Study|Other|1|||
48730263|NCT01163266|156863010|FG002|Overall Study|Other|2|||
48730264|NCT02719327|156863015|FG000|Overall Study|Withdrawal by Subject|11|||
48730265|NCT02719327|156863016|FG001|Overall Study|Withdrawal by Subject|8|||
48730266|NCT05008055|156863021|FG000|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|3|||
48730267|NCT05008055|156863022|FG001|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
48730268|NCT05008055|156863023|FG002|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
48730269|NCT06238362|156863024|FG000|Overall Study|Insufficient total sleep time|1|||
48730270|NCT06238362|156863025|FG001|Overall Study|Insufficient total sleep time|0|||
48730271|NCT06238362|156863024|FG000|Overall Study|Inadequate signal quality|1|||
48730272|NCT06238362|156863025|FG001|Overall Study|Inadequate signal quality|0|||
48730273|NCT05419908|156863026|FG000|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|1|||
48730274|NCT05419908|156863027|FG001|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|0|||
48730275|NCT05419908|156863026|FG000|Overall Study|Serious Adverse Event|0|||
48730276|NCT05419908|156863027|FG001|Overall Study|Serious Adverse Event|2|||
48730277|NCT05419908|156863026|FG000|Overall Study|Withdrawal by Subject|2|||
48730278|NCT05419908|156863027|FG001|Overall Study|Withdrawal by Subject|0|||
48730279|NCT05419908|156863026|FG000|Overall Study|Miscellaneous|1|||
48730280|NCT05419908|156863027|FG001|Overall Study|Miscellaneous|1|||
48730281|NCT04493333|156864258|FG000|Overall Study|Withdrawal by Subject|1|||
49012600|NCT03989115|157883495|FG001|Overall Study|Death|2|||
49012601|NCT03989115|157883496|FG002|Overall Study|Death|9|||
49143169|NCT03722030|158364404|FG000|Overall Study|Withdrawal by Subject|1|||
49143170|NCT03722030|158364405|FG001|Overall Study|Withdrawal by Subject|0|||
49143171|NCT00736476|158364413|FG000|Overall Study|Adverse Event|1|||
49143172|NCT00736476|158364414|FG001|Overall Study|Adverse Event|0|||
49143173|NCT02547987|158364417|FG000|Overall Study|Withdrawal by Subject|1|||
49143174|NCT02547987|158364417|FG000|Overall Study|Adverse Event|2|||
49143175|NCT00147537|158364427|FG000|Phase 1b|Death|0|||
49143176|NCT00147537|158364428|FG001|Phase 1b|Death|1|||
49143177|NCT00147537|158364429|FG002|Phase 1b|Death|2|||
49143178|NCT00147537|158364430|FG003|Phase 1b|Death|1|||
49143179|NCT00147537|158364431|FG004|Phase 1b|Death|2|||
49143180|NCT00147537|158364432|FG005|Phase 1b|Death|2|||
49143181|NCT00147537|158364433|FG006|Phase 1b|Death|1|||
49143182|NCT00147537|158364434|FG007|Phase 1b|Death|3|||
49143183|NCT00147537|158364435|FG008|Phase 1b|Death|9|||
49143184|NCT00147537|158364436|FG009|Phase 1b|Death|0|||
49143185|NCT00147537|158364437|FG010|Phase 1b|Death|0|||
49143186|NCT00147537|158364427|FG000|Phase 1b|Lost to Follow-up|2|||
49143187|NCT00147537|158364428|FG001|Phase 1b|Lost to Follow-up|1|||
49143188|NCT00147537|158364429|FG002|Phase 1b|Lost to Follow-up|0|||
49143189|NCT00147537|158364430|FG003|Phase 1b|Lost to Follow-up|0|||
49143190|NCT00147537|158364431|FG004|Phase 1b|Lost to Follow-up|0|||
49143191|NCT00147537|158364432|FG005|Phase 1b|Lost to Follow-up|0|||
49143192|NCT00147537|158364433|FG006|Phase 1b|Lost to Follow-up|2|||
49143193|NCT00147537|158364434|FG007|Phase 1b|Lost to Follow-up|0|||
49143194|NCT00147537|158364435|FG008|Phase 1b|Lost to Follow-up|1|||
49143195|NCT00147537|158364436|FG009|Phase 1b|Lost to Follow-up|0|||
49143196|NCT00147537|158364437|FG010|Phase 1b|Lost to Follow-up|0|||
49143197|NCT00147537|158364427|FG000|Phase 1b|Other|0|||
49143198|NCT00147537|158364428|FG001|Phase 1b|Other|0|||
49143199|NCT00147537|158364429|FG002|Phase 1b|Other|2|||
49143200|NCT00147537|158364430|FG003|Phase 1b|Other|1|||
49143201|NCT00147537|158364431|FG004|Phase 1b|Other|1|||
49143202|NCT00147537|158364432|FG005|Phase 1b|Other|1|||
49143203|NCT00147537|158364433|FG006|Phase 1b|Other|14|||
49143204|NCT00147537|158364434|FG007|Phase 1b|Other|4|||
49143205|NCT00147537|158364435|FG008|Phase 1b|Other|4|||
49143206|NCT00147537|158364436|FG009|Phase 1b|Other|0|||
49143207|NCT00147537|158364437|FG010|Phase 1b|Other|0|||
49143208|NCT00147537|158364427|FG000|Phase 1b|Withdrawal by Subject|0|||
49143209|NCT00147537|158364428|FG001|Phase 1b|Withdrawal by Subject|0|||
49143210|NCT00147537|158364429|FG002|Phase 1b|Withdrawal by Subject|0|||
49143211|NCT00147537|158364430|FG003|Phase 1b|Withdrawal by Subject|0|||
49143212|NCT00147537|158364431|FG004|Phase 1b|Withdrawal by Subject|0|||
49143213|NCT00147537|158364432|FG005|Phase 1b|Withdrawal by Subject|0|||
49143214|NCT00147537|158364433|FG006|Phase 1b|Withdrawal by Subject|0|||
49143215|NCT00147537|158364434|FG007|Phase 1b|Withdrawal by Subject|0|||
49143216|NCT00147537|158364435|FG008|Phase 1b|Withdrawal by Subject|2|||
49012602|NCT03989115|157883497|FG003|Overall Study|Death|6|||
49012603|NCT03989115|157883498|FG004|Overall Study|Death|31|||
49012604|NCT03989115|157883499|FG005|Overall Study|Death|6|||
49012605|NCT03989115|157883500|FG006|Overall Study|Death|2|||
49012606|NCT03989115|157883501|FG007|Overall Study|Death|3|||
49012607|NCT03989115|157883494|FG000|Overall Study|Other|1|||
49012608|NCT03989115|157883495|FG001|Overall Study|Other|2|||
49012609|NCT03989115|157883496|FG002|Overall Study|Other|0|||
49012610|NCT03989115|157883497|FG003|Overall Study|Other|0|||
49012611|NCT03989115|157883498|FG004|Overall Study|Other|5|||
49012612|NCT03989115|157883499|FG005|Overall Study|Other|0|||
49012613|NCT03989115|157883500|FG006|Overall Study|Other|0|||
49012614|NCT03989115|157883501|FG007|Overall Study|Other|0|||
49012615|NCT00326885|157883502|FG000|Overall Study|Adverse Event|1|||
49012616|NCT00326885|157883502|FG000|Overall Study|Withdrawal by Subject|3|||
49012617|NCT00326885|157883502|FG000|Overall Study|Physician Decision|1|||
49012618|NCT00326885|157883502|FG000|Overall Study|Hospice withdrew consent|2|||
49012619|NCT02424565|157883504|FG000|Period 1 (D0)|Protocol Violation|0|||
49012620|NCT02424565|157883505|FG001|Period 1 (D0)|Protocol Violation|1|||
49012621|NCT01473758|157883506|FG000|Cycle 1|Adverse Event|10|||
49012622|NCT01473758|157883507|FG001|Cycle 1|Adverse Event|2|||
49012623|NCT01473758|157883508|FG002|Cycle 1|Adverse Event|0|||
49143217|NCT00147537|158364436|FG009|Phase 1b|Withdrawal by Subject|0|||
49143218|NCT00147537|158364437|FG010|Phase 1b|Withdrawal by Subject|0|||
49012624|NCT01473758|157883509|FG003|Cycle 1|Adverse Event|0|||
49012625|NCT01473758|157883506|FG000|Cycle 1|Withdrawal by Subject|1|||
49012626|NCT01473758|157883507|FG001|Cycle 1|Withdrawal by Subject|1|||
49012627|NCT01473758|157883508|FG002|Cycle 1|Withdrawal by Subject|0|||
49012628|NCT01473758|157883509|FG003|Cycle 1|Withdrawal by Subject|0|||
49143219|NCT00147537|158364427|FG000|Phase 1b|Randomized but not treated|0|||
49143220|NCT00147537|158364428|FG001|Phase 1b|Randomized but not treated|0|||
49143221|NCT00147537|158364429|FG002|Phase 1b|Randomized but not treated|0|||
49143222|NCT00147537|158364430|FG003|Phase 1b|Randomized but not treated|0|||
49143223|NCT00147537|158364431|FG004|Phase 1b|Randomized but not treated|0|||
49143224|NCT00147537|158364432|FG005|Phase 1b|Randomized but not treated|0|||
49143225|NCT00147537|158364433|FG006|Phase 1b|Randomized but not treated|1|||
49143226|NCT00147537|158364434|FG007|Phase 1b|Randomized but not treated|0|||
49143227|NCT00147537|158364435|FG008|Phase 1b|Randomized but not treated|1|||
49143228|NCT00147537|158364436|FG009|Phase 1b|Randomized but not treated|0|||
49143229|NCT00147537|158364437|FG010|Phase 1b|Randomized but not treated|0|||
49143230|NCT00147537|158364427|FG000|Phase 2|Death|0|||
49143231|NCT00147537|158364428|FG001|Phase 2|Death|0|||
49143232|NCT00147537|158364429|FG002|Phase 2|Death|0|||
49143233|NCT00147537|158364430|FG003|Phase 2|Death|0|||
49143234|NCT00147537|158364431|FG004|Phase 2|Death|0|||
49143235|NCT00147537|158364432|FG005|Phase 2|Death|0|||
49143236|NCT00147537|158364433|FG006|Phase 2|Death|0|||
49143237|NCT00147537|158364434|FG007|Phase 2|Death|0|||
49143238|NCT00147537|158364435|FG008|Phase 2|Death|0|||
49143239|NCT00147537|158364436|FG009|Phase 2|Death|85|||
49143240|NCT00147537|158364437|FG010|Phase 2|Death|31|||
49143241|NCT00147537|158364427|FG000|Phase 2|Lost to Follow-up|0|||
49143242|NCT00147537|158364428|FG001|Phase 2|Lost to Follow-up|0|||
49143243|NCT00147537|158364429|FG002|Phase 2|Lost to Follow-up|0|||
49143244|NCT00147537|158364430|FG003|Phase 2|Lost to Follow-up|0|||
49143245|NCT00147537|158364431|FG004|Phase 2|Lost to Follow-up|0|||
49143246|NCT00147537|158364432|FG005|Phase 2|Lost to Follow-up|0|||
49143247|NCT00147537|158364433|FG006|Phase 2|Lost to Follow-up|0|||
49143248|NCT00147537|158364434|FG007|Phase 2|Lost to Follow-up|0|||
49143249|NCT00147537|158364435|FG008|Phase 2|Lost to Follow-up|0|||
49143250|NCT00147537|158364436|FG009|Phase 2|Lost to Follow-up|12|||
49143251|NCT00147537|158364437|FG010|Phase 2|Lost to Follow-up|4|||
49143252|NCT00147537|158364427|FG000|Phase 2|Other|0|||
49143253|NCT00147537|158364428|FG001|Phase 2|Other|0|||
49143254|NCT00147537|158364429|FG002|Phase 2|Other|0|||
49143255|NCT00147537|158364430|FG003|Phase 2|Other|0|||
49143256|NCT00147537|158364431|FG004|Phase 2|Other|0|||
49143257|NCT00147537|158364432|FG005|Phase 2|Other|0|||
49143258|NCT00147537|158364433|FG006|Phase 2|Other|0|||
49143259|NCT00147537|158364434|FG007|Phase 2|Other|0|||
49143260|NCT00147537|158364435|FG008|Phase 2|Other|0|||
49143261|NCT00147537|158364436|FG009|Phase 2|Other|47|||
49143262|NCT00147537|158364437|FG010|Phase 2|Other|12|||
49143263|NCT00147537|158364427|FG000|Phase 2|Withdrawal by Subject|0|||
49143264|NCT00147537|158364428|FG001|Phase 2|Withdrawal by Subject|0|||
49143265|NCT00147537|158364429|FG002|Phase 2|Withdrawal by Subject|0|||
49143266|NCT00147537|158364430|FG003|Phase 2|Withdrawal by Subject|0|||
49143267|NCT00147537|158364431|FG004|Phase 2|Withdrawal by Subject|0|||
49143268|NCT00147537|158364432|FG005|Phase 2|Withdrawal by Subject|0|||
49143269|NCT00147537|158364433|FG006|Phase 2|Withdrawal by Subject|0|||
49143270|NCT00147537|158364434|FG007|Phase 2|Withdrawal by Subject|0|||
49143271|NCT00147537|158364435|FG008|Phase 2|Withdrawal by Subject|0|||
49143272|NCT00147537|158364436|FG009|Phase 2|Withdrawal by Subject|16|||
49143273|NCT00147537|158364437|FG010|Phase 2|Withdrawal by Subject|4|||
49143274|NCT00147537|158364427|FG000|Phase 2|Randomized but not treated|0|||
49143275|NCT00147537|158364428|FG001|Phase 2|Randomized but not treated|0|||
49143276|NCT00147537|158364429|FG002|Phase 2|Randomized but not treated|0|||
49143277|NCT00147537|158364430|FG003|Phase 2|Randomized but not treated|0|||
49143278|NCT00147537|158364431|FG004|Phase 2|Randomized but not treated|0|||
49143279|NCT00147537|158364432|FG005|Phase 2|Randomized but not treated|0|||
49143280|NCT00147537|158364433|FG006|Phase 2|Randomized but not treated|0|||
49143281|NCT00147537|158364434|FG007|Phase 2|Randomized but not treated|0|||
49143282|NCT00147537|158364435|FG008|Phase 2|Randomized but not treated|0|||
49143283|NCT00147537|158364436|FG009|Phase 2|Randomized but not treated|1|||
49143284|NCT00147537|158364437|FG010|Phase 2|Randomized but not treated|1|||
49143285|NCT01089543|158364438|FG000|Overall Study|Withdrawal by Subject|2|||
49143286|NCT01089543|158364439|FG001|Overall Study|Withdrawal by Subject|3|||
49143287|NCT01089543|158364440|FG002|Overall Study|Withdrawal by Subject|3|||
49143288|NCT01089543|158364441|FG003|Overall Study|Withdrawal by Subject|1|||
49143289|NCT01089543|158364438|FG000|Overall Study|Physician Decision|1|||
49143290|NCT01089543|158364439|FG001|Overall Study|Physician Decision|0|||
49143291|NCT01089543|158364440|FG002|Overall Study|Physician Decision|0|||
49143292|NCT01089543|158364441|FG003|Overall Study|Physician Decision|1|||
49143293|NCT01089543|158364438|FG000|Overall Study|Adverse Event|0|||
49143294|NCT01089543|158364439|FG001|Overall Study|Adverse Event|1|||
49143295|NCT01089543|158364440|FG002|Overall Study|Adverse Event|0|||
49143296|NCT01089543|158364441|FG003|Overall Study|Adverse Event|0|||
49143297|NCT04146909|158364442|FG000|Overall Study|Withdrawal by Subject|3|||
49143298|NCT04146909|158364442|FG000|Overall Study|Did not qualify after consented|1|||
49143299|NCT00472641|158364446|FG000|Overall Study|Lack of Efficacy|3|||
49143300|NCT00472641|158364446|FG000|Overall Study|Adverse Event|3|||
49143301|NCT00472641|158364446|FG000|Overall Study|Lost to Follow-up|1|||
49143302|NCT00478140|158364447|FG000|Overall Study|Clinical Disease Progression|1|||
49143303|NCT04193527|158364448|FG000|Overall Study|Other|1|||
49143304|NCT04193527|158364449|FG001|Overall Study|Other|1|||
49143305|NCT04193527|158364450|FG002|Overall Study|Other|0|||
49143306|NCT03808909|158364452|FG000|Overall Study|Lost to Follow-up|3|||
49143307|NCT03808909|158364453|FG001|Overall Study|Lost to Follow-up|0|||
49143308|NCT01898091|158364454|FG000|Overall Study|Lost to Follow-up|1|||
49143309|NCT01898091|158364455|FG001|Overall Study|Lost to Follow-up|1|||
49143310|NCT01898091|158364454|FG000|Overall Study|Withdrawal by Subject|1|||
49143311|NCT01898091|158364455|FG001|Overall Study|Withdrawal by Subject|5|||
49143312|NCT00309244|158364458|FG000|Overall Study|Adverse Event|29|||
49143313|NCT00309244|158364459|FG001|Overall Study|Adverse Event|12|||
49143314|NCT00309244|158364458|FG000|Overall Study|Lost to Follow-up|6|||
49143315|NCT00309244|158364459|FG001|Overall Study|Lost to Follow-up|22|||
49143316|NCT00309244|158364458|FG000|Overall Study|Physician Decision|5|||
49143317|NCT00309244|158364459|FG001|Overall Study|Physician Decision|8|||
49143318|NCT00309244|158364458|FG000|Overall Study|Protocol Violation|6|||
49143319|NCT00309244|158364459|FG001|Overall Study|Protocol Violation|3|||
49143320|NCT00309244|158364458|FG000|Overall Study|Withdrawal by Subject|50|||
49143321|NCT00309244|158364459|FG001|Overall Study|Withdrawal by Subject|32|||
49143322|NCT00309244|158364458|FG000|Overall Study|Various|7|||
49143323|NCT00309244|158364459|FG001|Overall Study|Various|7|||
49143324|NCT00309244|158364458|FG000|Overall Study|Randomized but not dosed|11|||
49143325|NCT00309244|158364459|FG001|Overall Study|Randomized but not dosed|12|||
49143326|NCT00309244|158364458|FG000|Overall Study|Death|4|||
49143327|NCT00309244|158364459|FG001|Overall Study|Death|1|||
49143328|NCT01263028|158364460|FG000|Overall Study|Withdrawal by Subject|1|||
49143329|NCT01263028|158364460|FG000|Overall Study|Adverse Event|1|||
49143330|NCT01263028|158364460|FG000|Overall Study|Study terminated due to low enrollment.|4|||
49012629|NCT01473758|157883506|FG000|Cycle 2|Adverse Event|0|||
49012630|NCT01473758|157883507|FG001|Cycle 2|Adverse Event|0|||
49012631|NCT01473758|157883508|FG002|Cycle 2|Adverse Event|5|||
49012632|NCT01473758|157883509|FG003|Cycle 2|Adverse Event|0|||
49012633|NCT01489956|157883511|FG000|Overall Study|Lost to Follow-up|1|||
49012634|NCT01489956|157883512|FG001|Overall Study|Lost to Follow-up|0|||
49012635|NCT01489956|157883513|FG002|Overall Study|Lost to Follow-up|0|||
49012636|NCT01489956|157883511|FG000|Overall Study|Withdrawal by Subject|0|||
49012637|NCT01489956|157883512|FG001|Overall Study|Withdrawal by Subject|0|||
49012638|NCT01489956|157883513|FG002|Overall Study|Withdrawal by Subject|1|||
49012639|NCT01223196|157883514|FG000|Overall Study|Lost to Follow-up|2|||
49012640|NCT01223196|157883515|FG001|Overall Study|Lost to Follow-up|0|||
49012641|NCT01223196|157883514|FG000|Overall Study|Physician Decision|1|||
49012642|NCT01223196|157883515|FG001|Overall Study|Physician Decision|0|||
49012643|NCT01223196|157883514|FG000|Overall Study|Withdrawal by Subject|1|||
49012644|NCT01223196|157883515|FG001|Overall Study|Withdrawal by Subject|0|||
49012645|NCT01238822|157883516|FG000|Overall Study|COULD NOT SWALLOW PILLS|3|||
49012646|NCT03565211|157883520|FG000|Overall Study|Withdrawal by Subject|2|||
49012647|NCT03565211|157883520|FG000|Overall Study|Lost to Follow-up|1|||
49012648|NCT03565211|157883520|FG000|Overall Study|Adverse Event|44|||
49143331|NCT03888482|158364461|FG000|Second Wear (8 -1/+2 Days)|Adverse Event|0|||
49143332|NCT03888482|158364462|FG001|Second Wear (8 -1/+2 Days)|Adverse Event|1|||
49143333|NCT03888482|158364461|FG000|Second Wear (8 -1/+2 Days)|Other|1|||
49012649|NCT03565211|157883520|FG000|Overall Study|Personal issues|1|||
49012650|NCT00441584|157883521|FG000|Overall Study|Lack of Efficacy|79|||
49012651|NCT00441584|157883521|FG000|Overall Study|Withdrawal by Subject|8|||
49012652|NCT00441584|157883521|FG000|Overall Study|Adverse Event|6|||
49012653|NCT00441584|157883521|FG000|Overall Study|Protocol Violation|5|||
49012654|NCT00441584|157883521|FG000|Overall Study|Lost to Follow-up|4|||
49012655|NCT00441584|157883521|FG000|Overall Study|Failure to meet eligibility criteria|3|||
49012656|NCT03063632|157883524|FG000|Overall Study|Death|4|||
49143334|NCT03888482|158364462|FG001|Second Wear (8 -1/+2 Days)|Other|0|||
49143335|NCT00825175|158364463|FG000|Overall Study|Withdrawal by Subject|0|||
49143336|NCT00825175|158364464|FG001|Overall Study|Withdrawal by Subject|5|||
49143337|NCT03019588|158364465|FG000|Overall Study|Death|44|||
49143338|NCT03019588|158364466|FG001|Overall Study|Death|46|||
49143339|NCT03019588|158364465|FG000|Overall Study|Study terminated by Sponsor|3|||
49143340|NCT03019588|158364466|FG001|Overall Study|Study terminated by Sponsor|1|||
49143341|NCT02369159|158364467|FG000|Overall Study|Adverse Event|0|||
49143342|NCT02369159|158364468|FG001|Overall Study|Adverse Event|1|||
49143343|NCT02369159|158364467|FG000|Overall Study|Lost to Follow-up|1|||
49012657|NCT03063632|157883525|FG001|Overall Study|Death|6|||
49012658|NCT03063632|157883524|FG000|Overall Study|Lost to Follow-up|0|||
49012659|NCT03063632|157883525|FG001|Overall Study|Lost to Follow-up|1|||
49012660|NCT03063632|157883524|FG000|Overall Study|Withdrawal by Subject|0|||
49012661|NCT03063632|157883525|FG001|Overall Study|Withdrawal by Subject|2|||
49012662|NCT03063632|157883524|FG000|Overall Study|Physician Decision|2|||
49012663|NCT03063632|157883525|FG001|Overall Study|Physician Decision|0|||
49143344|NCT02369159|158364468|FG001|Overall Study|Lost to Follow-up|1|||
49143345|NCT02369159|158364467|FG000|Overall Study|Withdrawal by Subject|7|||
49143346|NCT02369159|158364468|FG001|Overall Study|Withdrawal by Subject|0|||
49143347|NCT00887588|158364469|FG000|Core Period|Death|1|||
49012664|NCT03063632|157883524|FG000|Overall Study|Other: Disease progression; starting another treatment|1|||
49012665|NCT03063632|157883525|FG001|Overall Study|Other: Disease progression; starting another treatment|1|||
49012666|NCT01798485|157883530|FG000|Overall Study|Adverse Event|32|||
49012667|NCT01798485|157883531|FG001|Overall Study|Adverse Event|40|||
49012668|NCT01798485|157883530|FG000|Overall Study|Withdrawal by Subject|27|||
49143348|NCT00887588|158364470|FG001|Core Period|Death|1|||
49143349|NCT00887588|158364469|FG000|Core Period|Lost to Follow-up|3|||
49143350|NCT00887588|158364470|FG001|Core Period|Lost to Follow-up|1|||
49143351|NCT00887588|158364469|FG000|Core Period|Withdrawal by Subject|6|||
49143352|NCT00887588|158364470|FG001|Core Period|Withdrawal by Subject|8|||
49143353|NCT00887588|158364469|FG000|Core Period|Adverse Event|9|||
49143354|NCT00887588|158364470|FG001|Core Period|Adverse Event|11|||
49143355|NCT00887588|158364469|FG000|Extension Period|Adverse Event|4|||
49143356|NCT00887588|158364470|FG001|Extension Period|Adverse Event|4|||
49143357|NCT00887588|158364469|FG000|Extension Period|Death|0|||
49143358|NCT00887588|158364470|FG001|Extension Period|Death|1|||
49143359|NCT00887588|158364469|FG000|Extension Period|Protocol deviation|1|||
49143360|NCT00887588|158364470|FG001|Extension Period|Protocol deviation|0|||
49143361|NCT00887588|158364469|FG000|Extension Period|Lost to Follow-up|1|||
49143362|NCT00887588|158364470|FG001|Extension Period|Lost to Follow-up|0|||
49143363|NCT03335566|158364471|FG000|Overall Study|Adverse Event|0|||
49143364|NCT03335566|158364472|FG001|Overall Study|Adverse Event|1|||
49143365|NCT03335566|158364471|FG000|Overall Study|Lost to Follow-up|1|||
49143366|NCT03335566|158364472|FG001|Overall Study|Lost to Follow-up|0|||
49143367|NCT03335566|158364471|FG000|Overall Study|Technical Problems|1|||
49143368|NCT03335566|158364472|FG001|Overall Study|Technical Problems|0|||
49143369|NCT03335566|158364471|FG000|Overall Study|Protocol Violation|1|||
49143370|NCT03335566|158364472|FG001|Overall Study|Protocol Violation|0|||
49143371|NCT03335566|158364471|FG000|Overall Study|Other than specified above|1|||
49143372|NCT03335566|158364472|FG001|Overall Study|Other than specified above|2|||
49143373|NCT00366535|158364473|FG000|First Phase: 12 Weeks|Adverse Event|1|||
49143374|NCT00366535|158364474|FG001|First Phase: 12 Weeks|Adverse Event|3|||
49143375|NCT00366535|158364473|FG000|First Phase: 12 Weeks|Withdrawal by Subject|2|||
49143376|NCT00366535|158364474|FG001|First Phase: 12 Weeks|Withdrawal by Subject|5|||
49143377|NCT00366535|158364473|FG000|Second Phase: 12 Weeks|Adverse Event|1|||
49143378|NCT00366535|158364474|FG001|Second Phase: 12 Weeks|Adverse Event|1|||
49143379|NCT00366535|158364473|FG000|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
49143380|NCT00366535|158364474|FG001|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
49143381|NCT00425854|158364475|FG000|Overall Study|Progressive Disease|19|||
49143382|NCT00425854|158364476|FG001|Overall Study|Progressive Disease|12|||
49143383|NCT00425854|158364475|FG000|Overall Study|Dose reduction toxicity AE|8|||
49143384|NCT00425854|158364476|FG001|Overall Study|Dose reduction toxicity AE|7|||
49143385|NCT00425854|158364475|FG000|Overall Study|Other Adverse Event|2|||
49143386|NCT00425854|158364476|FG001|Overall Study|Other Adverse Event|2|||
49143387|NCT00834587|158364477|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
49143388|NCT00834587|158364478|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
49143389|NCT01016015|158364479|FG000|Overall Study|Not Treated|3|||
49143390|NCT01016015|158364479|FG000|Overall Study|Withdrawal by Subject|1|||
49143391|NCT01016015|158364479|FG000|Overall Study|Adverse Event|15|||
49143392|NCT00968968|158364483|FG000|Overall Study|Study closed/terminated|10|||
49143393|NCT00968968|158364484|FG001|Overall Study|Study closed/terminated|10|||
49143394|NCT00968968|158364483|FG000|Overall Study|Protocol defined stopping criteria|3|||
49143395|NCT00968968|158364484|FG001|Overall Study|Protocol defined stopping criteria|1|||
49143396|NCT00968968|158364483|FG000|Overall Study|Withdrawal by Subject|2|||
49143397|NCT00968968|158364484|FG001|Overall Study|Withdrawal by Subject|0|||
49143398|NCT00968968|158364483|FG000|Overall Study|Physician Decision|1|||
49143399|NCT00968968|158364484|FG001|Overall Study|Physician Decision|2|||
49143400|NCT00968968|158364483|FG000|Overall Study|Lost to Follow-up|0|||
49143401|NCT00968968|158364484|FG001|Overall Study|Lost to Follow-up|1|||
49143402|NCT03624036|158364485|FG000|Overall Study|Death|2|||
49143403|NCT03624036|158364486|FG001|Overall Study|Death|3|||
49143404|NCT03624036|158364487|FG002|Overall Study|Death|0|||
49012669|NCT01798485|157883531|FG001|Overall Study|Withdrawal by Subject|31|||
49012670|NCT01798485|157883530|FG000|Overall Study|Lost to Follow-up|0|||
49012671|NCT01798485|157883531|FG001|Overall Study|Lost to Follow-up|3|||
49012672|NCT01798485|157883530|FG000|Overall Study|Physician Decision|14|||
49012673|NCT01798485|157883531|FG001|Overall Study|Physician Decision|10|||
49012674|NCT01798485|157883530|FG000|Overall Study|Objective Disease Progression|152|||
49012675|NCT01798485|157883531|FG001|Overall Study|Objective Disease Progression|106|||
49143405|NCT03624036|158364488|FG003|Overall Study|Death|1|||
49143406|NCT03624036|158364485|FG000|Overall Study|Withdrawal by Subject|1|||
49143407|NCT03624036|158364486|FG001|Overall Study|Withdrawal by Subject|0|||
49143408|NCT03624036|158364487|FG002|Overall Study|Withdrawal by Subject|1|||
49143409|NCT03624036|158364488|FG003|Overall Study|Withdrawal by Subject|0|||
49143410|NCT03624036|158364485|FG000|Overall Study|Enrolled but Never Treated|1|||
49143411|NCT03624036|158364486|FG001|Overall Study|Enrolled but Never Treated|0|||
49012676|NCT01798485|157883530|FG000|Overall Study|Death|25|||
49143412|NCT03624036|158364487|FG002|Overall Study|Enrolled but Never Treated|0|||
49143413|NCT03624036|158364488|FG003|Overall Study|Enrolled but Never Treated|0|||
49143414|NCT03624036|158364485|FG000|Overall Study|Reason not Specified|3|||
49143415|NCT03624036|158364486|FG001|Overall Study|Reason not Specified|0|||
49143416|NCT03624036|158364487|FG002|Overall Study|Reason not Specified|2|||
49012677|NCT01798485|157883531|FG001|Overall Study|Death|22|||
49143417|NCT03624036|158364488|FG003|Overall Study|Reason not Specified|2|||
49143418|NCT02774278|158364495|FG000|Overall Study|Lack of Efficacy|199|||
49012678|NCT01798485|157883530|FG000|Overall Study|Sponsor Decision|61|||
49012679|NCT01798485|157883531|FG001|Overall Study|Sponsor Decision|54|||
49012680|NCT01798485|157883530|FG000|Overall Study|Clinical Progression|35|||
49012681|NCT01798485|157883531|FG001|Overall Study|Clinical Progression|24|||
49012682|NCT02741271|157883534|FG000|Overall Study|Lost to Follow-up|2|||
49012683|NCT02741271|157883535|FG001|Overall Study|Lost to Follow-up|0|||
49012684|NCT02741271|157883534|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
49012685|NCT02741271|157883535|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
49012686|NCT01612156|157883537|FG000|Overall Study|Protocol Violation|2|||
49012687|NCT01612156|157883538|FG001|Overall Study|Protocol Violation|0|||
49012688|NCT01698320|157883539|FG000|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24|||
49012689|NCT01698320|157883540|FG001|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
49012690|NCT01698320|157883541|FG002|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
49012691|NCT01698320|157883539|FG000|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1|||
49012692|NCT01698320|157883540|FG001|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
49012693|NCT01698320|157883541|FG002|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
49012694|NCT01698320|157883539|FG000|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1|||
49012695|NCT01698320|157883540|FG001|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
49012696|NCT01698320|157883541|FG002|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
49012697|NCT01698320|157883539|FG000|Run-In Period (Week -1 to Day 0)|Other|1|||
49012698|NCT01698320|157883540|FG001|Run-In Period (Week -1 to Day 0)|Other|0|||
49012699|NCT01698320|157883541|FG002|Run-In Period (Week -1 to Day 0)|Other|0|||
49012700|NCT01698320|157883539|FG000|12-Week Double-Blind Period|Adverse Event|0|||
49012701|NCT01698320|157883540|FG001|12-Week Double-Blind Period|Adverse Event|1|||
49012702|NCT01698320|157883541|FG002|12-Week Double-Blind Period|Adverse Event|1|||
49012703|NCT01698320|157883539|FG000|12-Week Double-Blind Period|Withdrawal by Subject|0|||
49012704|NCT01698320|157883540|FG001|12-Week Double-Blind Period|Withdrawal by Subject|2|||
49012705|NCT01698320|157883541|FG002|12-Week Double-Blind Period|Withdrawal by Subject|2|||
49012706|NCT01698320|157883539|FG000|12-Week Double-Blind Period|Protocol Violation|0|||
49012707|NCT01698320|157883540|FG001|12-Week Double-Blind Period|Protocol Violation|0|||
49012708|NCT01698320|157883541|FG002|12-Week Double-Blind Period|Protocol Violation|2|||
49012709|NCT01698320|157883539|FG000|12-Week Double-Blind Period|Pregnancy|0|||
49012710|NCT01698320|157883540|FG001|12-Week Double-Blind Period|Pregnancy|1|||
49143419|NCT02774278|158364495|FG000|Overall Study|Death|29|||
49143420|NCT02774278|158364495|FG000|Overall Study|Adverse event/intercurrent illness|16|||
49143421|NCT02774278|158364495|FG000|Overall Study|Refused treatment/did not cooperate|9|||
49143422|NCT02774278|158364495|FG000|Overall Study|Administrative reasons|6|||
49143423|NCT02774278|158364495|FG000|Overall Study|Withdrawal by Subject|3|||
49143424|NCT02774278|158364495|FG000|Overall Study|Protocol Violation|2|||
49143425|NCT00127933|158364502|FG000|Overall Study|Randomized but not dosed|1|||
49143426|NCT00127933|158364503|FG001|Overall Study|Randomized but not dosed|0|||
49143427|NCT01783938|158364505|FG000|Overall Study|Disease Progression|18|||
49143428|NCT01783938|158364506|FG001|Overall Study|Disease Progression|41|||
49143429|NCT01783938|158364505|FG000|Overall Study|Study Drug Toxicity|27|||
49143430|NCT01783938|158364506|FG001|Overall Study|Study Drug Toxicity|14|||
49143431|NCT01783938|158364505|FG000|Overall Study|Adverse Event Unrelated to Study Drug|4|||
49143432|NCT01783938|158364506|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
49143433|NCT01783938|158364505|FG000|Overall Study|Participant Request to Discontinue Study Treatment|2|||
49143434|NCT01783938|158364506|FG001|Overall Study|Participant Request to Discontinue Study Treatment|3|||
49143435|NCT01783938|158364505|FG000|Overall Study|Participant Withdrew Consent|2|||
49143436|NCT01783938|158364506|FG001|Overall Study|Participant Withdrew Consent|0|||
49143437|NCT01783938|158364505|FG000|Overall Study|Maximum Clinical Benefit|1|||
49143438|NCT01783938|158364506|FG001|Overall Study|Maximum Clinical Benefit|0|||
49143439|NCT01783938|158364505|FG000|Overall Study|Other Reasons|3|||
49143440|NCT01783938|158364506|FG001|Overall Study|Other Reasons|1|||
49143441|NCT00498485|158364507|FG000|Overall Study|Adverse Event|1|||
49143442|NCT00498485|158364508|FG001|Overall Study|Adverse Event|5|||
49143443|NCT03061214|158364516|FG000|Overall Study|Withdrawal by Subject|21|||
49143444|NCT03061214|158364517|FG001|Overall Study|Withdrawal by Subject|26|||
49143445|NCT03061214|158364518|FG002|Overall Study|Withdrawal by Subject|9|||
49012711|NCT01698320|157883541|FG002|12-Week Double-Blind Period|Pregnancy|1|||
49012712|NCT01698320|157883539|FG000|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
49012713|NCT01698320|157883540|FG001|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
49012714|NCT01698320|157883541|FG002|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2|||
49012715|NCT01698320|157883539|FG000|12-Week Double-Blind Period|Lost to Follow-up|0|||
49012716|NCT01698320|157883540|FG001|12-Week Double-Blind Period|Lost to Follow-up|0|||
49012717|NCT01698320|157883541|FG002|12-Week Double-Blind Period|Lost to Follow-up|4|||
49012718|NCT01698320|157883539|FG000|40-Week Open-Label Period|Adverse Event|0|||
49012719|NCT01698320|157883540|FG001|40-Week Open-Label Period|Adverse Event|3|||
49143446|NCT03061214|158364516|FG000|Overall Study|Lost to Follow-up|3|||
49143447|NCT03061214|158364517|FG001|Overall Study|Lost to Follow-up|1|||
49143448|NCT03061214|158364518|FG002|Overall Study|Lost to Follow-up|1|||
49143449|NCT03061214|158364516|FG000|Overall Study|Death|1|||
49143450|NCT03061214|158364517|FG001|Overall Study|Death|1|||
49143451|NCT03061214|158364518|FG002|Overall Study|Death|0|||
48730282|NCT04493333|156864259|FG001|Overall Study|Withdrawal by Subject|1|||
48730283|NCT04493333|156864258|FG000|Overall Study|Ineligible|0|||
48730284|NCT04493333|156864259|FG001|Overall Study|Ineligible|1|||
48730285|NCT04493333|156864258|FG000|Overall Study|Noncompliance|2|||
48730286|NCT04493333|156864259|FG001|Overall Study|Noncompliance|1|||
48730287|NCT00674973|156864260|FG000|Overall Study|Insufficient Therapeutic Response|77|||
49143452|NCT01684033|158364521|FG000|Period 1, First 30 Days|Adverse Event|1|||
49143453|NCT01684033|158364522|FG001|Period 1, First 30 Days|Adverse Event|1|||
49143454|NCT01684033|158364521|FG000|Period 1, First 30 Days|Noncompliance|1|||
49143455|NCT01684033|158364522|FG001|Period 1, First 30 Days|Noncompliance|0|||
49143456|NCT01684033|158364521|FG000|Period 1, First 30 Days|Withdrawal by Subject|1|||
49143457|NCT01684033|158364522|FG001|Period 1, First 30 Days|Withdrawal by Subject|0|||
49143458|NCT01684033|158364521|FG000|Period 1, First 30 Days|Lost to Follow-up|1|||
49143459|NCT01684033|158364522|FG001|Period 1, First 30 Days|Lost to Follow-up|0|||
49143460|NCT01684033|158364521|FG000|Period 2, Second 30 Days|Adverse Event|1|||
49143461|NCT01684033|158364522|FG001|Period 2, Second 30 Days|Adverse Event|0|||
49143462|NCT01348490|158364523|FG000|Overall Study|Death|1|||
49143463|NCT01348490|158364523|FG000|Overall Study|Adverse Event|3|||
49143464|NCT01348490|158364523|FG000|Overall Study|Consent withdrawn|7|||
49143465|NCT01348490|158364523|FG000|Overall Study|Disease progression|3|||
49143466|NCT01348490|158364523|FG000|Overall Study|Lost to Follow-up|1|||
49143467|NCT01348490|158364523|FG000|Overall Study|Termination of clinical trial by sponsor|1|||
49143468|NCT01348490|158364523|FG000|Overall Study|Other Unspecified|8|||
49143469|NCT01412983|158364524|FG000|1st Period|Ineligible|0|||
48730288|NCT00674973|156864261|FG001|Overall Study|Insufficient Therapeutic Response|72|||
48730289|NCT00674973|156864260|FG000|Overall Study|Refused Treatment|1|||
48730290|NCT00674973|156864261|FG001|Overall Study|Refused Treatment|5|||
48730291|NCT00674973|156864260|FG000|Overall Study|Failure to Return|1|||
49143470|NCT01412983|158364525|FG001|1st Period|Ineligible|1|||
49143471|NCT01412983|158364524|FG000|1st Period|Positive slit lamp finding|0|||
49143472|NCT01412983|158364525|FG001|1st Period|Positive slit lamp finding|1|||
49143473|NCT01412983|158364524|FG000|1st Period|Unacceptable lens movement|0|||
49143474|NCT01412983|158364525|FG001|1st Period|Unacceptable lens movement|1|||
49143475|NCT01412983|158364524|FG000|1st Period|Inability to maintain wear|0|||
49143476|NCT01412983|158364525|FG001|1st Period|Inability to maintain wear|1|||
49143477|NCT01623154|158364526|FG000|Overall Study|Did not drink Pranactin Citric|4|||
49143478|NCT03921541|158366767|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
49143479|NCT03921541|158366768|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
49143480|NCT00212355|158366769|FG000|Overall Study|Adverse Event|1|||
49143481|NCT00212355|158366769|FG000|Overall Study|Withdrawal by Subject|1|||
48730292|NCT00674973|156864261|FG001|Overall Study|Failure to Return|0|||
48730293|NCT00674973|156864260|FG000|Overall Study|Adverse Event|2|||
48730294|NCT00674973|156864261|FG001|Overall Study|Adverse Event|9|||
48730295|NCT00674973|156864260|FG000|Overall Study|Death|19|||
48730296|NCT00674973|156864261|FG001|Overall Study|Death|15|||
48730297|NCT00674973|156864260|FG000|Overall Study|Protocol Violation|0|||
48730298|NCT00674973|156864261|FG001|Overall Study|Protocol Violation|1|||
48730299|NCT01801072|156864262|FG000|Overall Study|Lost to Follow-up|17|||
48730300|NCT01801072|156864263|FG001|Overall Study|Lost to Follow-up|14|||
48730301|NCT01801072|156864262|FG000|Overall Study|Physician Decision|2|||
48730302|NCT01801072|156864263|FG001|Overall Study|Physician Decision|3|||
48730303|NCT01801072|156864262|FG000|Overall Study|Withdrawal by Subject|1|||
48730304|NCT01801072|156864263|FG001|Overall Study|Withdrawal by Subject|0|||
48730305|NCT01801072|156864262|FG000|Overall Study|Protocol Violation|2|||
48730306|NCT01801072|156864263|FG001|Overall Study|Protocol Violation|0|||
48730307|NCT01801072|156864262|FG000|Overall Study|Death|7|||
48730308|NCT01801072|156864263|FG001|Overall Study|Death|8|||
48730309|NCT03190369|156864265|FG000|Overall Study|Poor compliance to protocol|0|||
48730310|NCT03190369|156864266|FG001|Overall Study|Poor compliance to protocol|1|||
48730311|NCT03190369|156864265|FG000|Overall Study|Withdraw before treatment|1|||
48730312|NCT03190369|156864266|FG001|Overall Study|Withdraw before treatment|5|||
48730313|NCT03190369|156864265|FG000|Overall Study|Randomized but not treated|0|||
48730314|NCT03190369|156864266|FG001|Overall Study|Randomized but not treated|2|||
48730315|NCT01143207|156864267|FG000|Overall Study|Lost to Follow-up|2|||
48730316|NCT00116168|156864268|FG000|Overall Study|Lost to Follow-up|6|||
48730317|NCT00116168|156864269|FG001|Overall Study|Lost to Follow-up|5|||
48730318|NCT00116168|156864270|FG002|Overall Study|Lost to Follow-up|0|||
48730319|NCT00116168|156864271|FG003|Overall Study|Lost to Follow-up|0|||
48730320|NCT03555435|156864272|FG000|Overall Study|Lost to Follow-up|17|||
48730321|NCT03555435|156864273|FG001|Overall Study|Lost to Follow-up|19|||
49143482|NCT00212355|158366769|FG000|Overall Study|A change of address|1|||
49143483|NCT01112267|158366770|FG000|Overall Study|Adverse Event|24|||
49143484|NCT01112267|158366771|FG001|Overall Study|Adverse Event|6|||
49143485|NCT01112267|158366770|FG000|Overall Study|Withdrawal by Subject|3|||
49143486|NCT01112267|158366771|FG001|Overall Study|Withdrawal by Subject|5|||
49143487|NCT01112267|158366770|FG000|Overall Study|Protocol Violation|5|||
49143488|NCT01112267|158366771|FG001|Overall Study|Protocol Violation|3|||
49143489|NCT01112267|158366770|FG000|Overall Study|Participants not compliant|1|||
49143490|NCT01112267|158366771|FG001|Overall Study|Participants not compliant|2|||
49143491|NCT01112267|158366770|FG000|Overall Study|Participants not receive any study drug|1|||
49143492|NCT01112267|158366771|FG001|Overall Study|Participants not receive any study drug|2|||
49143493|NCT00160615|158366772|FG000|Overall Study|Adverse Event|5|||
49143494|NCT00160615|158366773|FG001|Overall Study|Adverse Event|12|||
49143495|NCT00160615|158366772|FG000|Overall Study|Withdrawal by Subject|0|||
49143496|NCT00160615|158366773|FG001|Overall Study|Withdrawal by Subject|2|||
49143497|NCT00160615|158366772|FG000|Overall Study|Lack of Efficacy|11|||
49143498|NCT00160615|158366773|FG001|Overall Study|Lack of Efficacy|23|||
49143499|NCT00160615|158366772|FG000|Overall Study|Patient decision|1|||
49143500|NCT00160615|158366773|FG001|Overall Study|Patient decision|2|||
49143501|NCT00160615|158366772|FG000|Overall Study|Investigator decision|1|||
49143502|NCT00160615|158366773|FG001|Overall Study|Investigator decision|1|||
49143503|NCT00160615|158366772|FG000|Overall Study|AE agents had to be discontinued (exam.)|0|||
49143504|NCT00160615|158366773|FG001|Overall Study|AE agents had to be discontinued (exam.)|1|||
49143505|NCT00160615|158366772|FG000|Overall Study|Switch to surgical treatment|0|||
49143506|NCT00160615|158366773|FG001|Overall Study|Switch to surgical treatment|2|||
49143507|NCT00160615|158366772|FG000|Overall Study|Non-compliance was suspected|0|||
49143508|NCT00160615|158366773|FG001|Overall Study|Non-compliance was suspected|1|||
49143509|NCT00160615|158366772|FG000|Overall Study|Poor compliance|0|||
49143510|NCT00160615|158366773|FG001|Overall Study|Poor compliance|1|||
49143511|NCT03166631|158366774|FG000|Overall Study|Progressive disease|2|||
49143512|NCT03166631|158366775|FG001|Overall Study|Progressive disease|1|||
49143513|NCT03166631|158366776|FG002|Overall Study|Progressive disease|3|||
49143514|NCT03166631|158366777|FG003|Overall Study|Progressive disease|4|||
49143515|NCT03166631|158366778|FG004|Overall Study|Progressive disease|2|||
49143516|NCT03166631|158366779|FG005|Overall Study|Progressive disease|2|||
49143517|NCT03166631|158366780|FG006|Overall Study|Progressive disease|5|||
49143518|NCT03166631|158366781|FG007|Overall Study|Progressive disease|6|||
49143519|NCT03166631|158366782|FG008|Overall Study|Progressive disease|11|||
49143520|NCT03166631|158366783|FG009|Overall Study|Progressive disease|5|||
49143521|NCT03166631|158366784|FG010|Overall Study|Progressive disease|7|||
49143522|NCT03166631|158366774|FG000|Overall Study|Physician Decision|0|||
49143523|NCT03166631|158366775|FG001|Overall Study|Physician Decision|0|||
49143524|NCT03166631|158366776|FG002|Overall Study|Physician Decision|0|||
49143525|NCT03166631|158366777|FG003|Overall Study|Physician Decision|0|||
49143526|NCT03166631|158366778|FG004|Overall Study|Physician Decision|0|||
49143527|NCT03166631|158366779|FG005|Overall Study|Physician Decision|0|||
49143528|NCT03166631|158366780|FG006|Overall Study|Physician Decision|1|||
49143529|NCT03166631|158366781|FG007|Overall Study|Physician Decision|0|||
49143530|NCT03166631|158366782|FG008|Overall Study|Physician Decision|1|||
49143531|NCT03166631|158366783|FG009|Overall Study|Physician Decision|0|||
49143532|NCT03166631|158366784|FG010|Overall Study|Physician Decision|1|||
49143533|NCT03166631|158366774|FG000|Overall Study|Death|0|||
49143534|NCT03166631|158366775|FG001|Overall Study|Death|0|||
49143535|NCT03166631|158366776|FG002|Overall Study|Death|0|||
49143536|NCT03166631|158366777|FG003|Overall Study|Death|0|||
49143537|NCT03166631|158366778|FG004|Overall Study|Death|1|||
49143538|NCT03166631|158366779|FG005|Overall Study|Death|0|||
49143539|NCT03166631|158366780|FG006|Overall Study|Death|1|||
49143540|NCT03166631|158366781|FG007|Overall Study|Death|0|||
49143541|NCT03166631|158366782|FG008|Overall Study|Death|0|||
49143542|NCT03166631|158366783|FG009|Overall Study|Death|0|||
49143543|NCT03166631|158366784|FG010|Overall Study|Death|0|||
49143544|NCT03166631|158366774|FG000|Overall Study|Adverse Event|1|||
49143545|NCT03166631|158366775|FG001|Overall Study|Adverse Event|0|||
49143546|NCT03166631|158366776|FG002|Overall Study|Adverse Event|0|||
49143547|NCT03166631|158366777|FG003|Overall Study|Adverse Event|0|||
49143548|NCT03166631|158366778|FG004|Overall Study|Adverse Event|0|||
49143549|NCT03166631|158366779|FG005|Overall Study|Adverse Event|1|||
49143550|NCT03166631|158366780|FG006|Overall Study|Adverse Event|1|||
49143551|NCT03166631|158366781|FG007|Overall Study|Adverse Event|0|||
49143552|NCT03166631|158366782|FG008|Overall Study|Adverse Event|1|||
49143553|NCT03166631|158366783|FG009|Overall Study|Adverse Event|2|||
49143554|NCT03166631|158366784|FG010|Overall Study|Adverse Event|1|||
49143555|NCT03166631|158366774|FG000|Overall Study|Withdrawal by Subject|0|||
49143556|NCT03166631|158366775|FG001|Overall Study|Withdrawal by Subject|0|||
49143557|NCT03166631|158366776|FG002|Overall Study|Withdrawal by Subject|0|||
49143558|NCT03166631|158366777|FG003|Overall Study|Withdrawal by Subject|0|||
49143559|NCT03166631|158366778|FG004|Overall Study|Withdrawal by Subject|0|||
49143560|NCT03166631|158366779|FG005|Overall Study|Withdrawal by Subject|0|||
49143561|NCT03166631|158366780|FG006|Overall Study|Withdrawal by Subject|0|||
49143562|NCT03166631|158366781|FG007|Overall Study|Withdrawal by Subject|0|||
49143563|NCT03166631|158366782|FG008|Overall Study|Withdrawal by Subject|1|||
49143564|NCT03166631|158366783|FG009|Overall Study|Withdrawal by Subject|1|||
49143565|NCT03166631|158366784|FG010|Overall Study|Withdrawal by Subject|0|||
49143566|NCT03506633|158366787|FG000|Washout (14 Days)|Withdrawal by Subject|1|||
49143567|NCT03506633|158366788|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
49143568|NCT01565694|158366789|FG000|Dose-Titration Period|Adverse Event|4|||
49143569|NCT01565694|158366789|FG000|Dose-Titration Period|Protocol Violation|10|||
49143570|NCT01565694|158366789|FG000|Fixed-Dose Assessment Period|Withdrawal by Subject|4|||
49143571|NCT01166945|158366790|FG000|Randomized|diagnosed with Group A strep|4|||
49143572|NCT01166945|158366791|FG001|Randomized|diagnosed with Group A strep|4|||
49143573|NCT01166945|158366790|FG000|Day 10|NonCompliance/Lost to Follow Up|3|||
49143574|NCT01166945|158366791|FG001|Day 10|NonCompliance/Lost to Follow Up|2|||
49143575|NCT01166945|158366790|FG000|Day 15|NonCompliance/Lost to Follow Up|2|||
49143576|NCT01166945|158366791|FG001|Day 15|NonCompliance/Lost to Follow Up|1|||
49143577|NCT01166945|158366790|FG000|Day 30|Lost to Follow-up|4|||
49143578|NCT01166945|158366791|FG001|Day 30|Lost to Follow-up|3|||
49143579|NCT00454142|158366792|FG000|Overall Study|Withdrawal by Subject|1|||
49143580|NCT01699685|158366795|FG000|Period 1|Adverse Event|1|||
49143581|NCT01699685|158366796|FG001|Period 1|Adverse Event|1|||
49143582|NCT01699685|158366795|FG000|Period 1|Medical or ethical, noncompliance|2|||
49143583|NCT01699685|158366796|FG001|Period 1|Medical or ethical, noncompliance|0|||
49143584|NCT01699685|158366795|FG000|Period 1|Other|0|||
49143585|NCT01699685|158366796|FG001|Period 1|Other|1|||
49143586|NCT01699685|158366795|FG000|Period 1|Patient request|0|||
49143587|NCT01699685|158366796|FG001|Period 1|Patient request|1|||
49143588|NCT01699685|158366795|FG000|Period 2|Lost to Follow-up|1|||
49143589|NCT01699685|158366796|FG001|Period 2|Lost to Follow-up|0|||
49143590|NCT02545127|158366799|FG000|Overall Study|Lost to Follow-up|1|||
49143591|NCT02545127|158366800|FG001|Overall Study|Lost to Follow-up|0|||
49143592|NCT01129284|158366801|FG000|Overall Study|Adverse Event|2|||
49143593|NCT01129284|158366802|FG001|Overall Study|Adverse Event|0|||
49143594|NCT01129284|158366803|FG002|Overall Study|Adverse Event|1|||
49143595|NCT00784927|158366804|FG000|Overall Study|Cancel Prior to Initiating Treatment|1|||
49143596|NCT00784927|158366804|FG000|Overall Study|Protocol Violation|1|||
49143597|NCT00784927|158366804|FG000|Overall Study|Ineligible|1|||
49143598|NCT00422461|158366805|FG000|Overall Study|Adverse Event|1|||
49143599|NCT00422461|158366806|FG001|Overall Study|Adverse Event|2|||
49143600|NCT00422461|158366807|FG002|Overall Study|Adverse Event|1|||
49143601|NCT00422461|158366808|FG003|Overall Study|Adverse Event|1|||
49143602|NCT00422461|158366805|FG000|Overall Study|Other|0|||
49143603|NCT00422461|158366806|FG001|Overall Study|Other|0|||
49143604|NCT00422461|158366807|FG002|Overall Study|Other|0|||
49143605|NCT00422461|158366808|FG003|Overall Study|Other|2|||
49143606|NCT00422461|158366805|FG000|Overall Study|Participants no longer willing to participate in study|1|||
49143607|NCT00422461|158366806|FG001|Overall Study|Participants no longer willing to participate in study|0|||
49143608|NCT00422461|158366807|FG002|Overall Study|Participants no longer willing to participate in study|0|||
49143609|NCT00422461|158366808|FG003|Overall Study|Participants no longer willing to participate in study|0|||
49143610|NCT00422461|158366805|FG000|Overall Study|Randomized but not treated|1|||
49143611|NCT00422461|158366806|FG001|Overall Study|Randomized but not treated|1|||
49143612|NCT00422461|158366807|FG002|Overall Study|Randomized but not treated|0|||
49143613|NCT00422461|158366808|FG003|Overall Study|Randomized but not treated|0|||
49143614|NCT02493855|158366809|FG000|Overall Study|Non-compliance|1|||
49143615|NCT02493855|158366810|FG001|Overall Study|Non-compliance|0|||
49143616|NCT02493855|158366811|FG002|Overall Study|Non-compliance|0|||
49143617|NCT02493855|158366809|FG000|Overall Study|Adverse Event|0|||
49143618|NCT02493855|158366810|FG001|Overall Study|Adverse Event|1|||
49143619|NCT02493855|158366811|FG002|Overall Study|Adverse Event|0|||
49143620|NCT02493855|158366809|FG000|Overall Study|Withdrawal by Subject|1|||
49143621|NCT02493855|158366810|FG001|Overall Study|Withdrawal by Subject|0|||
49143622|NCT02493855|158366811|FG002|Overall Study|Withdrawal by Subject|0|||
49143623|NCT01471574|158366812|FG000|Treatment Period|Lack of Efficacy|12|||
49143624|NCT01471574|158366813|FG001|Treatment Period|Lack of Efficacy|4|||
49143625|NCT01471574|158366814|FG002|Treatment Period|Lack of Efficacy|14|||
49143626|NCT01471574|158366815|FG003|Treatment Period|Lack of Efficacy|1|||
49143627|NCT01471574|158366812|FG000|Treatment Period|Adverse Event|7|||
49143628|NCT01471574|158366813|FG001|Treatment Period|Adverse Event|3|||
49143629|NCT01471574|158366814|FG002|Treatment Period|Adverse Event|6|||
49143630|NCT01471574|158366815|FG003|Treatment Period|Adverse Event|1|||
49143631|NCT01471574|158366812|FG000|Treatment Period|Withdrawal by Subject|5|||
49143632|NCT01471574|158366813|FG001|Treatment Period|Withdrawal by Subject|1|||
49143633|NCT01471574|158366814|FG002|Treatment Period|Withdrawal by Subject|1|||
49143634|NCT01471574|158366815|FG003|Treatment Period|Withdrawal by Subject|0|||
49143635|NCT01471574|158366812|FG000|Treatment Period|Patient Requested Discontinue Study drug|4|||
49143636|NCT01471574|158366813|FG001|Treatment Period|Patient Requested Discontinue Study drug|0|||
49143637|NCT01471574|158366814|FG002|Treatment Period|Patient Requested Discontinue Study drug|1|||
49143638|NCT01471574|158366815|FG003|Treatment Period|Patient Requested Discontinue Study drug|1|||
49143639|NCT01471574|158366812|FG000|Treatment Period|Lost to Follow-up|1|||
49143640|NCT01471574|158366813|FG001|Treatment Period|Lost to Follow-up|2|||
49143641|NCT01471574|158366814|FG002|Treatment Period|Lost to Follow-up|2|||
49143642|NCT01471574|158366815|FG003|Treatment Period|Lost to Follow-up|0|||
49012720|NCT01698320|157883541|FG002|40-Week Open-Label Period|Adverse Event|2|||
49012721|NCT01698320|157883539|FG000|40-Week Open-Label Period|Withdrawal by Subject|0|||
49012722|NCT01698320|157883540|FG001|40-Week Open-Label Period|Withdrawal by Subject|11|||
49012723|NCT01698320|157883541|FG002|40-Week Open-Label Period|Withdrawal by Subject|7|||
49012724|NCT01698320|157883539|FG000|40-Week Open-Label Period|Pregnancy|0|||
49012725|NCT01698320|157883540|FG001|40-Week Open-Label Period|Pregnancy|2|||
49012726|NCT01698320|157883541|FG002|40-Week Open-Label Period|Pregnancy|1|||
49012727|NCT01698320|157883539|FG000|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
49012728|NCT01698320|157883540|FG001|40-Week Open-Label Period|Sponsor requested subject withdrawal|1|||
49012729|NCT01698320|157883541|FG002|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
48730322|NCT03555435|156864274|FG002|Overall Study|Lost to Follow-up|8|||
48730323|NCT01646073|156864275|FG000|Period A (12 Weeks)|Adverse Event|0|||
48730324|NCT01646073|156864276|FG001|Period A (12 Weeks)|Adverse Event|2|||
48730325|NCT01646073|156864275|FG000|Period A (12 Weeks)|Withdrawal by Subject|1|||
48730326|NCT01646073|156864276|FG001|Period A (12 Weeks)|Withdrawal by Subject|1|||
48730327|NCT01646073|156864275|FG000|Period A (12 Weeks)|Lack of Efficacy|1|||
49143643|NCT01471574|158366812|FG000|Treatment Period|Patient no Longer Meets Study Criteria|1|||
49012730|NCT01698320|157883539|FG000|40-Week Open-Label Period|Lost to Follow-up|0|||
49012731|NCT01698320|157883540|FG001|40-Week Open-Label Period|Lost to Follow-up|2|||
49012732|NCT01698320|157883541|FG002|40-Week Open-Label Period|Lost to Follow-up|0|||
49012733|NCT01952574|157883542|FG000|Double-blind Treatment Phase|Withdrawal by Subject|9|||
49012734|NCT01952574|157883543|FG001|Double-blind Treatment Phase|Withdrawal by Subject|3|||
49012735|NCT01952574|157883544|FG002|Double-blind Treatment Phase|Withdrawal by Subject|3|||
49012736|NCT01952574|157883545|FG003|Double-blind Treatment Phase|Withdrawal by Subject|4|||
49012737|NCT01952574|157883546|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
49012738|NCT01952574|157883547|FG005|Double-blind Treatment Phase|Withdrawal by Subject|0|||
49012739|NCT01952574|157883548|FG006|Double-blind Treatment Phase|Withdrawal by Subject|0|||
49012740|NCT01952574|157883542|FG000|Double-blind Treatment Phase|Sponsor Decision|6|||
49012741|NCT01952574|157883543|FG001|Double-blind Treatment Phase|Sponsor Decision|0|||
49012742|NCT01952574|157883544|FG002|Double-blind Treatment Phase|Sponsor Decision|5|||
49012743|NCT01952574|157883545|FG003|Double-blind Treatment Phase|Sponsor Decision|2|||
49012744|NCT01952574|157883546|FG004|Double-blind Treatment Phase|Sponsor Decision|0|||
49012745|NCT01952574|157883547|FG005|Double-blind Treatment Phase|Sponsor Decision|0|||
49012746|NCT01952574|157883548|FG006|Double-blind Treatment Phase|Sponsor Decision|0|||
49012747|NCT01952574|157883542|FG000|Double-blind Treatment Phase|Lost to Follow-up|2|||
49012748|NCT01952574|157883543|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
49012749|NCT01952574|157883544|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
49012750|NCT01952574|157883545|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
49012751|NCT01952574|157883546|FG004|Double-blind Treatment Phase|Lost to Follow-up|0|||
49012752|NCT01952574|157883547|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
49012753|NCT01952574|157883548|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
49012754|NCT01952574|157883542|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
48730328|NCT01646073|156864276|FG001|Period A (12 Weeks)|Lack of Efficacy|0|||
49143644|NCT01471574|158366813|FG001|Treatment Period|Patient no Longer Meets Study Criteria|0|||
49143645|NCT01471574|158366814|FG002|Treatment Period|Patient no Longer Meets Study Criteria|0|||
49143646|NCT01471574|158366815|FG003|Treatment Period|Patient no Longer Meets Study Criteria|0|||
49143647|NCT01471574|158366812|FG000|Treatment Period|Other|1|||
49143648|NCT01471574|158366813|FG001|Treatment Period|Other|0|||
49143649|NCT01471574|158366814|FG002|Treatment Period|Other|0|||
49143650|NCT01471574|158366815|FG003|Treatment Period|Other|0|||
49143651|NCT01471574|158366812|FG000|Follow-up Period|Withdrawal by Subject|3|||
49143652|NCT01471574|158366813|FG001|Follow-up Period|Withdrawal by Subject|0|||
49143653|NCT01471574|158366814|FG002|Follow-up Period|Withdrawal by Subject|3|||
49143654|NCT01471574|158366815|FG003|Follow-up Period|Withdrawal by Subject|1|||
49143655|NCT01471574|158366812|FG000|Follow-up Period|Lost to Follow-up|4|||
49143656|NCT01471574|158366813|FG001|Follow-up Period|Lost to Follow-up|1|||
49143657|NCT01471574|158366814|FG002|Follow-up Period|Lost to Follow-up|3|||
49143658|NCT01471574|158366815|FG003|Follow-up Period|Lost to Follow-up|2|||
49143659|NCT01471574|158366812|FG000|Follow-up Period|Death|0|||
49143660|NCT01471574|158366813|FG001|Follow-up Period|Death|0|||
48730329|NCT01646073|156864275|FG000|Period A (12 Weeks)|Protocol Violation|0|||
48730330|NCT01646073|156864276|FG001|Period A (12 Weeks)|Protocol Violation|1|||
48730331|NCT01646073|156864275|FG000|Period A (12 Weeks)|Other|0|||
49012755|NCT01952574|157883543|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
49012756|NCT01952574|157883544|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
48730332|NCT01646073|156864276|FG001|Period A (12 Weeks)|Other|1|||
49012757|NCT01952574|157883545|FG003|Open-label Treatment Phase|Withdrawal by Subject|0|||
49012758|NCT01952574|157883546|FG004|Open-label Treatment Phase|Withdrawal by Subject|121|||
49012759|NCT01952574|157883547|FG005|Open-label Treatment Phase|Withdrawal by Subject|0|||
49143661|NCT01471574|158366814|FG002|Follow-up Period|Death|1|||
49143662|NCT01471574|158366815|FG003|Follow-up Period|Death|0|||
49143663|NCT01471574|158366812|FG000|Follow-up Period|Follow-up no longer required|0|||
49012760|NCT01952574|157883548|FG006|Open-label Treatment Phase|Withdrawal by Subject|0|||
49012761|NCT01952574|157883542|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
49012762|NCT01952574|157883543|FG001|Open-label Treatment Phase|Decision by Sponsor|0|||
49012763|NCT01952574|157883544|FG002|Open-label Treatment Phase|Decision by Sponsor|0|||
49012764|NCT01952574|157883545|FG003|Open-label Treatment Phase|Decision by Sponsor|0|||
49012765|NCT01952574|157883546|FG004|Open-label Treatment Phase|Decision by Sponsor|17|||
49012766|NCT01952574|157883547|FG005|Open-label Treatment Phase|Decision by Sponsor|0|||
49012767|NCT01952574|157883548|FG006|Open-label Treatment Phase|Decision by Sponsor|0|||
49012768|NCT01952574|157883542|FG000|Open-label Treatment Phase|Missing|0|||
49012769|NCT01952574|157883543|FG001|Open-label Treatment Phase|Missing|0|||
49012770|NCT01952574|157883544|FG002|Open-label Treatment Phase|Missing|0|||
49012771|NCT01952574|157883545|FG003|Open-label Treatment Phase|Missing|0|||
49012772|NCT01952574|157883546|FG004|Open-label Treatment Phase|Missing|4|||
49012773|NCT01952574|157883547|FG005|Open-label Treatment Phase|Missing|0|||
49012774|NCT01952574|157883548|FG006|Open-label Treatment Phase|Missing|0|||
49012775|NCT01952574|157883542|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
49012776|NCT01952574|157883543|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
49012777|NCT01952574|157883544|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
49012778|NCT01952574|157883545|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
49012779|NCT01952574|157883546|FG004|Open-label Treatment Phase|Lost to Follow-up|19|||
49012780|NCT01952574|157883547|FG005|Open-label Treatment Phase|Lost to Follow-up|0|||
49012781|NCT01952574|157883548|FG006|Open-label Treatment Phase|Lost to Follow-up|0|||
49012782|NCT01952574|157883542|FG000|Open-label Treatment Phase|Death|0|||
49012783|NCT01952574|157883543|FG001|Open-label Treatment Phase|Death|0|||
49012784|NCT01952574|157883544|FG002|Open-label Treatment Phase|Death|0|||
49012785|NCT01952574|157883545|FG003|Open-label Treatment Phase|Death|0|||
49012786|NCT01952574|157883546|FG004|Open-label Treatment Phase|Death|1|||
49012787|NCT01952574|157883547|FG005|Open-label Treatment Phase|Death|0|||
49012788|NCT01952574|157883548|FG006|Open-label Treatment Phase|Death|0|||
49012789|NCT01952574|157883542|FG000|Clinical Home Use Substudy|Withdrawal by Subject|0|||
49012790|NCT01952574|157883543|FG001|Clinical Home Use Substudy|Withdrawal by Subject|0|||
49012791|NCT01952574|157883544|FG002|Clinical Home Use Substudy|Withdrawal by Subject|0|||
49012792|NCT01952574|157883545|FG003|Clinical Home Use Substudy|Withdrawal by Subject|0|||
49012793|NCT01952574|157883546|FG004|Clinical Home Use Substudy|Withdrawal by Subject|0|||
49012794|NCT01952574|157883547|FG005|Clinical Home Use Substudy|Withdrawal by Subject|1|||
49012795|NCT01952574|157883548|FG006|Clinical Home Use Substudy|Withdrawal by Subject|0|||
49012796|NCT01952574|157883542|FG000|Clinical Home Use Substudy|Decision by Sponsor|0|||
49012797|NCT01952574|157883543|FG001|Clinical Home Use Substudy|Decision by Sponsor|0|||
49012798|NCT01952574|157883544|FG002|Clinical Home Use Substudy|Decision by Sponsor|0|||
49012799|NCT01952574|157883545|FG003|Clinical Home Use Substudy|Decision by Sponsor|0|||
49012800|NCT01952574|157883546|FG004|Clinical Home Use Substudy|Decision by Sponsor|0|||
49012801|NCT01952574|157883547|FG005|Clinical Home Use Substudy|Decision by Sponsor|2|||
49012802|NCT01952574|157883548|FG006|Clinical Home Use Substudy|Decision by Sponsor|1|||
49012803|NCT00681863|157883549|FG000|Overall Study|Adverse Event|1|||
49012804|NCT00681863|157883549|FG000|Overall Study|Lost to Follow-up|2|||
49012805|NCT00681863|157883549|FG000|Overall Study|Lack of Efficacy|2|||
49012806|NCT00681863|157883549|FG000|Overall Study|Other|18|||
49012807|NCT01023269|157883553|FG000|Overall Study|early termination of the study|2|||
49012808|NCT01023269|157883554|FG001|Overall Study|early termination of the study|0|||
49012809|NCT01138150|157883559|FG000|Overall Study|blood unable to be processed|0|||
49012810|NCT01138150|157883560|FG001|Overall Study|blood unable to be processed|1|||
49012811|NCT01138150|157883559|FG000|Overall Study|Physician Decision|1|||
49012812|NCT01138150|157883560|FG001|Overall Study|Physician Decision|0|||
49012813|NCT01620983|157883561|FG000|Overall Study|Lost to Follow-up|8|||
49012814|NCT01620983|157883562|FG001|Overall Study|Lost to Follow-up|4|||
49012815|NCT01620983|157883563|FG002|Overall Study|Lost to Follow-up|9|||
49012816|NCT01620983|157883561|FG000|Overall Study|Withdrawal by Subject|6|||
49012817|NCT01620983|157883562|FG001|Overall Study|Withdrawal by Subject|8|||
49012818|NCT01620983|157883563|FG002|Overall Study|Withdrawal by Subject|1|||
49012819|NCT01620983|157883561|FG000|Overall Study|Death|2|||
49012820|NCT01620983|157883562|FG001|Overall Study|Death|0|||
49012821|NCT01620983|157883563|FG002|Overall Study|Death|0|||
48730333|NCT01646073|156864275|FG000|Period B (12 Weeks)|Adverse Event|0|||
48730334|NCT01646073|156864276|FG001|Period B (12 Weeks)|Adverse Event|7|||
49012822|NCT01620983|157883561|FG000|Overall Study|Physician Decision|3|||
49012823|NCT01620983|157883562|FG001|Overall Study|Physician Decision|10|||
49012824|NCT01620983|157883563|FG002|Overall Study|Physician Decision|5|||
49012825|NCT05085964|157883564|FG000|Overall Study|Premature termination of study|21|||
49012826|NCT05085964|157883565|FG001|Overall Study|Premature termination of study|0|||
48730335|NCT01646073|156864275|FG000|Period B (12 Weeks)|Withdrawal by Subject|1|||
48730336|NCT01646073|156864276|FG001|Period B (12 Weeks)|Withdrawal by Subject|5|||
49012827|NCT00545233|157883566|FG000|Overall Study|Adverse Event|10|||
49012828|NCT00545233|157883567|FG001|Overall Study|Adverse Event|5|||
49012829|NCT00545233|157883566|FG000|Overall Study|Violation of Selection Criteria at Entry|5|||
49015360|NCT00306384|157892157|FG001|Overall Study|Adverse Event|87|||
49012830|NCT00545233|157883567|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
49012831|NCT00545233|157883566|FG000|Overall Study|Protocol Violation|2|||
49012832|NCT00545233|157883567|FG001|Overall Study|Protocol Violation|0|||
49012833|NCT00545233|157883566|FG000|Overall Study|Refused Treatment|9|||
49012834|NCT00545233|157883567|FG001|Overall Study|Refused Treatment|7|||
49012835|NCT00545233|157883566|FG000|Overall Study|Failure to Return|4|||
49012836|NCT00545233|157883567|FG001|Overall Study|Failure to Return|6|||
49012837|NCT00545233|157883566|FG000|Overall Study|Insufficient response|14|||
49012838|NCT00545233|157883567|FG001|Overall Study|Insufficient response|15|||
49012839|NCT00545233|157883566|FG000|Overall Study|Physician Decision|2|||
49012840|NCT00545233|157883567|FG001|Overall Study|Physician Decision|1|||
49012841|NCT05017493|157883568|FG000|Overall Study|Withdrawal by Subject|26|||
49012842|NCT05017493|157883569|FG001|Overall Study|Withdrawal by Subject|0|||
49143664|NCT01471574|158366813|FG001|Follow-up Period|Follow-up no longer required|1|||
49143665|NCT01471574|158366814|FG002|Follow-up Period|Follow-up no longer required|0|||
49143666|NCT01471574|158366815|FG003|Follow-up Period|Follow-up no longer required|0|||
49143667|NCT01795937|158366816|FG000|Overall Study|Withdrawal by Subject|1|||
49143668|NCT01795937|158366817|FG001|Overall Study|Withdrawal by Subject|0|||
49143669|NCT01795937|158366818|FG002|Overall Study|Withdrawal by Subject|0|||
49143670|NCT01795937|158366816|FG000|Overall Study|Physician Decision|0|||
49143671|NCT01795937|158366817|FG001|Overall Study|Physician Decision|1|||
49143672|NCT01795937|158366818|FG002|Overall Study|Physician Decision|0|||
49143673|NCT01783015|158366822|FG000|Blinded Treatment|Adverse Event|0|||
49143674|NCT01783015|158366823|FG001|Blinded Treatment|Adverse Event|1|||
49143675|NCT01783015|158366824|FG002|Blinded Treatment|Adverse Event|0|||
49143676|NCT01783015|158366822|FG000|Blinded Treatment|Protocol Violation|0|||
49143677|NCT01783015|158366823|FG001|Blinded Treatment|Protocol Violation|1|||
49143678|NCT01783015|158366824|FG002|Blinded Treatment|Protocol Violation|0|||
49143679|NCT01783015|158366822|FG000|Blinded Treatment|Withdrawal by Subject|0|||
49143680|NCT01783015|158366823|FG001|Blinded Treatment|Withdrawal by Subject|1|||
49143681|NCT01783015|158366824|FG002|Blinded Treatment|Withdrawal by Subject|0|||
49143682|NCT01783015|158366822|FG000|Blinded Treatment|Study Terminated by Sponsor|2|||
49143683|NCT01783015|158366823|FG001|Blinded Treatment|Study Terminated by Sponsor|0|||
49143684|NCT01783015|158366824|FG002|Blinded Treatment|Study Terminated by Sponsor|0|||
49143685|NCT01783015|158366822|FG000|Open Label Treatment|Study Terminated by Sponsor|0|||
49143686|NCT01783015|158366823|FG001|Open Label Treatment|Study Terminated by Sponsor|0|||
49143687|NCT01783015|158366824|FG002|Open Label Treatment|Study Terminated by Sponsor|6|||
49143688|NCT03558672|158366827|FG000|Overall Study|Study Early Termination|10|||
49143689|NCT01529112|158366828|FG000|Overall Study|Adverse Event|2|||
49143690|NCT01529112|158366829|FG001|Overall Study|Adverse Event|0|||
49143691|NCT01529112|158366828|FG000|Overall Study|Death|59|||
49143692|NCT01529112|158366829|FG001|Overall Study|Death|38|||
49143693|NCT01529112|158366828|FG000|Overall Study|Protocol Violation|1|||
49143694|NCT01529112|158366829|FG001|Overall Study|Protocol Violation|0|||
49143695|NCT01529112|158366828|FG000|Overall Study|Withdrawal by Subject|7|||
49143696|NCT01529112|158366829|FG001|Overall Study|Withdrawal by Subject|3|||
49143697|NCT03607695|158366830|FG000|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1|||
49143698|NCT03607695|158366830|FG000|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2|||
49143699|NCT00585585|158366835|FG000|Overall Study|Adverse Event|1|||
49143700|NCT00574951|158366836|FG000|Overall Study|Ineligible - improper prior treatment|1|||
49143701|NCT01530256|158366837|FG000|Overall Study|Death|2|||
49143702|NCT00153920|158366838|FG000|Overall Study|Adverse Event|9|||
49143703|NCT00153920|158366838|FG000|Overall Study|Progressive Disease|9|||
49143704|NCT00153920|158366838|FG000|Overall Study|Physician Decision|3|||
49143705|NCT00153920|158366838|FG000|Overall Study|Lack of Response|3|||
49143706|NCT00153920|158366838|FG000|Overall Study|Death|2|||
49143707|NCT00153920|158366838|FG000|Overall Study|Withdrawal by Subject|1|||
49143708|NCT00153920|158366838|FG000|Overall Study|Non-Protocol Therapy|1|||
49143709|NCT00153920|158366838|FG000|Overall Study|Withdrawal of Consent before Trt|1|||
49143710|NCT00153920|158366838|FG000|Overall Study|Progressive Disease before Trt|1|||
49143711|NCT00500110|158366842|FG000|Overall Study|Withdrawal by Subject|3|||
49143712|NCT03446573|158366843|FG000|Early Switch Phase (Day 1 to Week 148)|Adverse Event|23|||
49143713|NCT03446573|158366844|FG001|Early Switch Phase (Day 1 to Week 148)|Adverse Event|7|||
49143714|NCT03446573|158366843|FG000|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|0|||
49143715|NCT03446573|158366844|FG001|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|6|||
49143716|NCT03446573|158366843|FG000|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|5|||
49143717|NCT03446573|158366844|FG001|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|6|||
49143718|NCT03446573|158366843|FG000|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|4|||
49012843|NCT05017493|157883568|FG000|Overall Study|Physician Decision|15|||
49143719|NCT03446573|158366844|FG001|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|10|||
49143720|NCT03446573|158366843|FG000|Early Switch Phase (Day 1 to Week 148)|Physician Decision|2|||
49143721|NCT03446573|158366844|FG001|Early Switch Phase (Day 1 to Week 148)|Physician Decision|11|||
49143722|NCT03446573|158366843|FG000|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|16|||
49143723|NCT03446573|158366844|FG001|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|33|||
48730337|NCT01646073|156864275|FG000|Period B (12 Weeks)|Lost to Follow-up|0|||
48730338|NCT01646073|156864276|FG001|Period B (12 Weeks)|Lost to Follow-up|1|||
48730339|NCT04950166|156864285|FG000|Overall Study|Withdrawal by Subject|1|||
48730340|NCT02969707|156864286|FG000|Overall Study|Withdrawal by Subject|6|||
48730341|NCT02969707|156864287|FG001|Overall Study|Withdrawal by Subject|5|||
48730342|NCT02969707|156864286|FG000|Overall Study|Severe anxiety|0|||
48730343|NCT02969707|156864287|FG001|Overall Study|Severe anxiety|1|||
48730344|NCT02969707|156864286|FG000|Overall Study|Positive toxicology screen|0|||
48730345|NCT02969707|156864287|FG001|Overall Study|Positive toxicology screen|2|||
48730346|NCT02969707|156864286|FG000|Overall Study|Claustrophobia|2|||
48730347|NCT02969707|156864287|FG001|Overall Study|Claustrophobia|2|||
48730348|NCT02969707|156864286|FG000|Overall Study|Non-compliance|1|||
48730349|NCT02969707|156864287|FG001|Overall Study|Non-compliance|2|||
48730350|NCT04718103|156864288|FG000|Overall Study|Adverse Event|1|||
48730351|NCT04718103|156864289|FG001|Overall Study|Adverse Event|1|||
48730352|NCT04718103|156864288|FG000|Overall Study|Lack of Efficacy|4|||
48730353|NCT04718103|156864289|FG001|Overall Study|Lack of Efficacy|1|||
48730354|NCT04718103|156864288|FG000|Overall Study|Lost to Follow-up|2|||
48730355|NCT04718103|156864289|FG001|Overall Study|Lost to Follow-up|2|||
48730356|NCT04718103|156864288|FG000|Overall Study|Physician Decision|2|||
48730357|NCT04718103|156864289|FG001|Overall Study|Physician Decision|0|||
48730358|NCT04718103|156864288|FG000|Overall Study|Pregnancy|0|||
48730359|NCT04718103|156864289|FG001|Overall Study|Pregnancy|1|||
48730360|NCT04718103|156864288|FG000|Overall Study|Withdrawal by Subject|10|||
48730361|NCT04718103|156864289|FG001|Overall Study|Withdrawal by Subject|6|||
48730362|NCT04718103|156864288|FG000|Overall Study|Randomized, not treated|4|||
48730363|NCT04718103|156864289|FG001|Overall Study|Randomized, not treated|1|||
48730364|NCT04718103|156864288|FG000|Overall Study|GCP violations|7|||
48730365|NCT04718103|156864289|FG001|Overall Study|GCP violations|5|||
48730366|NCT04795622|156864290|FG000|Overall Study|Adverse Event|1|||
48730367|NCT04795622|156864291|FG001|Overall Study|Adverse Event|0|||
48730368|NCT04795622|156864290|FG000|Overall Study|Withdrawal by Subject|3|||
48730369|NCT04795622|156864291|FG001|Overall Study|Withdrawal by Subject|3|||
48730370|NCT04795622|156864290|FG000|Overall Study|Protocol Violation|0|||
48730371|NCT04795622|156864291|FG001|Overall Study|Protocol Violation|2|||
48730372|NCT04795622|156864290|FG000|Overall Study|Lost to Follow-up|2|||
48730373|NCT04795622|156864291|FG001|Overall Study|Lost to Follow-up|3|||
48730374|NCT04795622|156864290|FG000|Overall Study|Other|7|||
48730375|NCT04795622|156864291|FG001|Overall Study|Other|8|||
48730376|NCT01437878|156864299|FG000|Overall Study|Withdrawal by Subject|1|||
48730377|NCT01437878|156864300|FG001|Overall Study|Withdrawal by Subject|0|||
48730378|NCT01070043|156864301|FG000|Run-In Phase|Did not Meet Inclusion Criteria|18|||
49143724|NCT03446573|158366843|FG000|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|2|||
49143725|NCT03446573|158366844|FG001|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|0|||
49143726|NCT03446573|158366843|FG000|Late Switch Phase (Week 148 to Week 196)|Adverse Event|2|||
49143727|NCT03446573|158366844|FG001|Late Switch Phase (Week 148 to Week 196)|Adverse Event|9|||
49143728|NCT03446573|158366843|FG000|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
49143729|NCT03446573|158366844|FG001|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
49143730|NCT03446573|158366843|FG000|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|0|||
49143731|NCT03446573|158366844|FG001|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|1|||
49143732|NCT03446573|158366843|FG000|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|5|||
49143733|NCT03446573|158366844|FG001|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|6|||
49143734|NCT03446573|158366843|FG000|Late Switch Phase (Week 148 to Week 196)|Physician Decision|0|||
49143735|NCT03446573|158366844|FG001|Late Switch Phase (Week 148 to Week 196)|Physician Decision|1|||
49143736|NCT03446573|158366843|FG000|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|4|||
49143737|NCT03446573|158366844|FG001|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|6|||
49143738|NCT00378560|158366845|FG000|Overall Study|Adverse Event|1|||
49143739|NCT00378560|158366846|FG001|Overall Study|Adverse Event|0|||
49143740|NCT00378560|158366845|FG000|Overall Study|Lost to Follow-up|24|||
49143741|NCT00378560|158366846|FG001|Overall Study|Lost to Follow-up|29|||
49143742|NCT00378560|158366845|FG000|Overall Study|Protocol Violation|2|||
49143743|NCT00378560|158366846|FG001|Overall Study|Protocol Violation|0|||
49143744|NCT00378560|158366845|FG000|Overall Study|Withdrawal by Subject|17|||
49143745|NCT00378560|158366846|FG001|Overall Study|Withdrawal by Subject|21|||
49143746|NCT00378560|158366845|FG000|Overall Study|Moved|4|||
49143747|NCT00378560|158366846|FG001|Overall Study|Moved|3|||
49143748|NCT00378560|158366845|FG000|Overall Study|Pregnancy|7|||
48730379|NCT01070043|156864302|FG001|Run-In Phase|Did not Meet Inclusion Criteria|0|||
49012844|NCT05017493|157883569|FG001|Overall Study|Physician Decision|0|||
48730380|NCT01070043|156864303|FG002|Run-In Phase|Did not Meet Inclusion Criteria|0|||
48730381|NCT01070043|156864301|FG000|Double-Blind Treatment|Adverse Event|0|||
48730382|NCT01070043|156864302|FG001|Double-Blind Treatment|Adverse Event|0|||
48730383|NCT01070043|156864303|FG002|Double-Blind Treatment|Adverse Event|2|||
48730384|NCT01309308|156864306|FG000|Overall Study|Lost to Follow-up|6|||
49143749|NCT00378560|158366846|FG001|Overall Study|Pregnancy|5|||
49012845|NCT05017493|157883568|FG000|Overall Study|Protocol Violation|81|||
49012846|NCT05017493|157883569|FG001|Overall Study|Protocol Violation|0|||
49012847|NCT02175966|157883574|FG000|Follow-up Period|Lack of Efficacy|10|||
49012848|NCT02175966|157883575|FG001|Follow-up Period|Lack of Efficacy|6|||
49012849|NCT01851590|157883578|FG000|Overall Study|Withdrawal by Subject|0|||
49012850|NCT01851590|157883579|FG001|Overall Study|Withdrawal by Subject|0|||
49012851|NCT01851590|157883580|FG002|Overall Study|Withdrawal by Subject|1|||
48730385|NCT01309308|156864307|FG001|Overall Study|Lost to Follow-up|4|||
48730386|NCT04223232|156864310|FG000|Overall Study|Withdrawal by Subject|1|||
48730387|NCT03488927|156864311|FG000|Overall Study|Withdrawal by Subject|44|||
48730388|NCT03488927|156864312|FG001|Overall Study|Withdrawal by Subject|118|||
48730389|NCT03488927|156864313|FG002|Overall Study|Withdrawal by Subject|217|||
48730390|NCT02927262|156864314|FG000|Treatment Period (Up to 744 Days)|Withdrawal by Subject|3|||
48730391|NCT02927262|156864315|FG001|Treatment Period (Up to 744 Days)|Withdrawal by Subject|0|||
48730392|NCT02927262|156864314|FG000|Treatment Period (Up to 744 Days)|Death|1|||
48730393|NCT02927262|156864315|FG001|Treatment Period (Up to 744 Days)|Death|0|||
48730394|NCT02927262|156864314|FG000|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|1|||
48730395|NCT02927262|156864315|FG001|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|0|||
48730396|NCT02927262|156864314|FG000|Treatment Period (Up to 744 Days)|Physician Decision|1|||
48730397|NCT02927262|156864315|FG001|Treatment Period (Up to 744 Days)|Physician Decision|0|||
48730398|NCT02927262|156864314|FG000|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|0|||
48730399|NCT02927262|156864315|FG001|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|1|||
48730400|NCT02927262|156864314|FG000|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|0|||
48730401|NCT02927262|156864315|FG001|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|1|||
48730402|NCT02927262|156864314|FG000|Treatment Period (Up to 744 Days)|Randomized in error|1|||
48730403|NCT02927262|156864315|FG001|Treatment Period (Up to 744 Days)|Randomized in error|0|||
48730404|NCT02927262|156864314|FG000|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|1|||
48730405|NCT02927262|156864315|FG001|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|0|||
48730406|NCT02927262|156864314|FG000|Treatment Period (Up to 744 Days)|MRD positive|0|||
48730407|NCT02927262|156864315|FG001|Treatment Period (Up to 744 Days)|MRD positive|1|||
48730408|NCT02927262|156864314|FG000|Treatment Period (Up to 744 Days)|Disease Relapse|23|||
48730409|NCT02927262|156864315|FG001|Treatment Period (Up to 744 Days)|Disease Relapse|18|||
48730410|NCT02927262|156864314|FG000|Treatment Period (Up to 744 Days)|Adverse Event|7|||
48730411|NCT02927262|156864315|FG001|Treatment Period (Up to 744 Days)|Adverse Event|1|||
48730412|NCT02927262|156864314|FG000|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|1|||
48730413|NCT02927262|156864315|FG001|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|0|||
48730414|NCT02927262|156864314|FG000|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|0|||
48730415|NCT02927262|156864315|FG001|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|1|||
48730416|NCT02927262|156864314|FG000|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|0|||
48730417|NCT02927262|156864315|FG001|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|2|||
48730418|NCT02927262|156864314|FG000|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|2|||
48730419|NCT02927262|156864315|FG001|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|0|||
48730420|NCT02927262|156864314|FG000|Long Term Follow-up (Up to 1201 Days)|Death|23|||
48730421|NCT02927262|156864315|FG001|Long Term Follow-up (Up to 1201 Days)|Death|12|||
48730422|NCT00620464|156864316|FG000|Overall Study|Adverse Event|15|||
48730423|NCT00620464|156864317|FG001|Overall Study|Adverse Event|17|||
48730424|NCT00620464|156864316|FG000|Overall Study|Lost to Follow-up|1|||
48730425|NCT00620464|156864317|FG001|Overall Study|Lost to Follow-up|1|||
48730426|NCT00620464|156864316|FG000|Overall Study|Planning Pregnancy|1|||
48730427|NCT00620464|156864317|FG001|Overall Study|Planning Pregnancy|4|||
48730428|NCT00620464|156864316|FG000|Overall Study|Personal|2|||
48730429|NCT00620464|156864317|FG001|Overall Study|Personal|2|||
48730430|NCT00620464|156864316|FG000|Overall Study|Used prohibited medication|1|||
48730431|NCT00620464|156864317|FG001|Overall Study|Used prohibited medication|0|||
48730432|NCT02038452|156864318|FG000|Overall Study|Withdrawal by Subject|7|||
48730433|NCT02038452|156864319|FG001|Overall Study|Withdrawal by Subject|9|||
48730434|NCT02038452|156864318|FG000|Overall Study|Lost to Follow-up|31|||
48730435|NCT02038452|156864319|FG001|Overall Study|Lost to Follow-up|28|||
48730436|NCT00410202|156864322|FG000|On-Treatment|Continuing treatment|69|||
48730437|NCT00410202|156864323|FG001|On-Treatment|Continuing treatment|71|||
48730438|NCT00410202|156864324|FG002|On-Treatment|Continuing treatment|66|||
48730439|NCT00410202|156864322|FG000|On-Treatment|Adverse Event|1|||
48730440|NCT00410202|156864323|FG001|On-Treatment|Adverse Event|3|||
48730441|NCT00410202|156864324|FG002|On-Treatment|Adverse Event|2|||
49012852|NCT01851590|157883578|FG000|Overall Study|Adverse Event|0|||
49012853|NCT01851590|157883579|FG001|Overall Study|Adverse Event|0|||
49012854|NCT01851590|157883580|FG002|Overall Study|Adverse Event|2|||
48730442|NCT00410202|156864322|FG000|On-Treatment|Death|1|||
49012855|NCT01851590|157883578|FG000|Overall Study|Lack of Efficacy|0|||
49012856|NCT01851590|157883579|FG001|Overall Study|Lack of Efficacy|1|||
49012857|NCT01851590|157883580|FG002|Overall Study|Lack of Efficacy|0|||
49143750|NCT00378560|158366845|FG000|Overall Study|Laboratory test values abnormal|1|||
49143751|NCT00378560|158366846|FG001|Overall Study|Laboratory test values abnormal|0|||
49143752|NCT00976391|158366847|FG000|Treatment Period (52 Weeks)|Adverse Event|16|||
49143753|NCT00976391|158366848|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
49143754|NCT00976391|158366847|FG000|Treatment Period (52 Weeks)|Protocol Violation|1|||
49143755|NCT00976391|158366848|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
49143756|NCT00976391|158366847|FG000|Treatment Period (52 Weeks)|Noncompliance|4|||
49143757|NCT00976391|158366848|FG001|Treatment Period (52 Weeks)|Noncompliance|4|||
49143758|NCT00976391|158366847|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|10|||
49143759|NCT00976391|158366848|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|8|||
49143760|NCT00976391|158366847|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|9|||
49143761|NCT00976391|158366848|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|19|||
49143762|NCT00976391|158366847|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
49143763|NCT00976391|158366848|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
49143764|NCT00976391|158366847|FG000|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0|||
49143765|NCT00976391|158366848|FG001|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4|||
49143766|NCT00976391|158366847|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
49143767|NCT00976391|158366848|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
49143768|NCT00976391|158366847|FG000|Follow-up Period (8 Weeks)|Adverse Event|3|||
49143769|NCT00976391|158366848|FG001|Follow-up Period (8 Weeks)|Adverse Event|1|||
49143770|NCT00976391|158366847|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
49143771|NCT00976391|158366848|FG001|Follow-up Period (8 Weeks)|Noncompliance|2|||
49143772|NCT00976391|158366847|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|14|||
49143773|NCT00976391|158366848|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
49143774|NCT00976391|158366847|FG000|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6|||
49143775|NCT00976391|158366848|FG001|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8|||
49143776|NCT00976391|158366847|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
49143777|NCT00976391|158366848|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|7|||
49143778|NCT00976391|158366847|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
49143779|NCT00976391|158366848|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
49143780|NCT02852434|158366849|FG000|Overall Study|Withdrawal by Subject|0|||
49143781|NCT02852434|158366850|FG001|Overall Study|Withdrawal by Subject|1|||
49143782|NCT02852434|158366849|FG000|Overall Study|Unsuccessful Dilator Procedure|2|||
49143783|NCT02852434|158366850|FG001|Overall Study|Unsuccessful Dilator Procedure|0|||
49143784|NCT03188705|158366851|FG000|Clopidogrel Treatment|Withdrawal by Subject|1|||
49143785|NCT03188705|158366851|FG000|Clopidogrel Plus Aspirin Treatment|Withdrawal by Subject|1|||
49143786|NCT02018887|158366852|FG000|Part A: Cohorts 1-2: Period 3|Adverse Event|1|||
49143787|NCT02018887|158366853|FG001|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
49143788|NCT02018887|158366854|FG002|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
49143789|NCT02018887|158366855|FG003|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
49143790|NCT02018887|158366856|FG004|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
49143791|NCT02018887|158366857|FG005|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
49143792|NCT02018887|158366858|FG006|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
49143793|NCT02018887|158366859|FG007|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
49143794|NCT02018887|158366860|FG008|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
49143795|NCT02018887|158366861|FG009|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
49143796|NCT02018887|158366862|FG010|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
49143797|NCT02018887|158366852|FG000|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
49143798|NCT02018887|158366853|FG001|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
49143799|NCT02018887|158366854|FG002|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
49143800|NCT02018887|158366855|FG003|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
49143801|NCT02018887|158366856|FG004|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
49143802|NCT02018887|158366857|FG005|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
49143803|NCT02018887|158366858|FG006|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
49143804|NCT02018887|158366859|FG007|Part B: Cohorts 3-7 Overall|Adverse Event|4|||
49143805|NCT02018887|158366860|FG008|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
49143806|NCT02018887|158366861|FG009|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
49143807|NCT02018887|158366862|FG010|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
49143808|NCT02018887|158366852|FG000|Part C: Cohort 8 Overall|Adverse Event|0|||
49143809|NCT02018887|158366853|FG001|Part C: Cohort 8 Overall|Adverse Event|0|||
49143810|NCT02018887|158366854|FG002|Part C: Cohort 8 Overall|Adverse Event|0|||
49143811|NCT02018887|158366855|FG003|Part C: Cohort 8 Overall|Adverse Event|0|||
49143812|NCT02018887|158366856|FG004|Part C: Cohort 8 Overall|Adverse Event|0|||
49143813|NCT02018887|158366857|FG005|Part C: Cohort 8 Overall|Adverse Event|0|||
49143814|NCT02018887|158366858|FG006|Part C: Cohort 8 Overall|Adverse Event|0|||
49143815|NCT02018887|158366859|FG007|Part C: Cohort 8 Overall|Adverse Event|0|||
49143816|NCT02018887|158366860|FG008|Part C: Cohort 8 Overall|Adverse Event|1|||
49143817|NCT02018887|158366861|FG009|Part C: Cohort 8 Overall|Adverse Event|3|||
49143818|NCT02018887|158366862|FG010|Part C: Cohort 8 Overall|Adverse Event|0|||
49143819|NCT02018887|158366852|FG000|Part C: Cohort 8 Overall|Physician Decision|0|||
49012858|NCT01862328|157883585|FG000|Overall Study|Progressive Disease|3|||
49143820|NCT02018887|158366853|FG001|Part C: Cohort 8 Overall|Physician Decision|0|||
49143821|NCT02018887|158366854|FG002|Part C: Cohort 8 Overall|Physician Decision|0|||
49143822|NCT02018887|158366855|FG003|Part C: Cohort 8 Overall|Physician Decision|0|||
49143823|NCT02018887|158366856|FG004|Part C: Cohort 8 Overall|Physician Decision|0|||
49143824|NCT02018887|158366857|FG005|Part C: Cohort 8 Overall|Physician Decision|0|||
49143825|NCT02018887|158366858|FG006|Part C: Cohort 8 Overall|Physician Decision|0|||
49143826|NCT02018887|158366859|FG007|Part C: Cohort 8 Overall|Physician Decision|0|||
49143827|NCT02018887|158366860|FG008|Part C: Cohort 8 Overall|Physician Decision|2|||
49143828|NCT02018887|158366861|FG009|Part C: Cohort 8 Overall|Physician Decision|0|||
49143829|NCT02018887|158366862|FG010|Part C: Cohort 8 Overall|Physician Decision|1|||
49143830|NCT01174459|158366863|FG000|Overall Study|case report form (CRF) not collected|5|||
49143831|NCT03123588|158366864|FG000|Overall Study|Study Terminated by Sponsor|2|||
49143832|NCT03123588|158366865|FG001|Overall Study|Study Terminated by Sponsor|5|||
48730443|NCT00410202|156864323|FG001|On-Treatment|Death|0|||
48730444|NCT00410202|156864324|FG002|On-Treatment|Death|0|||
48730445|NCT00410202|156864322|FG000|On-Treatment|Lost to Follow-up|1|||
48730446|NCT00410202|156864323|FG001|On-Treatment|Lost to Follow-up|0|||
48730447|NCT00410202|156864324|FG002|On-Treatment|Lost to Follow-up|1|||
49143833|NCT03123588|158366864|FG000|Overall Study|Withdrawal by Subject|1|||
49143834|NCT03123588|158366865|FG001|Overall Study|Withdrawal by Subject|0|||
49143835|NCT03123588|158366864|FG000|Overall Study|Adverse Event|1|||
49143836|NCT03123588|158366865|FG001|Overall Study|Adverse Event|0|||
49143837|NCT03123588|158366864|FG000|Overall Study|Physician Decision|2|||
49143838|NCT03123588|158366865|FG001|Overall Study|Physician Decision|1|||
49143839|NCT01698008|158366866|FG000|Overall Study|Withdrawal by Subject|1|||
49143840|NCT01698008|158366867|FG001|Overall Study|Withdrawal by Subject|2|||
49143841|NCT00290758|158366870|FG000|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1|||
49143842|NCT00290758|158366871|FG001|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2|||
49143843|NCT00290758|158366870|FG000|Pre-Intervention rFNA Through Follow-Up|ConMeds|1|||
49143844|NCT00290758|158366871|FG001|Pre-Intervention rFNA Through Follow-Up|ConMeds|0|||
48730448|NCT00410202|156864322|FG000|On-Treatment|Lack of Efficacy|1|||
48730449|NCT00410202|156864323|FG001|On-Treatment|Lack of Efficacy|4|||
49143845|NCT00290758|158366870|FG000|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3|||
49143846|NCT00290758|158366871|FG001|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1|||
49143847|NCT00290758|158366870|FG000|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
49143848|NCT00290758|158366871|FG001|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
49143849|NCT00290758|158366870|FG000|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0|||
49143850|NCT00290758|158366871|FG001|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5|||
49143851|NCT00290758|158366870|FG000|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1|||
49143852|NCT00290758|158366871|FG001|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0|||
49143853|NCT00290758|158366870|FG000|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0|||
49143854|NCT00290758|158366871|FG001|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1|||
49143855|NCT00290758|158366870|FG000|Post Intervention rFNA|<4000 Epithelial Cells|6|||
49143856|NCT00290758|158366871|FG001|Post Intervention rFNA|<4000 Epithelial Cells|5|||
49143857|NCT03436420|158366872|FG000|Overall Study|Lack of Efficacy|3|||
49143858|NCT04389671|158366873|FG000|Overall Study|Death|7|||
49143859|NCT03994120|158366874|FG000|Overall Study|Lost to Follow-up|3|||
49143860|NCT03994120|158366875|FG001|Overall Study|Lost to Follow-up|1|||
49143861|NCT00215553|158366876|FG000|Overall Study|Adverse Event|0|||
49143862|NCT00215553|158366877|FG001|Overall Study|Adverse Event|1|||
49143863|NCT00215553|158366878|FG002|Overall Study|Adverse Event|2|||
48730450|NCT00410202|156864324|FG002|On-Treatment|Lack of Efficacy|0|||
48730451|NCT00410202|156864322|FG000|On-Treatment|Withdrawal by Subject|2|||
48730452|NCT00410202|156864323|FG001|On-Treatment|Withdrawal by Subject|1|||
48730453|NCT00410202|156864324|FG002|On-Treatment|Withdrawal by Subject|1|||
48730454|NCT00410202|156864322|FG000|On-Treatment|Other Reason|0|||
48730455|NCT00410202|156864323|FG001|On-Treatment|Other Reason|0|||
48730456|NCT00410202|156864324|FG002|On-Treatment|Other Reason|1|||
49143864|NCT00215553|158366879|FG003|Overall Study|Adverse Event|1|||
49143865|NCT00215553|158366880|FG004|Overall Study|Adverse Event|2|||
49143866|NCT00215553|158366881|FG005|Overall Study|Adverse Event|6|||
49143867|NCT00215553|158366882|FG006|Overall Study|Adverse Event|0|||
49143868|NCT03178942|158366883|FG000|Overall Study|Withdrawal by Subject|2|||
49143869|NCT03178942|158366884|FG001|Overall Study|Withdrawal by Subject|0|||
49143870|NCT03178942|158366883|FG000|Overall Study|Lost to Follow-up|1|||
49143871|NCT03178942|158366884|FG001|Overall Study|Lost to Follow-up|2|||
48730457|NCT00410202|156864322|FG000|Off-treatment Follow up|Continuing off-treatment follow up|10|||
48730458|NCT00410202|156864323|FG001|Off-treatment Follow up|Continuing off-treatment follow up|8|||
48730459|NCT00410202|156864324|FG002|Off-treatment Follow up|Continuing off-treatment follow up|11|||
49143872|NCT01429623|158366885|FG000|Overall Study|Death|1|||
49143873|NCT01429623|158366886|FG001|Overall Study|Death|0|||
48730460|NCT00410202|156864322|FG000|Off-treatment Follow up|Follow up not required per protocol|3|||
48730461|NCT00410202|156864323|FG001|Off-treatment Follow up|Follow up not required per protocol|0|||
48730462|NCT00410202|156864324|FG002|Off-treatment Follow up|Follow up not required per protocol|1|||
48730463|NCT00410202|156864322|FG000|Off-treatment Follow up|Lost to Follow-up|1|||
48730464|NCT00410202|156864323|FG001|Off-treatment Follow up|Lost to Follow-up|0|||
48730465|NCT00410202|156864324|FG002|Off-treatment Follow up|Lost to Follow-up|0|||
48730466|NCT02676466|156864325|FG000|Overall Study|Death|0|||
48730467|NCT02676466|156864326|FG001|Overall Study|Death|2|||
48730468|NCT02676466|156864327|FG002|Overall Study|Death|1|||
48730469|NCT02676466|156864328|FG003|Overall Study|Death|0|||
48730470|NCT02676466|156864329|FG004|Overall Study|Death|0|||
48730471|NCT02676466|156864330|FG005|Overall Study|Death|0|||
48730472|NCT02676466|156864331|FG006|Overall Study|Death|0|||
48730473|NCT02676466|156864332|FG007|Overall Study|Death|0|||
48730474|NCT02676466|156864325|FG000|Overall Study|Withdrawal by Subject|4|||
48730475|NCT02676466|156864326|FG001|Overall Study|Withdrawal by Subject|3|||
48730476|NCT02676466|156864327|FG002|Overall Study|Withdrawal by Subject|1|||
48730477|NCT02676466|156864328|FG003|Overall Study|Withdrawal by Subject|0|||
48730478|NCT02676466|156864329|FG004|Overall Study|Withdrawal by Subject|3|||
48730479|NCT02676466|156864330|FG005|Overall Study|Withdrawal by Subject|1|||
48730480|NCT02676466|156864331|FG006|Overall Study|Withdrawal by Subject|1|||
48730481|NCT02676466|156864332|FG007|Overall Study|Withdrawal by Subject|1|||
48730482|NCT01178073|156864333|FG000|Overall Study|Adverse Event|34|||
49143874|NCT01429623|158366885|FG000|Overall Study|Adverse Event|7|||
49143875|NCT01429623|158366886|FG001|Overall Study|Adverse Event|14|||
49143876|NCT01429623|158366885|FG000|Overall Study|Withdrawal by Subject|19|||
49143877|NCT01429623|158366886|FG001|Overall Study|Withdrawal by Subject|13|||
49143878|NCT01429623|158366885|FG000|Overall Study|Physician Decision|2|||
49143879|NCT01429623|158366886|FG001|Overall Study|Physician Decision|3|||
49143880|NCT01429623|158366885|FG000|Overall Study|Protocol Violation|3|||
49143881|NCT01429623|158366886|FG001|Overall Study|Protocol Violation|2|||
49143882|NCT01429623|158366885|FG000|Overall Study|Assorted|1|||
49143883|NCT01429623|158366886|FG001|Overall Study|Assorted|2|||
49143884|NCT01429623|158366885|FG000|Overall Study|Conversion to Alzheimer's disease|14|||
49143885|NCT01429623|158366886|FG001|Overall Study|Conversion to Alzheimer's disease|21|||
49143886|NCT01429623|158366885|FG000|Overall Study|No post baseline data|4|||
49143887|NCT01429623|158366886|FG001|Overall Study|No post baseline data|4|||
48730483|NCT01178073|156864334|FG001|Overall Study|Adverse Event|27|||
48730484|NCT01178073|156864335|FG002|Overall Study|Adverse Event|24|||
48730485|NCT01178073|156864333|FG000|Overall Study|Protocol Violation|1|||
48730486|NCT01178073|156864334|FG001|Overall Study|Protocol Violation|1|||
48730487|NCT01178073|156864335|FG002|Overall Study|Protocol Violation|1|||
48730488|NCT01178073|156864333|FG000|Overall Study|Lost to Follow-up|2|||
48730489|NCT01178073|156864334|FG001|Overall Study|Lost to Follow-up|0|||
48730490|NCT01178073|156864335|FG002|Overall Study|Lost to Follow-up|3|||
48730491|NCT01178073|156864333|FG000|Overall Study|Physician Decision|14|||
48730492|NCT01178073|156864334|FG001|Overall Study|Physician Decision|10|||
48730493|NCT01178073|156864335|FG002|Overall Study|Physician Decision|10|||
48730494|NCT01178073|156864333|FG000|Overall Study|Withdrawal by Subject|10|||
48730495|NCT01178073|156864334|FG001|Overall Study|Withdrawal by Subject|6|||
48730496|NCT01178073|156864335|FG002|Overall Study|Withdrawal by Subject|8|||
48730497|NCT01178073|156864333|FG000|Overall Study|Missing Completion Status|1|||
48822711|NCT02081391|157190576|FG003|12-hour Treatment|Recovery (opioid no longer needed)|0|||
48822712|NCT02081391|157190573|FG000|12-hour Treatment|Further reasons|2|||
48822713|NCT02081391|157190574|FG001|12-hour Treatment|Further reasons|1|||
48822714|NCT02081391|157190575|FG002|12-hour Treatment|Further reasons|0|||
48822715|NCT02081391|157190576|FG003|12-hour Treatment|Further reasons|0|||
48822716|NCT02081391|157190573|FG000|24-hour Treatment and Trial Completion|Physician Decision|10|||
48822717|NCT02081391|157190574|FG001|24-hour Treatment and Trial Completion|Physician Decision|5|||
48822718|NCT02081391|157190575|FG002|24-hour Treatment and Trial Completion|Physician Decision|0|||
48822719|NCT02081391|157190576|FG003|24-hour Treatment and Trial Completion|Physician Decision|0|||
49012859|NCT01862328|157883586|FG001|Overall Study|Progressive Disease|11|||
48730498|NCT01178073|156864334|FG001|Overall Study|Missing Completion Status|0|||
49012860|NCT01862328|157883587|FG002|Overall Study|Progressive Disease|5|||
49012861|NCT01862328|157883588|FG003|Overall Study|Progressive Disease|6|||
48822720|NCT02081391|157190573|FG000|24-hour Treatment and Trial Completion|Lack of Efficacy|1|||
49012862|NCT01862328|157883589|FG004|Overall Study|Progressive Disease|7|||
49012863|NCT01862328|157883590|FG005|Overall Study|Progressive Disease|4|||
49012864|NCT01862328|157883591|FG006|Overall Study|Progressive Disease|3|||
49012865|NCT01862328|157883585|FG000|Overall Study|Adverse Event|0|||
49012866|NCT01862328|157883586|FG001|Overall Study|Adverse Event|4|||
49012867|NCT01862328|157883587|FG002|Overall Study|Adverse Event|0|||
49012868|NCT01862328|157883588|FG003|Overall Study|Adverse Event|1|||
49012869|NCT01862328|157883589|FG004|Overall Study|Adverse Event|0|||
49012870|NCT01862328|157883590|FG005|Overall Study|Adverse Event|2|||
49012871|NCT01862328|157883591|FG006|Overall Study|Adverse Event|4|||
49012872|NCT01862328|157883585|FG000|Overall Study|Other|0|||
49012873|NCT01862328|157883586|FG001|Overall Study|Other|2|||
49012874|NCT01862328|157883587|FG002|Overall Study|Other|1|||
49012875|NCT01862328|157883588|FG003|Overall Study|Other|0|||
49143888|NCT00981175|158366887|FG000|Primary Dose Vaccination|Adverse Event|1|||
49143889|NCT00981175|158366888|FG001|Primary Dose Vaccination|Adverse Event|0|||
49143890|NCT00981175|158366887|FG000|Primary Dose Vaccination|Protocol Violation|0|||
49143891|NCT00981175|158366888|FG001|Primary Dose Vaccination|Protocol Violation|1|||
49143892|NCT00981175|158366887|FG000|Primary Dose Vaccination|Lost to Follow-up|2|||
49143893|NCT00981175|158366888|FG001|Primary Dose Vaccination|Lost to Follow-up|1|||
49143894|NCT00981175|158366887|FG000|Booster Dose Vaccination|Lost to Follow-up|2|||
49143895|NCT00981175|158366888|FG001|Booster Dose Vaccination|Lost to Follow-up|3|||
49143896|NCT01096186|158366890|FG000|Overall Study|Adverse Event|16|||
49143897|NCT01096186|158366890|FG000|Overall Study|Death|4|||
49143898|NCT01096186|158366890|FG000|Overall Study|Lack of Efficacy|4|||
49143899|NCT01096186|158366890|FG000|Overall Study|Lost to Follow-up|2|||
49143900|NCT01096186|158366890|FG000|Overall Study|Withdrawal by Subject|22|||
49143901|NCT01096186|158366890|FG000|Overall Study|Physician Decision|1|||
49143902|NCT01096186|158366890|FG000|Overall Study|Noncompliance with study drug|1|||
49143903|NCT01061710|158366891|FG000|Overall Study|Protocol Violation|14|||
49143904|NCT03473301|158366892|FG000|Overall Study|Protocol Violation|4|||
49143905|NCT03473301|158366893|FG001|Overall Study|Protocol Violation|0|||
49143906|NCT03473301|158366894|FG002|Overall Study|Protocol Violation|0|||
49143907|NCT03473301|158366892|FG000|Overall Study|Withdrawal by Subject|0|||
49143908|NCT03473301|158366893|FG001|Overall Study|Withdrawal by Subject|1|||
49143909|NCT03473301|158366894|FG002|Overall Study|Withdrawal by Subject|0|||
49143910|NCT03473301|158366892|FG000|Overall Study|Missed study visit due to pandemic restrictions|7|||
49143911|NCT03473301|158366893|FG001|Overall Study|Missed study visit due to pandemic restrictions|5|||
49143912|NCT03473301|158366894|FG002|Overall Study|Missed study visit due to pandemic restrictions|6|||
49143913|NCT04913675|158366895|FG000|Main Study (Up to Week 36)|Death|0|||
49143914|NCT04913675|158366896|FG001|Main Study (Up to Week 36)|Death|2|||
49143915|NCT04913675|158366897|FG002|Main Study (Up to Week 36)|Death|2|||
49143916|NCT04913675|158366898|FG003|Main Study (Up to Week 36)|Death|0|||
49143917|NCT04913675|158366895|FG000|Main Study (Up to Week 36)|Lost to Follow-up|12|||
49143918|NCT04913675|158366896|FG001|Main Study (Up to Week 36)|Lost to Follow-up|8|||
49143919|NCT04913675|158366897|FG002|Main Study (Up to Week 36)|Lost to Follow-up|4|||
49143920|NCT04913675|158366898|FG003|Main Study (Up to Week 36)|Lost to Follow-up|0|||
49143921|NCT04913675|158366895|FG000|Main Study (Up to Week 36)|Physician Decision|0|||
49143922|NCT04913675|158366896|FG001|Main Study (Up to Week 36)|Physician Decision|1|||
49143923|NCT04913675|158366897|FG002|Main Study (Up to Week 36)|Physician Decision|1|||
49143924|NCT04913675|158366898|FG003|Main Study (Up to Week 36)|Physician Decision|0|||
49143925|NCT04913675|158366895|FG000|Main Study (Up to Week 36)|Withdrawal by Subject|25|||
49143926|NCT04913675|158366896|FG001|Main Study (Up to Week 36)|Withdrawal by Subject|33|||
49143927|NCT04913675|158366897|FG002|Main Study (Up to Week 36)|Withdrawal by Subject|12|||
49143928|NCT04913675|158366898|FG003|Main Study (Up to Week 36)|Withdrawal by Subject|0|||
49143929|NCT04913675|158366895|FG000|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
49143930|NCT04913675|158366896|FG001|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
49143931|NCT04913675|158366897|FG002|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
49143932|NCT04913675|158366898|FG003|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|1|||
49143933|NCT04648241|158366899|FG000|Overall Study|Lost to Follow-up|1|||
49143934|NCT04648241|158366900|FG001|Overall Study|Lost to Follow-up|0|||
49143935|NCT02218268|158366901|FG000|24 Hour Washout|Physician Decision|11|||
49143936|NCT02218268|158366902|FG001|24 Hour Washout|Physician Decision|9|||
49143937|NCT00689052|158366903|FG000|Overall Study|Adverse Event|4|||
49143938|NCT00689052|158366904|FG001|Overall Study|Adverse Event|6|||
49143939|NCT00689052|158366903|FG000|Overall Study|Protocol Violation|1|||
49143940|NCT00689052|158366904|FG001|Overall Study|Protocol Violation|0|||
49143941|NCT00689052|158366903|FG000|Overall Study|Lost to Follow-up|2|||
49143942|NCT00689052|158366904|FG001|Overall Study|Lost to Follow-up|0|||
49143943|NCT00689052|158366903|FG000|Overall Study|Withdrawal by Subject|2|||
49143944|NCT00689052|158366904|FG001|Overall Study|Withdrawal by Subject|0|||
49143945|NCT00689052|158366903|FG000|Overall Study|Early termination of the trial|22|||
49143946|NCT00689052|158366904|FG001|Overall Study|Early termination of the trial|24|||
49143947|NCT02569242|158366905|FG000|Overall Study|Death|1|||
49143948|NCT02569242|158366906|FG001|Overall Study|Death|0|||
49143949|NCT02569242|158366905|FG000|Overall Study|Withdrawal by Subject|0|||
49143950|NCT02569242|158366906|FG001|Overall Study|Withdrawal by Subject|1|||
49143951|NCT01117350|158366909|FG000|Comparative Period|Not Treated|5|||
49143952|NCT01117350|158366910|FG001|Comparative Period|Not Treated|8|||
49143953|NCT01117350|158366909|FG000|Comparative Period|Adverse Event|6|||
48730499|NCT01178073|156864335|FG002|Overall Study|Missing Completion Status|0|||
48730500|NCT00986479|156864336|FG000|Period 1|Improved mood|1|||
48730501|NCT00986479|156864337|FG001|Period 1|Improved mood|0|||
48730502|NCT00986479|156864336|FG000|Period 1|Administrative reasons|1|||
49143954|NCT01117350|158366910|FG001|Comparative Period|Adverse Event|33|||
49143955|NCT01117350|158366909|FG000|Comparative Period|Lost to Follow-up|11|||
49143956|NCT01117350|158366910|FG001|Comparative Period|Lost to Follow-up|7|||
49143957|NCT01117350|158366909|FG000|Comparative Period|Withdrawal by Subject|9|||
49143958|NCT01117350|158366910|FG001|Comparative Period|Withdrawal by Subject|13|||
49143959|NCT01117350|158366909|FG000|Comparative Period|Protocol Violation|8|||
49143960|NCT01117350|158366910|FG001|Comparative Period|Protocol Violation|12|||
49143961|NCT01117350|158366909|FG000|Comparative Period|Lack of Efficacy|1|||
49143962|NCT01117350|158366910|FG001|Comparative Period|Lack of Efficacy|0|||
49143963|NCT01117350|158366909|FG000|Comparative Period|Physician Decision|0|||
49143964|NCT01117350|158366910|FG001|Comparative Period|Physician Decision|1|||
49143965|NCT01117350|158366909|FG000|Comparative Period|Move to another city/country|2|||
49143966|NCT01117350|158366910|FG001|Comparative Period|Move to another city/country|1|||
49143967|NCT01117350|158366909|FG000|Extension Period|Not included in extension, not treated|0|||
49143968|NCT01117350|158366910|FG001|Extension Period|Not included in extension, not treated|50|||
49143969|NCT01117350|158366909|FG000|Extension Period|Adverse Event|0|||
49143970|NCT01117350|158366910|FG001|Extension Period|Adverse Event|2|||
49143971|NCT01117350|158366909|FG000|Extension Period|Protocol Violation|0|||
49143972|NCT01117350|158366910|FG001|Extension Period|Protocol Violation|2|||
49143973|NCT01117350|158366909|FG000|Extension Period|Lost to Follow-up|0|||
49143974|NCT01117350|158366910|FG001|Extension Period|Lost to Follow-up|2|||
49143975|NCT01117350|158366909|FG000|Extension Period|Withdrawal by Subject|0|||
49143976|NCT01117350|158366910|FG001|Extension Period|Withdrawal by Subject|3|||
49143977|NCT01117350|158366909|FG000|Extension Period|Lack of Efficacy|0|||
49143978|NCT01117350|158366910|FG001|Extension Period|Lack of Efficacy|2|||
49143979|NCT01117350|158366909|FG000|Extension Period|Inclusion criteria not respected|0|||
49143980|NCT01117350|158366910|FG001|Extension Period|Inclusion criteria not respected|1|||
49143981|NCT01117350|158366909|FG000|Extension Period|Prohibited medication|0|||
49143982|NCT01117350|158366910|FG001|Extension Period|Prohibited medication|1|||
49143983|NCT02975700|158366917|FG000|Overall Study|Adverse Event|1|||
49143984|NCT02975700|158366917|FG000|Overall Study|Progressive disease|3|||
49143985|NCT02975700|158366917|FG000|Overall Study|Failed screening criteria|2|||
49143986|NCT03511209|158366921|FG000|Overall Study|Withdrawal by Subject|2|||
49143987|NCT03511209|158366922|FG001|Overall Study|Withdrawal by Subject|4|||
49143988|NCT03511209|158366921|FG000|Overall Study|Death|1|||
49143989|NCT03511209|158366922|FG001|Overall Study|Death|0|||
49143990|NCT03511209|158366921|FG000|Overall Study|Lost to Follow-up|0|||
49143991|NCT03511209|158366922|FG001|Overall Study|Lost to Follow-up|2|||
49143992|NCT03462563|158366923|FG000|Overall Study|Death|1|||
49143993|NCT03462563|158366924|FG001|Overall Study|Death|1|||
49143994|NCT03462563|158366923|FG000|Overall Study|Termination of study|2|||
49143995|NCT03462563|158366924|FG001|Overall Study|Termination of study|1|||
49143996|NCT03462563|158366923|FG000|Overall Study|Adverse Event|1|||
48822721|NCT02081391|157190574|FG001|24-hour Treatment and Trial Completion|Lack of Efficacy|3|||
48822722|NCT02081391|157190575|FG002|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
48822723|NCT02081391|157190576|FG003|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
49143997|NCT03462563|158366924|FG001|Overall Study|Adverse Event|3|||
49143998|NCT03462563|158366923|FG000|Overall Study|Unspecified reason|10|||
49143999|NCT03462563|158366924|FG001|Overall Study|Unspecified reason|12|||
49144000|NCT03462563|158366923|FG000|Overall Study|Physician Decision|1|||
48822724|NCT02081391|157190573|FG000|24-hour Treatment and Trial Completion|Adverse Event|1|||
48822725|NCT02081391|157190574|FG001|24-hour Treatment and Trial Completion|Adverse Event|0|||
48822726|NCT02081391|157190575|FG002|24-hour Treatment and Trial Completion|Adverse Event|0|||
48822727|NCT02081391|157190576|FG003|24-hour Treatment and Trial Completion|Adverse Event|0|||
48822728|NCT02081391|157190573|FG000|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11|||
48822729|NCT02081391|157190574|FG001|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5|||
48822730|NCT02081391|157190575|FG002|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1|||
48822731|NCT02081391|157190576|FG003|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0|||
48822732|NCT02081391|157190573|FG000|24-hour Treatment and Trial Completion|Technical Problems|1|||
48822733|NCT02081391|157190574|FG001|24-hour Treatment and Trial Completion|Technical Problems|1|||
48822734|NCT02081391|157190575|FG002|24-hour Treatment and Trial Completion|Technical Problems|0|||
48822735|NCT02081391|157190576|FG003|24-hour Treatment and Trial Completion|Technical Problems|0|||
48822736|NCT02081391|157190573|FG000|24-hour Treatment and Trial Completion|Further reasons|3|||
48822737|NCT02081391|157190574|FG001|24-hour Treatment and Trial Completion|Further reasons|4|||
48822738|NCT02081391|157190575|FG002|24-hour Treatment and Trial Completion|Further reasons|0|||
48822739|NCT02081391|157190576|FG003|24-hour Treatment and Trial Completion|Further reasons|0|||
48822740|NCT01712685|157190580|FG000|Overall Study|pt declined to participate before trmt|1|||
48822741|NCT01449929|157190587|FG000|Randomization Phase 96 Week|Adverse Event|5|||
48822742|NCT01449929|157190588|FG001|Randomization Phase 96 Week|Adverse Event|13|||
49144001|NCT03462563|158366924|FG001|Overall Study|Physician Decision|0|||
49144002|NCT02021318|158366925|FG000|Overall Study|Adverse Event|2|||
49144003|NCT02021318|158366926|FG001|Overall Study|Adverse Event|1|||
49144004|NCT02021318|158366925|FG000|Overall Study|Death|33|||
49144005|NCT02021318|158366926|FG001|Overall Study|Death|34|||
49144006|NCT02021318|158366925|FG000|Overall Study|Lost to Follow-up|3|||
49144007|NCT02021318|158366926|FG001|Overall Study|Lost to Follow-up|3|||
49144008|NCT02021318|158366925|FG000|Overall Study|Progressive Disease|0|||
49144009|NCT02021318|158366926|FG001|Overall Study|Progressive Disease|1|||
49144010|NCT02021318|158366925|FG000|Overall Study|Withdrawal by Subject|30|||
49144011|NCT02021318|158366926|FG001|Overall Study|Withdrawal by Subject|18|||
49144012|NCT02021318|158366925|FG000|Overall Study|Physician Decision|3|||
49144013|NCT02021318|158366926|FG001|Overall Study|Physician Decision|3|||
49144014|NCT02021318|158366925|FG000|Overall Study|Miscellaneous|2|||
48730503|NCT00986479|156864337|FG001|Period 1|Administrative reasons|0|||
48730504|NCT00771316|156864345|FG000|Overall Study|Adverse Event|0|||
49144015|NCT02021318|158366926|FG001|Overall Study|Miscellaneous|3|||
49144016|NCT01602666|158366927|FG000|Induction Chemotherapy|Death|2|||
49144017|NCT01602666|158366928|FG001|Induction Chemotherapy|Death|1|||
49144018|NCT01602666|158366927|FG000|Induction Chemotherapy|Lack of Efficacy|16|||
49144019|NCT01602666|158366928|FG001|Induction Chemotherapy|Lack of Efficacy|7|||
49144020|NCT01602666|158366927|FG000|Induction Chemotherapy|Physician Decision|12|||
49144021|NCT01602666|158366928|FG001|Induction Chemotherapy|Physician Decision|5|||
49144022|NCT01602666|158366927|FG000|Induction Chemotherapy|Withdrawal by Subject|0|||
49144023|NCT01602666|158366928|FG001|Induction Chemotherapy|Withdrawal by Subject|2|||
49144024|NCT01602666|158366927|FG000|Induction Chemotherapy|Refusal of further protocol therapy|5|||
49144025|NCT01602666|158366928|FG001|Induction Chemotherapy|Refusal of further protocol therapy|6|||
49144026|NCT01602666|158366927|FG000|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2|||
49144027|NCT01602666|158366928|FG001|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3|||
49144028|NCT01602666|158366927|FG000|Radiation Therapy on Protocol|Lost to Follow-up|4|||
49144029|NCT01602666|158366928|FG001|Radiation Therapy on Protocol|Lost to Follow-up|5|||
49144030|NCT01602666|158366927|FG000|Radiation Therapy on Protocol|Withdrawal by Subject|2|||
49144031|NCT01602666|158366928|FG001|Radiation Therapy on Protocol|Withdrawal by Subject|3|||
49144032|NCT01602666|158366927|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4|||
49144033|NCT01602666|158366928|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0|||
49144034|NCT01602666|158366927|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0|||
49144035|NCT01602666|158366928|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14|||
49144036|NCT01602666|158366927|FG000|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0|||
49144037|NCT01602666|158366928|FG001|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9|||
49144038|NCT02614066|158366929|FG000|Overall Study|Death|6|||
49144039|NCT02614066|158366930|FG001|Overall Study|Death|14|||
49144040|NCT02614066|158366931|FG002|Overall Study|Death|11|||
49144041|NCT02614066|158366932|FG003|Overall Study|Death|29|||
49144042|NCT02614066|158366929|FG000|Overall Study|Full consent withdrawn|0|||
49144043|NCT02614066|158366930|FG001|Overall Study|Full consent withdrawn|1|||
49144044|NCT02614066|158366931|FG002|Overall Study|Full consent withdrawn|0|||
49144045|NCT02614066|158366932|FG003|Overall Study|Full consent withdrawn|8|||
49144046|NCT02614066|158366929|FG000|Overall Study|Lost to Follow-up|0|||
49144047|NCT02614066|158366930|FG001|Overall Study|Lost to Follow-up|2|||
49144048|NCT02614066|158366931|FG002|Overall Study|Lost to Follow-up|2|||
49144049|NCT02614066|158366932|FG003|Overall Study|Lost to Follow-up|2|||
49144050|NCT02614066|158366929|FG000|Overall Study|Enrolled but did not Initiate KTE-X19|0|||
49144051|NCT02614066|158366930|FG001|Overall Study|Enrolled but did not Initiate KTE-X19|5|||
49144052|NCT02614066|158366931|FG002|Overall Study|Enrolled but did not Initiate KTE-X19|4|||
49144053|NCT02614066|158366932|FG003|Overall Study|Enrolled but did not Initiate KTE-X19|16|||
49144054|NCT02614066|158366929|FG000|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|0|||
49144055|NCT02614066|158366930|FG001|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|4|||
49144056|NCT02614066|158366931|FG002|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|2|||
49144057|NCT02614066|158366932|FG003|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|15|||
49144058|NCT02614066|158366929|FG000|Overall Study|Reason not specified|0|||
49144059|NCT02614066|158366930|FG001|Overall Study|Reason not specified|2|||
49144060|NCT02614066|158366931|FG002|Overall Study|Reason not specified|1|||
49144061|NCT02614066|158366932|FG003|Overall Study|Reason not specified|1|||
49144062|NCT01185366|158366933|FG000|First Line Therapy|Insurance Coverage Denied|1|||
49144063|NCT01185366|158366934|FG001|First Line Therapy|Insurance Coverage Denied|1|||
49144064|NCT01185366|158366933|FG000|First Line Therapy|Withdrawal by Subject|1|||
49144065|NCT01185366|158366934|FG001|First Line Therapy|Withdrawal by Subject|0|||
49144066|NCT01185366|158366933|FG000|First Line Therapy|Lack of Metastatic Site|1|||
49144067|NCT01185366|158366934|FG001|First Line Therapy|Lack of Metastatic Site|0|||
49144068|NCT01185366|158366933|FG000|Crossover to Second Line Therapy|Adverse Event|3|||
49144069|NCT01185366|158366934|FG001|Crossover to Second Line Therapy|Adverse Event|6|||
49144070|NCT01185366|158366933|FG000|Crossover to Second Line Therapy|Physician Decision|5|||
49144071|NCT01185366|158366934|FG001|Crossover to Second Line Therapy|Physician Decision|1|||
49144072|NCT01185366|158366933|FG000|Crossover to Second Line Therapy|Withdrawal by Subject|1|||
49144073|NCT01185366|158366934|FG001|Crossover to Second Line Therapy|Withdrawal by Subject|0|||
49012876|NCT01862328|157883589|FG004|Overall Study|Other|4|||
49144074|NCT01185366|158366933|FG000|Crossover to Second Line Therapy|Continued with 1st drug|5|||
49144075|NCT01185366|158366934|FG001|Crossover to Second Line Therapy|Continued with 1st drug|3|||
49144076|NCT00930176|158366935|FG000|Overall Study|Death|1|||
49144077|NCT00300495|158366936|FG000|Overall Study|Protocol Violation|4|||
49144078|NCT00300495|158366937|FG001|Overall Study|Protocol Violation|1|||
49144079|NCT03632720|158366940|FG000|Overall Study|Adverse Event|2|||
49144080|NCT03632720|158366941|FG001|Overall Study|Adverse Event|0|||
49144081|NCT03632720|158366942|FG002|Overall Study|Adverse Event|0|||
49144082|NCT03632720|158366940|FG000|Overall Study|Lost to Follow-up|0|||
49144083|NCT03632720|158366941|FG001|Overall Study|Lost to Follow-up|1|||
49144084|NCT03632720|158366942|FG002|Overall Study|Lost to Follow-up|0|||
49144085|NCT03632720|158366940|FG000|Overall Study|Withdrawal by parent/legally acceptable representative|11|||
49144086|NCT03632720|158366941|FG001|Overall Study|Withdrawal by parent/legally acceptable representative|9|||
49144087|NCT03632720|158366942|FG002|Overall Study|Withdrawal by parent/legally acceptable representative|8|||
49144088|NCT03632720|158366940|FG000|Overall Study|Screen failure|0|||
49144089|NCT03632720|158366941|FG001|Overall Study|Screen failure|1|||
49144090|NCT03632720|158366942|FG002|Overall Study|Screen failure|0|||
49144091|NCT00553475|158366945|FG000|Overall Study|Adverse Event|7|||
49144092|NCT00553475|158366946|FG001|Overall Study|Adverse Event|17|||
49144093|NCT00553475|158366947|FG002|Overall Study|Adverse Event|13|||
49144094|NCT00553475|158366945|FG000|Overall Study|Lack of Efficacy|7|||
49144095|NCT00553475|158366946|FG001|Overall Study|Lack of Efficacy|1|||
49144096|NCT00553475|158366947|FG002|Overall Study|Lack of Efficacy|0|||
49144097|NCT00553475|158366945|FG000|Overall Study|Withdrawal by Subject|1|||
49144098|NCT00553475|158366946|FG001|Overall Study|Withdrawal by Subject|1|||
49144099|NCT00553475|158366947|FG002|Overall Study|Withdrawal by Subject|0|||
49144100|NCT00553475|158366945|FG000|Overall Study|Physician Decision|1|||
49144101|NCT00553475|158366946|FG001|Overall Study|Physician Decision|0|||
49144102|NCT00553475|158366947|FG002|Overall Study|Physician Decision|0|||
49144103|NCT00553475|158366945|FG000|Overall Study|Due to moving|0|||
49144104|NCT00553475|158366946|FG001|Overall Study|Due to moving|1|||
49144105|NCT00553475|158366947|FG002|Overall Study|Due to moving|0|||
48822743|NCT01449929|157190589|FG002|Randomization Phase 96 Week|Adverse Event|0|||
48822744|NCT01449929|157190587|FG000|Randomization Phase 96 Week|Lack of Efficacy|3|||
49144106|NCT00289900|158366951|FG000|Overall Study|Adverse Event|28|||
49144107|NCT00289900|158366952|FG001|Overall Study|Adverse Event|40|||
49144108|NCT00289900|158366953|FG002|Overall Study|Adverse Event|13|||
49144109|NCT00289900|158366954|FG003|Overall Study|Adverse Event|19|||
49144110|NCT00289900|158366955|FG004|Overall Study|Adverse Event|20|||
49144111|NCT00289900|158366956|FG005|Overall Study|Adverse Event|33|||
49144112|NCT00289900|158366951|FG000|Overall Study|Lost to Follow-up|7|||
49144113|NCT00289900|158366952|FG001|Overall Study|Lost to Follow-up|7|||
49144114|NCT00289900|158366953|FG002|Overall Study|Lost to Follow-up|8|||
49144115|NCT00289900|158366954|FG003|Overall Study|Lost to Follow-up|8|||
49144116|NCT00289900|158366955|FG004|Overall Study|Lost to Follow-up|4|||
49144117|NCT00289900|158366956|FG005|Overall Study|Lost to Follow-up|8|||
49144118|NCT00289900|158366951|FG000|Overall Study|Participant had flushing|18|||
48822745|NCT01449929|157190588|FG001|Randomization Phase 96 Week|Lack of Efficacy|4|||
48822746|NCT01449929|157190589|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
48822747|NCT01449929|157190587|FG000|Randomization Phase 96 Week|Protocol Violation|5|||
48822748|NCT01449929|157190588|FG001|Randomization Phase 96 Week|Protocol Violation|6|||
48822749|NCT01449929|157190589|FG002|Randomization Phase 96 Week|Protocol Violation|0|||
48822750|NCT01449929|157190587|FG000|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1|||
48822751|NCT01449929|157190588|FG001|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
48822752|NCT01449929|157190589|FG002|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
48822753|NCT01449929|157190587|FG000|Randomization Phase 96 Week|Lost to Follow-up|15|||
48822754|NCT01449929|157190588|FG001|Randomization Phase 96 Week|Lost to Follow-up|18|||
48822755|NCT01449929|157190589|FG002|Randomization Phase 96 Week|Lost to Follow-up|0|||
48822756|NCT01449929|157190587|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
48822757|NCT01449929|157190588|FG001|Randomization Phase 96 Week|Withdrawal by Subject|8|||
48822758|NCT01449929|157190589|FG002|Randomization Phase 96 Week|Withdrawal by Subject|0|||
49012877|NCT01862328|157883590|FG005|Overall Study|Other|0|||
49144119|NCT00289900|158366952|FG001|Overall Study|Participant had flushing|42|||
49144120|NCT00289900|158366953|FG002|Overall Study|Participant had flushing|1|||
49144121|NCT00289900|158366954|FG003|Overall Study|Participant had flushing|2|||
49144122|NCT00289900|158366955|FG004|Overall Study|Participant had flushing|0|||
49144123|NCT00289900|158366956|FG005|Overall Study|Participant had flushing|4|||
49144124|NCT00289900|158366951|FG000|Overall Study|Other|0|||
49144125|NCT00289900|158366952|FG001|Overall Study|Other|0|||
49144126|NCT00289900|158366953|FG002|Overall Study|Other|0|||
49144127|NCT00289900|158366954|FG003|Overall Study|Other|5|||
49144128|NCT00289900|158366955|FG004|Overall Study|Other|1|||
49144129|NCT00289900|158366956|FG005|Overall Study|Other|0|||
48822759|NCT01449929|157190587|FG000|Randomization Phase 96 Week|Physician Decision|2|||
48822760|NCT01449929|157190588|FG001|Randomization Phase 96 Week|Physician Decision|3|||
48822761|NCT01449929|157190589|FG002|Randomization Phase 96 Week|Physician Decision|0|||
48822762|NCT01449929|157190587|FG000|Randomization Phase 96 Week|Other: study closed/terminated|0|||
49012878|NCT01862328|157883591|FG006|Overall Study|Other|1|||
49144130|NCT00289900|158366951|FG000|Overall Study|Participant moved|1|||
48822763|NCT01449929|157190588|FG001|Randomization Phase 96 Week|Other: study closed/terminated|1|||
48822764|NCT01449929|157190589|FG002|Randomization Phase 96 Week|Other: study closed/terminated|0|||
48822765|NCT01449929|157190587|FG000|Extension Phase Approximately 3 Years|Adverse Event|0|||
48822766|NCT01449929|157190588|FG001|Extension Phase Approximately 3 Years|Adverse Event|0|||
48822767|NCT01449929|157190589|FG002|Extension Phase Approximately 3 Years|Adverse Event|2|||
48822768|NCT01449929|157190587|FG000|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
48822769|NCT01449929|157190588|FG001|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
48822770|NCT01449929|157190589|FG002|Extension Phase Approximately 3 Years|Lack of Efficacy|2|||
48822771|NCT01449929|157190587|FG000|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
48822772|NCT01449929|157190588|FG001|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
48822773|NCT01449929|157190589|FG002|Extension Phase Approximately 3 Years|Lost to Follow-up|4|||
48822774|NCT00901485|157190590|FG000|Overall Study|Lack of Efficacy|0|||
48822775|NCT00901485|157190591|FG001|Overall Study|Lack of Efficacy|2|||
48822776|NCT00901485|157190590|FG000|Overall Study|Withdrawal by Subject|1|||
48822777|NCT00901485|157190591|FG001|Overall Study|Withdrawal by Subject|2|||
48822778|NCT02449044|157190592|FG000|Overall Study|Lost to Follow-up|2|||
48822779|NCT02449044|157190592|FG000|Overall Study|Withdrawal by Subject|13|||
48822780|NCT02449044|157190592|FG000|Overall Study|Adverse Event|30|||
48822781|NCT02449044|157190592|FG000|Overall Study|Met Withdrawal Criteria|7|||
48822782|NCT02449044|157190592|FG000|Overall Study|Physician Decision|9|||
48822783|NCT02449044|157190592|FG000|Overall Study|Sponsor Discontinued Trial|3|||
48822784|NCT01040780|157192214|FG000|Overall Study|Protocol Violation|1|||
48822785|NCT01040780|157192215|FG001|Overall Study|Protocol Violation|3|||
49012879|NCT01862328|157883585|FG000|Overall Study|Withdrawal by Subject|1|||
49012880|NCT01862328|157883586|FG001|Overall Study|Withdrawal by Subject|1|||
49012881|NCT01862328|157883587|FG002|Overall Study|Withdrawal by Subject|0|||
49012882|NCT01862328|157883588|FG003|Overall Study|Withdrawal by Subject|0|||
49012883|NCT01862328|157883589|FG004|Overall Study|Withdrawal by Subject|1|||
49012884|NCT01862328|157883590|FG005|Overall Study|Withdrawal by Subject|1|||
49012885|NCT01862328|157883591|FG006|Overall Study|Withdrawal by Subject|1|||
49012886|NCT01862328|157883585|FG000|Overall Study|Symptomatic Deterioration|0|||
49012887|NCT01862328|157883586|FG001|Overall Study|Symptomatic Deterioration|0|||
49012888|NCT01862328|157883587|FG002|Overall Study|Symptomatic Deterioration|0|||
49012889|NCT01862328|157883588|FG003|Overall Study|Symptomatic Deterioration|0|||
49012890|NCT01862328|157883589|FG004|Overall Study|Symptomatic Deterioration|0|||
49012891|NCT01862328|157883590|FG005|Overall Study|Symptomatic Deterioration|0|||
49012892|NCT01862328|157883591|FG006|Overall Study|Symptomatic Deterioration|1|||
49012893|NCT01348542|157883592|FG000|Overall Study|Withdrawal by Subject|3|||
49012894|NCT01348542|157883593|FG001|Overall Study|Withdrawal by Subject|0|||
49012895|NCT01121900|157883594|FG000|First Intervention Period|Adverse Event|1|||
49012896|NCT01121900|157883595|FG001|First Intervention Period|Adverse Event|1|||
49012897|NCT01121900|157883594|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
49012898|NCT01121900|157883595|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
49012899|NCT00467584|157883596|FG000|Overall Study|Withdrawal by Subject|4|||
49012900|NCT00467584|157883597|FG001|Overall Study|Withdrawal by Subject|5|||
49012901|NCT00467584|157883598|FG002|Overall Study|Withdrawal by Subject|1|||
49012902|NCT00936975|157883599|FG000|Overall Study|Withdrawal by Subject|1|||
49012903|NCT00936975|157883599|FG000|Overall Study|Disease progression|3|||
49012904|NCT00936975|157883599|FG000|Overall Study|Post-Tx scan uninterpretable|2|||
49012905|NCT03404206|157883600|FG000|Overall Study|Withdrawal by Subject|1|||
49012906|NCT03404206|157883601|FG001|Overall Study|Withdrawal by Subject|1|||
49012907|NCT03404206|157883602|FG002|Overall Study|Withdrawal by Subject|0|||
49012908|NCT03404206|157883600|FG000|Overall Study|Lost to Follow-up|3|||
49012909|NCT03404206|157883601|FG001|Overall Study|Lost to Follow-up|1|||
49012910|NCT03404206|157883602|FG002|Overall Study|Lost to Follow-up|0|||
49012911|NCT02521948|157883603|FG000|Overall Study|Adverse Event|2|||
49012912|NCT02521948|157883603|FG000|Overall Study|Death|4|||
49012913|NCT02521948|157883603|FG000|Overall Study|Lost to Follow-up|1|||
49012914|NCT02521948|157883603|FG000|Overall Study|Did not attend one or both follow-ups|6|||
49012915|NCT02109133|157883604|FG000|Overall Study|Lost to Follow-up|1|||
49012916|NCT02109133|157883605|FG001|Overall Study|Lost to Follow-up|0|||
49012917|NCT01488578|157883608|FG000|Overall Study|Protocol Violation|1836|||
49012918|NCT04535583|157883616|FG000|Overall Study|Lost to Follow-up|1|||
49012919|NCT04535583|157883616|FG000|Overall Study|Physician Decision|1|||
49012920|NCT04535583|157883616|FG000|Overall Study|Withdrawal by Subject|1|||
49012921|NCT03828461|157883618|FG000|Overall Study|Lost to Follow-up|1|||
49012922|NCT03828461|157883618|FG000|Overall Study|Withdrawal by Subject|3|||
49012923|NCT02451670|157885120|FG000|Overall Study|Did not have qualifying follow-up visit.|714|||
49012924|NCT02451670|157885121|FG001|Overall Study|Did not have qualifying follow-up visit.|696|||
49012925|NCT01073020|157885124|FG000|Overall Study|Withdrawal by Subject|6|||
49012926|NCT01073020|157885125|FG001|Overall Study|Withdrawal by Subject|4|||
49012927|NCT01073020|157885126|FG002|Overall Study|Withdrawal by Subject|1|||
49012928|NCT01073020|157885127|FG003|Overall Study|Withdrawal by Subject|2|||
49012929|NCT01073020|157885124|FG000|Overall Study|Physician Decision|1|||
49144131|NCT00289900|158366952|FG001|Overall Study|Participant moved|0|||
49144132|NCT00289900|158366953|FG002|Overall Study|Participant moved|0|||
48822786|NCT00654940|157192216|FG000|Period 1|Adverse Event|0|||
48822787|NCT00654940|157192217|FG001|Period 1|Adverse Event|1|||
48822788|NCT00654940|157192216|FG000|Period 1|Intolerable Pain Level|1|||
48822789|NCT00654940|157192217|FG001|Period 1|Intolerable Pain Level|0|||
48822790|NCT02906683|157192218|FG000|Overall Study|Adverse Event|0|||
48822791|NCT02906683|157192219|FG001|Overall Study|Adverse Event|1|||
48822792|NCT02906683|157192220|FG002|Overall Study|Adverse Event|0|||
48822793|NCT02906683|157192218|FG000|Overall Study|Physician Decision|0|||
48822794|NCT02906683|157192219|FG001|Overall Study|Physician Decision|1|||
48822795|NCT02906683|157192220|FG002|Overall Study|Physician Decision|1|||
48822796|NCT02906683|157192218|FG000|Overall Study|Withdrawal by Subject|0|||
48822797|NCT02906683|157192219|FG001|Overall Study|Withdrawal by Subject|2|||
49144133|NCT00289900|158366954|FG003|Overall Study|Participant moved|1|||
49144134|NCT00289900|158366955|FG004|Overall Study|Participant moved|1|||
48822798|NCT02906683|157192220|FG002|Overall Study|Withdrawal by Subject|1|||
48822799|NCT02906683|157192218|FG000|Overall Study|Patient did not meet the eligibility criteria for the study|1|||
48822800|NCT02906683|157192219|FG001|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
48822801|NCT02906683|157192220|FG002|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
48822802|NCT02906683|157192218|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
49012930|NCT01073020|157885125|FG001|Overall Study|Physician Decision|0|||
49012931|NCT01073020|157885126|FG002|Overall Study|Physician Decision|2|||
49144135|NCT00289900|158366956|FG005|Overall Study|Participant moved|1|||
49144136|NCT00289900|158366951|FG000|Overall Study|Withdrawal by Subject|10|||
49144137|NCT00289900|158366952|FG001|Overall Study|Withdrawal by Subject|21|||
49144138|NCT00289900|158366953|FG002|Overall Study|Withdrawal by Subject|8|||
49144139|NCT00289900|158366954|FG003|Overall Study|Withdrawal by Subject|18|||
49144140|NCT00289900|158366955|FG004|Overall Study|Withdrawal by Subject|12|||
49144141|NCT00289900|158366956|FG005|Overall Study|Withdrawal by Subject|11|||
49144142|NCT00289900|158366951|FG000|Overall Study|Protocol Violation|3|||
49144143|NCT00289900|158366952|FG001|Overall Study|Protocol Violation|9|||
49144144|NCT00289900|158366953|FG002|Overall Study|Protocol Violation|2|||
49144145|NCT00289900|158366954|FG003|Overall Study|Protocol Violation|6|||
49144146|NCT00289900|158366955|FG004|Overall Study|Protocol Violation|7|||
49144147|NCT00289900|158366956|FG005|Overall Study|Protocol Violation|4|||
49144148|NCT00289900|158366951|FG000|Overall Study|site terminated|1|||
49144149|NCT00289900|158366952|FG001|Overall Study|site terminated|0|||
49144150|NCT00289900|158366953|FG002|Overall Study|site terminated|1|||
49144151|NCT00289900|158366954|FG003|Overall Study|site terminated|0|||
49144152|NCT00289900|158366955|FG004|Overall Study|site terminated|0|||
49144153|NCT00289900|158366956|FG005|Overall Study|site terminated|0|||
49144154|NCT00289900|158366951|FG000|Overall Study|Not treated|0|||
49144155|NCT00289900|158366952|FG001|Overall Study|Not treated|1|||
49012932|NCT01073020|157885127|FG003|Overall Study|Physician Decision|0|||
48730505|NCT00771316|156864346|FG001|Overall Study|Adverse Event|1|||
48730506|NCT00771316|156864345|FG000|Overall Study|Patient withdrew consent|1|||
48730507|NCT00771316|156864346|FG001|Overall Study|Patient withdrew consent|0|||
48730508|NCT00771316|156864345|FG000|Overall Study|Discontinued due to early termination|1|||
48730509|NCT00771316|156864346|FG001|Overall Study|Discontinued due to early termination|0|||
48730510|NCT00945555|156864349|FG000|Overall Study|Referred to another hospital|5|||
48730511|NCT00945555|156864349|FG000|Overall Study|Worsening condition, intensive care unit|1|||
48730512|NCT00945555|156864349|FG000|Overall Study|Withdrawal by Subject|2|||
48730513|NCT00945555|156864349|FG000|Overall Study|Participant continued treatment at home|1|||
48730514|NCT00945555|156864349|FG000|Overall Study|Death|18|||
48730515|NCT00945555|156864349|FG000|Overall Study|Other|1|||
48730516|NCT01067976|156864350|FG000|Overall Study|Study drug never administered|20|||
48730517|NCT01067976|156864350|FG000|Overall Study|Study prematurely discontinued|2|||
48730518|NCT00589290|156864351|FG000|Overall Study|Withdrawal by Subject|1|||
48730519|NCT04815031|156864352|FG000|Overall Study|No adverse event information (missing information)|33|||
48730520|NCT00932737|156864353|FG000|Overall Study|Not treated in second episode|1|||
48730521|NCT00932737|156864354|FG001|Overall Study|Not treated in second episode|0|||
48822803|NCT02906683|157192219|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
49012933|NCT01073020|157885124|FG000|Overall Study|Death|0|||
49012934|NCT01073020|157885125|FG001|Overall Study|Death|1|||
49012935|NCT01073020|157885126|FG002|Overall Study|Death|0|||
49012936|NCT01073020|157885127|FG003|Overall Study|Death|0|||
49012937|NCT01872689|157885137|FG000|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
49012938|NCT01872689|157885138|FG001|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1|||
49012939|NCT01872689|157885139|FG002|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
49012940|NCT01872689|157885140|FG003|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
49012941|NCT01872689|157885137|FG000|Double-Blind/Placebo-Controlled Period|Other|1|||
49012942|NCT01872689|157885138|FG001|Double-Blind/Placebo-Controlled Period|Other|1|||
49144156|NCT00289900|158366953|FG002|Overall Study|Not treated|0|||
49144157|NCT00289900|158366954|FG003|Overall Study|Not treated|0|||
49144158|NCT00289900|158366955|FG004|Overall Study|Not treated|0|||
49144159|NCT00289900|158366956|FG005|Overall Study|Not treated|0|||
49144160|NCT02186171|158366957|FG000|Overall Study|Withdrawal by Subject|1|||
49144161|NCT02186171|158366958|FG001|Overall Study|Withdrawal by Subject|9|||
49144162|NCT02186171|158366957|FG000|Overall Study|Lost to Follow-up|2|||
49144163|NCT02186171|158366958|FG001|Overall Study|Lost to Follow-up|2|||
49144164|NCT02186171|158366957|FG000|Overall Study|Death|1|||
49144165|NCT02186171|158366958|FG001|Overall Study|Death|2|||
49144166|NCT02186171|158366957|FG000|Overall Study|Protocol-specified Criteria|0|||
49144167|NCT02186171|158366958|FG001|Overall Study|Protocol-specified Criteria|2|||
49144168|NCT01703221|158366959|FG000|Phase A (Up to 24 Weeks)|Adverse Event|2|||
49144169|NCT01703221|158366960|FG001|Phase A (Up to 24 Weeks)|Adverse Event|4|||
49144170|NCT01703221|158366961|FG002|Phase A (Up to 24 Weeks)|Adverse Event|0|||
49144171|NCT01703221|158366959|FG000|Phase A (Up to 24 Weeks)|Lack of Efficacy|2|||
49144172|NCT01703221|158366960|FG001|Phase A (Up to 24 Weeks)|Lack of Efficacy|0|||
49144173|NCT01703221|158366961|FG002|Phase A (Up to 24 Weeks)|Lack of Efficacy|1|||
49144174|NCT01703221|158366959|FG000|Phase A (Up to 24 Weeks)|Physician Decision|1|||
49144175|NCT01703221|158366960|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
49144176|NCT01703221|158366961|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
49144177|NCT01703221|158366959|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2|||
49144178|NCT01703221|158366960|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
49144179|NCT01703221|158366961|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
49144180|NCT01703221|158366959|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
49144181|NCT01703221|158366960|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
49144182|NCT01703221|158366961|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
49144183|NCT01703221|158366959|FG000|Phase B - (Week 25 to 52)|Withdrawal by Subject|2|||
49144184|NCT01703221|158366960|FG001|Phase B - (Week 25 to 52)|Withdrawal by Subject|1|||
49144185|NCT01703221|158366961|FG002|Phase B - (Week 25 to 52)|Withdrawal by Subject|0|||
49144186|NCT01703221|158366959|FG000|Phase B - (Week 25 to 52)|Adverse Event|2|||
49144187|NCT01703221|158366960|FG001|Phase B - (Week 25 to 52)|Adverse Event|3|||
49144188|NCT01703221|158366961|FG002|Phase B - (Week 25 to 52)|Adverse Event|2|||
49144189|NCT01703221|158366959|FG000|Phase B - (Week 25 to 52)|Lack of Efficacy|12|||
49144190|NCT01703221|158366960|FG001|Phase B - (Week 25 to 52)|Lack of Efficacy|10|||
49144191|NCT01703221|158366961|FG002|Phase B - (Week 25 to 52)|Lack of Efficacy|3|||
49144192|NCT00504231|158368341|FG000|Overall Study|Discrepant chart documentation re route|0|||
49144193|NCT00504231|158368342|FG001|Overall Study|Discrepant chart documentation re route|0|||
49144194|NCT00504231|158368343|FG002|Overall Study|Discrepant chart documentation re route|1|||
49144195|NCT00504231|158368344|FG003|Overall Study|Discrepant chart documentation re route|0|||
49144196|NCT01902303|158368345|FG000|Overall Study|Adverse Event|0|||
48822804|NCT02906683|157192220|FG002|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
48822805|NCT02328014|157192221|FG000|Overall Study|Adverse Event|1|||
48822806|NCT02328014|157192222|FG001|Overall Study|Adverse Event|0|||
48822807|NCT02328014|157192223|FG002|Overall Study|Adverse Event|0|||
48822808|NCT02328014|157192224|FG003|Overall Study|Adverse Event|1|||
48822809|NCT02328014|157192221|FG000|Overall Study|Death|0|||
48822810|NCT02328014|157192222|FG001|Overall Study|Death|0|||
48822811|NCT02328014|157192223|FG002|Overall Study|Death|0|||
48822812|NCT02328014|157192224|FG003|Overall Study|Death|4|||
48822813|NCT02328014|157192221|FG000|Overall Study|Physician Decision|0|||
48822814|NCT02328014|157192222|FG001|Overall Study|Physician Decision|0|||
48822815|NCT02328014|157192223|FG002|Overall Study|Physician Decision|0|||
48822816|NCT02328014|157192224|FG003|Overall Study|Physician Decision|1|||
48822817|NCT02328014|157192221|FG000|Overall Study|Disease Progression|1|||
48822818|NCT02328014|157192222|FG001|Overall Study|Disease Progression|0|||
49144197|NCT01902303|158368346|FG001|Overall Study|Adverse Event|1|||
49144198|NCT01902303|158368345|FG000|Overall Study|Lost to Follow-up|0|||
49144199|NCT01902303|158368346|FG001|Overall Study|Lost to Follow-up|1|||
49144200|NCT01902303|158368345|FG000|Overall Study|Protocol Violation|2|||
48822819|NCT02328014|157192223|FG002|Overall Study|Disease Progression|1|||
49144201|NCT01902303|158368346|FG001|Overall Study|Protocol Violation|2|||
49144202|NCT01902303|158368345|FG000|Overall Study|subject lost investigational product|0|||
49144203|NCT01902303|158368346|FG001|Overall Study|subject lost investigational product|1|||
49015361|NCT00306384|157892158|FG002|Overall Study|Adverse Event|40|||
49144204|NCT01902303|158368345|FG000|Overall Study|Did not develop a cold sore|21|||
49144205|NCT01902303|158368346|FG001|Overall Study|Did not develop a cold sore|19|||
49144206|NCT05938010|158368350|FG000|Overall Study|Lost to Follow-up|2|||
49144207|NCT04076579|158368351|FG000|Overall Study|Adverse Event|2|||
49144208|NCT04076579|158368352|FG001|Overall Study|Adverse Event|0|||
49144209|NCT04076579|158368351|FG000|Overall Study|discontinued due to toxicity|1|||
49144210|NCT04076579|158368352|FG001|Overall Study|discontinued due to toxicity|0|||
49144211|NCT04076579|158368351|FG000|Overall Study|Physician Decision|1|||
48822820|NCT02328014|157192224|FG003|Overall Study|Disease Progression|3|||
48822821|NCT02328014|157192221|FG000|Overall Study|Study Terminated by Sponsor|4|||
48822822|NCT02328014|157192222|FG001|Overall Study|Study Terminated by Sponsor|1|||
48822823|NCT02328014|157192223|FG002|Overall Study|Study Terminated by Sponsor|1|||
49144212|NCT04076579|158368352|FG001|Overall Study|Physician Decision|0|||
49144213|NCT04076579|158368351|FG000|Overall Study|Patient was deemed ineligible before starting study treatment|0|||
49144214|NCT04076579|158368352|FG001|Overall Study|Patient was deemed ineligible before starting study treatment|1|||
49144215|NCT04076579|158368351|FG000|Overall Study|Noncompliance|0|||
49144216|NCT04076579|158368352|FG001|Overall Study|Noncompliance|1|||
49144217|NCT04076579|158368351|FG000|Overall Study|Withdrawal by Subject|0|||
49144218|NCT04076579|158368352|FG001|Overall Study|Withdrawal by Subject|2|||
49144219|NCT00983957|158368353|FG000|Overall Study|Adverse Event|1|||
49144220|NCT00983957|158368353|FG000|Overall Study|Personal Reasons|1|||
49144221|NCT00421733|158368354|FG000|Overall Study|Adverse Event|4|||
49144222|NCT00421733|158368355|FG001|Overall Study|Adverse Event|9|||
49144223|NCT00421733|158368356|FG002|Overall Study|Adverse Event|2|||
49144224|NCT00421733|158368354|FG000|Overall Study|Lost to Follow-up|1|||
49144225|NCT00421733|158368355|FG001|Overall Study|Lost to Follow-up|2|||
49144226|NCT00421733|158368356|FG002|Overall Study|Lost to Follow-up|4|||
49144227|NCT00421733|158368354|FG000|Overall Study|Withdrawal by Subject|1|||
49144228|NCT00421733|158368355|FG001|Overall Study|Withdrawal by Subject|2|||
49144229|NCT00421733|158368356|FG002|Overall Study|Withdrawal by Subject|7|||
49144230|NCT00421733|158368354|FG000|Overall Study|Death|0|||
49144231|NCT00421733|158368355|FG001|Overall Study|Death|3|||
49144232|NCT00421733|158368356|FG002|Overall Study|Death|0|||
49144233|NCT00421733|158368354|FG000|Overall Study|Required dialysis|1|||
49144234|NCT00421733|158368355|FG001|Overall Study|Required dialysis|0|||
49144235|NCT00421733|158368356|FG002|Overall Study|Required dialysis|0|||
49144236|NCT00421733|158368354|FG000|Overall Study|Administrative|2|||
49144237|NCT00421733|158368355|FG001|Overall Study|Administrative|0|||
49144238|NCT00421733|158368356|FG002|Overall Study|Administrative|0|||
49144239|NCT00421733|158368354|FG000|Overall Study|Did not satisfy entry criteria|1|||
49144240|NCT00421733|158368355|FG001|Overall Study|Did not satisfy entry criteria|3|||
49144241|NCT00421733|158368356|FG002|Overall Study|Did not satisfy entry criteria|2|||
49144242|NCT00421733|158368354|FG000|Overall Study|Sponsor request|1|||
49144243|NCT00421733|158368355|FG001|Overall Study|Sponsor request|0|||
49144244|NCT00421733|158368356|FG002|Overall Study|Sponsor request|3|||
49144245|NCT00421733|158368354|FG000|Overall Study|Protocol deviation|4|||
49012943|NCT01872689|157885139|FG002|Double-Blind/Placebo-Controlled Period|Other|6|||
49144246|NCT00421733|158368355|FG001|Overall Study|Protocol deviation|7|||
49144247|NCT00421733|158368356|FG002|Overall Study|Protocol deviation|2|||
49144248|NCT01524705|158368357|FG000|Overall Study|Adverse Event|2|||
49144249|NCT01524705|158368358|FG001|Overall Study|Adverse Event|0|||
49144250|NCT01524705|158368357|FG000|Overall Study|Death|1|||
49144251|NCT01524705|158368358|FG001|Overall Study|Death|0|||
49144252|NCT01524705|158368357|FG000|Overall Study|Lost to Follow-up|0|||
49144253|NCT01524705|158368358|FG001|Overall Study|Lost to Follow-up|1|||
49144254|NCT01524705|158368357|FG000|Overall Study|Withdrawal by Subject|0|||
49144255|NCT01524705|158368358|FG001|Overall Study|Withdrawal by Subject|1|||
49144256|NCT01524705|158368357|FG000|Overall Study|Pancreatic Cancer|0|||
49144257|NCT01524705|158368358|FG001|Overall Study|Pancreatic Cancer|1|||
49144258|NCT01755156|158368359|FG000|Phase A (Weeks 0-24)|Adverse Event|2|||
49144259|NCT01755156|158368360|FG001|Phase A (Weeks 0-24)|Adverse Event|3|||
48730522|NCT00932737|156864353|FG000|Overall Study|Adverse Event|0|||
48730523|NCT00932737|156864354|FG001|Overall Study|Adverse Event|1|||
48730524|NCT05156073|156864356|FG000|Overall Study|Patient canceled appointment with PCP|1|||
48730525|NCT02891161|156864357|FG000|Study Treatment|Disease Progression|2|||
48730526|NCT02891161|156864358|FG001|Study Treatment|Disease Progression|4|||
48730527|NCT02891161|156864357|FG000|Study Treatment|AE/Side Effects/Complications|1|||
48730528|NCT02891161|156864358|FG001|Study Treatment|AE/Side Effects/Complications|5|||
48730529|NCT02891161|156864357|FG000|Study Treatment|Patient withdrawal After Therapy Start|1|||
48730530|NCT02891161|156864358|FG001|Study Treatment|Patient withdrawal After Therapy Start|4|||
48730531|NCT02891161|156864357|FG000|Follow up|Death|4|||
48730532|NCT02891161|156864358|FG001|Follow up|Death|8|||
48730533|NCT02891161|156864357|FG000|Follow up|Refused to Follow up|0|||
48730534|NCT02891161|156864358|FG001|Follow up|Refused to Follow up|2|||
48730535|NCT02891161|156864357|FG000|Follow up|Symptomatic deterioration|0|||
48730536|NCT02891161|156864358|FG001|Follow up|Symptomatic deterioration|1|||
48730537|NCT02891161|156864357|FG000|Follow up|Study terminated|0|||
48730538|NCT02891161|156864358|FG001|Follow up|Study terminated|6|||
48730539|NCT03350620|156864360|FG000|Stage 2|Adverse Event|0|||
48730540|NCT03350620|156864361|FG001|Stage 2|Adverse Event|1|||
48730541|NCT03350620|156864362|FG002|Stage 2|Adverse Event|1|||
48730542|NCT03350620|156864360|FG000|Stage 2|Lack of Efficacy|0|||
48730543|NCT03350620|156864361|FG001|Stage 2|Lack of Efficacy|2|||
48730544|NCT03350620|156864362|FG002|Stage 2|Lack of Efficacy|0|||
48730545|NCT03350620|156864360|FG000|Stage 2|Lost to Follow-up|1|||
48730546|NCT03350620|156864361|FG001|Stage 2|Lost to Follow-up|2|||
48730547|NCT03350620|156864362|FG002|Stage 2|Lost to Follow-up|2|||
48730548|NCT03350620|156864360|FG000|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|2|||
48730549|NCT03350620|156864361|FG001|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|4|||
48730550|NCT03350620|156864362|FG002|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|0|||
48730551|NCT02544074|156865805|FG000|Overall Study|Withdrawal by Subject|0|||
48730552|NCT02544074|156865806|FG001|Overall Study|Withdrawal by Subject|1|||
48730553|NCT02544074|156865807|FG002|Overall Study|Withdrawal by Subject|0|||
48730554|NCT02544074|156865808|FG003|Overall Study|Withdrawal by Subject|0|||
49144260|NCT01755156|158368359|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|1|||
49144261|NCT01755156|158368360|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|0|||
49144262|NCT01755156|158368359|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
49144263|NCT01755156|158368360|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|3|||
49144264|NCT01755156|158368359|FG000|Phase A (Weeks 0-24)|Non-compliance with study drug|1|||
49144265|NCT01755156|158368360|FG001|Phase A (Weeks 0-24)|Non-compliance with study drug|0|||
49144266|NCT01755156|158368359|FG000|Phase A (Weeks 0-24)|Physician Decision|0|||
49144267|NCT01755156|158368360|FG001|Phase A (Weeks 0-24)|Physician Decision|1|||
49144268|NCT01755156|158368359|FG000|Phase A (Weeks 0-24)|Protocol Violation|1|||
49144269|NCT01755156|158368360|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
49144270|NCT01755156|158368359|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|6|||
49144271|NCT01755156|158368360|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|13|||
49144272|NCT01755156|158368359|FG000|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0|||
49144273|NCT01755156|158368360|FG001|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2|||
49144274|NCT01755156|158368359|FG000|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
49144275|NCT01755156|158368360|FG001|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
49144276|NCT01755156|158368359|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|12|||
49144277|NCT01755156|158368360|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|5|||
49144278|NCT01755156|158368359|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|27|||
49144279|NCT01755156|158368360|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|31|||
49144280|NCT03142451|158368361|FG000|Overall Study|Adverse Event|5|||
49144281|NCT03142451|158368362|FG001|Overall Study|Adverse Event|2|||
49144282|NCT03142451|158368361|FG000|Overall Study|Lost to Follow-up|25|||
49144283|NCT03142451|158368362|FG001|Overall Study|Lost to Follow-up|8|||
49144284|NCT03142451|158368361|FG000|Overall Study|Participant request|24|||
49144285|NCT03142451|158368362|FG001|Overall Study|Participant request|12|||
49144286|NCT03142451|158368361|FG000|Overall Study|Protocol Violation|3|||
49144287|NCT03142451|158368362|FG001|Overall Study|Protocol Violation|1|||
49144288|NCT03142451|158368361|FG000|Overall Study|Other|1|||
49144289|NCT03142451|158368362|FG001|Overall Study|Other|1|||
49144290|NCT00585169|158368363|FG000|Overall Study|Withdrawal by Subject|1|||
49144291|NCT00710970|158368366|FG000|Overall Study|Never took drug|3|||
48730555|NCT02544074|156865809|FG004|Overall Study|Withdrawal by Subject|0|||
48730556|NCT02544074|156865810|FG005|Overall Study|Withdrawal by Subject|0|||
48730557|NCT02544074|156865811|FG006|Overall Study|Withdrawal by Subject|0|||
48730558|NCT02544074|156865812|FG007|Overall Study|Withdrawal by Subject|0|||
49012944|NCT01872689|157885140|FG003|Double-Blind/Placebo-Controlled Period|Other|3|||
49012945|NCT01872689|157885137|FG000|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9|||
49012946|NCT01872689|157885138|FG001|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8|||
49012947|NCT01872689|157885139|FG002|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14|||
49012948|NCT01872689|157885140|FG003|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16|||
49012949|NCT01872689|157885137|FG000|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
49144292|NCT02391584|158368369|FG000|Primary Endpoint (6-weeks)|Lost to Follow-up|1|||
48730559|NCT02544074|156865813|FG008|Overall Study|Withdrawal by Subject|0|||
48730560|NCT02544074|156865814|FG009|Overall Study|Withdrawal by Subject|0|||
48730561|NCT02544074|156865815|FG010|Overall Study|Withdrawal by Subject|0|||
48730562|NCT02544074|156865816|FG011|Overall Study|Withdrawal by Subject|0|||
48730563|NCT02544074|156865817|FG012|Overall Study|Withdrawal by Subject|0|||
48730564|NCT02544074|156865818|FG013|Overall Study|Withdrawal by Subject|0|||
48730565|NCT02544074|156865819|FG014|Overall Study|Withdrawal by Subject|0|||
49144293|NCT02391584|158368370|FG001|Primary Endpoint (6-weeks)|Lost to Follow-up|2|||
49144294|NCT02391584|158368369|FG000|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1|||
49144295|NCT02391584|158368370|FG001|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0|||
49144296|NCT02391584|158368369|FG000|3 Month|Lost to Follow-up|1|||
49144297|NCT02391584|158368370|FG001|3 Month|Lost to Follow-up|0|||
49144298|NCT02391584|158368369|FG000|6 Month|Withdrawal by Subject|1|||
49144299|NCT02391584|158368370|FG001|6 Month|Withdrawal by Subject|0|||
49144300|NCT02391584|158368369|FG000|12 Month (End of Study)|Lost to Follow-up|2|||
49144301|NCT02391584|158368370|FG001|12 Month (End of Study)|Lost to Follow-up|0|||
49144302|NCT04621786|158368375|FG000|Overall Study|Lost to Follow-up|9|||
49144303|NCT04621786|158368375|FG000|Overall Study|Protocol Violation|3|||
49144304|NCT01093885|158368376|FG000|Overall Study|Adverse Event|4|||
49144305|NCT01093885|158368376|FG000|Overall Study|Lost to Follow-up|1|||
49144306|NCT01301001|158368377|FG000|First Intervention|Lost to Follow-up|4|||
49144307|NCT01301001|158368378|FG001|First Intervention|Lost to Follow-up|4|||
49144308|NCT01301001|158368377|FG000|First Intervention|Withdrawal by Subject|1|||
49144309|NCT01301001|158368378|FG001|First Intervention|Withdrawal by Subject|4|||
49144310|NCT01301001|158368377|FG000|First Intervention|Adverse Event|5|||
49012950|NCT01872689|157885138|FG001|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
49012951|NCT01872689|157885139|FG002|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
49012952|NCT01872689|157885140|FG003|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
49012953|NCT01872689|157885137|FG000|Double-Blind/Placebo-Controlled Period|Physician Decision|0|||
49012954|NCT01872689|157885138|FG001|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
49012955|NCT01872689|157885139|FG002|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
49012956|NCT01872689|157885140|FG003|Double-Blind/Placebo-Controlled Period|Physician Decision|1|||
49012957|NCT01872689|157885137|FG000|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
49012958|NCT01872689|157885138|FG001|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
49012959|NCT01872689|157885139|FG002|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
49012960|NCT01872689|157885140|FG003|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
49012961|NCT01872689|157885137|FG000|Double-Blind/Placebo-Controlled Period|Death|3|||
49012962|NCT01872689|157885138|FG001|Double-Blind/Placebo-Controlled Period|Death|4|||
49012963|NCT01872689|157885139|FG002|Double-Blind/Placebo-Controlled Period|Death|14|||
49012964|NCT01872689|157885140|FG003|Double-Blind/Placebo-Controlled Period|Death|9|||
49012965|NCT01872689|157885137|FG000|Double-Blind/Placebo-Controlled Period|Adverse Event|6|||
49012966|NCT01872689|157885138|FG001|Double-Blind/Placebo-Controlled Period|Adverse Event|3|||
49012967|NCT01872689|157885139|FG002|Double-Blind/Placebo-Controlled Period|Adverse Event|10|||
49012968|NCT01872689|157885140|FG003|Double-Blind/Placebo-Controlled Period|Adverse Event|7|||
49012969|NCT01872689|157885137|FG000|Open-Label Period (Only For Monotherapy)|Other|2|||
49012970|NCT01872689|157885138|FG001|Open-Label Period (Only For Monotherapy)|Other|3|||
49012971|NCT01872689|157885139|FG002|Open-Label Period (Only For Monotherapy)|Other|0|||
48822824|NCT02328014|157192224|FG003|Overall Study|Study Terminated by Sponsor|0|||
48822825|NCT02328014|157192221|FG000|Overall Study|Subject Started Another Cancer Therapy|0|||
48822826|NCT02328014|157192222|FG001|Overall Study|Subject Started Another Cancer Therapy|5|||
48822827|NCT02328014|157192223|FG002|Overall Study|Subject Started Another Cancer Therapy|4|||
48822828|NCT02328014|157192224|FG003|Overall Study|Subject Started Another Cancer Therapy|12|||
48822829|NCT02328014|157192221|FG000|Overall Study|Withdrawal by Subject|0|||
48822830|NCT02328014|157192222|FG001|Overall Study|Withdrawal by Subject|0|||
48822831|NCT02328014|157192223|FG002|Overall Study|Withdrawal by Subject|0|||
48822832|NCT02328014|157192224|FG003|Overall Study|Withdrawal by Subject|1|||
48822833|NCT02692235|157192227|FG000|Overall Study|Withdrawal by Subject|2|||
48822834|NCT02692235|157192228|FG001|Overall Study|Withdrawal by Subject|1|||
48822835|NCT02692235|157192227|FG000|Overall Study|Adverse Event|1|||
48822836|NCT02692235|157192228|FG001|Overall Study|Adverse Event|2|||
48822837|NCT00121199|157192230|FG000|Overall Study|Adverse Event|11|||
48822838|NCT00121199|157192230|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
48822839|NCT00121199|157192230|FG000|Overall Study|Progression/Relapse|1|||
48822840|NCT00121199|157192230|FG000|Overall Study|Death|3|||
48822841|NCT00121199|157192230|FG000|Overall Study|Other - Not Protocol Specified|3|||
48822842|NCT00121199|157192230|FG000|Overall Study|Ineligible|9|||
48822843|NCT01256476|157192231|FG000|Overall Study|Adverse Event|2|||
48822844|NCT01256476|157192232|FG001|Overall Study|Adverse Event|1|||
48822845|NCT01256476|157192231|FG000|Overall Study|Withdrawal by Subject|2|||
48822846|NCT01256476|157192232|FG001|Overall Study|Withdrawal by Subject|1|||
48822847|NCT01256476|157192231|FG000|Overall Study|Lost to Follow-up|1|||
48822848|NCT01256476|157192232|FG001|Overall Study|Lost to Follow-up|2|||
48822849|NCT01256476|157192231|FG000|Overall Study|Persistent ALT or AST elevation|1|||
48822850|NCT01256476|157192232|FG001|Overall Study|Persistent ALT or AST elevation|0|||
48822851|NCT01256476|157192231|FG000|Overall Study|Physician Decision|0|||
48822852|NCT01256476|157192232|FG001|Overall Study|Physician Decision|1|||
48822853|NCT01256476|157192231|FG000|Overall Study|Subject non-compliance|0|||
48822854|NCT01256476|157192232|FG001|Overall Study|Subject non-compliance|1|||
48822855|NCT01256476|157192231|FG000|Overall Study|LDL-C elevation exceeding 250 mg/dL|0|||
48822856|NCT01256476|157192232|FG001|Overall Study|LDL-C elevation exceeding 250 mg/dL|1|||
48822857|NCT02018861|157192233|FG000|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
48822858|NCT02018861|157192234|FG001|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|2|||
48822859|NCT02018861|157192235|FG002|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
48822860|NCT02018861|157192236|FG003|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|6|||
48822861|NCT02018861|157192237|FG004|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|4|||
48822862|NCT02018861|157192238|FG005|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
49012972|NCT01872689|157885140|FG003|Open-Label Period (Only For Monotherapy)|Other|0|||
49012973|NCT01872689|157885137|FG000|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11|||
49012974|NCT01872689|157885138|FG001|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12|||
48822863|NCT02018861|157192239|FG006|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
48822864|NCT02018861|157192240|FG007|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
48822865|NCT02018861|157192241|FG008|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
48822866|NCT02018861|157192242|FG009|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
48822867|NCT02018861|157192233|FG000|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
48822868|NCT02018861|157192234|FG001|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
49144311|NCT01301001|158368378|FG001|First Intervention|Adverse Event|0|||
49144312|NCT01301001|158368377|FG000|First Intervention|Protocol Violation|0|||
49144313|NCT01301001|158368378|FG001|First Intervention|Protocol Violation|1|||
49144314|NCT01301001|158368377|FG000|Second Intervention|Adverse Event|2|||
49144315|NCT01301001|158368378|FG001|Second Intervention|Adverse Event|0|||
49144316|NCT01301001|158368377|FG000|Second Intervention|Withdrawal by Subject|2|||
49144317|NCT01301001|158368378|FG001|Second Intervention|Withdrawal by Subject|0|||
49144318|NCT01346709|158368379|FG000|Overall Study|Protocol Violation|35|||
49144319|NCT01346709|158368379|FG000|Overall Study|Lost to Follow-up|31|||
49144320|NCT01346709|158368379|FG000|Overall Study|Missing data in candidate risk factor|285|||
49144321|NCT01292473|158368384|FG000|Overall Study|Adverse Event|1|||
49144322|NCT01292473|158368385|FG001|Overall Study|Adverse Event|0|||
49144323|NCT01292473|158368386|FG002|Overall Study|Adverse Event|1|||
49144324|NCT01292473|158368387|FG003|Overall Study|Adverse Event|1|||
49144325|NCT01292473|158368384|FG000|Overall Study|Lost to Follow-up|1|||
49144326|NCT01292473|158368385|FG001|Overall Study|Lost to Follow-up|1|||
49144327|NCT01292473|158368386|FG002|Overall Study|Lost to Follow-up|2|||
49144328|NCT01292473|158368387|FG003|Overall Study|Lost to Follow-up|2|||
49144329|NCT01292473|158368384|FG000|Overall Study|Withdrawal by Subject|3|||
49144330|NCT01292473|158368385|FG001|Overall Study|Withdrawal by Subject|4|||
49144331|NCT01292473|158368386|FG002|Overall Study|Withdrawal by Subject|3|||
49144332|NCT01292473|158368387|FG003|Overall Study|Withdrawal by Subject|3|||
49144333|NCT01292473|158368384|FG000|Overall Study|Physician Decision|0|||
49144334|NCT01292473|158368385|FG001|Overall Study|Physician Decision|1|||
49144335|NCT01292473|158368386|FG002|Overall Study|Physician Decision|0|||
49144336|NCT01292473|158368387|FG003|Overall Study|Physician Decision|0|||
49144337|NCT01292473|158368384|FG000|Overall Study|Disease Progression|0|||
49144338|NCT01292473|158368385|FG001|Overall Study|Disease Progression|1|||
49144339|NCT01292473|158368386|FG002|Overall Study|Disease Progression|3|||
49144340|NCT01292473|158368387|FG003|Overall Study|Disease Progression|6|||
49144341|NCT01133977|158368401|FG000|Overall Study|Adverse Event|0|||
49144342|NCT01133977|158368402|FG001|Overall Study|Adverse Event|0|||
49144343|NCT01133977|158368403|FG002|Overall Study|Adverse Event|1|||
49144344|NCT01133977|158368404|FG003|Overall Study|Adverse Event|0|||
49144345|NCT01133977|158368405|FG004|Overall Study|Adverse Event|0|||
49144346|NCT01133977|158368401|FG000|Overall Study|Death|1|||
49144347|NCT01133977|158368402|FG001|Overall Study|Death|1|||
49144348|NCT01133977|158368403|FG002|Overall Study|Death|1|||
49144349|NCT01133977|158368404|FG003|Overall Study|Death|7|||
49144350|NCT01133977|158368405|FG004|Overall Study|Death|3|||
49144351|NCT01133977|158368401|FG000|Overall Study|Started a New Line of Therapy|2|||
49144352|NCT01133977|158368402|FG001|Overall Study|Started a New Line of Therapy|6|||
49144353|NCT01133977|158368403|FG002|Overall Study|Started a New Line of Therapy|4|||
49144354|NCT01133977|158368404|FG003|Overall Study|Started a New Line of Therapy|25|||
49144355|NCT01133977|158368405|FG004|Overall Study|Started a New Line of Therapy|33|||
49144356|NCT01133977|158368401|FG000|Overall Study|Lost to Follow-up|0|||
49144357|NCT01133977|158368402|FG001|Overall Study|Lost to Follow-up|0|||
49144358|NCT01133977|158368403|FG002|Overall Study|Lost to Follow-up|0|||
49144359|NCT01133977|158368404|FG003|Overall Study|Lost to Follow-up|2|||
49144360|NCT01133977|158368405|FG004|Overall Study|Lost to Follow-up|1|||
49144361|NCT01133977|158368401|FG000|Overall Study|Withdrawal by Subject|0|||
49144362|NCT01133977|158368402|FG001|Overall Study|Withdrawal by Subject|0|||
49144363|NCT01133977|158368403|FG002|Overall Study|Withdrawal by Subject|0|||
49144364|NCT01133977|158368404|FG003|Overall Study|Withdrawal by Subject|5|||
49144365|NCT01133977|158368405|FG004|Overall Study|Withdrawal by Subject|1|||
49144366|NCT01371565|158368406|FG000|Overall Study|Withdrawal by Subject|1|||
49144367|NCT01371565|158368406|FG000|Overall Study|Death|1|||
49144368|NCT01371565|158368406|FG000|Overall Study|Resection of neuroendocrine tumor|1|||
49144369|NCT02609633|158368407|FG000|Overall Study|Consent Withdrawn|0|||
49144370|NCT02609633|158368408|FG001|Overall Study|Consent Withdrawn|1|||
49144371|NCT02609633|158368407|FG000|Overall Study|Protocol Deviation|1|||
49144372|NCT02609633|158368408|FG001|Overall Study|Protocol Deviation|0|||
49144373|NCT02609633|158368407|FG000|Overall Study|Non-Compliant with Study Procedures|2|||
49144374|NCT02609633|158368408|FG001|Overall Study|Non-Compliant with Study Procedures|0|||
49144375|NCT02609633|158368407|FG000|Overall Study|Reason not Specified|2|||
49144376|NCT02609633|158368408|FG001|Overall Study|Reason not Specified|1|||
49144377|NCT00337194|158368409|FG000|Overall Study|Adverse Event|5|||
49144378|NCT00337194|158368410|FG001|Overall Study|Adverse Event|1|||
49144379|NCT00337194|158368409|FG000|Overall Study|Death|2|||
49144380|NCT00337194|158368410|FG001|Overall Study|Death|0|||
49144381|NCT00337194|158368409|FG000|Overall Study|Withdrawal by Subject|1|||
49144382|NCT00337194|158368410|FG001|Overall Study|Withdrawal by Subject|0|||
49144383|NCT00337194|158368409|FG000|Overall Study|Disease progression|1|||
49144384|NCT00337194|158368410|FG001|Overall Study|Disease progression|2|||
49144385|NCT00337194|158368409|FG000|Overall Study|Subsequent non-protocol therapy|3|||
49144386|NCT00337194|158368410|FG001|Overall Study|Subsequent non-protocol therapy|1|||
49144387|NCT01657500|158368418|FG000|Overall Study|set impropperly matched|3|||
49144388|NCT01657500|158368419|FG001|Overall Study|set impropperly matched|3|||
49012975|NCT01872689|157885139|FG002|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
49012976|NCT01872689|157885140|FG003|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
49012977|NCT01872689|157885137|FG000|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
49012978|NCT01872689|157885138|FG001|Open-Label Period (Only For Monotherapy)|Physician Decision|1|||
49012979|NCT01872689|157885139|FG002|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
49012980|NCT01872689|157885140|FG003|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
49012981|NCT01872689|157885137|FG000|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1|||
49012982|NCT01872689|157885138|FG001|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3|||
49012983|NCT01872689|157885139|FG002|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
49012984|NCT01872689|157885140|FG003|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
49012985|NCT01872689|157885137|FG000|Open-Label Period (Only For Monotherapy)|Death|5|||
49012986|NCT01872689|157885138|FG001|Open-Label Period (Only For Monotherapy)|Death|3|||
49012987|NCT01872689|157885139|FG002|Open-Label Period (Only For Monotherapy)|Death|0|||
49012988|NCT01872689|157885140|FG003|Open-Label Period (Only For Monotherapy)|Death|0|||
49012989|NCT01872689|157885137|FG000|Open-Label Period (Only For Monotherapy)|Adverse Event|2|||
49012990|NCT01872689|157885138|FG001|Open-Label Period (Only For Monotherapy)|Adverse Event|1|||
49012991|NCT01872689|157885139|FG002|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
49012992|NCT01872689|157885140|FG003|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
49012993|NCT01017029|157885141|FG000|Overall Study|Lost to Follow-up|1|||
49012994|NCT01017029|157885142|FG001|Overall Study|Lost to Follow-up|0|||
49012995|NCT01017029|157885141|FG000|Overall Study|Administrative problem|0|||
49012996|NCT01017029|157885142|FG001|Overall Study|Administrative problem|1|||
49012997|NCT01017029|157885141|FG000|Overall Study|Death|3|||
49012998|NCT01017029|157885142|FG001|Overall Study|Death|1|||
49012999|NCT00515073|157885143|FG000|Overall Study|Withdrawal by Subject|1|||
49013000|NCT00515073|157885143|FG000|Overall Study|Physician Decision|1|||
49013001|NCT02764489|157885144|FG000|Part 1: Day 1 up to Day 16|Adverse Event|2|||
49013002|NCT02764489|157885145|FG001|Part 1: Day 1 up to Day 16|Adverse Event|0|||
49013003|NCT02764489|157885144|FG000|Part 1: Day 1 up to Day 16|Withdrawal by Subject|1|||
49013004|NCT02764489|157885145|FG001|Part 1: Day 1 up to Day 16|Withdrawal by Subject|0|||
49013005|NCT02764489|157885144|FG000|Part 2: Day 19 up to Day 41|Adverse Event|1|||
49013006|NCT02764489|157885145|FG001|Part 2: Day 19 up to Day 41|Adverse Event|0|||
49013007|NCT02764489|157885144|FG000|Part 2: Day 19 up to Day 41|Physician Decision|1|||
49013008|NCT02764489|157885145|FG001|Part 2: Day 19 up to Day 41|Physician Decision|0|||
49013009|NCT00660790|157885146|FG000|Baseline to 3 Months|Death|1|||
49013010|NCT00660790|157885146|FG000|Baseline to 3 Months|Withdrawal by Subject|2|||
49013011|NCT00660790|157885146|FG000|3 Months to 2 Years|Withdrawal by Subject|17|||
49013012|NCT03840811|157885149|FG000|Overall Study|Lost to Follow-up|0|||
49013013|NCT03840811|157885150|FG001|Overall Study|Lost to Follow-up|0|||
49013014|NCT03840811|157885151|FG002|Overall Study|Lost to Follow-up|1|||
49013015|NCT01904383|157885152|FG000|Overall Study|CRF not collected|117|||
49013016|NCT01904383|157885152|FG000|Overall Study|Reason not listed|147|||
49013017|NCT01904383|157885152|FG000|Overall Study|Lost to Follow-up|674|||
49013018|NCT01904383|157885152|FG000|Overall Study|Lack of Efficacy|370|||
49013019|NCT01904383|157885152|FG000|Overall Study|Improvement|141|||
49013020|NCT01904383|157885152|FG000|Overall Study|Adverse Event|271|||
49013021|NCT01904383|157885152|FG000|Overall Study|No patient visit after entry|54|||
49013022|NCT01077713|157885155|FG000|Overall Study|Withdrawal by Subject|1|||
49013023|NCT01077713|157885156|FG001|Overall Study|Withdrawal by Subject|2|||
49013024|NCT01077713|157885155|FG000|Overall Study|Progressive Disease (PD)|0|||
49013025|NCT01077713|157885156|FG001|Overall Study|Progressive Disease (PD)|1|||
49013026|NCT01077713|157885155|FG000|Overall Study|Death|28|||
49013027|NCT01077713|157885156|FG001|Overall Study|Death|29|||
49013028|NCT01077713|157885155|FG000|Overall Study|Lost to Follow-up|1|||
49013029|NCT01077713|157885156|FG001|Overall Study|Lost to Follow-up|1|||
49013030|NCT01077713|157885155|FG000|Overall Study|Adverse Event|2|||
49013031|NCT01077713|157885156|FG001|Overall Study|Adverse Event|1|||
49013032|NCT01077713|157885155|FG000|Overall Study|Other|4|||
49013033|NCT01077713|157885156|FG001|Overall Study|Other|2|||
49013034|NCT03031899|157885158|FG000|Overall Study|Protocol Violation|1|||
49013035|NCT03031899|157885158|FG000|Overall Study|lesion disappeared after stopping habit|1|||
49013036|NCT01664052|157885159|FG000|Phase 1|No device placement|6|||
49013037|NCT01664052|157885160|FG001|Phase 1|No device placement|0|||
49013038|NCT01664052|157885159|FG000|Phase 1|No HSG 1 hr post placement|1|||
49013039|NCT01664052|157885160|FG001|Phase 1|No HSG 1 hr post placement|0|||
49013040|NCT01664052|157885159|FG000|Phase 2|No device placement|0|||
49013041|NCT01664052|157885160|FG001|Phase 2|No device placement|4|||
49013042|NCT01706198|157885161|FG000|Overall Study|Adverse Event|12|||
49013043|NCT01706198|157885162|FG001|Overall Study|Adverse Event|15|||
49013044|NCT01706198|157885161|FG000|Overall Study|Protocol Violation|7|||
49013045|NCT01706198|157885162|FG001|Overall Study|Protocol Violation|5|||
49013046|NCT01706198|157885161|FG000|Overall Study|Other: Subject reached stopping criteria|11|||
49013047|NCT01706198|157885162|FG001|Overall Study|Other: Subject reached stopping criteria|13|||
49013048|NCT01706198|157885161|FG000|Overall Study|Lost to Follow-up|97|||
49144389|NCT01657500|158368418|FG000|Overall Study|Lost to Follow-up|2|||
49144390|NCT01657500|158368419|FG001|Overall Study|Lost to Follow-up|2|||
49144391|NCT03225989|158368420|FG000|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|2|||
49144392|NCT03225989|158368421|FG001|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
49144393|NCT03225989|158368422|FG002|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
49144394|NCT03225989|158368420|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
49144395|NCT03225989|158368421|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|1|||
49144396|NCT03225989|158368422|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
49144397|NCT03225989|158368420|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
49144398|NCT03225989|158368421|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|1|||
49144399|NCT03225989|158368422|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
49144400|NCT03225989|158368420|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
49144401|NCT03225989|158368421|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|7|||
49144402|NCT03225989|158368422|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
49144403|NCT03225989|158368420|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
49144404|NCT03225989|158368421|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|1|||
49144405|NCT03225989|158368422|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
49144406|NCT03225989|158368420|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
49144407|NCT03225989|158368421|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
49144408|NCT03225989|158368422|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|1|||
49144409|NCT03225989|158368420|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
49144410|NCT03225989|158368421|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
49144411|NCT03225989|158368422|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|2|||
49144412|NCT03225989|158368420|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
49144413|NCT03225989|158368421|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
49144414|NCT03225989|158368422|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Death|4|||
49144415|NCT03225989|158368420|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
49144416|NCT03225989|158368421|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
49144417|NCT03225989|158368422|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|16|||
49144418|NCT03225989|158368420|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
49144419|NCT03225989|158368421|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
49144420|NCT03225989|158368422|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|1|||
49144421|NCT03225989|158368420|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
49144422|NCT03225989|158368421|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
49144423|NCT03225989|158368422|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|1|||
49144424|NCT03225989|158368420|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
49144425|NCT03225989|158368421|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
49144426|NCT03225989|158368422|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|1|||
49144427|NCT00098293|158368423|FG000|Double-blind (DB) Phase|Adverse Event|14|||
49144428|NCT00098293|158368424|FG001|Double-blind (DB) Phase|Adverse Event|27|||
49144429|NCT00098293|158368425|FG002|Double-blind (DB) Phase|Adverse Event|60|||
49144430|NCT00098293|158368426|FG003|Double-blind (DB) Phase|Adverse Event|0|||
49144431|NCT00098293|158368427|FG004|Double-blind (DB) Phase|Adverse Event|0|||
49144432|NCT00098293|158368423|FG000|Double-blind (DB) Phase|Pregnancy|0|||
49144433|NCT00098293|158368424|FG001|Double-blind (DB) Phase|Pregnancy|7|||
49144434|NCT00098293|158368425|FG002|Double-blind (DB) Phase|Pregnancy|9|||
49144435|NCT00098293|158368426|FG003|Double-blind (DB) Phase|Pregnancy|0|||
49144436|NCT00098293|158368427|FG004|Double-blind (DB) Phase|Pregnancy|0|||
49144437|NCT00098293|158368423|FG000|Double-blind (DB) Phase|Participant Defaulted|11|||
49144438|NCT00098293|158368424|FG001|Double-blind (DB) Phase|Participant Defaulted|40|||
49144439|NCT00098293|158368425|FG002|Double-blind (DB) Phase|Participant Defaulted|36|||
49144440|NCT00098293|158368426|FG003|Double-blind (DB) Phase|Participant Defaulted|0|||
49144441|NCT00098293|158368427|FG004|Double-blind (DB) Phase|Participant Defaulted|0|||
49144442|NCT00098293|158368423|FG000|Double-blind (DB) Phase|Lack of Efficacy|11|||
49144443|NCT00098293|158368424|FG001|Double-blind (DB) Phase|Lack of Efficacy|64|||
49144444|NCT00098293|158368425|FG002|Double-blind (DB) Phase|Lack of Efficacy|30|||
49144445|NCT00098293|158368426|FG003|Double-blind (DB) Phase|Lack of Efficacy|0|||
49144446|NCT00098293|158368427|FG004|Double-blind (DB) Phase|Lack of Efficacy|0|||
49144447|NCT00098293|158368423|FG000|Double-blind (DB) Phase|Death|1|||
49144448|NCT00098293|158368424|FG001|Double-blind (DB) Phase|Death|2|||
49144449|NCT00098293|158368425|FG002|Double-blind (DB) Phase|Death|2|||
49144450|NCT00098293|158368426|FG003|Double-blind (DB) Phase|Death|0|||
49144451|NCT00098293|158368427|FG004|Double-blind (DB) Phase|Death|0|||
49144452|NCT00098293|158368423|FG000|Double-blind (DB) Phase|Randomized, Not Treated|3|||
49144453|NCT00098293|158368424|FG001|Double-blind (DB) Phase|Randomized, Not Treated|8|||
49144454|NCT00098293|158368425|FG002|Double-blind (DB) Phase|Randomized, Not Treated|11|||
49144455|NCT00098293|158368426|FG003|Double-blind (DB) Phase|Randomized, Not Treated|0|||
49144456|NCT00098293|158368427|FG004|Double-blind (DB) Phase|Randomized, Not Treated|0|||
49144457|NCT00098293|158368423|FG000|Double-blind (DB) Phase|Protocol Violation|2|||
49144458|NCT00098293|158368424|FG001|Double-blind (DB) Phase|Protocol Violation|18|||
49013049|NCT01706198|157885162|FG001|Overall Study|Lost to Follow-up|93|||
49013050|NCT01706198|157885161|FG000|Overall Study|Physician Decision|23|||
49013051|NCT01706198|157885162|FG001|Overall Study|Physician Decision|37|||
49013052|NCT01706198|157885161|FG000|Overall Study|Withdrawal by Subject|23|||
49013053|NCT01706198|157885162|FG001|Overall Study|Withdrawal by Subject|31|||
49013054|NCT01042977|157885164|FG000|Overall Study|Adverse Event|4|||
49013055|NCT01042977|157885165|FG001|Overall Study|Adverse Event|12|||
49013056|NCT01042977|157885164|FG000|Overall Study|Death|2|||
49013057|NCT01042977|157885165|FG001|Overall Study|Death|1|||
49013058|NCT01042977|157885164|FG000|Overall Study|Withdrawal by Subject|8|||
49013059|NCT01042977|157885165|FG001|Overall Study|Withdrawal by Subject|16|||
49013060|NCT01042977|157885164|FG000|Overall Study|Lost to Follow-up|0|||
49013061|NCT01042977|157885165|FG001|Overall Study|Lost to Follow-up|2|||
49013062|NCT01042977|157885164|FG000|Overall Study|Poor/non-compliance|3|||
49013063|NCT01042977|157885165|FG001|Overall Study|Poor/non-compliance|4|||
49013064|NCT01042977|157885164|FG000|Overall Study|Subject no longer meets study criteria|15|||
49013065|NCT01042977|157885165|FG001|Overall Study|Subject no longer meets study criteria|13|||
49013066|NCT01042977|157885164|FG000|Overall Study|Incorrect enrollment|6|||
49013067|NCT01042977|157885165|FG001|Overall Study|Incorrect enrollment|4|||
49013068|NCT01042977|157885164|FG000|Overall Study|Safety|0|||
49013069|NCT01042977|157885165|FG001|Overall Study|Safety|2|||
49013070|NCT01042977|157885164|FG000|Overall Study|Administrative reason by sponsor|0|||
49013071|NCT01042977|157885165|FG001|Overall Study|Administrative reason by sponsor|1|||
49013072|NCT01042977|157885164|FG000|Overall Study|Various|3|||
49013073|NCT01042977|157885165|FG001|Overall Study|Various|0|||
49013074|NCT02499354|157885166|FG000|Overall Study|Withdrawal by Subject|1|||
49013075|NCT02499354|157885167|FG001|Overall Study|Withdrawal by Subject|0|||
49013076|NCT04313283|157885168|FG000|Overall Study|did not complete intervention|4|||
49013077|NCT01084005|157885169|FG000|Overall Study|Adverse Event|1|||
49013078|NCT01084005|157885170|FG001|Overall Study|Adverse Event|8|||
49013079|NCT01084005|157885169|FG000|Overall Study|Protocol Violation|3|||
49013080|NCT01084005|157885170|FG001|Overall Study|Protocol Violation|7|||
49013081|NCT01084005|157885169|FG000|Overall Study|Withdrawal by Subject|1|||
49013082|NCT01084005|157885170|FG001|Overall Study|Withdrawal by Subject|1|||
49013083|NCT03740698|157885171|FG000|Overall Study|Physician Decision|0|||
49013084|NCT03740698|157885172|FG001|Overall Study|Physician Decision|1|||
49013085|NCT03740698|157885173|FG002|Overall Study|Physician Decision|1|||
49013086|NCT00549198|157885175|FG000|Overall Study|Adverse Event|28|||
49013087|NCT00549198|157885176|FG001|Overall Study|Adverse Event|26|||
49013088|NCT00549198|157885175|FG000|Overall Study|Insufficient Viral Load Response|4|||
49013089|NCT00549198|157885176|FG001|Overall Study|Insufficient Viral Load Response|2|||
49013090|NCT00549198|157885175|FG000|Overall Study|Protocol-defined Virological Failure|7|||
49013091|NCT00549198|157885176|FG001|Overall Study|Protocol-defined Virological Failure|0|||
49013092|NCT00549198|157885175|FG000|Overall Study|Non-compliance|2|||
49013093|NCT00549198|157885176|FG001|Overall Study|Non-compliance|4|||
49013094|NCT00549198|157885175|FG000|Overall Study|Lost to Follow-up|7|||
49013095|NCT00549198|157885176|FG001|Overall Study|Lost to Follow-up|8|||
49013096|NCT00549198|157885175|FG000|Overall Study|Treatment Eligibility Criteria Not Met|3|||
49013097|NCT00549198|157885176|FG001|Overall Study|Treatment Eligibility Criteria Not Met|0|||
49013098|NCT00549198|157885175|FG000|Overall Study|Protocol Violation|7|||
49013099|NCT00549198|157885176|FG001|Overall Study|Protocol Violation|2|||
49013100|NCT00549198|157885175|FG000|Overall Study|Investigator Decision|4|||
49013101|NCT00549198|157885176|FG001|Overall Study|Investigator Decision|3|||
49013102|NCT00549198|157885175|FG000|Overall Study|Withdrawal by Subject|7|||
49013103|NCT00549198|157885176|FG001|Overall Study|Withdrawal by Subject|7|||
49013104|NCT00549198|157885175|FG000|Overall Study|Disease Progression|1|||
49013105|NCT00549198|157885176|FG001|Overall Study|Disease Progression|0|||
49013106|NCT00549198|157885175|FG000|Overall Study|Participant Moved|2|||
49013107|NCT00549198|157885176|FG001|Overall Study|Participant Moved|0|||
49013108|NCT00549198|157885175|FG000|Overall Study|Participant not able to perform Week 96|1|||
49013109|NCT00549198|157885176|FG001|Overall Study|Participant not able to perform Week 96|0|||
49013110|NCT00549198|157885175|FG000|Overall Study|Participant moved.Week 96 visit, no scan|1|||
49013111|NCT00549198|157885176|FG001|Overall Study|Participant moved.Week 96 visit, no scan|0|||
49013112|NCT00549198|157885175|FG000|Overall Study|Prohibited Medication|1|||
49013113|NCT00549198|157885176|FG001|Overall Study|Prohibited Medication|2|||
49013114|NCT00549198|157885175|FG000|Overall Study|Participant planning pregnancy|1|||
49013115|NCT00549198|157885176|FG001|Overall Study|Participant planning pregnancy|0|||
49013116|NCT00549198|157885175|FG000|Overall Study|Participant overweight, no scan possible|1|||
49013117|NCT00549198|157885176|FG001|Overall Study|Participant overweight, no scan possible|0|||
49013118|NCT00549198|157885175|FG000|Overall Study|No scan facilities|0|||
49013119|NCT00549198|157885176|FG001|Overall Study|No scan facilities|2|||
49013120|NCT00549198|157885175|FG000|Overall Study|Pregnancy|0|||
49013121|NCT00549198|157885176|FG001|Overall Study|Pregnancy|3|||
49013122|NCT00549198|157885175|FG000|Overall Study|Not Exposed to Study Drug|3|||
49013123|NCT00549198|157885176|FG001|Overall Study|Not Exposed to Study Drug|4|||
49013124|NCT04356573|157885177|FG000|Overall Study|Didn't Qualify|1|||
48822869|NCT02018861|157192235|FG002|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
48822870|NCT02018861|157192236|FG003|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
48730566|NCT02544074|156865820|FG015|Overall Study|Withdrawal by Subject|0|||
48822871|NCT02018861|157192237|FG004|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
48730567|NCT02544074|156865821|FG016|Overall Study|Withdrawal by Subject|0|||
48730568|NCT02544074|156865822|FG017|Overall Study|Withdrawal by Subject|0|||
48822872|NCT02018861|157192238|FG005|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
48822873|NCT02018861|157192239|FG006|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
48822874|NCT02018861|157192240|FG007|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
48822875|NCT02018861|157192241|FG008|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
48822876|NCT02018861|157192242|FG009|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
48822877|NCT02018861|157192233|FG000|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
49013125|NCT04356573|157885178|FG001|Overall Study|Didn't Qualify|0|||
48730569|NCT02544074|156865823|FG018|Overall Study|Withdrawal by Subject|0|||
48730570|NCT02544074|156865824|FG019|Overall Study|Withdrawal by Subject|0|||
48730571|NCT02544074|156865825|FG020|Overall Study|Withdrawal by Subject|0|||
48730572|NCT02544074|156865805|FG000|Overall Study|Tablet error|0|||
48730573|NCT02544074|156865806|FG001|Overall Study|Tablet error|0|||
48730574|NCT02544074|156865807|FG002|Overall Study|Tablet error|0|||
48730575|NCT02544074|156865808|FG003|Overall Study|Tablet error|0|||
48730576|NCT02544074|156865809|FG004|Overall Study|Tablet error|0|||
48730577|NCT02544074|156865810|FG005|Overall Study|Tablet error|1|||
48730578|NCT02544074|156865811|FG006|Overall Study|Tablet error|0|||
48730579|NCT02544074|156865812|FG007|Overall Study|Tablet error|0|||
48730580|NCT02544074|156865813|FG008|Overall Study|Tablet error|0|||
48730581|NCT02544074|156865814|FG009|Overall Study|Tablet error|1|||
48730582|NCT02544074|156865815|FG010|Overall Study|Tablet error|0|||
48730583|NCT02544074|156865816|FG011|Overall Study|Tablet error|0|||
48730584|NCT02544074|156865817|FG012|Overall Study|Tablet error|0|||
48730585|NCT02544074|156865818|FG013|Overall Study|Tablet error|0|||
48730586|NCT02544074|156865819|FG014|Overall Study|Tablet error|0|||
48730587|NCT02544074|156865820|FG015|Overall Study|Tablet error|0|||
48730588|NCT02544074|156865821|FG016|Overall Study|Tablet error|0|||
48730589|NCT02544074|156865822|FG017|Overall Study|Tablet error|0|||
48730590|NCT02544074|156865823|FG018|Overall Study|Tablet error|0|||
48730591|NCT02544074|156865824|FG019|Overall Study|Tablet error|0|||
48730592|NCT02544074|156865825|FG020|Overall Study|Tablet error|0|||
48730593|NCT03384693|156865832|FG000|Overall Study|Adverse Event|3|||
48730594|NCT01394718|156865833|FG000|Overall Study|Met protocol-specific stopping criteria|2|||
48730595|NCT01394718|156865834|FG001|Overall Study|Met protocol-specific stopping criteria|1|||
48730596|NCT03693170|156865835|FG000|Overall Study|Disease Progression|48|||
48730597|NCT03693170|156865835|FG000|Overall Study|Adverse Event|16|||
48730598|NCT03693170|156865835|FG000|Overall Study|Physician Decision|6|||
48730599|NCT03693170|156865835|FG000|Overall Study|Protocol Violation|2|||
48730600|NCT03693170|156865835|FG000|Overall Study|Death|1|||
48730601|NCT03693170|156865835|FG000|Overall Study|Non compliance with study drug|1|||
48730602|NCT03693170|156865835|FG000|Overall Study|Withdrawal by Subject|1|||
48822878|NCT02018861|157192234|FG001|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
49013126|NCT02480010|157885185|FG000|Overall Study|Adverse Event|3|||
49013127|NCT02480010|157885186|FG001|Overall Study|Adverse Event|1|||
49013128|NCT02480010|157885185|FG000|Overall Study|Death|1|||
49013129|NCT02480010|157885186|FG001|Overall Study|Death|0|||
49013130|NCT02480010|157885185|FG000|Overall Study|Insufficient therapeutic response|31|||
49013131|NCT02480010|157885186|FG001|Overall Study|Insufficient therapeutic response|29|||
49013132|NCT02480010|157885185|FG000|Overall Study|Refused Treatment|0|||
49013133|NCT02480010|157885186|FG001|Overall Study|Refused Treatment|3|||
49013134|NCT01677910|157885187|FG000|Double-Blind Treatment Period|Adverse Event|6|||
49013135|NCT01677910|157885188|FG001|Double-Blind Treatment Period|Adverse Event|2|||
49013136|NCT01677910|157885189|FG002|Double-Blind Treatment Period|Adverse Event|3|||
49013137|NCT01677910|157885190|FG003|Double-Blind Treatment Period|Adverse Event|0|||
49013138|NCT01677910|157885187|FG000|Double-Blind Treatment Period|Physician Decision|0|||
49013139|NCT01677910|157885188|FG001|Double-Blind Treatment Period|Physician Decision|0|||
49013140|NCT01677910|157885189|FG002|Double-Blind Treatment Period|Physician Decision|1|||
49013141|NCT01677910|157885190|FG003|Double-Blind Treatment Period|Physician Decision|0|||
49013142|NCT01677910|157885187|FG000|Double-Blind Treatment Period|Withdrawal of consent|1|||
49013143|NCT01677910|157885188|FG001|Double-Blind Treatment Period|Withdrawal of consent|0|||
49013144|NCT01677910|157885189|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
49013145|NCT01677910|157885190|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
49013146|NCT01677910|157885187|FG000|Double-Blind Treatment Period|Reason Not Specified|0|||
49013147|NCT01677910|157885188|FG001|Double-Blind Treatment Period|Reason Not Specified|1|||
49013148|NCT01677910|157885189|FG002|Double-Blind Treatment Period|Reason Not Specified|0|||
49013149|NCT01677910|157885190|FG003|Double-Blind Treatment Period|Reason Not Specified|0|||
49013150|NCT01677910|157885187|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
48822879|NCT02018861|157192235|FG002|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
48822880|NCT02018861|157192236|FG003|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|13|||
48822881|NCT02018861|157192237|FG004|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|18|||
48822882|NCT02018861|157192238|FG005|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
48822883|NCT02018861|157192239|FG006|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
48822884|NCT02018861|157192240|FG007|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
48822885|NCT02018861|157192241|FG008|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
48822886|NCT02018861|157192242|FG009|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
48822887|NCT02018861|157192233|FG000|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
48822888|NCT02018861|157192234|FG001|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
48822889|NCT02018861|157192235|FG002|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
49144459|NCT00098293|158368425|FG002|Double-blind (DB) Phase|Protocol Violation|22|||
49144460|NCT00098293|158368426|FG003|Double-blind (DB) Phase|Protocol Violation|0|||
49144461|NCT00098293|158368427|FG004|Double-blind (DB) Phase|Protocol Violation|0|||
49144462|NCT00098293|158368423|FG000|Double-blind (DB) Phase|Terminated by sponsor|135|||
49144463|NCT00098293|158368424|FG001|Double-blind (DB) Phase|Terminated by sponsor|0|||
49144464|NCT00098293|158368425|FG002|Double-blind (DB) Phase|Terminated by sponsor|0|||
48822890|NCT02018861|157192236|FG003|Parsaclisib Monotherapy: 21-day Cycles|Death|3|||
48822891|NCT02018861|157192237|FG004|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
48822892|NCT02018861|157192238|FG005|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
48822893|NCT02018861|157192239|FG006|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
48822894|NCT02018861|157192240|FG007|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
48822895|NCT02018861|157192241|FG008|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
48822896|NCT02018861|157192242|FG009|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
48822897|NCT02018861|157192233|FG000|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
48822898|NCT02018861|157192234|FG001|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
48822899|NCT02018861|157192235|FG002|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
48822900|NCT02018861|157192236|FG003|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
48822901|NCT02018861|157192237|FG004|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
48822902|NCT02018861|157192238|FG005|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
48822903|NCT02018861|157192239|FG006|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
49144465|NCT00098293|158368426|FG003|Double-blind (DB) Phase|Terminated by sponsor|0|||
49144466|NCT00098293|158368427|FG004|Double-blind (DB) Phase|Terminated by sponsor|0|||
49144467|NCT00098293|158368423|FG000|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
49144468|NCT00098293|158368424|FG001|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
49144469|NCT00098293|158368425|FG002|Between DB and OL Phase|Did Not Enter Open-label Phase|3|||
49144470|NCT00098293|158368426|FG003|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
49144471|NCT00098293|158368427|FG004|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
49144472|NCT00098293|158368423|FG000|Open-label (OL) Phase|Adverse Event|0|||
49144473|NCT00098293|158368424|FG001|Open-label (OL) Phase|Adverse Event|3|||
49144474|NCT00098293|158368425|FG002|Open-label (OL) Phase|Adverse Event|7|||
49144475|NCT00098293|158368426|FG003|Open-label (OL) Phase|Adverse Event|6|||
49144476|NCT00098293|158368427|FG004|Open-label (OL) Phase|Adverse Event|0|||
49144477|NCT00098293|158368423|FG000|Open-label (OL) Phase|Lack of Efficacy|0|||
49144478|NCT00098293|158368424|FG001|Open-label (OL) Phase|Lack of Efficacy|7|||
49144479|NCT00098293|158368425|FG002|Open-label (OL) Phase|Lack of Efficacy|2|||
49144480|NCT00098293|158368426|FG003|Open-label (OL) Phase|Lack of Efficacy|20|||
49144481|NCT00098293|158368427|FG004|Open-label (OL) Phase|Lack of Efficacy|0|||
49144482|NCT00098293|158368423|FG000|Open-label (OL) Phase|Pregnancy|0|||
49144483|NCT00098293|158368424|FG001|Open-label (OL) Phase|Pregnancy|1|||
49144484|NCT00098293|158368425|FG002|Open-label (OL) Phase|Pregnancy|0|||
49144485|NCT00098293|158368426|FG003|Open-label (OL) Phase|Pregnancy|3|||
49144486|NCT00098293|158368427|FG004|Open-label (OL) Phase|Pregnancy|0|||
49144487|NCT00098293|158368423|FG000|Open-label (OL) Phase|Protocol Violation|0|||
49144488|NCT00098293|158368424|FG001|Open-label (OL) Phase|Protocol Violation|6|||
49144489|NCT00098293|158368425|FG002|Open-label (OL) Phase|Protocol Violation|13|||
49144490|NCT00098293|158368426|FG003|Open-label (OL) Phase|Protocol Violation|16|||
48822904|NCT02018861|157192240|FG007|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
48822905|NCT02018861|157192241|FG008|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
48822906|NCT02018861|157192242|FG009|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
48856507|NCT01159600|157312866|FG005|Overall Study|Patient refusal to continue,not due toAE|4|||
49144491|NCT00098293|158368427|FG004|Open-label (OL) Phase|Protocol Violation|0|||
49144492|NCT00098293|158368423|FG000|Open-label (OL) Phase|Participant Defaulted|0|||
49144493|NCT00098293|158368424|FG001|Open-label (OL) Phase|Participant Defaulted|6|||
49144494|NCT00098293|158368425|FG002|Open-label (OL) Phase|Participant Defaulted|16|||
49144495|NCT00098293|158368426|FG003|Open-label (OL) Phase|Participant Defaulted|20|||
49144496|NCT00098293|158368427|FG004|Open-label (OL) Phase|Participant Defaulted|0|||
49144497|NCT00098293|158368423|FG000|Open-label (OL) Phase|Death|0|||
49144498|NCT00098293|158368424|FG001|Open-label (OL) Phase|Death|2|||
49144499|NCT00098293|158368425|FG002|Open-label (OL) Phase|Death|3|||
48822907|NCT02018861|157192233|FG000|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
48822908|NCT02018861|157192234|FG001|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
48822909|NCT02018861|157192235|FG002|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
48822910|NCT02018861|157192236|FG003|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
48822911|NCT02018861|157192237|FG004|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|1|||
48822912|NCT02018861|157192238|FG005|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
48822913|NCT02018861|157192239|FG006|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
48822914|NCT02018861|157192240|FG007|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
48822915|NCT02018861|157192241|FG008|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
48822916|NCT02018861|157192242|FG009|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
48822917|NCT02018861|157192233|FG000|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
48822918|NCT02018861|157192234|FG001|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
48822919|NCT02018861|157192235|FG002|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
48822920|NCT02018861|157192236|FG003|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|4|||
48822921|NCT02018861|157192237|FG004|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|1|||
48822922|NCT02018861|157192238|FG005|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|2|||
48822923|NCT02018861|157192239|FG006|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
48822924|NCT02018861|157192240|FG007|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
48822925|NCT02018861|157192241|FG008|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
48822926|NCT02018861|157192242|FG009|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
48822927|NCT02018861|157192233|FG000|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
48822928|NCT02018861|157192234|FG001|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
48822929|NCT02018861|157192235|FG002|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
48822930|NCT02018861|157192236|FG003|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|2|||
48822931|NCT02018861|157192237|FG004|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|1|||
48822932|NCT02018861|157192238|FG005|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
48822933|NCT02018861|157192239|FG006|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
48822934|NCT02018861|157192240|FG007|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
48822935|NCT02018861|157192241|FG008|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
48822936|NCT02018861|157192242|FG009|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
48822937|NCT02018861|157192233|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
48822938|NCT02018861|157192234|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
48822939|NCT02018861|157192235|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
48822940|NCT02018861|157192236|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
48822941|NCT02018861|157192237|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
48822942|NCT02018861|157192238|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
48822943|NCT02018861|157192239|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|5|||
48822944|NCT02018861|157192240|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|2|||
48822945|NCT02018861|157192241|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
48822946|NCT02018861|157192242|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
48822947|NCT02018861|157192233|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
48822948|NCT02018861|157192234|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
48822949|NCT02018861|157192235|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
48822950|NCT02018861|157192236|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
48822951|NCT02018861|157192237|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
48822952|NCT02018861|157192238|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
48822953|NCT02018861|157192239|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|3|||
48822954|NCT02018861|157192240|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|1|||
48822955|NCT02018861|157192241|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
48822956|NCT02018861|157192242|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
48822957|NCT02018861|157192233|FG000|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
48822958|NCT02018861|157192234|FG001|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
48822959|NCT02018861|157192235|FG002|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
48822960|NCT02018861|157192236|FG003|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
48822961|NCT02018861|157192237|FG004|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
48822962|NCT02018861|157192238|FG005|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
48822963|NCT02018861|157192239|FG006|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
48822964|NCT02018861|157192240|FG007|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
48822965|NCT02018861|157192241|FG008|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|1|||
48822966|NCT02018861|157192242|FG009|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
49013151|NCT01677910|157885188|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
49013152|NCT01677910|157885189|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
48822967|NCT02018861|157192233|FG000|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
48822968|NCT02018861|157192234|FG001|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
48822969|NCT02018861|157192235|FG002|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
48822970|NCT02018861|157192236|FG003|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
48822971|NCT02018861|157192237|FG004|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
48822972|NCT02018861|157192238|FG005|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
48822973|NCT02018861|157192239|FG006|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
48822974|NCT02018861|157192240|FG007|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
48822975|NCT02018861|157192241|FG008|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|1|||
48822976|NCT02018861|157192242|FG009|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
48822977|NCT02018861|157192233|FG000|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
48822978|NCT02018861|157192234|FG001|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
48822979|NCT02018861|157192235|FG002|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
48822980|NCT02018861|157192236|FG003|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
48822981|NCT02018861|157192237|FG004|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
48822982|NCT02018861|157192238|FG005|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
48822983|NCT02018861|157192239|FG006|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
48822984|NCT02018861|157192240|FG007|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
48822985|NCT02018861|157192241|FG008|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|1|||
48822986|NCT02018861|157192242|FG009|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
48822987|NCT03673098|157192243|FG000|Overall Study|Lost to Follow-up|2|||
48822988|NCT03673098|157192244|FG001|Overall Study|Lost to Follow-up|3|||
48822989|NCT03673098|157192243|FG000|Overall Study|Withdrawal by Subject|6|||
48822990|NCT03673098|157192244|FG001|Overall Study|Withdrawal by Subject|1|||
49013153|NCT01677910|157885190|FG003|Open-Label Extension Period (OLE)|Physician Decision|4|||
49013154|NCT01677910|157885187|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
49013155|NCT01677910|157885188|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
49013156|NCT01677910|157885189|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
49013157|NCT01677910|157885190|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
49144500|NCT00098293|158368426|FG003|Open-label (OL) Phase|Death|0|||
49013158|NCT01677910|157885187|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
49013159|NCT01677910|157885188|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
49013160|NCT01677910|157885189|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
49013161|NCT01677910|157885190|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
49013162|NCT01677910|157885187|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
49013163|NCT01677910|157885188|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
49013164|NCT01677910|157885189|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
49013165|NCT01677910|157885190|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|5|||
49013166|NCT01677910|157885187|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
49013167|NCT01677910|157885188|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
49013168|NCT01677910|157885189|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
49013169|NCT01677910|157885190|FG003|Open-Label Extension Period (OLE)|Adverse Event|15|||
49013170|NCT01677910|157885187|FG000|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
49013171|NCT01677910|157885188|FG001|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
49144501|NCT00098293|158368427|FG004|Open-label (OL) Phase|Death|0|||
49144502|NCT00098293|158368423|FG000|Supplemental Phase (SP)|Death|0|||
49144503|NCT00098293|158368424|FG001|Supplemental Phase (SP)|Death|0|||
48822991|NCT03673098|157192243|FG000|Overall Study|Could not participate due to scheduling conflicts or health issues|2|||
48822992|NCT03673098|157192244|FG001|Overall Study|Could not participate due to scheduling conflicts or health issues|0|||
48822993|NCT01642186|157192248|FG000|Overall Study|Death|0|||
48822994|NCT01642186|157192249|FG001|Overall Study|Death|2|||
48822995|NCT01642186|157192250|FG002|Overall Study|Death|2|||
49144504|NCT00098293|158368425|FG002|Supplemental Phase (SP)|Death|0|||
49144505|NCT00098293|158368426|FG003|Supplemental Phase (SP)|Death|0|||
49144506|NCT00098293|158368427|FG004|Supplemental Phase (SP)|Death|1|||
49144507|NCT00098293|158368423|FG000|Supplemental Phase (SP)|Lost to Follow-up|0|||
49144508|NCT00098293|158368424|FG001|Supplemental Phase (SP)|Lost to Follow-up|0|||
49144509|NCT00098293|158368425|FG002|Supplemental Phase (SP)|Lost to Follow-up|0|||
49144510|NCT00098293|158368426|FG003|Supplemental Phase (SP)|Lost to Follow-up|0|||
49144511|NCT00098293|158368427|FG004|Supplemental Phase (SP)|Lost to Follow-up|2|||
49144512|NCT00098293|158368423|FG000|Supplemental Phase (SP)|Withdrawal by Subject|0|||
49144513|NCT00098293|158368424|FG001|Supplemental Phase (SP)|Withdrawal by Subject|0|||
49144514|NCT00098293|158368425|FG002|Supplemental Phase (SP)|Withdrawal by Subject|0|||
49144515|NCT00098293|158368426|FG003|Supplemental Phase (SP)|Withdrawal by Subject|0|||
48822996|NCT01642186|157192248|FG000|Overall Study|Lost to Follow-up|0|||
49144516|NCT00098293|158368427|FG004|Supplemental Phase (SP)|Withdrawal by Subject|8|||
49144517|NCT00098293|158368423|FG000|Supplemental Phase (SP)|Other|0|||
49144518|NCT00098293|158368424|FG001|Supplemental Phase (SP)|Other|0|||
49144519|NCT00098293|158368425|FG002|Supplemental Phase (SP)|Other|0|||
49144520|NCT00098293|158368426|FG003|Supplemental Phase (SP)|Other|0|||
49144521|NCT00098293|158368427|FG004|Supplemental Phase (SP)|Other|22|||
49144522|NCT03518203|158368428|FG000|Overall Study|The participant died on study prior to receiving 4 doses and was not evaluable.|1|||
49144523|NCT03518203|158368428|FG000|Overall Study|Relapsed with primary malignancy within 6 months of TMA diagnosis making participant unevaluable.|1|||
49144524|NCT02829957|158368429|FG000|Overall Study|Lost to Follow-up|2|||
49144525|NCT02829957|158368430|FG001|Overall Study|Lost to Follow-up|1|||
49144526|NCT03511066|158368431|FG000|Overall Study|Withdrawal by Subject|1|||
49144527|NCT03511066|158368432|FG001|Overall Study|Withdrawal by Subject|2|||
49144528|NCT03511066|158368433|FG002|Overall Study|Withdrawal by Subject|3|||
49144529|NCT03511066|158368431|FG000|Overall Study|Lost to Follow-up|2|||
49144530|NCT03511066|158368432|FG001|Overall Study|Lost to Follow-up|3|||
49144531|NCT03511066|158368433|FG002|Overall Study|Lost to Follow-up|0|||
49013172|NCT01677910|157885189|FG002|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
49013173|NCT01677910|157885190|FG003|Open-Label Extension Period (OLE)|Lost to Follow-up|1|||
49013174|NCT03705351|157885192|FG000|Overall Study|Study termination|3|||
49013175|NCT03705351|157885192|FG000|Overall Study|Death|1|||
49013176|NCT03705351|157885192|FG000|Overall Study|Lack of Efficacy|2|||
49013177|NCT03705351|157885192|FG000|Overall Study|Withdrawal by Subject|1|||
49013178|NCT03141177|157885193|FG000|Overall Study|Death|62|||
49013179|NCT03141177|157885194|FG001|Overall Study|Death|13|||
49013180|NCT03141177|157885195|FG002|Overall Study|Death|84|||
49013181|NCT03141177|157885193|FG000|Overall Study|Participant withdrew consent|9|||
49013182|NCT03141177|157885194|FG001|Overall Study|Participant withdrew consent|2|||
49013183|NCT03141177|157885195|FG002|Overall Study|Participant withdrew consent|13|||
49013184|NCT03141177|157885193|FG000|Overall Study|Not reported|1|||
49013185|NCT03141177|157885194|FG001|Overall Study|Not reported|0|||
49013186|NCT03141177|157885195|FG002|Overall Study|Not reported|1|||
49013187|NCT03141177|157885193|FG000|Overall Study|Lost to Follow-up|2|||
49013188|NCT03141177|157885194|FG001|Overall Study|Lost to Follow-up|1|||
49013189|NCT03141177|157885195|FG002|Overall Study|Lost to Follow-up|1|||
49013190|NCT03141177|157885193|FG000|Overall Study|Other reasons|4|||
49144532|NCT01189227|158368434|FG000|Overall Study|Study terminated due to low accrual|6|||
49144533|NCT01189227|158368435|FG001|Overall Study|Study terminated due to low accrual|3|||
49144534|NCT04595370|158368436|FG000|Overall Study|Subjects randomised, not treated, Protocol Deviation|1|||
49144535|NCT04595370|158368437|FG001|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
49144536|NCT04595370|158368438|FG002|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
49144537|NCT04595370|158368439|FG003|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
49144538|NCT04595370|158368440|FG004|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
49144539|NCT04595370|158368441|FG005|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
49144540|NCT04595370|158368436|FG000|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
49144541|NCT04595370|158368437|FG001|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
49144542|NCT04595370|158368438|FG002|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|1|||
49144543|NCT04595370|158368439|FG003|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
49144544|NCT04595370|158368440|FG004|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
49144545|NCT04595370|158368441|FG005|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
49144546|NCT04595370|158368436|FG000|Overall Study|Adverse Event|0|||
49144547|NCT04595370|158368437|FG001|Overall Study|Adverse Event|4|||
49144548|NCT04595370|158368438|FG002|Overall Study|Adverse Event|3|||
49144549|NCT04595370|158368439|FG003|Overall Study|Adverse Event|1|||
49144550|NCT04595370|158368440|FG004|Overall Study|Adverse Event|1|||
49144551|NCT04595370|158368441|FG005|Overall Study|Adverse Event|1|||
49144552|NCT04595370|158368436|FG000|Overall Study|Withdrawal of Consent|1|||
49144553|NCT04595370|158368437|FG001|Overall Study|Withdrawal of Consent|1|||
49144554|NCT04595370|158368438|FG002|Overall Study|Withdrawal of Consent|1|||
49144555|NCT04595370|158368439|FG003|Overall Study|Withdrawal of Consent|0|||
49144556|NCT04595370|158368440|FG004|Overall Study|Withdrawal of Consent|0|||
49144557|NCT04595370|158368441|FG005|Overall Study|Withdrawal of Consent|0|||
49144558|NCT04595370|158368436|FG000|Overall Study|Death|0|||
49144559|NCT04595370|158368437|FG001|Overall Study|Death|1|||
49144560|NCT04595370|158368438|FG002|Overall Study|Death|0|||
48730603|NCT01347307|156865836|FG000|Overall Study|Death|0|||
48730604|NCT01347307|156865837|FG001|Overall Study|Death|4|||
48730605|NCT01347307|156865836|FG000|Overall Study|Physician Decision|0|||
48730606|NCT01347307|156865837|FG001|Overall Study|Physician Decision|1|||
48730607|NCT04533880|156865838|FG000|Overall Study|Lost to Follow-up|0|||
48730608|NCT04533880|156865839|FG001|Overall Study|Lost to Follow-up|1|||
48730609|NCT04533880|156865840|FG002|Overall Study|Lost to Follow-up|1|||
48730610|NCT02237911|156865842|FG000|Overall Study|Withdrawal by Subject|4|||
48730611|NCT02237911|156865843|FG001|Overall Study|Withdrawal by Subject|7|||
48730612|NCT02237911|156865844|FG002|Overall Study|Withdrawal by Subject|2|||
48730613|NCT02237911|156865842|FG000|Overall Study|Lost to Follow-up|3|||
48730614|NCT02237911|156865843|FG001|Overall Study|Lost to Follow-up|1|||
48730615|NCT02237911|156865844|FG002|Overall Study|Lost to Follow-up|1|||
49144561|NCT04595370|158368439|FG003|Overall Study|Death|0|||
49144562|NCT04595370|158368440|FG004|Overall Study|Death|1|||
49144563|NCT04595370|158368441|FG005|Overall Study|Death|0|||
49144564|NCT04595370|158368436|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
49144565|NCT04595370|158368437|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
49013191|NCT03141177|157885194|FG001|Overall Study|Other reasons|0|||
49013192|NCT03141177|157885195|FG002|Overall Study|Other reasons|11|||
49013193|NCT03141177|157885193|FG000|Overall Study|Participants did not start treatment period|3|||
49013194|NCT03141177|157885194|FG001|Overall Study|Participants did not start treatment period|0|||
49013195|NCT03141177|157885195|FG002|Overall Study|Participants did not start treatment period|8|||
49013196|NCT02114931|157885196|FG000|Overall Study|Withdrawal by Subject|15|||
49013197|NCT02114931|157885197|FG001|Overall Study|Withdrawal by Subject|18|||
49013198|NCT02114931|157885196|FG000|Overall Study|Adverse Event|4|||
49013199|NCT02114931|157885197|FG001|Overall Study|Adverse Event|6|||
49013200|NCT02114931|157885196|FG000|Overall Study|Lost to Follow-up|3|||
49013201|NCT02114931|157885197|FG001|Overall Study|Lost to Follow-up|3|||
49013202|NCT02114931|157885196|FG000|Overall Study|Physician Decision|1|||
49013203|NCT02114931|157885197|FG001|Overall Study|Physician Decision|2|||
49013204|NCT02114931|157885196|FG000|Overall Study|Other|2|||
49013205|NCT02114931|157885197|FG001|Overall Study|Other|1|||
49013206|NCT02385526|157885198|FG000|Overall Study|Withdrawal by Subject|0|||
49013207|NCT02385526|157885199|FG001|Overall Study|Withdrawal by Subject|2|||
49013208|NCT02385526|157885200|FG002|Overall Study|Withdrawal by Subject|0|||
49013209|NCT02385526|157885198|FG000|Overall Study|Lost to Follow-up|0|||
49144566|NCT04595370|158368438|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
49144567|NCT04595370|158368439|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
49144568|NCT04595370|158368440|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
49144569|NCT04595370|158368441|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
49144570|NCT04595370|158368436|FG000|Overall Study|Withdrawal by Subject|0|||
49144571|NCT04595370|158368437|FG001|Overall Study|Withdrawal by Subject|0|||
49144572|NCT04595370|158368438|FG002|Overall Study|Withdrawal by Subject|1|||
49144573|NCT04595370|158368439|FG003|Overall Study|Withdrawal by Subject|0|||
49144574|NCT04595370|158368440|FG004|Overall Study|Withdrawal by Subject|2|||
49144575|NCT04595370|158368441|FG005|Overall Study|Withdrawal by Subject|0|||
49144576|NCT04595370|158368436|FG000|Overall Study|Lost to Follow-up|0|||
49144577|NCT04595370|158368437|FG001|Overall Study|Lost to Follow-up|0|||
49144578|NCT04595370|158368438|FG002|Overall Study|Lost to Follow-up|0|||
49144579|NCT04595370|158368439|FG003|Overall Study|Lost to Follow-up|0|||
49144580|NCT04595370|158368440|FG004|Overall Study|Lost to Follow-up|1|||
49144581|NCT04595370|158368441|FG005|Overall Study|Lost to Follow-up|0|||
49144582|NCT04595370|158368436|FG000|Overall Study|Participants discontinued study treatment due to other reasons|0|||
49144583|NCT04595370|158368437|FG001|Overall Study|Participants discontinued study treatment due to other reasons|2|||
49013210|NCT02385526|157885199|FG001|Overall Study|Lost to Follow-up|1|||
49013211|NCT02385526|157885200|FG002|Overall Study|Lost to Follow-up|0|||
49144584|NCT04595370|158368438|FG002|Overall Study|Participants discontinued study treatment due to other reasons|2|||
49144585|NCT04595370|158368439|FG003|Overall Study|Participants discontinued study treatment due to other reasons|0|||
49144586|NCT04595370|158368440|FG004|Overall Study|Participants discontinued study treatment due to other reasons|1|||
49013212|NCT02385526|157885198|FG000|Overall Study|Physician Decision|1|||
49013213|NCT02385526|157885199|FG001|Overall Study|Physician Decision|0|||
49013214|NCT02385526|157885200|FG002|Overall Study|Physician Decision|0|||
49013215|NCT02385526|157885198|FG000|Overall Study|Protocol Violation|1|||
49144587|NCT04595370|158368441|FG005|Overall Study|Participants discontinued study treatment due to other reasons|0|||
49144588|NCT02520154|158368443|FG000|Overall Study|Death|1|||
49144589|NCT02520154|158368443|FG000|Overall Study|Withdrawal by Subject|2|||
49144590|NCT02520154|158368443|FG000|Overall Study|Physician Decision|2|||
49144591|NCT01740427|158368447|FG000|Overall Study|Objective Progression or Relapse|286|||
49144592|NCT01740427|158368448|FG001|Overall Study|Objective Progression or Relapse|172|||
49013216|NCT02385526|157885199|FG001|Overall Study|Protocol Violation|0|||
49013217|NCT02385526|157885200|FG002|Overall Study|Protocol Violation|0|||
49013218|NCT02570165|157885201|FG000|Overall Study|Adverse Event|1|||
49013219|NCT02570165|157885202|FG001|Overall Study|Adverse Event|0|||
49144593|NCT01740427|158368447|FG000|Overall Study|Adverse Event|32|||
49144594|NCT01740427|158368448|FG001|Overall Study|Adverse Event|9|||
49144595|NCT01740427|158368447|FG000|Overall Study|Global Deterioration of Health Status|28|||
49144596|NCT01740427|158368448|FG001|Overall Study|Global Deterioration of Health Status|12|||
49144597|NCT01740427|158368447|FG000|Overall Study|Participant Refused Continued Treatment|27|||
49013220|NCT02570165|157885203|FG002|Overall Study|Adverse Event|2|||
49013221|NCT02570165|157885204|FG003|Overall Study|Adverse Event|0|||
49013222|NCT02570165|157885205|FG004|Overall Study|Adverse Event|0|||
49013223|NCT02570165|157885206|FG005|Overall Study|Adverse Event|0|||
49013224|NCT02570165|157885207|FG006|Overall Study|Adverse Event|0|||
49144598|NCT01740427|158368448|FG001|Overall Study|Participant Refused Continued Treatment|15|||
49144599|NCT01740427|158368447|FG000|Overall Study|Unspecified reasons|52|||
49144600|NCT01740427|158368448|FG001|Overall Study|Unspecified reasons|8|||
49013225|NCT02570165|157885201|FG000|Overall Study|Lack of Efficacy|0|||
49013226|NCT02570165|157885202|FG001|Overall Study|Lack of Efficacy|1|||
48730616|NCT02239224|156865846|FG000|Overall Study|Administrative|0|||
48730617|NCT02239224|156865847|FG001|Overall Study|Administrative|0|||
48730618|NCT02239224|156865848|FG002|Overall Study|Administrative|3|||
49144601|NCT01740427|158368447|FG000|Overall Study|Death|10|||
49144602|NCT01740427|158368448|FG001|Overall Study|Death|3|||
49144603|NCT01740427|158368447|FG000|Overall Study|Protocol Violation|5|||
49144604|NCT01740427|158368448|FG001|Overall Study|Protocol Violation|3|||
49144605|NCT01740427|158368447|FG000|Overall Study|Lost to Follow-up|3|||
49144606|NCT01740427|158368448|FG001|Overall Study|Lost to Follow-up|0|||
49144607|NCT01740427|158368447|FG000|Overall Study|Site Terminated by Sponsor|1|||
49144608|NCT01740427|158368448|FG001|Overall Study|Site Terminated by Sponsor|0|||
49144609|NCT01390584|158368453|FG000|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
49144610|NCT01390584|158368454|FG001|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
49144611|NCT01390584|158368455|FG002|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1|||
49144612|NCT00362609|158368458|FG000|Overall Study|Withdrawal by Subject|0|||
49144613|NCT00362609|158368459|FG001|Overall Study|Withdrawal by Subject|1|||
49144614|NCT00362609|158368458|FG000|Overall Study|Protocol Violation|0|||
49144615|NCT00362609|158368459|FG001|Overall Study|Protocol Violation|1|||
49144616|NCT02539394|158368460|FG000|Overall Study|Protocol Violation|1|||
49144617|NCT02539394|158368461|FG001|Overall Study|Protocol Violation|3|||
49144618|NCT02539394|158368460|FG000|Overall Study|Lost to Follow-up|1|||
48822997|NCT01642186|157192249|FG001|Overall Study|Lost to Follow-up|0|||
48822998|NCT01642186|157192250|FG002|Overall Study|Lost to Follow-up|1|||
49144619|NCT02539394|158368461|FG001|Overall Study|Lost to Follow-up|2|||
49144620|NCT02539394|158368460|FG000|Overall Study|Incomplete dataset|6|||
49144621|NCT02539394|158368461|FG001|Overall Study|Incomplete dataset|6|||
49144622|NCT03020888|158368464|FG000|Overall Study|Physician Decision|4|||
49144623|NCT03020888|158368464|FG000|Overall Study|Withdrawal by Subject|6|||
49144624|NCT03020888|158368464|FG000|Overall Study|Insurance coverage|2|||
49144625|NCT03020888|158368464|FG000|Overall Study|Lost to Follow-up|1|||
49144626|NCT00992394|158368469|FG000|Overall Study|Lack of Efficacy|6|||
49144627|NCT00992394|158368470|FG001|Overall Study|Lack of Efficacy|3|||
49144628|NCT00992394|158368469|FG000|Overall Study|Adverse Event|4|||
49144629|NCT00992394|158368470|FG001|Overall Study|Adverse Event|5|||
49144630|NCT00992394|158368469|FG000|Overall Study|Withdrawal by Subject|8|||
49144631|NCT00992394|158368470|FG001|Overall Study|Withdrawal by Subject|2|||
49144632|NCT00992394|158368469|FG000|Overall Study|Physician Decision|1|||
49144633|NCT00992394|158368470|FG001|Overall Study|Physician Decision|0|||
49144634|NCT00992394|158368469|FG000|Overall Study|Protocol Violation|2|||
49144635|NCT00992394|158368470|FG001|Overall Study|Protocol Violation|4|||
49144636|NCT00992394|158368469|FG000|Overall Study|Lost to Follow-up|2|||
49144637|NCT00992394|158368470|FG001|Overall Study|Lost to Follow-up|0|||
49144638|NCT00992394|158368469|FG000|Overall Study|Other event|1|||
49144639|NCT00992394|158368470|FG001|Overall Study|Other event|0|||
49144640|NCT02568254|158368471|FG000|Period 2|Adverse Event|0|||
49144641|NCT02568254|158368472|FG001|Period 2|Adverse Event|0|||
49144642|NCT02568254|158368473|FG002|Period 2|Adverse Event|1|||
49144643|NCT02568254|158368474|FG003|Period 2|Adverse Event|0|||
49144644|NCT02568254|158368475|FG004|Period 2|Adverse Event|0|||
49144645|NCT02568254|158368476|FG005|Period 2|Adverse Event|0|||
49144646|NCT02568254|158368471|FG000|Period 3|Unstatisfactory Lens fitting|0|||
49144647|NCT02568254|158368472|FG001|Period 3|Unstatisfactory Lens fitting|0|||
49144648|NCT02568254|158368473|FG002|Period 3|Unstatisfactory Lens fitting|0|||
48730619|NCT02239224|156865849|FG003|Overall Study|Administrative|1|||
48730620|NCT01466179|156865850|FG000|Overall Study|Ongoing in core study|2|||
48730621|NCT01466179|156865850|FG000|Overall Study|Physician Decision|46|||
48730622|NCT01466179|156865850|FG000|Overall Study|Progressive disease|43|||
48730623|NCT01466179|156865850|FG000|Overall Study|Adverse Event|32|||
48730624|NCT01466179|156865850|FG000|Overall Study|Disease relapse|23|||
48730625|NCT01466179|156865850|FG000|Overall Study|Lack of Efficacy|14|||
48730626|NCT01466179|156865850|FG000|Overall Study|Death|7|||
48730627|NCT01466179|156865850|FG000|Overall Study|Withdrawal by Subject|7|||
48730628|NCT01466179|156865850|FG000|Overall Study|Protocol Violation|2|||
48730629|NCT01466179|156865850|FG000|Overall Study|Other|3|||
48730630|NCT01886716|156865852|FG000|Week 1|Lost to Follow-up|0|||
48730631|NCT01886716|156865853|FG001|Week 1|Lost to Follow-up|0|||
48730632|NCT01886716|156865854|FG002|Week 1|Lost to Follow-up|2|||
48730633|NCT01886716|156865855|FG003|Week 1|Lost to Follow-up|2|||
48730634|NCT01886716|156865852|FG000|Week 2|Lost to Follow-up|3|||
48730635|NCT01886716|156865853|FG001|Week 2|Lost to Follow-up|2|||
48730636|NCT01886716|156865854|FG002|Week 2|Lost to Follow-up|1|||
48730637|NCT01886716|156865855|FG003|Week 2|Lost to Follow-up|3|||
48730638|NCT01886716|156865852|FG000|Week 3|Lost to Follow-up|1|||
48730639|NCT01886716|156865853|FG001|Week 3|Lost to Follow-up|1|||
48730640|NCT01886716|156865854|FG002|Week 3|Lost to Follow-up|0|||
48730641|NCT01886716|156865855|FG003|Week 3|Lost to Follow-up|1|||
48730642|NCT03589469|156865857|FG000|Overall Study|Withdrawal by Subject|8|||
48730643|NCT03589469|156865857|FG000|Overall Study|Physician Decision|20|||
48730644|NCT03589469|156865857|FG000|Overall Study|Death|97|||
49144649|NCT02568254|158368474|FG003|Period 3|Unstatisfactory Lens fitting|0|||
49144650|NCT02568254|158368475|FG004|Period 3|Unstatisfactory Lens fitting|1|||
49144651|NCT02568254|158368476|FG005|Period 3|Unstatisfactory Lens fitting|0|||
49144652|NCT04495478|158368479|FG000|Overall Study|Withdrawal by Subject|0|||
49144653|NCT04495478|158368480|FG001|Overall Study|Withdrawal by Subject|0|||
49144654|NCT04495478|158368481|FG002|Overall Study|Withdrawal by Subject|0|||
49144655|NCT04495478|158368482|FG003|Overall Study|Withdrawal by Subject|1|||
49144656|NCT04495478|158368483|FG004|Overall Study|Withdrawal by Subject|0|||
49144657|NCT04495478|158368484|FG005|Overall Study|Withdrawal by Subject|0|||
49144658|NCT04495478|158368485|FG006|Overall Study|Withdrawal by Subject|0|||
49144659|NCT04495478|158368479|FG000|Overall Study|Physician Decision|0|||
49144660|NCT04495478|158368480|FG001|Overall Study|Physician Decision|1|||
49144661|NCT04495478|158368481|FG002|Overall Study|Physician Decision|0|||
49144662|NCT04495478|158368482|FG003|Overall Study|Physician Decision|0|||
48822999|NCT01268059|157192256|FG000|Overall Study|Lost to Follow-up|0|||
48823000|NCT01268059|157192257|FG001|Overall Study|Lost to Follow-up|1|||
48823001|NCT01268059|157192258|FG002|Overall Study|Lost to Follow-up|0|||
49013227|NCT02570165|157885203|FG002|Overall Study|Lack of Efficacy|0|||
49013228|NCT02570165|157885204|FG003|Overall Study|Lack of Efficacy|0|||
49013229|NCT02570165|157885205|FG004|Overall Study|Lack of Efficacy|4|||
49013230|NCT02570165|157885206|FG005|Overall Study|Lack of Efficacy|0|||
48823002|NCT01268059|157192259|FG003|Overall Study|Lost to Follow-up|0|||
48823003|NCT01268059|157192256|FG000|Overall Study|Withdrawal by Subject|7|||
48823004|NCT01268059|157192257|FG001|Overall Study|Withdrawal by Subject|4|||
48823005|NCT01268059|157192258|FG002|Overall Study|Withdrawal by Subject|0|||
48823006|NCT01268059|157192259|FG003|Overall Study|Withdrawal by Subject|0|||
48823007|NCT01268059|157192256|FG000|Overall Study|Death|20|||
48823008|NCT01268059|157192257|FG001|Overall Study|Death|30|||
48823009|NCT01268059|157192258|FG002|Overall Study|Death|3|||
48823010|NCT01268059|157192259|FG003|Overall Study|Death|5|||
48823011|NCT01268059|157192256|FG000|Overall Study|Progression of disease|1|||
48823012|NCT01268059|157192257|FG001|Overall Study|Progression of disease|0|||
48823013|NCT01268059|157192258|FG002|Overall Study|Progression of disease|0|||
48823014|NCT01268059|157192259|FG003|Overall Study|Progression of disease|0|||
48823015|NCT03660943|157192260|FG000|Overall Study|Adverse Event|5|||
48823016|NCT03660943|157192261|FG001|Overall Study|Adverse Event|3|||
48823017|NCT03660943|157192260|FG000|Overall Study|Death|0|||
48823018|NCT03660943|157192261|FG001|Overall Study|Death|2|||
48823019|NCT03660943|157192260|FG000|Overall Study|Lost to Follow-up|7|||
48823020|NCT03660943|157192261|FG001|Overall Study|Lost to Follow-up|3|||
48823021|NCT03660943|157192260|FG000|Overall Study|Protocol Violation|3|||
48823022|NCT03660943|157192261|FG001|Overall Study|Protocol Violation|5|||
48823023|NCT03660943|157192260|FG000|Overall Study|Withdrawal by Subject|8|||
48823024|NCT03660943|157192261|FG001|Overall Study|Withdrawal by Subject|15|||
48823025|NCT03660943|157192260|FG000|Overall Study|Lack of Efficacy|9|||
48823026|NCT03660943|157192261|FG001|Overall Study|Lack of Efficacy|12|||
48823027|NCT03660943|157192260|FG000|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|4|||
48823028|NCT03660943|157192261|FG001|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|13|||
48823029|NCT02491411|157192262|FG000|Overall Study|Physician Decision|4|||
48823030|NCT01036087|157192267|FG000|Overall Study|Adverse Event|2|||
48823031|NCT01036087|157192267|FG000|Overall Study|Lack of Efficacy|1|||
48823032|NCT02123966|157192268|FG000|Overall Study|Intercurrent Illness|1|||
48823033|NCT00465361|157192269|FG000|Baseline Assessment|Personal Issues/Scheduling|4|||
48823034|NCT02451930|157192270|FG000|Overall Study|Death|0|||
48823035|NCT02451930|157192271|FG001|Overall Study|Death|15|||
48823036|NCT02451930|157192270|FG000|Overall Study|Lost to Follow-up|0|||
48823037|NCT02451930|157192271|FG001|Overall Study|Lost to Follow-up|3|||
48823038|NCT02451930|157192270|FG000|Overall Study|Sponsor Decision|2|||
48823039|NCT02451930|157192271|FG001|Overall Study|Sponsor Decision|10|||
48823040|NCT02451930|157192270|FG000|Overall Study|Withdrawal by Subject|0|||
49013231|NCT02570165|157885207|FG006|Overall Study|Lack of Efficacy|0|||
49013232|NCT02570165|157885201|FG000|Overall Study|Par. Reached Stopping Criteria|1|||
49144663|NCT04495478|158368483|FG004|Overall Study|Physician Decision|1|||
48823041|NCT02451930|157192271|FG001|Overall Study|Withdrawal by Subject|1|||
48823042|NCT02451930|157192270|FG000|Overall Study|Other|0|||
48823043|NCT02451930|157192271|FG001|Overall Study|Other|1|||
48823044|NCT03639675|157192272|FG000|Overall Study|Withdrawal by Subject|1|||
48823045|NCT02748512|157192273|FG000|Overall Study|Lost to Follow-up|1|||
48823046|NCT02748512|157192274|FG001|Overall Study|Lost to Follow-up|1|||
48823047|NCT01403987|157192275|FG000|Overall Study|Residents forgot their secret PIN|18|||
48823048|NCT01403987|157192276|FG001|Overall Study|Residents forgot their secret PIN|17|||
49144664|NCT04495478|158368484|FG005|Overall Study|Physician Decision|0|||
49144665|NCT04495478|158368485|FG006|Overall Study|Physician Decision|0|||
48823049|NCT01403987|157192277|FG002|Overall Study|Residents forgot their secret PIN|18|||
48823050|NCT00180674|157192280|FG000|Phase 1, Observation Period|Withdrawal by Subject|4|||
49013233|NCT02570165|157885202|FG001|Overall Study|Par. Reached Stopping Criteria|1|||
49013234|NCT02570165|157885203|FG002|Overall Study|Par. Reached Stopping Criteria|0|||
49144666|NCT03882801|158370301|FG000|Period 1|Adverse Event|0|||
49144667|NCT03882801|158370302|FG001|Period 1|Adverse Event|1|||
49013235|NCT02570165|157885204|FG003|Overall Study|Par. Reached Stopping Criteria|2|||
49013236|NCT02570165|157885205|FG004|Overall Study|Par. Reached Stopping Criteria|1|||
49013237|NCT02570165|157885206|FG005|Overall Study|Par. Reached Stopping Criteria|1|||
49013238|NCT02570165|157885207|FG006|Overall Study|Par. Reached Stopping Criteria|0|||
49013239|NCT02570165|157885201|FG000|Overall Study|Lost to Follow-up|0|||
49013240|NCT02570165|157885202|FG001|Overall Study|Lost to Follow-up|0|||
49013241|NCT02570165|157885203|FG002|Overall Study|Lost to Follow-up|1|||
49013242|NCT02570165|157885204|FG003|Overall Study|Lost to Follow-up|1|||
49013243|NCT02570165|157885205|FG004|Overall Study|Lost to Follow-up|0|||
49013244|NCT02570165|157885206|FG005|Overall Study|Lost to Follow-up|0|||
49013245|NCT02570165|157885207|FG006|Overall Study|Lost to Follow-up|0|||
49013246|NCT02570165|157885201|FG000|Overall Study|Physician Decision|0|||
49144668|NCT03882801|158370301|FG000|Period 1|Non-compliance with study drug|1|||
49144669|NCT03882801|158370302|FG001|Period 1|Non-compliance with study drug|1|||
49144670|NCT03882801|158370301|FG000|Period 1|Never treated with study drug|1|||
49144671|NCT03882801|158370302|FG001|Period 1|Never treated with study drug|0|||
49013247|NCT02570165|157885202|FG001|Overall Study|Physician Decision|1|||
49013248|NCT02570165|157885203|FG002|Overall Study|Physician Decision|0|||
49144672|NCT03882801|158370301|FG000|Washout Period|Physician Decision|0|||
49144673|NCT03882801|158370302|FG001|Washout Period|Physician Decision|1|||
49144674|NCT03882801|158370301|FG000|Period 2|Non-compliance with study drug|0|||
49144675|NCT03882801|158370302|FG001|Period 2|Non-compliance with study drug|1|||
49144676|NCT02642679|158370303|FG000|Overall Study|Withdrawal by Subject|1|||
49144677|NCT02642679|158370303|FG000|Overall Study|Physician Decision|1|||
49144678|NCT02642679|158370303|FG000|Overall Study|Physician Decision|1|||
49144679|NCT03735498|158370304|FG000|Overall Study|Withdrawal by Subject|3|||
49144680|NCT03735498|158370304|FG000|Overall Study|Two participants did not complete all 6 sessions|2|||
49144681|NCT00420407|158370305|FG000|Overall Study|Lost to Follow-up|0|||
49144682|NCT00420407|158370306|FG001|Overall Study|Lost to Follow-up|3|||
49144683|NCT00420407|158370305|FG000|Overall Study|Physician Decision|2|||
49144684|NCT00420407|158370306|FG001|Overall Study|Physician Decision|1|||
49144685|NCT00420407|158370305|FG000|Overall Study|subject identified as detainee|1|||
49144686|NCT00420407|158370306|FG001|Overall Study|subject identified as detainee|0|||
49144687|NCT00420407|158370305|FG000|Overall Study|subject identified as Jehovah's witness|1|||
49144688|NCT00420407|158370306|FG001|Overall Study|subject identified as Jehovah's witness|0|||
49144689|NCT00420407|158370305|FG000|Overall Study|Withdrawal by Subject|0|||
49144690|NCT00420407|158370306|FG001|Overall Study|Withdrawal by Subject|2|||
49144691|NCT02562040|158370313|FG000|Overall Study|Lost to Follow-up|20|||
49144692|NCT02562040|158370314|FG001|Overall Study|Lost to Follow-up|28|||
49144693|NCT02562040|158370313|FG000|Overall Study|Withdrawal by Subject|8|||
49144694|NCT02562040|158370314|FG001|Overall Study|Withdrawal by Subject|7|||
49144695|NCT02562040|158370313|FG000|Overall Study|Adverse Event|1|||
49144696|NCT02562040|158370314|FG001|Overall Study|Adverse Event|0|||
49144697|NCT02821000|158370315|FG000|Overall Study|Death|89|||
49144698|NCT02821000|158370315|FG000|Overall Study|Sponsor Decision|12|||
49144699|NCT02821000|158370315|FG000|Overall Study|Withdrawal by Subject|2|||
49144700|NCT03437733|158370319|FG000|Overall Study|Eligibility criteria not met|0|||
49144701|NCT03437733|158370320|FG001|Overall Study|Eligibility criteria not met|3|||
49144702|NCT02143778|158370323|FG000|Overall Study|Withdrawal by Subject|2|||
49144703|NCT02143778|158370323|FG000|Overall Study|Device malfunction|1|||
49144704|NCT02565186|158370327|FG000|Overall Study|Adverse Event|113|||
49144705|NCT02565186|158370328|FG001|Overall Study|Adverse Event|148|||
49144706|NCT02565186|158370327|FG000|Overall Study|Lost to Follow-up|102|||
49144707|NCT02565186|158370328|FG001|Overall Study|Lost to Follow-up|93|||
49144708|NCT02565186|158370327|FG000|Overall Study|Non-Compliance|57|||
49144709|NCT02565186|158370328|FG001|Overall Study|Non-Compliance|55|||
49144710|NCT02565186|158370327|FG000|Overall Study|Withdrawal by Subject|229|||
49144711|NCT02565186|158370328|FG001|Overall Study|Withdrawal by Subject|214|||
49144712|NCT02565186|158370327|FG000|Overall Study|Physician Decision|18|||
49144713|NCT02565186|158370328|FG001|Overall Study|Physician Decision|16|||
49144714|NCT02565186|158370327|FG000|Overall Study|Sponsor Request|5|||
49144715|NCT02565186|158370328|FG001|Overall Study|Sponsor Request|9|||
49144716|NCT02565186|158370327|FG000|Overall Study|Missing|1|||
49144717|NCT02565186|158370328|FG001|Overall Study|Missing|0|||
49144718|NCT02565186|158370327|FG000|Overall Study|Did Not Receive Study Drug|55|||
49144719|NCT02565186|158370328|FG001|Overall Study|Did Not Receive Study Drug|86|||
49144720|NCT01975285|158370339|FG000|Overall Study|Failed Block and follow up|2|||
49144721|NCT01975285|158370340|FG001|Overall Study|Failed Block and follow up|2|||
49144722|NCT06074523|158370341|FG000|Overall Study|missing data in one condition, participant failed to fill out all data forms|9|||
49144723|NCT06074523|158370341|FG000|Overall Study|Withdrawal by Subject|1|||
49144724|NCT02619812|158370342|FG000|Overall Study|Withdrawal by Subject|0|||
49144725|NCT02619812|158370343|FG001|Overall Study|Withdrawal by Subject|0|||
49144726|NCT02619812|158370344|FG002|Overall Study|Withdrawal by Subject|1|||
49013249|NCT02570165|157885204|FG003|Overall Study|Physician Decision|0|||
49013250|NCT02570165|157885205|FG004|Overall Study|Physician Decision|0|||
49013251|NCT02570165|157885206|FG005|Overall Study|Physician Decision|0|||
49013252|NCT02570165|157885207|FG006|Overall Study|Physician Decision|0|||
49144727|NCT02619812|158370345|FG003|Overall Study|Withdrawal by Subject|2|||
49144728|NCT04189588|158370350|FG000|Overall Study|Death|0|||
49144729|NCT04189588|158370351|FG001|Overall Study|Death|1|||
49144730|NCT04189588|158370350|FG000|Overall Study|Lost to Follow-up|0|||
49144731|NCT04189588|158370351|FG001|Overall Study|Lost to Follow-up|1|||
49144732|NCT02872142|158370359|FG000|Overall Study|Adverse Event|2|||
49144733|NCT02872142|158370359|FG000|Overall Study|Death|1|||
49144734|NCT02872142|158370359|FG000|Overall Study|Participant Decision|3|||
49144735|NCT03156621|158370362|FG000|Open-Label Treatment Period (OLTP)|Adverse Event|0|||
49144736|NCT03156621|158370363|FG001|Open-Label Treatment Period (OLTP)|Adverse Event|2|||
49144737|NCT03156621|158370362|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
49144738|NCT03156621|158370363|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
49144739|NCT03016403|158370368|FG000|Baseline|Death|5|||
49144740|NCT03016403|158370369|FG001|Baseline|Death|8|||
49144741|NCT03016403|158370370|FG002|Baseline|Death|1|||
49144742|NCT03016403|158370371|FG003|Baseline|Death|0|||
49144743|NCT03016403|158370368|FG000|Baseline|Withdrawal by Subject|2|||
49144744|NCT03016403|158370369|FG001|Baseline|Withdrawal by Subject|8|||
49144745|NCT03016403|158370370|FG002|Baseline|Withdrawal by Subject|4|||
49144746|NCT03016403|158370371|FG003|Baseline|Withdrawal by Subject|10|||
49144747|NCT03016403|158370368|FG000|Baseline|Lost to Follow-up|9|||
49144748|NCT03016403|158370369|FG001|Baseline|Lost to Follow-up|11|||
49144749|NCT03016403|158370370|FG002|Baseline|Lost to Follow-up|6|||
49144750|NCT03016403|158370371|FG003|Baseline|Lost to Follow-up|24|||
49144751|NCT03016403|158370368|FG000|6-week Follow-up|Death|1|||
49144752|NCT03016403|158370369|FG001|6-week Follow-up|Death|4|||
49144753|NCT03016403|158370370|FG002|6-week Follow-up|Death|0|||
49144754|NCT03016403|158370371|FG003|6-week Follow-up|Death|0|||
49144755|NCT03016403|158370368|FG000|6-week Follow-up|Lost to Follow-up|2|||
49144756|NCT03016403|158370369|FG001|6-week Follow-up|Lost to Follow-up|7|||
49144757|NCT03016403|158370370|FG002|6-week Follow-up|Lost to Follow-up|4|||
49144758|NCT03016403|158370371|FG003|6-week Follow-up|Lost to Follow-up|8|||
49144759|NCT03016403|158370368|FG000|6-week Follow-up|Withdrawal by Subject|0|||
49144760|NCT03016403|158370369|FG001|6-week Follow-up|Withdrawal by Subject|2|||
49144761|NCT03016403|158370370|FG002|6-week Follow-up|Withdrawal by Subject|0|||
49144762|NCT03016403|158370371|FG003|6-week Follow-up|Withdrawal by Subject|1|||
49144763|NCT03016403|158370368|FG000|3-month Follow-up and 6-month Follow-up|Death|6|||
49144764|NCT03016403|158370369|FG001|3-month Follow-up and 6-month Follow-up|Death|4|||
49144765|NCT03016403|158370370|FG002|3-month Follow-up and 6-month Follow-up|Death|0|||
49144766|NCT03016403|158370371|FG003|3-month Follow-up and 6-month Follow-up|Death|0|||
49144767|NCT03016403|158370368|FG000|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
49144768|NCT03016403|158370369|FG001|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7|||
49144769|NCT03016403|158370370|FG002|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8|||
49144770|NCT03016403|158370371|FG003|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
49144771|NCT03016403|158370368|FG000|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
49144772|NCT03016403|158370369|FG001|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
49144773|NCT03016403|158370370|FG002|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
49144774|NCT03016403|158370371|FG003|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1|||
49144775|NCT00799864|158370372|FG000|Overall Study|Participant reached a virologic endpoint|9|||
49144776|NCT00799864|158370373|FG001|Overall Study|Participant reached a virologic endpoint|2|||
49144777|NCT00799864|158370374|FG002|Overall Study|Participant reached a virologic endpoint|2|||
49144778|NCT00799864|158370375|FG003|Overall Study|Participant reached a virologic endpoint|0|||
49144779|NCT00799864|158370376|FG004|Overall Study|Participant reached a virologic endpoint|0|||
49144780|NCT00799864|158370372|FG000|Overall Study|Other|2|||
49144781|NCT00799864|158370373|FG001|Overall Study|Other|1|||
49144782|NCT00799864|158370374|FG002|Overall Study|Other|0|||
49144783|NCT00799864|158370375|FG003|Overall Study|Other|0|||
49144784|NCT00799864|158370376|FG004|Overall Study|Other|0|||
49144785|NCT05529173|158370382|FG000|Overall Study|Physician Decision|3|||
49144786|NCT05529173|158370383|FG001|Overall Study|Physician Decision|6|||
49144787|NCT05529173|158370382|FG000|Overall Study|Sample shipment delay more than one day|4|||
49144788|NCT05529173|158370383|FG001|Overall Study|Sample shipment delay more than one day|0|||
49144789|NCT04865978|158370384|FG000|Overall Study|One patient did not complete the study due to infection and device explant|1|||
49144790|NCT04865978|158370385|FG001|Overall Study|One patient did not complete the study due to infection and device explant|0|||
49144791|NCT00986102|158370386|FG000|Overall Study|Lost to Follow-up|0|||
49144792|NCT00986102|158370387|FG001|Overall Study|Lost to Follow-up|1|||
49144793|NCT00986102|158370388|FG002|Overall Study|Lost to Follow-up|0|||
49144794|NCT00986102|158370389|FG003|Overall Study|Lost to Follow-up|1|||
49144795|NCT00986102|158370386|FG000|Overall Study|Withdrawal by Subject|1|||
49144796|NCT00986102|158370387|FG001|Overall Study|Withdrawal by Subject|1|||
49144797|NCT00986102|158370388|FG002|Overall Study|Withdrawal by Subject|0|||
49144798|NCT00986102|158370389|FG003|Overall Study|Withdrawal by Subject|0|||
49144799|NCT06083493|158370390|FG000|Overall Study|Technical issues with the interventional device|2|||
49144800|NCT06083493|158370391|FG001|Overall Study|Technical issues with the interventional device|2|||
49144801|NCT06083493|158370390|FG000|Overall Study|Performed incorrect visual task|1|||
49144802|NCT06083493|158370391|FG001|Overall Study|Performed incorrect visual task|0|||
49144803|NCT06083493|158370390|FG000|Overall Study|Insufficient baseline performance|0|||
49144804|NCT06083493|158370391|FG001|Overall Study|Insufficient baseline performance|1|||
49144805|NCT02048813|158370392|FG000|Overall Study|Still on treatment|279|||
49144806|NCT02048813|158370393|FG001|Overall Study|Still on treatment|0|||
49144807|NCT02048813|158370392|FG000|Overall Study|Adverse Event|40|||
49144808|NCT02048813|158370393|FG001|Overall Study|Adverse Event|38|||
49144809|NCT02048813|158370392|FG000|Overall Study|Disease progression|13|||
49144810|NCT02048813|158370393|FG001|Overall Study|Disease progression|3|||
49144811|NCT02048813|158370392|FG000|Overall Study|Withdrawal by Subject|7|||
49144812|NCT02048813|158370393|FG001|Overall Study|Withdrawal by Subject|8|||
49144813|NCT02048813|158370392|FG000|Overall Study|Death|2|||
49144814|NCT02048813|158370393|FG001|Overall Study|Death|1|||
49144815|NCT02048813|158370392|FG000|Overall Study|Complication|2|||
49144816|NCT02048813|158370393|FG001|Overall Study|Complication|2|||
49144817|NCT02048813|158370392|FG000|Overall Study|Non-protocol therapy|0|||
49144818|NCT02048813|158370393|FG001|Overall Study|Non-protocol therapy|1|||
49144819|NCT02048813|158370392|FG000|Overall Study|Second primary cancer|2|||
49144820|NCT02048813|158370393|FG001|Overall Study|Second primary cancer|0|||
49144821|NCT02048813|158370392|FG000|Overall Study|Insurance|2|||
49144822|NCT02048813|158370393|FG001|Overall Study|Insurance|0|||
49144823|NCT02048813|158370392|FG000|Overall Study|Wound infection/healing|2|||
49144824|NCT02048813|158370393|FG001|Overall Study|Wound infection/healing|0|||
49144825|NCT02048813|158370392|FG000|Overall Study|Missed appointment|3|||
49144826|NCT02048813|158370393|FG001|Overall Study|Missed appointment|0|||
49144827|NCT02048813|158370392|FG000|Overall Study|Never started treatment|2|||
49144828|NCT02048813|158370393|FG001|Overall Study|Never started treatment|17|||
49144829|NCT00507507|158370398|FG000|Treatment Period|Lost to Follow-up|0|||
49144830|NCT00507507|158370399|FG001|Treatment Period|Lost to Follow-up|2|||
49144831|NCT00507507|158370398|FG000|Treatment Period|Physician Decision|4|||
49144832|NCT00507507|158370399|FG001|Treatment Period|Physician Decision|1|||
49144833|NCT00507507|158370398|FG000|Treatment Period|Protocol Violation|1|||
49144834|NCT00507507|158370399|FG001|Treatment Period|Protocol Violation|2|||
49144835|NCT00507507|158370398|FG000|Treatment Period|Adverse Event|1|||
49144836|NCT00507507|158370399|FG001|Treatment Period|Adverse Event|1|||
49144837|NCT00507507|158370398|FG000|Treatment Period|Withdrawal by Subject|46|||
49144838|NCT00507507|158370399|FG001|Treatment Period|Withdrawal by Subject|47|||
49144839|NCT00507507|158370398|FG000|24-week Treatment-free Follow-up Period|Physician Decision|1|||
49144840|NCT00507507|158370399|FG001|24-week Treatment-free Follow-up Period|Physician Decision|0|||
49144841|NCT00507507|158370398|FG000|24-week Treatment-free Follow-up Period|Adverse Event|0|||
49144842|NCT00507507|158370399|FG001|24-week Treatment-free Follow-up Period|Adverse Event|1|||
48823051|NCT00180674|157192280|FG000|Phase 2, Warfarin Treatment Period|Adverse Event|1|||
48823052|NCT02851511|157192290|FG000|Overall (Phase I + Phase II)|Physician Decision|18|||
48823053|NCT02851511|157192291|FG001|Overall (Phase I + Phase II)|Physician Decision|16|||
48823054|NCT02851511|157192292|FG002|Overall (Phase I + Phase II)|Physician Decision|0|||
48823055|NCT02851511|157192293|FG003|Overall (Phase I + Phase II)|Physician Decision|1|||
48823056|NCT02851511|157192290|FG000|Overall (Phase I + Phase II)|Withdrawal by Subject|20|||
48823057|NCT02851511|157192291|FG001|Overall (Phase I + Phase II)|Withdrawal by Subject|17|||
48823058|NCT02851511|157192292|FG002|Overall (Phase I + Phase II)|Withdrawal by Subject|0|||
49144843|NCT00507507|158370398|FG000|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9|||
49144844|NCT00507507|158370399|FG001|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16|||
49144845|NCT00183391|158370400|FG000|Block 1 - 5 Weeks|Withdrawal by Subject|13|||
49144846|NCT00183391|158370401|FG001|Block 1 - 5 Weeks|Withdrawal by Subject|14|||
49144847|NCT00183391|158370400|FG000|Block 2 - 5 Weeks|Withdrawal by Subject|4|||
49144848|NCT00183391|158370401|FG001|Block 2 - 5 Weeks|Withdrawal by Subject|2|||
49144849|NCT00395512|158370402|FG000|Overall Study|Adverse Event|3|||
49144850|NCT00395512|158370403|FG001|Overall Study|Adverse Event|8|||
49144851|NCT00395512|158370404|FG002|Overall Study|Adverse Event|6|||
49144852|NCT00395512|158370405|FG003|Overall Study|Adverse Event|6|||
49144853|NCT00395512|158370402|FG000|Overall Study|Protocol Violation|2|||
49144854|NCT00395512|158370403|FG001|Overall Study|Protocol Violation|3|||
49144855|NCT00395512|158370404|FG002|Overall Study|Protocol Violation|6|||
49144856|NCT00395512|158370405|FG003|Overall Study|Protocol Violation|7|||
49144857|NCT00395512|158370402|FG000|Overall Study|Lost to Follow-up|2|||
49144858|NCT00395512|158370403|FG001|Overall Study|Lost to Follow-up|6|||
49144859|NCT00395512|158370404|FG002|Overall Study|Lost to Follow-up|5|||
49144860|NCT00395512|158370405|FG003|Overall Study|Lost to Follow-up|5|||
48823059|NCT02851511|157192293|FG003|Overall (Phase I + Phase II)|Withdrawal by Subject|3|||
49144861|NCT00395512|158370402|FG000|Overall Study|Withdrawal by Subject|6|||
49144862|NCT00395512|158370403|FG001|Overall Study|Withdrawal by Subject|5|||
49144863|NCT00395512|158370404|FG002|Overall Study|Withdrawal by Subject|5|||
49144864|NCT00395512|158370405|FG003|Overall Study|Withdrawal by Subject|12|||
49144865|NCT00395512|158370402|FG000|Overall Study|Physician Decision|6|||
49144866|NCT00395512|158370403|FG001|Overall Study|Physician Decision|4|||
49144867|NCT00395512|158370404|FG002|Overall Study|Physician Decision|2|||
49144868|NCT00395512|158370405|FG003|Overall Study|Physician Decision|2|||
49144869|NCT00395512|158370402|FG000|Overall Study|Other|1|||
49144870|NCT00395512|158370403|FG001|Overall Study|Other|1|||
49144871|NCT00395512|158370404|FG002|Overall Study|Other|0|||
49144872|NCT00395512|158370405|FG003|Overall Study|Other|0|||
49144873|NCT00395512|158370402|FG000|Overall Study|Hyperglycemic Rescue|18|||
49144874|NCT00395512|158370403|FG001|Overall Study|Hyperglycemic Rescue|10|||
49144875|NCT00395512|158370404|FG002|Overall Study|Hyperglycemic Rescue|4|||
49144876|NCT00395512|158370405|FG003|Overall Study|Hyperglycemic Rescue|6|||
49144877|NCT03180138|158370407|FG000|Overall Study|Mobile-phone could not be verified|2|||
49144878|NCT03180138|158370408|FG001|Overall Study|Mobile-phone could not be verified|13|||
49144879|NCT03180138|158370409|FG002|Overall Study|Mobile-phone could not be verified|15|||
49144880|NCT03180138|158370407|FG000|Overall Study|No prior immunization records|17|||
49144881|NCT03180138|158370408|FG001|Overall Study|No prior immunization records|0|||
49144882|NCT03180138|158370409|FG002|Overall Study|No prior immunization records|6|||
49144883|NCT03180138|158370407|FG000|Overall Study|Found to be >24 mon after randomization|3|||
49144884|NCT03180138|158370408|FG001|Overall Study|Found to be >24 mon after randomization|0|||
49144885|NCT03180138|158370409|FG002|Overall Study|Found to be >24 mon after randomization|3|||
49144886|NCT04576949|158370410|FG000|Overall Study|Adverse Event|1|||
49144887|NCT04576949|158370411|FG001|Overall Study|Adverse Event|3|||
49144888|NCT04576949|158370412|FG002|Overall Study|Adverse Event|2|||
49144889|NCT04576949|158370410|FG000|Overall Study|Withdrawal by Subject|41|||
49144890|NCT04576949|158370411|FG001|Overall Study|Withdrawal by Subject|26|||
49144891|NCT04576949|158370412|FG002|Overall Study|Withdrawal by Subject|18|||
49144892|NCT04576949|158370410|FG000|Overall Study|Physician Decision|3|||
49144893|NCT04576949|158370411|FG001|Overall Study|Physician Decision|0|||
49144894|NCT04576949|158370412|FG002|Overall Study|Physician Decision|0|||
49144895|NCT04576949|158370410|FG000|Overall Study|Death|0|||
49144896|NCT04576949|158370411|FG001|Overall Study|Death|1|||
49144897|NCT04576949|158370412|FG002|Overall Study|Death|0|||
49144898|NCT04576949|158370410|FG000|Overall Study|Lost to Follow-up|29|||
49144899|NCT04576949|158370411|FG001|Overall Study|Lost to Follow-up|37|||
49144900|NCT04576949|158370412|FG002|Overall Study|Lost to Follow-up|24|||
49144901|NCT04576949|158370410|FG000|Overall Study|Other, Not Specified|2|||
49144902|NCT04576949|158370411|FG001|Overall Study|Other, Not Specified|3|||
49144903|NCT04576949|158370412|FG002|Overall Study|Other, Not Specified|1|||
49144904|NCT04576949|158370410|FG000|Overall Study|Other|1|||
49144905|NCT04576949|158370411|FG001|Overall Study|Other|0|||
49144906|NCT04576949|158370412|FG002|Overall Study|Other|0|||
49144907|NCT03438656|158370421|FG000|Overall Study|Lost to Follow-up|2|||
49144908|NCT01065766|158370422|FG000|Overall Study|Assessed before the contracted date|1|||
49144909|NCT01065766|158370422|FG000|Overall Study|Contraindication to administration|6|||
49144910|NCT01065766|158370422|FG000|Overall Study|Violated dosage/administration|25|||
49144911|NCT02362412|158370426|FG000|Treatment Period III|Lost to Follow-up|0|||
49144912|NCT02362412|158370427|FG001|Treatment Period III|Lost to Follow-up|1|||
49144913|NCT01725308|158370428|FG000|Treatment Period I|Did Not Receive Drug|1|||
49144914|NCT01725308|158370429|FG001|Treatment Period I|Did Not Receive Drug|0|||
49144915|NCT01725308|158370430|FG002|Treatment Period I|Did Not Receive Drug|0|||
49144916|NCT01725308|158370428|FG000|Treatment Period I|Adverse Event|5|||
49144917|NCT01725308|158370429|FG001|Treatment Period I|Adverse Event|4|||
49144918|NCT01725308|158370430|FG002|Treatment Period I|Adverse Event|21|||
49144919|NCT01725308|158370428|FG000|Treatment Period I|Insufficient Response|7|||
49144920|NCT01725308|158370429|FG001|Treatment Period I|Insufficient Response|0|||
49144921|NCT01725308|158370430|FG002|Treatment Period I|Insufficient Response|5|||
49144922|NCT01725308|158370428|FG000|Treatment Period I|Worsening of the Target Disease|8|||
49144923|NCT01725308|158370429|FG001|Treatment Period I|Worsening of the Target Disease|0|||
49144924|NCT01725308|158370430|FG002|Treatment Period I|Worsening of the Target Disease|2|||
49144925|NCT01725308|158370428|FG000|Treatment Period I|Changes in the Episodes|3|||
49144926|NCT01725308|158370429|FG001|Treatment Period I|Changes in the Episodes|0|||
49144927|NCT01725308|158370430|FG002|Treatment Period I|Changes in the Episodes|2|||
49144928|NCT01725308|158370428|FG000|Treatment Period I|Withdrawal of Consent|12|||
49144929|NCT01725308|158370429|FG001|Treatment Period I|Withdrawal of Consent|7|||
49144930|NCT01725308|158370430|FG002|Treatment Period I|Withdrawal of Consent|5|||
49144931|NCT01725308|158370428|FG000|Treatment Period I|Lost to Follow-up|3|||
49144932|NCT01725308|158370429|FG001|Treatment Period I|Lost to Follow-up|2|||
49144933|NCT01725308|158370430|FG002|Treatment Period I|Lost to Follow-up|2|||
49144934|NCT01725308|158370428|FG000|Treatment Period I|Protocol Deviations|3|||
49144935|NCT01725308|158370429|FG001|Treatment Period I|Protocol Deviations|1|||
49144936|NCT01725308|158370430|FG002|Treatment Period I|Protocol Deviations|1|||
49144937|NCT01725308|158370428|FG000|Treatment Period I|Miscellaneous|2|||
49144938|NCT01725308|158370429|FG001|Treatment Period I|Miscellaneous|0|||
49144939|NCT01725308|158370430|FG002|Treatment Period I|Miscellaneous|3|||
49144940|NCT01725308|158370428|FG000|Treatment Period II|Did Not Meet Transition Criteria|0|||
49144941|NCT01725308|158370429|FG001|Treatment Period II|Did Not Meet Transition Criteria|3|||
49144942|NCT01725308|158370430|FG002|Treatment Period II|Did Not Meet Transition Criteria|4|||
49144943|NCT01725308|158370428|FG000|Treatment Period II|Did Not Receive Drug|4|||
49144944|NCT01725308|158370429|FG001|Treatment Period II|Did Not Receive Drug|0|||
48730645|NCT03589469|156865857|FG000|Overall Study|Lost to Follow-up|8|||
49013253|NCT02570165|157885201|FG000|Overall Study|Withdrawal by Subject|0|||
49013254|NCT02570165|157885202|FG001|Overall Study|Withdrawal by Subject|0|||
49013255|NCT02570165|157885203|FG002|Overall Study|Withdrawal by Subject|0|||
49013256|NCT02570165|157885204|FG003|Overall Study|Withdrawal by Subject|2|||
49013257|NCT02570165|157885205|FG004|Overall Study|Withdrawal by Subject|1|||
49013258|NCT02570165|157885206|FG005|Overall Study|Withdrawal by Subject|0|||
49013259|NCT02570165|157885207|FG006|Overall Study|Withdrawal by Subject|0|||
49013260|NCT02570165|157885201|FG000|Overall Study|Par. did not Meet Continuation Criteria|0|||
49013261|NCT02570165|157885202|FG001|Overall Study|Par. did not Meet Continuation Criteria|0|||
49013262|NCT02570165|157885203|FG002|Overall Study|Par. did not Meet Continuation Criteria|0|||
49013263|NCT02570165|157885204|FG003|Overall Study|Par. did not Meet Continuation Criteria|0|||
49013264|NCT02570165|157885205|FG004|Overall Study|Par. did not Meet Continuation Criteria|0|||
49013265|NCT02570165|157885206|FG005|Overall Study|Par. did not Meet Continuation Criteria|1|||
49013266|NCT02570165|157885207|FG006|Overall Study|Par. did not Meet Continuation Criteria|0|||
49013267|NCT02570165|157885201|FG000|Overall Study|Withdrawal Request by GSK|0|||
49013268|NCT02570165|157885202|FG001|Overall Study|Withdrawal Request by GSK|0|||
49013269|NCT02570165|157885203|FG002|Overall Study|Withdrawal Request by GSK|2|||
48823060|NCT02851511|157192290|FG000|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|4|||
48823061|NCT02851511|157192291|FG001|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|5|||
49013270|NCT02570165|157885204|FG003|Overall Study|Withdrawal Request by GSK|0|||
49013271|NCT02570165|157885205|FG004|Overall Study|Withdrawal Request by GSK|0|||
49013272|NCT02570165|157885206|FG005|Overall Study|Withdrawal Request by GSK|0|||
49013273|NCT02570165|157885207|FG006|Overall Study|Withdrawal Request by GSK|0|||
49013274|NCT00410410|157885208|FG000|Induction Period (IP)|Death|1|||
49013275|NCT00410410|157885209|FG001|Induction Period (IP)|Death|0|||
49013276|NCT00410410|157885210|FG002|Induction Period (IP)|Death|0|||
49013277|NCT00410410|157885211|FG003|Induction Period (IP)|Death|0|||
48730646|NCT03589469|156865857|FG000|Overall Study|Miscellaneous|1|||
48730647|NCT04439279|156865858|FG000|Overall Study|Adverse Event|7|||
48730648|NCT04439279|156865858|FG000|Overall Study|Death|4|||
48730649|NCT04439279|156865858|FG000|Overall Study|Disease progression|17|||
48730650|NCT04439279|156865858|FG000|Overall Study|Complicating disease|3|||
48730651|NCT04439279|156865858|FG000|Overall Study|Withdrawal by Subject|2|||
48730652|NCT04439279|156865858|FG000|Overall Study|Ineligible|1|||
48730653|NCT04439279|156865858|FG000|Overall Study|Treatment still ongoing|1|||
49144945|NCT01725308|158370430|FG002|Treatment Period II|Did Not Receive Drug|0|||
49144946|NCT01725308|158370428|FG000|Treatment Period II|Adverse Event|13|||
49144947|NCT01725308|158370429|FG001|Treatment Period II|Adverse Event|8|||
49144948|NCT01725308|158370430|FG002|Treatment Period II|Adverse Event|20|||
49144949|NCT01725308|158370428|FG000|Treatment Period II|Insufficient Response|2|||
49144950|NCT01725308|158370429|FG001|Treatment Period II|Insufficient Response|4|||
49144951|NCT01725308|158370430|FG002|Treatment Period II|Insufficient Response|6|||
49144952|NCT01725308|158370428|FG000|Treatment Period II|Worsening of the Target Disease|1|||
49144953|NCT01725308|158370429|FG001|Treatment Period II|Worsening of the Target Disease|4|||
48730654|NCT04963231|156865863|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|43|||
48823062|NCT02851511|157192292|FG002|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
48823063|NCT02851511|157192293|FG003|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
48823064|NCT02851511|157192290|FG000|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
49013278|NCT00410410|157885212|FG004|Induction Period (IP)|Death|0|||
49013279|NCT00410410|157885213|FG005|Induction Period (IP)|Death|0|||
49013280|NCT00410410|157885214|FG006|Induction Period (IP)|Death|0|||
49013281|NCT00410410|157885215|FG007|Induction Period (IP)|Death|0|||
49013282|NCT00410410|157885216|FG008|Induction Period (IP)|Death|0|||
49013283|NCT00410410|157885208|FG000|Induction Period (IP)|Adverse Event|3|||
49013284|NCT00410410|157885209|FG001|Induction Period (IP)|Adverse Event|4|||
49013285|NCT00410410|157885210|FG002|Induction Period (IP)|Adverse Event|2|||
49013286|NCT00410410|157885211|FG003|Induction Period (IP)|Adverse Event|4|||
49013287|NCT00410410|157885212|FG004|Induction Period (IP)|Adverse Event|1|||
49013288|NCT00410410|157885213|FG005|Induction Period (IP)|Adverse Event|0|||
49013289|NCT00410410|157885214|FG006|Induction Period (IP)|Adverse Event|0|||
49013290|NCT00410410|157885215|FG007|Induction Period (IP)|Adverse Event|0|||
49013291|NCT00410410|157885216|FG008|Induction Period (IP)|Adverse Event|0|||
49013292|NCT00410410|157885208|FG000|Induction Period (IP)|Lack of Efficacy|26|||
49013293|NCT00410410|157885209|FG001|Induction Period (IP)|Lack of Efficacy|24|||
49013294|NCT00410410|157885210|FG002|Induction Period (IP)|Lack of Efficacy|8|||
49013295|NCT00410410|157885211|FG003|Induction Period (IP)|Lack of Efficacy|8|||
49013296|NCT00410410|157885212|FG004|Induction Period (IP)|Lack of Efficacy|7|||
49013297|NCT00410410|157885213|FG005|Induction Period (IP)|Lack of Efficacy|7|||
49013298|NCT00410410|157885214|FG006|Induction Period (IP)|Lack of Efficacy|0|||
49013299|NCT00410410|157885215|FG007|Induction Period (IP)|Lack of Efficacy|0|||
49013300|NCT00410410|157885216|FG008|Induction Period (IP)|Lack of Efficacy|0|||
49013301|NCT00410410|157885208|FG000|Induction Period (IP)|Lost to Follow-up|2|||
49144954|NCT01725308|158370430|FG002|Treatment Period II|Worsening of the Target Disease|2|||
49144955|NCT01725308|158370428|FG000|Treatment Period II|Changes in the Episodes|1|||
49144956|NCT01725308|158370429|FG001|Treatment Period II|Changes in the Episodes|0|||
49144957|NCT01725308|158370430|FG002|Treatment Period II|Changes in the Episodes|5|||
49013302|NCT00410410|157885209|FG001|Induction Period (IP)|Lost to Follow-up|2|||
49013303|NCT00410410|157885210|FG002|Induction Period (IP)|Lost to Follow-up|2|||
49013304|NCT00410410|157885211|FG003|Induction Period (IP)|Lost to Follow-up|3|||
49013305|NCT00410410|157885212|FG004|Induction Period (IP)|Lost to Follow-up|0|||
49013306|NCT00410410|157885213|FG005|Induction Period (IP)|Lost to Follow-up|1|||
49013307|NCT00410410|157885214|FG006|Induction Period (IP)|Lost to Follow-up|0|||
49013308|NCT00410410|157885215|FG007|Induction Period (IP)|Lost to Follow-up|0|||
49013309|NCT00410410|157885216|FG008|Induction Period (IP)|Lost to Follow-up|0|||
49013310|NCT00410410|157885208|FG000|Induction Period (IP)|Withdrawal by Subject|3|||
49013311|NCT00410410|157885209|FG001|Induction Period (IP)|Withdrawal by Subject|5|||
49013312|NCT00410410|157885210|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
49013313|NCT00410410|157885211|FG003|Induction Period (IP)|Withdrawal by Subject|5|||
49013314|NCT00410410|157885212|FG004|Induction Period (IP)|Withdrawal by Subject|2|||
49013315|NCT00410410|157885213|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
49013316|NCT00410410|157885214|FG006|Induction Period (IP)|Withdrawal by Subject|0|||
49013317|NCT00410410|157885215|FG007|Induction Period (IP)|Withdrawal by Subject|0|||
49013318|NCT00410410|157885216|FG008|Induction Period (IP)|Withdrawal by Subject|0|||
49013319|NCT00410410|157885208|FG000|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
49013320|NCT00410410|157885209|FG001|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
49013321|NCT00410410|157885210|FG002|Induction Period (IP)|Subject No Longer Meets Study Criteria|1|||
49013322|NCT00410410|157885211|FG003|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
49013323|NCT00410410|157885212|FG004|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
49013324|NCT00410410|157885213|FG005|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
49013325|NCT00410410|157885214|FG006|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
49013326|NCT00410410|157885215|FG007|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
49013327|NCT00410410|157885216|FG008|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
49013328|NCT00410410|157885208|FG000|Induction Period (IP)|Administrative Reason By Sponsor|0|||
49013329|NCT00410410|157885209|FG001|Induction Period (IP)|Administrative Reason By Sponsor|0|||
49013330|NCT00410410|157885210|FG002|Induction Period (IP)|Administrative Reason By Sponsor|0|||
49013331|NCT00410410|157885211|FG003|Induction Period (IP)|Administrative Reason By Sponsor|0|||
49144958|NCT01725308|158370428|FG000|Treatment Period II|Withdrawal of Consent|28|||
49144959|NCT01725308|158370429|FG001|Treatment Period II|Withdrawal of Consent|2|||
49144960|NCT01725308|158370430|FG002|Treatment Period II|Withdrawal of Consent|16|||
49144961|NCT01725308|158370428|FG000|Treatment Period II|Lost to Follow-up|1|||
49144962|NCT01725308|158370429|FG001|Treatment Period II|Lost to Follow-up|5|||
49144963|NCT01725308|158370430|FG002|Treatment Period II|Lost to Follow-up|3|||
49144964|NCT01725308|158370428|FG000|Treatment Period II|Protocol Deviations|0|||
49144965|NCT01725308|158370429|FG001|Treatment Period II|Protocol Deviations|0|||
48823065|NCT02851511|157192291|FG001|Overall (Phase I + Phase II)|Lost to Follow-up|1|||
48823066|NCT02851511|157192292|FG002|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
48823067|NCT02851511|157192293|FG003|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
48823068|NCT02851511|157192290|FG000|Phase I|Physician Decision|0|||
48823069|NCT02851511|157192291|FG001|Phase I|Physician Decision|0|||
48823070|NCT02851511|157192292|FG002|Phase I|Physician Decision|0|||
48823071|NCT02851511|157192293|FG003|Phase I|Physician Decision|1|||
48823072|NCT02851511|157192290|FG000|Phase I|Withdrawal by Subject|2|||
49144966|NCT01725308|158370430|FG002|Treatment Period II|Protocol Deviations|1|||
49144967|NCT01725308|158370428|FG000|Treatment Period II|Miscellaneous|5|||
49144968|NCT01725308|158370429|FG001|Treatment Period II|Miscellaneous|3|||
49144969|NCT01725308|158370430|FG002|Treatment Period II|Miscellaneous|7|||
49144970|NCT04128228|158370432|FG000|Overall Study|Withdrawal by Subject|3|||
49144971|NCT04128228|158370433|FG001|Overall Study|Withdrawal by Subject|3|||
49144972|NCT04128228|158370434|FG002|Overall Study|Withdrawal by Subject|0|||
49144973|NCT04128228|158370435|FG003|Overall Study|Withdrawal by Subject|0|||
49144974|NCT04128228|158370432|FG000|Overall Study|noncompliance|2|||
49144975|NCT04128228|158370433|FG001|Overall Study|noncompliance|2|||
49144976|NCT04128228|158370434|FG002|Overall Study|noncompliance|0|||
49144977|NCT04128228|158370435|FG003|Overall Study|noncompliance|0|||
49144978|NCT05652140|158370436|FG000|Overall Study|Lost to Follow-up|7|||
49144979|NCT05652140|158370437|FG001|Overall Study|Lost to Follow-up|16|||
49013332|NCT00410410|157885212|FG004|Induction Period (IP)|Administrative Reason By Sponsor|22|||
48823073|NCT02851511|157192291|FG001|Phase I|Withdrawal by Subject|1|||
49144980|NCT05652140|158370438|FG002|Overall Study|Lost to Follow-up|22|||
48823074|NCT02851511|157192292|FG002|Phase I|Withdrawal by Subject|0|||
49144981|NCT05652140|158370439|FG003|Overall Study|Lost to Follow-up|31|||
49144982|NCT01245049|158370440|FG000|Overall Study|Migrated/moved from study area|0|||
48823075|NCT02851511|157192293|FG003|Phase I|Withdrawal by Subject|3|||
49013333|NCT00410410|157885213|FG005|Induction Period (IP)|Administrative Reason By Sponsor|21|||
49013334|NCT00410410|157885214|FG006|Induction Period (IP)|Administrative Reason By Sponsor|0|||
49013335|NCT00410410|157885215|FG007|Induction Period (IP)|Administrative Reason By Sponsor|0|||
49013336|NCT00410410|157885216|FG008|Induction Period (IP)|Administrative Reason By Sponsor|0|||
49013337|NCT00410410|157885208|FG000|Induction Period (IP)|Other|0|||
49013338|NCT00410410|157885209|FG001|Induction Period (IP)|Other|0|||
49144983|NCT01245049|158370441|FG001|Overall Study|Migrated/moved from study area|1|||
49144984|NCT01245049|158370440|FG000|Overall Study|Withdrawal by Subject|0|||
49144985|NCT01245049|158370441|FG001|Overall Study|Withdrawal by Subject|1|||
49144986|NCT01245049|158370440|FG000|Overall Study|Lost to Follow-up|1|||
49144987|NCT01245049|158370441|FG001|Overall Study|Lost to Follow-up|2|||
49144988|NCT00974233|158370445|FG000|Induction Chemoimmunotherapy|Death|2|||
49013339|NCT00410410|157885210|FG002|Induction Period (IP)|Other|1|||
49013340|NCT00410410|157885211|FG003|Induction Period (IP)|Other|0|||
49013341|NCT00410410|157885212|FG004|Induction Period (IP)|Other|0|||
49013342|NCT00410410|157885213|FG005|Induction Period (IP)|Other|0|||
49013343|NCT00410410|157885214|FG006|Induction Period (IP)|Other|0|||
49013344|NCT00410410|157885215|FG007|Induction Period (IP)|Other|0|||
49013345|NCT00410410|157885216|FG008|Induction Period (IP)|Other|0|||
49013346|NCT00410410|157885208|FG000|Maintenance Period (MP)|Death|0|||
49013347|NCT00410410|157885209|FG001|Maintenance Period (MP)|Death|0|||
49013348|NCT00410410|157885210|FG002|Maintenance Period (MP)|Death|0|||
49013349|NCT00410410|157885211|FG003|Maintenance Period (MP)|Death|0|||
49144989|NCT00974233|158370445|FG000|Induction Chemoimmunotherapy|Lack of Efficacy|5|||
49013350|NCT00410410|157885212|FG004|Maintenance Period (MP)|Death|0|||
49013351|NCT00410410|157885213|FG005|Maintenance Period (MP)|Death|0|||
49013352|NCT00410410|157885214|FG006|Maintenance Period (MP)|Death|1|||
49013353|NCT00410410|157885215|FG007|Maintenance Period (MP)|Death|0|||
49013354|NCT00410410|157885216|FG008|Maintenance Period (MP)|Death|0|||
49013355|NCT00410410|157885208|FG000|Maintenance Period (MP)|Adverse Event|0|||
49013356|NCT00410410|157885209|FG001|Maintenance Period (MP)|Adverse Event|0|||
49013357|NCT00410410|157885210|FG002|Maintenance Period (MP)|Adverse Event|0|||
49144990|NCT00974233|158370445|FG000|Induction Chemoimmunotherapy|Adverse Event|7|||
49144991|NCT00974233|158370445|FG000|Induction Chemoimmunotherapy|Withdrawal by Subject|1|||
49144992|NCT00974233|158370445|FG000|Maintenance Lenalidomide|Lack of Efficacy|5|||
49013358|NCT00410410|157885211|FG003|Maintenance Period (MP)|Adverse Event|0|||
49013359|NCT00410410|157885212|FG004|Maintenance Period (MP)|Adverse Event|0|||
49013360|NCT00410410|157885213|FG005|Maintenance Period (MP)|Adverse Event|0|||
49013361|NCT00410410|157885214|FG006|Maintenance Period (MP)|Adverse Event|1|||
49013362|NCT00410410|157885215|FG007|Maintenance Period (MP)|Adverse Event|3|||
49013363|NCT00410410|157885216|FG008|Maintenance Period (MP)|Adverse Event|0|||
49013364|NCT00410410|157885208|FG000|Maintenance Period (MP)|Lack of Efficacy|0|||
49013365|NCT00410410|157885209|FG001|Maintenance Period (MP)|Lack of Efficacy|0|||
49013366|NCT00410410|157885210|FG002|Maintenance Period (MP)|Lack of Efficacy|0|||
49013367|NCT00410410|157885211|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
49013368|NCT00410410|157885212|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
49013369|NCT00410410|157885213|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
49013370|NCT00410410|157885214|FG006|Maintenance Period (MP)|Lack of Efficacy|25|||
49013371|NCT00410410|157885215|FG007|Maintenance Period (MP)|Lack of Efficacy|24|||
49013372|NCT00410410|157885216|FG008|Maintenance Period (MP)|Lack of Efficacy|0|||
49013373|NCT00410410|157885208|FG000|Maintenance Period (MP)|Lost to Follow-up|0|||
49013374|NCT00410410|157885209|FG001|Maintenance Period (MP)|Lost to Follow-up|0|||
49013375|NCT00410410|157885210|FG002|Maintenance Period (MP)|Lost to Follow-up|0|||
49013376|NCT00410410|157885211|FG003|Maintenance Period (MP)|Lost to Follow-up|0|||
49013377|NCT00410410|157885212|FG004|Maintenance Period (MP)|Lost to Follow-up|0|||
49013378|NCT00410410|157885213|FG005|Maintenance Period (MP)|Lost to Follow-up|0|||
49013379|NCT00410410|157885214|FG006|Maintenance Period (MP)|Lost to Follow-up|1|||
49013380|NCT00410410|157885215|FG007|Maintenance Period (MP)|Lost to Follow-up|2|||
49013381|NCT00410410|157885216|FG008|Maintenance Period (MP)|Lost to Follow-up|0|||
49013382|NCT00410410|157885208|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
49013383|NCT00410410|157885209|FG001|Maintenance Period (MP)|Withdrawal by Subject|0|||
49013384|NCT00410410|157885210|FG002|Maintenance Period (MP)|Withdrawal by Subject|0|||
49013385|NCT00410410|157885211|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
49013386|NCT00410410|157885212|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
49013387|NCT00410410|157885213|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
49144993|NCT00974233|158370445|FG000|Maintenance Lenalidomide|Adverse Event|8|||
49013388|NCT00410410|157885214|FG006|Maintenance Period (MP)|Withdrawal by Subject|1|||
49144994|NCT00620035|158371756|FG000|Overall Study|Adverse Event|106|||
49144995|NCT00620035|158371756|FG000|Overall Study|Withdrawal of Informed Consent|1|||
49144996|NCT00620035|158371756|FG000|Overall Study|Other Reason|38|||
48730655|NCT04963231|156865864|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
48730656|NCT04963231|156865865|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
48730657|NCT04963231|156865863|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|3|||
49013389|NCT00410410|157885215|FG007|Maintenance Period (MP)|Withdrawal by Subject|1|||
49013390|NCT00410410|157885216|FG008|Maintenance Period (MP)|Withdrawal by Subject|0|||
49013391|NCT00410410|157885208|FG000|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
49013392|NCT00410410|157885209|FG001|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
49013393|NCT00410410|157885210|FG002|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
49144997|NCT03928704|158371757|FG000|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
49144998|NCT03928704|158371758|FG001|Double-Blind Treatment Period:Week 1-16|Patient Compliance|1|||
49144999|NCT03928704|158371759|FG002|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
49145000|NCT03928704|158371760|FG003|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
49145001|NCT03928704|158371761|FG004|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
49145002|NCT03928704|158371762|FG005|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
49013394|NCT00410410|157885211|FG003|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
49013395|NCT00410410|157885212|FG004|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
49145003|NCT03928704|158371757|FG000|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|4|||
49145004|NCT03928704|158371758|FG001|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
49145005|NCT03928704|158371759|FG002|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
49145006|NCT03928704|158371760|FG003|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
49145007|NCT03928704|158371761|FG004|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
49145008|NCT03928704|158371762|FG005|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
49145009|NCT03928704|158371757|FG000|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|1|||
49145010|NCT03928704|158371758|FG001|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
49145011|NCT03928704|158371759|FG002|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
49145012|NCT03928704|158371760|FG003|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
48823076|NCT02851511|157192290|FG000|Phase II|Physician Decision|18|||
48823077|NCT02851511|157192291|FG001|Phase II|Physician Decision|16|||
48823078|NCT02851511|157192292|FG002|Phase II|Physician Decision|0|||
48823079|NCT02851511|157192293|FG003|Phase II|Physician Decision|0|||
48823080|NCT02851511|157192290|FG000|Phase II|Withdrawal by Subject|18|||
48823081|NCT02851511|157192291|FG001|Phase II|Withdrawal by Subject|16|||
48823082|NCT02851511|157192292|FG002|Phase II|Withdrawal by Subject|0|||
48823083|NCT02851511|157192293|FG003|Phase II|Withdrawal by Subject|0|||
48823084|NCT02851511|157192290|FG000|Phase II|COVID-19 lockdown, no reason specified|4|||
48823085|NCT02851511|157192291|FG001|Phase II|COVID-19 lockdown, no reason specified|5|||
48823086|NCT02851511|157192292|FG002|Phase II|COVID-19 lockdown, no reason specified|0|||
48823087|NCT02851511|157192293|FG003|Phase II|COVID-19 lockdown, no reason specified|0|||
48823088|NCT02851511|157192290|FG000|Phase II|Lost to Follow-up|0|||
48823089|NCT02851511|157192291|FG001|Phase II|Lost to Follow-up|1|||
48823090|NCT02851511|157192292|FG002|Phase II|Lost to Follow-up|0|||
48823091|NCT02851511|157192293|FG003|Phase II|Lost to Follow-up|0|||
49013396|NCT00410410|157885213|FG005|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
49013397|NCT00410410|157885214|FG006|Maintenance Period (MP)|Administrative Reason By Sponsor|21|||
48823092|NCT02056119|157192302|FG000|Overall Study|Death|1|||
49111482|NCT02452554|158242909|FG001|Overall Study|Lack of Efficacy|14|||
48823093|NCT02056119|157192303|FG001|Overall Study|Death|2|||
48823094|NCT02056119|157192302|FG000|Overall Study|Intubated for less than 24 hrs|2|||
49111483|NCT02452554|158242910|FG002|Overall Study|Lack of Efficacy|9|||
49111484|NCT02452554|158242911|FG003|Overall Study|Lack of Efficacy|1|||
49111485|NCT02452554|158242912|FG004|Overall Study|Lack of Efficacy|5|||
49111486|NCT02452554|158242913|FG005|Overall Study|Lack of Efficacy|8|||
49111487|NCT02452554|158242908|FG000|Overall Study|Physician Decision|0|||
49111488|NCT02452554|158242909|FG001|Overall Study|Physician Decision|1|||
49111489|NCT02452554|158242910|FG002|Overall Study|Physician Decision|0|||
49111490|NCT02452554|158242911|FG003|Overall Study|Physician Decision|0|||
49111491|NCT02452554|158242912|FG004|Overall Study|Physician Decision|0|||
49111492|NCT02452554|158242913|FG005|Overall Study|Physician Decision|0|||
49111493|NCT02452554|158242908|FG000|Overall Study|Withdrawal by Subject|1|||
49111494|NCT02452554|158242909|FG001|Overall Study|Withdrawal by Subject|0|||
49111495|NCT02452554|158242910|FG002|Overall Study|Withdrawal by Subject|2|||
49111496|NCT02452554|158242911|FG003|Overall Study|Withdrawal by Subject|0|||
49111497|NCT02452554|158242912|FG004|Overall Study|Withdrawal by Subject|0|||
49111498|NCT02452554|158242913|FG005|Overall Study|Withdrawal by Subject|1|||
49111499|NCT02452554|158242908|FG000|Overall Study|Ineligible|0|||
49111500|NCT02452554|158242909|FG001|Overall Study|Ineligible|1|||
49111501|NCT02452554|158242910|FG002|Overall Study|Ineligible|0|||
49111502|NCT02452554|158242911|FG003|Overall Study|Ineligible|0|||
49111503|NCT02452554|158242912|FG004|Overall Study|Ineligible|0|||
49111504|NCT02452554|158242913|FG005|Overall Study|Ineligible|0|||
49111505|NCT02452554|158242908|FG000|Overall Study|Never Received Treatment|1|||
49111506|NCT02452554|158242909|FG001|Overall Study|Never Received Treatment|0|||
49111507|NCT02452554|158242910|FG002|Overall Study|Never Received Treatment|0|||
49111508|NCT02452554|158242911|FG003|Overall Study|Never Received Treatment|0|||
49111509|NCT02452554|158242912|FG004|Overall Study|Never Received Treatment|0|||
49111510|NCT02452554|158242913|FG005|Overall Study|Never Received Treatment|0|||
49145013|NCT03928704|158371761|FG004|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
49145014|NCT03928704|158371762|FG005|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
49145015|NCT03928704|158371757|FG000|Double-Blind Treatment Period:Week 1-16|Adverse Event|3|||
49145016|NCT03928704|158371758|FG001|Double-Blind Treatment Period:Week 1-16|Adverse Event|1|||
49145017|NCT03928704|158371759|FG002|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
49145018|NCT03928704|158371760|FG003|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
49145019|NCT03928704|158371761|FG004|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
49145020|NCT03928704|158371762|FG005|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
49145021|NCT03928704|158371757|FG000|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
49145022|NCT03928704|158371758|FG001|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
49145023|NCT03928704|158371759|FG002|Maintenance Period: Week 16-52|Withdrawal By Study Participant|12|||
49145024|NCT03928704|158371760|FG003|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
49145025|NCT03928704|158371761|FG004|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
49145026|NCT03928704|158371762|FG005|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
49145027|NCT03928704|158371757|FG000|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
49145028|NCT03928704|158371758|FG001|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
49145029|NCT03928704|158371759|FG002|Maintenance Period: Week 16-52|Lack of Efficacy|4|||
49145030|NCT03928704|158371760|FG003|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
49145031|NCT03928704|158371761|FG004|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
49145032|NCT03928704|158371762|FG005|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
49145033|NCT03928704|158371757|FG000|Maintenance Period: Week 16-52|Adverse Event|0|||
49145034|NCT03928704|158371758|FG001|Maintenance Period: Week 16-52|Adverse Event|0|||
49145035|NCT03928704|158371759|FG002|Maintenance Period: Week 16-52|Adverse Event|5|||
49145036|NCT03928704|158371760|FG003|Maintenance Period: Week 16-52|Adverse Event|0|||
49145037|NCT03928704|158371761|FG004|Maintenance Period: Week 16-52|Adverse Event|0|||
49145038|NCT03928704|158371762|FG005|Maintenance Period: Week 16-52|Adverse Event|0|||
49145039|NCT03928704|158371757|FG000|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
49145040|NCT03928704|158371758|FG001|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
48823095|NCT02056119|157192303|FG001|Overall Study|Intubated for less than 24 hrs|7|||
48823096|NCT02056119|157192302|FG000|Overall Study|No aerosol treatments were given.|3|||
48823097|NCT02056119|157192303|FG001|Overall Study|No aerosol treatments were given.|2|||
48823098|NCT02056119|157192302|FG000|Overall Study|Received Metaneb treatment|0|||
48823099|NCT02056119|157192303|FG001|Overall Study|Received Metaneb treatment|2|||
48823100|NCT02056119|157192302|FG000|Overall Study|Protocol Violation|4|||
48823101|NCT02056119|157192303|FG001|Overall Study|Protocol Violation|7|||
48823102|NCT01348854|157192304|FG000|Overall Study|Lost to Follow-up|2|||
48823103|NCT01348854|157192305|FG001|Overall Study|Lost to Follow-up|1|||
48823104|NCT01348854|157192304|FG000|Overall Study|Withdrawal by Subject|1|||
48823105|NCT01348854|157192305|FG001|Overall Study|Withdrawal by Subject|0|||
48823106|NCT04170023|157192306|FG000|LTE Period|Withdrawal by Subject|1|||
48823107|NCT04170023|157192307|FG001|LTE Period|Withdrawal by Subject|0|||
48823108|NCT04170023|157192308|FG002|LTE Period|Withdrawal by Subject|0|||
48823109|NCT04170023|157192306|FG000|LTE Period|Study Termination|11|||
48823110|NCT04170023|157192307|FG001|LTE Period|Study Termination|11|||
48823111|NCT04170023|157192308|FG002|LTE Period|Study Termination|5|||
48823112|NCT00003377|157192309|FG000|Period I|Dose Limiting Toxicity(DLT)|0|||
48823113|NCT00003377|157192310|FG001|Period I|Dose Limiting Toxicity(DLT)|0|||
48823114|NCT00003377|157192311|FG002|Period I|Dose Limiting Toxicity(DLT)|1|||
48823115|NCT00003377|157192312|FG003|Period I|Dose Limiting Toxicity(DLT)|1|||
48823116|NCT00003377|157192313|FG004|Period I|Dose Limiting Toxicity(DLT)|0|||
48823117|NCT00003377|157192309|FG000|Period II|Ureteral stent complications|0|||
48823118|NCT00003377|157192310|FG001|Period II|Ureteral stent complications|0|||
48823119|NCT00003377|157192311|FG002|Period II|Ureteral stent complications|0|||
48823120|NCT00003377|157192312|FG003|Period II|Ureteral stent complications|0|||
48823121|NCT00003377|157192313|FG004|Period II|Ureteral stent complications|1|||
48823122|NCT04541186|157192316|FG000|Main Study|Adverse Event|0|||
48823123|NCT04541186|157192317|FG001|Main Study|Adverse Event|0|||
48823124|NCT04541186|157192318|FG002|Main Study|Adverse Event|4|||
48823125|NCT04541186|157192319|FG003|Main Study|Adverse Event|0|||
48823126|NCT04541186|157192320|FG004|Main Study|Adverse Event|0|||
48823127|NCT04541186|157192316|FG000|Main Study|Investigator Decision|0|||
48823128|NCT04541186|157192317|FG001|Main Study|Investigator Decision|0|||
48823129|NCT04541186|157192318|FG002|Main Study|Investigator Decision|1|||
48823130|NCT04541186|157192319|FG003|Main Study|Investigator Decision|1|||
48823131|NCT04541186|157192320|FG004|Main Study|Investigator Decision|0|||
49145041|NCT03928704|158371759|FG002|Maintenance Period: Week 16-52|Lost to Follow-up|1|||
48823132|NCT04541186|157192316|FG000|Main Study|Withdrawal by Subject|1|||
48823133|NCT04541186|157192317|FG001|Main Study|Withdrawal by Subject|1|||
48823134|NCT04541186|157192318|FG002|Main Study|Withdrawal by Subject|0|||
48823135|NCT04541186|157192319|FG003|Main Study|Withdrawal by Subject|0|||
48823136|NCT04541186|157192320|FG004|Main Study|Withdrawal by Subject|0|||
48823137|NCT04541186|157192316|FG000|Main Study|COVID-19-related Dose Interruption|0|||
49111580|NCT00513357|158244462|FG001|Overall Study|Disease Progression|1|||
49145042|NCT03928704|158371760|FG003|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
49145043|NCT03928704|158371761|FG004|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
49145044|NCT03928704|158371762|FG005|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
49145045|NCT03928704|158371757|FG000|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
49145046|NCT03928704|158371758|FG001|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
49145047|NCT03928704|158371759|FG002|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
49111581|NCT01162122|158244463|FG000|Overall Study|Withdrawal by Subject|52|||
49111582|NCT01162122|158244464|FG001|Overall Study|Withdrawal by Subject|43|||
49111583|NCT01162122|158244463|FG000|Overall Study|Lost to Follow-up|73|||
49111584|NCT01162122|158244464|FG001|Overall Study|Lost to Follow-up|91|||
49111585|NCT01162122|158244463|FG000|Overall Study|Adverse Event|3|||
49111586|NCT01162122|158244464|FG001|Overall Study|Adverse Event|2|||
49111587|NCT01162122|158244463|FG000|Overall Study|Death|51|||
49111588|NCT01162122|158244464|FG001|Overall Study|Death|46|||
49111589|NCT01162122|158244463|FG000|Overall Study|Protocol Violation|2|||
49111590|NCT01162122|158244464|FG001|Overall Study|Protocol Violation|2|||
49111591|NCT01162122|158244463|FG000|Overall Study|Inappropriate enrollment|5|||
49111592|NCT01162122|158244464|FG001|Overall Study|Inappropriate enrollment|4|||
49111593|NCT01162122|158244463|FG000|Overall Study|Administrative reason|1|||
49111594|NCT01162122|158244464|FG001|Overall Study|Administrative reason|1|||
49111595|NCT01162122|158244463|FG000|Overall Study|Unable to classify|3|||
49111596|NCT01162122|158244464|FG001|Overall Study|Unable to classify|7|||
49111597|NCT01162122|158244463|FG000|Overall Study|Missing primary reason|1|||
49111598|NCT01162122|158244464|FG001|Overall Study|Missing primary reason|0|||
49111599|NCT02020512|158244465|FG000|Overall Study|Adverse Event|1|||
49111600|NCT02020512|158244465|FG000|Overall Study|Lost to Follow-up|3|||
49111601|NCT02020512|158244465|FG000|Overall Study|Protocol Violation|4|||
49111602|NCT04490018|158244466|FG000|Overall Study|Protocol Violation|0|||
49111603|NCT04490018|158244467|FG001|Overall Study|Protocol Violation|2|||
49111604|NCT04490018|158244468|FG002|Overall Study|Protocol Violation|1|||
49111605|NCT04490018|158244466|FG000|Overall Study|Lost to Follow-up|2|||
49111606|NCT04490018|158244467|FG001|Overall Study|Lost to Follow-up|2|||
49111607|NCT04490018|158244468|FG002|Overall Study|Lost to Follow-up|0|||
49111608|NCT04490018|158244466|FG000|Overall Study|Withdrawal by Subject|2|||
49111609|NCT04490018|158244467|FG001|Overall Study|Withdrawal by Subject|1|||
49111610|NCT04490018|158244468|FG002|Overall Study|Withdrawal by Subject|0|||
49111611|NCT04490018|158244466|FG000|Overall Study|Withdrawal by parent/guardian|2|||
49111612|NCT04490018|158244467|FG001|Overall Study|Withdrawal by parent/guardian|3|||
49111613|NCT04490018|158244468|FG002|Overall Study|Withdrawal by parent/guardian|0|||
49111614|NCT02943785|158244472|FG000|Overall Study|Adverse Event|112|||
49111615|NCT02943785|158244473|FG001|Overall Study|Adverse Event|97|||
49111616|NCT02943785|158244472|FG000|Overall Study|Withdrawal by Subject|63|||
49111617|NCT02943785|158244473|FG001|Overall Study|Withdrawal by Subject|126|||
49111618|NCT02943785|158244472|FG000|Overall Study|Physician Decision|23|||
49111619|NCT02943785|158244473|FG001|Overall Study|Physician Decision|47|||
49111620|NCT02943785|158244472|FG000|Overall Study|Death|46|||
49111621|NCT02943785|158244473|FG001|Overall Study|Death|46|||
49111622|NCT02943785|158244472|FG000|Overall Study|Lost to Follow-up|1|||
49111623|NCT02943785|158244473|FG001|Overall Study|Lost to Follow-up|0|||
49111624|NCT02943785|158244472|FG000|Overall Study|Other|16|||
49111625|NCT02943785|158244473|FG001|Overall Study|Other|19|||
49111626|NCT02943785|158244472|FG000|Overall Study|Did not receive any study medication|21|||
49111627|NCT02943785|158244473|FG001|Overall Study|Did not receive any study medication|28|||
49111628|NCT00524680|158244476|FG000|Overall Study|progression|0|||
49111629|NCT00524680|158244477|FG001|Overall Study|progression|0|||
49111630|NCT00524680|158244478|FG002|Overall Study|progression|0|||
49111631|NCT00524680|158244479|FG003|Overall Study|progression|1|||
49111632|NCT00524680|158244476|FG000|Overall Study|Adverse Event|2|||
49111633|NCT00524680|158244477|FG001|Overall Study|Adverse Event|0|||
49111634|NCT00524680|158244478|FG002|Overall Study|Adverse Event|0|||
49111635|NCT00524680|158244479|FG003|Overall Study|Adverse Event|1|||
49111636|NCT00524680|158244476|FG000|Overall Study|Other|0|||
49111637|NCT00524680|158244477|FG001|Overall Study|Other|1|||
49111638|NCT00524680|158244478|FG002|Overall Study|Other|2|||
49111639|NCT00524680|158244479|FG003|Overall Study|Other|3|||
49111640|NCT00524680|158244476|FG000|Overall Study|Withdrawal by Subject|1|||
49111641|NCT00524680|158244477|FG001|Overall Study|Withdrawal by Subject|0|||
49111642|NCT00524680|158244478|FG002|Overall Study|Withdrawal by Subject|1|||
49111643|NCT00524680|158244479|FG003|Overall Study|Withdrawal by Subject|1|||
49111644|NCT01281956|158244481|FG000|2nd Intervention (3 Months)|Withdrawal by Subject|1|||
49111645|NCT01281956|158244482|FG001|2nd Intervention (3 Months)|Withdrawal by Subject|0|||
49111646|NCT03170609|158244483|FG000|Overall Study|Death|0|||
49111647|NCT03170609|158244484|FG001|Overall Study|Death|0|||
49111648|NCT03170609|158244485|FG002|Overall Study|Death|1|||
49145048|NCT03928704|158371760|FG003|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
49145049|NCT03928704|158371761|FG004|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
49145050|NCT03928704|158371762|FG005|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|2|||
49145051|NCT03928704|158371757|FG000|Maintenance Period: Week 16-52|Non- Compliance|0|||
49145052|NCT03928704|158371758|FG001|Maintenance Period: Week 16-52|Non- Compliance|0|||
49145053|NCT03928704|158371759|FG002|Maintenance Period: Week 16-52|Non- Compliance|0|||
49145054|NCT03928704|158371760|FG003|Maintenance Period: Week 16-52|Non- Compliance|0|||
49145055|NCT03928704|158371761|FG004|Maintenance Period: Week 16-52|Non- Compliance|0|||
49145056|NCT03928704|158371762|FG005|Maintenance Period: Week 16-52|Non- Compliance|1|||
49145057|NCT01454063|158371769|FG000|Randomized|Adverse Event|1|||
49145058|NCT01454063|158371770|FG001|Randomized|Adverse Event|1|||
49145059|NCT01454063|158371769|FG000|Randomized|Protocol Violation|0|||
49145060|NCT01454063|158371770|FG001|Randomized|Protocol Violation|1|||
49145061|NCT02741193|158371777|FG000|Overall Study|Participant deemed not to be a surgical resection candidate|1|||
49145062|NCT02741193|158371777|FG000|Overall Study|Participant found to be seizure-free due to new epilepsy medication, did not participate|1|||
49145063|NCT00120250|158371779|FG000|Overall Study|Lost to Follow-up|1|||
49145064|NCT00120250|158371780|FG001|Overall Study|Lost to Follow-up|1|||
49145065|NCT00120250|158371779|FG000|Overall Study|Protocol Violation|0|||
49145066|NCT00120250|158371780|FG001|Overall Study|Protocol Violation|1|||
49145067|NCT02168439|158371786|FG000|Overall Study|Protocol Violation|0|||
49013398|NCT00410410|157885215|FG007|Maintenance Period (MP)|Administrative Reason By Sponsor|25|||
49013399|NCT00410410|157885216|FG008|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
49013400|NCT00410410|157885208|FG000|Open-Label Period (OL)|Death|0|||
49013401|NCT00410410|157885209|FG001|Open-Label Period (OL)|Death|0|||
49013402|NCT00410410|157885210|FG002|Open-Label Period (OL)|Death|0|||
49145068|NCT02168439|158371787|FG001|Overall Study|Protocol Violation|2|||
49145069|NCT02004275|158371788|FG000|Phase 1|Ineligible|0|||
49145070|NCT02004275|158371789|FG001|Phase 1|Ineligible|0|||
49145071|NCT02004275|158371790|FG002|Phase 1|Ineligible|0|||
49145072|NCT02004275|158371791|FG003|Phase 1|Ineligible|1|||
49145073|NCT02004275|158371792|FG004|Phase 1|Ineligible|1|||
49145074|NCT02004275|158371793|FG005|Phase 1|Ineligible|0|||
49145075|NCT02004275|158371788|FG000|Phase 1|Protocol Violation|0|||
49145076|NCT02004275|158371789|FG001|Phase 1|Protocol Violation|0|||
49145077|NCT02004275|158371790|FG002|Phase 1|Protocol Violation|0|||
49145078|NCT02004275|158371791|FG003|Phase 1|Protocol Violation|1|||
49145079|NCT02004275|158371792|FG004|Phase 1|Protocol Violation|0|||
49145080|NCT02004275|158371793|FG005|Phase 1|Protocol Violation|5|||
49145081|NCT02004275|158371788|FG000|Phase 2 Part 1|Ineligible|6|||
49145082|NCT02004275|158371789|FG001|Phase 2 Part 1|Ineligible|9|||
49145083|NCT02004275|158371790|FG002|Phase 2 Part 1|Ineligible|0|||
49145084|NCT02004275|158371791|FG003|Phase 2 Part 1|Ineligible|0|||
49145085|NCT02004275|158371792|FG004|Phase 2 Part 1|Ineligible|0|||
49145086|NCT02004275|158371793|FG005|Phase 2 Part 1|Ineligible|0|||
49145087|NCT02004275|158371788|FG000|Phase 2 Part 2|Withdrawal by Subject|4|||
49145088|NCT02004275|158371789|FG001|Phase 2 Part 2|Withdrawal by Subject|0|||
49145089|NCT02004275|158371790|FG002|Phase 2 Part 2|Withdrawal by Subject|0|||
49145090|NCT02004275|158371791|FG003|Phase 2 Part 2|Withdrawal by Subject|0|||
49145091|NCT02004275|158371792|FG004|Phase 2 Part 2|Withdrawal by Subject|0|||
49145092|NCT02004275|158371793|FG005|Phase 2 Part 2|Withdrawal by Subject|0|||
49145093|NCT02533674|158371794|FG000|Dose Level I|Progressive disease|1|||
49145094|NCT02533674|158371795|FG001|Dose Level I|Progressive disease|0|||
49145095|NCT02533674|158371796|FG002|Dose Level I|Progressive disease|0|||
49145096|NCT02533674|158371797|FG003|Dose Level I|Progressive disease|0|||
49145097|NCT02533674|158371798|FG004|Dose Level I|Progressive disease|0|||
49145098|NCT02533674|158371799|FG005|Dose Level I|Progressive disease|0|||
49145099|NCT02533674|158371800|FG006|Dose Level I|Progressive disease|0|||
49145100|NCT02533674|158371801|FG007|Dose Level I|Progressive disease|0|||
49145101|NCT02533674|158371794|FG000|Dose Level I|Withdrawal by Subject|1|||
49145102|NCT02533674|158371795|FG001|Dose Level I|Withdrawal by Subject|0|||
49145103|NCT02533674|158371796|FG002|Dose Level I|Withdrawal by Subject|0|||
49145104|NCT02533674|158371797|FG003|Dose Level I|Withdrawal by Subject|0|||
49145105|NCT02533674|158371798|FG004|Dose Level I|Withdrawal by Subject|0|||
49145106|NCT02533674|158371799|FG005|Dose Level I|Withdrawal by Subject|0|||
48823138|NCT04541186|157192317|FG001|Main Study|COVID-19-related Dose Interruption|0|||
49145107|NCT02533674|158371800|FG006|Dose Level I|Withdrawal by Subject|0|||
49013403|NCT00410410|157885211|FG003|Open-Label Period (OL)|Death|0|||
49013404|NCT00410410|157885212|FG004|Open-Label Period (OL)|Death|0|||
49013405|NCT00410410|157885213|FG005|Open-Label Period (OL)|Death|0|||
49013406|NCT00410410|157885214|FG006|Open-Label Period (OL)|Death|0|||
49145108|NCT02533674|158371801|FG007|Dose Level I|Withdrawal by Subject|0|||
49145109|NCT02533674|158371794|FG000|Dose Level I|Physician Decision|1|||
49145110|NCT02533674|158371795|FG001|Dose Level I|Physician Decision|0|||
49145111|NCT02533674|158371796|FG002|Dose Level I|Physician Decision|0|||
49145112|NCT02533674|158371797|FG003|Dose Level I|Physician Decision|0|||
49145113|NCT02533674|158371798|FG004|Dose Level I|Physician Decision|0|||
49013407|NCT00410410|157885215|FG007|Open-Label Period (OL)|Death|0|||
49145114|NCT02533674|158371799|FG005|Dose Level I|Physician Decision|0|||
49145115|NCT02533674|158371800|FG006|Dose Level I|Physician Decision|0|||
49145116|NCT02533674|158371801|FG007|Dose Level I|Physician Decision|0|||
49145117|NCT02533674|158371794|FG000|Dose Level I|Death|1|||
49145118|NCT02533674|158371795|FG001|Dose Level I|Death|0|||
49145119|NCT02533674|158371796|FG002|Dose Level I|Death|0|||
49145120|NCT02533674|158371797|FG003|Dose Level I|Death|0|||
49145121|NCT02533674|158371798|FG004|Dose Level I|Death|0|||
49145122|NCT02533674|158371799|FG005|Dose Level I|Death|0|||
49145123|NCT02533674|158371800|FG006|Dose Level I|Death|0|||
49145124|NCT02533674|158371801|FG007|Dose Level I|Death|0|||
49145125|NCT02533674|158371794|FG000|Dose Level I|Never Treated|1|||
49145126|NCT02533674|158371795|FG001|Dose Level I|Never Treated|0|||
49145127|NCT02533674|158371796|FG002|Dose Level I|Never Treated|0|||
49145128|NCT02533674|158371797|FG003|Dose Level I|Never Treated|0|||
49145129|NCT02533674|158371798|FG004|Dose Level I|Never Treated|0|||
49145130|NCT02533674|158371799|FG005|Dose Level I|Never Treated|0|||
49145131|NCT02533674|158371800|FG006|Dose Level I|Never Treated|0|||
49145132|NCT02533674|158371801|FG007|Dose Level I|Never Treated|0|||
49145133|NCT02533674|158371794|FG000|Dose Level II|Progressive disease|0|||
49145134|NCT02533674|158371795|FG001|Dose Level II|Progressive disease|3|||
49145135|NCT02533674|158371796|FG002|Dose Level II|Progressive disease|0|||
49145136|NCT02533674|158371797|FG003|Dose Level II|Progressive disease|0|||
49145137|NCT02533674|158371798|FG004|Dose Level II|Progressive disease|0|||
49145138|NCT02533674|158371799|FG005|Dose Level II|Progressive disease|0|||
49145139|NCT02533674|158371800|FG006|Dose Level II|Progressive disease|0|||
49145140|NCT02533674|158371801|FG007|Dose Level II|Progressive disease|0|||
49145141|NCT02533674|158371794|FG000|Dose Level II|Withdrawal by Subject|0|||
49145142|NCT02533674|158371795|FG001|Dose Level II|Withdrawal by Subject|1|||
49145143|NCT02533674|158371796|FG002|Dose Level II|Withdrawal by Subject|0|||
49145144|NCT02533674|158371797|FG003|Dose Level II|Withdrawal by Subject|0|||
49145145|NCT02533674|158371798|FG004|Dose Level II|Withdrawal by Subject|0|||
49145146|NCT02533674|158371799|FG005|Dose Level II|Withdrawal by Subject|0|||
49145147|NCT02533674|158371800|FG006|Dose Level II|Withdrawal by Subject|0|||
49145148|NCT02533674|158371801|FG007|Dose Level II|Withdrawal by Subject|0|||
49145149|NCT02533674|158371794|FG000|Dose Level II|Treatment-related AE|0|||
49145150|NCT02533674|158371795|FG001|Dose Level II|Treatment-related AE|1|||
49145151|NCT02533674|158371796|FG002|Dose Level II|Treatment-related AE|0|||
49145152|NCT02533674|158371797|FG003|Dose Level II|Treatment-related AE|0|||
49145153|NCT02533674|158371798|FG004|Dose Level II|Treatment-related AE|0|||
49145154|NCT02533674|158371799|FG005|Dose Level II|Treatment-related AE|0|||
49145155|NCT02533674|158371800|FG006|Dose Level II|Treatment-related AE|0|||
49145156|NCT02533674|158371801|FG007|Dose Level II|Treatment-related AE|0|||
49145157|NCT02533674|158371794|FG000|Dose Level II|Physician Decision|0|||
49145158|NCT02533674|158371795|FG001|Dose Level II|Physician Decision|1|||
49145159|NCT02533674|158371796|FG002|Dose Level II|Physician Decision|0|||
49145160|NCT02533674|158371797|FG003|Dose Level II|Physician Decision|0|||
49145161|NCT02533674|158371798|FG004|Dose Level II|Physician Decision|0|||
49145162|NCT02533674|158371799|FG005|Dose Level II|Physician Decision|0|||
49145163|NCT02533674|158371800|FG006|Dose Level II|Physician Decision|0|||
49145164|NCT02533674|158371801|FG007|Dose Level II|Physician Decision|0|||
49145165|NCT02533674|158371794|FG000|Dose Level II|Non-treatment-related AE|0|||
49145166|NCT02533674|158371795|FG001|Dose Level II|Non-treatment-related AE|1|||
49145167|NCT02533674|158371796|FG002|Dose Level II|Non-treatment-related AE|0|||
49145168|NCT02533674|158371797|FG003|Dose Level II|Non-treatment-related AE|0|||
49145169|NCT02533674|158371798|FG004|Dose Level II|Non-treatment-related AE|0|||
48823139|NCT04541186|157192318|FG002|Main Study|COVID-19-related Dose Interruption|0|||
49145170|NCT02533674|158371799|FG005|Dose Level II|Non-treatment-related AE|0|||
49145171|NCT02533674|158371800|FG006|Dose Level II|Non-treatment-related AE|0|||
49145172|NCT02533674|158371801|FG007|Dose Level II|Non-treatment-related AE|0|||
49145173|NCT02533674|158371794|FG000|Dose Level III|Progressive disease|0|||
49145174|NCT02533674|158371795|FG001|Dose Level III|Progressive disease|0|||
49145175|NCT02533674|158371796|FG002|Dose Level III|Progressive disease|2|||
48823140|NCT04541186|157192319|FG003|Main Study|COVID-19-related Dose Interruption|0|||
49145176|NCT02533674|158371797|FG003|Dose Level III|Progressive disease|0|||
49145177|NCT02533674|158371798|FG004|Dose Level III|Progressive disease|0|||
49145178|NCT02533674|158371799|FG005|Dose Level III|Progressive disease|0|||
49145179|NCT02533674|158371800|FG006|Dose Level III|Progressive disease|0|||
49145180|NCT02533674|158371801|FG007|Dose Level III|Progressive disease|0|||
49145181|NCT02533674|158371794|FG000|Dose Level III|Withdrawal by Subject|0|||
49145182|NCT02533674|158371795|FG001|Dose Level III|Withdrawal by Subject|0|||
49145183|NCT02533674|158371796|FG002|Dose Level III|Withdrawal by Subject|1|||
49013408|NCT00410410|157885216|FG008|Open-Label Period (OL)|Death|1|||
49145184|NCT02533674|158371797|FG003|Dose Level III|Withdrawal by Subject|0|||
49145185|NCT02533674|158371798|FG004|Dose Level III|Withdrawal by Subject|0|||
49145186|NCT02533674|158371799|FG005|Dose Level III|Withdrawal by Subject|0|||
49145187|NCT02533674|158371800|FG006|Dose Level III|Withdrawal by Subject|0|||
49145188|NCT02533674|158371801|FG007|Dose Level III|Withdrawal by Subject|0|||
49145189|NCT02533674|158371794|FG000|Dose Level III|Treatment-related AE|0|||
49145190|NCT02533674|158371795|FG001|Dose Level III|Treatment-related AE|0|||
49145191|NCT02533674|158371796|FG002|Dose Level III|Treatment-related AE|1|||
49145192|NCT02533674|158371797|FG003|Dose Level III|Treatment-related AE|0|||
49145193|NCT02533674|158371798|FG004|Dose Level III|Treatment-related AE|0|||
49145194|NCT02533674|158371799|FG005|Dose Level III|Treatment-related AE|0|||
49145195|NCT02533674|158371800|FG006|Dose Level III|Treatment-related AE|0|||
49145196|NCT02533674|158371801|FG007|Dose Level III|Treatment-related AE|0|||
49145197|NCT02533674|158371794|FG000|Dose Level IV|Progressive disease|0|||
49145198|NCT02533674|158371795|FG001|Dose Level IV|Progressive disease|0|||
49145199|NCT02533674|158371796|FG002|Dose Level IV|Progressive disease|0|||
49145200|NCT02533674|158371797|FG003|Dose Level IV|Progressive disease|3|||
49145201|NCT02533674|158371798|FG004|Dose Level IV|Progressive disease|0|||
49145202|NCT02533674|158371799|FG005|Dose Level IV|Progressive disease|0|||
49145203|NCT02533674|158371800|FG006|Dose Level IV|Progressive disease|0|||
49145204|NCT02533674|158371801|FG007|Dose Level IV|Progressive disease|0|||
49145205|NCT02533674|158371794|FG000|Dose Level IV|Withdrawal by Subject|0|||
49145206|NCT02533674|158371795|FG001|Dose Level IV|Withdrawal by Subject|0|||
49145207|NCT02533674|158371796|FG002|Dose Level IV|Withdrawal by Subject|0|||
49145208|NCT02533674|158371797|FG003|Dose Level IV|Withdrawal by Subject|1|||
49145209|NCT02533674|158371798|FG004|Dose Level IV|Withdrawal by Subject|0|||
49145210|NCT02533674|158371799|FG005|Dose Level IV|Withdrawal by Subject|0|||
49145211|NCT02533674|158371800|FG006|Dose Level IV|Withdrawal by Subject|0|||
49145212|NCT02533674|158371801|FG007|Dose Level IV|Withdrawal by Subject|0|||
49145213|NCT02533674|158371794|FG000|Dose Level IV|Physician Decision|0|||
49145214|NCT02533674|158371795|FG001|Dose Level IV|Physician Decision|0|||
49145215|NCT02533674|158371796|FG002|Dose Level IV|Physician Decision|0|||
49145216|NCT02533674|158371797|FG003|Dose Level IV|Physician Decision|1|||
49145217|NCT02533674|158371798|FG004|Dose Level IV|Physician Decision|0|||
49145218|NCT02533674|158371799|FG005|Dose Level IV|Physician Decision|0|||
49145219|NCT02533674|158371800|FG006|Dose Level IV|Physician Decision|0|||
49145220|NCT02533674|158371801|FG007|Dose Level IV|Physician Decision|0|||
49145221|NCT02533674|158371794|FG000|Dose Level V|Progressive disease|0|||
49145222|NCT02533674|158371795|FG001|Dose Level V|Progressive disease|0|||
49145223|NCT02533674|158371796|FG002|Dose Level V|Progressive disease|0|||
49145224|NCT02533674|158371797|FG003|Dose Level V|Progressive disease|0|||
49145225|NCT02533674|158371798|FG004|Dose Level V|Progressive disease|3|||
49145226|NCT02533674|158371799|FG005|Dose Level V|Progressive disease|0|||
49145227|NCT02533674|158371800|FG006|Dose Level V|Progressive disease|0|||
49145228|NCT02533674|158371801|FG007|Dose Level V|Progressive disease|0|||
49145229|NCT02533674|158371794|FG000|Dose Level V|Withdrawal by Subject|0|||
49145230|NCT02533674|158371795|FG001|Dose Level V|Withdrawal by Subject|0|||
49145231|NCT02533674|158371796|FG002|Dose Level V|Withdrawal by Subject|0|||
49145232|NCT02533674|158371797|FG003|Dose Level V|Withdrawal by Subject|0|||
49145233|NCT02533674|158371798|FG004|Dose Level V|Withdrawal by Subject|1|||
49145234|NCT02533674|158371799|FG005|Dose Level V|Withdrawal by Subject|0|||
49145235|NCT02533674|158371800|FG006|Dose Level V|Withdrawal by Subject|0|||
49145236|NCT02533674|158371801|FG007|Dose Level V|Withdrawal by Subject|0|||
49145237|NCT02533674|158371794|FG000|Dose Level V|Physician Decision|0|||
49145238|NCT02533674|158371795|FG001|Dose Level V|Physician Decision|0|||
49145239|NCT02533674|158371796|FG002|Dose Level V|Physician Decision|0|||
49145240|NCT02533674|158371797|FG003|Dose Level V|Physician Decision|0|||
49145241|NCT02533674|158371798|FG004|Dose Level V|Physician Decision|1|||
49145242|NCT02533674|158371799|FG005|Dose Level V|Physician Decision|0|||
49145243|NCT02533674|158371800|FG006|Dose Level V|Physician Decision|0|||
49145244|NCT02533674|158371801|FG007|Dose Level V|Physician Decision|0|||
49145245|NCT02533674|158371794|FG000|Dose Level VI|Progressive disease|0|||
49145246|NCT02533674|158371795|FG001|Dose Level VI|Progressive disease|0|||
49145247|NCT02533674|158371796|FG002|Dose Level VI|Progressive disease|0|||
49145248|NCT02533674|158371797|FG003|Dose Level VI|Progressive disease|0|||
49145249|NCT02533674|158371798|FG004|Dose Level VI|Progressive disease|0|||
49145250|NCT02533674|158371799|FG005|Dose Level VI|Progressive disease|7|||
49145251|NCT02533674|158371800|FG006|Dose Level VI|Progressive disease|0|||
49145252|NCT02533674|158371801|FG007|Dose Level VI|Progressive disease|0|||
49145253|NCT02533674|158371794|FG000|Dose Level VI|Withdrawal by Subject|0|||
49145254|NCT02533674|158371795|FG001|Dose Level VI|Withdrawal by Subject|0|||
49145255|NCT02533674|158371796|FG002|Dose Level VI|Withdrawal by Subject|0|||
49145256|NCT02533674|158371797|FG003|Dose Level VI|Withdrawal by Subject|0|||
49145257|NCT02533674|158371798|FG004|Dose Level VI|Withdrawal by Subject|0|||
49145258|NCT02533674|158371799|FG005|Dose Level VI|Withdrawal by Subject|1|||
49145259|NCT02533674|158371800|FG006|Dose Level VI|Withdrawal by Subject|0|||
49145260|NCT02533674|158371801|FG007|Dose Level VI|Withdrawal by Subject|0|||
49145261|NCT02533674|158371794|FG000|Dose Level VI|Treatment-related AE|0|||
49145262|NCT02533674|158371795|FG001|Dose Level VI|Treatment-related AE|0|||
49145263|NCT02533674|158371796|FG002|Dose Level VI|Treatment-related AE|0|||
49145264|NCT02533674|158371797|FG003|Dose Level VI|Treatment-related AE|0|||
49145265|NCT02533674|158371798|FG004|Dose Level VI|Treatment-related AE|0|||
49145266|NCT02533674|158371799|FG005|Dose Level VI|Treatment-related AE|1|||
49145267|NCT02533674|158371800|FG006|Dose Level VI|Treatment-related AE|0|||
49145268|NCT02533674|158371801|FG007|Dose Level VI|Treatment-related AE|0|||
49145269|NCT02533674|158371794|FG000|Dose Level VII|Progressive disease|0|||
49145270|NCT02533674|158371795|FG001|Dose Level VII|Progressive disease|0|||
49145271|NCT02533674|158371796|FG002|Dose Level VII|Progressive disease|0|||
49145272|NCT02533674|158371797|FG003|Dose Level VII|Progressive disease|0|||
49145273|NCT02533674|158371798|FG004|Dose Level VII|Progressive disease|0|||
49145274|NCT02533674|158371799|FG005|Dose Level VII|Progressive disease|0|||
49145275|NCT02533674|158371800|FG006|Dose Level VII|Progressive disease|10|||
49145276|NCT02533674|158371801|FG007|Dose Level VII|Progressive disease|0|||
49145277|NCT02533674|158371794|FG000|Dose Level VII|Withdrawal by Subject|0|||
49145278|NCT02533674|158371795|FG001|Dose Level VII|Withdrawal by Subject|0|||
49145279|NCT02533674|158371796|FG002|Dose Level VII|Withdrawal by Subject|0|||
49145280|NCT02533674|158371797|FG003|Dose Level VII|Withdrawal by Subject|0|||
49145281|NCT02533674|158371798|FG004|Dose Level VII|Withdrawal by Subject|0|||
49145282|NCT02533674|158371799|FG005|Dose Level VII|Withdrawal by Subject|0|||
49145283|NCT02533674|158371800|FG006|Dose Level VII|Withdrawal by Subject|3|||
49145284|NCT02533674|158371801|FG007|Dose Level VII|Withdrawal by Subject|0|||
49145285|NCT02533674|158371794|FG000|Dose Level VII|Treatment-related AE|0|||
49145286|NCT02533674|158371795|FG001|Dose Level VII|Treatment-related AE|0|||
49145287|NCT02533674|158371796|FG002|Dose Level VII|Treatment-related AE|0|||
49145288|NCT02533674|158371797|FG003|Dose Level VII|Treatment-related AE|0|||
49145289|NCT02533674|158371798|FG004|Dose Level VII|Treatment-related AE|0|||
49145290|NCT02533674|158371799|FG005|Dose Level VII|Treatment-related AE|0|||
49145291|NCT02533674|158371800|FG006|Dose Level VII|Treatment-related AE|1|||
49145292|NCT02533674|158371801|FG007|Dose Level VII|Treatment-related AE|0|||
49145293|NCT02533674|158371794|FG000|Dose Level VII|Death|0|||
49145294|NCT02533674|158371795|FG001|Dose Level VII|Death|0|||
49145295|NCT02533674|158371796|FG002|Dose Level VII|Death|0|||
49145296|NCT02533674|158371797|FG003|Dose Level VII|Death|0|||
49145297|NCT02533674|158371798|FG004|Dose Level VII|Death|0|||
49145298|NCT02533674|158371799|FG005|Dose Level VII|Death|0|||
49145299|NCT02533674|158371800|FG006|Dose Level VII|Death|2|||
49145300|NCT02533674|158371801|FG007|Dose Level VII|Death|0|||
49145301|NCT02533674|158371794|FG000|Dose Level VIII|Progressive disease|0|||
49145302|NCT02533674|158371795|FG001|Dose Level VIII|Progressive disease|0|||
49145303|NCT02533674|158371796|FG002|Dose Level VIII|Progressive disease|0|||
49145304|NCT02533674|158371797|FG003|Dose Level VIII|Progressive disease|0|||
49145305|NCT02533674|158371798|FG004|Dose Level VIII|Progressive disease|0|||
49145306|NCT02533674|158371799|FG005|Dose Level VIII|Progressive disease|0|||
49145307|NCT02533674|158371800|FG006|Dose Level VIII|Progressive disease|0|||
49145308|NCT02533674|158371801|FG007|Dose Level VIII|Progressive disease|3|||
49013409|NCT00410410|157885208|FG000|Open-Label Period (OL)|Adverse Event|0|||
49013410|NCT00410410|157885209|FG001|Open-Label Period (OL)|Adverse Event|0|||
49013411|NCT00410410|157885210|FG002|Open-Label Period (OL)|Adverse Event|0|||
49013412|NCT00410410|157885211|FG003|Open-Label Period (OL)|Adverse Event|0|||
49013413|NCT00410410|157885212|FG004|Open-Label Period (OL)|Adverse Event|0|||
49013414|NCT00410410|157885213|FG005|Open-Label Period (OL)|Adverse Event|0|||
49013415|NCT00410410|157885214|FG006|Open-Label Period (OL)|Adverse Event|0|||
49013416|NCT00410410|157885215|FG007|Open-Label Period (OL)|Adverse Event|0|||
49013417|NCT00410410|157885216|FG008|Open-Label Period (OL)|Adverse Event|10|||
49013418|NCT00410410|157885208|FG000|Open-Label Period (OL)|Lack of Efficacy|0|||
49013419|NCT00410410|157885209|FG001|Open-Label Period (OL)|Lack of Efficacy|0|||
49013420|NCT00410410|157885210|FG002|Open-Label Period (OL)|Lack of Efficacy|0|||
49013421|NCT00410410|157885211|FG003|Open-Label Period (OL)|Lack of Efficacy|0|||
49013422|NCT00410410|157885212|FG004|Open-Label Period (OL)|Lack of Efficacy|0|||
49013423|NCT00410410|157885213|FG005|Open-Label Period (OL)|Lack of Efficacy|0|||
49013424|NCT00410410|157885214|FG006|Open-Label Period (OL)|Lack of Efficacy|0|||
49013425|NCT00410410|157885215|FG007|Open-Label Period (OL)|Lack of Efficacy|0|||
49013426|NCT00410410|157885216|FG008|Open-Label Period (OL)|Lack of Efficacy|161|||
49013427|NCT00410410|157885208|FG000|Open-Label Period (OL)|Lost to Follow-up|0|||
49013428|NCT00410410|157885209|FG001|Open-Label Period (OL)|Lost to Follow-up|0|||
49013429|NCT00410410|157885210|FG002|Open-Label Period (OL)|Lost to Follow-up|0|||
49013430|NCT00410410|157885211|FG003|Open-Label Period (OL)|Lost to Follow-up|0|||
49013431|NCT00410410|157885212|FG004|Open-Label Period (OL)|Lost to Follow-up|0|||
49013432|NCT00410410|157885213|FG005|Open-Label Period (OL)|Lost to Follow-up|0|||
48730658|NCT04963231|156865864|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
49145309|NCT02533674|158371794|FG000|Dose Level VIII|Withdrawal by Subject|0|||
49145310|NCT02533674|158371795|FG001|Dose Level VIII|Withdrawal by Subject|0|||
49145311|NCT02533674|158371796|FG002|Dose Level VIII|Withdrawal by Subject|0|||
49145312|NCT02533674|158371797|FG003|Dose Level VIII|Withdrawal by Subject|0|||
49145313|NCT02533674|158371798|FG004|Dose Level VIII|Withdrawal by Subject|0|||
48730659|NCT04963231|156865865|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
48730660|NCT04963231|156865863|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|16|||
49013433|NCT00410410|157885214|FG006|Open-Label Period (OL)|Lost to Follow-up|0|||
49145314|NCT02533674|158371799|FG005|Dose Level VIII|Withdrawal by Subject|0|||
48823141|NCT04541186|157192320|FG004|Main Study|COVID-19-related Dose Interruption|1|||
49111649|NCT03170609|158244486|FG003|Overall Study|Death|0|||
48823142|NCT04541186|157192316|FG000|Main Study|Randomized in Error Not Treated|0|||
48823143|NCT04541186|157192317|FG001|Main Study|Randomized in Error Not Treated|0|||
48823144|NCT04541186|157192318|FG002|Main Study|Randomized in Error Not Treated|1|||
48823145|NCT04541186|157192319|FG003|Main Study|Randomized in Error Not Treated|0|||
48823146|NCT04541186|157192320|FG004|Main Study|Randomized in Error Not Treated|0|||
48823147|NCT04541186|157192316|FG000|Fibrate Expansion Study|Other than Specified|0|||
48823148|NCT04541186|157192317|FG001|Fibrate Expansion Study|Other than Specified|0|||
48823149|NCT04541186|157192318|FG002|Fibrate Expansion Study|Other than Specified|0|||
48823150|NCT04541186|157192319|FG003|Fibrate Expansion Study|Other than Specified|0|||
49111650|NCT03170609|158244487|FG004|Overall Study|Death|0|||
49111651|NCT03170609|158244488|FG005|Overall Study|Death|0|||
49111652|NCT03170609|158244489|FG006|Overall Study|Death|0|||
49111653|NCT03170609|158244483|FG000|Overall Study|Withdrawal by Subject|1|||
49111654|NCT03170609|158244484|FG001|Overall Study|Withdrawal by Subject|2|||
49111655|NCT03170609|158244485|FG002|Overall Study|Withdrawal by Subject|0|||
49111656|NCT03170609|158244486|FG003|Overall Study|Withdrawal by Subject|0|||
49111657|NCT03170609|158244487|FG004|Overall Study|Withdrawal by Subject|0|||
49111658|NCT03170609|158244488|FG005|Overall Study|Withdrawal by Subject|0|||
49111659|NCT03170609|158244489|FG006|Overall Study|Withdrawal by Subject|1|||
49111660|NCT03170609|158244483|FG000|Overall Study|Lost to Follow-up|1|||
49111661|NCT03170609|158244484|FG001|Overall Study|Lost to Follow-up|0|||
49111662|NCT03170609|158244485|FG002|Overall Study|Lost to Follow-up|5|||
49111663|NCT03170609|158244486|FG003|Overall Study|Lost to Follow-up|2|||
49111664|NCT03170609|158244487|FG004|Overall Study|Lost to Follow-up|1|||
49111665|NCT03170609|158244488|FG005|Overall Study|Lost to Follow-up|1|||
49111666|NCT03170609|158244489|FG006|Overall Study|Lost to Follow-up|0|||
49111667|NCT03170609|158244483|FG000|Overall Study|Other|1|||
49111668|NCT03170609|158244484|FG001|Overall Study|Other|0|||
49111669|NCT03170609|158244485|FG002|Overall Study|Other|0|||
49111670|NCT03170609|158244486|FG003|Overall Study|Other|0|||
49111671|NCT03170609|158244487|FG004|Overall Study|Other|0|||
49111672|NCT03170609|158244488|FG005|Overall Study|Other|1|||
49111673|NCT03170609|158244489|FG006|Overall Study|Other|0|||
49111674|NCT03124537|158244492|FG000|Overall Study|Lost to Follow-up|3|||
49111675|NCT03124537|158244493|FG001|Overall Study|Lost to Follow-up|5|||
49111676|NCT03124537|158244492|FG000|Overall Study|App Crash, Incomplete Data|7|||
49111677|NCT03124537|158244493|FG001|Overall Study|App Crash, Incomplete Data|8|||
49111678|NCT01593254|158244494|FG000|Overall Study|Disease progression|2|||
49111679|NCT01593254|158244495|FG001|Overall Study|Disease progression|7|||
49111680|NCT01593254|158244494|FG000|Overall Study|Study drug toxicity|6|||
49111681|NCT01593254|158244495|FG001|Overall Study|Study drug toxicity|20|||
49111682|NCT01593254|158244494|FG000|Overall Study|Death|3|||
49111683|NCT01593254|158244495|FG001|Overall Study|Death|3|||
49111684|NCT01593254|158244494|FG000|Overall Study|AE unrelated to study drug|0|||
49111685|NCT01593254|158244495|FG001|Overall Study|AE unrelated to study drug|1|||
49111686|NCT01593254|158244494|FG000|Overall Study|participant request to discontinue study treatment|1|||
49111687|NCT01593254|158244495|FG001|Overall Study|participant request to discontinue study treatment|3|||
49111688|NCT01593254|158244494|FG000|Overall Study|participant withdrew consent|0|||
49111689|NCT01593254|158244495|FG001|Overall Study|participant withdrew consent|9|||
49111690|NCT01593254|158244494|FG000|Overall Study|lost to follow up|1|||
49111691|NCT01593254|158244495|FG001|Overall Study|lost to follow up|6|||
49111692|NCT01593254|158244494|FG000|Overall Study|maximum clinical benefit|1|||
49111693|NCT01593254|158244495|FG001|Overall Study|maximum clinical benefit|2|||
49111694|NCT01593254|158244494|FG000|Overall Study|Poor/non compliance|1|||
49111695|NCT01593254|158244495|FG001|Overall Study|Poor/non compliance|1|||
49111696|NCT01593254|158244494|FG000|Overall Study|Pregnancy|0|||
49111697|NCT01593254|158244495|FG001|Overall Study|Pregnancy|3|||
49111698|NCT01593254|158244494|FG000|Overall Study|participant no longer meets study criteria|1|||
49111699|NCT01593254|158244495|FG001|Overall Study|participant no longer meets study criteria|1|||
49111700|NCT01593254|158244494|FG000|Overall Study|Admin reason by sponsor|7|||
49111701|NCT01593254|158244495|FG001|Overall Study|Admin reason by sponsor|3|||
49111702|NCT01593254|158244494|FG000|Overall Study|Imatinib treatment failure|2|||
49111703|NCT01593254|158244495|FG001|Overall Study|Imatinib treatment failure|0|||
49111704|NCT01593254|158244494|FG000|Overall Study|Other Reasons|61|||
49111705|NCT01593254|158244495|FG001|Overall Study|Other Reasons|115|||
49111706|NCT01868165|158244501|FG000|Overall Study|Withdrawal by Subject|36|||
49111707|NCT01868165|158244501|FG000|Overall Study|Physician Decision|2|||
49111708|NCT01868165|158244501|FG000|Overall Study|Lost to Follow-up|3|||
49111709|NCT01868165|158244501|FG000|Overall Study|Death|4|||
49111710|NCT03420222|158244502|FG000|Overall Study|Withdrawal by Subject|5|||
49111711|NCT03420222|158244503|FG001|Overall Study|Withdrawal by Subject|0|||
49111712|NCT03420222|158244502|FG000|Overall Study|Physician Decision|0|||
49111713|NCT03420222|158244503|FG001|Overall Study|Physician Decision|1|||
49145315|NCT02533674|158371800|FG006|Dose Level VIII|Withdrawal by Subject|0|||
49145316|NCT02533674|158371801|FG007|Dose Level VIII|Withdrawal by Subject|1|||
49145317|NCT02533674|158371794|FG000|Dose Level VIII|Treatment-related AE|0|||
49145318|NCT02533674|158371795|FG001|Dose Level VIII|Treatment-related AE|0|||
49145319|NCT02533674|158371796|FG002|Dose Level VIII|Treatment-related AE|0|||
49145320|NCT02533674|158371797|FG003|Dose Level VIII|Treatment-related AE|0|||
49145321|NCT02533674|158371798|FG004|Dose Level VIII|Treatment-related AE|0|||
49145322|NCT02533674|158371799|FG005|Dose Level VIII|Treatment-related AE|0|||
49145323|NCT02533674|158371800|FG006|Dose Level VIII|Treatment-related AE|0|||
49145324|NCT02533674|158371801|FG007|Dose Level VIII|Treatment-related AE|1|||
49145325|NCT02533674|158371794|FG000|Dose Level VIII|Never treated|0|||
49145326|NCT02533674|158371795|FG001|Dose Level VIII|Never treated|0|||
49145327|NCT02533674|158371796|FG002|Dose Level VIII|Never treated|0|||
49145328|NCT02533674|158371797|FG003|Dose Level VIII|Never treated|0|||
49145329|NCT02533674|158371798|FG004|Dose Level VIII|Never treated|0|||
49145330|NCT02533674|158371799|FG005|Dose Level VIII|Never treated|0|||
49145331|NCT02533674|158371800|FG006|Dose Level VIII|Never treated|0|||
49145332|NCT02533674|158371801|FG007|Dose Level VIII|Never treated|1|||
49145333|NCT04432298|158371806|FG000|Overall Study|Other than specified|1|||
49145334|NCT04432298|158371807|FG001|Overall Study|Other than specified|0|||
49145335|NCT04432298|158371806|FG000|Overall Study|Lost to Follow-up|0|||
49145336|NCT04432298|158371807|FG001|Overall Study|Lost to Follow-up|1|||
49145337|NCT04432298|158371806|FG000|Overall Study|Death|3|||
49145338|NCT04432298|158371807|FG001|Overall Study|Death|2|||
49145339|NCT04432298|158371806|FG000|Overall Study|Withdrawal by Subject|2|||
49145340|NCT04432298|158371807|FG001|Overall Study|Withdrawal by Subject|0|||
49145341|NCT01336972|158371810|FG000|Overall Study|Adverse Event|1|||
49145342|NCT01336972|158371811|FG001|Overall Study|Adverse Event|1|||
49145343|NCT01336972|158371812|FG002|Overall Study|Adverse Event|0|||
49145344|NCT01716559|158371813|FG000|Overall Study|Adverse Event|11|||
49145345|NCT01716559|158371813|FG000|Overall Study|Death|21|||
49145346|NCT01716559|158371813|FG000|Overall Study|Withdrawal by Subject|4|||
49145347|NCT01716559|158371813|FG000|Overall Study|Other withdrawal reason|75|||
49145348|NCT00617903|158371824|FG000|Overall Study|Withdrawal by Subject|2|||
48730661|NCT04963231|156865864|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
48730662|NCT04963231|156865865|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
48730663|NCT04963231|156865863|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|2|||
48730664|NCT04963231|156865864|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
48730665|NCT04963231|156865865|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
48730666|NCT04963231|156865863|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
48730667|NCT04963231|156865864|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
48730668|NCT04963231|156865865|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|1|||
48730669|NCT04963231|156865863|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|0|||
48730670|NCT04963231|156865864|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
48730671|NCT04963231|156865865|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
48730672|NCT04963231|156865863|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|0|||
48921407|NCT00763815|157546376|FG000|Overall Study|Withdrawal by Subject|7|||
48921408|NCT00763815|157546377|FG001|Overall Study|Withdrawal by Subject|12|||
48921409|NCT00763815|157546376|FG000|Overall Study|Protocol Violation|2|||
48921410|NCT00763815|157546377|FG001|Overall Study|Protocol Violation|5|||
48921411|NCT00763815|157546376|FG000|Overall Study|Sponsor's Decision|0|||
48921412|NCT00763815|157546377|FG001|Overall Study|Sponsor's Decision|1|||
48921413|NCT03699007|157546378|FG000|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|7|||
48921414|NCT03699007|157546379|FG001|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|2|||
48921415|NCT03699007|157546378|FG000|6-month Follow Up|Lost to Follow-up|2|||
48921416|NCT03699007|157546379|FG001|6-month Follow Up|Lost to Follow-up|3|||
48921417|NCT00414453|157546380|FG000|Overall Study|Abnormal lab work|16|||
48921418|NCT01895322|157546385|FG000|Overall Study|Adverse Event|1|||
48921419|NCT01895322|157546385|FG000|Overall Study|Withdrawal by Subject|2|||
48921420|NCT01895322|157546385|FG000|Overall Study|Protocol Violation|10|||
48921421|NCT00978029|157546386|FG000|Overall Study|Adverse Event|1|||
48921422|NCT00978029|157546387|FG001|Overall Study|Adverse Event|2|||
48921423|NCT00978029|157546388|FG002|Overall Study|Adverse Event|5|||
48921424|NCT00978029|157546386|FG000|Overall Study|Withdrawal by Subject|0|||
48921425|NCT00978029|157546387|FG001|Overall Study|Withdrawal by Subject|0|||
48921426|NCT00978029|157546388|FG002|Overall Study|Withdrawal by Subject|1|||
48921427|NCT00978029|157546386|FG000|Overall Study|Protocol Violation|0|||
48921428|NCT00978029|157546387|FG001|Overall Study|Protocol Violation|1|||
48921429|NCT00978029|157546388|FG002|Overall Study|Protocol Violation|0|||
48921430|NCT02863809|157546389|FG000|Overall Study|Adverse Event|8|||
48921431|NCT02863809|157546390|FG001|Overall Study|Adverse Event|8|||
48921432|NCT02863809|157546389|FG000|Overall Study|Withdrawal by Subject|0|||
48921433|NCT02863809|157546390|FG001|Overall Study|Withdrawal by Subject|1|||
49145349|NCT00617903|158371825|FG001|Overall Study|Withdrawal by Subject|3|||
49145350|NCT00617903|158371824|FG000|Overall Study|Lost to Follow-up|1|||
49013434|NCT00410410|157885215|FG007|Open-Label Period (OL)|Lost to Follow-up|0|||
49013435|NCT00410410|157885216|FG008|Open-Label Period (OL)|Lost to Follow-up|4|||
49013436|NCT00410410|157885208|FG000|Open-Label Period (OL)|Withdrawal by Subject|0|||
49013437|NCT00410410|157885209|FG001|Open-Label Period (OL)|Withdrawal by Subject|0|||
49013438|NCT00410410|157885210|FG002|Open-Label Period (OL)|Withdrawal by Subject|0|||
49013439|NCT00410410|157885211|FG003|Open-Label Period (OL)|Withdrawal by Subject|0|||
49013440|NCT00410410|157885212|FG004|Open-Label Period (OL)|Withdrawal by Subject|0|||
49013441|NCT00410410|157885213|FG005|Open-Label Period (OL)|Withdrawal by Subject|0|||
49013442|NCT00410410|157885214|FG006|Open-Label Period (OL)|Withdrawal by Subject|0|||
49013443|NCT00410410|157885215|FG007|Open-Label Period (OL)|Withdrawal by Subject|0|||
49013444|NCT00410410|157885216|FG008|Open-Label Period (OL)|Withdrawal by Subject|20|||
49013445|NCT00410410|157885208|FG000|Open-Label Period (OL)|Pregnancy|0|||
49013446|NCT00410410|157885209|FG001|Open-Label Period (OL)|Pregnancy|0|||
49013447|NCT00410410|157885210|FG002|Open-Label Period (OL)|Pregnancy|0|||
49013448|NCT00410410|157885211|FG003|Open-Label Period (OL)|Pregnancy|0|||
49013449|NCT00410410|157885212|FG004|Open-Label Period (OL)|Pregnancy|0|||
49013450|NCT00410410|157885213|FG005|Open-Label Period (OL)|Pregnancy|0|||
49013451|NCT00410410|157885214|FG006|Open-Label Period (OL)|Pregnancy|0|||
49013452|NCT00410410|157885215|FG007|Open-Label Period (OL)|Pregnancy|0|||
49013453|NCT00410410|157885216|FG008|Open-Label Period (OL)|Pregnancy|1|||
49013454|NCT00410410|157885208|FG000|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
49013455|NCT00410410|157885209|FG001|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
49013456|NCT00410410|157885210|FG002|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
49013457|NCT00410410|157885211|FG003|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
49013458|NCT00410410|157885212|FG004|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
49013459|NCT00410410|157885213|FG005|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
49013460|NCT00410410|157885214|FG006|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
49013461|NCT00410410|157885215|FG007|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
49013462|NCT00410410|157885216|FG008|Open-Label Period (OL)|Administrative Reason By Sponsor|145|||
49013463|NCT00410410|157885208|FG000|Open-Label Period (OL)|Other|0|||
49013464|NCT00410410|157885209|FG001|Open-Label Period (OL)|Other|0|||
49013465|NCT00410410|157885210|FG002|Open-Label Period (OL)|Other|0|||
49013466|NCT00410410|157885211|FG003|Open-Label Period (OL)|Other|0|||
49013467|NCT00410410|157885212|FG004|Open-Label Period (OL)|Other|0|||
49013468|NCT00410410|157885213|FG005|Open-Label Period (OL)|Other|0|||
49013469|NCT00410410|157885214|FG006|Open-Label Period (OL)|Other|0|||
49013470|NCT00410410|157885215|FG007|Open-Label Period (OL)|Other|0|||
49013471|NCT00410410|157885216|FG008|Open-Label Period (OL)|Other|7|||
49013472|NCT01783496|157885217|FG000|Overall Study|Lost to Follow-up|0|||
49013473|NCT01783496|157885218|FG001|Overall Study|Lost to Follow-up|0|||
49013474|NCT01783496|157885219|FG002|Overall Study|Lost to Follow-up|0|||
49013475|NCT01783496|157885220|FG003|Overall Study|Lost to Follow-up|2|||
49013476|NCT01783496|157885221|FG004|Overall Study|Lost to Follow-up|0|||
49013477|NCT01783496|157885222|FG005|Overall Study|Lost to Follow-up|1|||
49013478|NCT01783496|157885217|FG000|Overall Study|Withdrawal by Subject|1|||
49013479|NCT01783496|157885218|FG001|Overall Study|Withdrawal by Subject|0|||
49013480|NCT01783496|157885219|FG002|Overall Study|Withdrawal by Subject|0|||
49013481|NCT01783496|157885220|FG003|Overall Study|Withdrawal by Subject|0|||
49013482|NCT01783496|157885221|FG004|Overall Study|Withdrawal by Subject|0|||
49013483|NCT01783496|157885222|FG005|Overall Study|Withdrawal by Subject|0|||
49013484|NCT01789281|157885223|FG000|Overall Study|Disease progression|15|||
49013485|NCT01789281|157885224|FG001|Overall Study|Disease progression|4|||
49013486|NCT01789281|157885223|FG000|Overall Study|Adverse Event|5|||
49013487|NCT01789281|157885224|FG001|Overall Study|Adverse Event|5|||
49013488|NCT01789281|157885223|FG000|Overall Study|Withdrawal by Subject|1|||
49013489|NCT01789281|157885224|FG001|Overall Study|Withdrawal by Subject|0|||
49013490|NCT01789281|157885223|FG000|Overall Study|Lost to Follow-up|1|||
49013491|NCT01789281|157885224|FG001|Overall Study|Lost to Follow-up|0|||
49013492|NCT01789281|157885223|FG000|Overall Study|Administrative problems|0|||
49013493|NCT01789281|157885224|FG001|Overall Study|Administrative problems|1|||
49013494|NCT00106028|157885229|FG000|Overall Study|Adverse Event|3|||
49013495|NCT00106028|157885230|FG001|Overall Study|Adverse Event|2|||
49013496|NCT00106028|157885229|FG000|Overall Study|Protocol Violation|1|||
49013497|NCT00106028|157885230|FG001|Overall Study|Protocol Violation|1|||
49013498|NCT00106028|157885229|FG000|Overall Study|Withdrawal by Subject|2|||
49013499|NCT00106028|157885230|FG001|Overall Study|Withdrawal by Subject|8|||
49013500|NCT00106028|157885229|FG000|Overall Study|Lost to Follow-up|0|||
49013501|NCT00106028|157885230|FG001|Overall Study|Lost to Follow-up|1|||
49013502|NCT00686920|157885231|FG000|Overall Study|Death|45|||
49013503|NCT00686920|157885232|FG001|Overall Study|Death|14|||
49013504|NCT00686920|157885231|FG000|Overall Study|Liver Transplant|23|||
49013505|NCT00686920|157885232|FG001|Overall Study|Liver Transplant|8|||
49013506|NCT00686920|157885231|FG000|Overall Study|Recurrent Hepatic Encephalopathy Episode|1|||
49013507|NCT00686920|157885232|FG001|Overall Study|Recurrent Hepatic Encephalopathy Episode|2|||
49013508|NCT00686920|157885231|FG000|Overall Study|Withdrawal by Subject|23|||
49013509|NCT00686920|157885232|FG001|Overall Study|Withdrawal by Subject|5|||
49145351|NCT00617903|158371825|FG001|Overall Study|Lost to Follow-up|1|||
49145352|NCT00617903|158371824|FG000|Overall Study|Lack of Efficacy|0|||
49145353|NCT00617903|158371825|FG001|Overall Study|Lack of Efficacy|1|||
49145354|NCT00617903|158371824|FG000|Overall Study|Adverse Event|0|||
49145355|NCT00617903|158371825|FG001|Overall Study|Adverse Event|1|||
49145356|NCT00617903|158371824|FG000|Overall Study|noncompliance|0|||
49145357|NCT00617903|158371825|FG001|Overall Study|noncompliance|1|||
49145358|NCT00414609|158371826|FG000|Core Study|Adverse Event|9|||
49145359|NCT00414609|158371827|FG001|Core Study|Adverse Event|11|||
49145360|NCT00414609|158371828|FG002|Core Study|Adverse Event|0|||
49145361|NCT00414609|158371826|FG000|Core Study|Abnormal laboratory values|0|||
49145362|NCT00414609|158371827|FG001|Core Study|Abnormal laboratory values|1|||
49145363|NCT00414609|158371828|FG002|Core Study|Abnormal laboratory values|0|||
48730673|NCT04963231|156865864|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|1|||
48730674|NCT04963231|156865865|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|4|||
49145364|NCT00414609|158371826|FG000|Core Study|Abnormal test procedure results|1|||
49145365|NCT00414609|158371827|FG001|Core Study|Abnormal test procedure results|1|||
49013510|NCT00686920|157885231|FG000|Overall Study|Protocol Violation|2|||
49013511|NCT00686920|157885232|FG001|Overall Study|Protocol Violation|1|||
49013512|NCT00686920|157885231|FG000|Overall Study|Adverse Event|10|||
49013513|NCT00686920|157885232|FG001|Overall Study|Adverse Event|2|||
49013514|NCT00686920|157885231|FG000|Overall Study|Personal Reason|0|||
49013515|NCT00686920|157885232|FG001|Overall Study|Personal Reason|1|||
49013516|NCT00686920|157885231|FG000|Overall Study|Lost to Follow-up|15|||
48730675|NCT03315754|156865866|FG000|Overall Study|COVID-19 complications leading to death|1|||
48730676|NCT03315754|156865866|FG000|Overall Study|insurance coverage issue|1|||
48730677|NCT04612790|156865867|FG000|DB Period (Up to 36 Weeks)|Death|1|||
48730678|NCT04612790|156865868|FG001|DB Period (Up to 36 Weeks)|Death|1|||
48730679|NCT04612790|156865869|FG002|DB Period (Up to 36 Weeks)|Death|0|||
49145366|NCT00414609|158371828|FG002|Core Study|Abnormal test procedure results|0|||
49013517|NCT00686920|157885232|FG001|Overall Study|Lost to Follow-up|3|||
49013518|NCT00686920|157885231|FG000|Overall Study|Moved to Another State|1|||
49013519|NCT00686920|157885232|FG001|Overall Study|Moved to Another State|0|||
49013520|NCT00686920|157885231|FG000|Overall Study|Transferred to Nursing Home|1|||
49013521|NCT00686920|157885232|FG001|Overall Study|Transferred to Nursing Home|0|||
49013522|NCT00686920|157885231|FG000|Overall Study|Noncompliance|9|||
49013523|NCT00686920|157885232|FG001|Overall Study|Noncompliance|0|||
49013524|NCT00686920|157885231|FG000|Overall Study|Principal Investigator Decision|2|||
49013525|NCT00686920|157885232|FG001|Overall Study|Principal Investigator Decision|0|||
49013526|NCT01280981|157885235|FG000|Overall Study|Withdrawal by Subject|11|||
49013527|NCT01280981|157885235|FG000|Overall Study|Protocol Violation|2|||
49013528|NCT01280981|157885235|FG000|Overall Study|Lack of Efficacy|13|||
49145367|NCT00414609|158371826|FG000|Core Study|Protocol deviation|0|||
49145368|NCT00414609|158371827|FG001|Core Study|Protocol deviation|1|||
49145369|NCT00414609|158371828|FG002|Core Study|Protocol deviation|0|||
49145370|NCT00414609|158371826|FG000|Core Study|Patient withdrew consent|10|||
49145371|NCT00414609|158371827|FG001|Core Study|Patient withdrew consent|11|||
49145372|NCT00414609|158371828|FG002|Core Study|Patient withdrew consent|0|||
49013529|NCT01280981|157885235|FG000|Overall Study|Lost to Follow-up|3|||
49013530|NCT01280981|157885235|FG000|Overall Study|Adverse Event|6|||
49145373|NCT00414609|158371826|FG000|Core Study|Lost to Follow-up|7|||
49145374|NCT00414609|158371827|FG001|Core Study|Lost to Follow-up|4|||
49145375|NCT00414609|158371828|FG002|Core Study|Lost to Follow-up|0|||
49145376|NCT00414609|158371826|FG000|Core Study|Administrative problems|0|||
48730680|NCT04612790|156865870|FG003|DB Period (Up to 36 Weeks)|Death|0|||
48730681|NCT04612790|156865867|FG000|DB Period (Up to 36 Weeks)|Adverse Event|2|||
48730682|NCT04612790|156865868|FG001|DB Period (Up to 36 Weeks)|Adverse Event|0|||
48730683|NCT04612790|156865869|FG002|DB Period (Up to 36 Weeks)|Adverse Event|0|||
48730684|NCT04612790|156865870|FG003|DB Period (Up to 36 Weeks)|Adverse Event|0|||
48730685|NCT04612790|156865867|FG000|DB Period (Up to 36 Weeks)|Study terminated by sponsor|8|||
48730686|NCT04612790|156865868|FG001|DB Period (Up to 36 Weeks)|Study terminated by sponsor|6|||
48730687|NCT04612790|156865869|FG002|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
48730688|NCT04612790|156865870|FG003|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
48730689|NCT04612790|156865867|FG000|DB Period (Up to 36 Weeks)|Withdrawal by Subject|2|||
48730690|NCT04612790|156865868|FG001|DB Period (Up to 36 Weeks)|Withdrawal by Subject|4|||
48730691|NCT04612790|156865869|FG002|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
48730692|NCT04612790|156865870|FG003|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
48730693|NCT04612790|156865867|FG000|DB Period (Up to 36 Weeks)|Physician Decision|4|||
48730694|NCT04612790|156865868|FG001|DB Period (Up to 36 Weeks)|Physician Decision|3|||
48730695|NCT04612790|156865869|FG002|DB Period (Up to 36 Weeks)|Physician Decision|0|||
48730696|NCT04612790|156865870|FG003|DB Period (Up to 36 Weeks)|Physician Decision|0|||
48730697|NCT04612790|156865867|FG000|DB Period (Up to 36 Weeks)|Other|1|||
48730698|NCT04612790|156865868|FG001|DB Period (Up to 36 Weeks)|Other|0|||
48730699|NCT04612790|156865869|FG002|DB Period (Up to 36 Weeks)|Other|0|||
48730700|NCT04612790|156865870|FG003|DB Period (Up to 36 Weeks)|Other|0|||
49145377|NCT00414609|158371827|FG001|Core Study|Administrative problems|2|||
49145378|NCT00414609|158371828|FG002|Core Study|Administrative problems|0|||
49145379|NCT00414609|158371826|FG000|Core Study|Death|7|||
49145380|NCT00414609|158371827|FG001|Core Study|Death|14|||
49145381|NCT00414609|158371828|FG002|Core Study|Death|0|||
49145382|NCT00414609|158371826|FG000|Extension Study|Adverse Event|0|||
49145383|NCT00414609|158371827|FG001|Extension Study|Adverse Event|0|||
49145384|NCT00414609|158371828|FG002|Extension Study|Adverse Event|14|||
49145385|NCT00414609|158371826|FG000|Extension Study|Unsatisfactory therapeutic effect|0|||
49145386|NCT00414609|158371827|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
49145387|NCT00414609|158371828|FG002|Extension Study|Unsatisfactory therapeutic effect|2|||
49145388|NCT00414609|158371826|FG000|Extension Study|Withdrawal by Subject|0|||
49145389|NCT00414609|158371827|FG001|Extension Study|Withdrawal by Subject|0|||
49145390|NCT00414609|158371828|FG002|Extension Study|Withdrawal by Subject|13|||
49145391|NCT00414609|158371826|FG000|Extension Study|Lost to Follow-up|0|||
49145392|NCT00414609|158371827|FG001|Extension Study|Lost to Follow-up|0|||
49145393|NCT00414609|158371828|FG002|Extension Study|Lost to Follow-up|10|||
49145394|NCT00414609|158371826|FG000|Extension Study|Administrative problems|0|||
49145395|NCT00414609|158371827|FG001|Extension Study|Administrative problems|0|||
49145396|NCT00414609|158371828|FG002|Extension Study|Administrative problems|1|||
49145397|NCT00414609|158371826|FG000|Extension Study|Death|0|||
49145398|NCT00414609|158371827|FG001|Extension Study|Death|0|||
49145399|NCT00414609|158371828|FG002|Extension Study|Death|17|||
49145400|NCT00576407|158371829|FG000|Overall Study|Death|7|||
49145401|NCT00576407|158371829|FG000|Overall Study|Physician Decision|1|||
49145402|NCT04641975|158371830|FG000|Overall Study|Protocol Violation|1|||
49145403|NCT04641975|158371831|FG001|Overall Study|Protocol Violation|2|||
49145404|NCT04641975|158371832|FG002|Overall Study|Protocol Violation|0|||
49145405|NCT04641975|158371833|FG003|Overall Study|Protocol Violation|0|||
49145406|NCT04641975|158371830|FG000|Overall Study|Adverse Event|0|||
49145407|NCT04641975|158371831|FG001|Overall Study|Adverse Event|0|||
49145408|NCT04641975|158371832|FG002|Overall Study|Adverse Event|1|||
49145409|NCT04641975|158371833|FG003|Overall Study|Adverse Event|1|||
49145410|NCT04641975|158371830|FG000|Overall Study|Withdrawal by Subject|1|||
49145411|NCT04641975|158371831|FG001|Overall Study|Withdrawal by Subject|0|||
49145412|NCT04641975|158371832|FG002|Overall Study|Withdrawal by Subject|0|||
49145413|NCT04641975|158371833|FG003|Overall Study|Withdrawal by Subject|0|||
49145414|NCT03142334|158371837|FG000|Overall Study|Death|18|||
49145415|NCT03142334|158371838|FG001|Overall Study|Death|33|||
49145416|NCT03142334|158371837|FG000|Overall Study|Withdrawal by Subject|15|||
49145417|NCT03142334|158371838|FG001|Overall Study|Withdrawal by Subject|11|||
49145418|NCT03142334|158371837|FG000|Overall Study|Ongoing on trial follow up|463|||
49145419|NCT03142334|158371838|FG001|Overall Study|Ongoing on trial follow up|454|||
49145420|NCT00191152|158371844|FG000|Initial Treatment|Adverse Event|43|||
49145421|NCT00191152|158371845|FG001|Initial Treatment|Adverse Event|67|||
49145422|NCT00191152|158371844|FG000|Initial Treatment|Physician Decision|40|||
49145423|NCT00191152|158371845|FG001|Initial Treatment|Physician Decision|31|||
49145424|NCT00191152|158371844|FG000|Initial Treatment|Withdrawal by Subject|40|||
49145425|NCT00191152|158371845|FG001|Initial Treatment|Withdrawal by Subject|28|||
49145426|NCT00191152|158371844|FG000|Initial Treatment|Lost to Follow-up|0|||
49145427|NCT00191152|158371845|FG001|Initial Treatment|Lost to Follow-up|6|||
49145428|NCT00191152|158371844|FG000|Initial Treatment|Other|18|||
49145429|NCT00191152|158371845|FG001|Initial Treatment|Other|21|||
49145430|NCT00191152|158371844|FG000|Crossover Treatment|Adverse Event|8|||
49145431|NCT00191152|158371845|FG001|Crossover Treatment|Adverse Event|8|||
49145432|NCT00191152|158371844|FG000|Crossover Treatment|Physician Decision|7|||
49145433|NCT00191152|158371845|FG001|Crossover Treatment|Physician Decision|7|||
49145434|NCT00191152|158371844|FG000|Crossover Treatment|Withdrawal by Subject|6|||
49145435|NCT00191152|158371845|FG001|Crossover Treatment|Withdrawal by Subject|9|||
49145436|NCT00191152|158371844|FG000|Crossover Treatment|Lost to Follow-up|2|||
49145437|NCT00191152|158371845|FG001|Crossover Treatment|Lost to Follow-up|1|||
49145438|NCT00191152|158371844|FG000|Crossover Treatment|Other|4|||
49145439|NCT00191152|158371845|FG001|Crossover Treatment|Other|3|||
49145440|NCT02739828|158371846|FG000|Overall Study|Adverse Event|1|||
49145441|NCT02739828|158371846|FG000|Overall Study|Lost to Follow-up|4|||
49145442|NCT03364686|158371847|FG000|Overall Study|Physician Decision|2|||
49145443|NCT01953354|158371848|FG000|Overall Study|Withdrawal by Subject|0|||
49145444|NCT01953354|158371849|FG001|Overall Study|Withdrawal by Subject|1|||
49145445|NCT01953354|158371848|FG000|Overall Study|Decision of Sponsor|0|||
49145446|NCT01953354|158371849|FG001|Overall Study|Decision of Sponsor|1|||
49145447|NCT01953354|158371848|FG000|Overall Study|Disease Exacerbation|1|||
48921434|NCT02863809|157546389|FG000|Overall Study|Lost to Follow-up|1|||
48921435|NCT02863809|157546390|FG001|Overall Study|Lost to Follow-up|1|||
48921436|NCT02863809|157546389|FG000|Overall Study|Death|1|||
48921437|NCT02863809|157546390|FG001|Overall Study|Death|0|||
48921438|NCT02970292|157546393|FG000|Overall Study|Physician Decision|1|||
49145448|NCT01953354|158371849|FG001|Overall Study|Disease Exacerbation|0|||
49145449|NCT01392495|158371850|FG000|Overall Study|Death|3|||
49145450|NCT01392495|158371850|FG000|Overall Study|Administrative problems|8|||
49145451|NCT01392495|158371850|FG000|Overall Study|Withdrawal by Subject|2|||
49145452|NCT01392495|158371850|FG000|Overall Study|Adverse Event|3|||
49145453|NCT01986751|158371851|FG000|Overall Study|improperly consented|10|||
49145454|NCT01986751|158371852|FG001|Overall Study|improperly consented|2|||
49145455|NCT00063999|158371853|FG000|Overall Study|Withdrawal by Subject|1|||
49145456|NCT00063999|158371854|FG001|Overall Study|Withdrawal by Subject|0|||
49145457|NCT00063999|158371853|FG000|Overall Study|Ineligible|44|||
49145458|NCT00063999|158371854|FG001|Overall Study|Ineligible|24|||
49145459|NCT01340170|158371856|FG000|Overall Study|Lost to Follow-up|2|||
49145460|NCT01340170|158371857|FG001|Overall Study|Lost to Follow-up|4|||
49145461|NCT01340170|158371858|FG002|Overall Study|Lost to Follow-up|0|||
49145462|NCT01340170|158371856|FG000|Overall Study|Implant failure|1|||
49145463|NCT01340170|158371857|FG001|Overall Study|Implant failure|3|||
49145464|NCT01340170|158371858|FG002|Overall Study|Implant failure|0|||
49145465|NCT02191397|158371859|FG000|Overall Study|Adverse Event|28|||
49145466|NCT02191397|158371860|FG001|Overall Study|Adverse Event|17|||
49145467|NCT02191397|158371859|FG000|Overall Study|Lack of Efficacy|10|||
49145468|NCT02191397|158371860|FG001|Overall Study|Lack of Efficacy|5|||
49145469|NCT02191397|158371859|FG000|Overall Study|Protocol Violation|0|||
48823151|NCT04541186|157192320|FG004|Fibrate Expansion Study|Other than Specified|1|||
48823152|NCT03836664|157192335|FG000|Overall Study|Didn't complete forms and lost drug|3|||
48823153|NCT03836664|157192336|FG001|Overall Study|Didn't complete forms and lost drug|3|||
48823154|NCT01427907|157192338|FG000|Overall Study|Withdrawal by Subject|3|||
48823155|NCT01427907|157192339|FG001|Overall Study|Withdrawal by Subject|4|||
48823156|NCT04011384|157192344|FG000|Overall Study|Withdrawal by Subject|2|||
48823157|NCT04011384|157192345|FG001|Overall Study|Withdrawal by Subject|0|||
48823158|NCT01686932|157192346|FG000|Period 1|Adverse Event|1|||
48823159|NCT01686932|157192347|FG001|Period 1|Adverse Event|1|||
48823160|NCT00463151|157192348|FG000|Overall Study|Adverse Event|0|||
49145470|NCT02191397|158371860|FG001|Overall Study|Protocol Violation|3|||
49145471|NCT02191397|158371859|FG000|Overall Study|Met protocol-defined stopping criteria|5|||
49145472|NCT02191397|158371860|FG001|Overall Study|Met protocol-defined stopping criteria|4|||
48823161|NCT00463151|157192349|FG001|Overall Study|Adverse Event|0|||
48823162|NCT00463151|157192350|FG002|Overall Study|Adverse Event|1|||
49145473|NCT02191397|158371859|FG000|Overall Study|Lost to Follow-up|10|||
49145474|NCT02191397|158371860|FG001|Overall Study|Lost to Follow-up|11|||
49145475|NCT02191397|158371859|FG000|Overall Study|Physician Decision|8|||
49145476|NCT02191397|158371860|FG001|Overall Study|Physician Decision|3|||
49145477|NCT02191397|158371859|FG000|Overall Study|Withdrawal by Subject|22|||
49145478|NCT02191397|158371860|FG001|Overall Study|Withdrawal by Subject|27|||
49145479|NCT02852005|158371863|FG000|Overall Study|Lost to Follow-up|0|||
49145480|NCT02852005|158371864|FG001|Overall Study|Lost to Follow-up|0|||
49145481|NCT02852005|158371865|FG002|Overall Study|Lost to Follow-up|0|||
49145482|NCT02852005|158371866|FG003|Overall Study|Lost to Follow-up|0|||
49145483|NCT02852005|158371867|FG004|Overall Study|Lost to Follow-up|1|||
49145484|NCT02852005|158371863|FG000|Overall Study|Withdrawal by Subject|1|||
49145485|NCT02852005|158371864|FG001|Overall Study|Withdrawal by Subject|0|||
49145486|NCT02852005|158371865|FG002|Overall Study|Withdrawal by Subject|0|||
49145487|NCT02852005|158371866|FG003|Overall Study|Withdrawal by Subject|0|||
49145488|NCT02852005|158371867|FG004|Overall Study|Withdrawal by Subject|0|||
49145489|NCT00545948|158371868|FG000|Overall Study|Not Treated|1|||
49145490|NCT00545948|158371869|FG001|Overall Study|Not Treated|1|||
49145491|NCT00545948|158371870|FG002|Overall Study|Not Treated|7|||
49145492|NCT03976375|158371873|FG000|Overall Study|Death|147|||
49145493|NCT03976375|158371874|FG001|Overall Study|Death|150|||
49145494|NCT03976375|158371875|FG002|Overall Study|Death|38|||
49145495|NCT03976375|158371873|FG000|Overall Study|Lost to Follow-up|1|||
49145496|NCT03976375|158371874|FG001|Overall Study|Lost to Follow-up|1|||
49145497|NCT03976375|158371875|FG002|Overall Study|Lost to Follow-up|1|||
49145498|NCT03976375|158371873|FG000|Overall Study|Withdrawal by Subject|4|||
49145499|NCT03976375|158371874|FG001|Overall Study|Withdrawal by Subject|9|||
49145500|NCT03976375|158371875|FG002|Overall Study|Withdrawal by Subject|4|||
49145501|NCT03976375|158371873|FG000|Overall Study|Ongoing|33|||
48823163|NCT00463151|157192351|FG003|Overall Study|Adverse Event|0|||
48921439|NCT02970292|157546394|FG001|Overall Study|Physician Decision|1|||
49145502|NCT03976375|158371874|FG001|Overall Study|Ongoing|29|||
49145503|NCT03976375|158371875|FG002|Overall Study|Ongoing|5|||
49145504|NCT00562861|158371876|FG000|Overall Study|Adverse Event|1|||
49145505|NCT00562861|158371877|FG001|Overall Study|Adverse Event|1|||
48823164|NCT00463151|157192348|FG000|Overall Study|Lack of Efficacy|2|||
48823165|NCT00463151|157192349|FG001|Overall Study|Lack of Efficacy|5|||
48823166|NCT00463151|157192350|FG002|Overall Study|Lack of Efficacy|2|||
49145506|NCT00562861|158371876|FG000|Overall Study|Lack of Efficacy|5|||
49145507|NCT00562861|158371877|FG001|Overall Study|Lack of Efficacy|5|||
49145508|NCT00562861|158371876|FG000|Overall Study|noncompliance, moved|7|||
49145509|NCT00562861|158371877|FG001|Overall Study|noncompliance, moved|2|||
49145510|NCT00562861|158371876|FG000|Overall Study|Lost to Follow-up|7|||
49145511|NCT00562861|158371877|FG001|Overall Study|Lost to Follow-up|3|||
49145512|NCT00655356|158371878|FG000|Overall Study|Withdrawal by Subject|3|||
49145513|NCT00655356|158371879|FG001|Overall Study|Withdrawal by Subject|4|||
49145514|NCT00655356|158371878|FG000|Overall Study|Sponsor Request|10|||
49145515|NCT00655356|158371879|FG001|Overall Study|Sponsor Request|4|||
49145516|NCT00655356|158371878|FG000|Overall Study|Adverse Event|1|||
49145517|NCT00655356|158371879|FG001|Overall Study|Adverse Event|1|||
49145518|NCT00655356|158371878|FG000|Overall Study|Protocol Violation|2|||
49145519|NCT00655356|158371879|FG001|Overall Study|Protocol Violation|1|||
49145520|NCT00655356|158371878|FG000|Overall Study|Other Reason|1|||
49145521|NCT00655356|158371879|FG001|Overall Study|Other Reason|0|||
49145522|NCT01657942|158371880|FG000|Overall Study|Alternative Treatment|7|||
49145523|NCT01657942|158371880|FG000|Overall Study|Lost to Follow-up|1|||
49145524|NCT01734928|158373262|FG000|Randomization|Physician Decision|0|||
49145525|NCT01734928|158373263|FG001|Randomization|Physician Decision|1|||
49145526|NCT01734928|158373262|FG000|Randomization|clinical progression|0|||
49145527|NCT01734928|158373263|FG001|Randomization|clinical progression|1|||
49145528|NCT01734928|158373262|FG000|Randomization|progressive disease|0|||
49145529|NCT01734928|158373263|FG001|Randomization|progressive disease|2|||
49145530|NCT01734928|158373262|FG000|Randomization|Withdrew informed consent|0|||
49145531|NCT01734928|158373263|FG001|Randomization|Withdrew informed consent|4|||
49145532|NCT01734928|158373262|FG000|Randomization|Death|1|||
49145533|NCT01734928|158373263|FG001|Randomization|Death|0|||
49145534|NCT01734928|158373262|FG000|Randomization|Randomization error|1|||
49145535|NCT01734928|158373263|FG001|Randomization|Randomization error|0|||
49145536|NCT01734928|158373262|FG000|Randomization|Lost to Follow-up|1|||
49145537|NCT01734928|158373263|FG001|Randomization|Lost to Follow-up|0|||
49145538|NCT01734928|158373262|FG000|Treatment Period|Lost to Follow-up|0|||
49145539|NCT01734928|158373263|FG001|Treatment Period|Lost to Follow-up|2|||
49145540|NCT01734928|158373262|FG000|Treatment Period|Progressive Disease|167|||
49145541|NCT01734928|158373263|FG001|Treatment Period|Progressive Disease|165|||
49145542|NCT01734928|158373262|FG000|Treatment Period|Adverse Event|39|||
49145543|NCT01734928|158373263|FG001|Treatment Period|Adverse Event|52|||
49145544|NCT01734928|158373262|FG000|Treatment Period|Withdrawal of Consent|25|||
49145545|NCT01734928|158373263|FG001|Treatment Period|Withdrawal of Consent|22|||
49145546|NCT01734928|158373262|FG000|Treatment Period|Death|20|||
49145547|NCT01734928|158373263|FG001|Treatment Period|Death|9|||
49145548|NCT01734928|158373262|FG000|Treatment Period|Other Reasons|27|||
49145549|NCT01734928|158373263|FG001|Treatment Period|Other Reasons|19|||
49145550|NCT01734928|158373262|FG000|Treatment Period|Pregnancy|0|||
49145551|NCT01734928|158373263|FG001|Treatment Period|Pregnancy|1|||
49145552|NCT04359680|158373270|FG000|Overall Study|Withdrawal by Subject|29|||
49145553|NCT04359680|158373271|FG001|Overall Study|Withdrawal by Subject|24|||
49145554|NCT04359680|158373270|FG000|Overall Study|Adverse Event|6|||
49145555|NCT04359680|158373271|FG001|Overall Study|Adverse Event|2|||
49145556|NCT04359680|158373270|FG000|Overall Study|Lost to Follow-up|56|||
49145557|NCT04359680|158373271|FG001|Overall Study|Lost to Follow-up|59|||
49145558|NCT04359680|158373270|FG000|Overall Study|Protocol Violation|3|||
49145559|NCT04359680|158373271|FG001|Overall Study|Protocol Violation|5|||
49145560|NCT04359680|158373270|FG000|Overall Study|Physician Decision|1|||
49145561|NCT04359680|158373271|FG001|Overall Study|Physician Decision|1|||
49145562|NCT04359680|158373270|FG000|Overall Study|Sponsor Decision|0|||
49145563|NCT04359680|158373271|FG001|Overall Study|Sponsor Decision|1|||
49145564|NCT02181621|158373272|FG000|Overall Study|Adverse Event|1|||
49145565|NCT02181621|158373273|FG001|Overall Study|Adverse Event|0|||
49145566|NCT02181621|158373272|FG000|Overall Study|Previously Enrolled|0|||
49145567|NCT02181621|158373273|FG001|Overall Study|Previously Enrolled|1|||
49145568|NCT02181621|158373272|FG000|Overall Study|Enrollment Hold|1|||
49145569|NCT02181621|158373273|FG001|Overall Study|Enrollment Hold|1|||
49145570|NCT02802865|158373274|FG000|Overall Study|Pregnancy|1|||
49145571|NCT02802865|158373275|FG001|Overall Study|Pregnancy|1|||
49145572|NCT02802865|158373274|FG000|Overall Study|Ineliegible due to tuberculosis|0|||
49145573|NCT02802865|158373275|FG001|Overall Study|Ineliegible due to tuberculosis|1|||
49145574|NCT01654250|158373276|FG000|Overall Study|Lost to Follow-up|1|||
49145575|NCT01654250|158373277|FG001|Overall Study|Lost to Follow-up|0|||
49145576|NCT01964560|158373278|FG000|Overall Study|Adverse Event|23|||
49145577|NCT01964560|158373278|FG000|Overall Study|Lack of Efficacy|46|||
49145578|NCT01964560|158373278|FG000|Overall Study|Protocol deviation|2|||
49145579|NCT01964560|158373278|FG000|Overall Study|Lost to Follow-up|4|||
49145580|NCT01964560|158373278|FG000|Overall Study|Withdrawal by Subject|64|||
49145581|NCT01964560|158373278|FG000|Overall Study|Surgery-hemispherotomy|1|||
49145582|NCT01964560|158373278|FG000|Overall Study|Surgery|1|||
49145583|NCT01964560|158373278|FG000|Overall Study|Seizures appeared resolved with epilepsy surgery|1|||
49145584|NCT01964560|158373278|FG000|Overall Study|Patient and Investigator choice|1|||
49145585|NCT01964560|158373278|FG000|Overall Study|Patient was prescribed CBD|1|||
49145586|NCT01964560|158373278|FG000|Overall Study|Participant moved to another country|1|||
49145587|NCT02301429|158373279|FG000|Overall Study|not acceptable vascular anatomy|3|||
49145588|NCT01502072|158373280|FG000|Overall Study|Withdrawal by Subject|1|||
49145589|NCT01502072|158373281|FG001|Overall Study|Withdrawal by Subject|0|||
49145590|NCT01502072|158373282|FG002|Overall Study|Withdrawal by Subject|0|||
49145591|NCT01502072|158373280|FG000|Overall Study|Death|0|||
49145592|NCT01502072|158373281|FG001|Overall Study|Death|1|||
49145593|NCT01502072|158373282|FG002|Overall Study|Death|0|||
49145594|NCT02123511|158373287|FG000|Overall Study|Cancelled treatment|1|||
49145595|NCT02123511|158373288|FG001|Overall Study|Cancelled treatment|0|||
49145596|NCT02123511|158373287|FG000|Overall Study|Incomplete data|1|||
49145597|NCT02123511|158373288|FG001|Overall Study|Incomplete data|3|||
49145598|NCT02123511|158373287|FG000|Overall Study|Ineligible|0|||
49145599|NCT02123511|158373288|FG001|Overall Study|Ineligible|1|||
49145600|NCT03954938|158373289|FG000|Overall Study|Withdrawal by Subject|2|||
49145601|NCT03954938|158373289|FG000|Overall Study|Adverse Event|1|||
49145602|NCT05156125|158373290|FG000|Overall Study|Lack of Efficacy|1|||
49145603|NCT05156125|158373291|FG001|Overall Study|Lack of Efficacy|1|||
49145604|NCT05156125|158373292|FG002|Overall Study|Lack of Efficacy|1|||
49145605|NCT05156125|158373290|FG000|Overall Study|Physician Decision|0|||
49145606|NCT05156125|158373291|FG001|Overall Study|Physician Decision|0|||
49145607|NCT05156125|158373292|FG002|Overall Study|Physician Decision|1|||
49145608|NCT05156125|158373290|FG000|Overall Study|Non-compliance|0|||
49145609|NCT05156125|158373291|FG001|Overall Study|Non-compliance|1|||
49145610|NCT05156125|158373292|FG002|Overall Study|Non-compliance|1|||
49145611|NCT05156125|158373290|FG000|Overall Study|Withdrawal by Subject|0|||
49145612|NCT05156125|158373291|FG001|Overall Study|Withdrawal by Subject|0|||
49145613|NCT05156125|158373292|FG002|Overall Study|Withdrawal by Subject|1|||
49145614|NCT05156125|158373290|FG000|Overall Study|Adverse Event|2|||
49145615|NCT05156125|158373291|FG001|Overall Study|Adverse Event|1|||
49145616|NCT05156125|158373292|FG002|Overall Study|Adverse Event|0|||
49145617|NCT05287685|158373293|FG000|Pilot Randomized Controlled Trial|Withdrawal by Subject|2|||
49145618|NCT05287685|158373294|FG001|Pilot Randomized Controlled Trial|Withdrawal by Subject|1|||
49145619|NCT05287685|158373293|FG000|Pilot Randomized Controlled Trial|Lost to Follow-up|1|||
49145620|NCT05287685|158373294|FG001|Pilot Randomized Controlled Trial|Lost to Follow-up|0|||
49145621|NCT03671148|158373295|FG000|Overall Study|Adverse Event|3|||
49145622|NCT03671148|158373296|FG001|Overall Study|Adverse Event|2|||
49145623|NCT03671148|158373295|FG000|Overall Study|Withdrawal by Subject|8|||
49013531|NCT01280981|157885235|FG000|Overall Study|Irregular or discontinued menses|3|||
49013532|NCT01280981|157885235|FG000|Overall Study|Failed to return|45|||
49013533|NCT01280981|157885235|FG000|Overall Study|Non-compliance with protocol|3|||
49013534|NCT01280981|157885235|FG000|Overall Study|Withdrawal of consent|3|||
49013535|NCT01280981|157885235|FG000|Overall Study|Elective surgery|2|||
49013536|NCT01280981|157885235|FG000|Overall Study|Study site closure|1|||
49013537|NCT01752920|157885243|FG000|Overall Study|Adverse Event|1|||
49013538|NCT01752920|157885244|FG001|Overall Study|Adverse Event|0|||
49013539|NCT01752920|157885245|FG002|Overall Study|Adverse Event|5|||
49013540|NCT01752920|157885246|FG003|Overall Study|Adverse Event|10|||
49013541|NCT01752920|157885243|FG000|Overall Study|Clinical Disease Progression|6|||
49013542|NCT01752920|157885244|FG001|Overall Study|Clinical Disease Progression|4|||
49013543|NCT01752920|157885245|FG002|Overall Study|Clinical Disease Progression|1|||
49145624|NCT03671148|158373296|FG001|Overall Study|Withdrawal by Subject|2|||
49145625|NCT03671148|158373295|FG000|Overall Study|Lost to Follow-up|1|||
49145626|NCT03671148|158373296|FG001|Overall Study|Lost to Follow-up|2|||
49145627|NCT03671148|158373295|FG000|Overall Study|Lack of Efficacy|7|||
49145628|NCT03671148|158373296|FG001|Overall Study|Lack of Efficacy|2|||
49145629|NCT03671148|158373295|FG000|Overall Study|COVID-19 Logistical Restrictions|0|||
49145630|NCT03671148|158373296|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
49145631|NCT03671148|158373295|FG000|Overall Study|Other|1|||
49145632|NCT03671148|158373296|FG001|Overall Study|Other|0|||
49145633|NCT03671148|158373295|FG000|Overall Study|Incomplete Randomization Visit|1|||
49145634|NCT03671148|158373296|FG001|Overall Study|Incomplete Randomization Visit|0|||
49145635|NCT03892915|158373300|FG000|Overall Study|Lost to Follow-up|6|||
49145636|NCT03892915|158373301|FG001|Overall Study|Lost to Follow-up|12|||
49145637|NCT03892915|158373300|FG000|Overall Study|Death|0|||
49145638|NCT03892915|158373301|FG001|Overall Study|Death|2|||
49145639|NCT03892915|158373300|FG000|Overall Study|Withdrawal by Subject|1|||
49145640|NCT03892915|158373301|FG001|Overall Study|Withdrawal by Subject|1|||
49145641|NCT03892915|158373300|FG000|Overall Study|unsuccessful delivery|13|||
49145642|NCT03892915|158373301|FG001|Overall Study|unsuccessful delivery|18|||
49145643|NCT01520714|158373302|FG000|Overall Study|Protocol Violation|0|||
49145644|NCT01520714|158373303|FG001|Overall Study|Protocol Violation|3|||
49145645|NCT01520714|158373302|FG000|Overall Study|Adverse Event|0|||
49145646|NCT01520714|158373303|FG001|Overall Study|Adverse Event|2|||
49145647|NCT01520714|158373302|FG000|Overall Study|Lack of Efficacy|0|||
49145648|NCT01520714|158373303|FG001|Overall Study|Lack of Efficacy|1|||
49145649|NCT01570192|158373304|FG000|Overall Study|no qualifying organism|6|||
49145650|NCT01570192|158373305|FG001|Overall Study|no qualifying organism|12|||
49013544|NCT01752920|157885246|FG003|Overall Study|Clinical Disease Progression|13|||
49013545|NCT01752920|157885243|FG000|Overall Study|Physician Decision|1|||
49013546|NCT01752920|157885244|FG001|Overall Study|Physician Decision|0|||
49145651|NCT01570192|158373304|FG000|Overall Study|changed to palliative care|1|||
49013547|NCT01752920|157885245|FG002|Overall Study|Physician Decision|0|||
49013548|NCT01752920|157885246|FG003|Overall Study|Physician Decision|3|||
49145652|NCT01570192|158373305|FG001|Overall Study|changed to palliative care|0|||
49145653|NCT01570192|158373304|FG000|Overall Study|Physician Decision|0|||
49145654|NCT01570192|158373305|FG001|Overall Study|Physician Decision|1|||
49145655|NCT01478087|158373306|FG000|Overall Study|due to sponsor closing study|1|||
49145656|NCT04191733|158373312|FG000|Overall Study|Withdrawn due to study closure|13|||
49145657|NCT04191733|158373313|FG001|Overall Study|Withdrawn due to study closure|14|||
49145658|NCT04191733|158373312|FG000|Overall Study|Withdrawal by Subject|2|||
49145659|NCT04191733|158373313|FG001|Overall Study|Withdrawal by Subject|4|||
49145660|NCT04191733|158373312|FG000|Overall Study|Physician Decision|1|||
49145661|NCT04191733|158373313|FG001|Overall Study|Physician Decision|1|||
49145662|NCT04191733|158373312|FG000|Overall Study|Lost to Follow-up|5|||
49145663|NCT04191733|158373313|FG001|Overall Study|Lost to Follow-up|6|||
49145664|NCT04191733|158373312|FG000|Overall Study|Death|0|||
49145665|NCT04191733|158373313|FG001|Overall Study|Death|1|||
49145666|NCT01309100|158373316|FG000|Overall Study|Protocol Violation|1|||
49145667|NCT01309100|158373316|FG000|Overall Study|Positive Slit lamp finding|1|||
49145668|NCT02176525|158373317|FG000|Overall Study|Adverse Event|0|||
49145669|NCT02176525|158373318|FG001|Overall Study|Adverse Event|0|||
49145670|NCT02176525|158373319|FG002|Overall Study|Adverse Event|0|||
49145671|NCT02176525|158373320|FG003|Overall Study|Adverse Event|1|||
49145672|NCT02176525|158373321|FG004|Overall Study|Adverse Event|1|||
49145673|NCT02176525|158373322|FG005|Overall Study|Adverse Event|0|||
49145674|NCT02176525|158373323|FG006|Overall Study|Adverse Event|1|||
49145675|NCT02176525|158373324|FG007|Overall Study|Adverse Event|0|||
49145676|NCT02176525|158373317|FG000|Overall Study|not treated|1|||
49145677|NCT02176525|158373318|FG001|Overall Study|not treated|0|||
49145678|NCT02176525|158373319|FG002|Overall Study|not treated|0|||
49145679|NCT02176525|158373320|FG003|Overall Study|not treated|0|||
49145680|NCT02176525|158373321|FG004|Overall Study|not treated|0|||
49145681|NCT02176525|158373322|FG005|Overall Study|not treated|1|||
49145682|NCT02176525|158373323|FG006|Overall Study|not treated|0|||
49145683|NCT02176525|158373324|FG007|Overall Study|not treated|0|||
49145684|NCT03721107|158373327|FG000|Overall Study|Adverse Event|1|||
49145685|NCT03721107|158373328|FG001|Overall Study|Adverse Event|1|||
48823167|NCT00463151|157192351|FG003|Overall Study|Lack of Efficacy|5|||
48823168|NCT00463151|157192348|FG000|Overall Study|Protocol Violation|0|||
48823169|NCT00463151|157192349|FG001|Overall Study|Protocol Violation|0|||
48823170|NCT00463151|157192350|FG002|Overall Study|Protocol Violation|0|||
48823171|NCT00463151|157192351|FG003|Overall Study|Protocol Violation|1|||
48823172|NCT00463151|157192348|FG000|Overall Study|Withdrawal by Subject|0|||
48823173|NCT00463151|157192349|FG001|Overall Study|Withdrawal by Subject|0|||
48823174|NCT00463151|157192350|FG002|Overall Study|Withdrawal by Subject|0|||
49145686|NCT03721107|158373329|FG002|Overall Study|Adverse Event|6|||
49145687|NCT03721107|158373330|FG003|Overall Study|Adverse Event|5|||
49145688|NCT03721107|158373327|FG000|Overall Study|Lost to Follow-up|2|||
49145689|NCT03721107|158373328|FG001|Overall Study|Lost to Follow-up|0|||
49145690|NCT03721107|158373329|FG002|Overall Study|Lost to Follow-up|3|||
49145691|NCT03721107|158373330|FG003|Overall Study|Lost to Follow-up|0|||
49145692|NCT03721107|158373327|FG000|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
49145693|NCT03721107|158373328|FG001|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
49145694|NCT03721107|158373329|FG002|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
49145695|NCT03721107|158373330|FG003|Overall Study|Inclusion/Exclusion Criteria not Met|1|||
49145696|NCT03721107|158373327|FG000|Overall Study|Physician Decision|0|||
49145697|NCT03721107|158373328|FG001|Overall Study|Physician Decision|1|||
49145698|NCT03721107|158373329|FG002|Overall Study|Physician Decision|0|||
49145699|NCT03721107|158373330|FG003|Overall Study|Physician Decision|0|||
49145700|NCT03721107|158373327|FG000|Overall Study|Pregnancy|0|||
49145701|NCT03721107|158373328|FG001|Overall Study|Pregnancy|0|||
49145702|NCT03721107|158373329|FG002|Overall Study|Pregnancy|1|||
49145703|NCT03721107|158373330|FG003|Overall Study|Pregnancy|0|||
49145704|NCT03721107|158373327|FG000|Overall Study|Withdrawal by Subject|1|||
49145705|NCT03721107|158373328|FG001|Overall Study|Withdrawal by Subject|1|||
49145706|NCT03721107|158373329|FG002|Overall Study|Withdrawal by Subject|5|||
49145707|NCT03721107|158373330|FG003|Overall Study|Withdrawal by Subject|5|||
49145708|NCT03721107|158373327|FG000|Overall Study|Other|1|||
49145709|NCT03721107|158373328|FG001|Overall Study|Other|0|||
49145710|NCT03721107|158373329|FG002|Overall Study|Other|0|||
49145711|NCT03721107|158373330|FG003|Overall Study|Other|1|||
49145712|NCT02294019|158373331|FG000|Overall Study|Adverse Event|2|||
49145713|NCT02294019|158373331|FG000|Overall Study|Protocol Violation|68|||
49145714|NCT02294019|158373331|FG000|Overall Study|Lost to Follow-up|31|||
49145715|NCT02294019|158373331|FG000|Overall Study|Other|1|||
49145716|NCT02294019|158373331|FG000|Overall Study|Withdrawal by Subject|1|||
49145717|NCT01084135|158373332|FG000|20 Week|Physician Decision|0|||
49145718|NCT01084135|158373333|FG001|20 Week|Physician Decision|1|||
49145719|NCT02991859|158373334|FG000|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
48823175|NCT00463151|157192351|FG003|Overall Study|Withdrawal by Subject|1|||
48823176|NCT01628874|157192352|FG000|Overall Study|Physician Decision|1|||
49145720|NCT02991859|158373335|FG001|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
49145721|NCT02991859|158373336|FG002|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
49145722|NCT02991859|158373337|FG003|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
49145723|NCT02991859|158373338|FG004|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
49145724|NCT02991859|158373339|FG005|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
49145725|NCT02991859|158373340|FG006|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
49145726|NCT02991859|158373341|FG007|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
49145727|NCT02991859|158373342|FG008|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
49145728|NCT02991859|158373343|FG009|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
49145729|NCT02991859|158373344|FG010|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
49145730|NCT02991859|158373345|FG011|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
49145731|NCT02991859|158373346|FG012|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
49145732|NCT02991859|158373347|FG013|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
49145733|NCT02991859|158373348|FG014|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
49145734|NCT02991859|158373349|FG015|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
49145735|NCT02991859|158373350|FG016|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
49145736|NCT02991859|158373334|FG000|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
49145737|NCT02991859|158373335|FG001|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
49145738|NCT02991859|158373336|FG002|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
49145739|NCT02991859|158373337|FG003|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
49145740|NCT02991859|158373338|FG004|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
49145741|NCT02991859|158373339|FG005|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
49145742|NCT02991859|158373340|FG006|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
49145743|NCT02991859|158373341|FG007|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
49145744|NCT02991859|158373342|FG008|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
49145745|NCT02991859|158373343|FG009|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
49013549|NCT01752920|157885243|FG000|Overall Study|Radiographic Disease Progression|20|||
49013550|NCT01752920|157885244|FG001|Overall Study|Radiographic Disease Progression|7|||
49013551|NCT01752920|157885245|FG002|Overall Study|Radiographic Disease Progression|12|||
49013552|NCT01752920|157885246|FG003|Overall Study|Radiographic Disease Progression|29|||
49013553|NCT01752920|157885243|FG000|Overall Study|Study Terminated by Sponsor|0|||
49013554|NCT01752920|157885244|FG001|Overall Study|Study Terminated by Sponsor|0|||
49013555|NCT01752920|157885245|FG002|Overall Study|Study Terminated by Sponsor|0|||
49013556|NCT01752920|157885246|FG003|Overall Study|Study Terminated by Sponsor|1|||
49013557|NCT01752920|157885243|FG000|Overall Study|Withdrawal by Subject|0|||
49013558|NCT01752920|157885244|FG001|Overall Study|Withdrawal by Subject|1|||
49013559|NCT01752920|157885245|FG002|Overall Study|Withdrawal by Subject|0|||
49013560|NCT01752920|157885246|FG003|Overall Study|Withdrawal by Subject|1|||
49013561|NCT01752920|157885243|FG000|Overall Study|Lack of clinical benefit|1|||
49013562|NCT01752920|157885244|FG001|Overall Study|Lack of clinical benefit|1|||
49013563|NCT01752920|157885245|FG002|Overall Study|Lack of clinical benefit|1|||
49013564|NCT01752920|157885246|FG003|Overall Study|Lack of clinical benefit|1|||
49013565|NCT02970669|157885250|FG000|Double-blind Period|Adverse Event|4|||
49013566|NCT02970669|157885251|FG001|Double-blind Period|Adverse Event|0|||
49013567|NCT02970669|157885250|FG000|Double-blind Period|Death|1|||
49013568|NCT02970669|157885251|FG001|Double-blind Period|Death|0|||
49013569|NCT02970669|157885250|FG000|Double-blind Period|Study terminated by sponsor|1|||
49013570|NCT02970669|157885251|FG001|Double-blind Period|Study terminated by sponsor|2|||
49013571|NCT02970669|157885250|FG000|Double-blind Period|Physician Decision|0|||
49013572|NCT02970669|157885251|FG001|Double-blind Period|Physician Decision|2|||
49013573|NCT02970669|157885250|FG000|Double-blind Period|Withdrawal by Subject|2|||
49013574|NCT02970669|157885251|FG001|Double-blind Period|Withdrawal by Subject|2|||
49013575|NCT02970669|157885250|FG000|Open-label Period|Withdrawal by Subject|2|||
49013576|NCT02970669|157885251|FG001|Open-label Period|Withdrawal by Subject|2|||
49013577|NCT02970669|157885250|FG000|Open-label Period|Adverse Event|1|||
49013578|NCT02970669|157885251|FG001|Open-label Period|Adverse Event|0|||
49013579|NCT02970669|157885250|FG000|Open-label Period|Physician Decision|1|||
49013580|NCT02970669|157885251|FG001|Open-label Period|Physician Decision|0|||
49013581|NCT01738581|157885253|FG000|Overall Study|Lost to Follow-up|1|||
49013582|NCT01738581|157885254|FG001|Overall Study|Lost to Follow-up|0|||
49013583|NCT00876733|157885255|FG000|Overall Study|Adverse Event|34|||
49013584|NCT00876733|157885256|FG001|Overall Study|Adverse Event|20|||
49013585|NCT00876733|157885257|FG002|Overall Study|Adverse Event|10|||
49013586|NCT00876733|157885258|FG003|Overall Study|Adverse Event|3|||
49013587|NCT00876733|157885255|FG000|Overall Study|Lack of Efficacy|17|||
49013588|NCT00876733|157885256|FG001|Overall Study|Lack of Efficacy|9|||
49013589|NCT00876733|157885257|FG002|Overall Study|Lack of Efficacy|10|||
49013590|NCT00876733|157885258|FG003|Overall Study|Lack of Efficacy|1|||
49013591|NCT00876733|157885255|FG000|Overall Study|Lost to Follow-up|26|||
49013592|NCT00876733|157885256|FG001|Overall Study|Lost to Follow-up|10|||
49013593|NCT00876733|157885257|FG002|Overall Study|Lost to Follow-up|3|||
49013594|NCT00876733|157885258|FG003|Overall Study|Lost to Follow-up|2|||
49013595|NCT00876733|157885255|FG000|Overall Study|Data not available|14|||
49013596|NCT00876733|157885256|FG001|Overall Study|Data not available|3|||
49013597|NCT00876733|157885257|FG002|Overall Study|Data not available|7|||
49013598|NCT00876733|157885258|FG003|Overall Study|Data not available|1|||
49013599|NCT01154153|157885259|FG000|Overall Study|Poor compliance to protocol|2|||
49013600|NCT01154153|157885260|FG001|Overall Study|Poor compliance to protocol|0|||
49013601|NCT01154153|157885259|FG000|Overall Study|Unable to use labs|2|||
49013602|NCT01154153|157885260|FG001|Overall Study|Unable to use labs|3|||
49013603|NCT01154153|157885259|FG000|Overall Study|Withdrew consent|1|||
49013604|NCT01154153|157885260|FG001|Overall Study|Withdrew consent|0|||
49013605|NCT02497391|157887137|FG000|Period 2 (14 Days)|Withdrawal by Subject|1|||
49013606|NCT02497391|157887138|FG001|Period 2 (14 Days)|Withdrawal by Subject|0|||
49013607|NCT02497391|157887139|FG002|Period 2 (14 Days)|Withdrawal by Subject|1|||
49013608|NCT02497391|157887140|FG003|Period 2 (14 Days)|Withdrawal by Subject|0|||
49013609|NCT02497391|157887141|FG004|Period 2 (14 Days)|Withdrawal by Subject|0|||
49013610|NCT02497391|157887142|FG005|Period 2 (14 Days)|Withdrawal by Subject|0|||
49013611|NCT02497391|157887137|FG000|Period 2 (14 Days)|Sponsor Decision|3|||
49013612|NCT02497391|157887138|FG001|Period 2 (14 Days)|Sponsor Decision|1|||
49013613|NCT02497391|157887139|FG002|Period 2 (14 Days)|Sponsor Decision|2|||
49013614|NCT02497391|157887140|FG003|Period 2 (14 Days)|Sponsor Decision|3|||
49013615|NCT02497391|157887141|FG004|Period 2 (14 Days)|Sponsor Decision|2|||
49013616|NCT02497391|157887142|FG005|Period 2 (14 Days)|Sponsor Decision|3|||
49013617|NCT02497391|157887137|FG000|Period 3 (14 Days)|Adverse Event|0|||
49013618|NCT02497391|157887138|FG001|Period 3 (14 Days)|Adverse Event|1|||
49013619|NCT02497391|157887139|FG002|Period 3 (14 Days)|Adverse Event|0|||
49013620|NCT02497391|157887140|FG003|Period 3 (14 Days)|Adverse Event|0|||
49013621|NCT02497391|157887141|FG004|Period 3 (14 Days)|Adverse Event|0|||
49013622|NCT02497391|157887142|FG005|Period 3 (14 Days)|Adverse Event|0|||
49013623|NCT02497391|157887137|FG000|Period 3 (14 Days)|Sponsor Decision|0|||
49013624|NCT02497391|157887138|FG001|Period 3 (14 Days)|Sponsor Decision|0|||
49013625|NCT02497391|157887139|FG002|Period 3 (14 Days)|Sponsor Decision|0|||
49013626|NCT02497391|157887140|FG003|Period 3 (14 Days)|Sponsor Decision|0|||
49013627|NCT02497391|157887141|FG004|Period 3 (14 Days)|Sponsor Decision|1|||
49013628|NCT02497391|157887142|FG005|Period 3 (14 Days)|Sponsor Decision|0|||
49013629|NCT02497391|157887137|FG000|Period 3 (14 Days)|Withdrawal by Subject|0|||
49013630|NCT02497391|157887138|FG001|Period 3 (14 Days)|Withdrawal by Subject|0|||
49013631|NCT02497391|157887139|FG002|Period 3 (14 Days)|Withdrawal by Subject|1|||
49013632|NCT02497391|157887140|FG003|Period 3 (14 Days)|Withdrawal by Subject|0|||
49013633|NCT02497391|157887141|FG004|Period 3 (14 Days)|Withdrawal by Subject|0|||
49013634|NCT02497391|157887142|FG005|Period 3 (14 Days)|Withdrawal by Subject|0|||
49013635|NCT02853929|157887143|FG000|Overall Study|Lost to Follow-up|3|||
49013636|NCT02853929|157887144|FG001|Overall Study|Lost to Follow-up|0|||
49013637|NCT02853929|157887143|FG000|Overall Study|Withdrawal by Subject|1|||
49013638|NCT02853929|157887144|FG001|Overall Study|Withdrawal by Subject|0|||
49013639|NCT02853929|157887143|FG000|Overall Study|Subjects enrolled but not vaccinated|7|||
49013640|NCT02853929|157887144|FG001|Overall Study|Subjects enrolled but not vaccinated|4|||
49013641|NCT01070966|157887145|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|59|||
49013642|NCT01070966|157887145|FG000|Participants for Safety Evaluation|Off-label use|9|||
49013643|NCT01070966|157887145|FG000|Participants for Safety Evaluation|Duplicate Participants|4|||
49013644|NCT01070966|157887145|FG000|Participants for Safety Evaluation|Violation inclusion criteria/off label|3|||
49013645|NCT01070966|157887145|FG000|Participants for Safety Evaluation|TMT given before date of contract|3|||
49013646|NCT01070966|157887145|FG000|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61|||
49013647|NCT01070966|157887145|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|19|||
49013648|NCT01070966|157887145|FG000|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2|||
49013649|NCT00693784|157887147|FG000|Overall Study|Lost to Follow-up|2|||
49013650|NCT00693784|157887147|FG000|Overall Study|Withdrawal by Subject|2|||
49013651|NCT04274192|157887150|FG000|Overall Study|Protocol Violation|1|||
49013652|NCT04274192|157887151|FG001|Overall Study|Protocol Violation|0|||
49013653|NCT02763579|157887152|FG000|Global Period|Death|167|||
49013654|NCT02763579|157887153|FG001|Global Period|Death|151|||
49013655|NCT02763579|157887154|FG002|Global Period|Death|0|||
49013656|NCT02763579|157887155|FG003|Global Period|Death|0|||
49013657|NCT02763579|157887152|FG000|Global Period|Lost to Follow-up|2|||
49013658|NCT02763579|157887153|FG001|Global Period|Lost to Follow-up|4|||
49013659|NCT02763579|157887154|FG002|Global Period|Lost to Follow-up|0|||
49013660|NCT02763579|157887155|FG003|Global Period|Lost to Follow-up|0|||
49013661|NCT02763579|157887152|FG000|Global Period|Physician Decision|0|||
49013662|NCT02763579|157887153|FG001|Global Period|Physician Decision|2|||
49013663|NCT02763579|157887154|FG002|Global Period|Physician Decision|0|||
49013664|NCT02763579|157887155|FG003|Global Period|Physician Decision|0|||
49013665|NCT02763579|157887152|FG000|Global Period|Study Terminated By Sponsor|21|||
49111714|NCT03013985|158244504|FG000|Overall Study|Protocol Violation|2|||
49111715|NCT03013985|158244505|FG001|Overall Study|Protocol Violation|2|||
49111716|NCT03013985|158244504|FG000|Overall Study|Withdrawal by Subject|14|||
49111717|NCT03013985|158244505|FG001|Overall Study|Withdrawal by Subject|17|||
49111718|NCT01887678|158244506|FG000|Overall Study|Adverse Event|4|||
49111719|NCT01887678|158244507|FG001|Overall Study|Adverse Event|6|||
49013666|NCT02763579|157887153|FG001|Global Period|Study Terminated By Sponsor|26|||
49013667|NCT02763579|157887154|FG002|Global Period|Study Terminated By Sponsor|0|||
49013668|NCT02763579|157887155|FG003|Global Period|Study Terminated By Sponsor|0|||
49013669|NCT02763579|157887152|FG000|Global Period|Withdrawal by Subject|12|||
49013670|NCT02763579|157887153|FG001|Global Period|Withdrawal by Subject|18|||
49013671|NCT02763579|157887154|FG002|Global Period|Withdrawal by Subject|0|||
49013672|NCT02763579|157887155|FG003|Global Period|Withdrawal by Subject|0|||
49013673|NCT02763579|157887152|FG000|China Period|Death|0|||
49013674|NCT02763579|157887153|FG001|China Period|Death|0|||
49013675|NCT02763579|157887154|FG002|China Period|Death|46|||
49013676|NCT02763579|157887155|FG003|China Period|Death|48|||
49013677|NCT02763579|157887152|FG000|China Period|Lost to Follow-up|0|||
49013678|NCT02763579|157887153|FG001|China Period|Lost to Follow-up|0|||
49013679|NCT02763579|157887154|FG002|China Period|Lost to Follow-up|1|||
49013680|NCT02763579|157887155|FG003|China Period|Lost to Follow-up|1|||
49013681|NCT02763579|157887152|FG000|China Period|Physician Decision|0|||
49013682|NCT02763579|157887153|FG001|China Period|Physician Decision|0|||
49013683|NCT02763579|157887154|FG002|China Period|Physician Decision|0|||
49013684|NCT02763579|157887155|FG003|China Period|Physician Decision|1|||
48730701|NCT04612790|156865867|FG000|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
48730702|NCT04612790|156865868|FG001|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
48730703|NCT04612790|156865869|FG002|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
49145746|NCT02991859|158373344|FG010|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
49145747|NCT02991859|158373345|FG011|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
49145748|NCT02991859|158373346|FG012|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
49145749|NCT02991859|158373347|FG013|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
49145750|NCT02991859|158373348|FG014|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
49145751|NCT02991859|158373349|FG015|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
49145752|NCT02991859|158373350|FG016|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
49145753|NCT02991859|158373334|FG000|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
49145754|NCT02991859|158373335|FG001|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
49145755|NCT02991859|158373336|FG002|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
49145756|NCT02991859|158373337|FG003|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
49145757|NCT02991859|158373338|FG004|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
49145758|NCT02991859|158373339|FG005|Wash Out, Up to Day 77|Withdrawal by Subject|1|||
49145759|NCT02991859|158373340|FG006|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
49145760|NCT02991859|158373341|FG007|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
49145761|NCT02991859|158373342|FG008|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
49145762|NCT02991859|158373343|FG009|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
49145763|NCT02991859|158373344|FG010|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
49145764|NCT02991859|158373345|FG011|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
49145765|NCT02991859|158373346|FG012|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
49145766|NCT02991859|158373347|FG013|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
49145767|NCT02991859|158373348|FG014|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
49013685|NCT02763579|157887152|FG000|China Period|Study Terminated By Sponsor|0|||
49013686|NCT02763579|157887153|FG001|China Period|Study Terminated By Sponsor|0|||
49013687|NCT02763579|157887154|FG002|China Period|Study Terminated By Sponsor|3|||
49013688|NCT02763579|157887155|FG003|China Period|Study Terminated By Sponsor|4|||
49013689|NCT02763579|157887152|FG000|China Period|Withdrawal by Subject|0|||
49013690|NCT02763579|157887153|FG001|China Period|Withdrawal by Subject|0|||
49013691|NCT02763579|157887154|FG002|China Period|Withdrawal by Subject|3|||
49013692|NCT02763579|157887155|FG003|China Period|Withdrawal by Subject|3|||
49013693|NCT00606684|157887156|FG000|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173|||
49111796|NCT02774005|158244534|FG000|Overall Study|another study|1|||
49111797|NCT02774005|158244534|FG000|Overall Study|cardiologist imposed travel restriction|1|||
49111798|NCT00845676|158244535|FG000|Overall Study|Virologic breakthrough at week 20|1|||
49111799|NCT00845676|158244535|FG000|Overall Study|Adverse Event|1|||
49111800|NCT02432144|158244540|FG000|Overall Study|Participant Non-Compliance|1|||
49111801|NCT02494401|158244542|FG000|Overall Study|Lost to Follow-up|22|||
49111802|NCT02494401|158244543|FG001|Overall Study|Lost to Follow-up|25|||
49111803|NCT02494401|158244542|FG000|Overall Study|Withdrawal by Subject|3|||
49111804|NCT02494401|158244543|FG001|Overall Study|Withdrawal by Subject|2|||
49111805|NCT02636439|158244544|FG000|Overall Study|Adverse Event|2|||
49111806|NCT02636439|158244545|FG001|Overall Study|Adverse Event|2|||
49111807|NCT02636439|158244544|FG000|Overall Study|Lost to Follow-up|1|||
49111808|NCT02636439|158244545|FG001|Overall Study|Lost to Follow-up|0|||
49111809|NCT02636439|158244544|FG000|Overall Study|Non-compliance|1|||
49111810|NCT02636439|158244545|FG001|Overall Study|Non-compliance|1|||
49111811|NCT02636439|158244544|FG000|Overall Study|Personal reasons|2|||
49111812|NCT02636439|158244545|FG001|Overall Study|Personal reasons|0|||
49111813|NCT03035916|158244548|FG000|Overall Study|Puncture failed|0|||
49111814|NCT03035916|158244549|FG001|Overall Study|Puncture failed|2|||
49111815|NCT03035916|158244550|FG002|Overall Study|Puncture failed|0|||
49013694|NCT00606684|157887157|FG001|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
49013695|NCT00606684|157887158|FG002|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
49013696|NCT00606684|157887159|FG003|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
49013697|NCT00606684|157887160|FG004|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
49013698|NCT00606684|157887161|FG005|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
49013699|NCT00606684|157887162|FG006|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
49013700|NCT00606684|157887156|FG000|2-week Single-Blind Run-in Period|Study Closed/Terminated|32|||
49013701|NCT00606684|157887157|FG001|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
49145768|NCT02991859|158373349|FG015|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
49145769|NCT02991859|158373350|FG016|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
49145770|NCT02991859|158373334|FG000|Wash Out, Up to Day 77|Lost to Follow-up|0|||
49145771|NCT02991859|158373335|FG001|Wash Out, Up to Day 77|Lost to Follow-up|0|||
49145772|NCT02991859|158373336|FG002|Wash Out, Up to Day 77|Lost to Follow-up|0|||
49145773|NCT02991859|158373337|FG003|Wash Out, Up to Day 77|Lost to Follow-up|0|||
49145774|NCT02991859|158373338|FG004|Wash Out, Up to Day 77|Lost to Follow-up|0|||
49145775|NCT02991859|158373339|FG005|Wash Out, Up to Day 77|Lost to Follow-up|0|||
49145776|NCT02991859|158373340|FG006|Wash Out, Up to Day 77|Lost to Follow-up|0|||
49145777|NCT02991859|158373341|FG007|Wash Out, Up to Day 77|Lost to Follow-up|0|||
49145778|NCT02991859|158373342|FG008|Wash Out, Up to Day 77|Lost to Follow-up|0|||
49145779|NCT02991859|158373343|FG009|Wash Out, Up to Day 77|Lost to Follow-up|1|||
49145780|NCT02991859|158373344|FG010|Wash Out, Up to Day 77|Lost to Follow-up|0|||
49145781|NCT02991859|158373345|FG011|Wash Out, Up to Day 77|Lost to Follow-up|0|||
49145782|NCT02991859|158373346|FG012|Wash Out, Up to Day 77|Lost to Follow-up|0|||
49145783|NCT02991859|158373347|FG013|Wash Out, Up to Day 77|Lost to Follow-up|0|||
49145784|NCT02991859|158373348|FG014|Wash Out, Up to Day 77|Lost to Follow-up|0|||
49145785|NCT02991859|158373349|FG015|Wash Out, Up to Day 77|Lost to Follow-up|0|||
49145786|NCT02991859|158373350|FG016|Wash Out, Up to Day 77|Lost to Follow-up|0|||
49145787|NCT02991859|158373334|FG000|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
49145788|NCT02991859|158373335|FG001|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
49145789|NCT02991859|158373336|FG002|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
49145790|NCT02991859|158373337|FG003|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
49145791|NCT02991859|158373338|FG004|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
49145792|NCT02991859|158373339|FG005|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
49145793|NCT02991859|158373340|FG006|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
49145794|NCT02991859|158373341|FG007|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
49145795|NCT02991859|158373342|FG008|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1|||
49145796|NCT02991859|158373343|FG009|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
49145797|NCT02991859|158373344|FG010|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
49145798|NCT02991859|158373345|FG011|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
49145799|NCT02991859|158373346|FG012|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
49145800|NCT02991859|158373347|FG013|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
49145801|NCT02991859|158373348|FG014|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
49145802|NCT02991859|158373349|FG015|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
49145803|NCT02991859|158373350|FG016|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
49145804|NCT01630811|158373351|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
49145805|NCT01630811|158373352|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
49145806|NCT02057666|158373356|FG000|Double Blind Treatment Period|Withdrawal by Subject|8|||
49145807|NCT02057666|158373357|FG001|Double Blind Treatment Period|Withdrawal by Subject|5|||
49145808|NCT02057666|158373356|FG000|Double Blind Treatment Period|Poor tolerability|7|||
49145809|NCT02057666|158373357|FG001|Double Blind Treatment Period|Poor tolerability|2|||
49145810|NCT02057666|158373356|FG000|Double Blind Treatment Period|Symptomatic disease progression|8|||
49145811|NCT02057666|158373357|FG001|Double Blind Treatment Period|Symptomatic disease progression|3|||
49145812|NCT02057666|158373356|FG000|Double Blind Treatment Period|Physician Decision|1|||
49145813|NCT02057666|158373357|FG001|Double Blind Treatment Period|Physician Decision|0|||
49145814|NCT02057666|158373356|FG000|Double Blind Treatment Period|Progressive disease for bone lesion|1|||
49145815|NCT02057666|158373357|FG001|Double Blind Treatment Period|Progressive disease for bone lesion|0|||
49145816|NCT02057666|158373356|FG000|Double Blind Treatment Period|Subject planning to withdraw|1|||
49145817|NCT02057666|158373357|FG001|Double Blind Treatment Period|Subject planning to withdraw|0|||
49145818|NCT02057666|158373356|FG000|Double Blind Treatment Period|Sponsor's request|70|||
49145819|NCT02057666|158373357|FG001|Double Blind Treatment Period|Sponsor's request|34|||
49145820|NCT02057666|158373356|FG000|Open-Label Treatment Period|Poor tolerability|0|||
49145821|NCT02057666|158373357|FG001|Open-Label Treatment Period|Poor tolerability|1|||
49145822|NCT02057666|158373356|FG000|Open-Label Treatment Period|Symptomatic disease progression|0|||
49145823|NCT02057666|158373357|FG001|Open-Label Treatment Period|Symptomatic disease progression|1|||
49013702|NCT00606684|157887158|FG002|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
49013703|NCT00606684|157887159|FG003|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
49013704|NCT00606684|157887160|FG004|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
49013705|NCT00606684|157887161|FG005|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
49013706|NCT00606684|157887162|FG006|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
49013707|NCT00606684|157887156|FG000|2-week Single-Blind Run-in Period|Physician Decision|18|||
49013708|NCT00606684|157887157|FG001|2-week Single-Blind Run-in Period|Physician Decision|0|||
49013709|NCT00606684|157887158|FG002|2-week Single-Blind Run-in Period|Physician Decision|0|||
49013710|NCT00606684|157887159|FG003|2-week Single-Blind Run-in Period|Physician Decision|0|||
49013711|NCT00606684|157887160|FG004|2-week Single-Blind Run-in Period|Physician Decision|0|||
49013712|NCT00606684|157887161|FG005|2-week Single-Blind Run-in Period|Physician Decision|0|||
49013713|NCT00606684|157887162|FG006|2-week Single-Blind Run-in Period|Physician Decision|0|||
49013714|NCT00606684|157887156|FG000|2-week Single-Blind Run-in Period|Withdrawal by Subject|15|||
49013715|NCT00606684|157887157|FG001|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
49145824|NCT02057666|158373356|FG000|Open-Label Treatment Period|Sponsor's request|0|||
49145825|NCT02057666|158373357|FG001|Open-Label Treatment Period|Sponsor's request|4|||
49145826|NCT03769116|158373360|FG000|Part 3 - Open Label|Study Terminated by Sponsor|1|||
49145827|NCT03769116|158373361|FG001|Part 3 - Open Label|Study Terminated by Sponsor|2|||
49013716|NCT00606684|157887158|FG002|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
49013717|NCT00606684|157887159|FG003|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
49013718|NCT00606684|157887160|FG004|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
49013719|NCT00606684|157887161|FG005|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
49013720|NCT00606684|157887162|FG006|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
49013721|NCT00606684|157887156|FG000|2-week Single-Blind Run-in Period|Lost to Follow-up|5|||
49013722|NCT00606684|157887157|FG001|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
49013723|NCT00606684|157887158|FG002|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
48823177|NCT01628874|157192353|FG001|Overall Study|Physician Decision|1|||
48823178|NCT01628874|157192352|FG000|Overall Study|Age >4 months|4|||
49145828|NCT03769116|158373360|FG000|Part 3 - Open Label|Physician Decision|1|||
49145829|NCT03769116|158373361|FG001|Part 3 - Open Label|Physician Decision|0|||
49145830|NCT03769116|158373360|FG000|Part 3 - Open Label|Withdrawal by Subject|1|||
49145831|NCT03769116|158373361|FG001|Part 3 - Open Label|Withdrawal by Subject|0|||
49145832|NCT06048705|158373362|FG000|Overall Study|Physician Decision|1|||
49145833|NCT06048705|158373363|FG001|Overall Study|Physician Decision|0|||
49145834|NCT06048705|158373364|FG002|Overall Study|Physician Decision|0|||
49145835|NCT06048705|158373362|FG000|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
49145836|NCT06048705|158373363|FG001|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
49145837|NCT06048705|158373364|FG002|Overall Study|Did not meet Inclusion/Exclusion Criteria|1|||
49145838|NCT06048705|158373362|FG000|Overall Study|Death prior to lymphodepletion|0|||
49145839|NCT06048705|158373363|FG001|Overall Study|Death prior to lymphodepletion|0|||
49145840|NCT06048705|158373364|FG002|Overall Study|Death prior to lymphodepletion|1|||
49145841|NCT04042311|158373365|FG000|Overall Study|Abnormal cardiopulmonary exercise test (CPET) or unable to achieve a maximal test|9|||
49145842|NCT04042311|158373365|FG000|Overall Study|Unable to tolerate|4|||
49145843|NCT04042311|158373365|FG000|Overall Study|Concurrent illness|2|||
49145844|NCT04042311|158373365|FG000|Overall Study|Adverse Event|2|||
49145845|NCT04042311|158373365|FG000|Overall Study|No longer meeting inclusion criteria|2|||
49145846|NCT04042311|158373365|FG000|Overall Study|No reason given|1|||
49145847|NCT04042311|158373365|FG000|Overall Study|Withdrawal by Subject|4|||
49145848|NCT01341990|158373366|FG000|Overall Study|Adverse Event|0|||
49145849|NCT01341990|158373367|FG001|Overall Study|Adverse Event|1|||
49145850|NCT01341990|158373366|FG000|Overall Study|Torn Study Lens|1|||
49145851|NCT01341990|158373367|FG001|Overall Study|Torn Study Lens|0|||
49145852|NCT01341990|158373366|FG000|Overall Study|Withdrawal by Subject|2|||
49145853|NCT01341990|158373367|FG001|Overall Study|Withdrawal by Subject|0|||
49145854|NCT01943825|158373368|FG000|Overall Study|Lost to Follow-up|9|||
49145855|NCT01943825|158373369|FG001|Overall Study|Lost to Follow-up|3|||
49013724|NCT00606684|157887159|FG003|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
49145856|NCT01943825|158373370|FG002|Overall Study|Lost to Follow-up|12|||
49145857|NCT01943825|158373371|FG003|Overall Study|Lost to Follow-up|8|||
49145858|NCT01943825|158373368|FG000|Overall Study|Withdrawal by Subject|1|||
49145859|NCT01943825|158373369|FG001|Overall Study|Withdrawal by Subject|0|||
49145860|NCT01943825|158373370|FG002|Overall Study|Withdrawal by Subject|3|||
49013725|NCT00606684|157887160|FG004|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
49013726|NCT00606684|157887161|FG005|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
49145861|NCT01943825|158373371|FG003|Overall Study|Withdrawal by Subject|2|||
49145862|NCT01943825|158373368|FG000|Overall Study|Other than specified above|0|||
49145863|NCT01943825|158373369|FG001|Overall Study|Other than specified above|1|||
49145864|NCT01943825|158373370|FG002|Overall Study|Other than specified above|0|||
49145865|NCT01943825|158373371|FG003|Overall Study|Other than specified above|1|||
49145866|NCT02268851|158373373|FG000|Overall Study|Death|0|||
49145867|NCT02268851|158373374|FG001|Overall Study|Death|0|||
48823179|NCT01628874|157192353|FG001|Overall Study|Age >4 months|2|||
49145868|NCT02268851|158373375|FG002|Overall Study|Death|0|||
49145869|NCT02268851|158373376|FG003|Overall Study|Death|1|||
48823180|NCT03398356|157192367|FG000|Before Treatment|Lost to Follow-up|1|||
48823181|NCT03398356|157192368|FG001|Before Treatment|Lost to Follow-up|2|||
48823182|NCT03398356|157192369|FG002|Before Treatment|Lost to Follow-up|0|||
49145870|NCT02268851|158373377|FG004|Overall Study|Death|2|||
49145871|NCT02268851|158373378|FG005|Overall Study|Death|1|||
49145872|NCT02268851|158373373|FG000|Overall Study|Adverse Event|0|||
49145873|NCT02268851|158373374|FG001|Overall Study|Adverse Event|0|||
49145874|NCT02268851|158373375|FG002|Overall Study|Adverse Event|0|||
49145875|NCT02268851|158373376|FG003|Overall Study|Adverse Event|0|||
49145876|NCT02268851|158373377|FG004|Overall Study|Adverse Event|2|||
49145877|NCT02268851|158373378|FG005|Overall Study|Adverse Event|2|||
48823183|NCT03398356|157192367|FG000|Before Treatment|drug intolerance|2|||
48823184|NCT03398356|157192368|FG001|Before Treatment|drug intolerance|1|||
48823185|NCT03398356|157192369|FG002|Before Treatment|drug intolerance|0|||
48823186|NCT03398356|157192367|FG000|Before Treatment|Withdrawal by Subject|0|||
48823187|NCT03398356|157192368|FG001|Before Treatment|Withdrawal by Subject|5|||
48823188|NCT03398356|157192369|FG002|Before Treatment|Withdrawal by Subject|0|||
48823189|NCT03398356|157192367|FG000|Before Treatment|Physician Decision|0|||
48823190|NCT03398356|157192368|FG001|Before Treatment|Physician Decision|0|||
49145878|NCT02268851|158373373|FG000|Overall Study|Withdrawal by Subject|0|||
49145879|NCT02268851|158373374|FG001|Overall Study|Withdrawal by Subject|0|||
49145880|NCT02268851|158373375|FG002|Overall Study|Withdrawal by Subject|0|||
49145881|NCT02268851|158373376|FG003|Overall Study|Withdrawal by Subject|2|||
49145882|NCT02268851|158373377|FG004|Overall Study|Withdrawal by Subject|0|||
49145883|NCT02268851|158373378|FG005|Overall Study|Withdrawal by Subject|1|||
49145884|NCT02268851|158373373|FG000|Overall Study|Progressive Disease|1|||
48823191|NCT03398356|157192369|FG002|Before Treatment|Physician Decision|11|||
48823192|NCT03398356|157192367|FG000|After 6 Weeks of Treatment|Physician Decision|0|||
48823193|NCT03398356|157192368|FG001|After 6 Weeks of Treatment|Physician Decision|2|||
48823194|NCT03398356|157192369|FG002|After 6 Weeks of Treatment|Physician Decision|0|||
48823195|NCT01627340|157192370|FG000|Overall Study|Adverse Event|1|||
48823196|NCT01627340|157192371|FG001|Overall Study|Adverse Event|0|||
48823197|NCT01627340|157192370|FG000|Overall Study|Lost to Follow-up|8|||
48823198|NCT01627340|157192371|FG001|Overall Study|Lost to Follow-up|4|||
48823199|NCT01627340|157192370|FG000|Overall Study|Pregnancy|1|||
48823200|NCT01627340|157192371|FG001|Overall Study|Pregnancy|0|||
49145885|NCT02268851|158373374|FG001|Overall Study|Progressive Disease|3|||
49145886|NCT02268851|158373375|FG002|Overall Study|Progressive Disease|0|||
49145887|NCT02268851|158373376|FG003|Overall Study|Progressive Disease|0|||
49145888|NCT02268851|158373377|FG004|Overall Study|Progressive Disease|1|||
48730704|NCT04612790|156865870|FG003|OLE Period (Up to 1 Year)|Withdrawal by Subject|1|||
48730705|NCT04612790|156865867|FG000|OLE Period (Up to 1 Year)|Investigator decision|0|||
48730706|NCT04612790|156865868|FG001|OLE Period (Up to 1 Year)|Investigator decision|0|||
48730707|NCT04612790|156865869|FG002|OLE Period (Up to 1 Year)|Investigator decision|2|||
48730708|NCT04612790|156865870|FG003|OLE Period (Up to 1 Year)|Investigator decision|1|||
48730709|NCT04612790|156865867|FG000|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
48730710|NCT04612790|156865868|FG001|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
48823201|NCT01627340|157192370|FG000|Overall Study|Withdrawal by Subject|2|||
48823202|NCT01627340|157192371|FG001|Overall Study|Withdrawal by Subject|0|||
48823203|NCT01272011|157192372|FG000|Overall Study|Withdrawal By Subject or Failed Screen|0|||
48823204|NCT01272011|157192373|FG001|Overall Study|Withdrawal By Subject or Failed Screen|2|||
48823205|NCT01272011|157192374|FG002|Overall Study|Withdrawal By Subject or Failed Screen|0|||
48823206|NCT02240680|157192375|FG000|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
48823207|NCT02240680|157192376|FG001|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
48823208|NCT02240680|157192377|FG002|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
48823209|NCT02240680|157192378|FG003|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
48823210|NCT02240680|157192375|FG000|Overall Study (Up to 24 Weeks)|Protocol Violation|4|||
48823211|NCT02240680|157192376|FG001|Overall Study (Up to 24 Weeks)|Protocol Violation|1|||
48823212|NCT02240680|157192377|FG002|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
48823213|NCT02240680|157192378|FG003|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
48823214|NCT02240680|157192375|FG000|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1|||
49145889|NCT02268851|158373378|FG005|Overall Study|Progressive Disease|4|||
49145890|NCT02268851|158373373|FG000|Overall Study|Physician Decision|0|||
49145891|NCT02268851|158373374|FG001|Overall Study|Physician Decision|0|||
49145892|NCT02268851|158373375|FG002|Overall Study|Physician Decision|1|||
49145893|NCT02268851|158373376|FG003|Overall Study|Physician Decision|0|||
49145894|NCT02268851|158373377|FG004|Overall Study|Physician Decision|0|||
49145895|NCT02268851|158373378|FG005|Overall Study|Physician Decision|1|||
49145896|NCT02268851|158373373|FG000|Overall Study|Patient Compliance|0|||
49145897|NCT02268851|158373374|FG001|Overall Study|Patient Compliance|0|||
49145898|NCT02268851|158373375|FG002|Overall Study|Patient Compliance|0|||
49145899|NCT02268851|158373376|FG003|Overall Study|Patient Compliance|0|||
49145900|NCT02268851|158373377|FG004|Overall Study|Patient Compliance|1|||
49145901|NCT02268851|158373378|FG005|Overall Study|Patient Compliance|1|||
49145902|NCT02268851|158373373|FG000|Overall Study|Co-Morbid Condition|0|||
49145903|NCT02268851|158373374|FG001|Overall Study|Co-Morbid Condition|0|||
49145904|NCT02268851|158373375|FG002|Overall Study|Co-Morbid Condition|0|||
49145905|NCT02268851|158373376|FG003|Overall Study|Co-Morbid Condition|0|||
49145906|NCT02268851|158373377|FG004|Overall Study|Co-Morbid Condition|1|||
49145907|NCT02268851|158373378|FG005|Overall Study|Co-Morbid Condition|1|||
49145908|NCT01694771|158373397|FG000|Overall Study|Adverse Event|18|||
49145909|NCT01694771|158373398|FG001|Overall Study|Adverse Event|16|||
49145910|NCT01694771|158373397|FG000|Overall Study|Lack of Efficacy|1|||
49145911|NCT01694771|158373398|FG001|Overall Study|Lack of Efficacy|0|||
49145912|NCT01694771|158373397|FG000|Overall Study|Non compliance protocol|7|||
49145913|NCT01694771|158373398|FG001|Overall Study|Non compliance protocol|6|||
49145914|NCT01694771|158373397|FG000|Overall Study|Lost to Follow-up|2|||
49145915|NCT01694771|158373398|FG001|Overall Study|Lost to Follow-up|3|||
49145916|NCT01694771|158373397|FG000|Overall Study|Consent withdrawn|7|||
49145917|NCT01694771|158373398|FG001|Overall Study|Consent withdrawn|9|||
49145918|NCT01694771|158373397|FG000|Overall Study|Other reasons|5|||
49145919|NCT01694771|158373398|FG001|Overall Study|Other reasons|6|||
49145920|NCT00890097|158373399|FG000|Overall Study|Adverse Event|21|||
49145921|NCT00890097|158373400|FG001|Overall Study|Adverse Event|32|||
49145922|NCT00890097|158373401|FG002|Overall Study|Adverse Event|28|||
49145923|NCT00890097|158373399|FG000|Overall Study|Decision Unrelated to an Adverse Event|15|||
49145924|NCT00890097|158373400|FG001|Overall Study|Decision Unrelated to an Adverse Event|12|||
49145925|NCT00890097|158373401|FG002|Overall Study|Decision Unrelated to an Adverse Event|17|||
49145926|NCT00890097|158373399|FG000|Overall Study|Withdrew Consent|9|||
49145927|NCT00890097|158373400|FG001|Overall Study|Withdrew Consent|6|||
49145928|NCT00890097|158373401|FG002|Overall Study|Withdrew Consent|9|||
49145929|NCT00890097|158373399|FG000|Overall Study|Lost to Follow-up|5|||
49145930|NCT00890097|158373400|FG001|Overall Study|Lost to Follow-up|5|||
49145931|NCT00890097|158373401|FG002|Overall Study|Lost to Follow-up|5|||
49145932|NCT00890097|158373399|FG000|Overall Study|Noncompliance|0|||
49145933|NCT00890097|158373400|FG001|Overall Study|Noncompliance|4|||
49145934|NCT00890097|158373401|FG002|Overall Study|Noncompliance|4|||
49145935|NCT00890097|158373399|FG000|Overall Study|Sponsor Decision|7|||
49145936|NCT00890097|158373400|FG001|Overall Study|Sponsor Decision|11|||
49145937|NCT00890097|158373401|FG002|Overall Study|Sponsor Decision|7|||
49145938|NCT00890097|158373399|FG000|Overall Study|Did not attend final visit|2|||
49145939|NCT00890097|158373400|FG001|Overall Study|Did not attend final visit|3|||
49145940|NCT00890097|158373401|FG002|Overall Study|Did not attend final visit|0|||
49145941|NCT00890097|158373399|FG000|Overall Study|Subject Decision|3|||
49145942|NCT00890097|158373400|FG001|Overall Study|Subject Decision|2|||
49145943|NCT00890097|158373401|FG002|Overall Study|Subject Decision|6|||
49145944|NCT00890097|158373399|FG000|Overall Study|Randomization Error|2|||
49145945|NCT00890097|158373400|FG001|Overall Study|Randomization Error|0|||
49145946|NCT00890097|158373401|FG002|Overall Study|Randomization Error|0|||
49145947|NCT00890097|158373399|FG000|Overall Study|Failed inclusion criteria|3|||
49145948|NCT00890097|158373400|FG001|Overall Study|Failed inclusion criteria|4|||
49145949|NCT00890097|158373401|FG002|Overall Study|Failed inclusion criteria|0|||
49145950|NCT00890097|158373399|FG000|Overall Study|Transportation|0|||
49145951|NCT00890097|158373400|FG001|Overall Study|Transportation|2|||
49145952|NCT00890097|158373401|FG002|Overall Study|Transportation|0|||
49145953|NCT00890097|158373399|FG000|Overall Study|Subject Moved|0|||
49145954|NCT00890097|158373400|FG001|Overall Study|Subject Moved|4|||
49145955|NCT00890097|158373401|FG002|Overall Study|Subject Moved|0|||
49145956|NCT00890097|158373399|FG000|Overall Study|Protocol Deviation|1|||
49145957|NCT00890097|158373400|FG001|Overall Study|Protocol Deviation|1|||
49145958|NCT00890097|158373401|FG002|Overall Study|Protocol Deviation|1|||
49145959|NCT00176254|158373402|FG000|Overall Study|Lost to Follow-up|1|||
49145960|NCT02613507|158373405|FG000|Pre-Treamtent|Participant request to discontinue study treatment|0|||
49145961|NCT02613507|158373406|FG001|Pre-Treamtent|Participant request to discontinue study treatment|5|||
49145962|NCT02613507|158373405|FG000|Pre-Treamtent|Participant withdrew consent|0|||
49145963|NCT02613507|158373406|FG001|Pre-Treamtent|Participant withdrew consent|4|||
49145964|NCT02613507|158373405|FG000|Pre-Treamtent|Participant no longer meets study criteria|1|||
48823215|NCT02240680|157192376|FG001|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
49145965|NCT02613507|158373406|FG001|Pre-Treamtent|Participant no longer meets study criteria|1|||
49145966|NCT02613507|158373405|FG000|Treatment|Not reported|3|||
49145967|NCT02613507|158373406|FG001|Treatment|Not reported|0|||
49145968|NCT02613507|158373405|FG000|Treatment|Other reasons|8|||
49145969|NCT02613507|158373406|FG001|Treatment|Other reasons|0|||
48823216|NCT02240680|157192377|FG002|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
48823217|NCT02240680|157192378|FG003|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
49145970|NCT02613507|158373405|FG000|Treatment|Participant no longer meets criteria|3|||
49145971|NCT02613507|158373406|FG001|Treatment|Participant no longer meets criteria|0|||
49145972|NCT02613507|158373405|FG000|Treatment|Maximum clinical benefit|5|||
49145973|NCT02613507|158373406|FG001|Treatment|Maximum clinical benefit|10|||
49145974|NCT02613507|158373405|FG000|Treatment|Lost to Follow-up|1|||
49145975|NCT02613507|158373406|FG001|Treatment|Lost to Follow-up|0|||
49145976|NCT02613507|158373405|FG000|Treatment|Participant withdrew consent|0|||
49145977|NCT02613507|158373406|FG001|Treatment|Participant withdrew consent|2|||
49145978|NCT02613507|158373405|FG000|Treatment|Participant request to discontinue study treatment|13|||
48823218|NCT02240680|157192375|FG000|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3|||
48823219|NCT02240680|157192376|FG001|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1|||
48823220|NCT02240680|157192377|FG002|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
48823221|NCT02240680|157192378|FG003|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
48823222|NCT02240680|157192375|FG000|Overall Study (Up to 24 Weeks)|Other than specified|1|||
48823223|NCT02240680|157192376|FG001|Overall Study (Up to 24 Weeks)|Other than specified|0|||
48823224|NCT02240680|157192377|FG002|Overall Study (Up to 24 Weeks)|Other than specified|0|||
48823225|NCT02240680|157192378|FG003|Overall Study (Up to 24 Weeks)|Other than specified|0|||
48823226|NCT02240680|157192375|FG000|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
48823227|NCT02240680|157192376|FG001|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
48823228|NCT02240680|157192377|FG002|Japanese Patients (Up to 52 Weeks)|Adverse Event|6|||
48823229|NCT02240680|157192378|FG003|Japanese Patients (Up to 52 Weeks)|Adverse Event|7|||
48823230|NCT02240680|157192375|FG000|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
48823231|NCT02240680|157192376|FG001|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
48823232|NCT02240680|157192377|FG002|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1|||
48823233|NCT02240680|157192378|FG003|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
48823234|NCT02240680|157192375|FG000|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
48823235|NCT02240680|157192376|FG001|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
48823236|NCT02240680|157192377|FG002|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1|||
48823237|NCT02240680|157192378|FG003|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
49145979|NCT02613507|158373406|FG001|Treatment|Participant request to discontinue study treatment|17|||
49145980|NCT02613507|158373405|FG000|Treatment|Adverse event unrelated to study drug|20|||
49145981|NCT02613507|158373406|FG001|Treatment|Adverse event unrelated to study drug|3|||
49145982|NCT02613507|158373405|FG000|Treatment|Death|2|||
49145983|NCT02613507|158373406|FG001|Treatment|Death|0|||
49145984|NCT02613507|158373405|FG000|Treatment|Study drug toxicity|19|||
49145985|NCT02613507|158373406|FG001|Treatment|Study drug toxicity|14|||
49145986|NCT02613507|158373405|FG000|Treatment|Disease progression|263|||
49145987|NCT02613507|158373406|FG001|Treatment|Disease progression|110|||
49145988|NCT02536339|158373407|FG000|Overall Study|Death|20|||
49145989|NCT02536339|158373407|FG000|Overall Study|Withdrawal by Subject|3|||
49145990|NCT02536339|158373407|FG000|Overall Study|Lost to Follow-up|2|||
49145991|NCT02536339|158373407|FG000|Overall Study|Treatment discontinued|2|||
49145992|NCT02536339|158373407|FG000|Overall Study|Physician Decision|1|||
49145993|NCT04579380|158374439|FG000|Overall Study|Death|9|||
49145994|NCT04579380|158374440|FG001|Overall Study|Death|22|||
49145995|NCT04579380|158374441|FG002|Overall Study|Death|22|||
49145996|NCT04579380|158374442|FG003|Overall Study|Death|17|||
49145997|NCT04579380|158374443|FG004|Overall Study|Death|6|||
49145998|NCT04579380|158374444|FG005|Overall Study|Death|21|||
49145999|NCT04579380|158374445|FG006|Overall Study|Death|10|||
49146000|NCT04579380|158374446|FG007|Overall Study|Death|11|||
49146001|NCT04579380|158374447|FG008|Overall Study|Death|25|||
49146002|NCT04579380|158374439|FG000|Overall Study|Withdrawal by Subject|0|||
49146003|NCT04579380|158374440|FG001|Overall Study|Withdrawal by Subject|3|||
49146004|NCT04579380|158374441|FG002|Overall Study|Withdrawal by Subject|4|||
49146005|NCT04579380|158374442|FG003|Overall Study|Withdrawal by Subject|0|||
49146006|NCT04579380|158374443|FG004|Overall Study|Withdrawal by Subject|1|||
49146007|NCT04579380|158374444|FG005|Overall Study|Withdrawal by Subject|2|||
49146008|NCT04579380|158374445|FG006|Overall Study|Withdrawal by Subject|0|||
49146009|NCT04579380|158374446|FG007|Overall Study|Withdrawal by Subject|1|||
49146010|NCT04579380|158374447|FG008|Overall Study|Withdrawal by Subject|2|||
49146011|NCT04579380|158374439|FG000|Overall Study|Ongoing|2|||
48823238|NCT03704298|157192379|FG000|Overall Study|Death|3|||
48823239|NCT03704298|157192380|FG001|Overall Study|Death|1|||
48823240|NCT03704298|157192381|FG002|Overall Study|Death|1|||
48823241|NCT03704298|157192382|FG003|Overall Study|Death|0|||
48823242|NCT03704298|157192379|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|1|||
48823243|NCT03704298|157192380|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
49146012|NCT04579380|158374440|FG001|Overall Study|Ongoing|6|||
48823244|NCT03704298|157192381|FG002|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
48823245|NCT03704298|157192382|FG003|Overall Study|Rollover to Long-term Follow-up Study Criteria|3|||
49146013|NCT04579380|158374441|FG002|Overall Study|Ongoing|4|||
48823246|NCT03704298|157192379|FG000|Overall Study|Withdrawal by Subject|1|||
49146014|NCT04579380|158374442|FG003|Overall Study|Ongoing|8|||
49146015|NCT04579380|158374443|FG004|Overall Study|Ongoing|5|||
49146016|NCT04579380|158374444|FG005|Overall Study|Ongoing|8|||
49146017|NCT04579380|158374445|FG006|Overall Study|Ongoing|3|||
49146018|NCT04579380|158374446|FG007|Overall Study|Ongoing|19|||
49146019|NCT04579380|158374447|FG008|Overall Study|Ongoing|6|||
49146020|NCT05206604|158374448|FG000|Overall Study|Non-compliance with study drug|0|||
49146021|NCT05206604|158374449|FG001|Overall Study|Non-compliance with study drug|0|||
49146022|NCT05206604|158374450|FG002|Overall Study|Non-compliance with study drug|0|||
48823247|NCT03704298|157192380|FG001|Overall Study|Withdrawal by Subject|0|||
48823248|NCT03704298|157192381|FG002|Overall Study|Withdrawal by Subject|0|||
48823249|NCT03704298|157192382|FG003|Overall Study|Withdrawal by Subject|0|||
48823250|NCT03704298|157192379|FG000|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
48823251|NCT03704298|157192380|FG001|Overall Study|Developed Other Infection Before Starting the Treatment|1|||
48823252|NCT03704298|157192381|FG002|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
48823253|NCT03704298|157192382|FG003|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
49146023|NCT05206604|158374451|FG003|Overall Study|Non-compliance with study drug|0|||
49146024|NCT05206604|158374452|FG004|Overall Study|Non-compliance with study drug|0|||
49146025|NCT05206604|158374453|FG005|Overall Study|Non-compliance with study drug|1|||
49146026|NCT05206604|158374454|FG006|Overall Study|Non-compliance with study drug|0|||
49146027|NCT05206604|158374455|FG007|Overall Study|Non-compliance with study drug|0|||
49146028|NCT04941898|158374456|FG000|Overall Study|Protocol Violation|1|||
48823254|NCT00184028|157192385|FG000|Overall Study|Death|1|||
48823255|NCT00184028|157192385|FG000|Overall Study|Lack of Efficacy|4|||
48823256|NCT00184028|157192385|FG000|Overall Study|Adverse Event|2|||
48823257|NCT00184028|157192385|FG000|Overall Study|Withdrawal by Subject|1|||
48823258|NCT00184028|157192385|FG000|Overall Study|Non-compliance|2|||
48823259|NCT01606189|157192386|FG000|Second Intenvention (14-20 Days)|Adverse Event|0|||
49146029|NCT01862029|158374457|FG000|Overall Study|Physician Decision|1|||
49146030|NCT03931785|158374458|FG000|Overall Study|Lost to Follow-up|4|||
49146031|NCT03931785|158374459|FG001|Overall Study|Lost to Follow-up|1|||
49146032|NCT03931785|158374460|FG002|Overall Study|Lost to Follow-up|4|||
49146033|NCT03931785|158374461|FG003|Overall Study|Lost to Follow-up|3|||
49146034|NCT03931785|158374458|FG000|Overall Study|Adverse Event|1|||
49146035|NCT03931785|158374459|FG001|Overall Study|Adverse Event|0|||
49146036|NCT03931785|158374460|FG002|Overall Study|Adverse Event|3|||
49146037|NCT03931785|158374461|FG003|Overall Study|Adverse Event|4|||
49146038|NCT03931785|158374458|FG000|Overall Study|Protocol Violation|0|||
49146039|NCT03931785|158374459|FG001|Overall Study|Protocol Violation|1|||
49146040|NCT03931785|158374460|FG002|Overall Study|Protocol Violation|0|||
49146041|NCT03931785|158374461|FG003|Overall Study|Protocol Violation|0|||
49146042|NCT03931785|158374458|FG000|Overall Study|Noncompliance With Study drug|0|||
49146043|NCT03931785|158374459|FG001|Overall Study|Noncompliance With Study drug|1|||
49146044|NCT03931785|158374460|FG002|Overall Study|Noncompliance With Study drug|0|||
49146045|NCT03931785|158374461|FG003|Overall Study|Noncompliance With Study drug|0|||
49146046|NCT03931785|158374458|FG000|Overall Study|Other Not specified|0|||
49146047|NCT03931785|158374459|FG001|Overall Study|Other Not specified|2|||
49146048|NCT03931785|158374460|FG002|Overall Study|Other Not specified|2|||
49146049|NCT03931785|158374461|FG003|Overall Study|Other Not specified|2|||
49146050|NCT03931785|158374458|FG000|Overall Study|Withdrawal by Subject|0|||
49146051|NCT03931785|158374459|FG001|Overall Study|Withdrawal by Subject|2|||
49146052|NCT03931785|158374460|FG002|Overall Study|Withdrawal by Subject|4|||
49146053|NCT03931785|158374461|FG003|Overall Study|Withdrawal by Subject|1|||
48823260|NCT01606189|157192387|FG001|Second Intenvention (14-20 Days)|Adverse Event|0|||
48823261|NCT01606189|157192388|FG002|Second Intenvention (14-20 Days)|Adverse Event|0|||
48823262|NCT01606189|157192389|FG003|Second Intenvention (14-20 Days)|Adverse Event|0|||
49146054|NCT03931785|158374458|FG000|Overall Study|Pregnancy|0|||
49146055|NCT03931785|158374459|FG001|Overall Study|Pregnancy|0|||
49146056|NCT03931785|158374460|FG002|Overall Study|Pregnancy|0|||
49146057|NCT03931785|158374461|FG003|Overall Study|Pregnancy|1|||
49146058|NCT04605588|158374465|FG000|Overall Study|Withdrawal by Subject|1|||
49146059|NCT04605588|158374466|FG001|Overall Study|Withdrawal by Subject|0|||
49146060|NCT01230814|158374467|FG000|Overall Study|Lost to Follow-up|11|||
49146061|NCT01230814|158374468|FG001|Overall Study|Lost to Follow-up|3|||
49146062|NCT01230814|158374467|FG000|Overall Study|Discontinued (not due to adverse event)|2|||
49146063|NCT01230814|158374468|FG001|Overall Study|Discontinued (not due to adverse event)|1|||
49146064|NCT01803737|158374471|FG000|Overall Study|Lack of Time|1|||
49146065|NCT01803737|158374472|FG001|Overall Study|Lack of Time|0|||
49146066|NCT01803737|158374471|FG000|Overall Study|Medical Reason|0|||
49146067|NCT01803737|158374472|FG001|Overall Study|Medical Reason|1|||
49146068|NCT01803737|158374471|FG000|Overall Study|Lost to Follow-up|0|||
49146069|NCT01803737|158374472|FG001|Overall Study|Lost to Follow-up|2|||
49146070|NCT02502383|158374475|FG000|Overall Study|Lost to Follow-up|130|||
49146071|NCT02502383|158374476|FG001|Overall Study|Lost to Follow-up|131|||
49146072|NCT02502383|158374475|FG000|Overall Study|Withdrawal by Subject|31|||
49146073|NCT02502383|158374476|FG001|Overall Study|Withdrawal by Subject|24|||
49146074|NCT01052428|158374477|FG000|Overall Study|Death|1|||
49146075|NCT01052428|158374478|FG001|Overall Study|Death|0|||
49146076|NCT01052428|158374477|FG000|Overall Study|Withdrawal by Subject|0|||
49146077|NCT01052428|158374478|FG001|Overall Study|Withdrawal by Subject|1|||
48823263|NCT01606189|157192390|FG004|Second Intenvention (14-20 Days)|Adverse Event|0|||
48823264|NCT01606189|157192391|FG005|Second Intenvention (14-20 Days)|Adverse Event|1|||
49146078|NCT01034657|158374479|FG000|Core Phase|Withdrawal by Subject|1|||
49146079|NCT01034657|158374480|FG001|Core Phase|Withdrawal by Subject|0|||
49146080|NCT01034657|158374481|FG002|Core Phase|Withdrawal by Subject|0|||
49146081|NCT01034657|158374479|FG000|Core Phase|Lack of Efficacy|2|||
49146082|NCT01034657|158374480|FG001|Core Phase|Lack of Efficacy|0|||
49146083|NCT01034657|158374481|FG002|Core Phase|Lack of Efficacy|0|||
49146084|NCT01034657|158374479|FG000|Core Phase|Abnormal laboratory value|1|||
49146085|NCT01034657|158374480|FG001|Core Phase|Abnormal laboratory value|0|||
49146086|NCT01034657|158374481|FG002|Core Phase|Abnormal laboratory value|0|||
49146087|NCT01034657|158374479|FG000|Core Phase|Adverse Event|8|||
49146088|NCT01034657|158374480|FG001|Core Phase|Adverse Event|0|||
49146089|NCT01034657|158374481|FG002|Core Phase|Adverse Event|0|||
49146090|NCT01034657|158374479|FG000|Core Phase|Protocol Violation|2|||
49146091|NCT01034657|158374480|FG001|Core Phase|Protocol Violation|0|||
49146092|NCT01034657|158374481|FG002|Core Phase|Protocol Violation|0|||
49146093|NCT01034657|158374479|FG000|Randomized Phase|Withdrawal by Subject|0|||
49146094|NCT01034657|158374480|FG001|Randomized Phase|Withdrawal by Subject|2|||
49146095|NCT01034657|158374481|FG002|Randomized Phase|Withdrawal by Subject|0|||
49146096|NCT01034657|158374479|FG000|Randomized Phase|Lack of Efficacy|5|||
49146097|NCT01034657|158374480|FG001|Randomized Phase|Lack of Efficacy|1|||
49146098|NCT01034657|158374481|FG002|Randomized Phase|Lack of Efficacy|0|||
49146099|NCT01034657|158374479|FG000|Randomized Phase|Abnormal laboratory value|0|||
49146100|NCT01034657|158374480|FG001|Randomized Phase|Abnormal laboratory value|1|||
49146101|NCT01034657|158374481|FG002|Randomized Phase|Abnormal laboratory value|0|||
49146102|NCT01034657|158374479|FG000|Randomized Phase|Adverse Event|0|||
49146103|NCT01034657|158374480|FG001|Randomized Phase|Adverse Event|2|||
49146104|NCT01034657|158374481|FG002|Randomized Phase|Adverse Event|1|||
49146105|NCT01682603|158374482|FG000|Overall Study|Lost to Follow-up|3|||
49146106|NCT01840163|158374483|FG000|First Follow up -Primary Outcome|Lost to Follow-up|19|||
49146107|NCT01840163|158374484|FG001|First Follow up -Primary Outcome|Lost to Follow-up|16|||
49146108|NCT01840163|158374483|FG000|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48|||
49146109|NCT01840163|158374484|FG001|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40|||
49146110|NCT01840163|158374483|FG000|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43|||
49146111|NCT01840163|158374484|FG001|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35|||
49146112|NCT03636269|158374485|FG000|Period 1: Double-blind Phase|Adverse Event|13|||
49146113|NCT03636269|158374486|FG001|Period 1: Double-blind Phase|Adverse Event|7|||
49146114|NCT03636269|158374487|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
49146115|NCT03636269|158374485|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
49146116|NCT03636269|158374486|FG001|Period 1: Double-blind Phase|Lack of Efficacy|0|||
49146117|NCT03636269|158374487|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
49146118|NCT03636269|158374485|FG000|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|2|||
49146119|NCT03636269|158374486|FG001|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
49146120|NCT03636269|158374487|FG002|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
49146121|NCT03636269|158374485|FG000|Period 1: Double-blind Phase|Withdrawal by Subject|5|||
49146122|NCT03636269|158374486|FG001|Period 1: Double-blind Phase|Withdrawal by Subject|1|||
49146123|NCT03636269|158374487|FG002|Period 1: Double-blind Phase|Withdrawal by Subject|0|||
49146124|NCT03636269|158374485|FG000|Period 1: Double-blind Phase|Other|6|||
49146125|NCT03636269|158374486|FG001|Period 1: Double-blind Phase|Other|3|||
49146126|NCT03636269|158374487|FG002|Period 1: Double-blind Phase|Other|0|||
49146127|NCT03636269|158374485|FG000|Period 1: Double-blind Phase|Lost to Follow-up|1|||
49146128|NCT03636269|158374486|FG001|Period 1: Double-blind Phase|Lost to Follow-up|0|||
49146129|NCT03636269|158374487|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
49146130|NCT03636269|158374485|FG000|Period 1: Double-blind Phase|Subject non-compliance|1|||
49146131|NCT03636269|158374486|FG001|Period 1: Double-blind Phase|Subject non-compliance|2|||
49146132|NCT03636269|158374487|FG002|Period 1: Double-blind Phase|Subject non-compliance|0|||
49146133|NCT03636269|158374485|FG000|Period 2: Open-label Phase|Adverse Event|0|||
49146134|NCT03636269|158374486|FG001|Period 2: Open-label Phase|Adverse Event|0|||
49146135|NCT03636269|158374487|FG002|Period 2: Open-label Phase|Adverse Event|21|||
49146136|NCT03636269|158374485|FG000|Period 2: Open-label Phase|Lack of Efficacy|0|||
49146137|NCT03636269|158374486|FG001|Period 2: Open-label Phase|Lack of Efficacy|0|||
49146138|NCT03636269|158374487|FG002|Period 2: Open-label Phase|Lack of Efficacy|2|||
49146139|NCT03636269|158374485|FG000|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
49146140|NCT03636269|158374486|FG001|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
49146141|NCT03636269|158374487|FG002|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|2|||
49146142|NCT03636269|158374485|FG000|Period 2: Open-label Phase|Withdrawal by Subject|0|||
49146143|NCT03636269|158374486|FG001|Period 2: Open-label Phase|Withdrawal by Subject|0|||
49146144|NCT03636269|158374487|FG002|Period 2: Open-label Phase|Withdrawal by Subject|11|||
49146145|NCT03636269|158374485|FG000|Period 2: Open-label Phase|Administrative|0|||
49146146|NCT03636269|158374486|FG001|Period 2: Open-label Phase|Administrative|0|||
49146147|NCT03636269|158374487|FG002|Period 2: Open-label Phase|Administrative|36|||
49146148|NCT03636269|158374485|FG000|Period 2: Open-label Phase|Other|0|||
49146149|NCT03636269|158374486|FG001|Period 2: Open-label Phase|Other|0|||
49146150|NCT03636269|158374487|FG002|Period 2: Open-label Phase|Other|9|||
49146151|NCT03636269|158374485|FG000|Period 2: Open-label Phase|Sponsor stopping study|0|||
49146152|NCT03636269|158374486|FG001|Period 2: Open-label Phase|Sponsor stopping study|0|||
49146153|NCT03636269|158374487|FG002|Period 2: Open-label Phase|Sponsor stopping study|313|||
49146154|NCT02217982|158374488|FG000|Overall Study|Trial discontinued|1|||
49146155|NCT02217982|158374489|FG001|Overall Study|Trial discontinued|0|||
49146156|NCT02217982|158374488|FG000|Overall Study|Adverse Event|0|||
49146157|NCT02217982|158374489|FG001|Overall Study|Adverse Event|1|||
49146158|NCT03865706|158374506|FG000|Overall Study|Death|0|||
49146159|NCT03865706|158374507|FG001|Overall Study|Death|3|||
49146160|NCT03865706|158374508|FG002|Overall Study|Death|1|||
49146161|NCT04829214|158374509|FG000|Follow-up and Efficacy Analysis|Withdrawal by Subject|5|||
49146162|NCT04829214|158374510|FG001|Follow-up and Efficacy Analysis|Withdrawal by Subject|3|||
49146163|NCT04829214|158374509|FG000|Follow-up and Efficacy Analysis|Lost to Follow-up|2|||
49146164|NCT04829214|158374510|FG001|Follow-up and Efficacy Analysis|Lost to Follow-up|1|||
49146165|NCT01229111|158374511|FG000|Overall Study|Death|1|||
49146166|NCT03093870|158374514|FG000|Overall Study|Withdrawal by Subject|2|||
49146167|NCT03093870|158374515|FG001|Overall Study|Withdrawal by Subject|6|||
49146168|NCT03093870|158374516|FG002|Overall Study|Withdrawal by Subject|5|||
49146169|NCT03093870|158374514|FG000|Overall Study|Death|1|||
48730711|NCT04612790|156865869|FG002|OLE Period (Up to 1 Year)|Study terminated by sponsor|14|||
49146170|NCT03093870|158374515|FG001|Overall Study|Death|35|||
49146171|NCT03093870|158374516|FG002|Overall Study|Death|35|||
49146172|NCT03093870|158374514|FG000|Overall Study|Radiographic disease progression|10|||
49146173|NCT03093870|158374515|FG001|Overall Study|Radiographic disease progression|0|||
49146174|NCT03093870|158374516|FG002|Overall Study|Radiographic disease progression|0|||
49146175|NCT03093870|158374514|FG000|Overall Study|Clinical disease progression|1|||
49146176|NCT03093870|158374515|FG001|Overall Study|Clinical disease progression|0|||
49146177|NCT03093870|158374516|FG002|Overall Study|Clinical disease progression|0|||
49146178|NCT03093870|158374514|FG000|Overall Study|Physician Decision|2|||
49146179|NCT03093870|158374515|FG001|Overall Study|Physician Decision|0|||
49146180|NCT03093870|158374516|FG002|Overall Study|Physician Decision|0|||
49146181|NCT03093870|158374514|FG000|Overall Study|Adverse Event|7|||
49146182|NCT03093870|158374515|FG001|Overall Study|Adverse Event|0|||
49146183|NCT03093870|158374516|FG002|Overall Study|Adverse Event|0|||
49146184|NCT03093870|158374514|FG000|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1|||
49146185|NCT03093870|158374515|FG001|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
49146186|NCT03093870|158374516|FG002|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
49146187|NCT03093870|158374514|FG000|Overall Study|Lost to Follow-up|0|||
49146188|NCT03093870|158374515|FG001|Overall Study|Lost to Follow-up|0|||
49146189|NCT03093870|158374516|FG002|Overall Study|Lost to Follow-up|1|||
49146190|NCT05261490|158374517|FG000|Overall Study|Other|1|||
49146191|NCT05261490|158374518|FG001|Overall Study|Other|0|||
49146192|NCT05261490|158374519|FG002|Overall Study|Other|0|||
49146193|NCT05261490|158374517|FG000|Overall Study|Study Terminated by Sponsor|1|||
49146194|NCT05261490|158374518|FG001|Overall Study|Study Terminated by Sponsor|1|||
49146195|NCT05261490|158374519|FG002|Overall Study|Study Terminated by Sponsor|4|||
49146196|NCT05261490|158374517|FG000|Overall Study|Death|1|||
49146197|NCT05261490|158374518|FG001|Overall Study|Death|2|||
49146198|NCT05261490|158374519|FG002|Overall Study|Death|0|||
49146199|NCT02314247|158374520|FG000|Overall Study|Adverse Event|2|||
49146200|NCT02314247|158374521|FG001|Overall Study|Adverse Event|1|||
49146201|NCT02314247|158374522|FG002|Overall Study|Adverse Event|0|||
49146202|NCT02314247|158374520|FG000|Overall Study|Withdrawal by Subject|1|||
49146203|NCT02314247|158374521|FG001|Overall Study|Withdrawal by Subject|3|||
49146204|NCT02314247|158374522|FG002|Overall Study|Withdrawal by Subject|1|||
49146205|NCT02314247|158374520|FG000|Overall Study|Progression of Disease|6|||
49146206|NCT02314247|158374521|FG001|Overall Study|Progression of Disease|2|||
49146207|NCT02314247|158374522|FG002|Overall Study|Progression of Disease|0|||
49146208|NCT05085405|158374523|FG000|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
49146209|NCT05085405|158374524|FG001|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
49146210|NCT05085405|158374525|FG002|Overall Study|Patient closed to the anticoagulation clinic monitoring service|1|||
48730712|NCT04612790|156865870|FG003|OLE Period (Up to 1 Year)|Study terminated by sponsor|15|||
48730713|NCT04612790|156865867|FG000|OLE Period (Up to 1 Year)|Other|0|||
48730714|NCT04612790|156865868|FG001|OLE Period (Up to 1 Year)|Other|0|||
48730715|NCT04612790|156865869|FG002|OLE Period (Up to 1 Year)|Other|0|||
48730716|NCT04612790|156865870|FG003|OLE Period (Up to 1 Year)|Other|1|||
48730717|NCT02806973|156865872|FG000|Period 1|Withdrawal by Subject|0|||
48730718|NCT02806973|156865873|FG001|Period 1|Withdrawal by Subject|2|||
48730719|NCT02806973|156865874|FG002|Period 1|Withdrawal by Subject|1|||
48730720|NCT02806973|156865875|FG003|Period 1|Withdrawal by Subject|1|||
48730721|NCT02806973|156865872|FG000|Period 1|Adverse Event|0|||
48730722|NCT02806973|156865873|FG001|Period 1|Adverse Event|0|||
48730723|NCT02806973|156865874|FG002|Period 1|Adverse Event|0|||
48730724|NCT02806973|156865875|FG003|Period 1|Adverse Event|1|||
48730725|NCT02806973|156865872|FG000|Period 3|Withdrawal by Subject|0|||
48730726|NCT02806973|156865873|FG001|Period 3|Withdrawal by Subject|0|||
48730727|NCT02806973|156865874|FG002|Period 3|Withdrawal by Subject|0|||
49146211|NCT05085405|158374526|FG003|Overall Study|Patient closed to the anticoagulation clinic monitoring service|2|||
49146212|NCT05085405|158374527|FG004|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
49146213|NCT05085405|158374528|FG005|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
49146214|NCT05085405|158374523|FG000|Overall Study|Patient started PPI prior to intervention delivery.|0|||
49146215|NCT05085405|158374524|FG001|Overall Study|Patient started PPI prior to intervention delivery.|0|||
49146216|NCT05085405|158374525|FG002|Overall Study|Patient started PPI prior to intervention delivery.|0|||
49146217|NCT05085405|158374526|FG003|Overall Study|Patient started PPI prior to intervention delivery.|1|||
49146218|NCT05085405|158374527|FG004|Overall Study|Patient started PPI prior to intervention delivery.|0|||
49146219|NCT05085405|158374528|FG005|Overall Study|Patient started PPI prior to intervention delivery.|0|||
49146220|NCT01871727|158374529|FG000|Lead-In Part (1 Year 2 Months)|Disease Progression|1|||
49146221|NCT01871727|158374530|FG001|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
49146222|NCT01871727|158374531|FG002|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
49146223|NCT01871727|158374532|FG003|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
49146224|NCT01871727|158374533|FG004|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
49146225|NCT01871727|158374529|FG000|Main Study Part (2 Years 4 Months)|Other|0|||
49146226|NCT01871727|158374530|FG001|Main Study Part (2 Years 4 Months)|Other|0|||
49146227|NCT01871727|158374531|FG002|Main Study Part (2 Years 4 Months)|Other|0|||
49146228|NCT01871727|158374532|FG003|Main Study Part (2 Years 4 Months)|Other|0|||
49146229|NCT01871727|158374533|FG004|Main Study Part (2 Years 4 Months)|Other|2|||
49146230|NCT01871727|158374529|FG000|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
49146231|NCT01871727|158374530|FG001|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
49146232|NCT01871727|158374531|FG002|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
49146233|NCT01871727|158374532|FG003|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
49146234|NCT01871727|158374533|FG004|Main Study Part (2 Years 4 Months)|Sponsor Decision|11|||
49146235|NCT01871727|158374529|FG000|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
49146236|NCT01871727|158374530|FG001|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
49146237|NCT01871727|158374531|FG002|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
48730728|NCT02806973|156865875|FG003|Period 3|Withdrawal by Subject|3|||
49146238|NCT01871727|158374532|FG003|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
49146239|NCT01871727|158374533|FG004|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|9|||
49146240|NCT01871727|158374529|FG000|Main Study Part (2 Years 4 Months)|Disease progression|0|||
49146241|NCT01871727|158374530|FG001|Main Study Part (2 Years 4 Months)|Disease progression|0|||
49146242|NCT01871727|158374531|FG002|Main Study Part (2 Years 4 Months)|Disease progression|0|||
49146243|NCT01871727|158374532|FG003|Main Study Part (2 Years 4 Months)|Disease progression|0|||
49146244|NCT01871727|158374533|FG004|Main Study Part (2 Years 4 Months)|Disease progression|20|||
49146245|NCT01871727|158374529|FG000|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
49146246|NCT01871727|158374530|FG001|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
49146247|NCT01871727|158374531|FG002|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
49146248|NCT01871727|158374532|FG003|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
49146249|NCT01871727|158374533|FG004|Main Study Part (2 Years 4 Months)|Lost to Follow-up|2|||
49146250|NCT01871727|158374529|FG000|Main Study Part (2 Years 4 Months)|Not treated|0|||
49146251|NCT01871727|158374530|FG001|Main Study Part (2 Years 4 Months)|Not treated|0|||
49146252|NCT01871727|158374531|FG002|Main Study Part (2 Years 4 Months)|Not treated|0|||
49146253|NCT01871727|158374532|FG003|Main Study Part (2 Years 4 Months)|Not treated|0|||
49146254|NCT01871727|158374533|FG004|Main Study Part (2 Years 4 Months)|Not treated|1|||
49146255|NCT01905267|158374534|FG000|Overall Study|Physician Decision|2|||
49146256|NCT01905267|158374535|FG001|Overall Study|Physician Decision|2|||
49146257|NCT03688139|158374541|FG000|Overall Study|Lost to Follow-up|2|||
49146258|NCT03688139|158374542|FG001|Overall Study|Lost to Follow-up|0|||
49146259|NCT03688139|158374541|FG000|Overall Study|Physician Decision|0|||
49146260|NCT03688139|158374542|FG001|Overall Study|Physician Decision|1|||
49146261|NCT03688139|158374541|FG000|Overall Study|Withdrawal by Subject|2|||
49146262|NCT03688139|158374542|FG001|Overall Study|Withdrawal by Subject|3|||
49146263|NCT00231465|158374543|FG000|Overall Study|Completed only one cycle|1|||
49146264|NCT00231465|158374543|FG000|Overall Study|Did not have follow up CT scans|1|||
49146265|NCT04380753|158374544|FG000|Overall Study|Participants continuing study|4|||
49146266|NCT04380753|158374544|FG000|Overall Study|Death|2|||
49146267|NCT01720602|158374545|FG000|Overall Study|Adverse Event|3|||
49146268|NCT01720602|158374545|FG000|Overall Study|Progressive disease on therapy|2|||
49146269|NCT01539525|158374548|FG000|Overall Study|Lost to Follow-up|19|||
49146270|NCT01539525|158374549|FG001|Overall Study|Lost to Follow-up|12|||
49146271|NCT01539525|158374550|FG002|Overall Study|Lost to Follow-up|11|||
49146272|NCT01539525|158374548|FG000|Overall Study|Withdrawal by Subject|0|||
48730729|NCT02806973|156865872|FG000|Period 3|Adverse Event|0|||
48730730|NCT02806973|156865873|FG001|Period 3|Adverse Event|0|||
48730731|NCT02806973|156865874|FG002|Period 3|Adverse Event|1|||
48730732|NCT02806973|156865875|FG003|Period 3|Adverse Event|0|||
48730733|NCT04029688|156865876|FG000|Overall Study|Death|8|||
48730734|NCT04029688|156865877|FG001|Overall Study|Death|3|||
48730735|NCT04029688|156865878|FG002|Overall Study|Death|6|||
49146273|NCT01539525|158374549|FG001|Overall Study|Withdrawal by Subject|3|||
49146274|NCT01539525|158374550|FG002|Overall Study|Withdrawal by Subject|2|||
49146275|NCT01539525|158374548|FG000|Overall Study|Protocol Violation|1|||
49146276|NCT01539525|158374549|FG001|Overall Study|Protocol Violation|1|||
49146277|NCT01539525|158374550|FG002|Overall Study|Protocol Violation|4|||
49146278|NCT02528305|158374551|FG000|Overall Study|Withdrawal by Subject|1|||
49146279|NCT02528305|158374551|FG000|Overall Study|Adverse Event|1|||
49146280|NCT02528305|158374551|FG000|Overall Study|Physician Decision|1|||
49146281|NCT03425188|158374552|FG000|Overall Study|Withdrawal by Subject|1|||
49146282|NCT01835431|158374553|FG000|Overall Study|Adverse Event|1|||
49146283|NCT01835431|158374554|FG001|Overall Study|Adverse Event|0|||
49146284|NCT01835431|158374553|FG000|Overall Study|other|0|||
49146285|NCT01835431|158374554|FG001|Overall Study|other|2|||
49146286|NCT01835431|158374553|FG000|Overall Study|Withdrawal by Subject|6|||
48823265|NCT01606189|157192386|FG000|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
48823266|NCT01606189|157192387|FG001|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
48823267|NCT01606189|157192388|FG002|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
48823268|NCT01606189|157192389|FG003|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
48823269|NCT01606189|157192390|FG004|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
48823270|NCT01606189|157192391|FG005|Third Intenvention (14-20 Days)|Withdrawal by Subject|1|||
48823271|NCT04796935|157192392|FG000|Overall Study|Withdrawal by Subject|0|||
48823272|NCT04796935|157192393|FG001|Overall Study|Withdrawal by Subject|1|||
48823273|NCT04796935|157192392|FG000|Overall Study|Physician Decision|0|||
48823274|NCT04796935|157192393|FG001|Overall Study|Physician Decision|1|||
48823275|NCT04796935|157192392|FG000|Overall Study|Device not available|1|||
48823276|NCT04796935|157192393|FG001|Overall Study|Device not available|0|||
48823277|NCT04796935|157192392|FG000|Overall Study|Trained provider not available|1|||
48823278|NCT04796935|157192393|FG001|Overall Study|Trained provider not available|0|||
49146287|NCT01835431|158374554|FG001|Overall Study|Withdrawal by Subject|10|||
49146288|NCT01835431|158374553|FG000|Overall Study|Protocol Violation|1|||
49146289|NCT01835431|158374554|FG001|Overall Study|Protocol Violation|0|||
49146290|NCT03878069|158374555|FG000|Overall Study|Death|0|||
49146291|NCT03878069|158374556|FG001|Overall Study|Death|1|||
49146292|NCT03878069|158374557|FG002|Overall Study|Death|0|||
49146293|NCT04971837|158375829|FG000|Overall Study|Long Term Illness|1|||
49146294|NCT04971837|158375829|FG000|Overall Study|BMI too low|9|||
49146295|NCT04971837|158375829|FG000|Overall Study|geographic location|1|||
49146296|NCT04971837|158375829|FG000|Overall Study|Discontinued scheduling conflict|1|||
49146297|NCT00758043|158375830|FG000|Overall Study|Adverse Event|1|||
49146298|NCT00758043|158375831|FG001|Overall Study|Adverse Event|20|||
49146299|NCT00758043|158375832|FG002|Overall Study|Adverse Event|12|||
49146300|NCT00758043|158375833|FG003|Overall Study|Adverse Event|62|||
49146301|NCT00758043|158375830|FG000|Overall Study|Lack of Efficacy|0|||
49146302|NCT00758043|158375831|FG001|Overall Study|Lack of Efficacy|6|||
49146303|NCT00758043|158375832|FG002|Overall Study|Lack of Efficacy|18|||
49146304|NCT00758043|158375833|FG003|Overall Study|Lack of Efficacy|12|||
49146305|NCT00758043|158375830|FG000|Overall Study|Refused Further Treatment|0|||
49146306|NCT00758043|158375831|FG001|Overall Study|Refused Further Treatment|11|||
49146307|NCT00758043|158375832|FG002|Overall Study|Refused Further Treatment|5|||
49146308|NCT00758043|158375833|FG003|Overall Study|Refused Further Treatment|8|||
49146309|NCT00758043|158375830|FG000|Overall Study|Lost to Follow-up|0|||
49146310|NCT00758043|158375831|FG001|Overall Study|Lost to Follow-up|2|||
49146311|NCT00758043|158375832|FG002|Overall Study|Lost to Follow-up|2|||
49146312|NCT00758043|158375833|FG003|Overall Study|Lost to Follow-up|5|||
49146313|NCT00758043|158375830|FG000|Overall Study|Withdrawal by Subject|0|||
49146314|NCT00758043|158375831|FG001|Overall Study|Withdrawal by Subject|1|||
49146315|NCT00758043|158375832|FG002|Overall Study|Withdrawal by Subject|1|||
49146316|NCT00758043|158375833|FG003|Overall Study|Withdrawal by Subject|4|||
49146317|NCT00758043|158375830|FG000|Overall Study|Required Prohibited Medication|0|||
49146318|NCT00758043|158375831|FG001|Overall Study|Required Prohibited Medication|0|||
49146319|NCT00758043|158375832|FG002|Overall Study|Required Prohibited Medication|1|||
49146320|NCT00758043|158375833|FG003|Overall Study|Required Prohibited Medication|3|||
49146321|NCT00758043|158375830|FG000|Overall Study|Non-Compliant With study Drug|0|||
48823279|NCT02162732|157192394|FG000|Overall Study|Biopsy not performed.|18|||
48823280|NCT02362035|157192395|FG000|Overall Study|Death|67|||
48823281|NCT02362035|157192395|FG000|Overall Study|Lost to Follow-up|3|||
48823282|NCT02362035|157192395|FG000|Overall Study|Adverse Event|1|||
48823283|NCT02362035|157192395|FG000|Overall Study|Physician Decision|1|||
48823284|NCT02362035|157192395|FG000|Overall Study|Subject started another cancer therapy|10|||
49146322|NCT00758043|158375831|FG001|Overall Study|Non-Compliant With study Drug|0|||
49146323|NCT00758043|158375832|FG002|Overall Study|Non-Compliant With study Drug|0|||
49146324|NCT00758043|158375833|FG003|Overall Study|Non-Compliant With study Drug|1|||
49146325|NCT00758043|158375830|FG000|Overall Study|Other Reasons|0|||
49146326|NCT00758043|158375831|FG001|Overall Study|Other Reasons|1|||
49146327|NCT00758043|158375832|FG002|Overall Study|Other Reasons|0|||
49146328|NCT00758043|158375833|FG003|Overall Study|Other Reasons|5|||
49146329|NCT00520572|158375834|FG000|Overall Study|Adverse Event|9|||
48823285|NCT02362035|157192395|FG000|Overall Study|Study terminated by sponsor|45|||
48823286|NCT02362035|157192395|FG000|Overall Study|Decision by subject not related to AE/SAE|2|||
49146330|NCT00520572|158375835|FG001|Overall Study|Adverse Event|3|||
49146331|NCT00520572|158375836|FG002|Overall Study|Adverse Event|6|||
49146332|NCT00520572|158375837|FG003|Overall Study|Adverse Event|9|||
49146333|NCT00520572|158375838|FG004|Overall Study|Adverse Event|7|||
49146334|NCT00520572|158375839|FG005|Overall Study|Adverse Event|2|||
49146335|NCT00520572|158375834|FG000|Overall Study|Withdrawal by Subject|0|||
49146336|NCT00520572|158375835|FG001|Overall Study|Withdrawal by Subject|9|||
49146337|NCT00520572|158375836|FG002|Overall Study|Withdrawal by Subject|5|||
49146338|NCT00520572|158375837|FG003|Overall Study|Withdrawal by Subject|2|||
49146339|NCT00520572|158375838|FG004|Overall Study|Withdrawal by Subject|2|||
49146340|NCT00520572|158375839|FG005|Overall Study|Withdrawal by Subject|0|||
49146341|NCT00520572|158375834|FG000|Overall Study|Protocol Violation|0|||
49146342|NCT00520572|158375835|FG001|Overall Study|Protocol Violation|0|||
49146343|NCT00520572|158375836|FG002|Overall Study|Protocol Violation|1|||
49146344|NCT00520572|158375837|FG003|Overall Study|Protocol Violation|0|||
49146345|NCT00520572|158375838|FG004|Overall Study|Protocol Violation|0|||
49146346|NCT00520572|158375839|FG005|Overall Study|Protocol Violation|0|||
49146347|NCT00520572|158375834|FG000|Overall Study|Lack of Efficacy|1|||
49146348|NCT00520572|158375835|FG001|Overall Study|Lack of Efficacy|1|||
49146349|NCT00520572|158375836|FG002|Overall Study|Lack of Efficacy|1|||
49146350|NCT00520572|158375837|FG003|Overall Study|Lack of Efficacy|2|||
49146351|NCT00520572|158375838|FG004|Overall Study|Lack of Efficacy|1|||
49146352|NCT00520572|158375839|FG005|Overall Study|Lack of Efficacy|0|||
49146353|NCT00520572|158375834|FG000|Overall Study|Lost to Follow-up|0|||
49146354|NCT00520572|158375835|FG001|Overall Study|Lost to Follow-up|0|||
49146355|NCT00520572|158375836|FG002|Overall Study|Lost to Follow-up|0|||
49146356|NCT00520572|158375837|FG003|Overall Study|Lost to Follow-up|0|||
49146357|NCT00520572|158375838|FG004|Overall Study|Lost to Follow-up|1|||
49146358|NCT00520572|158375839|FG005|Overall Study|Lost to Follow-up|0|||
49146359|NCT00520572|158375834|FG000|Overall Study|Incorrect enrollment|1|||
49146360|NCT00520572|158375835|FG001|Overall Study|Incorrect enrollment|0|||
49146361|NCT00520572|158375836|FG002|Overall Study|Incorrect enrollment|1|||
49146362|NCT00520572|158375837|FG003|Overall Study|Incorrect enrollment|0|||
49146363|NCT00520572|158375838|FG004|Overall Study|Incorrect enrollment|1|||
49146364|NCT00520572|158375839|FG005|Overall Study|Incorrect enrollment|0|||
48823287|NCT02362035|157192395|FG000|Overall Study|Decision by PI not related to AE/SAE|1|||
48823288|NCT02362035|157192395|FG000|Overall Study|Disease progression|11|||
48823289|NCT02362035|157192395|FG000|Overall Study|Withdrawal by Subject|20|||
48823290|NCT01222247|157192398|FG000|Overall Study|Lost to Follow-up|2|||
48823291|NCT01222247|157192399|FG001|Overall Study|Lost to Follow-up|2|||
48823292|NCT02338609|157192402|FG000|Overall Study|Physician Decision|1|||
48823293|NCT02338609|157192402|FG000|Overall Study|Death|1|||
48823294|NCT03884231|157193911|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
48823295|NCT03884231|157193911|FG000|Overall Study|Subject Withdrew Consent|1|||
48823296|NCT03884231|157193911|FG000|Overall Study|MRI Scan Not Performed|1|||
48823297|NCT01929993|157193912|FG000|Overall Study|Protocol Violation|4|||
48823298|NCT01929993|157193913|FG001|Overall Study|Protocol Violation|6|||
49146365|NCT00520572|158375834|FG000|Overall Study|Oral corticotherapy for acute urticaria|0|||
49146366|NCT00520572|158375835|FG001|Overall Study|Oral corticotherapy for acute urticaria|1|||
49146367|NCT00520572|158375836|FG002|Overall Study|Oral corticotherapy for acute urticaria|0|||
49146368|NCT00520572|158375837|FG003|Overall Study|Oral corticotherapy for acute urticaria|0|||
49146369|NCT00520572|158375838|FG004|Overall Study|Oral corticotherapy for acute urticaria|0|||
49146370|NCT00520572|158375839|FG005|Overall Study|Oral corticotherapy for acute urticaria|0|||
49146371|NCT00520572|158375834|FG000|Overall Study|Long break in taking Medication|0|||
49146372|NCT00520572|158375835|FG001|Overall Study|Long break in taking Medication|0|||
49146373|NCT00520572|158375836|FG002|Overall Study|Long break in taking Medication|0|||
49013727|NCT00606684|157887162|FG006|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
49013728|NCT00606684|157887156|FG000|2-week Single-Blind Run-in Period|Adverse Event|2|||
49146374|NCT00520572|158375837|FG003|Overall Study|Long break in taking Medication|1|||
49146375|NCT00520572|158375838|FG004|Overall Study|Long break in taking Medication|0|||
49146376|NCT00520572|158375839|FG005|Overall Study|Long break in taking Medication|0|||
49146377|NCT00520572|158375834|FG000|Overall Study|Did not receive Treatment|1|||
48823299|NCT01929993|157193912|FG000|Overall Study|Absent CIN, invasion present or artifact|26|||
48823300|NCT01929993|157193913|FG001|Overall Study|Absent CIN, invasion present or artifact|22|||
48823301|NCT02065245|157193922|FG000|Infusion 1|Lost to Follow-up|0|||
49013729|NCT00606684|157887157|FG001|2-week Single-Blind Run-in Period|Adverse Event|0|||
49146378|NCT00520572|158375835|FG001|Overall Study|Did not receive Treatment|0|||
49146379|NCT00520572|158375836|FG002|Overall Study|Did not receive Treatment|1|||
48823302|NCT02065245|157193923|FG001|Infusion 1|Lost to Follow-up|0|||
48823303|NCT02065245|157193924|FG002|Infusion 1|Lost to Follow-up|0|||
48823304|NCT02065245|157193925|FG003|Infusion 1|Lost to Follow-up|0|||
49146380|NCT00520572|158375837|FG003|Overall Study|Did not receive Treatment|0|||
49146381|NCT00520572|158375838|FG004|Overall Study|Did not receive Treatment|0|||
49146382|NCT00520572|158375839|FG005|Overall Study|Did not receive Treatment|0|||
49146383|NCT01433978|158375840|FG000|Core Study|Adverse Event, Non-Fatal|0|||
48730736|NCT04029688|156865879|FG003|Overall Study|Death|2|||
48730737|NCT04029688|156865880|FG004|Overall Study|Death|5|||
48730738|NCT04029688|156865881|FG005|Overall Study|Death|0|||
48730739|NCT04029688|156865882|FG006|Overall Study|Death|2|||
48730740|NCT04029688|156865883|FG007|Overall Study|Death|3|||
48730741|NCT04029688|156865876|FG000|Overall Study|Study Terminated by Sponsor|0|||
49146384|NCT01433978|158375841|FG001|Core Study|Adverse Event, Non-Fatal|1|||
49146385|NCT01433978|158375842|FG002|Core Study|Adverse Event, Non-Fatal|0|||
49146386|NCT01433978|158375840|FG000|Core Study|Lack of Efficacy|5|||
49146387|NCT01433978|158375841|FG001|Core Study|Lack of Efficacy|1|||
49146388|NCT01433978|158375842|FG002|Core Study|Lack of Efficacy|0|||
49146389|NCT01433978|158375840|FG000|Core Study|Study Terminated by Sponsor|6|||
49146390|NCT01433978|158375841|FG001|Core Study|Study Terminated by Sponsor|9|||
49146391|NCT01433978|158375842|FG002|Core Study|Study Terminated by Sponsor|0|||
49146392|NCT01433978|158375840|FG000|Extension Phase|Adverse Event, Non-Fatal|0|||
49146393|NCT01433978|158375841|FG001|Extension Phase|Adverse Event, Non-Fatal|0|||
49146394|NCT01433978|158375842|FG002|Extension Phase|Adverse Event, Non-Fatal|1|||
49146395|NCT01433978|158375840|FG000|Extension Phase|Lack of Efficacy|0|||
49146396|NCT01433978|158375841|FG001|Extension Phase|Lack of Efficacy|0|||
49146397|NCT01433978|158375842|FG002|Extension Phase|Lack of Efficacy|1|||
49146398|NCT01433978|158375840|FG000|Extension Phase|Study Terminated by Sponsor|0|||
49146399|NCT01433978|158375841|FG001|Extension Phase|Study Terminated by Sponsor|0|||
49146400|NCT01433978|158375842|FG002|Extension Phase|Study Terminated by Sponsor|4|||
49146401|NCT01773889|158375843|FG000|Overall Study|lack of funding|2|||
49146402|NCT00866775|158375846|FG000|Overall Study|Adverse Event|5|||
49146403|NCT00866775|158375847|FG001|Overall Study|Adverse Event|19|||
49146404|NCT00866775|158375846|FG000|Overall Study|Death|1|||
49146405|NCT00866775|158375847|FG001|Overall Study|Death|0|||
49146406|NCT00866775|158375846|FG000|Overall Study|Lost to Follow-up|0|||
49146407|NCT00866775|158375847|FG001|Overall Study|Lost to Follow-up|4|||
49146408|NCT00866775|158375846|FG000|Overall Study|Physician Decision|0|||
49146409|NCT00866775|158375847|FG001|Overall Study|Physician Decision|3|||
49146410|NCT00866775|158375846|FG000|Overall Study|Protocol Violation|3|||
49146411|NCT00866775|158375847|FG001|Overall Study|Protocol Violation|4|||
49146412|NCT00866775|158375846|FG000|Overall Study|Withdrawal by Subject|4|||
49146413|NCT00866775|158375847|FG001|Overall Study|Withdrawal by Subject|4|||
49146414|NCT00866775|158375846|FG000|Overall Study|met exit criteria|23|||
49146415|NCT00866775|158375847|FG001|Overall Study|met exit criteria|17|||
49146416|NCT00866775|158375846|FG000|Overall Study|discontinued due to communication error|0|||
49146417|NCT00866775|158375847|FG001|Overall Study|discontinued due to communication error|1|||
49146418|NCT02773537|158375850|FG000|Overall Study|Lost to Follow-up|0|||
49146419|NCT02773537|158375851|FG001|Overall Study|Lost to Follow-up|1|||
49146420|NCT02773537|158375852|FG002|Overall Study|Lost to Follow-up|4|||
49146421|NCT02595879|158375854|FG000|Expansion Cohort|Did not complete treatment regimen|1|||
49146422|NCT02595879|158375855|FG001|Expansion Cohort|Did not complete treatment regimen|0|||
49146423|NCT00756314|158375857|FG000|Overall Study|Lost to Follow-up|2|||
49146424|NCT00756314|158375858|FG001|Overall Study|Lost to Follow-up|59|||
49146425|NCT05587998|158375859|FG000|Overall Study|Withdrawal by Subject|1|||
49146426|NCT05587998|158375860|FG001|Overall Study|Withdrawal by Subject|1|||
49146427|NCT05587998|158375859|FG000|Overall Study|Not treated|3|||
49146428|NCT05587998|158375860|FG001|Overall Study|Not treated|1|||
49146429|NCT05587998|158375859|FG000|Overall Study|Non-compliance with study procedures|0|||
49146430|NCT05587998|158375860|FG001|Overall Study|Non-compliance with study procedures|1|||
49146431|NCT01725282|158375861|FG000|Overall Study|Adverse Event|1|||
49146432|NCT01725282|158375862|FG001|Overall Study|Adverse Event|3|||
49146433|NCT01725282|158375863|FG002|Overall Study|Adverse Event|6|||
48730742|NCT04029688|156865877|FG001|Overall Study|Study Terminated by Sponsor|0|||
48730743|NCT04029688|156865878|FG002|Overall Study|Study Terminated by Sponsor|0|||
48730744|NCT04029688|156865879|FG003|Overall Study|Study Terminated by Sponsor|0|||
48730745|NCT04029688|156865880|FG004|Overall Study|Study Terminated by Sponsor|1|||
48730746|NCT04029688|156865881|FG005|Overall Study|Study Terminated by Sponsor|3|||
48730747|NCT04029688|156865882|FG006|Overall Study|Study Terminated by Sponsor|1|||
48730748|NCT04029688|156865883|FG007|Overall Study|Study Terminated by Sponsor|3|||
48730749|NCT04029688|156865876|FG000|Overall Study|Withdrawal by Subject|0|||
48730750|NCT04029688|156865877|FG001|Overall Study|Withdrawal by Subject|0|||
48730751|NCT04029688|156865878|FG002|Overall Study|Withdrawal by Subject|0|||
48730752|NCT04029688|156865879|FG003|Overall Study|Withdrawal by Subject|1|||
48730753|NCT04029688|156865880|FG004|Overall Study|Withdrawal by Subject|0|||
48730754|NCT04029688|156865881|FG005|Overall Study|Withdrawal by Subject|0|||
48730755|NCT04029688|156865882|FG006|Overall Study|Withdrawal by Subject|0|||
48730756|NCT04029688|156865883|FG007|Overall Study|Withdrawal by Subject|0|||
49146434|NCT01725282|158375864|FG003|Overall Study|Adverse Event|4|||
49146435|NCT01725282|158375861|FG000|Overall Study|Exacerbation of Target Disease|1|||
49146436|NCT01725282|158375862|FG001|Overall Study|Exacerbation of Target Disease|0|||
49146437|NCT01725282|158375863|FG002|Overall Study|Exacerbation of Target Disease|0|||
49146438|NCT01725282|158375864|FG003|Overall Study|Exacerbation of Target Disease|1|||
49146439|NCT01725282|158375861|FG000|Overall Study|Met Exclusion Criteria|0|||
49146440|NCT01725282|158375862|FG001|Overall Study|Met Exclusion Criteria|0|||
49146441|NCT01725282|158375863|FG002|Overall Study|Met Exclusion Criteria|1|||
49146442|NCT01725282|158375864|FG003|Overall Study|Met Exclusion Criteria|0|||
49146443|NCT01725282|158375861|FG000|Overall Study|Study Site Withdrawal|0|||
49146444|NCT01725282|158375862|FG001|Overall Study|Study Site Withdrawal|1|||
48823305|NCT02065245|157193926|FG004|Infusion 1|Lost to Follow-up|0|||
48823306|NCT02065245|157193927|FG005|Infusion 1|Lost to Follow-up|0|||
49146445|NCT01725282|158375863|FG002|Overall Study|Study Site Withdrawal|0|||
49146446|NCT01725282|158375864|FG003|Overall Study|Study Site Withdrawal|0|||
49013730|NCT00606684|157887158|FG002|2-week Single-Blind Run-in Period|Adverse Event|0|||
49013731|NCT00606684|157887159|FG003|2-week Single-Blind Run-in Period|Adverse Event|0|||
49013732|NCT00606684|157887160|FG004|2-week Single-Blind Run-in Period|Adverse Event|0|||
49013733|NCT00606684|157887161|FG005|2-week Single-Blind Run-in Period|Adverse Event|0|||
49013734|NCT00606684|157887162|FG006|2-week Single-Blind Run-in Period|Adverse Event|0|||
49013735|NCT00606684|157887156|FG000|2-week Single-Blind Run-in Period|Received Study Medication in Error|1|||
49013736|NCT00606684|157887157|FG001|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
49013737|NCT00606684|157887158|FG002|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
49013738|NCT00606684|157887159|FG003|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
49013739|NCT00606684|157887160|FG004|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
49146447|NCT01725282|158375861|FG000|Overall Study|Withdrawal by Subject|0|||
49146448|NCT01725282|158375862|FG001|Overall Study|Withdrawal by Subject|0|||
49146449|NCT01725282|158375863|FG002|Overall Study|Withdrawal by Subject|1|||
49146450|NCT01725282|158375864|FG003|Overall Study|Withdrawal by Subject|1|||
48823307|NCT02065245|157193928|FG006|Infusion 1|Lost to Follow-up|1|||
49146451|NCT01725282|158375861|FG000|Overall Study|Lack of Efficacy|0|||
49146452|NCT01725282|158375862|FG001|Overall Study|Lack of Efficacy|1|||
49146453|NCT01725282|158375863|FG002|Overall Study|Lack of Efficacy|0|||
49146454|NCT01725282|158375864|FG003|Overall Study|Lack of Efficacy|1|||
49146455|NCT01260311|158375865|FG000|Overall Study|Adverse Event|11|||
49146456|NCT01260311|158375865|FG000|Overall Study|Lack of Efficacy|4|||
49146457|NCT01260311|158375865|FG000|Overall Study|Lost to Follow-up|25|||
49146458|NCT01260311|158375865|FG000|Overall Study|Withdrawal by Subject|6|||
49146459|NCT01260311|158375865|FG000|Overall Study|Financial Constraints|77|||
49146460|NCT01260311|158375865|FG000|Overall Study|Gone to Province|2|||
49146461|NCT01260311|158375865|FG000|Overall Study|Medication Stopped|1|||
49146462|NCT01260311|158375865|FG000|Overall Study|Fesoterodine Started Before Enrollment|1|||
49146463|NCT02965456|158375866|FG000|Overall Study|Lost to Follow-up|40|||
49146464|NCT02965456|158375867|FG001|Overall Study|Lost to Follow-up|18|||
49146465|NCT02965456|158375866|FG000|Overall Study|Subject Request|22|||
49146466|NCT02965456|158375867|FG001|Overall Study|Subject Request|13|||
49146467|NCT02965456|158375866|FG000|Overall Study|Withdrawal by Parent or Guardian|3|||
49146468|NCT02965456|158375867|FG001|Overall Study|Withdrawal by Parent or Guardian|6|||
49146469|NCT02965456|158375866|FG000|Overall Study|Adverse Event|3|||
49146470|NCT02965456|158375867|FG001|Overall Study|Adverse Event|0|||
49146471|NCT02965456|158375866|FG000|Overall Study|Noncompliance with Study Drug|1|||
49146472|NCT02965456|158375867|FG001|Overall Study|Noncompliance with Study Drug|1|||
49146473|NCT02965456|158375866|FG000|Overall Study|Worsening Condition|0|||
49146474|NCT02965456|158375867|FG001|Overall Study|Worsening Condition|2|||
49146475|NCT02965456|158375866|FG000|Overall Study|Lack of Efficacy|1|||
49146476|NCT02965456|158375867|FG001|Overall Study|Lack of Efficacy|0|||
49146477|NCT02965456|158375866|FG000|Overall Study|Physician Decision|0|||
49146478|NCT02965456|158375867|FG001|Overall Study|Physician Decision|1|||
49146479|NCT02965456|158375866|FG000|Overall Study|Pregnancy|1|||
49146480|NCT02965456|158375867|FG001|Overall Study|Pregnancy|0|||
49146481|NCT02965456|158375866|FG000|Overall Study|Protocol Violation|0|||
49146482|NCT02965456|158375867|FG001|Overall Study|Protocol Violation|1|||
49146483|NCT02965456|158375866|FG000|Overall Study|Participant ran out of study drug|0|||
49146484|NCT02965456|158375867|FG001|Overall Study|Participant ran out of study drug|1|||
49146485|NCT00452530|158375870|FG000|Overall Study|Death|1|||
49146486|NCT00452530|158375871|FG001|Overall Study|Death|0|||
49146487|NCT00452530|158375870|FG000|Overall Study|Adverse Event|40|||
49146488|NCT00452530|158375871|FG001|Overall Study|Adverse Event|44|||
49146489|NCT00452530|158375870|FG000|Overall Study|Withdrawal by Subject|68|||
49146490|NCT00452530|158375871|FG001|Overall Study|Withdrawal by Subject|57|||
49146491|NCT00452530|158375870|FG000|Overall Study|Lost to Follow-up|1|||
49146492|NCT00452530|158375871|FG001|Overall Study|Lost to Follow-up|0|||
49146493|NCT00452530|158375870|FG000|Overall Study|Poor compliance/noncompliance|1|||
49146494|NCT00452530|158375871|FG001|Overall Study|Poor compliance/noncompliance|2|||
49146495|NCT00452530|158375870|FG000|Overall Study|No longer met study criteria|18|||
49146496|NCT00452530|158375871|FG001|Overall Study|No longer met study criteria|22|||
49146497|NCT00452530|158375870|FG000|Overall Study|Other|7|||
49146498|NCT00452530|158375871|FG001|Overall Study|Other|11|||
49146499|NCT03760068|158375874|FG000|Overall Study|Withdrawal by Subject|7|||
49013740|NCT00606684|157887161|FG005|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
49146500|NCT03760068|158375875|FG001|Overall Study|Withdrawal by Subject|8|||
49146501|NCT03760068|158375874|FG000|Overall Study|Adverse Event|1|||
49146502|NCT03760068|158375875|FG001|Overall Study|Adverse Event|2|||
49146503|NCT03760068|158375874|FG000|Overall Study|Administrative Decision by Sponsor|0|||
49146504|NCT03760068|158375875|FG001|Overall Study|Administrative Decision by Sponsor|2|||
49146505|NCT03760068|158375874|FG000|Overall Study|Physician Decision|1|||
49146506|NCT03760068|158375875|FG001|Overall Study|Physician Decision|2|||
49146507|NCT03760068|158375874|FG000|Overall Study|Lost to Follow-up|4|||
49146508|NCT03760068|158375875|FG001|Overall Study|Lost to Follow-up|9|||
49146509|NCT03760068|158375874|FG000|Overall Study|Subject Moved Out of State|1|||
49146510|NCT03760068|158375875|FG001|Overall Study|Subject Moved Out of State|0|||
49146511|NCT04003389|158375887|FG000|Overall Study|Adverse Event|27|||
49146512|NCT04003389|158375888|FG001|Overall Study|Adverse Event|34|||
49146513|NCT04003389|158375889|FG002|Overall Study|Adverse Event|28|||
49146514|NCT04003389|158375887|FG000|Overall Study|Lost to Follow-up|39|||
49146515|NCT04003389|158375888|FG001|Overall Study|Lost to Follow-up|30|||
49146516|NCT04003389|158375889|FG002|Overall Study|Lost to Follow-up|33|||
49146517|NCT04003389|158375887|FG000|Overall Study|Protocol Violation|1|||
49146518|NCT04003389|158375888|FG001|Overall Study|Protocol Violation|6|||
49146519|NCT04003389|158375889|FG002|Overall Study|Protocol Violation|5|||
49146520|NCT04003389|158375887|FG000|Overall Study|Withdrawal by Subject|119|||
49146521|NCT04003389|158375888|FG001|Overall Study|Withdrawal by Subject|79|||
49146522|NCT04003389|158375889|FG002|Overall Study|Withdrawal by Subject|85|||
49146523|NCT04003389|158375887|FG000|Overall Study|Miscellaneous|14|||
49146524|NCT04003389|158375888|FG001|Overall Study|Miscellaneous|11|||
49146525|NCT04003389|158375889|FG002|Overall Study|Miscellaneous|14|||
49146526|NCT04003389|158375887|FG000|Overall Study|Participant did not receive study drug|1|||
49146527|NCT04003389|158375888|FG001|Overall Study|Participant did not receive study drug|0|||
49146528|NCT04003389|158375889|FG002|Overall Study|Participant did not receive study drug|0|||
49146529|NCT04439903|158375890|FG000|Overall Study|Withdrawal by Subject|2|||
49146530|NCT04439903|158375890|FG000|Overall Study|Screen Failure|1|||
49146533|NCT03163264|158375893|FG000|Overall Study|Withdrawal by Subject|13|||
49146534|NCT03163264|158375894|FG001|Overall Study|Withdrawal by Subject|3|||
49146535|NCT03163264|158375895|FG002|Overall Study|Withdrawal by Subject|4|||
49146536|NCT03163264|158375896|FG003|Overall Study|Withdrawal by Subject|2|||
49146537|NCT03163264|158375893|FG000|Overall Study|Lost to Follow-up|17|||
49146538|NCT03163264|158375894|FG001|Overall Study|Lost to Follow-up|20|||
49146539|NCT03163264|158375895|FG002|Overall Study|Lost to Follow-up|0|||
49146540|NCT03163264|158375896|FG003|Overall Study|Lost to Follow-up|0|||
49146541|NCT03163264|158375893|FG000|Overall Study|Death|0|||
49146542|NCT03163264|158375894|FG001|Overall Study|Death|2|||
49146543|NCT03163264|158375895|FG002|Overall Study|Death|0|||
49146544|NCT03163264|158375896|FG003|Overall Study|Death|0|||
49146545|NCT00401830|158375903|FG000|Overall Study|Adverse Event|10|||
49146546|NCT00401830|158375904|FG001|Overall Study|Adverse Event|18|||
49146547|NCT00401830|158375903|FG000|Overall Study|Lack of Efficacy|11|||
49146548|NCT00401830|158375904|FG001|Overall Study|Lack of Efficacy|5|||
49146549|NCT00401830|158375903|FG000|Overall Study|Withdrawal by Subject|4|||
49146550|NCT00401830|158375904|FG001|Overall Study|Withdrawal by Subject|3|||
49146551|NCT00401830|158375903|FG000|Overall Study|Protocol Violation|3|||
49146552|NCT00401830|158375904|FG001|Overall Study|Protocol Violation|3|||
49146553|NCT00401830|158375903|FG000|Overall Study|Non-compliance with drug study|1|||
49146554|NCT00401830|158375904|FG001|Overall Study|Non-compliance with drug study|0|||
49146555|NCT00401830|158375903|FG000|Overall Study|Lost to Follow-up|1|||
49146556|NCT00401830|158375904|FG001|Overall Study|Lost to Follow-up|3|||
49146557|NCT00401830|158375903|FG000|Overall Study|Other: Personal / Family problems|1|||
49146558|NCT00401830|158375904|FG001|Overall Study|Other: Personal / Family problems|0|||
49146559|NCT04090749|158375905|FG000|Open Label Pilot|Lost to Follow-up|1|||
49146560|NCT04090749|158375906|FG001|Open Label Pilot|Lost to Follow-up|0|||
49146561|NCT04090749|158375907|FG002|Open Label Pilot|Lost to Follow-up|0|||
49146562|NCT04090749|158375905|FG000|Pilot Trial|Care recipient of enrolled caregiver died|0|||
49146563|NCT04090749|158375906|FG001|Pilot Trial|Care recipient of enrolled caregiver died|1|||
49146564|NCT04090749|158375907|FG002|Pilot Trial|Care recipient of enrolled caregiver died|0|||
49013741|NCT00606684|157887162|FG006|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
49146565|NCT04090749|158375905|FG000|Pilot Trial|Lost to Follow-up|0|||
49146566|NCT04090749|158375906|FG001|Pilot Trial|Lost to Follow-up|1|||
49146567|NCT04090749|158375907|FG002|Pilot Trial|Lost to Follow-up|1|||
49146568|NCT04091438|158375908|FG000|Treatment Period 1 (1 Day)|Other|1|||
49146569|NCT04091438|158375909|FG001|Treatment Period 1 (1 Day)|Other|0|||
49146570|NCT04091438|158375908|FG000|Washout Period (1 Day)|Protocol deviation|0|||
49146571|NCT04091438|158375909|FG001|Washout Period (1 Day)|Protocol deviation|1|||
49146572|NCT04091438|158375908|FG000|Washout Period (1 Day)|Other|0|||
49146573|NCT04091438|158375909|FG001|Washout Period (1 Day)|Other|1|||
49146574|NCT04105725|158375910|FG000|Primary Intervention|Lost to Follow-up|0|||
49146575|NCT04105725|158375911|FG001|Primary Intervention|Lost to Follow-up|2|||
49146576|NCT04105725|158375910|FG000|Primary Intervention|Withdrawal by Subject|0|||
49146577|NCT04105725|158375911|FG001|Primary Intervention|Withdrawal by Subject|1|||
49146578|NCT00787800|158375912|FG000|Overall Study|Withdrawal by Subject|3|||
49146579|NCT00787800|158375913|FG001|Overall Study|Withdrawal by Subject|5|||
49146580|NCT00787800|158375912|FG000|Overall Study|Death|0|||
49146581|NCT00787800|158375913|FG001|Overall Study|Death|2|||
49146582|NCT04634331|158375914|FG000|Overall Study|Withdrawal by Subject|2|||
49146583|NCT04634331|158375915|FG001|Overall Study|Withdrawal by Subject|2|||
49146584|NCT05626686|158375917|FG000|Overall Study|Protocol Violation|3|||
49146585|NCT05626686|158375917|FG000|Overall Study|Withdrawal by Subject|3|||
49146586|NCT00089583|158375918|FG000|Overall Study|Adverse Event|0|||
49146587|NCT00089583|158375919|FG001|Overall Study|Adverse Event|3|||
49146588|NCT00089583|158375918|FG000|Overall Study|Insufficient Viral Load Response|5|||
49146589|NCT00089583|158375919|FG001|Overall Study|Insufficient Viral Load Response|5|||
49146590|NCT00089583|158375918|FG000|Overall Study|Withdrawal by Subject|0|||
49146591|NCT00089583|158375919|FG001|Overall Study|Withdrawal by Subject|4|||
49146592|NCT00089583|158375918|FG000|Overall Study|Participant (Par) Didn't Take Medication|1|||
49146593|NCT00089583|158375919|FG001|Overall Study|Participant (Par) Didn't Take Medication|0|||
48823308|NCT02065245|157193922|FG000|Infusion 1|Death|0|||
48823309|NCT02065245|157193923|FG001|Infusion 1|Death|0|||
48823310|NCT02065245|157193924|FG002|Infusion 1|Death|1|||
49146594|NCT00089583|158375918|FG000|Overall Study|Participant Refused Study Medication|0|||
49146595|NCT00089583|158375919|FG001|Overall Study|Participant Refused Study Medication|2|||
48823311|NCT02065245|157193925|FG003|Infusion 1|Death|0|||
48823312|NCT02065245|157193926|FG004|Infusion 1|Death|1|||
48823313|NCT02065245|157193927|FG005|Infusion 1|Death|0|||
48823314|NCT02065245|157193928|FG006|Infusion 1|Death|0|||
48823315|NCT02065245|157193922|FG000|Infusion 2|Death|0|||
48823316|NCT02065245|157193923|FG001|Infusion 2|Death|0|||
48823317|NCT02065245|157193924|FG002|Infusion 2|Death|0|||
48823318|NCT02065245|157193925|FG003|Infusion 2|Death|0|||
49146596|NCT00089583|158375918|FG000|Overall Study|Non-Compliance|0|||
49146597|NCT00089583|158375919|FG001|Overall Study|Non-Compliance|4|||
49146598|NCT00089583|158375918|FG000|Overall Study|Poor Medical Compliance/Adherence Issues|0|||
49146599|NCT00089583|158375919|FG001|Overall Study|Poor Medical Compliance/Adherence Issues|3|||
49146600|NCT00089583|158375918|FG000|Overall Study|Participant Management Criteria Met|0|||
49146601|NCT00089583|158375919|FG001|Overall Study|Participant Management Criteria Met|1|||
49146602|NCT00089583|158375918|FG000|Overall Study|Reason Not Provided|0|||
49146603|NCT00089583|158375919|FG001|Overall Study|Reason Not Provided|1|||
49146604|NCT00089583|158375918|FG000|Overall Study|Protocol Violation|0|||
49146605|NCT00089583|158375919|FG001|Overall Study|Protocol Violation|3|||
49146606|NCT00089583|158375918|FG000|Overall Study|Principal Investigator Decision|0|||
49146607|NCT00089583|158375919|FG001|Overall Study|Principal Investigator Decision|10|||
49146608|NCT00089583|158375918|FG000|Overall Study|Start of Disallowed Medication|0|||
49146609|NCT00089583|158375919|FG001|Overall Study|Start of Disallowed Medication|1|||
49146610|NCT00089583|158375918|FG000|Overall Study|Necessity to Use Prohibited Drug|1|||
49146611|NCT00089583|158375919|FG001|Overall Study|Necessity to Use Prohibited Drug|0|||
49146612|NCT00089583|158375918|FG000|Overall Study|Participant Incarcerated|0|||
49146613|NCT00089583|158375919|FG001|Overall Study|Participant Incarcerated|1|||
49146614|NCT05569954|158375920|FG000|Overall Study|Lost to Follow-up|3|||
49146615|NCT05569954|158375921|FG001|Overall Study|Lost to Follow-up|4|||
49146616|NCT05569954|158375920|FG000|Overall Study|Protocol Violation|1|||
49146617|NCT05569954|158375921|FG001|Overall Study|Protocol Violation|2|||
49146618|NCT05569954|158375920|FG000|Overall Study|Withdrawal by Subject|4|||
49146619|NCT05569954|158375921|FG001|Overall Study|Withdrawal by Subject|2|||
49146620|NCT02656173|158375928|FG000|Overall Study|Deviation from the Eligible Criteria|3|||
49146621|NCT02656173|158375929|FG001|Overall Study|Deviation from the Eligible Criteria|2|||
49146622|NCT02656173|158375928|FG000|Overall Study|Adverse Event|7|||
49146623|NCT02656173|158375929|FG001|Overall Study|Adverse Event|5|||
49146624|NCT02656173|158375928|FG000|Overall Study|Withdrawal by Subject|1|||
49146625|NCT02656173|158375929|FG001|Overall Study|Withdrawal by Subject|3|||
49146626|NCT02656173|158375928|FG000|Overall Study|Protocol Violation|0|||
49146627|NCT02656173|158375929|FG001|Overall Study|Protocol Violation|1|||
49146628|NCT02656173|158375928|FG000|Overall Study|Miscellaneous|2|||
49146629|NCT02656173|158375929|FG001|Overall Study|Miscellaneous|0|||
49146630|NCT01064622|158375930|FG000|Randomized Phase II|Withdrawal by Subject|2|||
48823319|NCT02065245|157193926|FG004|Infusion 2|Death|0|||
48823320|NCT02065245|157193927|FG005|Infusion 2|Death|0|||
48823321|NCT02065245|157193928|FG006|Infusion 2|Death|1|||
48823322|NCT02065245|157193922|FG000|Infusion 3|Lost to Follow-up|1|||
48823323|NCT02065245|157193923|FG001|Infusion 3|Lost to Follow-up|1|||
49146631|NCT01064622|158375931|FG001|Randomized Phase II|Withdrawal by Subject|2|||
49146632|NCT01064622|158375930|FG000|Randomized Phase II|Protocol Violation|0|||
49146633|NCT01064622|158375931|FG001|Randomized Phase II|Protocol Violation|1|||
49146634|NCT03927846|158375932|FG000|Overall Study|Lost to Follow-up|10|||
49146635|NCT03927846|158375933|FG001|Overall Study|Lost to Follow-up|11|||
49146636|NCT00964678|158375936|FG000|Overall Study|Physician Decision|4|||
49146637|NCT03164356|158375939|FG000|Overall Study|Lost to Follow-up|1|||
49146638|NCT03164356|158375940|FG001|Overall Study|Lost to Follow-up|1|||
49146639|NCT03164356|158375941|FG002|Overall Study|Lost to Follow-up|2|||
49146640|NCT03164356|158375942|FG003|Overall Study|Lost to Follow-up|1|||
49146641|NCT03164356|158375939|FG000|Overall Study|Physician Decision|0|||
49146642|NCT03164356|158375940|FG001|Overall Study|Physician Decision|0|||
49146643|NCT03164356|158375941|FG002|Overall Study|Physician Decision|3|||
49146644|NCT03164356|158375942|FG003|Overall Study|Physician Decision|0|||
49146645|NCT03164356|158375939|FG000|Overall Study|Protocol Violation|2|||
49146646|NCT03164356|158375940|FG001|Overall Study|Protocol Violation|1|||
49146647|NCT03164356|158375941|FG002|Overall Study|Protocol Violation|0|||
49146648|NCT03164356|158375942|FG003|Overall Study|Protocol Violation|0|||
49146649|NCT03164356|158375939|FG000|Overall Study|Withdrawal by Subject|1|||
49146650|NCT03164356|158375940|FG001|Overall Study|Withdrawal by Subject|0|||
49146651|NCT03164356|158375941|FG002|Overall Study|Withdrawal by Subject|0|||
49146652|NCT03164356|158375942|FG003|Overall Study|Withdrawal by Subject|0|||
49146653|NCT03164356|158375939|FG000|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
49146654|NCT03164356|158375940|FG001|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
49146655|NCT03164356|158375941|FG002|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
49146656|NCT03164356|158375942|FG003|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
49146657|NCT03164356|158375939|FG000|Overall Study|Subject Incarcerated|0|||
49146658|NCT03164356|158375940|FG001|Overall Study|Subject Incarcerated|1|||
49146659|NCT03164356|158375941|FG002|Overall Study|Subject Incarcerated|0|||
49146660|NCT03164356|158375942|FG003|Overall Study|Subject Incarcerated|0|||
49146661|NCT03164356|158375939|FG000|Overall Study|Prosthetist unable to participate|0|||
49146662|NCT03164356|158375940|FG001|Overall Study|Prosthetist unable to participate|2|||
49146663|NCT03164356|158375941|FG002|Overall Study|Prosthetist unable to participate|1|||
49146664|NCT03164356|158375942|FG003|Overall Study|Prosthetist unable to participate|0|||
49146665|NCT03787212|158377477|FG000|Period 1|Study Termination|2|||
49146666|NCT03787212|158377478|FG001|Period 1|Study Termination|2|||
49146667|NCT03004183|158377481|FG000|Overall Study|Adverse Event|7|||
49146668|NCT03004183|158377481|FG000|Overall Study|Lost to Follow-up|1|||
49146669|NCT03004183|158377481|FG000|Overall Study|Physician Decision|40|||
49146670|NCT03004183|158377481|FG000|Overall Study|Withdrawal by Subject|1|||
49146671|NCT03004183|158377481|FG000|Overall Study|COVID-19|1|||
49146672|NCT03681093|158377482|FG000|Overall Study|Subject decision|0|||
49146673|NCT03681093|158377483|FG001|Overall Study|Subject decision|2|||
49146674|NCT03681093|158377484|FG002|Overall Study|Subject decision|1|||
49146675|NCT02469961|158377490|FG000|Overall Study|Physician Decision|4|||
49146676|NCT02469961|158377491|FG001|Overall Study|Physician Decision|1|||
49146677|NCT03537729|158377492|FG000|Overall Study|Death|2|||
49146678|NCT03537729|158377493|FG001|Overall Study|Death|2|||
49146679|NCT03537729|158377494|FG002|Overall Study|Death|7|||
49146680|NCT03537729|158377492|FG000|Overall Study|Withdrawal by Subject|3|||
49146681|NCT03537729|158377493|FG001|Overall Study|Withdrawal by Subject|3|||
49146682|NCT03537729|158377494|FG002|Overall Study|Withdrawal by Subject|0|||
49146683|NCT03537729|158377492|FG000|Overall Study|Subject Moved|8|||
49146684|NCT03537729|158377493|FG001|Overall Study|Subject Moved|5|||
49146685|NCT03537729|158377494|FG002|Overall Study|Subject Moved|4|||
49146686|NCT03537729|158377492|FG000|Overall Study|Investigator determined not in best interest for subject to continue|1|||
49146687|NCT03537729|158377493|FG001|Overall Study|Investigator determined not in best interest for subject to continue|0|||
49146688|NCT03537729|158377494|FG002|Overall Study|Investigator determined not in best interest for subject to continue|0|||
49146689|NCT03537729|158377492|FG000|Overall Study|COVID-19 Site Restrictions|11|||
49146690|NCT03537729|158377493|FG001|Overall Study|COVID-19 Site Restrictions|15|||
49146691|NCT03537729|158377494|FG002|Overall Study|COVID-19 Site Restrictions|18|||
49146692|NCT03537729|158377492|FG000|Overall Study|Decline in Health|5|||
49146693|NCT03537729|158377493|FG001|Overall Study|Decline in Health|9|||
49146694|NCT03537729|158377494|FG002|Overall Study|Decline in Health|4|||
49146695|NCT03537729|158377492|FG000|Overall Study|Determined Ineligible|0|||
49146696|NCT03537729|158377493|FG001|Overall Study|Determined Ineligible|0|||
49146697|NCT03537729|158377494|FG002|Overall Study|Determined Ineligible|1|||
49146698|NCT00960856|158377495|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
49146699|NCT00960856|158377496|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
48823324|NCT02065245|157193924|FG002|Infusion 3|Lost to Follow-up|0|||
48823325|NCT02065245|157193925|FG003|Infusion 3|Lost to Follow-up|0|||
49146700|NCT00960856|158377497|FG002|Washout Period of 7 Days|Withdrawal by Subject|0|||
49146701|NCT00960856|158377498|FG003|Washout Period of 7 Days|Withdrawal by Subject|0|||
49146702|NCT00960856|158377495|FG000|Washout Period of 7 Days|Adverse Event|0|||
49146703|NCT00960856|158377496|FG001|Washout Period of 7 Days|Adverse Event|0|||
49146704|NCT00960856|158377497|FG002|Washout Period of 7 Days|Adverse Event|1|||
49146705|NCT00960856|158377498|FG003|Washout Period of 7 Days|Adverse Event|0|||
49146706|NCT00985192|158377499|FG000|Overall Study|Withdrawal by Subject|1|||
49146707|NCT00985192|158377499|FG000|Overall Study|Disease Progression|1|||
49146708|NCT00985192|158377499|FG000|Overall Study|Determined to be Ineligible During Trial|2|||
48823326|NCT02065245|157193926|FG004|Infusion 3|Lost to Follow-up|0|||
49146709|NCT03794544|158377500|FG000|Overall Study|Withdrawal by Subject|1|||
49146710|NCT03794544|158377501|FG001|Overall Study|Withdrawal by Subject|1|||
49146711|NCT03794544|158377502|FG002|Overall Study|Withdrawal by Subject|0|||
49146712|NCT03794544|158377503|FG003|Overall Study|Withdrawal by Subject|0|||
49146713|NCT03794544|158377500|FG000|Overall Study|Death|0|||
49146714|NCT03794544|158377501|FG001|Overall Study|Death|0|||
49146715|NCT03794544|158377502|FG002|Overall Study|Death|0|||
49146716|NCT03794544|158377503|FG003|Overall Study|Death|1|||
49146717|NCT03794544|158377500|FG000|Overall Study|Lost to Follow-up|0|||
49146718|NCT03794544|158377501|FG001|Overall Study|Lost to Follow-up|1|||
48823327|NCT02065245|157193927|FG005|Infusion 3|Lost to Follow-up|0|||
48823328|NCT02065245|157193928|FG006|Infusion 3|Lost to Follow-up|0|||
48823329|NCT01089556|157193929|FG000|Study Period II (Weeks 1-8)|Adverse Event|35|||
48823330|NCT01089556|157193930|FG001|Study Period II (Weeks 1-8)|Adverse Event|39|||
48823331|NCT01089556|157193931|FG002|Study Period II (Weeks 1-8)|Adverse Event|0|||
48823332|NCT01089556|157193932|FG003|Study Period II (Weeks 1-8)|Adverse Event|0|||
48823333|NCT01089556|157193933|FG004|Study Period II (Weeks 1-8)|Adverse Event|0|||
48823334|NCT01089556|157193934|FG005|Study Period II (Weeks 1-8)|Adverse Event|0|||
48823335|NCT01089556|157193929|FG000|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12|||
48823336|NCT01089556|157193930|FG001|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8|||
48823337|NCT01089556|157193931|FG002|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
48823338|NCT01089556|157193932|FG003|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
48823339|NCT01089556|157193933|FG004|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
48823340|NCT01089556|157193934|FG005|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
48823341|NCT01089556|157193929|FG000|Study Period II (Weeks 1-8)|Lack of Efficacy|1|||
48823342|NCT01089556|157193930|FG001|Study Period II (Weeks 1-8)|Lack of Efficacy|2|||
48823343|NCT01089556|157193931|FG002|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
48823344|NCT01089556|157193932|FG003|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
48823345|NCT01089556|157193933|FG004|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
48823346|NCT01089556|157193934|FG005|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
48823347|NCT01089556|157193929|FG000|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
48823348|NCT01089556|157193930|FG001|Study Period II (Weeks 1-8)|Lost to Follow-up|3|||
48823349|NCT01089556|157193931|FG002|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
48823350|NCT01089556|157193932|FG003|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
48823351|NCT01089556|157193933|FG004|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
48823352|NCT01089556|157193934|FG005|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
48823353|NCT01089556|157193929|FG000|Study Period II (Weeks 1-8)|Physician Decision|4|||
48823354|NCT01089556|157193930|FG001|Study Period II (Weeks 1-8)|Physician Decision|0|||
48823355|NCT01089556|157193931|FG002|Study Period II (Weeks 1-8)|Physician Decision|0|||
48823356|NCT01089556|157193932|FG003|Study Period II (Weeks 1-8)|Physician Decision|0|||
48823357|NCT01089556|157193933|FG004|Study Period II (Weeks 1-8)|Physician Decision|0|||
48823358|NCT01089556|157193934|FG005|Study Period II (Weeks 1-8)|Physician Decision|0|||
48823359|NCT01089556|157193929|FG000|Study Period II (Weeks 1-8)|Protocol Violation|4|||
48823360|NCT01089556|157193930|FG001|Study Period II (Weeks 1-8)|Protocol Violation|4|||
48823361|NCT01089556|157193931|FG002|Study Period II (Weeks 1-8)|Protocol Violation|0|||
48823362|NCT01089556|157193932|FG003|Study Period II (Weeks 1-8)|Protocol Violation|0|||
48823363|NCT01089556|157193933|FG004|Study Period II (Weeks 1-8)|Protocol Violation|0|||
48823364|NCT01089556|157193934|FG005|Study Period II (Weeks 1-8)|Protocol Violation|0|||
48823365|NCT01089556|157193929|FG000|Study Period II (Weeks 1-8)|Withdrawal by Subject|12|||
48823366|NCT01089556|157193930|FG001|Study Period II (Weeks 1-8)|Withdrawal by Subject|14|||
48823367|NCT01089556|157193931|FG002|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
48823368|NCT01089556|157193932|FG003|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
48823369|NCT01089556|157193933|FG004|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
49146719|NCT03794544|158377502|FG002|Overall Study|Lost to Follow-up|1|||
49146720|NCT03794544|158377503|FG003|Overall Study|Lost to Follow-up|0|||
49146721|NCT03794544|158377500|FG000|Overall Study|Other|0|||
48823370|NCT01089556|157193934|FG005|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
49146722|NCT03794544|158377501|FG001|Overall Study|Other|1|||
49146723|NCT03794544|158377502|FG002|Overall Study|Other|0|||
49146724|NCT03794544|158377503|FG003|Overall Study|Other|0|||
49146725|NCT01013870|158377504|FG000|Overall Study|Lost to Follow-up|1|||
49146726|NCT01013870|158377505|FG001|Overall Study|Lost to Follow-up|3|||
49146727|NCT00289978|158377507|FG000|Overall Study|Withdrawal by Subject|31|||
49146728|NCT00289978|158377508|FG001|Overall Study|Withdrawal by Subject|17|||
48823371|NCT01089556|157193929|FG000|Study Period II (Weeks 1-8)|Not received any study drug|3|||
48823372|NCT01089556|157193930|FG001|Study Period II (Weeks 1-8)|Not received any study drug|4|||
48823373|NCT01089556|157193931|FG002|Study Period II (Weeks 1-8)|Not received any study drug|0|||
49146729|NCT00289978|158377509|FG002|Overall Study|Withdrawal by Subject|28|||
49146730|NCT00289978|158377507|FG000|Overall Study|Adverse Event|22|||
49146731|NCT00289978|158377508|FG001|Overall Study|Adverse Event|13|||
49146732|NCT00289978|158377509|FG002|Overall Study|Adverse Event|18|||
49146733|NCT00289978|158377507|FG000|Overall Study|Lack of Efficacy|13|||
49146734|NCT00289978|158377508|FG001|Overall Study|Lack of Efficacy|6|||
49146735|NCT00289978|158377509|FG002|Overall Study|Lack of Efficacy|25|||
49146736|NCT00289978|158377507|FG000|Overall Study|Abnormal laboratory value(s)|20|||
49146737|NCT00289978|158377508|FG001|Overall Study|Abnormal laboratory value(s)|9|||
49146738|NCT00289978|158377509|FG002|Overall Study|Abnormal laboratory value(s)|1|||
49146739|NCT00289978|158377507|FG000|Overall Study|Lost to Follow-up|3|||
49146740|NCT00289978|158377508|FG001|Overall Study|Lost to Follow-up|5|||
49146741|NCT00289978|158377509|FG002|Overall Study|Lost to Follow-up|7|||
49146742|NCT00289978|158377507|FG000|Overall Study|Protocol Violation|5|||
49146743|NCT00289978|158377508|FG001|Overall Study|Protocol Violation|5|||
49146744|NCT00289978|158377509|FG002|Overall Study|Protocol Violation|4|||
49146745|NCT00289978|158377507|FG000|Overall Study|Abnormal test procedure result(s)|2|||
49146746|NCT00289978|158377508|FG001|Overall Study|Abnormal test procedure result(s)|1|||
49146747|NCT00289978|158377509|FG002|Overall Study|Abnormal test procedure result(s)|1|||
49146748|NCT00289978|158377507|FG000|Overall Study|Death|1|||
48823374|NCT01089556|157193932|FG003|Study Period II (Weeks 1-8)|Not received any study drug|0|||
48823375|NCT01089556|157193933|FG004|Study Period II (Weeks 1-8)|Not received any study drug|0|||
48823376|NCT01089556|157193934|FG005|Study Period II (Weeks 1-8)|Not received any study drug|0|||
48823377|NCT01089556|157193929|FG000|Study Period III (Weeks 9-16)|Adverse Event|0|||
48823378|NCT01089556|157193930|FG001|Study Period III (Weeks 9-16)|Adverse Event|0|||
48823379|NCT01089556|157193931|FG002|Study Period III (Weeks 9-16)|Adverse Event|4|||
48823380|NCT01089556|157193932|FG003|Study Period III (Weeks 9-16)|Adverse Event|2|||
48823381|NCT01089556|157193933|FG004|Study Period III (Weeks 9-16)|Adverse Event|4|||
48823382|NCT01089556|157193934|FG005|Study Period III (Weeks 9-16)|Adverse Event|3|||
48823383|NCT01089556|157193929|FG000|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
48823384|NCT01089556|157193930|FG001|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
48823385|NCT01089556|157193931|FG002|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
48823386|NCT01089556|157193932|FG003|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
48823387|NCT01089556|157193933|FG004|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
48823388|NCT01089556|157193934|FG005|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
49146749|NCT00289978|158377508|FG001|Overall Study|Death|0|||
49146750|NCT00289978|158377509|FG002|Overall Study|Death|2|||
49146751|NCT00432991|158377510|FG000|Overall Study|Protocol Violation|7|||
49146752|NCT00432991|158377511|FG001|Overall Study|Protocol Violation|12|||
49146753|NCT00720083|158377512|FG000|Overall Study|Ineligible|1|||
49146754|NCT00720083|158377513|FG001|Overall Study|Ineligible|2|||
49146755|NCT00862277|158377523|FG000|Overall Study|Protocol Violation|1|||
49146756|NCT00862277|158377524|FG001|Overall Study|Protocol Violation|2|||
49146757|NCT00862277|158377525|FG002|Overall Study|Protocol Violation|5|||
49146758|NCT00871000|158377526|FG000|Overall Study|Withdrawal by Subject|1|||
49146759|NCT00871000|158377527|FG001|Overall Study|Withdrawal by Subject|0|||
49146760|NCT02715856|158377528|FG000|Overall Study|Software Issues|12|||
49146761|NCT02715856|158377529|FG001|Overall Study|Software Issues|7|||
49146762|NCT02715856|158377528|FG000|Overall Study|Death|6|||
49146763|NCT02715856|158377529|FG001|Overall Study|Death|5|||
49146764|NCT02715856|158377528|FG000|Overall Study|Non- Compliant|0|||
49146765|NCT02715856|158377529|FG001|Overall Study|Non- Compliant|40|||
49146766|NCT01772693|158377534|FG000|Overall Study|Health Concerns Unrelated to Study|2|||
49146767|NCT01772693|158377535|FG001|Overall Study|Health Concerns Unrelated to Study|1|||
49146768|NCT01772693|158377534|FG000|Overall Study|Withdrawal by Subject|2|||
49146769|NCT01772693|158377535|FG001|Overall Study|Withdrawal by Subject|0|||
49146770|NCT01772693|158377534|FG000|Overall Study|Alternative Treatment|2|||
49146771|NCT01772693|158377535|FG001|Overall Study|Alternative Treatment|0|||
49146772|NCT01633112|158377536|FG000|Overall Study|Lack of Efficacy|1|||
49146773|NCT01633112|158377537|FG001|Overall Study|Lack of Efficacy|6|||
49146774|NCT01633112|158377538|FG002|Overall Study|Lack of Efficacy|13|||
49146775|NCT01633112|158377536|FG000|Overall Study|Abnormal laboratory value(s)|3|||
49146776|NCT01633112|158377537|FG001|Overall Study|Abnormal laboratory value(s)|1|||
49146777|NCT01633112|158377538|FG002|Overall Study|Abnormal laboratory value(s)|0|||
49146778|NCT01633112|158377536|FG000|Overall Study|Abnormal test procedure result(s)|0|||
49146779|NCT01633112|158377537|FG001|Overall Study|Abnormal test procedure result(s)|1|||
49146780|NCT01633112|158377538|FG002|Overall Study|Abnormal test procedure result(s)|0|||
49146781|NCT01633112|158377536|FG000|Overall Study|Administrative problems|1|||
49146782|NCT01633112|158377537|FG001|Overall Study|Administrative problems|2|||
49146783|NCT01633112|158377538|FG002|Overall Study|Administrative problems|5|||
49146784|NCT01633112|158377536|FG000|Overall Study|Adverse Event|16|||
49146785|NCT01633112|158377537|FG001|Overall Study|Adverse Event|18|||
49013742|NCT00606684|157887156|FG000|Double-Blind Treatment Period|Adverse Event|0|||
49146786|NCT01633112|158377538|FG002|Overall Study|Adverse Event|20|||
49146787|NCT01633112|158377536|FG000|Overall Study|Lost to Follow-up|7|||
49146788|NCT01633112|158377537|FG001|Overall Study|Lost to Follow-up|19|||
49146789|NCT01633112|158377538|FG002|Overall Study|Lost to Follow-up|6|||
49146790|NCT01633112|158377536|FG000|Overall Study|Protocol Violation|4|||
49146791|NCT01633112|158377537|FG001|Overall Study|Protocol Violation|0|||
49146792|NCT01633112|158377538|FG002|Overall Study|Protocol Violation|2|||
49146793|NCT01633112|158377536|FG000|Overall Study|Subject no longer requires study drug|0|||
49146794|NCT01633112|158377537|FG001|Overall Study|Subject no longer requires study drug|0|||
49146795|NCT01633112|158377538|FG002|Overall Study|Subject no longer requires study drug|1|||
49013743|NCT00606684|157887157|FG001|Double-Blind Treatment Period|Adverse Event|3|||
49013744|NCT00606684|157887158|FG002|Double-Blind Treatment Period|Adverse Event|2|||
49013745|NCT00606684|157887159|FG003|Double-Blind Treatment Period|Adverse Event|4|||
49013746|NCT00606684|157887160|FG004|Double-Blind Treatment Period|Adverse Event|2|||
49013747|NCT00606684|157887161|FG005|Double-Blind Treatment Period|Adverse Event|0|||
49013748|NCT00606684|157887162|FG006|Double-Blind Treatment Period|Adverse Event|1|||
49013749|NCT00606684|157887156|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
49013750|NCT00606684|157887157|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
49146796|NCT01633112|158377536|FG000|Overall Study|Withdrawal by Subject|20|||
49146797|NCT01633112|158377537|FG001|Overall Study|Withdrawal by Subject|12|||
49146798|NCT01633112|158377538|FG002|Overall Study|Withdrawal by Subject|41|||
49146799|NCT01633112|158377536|FG000|Overall Study|missing Study Completion CRF|1|||
49146800|NCT01633112|158377537|FG001|Overall Study|missing Study Completion CRF|1|||
49146801|NCT01633112|158377538|FG002|Overall Study|missing Study Completion CRF|4|||
49146802|NCT03021005|158377539|FG000|Overall Study|Lost to Follow-up|39|||
49146803|NCT03021005|158377540|FG001|Overall Study|Lost to Follow-up|26|||
49146804|NCT00159874|158377547|FG000|Overall Study|Adverse Event|2|||
49146805|NCT00159874|158377548|FG001|Overall Study|Adverse Event|2|||
49146806|NCT00159874|158377549|FG002|Overall Study|Adverse Event|5|||
49146807|NCT00159874|158377550|FG003|Overall Study|Adverse Event|1|||
49146808|NCT00159874|158377551|FG004|Overall Study|Adverse Event|1|||
49146809|NCT00159874|158377552|FG005|Overall Study|Adverse Event|2|||
49146810|NCT00159874|158377553|FG006|Overall Study|Adverse Event|0|||
49146811|NCT00159874|158377547|FG000|Overall Study|Does Not Meet Entrance Criteria|1|||
49146812|NCT00159874|158377548|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
49146813|NCT00159874|158377549|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
49146814|NCT00159874|158377550|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
49146815|NCT00159874|158377551|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
48823389|NCT01089556|157193929|FG000|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
48823390|NCT01089556|157193930|FG001|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
48823391|NCT01089556|157193931|FG002|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
49146816|NCT00159874|158377552|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
49146817|NCT00159874|158377553|FG006|Overall Study|Does Not Meet Entrance Criteria|0|||
49146818|NCT00159874|158377547|FG000|Overall Study|Lack of Efficacy|2|||
49146819|NCT00159874|158377548|FG001|Overall Study|Lack of Efficacy|0|||
49146820|NCT00159874|158377549|FG002|Overall Study|Lack of Efficacy|1|||
49146821|NCT00159874|158377550|FG003|Overall Study|Lack of Efficacy|1|||
49146822|NCT00159874|158377551|FG004|Overall Study|Lack of Efficacy|0|||
49146823|NCT00159874|158377552|FG005|Overall Study|Lack of Efficacy|3|||
49146824|NCT00159874|158377553|FG006|Overall Study|Lack of Efficacy|0|||
49146825|NCT00159874|158377547|FG000|Overall Study|Lost to Follow-up|1|||
49146826|NCT00159874|158377548|FG001|Overall Study|Lost to Follow-up|0|||
49146827|NCT00159874|158377549|FG002|Overall Study|Lost to Follow-up|3|||
49146828|NCT00159874|158377550|FG003|Overall Study|Lost to Follow-up|0|||
49146829|NCT00159874|158377551|FG004|Overall Study|Lost to Follow-up|1|||
49146830|NCT00159874|158377552|FG005|Overall Study|Lost to Follow-up|2|||
49146831|NCT00159874|158377553|FG006|Overall Study|Lost to Follow-up|1|||
49146832|NCT00159874|158377547|FG000|Overall Study|Other|8|||
49013751|NCT00606684|157887158|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
49013752|NCT00606684|157887159|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
49146833|NCT00159874|158377548|FG001|Overall Study|Other|8|||
49146834|NCT00159874|158377549|FG002|Overall Study|Other|8|||
49146835|NCT00159874|158377550|FG003|Overall Study|Other|0|||
49146836|NCT00159874|158377551|FG004|Overall Study|Other|2|||
49146837|NCT00159874|158377552|FG005|Overall Study|Other|1|||
49146838|NCT00159874|158377553|FG006|Overall Study|Other|3|||
49146839|NCT00159874|158377547|FG000|Overall Study|Protocol Violation|0|||
49146840|NCT00159874|158377548|FG001|Overall Study|Protocol Violation|5|||
49146841|NCT00159874|158377549|FG002|Overall Study|Protocol Violation|2|||
49146842|NCT00159874|158377550|FG003|Overall Study|Protocol Violation|0|||
49146843|NCT00159874|158377551|FG004|Overall Study|Protocol Violation|0|||
49146844|NCT00159874|158377552|FG005|Overall Study|Protocol Violation|0|||
49146845|NCT00159874|158377553|FG006|Overall Study|Protocol Violation|0|||
49146846|NCT00159874|158377547|FG000|Overall Study|Death|3|||
49146847|NCT00159874|158377548|FG001|Overall Study|Death|8|||
49146848|NCT00159874|158377549|FG002|Overall Study|Death|15|||
49146849|NCT00159874|158377550|FG003|Overall Study|Death|0|||
49146850|NCT00159874|158377551|FG004|Overall Study|Death|1|||
49146851|NCT00159874|158377552|FG005|Overall Study|Death|2|||
49146852|NCT00159874|158377553|FG006|Overall Study|Death|0|||
49146853|NCT00159874|158377547|FG000|Overall Study|Withdrawal by Subject|2|||
49146854|NCT00159874|158377548|FG001|Overall Study|Withdrawal by Subject|6|||
48823392|NCT01089556|157193932|FG003|Study Period III (Weeks 9-16)|Lack of Efficacy|2|||
48823393|NCT01089556|157193933|FG004|Study Period III (Weeks 9-16)|Lack of Efficacy|1|||
49146855|NCT00159874|158377549|FG002|Overall Study|Withdrawal by Subject|8|||
48823394|NCT01089556|157193934|FG005|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
48823395|NCT01089556|157193929|FG000|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
48823396|NCT01089556|157193930|FG001|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
48823397|NCT01089556|157193931|FG002|Study Period III (Weeks 9-16)|Lost to Follow-up|1|||
48823398|NCT01089556|157193932|FG003|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
48823399|NCT01089556|157193933|FG004|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
48823400|NCT01089556|157193934|FG005|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
48823401|NCT01089556|157193929|FG000|Study Period III (Weeks 9-16)|Protocol Violation|0|||
48823402|NCT01089556|157193930|FG001|Study Period III (Weeks 9-16)|Protocol Violation|0|||
48823403|NCT01089556|157193931|FG002|Study Period III (Weeks 9-16)|Protocol Violation|1|||
48823404|NCT01089556|157193932|FG003|Study Period III (Weeks 9-16)|Protocol Violation|1|||
48823405|NCT01089556|157193933|FG004|Study Period III (Weeks 9-16)|Protocol Violation|1|||
48823406|NCT01089556|157193934|FG005|Study Period III (Weeks 9-16)|Protocol Violation|0|||
49013753|NCT00606684|157887160|FG004|Double-Blind Treatment Period|Lack of Efficacy|1|||
49013754|NCT00606684|157887161|FG005|Double-Blind Treatment Period|Lack of Efficacy|0|||
49013755|NCT00606684|157887162|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
49013756|NCT00606684|157887156|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
49013757|NCT00606684|157887157|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
49013758|NCT00606684|157887158|FG002|Double-Blind Treatment Period|Protocol Violation|5|||
49013759|NCT00606684|157887159|FG003|Double-Blind Treatment Period|Protocol Violation|3|||
49013760|NCT00606684|157887160|FG004|Double-Blind Treatment Period|Protocol Violation|0|||
49013761|NCT00606684|157887161|FG005|Double-Blind Treatment Period|Protocol Violation|3|||
49013762|NCT00606684|157887162|FG006|Double-Blind Treatment Period|Protocol Violation|4|||
49013763|NCT00606684|157887156|FG000|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0|||
49013764|NCT00606684|157887157|FG001|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
49013765|NCT00606684|157887158|FG002|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
49013766|NCT00606684|157887159|FG003|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
49013767|NCT00606684|157887160|FG004|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
49013768|NCT00606684|157887161|FG005|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3|||
49013769|NCT00606684|157887162|FG006|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
49013770|NCT00606684|157887156|FG000|Double-Blind Treatment Period|Physician Decision|0|||
49013771|NCT00606684|157887157|FG001|Double-Blind Treatment Period|Physician Decision|5|||
49013772|NCT00606684|157887158|FG002|Double-Blind Treatment Period|Physician Decision|1|||
49013773|NCT00606684|157887159|FG003|Double-Blind Treatment Period|Physician Decision|0|||
49013774|NCT00606684|157887160|FG004|Double-Blind Treatment Period|Physician Decision|3|||
49013775|NCT00606684|157887161|FG005|Double-Blind Treatment Period|Physician Decision|1|||
49013776|NCT00606684|157887162|FG006|Double-Blind Treatment Period|Physician Decision|2|||
49013777|NCT00606684|157887156|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
49111973|NCT02749799|158244585|FG000|Overall Study|Protocol Violation|1|||
49111974|NCT02749799|158244585|FG000|Overall Study|Withdrawal by Subject|1|||
49111975|NCT01941537|158244586|FG000|Overall Study|Lack of Efficacy|1|||
49111976|NCT01941537|158244587|FG001|Overall Study|Lack of Efficacy|2|||
49111977|NCT01941537|158244586|FG000|Overall Study|Lost to Follow-up|1|||
49111978|NCT01941537|158244587|FG001|Overall Study|Lost to Follow-up|0|||
49111979|NCT01941537|158244586|FG000|Overall Study|Pregnancy|1|||
49111980|NCT01941537|158244587|FG001|Overall Study|Pregnancy|0|||
49111981|NCT01941537|158244586|FG000|Overall Study|Adverse Event|1|||
49111982|NCT01941537|158244587|FG001|Overall Study|Adverse Event|0|||
49111983|NCT01941537|158244586|FG000|Overall Study|Withdrawal by Subject|0|||
49111984|NCT01941537|158244587|FG001|Overall Study|Withdrawal by Subject|1|||
49111985|NCT02070978|158244588|FG000|Overall Study|Adverse Event|6|||
49111986|NCT02070978|158244589|FG001|Overall Study|Adverse Event|2|||
49111987|NCT02070978|158244590|FG002|Overall Study|Adverse Event|0|||
49111988|NCT02070978|158244588|FG000|Overall Study|Lost to Follow-up|1|||
49111989|NCT02070978|158244589|FG001|Overall Study|Lost to Follow-up|3|||
49111990|NCT02070978|158244590|FG002|Overall Study|Lost to Follow-up|4|||
49111991|NCT02070978|158244588|FG000|Overall Study|Withdrawal by Subject|3|||
49111992|NCT02070978|158244589|FG001|Overall Study|Withdrawal by Subject|5|||
49111993|NCT02070978|158244590|FG002|Overall Study|Withdrawal by Subject|3|||
49111994|NCT02070978|158244588|FG000|Overall Study|Protocol Violation|1|||
49111995|NCT02070978|158244589|FG001|Overall Study|Protocol Violation|0|||
49111996|NCT02070978|158244590|FG002|Overall Study|Protocol Violation|3|||
49111997|NCT02070978|158244588|FG000|Overall Study|Lack of Efficacy|0|||
49111998|NCT02070978|158244589|FG001|Overall Study|Lack of Efficacy|1|||
49111999|NCT02070978|158244590|FG002|Overall Study|Lack of Efficacy|0|||
49112000|NCT02070978|158244588|FG000|Overall Study|Death|0|||
49112001|NCT02070978|158244589|FG001|Overall Study|Death|0|||
49112002|NCT02070978|158244590|FG002|Overall Study|Death|2|||
49112003|NCT02070978|158244588|FG000|Overall Study|Un-specified|3|||
49112004|NCT02070978|158244589|FG001|Overall Study|Un-specified|2|||
49112005|NCT02070978|158244590|FG002|Overall Study|Un-specified|2|||
49112006|NCT02070978|158244588|FG000|Overall Study|Terminated by Sponsor|33|||
49146856|NCT00159874|158377550|FG003|Overall Study|Withdrawal by Subject|4|||
49146857|NCT00159874|158377551|FG004|Overall Study|Withdrawal by Subject|3|||
49146858|NCT00159874|158377552|FG005|Overall Study|Withdrawal by Subject|2|||
49146859|NCT00159874|158377553|FG006|Overall Study|Withdrawal by Subject|1|||
49146860|NCT00159874|158377547|FG000|Overall Study|Pregnancy|1|||
49146861|NCT00159874|158377548|FG001|Overall Study|Pregnancy|1|||
49146862|NCT00159874|158377549|FG002|Overall Study|Pregnancy|0|||
49146863|NCT00159874|158377550|FG003|Overall Study|Pregnancy|0|||
49146864|NCT00159874|158377551|FG004|Overall Study|Pregnancy|0|||
49146865|NCT00159874|158377552|FG005|Overall Study|Pregnancy|0|||
49146866|NCT00159874|158377553|FG006|Overall Study|Pregnancy|0|||
49146867|NCT03302936|158377554|FG000|Overall Study|Protocol Violation|3|||
49146868|NCT03302936|158377555|FG001|Overall Study|Protocol Violation|4|||
49146869|NCT01104870|158377556|FG000|Overall Study|Adverse Event|1|||
49146870|NCT01104870|158377557|FG001|Overall Study|Adverse Event|1|||
49146871|NCT01104870|158377558|FG002|Overall Study|Adverse Event|0|||
49146872|NCT01104870|158377556|FG000|Overall Study|Death|0|||
49146873|NCT01104870|158377557|FG001|Overall Study|Death|0|||
49146874|NCT01104870|158377558|FG002|Overall Study|Death|1|||
49146875|NCT01104870|158377556|FG000|Overall Study|Withdrawal by Subject|0|||
49146876|NCT01104870|158377557|FG001|Overall Study|Withdrawal by Subject|0|||
49146877|NCT01104870|158377558|FG002|Overall Study|Withdrawal by Subject|1|||
49146878|NCT01122680|158377559|FG000|Period 1 (4 Weeks)|Adverse Event|1|||
49146879|NCT01122680|158377560|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
49146880|NCT01122680|158377561|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
49146881|NCT01122680|158377562|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
49146882|NCT01122680|158377559|FG000|Period 1 (4 Weeks)|Protocol Violation|1|||
49146883|NCT01122680|158377560|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
49146884|NCT01122680|158377561|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
49146885|NCT01122680|158377562|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
49146886|NCT01122680|158377559|FG000|Period 1 (4 Weeks)|Other|1|||
49146887|NCT01122680|158377560|FG001|Period 1 (4 Weeks)|Other|1|||
49146888|NCT01122680|158377561|FG002|Period 1 (4 Weeks)|Other|0|||
49146889|NCT01122680|158377562|FG003|Period 1 (4 Weeks)|Other|0|||
49146890|NCT01122680|158377559|FG000|Period 2 (4 Weeks)|Protocol Violation|0|||
49146891|NCT01122680|158377560|FG001|Period 2 (4 Weeks)|Protocol Violation|0|||
49146892|NCT01122680|158377561|FG002|Period 2 (4 Weeks)|Protocol Violation|0|||
49146893|NCT01122680|158377562|FG003|Period 2 (4 Weeks)|Protocol Violation|1|||
49146894|NCT01122680|158377559|FG000|Period 2 (4 Weeks)|Other|1|||
49146895|NCT01122680|158377560|FG001|Period 2 (4 Weeks)|Other|0|||
49146896|NCT01122680|158377561|FG002|Period 2 (4 Weeks)|Other|0|||
49146897|NCT01122680|158377562|FG003|Period 2 (4 Weeks)|Other|0|||
49146898|NCT01122680|158377559|FG000|Period 3 (4 Weeks)|Adverse Event|1|||
49146899|NCT01122680|158377560|FG001|Period 3 (4 Weeks)|Adverse Event|0|||
49146900|NCT01122680|158377561|FG002|Period 3 (4 Weeks)|Adverse Event|0|||
49146901|NCT01122680|158377562|FG003|Period 3 (4 Weeks)|Adverse Event|0|||
49146902|NCT01122680|158377559|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
49146903|NCT01122680|158377560|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
49146904|NCT01122680|158377561|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
49146905|NCT01122680|158377562|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
49146906|NCT00692237|158377565|FG000|Overall Study|Withdrawal by Subject|1|||
49146907|NCT00692237|158377566|FG001|Overall Study|Withdrawal by Subject|3|||
49146908|NCT00692237|158377565|FG000|Overall Study|Adverse Event|0|||
49146909|NCT00692237|158377566|FG001|Overall Study|Adverse Event|1|||
49146910|NCT01530997|158377567|FG000|Overall Study|Physician Decision|1|||
49146911|NCT01530997|158377567|FG000|Overall Study|Withdrawal by Subject|1|||
49146912|NCT01063881|158377568|FG000|Overall Study|Adverse Event|12|||
49146913|NCT01063881|158377569|FG001|Overall Study|Adverse Event|2|||
49146914|NCT01063881|158377570|FG002|Overall Study|Adverse Event|0|||
49146915|NCT01063881|158377568|FG000|Overall Study|Lost to Follow-up|13|||
49146916|NCT01063881|158377569|FG001|Overall Study|Lost to Follow-up|7|||
49146917|NCT01063881|158377570|FG002|Overall Study|Lost to Follow-up|1|||
49146918|NCT01063881|158377568|FG000|Overall Study|Withdrawal by Subject|25|||
49146919|NCT01063881|158377569|FG001|Overall Study|Withdrawal by Subject|1|||
49146920|NCT01063881|158377570|FG002|Overall Study|Withdrawal by Subject|0|||
49146921|NCT01063881|158377568|FG000|Overall Study|Reason for not completed not specified|5|||
49146922|NCT01063881|158377569|FG001|Overall Study|Reason for not completed not specified|1|||
49146923|NCT01063881|158377570|FG002|Overall Study|Reason for not completed not specified|0|||
49146924|NCT01927861|158377573|FG000|Extension Phase (104 Weeks)|Adverse Event|0|||
49146925|NCT01927861|158377574|FG001|Extension Phase (104 Weeks)|Adverse Event|2|||
49146926|NCT01927861|158377573|FG000|Extension Phase (104 Weeks)|Unclassified|0|||
49146927|NCT01927861|158377574|FG001|Extension Phase (104 Weeks)|Unclassified|1|||
49146928|NCT00987935|158377575|FG000|Overall Study|Progressive disease|3|||
49146929|NCT00987935|158377576|FG001|Overall Study|Progressive disease|2|||
49146930|NCT00987935|158377577|FG002|Overall Study|Progressive disease|3|||
49146931|NCT00987935|158377578|FG003|Overall Study|Progressive disease|2|||
49146932|NCT00987935|158377579|FG004|Overall Study|Progressive disease|5|||
49146933|NCT00987935|158377580|FG005|Overall Study|Progressive disease|3|||
49146934|NCT00987935|158377581|FG006|Overall Study|Progressive disease|9|||
49146935|NCT00987935|158377582|FG007|Overall Study|Progressive disease|48|||
49146936|NCT00987935|158377583|FG008|Overall Study|Progressive disease|23|||
49146937|NCT00987935|158377575|FG000|Overall Study|Adverse Event|0|||
49146938|NCT00987935|158377576|FG001|Overall Study|Adverse Event|1|||
49146939|NCT00987935|158377577|FG002|Overall Study|Adverse Event|0|||
49146940|NCT00987935|158377578|FG003|Overall Study|Adverse Event|1|||
49146941|NCT00987935|158377579|FG004|Overall Study|Adverse Event|1|||
49146942|NCT00987935|158377580|FG005|Overall Study|Adverse Event|0|||
49146943|NCT00987935|158377581|FG006|Overall Study|Adverse Event|2|||
49146944|NCT00987935|158377582|FG007|Overall Study|Adverse Event|10|||
49146945|NCT00987935|158377583|FG008|Overall Study|Adverse Event|6|||
49146946|NCT00987935|158377575|FG000|Overall Study|Refused to continue taking trial med.|1|||
49146947|NCT00987935|158377576|FG001|Overall Study|Refused to continue taking trial med.|0|||
49146948|NCT00987935|158377577|FG002|Overall Study|Refused to continue taking trial med.|0|||
49146949|NCT00987935|158377578|FG003|Overall Study|Refused to continue taking trial med.|0|||
49146950|NCT00987935|158377579|FG004|Overall Study|Refused to continue taking trial med.|1|||
49146951|NCT00987935|158377580|FG005|Overall Study|Refused to continue taking trial med.|0|||
49146952|NCT00987935|158377581|FG006|Overall Study|Refused to continue taking trial med.|4|||
49146953|NCT00987935|158377582|FG007|Overall Study|Refused to continue taking trial med.|4|||
49146954|NCT00987935|158377583|FG008|Overall Study|Refused to continue taking trial med.|2|||
49146955|NCT00987935|158377575|FG000|Overall Study|Reason other than those specified above|0|||
49146956|NCT00987935|158377576|FG001|Overall Study|Reason other than those specified above|0|||
49146957|NCT00987935|158377577|FG002|Overall Study|Reason other than those specified above|0|||
48823407|NCT01089556|157193929|FG000|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
48823408|NCT01089556|157193930|FG001|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
49146958|NCT00987935|158377578|FG003|Overall Study|Reason other than those specified above|0|||
49146959|NCT00987935|158377579|FG004|Overall Study|Reason other than those specified above|0|||
48823409|NCT01089556|157193931|FG002|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
48823410|NCT01089556|157193932|FG003|Study Period III (Weeks 9-16)|Satisfactory Response|3|||
48823411|NCT01089556|157193933|FG004|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
48823412|NCT01089556|157193934|FG005|Study Period III (Weeks 9-16)|Satisfactory Response|1|||
48823413|NCT01089556|157193929|FG000|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
48823414|NCT01089556|157193930|FG001|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
48823415|NCT01089556|157193931|FG002|Study Period III (Weeks 9-16)|Withdrawal by Subject|3|||
48823416|NCT01089556|157193932|FG003|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
48823417|NCT01089556|157193933|FG004|Study Period III (Weeks 9-16)|Withdrawal by Subject|1|||
48823418|NCT01089556|157193934|FG005|Study Period III (Weeks 9-16)|Withdrawal by Subject|2|||
48823419|NCT01890967|157193935|FG000|Overall Study|Adverse Event|3|||
48823420|NCT01890967|157193936|FG001|Overall Study|Adverse Event|3|||
48823421|NCT01890967|157193937|FG002|Overall Study|Adverse Event|3|||
48823422|NCT01890967|157193938|FG003|Overall Study|Adverse Event|2|||
48823423|NCT01890967|157193939|FG004|Overall Study|Adverse Event|1|||
48823424|NCT01890967|157193940|FG005|Overall Study|Adverse Event|7|||
48823425|NCT01890967|157193935|FG000|Overall Study|Death|1|||
48823426|NCT01890967|157193936|FG001|Overall Study|Death|0|||
48823427|NCT01890967|157193937|FG002|Overall Study|Death|0|||
48823428|NCT01890967|157193938|FG003|Overall Study|Death|0|||
48823429|NCT01890967|157193939|FG004|Overall Study|Death|0|||
48921440|NCT02970292|157546393|FG000|Overall Study|Withdrawal by Subject|11|||
49146960|NCT00987935|158377580|FG005|Overall Study|Reason other than those specified above|0|||
49146961|NCT00987935|158377581|FG006|Overall Study|Reason other than those specified above|0|||
49146962|NCT00987935|158377582|FG007|Overall Study|Reason other than those specified above|0|||
49146963|NCT00987935|158377583|FG008|Overall Study|Reason other than those specified above|1|||
49146964|NCT04560309|158377584|FG000|Overall Study|Meet drop out criteria|1|||
49146965|NCT04560309|158377585|FG001|Overall Study|Meet drop out criteria|1|||
49146966|NCT02100644|158377586|FG000|LTG Escalation Phase|Adverse Event|9|||
49146967|NCT02100644|158377587|FG001|LTG Escalation Phase|Adverse Event|0|||
49146968|NCT02100644|158377588|FG002|LTG Escalation Phase|Adverse Event|0|||
49146969|NCT02100644|158377586|FG000|LTG Escalation Phase|Protocol-defined Stopping Criteria|1|||
49146970|NCT02100644|158377587|FG001|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
49146971|NCT02100644|158377588|FG002|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
49146972|NCT02100644|158377586|FG000|LTG Escalation Phase|Withdrawal by Subject|3|||
49146973|NCT02100644|158377587|FG001|LTG Escalation Phase|Withdrawal by Subject|0|||
49146974|NCT02100644|158377588|FG002|LTG Escalation Phase|Withdrawal by Subject|0|||
49146975|NCT02940223|158377589|FG000|Overall Study|Failed Requirement|2|||
49146976|NCT02940223|158377590|FG001|Overall Study|Failed Requirement|0|||
49146977|NCT01608308|158377591|FG000|Overall Study|pretreatment medical and billing reasons|0|||
49146978|NCT01608308|158377592|FG001|Overall Study|pretreatment medical and billing reasons|2|||
49146979|NCT03382873|158377597|FG000|Overall Study|Lost to Follow-up|9|||
49146980|NCT03382873|158377598|FG001|Overall Study|Lost to Follow-up|10|||
49146981|NCT03382873|158377597|FG000|Overall Study|Withdrawal by Subject|6|||
49146982|NCT03382873|158377598|FG001|Overall Study|Withdrawal by Subject|11|||
49146983|NCT03382873|158377597|FG000|Overall Study|Visit not completed due to pandemic|16|||
49146984|NCT03382873|158377598|FG001|Overall Study|Visit not completed due to pandemic|41|||
49146985|NCT03769467|158377600|FG000|Overall Study|Adverse Event|1|||
49146986|NCT03769467|158377601|FG001|Overall Study|Adverse Event|1|||
49146987|NCT03769467|158377602|FG002|Overall Study|Adverse Event|0|||
49146988|NCT03769467|158377600|FG000|Overall Study|Death|3|||
49146989|NCT03769467|158377601|FG001|Overall Study|Death|3|||
49146990|NCT03769467|158377602|FG002|Overall Study|Death|0|||
49146991|NCT03769467|158377600|FG000|Overall Study|Study Terminated By Sponsor|2|||
49146992|NCT03769467|158377601|FG001|Overall Study|Study Terminated By Sponsor|1|||
49146993|NCT03769467|158377602|FG002|Overall Study|Study Terminated By Sponsor|0|||
49146994|NCT03769467|158377600|FG000|Overall Study|Withdrawal by Subject|0|||
49146995|NCT03769467|158377601|FG001|Overall Study|Withdrawal by Subject|1|||
49146996|NCT03769467|158377602|FG002|Overall Study|Withdrawal by Subject|0|||
49146997|NCT00461812|158377605|FG000|Overall Study|study terminated|10|||
49146998|NCT03760666|158377606|FG000|Overall Study|Adverse Event|2|||
49146999|NCT03760666|158377607|FG001|Overall Study|Adverse Event|4|||
49147000|NCT03760666|158377608|FG002|Overall Study|Adverse Event|1|||
49147001|NCT03760666|158377606|FG000|Overall Study|AML Disease Progression|3|||
49147002|NCT03760666|158377607|FG001|Overall Study|AML Disease Progression|3|||
49147003|NCT03760666|158377608|FG002|Overall Study|AML Disease Progression|0|||
49147004|NCT03760666|158377606|FG000|Overall Study|Physician Decision|0|||
49147005|NCT03760666|158377607|FG001|Overall Study|Physician Decision|3|||
49147006|NCT03760666|158377608|FG002|Overall Study|Physician Decision|0|||
49147007|NCT03760666|158377606|FG000|Overall Study|Withdrawal by Subject|0|||
49147008|NCT03760666|158377607|FG001|Overall Study|Withdrawal by Subject|1|||
49147009|NCT03760666|158377608|FG002|Overall Study|Withdrawal by Subject|0|||
49147010|NCT01152385|158377609|FG000|Overall Study|Withdrawal by Subject|3|||
49147011|NCT01152385|158377610|FG001|Overall Study|Withdrawal by Subject|1|||
49147012|NCT01152385|158377611|FG002|Overall Study|Withdrawal by Subject|1|||
49147013|NCT01152385|158377612|FG003|Overall Study|Withdrawal by Subject|1|||
49147014|NCT01152385|158377609|FG000|Overall Study|Protocol Violation|0|||
49147015|NCT01152385|158377610|FG001|Overall Study|Protocol Violation|0|||
49147016|NCT01152385|158377611|FG002|Overall Study|Protocol Violation|0|||
49147017|NCT01152385|158377612|FG003|Overall Study|Protocol Violation|1|||
49147018|NCT01152385|158377609|FG000|Overall Study|Adverse Event|1|||
49147019|NCT01152385|158377610|FG001|Overall Study|Adverse Event|1|||
49147020|NCT01152385|158377611|FG002|Overall Study|Adverse Event|0|||
49147021|NCT01152385|158377612|FG003|Overall Study|Adverse Event|0|||
49147022|NCT01152385|158377609|FG000|Overall Study|Study-specific withdrawal criteria|1|||
49147023|NCT01152385|158377610|FG001|Overall Study|Study-specific withdrawal criteria|1|||
49147024|NCT01152385|158377611|FG002|Overall Study|Study-specific withdrawal criteria|2|||
49147025|NCT01152385|158377612|FG003|Overall Study|Study-specific withdrawal criteria|0|||
49147026|NCT01152385|158377609|FG000|Overall Study|Other|4|||
49147027|NCT01152385|158377610|FG001|Overall Study|Other|3|||
49147028|NCT01152385|158377611|FG002|Overall Study|Other|2|||
49147029|NCT01152385|158377612|FG003|Overall Study|Other|3|||
49147030|NCT03249558|158377613|FG000|Overall Study|Lost to Follow-up|2|||
49147031|NCT03249558|158377614|FG001|Overall Study|Lost to Follow-up|1|||
49147032|NCT03249558|158377615|FG002|Overall Study|Lost to Follow-up|4|||
49147033|NCT03249558|158377613|FG000|Overall Study|Physician Decision|1|||
49147034|NCT03249558|158377614|FG001|Overall Study|Physician Decision|0|||
49147035|NCT03249558|158377615|FG002|Overall Study|Physician Decision|0|||
49147036|NCT03249558|158377613|FG000|Overall Study|Withdrawal by Subject|6|||
49147037|NCT03249558|158377614|FG001|Overall Study|Withdrawal by Subject|5|||
49147038|NCT03249558|158377615|FG002|Overall Study|Withdrawal by Subject|7|||
49147039|NCT03249558|158377613|FG000|Overall Study|COVID-19 pandemic shutdown|1|||
49147040|NCT03249558|158377614|FG001|Overall Study|COVID-19 pandemic shutdown|0|||
49147041|NCT03249558|158377615|FG002|Overall Study|COVID-19 pandemic shutdown|0|||
49147042|NCT03249558|158377613|FG000|Overall Study|Protocol Violation|1|||
49147043|NCT03249558|158377614|FG001|Overall Study|Protocol Violation|1|||
49147044|NCT03249558|158377615|FG002|Overall Study|Protocol Violation|2|||
49147045|NCT04398706|158377616|FG000|Overall Study|Adverse Event|0|||
49147046|NCT04398706|158377617|FG001|Overall Study|Adverse Event|0|||
49147047|NCT04398706|158377618|FG002|Overall Study|Adverse Event|0|||
49147048|NCT04398706|158377619|FG003|Overall Study|Adverse Event|0|||
49147049|NCT04398706|158377620|FG004|Overall Study|Adverse Event|0|||
49147050|NCT04398706|158377621|FG005|Overall Study|Adverse Event|1|||
49147051|NCT04398706|158377622|FG006|Overall Study|Adverse Event|1|||
49147052|NCT04398706|158377623|FG007|Overall Study|Adverse Event|0|||
49147053|NCT04398706|158377616|FG000|Overall Study|Lost to Follow-up|0|||
49147054|NCT04398706|158377617|FG001|Overall Study|Lost to Follow-up|1|||
49147055|NCT04398706|158377618|FG002|Overall Study|Lost to Follow-up|2|||
49147056|NCT04398706|158377619|FG003|Overall Study|Lost to Follow-up|1|||
49147057|NCT04398706|158377620|FG004|Overall Study|Lost to Follow-up|6|||
49147058|NCT04398706|158377621|FG005|Overall Study|Lost to Follow-up|3|||
49147059|NCT04398706|158377622|FG006|Overall Study|Lost to Follow-up|8|||
49147060|NCT04398706|158377623|FG007|Overall Study|Lost to Follow-up|2|||
49013778|NCT00606684|157887157|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
49013779|NCT00606684|157887158|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
49013780|NCT00606684|157887159|FG003|Double-Blind Treatment Period|Withdrawal by Subject|2|||
49013781|NCT00606684|157887160|FG004|Double-Blind Treatment Period|Withdrawal by Subject|1|||
49112164|NCT03877224|158245789|FG001|Overall Study|Death|2|||
49112165|NCT03877224|158245788|FG000|Overall Study|Withdrawal by Subject|1|||
49112166|NCT03877224|158245789|FG001|Overall Study|Withdrawal by Subject|6|||
49112167|NCT03877224|158245788|FG000|Overall Study|Participant is alive, just unable to come for visits|1|||
49112168|NCT03877224|158245789|FG001|Overall Study|Participant is alive, just unable to come for visits|0|||
49112169|NCT03749109|158245794|FG000|Overall Study|Adverse Event|2|||
49112170|NCT03749109|158245795|FG001|Overall Study|Adverse Event|0|||
49112171|NCT01243177|158245797|FG000|Overall Study|Lack of Efficacy|47|||
49112172|NCT01243177|158245798|FG001|Overall Study|Lack of Efficacy|31|||
49112173|NCT01243177|158245797|FG000|Overall Study|Protocol Violation|11|||
49112174|NCT01243177|158245798|FG001|Overall Study|Protocol Violation|10|||
49112175|NCT01243177|158245797|FG000|Overall Study|Lost to Follow-up|15|||
49112176|NCT01243177|158245798|FG001|Overall Study|Lost to Follow-up|18|||
49112177|NCT01243177|158245797|FG000|Overall Study|Withdrawal by Subject|46|||
49112178|NCT01243177|158245798|FG001|Overall Study|Withdrawal by Subject|38|||
49112179|NCT01243177|158245797|FG000|Overall Study|AE, serious fatal|0|||
49112180|NCT01243177|158245798|FG001|Overall Study|AE, serious fatal|1|||
49112181|NCT01243177|158245797|FG000|Overall Study|SAE, non-fatal|7|||
49112182|NCT01243177|158245798|FG001|Overall Study|SAE, non-fatal|9|||
49112183|NCT01243177|158245797|FG000|Overall Study|AE, non-serious non-fatal|40|||
49112184|NCT01243177|158245798|FG001|Overall Study|AE, non-serious non-fatal|58|||
49112185|NCT01243177|158245797|FG000|Overall Study|SAE, fatal + SAE, non-fatal|1|||
49112186|NCT01243177|158245798|FG001|Overall Study|SAE, fatal + SAE, non-fatal|0|||
49112187|NCT01243177|158245797|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
49112188|NCT01243177|158245798|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
49112189|NCT01243177|158245797|FG000|Overall Study|Other Reason|11|||
49112190|NCT01243177|158245798|FG001|Overall Study|Other Reason|12|||
49112191|NCT02513394|158245800|FG000|Overall Study|Withdrawal by Subject|11|||
49112192|NCT02513394|158245801|FG001|Overall Study|Withdrawal by Subject|23|||
49112193|NCT02513394|158245800|FG000|Overall Study|Ineligible|1|||
49112194|NCT02513394|158245801|FG001|Overall Study|Ineligible|0|||
49112195|NCT04445831|158245802|FG000|Overall Study|Withdrawal by Subject|2|||
49112196|NCT04445831|158245803|FG001|Overall Study|Withdrawal by Subject|1|||
49112197|NCT04445831|158245804|FG002|Overall Study|Withdrawal by Subject|1|||
49112198|NCT04445831|158245805|FG003|Overall Study|Withdrawal by Subject|0|||
49112199|NCT04445831|158245806|FG004|Overall Study|Withdrawal by Subject|0|||
49112200|NCT04445831|158245807|FG005|Overall Study|Withdrawal by Subject|0|||
49112201|NCT04445831|158245808|FG006|Overall Study|Withdrawal by Subject|0|||
49112202|NCT04445831|158245802|FG000|Overall Study|Subject withdrawal by caregiver|0|||
49112203|NCT04445831|158245803|FG001|Overall Study|Subject withdrawal by caregiver|1|||
49112204|NCT04445831|158245804|FG002|Overall Study|Subject withdrawal by caregiver|0|||
49112361|NCT04424914|158247431|FG000|Overall Study|Lost to Follow-up|0|||
49112362|NCT04424914|158247432|FG001|Overall Study|Lost to Follow-up|0|||
49112363|NCT04424914|158247433|FG002|Overall Study|Lost to Follow-up|1|||
49112364|NCT04424914|158247431|FG000|Overall Study|Death|3|||
49112365|NCT04424914|158247432|FG001|Overall Study|Death|1|||
49112366|NCT04424914|158247433|FG002|Overall Study|Death|0|||
49112367|NCT00073008|158247434|FG000|Overall Study|Missing|6|||
49112368|NCT00073008|158247435|FG001|Overall Study|Missing|6|||
49112369|NCT00073008|158247434|FG000|Overall Study|Withdrawal by Subject|2|||
49112370|NCT00073008|158247435|FG001|Overall Study|Withdrawal by Subject|2|||
49112371|NCT00073008|158247434|FG000|Overall Study|Lost to Follow-up|1|||
49112372|NCT00073008|158247435|FG001|Overall Study|Lost to Follow-up|3|||
49112373|NCT00073008|158247434|FG000|Overall Study|Death|46|||
49112374|NCT00073008|158247435|FG001|Overall Study|Death|47|||
49112375|NCT00073008|158247434|FG000|Overall Study|"Other selected on Case Report Form"|7|||
49112376|NCT00073008|158247435|FG001|Overall Study|"Other selected on Case Report Form"|5|||
49112377|NCT02069093|158247441|FG000|Overall Study|Disease progression|14|||
49112378|NCT02069093|158247441|FG000|Overall Study|New cancer therapy|1|||
49112379|NCT02069093|158247441|FG000|Overall Study|Death|1|||
49112380|NCT02069093|158247441|FG000|Overall Study|Administrative problems|1|||
49112381|NCT02069093|158247441|FG000|Overall Study|Withdrawal by Subject|2|||
49112382|NCT02069093|158247441|FG000|Overall Study|Abnormal laboratory values|1|||
49112383|NCT02069093|158247441|FG000|Overall Study|Adverse Event|10|||
49112384|NCT01900899|158247444|FG000|Overall Study|Withdrawal by Subject|7|||
49112385|NCT01900899|158247445|FG001|Overall Study|Withdrawal by Subject|1|||
49112386|NCT01900899|158247444|FG000|Overall Study|Migrated from study area|2|||
49112387|NCT01900899|158247445|FG001|Overall Study|Migrated from study area|0|||
49112388|NCT02634983|158247448|FG000|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2|||
49147061|NCT04398706|158377616|FG000|Overall Study|Withdrawal by parent/guardian|0|||
49147062|NCT04398706|158377617|FG001|Overall Study|Withdrawal by parent/guardian|2|||
49147063|NCT04398706|158377618|FG002|Overall Study|Withdrawal by parent/guardian|1|||
49147064|NCT04398706|158377619|FG003|Overall Study|Withdrawal by parent/guardian|2|||
49147065|NCT04398706|158377620|FG004|Overall Study|Withdrawal by parent/guardian|19|||
49147066|NCT04398706|158377621|FG005|Overall Study|Withdrawal by parent/guardian|23|||
49147067|NCT04398706|158377622|FG006|Overall Study|Withdrawal by parent/guardian|13|||
49147068|NCT04398706|158377623|FG007|Overall Study|Withdrawal by parent/guardian|11|||
49147069|NCT04398706|158377616|FG000|Overall Study|Protocol deviation|0|||
49147070|NCT04398706|158377617|FG001|Overall Study|Protocol deviation|1|||
49147071|NCT04398706|158377618|FG002|Overall Study|Protocol deviation|0|||
49147072|NCT04398706|158377619|FG003|Overall Study|Protocol deviation|0|||
49147073|NCT04398706|158377620|FG004|Overall Study|Protocol deviation|6|||
49147074|NCT04398706|158377621|FG005|Overall Study|Protocol deviation|4|||
49147075|NCT04398706|158377622|FG006|Overall Study|Protocol deviation|6|||
49147076|NCT04398706|158377623|FG007|Overall Study|Protocol deviation|3|||
49147077|NCT02037984|158377624|FG000|Overall Study|Lack of Efficacy|0|||
49147078|NCT02037984|158377625|FG001|Overall Study|Lack of Efficacy|0|||
49147079|NCT02037984|158377626|FG002|Overall Study|Lack of Efficacy|3|||
49147080|NCT02037984|158377627|FG003|Overall Study|Lack of Efficacy|10|||
49147081|NCT02037984|158377628|FG004|Overall Study|Lack of Efficacy|2|||
49147082|NCT02037984|158377629|FG005|Overall Study|Lack of Efficacy|2|||
49147083|NCT02037984|158377630|FG006|Overall Study|Lack of Efficacy|4|||
49147084|NCT02037984|158377631|FG007|Overall Study|Lack of Efficacy|3|||
49147085|NCT02037984|158377624|FG000|Overall Study|Lost to Follow-up|1|||
49147086|NCT02037984|158377625|FG001|Overall Study|Lost to Follow-up|0|||
49013782|NCT00606684|157887161|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
49013783|NCT00606684|157887162|FG006|Double-Blind Treatment Period|Withdrawal by Subject|0|||
49013784|NCT00006721|157887163|FG000|Overall Study|Adverse Event|0|||
49013785|NCT00006721|157887164|FG001|Overall Study|Adverse Event|4|||
49013786|NCT00006721|157887165|FG002|Overall Study|Adverse Event|4|||
49013787|NCT00006721|157887163|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
49013788|NCT00006721|157887164|FG001|Overall Study|Refusal Unrelated to Adverse Event|0|||
49013789|NCT00006721|157887165|FG002|Overall Study|Refusal Unrelated to Adverse Event|8|||
49013790|NCT00006721|157887163|FG000|Overall Study|Progression/Relapse|0|||
49013791|NCT00006721|157887164|FG001|Overall Study|Progression/Relapse|1|||
49013792|NCT00006721|157887165|FG002|Overall Study|Progression/Relapse|2|||
49013793|NCT00006721|157887163|FG000|Overall Study|Death|0|||
49013794|NCT00006721|157887164|FG001|Overall Study|Death|1|||
49013795|NCT00006721|157887165|FG002|Overall Study|Death|2|||
49013796|NCT00006721|157887163|FG000|Overall Study|Other - Not Protocol Specified|0|||
49013797|NCT00006721|157887164|FG001|Overall Study|Other - Not Protocol Specified|7|||
49013798|NCT00006721|157887165|FG002|Overall Study|Other - Not Protocol Specified|7|||
49013799|NCT00006721|157887163|FG000|Overall Study|Ineligible|2|||
49013800|NCT00006721|157887164|FG001|Overall Study|Ineligible|12|||
49013801|NCT00006721|157887165|FG002|Overall Study|Ineligible|10|||
49013802|NCT00006721|157887163|FG000|Overall Study|Eligible but no Treatment Received|1|||
49013803|NCT00006721|157887164|FG001|Overall Study|Eligible but no Treatment Received|0|||
49013804|NCT00006721|157887165|FG002|Overall Study|Eligible but no Treatment Received|0|||
49013805|NCT03568500|157887166|FG000|Overall Study|Lost to Follow-up|1|||
49013806|NCT03568500|157887167|FG001|Overall Study|Lost to Follow-up|1|||
49013807|NCT03568500|157887168|FG002|Overall Study|Lost to Follow-up|2|||
49013808|NCT03568500|157887166|FG000|Overall Study|Adverse Event|1|||
49013809|NCT03568500|157887167|FG001|Overall Study|Adverse Event|1|||
49013810|NCT03568500|157887168|FG002|Overall Study|Adverse Event|2|||
49013811|NCT03568500|157887166|FG000|Overall Study|Physician Decision|1|||
49013812|NCT03568500|157887167|FG001|Overall Study|Physician Decision|0|||
49013813|NCT03568500|157887168|FG002|Overall Study|Physician Decision|0|||
49013814|NCT03568500|157887166|FG000|Overall Study|Withdrawal by Subject|4|||
49013815|NCT03568500|157887167|FG001|Overall Study|Withdrawal by Subject|2|||
49013816|NCT03568500|157887168|FG002|Overall Study|Withdrawal by Subject|0|||
49013817|NCT03568500|157887166|FG000|Overall Study|Technical Problems|2|||
49013818|NCT03568500|157887167|FG001|Overall Study|Technical Problems|1|||
49013819|NCT03568500|157887168|FG002|Overall Study|Technical Problems|0|||
49013820|NCT03568500|157887166|FG000|Overall Study|Participant Noncompliance|1|||
49013821|NCT03568500|157887167|FG001|Overall Study|Participant Noncompliance|1|||
49013822|NCT03568500|157887168|FG002|Overall Study|Participant Noncompliance|0|||
49013823|NCT03650400|157887173|FG000|Overall Study|Study terminated by sponsor|0|||
49013824|NCT03650400|157887174|FG001|Overall Study|Study terminated by sponsor|5|||
49013825|NCT01034137|157887181|FG000|Overall Study|Adverse Event|9|||
49013826|NCT01034137|157887182|FG001|Overall Study|Adverse Event|10|||
49013827|NCT01034137|157887183|FG002|Overall Study|Adverse Event|8|||
49147087|NCT02037984|158377626|FG002|Overall Study|Lost to Follow-up|3|||
49147088|NCT02037984|158377627|FG003|Overall Study|Lost to Follow-up|5|||
49147089|NCT02037984|158377628|FG004|Overall Study|Lost to Follow-up|2|||
49147090|NCT02037984|158377629|FG005|Overall Study|Lost to Follow-up|2|||
49147091|NCT02037984|158377630|FG006|Overall Study|Lost to Follow-up|2|||
49147092|NCT02037984|158377631|FG007|Overall Study|Lost to Follow-up|4|||
49147093|NCT02037984|158377624|FG000|Overall Study|Physician Decision|0|||
49147094|NCT02037984|158377625|FG001|Overall Study|Physician Decision|0|||
49147095|NCT02037984|158377626|FG002|Overall Study|Physician Decision|0|||
49147096|NCT02037984|158377627|FG003|Overall Study|Physician Decision|0|||
49147097|NCT02037984|158377628|FG004|Overall Study|Physician Decision|0|||
49147098|NCT02037984|158377629|FG005|Overall Study|Physician Decision|0|||
49147099|NCT02037984|158377630|FG006|Overall Study|Physician Decision|1|||
49147100|NCT02037984|158377631|FG007|Overall Study|Physician Decision|0|||
48823430|NCT01890967|157193940|FG005|Overall Study|Death|0|||
49147101|NCT02037984|158377624|FG000|Overall Study|Protocol Violation|0|||
49147102|NCT02037984|158377625|FG001|Overall Study|Protocol Violation|0|||
49147103|NCT02037984|158377626|FG002|Overall Study|Protocol Violation|0|||
49147104|NCT02037984|158377627|FG003|Overall Study|Protocol Violation|0|||
49147105|NCT02037984|158377628|FG004|Overall Study|Protocol Violation|0|||
49147106|NCT02037984|158377629|FG005|Overall Study|Protocol Violation|1|||
49147107|NCT02037984|158377630|FG006|Overall Study|Protocol Violation|2|||
49147108|NCT02037984|158377631|FG007|Overall Study|Protocol Violation|0|||
49147109|NCT02037984|158377624|FG000|Overall Study|Technical Problems|0|||
49147110|NCT02037984|158377625|FG001|Overall Study|Technical Problems|0|||
49147111|NCT02037984|158377626|FG002|Overall Study|Technical Problems|3|||
49147112|NCT02037984|158377627|FG003|Overall Study|Technical Problems|3|||
49147113|NCT02037984|158377628|FG004|Overall Study|Technical Problems|2|||
49147114|NCT02037984|158377629|FG005|Overall Study|Technical Problems|3|||
49147115|NCT02037984|158377630|FG006|Overall Study|Technical Problems|4|||
49147116|NCT02037984|158377631|FG007|Overall Study|Technical Problems|2|||
49147117|NCT02037984|158377624|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
49147118|NCT02037984|158377625|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
49147119|NCT02037984|158377626|FG002|Overall Study|Withdrawal by Parent/Guardian|3|||
49147120|NCT02037984|158377627|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
49147121|NCT02037984|158377628|FG004|Overall Study|Withdrawal by Parent/Guardian|5|||
49147122|NCT02037984|158377629|FG005|Overall Study|Withdrawal by Parent/Guardian|1|||
49147123|NCT02037984|158377630|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
49147124|NCT02037984|158377631|FG007|Overall Study|Withdrawal by Parent/Guardian|2|||
49147125|NCT02037984|158377624|FG000|Overall Study|Withdrawal by Subject|0|||
49147126|NCT02037984|158377625|FG001|Overall Study|Withdrawal by Subject|0|||
49147127|NCT02037984|158377626|FG002|Overall Study|Withdrawal by Subject|0|||
49147128|NCT02037984|158377627|FG003|Overall Study|Withdrawal by Subject|1|||
49147129|NCT02037984|158377628|FG004|Overall Study|Withdrawal by Subject|1|||
49147130|NCT02037984|158377629|FG005|Overall Study|Withdrawal by Subject|3|||
49147131|NCT02037984|158377630|FG006|Overall Study|Withdrawal by Subject|0|||
49147132|NCT02037984|158377631|FG007|Overall Study|Withdrawal by Subject|1|||
49147133|NCT00908141|158377634|FG000|Overall Study|Withdrawal by Subject|0|||
49147134|NCT00908141|158377635|FG001|Overall Study|Withdrawal by Subject|1|||
49147135|NCT05943990|158377636|FG000|Overall Study|Study Terminated by Sponsor|0|||
49147136|NCT05943990|158377637|FG001|Overall Study|Study Terminated by Sponsor|0|||
49147137|NCT05943990|158377638|FG002|Overall Study|Study Terminated by Sponsor|1|||
49147138|NCT01569763|158378711|FG000|Overall Study|Lack of Efficacy|2|||
49147139|NCT01569763|158378712|FG001|Overall Study|Lack of Efficacy|7|||
49147140|NCT01569763|158378711|FG000|Overall Study|Adverse Event|1|||
49147141|NCT01569763|158378712|FG001|Overall Study|Adverse Event|0|||
49147142|NCT00088881|158378715|FG000|Step 1 - R-CHOP|Patient ineligible|9|||
49147143|NCT00088881|158378715|FG000|Step 1 - R-CHOP|Adverse Event|1|||
49147144|NCT00088881|158378715|FG000|Step 1 - R-CHOP|Withdrawal by Subject|2|||
49147145|NCT00088881|158378715|FG000|Step 1 - R-CHOP|Physician Decision|1|||
49147146|NCT00088881|158378715|FG000|Step 1 - R-CHOP|Insurance company refused to cover|1|||
49147147|NCT00088881|158378715|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8|||
49147148|NCT00088881|158378715|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Other|3|||
49147149|NCT01748552|158378719|FG000|Intervention Period 2 and Washout|Physician Decision|0|||
49147150|NCT01748552|158378720|FG001|Intervention Period 2 and Washout|Physician Decision|0|||
49147151|NCT01748552|158378721|FG002|Intervention Period 2 and Washout|Physician Decision|1|||
49147152|NCT01748552|158378722|FG003|Intervention Period 2 and Washout|Physician Decision|0|||
49147153|NCT01748552|158378723|FG004|Intervention Period 2 and Washout|Physician Decision|0|||
48823431|NCT01890967|157193935|FG000|Overall Study|Lost to Follow-up|1|||
49147154|NCT01748552|158378724|FG005|Intervention Period 2 and Washout|Physician Decision|0|||
49147155|NCT01748552|158378725|FG006|Intervention Period 2 and Washout|Physician Decision|0|||
49147156|NCT01748552|158378726|FG007|Intervention Period 2 and Washout|Physician Decision|0|||
49147157|NCT01748552|158378727|FG008|Intervention Period 2 and Washout|Physician Decision|0|||
49147158|NCT01748552|158378728|FG009|Intervention Period 2 and Washout|Physician Decision|0|||
49147159|NCT01748552|158378729|FG010|Intervention Period 2 and Washout|Physician Decision|0|||
49147160|NCT01748552|158378730|FG011|Intervention Period 2 and Washout|Physician Decision|0|||
49147161|NCT01748552|158378719|FG000|Intervention Period 2 and Washout|Contingency dose not tested|0|||
48823432|NCT01890967|157193936|FG001|Overall Study|Lost to Follow-up|1|||
48823433|NCT01890967|157193937|FG002|Overall Study|Lost to Follow-up|1|||
48823434|NCT01890967|157193938|FG003|Overall Study|Lost to Follow-up|1|||
49147162|NCT01748552|158378720|FG001|Intervention Period 2 and Washout|Contingency dose not tested|0|||
49147163|NCT01748552|158378721|FG002|Intervention Period 2 and Washout|Contingency dose not tested|0|||
49147164|NCT01748552|158378722|FG003|Intervention Period 2 and Washout|Contingency dose not tested|0|||
49147165|NCT01748552|158378723|FG004|Intervention Period 2 and Washout|Contingency dose not tested|0|||
49147166|NCT01748552|158378724|FG005|Intervention Period 2 and Washout|Contingency dose not tested|0|||
49147167|NCT01748552|158378725|FG006|Intervention Period 2 and Washout|Contingency dose not tested|3|||
49147168|NCT01748552|158378726|FG007|Intervention Period 2 and Washout|Contingency dose not tested|3|||
49147169|NCT01748552|158378727|FG008|Intervention Period 2 and Washout|Contingency dose not tested|3|||
49147170|NCT01748552|158378728|FG009|Intervention Period 2 and Washout|Contingency dose not tested|0|||
49147171|NCT01748552|158378729|FG010|Intervention Period 2 and Washout|Contingency dose not tested|0|||
49147172|NCT01748552|158378730|FG011|Intervention Period 2 and Washout|Contingency dose not tested|0|||
49147173|NCT02596893|158378731|FG000|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61|||
49147174|NCT02596893|158378732|FG001|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56|||
49147175|NCT02596893|158378733|FG002|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48|||
49147176|NCT02596893|158378734|FG003|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58|||
49147177|NCT02596893|158378731|FG000|Overall Double-Blind Period Weeks 0-52|Adverse Event|11|||
49147178|NCT02596893|158378732|FG001|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
49147179|NCT02596893|158378733|FG002|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
49147180|NCT02596893|158378734|FG003|Overall Double-Blind Period Weeks 0-52|Adverse Event|12|||
49147181|NCT02596893|158378731|FG000|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
49147182|NCT02596893|158378732|FG001|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
49147183|NCT02596893|158378733|FG002|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
49147184|NCT02596893|158378734|FG003|Overall Double-Blind Period Weeks 0-52|Pregnancy|1|||
49147185|NCT02596893|158378731|FG000|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15|||
49147186|NCT02596893|158378732|FG001|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
49147187|NCT02596893|158378733|FG002|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
49147188|NCT02596893|158378734|FG003|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13|||
49147189|NCT02596893|158378731|FG000|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10|||
49147190|NCT02596893|158378732|FG001|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4|||
49147191|NCT02596893|158378733|FG002|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13|||
49147192|NCT02596893|158378734|FG003|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5|||
49147193|NCT02596893|158378731|FG000|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1|||
49147194|NCT02596893|158378732|FG001|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
49147195|NCT02596893|158378733|FG002|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0|||
49147196|NCT02596893|158378734|FG003|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
49147197|NCT02596893|158378731|FG000|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0|||
49147198|NCT02596893|158378732|FG001|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
49147199|NCT02596893|158378733|FG002|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
49147200|NCT02596893|158378734|FG003|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
49147201|NCT02596893|158378731|FG000|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
49147202|NCT02596893|158378732|FG001|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
49147203|NCT02596893|158378733|FG002|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1|||
49147204|NCT02596893|158378734|FG003|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2|||
49147205|NCT02596893|158378731|FG000|Overall Double-Blind Period Weeks 0-52|Death|0|||
49147206|NCT02596893|158378732|FG001|Overall Double-Blind Period Weeks 0-52|Death|0|||
49147207|NCT02596893|158378733|FG002|Overall Double-Blind Period Weeks 0-52|Death|1|||
49147208|NCT02596893|158378734|FG003|Overall Double-Blind Period Weeks 0-52|Death|0|||
49147209|NCT02596893|158378731|FG000|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
49147210|NCT02596893|158378732|FG001|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
49147211|NCT02596893|158378733|FG002|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
49147212|NCT02596893|158378734|FG003|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2|||
49147213|NCT02596893|158378731|FG000|Overall Double-Blind Period Weeks 0-52|Early Escape|66|||
49147214|NCT02596893|158378732|FG001|Overall Double-Blind Period Weeks 0-52|Early Escape|76|||
49147215|NCT02596893|158378733|FG002|Overall Double-Blind Period Weeks 0-52|Early Escape|69|||
49147216|NCT02596893|158378734|FG003|Overall Double-Blind Period Weeks 0-52|Early Escape|70|||
49147217|NCT03280615|158378735|FG000|Overall Study|Lost to Follow-up|1|||
49147218|NCT03280615|158378736|FG001|Overall Study|Lost to Follow-up|2|||
49147219|NCT03280615|158378735|FG000|Overall Study|Adverse Event|1|||
49147220|NCT03280615|158378736|FG001|Overall Study|Adverse Event|1|||
49147221|NCT03280615|158378735|FG000|Overall Study|Withdrawal by Subject|2|||
49147222|NCT03280615|158378736|FG001|Overall Study|Withdrawal by Subject|2|||
49147223|NCT00185614|158378740|FG000|Inter-treatment Period|Physician Decision|1|||
49147224|NCT00185614|158378740|FG000|Inter-treatment Period|Relapse|2|||
49147225|NCT00185614|158378740|FG000|Inter-treatment Period|Lack of allogenic donor|1|||
49147226|NCT02410200|158378741|FG000|Overall Study|Adverse Event|2|||
49147227|NCT00527748|158378743|FG000|Overall Study|Other|3|||
49147228|NCT00382863|158378744|FG000|Overall Study|Death|9|||
49147229|NCT00382863|158378745|FG001|Overall Study|Death|9|||
49147230|NCT00382863|158378744|FG000|Overall Study|Lost to Follow-up|1|||
49147231|NCT00382863|158378745|FG001|Overall Study|Lost to Follow-up|2|||
49147232|NCT00382863|158378744|FG000|Overall Study|Withdrawal by Subject|5|||
49147233|NCT00382863|158378745|FG001|Overall Study|Withdrawal by Subject|25|||
49147234|NCT00292370|158378746|FG000|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12|||
49147235|NCT00292370|158378747|FG001|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
49147236|NCT00292370|158378748|FG002|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
49147237|NCT00292370|158378746|FG000|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22|||
49147238|NCT00292370|158378747|FG001|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
49147239|NCT00292370|158378748|FG002|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
49147240|NCT00292370|158378746|FG000|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8|||
49147241|NCT00292370|158378747|FG001|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
49147242|NCT00292370|158378748|FG002|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
49147243|NCT00292370|158378746|FG000|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4|||
49147244|NCT00292370|158378747|FG001|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
49147245|NCT00292370|158378748|FG002|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
49147246|NCT00292370|158378746|FG000|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0|||
49147247|NCT00292370|158378747|FG001|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3|||
49147248|NCT00292370|158378748|FG002|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2|||
49147249|NCT00292370|158378746|FG000|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0|||
49147250|NCT00292370|158378747|FG001|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1|||
49147251|NCT00292370|158378748|FG002|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5|||
49147252|NCT00458705|158378750|FG000|Overall Study|Adverse Event|4|||
49147253|NCT00458705|158378750|FG000|Overall Study|Not Treated|1|||
49147254|NCT02070380|158378753|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|0|||
49147255|NCT02070380|158378754|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|5|||
49147256|NCT02070380|158378755|FG002|Washout (no Second Injection/MRI)|Withdrawal by Subject|2|||
49147257|NCT02070380|158378756|FG003|Washout (no Second Injection/MRI)|Withdrawal by Subject|3|||
49147258|NCT02070380|158378753|FG000|Second Injection|Image sets missing or technically inadeq|0|||
49147259|NCT02070380|158378754|FG001|Second Injection|Image sets missing or technically inadeq|1|||
49147260|NCT02070380|158378755|FG002|Second Injection|Image sets missing or technically inadeq|0|||
49147261|NCT02070380|158378756|FG003|Second Injection|Image sets missing or technically inadeq|0|||
49147262|NCT02070380|158378753|FG000|Second Injection|Protocol Violation|0|||
49147263|NCT02070380|158378754|FG001|Second Injection|Protocol Violation|1|||
49147264|NCT02070380|158378755|FG002|Second Injection|Protocol Violation|1|||
49147265|NCT02070380|158378756|FG003|Second Injection|Protocol Violation|5|||
49147266|NCT01362530|158378759|FG000|Base Study (Cycle 1)|Adverse Event|2|||
49147267|NCT01362530|158378760|FG001|Base Study (Cycle 1)|Adverse Event|0|||
49147268|NCT01362530|158378759|FG000|Base Study (Cycle 1)|Physician Decision|0|||
49147269|NCT01362530|158378760|FG001|Base Study (Cycle 1)|Physician Decision|1|||
49147270|NCT01362530|158378759|FG000|Base Study (Cycle 1)|Protocol Violation|2|||
49147271|NCT01362530|158378760|FG001|Base Study (Cycle 1)|Protocol Violation|0|||
49147272|NCT01362530|158378759|FG000|Base Study (Cycle 1)|Withdrawal by Subject|1|||
49147273|NCT01362530|158378760|FG001|Base Study (Cycle 1)|Withdrawal by Subject|2|||
49147274|NCT01362530|158378759|FG000|Optional Extension (Cycles 2-6)|Adverse Event|2|||
49147275|NCT01362530|158378760|FG001|Optional Extension (Cycles 2-6)|Adverse Event|0|||
49147276|NCT01362530|158378759|FG000|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51|||
49147277|NCT01362530|158378760|FG001|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0|||
49147278|NCT01362530|158378759|FG000|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25|||
49147279|NCT01362530|158378760|FG001|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0|||
49147280|NCT01362530|158378759|FG000|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4|||
49147281|NCT01362530|158378760|FG001|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0|||
49147282|NCT01362530|158378759|FG000|Optional Extension (Cycles 2-6)|Lack of Efficacy|1|||
49147283|NCT01362530|158378760|FG001|Optional Extension (Cycles 2-6)|Lack of Efficacy|0|||
49147284|NCT01362530|158378759|FG000|Optional Extension (Cycles 2-6)|Lost to Follow-up|1|||
49147285|NCT01362530|158378760|FG001|Optional Extension (Cycles 2-6)|Lost to Follow-up|0|||
49147286|NCT01362530|158378759|FG000|Optional Extension (Cycles 2-6)|Physician Decision|19|||
49147287|NCT01362530|158378760|FG001|Optional Extension (Cycles 2-6)|Physician Decision|0|||
49147288|NCT01362530|158378759|FG000|Optional Extension (Cycles 2-6)|Protocol Violation|4|||
49147289|NCT01362530|158378760|FG001|Optional Extension (Cycles 2-6)|Protocol Violation|0|||
49147290|NCT01362530|158378759|FG000|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18|||
49147291|NCT01362530|158378760|FG001|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0|||
49147292|NCT02336555|158378763|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
49147293|NCT02336555|158378764|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
49147294|NCT02336555|158378763|FG000|Treatment Period 1 (28 Days)|Physician Decision|2|||
49147295|NCT02336555|158378764|FG001|Treatment Period 1 (28 Days)|Physician Decision|0|||
49147296|NCT02336555|158378763|FG000|Treatment Period 2 (28 Days)|Adverse Event|0|||
49147297|NCT02336555|158378764|FG001|Treatment Period 2 (28 Days)|Adverse Event|1|||
49147298|NCT00395447|158378766|FG000|Overall Study|Death|37|||
49147299|NCT00395447|158378767|FG001|Overall Study|Death|32|||
49147300|NCT00395447|158378766|FG000|Overall Study|Lost to Follow-up|52|||
49147301|NCT00395447|158378767|FG001|Overall Study|Lost to Follow-up|43|||
49147302|NCT00395447|158378766|FG000|Overall Study|Withdrawal by Subject|24|||
49147303|NCT00395447|158378767|FG001|Overall Study|Withdrawal by Subject|19|||
49147304|NCT00395447|158378766|FG000|Overall Study|Withdrawl - Other (not subject)|8|||
49147305|NCT00395447|158378767|FG001|Overall Study|Withdrawl - Other (not subject)|17|||
49147306|NCT00276380|158378768|FG000|Overall Study|Adverse Event|5|||
49147307|NCT00276380|158378769|FG001|Overall Study|Adverse Event|3|||
49013828|NCT01034137|157887181|FG000|Overall Study|Withdrawal by Subject|4|||
49013829|NCT01034137|157887182|FG001|Overall Study|Withdrawal by Subject|3|||
49013830|NCT01034137|157887183|FG002|Overall Study|Withdrawal by Subject|3|||
49013831|NCT01034137|157887181|FG000|Overall Study|Lack of Efficacy|9|||
49013832|NCT01034137|157887182|FG001|Overall Study|Lack of Efficacy|4|||
49013833|NCT01034137|157887183|FG002|Overall Study|Lack of Efficacy|13|||
49013834|NCT01034137|157887181|FG000|Overall Study|Protocol Violation|2|||
49147308|NCT00276380|158378768|FG000|Overall Study|Lost to Follow-up|1|||
49147309|NCT00276380|158378769|FG001|Overall Study|Lost to Follow-up|1|||
49147310|NCT00276380|158378768|FG000|Overall Study|Withdrawal by Subject|3|||
49147311|NCT00276380|158378769|FG001|Overall Study|Withdrawal by Subject|6|||
49147312|NCT00276380|158378768|FG000|Overall Study|Death|5|||
49147313|NCT00276380|158378769|FG001|Overall Study|Death|3|||
49147314|NCT00276380|158378768|FG000|Overall Study|Abnormal aPPT Levels|0|||
49147315|NCT00276380|158378769|FG001|Overall Study|Abnormal aPPT Levels|1|||
49147316|NCT03596983|158378770|FG000|Overall Study|Withdrawal by Subject|3|||
49147317|NCT01655069|158378771|FG000|Overall Study|Physician Decision|0|||
49147318|NCT01655069|158378772|FG001|Overall Study|Physician Decision|0|||
49147319|NCT01655069|158378773|FG002|Overall Study|Physician Decision|0|||
49147320|NCT01655069|158378774|FG003|Overall Study|Physician Decision|1|||
49147321|NCT01655069|158378771|FG000|Overall Study|Adverse Event|6|||
49147322|NCT01655069|158378772|FG001|Overall Study|Adverse Event|7|||
48823435|NCT01890967|157193939|FG004|Overall Study|Lost to Follow-up|0|||
49147323|NCT01655069|158378773|FG002|Overall Study|Adverse Event|2|||
49147324|NCT01655069|158378774|FG003|Overall Study|Adverse Event|3|||
49147325|NCT01655069|158378771|FG000|Overall Study|Lack of Efficacy|0|||
49147326|NCT01655069|158378772|FG001|Overall Study|Lack of Efficacy|1|||
49147327|NCT01655069|158378773|FG002|Overall Study|Lack of Efficacy|0|||
49147328|NCT01655069|158378774|FG003|Overall Study|Lack of Efficacy|0|||
49147329|NCT01655069|158378771|FG000|Overall Study|No Treatment Needed|0|||
49147330|NCT01655069|158378772|FG001|Overall Study|No Treatment Needed|1|||
49147331|NCT01655069|158378773|FG002|Overall Study|No Treatment Needed|0|||
49147332|NCT01655069|158378774|FG003|Overall Study|No Treatment Needed|0|||
49147333|NCT01655069|158378771|FG000|Overall Study|Withdrawal by Subject|2|||
49147334|NCT01655069|158378772|FG001|Overall Study|Withdrawal by Subject|3|||
49147335|NCT01655069|158378773|FG002|Overall Study|Withdrawal by Subject|0|||
49147336|NCT01655069|158378774|FG003|Overall Study|Withdrawal by Subject|0|||
49147337|NCT06399471|158378775|FG000|Overall Study|Withdrawal by Subject|1|||
49147338|NCT03566550|158378784|FG000|Overall Study|Withdrawal by Subject|0|||
49147339|NCT03566550|158378785|FG001|Overall Study|Withdrawal by Subject|1|||
49147340|NCT03745313|158378794|FG000|At 30 Days Follow-up|Death|2|||
49147341|NCT03745313|158378794|FG000|At 6 Months Follow-up|Death|1|||
49147342|NCT03745313|158378794|FG000|At 6 Months Follow-up|Missed Visit|1|||
49147343|NCT03745313|158378794|FG000|At 6 Months Follow-up|Exited for Other Reason Within Window|1|||
49147344|NCT03745313|158378794|FG000|At 1 Year Follow-up|Death|2|||
49147345|NCT03745313|158378794|FG000|At 1 Year Follow-up|Missed Visit|2|||
49147346|NCT03745313|158378794|FG000|At 2 Year Follow-up|Missed Visit|1|||
49147347|NCT02181413|158378795|FG000|Overall Study|Withdrawal by Subject|45|||
49147348|NCT02181413|158378796|FG001|Overall Study|Withdrawal by Subject|61|||
49147349|NCT02181413|158378795|FG000|Overall Study|Reason Not Specified|2|||
49147350|NCT02181413|158378796|FG001|Overall Study|Reason Not Specified|5|||
49147351|NCT02181413|158378795|FG000|Overall Study|Lost to Follow-up|8|||
49147352|NCT02181413|158378796|FG001|Overall Study|Lost to Follow-up|7|||
49147353|NCT03973489|158378797|FG000|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
49147354|NCT03973489|158378798|FG001|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
49147355|NCT03973489|158378799|FG002|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
49147356|NCT03973489|158378800|FG003|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
49147357|NCT03973489|158378801|FG004|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
49013835|NCT01034137|157887182|FG001|Overall Study|Protocol Violation|2|||
49147358|NCT03973489|158378802|FG005|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
49147359|NCT03973489|158378803|FG006|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
49147360|NCT03973489|158378804|FG007|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
49147361|NCT03973489|158378797|FG000|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
49147362|NCT03973489|158378798|FG001|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
49147363|NCT03973489|158378799|FG002|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
49147364|NCT03973489|158378800|FG003|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
49147365|NCT03973489|158378801|FG004|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
49147366|NCT03973489|158378802|FG005|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
49147367|NCT03973489|158378803|FG006|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
49147368|NCT03973489|158378804|FG007|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
49147369|NCT03973489|158378797|FG000|Washout Period (at Least 3 Days)|Physician Decision|0|||
49147370|NCT03973489|158378798|FG001|Washout Period (at Least 3 Days)|Physician Decision|0|||
49147371|NCT03973489|158378799|FG002|Washout Period (at Least 3 Days)|Physician Decision|0|||
49147372|NCT03973489|158378800|FG003|Washout Period (at Least 3 Days)|Physician Decision|0|||
49147373|NCT03973489|158378801|FG004|Washout Period (at Least 3 Days)|Physician Decision|1|||
49147374|NCT03973489|158378802|FG005|Washout Period (at Least 3 Days)|Physician Decision|0|||
49147375|NCT03973489|158378803|FG006|Washout Period (at Least 3 Days)|Physician Decision|1|||
49147376|NCT03973489|158378804|FG007|Washout Period (at Least 3 Days)|Physician Decision|0|||
49147377|NCT03973489|158378797|FG000|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
49147378|NCT03973489|158378798|FG001|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
49147379|NCT03973489|158378799|FG002|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
49147380|NCT03973489|158378800|FG003|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
49147381|NCT03973489|158378801|FG004|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
49147382|NCT03973489|158378802|FG005|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
49147383|NCT03973489|158378803|FG006|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
49147384|NCT03973489|158378804|FG007|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
49147385|NCT03973489|158378797|FG000|Second Intervention (1 Day)|Adverse Event|0|||
49147386|NCT03973489|158378798|FG001|Second Intervention (1 Day)|Adverse Event|0|||
49147387|NCT03973489|158378799|FG002|Second Intervention (1 Day)|Adverse Event|0|||
49147388|NCT03973489|158378800|FG003|Second Intervention (1 Day)|Adverse Event|1|||
49147389|NCT03973489|158378801|FG004|Second Intervention (1 Day)|Adverse Event|0|||
49147390|NCT03973489|158378802|FG005|Second Intervention (1 Day)|Adverse Event|0|||
49147391|NCT03973489|158378803|FG006|Second Intervention (1 Day)|Adverse Event|0|||
49147392|NCT03973489|158378804|FG007|Second Intervention (1 Day)|Adverse Event|0|||
49147393|NCT03247673|158378805|FG000|Overall Study|Withdrawal by Subject|1|||
49147394|NCT03247673|158378806|FG001|Overall Study|Withdrawal by Subject|0|||
49147395|NCT03247673|158378807|FG002|Overall Study|Withdrawal by Subject|3|||
49147396|NCT03247673|158378805|FG000|Overall Study|Lost to Follow-up|0|||
49147397|NCT03247673|158378806|FG001|Overall Study|Lost to Follow-up|0|||
49147398|NCT03247673|158378807|FG002|Overall Study|Lost to Follow-up|1|||
49147399|NCT00215657|158378808|FG000|Overall Study|Adverse Event|5|||
49147400|NCT00215657|158378809|FG001|Overall Study|Adverse Event|1|||
49147401|NCT00215657|158378810|FG002|Overall Study|Adverse Event|3|||
49147402|NCT00215657|158378811|FG003|Overall Study|Adverse Event|0|||
49147403|NCT00215657|158378812|FG004|Overall Study|Adverse Event|3|||
49147404|NCT00215657|158378813|FG005|Overall Study|Adverse Event|1|||
49147405|NCT00215657|158378814|FG006|Overall Study|Adverse Event|0|||
49147406|NCT00215657|158378815|FG007|Overall Study|Adverse Event|3|||
49147407|NCT00215657|158378808|FG000|Overall Study|Withdrawal by Subject|6|||
49147408|NCT00215657|158378809|FG001|Overall Study|Withdrawal by Subject|3|||
49147409|NCT00215657|158378810|FG002|Overall Study|Withdrawal by Subject|3|||
49147410|NCT00215657|158378811|FG003|Overall Study|Withdrawal by Subject|1|||
49147411|NCT00215657|158378812|FG004|Overall Study|Withdrawal by Subject|6|||
49147412|NCT00215657|158378813|FG005|Overall Study|Withdrawal by Subject|1|||
49147413|NCT00215657|158378814|FG006|Overall Study|Withdrawal by Subject|10|||
49147414|NCT00215657|158378815|FG007|Overall Study|Withdrawal by Subject|3|||
49147415|NCT00215657|158378808|FG000|Overall Study|Insuff prostate specific antigen resp|3|||
49147416|NCT00215657|158378809|FG001|Overall Study|Insuff prostate specific antigen resp|2|||
49147417|NCT00215657|158378810|FG002|Overall Study|Insuff prostate specific antigen resp|2|||
49147418|NCT00215657|158378811|FG003|Overall Study|Insuff prostate specific antigen resp|2|||
49147419|NCT00215657|158378812|FG004|Overall Study|Insuff prostate specific antigen resp|1|||
49147420|NCT00215657|158378813|FG005|Overall Study|Insuff prostate specific antigen resp|2|||
48921441|NCT02970292|157546394|FG001|Overall Study|Withdrawal by Subject|5|||
49147421|NCT00215657|158378814|FG006|Overall Study|Insuff prostate specific antigen resp|3|||
49147422|NCT00215657|158378815|FG007|Overall Study|Insuff prostate specific antigen resp|2|||
49147423|NCT00215657|158378808|FG000|Overall Study|Insufficient testosterone response|5|||
49147424|NCT00215657|158378809|FG001|Overall Study|Insufficient testosterone response|4|||
49147425|NCT00215657|158378810|FG002|Overall Study|Insufficient testosterone response|1|||
49147426|NCT00215657|158378811|FG003|Overall Study|Insufficient testosterone response|12|||
49147427|NCT00215657|158378812|FG004|Overall Study|Insufficient testosterone response|8|||
49147428|NCT00215657|158378813|FG005|Overall Study|Insufficient testosterone response|12|||
48921442|NCT02970292|157546393|FG000|Overall Study|Noncompliance with study drug|2|||
49147429|NCT00215657|158378814|FG006|Overall Study|Insufficient testosterone response|4|||
49147430|NCT00215657|158378815|FG007|Overall Study|Insufficient testosterone response|7|||
49147431|NCT00215657|158378808|FG000|Overall Study|Other|3|||
49147432|NCT00215657|158378809|FG001|Overall Study|Other|1|||
49147433|NCT00215657|158378810|FG002|Overall Study|Other|2|||
49147434|NCT00215657|158378811|FG003|Overall Study|Other|3|||
49147435|NCT00215657|158378812|FG004|Overall Study|Other|5|||
49147436|NCT00215657|158378813|FG005|Overall Study|Other|4|||
49147437|NCT00215657|158378814|FG006|Overall Study|Other|6|||
49147438|NCT00215657|158378815|FG007|Overall Study|Other|1|||
49147439|NCT01093573|158378816|FG000|Overall Study|Physician Decision|0|||
49147440|NCT01093573|158378817|FG001|Overall Study|Physician Decision|0|||
49147441|NCT01093573|158378818|FG002|Overall Study|Physician Decision|1|||
49147442|NCT01093573|158378816|FG000|Overall Study|Insurance Denied|0|||
49147443|NCT01093573|158378817|FG001|Overall Study|Insurance Denied|0|||
49147444|NCT01093573|158378818|FG002|Overall Study|Insurance Denied|1|||
49147445|NCT01385995|158378819|FG000|Period 1, 2 Months|Physician Decision|1|||
49147446|NCT01385995|158378820|FG001|Period 1, 2 Months|Physician Decision|0|||
49147447|NCT03359395|158378824|FG000|First Intervention A / B|Withdrawal by Subject|1|||
49147448|NCT03359395|158378825|FG001|First Intervention A / B|Withdrawal by Subject|0|||
49147449|NCT03359395|158378824|FG000|First Intervention A / B|Lost to Follow-up|2|||
49147450|NCT03359395|158378825|FG001|First Intervention A / B|Lost to Follow-up|3|||
49147451|NCT03359395|158378824|FG000|Second Intervention B/A|Exclusion criteria|0|||
49147452|NCT03359395|158378825|FG001|Second Intervention B/A|Exclusion criteria|1|||
49147453|NCT03359395|158378824|FG000|Second Intervention B/A|Lost to Follow-up|3|||
49147454|NCT03359395|158378825|FG001|Second Intervention B/A|Lost to Follow-up|2|||
49147455|NCT05788328|158379929|FG000|Treatment Period 4 (5 Days)|Other|1|||
49147456|NCT05788328|158379929|FG000|Treatment Period 8 (4 Days)|Adverse Event|1|||
49147457|NCT01386645|158379932|FG000|Overall Study|Physician Decision|0|||
49147458|NCT01386645|158379933|FG001|Overall Study|Physician Decision|0|||
49147459|NCT01386645|158379934|FG002|Overall Study|Physician Decision|1|||
49147460|NCT01386645|158379932|FG000|Overall Study|Withdrawal by Subject|0|||
49147461|NCT01386645|158379933|FG001|Overall Study|Withdrawal by Subject|1|||
49147462|NCT01386645|158379934|FG002|Overall Study|Withdrawal by Subject|1|||
49013836|NCT01034137|157887183|FG002|Overall Study|Protocol Violation|1|||
49013837|NCT01034137|157887181|FG000|Overall Study|Refused treatment or did not cooperate|2|||
49013838|NCT01034137|157887182|FG001|Overall Study|Refused treatment or did not cooperate|0|||
49013839|NCT01034137|157887183|FG002|Overall Study|Refused treatment or did not cooperate|1|||
49147463|NCT00101400|158379935|FG000|Survival Follow-Up|Alive|7|||
49147464|NCT03048019|158379936|FG000|Overall Study|Adverse Event|1|||
49147465|NCT03048019|158379937|FG001|Overall Study|Adverse Event|0|||
49147466|NCT02365064|158379940|FG000|Overall Study|Patients met baseline exclusion requirem|2|||
49147467|NCT02365064|158379941|FG001|Overall Study|Patients met baseline exclusion requirem|15|||
49147468|NCT02365064|158379940|FG000|Overall Study|Withdrawal by Subject|6|||
49147469|NCT02365064|158379941|FG001|Overall Study|Withdrawal by Subject|9|||
49147470|NCT02365064|158379940|FG000|Overall Study|Treatment intolerance|2|||
49147471|NCT02365064|158379941|FG001|Overall Study|Treatment intolerance|4|||
49147472|NCT02451007|158379942|FG000|Overall Study|Withdrawal by Subject|4|||
49147473|NCT02451007|158379942|FG000|Overall Study|Adverse Event|1|||
49147474|NCT02451007|158379942|FG000|Overall Study|Disease Progression|2|||
49147475|NCT00449787|158379943|FG000|Overall Study|Lost to Follow-up|10|||
49147476|NCT00449787|158379944|FG001|Overall Study|Lost to Follow-up|8|||
49147477|NCT00449787|158379943|FG000|Overall Study|Did not require medication|95|||
49147478|NCT00449787|158379944|FG001|Overall Study|Did not require medication|92|||
49147479|NCT00348374|158379945|FG000|Overall Study|Adverse Event|1|||
49147480|NCT00348374|158379946|FG001|Overall Study|Adverse Event|4|||
49147481|NCT00348374|158379945|FG000|Overall Study|Lost to Follow-up|1|||
49147482|NCT00348374|158379946|FG001|Overall Study|Lost to Follow-up|3|||
49147483|NCT00348374|158379945|FG000|Overall Study|Withdrawal by Subject|5|||
49147484|NCT00348374|158379946|FG001|Overall Study|Withdrawal by Subject|5|||
49147485|NCT00348374|158379945|FG000|Overall Study|Other|11|||
49147486|NCT00348374|158379946|FG001|Overall Study|Other|12|||
49147487|NCT00348374|158379945|FG000|Overall Study|ongoing at date of cutoff|1|||
49147488|NCT00348374|158379946|FG001|Overall Study|ongoing at date of cutoff|1|||
49147489|NCT00348374|158379945|FG000|Overall Study|randomized but did not receive treatment|0|||
49147490|NCT00348374|158379946|FG001|Overall Study|randomized but did not receive treatment|7|||
49013840|NCT01034137|157887181|FG000|Overall Study|Administrative or other|2|||
49013841|NCT01034137|157887182|FG001|Overall Study|Administrative or other|3|||
49147491|NCT00128492|158379950|FG000|Overall Study|AE unrelated to study|2|||
49147492|NCT00128492|158379951|FG001|Overall Study|AE unrelated to study|9|||
49147493|NCT00128492|158379950|FG000|Overall Study|Study drug intolerance (AE)|2|||
49147494|NCT00128492|158379951|FG001|Overall Study|Study drug intolerance (AE)|8|||
49147495|NCT00128492|158379950|FG000|Overall Study|AE related to study|1|||
49147496|NCT00128492|158379951|FG001|Overall Study|AE related to study|4|||
49147497|NCT00128492|158379950|FG000|Overall Study|Death|1|||
49147498|NCT00128492|158379951|FG001|Overall Study|Death|0|||
49147499|NCT00128492|158379950|FG000|Overall Study|Lost to Follow-up|1|||
49147500|NCT00128492|158379951|FG001|Overall Study|Lost to Follow-up|5|||
49147501|NCT00128492|158379950|FG000|Overall Study|Noncompliance|0|||
49147502|NCT00128492|158379951|FG001|Overall Study|Noncompliance|5|||
49147503|NCT00128492|158379950|FG000|Overall Study|Personal or administrative|10|||
49147504|NCT00128492|158379951|FG001|Overall Study|Personal or administrative|22|||
49147505|NCT00128492|158379950|FG000|Overall Study|Withdrawal by Subject|3|||
49147506|NCT00128492|158379951|FG001|Overall Study|Withdrawal by Subject|5|||
49147507|NCT00128492|158379950|FG000|Overall Study|Pregnancy|0|||
49147508|NCT00128492|158379951|FG001|Overall Study|Pregnancy|1|||
49147509|NCT02605967|158379952|FG000|Overall Study|subject / guardian decision|1|||
49147510|NCT02605967|158379953|FG001|Overall Study|subject / guardian decision|2|||
49147511|NCT02605967|158379952|FG000|Overall Study|Physician Decision|10|||
49147512|NCT02605967|158379953|FG001|Overall Study|Physician Decision|1|||
49147513|NCT02605967|158379952|FG000|Overall Study|Death|4|||
49147514|NCT02605967|158379953|FG001|Overall Study|Death|2|||
49147515|NCT02605967|158379952|FG000|Overall Study|Adverse Event|1|||
49147516|NCT02605967|158379953|FG001|Overall Study|Adverse Event|0|||
49147517|NCT02605967|158379952|FG000|Overall Study|progressive disease|66|||
49147518|NCT02605967|158379953|FG001|Overall Study|progressive disease|35|||
49147519|NCT00079781|158379956|FG000|Pre-implant Period|Withdrawal by Subject|2|||
49147520|NCT00079781|158379957|FG001|Pre-implant Period|Withdrawal by Subject|0|||
49147521|NCT00079781|158379958|FG002|Pre-implant Period|Withdrawal by Subject|0|||
49147522|NCT00079781|158379956|FG000|Pre-implant Period|Did not meet I/E criteria|1|||
49147523|NCT00079781|158379957|FG001|Pre-implant Period|Did not meet I/E criteria|1|||
49147524|NCT00079781|158379958|FG002|Pre-implant Period|Did not meet I/E criteria|1|||
49147525|NCT00079781|158379956|FG000|Follow-up Period|Withdrawal by Subject|3|||
49147526|NCT00079781|158379957|FG001|Follow-up Period|Withdrawal by Subject|0|||
49147527|NCT00079781|158379958|FG002|Follow-up Period|Withdrawal by Subject|1|||
49147528|NCT00079781|158379956|FG000|Follow-up Period|Lost to Follow-up|1|||
49147529|NCT00079781|158379957|FG001|Follow-up Period|Lost to Follow-up|0|||
49147530|NCT00079781|158379958|FG002|Follow-up Period|Lost to Follow-up|0|||
49147531|NCT00079781|158379956|FG000|Follow-up Period|Death|0|||
49147532|NCT00079781|158379957|FG001|Follow-up Period|Death|0|||
49147533|NCT00079781|158379958|FG002|Follow-up Period|Death|1|||
49147534|NCT01217047|158379959|FG000|Overall Study|Lost to Follow-up|0|||
49147535|NCT01217047|158379960|FG001|Overall Study|Lost to Follow-up|1|||
49147536|NCT01217047|158379961|FG002|Overall Study|Lost to Follow-up|0|||
49147537|NCT03268499|158379962|FG000|Overall Study|Withdrawal by Subject|2|||
49147538|NCT03268499|158379963|FG001|Overall Study|Withdrawal by Subject|1|||
49147539|NCT02662582|158379966|FG000|Treatment Period 1 (14 Days)|Adverse Event|3|||
49147540|NCT02662582|158379967|FG001|Treatment Period 1 (14 Days)|Adverse Event|2|||
49147541|NCT02662582|158379966|FG000|Treatment Period 1 (14 Days)|Miscellaneous|0|||
49147542|NCT02662582|158379967|FG001|Treatment Period 1 (14 Days)|Miscellaneous|1|||
49147543|NCT02662582|158379966|FG000|Treatment Period 1 (14 Days)|Protocol Deviation|1|||
49147544|NCT02662582|158379967|FG001|Treatment Period 1 (14 Days)|Protocol Deviation|0|||
49147545|NCT02662582|158379966|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
49147546|NCT02662582|158379967|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
49147547|NCT04576481|158379968|FG000|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|0|||
49147548|NCT04576481|158379969|FG001|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
49147549|NCT04576481|158379970|FG002|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|3|||
49147550|NCT04576481|158379971|FG003|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
49147551|NCT05463952|158379972|FG000|Treatment|Progressive disease|4|||
49147552|NCT05463952|158379972|FG000|Treatment|Ongoing|2|||
49147553|NCT04135352|158379973|FG000|Overall Study|Not treated-randomization error|0|||
49147554|NCT04135352|158379974|FG001|Overall Study|Not treated-randomization error|0|||
49147555|NCT04135352|158379975|FG002|Overall Study|Not treated-randomization error|1|||
49147556|NCT04135352|158379976|FG003|Overall Study|Not treated-randomization error|0|||
49147557|NCT04135352|158379977|FG004|Overall Study|Not treated-randomization error|0|||
49147558|NCT04135352|158379978|FG005|Overall Study|Not treated-randomization error|0|||
49147559|NCT04135352|158379979|FG006|Overall Study|Not treated-randomization error|0|||
49147560|NCT04135352|158379980|FG007|Overall Study|Not treated-randomization error|0|||
49147561|NCT04135352|158379973|FG000|Overall Study|Withdrawal by Subject|0|||
49147562|NCT04135352|158379974|FG001|Overall Study|Withdrawal by Subject|0|||
49147563|NCT04135352|158379975|FG002|Overall Study|Withdrawal by Subject|2|||
49147564|NCT04135352|158379976|FG003|Overall Study|Withdrawal by Subject|0|||
49147565|NCT04135352|158379977|FG004|Overall Study|Withdrawal by Subject|0|||
49147566|NCT04135352|158379978|FG005|Overall Study|Withdrawal by Subject|0|||
48823436|NCT01890967|157193940|FG005|Overall Study|Lost to Follow-up|1|||
49147567|NCT04135352|158379979|FG006|Overall Study|Withdrawal by Subject|0|||
49147568|NCT04135352|158379980|FG007|Overall Study|Withdrawal by Subject|0|||
49147569|NCT04135352|158379973|FG000|Overall Study|Sponsor Decision|0|||
49147570|NCT04135352|158379974|FG001|Overall Study|Sponsor Decision|0|||
49147571|NCT04135352|158379975|FG002|Overall Study|Sponsor Decision|2|||
49147572|NCT04135352|158379976|FG003|Overall Study|Sponsor Decision|5|||
49147573|NCT04135352|158379977|FG004|Overall Study|Sponsor Decision|1|||
49147574|NCT04135352|158379978|FG005|Overall Study|Sponsor Decision|4|||
49147575|NCT04135352|158379979|FG006|Overall Study|Sponsor Decision|0|||
48823437|NCT01890967|157193935|FG000|Overall Study|Protocol Violation|0|||
48823438|NCT01890967|157193936|FG001|Overall Study|Protocol Violation|3|||
48823439|NCT01890967|157193937|FG002|Overall Study|Protocol Violation|3|||
48823440|NCT01890967|157193938|FG003|Overall Study|Protocol Violation|2|||
48823441|NCT01890967|157193939|FG004|Overall Study|Protocol Violation|4|||
48823442|NCT01890967|157193940|FG005|Overall Study|Protocol Violation|1|||
48823443|NCT01890967|157193935|FG000|Overall Study|Sponsor Decision|2|||
48823444|NCT01890967|157193936|FG001|Overall Study|Sponsor Decision|0|||
48823445|NCT01890967|157193937|FG002|Overall Study|Sponsor Decision|1|||
49013842|NCT01034137|157887183|FG002|Overall Study|Administrative or other|4|||
48823446|NCT01890967|157193938|FG003|Overall Study|Sponsor Decision|3|||
48823447|NCT01890967|157193939|FG004|Overall Study|Sponsor Decision|2|||
48823448|NCT01890967|157193940|FG005|Overall Study|Sponsor Decision|3|||
48823449|NCT01890967|157193935|FG000|Overall Study|Withdrawal by Subject|3|||
48823450|NCT01890967|157193936|FG001|Overall Study|Withdrawal by Subject|4|||
48823451|NCT01890967|157193937|FG002|Overall Study|Withdrawal by Subject|2|||
48823452|NCT01890967|157193938|FG003|Overall Study|Withdrawal by Subject|3|||
48823453|NCT01890967|157193939|FG004|Overall Study|Withdrawal by Subject|3|||
48823454|NCT01890967|157193940|FG005|Overall Study|Withdrawal by Subject|1|||
48823455|NCT02424344|157193943|FG000|Overall Study|Lack of Efficacy|0|||
48823456|NCT02424344|157193944|FG001|Overall Study|Lack of Efficacy|1|||
48823457|NCT02424344|157193943|FG000|Overall Study|Withdrawal by Subject|2|||
48823458|NCT02424344|157193944|FG001|Overall Study|Withdrawal by Subject|1|||
48823459|NCT02424344|157193943|FG000|Overall Study|Lost to Follow-up|1|||
48823460|NCT02424344|157193944|FG001|Overall Study|Lost to Follow-up|0|||
48823461|NCT02424344|157193943|FG000|Overall Study|Adverse Event|4|||
49013843|NCT03572933|157887184|FG000|Overall Study|Adverse Event|4|||
48823462|NCT02424344|157193944|FG001|Overall Study|Adverse Event|8|||
48823463|NCT00852475|157193945|FG000|Overall Study|Lost to Follow-up|3|||
48823464|NCT00852475|157193946|FG001|Overall Study|Lost to Follow-up|4|||
48823465|NCT00354029|157193947|FG000|Overall Study|Protocol Violation|4|||
48823466|NCT00354029|157193948|FG001|Overall Study|Protocol Violation|2|||
48823467|NCT01764386|157193953|FG000|Controlled Treatment Period (CTP)|Adverse Event|35|||
48823468|NCT01764386|157193954|FG001|Controlled Treatment Period (CTP)|Adverse Event|0|||
48823469|NCT01764386|157193953|FG000|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32|||
48823470|NCT01764386|157193954|FG001|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0|||
48823471|NCT01764386|157193953|FG000|Controlled Treatment Period (CTP)|Lost to Follow-up|9|||
48823472|NCT01764386|157193954|FG001|Controlled Treatment Period (CTP)|Lost to Follow-up|5|||
48823473|NCT01764386|157193953|FG000|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6|||
48823474|NCT01764386|157193954|FG001|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2|||
48823475|NCT01764386|157193953|FG000|Uncontrolled Treatment Period (UTP)|Adverse Event|2|||
48823476|NCT01764386|157193954|FG001|Uncontrolled Treatment Period (UTP)|Adverse Event|13|||
48823477|NCT01764386|157193953|FG000|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0|||
48823478|NCT01764386|157193954|FG001|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26|||
48823479|NCT01764386|157193953|FG000|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
48823480|NCT01764386|157193954|FG001|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
48823481|NCT01764386|157193953|FG000|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
48823482|NCT01764386|157193954|FG001|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
48823483|NCT00557505|157193956|FG000|Overall Study|Death|0|||
48823484|NCT00557505|157193957|FG001|Overall Study|Death|0|||
48823485|NCT00557505|157193958|FG002|Overall Study|Death|0|||
48823486|NCT00557505|157193959|FG003|Overall Study|Death|0|||
48823487|NCT00557505|157193960|FG004|Overall Study|Death|0|||
48823488|NCT00557505|157193961|FG005|Overall Study|Death|0|||
48823489|NCT00557505|157193962|FG006|Overall Study|Death|0|||
48823490|NCT00557505|157193963|FG007|Overall Study|Death|0|||
48823491|NCT00557505|157193964|FG008|Overall Study|Death|1|||
48823492|NCT00557505|157193956|FG000|Overall Study|Adverse Event|0|||
48823493|NCT00557505|157193957|FG001|Overall Study|Adverse Event|0|||
48823494|NCT00557505|157193958|FG002|Overall Study|Adverse Event|1|||
48823495|NCT00557505|157193959|FG003|Overall Study|Adverse Event|0|||
48823496|NCT00557505|157193960|FG004|Overall Study|Adverse Event|0|||
48823497|NCT00557505|157193961|FG005|Overall Study|Adverse Event|0|||
49013844|NCT03572933|157887185|FG001|Overall Study|Adverse Event|1|||
49013845|NCT03572933|157887184|FG000|Overall Study|Withdrawal by Subject|0|||
49013846|NCT03572933|157887185|FG001|Overall Study|Withdrawal by Subject|1|||
49013847|NCT02143947|157887188|FG000|Overall Study|Lost to Follow-up|4|||
49013848|NCT02143947|157887189|FG001|Overall Study|Lost to Follow-up|2|||
49013849|NCT01764854|157887198|FG000|Overall Study|Adverse Event|0|||
49013850|NCT01764854|157887199|FG001|Overall Study|Adverse Event|0|||
49013851|NCT01764854|157887200|FG002|Overall Study|Adverse Event|2|||
49013852|NCT01764854|157887201|FG003|Overall Study|Adverse Event|0|||
49013853|NCT01764854|157887198|FG000|Overall Study|Withdrawal by Subject|0|||
49013854|NCT01764854|157887199|FG001|Overall Study|Withdrawal by Subject|0|||
49013855|NCT01764854|157887200|FG002|Overall Study|Withdrawal by Subject|1|||
49147576|NCT04135352|158379980|FG007|Overall Study|Sponsor Decision|0|||
49147577|NCT04135352|158379973|FG000|Overall Study|Physician Decision|0|||
49147578|NCT04135352|158379974|FG001|Overall Study|Physician Decision|0|||
49147579|NCT04135352|158379975|FG002|Overall Study|Physician Decision|1|||
49147580|NCT04135352|158379976|FG003|Overall Study|Physician Decision|0|||
49147581|NCT04135352|158379977|FG004|Overall Study|Physician Decision|1|||
49147582|NCT04135352|158379978|FG005|Overall Study|Physician Decision|0|||
49147583|NCT04135352|158379979|FG006|Overall Study|Physician Decision|0|||
49147584|NCT04135352|158379980|FG007|Overall Study|Physician Decision|0|||
49147585|NCT04135352|158379973|FG000|Overall Study|Death|3|||
49147586|NCT04135352|158379974|FG001|Overall Study|Death|4|||
49147587|NCT04135352|158379975|FG002|Overall Study|Death|7|||
49147588|NCT04135352|158379976|FG003|Overall Study|Death|0|||
49147589|NCT04135352|158379977|FG004|Overall Study|Death|3|||
49147590|NCT04135352|158379978|FG005|Overall Study|Death|1|||
49147591|NCT04135352|158379979|FG006|Overall Study|Death|0|||
49147592|NCT04135352|158379980|FG007|Overall Study|Death|0|||
49147593|NCT01682720|158379982|FG000|Overall Study|Randomized but Not Treated|0|||
49147594|NCT01682720|158379983|FG001|Overall Study|Randomized but Not Treated|1|||
49147595|NCT01682720|158379984|FG002|Overall Study|Randomized but Not Treated|1|||
49147596|NCT01682720|158379985|FG003|Overall Study|Randomized but Not Treated|0|||
49147597|NCT01682720|158379982|FG000|Overall Study|Terminated by Sponsor|83|||
49147598|NCT01682720|158379983|FG001|Overall Study|Terminated by Sponsor|0|||
49147599|NCT01682720|158379984|FG002|Overall Study|Terminated by Sponsor|0|||
49147600|NCT01682720|158379985|FG003|Overall Study|Terminated by Sponsor|0|||
49147601|NCT01682720|158379982|FG000|Overall Study|Efficacy Failure|0|||
49147602|NCT01682720|158379983|FG001|Overall Study|Efficacy Failure|3|||
49147603|NCT01682720|158379984|FG002|Overall Study|Efficacy Failure|3|||
49147604|NCT01682720|158379985|FG003|Overall Study|Efficacy Failure|30|||
49147605|NCT01682720|158379982|FG000|Overall Study|Lost to Follow-up|1|||
49147606|NCT01682720|158379983|FG001|Overall Study|Lost to Follow-up|1|||
49147607|NCT01682720|158379984|FG002|Overall Study|Lost to Follow-up|0|||
49147608|NCT01682720|158379985|FG003|Overall Study|Lost to Follow-up|6|||
49147609|NCT01682720|158379982|FG000|Overall Study|Subject Withdrew Consent|0|||
49147610|NCT01682720|158379983|FG001|Overall Study|Subject Withdrew Consent|0|||
49147611|NCT01682720|158379984|FG002|Overall Study|Subject Withdrew Consent|2|||
49147612|NCT01682720|158379985|FG003|Overall Study|Subject Withdrew Consent|2|||
49147613|NCT01682720|158379982|FG000|Overall Study|Adverse Event|1|||
49147614|NCT01682720|158379983|FG001|Overall Study|Adverse Event|0|||
49147615|NCT01682720|158379984|FG002|Overall Study|Adverse Event|1|||
49147616|NCT01682720|158379985|FG003|Overall Study|Adverse Event|1|||
49147617|NCT00069953|158379989|FG000|Overall Study|Protocol Violation|2|||
49147618|NCT01299961|158379994|FG000|Overall Study|Adverse Event|3|||
49147619|NCT01299961|158379994|FG000|Overall Study|Lack of Efficacy|2|||
49147620|NCT01299961|158379994|FG000|Overall Study|Lost to Follow-up|1|||
49147621|NCT04223687|158379995|FG000|Overall Study|Missing primary outcome|1|||
49147622|NCT04223687|158379996|FG001|Overall Study|Missing primary outcome|0|||
49147623|NCT01272219|158380010|FG000|Main Period: Week 0 to Week 56|Adverse Event|86|||
49147624|NCT01272219|158380011|FG001|Main Period: Week 0 to Week 56|Adverse Event|0|||
49147625|NCT01272219|158380012|FG002|Main Period: Week 0 to Week 56|Adverse Event|0|||
49147626|NCT01272219|158380013|FG003|Main Period: Week 0 to Week 56|Adverse Event|16|||
49147627|NCT01272219|158380014|FG004|Main Period: Week 0 to Week 56|Adverse Event|152|||
49147628|NCT01272219|158380015|FG005|Main Period: Week 0 to Week 56|Adverse Event|29|||
49147629|NCT01272219|158380010|FG000|Main Period: Week 0 to Week 56|Lack of Efficacy|11|||
49147630|NCT01272219|158380011|FG001|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
49147631|NCT01272219|158380012|FG002|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
49147632|NCT01272219|158380013|FG003|Main Period: Week 0 to Week 56|Lack of Efficacy|14|||
49147633|NCT01272219|158380014|FG004|Main Period: Week 0 to Week 56|Lack of Efficacy|12|||
49013856|NCT01764854|157887201|FG003|Overall Study|Withdrawal by Subject|0|||
49013857|NCT01764854|157887198|FG000|Overall Study|relocation|0|||
49147634|NCT01272219|158380015|FG005|Main Period: Week 0 to Week 56|Lack of Efficacy|22|||
49147635|NCT01272219|158380010|FG000|Main Period: Week 0 to Week 56|Protocol Violation|25|||
49147636|NCT01272219|158380011|FG001|Main Period: Week 0 to Week 56|Protocol Violation|0|||
49147637|NCT01272219|158380012|FG002|Main Period: Week 0 to Week 56|Protocol Violation|0|||
49147638|NCT01272219|158380013|FG003|Main Period: Week 0 to Week 56|Protocol Violation|18|||
49147639|NCT01272219|158380014|FG004|Main Period: Week 0 to Week 56|Protocol Violation|40|||
49147640|NCT01272219|158380015|FG005|Main Period: Week 0 to Week 56|Protocol Violation|20|||
49147641|NCT01272219|158380010|FG000|Main Period: Week 0 to Week 56|Withdrawal criteria|122|||
49147642|NCT01272219|158380011|FG001|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
49147643|NCT01272219|158380012|FG002|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
49147644|NCT01272219|158380013|FG003|Main Period: Week 0 to Week 56|Withdrawal criteria|114|||
49147645|NCT01272219|158380014|FG004|Main Period: Week 0 to Week 56|Withdrawal criteria|172|||
49147646|NCT01272219|158380015|FG005|Main Period: Week 0 to Week 56|Withdrawal criteria|147|||
49147647|NCT01272219|158380010|FG000|Main Period: Week 0 to Week 56|Unclassified|36|||
49147648|NCT01272219|158380011|FG001|Main Period: Week 0 to Week 56|Unclassified|0|||
49147649|NCT01272219|158380012|FG002|Main Period: Week 0 to Week 56|Unclassified|0|||
49147650|NCT01272219|158380013|FG003|Main Period: Week 0 to Week 56|Unclassified|29|||
49147651|NCT01272219|158380014|FG004|Main Period: Week 0 to Week 56|Unclassified|42|||
49147652|NCT01272219|158380015|FG005|Main Period: Week 0 to Week 56|Unclassified|34|||
49147653|NCT01272219|158380010|FG000|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
49147654|NCT01272219|158380011|FG001|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
49147655|NCT01272219|158380012|FG002|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
49147656|NCT01272219|158380013|FG003|Re-randomised Period: Week 56 to Week 68|Adverse Event|2|||
49147657|NCT01272219|158380014|FG004|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
49147658|NCT01272219|158380015|FG005|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
49147659|NCT01272219|158380010|FG000|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
49147660|NCT01272219|158380011|FG001|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
49147661|NCT01272219|158380012|FG002|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
49147662|NCT01272219|158380013|FG003|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1|||
49147663|NCT01272219|158380014|FG004|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
49147664|NCT01272219|158380015|FG005|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
49147665|NCT01272219|158380010|FG000|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
49147666|NCT01272219|158380011|FG001|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1|||
49147667|NCT01272219|158380012|FG002|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
49147668|NCT01272219|158380013|FG003|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3|||
49147669|NCT01272219|158380014|FG004|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
49147670|NCT01272219|158380015|FG005|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
49147671|NCT01272219|158380010|FG000|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
49147672|NCT01272219|158380011|FG001|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6|||
49147673|NCT01272219|158380012|FG002|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4|||
49147674|NCT01272219|158380013|FG003|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7|||
49147675|NCT01272219|158380014|FG004|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
49147676|NCT01272219|158380015|FG005|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
49147677|NCT01272219|158380010|FG000|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
49147678|NCT01272219|158380011|FG001|Re-randomised Period: Week 56 to Week 68|Unclassified|1|||
49147679|NCT01272219|158380012|FG002|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
49147680|NCT01272219|158380013|FG003|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
49147681|NCT01272219|158380014|FG004|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
49147682|NCT01272219|158380015|FG005|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
49147683|NCT01272219|158380010|FG000|Main + Extension Period: Week 0-172|Adverse Event|0|||
49147684|NCT01272219|158380011|FG001|Main + Extension Period: Week 0-172|Adverse Event|0|||
49147685|NCT01272219|158380012|FG002|Main + Extension Period: Week 0-172|Adverse Event|0|||
49147686|NCT01272219|158380013|FG003|Main + Extension Period: Week 0-172|Adverse Event|0|||
49147687|NCT01272219|158380014|FG004|Main + Extension Period: Week 0-172|Adverse Event|191|||
49147688|NCT01272219|158380015|FG005|Main + Extension Period: Week 0-172|Adverse Event|43|||
49147689|NCT01272219|158380010|FG000|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
49147690|NCT01272219|158380011|FG001|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
49147691|NCT01272219|158380012|FG002|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
49147692|NCT01272219|158380013|FG003|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
49147693|NCT01272219|158380014|FG004|Main + Extension Period: Week 0-172|Lack of Efficacy|29|||
49147694|NCT01272219|158380015|FG005|Main + Extension Period: Week 0-172|Lack of Efficacy|36|||
49147695|NCT01272219|158380010|FG000|Main + Extension Period: Week 0-172|Protocol Violation|0|||
49147696|NCT01272219|158380011|FG001|Main + Extension Period: Week 0-172|Protocol Violation|0|||
49147697|NCT01272219|158380012|FG002|Main + Extension Period: Week 0-172|Protocol Violation|0|||
49147698|NCT01272219|158380013|FG003|Main + Extension Period: Week 0-172|Protocol Violation|0|||
49147699|NCT01272219|158380014|FG004|Main + Extension Period: Week 0-172|Protocol Violation|76|||
49147700|NCT01272219|158380015|FG005|Main + Extension Period: Week 0-172|Protocol Violation|36|||
49147701|NCT01272219|158380010|FG000|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
49147702|NCT01272219|158380011|FG001|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
49147703|NCT01272219|158380012|FG002|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
49147704|NCT01272219|158380013|FG003|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
49147705|NCT01272219|158380014|FG004|Main + Extension Period: Week 0-172|Withdrawal criteria|364|||
49147706|NCT01272219|158380015|FG005|Main + Extension Period: Week 0-172|Withdrawal criteria|256|||
49147707|NCT01272219|158380010|FG000|Main + Extension Period: Week 0-172|Missing reason|0|||
49147708|NCT01272219|158380011|FG001|Main + Extension Period: Week 0-172|Missing reason|0|||
49147709|NCT01272219|158380012|FG002|Main + Extension Period: Week 0-172|Missing reason|0|||
49147710|NCT01272219|158380013|FG003|Main + Extension Period: Week 0-172|Missing reason|0|||
49147711|NCT01272219|158380014|FG004|Main + Extension Period: Week 0-172|Missing reason|1|||
49147712|NCT01272219|158380015|FG005|Main + Extension Period: Week 0-172|Missing reason|0|||
49147713|NCT01272219|158380010|FG000|Main + Extension Period: Week 0-172|Unclassified|0|||
48823498|NCT00557505|157193962|FG006|Overall Study|Adverse Event|1|||
49147714|NCT01272219|158380011|FG001|Main + Extension Period: Week 0-172|Unclassified|0|||
49147715|NCT01272219|158380012|FG002|Main + Extension Period: Week 0-172|Unclassified|0|||
49147716|NCT01272219|158380013|FG003|Main + Extension Period: Week 0-172|Unclassified|0|||
49147717|NCT01272219|158380014|FG004|Main + Extension Period: Week 0-172|Unclassified|61|||
49147718|NCT01272219|158380015|FG005|Main + Extension Period: Week 0-172|Unclassified|51|||
49147719|NCT04818086|158380016|FG000|Overall Study|Physician Decision|1|||
49147720|NCT04818086|158380017|FG001|Overall Study|Physician Decision|0|||
49147721|NCT04818086|158380016|FG000|Overall Study|Withdrawal by Subject|0|||
49147722|NCT04818086|158380017|FG001|Overall Study|Withdrawal by Subject|1|||
49147723|NCT01852214|158380024|FG000|Period 1|Adverse Event|1|||
49147724|NCT01852214|158380025|FG001|Period 1|Adverse Event|2|||
49147725|NCT01852214|158380024|FG000|Period 1|Withdrawal by Subject|0|||
49147726|NCT01852214|158380025|FG001|Period 1|Withdrawal by Subject|1|||
49147727|NCT01852214|158380024|FG000|Washout Period|Withdrawal by Subject|0|||
49147728|NCT01852214|158380025|FG001|Washout Period|Withdrawal by Subject|1|||
49147729|NCT02691494|158380026|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
49147730|NCT02691494|158380027|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
49147731|NCT02691494|158380028|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
49147732|NCT02691494|158380026|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
49147733|NCT02691494|158380027|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
49147734|NCT02691494|158380028|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
49147735|NCT02691494|158380026|FG000|Post-Treatment Follow-Up Period|Other|2|||
49147736|NCT02691494|158380027|FG001|Post-Treatment Follow-Up Period|Other|1|||
49147737|NCT02691494|158380028|FG002|Post-Treatment Follow-Up Period|Other|1|||
49147738|NCT02691494|158380026|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
49147739|NCT02691494|158380027|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
49147740|NCT02691494|158380028|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3|||
49147741|NCT02691494|158380026|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
49147742|NCT02691494|158380027|FG001|Post-Treatment Follow-Up Period|Non-Compliance|1|||
49147743|NCT02691494|158380028|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
49147744|NCT00236197|158380029|FG000|Overall Study|Withdrawal by Subject|3|||
49147745|NCT00236197|158380030|FG001|Overall Study|Withdrawal by Subject|2|||
49147746|NCT00236197|158380029|FG000|Overall Study|Lost to Follow-up|1|||
49147747|NCT00236197|158380030|FG001|Overall Study|Lost to Follow-up|5|||
49147748|NCT00236197|158380029|FG000|Overall Study|Protocol Violation|0|||
49147749|NCT00236197|158380030|FG001|Overall Study|Protocol Violation|3|||
49147750|NCT00236197|158380029|FG000|Overall Study|Medication non-compliance|1|||
49147751|NCT00236197|158380030|FG001|Overall Study|Medication non-compliance|2|||
49147752|NCT00236197|158380029|FG000|Overall Study|Other|0|||
49147753|NCT00236197|158380030|FG001|Overall Study|Other|2|||
49147754|NCT05346640|158380031|FG000|Overall Study|Lack of Efficacy|2|||
49147755|NCT05346640|158380031|FG000|Overall Study|Lost to Follow-up|14|||
49147756|NCT05346640|158380031|FG000|Overall Study|Protocol Violation|4|||
49147757|NCT05346640|158380031|FG000|Overall Study|Withdrawal by Subject|2|||
49147758|NCT05346640|158380031|FG000|Overall Study|Physiological Complications|3|||
49147759|NCT05346640|158380031|FG000|Overall Study|Other Reason|3|||
49147760|NCT03941093|158380038|FG000|Overall Study|Protocol Violation|0|||
49147761|NCT03941093|158380039|FG001|Overall Study|Protocol Violation|1|||
49147762|NCT03941093|158380038|FG000|Overall Study|Withdrawal by Subject|9|||
49147763|NCT03941093|158380039|FG001|Overall Study|Withdrawal by Subject|6|||
49147764|NCT01897896|158382063|FG000|Overall Study|Death|1|||
49147765|NCT01897896|158382064|FG001|Overall Study|Death|0|||
49147766|NCT01897896|158382063|FG000|Overall Study|Adverse Event|11|||
49147767|NCT01897896|158382064|FG001|Overall Study|Adverse Event|1|||
49147768|NCT01897896|158382063|FG000|Overall Study|Lost to Follow-up|1|||
49147769|NCT01897896|158382064|FG001|Overall Study|Lost to Follow-up|0|||
49147770|NCT01897896|158382063|FG000|Overall Study|Non-compliance with study drug dosing|1|||
49147771|NCT01897896|158382064|FG001|Overall Study|Non-compliance with study drug dosing|1|||
49147772|NCT01897896|158382063|FG000|Overall Study|Withdrawal by Subject|7|||
49147773|NCT01897896|158382064|FG001|Overall Study|Withdrawal by Subject|1|||
49147774|NCT01897896|158382063|FG000|Overall Study|Require drug that interfere with study|1|||
49147775|NCT01897896|158382064|FG001|Overall Study|Require drug that interfere with study|4|||
49147776|NCT01897896|158382063|FG000|Overall Study|Protocol Violation|1|||
49147777|NCT01897896|158382064|FG001|Overall Study|Protocol Violation|1|||
49147778|NCT01897896|158382063|FG000|Overall Study|Withdrawal per Investigator's judgement|1|||
49147779|NCT01897896|158382064|FG001|Overall Study|Withdrawal per Investigator's judgement|1|||
49147780|NCT01897896|158382063|FG000|Overall Study|Caregiver can no longer participate|0|||
49147781|NCT01897896|158382064|FG001|Overall Study|Caregiver can no longer participate|2|||
49147782|NCT01897896|158382063|FG000|Overall Study|Other than specified|2|||
49147783|NCT01897896|158382064|FG001|Overall Study|Other than specified|1|||
49147784|NCT04821245|158382067|FG000|Overall Study|Withdrawal by Subject|3|||
49147785|NCT04821245|158382067|FG000|Overall Study|Physician Decision|1|||
49147786|NCT04821245|158382067|FG000|Overall Study|Protocol Violation|5|||
49147787|NCT02105012|158382071|FG000|Overall Study|Withdrawal by Subject|11|||
49147788|NCT02105012|158382071|FG000|Overall Study|Protocol Specified Criteria|9|||
49147789|NCT02105012|158382071|FG000|Overall Study|Lost to Follow-up|4|||
49147790|NCT02105012|158382071|FG000|Overall Study|Protocol Violation|4|||
49147791|NCT02105012|158382071|FG000|Overall Study|Physician Decision|3|||
49147792|NCT02105012|158382071|FG000|Overall Study|Adverse Event|1|||
49147793|NCT02105012|158382071|FG000|Overall Study|Lack of Efficacy|1|||
48823499|NCT00557505|157193963|FG007|Overall Study|Adverse Event|0|||
48823500|NCT00557505|157193964|FG008|Overall Study|Adverse Event|0|||
48823501|NCT00557505|157193956|FG000|Overall Study|Global deterioration of health|1|||
48823502|NCT00557505|157193957|FG001|Overall Study|Global deterioration of health|0|||
48823503|NCT00557505|157193958|FG002|Overall Study|Global deterioration of health|0|||
48823504|NCT00557505|157193959|FG003|Overall Study|Global deterioration of health|0|||
48823505|NCT00557505|157193960|FG004|Overall Study|Global deterioration of health|0|||
48823506|NCT00557505|157193961|FG005|Overall Study|Global deterioration of health|0|||
48823507|NCT00557505|157193962|FG006|Overall Study|Global deterioration of health|0|||
48823508|NCT00557505|157193963|FG007|Overall Study|Global deterioration of health|0|||
48823509|NCT00557505|157193964|FG008|Overall Study|Global deterioration of health|0|||
48823510|NCT00557505|157193956|FG000|Overall Study|Objective progression or relapse|2|||
48823511|NCT00557505|157193957|FG001|Overall Study|Objective progression or relapse|3|||
48823512|NCT00557505|157193958|FG002|Overall Study|Objective progression or relapse|3|||
48823513|NCT00557505|157193959|FG003|Overall Study|Objective progression or relapse|2|||
48823514|NCT00557505|157193960|FG004|Overall Study|Objective progression or relapse|2|||
48823515|NCT00557505|157193961|FG005|Overall Study|Objective progression or relapse|3|||
48823516|NCT00557505|157193962|FG006|Overall Study|Objective progression or relapse|2|||
48823517|NCT00557505|157193963|FG007|Overall Study|Objective progression or relapse|5|||
48823518|NCT00557505|157193964|FG008|Overall Study|Objective progression or relapse|15|||
48823519|NCT00557505|157193956|FG000|Overall Study|Withdrawal by Subject|0|||
48823520|NCT00557505|157193957|FG001|Overall Study|Withdrawal by Subject|0|||
48823521|NCT00557505|157193958|FG002|Overall Study|Withdrawal by Subject|0|||
48823522|NCT00557505|157193959|FG003|Overall Study|Withdrawal by Subject|1|||
48823523|NCT00557505|157193960|FG004|Overall Study|Withdrawal by Subject|0|||
48823524|NCT00557505|157193961|FG005|Overall Study|Withdrawal by Subject|0|||
48823525|NCT00557505|157193962|FG006|Overall Study|Withdrawal by Subject|0|||
48823526|NCT00557505|157193963|FG007|Overall Study|Withdrawal by Subject|0|||
48823527|NCT00557505|157193964|FG008|Overall Study|Withdrawal by Subject|1|||
48823528|NCT03169361|157193967|FG000|Overall Study|Protocol Violation|32|||
48823529|NCT02788656|157193968|FG000|Overall Study|Withdrawal by Subject|1|||
48823530|NCT02788656|157193969|FG001|Overall Study|Withdrawal by Subject|0|||
48823531|NCT02271594|157193970|FG000|Overall Study|Study closed; recruiting failure|19|||
48823532|NCT02271594|157193971|FG001|Overall Study|Study closed; recruiting failure|12|||
48823533|NCT01561079|157193972|FG000|Overall Study|Physician Decision|17|||
48823534|NCT01561079|157193972|FG000|Overall Study|Withdrawal by Subject|59|||
48823535|NCT01561079|157193972|FG000|Overall Study|Protocol Violation|2|||
48823536|NCT00664521|157193979|FG000|Overall Study|Adverse Event|4|||
48823537|NCT00664521|157193980|FG001|Overall Study|Adverse Event|1|||
48823538|NCT00664521|157193979|FG000|Overall Study|Lost to Follow-up|1|||
48823539|NCT00664521|157193980|FG001|Overall Study|Lost to Follow-up|0|||
48823540|NCT00664521|157193979|FG000|Overall Study|Other|1|||
48823541|NCT00664521|157193980|FG001|Overall Study|Other|0|||
48823542|NCT00367237|157193981|FG000|Overall Study|Adverse Event|7|||
48823543|NCT00367237|157193982|FG001|Overall Study|Adverse Event|2|||
48823544|NCT00367237|157193981|FG000|Overall Study|Lost to Follow-up|1|||
48823545|NCT00367237|157193982|FG001|Overall Study|Lost to Follow-up|0|||
48823546|NCT00367237|157193981|FG000|Overall Study|Withdrawal by Subject|0|||
49147794|NCT05071027|158382072|FG000|Overall Study|Lost to Follow-up|1|||
49147795|NCT05071027|158382073|FG001|Overall Study|Lost to Follow-up|4|||
49147796|NCT05524948|158382078|FG000|Overall Study|Withdrawal by Subject|1|||
49147797|NCT05524948|158382079|FG001|Overall Study|Withdrawal by Subject|0|||
49147798|NCT05524948|158382078|FG000|Overall Study|Participant did not receive call or showed up for final visit|1|||
49147799|NCT05524948|158382079|FG001|Overall Study|Participant did not receive call or showed up for final visit|1|||
49147800|NCT01796470|158382080|FG000|Overall Study|Adverse Event|4|||
49147801|NCT01796470|158382081|FG001|Overall Study|Adverse Event|2|||
49147802|NCT01796470|158382082|FG002|Overall Study|Adverse Event|2|||
49147803|NCT01796470|158382083|FG003|Overall Study|Adverse Event|1|||
49147804|NCT01796470|158382084|FG004|Overall Study|Adverse Event|3|||
49147805|NCT01796470|158382080|FG000|Overall Study|Death|2|||
49147806|NCT01796470|158382081|FG001|Overall Study|Death|0|||
49147807|NCT01796470|158382082|FG002|Overall Study|Death|0|||
49147808|NCT01796470|158382083|FG003|Overall Study|Death|0|||
49147809|NCT01796470|158382084|FG004|Overall Study|Death|1|||
49147810|NCT01796470|158382080|FG000|Overall Study|Initiated New Therapy|9|||
49147811|NCT01796470|158382081|FG001|Overall Study|Initiated New Therapy|0|||
49147812|NCT01796470|158382082|FG002|Overall Study|Initiated New Therapy|0|||
49147813|NCT01796470|158382083|FG003|Overall Study|Initiated New Therapy|0|||
49147814|NCT01796470|158382084|FG004|Overall Study|Initiated New Therapy|2|||
49147815|NCT01796470|158382080|FG000|Overall Study|Lost to Follow-up|0|||
49147816|NCT01796470|158382081|FG001|Overall Study|Lost to Follow-up|1|||
49013858|NCT01764854|157887199|FG001|Overall Study|relocation|0|||
49013859|NCT01764854|157887200|FG002|Overall Study|relocation|2|||
49147817|NCT01796470|158382082|FG002|Overall Study|Lost to Follow-up|0|||
49147818|NCT01796470|158382083|FG003|Overall Study|Lost to Follow-up|0|||
49147819|NCT01796470|158382084|FG004|Overall Study|Lost to Follow-up|0|||
49147820|NCT01796470|158382080|FG000|Overall Study|Physician Decision|5|||
49147821|NCT01796470|158382081|FG001|Overall Study|Physician Decision|4|||
49147822|NCT01796470|158382082|FG002|Overall Study|Physician Decision|1|||
49147823|NCT01796470|158382083|FG003|Overall Study|Physician Decision|0|||
49147824|NCT01796470|158382084|FG004|Overall Study|Physician Decision|1|||
49147825|NCT01796470|158382080|FG000|Overall Study|Progressive Disease|7|||
49147826|NCT01796470|158382081|FG001|Overall Study|Progressive Disease|7|||
49147827|NCT01796470|158382082|FG002|Overall Study|Progressive Disease|3|||
49147828|NCT01796470|158382083|FG003|Overall Study|Progressive Disease|2|||
49147829|NCT01796470|158382084|FG004|Overall Study|Progressive Disease|0|||
49147830|NCT01796470|158382080|FG000|Overall Study|Protocol Criteria for Withdrawal|1|||
49147831|NCT01796470|158382081|FG001|Overall Study|Protocol Criteria for Withdrawal|0|||
49147832|NCT01796470|158382082|FG002|Overall Study|Protocol Criteria for Withdrawal|0|||
49147833|NCT01796470|158382083|FG003|Overall Study|Protocol Criteria for Withdrawal|0|||
49147834|NCT01796470|158382084|FG004|Overall Study|Protocol Criteria for Withdrawal|0|||
49147835|NCT01796470|158382080|FG000|Overall Study|Withdrawal by Subject|7|||
49147836|NCT01796470|158382081|FG001|Overall Study|Withdrawal by Subject|0|||
49147837|NCT01796470|158382082|FG002|Overall Study|Withdrawal by Subject|0|||
49147838|NCT01796470|158382083|FG003|Overall Study|Withdrawal by Subject|0|||
49147839|NCT01796470|158382084|FG004|Overall Study|Withdrawal by Subject|1|||
49147840|NCT02633527|158382085|FG000|Overall Study|Failed to meet eligibility|0|||
49147841|NCT02633527|158382086|FG001|Overall Study|Failed to meet eligibility|1|||
49147842|NCT02633527|158382087|FG002|Overall Study|Failed to meet eligibility|1|||
49147843|NCT02633527|158382088|FG003|Overall Study|Failed to meet eligibility|0|||
49147844|NCT02633527|158382089|FG004|Overall Study|Failed to meet eligibility|1|||
49147845|NCT02633527|158382085|FG000|Overall Study|Adverse Event|0|||
49147846|NCT02633527|158382086|FG001|Overall Study|Adverse Event|4|||
49147847|NCT02633527|158382087|FG002|Overall Study|Adverse Event|3|||
49147848|NCT02633527|158382088|FG003|Overall Study|Adverse Event|1|||
49147849|NCT02633527|158382089|FG004|Overall Study|Adverse Event|5|||
49147850|NCT02633527|158382085|FG000|Overall Study|Lost to Follow-up|1|||
49147851|NCT02633527|158382086|FG001|Overall Study|Lost to Follow-up|2|||
49147852|NCT02633527|158382087|FG002|Overall Study|Lost to Follow-up|5|||
49147853|NCT02633527|158382088|FG003|Overall Study|Lost to Follow-up|5|||
49147854|NCT02633527|158382089|FG004|Overall Study|Lost to Follow-up|4|||
49013860|NCT01764854|157887201|FG003|Overall Study|relocation|0|||
49013861|NCT01764854|157887198|FG000|Overall Study|Protocol Violation|0|||
49013862|NCT01764854|157887199|FG001|Overall Study|Protocol Violation|0|||
49147855|NCT02633527|158382085|FG000|Overall Study|Withdrawal by Subject|0|||
49147856|NCT02633527|158382086|FG001|Overall Study|Withdrawal by Subject|3|||
49147857|NCT02633527|158382087|FG002|Overall Study|Withdrawal by Subject|5|||
49147858|NCT02633527|158382088|FG003|Overall Study|Withdrawal by Subject|4|||
49147859|NCT02633527|158382089|FG004|Overall Study|Withdrawal by Subject|4|||
49147860|NCT02633527|158382085|FG000|Overall Study|Protocol Violation|0|||
49147861|NCT02633527|158382086|FG001|Overall Study|Protocol Violation|1|||
49147862|NCT02633527|158382087|FG002|Overall Study|Protocol Violation|1|||
49147863|NCT02633527|158382088|FG003|Overall Study|Protocol Violation|1|||
49147864|NCT02633527|158382089|FG004|Overall Study|Protocol Violation|1|||
49147865|NCT02633527|158382085|FG000|Overall Study|Physician Decision|0|||
49147866|NCT02633527|158382086|FG001|Overall Study|Physician Decision|0|||
49147867|NCT02633527|158382087|FG002|Overall Study|Physician Decision|0|||
49147868|NCT02633527|158382088|FG003|Overall Study|Physician Decision|0|||
49147869|NCT02633527|158382089|FG004|Overall Study|Physician Decision|1|||
49147870|NCT02633527|158382085|FG000|Overall Study|Administrative reason|1|||
49147871|NCT02633527|158382086|FG001|Overall Study|Administrative reason|0|||
49147872|NCT02633527|158382087|FG002|Overall Study|Administrative reason|0|||
49147873|NCT02633527|158382088|FG003|Overall Study|Administrative reason|1|||
49147874|NCT02633527|158382089|FG004|Overall Study|Administrative reason|0|||
49147875|NCT02633527|158382085|FG000|Overall Study|Multiple reasons|1|||
49147876|NCT02633527|158382086|FG001|Overall Study|Multiple reasons|0|||
49147877|NCT02633527|158382087|FG002|Overall Study|Multiple reasons|2|||
49147878|NCT02633527|158382088|FG003|Overall Study|Multiple reasons|2|||
49147879|NCT02633527|158382089|FG004|Overall Study|Multiple reasons|1|||
49147880|NCT04439357|158382090|FG000|Overall Study|Disease Progression|4|||
48730757|NCT03611010|156865885|FG000|Period 2: 15 Day Treatment|Inaccessible veins|1|||
49013863|NCT01764854|157887200|FG002|Overall Study|Protocol Violation|1|||
49147881|NCT00754559|158382091|FG000|Overall Study|Adverse Event|15|||
49147882|NCT00754559|158382091|FG000|Overall Study|Protocol Violation|11|||
49147883|NCT00754559|158382091|FG000|Overall Study|Lack of Efficacy|10|||
49147884|NCT00754559|158382091|FG000|Overall Study|Lost to Follow-up|2|||
49147885|NCT00754559|158382091|FG000|Overall Study|Administrative reason|1|||
49147886|NCT00754559|158382091|FG000|Overall Study|Other|5|||
49147887|NCT00754559|158382091|FG000|Overall Study|Withdrawal by Subject|3|||
49147888|NCT03829683|158382092|FG000|Overall Study|Lost to Follow-up|1|||
48823547|NCT00367237|157193982|FG001|Overall Study|Withdrawal by Subject|4|||
48823548|NCT00367237|157193981|FG000|Overall Study|Protocol Violation|2|||
48823549|NCT00367237|157193982|FG001|Overall Study|Protocol Violation|5|||
48823550|NCT02368886|157193983|FG000|Overall Study|Cancel|1|||
48823551|NCT02368886|157193984|FG001|Overall Study|Cancel|1|||
48823552|NCT02368886|157193985|FG002|Overall Study|Cancel|1|||
48823553|NCT02368886|157193986|FG003|Overall Study|Cancel|3|||
48823554|NCT02368886|157193983|FG000|Overall Study|Ineligible|0|||
48823555|NCT02368886|157193984|FG001|Overall Study|Ineligible|0|||
48823556|NCT02368886|157193985|FG002|Overall Study|Ineligible|0|||
48823557|NCT02368886|157193986|FG003|Overall Study|Ineligible|1|||
48823558|NCT00550732|157193987|FG000|Overall Study|Death|4|||
48823559|NCT00550732|157193987|FG000|Overall Study|Withdrawal by Subject|2|||
48823560|NCT00550732|157193987|FG000|Overall Study|Physician Decision|2|||
48823561|NCT00550732|157193987|FG000|Overall Study|Lost to Follow-up|1|||
48823562|NCT00550732|157193987|FG000|Overall Study|Palliative care|1|||
49147889|NCT03829683|158382093|FG001|Overall Study|Lost to Follow-up|0|||
49147890|NCT03829683|158382092|FG000|Overall Study|Physician Decision|3|||
49147891|NCT03829683|158382093|FG001|Overall Study|Physician Decision|1|||
49147892|NCT03829683|158382092|FG000|Overall Study|Withdrawal by Subject|0|||
49147893|NCT03829683|158382093|FG001|Overall Study|Withdrawal by Subject|1|||
49147894|NCT03829683|158382092|FG000|Overall Study|Discharge from hospital|1|||
49147895|NCT03829683|158382093|FG001|Overall Study|Discharge from hospital|0|||
49147896|NCT01248468|158382094|FG000|Overall Study|Administrative problem|1|||
49147897|NCT01248468|158382095|FG001|Overall Study|Administrative problem|0|||
49147898|NCT01248468|158382096|FG002|Overall Study|Administrative problem|0|||
49147899|NCT01248468|158382094|FG000|Overall Study|Lost to Follow-up|9|||
49147900|NCT01248468|158382095|FG001|Overall Study|Lost to Follow-up|12|||
49147901|NCT01248468|158382096|FG002|Overall Study|Lost to Follow-up|4|||
49147902|NCT01248468|158382094|FG000|Overall Study|Pregnancy|1|||
49147903|NCT01248468|158382095|FG001|Overall Study|Pregnancy|0|||
49147904|NCT01248468|158382096|FG002|Overall Study|Pregnancy|0|||
49147905|NCT01248468|158382094|FG000|Overall Study|Withdrawal by Subject|4|||
49147906|NCT01248468|158382095|FG001|Overall Study|Withdrawal by Subject|2|||
49147907|NCT01248468|158382096|FG002|Overall Study|Withdrawal by Subject|0|||
49147908|NCT02226653|158382100|FG000|Treatment Period 2 Fasted State|Lost to Follow-up|1|||
49147909|NCT02226653|158382101|FG001|Treatment Period 2 Fasted State|Lost to Follow-up|0|||
49147910|NCT02226653|158382100|FG000|Treatment Period 5 Fed State|Adverse Event|0|||
49147911|NCT02226653|158382101|FG001|Treatment Period 5 Fed State|Adverse Event|1|||
49147912|NCT00635050|158382102|FG000|Overall Study|Withdrawal by Subject|1|||
49147913|NCT04525183|158382103|FG000|Overall Study|Withdrawal by Subject|0|||
49147914|NCT04525183|158382104|FG001|Overall Study|Withdrawal by Subject|0|||
49147915|NCT04525183|158382105|FG002|Overall Study|Withdrawal by Subject|3|||
49147916|NCT04525183|158382103|FG000|Overall Study|Study non-compliance|0|||
49147917|NCT04525183|158382104|FG001|Overall Study|Study non-compliance|0|||
48823563|NCT00550732|157193987|FG000|Overall Study|Adverse Event|1|||
48823564|NCT02688621|157193990|FG000|Overall Study|Pregnancy|1|||
48823565|NCT02688621|157193991|FG001|Overall Study|Pregnancy|3|||
48823566|NCT02688621|157193990|FG000|Overall Study|Lost to Follow-up|38|||
48823567|NCT02688621|157193991|FG001|Overall Study|Lost to Follow-up|15|||
48823568|NCT02688621|157193990|FG000|Overall Study|Withdrawal by Subject|1|||
48823569|NCT02688621|157193991|FG001|Overall Study|Withdrawal by Subject|0|||
48823570|NCT03415022|157193992|FG000|Overall Study|Withdrawal by Subject|1|||
48823571|NCT03415022|157193993|FG001|Overall Study|Withdrawal by Subject|2|||
48823572|NCT03415022|157193992|FG000|Overall Study|COVID-19 Suspension|2|||
48823573|NCT03415022|157193993|FG001|Overall Study|COVID-19 Suspension|3|||
48823574|NCT03415022|157193992|FG000|Overall Study|Lost to Follow-up|2|||
48823575|NCT03415022|157193993|FG001|Overall Study|Lost to Follow-up|0|||
48823576|NCT01094743|157193994|FG000|Period 1|Unsatisfactory comfort at lens fitting|2|||
49147918|NCT04525183|158382105|FG002|Overall Study|Study non-compliance|1|||
49147919|NCT04525183|158382103|FG000|Overall Study|Recurrent disease before starting on study|0|||
49147920|NCT04525183|158382104|FG001|Overall Study|Recurrent disease before starting on study|0|||
48823577|NCT00742274|157193997|FG000|Overall Study|Death|1|||
48823578|NCT00742274|157193998|FG001|Overall Study|Death|0|||
48823579|NCT00742274|157193997|FG000|Overall Study|Withdrawal by Subject|1|||
48823580|NCT00742274|157193998|FG001|Overall Study|Withdrawal by Subject|2|||
48823581|NCT00742274|157193997|FG000|Overall Study|Removed for medical reasons|1|||
48823582|NCT00742274|157193998|FG001|Overall Study|Removed for medical reasons|1|||
48823583|NCT02034435|157194008|FG000|Overall Study|Withdrawal by Subject|1|||
48823584|NCT02034435|157194009|FG001|Overall Study|Withdrawal by Subject|0|||
48823585|NCT02034435|157194010|FG002|Overall Study|Withdrawal by Subject|0|||
48823586|NCT02034435|157194011|FG003|Overall Study|Withdrawal by Subject|0|||
49147921|NCT04525183|158382105|FG002|Overall Study|Recurrent disease before starting on study|1|||
49147922|NCT04629521|158382106|FG000|Overall Study|Death|1|||
49147923|NCT04629521|158382106|FG000|Overall Study|Lost to Follow-up|3|||
49147924|NCT04629521|158382106|FG000|Overall Study|Subject withdrew consent|3|||
49147925|NCT04629521|158382106|FG000|Overall Study|Enrolled in error|1|||
49147926|NCT01916226|158382107|FG000|Overall Study|Adverse Event|1|||
48823587|NCT02034435|157194008|FG000|Overall Study|Illness|0|||
48823588|NCT02034435|157194009|FG001|Overall Study|Illness|2|||
48823589|NCT02034435|157194010|FG002|Overall Study|Illness|0|||
48823590|NCT02034435|157194011|FG003|Overall Study|Illness|0|||
48823591|NCT02034435|157194008|FG000|Overall Study|Inadequate IV access|1|||
48823592|NCT02034435|157194009|FG001|Overall Study|Inadequate IV access|0|||
48823593|NCT02034435|157194010|FG002|Overall Study|Inadequate IV access|0|||
48823594|NCT02034435|157194011|FG003|Overall Study|Inadequate IV access|1|||
48823595|NCT02300311|157194012|FG000|Overall Study|Other than the reason specified|1|||
48823596|NCT02300311|157194013|FG001|Overall Study|Other than the reason specified|0|||
48823597|NCT02300311|157194012|FG000|Overall Study|Refused to continue taking medication|18|||
49147927|NCT01916226|158382108|FG001|Overall Study|Adverse Event|0|||
49147928|NCT01916226|158382109|FG002|Overall Study|Adverse Event|1|||
49147929|NCT01916226|158382110|FG003|Overall Study|Adverse Event|1|||
49147930|NCT01916226|158382107|FG000|Overall Study|Lack of Efficacy|0|||
49147931|NCT01916226|158382108|FG001|Overall Study|Lack of Efficacy|0|||
49147932|NCT01916226|158382109|FG002|Overall Study|Lack of Efficacy|2|||
49147933|NCT01916226|158382110|FG003|Overall Study|Lack of Efficacy|1|||
49147934|NCT01916226|158382107|FG000|Overall Study|Protocol Violation|0|||
49147935|NCT01916226|158382108|FG001|Overall Study|Protocol Violation|1|||
49147936|NCT01916226|158382109|FG002|Overall Study|Protocol Violation|0|||
49147937|NCT01916226|158382110|FG003|Overall Study|Protocol Violation|1|||
49147938|NCT01916226|158382107|FG000|Overall Study|Physician Decision|0|||
49147939|NCT01916226|158382108|FG001|Overall Study|Physician Decision|0|||
49147940|NCT01916226|158382109|FG002|Overall Study|Physician Decision|0|||
49147941|NCT01916226|158382110|FG003|Overall Study|Physician Decision|1|||
49147942|NCT02420314|158382111|FG000|Overall Study|Withdrawal by Subject|1|||
49147943|NCT02420314|158382111|FG000|Overall Study|Protocol Violation|1|||
49147944|NCT04875533|158382114|FG000|Overall Study|Adverse Event|6|||
49147945|NCT04875533|158382115|FG001|Overall Study|Adverse Event|4|||
49147946|NCT04875533|158382114|FG000|Overall Study|Protocol Violation|4|||
49147947|NCT04875533|158382115|FG001|Overall Study|Protocol Violation|0|||
49147948|NCT04875533|158382114|FG000|Overall Study|Withdrawal by Subject|8|||
49147949|NCT04875533|158382115|FG001|Overall Study|Withdrawal by Subject|5|||
49147950|NCT04875533|158382114|FG000|Overall Study|No longer meets eligibility criteria|1|||
49147951|NCT04875533|158382115|FG001|Overall Study|No longer meets eligibility criteria|0|||
49147952|NCT04875533|158382114|FG000|Overall Study|Other|0|||
49147953|NCT04875533|158382115|FG001|Overall Study|Other|2|||
49147954|NCT00680914|158382116|FG000|Overall Study|Consent withdrawal|6|||
49147955|NCT00680914|158382117|FG001|Overall Study|Consent withdrawal|3|||
48823598|NCT02300311|157194013|FG001|Overall Study|Refused to continue taking medication|0|||
49147956|NCT00680914|158382116|FG000|Overall Study|Lost to Follow-up|4|||
49147957|NCT00680914|158382117|FG001|Overall Study|Lost to Follow-up|0|||
49147958|NCT00680914|158382116|FG000|Overall Study|serious adverse event (SAE)|0|||
49147959|NCT00680914|158382117|FG001|Overall Study|serious adverse event (SAE)|1|||
49147960|NCT01487161|158382118|FG000|Overall Study|Adverse Event|1|||
49147961|NCT01487161|158382119|FG001|Overall Study|Adverse Event|0|||
49147962|NCT01487161|158382120|FG002|Overall Study|Adverse Event|0|||
49147963|NCT01487161|158382121|FG003|Overall Study|Adverse Event|0|||
49147964|NCT01487161|158382118|FG000|Overall Study|Withdrawal by Subject|1|||
49147965|NCT01487161|158382119|FG001|Overall Study|Withdrawal by Subject|1|||
49147966|NCT01487161|158382120|FG002|Overall Study|Withdrawal by Subject|1|||
49147967|NCT01487161|158382121|FG003|Overall Study|Withdrawal by Subject|2|||
49147968|NCT01487161|158382118|FG000|Overall Study|missing data|0|||
49147969|NCT01487161|158382119|FG001|Overall Study|missing data|1|||
49147970|NCT01487161|158382120|FG002|Overall Study|missing data|0|||
49147971|NCT01487161|158382121|FG003|Overall Study|missing data|0|||
49147972|NCT02554474|158382122|FG000|Overall Study|Protocol Violation|1|||
49147973|NCT02554474|158382123|FG001|Overall Study|Protocol Violation|1|||
48823599|NCT02531438|157194014|FG000|Overall Study|Adverse Event|7|||
49147974|NCT02554474|158382122|FG000|Overall Study|Health issue not related to the study|1|||
49147975|NCT02554474|158382123|FG001|Overall Study|Health issue not related to the study|0|||
49147976|NCT02554474|158382122|FG000|Overall Study|Withdrawal by Subject|1|||
49147977|NCT02554474|158382123|FG001|Overall Study|Withdrawal by Subject|1|||
49147978|NCT03186378|158382124|FG000|Overall Study|Lost to Follow-up|1|||
49147979|NCT03186378|158382125|FG001|Overall Study|Lost to Follow-up|0|||
48823600|NCT02531438|157194015|FG001|Overall Study|Adverse Event|9|||
48823601|NCT02531438|157194014|FG000|Overall Study|Lost to Follow-up|0|||
49147980|NCT01848457|158382128|FG000|Overall Study|Death|1|||
49147981|NCT01848457|158382129|FG001|Overall Study|Death|0|||
49147982|NCT01848457|158382130|FG002|Overall Study|Death|0|||
49147983|NCT01848457|158382131|FG003|Overall Study|Death|0|||
49147984|NCT00489476|158382134|FG000|Overall Study|Lost to Follow-up|0|||
49147985|NCT00489476|158382135|FG001|Overall Study|Lost to Follow-up|1|||
49147986|NCT00489476|158382136|FG002|Overall Study|Lost to Follow-up|0|||
49147987|NCT00489476|158382137|FG003|Overall Study|Lost to Follow-up|0|||
49147988|NCT03460704|158382138|FG000|Overall Study|Withdrawal by Subject|11|||
49147989|NCT03460704|158382139|FG001|Overall Study|Withdrawal by Subject|14|||
49147990|NCT03460704|158382138|FG000|Overall Study|Study terminated by the Sponsor|29|||
49147991|NCT03460704|158382139|FG001|Overall Study|Study terminated by the Sponsor|19|||
48823602|NCT02531438|157194015|FG001|Overall Study|Lost to Follow-up|3|||
48823603|NCT02531438|157194014|FG000|Overall Study|Withdrawal by Subject|7|||
48823604|NCT02531438|157194015|FG001|Overall Study|Withdrawal by Subject|8|||
48823605|NCT02531438|157194014|FG000|Overall Study|Physician Decision|0|||
48823606|NCT02531438|157194015|FG001|Overall Study|Physician Decision|1|||
48823607|NCT02531438|157194014|FG000|Overall Study|Death|6|||
48823608|NCT02531438|157194015|FG001|Overall Study|Death|3|||
48823609|NCT02531438|157194014|FG000|Overall Study|Randomized, but Not Treated|4|||
48823610|NCT02531438|157194015|FG001|Overall Study|Randomized, but Not Treated|0|||
48823611|NCT02531438|157194014|FG000|Overall Study|Missed EOT/PTE Visit|5|||
48823612|NCT02531438|157194015|FG001|Overall Study|Missed EOT/PTE Visit|2|||
48823613|NCT02531438|157194014|FG000|Overall Study|Randomized with Exclusion Criteria|1|||
48823614|NCT02531438|157194015|FG001|Overall Study|Randomized with Exclusion Criteria|0|||
48823615|NCT01124617|157194016|FG000|Overall Study|Adverse Event|5|||
49147992|NCT03460704|158382138|FG000|Overall Study|Adverse Event|10|||
49147993|NCT03460704|158382139|FG001|Overall Study|Adverse Event|5|||
49147994|NCT03460704|158382138|FG000|Overall Study|Death|3|||
49147995|NCT03460704|158382139|FG001|Overall Study|Death|2|||
49147996|NCT03460704|158382138|FG000|Overall Study|Non-Compliance with Study Drug|3|||
49147997|NCT03460704|158382139|FG001|Overall Study|Non-Compliance with Study Drug|0|||
49147998|NCT03460704|158382138|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
49147999|NCT03460704|158382139|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
49148000|NCT03460704|158382138|FG000|Overall Study|Other|2|||
49148001|NCT03460704|158382139|FG001|Overall Study|Other|1|||
49148002|NCT03620981|158382140|FG000|Overall Study|Adverse Event|14|||
49148003|NCT03620981|158382141|FG001|Overall Study|Adverse Event|38|||
49148004|NCT03620981|158382142|FG002|Overall Study|Adverse Event|25|||
49148005|NCT03620981|158382140|FG000|Overall Study|Lack of Efficacy|2|||
49148006|NCT03620981|158382141|FG001|Overall Study|Lack of Efficacy|1|||
49148007|NCT03620981|158382142|FG002|Overall Study|Lack of Efficacy|1|||
49148008|NCT03620981|158382140|FG000|Overall Study|Physician Decision|7|||
49148009|NCT03620981|158382141|FG001|Overall Study|Physician Decision|4|||
49148010|NCT03620981|158382142|FG002|Overall Study|Physician Decision|4|||
49148011|NCT03620981|158382140|FG000|Overall Study|Protocol Violation|1|||
49148012|NCT03620981|158382141|FG001|Overall Study|Protocol Violation|2|||
49148013|NCT03620981|158382142|FG002|Overall Study|Protocol Violation|1|||
49148014|NCT03620981|158382140|FG000|Overall Study|Withdrawal by Legal Representative|2|||
48823616|NCT01124617|157194017|FG001|Overall Study|Adverse Event|2|||
48823617|NCT01124617|157194016|FG000|Overall Study|Lack of Efficacy|2|||
48823618|NCT01124617|157194017|FG001|Overall Study|Lack of Efficacy|1|||
49013864|NCT01764854|157887201|FG003|Overall Study|Protocol Violation|2|||
49013865|NCT01466686|157887209|FG000|Overall Study|Withdrawal by Subject|1|||
49013866|NCT01759381|157887214|FG000|Overall Study|Death|1|||
49013867|NCT01759381|157887215|FG001|Overall Study|Death|0|||
49013868|NCT00633152|157887222|FG000|Overall Study|Adverse Event|1|||
49013869|NCT00633152|157887223|FG001|Overall Study|Adverse Event|0|||
49013870|NCT00633152|157887222|FG000|Overall Study|Randomized, did not receive study drug|5|||
49013871|NCT00633152|157887223|FG001|Overall Study|Randomized, did not receive study drug|2|||
49013872|NCT00633152|157887222|FG000|Overall Study|Withdrawal by Subject|1|||
49013873|NCT00633152|157887223|FG001|Overall Study|Withdrawal by Subject|1|||
49013874|NCT00633152|157887222|FG000|Overall Study|Lost to Follow-up|4|||
49013875|NCT00633152|157887223|FG001|Overall Study|Lost to Follow-up|1|||
49013876|NCT00633152|157887222|FG000|Overall Study|Miscellaneous Other|3|||
49013877|NCT00633152|157887223|FG001|Overall Study|Miscellaneous Other|2|||
49013878|NCT01907087|157887224|FG000|Overall Study|Withdrawal by Subject|1|||
49013879|NCT03273387|157887225|FG000|Overall Study|Death|2|||
49013880|NCT03273387|157887226|FG001|Overall Study|Death|2|||
49013881|NCT03273387|157887225|FG000|Overall Study|Withdrawal by Subject|1|||
49013882|NCT03273387|157887226|FG001|Overall Study|Withdrawal by Subject|1|||
49013883|NCT01244815|157887227|FG000|Overall Study|Not Treated|0|||
49013884|NCT01244815|157887228|FG001|Overall Study|Not Treated|1|||
49013885|NCT01244815|157887229|FG002|Overall Study|Not Treated|0|||
49013886|NCT01244815|157887230|FG003|Overall Study|Not Treated|0|||
49013887|NCT01244815|157887227|FG000|Overall Study|Adverse Event|4|||
49013888|NCT01244815|157887228|FG001|Overall Study|Adverse Event|7|||
49013889|NCT01244815|157887229|FG002|Overall Study|Adverse Event|5|||
49013890|NCT01244815|157887230|FG003|Overall Study|Adverse Event|5|||
49013891|NCT01244815|157887227|FG000|Overall Study|Treatment Failure|0|||
49013892|NCT01244815|157887228|FG001|Overall Study|Treatment Failure|0|||
49013893|NCT01244815|157887229|FG002|Overall Study|Treatment Failure|0|||
49013894|NCT01244815|157887230|FG003|Overall Study|Treatment Failure|1|||
49013895|NCT01244815|157887227|FG000|Overall Study|Lost to Follow-up|3|||
49013896|NCT01244815|157887228|FG001|Overall Study|Lost to Follow-up|2|||
49013897|NCT01244815|157887229|FG002|Overall Study|Lost to Follow-up|3|||
49013898|NCT01244815|157887230|FG003|Overall Study|Lost to Follow-up|2|||
49148015|NCT03620981|158382141|FG001|Overall Study|Withdrawal by Legal Representative|1|||
49148016|NCT03620981|158382142|FG002|Overall Study|Withdrawal by Legal Representative|1|||
49148017|NCT03620981|158382140|FG000|Overall Study|Withdrawal by Care Giver|2|||
48823619|NCT01124617|157194016|FG000|Overall Study|Protocol Violation|1|||
48823620|NCT01124617|157194017|FG001|Overall Study|Protocol Violation|1|||
48823621|NCT01124617|157194016|FG000|Overall Study|Withdrawal by Subject|9|||
48823622|NCT01124617|157194017|FG001|Overall Study|Withdrawal by Subject|1|||
49148018|NCT03620981|158382141|FG001|Overall Study|Withdrawal by Care Giver|0|||
49148019|NCT03620981|158382142|FG002|Overall Study|Withdrawal by Care Giver|1|||
49148020|NCT03620981|158382140|FG000|Overall Study|Non-compliance with Study Drug|1|||
49148021|NCT03620981|158382141|FG001|Overall Study|Non-compliance with Study Drug|1|||
49148022|NCT03620981|158382142|FG002|Overall Study|Non-compliance with Study Drug|0|||
49148023|NCT02899754|158382143|FG000|Overall Study|Lost to Follow-up|7|||
49148024|NCT02899754|158382144|FG001|Overall Study|Lost to Follow-up|9|||
49148025|NCT02514746|158382145|FG000|Overall Study|Chronically Ill|1|||
49148026|NCT02514746|158382146|FG001|Overall Study|Chronically Ill|2|||
49148027|NCT02514746|158382145|FG000|Overall Study|Physician Decision|4|||
49148028|NCT02514746|158382146|FG001|Overall Study|Physician Decision|2|||
48823623|NCT01124617|157194016|FG000|Overall Study|Other|2|||
48823624|NCT01124617|157194017|FG001|Overall Study|Other|1|||
48823625|NCT01653743|157194018|FG000|Overall Study|Withdrawal by Subject|1|||
48823626|NCT01653743|157194019|FG001|Overall Study|Withdrawal by Subject|0|||
48823627|NCT01653743|157194018|FG000|Overall Study|Investigator discretion|3|||
48823628|NCT01653743|157194019|FG001|Overall Study|Investigator discretion|0|||
48823629|NCT03246672|157194020|FG000|Overall Study|Lost to Follow-up|2|||
49148029|NCT02514746|158382145|FG000|Overall Study|Withdrawal by Subject|12|||
49148030|NCT02514746|158382146|FG001|Overall Study|Withdrawal by Subject|10|||
48823630|NCT00811187|157194021|FG000|Overall Study|Unable to place device / procedure abort|3|||
48823631|NCT00811187|157194022|FG001|Overall Study|Unable to place device / procedure abort|3|||
48823632|NCT00329303|157194023|FG000|Overall Study|Lack of Efficacy|1|||
49148031|NCT02514746|158382145|FG000|Overall Study|Other|5|||
48823633|NCT00329303|157194024|FG001|Overall Study|Lack of Efficacy|0|||
48823634|NCT00329303|157194023|FG000|Overall Study|Decision of the sponsor|0|||
48823635|NCT00329303|157194024|FG001|Overall Study|Decision of the sponsor|1|||
48823636|NCT00329303|157194023|FG000|Overall Study|Patient no longer available|1|||
48823637|NCT00329303|157194024|FG001|Overall Study|Patient no longer available|0|||
48823638|NCT00329303|157194023|FG000|Overall Study|Patient relocated|0|||
48823639|NCT00329303|157194024|FG001|Overall Study|Patient relocated|1|||
48823640|NCT03697460|157194026|FG000|Overall Study|Withdrawal by Subject|3|||
48823641|NCT01559090|157194027|FG000|Stage I|Withdrawal by Subject|2|||
48823642|NCT01559090|157194028|FG001|Stage I|Withdrawal by Subject|2|||
48823643|NCT01559090|157194029|FG002|Stage I|Withdrawal by Subject|3|||
48823644|NCT01559090|157194027|FG000|Stage II|Withdrawal by Subject|1|||
48823645|NCT01559090|157194028|FG001|Stage II|Withdrawal by Subject|0|||
48823646|NCT01559090|157194029|FG002|Stage II|Withdrawal by Subject|0|||
48823647|NCT00062868|157194030|FG000|Dose Level 1|Death|2|||
48823648|NCT00062868|157194031|FG001|Dose Level 1|Death|0|||
48823649|NCT00062868|157194032|FG002|Dose Level 1|Death|0|||
48823650|NCT00062868|157194033|FG003|Dose Level 1|Death|2|||
48823651|NCT00062868|157194034|FG004|Dose Level 1|Death|0|||
48823652|NCT00062868|157194035|FG005|Dose Level 1|Death|0|||
48823653|NCT00062868|157194036|FG006|Dose Level 1|Death|3|||
48823654|NCT00062868|157194037|FG007|Dose Level 1|Death|0|||
48823655|NCT00062868|157194038|FG008|Dose Level 1|Death|0|||
48823656|NCT00062868|157194039|FG009|Dose Level 1|Death|0|||
48823657|NCT00062868|157194040|FG010|Dose Level 1|Death|0|||
48823658|NCT00062868|157194041|FG011|Dose Level 1|Death|0|||
49148032|NCT02514746|158382146|FG001|Overall Study|Other|1|||
49148033|NCT03633058|158382149|FG000|Overall Study|Adverse Event|0|||
49148034|NCT03633058|158382150|FG001|Overall Study|Adverse Event|0|||
49148035|NCT03633058|158382151|FG002|Overall Study|Adverse Event|1|||
49148036|NCT03633058|158382152|FG003|Overall Study|Adverse Event|0|||
49148037|NCT04551053|158382156|FG000|Overall Study|Death|9|||
49148038|NCT04551053|158382157|FG001|Overall Study|Death|9|||
49148039|NCT04551053|158382156|FG000|Overall Study|Lost to Follow-up|0|||
49148040|NCT04551053|158382157|FG001|Overall Study|Lost to Follow-up|2|||
49148041|NCT04551053|158382156|FG000|Overall Study|Study Terminated by Sponsor|53|||
49148042|NCT04551053|158382157|FG001|Overall Study|Study Terminated by Sponsor|63|||
48823659|NCT00062868|157194042|FG012|Dose Level 1|Death|0|||
48823660|NCT00062868|157194043|FG013|Dose Level 1|Death|0|||
48823661|NCT00062868|157194044|FG014|Dose Level 1|Death|0|||
48823662|NCT00062868|157194045|FG015|Dose Level 1|Death|0|||
48823663|NCT00062868|157194046|FG016|Dose Level 1|Death|0|||
48823664|NCT00062868|157194047|FG017|Dose Level 1|Death|0|||
48823665|NCT00062868|157194048|FG018|Dose Level 1|Death|7|||
48823666|NCT00062868|157194049|FG019|Dose Level 1|Death|0|||
49148043|NCT04551053|158382156|FG000|Overall Study|Withdrawal by Subject|12|||
49148044|NCT04551053|158382157|FG001|Overall Study|Withdrawal by Subject|5|||
48823667|NCT00062868|157194050|FG020|Dose Level 1|Death|1|||
48823668|NCT00062868|157194030|FG000|Dose Level 1|Lost to Follow-up|0|||
49148045|NCT04551053|158382156|FG000|Overall Study|Adverse Event|1|||
49148046|NCT04551053|158382157|FG001|Overall Study|Adverse Event|0|||
49148047|NCT04551053|158382156|FG000|Overall Study|Lack of Efficacy|2|||
49148048|NCT04551053|158382157|FG001|Overall Study|Lack of Efficacy|0|||
48823669|NCT00062868|157194031|FG001|Dose Level 1|Lost to Follow-up|0|||
48823670|NCT00062868|157194032|FG002|Dose Level 1|Lost to Follow-up|0|||
48823671|NCT00062868|157194033|FG003|Dose Level 1|Lost to Follow-up|0|||
48823672|NCT00062868|157194034|FG004|Dose Level 1|Lost to Follow-up|0|||
48823673|NCT00062868|157194035|FG005|Dose Level 1|Lost to Follow-up|0|||
48823674|NCT00062868|157194036|FG006|Dose Level 1|Lost to Follow-up|0|||
48823675|NCT00062868|157194037|FG007|Dose Level 1|Lost to Follow-up|0|||
48823676|NCT00062868|157194038|FG008|Dose Level 1|Lost to Follow-up|0|||
48823677|NCT00062868|157194039|FG009|Dose Level 1|Lost to Follow-up|0|||
48823678|NCT00062868|157194040|FG010|Dose Level 1|Lost to Follow-up|0|||
49148049|NCT04551053|158382156|FG000|Overall Study|Transitioned to Rollover per Protocol|5|||
49148050|NCT04551053|158382157|FG001|Overall Study|Transitioned to Rollover per Protocol|3|||
49148051|NCT04551053|158382156|FG000|Overall Study|Splenapendectomi|1|||
49148052|NCT04551053|158382157|FG001|Overall Study|Splenapendectomi|0|||
49148053|NCT04551053|158382156|FG000|Overall Study|Cytomegalovirus pneumonia|1|||
49148054|NCT04551053|158382157|FG001|Overall Study|Cytomegalovirus pneumonia|0|||
49148055|NCT04551053|158382156|FG000|Overall Study|Medical Decision|0|||
49148056|NCT04551053|158382157|FG001|Overall Study|Medical Decision|1|||
49148057|NCT04551053|158382156|FG000|Overall Study|Ongoing|6|||
49148058|NCT04551053|158382157|FG001|Overall Study|Ongoing|4|||
49148059|NCT03301415|158382162|FG000|Overall Study|Lost to Follow-up|2|||
49148060|NCT03301415|158382162|FG000|Overall Study|Unable to comply with visit schedule|2|||
49148061|NCT02489045|158382165|FG000|Overall Study|unable to collect usable data|53|||
49148062|NCT02489045|158382165|FG000|Follow-up|Lost to Follow-up|10|||
49148063|NCT01887600|158382170|FG000|Overall Study|Death|39|||
48823679|NCT00062868|157194041|FG011|Dose Level 1|Lost to Follow-up|0|||
48823680|NCT00062868|157194042|FG012|Dose Level 1|Lost to Follow-up|1|||
48823681|NCT00062868|157194043|FG013|Dose Level 1|Lost to Follow-up|0|||
48823682|NCT00062868|157194044|FG014|Dose Level 1|Lost to Follow-up|0|||
48823683|NCT00062868|157194045|FG015|Dose Level 1|Lost to Follow-up|0|||
48823684|NCT00062868|157194046|FG016|Dose Level 1|Lost to Follow-up|0|||
48823685|NCT00062868|157194047|FG017|Dose Level 1|Lost to Follow-up|0|||
48823686|NCT00062868|157194048|FG018|Dose Level 1|Lost to Follow-up|2|||
48823687|NCT00062868|157194049|FG019|Dose Level 1|Lost to Follow-up|0|||
48823688|NCT00062868|157194050|FG020|Dose Level 1|Lost to Follow-up|1|||
48823689|NCT00062868|157194030|FG000|Dose Level 2|Death|0|||
48823690|NCT00062868|157194031|FG001|Dose Level 2|Death|3|||
48823691|NCT00062868|157194032|FG002|Dose Level 2|Death|0|||
48823692|NCT00062868|157194033|FG003|Dose Level 2|Death|0|||
48823693|NCT00062868|157194034|FG004|Dose Level 2|Death|2|||
48823694|NCT00062868|157194035|FG005|Dose Level 2|Death|0|||
48823695|NCT00062868|157194036|FG006|Dose Level 2|Death|0|||
48823696|NCT00062868|157194037|FG007|Dose Level 2|Death|0|||
48823697|NCT00062868|157194038|FG008|Dose Level 2|Death|0|||
48823698|NCT00062868|157194039|FG009|Dose Level 2|Death|0|||
48823699|NCT00062868|157194040|FG010|Dose Level 2|Death|1|||
48823700|NCT00062868|157194041|FG011|Dose Level 2|Death|0|||
48823701|NCT00062868|157194042|FG012|Dose Level 2|Death|0|||
48823702|NCT00062868|157194043|FG013|Dose Level 2|Death|0|||
48823703|NCT00062868|157194044|FG014|Dose Level 2|Death|0|||
49148064|NCT01887600|158382171|FG001|Overall Study|Death|16|||
49148065|NCT01887600|158382170|FG000|Overall Study|Lack of Efficacy|3|||
49148066|NCT01887600|158382171|FG001|Overall Study|Lack of Efficacy|26|||
49148067|NCT01887600|158382170|FG000|Overall Study|Lost to Follow-up|5|||
49148068|NCT01887600|158382171|FG001|Overall Study|Lost to Follow-up|1|||
49148069|NCT01887600|158382170|FG000|Overall Study|Physician Decision|7|||
48823704|NCT00062868|157194045|FG015|Dose Level 2|Death|0|||
48823705|NCT00062868|157194046|FG016|Dose Level 2|Death|2|||
48823706|NCT00062868|157194047|FG017|Dose Level 2|Death|0|||
48823707|NCT00062868|157194048|FG018|Dose Level 2|Death|0|||
48823708|NCT00062868|157194049|FG019|Dose Level 2|Death|0|||
48823709|NCT00062868|157194050|FG020|Dose Level 2|Death|0|||
48823710|NCT00062868|157194030|FG000|Dose Level 2|Lost to Follow-up|0|||
49148070|NCT01887600|158382171|FG001|Overall Study|Physician Decision|8|||
49148071|NCT01887600|158382170|FG000|Overall Study|Protocol Deviation|3|||
48823711|NCT00062868|157194031|FG001|Dose Level 2|Lost to Follow-up|0|||
48823712|NCT00062868|157194032|FG002|Dose Level 2|Lost to Follow-up|0|||
48823713|NCT00062868|157194033|FG003|Dose Level 2|Lost to Follow-up|0|||
48823714|NCT00062868|157194034|FG004|Dose Level 2|Lost to Follow-up|0|||
48823715|NCT00062868|157194035|FG005|Dose Level 2|Lost to Follow-up|0|||
48823716|NCT00062868|157194036|FG006|Dose Level 2|Lost to Follow-up|0|||
48823717|NCT00062868|157194037|FG007|Dose Level 2|Lost to Follow-up|0|||
48823718|NCT00062868|157194038|FG008|Dose Level 2|Lost to Follow-up|0|||
48823719|NCT00062868|157194039|FG009|Dose Level 2|Lost to Follow-up|0|||
48823720|NCT00062868|157194040|FG010|Dose Level 2|Lost to Follow-up|0|||
48823721|NCT00062868|157194041|FG011|Dose Level 2|Lost to Follow-up|0|||
48823722|NCT00062868|157194042|FG012|Dose Level 2|Lost to Follow-up|0|||
48823723|NCT00062868|157194043|FG013|Dose Level 2|Lost to Follow-up|1|||
49148072|NCT01887600|158382171|FG001|Overall Study|Protocol Deviation|0|||
49148073|NCT01887600|158382170|FG000|Overall Study|Withdrawal by Subject|58|||
49148074|NCT01887600|158382171|FG001|Overall Study|Withdrawal by Subject|52|||
49148075|NCT01887600|158382170|FG000|Overall Study|Adverse Event|21|||
48823724|NCT00062868|157194044|FG014|Dose Level 2|Lost to Follow-up|0|||
48823725|NCT00062868|157194045|FG015|Dose Level 2|Lost to Follow-up|0|||
48823726|NCT00062868|157194046|FG016|Dose Level 2|Lost to Follow-up|1|||
48823727|NCT00062868|157194047|FG017|Dose Level 2|Lost to Follow-up|0|||
48823728|NCT00062868|157194048|FG018|Dose Level 2|Lost to Follow-up|0|||
48823729|NCT00062868|157194049|FG019|Dose Level 2|Lost to Follow-up|0|||
48823730|NCT00062868|157194050|FG020|Dose Level 2|Lost to Follow-up|0|||
48823731|NCT00062868|157194030|FG000|Dose Level 3|Death|0|||
48823732|NCT00062868|157194031|FG001|Dose Level 3|Death|0|||
48823733|NCT00062868|157194032|FG002|Dose Level 3|Death|0|||
48823734|NCT00062868|157194033|FG003|Dose Level 3|Death|0|||
48823735|NCT00062868|157194034|FG004|Dose Level 3|Death|0|||
48823736|NCT00062868|157194035|FG005|Dose Level 3|Death|0|||
48823737|NCT00062868|157194036|FG006|Dose Level 3|Death|0|||
48823738|NCT00062868|157194037|FG007|Dose Level 3|Death|0|||
48823739|NCT00062868|157194038|FG008|Dose Level 3|Death|0|||
48823740|NCT00062868|157194039|FG009|Dose Level 3|Death|0|||
48823741|NCT00062868|157194040|FG010|Dose Level 3|Death|0|||
48823742|NCT00062868|157194041|FG011|Dose Level 3|Death|1|||
48823743|NCT00062868|157194042|FG012|Dose Level 3|Death|0|||
48823744|NCT00062868|157194043|FG013|Dose Level 3|Death|0|||
48823745|NCT00062868|157194044|FG014|Dose Level 3|Death|0|||
48823746|NCT00062868|157194045|FG015|Dose Level 3|Death|0|||
48823747|NCT00062868|157194046|FG016|Dose Level 3|Death|0|||
48823748|NCT00062868|157194047|FG017|Dose Level 3|Death|1|||
48823749|NCT00062868|157194048|FG018|Dose Level 3|Death|0|||
49148076|NCT01887600|158382171|FG001|Overall Study|Adverse Event|9|||
49148077|NCT01887600|158382170|FG000|Overall Study|Non-compliance with study drug|3|||
49148078|NCT01887600|158382171|FG001|Overall Study|Non-compliance with study drug|0|||
49148079|NCT01887600|158382170|FG000|Overall Study|Miscellaneous|6|||
49148080|NCT01887600|158382171|FG001|Overall Study|Miscellaneous|2|||
49148081|NCT01887600|158382170|FG000|Overall Study|Progressive Disease|1|||
49148082|NCT01887600|158382171|FG001|Overall Study|Progressive Disease|0|||
49148083|NCT00420056|158382172|FG000|Overall Study|Objective progression or relapse|17|||
49148084|NCT02184442|158382178|FG000|Overall Study|Death|61|||
49148085|NCT02184442|158382179|FG001|Overall Study|Death|65|||
49148086|NCT02184442|158382178|FG000|Overall Study|Withdrawal by Subject|3|||
49148087|NCT02184442|158382179|FG001|Overall Study|Withdrawal by Subject|11|||
49148088|NCT00421408|158382180|FG000|Overall Study|Lost to Follow-up|30|||
49148089|NCT00421408|158382181|FG001|Overall Study|Lost to Follow-up|20|||
49148090|NCT00421408|158382180|FG000|Overall Study|Discountinued from treatment/ f/u cont.|12|||
49148091|NCT00421408|158382181|FG001|Overall Study|Discountinued from treatment/ f/u cont.|25|||
49148092|NCT04309500|158382184|FG000|Overall Study|Lost to Follow-up|1|||
49148093|NCT04309500|158382185|FG001|Overall Study|Lost to Follow-up|0|||
49148094|NCT04309500|158382186|FG002|Overall Study|Lost to Follow-up|0|||
49148095|NCT04309500|158382187|FG003|Overall Study|Lost to Follow-up|0|||
49148096|NCT00637156|158382188|FG000|Overall Study|Withdrawal by Subject|0|||
49148097|NCT00637156|158382189|FG001|Overall Study|Withdrawal by Subject|7|||
49148098|NCT00637156|158382188|FG000|Overall Study|Death|0|||
49148099|NCT00637156|158382189|FG001|Overall Study|Death|1|||
49148100|NCT00637156|158382188|FG000|Overall Study|Lost to Follow-up|10|||
49148101|NCT00637156|158382189|FG001|Overall Study|Lost to Follow-up|16|||
49148102|NCT03193437|158382190|FG000|Overall Study|Adverse Event|4|||
49148103|NCT03193437|158382190|FG000|Overall Study|Withdrawal by Subject|2|||
49148104|NCT03193437|158382190|FG000|Overall Study|Disease Progression|2|||
48823750|NCT00062868|157194049|FG019|Dose Level 3|Death|0|||
48823751|NCT00062868|157194050|FG020|Dose Level 3|Death|0|||
48823752|NCT00062868|157194030|FG000|Dose Level 3|Lost to Follow-up|0|||
48823753|NCT00062868|157194031|FG001|Dose Level 3|Lost to Follow-up|0|||
48823754|NCT00062868|157194032|FG002|Dose Level 3|Lost to Follow-up|0|||
49148105|NCT00561821|158382193|FG000|Overall Study|Not treated|0|||
48823755|NCT00062868|157194033|FG003|Dose Level 3|Lost to Follow-up|0|||
48823756|NCT00062868|157194034|FG004|Dose Level 3|Lost to Follow-up|0|||
48823757|NCT00062868|157194035|FG005|Dose Level 3|Lost to Follow-up|0|||
49148106|NCT00561821|158382194|FG001|Overall Study|Not treated|0|||
48823758|NCT00062868|157194036|FG006|Dose Level 3|Lost to Follow-up|0|||
48823759|NCT00062868|157194037|FG007|Dose Level 3|Lost to Follow-up|0|||
49148107|NCT00561821|158382195|FG002|Overall Study|Not treated|1|||
48823760|NCT00062868|157194038|FG008|Dose Level 3|Lost to Follow-up|0|||
48823761|NCT00062868|157194039|FG009|Dose Level 3|Lost to Follow-up|0|||
48823762|NCT00062868|157194040|FG010|Dose Level 3|Lost to Follow-up|0|||
48823763|NCT00062868|157194041|FG011|Dose Level 3|Lost to Follow-up|0|||
48823764|NCT00062868|157194042|FG012|Dose Level 3|Lost to Follow-up|0|||
48823765|NCT00062868|157194043|FG013|Dose Level 3|Lost to Follow-up|0|||
48823766|NCT00062868|157194044|FG014|Dose Level 3|Lost to Follow-up|1|||
48823767|NCT00062868|157194045|FG015|Dose Level 3|Lost to Follow-up|0|||
49148108|NCT00561821|158382196|FG003|Overall Study|Not treated|0|||
49148109|NCT00561821|158382193|FG000|Overall Study|Withdrawal by Subject|0|||
49148110|NCT00561821|158382194|FG001|Overall Study|Withdrawal by Subject|1|||
49148111|NCT00561821|158382195|FG002|Overall Study|Withdrawal by Subject|0|||
49148112|NCT00561821|158382196|FG003|Overall Study|Withdrawal by Subject|2|||
49148113|NCT00561821|158382193|FG000|Overall Study|Reasons not related to trial|2|||
49148114|NCT00561821|158382194|FG001|Overall Study|Reasons not related to trial|1|||
49148115|NCT00561821|158382195|FG002|Overall Study|Reasons not related to trial|0|||
49148116|NCT00561821|158382196|FG003|Overall Study|Reasons not related to trial|0|||
49148117|NCT00561821|158382193|FG000|Overall Study|Other (reason not specified)|1|||
49148118|NCT00561821|158382194|FG001|Overall Study|Other (reason not specified)|1|||
49148119|NCT00561821|158382195|FG002|Overall Study|Other (reason not specified)|0|||
49148120|NCT00561821|158382196|FG003|Overall Study|Other (reason not specified)|0|||
49148121|NCT00561821|158382193|FG000|Overall Study|Adverse Event|2|||
49148122|NCT00561821|158382194|FG001|Overall Study|Adverse Event|3|||
49148123|NCT00561821|158382195|FG002|Overall Study|Adverse Event|1|||
49148124|NCT00561821|158382196|FG003|Overall Study|Adverse Event|1|||
48823768|NCT00062868|157194046|FG016|Dose Level 3|Lost to Follow-up|0|||
49148125|NCT03648372|158382197|FG000|Overall Study|Withdrawal by Subject|2|||
49148126|NCT03648372|158382198|FG001|Overall Study|Withdrawal by Subject|0|||
49148127|NCT03648372|158382199|FG002|Overall Study|Withdrawal by Subject|0|||
49148128|NCT03648372|158382200|FG003|Overall Study|Withdrawal by Subject|0|||
49148129|NCT03648372|158382201|FG004|Overall Study|Withdrawal by Subject|0|||
49148130|NCT03648372|158382202|FG005|Overall Study|Withdrawal by Subject|1|||
49148131|NCT03648372|158382203|FG006|Overall Study|Withdrawal by Subject|2|||
49148132|NCT03648372|158382204|FG007|Overall Study|Withdrawal by Subject|0|||
49148133|NCT03648372|158382205|FG008|Overall Study|Withdrawal by Subject|0|||
49148134|NCT03648372|158382206|FG009|Overall Study|Withdrawal by Subject|0|||
49148135|NCT03648372|158382207|FG010|Overall Study|Withdrawal by Subject|2|||
49148136|NCT03648372|158382208|FG011|Overall Study|Withdrawal by Subject|0|||
48823769|NCT00062868|157194047|FG017|Dose Level 3|Lost to Follow-up|0|||
48823770|NCT00062868|157194048|FG018|Dose Level 3|Lost to Follow-up|0|||
48823771|NCT00062868|157194049|FG019|Dose Level 3|Lost to Follow-up|0|||
48823772|NCT00062868|157194050|FG020|Dose Level 3|Lost to Follow-up|0|||
48823773|NCT00062868|157194030|FG000|Dose Level 3|Withdrew|0|||
48823774|NCT00062868|157194031|FG001|Dose Level 3|Withdrew|0|||
48823775|NCT00062868|157194032|FG002|Dose Level 3|Withdrew|2|||
48823776|NCT00062868|157194033|FG003|Dose Level 3|Withdrew|0|||
48823777|NCT00062868|157194034|FG004|Dose Level 3|Withdrew|0|||
48823778|NCT00062868|157194035|FG005|Dose Level 3|Withdrew|0|||
48823779|NCT00062868|157194036|FG006|Dose Level 3|Withdrew|0|||
48823780|NCT00062868|157194037|FG007|Dose Level 3|Withdrew|0|||
48823781|NCT00062868|157194038|FG008|Dose Level 3|Withdrew|0|||
48823782|NCT00062868|157194039|FG009|Dose Level 3|Withdrew|0|||
48823783|NCT00062868|157194040|FG010|Dose Level 3|Withdrew|0|||
48823784|NCT00062868|157194041|FG011|Dose Level 3|Withdrew|0|||
48823785|NCT00062868|157194042|FG012|Dose Level 3|Withdrew|0|||
48823786|NCT00062868|157194043|FG013|Dose Level 3|Withdrew|0|||
48823787|NCT00062868|157194044|FG014|Dose Level 3|Withdrew|0|||
48823788|NCT00062868|157194045|FG015|Dose Level 3|Withdrew|0|||
48823789|NCT00062868|157194046|FG016|Dose Level 3|Withdrew|0|||
48823790|NCT00062868|157194047|FG017|Dose Level 3|Withdrew|0|||
48823791|NCT00062868|157194048|FG018|Dose Level 3|Withdrew|0|||
48823792|NCT00062868|157194049|FG019|Dose Level 3|Withdrew|0|||
49013899|NCT01244815|157887227|FG000|Overall Study|Withdrawal by Subject|0|||
49148137|NCT03648372|158382209|FG012|Overall Study|Withdrawal by Subject|2|||
49148138|NCT03648372|158382210|FG013|Overall Study|Withdrawal by Subject|0|||
49148139|NCT03648372|158382211|FG014|Overall Study|Withdrawal by Subject|0|||
49148140|NCT03648372|158382212|FG015|Overall Study|Withdrawal by Subject|0|||
49148141|NCT03648372|158382213|FG016|Overall Study|Withdrawal by Subject|1|||
49148142|NCT03648372|158382214|FG017|Overall Study|Withdrawal by Subject|0|||
49148143|NCT03648372|158382215|FG018|Overall Study|Withdrawal by Subject|0|||
49148144|NCT03648372|158382216|FG019|Overall Study|Withdrawal by Subject|0|||
49148145|NCT03648372|158382217|FG020|Overall Study|Withdrawal by Subject|0|||
49148146|NCT03648372|158382197|FG000|Overall Study|Progressive Disease|2|||
49148147|NCT03648372|158382198|FG001|Overall Study|Progressive Disease|3|||
49148148|NCT03648372|158382199|FG002|Overall Study|Progressive Disease|4|||
49148149|NCT03648372|158382200|FG003|Overall Study|Progressive Disease|3|||
49148150|NCT03648372|158382201|FG004|Overall Study|Progressive Disease|2|||
49148151|NCT03648372|158382202|FG005|Overall Study|Progressive Disease|2|||
48823793|NCT00062868|157194050|FG020|Dose Level 3|Withdrew|0|||
48823794|NCT01101542|157194054|FG000|Year 3 Surveillance Period|Lost to Follow-up|7|||
48823795|NCT01101542|157194054|FG000|Year 3 Surveillance Period|Withdrawal by Subject|4|||
48823796|NCT01101542|157194054|FG000|Year 4 Surveillance Period|Other|287|||
49148152|NCT03648372|158382203|FG006|Overall Study|Progressive Disease|3|||
49148153|NCT03648372|158382204|FG007|Overall Study|Progressive Disease|3|||
49148154|NCT03648372|158382205|FG008|Overall Study|Progressive Disease|5|||
49148155|NCT03648372|158382206|FG009|Overall Study|Progressive Disease|5|||
49148156|NCT03648372|158382207|FG010|Overall Study|Progressive Disease|2|||
49148157|NCT03648372|158382208|FG011|Overall Study|Progressive Disease|3|||
48823797|NCT01101542|157194054|FG000|Year 5 Surveillance Period|Lost to Follow-up|140|||
48823798|NCT01101542|157194054|FG000|Year 5 Surveillance Period|Pregnancy|1|||
49148158|NCT03648372|158382209|FG012|Overall Study|Progressive Disease|3|||
49148159|NCT03648372|158382210|FG013|Overall Study|Progressive Disease|3|||
49148160|NCT03648372|158382211|FG014|Overall Study|Progressive Disease|6|||
49148161|NCT03648372|158382212|FG015|Overall Study|Progressive Disease|0|||
49148162|NCT03648372|158382213|FG016|Overall Study|Progressive Disease|0|||
49148163|NCT03648372|158382214|FG017|Overall Study|Progressive Disease|0|||
49148164|NCT03648372|158382215|FG018|Overall Study|Progressive Disease|0|||
49148165|NCT03648372|158382216|FG019|Overall Study|Progressive Disease|0|||
49148166|NCT03648372|158382217|FG020|Overall Study|Progressive Disease|0|||
49148167|NCT03648372|158382197|FG000|Overall Study|Other|0|||
49148168|NCT03648372|158382198|FG001|Overall Study|Other|0|||
49148169|NCT03648372|158382199|FG002|Overall Study|Other|0|||
49148170|NCT03648372|158382200|FG003|Overall Study|Other|0|||
49148171|NCT03648372|158382201|FG004|Overall Study|Other|1|||
49148172|NCT03648372|158382202|FG005|Overall Study|Other|0|||
49148173|NCT03648372|158382203|FG006|Overall Study|Other|0|||
49148174|NCT03648372|158382204|FG007|Overall Study|Other|0|||
49148175|NCT03648372|158382205|FG008|Overall Study|Other|0|||
49148176|NCT03648372|158382206|FG009|Overall Study|Other|0|||
49148177|NCT03648372|158382207|FG010|Overall Study|Other|1|||
49148178|NCT03648372|158382208|FG011|Overall Study|Other|2|||
49148179|NCT03648372|158382209|FG012|Overall Study|Other|1|||
49148180|NCT03648372|158382210|FG013|Overall Study|Other|3|||
49148181|NCT03648372|158382211|FG014|Overall Study|Other|0|||
49148182|NCT03648372|158382212|FG015|Overall Study|Other|5|||
49148183|NCT03648372|158382213|FG016|Overall Study|Other|1|||
49148184|NCT03648372|158382214|FG017|Overall Study|Other|5|||
49148185|NCT03648372|158382215|FG018|Overall Study|Other|0|||
49148186|NCT03648372|158382216|FG019|Overall Study|Other|1|||
49148187|NCT03648372|158382217|FG020|Overall Study|Other|0|||
49148188|NCT03648372|158382197|FG000|Overall Study|Lost to Follow-up|0|||
49148189|NCT03648372|158382198|FG001|Overall Study|Lost to Follow-up|0|||
49148190|NCT03648372|158382199|FG002|Overall Study|Lost to Follow-up|0|||
49148191|NCT03648372|158382200|FG003|Overall Study|Lost to Follow-up|0|||
49148192|NCT03648372|158382201|FG004|Overall Study|Lost to Follow-up|0|||
49148193|NCT03648372|158382202|FG005|Overall Study|Lost to Follow-up|0|||
49148194|NCT03648372|158382203|FG006|Overall Study|Lost to Follow-up|0|||
49148195|NCT03648372|158382204|FG007|Overall Study|Lost to Follow-up|0|||
49148196|NCT03648372|158382205|FG008|Overall Study|Lost to Follow-up|0|||
49148197|NCT03648372|158382206|FG009|Overall Study|Lost to Follow-up|0|||
49148198|NCT03648372|158382207|FG010|Overall Study|Lost to Follow-up|0|||
49148199|NCT03648372|158382208|FG011|Overall Study|Lost to Follow-up|0|||
49148200|NCT03648372|158382209|FG012|Overall Study|Lost to Follow-up|0|||
49148201|NCT03648372|158382210|FG013|Overall Study|Lost to Follow-up|1|||
49148202|NCT03648372|158382211|FG014|Overall Study|Lost to Follow-up|0|||
49148203|NCT03648372|158382212|FG015|Overall Study|Lost to Follow-up|1|||
49148204|NCT03648372|158382213|FG016|Overall Study|Lost to Follow-up|0|||
49148205|NCT03648372|158382214|FG017|Overall Study|Lost to Follow-up|1|||
49148206|NCT03648372|158382215|FG018|Overall Study|Lost to Follow-up|0|||
48730758|NCT03611010|156865886|FG001|Period 2: 15 Day Treatment|Inaccessible veins|0|||
48730759|NCT03611010|156865887|FG002|Period 2: 15 Day Treatment|Inaccessible veins|0|||
48730760|NCT03611010|156865888|FG003|Period 2: 15 Day Treatment|Inaccessible veins|0|||
48730761|NCT02063880|156865891|FG000|Overall Study|Death|21|||
49013900|NCT01244815|157887228|FG001|Overall Study|Withdrawal by Subject|2|||
49013901|NCT01244815|157887229|FG002|Overall Study|Withdrawal by Subject|0|||
49013902|NCT01244815|157887230|FG003|Overall Study|Withdrawal by Subject|3|||
49013903|NCT01244815|157887227|FG000|Overall Study|Protocol Violation|7|||
49013904|NCT01244815|157887228|FG001|Overall Study|Protocol Violation|4|||
49013905|NCT01244815|157887229|FG002|Overall Study|Protocol Violation|3|||
48730762|NCT02063880|156865892|FG001|Overall Study|Death|18|||
48730763|NCT02063880|156865891|FG000|Overall Study|Lost to Follow-up|7|||
48730764|NCT02063880|156865892|FG001|Overall Study|Lost to Follow-up|7|||
48730765|NCT02063880|156865891|FG000|Overall Study|Ineligible|0|||
49013906|NCT01244815|157887230|FG003|Overall Study|Protocol Violation|1|||
49013907|NCT01244815|157887227|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
49013908|NCT01244815|157887228|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
49013909|NCT01244815|157887229|FG002|Overall Study|Did Not Meet Protocol Eligibility|0|||
48730766|NCT02063880|156865892|FG001|Overall Study|Ineligible|2|||
48730767|NCT00567593|156865893|FG000|Overall Study|Adverse Event|1|||
49013910|NCT01244815|157887230|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
49013911|NCT02049359|157887231|FG000|Overall Study|Lost to Follow-up|26|||
49013912|NCT02049359|157887232|FG001|Overall Study|Lost to Follow-up|19|||
49148207|NCT03648372|158382216|FG019|Overall Study|Lost to Follow-up|0|||
49148208|NCT03648372|158382217|FG020|Overall Study|Lost to Follow-up|0|||
49148209|NCT03648372|158382197|FG000|Overall Study|Start of a New Systemic Treatment|0|||
49148210|NCT03648372|158382198|FG001|Overall Study|Start of a New Systemic Treatment|0|||
49148211|NCT03648372|158382199|FG002|Overall Study|Start of a New Systemic Treatment|0|||
49148212|NCT03648372|158382200|FG003|Overall Study|Start of a New Systemic Treatment|0|||
49148213|NCT03648372|158382201|FG004|Overall Study|Start of a New Systemic Treatment|0|||
49148214|NCT03648372|158382202|FG005|Overall Study|Start of a New Systemic Treatment|0|||
49148215|NCT03648372|158382203|FG006|Overall Study|Start of a New Systemic Treatment|0|||
49148216|NCT03648372|158382204|FG007|Overall Study|Start of a New Systemic Treatment|2|||
48730768|NCT00567593|156865893|FG000|Overall Study|Physician Decision|1|||
48730769|NCT02476422|156865895|FG000|Overall Study|Subject/guardian decision|0|||
48730770|NCT02476422|156865896|FG001|Overall Study|Subject/guardian decision|1|||
48730771|NCT01859143|156865897|FG000|Overall Study|Lost to Follow-up|2|||
48730772|NCT01859143|156865898|FG001|Overall Study|Lost to Follow-up|0|||
48730773|NCT01241240|156865899|FG000|Overall Study|Adverse Event|5|||
48730774|NCT01241240|156865900|FG001|Overall Study|Adverse Event|4|||
48730775|NCT01241240|156865899|FG000|Overall Study|Lost to Follow-up|2|||
48730776|NCT01241240|156865900|FG001|Overall Study|Lost to Follow-up|4|||
48730777|NCT01241240|156865899|FG000|Overall Study|Personal Reasons|1|||
48730778|NCT01241240|156865900|FG001|Overall Study|Personal Reasons|1|||
48730779|NCT00760214|156865901|FG000|Overall Study|Adverse Event|8|||
48730780|NCT00760214|156865902|FG001|Overall Study|Adverse Event|9|||
48730781|NCT00760214|156865903|FG002|Overall Study|Adverse Event|12|||
48730782|NCT00760214|156865901|FG000|Overall Study|Protocol Violation|3|||
48730783|NCT00760214|156865902|FG001|Overall Study|Protocol Violation|0|||
49148217|NCT03648372|158382205|FG008|Overall Study|Start of a New Systemic Treatment|0|||
49148218|NCT03648372|158382206|FG009|Overall Study|Start of a New Systemic Treatment|0|||
49148219|NCT03648372|158382207|FG010|Overall Study|Start of a New Systemic Treatment|1|||
49148220|NCT03648372|158382208|FG011|Overall Study|Start of a New Systemic Treatment|0|||
49148221|NCT03648372|158382209|FG012|Overall Study|Start of a New Systemic Treatment|0|||
49013913|NCT03377556|157887235|FG000|Overall Study|Adverse Event|5|||
49013914|NCT03377556|157887235|FG000|Overall Study|Refusal unrelated to adverse events|1|||
49148222|NCT03648372|158382210|FG013|Overall Study|Start of a New Systemic Treatment|0|||
49148223|NCT03648372|158382211|FG014|Overall Study|Start of a New Systemic Treatment|0|||
49148224|NCT03648372|158382212|FG015|Overall Study|Start of a New Systemic Treatment|0|||
49148225|NCT03648372|158382213|FG016|Overall Study|Start of a New Systemic Treatment|0|||
49148226|NCT03648372|158382214|FG017|Overall Study|Start of a New Systemic Treatment|0|||
49148227|NCT03648372|158382215|FG018|Overall Study|Start of a New Systemic Treatment|0|||
49148228|NCT03648372|158382216|FG019|Overall Study|Start of a New Systemic Treatment|0|||
48730784|NCT00760214|156865903|FG002|Overall Study|Protocol Violation|3|||
48730785|NCT00760214|156865901|FG000|Overall Study|Lost to Follow-up|0|||
48730786|NCT00760214|156865902|FG001|Overall Study|Lost to Follow-up|0|||
48730787|NCT00760214|156865903|FG002|Overall Study|Lost to Follow-up|1|||
48730788|NCT00760214|156865901|FG000|Overall Study|Withdrawal by Subject|12|||
48730789|NCT00760214|156865902|FG001|Overall Study|Withdrawal by Subject|14|||
48730790|NCT00760214|156865903|FG002|Overall Study|Withdrawal by Subject|13|||
48730791|NCT00760214|156865901|FG000|Overall Study|Lack of Efficacy|3|||
49148229|NCT03648372|158382217|FG020|Overall Study|Start of a New Systemic Treatment|0|||
49148230|NCT01197300|158383328|FG000|Overall Study|Lost to Follow-up|0|||
48730792|NCT00760214|156865902|FG001|Overall Study|Lack of Efficacy|2|||
48730793|NCT00760214|156865903|FG002|Overall Study|Lack of Efficacy|4|||
48730794|NCT00760214|156865901|FG000|Overall Study|Pregnancy|0|||
48730795|NCT00760214|156865902|FG001|Overall Study|Pregnancy|0|||
49148231|NCT01197300|158383329|FG001|Overall Study|Lost to Follow-up|1|||
49148232|NCT01197300|158383328|FG000|Overall Study|Protocol Violation|0|||
49148233|NCT01197300|158383329|FG001|Overall Study|Protocol Violation|1|||
49148234|NCT04744831|158383330|FG000|Overall Study|Progressive Disease|31|||
49148235|NCT04744831|158383331|FG001|Overall Study|Progressive Disease|27|||
49148236|NCT04744831|158383332|FG002|Overall Study|Progressive Disease|25|||
49148237|NCT04744831|158383330|FG000|Overall Study|Adverse Event|3|||
49148238|NCT04744831|158383331|FG001|Overall Study|Adverse Event|3|||
49148239|NCT04744831|158383332|FG002|Overall Study|Adverse Event|3|||
49148240|NCT04744831|158383330|FG000|Overall Study|Clinical Progression|3|||
49148241|NCT04744831|158383331|FG001|Overall Study|Clinical Progression|2|||
49148242|NCT04744831|158383332|FG002|Overall Study|Clinical Progression|5|||
49148243|NCT04744831|158383330|FG000|Overall Study|Other|0|||
49148244|NCT04744831|158383331|FG001|Overall Study|Other|2|||
49148245|NCT04744831|158383332|FG002|Overall Study|Other|1|||
49148246|NCT04744831|158383330|FG000|Overall Study|Death|0|||
49148247|NCT04744831|158383331|FG001|Overall Study|Death|2|||
49148248|NCT04744831|158383332|FG002|Overall Study|Death|1|||
49148249|NCT04101331|158383333|FG000|Overall Study|Adverse Event|9|||
49148250|NCT04101331|158383333|FG000|Overall Study|Disease progression|82|||
49148251|NCT04101331|158383333|FG000|Overall Study|Withdrawal by Subject|1|||
49148252|NCT04101331|158383333|FG000|Overall Study|Investigator decision|6|||
49148253|NCT04101331|158383333|FG000|Overall Study|Death|6|||
49148254|NCT04101331|158383333|FG000|Overall Study|Allogenic transplant|1|||
49148255|NCT04193176|158383335|FG000|Overall Study|Withdrawal by Subject|6|||
48730796|NCT00760214|156865903|FG002|Overall Study|Pregnancy|1|||
48730797|NCT00760214|156865901|FG000|Overall Study|Physician Decision|1|||
49013915|NCT03377556|157887235|FG000|Overall Study|Progression/relapse|38|||
49148256|NCT04193176|158383336|FG001|Overall Study|Withdrawal by Subject|10|||
49148257|NCT01027754|158383337|FG000|Overall Study|withdrew/lost to follow-up after interve|2|||
49148258|NCT01027754|158383338|FG001|Overall Study|withdrew/lost to follow-up after interve|3|||
49148259|NCT01027754|158383337|FG000|Overall Study|Withdrawal by Subject|0|||
49148260|NCT01027754|158383338|FG001|Overall Study|Withdrawal by Subject|5|||
49148261|NCT02529488|158383339|FG000|Overall Study|Adverse Event|1|||
48730798|NCT00760214|156865902|FG001|Overall Study|Physician Decision|1|||
48730799|NCT00760214|156865903|FG002|Overall Study|Physician Decision|1|||
48730800|NCT00760214|156865901|FG000|Overall Study|Other|3|||
48730801|NCT00760214|156865902|FG001|Overall Study|Other|4|||
48730802|NCT00760214|156865903|FG002|Overall Study|Other|6|||
48730803|NCT00518973|156865905|FG000|Overall Study|Withdrawal by Subject|3|||
48730804|NCT00518973|156865906|FG001|Overall Study|Withdrawal by Subject|2|||
48730805|NCT02545075|156865907|FG000|Randomization|Lost to Follow-up|0|||
48730806|NCT02545075|156865908|FG001|Randomization|Lost to Follow-up|1|||
48730807|NCT02545075|156865907|FG000|Randomization|Withdrawal by Subject|0|||
48730808|NCT02545075|156865908|FG001|Randomization|Withdrawal by Subject|6|||
48730809|NCT02545075|156865907|FG000|Treatment|Disease progression|71|||
48730810|NCT02545075|156865908|FG001|Treatment|Disease progression|32|||
48730811|NCT02545075|156865907|FG000|Treatment|Participant dicontinued study treatment|7|||
48730812|NCT02545075|156865908|FG001|Treatment|Participant dicontinued study treatment|9|||
48730813|NCT02545075|156865907|FG000|Treatment|Withdrawal by Subject|1|||
48730814|NCT02545075|156865908|FG001|Treatment|Withdrawal by Subject|0|||
48730815|NCT02545075|156865907|FG000|Treatment|Adverse event not related to study drug|1|||
48730816|NCT02545075|156865908|FG001|Treatment|Adverse event not related to study drug|0|||
48730817|NCT02545075|156865907|FG000|Treatment|Death|1|||
48730818|NCT02545075|156865908|FG001|Treatment|Death|0|||
48730819|NCT02545075|156865907|FG000|Treatment|Participant drug toxicity|1|||
48730820|NCT02545075|156865908|FG001|Treatment|Participant drug toxicity|0|||
48730821|NCT02545075|156865907|FG000|Treatment|Completed treatment|40|||
48730822|NCT02545075|156865908|FG001|Treatment|Completed treatment|12|||
49148262|NCT02529488|158383339|FG000|Overall Study|Death|3|||
49148263|NCT01832038|158383353|FG000|Overall Study|Death|5|||
49148264|NCT01832038|158383353|FG000|Overall Study|Adverse Event|50|||
49148265|NCT01832038|158383353|FG000|Overall Study|Lack of Efficacy|81|||
49148266|NCT01832038|158383353|FG000|Overall Study|Protocol Violation|7|||
49148267|NCT01832038|158383353|FG000|Overall Study|Lost to Follow-up|10|||
49148268|NCT01832038|158383353|FG000|Overall Study|Withdrawal by Subject|49|||
49148269|NCT01832038|158383353|FG000|Overall Study|Visit non-compliance|2|||
49148270|NCT01832038|158383353|FG000|Overall Study|Subject refused to return visit|2|||
49148271|NCT01832038|158383353|FG000|Overall Study|Not convenient to come back to site|2|||
49148272|NCT01832038|158383353|FG000|Overall Study|Participant was asked to quit|5|||
49148273|NCT01832038|158383353|FG000|Overall Study|Back home|1|||
49148274|NCT01832038|158383353|FG000|Overall Study|Pregnancy|1|||
49148275|NCT01832038|158383353|FG000|Overall Study|Low compliance|3|||
49148276|NCT01832038|158383353|FG000|Overall Study|Prohibit procedure|2|||
49148277|NCT01832038|158383353|FG000|Overall Study|Not possible to visit the hospital|1|||
49148278|NCT01832038|158383353|FG000|Overall Study|Changes of implementation system|3|||
49148279|NCT01832038|158383353|FG000|Overall Study|Plan to pregnancy|7|||
49148280|NCT01832038|158383353|FG000|Overall Study|Bad mood and has suicidal thought|1|||
49148281|NCT01832038|158383353|FG000|Overall Study|Prohibited concomitant medication|1|||
49148282|NCT01832038|158383353|FG000|Overall Study|Pregnancy and abortion in EP0008 study|1|||
49148283|NCT01832038|158383353|FG000|Overall Study|Subject considered the efficacy was poor|1|||
49148284|NCT00504556|158383354|FG000|Overall Study|Adverse Event|11|||
49148285|NCT00504556|158383355|FG001|Overall Study|Adverse Event|11|||
49148286|NCT00504556|158383356|FG002|Overall Study|Adverse Event|14|||
49148287|NCT00504556|158383357|FG003|Overall Study|Adverse Event|13|||
49148288|NCT00504556|158383358|FG004|Overall Study|Adverse Event|5|||
49148289|NCT00504556|158383354|FG000|Overall Study|Death|3|||
49148290|NCT00504556|158383355|FG001|Overall Study|Death|3|||
49148291|NCT00504556|158383356|FG002|Overall Study|Death|1|||
49148292|NCT00504556|158383357|FG003|Overall Study|Death|0|||
49148293|NCT00504556|158383358|FG004|Overall Study|Death|2|||
49148294|NCT00504556|158383354|FG000|Overall Study|Protocol Violation|1|||
49148295|NCT00504556|158383355|FG001|Overall Study|Protocol Violation|3|||
49148296|NCT00504556|158383356|FG002|Overall Study|Protocol Violation|2|||
49148297|NCT00504556|158383357|FG003|Overall Study|Protocol Violation|1|||
49148298|NCT00504556|158383358|FG004|Overall Study|Protocol Violation|2|||
49148299|NCT00504556|158383354|FG000|Overall Study|Lost to Follow-up|0|||
49148300|NCT00504556|158383355|FG001|Overall Study|Lost to Follow-up|0|||
49148301|NCT00504556|158383356|FG002|Overall Study|Lost to Follow-up|1|||
49148302|NCT00504556|158383357|FG003|Overall Study|Lost to Follow-up|1|||
49148303|NCT00504556|158383358|FG004|Overall Study|Lost to Follow-up|1|||
49148304|NCT00504556|158383354|FG000|Overall Study|Withdrawal by Subject|16|||
49148305|NCT00504556|158383355|FG001|Overall Study|Withdrawal by Subject|16|||
49148306|NCT00504556|158383356|FG002|Overall Study|Withdrawal by Subject|7|||
49148307|NCT00504556|158383357|FG003|Overall Study|Withdrawal by Subject|8|||
49148308|NCT00504556|158383358|FG004|Overall Study|Withdrawal by Subject|12|||
48730823|NCT00736879|156865911|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
48730824|NCT00736879|156865912|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
48730825|NCT00736879|156865913|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
48730826|NCT00736879|156865914|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
49148309|NCT00504556|158383354|FG000|Overall Study|administrative reasons|0|||
49148310|NCT00504556|158383355|FG001|Overall Study|administrative reasons|2|||
49148311|NCT00504556|158383356|FG002|Overall Study|administrative reasons|2|||
49148312|NCT00504556|158383357|FG003|Overall Study|administrative reasons|1|||
49148313|NCT00504556|158383358|FG004|Overall Study|administrative reasons|2|||
49148314|NCT00504556|158383354|FG000|Overall Study|did not meet entry criteria|2|||
48730827|NCT00736879|156865911|FG000|Double Blind Treatment Period|Adverse Event|0|||
48730828|NCT00736879|156865912|FG001|Double Blind Treatment Period|Adverse Event|1|||
48730829|NCT00736879|156865913|FG002|Double Blind Treatment Period|Adverse Event|1|||
49148315|NCT00504556|158383355|FG001|Overall Study|did not meet entry criteria|0|||
49148316|NCT00504556|158383356|FG002|Overall Study|did not meet entry criteria|1|||
49148317|NCT00504556|158383357|FG003|Overall Study|did not meet entry criteria|1|||
49148318|NCT00504556|158383358|FG004|Overall Study|did not meet entry criteria|0|||
49148319|NCT00504556|158383354|FG000|Overall Study|data monitor committee decision|0|||
49148320|NCT00504556|158383355|FG001|Overall Study|data monitor committee decision|0|||
49148321|NCT00504556|158383356|FG002|Overall Study|data monitor committee decision|0|||
49148322|NCT00504556|158383357|FG003|Overall Study|data monitor committee decision|100|||
49148323|NCT00504556|158383358|FG004|Overall Study|data monitor committee decision|0|||
49148324|NCT00504556|158383354|FG000|Overall Study|Other|2|||
49148325|NCT00504556|158383355|FG001|Overall Study|Other|2|||
49148326|NCT00504556|158383356|FG002|Overall Study|Other|2|||
49148327|NCT00504556|158383357|FG003|Overall Study|Other|3|||
49148328|NCT00504556|158383358|FG004|Overall Study|Other|0|||
49148329|NCT00504556|158383354|FG000|Overall Study|not in safety analysis set|0|||
49148330|NCT00504556|158383355|FG001|Overall Study|not in safety analysis set|1|||
49148331|NCT00504556|158383356|FG002|Overall Study|not in safety analysis set|1|||
49148332|NCT00504556|158383357|FG003|Overall Study|not in safety analysis set|0|||
49148333|NCT00504556|158383358|FG004|Overall Study|not in safety analysis set|1|||
49148334|NCT03810365|158383359|FG000|Overall Study|Lost to Follow-up|2|||
49148335|NCT03810365|158383360|FG001|Overall Study|Lost to Follow-up|2|||
49148336|NCT03810365|158383359|FG000|Overall Study|Withdrawal by Subject|4|||
49148337|NCT03810365|158383360|FG001|Overall Study|Withdrawal by Subject|5|||
49148338|NCT00004228|158383363|FG000|Overall Study|Adverse Event|0|||
49148339|NCT00004228|158383364|FG001|Overall Study|Adverse Event|1|||
49148340|NCT00004228|158383365|FG002|Overall Study|Adverse Event|0|||
49148341|NCT00004228|158383366|FG003|Overall Study|Adverse Event|0|||
49148342|NCT00004228|158383367|FG004|Overall Study|Adverse Event|1|||
49148343|NCT00004228|158383368|FG005|Overall Study|Adverse Event|0|||
49148344|NCT00004228|158383369|FG006|Overall Study|Adverse Event|0|||
49148345|NCT00004228|158383363|FG000|Overall Study|Death|0|||
49148346|NCT00004228|158383364|FG001|Overall Study|Death|1|||
49148347|NCT00004228|158383365|FG002|Overall Study|Death|2|||
49148348|NCT00004228|158383366|FG003|Overall Study|Death|0|||
49148349|NCT00004228|158383367|FG004|Overall Study|Death|1|||
49148350|NCT00004228|158383368|FG005|Overall Study|Death|0|||
49148351|NCT00004228|158383369|FG006|Overall Study|Death|0|||
49148352|NCT00004228|158383363|FG000|Overall Study|Lack of Efficacy|1|||
49148353|NCT00004228|158383364|FG001|Overall Study|Lack of Efficacy|6|||
49148354|NCT00004228|158383365|FG002|Overall Study|Lack of Efficacy|5|||
49148355|NCT00004228|158383366|FG003|Overall Study|Lack of Efficacy|3|||
49148356|NCT00004228|158383367|FG004|Overall Study|Lack of Efficacy|9|||
49148357|NCT00004228|158383368|FG005|Overall Study|Lack of Efficacy|8|||
49148358|NCT00004228|158383369|FG006|Overall Study|Lack of Efficacy|4|||
49148359|NCT00004228|158383363|FG000|Overall Study|Lost to Follow-up|0|||
49148360|NCT00004228|158383364|FG001|Overall Study|Lost to Follow-up|0|||
49148361|NCT00004228|158383365|FG002|Overall Study|Lost to Follow-up|1|||
49148362|NCT00004228|158383366|FG003|Overall Study|Lost to Follow-up|0|||
49148363|NCT00004228|158383367|FG004|Overall Study|Lost to Follow-up|0|||
49148364|NCT00004228|158383368|FG005|Overall Study|Lost to Follow-up|0|||
49148365|NCT00004228|158383369|FG006|Overall Study|Lost to Follow-up|0|||
49148366|NCT00004228|158383363|FG000|Overall Study|Physician Decision|1|||
49148367|NCT00004228|158383364|FG001|Overall Study|Physician Decision|0|||
48730830|NCT00736879|156865914|FG003|Double Blind Treatment Period|Adverse Event|0|||
48730831|NCT00736879|156865911|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
48730832|NCT00736879|156865912|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
48730833|NCT00736879|156865913|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
48730834|NCT00736879|156865914|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
48730835|NCT00736879|156865911|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
48730836|NCT00736879|156865912|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
48730837|NCT00736879|156865913|FG002|Double Blind Treatment Period|Lost to Follow-up|2|||
48730838|NCT00736879|156865914|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
48730839|NCT00736879|156865911|FG000|Double Blind Treatment Period|Poor non-compliance|0|||
48730840|NCT00736879|156865912|FG001|Double Blind Treatment Period|Poor non-compliance|0|||
48730841|NCT00736879|156865913|FG002|Double Blind Treatment Period|Poor non-compliance|1|||
48730842|NCT00736879|156865914|FG003|Double Blind Treatment Period|Poor non-compliance|1|||
48730843|NCT00736879|156865911|FG000|Double Blind Treatment Period|No longer met criteria|0|||
48730844|NCT00736879|156865912|FG001|Double Blind Treatment Period|No longer met criteria|1|||
49013916|NCT03377556|157887235|FG000|Overall Study|Death|3|||
49148368|NCT00004228|158383365|FG002|Overall Study|Physician Decision|3|||
49148369|NCT00004228|158383366|FG003|Overall Study|Physician Decision|2|||
49148370|NCT00004228|158383367|FG004|Overall Study|Physician Decision|1|||
49148371|NCT00004228|158383368|FG005|Overall Study|Physician Decision|1|||
49148372|NCT00004228|158383369|FG006|Overall Study|Physician Decision|1|||
49148373|NCT00004228|158383363|FG000|Overall Study|Protocol Violation|0|||
49148374|NCT00004228|158383364|FG001|Overall Study|Protocol Violation|5|||
49148375|NCT00004228|158383365|FG002|Overall Study|Protocol Violation|2|||
49148376|NCT00004228|158383366|FG003|Overall Study|Protocol Violation|1|||
49148377|NCT00004228|158383367|FG004|Overall Study|Protocol Violation|1|||
49148378|NCT00004228|158383368|FG005|Overall Study|Protocol Violation|2|||
49148379|NCT00004228|158383369|FG006|Overall Study|Protocol Violation|0|||
49148380|NCT00004228|158383363|FG000|Overall Study|Withdrawal by Subject|3|||
49148381|NCT00004228|158383364|FG001|Overall Study|Withdrawal by Subject|0|||
49148382|NCT00004228|158383365|FG002|Overall Study|Withdrawal by Subject|1|||
49148383|NCT00004228|158383366|FG003|Overall Study|Withdrawal by Subject|0|||
49148384|NCT00004228|158383367|FG004|Overall Study|Withdrawal by Subject|2|||
48921443|NCT02970292|157546394|FG001|Overall Study|Noncompliance with study drug|2|||
49148385|NCT00004228|158383368|FG005|Overall Study|Withdrawal by Subject|1|||
49148386|NCT00004228|158383369|FG006|Overall Study|Withdrawal by Subject|2|||
49148387|NCT00004228|158383363|FG000|Overall Study|Other|0|||
49148388|NCT00004228|158383364|FG001|Overall Study|Other|0|||
49148389|NCT00004228|158383365|FG002|Overall Study|Other|1|||
49148390|NCT00004228|158383366|FG003|Overall Study|Other|0|||
49148391|NCT00004228|158383367|FG004|Overall Study|Other|0|||
49148392|NCT00004228|158383368|FG005|Overall Study|Other|0|||
49148393|NCT00004228|158383369|FG006|Overall Study|Other|0|||
49148394|NCT00004228|158383363|FG000|Overall Study|ineligible|4|||
49148395|NCT00004228|158383364|FG001|Overall Study|ineligible|2|||
49148396|NCT00004228|158383365|FG002|Overall Study|ineligible|4|||
49148397|NCT00004228|158383366|FG003|Overall Study|ineligible|1|||
49148398|NCT00004228|158383367|FG004|Overall Study|ineligible|1|||
49148399|NCT00004228|158383368|FG005|Overall Study|ineligible|2|||
49148400|NCT00004228|158383369|FG006|Overall Study|ineligible|5|||
49148401|NCT03160573|158383374|FG000|First Sequence (3 Weeks)|Withdrawal by Subject|1|||
49148402|NCT03160573|158383375|FG001|First Sequence (3 Weeks)|Withdrawal by Subject|3|||
49148403|NCT03160573|158383376|FG002|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
49148404|NCT03160573|158383377|FG003|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
48730845|NCT00736879|156865913|FG002|Double Blind Treatment Period|No longer met criteria|0|||
48730846|NCT00736879|156865914|FG003|Double Blind Treatment Period|No longer met criteria|0|||
48730847|NCT00736879|156865911|FG000|Double Blind Treatment Period|non-specified|0|||
48730848|NCT00736879|156865912|FG001|Double Blind Treatment Period|non-specified|1|||
48730849|NCT00736879|156865913|FG002|Double Blind Treatment Period|non-specified|0|||
48730850|NCT00736879|156865914|FG003|Double Blind Treatment Period|non-specified|0|||
48730851|NCT00736879|156865911|FG000|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
49148405|NCT00488293|158383381|FG000|Overall Study|Lost to Follow-up|28|||
49148406|NCT00488293|158383382|FG001|Overall Study|Lost to Follow-up|25|||
49148407|NCT00488293|158383381|FG000|Overall Study|Withdrawal by Subject|5|||
49148408|NCT00488293|158383382|FG001|Overall Study|Withdrawal by Subject|3|||
49148409|NCT00488293|158383381|FG000|Overall Study|Death|2|||
49148410|NCT00488293|158383382|FG001|Overall Study|Death|1|||
49148411|NCT00488293|158383381|FG000|Overall Study|Misrandomization/Other Unspecified|1|||
48730852|NCT00736879|156865912|FG001|Follow up Period - No Drug Treatment|Withdrawal by Subject|1|||
48730853|NCT00736879|156865913|FG002|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
48730854|NCT00736879|156865914|FG003|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
48730855|NCT00736879|156865911|FG000|Follow up Period - No Drug Treatment|non-specified|1|||
48730856|NCT00736879|156865912|FG001|Follow up Period - No Drug Treatment|non-specified|2|||
48730857|NCT00736879|156865913|FG002|Follow up Period - No Drug Treatment|non-specified|0|||
48730858|NCT00736879|156865914|FG003|Follow up Period - No Drug Treatment|non-specified|0|||
48730859|NCT02360111|156865915|FG000|Overall Study|Death|2|||
48730860|NCT01933217|156865920|FG000|Randomization (4 Weeks)|Withdrawal by Subject|1|||
48730861|NCT01933217|156865921|FG001|Randomization (4 Weeks)|Withdrawal by Subject|3|||
48730862|NCT01933217|156865920|FG000|Randomization (4 Weeks)|Lost to Follow-up|1|||
48730863|NCT01933217|156865921|FG001|Randomization (4 Weeks)|Lost to Follow-up|1|||
48730864|NCT03923738|156865923|FG000|Period 1|Adverse Event|1|||
48730865|NCT03923738|156865923|FG000|Period 1|Withdrawal by Subject|1|||
48730866|NCT03583164|156865924|FG000|Overall Study|Death in Main Phase|35|||
48730867|NCT03583164|156865924|FG000|Overall Study|Lost to Follow up in Main Phase|1|||
48730868|NCT03583164|156865924|FG000|Overall Study|Lost to follow up in Extended Phase|3|||
48730869|NCT03583164|156865924|FG000|Overall Study|Clinically significant lab value in Main Phase|2|||
48730870|NCT03583164|156865924|FG000|Overall Study|Clinically significant lab value in Extended Phase|4|||
49148412|NCT00488293|158383382|FG001|Overall Study|Misrandomization/Other Unspecified|1|||
49148413|NCT01028560|158383383|FG000|Overall Study|Lack of Efficacy|3|||
49148414|NCT01028560|158383384|FG001|Overall Study|Lack of Efficacy|6|||
49148415|NCT01028560|158383383|FG000|Overall Study|Withdrawal by Subject|7|||
49148416|NCT01028560|158383384|FG001|Overall Study|Withdrawal by Subject|12|||
49148417|NCT03400787|158383385|FG000|Overall Study|Lost to Follow-up|1|||
49148418|NCT03400787|158383386|FG001|Overall Study|Lost to Follow-up|0|||
49148419|NCT03400787|158383385|FG000|Overall Study|Death|1|||
49148420|NCT03400787|158383386|FG001|Overall Study|Death|0|||
49148421|NCT03400787|158383385|FG000|Overall Study|Protocol Violation|0|||
49148422|NCT03400787|158383386|FG001|Overall Study|Protocol Violation|2|||
49148423|NCT03400787|158383385|FG000|Overall Study|Unblinded before 3-month follow-upa-|0|||
49148424|NCT03400787|158383386|FG001|Overall Study|Unblinded before 3-month follow-upa-|6|||
49148425|NCT00662038|158383393|FG000|Overall Study|Reason not specified|3|||
49148426|NCT00662038|158383393|FG000|Overall Study|Withdrawn consent|22|||
49148427|NCT00662038|158383393|FG000|Overall Study|Withdrawal by Subject|83|||
49148428|NCT00662038|158383393|FG000|Overall Study|Sponsor decision|1|||
49148429|NCT00662038|158383393|FG000|Overall Study|Physician Decision|19|||
49148430|NCT00662038|158383393|FG000|Overall Study|Lung transplantation|44|||
49148431|NCT00662038|158383393|FG000|Overall Study|Lost to Follow-up|1|||
49148432|NCT00662038|158383393|FG000|Overall Study|Death|95|||
49148433|NCT00662038|158383393|FG000|Overall Study|Adverse Event|358|||
49148434|NCT00662038|158383393|FG000|Overall Study|Continued treatment|5|||
49148435|NCT00397046|158383395|FG000|Overall Study|Disease Progression|3|||
49148436|NCT00397046|158383396|FG001|Overall Study|Disease Progression|3|||
49148437|NCT00397046|158383397|FG002|Overall Study|Disease Progression|10|||
49148438|NCT00397046|158383398|FG003|Overall Study|Disease Progression|5|||
49148439|NCT01791205|158383401|FG000|Phase II|Lack of Efficacy|6|||
49148440|NCT01791205|158383402|FG001|Phase II|Lack of Efficacy|0|||
49148441|NCT01791205|158383401|FG000|Phase II|Adverse Event|2|||
49148442|NCT01791205|158383402|FG001|Phase II|Adverse Event|0|||
49148443|NCT01791205|158383401|FG000|Phase II|Safety|1|||
49148444|NCT01791205|158383402|FG001|Phase II|Safety|0|||
48730871|NCT03583164|156865924|FG000|Overall Study|Physician decision in Main Phase|1|||
49148445|NCT01791205|158383401|FG000|Phase II|Lost to Follow-up|1|||
49148446|NCT01791205|158383402|FG001|Phase II|Lost to Follow-up|0|||
49148447|NCT01791205|158383401|FG000|Phase II|Remission of disease|1|||
49148448|NCT01791205|158383402|FG001|Phase II|Remission of disease|0|||
49148449|NCT01791205|158383401|FG000|Phase II|Physician's decision|1|||
49148450|NCT01791205|158383402|FG001|Phase II|Physician's decision|0|||
49148451|NCT02242903|158383408|FG000|Overall Study|Withdrawal by Subject|1|||
49148452|NCT02242903|158383409|FG001|Overall Study|Withdrawal by Subject|0|||
49148453|NCT02242903|158383410|FG002|Overall Study|Withdrawal by Subject|0|||
49148454|NCT02242903|158383411|FG003|Overall Study|Withdrawal by Subject|0|||
49148455|NCT02242903|158383412|FG004|Overall Study|Withdrawal by Subject|0|||
49148456|NCT02242903|158383413|FG005|Overall Study|Withdrawal by Subject|0|||
49148457|NCT02242903|158383414|FG006|Overall Study|Withdrawal by Subject|0|||
49148458|NCT02094885|158383415|FG000|Overall Study|Death|1|||
49148459|NCT02094885|158383416|FG001|Overall Study|Death|5|||
48730872|NCT03583164|156865924|FG000|Overall Study|Physician decision in Extended Phase|2|||
48730873|NCT03583164|156865924|FG000|Overall Study|Death in Extended Phase|13|||
48730874|NCT03583164|156865924|FG000|Overall Study|Intolerable adverse event in Main Phase|3|||
48730875|NCT03583164|156865924|FG000|Overall Study|Intolerable adverse event in Extended Phase|1|||
48730876|NCT03583164|156865924|FG000|Overall Study|Lack of compliance in Extended Phase|2|||
48730877|NCT03583164|156865924|FG000|Overall Study|Treatment failure in Main Phase|2|||
48730878|NCT03583164|156865924|FG000|Overall Study|Treatment failure in Extended Phase|4|||
48730879|NCT03583164|156865924|FG000|Overall Study|Withdrawal of consent in Extended Phase|2|||
48823799|NCT01101542|157194054|FG000|Year 6 Surveillance Period|Lost to Follow-up|986|||
48823800|NCT01101542|157194054|FG000|Year 6 Surveillance Period|Pregnancy|1|||
48823801|NCT01101542|157194054|FG000|Year 6 Surveillance Period|Withdrawal by Subject|4|||
48823802|NCT03681639|157195481|FG000|Overall Study|Death|4|||
48823803|NCT03681639|157195481|FG000|Overall Study|Lost to Follow-up|2|||
48823804|NCT03681639|157195481|FG000|Overall Study|Withdrawal by Subject|1|||
48823805|NCT03681639|157195481|FG000|Overall Study|Adverse Event|2|||
48823806|NCT04129580|157195484|FG000|Overall Study|Lost to Follow-up|14|||
48823807|NCT04129580|157195485|FG001|Overall Study|Lost to Follow-up|25|||
48823808|NCT00432159|157195488|FG000|Overall Study|Death|0|||
48823809|NCT00432159|157195489|FG001|Overall Study|Death|1|||
48823810|NCT00432159|157195490|FG002|Overall Study|Death|0|||
48823811|NCT00432159|157195491|FG003|Overall Study|Death|0|||
48823812|NCT00432159|157195492|FG004|Overall Study|Death|0|||
48823813|NCT00432159|157195488|FG000|Overall Study|Failure|9|||
49148460|NCT02094885|158383415|FG000|Overall Study|Withdrawn due to age|1|||
49148461|NCT02094885|158383416|FG001|Overall Study|Withdrawn due to age|0|||
48730880|NCT03583164|156865924|FG000|Overall Study|Other not specified reason in Main Phase|2|||
48823814|NCT00432159|157195489|FG001|Overall Study|Failure|5|||
49148462|NCT02272985|158383417|FG000|Overall Study|Withdrawal by Subject|1|||
49148463|NCT02272985|158383417|FG000|Overall Study|hip fracture|1|||
49148464|NCT02272985|158383417|FG000|Overall Study|kidney transplantation|1|||
49148465|NCT03791060|158383418|FG000|Overall Study|Withdrawal by Subject|1|||
49148466|NCT01546987|158383419|FG000|Overall Study|Protocol Violation|3|||
49148467|NCT01546987|158383420|FG001|Overall Study|Protocol Violation|4|||
49148468|NCT02771145|158383423|FG000|Overall Study|Adverse Event|3|||
48823815|NCT00432159|157195490|FG002|Overall Study|Failure|3|||
48823816|NCT00432159|157195491|FG003|Overall Study|Failure|2|||
48823817|NCT00432159|157195492|FG004|Overall Study|Failure|3|||
48823818|NCT00432159|157195488|FG000|Overall Study|Missing NDI and/or neuro. assessment|13|||
48823819|NCT00432159|157195489|FG001|Overall Study|Missing NDI and/or neuro. assessment|24|||
48823820|NCT00432159|157195490|FG002|Overall Study|Missing NDI and/or neuro. assessment|1|||
48823821|NCT00432159|157195491|FG003|Overall Study|Missing NDI and/or neuro. assessment|3|||
48823822|NCT00432159|157195492|FG004|Overall Study|Missing NDI and/or neuro. assessment|7|||
48823823|NCT04822298|157195494|FG000|Overall Study|Death|3|||
48823824|NCT01575860|157195495|FG000|Overall Study|Withdrawal by Subject|1|||
48823825|NCT01575860|157195495|FG000|Overall Study|Progression Prior to Lenalidomide Maint.|1|||
48823826|NCT00594932|157195502|FG000|First 3 Months|Withdrawal by Subject|1|||
48823827|NCT00594932|157195503|FG001|First 3 Months|Withdrawal by Subject|3|||
48823828|NCT00594932|157195502|FG000|Final 3 Months|Withdrawal by Subject|4|||
48823829|NCT00594932|157195503|FG001|Final 3 Months|Withdrawal by Subject|3|||
48823830|NCT00582790|157195504|FG000|Overall Study|Rapid progression of disease|1|||
48823831|NCT00480441|157195505|FG000|Screening|Not Eligible|37|||
48823832|NCT00480441|157195506|FG001|Screening|Not Eligible|0|||
48823833|NCT00480441|157195507|FG002|Screening|Not Eligible|0|||
48823834|NCT00480441|157195505|FG000|Baseline Functional MRI|Functional MRI data not usable|4|||
48823835|NCT00480441|157195506|FG001|Baseline Functional MRI|Functional MRI data not usable|0|||
48823836|NCT00480441|157195507|FG002|Baseline Functional MRI|Functional MRI data not usable|0|||
48823837|NCT00480441|157195505|FG000|Baseline Functional MRI|Lost to Follow-up|4|||
48823838|NCT00480441|157195506|FG001|Baseline Functional MRI|Lost to Follow-up|0|||
48823839|NCT00480441|157195507|FG002|Baseline Functional MRI|Lost to Follow-up|0|||
48823840|NCT00480441|157195505|FG000|Baseline Functional MRI|physical contraindication|4|||
48823841|NCT00480441|157195506|FG001|Baseline Functional MRI|physical contraindication|0|||
48823842|NCT00480441|157195507|FG002|Baseline Functional MRI|physical contraindication|0|||
48823843|NCT00480441|157195505|FG000|Randomization|Lost to Follow-up|0|||
48823844|NCT00480441|157195506|FG001|Randomization|Lost to Follow-up|7|||
48823845|NCT00480441|157195507|FG002|Randomization|Lost to Follow-up|2|||
48823846|NCT01687270|157195508|FG000|Overall Study|Lack of Efficacy|11|||
48823847|NCT01687270|157195508|FG000|Overall Study|Lost to Follow-up|1|||
48823848|NCT02179918|157195509|FG000|Overall Study|Death|0|||
48823849|NCT02179918|157195510|FG001|Overall Study|Death|0|||
48823850|NCT02179918|157195511|FG002|Overall Study|Death|0|||
48823851|NCT02179918|157195512|FG003|Overall Study|Death|1|||
48823852|NCT02179918|157195513|FG004|Overall Study|Death|0|||
48823853|NCT02179918|157195509|FG000|Overall Study|Lost to Follow-up|0|||
48823854|NCT02179918|157195510|FG001|Overall Study|Lost to Follow-up|0|||
48823855|NCT02179918|157195511|FG002|Overall Study|Lost to Follow-up|1|||
48823856|NCT02179918|157195512|FG003|Overall Study|Lost to Follow-up|0|||
48823857|NCT02179918|157195513|FG004|Overall Study|Lost to Follow-up|0|||
48823858|NCT02179918|157195509|FG000|Overall Study|Progressive Disease|4|||
48823859|NCT02179918|157195510|FG001|Overall Study|Progressive Disease|1|||
48823860|NCT02179918|157195511|FG002|Overall Study|Progressive Disease|1|||
48823861|NCT02179918|157195512|FG003|Overall Study|Progressive Disease|2|||
48823862|NCT02179918|157195513|FG004|Overall Study|Progressive Disease|6|||
48823863|NCT02179918|157195509|FG000|Overall Study|Other|0|||
48823864|NCT02179918|157195510|FG001|Overall Study|Other|1|||
48823865|NCT02179918|157195511|FG002|Overall Study|Other|0|||
48823866|NCT02179918|157195512|FG003|Overall Study|Other|0|||
48823867|NCT02179918|157195513|FG004|Overall Study|Other|1|||
48823868|NCT02179918|157195509|FG000|Overall Study|Subject refused further follow-up|0|||
48823869|NCT02179918|157195510|FG001|Overall Study|Subject refused further follow-up|1|||
48823870|NCT02179918|157195511|FG002|Overall Study|Subject refused further follow-up|0|||
48823871|NCT02179918|157195512|FG003|Overall Study|Subject refused further follow-up|0|||
48823872|NCT02179918|157195513|FG004|Overall Study|Subject refused further follow-up|1|||
48823873|NCT00293462|157195514|FG000|Overall Study|Withdrawal by Subject|4|||
48823874|NCT00293462|157195515|FG001|Overall Study|Withdrawal by Subject|3|||
48823875|NCT00293462|157195516|FG002|Overall Study|Withdrawal by Subject|8|||
48823876|NCT00293462|157195514|FG000|Overall Study|Death|1|||
48823877|NCT00293462|157195515|FG001|Overall Study|Death|0|||
48823878|NCT00293462|157195516|FG002|Overall Study|Death|0|||
48823879|NCT00293462|157195514|FG000|Overall Study|Lost to Follow-up|0|||
48823880|NCT00293462|157195515|FG001|Overall Study|Lost to Follow-up|1|||
48823881|NCT00293462|157195516|FG002|Overall Study|Lost to Follow-up|0|||
48823882|NCT00293462|157195514|FG000|Overall Study|Change Treatment Regimen (ineligible)|1|||
48823883|NCT00293462|157195515|FG001|Overall Study|Change Treatment Regimen (ineligible)|0|||
48823884|NCT00293462|157195516|FG002|Overall Study|Change Treatment Regimen (ineligible)|0|||
48823885|NCT00293462|157195514|FG000|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
48823886|NCT00293462|157195515|FG001|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1|||
48823887|NCT00293462|157195516|FG002|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
48823888|NCT00293462|157195514|FG000|Overall Study|Refuse Radiation Treatment|1|||
48823889|NCT00293462|157195515|FG001|Overall Study|Refuse Radiation Treatment|0|||
48823890|NCT00293462|157195516|FG002|Overall Study|Refuse Radiation Treatment|0|||
48823891|NCT00293462|157195514|FG000|Overall Study|No Show|0|||
49148469|NCT02771145|158383423|FG000|Overall Study|Lost to Follow-up|1|||
49148470|NCT03533491|158383431|FG000|Overall Study|Lost to Follow-up|2|||
49148471|NCT04204902|158383434|FG000|Treatment Period 2 (Day 22)|Withdrawal by Subject|0|||
49148472|NCT04204902|158383435|FG001|Treatment Period 2 (Day 22)|Withdrawal by Subject|1|||
49148473|NCT01903733|158383436|FG000|Overall Study|Death|23|||
49148474|NCT01903733|158383437|FG001|Overall Study|Death|54|||
49148475|NCT01903733|158383438|FG002|Overall Study|Death|30|||
49148476|NCT01903733|158383439|FG003|Overall Study|Death|98|||
49148477|NCT01903733|158383436|FG000|Overall Study|Participant refused further follow-up|35|||
49148478|NCT01903733|158383437|FG001|Overall Study|Participant refused further follow-up|38|||
49148479|NCT01903733|158383438|FG002|Overall Study|Participant refused further follow-up|13|||
49148480|NCT01903733|158383439|FG003|Overall Study|Participant refused further follow-up|9|||
48730881|NCT02943460|156865928|FG000|Blinded Study Phase|Adverse Event|3|||
48730882|NCT02943460|156865929|FG001|Blinded Study Phase|Adverse Event|0|||
48730883|NCT02943460|156865930|FG002|Blinded Study Phase|Adverse Event|0|||
48730884|NCT02943460|156865928|FG000|Blinded Study Phase|Withdrew Consent|0|||
48730885|NCT02943460|156865929|FG001|Blinded Study Phase|Withdrew Consent|1|||
48730886|NCT02943460|156865930|FG002|Blinded Study Phase|Withdrew Consent|0|||
48730887|NCT02943460|156865928|FG000|Open Label Extension (OLE) Phase|Adverse Event|2|||
48730888|NCT02943460|156865929|FG001|Open Label Extension (OLE) Phase|Adverse Event|5|||
48730889|NCT02943460|156865930|FG002|Open Label Extension (OLE) Phase|Adverse Event|2|||
48730890|NCT02943460|156865928|FG000|Open Label Extension (OLE) Phase|Withdrew Consent|2|||
48730891|NCT02943460|156865929|FG001|Open Label Extension (OLE) Phase|Withdrew Consent|1|||
48730892|NCT02943460|156865930|FG002|Open Label Extension (OLE) Phase|Withdrew Consent|0|||
48730893|NCT02943460|156865928|FG000|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
48730894|NCT02943460|156865929|FG001|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
48730895|NCT02943460|156865930|FG002|Open Label Extension (OLE) Phase|Investigator's Discretion|0|||
48730896|NCT01264016|156865931|FG000|Overall Study|Withdrawal by Subject|1|||
49148481|NCT01903733|158383436|FG000|Overall Study|Lost to Follow-up|18|||
49148482|NCT01903733|158383437|FG001|Overall Study|Lost to Follow-up|19|||
49148483|NCT01903733|158383438|FG002|Overall Study|Lost to Follow-up|6|||
49148484|NCT01903733|158383439|FG003|Overall Study|Lost to Follow-up|9|||
49148485|NCT01903733|158383436|FG000|Overall Study|Other|10|||
49148486|NCT01903733|158383437|FG001|Overall Study|Other|15|||
49148487|NCT01903733|158383438|FG002|Overall Study|Other|12|||
49148488|NCT01903733|158383439|FG003|Overall Study|Other|3|||
49148489|NCT01903733|158383436|FG000|Overall Study|Missing|2|||
48730897|NCT01264016|156865931|FG000|Overall Study|Felt faint at sight of blood|1|||
48730898|NCT00267189|156865932|FG000|Overall Study|Patient withdrew consent|1|||
48730899|NCT00267189|156865933|FG001|Overall Study|Patient withdrew consent|1|||
48730900|NCT00267189|156865932|FG000|Overall Study|Death|1|||
48730901|NCT00267189|156865933|FG001|Overall Study|Death|0|||
48730902|NCT00267189|156865932|FG000|Overall Study|Missing|3|||
48730903|NCT00267189|156865933|FG001|Overall Study|Missing|0|||
48730904|NCT00777205|156865934|FG000|Overall Study|Lost to Follow-up|25|||
48730905|NCT00777205|156865935|FG001|Overall Study|Lost to Follow-up|9|||
48730906|NCT00777205|156865934|FG000|Overall Study|Withdrawal by Subject|6|||
48730907|NCT00777205|156865935|FG001|Overall Study|Withdrawal by Subject|4|||
48730908|NCT00777205|156865934|FG000|Overall Study|Death|0|||
48730909|NCT00777205|156865935|FG001|Overall Study|Death|2|||
48730910|NCT00777205|156865934|FG000|Overall Study|Protocol Violation|0|||
48730911|NCT00777205|156865935|FG001|Overall Study|Protocol Violation|56|||
48730912|NCT00751621|156865936|FG000|Overall Study|Adverse Event|1|||
48730913|NCT00751621|156865936|FG000|Overall Study|Withdrawal by Subject|1|||
48730914|NCT00751621|156865936|FG000|Overall Study|Subject moved to another country|1|||
48730915|NCT00751621|156865936|FG000|Overall Study|Poor adherence to asthma treatment|1|||
48730916|NCT03114488|156865938|FG000|Time Period 2|Withdrawal by Subject|1|||
48730917|NCT03114488|156865939|FG001|Time Period 2|Withdrawal by Subject|3|||
48730918|NCT01243671|156865940|FG000|Overall Study|Adverse Event|3|||
48730919|NCT01243671|156865940|FG000|Overall Study|Anti-adalimumab antibody positive|1|||
48730920|NCT01243671|156865940|FG000|Overall Study|Other|1|||
48730921|NCT00629772|156865945|FG000|Second Intervention Week 14 - Week 26|Adverse Event|1|||
48730922|NCT00629772|156865946|FG001|Second Intervention Week 14 - Week 26|Adverse Event|1|||
48730923|NCT00629772|156865945|FG000|Second Intervention Week 14 - Week 26|Lack of Efficacy|0|||
48730924|NCT00629772|156865946|FG001|Second Intervention Week 14 - Week 26|Lack of Efficacy|1|||
48730925|NCT03519386|156865948|FG000|Overall Study|Withdrawal by Subject|4|||
48730926|NCT03519386|156865949|FG001|Overall Study|Withdrawal by Subject|1|||
48730927|NCT03519386|156865950|FG002|Overall Study|Withdrawal by Subject|2|||
48730928|NCT03519386|156865948|FG000|Overall Study|Physician Decision|1|||
48730929|NCT03519386|156865949|FG001|Overall Study|Physician Decision|1|||
48730930|NCT03519386|156865950|FG002|Overall Study|Physician Decision|1|||
48730931|NCT03519386|156865948|FG000|Overall Study|Lost to Follow-up|0|||
49148490|NCT01903733|158383437|FG001|Overall Study|Missing|0|||
48730932|NCT03519386|156865949|FG001|Overall Study|Lost to Follow-up|1|||
48730933|NCT03519386|156865950|FG002|Overall Study|Lost to Follow-up|1|||
48730934|NCT03519386|156865948|FG000|Overall Study|Death|1|||
49148491|NCT01903733|158383438|FG002|Overall Study|Missing|0|||
48730935|NCT03519386|156865949|FG001|Overall Study|Death|0|||
48730936|NCT03519386|156865950|FG002|Overall Study|Death|4|||
48730937|NCT03519386|156865948|FG000|Overall Study|Adverse Event|2|||
48730938|NCT03519386|156865949|FG001|Overall Study|Adverse Event|1|||
48730939|NCT03519386|156865950|FG002|Overall Study|Adverse Event|2|||
48730940|NCT03519386|156865948|FG000|Overall Study|Explanted|2|||
48730941|NCT03519386|156865949|FG001|Overall Study|Explanted|1|||
48730942|NCT03519386|156865950|FG002|Overall Study|Explanted|0|||
48823892|NCT00293462|157195515|FG001|Overall Study|No Show|0|||
48823893|NCT00293462|157195516|FG002|Overall Study|No Show|1|||
48823894|NCT00293462|157195514|FG000|Overall Study|Went back to his home country|0|||
48823895|NCT00293462|157195515|FG001|Overall Study|Went back to his home country|0|||
48823896|NCT00293462|157195516|FG002|Overall Study|Went back to his home country|1|||
48823897|NCT00293462|157195514|FG000|Overall Study|Blood clot after chemotherapy|0|||
48730943|NCT03519386|156865948|FG000|Overall Study|Ongoing in study|190|||
48730944|NCT03519386|156865949|FG001|Overall Study|Ongoing in study|192|||
48730945|NCT03519386|156865950|FG002|Overall Study|Ongoing in study|183|||
48730946|NCT00573248|156865951|FG000|Overall Study|scheduling conflicts|15|||
48730947|NCT00573248|156865952|FG001|Overall Study|scheduling conflicts|11|||
48730948|NCT03583073|156865953|FG000|Overall Study|Lost to Follow-up|8|||
48730949|NCT03583073|156865954|FG001|Overall Study|Lost to Follow-up|12|||
48730950|NCT03063203|156865955|FG000|Overall Study|Chose alternative therapy|3|||
48730951|NCT03063203|156865955|FG000|Overall Study|Death|2|||
48730952|NCT03063203|156865955|FG000|Overall Study|Disease progression|4|||
48730953|NCT03063203|156865955|FG000|Overall Study|Physician Decision|5|||
48730954|NCT01916967|156865956|FG000|Overall Study|Adverse Event|0|||
48730955|NCT01916967|156865957|FG001|Overall Study|Adverse Event|0|||
48730956|NCT01916967|156865958|FG002|Overall Study|Adverse Event|2|||
48730957|NCT01916967|156865956|FG000|Overall Study|Lack of Efficacy|0|||
48730958|NCT01916967|156865957|FG001|Overall Study|Lack of Efficacy|0|||
48730959|NCT01916967|156865958|FG002|Overall Study|Lack of Efficacy|6|||
48730960|NCT01916967|156865956|FG000|Overall Study|Physician Decision|0|||
48730961|NCT01916967|156865957|FG001|Overall Study|Physician Decision|0|||
48730962|NCT01916967|156865958|FG002|Overall Study|Physician Decision|1|||
48730963|NCT01916967|156865956|FG000|Overall Study|Protocol Violation|0|||
48730964|NCT01916967|156865957|FG001|Overall Study|Protocol Violation|1|||
48730965|NCT01916967|156865958|FG002|Overall Study|Protocol Violation|0|||
48730966|NCT01986140|156865959|FG000|Overall Study|Withdrawal by Subject|31|||
48730967|NCT01986140|156865960|FG001|Overall Study|Withdrawal by Subject|25|||
48730968|NCT01986140|156865959|FG000|Overall Study|alternative treatment|1|||
48730969|NCT01986140|156865960|FG001|Overall Study|alternative treatment|1|||
48730970|NCT01986140|156865959|FG000|Overall Study|found not eligible|3|||
48730971|NCT01986140|156865960|FG001|Overall Study|found not eligible|0|||
48730972|NCT01986140|156865959|FG000|Overall Study|Adverse Event|0|||
48730973|NCT01986140|156865960|FG001|Overall Study|Adverse Event|1|||
48730974|NCT01986140|156865959|FG000|Overall Study|progression disease|0|||
48730975|NCT01986140|156865960|FG001|Overall Study|progression disease|1|||
48730976|NCT00764491|156865962|FG000|Overall Study|Lost to Follow-up|35|||
48730977|NCT00764491|156865963|FG001|Overall Study|Lost to Follow-up|17|||
48730978|NCT01462227|156865964|FG000|Second Assignment|Lost to Follow-up|1|||
48730979|NCT01462227|156865965|FG001|Second Assignment|Lost to Follow-up|0|||
49148492|NCT01903733|158383439|FG003|Overall Study|Missing|0|||
49148493|NCT01903733|158383436|FG000|Overall Study|Investigator request|18|||
49148494|NCT01903733|158383437|FG001|Overall Study|Investigator request|0|||
49148495|NCT01903733|158383438|FG002|Overall Study|Investigator request|0|||
49148496|NCT01903733|158383439|FG003|Overall Study|Investigator request|0|||
49148497|NCT04191616|158383440|FG000|Overall Study|Death|26|||
49148498|NCT04191616|158383440|FG000|Overall Study|Withdrawal by Subject|1|||
49148499|NCT04191616|158383440|FG000|Overall Study|Sponsor decision|2|||
49148500|NCT04191616|158383440|FG000|Overall Study|Continuing study|25|||
48823898|NCT00293462|157195515|FG001|Overall Study|Blood clot after chemotherapy|0|||
49148501|NCT02414841|158383448|FG000|Overall Study|Withdrawal by Subject|7|||
49148502|NCT02414841|158383449|FG001|Overall Study|Withdrawal by Subject|5|||
49148503|NCT02414841|158383448|FG000|Overall Study|Lost to Follow-up|13|||
49148504|NCT02414841|158383449|FG001|Overall Study|Lost to Follow-up|6|||
48730980|NCT01462227|156865966|FG002|Second Assignment|Lost to Follow-up|0|||
48730981|NCT01462227|156865967|FG003|Second Assignment|Lost to Follow-up|0|||
48730982|NCT01462227|156865964|FG000|Second Assignment|Protocol Violation|0|||
48730983|NCT01462227|156865965|FG001|Second Assignment|Protocol Violation|1|||
48730984|NCT01462227|156865966|FG002|Second Assignment|Protocol Violation|1|||
48730985|NCT01462227|156865967|FG003|Second Assignment|Protocol Violation|0|||
48730986|NCT02035475|156865973|FG000|Overall Study|Withdrawal by Subject|4|||
48730987|NCT02035475|156865973|FG000|Overall Study|Physician Decision|1|||
48730988|NCT02035475|156865973|FG000|Overall Study|Equipment Error|1|||
48730989|NCT00191646|156865974|FG000|Overall Study|Toxicity|26|||
49148505|NCT02414841|158383448|FG000|Overall Study|Death|17|||
49148506|NCT02414841|158383449|FG001|Overall Study|Death|14|||
49148507|NCT02414841|158383448|FG000|Overall Study|Received a Kidney Transplant|13|||
48730990|NCT00191646|156865975|FG001|Overall Study|Toxicity|37|||
49148508|NCT02414841|158383449|FG001|Overall Study|Received a Kidney Transplant|4|||
49148509|NCT02414841|158383448|FG000|Overall Study|Randomized But Not Treated|6|||
49148510|NCT02414841|158383449|FG001|Overall Study|Randomized But Not Treated|4|||
49148511|NCT05486065|158383453|FG000|Overall Study|Withdrawal by Subject|1|||
49148512|NCT05486065|158383454|FG001|Overall Study|Withdrawal by Subject|5|||
49148513|NCT05486065|158383455|FG002|Overall Study|Withdrawal by Subject|4|||
49148514|NCT05486065|158383456|FG003|Overall Study|Withdrawal by Subject|3|||
49148515|NCT05486065|158383453|FG000|Overall Study|Lost to Follow-up|4|||
49148516|NCT05486065|158383454|FG001|Overall Study|Lost to Follow-up|2|||
49148517|NCT05486065|158383455|FG002|Overall Study|Lost to Follow-up|2|||
49148518|NCT05486065|158383456|FG003|Overall Study|Lost to Follow-up|2|||
49148519|NCT05486065|158383453|FG000|Overall Study|Physician Decision|0|||
49148520|NCT05486065|158383454|FG001|Overall Study|Physician Decision|1|||
49148521|NCT05486065|158383455|FG002|Overall Study|Physician Decision|1|||
49148522|NCT05486065|158383456|FG003|Overall Study|Physician Decision|0|||
49148523|NCT05486065|158383453|FG000|Overall Study|Failure to meet randomization criteria|0|||
49148524|NCT05486065|158383454|FG001|Overall Study|Failure to meet randomization criteria|0|||
49148525|NCT05486065|158383455|FG002|Overall Study|Failure to meet randomization criteria|0|||
49148526|NCT05486065|158383456|FG003|Overall Study|Failure to meet randomization criteria|1|||
49148527|NCT00903344|158385182|FG000|Overall Study|Pregnancy|2|||
49148528|NCT00903344|158385183|FG001|Overall Study|Pregnancy|3|||
49148529|NCT00903344|158385182|FG000|Overall Study|Lost to Follow-up|3|||
49148530|NCT00903344|158385183|FG001|Overall Study|Lost to Follow-up|0|||
49148531|NCT02595437|158385189|FG000|Triferic Via IV|Withdrawal by Subject|1|||
49148532|NCT01423084|158385190|FG000|Overall Study|Adverse Event|0|||
49148533|NCT01423084|158385191|FG001|Overall Study|Adverse Event|1|||
49148534|NCT01423084|158385190|FG000|Overall Study|Withdrawal by Subject|2|||
49148535|NCT01423084|158385191|FG001|Overall Study|Withdrawal by Subject|3|||
49148536|NCT03574389|158385192|FG000|Vaccination Period|Noncompliance With Investigational Product|3|||
49148537|NCT03574389|158385193|FG001|Vaccination Period|Noncompliance With Investigational Product|0|||
49148538|NCT03574389|158385194|FG002|Vaccination Period|Noncompliance With Investigational Product|0|||
49148539|NCT03574389|158385195|FG003|Vaccination Period|Noncompliance With Investigational Product|0|||
48823899|NCT00293462|157195516|FG002|Overall Study|Blood clot after chemotherapy|1|||
49148540|NCT03574389|158385196|FG004|Vaccination Period|Noncompliance With Investigational Product|0|||
49148541|NCT03574389|158385197|FG005|Vaccination Period|Noncompliance With Investigational Product|0|||
49148542|NCT03574389|158385198|FG006|Vaccination Period|Noncompliance With Investigational Product|0|||
49148543|NCT03574389|158385192|FG000|Vaccination Period|Withdrawal by Parent/guardian|26|||
49148544|NCT03574389|158385193|FG001|Vaccination Period|Withdrawal by Parent/guardian|21|||
49148545|NCT03574389|158385194|FG002|Vaccination Period|Withdrawal by Parent/guardian|10|||
49148546|NCT03574389|158385195|FG003|Vaccination Period|Withdrawal by Parent/guardian|19|||
49148547|NCT03574389|158385196|FG004|Vaccination Period|Withdrawal by Parent/guardian|0|||
49148548|NCT03574389|158385197|FG005|Vaccination Period|Withdrawal by Parent/guardian|0|||
49148549|NCT03574389|158385198|FG006|Vaccination Period|Withdrawal by Parent/guardian|0|||
49148550|NCT03574389|158385192|FG000|Vaccination Period|Other|6|||
49148551|NCT03574389|158385193|FG001|Vaccination Period|Other|0|||
49148552|NCT03574389|158385194|FG002|Vaccination Period|Other|0|||
49148553|NCT03574389|158385195|FG003|Vaccination Period|Other|0|||
49148554|NCT03574389|158385196|FG004|Vaccination Period|Other|0|||
48823900|NCT00293462|157195514|FG000|Overall Study|Ischemic stroke after chemotherapy|0|||
48823901|NCT00293462|157195515|FG001|Overall Study|Ischemic stroke after chemotherapy|0|||
48823902|NCT00293462|157195516|FG002|Overall Study|Ischemic stroke after chemotherapy|1|||
48823903|NCT00293462|157195514|FG000|Overall Study|Possible Tracheostomy leakage|0|||
48823904|NCT00293462|157195515|FG001|Overall Study|Possible Tracheostomy leakage|1|||
48823905|NCT00293462|157195516|FG002|Overall Study|Possible Tracheostomy leakage|0|||
48823906|NCT00293462|157195514|FG000|Overall Study|Low radiation dose in oral cavity|0|||
48823907|NCT00293462|157195515|FG001|Overall Study|Low radiation dose in oral cavity|1|||
48823908|NCT00293462|157195516|FG002|Overall Study|Low radiation dose in oral cavity|0|||
48823909|NCT00293462|157195514|FG000|Overall Study|Physician Decision|0|||
48823910|NCT00293462|157195515|FG001|Overall Study|Physician Decision|1|||
49148555|NCT03574389|158385197|FG005|Vaccination Period|Other|0|||
48921444|NCT02970292|157546393|FG000|Overall Study|Adverse Event|5|||
49148556|NCT03574389|158385198|FG006|Vaccination Period|Other|0|||
49148557|NCT03574389|158385192|FG000|Vaccination Period|Adverse Event|0|||
49148558|NCT03574389|158385193|FG001|Vaccination Period|Adverse Event|1|||
49148559|NCT03574389|158385194|FG002|Vaccination Period|Adverse Event|0|||
48823911|NCT00293462|157195516|FG002|Overall Study|Physician Decision|0|||
48921445|NCT02970292|157546394|FG001|Overall Study|Adverse Event|0|||
48921446|NCT02970292|157546393|FG000|Overall Study|Lack of Efficacy|1|||
48921447|NCT02970292|157546394|FG001|Overall Study|Lack of Efficacy|0|||
48921448|NCT02970292|157546393|FG000|Overall Study|Lost to Follow-up|1|||
49148560|NCT03574389|158385195|FG003|Vaccination Period|Adverse Event|0|||
49148561|NCT03574389|158385196|FG004|Vaccination Period|Adverse Event|0|||
49148562|NCT03574389|158385197|FG005|Vaccination Period|Adverse Event|0|||
49148563|NCT03574389|158385198|FG006|Vaccination Period|Adverse Event|0|||
49148564|NCT03574389|158385192|FG000|Follow-up Period|Withdrawal by parent/guardian|1|||
49148565|NCT03574389|158385193|FG001|Follow-up Period|Withdrawal by parent/guardian|13|||
49148566|NCT03574389|158385194|FG002|Follow-up Period|Withdrawal by parent/guardian|9|||
49148567|NCT03574389|158385195|FG003|Follow-up Period|Withdrawal by parent/guardian|9|||
49148568|NCT03574389|158385196|FG004|Follow-up Period|Withdrawal by parent/guardian|7|||
49148569|NCT03574389|158385197|FG005|Follow-up Period|Withdrawal by parent/guardian|7|||
49148570|NCT03574389|158385198|FG006|Follow-up Period|Withdrawal by parent/guardian|1|||
49148571|NCT01517178|158385199|FG000|Period 1|Adverse Event|1|||
49148572|NCT01517178|158385200|FG001|Period 1|Adverse Event|2|||
49148573|NCT01517178|158385199|FG000|Period 1|Lack of Efficacy|0|||
49148574|NCT01517178|158385200|FG001|Period 1|Lack of Efficacy|1|||
49148575|NCT01517178|158385199|FG000|Period 1|E.g. study termination|3|||
49148576|NCT01517178|158385200|FG001|Period 1|E.g. study termination|1|||
49148577|NCT01517178|158385199|FG000|Period 1|Withdrawal by Subject|0|||
49148578|NCT01517178|158385200|FG001|Period 1|Withdrawal by Subject|1|||
49148579|NCT01517178|158385199|FG000|Period 2|Adverse Event|1|||
49148580|NCT01517178|158385200|FG001|Period 2|Adverse Event|0|||
49148581|NCT01517178|158385199|FG000|Period 2|Withdrawal by Subject|3|||
49148582|NCT01517178|158385200|FG001|Period 2|Withdrawal by Subject|0|||
49148583|NCT01517178|158385199|FG000|Period 2|E.g. study termination|2|||
49148584|NCT01517178|158385200|FG001|Period 2|E.g. study termination|2|||
49148585|NCT01908699|158385201|FG000|Overall Study|Adverse Event|8|||
49148586|NCT01908699|158385202|FG001|Overall Study|Adverse Event|12|||
49148587|NCT01908699|158385201|FG000|Overall Study|Lack of Efficacy|2|||
49148588|NCT01908699|158385202|FG001|Overall Study|Lack of Efficacy|2|||
49148589|NCT01908699|158385201|FG000|Overall Study|Lost to Follow-up|2|||
49148590|NCT01908699|158385202|FG001|Overall Study|Lost to Follow-up|4|||
49148591|NCT01908699|158385201|FG000|Overall Study|Physician Decision|8|||
49148592|NCT01908699|158385202|FG001|Overall Study|Physician Decision|8|||
49148593|NCT01908699|158385201|FG000|Overall Study|Withdrawal by Subject|15|||
49148594|NCT01908699|158385202|FG001|Overall Study|Withdrawal by Subject|10|||
49148595|NCT01908699|158385201|FG000|Overall Study|Pregnancy|0|||
49148596|NCT01908699|158385202|FG001|Overall Study|Pregnancy|1|||
49148597|NCT01908699|158385201|FG000|Overall Study|Randomized in Error|1|||
49148598|NCT01908699|158385202|FG001|Overall Study|Randomized in Error|0|||
49148599|NCT01908699|158385201|FG000|Overall Study|Death|9|||
49148600|NCT01908699|158385202|FG001|Overall Study|Death|12|||
49148601|NCT01908699|158385201|FG000|Overall Study|Progressive Disease|30|||
49148602|NCT01908699|158385202|FG001|Overall Study|Progressive Disease|29|||
49148603|NCT00493285|158385205|FG000|Overall Study|Lost to Follow-up|0|||
49148604|NCT00493285|158385206|FG001|Overall Study|Lost to Follow-up|0|||
49148605|NCT00493285|158385207|FG002|Overall Study|Lost to Follow-up|0|||
49148606|NCT00493285|158385208|FG003|Overall Study|Lost to Follow-up|0|||
49148607|NCT00493285|158385209|FG004|Overall Study|Lost to Follow-up|1|||
49148608|NCT00493285|158385210|FG005|Overall Study|Lost to Follow-up|0|||
48730991|NCT00191646|156865974|FG000|Overall Study|Disease Progression|5|||
48730992|NCT00191646|156865975|FG001|Overall Study|Disease Progression|6|||
48730993|NCT00191646|156865974|FG000|Overall Study|Physician Decision|20|||
48730994|NCT00191646|156865975|FG001|Overall Study|Physician Decision|11|||
48730995|NCT00191646|156865974|FG000|Overall Study|Withdrawal by Subject|58|||
48730996|NCT00191646|156865975|FG001|Overall Study|Withdrawal by Subject|39|||
48730997|NCT00191646|156865974|FG000|Overall Study|Protocol Violation|5|||
48730998|NCT00191646|156865975|FG001|Overall Study|Protocol Violation|7|||
48730999|NCT00191646|156865974|FG000|Overall Study|Death|6|||
48731000|NCT00191646|156865975|FG001|Overall Study|Death|8|||
48731001|NCT00191646|156865974|FG000|Overall Study|Other|33|||
48731002|NCT00191646|156865975|FG001|Overall Study|Other|34|||
48731003|NCT00191646|156865974|FG000|Overall Study|Missing Data|18|||
48731004|NCT00191646|156865975|FG001|Overall Study|Missing Data|11|||
48731005|NCT01927341|156867721|FG000|Phase 1b|Lost to Follow-up|1|||
48731006|NCT01927341|156867722|FG001|Phase 1b|Lost to Follow-up|0|||
48731007|NCT01927341|156867723|FG002|Phase 1b|Lost to Follow-up|0|||
48731008|NCT01927341|156867724|FG003|Phase 1b|Lost to Follow-up|0|||
48731009|NCT01927341|156867725|FG004|Phase 1b|Lost to Follow-up|0|||
48731010|NCT01927341|156867721|FG000|Phase 1b|Death|2|||
48731011|NCT01927341|156867722|FG001|Phase 1b|Death|0|||
48731012|NCT01927341|156867723|FG002|Phase 1b|Death|0|||
48731013|NCT01927341|156867724|FG003|Phase 1b|Death|0|||
48731014|NCT01927341|156867725|FG004|Phase 1b|Death|0|||
48731015|NCT01927341|156867721|FG000|Phase 1b|Follow-up completed|7|||
48731016|NCT01927341|156867722|FG001|Phase 1b|Follow-up completed|0|||
48731017|NCT01927341|156867723|FG002|Phase 1b|Follow-up completed|0|||
48731018|NCT01927341|156867724|FG003|Phase 1b|Follow-up completed|0|||
48731019|NCT01927341|156867725|FG004|Phase 1b|Follow-up completed|0|||
48731020|NCT01927341|156867721|FG000|Phase 2|Lost to Follow-up|0|||
48731021|NCT01927341|156867722|FG001|Phase 2|Lost to Follow-up|1|||
48731022|NCT01927341|156867723|FG002|Phase 2|Lost to Follow-up|0|||
48731023|NCT01927341|156867724|FG003|Phase 2|Lost to Follow-up|0|||
48731024|NCT01927341|156867725|FG004|Phase 2|Lost to Follow-up|0|||
48731025|NCT01927341|156867721|FG000|Phase 2|Participant withdrew consent|0|||
49148609|NCT02003898|158385211|FG000|Overall Study|Death|3|||
49148610|NCT02003898|158385211|FG000|Overall Study|Lost to Follow-up|12|||
49148611|NCT02003898|158385211|FG000|Overall Study|Withdrawal by Subject|52|||
49148612|NCT04535362|158385212|FG000|Overall Study|Lost to Follow-up|3|||
49148613|NCT04535362|158385213|FG001|Overall Study|Lost to Follow-up|1|||
49148614|NCT01592747|158385220|FG000|Overall Study|Loss of Therapeutic Response|107|||
49148615|NCT01592747|158385221|FG001|Overall Study|Loss of Therapeutic Response|108|||
49148616|NCT01592747|158385222|FG002|Overall Study|Loss of Therapeutic Response|100|||
49148617|NCT01592747|158385220|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
49148618|NCT01592747|158385221|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
49148619|NCT01592747|158385222|FG002|Overall Study|Inclusion/Exclusion criteria not met|1|||
48731026|NCT01927341|156867722|FG001|Phase 2|Participant withdrew consent|2|||
48731027|NCT01927341|156867723|FG002|Phase 2|Participant withdrew consent|1|||
48731028|NCT01927341|156867724|FG003|Phase 2|Participant withdrew consent|2|||
48731029|NCT01927341|156867725|FG004|Phase 2|Participant withdrew consent|3|||
48731030|NCT01927341|156867721|FG000|Phase 2|Death|0|||
48731031|NCT01927341|156867722|FG001|Phase 2|Death|4|||
48731032|NCT01927341|156867723|FG002|Phase 2|Death|0|||
48731033|NCT01927341|156867724|FG003|Phase 2|Death|3|||
48731034|NCT01927341|156867725|FG004|Phase 2|Death|2|||
48731035|NCT01927341|156867721|FG000|Phase 2|New cancer therapy|0|||
48731036|NCT01927341|156867722|FG001|Phase 2|New cancer therapy|1|||
48731037|NCT01927341|156867723|FG002|Phase 2|New cancer therapy|0|||
49148620|NCT01592747|158385220|FG000|Overall Study|Adverse Event|1|||
49148621|NCT01592747|158385221|FG001|Overall Study|Adverse Event|0|||
49148622|NCT01592747|158385222|FG002|Overall Study|Adverse Event|0|||
49148623|NCT01592747|158385220|FG000|Overall Study|Protocol Violation|4|||
49148624|NCT01592747|158385221|FG001|Overall Study|Protocol Violation|0|||
49148625|NCT01592747|158385222|FG002|Overall Study|Protocol Violation|4|||
48731038|NCT01927341|156867724|FG003|Phase 2|New cancer therapy|4|||
48731039|NCT01927341|156867725|FG004|Phase 2|New cancer therapy|1|||
48731040|NCT01927341|156867721|FG000|Phase 2|Disease progression|0|||
48731041|NCT01927341|156867722|FG001|Phase 2|Disease progression|1|||
48731042|NCT01927341|156867723|FG002|Phase 2|Disease progression|1|||
48731043|NCT01927341|156867724|FG003|Phase 2|Disease progression|1|||
48731044|NCT01927341|156867725|FG004|Phase 2|Disease progression|0|||
48731045|NCT01927341|156867721|FG000|Phase 2|Follow-up completed|0|||
48731046|NCT01927341|156867722|FG001|Phase 2|Follow-up completed|6|||
48731047|NCT01927341|156867723|FG002|Phase 2|Follow-up completed|3|||
48731048|NCT01927341|156867724|FG003|Phase 2|Follow-up completed|5|||
49148626|NCT01592747|158385220|FG000|Overall Study|Lack of Efficacy|0|||
49148627|NCT01592747|158385221|FG001|Overall Study|Lack of Efficacy|1|||
49148628|NCT01592747|158385222|FG002|Overall Study|Lack of Efficacy|0|||
48731049|NCT01927341|156867725|FG004|Phase 2|Follow-up completed|2|||
48731050|NCT00884377|156867726|FG000|Overall Study|Withdrawal by Subject|1|||
48731051|NCT00884377|156867727|FG001|Overall Study|Withdrawal by Subject|0|||
48731052|NCT00884377|156867726|FG000|Overall Study|Could not confirm diagnosis|1|||
48731053|NCT00884377|156867727|FG001|Overall Study|Could not confirm diagnosis|0|||
48731054|NCT00884377|156867726|FG000|Overall Study|Physician Decision|0|||
48731055|NCT00884377|156867727|FG001|Overall Study|Physician Decision|1|||
48731056|NCT01397201|156867728|FG000|Overall Study|Not treated|0|||
48731057|NCT01397201|156867729|FG001|Overall Study|Not treated|0|||
48731058|NCT01397201|156867730|FG002|Overall Study|Not treated|1|||
48731059|NCT01397201|156867731|FG003|Overall Study|Not treated|0|||
48731060|NCT01397201|156867732|FG004|Overall Study|Not treated|0|||
48731061|NCT01397201|156867728|FG000|Overall Study|Not yet defined|3|||
48731062|NCT01397201|156867729|FG001|Overall Study|Not yet defined|6|||
48731063|NCT01397201|156867730|FG002|Overall Study|Not yet defined|5|||
48731064|NCT01397201|156867731|FG003|Overall Study|Not yet defined|5|||
48731065|NCT01397201|156867732|FG004|Overall Study|Not yet defined|4|||
48731066|NCT01397201|156867728|FG000|Overall Study|Adverse Event|2|||
48731067|NCT01397201|156867729|FG001|Overall Study|Adverse Event|0|||
48731068|NCT01397201|156867730|FG002|Overall Study|Adverse Event|0|||
48731069|NCT01397201|156867731|FG003|Overall Study|Adverse Event|0|||
48731070|NCT01397201|156867732|FG004|Overall Study|Adverse Event|0|||
48731071|NCT00562627|156867739|FG000|Overall Study|Protocol Violation|1|||
48731072|NCT00562627|156867740|FG001|Overall Study|Protocol Violation|1|||
48731073|NCT00562627|156867741|FG002|Overall Study|Protocol Violation|1|||
48731074|NCT00122278|156867742|FG000|Overall Study|Lost to Follow-up|2|||
48731075|NCT00122278|156867743|FG001|Overall Study|Lost to Follow-up|0|||
48731076|NCT01994590|156867749|FG000|Overall Study|Adverse Event|1|||
48731077|NCT01994590|156867749|FG000|Overall Study|Trial Terminated|1|||
48921449|NCT02970292|157546394|FG001|Overall Study|Lost to Follow-up|0|||
48921450|NCT02970292|157546393|FG000|Overall Study|Protocol Violation|2|||
48921451|NCT02970292|157546394|FG001|Overall Study|Protocol Violation|0|||
48921452|NCT02970292|157546393|FG000|Overall Study|Other|1|||
48921453|NCT02970292|157546394|FG001|Overall Study|Other|0|||
48921454|NCT00193063|157546397|FG000|Overall Study|Lack of Efficacy|3|||
49148629|NCT01592747|158385220|FG000|Overall Study|Withdrawal by Subject|2|||
48921455|NCT00193063|157546397|FG000|Overall Study|Adverse Event|1|||
48731085|NCT04761822|156867757|FG000|Overall Study|Adverse Event|3|||
49148630|NCT01592747|158385221|FG001|Overall Study|Withdrawal by Subject|0|||
49148631|NCT01592747|158385222|FG002|Overall Study|Withdrawal by Subject|2|||
49148632|NCT01592747|158385220|FG000|Overall Study|Lost to Follow-up|1|||
49148633|NCT01592747|158385221|FG001|Overall Study|Lost to Follow-up|0|||
49148634|NCT01592747|158385222|FG002|Overall Study|Lost to Follow-up|1|||
49148635|NCT01592747|158385220|FG000|Overall Study|Other Reasons|1|||
49148636|NCT01592747|158385221|FG001|Overall Study|Other Reasons|1|||
49148637|NCT01592747|158385222|FG002|Overall Study|Other Reasons|0|||
49148638|NCT00266032|158385223|FG000|Treatment|Adverse Event|42|||
49148639|NCT00266032|158385224|FG001|Treatment|Adverse Event|26|||
49148640|NCT00266032|158385225|FG002|Treatment|Adverse Event|10|||
49148641|NCT00266032|158385223|FG000|Treatment|Lost to Follow-up|19|||
49148642|NCT00266032|158385224|FG001|Treatment|Lost to Follow-up|4|||
49148643|NCT00266032|158385225|FG002|Treatment|Lost to Follow-up|2|||
49148644|NCT00266032|158385223|FG000|Treatment|Pregnancy|3|||
49148645|NCT00266032|158385224|FG001|Treatment|Pregnancy|2|||
49148646|NCT00266032|158385225|FG002|Treatment|Pregnancy|2|||
49148647|NCT00266032|158385223|FG000|Treatment|Protocol Violation|6|||
49148648|NCT00266032|158385224|FG001|Treatment|Protocol Violation|14|||
49148649|NCT00266032|158385225|FG002|Treatment|Protocol Violation|13|||
49148650|NCT00266032|158385223|FG000|Treatment|Withdrawal by Subject|28|||
49148651|NCT00266032|158385224|FG001|Treatment|Withdrawal by Subject|13|||
49148652|NCT00266032|158385225|FG002|Treatment|Withdrawal by Subject|12|||
49148653|NCT00266032|158385223|FG000|Treatment|patient moved/wish for pregnancy/no need|13|||
49148654|NCT00266032|158385224|FG001|Treatment|patient moved/wish for pregnancy/no need|5|||
49148655|NCT00266032|158385225|FG002|Treatment|patient moved/wish for pregnancy/no need|8|||
49148656|NCT00266032|158385223|FG000|Open-label Safety Extension|Adverse Event|5|||
49148657|NCT00266032|158385224|FG001|Open-label Safety Extension|Adverse Event|0|||
49148658|NCT00266032|158385225|FG002|Open-label Safety Extension|Adverse Event|4|||
49148659|NCT00266032|158385223|FG000|Open-label Safety Extension|Lost to Follow-up|2|||
49148660|NCT00266032|158385224|FG001|Open-label Safety Extension|Lost to Follow-up|5|||
49148661|NCT00266032|158385225|FG002|Open-label Safety Extension|Lost to Follow-up|4|||
49148662|NCT00266032|158385223|FG000|Open-label Safety Extension|Pregnancy|4|||
48731086|NCT04761822|156867758|FG001|Overall Study|Adverse Event|1|||
48731087|NCT04761822|156867759|FG002|Overall Study|Adverse Event|1|||
48731088|NCT04761822|156867760|FG003|Overall Study|Adverse Event|3|||
48731089|NCT04761822|156867757|FG000|Overall Study|Lost to Follow-up|1|||
48731090|NCT04761822|156867758|FG001|Overall Study|Lost to Follow-up|0|||
48731091|NCT04761822|156867759|FG002|Overall Study|Lost to Follow-up|2|||
48731092|NCT04761822|156867760|FG003|Overall Study|Lost to Follow-up|3|||
48731093|NCT04761822|156867757|FG000|Overall Study|Physician Decision|0|||
48731094|NCT04761822|156867758|FG001|Overall Study|Physician Decision|1|||
48731095|NCT04761822|156867759|FG002|Overall Study|Physician Decision|0|||
48731096|NCT04761822|156867760|FG003|Overall Study|Physician Decision|0|||
48731097|NCT04761822|156867757|FG000|Overall Study|Withdrawal by Subject|3|||
48731098|NCT04761822|156867758|FG001|Overall Study|Withdrawal by Subject|8|||
48731099|NCT04761822|156867759|FG002|Overall Study|Withdrawal by Subject|1|||
48731100|NCT04761822|156867760|FG003|Overall Study|Withdrawal by Subject|11|||
48731101|NCT04761822|156867757|FG000|Overall Study|Previously rec'd COVID-19 vaccine|1|||
48731102|NCT04761822|156867758|FG001|Overall Study|Previously rec'd COVID-19 vaccine|0|||
48731103|NCT04761822|156867759|FG002|Overall Study|Previously rec'd COVID-19 vaccine|0|||
48731104|NCT04761822|156867760|FG003|Overall Study|Previously rec'd COVID-19 vaccine|0|||
48731105|NCT04761822|156867757|FG000|Overall Study|Participant requested unblinding|0|||
48731106|NCT04761822|156867758|FG001|Overall Study|Participant requested unblinding|0|||
48731107|NCT04761822|156867759|FG002|Overall Study|Participant requested unblinding|0|||
48731108|NCT04761822|156867760|FG003|Overall Study|Participant requested unblinding|1|||
48731109|NCT02395016|156867761|FG000|Overall Study|Adverse Event|4|||
48731110|NCT02395016|156867762|FG001|Overall Study|Adverse Event|3|||
48731111|NCT02395016|156867761|FG000|Overall Study|Withdrawal by Subject|9|||
48731112|NCT02395016|156867762|FG001|Overall Study|Withdrawal by Subject|6|||
48731113|NCT02395016|156867761|FG000|Overall Study|Protocol Violation|2|||
48731114|NCT02395016|156867762|FG001|Overall Study|Protocol Violation|3|||
48731115|NCT01442038|156867764|FG000|Overall Study|Death|35|||
48731116|NCT01442038|156867765|FG001|Overall Study|Death|29|||
48731117|NCT01442038|156867764|FG000|Overall Study|Investigator-Initiated Early Closure|44|||
48731118|NCT01442038|156867765|FG001|Overall Study|Investigator-Initiated Early Closure|43|||
48731119|NCT01442038|156867764|FG000|Overall Study|Participant Withdrew Consent|137|||
49148663|NCT00266032|158385224|FG001|Open-label Safety Extension|Pregnancy|1|||
49148664|NCT00266032|158385225|FG002|Open-label Safety Extension|Pregnancy|2|||
49148665|NCT00266032|158385223|FG000|Open-label Safety Extension|Protocol Violation|1|||
49148666|NCT00266032|158385224|FG001|Open-label Safety Extension|Protocol Violation|3|||
49148667|NCT00266032|158385225|FG002|Open-label Safety Extension|Protocol Violation|2|||
49148668|NCT00266032|158385223|FG000|Open-label Safety Extension|Withdrawal by Subject|19|||
49148669|NCT00266032|158385224|FG001|Open-label Safety Extension|Withdrawal by Subject|3|||
49148670|NCT00266032|158385225|FG002|Open-label Safety Extension|Withdrawal by Subject|12|||
49148671|NCT00266032|158385223|FG000|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10|||
48823912|NCT00688688|157195517|FG000|Overall Study|Eligibility criterion not met|7|||
48823913|NCT00688688|157195518|FG001|Overall Study|Eligibility criterion not met|7|||
48823914|NCT00688688|157195519|FG002|Overall Study|Eligibility criterion not met|10|||
48823915|NCT00688688|157195517|FG000|Overall Study|Adverse Event|52|||
48823916|NCT00688688|157195518|FG001|Overall Study|Adverse Event|51|||
48823917|NCT00688688|157195519|FG002|Overall Study|Adverse Event|50|||
48823918|NCT00688688|157195517|FG000|Overall Study|Lack of Efficacy|34|||
48823919|NCT00688688|157195518|FG001|Overall Study|Lack of Efficacy|25|||
48823920|NCT00688688|157195519|FG002|Overall Study|Lack of Efficacy|45|||
48823921|NCT00688688|157195517|FG000|Overall Study|Withdrawal by Subject|66|||
48823922|NCT00688688|157195518|FG001|Overall Study|Withdrawal by Subject|75|||
48823923|NCT00688688|157195519|FG002|Overall Study|Withdrawal by Subject|65|||
48823924|NCT00688688|157195517|FG000|Overall Study|Lost to Follow-up|14|||
48823925|NCT00688688|157195518|FG001|Overall Study|Lost to Follow-up|7|||
48823926|NCT00688688|157195519|FG002|Overall Study|Lost to Follow-up|7|||
48823927|NCT00688688|157195517|FG000|Overall Study|Protocol Violation|6|||
48823928|NCT00688688|157195518|FG001|Overall Study|Protocol Violation|9|||
48823929|NCT00688688|157195519|FG002|Overall Study|Protocol Violation|11|||
48823930|NCT00688688|157195517|FG000|Overall Study|Randomized but never received study drug|1|||
48823931|NCT00688688|157195518|FG001|Overall Study|Randomized but never received study drug|0|||
48823932|NCT00688688|157195519|FG002|Overall Study|Randomized but never received study drug|0|||
48823933|NCT00688688|157195517|FG000|Overall Study|Non-compliance with study procedures|5|||
48823934|NCT00688688|157195518|FG001|Overall Study|Non-compliance with study procedures|3|||
48823935|NCT00688688|157195519|FG002|Overall Study|Non-compliance with study procedures|4|||
48823936|NCT00688688|157195517|FG000|Overall Study|Taking exclusionary medications|1|||
48823937|NCT00688688|157195518|FG001|Overall Study|Taking exclusionary medications|0|||
48823938|NCT00688688|157195519|FG002|Overall Study|Taking exclusionary medications|0|||
48823939|NCT00688688|157195517|FG000|Overall Study|Site closure|0|||
48823940|NCT00688688|157195518|FG001|Overall Study|Site closure|1|||
48823941|NCT00688688|157195519|FG002|Overall Study|Site closure|0|||
49148672|NCT00266032|158385224|FG001|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2|||
49148673|NCT00266032|158385225|FG002|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1|||
49148674|NCT00124657|158385227|FG000|Overall Study|Toxicity|0|||
49148675|NCT00124657|158385228|FG001|Overall Study|Toxicity|0|||
49148676|NCT00124657|158385229|FG002|Overall Study|Toxicity|1|||
49148677|NCT00124657|158385227|FG000|Overall Study|Non-compliance|1|||
49148678|NCT00124657|158385228|FG001|Overall Study|Non-compliance|0|||
49148679|NCT00124657|158385229|FG002|Overall Study|Non-compliance|4|||
49148680|NCT00124657|158385227|FG000|Overall Study|Progressive disease|14|||
49148681|NCT00124657|158385228|FG001|Overall Study|Progressive disease|5|||
49148682|NCT00124657|158385229|FG002|Overall Study|Progressive disease|27|||
49148683|NCT00124657|158385227|FG000|Overall Study|Intercurrent illness|1|||
48823942|NCT00688688|157195517|FG000|Overall Study|Violation of exclusion criterion|0|||
48823943|NCT00688688|157195518|FG001|Overall Study|Violation of exclusion criterion|1|||
48823944|NCT00688688|157195519|FG002|Overall Study|Violation of exclusion criterion|0|||
48823945|NCT02950545|157195520|FG000|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
48823946|NCT02950545|157195521|FG001|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
48823947|NCT02950545|157195522|FG002|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
48823948|NCT02950545|157195523|FG003|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
49148684|NCT00124657|158385228|FG001|Overall Study|Intercurrent illness|0|||
49148685|NCT00124657|158385229|FG002|Overall Study|Intercurrent illness|0|||
49148686|NCT04985682|158385232|FG000|Overall Study|Withdrawal by Subject|1|||
49148687|NCT05122143|158385233|FG000|Overall Study|Adverse Event|1|||
49148688|NCT05122143|158385234|FG001|Overall Study|Adverse Event|0|||
49148689|NCT05122143|158385235|FG002|Overall Study|Adverse Event|0|||
49148690|NCT05122143|158385236|FG003|Overall Study|Adverse Event|0|||
48823949|NCT02950545|157195524|FG004|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
48823950|NCT02950545|157195525|FG005|Session 1 (70 Minutes)|Withdrawal by Subject|1|||
48823951|NCT02950545|157195520|FG000|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
48823952|NCT02950545|157195521|FG001|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
48823953|NCT02950545|157195522|FG002|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
48823954|NCT02950545|157195523|FG003|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
49148691|NCT05122143|158385237|FG004|Overall Study|Adverse Event|1|||
49148692|NCT05122143|158385238|FG005|Overall Study|Adverse Event|0|||
49148693|NCT05122143|158385233|FG000|Overall Study|Protocol non-compliance|0|||
48823955|NCT02950545|157195524|FG004|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
49148694|NCT05122143|158385234|FG001|Overall Study|Protocol non-compliance|0|||
49148695|NCT05122143|158385235|FG002|Overall Study|Protocol non-compliance|1|||
49148696|NCT05122143|158385236|FG003|Overall Study|Protocol non-compliance|0|||
49148697|NCT05122143|158385237|FG004|Overall Study|Protocol non-compliance|0|||
49148698|NCT05122143|158385238|FG005|Overall Study|Protocol non-compliance|0|||
49148699|NCT05122143|158385233|FG000|Overall Study|Covid contact|0|||
49148700|NCT05122143|158385234|FG001|Overall Study|Covid contact|0|||
49148701|NCT05122143|158385235|FG002|Overall Study|Covid contact|0|||
49148702|NCT05122143|158385236|FG003|Overall Study|Covid contact|0|||
49148703|NCT05122143|158385237|FG004|Overall Study|Covid contact|1|||
49148704|NCT05122143|158385238|FG005|Overall Study|Covid contact|0|||
49148705|NCT01475825|158385244|FG000|Overall Study|Adverse Event|41|||
49148706|NCT01475825|158385245|FG001|Overall Study|Adverse Event|15|||
49148707|NCT01475825|158385246|FG002|Overall Study|Adverse Event|27|||
49148708|NCT01475825|158385247|FG003|Overall Study|Adverse Event|11|||
49148709|NCT01475825|158385244|FG000|Overall Study|Death|1|||
49148710|NCT01475825|158385245|FG001|Overall Study|Death|0|||
49148711|NCT01475825|158385246|FG002|Overall Study|Death|1|||
49148712|NCT01475825|158385247|FG003|Overall Study|Death|0|||
49148713|NCT01475825|158385244|FG000|Overall Study|Lack of Efficacy|0|||
49148714|NCT01475825|158385245|FG001|Overall Study|Lack of Efficacy|0|||
49148715|NCT01475825|158385246|FG002|Overall Study|Lack of Efficacy|1|||
49148716|NCT01475825|158385247|FG003|Overall Study|Lack of Efficacy|0|||
49148717|NCT01475825|158385244|FG000|Overall Study|Lost to Follow-up|0|||
49148718|NCT01475825|158385245|FG001|Overall Study|Lost to Follow-up|0|||
49148719|NCT01475825|158385246|FG002|Overall Study|Lost to Follow-up|3|||
49148720|NCT01475825|158385247|FG003|Overall Study|Lost to Follow-up|1|||
49148721|NCT01475825|158385244|FG000|Overall Study|Non-compliance with Study Drug|1|||
49148722|NCT01475825|158385245|FG001|Overall Study|Non-compliance with Study Drug|2|||
49148723|NCT01475825|158385246|FG002|Overall Study|Non-compliance with Study Drug|4|||
49148724|NCT01475825|158385247|FG003|Overall Study|Non-compliance with Study Drug|0|||
49148725|NCT01475825|158385244|FG000|Overall Study|Other: Not available|0|||
49148726|NCT01475825|158385245|FG001|Overall Study|Other: Not available|0|||
49148727|NCT01475825|158385246|FG002|Overall Study|Other: Not available|2|||
49148728|NCT01475825|158385247|FG003|Overall Study|Other: Not available|0|||
49148729|NCT01475825|158385244|FG000|Overall Study|Protocol Violation|1|||
49148730|NCT01475825|158385245|FG001|Overall Study|Protocol Violation|0|||
49148731|NCT01475825|158385246|FG002|Overall Study|Protocol Violation|0|||
49148732|NCT01475825|158385247|FG003|Overall Study|Protocol Violation|0|||
49148733|NCT01475825|158385244|FG000|Overall Study|Physician Decision|0|||
49148734|NCT01475825|158385245|FG001|Overall Study|Physician Decision|1|||
49148735|NCT01475825|158385246|FG002|Overall Study|Physician Decision|0|||
49148736|NCT01475825|158385247|FG003|Overall Study|Physician Decision|0|||
49148737|NCT01475825|158385244|FG000|Overall Study|Withdrawal by Subject|8|||
49148738|NCT01475825|158385245|FG001|Overall Study|Withdrawal by Subject|3|||
49148739|NCT01475825|158385246|FG002|Overall Study|Withdrawal by Subject|11|||
49148740|NCT01475825|158385247|FG003|Overall Study|Withdrawal by Subject|7|||
49148741|NCT01475825|158385244|FG000|Overall Study|Did not enter OLC|15|||
49148742|NCT01475825|158385245|FG001|Overall Study|Did not enter OLC|11|||
49148743|NCT01475825|158385246|FG002|Overall Study|Did not enter OLC|15|||
49148744|NCT01475825|158385247|FG003|Overall Study|Did not enter OLC|11|||
49148745|NCT04157738|158385250|FG000|Overall Study|Moved out of state|0|||
49148746|NCT04157738|158385251|FG001|Overall Study|Moved out of state|2|||
49148747|NCT04157738|158385250|FG000|Overall Study|Did not show up to the Follow-up appointment|1|||
49148748|NCT04157738|158385251|FG001|Overall Study|Did not show up to the Follow-up appointment|0|||
49148749|NCT00309946|158385252|FG000|Overall Study|Withdrawal by Subject|1|||
49148750|NCT02244957|158385256|FG000|Overall Study|Lack of Efficacy|1|||
49148751|NCT02244957|158385257|FG001|Overall Study|Lack of Efficacy|0|||
49148752|NCT01347086|158385259|FG000|Overall Study|failed screening visit|0|||
49148753|NCT01347086|158385260|FG001|Overall Study|failed screening visit|0|||
49148754|NCT01347086|158385261|FG002|Overall Study|failed screening visit|1|||
49148755|NCT01347086|158385262|FG003|Overall Study|failed screening visit|0|||
49148756|NCT01347086|158385263|FG004|Overall Study|failed screening visit|0|||
49148757|NCT01347086|158385264|FG005|Overall Study|failed screening visit|0|||
49148758|NCT01347086|158385265|FG006|Overall Study|failed screening visit|1|||
48731120|NCT01442038|156867765|FG001|Overall Study|Participant Withdrew Consent|102|||
48731121|NCT01442038|156867764|FG000|Overall Study|Lost to Follow-up|37|||
48731122|NCT01442038|156867765|FG001|Overall Study|Lost to Follow-up|51|||
48731123|NCT01442038|156867764|FG000|Overall Study|Adverse Event|26|||
48731124|NCT01442038|156867765|FG001|Overall Study|Adverse Event|15|||
48731125|NCT01442038|156867764|FG000|Overall Study|Protocol Deviation|9|||
48731126|NCT01442038|156867765|FG001|Overall Study|Protocol Deviation|20|||
48731127|NCT01442038|156867764|FG000|Overall Study|Investigator's Discretion|13|||
49148759|NCT01347086|158385266|FG007|Overall Study|failed screening visit|1|||
49148760|NCT01347086|158385267|FG008|Overall Study|failed screening visit|0|||
49148761|NCT01347086|158385268|FG009|Overall Study|failed screening visit|1|||
49148762|NCT03766906|158385270|FG000|Overall Study|Withdrawal by Subject|6|||
48731128|NCT01442038|156867765|FG001|Overall Study|Investigator's Discretion|16|||
49148763|NCT02624687|158385271|FG000|Overall Study|Withdrawal by Subject|1|||
49148764|NCT02624687|158385272|FG001|Overall Study|Withdrawal by Subject|1|||
49148765|NCT02624687|158385271|FG000|Overall Study|medical leave from work|0|||
49148766|NCT02624687|158385272|FG001|Overall Study|medical leave from work|1|||
49148767|NCT03111108|158385273|FG000|Overall Study|Death|0|||
49148768|NCT03111108|158385274|FG001|Overall Study|Death|1|||
49148769|NCT03111108|158385273|FG000|Overall Study|Withdrawal by Subject|1|||
49148770|NCT03111108|158385274|FG001|Overall Study|Withdrawal by Subject|0|||
49148771|NCT01689649|158385279|FG000|Overall Study|Lack of Efficacy|3|||
49148772|NCT01689649|158385279|FG000|Overall Study|Non-compliance|11|||
49148773|NCT01689649|158385279|FG000|Overall Study|Protocol Violation|3|||
49148774|NCT01689649|158385279|FG000|Overall Study|Lost to Follow-up|5|||
49148775|NCT03760081|158385280|FG000|Overall Study|Miscellaneous|0|||
49148776|NCT03760081|158385281|FG001|Overall Study|Miscellaneous|1|||
49148777|NCT03760081|158385280|FG000|Overall Study|Progressive Disease|5|||
49148778|NCT03760081|158385281|FG001|Overall Study|Progressive Disease|10|||
49148779|NCT03760081|158385280|FG000|Overall Study|Death|1|||
49148780|NCT03760081|158385281|FG001|Overall Study|Death|1|||
48731129|NCT01442038|156867764|FG000|Overall Study|Study Terminated By Sponsor|2|||
49148781|NCT04725188|158385283|FG000|Overall Study|Death|44|||
49148782|NCT04725188|158385284|FG001|Overall Study|Death|46|||
49148783|NCT04725188|158385285|FG002|Overall Study|Death|48|||
49148784|NCT04725188|158385283|FG000|Overall Study|Lost to Follow-up|0|||
49148785|NCT04725188|158385284|FG001|Overall Study|Lost to Follow-up|0|||
49148786|NCT04725188|158385285|FG002|Overall Study|Lost to Follow-up|1|||
49148787|NCT04725188|158385283|FG000|Overall Study|Withdrawal by Subject|2|||
49148788|NCT04725188|158385284|FG001|Overall Study|Withdrawal by Subject|2|||
48731130|NCT01442038|156867765|FG001|Overall Study|Study Terminated By Sponsor|3|||
48731131|NCT00089284|156867766|FG000|Overall Study|Adverse event before starting treatment|0|||
48731132|NCT00089284|156867767|FG001|Overall Study|Adverse event before starting treatment|0|||
48731133|NCT00089284|156867768|FG002|Overall Study|Adverse event before starting treatment|0|||
48731134|NCT00089284|156867769|FG003|Overall Study|Adverse event before starting treatment|0|||
48731135|NCT00089284|156867770|FG004|Overall Study|Adverse event before starting treatment|0|||
48731136|NCT00089284|156867771|FG005|Overall Study|Adverse event before starting treatment|0|||
48731137|NCT00089284|156867772|FG006|Overall Study|Adverse event before starting treatment|1|||
48731138|NCT00053365|156867773|FG000|Overall Study|Incorrect cell type|1|||
48731139|NCT00053365|156867773|FG000|Overall Study|Platinum-sensitive interval >12 months|1|||
48731140|NCT00053365|156867773|FG000|Overall Study|Never treated|4|||
48731141|NCT00478881|156867779|FG000|Overall Study|Adverse Event|31|||
48731142|NCT00478881|156867780|FG001|Overall Study|Adverse Event|12|||
48731143|NCT00478881|156867779|FG000|Overall Study|Lack of Efficacy|0|||
48731144|NCT00478881|156867780|FG001|Overall Study|Lack of Efficacy|3|||
48731145|NCT00478881|156867779|FG000|Overall Study|Lost to Follow-up|0|||
48731146|NCT00478881|156867780|FG001|Overall Study|Lost to Follow-up|1|||
48731147|NCT00478881|156867779|FG000|Overall Study|Protocol Violation|2|||
49148789|NCT04725188|158385285|FG002|Overall Study|Withdrawal by Subject|1|||
49148790|NCT04725188|158385283|FG000|Overall Study|Participants ongoing in the study|41|||
49148791|NCT04725188|158385284|FG001|Overall Study|Participants ongoing in the study|35|||
49148792|NCT04725188|158385285|FG002|Overall Study|Participants ongoing in the study|35|||
49148793|NCT03258593|158385287|FG000|Run-In Maintenance Phase|Disease recurrence|4|||
49148794|NCT03258593|158385288|FG001|Run-In Maintenance Phase|Disease recurrence|0|||
49148795|NCT03258593|158385289|FG002|Run-In Maintenance Phase|Disease recurrence|0|||
49148796|NCT03258593|158385290|FG003|Run-In Maintenance Phase|Disease recurrence|0|||
48731148|NCT00478881|156867780|FG001|Overall Study|Protocol Violation|2|||
48731149|NCT00478881|156867779|FG000|Overall Study|Withdrawal by Subject|6|||
48731150|NCT00478881|156867780|FG001|Overall Study|Withdrawal by Subject|2|||
48731151|NCT00478881|156867779|FG000|Overall Study|Non-Compliance with Study Medication|0|||
48731152|NCT00478881|156867780|FG001|Overall Study|Non-Compliance with Study Medication|2|||
48731153|NCT03956056|156867781|FG000|Overall Study|Cannot make vaccine due to lack of tissue variants|2|||
48731154|NCT03956056|156867781|FG000|Overall Study|Lack of Efficacy|1|||
48731155|NCT01193660|156867785|FG000|Overall Study|Withdrawal by Subject|2|||
48731156|NCT01193660|156867786|FG001|Overall Study|Withdrawal by Subject|3|||
48731157|NCT01193660|156867787|FG002|Overall Study|Withdrawal by Subject|1|||
48731158|NCT01193660|156867785|FG000|Overall Study|Death|1|||
49148797|NCT03258593|158385287|FG000|Run-In Maintenance Phase|Disease progression|3|||
49148798|NCT03258593|158385288|FG001|Run-In Maintenance Phase|Disease progression|0|||
49148799|NCT03258593|158385289|FG002|Run-In Maintenance Phase|Disease progression|0|||
49148800|NCT03258593|158385290|FG003|Run-In Maintenance Phase|Disease progression|0|||
49148801|NCT03258593|158385287|FG000|Expansion Maintenance Phase|Withdrawal by Subject|0|||
48823956|NCT02950545|157195525|FG005|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
48823957|NCT02950545|157195520|FG000|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
48823958|NCT02950545|157195521|FG001|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
48823959|NCT02950545|157195522|FG002|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
48823960|NCT02950545|157195523|FG003|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
48823961|NCT02950545|157195524|FG004|Session 2 (70 Minutes)|Withdrawal by Subject|1|||
48823962|NCT02950545|157195525|FG005|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
48823963|NCT02950545|157195520|FG000|Washout 2 (5 Minutes)|Withdrawal by Subject|1|||
48823964|NCT02950545|157195521|FG001|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
48823965|NCT02950545|157195522|FG002|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
48823966|NCT02950545|157195523|FG003|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
48823967|NCT02950545|157195524|FG004|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
48823968|NCT02950545|157195525|FG005|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
48823969|NCT02950545|157195520|FG000|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
48823970|NCT02950545|157195521|FG001|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
48823971|NCT02950545|157195522|FG002|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
48823972|NCT02950545|157195523|FG003|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
48823973|NCT02950545|157195524|FG004|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
48823974|NCT02950545|157195525|FG005|Session 3 (70 Minutes)|Withdrawal by Subject|1|||
48823975|NCT04003974|157195526|FG000|Overall Study|Missing|1|||
48823976|NCT04003974|157195527|FG001|Overall Study|Missing|0|||
48823977|NCT04003974|157195526|FG000|Overall Study|Withdrawal by Subject|0|||
48823978|NCT04003974|157195527|FG001|Overall Study|Withdrawal by Subject|2|||
48823979|NCT02478359|157195528|FG000|Overall Study|Disenrolled from health plan|106|||
48823980|NCT02478359|157195529|FG001|Overall Study|Disenrolled from health plan|65|||
48823981|NCT01770860|157195530|FG000|Overall Study|Withdrawal by Subject|4|||
48823982|NCT01770860|157195530|FG000|Overall Study|Lost to Follow-up|1|||
48823983|NCT01770860|157195530|FG000|Overall Study|Administrative decision made by the PI|1|||
48823984|NCT02100722|157195531|FG000|Overall Study|Withdrawal pre-procedure|4|||
48823985|NCT02100722|157195532|FG001|Overall Study|Withdrawal pre-procedure|9|||
48823986|NCT02100722|157195531|FG000|Overall Study|Withdrawal post-procedure|0|||
48823987|NCT02100722|157195532|FG001|Overall Study|Withdrawal post-procedure|3|||
48823988|NCT02100722|157195531|FG000|Overall Study|Lost to Follow-up|2|||
48823989|NCT02100722|157195532|FG001|Overall Study|Lost to Follow-up|2|||
48823990|NCT02100722|157195531|FG000|Overall Study|Continuing on study|751|||
49148802|NCT03258593|158385288|FG001|Expansion Maintenance Phase|Withdrawal by Subject|1|||
49148803|NCT03258593|158385289|FG002|Expansion Maintenance Phase|Withdrawal by Subject|0|||
49148804|NCT03258593|158385290|FG003|Expansion Maintenance Phase|Withdrawal by Subject|0|||
49148805|NCT03258593|158385287|FG000|Expansion Maintenance Phase|Physician Decision|0|||
49148806|NCT03258593|158385288|FG001|Expansion Maintenance Phase|Physician Decision|1|||
49148807|NCT03258593|158385289|FG002|Expansion Maintenance Phase|Physician Decision|0|||
49148808|NCT03258593|158385290|FG003|Expansion Maintenance Phase|Physician Decision|0|||
49148809|NCT03464461|158385291|FG000|Overall Study|exclusionary medication given ,|1|||
49148810|NCT03464461|158385292|FG001|Overall Study|exclusionary medication given ,|2|||
49148811|NCT03464461|158385293|FG002|Overall Study|exclusionary medication given ,|0|||
49148812|NCT03464461|158385291|FG000|Overall Study|Physician Decision|0|||
49148813|NCT03464461|158385292|FG001|Overall Study|Physician Decision|1|||
49148814|NCT03464461|158385293|FG002|Overall Study|Physician Decision|0|||
49148815|NCT00595075|158385294|FG000|Overall Study|Withdrawal by Subject|1|||
49148816|NCT00595075|158385295|FG001|Overall Study|Withdrawal by Subject|0|||
49148817|NCT04008069|158385296|FG000|Open-Label Period|Adverse Event|1|||
49148818|NCT04008069|158385297|FG001|Open-Label Period|Adverse Event|0|||
49148819|NCT04008069|158385298|FG002|Open-Label Period|Adverse Event|0|||
49148820|NCT04008069|158385296|FG000|Open-Label Period|Lack of Efficacy|4|||
49148821|NCT04008069|158385297|FG001|Open-Label Period|Lack of Efficacy|0|||
49148822|NCT04008069|158385298|FG002|Open-Label Period|Lack of Efficacy|0|||
49148823|NCT04008069|158385296|FG000|Randomized-Withdrawal Period|Adverse Event|0|||
49148824|NCT04008069|158385297|FG001|Randomized-Withdrawal Period|Adverse Event|1|||
49148825|NCT04008069|158385298|FG002|Randomized-Withdrawal Period|Adverse Event|2|||
49148826|NCT04008069|158385296|FG000|Randomized-Withdrawal Period|Lack of Efficacy|0|||
49148827|NCT04008069|158385297|FG001|Randomized-Withdrawal Period|Lack of Efficacy|0|||
49148828|NCT04008069|158385298|FG002|Randomized-Withdrawal Period|Lack of Efficacy|1|||
49148829|NCT01674062|158385299|FG000|Overall Study|Insufficient Therapeutic Response|56|||
48823991|NCT02100722|157195532|FG001|Overall Study|Continuing on study|729|||
48823992|NCT01528709|157195533|FG000|Overall Study|Death|2|||
48921456|NCT00143455|157546400|FG000|Cohort 1|Adverse Event|8|||
49148830|NCT01674062|158385300|FG001|Overall Study|Insufficient Therapeutic Response|26|||
49148831|NCT01674062|158385299|FG000|Overall Study|Other|8|||
48823993|NCT01528709|157195534|FG001|Overall Study|Death|0|||
48823994|NCT01528709|157195533|FG000|Overall Study|Withdrawal by Subject|10|||
48823995|NCT01528709|157195534|FG001|Overall Study|Withdrawal by Subject|15|||
48921457|NCT00143455|157546401|FG001|Cohort 1|Adverse Event|4|||
49148832|NCT01674062|158385300|FG001|Overall Study|Other|1|||
49148833|NCT01674062|158385299|FG000|Overall Study|Adverse Event|1|||
48731159|NCT01193660|156867786|FG001|Overall Study|Death|0|||
48731160|NCT01193660|156867787|FG002|Overall Study|Death|0|||
48731161|NCT01193660|156867785|FG000|Overall Study|Physician Decision|1|||
49148834|NCT01674062|158385300|FG001|Overall Study|Adverse Event|1|||
49148835|NCT01674062|158385299|FG000|Overall Study|Death|0|||
49148836|NCT01674062|158385300|FG001|Overall Study|Death|1|||
49148837|NCT01674062|158385299|FG000|Overall Study|Programming Error|1|||
49148838|NCT01674062|158385300|FG001|Overall Study|Programming Error|0|||
49148839|NCT04620668|158385301|FG000|Overall Study|Withdrawal by Subject|2|||
49148840|NCT04620668|158385302|FG001|Overall Study|Withdrawal by Subject|0|||
49148841|NCT04620668|158385301|FG000|Overall Study|Ineligible despite claims at outset of the study|1|||
49148842|NCT04620668|158385302|FG001|Overall Study|Ineligible despite claims at outset of the study|0|||
49148843|NCT04620668|158385301|FG000|Overall Study|Removed before analysis: missing data|2|||
49148844|NCT04620668|158385302|FG001|Overall Study|Removed before analysis: missing data|0|||
49148845|NCT04620668|158385301|FG000|Overall Study|Removed before analysis: failed multiple quality check questions|1|||
49148846|NCT04620668|158385302|FG001|Overall Study|Removed before analysis: failed multiple quality check questions|2|||
49148847|NCT04620668|158385301|FG000|Overall Study|Removed before analysis: statistical outlier|1|||
49148848|NCT04620668|158385302|FG001|Overall Study|Removed before analysis: statistical outlier|2|||
49148849|NCT01946880|158385303|FG000|Overall Study|Lost to Follow-up|1|||
49148850|NCT01946880|158385304|FG001|Overall Study|Lost to Follow-up|0|||
49148851|NCT01946880|158385303|FG000|Overall Study|Physician Decision|1|||
49148852|NCT01946880|158385304|FG001|Overall Study|Physician Decision|1|||
49148853|NCT01946880|158385303|FG000|Overall Study|Withdrawal by Subject|3|||
49148854|NCT01946880|158385304|FG001|Overall Study|Withdrawal by Subject|2|||
49148855|NCT01946880|158385303|FG000|Overall Study|Met Primary Endpoint|1|||
49148856|NCT01946880|158385304|FG001|Overall Study|Met Primary Endpoint|0|||
49148857|NCT01946880|158385303|FG000|Overall Study|Personal and Family Issues|1|||
49148858|NCT01946880|158385304|FG001|Overall Study|Personal and Family Issues|0|||
49148859|NCT00511199|158385305|FG000|Overall Study|Unacceptable Vaginal Bleeding|63|||
49148860|NCT00511199|158385306|FG001|Overall Study|Unacceptable Vaginal Bleeding|4|||
49148861|NCT00511199|158385305|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|227|||
49148862|NCT00511199|158385306|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|52|||
49148863|NCT00511199|158385305|FG000|Overall Study|Withdrawal of Informed Consent|19|||
49148864|NCT00511199|158385306|FG001|Overall Study|Withdrawal of Informed Consent|4|||
49148865|NCT00511199|158385305|FG000|Overall Study|Pregnancy|6|||
49148866|NCT00511199|158385306|FG001|Overall Study|Pregnancy|3|||
49148867|NCT00511199|158385305|FG000|Overall Study|Pregnancy Wish|16|||
49148868|NCT00511199|158385306|FG001|Overall Study|Pregnancy Wish|8|||
49148869|NCT00511199|158385305|FG000|Overall Study|Lost to Follow-up|40|||
49148870|NCT00511199|158385306|FG001|Overall Study|Lost to Follow-up|17|||
49148871|NCT00511199|158385305|FG000|Overall Study|Other Reason|78|||
49148872|NCT00511199|158385306|FG001|Overall Study|Other Reason|37|||
49148873|NCT01687595|158385307|FG000|Overall Study|Withdrawal by Subject|8|||
49148874|NCT01687595|158385308|FG001|Overall Study|Withdrawal by Subject|0|||
48731162|NCT01193660|156867786|FG001|Overall Study|Physician Decision|0|||
48731163|NCT01193660|156867787|FG002|Overall Study|Physician Decision|1|||
48731164|NCT02595970|156867788|FG000|Overall Study|Withdrawal by Subject|2|||
48731165|NCT02595970|156867788|FG000|Overall Study|Physician Decision|2|||
48731166|NCT02595970|156867788|FG000|Overall Study|Protocol Violation|4|||
48731167|NCT02595970|156867788|FG000|Overall Study|Adverse Event|5|||
48731168|NCT02595970|156867788|FG000|Overall Study|Lack of Efficacy|7|||
48731169|NCT02367131|156867789|FG000|Overall Study|Adverse Event|64|||
48731170|NCT02367131|156867789|FG000|Overall Study|No visit since the first visit|3|||
48731171|NCT02367131|156867789|FG000|Overall Study|Request by patient|53|||
48823996|NCT01528709|157195533|FG000|Overall Study|allergy|1|||
49148875|NCT01687595|158385307|FG000|Overall Study|Lost to Follow-up|3|||
49148876|NCT01687595|158385308|FG001|Overall Study|Lost to Follow-up|1|||
49148877|NCT01687595|158385307|FG000|Overall Study|Investigator's decision|1|||
49148878|NCT01687595|158385308|FG001|Overall Study|Investigator's decision|0|||
49148879|NCT01687595|158385307|FG000|Overall Study|Sponsor's decision|1|||
49148880|NCT01687595|158385308|FG001|Overall Study|Sponsor's decision|0|||
49148881|NCT01687595|158385307|FG000|Overall Study|Noncompliance|1|||
48731172|NCT02367131|156867789|FG000|Overall Study|Improvement/remission|2|||
48731173|NCT02367131|156867789|FG000|Overall Study|No change/progressive disease|78|||
49148882|NCT01687595|158385308|FG001|Overall Study|Noncompliance|2|||
49148883|NCT01687595|158385307|FG000|Overall Study|Other than specified|56|||
48823997|NCT01528709|157195534|FG001|Overall Study|allergy|0|||
49148884|NCT01687595|158385308|FG001|Overall Study|Other than specified|7|||
48823998|NCT01237678|157195535|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5|||
48823999|NCT01237678|157195536|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
49148885|NCT00489359|158385309|FG000|Overall Study|Death|0|||
49148886|NCT00489359|158385310|FG001|Overall Study|Death|2|||
49148887|NCT00489359|158385309|FG000|Overall Study|Progressive Disease|5|||
49148888|NCT00489359|158385310|FG001|Overall Study|Progressive Disease|6|||
49148889|NCT00489359|158385309|FG000|Overall Study|Lost to Follow-up|1|||
48921458|NCT00143455|157546402|FG002|Cohort 1|Adverse Event|0|||
49148890|NCT00489359|158385310|FG001|Overall Study|Lost to Follow-up|0|||
49148891|NCT00489359|158385309|FG000|Overall Study|Withdrawal by Subject|1|||
49148892|NCT00489359|158385310|FG001|Overall Study|Withdrawal by Subject|5|||
49148893|NCT00489359|158385309|FG000|Overall Study|Adverse Event|0|||
49148894|NCT00489359|158385310|FG001|Overall Study|Adverse Event|16|||
49148895|NCT00456365|158385311|FG000|Overall Study|Lost to Follow-up|1|||
49148896|NCT00456365|158385312|FG001|Overall Study|Lost to Follow-up|3|||
49148897|NCT00456365|158385311|FG000|Overall Study|Withdrawal by Subject|4|||
49148898|NCT00456365|158385312|FG001|Overall Study|Withdrawal by Subject|7|||
49148899|NCT00456365|158385311|FG000|Overall Study|Pregnancy|1|||
49148900|NCT00456365|158385312|FG001|Overall Study|Pregnancy|1|||
49148901|NCT00456365|158385311|FG000|Overall Study|oncologic diagnosis|1|||
49148902|NCT00456365|158385312|FG001|Overall Study|oncologic diagnosis|1|||
49148903|NCT01714063|158385313|FG000|Overall Study|Equipment malfunction|2|||
49148904|NCT00345592|158385314|FG000|Overall Study|Death|14|||
49148905|NCT00345592|158385315|FG001|Overall Study|Death|16|||
49148906|NCT00345592|158385314|FG000|Overall Study|Withdrawal by Subject|11|||
49148907|NCT00345592|158385315|FG001|Overall Study|Withdrawal by Subject|8|||
49148908|NCT00468546|158385323|FG000|Week 24 Analysis|Lack of Efficacy|83|||
49148909|NCT00468546|158385324|FG001|Week 24 Analysis|Lack of Efficacy|37|||
49148910|NCT00468546|158385323|FG000|Week 24 Analysis|Refused treatment|5|||
49148911|NCT00468546|158385324|FG001|Week 24 Analysis|Refused treatment|5|||
49148912|NCT00468546|158385323|FG000|Week 24 Analysis|Adverse Event|1|||
49148913|NCT00468546|158385324|FG001|Week 24 Analysis|Adverse Event|8|||
49148914|NCT00468546|158385323|FG000|Week 24 Analysis|Failure to return|3|||
49148915|NCT00468546|158385324|FG001|Week 24 Analysis|Failure to return|4|||
49148916|NCT00468546|158385323|FG000|Week 24 Analysis|Rescue therapy|2|||
49148917|NCT00468546|158385324|FG001|Week 24 Analysis|Rescue therapy|0|||
49148918|NCT00468546|158385323|FG000|Week 24 Analysis|Incorrect diagnosis and treatment|0|||
49148919|NCT00468546|158385324|FG001|Week 24 Analysis|Incorrect diagnosis and treatment|1|||
49148920|NCT00468546|158385323|FG000|Week 24 Analysis|Due to clinical hold|1|||
49148921|NCT00468546|158385324|FG001|Week 24 Analysis|Due to clinical hold|0|||
49148922|NCT00468546|158385323|FG000|Week 24 Analysis|Went onto rescue therapy|1|||
49148923|NCT00468546|158385324|FG001|Week 24 Analysis|Went onto rescue therapy|0|||
49148924|NCT00468546|158385323|FG000|Week 24 Analysis|Participant unblinded (clinical hold)|1|||
49148925|NCT00468546|158385324|FG001|Week 24 Analysis|Participant unblinded (clinical hold)|0|||
49148926|NCT00468546|158385323|FG000|Week 24 to Week 104 Analysis|Adverse Event|2|||
49148927|NCT00468546|158385324|FG001|Week 24 to Week 104 Analysis|Adverse Event|5|||
49148928|NCT00468546|158385323|FG000|Week 24 to Week 104 Analysis|Death|1|||
49148929|NCT00468546|158385324|FG001|Week 24 to Week 104 Analysis|Death|0|||
49013917|NCT05216978|157887237|FG000|Overall Study|Withdrawal by Subject|3|||
49013918|NCT05216978|157887237|FG000|Overall Study|Lost to Follow-up|5|||
49013919|NCT02180061|157887238|FG000|Overall Study|Adverse Event|4|||
49013920|NCT02180061|157887239|FG001|Overall Study|Adverse Event|2|||
49013921|NCT02180061|157887238|FG000|Overall Study|Clinical Progression|5|||
49013922|NCT02180061|157887239|FG001|Overall Study|Clinical Progression|1|||
49013923|NCT02180061|157887238|FG000|Overall Study|Progressive Disease|15|||
49013924|NCT02180061|157887239|FG001|Overall Study|Progressive Disease|5|||
49013925|NCT02180061|157887238|FG000|Overall Study|Physician Decision|1|||
49013926|NCT02180061|157887239|FG001|Overall Study|Physician Decision|0|||
49013927|NCT01808209|157887243|FG000|Overall Study|Lost to Follow-up|0|||
49013928|NCT01808209|157887244|FG001|Overall Study|Lost to Follow-up|1|||
49013929|NCT00472446|157887245|FG000|Overall Study|Protocol Violation|0|||
49013930|NCT00472446|157887246|FG001|Overall Study|Protocol Violation|0|||
49013931|NCT00472446|157887247|FG002|Overall Study|Protocol Violation|0|||
49013932|NCT00472446|157887248|FG003|Overall Study|Protocol Violation|1|||
49013933|NCT00472446|157887245|FG000|Overall Study|Reintervention|0|||
49013934|NCT00472446|157887246|FG001|Overall Study|Reintervention|0|||
49013935|NCT00472446|157887247|FG002|Overall Study|Reintervention|1|||
49013936|NCT00472446|157887248|FG003|Overall Study|Reintervention|1|||
49013937|NCT00472446|157887245|FG000|Overall Study|Questionnaires not returned|5|||
49013938|NCT00472446|157887246|FG001|Overall Study|Questionnaires not returned|6|||
49013939|NCT00472446|157887247|FG002|Overall Study|Questionnaires not returned|6|||
49013940|NCT00472446|157887248|FG003|Overall Study|Questionnaires not returned|4|||
49013941|NCT00910858|157887249|FG000|Pharmacokinetic Phase|Adverse Event|1|||
49013942|NCT00910858|157887250|FG001|Pharmacokinetic Phase|Adverse Event|0|||
49013943|NCT00910858|157887251|FG002|Pharmacokinetic Phase|Adverse Event|0|||
49013944|NCT00910858|157887249|FG000|Monotherapy Phase|Adverse Event|3|||
49013945|NCT00910858|157887250|FG001|Monotherapy Phase|Adverse Event|2|||
49013946|NCT00910858|157887251|FG002|Monotherapy Phase|Adverse Event|0|||
49013947|NCT00910858|157887249|FG000|Monotherapy Phase|Lack of therapeutic effect|9|||
49013948|NCT00910858|157887250|FG001|Monotherapy Phase|Lack of therapeutic effect|6|||
49013949|NCT00910858|157887251|FG002|Monotherapy Phase|Lack of therapeutic effect|4|||
49013950|NCT00910858|157887249|FG000|Monotherapy Phase|Withdrawal by Subject|1|||
49013951|NCT00910858|157887250|FG001|Monotherapy Phase|Withdrawal by Subject|3|||
49148930|NCT00468546|158385323|FG000|Week 24 to Week 104 Analysis|Lack of Efficacy|3|||
49148931|NCT00468546|158385324|FG001|Week 24 to Week 104 Analysis|Lack of Efficacy|12|||
49148932|NCT00468546|158385323|FG000|Week 24 to Week 104 Analysis|Protocol Violation|0|||
49148933|NCT00468546|158385324|FG001|Week 24 to Week 104 Analysis|Protocol Violation|2|||
49148934|NCT00468546|158385323|FG000|Week 24 to Week 104 Analysis|Refused treatment|4|||
49148935|NCT00468546|158385324|FG001|Week 24 to Week 104 Analysis|Refused treatment|7|||
49148936|NCT00468546|158385323|FG000|Week 24 to Week 104 Analysis|Failure to return|1|||
48731174|NCT02367131|156867789|FG000|Overall Study|Other than stated above|20|||
48731175|NCT02367131|156867789|FG000|Overall Study|Not treated|2|||
49148937|NCT00468546|158385324|FG001|Week 24 to Week 104 Analysis|Failure to return|2|||
49148938|NCT00468546|158385323|FG000|Week 24 to Week 104 Analysis|Movement into re-treatment study|77|||
49148939|NCT00468546|158385324|FG001|Week 24 to Week 104 Analysis|Movement into re-treatment study|183|||
48731176|NCT02428608|156867793|FG000|Overall Study|Pregnancy|2|||
48731177|NCT02428608|156867793|FG000|Overall Study|Lost to Follow-up|37|||
48731178|NCT02428608|156867793|FG000|Overall Study|Withdrawal by Subject|2|||
48731179|NCT02428608|156867793|FG000|Overall Study|scheduling conflicts|15|||
48731180|NCT02428608|156867793|FG000|Overall Study|moved away|10|||
48731181|NCT02428608|156867793|FG000|Overall Study|Death|1|||
48731182|NCT02428608|156867793|FG000|Overall Study|various|16|||
48731183|NCT04073368|156867797|FG000|Overall Study|Adverse Event|2|||
48731184|NCT04073368|156867798|FG001|Overall Study|Adverse Event|0|||
48731185|NCT04073368|156867799|FG002|Overall Study|Adverse Event|1|||
48731186|NCT04073368|156867800|FG003|Overall Study|Adverse Event|1|||
48731187|NCT04073368|156867797|FG000|Overall Study|Withdrawal by Subject|2|||
48731188|NCT04073368|156867798|FG001|Overall Study|Withdrawal by Subject|2|||
48731189|NCT04073368|156867799|FG002|Overall Study|Withdrawal by Subject|1|||
48731190|NCT04073368|156867800|FG003|Overall Study|Withdrawal by Subject|1|||
48731191|NCT04073368|156867797|FG000|Overall Study|Lost to Follow-up|1|||
48731192|NCT04073368|156867798|FG001|Overall Study|Lost to Follow-up|1|||
48731193|NCT04073368|156867799|FG002|Overall Study|Lost to Follow-up|1|||
48824000|NCT01237678|157195537|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
48824001|NCT01237678|157195535|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24|||
48824002|NCT01237678|157195536|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
48824003|NCT01237678|157195537|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
48824004|NCT01237678|157195535|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3|||
48824005|NCT01237678|157195536|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
48824006|NCT01237678|157195537|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
48824007|NCT01237678|157195535|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1|||
48824008|NCT01237678|157195536|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
48824009|NCT01237678|157195537|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
48824010|NCT01237678|157195535|FG000|Phase II|Adverse Event|0|||
48824011|NCT01237678|157195536|FG001|Phase II|Adverse Event|39|||
48824012|NCT01237678|157195537|FG002|Phase II|Adverse Event|9|||
48824013|NCT01237678|157195535|FG000|Phase II|Death|0|||
48824014|NCT01237678|157195536|FG001|Phase II|Death|0|||
48824015|NCT01237678|157195537|FG002|Phase II|Death|2|||
48824016|NCT01237678|157195535|FG000|Phase II|Lack of Efficacy|0|||
48824017|NCT01237678|157195536|FG001|Phase II|Lack of Efficacy|25|||
48824018|NCT01237678|157195537|FG002|Phase II|Lack of Efficacy|3|||
48824019|NCT01237678|157195535|FG000|Phase II|Withdrawal by Subject|0|||
48824020|NCT01237678|157195536|FG001|Phase II|Withdrawal by Subject|1|||
48824021|NCT01237678|157195537|FG002|Phase II|Withdrawal by Subject|5|||
48824022|NCT01237678|157195535|FG000|Phase II|Completed Cycles 4-6|0|||
48824023|NCT01237678|157195536|FG001|Phase II|Completed Cycles 4-6|11|||
48824024|NCT01237678|157195537|FG002|Phase II|Completed Cycles 4-6|21|||
48824025|NCT01237678|157195535|FG000|Phase II|Sponsor Decision/Study Closed|0|||
48824026|NCT01237678|157195536|FG001|Phase II|Sponsor Decision/Study Closed|18|||
48824027|NCT01237678|157195537|FG002|Phase II|Sponsor Decision/Study Closed|7|||
48824028|NCT01237678|157195535|FG000|Phase II|Randomized but were not treated|0|||
48824029|NCT01237678|157195536|FG001|Phase II|Randomized but were not treated|4|||
49148940|NCT00468546|158385323|FG000|Week 24 to Week 104 Analysis|Other|17|||
49148941|NCT00468546|158385324|FG001|Week 24 to Week 104 Analysis|Other|14|||
49148942|NCT01922895|158385325|FG000|Overall Study|Death|0|||
49148943|NCT01922895|158385326|FG001|Overall Study|Death|1|||
49148944|NCT01922895|158385325|FG000|Overall Study|Withdrawal by Subject|1|||
49148945|NCT01922895|158385326|FG001|Overall Study|Withdrawal by Subject|2|||
49148946|NCT01922895|158385325|FG000|Overall Study|Lost to Follow-up|5|||
49148947|NCT01922895|158385326|FG001|Overall Study|Lost to Follow-up|11|||
49148948|NCT04918771|158385327|FG000|Overall Study|Withdrawal by Subject|4|||
49148949|NCT04918771|158385328|FG001|Overall Study|Withdrawal by Subject|5|||
49148950|NCT04918771|158385327|FG000|Overall Study|Incorrect inclusion ineligible patient|3|||
49148951|NCT04918771|158385328|FG001|Overall Study|Incorrect inclusion ineligible patient|4|||
49148952|NCT00855166|158385329|FG000|Overall Study|Adverse Event|0|||
48731194|NCT04073368|156867800|FG003|Overall Study|Lost to Follow-up|0|||
48731195|NCT04073368|156867797|FG000|Overall Study|Protocol Violation|0|||
48731196|NCT04073368|156867798|FG001|Overall Study|Protocol Violation|1|||
48731197|NCT04073368|156867799|FG002|Overall Study|Protocol Violation|0|||
48731198|NCT04073368|156867800|FG003|Overall Study|Protocol Violation|0|||
48731199|NCT04073368|156867797|FG000|Overall Study|Subject noncompliance|7|||
48731200|NCT04073368|156867798|FG001|Overall Study|Subject noncompliance|4|||
48731201|NCT04073368|156867799|FG002|Overall Study|Subject noncompliance|0|||
48731202|NCT04073368|156867800|FG003|Overall Study|Subject noncompliance|0|||
48731203|NCT00900601|156867801|FG000|Overall Study|Physician Decision|1|||
48731204|NCT02106910|156867809|FG000|Overall Study|Lost to Follow-up|1|||
49148953|NCT00855166|158385330|FG001|Overall Study|Adverse Event|2|||
49148954|NCT00855166|158385329|FG000|Overall Study|Death|0|||
49148955|NCT00855166|158385330|FG001|Overall Study|Death|1|||
49148956|NCT00855166|158385329|FG000|Overall Study|Withdrawal by Subject|1|||
49148957|NCT00855166|158385330|FG001|Overall Study|Withdrawal by Subject|4|||
49148958|NCT00855166|158385329|FG000|Overall Study|Poor/non-compliance|2|||
49148959|NCT00855166|158385330|FG001|Overall Study|Poor/non-compliance|0|||
49148960|NCT00855166|158385329|FG000|Overall Study|Administrative reasons by sponsor|1|||
49148961|NCT00855166|158385330|FG001|Overall Study|Administrative reasons by sponsor|0|||
49148962|NCT00855166|158385329|FG000|Overall Study|Subject no longer meets study criteria|1|||
49148963|NCT00855166|158385330|FG001|Overall Study|Subject no longer meets study criteria|1|||
49148964|NCT03996395|158385332|FG000|Overall Study|Lost to Follow-up|4|||
49148965|NCT03996395|158385332|FG000|Overall Study|Withdrawal by Subject|1|||
49148966|NCT03996395|158385332|FG000|Overall Study|Study halted due to COVID-19 pandemic.|7|||
49148967|NCT02496156|158385333|FG000|Overall Study|Lost to Follow-up|5|||
49148968|NCT02496156|158385334|FG001|Overall Study|Lost to Follow-up|0|||
49148969|NCT02496156|158385333|FG000|Overall Study|13SDM dyads did not access Decision Aids|0|||
49148970|NCT02496156|158385334|FG001|Overall Study|13SDM dyads did not access Decision Aids|13|||
49148971|NCT04349098|158385335|FG000|Overall Study|Death|16|||
48731205|NCT02106910|156867810|FG001|Overall Study|Lost to Follow-up|1|||
48731206|NCT01134315|156867819|FG000|Overall Study|Adverse Event|1|||
48731207|NCT01134315|156867820|FG001|Overall Study|Adverse Event|2|||
48731208|NCT01134315|156867819|FG000|Overall Study|Other Reason|8|||
48731209|NCT01134315|156867820|FG001|Overall Study|Other Reason|17|||
48731210|NCT01251744|156867823|FG000|Overall Study|Lost to Follow-up|1|||
48731211|NCT01251744|156867824|FG001|Overall Study|Lost to Follow-up|0|||
48731212|NCT05939388|156867828|FG000|Overall Study|Lost to Follow-up|1|||
48731213|NCT01822678|156867833|FG000|Overall Study|Withdrawal by Subject|5|||
48731214|NCT01822678|156867834|FG001|Overall Study|Withdrawal by Subject|4|||
48731215|NCT01822678|156867835|FG002|Overall Study|Withdrawal by Subject|4|||
48731216|NCT01822678|156867833|FG000|Overall Study|Adverse Event|4|||
49148972|NCT04349098|158385336|FG001|Overall Study|Death|8|||
49148973|NCT04349098|158385335|FG000|Overall Study|Lost to Follow-up|11|||
49148974|NCT04349098|158385336|FG001|Overall Study|Lost to Follow-up|8|||
49148975|NCT04349098|158385335|FG000|Overall Study|Withdrawal by Subject|8|||
49148976|NCT04349098|158385336|FG001|Overall Study|Withdrawal by Subject|5|||
48731217|NCT01822678|156867834|FG001|Overall Study|Adverse Event|3|||
48731218|NCT01822678|156867835|FG002|Overall Study|Adverse Event|1|||
48731219|NCT01822678|156867833|FG000|Overall Study|Lack of Efficacy|3|||
48731220|NCT01822678|156867834|FG001|Overall Study|Lack of Efficacy|6|||
48731221|NCT01822678|156867835|FG002|Overall Study|Lack of Efficacy|5|||
48731222|NCT01822678|156867833|FG000|Overall Study|Lost to Follow-up|0|||
48731223|NCT01822678|156867834|FG001|Overall Study|Lost to Follow-up|2|||
48731224|NCT01822678|156867835|FG002|Overall Study|Lost to Follow-up|1|||
48731225|NCT04041375|156867836|FG000|Intervention Phase|Withdrawal by Subject|2|||
48731226|NCT04041375|156867837|FG001|Intervention Phase|Withdrawal by Subject|2|||
48731227|NCT04041375|156867836|FG000|Follow-up Phase|Death|2|||
48731228|NCT04041375|156867837|FG001|Follow-up Phase|Death|0|||
48731229|NCT04041375|156867836|FG000|Follow-up Phase|Lost to Follow-up|2|||
48731230|NCT04041375|156867837|FG001|Follow-up Phase|Lost to Follow-up|1|||
48731231|NCT04041375|156867836|FG000|Follow-up Phase|Too ill|3|||
48731232|NCT04041375|156867837|FG001|Follow-up Phase|Too ill|0|||
48731233|NCT01230710|156867838|FG000|Overall Study|Disease Progression|41|||
48731234|NCT01230710|156867838|FG000|Overall Study|Lost to Follow-up|3|||
48731235|NCT01230710|156867838|FG000|Overall Study|Death|4|||
48731236|NCT01230710|156867838|FG000|Overall Study|Withdrawal of Consent|1|||
48731237|NCT00943124|156867839|FG000|Period 1|Withdrawal by Subject|1|||
48731238|NCT00943124|156867840|FG001|Period 1|Withdrawal by Subject|1|||
48731239|NCT00943124|156867839|FG000|Period 1|Did Not Follow Study Procedures|1|||
48731240|NCT00943124|156867840|FG001|Period 1|Did Not Follow Study Procedures|0|||
48731241|NCT00943124|156867839|FG000|Period 1|Personal Reasons|0|||
48731242|NCT00943124|156867840|FG001|Period 1|Personal Reasons|1|||
48731243|NCT02305888|156867841|FG000|Overall Study|Lost to Follow-up|0|||
48731244|NCT02305888|156867842|FG001|Overall Study|Lost to Follow-up|0|||
48731245|NCT02305888|156867843|FG002|Overall Study|Lost to Follow-up|1|||
48731246|NCT02305888|156867841|FG000|Overall Study|Adverse Event|0|||
48731247|NCT02305888|156867842|FG001|Overall Study|Adverse Event|1|||
48731248|NCT02305888|156867843|FG002|Overall Study|Adverse Event|0|||
48731249|NCT01369615|156867844|FG000|Overall Study|Withdrawal by Subject|0|||
48921459|NCT00143455|157546403|FG003|Cohort 1|Adverse Event|0|||
49148977|NCT04349098|158385335|FG000|Overall Study|Other|3|||
49148978|NCT04349098|158385336|FG001|Overall Study|Other|5|||
49148979|NCT00112385|158385338|FG000|Overall Study|Lost to Follow-up|1|||
49148980|NCT00112385|158385339|FG001|Overall Study|Lost to Follow-up|0|||
49148981|NCT00112385|158385338|FG000|Overall Study|Withdrawal by Subject|0|||
49148982|NCT00112385|158385339|FG001|Overall Study|Withdrawal by Subject|1|||
49148983|NCT03810495|158385343|FG000|Overall Study|Lost to Follow-up|2|||
49148984|NCT03810495|158385343|FG000|Overall Study|Withdrawal by Subject|1|||
49148985|NCT02014103|158386736|FG000|Overall Study|Protocol Violation|7|||
49148986|NCT02014103|158386737|FG001|Overall Study|Protocol Violation|7|||
49148987|NCT02014103|158386736|FG000|Overall Study|Adverse Event|1|||
49148988|NCT02014103|158386737|FG001|Overall Study|Adverse Event|0|||
49148989|NCT02014103|158386736|FG000|Overall Study|Lost venous access|1|||
49148990|NCT02014103|158386737|FG001|Overall Study|Lost venous access|0|||
48731250|NCT01369615|156867845|FG001|Overall Study|Withdrawal by Subject|1|||
48731251|NCT01369615|156867844|FG000|Overall Study|Lost to Follow-up|0|||
48731252|NCT01369615|156867845|FG001|Overall Study|Lost to Follow-up|1|||
48731253|NCT01702571|156867846|FG000|Overall Study|Death|1067|||
48731254|NCT01702571|156867847|FG001|Overall Study|Death|76|||
48731255|NCT01702571|156867846|FG000|Overall Study|Lost to Follow-up|144|||
48731256|NCT01702571|156867847|FG001|Overall Study|Lost to Follow-up|10|||
48731257|NCT01702571|156867846|FG000|Overall Study|Adverse Event/Unacceptable Toxicity|4|||
48731258|NCT01702571|156867847|FG001|Overall Study|Adverse Event/Unacceptable Toxicity|0|||
49148991|NCT02014103|158386736|FG000|Overall Study|Withdrawal by Subject|0|||
49148992|NCT02014103|158386737|FG001|Overall Study|Withdrawal by Subject|2|||
49148993|NCT01882829|158386739|FG000|Overall Study|Adverse Event|4|||
48731259|NCT01702571|156867846|FG000|Overall Study|Investigator Decision|5|||
48731260|NCT01702571|156867847|FG001|Overall Study|Investigator Decision|0|||
48731261|NCT01702571|156867846|FG000|Overall Study|Not Classifiable|1|||
48731262|NCT01702571|156867847|FG001|Overall Study|Not Classifiable|0|||
48731263|NCT01702571|156867846|FG000|Overall Study|On Study Treatment At Lplv/Cohort 1|93|||
48731264|NCT01702571|156867847|FG001|Overall Study|On Study Treatment At Lplv/Cohort 1|0|||
48731265|NCT01702571|156867846|FG000|Overall Study|On Study Treatment At Lplv/Cohort 2|0|||
48731266|NCT01702571|156867847|FG001|Overall Study|On Study Treatment At Lplv/Cohort 2|1|||
48731267|NCT01702571|156867846|FG000|Overall Study|Progressive Disease|3|||
48731268|NCT01702571|156867847|FG001|Overall Study|Progressive Disease|0|||
48731269|NCT01702571|156867846|FG000|Overall Study|Protocol Violation|2|||
48731270|NCT01702571|156867847|FG001|Overall Study|Protocol Violation|0|||
48731271|NCT01702571|156867846|FG000|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9|||
48731272|NCT01702571|156867847|FG001|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1|||
48731273|NCT01702571|156867846|FG000|Overall Study|Termination By Sponsor|4|||
48731274|NCT01702571|156867847|FG001|Overall Study|Termination By Sponsor|0|||
48731275|NCT01702571|156867846|FG000|Overall Study|Withdrawal by Subject|177|||
48731276|NCT01702571|156867847|FG001|Overall Study|Withdrawal by Subject|29|||
48731277|NCT02027376|156867848|FG000|Overall Study|Death|1|||
48731278|NCT02027376|156867849|FG001|Overall Study|Death|0|||
48731279|NCT02027376|156867850|FG002|Overall Study|Death|0|||
48731280|NCT04176705|156867851|FG000|Overall Study|Withdrawal by Subject|4|||
48731281|NCT04176705|156867852|FG001|Overall Study|Withdrawal by Subject|4|||
48731282|NCT04176705|156867851|FG000|Overall Study|Death|1|||
48731283|NCT04176705|156867852|FG001|Overall Study|Death|1|||
48731284|NCT04176705|156867851|FG000|Overall Study|Lost to Follow-up|3|||
48731285|NCT04176705|156867852|FG001|Overall Study|Lost to Follow-up|3|||
48731286|NCT03104374|156867861|FG000|Overall Study|Adverse Event|7|||
48731287|NCT03104374|156867862|FG001|Overall Study|Adverse Event|6|||
48731288|NCT03104374|156867863|FG002|Overall Study|Adverse Event|12|||
48824030|NCT01237678|157195537|FG002|Phase II|Randomized but were not treated|3|||
49013952|NCT00910858|157887251|FG002|Monotherapy Phase|Withdrawal by Subject|1|||
49013953|NCT00910858|157887249|FG000|Monotherapy Phase|Protocol Violation|1|||
48824031|NCT02412761|157195538|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
49013954|NCT00910858|157887250|FG001|Monotherapy Phase|Protocol Violation|0|||
49013955|NCT00910858|157887251|FG002|Monotherapy Phase|Protocol Violation|0|||
49013956|NCT00910858|157887249|FG000|Monotherapy Phase|Other|3|||
49013957|NCT00910858|157887250|FG001|Monotherapy Phase|Other|4|||
49013958|NCT00910858|157887251|FG002|Monotherapy Phase|Other|2|||
49013959|NCT00910858|157887249|FG000|Combined Treatment Phase|Lack of therapeutic effect|8|||
49013960|NCT00910858|157887250|FG001|Combined Treatment Phase|Lack of therapeutic effect|6|||
49013961|NCT00910858|157887251|FG002|Combined Treatment Phase|Lack of therapeutic effect|3|||
49013962|NCT00910858|157887249|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
48824032|NCT02412761|157195539|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
48824033|NCT02412761|157195540|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
48824034|NCT02412761|157195541|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
48824035|NCT02412761|157195542|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
48824036|NCT02412761|157195543|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
48824037|NCT00562965|157195551|FG000|Overall Study|Withdrawal by Subject|0|||
48824038|NCT00562965|157195552|FG001|Overall Study|Withdrawal by Subject|1|||
48824039|NCT00562965|157195551|FG000|Overall Study|Death|2|||
48824040|NCT00562965|157195552|FG001|Overall Study|Death|4|||
48824041|NCT00562965|157195551|FG000|Overall Study|Lost to Follow-up|1|||
48824042|NCT00562965|157195552|FG001|Overall Study|Lost to Follow-up|0|||
48824043|NCT00562965|157195551|FG000|Overall Study|Other|0|||
48824044|NCT00562965|157195552|FG001|Overall Study|Other|1|||
48824045|NCT01657682|157195553|FG000|Overall Study|Lost to Follow-up|1|||
48824046|NCT01657682|157195554|FG001|Overall Study|Lost to Follow-up|0|||
48824047|NCT01657682|157195555|FG002|Overall Study|Lost to Follow-up|0|||
48824048|NCT01657682|157195553|FG000|Overall Study|Withdrawal by Subject|0|||
48824049|NCT01657682|157195554|FG001|Overall Study|Withdrawal by Subject|1|||
49013963|NCT00910858|157887250|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
49112467|NCT02557516|158247468|FG001|Overall Study|Sponsor decision|1|||
49112468|NCT02557516|158247469|FG002|Overall Study|Sponsor decision|2|||
49112469|NCT02557516|158247470|FG003|Overall Study|Sponsor decision|8|||
49112470|NCT04399538|158247472|FG000|Double-Blind Treatment|Work schedule conflicts|0|||
49112471|NCT04399538|158247473|FG001|Double-Blind Treatment|Work schedule conflicts|0|||
49112472|NCT04399538|158247474|FG002|Double-Blind Treatment|Work schedule conflicts|0|||
49112473|NCT04399538|158247475|FG003|Double-Blind Treatment|Work schedule conflicts|1|||
49112474|NCT04399538|158247476|FG004|Double-Blind Treatment|Work schedule conflicts|1|||
49112475|NCT04399538|158247472|FG000|Double-Blind Treatment|Adverse Event|0|||
49112476|NCT04399538|158247473|FG001|Double-Blind Treatment|Adverse Event|0|||
49112477|NCT04399538|158247474|FG002|Double-Blind Treatment|Adverse Event|0|||
48824050|NCT01657682|157195555|FG002|Overall Study|Withdrawal by Subject|1|||
48824051|NCT01657682|157195553|FG000|Overall Study|Adverse Event|0|||
48824052|NCT01657682|157195554|FG001|Overall Study|Adverse Event|1|||
48824053|NCT01657682|157195555|FG002|Overall Study|Adverse Event|0|||
48824054|NCT00958009|157195558|FG000|Overall Study|Adverse Event|1|||
48824055|NCT00958009|157195558|FG000|Overall Study|Subject found device difficult to use|1|||
48824056|NCT00821236|157195565|FG000|Overall Study|Lost to Follow-up|3|||
48824057|NCT00859014|157195568|FG000|Overall Study|Death|4|||
48824058|NCT00859014|157195568|FG000|Overall Study|Lost to Follow-up|1|||
48731289|NCT03104374|156867864|FG003|Overall Study|Adverse Event|15|||
48731290|NCT03104374|156867861|FG000|Overall Study|Withdrawal by Subject|18|||
48731291|NCT03104374|156867862|FG001|Overall Study|Withdrawal by Subject|10|||
48731292|NCT03104374|156867863|FG002|Overall Study|Withdrawal by Subject|10|||
48731293|NCT03104374|156867864|FG003|Overall Study|Withdrawal by Subject|17|||
48731294|NCT03104374|156867861|FG000|Overall Study|Lost to Follow-up|4|||
48731295|NCT03104374|156867862|FG001|Overall Study|Lost to Follow-up|4|||
48731296|NCT03104374|156867863|FG002|Overall Study|Lost to Follow-up|6|||
48731297|NCT03104374|156867864|FG003|Overall Study|Lost to Follow-up|8|||
48731298|NCT03104374|156867861|FG000|Overall Study|Lack of Efficacy|6|||
48731299|NCT03104374|156867862|FG001|Overall Study|Lack of Efficacy|7|||
48731300|NCT03104374|156867863|FG002|Overall Study|Lack of Efficacy|12|||
48731301|NCT03104374|156867864|FG003|Overall Study|Lack of Efficacy|6|||
48731302|NCT03104374|156867861|FG000|Overall Study|Other|2|||
48731303|NCT03104374|156867862|FG001|Overall Study|Other|2|||
48731304|NCT03104374|156867863|FG002|Overall Study|Other|4|||
48731305|NCT03104374|156867864|FG003|Overall Study|Other|7|||
48731306|NCT01602380|156867865|FG000|Overall Study|Death|147|||
48731307|NCT01602380|156867866|FG001|Overall Study|Death|145|||
48731308|NCT01602380|156867865|FG000|Overall Study|Withdrawal by Subject|39|||
48731309|NCT01602380|156867866|FG001|Overall Study|Withdrawal by Subject|41|||
48731310|NCT01602380|156867865|FG000|Overall Study|Lost to Follow-up|15|||
48731311|NCT01602380|156867866|FG001|Overall Study|Lost to Follow-up|12|||
48731312|NCT01602380|156867865|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
48731313|NCT01602380|156867866|FG001|Overall Study|Eligibility criteria not fulfilled|3|||
48731314|NCT01602380|156867865|FG000|Overall Study|Other|2|||
48731315|NCT01602380|156867866|FG001|Overall Study|Other|0|||
48731316|NCT02612129|156867867|FG000|Single Dose Treatment Period|Screening Failure|1|||
48731317|NCT02612129|156867868|FG001|Single Dose Treatment Period|Screening Failure|0|||
48731318|NCT02612129|156867869|FG002|Single Dose Treatment Period|Screening Failure|0|||
48731319|NCT02612129|156867867|FG000|Continuous Treatment Period|Early Escape|0|||
48731320|NCT02612129|156867868|FG001|Continuous Treatment Period|Early Escape|2|||
48731321|NCT02612129|156867869|FG002|Continuous Treatment Period|Early Escape|0|||
48731322|NCT02612129|156867867|FG000|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
48731323|NCT02612129|156867868|FG001|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|1|||
48731324|NCT02612129|156867869|FG002|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
48731325|NCT02612129|156867867|FG000|Continuous Treatment Period|Safety Reasons|0|||
48731326|NCT02612129|156867868|FG001|Continuous Treatment Period|Safety Reasons|3|||
48731327|NCT02612129|156867869|FG002|Continuous Treatment Period|Safety Reasons|0|||
48731328|NCT02612129|156867867|FG000|Continuous Treatment Period|Death|0|||
48731329|NCT02612129|156867868|FG001|Continuous Treatment Period|Death|1|||
48731330|NCT02612129|156867869|FG002|Continuous Treatment Period|Death|0|||
48731331|NCT02612129|156867867|FG000|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
48731332|NCT02612129|156867868|FG001|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
48731333|NCT02612129|156867869|FG002|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|1|||
48731334|NCT02557295|156867870|FG000|Overall Study|Withdrawal by Subject|9|||
48731335|NCT02557295|156867871|FG001|Overall Study|Withdrawal by Subject|2|||
48731336|NCT02557295|156867872|FG002|Overall Study|Withdrawal by Subject|4|||
48731337|NCT02557295|156867873|FG003|Overall Study|Withdrawal by Subject|0|||
48731338|NCT02557295|156867874|FG004|Overall Study|Withdrawal by Subject|0|||
48824059|NCT00410384|157195569|FG000|Overall Study|Withdrawal by Subject|28|||
48824060|NCT00410384|157195570|FG001|Overall Study|Withdrawal by Subject|17|||
48731339|NCT02557295|156867875|FG005|Overall Study|Withdrawal by Subject|0|||
48731340|NCT02557295|156867876|FG006|Overall Study|Withdrawal by Subject|15|||
48731341|NCT02557295|156867877|FG007|Overall Study|Withdrawal by Subject|1|||
48731342|NCT02557295|156867878|FG008|Overall Study|Withdrawal by Subject|3|||
48731343|NCT02557295|156867870|FG000|Overall Study|Disease Progression|0|||
48731344|NCT02557295|156867871|FG001|Overall Study|Disease Progression|0|||
48731345|NCT02557295|156867872|FG002|Overall Study|Disease Progression|0|||
48731346|NCT02557295|156867873|FG003|Overall Study|Disease Progression|0|||
48731347|NCT02557295|156867874|FG004|Overall Study|Disease Progression|0|||
48731348|NCT02557295|156867875|FG005|Overall Study|Disease Progression|0|||
48731349|NCT02557295|156867876|FG006|Overall Study|Disease Progression|1|||
48731350|NCT02557295|156867877|FG007|Overall Study|Disease Progression|0|||
48731351|NCT02557295|156867878|FG008|Overall Study|Disease Progression|0|||
48731352|NCT02557295|156867870|FG000|Overall Study|Lack of Efficacy|24|||
48731353|NCT02557295|156867871|FG001|Overall Study|Lack of Efficacy|1|||
48731354|NCT02557295|156867872|FG002|Overall Study|Lack of Efficacy|3|||
48731355|NCT02557295|156867873|FG003|Overall Study|Lack of Efficacy|0|||
48731356|NCT02557295|156867874|FG004|Overall Study|Lack of Efficacy|0|||
48731357|NCT02557295|156867875|FG005|Overall Study|Lack of Efficacy|0|||
48731358|NCT02557295|156867876|FG006|Overall Study|Lack of Efficacy|12|||
48731359|NCT02557295|156867877|FG007|Overall Study|Lack of Efficacy|1|||
48731360|NCT02557295|156867878|FG008|Overall Study|Lack of Efficacy|0|||
48731361|NCT02557295|156867870|FG000|Overall Study|Adverse Event|16|||
48731362|NCT02557295|156867871|FG001|Overall Study|Adverse Event|2|||
48731363|NCT02557295|156867872|FG002|Overall Study|Adverse Event|3|||
48731364|NCT02557295|156867873|FG003|Overall Study|Adverse Event|0|||
48731365|NCT02557295|156867874|FG004|Overall Study|Adverse Event|0|||
48731366|NCT02557295|156867875|FG005|Overall Study|Adverse Event|0|||
48731367|NCT02557295|156867876|FG006|Overall Study|Adverse Event|2|||
48731368|NCT02557295|156867877|FG007|Overall Study|Adverse Event|1|||
48731369|NCT02557295|156867878|FG008|Overall Study|Adverse Event|1|||
48731370|NCT02557295|156867870|FG000|Overall Study|Lost to Follow-up|4|||
48731371|NCT02557295|156867871|FG001|Overall Study|Lost to Follow-up|0|||
48731372|NCT02557295|156867872|FG002|Overall Study|Lost to Follow-up|0|||
48731373|NCT02557295|156867873|FG003|Overall Study|Lost to Follow-up|0|||
48731374|NCT02557295|156867874|FG004|Overall Study|Lost to Follow-up|0|||
48731375|NCT02557295|156867875|FG005|Overall Study|Lost to Follow-up|0|||
48731376|NCT02557295|156867876|FG006|Overall Study|Lost to Follow-up|9|||
48731377|NCT02557295|156867877|FG007|Overall Study|Lost to Follow-up|0|||
48731378|NCT02557295|156867878|FG008|Overall Study|Lost to Follow-up|0|||
48731379|NCT02557295|156867870|FG000|Overall Study|Study Close|54|||
48731380|NCT02557295|156867871|FG001|Overall Study|Study Close|3|||
48731381|NCT02557295|156867872|FG002|Overall Study|Study Close|5|||
48731382|NCT02557295|156867873|FG003|Overall Study|Study Close|3|||
48731383|NCT02557295|156867874|FG004|Overall Study|Study Close|0|||
48731384|NCT02557295|156867875|FG005|Overall Study|Study Close|0|||
48731385|NCT02557295|156867876|FG006|Overall Study|Study Close|37|||
48731386|NCT02557295|156867877|FG007|Overall Study|Study Close|3|||
48731387|NCT02557295|156867878|FG008|Overall Study|Study Close|19|||
48731388|NCT02557295|156867870|FG000|Overall Study|except for study close|4|||
48824061|NCT00410384|157195571|FG002|Overall Study|Withdrawal by Subject|20|||
49148994|NCT01882829|158386739|FG000|Overall Study|Protocol Violation|1|||
49148995|NCT01882829|158386739|FG000|Overall Study|Withdrawal by Subject|1|||
49148996|NCT05130281|158386741|FG000|Overall Study|Withdrawal by Subject|0|||
49148997|NCT05130281|158386742|FG001|Overall Study|Withdrawal by Subject|0|||
49148998|NCT05130281|158386743|FG002|Overall Study|Withdrawal by Subject|1|||
49148999|NCT03211858|158386745|FG000|Overall Study|Adverse Event|8|||
49149000|NCT03211858|158386746|FG001|Overall Study|Adverse Event|6|||
49149001|NCT03211858|158386745|FG000|Overall Study|Lack of Efficacy|0|||
49149002|NCT03211858|158386746|FG001|Overall Study|Lack of Efficacy|4|||
49149003|NCT03211858|158386745|FG000|Overall Study|Poor compliance to protocol|6|||
49149004|NCT03211858|158386746|FG001|Overall Study|Poor compliance to protocol|2|||
49149005|NCT03211858|158386745|FG000|Overall Study|Non-serious Hypoglycemia|1|||
49149006|NCT03211858|158386746|FG001|Overall Study|Non-serious Hypoglycemia|0|||
49149007|NCT03211858|158386745|FG000|Overall Study|Other than specified above|22|||
49149008|NCT03211858|158386746|FG001|Overall Study|Other than specified above|21|||
48731389|NCT02557295|156867871|FG001|Overall Study|except for study close|0|||
48731390|NCT02557295|156867872|FG002|Overall Study|except for study close|0|||
48731391|NCT02557295|156867873|FG003|Overall Study|except for study close|0|||
48731392|NCT02557295|156867874|FG004|Overall Study|except for study close|0|||
48731393|NCT02557295|156867875|FG005|Overall Study|except for study close|0|||
48824062|NCT00410384|157195569|FG000|Overall Study|Adverse Event|23|||
48731394|NCT02557295|156867876|FG006|Overall Study|except for study close|5|||
48731395|NCT02557295|156867877|FG007|Overall Study|except for study close|1|||
48731396|NCT02557295|156867878|FG008|Overall Study|except for study close|0|||
48731397|NCT04340193|156867879|FG000|Overall Study|Other reason|0|||
48731398|NCT04340193|156867880|FG001|Overall Study|Other reason|0|||
48731399|NCT04340193|156867881|FG002|Overall Study|Other reason|1|||
48731400|NCT04340193|156867879|FG000|Overall Study|Disease recurrence|0|||
48731401|NCT04340193|156867880|FG001|Overall Study|Disease recurrence|1|||
48731402|NCT04340193|156867881|FG002|Overall Study|Disease recurrence|0|||
48731403|NCT04340193|156867879|FG000|Overall Study|Study drug toxicity|1|||
48731404|NCT04340193|156867880|FG001|Overall Study|Study drug toxicity|0|||
48731405|NCT04340193|156867881|FG002|Overall Study|Study drug toxicity|0|||
48731406|NCT04340193|156867879|FG000|Overall Study|Disease progression|1|||
48731407|NCT04340193|156867880|FG001|Overall Study|Disease progression|2|||
48731408|NCT04340193|156867881|FG002|Overall Study|Disease progression|3|||
48731409|NCT04340193|156867879|FG000|Overall Study|Administrative reasons by sponsor|0|||
48731410|NCT04340193|156867880|FG001|Overall Study|Administrative reasons by sponsor|1|||
48731411|NCT04340193|156867881|FG002|Overall Study|Administrative reasons by sponsor|0|||
48731412|NCT04340193|156867879|FG000|Overall Study|Adverse Event|1|||
48731413|NCT04340193|156867880|FG001|Overall Study|Adverse Event|1|||
48731414|NCT04340193|156867881|FG002|Overall Study|Adverse Event|0|||
48731415|NCT00976677|156867884|FG000|Overall Study|Adverse Event|1|||
48731416|NCT00976677|156867885|FG001|Overall Study|Adverse Event|0|||
48731417|NCT00976677|156867884|FG000|Overall Study|Withdrawal by Subject|0|||
48731418|NCT00976677|156867885|FG001|Overall Study|Withdrawal by Subject|2|||
48731419|NCT00976677|156867884|FG000|Overall Study|Disease progression|1|||
48731420|NCT00976677|156867885|FG001|Overall Study|Disease progression|1|||
48731421|NCT00976677|156867884|FG000|Overall Study|Trial unblinded|2|||
48824063|NCT00410384|157195570|FG001|Overall Study|Adverse Event|18|||
48824064|NCT00410384|157195571|FG002|Overall Study|Adverse Event|23|||
48824065|NCT00410384|157195569|FG000|Overall Study|Lack of Efficacy|20|||
48824066|NCT00410384|157195570|FG001|Overall Study|Lack of Efficacy|12|||
48824067|NCT00410384|157195571|FG002|Overall Study|Lack of Efficacy|17|||
49149009|NCT02904265|158386748|FG000|Overall Study|Physician Decision|1|||
49149010|NCT02904265|158386749|FG001|Overall Study|Physician Decision|2|||
48824068|NCT00410384|157195569|FG000|Overall Study|Lack of Compliance|2|||
48824069|NCT00410384|157195570|FG001|Overall Study|Lack of Compliance|2|||
48824070|NCT00410384|157195571|FG002|Overall Study|Lack of Compliance|2|||
48824071|NCT00410384|157195569|FG000|Overall Study|Lost to Follow-up|4|||
48824072|NCT00410384|157195570|FG001|Overall Study|Lost to Follow-up|6|||
48824073|NCT00410384|157195571|FG002|Overall Study|Lost to Follow-up|6|||
48824074|NCT00410384|157195569|FG000|Overall Study|Protocol Violation|6|||
48824075|NCT00410384|157195570|FG001|Overall Study|Protocol Violation|6|||
48824076|NCT00410384|157195571|FG002|Overall Study|Protocol Violation|6|||
48824077|NCT00410384|157195569|FG000|Overall Study|Physician Decision|3|||
48824078|NCT00410384|157195570|FG001|Overall Study|Physician Decision|3|||
48824079|NCT00410384|157195571|FG002|Overall Study|Physician Decision|4|||
48824080|NCT00410384|157195569|FG000|Overall Study|Other|3|||
48824081|NCT00410384|157195570|FG001|Overall Study|Other|8|||
48824082|NCT00410384|157195571|FG002|Overall Study|Other|4|||
48824083|NCT01027871|157195577|FG000|Overall Study|Physician Decision|1|||
48824084|NCT01027871|157195578|FG001|Overall Study|Physician Decision|5|||
48824085|NCT01027871|157195579|FG002|Overall Study|Physician Decision|0|||
48824086|NCT01027871|157195577|FG000|Overall Study|Protocol Violation|0|||
48824087|NCT01027871|157195578|FG001|Overall Study|Protocol Violation|2|||
48824088|NCT01027871|157195579|FG002|Overall Study|Protocol Violation|2|||
48824089|NCT01027871|157195577|FG000|Overall Study|Withdrawal by Subject|1|||
48824090|NCT01027871|157195578|FG001|Overall Study|Withdrawal by Subject|2|||
48824091|NCT01027871|157195579|FG002|Overall Study|Withdrawal by Subject|2|||
48824092|NCT01027871|157195577|FG000|Overall Study|Adverse Event|0|||
48824093|NCT01027871|157195578|FG001|Overall Study|Adverse Event|2|||
48824094|NCT01027871|157195579|FG002|Overall Study|Adverse Event|2|||
48824095|NCT01027871|157195577|FG000|Overall Study|Sponsor Decision|0|||
48824096|NCT01027871|157195578|FG001|Overall Study|Sponsor Decision|2|||
48824097|NCT01027871|157195579|FG002|Overall Study|Sponsor Decision|0|||
48824098|NCT01027871|157195577|FG000|Overall Study|Discontinued Prior to Treatment|0|||
48824099|NCT01027871|157195578|FG001|Overall Study|Discontinued Prior to Treatment|0|||
48824100|NCT01027871|157195579|FG002|Overall Study|Discontinued Prior to Treatment|1|||
48824101|NCT02084082|157195582|FG000|Washout Period 1 (35 Days)|Adverse Event|0|||
48824102|NCT02084082|157195583|FG001|Washout Period 1 (35 Days)|Adverse Event|0|||
48824103|NCT02084082|157195584|FG002|Washout Period 1 (35 Days)|Adverse Event|1|||
48824104|NCT02084082|157195585|FG003|Washout Period 1 (35 Days)|Adverse Event|1|||
48824105|NCT02084082|157195582|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
48824106|NCT02084082|157195583|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
48824107|NCT02084082|157195584|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
48824108|NCT02084082|157195585|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
48824109|NCT01767909|157195588|FG000|Overall Study|Withdrawal by Subject|4|||
49149011|NCT03523585|158386750|FG000|Overall Study|Progressive Disease|174|||
49149012|NCT03523585|158386751|FG001|Overall Study|Progressive Disease|64|||
49149013|NCT03523585|158386752|FG002|Overall Study|Progressive Disease|77|||
49149014|NCT03523585|158386750|FG000|Overall Study|Adverse Event|74|||
49149015|NCT03523585|158386751|FG001|Overall Study|Adverse Event|5|||
49149016|NCT03523585|158386752|FG002|Overall Study|Adverse Event|9|||
49149017|NCT03523585|158386750|FG000|Overall Study|Withdrawal by Subject|30|||
49149018|NCT03523585|158386751|FG001|Overall Study|Withdrawal by Subject|11|||
49149019|NCT03523585|158386752|FG002|Overall Study|Withdrawal by Subject|6|||
49149020|NCT03523585|158386750|FG000|Overall Study|Clinical Progression|23|||
49149021|NCT03523585|158386751|FG001|Overall Study|Clinical Progression|5|||
49149022|NCT03523585|158386752|FG002|Overall Study|Clinical Progression|10|||
49149023|NCT03523585|158386750|FG000|Overall Study|Death|4|||
49149024|NCT03523585|158386751|FG001|Overall Study|Death|0|||
49149025|NCT03523585|158386752|FG002|Overall Study|Death|1|||
48824110|NCT01767909|157195589|FG001|Overall Study|Withdrawal by Subject|7|||
48824111|NCT01767909|157195588|FG000|Overall Study|Adverse Event|3|||
49149026|NCT03523585|158386750|FG000|Overall Study|Physician Decision|2|||
49149027|NCT03523585|158386751|FG001|Overall Study|Physician Decision|1|||
49149028|NCT03523585|158386752|FG002|Overall Study|Physician Decision|0|||
48824112|NCT01767909|157195589|FG001|Overall Study|Adverse Event|1|||
48824113|NCT01767909|157195588|FG000|Overall Study|Withdrawal by Study Partner|3|||
48824114|NCT01767909|157195589|FG001|Overall Study|Withdrawal by Study Partner|1|||
48824115|NCT01767909|157195588|FG000|Overall Study|Non-Compliance|2|||
48824116|NCT01767909|157195589|FG001|Overall Study|Non-Compliance|0|||
48824117|NCT01767909|157195588|FG000|Overall Study|Perceived Lack of Efficacy|1|||
49149029|NCT03523585|158386750|FG000|Overall Study|Lost to Follow-up|1|||
48824118|NCT01767909|157195589|FG001|Overall Study|Perceived Lack of Efficacy|0|||
48824119|NCT01767909|157195588|FG000|Overall Study|Investigator Recommendation|0|||
49149030|NCT03523585|158386751|FG001|Overall Study|Lost to Follow-up|0|||
48824120|NCT01767909|157195589|FG001|Overall Study|Investigator Recommendation|1|||
48824121|NCT01767909|157195588|FG000|Overall Study|Lost to Follow-up|0|||
48824122|NCT01767909|157195589|FG001|Overall Study|Lost to Follow-up|1|||
48824123|NCT01767909|157195588|FG000|Overall Study|LP uncessessful|0|||
48824124|NCT01767909|157195589|FG001|Overall Study|LP uncessessful|1|||
48824125|NCT00654238|157195595|FG000|Overall Study|Screen Failures|4|||
48824126|NCT02320253|157195599|FG000|Overall Study|Withdrawal by Subject|3|||
48824127|NCT02320253|157195600|FG001|Overall Study|Withdrawal by Subject|0|||
48824128|NCT02320253|157195601|FG002|Overall Study|Withdrawal by Subject|0|||
48824129|NCT02320253|157195599|FG000|Overall Study|Lost to Follow-up|2|||
48731422|NCT00976677|156867885|FG001|Overall Study|Trial unblinded|2|||
48731423|NCT00976677|156867884|FG000|Overall Study|Unknown/Missing|1|||
48731424|NCT00976677|156867885|FG001|Overall Study|Unknown/Missing|0|||
48731425|NCT05268055|156867886|FG000|Overall Study|Lost to Follow-up|68|||
48731426|NCT05268055|156867887|FG001|Overall Study|Lost to Follow-up|68|||
48731427|NCT05268055|156867886|FG000|Overall Study|Withdrawal by Subject|12|||
48731428|NCT05268055|156867887|FG001|Overall Study|Withdrawal by Subject|8|||
48731429|NCT01555983|156867888|FG000|Overall Study|Withdrawal by Subject|1|||
48731430|NCT01555983|156867889|FG001|Overall Study|Withdrawal by Subject|0|||
48731431|NCT01555983|156867890|FG002|Overall Study|Withdrawal by Subject|0|||
48731432|NCT01555983|156867891|FG003|Overall Study|Withdrawal by Subject|0|||
48731433|NCT01555983|156867892|FG004|Overall Study|Withdrawal by Subject|1|||
48731434|NCT01555983|156867893|FG005|Overall Study|Withdrawal by Subject|1|||
48731435|NCT03148275|156867894|FG000|Overall Study|Death|6|||
48731436|NCT03148275|156867894|FG000|Overall Study|Adverse Event|3|||
48731437|NCT03148275|156867894|FG000|Overall Study|Liver transplant|2|||
48731438|NCT03148275|156867894|FG000|Overall Study|Patient decision|5|||
48731439|NCT03148275|156867894|FG000|Overall Study|transition to commercial drug|1|||
48731440|NCT03148275|156867894|FG000|Overall Study|subjects withdrew from the trial after registration, but before starting study treatment|2|||
48731441|NCT03332771|156869407|FG000|Overall Study|Adverse Event|6|||
48731442|NCT03332771|156869408|FG001|Overall Study|Adverse Event|4|||
48731443|NCT03332771|156869409|FG002|Overall Study|Adverse Event|1|||
48731444|NCT03332771|156869410|FG003|Overall Study|Adverse Event|3|||
48731445|NCT03332771|156869407|FG000|Overall Study|Poor Compliance to Protocol|0|||
48731446|NCT03332771|156869408|FG001|Overall Study|Poor Compliance to Protocol|1|||
48731447|NCT03332771|156869409|FG002|Overall Study|Poor Compliance to Protocol|0|||
48731448|NCT03332771|156869410|FG003|Overall Study|Poor Compliance to Protocol|1|||
48731449|NCT03332771|156869407|FG000|Overall Study|Lost to Follow-up|2|||
48731450|NCT03332771|156869408|FG001|Overall Study|Lost to Follow-up|2|||
48731451|NCT03332771|156869409|FG002|Overall Study|Lost to Follow-up|1|||
48731452|NCT03332771|156869410|FG003|Overall Study|Lost to Follow-up|2|||
48731453|NCT03332771|156869407|FG000|Overall Study|At the Participant's own request|20|||
48731454|NCT03332771|156869408|FG001|Overall Study|At the Participant's own request|26|||
48731455|NCT03332771|156869409|FG002|Overall Study|At the Participant's own request|14|||
48731456|NCT03332771|156869410|FG003|Overall Study|At the Participant's own request|23|||
48731457|NCT03332771|156869407|FG000|Overall Study|Reason Not Specified|6|||
48731458|NCT03332771|156869408|FG001|Overall Study|Reason Not Specified|18|||
48731459|NCT03332771|156869409|FG002|Overall Study|Reason Not Specified|16|||
48731460|NCT03332771|156869410|FG003|Overall Study|Reason Not Specified|19|||
48731461|NCT03875118|156869415|FG000|Overall Study|Withdrawal by Subject|4|||
48731462|NCT03875118|156869416|FG001|Overall Study|Withdrawal by Subject|4|||
48731463|NCT02213926|156869419|FG000|Overall Study|Death|59|||
48731464|NCT02213926|156869419|FG000|Overall Study|Withdrawal by Subject|10|||
48731465|NCT02213926|156869419|FG000|Overall Study|study terminated by sponsor|51|||
48731466|NCT02213926|156869419|FG000|Overall Study|Lost to Follow-up|3|||
48731467|NCT02213926|156869419|FG000|Overall Study|SITE CLOSURE - PI RETIREMENT|1|||
48731468|NCT00423670|156869421|FG000|Treatment Period|Switched to Arm 8 at TW 24|36|||
48824130|NCT02320253|157195600|FG001|Overall Study|Lost to Follow-up|2|||
48824131|NCT02320253|157195601|FG002|Overall Study|Lost to Follow-up|1|||
48824132|NCT02320253|157195599|FG000|Overall Study|Death|1|||
48824133|NCT02320253|157195600|FG001|Overall Study|Death|0|||
48824134|NCT02320253|157195601|FG002|Overall Study|Death|1|||
48824135|NCT05750745|157195602|FG000|Overall Study|Adverse Event|1|||
48824136|NCT05750745|157195603|FG001|Overall Study|Adverse Event|0|||
48824137|NCT05750745|157195604|FG002|Overall Study|Adverse Event|0|||
48824138|NCT05750745|157195602|FG000|Overall Study|Protocol Violation|1|||
48824139|NCT05750745|157195603|FG001|Overall Study|Protocol Violation|0|||
48824140|NCT05750745|157195604|FG002|Overall Study|Protocol Violation|0|||
48824141|NCT05750745|157195602|FG000|Overall Study|Withdrawal by Subject|0|||
48824142|NCT05750745|157195603|FG001|Overall Study|Withdrawal by Subject|1|||
48824143|NCT05750745|157195604|FG002|Overall Study|Withdrawal by Subject|0|||
48824144|NCT05196737|157195605|FG000|Non-intervention Week|Lost to Follow-up|2|||
48824145|NCT05196737|157195605|FG000|Dry Needling Reflex Measurment Week|Protocol Violation|1|||
48824146|NCT02926937|157195606|FG000|Overall Study|Adverse Event|0|||
48824147|NCT02926937|157195607|FG001|Overall Study|Adverse Event|1|||
48824148|NCT02926937|157195608|FG002|Overall Study|Adverse Event|1|||
48824149|NCT02926937|157195606|FG000|Overall Study|Poor Compliance to Protocol|1|||
48824150|NCT02926937|157195607|FG001|Overall Study|Poor Compliance to Protocol|0|||
48824151|NCT02926937|157195608|FG002|Overall Study|Poor Compliance to Protocol|0|||
48824152|NCT02926937|157195606|FG000|Overall Study|Lost to Follow-up|4|||
48824153|NCT02926937|157195607|FG001|Overall Study|Lost to Follow-up|5|||
48824154|NCT02926937|157195608|FG002|Overall Study|Lost to Follow-up|0|||
48824155|NCT02926937|157195606|FG000|Overall Study|At the Participant's own Request|11|||
48824156|NCT02926937|157195607|FG001|Overall Study|At the Participant's own Request|5|||
48824157|NCT02926937|157195608|FG002|Overall Study|At the Participant's own Request|8|||
48824158|NCT02926937|157195606|FG000|Overall Study|Reason not Specified|3|||
48824159|NCT02926937|157195607|FG001|Overall Study|Reason not Specified|4|||
48824160|NCT02926937|157195608|FG002|Overall Study|Reason not Specified|2|||
48824161|NCT03824236|157195611|FG000|Overall Study|Lost to Follow-up|0|||
48824162|NCT03824236|157195612|FG001|Overall Study|Lost to Follow-up|0|||
48824163|NCT03824236|157195613|FG002|Overall Study|Lost to Follow-up|1|||
48824164|NCT00924664|157197168|FG000|Overall Study|Adverse Event|23|||
48824165|NCT00924664|157197169|FG001|Overall Study|Adverse Event|39|||
48824166|NCT00924664|157197168|FG000|Overall Study|Lack of Efficacy|10|||
48824167|NCT00924664|157197169|FG001|Overall Study|Lack of Efficacy|15|||
48824168|NCT00924664|157197168|FG000|Overall Study|Lost to Follow-up|10|||
48824169|NCT00924664|157197169|FG001|Overall Study|Lost to Follow-up|12|||
48824170|NCT00924664|157197168|FG000|Overall Study|Withdrawal by Subject|47|||
48824171|NCT00924664|157197169|FG001|Overall Study|Withdrawal by Subject|71|||
48824172|NCT00924664|157197168|FG000|Overall Study|Protocol Violation|2|||
48824173|NCT00924664|157197169|FG001|Overall Study|Protocol Violation|5|||
49149031|NCT03523585|158386752|FG002|Overall Study|Lost to Follow-up|0|||
49149032|NCT03523585|158386750|FG000|Overall Study|Miscellaneous|1|||
48824174|NCT00924664|157197168|FG000|Overall Study|Pregnancy|1|||
48824175|NCT00924664|157197169|FG001|Overall Study|Pregnancy|1|||
48824176|NCT00924664|157197168|FG000|Overall Study|Death|0|||
48824177|NCT00924664|157197169|FG001|Overall Study|Death|2|||
48824178|NCT00924664|157197168|FG000|Overall Study|Study terminated by sponsor|199|||
49149033|NCT03523585|158386751|FG001|Overall Study|Miscellaneous|0|||
49149034|NCT03523585|158386752|FG002|Overall Study|Miscellaneous|0|||
49149035|NCT03523585|158386750|FG000|Overall Study|Protocol Deviation|1|||
49149036|NCT03523585|158386751|FG001|Overall Study|Protocol Deviation|0|||
49149037|NCT03523585|158386752|FG002|Overall Study|Protocol Deviation|1|||
49149038|NCT03523585|158386750|FG000|Overall Study|Randomized But Not Treated|2|||
49149039|NCT03523585|158386751|FG001|Overall Study|Randomized But Not Treated|4|||
49149040|NCT03523585|158386752|FG002|Overall Study|Randomized But Not Treated|3|||
49149041|NCT01903720|158386753|FG000|Overall Study|Inclusion / exclusion criteria not met|6|||
49149042|NCT01903720|158386753|FG000|Overall Study|Adverse Event|1|||
49149043|NCT01903720|158386753|FG000|Overall Study|Rescinding of informed consent|2|||
49149044|NCT01903720|158386753|FG000|Overall Study|Lost to Follow-up|2|||
49149045|NCT01903720|158386753|FG000|Overall Study|Treatment with alternative drug|1|||
49149046|NCT01379937|158386754|FG000|Overall Study|Protocol Violation|0|||
49149047|NCT01379937|158386755|FG001|Overall Study|Protocol Violation|0|||
49149048|NCT01379937|158386756|FG002|Overall Study|Protocol Violation|0|||
49149049|NCT01379937|158386757|FG003|Overall Study|Protocol Violation|1|||
49149050|NCT01379937|158386754|FG000|Overall Study|Consent withdrawal|0|||
49149051|NCT01379937|158386755|FG001|Overall Study|Consent withdrawal|1|||
49149052|NCT01379937|158386756|FG002|Overall Study|Consent withdrawal|0|||
49149053|NCT01379937|158386757|FG003|Overall Study|Consent withdrawal|0|||
48824179|NCT00924664|157197169|FG001|Overall Study|Study terminated by sponsor|330|||
48824180|NCT00924664|157197168|FG000|Overall Study|Other|29|||
48824181|NCT00924664|157197169|FG001|Overall Study|Other|52|||
48824182|NCT00924664|157197168|FG000|Overall Study|Randomized but not Treated|1|||
49149054|NCT01379937|158386754|FG000|Overall Study|Lost to Follow-up|1|||
49149055|NCT01379937|158386755|FG001|Overall Study|Lost to Follow-up|2|||
49149056|NCT01379937|158386756|FG002|Overall Study|Lost to Follow-up|2|||
49149057|NCT01379937|158386757|FG003|Overall Study|Lost to Follow-up|0|||
49149058|NCT02264821|158386759|FG000|Overall Study|Protocol Violation|1|||
48824183|NCT00924664|157197169|FG001|Overall Study|Randomized but not Treated|0|||
48824184|NCT02107274|157197170|FG000|Treatment vs. Placebo|Adverse Event|3|||
48824185|NCT02107274|157197171|FG001|Treatment vs. Placebo|Adverse Event|0|||
48824186|NCT02107274|157197170|FG000|Treatment vs. Placebo|Lost to Follow-up|0|||
48824187|NCT02107274|157197171|FG001|Treatment vs. Placebo|Lost to Follow-up|2|||
48824188|NCT02107274|157197170|FG000|Control Phase|Lost to Follow-up|1|||
48824189|NCT02107274|157197171|FG001|Control Phase|Lost to Follow-up|1|||
48824190|NCT02107274|157197170|FG000|Control Phase|Death|2|||
48824191|NCT02107274|157197171|FG001|Control Phase|Death|0|||
48824192|NCT02107274|157197170|FG000|Control Phase|Adverse Event|0|||
48824193|NCT02107274|157197171|FG001|Control Phase|Adverse Event|1|||
48824194|NCT01616563|157197173|FG000|Overall Study|Lost to Follow-up|40|||
48824195|NCT01033643|157197174|FG000|Overall Study|Withdrew Consent|0|||
48824196|NCT01033643|157197175|FG001|Overall Study|Withdrew Consent|3|||
48824197|NCT01033643|157197176|FG002|Overall Study|Withdrew Consent|0|||
48824198|NCT01033643|157197177|FG003|Overall Study|Withdrew Consent|0|||
48824199|NCT01033643|157197178|FG004|Overall Study|Withdrew Consent|0|||
48824200|NCT01033643|157197179|FG005|Overall Study|Withdrew Consent|1|||
48824201|NCT00031447|157197183|FG000|Overall Study|Lost to Follow-up|0|||
48824202|NCT00031447|157197184|FG001|Overall Study|Lost to Follow-up|1|||
48824203|NCT00031447|157197183|FG000|Overall Study|Non-compliant|1|||
48824204|NCT00031447|157197184|FG001|Overall Study|Non-compliant|1|||
48824205|NCT00031447|157197183|FG000|Overall Study|Re-activation of Disease|2|||
48824206|NCT00031447|157197184|FG001|Overall Study|Re-activation of Disease|1|||
48824207|NCT00031447|157197183|FG000|Overall Study|Disruption of blinded study drug supply|7|||
48824208|NCT00031447|157197184|FG001|Overall Study|Disruption of blinded study drug supply|4|||
48824209|NCT00519779|157197185|FG000|Overall Study|Withdrawal by Subject|0|||
48824210|NCT00519779|157197186|FG001|Overall Study|Withdrawal by Subject|1|||
48824211|NCT00724061|157197190|FG000|Dose Escalation Phase|Adverse Event|2|||
48824212|NCT00724061|157197190|FG000|Dose Escalation Phase|Disease Progression|3|||
48824213|NCT00953160|157197191|FG000|Overall Study|Lost to Follow-up|23|||
48824214|NCT00953160|157197191|FG000|Overall Study|Withdrawal by Subject|4|||
48824215|NCT02724020|157197196|FG000|Overall Study|Death|16|||
48824216|NCT02724020|157197197|FG001|Overall Study|Death|18|||
48824217|NCT02724020|157197198|FG002|Overall Study|Death|19|||
49112688|NCT02276547|158247505|FG000|Overall Study|Explant|2|||
48824218|NCT02724020|157197196|FG000|Overall Study|Lost to Follow-up|0|||
48824219|NCT02724020|157197197|FG001|Overall Study|Lost to Follow-up|3|||
48824220|NCT02724020|157197198|FG002|Overall Study|Lost to Follow-up|0|||
48824221|NCT02724020|157197196|FG000|Overall Study|Site Terminated by Sponsor|15|||
48824222|NCT02724020|157197197|FG001|Overall Study|Site Terminated by Sponsor|8|||
48824223|NCT02724020|157197198|FG002|Overall Study|Site Terminated by Sponsor|8|||
48824224|NCT02724020|157197196|FG000|Overall Study|Withdrawal by Subject|1|||
48824225|NCT02724020|157197197|FG001|Overall Study|Withdrawal by Subject|3|||
48824226|NCT02724020|157197198|FG002|Overall Study|Withdrawal by Subject|5|||
49149059|NCT02264821|158386760|FG001|Overall Study|Protocol Violation|3|||
49149060|NCT02264821|158386761|FG002|Overall Study|Protocol Violation|6|||
49149061|NCT02067156|158386764|FG000|Overall Study|Lost to Follow-up|4|||
49149062|NCT03654326|158386768|FG000|Overall Study|Withdrawal by Subject|5|||
49149063|NCT03654326|158386769|FG001|Overall Study|Withdrawal by Subject|3|||
48731469|NCT00423670|156869422|FG001|Treatment Period|Switched to Arm 8 at TW 24|0|||
48731470|NCT00423670|156869423|FG002|Treatment Period|Switched to Arm 8 at TW 24|0|||
48731471|NCT00423670|156869424|FG003|Treatment Period|Switched to Arm 8 at TW 24|0|||
48731472|NCT00423670|156869425|FG004|Treatment Period|Switched to Arm 8 at TW 24|0|||
48921460|NCT00143455|157546400|FG000|Cohort 1|Death|5|||
49149064|NCT03654326|158386768|FG000|Overall Study|Physician Decision|0|||
49149065|NCT03654326|158386769|FG001|Overall Study|Physician Decision|1|||
49149066|NCT03654326|158386768|FG000|Overall Study|Unable to adhere to study schedule|0|||
49149067|NCT03654326|158386769|FG001|Overall Study|Unable to adhere to study schedule|1|||
49149068|NCT03654326|158386768|FG000|Overall Study|Lost to Follow-up|1|||
49149069|NCT03654326|158386769|FG001|Overall Study|Lost to Follow-up|1|||
49149070|NCT02076009|158386771|FG000|Overall Study|Death|172|||
49149071|NCT02076009|158386772|FG001|Overall Study|Death|153|||
49149072|NCT02076009|158386771|FG000|Overall Study|Withdrawal by Subject|16|||
49149073|NCT02076009|158386772|FG001|Overall Study|Withdrawal by Subject|12|||
49149074|NCT02076009|158386771|FG000|Overall Study|Lost to Follow-up|4|||
49149075|NCT02076009|158386772|FG001|Overall Study|Lost to Follow-up|2|||
49149076|NCT02076009|158386771|FG000|Overall Study|Progressive Disease|1|||
49149077|NCT02076009|158386772|FG001|Overall Study|Progressive Disease|0|||
49149078|NCT02076009|158386771|FG000|Overall Study|Physician Decision|0|||
49149079|NCT02076009|158386772|FG001|Overall Study|Physician Decision|1|||
49149080|NCT02076009|158386771|FG000|Overall Study|End of data collection|90|||
49149081|NCT02076009|158386772|FG001|Overall Study|End of data collection|118|||
49149082|NCT05418426|158386773|FG000|Overall Study|Adverse Event|0|||
49149083|NCT05418426|158386774|FG001|Overall Study|Adverse Event|1|||
49149084|NCT05418426|158386775|FG002|Overall Study|Adverse Event|0|||
49149085|NCT05418426|158386773|FG000|Overall Study|Withdrawal by Subject|0|||
49149086|NCT05418426|158386774|FG001|Overall Study|Withdrawal by Subject|1|||
49149087|NCT05418426|158386775|FG002|Overall Study|Withdrawal by Subject|0|||
49149088|NCT05418426|158386773|FG000|Overall Study|Protocol Violation|0|||
49149089|NCT05418426|158386774|FG001|Overall Study|Protocol Violation|0|||
49149090|NCT05418426|158386775|FG002|Overall Study|Protocol Violation|1|||
49149091|NCT02609503|158386781|FG000|Overall Study|Adverse Event|1|||
49149092|NCT02609503|158386781|FG000|Overall Study|Death|1|||
49149093|NCT02609503|158386781|FG000|Overall Study|Withdrawal by Subject|1|||
49149094|NCT02609503|158386781|FG000|Overall Study|Disease progression|1|||
49149095|NCT03715829|158386784|FG000|Dose Ranging Period|Adverse Event|2|||
49149096|NCT03715829|158386785|FG001|Dose Ranging Period|Adverse Event|4|||
48731473|NCT00423670|156869426|FG005|Treatment Period|Switched to Arm 8 at TW 24|0|||
48731474|NCT00423670|156869427|FG006|Treatment Period|Switched to Arm 8 at TW 24|0|||
48731475|NCT00423670|156869428|FG007|Treatment Period|Switched to Arm 8 at TW 24|0|||
48731476|NCT00423670|156869421|FG000|Treatment Period|Adverse Event|8|||
48731477|NCT00423670|156869422|FG001|Treatment Period|Adverse Event|12|||
48731478|NCT00423670|156869423|FG002|Treatment Period|Adverse Event|15|||
48731479|NCT00423670|156869424|FG003|Treatment Period|Adverse Event|20|||
48731480|NCT00423670|156869425|FG004|Treatment Period|Adverse Event|9|||
48731481|NCT00423670|156869426|FG005|Treatment Period|Adverse Event|4|||
48731482|NCT00423670|156869427|FG006|Treatment Period|Adverse Event|7|||
48731483|NCT00423670|156869428|FG007|Treatment Period|Adverse Event|2|||
48731484|NCT00423670|156869421|FG000|Treatment Period|Protocol-defined clinical event|0|||
48731485|NCT00423670|156869422|FG001|Treatment Period|Protocol-defined clinical event|7|||
48731486|NCT00423670|156869423|FG002|Treatment Period|Protocol-defined clinical event|4|||
48731487|NCT00423670|156869424|FG003|Treatment Period|Protocol-defined clinical event|12|||
48731488|NCT00423670|156869425|FG004|Treatment Period|Protocol-defined clinical event|5|||
48731489|NCT00423670|156869426|FG005|Treatment Period|Protocol-defined clinical event|4|||
48731490|NCT00423670|156869427|FG006|Treatment Period|Protocol-defined clinical event|16|||
48731491|NCT00423670|156869428|FG007|Treatment Period|Protocol-defined clinical event|15|||
48731492|NCT00423670|156869421|FG000|Treatment Period|Lost to Follow-up|2|||
48731493|NCT00423670|156869422|FG001|Treatment Period|Lost to Follow-up|1|||
48731494|NCT00423670|156869423|FG002|Treatment Period|Lost to Follow-up|3|||
48731495|NCT00423670|156869424|FG003|Treatment Period|Lost to Follow-up|1|||
48731496|NCT00423670|156869425|FG004|Treatment Period|Lost to Follow-up|6|||
48731497|NCT00423670|156869426|FG005|Treatment Period|Lost to Follow-up|0|||
48731498|NCT00423670|156869427|FG006|Treatment Period|Lost to Follow-up|3|||
48731499|NCT00423670|156869428|FG007|Treatment Period|Lost to Follow-up|1|||
48921461|NCT00143455|157546401|FG001|Cohort 1|Death|2|||
48921462|NCT00143455|157546402|FG002|Cohort 1|Death|0|||
49149097|NCT03715829|158386786|FG002|Dose Ranging Period|Adverse Event|5|||
49149098|NCT03715829|158386787|FG003|Dose Ranging Period|Adverse Event|2|||
49149099|NCT03715829|158386788|FG004|Dose Ranging Period|Adverse Event|3|||
49149100|NCT03715829|158386789|FG005|Dose Ranging Period|Adverse Event|3|||
49149101|NCT03715829|158386790|FG006|Dose Ranging Period|Adverse Event|0|||
49149102|NCT03715829|158386791|FG007|Dose Ranging Period|Adverse Event|0|||
49149103|NCT03715829|158386792|FG008|Dose Ranging Period|Adverse Event|0|||
49149104|NCT03715829|158386793|FG009|Dose Ranging Period|Adverse Event|0|||
48731500|NCT00423670|156869421|FG000|Treatment Period|Subject withdrew (not treatment related)|3|||
48731501|NCT00423670|156869422|FG001|Treatment Period|Subject withdrew (not treatment related)|9|||
48731502|NCT00423670|156869423|FG002|Treatment Period|Subject withdrew (not treatment related)|4|||
48731503|NCT00423670|156869424|FG003|Treatment Period|Subject withdrew (not treatment related)|4|||
48731504|NCT00423670|156869425|FG004|Treatment Period|Subject withdrew (not treatment related)|5|||
48731505|NCT00423670|156869426|FG005|Treatment Period|Subject withdrew (not treatment related)|0|||
49149105|NCT03715829|158386794|FG010|Dose Ranging Period|Adverse Event|0|||
49149106|NCT03715829|158386784|FG000|Dose Ranging Period|Lack of Efficacy|0|||
48731506|NCT00423670|156869427|FG006|Treatment Period|Subject withdrew (not treatment related)|3|||
48731507|NCT00423670|156869428|FG007|Treatment Period|Subject withdrew (not treatment related)|0|||
48731508|NCT00423670|156869421|FG000|Treatment Period|Investigator decision|0|||
48731509|NCT00423670|156869422|FG001|Treatment Period|Investigator decision|0|||
48731510|NCT00423670|156869423|FG002|Treatment Period|Investigator decision|0|||
49149107|NCT03715829|158386785|FG001|Dose Ranging Period|Lack of Efficacy|1|||
49149108|NCT03715829|158386786|FG002|Dose Ranging Period|Lack of Efficacy|0|||
49149109|NCT03715829|158386787|FG003|Dose Ranging Period|Lack of Efficacy|1|||
49149110|NCT03715829|158386788|FG004|Dose Ranging Period|Lack of Efficacy|0|||
49149111|NCT03715829|158386789|FG005|Dose Ranging Period|Lack of Efficacy|0|||
49149112|NCT03715829|158386790|FG006|Dose Ranging Period|Lack of Efficacy|0|||
49149113|NCT03715829|158386791|FG007|Dose Ranging Period|Lack of Efficacy|0|||
49149114|NCT03715829|158386792|FG008|Dose Ranging Period|Lack of Efficacy|0|||
49149115|NCT03715829|158386793|FG009|Dose Ranging Period|Lack of Efficacy|0|||
49149116|NCT03715829|158386794|FG010|Dose Ranging Period|Lack of Efficacy|0|||
49149117|NCT03715829|158386784|FG000|Dose Ranging Period|Lost to Follow-up|2|||
49149118|NCT03715829|158386785|FG001|Dose Ranging Period|Lost to Follow-up|0|||
49149119|NCT03715829|158386786|FG002|Dose Ranging Period|Lost to Follow-up|1|||
49149120|NCT03715829|158386787|FG003|Dose Ranging Period|Lost to Follow-up|1|||
49149121|NCT03715829|158386788|FG004|Dose Ranging Period|Lost to Follow-up|1|||
49149122|NCT03715829|158386789|FG005|Dose Ranging Period|Lost to Follow-up|2|||
49149123|NCT03715829|158386790|FG006|Dose Ranging Period|Lost to Follow-up|0|||
49149124|NCT03715829|158386791|FG007|Dose Ranging Period|Lost to Follow-up|0|||
49149125|NCT03715829|158386792|FG008|Dose Ranging Period|Lost to Follow-up|0|||
48731511|NCT00423670|156869424|FG003|Treatment Period|Investigator decision|0|||
48731512|NCT00423670|156869425|FG004|Treatment Period|Investigator decision|0|||
48731513|NCT00423670|156869426|FG005|Treatment Period|Investigator decision|0|||
48731514|NCT00423670|156869427|FG006|Treatment Period|Investigator decision|0|||
48731515|NCT00423670|156869428|FG007|Treatment Period|Investigator decision|1|||
48731516|NCT00423670|156869421|FG000|Treatment Period|Non-compliance with protocol|3|||
48731517|NCT00423670|156869422|FG001|Treatment Period|Non-compliance with protocol|1|||
49149126|NCT03715829|158386793|FG009|Dose Ranging Period|Lost to Follow-up|0|||
49149127|NCT03715829|158386794|FG010|Dose Ranging Period|Lost to Follow-up|0|||
49149128|NCT03715829|158386784|FG000|Dose Ranging Period|Protocol Violation|0|||
49149129|NCT03715829|158386785|FG001|Dose Ranging Period|Protocol Violation|0|||
49149130|NCT03715829|158386786|FG002|Dose Ranging Period|Protocol Violation|0|||
48824227|NCT01094171|157197199|FG000|Overall Study|Lost to Follow-up|2|||
48824228|NCT01094171|157197199|FG000|Overall Study|Informed consent withdrawal|4|||
48824229|NCT01094171|157197199|FG000|Overall Study|Migration from the study area|3|||
48824230|NCT01094171|157197199|FG000|Overall Study|Other|1|||
48824231|NCT03283553|157197200|FG000|Patient Participant Flow|Death|5|||
48824232|NCT03283553|157197201|FG001|Patient Participant Flow|Death|10|||
48824233|NCT03283553|157197200|FG000|Patient Participant Flow|Withdrawal by Subject|4|||
48824234|NCT03283553|157197201|FG001|Patient Participant Flow|Withdrawal by Subject|2|||
48824235|NCT03283553|157197200|FG000|Patient Participant Flow|Lost to Follow-up|1|||
48824236|NCT03283553|157197201|FG001|Patient Participant Flow|Lost to Follow-up|1|||
48824237|NCT03283553|157197200|FG000|Care Partner Participant Flow|Withdrawal by Subject|4|||
48824238|NCT03283553|157197201|FG001|Care Partner Participant Flow|Withdrawal by Subject|3|||
48824239|NCT03283553|157197200|FG000|Care Partner Participant Flow|Lost to Follow-up|1|||
48824240|NCT03283553|157197201|FG001|Care Partner Participant Flow|Lost to Follow-up|1|||
48824241|NCT03283553|157197200|FG000|Care Partner Participant Flow|Discontinued because patient death|5|||
48824242|NCT03283553|157197201|FG001|Care Partner Participant Flow|Discontinued because patient death|11|||
48824243|NCT01982760|157197205|FG000|Overall Study|Physician Decision|1|||
48824244|NCT01982760|157197206|FG001|Overall Study|Physician Decision|0|||
48824245|NCT00162942|157197207|FG000|Overall Study|Adverse Event|10|||
48824246|NCT00162942|157197208|FG001|Overall Study|Adverse Event|6|||
48824247|NCT00162942|157197207|FG000|Overall Study|Death|1|||
48824248|NCT00162942|157197208|FG001|Overall Study|Death|0|||
49149131|NCT03715829|158386787|FG003|Dose Ranging Period|Protocol Violation|1|||
49149132|NCT03715829|158386788|FG004|Dose Ranging Period|Protocol Violation|0|||
49149133|NCT03715829|158386789|FG005|Dose Ranging Period|Protocol Violation|0|||
49149134|NCT03715829|158386790|FG006|Dose Ranging Period|Protocol Violation|0|||
49149135|NCT03715829|158386791|FG007|Dose Ranging Period|Protocol Violation|0|||
49149136|NCT03715829|158386792|FG008|Dose Ranging Period|Protocol Violation|0|||
49149137|NCT03715829|158386793|FG009|Dose Ranging Period|Protocol Violation|0|||
49149138|NCT03715829|158386794|FG010|Dose Ranging Period|Protocol Violation|0|||
49149139|NCT03715829|158386784|FG000|Dose Ranging Period|Withdrawal by Subject|8|||
49149140|NCT03715829|158386785|FG001|Dose Ranging Period|Withdrawal by Subject|4|||
49149141|NCT03715829|158386786|FG002|Dose Ranging Period|Withdrawal by Subject|3|||
49149142|NCT03715829|158386787|FG003|Dose Ranging Period|Withdrawal by Subject|9|||
48824249|NCT00162942|157197207|FG000|Overall Study|Withdrawal by Subject|3|||
48824250|NCT00162942|157197208|FG001|Overall Study|Withdrawal by Subject|6|||
48824251|NCT00162942|157197207|FG000|Overall Study|Physician Decision|1|||
49149143|NCT03715829|158386788|FG004|Dose Ranging Period|Withdrawal by Subject|2|||
49149144|NCT03715829|158386789|FG005|Dose Ranging Period|Withdrawal by Subject|3|||
49149145|NCT03715829|158386790|FG006|Dose Ranging Period|Withdrawal by Subject|0|||
49149146|NCT03715829|158386791|FG007|Dose Ranging Period|Withdrawal by Subject|0|||
48731518|NCT00423670|156869423|FG002|Treatment Period|Non-compliance with protocol|1|||
48731519|NCT00423670|156869424|FG003|Treatment Period|Non-compliance with protocol|3|||
48731520|NCT00423670|156869425|FG004|Treatment Period|Non-compliance with protocol|2|||
48731521|NCT00423670|156869426|FG005|Treatment Period|Non-compliance with protocol|0|||
48731522|NCT00423670|156869427|FG006|Treatment Period|Non-compliance with protocol|2|||
48731523|NCT00423670|156869428|FG007|Treatment Period|Non-compliance with protocol|2|||
48731524|NCT00423670|156869421|FG000|Follow-up Period|Lost to Follow-up|0|||
48731525|NCT00423670|156869422|FG001|Follow-up Period|Lost to Follow-up|12|||
48731526|NCT00423670|156869423|FG002|Follow-up Period|Lost to Follow-up|8|||
48731527|NCT00423670|156869424|FG003|Follow-up Period|Lost to Follow-up|3|||
48731528|NCT00423670|156869425|FG004|Follow-up Period|Lost to Follow-up|1|||
48731529|NCT00423670|156869426|FG005|Follow-up Period|Lost to Follow-up|0|||
48731530|NCT00423670|156869427|FG006|Follow-up Period|Lost to Follow-up|5|||
48731531|NCT00423670|156869428|FG007|Follow-up Period|Lost to Follow-up|0|||
48731532|NCT00423670|156869421|FG000|Follow-up Period|Subject withdrew (not treatment related)|1|||
48731533|NCT00423670|156869422|FG001|Follow-up Period|Subject withdrew (not treatment related)|4|||
48731534|NCT00423670|156869423|FG002|Follow-up Period|Subject withdrew (not treatment related)|2|||
48731535|NCT00423670|156869424|FG003|Follow-up Period|Subject withdrew (not treatment related)|1|||
48731536|NCT00423670|156869425|FG004|Follow-up Period|Subject withdrew (not treatment related)|1|||
48731537|NCT00423670|156869426|FG005|Follow-up Period|Subject withdrew (not treatment related)|0|||
48731538|NCT00423670|156869427|FG006|Follow-up Period|Subject withdrew (not treatment related)|1|||
48731539|NCT00423670|156869428|FG007|Follow-up Period|Subject withdrew (not treatment related)|1|||
48731540|NCT00423670|156869421|FG000|Follow-up Period|Non-compliance with protocol|2|||
48731541|NCT00423670|156869422|FG001|Follow-up Period|Non-compliance with protocol|0|||
48731542|NCT00423670|156869423|FG002|Follow-up Period|Non-compliance with protocol|1|||
48731543|NCT00423670|156869424|FG003|Follow-up Period|Non-compliance with protocol|1|||
48731544|NCT00423670|156869425|FG004|Follow-up Period|Non-compliance with protocol|0|||
48731545|NCT00423670|156869426|FG005|Follow-up Period|Non-compliance with protocol|0|||
48731546|NCT00423670|156869427|FG006|Follow-up Period|Non-compliance with protocol|3|||
48731547|NCT00423670|156869428|FG007|Follow-up Period|Non-compliance with protocol|2|||
48731548|NCT01282203|156869429|FG000|Overall Study|Adverse Event|1|||
48731549|NCT01869725|156869430|FG000|Overall Study|ineligible after registration|1|||
48731550|NCT01869725|156869430|FG000|Overall Study|Death|1|||
48731551|NCT01869725|156869430|FG000|Overall Study|Lost to Follow-up|2|||
48731552|NCT00735254|156869433|FG000|Overall Study|Protocol Violation|1|||
48731553|NCT00735254|156869434|FG001|Overall Study|Protocol Violation|1|||
48731554|NCT00735254|156869435|FG002|Overall Study|Protocol Violation|1|||
48731555|NCT00735254|156869436|FG003|Overall Study|Protocol Violation|0|||
48731556|NCT01068652|156869437|FG000|Overall Study|Adverse Event|4|||
48731557|NCT01068652|156869438|FG001|Overall Study|Adverse Event|0|||
48731558|NCT01068652|156869437|FG000|Overall Study|Lack of Efficacy|0|||
48731559|NCT01068652|156869438|FG001|Overall Study|Lack of Efficacy|2|||
48731560|NCT01068652|156869437|FG000|Overall Study|Lost to Follow-up|2|||
48731561|NCT01068652|156869438|FG001|Overall Study|Lost to Follow-up|1|||
48731562|NCT01068652|156869437|FG000|Overall Study|Protocol Violation|3|||
48731563|NCT01068652|156869438|FG001|Overall Study|Protocol Violation|6|||
48731564|NCT01068652|156869437|FG000|Overall Study|Withdrawal criteria|1|||
48731565|NCT01068652|156869438|FG001|Overall Study|Withdrawal criteria|2|||
48731566|NCT01068652|156869437|FG000|Overall Study|Patient was not eligible|1|||
48731567|NCT01068652|156869438|FG001|Overall Study|Patient was not eligible|0|||
48731568|NCT01068652|156869437|FG000|Overall Study|Unclassified|7|||
48731569|NCT01068652|156869438|FG001|Overall Study|Unclassified|4|||
48731570|NCT00147251|156869439|FG000|Recruitment and Enrollment|change in treatment guidelines|24|||
48731571|NCT00147251|156869440|FG001|Recruitment and Enrollment|change in treatment guidelines|25|||
48731572|NCT01669928|156869441|FG000|First Intervention|Withdrawal by Subject|3|||
48731573|NCT01669928|156869442|FG001|First Intervention|Withdrawal by Subject|5|||
48731574|NCT03387683|156869445|FG000|Overall Study|In receipt of disallowed medication|1|||
48731575|NCT03387683|156869446|FG001|Overall Study|In receipt of disallowed medication|0|||
48824252|NCT00162942|157197208|FG001|Overall Study|Physician Decision|0|||
48824253|NCT00162942|157197207|FG000|Overall Study|Enter Open-Label Study|76|||
48824254|NCT00162942|157197208|FG001|Overall Study|Enter Open-Label Study|35|||
48824255|NCT00162942|157197207|FG000|Overall Study|Alternate Therapy|6|||
48824256|NCT00162942|157197208|FG001|Overall Study|Alternate Therapy|2|||
48824257|NCT00162942|157197207|FG000|Overall Study|Lack of Efficacy|1|||
48824258|NCT00162942|157197208|FG001|Overall Study|Lack of Efficacy|0|||
48824259|NCT00162942|157197207|FG000|Overall Study|Flare During Active Treatment|7|||
48824260|NCT00162942|157197208|FG001|Overall Study|Flare During Active Treatment|3|||
48824261|NCT00162942|157197207|FG000|Overall Study|2 or more consecutive treatments missed|1|||
48824262|NCT00162942|157197208|FG001|Overall Study|2 or more consecutive treatments missed|0|||
48824263|NCT01354938|157197209|FG000|Overall Study|Lost to Follow-up|1|||
48824264|NCT02335268|157197210|FG000|Overall Study|Physician Decision|5|||
48824265|NCT02335268|157197211|FG001|Overall Study|Physician Decision|1|||
48824266|NCT02335268|157197210|FG000|Overall Study|Lack of Efficacy|2|||
48824267|NCT02335268|157197211|FG001|Overall Study|Lack of Efficacy|1|||
48824268|NCT02335268|157197210|FG000|Overall Study|Adverse Event|5|||
48824269|NCT02335268|157197211|FG001|Overall Study|Adverse Event|2|||
48824270|NCT02335268|157197210|FG000|Overall Study|increase blasts|2|||
48824271|NCT02335268|157197211|FG001|Overall Study|increase blasts|0|||
48824272|NCT02335268|157197210|FG000|Overall Study|Withdrawal by Subject|3|||
48824273|NCT02335268|157197211|FG001|Overall Study|Withdrawal by Subject|2|||
48824274|NCT01192295|157197212|FG000|Overall Study|Adverse Event|3|||
48824275|NCT01192295|157197213|FG001|Overall Study|Adverse Event|7|||
48824276|NCT01192295|157197212|FG000|Overall Study|Withdrawal by Subject|3|||
48824277|NCT01192295|157197213|FG001|Overall Study|Withdrawal by Subject|4|||
48824278|NCT01192295|157197212|FG000|Overall Study|Lost to Follow-up|0|||
48824279|NCT01192295|157197213|FG001|Overall Study|Lost to Follow-up|1|||
48824280|NCT01192295|157197212|FG000|Overall Study|Lack of Efficacy|0|||
48824281|NCT01192295|157197213|FG001|Overall Study|Lack of Efficacy|5|||
48824282|NCT01192295|157197212|FG000|Overall Study|Administrative|4|||
48824283|NCT01192295|157197213|FG001|Overall Study|Administrative|6|||
48921463|NCT00143455|157546403|FG003|Cohort 1|Death|0|||
48824284|NCT00630539|157197214|FG000|Overall Study|Adverse Event|1|||
48731576|NCT03387683|156869445|FG000|Overall Study|Did not receive treatment|1|||
48731577|NCT03387683|156869446|FG001|Overall Study|Did not receive treatment|0|||
48731578|NCT01368432|156869448|FG000|Overall Study|Lost to Follow-up|0|||
48731579|NCT01368432|156869449|FG001|Overall Study|Lost to Follow-up|1|||
48731580|NCT02169284|156869452|FG000|Overall Study|Physician Decision|0|||
48731581|NCT02169284|156869453|FG001|Overall Study|Physician Decision|1|||
48731582|NCT01008150|156869454|FG000|Overall Study|did not receive study drug|1|||
48731583|NCT01008150|156869455|FG001|Overall Study|did not receive study drug|1|||
48731584|NCT01008150|156869456|FG002|Overall Study|did not receive study drug|1|||
48731585|NCT01008150|156869457|FG003|Overall Study|did not receive study drug|0|||
48731586|NCT01938573|156869459|FG000|Overall Study|Lack of Efficacy|1|||
48731587|NCT01938573|156869460|FG001|Overall Study|Lack of Efficacy|0|||
48731588|NCT01938573|156869459|FG000|Overall Study|Operation at other hospital|1|||
48731589|NCT01938573|156869460|FG001|Overall Study|Operation at other hospital|0|||
49149147|NCT03715829|158386792|FG008|Dose Ranging Period|Withdrawal by Subject|0|||
49149148|NCT03715829|158386793|FG009|Dose Ranging Period|Withdrawal by Subject|0|||
49149149|NCT03715829|158386794|FG010|Dose Ranging Period|Withdrawal by Subject|0|||
49149150|NCT03715829|158386784|FG000|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
49149151|NCT03715829|158386785|FG001|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
49149152|NCT03715829|158386786|FG002|Dose Ranging Period|Medication Error Without Associated Adverse Event|1|||
49149153|NCT03715829|158386787|FG003|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
49149154|NCT03715829|158386788|FG004|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
49149155|NCT03715829|158386789|FG005|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
49149156|NCT03715829|158386790|FG006|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
49149157|NCT03715829|158386791|FG007|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
48731590|NCT03766685|156869466|FG000|Overall Study|Lost to Follow-up|1|||
48731591|NCT03766685|156869467|FG001|Overall Study|Lost to Follow-up|1|||
48731592|NCT03766685|156869468|FG002|Overall Study|Lost to Follow-up|0|||
48731593|NCT03766685|156869469|FG003|Overall Study|Lost to Follow-up|0|||
49149158|NCT03715829|158386792|FG008|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
49149159|NCT03715829|158386793|FG009|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
49149160|NCT03715829|158386794|FG010|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
49149161|NCT03715829|158386784|FG000|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
49149162|NCT03715829|158386785|FG001|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
49149163|NCT03715829|158386786|FG002|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
49149164|NCT03715829|158386787|FG003|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
49149165|NCT03715829|158386788|FG004|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
49149166|NCT03715829|158386789|FG005|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
49149167|NCT03715829|158386790|FG006|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
49149168|NCT03715829|158386791|FG007|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
49149169|NCT03715829|158386792|FG008|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
49149170|NCT03715829|158386793|FG009|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
49149171|NCT03715829|158386794|FG010|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
49149172|NCT03715829|158386784|FG000|Dose Ranging Period|Other|0|||
49149173|NCT03715829|158386785|FG001|Dose Ranging Period|Other|0|||
49149174|NCT03715829|158386786|FG002|Dose Ranging Period|Other|2|||
49149175|NCT03715829|158386787|FG003|Dose Ranging Period|Other|0|||
49149176|NCT03715829|158386788|FG004|Dose Ranging Period|Other|0|||
49149177|NCT03715829|158386789|FG005|Dose Ranging Period|Other|3|||
49149178|NCT03715829|158386790|FG006|Dose Ranging Period|Other|0|||
49149179|NCT03715829|158386791|FG007|Dose Ranging Period|Other|0|||
49149180|NCT03715829|158386792|FG008|Dose Ranging Period|Other|0|||
49149181|NCT03715829|158386793|FG009|Dose Ranging Period|Other|0|||
49149182|NCT03715829|158386794|FG010|Dose Ranging Period|Other|0|||
49149183|NCT03715829|158386784|FG000|Extension Period|Adverse Event|0|||
49149184|NCT03715829|158386785|FG001|Extension Period|Adverse Event|0|||
49149185|NCT03715829|158386786|FG002|Extension Period|Adverse Event|0|||
49149186|NCT03715829|158386787|FG003|Extension Period|Adverse Event|0|||
49149187|NCT03715829|158386788|FG004|Extension Period|Adverse Event|0|||
49149188|NCT03715829|158386789|FG005|Extension Period|Adverse Event|0|||
49149189|NCT03715829|158386790|FG006|Extension Period|Adverse Event|3|||
49149190|NCT03715829|158386791|FG007|Extension Period|Adverse Event|1|||
49149191|NCT03715829|158386792|FG008|Extension Period|Adverse Event|6|||
49149192|NCT03715829|158386793|FG009|Extension Period|Adverse Event|0|||
49149193|NCT03715829|158386794|FG010|Extension Period|Adverse Event|0|||
49149194|NCT03715829|158386784|FG000|Extension Period|Lack of Efficacy|0|||
49149195|NCT03715829|158386785|FG001|Extension Period|Lack of Efficacy|0|||
49149196|NCT03715829|158386786|FG002|Extension Period|Lack of Efficacy|0|||
49149197|NCT03715829|158386787|FG003|Extension Period|Lack of Efficacy|0|||
49149198|NCT03715829|158386788|FG004|Extension Period|Lack of Efficacy|0|||
49149199|NCT03715829|158386789|FG005|Extension Period|Lack of Efficacy|0|||
49149200|NCT03715829|158386790|FG006|Extension Period|Lack of Efficacy|1|||
49149201|NCT03715829|158386791|FG007|Extension Period|Lack of Efficacy|9|||
49149202|NCT03715829|158386792|FG008|Extension Period|Lack of Efficacy|2|||
49149203|NCT03715829|158386793|FG009|Extension Period|Lack of Efficacy|0|||
49149204|NCT03715829|158386794|FG010|Extension Period|Lack of Efficacy|0|||
49149205|NCT03715829|158386784|FG000|Extension Period|Lost to Follow-up|0|||
49149206|NCT03715829|158386785|FG001|Extension Period|Lost to Follow-up|0|||
49149207|NCT03715829|158386786|FG002|Extension Period|Lost to Follow-up|0|||
49149208|NCT03715829|158386787|FG003|Extension Period|Lost to Follow-up|0|||
49149209|NCT03715829|158386788|FG004|Extension Period|Lost to Follow-up|0|||
49149210|NCT03715829|158386789|FG005|Extension Period|Lost to Follow-up|0|||
49149211|NCT03715829|158386790|FG006|Extension Period|Lost to Follow-up|0|||
49149212|NCT03715829|158386791|FG007|Extension Period|Lost to Follow-up|0|||
49149213|NCT03715829|158386792|FG008|Extension Period|Lost to Follow-up|2|||
49149214|NCT03715829|158386793|FG009|Extension Period|Lost to Follow-up|0|||
49149215|NCT03715829|158386794|FG010|Extension Period|Lost to Follow-up|0|||
49149216|NCT03715829|158386784|FG000|Extension Period|Protocol Violation|0|||
49149217|NCT03715829|158386785|FG001|Extension Period|Protocol Violation|0|||
49149218|NCT03715829|158386786|FG002|Extension Period|Protocol Violation|0|||
49149219|NCT03715829|158386787|FG003|Extension Period|Protocol Violation|0|||
49149220|NCT03715829|158386788|FG004|Extension Period|Protocol Violation|0|||
49149221|NCT03715829|158386789|FG005|Extension Period|Protocol Violation|0|||
49149222|NCT03715829|158386790|FG006|Extension Period|Protocol Violation|0|||
49149223|NCT03715829|158386791|FG007|Extension Period|Protocol Violation|0|||
49149224|NCT03715829|158386792|FG008|Extension Period|Protocol Violation|1|||
49149225|NCT03715829|158386793|FG009|Extension Period|Protocol Violation|0|||
49149226|NCT03715829|158386794|FG010|Extension Period|Protocol Violation|0|||
49149227|NCT03715829|158386784|FG000|Extension Period|Withdrawal by Subject|0|||
49149228|NCT03715829|158386785|FG001|Extension Period|Withdrawal by Subject|0|||
49149229|NCT03715829|158386786|FG002|Extension Period|Withdrawal by Subject|0|||
49149230|NCT03715829|158386787|FG003|Extension Period|Withdrawal by Subject|0|||
49149231|NCT03715829|158386788|FG004|Extension Period|Withdrawal by Subject|0|||
49149232|NCT03715829|158386789|FG005|Extension Period|Withdrawal by Subject|0|||
49149233|NCT03715829|158386790|FG006|Extension Period|Withdrawal by Subject|3|||
49149234|NCT03715829|158386791|FG007|Extension Period|Withdrawal by Subject|3|||
49149235|NCT03715829|158386792|FG008|Extension Period|Withdrawal by Subject|12|||
49149236|NCT03715829|158386793|FG009|Extension Period|Withdrawal by Subject|3|||
49149237|NCT03715829|158386794|FG010|Extension Period|Withdrawal by Subject|0|||
49149238|NCT03715829|158386784|FG000|Extension Period|Medication Error Without Associated Adverse Event|0|||
49149239|NCT03715829|158386785|FG001|Extension Period|Medication Error Without Associated Adverse Event|0|||
49149240|NCT03715829|158386786|FG002|Extension Period|Medication Error Without Associated Adverse Event|0|||
49149241|NCT03715829|158386787|FG003|Extension Period|Medication Error Without Associated Adverse Event|0|||
49149242|NCT03715829|158386788|FG004|Extension Period|Medication Error Without Associated Adverse Event|0|||
49149243|NCT03715829|158386789|FG005|Extension Period|Medication Error Without Associated Adverse Event|0|||
49149244|NCT03715829|158386790|FG006|Extension Period|Medication Error Without Associated Adverse Event|0|||
49149245|NCT03715829|158386791|FG007|Extension Period|Medication Error Without Associated Adverse Event|1|||
49149246|NCT03715829|158386792|FG008|Extension Period|Medication Error Without Associated Adverse Event|1|||
49149247|NCT03715829|158386793|FG009|Extension Period|Medication Error Without Associated Adverse Event|0|||
49149248|NCT03715829|158386794|FG010|Extension Period|Medication Error Without Associated Adverse Event|0|||
49149249|NCT03715829|158386784|FG000|Extension Period|No Longer Meets Eligibility Criteria|0|||
49149250|NCT03715829|158386785|FG001|Extension Period|No Longer Meets Eligibility Criteria|0|||
49149251|NCT03715829|158386786|FG002|Extension Period|No Longer Meets Eligibility Criteria|0|||
49149252|NCT03715829|158386787|FG003|Extension Period|No Longer Meets Eligibility Criteria|0|||
49149253|NCT03715829|158386788|FG004|Extension Period|No Longer Meets Eligibility Criteria|0|||
49149254|NCT03715829|158386789|FG005|Extension Period|No Longer Meets Eligibility Criteria|0|||
49149255|NCT03715829|158386790|FG006|Extension Period|No Longer Meets Eligibility Criteria|0|||
49149256|NCT03715829|158386791|FG007|Extension Period|No Longer Meets Eligibility Criteria|0|||
49149257|NCT03715829|158386792|FG008|Extension Period|No Longer Meets Eligibility Criteria|1|||
49149258|NCT03715829|158386793|FG009|Extension Period|No Longer Meets Eligibility Criteria|0|||
49149259|NCT03715829|158386794|FG010|Extension Period|No Longer Meets Eligibility Criteria|0|||
49149260|NCT03715829|158386784|FG000|Extension Period|Other|0|||
49149261|NCT03715829|158386785|FG001|Extension Period|Other|0|||
49149262|NCT03715829|158386786|FG002|Extension Period|Other|0|||
49149263|NCT03715829|158386787|FG003|Extension Period|Other|0|||
49149264|NCT03715829|158386788|FG004|Extension Period|Other|0|||
49149265|NCT03715829|158386789|FG005|Extension Period|Other|0|||
49149266|NCT03715829|158386790|FG006|Extension Period|Other|1|||
49149267|NCT03715829|158386791|FG007|Extension Period|Other|2|||
49149268|NCT03715829|158386792|FG008|Extension Period|Other|4|||
49149269|NCT03715829|158386793|FG009|Extension Period|Other|0|||
49149270|NCT03715829|158386794|FG010|Extension Period|Other|0|||
49149271|NCT01681849|158386798|FG000|Overall Study|Protocol Violation|2|||
49149272|NCT01681849|158386799|FG001|Overall Study|Protocol Violation|0|||
49149273|NCT01681849|158386800|FG002|Overall Study|Protocol Violation|0|||
49149274|NCT01681849|158386798|FG000|Overall Study|Withdrawal by Subject|3|||
49149275|NCT01681849|158386799|FG001|Overall Study|Withdrawal by Subject|5|||
49149276|NCT01681849|158386800|FG002|Overall Study|Withdrawal by Subject|33|||
49149277|NCT01681849|158386798|FG000|Overall Study|Lost to Follow-up|3|||
49149278|NCT01681849|158386799|FG001|Overall Study|Lost to Follow-up|2|||
49149279|NCT01681849|158386800|FG002|Overall Study|Lost to Follow-up|6|||
49149280|NCT02298946|158386811|FG000|Overall Study|Did not receive treatment|2|||
49149281|NCT02298946|158386812|FG001|Overall Study|Did not receive treatment|0|||
49149282|NCT02298946|158386811|FG000|Overall Study|Unevaluable|2|||
49149283|NCT02298946|158386812|FG001|Overall Study|Unevaluable|1|||
49149284|NCT00050011|158386815|FG000|Overall Study|Adverse Event|41|||
49149285|NCT00050011|158386816|FG001|Overall Study|Adverse Event|46|||
49149286|NCT00050011|158386815|FG000|Overall Study|Abnormal laboratory value(s)|1|||
49149287|NCT00050011|158386816|FG001|Overall Study|Abnormal laboratory value(s)|1|||
49149288|NCT00050011|158386815|FG000|Overall Study|Abnormal test procedure results|0|||
49149289|NCT00050011|158386816|FG001|Overall Study|Abnormal test procedure results|1|||
49149290|NCT00050011|158386815|FG000|Overall Study|Lack of Efficacy|16|||
49149291|NCT00050011|158386816|FG001|Overall Study|Lack of Efficacy|21|||
49149292|NCT00050011|158386815|FG000|Overall Study|Participant condition no longer required|1|||
49149293|NCT00050011|158386816|FG001|Overall Study|Participant condition no longer required|0|||
49149294|NCT00050011|158386815|FG000|Overall Study|Protocol Violation|4|||
49149295|NCT00050011|158386816|FG001|Overall Study|Protocol Violation|10|||
49149296|NCT00050011|158386815|FG000|Overall Study|Withdrawal by Subject|34|||
49149297|NCT00050011|158386816|FG001|Overall Study|Withdrawal by Subject|26|||
49149298|NCT00050011|158386815|FG000|Overall Study|Lost to Follow-up|7|||
49149299|NCT00050011|158386816|FG001|Overall Study|Lost to Follow-up|9|||
49149300|NCT00050011|158386815|FG000|Overall Study|Administrative problems|10|||
49149301|NCT00050011|158386816|FG001|Overall Study|Administrative problems|6|||
49149302|NCT00050011|158386815|FG000|Overall Study|Death|7|||
49149303|NCT00050011|158386816|FG001|Overall Study|Death|4|||
49149304|NCT00050011|158386815|FG000|Overall Study|Unknown - Reason is missing|0|||
49149305|NCT00050011|158386816|FG001|Overall Study|Unknown - Reason is missing|2|||
49149306|NCT05013905|158386817|FG000|Overall Study|Adverse Event|1|||
49149307|NCT05013905|158386817|FG000|Overall Study|Lack of Efficacy|1|||
49149308|NCT04003142|158386818|FG000|Double-blind Period (12 Weeks)|Adverse Event|1|||
49149309|NCT04003142|158386819|FG001|Double-blind Period (12 Weeks)|Adverse Event|1|||
49149310|NCT04003142|158386820|FG002|Double-blind Period (12 Weeks)|Adverse Event|2|||
49149311|NCT04003142|158386821|FG003|Double-blind Period (12 Weeks)|Adverse Event|0|||
49149312|NCT04003142|158386822|FG004|Double-blind Period (12 Weeks)|Adverse Event|0|||
49149313|NCT04003142|158386818|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
49149314|NCT04003142|158386819|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
49149315|NCT04003142|158386820|FG002|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
49149316|NCT04003142|158386821|FG003|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
49149317|NCT04003142|158386822|FG004|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
49149318|NCT04003142|158386818|FG000|Double-blind Period (12 Weeks)|Protocol Deviation|1|||
49149319|NCT04003142|158386819|FG001|Double-blind Period (12 Weeks)|Protocol Deviation|5|||
49149320|NCT04003142|158386820|FG002|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
49149321|NCT04003142|158386821|FG003|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
49149322|NCT04003142|158386822|FG004|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
49149323|NCT04003142|158386818|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|11|||
49149324|NCT04003142|158386819|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
49149325|NCT04003142|158386820|FG002|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
49149326|NCT04003142|158386821|FG003|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
49149327|NCT04003142|158386822|FG004|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
49149328|NCT04003142|158386818|FG000|Double-blind Period (12 Weeks)|Miscellaneous|2|||
49149329|NCT04003142|158386819|FG001|Double-blind Period (12 Weeks)|Miscellaneous|1|||
48824285|NCT00630539|157197215|FG001|Overall Study|Adverse Event|3|||
49149330|NCT04003142|158386820|FG002|Double-blind Period (12 Weeks)|Miscellaneous|2|||
49149331|NCT04003142|158386821|FG003|Double-blind Period (12 Weeks)|Miscellaneous|0|||
49149332|NCT04003142|158386822|FG004|Double-blind Period (12 Weeks)|Miscellaneous|0|||
49149333|NCT04003142|158386818|FG000|Extension Period (40 Weeks)|Adverse Event|0|||
49149334|NCT04003142|158386819|FG001|Extension Period (40 Weeks)|Adverse Event|4|||
49149335|NCT04003142|158386820|FG002|Extension Period (40 Weeks)|Adverse Event|4|||
48824286|NCT00630539|157197216|FG002|Overall Study|Adverse Event|1|||
49149336|NCT04003142|158386821|FG003|Extension Period (40 Weeks)|Adverse Event|2|||
49149337|NCT04003142|158386822|FG004|Extension Period (40 Weeks)|Adverse Event|3|||
49149338|NCT04003142|158386818|FG000|Extension Period (40 Weeks)|Death|0|||
49149339|NCT04003142|158386819|FG001|Extension Period (40 Weeks)|Death|0|||
49149340|NCT04003142|158386820|FG002|Extension Period (40 Weeks)|Death|0|||
49149341|NCT04003142|158386821|FG003|Extension Period (40 Weeks)|Death|0|||
49149342|NCT04003142|158386822|FG004|Extension Period (40 Weeks)|Death|1|||
49149343|NCT04003142|158386818|FG000|Extension Period (40 Weeks)|Lost to Follow-up|0|||
49149344|NCT04003142|158386819|FG001|Extension Period (40 Weeks)|Lost to Follow-up|2|||
49149345|NCT04003142|158386820|FG002|Extension Period (40 Weeks)|Lost to Follow-up|1|||
48824287|NCT00630539|157197217|FG003|Overall Study|Adverse Event|2|||
48824288|NCT00630539|157197214|FG000|Overall Study|Withdrawal by Subject|0|||
48824289|NCT00630539|157197215|FG001|Overall Study|Withdrawal by Subject|1|||
48824290|NCT00630539|157197216|FG002|Overall Study|Withdrawal by Subject|0|||
48824291|NCT00630539|157197217|FG003|Overall Study|Withdrawal by Subject|1|||
48824292|NCT00577629|157197218|FG000|Treatment Period|Death|1|||
48824293|NCT00577629|157197218|FG000|Long Term Follow-Up|Death|15|||
48824294|NCT00577629|157197218|FG000|Long Term Follow-Up|Lost to Follow-up|5|||
48824295|NCT00577629|157197218|FG000|Long Term Follow-Up|Withdrawal by Subject|4|||
48824296|NCT00577629|157197218|FG000|Long Term Follow-Up|Physician Decision|1|||
48824297|NCT01072929|157197219|FG000|Overall Study|Adverse Event|8|||
48824298|NCT01072929|157197220|FG001|Overall Study|Adverse Event|11|||
48824299|NCT01072929|157197221|FG002|Overall Study|Adverse Event|2|||
48824300|NCT01072929|157197219|FG000|Overall Study|Lack of Efficacy|7|||
48824301|NCT01072929|157197220|FG001|Overall Study|Lack of Efficacy|4|||
49149346|NCT04003142|158386821|FG003|Extension Period (40 Weeks)|Lost to Follow-up|2|||
49149347|NCT04003142|158386822|FG004|Extension Period (40 Weeks)|Lost to Follow-up|1|||
49149348|NCT04003142|158386818|FG000|Extension Period (40 Weeks)|Protocol Deviation|0|||
49149349|NCT04003142|158386819|FG001|Extension Period (40 Weeks)|Protocol Deviation|0|||
49149350|NCT04003142|158386820|FG002|Extension Period (40 Weeks)|Protocol Deviation|2|||
48824302|NCT01072929|157197221|FG002|Overall Study|Lack of Efficacy|0|||
48824303|NCT01072929|157197219|FG000|Overall Study|Withdrawal by Subject|7|||
48824304|NCT01072929|157197220|FG001|Overall Study|Withdrawal by Subject|15|||
48824305|NCT01072929|157197221|FG002|Overall Study|Withdrawal by Subject|3|||
48824306|NCT01072929|157197219|FG000|Overall Study|Protocol Violation|13|||
48731594|NCT03766685|156869466|FG000|Overall Study|Adverse Event, not fatal|0|||
48731595|NCT03766685|156869467|FG001|Overall Study|Adverse Event, not fatal|1|||
48731596|NCT03766685|156869468|FG002|Overall Study|Adverse Event, not fatal|0|||
48731597|NCT03766685|156869469|FG003|Overall Study|Adverse Event, not fatal|1|||
48731598|NCT03766685|156869466|FG000|Overall Study|Withdrawal by Subject|0|||
48731599|NCT03766685|156869467|FG001|Overall Study|Withdrawal by Subject|2|||
48731600|NCT03766685|156869468|FG002|Overall Study|Withdrawal by Subject|0|||
49149351|NCT04003142|158386821|FG003|Extension Period (40 Weeks)|Protocol Deviation|0|||
49149352|NCT04003142|158386822|FG004|Extension Period (40 Weeks)|Protocol Deviation|0|||
49149353|NCT04003142|158386818|FG000|Extension Period (40 Weeks)|Withdrawal by Subject|0|||
49149354|NCT04003142|158386819|FG001|Extension Period (40 Weeks)|Withdrawal by Subject|17|||
49149355|NCT04003142|158386820|FG002|Extension Period (40 Weeks)|Withdrawal by Subject|14|||
49149356|NCT04003142|158386821|FG003|Extension Period (40 Weeks)|Withdrawal by Subject|9|||
49149357|NCT04003142|158386822|FG004|Extension Period (40 Weeks)|Withdrawal by Subject|5|||
49149358|NCT04003142|158386818|FG000|Extension Period (40 Weeks)|Miscellaneous|0|||
49149359|NCT04003142|158386819|FG001|Extension Period (40 Weeks)|Miscellaneous|4|||
49149360|NCT04003142|158386820|FG002|Extension Period (40 Weeks)|Miscellaneous|1|||
49149361|NCT04003142|158386821|FG003|Extension Period (40 Weeks)|Miscellaneous|0|||
49149362|NCT04003142|158386822|FG004|Extension Period (40 Weeks)|Miscellaneous|2|||
49149363|NCT03734536|158386827|FG000|Overall Study|Withdrew Consent|1|||
49149364|NCT03734536|158386828|FG001|Overall Study|Withdrew Consent|5|||
49149365|NCT03734536|158386827|FG000|Overall Study|Lost to Follow-up|10|||
49149366|NCT03734536|158386828|FG001|Overall Study|Lost to Follow-up|7|||
49149367|NCT02757963|158386829|FG000|Overall Study|Adverse Event|3|||
49149368|NCT02757963|158386829|FG000|Overall Study|Reached Stopping Criteria|1054|||
49149369|NCT02757963|158386829|FG000|Overall Study|Lost to Follow-up|5|||
49149370|NCT02757963|158386829|FG000|Overall Study|Physician Decision|1|||
49149371|NCT02757963|158386829|FG000|Overall Study|Withdrawal by Subject|34|||
49149372|NCT00911157|158386830|FG000|Overall Study|Adverse Event|4|||
49149373|NCT00911157|158386831|FG001|Overall Study|Adverse Event|1|||
49149374|NCT00911157|158386830|FG000|Overall Study|Withdrawal by Subject|1|||
49149375|NCT00911157|158386831|FG001|Overall Study|Withdrawal by Subject|1|||
49149376|NCT00911157|158386830|FG000|Overall Study|Need for prohibited drug (heparin)|1|||
49149377|NCT00911157|158386831|FG001|Overall Study|Need for prohibited drug (heparin)|0|||
49149378|NCT00911157|158386830|FG000|Overall Study|Need to treat for lung cancer|1|||
49149379|NCT00911157|158386831|FG001|Overall Study|Need to treat for lung cancer|0|||
49149380|NCT04755231|158386832|FG000|Overall Study|Lost to Follow-up|5|||
49149381|NCT04755231|158386832|FG000|Overall Study|Withdrawal by Subject|5|||
49149382|NCT02769481|158386835|FG000|Overall Study|Protocol Violation|1|||
49149383|NCT02769481|158386836|FG001|Overall Study|Protocol Violation|0|||
48731601|NCT03766685|156869469|FG003|Overall Study|Withdrawal by Subject|0|||
48824307|NCT01072929|157197220|FG001|Overall Study|Protocol Violation|11|||
48824308|NCT01072929|157197221|FG002|Overall Study|Protocol Violation|2|||
48824309|NCT01072929|157197219|FG000|Overall Study|Lost to Follow-up|8|||
48824310|NCT01072929|157197220|FG001|Overall Study|Lost to Follow-up|4|||
48824311|NCT01072929|157197221|FG002|Overall Study|Lost to Follow-up|1|||
48824312|NCT01072929|157197219|FG000|Overall Study|Noncompliance with study medication|0|||
48824313|NCT01072929|157197220|FG001|Overall Study|Noncompliance with study medication|3|||
48824314|NCT01072929|157197221|FG002|Overall Study|Noncompliance with study medication|0|||
48824315|NCT01072929|157197219|FG000|Overall Study|Noncompliance with study procedures|1|||
48824316|NCT01072929|157197220|FG001|Overall Study|Noncompliance with study procedures|0|||
48824317|NCT01072929|157197221|FG002|Overall Study|Noncompliance with study procedures|1|||
48824318|NCT01072929|157197219|FG000|Overall Study|Other|0|||
48824319|NCT01072929|157197220|FG001|Overall Study|Other|3|||
48824320|NCT01072929|157197221|FG002|Overall Study|Other|0|||
48824321|NCT03782727|157197223|FG000|Overall Study|Lost to Follow-up|32|||
48824322|NCT03682536|157197224|FG000|Randomization|Withdrawal by Subject|0|||
48824323|NCT03682536|157197225|FG001|Randomization|Withdrawal by Subject|2|||
48824324|NCT03682536|157197224|FG000|Treatment|Other Reasons|8|||
48824325|NCT03682536|157197225|FG001|Treatment|Other Reasons|7|||
49149384|NCT02769481|158386835|FG000|Overall Study|Adverse Event|3|||
49149385|NCT02769481|158386836|FG001|Overall Study|Adverse Event|6|||
49149386|NCT02769481|158386835|FG000|Overall Study|Entry Criteria Not Met|1|||
49149387|NCT02769481|158386836|FG001|Overall Study|Entry Criteria Not Met|2|||
49149388|NCT02769481|158386835|FG000|Overall Study|Withdrawal by Subject|14|||
49149389|NCT02769481|158386836|FG001|Overall Study|Withdrawal by Subject|16|||
49149390|NCT02769481|158386835|FG000|Overall Study|Lost to Follow-up|9|||
49149391|NCT02769481|158386836|FG001|Overall Study|Lost to Follow-up|9|||
49149392|NCT02769481|158386835|FG000|Overall Study|Physician Decision|0|||
49149393|NCT02769481|158386836|FG001|Overall Study|Physician Decision|1|||
49149394|NCT02769481|158386835|FG000|Overall Study|Terminated by Sponsor|1|||
49149395|NCT02769481|158386836|FG001|Overall Study|Terminated by Sponsor|0|||
49149396|NCT02769481|158386835|FG000|Overall Study|Death|0|||
48824326|NCT03682536|157197224|FG000|Treatment|Physician Decision|5|||
48824327|NCT03682536|157197225|FG001|Treatment|Physician Decision|5|||
49149397|NCT02769481|158386836|FG001|Overall Study|Death|1|||
49149398|NCT02769481|158386835|FG000|Overall Study|Undefined|4|||
49149399|NCT02769481|158386836|FG001|Overall Study|Undefined|1|||
49149400|NCT01346592|158386838|FG000|Overall Study|Lost to Follow-up|62|||
49149401|NCT01346592|158386839|FG001|Overall Study|Lost to Follow-up|29|||
48731602|NCT03766685|156869466|FG000|Overall Study|Protocol Violation|0|||
48731603|NCT03766685|156869467|FG001|Overall Study|Protocol Violation|1|||
48731604|NCT03766685|156869468|FG002|Overall Study|Protocol Violation|0|||
48731605|NCT03766685|156869469|FG003|Overall Study|Protocol Violation|0|||
48731606|NCT03766685|156869466|FG000|Overall Study|Non-compliance|0|||
48731607|NCT03766685|156869467|FG001|Overall Study|Non-compliance|2|||
48731608|NCT03766685|156869468|FG002|Overall Study|Non-compliance|0|||
48731609|NCT03766685|156869469|FG003|Overall Study|Non-compliance|0|||
48824328|NCT03682536|157197224|FG000|Treatment|Protocol Violation|1|||
48824329|NCT03682536|157197225|FG001|Treatment|Protocol Violation|0|||
48824330|NCT03682536|157197224|FG000|Treatment|Study Terminated by Sponsor|1|||
48824331|NCT03682536|157197225|FG001|Treatment|Study Terminated by Sponsor|2|||
48824332|NCT03682536|157197224|FG000|Treatment|Lost to Follow-up|0|||
48824333|NCT03682536|157197225|FG001|Treatment|Lost to Follow-up|1|||
48824334|NCT03682536|157197224|FG000|Treatment|Withdrawal by Subject|16|||
48824335|NCT03682536|157197225|FG001|Treatment|Withdrawal by Subject|18|||
48824336|NCT03682536|157197224|FG000|Treatment|Lack of Efficacy|41|||
48824337|NCT03682536|157197225|FG001|Treatment|Lack of Efficacy|68|||
48824338|NCT03682536|157197224|FG000|Treatment|Disease Progression|9|||
48824339|NCT03682536|157197225|FG001|Treatment|Disease Progression|7|||
48824340|NCT03682536|157197224|FG000|Treatment|Adverse Event|9|||
48824341|NCT03682536|157197225|FG001|Treatment|Adverse Event|5|||
48824342|NCT03682536|157197224|FG000|Treatment|Death|14|||
48824343|NCT03682536|157197225|FG001|Treatment|Death|13|||
48824344|NCT03176134|157197226|FG000|Overall Study|Lost to Follow-up|0|||
48824345|NCT03176134|157197227|FG001|Overall Study|Lost to Follow-up|2|||
48824346|NCT03176134|157197228|FG002|Overall Study|Lost to Follow-up|0|||
48824347|NCT03176134|157197229|FG003|Overall Study|Lost to Follow-up|0|||
48824348|NCT03176134|157197230|FG004|Overall Study|Lost to Follow-up|0|||
48824349|NCT03176134|157197231|FG005|Overall Study|Lost to Follow-up|0|||
48824350|NCT03176134|157197232|FG006|Overall Study|Lost to Follow-up|0|||
48824351|NCT03176134|157197233|FG007|Overall Study|Lost to Follow-up|0|||
48824352|NCT03176134|157197226|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
48824353|NCT03176134|157197227|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
48824354|NCT03176134|157197228|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
48824355|NCT03176134|157197229|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
48824356|NCT03176134|157197230|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
48824357|NCT03176134|157197231|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
48824358|NCT03176134|157197232|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
48824359|NCT03176134|157197233|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
48824360|NCT05008224|157197234|FG000|Overall Study|Death|3|||
48824361|NCT05008224|157197234|FG000|Overall Study|Lost to Follow-up|2|||
48824362|NCT05008224|157197234|FG000|Overall Study|Did Not Continue on Extension Study|39|||
48824363|NCT05008224|157197234|FG000|Overall Study|Transferred to Extension Study|100|||
49149402|NCT01346592|158386840|FG002|Overall Study|Lost to Follow-up|29|||
49149403|NCT01346592|158386838|FG000|Overall Study|Protocol Violation|2|||
49149404|NCT01346592|158386839|FG001|Overall Study|Protocol Violation|1|||
49149405|NCT01346592|158386840|FG002|Overall Study|Protocol Violation|0|||
49149406|NCT01346592|158386838|FG000|Overall Study|Death|1|||
49149407|NCT01346592|158386839|FG001|Overall Study|Death|3|||
49149408|NCT01346592|158386840|FG002|Overall Study|Death|4|||
49149409|NCT01346592|158386838|FG000|Overall Study|Adverse Event|0|||
49149410|NCT01346592|158386839|FG001|Overall Study|Adverse Event|1|||
49149411|NCT01346592|158386840|FG002|Overall Study|Adverse Event|0|||
49149412|NCT01346592|158386838|FG000|Overall Study|Withdrawal by Subject|77|||
49149413|NCT01346592|158386839|FG001|Overall Study|Withdrawal by Subject|51|||
49149414|NCT01346592|158386840|FG002|Overall Study|Withdrawal by Subject|38|||
49149415|NCT01346592|158386838|FG000|Overall Study|Inappropriate enrollment|3|||
49149416|NCT01346592|158386839|FG001|Overall Study|Inappropriate enrollment|1|||
49149417|NCT01346592|158386840|FG002|Overall Study|Inappropriate enrollment|1|||
49149418|NCT01346592|158386838|FG000|Overall Study|Administrative reason|1|||
49149419|NCT01346592|158386839|FG001|Overall Study|Administrative reason|0|||
49149420|NCT01346592|158386840|FG002|Overall Study|Administrative reason|0|||
49149421|NCT01346592|158386838|FG000|Overall Study|Unable to Classify|7|||
48824364|NCT05008224|157197234|FG000|Overall Study|Withdrawal by Subject|2|||
48824365|NCT02223182|157197235|FG000|Double-Blind Period|Adverse Event|0|||
49149422|NCT01346592|158386839|FG001|Overall Study|Unable to Classify|3|||
49149423|NCT01346592|158386840|FG002|Overall Study|Unable to Classify|6|||
49149424|NCT04191135|158386843|FG000|Induction Treatment|Not Treated|2|||
48731610|NCT01484132|156869472|FG000|Overall Study|Lost to Follow-up|8|||
48824366|NCT02223182|157197236|FG001|Double-Blind Period|Adverse Event|2|||
48824367|NCT02223182|157197237|FG002|Double-Blind Period|Adverse Event|1|||
48824368|NCT02223182|157197238|FG003|Double-Blind Period|Adverse Event|0|||
48824369|NCT02223182|157197235|FG000|Double-Blind Period|Withdrawal by Subject|1|||
48824370|NCT02223182|157197236|FG001|Double-Blind Period|Withdrawal by Subject|1|||
49149425|NCT04191135|158386844|FG001|Induction Treatment|Not Treated|0|||
49149426|NCT04191135|158386845|FG002|Induction Treatment|Not Treated|0|||
49149427|NCT04191135|158386843|FG000|Induction Treatment|Ongoing to Blinded Treatment Period|271|||
49149428|NCT04191135|158386844|FG001|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
49149429|NCT04191135|158386845|FG002|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
49149430|NCT04191135|158386843|FG000|Induction Treatment|Adverse Event|25|||
49149431|NCT04191135|158386844|FG001|Induction Treatment|Adverse Event|0|||
49149432|NCT04191135|158386845|FG002|Induction Treatment|Adverse Event|0|||
49149433|NCT04191135|158386843|FG000|Induction Treatment|Clinical Progression|8|||
49149434|NCT04191135|158386844|FG001|Induction Treatment|Clinical Progression|0|||
49149435|NCT04191135|158386845|FG002|Induction Treatment|Clinical Progression|0|||
49149436|NCT04191135|158386843|FG000|Induction Treatment|Excluded Medication|1|||
49149437|NCT04191135|158386844|FG001|Induction Treatment|Excluded Medication|0|||
49149438|NCT04191135|158386845|FG002|Induction Treatment|Excluded Medication|0|||
49149439|NCT04191135|158386843|FG000|Induction Treatment|Failure to Meet Continuation Criteria|2|||
49149440|NCT04191135|158386844|FG001|Induction Treatment|Failure to Meet Continuation Criteria|0|||
49149441|NCT04191135|158386845|FG002|Induction Treatment|Failure to Meet Continuation Criteria|0|||
49149442|NCT04191135|158386843|FG000|Induction Treatment|Failure to Meet Randomization Criteria|2|||
49149443|NCT04191135|158386844|FG001|Induction Treatment|Failure to Meet Randomization Criteria|0|||
49149444|NCT04191135|158386845|FG002|Induction Treatment|Failure to Meet Randomization Criteria|0|||
49149445|NCT04191135|158386843|FG000|Induction Treatment|Physician Decision|2|||
49149446|NCT04191135|158386844|FG001|Induction Treatment|Physician Decision|0|||
49149447|NCT04191135|158386845|FG002|Induction Treatment|Physician Decision|0|||
49149448|NCT04191135|158386843|FG000|Induction Treatment|Progressive Disease|135|||
49149449|NCT04191135|158386844|FG001|Induction Treatment|Progressive Disease|0|||
49149450|NCT04191135|158386845|FG002|Induction Treatment|Progressive Disease|0|||
49149451|NCT04191135|158386843|FG000|Induction Treatment|Protocol Violation|10|||
49149452|NCT04191135|158386844|FG001|Induction Treatment|Protocol Violation|0|||
49149453|NCT04191135|158386845|FG002|Induction Treatment|Protocol Violation|0|||
49149454|NCT04191135|158386843|FG000|Induction Treatment|Withdrawal by Subject|4|||
49149455|NCT04191135|158386844|FG001|Induction Treatment|Withdrawal by Subject|0|||
49149456|NCT04191135|158386845|FG002|Induction Treatment|Withdrawal by Subject|0|||
49149457|NCT04191135|158386843|FG000|Randomized Treatment|Death|0|||
49149458|NCT04191135|158386844|FG001|Randomized Treatment|Death|50|||
49149459|NCT04191135|158386845|FG002|Randomized Treatment|Death|54|||
49149460|NCT04191135|158386843|FG000|Randomized Treatment|Lost to Follow-up|0|||
49149461|NCT04191135|158386844|FG001|Randomized Treatment|Lost to Follow-up|0|||
49149462|NCT04191135|158386845|FG002|Randomized Treatment|Lost to Follow-up|1|||
49149463|NCT04191135|158386843|FG000|Randomized Treatment|Withdrawal by Subject|0|||
49149464|NCT04191135|158386844|FG001|Randomized Treatment|Withdrawal by Subject|2|||
49149465|NCT04191135|158386845|FG002|Randomized Treatment|Withdrawal by Subject|0|||
49149466|NCT04191135|158386843|FG000|Randomized Treatment|Ongoing in Trial|0|||
49149467|NCT04191135|158386844|FG001|Randomized Treatment|Ongoing in Trial|83|||
49149468|NCT04191135|158386845|FG002|Randomized Treatment|Ongoing in Trial|81|||
49149469|NCT04115293|158388340|FG000|Overall Study|Adverse Event|0|||
49149470|NCT04115293|158388341|FG001|Overall Study|Adverse Event|2|||
49149471|NCT04115293|158388340|FG000|Overall Study|Withdrawal by Subject|2|||
49149472|NCT04115293|158388341|FG001|Overall Study|Withdrawal by Subject|1|||
49149473|NCT04115293|158388340|FG000|Overall Study|Physician Decision|1|||
49149474|NCT04115293|158388341|FG001|Overall Study|Physician Decision|0|||
49149475|NCT04115293|158388340|FG000|Overall Study|Death|1|||
49149476|NCT04115293|158388341|FG001|Overall Study|Death|1|||
49149477|NCT05543174|158388342|FG000|Overall Study|Ongoing|7|||
49149478|NCT02363283|158388343|FG000|Overall Study|Withdrawal by Subject|1|||
49149479|NCT02363283|158388343|FG000|Overall Study|Not eligible due to transaminitis|1|||
48731611|NCT01484132|156869472|FG000|Overall Study|Difficulty with time commitment|2|||
48731612|NCT01484132|156869472|FG000|Overall Study|Ineligible|1|||
48731613|NCT01484132|156869472|FG000|Overall Study|No pre-treatment urine sample collected|1|||
48731614|NCT01484132|156869472|FG000|Overall Study|No post-treatment urine sample collected|10|||
48731615|NCT01672736|156869473|FG000|Overall Study|Available drug expired on 31 May 16|3|||
48921464|NCT00143455|157546400|FG000|Cohort 1|Progressive Disease|0|||
48921465|NCT00143455|157546401|FG001|Cohort 1|Progressive Disease|6|||
48921466|NCT00143455|157546402|FG002|Cohort 1|Progressive Disease|0|||
48921467|NCT00143455|157546403|FG003|Cohort 1|Progressive Disease|0|||
48921468|NCT00143455|157546400|FG000|Cohort 1|Withdrawal by Subject|1|||
48921469|NCT00143455|157546401|FG001|Cohort 1|Withdrawal by Subject|4|||
48921470|NCT00143455|157546402|FG002|Cohort 1|Withdrawal by Subject|0|||
48921471|NCT00143455|157546403|FG003|Cohort 1|Withdrawal by Subject|0|||
48921472|NCT00143455|157546400|FG000|Cohort 1|Randomized But Not Treated|0|||
48921473|NCT00143455|157546401|FG001|Cohort 1|Randomized But Not Treated|1|||
48921474|NCT00143455|157546402|FG002|Cohort 1|Randomized But Not Treated|0|||
48921475|NCT00143455|157546403|FG003|Cohort 1|Randomized But Not Treated|0|||
48921476|NCT00143455|157546400|FG000|Cohort 2|Adverse Event|0|||
48921477|NCT00143455|157546401|FG001|Cohort 2|Adverse Event|0|||
48921478|NCT00143455|157546402|FG002|Cohort 2|Adverse Event|42|||
48921479|NCT00143455|157546403|FG003|Cohort 2|Adverse Event|30|||
48824371|NCT02223182|157197237|FG002|Double-Blind Period|Withdrawal by Subject|1|||
48824372|NCT02223182|157197238|FG003|Double-Blind Period|Withdrawal by Subject|0|||
48824373|NCT02223182|157197235|FG000|Double-Blind Period|Lost to Follow-up|0|||
48824374|NCT02223182|157197236|FG001|Double-Blind Period|Lost to Follow-up|1|||
48824375|NCT02223182|157197237|FG002|Double-Blind Period|Lost to Follow-up|0|||
48824376|NCT02223182|157197238|FG003|Double-Blind Period|Lost to Follow-up|0|||
48824377|NCT02223182|157197235|FG000|Double-Blind Period|Non Compliance|0|||
48824378|NCT02223182|157197236|FG001|Double-Blind Period|Non Compliance|0|||
48824379|NCT02223182|157197237|FG002|Double-Blind Period|Non Compliance|0|||
48824380|NCT02223182|157197238|FG003|Double-Blind Period|Non Compliance|1|||
48824381|NCT02223182|157197235|FG000|Double-Blind Period|Sponsor or Regulatory Authorities Decision|1|||
48824382|NCT02223182|157197236|FG001|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
48824383|NCT02223182|157197237|FG002|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
48824384|NCT02223182|157197238|FG003|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
48824385|NCT02223182|157197235|FG000|Open-Label 500 Period|Adverse Event|1|||
48824386|NCT02223182|157197236|FG001|Open-Label 500 Period|Adverse Event|0|||
48824387|NCT02223182|157197237|FG002|Open-Label 500 Period|Adverse Event|2|||
48824388|NCT02223182|157197238|FG003|Open-Label 500 Period|Adverse Event|1|||
48824389|NCT02223182|157197235|FG000|Open-Label 500 Period|Withdrawal by Subject|5|||
48824390|NCT02223182|157197236|FG001|Open-Label 500 Period|Withdrawal by Subject|2|||
48824391|NCT02223182|157197237|FG002|Open-Label 500 Period|Withdrawal by Subject|9|||
48824392|NCT02223182|157197238|FG003|Open-Label 500 Period|Withdrawal by Subject|8|||
48824393|NCT02223182|157197235|FG000|Open-Label 500 Period|Physician Decision|0|||
48824394|NCT02223182|157197236|FG001|Open-Label 500 Period|Physician Decision|0|||
48824395|NCT02223182|157197237|FG002|Open-Label 500 Period|Physician Decision|0|||
48824396|NCT02223182|157197238|FG003|Open-Label 500 Period|Physician Decision|1|||
48824397|NCT02223182|157197235|FG000|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
48824398|NCT02223182|157197236|FG001|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
48824399|NCT02223182|157197237|FG002|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|1|||
48824400|NCT02223182|157197238|FG003|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
49149480|NCT02698787|158388344|FG000|Second Intervention (3 Months)|Withdrawal by Subject|0|||
48824401|NCT02223182|157197235|FG000|Open-Label 300 Period|Withdrawal by Subject|10|||
49149481|NCT02698787|158388345|FG001|Second Intervention (3 Months)|Withdrawal by Subject|1|||
49149482|NCT00107614|158388346|FG000|Overall Study|Physician Decision|10|||
49149483|NCT00107614|158388346|FG000|Overall Study|Death|2|||
49149484|NCT01428713|158388347|FG000|Overall Study|Non-compliance|2|||
49149485|NCT01428713|158388348|FG001|Overall Study|Non-compliance|2|||
49149486|NCT01428713|158388347|FG000|Overall Study|Withdrawal by Subject|1|||
49149487|NCT01428713|158388348|FG001|Overall Study|Withdrawal by Subject|1|||
49149488|NCT01428713|158388347|FG000|Overall Study|Adverse Event|0|||
49149489|NCT01428713|158388348|FG001|Overall Study|Adverse Event|2|||
49149490|NCT05333965|158388370|FG000|First Intervention|Adverse Event|0|||
49149491|NCT05333965|158388371|FG001|First Intervention|Adverse Event|1|||
49149492|NCT05333965|158388370|FG000|First Intervention|Withdrawal by Subject|0|||
49149493|NCT05333965|158388371|FG001|First Intervention|Withdrawal by Subject|1|||
49149494|NCT01730729|158388374|FG000|Overall Study|Adverse Event|1|||
49149495|NCT01730729|158388374|FG000|Overall Study|Death|1|||
49149496|NCT01730729|158388374|FG000|Overall Study|Progressive Disease|12|||
49149497|NCT02402907|158388375|FG000|Overall Study|Delivered vaginally|9|||
49149498|NCT02402907|158388376|FG001|Overall Study|Delivered vaginally|3|||
49149499|NCT02402907|158388375|FG000|Overall Study|Delivered outside of Sinai|1|||
49149500|NCT02402907|158388376|FG001|Overall Study|Delivered outside of Sinai|1|||
49149501|NCT02402907|158388375|FG000|Overall Study|Lost to follow up after C-Section|10|||
49149502|NCT02402907|158388376|FG001|Overall Study|Lost to follow up after C-Section|23|||
49149503|NCT02462057|158388379|FG000|Overall Study|Left Vitality|32|||
49149504|NCT02462057|158388380|FG001|Overall Study|Left Vitality|27|||
49149505|NCT02462057|158388381|FG002|Overall Study|Left Vitality|23|||
49149506|NCT02462057|158388382|FG003|Overall Study|Left Vitality|35|||
49149507|NCT02462057|158388383|FG004|Overall Study|Left Vitality|33|||
49149508|NCT02462057|158388379|FG000|Overall Study|Joined HealthyFood Before Intervention|22|||
49149509|NCT02462057|158388380|FG001|Overall Study|Joined HealthyFood Before Intervention|13|||
49149510|NCT02462057|158388381|FG002|Overall Study|Joined HealthyFood Before Intervention|23|||
49149511|NCT02462057|158388382|FG003|Overall Study|Joined HealthyFood Before Intervention|16|||
49149512|NCT02462057|158388383|FG004|Overall Study|Joined HealthyFood Before Intervention|17|||
49149513|NCT01697501|158388385|FG000|Overall Study|Protocol Violation|2|||
49149514|NCT00836901|158388389|FG000|First Intervention|Withdrawal by Subject|1|||
49149515|NCT00836901|158388390|FG001|First Intervention|Withdrawal by Subject|0|||
49149516|NCT04893811|158388391|FG000|Vaccination Phase|Death|1|||
49149517|NCT04893811|158388392|FG001|Vaccination Phase|Death|0|||
49149518|NCT04893811|158388391|FG000|Vaccination Phase|Lost to Follow-up|1|||
49149519|NCT04893811|158388392|FG001|Vaccination Phase|Lost to Follow-up|1|||
49149520|NCT04893811|158388391|FG000|Vaccination Phase|Protocol Violation|2|||
49149521|NCT04893811|158388392|FG001|Vaccination Phase|Protocol Violation|0|||
49149522|NCT04893811|158388391|FG000|Vaccination Phase|Withdrawal by Subject|2|||
49149523|NCT04893811|158388392|FG001|Vaccination Phase|Withdrawal by Subject|1|||
49149524|NCT04893811|158388391|FG000|Vaccination Phase|Other|0|||
49149525|NCT04893811|158388392|FG001|Vaccination Phase|Other|1|||
49149526|NCT04893811|158388391|FG000|Vaccination Phase|No longer met eligibility criteria|0|||
49149527|NCT04893811|158388392|FG001|Vaccination Phase|No longer met eligibility criteria|1|||
49149528|NCT04893811|158388391|FG000|Follow-up Phase|Lost to Follow-up|0|||
49149529|NCT04893811|158388392|FG001|Follow-up Phase|Lost to Follow-up|1|||
49149530|NCT02951819|158388406|FG000|Overall Study|Death|9|||
49149531|NCT02951819|158388407|FG001|Overall Study|Death|7|||
49149532|NCT02951819|158388406|FG000|Overall Study|Withdrawal by Subject|3|||
49149533|NCT02951819|158388407|FG001|Overall Study|Withdrawal by Subject|0|||
49149534|NCT02951819|158388406|FG000|Overall Study|Adverse Event|1|||
49149535|NCT02951819|158388407|FG001|Overall Study|Adverse Event|0|||
48921480|NCT00143455|157546400|FG000|Cohort 2|No Longer Required Study Treatment|0|||
48921481|NCT00143455|157546401|FG001|Cohort 2|No Longer Required Study Treatment|0|||
48921482|NCT00143455|157546402|FG002|Cohort 2|No Longer Required Study Treatment|1|||
48921483|NCT00143455|157546403|FG003|Cohort 2|No Longer Required Study Treatment|0|||
48921484|NCT00143455|157546400|FG000|Cohort 2|Protocol Violation|0|||
48921485|NCT00143455|157546401|FG001|Cohort 2|Protocol Violation|0|||
48921486|NCT00143455|157546402|FG002|Cohort 2|Protocol Violation|1|||
48921487|NCT00143455|157546403|FG003|Cohort 2|Protocol Violation|1|||
48921488|NCT00143455|157546400|FG000|Cohort 2|Lost to Follow-up|0|||
48921489|NCT00143455|157546401|FG001|Cohort 2|Lost to Follow-up|0|||
48921490|NCT00143455|157546402|FG002|Cohort 2|Lost to Follow-up|1|||
48921491|NCT00143455|157546403|FG003|Cohort 2|Lost to Follow-up|4|||
48921492|NCT00143455|157546400|FG000|Cohort 2|Death|0|||
48921493|NCT00143455|157546401|FG001|Cohort 2|Death|0|||
48921494|NCT00143455|157546402|FG002|Cohort 2|Death|20|||
48921495|NCT00143455|157546403|FG003|Cohort 2|Death|12|||
48921496|NCT00143455|157546400|FG000|Cohort 2|Progressive Disease|0|||
48921497|NCT00143455|157546401|FG001|Cohort 2|Progressive Disease|0|||
48921498|NCT00143455|157546402|FG002|Cohort 2|Progressive Disease|20|||
48921499|NCT00143455|157546403|FG003|Cohort 2|Progressive Disease|27|||
48921500|NCT00143455|157546400|FG000|Cohort 2|Withdrawal by Subject|0|||
48921501|NCT00143455|157546401|FG001|Cohort 2|Withdrawal by Subject|0|||
48921502|NCT00143455|157546402|FG002|Cohort 2|Withdrawal by Subject|13|||
49149536|NCT02951819|158388406|FG000|Overall Study|Lack of Efficacy|4|||
49149537|NCT02951819|158388407|FG001|Overall Study|Lack of Efficacy|0|||
48921503|NCT00143455|157546403|FG003|Cohort 2|Withdrawal by Subject|12|||
48921504|NCT00143455|157546400|FG000|Cohort 2|Other|0|||
48921505|NCT00143455|157546401|FG001|Cohort 2|Other|0|||
48921506|NCT00143455|157546402|FG002|Cohort 2|Other|7|||
48921507|NCT00143455|157546403|FG003|Cohort 2|Other|6|||
48921508|NCT00143455|157546400|FG000|Cohort 2|Randomized But Not Treated|0|||
48921509|NCT00143455|157546401|FG001|Cohort 2|Randomized But Not Treated|0|||
48921510|NCT00143455|157546402|FG002|Cohort 2|Randomized But Not Treated|1|||
48921511|NCT00143455|157546403|FG003|Cohort 2|Randomized But Not Treated|1|||
48921512|NCT02109484|157546404|FG000|Overall Study|Lost to Follow-up|0|||
48921513|NCT02109484|157546405|FG001|Overall Study|Lost to Follow-up|0|||
48921514|NCT02109484|157546406|FG002|Overall Study|Lost to Follow-up|0|||
48921515|NCT02109484|157546407|FG003|Overall Study|Lost to Follow-up|1|||
48921516|NCT02109484|157546408|FG004|Overall Study|Lost to Follow-up|1|||
48921517|NCT02109484|157546409|FG005|Overall Study|Lost to Follow-up|0|||
48921518|NCT02109484|157546410|FG006|Overall Study|Lost to Follow-up|1|||
48921519|NCT02109484|157546411|FG007|Overall Study|Lost to Follow-up|0|||
49149538|NCT02951819|158388406|FG000|Overall Study|Lost to Follow-up|1|||
49149539|NCT02951819|158388407|FG001|Overall Study|Lost to Follow-up|0|||
48731664|NCT01570868|156869477|FG000|Overall Study|Adverse Event|8|||
48731665|NCT01570868|156869478|FG001|Overall Study|Adverse Event|1|||
48731666|NCT01570868|156869477|FG000|Overall Study|FDA Recommendation|23|||
48731667|NCT01570868|156869478|FG001|Overall Study|FDA Recommendation|3|||
49149540|NCT02951819|158388406|FG000|Overall Study|Progressive Disease|1|||
49149541|NCT02951819|158388407|FG001|Overall Study|Progressive Disease|0|||
49149542|NCT02951819|158388406|FG000|Overall Study|Other|9|||
49149543|NCT02951819|158388407|FG001|Overall Study|Other|0|||
49149544|NCT01443026|158388408|FG000|Overall Study|Physician Decision|1|||
49149545|NCT01443026|158388409|FG001|Overall Study|Physician Decision|0|||
49149546|NCT01443026|158388408|FG000|Overall Study|Death|0|||
49149547|NCT01443026|158388409|FG001|Overall Study|Death|1|||
49149548|NCT01443026|158388408|FG000|Overall Study|Withdrawal by Subject|0|||
49149549|NCT01443026|158388409|FG001|Overall Study|Withdrawal by Subject|3|||
49149550|NCT01443026|158388408|FG000|Overall Study|Lost to Follow-up|2|||
49149551|NCT01443026|158388409|FG001|Overall Study|Lost to Follow-up|1|||
49149552|NCT02202577|158388410|FG000|Overall Study|Lost to Follow-up|6|||
49149553|NCT02202577|158388411|FG001|Overall Study|Lost to Follow-up|16|||
49149554|NCT02202577|158388410|FG000|Overall Study|Protocol Violation|7|||
49149555|NCT02202577|158388411|FG001|Overall Study|Protocol Violation|3|||
49149556|NCT03878602|158388412|FG000|Overall Study|cord blood donation|7|||
49149557|NCT03878602|158388413|FG001|Overall Study|cord blood donation|1|||
48921520|NCT02109484|157546404|FG000|Overall Study|Withdrawal by Subject|0|||
48921521|NCT02109484|157546405|FG001|Overall Study|Withdrawal by Subject|0|||
48921522|NCT02109484|157546406|FG002|Overall Study|Withdrawal by Subject|0|||
48921523|NCT02109484|157546407|FG003|Overall Study|Withdrawal by Subject|0|||
48921524|NCT02109484|157546408|FG004|Overall Study|Withdrawal by Subject|1|||
48921525|NCT02109484|157546409|FG005|Overall Study|Withdrawal by Subject|1|||
49149558|NCT03878602|158388412|FG000|Overall Study|incomplete data collection|2|||
49149559|NCT03878602|158388413|FG001|Overall Study|incomplete data collection|0|||
48921526|NCT02109484|157546410|FG006|Overall Study|Withdrawal by Subject|1|||
49149560|NCT02395627|158388414|FG000|Overall Study|Withdrawal by Subject|0|||
49149561|NCT02395627|158388415|FG001|Overall Study|Withdrawal by Subject|2|||
49149562|NCT02395627|158388416|FG002|Overall Study|Withdrawal by Subject|0|||
48731668|NCT01570868|156869477|FG000|Overall Study|Physician Decision|10|||
48731669|NCT01570868|156869478|FG001|Overall Study|Physician Decision|4|||
48731670|NCT01570868|156869477|FG000|Overall Study|Lost to Follow-up|1|||
48731671|NCT01570868|156869478|FG001|Overall Study|Lost to Follow-up|0|||
48731672|NCT01570868|156869477|FG000|Overall Study|Withdrawal by Subject|1|||
48731673|NCT01570868|156869478|FG001|Overall Study|Withdrawal by Subject|0|||
48731674|NCT00923936|156869481|FG000|Overall Study|progressive disease on study|2|||
48731675|NCT00923936|156869482|FG001|Overall Study|progressive disease on study|1|||
48731676|NCT00923936|156869481|FG000|Overall Study|Adverse Event|2|||
48731677|NCT00923936|156869482|FG001|Overall Study|Adverse Event|1|||
48731678|NCT00923936|156869481|FG000|Overall Study|Lost to follow up|2|||
48731679|NCT00923936|156869482|FG001|Overall Study|Lost to follow up|0|||
48731680|NCT00923936|156869481|FG000|Overall Study|Continuing in follow up period|2|||
48731681|NCT00923936|156869482|FG001|Overall Study|Continuing in follow up period|1|||
48731682|NCT01697358|156869487|FG000|Period I: Randomization to 6 Months|Withdrawal by Subject|6|||
49149563|NCT02395627|158388414|FG000|Overall Study|Did not receive pembrolizumab|3|||
49149564|NCT02395627|158388415|FG001|Overall Study|Did not receive pembrolizumab|1|||
49149565|NCT02395627|158388416|FG002|Overall Study|Did not receive pembrolizumab|0|||
49149566|NCT00721110|158388417|FG000|Overall Study|Ultram use|1|||
49149567|NCT00721110|158388418|FG001|Overall Study|Ultram use|0|||
49149568|NCT00721110|158388419|FG002|Overall Study|Ultram use|0|||
49149569|NCT00721110|158388420|FG003|Overall Study|Ultram use|0|||
49149570|NCT00721110|158388417|FG000|Overall Study|vertical incision|0|||
49149571|NCT00721110|158388418|FG001|Overall Study|vertical incision|0|||
49149572|NCT00721110|158388419|FG002|Overall Study|vertical incision|1|||
49149573|NCT00721110|158388420|FG003|Overall Study|vertical incision|0|||
49149574|NCT02799043|158388421|FG000|Overall Study|Adverse Event|0|||
49149575|NCT02799043|158388422|FG001|Overall Study|Adverse Event|1|||
49149576|NCT02799043|158388421|FG000|Overall Study|Death|1|||
49149577|NCT02799043|158388422|FG001|Overall Study|Death|1|||
49149578|NCT02799043|158388421|FG000|Overall Study|Lost to Follow-up|3|||
49149579|NCT02799043|158388422|FG001|Overall Study|Lost to Follow-up|6|||
49149580|NCT02799043|158388421|FG000|Overall Study|Withdrawal by Subject|4|||
49149581|NCT02799043|158388422|FG001|Overall Study|Withdrawal by Subject|4|||
49149582|NCT02799043|158388421|FG000|Overall Study|Moved to different country|0|||
49149583|NCT02799043|158388422|FG001|Overall Study|Moved to different country|1|||
49149584|NCT02799043|158388421|FG000|Overall Study|Trial Screen Failure|1|||
49149585|NCT02799043|158388422|FG001|Overall Study|Trial Screen Failure|0|||
49149586|NCT02799043|158388421|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
49149587|NCT02799043|158388422|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
49149588|NCT06351371|158388423|FG000|Overall Study|Mutation Status Not Confirmed|9|||
49149589|NCT06351371|158388423|FG000|Overall Study|Ineligible|1|||
49149590|NCT06351371|158388423|FG000|Overall Study|Adverse Event|4|||
49149591|NCT06351371|158388423|FG000|Overall Study|Death|1|||
49149592|NCT06351371|158388423|FG000|Overall Study|Disease progression|14|||
49149593|NCT06351371|158388423|FG000|Overall Study|Withdrawal by Subject|3|||
48824402|NCT02223182|157197236|FG001|Open-Label 300 Period|Withdrawal by Subject|13|||
48824403|NCT02223182|157197237|FG002|Open-Label 300 Period|Withdrawal by Subject|13|||
48824404|NCT02223182|157197238|FG003|Open-Label 300 Period|Withdrawal by Subject|15|||
48824405|NCT02223182|157197235|FG000|Open-Label 300 Period|Lost to Follow-up|1|||
48824406|NCT02223182|157197236|FG001|Open-Label 300 Period|Lost to Follow-up|0|||
48824407|NCT02223182|157197237|FG002|Open-Label 300 Period|Lost to Follow-up|1|||
48824408|NCT02223182|157197238|FG003|Open-Label 300 Period|Lost to Follow-up|0|||
49149594|NCT06351371|158388423|FG000|Overall Study|Physician Decision|3|||
48824409|NCT02223182|157197235|FG000|Open-Label 300 Period|Non Compliance|0|||
48824410|NCT02223182|157197236|FG001|Open-Label 300 Period|Non Compliance|2|||
49149595|NCT04642079|158388429|FG000|Overall Study|Lost to Follow-up|2|||
49149596|NCT04642079|158388430|FG001|Overall Study|Lost to Follow-up|5|||
48824411|NCT02223182|157197237|FG002|Open-Label 300 Period|Non Compliance|1|||
49149597|NCT04642079|158388431|FG002|Overall Study|Lost to Follow-up|2|||
49149598|NCT04642079|158388432|FG003|Overall Study|Lost to Follow-up|0|||
48731683|NCT01697358|156869488|FG001|Period I: Randomization to 6 Months|Withdrawal by Subject|0|||
48731684|NCT01697358|156869487|FG000|Period I: Randomization to 6 Months|Physician Decision|4|||
48731685|NCT01697358|156869488|FG001|Period I: Randomization to 6 Months|Physician Decision|0|||
49149599|NCT04642079|158388429|FG000|Overall Study|Withdrawal by Subject|0|||
49149600|NCT04642079|158388430|FG001|Overall Study|Withdrawal by Subject|4|||
49149601|NCT04642079|158388431|FG002|Overall Study|Withdrawal by Subject|1|||
49149602|NCT04642079|158388432|FG003|Overall Study|Withdrawal by Subject|2|||
49149603|NCT04642079|158388429|FG000|Overall Study|Other|0|||
49149604|NCT04642079|158388430|FG001|Overall Study|Other|0|||
49149605|NCT04642079|158388431|FG002|Overall Study|Other|0|||
48731686|NCT01697358|156869487|FG000|Period I: Randomization to 6 Months|Adverse Event|1|||
48824412|NCT02223182|157197238|FG003|Open-Label 300 Period|Non Compliance|0|||
48824413|NCT01321073|157197239|FG000|Overall Study|Did not attempt implant|4|||
48824414|NCT01321073|157197239|FG000|Overall Study|Death|3|||
49149606|NCT04642079|158388432|FG003|Overall Study|Other|1|||
48731687|NCT01697358|156869488|FG001|Period I: Randomization to 6 Months|Adverse Event|1|||
48731688|NCT01697358|156869487|FG000|Period I: Randomization to 6 Months|Lost to Follow-up|2|||
48824415|NCT04956692|157197240|FG000|Overall Study|Death|115|||
48824416|NCT04956692|157197241|FG001|Overall Study|Death|47|||
48731689|NCT01697358|156869488|FG001|Period I: Randomization to 6 Months|Lost to Follow-up|0|||
48731690|NCT01697358|156869487|FG000|Period II: 6-24M Long-term Follow-up|Physician Decision|3|||
48731691|NCT01697358|156869488|FG001|Period II: 6-24M Long-term Follow-up|Physician Decision|12|||
48731692|NCT01697358|156869487|FG000|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8|||
48731693|NCT01697358|156869488|FG001|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10|||
48731694|NCT01697358|156869487|FG000|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
48731695|NCT01697358|156869488|FG001|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
48731696|NCT01697358|156869487|FG000|Period II: 6-24M Long-term Follow-up|Death|1|||
48731697|NCT01697358|156869488|FG001|Period II: 6-24M Long-term Follow-up|Death|1|||
48731698|NCT01697358|156869487|FG000|Period II: 6-24M Long-term Follow-up|Adverse Event|0|||
48731699|NCT01697358|156869488|FG001|Period II: 6-24M Long-term Follow-up|Adverse Event|3|||
48731700|NCT01697358|156869487|FG000|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34|||
48731701|NCT01697358|156869488|FG001|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26|||
48731702|NCT03538431|156869490|FG000|Overall Study|Physician Decision|0|||
48824417|NCT04956692|157197240|FG000|Overall Study|Lost to Follow-up|0|||
48824418|NCT04956692|157197241|FG001|Overall Study|Lost to Follow-up|1|||
48824419|NCT04956692|157197240|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
48824420|NCT04956692|157197241|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
48824421|NCT04956692|157197240|FG000|Overall Study|Withdrawal by Subject|5|||
48824422|NCT04956692|157197241|FG001|Overall Study|Withdrawal by Subject|2|||
48824423|NCT04956692|157197240|FG000|Overall Study|Ongoing in Study|236|||
48824424|NCT04956692|157197241|FG001|Overall Study|Ongoing in Study|123|||
48824425|NCT03424239|157197245|FG000|Overall Study|Withdrawal by Subject|2|||
48824426|NCT03289455|157197247|FG000|Overall Study|Death|1|||
48824427|NCT03289455|157197248|FG001|Overall Study|Death|0|||
48824428|NCT03289455|157197249|FG002|Overall Study|Death|0|||
48824429|NCT03289455|157197247|FG000|Overall Study|Sponsor decision due to covid19 restrictions|0|||
48824430|NCT03289455|157197248|FG001|Overall Study|Sponsor decision due to covid19 restrictions|1|||
48824431|NCT03289455|157197249|FG002|Overall Study|Sponsor decision due to covid19 restrictions|0|||
48824432|NCT03289455|157197247|FG000|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
48824433|NCT03289455|157197248|FG001|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
48824434|NCT03289455|157197249|FG002|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1|||
48824435|NCT03289455|157197247|FG000|Overall Study|Progressive disease|3|||
48824436|NCT03289455|157197248|FG001|Overall Study|Progressive disease|4|||
48824437|NCT03289455|157197249|FG002|Overall Study|Progressive disease|5|||
48824438|NCT01822821|157197250|FG000|Overall Study|Eligible surgery cancelled|1|||
48824439|NCT01822821|157197251|FG001|Overall Study|Eligible surgery cancelled|1|||
48824440|NCT01822821|157197250|FG000|Overall Study|Other reasons|1|||
48824441|NCT01822821|157197251|FG001|Overall Study|Other reasons|0|||
48824442|NCT04305912|157197252|FG000|First Intervention|COVID-19 Suspension|2|||
48824443|NCT04305912|157197253|FG001|First Intervention|COVID-19 Suspension|0|||
48824444|NCT04305912|157197252|FG000|First Intervention|Withdrawal by Subject|0|||
48824445|NCT04305912|157197253|FG001|First Intervention|Withdrawal by Subject|1|||
48824446|NCT04305912|157197252|FG000|Second Intervention|Adverse Event|0|||
48824447|NCT04305912|157197253|FG001|Second Intervention|Adverse Event|1|||
48824448|NCT01649427|157197260|FG000|Overall Study|Adverse Event|1|||
48824449|NCT01649427|157197261|FG001|Overall Study|Adverse Event|1|||
48824450|NCT01649427|157197260|FG000|Overall Study|Withdrawal by Subject|8|||
48824451|NCT01649427|157197261|FG001|Overall Study|Withdrawal by Subject|7|||
48824452|NCT01649427|157197260|FG000|Overall Study|Lost to Follow-up|0|||
48824453|NCT01649427|157197261|FG001|Overall Study|Lost to Follow-up|1|||
48824454|NCT01649427|157197260|FG000|Overall Study|Graft loss|0|||
48824455|NCT01649427|157197261|FG001|Overall Study|Graft loss|1|||
48824456|NCT01649427|157197260|FG000|Overall Study|Surgical problems during nephrectomy|2|||
48824457|NCT01649427|157197261|FG001|Overall Study|Surgical problems during nephrectomy|2|||
48824458|NCT04794179|157197264|FG000|Overall Study|This participant didn't meet criteria after screening|1|||
48824459|NCT04794179|157197265|FG001|Overall Study|This participant didn't meet criteria after screening|0|||
48824460|NCT05780047|157197266|FG000|Overall Study|Did not submit baseline urine test kit|226|||
48824461|NCT05780047|157197266|FG000|Overall Study|Lost to Follow-up|34|||
48824462|NCT05780047|157197266|FG000|Overall Study|Did not submit second urine test kit|124|||
48824463|NCT03212365|157197271|FG000|Overall Study|Discharged prior to Xa level|12|||
49149607|NCT04642079|158388429|FG000|Overall Study|No longer met eligibility criteria|1|||
48824464|NCT03212365|157197272|FG001|Overall Study|Discharged prior to Xa level|8|||
48824465|NCT03212365|157197271|FG000|Overall Study|Bled requiring enoxaparin cessation|4|||
49149608|NCT04642079|158388430|FG001|Overall Study|No longer met eligibility criteria|0|||
49149609|NCT04642079|158388431|FG002|Overall Study|No longer met eligibility criteria|1|||
49149610|NCT04642079|158388432|FG003|Overall Study|No longer met eligibility criteria|1|||
48731703|NCT03538431|156869491|FG001|Overall Study|Physician Decision|1|||
48731704|NCT03538431|156869490|FG000|Overall Study|Withdrawal by Subject|1|||
48731705|NCT03538431|156869491|FG001|Overall Study|Withdrawal by Subject|0|||
48731706|NCT00586066|156869492|FG000|Overall Study|Lost to Follow-up|6|||
48731707|NCT00586066|156869493|FG001|Overall Study|Lost to Follow-up|3|||
48731708|NCT00586066|156869492|FG000|Overall Study|Lack of Efficacy|5|||
48731709|NCT00586066|156869493|FG001|Overall Study|Lack of Efficacy|3|||
48731710|NCT00586066|156869492|FG000|Overall Study|Adverse Event|2|||
48731711|NCT00586066|156869493|FG001|Overall Study|Adverse Event|2|||
48731712|NCT00586066|156869492|FG000|Overall Study|Physician Decision|1|||
48731713|NCT00586066|156869493|FG001|Overall Study|Physician Decision|0|||
48731714|NCT00586066|156869492|FG000|Overall Study|Withdrawal of consent|4|||
48731715|NCT00586066|156869493|FG001|Overall Study|Withdrawal of consent|2|||
48731716|NCT01231347|156869496|FG000|Overall Study|Full Consent withdrawn|19|||
48731717|NCT01231347|156869497|FG001|Overall Study|Full Consent withdrawn|19|||
48731718|NCT01231347|156869498|FG002|Overall Study|Full Consent withdrawn|11|||
48731719|NCT01231347|156869496|FG000|Overall Study|Lost to Follow-up|4|||
48731720|NCT01231347|156869497|FG001|Overall Study|Lost to Follow-up|2|||
48731721|NCT01231347|156869498|FG002|Overall Study|Lost to Follow-up|2|||
48731722|NCT01231347|156869496|FG000|Overall Study|Death|202|||
48731723|NCT01231347|156869497|FG001|Overall Study|Death|210|||
48731724|NCT01231347|156869498|FG002|Overall Study|Death|101|||
48731725|NCT01231347|156869496|FG000|Overall Study|other event|7|||
48731726|NCT01231347|156869497|FG001|Overall Study|other event|9|||
48731727|NCT01231347|156869498|FG002|Overall Study|other event|3|||
48731728|NCT00910988|156869505|FG000|Overall Study|Lost to Follow-up|2|||
48731729|NCT00910988|156869506|FG001|Overall Study|Lost to Follow-up|4|||
48731730|NCT00910988|156869507|FG002|Overall Study|Lost to Follow-up|3|||
48731731|NCT00910988|156869508|FG003|Overall Study|Lost to Follow-up|0|||
48731732|NCT04545554|156869509|FG000|Overall Study|Withdrawal by Subject|0|||
48731733|NCT04545554|156869510|FG001|Overall Study|Withdrawal by Subject|0|||
48731734|NCT04545554|156869511|FG002|Overall Study|Withdrawal by Subject|0|||
48731735|NCT04545554|156869512|FG003|Overall Study|Withdrawal by Subject|1|||
48731736|NCT04545554|156869513|FG004|Overall Study|Withdrawal by Subject|0|||
48731737|NCT04545554|156869514|FG005|Overall Study|Withdrawal by Subject|0|||
48731738|NCT03004443|156869515|FG000|Overall Study|Pregnancy|0|||
48731739|NCT03004443|156869516|FG001|Overall Study|Pregnancy|1|||
48731740|NCT00915356|156869517|FG000|Overall Study|Withdrawal by Subject|1|||
48731741|NCT00915356|156869518|FG001|Overall Study|Withdrawal by Subject|0|||
48731742|NCT00915356|156869519|FG002|Overall Study|Withdrawal by Subject|0|||
48731743|NCT00915356|156869520|FG003|Overall Study|Withdrawal by Subject|0|||
48731744|NCT00915356|156869521|FG004|Overall Study|Withdrawal by Subject|0|||
48731745|NCT02713204|156869524|FG000|Baseline (Day 1) up to Week 12|Adverse Event|1|||
48731746|NCT02713204|156869525|FG001|Baseline (Day 1) up to Week 12|Adverse Event|0|||
48731747|NCT02713204|156869526|FG002|Baseline (Day 1) up to Week 12|Adverse Event|1|||
48731748|NCT02713204|156869527|FG003|Baseline (Day 1) up to Week 12|Adverse Event|0|||
48731749|NCT02713204|156869528|FG004|Baseline (Day 1) up to Week 12|Adverse Event|0|||
48731750|NCT02713204|156869529|FG005|Baseline (Day 1) up to Week 12|Adverse Event|0|||
48731751|NCT02713204|156869530|FG006|Baseline (Day 1) up to Week 12|Adverse Event|0|||
48731752|NCT02713204|156869531|FG007|Baseline (Day 1) up to Week 12|Adverse Event|0|||
48731753|NCT02713204|156869524|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
48731754|NCT02713204|156869525|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
48731755|NCT02713204|156869526|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
48731756|NCT02713204|156869527|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
48731757|NCT02713204|156869528|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
48731758|NCT02713204|156869529|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
48731759|NCT02713204|156869530|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
48731760|NCT02713204|156869531|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
48731761|NCT02713204|156869524|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
48731762|NCT02713204|156869525|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
48731763|NCT02713204|156869526|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
48731764|NCT02713204|156869527|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
48731765|NCT02713204|156869528|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
48731766|NCT02713204|156869529|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
48731767|NCT02713204|156869530|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
48731768|NCT02713204|156869531|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
48731769|NCT02713204|156869524|FG000|From Week 12 up to Week 36|Adverse Event|1|||
48731770|NCT02713204|156869525|FG001|From Week 12 up to Week 36|Adverse Event|0|||
48731771|NCT02713204|156869526|FG002|From Week 12 up to Week 36|Adverse Event|0|||
48731772|NCT02713204|156869527|FG003|From Week 12 up to Week 36|Adverse Event|1|||
48731773|NCT02713204|156869528|FG004|From Week 12 up to Week 36|Adverse Event|1|||
48731774|NCT02713204|156869529|FG005|From Week 12 up to Week 36|Adverse Event|0|||
48731775|NCT02713204|156869530|FG006|From Week 12 up to Week 36|Adverse Event|2|||
48731776|NCT02713204|156869531|FG007|From Week 12 up to Week 36|Adverse Event|1|||
48731777|NCT02713204|156869524|FG000|From Week 12 up to Week 36|Death|0|||
48824466|NCT03212365|157197272|FG001|Overall Study|Bled requiring enoxaparin cessation|2|||
48824467|NCT03212365|157197271|FG000|Overall Study|Refused study medication|3|||
48824468|NCT03212365|157197272|FG001|Overall Study|Refused study medication|0|||
48824469|NCT03212365|157197271|FG000|Overall Study|Initiated heparin infusion on floor|1|||
48824470|NCT03212365|157197272|FG001|Overall Study|Initiated heparin infusion on floor|1|||
48824471|NCT03212365|157197271|FG000|Overall Study|Unexpected return to OR|1|||
48824472|NCT03212365|157197272|FG001|Overall Study|Unexpected return to OR|1|||
48824473|NCT03212365|157197271|FG000|Overall Study|Medication distribution error|1|||
48824474|NCT03212365|157197272|FG001|Overall Study|Medication distribution error|0|||
48824475|NCT03212365|157197271|FG000|Overall Study|Required epidural placement|1|||
48824476|NCT03212365|157197272|FG001|Overall Study|Required epidural placement|0|||
48824477|NCT03212365|157197271|FG000|Overall Study|Withdrawal by Subject|0|||
48824478|NCT03212365|157197272|FG001|Overall Study|Withdrawal by Subject|1|||
48824479|NCT03212365|157197271|FG000|Overall Study|developed acute renal failure|0|||
48824480|NCT03212365|157197272|FG001|Overall Study|developed acute renal failure|1|||
48824481|NCT04394624|157197273|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|6|||
48824482|NCT04394624|157197273|FG000|Overall Study|Adverse Event|5|||
48824483|NCT04394624|157197273|FG000|Overall Study|Progressive disease|20|||
48824484|NCT03369951|157197274|FG000|Overall Study|Withdrawal by Subject|3|||
48824485|NCT03369951|157197274|FG000|Overall Study|Death|1|||
48824486|NCT03369951|157197274|FG000|Overall Study|Lost to Follow-up|1|||
48824487|NCT03369951|157197274|FG000|Overall Study|Protocol Violation|1|||
48824488|NCT01641861|157197280|FG000|Overall Study|Lost to Follow-up|21|||
48824489|NCT01641861|157197281|FG001|Overall Study|Lost to Follow-up|16|||
48824490|NCT01641861|157197280|FG000|Overall Study|Lost the tooth due to normal exfoliation|14|||
48824491|NCT01641861|157197281|FG001|Overall Study|Lost the tooth due to normal exfoliation|8|||
48824492|NCT01641861|157197280|FG000|Overall Study|Died due to drowning|0|||
48824493|NCT01641861|157197281|FG001|Overall Study|Died due to drowning|1|||
48824494|NCT01556243|157197282|FG000|Overall Study|Ineligible|34|||
48824495|NCT01556243|157197282|FG000|Overall Study|Converted to mastectomy|14|||
48824496|NCT01556243|157197282|FG000|Overall Study|Unable to achieve negative margins|2|||
48824497|NCT01556243|157197282|FG000|Overall Study|Withdrawal by Subject|16|||
48824498|NCT01388543|157197283|FG000|Day 14|Adverse Event|1|||
48824499|NCT01388543|157197284|FG001|Day 14|Adverse Event|4|||
48824500|NCT00430677|157197287|FG000|Short-term Period|Death|1|||
48824501|NCT00430677|157197288|FG001|Short-term Period|Death|1|||
48824502|NCT00430677|157197289|FG002|Short-term Period|Death|5|||
48824503|NCT00430677|157197287|FG000|Short-term Period|Adverse Event|15|||
48824504|NCT00430677|157197288|FG001|Short-term Period|Adverse Event|13|||
48824505|NCT00430677|157197289|FG002|Short-term Period|Adverse Event|9|||
48824506|NCT00430677|157197287|FG000|Short-term Period|Lack of Efficacy|5|||
48824507|NCT00430677|157197288|FG001|Short-term Period|Lack of Efficacy|6|||
48824508|NCT00430677|157197289|FG002|Short-term Period|Lack of Efficacy|4|||
48824509|NCT00430677|157197287|FG000|Short-term Period|Withdrawal by Subject|1|||
48824510|NCT00430677|157197288|FG001|Short-term Period|Withdrawal by Subject|1|||
48824511|NCT00430677|157197289|FG002|Short-term Period|Withdrawal by Subject|2|||
48824512|NCT00430677|157197287|FG000|Short-term Period|Participant no longer met study criteria|1|||
48824513|NCT00430677|157197288|FG001|Short-term Period|Participant no longer met study criteria|1|||
48824514|NCT00430677|157197289|FG002|Short-term Period|Participant no longer met study criteria|2|||
48824515|NCT00430677|157197287|FG000|Short-term Period|Poor compliance/ noncompliance|0|||
48824516|NCT00430677|157197288|FG001|Short-term Period|Poor compliance/ noncompliance|1|||
48824517|NCT00430677|157197289|FG002|Short-term Period|Poor compliance/ noncompliance|0|||
48824518|NCT00430677|157197287|FG000|Short-term Period|Pregnancy|0|||
48824519|NCT00430677|157197288|FG001|Short-term Period|Pregnancy|2|||
48824520|NCT00430677|157197289|FG002|Short-term Period|Pregnancy|0|||
48824521|NCT00430677|157197287|FG000|Long-term Extension Period|Death|1|||
48824522|NCT00430677|157197288|FG001|Long-term Extension Period|Death|0|||
48824523|NCT00430677|157197289|FG002|Long-term Extension Period|Death|0|||
48824524|NCT00430677|157197287|FG000|Long-term Extension Period|Adverse Event|3|||
48824525|NCT00430677|157197288|FG001|Long-term Extension Period|Adverse Event|2|||
48824526|NCT00430677|157197289|FG002|Long-term Extension Period|Adverse Event|5|||
48824527|NCT00430677|157197287|FG000|Long-term Extension Period|Lack of Efficacy|5|||
48824528|NCT00430677|157197288|FG001|Long-term Extension Period|Lack of Efficacy|3|||
48824529|NCT00430677|157197289|FG002|Long-term Extension Period|Lack of Efficacy|8|||
48824530|NCT00430677|157197287|FG000|Long-term Extension Period|Lost to Follow-up|1|||
48824531|NCT00430677|157197288|FG001|Long-term Extension Period|Lost to Follow-up|1|||
48824532|NCT00430677|157197289|FG002|Long-term Extension Period|Lost to Follow-up|1|||
48824533|NCT00430677|157197287|FG000|Long-term Extension Period|Withdrawal by Subject|5|||
48824534|NCT00430677|157197288|FG001|Long-term Extension Period|Withdrawal by Subject|1|||
48824535|NCT00430677|157197289|FG002|Long-term Extension Period|Withdrawal by Subject|2|||
48824536|NCT00430677|157197287|FG000|Long-term Extension Period|Pregnancy|1|||
48824537|NCT00430677|157197288|FG001|Long-term Extension Period|Pregnancy|1|||
48824538|NCT00430677|157197289|FG002|Long-term Extension Period|Pregnancy|0|||
48824539|NCT00430677|157197287|FG000|Long-term Extension Period|Administrative reason by sponsor|41|||
48824540|NCT00430677|157197288|FG001|Long-term Extension Period|Administrative reason by sponsor|49|||
48824541|NCT00430677|157197289|FG002|Long-term Extension Period|Administrative reason by sponsor|46|||
48824542|NCT00430677|157197287|FG000|Long-term Extension Period|Other|2|||
48824543|NCT00430677|157197288|FG001|Long-term Extension Period|Other|1|||
48824544|NCT00430677|157197289|FG002|Long-term Extension Period|Other|1|||
48824545|NCT00430677|157197287|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
48824546|NCT00430677|157197288|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
48824547|NCT00430677|157197289|FG002|Long-term Extension Period|Poor compliance/noncompliance|0|||
48824548|NCT00670540|157197290|FG000|Overall Study|ineligible|17|||
48731778|NCT02713204|156869525|FG001|From Week 12 up to Week 36|Death|0|||
48824549|NCT00670540|157197290|FG000|Overall Study|not living in France|348|||
48731779|NCT02713204|156869526|FG002|From Week 12 up to Week 36|Death|0|||
48731780|NCT02713204|156869527|FG003|From Week 12 up to Week 36|Death|1|||
48731781|NCT02713204|156869528|FG004|From Week 12 up to Week 36|Death|0|||
48731782|NCT02713204|156869529|FG005|From Week 12 up to Week 36|Death|1|||
48731783|NCT02713204|156869530|FG006|From Week 12 up to Week 36|Death|0|||
48731784|NCT02713204|156869531|FG007|From Week 12 up to Week 36|Death|3|||
48731785|NCT02713204|156869524|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
48731786|NCT02713204|156869525|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
48731787|NCT02713204|156869526|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
48731788|NCT02713204|156869527|FG003|From Week 12 up to Week 36|Lost to Follow-up|2|||
48731789|NCT02713204|156869528|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
48731790|NCT02713204|156869529|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
48731791|NCT02713204|156869530|FG006|From Week 12 up to Week 36|Lost to Follow-up|0|||
48731792|NCT02713204|156869531|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
48731793|NCT02713204|156869524|FG000|From Week 12 up to Week 36|Participant Re-located|0|||
48731794|NCT02713204|156869525|FG001|From Week 12 up to Week 36|Participant Re-located|0|||
48731795|NCT02713204|156869526|FG002|From Week 12 up to Week 36|Participant Re-located|0|||
48731796|NCT02713204|156869527|FG003|From Week 12 up to Week 36|Participant Re-located|0|||
48731797|NCT02713204|156869528|FG004|From Week 12 up to Week 36|Participant Re-located|1|||
48731798|NCT02713204|156869529|FG005|From Week 12 up to Week 36|Participant Re-located|0|||
48731799|NCT02713204|156869530|FG006|From Week 12 up to Week 36|Participant Re-located|0|||
48731800|NCT02713204|156869531|FG007|From Week 12 up to Week 36|Participant Re-located|0|||
48731801|NCT04399837|156869539|FG000|Overall Study|Other than listed|0|||
48731802|NCT04399837|156869540|FG001|Overall Study|Other than listed|2|||
48731803|NCT04399837|156869541|FG002|Overall Study|Other than listed|2|||
48731804|NCT04399837|156869542|FG003|Overall Study|Other than listed|3|||
48731805|NCT04399837|156869539|FG000|Overall Study|Withdrawal by Subject|1|||
48731806|NCT04399837|156869540|FG001|Overall Study|Withdrawal by Subject|2|||
48731807|NCT04399837|156869541|FG002|Overall Study|Withdrawal by Subject|1|||
48731808|NCT04399837|156869542|FG003|Overall Study|Withdrawal by Subject|1|||
48731809|NCT03698331|156869546|FG000|Overall Study|Adverse Event|2|||
48731810|NCT03698331|156869547|FG001|Overall Study|Adverse Event|3|||
48731811|NCT03698331|156869546|FG000|Overall Study|Withdrawal by Subject|1|||
48731812|NCT03698331|156869547|FG001|Overall Study|Withdrawal by Subject|1|||
48731813|NCT03698331|156869546|FG000|Overall Study|Lost to Follow-up|0|||
49149611|NCT01335685|158388436|FG000|Overall Study|Study Terminated by Sponsor|2|||
49149612|NCT01335685|158388437|FG001|Overall Study|Study Terminated by Sponsor|1|||
49149613|NCT01335685|158388438|FG002|Overall Study|Study Terminated by Sponsor|1|||
49149614|NCT01335685|158388439|FG003|Overall Study|Study Terminated by Sponsor|10|||
49149615|NCT01335685|158388440|FG004|Overall Study|Study Terminated by Sponsor|0|||
49149616|NCT01335685|158388441|FG005|Overall Study|Study Terminated by Sponsor|4|||
48731814|NCT03698331|156869547|FG001|Overall Study|Lost to Follow-up|2|||
48731815|NCT03698331|156869546|FG000|Overall Study|Non-compliance with study drug|1|||
48824550|NCT00670540|157197290|FG000|Overall Study|refused to participate|189|||
48824551|NCT00670540|157197290|FG000|Overall Study|controls randomised for no follow up|2770|||
49149617|NCT01335685|158388442|FG006|Overall Study|Study Terminated by Sponsor|2|||
48731816|NCT03698331|156869547|FG001|Overall Study|Non-compliance with study drug|0|||
48731817|NCT00678080|156869548|FG000|Overall Study|Physician Decision|2|||
48731818|NCT00678080|156869549|FG001|Overall Study|Physician Decision|0|||
48731819|NCT00678080|156869548|FG000|Overall Study|Lost to Follow-up|1|||
48731820|NCT00678080|156869549|FG001|Overall Study|Lost to Follow-up|0|||
48731821|NCT00678080|156869548|FG000|Overall Study|Withdrawal by Subject|0|||
48824552|NCT00670540|157197290|FG000|Overall Study|missing information inclusion criteria|1|||
48824553|NCT00681811|157197291|FG000|Overall Study|Adverse Event|1|||
48824554|NCT00681811|157197292|FG001|Overall Study|Adverse Event|1|||
49149618|NCT01335685|158388443|FG007|Overall Study|Study Terminated by Sponsor|3|||
49149619|NCT01335685|158388436|FG000|Overall Study|Withdrawal by Subject|1|||
48731822|NCT00678080|156869549|FG001|Overall Study|Withdrawal by Subject|1|||
48731823|NCT05274165|156869550|FG000|Overall Study|Withdrawal by Subject|3|||
48731824|NCT05274165|156869551|FG001|Overall Study|Withdrawal by Subject|3|||
48731825|NCT02484690|156869552|FG000|Overall Study|Adverse Event|1|||
49149620|NCT01335685|158388437|FG001|Overall Study|Withdrawal by Subject|0|||
49149621|NCT01335685|158388438|FG002|Overall Study|Withdrawal by Subject|0|||
49149622|NCT01335685|158388439|FG003|Overall Study|Withdrawal by Subject|1|||
49149623|NCT01335685|158388440|FG004|Overall Study|Withdrawal by Subject|0|||
49149624|NCT01335685|158388441|FG005|Overall Study|Withdrawal by Subject|0|||
49149625|NCT01335685|158388442|FG006|Overall Study|Withdrawal by Subject|0|||
49149626|NCT01335685|158388443|FG007|Overall Study|Withdrawal by Subject|0|||
49149627|NCT01335685|158388436|FG000|Overall Study|Reason not Specified|0|||
49149628|NCT01335685|158388437|FG001|Overall Study|Reason not Specified|0|||
49149629|NCT01335685|158388438|FG002|Overall Study|Reason not Specified|1|||
49149630|NCT01335685|158388439|FG003|Overall Study|Reason not Specified|0|||
49149631|NCT01335685|158388440|FG004|Overall Study|Reason not Specified|0|||
49149632|NCT01335685|158388441|FG005|Overall Study|Reason not Specified|1|||
49149633|NCT01335685|158388442|FG006|Overall Study|Reason not Specified|0|||
49149634|NCT01335685|158388443|FG007|Overall Study|Reason not Specified|0|||
49149635|NCT00563316|158388448|FG000|Overall Study|Adverse Event|2|||
48731826|NCT02484690|156869553|FG001|Overall Study|Adverse Event|3|||
49149636|NCT00563316|158388448|FG000|Overall Study|Physician Decision|1|||
49149637|NCT00563316|158388448|FG000|Overall Study|Lost to Follow-up|2|||
49149638|NCT00563316|158388448|FG000|Overall Study|Death|1|||
49149639|NCT00563316|158388448|FG000|Overall Study|On-going in study as of 16 July 2009.|5|||
49149640|NCT00563316|158388448|FG000|Overall Study|Other|1|||
49149641|NCT02011542|158388451|FG000|Overall Study|Physician Decision|1|||
49149642|NCT02913326|158388452|FG000|Overall Study|Reason not listed|0|||
49149643|NCT02913326|158388453|FG001|Overall Study|Reason not listed|1|||
49149644|NCT02913326|158388452|FG000|Overall Study|Lost to Follow-up|0|||
49149645|NCT02913326|158388453|FG001|Overall Study|Lost to Follow-up|1|||
49149646|NCT02913326|158388452|FG000|Overall Study|Adverse Event|1|||
49149647|NCT02913326|158388453|FG001|Overall Study|Adverse Event|0|||
49149648|NCT01767857|158388454|FG000|Overall Study|Adverse Event|27|||
49149649|NCT01767857|158388455|FG001|Overall Study|Adverse Event|7|||
49149650|NCT01767857|158388454|FG000|Overall Study|Death|28|||
49149651|NCT01767857|158388455|FG001|Overall Study|Death|13|||
49149652|NCT01767857|158388454|FG000|Overall Study|Lack of Efficacy|299|||
49149653|NCT01767857|158388455|FG001|Overall Study|Lack of Efficacy|151|||
49149654|NCT01767857|158388454|FG000|Overall Study|Lost to Follow-up|1|||
49149655|NCT01767857|158388455|FG001|Overall Study|Lost to Follow-up|1|||
49149656|NCT01767857|158388454|FG000|Overall Study|Withdrawal by Subject|38|||
49149657|NCT01767857|158388455|FG001|Overall Study|Withdrawal by Subject|18|||
49149658|NCT01767857|158388454|FG000|Overall Study|Physician Decision|17|||
48731827|NCT02484690|156869554|FG002|Overall Study|Adverse Event|0|||
48731828|NCT02484690|156869555|FG003|Overall Study|Adverse Event|0|||
48731829|NCT02484690|156869556|FG004|Overall Study|Adverse Event|5|||
48731830|NCT02484690|156869552|FG000|Overall Study|Death|0|||
48731831|NCT02484690|156869553|FG001|Overall Study|Death|0|||
48731832|NCT02484690|156869554|FG002|Overall Study|Death|0|||
48731833|NCT02484690|156869555|FG003|Overall Study|Death|0|||
48731834|NCT02484690|156869556|FG004|Overall Study|Death|1|||
48731835|NCT02484690|156869552|FG000|Overall Study|Withdrawal by Subject|1|||
48731836|NCT02484690|156869553|FG001|Overall Study|Withdrawal by Subject|3|||
48731837|NCT02484690|156869554|FG002|Overall Study|Withdrawal by Subject|1|||
48731838|NCT02484690|156869555|FG003|Overall Study|Withdrawal by Subject|2|||
48731839|NCT02484690|156869556|FG004|Overall Study|Withdrawal by Subject|0|||
48731840|NCT02484690|156869552|FG000|Overall Study|Physician Decision|2|||
48731841|NCT02484690|156869553|FG001|Overall Study|Physician Decision|0|||
48731842|NCT02484690|156869554|FG002|Overall Study|Physician Decision|1|||
48731843|NCT02484690|156869555|FG003|Overall Study|Physician Decision|0|||
48731844|NCT02484690|156869556|FG004|Overall Study|Physician Decision|0|||
48731845|NCT02484690|156869552|FG000|Overall Study|Lost to Follow-up|0|||
48731846|NCT02484690|156869553|FG001|Overall Study|Lost to Follow-up|0|||
48731847|NCT02484690|156869554|FG002|Overall Study|Lost to Follow-up|1|||
48731848|NCT02484690|156869555|FG003|Overall Study|Lost to Follow-up|0|||
48731849|NCT02484690|156869556|FG004|Overall Study|Lost to Follow-up|0|||
48731850|NCT03360747|156869557|FG000|Overall Study|Voluntary Withdrawal|1|||
48731851|NCT04916769|156869559|FG000|Period 1|Physician Decision|0|||
48731852|NCT04916769|156869560|FG001|Period 1|Physician Decision|0|||
48731853|NCT04916769|156869561|FG002|Period 1|Physician Decision|0|||
48731854|NCT04916769|156869562|FG003|Period 1|Physician Decision|0|||
48731855|NCT04916769|156869563|FG004|Period 1|Physician Decision|0|||
48731856|NCT04916769|156869564|FG005|Period 1|Physician Decision|1|||
49149659|NCT01767857|158388455|FG001|Overall Study|Physician Decision|10|||
49149660|NCT01767857|158388454|FG000|Overall Study|Protocol Terminated|1|||
49149661|NCT01767857|158388455|FG001|Overall Study|Protocol Terminated|0|||
49149662|NCT01767857|158388454|FG000|Overall Study|Randomized But Never Treated|19|||
49149663|NCT01767857|158388455|FG001|Overall Study|Randomized But Never Treated|13|||
49149664|NCT01421459|158388456|FG000|Overall Study|Adverse Event|6|||
49149665|NCT01421459|158388457|FG001|Overall Study|Adverse Event|10|||
49149666|NCT01421459|158388456|FG000|Overall Study|Death|1|||
49149667|NCT01421459|158388457|FG001|Overall Study|Death|1|||
49149668|NCT01421459|158388456|FG000|Overall Study|Lack of Efficacy|1|||
49149669|NCT01421459|158388457|FG001|Overall Study|Lack of Efficacy|2|||
49149670|NCT01421459|158388456|FG000|Overall Study|Lost to Follow-up|8|||
49149671|NCT01421459|158388457|FG001|Overall Study|Lost to Follow-up|9|||
49149672|NCT01421459|158388456|FG000|Overall Study|Physician Decision|9|||
49149673|NCT01421459|158388457|FG001|Overall Study|Physician Decision|9|||
49149674|NCT01421459|158388456|FG000|Overall Study|Protocol Violation|8|||
49149675|NCT01421459|158388457|FG001|Overall Study|Protocol Violation|5|||
49149676|NCT01421459|158388456|FG000|Overall Study|Withdrawal by Subject|12|||
49149677|NCT01421459|158388457|FG001|Overall Study|Withdrawal by Subject|16|||
49149678|NCT04126174|158388458|FG000|Overall Study|Lost to Follow-up|3|||
49149679|NCT04126174|158388459|FG001|Overall Study|Lost to Follow-up|3|||
49149680|NCT02231580|158388460|FG000|Overall Study|Adverse Event|5|||
49149681|NCT02231580|158388461|FG001|Overall Study|Adverse Event|0|||
49149682|NCT03238196|158388462|FG000|Overall Study|Adverse Event|3|||
49149683|NCT03238196|158388463|FG001|Overall Study|Adverse Event|0|||
49149684|NCT03238196|158388464|FG002|Overall Study|Adverse Event|2|||
49149685|NCT03238196|158388465|FG003|Overall Study|Adverse Event|2|||
49149686|NCT03238196|158388462|FG000|Overall Study|Withdrawal by Subject|4|||
49149687|NCT03238196|158388463|FG001|Overall Study|Withdrawal by Subject|1|||
48824555|NCT00681811|157197291|FG000|Overall Study|Withdrawal by Subject|2|||
48824556|NCT00681811|157197292|FG001|Overall Study|Withdrawal by Subject|2|||
48824557|NCT00681811|157197291|FG000|Overall Study|Non-compliance|0|||
48824558|NCT00681811|157197292|FG001|Overall Study|Non-compliance|1|||
48824559|NCT00814489|157197293|FG000|Overall Study|Other|2|||
48824560|NCT00814489|157197294|FG001|Overall Study|Other|0|||
48824561|NCT00814489|157197295|FG002|Overall Study|Other|1|||
48824562|NCT01244828|157197298|FG000|Overall Study|Adverse Event|37|||
48824563|NCT01244828|157197298|FG000|Overall Study|Withdrawal by Subject|31|||
48824564|NCT01244828|157197298|FG000|Overall Study|Lack of Efficacy|7|||
48824565|NCT01244828|157197298|FG000|Overall Study|Lost to Follow-up|2|||
48824566|NCT01244828|157197298|FG000|Overall Study|Other reason (not specified)|1|||
48824567|NCT04155424|157197299|FG000|Overall Study|Other than specified|3|||
48824568|NCT04155424|157197299|FG000|Overall Study|Withdrawal by Subject|1|||
48824569|NCT04155424|157197299|FG000|Overall Study|Adverse Event|1|||
48824570|NCT03015740|157197300|FG000|Overall Study|Adverse Event|1|||
48824571|NCT03015740|157197301|FG001|Overall Study|Adverse Event|0|||
48824572|NCT03015740|157197302|FG002|Overall Study|Adverse Event|0|||
48824573|NCT03015740|157197300|FG000|Overall Study|Death|3|||
48824574|NCT03015740|157197301|FG001|Overall Study|Death|5|||
48824575|NCT03015740|157197302|FG002|Overall Study|Death|0|||
48824576|NCT03015740|157197300|FG000|Overall Study|Withdrawal by Subject|2|||
48824577|NCT03015740|157197301|FG001|Overall Study|Withdrawal by Subject|0|||
48824578|NCT03015740|157197302|FG002|Overall Study|Withdrawal by Subject|0|||
48824579|NCT04610684|157198907|FG000|Study Treatment|Withdrawal by Subject|1|||
48824580|NCT04610684|157198907|FG000|Study Treatment|Disease Progression|2|||
48824581|NCT04610684|157198907|FG000|Follow up|Death|2|||
48824582|NCT04610684|157198907|FG000|Follow up|Withdrawal by Subject|1|||
48824583|NCT01598987|157198908|FG000|Baseline to Month 12|Administrative problems|2|||
48824584|NCT01598987|157198908|FG000|Baseline to Month 12|Withdrawal by Subject|4|||
48824585|NCT01598987|157198908|FG000|Baseline to 24 Month|Withdrawal by Subject|5|||
48824586|NCT01598987|157198908|FG000|Baseline to 24 Month|Administrative problems|2|||
48824587|NCT01598987|157198908|FG000|Baseline to 24 Month|Lost to Follow-up|1|||
48824588|NCT00551213|157198910|FG000|Overall Study|Adverse Event|6|||
48824589|NCT00551213|157198911|FG001|Overall Study|Adverse Event|3|||
48824590|NCT00551213|157198910|FG000|Overall Study|Progressive Disease|41|||
48824591|NCT00551213|157198911|FG001|Overall Study|Progressive Disease|12|||
48824592|NCT00551213|157198910|FG000|Overall Study|Withdrawal by Subject|2|||
48824593|NCT00551213|157198911|FG001|Overall Study|Withdrawal by Subject|0|||
48824594|NCT00551213|157198910|FG000|Overall Study|Not Treated|1|||
48824595|NCT00551213|157198911|FG001|Overall Study|Not Treated|2|||
48824596|NCT01021878|157198912|FG000|Overall Study|Lost to Follow-up|4|||
48824597|NCT01021878|157198913|FG001|Overall Study|Lost to Follow-up|3|||
48824598|NCT01021878|157198912|FG000|Overall Study|Death|0|||
48824599|NCT01021878|157198913|FG001|Overall Study|Death|1|||
49149688|NCT03238196|158388464|FG002|Overall Study|Withdrawal by Subject|1|||
48824600|NCT01021878|157198912|FG000|Overall Study|Adverse Event|6|||
48824601|NCT01021878|157198913|FG001|Overall Study|Adverse Event|5|||
48824602|NCT01021878|157198912|FG000|Overall Study|Transplantation|6|||
48824603|NCT01021878|157198913|FG001|Overall Study|Transplantation|1|||
48824604|NCT02892409|157198914|FG000|Overall Study|Adverse Event|1|||
48824605|NCT02892409|157198915|FG001|Overall Study|Adverse Event|0|||
48824606|NCT02892409|157198914|FG000|Overall Study|Withdrawal by Subject|2|||
48824607|NCT02892409|157198915|FG001|Overall Study|Withdrawal by Subject|1|||
48824608|NCT04672460|157198916|FG000|Bioequivalence Phase: Period 1 (28 Days)|Death|1|||
48824609|NCT04672460|157198917|FG001|Bioequivalence Phase: Period 1 (28 Days)|Death|2|||
49149689|NCT03238196|158388465|FG003|Overall Study|Withdrawal by Subject|0|||
49149690|NCT03238196|158388462|FG000|Overall Study|Disease progression|14|||
49149691|NCT03238196|158388463|FG001|Overall Study|Disease progression|2|||
49149692|NCT03238196|158388464|FG002|Overall Study|Disease progression|3|||
49149693|NCT03238196|158388465|FG003|Overall Study|Disease progression|2|||
49149694|NCT03238196|158388462|FG000|Overall Study|Still on treatment|1|||
49149695|NCT03238196|158388463|FG001|Overall Study|Still on treatment|0|||
49149696|NCT03238196|158388464|FG002|Overall Study|Still on treatment|0|||
49149697|NCT03238196|158388465|FG003|Overall Study|Still on treatment|0|||
49149698|NCT04562090|158388466|FG000|Overall Study|Withdrawal by Subject|3|||
49149699|NCT04562090|158388467|FG001|Overall Study|Withdrawal by Subject|4|||
49149700|NCT04562090|158388466|FG000|Overall Study|Protocol Violation|2|||
49149701|NCT04562090|158388467|FG001|Overall Study|Protocol Violation|0|||
49149702|NCT04562090|158388466|FG000|Overall Study|Lack of Efficacy|0|||
49149703|NCT04562090|158388467|FG001|Overall Study|Lack of Efficacy|1|||
49149704|NCT04562090|158388466|FG000|Overall Study|Adverse Event|1|||
49149705|NCT04562090|158388467|FG001|Overall Study|Adverse Event|4|||
49149706|NCT04562090|158388466|FG000|Overall Study|Miscellaneous|0|||
49149707|NCT04562090|158388467|FG001|Overall Study|Miscellaneous|3|||
49149708|NCT03934684|158388470|FG000|Overall Study|Participants continuing in study|11|||
49149709|NCT03934684|158388471|FG001|Overall Study|Participants continuing in study|4|||
49149710|NCT03934684|158388470|FG000|Overall Study|Discontinuation of carfilzomib|20|||
49149711|NCT03934684|158388471|FG001|Overall Study|Discontinuation of carfilzomib|30|||
49149712|NCT03934684|158388470|FG000|Overall Study|Death|2|||
49149713|NCT03934684|158388471|FG001|Overall Study|Death|2|||
49149714|NCT03934684|158388470|FG000|Overall Study|Lost to Follow-up|2|||
49149715|NCT03934684|158388471|FG001|Overall Study|Lost to Follow-up|5|||
49149716|NCT03934684|158388470|FG000|Overall Study|Withdrawal by Subject|7|||
49149717|NCT03934684|158388471|FG001|Overall Study|Withdrawal by Subject|8|||
49149718|NCT03312543|158388472|FG000|Before Treatment (Screening to Baseline)|Lost to Follow-up|0|||
49149719|NCT03312543|158388473|FG001|Before Treatment (Screening to Baseline)|Lost to Follow-up|2|||
49149720|NCT03312543|158388472|FG000|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1|||
49149721|NCT03312543|158388473|FG001|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2|||
49149722|NCT03312543|158388472|FG000|Treatment (Baseline to Week 12)|Withdrawal by Subject|3|||
49149723|NCT03312543|158388473|FG001|Treatment (Baseline to Week 12)|Withdrawal by Subject|4|||
49149724|NCT03312543|158388472|FG000|Treatment (Baseline to Week 12)|Protocol Violation|1|||
49149725|NCT03312543|158388473|FG001|Treatment (Baseline to Week 12)|Protocol Violation|1|||
49149726|NCT03312543|158388472|FG000|Regression (Week 12 to Week 24)|Protocol Violation|1|||
49149727|NCT03312543|158388473|FG001|Regression (Week 12 to Week 24)|Protocol Violation|1|||
49149728|NCT03312543|158388472|FG000|Regression (Week 12 to Week 24)|Death|0|||
49149729|NCT03312543|158388473|FG001|Regression (Week 12 to Week 24)|Death|1|||
49149730|NCT03034044|158388474|FG000|Overall Study|Enrolled, but not received Xyntha|1|||
49149731|NCT05852470|158388475|FG000|Overall Study|Withdrawal by Subject|0|||
49149732|NCT05852470|158388476|FG001|Overall Study|Withdrawal by Subject|1|||
49149733|NCT03518060|158388477|FG000|Overall Study|Death|1|||
49149734|NCT03518060|158388477|FG000|Overall Study|Poor adherence|1|||
49149735|NCT03518060|158388477|FG000|Overall Study|Withdrawal of informed consent|2|||
49149736|NCT03518060|158388477|FG000|Overall Study|Interaction with comedication or comorbidities|4|||
49149737|NCT03518060|158388477|FG000|Overall Study|Physician Decision|7|||
49149738|NCT03518060|158388477|FG000|Overall Study|Adverse drug reactions|23|||
49149739|NCT03518060|158388477|FG000|Overall Study|Withdrawal by Subject|25|||
49149740|NCT03518060|158388477|FG000|Overall Study|Lost to Follow-up|13|||
49149741|NCT02412436|158388478|FG000|Overall Study|Protocol-mandated Discontinuation|7|||
49149742|NCT02412436|158388478|FG000|Overall Study|Lost to Follow-up|6|||
49149743|NCT02412436|158388478|FG000|Overall Study|Unable to get to clinic|3|||
49149744|NCT02412436|158388478|FG000|Overall Study|Death|1|||
49149745|NCT02412436|158388478|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
49149746|NCT02544763|158388479|FG000|Overall Study|Adverse Event|8|||
49149747|NCT02544763|158388480|FG001|Overall Study|Adverse Event|8|||
49149748|NCT02544763|158388481|FG002|Overall Study|Adverse Event|0|||
49149749|NCT02544763|158388479|FG000|Overall Study|Withdrawn by parent/guardian|1|||
49149750|NCT02544763|158388480|FG001|Overall Study|Withdrawn by parent/guardian|1|||
49149751|NCT02544763|158388481|FG002|Overall Study|Withdrawn by parent/guardian|1|||
49149752|NCT02544763|158388479|FG000|Overall Study|Met withdrawal criteria|0|||
49149753|NCT02544763|158388480|FG001|Overall Study|Met withdrawal criteria|2|||
49149754|NCT02544763|158388481|FG002|Overall Study|Met withdrawal criteria|0|||
49149755|NCT02544763|158388479|FG000|Overall Study|Physician Decision|0|||
49149756|NCT02544763|158388480|FG001|Overall Study|Physician Decision|1|||
49149757|NCT02544763|158388481|FG002|Overall Study|Physician Decision|0|||
49149758|NCT02544763|158388479|FG000|Overall Study|Difficulties taking IMP|1|||
49149759|NCT02544763|158388480|FG001|Overall Study|Difficulties taking IMP|0|||
49149760|NCT02544763|158388481|FG002|Overall Study|Difficulties taking IMP|0|||
49149761|NCT01877278|158388482|FG000|Overall Study|Lost to Follow-up|3|||
49149762|NCT01877278|158388483|FG001|Overall Study|Lost to Follow-up|3|||
49149763|NCT03726879|158388486|FG000|Overall Study|Death|11|||
49149764|NCT03726879|158388487|FG001|Overall Study|Death|13|||
49149765|NCT03726879|158388486|FG000|Overall Study|Physician Decision|0|||
49149766|NCT03726879|158388487|FG001|Overall Study|Physician Decision|2|||
49149767|NCT03726879|158388486|FG000|Overall Study|Protocol Violation|0|||
49149768|NCT03726879|158388487|FG001|Overall Study|Protocol Violation|1|||
49149769|NCT03726879|158388486|FG000|Overall Study|Withdrawal by Subject|5|||
49149770|NCT03726879|158388487|FG001|Overall Study|Withdrawal by Subject|6|||
49149771|NCT03726879|158388486|FG000|Overall Study|TSH result is unstable|0|||
49149772|NCT03726879|158388487|FG001|Overall Study|TSH result is unstable|1|||
49149773|NCT03726879|158388486|FG000|Overall Study|Disease relapse|1|||
49149774|NCT03726879|158388487|FG001|Overall Study|Disease relapse|0|||
49149775|NCT03726879|158388486|FG000|Overall Study|Lost to Follow-up|3|||
49149776|NCT03726879|158388487|FG001|Overall Study|Lost to Follow-up|0|||
49149777|NCT02766478|158388488|FG000|Overall Study|Withdrawal by Subject|1|||
49149778|NCT02766478|158388489|FG001|Overall Study|Withdrawal by Subject|1|||
48731857|NCT04916769|156869559|FG000|Period 2|Physician Decision|0|||
48731858|NCT04916769|156869560|FG001|Period 2|Physician Decision|1|||
48731859|NCT04916769|156869561|FG002|Period 2|Physician Decision|0|||
48731860|NCT04916769|156869562|FG003|Period 2|Physician Decision|0|||
48731861|NCT04916769|156869563|FG004|Period 2|Physician Decision|0|||
48731862|NCT04916769|156869564|FG005|Period 2|Physician Decision|0|||
48731863|NCT05430022|156869577|FG000|Overall Study|Withdrawal by Subject|4|||
48731864|NCT05430022|156869578|FG001|Overall Study|Withdrawal by Subject|4|||
48731867|NCT03487549|156869583|FG000|Overall Study|Protocol Violation|0|||
48731868|NCT03487549|156869584|FG001|Overall Study|Protocol Violation|1|||
48731869|NCT03487549|156869583|FG000|Overall Study|Lost to Follow-up|2|||
48731870|NCT03487549|156869584|FG001|Overall Study|Lost to Follow-up|1|||
48731871|NCT03487549|156869583|FG000|Overall Study|Withdrawal by Subject|2|||
48731872|NCT03487549|156869584|FG001|Overall Study|Withdrawal by Subject|0|||
48731873|NCT05136690|156869585|FG000|Period 1|Withdrawal by Subject|0|||
48731874|NCT05136690|156869586|FG001|Period 1|Withdrawal by Subject|1|||
48731875|NCT05136690|156869585|FG000|Period 2|Lost to Follow-up|0|||
48731876|NCT05136690|156869586|FG001|Period 2|Lost to Follow-up|3|||
48731877|NCT05136690|156869585|FG000|Period 2|Withdrawal by Subject|0|||
48731878|NCT05136690|156869586|FG001|Period 2|Withdrawal by Subject|1|||
48731879|NCT03730012|156869587|FG000|Overall Study|Adverse Event|0|||
48731880|NCT03730012|156869588|FG001|Overall Study|Adverse Event|1|||
48731881|NCT03730012|156869587|FG000|Overall Study|Lack of Efficacy|1|||
48731882|NCT03730012|156869588|FG001|Overall Study|Lack of Efficacy|5|||
48731883|NCT03730012|156869587|FG000|Overall Study|Withdrawal by Subject|0|||
48731884|NCT03730012|156869588|FG001|Overall Study|Withdrawal by Subject|1|||
48731885|NCT03730012|156869587|FG000|Overall Study|Miscellaneous|2|||
48731886|NCT03730012|156869588|FG001|Overall Study|Miscellaneous|1|||
48731887|NCT00215683|156871189|FG000|Overall Study|Adverse Event|15|||
48731888|NCT00215683|156871190|FG001|Overall Study|Adverse Event|16|||
48731889|NCT00215683|156871191|FG002|Overall Study|Adverse Event|15|||
48731890|NCT00215683|156871189|FG000|Overall Study|Lack of Efficacy|5|||
48731891|NCT00215683|156871190|FG001|Overall Study|Lack of Efficacy|1|||
48731892|NCT00215683|156871191|FG002|Overall Study|Lack of Efficacy|2|||
48731893|NCT00215683|156871189|FG000|Overall Study|Lost to Follow-up|0|||
48731894|NCT00215683|156871190|FG001|Overall Study|Lost to Follow-up|2|||
48731895|NCT00215683|156871191|FG002|Overall Study|Lost to Follow-up|1|||
48731896|NCT00215683|156871189|FG000|Overall Study|Withdrawal by Subject|9|||
48731897|NCT00215683|156871190|FG001|Overall Study|Withdrawal by Subject|4|||
48731898|NCT00215683|156871191|FG002|Overall Study|Withdrawal by Subject|13|||
48731899|NCT00215683|156871189|FG000|Overall Study|Physician Decision|0|||
48731900|NCT00215683|156871190|FG001|Overall Study|Physician Decision|0|||
48731901|NCT00215683|156871191|FG002|Overall Study|Physician Decision|1|||
48731902|NCT00215683|156871189|FG000|Overall Study|Difficult to attend visits|0|||
48731903|NCT00215683|156871190|FG001|Overall Study|Difficult to attend visits|1|||
48731904|NCT00215683|156871191|FG002|Overall Study|Difficult to attend visits|0|||
48731905|NCT00215683|156871189|FG000|Overall Study|No study drug available|0|||
48731906|NCT00215683|156871190|FG001|Overall Study|No study drug available|1|||
48731907|NCT00215683|156871191|FG002|Overall Study|No study drug available|0|||
48731908|NCT00215683|156871189|FG000|Overall Study|Intermittent therapy required|0|||
48731909|NCT00215683|156871190|FG001|Overall Study|Intermittent therapy required|1|||
48731910|NCT00215683|156871191|FG002|Overall Study|Intermittent therapy required|0|||
48731911|NCT03894046|156871198|FG000|Overall Study|Protocol Violation|1|||
48731912|NCT03894046|156871199|FG001|Overall Study|Protocol Violation|0|||
48731913|NCT03894046|156871200|FG002|Overall Study|Protocol Violation|0|||
49149779|NCT00913835|158388490|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2|||
48731914|NCT03894046|156871198|FG000|Overall Study|Adverse Event|0|||
48731915|NCT03894046|156871199|FG001|Overall Study|Adverse Event|1|||
48731916|NCT03894046|156871200|FG002|Overall Study|Adverse Event|0|||
48731917|NCT03894046|156871198|FG000|Overall Study|Withdrawal by Subject|2|||
48731918|NCT03894046|156871199|FG001|Overall Study|Withdrawal by Subject|3|||
48731919|NCT03894046|156871200|FG002|Overall Study|Withdrawal by Subject|1|||
48731920|NCT03894046|156871198|FG000|Overall Study|Death|15|||
49149780|NCT00913835|158388491|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3|||
49149781|NCT00913835|158388490|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1|||
49149782|NCT00913835|158388491|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0|||
49149783|NCT00913835|158388490|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Other|4|||
49149784|NCT00913835|158388491|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Other|3|||
49149785|NCT00913835|158388490|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
49149786|NCT00913835|158388491|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
49149787|NCT00913835|158388490|FG000|Lip Dox: Olaratumab Monotherapy|Other|0|||
49149788|NCT00913835|158388491|FG001|Lip Dox: Olaratumab Monotherapy|Other|3|||
49149789|NCT01793129|158389883|FG000|Overall Study|Lost to Follow-up|3|||
49149790|NCT01793129|158389884|FG001|Overall Study|Lost to Follow-up|7|||
49149791|NCT01793129|158389883|FG000|Overall Study|Withdrawal by Subject|0|||
48731921|NCT03894046|156871199|FG001|Overall Study|Death|21|||
48824610|NCT04672460|157198916|FG000|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|2|||
48824611|NCT04672460|157198917|FG001|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|4|||
48824612|NCT04672460|157198916|FG000|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|0|||
48824613|NCT04672460|157198917|FG001|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|3|||
48824614|NCT04672460|157198916|FG000|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|0|||
48824615|NCT04672460|157198917|FG001|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|1|||
48824616|NCT04672460|157198916|FG000|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|3|||
48824617|NCT04672460|157198917|FG001|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|0|||
48824618|NCT04672460|157198916|FG000|Bioequivalence Phase: Period 1 (28 Days)|Other|1|||
48824619|NCT04672460|157198917|FG001|Bioequivalence Phase: Period 1 (28 Days)|Other|0|||
48824620|NCT04672460|157198916|FG000|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|1|||
48824621|NCT04672460|157198917|FG001|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|5|||
48824622|NCT04672460|157198916|FG000|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|1|||
48824623|NCT04672460|157198917|FG001|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|0|||
48731922|NCT03894046|156871200|FG002|Overall Study|Death|4|||
48731923|NCT03894046|156871198|FG000|Overall Study|No growth of ABC|2|||
48731924|NCT03894046|156871199|FG001|Overall Study|No growth of ABC|1|||
48731925|NCT03894046|156871200|FG002|Overall Study|No growth of ABC|0|||
48731926|NCT03894046|156871198|FG000|Overall Study|Physician Decision|1|||
48731927|NCT03894046|156871199|FG001|Overall Study|Physician Decision|1|||
48731928|NCT03894046|156871200|FG002|Overall Study|Physician Decision|1|||
48731929|NCT03894046|156871198|FG000|Overall Study|Prohibited concomitant medication|1|||
48731930|NCT03894046|156871199|FG001|Overall Study|Prohibited concomitant medication|0|||
48731931|NCT03894046|156871200|FG002|Overall Study|Prohibited concomitant medication|0|||
48731932|NCT03894046|156871198|FG000|Overall Study|Transferred to other arm/group|1|||
48731933|NCT03894046|156871199|FG001|Overall Study|Transferred to other arm/group|1|||
48731934|NCT03894046|156871200|FG002|Overall Study|Transferred to other arm/group|0|||
48731935|NCT02611960|156871201|FG000|Overall Study|Adverse Event|7|||
48731936|NCT02611960|156871202|FG001|Overall Study|Adverse Event|8|||
48731937|NCT02611960|156871201|FG000|Overall Study|Death|98|||
48731938|NCT02611960|156871202|FG001|Overall Study|Death|92|||
48731939|NCT02611960|156871201|FG000|Overall Study|Withdrawal by Subject|1|||
48731940|NCT02611960|156871202|FG001|Overall Study|Withdrawal by Subject|5|||
48731941|NCT02611960|156871201|FG000|Overall Study|Sponsor Decision|11|||
48731942|NCT02611960|156871202|FG001|Overall Study|Sponsor Decision|11|||
49149792|NCT01793129|158389884|FG001|Overall Study|Withdrawal by Subject|2|||
49149793|NCT05654181|158389885|FG000|Overall Study|Adverse Event|1|||
49149794|NCT05654181|158389886|FG001|Overall Study|Adverse Event|0|||
49149795|NCT05654181|158389887|FG002|Overall Study|Adverse Event|0|||
49149796|NCT05654181|158389888|FG003|Overall Study|Adverse Event|0|||
49149797|NCT05654181|158389889|FG004|Overall Study|Adverse Event|0|||
49149798|NCT05654181|158389890|FG005|Overall Study|Adverse Event|0|||
49149799|NCT05654181|158389891|FG006|Overall Study|Adverse Event|0|||
49149800|NCT05654181|158389892|FG007|Overall Study|Adverse Event|1|||
49149801|NCT05654181|158389893|FG008|Overall Study|Adverse Event|0|||
48731943|NCT03793556|156871203|FG000|Overall Study|Withdrawal by Subject|12|||
48731944|NCT03793556|156871204|FG001|Overall Study|Withdrawal by Subject|1|||
48731945|NCT03793556|156871203|FG000|Overall Study|Lost to Follow-up|1|||
48824624|NCT04672460|157198916|FG000|Food Effect Phase: Period 3 (21 Days)|Adverse Event|1|||
48731946|NCT03793556|156871204|FG001|Overall Study|Lost to Follow-up|1|||
48824625|NCT04672460|157198917|FG001|Food Effect Phase: Period 3 (21 Days)|Adverse Event|0|||
49149802|NCT05654181|158389894|FG009|Overall Study|Adverse Event|0|||
49149803|NCT05654181|158389885|FG000|Overall Study|Withdrawal by Subject|0|||
49149804|NCT05654181|158389886|FG001|Overall Study|Withdrawal by Subject|0|||
49149805|NCT05654181|158389887|FG002|Overall Study|Withdrawal by Subject|0|||
49149806|NCT05654181|158389888|FG003|Overall Study|Withdrawal by Subject|0|||
49149807|NCT05654181|158389889|FG004|Overall Study|Withdrawal by Subject|0|||
49149808|NCT05654181|158389890|FG005|Overall Study|Withdrawal by Subject|0|||
49149809|NCT05654181|158389891|FG006|Overall Study|Withdrawal by Subject|0|||
49149810|NCT05654181|158389892|FG007|Overall Study|Withdrawal by Subject|1|||
49149811|NCT05654181|158389893|FG008|Overall Study|Withdrawal by Subject|0|||
49149812|NCT05654181|158389894|FG009|Overall Study|Withdrawal by Subject|0|||
49149813|NCT05654181|158389885|FG000|Overall Study|Other|0|||
49149814|NCT05654181|158389886|FG001|Overall Study|Other|0|||
49149815|NCT05654181|158389887|FG002|Overall Study|Other|0|||
49149816|NCT05654181|158389888|FG003|Overall Study|Other|0|||
49149817|NCT05654181|158389889|FG004|Overall Study|Other|1|||
49149818|NCT05654181|158389890|FG005|Overall Study|Other|1|||
49149819|NCT05654181|158389891|FG006|Overall Study|Other|0|||
49149820|NCT05654181|158389892|FG007|Overall Study|Other|0|||
49149821|NCT05654181|158389893|FG008|Overall Study|Other|0|||
49149822|NCT05654181|158389894|FG009|Overall Study|Other|0|||
48731965|NCT02963831|156871209|FG000|Overall Study|Progressive Disease|3|||
48731966|NCT02963831|156871210|FG001|Overall Study|Progressive Disease|3|||
48731967|NCT02963831|156871211|FG002|Overall Study|Progressive Disease|16|||
48731968|NCT02963831|156871212|FG003|Overall Study|Progressive Disease|27|||
48731969|NCT02963831|156871209|FG000|Overall Study|Withdrawal by Subject|1|||
48731970|NCT02963831|156871210|FG001|Overall Study|Withdrawal by Subject|0|||
48731971|NCT02963831|156871211|FG002|Overall Study|Withdrawal by Subject|2|||
48731972|NCT02963831|156871212|FG003|Overall Study|Withdrawal by Subject|4|||
48731973|NCT02963831|156871209|FG000|Overall Study|Adverse Event|0|||
48731974|NCT02963831|156871210|FG001|Overall Study|Adverse Event|1|||
48731975|NCT02963831|156871211|FG002|Overall Study|Adverse Event|1|||
48731976|NCT02963831|156871212|FG003|Overall Study|Adverse Event|2|||
48731977|NCT02963831|156871209|FG000|Overall Study|Death|0|||
48731978|NCT02963831|156871210|FG001|Overall Study|Death|0|||
48731979|NCT02963831|156871211|FG002|Overall Study|Death|0|||
48731980|NCT02963831|156871212|FG003|Overall Study|Death|2|||
48731981|NCT01675427|156871217|FG000|Overall Study|Withdrawal by Subject|7|||
48731982|NCT01675427|156871217|FG000|Overall Study|Participant Refused Sample Collection|18|||
48731983|NCT01675427|156871217|FG000|Overall Study|Sample not Collected by Mistake|2|||
48731984|NCT01675427|156871217|FG000|Overall Study|Lost to Follow-up|5|||
48731985|NCT01675427|156871217|FG000|Overall Study|Other|2|||
48731986|NCT00700570|156871218|FG000|Overall Study|Adverse Event|2|||
48731987|NCT00700570|156871219|FG001|Overall Study|Adverse Event|6|||
48731988|NCT00700570|156871218|FG000|Overall Study|Discretion of Investigator or Sponsor|0|||
48731989|NCT00700570|156871219|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
48731990|NCT00700570|156871218|FG000|Overall Study|Disease Progression|8|||
48731991|NCT00700570|156871219|FG001|Overall Study|Disease Progression|11|||
48731992|NCT00700570|156871218|FG000|Overall Study|Withdrawal by Subject|1|||
48731993|NCT00700570|156871219|FG001|Overall Study|Withdrawal by Subject|6|||
48731994|NCT02517866|156871222|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
48731995|NCT02517866|156871223|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
48731996|NCT02517866|156871224|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
48731997|NCT02517866|156871222|FG000|Overall Study|Significant Protocol Deviation|4|||
48731998|NCT02517866|156871223|FG001|Overall Study|Significant Protocol Deviation|1|||
48731999|NCT02517866|156871224|FG002|Overall Study|Significant Protocol Deviation|0|||
48732000|NCT02517866|156871222|FG000|Overall Study|Lost to Follow-up|1|||
48732001|NCT02517866|156871223|FG001|Overall Study|Lost to Follow-up|0|||
48732002|NCT02517866|156871224|FG002|Overall Study|Lost to Follow-up|0|||
48732003|NCT02517866|156871222|FG000|Overall Study|Voluntary Withdrawal|2|||
48732004|NCT02517866|156871223|FG001|Overall Study|Voluntary Withdrawal|2|||
48732005|NCT02517866|156871224|FG002|Overall Study|Voluntary Withdrawal|0|||
48732006|NCT02517866|156871222|FG000|Overall Study|Investigator Decision|2|||
49149823|NCT01213251|158389895|FG000|Overall Study|Death|2|||
49149824|NCT01213251|158389896|FG001|Overall Study|Death|1|||
49149825|NCT01213251|158389897|FG002|Overall Study|Death|2|||
49149826|NCT01213251|158389895|FG000|Overall Study|Exit|3|||
49149827|NCT01213251|158389896|FG001|Overall Study|Exit|2|||
48732007|NCT02517866|156871223|FG001|Overall Study|Investigator Decision|1|||
48732008|NCT02517866|156871224|FG002|Overall Study|Investigator Decision|0|||
48732009|NCT02517866|156871222|FG000|Overall Study|Reason not specified|2|||
48732010|NCT02517866|156871223|FG001|Overall Study|Reason not specified|0|||
48732011|NCT02517866|156871224|FG002|Overall Study|Reason not specified|0|||
48732012|NCT02791594|156871225|FG000|Overall Study|Physician Decision|2|||
48732013|NCT03845543|156871226|FG000|Overall Study|Death|25|||
48732014|NCT03845543|156871226|FG000|Overall Study|Withdrawal by Subject|2|||
48732015|NCT03845543|156871226|FG000|Overall Study|Lost to Follow-up|12|||
48732016|NCT03845543|156871226|FG000|Overall Study|Adverse Event|17|||
48732017|NCT02046733|156871227|FG000|Overall Study|never initiated 'treatment visits'|6|||
48732018|NCT02046733|156871228|FG001|Overall Study|never initiated 'treatment visits'|0|||
48732019|NCT01199731|156871229|FG000|Overall Study|Adverse Event|0|||
48732020|NCT01199731|156871230|FG001|Overall Study|Adverse Event|1|||
48732021|NCT01199731|156871231|FG002|Overall Study|Adverse Event|0|||
48732022|NCT01199731|156871229|FG000|Overall Study|Study closed/terminated|7|||
48732023|NCT01199731|156871230|FG001|Overall Study|Study closed/terminated|9|||
48732024|NCT01199731|156871231|FG002|Overall Study|Study closed/terminated|7|||
48732025|NCT01199731|156871229|FG000|Overall Study|Lost to Follow-up|0|||
48732026|NCT01199731|156871230|FG001|Overall Study|Lost to Follow-up|0|||
48732027|NCT01199731|156871231|FG002|Overall Study|Lost to Follow-up|2|||
48732028|NCT01199731|156871229|FG000|Overall Study|Physician Decision|0|||
48732029|NCT01199731|156871230|FG001|Overall Study|Physician Decision|1|||
48732030|NCT01199731|156871231|FG002|Overall Study|Physician Decision|1|||
48732031|NCT01199731|156871229|FG000|Overall Study|Withdrawal by Subject|2|||
48732032|NCT01199731|156871230|FG001|Overall Study|Withdrawal by Subject|0|||
48732033|NCT01199731|156871231|FG002|Overall Study|Withdrawal by Subject|0|||
48732034|NCT01756053|156871233|FG000|Period 1 (10 Days)|Protocol Violation|1|||
48732035|NCT01756053|156871234|FG001|Period 1 (10 Days)|Protocol Violation|1|||
48732036|NCT01756053|156871233|FG000|Period 2 (10 Days)|Protocol Violation|0|||
48732037|NCT01756053|156871234|FG001|Period 2 (10 Days)|Protocol Violation|2|||
48732038|NCT01642407|156871235|FG000|Part 1 (Screening Till Week 16)|Insufficient clinical response|3|||
48732039|NCT01642407|156871235|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1|||
48732040|NCT01642407|156871235|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1|||
48732041|NCT02448810|156871236|FG000|Overall Study|Adverse Event|0|||
48732042|NCT02448810|156871237|FG001|Overall Study|Adverse Event|0|||
48732043|NCT02448810|156871238|FG002|Overall Study|Adverse Event|1|||
48732044|NCT02448810|156871239|FG003|Overall Study|Adverse Event|0|||
48732045|NCT02448810|156871240|FG004|Overall Study|Adverse Event|0|||
48732046|NCT02448810|156871241|FG005|Overall Study|Adverse Event|0|||
48732047|NCT02448810|156871242|FG006|Overall Study|Adverse Event|0|||
48732048|NCT02448810|156871243|FG007|Overall Study|Adverse Event|0|||
48732049|NCT02448810|156871236|FG000|Overall Study|Withdrawal by Subject|0|||
48732050|NCT02448810|156871237|FG001|Overall Study|Withdrawal by Subject|0|||
48732051|NCT02448810|156871238|FG002|Overall Study|Withdrawal by Subject|1|||
48732052|NCT02448810|156871239|FG003|Overall Study|Withdrawal by Subject|0|||
48732053|NCT02448810|156871240|FG004|Overall Study|Withdrawal by Subject|3|||
48732054|NCT02448810|156871241|FG005|Overall Study|Withdrawal by Subject|5|||
48732055|NCT02448810|156871242|FG006|Overall Study|Withdrawal by Subject|0|||
48732056|NCT02448810|156871243|FG007|Overall Study|Withdrawal by Subject|2|||
48732057|NCT02448810|156871236|FG000|Overall Study|Other (study terminated by sponsor)|0|||
48732058|NCT02448810|156871237|FG001|Overall Study|Other (study terminated by sponsor)|0|||
48732059|NCT02448810|156871238|FG002|Overall Study|Other (study terminated by sponsor)|0|||
48732060|NCT02448810|156871239|FG003|Overall Study|Other (study terminated by sponsor)|0|||
48732061|NCT02448810|156871240|FG004|Overall Study|Other (study terminated by sponsor)|4|||
48732062|NCT02448810|156871241|FG005|Overall Study|Other (study terminated by sponsor)|2|||
48732063|NCT02448810|156871242|FG006|Overall Study|Other (study terminated by sponsor)|2|||
48732064|NCT02448810|156871243|FG007|Overall Study|Other (study terminated by sponsor)|1|||
48732065|NCT02448810|156871236|FG000|Overall Study|Death|1|||
48732066|NCT02448810|156871237|FG001|Overall Study|Death|0|||
48732067|NCT02448810|156871238|FG002|Overall Study|Death|1|||
48732068|NCT02448810|156871239|FG003|Overall Study|Death|0|||
48732069|NCT02448810|156871240|FG004|Overall Study|Death|1|||
48732070|NCT02448810|156871241|FG005|Overall Study|Death|0|||
48732071|NCT02448810|156871242|FG006|Overall Study|Death|0|||
48732072|NCT02448810|156871243|FG007|Overall Study|Death|0|||
48732073|NCT02448810|156871236|FG000|Overall Study|Other (Progressive disease)|2|||
48732074|NCT02448810|156871237|FG001|Overall Study|Other (Progressive disease)|2|||
48732075|NCT02448810|156871238|FG002|Overall Study|Other (Progressive disease)|0|||
48732076|NCT02448810|156871239|FG003|Overall Study|Other (Progressive disease)|3|||
48732077|NCT02448810|156871240|FG004|Overall Study|Other (Progressive disease)|23|||
48732078|NCT02448810|156871241|FG005|Overall Study|Other (Progressive disease)|9|||
48732079|NCT02448810|156871242|FG006|Overall Study|Other (Progressive disease)|14|||
48732080|NCT02448810|156871243|FG007|Overall Study|Other (Progressive disease)|5|||
48732081|NCT02448810|156871236|FG000|Overall Study|Lost to Follow-up|0|||
48732082|NCT02448810|156871237|FG001|Overall Study|Lost to Follow-up|1|||
48732083|NCT02448810|156871238|FG002|Overall Study|Lost to Follow-up|0|||
49149828|NCT01213251|158389897|FG002|Overall Study|Exit|8|||
48824626|NCT04672460|157198916|FG000|Food Effect Phase: Period 3 (21 Days)|Progressive disease|3|||
48824627|NCT04672460|157198917|FG001|Food Effect Phase: Period 3 (21 Days)|Progressive disease|1|||
49149829|NCT01213251|158389895|FG000|Overall Study|Protocol Violation|1|||
48824628|NCT04672460|157198916|FG000|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|0|||
48824629|NCT04672460|157198917|FG001|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|1|||
48824630|NCT04672460|157198916|FG000|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|0|||
48824631|NCT04672460|157198917|FG001|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|1|||
48824632|NCT04672460|157198916|FG000|Food Effect Phase: Period 3 (21 Days)|Other|1|||
48824633|NCT04672460|157198917|FG001|Food Effect Phase: Period 3 (21 Days)|Other|0|||
48824634|NCT04672460|157198916|FG000|Maintenance Phase: Period 4 (28 Days)|Adverse Event|1|||
48824635|NCT04672460|157198917|FG001|Maintenance Phase: Period 4 (28 Days)|Adverse Event|0|||
48824636|NCT04672460|157198916|FG000|Maintenance Phase: Period 4 (28 Days)|Progressive disease|10|||
48824637|NCT04672460|157198917|FG001|Maintenance Phase: Period 4 (28 Days)|Progressive disease|12|||
48824638|NCT04672460|157198916|FG000|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|1|||
48824639|NCT04672460|157198917|FG001|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|0|||
48824640|NCT04672460|157198916|FG000|Maintenance Phase: Period 4 (28 Days)|Other|9|||
48824641|NCT04672460|157198917|FG001|Maintenance Phase: Period 4 (28 Days)|Other|8|||
48824642|NCT01876043|157198918|FG000|Overall Study|Death|1|||
48824643|NCT01876043|157198918|FG000|Overall Study|Withdrawal by Subject|1|||
48824644|NCT00079937|157198919|FG000|Overall Study|Adverse Event|2|||
48824645|NCT00079937|157198920|FG001|Overall Study|Adverse Event|1|||
48824646|NCT00079937|157198919|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
48824647|NCT00079937|157198920|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
48824648|NCT00079937|157198919|FG000|Overall Study|Subject no longer requires study drug|3|||
48824649|NCT00079937|157198920|FG001|Overall Study|Subject no longer requires study drug|0|||
48824650|NCT00079937|157198919|FG000|Overall Study|Protocol Violation|8|||
48824651|NCT00079937|157198920|FG001|Overall Study|Protocol Violation|6|||
49149830|NCT01213251|158389896|FG001|Overall Study|Protocol Violation|1|||
49149831|NCT01213251|158389897|FG002|Overall Study|Protocol Violation|0|||
49149832|NCT01213251|158389895|FG000|Overall Study|Missed 18-Month Follow-up|0|||
49149833|NCT01213251|158389896|FG001|Overall Study|Missed 18-Month Follow-up|0|||
49149834|NCT01213251|158389897|FG002|Overall Study|Missed 18-Month Follow-up|1|||
49149835|NCT01629563|158389898|FG000|Overall Study|Adverse Event|16|||
49149836|NCT01629563|158389899|FG001|Overall Study|Adverse Event|16|||
49149837|NCT01629563|158389898|FG000|Overall Study|Death|2|||
49149838|NCT01629563|158389899|FG001|Overall Study|Death|0|||
49149839|NCT01629563|158389898|FG000|Overall Study|Lack of Efficacy|2|||
49149840|NCT01629563|158389899|FG001|Overall Study|Lack of Efficacy|3|||
49149841|NCT01629563|158389898|FG000|Overall Study|Lost to Follow-up|1|||
49149842|NCT01629563|158389899|FG001|Overall Study|Lost to Follow-up|0|||
49149843|NCT01629563|158389898|FG000|Overall Study|Pregnancy|1|||
49149844|NCT01629563|158389899|FG001|Overall Study|Pregnancy|2|||
49149845|NCT01629563|158389898|FG000|Overall Study|Protocol Violation|0|||
49149846|NCT01629563|158389899|FG001|Overall Study|Protocol Violation|1|||
49149847|NCT01629563|158389898|FG000|Overall Study|Withdrawal by Subject|27|||
49149848|NCT01629563|158389899|FG001|Overall Study|Withdrawal by Subject|20|||
49149849|NCT01629563|158389898|FG000|Overall Study|surgery|0|||
49149850|NCT01629563|158389899|FG001|Overall Study|surgery|3|||
49149851|NCT01629563|158389898|FG000|Overall Study|Lack of return of menses|12|||
49149852|NCT01629563|158389899|FG001|Overall Study|Lack of return of menses|7|||
49149853|NCT01629563|158389898|FG000|Overall Study|Protocol Violation|0|||
49149854|NCT01629563|158389899|FG001|Overall Study|Protocol Violation|1|||
48732084|NCT02448810|156871239|FG003|Overall Study|Lost to Follow-up|0|||
48732085|NCT02448810|156871240|FG004|Overall Study|Lost to Follow-up|0|||
48732086|NCT02448810|156871241|FG005|Overall Study|Lost to Follow-up|0|||
48732087|NCT02448810|156871242|FG006|Overall Study|Lost to Follow-up|0|||
48732088|NCT02448810|156871243|FG007|Overall Study|Lost to Follow-up|0|||
48732089|NCT02448810|156871236|FG000|Overall Study|Other (unspecified)|0|||
48732090|NCT02448810|156871237|FG001|Overall Study|Other (unspecified)|0|||
48732091|NCT02448810|156871238|FG002|Overall Study|Other (unspecified)|0|||
48732092|NCT02448810|156871239|FG003|Overall Study|Other (unspecified)|0|||
48732093|NCT02448810|156871240|FG004|Overall Study|Other (unspecified)|0|||
48824652|NCT00079937|157198919|FG000|Overall Study|Withdrawal by Subject|21|||
48824653|NCT00079937|157198920|FG001|Overall Study|Withdrawal by Subject|7|||
48824654|NCT00079937|157198919|FG000|Overall Study|Lost to Follow-up|12|||
48824655|NCT00079937|157198920|FG001|Overall Study|Lost to Follow-up|5|||
48824656|NCT00079937|157198919|FG000|Overall Study|Administrative problems|22|||
48824657|NCT00079937|157198920|FG001|Overall Study|Administrative problems|11|||
48921527|NCT02109484|157546411|FG007|Overall Study|Withdrawal by Subject|0|||
49149855|NCT03635996|158389900|FG000|Overall Study|Study terminated by Sponsor|94|||
49149856|NCT03635996|158389900|FG000|Overall Study|Withdrawal by Subject|20|||
49149857|NCT03635996|158389900|FG000|Overall Study|Ablation|26|||
49149858|NCT03635996|158389900|FG000|Overall Study|Adverse Event|7|||
49149859|NCT03635996|158389900|FG000|Overall Study|Physician Decision|3|||
49149860|NCT03635996|158389900|FG000|Overall Study|Prohibited medication|5|||
49149861|NCT03635996|158389900|FG000|Overall Study|Did not meet eligibility criteria|5|||
49149862|NCT03635996|158389900|FG000|Overall Study|Site closure (2), compliance with IP, directed by sponsor and site termination.|5|||
49149863|NCT03635996|158389900|FG000|Overall Study|Protocol Violation|1|||
49149864|NCT03635996|158389900|FG000|Overall Study|Lost to Follow-up|1|||
49149865|NCT02933151|158389901|FG000|Overall Study|Lost to Follow-up|19|||
49149866|NCT02933151|158389902|FG001|Overall Study|Lost to Follow-up|18|||
49149867|NCT02933151|158389901|FG000|Overall Study|Death|1732|||
49149868|NCT02933151|158389902|FG001|Overall Study|Death|1827|||
49149869|NCT02933151|158389901|FG000|Overall Study|Transplant|210|||
49149870|NCT02933151|158389902|FG001|Overall Study|Transplant|278|||
49149871|NCT02933151|158389901|FG000|Overall Study|Withdrawal from HD (Death equivalent analytically)|24|||
49149872|NCT02933151|158389902|FG001|Overall Study|Withdrawal from HD (Death equivalent analytically)|29|||
49149873|NCT02933151|158389901|FG000|Overall Study|Transferred to PD or a non-DCI facility|516|||
49149874|NCT02933151|158389902|FG001|Overall Study|Transferred to PD or a non-DCI facility|632|||
49149875|NCT02933151|158389901|FG000|Overall Study|Recovered Kidney Function|47|||
49149876|NCT02933151|158389902|FG001|Overall Study|Recovered Kidney Function|29|||
49149877|NCT00912509|158389906|FG000|Overall Study|Lost to Follow-up|1|||
49149878|NCT00912509|158389907|FG001|Overall Study|Lost to Follow-up|0|||
49149879|NCT00912509|158389906|FG000|Overall Study|Lack of Efficacy|4|||
49149880|NCT00912509|158389907|FG001|Overall Study|Lack of Efficacy|3|||
49149881|NCT02837952|158389908|FG000|Overall Study|Adverse Event|0|||
49149882|NCT02837952|158389909|FG001|Overall Study|Adverse Event|1|||
49149883|NCT02837952|158389908|FG000|Overall Study|Withdrawal by Subject|4|||
49149884|NCT02837952|158389909|FG001|Overall Study|Withdrawal by Subject|5|||
49149885|NCT02837952|158389908|FG000|Overall Study|Medication Error|1|||
49149886|NCT02837952|158389909|FG001|Overall Study|Medication Error|0|||
49149887|NCT01557569|158389910|FG000|Overall Study|Adverse Event|2|||
49149888|NCT01557569|158389911|FG001|Overall Study|Adverse Event|0|||
49149889|NCT01557569|158389910|FG000|Overall Study|high blood pressure|0|||
49149890|NCT01557569|158389911|FG001|Overall Study|high blood pressure|1|||
49149891|NCT01557569|158389910|FG000|Overall Study|Withdrawal by Subject|3|||
49149892|NCT01557569|158389911|FG001|Overall Study|Withdrawal by Subject|5|||
49149893|NCT01557569|158389910|FG000|Overall Study|noncompliance with rules of residential|0|||
49149894|NCT01557569|158389911|FG001|Overall Study|noncompliance with rules of residential|1|||
49149895|NCT00993473|158389912|FG000|Overall Study|Adverse Event|0|||
49149896|NCT00993473|158389913|FG001|Overall Study|Adverse Event|2|||
49149897|NCT00993473|158389912|FG000|Overall Study|Protocol Violation|1|||
49149898|NCT00993473|158389913|FG001|Overall Study|Protocol Violation|2|||
49149899|NCT00993473|158389912|FG000|Overall Study|Lost to Follow-up|1|||
49149900|NCT00993473|158389913|FG001|Overall Study|Lost to Follow-up|0|||
49149901|NCT00993473|158389912|FG000|Overall Study|Withdrawal by Subject|1|||
49149902|NCT00993473|158389913|FG001|Overall Study|Withdrawal by Subject|5|||
49149903|NCT00993473|158389912|FG000|Overall Study|Technical problem with CGM device|0|||
49149904|NCT00993473|158389913|FG001|Overall Study|Technical problem with CGM device|1|||
49149905|NCT00993473|158389912|FG000|Overall Study|Family event|1|||
49149906|NCT00993473|158389913|FG001|Overall Study|Family event|0|||
49149907|NCT03757715|158389916|FG000|Overall Study|Lost to Follow-up|4|||
49149908|NCT03757715|158389917|FG001|Overall Study|Lost to Follow-up|9|||
49149909|NCT03757715|158389916|FG000|Overall Study|Withdrawal by Subject|1|||
49149910|NCT03757715|158389917|FG001|Overall Study|Withdrawal by Subject|1|||
49149911|NCT00552279|158389920|FG000|Overall Study|Adverse Event|0|||
49149912|NCT00552279|158389921|FG001|Overall Study|Adverse Event|1|||
49149913|NCT00552279|158389920|FG000|Overall Study|Withdrawal by Subject|12|||
49149914|NCT00552279|158389921|FG001|Overall Study|Withdrawal by Subject|1|||
49149915|NCT00552279|158389920|FG000|Overall Study|Lost to Follow-up|1|||
49149916|NCT00552279|158389921|FG001|Overall Study|Lost to Follow-up|0|||
49149917|NCT00552279|158389920|FG000|Overall Study|Other|1|||
49149918|NCT00552279|158389921|FG001|Overall Study|Other|1|||
49149919|NCT02661815|158389925|FG000|Overall Study|Withdrawal by Subject|1|||
49149920|NCT02661815|158389926|FG001|Overall Study|Withdrawal by Subject|0|||
49149921|NCT02661815|158389927|FG002|Overall Study|Withdrawal by Subject|0|||
49149922|NCT02661815|158389928|FG003|Overall Study|Withdrawal by Subject|0|||
48921528|NCT02109484|157546404|FG000|Overall Study|Physician Decision|0|||
49149923|NCT03647137|158389929|FG000|Overall Study|Scan Limitation|2|||
49149924|NCT03647137|158389930|FG001|Overall Study|Scan Limitation|1|||
49149925|NCT03647137|158389931|FG002|Overall Study|Scan Limitation|1|||
49149926|NCT03647137|158389932|FG003|Overall Study|Scan Limitation|2|||
49149927|NCT05451329|158389933|FG000|Overall Study|Adverse Event|1|||
49149928|NCT05451329|158389934|FG001|Overall Study|Adverse Event|1|||
49149929|NCT05451329|158389935|FG002|Overall Study|Adverse Event|0|||
49149930|NCT05451329|158389933|FG000|Overall Study|Withdrawal by Subject|1|||
49149931|NCT05451329|158389934|FG001|Overall Study|Withdrawal by Subject|0|||
49149932|NCT05451329|158389935|FG002|Overall Study|Withdrawal by Subject|0|||
48732094|NCT02448810|156871241|FG005|Overall Study|Other (unspecified)|0|||
48732095|NCT02448810|156871242|FG006|Overall Study|Other (unspecified)|2|||
48732096|NCT02448810|156871243|FG007|Overall Study|Other (unspecified)|0|||
48732097|NCT00470847|156871246|FG000|Overall Study|Pt still receiving treatment|1|||
48732098|NCT01268150|156871247|FG000|Treatment Phase|Progression of disease|18|||
48732099|NCT01268150|156871247|FG000|Treatment Phase|Adverse Event|3|||
48732100|NCT01268150|156871247|FG000|Treatment Phase|Withdrawal by Subject|3|||
48824658|NCT05257837|157198923|FG000|Overall Study|Excluded (did not find the guns)|4|||
48824659|NCT05257837|157198924|FG001|Overall Study|Excluded (did not find the guns)|2|||
48824660|NCT05257837|157198925|FG002|Overall Study|Excluded (did not find the guns)|4|||
48824661|NCT05257837|157198926|FG003|Overall Study|Excluded (did not find the guns)|0|||
48824662|NCT02561455|157198927|FG000|Overall Study|Participant Transitioned to Commercial Drug|1|||
48824663|NCT02561455|157198928|FG001|Overall Study|Participant Transitioned to Commercial Drug|1|||
48824664|NCT02561455|157198929|FG002|Overall Study|Participant Transitioned to Commercial Drug|2|||
48824665|NCT02561455|157198930|FG003|Overall Study|Participant Transitioned to Commercial Drug|1|||
48824666|NCT02561455|157198927|FG000|Overall Study|Withdrawal by Subject|1|||
48824667|NCT02561455|157198928|FG001|Overall Study|Withdrawal by Subject|0|||
48824668|NCT02561455|157198929|FG002|Overall Study|Withdrawal by Subject|1|||
49149933|NCT05451329|158389933|FG000|Overall Study|Investigational Product Lot exchange|1|||
49149934|NCT05451329|158389934|FG001|Overall Study|Investigational Product Lot exchange|1|||
49149935|NCT05451329|158389935|FG002|Overall Study|Investigational Product Lot exchange|0|||
48824669|NCT02561455|157198930|FG003|Overall Study|Withdrawal by Subject|0|||
49149936|NCT02034565|158389939|FG000|Overall Study|Adverse Event|1|||
49149937|NCT02034565|158389940|FG001|Overall Study|Adverse Event|0|||
49149938|NCT00265122|158389946|FG000|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
49149939|NCT00265122|158389947|FG001|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
49149940|NCT00265122|158389948|FG002|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3|||
49149941|NCT00265122|158389949|FG003|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
49149942|NCT00265122|158389950|FG004|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
49149943|NCT00265122|158389951|FG005|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
49149944|NCT00265122|158389946|FG000|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
48824670|NCT02561455|157198927|FG000|Overall Study|Disease Progression|0|||
48824671|NCT02561455|157198928|FG001|Overall Study|Disease Progression|1|||
48824672|NCT02561455|157198929|FG002|Overall Study|Disease Progression|0|||
48824673|NCT02561455|157198930|FG003|Overall Study|Disease Progression|0|||
48824674|NCT00409708|157198941|FG000|Treatment|Abnormal test procedure result(s)|1|||
48824675|NCT00409708|157198942|FG001|Treatment|Abnormal test procedure result(s)|0|||
48824676|NCT00409708|157198941|FG000|Treatment|Lack of Efficacy|0|||
48824677|NCT00409708|157198942|FG001|Treatment|Lack of Efficacy|1|||
48824678|NCT00409708|157198941|FG000|Treatment|Protocol Violation|6|||
48824679|NCT00409708|157198942|FG001|Treatment|Protocol Violation|2|||
48824680|NCT00409708|157198941|FG000|Treatment|Withdrawal by Subject|3|||
48824681|NCT00409708|157198942|FG001|Treatment|Withdrawal by Subject|8|||
48824682|NCT00409708|157198941|FG000|Treatment|Lost to Follow-up|0|||
48824683|NCT00409708|157198942|FG001|Treatment|Lost to Follow-up|6|||
48824684|NCT00409708|157198941|FG000|Treatment|Administrative problems|5|||
48824685|NCT00409708|157198942|FG001|Treatment|Administrative problems|0|||
48824686|NCT00409708|157198941|FG000|Washout|Lack of Efficacy|9|||
48824687|NCT00409708|157198942|FG001|Washout|Lack of Efficacy|1|||
48824688|NCT00409708|157198941|FG000|Washout|Protocol Violation|0|||
48824689|NCT00409708|157198942|FG001|Washout|Protocol Violation|1|||
48824690|NCT00409708|157198941|FG000|Washout|Withdrawal by Subject|11|||
48824691|NCT00409708|157198942|FG001|Washout|Withdrawal by Subject|5|||
48824692|NCT00409708|157198941|FG000|Washout|Lost to Follow-up|1|||
48824693|NCT00409708|157198942|FG001|Washout|Lost to Follow-up|3|||
48732101|NCT01268150|156871247|FG000|Treatment Phase|Other|4|||
48732102|NCT01268150|156871247|FG000|Extension Phase|Adverse Event|3|||
48732103|NCT01268150|156871247|FG000|Extension Phase|Disease progression|18|||
48732104|NCT01268150|156871247|FG000|Extension Phase|Other|6|||
48824694|NCT02485353|157198943|FG000|Overall Study|Death|1|||
49149945|NCT00265122|158389947|FG001|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
48732105|NCT01147172|156871248|FG000|Overall Study|Withdrawal by Subject|2|||
48732106|NCT01147172|156871248|FG000|Overall Study|Lost to Follow-up|2|||
48824695|NCT02485353|157198943|FG000|Overall Study|Disease Progression|1|||
48824696|NCT02373813|157198944|FG000|Run-In Period|Other, Not Specified|5|||
48732107|NCT02808650|156871249|FG000|Overall Study|Death|0|||
48732108|NCT02808650|156871250|FG001|Overall Study|Death|0|||
48824697|NCT02373813|157198945|FG001|Run-In Period|Other, Not Specified|0|||
48824698|NCT02373813|157198946|FG002|Run-In Period|Other, Not Specified|0|||
49149946|NCT00265122|158389948|FG002|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
48824699|NCT02373813|157198947|FG003|Run-In Period|Other, Not Specified|0|||
48824700|NCT02373813|157198944|FG000|Run-In Period|Withdrawal by Subject|16|||
48824701|NCT02373813|157198945|FG001|Run-In Period|Withdrawal by Subject|0|||
48824702|NCT02373813|157198946|FG002|Run-In Period|Withdrawal by Subject|0|||
48824703|NCT02373813|157198947|FG003|Run-In Period|Withdrawal by Subject|0|||
48824704|NCT02373813|157198944|FG000|Run-In Period|Decision by Sponsor|11|||
48824705|NCT02373813|157198945|FG001|Run-In Period|Decision by Sponsor|0|||
48824706|NCT02373813|157198946|FG002|Run-In Period|Decision by Sponsor|0|||
48824707|NCT02373813|157198947|FG003|Run-In Period|Decision by Sponsor|0|||
48824708|NCT02373813|157198944|FG000|Run-In Period|Protocol Violation|75|||
48824709|NCT02373813|157198945|FG001|Run-In Period|Protocol Violation|0|||
48824710|NCT02373813|157198946|FG002|Run-In Period|Protocol Violation|0|||
48824711|NCT02373813|157198947|FG003|Run-In Period|Protocol Violation|0|||
48824712|NCT02373813|157198944|FG000|Run-In Period|Lost to Follow-up|2|||
48824713|NCT02373813|157198945|FG001|Run-In Period|Lost to Follow-up|0|||
48824714|NCT02373813|157198946|FG002|Run-In Period|Lost to Follow-up|0|||
48824715|NCT02373813|157198947|FG003|Run-In Period|Lost to Follow-up|0|||
49149947|NCT00265122|158389949|FG003|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
49149948|NCT00265122|158389950|FG004|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
49149949|NCT00265122|158389951|FG005|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
48824716|NCT02373813|157198944|FG000|Run-In Period|Adverse Event|3|||
48824717|NCT02373813|157198945|FG001|Run-In Period|Adverse Event|0|||
48824718|NCT02373813|157198946|FG002|Run-In Period|Adverse Event|0|||
48824719|NCT02373813|157198947|FG003|Run-In Period|Adverse Event|0|||
48824720|NCT02373813|157198944|FG000|Run-In Period|Noncompliance|1|||
48824721|NCT02373813|157198945|FG001|Run-In Period|Noncompliance|0|||
48824722|NCT02373813|157198946|FG002|Run-In Period|Noncompliance|0|||
48824723|NCT02373813|157198947|FG003|Run-In Period|Noncompliance|0|||
48824724|NCT02373813|157198944|FG000|Run-In Period|Ineligibility Determined|3|||
48824725|NCT02373813|157198945|FG001|Run-In Period|Ineligibility Determined|0|||
48824726|NCT02373813|157198946|FG002|Run-In Period|Ineligibility Determined|0|||
48824727|NCT02373813|157198947|FG003|Run-In Period|Ineligibility Determined|0|||
48824728|NCT02373813|157198944|FG000|Double-Blind Treatment Period|Decision by Sponsor|0|||
48824729|NCT02373813|157198945|FG001|Double-Blind Treatment Period|Decision by Sponsor|1|||
48824730|NCT02373813|157198946|FG002|Double-Blind Treatment Period|Decision by Sponsor|2|||
48824731|NCT02373813|157198947|FG003|Double-Blind Treatment Period|Decision by Sponsor|0|||
48824732|NCT02373813|157198944|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
48824733|NCT02373813|157198945|FG001|Double-Blind Treatment Period|Protocol Violation|2|||
48824734|NCT02373813|157198946|FG002|Double-Blind Treatment Period|Protocol Violation|0|||
48824735|NCT02373813|157198947|FG003|Double-Blind Treatment Period|Protocol Violation|0|||
48824736|NCT02373813|157198944|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
48824737|NCT02373813|157198945|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
48824738|NCT02373813|157198946|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
48824739|NCT02373813|157198947|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
48824740|NCT02373813|157198944|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
48824741|NCT02373813|157198945|FG001|Double-Blind Treatment Period|Withdrawal by Subject|10|||
48824742|NCT02373813|157198946|FG002|Double-Blind Treatment Period|Withdrawal by Subject|6|||
48824743|NCT02373813|157198947|FG003|Double-Blind Treatment Period|Withdrawal by Subject|3|||
48824744|NCT00826280|157198948|FG000|Overall Study|Randomized but drug not received|1|||
48824745|NCT00826280|157198949|FG001|Overall Study|Randomized but drug not received|0|||
48824746|NCT00826280|157198950|FG002|Overall Study|Randomized but drug not received|1|||
48824747|NCT00826280|157198948|FG000|Overall Study|Adverse Event|1|||
48824748|NCT00826280|157198949|FG001|Overall Study|Adverse Event|3|||
48824749|NCT00826280|157198950|FG002|Overall Study|Adverse Event|0|||
48824750|NCT00826280|157198948|FG000|Overall Study|Lost to Follow-up|0|||
48824751|NCT00826280|157198949|FG001|Overall Study|Lost to Follow-up|1|||
48824752|NCT00826280|157198950|FG002|Overall Study|Lost to Follow-up|0|||
48824753|NCT00826280|157198948|FG000|Overall Study|Sponsor discontinued subject or study|1|||
48824754|NCT00826280|157198949|FG001|Overall Study|Sponsor discontinued subject or study|0|||
48824755|NCT00826280|157198950|FG002|Overall Study|Sponsor discontinued subject or study|0|||
49149950|NCT00265122|158389946|FG000|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
48824756|NCT00826280|157198948|FG000|Overall Study|Reversible ischemic defect not present|43|||
48824757|NCT00826280|157198949|FG001|Overall Study|Reversible ischemic defect not present|40|||
48824758|NCT00826280|157198950|FG002|Overall Study|Reversible ischemic defect not present|44|||
48824759|NCT00826280|157198948|FG000|Overall Study|Interpretation Failure|1|||
48824760|NCT00826280|157198949|FG001|Overall Study|Interpretation Failure|0|||
48824761|NCT00826280|157198950|FG002|Overall Study|Interpretation Failure|0|||
48824762|NCT00826280|157198948|FG000|Overall Study|Machine Failure|1|||
48824763|NCT00826280|157198949|FG001|Overall Study|Machine Failure|1|||
48824764|NCT00826280|157198950|FG002|Overall Study|Machine Failure|0|||
48824765|NCT00826280|157198948|FG000|Overall Study|One or more non-interpretable scan|0|||
48824766|NCT00826280|157198949|FG001|Overall Study|One or more non-interpretable scan|1|||
48824767|NCT00826280|157198950|FG002|Overall Study|One or more non-interpretable scan|1|||
48824768|NCT01511536|157198953|FG000|Phase 1|Other|0|||
48824769|NCT01511536|157198954|FG001|Phase 1|Other|1|||
48824770|NCT01511536|157198955|FG002|Phase 1|Other|0|||
48824771|NCT01511536|157198953|FG000|Phase 2|Other|0|||
48824772|NCT01511536|157198954|FG001|Phase 2|Other|0|||
48824773|NCT01511536|157198955|FG002|Phase 2|Other|9|||
48824774|NCT02703532|157198956|FG000|Overall Study|Withdrawal by Subject|0|||
48824775|NCT02703532|157198957|FG001|Overall Study|Withdrawal by Subject|1|||
48824776|NCT02703532|157198958|FG002|Overall Study|Withdrawal by Subject|0|||
48824777|NCT02703532|157198959|FG003|Overall Study|Withdrawal by Subject|1|||
48824778|NCT02703532|157198956|FG000|Overall Study|Lost to Follow-up|2|||
48824779|NCT02703532|157198957|FG001|Overall Study|Lost to Follow-up|0|||
48824780|NCT02703532|157198958|FG002|Overall Study|Lost to Follow-up|2|||
48824781|NCT02703532|157198959|FG003|Overall Study|Lost to Follow-up|0|||
48824782|NCT03239210|157198972|FG000|Overall Study|Lost to Follow-up|2|||
48824783|NCT03239210|157198973|FG001|Overall Study|Lost to Follow-up|2|||
48824784|NCT03239210|157198972|FG000|Overall Study|Withdrawal by subject (personal reasons)|2|||
48824785|NCT03239210|157198973|FG001|Overall Study|Withdrawal by subject (personal reasons)|2|||
48824786|NCT03239210|157198972|FG000|Overall Study|Withdrawal by subject (reported medical side effects)|2|||
48824787|NCT03239210|157198973|FG001|Overall Study|Withdrawal by subject (reported medical side effects)|1|||
48824788|NCT02359435|157198978|FG000|Overall Study|Lost to Follow-up|4|||
48824789|NCT02359435|157198979|FG001|Overall Study|Lost to Follow-up|4|||
48824790|NCT02321540|157198984|FG000|Overall Study|Death|0|||
48824791|NCT02321540|157198985|FG001|Overall Study|Death|1|||
49149951|NCT00265122|158389947|FG001|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
48824792|NCT02321540|157198984|FG000|Overall Study|Progression|3|||
48824793|NCT02321540|157198985|FG001|Overall Study|Progression|9|||
48824794|NCT00051311|157198986|FG000|Overall Study|Starting new study|0|||
48824795|NCT00051311|157198987|FG001|Overall Study|Starting new study|1|||
48824796|NCT00051311|157198986|FG000|Overall Study|Pt. to pursue treatment for progressive disease|0|||
48824797|NCT00051311|157198987|FG001|Overall Study|Pt. to pursue treatment for progressive disease|1|||
48824798|NCT00051311|157198986|FG000|Overall Study|Death of recipient|8|||
49149952|NCT00265122|158389948|FG002|Intervention Period 1 (Weeks 0 to 8):|Other|2|||
48824799|NCT00051311|157198987|FG001|Overall Study|Death of recipient|8|||
48824800|NCT00051311|157198986|FG000|Overall Study|Recipient taken off study|4|||
48824801|NCT00051311|157198987|FG001|Overall Study|Recipient taken off study|4|||
48824802|NCT03532178|157198994|FG000|First Period|Withdrawal by Subject|1|||
48824803|NCT03532178|157198995|FG001|First Period|Withdrawal by Subject|3|||
48824804|NCT03532178|157198994|FG000|First Period|technical issues in data collection Technical issues|0|||
48824805|NCT03532178|157198995|FG001|First Period|technical issues in data collection Technical issues|1|||
48824806|NCT03532178|157198994|FG000|Second Period|Withdrawal by Subject|1|||
48824807|NCT03532178|157198995|FG001|Second Period|Withdrawal by Subject|1|||
48824808|NCT03532178|157198994|FG000|Second Period|Technical issues|0|||
48824809|NCT03532178|157198995|FG001|Second Period|Technical issues|1|||
48824810|NCT05349084|157198996|FG000|Overall Study|Radiotracer production failed. Patient received an intervention so did not qualify to come back.|1|||
48824811|NCT05124899|157198997|FG000|Overall Study|Lost to Follow-up|3|||
48824812|NCT03633903|157198998|FG000|Overall Study|Withdrawal by Subject|1|||
48824813|NCT03633903|157198999|FG001|Overall Study|Withdrawal by Subject|2|||
49149953|NCT00265122|158389949|FG003|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
49149954|NCT00265122|158389950|FG004|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
49149955|NCT00265122|158389951|FG005|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
49149956|NCT00265122|158389946|FG000|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2|||
49149957|NCT00265122|158389947|FG001|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
49149958|NCT00265122|158389948|FG002|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
49149959|NCT00265122|158389949|FG003|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
49149960|NCT00265122|158389950|FG004|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
49149961|NCT00265122|158389951|FG005|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0|||
49149962|NCT00265122|158389946|FG000|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
49149963|NCT00265122|158389947|FG001|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
49149964|NCT00265122|158389948|FG002|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
48824814|NCT03633903|157198998|FG000|Overall Study|Lost to Follow-up|5|||
48824815|NCT03633903|157198999|FG001|Overall Study|Lost to Follow-up|5|||
48824816|NCT00087490|157199000|FG000|Overall Study|Death|6|||
49149965|NCT00265122|158389949|FG003|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
49149966|NCT00265122|158389950|FG004|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
48824817|NCT00087490|157199001|FG001|Overall Study|Death|4|||
48824818|NCT00087490|157199000|FG000|Overall Study|Adverse Event|3|||
48824819|NCT00087490|157199001|FG001|Overall Study|Adverse Event|8|||
48824820|NCT00087490|157199000|FG000|Overall Study|Lack of Efficacy|0|||
48824821|NCT00087490|157199001|FG001|Overall Study|Lack of Efficacy|2|||
48824822|NCT00087490|157199000|FG000|Overall Study|Protocol Violation or (/) Unspecified|214|||
48824823|NCT00087490|157199001|FG001|Overall Study|Protocol Violation or (/) Unspecified|201|||
48824824|NCT00087490|157199000|FG000|Overall Study|Lost to Follow-Up/participant withdrawal|28|||
48921529|NCT02109484|157546405|FG001|Overall Study|Physician Decision|0|||
48732109|NCT02808650|156871251|FG002|Overall Study|Death|0|||
48824825|NCT00087490|157199001|FG001|Overall Study|Lost to Follow-Up/participant withdrawal|36|||
48732110|NCT02808650|156871252|FG003|Overall Study|Death|0|||
48732111|NCT02808650|156871253|FG004|Overall Study|Death|1|||
48732112|NCT02808650|156871249|FG000|Overall Study|Lack of Efficacy|5|||
48732113|NCT02808650|156871250|FG001|Overall Study|Lack of Efficacy|5|||
48732114|NCT02808650|156871251|FG002|Overall Study|Lack of Efficacy|6|||
48732115|NCT02808650|156871252|FG003|Overall Study|Lack of Efficacy|5|||
48732116|NCT02808650|156871253|FG004|Overall Study|Lack of Efficacy|4|||
48732117|NCT02808650|156871249|FG000|Overall Study|Physician Decision|1|||
48732118|NCT02808650|156871250|FG001|Overall Study|Physician Decision|1|||
48732119|NCT02808650|156871251|FG002|Overall Study|Physician Decision|0|||
48732120|NCT02808650|156871252|FG003|Overall Study|Physician Decision|0|||
48732121|NCT02808650|156871253|FG004|Overall Study|Physician Decision|0|||
48732122|NCT02808650|156871249|FG000|Overall Study|Withdrawal by Subject|0|||
48732123|NCT02808650|156871250|FG001|Overall Study|Withdrawal by Subject|0|||
48824826|NCT00087490|157199000|FG000|Overall Study|Randomized but not treated|7|||
48824827|NCT00087490|157199001|FG001|Overall Study|Randomized but not treated|18|||
48824828|NCT03382821|157199009|FG000|Overall Study|Did not receive allocated intervention.|0|||
48824829|NCT03382821|157199010|FG001|Overall Study|Did not receive allocated intervention.|3|||
48824830|NCT01141660|157199013|FG000|Overall Study|Physician Decision|0|||
48824831|NCT01141660|157199014|FG001|Overall Study|Physician Decision|12|||
48824832|NCT02775435|157199017|FG000|Overall Study|Adverse Event|32|||
48824833|NCT02775435|157199018|FG001|Overall Study|Adverse Event|27|||
48824834|NCT02775435|157199017|FG000|Overall Study|Lost to Follow-up|2|||
48824835|NCT02775435|157199018|FG001|Overall Study|Lost to Follow-up|2|||
48824836|NCT02775435|157199017|FG000|Overall Study|Sponsor decision|44|||
48824837|NCT02775435|157199018|FG001|Overall Study|Sponsor decision|19|||
48824838|NCT02775435|157199017|FG000|Overall Study|Withdrawal by Subject|4|||
48824839|NCT02775435|157199018|FG001|Overall Study|Withdrawal by Subject|9|||
48824840|NCT02775435|157199017|FG000|Overall Study|Death|196|||
48824841|NCT02775435|157199018|FG001|Overall Study|Death|224|||
48824842|NCT00052962|157199019|FG000|Overall Study|Not evaluable|0|||
48824843|NCT00052962|157199020|FG001|Overall Study|Not evaluable|2|||
48824844|NCT00052962|157199019|FG000|Overall Study|Not randomized/not evaluable|1|||
48824845|NCT00052962|157199020|FG001|Overall Study|Not randomized/not evaluable|0|||
48824846|NCT02099539|157199023|FG000|Overall Study|Progressive Disease|3|||
48824847|NCT02099539|157199024|FG001|Overall Study|Progressive Disease|2|||
48824848|NCT02099539|157199025|FG002|Overall Study|Progressive Disease|2|||
48824849|NCT02099539|157199026|FG003|Overall Study|Progressive Disease|1|||
48824850|NCT02099539|157199027|FG004|Overall Study|Progressive Disease|4|||
48824851|NCT02099539|157199028|FG005|Overall Study|Progressive Disease|2|||
48824852|NCT02099539|157199029|FG006|Overall Study|Progressive Disease|0|||
48824853|NCT02099539|157199023|FG000|Overall Study|Adverse Event|0|||
48824854|NCT02099539|157199024|FG001|Overall Study|Adverse Event|0|||
48824855|NCT02099539|157199025|FG002|Overall Study|Adverse Event|1|||
48824856|NCT02099539|157199026|FG003|Overall Study|Adverse Event|1|||
48824857|NCT02099539|157199027|FG004|Overall Study|Adverse Event|0|||
48824858|NCT02099539|157199028|FG005|Overall Study|Adverse Event|0|||
48824859|NCT02099539|157199029|FG006|Overall Study|Adverse Event|0|||
48824860|NCT02099539|157199023|FG000|Overall Study|Physician Decision|0|||
48824861|NCT02099539|157199024|FG001|Overall Study|Physician Decision|0|||
48824862|NCT02099539|157199025|FG002|Overall Study|Physician Decision|0|||
48824863|NCT02099539|157199026|FG003|Overall Study|Physician Decision|0|||
48824864|NCT02099539|157199027|FG004|Overall Study|Physician Decision|0|||
48824865|NCT02099539|157199028|FG005|Overall Study|Physician Decision|1|||
48824866|NCT02099539|157199029|FG006|Overall Study|Physician Decision|0|||
48824867|NCT04863898|157199031|FG000|Overall Study|Away from study clinic during intervention training period|2|||
48824868|NCT04863898|157199031|FG000|Overall Study|Preferred not to answer on endline survey why they did not participate in the training|1|||
48824869|NCT04863898|157199031|FG000|Overall Study|Lost to Follow-up|3|||
49149967|NCT00265122|158389951|FG005|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
49149968|NCT00265122|158389946|FG000|Intervention Period 2 (Weeks 8 to 28):|Other|4|||
48824870|NCT04863898|157199031|FG000|Overall Study|Self reported at endline that they had not received information about the training|1|||
48824871|NCT04863898|157199031|FG000|Overall Study|No longer employed at clinic|3|||
48824872|NCT00614744|157199032|FG000|Overall Study|Lost to Follow-up|5|||
48824873|NCT00614744|157199033|FG001|Overall Study|Lost to Follow-up|4|||
48824874|NCT00614744|157199032|FG000|Overall Study|Incomplete for Behavior Issues|0|||
48824875|NCT00614744|157199033|FG001|Overall Study|Incomplete for Behavior Issues|2|||
48824876|NCT00770211|157199041|FG000|Overall Study|Lost to Follow-up|1|||
48824877|NCT00770211|157199042|FG001|Overall Study|Lost to Follow-up|0|||
48824878|NCT00770211|157199041|FG000|Overall Study|Withdrawal by Subject|0|||
48824879|NCT00770211|157199042|FG001|Overall Study|Withdrawal by Subject|2|||
48732124|NCT02808650|156871251|FG002|Overall Study|Withdrawal by Subject|0|||
48824880|NCT03005288|157199049|FG000|Overall Study|Withdrawal by Subject|7|||
48824881|NCT03005288|157199050|FG001|Overall Study|Withdrawal by Subject|5|||
48824882|NCT03005288|157199049|FG000|Overall Study|Lost to Follow-up|0|||
49149969|NCT00265122|158389947|FG001|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
48732125|NCT02808650|156871252|FG003|Overall Study|Withdrawal by Subject|1|||
48732126|NCT02808650|156871253|FG004|Overall Study|Withdrawal by Subject|1|||
48732127|NCT03799211|156871256|FG000|Overall Study|Lost to Follow-up|2|||
48732128|NCT03799211|156871257|FG001|Overall Study|Lost to Follow-up|13|||
49149970|NCT00265122|158389948|FG002|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
49149971|NCT00265122|158389949|FG003|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
49149972|NCT00265122|158389950|FG004|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
49149973|NCT00265122|158389951|FG005|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
48732129|NCT03799211|156871256|FG000|Overall Study|Withdrawal by Subject|2|||
48732130|NCT03799211|156871257|FG001|Overall Study|Withdrawal by Subject|0|||
48732131|NCT01069627|156871259|FG000|Overall Study|Disease progression|7|||
48824883|NCT03005288|157199050|FG001|Overall Study|Lost to Follow-up|1|||
48732132|NCT01069627|156871259|FG000|Overall Study|Adverse Event|12|||
48732133|NCT01069627|156871259|FG000|Overall Study|Protocol Violation|1|||
48732134|NCT04209348|156871260|FG000|Overall Study|Lost to Follow-up|1|||
48732135|NCT04209348|156871261|FG001|Overall Study|Lost to Follow-up|0|||
48732136|NCT03139279|156871262|FG000|Overall Study|Physician Decision|2|||
48732137|NCT03139279|156871263|FG001|Overall Study|Physician Decision|0|||
48732138|NCT03139279|156871262|FG000|Overall Study|Protocol Violation|5|||
48732139|NCT03139279|156871263|FG001|Overall Study|Protocol Violation|4|||
48732140|NCT03139279|156871262|FG000|Overall Study|Withdrawal by Subject|0|||
48732141|NCT03139279|156871263|FG001|Overall Study|Withdrawal by Subject|2|||
48732142|NCT05394350|156871264|FG000|Overall Study|Death|2|||
48732143|NCT05394350|156871265|FG001|Overall Study|Death|2|||
48732144|NCT05394350|156871266|FG002|Overall Study|Death|4|||
48732145|NCT05394350|156871267|FG003|Overall Study|Death|0|||
48732146|NCT05394350|156871268|FG004|Overall Study|Death|1|||
48732147|NCT05394350|156871269|FG005|Overall Study|Death|0|||
49149974|NCT02251041|158389953|FG000|Overall Study|Did not receive intervention|15|||
48732148|NCT05394350|156871264|FG000|Overall Study|Study terminated by sponsor|1|||
48732149|NCT05394350|156871265|FG001|Overall Study|Study terminated by sponsor|1|||
48732150|NCT05394350|156871266|FG002|Overall Study|Study terminated by sponsor|7|||
48732151|NCT05394350|156871267|FG003|Overall Study|Study terminated by sponsor|3|||
48824884|NCT03005288|157199049|FG000|Overall Study|Adverse Event|5|||
48824885|NCT03005288|157199050|FG001|Overall Study|Adverse Event|0|||
48824886|NCT03005288|157199049|FG000|Overall Study|Protocol deviation|0|||
48824887|NCT03005288|157199050|FG001|Overall Study|Protocol deviation|1|||
48824888|NCT03005288|157199049|FG000|Overall Study|Physician Decision|0|||
48824889|NCT03005288|157199050|FG001|Overall Study|Physician Decision|1|||
48824890|NCT03717194|157199053|FG000|Overall Study|Withdrawal by Subject|2|||
48824891|NCT03717194|157199054|FG001|Overall Study|Withdrawal by Subject|4|||
48824892|NCT03717194|157199053|FG000|Overall Study|Adverse Event|1|||
48824893|NCT03717194|157199054|FG001|Overall Study|Adverse Event|1|||
48824894|NCT00689104|157199055|FG000|Overall Study|Eligibility criterion not met|5|||
48824895|NCT00689104|157199056|FG001|Overall Study|Eligibility criterion not met|8|||
48824896|NCT00689104|157199057|FG002|Overall Study|Eligibility criterion not met|0|||
48824897|NCT00689104|157199058|FG003|Overall Study|Eligibility criterion not met|4|||
48824898|NCT00689104|157199055|FG000|Overall Study|Adverse Event|13|||
48824899|NCT00689104|157199056|FG001|Overall Study|Adverse Event|25|||
48824900|NCT00689104|157199057|FG002|Overall Study|Adverse Event|16|||
48732152|NCT05394350|156871268|FG004|Overall Study|Study terminated by sponsor|2|||
48732153|NCT05394350|156871269|FG005|Overall Study|Study terminated by sponsor|4|||
48732154|NCT02963935|156871270|FG000|Overall Study|Adverse Event|12|||
48732155|NCT02963935|156871271|FG001|Overall Study|Adverse Event|6|||
48824901|NCT00689104|157199058|FG003|Overall Study|Adverse Event|24|||
48824902|NCT00689104|157199055|FG000|Overall Study|Lack of Efficacy|5|||
48824903|NCT00689104|157199056|FG001|Overall Study|Lack of Efficacy|6|||
48824904|NCT00689104|157199057|FG002|Overall Study|Lack of Efficacy|2|||
49149975|NCT02251041|158389954|FG001|Overall Study|Did not receive intervention|4|||
48824905|NCT00689104|157199058|FG003|Overall Study|Lack of Efficacy|3|||
48921530|NCT02109484|157546406|FG002|Overall Study|Physician Decision|0|||
49149976|NCT05430919|158389955|FG000|Overall Study|Protocol Violation|0|||
49149977|NCT05430919|158389956|FG001|Overall Study|Protocol Violation|0|||
49149978|NCT05430919|158389957|FG002|Overall Study|Protocol Violation|1|||
49149979|NCT05430919|158389958|FG003|Overall Study|Protocol Violation|0|||
49149980|NCT05430919|158389955|FG000|Overall Study|Lost to Follow-up|0|||
49149981|NCT05430919|158389956|FG001|Overall Study|Lost to Follow-up|1|||
49149982|NCT05430919|158389957|FG002|Overall Study|Lost to Follow-up|0|||
49149983|NCT05430919|158389958|FG003|Overall Study|Lost to Follow-up|0|||
49149984|NCT05430919|158389955|FG000|Overall Study|Withdrawal by Subject|3|||
49149985|NCT05430919|158389956|FG001|Overall Study|Withdrawal by Subject|0|||
49149986|NCT05430919|158389957|FG002|Overall Study|Withdrawal by Subject|0|||
49149987|NCT05430919|158389958|FG003|Overall Study|Withdrawal by Subject|1|||
48732156|NCT02963935|156871270|FG000|Overall Study|Protocol Violation|2|||
48732157|NCT02963935|156871271|FG001|Overall Study|Protocol Violation|1|||
48824906|NCT00689104|157199055|FG000|Overall Study|Withdrawal by Subject|12|||
48824907|NCT00689104|157199056|FG001|Overall Study|Withdrawal by Subject|11|||
48921531|NCT02109484|157546407|FG003|Overall Study|Physician Decision|0|||
49149988|NCT02904096|158389968|FG000|Overall Study|Adverse Event|1|||
49149989|NCT02904096|158389969|FG001|Overall Study|Adverse Event|0|||
49149990|NCT02904096|158389968|FG000|Overall Study|Withdrawal by Subject|4|||
49149991|NCT02904096|158389969|FG001|Overall Study|Withdrawal by Subject|3|||
49149992|NCT02904096|158389968|FG000|Overall Study|Lost to Follow-up|10|||
49149993|NCT02904096|158389969|FG001|Overall Study|Lost to Follow-up|17|||
48732158|NCT02963935|156871270|FG000|Overall Study|Lack of Efficacy|0|||
48732159|NCT02963935|156871271|FG001|Overall Study|Lack of Efficacy|2|||
48732160|NCT02963935|156871270|FG000|Overall Study|Lost to Follow-up|1|||
48732161|NCT02963935|156871271|FG001|Overall Study|Lost to Follow-up|6|||
48732162|NCT02963935|156871270|FG000|Overall Study|Unclassified|13|||
48732163|NCT02963935|156871271|FG001|Overall Study|Unclassified|22|||
48732164|NCT00237185|156871272|FG000|Core|Adverse Event|3|||
48732165|NCT00237185|156871273|FG001|Core|Adverse Event|4|||
48732166|NCT00237185|156871272|FG000|Core|Abnormal laboratory value|0|||
48732167|NCT00237185|156871273|FG001|Core|Abnormal laboratory value|4|||
48732168|NCT00237185|156871272|FG000|Core|Abnormal test procedure results|1|||
48732169|NCT00237185|156871273|FG001|Core|Abnormal test procedure results|0|||
48732170|NCT00237185|156871272|FG000|Core|Lack of Efficacy|30|||
48732171|NCT00237185|156871273|FG001|Core|Lack of Efficacy|23|||
48732172|NCT00237185|156871272|FG000|Core|Protocol Violation|1|||
48732173|NCT00237185|156871273|FG001|Core|Protocol Violation|1|||
49149994|NCT02904096|158389968|FG000|Overall Study|Non-compliant|3|||
49149995|NCT02904096|158389969|FG001|Overall Study|Non-compliant|1|||
49149996|NCT02904096|158389968|FG000|Overall Study|Sponsor instructed|1|||
49149997|NCT02904096|158389969|FG001|Overall Study|Sponsor instructed|0|||
49149998|NCT01422382|158389974|FG000|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1|||
49149999|NCT01514422|158389975|FG000|Overall Study|Lost to Follow-up|1|||
49150000|NCT01813357|158389978|FG000|Overall Study|Lost to Follow-up|5|||
49150001|NCT01813357|158389979|FG001|Overall Study|Lost to Follow-up|6|||
49150002|NCT03773562|158389980|FG000|Overall Study|Did not have 6-25 migraine days during run-in|10|||
49150003|NCT03773562|158389980|FG000|Overall Study|Lost to Follow-up|10|||
49150004|NCT03773562|158389980|FG000|Overall Study|Withdrawal by Subject|1|||
49150005|NCT03378635|158389986|FG000|Overall Study|Adverse Event|1|||
49150006|NCT03378635|158389987|FG001|Overall Study|Adverse Event|0|||
49150007|NCT03378635|158389988|FG002|Overall Study|Adverse Event|0|||
49150008|NCT03378635|158389986|FG000|Overall Study|Withdrawal by Subject|1|||
49150009|NCT03378635|158389987|FG001|Overall Study|Withdrawal by Subject|0|||
49150010|NCT03378635|158389988|FG002|Overall Study|Withdrawal by Subject|0|||
49150011|NCT00773461|158389989|FG000|Overall Study|Adverse Event|1|||
49150012|NCT00773461|158389990|FG001|Overall Study|Adverse Event|3|||
49150013|NCT00773461|158389989|FG000|Overall Study|Withdrawal by Subject|4|||
48732174|NCT00237185|156871272|FG000|Core|Withdrawal by Subject|4|||
48732175|NCT00237185|156871273|FG001|Core|Withdrawal by Subject|4|||
48732176|NCT00237185|156871272|FG000|Core|Administrative problems|0|||
48732177|NCT00237185|156871273|FG001|Core|Administrative problems|1|||
48732178|NCT00237185|156871272|FG000|Core|Death|4|||
48732179|NCT00237185|156871273|FG001|Core|Death|0|||
48732180|NCT00237185|156871272|FG000|Core|Determined ineligible post randomization|1|||
48732181|NCT00237185|156871273|FG001|Core|Determined ineligible post randomization|0|||
48732182|NCT00237185|156871272|FG000|Extension|Adverse Event|1|||
48732183|NCT00237185|156871273|FG001|Extension|Adverse Event|0|||
48732184|NCT00237185|156871272|FG000|Extension|Abnormal laboratory value|0|||
48732185|NCT00237185|156871273|FG001|Extension|Abnormal laboratory value|1|||
48732186|NCT00237185|156871272|FG000|Extension|Lack of Efficacy|9|||
48732187|NCT00237185|156871273|FG001|Extension|Lack of Efficacy|14|||
48732188|NCT00237185|156871272|FG000|Extension|Condition no longer required study drug|0|||
48732189|NCT00237185|156871273|FG001|Extension|Condition no longer required study drug|1|||
48732190|NCT00237185|156871272|FG000|Extension|Withdrawal by Subject|3|||
48732191|NCT00237185|156871273|FG001|Extension|Withdrawal by Subject|2|||
48732192|NCT00237185|156871272|FG000|Extension|Lost to Follow-up|1|||
48732193|NCT00237185|156871273|FG001|Extension|Lost to Follow-up|0|||
48732194|NCT00237185|156871272|FG000|Extension|Administrative problems|1|||
48732195|NCT00237185|156871273|FG001|Extension|Administrative problems|0|||
48732196|NCT00237185|156871272|FG000|Extension|Death|1|||
48732197|NCT00237185|156871273|FG001|Extension|Death|1|||
48732198|NCT02322021|156871274|FG000|Core Phase|Adverse Event|1|||
48732199|NCT02322021|156871275|FG001|Core Phase|Adverse Event|3|||
48732200|NCT02322021|156871276|FG002|Core Phase|Adverse Event|4|||
48732201|NCT02322021|156871277|FG003|Core Phase|Adverse Event|2|||
48732202|NCT02322021|156871278|FG004|Core Phase|Adverse Event|0|||
48732203|NCT02322021|156871274|FG000|Core Phase|Participant Choice|4|||
48732204|NCT02322021|156871275|FG001|Core Phase|Participant Choice|5|||
48732205|NCT02322021|156871276|FG002|Core Phase|Participant Choice|4|||
48732206|NCT02322021|156871277|FG003|Core Phase|Participant Choice|2|||
48732207|NCT02322021|156871278|FG004|Core Phase|Participant Choice|0|||
48732208|NCT02322021|156871274|FG000|Core Phase|Lost to Follow-up|0|||
48732209|NCT02322021|156871275|FG001|Core Phase|Lost to Follow-up|0|||
48732210|NCT02322021|156871276|FG002|Core Phase|Lost to Follow-up|0|||
48732211|NCT02322021|156871277|FG003|Core Phase|Lost to Follow-up|1|||
48732212|NCT02322021|156871278|FG004|Core Phase|Lost to Follow-up|0|||
48732213|NCT02322021|156871274|FG000|Core Phase|Other|0|||
48732214|NCT02322021|156871275|FG001|Core Phase|Other|0|||
48732215|NCT02322021|156871276|FG002|Core Phase|Other|1|||
48732216|NCT02322021|156871277|FG003|Core Phase|Other|0|||
48732217|NCT02322021|156871278|FG004|Core Phase|Other|0|||
48732218|NCT02322021|156871274|FG000|Extension Phase|Adverse Event|0|||
48732219|NCT02322021|156871275|FG001|Extension Phase|Adverse Event|0|||
48732220|NCT02322021|156871276|FG002|Extension Phase|Adverse Event|0|||
48732221|NCT02322021|156871277|FG003|Extension Phase|Adverse Event|0|||
48732222|NCT02322021|156871278|FG004|Extension Phase|Adverse Event|3|||
49150014|NCT00773461|158389990|FG001|Overall Study|Withdrawal by Subject|1|||
49150015|NCT01308788|158389991|FG000|2-year Treatment|medication change by treating physician|4|||
48732223|NCT02322021|156871274|FG000|Extension Phase|Participant Choice|0|||
48732224|NCT02322021|156871275|FG001|Extension Phase|Participant Choice|0|||
48732225|NCT02322021|156871276|FG002|Extension Phase|Participant Choice|0|||
48732226|NCT02322021|156871277|FG003|Extension Phase|Participant Choice|0|||
49150016|NCT01308788|158389992|FG001|2-year Treatment|medication change by treating physician|11|||
49150017|NCT04976855|158389999|FG000|Part I|Withdrawal by Subject|0|||
49150018|NCT04976855|158390000|FG001|Part I|Withdrawal by Subject|1|||
49150019|NCT04976855|158390001|FG002|Part I|Withdrawal by Subject|0|||
49150020|NCT04976855|158390002|FG003|Part I|Withdrawal by Subject|0|||
49150021|NCT04976855|158390003|FG004|Part I|Withdrawal by Subject|0|||
49150022|NCT04976855|158390004|FG005|Part I|Withdrawal by Subject|0|||
49150023|NCT04976855|158390005|FG006|Part I|Withdrawal by Subject|0|||
49150024|NCT04976855|158389999|FG000|Part II|Adverse Event|0|||
49150025|NCT04976855|158390000|FG001|Part II|Adverse Event|0|||
49150026|NCT04976855|158390001|FG002|Part II|Adverse Event|0|||
49150027|NCT04976855|158390002|FG003|Part II|Adverse Event|1|||
49150028|NCT04976855|158390003|FG004|Part II|Adverse Event|0|||
49150029|NCT04976855|158390004|FG005|Part II|Adverse Event|0|||
49150030|NCT04976855|158390005|FG006|Part II|Adverse Event|0|||
49150031|NCT04976855|158389999|FG000|Part II|Withdrawal by Subject|0|||
49150032|NCT04976855|158390000|FG001|Part II|Withdrawal by Subject|0|||
49150033|NCT04976855|158390001|FG002|Part II|Withdrawal by Subject|0|||
49150034|NCT04976855|158390002|FG003|Part II|Withdrawal by Subject|0|||
49150035|NCT04976855|158390003|FG004|Part II|Withdrawal by Subject|1|||
49150036|NCT04976855|158390004|FG005|Part II|Withdrawal by Subject|0|||
49150037|NCT04976855|158390005|FG006|Part II|Withdrawal by Subject|0|||
49150038|NCT04976855|158389999|FG000|Part II|Lost to Follow-up|0|||
49150039|NCT04976855|158390000|FG001|Part II|Lost to Follow-up|0|||
49150040|NCT04976855|158390001|FG002|Part II|Lost to Follow-up|0|||
49150041|NCT04976855|158390002|FG003|Part II|Lost to Follow-up|0|||
49150042|NCT04976855|158390003|FG004|Part II|Lost to Follow-up|0|||
49150043|NCT04976855|158390004|FG005|Part II|Lost to Follow-up|1|||
49150044|NCT04976855|158390005|FG006|Part II|Lost to Follow-up|0|||
49150045|NCT02457793|158390006|FG000|Overall Study|Reason not specified|0|||
49150046|NCT02457793|158390007|FG001|Overall Study|Reason not specified|0|||
49150047|NCT02457793|158390008|FG002|Overall Study|Reason not specified|0|||
49150048|NCT02457793|158390009|FG003|Overall Study|Reason not specified|1|||
49150049|NCT02457793|158390010|FG004|Overall Study|Reason not specified|1|||
49150050|NCT02457793|158390011|FG005|Overall Study|Reason not specified|1|||
49150051|NCT02457793|158390006|FG000|Overall Study|Withdrawal by Subject|0|||
49150052|NCT02457793|158390007|FG001|Overall Study|Withdrawal by Subject|4|||
49150053|NCT02457793|158390008|FG002|Overall Study|Withdrawal by Subject|2|||
49150054|NCT02457793|158390009|FG003|Overall Study|Withdrawal by Subject|2|||
49150055|NCT02457793|158390010|FG004|Overall Study|Withdrawal by Subject|2|||
49150056|NCT02457793|158390011|FG005|Overall Study|Withdrawal by Subject|2|||
48732227|NCT02322021|156871278|FG004|Extension Phase|Participant Choice|6|||
48732228|NCT02322021|156871274|FG000|Extension Phase|Other|0|||
48732229|NCT02322021|156871275|FG001|Extension Phase|Other|0|||
48732230|NCT02322021|156871276|FG002|Extension Phase|Other|0|||
48732231|NCT02322021|156871277|FG003|Extension Phase|Other|0|||
48732232|NCT02322021|156871278|FG004|Extension Phase|Other|3|||
48732233|NCT02322021|156871274|FG000|Extension Phase|Lost to Follow-up|0|||
49150057|NCT02457793|158390006|FG000|Overall Study|Adverse Event|0|||
49150058|NCT02457793|158390007|FG001|Overall Study|Adverse Event|0|||
49150059|NCT02457793|158390008|FG002|Overall Study|Adverse Event|0|||
49150060|NCT02457793|158390009|FG003|Overall Study|Adverse Event|1|||
49150061|NCT02457793|158390010|FG004|Overall Study|Adverse Event|0|||
49150062|NCT02457793|158390011|FG005|Overall Study|Adverse Event|0|||
49150063|NCT02457793|158390006|FG000|Overall Study|Physician Decision|1|||
49150064|NCT02457793|158390007|FG001|Overall Study|Physician Decision|0|||
49150065|NCT02457793|158390008|FG002|Overall Study|Physician Decision|1|||
49150066|NCT02457793|158390009|FG003|Overall Study|Physician Decision|1|||
49150067|NCT02457793|158390010|FG004|Overall Study|Physician Decision|1|||
49150068|NCT02457793|158390011|FG005|Overall Study|Physician Decision|3|||
49150069|NCT02757768|158390012|FG000|Overall Study|Randomized Never Received Study Drug|3|||
49150070|NCT02757768|158390013|FG001|Overall Study|Randomized Never Received Study Drug|4|||
49150071|NCT02757768|158390012|FG000|Overall Study|Adverse Event|5|||
49150072|NCT02757768|158390013|FG001|Overall Study|Adverse Event|3|||
49150073|NCT02757768|158390012|FG000|Overall Study|Lack of Efficacy|2|||
49150074|NCT02757768|158390013|FG001|Overall Study|Lack of Efficacy|1|||
49150075|NCT02757768|158390012|FG000|Overall Study|Lost to Follow-up|1|||
49150076|NCT02757768|158390013|FG001|Overall Study|Lost to Follow-up|0|||
49150077|NCT02757768|158390012|FG000|Overall Study|Protocol Deviation|2|||
49150078|NCT02757768|158390013|FG001|Overall Study|Protocol Deviation|9|||
49150079|NCT02757768|158390012|FG000|Overall Study|Withdrawal by Subject|16|||
49150080|NCT02757768|158390013|FG001|Overall Study|Withdrawal by Subject|9|||
49150081|NCT02757768|158390012|FG000|Overall Study|Miscellaneous|4|||
49150082|NCT02757768|158390013|FG001|Overall Study|Miscellaneous|2|||
49150083|NCT01557244|158391326|FG000|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
49150084|NCT01557244|158391327|FG001|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
49150085|NCT01557244|158391328|FG002|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
49150086|NCT01557244|158391329|FG003|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
49150087|NCT01557244|158391330|FG004|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
49150088|NCT01557244|158391331|FG005|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
49150089|NCT01557244|158391332|FG006|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
49150090|NCT01557244|158391326|FG000|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2|||
49150091|NCT01557244|158391327|FG001|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
49150092|NCT01557244|158391328|FG002|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1|||
49150093|NCT01557244|158391329|FG003|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
49150094|NCT01557244|158391330|FG004|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
49150095|NCT01557244|158391331|FG005|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
49150096|NCT01557244|158391332|FG006|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
49150097|NCT01557244|158391326|FG000|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1|||
49150098|NCT01557244|158391327|FG001|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
49150099|NCT01557244|158391328|FG002|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
49150100|NCT01557244|158391329|FG003|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
49150101|NCT01557244|158391330|FG004|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
49150102|NCT01557244|158391331|FG005|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
49150103|NCT01557244|158391332|FG006|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
49150104|NCT01557244|158391326|FG000|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2|||
49150105|NCT01557244|158391327|FG001|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
49150106|NCT01557244|158391328|FG002|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
49150107|NCT01557244|158391329|FG003|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
49150108|NCT01557244|158391330|FG004|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
49150109|NCT01557244|158391331|FG005|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3|||
49150110|NCT01557244|158391332|FG006|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
49150111|NCT01557244|158391326|FG000|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
49150112|NCT01557244|158391327|FG001|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1|||
49150113|NCT01557244|158391328|FG002|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
49150114|NCT01557244|158391329|FG003|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
49150115|NCT01557244|158391330|FG004|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
49150116|NCT01557244|158391331|FG005|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
49150117|NCT01557244|158391332|FG006|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
49150118|NCT01557244|158391326|FG000|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
49150119|NCT01557244|158391327|FG001|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
49150120|NCT01557244|158391328|FG002|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
49150121|NCT01557244|158391329|FG003|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
49150122|NCT01557244|158391330|FG004|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
49150123|NCT01557244|158391331|FG005|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
49150124|NCT01557244|158391332|FG006|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
49150125|NCT01557244|158391326|FG000|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
48824908|NCT00689104|157199057|FG002|Overall Study|Withdrawal by Subject|18|||
48824909|NCT00689104|157199058|FG003|Overall Study|Withdrawal by Subject|11|||
48824910|NCT00689104|157199055|FG000|Overall Study|Lost to Follow-up|4|||
49150126|NCT01557244|158391327|FG001|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
49150127|NCT01557244|158391328|FG002|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
49150128|NCT01557244|158391329|FG003|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
49150129|NCT01557244|158391330|FG004|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
49150130|NCT01557244|158391331|FG005|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
49150131|NCT01557244|158391332|FG006|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
49150132|NCT01557244|158391326|FG000|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
49150133|NCT01557244|158391327|FG001|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
49150134|NCT01557244|158391328|FG002|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
49150135|NCT01557244|158391329|FG003|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
49150136|NCT01557244|158391330|FG004|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
49150137|NCT01557244|158391331|FG005|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
49150138|NCT01557244|158391332|FG006|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
49150139|NCT01557244|158391326|FG000|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
49150140|NCT01557244|158391327|FG001|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
49150141|NCT01557244|158391328|FG002|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
49150142|NCT01557244|158391329|FG003|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
49150143|NCT01557244|158391330|FG004|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
49150144|NCT01557244|158391331|FG005|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
49150145|NCT01557244|158391332|FG006|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
49150146|NCT01557244|158391326|FG000|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
49150147|NCT01557244|158391327|FG001|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
49150148|NCT01557244|158391328|FG002|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
49150149|NCT01557244|158391329|FG003|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
49150150|NCT01557244|158391330|FG004|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
49150151|NCT01557244|158391331|FG005|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
49150152|NCT01557244|158391332|FG006|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
49150153|NCT01557244|158391326|FG000|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
49150154|NCT01557244|158391327|FG001|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
49150155|NCT01557244|158391328|FG002|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
49150156|NCT01557244|158391329|FG003|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1|||
49150157|NCT01557244|158391330|FG004|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
49150158|NCT01557244|158391331|FG005|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
49150159|NCT01557244|158391332|FG006|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
49150160|NCT01557244|158391326|FG000|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1|||
49150161|NCT01557244|158391327|FG001|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2|||
49150162|NCT01557244|158391328|FG002|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
49150163|NCT01557244|158391329|FG003|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
49150164|NCT01557244|158391330|FG004|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
49150165|NCT01557244|158391331|FG005|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
49150166|NCT01557244|158391332|FG006|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
49150167|NCT02457546|158391333|FG000|Overall Study|Other reasons|4|||
49150168|NCT02457546|158391334|FG001|Overall Study|Other reasons|1|||
49150169|NCT02457546|158391333|FG000|Overall Study|Refused to complete study/procedures|1|||
49150170|NCT02457546|158391334|FG001|Overall Study|Refused to complete study/procedures|1|||
49150171|NCT02457546|158391333|FG000|Overall Study|Lost to Follow-up|4|||
49150172|NCT02457546|158391334|FG001|Overall Study|Lost to Follow-up|1|||
49150173|NCT02457546|158391333|FG000|Overall Study|Adverse Event|0|||
49150174|NCT02457546|158391334|FG001|Overall Study|Adverse Event|1|||
49150175|NCT05069415|158391335|FG000|Overall Study|Withdrawal by Subject|2|||
49150176|NCT05069415|158391336|FG001|Overall Study|Withdrawal by Subject|0|||
49150177|NCT05069415|158391335|FG000|Overall Study|Adverse Event|2|||
49150178|NCT05069415|158391336|FG001|Overall Study|Adverse Event|0|||
49150179|NCT02144337|158391337|FG000|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
49150180|NCT02144337|158391338|FG001|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
49150181|NCT02144337|158391337|FG000|T2 Follow-up (Post-intervention)|Lost to Follow-up|2|||
49150182|NCT02144337|158391338|FG001|T2 Follow-up (Post-intervention)|Lost to Follow-up|0|||
49150183|NCT02144337|158391337|FG000|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1|||
48824911|NCT00689104|157199056|FG001|Overall Study|Lost to Follow-up|3|||
48824912|NCT00689104|157199057|FG002|Overall Study|Lost to Follow-up|2|||
48824913|NCT00689104|157199058|FG003|Overall Study|Lost to Follow-up|5|||
49150184|NCT02144337|158391338|FG001|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0|||
49150185|NCT02144337|158391337|FG000|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2|||
49150186|NCT02144337|158391338|FG001|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0|||
49150187|NCT02144337|158391337|FG000|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1|||
49150188|NCT02144337|158391338|FG001|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0|||
49150189|NCT00203242|158391341|FG000|Overall Study|Lost to Follow-up|1|||
49150190|NCT03449147|158391343|FG000|52-week Treatment Period|Death|0|||
49150191|NCT03449147|158391344|FG001|52-week Treatment Period|Death|1|||
49150192|NCT03449147|158391345|FG002|52-week Treatment Period|Death|0|||
49150193|NCT03449147|158391343|FG000|52-week Treatment Period|Lost to Follow-up|6|||
49150194|NCT03449147|158391344|FG001|52-week Treatment Period|Lost to Follow-up|2|||
49150195|NCT03449147|158391345|FG002|52-week Treatment Period|Lost to Follow-up|5|||
49150196|NCT03449147|158391343|FG000|52-week Treatment Period|Other|0|||
49150197|NCT03449147|158391344|FG001|52-week Treatment Period|Other|1|||
49150198|NCT03449147|158391345|FG002|52-week Treatment Period|Other|2|||
49150199|NCT03449147|158391343|FG000|52-week Treatment Period|Physician Decision|1|||
49150200|NCT03449147|158391344|FG001|52-week Treatment Period|Physician Decision|0|||
49150201|NCT03449147|158391345|FG002|52-week Treatment Period|Physician Decision|3|||
49150202|NCT03449147|158391343|FG000|52-week Treatment Period|Screen Failure|1|||
49150203|NCT03449147|158391344|FG001|52-week Treatment Period|Screen Failure|2|||
49150204|NCT03449147|158391345|FG002|52-week Treatment Period|Screen Failure|0|||
49150205|NCT03449147|158391343|FG000|52-week Treatment Period|Withdrawal by Subject|46|||
49150206|NCT03449147|158391344|FG001|52-week Treatment Period|Withdrawal by Subject|68|||
49150207|NCT03449147|158391345|FG002|52-week Treatment Period|Withdrawal by Subject|74|||
49150208|NCT03449147|158391343|FG000|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1|||
49150209|NCT03449147|158391344|FG001|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
49150210|NCT03449147|158391345|FG002|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
49150211|NCT03449147|158391343|FG000|12-Week Off-Treatment Durability Period|Other|0|||
49150212|NCT03449147|158391344|FG001|12-Week Off-Treatment Durability Period|Other|1|||
49150213|NCT03449147|158391345|FG002|12-Week Off-Treatment Durability Period|Other|0|||
49150214|NCT00605657|158391346|FG000|Overall Study|Adverse Event|1|||
49150215|NCT00605657|158391346|FG000|Overall Study|Protocol Violation|1|||
49150216|NCT01050218|158391347|FG000|Overall Study|Adverse Event|37|||
49150217|NCT01050218|158391347|FG000|Overall Study|Lack of Efficacy|8|||
49150218|NCT01050218|158391347|FG000|Overall Study|Protocol Violation|3|||
49150219|NCT01050218|158391347|FG000|Overall Study|Withdrawal by Subject|18|||
49150220|NCT01050218|158391347|FG000|Overall Study|Discontinued by sponsor|18|||
49150221|NCT01050218|158391347|FG000|Overall Study|Compliance|2|||
49150222|NCT01050218|158391347|FG000|Overall Study|Failed to return|7|||
49150223|NCT01050218|158391347|FG000|Overall Study|Serious Adverse Event|1|||
49150224|NCT01050218|158391347|FG000|Overall Study|Family emergency|1|||
49150225|NCT01959919|158391348|FG000|Overall Study|Did not meet the eligibility criteria|2|||
49150226|NCT01550965|158391353|FG000|Overall Study|Adverse Event|26|||
49150227|NCT01550965|158391353|FG000|Overall Study|Withdrawal by Subject|10|||
49150228|NCT01550965|158391353|FG000|Overall Study|Lost to Follow-up|2|||
49150229|NCT01550965|158391353|FG000|Overall Study|Lack of Efficacy|59|||
49150230|NCT01550965|158391353|FG000|Overall Study|Other|13|||
49150231|NCT04691115|158391358|FG000|Overall Study|Withdrawal by Subject|0|||
49150232|NCT04691115|158391359|FG001|Overall Study|Withdrawal by Subject|0|||
49150233|NCT04691115|158391360|FG002|Overall Study|Withdrawal by Subject|0|||
49150234|NCT04691115|158391361|FG003|Overall Study|Withdrawal by Subject|0|||
49150235|NCT04691115|158391362|FG004|Overall Study|Withdrawal by Subject|0|||
49150236|NCT04691115|158391363|FG005|Overall Study|Withdrawal by Subject|1|||
49150237|NCT04691115|158391364|FG006|Overall Study|Withdrawal by Subject|0|||
49150238|NCT04691115|158391365|FG007|Overall Study|Withdrawal by Subject|0|||
48921532|NCT02109484|157546408|FG004|Overall Study|Physician Decision|2|||
48921533|NCT02109484|157546409|FG005|Overall Study|Physician Decision|0|||
49150239|NCT04691115|158391366|FG008|Overall Study|Withdrawal by Subject|0|||
49150240|NCT04691115|158391367|FG009|Overall Study|Withdrawal by Subject|0|||
49150241|NCT04691115|158391368|FG010|Overall Study|Withdrawal by Subject|0|||
49150242|NCT04691115|158391369|FG011|Overall Study|Withdrawal by Subject|0|||
49150243|NCT04691115|158391370|FG012|Overall Study|Withdrawal by Subject|0|||
49150244|NCT04691115|158391371|FG013|Overall Study|Withdrawal by Subject|0|||
49150245|NCT06582732|158391372|FG000|Initial Study Period|Adverse Event|0|||
49150246|NCT06582732|158391373|FG001|Initial Study Period|Adverse Event|0|||
49150247|NCT06582732|158391374|FG002|Initial Study Period|Adverse Event|0|||
49150248|NCT06582732|158391375|FG003|Initial Study Period|Adverse Event|2|||
49150249|NCT06582732|158391376|FG004|Initial Study Period|Adverse Event|0|||
49150250|NCT06582732|158391377|FG005|Initial Study Period|Adverse Event|0|||
48732234|NCT02322021|156871275|FG001|Extension Phase|Lost to Follow-up|0|||
48732235|NCT02322021|156871276|FG002|Extension Phase|Lost to Follow-up|0|||
48732236|NCT02322021|156871277|FG003|Extension Phase|Lost to Follow-up|0|||
48732237|NCT02322021|156871278|FG004|Extension Phase|Lost to Follow-up|1|||
48732238|NCT02322021|156871274|FG000|Extension Phase|Study terminated by sponsor|0|||
48732239|NCT02322021|156871275|FG001|Extension Phase|Study terminated by sponsor|0|||
48732240|NCT02322021|156871276|FG002|Extension Phase|Study terminated by sponsor|0|||
48732241|NCT02322021|156871277|FG003|Extension Phase|Study terminated by sponsor|0|||
48732242|NCT02322021|156871278|FG004|Extension Phase|Study terminated by sponsor|28|||
48732243|NCT01385371|156871279|FG000|Overall Study|Adverse Event|54|||
48732244|NCT01385371|156871280|FG001|Overall Study|Adverse Event|19|||
48732245|NCT01385371|156871279|FG000|Overall Study|Lost to Follow-up|16|||
48732246|NCT01385371|156871280|FG001|Overall Study|Lost to Follow-up|16|||
48732247|NCT01385371|156871279|FG000|Overall Study|Withdrawal by Subject|52|||
48732248|NCT01385371|156871280|FG001|Overall Study|Withdrawal by Subject|39|||
48732249|NCT01385371|156871279|FG000|Overall Study|Protocol Violation|25|||
48732250|NCT01385371|156871280|FG001|Overall Study|Protocol Violation|21|||
48732251|NCT01385371|156871279|FG000|Overall Study|Administrative|2|||
48732252|NCT01385371|156871280|FG001|Overall Study|Administrative|2|||
48732253|NCT00828854|156871281|FG000|Overall Study|Disease Progression|17|||
48732254|NCT00828854|156871281|FG000|Overall Study|Adverse Event|9|||
48732255|NCT00828854|156871281|FG000|Overall Study|Reason not Specified|1|||
48732256|NCT00116428|156871282|FG000|Overall Study|Withdrawal by Subject|2|||
48732257|NCT00116428|156871283|FG001|Overall Study|Withdrawal by Subject|5|||
48732258|NCT00116428|156871282|FG000|Overall Study|Did not meet inclusion criteria|1|||
48732259|NCT00116428|156871283|FG001|Overall Study|Did not meet inclusion criteria|0|||
48732260|NCT00386607|156871284|FG000|Core|Adverse Event|40|||
48732261|NCT00386607|156871285|FG001|Core|Adverse Event|0|||
48732262|NCT00386607|156871284|FG000|Core|Abnormal laboratory value(s)|3|||
48732263|NCT00386607|156871285|FG001|Core|Abnormal laboratory value(s)|0|||
48732264|NCT00386607|156871284|FG000|Core|Unsatisfactory therapeutic effect|23|||
48732265|NCT00386607|156871285|FG001|Core|Unsatisfactory therapeutic effect|0|||
48732266|NCT00386607|156871284|FG000|Core|Condition no longer requires study drug|4|||
48732267|NCT00386607|156871285|FG001|Core|Condition no longer requires study drug|0|||
48732268|NCT00386607|156871284|FG000|Core|Patient withdrew consent|15|||
48732269|NCT00386607|156871285|FG001|Core|Patient withdrew consent|0|||
48732270|NCT00386607|156871284|FG000|Core|Lost to Follow-up|23|||
48732271|NCT00386607|156871285|FG001|Core|Lost to Follow-up|0|||
48732272|NCT00386607|156871284|FG000|Core|Administrative problems|1|||
48732273|NCT00386607|156871285|FG001|Core|Administrative problems|0|||
48732274|NCT00386607|156871284|FG000|Core|Protocol Deviation|6|||
48732275|NCT00386607|156871285|FG001|Core|Protocol Deviation|0|||
48732276|NCT00386607|156871284|FG000|Extension|Adverse Event|0|||
48824914|NCT00689104|157199055|FG000|Overall Study|Protocol Violation|2|||
48732277|NCT00386607|156871285|FG001|Extension|Adverse Event|6|||
48732278|NCT00386607|156871284|FG000|Extension|Abnormal laboratory value(s)|0|||
48732279|NCT00386607|156871285|FG001|Extension|Abnormal laboratory value(s)|1|||
48732280|NCT00386607|156871284|FG000|Extension|Administrative problems|0|||
48732281|NCT00386607|156871285|FG001|Extension|Administrative problems|1|||
48732282|NCT00386607|156871284|FG000|Extension|Lost to Follow-up|0|||
48824915|NCT00689104|157199056|FG001|Overall Study|Protocol Violation|3|||
49150251|NCT06582732|158391378|FG006|Initial Study Period|Adverse Event|0|||
49150252|NCT06582732|158391372|FG000|Initial Study Period|Death|1|||
48824916|NCT00689104|157199057|FG002|Overall Study|Protocol Violation|5|||
48824917|NCT00689104|157199058|FG003|Overall Study|Protocol Violation|3|||
48824918|NCT00689104|157199055|FG000|Overall Study|Randomized but never received study drug|2|||
48824919|NCT00689104|157199056|FG001|Overall Study|Randomized but never received study drug|1|||
48824920|NCT00689104|157199057|FG002|Overall Study|Randomized but never received study drug|1|||
48824921|NCT00689104|157199058|FG003|Overall Study|Randomized but never received study drug|0|||
48824922|NCT00689104|157199055|FG000|Overall Study|Physician Decision|1|||
48824923|NCT00689104|157199056|FG001|Overall Study|Physician Decision|0|||
48824924|NCT00689104|157199057|FG002|Overall Study|Physician Decision|0|||
48824925|NCT00689104|157199058|FG003|Overall Study|Physician Decision|0|||
48824926|NCT00689104|157199055|FG000|Overall Study|Non-compliance with study procedures|0|||
48824927|NCT00689104|157199056|FG001|Overall Study|Non-compliance with study procedures|0|||
48824928|NCT00689104|157199057|FG002|Overall Study|Non-compliance with study procedures|1|||
48824929|NCT00689104|157199058|FG003|Overall Study|Non-compliance with study procedures|0|||
48824930|NCT01737268|157199059|FG000|Overall Study|Adverse Event|6|||
48824931|NCT01737268|157199059|FG000|Overall Study|Worsening of Target Disease|2|||
48824932|NCT01737268|157199059|FG000|Overall Study|In consideration of the patient's safety|1|||
48824933|NCT01543685|157199061|FG000|Overall Study|Lack of Efficacy|1|||
48824934|NCT01543685|157199062|FG001|Overall Study|Lack of Efficacy|2|||
48824935|NCT01543685|157199063|FG002|Overall Study|Lack of Efficacy|2|||
48921534|NCT02109484|157546410|FG006|Overall Study|Physician Decision|0|||
49150253|NCT06582732|158391373|FG001|Initial Study Period|Death|0|||
49150254|NCT06582732|158391374|FG002|Initial Study Period|Death|0|||
49150255|NCT06582732|158391375|FG003|Initial Study Period|Death|0|||
49150256|NCT06582732|158391376|FG004|Initial Study Period|Death|1|||
49150257|NCT06582732|158391377|FG005|Initial Study Period|Death|0|||
48732283|NCT00386607|156871285|FG001|Extension|Lost to Follow-up|3|||
48732284|NCT00386607|156871284|FG000|Extension|Patient withdrew consent|0|||
48732285|NCT00386607|156871285|FG001|Extension|Patient withdrew consent|5|||
48732286|NCT00386607|156871284|FG000|Extension|Unsatisfactory therapeutic effect|0|||
48732287|NCT00386607|156871285|FG001|Extension|Unsatisfactory therapeutic effect|1|||
48732288|NCT02001181|156871286|FG000|Overall Study|Adverse Event|0|||
48732289|NCT02001181|156871287|FG001|Overall Study|Adverse Event|2|||
48732290|NCT02001181|156871286|FG000|Overall Study|Lost to Follow-up|1|||
48732291|NCT02001181|156871287|FG001|Overall Study|Lost to Follow-up|0|||
48732292|NCT02001181|156871286|FG000|Overall Study|Withdrawal by Subject|0|||
48732293|NCT02001181|156871287|FG001|Overall Study|Withdrawal by Subject|1|||
48732294|NCT01626495|156871288|FG000|Overall Study|Adverse Event|3|||
48732295|NCT01626495|156871288|FG000|Overall Study|Disease progression|27|||
48732296|NCT01626495|156871288|FG000|Overall Study|Withdrawal by Subject|1|||
48732297|NCT01626495|156871288|FG000|Overall Study|Administrative problem|1|||
48732298|NCT01626495|156871288|FG000|Overall Study|Death|2|||
48732299|NCT01626495|156871288|FG000|Overall Study|Physician Decision|1|||
48732300|NCT01626495|156871288|FG000|Overall Study|New cancer therapy|16|||
48732301|NCT01626495|156871288|FG000|Overall Study|Manufacturing failure|1|||
48732302|NCT01631812|156871291|FG000|Overall Study|Adverse Event|25|||
48732303|NCT01631812|156871291|FG000|Overall Study|Lack of Efficacy|5|||
48732304|NCT01631812|156871291|FG000|Overall Study|Withdrawal by Subject|4|||
48732305|NCT01631812|156871291|FG000|Overall Study|Physician Decision|3|||
48732306|NCT01907100|156871292|FG000|Overall Study|PD based on modified RECIST criteria|31|||
48732307|NCT01907100|156871293|FG001|Overall Study|PD based on modified RECIST criteria|32|||
48732308|NCT01907100|156871294|FG002|Overall Study|PD based on modified RECIST criteria|95|||
48732309|NCT01907100|156871295|FG003|Overall Study|PD based on modified RECIST criteria|92|||
48732310|NCT01907100|156871292|FG000|Overall Study|Withdrawal by Subject|2|||
48732311|NCT01907100|156871293|FG001|Overall Study|Withdrawal by Subject|5|||
48732312|NCT01907100|156871294|FG002|Overall Study|Withdrawal by Subject|10|||
48732313|NCT01907100|156871295|FG003|Overall Study|Withdrawal by Subject|13|||
48732314|NCT01907100|156871292|FG000|Overall Study|Protocol Violation|0|||
48732315|NCT01907100|156871293|FG001|Overall Study|Protocol Violation|0|||
48732316|NCT01907100|156871294|FG002|Overall Study|Protocol Violation|1|||
48732317|NCT01907100|156871295|FG003|Overall Study|Protocol Violation|1|||
48732318|NCT01907100|156871292|FG000|Overall Study|Lost to Follow-up|0|||
48732319|NCT01907100|156871293|FG001|Overall Study|Lost to Follow-up|0|||
48732320|NCT01907100|156871294|FG002|Overall Study|Lost to Follow-up|0|||
48732321|NCT01907100|156871295|FG003|Overall Study|Lost to Follow-up|1|||
48732322|NCT01907100|156871292|FG000|Overall Study|Not treated|2|||
48732323|NCT01907100|156871293|FG001|Overall Study|Not treated|0|||
48732324|NCT01907100|156871294|FG002|Overall Study|Not treated|1|||
48732325|NCT01907100|156871295|FG003|Overall Study|Not treated|2|||
48732326|NCT01907100|156871292|FG000|Overall Study|Other than reasons specified|1|||
48732327|NCT01907100|156871293|FG001|Overall Study|Other than reasons specified|0|||
48732328|NCT01907100|156871294|FG002|Overall Study|Other than reasons specified|10|||
48732329|NCT01907100|156871295|FG003|Overall Study|Other than reasons specified|6|||
48732330|NCT01907100|156871292|FG000|Overall Study|Adverse event (AE)|6|||
49150258|NCT06582732|158391378|FG006|Initial Study Period|Death|0|||
49150259|NCT06582732|158391372|FG000|Initial Study Period|Lost to Follow-up|0|||
49150260|NCT06582732|158391373|FG001|Initial Study Period|Lost to Follow-up|0|||
49150261|NCT06582732|158391374|FG002|Initial Study Period|Lost to Follow-up|2|||
49150262|NCT06582732|158391375|FG003|Initial Study Period|Lost to Follow-up|0|||
49150263|NCT06582732|158391376|FG004|Initial Study Period|Lost to Follow-up|0|||
49150264|NCT06582732|158391377|FG005|Initial Study Period|Lost to Follow-up|0|||
49150265|NCT06582732|158391378|FG006|Initial Study Period|Lost to Follow-up|0|||
49150266|NCT06582732|158391372|FG000|Initial Study Period|Withdrawal by Subject|0|||
49150267|NCT06582732|158391373|FG001|Initial Study Period|Withdrawal by Subject|1|||
49150268|NCT06582732|158391374|FG002|Initial Study Period|Withdrawal by Subject|0|||
49150269|NCT06582732|158391375|FG003|Initial Study Period|Withdrawal by Subject|1|||
49150270|NCT06582732|158391376|FG004|Initial Study Period|Withdrawal by Subject|3|||
49150271|NCT06582732|158391377|FG005|Initial Study Period|Withdrawal by Subject|1|||
49150272|NCT06582732|158391378|FG006|Initial Study Period|Withdrawal by Subject|2|||
49150273|NCT06582732|158391372|FG000|Initial Study Period|Moved Away|0|||
49150274|NCT06582732|158391373|FG001|Initial Study Period|Moved Away|0|||
49150275|NCT06582732|158391374|FG002|Initial Study Period|Moved Away|0|||
49150276|NCT06582732|158391375|FG003|Initial Study Period|Moved Away|0|||
49150277|NCT06582732|158391376|FG004|Initial Study Period|Moved Away|1|||
49150278|NCT06582732|158391377|FG005|Initial Study Period|Moved Away|0|||
49150279|NCT06582732|158391378|FG006|Initial Study Period|Moved Away|0|||
49150280|NCT01472185|158391384|FG000|Overall Study|Randomized but Not Treated|0|||
49150281|NCT01472185|158391385|FG001|Overall Study|Randomized but Not Treated|1|||
49150282|NCT01472185|158391384|FG000|Overall Study|Adverse Event Other than Hyperglycemia|3|||
49150283|NCT01472185|158391385|FG001|Overall Study|Adverse Event Other than Hyperglycemia|10|||
49150284|NCT01472185|158391384|FG000|Overall Study|Hyperglycemia|5|||
49150285|NCT01472185|158391385|FG001|Overall Study|Hyperglycemia|2|||
49150286|NCT01472185|158391384|FG000|Overall Study|Investigator's Discretion|3|||
49150287|NCT01472185|158391385|FG001|Overall Study|Investigator's Discretion|1|||
49150288|NCT01472185|158391384|FG000|Overall Study|Lost to Follow-up|4|||
49150289|NCT01472185|158391385|FG001|Overall Study|Lost to Follow-up|1|||
49150290|NCT01472185|158391384|FG000|Overall Study|Protocol Violation|5|||
49150291|NCT01472185|158391385|FG001|Overall Study|Protocol Violation|1|||
49150292|NCT01472185|158391384|FG000|Overall Study|Subject Noncompliance|8|||
49150293|NCT01472185|158391385|FG001|Overall Study|Subject Noncompliance|15|||
49150294|NCT01472185|158391384|FG000|Overall Study|Subject Withdrew Consent|6|||
49150295|NCT01472185|158391385|FG001|Overall Study|Subject Withdrew Consent|3|||
49150296|NCT00979407|158391388|FG000|Overall Study|Withdrawal by Subject|3|||
49150297|NCT00979407|158391389|FG001|Overall Study|Withdrawal by Subject|4|||
49150298|NCT00979407|158391388|FG000|Overall Study|Lost to Follow-up|3|||
49150299|NCT00979407|158391389|FG001|Overall Study|Lost to Follow-up|3|||
49150300|NCT01166646|158391390|FG000|Overall Study|Protocol Violation|0|||
49150301|NCT01166646|158391391|FG001|Overall Study|Protocol Violation|1|||
49150302|NCT01166646|158391390|FG000|Overall Study|Adverse Event|1|||
49150303|NCT01166646|158391391|FG001|Overall Study|Adverse Event|0|||
49150304|NCT00437073|158391392|FG000|Overall Study|Sponsor Terminated Study|1|||
49150305|NCT00437073|158391393|FG001|Overall Study|Sponsor Terminated Study|0|||
49150306|NCT00437073|158391392|FG000|Overall Study|Physician Decision|0|||
49150307|NCT00437073|158391393|FG001|Overall Study|Physician Decision|1|||
49150308|NCT05535972|158391402|FG000|Overall Study|Withdrawal by Subject|31|||
49150309|NCT05535972|158391402|FG000|Overall Study|Lost to Follow-up|5|||
49150310|NCT05535972|158391402|FG000|Overall Study|Adverse Event|6|||
49150311|NCT05535972|158391402|FG000|Overall Study|Protocol Deviation|2|||
49150312|NCT04507269|158391403|FG000|Overall Study|Withdrawal by Subject|1|||
49150313|NCT04507269|158391404|FG001|Overall Study|Withdrawal by Subject|1|||
49150314|NCT04507269|158391405|FG002|Overall Study|Withdrawal by Subject|0|||
49150315|NCT04507269|158391406|FG003|Overall Study|Withdrawal by Subject|0|||
49150316|NCT04507269|158391407|FG004|Overall Study|Withdrawal by Subject|0|||
49150317|NCT04507269|158391408|FG005|Overall Study|Withdrawal by Subject|0|||
49150318|NCT04507269|158391403|FG000|Overall Study|Lost to Follow-up|0|||
49150319|NCT04507269|158391404|FG001|Overall Study|Lost to Follow-up|0|||
49150320|NCT04507269|158391405|FG002|Overall Study|Lost to Follow-up|0|||
49150321|NCT04507269|158391406|FG003|Overall Study|Lost to Follow-up|0|||
48732331|NCT01907100|156871293|FG001|Overall Study|Adverse event (AE)|3|||
48732332|NCT01907100|156871294|FG002|Overall Study|Adverse event (AE)|22|||
48732333|NCT01907100|156871295|FG003|Overall Study|Adverse event (AE)|23|||
49150322|NCT04507269|158391407|FG004|Overall Study|Lost to Follow-up|1|||
49150323|NCT04507269|158391408|FG005|Overall Study|Lost to Follow-up|0|||
49150324|NCT04134936|158391409|FG000|Overall Study|Adverse Event|3|||
49150325|NCT04134936|158391410|FG001|Overall Study|Adverse Event|2|||
49150326|NCT04134936|158391409|FG000|Overall Study|Withdrawal by Subject|2|||
49150327|NCT04134936|158391410|FG001|Overall Study|Withdrawal by Subject|3|||
49150328|NCT04134936|158391409|FG000|Overall Study|Physician Decision|0|||
49150329|NCT04134936|158391410|FG001|Overall Study|Physician Decision|1|||
49150330|NCT04134936|158391409|FG000|Overall Study|Progressive disease, joined another trial|1|||
49150331|NCT04134936|158391410|FG001|Overall Study|Progressive disease, joined another trial|0|||
48732334|NCT01907100|156871292|FG000|Overall Study|Worsening/AE underlying cancer disease|0|||
48732335|NCT01907100|156871293|FG001|Overall Study|Worsening/AE underlying cancer disease|0|||
48732336|NCT01907100|156871294|FG002|Overall Study|Worsening/AE underlying cancer disease|8|||
48732337|NCT01907100|156871295|FG003|Overall Study|Worsening/AE underlying cancer disease|8|||
48732338|NCT04068610|156871296|FG000|Overall Study|Death|4|||
48732339|NCT04068610|156871297|FG001|Overall Study|Death|8|||
48732340|NCT04068610|156871298|FG002|Overall Study|Death|13|||
48732341|NCT04068610|156871296|FG000|Overall Study|Lost to Follow-up|0|||
48732342|NCT04068610|156871297|FG001|Overall Study|Lost to Follow-up|2|||
48732343|NCT04068610|156871298|FG002|Overall Study|Lost to Follow-up|0|||
48732344|NCT04068610|156871296|FG000|Overall Study|Withdrawal by Subject|0|||
48732345|NCT04068610|156871297|FG001|Overall Study|Withdrawal by Subject|4|||
48732346|NCT04068610|156871298|FG002|Overall Study|Withdrawal by Subject|2|||
48732347|NCT04068610|156871296|FG000|Overall Study|Other|3|||
48732348|NCT04068610|156871297|FG001|Overall Study|Other|12|||
48732349|NCT04068610|156871298|FG002|Overall Study|Other|11|||
48732350|NCT04502979|156871299|FG000|Overall Study|Lost to Follow-up|1|||
48732351|NCT04502979|156871300|FG001|Overall Study|Lost to Follow-up|3|||
48732352|NCT04502979|156871299|FG000|Overall Study|Withdrawal by Subject|2|||
48732353|NCT04502979|156871300|FG001|Overall Study|Withdrawal by Subject|1|||
48732354|NCT00423514|156871304|FG000|Overall Study|Ineligible|1|||
48732355|NCT00423514|156871305|FG001|Overall Study|Ineligible|0|||
48732356|NCT03113916|156871310|FG000|Overall Study|Withdrawal by Subject|9|||
48732357|NCT03113916|156871311|FG001|Overall Study|Withdrawal by Subject|7|||
48732358|NCT03113916|156871310|FG000|Overall Study|Pregnancy|1|||
48732359|NCT03113916|156871311|FG001|Overall Study|Pregnancy|3|||
48732360|NCT03113916|156871310|FG000|Overall Study|Lost to Follow-up|1|||
48732361|NCT03113916|156871311|FG001|Overall Study|Lost to Follow-up|2|||
48732362|NCT03439657|156871312|FG000|Overall Study|Adverse Event|2|||
48732363|NCT03439657|156871313|FG001|Overall Study|Adverse Event|3|||
48732364|NCT03439657|156871312|FG000|Overall Study|Lost to Follow-up|1|||
48732365|NCT03439657|156871313|FG001|Overall Study|Lost to Follow-up|0|||
48732366|NCT03439657|156871312|FG000|Overall Study|Protocol Violation|1|||
48732367|NCT03439657|156871313|FG001|Overall Study|Protocol Violation|1|||
48732368|NCT03439657|156871312|FG000|Overall Study|Consent withdrawal, not due to an Adverse Event|3|||
48732369|NCT03439657|156871313|FG001|Overall Study|Consent withdrawal, not due to an Adverse Event|0|||
48732370|NCT02764697|156871314|FG000|Overall Study|Lack of Efficacy|3|||
48732371|NCT04996797|156871315|FG000|Overall Study|Adverse Event|0|||
48732372|NCT04996797|156871316|FG001|Overall Study|Adverse Event|2|||
48732373|NCT04996797|156871317|FG002|Overall Study|Adverse Event|0|||
48732374|NCT04996797|156871318|FG003|Overall Study|Adverse Event|1|||
48732375|NCT04996797|156871315|FG000|Overall Study|Lack of Efficacy|0|||
48732376|NCT04996797|156871316|FG001|Overall Study|Lack of Efficacy|2|||
48732377|NCT04996797|156871317|FG002|Overall Study|Lack of Efficacy|0|||
48732378|NCT04996797|156871318|FG003|Overall Study|Lack of Efficacy|0|||
48732379|NCT04996797|156871315|FG000|Overall Study|Prohibited Medication|0|||
48732380|NCT04996797|156871316|FG001|Overall Study|Prohibited Medication|1|||
48732381|NCT04996797|156871317|FG002|Overall Study|Prohibited Medication|0|||
48732382|NCT04996797|156871318|FG003|Overall Study|Prohibited Medication|0|||
48732383|NCT04996797|156871315|FG000|Overall Study|Ongoing|68|||
48732384|NCT04996797|156871316|FG001|Overall Study|Ongoing|60|||
48732385|NCT04996797|156871317|FG002|Overall Study|Ongoing|22|||
48732386|NCT04996797|156871318|FG003|Overall Study|Ongoing|20|||
48732387|NCT04996797|156871315|FG000|Overall Study|Withdrawal by Subject|0|||
48732388|NCT04996797|156871316|FG001|Overall Study|Withdrawal by Subject|2|||
48732389|NCT04996797|156871317|FG002|Overall Study|Withdrawal by Subject|0|||
48732390|NCT04996797|156871318|FG003|Overall Study|Withdrawal by Subject|0|||
48732391|NCT02423772|156871319|FG000|Overall Study|Lost to Follow-up|3|||
48732392|NCT02423772|156871320|FG001|Overall Study|Lost to Follow-up|3|||
48732393|NCT02423772|156871319|FG000|Overall Study|Did not begin intervention|2|||
48732394|NCT02423772|156871320|FG001|Overall Study|Did not begin intervention|5|||
48732395|NCT02003365|156872306|FG000|Overall Study|Lost to Follow-up|0|||
48732396|NCT02003365|156872307|FG001|Overall Study|Lost to Follow-up|0|||
48732397|NCT02003365|156872308|FG002|Overall Study|Lost to Follow-up|1|||
48732398|NCT04078178|156872309|FG000|Lead-In Period (4-Weeks)|Withdrawal by Subject|0|||
48732399|NCT04078178|156872310|FG001|Lead-In Period (4-Weeks)|Withdrawal by Subject|1|||
49150332|NCT04134936|158391409|FG000|Overall Study|Progressive disease|1|||
48732400|NCT04078178|156872309|FG000|Lead-In Period (4-Weeks)|Screen Fail|1|||
48732401|NCT04078178|156872310|FG001|Lead-In Period (4-Weeks)|Screen Fail|2|||
48732402|NCT04078178|156872309|FG000|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|1|||
48732403|NCT04078178|156872310|FG001|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|2|||
48732404|NCT04078178|156872309|FG000|Baseline/Initial Treatment (8 Weeks)|Early Termination|1|||
48732405|NCT04078178|156872310|FG001|Baseline/Initial Treatment (8 Weeks)|Early Termination|0|||
49150333|NCT04134936|158391410|FG001|Overall Study|Progressive disease|0|||
48732406|NCT04078178|156872309|FG000|Crossover Treatment (8 Weeks)|Early Termination|0|||
48732407|NCT04078178|156872310|FG001|Crossover Treatment (8 Weeks)|Early Termination|1|||
48732408|NCT03078907|156872311|FG000|Overall Study|Adverse Event|2|||
48732409|NCT03078907|156872312|FG001|Overall Study|Adverse Event|0|||
49150334|NCT01903863|158391411|FG000|Overall Study|Physician Decision|2|||
49150335|NCT01903863|158391412|FG001|Overall Study|Physician Decision|0|||
49150336|NCT04903093|158391414|FG000|Overall Study|Withdrawal by Subject|0|||
49150337|NCT04903093|158391415|FG001|Overall Study|Withdrawal by Subject|0|||
49150338|NCT04903093|158391416|FG002|Overall Study|Withdrawal by Subject|0|||
49150339|NCT04903093|158391417|FG003|Overall Study|Withdrawal by Subject|1|||
49150340|NCT04903093|158391418|FG004|Overall Study|Withdrawal by Subject|0|||
49150341|NCT04903093|158391419|FG005|Overall Study|Withdrawal by Subject|0|||
49150342|NCT05375929|158391420|FG000|Main Study: Treatment Phase (12 Weeks)|Adverse Event|1|||
49150343|NCT05375929|158391421|FG001|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
49150344|NCT05375929|158391422|FG002|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
49150345|NCT05375929|158391423|FG003|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
49150346|NCT05375929|158391420|FG000|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
49150347|NCT05375929|158391421|FG001|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
49150348|NCT05375929|158391422|FG002|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
49150349|NCT05375929|158391423|FG003|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
49150350|NCT05375929|158391420|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|6|||
49150351|NCT05375929|158391421|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|5|||
49150352|NCT05375929|158391422|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
49150353|NCT05375929|158391423|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
49150354|NCT05375929|158391420|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
49150355|NCT05375929|158391421|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|1|||
49150356|NCT05375929|158391422|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
49150357|NCT05375929|158391423|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
49150358|NCT05375929|158391420|FG000|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|1|||
49150359|NCT05375929|158391421|FG001|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
49150360|NCT05375929|158391422|FG002|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
49150361|NCT05375929|158391423|FG003|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
49150362|NCT05375929|158391420|FG000|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
49150363|NCT05375929|158391421|FG001|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|1|||
49150364|NCT05375929|158391422|FG002|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
49150365|NCT05375929|158391423|FG003|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
49150366|NCT05375929|158391420|FG000|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
49150367|NCT05375929|158391421|FG001|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
49150368|NCT05375929|158391422|FG002|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
49150369|NCT05375929|158391423|FG003|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|1|||
49150370|NCT05375929|158391420|FG000|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
49150371|NCT05375929|158391421|FG001|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
49150372|NCT05375929|158391422|FG002|Substudy: Treatment Phase (1 Year)|Physician Decision|4|||
49150373|NCT05375929|158391423|FG003|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
49150374|NCT05375929|158391420|FG000|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
49150375|NCT05375929|158391421|FG001|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
49150376|NCT05375929|158391422|FG002|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|1|||
49150377|NCT05375929|158391423|FG003|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
49150378|NCT05375929|158391420|FG000|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
49150379|NCT05375929|158391421|FG001|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
49150380|NCT05375929|158391422|FG002|Substudy: Treatment Phase (1 Year)|Adverse Event|2|||
49150381|NCT05375929|158391423|FG003|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
49150382|NCT01107496|158391429|FG000|Overall Study|Adverse Event|1|||
49150383|NCT01107496|158391430|FG001|Overall Study|Adverse Event|0|||
48732410|NCT03078907|156872311|FG000|Overall Study|Other|1|||
48732411|NCT03078907|156872312|FG001|Overall Study|Other|0|||
48732412|NCT03078907|156872311|FG000|Overall Study|Protocol Violation|0|||
48732413|NCT03078907|156872312|FG001|Overall Study|Protocol Violation|1|||
48732414|NCT04439175|156872313|FG000|Overall Study|Never started treatment|4|||
48732415|NCT04439175|156872313|FG000|Overall Study|Ineligible|5|||
48732416|NCT04439175|156872313|FG000|Overall Study|Adverse Event|6|||
48732417|NCT04439175|156872313|FG000|Overall Study|Death|4|||
48732418|NCT04439175|156872313|FG000|Overall Study|Disease progression|44|||
48732419|NCT04439175|156872313|FG000|Overall Study|Withdrawal by Subject|4|||
48732420|NCT04439175|156872313|FG000|Overall Study|Alternative Therapy|1|||
48732421|NCT04439175|156872313|FG000|Overall Study|Other|2|||
48732422|NCT00107783|156872314|FG000|Overall Study|Adverse Event|0|||
48732423|NCT00107783|156872315|FG001|Overall Study|Adverse Event|2|||
48732424|NCT00107783|156872314|FG000|Overall Study|Death|0|||
48824936|NCT01543685|157199064|FG003|Overall Study|Lack of Efficacy|0|||
48732425|NCT00107783|156872315|FG001|Overall Study|Death|1|||
48824937|NCT01543685|157199065|FG004|Overall Study|Lack of Efficacy|2|||
48732426|NCT00107783|156872314|FG000|Overall Study|Withdrawal by Subject|2|||
49150384|NCT01107496|158391429|FG000|Overall Study|Lack of Efficacy|1|||
49150385|NCT01107496|158391430|FG001|Overall Study|Lack of Efficacy|0|||
49150386|NCT01107496|158391429|FG000|Overall Study|Protocol Violation|0|||
49150387|NCT01107496|158391430|FG001|Overall Study|Protocol Violation|1|||
49150388|NCT01107496|158391429|FG000|Overall Study|Lost to Follow-up|0|||
49150389|NCT01107496|158391430|FG001|Overall Study|Lost to Follow-up|1|||
49150390|NCT03709472|158391431|FG000|4 Month Assessment (Post Treatment)|Lost to Follow-up|8|||
49150391|NCT03709472|158391432|FG001|4 Month Assessment (Post Treatment)|Lost to Follow-up|30|||
49150392|NCT03709472|158391431|FG000|Assessment (12-month Post Baseline)|Lost to Follow-up|12|||
49150393|NCT03709472|158391432|FG001|Assessment (12-month Post Baseline)|Lost to Follow-up|46|||
49150394|NCT00392288|158391435|FG000|Overall Study|Adverse Event|17|||
49150395|NCT00392288|158391436|FG001|Overall Study|Adverse Event|7|||
49150396|NCT00392288|158391437|FG002|Overall Study|Adverse Event|8|||
49150397|NCT00392288|158391435|FG000|Overall Study|Lack of Efficacy|8|||
49150398|NCT00392288|158391436|FG001|Overall Study|Lack of Efficacy|5|||
49150399|NCT00392288|158391437|FG002|Overall Study|Lack of Efficacy|3|||
49150400|NCT00392288|158391435|FG000|Overall Study|Protocol Violation|1|||
49150401|NCT00392288|158391436|FG001|Overall Study|Protocol Violation|3|||
49150402|NCT00392288|158391437|FG002|Overall Study|Protocol Violation|1|||
49150403|NCT00392288|158391435|FG000|Overall Study|Lost to Follow-up|1|||
48732427|NCT00107783|156872315|FG001|Overall Study|Withdrawal by Subject|0|||
49150404|NCT00392288|158391436|FG001|Overall Study|Lost to Follow-up|1|||
49150405|NCT00392288|158391437|FG002|Overall Study|Lost to Follow-up|1|||
49150406|NCT00392288|158391435|FG000|Overall Study|Withdrawal by Subject|1|||
49150407|NCT00392288|158391436|FG001|Overall Study|Withdrawal by Subject|0|||
49150408|NCT00392288|158391437|FG002|Overall Study|Withdrawal by Subject|2|||
49150409|NCT00392288|158391435|FG000|Overall Study|Parent/legal guardian withdrawal|1|||
49150410|NCT00392288|158391436|FG001|Overall Study|Parent/legal guardian withdrawal|2|||
49150411|NCT00392288|158391437|FG002|Overall Study|Parent/legal guardian withdrawal|1|||
49150412|NCT00392288|158391435|FG000|Overall Study|Other|3|||
49150413|NCT00392288|158391436|FG001|Overall Study|Other|4|||
49150414|NCT00392288|158391437|FG002|Overall Study|Other|1|||
49150415|NCT01027351|158391438|FG000|Overall Study|Withdrawal by Subject|1|||
49150416|NCT01027351|158391439|FG001|Overall Study|Withdrawal by Subject|0|||
49150417|NCT01027351|158391440|FG002|Overall Study|Withdrawal by Subject|1|||
49150418|NCT01027351|158391441|FG003|Overall Study|Withdrawal by Subject|0|||
48732428|NCT00107783|156872314|FG000|Overall Study|Second hip replacement|1|||
48732429|NCT00107783|156872315|FG001|Overall Study|Second hip replacement|1|||
48732430|NCT01092507|156872316|FG000|Overall Study|Withdrawal by Subject|2|||
48732431|NCT01092507|156872317|FG001|Overall Study|Withdrawal by Subject|0|||
49150419|NCT01027351|158391442|FG004|Overall Study|Withdrawal by Subject|3|||
49150420|NCT01027351|158391443|FG005|Overall Study|Withdrawal by Subject|5|||
49150421|NCT01027351|158391438|FG000|Overall Study|Lost to Follow-up|1|||
49150422|NCT01027351|158391439|FG001|Overall Study|Lost to Follow-up|1|||
49150423|NCT01027351|158391440|FG002|Overall Study|Lost to Follow-up|0|||
49150424|NCT01027351|158391441|FG003|Overall Study|Lost to Follow-up|1|||
49150425|NCT01027351|158391442|FG004|Overall Study|Lost to Follow-up|6|||
49150426|NCT01027351|158391443|FG005|Overall Study|Lost to Follow-up|0|||
49150427|NCT01027351|158391438|FG000|Overall Study|Inappropriate enrollment|0|||
49150428|NCT01027351|158391439|FG001|Overall Study|Inappropriate enrollment|0|||
49150429|NCT01027351|158391440|FG002|Overall Study|Inappropriate enrollment|0|||
49150430|NCT01027351|158391441|FG003|Overall Study|Inappropriate enrollment|0|||
48732432|NCT03468985|156872318|FG000|Overall Study|Adverse Event|0|||
48732433|NCT03468985|156872319|FG001|Overall Study|Adverse Event|2|||
48732434|NCT03468985|156872320|FG002|Overall Study|Adverse Event|0|||
49150431|NCT01027351|158391442|FG004|Overall Study|Inappropriate enrollment|1|||
48732435|NCT03468985|156872321|FG003|Overall Study|Adverse Event|0|||
48732436|NCT03468985|156872318|FG000|Overall Study|Withdrawal by Subject|0|||
48732437|NCT03468985|156872319|FG001|Overall Study|Withdrawal by Subject|0|||
48732438|NCT03468985|156872320|FG002|Overall Study|Withdrawal by Subject|0|||
48732439|NCT03468985|156872321|FG003|Overall Study|Withdrawal by Subject|1|||
48732440|NCT04060862|156872324|FG000|Overall Study|Symptomatic Deterioration|1|||
48732441|NCT04060862|156872324|FG000|Overall Study|Un-specified|6|||
48732442|NCT04060862|156872324|FG000|Overall Study|Progressive disease|12|||
48732443|NCT04060862|156872324|FG000|Overall Study|Physician Decision|1|||
48732444|NCT03282565|156872325|FG000|Overall Study|COVID-19 Research Shutdown|0|||
49150432|NCT01027351|158391443|FG005|Overall Study|Inappropriate enrollment|0|||
49150433|NCT01027351|158391438|FG000|Overall Study|Protocol Violation|1|||
49150434|NCT01027351|158391439|FG001|Overall Study|Protocol Violation|0|||
49150435|NCT01027351|158391440|FG002|Overall Study|Protocol Violation|0|||
49150436|NCT01027351|158391441|FG003|Overall Study|Protocol Violation|1|||
49150437|NCT01027351|158391442|FG004|Overall Study|Protocol Violation|1|||
48732445|NCT03282565|156872326|FG001|Overall Study|COVID-19 Research Shutdown|2|||
48732446|NCT03282565|156872327|FG002|Overall Study|COVID-19 Research Shutdown|2|||
48732447|NCT00950911|156872328|FG000|Overall Study|Adverse Event|0|||
48732448|NCT00950911|156872329|FG001|Overall Study|Adverse Event|2|||
48732449|NCT00950911|156872328|FG000|Overall Study|Death|4|||
49150438|NCT01027351|158391443|FG005|Overall Study|Protocol Violation|0|||
48732450|NCT00950911|156872329|FG001|Overall Study|Death|6|||
48732451|NCT00950911|156872328|FG000|Overall Study|Disease progression|2|||
48732452|NCT00950911|156872329|FG001|Overall Study|Disease progression|2|||
49150439|NCT00480025|158391445|FG000|Overall Study|Protocol Violation|12|||
49150440|NCT00480025|158391446|FG001|Overall Study|Protocol Violation|7|||
49150441|NCT00480025|158391445|FG000|Overall Study|Patients remaining ongoing at Data Lock|101|||
49150442|NCT00480025|158391446|FG001|Overall Study|Patients remaining ongoing at Data Lock|55|||
49150443|NCT00480025|158391445|FG000|Overall Study|Disease Progression / Recurrence|449|||
49150444|NCT00480025|158391446|FG001|Overall Study|Disease Progression / Recurrence|224|||
49150445|NCT00480025|158391445|FG000|Overall Study|Adverse Event|44|||
49150446|NCT00480025|158391446|FG001|Overall Study|Adverse Event|12|||
49150447|NCT00480025|158391445|FG000|Overall Study|Other|70|||
49150448|NCT00480025|158391446|FG001|Overall Study|Other|29|||
49150449|NCT00480025|158391445|FG000|Overall Study|SAE including intercurrent illness|76|||
49150450|NCT00480025|158391446|FG001|Overall Study|SAE including intercurrent illness|42|||
49150451|NCT01500135|158392538|FG000|Overall Study|Withdrawal of Consent|4|||
49150452|NCT01500135|158392539|FG001|Overall Study|Withdrawal of Consent|0|||
49150453|NCT01500135|158392538|FG000|Overall Study|Lost to Follow-up|6|||
49150454|NCT01500135|158392539|FG001|Overall Study|Lost to Follow-up|4|||
49150455|NCT01500135|158392538|FG000|Overall Study|Fatal Adverse Event (AE)|5|||
49150456|NCT01500135|158392539|FG001|Overall Study|Fatal Adverse Event (AE)|5|||
49150457|NCT01500135|158392538|FG000|Overall Study|Principal Investigator (PI) Discretion|1|||
49150458|NCT01500135|158392539|FG001|Overall Study|Principal Investigator (PI) Discretion|0|||
49150459|NCT01500135|158392538|FG000|Overall Study|Patient Missed Scheduled Appointments|0|||
49150460|NCT01500135|158392539|FG001|Overall Study|Patient Missed Scheduled Appointments|1|||
49150461|NCT01500135|158392538|FG000|Overall Study|Participant was a Safety Concern|1|||
49150462|NCT01500135|158392539|FG001|Overall Study|Participant was a Safety Concern|0|||
49150463|NCT01500135|158392538|FG000|Overall Study|Patient Unable to Make Follow-up Visit|0|||
49150464|NCT01500135|158392539|FG001|Overall Study|Patient Unable to Make Follow-up Visit|1|||
49150465|NCT02180672|158392540|FG000|Overall Study|Lost to Follow-up|5|||
49150466|NCT02180672|158392541|FG001|Overall Study|Lost to Follow-up|7|||
49150467|NCT00661687|158392543|FG000|Overall Study|Study related symptoms and complaints|5|||
49150468|NCT00661687|158392543|FG000|Overall Study|Positive slit lamp findings|4|||
49150469|NCT00661687|158392543|FG000|Overall Study|Inability to maintain wearing schedule|3|||
49150470|NCT00661687|158392543|FG000|Overall Study|Physician Decision|1|||
49150471|NCT00661687|158392543|FG000|Overall Study|Adverse Event|2|||
49150472|NCT00003907|158392544|FG000|Overall Study|Adverse Event|2|||
49150473|NCT00003907|158392545|FG001|Overall Study|Adverse Event|11|||
49150474|NCT00003907|158392544|FG000|Overall Study|Death|2|||
49150475|NCT00003907|158392545|FG001|Overall Study|Death|0|||
49150476|NCT00003907|158392544|FG000|Overall Study|Withdrawal by Subject|1|||
49150477|NCT00003907|158392545|FG001|Overall Study|Withdrawal by Subject|3|||
49150478|NCT00003907|158392544|FG000|Overall Study|Progressive disease|4|||
49150479|NCT00003907|158392545|FG001|Overall Study|Progressive disease|4|||
49150480|NCT00003907|158392544|FG000|Overall Study|Complicating disease|1|||
49150481|NCT00003907|158392545|FG001|Overall Study|Complicating disease|0|||
49150482|NCT00003907|158392544|FG000|Overall Study|Other|1|||
49150483|NCT00003907|158392545|FG001|Overall Study|Other|3|||
49150484|NCT00003907|158392544|FG000|Overall Study|ineligible or not treated|2|||
49150485|NCT00003907|158392545|FG001|Overall Study|ineligible or not treated|2|||
49150486|NCT01904279|158392552|FG000|Overall Study|Lack of Efficacy|2|||
49150487|NCT01904279|158392553|FG001|Overall Study|Lack of Efficacy|3|||
49150488|NCT01904279|158392552|FG000|Overall Study|Withdrawal by Subject|1|||
49150489|NCT01904279|158392553|FG001|Overall Study|Withdrawal by Subject|0|||
49150490|NCT03439072|158392556|FG000|Overall Study|Withdrawal by Subject|2|||
49150491|NCT03439072|158392557|FG001|Overall Study|Withdrawal by Subject|3|||
49150492|NCT03439072|158392556|FG000|Overall Study|Physician Decision|0|||
49150493|NCT03439072|158392557|FG001|Overall Study|Physician Decision|1|||
48732453|NCT00950911|156872328|FG000|Overall Study|Consent withdrawn|1|||
48732454|NCT00950911|156872329|FG001|Overall Study|Consent withdrawn|3|||
48732455|NCT00950911|156872328|FG000|Overall Study|Administrative decision|3|||
48732456|NCT00950911|156872329|FG001|Overall Study|Administrative decision|1|||
48732457|NCT00950911|156872328|FG000|Overall Study|Ineligibility determined|1|||
48732458|NCT00950911|156872329|FG001|Overall Study|Ineligibility determined|0|||
48732459|NCT00950911|156872328|FG000|Overall Study|Noncompliance|1|||
48732460|NCT00950911|156872329|FG001|Overall Study|Noncompliance|0|||
48732461|NCT00950911|156872328|FG000|Overall Study|Poor performance status|0|||
48732462|NCT00950911|156872329|FG001|Overall Study|Poor performance status|1|||
48732463|NCT02642029|156872332|FG000|Washout 1 (≥ 36 Hours)|Adverse Event|1|||
48732464|NCT02642029|156872333|FG001|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
48732465|NCT02642029|156872334|FG002|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
49150494|NCT03906071|158392559|FG000|Overall Study|Death|180|||
49150495|NCT03906071|158392560|FG001|Overall Study|Death|185|||
49150496|NCT03906071|158392559|FG000|Overall Study|Lost to Follow-up|3|||
49150497|NCT03906071|158392560|FG001|Overall Study|Lost to Follow-up|3|||
48732466|NCT02642029|156872335|FG003|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
49150498|NCT03906071|158392559|FG000|Overall Study|Withdrawal by Subject|15|||
49150499|NCT03906071|158392560|FG001|Overall Study|Withdrawal by Subject|27|||
49150500|NCT03906071|158392559|FG000|Overall Study|Other|2|||
49150501|NCT03906071|158392560|FG001|Overall Study|Other|1|||
49150502|NCT00814983|158392561|FG000|Overall Study|Screen failure|1|||
49150503|NCT00814983|158392562|FG001|Overall Study|Screen failure|0|||
49150504|NCT00814983|158392561|FG000|Overall Study|Withdrawal by Subject|1|||
49150505|NCT00814983|158392562|FG001|Overall Study|Withdrawal by Subject|0|||
49150506|NCT00814983|158392561|FG000|Overall Study|Graft failure|1|||
49150507|NCT00814983|158392562|FG001|Overall Study|Graft failure|0|||
49150508|NCT02150863|158392566|FG000|Overall Study|Lost to Follow-up|0|||
49150509|NCT02150863|158392567|FG001|Overall Study|Lost to Follow-up|1|||
49150510|NCT02150863|158392568|FG002|Overall Study|Lost to Follow-up|0|||
49150511|NCT03729609|158392569|FG000|Overall Study|Protocol Violation|1|||
49150512|NCT01416831|158392571|FG000|Cycles 1 & 2 (Weeks 1-14)|Death|1|||
49150513|NCT01416831|158392572|FG001|Cycles 1 & 2 (Weeks 1-14)|Death|2|||
49150514|NCT00830336|158392573|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
49150515|NCT00830336|158392574|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
49150516|NCT00835549|158392580|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
49150517|NCT00835549|158392581|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
49150518|NCT00835042|158392582|FG000|First Intervention|Withdrawal by Subject|3|||
49150519|NCT00835042|158392583|FG001|First Intervention|Withdrawal by Subject|0|||
49150520|NCT00835042|158392582|FG000|First Intervention|Adverse Event|1|||
49150521|NCT00835042|158392583|FG001|First Intervention|Adverse Event|2|||
49150522|NCT00835042|158392582|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
49150523|NCT00835042|158392583|FG001|Washout of 21 Days|Withdrawal by Subject|2|||
49150524|NCT00619918|158392584|FG000|Overall Study|Withdrawal by Subject|4|||
49150525|NCT00619918|158392585|FG001|Overall Study|Withdrawal by Subject|3|||
49150526|NCT00619918|158392584|FG000|Overall Study|Physician Decision|2|||
49150527|NCT00619918|158392585|FG001|Overall Study|Physician Decision|4|||
49150528|NCT00619918|158392584|FG000|Overall Study|Transfer to outside facility|3|||
49150529|NCT00619918|158392585|FG001|Overall Study|Transfer to outside facility|3|||
49150530|NCT00619918|158392584|FG000|Overall Study|Left before receiving first dose|7|||
49150531|NCT00619918|158392585|FG001|Overall Study|Left before receiving first dose|6|||
49150532|NCT00619918|158392584|FG000|Overall Study|ICU admission|4|||
49150533|NCT00619918|158392585|FG001|Overall Study|ICU admission|6|||
49150534|NCT02088554|158392591|FG000|Overall Study|Exited before procedure|130|||
49150535|NCT02088554|158392591|FG000|Overall Study|Attempted but not implanted|31|||
49150536|NCT02088554|158392591|FG000|Overall Study|Implant not attempted|19|||
49150537|NCT02088554|158392591|FG000|Overall Study|Pending next visit|532|||
49150538|NCT02088554|158392591|FG000|Overall Study|Death|170|||
49150539|NCT02088554|158392591|FG000|Overall Study|Subject Withdrew + Physician Withdrew + Subject Not Implanted With Study Valve|96|||
48824938|NCT01543685|157199061|FG000|Overall Study|Adverse Event|2|||
48824939|NCT01543685|157199062|FG001|Overall Study|Adverse Event|1|||
48824940|NCT01543685|157199063|FG002|Overall Study|Adverse Event|0|||
48824941|NCT01543685|157199064|FG003|Overall Study|Adverse Event|0|||
48824942|NCT01543685|157199065|FG004|Overall Study|Adverse Event|2|||
48824943|NCT00665561|157199066|FG000|Overall Study|Death recorded on subject summary pages|75|||
48824944|NCT00665561|157199067|FG001|Overall Study|Death recorded on subject summary pages|75|||
48824945|NCT00665561|157199066|FG000|Overall Study|Does not meet entrance criteria|19|||
48824946|NCT00665561|157199067|FG001|Overall Study|Does not meet entrance criteria|21|||
49150540|NCT02088554|158392591|FG000|Overall Study|Lost to Follow-up|23|||
49150541|NCT02088554|158392591|FG000|Overall Study|Explanted|32|||
49150542|NCT02088554|158392591|FG000|Overall Study|Any other reason not covered by previous categories|11|||
49150543|NCT02743221|158392592|FG000|Overall Study|Progressive disease|29|||
49150544|NCT02743221|158392593|FG001|Overall Study|Progressive disease|38|||
49150545|NCT02743221|158392592|FG000|Overall Study|Adverse Event|17|||
49150546|NCT02743221|158392593|FG001|Overall Study|Adverse Event|14|||
48824947|NCT00665561|157199066|FG000|Overall Study|Lost to Follow-up|203|||
48824948|NCT00665561|157199067|FG001|Overall Study|Lost to Follow-up|264|||
48824949|NCT00665561|157199066|FG000|Overall Study|Withdrawal by Subject|74|||
48824950|NCT00665561|157199067|FG001|Overall Study|Withdrawal by Subject|65|||
49150547|NCT02743221|158392592|FG000|Overall Study|non medical reason|8|||
49150548|NCT02743221|158392593|FG001|Overall Study|non medical reason|2|||
49150549|NCT02743221|158392592|FG000|Overall Study|Physician Decision|2|||
48824951|NCT00665561|157199066|FG000|Overall Study|Other|123|||
48824952|NCT00665561|157199067|FG001|Overall Study|Other|108|||
48824953|NCT00665561|157199066|FG000|Overall Study|Site closed|8|||
49150550|NCT02743221|158392593|FG001|Overall Study|Physician Decision|5|||
49150551|NCT02743221|158392592|FG000|Overall Study|Patient not eligible, not treated|0|||
49150552|NCT02743221|158392593|FG001|Overall Study|Patient not eligible, not treated|1|||
49150553|NCT03411044|158392594|FG000|Overall Study|Death|30|||
49150554|NCT03411044|158392594|FG000|Overall Study|Withdrawal by Subject|48|||
49150555|NCT03411044|158392594|FG000|Overall Study|Lost to Follow-up|78|||
49150556|NCT03411044|158392594|FG000|Overall Study|Adverse Event|30|||
49150557|NCT03411044|158392594|FG000|Overall Study|Missing status|4|||
49150558|NCT03579719|158392601|FG000|Overall Study|Protocol deviation, pre-existent disease|1|||
49150559|NCT00581919|158392602|FG000|Overall Study|Adverse Event|8|||
48824954|NCT00665561|157199067|FG001|Overall Study|Site closed|0|||
48824955|NCT00665561|157199066|FG000|Overall Study|Withdrawn due to pregnancy|0|||
48732467|NCT02642029|156872336|FG004|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
48732468|NCT02642029|156872337|FG005|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
49150560|NCT00581919|158392602|FG000|Overall Study|Death|1|||
49150561|NCT00581919|158392602|FG000|Overall Study|Disease Progression|10|||
49150562|NCT00581919|158392602|FG000|Overall Study|Physician Decision|1|||
49150563|NCT00581919|158392602|FG000|Overall Study|Other Complicating Disease|1|||
49150564|NCT00581919|158392602|FG000|Overall Study|Started Non-Protocol Therapy|2|||
49150565|NCT00581919|158392602|FG000|Overall Study|Withdrawal by Subject|1|||
49150566|NCT00522379|158392603|FG000|Overall Study|Adverse Event|12|||
49150567|NCT00522379|158392604|FG001|Overall Study|Adverse Event|15|||
49150568|NCT00522379|158392605|FG002|Overall Study|Adverse Event|12|||
49150569|NCT00522379|158392606|FG003|Overall Study|Adverse Event|5|||
49150570|NCT00522379|158392607|FG004|Overall Study|Adverse Event|17|||
49150571|NCT00522379|158392603|FG000|Overall Study|Lack of Efficacy|3|||
49150572|NCT00522379|158392604|FG001|Overall Study|Lack of Efficacy|0|||
49150573|NCT00522379|158392605|FG002|Overall Study|Lack of Efficacy|2|||
49150574|NCT00522379|158392606|FG003|Overall Study|Lack of Efficacy|2|||
49150575|NCT00522379|158392607|FG004|Overall Study|Lack of Efficacy|7|||
49150576|NCT00522379|158392603|FG000|Overall Study|Withdrawal by Subject|2|||
48732469|NCT02642029|156872332|FG000|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
48732470|NCT02642029|156872333|FG001|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|1|||
48732471|NCT02642029|156872334|FG002|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
48732472|NCT02642029|156872335|FG003|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
49150577|NCT00522379|158392604|FG001|Overall Study|Withdrawal by Subject|3|||
49150578|NCT00522379|158392605|FG002|Overall Study|Withdrawal by Subject|1|||
49150579|NCT00522379|158392606|FG003|Overall Study|Withdrawal by Subject|2|||
49150580|NCT00522379|158392607|FG004|Overall Study|Withdrawal by Subject|0|||
49150581|NCT00522379|158392603|FG000|Overall Study|Protocol Violation|1|||
49150582|NCT00522379|158392604|FG001|Overall Study|Protocol Violation|1|||
48732473|NCT02642029|156872336|FG004|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
48732474|NCT02642029|156872337|FG005|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
48824956|NCT00665561|157199067|FG001|Overall Study|Withdrawn due to pregnancy|1|||
48824957|NCT00604721|157199069|FG000|Overall Study|Physician Decision|1|||
48824958|NCT00604721|157199069|FG000|Overall Study|Withdrawal by Subject|1|||
48824959|NCT04776213|157199070|FG000|Overall Study|Other|1|||
48732475|NCT02642029|156872332|FG000|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
48732476|NCT02642029|156872333|FG001|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
48732477|NCT02642029|156872334|FG002|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
49150583|NCT00522379|158392605|FG002|Overall Study|Protocol Violation|2|||
49150584|NCT00522379|158392606|FG003|Overall Study|Protocol Violation|0|||
49150585|NCT00522379|158392607|FG004|Overall Study|Protocol Violation|0|||
49150586|NCT00522379|158392603|FG000|Overall Study|Unsatisfactory Subject Compliance|1|||
49150587|NCT00522379|158392604|FG001|Overall Study|Unsatisfactory Subject Compliance|2|||
49150588|NCT00522379|158392605|FG002|Overall Study|Unsatisfactory Subject Compliance|0|||
49150589|NCT00522379|158392606|FG003|Overall Study|Unsatisfactory Subject Compliance|0|||
49150590|NCT00522379|158392607|FG004|Overall Study|Unsatisfactory Subject Compliance|0|||
49150591|NCT00522379|158392603|FG000|Overall Study|Lost to Follow-up|1|||
49150592|NCT00522379|158392604|FG001|Overall Study|Lost to Follow-up|0|||
48824960|NCT04776213|157199070|FG000|Overall Study|Withdrawal by Subject|7|||
49150593|NCT00522379|158392605|FG002|Overall Study|Lost to Follow-up|4|||
49150594|NCT00522379|158392606|FG003|Overall Study|Lost to Follow-up|2|||
48732478|NCT02642029|156872335|FG003|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
49150595|NCT00522379|158392607|FG004|Overall Study|Lost to Follow-up|2|||
49150596|NCT00522379|158392603|FG000|Overall Study|Randomization error|0|||
48732479|NCT02642029|156872336|FG004|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|1|||
48732480|NCT02642029|156872337|FG005|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
48732481|NCT02642029|156872332|FG000|Study Visit 2 (1 Day)|Adverse Event|1|||
49150597|NCT00522379|158392604|FG001|Overall Study|Randomization error|0|||
48732482|NCT02642029|156872333|FG001|Study Visit 2 (1 Day)|Adverse Event|0|||
48824961|NCT04776213|157199070|FG000|Overall Study|Protocol Violation|1|||
49150598|NCT00522379|158392605|FG002|Overall Study|Randomization error|0|||
49150599|NCT00522379|158392606|FG003|Overall Study|Randomization error|0|||
49150600|NCT00522379|158392607|FG004|Overall Study|Randomization error|1|||
49150601|NCT00522379|158392603|FG000|Overall Study|Dispensing error|1|||
49150602|NCT00522379|158392604|FG001|Overall Study|Dispensing error|0|||
49150603|NCT00522379|158392605|FG002|Overall Study|Dispensing error|0|||
49150604|NCT00522379|158392606|FG003|Overall Study|Dispensing error|1|||
49150605|NCT00522379|158392607|FG004|Overall Study|Dispensing error|0|||
49150606|NCT00522379|158392603|FG000|Overall Study|Subject Moved|1|||
49150607|NCT00522379|158392604|FG001|Overall Study|Subject Moved|1|||
49150608|NCT00522379|158392605|FG002|Overall Study|Subject Moved|0|||
49150609|NCT00522379|158392606|FG003|Overall Study|Subject Moved|0|||
49150610|NCT00522379|158392607|FG004|Overall Study|Subject Moved|0|||
49150611|NCT00522379|158392603|FG000|Overall Study|Sponsor Request|0|||
49150612|NCT00522379|158392604|FG001|Overall Study|Sponsor Request|1|||
49150613|NCT00522379|158392605|FG002|Overall Study|Sponsor Request|0|||
49150614|NCT00522379|158392606|FG003|Overall Study|Sponsor Request|0|||
49150615|NCT00522379|158392607|FG004|Overall Study|Sponsor Request|0|||
49150616|NCT00522379|158392603|FG000|Overall Study|Family Problem|0|||
49150617|NCT00522379|158392604|FG001|Overall Study|Family Problem|0|||
49150618|NCT00522379|158392605|FG002|Overall Study|Family Problem|1|||
49150619|NCT00522379|158392606|FG003|Overall Study|Family Problem|0|||
49150620|NCT00522379|158392607|FG004|Overall Study|Family Problem|0|||
49150621|NCT00522379|158392603|FG000|Overall Study|Site Closed|0|||
49150622|NCT00522379|158392604|FG001|Overall Study|Site Closed|0|||
49150623|NCT00522379|158392605|FG002|Overall Study|Site Closed|0|||
49150624|NCT00522379|158392606|FG003|Overall Study|Site Closed|1|||
49150625|NCT00522379|158392607|FG004|Overall Study|Site Closed|0|||
49150626|NCT00522379|158392603|FG000|Overall Study|Subject Withdrawal|0|||
49150627|NCT00522379|158392604|FG001|Overall Study|Subject Withdrawal|0|||
48732483|NCT02642029|156872334|FG002|Study Visit 2 (1 Day)|Adverse Event|0|||
48732484|NCT02642029|156872335|FG003|Study Visit 2 (1 Day)|Adverse Event|0|||
49150628|NCT00522379|158392605|FG002|Overall Study|Subject Withdrawal|0|||
49150629|NCT00522379|158392606|FG003|Overall Study|Subject Withdrawal|1|||
49150630|NCT00522379|158392607|FG004|Overall Study|Subject Withdrawal|0|||
49150631|NCT05252702|158392608|FG000|Overall Study|No attempted implant, subjects withdrawn|12|||
49150632|NCT05252702|158392608|FG000|Overall Study|Death|16|||
49150633|NCT05252702|158392608|FG000|Overall Study|System explant|5|||
49150634|NCT05252702|158392608|FG000|Overall Study|Lost to Follow-up|1|||
49150635|NCT05252702|158392608|FG000|Overall Study|Withdrawn by investigator|1|||
49150636|NCT05252702|158392608|FG000|Overall Study|Visit not due|306|||
49150637|NCT05252702|158392608|FG000|Overall Study|Visit within window but not completed|92|||
49150638|NCT05252702|158392608|FG000|Overall Study|Unsuccessful implant|1|||
49150639|NCT04818229|158392609|FG000|Overall Study|The cohort was canceled due to COVID-19|20|||
49150640|NCT04818229|158392610|FG001|Overall Study|The cohort was canceled due to COVID-19|10|||
49150641|NCT04818229|158392611|FG002|Overall Study|The cohort was canceled due to COVID-19|10|||
49150642|NCT04818229|158392609|FG000|Overall Study|Adverse Event|3|||
49150643|NCT04818229|158392610|FG001|Overall Study|Adverse Event|1|||
49150644|NCT04818229|158392611|FG002|Overall Study|Adverse Event|1|||
49150645|NCT04818229|158392609|FG000|Overall Study|Withdrawal by Subject|0|||
49150646|NCT04818229|158392610|FG001|Overall Study|Withdrawal by Subject|0|||
49150647|NCT04818229|158392611|FG002|Overall Study|Withdrawal by Subject|2|||
49150648|NCT04818229|158392609|FG000|Overall Study|Lost to Follow-up|0|||
49150649|NCT04818229|158392610|FG001|Overall Study|Lost to Follow-up|0|||
49150650|NCT04818229|158392611|FG002|Overall Study|Lost to Follow-up|1|||
49150651|NCT01450631|158392612|FG000|Overall Study|Lost to Follow-up|2|||
49150652|NCT01450631|158392613|FG001|Overall Study|Lost to Follow-up|4|||
49150653|NCT01450631|158392612|FG000|Overall Study|Withdrawal by Subject|1|||
49150654|NCT01450631|158392613|FG001|Overall Study|Withdrawal by Subject|0|||
49150655|NCT01854775|158392620|FG000|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
48732485|NCT02642029|156872336|FG004|Study Visit 2 (1 Day)|Adverse Event|0|||
48732486|NCT02642029|156872337|FG005|Study Visit 2 (1 Day)|Adverse Event|0|||
48732487|NCT02642029|156872332|FG000|Washout 2 (≥ 36 Hours)|Adverse Event|1|||
48732488|NCT02642029|156872333|FG001|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
48732489|NCT02642029|156872334|FG002|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
48732490|NCT02642029|156872335|FG003|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
48732491|NCT02642029|156872336|FG004|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
48732492|NCT02642029|156872337|FG005|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
48824962|NCT04776213|157199070|FG000|Overall Study|Lost to Follow-up|2|||
49150656|NCT01854775|158392621|FG001|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
49150657|NCT01854775|158392622|FG002|Treatment Phase (48 Weeks)|Withdrawal by Subject|0|||
49150658|NCT01854775|158392620|FG000|Treatment Phase (48 Weeks)|Lost to Follow-up|1|||
48732493|NCT02642029|156872332|FG000|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|1|||
48732494|NCT02642029|156872333|FG001|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
48732495|NCT02642029|156872334|FG002|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
48732496|NCT02642029|156872335|FG003|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
48732497|NCT02642029|156872336|FG004|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
48732498|NCT02642029|156872337|FG005|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
48732499|NCT01086423|156872344|FG000|Overall Study|Protocol Violation|0|||
48732500|NCT01086423|156872345|FG001|Overall Study|Protocol Violation|0|||
48732501|NCT01086423|156872346|FG002|Overall Study|Protocol Violation|1|||
48732502|NCT01086423|156872344|FG000|Overall Study|Migrated/moved from study area|2|||
48732503|NCT01086423|156872345|FG001|Overall Study|Migrated/moved from study area|0|||
48732504|NCT01086423|156872346|FG002|Overall Study|Migrated/moved from study area|4|||
48732505|NCT01086423|156872344|FG000|Overall Study|Adverse event, fatal|1|||
48732506|NCT01086423|156872345|FG001|Overall Study|Adverse event, fatal|1|||
48732507|NCT01086423|156872346|FG002|Overall Study|Adverse event, fatal|0|||
48732508|NCT01086423|156872344|FG000|Overall Study|Adverse event, non-fatal|2|||
48732509|NCT01086423|156872345|FG001|Overall Study|Adverse event, non-fatal|1|||
48732510|NCT01086423|156872346|FG002|Overall Study|Adverse event, non-fatal|0|||
48732511|NCT01086423|156872344|FG000|Overall Study|Withdrawal by Subject|5|||
48732512|NCT01086423|156872345|FG001|Overall Study|Withdrawal by Subject|1|||
48732513|NCT01086423|156872346|FG002|Overall Study|Withdrawal by Subject|3|||
48732514|NCT01086423|156872344|FG000|Overall Study|Lost to Follow-up|0|||
48732515|NCT01086423|156872345|FG001|Overall Study|Lost to Follow-up|0|||
48732516|NCT01086423|156872346|FG002|Overall Study|Lost to Follow-up|1|||
48732517|NCT01225887|156872347|FG000|Overall Study|Ineligible:required test not done|2|||
48732518|NCT01225887|156872347|FG000|Overall Study|Ineligible;improper pre-protocol therapy|1|||
48732519|NCT01225887|156872347|FG000|Overall Study|Ineligible:inadequate pathology|2|||
48732520|NCT02869438|156872348|FG000|Overall Study|Lost to Follow-up|1|||
48732521|NCT02869438|156872349|FG001|Overall Study|Lost to Follow-up|0|||
48732522|NCT02869438|156872348|FG000|Overall Study|Adverse Event|1|||
49150659|NCT01854775|158392621|FG001|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
48732523|NCT02869438|156872349|FG001|Overall Study|Adverse Event|0|||
48732524|NCT02869438|156872348|FG000|Overall Study|Withdrawal by Subject|1|||
49150660|NCT01854775|158392622|FG002|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
49150661|NCT01854775|158392620|FG000|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
49150662|NCT01854775|158392621|FG001|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
49150663|NCT01854775|158392622|FG002|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|9|||
49150664|NCT01854775|158392620|FG000|Extension Phase|Pregnancy|3|||
49150665|NCT01854775|158392621|FG001|Extension Phase|Pregnancy|0|||
49150666|NCT01854775|158392622|FG002|Extension Phase|Pregnancy|0|||
49150667|NCT01854775|158392620|FG000|Extension Phase|Investigator's Discretion|1|||
49150668|NCT01854775|158392621|FG001|Extension Phase|Investigator's Discretion|0|||
49150669|NCT01854775|158392622|FG002|Extension Phase|Investigator's Discretion|0|||
49150670|NCT01854775|158392620|FG000|Extension Phase|Non-Compliance with Study Drug|1|||
49150671|NCT01854775|158392621|FG001|Extension Phase|Non-Compliance with Study Drug|0|||
49150672|NCT01854775|158392622|FG002|Extension Phase|Non-Compliance with Study Drug|0|||
49150673|NCT01854775|158392620|FG000|Extension Phase|Lost to Follow-up|2|||
49150674|NCT01854775|158392621|FG001|Extension Phase|Lost to Follow-up|0|||
49150675|NCT01854775|158392622|FG002|Extension Phase|Lost to Follow-up|0|||
49150676|NCT01854775|158392620|FG000|Extension Phase|Still on Study|32|||
49150677|NCT01854775|158392621|FG001|Extension Phase|Still on Study|47|||
49150678|NCT01854775|158392622|FG002|Extension Phase|Still on Study|18|||
49150679|NCT03559556|158392623|FG000|Overall Study|Withdrawal by Subject|1|||
49150680|NCT02097225|158392624|FG000|Dose Level 4|Adverse Event|0|||
49150681|NCT02097225|158392625|FG001|Dose Level 4|Adverse Event|0|||
49150682|NCT02097225|158392626|FG002|Dose Level 4|Adverse Event|0|||
49150683|NCT02097225|158392627|FG003|Dose Level 4|Adverse Event|0|||
49150684|NCT02097225|158392628|FG004|Dose Level 4|Adverse Event|1|||
49150685|NCT02971137|158392629|FG000|Overall Study|Lost to Follow-up|44|||
49150686|NCT02971137|158392630|FG001|Overall Study|Lost to Follow-up|56|||
49150687|NCT04650893|158392635|FG000|Overall Study|Lost to Follow-up|11|||
49150688|NCT04650893|158392636|FG001|Overall Study|Lost to Follow-up|10|||
49150689|NCT04650893|158392637|FG002|Overall Study|Lost to Follow-up|11|||
49150690|NCT01044459|158392638|FG000|Overall Study|Withdrawal by Subject|21|||
49150691|NCT01044459|158392639|FG001|Overall Study|Withdrawal by Subject|28|||
49150692|NCT01044459|158392638|FG000|Overall Study|Terminated by Sponsor|22|||
49150693|NCT01044459|158392639|FG001|Overall Study|Terminated by Sponsor|21|||
49150694|NCT01044459|158392638|FG000|Overall Study|Adverse Event|22|||
49150695|NCT01044459|158392639|FG001|Overall Study|Adverse Event|20|||
49150696|NCT01044459|158392638|FG000|Overall Study|Lack of Efficacy|23|||
49150697|NCT01044459|158392639|FG001|Overall Study|Lack of Efficacy|12|||
49150698|NCT01044459|158392638|FG000|Overall Study|Protocol Violation|11|||
49150699|NCT01044459|158392639|FG001|Overall Study|Protocol Violation|16|||
49150700|NCT01044459|158392638|FG000|Overall Study|Other Reason|7|||
48732525|NCT02869438|156872349|FG001|Overall Study|Withdrawal by Subject|2|||
48732526|NCT00591344|156872350|FG000|Overall Study|Transportation issues|1|||
48732527|NCT00591344|156872351|FG001|Overall Study|Transportation issues|0|||
48732528|NCT00591344|156872350|FG000|Overall Study|Moved out of state|1|||
48732529|NCT00591344|156872351|FG001|Overall Study|Moved out of state|0|||
48732530|NCT00591344|156872350|FG000|Overall Study|Medical complications|1|||
48732531|NCT00591344|156872351|FG001|Overall Study|Medical complications|3|||
48732532|NCT00591344|156872350|FG000|Overall Study|Underwent DBS|2|||
48732533|NCT00591344|156872351|FG001|Overall Study|Underwent DBS|2|||
48732534|NCT00591344|156872350|FG000|Overall Study|Death|0|||
48732535|NCT00591344|156872351|FG001|Overall Study|Death|1|||
48732536|NCT00591344|156872350|FG000|Overall Study|Lost to Follow-up|0|||
48732537|NCT00591344|156872351|FG001|Overall Study|Lost to Follow-up|1|||
48732538|NCT00591344|156872350|FG000|Overall Study|Did not want to come off medication|0|||
48732539|NCT00591344|156872351|FG001|Overall Study|Did not want to come off medication|1|||
48732540|NCT00694707|156872352|FG000|Overall Study|Did Not Receive Treatment|0|||
48732541|NCT00694707|156872353|FG001|Overall Study|Did Not Receive Treatment|0|||
48732542|NCT00694707|156872354|FG002|Overall Study|Did Not Receive Treatment|1|||
48732543|NCT00694707|156872355|FG003|Overall Study|Did Not Receive Treatment|1|||
48732544|NCT00694707|156872356|FG004|Overall Study|Did Not Receive Treatment|1|||
48732545|NCT00694707|156872352|FG000|Overall Study|Adverse Event|22|||
48732546|NCT00694707|156872353|FG001|Overall Study|Adverse Event|14|||
48732547|NCT00694707|156872354|FG002|Overall Study|Adverse Event|8|||
48732548|NCT00694707|156872355|FG003|Overall Study|Adverse Event|12|||
48732549|NCT00694707|156872356|FG004|Overall Study|Adverse Event|13|||
48732550|NCT00694707|156872352|FG000|Overall Study|Insufficient Therapeutic Response|33|||
48732551|NCT00694707|156872353|FG001|Overall Study|Insufficient Therapeutic Response|18|||
48732552|NCT00694707|156872354|FG002|Overall Study|Insufficient Therapeutic Response|17|||
48732553|NCT00694707|156872355|FG003|Overall Study|Insufficient Therapeutic Response|15|||
48732554|NCT00694707|156872356|FG004|Overall Study|Insufficient Therapeutic Response|10|||
48732555|NCT00694707|156872352|FG000|Overall Study|Protocol Violation|1|||
48732556|NCT00694707|156872353|FG001|Overall Study|Protocol Violation|2|||
48732557|NCT00694707|156872354|FG002|Overall Study|Protocol Violation|1|||
49150701|NCT01044459|158392639|FG001|Overall Study|Other Reason|14|||
49150702|NCT01044459|158392638|FG000|Overall Study|COPD exacerbation|9|||
49150703|NCT01044459|158392639|FG001|Overall Study|COPD exacerbation|8|||
49150704|NCT01044459|158392638|FG000|Overall Study|Lost to Follow-up|18|||
49150705|NCT01044459|158392639|FG001|Overall Study|Lost to Follow-up|12|||
49150706|NCT02679274|158392640|FG000|Overall Study|Withdrawal by Subject|1|||
48732558|NCT00694707|156872355|FG003|Overall Study|Protocol Violation|3|||
48732559|NCT00694707|156872356|FG004|Overall Study|Protocol Violation|1|||
48732560|NCT00694707|156872352|FG000|Overall Study|Withdrawal of Consent|14|||
49150707|NCT02679274|158392641|FG001|Overall Study|Withdrawal by Subject|0|||
49150708|NCT02781558|158392642|FG000|Overall Study|Lost to Follow-up|2|||
49150709|NCT02781558|158392643|FG001|Overall Study|Lost to Follow-up|2|||
49150710|NCT02781558|158392642|FG000|Overall Study|Adverse Event|1|||
49150711|NCT02781558|158392643|FG001|Overall Study|Adverse Event|0|||
49150712|NCT03984188|158392648|FG000|Overall Study|Death|2|||
49150713|NCT03984188|158392649|FG001|Overall Study|Death|4|||
49150714|NCT03984188|158392648|FG000|Overall Study|Physician Decision|0|||
49150715|NCT03984188|158392649|FG001|Overall Study|Physician Decision|2|||
49150716|NCT03984188|158392648|FG000|Overall Study|Lost to Follow-up|3|||
49150717|NCT03984188|158392649|FG001|Overall Study|Lost to Follow-up|2|||
49150718|NCT03984188|158392648|FG000|Overall Study|Withdrawal by Subject|6|||
49150719|NCT03984188|158392649|FG001|Overall Study|Withdrawal by Subject|0|||
49150720|NCT01586910|158393941|FG000|Overall Study|Death|4|||
49150721|NCT01586910|158393942|FG001|Overall Study|Death|4|||
49150722|NCT01586910|158393941|FG000|Overall Study|Withdrawal by Subject|6|||
49150723|NCT01586910|158393942|FG001|Overall Study|Withdrawal by Subject|43|||
49150724|NCT01586910|158393941|FG000|Overall Study|Physician withdrew Subject|5|||
49150725|NCT01586910|158393942|FG001|Overall Study|Physician withdrew Subject|24|||
49150726|NCT02113878|158393943|FG000|Overall Study|Adverse Event|1|||
49150727|NCT02113878|158393944|FG001|Overall Study|Adverse Event|0|||
48732561|NCT00694707|156872353|FG001|Overall Study|Withdrawal of Consent|18|||
48732562|NCT00694707|156872354|FG002|Overall Study|Withdrawal of Consent|22|||
48732563|NCT00694707|156872355|FG003|Overall Study|Withdrawal of Consent|16|||
48732564|NCT00694707|156872356|FG004|Overall Study|Withdrawal of Consent|15|||
48732565|NCT00694707|156872352|FG000|Overall Study|Lost to Follow-up|0|||
48732566|NCT00694707|156872353|FG001|Overall Study|Lost to Follow-up|1|||
48732567|NCT00694707|156872354|FG002|Overall Study|Lost to Follow-up|2|||
48732568|NCT00694707|156872355|FG003|Overall Study|Lost to Follow-up|0|||
48732569|NCT00694707|156872356|FG004|Overall Study|Lost to Follow-up|0|||
49150728|NCT02113878|158393943|FG000|Overall Study|Withdrawal by Subject|1|||
49150729|NCT02113878|158393944|FG001|Overall Study|Withdrawal by Subject|0|||
49150730|NCT02113878|158393943|FG000|Overall Study|patient non-compliance|1|||
49150731|NCT02113878|158393944|FG001|Overall Study|patient non-compliance|0|||
49150732|NCT04280783|158393945|FG000|Overall Study|Family issues unrelated to the study.|1|||
49150733|NCT04280783|158393946|FG001|Overall Study|Family issues unrelated to the study.|0|||
48732570|NCT00694707|156872352|FG000|Overall Study|Jeopardizing Parole Status|1|||
48732571|NCT00694707|156872353|FG001|Overall Study|Jeopardizing Parole Status|0|||
48732572|NCT00694707|156872354|FG002|Overall Study|Jeopardizing Parole Status|0|||
48732573|NCT00694707|156872355|FG003|Overall Study|Jeopardizing Parole Status|0|||
48732574|NCT00694707|156872356|FG004|Overall Study|Jeopardizing Parole Status|0|||
48732575|NCT00694707|156872352|FG000|Overall Study|Death in the Family|1|||
48732576|NCT00694707|156872353|FG001|Overall Study|Death in the Family|0|||
48732577|NCT00694707|156872354|FG002|Overall Study|Death in the Family|0|||
48732578|NCT00694707|156872355|FG003|Overall Study|Death in the Family|0|||
48732579|NCT00694707|156872356|FG004|Overall Study|Death in the Family|0|||
48732580|NCT00694707|156872352|FG000|Overall Study|Arrest by Police|0|||
48732581|NCT00694707|156872353|FG001|Overall Study|Arrest by Police|1|||
48732582|NCT00694707|156872354|FG002|Overall Study|Arrest by Police|0|||
48732583|NCT00694707|156872355|FG003|Overall Study|Arrest by Police|0|||
48732584|NCT00694707|156872356|FG004|Overall Study|Arrest by Police|0|||
48732585|NCT00694707|156872352|FG000|Overall Study|Administrative Reasons|0|||
48732586|NCT00694707|156872353|FG001|Overall Study|Administrative Reasons|1|||
48732587|NCT00694707|156872354|FG002|Overall Study|Administrative Reasons|0|||
48732588|NCT00694707|156872355|FG003|Overall Study|Administrative Reasons|2|||
48732589|NCT00694707|156872356|FG004|Overall Study|Administrative Reasons|0|||
48732590|NCT00694707|156872352|FG000|Overall Study|Notification of Past Head Injury|0|||
48732591|NCT00694707|156872353|FG001|Overall Study|Notification of Past Head Injury|0|||
48732592|NCT00694707|156872354|FG002|Overall Study|Notification of Past Head Injury|0|||
48732593|NCT00694707|156872355|FG003|Overall Study|Notification of Past Head Injury|1|||
48732594|NCT00694707|156872356|FG004|Overall Study|Notification of Past Head Injury|0|||
48732595|NCT01400815|156872357|FG000|Overall Study|Adverse Event|3|||
48732596|NCT01400815|156872358|FG001|Overall Study|Adverse Event|0|||
48824963|NCT01143077|157199072|FG000|Overall Study|Lack of Efficacy|0|||
48824964|NCT01143077|157199073|FG001|Overall Study|Lack of Efficacy|2|||
48732597|NCT01400815|156872357|FG000|Overall Study|Death|0|||
48732598|NCT01400815|156872358|FG001|Overall Study|Death|1|||
48732599|NCT01400815|156872357|FG000|Overall Study|Lost to Follow-up|18|||
48732600|NCT01400815|156872358|FG001|Overall Study|Lost to Follow-up|11|||
48732601|NCT01400815|156872357|FG000|Overall Study|Protocol Violation|0|||
48732602|NCT01400815|156872358|FG001|Overall Study|Protocol Violation|1|||
48732603|NCT01400815|156872357|FG000|Overall Study|Physician Decision|1|||
48824965|NCT01143077|157199074|FG002|Overall Study|Lack of Efficacy|1|||
48824966|NCT01143077|157199072|FG000|Overall Study|Adverse Event|5|||
48824967|NCT01143077|157199073|FG001|Overall Study|Adverse Event|6|||
49150734|NCT04280783|158393945|FG000|Overall Study|Withdrawal by Subject|0|||
49150735|NCT04280783|158393946|FG001|Overall Study|Withdrawal by Subject|1|||
49150736|NCT03443401|158393947|FG000|Overall Study|Lost to Follow-up|13|||
49150737|NCT03443401|158393947|FG000|Overall Study|Influential outlier|1|||
49150738|NCT00530257|158393948|FG000|Overall Study|Lost to Follow-up|1|||
49150739|NCT00944645|158393950|FG000|Period 2|Adverse Event|1|||
49150740|NCT00944645|158393951|FG001|Period 2|Adverse Event|0|||
49150741|NCT00944645|158393950|FG000|Period 2|Lost to Follow-up|0|||
49150742|NCT00944645|158393951|FG001|Period 2|Lost to Follow-up|3|||
49150743|NCT00944645|158393950|FG000|Period 2|Withdrawal by Subject|7|||
49150744|NCT00944645|158393951|FG001|Period 2|Withdrawal by Subject|6|||
49150745|NCT02579759|158393952|FG000|Overall Study|Protocol Violation|2|||
49150746|NCT02579759|158393953|FG001|Overall Study|Protocol Violation|0|||
49150747|NCT02579759|158393954|FG002|Overall Study|Protocol Violation|0|||
49150748|NCT02579759|158393952|FG000|Overall Study|Other (Sponsor stopped Dose 2)|0|||
49150749|NCT02579759|158393953|FG001|Overall Study|Other (Sponsor stopped Dose 2)|1|||
48824968|NCT01143077|157199074|FG002|Overall Study|Adverse Event|5|||
49150750|NCT02579759|158393954|FG002|Overall Study|Other (Sponsor stopped Dose 2)|0|||
49150751|NCT02579759|158393952|FG000|Overall Study|BfArM hold|13|||
48732604|NCT01400815|156872358|FG001|Overall Study|Physician Decision|0|||
48732605|NCT01400815|156872357|FG000|Overall Study|Withdrawal by Subject|15|||
48732606|NCT01400815|156872358|FG001|Overall Study|Withdrawal by Subject|8|||
48732607|NCT01400815|156872357|FG000|Overall Study|Subject in jail|1|||
48732608|NCT01400815|156872358|FG001|Overall Study|Subject in jail|0|||
48732609|NCT00857415|156872362|FG000|Overall Study|Image acquisition failure|2|||
48732610|NCT00857415|156872363|FG001|Overall Study|Image acquisition failure|0|||
48732611|NCT00857415|156872362|FG000|Overall Study|Invalid image or not imaged|3|||
48732612|NCT00857415|156872363|FG001|Overall Study|Invalid image or not imaged|0|||
48732613|NCT00857415|156872362|FG000|Overall Study|Subject still living at end of study|110|||
48732614|NCT00857415|156872363|FG001|Overall Study|Subject still living at end of study|0|||
48732615|NCT00857415|156872362|FG000|Overall Study|Deceased with no autopsy|2|||
48732616|NCT00857415|156872363|FG001|Overall Study|Deceased with no autopsy|0|||
48732617|NCT01130103|156872364|FG000|Randomized Treatment|Adverse Event|1|||
48732618|NCT01130103|156872365|FG001|Randomized Treatment|Adverse Event|1|||
48732619|NCT01130103|156872364|FG000|Randomized Treatment|Lost to Follow-up|1|||
48824969|NCT01143077|157199072|FG000|Overall Study|Lost to Follow-up|2|||
49150752|NCT02579759|158393953|FG001|Overall Study|BfArM hold|12|||
49150753|NCT02579759|158393954|FG002|Overall Study|BfArM hold|12|||
49150754|NCT02579759|158393952|FG000|Overall Study|Sponsor stopped Dose 2|0|||
49150755|NCT02579759|158393953|FG001|Overall Study|Sponsor stopped Dose 2|41|||
49150756|NCT02579759|158393954|FG002|Overall Study|Sponsor stopped Dose 2|0|||
49150757|NCT02579759|158393952|FG000|Overall Study|Non compliance|0|||
49150758|NCT02579759|158393953|FG001|Overall Study|Non compliance|1|||
49150759|NCT02579759|158393954|FG002|Overall Study|Non compliance|0|||
49150760|NCT02579759|158393952|FG000|Overall Study|Pregnancy|0|||
49150761|NCT02579759|158393953|FG001|Overall Study|Pregnancy|1|||
49150762|NCT02579759|158393954|FG002|Overall Study|Pregnancy|0|||
49150763|NCT02579759|158393952|FG000|Overall Study|Inclusion/exclusion criteria|0|||
49150764|NCT02579759|158393953|FG001|Overall Study|Inclusion/exclusion criteria|0|||
49150765|NCT02579759|158393954|FG002|Overall Study|Inclusion/exclusion criteria|1|||
49150766|NCT02579759|158393952|FG000|Overall Study|Adverse Event|4|||
49150767|NCT02579759|158393953|FG001|Overall Study|Adverse Event|3|||
49150768|NCT02579759|158393954|FG002|Overall Study|Adverse Event|1|||
49150769|NCT02579759|158393952|FG000|Overall Study|Withdrawal by Subject|3|||
49150770|NCT02579759|158393953|FG001|Overall Study|Withdrawal by Subject|3|||
49150771|NCT02579759|158393954|FG002|Overall Study|Withdrawal by Subject|5|||
48824970|NCT01143077|157199073|FG001|Overall Study|Lost to Follow-up|3|||
48824971|NCT01143077|157199074|FG002|Overall Study|Lost to Follow-up|4|||
49150772|NCT02579759|158393952|FG000|Overall Study|Lost to Follow-up|2|||
49150773|NCT02579759|158393953|FG001|Overall Study|Lost to Follow-up|2|||
48824972|NCT01143077|157199072|FG000|Overall Study|Protocol Violation|2|||
48824973|NCT01143077|157199073|FG001|Overall Study|Protocol Violation|0|||
48824974|NCT01143077|157199074|FG002|Overall Study|Protocol Violation|0|||
48824975|NCT01143077|157199072|FG000|Overall Study|Withdrawal by Subject|4|||
48824976|NCT01143077|157199073|FG001|Overall Study|Withdrawal by Subject|3|||
48824977|NCT01143077|157199074|FG002|Overall Study|Withdrawal by Subject|3|||
48824978|NCT01143077|157199072|FG000|Overall Study|Non-compliance with study drug|0|||
48824979|NCT01143077|157199073|FG001|Overall Study|Non-compliance with study drug|1|||
49150774|NCT02579759|158393954|FG002|Overall Study|Lost to Follow-up|2|||
49150775|NCT03436732|158393955|FG000|Overall Study|Not treated-enrolled in different study|1|||
49150776|NCT03436732|158393956|FG001|Overall Study|Not treated-enrolled in different study|0|||
49150777|NCT03436732|158393955|FG000|Overall Study|Off study after cycle 1|1|||
49150778|NCT03436732|158393956|FG001|Overall Study|Off study after cycle 1|0|||
49150779|NCT03436732|158393955|FG000|Overall Study|Adverse Event|2|||
49150780|NCT03436732|158393956|FG001|Overall Study|Adverse Event|0|||
49150781|NCT03436732|158393955|FG000|Overall Study|Death|0|||
49150782|NCT03436732|158393956|FG001|Overall Study|Death|1|||
49150783|NCT02254460|158393959|FG000|Overall Study|Adverse Event|1|||
49150784|NCT02254460|158393960|FG001|Overall Study|Adverse Event|0|||
49150785|NCT02093520|158393961|FG000|Overall Study|Not treated|6|||
49150786|NCT02093520|158393962|FG001|Overall Study|Not treated|22|||
49150787|NCT01149460|158393963|FG000|Overall Study|Withdrawal by Subject|0|||
49150788|NCT01149460|158393964|FG001|Overall Study|Withdrawal by Subject|2|||
49150789|NCT01892189|158393976|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
49150790|NCT01892189|158393977|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
48732620|NCT01130103|156872365|FG001|Randomized Treatment|Lost to Follow-up|0|||
48824980|NCT01143077|157199074|FG002|Overall Study|Non-compliance with study drug|1|||
49150791|NCT01892189|158393978|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
48732621|NCT01130103|156872364|FG000|Randomized Treatment|Protocol Violation|3|||
48732622|NCT01130103|156872365|FG001|Randomized Treatment|Protocol Violation|2|||
48732623|NCT01130103|156872364|FG000|Randomized Treatment|Withdrawal by Subject|1|||
48732624|NCT01130103|156872365|FG001|Randomized Treatment|Withdrawal by Subject|2|||
48732625|NCT01130103|156872364|FG000|Maintenance Treatment|Lack of Efficacy|0|||
48732626|NCT01130103|156872365|FG001|Maintenance Treatment|Lack of Efficacy|1|||
48732627|NCT01130103|156872364|FG000|Maintenance Treatment|Lost to Follow-up|1|||
48732628|NCT01130103|156872365|FG001|Maintenance Treatment|Lost to Follow-up|1|||
48732629|NCT01130103|156872364|FG000|Maintenance Treatment|Withdrawal by Subject|1|||
48732630|NCT01130103|156872365|FG001|Maintenance Treatment|Withdrawal by Subject|0|||
48732631|NCT04025710|156872368|FG000|Overall Study|Death|3|||
48732632|NCT04025710|156872368|FG000|Overall Study|Lost to Follow-up|5|||
48732633|NCT04025710|156872368|FG000|Overall Study|Withdrawal by Subject|1|||
48732634|NCT04025710|156872368|FG000|Overall Study|Patient unable or unwilling to attend required visits|8|||
48732635|NCT04025710|156872368|FG000|Overall Study|Drop-out according to protocol|34|||
48732636|NCT02787551|156872369|FG000|Core Period: 26 Weeks|Adverse Event|10|||
48732637|NCT02787551|156872370|FG001|Core Period: 26 Weeks|Adverse Event|0|||
48824981|NCT01143077|157199072|FG000|Overall Study|Administrative|1|||
48824982|NCT01143077|157199073|FG001|Overall Study|Administrative|0|||
48824983|NCT01143077|157199074|FG002|Overall Study|Administrative|0|||
48824984|NCT01143077|157199072|FG000|Overall Study|Principal Investigator Decision|2|||
48824985|NCT01143077|157199073|FG001|Overall Study|Principal Investigator Decision|0|||
48824986|NCT01143077|157199074|FG002|Overall Study|Principal Investigator Decision|1|||
49150792|NCT01892189|158393979|FG003|Washout Period 1 (7 Days)|Adverse Event|0|||
49150793|NCT01892189|158393980|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
49150794|NCT01892189|158393981|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
49150795|NCT01892189|158393982|FG006|Washout Period 1 (7 Days)|Adverse Event|0|||
49150796|NCT01892189|158393983|FG007|Washout Period 1 (7 Days)|Adverse Event|0|||
48732638|NCT02787551|156872369|FG000|Core Period: 26 Weeks|Lack of Efficacy|1|||
48732639|NCT02787551|156872370|FG001|Core Period: 26 Weeks|Lack of Efficacy|0|||
48856508|NCT01159600|157312867|FG006|Overall Study|Patient refusal to continue,not due toAE|2|||
48856509|NCT01159600|157312868|FG007|Overall Study|Patient refusal to continue,not due toAE|5|||
49150797|NCT01892189|158393984|FG008|Washout Period 1 (7 Days)|Adverse Event|1|||
49150798|NCT01892189|158393976|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
49150799|NCT01892189|158393977|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
49150800|NCT01892189|158393978|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|2|||
49150801|NCT01892189|158393979|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
49150802|NCT01892189|158393980|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
49150803|NCT01892189|158393981|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
49150804|NCT01892189|158393982|FG006|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
49150805|NCT01892189|158393983|FG007|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
49150806|NCT01892189|158393984|FG008|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
49150807|NCT01892189|158393976|FG000|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
49150808|NCT01892189|158393977|FG001|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
49150809|NCT01892189|158393978|FG002|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
49150810|NCT01892189|158393979|FG003|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
49150811|NCT01892189|158393980|FG004|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
49150812|NCT01892189|158393981|FG005|Washout Period 1 (7 Days)|Noncompliance, Irritability|1|||
49150813|NCT01892189|158393982|FG006|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
49150814|NCT01892189|158393983|FG007|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
48856510|NCT01159600|157312861|FG000|Overall Study|Other reason not defined above|3|||
48856511|NCT01159600|157312862|FG001|Overall Study|Other reason not defined above|0|||
48856512|NCT01159600|157312863|FG002|Overall Study|Other reason not defined above|4|||
49150815|NCT01892189|158393984|FG008|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
49150816|NCT03802916|158393985|FG000|Overall Study|Adverse Event|0|||
49150817|NCT03802916|158393986|FG001|Overall Study|Adverse Event|1|||
49150818|NCT03802916|158393985|FG000|Overall Study|Withdrawal by Subject|0|||
49150819|NCT03802916|158393986|FG001|Overall Study|Withdrawal by Subject|1|||
49150820|NCT00605189|158393987|FG000|Overall Study|Adverse Event|1|||
49150821|NCT00605189|158393988|FG001|Overall Study|Adverse Event|0|||
49150822|NCT00605189|158393989|FG002|Overall Study|Adverse Event|0|||
49150823|NCT00605189|158393987|FG000|Overall Study|Other|2|||
49150824|NCT00605189|158393988|FG001|Overall Study|Other|2|||
48732640|NCT02787551|156872369|FG000|Core Period: 26 Weeks|Poor compliance to protocol|2|||
48732641|NCT02787551|156872370|FG001|Core Period: 26 Weeks|Poor compliance to protocol|0|||
48732642|NCT02787551|156872369|FG000|Core Period: 26 Weeks|Withdrawal by Subject|9|||
48732643|NCT02787551|156872370|FG001|Core Period: 26 Weeks|Withdrawal by Subject|9|||
48732644|NCT02787551|156872369|FG000|Core Period: 26 Weeks|Randomized but not treated|2|||
48856513|NCT01159600|157312864|FG003|Overall Study|Other reason not defined above|2|||
49150825|NCT00605189|158393989|FG002|Overall Study|Other|0|||
49150826|NCT03253627|158393990|FG000|Overall Study|Lost to Follow-up|1|||
49150827|NCT03253627|158393991|FG001|Overall Study|Lost to Follow-up|2|||
48732645|NCT02787551|156872370|FG001|Core Period: 26 Weeks|Randomized but not treated|1|||
48732646|NCT02787551|156872369|FG000|Core Period: 26 Weeks|Other than specified|3|||
48732647|NCT02787551|156872370|FG001|Core Period: 26 Weeks|Other than specified|1|||
48732648|NCT02787551|156872369|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1|||
48732649|NCT02787551|156872370|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0|||
48732650|NCT02787551|156872369|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3|||
48732651|NCT02787551|156872370|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0|||
48732652|NCT02787551|156872369|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5|||
48732653|NCT02787551|156872370|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0|||
48732654|NCT05490771|156872371|FG000|Overall Study|Disease progression|18|||
48732655|NCT05490771|156872371|FG000|Overall Study|Adverse Event|3|||
48732656|NCT05490771|156872371|FG000|Overall Study|Other complicating disease|1|||
48732657|NCT05490771|156872371|FG000|Overall Study|Withdrawal by Subject|3|||
48732658|NCT05490771|156872371|FG000|Overall Study|Physician Decision|1|||
48732659|NCT05490771|156872371|FG000|Overall Study|Still on treatment|2|||
48732660|NCT05490771|156872371|FG000|Overall Study|Never start protocol therapy|5|||
48732661|NCT05490771|156872371|FG000|Overall Study|Ineligible|2|||
48732662|NCT00591266|156872372|FG000|Overall Study|Adverse Event|2|||
48732663|NCT00591266|156872373|FG001|Overall Study|Adverse Event|2|||
48732664|NCT00591266|156872374|FG002|Overall Study|Adverse Event|3|||
48732665|NCT00591266|156872372|FG000|Overall Study|Lost to Follow-up|0|||
48732666|NCT00591266|156872373|FG001|Overall Study|Lost to Follow-up|1|||
48732667|NCT00591266|156872374|FG002|Overall Study|Lost to Follow-up|0|||
48732668|NCT00591266|156872372|FG000|Overall Study|Protocol Violation|0|||
48732669|NCT00591266|156872373|FG001|Overall Study|Protocol Violation|0|||
48732670|NCT00591266|156872374|FG002|Overall Study|Protocol Violation|1|||
48732671|NCT00591266|156872372|FG000|Overall Study|Withdrawal by Subject|6|||
48732672|NCT00591266|156872373|FG001|Overall Study|Withdrawal by Subject|2|||
48732673|NCT00591266|156872374|FG002|Overall Study|Withdrawal by Subject|5|||
48732674|NCT00591266|156872372|FG000|Overall Study|Lack of Efficacy|0|||
48732675|NCT00591266|156872373|FG001|Overall Study|Lack of Efficacy|2|||
48732676|NCT00591266|156872374|FG002|Overall Study|Lack of Efficacy|0|||
48732677|NCT00591266|156872372|FG000|Overall Study|Other|1|||
48732678|NCT00591266|156872373|FG001|Overall Study|Other|4|||
48732679|NCT00591266|156872374|FG002|Overall Study|Other|5|||
48732680|NCT02939079|156872375|FG000|Overall Study|Adverse Event|2|||
48732681|NCT02939079|156872376|FG001|Overall Study|Adverse Event|1|||
48732682|NCT02939079|156872375|FG000|Overall Study|Lost to Follow-up|0|||
48732683|NCT02939079|156872376|FG001|Overall Study|Lost to Follow-up|2|||
48732684|NCT02939079|156872375|FG000|Overall Study|Protocol Violation|1|||
48732685|NCT02939079|156872376|FG001|Overall Study|Protocol Violation|0|||
48824987|NCT00731042|157200684|FG000|Second Intervention|Did not meet inclusion criteria|0|||
49150828|NCT03253627|158393990|FG000|Overall Study|Withdrawal by Subject|0|||
49150829|NCT03253627|158393991|FG001|Overall Study|Withdrawal by Subject|2|||
49150830|NCT03253627|158393990|FG000|Overall Study|Inability to complete MRI|1|||
49150831|NCT03253627|158393991|FG001|Overall Study|Inability to complete MRI|0|||
49150832|NCT00539500|158393997|FG000|Overall Study|Disease Progression|1|||
49150833|NCT00539500|158393997|FG000|Overall Study|Lost to Follow-up|2|||
49150834|NCT03777020|158393998|FG000|Overall Study|Withdrawal by Subject|4|||
49150835|NCT03777020|158393999|FG001|Overall Study|Withdrawal by Subject|4|||
49150836|NCT03777020|158393998|FG000|Overall Study|No longer met inclusion criteria at initial visit|0|||
49150837|NCT03777020|158393999|FG001|Overall Study|No longer met inclusion criteria at initial visit|1|||
49150838|NCT00803049|158394001|FG000|Overall Study|Adverse Event|21|||
48732686|NCT02939079|156872375|FG000|Overall Study|Withdrawal by Subject|0|||
48732687|NCT02939079|156872376|FG001|Overall Study|Withdrawal by Subject|1|||
48732688|NCT02939079|156872375|FG000|Overall Study|relapse during the study|1|||
48732689|NCT02939079|156872376|FG001|Overall Study|relapse during the study|1|||
48732690|NCT04093414|156872377|FG000|3 Month Follow up|Physician Decision|0|||
48732691|NCT04093414|156872378|FG001|3 Month Follow up|Physician Decision|1|||
48732692|NCT04093414|156872377|FG000|6month Follow up|Physician Decision|1|||
48732693|NCT04093414|156872378|FG001|6month Follow up|Physician Decision|3|||
48732694|NCT02337738|156872379|FG000|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
49150839|NCT00803049|158394002|FG001|Overall Study|Adverse Event|33|||
49150840|NCT00803049|158394003|FG002|Overall Study|Adverse Event|13|||
49150841|NCT00803049|158394004|FG003|Overall Study|Adverse Event|27|||
49150842|NCT00803049|158394001|FG000|Overall Study|Lack of Efficacy|10|||
49150843|NCT00803049|158394002|FG001|Overall Study|Lack of Efficacy|19|||
49150844|NCT00803049|158394003|FG002|Overall Study|Lack of Efficacy|6|||
49150845|NCT00803049|158394004|FG003|Overall Study|Lack of Efficacy|13|||
49150846|NCT00803049|158394001|FG000|Overall Study|Lost to Follow-up|0|||
49150847|NCT00803049|158394002|FG001|Overall Study|Lost to Follow-up|2|||
49150848|NCT00803049|158394003|FG002|Overall Study|Lost to Follow-up|0|||
49150849|NCT00803049|158394004|FG003|Overall Study|Lost to Follow-up|3|||
49150850|NCT00803049|158394001|FG000|Overall Study|Death|2|||
49150851|NCT00803049|158394002|FG001|Overall Study|Death|1|||
49150852|NCT00803049|158394003|FG002|Overall Study|Death|0|||
49150853|NCT00803049|158394004|FG003|Overall Study|Death|2|||
49150854|NCT00803049|158394001|FG000|Overall Study|Progressive Disease|6|||
48824988|NCT00731042|157200685|FG001|Second Intervention|Did not meet inclusion criteria|2|||
48824989|NCT04213846|157200686|FG000|Overall Study|Withdrawal by Subject|7|||
48824990|NCT04213846|157200687|FG001|Overall Study|Withdrawal by Subject|6|||
48824991|NCT04213846|157200686|FG000|Overall Study|Lost to Follow-up|15|||
48824992|NCT04213846|157200687|FG001|Overall Study|Lost to Follow-up|21|||
48824993|NCT02264574|157200691|FG000|Overall Study|Death|21|||
48824994|NCT02264574|157200692|FG001|Overall Study|Death|21|||
48824995|NCT02264574|157200691|FG000|Overall Study|Withdrawal by Subject|8|||
48824996|NCT02264574|157200692|FG001|Overall Study|Withdrawal by Subject|6|||
48824997|NCT02264574|157200691|FG000|Overall Study|Other, Not Specified|0|||
48824998|NCT02264574|157200692|FG001|Overall Study|Other, Not Specified|3|||
48824999|NCT02263885|157200694|FG000|Overall Study|Withdrawal by Subject|7|||
48825000|NCT02263885|157200694|FG000|Overall Study|Alternative Treatment|3|||
48825001|NCT02256969|157200701|FG000|Overall Study|Screenfailed or withdrew|2|||
49150855|NCT00803049|158394002|FG001|Overall Study|Progressive Disease|10|||
49150856|NCT00803049|158394003|FG002|Overall Study|Progressive Disease|6|||
49150857|NCT00803049|158394004|FG003|Overall Study|Progressive Disease|6|||
49150858|NCT00803049|158394001|FG000|Overall Study|Withdrawal by Subject|19|||
49150859|NCT00803049|158394002|FG001|Overall Study|Withdrawal by Subject|43|||
48825002|NCT02256969|157200702|FG001|Overall Study|Screenfailed or withdrew|1|||
48825003|NCT02256969|157200703|FG002|Overall Study|Screenfailed or withdrew|1|||
48825004|NCT02347943|157200704|FG000|Overall Study|Study was cancelled|140|||
48825005|NCT02347943|157200705|FG001|Overall Study|Study was cancelled|67|||
48825006|NCT02347943|157200706|FG002|Overall Study|Study was cancelled|45|||
48825007|NCT02049437|157200711|FG000|Period 1|Adverse Event|1|||
48825008|NCT02049437|157200712|FG001|Period 1|Adverse Event|1|||
48825009|NCT02049437|157200711|FG000|Period 1|Adverse Event|1|||
48825010|NCT02049437|157200712|FG001|Period 1|Adverse Event|0|||
48825011|NCT00797225|157200720|FG000|Weeks 1 to 12|Adverse Event|0|||
48825012|NCT00797225|157200721|FG001|Weeks 1 to 12|Adverse Event|0|||
48825013|NCT00797225|157200722|FG002|Weeks 1 to 12|Adverse Event|1|||
48825014|NCT00797225|157200723|FG003|Weeks 1 to 12|Adverse Event|0|||
48825015|NCT00797225|157200724|FG004|Weeks 1 to 12|Adverse Event|0|||
48825016|NCT00797225|157200725|FG005|Weeks 1 to 12|Adverse Event|0|||
48825017|NCT00797225|157200726|FG006|Weeks 1 to 12|Adverse Event|0|||
48825018|NCT00797225|157200727|FG007|Weeks 1 to 12|Adverse Event|0|||
48825019|NCT00797225|157200720|FG000|Weeks 1 to 12|Non-compliance|0|||
49150860|NCT00803049|158394003|FG002|Overall Study|Withdrawal by Subject|16|||
48825020|NCT00797225|157200721|FG001|Weeks 1 to 12|Non-compliance|1|||
48825021|NCT00797225|157200722|FG002|Weeks 1 to 12|Non-compliance|0|||
48825022|NCT00797225|157200723|FG003|Weeks 1 to 12|Non-compliance|0|||
48825023|NCT00797225|157200724|FG004|Weeks 1 to 12|Non-compliance|0|||
49150861|NCT00803049|158394004|FG003|Overall Study|Withdrawal by Subject|44|||
49150862|NCT00803049|158394001|FG000|Overall Study|Protocol Violation|0|||
49150863|NCT00803049|158394002|FG001|Overall Study|Protocol Violation|1|||
49150864|NCT00803049|158394003|FG002|Overall Study|Protocol Violation|1|||
49150865|NCT00803049|158394004|FG003|Overall Study|Protocol Violation|0|||
49150866|NCT00803049|158394001|FG000|Overall Study|Randomized and Not Treated|0|||
49150867|NCT00803049|158394002|FG001|Overall Study|Randomized and Not Treated|0|||
49150868|NCT00803049|158394003|FG002|Overall Study|Randomized and Not Treated|0|||
49150869|NCT00803049|158394004|FG003|Overall Study|Randomized and Not Treated|2|||
49150870|NCT00803049|158394001|FG000|Overall Study|Other than Specified Above|3|||
49150871|NCT00803049|158394002|FG001|Overall Study|Other than Specified Above|9|||
49150872|NCT00803049|158394003|FG002|Overall Study|Other than Specified Above|2|||
49150873|NCT00803049|158394004|FG003|Overall Study|Other than Specified Above|5|||
49150874|NCT05852340|158394013|FG000|Period 5|Not completing the meal|0|||
49150875|NCT05852340|158394014|FG001|Period 5|Not completing the meal|1|||
49150876|NCT05852340|158394015|FG002|Period 5|Not completing the meal|0|||
48825024|NCT00797225|157200725|FG005|Weeks 1 to 12|Non-compliance|0|||
48825025|NCT00797225|157200726|FG006|Weeks 1 to 12|Non-compliance|0|||
48825026|NCT00797225|157200727|FG007|Weeks 1 to 12|Non-compliance|0|||
49150877|NCT05852340|158394016|FG003|Period 5|Not completing the meal|0|||
49150878|NCT05852340|158394013|FG000|Period 5|Adverse Event|0|||
49150879|NCT05852340|158394014|FG001|Period 5|Adverse Event|0|||
49150880|NCT05852340|158394015|FG002|Period 5|Adverse Event|0|||
49150881|NCT05852340|158394016|FG003|Period 5|Adverse Event|1|||
49150882|NCT02052882|158394017|FG000|Overall Study|Not treated|11|||
49150883|NCT02052882|158394017|FG000|Overall Study|Protocol Violation|1|||
49150884|NCT02052882|158394017|FG000|Overall Study|Inadequate testing|1|||
49150885|NCT01344226|158394018|FG000|Overall Study|Protocol Violation|2|||
49150886|NCT01344226|158394018|FG000|Overall Study|Withdrawal by Subject|3|||
49150887|NCT01344226|158394018|FG000|Overall Study|Lack of Efficacy|3|||
49150888|NCT02255656|158394019|FG000|Overall Study|Adverse Event|11|||
49150889|NCT02255656|158394019|FG000|Overall Study|Poor compliance to protocol|3|||
49150890|NCT02255656|158394019|FG000|Overall Study|Lost to Follow-up|30|||
49150891|NCT02255656|158394019|FG000|Overall Study|Due to Coronavirus Disease (Covid-19)|300|||
49150892|NCT02255656|158394019|FG000|Overall Study|Other|126|||
49150893|NCT02321514|158394021|FG000|Overall Study|Death|15|||
49150894|NCT02321514|158394021|FG000|Overall Study|Missed Visit|7|||
49150895|NCT02321514|158394021|FG000|Overall Study|Study Exit|3|||
49150896|NCT04576455|158394022|FG000|Overall Study|Ongoing in the Study|122|||
49150897|NCT04576455|158394023|FG001|Overall Study|Ongoing in the Study|135|||
49150898|NCT04576455|158394022|FG000|Overall Study|Death|18|||
49150899|NCT04576455|158394023|FG001|Overall Study|Death|12|||
49150900|NCT04576455|158394022|FG000|Overall Study|Lost to Follow-up|1|||
49150901|NCT04576455|158394023|FG001|Overall Study|Lost to Follow-up|0|||
49150902|NCT04576455|158394022|FG000|Overall Study|Withdrawal by Subject|10|||
49150903|NCT04576455|158394023|FG001|Overall Study|Withdrawal by Subject|5|||
49150904|NCT03510715|158394024|FG000|Overall Study|Adverse Event|1|||
49150905|NCT03510715|158394025|FG001|Overall Study|Adverse Event|0|||
49150906|NCT00322218|158394031|FG000|Overall Study|Death|3|||
49150907|NCT00322218|158394032|FG001|Overall Study|Death|6|||
49150908|NCT05185453|158394036|FG000|Overall Study|Lost to Follow-up|13|||
49150909|NCT05185453|158394037|FG001|Overall Study|Lost to Follow-up|3|||
49150910|NCT05715827|158394046|FG000|Overall Study|Physician Decision|0|||
49150911|NCT05715827|158394047|FG001|Overall Study|Physician Decision|1|||
49150912|NCT05715827|158394046|FG000|Overall Study|console communication error|0|||
49150913|NCT05715827|158394047|FG001|Overall Study|console communication error|1|||
49150919|NCT03274466|158394062|FG000|Overall Study|Withdrawal by Subject|7|||
49150920|NCT03274466|158394063|FG001|Overall Study|Withdrawal by Subject|3|||
49150921|NCT03274466|158394062|FG000|Overall Study|Protocol Specified Withdrawal|5|||
49150922|NCT03274466|158394063|FG001|Overall Study|Protocol Specified Withdrawal|11|||
49150923|NCT03274466|158394062|FG000|Overall Study|Lost to Follow-up|5|||
49150924|NCT03274466|158394063|FG001|Overall Study|Lost to Follow-up|7|||
49150925|NCT03274466|158394062|FG000|Overall Study|Subject Non-compliance|0|||
49150926|NCT03274466|158394063|FG001|Overall Study|Subject Non-compliance|1|||
49150927|NCT03274466|158394062|FG000|Overall Study|Adverse Event|3|||
49150928|NCT03274466|158394063|FG001|Overall Study|Adverse Event|3|||
49150929|NCT03274466|158394062|FG000|Overall Study|Physician Decision|0|||
49150930|NCT03274466|158394063|FG001|Overall Study|Physician Decision|1|||
49150931|NCT03274466|158394062|FG000|Overall Study|Protocol Violation|3|||
48825027|NCT00797225|157200720|FG000|Weeks 1 to 12|Lack of Efficacy|1|||
49150932|NCT03274466|158394063|FG001|Overall Study|Protocol Violation|3|||
49150933|NCT02776735|158394078|FG000|Overall Study|Adverse Event|0|||
49150934|NCT02776735|158394079|FG001|Overall Study|Adverse Event|0|||
49150935|NCT02776735|158394080|FG002|Overall Study|Adverse Event|0|||
49150936|NCT02776735|158394081|FG003|Overall Study|Adverse Event|1|||
49150937|NCT02776735|158394082|FG004|Overall Study|Adverse Event|0|||
49150938|NCT02776735|158394083|FG005|Overall Study|Adverse Event|1|||
49150939|NCT02776735|158394078|FG000|Overall Study|Lost to Follow-up|0|||
49150940|NCT02776735|158394079|FG001|Overall Study|Lost to Follow-up|0|||
49150941|NCT02776735|158394080|FG002|Overall Study|Lost to Follow-up|0|||
49150942|NCT02776735|158394081|FG003|Overall Study|Lost to Follow-up|1|||
49150943|NCT02776735|158394082|FG004|Overall Study|Lost to Follow-up|0|||
49150944|NCT02776735|158394083|FG005|Overall Study|Lost to Follow-up|0|||
49150945|NCT02776735|158394078|FG000|Overall Study|Withdrawal by parent/guardian|0|||
49150946|NCT02776735|158394079|FG001|Overall Study|Withdrawal by parent/guardian|0|||
49150947|NCT02776735|158394080|FG002|Overall Study|Withdrawal by parent/guardian|2|||
49150948|NCT02776735|158394081|FG003|Overall Study|Withdrawal by parent/guardian|2|||
49150949|NCT02776735|158394082|FG004|Overall Study|Withdrawal by parent/guardian|0|||
49150950|NCT02776735|158394083|FG005|Overall Study|Withdrawal by parent/guardian|0|||
49150951|NCT02776735|158394078|FG000|Overall Study|Withdrawal by Subject|1|||
49150952|NCT02776735|158394079|FG001|Overall Study|Withdrawal by Subject|0|||
49150953|NCT02776735|158394080|FG002|Overall Study|Withdrawal by Subject|0|||
49150954|NCT02776735|158394081|FG003|Overall Study|Withdrawal by Subject|0|||
49150955|NCT02776735|158394082|FG004|Overall Study|Withdrawal by Subject|0|||
49150956|NCT02776735|158394083|FG005|Overall Study|Withdrawal by Subject|1|||
49150957|NCT02776735|158394078|FG000|Overall Study|Other|0|||
48825028|NCT00797225|157200721|FG001|Weeks 1 to 12|Lack of Efficacy|0|||
48825029|NCT00797225|157200722|FG002|Weeks 1 to 12|Lack of Efficacy|0|||
48825030|NCT00797225|157200723|FG003|Weeks 1 to 12|Lack of Efficacy|0|||
48732695|NCT02337738|156872380|FG001|Overall Study|Major Protocol Deviation (Pre-Treatment)|1|||
49150958|NCT02776735|158394079|FG001|Overall Study|Other|0|||
49150959|NCT02776735|158394080|FG002|Overall Study|Other|3|||
49150960|NCT02776735|158394081|FG003|Overall Study|Other|0|||
48825031|NCT00797225|157200724|FG004|Weeks 1 to 12|Lack of Efficacy|0|||
48825032|NCT00797225|157200725|FG005|Weeks 1 to 12|Lack of Efficacy|0|||
48825033|NCT00797225|157200726|FG006|Weeks 1 to 12|Lack of Efficacy|0|||
48825034|NCT00797225|157200727|FG007|Weeks 1 to 12|Lack of Efficacy|0|||
48825035|NCT00797225|157200720|FG000|Weeks 1 to 12|Sponsor Decision|1|||
48825036|NCT00797225|157200721|FG001|Weeks 1 to 12|Sponsor Decision|0|||
48825037|NCT00797225|157200722|FG002|Weeks 1 to 12|Sponsor Decision|0|||
48825038|NCT00797225|157200723|FG003|Weeks 1 to 12|Sponsor Decision|0|||
48825039|NCT00797225|157200724|FG004|Weeks 1 to 12|Sponsor Decision|0|||
48732696|NCT02337738|156872381|FG002|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
48732697|NCT02337738|156872379|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
48732698|NCT02337738|156872380|FG001|Overall Study|Pretreatment Event/Adverse Event|18|||
48732699|NCT02337738|156872381|FG002|Overall Study|Pretreatment Event/Adverse Event|21|||
48732700|NCT02337738|156872379|FG000|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
48732701|NCT02337738|156872380|FG001|Overall Study|Major Protocol Deviation (in-Treatment)|1|||
48732702|NCT02337738|156872381|FG002|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
48732703|NCT02337738|156872379|FG000|Overall Study|Voluntary Withdrawal|10|||
48732704|NCT02337738|156872380|FG001|Overall Study|Voluntary Withdrawal|5|||
48732705|NCT02337738|156872381|FG002|Overall Study|Voluntary Withdrawal|2|||
48732706|NCT02337738|156872379|FG000|Overall Study|Lack of Efficacy|2|||
48732707|NCT02337738|156872380|FG001|Overall Study|Lack of Efficacy|4|||
48732708|NCT02337738|156872381|FG002|Overall Study|Lack of Efficacy|0|||
48825040|NCT00797225|157200725|FG005|Weeks 1 to 12|Sponsor Decision|0|||
48825041|NCT00797225|157200726|FG006|Weeks 1 to 12|Sponsor Decision|0|||
48825042|NCT00797225|157200727|FG007|Weeks 1 to 12|Sponsor Decision|0|||
48825043|NCT00797225|157200720|FG000|Weeks 13 to 24|Non-compliance|0|||
48732709|NCT02337738|156872379|FG000|Overall Study|Investigator's Judgment|1|||
48732710|NCT02337738|156872380|FG001|Overall Study|Investigator's Judgment|1|||
48732711|NCT02337738|156872381|FG002|Overall Study|Investigator's Judgment|3|||
48732712|NCT02047227|156872385|FG000|Overall Study|Adverse Event|2|||
48732713|NCT02047227|156872386|FG001|Overall Study|Adverse Event|4|||
48732714|NCT02047227|156872385|FG000|Overall Study|Lost to Follow-up|0|||
48732715|NCT02047227|156872386|FG001|Overall Study|Lost to Follow-up|3|||
48732716|NCT02047227|156872385|FG000|Overall Study|Protocol Violation|1|||
48732717|NCT02047227|156872386|FG001|Overall Study|Protocol Violation|0|||
48732718|NCT02047227|156872385|FG000|Overall Study|Spontaneous pregnancy|1|||
48732719|NCT02047227|156872386|FG001|Overall Study|Spontaneous pregnancy|0|||
48732720|NCT02047227|156872385|FG000|Overall Study|Lack of ovarian response to stimulation|35|||
48732721|NCT02047227|156872386|FG001|Overall Study|Lack of ovarian response to stimulation|32|||
48732722|NCT02047227|156872385|FG000|Overall Study|No oocytes retrieved|21|||
48732723|NCT02047227|156872386|FG001|Overall Study|No oocytes retrieved|20|||
48732724|NCT02047227|156872385|FG000|Overall Study|No fertilization|61|||
48732725|NCT02047227|156872386|FG001|Overall Study|No fertilization|51|||
48825044|NCT00797225|157200721|FG001|Weeks 13 to 24|Non-compliance|2|||
48825045|NCT00797225|157200722|FG002|Weeks 13 to 24|Non-compliance|0|||
49150961|NCT02776735|158394082|FG004|Overall Study|Other|0|||
49150962|NCT02776735|158394083|FG005|Overall Study|Other|0|||
49150963|NCT00267488|158395104|FG000|Overall Study|Sponsor Terminated Study|9|||
49150964|NCT00267488|158395104|FG000|Overall Study|Protocol Violation|1|||
49150965|NCT00267488|158395104|FG000|Overall Study|Other (Disease Progression)|1|||
49150966|NCT02374255|158395105|FG000|Overall Study|Withdrawal by Subject|2|||
49150967|NCT02374255|158395106|FG001|Overall Study|Withdrawal by Subject|0|||
49150968|NCT02374255|158395107|FG002|Overall Study|Withdrawal by Subject|0|||
49150969|NCT02374255|158395108|FG003|Overall Study|Withdrawal by Subject|0|||
49150970|NCT03384966|158395113|FG000|Randomized at End of Screening Period|Physician decision due to adverse event|1|||
49150971|NCT03384966|158395114|FG001|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
49150972|NCT03384966|158395115|FG002|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
49150973|NCT03384966|158395113|FG000|Follow-up Period|Adverse Event|1|||
49150974|NCT03384966|158395114|FG001|Follow-up Period|Adverse Event|0|||
49150975|NCT03384966|158395115|FG002|Follow-up Period|Adverse Event|0|||
49150976|NCT02801578|158395116|FG000|Overall Study|Adverse Event|2|||
48732726|NCT02047227|156872385|FG000|Overall Study|Intention to freeze all embryos|1|||
48732727|NCT02047227|156872386|FG001|Overall Study|Intention to freeze all embryos|0|||
48732728|NCT02047227|156872385|FG000|Overall Study|All embryos discarded|12|||
48732729|NCT02047227|156872386|FG001|Overall Study|All embryos discarded|11|||
48732730|NCT02047227|156872385|FG000|Overall Study|Other|10|||
48732731|NCT02047227|156872386|FG001|Overall Study|Other|9|||
49150977|NCT00137449|158395117|FG000|Overall Study|Disease Progression|8|||
48825046|NCT00797225|157200723|FG003|Weeks 13 to 24|Non-compliance|0|||
48825047|NCT00797225|157200724|FG004|Weeks 13 to 24|Non-compliance|0|||
48825048|NCT00797225|157200725|FG005|Weeks 13 to 24|Non-compliance|0|||
48732732|NCT01898208|156872395|FG000|Overall Study|Positive blood culture|17|||
48732733|NCT01898208|156872396|FG001|Overall Study|Positive blood culture|23|||
49150978|NCT00137449|158395118|FG001|Overall Study|Disease Progression|13|||
49150979|NCT00137449|158395117|FG000|Overall Study|Death|4|||
48732734|NCT01898208|156872397|FG002|Overall Study|Positive blood culture|15|||
48732735|NCT01898208|156872395|FG000|Overall Study|Death/comfort care within 24 hours|10|||
48732736|NCT01898208|156872396|FG001|Overall Study|Death/comfort care within 24 hours|9|||
48732737|NCT01898208|156872397|FG002|Overall Study|Death/comfort care within 24 hours|8|||
48825049|NCT00797225|157200726|FG006|Weeks 13 to 24|Non-compliance|0|||
48825050|NCT00797225|157200727|FG007|Weeks 13 to 24|Non-compliance|0|||
48825051|NCT00797225|157200720|FG000|Weeks 13 to 24|Withdrawal by Subject|0|||
48825052|NCT00797225|157200721|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
48732738|NCT01898208|156872395|FG000|Overall Study|Negative Gram Stain|6|||
48732739|NCT01898208|156872396|FG001|Overall Study|Negative Gram Stain|9|||
48732740|NCT01898208|156872397|FG002|Overall Study|Negative Gram Stain|6|||
48732741|NCT01898208|156872395|FG000|Overall Study|Non-Blood Specimens in Bottles|3|||
48732742|NCT01898208|156872396|FG001|Overall Study|Non-Blood Specimens in Bottles|5|||
48732743|NCT01898208|156872397|FG002|Overall Study|Non-Blood Specimens in Bottles|4|||
48732744|NCT01898208|156872395|FG000|Overall Study|System/Technical Error|1|||
48732745|NCT01898208|156872396|FG001|Overall Study|System/Technical Error|2|||
48825053|NCT00797225|157200722|FG002|Weeks 13 to 24|Withdrawal by Subject|1|||
48825054|NCT00797225|157200723|FG003|Weeks 13 to 24|Withdrawal by Subject|0|||
48732746|NCT01898208|156872397|FG002|Overall Study|System/Technical Error|3|||
48732747|NCT01898208|156872395|FG000|Overall Study|Lost to Follow-up|3|||
49150980|NCT00137449|158395118|FG001|Overall Study|Death|3|||
49150981|NCT00137449|158395117|FG000|Overall Study|Adverse Event|3|||
49150982|NCT00137449|158395118|FG001|Overall Study|Adverse Event|1|||
49150983|NCT00137449|158395117|FG000|Overall Study|Withdrawal by Subject|1|||
49150984|NCT00137449|158395118|FG001|Overall Study|Withdrawal by Subject|1|||
49150985|NCT01356940|158395119|FG000|First Intervention (28 Days)|Adverse Event|1|||
49150986|NCT01356940|158395120|FG001|First Intervention (28 Days)|Adverse Event|0|||
49150987|NCT01356940|158395119|FG000|Second Intervention (28 Days)|Withdrawal by Subject|1|||
49150988|NCT01356940|158395120|FG001|Second Intervention (28 Days)|Withdrawal by Subject|0|||
49150989|NCT03412591|158395123|FG000|Overall Study|Withdrawal by Subject|1|||
49150990|NCT03412591|158395124|FG001|Overall Study|Withdrawal by Subject|8|||
48732748|NCT01898208|156872396|FG001|Overall Study|Lost to Follow-up|1|||
48921535|NCT02109484|157546411|FG007|Overall Study|Physician Decision|0|||
48732749|NCT01898208|156872397|FG002|Overall Study|Lost to Follow-up|1|||
48732750|NCT03954132|156872398|FG000|Overall Study|Adverse Event|2|||
48732751|NCT03954132|156872399|FG001|Overall Study|Adverse Event|0|||
48732752|NCT03954132|156872398|FG000|Overall Study|Patient's wish|5|||
48732753|NCT03954132|156872399|FG001|Overall Study|Patient's wish|0|||
48732754|NCT03954132|156872398|FG000|Overall Study|Lost to Follow-up|10|||
48732755|NCT03954132|156872399|FG001|Overall Study|Lost to Follow-up|0|||
48732756|NCT03954132|156872398|FG000|Overall Study|Screening failure|0|||
48732757|NCT03954132|156872399|FG001|Overall Study|Screening failure|1|||
48732758|NCT03954132|156872398|FG000|Overall Study|No registration after Visit 1|5|||
48732759|NCT03954132|156872399|FG001|Overall Study|No registration after Visit 1|2|||
48732760|NCT03954132|156872398|FG000|Overall Study|Other reason than listed|2|||
48732761|NCT03954132|156872399|FG001|Overall Study|Other reason than listed|2|||
48732762|NCT03954132|156872398|FG000|Overall Study|Patient could not make visit due to vertebral fracture|1|||
48732763|NCT03954132|156872399|FG001|Overall Study|Patient could not make visit due to vertebral fracture|0|||
48732764|NCT03954132|156872398|FG000|Overall Study|False inclusion, violation of exclusion criteria|1|||
48825055|NCT00797225|157200724|FG004|Weeks 13 to 24|Withdrawal by Subject|0|||
48825056|NCT00797225|157200725|FG005|Weeks 13 to 24|Withdrawal by Subject|0|||
48825057|NCT00797225|157200726|FG006|Weeks 13 to 24|Withdrawal by Subject|0|||
48825058|NCT00797225|157200727|FG007|Weeks 13 to 24|Withdrawal by Subject|0|||
49150991|NCT03412591|158395123|FG000|Overall Study|Adverse Event|0|||
49150992|NCT03412591|158395124|FG001|Overall Study|Adverse Event|1|||
49150993|NCT02263547|158395125|FG000|Overall Study|Adverse Event|1|||
49150994|NCT02263547|158395125|FG000|Overall Study|Lost to Follow-up|2|||
49150995|NCT05166902|158395126|FG000|First Intervention|Lost to Follow-up|0|||
49150996|NCT05166902|158395127|FG001|First Intervention|Lost to Follow-up|1|||
49150997|NCT01381679|158395128|FG000|Overall Study|Adverse Event|3|||
49150998|NCT01381679|158395128|FG000|Overall Study|Lost to Follow-up|885|||
49150999|NCT01969409|158395131|FG000|Overall Study|Death|2|||
49151000|NCT01969409|158395132|FG001|Overall Study|Death|2|||
49151001|NCT01969409|158395131|FG000|Overall Study|Transplant|1|||
49151002|NCT01969409|158395132|FG001|Overall Study|Transplant|1|||
49151003|NCT01969409|158395131|FG000|Overall Study|Withdrawal by Subject|0|||
49151004|NCT01969409|158395132|FG001|Overall Study|Withdrawal by Subject|1|||
49151005|NCT00815633|158395136|FG000|Overall Study|study terminated|1|||
49151006|NCT02943473|158395137|FG000|Overall Study|enrolled but not dosed|1|||
49151007|NCT02943473|158395137|FG000|Overall Study|screen failure|1|||
48732765|NCT03954132|156872399|FG001|Overall Study|False inclusion, violation of exclusion criteria|0|||
48732766|NCT03516812|156872402|FG000|Overall Study|Adverse Event|4|||
48825059|NCT00797225|157200720|FG000|Weeks 13 to 24|Lost to Follow-up|0|||
49151008|NCT02943473|158395137|FG000|Overall Study|Physician Decision|4|||
49151009|NCT02038647|158395138|FG000|Overall Study|Progressive Disease|50|||
48732767|NCT03516812|156872402|FG000|Overall Study|Lack of Efficacy|2|||
48732768|NCT03945266|156872403|FG000|Overall Study|Withdrawal by Subject|1|||
48732769|NCT03945266|156872404|FG001|Overall Study|Withdrawal by Subject|0|||
48732770|NCT03945266|156872403|FG000|Overall Study|Miscarriage|0|||
48732771|NCT03945266|156872404|FG001|Overall Study|Miscarriage|2|||
48825060|NCT00797225|157200721|FG001|Weeks 13 to 24|Lost to Follow-up|0|||
48825061|NCT00797225|157200722|FG002|Weeks 13 to 24|Lost to Follow-up|1|||
49151010|NCT02038647|158395139|FG001|Overall Study|Progressive Disease|59|||
49151011|NCT02038647|158395138|FG000|Overall Study|Adverse Event|18|||
49151012|NCT02038647|158395139|FG001|Overall Study|Adverse Event|10|||
49151013|NCT02038647|158395138|FG000|Overall Study|Symptomatic Deterioration|7|||
49151014|NCT02038647|158395139|FG001|Overall Study|Symptomatic Deterioration|7|||
49151015|NCT02038647|158395138|FG000|Overall Study|Withdrawal by Subject|5|||
49151016|NCT02038647|158395139|FG001|Overall Study|Withdrawal by Subject|2|||
49151017|NCT02038647|158395138|FG000|Overall Study|Not Reported|0|||
49151018|NCT02038647|158395139|FG001|Overall Study|Not Reported|1|||
49151019|NCT02038647|158395138|FG000|Overall Study|Ongoing at Datacut|9|||
49151020|NCT02038647|158395139|FG001|Overall Study|Ongoing at Datacut|10|||
49151021|NCT05805150|158395140|FG000|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|0|||
48732772|NCT03945266|156872403|FG000|Overall Study|Lost to Follow-up|1|||
48732773|NCT03945266|156872404|FG001|Overall Study|Lost to Follow-up|0|||
48732774|NCT05147428|156872409|FG000|Overall Study|Removed prior to mailing|289|||
48732775|NCT05147428|156872410|FG001|Overall Study|Removed prior to mailing|306|||
48732776|NCT05147428|156872411|FG002|Overall Study|Removed prior to mailing|270|||
48732777|NCT05147428|156872409|FG000|Overall Study|Died or disenrolled during blackout period|239|||
48732778|NCT05147428|156872410|FG001|Overall Study|Died or disenrolled during blackout period|278|||
48825062|NCT00797225|157200723|FG003|Weeks 13 to 24|Lost to Follow-up|0|||
48825063|NCT00797225|157200724|FG004|Weeks 13 to 24|Lost to Follow-up|1|||
48825064|NCT00797225|157200725|FG005|Weeks 13 to 24|Lost to Follow-up|0|||
48825065|NCT00797225|157200726|FG006|Weeks 13 to 24|Lost to Follow-up|0|||
48825066|NCT00797225|157200727|FG007|Weeks 13 to 24|Lost to Follow-up|0|||
48825067|NCT00797225|157200720|FG000|Weeks 13 to 24|Adverse Event|0|||
48825068|NCT00797225|157200721|FG001|Weeks 13 to 24|Adverse Event|1|||
48825069|NCT00797225|157200722|FG002|Weeks 13 to 24|Adverse Event|0|||
48825070|NCT00797225|157200723|FG003|Weeks 13 to 24|Adverse Event|0|||
48825071|NCT00797225|157200724|FG004|Weeks 13 to 24|Adverse Event|0|||
48732779|NCT05147428|156872411|FG002|Overall Study|Died or disenrolled during blackout period|273|||
48732780|NCT00537238|156873740|FG000|Overall Study|Death|1|||
48732781|NCT00537238|156873741|FG001|Overall Study|Death|2|||
48732782|NCT00537238|156873740|FG000|Overall Study|Adverse Event|31|||
48732783|NCT00537238|156873741|FG001|Overall Study|Adverse Event|22|||
48732784|NCT00537238|156873740|FG000|Overall Study|Lack of Efficacy|20|||
48732785|NCT00537238|156873741|FG001|Overall Study|Lack of Efficacy|21|||
48732786|NCT00537238|156873740|FG000|Overall Study|Lost to Follow-up|12|||
48732787|NCT00537238|156873741|FG001|Overall Study|Lost to Follow-up|8|||
48732788|NCT00537238|156873740|FG000|Overall Study|Withdrawal by Subject|51|||
48732789|NCT00537238|156873741|FG001|Overall Study|Withdrawal by Subject|47|||
48732790|NCT00537238|156873740|FG000|Overall Study|Protocol Violation|15|||
48732791|NCT00537238|156873741|FG001|Overall Study|Protocol Violation|19|||
48732792|NCT00537238|156873740|FG000|Overall Study|Does not meet entrance criteria|0|||
48732793|NCT00537238|156873741|FG001|Overall Study|Does not meet entrance criteria|2|||
48732794|NCT00537238|156873740|FG000|Overall Study|Other|44|||
48732795|NCT00537238|156873741|FG001|Overall Study|Other|52|||
48732796|NCT01795638|156873744|FG000|Overall Study|Death|0|||
48732797|NCT01795638|156873745|FG001|Overall Study|Death|3|||
48732798|NCT01795638|156873744|FG000|Overall Study|transferred to quaternary hospital|2|||
48732799|NCT01795638|156873745|FG001|Overall Study|transferred to quaternary hospital|3|||
48732800|NCT01795638|156873744|FG000|Overall Study|Protocol Violation|3|||
48732801|NCT01795638|156873745|FG001|Overall Study|Protocol Violation|0|||
48825072|NCT00797225|157200725|FG005|Weeks 13 to 24|Adverse Event|0|||
48825073|NCT00797225|157200726|FG006|Weeks 13 to 24|Adverse Event|1|||
48825074|NCT00797225|157200727|FG007|Weeks 13 to 24|Adverse Event|0|||
48825075|NCT00797225|157200720|FG000|Weeks 13 to 24|Sponsor Decision|0|||
48825076|NCT00797225|157200721|FG001|Weeks 13 to 24|Sponsor Decision|0|||
49151022|NCT05805150|158395141|FG001|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|1|||
48732802|NCT01795638|156873744|FG000|Overall Study|discharged from hospital|7|||
48732803|NCT01795638|156873745|FG001|Overall Study|discharged from hospital|5|||
48732804|NCT01795638|156873744|FG000|Overall Study|Withdrawal by Subject|1|||
48732805|NCT01795638|156873745|FG001|Overall Study|Withdrawal by Subject|0|||
48732806|NCT03265665|156873746|FG000|24-week Data Collection|Withdrawal by Subject|2|||
48732807|NCT03265665|156873747|FG001|24-week Data Collection|Withdrawal by Subject|2|||
48825077|NCT00797225|157200722|FG002|Weeks 13 to 24|Sponsor Decision|0|||
49151023|NCT02284893|158395144|FG000|26 Week (Short Term)|Adverse Event|1|||
48732808|NCT03265665|156873746|FG000|24-week Data Collection|Lost to Follow-up|4|||
48732809|NCT03265665|156873747|FG001|24-week Data Collection|Lost to Follow-up|5|||
48732810|NCT03265665|156873746|FG000|36-week Data Collection|Lost to Follow-up|6|||
48825078|NCT00797225|157200723|FG003|Weeks 13 to 24|Sponsor Decision|0|||
48825079|NCT00797225|157200724|FG004|Weeks 13 to 24|Sponsor Decision|0|||
48825080|NCT00797225|157200725|FG005|Weeks 13 to 24|Sponsor Decision|0|||
48825081|NCT00797225|157200726|FG006|Weeks 13 to 24|Sponsor Decision|1|||
48825082|NCT00797225|157200727|FG007|Weeks 13 to 24|Sponsor Decision|0|||
48825083|NCT00578227|157200728|FG000|Overall Study|Lost to Follow-up|0|||
48825084|NCT00578227|157200729|FG001|Overall Study|Lost to Follow-up|1|||
48825085|NCT00578227|157200730|FG002|Overall Study|Lost to Follow-up|1|||
48825086|NCT00578227|157200728|FG000|Overall Study|Withdrawal by Subject|5|||
48825087|NCT00578227|157200729|FG001|Overall Study|Withdrawal by Subject|1|||
48825088|NCT00578227|157200730|FG002|Overall Study|Withdrawal by Subject|3|||
48825089|NCT02096003|157200731|FG000|Overall Study|Protocol Violation|0|||
48825090|NCT02096003|157200732|FG001|Overall Study|Protocol Violation|2|||
48825091|NCT02096003|157200731|FG000|Overall Study|additional surgery|2|||
48825092|NCT02096003|157200732|FG001|Overall Study|additional surgery|1|||
48825093|NCT01008748|157200733|FG000|Overall Study|Lost to Follow-up|80|||
48825094|NCT01008748|157200733|FG000|Overall Study|Other|1|||
48825095|NCT00506519|157200735|FG000|Overall Study|Death|4|||
48732811|NCT03265665|156873747|FG001|36-week Data Collection|Lost to Follow-up|8|||
48732812|NCT00721123|156873748|FG000|Overall Study|Adverse Event|96|||
48732813|NCT00721123|156873748|FG000|Overall Study|Death|10|||
48825096|NCT00506519|157200736|FG001|Overall Study|Death|6|||
48825097|NCT00506519|157200737|FG002|Overall Study|Death|0|||
48732814|NCT00721123|156873748|FG000|Overall Study|Insufficient Therapeutic Response|21|||
48732815|NCT00721123|156873748|FG000|Overall Study|Protocol Violation|1|||
48732816|NCT00721123|156873748|FG000|Overall Study|Refused Treatment|41|||
48732817|NCT00721123|156873748|FG000|Overall Study|Failure to Return|9|||
48825098|NCT00506519|157200735|FG000|Overall Study|Adverse Event|1|||
48825099|NCT00506519|157200736|FG001|Overall Study|Adverse Event|0|||
49151024|NCT02284893|158395145|FG001|26 Week (Short Term)|Adverse Event|9|||
49151025|NCT02284893|158395144|FG000|26 Week (Short Term)|Discontinuation by the subject|2|||
49151026|NCT02284893|158395145|FG001|26 Week (Short Term)|Discontinuation by the subject|2|||
49151027|NCT02284893|158395144|FG000|26 Week (Short Term)|Withrawal of the consent by the subject|7|||
49151028|NCT02284893|158395145|FG001|26 Week (Short Term)|Withrawal of the consent by the subject|10|||
49151029|NCT02284893|158395144|FG000|26 Week (Short Term)|Lost to Follow-up|3|||
49151030|NCT02284893|158395145|FG001|26 Week (Short Term)|Lost to Follow-up|1|||
49151031|NCT02284893|158395144|FG000|26 Week (Short Term)|Subject no longer meets study criteria|5|||
49151032|NCT02284893|158395145|FG001|26 Week (Short Term)|Subject no longer meets study criteria|8|||
49151033|NCT02284893|158395144|FG000|26 Week (Short Term)|Other|1|||
48825100|NCT00506519|157200737|FG002|Overall Study|Adverse Event|0|||
48825101|NCT01446003|157200738|FG000|Period 1|Protocol Violation|2|||
48825102|NCT01446003|157200739|FG001|Period 1|Protocol Violation|0|||
48825103|NCT01446003|157200738|FG000|Period 2|Adverse Event|1|||
48825104|NCT01446003|157200739|FG001|Period 2|Adverse Event|0|||
48732818|NCT00721123|156873748|FG000|Overall Study|Withdrawal by Subject|5|||
48732819|NCT02437513|156873749|FG000|Overall Study|Withdrawal by Subject|2|||
48732820|NCT03347188|156873757|FG000|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
48732821|NCT03347188|156873758|FG001|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
48732822|NCT03347188|156873757|FG000|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
48825105|NCT00318656|157200741|FG000|Overall Study|Took Avandamet instead of Glim/Met|0|||
48825106|NCT00318656|157200742|FG001|Overall Study|Took Avandamet instead of Glim/Met|1|||
48825107|NCT00318656|157200741|FG000|Overall Study|Did not receive any treatment|0|||
49151034|NCT02284893|158395145|FG001|26 Week (Short Term)|Other|1|||
49151035|NCT02284893|158395144|FG000|52 Week (Long Term)|Adverse Event|3|||
48732823|NCT03347188|156873758|FG001|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8|||
48732824|NCT03347188|156873757|FG000|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7|||
48825108|NCT00318656|157200742|FG001|Overall Study|Did not receive any treatment|1|||
48732825|NCT03347188|156873758|FG001|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
49151036|NCT02284893|158395145|FG001|52 Week (Long Term)|Adverse Event|1|||
49151037|NCT02284893|158395144|FG000|52 Week (Long Term)|Subject no longer meets study criteria|0|||
49151038|NCT02284893|158395145|FG001|52 Week (Long Term)|Subject no longer meets study criteria|1|||
49151039|NCT02284893|158395144|FG000|52 Week (Long Term)|Withrawal of the consent by the subject|4|||
49151040|NCT02284893|158395145|FG001|52 Week (Long Term)|Withrawal of the consent by the subject|6|||
49151041|NCT02284893|158395144|FG000|52 Week (Long Term)|Lost to Follow-up|2|||
49151042|NCT02284893|158395145|FG001|52 Week (Long Term)|Lost to Follow-up|2|||
49151043|NCT02284893|158395144|FG000|52 Week (Long Term)|Non-Compliance|2|||
49151044|NCT02284893|158395145|FG001|52 Week (Long Term)|Non-Compliance|3|||
49151045|NCT03078868|158395146|FG000|Overall Study|Physician Decision|3|||
49151046|NCT03502200|158395147|FG000|Overall Study|Adverse Event|1|||
49151047|NCT03502200|158395148|FG001|Overall Study|Adverse Event|0|||
49151048|NCT03502200|158395147|FG000|Overall Study|Lost to Follow-up|36|||
49151049|NCT03502200|158395148|FG001|Overall Study|Lost to Follow-up|38|||
49151050|NCT03502200|158395147|FG000|Overall Study|Study Team Decision|1|||
49151051|NCT03502200|158395148|FG001|Overall Study|Study Team Decision|1|||
49151052|NCT03502200|158395147|FG000|Overall Study|Withdrawal by Subject|5|||
49151053|NCT03502200|158395148|FG001|Overall Study|Withdrawal by Subject|7|||
49151054|NCT03502200|158395147|FG000|Overall Study|Death|0|||
49151055|NCT03502200|158395148|FG001|Overall Study|Death|2|||
49151056|NCT01435356|158395150|FG000|Overall Study|Adverse Event|2|||
49151057|NCT01435356|158395151|FG001|Overall Study|Adverse Event|0|||
49151058|NCT01435356|158395150|FG000|Overall Study|Disease progression/recurrence|17|||
49151059|NCT01435356|158395151|FG001|Overall Study|Disease progression/recurrence|10|||
49151060|NCT01435356|158395150|FG000|Overall Study|Protocol Violation|0|||
49151061|NCT01435356|158395151|FG001|Overall Study|Protocol Violation|1|||
49151062|NCT01435356|158395150|FG000|Overall Study|Study Discontinuation, amendment 4|5|||
49151063|NCT01435356|158395151|FG001|Overall Study|Study Discontinuation, amendment 4|11|||
49151064|NCT01435356|158395150|FG000|Overall Study|Withdrawal by Subject|1|||
49151065|NCT01435356|158395151|FG001|Overall Study|Withdrawal by Subject|1|||
49151066|NCT01435356|158395150|FG000|Overall Study|Facial palsy|1|||
49151067|NCT01435356|158395151|FG001|Overall Study|Facial palsy|0|||
49151068|NCT01435356|158395150|FG000|Overall Study|IC withdrawal due to study cancellation|1|||
49151069|NCT01435356|158395151|FG001|Overall Study|IC withdrawal due to study cancellation|0|||
49151070|NCT01435356|158395150|FG000|Overall Study|Physician Decision|1|||
49151071|NCT01435356|158395151|FG001|Overall Study|Physician Decision|0|||
49151072|NCT01435356|158395150|FG000|Overall Study|Patient decision|3|||
49151073|NCT01435356|158395151|FG001|Overall Study|Patient decision|0|||
49151074|NCT01435356|158395150|FG000|Overall Study|Patient moved to another city|1|||
49151075|NCT01435356|158395151|FG001|Overall Study|Patient moved to another city|1|||
49151076|NCT02971163|158395152|FG000|Overall Study|Lost to Follow-up|4|||
49151077|NCT02971163|158395153|FG001|Overall Study|Lost to Follow-up|2|||
49151078|NCT04100018|158395155|FG000|Pre-Treatment Period|Not Reported|0|||
49151079|NCT04100018|158395156|FG001|Pre-Treatment Period|Not Reported|4|||
49151080|NCT04100018|158395155|FG000|Pre-Treatment Period|Subject no longer meets study criteria|1|||
49151081|NCT04100018|158395156|FG001|Pre-Treatment Period|Subject no longer meets study criteria|1|||
49151082|NCT04100018|158395155|FG000|Pre-Treatment Period|Poor/Non-compliance|1|||
48825109|NCT04550039|157200743|FG000|Overall Study|discharge to acute care prior to completion of study|2|||
48825110|NCT04550039|157200744|FG001|Overall Study|discharge to acute care prior to completion of study|1|||
48825111|NCT04550039|157200743|FG000|Overall Study|patient self-withdrew from study|0|||
48825112|NCT04550039|157200744|FG001|Overall Study|patient self-withdrew from study|1|||
48825113|NCT02138916|157200745|FG000|Overall Study|eg., meds change, lack of efficacy, etc.|6|||
49151083|NCT04100018|158395156|FG001|Pre-Treatment Period|Poor/Non-compliance|0|||
49151084|NCT04100018|158395155|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
49151085|NCT04100018|158395156|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
49151086|NCT04100018|158395155|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
49151087|NCT04100018|158395156|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
49151088|NCT04100018|158395155|FG000|Treatment Period|Ongoing Treatment as of clinical cut off date|58|||
49151089|NCT04100018|158395156|FG001|Treatment Period|Ongoing Treatment as of clinical cut off date|52|||
49151090|NCT04100018|158395155|FG000|Treatment Period|Other Reason|18|||
49151091|NCT04100018|158395156|FG001|Treatment Period|Other Reason|29|||
49151092|NCT04100018|158395155|FG000|Treatment Period|Completed treatment as per protocol|0|||
49151093|NCT04100018|158395156|FG001|Treatment Period|Completed treatment as per protocol|1|||
49151094|NCT04100018|158395155|FG000|Treatment Period|Maximum clinical benefit|3|||
49151095|NCT04100018|158395156|FG001|Treatment Period|Maximum clinical benefit|0|||
49151096|NCT04100018|158395155|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
49151097|NCT04100018|158395156|FG001|Treatment Period|Adverse event unrelated to study drug|12|||
49151098|NCT04100018|158395155|FG000|Treatment Period|Study drug toxicity|67|||
49151099|NCT04100018|158395156|FG001|Treatment Period|Study drug toxicity|28|||
49151100|NCT04100018|158395155|FG000|Treatment Period|Disease Progression|269|||
49151101|NCT04100018|158395156|FG001|Treatment Period|Disease Progression|318|||
49151102|NCT04100018|158395155|FG000|Treatment Period|Administrative reasons by sponsor|1|||
49151103|NCT04100018|158395156|FG001|Treatment Period|Administrative reasons by sponsor|1|||
49151104|NCT04100018|158395155|FG000|Treatment Period|Poor/Non-Compliance|1|||
49151105|NCT04100018|158395156|FG001|Treatment Period|Poor/Non-Compliance|0|||
49151106|NCT04100018|158395155|FG000|Treatment Period|Lost to Follow-up|2|||
48732826|NCT03347188|156873757|FG000|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
48732827|NCT03347188|156873758|FG001|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
48732828|NCT03347188|156873757|FG000|Double-blind (DB) Period (12 Weeks)|Other than specified|1|||
48732829|NCT03347188|156873758|FG001|Double-blind (DB) Period (12 Weeks)|Other than specified|2|||
48732830|NCT03347188|156873757|FG000|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26|||
49151107|NCT04100018|158395156|FG001|Treatment Period|Lost to Follow-up|2|||
49151108|NCT04100018|158395155|FG000|Treatment Period|Death|14|||
49151109|NCT04100018|158395156|FG001|Treatment Period|Death|11|||
49151110|NCT04100018|158395155|FG000|Treatment Period|Participant withdrew consent|8|||
49151111|NCT04100018|158395156|FG001|Treatment Period|Participant withdrew consent|10|||
49151112|NCT04100018|158395155|FG000|Treatment Period|Participant request to discontinue study treatment|32|||
49151113|NCT04100018|158395156|FG001|Treatment Period|Participant request to discontinue study treatment|31|||
49151114|NCT04100018|158395155|FG000|Treatment Period|Adverse Event|12|||
49151115|NCT04100018|158395156|FG001|Treatment Period|Adverse Event|6|||
49151116|NCT04100018|158395155|FG000|Treatment Period|Lack of Efficacy|4|||
49151117|NCT04100018|158395156|FG001|Treatment Period|Lack of Efficacy|2|||
49151118|NCT00663260|158395158|FG000|Overall Study|Lack of Efficacy|2|||
49151119|NCT00663260|158395159|FG001|Overall Study|Lack of Efficacy|0|||
48732831|NCT03347188|156873758|FG001|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28|||
48732832|NCT03347188|156873757|FG000|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1|||
48732833|NCT03347188|156873758|FG001|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0|||
48732834|NCT03347188|156873757|FG000|Open-label (OL) Period (12 Weeks)|Other than specified|0|||
48732835|NCT03347188|156873758|FG001|Open-label (OL) Period (12 Weeks)|Other than specified|1|||
48732836|NCT01845818|156873759|FG000|Overall Study|Withdrawal by Subject|0|||
48732837|NCT01845818|156873760|FG001|Overall Study|Withdrawal by Subject|1|||
48732838|NCT01845818|156873759|FG000|Overall Study|Lost to Follow-up|7|||
48732839|NCT01845818|156873760|FG001|Overall Study|Lost to Follow-up|5|||
48732840|NCT01845818|156873759|FG000|Overall Study|Administrative Reasons|3|||
48732841|NCT01845818|156873760|FG001|Overall Study|Administrative Reasons|1|||
48732842|NCT01845818|156873759|FG000|Overall Study|Serious Adverse Event|1|||
48732843|NCT01845818|156873760|FG001|Overall Study|Serious Adverse Event|1|||
48732844|NCT01845818|156873759|FG000|Overall Study|Other|25|||
48732845|NCT01845818|156873760|FG001|Overall Study|Other|8|||
48732846|NCT01845818|156873759|FG000|Overall Study|Did Not Receive Any Dose of Adalimumab|5|||
48732847|NCT01845818|156873760|FG001|Overall Study|Did Not Receive Any Dose of Adalimumab|0|||
48732848|NCT01845818|156873759|FG000|Overall Study|No Follow-Up Data Available|4|||
48732849|NCT01845818|156873760|FG001|Overall Study|No Follow-Up Data Available|1|||
48732850|NCT03403374|156873761|FG000|Overall Study|Lost to Follow-up|1|||
48732851|NCT03228420|156873762|FG000|Overall Study|Lost to Follow-up|5|||
48732852|NCT03228420|156873763|FG001|Overall Study|Lost to Follow-up|3|||
48732853|NCT03228420|156873762|FG000|Overall Study|Withdrawal by Subject|10|||
48732854|NCT03228420|156873763|FG001|Overall Study|Withdrawal by Subject|0|||
48732855|NCT03228420|156873762|FG000|Overall Study|Adverse Event|5|||
48732856|NCT03228420|156873763|FG001|Overall Study|Adverse Event|2|||
48732857|NCT01298531|156873764|FG000|Overall Study|Lack of Efficacy|0|||
48732858|NCT01298531|156873765|FG001|Overall Study|Lack of Efficacy|1|||
48732859|NCT01298531|156873764|FG000|Overall Study|Lost to Follow-up|2|||
48732860|NCT01298531|156873765|FG001|Overall Study|Lost to Follow-up|0|||
48732861|NCT01298531|156873764|FG000|Overall Study|Protocol Violation|1|||
48732862|NCT01298531|156873765|FG001|Overall Study|Protocol Violation|1|||
48732863|NCT01298531|156873764|FG000|Overall Study|Adverse Event|4|||
48732864|NCT01298531|156873765|FG001|Overall Study|Adverse Event|3|||
48732865|NCT01298531|156873764|FG000|Overall Study|Does not meet entrance criteria|0|||
48732866|NCT01298531|156873765|FG001|Overall Study|Does not meet entrance criteria|1|||
49151120|NCT00663260|158395160|FG002|Overall Study|Lack of Efficacy|0|||
49151121|NCT00663260|158395158|FG000|Overall Study|Adverse Event|12|||
49151122|NCT00663260|158395159|FG001|Overall Study|Adverse Event|7|||
48732867|NCT01298531|156873764|FG000|Overall Study|Other|2|||
48732868|NCT01298531|156873765|FG001|Overall Study|Other|1|||
48732869|NCT00736957|156873766|FG000|Overall Study|Adverse Event|43|||
48732870|NCT00736957|156873766|FG000|Overall Study|Withdrawal by Subject|49|||
48732871|NCT00736957|156873766|FG000|Overall Study|violation of eligibility criteria|2|||
48732872|NCT00736957|156873766|FG000|Overall Study|did not attend hospital appointments|1|||
49151123|NCT00663260|158395160|FG002|Overall Study|Adverse Event|6|||
49151124|NCT00663260|158395158|FG000|Overall Study|Withdrawal by Subject|3|||
48921536|NCT02109484|157546404|FG000|Overall Study|Death|0|||
49151125|NCT00663260|158395159|FG001|Overall Study|Withdrawal by Subject|1|||
49151126|NCT00663260|158395160|FG002|Overall Study|Withdrawal by Subject|6|||
49151127|NCT00663260|158395158|FG000|Overall Study|Death|1|||
49151128|NCT00663260|158395159|FG001|Overall Study|Death|0|||
49151129|NCT00663260|158395160|FG002|Overall Study|Death|1|||
49151130|NCT00663260|158395158|FG000|Overall Study|Lost to Follow-up|0|||
49151131|NCT00663260|158395159|FG001|Overall Study|Lost to Follow-up|1|||
49151132|NCT00663260|158395160|FG002|Overall Study|Lost to Follow-up|0|||
49151133|NCT00663260|158395158|FG000|Overall Study|non-compliance, not met criteria, etc.|3|||
49151134|NCT00663260|158395159|FG001|Overall Study|non-compliance, not met criteria, etc.|2|||
49151135|NCT00663260|158395160|FG002|Overall Study|non-compliance, not met criteria, etc.|3|||
49151136|NCT03131479|158395164|FG000|Overall Study|Adverse Event|0|||
49151137|NCT03131479|158395165|FG001|Overall Study|Adverse Event|0|||
49151138|NCT03131479|158395166|FG002|Overall Study|Adverse Event|1|||
49151139|NCT03131479|158395167|FG003|Overall Study|Adverse Event|1|||
49151140|NCT03131479|158395168|FG004|Overall Study|Adverse Event|0|||
49151141|NCT03131479|158395164|FG000|Overall Study|Subject/Guardian Decision|0|||
49151142|NCT03131479|158395165|FG001|Overall Study|Subject/Guardian Decision|0|||
49151143|NCT03131479|158395166|FG002|Overall Study|Subject/Guardian Decision|0|||
49151144|NCT03131479|158395167|FG003|Overall Study|Subject/Guardian Decision|1|||
49151145|NCT03131479|158395168|FG004|Overall Study|Subject/Guardian Decision|0|||
49151146|NCT00980798|158395169|FG000|Overall Study|Adverse Event|7|||
49151147|NCT00980798|158395170|FG001|Overall Study|Adverse Event|36|||
49151148|NCT00980798|158395169|FG000|Overall Study|Lack of Efficacy|16|||
48732873|NCT00736957|156873766|FG000|Overall Study|not eligible for Treatment Period I|22|||
48732874|NCT00736957|156873766|FG000|Overall Study|Physician Decision|5|||
48732875|NCT00422097|156873767|FG000|Dose Level 2|Still on treatment|0|||
48732876|NCT00422097|156873768|FG001|Dose Level 2|Still on treatment|1|||
48732877|NCT00422097|156873769|FG002|Dose Level 2|Still on treatment|0|||
48732878|NCT00422097|156873770|FG003|Dose Level 2|Still on treatment|0|||
48732879|NCT00422097|156873771|FG004|Dose Level 2|Still on treatment|0|||
48732880|NCT00422097|156873772|FG005|Dose Level 2|Still on treatment|0|||
48732881|NCT00422097|156873773|FG006|Dose Level 2|Still on treatment|0|||
48732882|NCT00422097|156873774|FG007|Dose Level 2|Still on treatment|0|||
48732883|NCT01051466|156873775|FG000|Overall Study|Adverse Event|1|||
48732884|NCT01051466|156873776|FG001|Overall Study|Adverse Event|0|||
48732885|NCT01051466|156873775|FG000|Overall Study|Lost to Follow-up|1|||
48732886|NCT01051466|156873776|FG001|Overall Study|Lost to Follow-up|1|||
48732887|NCT01051466|156873775|FG000|Overall Study|Withdrawal by Subject|5|||
48825114|NCT02138916|157200746|FG001|Overall Study|eg., meds change, lack of efficacy, etc.|9|||
48825115|NCT02138916|157200747|FG002|Overall Study|eg., meds change, lack of efficacy, etc.|7|||
48825116|NCT02138916|157200745|FG000|Overall Study|Death|14|||
48825117|NCT02138916|157200746|FG001|Overall Study|Death|11|||
48825118|NCT02138916|157200747|FG002|Overall Study|Death|12|||
48825119|NCT02138916|157200745|FG000|Overall Study|Withdrawal by Subject|27|||
48825120|NCT02138916|157200746|FG001|Overall Study|Withdrawal by Subject|31|||
48825121|NCT02138916|157200747|FG002|Overall Study|Withdrawal by Subject|32|||
48825122|NCT02138916|157200745|FG000|Overall Study|Study specific withdrawal criteria|0|||
48825123|NCT02138916|157200746|FG001|Overall Study|Study specific withdrawal criteria|0|||
49151149|NCT00980798|158395170|FG001|Overall Study|Lack of Efficacy|5|||
48732888|NCT01051466|156873776|FG001|Overall Study|Withdrawal by Subject|1|||
48732889|NCT01051466|156873775|FG000|Overall Study|Entry Criteria Not Met|0|||
48732890|NCT01051466|156873776|FG001|Overall Study|Entry Criteria Not Met|3|||
48732891|NCT01051466|156873775|FG000|Overall Study|Physician Decision|1|||
48732892|NCT01051466|156873776|FG001|Overall Study|Physician Decision|0|||
48732893|NCT00331864|156873782|FG000|Overall Study|Adverse Event|30|||
48732894|NCT00331864|156873783|FG001|Overall Study|Adverse Event|1|||
48732895|NCT00331864|156873782|FG000|Overall Study|Lack of Efficacy|4|||
48732896|NCT00331864|156873783|FG001|Overall Study|Lack of Efficacy|0|||
48732897|NCT00331864|156873782|FG000|Overall Study|Protocol Violation|3|||
48732898|NCT00331864|156873783|FG001|Overall Study|Protocol Violation|0|||
48732899|NCT00331864|156873782|FG000|Overall Study|Withdrawal by Subject|10|||
48825124|NCT02138916|157200747|FG002|Overall Study|Study specific withdrawal criteria|1|||
48732900|NCT00331864|156873783|FG001|Overall Study|Withdrawal by Subject|0|||
48825125|NCT02138916|157200745|FG000|Overall Study|incorrect enrolment|1|||
49151150|NCT00980798|158395169|FG000|Overall Study|Lost to Follow-up|0|||
49151151|NCT00980798|158395170|FG001|Overall Study|Lost to Follow-up|1|||
49151152|NCT00980798|158395169|FG000|Overall Study|Physician Decision|2|||
49151153|NCT00980798|158395170|FG001|Overall Study|Physician Decision|1|||
49151154|NCT00980798|158395169|FG000|Overall Study|Withdrawal by Subject|8|||
49151155|NCT00980798|158395170|FG001|Overall Study|Withdrawal by Subject|11|||
48732901|NCT00331864|156873782|FG000|Overall Study|Lost to Follow-up|4|||
48732902|NCT00331864|156873783|FG001|Overall Study|Lost to Follow-up|3|||
48732903|NCT00331864|156873782|FG000|Overall Study|Administrative Problems|1|||
48732904|NCT00331864|156873783|FG001|Overall Study|Administrative Problems|0|||
48732905|NCT00331864|156873782|FG000|Overall Study|Death|6|||
48732906|NCT00331864|156873783|FG001|Overall Study|Death|0|||
49151156|NCT00980798|158395169|FG000|Overall Study|Other|0|||
48732907|NCT04521777|156873795|FG000|Overall Study|Death|2|||
48825126|NCT02138916|157200746|FG001|Overall Study|incorrect enrolment|1|||
48732908|NCT04521777|156873795|FG000|Overall Study|Withdrawal by Subject|2|||
48732909|NCT02213042|156873796|FG000|Overall Study|Disease progression (incl. death due to disease progression)|14|||
48825127|NCT02138916|157200747|FG002|Overall Study|incorrect enrolment|0|||
48825128|NCT02138916|157200745|FG000|Overall Study|Severe non-compliance|1|||
48825129|NCT02138916|157200746|FG001|Overall Study|Severe non-compliance|2|||
48825130|NCT02138916|157200747|FG002|Overall Study|Severe non-compliance|1|||
48732910|NCT02213042|156873797|FG001|Overall Study|Disease progression (incl. death due to disease progression)|13|||
48732911|NCT02213042|156873798|FG002|Overall Study|Disease progression (incl. death due to disease progression)|8|||
48732912|NCT02213042|156873796|FG000|Overall Study|Adverse Event|2|||
48732913|NCT02213042|156873797|FG001|Overall Study|Adverse Event|1|||
48732914|NCT02213042|156873798|FG002|Overall Study|Adverse Event|0|||
48732915|NCT02213042|156873796|FG000|Overall Study|Withdrawal by Subject|0|||
48732916|NCT02213042|156873797|FG001|Overall Study|Withdrawal by Subject|1|||
48732917|NCT02213042|156873798|FG002|Overall Study|Withdrawal by Subject|1|||
48732918|NCT02213042|156873796|FG000|Overall Study|Protocol Violation|1|||
48732919|NCT02213042|156873797|FG001|Overall Study|Protocol Violation|0|||
48732920|NCT02213042|156873798|FG002|Overall Study|Protocol Violation|0|||
48732921|NCT02213042|156873796|FG000|Overall Study|Investigator discretion|0|||
48732922|NCT02213042|156873797|FG001|Overall Study|Investigator discretion|0|||
48732923|NCT02213042|156873798|FG002|Overall Study|Investigator discretion|1|||
48732924|NCT04416633|156873799|FG000|Overall Study|Death|1|||
48825131|NCT02138916|157200745|FG000|Overall Study|Lost to Follow-up|4|||
48825132|NCT02138916|157200746|FG001|Overall Study|Lost to Follow-up|2|||
48825133|NCT02138916|157200747|FG002|Overall Study|Lost to Follow-up|3|||
48825134|NCT02138916|157200745|FG000|Overall Study|Adverse Event|4|||
48825135|NCT02138916|157200746|FG001|Overall Study|Adverse Event|4|||
48825136|NCT02138916|157200747|FG002|Overall Study|Adverse Event|3|||
48825137|NCT00783692|157200750|FG000|Induction Phase|Adverse Event|7|||
48825138|NCT00783692|157200751|FG001|Induction Phase|Adverse Event|9|||
48825139|NCT00783692|157200752|FG002|Induction Phase|Adverse Event|24|||
48825140|NCT00783692|157200753|FG003|Induction Phase|Adverse Event|0|||
48825141|NCT00783692|157200754|FG004|Induction Phase|Adverse Event|0|||
48825142|NCT00783692|157200755|FG005|Induction Phase|Adverse Event|0|||
48825143|NCT00783692|157200756|FG006|Induction Phase|Adverse Event|0|||
48825144|NCT00783692|157200750|FG000|Induction Phase|Protocol Violation|0|||
48825145|NCT00783692|157200751|FG001|Induction Phase|Protocol Violation|0|||
48825146|NCT00783692|157200752|FG002|Induction Phase|Protocol Violation|1|||
48825147|NCT00783692|157200753|FG003|Induction Phase|Protocol Violation|0|||
48825148|NCT00783692|157200754|FG004|Induction Phase|Protocol Violation|0|||
48825149|NCT00783692|157200755|FG005|Induction Phase|Protocol Violation|0|||
48825150|NCT00783692|157200756|FG006|Induction Phase|Protocol Violation|0|||
48825151|NCT00783692|157200750|FG000|Induction Phase|Lack of Efficacy|1|||
48825152|NCT00783692|157200751|FG001|Induction Phase|Lack of Efficacy|3|||
48825153|NCT00783692|157200752|FG002|Induction Phase|Lack of Efficacy|28|||
48825154|NCT00783692|157200753|FG003|Induction Phase|Lack of Efficacy|0|||
48825155|NCT00783692|157200754|FG004|Induction Phase|Lack of Efficacy|0|||
48825156|NCT00783692|157200755|FG005|Induction Phase|Lack of Efficacy|0|||
48825157|NCT00783692|157200756|FG006|Induction Phase|Lack of Efficacy|0|||
48825158|NCT00783692|157200750|FG000|Induction Phase|Withdrawal by Subject|3|||
48825159|NCT00783692|157200751|FG001|Induction Phase|Withdrawal by Subject|9|||
48825160|NCT00783692|157200752|FG002|Induction Phase|Withdrawal by Subject|16|||
48825161|NCT00783692|157200753|FG003|Induction Phase|Withdrawal by Subject|0|||
48825162|NCT00783692|157200754|FG004|Induction Phase|Withdrawal by Subject|0|||
48825163|NCT00783692|157200755|FG005|Induction Phase|Withdrawal by Subject|0|||
48825164|NCT00783692|157200756|FG006|Induction Phase|Withdrawal by Subject|0|||
48825165|NCT00783692|157200750|FG000|Induction Phase|Lost to Follow-up|0|||
48732925|NCT04416633|156873799|FG000|Overall Study|Disease progression as per investigator's clinical and imaging assessment|17|||
48732926|NCT04416633|156873799|FG000|Overall Study|AE greater than Grade 3 related to study drug|1|||
48732927|NCT04416633|156873799|FG000|Overall Study|Adverse Event|6|||
48825166|NCT00783692|157200751|FG001|Induction Phase|Lost to Follow-up|0|||
48825167|NCT00783692|157200752|FG002|Induction Phase|Lost to Follow-up|3|||
48732928|NCT04416633|156873799|FG000|Overall Study|Withdrawal by Subject|6|||
48732929|NCT05314478|156873800|FG000|Overall Study|Physician Decision|1|||
48825168|NCT00783692|157200753|FG003|Induction Phase|Lost to Follow-up|0|||
48825169|NCT00783692|157200754|FG004|Induction Phase|Lost to Follow-up|0|||
48825170|NCT00783692|157200755|FG005|Induction Phase|Lost to Follow-up|0|||
48825171|NCT00783692|157200756|FG006|Induction Phase|Lost to Follow-up|0|||
48825172|NCT00783692|157200750|FG000|Induction Phase|Other|0|||
48732930|NCT01025154|156873804|FG000|Overall Study|Lost to Follow-up|1|||
48825173|NCT00783692|157200751|FG001|Induction Phase|Other|0|||
48825174|NCT00783692|157200752|FG002|Induction Phase|Other|2|||
48732931|NCT01025154|156873804|FG000|Overall Study|Withdrawal by Subject|1|||
48732932|NCT03875768|156873806|FG000|Overall Study|Lost to Follow-up|16|||
48825175|NCT00783692|157200753|FG003|Induction Phase|Other|0|||
48732933|NCT03875768|156873807|FG001|Overall Study|Lost to Follow-up|13|||
48825176|NCT00783692|157200754|FG004|Induction Phase|Other|0|||
48921537|NCT02109484|157546405|FG001|Overall Study|Death|0|||
48732934|NCT03875768|156873806|FG000|Overall Study|Withdrawal by Subject|10|||
48732935|NCT03875768|156873807|FG001|Overall Study|Withdrawal by Subject|21|||
48732936|NCT03875768|156873806|FG000|Overall Study|Did not complete assessment|21|||
48732937|NCT03875768|156873807|FG001|Overall Study|Did not complete assessment|12|||
48732938|NCT03875768|156873806|FG000|Overall Study|Became ineligible|1|||
48921538|NCT02109484|157546406|FG002|Overall Study|Death|0|||
48921539|NCT02109484|157546407|FG003|Overall Study|Death|0|||
48921540|NCT02109484|157546408|FG004|Overall Study|Death|0|||
48732939|NCT03875768|156873807|FG001|Overall Study|Became ineligible|0|||
48732940|NCT03343067|156873808|FG000|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0|||
48921541|NCT02109484|157546409|FG005|Overall Study|Death|0|||
48921542|NCT02109484|157546410|FG006|Overall Study|Death|0|||
48921543|NCT02109484|157546411|FG007|Overall Study|Death|2|||
48921544|NCT02109484|157546404|FG000|Overall Study|Moved away from study area|0|||
48921545|NCT02109484|157546405|FG001|Overall Study|Moved away from study area|0|||
48921546|NCT02109484|157546406|FG002|Overall Study|Moved away from study area|0|||
48921547|NCT02109484|157546407|FG003|Overall Study|Moved away from study area|0|||
48921548|NCT02109484|157546408|FG004|Overall Study|Moved away from study area|0|||
48921549|NCT02109484|157546409|FG005|Overall Study|Moved away from study area|0|||
48921550|NCT02109484|157546410|FG006|Overall Study|Moved away from study area|1|||
48921551|NCT02109484|157546411|FG007|Overall Study|Moved away from study area|1|||
48921552|NCT00419380|157546414|FG000|Overall Study|Lack of Efficacy|1|||
48921553|NCT00419380|157546415|FG001|Overall Study|Lack of Efficacy|7|||
48921554|NCT00419380|157546414|FG000|Overall Study|Physician Decision|0|||
49151157|NCT00980798|158395170|FG001|Overall Study|Other|1|||
49151158|NCT02607722|158395174|FG000|Overall Study|No data reliability|1|||
48921555|NCT00419380|157546415|FG001|Overall Study|Physician Decision|1|||
48921556|NCT00419380|157546414|FG000|Overall Study|Lost to Follow-up|0|||
49151159|NCT02607722|158395174|FG000|Overall Study|no patient visit|18|||
48921557|NCT00419380|157546415|FG001|Overall Study|Lost to Follow-up|1|||
48921558|NCT00419380|157546414|FG000|Overall Study|Withdrawal by Subject|0|||
48921559|NCT00419380|157546415|FG001|Overall Study|Withdrawal by Subject|1|||
48921560|NCT03298022|157546416|FG000|Overall Study|Lack of Efficacy|4|||
48921561|NCT03298022|157546416|FG000|Overall Study|Withdrawal by Subject|7|||
48921562|NCT03298022|157546416|FG000|Overall Study|Adverse Event|1|||
48921563|NCT03298022|157546416|FG000|Overall Study|disease relapse|1|||
48921564|NCT00689871|157546423|FG000|Overall Study|Lost to Follow-up|123|||
48921565|NCT00689871|157546424|FG001|Overall Study|Lost to Follow-up|13|||
48921566|NCT00689871|157546425|FG002|Overall Study|Lost to Follow-up|37|||
48921567|NCT00689871|157546426|FG003|Overall Study|Lost to Follow-up|1|||
48921568|NCT00689871|157546423|FG000|Overall Study|Explanted of All Study Devices|36|||
48921569|NCT00689871|157546424|FG001|Overall Study|Explanted of All Study Devices|25|||
48921570|NCT00689871|157546425|FG002|Overall Study|Explanted of All Study Devices|29|||
48921571|NCT00689871|157546426|FG003|Overall Study|Explanted of All Study Devices|3|||
49151160|NCT02607722|158395174|FG000|Overall Study|missing info in CRF|13|||
48921572|NCT00689871|157546423|FG000|Overall Study|Withdrawal by Subject|13|||
48921573|NCT00689871|157546424|FG001|Overall Study|Withdrawal by Subject|3|||
48921574|NCT00689871|157546425|FG002|Overall Study|Withdrawal by Subject|4|||
48921575|NCT00689871|157546426|FG003|Overall Study|Withdrawal by Subject|1|||
48921576|NCT00689871|157546423|FG000|Overall Study|Death|1|||
48921577|NCT00689871|157546424|FG001|Overall Study|Death|10|||
48921578|NCT00689871|157546425|FG002|Overall Study|Death|2|||
48921579|NCT00689871|157546426|FG003|Overall Study|Death|2|||
48921580|NCT00689871|157546423|FG000|Overall Study|Physician Decision|2|||
48732941|NCT03343067|156873809|FG001|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3|||
48732942|NCT03343067|156873810|FG002|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1|||
48921581|NCT00689871|157546424|FG001|Overall Study|Physician Decision|1|||
49151161|NCT02607722|158395174|FG000|Overall Study|Withdrawal by Subject|616|||
48732943|NCT00580970|156873813|FG000|Pre-treatment|Non-compliance|1|||
49151162|NCT02607722|158395174|FG000|Overall Study|Lost to Follow-up|312|||
49151163|NCT02607722|158395174|FG000|Overall Study|Improved|22|||
48732944|NCT00580970|156873813|FG000|Treatment (Lovastatin)|Non-compliance|6|||
48732945|NCT00580970|156873813|FG000|Treatment (Lovastatin)|Intolerance of Lovastatin|7|||
48732946|NCT00580970|156873813|FG000|Treatment (Lovastatin)|Physician Decision|4|||
48732947|NCT00580970|156873813|FG000|Treatment (Lovastatin)|Development of metastatic second primary|1|||
48732948|NCT00580970|156873813|FG000|Treatment (Lovastatin)|Death|1|||
48732949|NCT01104155|156873821|FG000|Overall Study|Adverse Event|15|||
48732950|NCT01104155|156873822|FG001|Overall Study|Adverse Event|8|||
48732951|NCT01104155|156873821|FG000|Overall Study|Participant choice|6|||
48732952|NCT01104155|156873822|FG001|Overall Study|Participant choice|5|||
48732953|NCT01104155|156873821|FG000|Overall Study|Withdrawal of consent|1|||
48732954|NCT01104155|156873822|FG001|Overall Study|Withdrawal of consent|1|||
48732955|NCT01104155|156873821|FG000|Overall Study|Other|3|||
48732956|NCT01104155|156873822|FG001|Overall Study|Other|4|||
48921582|NCT00689871|157546425|FG002|Overall Study|Physician Decision|1|||
48921583|NCT00689871|157546426|FG003|Overall Study|Physician Decision|0|||
49151164|NCT02607722|158395174|FG000|Overall Study|Lack of Efficacy|316|||
49151165|NCT02607722|158395174|FG000|Overall Study|Adverse Event|2553|||
49151166|NCT02607722|158395174|FG000|Overall Study|Not treated|1|||
49151167|NCT02607722|158395174|FG000|Overall Study|No CRF collected|138|||
49151168|NCT02607722|158395174|FG000|Overall Study|without CRF|4225|||
49151169|NCT02607722|158395174|FG000|Overall Study|Physician Decision|367|||
49151170|NCT00432965|158395177|FG000|Overall Study|Lost to Follow-up|22|||
49151171|NCT00432965|158395178|FG001|Overall Study|Lost to Follow-up|19|||
49151172|NCT00432965|158395177|FG000|Overall Study|Withdrawal by Subject|13|||
49151173|NCT00432965|158395178|FG001|Overall Study|Withdrawal by Subject|13|||
49151174|NCT00432965|158395177|FG000|Overall Study|Physician Decision|14|||
49151175|NCT00432965|158395178|FG001|Overall Study|Physician Decision|13|||
49151176|NCT00432965|158395177|FG000|Overall Study|Lack of Efficacy|8|||
49151177|NCT00432965|158395178|FG001|Overall Study|Lack of Efficacy|13|||
49151178|NCT00432965|158395177|FG000|Overall Study|Non-compliance|7|||
49151179|NCT00432965|158395178|FG001|Overall Study|Non-compliance|0|||
49151180|NCT00432965|158395177|FG000|Overall Study|Adverse Event|22|||
49151181|NCT00432965|158395178|FG001|Overall Study|Adverse Event|19|||
49151182|NCT00432965|158395177|FG000|Overall Study|Death|3|||
49151183|NCT00432965|158395178|FG001|Overall Study|Death|4|||
49151184|NCT00432965|158395177|FG000|Overall Study|Exclusionary Methods|1|||
49151185|NCT00432965|158395178|FG001|Overall Study|Exclusionary Methods|2|||
49151186|NCT00432965|158395177|FG000|Overall Study|Incomplete Data|4|||
49151187|NCT00432965|158395178|FG001|Overall Study|Incomplete Data|3|||
49151188|NCT02402647|158395179|FG000|Overall Study|Lost to Follow-up|13|||
49151189|NCT02402647|158395180|FG001|Overall Study|Lost to Follow-up|7|||
49151190|NCT02402647|158395179|FG000|Overall Study|Protocol Violation|1|||
49151191|NCT02402647|158395180|FG001|Overall Study|Protocol Violation|1|||
49151192|NCT02402647|158395179|FG000|Overall Study|scheduled and timed out|2|||
49151193|NCT02402647|158395180|FG001|Overall Study|scheduled and timed out|1|||
48825177|NCT00783692|157200755|FG005|Induction Phase|Other|0|||
48825178|NCT00783692|157200756|FG006|Induction Phase|Other|0|||
49151194|NCT02402647|158395179|FG000|Overall Study|medical illness|2|||
49151195|NCT02402647|158395180|FG001|Overall Study|medical illness|4|||
48825179|NCT00783692|157200750|FG000|Maintenance Phase|Adverse Event|7|||
48825180|NCT00783692|157200751|FG001|Maintenance Phase|Adverse Event|0|||
49151196|NCT02402647|158395179|FG000|Overall Study|Moved|2|||
49151197|NCT02402647|158395180|FG001|Overall Study|Moved|0|||
49151198|NCT02402647|158395179|FG000|Overall Study|loved one illness|1|||
49151199|NCT02402647|158395180|FG001|Overall Study|loved one illness|0|||
49151200|NCT02402647|158395179|FG000|Overall Study|deceased preexisting condition|2|||
49151201|NCT02402647|158395180|FG001|Overall Study|deceased preexisting condition|0|||
49151202|NCT02402647|158395179|FG000|Overall Study|Other|2|||
49151203|NCT02402647|158395180|FG001|Overall Study|Other|1|||
49151204|NCT05810597|158395183|FG000|Period 1|Adverse Event|2|||
49151205|NCT05810597|158395184|FG001|Period 1|Adverse Event|0|||
49151206|NCT05810597|158395183|FG000|Period 1|Physician Decision|1|||
49151207|NCT05810597|158395184|FG001|Period 1|Physician Decision|0|||
49151208|NCT00835354|158395185|FG000|First Intervention|Adverse Event|0|||
49151209|NCT00835354|158395186|FG001|First Intervention|Adverse Event|1|||
49151210|NCT02302222|158395195|FG000|Overall Study|Physician Decision|0|||
49151211|NCT02302222|158395196|FG001|Overall Study|Physician Decision|4|||
49151212|NCT02302222|158395195|FG000|Overall Study|Lost to Follow-up|1|||
49151213|NCT02302222|158395196|FG001|Overall Study|Lost to Follow-up|0|||
48825181|NCT00783692|157200752|FG002|Maintenance Phase|Adverse Event|0|||
48825182|NCT00783692|157200753|FG003|Maintenance Phase|Adverse Event|15|||
48825183|NCT00783692|157200754|FG004|Maintenance Phase|Adverse Event|12|||
48825184|NCT00783692|157200755|FG005|Maintenance Phase|Adverse Event|9|||
49151214|NCT02302222|158395195|FG000|Overall Study|Treatment discontinued before day 5|0|||
49151215|NCT02302222|158395196|FG001|Overall Study|Treatment discontinued before day 5|1|||
49151216|NCT02302222|158395195|FG000|Overall Study|Withdrawn prior to any treatment|0|||
49151217|NCT02302222|158395196|FG001|Overall Study|Withdrawn prior to any treatment|1|||
49151218|NCT04116489|158395200|FG000|Overall Study|Participant left facility and was no longer eligible|4|||
49151219|NCT04116489|158395200|FG000|Overall Study|Withdrawal by Subject|1|||
49151220|NCT03189719|158395201|FG000|Overall Study|Death|325|||
49151221|NCT03189719|158395202|FG001|Overall Study|Death|361|||
49151222|NCT03189719|158395201|FG000|Overall Study|Physician Decision|1|||
49151223|NCT03189719|158395202|FG001|Overall Study|Physician Decision|0|||
49151224|NCT03189719|158395201|FG000|Overall Study|Sponsor Decision|40|||
49151225|NCT03189719|158395202|FG001|Overall Study|Sponsor Decision|12|||
49151226|NCT03189719|158395201|FG000|Overall Study|Withdrawal by Subject|7|||
49151227|NCT03189719|158395202|FG001|Overall Study|Withdrawal by Subject|3|||
49151228|NCT01400412|158395212|FG000|Overall Study|Lost to Follow-up|4|||
49151229|NCT01400412|158395213|FG001|Overall Study|Lost to Follow-up|7|||
49151230|NCT01400412|158395212|FG000|Overall Study|Withdrawal by Subject|3|||
49151231|NCT01400412|158395213|FG001|Overall Study|Withdrawal by Subject|4|||
49151232|NCT01400412|158395212|FG000|Overall Study|Unable to complete|3|||
49151233|NCT01400412|158395213|FG001|Overall Study|Unable to complete|3|||
49151234|NCT01400412|158395212|FG000|Overall Study|Never started study treatment|0|||
49151235|NCT01400412|158395213|FG001|Overall Study|Never started study treatment|3|||
49151236|NCT01926509|158396871|FG000|Overall Study|vital sign met discontinuation criteria|1|||
49151237|NCT01926509|158396872|FG001|Overall Study|vital sign met discontinuation criteria|0|||
49151238|NCT01926509|158396873|FG002|Overall Study|vital sign met discontinuation criteria|0|||
49151239|NCT01926509|158396874|FG003|Overall Study|vital sign met discontinuation criteria|0|||
49151240|NCT02730169|158396875|FG000|Overall Study|Protocol Violation|1|||
49151241|NCT02730169|158396876|FG001|Overall Study|Protocol Violation|0|||
49151242|NCT02730169|158396877|FG002|Overall Study|Protocol Violation|0|||
49151243|NCT02730169|158396878|FG003|Overall Study|Protocol Violation|1|||
49151244|NCT02730169|158396875|FG000|Overall Study|Adverse Event|2|||
49151245|NCT02730169|158396876|FG001|Overall Study|Adverse Event|3|||
49151246|NCT02730169|158396877|FG002|Overall Study|Adverse Event|3|||
49151247|NCT02730169|158396878|FG003|Overall Study|Adverse Event|0|||
49151248|NCT02730169|158396875|FG000|Overall Study|Adverse Event of Special Interest|0|||
49151249|NCT02730169|158396876|FG001|Overall Study|Adverse Event of Special Interest|1|||
49151250|NCT02730169|158396877|FG002|Overall Study|Adverse Event of Special Interest|2|||
49151251|NCT02730169|158396878|FG003|Overall Study|Adverse Event of Special Interest|0|||
49151252|NCT02730169|158396875|FG000|Overall Study|Withdrawal by Subject|6|||
49151253|NCT02730169|158396876|FG001|Overall Study|Withdrawal by Subject|11|||
49151254|NCT02730169|158396877|FG002|Overall Study|Withdrawal by Subject|6|||
49151255|NCT02730169|158396878|FG003|Overall Study|Withdrawal by Subject|8|||
49151256|NCT02730169|158396875|FG000|Overall Study|Lost to Follow-up|5|||
49151257|NCT02730169|158396876|FG001|Overall Study|Lost to Follow-up|6|||
49151258|NCT02730169|158396877|FG002|Overall Study|Lost to Follow-up|5|||
49151259|NCT02730169|158396878|FG003|Overall Study|Lost to Follow-up|6|||
49151260|NCT02730169|158396875|FG000|Overall Study|Other|0|||
49151261|NCT02730169|158396876|FG001|Overall Study|Other|0|||
49151262|NCT02730169|158396877|FG002|Overall Study|Other|1|||
49151263|NCT02730169|158396878|FG003|Overall Study|Other|1|||
49151264|NCT00581100|158396879|FG000|Overall Study|Death|1|||
49151265|NCT00581100|158396880|FG001|Overall Study|Death|0|||
49151266|NCT00581100|158396879|FG000|Overall Study|Adverse Event|2|||
49151267|NCT00581100|158396880|FG001|Overall Study|Adverse Event|1|||
49151268|NCT00581100|158396879|FG000|Overall Study|Withdrawal by Subject|1|||
49151269|NCT00581100|158396880|FG001|Overall Study|Withdrawal by Subject|4|||
49151270|NCT00581100|158396879|FG000|Overall Study|Other|3|||
49151271|NCT00581100|158396880|FG001|Overall Study|Other|0|||
49151272|NCT03977155|158396885|FG000|Overall Study|Adverse Event|3|||
49151273|NCT03977155|158396886|FG001|Overall Study|Adverse Event|0|||
49151274|NCT03977155|158396887|FG002|Overall Study|Adverse Event|0|||
49151275|NCT03977155|158396885|FG000|Overall Study|Lost to Follow-up|0|||
49151276|NCT03977155|158396886|FG001|Overall Study|Lost to Follow-up|1|||
49151277|NCT03977155|158396887|FG002|Overall Study|Lost to Follow-up|0|||
49151278|NCT03977155|158396885|FG000|Overall Study|Withdrawal by Subject|1|||
49151279|NCT03977155|158396886|FG001|Overall Study|Withdrawal by Subject|1|||
49151280|NCT03977155|158396887|FG002|Overall Study|Withdrawal by Subject|2|||
49151281|NCT03977155|158396885|FG000|Overall Study|Participant was unable to come in for the Visit|1|||
49151282|NCT03977155|158396886|FG001|Overall Study|Participant was unable to come in for the Visit|0|||
49151283|NCT03977155|158396887|FG002|Overall Study|Participant was unable to come in for the Visit|0|||
49151284|NCT00500331|158396891|FG000|Overall Study|Adverse Event|0|||
49151285|NCT00500331|158396892|FG001|Overall Study|Adverse Event|2|||
49151286|NCT00500331|158396893|FG002|Overall Study|Adverse Event|0|||
49151287|NCT00500331|158396894|FG003|Overall Study|Adverse Event|1|||
49151288|NCT00500331|158396895|FG004|Overall Study|Adverse Event|2|||
49151289|NCT00500331|158396896|FG005|Overall Study|Adverse Event|2|||
49151290|NCT00500331|158396897|FG006|Overall Study|Adverse Event|0|||
49151291|NCT00500331|158396891|FG000|Overall Study|Lost to Follow-up|1|||
49151292|NCT00500331|158396892|FG001|Overall Study|Lost to Follow-up|1|||
49151293|NCT00500331|158396893|FG002|Overall Study|Lost to Follow-up|1|||
49151294|NCT00500331|158396894|FG003|Overall Study|Lost to Follow-up|2|||
49151295|NCT00500331|158396895|FG004|Overall Study|Lost to Follow-up|1|||
49151296|NCT00500331|158396896|FG005|Overall Study|Lost to Follow-up|0|||
49151297|NCT00500331|158396897|FG006|Overall Study|Lost to Follow-up|0|||
49151298|NCT00500331|158396891|FG000|Overall Study|Protocol Violation|3|||
49151299|NCT00500331|158396892|FG001|Overall Study|Protocol Violation|1|||
49151300|NCT00500331|158396893|FG002|Overall Study|Protocol Violation|1|||
49151301|NCT00500331|158396894|FG003|Overall Study|Protocol Violation|0|||
49151302|NCT00500331|158396895|FG004|Overall Study|Protocol Violation|1|||
49151303|NCT00500331|158396896|FG005|Overall Study|Protocol Violation|1|||
49151304|NCT00500331|158396897|FG006|Overall Study|Protocol Violation|1|||
49151305|NCT00500331|158396891|FG000|Overall Study|Withdrawal by Subject|4|||
49151306|NCT00500331|158396892|FG001|Overall Study|Withdrawal by Subject|0|||
49151307|NCT00500331|158396893|FG002|Overall Study|Withdrawal by Subject|1|||
49151308|NCT00500331|158396894|FG003|Overall Study|Withdrawal by Subject|5|||
48825185|NCT00783692|157200756|FG006|Maintenance Phase|Adverse Event|38|||
48825186|NCT00783692|157200750|FG000|Maintenance Phase|Protocol Violation|0|||
48825187|NCT00783692|157200751|FG001|Maintenance Phase|Protocol Violation|0|||
48825188|NCT00783692|157200752|FG002|Maintenance Phase|Protocol Violation|0|||
48825189|NCT00783692|157200753|FG003|Maintenance Phase|Protocol Violation|1|||
48825190|NCT00783692|157200754|FG004|Maintenance Phase|Protocol Violation|2|||
48825191|NCT00783692|157200755|FG005|Maintenance Phase|Protocol Violation|3|||
48825192|NCT00783692|157200756|FG006|Maintenance Phase|Protocol Violation|4|||
48825193|NCT00783692|157200750|FG000|Maintenance Phase|Lack of Efficacy|79|||
48825194|NCT00783692|157200751|FG001|Maintenance Phase|Lack of Efficacy|0|||
48825195|NCT00783692|157200752|FG002|Maintenance Phase|Lack of Efficacy|0|||
48825196|NCT00783692|157200753|FG003|Maintenance Phase|Lack of Efficacy|64|||
48825197|NCT00783692|157200754|FG004|Maintenance Phase|Lack of Efficacy|58|||
48825198|NCT00783692|157200755|FG005|Maintenance Phase|Lack of Efficacy|48|||
48825199|NCT00783692|157200756|FG006|Maintenance Phase|Lack of Efficacy|177|||
48825200|NCT00783692|157200750|FG000|Maintenance Phase|Withdrawal by Subject|7|||
48825201|NCT00783692|157200751|FG001|Maintenance Phase|Withdrawal by Subject|0|||
48825202|NCT00783692|157200752|FG002|Maintenance Phase|Withdrawal by Subject|0|||
48825203|NCT00783692|157200753|FG003|Maintenance Phase|Withdrawal by Subject|7|||
48825204|NCT00783692|157200754|FG004|Maintenance Phase|Withdrawal by Subject|6|||
48825205|NCT00783692|157200755|FG005|Maintenance Phase|Withdrawal by Subject|9|||
48825206|NCT00783692|157200756|FG006|Maintenance Phase|Withdrawal by Subject|24|||
48825207|NCT00783692|157200750|FG000|Maintenance Phase|Lost to Follow-up|2|||
48825208|NCT00783692|157200751|FG001|Maintenance Phase|Lost to Follow-up|0|||
48825209|NCT00783692|157200752|FG002|Maintenance Phase|Lost to Follow-up|0|||
48825210|NCT00783692|157200753|FG003|Maintenance Phase|Lost to Follow-up|1|||
48825211|NCT00783692|157200754|FG004|Maintenance Phase|Lost to Follow-up|3|||
48825212|NCT00783692|157200755|FG005|Maintenance Phase|Lost to Follow-up|2|||
48825213|NCT00783692|157200756|FG006|Maintenance Phase|Lost to Follow-up|5|||
48825214|NCT00783692|157200750|FG000|Maintenance Phase|Other|0|||
48825215|NCT00783692|157200751|FG001|Maintenance Phase|Other|0|||
48825216|NCT00783692|157200752|FG002|Maintenance Phase|Other|0|||
48825217|NCT00783692|157200753|FG003|Maintenance Phase|Other|1|||
48825218|NCT00783692|157200754|FG004|Maintenance Phase|Other|0|||
48825219|NCT00783692|157200755|FG005|Maintenance Phase|Other|1|||
48825220|NCT00783692|157200756|FG006|Maintenance Phase|Other|1|||
48825221|NCT05550337|157200757|FG000|Overall Study|Lack of Efficacy|0|||
48825222|NCT05550337|157200758|FG001|Overall Study|Lack of Efficacy|0|||
48825223|NCT05550337|157200759|FG002|Overall Study|Lack of Efficacy|1|||
48825224|NCT05550337|157200757|FG000|Overall Study|Adverse Event|1|||
48825225|NCT05550337|157200758|FG001|Overall Study|Adverse Event|5|||
48825226|NCT05550337|157200759|FG002|Overall Study|Adverse Event|0|||
48825227|NCT05550337|157200757|FG000|Overall Study|Withdrawal by Subject|8|||
48825228|NCT05550337|157200758|FG001|Overall Study|Withdrawal by Subject|14|||
48825229|NCT05550337|157200759|FG002|Overall Study|Withdrawal by Subject|10|||
48825230|NCT05550337|157200757|FG000|Overall Study|Pregnancy|0|||
48825231|NCT05550337|157200758|FG001|Overall Study|Pregnancy|0|||
48825232|NCT05550337|157200759|FG002|Overall Study|Pregnancy|1|||
48825233|NCT05550337|157200757|FG000|Overall Study|Protocol Violation|1|||
48825234|NCT05550337|157200758|FG001|Overall Study|Protocol Violation|3|||
48825235|NCT05550337|157200759|FG002|Overall Study|Protocol Violation|4|||
48825236|NCT05550337|157200757|FG000|Overall Study|Physician Decision|2|||
48825237|NCT05550337|157200758|FG001|Overall Study|Physician Decision|1|||
48825238|NCT05550337|157200759|FG002|Overall Study|Physician Decision|1|||
48825239|NCT05550337|157200757|FG000|Overall Study|Lost to Follow-up|16|||
48921584|NCT01505634|157546428|FG000|Overall Study|Withdrawal by Subject|2|||
49013964|NCT00910858|157887251|FG002|Combined Treatment Phase|Withdrawal by Subject|0|||
49013965|NCT00910858|157887249|FG000|Combined Treatment Phase|Protocol Violation|1|||
49013966|NCT00910858|157887250|FG001|Combined Treatment Phase|Protocol Violation|0|||
49013967|NCT00910858|157887251|FG002|Combined Treatment Phase|Protocol Violation|0|||
49013968|NCT00910858|157887249|FG000|Combined Treatment Phase|Other|0|||
49013969|NCT00910858|157887250|FG001|Combined Treatment Phase|Other|2|||
49013970|NCT00910858|157887251|FG002|Combined Treatment Phase|Other|1|||
49013971|NCT00696709|157887254|FG000|Overall Study|Withdrawal by Subject|1|||
49013972|NCT00696709|157887255|FG001|Overall Study|Withdrawal by Subject|2|||
49013973|NCT00696709|157887256|FG002|Overall Study|Withdrawal by Subject|1|||
49013974|NCT00696709|157887257|FG003|Overall Study|Withdrawal by Subject|4|||
49013975|NCT00696709|157887258|FG004|Overall Study|Withdrawal by Subject|3|||
49013976|NCT00696709|157887254|FG000|Overall Study|Protocol Violation|1|||
49013977|NCT00696709|157887255|FG001|Overall Study|Protocol Violation|0|||
49013978|NCT00696709|157887256|FG002|Overall Study|Protocol Violation|0|||
49013979|NCT00696709|157887257|FG003|Overall Study|Protocol Violation|0|||
49013980|NCT00696709|157887258|FG004|Overall Study|Protocol Violation|0|||
49013981|NCT00696709|157887254|FG000|Overall Study|Lost to Follow-up|1|||
49013982|NCT00696709|157887255|FG001|Overall Study|Lost to Follow-up|1|||
49013983|NCT00696709|157887256|FG002|Overall Study|Lost to Follow-up|0|||
49013984|NCT00696709|157887257|FG003|Overall Study|Lost to Follow-up|0|||
49013985|NCT00696709|157887258|FG004|Overall Study|Lost to Follow-up|0|||
48825240|NCT05550337|157200758|FG001|Overall Study|Lost to Follow-up|11|||
48825241|NCT05550337|157200759|FG002|Overall Study|Lost to Follow-up|11|||
48825242|NCT03861273|157200760|FG000|Screening Phase (3 Weeks)|Other|1|||
48825243|NCT03861273|157200760|FG000|Screening Phase (3 Weeks)|Screen failure|5|||
48825244|NCT03861273|157200760|FG000|Follow-up Phase (Year 1)|Ongoing|2|||
48825245|NCT03861273|157200760|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Ongoing|42|||
48825246|NCT03861273|157200760|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Withdrawal by Subject|1|||
48825247|NCT04873817|157200762|FG000|Overall Study|Subject and/or Family Request Withdrew Consent|3|||
49151309|NCT00500331|158396895|FG004|Overall Study|Withdrawal by Subject|0|||
49151310|NCT00500331|158396896|FG005|Overall Study|Withdrawal by Subject|1|||
49151311|NCT00500331|158396897|FG006|Overall Study|Withdrawal by Subject|1|||
49151312|NCT00500331|158396891|FG000|Overall Study|Lack of Efficacy|3|||
49151313|NCT00500331|158396892|FG001|Overall Study|Lack of Efficacy|1|||
49151314|NCT00500331|158396893|FG002|Overall Study|Lack of Efficacy|0|||
49151315|NCT00500331|158396894|FG003|Overall Study|Lack of Efficacy|0|||
49151316|NCT00500331|158396895|FG004|Overall Study|Lack of Efficacy|0|||
49151317|NCT00500331|158396896|FG005|Overall Study|Lack of Efficacy|0|||
49151318|NCT00500331|158396897|FG006|Overall Study|Lack of Efficacy|0|||
49151319|NCT00500331|158396891|FG000|Overall Study|Liver function test abnormality|0|||
49151320|NCT00500331|158396892|FG001|Overall Study|Liver function test abnormality|0|||
49151321|NCT00500331|158396893|FG002|Overall Study|Liver function test abnormality|1|||
49151322|NCT00500331|158396894|FG003|Overall Study|Liver function test abnormality|0|||
49151323|NCT00500331|158396895|FG004|Overall Study|Liver function test abnormality|0|||
49151324|NCT00500331|158396896|FG005|Overall Study|Liver function test abnormality|0|||
49151325|NCT00500331|158396897|FG006|Overall Study|Liver function test abnormality|0|||
49151326|NCT00500331|158396891|FG000|Overall Study|Increased serum creatinine from Baseline|0|||
49151327|NCT00500331|158396892|FG001|Overall Study|Increased serum creatinine from Baseline|0|||
49151328|NCT00500331|158396893|FG002|Overall Study|Increased serum creatinine from Baseline|0|||
49151329|NCT00500331|158396894|FG003|Overall Study|Increased serum creatinine from Baseline|0|||
49151330|NCT00500331|158396895|FG004|Overall Study|Increased serum creatinine from Baseline|0|||
49151331|NCT00500331|158396896|FG005|Overall Study|Increased serum creatinine from Baseline|1|||
49151332|NCT00500331|158396897|FG006|Overall Study|Increased serum creatinine from Baseline|0|||
49151333|NCT00500331|158396891|FG000|Overall Study|Didn't return for continuation of study|1|||
49151334|NCT00500331|158396892|FG001|Overall Study|Didn't return for continuation of study|0|||
49151335|NCT00500331|158396893|FG002|Overall Study|Didn't return for continuation of study|0|||
49151336|NCT00500331|158396894|FG003|Overall Study|Didn't return for continuation of study|0|||
49151337|NCT00500331|158396895|FG004|Overall Study|Didn't return for continuation of study|0|||
49151338|NCT00500331|158396896|FG005|Overall Study|Didn't return for continuation of study|0|||
49151339|NCT00500331|158396897|FG006|Overall Study|Didn't return for continuation of study|0|||
49151340|NCT00500331|158396891|FG000|Overall Study|Exclusion citeria not met on Visit 4|1|||
49151341|NCT00500331|158396892|FG001|Overall Study|Exclusion citeria not met on Visit 4|0|||
49151342|NCT00500331|158396893|FG002|Overall Study|Exclusion citeria not met on Visit 4|0|||
49151343|NCT00500331|158396894|FG003|Overall Study|Exclusion citeria not met on Visit 4|0|||
49151344|NCT00500331|158396895|FG004|Overall Study|Exclusion citeria not met on Visit 4|0|||
49151345|NCT00500331|158396896|FG005|Overall Study|Exclusion citeria not met on Visit 4|0|||
49151346|NCT00500331|158396897|FG006|Overall Study|Exclusion citeria not met on Visit 4|0|||
49151347|NCT00500331|158396891|FG000|Overall Study|Sponsor decided to withdraw participant|1|||
49151348|NCT00500331|158396892|FG001|Overall Study|Sponsor decided to withdraw participant|0|||
49151349|NCT00500331|158396893|FG002|Overall Study|Sponsor decided to withdraw participant|0|||
49151350|NCT00500331|158396894|FG003|Overall Study|Sponsor decided to withdraw participant|0|||
49151351|NCT00500331|158396895|FG004|Overall Study|Sponsor decided to withdraw participant|0|||
49151352|NCT00500331|158396896|FG005|Overall Study|Sponsor decided to withdraw participant|0|||
49151353|NCT00500331|158396897|FG006|Overall Study|Sponsor decided to withdraw participant|0|||
49151354|NCT00500331|158396891|FG000|Overall Study|Participant was randomized by mistake|1|||
49151355|NCT00500331|158396892|FG001|Overall Study|Participant was randomized by mistake|0|||
49151356|NCT00500331|158396893|FG002|Overall Study|Participant was randomized by mistake|0|||
49151357|NCT00500331|158396894|FG003|Overall Study|Participant was randomized by mistake|0|||
49151358|NCT00500331|158396895|FG004|Overall Study|Participant was randomized by mistake|0|||
49151359|NCT00500331|158396896|FG005|Overall Study|Participant was randomized by mistake|0|||
49151360|NCT00500331|158396897|FG006|Overall Study|Participant was randomized by mistake|0|||
49151361|NCT00500331|158396891|FG000|Overall Study|Diabetologist nurse in the study|0|||
49151362|NCT00500331|158396892|FG001|Overall Study|Diabetologist nurse in the study|0|||
49151363|NCT00500331|158396893|FG002|Overall Study|Diabetologist nurse in the study|1|||
49151364|NCT00500331|158396894|FG003|Overall Study|Diabetologist nurse in the study|0|||
49151365|NCT00500331|158396895|FG004|Overall Study|Diabetologist nurse in the study|0|||
49151366|NCT00500331|158396896|FG005|Overall Study|Diabetologist nurse in the study|0|||
48825248|NCT04873817|157200762|FG000|Overall Study|Lost to Follow-up|4|||
48825249|NCT04873817|157200762|FG000|Overall Study|Unsuccessful RFA Procedure|1|||
48825250|NCT04873817|157200762|FG000|Overall Study|Additional Chronic Pain Treatment for The Same Anatomical Region|8|||
48825251|NCT04873817|157200762|FG000|Overall Study|Other Reasons|3|||
48825252|NCT00813488|157200763|FG000|Titration Period 1|Adverse Event|6|||
48825253|NCT00813488|157200764|FG001|Titration Period 1|Adverse Event|1|||
48825254|NCT00813488|157200763|FG000|Titration Period 1|Lack of Efficacy|9|||
48825255|NCT00813488|157200764|FG001|Titration Period 1|Lack of Efficacy|7|||
48825256|NCT00813488|157200763|FG000|Titration Period 1|Withdrawal by Subject|2|||
48825257|NCT00813488|157200764|FG001|Titration Period 1|Withdrawal by Subject|2|||
48825258|NCT00813488|157200763|FG000|Titration Period 1|Protocol Violation|4|||
48825259|NCT00813488|157200764|FG001|Titration Period 1|Protocol Violation|3|||
48825260|NCT00813488|157200763|FG000|Titration Period 1|Non-compliance to study medication|4|||
48825261|NCT00813488|157200764|FG001|Titration Period 1|Non-compliance to study medication|1|||
48825262|NCT00813488|157200763|FG000|Titration Period 1|Non-compliance to study procedures|2|||
49151367|NCT00500331|158396897|FG006|Overall Study|Diabetologist nurse in the study|0|||
49151368|NCT00500331|158396891|FG000|Overall Study|State ban of biological samples export|0|||
49151369|NCT00500331|158396892|FG001|Overall Study|State ban of biological samples export|0|||
48732957|NCT04738734|156873823|FG000|Overall Study|Withdrawal by Subject|2|||
48732958|NCT04738734|156873824|FG001|Overall Study|Withdrawal by Subject|4|||
48732959|NCT04738734|156873823|FG000|Overall Study|Lost to Follow-up|5|||
48732960|NCT04738734|156873824|FG001|Overall Study|Lost to Follow-up|2|||
48732961|NCT04738734|156873823|FG000|Overall Study|Physician Decision|0|||
48732962|NCT04738734|156873824|FG001|Overall Study|Physician Decision|1|||
48732963|NCT04738734|156873823|FG000|Overall Study|Mistake of termination of subject by clinical site|0|||
48732964|NCT04738734|156873824|FG001|Overall Study|Mistake of termination of subject by clinical site|1|||
48732965|NCT01977937|156873828|FG000|Overall Study|Withdrawal by Subject|2|||
48732966|NCT01977937|156873829|FG001|Overall Study|Withdrawal by Subject|1|||
49151370|NCT00500331|158396893|FG002|Overall Study|State ban of biological samples export|0|||
49151371|NCT00500331|158396894|FG003|Overall Study|State ban of biological samples export|1|||
49151372|NCT00500331|158396895|FG004|Overall Study|State ban of biological samples export|0|||
49151373|NCT00500331|158396896|FG005|Overall Study|State ban of biological samples export|0|||
49151374|NCT00500331|158396897|FG006|Overall Study|State ban of biological samples export|0|||
48732967|NCT01977937|156873828|FG000|Overall Study|Adverse Event|1|||
48732968|NCT01977937|156873829|FG001|Overall Study|Adverse Event|0|||
48732969|NCT01977937|156873828|FG000|Overall Study|Physician Decision|0|||
48732970|NCT01977937|156873829|FG001|Overall Study|Physician Decision|1|||
48732971|NCT00810693|156873830|FG000|Treatment Period|Adverse Event|8|||
48732972|NCT00810693|156873831|FG001|Treatment Period|Adverse Event|1|||
48732973|NCT00810693|156873832|FG002|Treatment Period|Adverse Event|7|||
48732974|NCT00810693|156873830|FG000|Treatment Period|Death|0|||
48732975|NCT00810693|156873831|FG001|Treatment Period|Death|1|||
48732976|NCT00810693|156873832|FG002|Treatment Period|Death|2|||
48732977|NCT00810693|156873830|FG000|Treatment Period|Lack of Efficacy|0|||
48732978|NCT00810693|156873831|FG001|Treatment Period|Lack of Efficacy|0|||
48732979|NCT00810693|156873832|FG002|Treatment Period|Lack of Efficacy|1|||
48732980|NCT00810693|156873830|FG000|Treatment Period|Lost to Follow-up|1|||
48732981|NCT00810693|156873831|FG001|Treatment Period|Lost to Follow-up|0|||
48732982|NCT00810693|156873832|FG002|Treatment Period|Lost to Follow-up|0|||
48732983|NCT00810693|156873830|FG000|Treatment Period|Non-compliance|1|||
48732984|NCT00810693|156873831|FG001|Treatment Period|Non-compliance|0|||
48732985|NCT00810693|156873832|FG002|Treatment Period|Non-compliance|0|||
48732986|NCT00810693|156873830|FG000|Treatment Period|Protocol Violation|1|||
49151375|NCT00500331|158396891|FG000|Overall Study|Protocol violated|0|||
49151376|NCT00500331|158396892|FG001|Overall Study|Protocol violated|0|||
49151377|NCT00500331|158396893|FG002|Overall Study|Protocol violated|0|||
49151378|NCT00500331|158396894|FG003|Overall Study|Protocol violated|1|||
49151379|NCT00500331|158396895|FG004|Overall Study|Protocol violated|0|||
49151380|NCT00500331|158396896|FG005|Overall Study|Protocol violated|0|||
49151381|NCT00500331|158396897|FG006|Overall Study|Protocol violated|0|||
49151382|NCT00959049|158396904|FG000|Overall Study|Adverse Event|1|||
49151383|NCT00959049|158396905|FG001|Overall Study|Adverse Event|0|||
49151384|NCT00959049|158396906|FG002|Overall Study|Adverse Event|0|||
49151385|NCT00959049|158396907|FG003|Overall Study|Adverse Event|0|||
48732987|NCT00810693|156873831|FG001|Treatment Period|Protocol Violation|2|||
48732988|NCT00810693|156873832|FG002|Treatment Period|Protocol Violation|2|||
48732989|NCT00810693|156873830|FG000|Treatment Period|Withdrawal by Subject|6|||
48732990|NCT00810693|156873831|FG001|Treatment Period|Withdrawal by Subject|2|||
48825263|NCT00813488|157200764|FG001|Titration Period 1|Non-compliance to study procedures|2|||
48825264|NCT00813488|157200763|FG000|Titration Period 1|Technical Difficulties|0|||
48825265|NCT00813488|157200764|FG001|Titration Period 1|Technical Difficulties|1|||
48825266|NCT00813488|157200763|FG000|Titration Period 2|Adverse Event|2|||
48825267|NCT00813488|157200764|FG001|Titration Period 2|Adverse Event|3|||
48732991|NCT00810693|156873832|FG002|Treatment Period|Withdrawal by Subject|3|||
48732992|NCT00810693|156873830|FG000|Treatment Period|Not treated|0|||
48732993|NCT00810693|156873831|FG001|Treatment Period|Not treated|1|||
49151386|NCT00959049|158396908|FG004|Overall Study|Adverse Event|0|||
49151387|NCT00959049|158396909|FG005|Overall Study|Adverse Event|0|||
49151388|NCT00959049|158396904|FG000|Overall Study|Lost to Follow-up|17|||
49151389|NCT00959049|158396905|FG001|Overall Study|Lost to Follow-up|5|||
49151390|NCT00959049|158396906|FG002|Overall Study|Lost to Follow-up|1|||
49151391|NCT00959049|158396907|FG003|Overall Study|Lost to Follow-up|10|||
49151392|NCT00959049|158396908|FG004|Overall Study|Lost to Follow-up|9|||
49151393|NCT00959049|158396909|FG005|Overall Study|Lost to Follow-up|1|||
49151394|NCT00959049|158396904|FG000|Overall Study|Contraindicated medication|0|||
49151395|NCT00959049|158396905|FG001|Overall Study|Contraindicated medication|0|||
49151396|NCT00959049|158396906|FG002|Overall Study|Contraindicated medication|0|||
49151397|NCT00959049|158396907|FG003|Overall Study|Contraindicated medication|1|||
49151398|NCT00959049|158396908|FG004|Overall Study|Contraindicated medication|0|||
49151399|NCT00959049|158396909|FG005|Overall Study|Contraindicated medication|0|||
49151400|NCT00959049|158396904|FG000|Overall Study|Withdrawal by Subject|0|||
49151401|NCT00959049|158396905|FG001|Overall Study|Withdrawal by Subject|2|||
49151402|NCT00959049|158396906|FG002|Overall Study|Withdrawal by Subject|0|||
49151403|NCT00959049|158396907|FG003|Overall Study|Withdrawal by Subject|0|||
49151404|NCT00959049|158396908|FG004|Overall Study|Withdrawal by Subject|0|||
49151405|NCT00959049|158396909|FG005|Overall Study|Withdrawal by Subject|0|||
49151406|NCT00770679|158396910|FG000|Overall Study|Lost to Follow-up|3|||
49151407|NCT00770679|158396910|FG000|Overall Study|Follow-up LDL measurement not collected|3|||
49151408|NCT01285102|158396911|FG000|Overall Study|Closed to accrual by sponsor due to poor accrual and challenge with dosing|4|||
49151409|NCT03242434|158396912|FG000|Overall Study|Death|0|||
49151410|NCT03242434|158396913|FG001|Overall Study|Death|2|||
49151411|NCT02367885|158396914|FG000|Overall Study|Lost to Follow-up|1|||
49151412|NCT02367885|158396915|FG001|Overall Study|Lost to Follow-up|0|||
49151413|NCT02367885|158396916|FG002|Overall Study|Lost to Follow-up|0|||
49151414|NCT02367885|158396914|FG000|Overall Study|Withdrawal by Subject|1|||
49151415|NCT02367885|158396915|FG001|Overall Study|Withdrawal by Subject|0|||
49151416|NCT02367885|158396916|FG002|Overall Study|Withdrawal by Subject|0|||
49151417|NCT03847519|158396917|FG000|Overall Study|Death|5|||
49151418|NCT03847519|158396918|FG001|Overall Study|Death|8|||
49151419|NCT03847519|158396919|FG002|Overall Study|Death|1|||
49151420|NCT03847519|158396917|FG000|Overall Study|Lost to Follow-up|1|||
49151421|NCT03847519|158396918|FG001|Overall Study|Lost to Follow-up|2|||
49151422|NCT03847519|158396919|FG002|Overall Study|Lost to Follow-up|0|||
49151423|NCT03847519|158396917|FG000|Overall Study|Study Terminated by Sponsor|0|||
49151424|NCT03847519|158396918|FG001|Overall Study|Study Terminated by Sponsor|3|||
49151425|NCT03847519|158396919|FG002|Overall Study|Study Terminated by Sponsor|2|||
49151426|NCT00754572|158396920|FG000|Overall Study|Adverse Event|19|||
49151427|NCT00754572|158396920|FG000|Overall Study|Other|39|||
49151428|NCT00754572|158396920|FG000|Overall Study|Protocol Violation|3|||
49151429|NCT00754572|158396920|FG000|Overall Study|Withdrawal by Subject|3|||
48732994|NCT00810693|156873832|FG002|Treatment Period|Not treated|1|||
49151430|NCT00754572|158396920|FG000|Overall Study|Lack of Efficacy|2|||
49151431|NCT00754572|158396920|FG000|Overall Study|Death|1|||
49151432|NCT00754572|158396920|FG000|Overall Study|Administrative Reason|3|||
49151433|NCT00754572|158396920|FG000|Overall Study|Lost to Follow-up|1|||
49151434|NCT01148771|158396923|FG000|Washout Period|Withdrawal by Subject|0|||
48732995|NCT00810693|156873830|FG000|Follow-up Period (FUP)|Adverse Event|3|||
48732996|NCT00810693|156873831|FG001|Follow-up Period (FUP)|Adverse Event|1|||
48732997|NCT00810693|156873832|FG002|Follow-up Period (FUP)|Adverse Event|1|||
48732998|NCT00810693|156873830|FG000|Follow-up Period (FUP)|Death|2|||
48732999|NCT00810693|156873831|FG001|Follow-up Period (FUP)|Death|0|||
48733000|NCT00810693|156873832|FG002|Follow-up Period (FUP)|Death|1|||
48733001|NCT00810693|156873830|FG000|Follow-up Period (FUP)|Lost to Follow-up|1|||
48733002|NCT00810693|156873831|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
48733003|NCT00810693|156873832|FG002|Follow-up Period (FUP)|Lost to Follow-up|2|||
48733004|NCT00810693|156873830|FG000|Follow-up Period (FUP)|Protocol Violation|0|||
48733005|NCT00810693|156873831|FG001|Follow-up Period (FUP)|Protocol Violation|1|||
48733006|NCT00810693|156873832|FG002|Follow-up Period (FUP)|Protocol Violation|0|||
48733007|NCT00810693|156873830|FG000|Follow-up Period (FUP)|Withdrawal by Subject|2|||
48733008|NCT00810693|156873831|FG001|Follow-up Period (FUP)|Withdrawal by Subject|1|||
48733009|NCT00810693|156873832|FG002|Follow-up Period (FUP)|Withdrawal by Subject|0|||
48733010|NCT02955797|156873833|FG000|Overall Study|Protocol Violation|1|||
48733011|NCT02955797|156873834|FG001|Overall Study|Protocol Violation|0|||
48733012|NCT02955797|156873835|FG002|Overall Study|Protocol Violation|0|||
48733013|NCT02955797|156873836|FG003|Overall Study|Protocol Violation|1|||
49151435|NCT01148771|158396924|FG001|Washout Period|Withdrawal by Subject|1|||
49151436|NCT01437189|158396925|FG000|Overall Study|Adverse Event|3|||
48733014|NCT02955797|156873833|FG000|Overall Study|Withdrawal by Subject|2|||
48733015|NCT02955797|156873834|FG001|Overall Study|Withdrawal by Subject|2|||
49151437|NCT01437189|158396925|FG000|Overall Study|Lack of Efficacy|4|||
49151438|NCT01437189|158396925|FG000|Overall Study|Withdrawal by Subject|8|||
49151439|NCT00347269|158396928|FG000|Overall Study|Lost to Follow-up|74|||
49151440|NCT00347269|158396929|FG001|Overall Study|Lost to Follow-up|65|||
49151441|NCT00347269|158396928|FG000|Overall Study|Withdrawal by Subject|18|||
49151442|NCT00347269|158396929|FG001|Overall Study|Withdrawal by Subject|38|||
49151443|NCT00347269|158396928|FG000|Overall Study|Death|2|||
49151444|NCT00347269|158396929|FG001|Overall Study|Death|3|||
49151445|NCT01853280|158396930|FG000|Overall Study|Lack of Efficacy|2|||
49151446|NCT01853280|158396931|FG001|Overall Study|Lack of Efficacy|2|||
49151447|NCT01853280|158396930|FG000|Overall Study|Lost to Follow-up|0|||
49151448|NCT01853280|158396931|FG001|Overall Study|Lost to Follow-up|1|||
49151449|NCT01853280|158396930|FG000|Overall Study|Physician Decision|0|||
48825268|NCT00813488|157200763|FG000|Titration Period 2|Lack of Efficacy|8|||
48825269|NCT00813488|157200764|FG001|Titration Period 2|Lack of Efficacy|4|||
49151450|NCT01853280|158396931|FG001|Overall Study|Physician Decision|1|||
49151451|NCT01853280|158396930|FG000|Overall Study|Withdrawal by Subject|0|||
49151452|NCT01853280|158396931|FG001|Overall Study|Withdrawal by Subject|1|||
49151453|NCT01853280|158396930|FG000|Overall Study|Ineligible|0|||
49151454|NCT01853280|158396931|FG001|Overall Study|Ineligible|1|||
49151455|NCT00104884|158396932|FG000|Overall Study|Disease progression|4|||
49151456|NCT03032484|158396933|FG000|Overall Study Cycle 1 (C1)|Withdrawal by Subject|1|||
49151457|NCT03032484|158396934|FG001|Overall Study Cycle 1 (C1)|Withdrawal by Subject|0|||
49151458|NCT03032484|158396933|FG000|Start of Second Cycle (C2)|Withdrawal by Subject|1|||
49151459|NCT03032484|158396934|FG001|Start of Second Cycle (C2)|Withdrawal by Subject|0|||
49151460|NCT04023487|158396935|FG000|Overall Study|Lost to Follow-up|5|||
49151461|NCT04023487|158396936|FG001|Overall Study|Lost to Follow-up|4|||
49151462|NCT04023487|158396935|FG000|Overall Study|Pregnancy|1|||
49151463|NCT04023487|158396936|FG001|Overall Study|Pregnancy|2|||
49151464|NCT04023487|158396935|FG000|Overall Study|Withdrawal by Subject|4|||
49151465|NCT04023487|158396936|FG001|Overall Study|Withdrawal by Subject|5|||
49151466|NCT04023487|158396935|FG000|Overall Study|Partially completed testing|8|||
49151467|NCT04023487|158396936|FG001|Overall Study|Partially completed testing|4|||
49151468|NCT02697448|158396937|FG000|Overall Study|Protocol Violation|2|||
49151469|NCT02697448|158396938|FG001|Overall Study|Protocol Violation|4|||
49151470|NCT02697448|158396937|FG000|Overall Study|Clinical concerns during ablation|1|||
49151471|NCT02697448|158396938|FG001|Overall Study|Clinical concerns during ablation|1|||
49151472|NCT02697448|158396937|FG000|Overall Study|No data collected|2|||
49151473|NCT02697448|158396938|FG001|Overall Study|No data collected|0|||
49151474|NCT02507934|158396939|FG000|Overall Study|Lost to Follow-up|2|||
49151475|NCT02507934|158396940|FG001|Overall Study|Lost to Follow-up|0|||
49151476|NCT02507934|158396939|FG000|Overall Study|Withdrawal by Subject|2|||
49151477|NCT02507934|158396940|FG001|Overall Study|Withdrawal by Subject|0|||
49151478|NCT02592863|158396945|FG000|Overall Study|Withdrawal by Subject|2|||
49151479|NCT02592863|158396946|FG001|Overall Study|Withdrawal by Subject|2|||
49151480|NCT02592863|158396945|FG000|Overall Study|Lost to Follow-up|1|||
48733016|NCT02955797|156873835|FG002|Overall Study|Withdrawal by Subject|0|||
48733017|NCT02955797|156873836|FG003|Overall Study|Withdrawal by Subject|1|||
48733018|NCT02955797|156873833|FG000|Overall Study|Lost to Follow-up|0|||
48733019|NCT02955797|156873834|FG001|Overall Study|Lost to Follow-up|1|||
48733020|NCT02955797|156873835|FG002|Overall Study|Lost to Follow-up|0|||
48733021|NCT02955797|156873836|FG003|Overall Study|Lost to Follow-up|0|||
48733022|NCT01033851|156873839|FG000|Overall Study|Withdrawal by Subject|3|||
48733023|NCT01033851|156873840|FG001|Overall Study|Withdrawal by Subject|7|||
48733024|NCT02520661|156873843|FG000|Overall Study|Lost to Follow-up|7|||
48733025|NCT02520661|156873844|FG001|Overall Study|Lost to Follow-up|3|||
48733026|NCT02520661|156873843|FG000|Overall Study|Admitted from ED|49|||
48733027|NCT02520661|156873844|FG001|Overall Study|Admitted from ED|48|||
48733028|NCT02520661|156873843|FG000|Overall Study|ED greater than 24 hours|29|||
48733029|NCT02520661|156873844|FG001|Overall Study|ED greater than 24 hours|38|||
48733030|NCT02520661|156873843|FG000|Overall Study|other ineligibility|14|||
48733031|NCT02520661|156873844|FG001|Overall Study|other ineligibility|22|||
48733032|NCT02520661|156873843|FG000|Overall Study|Withdrawal by Subject|7|||
48733033|NCT02520661|156873844|FG001|Overall Study|Withdrawal by Subject|16|||
48733034|NCT02586064|156873847|FG000|Overall Study|Other Obligations|6|||
48733035|NCT02586064|156873848|FG001|Overall Study|Other Obligations|6|||
48733036|NCT02586064|156873847|FG000|Overall Study|Other|3|||
48733037|NCT02586064|156873848|FG001|Overall Study|Other|7|||
48733038|NCT02586064|156873847|FG000|Overall Study|Never Started|3|||
48733039|NCT02586064|156873848|FG001|Overall Study|Never Started|3|||
48733040|NCT02586064|156873847|FG000|Overall Study|Lost Interest|1|||
48733041|NCT02586064|156873848|FG001|Overall Study|Lost Interest|4|||
48733042|NCT02586064|156873847|FG000|Overall Study|Miscellaneous Life Issues|0|||
48733043|NCT02586064|156873848|FG001|Overall Study|Miscellaneous Life Issues|5|||
48733044|NCT02586064|156873847|FG000|Overall Study|Infrequent Attendance|2|||
48733045|NCT02586064|156873848|FG001|Overall Study|Infrequent Attendance|1|||
48733046|NCT02586064|156873847|FG000|Overall Study|Timed Out|2|||
48733047|NCT02586064|156873848|FG001|Overall Study|Timed Out|0|||
48733048|NCT02586064|156873847|FG000|Overall Study|AUD relapse|0|||
48733049|NCT02586064|156873848|FG001|Overall Study|AUD relapse|2|||
49151481|NCT02592863|158396946|FG001|Overall Study|Lost to Follow-up|1|||
49151482|NCT04770285|158396948|FG000|Overall Study|Non-Compliance With Study Treatment|3|||
49151483|NCT04770285|158396949|FG001|Overall Study|Non-Compliance With Study Treatment|3|||
49151484|NCT04770285|158396948|FG000|Overall Study|Lack of Efficacy|0|||
49151485|NCT04770285|158396949|FG001|Overall Study|Lack of Efficacy|1|||
49151486|NCT04770285|158396948|FG000|Overall Study|Lost to Follow-up|11|||
49151487|NCT04770285|158396949|FG001|Overall Study|Lost to Follow-up|8|||
49151488|NCT04770285|158396948|FG000|Overall Study|Protocol Deviation|6|||
49151489|NCT04770285|158396949|FG001|Overall Study|Protocol Deviation|6|||
49151490|NCT04770285|158396948|FG000|Overall Study|Technical Problem|0|||
49151491|NCT04770285|158396949|FG001|Overall Study|Technical Problem|1|||
49151492|NCT04770285|158396948|FG000|Overall Study|Withdrawal by Subject|9|||
49151493|NCT04770285|158396949|FG001|Overall Study|Withdrawal by Subject|8|||
49151494|NCT04770285|158396948|FG000|Overall Study|Reason Not Specified|0|||
49151495|NCT04770285|158396949|FG001|Overall Study|Reason Not Specified|1|||
49151496|NCT03766399|158396950|FG000|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
49151497|NCT03766399|158396951|FG001|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
49151498|NCT03766399|158396952|FG002|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
49151499|NCT03766399|158396953|FG003|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
49151500|NCT03766399|158396954|FG004|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
49151501|NCT03766399|158396955|FG005|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
49151502|NCT03766399|158396956|FG006|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
49151503|NCT03766399|158396957|FG007|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
49151504|NCT03766399|158396958|FG008|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
49151505|NCT03766399|158396959|FG009|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
49151506|NCT03766399|158396960|FG010|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
49151507|NCT03766399|158396961|FG011|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
49151508|NCT03766399|158396962|FG012|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
48733050|NCT02586064|156873847|FG000|Overall Study|Legal Issue|1|||
48733051|NCT02586064|156873848|FG001|Overall Study|Legal Issue|0|||
48733052|NCT04128371|156873849|FG000|Overall Study|Lack of Efficacy|1|||
48733053|NCT01346969|156873850|FG000|Overall Study|Withdrawal by Subject|0|||
48733054|NCT01346969|156873851|FG001|Overall Study|Withdrawal by Subject|0|||
48733055|NCT01346969|156873852|FG002|Overall Study|Withdrawal by Subject|1|||
48733056|NCT01346969|156873853|FG003|Overall Study|Withdrawal by Subject|0|||
48921585|NCT01505634|157546429|FG001|Overall Study|Withdrawal by Subject|5|||
48921586|NCT01505634|157546430|FG002|Overall Study|Withdrawal by Subject|1|||
48921587|NCT01505634|157546428|FG000|Overall Study|Physician Decision|1|||
48921588|NCT01505634|157546429|FG001|Overall Study|Physician Decision|1|||
48921589|NCT01505634|157546430|FG002|Overall Study|Physician Decision|0|||
49151509|NCT03766399|158396963|FG013|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|1|||
49151510|NCT03766399|158396964|FG014|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
49151511|NCT03766399|158396965|FG015|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
49151512|NCT03766399|158396966|FG016|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
49151513|NCT03766399|158396967|FG017|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
49151514|NCT02758626|158396968|FG000|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|1|||
49151515|NCT02758626|158396969|FG001|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|0|||
49151516|NCT02758626|158396968|FG000|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
49151517|NCT02758626|158396969|FG001|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
49151518|NCT02758626|158396968|FG000|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
49151519|NCT02758626|158396969|FG001|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
49151520|NCT02758626|158396968|FG000|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|0|||
49151521|NCT02758626|158396969|FG001|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|1|||
49151522|NCT00855335|158396972|FG000|Overall Study|Lost to Follow-up|0|||
49151523|NCT00855335|158396973|FG001|Overall Study|Lost to Follow-up|0|||
49151524|NCT00855335|158396974|FG002|Overall Study|Lost to Follow-up|3|||
49151525|NCT00855335|158396975|FG003|Overall Study|Lost to Follow-up|1|||
49151526|NCT00855335|158396976|FG004|Overall Study|Lost to Follow-up|0|||
49151527|NCT00855335|158396972|FG000|Overall Study|Withdrawal by Subject|0|||
48733057|NCT01346969|156873850|FG000|Overall Study|Lost to Follow-up|1|||
48733058|NCT01346969|156873851|FG001|Overall Study|Lost to Follow-up|0|||
48733059|NCT01346969|156873852|FG002|Overall Study|Lost to Follow-up|2|||
48733060|NCT01346969|156873853|FG003|Overall Study|Lost to Follow-up|0|||
48733061|NCT01346969|156873850|FG000|Overall Study|Physician Decision|0|||
48733062|NCT01346969|156873851|FG001|Overall Study|Physician Decision|0|||
48733063|NCT01346969|156873852|FG002|Overall Study|Physician Decision|0|||
48733064|NCT01346969|156873853|FG003|Overall Study|Physician Decision|1|||
48733065|NCT01346969|156873850|FG000|Overall Study|Randomized but not treated|1|||
48733066|NCT01346969|156873851|FG001|Overall Study|Randomized but not treated|0|||
48733067|NCT01346969|156873852|FG002|Overall Study|Randomized but not treated|0|||
48733068|NCT01346969|156873853|FG003|Overall Study|Randomized but not treated|0|||
48921590|NCT01505634|157546428|FG000|Overall Study|Adverse Event|1|||
48733069|NCT01187433|156873859|FG000|Overall Study|Protocol Violation|6|||
48733070|NCT01187433|156873860|FG001|Overall Study|Protocol Violation|2|||
48733071|NCT01187433|156873859|FG000|Overall Study|Withdrawal by Subject|5|||
48921591|NCT01505634|157546429|FG001|Overall Study|Adverse Event|0|||
49151528|NCT00855335|158396973|FG001|Overall Study|Withdrawal by Subject|0|||
49151529|NCT00855335|158396974|FG002|Overall Study|Withdrawal by Subject|0|||
49151530|NCT00855335|158396975|FG003|Overall Study|Withdrawal by Subject|1|||
49151531|NCT00855335|158396976|FG004|Overall Study|Withdrawal by Subject|0|||
49151532|NCT00855335|158396972|FG000|Overall Study|Adverse Event|2|||
49151533|NCT00855335|158396973|FG001|Overall Study|Adverse Event|0|||
49151534|NCT00855335|158396974|FG002|Overall Study|Adverse Event|0|||
49151535|NCT00855335|158396975|FG003|Overall Study|Adverse Event|0|||
49151536|NCT00855335|158396976|FG004|Overall Study|Adverse Event|0|||
49151537|NCT00855335|158396972|FG000|Overall Study|Physician Decision|1|||
49151538|NCT00855335|158396973|FG001|Overall Study|Physician Decision|1|||
49151539|NCT00855335|158396974|FG002|Overall Study|Physician Decision|0|||
49151540|NCT00855335|158396975|FG003|Overall Study|Physician Decision|0|||
49151541|NCT00855335|158396976|FG004|Overall Study|Physician Decision|0|||
49151542|NCT00855335|158396972|FG000|Overall Study|Other|2|||
48733072|NCT01187433|156873860|FG001|Overall Study|Withdrawal by Subject|2|||
48733073|NCT03553927|156873861|FG000|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
49151543|NCT00855335|158396973|FG001|Overall Study|Other|1|||
49151544|NCT00855335|158396974|FG002|Overall Study|Other|2|||
49151545|NCT00855335|158396975|FG003|Overall Study|Other|5|||
49151546|NCT00855335|158396976|FG004|Overall Study|Other|1|||
49151547|NCT00879398|158396980|FG000|Overall Study|Visit Stop|399|||
49151548|NCT00879398|158396980|FG000|Overall Study|Lack of Efficacy|64|||
49151549|NCT00879398|158396980|FG000|Overall Study|Adverse Event|41|||
49151550|NCT00879398|158396980|FG000|Overall Study|Other Reasons|171|||
49151551|NCT05305651|158396981|FG000|Overall Study|Death|1|||
49151552|NCT05305651|158396981|FG000|Overall Study|Withdrawal by Subject|4|||
49151553|NCT05305651|158396981|FG000|Overall Study|Lost to Follow-up|4|||
49151554|NCT01506726|158396982|FG000|Overall Study|Adverse Event|1|||
49151555|NCT01506726|158396983|FG001|Overall Study|Adverse Event|2|||
49151556|NCT01491919|158396984|FG000|Overall Study|Insufficient PK sampling|1|||
49151557|NCT01491919|158396985|FG001|Overall Study|Insufficient PK sampling|2|||
49151558|NCT01491919|158396986|FG002|Overall Study|Insufficient PK sampling|1|||
49151559|NCT04724837|158396987|FG000|Overall Study|Other|4|||
49151560|NCT04724837|158396988|FG001|Overall Study|Other|16|||
49151561|NCT04724837|158396989|FG002|Overall Study|Other|0|||
49151562|NCT04724837|158396987|FG000|Overall Study|Withdrawal by Subject|2|||
49151563|NCT04724837|158396988|FG001|Overall Study|Withdrawal by Subject|9|||
49151564|NCT04724837|158396989|FG002|Overall Study|Withdrawal by Subject|9|||
49151565|NCT04724837|158396987|FG000|Overall Study|Adverse Event|2|||
49151566|NCT04724837|158396988|FG001|Overall Study|Adverse Event|7|||
49151567|NCT04724837|158396989|FG002|Overall Study|Adverse Event|4|||
49151568|NCT04724837|158396987|FG000|Overall Study|Lost to Follow-up|0|||
49151569|NCT04724837|158396988|FG001|Overall Study|Lost to Follow-up|1|||
49151570|NCT04724837|158396989|FG002|Overall Study|Lost to Follow-up|3|||
49151571|NCT04724837|158396987|FG000|Overall Study|Physician Decision|1|||
49151572|NCT04724837|158396988|FG001|Overall Study|Physician Decision|2|||
49151573|NCT04724837|158396989|FG002|Overall Study|Physician Decision|0|||
49151574|NCT04724837|158396987|FG000|Overall Study|Death|0|||
49151575|NCT04724837|158396988|FG001|Overall Study|Death|0|||
49151576|NCT04724837|158396989|FG002|Overall Study|Death|1|||
49151577|NCT04724837|158396987|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
49151578|NCT04724837|158396988|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
49151579|NCT04724837|158396989|FG002|Overall Study|Failure to Meet Randomization Criteria|3|||
48733074|NCT03553927|156873862|FG001|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
48733075|NCT03553927|156873861|FG000|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|2|||
48733076|NCT03553927|156873862|FG001|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|0|||
48733077|NCT01193842|156873863|FG000|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
48733078|NCT01193842|156873864|FG001|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1|||
48733079|NCT01193842|156873865|FG002|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
48733080|NCT01193842|156873866|FG003|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
48733081|NCT01193842|156873867|FG004|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
48921592|NCT01505634|157546430|FG002|Overall Study|Adverse Event|0|||
49151580|NCT04724837|158396987|FG000|Overall Study|Study Terminated by Sponsor|0|||
49151581|NCT04724837|158396988|FG001|Overall Study|Study Terminated by Sponsor|1|||
48733082|NCT01193842|156873863|FG000|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1|||
48825270|NCT00813488|157200763|FG000|Titration Period 2|Protocol Violation|3|||
48825271|NCT00813488|157200764|FG001|Titration Period 2|Protocol Violation|2|||
48825272|NCT00813488|157200763|FG000|Titration Period 2|Lost to Follow-up|1|||
48825273|NCT00813488|157200764|FG001|Titration Period 2|Lost to Follow-up|0|||
48825274|NCT00813488|157200763|FG000|Titration Period 2|Non-compliance with study procedures|2|||
48825275|NCT00813488|157200764|FG001|Titration Period 2|Non-compliance with study procedures|1|||
48825276|NCT00813488|157200763|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
48825277|NCT00813488|157200764|FG001|Double-blind Treatment Period 1|Adverse Event|1|||
48733083|NCT01193842|156873864|FG001|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
48733084|NCT01193842|156873865|FG002|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
48733085|NCT01193842|156873866|FG003|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
48733086|NCT01193842|156873867|FG004|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
48733087|NCT01193842|156873863|FG000|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
48733088|NCT01193842|156873864|FG001|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
48733089|NCT01193842|156873865|FG002|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1|||
48825278|NCT00813488|157200763|FG000|Double-blind Treatment Period 1|Withdrawal by Subject|0|||
48825279|NCT00813488|157200764|FG001|Double-blind Treatment Period 1|Withdrawal by Subject|1|||
48825280|NCT00813488|157200763|FG000|Double-blind Treatment Period 1|Protocol Violation|0|||
48825281|NCT00813488|157200764|FG001|Double-blind Treatment Period 1|Protocol Violation|2|||
48825282|NCT00813488|157200763|FG000|Double-blind Treatment Period 1|Lost to Follow-up|0|||
49151582|NCT04724837|158396989|FG002|Overall Study|Study Terminated by Sponsor|0|||
49151583|NCT04347538|158396993|FG000|Overall Study|Lost to Follow-up|4|||
49151584|NCT04347538|158396994|FG001|Overall Study|Lost to Follow-up|5|||
49151585|NCT04347538|158396995|FG002|Overall Study|Lost to Follow-up|7|||
49151586|NCT04938427|158396996|FG000|Overall Study|Adverse Event|5|||
49151587|NCT04938427|158396997|FG001|Overall Study|Adverse Event|19|||
49151588|NCT04938427|158396996|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
49151589|NCT04938427|158396997|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
49151590|NCT04938427|158396996|FG000|Overall Study|Withdrawal by Subject|1|||
49151591|NCT04938427|158396997|FG001|Overall Study|Withdrawal by Subject|0|||
48825283|NCT00813488|157200764|FG001|Double-blind Treatment Period 1|Lost to Follow-up|1|||
48825284|NCT00813488|157200763|FG000|Double-blind Treatment Period 2|Adverse Event|1|||
48825285|NCT00813488|157200764|FG001|Double-blind Treatment Period 2|Adverse Event|0|||
48825286|NCT00813488|157200763|FG000|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
48825287|NCT00813488|157200764|FG001|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
48825288|NCT00813488|157200763|FG000|Double-blind Treatment Period 2|Protocol Violation|2|||
48825289|NCT00813488|157200764|FG001|Double-blind Treatment Period 2|Protocol Violation|0|||
49151592|NCT04938427|158396996|FG000|Overall Study|Reason Not Specified|2|||
49151593|NCT04938427|158396997|FG001|Overall Study|Reason Not Specified|1|||
49151594|NCT03537508|158396998|FG000|Overall Study|Adverse Event|2|||
48825290|NCT00813488|157200763|FG000|Double-blind Treatment Period 2|Other|1|||
48825291|NCT00813488|157200764|FG001|Double-blind Treatment Period 2|Other|0|||
48825292|NCT00813488|157200763|FG000|Open-label Extension|Adverse Event|1|||
48825293|NCT00813488|157200764|FG001|Open-label Extension|Adverse Event|2|||
48825294|NCT00813488|157200763|FG000|Open-label Extension|Lack of Efficacy|3|||
48825295|NCT00813488|157200764|FG001|Open-label Extension|Lack of Efficacy|0|||
48825296|NCT00813488|157200763|FG000|Open-label Extension|Withdrawal by Subject|0|||
48825297|NCT00813488|157200764|FG001|Open-label Extension|Withdrawal by Subject|2|||
48825298|NCT00813488|157200763|FG000|Open-label Extension|Protocol Violation|1|||
48825299|NCT00813488|157200764|FG001|Open-label Extension|Protocol Violation|2|||
48825300|NCT00813488|157200763|FG000|Open-label Extension|Non-compliance study medication|4|||
48825301|NCT00813488|157200764|FG001|Open-label Extension|Non-compliance study medication|0|||
48825302|NCT00813488|157200763|FG000|Open-label Extension|Non-compliance study procedures|2|||
49151595|NCT03537508|158396999|FG001|Overall Study|Adverse Event|1|||
49151596|NCT03537508|158396998|FG000|Overall Study|Protocol Violation|65|||
49151597|NCT03537508|158396999|FG001|Overall Study|Protocol Violation|48|||
49151598|NCT03537508|158396998|FG000|Overall Study|Lost to Follow-up|86|||
49151599|NCT03537508|158396999|FG001|Overall Study|Lost to Follow-up|60|||
49151600|NCT03537508|158396998|FG000|Overall Study|Withdrawal by parent/guardian|263|||
48733090|NCT01193842|156873866|FG003|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
48733091|NCT01193842|156873867|FG004|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
48825303|NCT00813488|157200764|FG001|Open-label Extension|Non-compliance study procedures|1|||
49151601|NCT03537508|158396999|FG001|Overall Study|Withdrawal by parent/guardian|149|||
49151602|NCT01649869|158397014|FG000|Overall Study|Family member illness|1|||
49151603|NCT01649869|158397015|FG001|Overall Study|Family member illness|0|||
49151604|NCT01649869|158397014|FG000|Overall Study|Required treatment outside protocol|1|||
48825304|NCT00813488|157200763|FG000|Open-label Extension|Other|1|||
48825305|NCT00813488|157200764|FG001|Open-label Extension|Other|0|||
48825306|NCT03677375|157200766|FG000|Overall Study|Incomplete procedure|8|||
49151605|NCT01649869|158397015|FG001|Overall Study|Required treatment outside protocol|0|||
49151606|NCT01649869|158397014|FG000|Overall Study|Severe hearing loss borderline eligible|0|||
49151607|NCT01649869|158397015|FG001|Overall Study|Severe hearing loss borderline eligible|1|||
49151608|NCT04486716|158398691|FG000|Overall Study|Subject decision|6|||
49151609|NCT04486716|158398691|FG000|Overall Study|Adverse Event|5|||
49151610|NCT04486716|158398691|FG000|Overall Study|Lost to Follow-up|1|||
49151611|NCT04486716|158398691|FG000|Overall Study|Physician Decision|1|||
49151612|NCT04486716|158398691|FG000|Overall Study|Enrolled subjects not treated|9|||
49151613|NCT03379870|158398692|FG000|Overall Study|Lost to Follow-up|1|||
49151614|NCT03379870|158398693|FG001|Overall Study|Lost to Follow-up|0|||
49151615|NCT03379870|158398692|FG000|Overall Study|Protocol Violation|1|||
49151616|NCT03379870|158398693|FG001|Overall Study|Protocol Violation|1|||
49151617|NCT02723955|158398694|FG000|Escalation Phase|Death|1|||
49151618|NCT02723955|158398695|FG001|Escalation Phase|Death|1|||
49151619|NCT02723955|158398696|FG002|Escalation Phase|Death|2|||
49151620|NCT02723955|158398697|FG003|Escalation Phase|Death|7|||
49151621|NCT02723955|158398698|FG004|Escalation Phase|Death|18|||
49151622|NCT02723955|158398699|FG005|Escalation Phase|Death|17|||
49151623|NCT02723955|158398700|FG006|Escalation Phase|Death|11|||
49151624|NCT02723955|158398701|FG007|Escalation Phase|Death|21|||
49151625|NCT02723955|158398702|FG008|Escalation Phase|Death|3|||
49151626|NCT02723955|158398703|FG009|Escalation Phase|Death|0|||
49151627|NCT02723955|158398704|FG010|Escalation Phase|Death|0|||
49151628|NCT02723955|158398705|FG011|Escalation Phase|Death|0|||
49151629|NCT02723955|158398706|FG012|Escalation Phase|Death|2|||
49151630|NCT02723955|158398707|FG013|Escalation Phase|Death|4|||
49151631|NCT02723955|158398708|FG014|Escalation Phase|Death|5|||
49151632|NCT02723955|158398709|FG015|Escalation Phase|Death|6|||
49151633|NCT02723955|158398710|FG016|Escalation Phase|Death|6|||
49151634|NCT02723955|158398711|FG017|Escalation Phase|Death|7|||
49151635|NCT02723955|158398712|FG018|Escalation Phase|Death|1|||
49151636|NCT02723955|158398713|FG019|Escalation Phase|Death|3|||
49151637|NCT02723955|158398714|FG020|Escalation Phase|Death|13|||
49151638|NCT02723955|158398715|FG021|Escalation Phase|Death|3|||
49151639|NCT02723955|158398716|FG022|Escalation Phase|Death|2|||
48733092|NCT01193842|156873863|FG000|Phase II: Randomized Groups|Death|0|||
48921593|NCT01505634|157546428|FG000|Overall Study|Insufficient supply of drug at site|1|||
49151640|NCT02723955|158398717|FG023|Escalation Phase|Death|4|||
49151641|NCT02723955|158398718|FG024|Escalation Phase|Death|31|||
49151642|NCT02723955|158398719|FG025|Escalation Phase|Death|7|||
49151643|NCT02723955|158398720|FG026|Escalation Phase|Death|13|||
49151644|NCT02723955|158398721|FG027|Escalation Phase|Death|0|||
49151645|NCT02723955|158398722|FG028|Escalation Phase|Death|1|||
49151646|NCT02723955|158398723|FG029|Escalation Phase|Death|0|||
49151647|NCT02723955|158398724|FG030|Escalation Phase|Death|0|||
49151648|NCT02723955|158398725|FG031|Escalation Phase|Death|0|||
49151649|NCT02723955|158398726|FG032|Escalation Phase|Death|0|||
49151650|NCT02723955|158398727|FG033|Escalation Phase|Death|0|||
49151651|NCT02723955|158398728|FG034|Escalation Phase|Death|0|||
49151652|NCT02723955|158398729|FG035|Escalation Phase|Death|0|||
49151653|NCT02723955|158398730|FG036|Escalation Phase|Death|0|||
49151654|NCT02723955|158398731|FG037|Escalation Phase|Death|0|||
49151655|NCT02723955|158398732|FG038|Escalation Phase|Death|0|||
48733093|NCT01193842|156873864|FG001|Phase II: Randomized Groups|Death|0|||
48733094|NCT01193842|156873865|FG002|Phase II: Randomized Groups|Death|0|||
48733095|NCT01193842|156873866|FG003|Phase II: Randomized Groups|Death|1|||
48733096|NCT01193842|156873867|FG004|Phase II: Randomized Groups|Death|1|||
48733097|NCT01193842|156873863|FG000|Phase II: Randomized Groups|Adverse Event|0|||
48733098|NCT01193842|156873864|FG001|Phase II: Randomized Groups|Adverse Event|0|||
48733099|NCT01193842|156873865|FG002|Phase II: Randomized Groups|Adverse Event|0|||
48733100|NCT01193842|156873866|FG003|Phase II: Randomized Groups|Adverse Event|5|||
48733101|NCT01193842|156873867|FG004|Phase II: Randomized Groups|Adverse Event|3|||
48733102|NCT01193842|156873863|FG000|Phase II: Randomized Groups|Withdrawal by Subject|0|||
48733103|NCT01193842|156873864|FG001|Phase II: Randomized Groups|Withdrawal by Subject|0|||
48733104|NCT01193842|156873865|FG002|Phase II: Randomized Groups|Withdrawal by Subject|0|||
48733105|NCT01193842|156873866|FG003|Phase II: Randomized Groups|Withdrawal by Subject|1|||
48733106|NCT01193842|156873867|FG004|Phase II: Randomized Groups|Withdrawal by Subject|2|||
48733107|NCT01193842|156873863|FG000|Phase II: Randomized Groups|Ineligible|0|||
48733108|NCT01193842|156873864|FG001|Phase II: Randomized Groups|Ineligible|0|||
48733109|NCT01193842|156873865|FG002|Phase II: Randomized Groups|Ineligible|0|||
49151656|NCT02723955|158398733|FG039|Escalation Phase|Death|0|||
49151657|NCT02723955|158398734|FG040|Escalation Phase|Death|0|||
48733110|NCT01193842|156873866|FG003|Phase II: Randomized Groups|Ineligible|0|||
48733111|NCT01193842|156873867|FG004|Phase II: Randomized Groups|Ineligible|1|||
48733112|NCT01193842|156873863|FG000|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
49151658|NCT02723955|158398735|FG041|Escalation Phase|Death|0|||
49151659|NCT02723955|158398736|FG042|Escalation Phase|Death|0|||
49151660|NCT02723955|158398694|FG000|Escalation Phase|Lost to Follow-up|0|||
49151661|NCT02723955|158398695|FG001|Escalation Phase|Lost to Follow-up|0|||
49151662|NCT02723955|158398696|FG002|Escalation Phase|Lost to Follow-up|0|||
49151663|NCT02723955|158398697|FG003|Escalation Phase|Lost to Follow-up|0|||
48825307|NCT03677375|157200766|FG000|Overall Study|Adverse Event|3|||
48825308|NCT03677375|157200766|FG000|Overall Study|Physician Decision|1|||
48825309|NCT01734811|157200767|FG000|Overall Study|Lost to Follow-up|2|||
48825310|NCT01734811|157200768|FG001|Overall Study|Lost to Follow-up|3|||
48825311|NCT01734811|157200767|FG000|Overall Study|Withdrawal by Subject|2|||
48825312|NCT01734811|157200768|FG001|Overall Study|Withdrawal by Subject|0|||
48825313|NCT00708097|157200773|FG000|Period 1|Protocol Violation|0|||
48825314|NCT00708097|157200774|FG001|Period 1|Protocol Violation|1|||
48825315|NCT00708097|157200775|FG002|Period 1|Protocol Violation|0|||
48825316|NCT00708097|157200776|FG003|Period 1|Protocol Violation|2|||
48825317|NCT00708097|157200777|FG004|Period 1|Protocol Violation|0|||
48825318|NCT00708097|157200773|FG000|Period 1|Other Reason|0|||
48825319|NCT00708097|157200774|FG001|Period 1|Other Reason|0|||
48825320|NCT00708097|157200775|FG002|Period 1|Other Reason|0|||
49151664|NCT02723955|158398698|FG004|Escalation Phase|Lost to Follow-up|0|||
49151665|NCT02723955|158398699|FG005|Escalation Phase|Lost to Follow-up|2|||
49151666|NCT02723955|158398700|FG006|Escalation Phase|Lost to Follow-up|1|||
49151667|NCT02723955|158398701|FG007|Escalation Phase|Lost to Follow-up|1|||
49151668|NCT02723955|158398702|FG008|Escalation Phase|Lost to Follow-up|1|||
49151669|NCT02723955|158398703|FG009|Escalation Phase|Lost to Follow-up|0|||
49151670|NCT02723955|158398704|FG010|Escalation Phase|Lost to Follow-up|0|||
49151671|NCT02723955|158398705|FG011|Escalation Phase|Lost to Follow-up|0|||
49151672|NCT02723955|158398706|FG012|Escalation Phase|Lost to Follow-up|1|||
49151673|NCT02723955|158398707|FG013|Escalation Phase|Lost to Follow-up|0|||
49151674|NCT02723955|158398708|FG014|Escalation Phase|Lost to Follow-up|0|||
49151675|NCT02723955|158398709|FG015|Escalation Phase|Lost to Follow-up|0|||
49151676|NCT02723955|158398710|FG016|Escalation Phase|Lost to Follow-up|1|||
49151677|NCT02723955|158398711|FG017|Escalation Phase|Lost to Follow-up|2|||
49151678|NCT02723955|158398712|FG018|Escalation Phase|Lost to Follow-up|0|||
49151679|NCT02723955|158398713|FG019|Escalation Phase|Lost to Follow-up|1|||
49151680|NCT02723955|158398714|FG020|Escalation Phase|Lost to Follow-up|2|||
49151681|NCT02723955|158398715|FG021|Escalation Phase|Lost to Follow-up|1|||
49151682|NCT02723955|158398716|FG022|Escalation Phase|Lost to Follow-up|0|||
49151683|NCT02723955|158398717|FG023|Escalation Phase|Lost to Follow-up|0|||
49151684|NCT02723955|158398718|FG024|Escalation Phase|Lost to Follow-up|1|||
49151685|NCT02723955|158398719|FG025|Escalation Phase|Lost to Follow-up|1|||
49151686|NCT02723955|158398720|FG026|Escalation Phase|Lost to Follow-up|3|||
49151687|NCT02723955|158398721|FG027|Escalation Phase|Lost to Follow-up|0|||
49151688|NCT02723955|158398722|FG028|Escalation Phase|Lost to Follow-up|1|||
49151689|NCT02723955|158398723|FG029|Escalation Phase|Lost to Follow-up|0|||
49151690|NCT02723955|158398724|FG030|Escalation Phase|Lost to Follow-up|0|||
49151691|NCT02723955|158398725|FG031|Escalation Phase|Lost to Follow-up|0|||
49151692|NCT02723955|158398726|FG032|Escalation Phase|Lost to Follow-up|0|||
48825321|NCT00708097|157200776|FG003|Period 1|Other Reason|0|||
48825322|NCT00708097|157200777|FG004|Period 1|Other Reason|1|||
48825323|NCT00708097|157200773|FG000|Period 2|Protocol Violation|0|||
48825324|NCT00708097|157200774|FG001|Period 2|Protocol Violation|1|||
48921594|NCT01505634|157546429|FG001|Overall Study|Insufficient supply of drug at site|0|||
48921595|NCT01505634|157546430|FG002|Overall Study|Insufficient supply of drug at site|0|||
48921596|NCT01505634|157546428|FG000|Overall Study|Protocol Violation|2|||
48921597|NCT01505634|157546429|FG001|Overall Study|Protocol Violation|0|||
48921598|NCT01505634|157546430|FG002|Overall Study|Protocol Violation|0|||
48921599|NCT01505634|157546428|FG000|Overall Study|Lost to Follow-up|1|||
48921600|NCT01505634|157546429|FG001|Overall Study|Lost to Follow-up|4|||
48921601|NCT01505634|157546430|FG002|Overall Study|Lost to Follow-up|4|||
48921602|NCT01505634|157546428|FG000|Overall Study|Death|1|||
48921603|NCT01505634|157546429|FG001|Overall Study|Death|0|||
48921604|NCT01505634|157546430|FG002|Overall Study|Death|0|||
48825325|NCT00708097|157200775|FG002|Period 2|Protocol Violation|1|||
48825326|NCT00708097|157200776|FG003|Period 2|Protocol Violation|1|||
48825327|NCT00708097|157200777|FG004|Period 2|Protocol Violation|0|||
48825328|NCT00561574|157200778|FG000|Overall Study|Adverse Event|21|||
48825329|NCT00561574|157200779|FG001|Overall Study|Adverse Event|24|||
49151693|NCT02723955|158398727|FG033|Escalation Phase|Lost to Follow-up|0|||
48825330|NCT00561574|157200778|FG000|Overall Study|Lack of Efficacy|11|||
48825331|NCT00561574|157200779|FG001|Overall Study|Lack of Efficacy|21|||
48825332|NCT00561574|157200778|FG000|Overall Study|Withdrawal by Subject|4|||
48825333|NCT00561574|157200779|FG001|Overall Study|Withdrawal by Subject|4|||
48825334|NCT00561574|157200778|FG000|Overall Study|Reason Unrelated to Trial|6|||
49151694|NCT02723955|158398728|FG034|Escalation Phase|Lost to Follow-up|0|||
48825335|NCT00561574|157200779|FG001|Overall Study|Reason Unrelated to Trial|2|||
48825336|NCT00561574|157200778|FG000|Overall Study|Lost to Follow-up|1|||
48921605|NCT01505634|157546428|FG000|Overall Study|In a conflict zone|0|||
48825337|NCT00561574|157200779|FG001|Overall Study|Lost to Follow-up|0|||
48921606|NCT01505634|157546429|FG001|Overall Study|In a conflict zone|0|||
48921607|NCT01505634|157546430|FG002|Overall Study|In a conflict zone|1|||
49151695|NCT02723955|158398729|FG035|Escalation Phase|Lost to Follow-up|0|||
49151696|NCT02723955|158398730|FG036|Escalation Phase|Lost to Follow-up|0|||
49013986|NCT00696709|157887254|FG000|Overall Study|Adverse Event|0|||
49013987|NCT00696709|157887255|FG001|Overall Study|Adverse Event|0|||
49013988|NCT00696709|157887256|FG002|Overall Study|Adverse Event|0|||
49151697|NCT02723955|158398731|FG037|Escalation Phase|Lost to Follow-up|0|||
49151698|NCT02723955|158398732|FG038|Escalation Phase|Lost to Follow-up|0|||
49151699|NCT02723955|158398733|FG039|Escalation Phase|Lost to Follow-up|0|||
49151700|NCT02723955|158398734|FG040|Escalation Phase|Lost to Follow-up|0|||
49151701|NCT02723955|158398735|FG041|Escalation Phase|Lost to Follow-up|0|||
49151702|NCT02723955|158398736|FG042|Escalation Phase|Lost to Follow-up|0|||
49151703|NCT02723955|158398694|FG000|Escalation Phase|Physician Decision|0|||
49151704|NCT02723955|158398695|FG001|Escalation Phase|Physician Decision|0|||
49151705|NCT02723955|158398696|FG002|Escalation Phase|Physician Decision|0|||
49151706|NCT02723955|158398697|FG003|Escalation Phase|Physician Decision|0|||
49151707|NCT02723955|158398698|FG004|Escalation Phase|Physician Decision|0|||
49151708|NCT02723955|158398699|FG005|Escalation Phase|Physician Decision|2|||
49151709|NCT02723955|158398700|FG006|Escalation Phase|Physician Decision|0|||
49151710|NCT02723955|158398701|FG007|Escalation Phase|Physician Decision|0|||
48733113|NCT01193842|156873864|FG001|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
48733114|NCT01193842|156873865|FG002|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
48733115|NCT01193842|156873866|FG003|Phase II: Randomized Groups|Disease progression/relapse on treatment|5|||
48733116|NCT01193842|156873867|FG004|Phase II: Randomized Groups|Disease progression/relapse on treatment|3|||
48733117|NCT03672643|156873868|FG000|Overall Study|Adverse Event|3|||
48733118|NCT03672643|156873868|FG000|Overall Study|Death|2|||
48733119|NCT03672643|156873868|FG000|Overall Study|Withdrawal by Subject|1|||
48733120|NCT03672643|156873868|FG000|Overall Study|Progressive disease|11|||
48733121|NCT03672643|156873868|FG000|Overall Study|Global deterioration of health status|1|||
48733122|NCT03672643|156873868|FG000|Overall Study|Refused further treatment|7|||
48733123|NCT03672643|156873868|FG000|Overall Study|Rolled over to a continuous study for Crizotinib treatment|16|||
48733124|NCT02900976|156873873|FG000|Overall Study|Adverse Event|0|||
48733125|NCT02900976|156873874|FG001|Overall Study|Adverse Event|1|||
48733126|NCT02900976|156873873|FG000|Overall Study|Physician Decision|0|||
48733127|NCT02900976|156873874|FG001|Overall Study|Physician Decision|2|||
48733128|NCT02900976|156873873|FG000|Overall Study|Progressive disease|0|||
48733129|NCT02900976|156873874|FG001|Overall Study|Progressive disease|6|||
48733130|NCT02160782|156876104|FG000|Open-label Period: Maralixibat|Adverse Event|2|||
48733131|NCT02160782|156876105|FG001|Open-label Period: Maralixibat|Adverse Event|0|||
48733132|NCT02160782|156876106|FG002|Open-label Period: Maralixibat|Adverse Event|0|||
48733133|NCT02160782|156876107|FG003|Open-label Period: Maralixibat|Adverse Event|0|||
48733134|NCT02160782|156876108|FG004|Open-label Period: Maralixibat|Adverse Event|0|||
48733135|NCT02160782|156876104|FG000|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
48733136|NCT02160782|156876105|FG001|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
48733137|NCT02160782|156876106|FG002|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
49013989|NCT00696709|157887257|FG003|Overall Study|Adverse Event|1|||
49013990|NCT00696709|157887258|FG004|Overall Study|Adverse Event|0|||
49013991|NCT02984683|157887259|FG000|Overall Study|Adverse Event|3|||
49013992|NCT02984683|157887260|FG001|Overall Study|Adverse Event|3|||
49013993|NCT02984683|157887259|FG000|Overall Study|Withdrawal by Subject|1|||
49013994|NCT02984683|157887260|FG001|Overall Study|Withdrawal by Subject|0|||
49013995|NCT02984683|157887259|FG000|Overall Study|Disease progression|7|||
49013996|NCT02984683|157887260|FG001|Overall Study|Disease progression|9|||
49013997|NCT01118728|157887265|FG000|Overall Study|Adverse Event|17|||
49013998|NCT01118728|157887265|FG000|Overall Study|Lack of Efficacy|27|||
49013999|NCT01118728|157887265|FG000|Overall Study|Sponsor's decision to discontinue study|172|||
49014000|NCT01118728|157887265|FG000|Overall Study|Withdrawal by Subject|3|||
49014001|NCT01118728|157887265|FG000|Overall Study|Lost to Follow-up|4|||
49014002|NCT00321711|157887266|FG000|Part A|Adverse Event|3|||
49014003|NCT00321711|157887267|FG001|Part A|Adverse Event|3|||
49014004|NCT00321711|157887268|FG002|Part A|Adverse Event|2|||
49014005|NCT00321711|157887269|FG003|Part A|Adverse Event|0|||
49014006|NCT00321711|157887270|FG004|Part A|Adverse Event|0|||
49014007|NCT00321711|157887266|FG000|Part A|Withdrawal by Subject|1|||
49014008|NCT00321711|157887267|FG001|Part A|Withdrawal by Subject|1|||
49014009|NCT00321711|157887268|FG002|Part A|Withdrawal by Subject|1|||
49014010|NCT00321711|157887269|FG003|Part A|Withdrawal by Subject|0|||
49014011|NCT00321711|157887270|FG004|Part A|Withdrawal by Subject|0|||
49014012|NCT00321711|157887266|FG000|Part A|Disease progression|0|||
49014013|NCT00321711|157887267|FG001|Part A|Disease progression|1|||
49014014|NCT00321711|157887268|FG002|Part A|Disease progression|0|||
49014015|NCT00321711|157887269|FG003|Part A|Disease progression|0|||
49014016|NCT00321711|157887270|FG004|Part A|Disease progression|0|||
49014017|NCT00321711|157887266|FG000|Part A|Requirement for alternative therapy|0|||
49151711|NCT02723955|158398702|FG008|Escalation Phase|Physician Decision|0|||
49151712|NCT02723955|158398703|FG009|Escalation Phase|Physician Decision|0|||
49151713|NCT02723955|158398704|FG010|Escalation Phase|Physician Decision|0|||
48921608|NCT02846532|157546431|FG000|Overall Study|Lost to Follow-up|0|||
48921609|NCT02846532|157546432|FG001|Overall Study|Lost to Follow-up|1|||
49151714|NCT02723955|158398705|FG011|Escalation Phase|Physician Decision|0|||
49151715|NCT02723955|158398706|FG012|Escalation Phase|Physician Decision|0|||
49151716|NCT02723955|158398707|FG013|Escalation Phase|Physician Decision|0|||
49151717|NCT02723955|158398708|FG014|Escalation Phase|Physician Decision|0|||
49151718|NCT02723955|158398709|FG015|Escalation Phase|Physician Decision|0|||
49151719|NCT02723955|158398710|FG016|Escalation Phase|Physician Decision|0|||
49151720|NCT02723955|158398711|FG017|Escalation Phase|Physician Decision|0|||
49151721|NCT02723955|158398712|FG018|Escalation Phase|Physician Decision|0|||
48733138|NCT02160782|156876107|FG003|After Randomized Withdrawal: Maralixibat|Adverse Event|1|||
48733139|NCT02160782|156876108|FG004|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
48733140|NCT02160782|156876104|FG000|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
48733141|NCT02160782|156876105|FG001|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
48733142|NCT02160782|156876106|FG002|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
48733143|NCT02160782|156876107|FG003|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5|||
48733144|NCT02160782|156876108|FG004|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
48733145|NCT02160782|156876104|FG000|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
48733146|NCT02160782|156876105|FG001|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
48733147|NCT02160782|156876106|FG002|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
48733148|NCT02160782|156876107|FG003|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
48733149|NCT02160782|156876108|FG004|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4|||
48733150|NCT02160782|156876104|FG000|Long-term Extension Period: Maralixibat|Physician Decision|0|||
48733151|NCT02160782|156876105|FG001|Long-term Extension Period: Maralixibat|Physician Decision|0|||
48733152|NCT02160782|156876106|FG002|Long-term Extension Period: Maralixibat|Physician Decision|0|||
48733153|NCT02160782|156876107|FG003|Long-term Extension Period: Maralixibat|Physician Decision|0|||
48733154|NCT02160782|156876108|FG004|Long-term Extension Period: Maralixibat|Physician Decision|1|||
48733155|NCT02160782|156876104|FG000|Long-term Extension Period: Maralixibat|Adverse Event|0|||
48733156|NCT02160782|156876105|FG001|Long-term Extension Period: Maralixibat|Adverse Event|0|||
48733157|NCT02160782|156876106|FG002|Long-term Extension Period: Maralixibat|Adverse Event|0|||
48733158|NCT02160782|156876107|FG003|Long-term Extension Period: Maralixibat|Adverse Event|0|||
48733159|NCT02160782|156876108|FG004|Long-term Extension Period: Maralixibat|Adverse Event|3|||
48733160|NCT02160782|156876104|FG000|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
48733161|NCT02160782|156876105|FG001|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
48733162|NCT02160782|156876106|FG002|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
48733163|NCT02160782|156876107|FG003|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
48733164|NCT02160782|156876108|FG004|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1|||
48733165|NCT00891462|156876112|FG000|Overall Study|Withdrawal by Subject|9|||
48733166|NCT00891462|156876113|FG001|Overall Study|Withdrawal by Subject|6|||
48733167|NCT00891462|156876114|FG002|Overall Study|Withdrawal by Subject|7|||
48733168|NCT00891462|156876112|FG000|Overall Study|Adverse Event|7|||
48733169|NCT00891462|156876113|FG001|Overall Study|Adverse Event|8|||
48733170|NCT00891462|156876114|FG002|Overall Study|Adverse Event|7|||
48733171|NCT00891462|156876112|FG000|Overall Study|Lack of Efficacy|10|||
48733172|NCT00891462|156876113|FG001|Overall Study|Lack of Efficacy|5|||
48733173|NCT00891462|156876114|FG002|Overall Study|Lack of Efficacy|1|||
48733174|NCT00891462|156876112|FG000|Overall Study|COPD exacerbation|7|||
48733175|NCT00891462|156876113|FG001|Overall Study|COPD exacerbation|4|||
48733176|NCT00891462|156876114|FG002|Overall Study|COPD exacerbation|1|||
48733177|NCT00891462|156876112|FG000|Overall Study|Other Reason|2|||
48733178|NCT00891462|156876113|FG001|Overall Study|Other Reason|5|||
48733179|NCT00891462|156876114|FG002|Overall Study|Other Reason|3|||
48733180|NCT00891462|156876112|FG000|Overall Study|Protocol Violation|2|||
48733181|NCT00891462|156876113|FG001|Overall Study|Protocol Violation|1|||
48733182|NCT00891462|156876114|FG002|Overall Study|Protocol Violation|3|||
48733183|NCT00891462|156876112|FG000|Overall Study|Inclusion/exclusion criteria|0|||
48733184|NCT00891462|156876113|FG001|Overall Study|Inclusion/exclusion criteria|2|||
48733185|NCT00891462|156876114|FG002|Overall Study|Inclusion/exclusion criteria|2|||
48733186|NCT00891462|156876112|FG000|Overall Study|Lost to Follow-up|0|||
48733187|NCT00891462|156876113|FG001|Overall Study|Lost to Follow-up|2|||
48733188|NCT00891462|156876114|FG002|Overall Study|Lost to Follow-up|0|||
48733189|NCT05036369|156876117|FG000|Overall Study|Run In non compliance|1|||
48733190|NCT05036369|156876118|FG001|Overall Study|Run In non compliance|2|||
48733191|NCT05036369|156876117|FG000|Overall Study|Change in eligibility criteria|0|||
48733192|NCT05036369|156876118|FG001|Overall Study|Change in eligibility criteria|1|||
48921610|NCT02846532|157546433|FG002|Overall Study|Lost to Follow-up|1|||
49151722|NCT02723955|158398713|FG019|Escalation Phase|Physician Decision|0|||
48825338|NCT00561574|157200778|FG000|Overall Study|Other|5|||
48825339|NCT00561574|157200779|FG001|Overall Study|Other|7|||
48825340|NCT00445692|157200780|FG000|Overall Study|Adverse Event|11|||
48825341|NCT00445692|157200780|FG000|Overall Study|Lack of Efficacy|5|||
48825342|NCT01555762|157200781|FG000|Overall Study|No information on Bevacizumab intake|11|||
48825343|NCT01555762|157200781|FG000|Overall Study|Missing start date of infusion|8|||
48825344|NCT01555762|157200781|FG000|Overall Study|75 years old or more ticked No|1|||
48825345|NCT01555762|157200781|FG000|Overall Study|Treatment with Bevacizumab ticked No|24|||
48825346|NCT01555762|157200781|FG000|Overall Study|Death linked to progression of disease|165|||
48825347|NCT01555762|157200781|FG000|Overall Study|Lost follow-up/moved house/changed team|35|||
48825348|NCT01555762|157200781|FG000|Overall Study|Investigator's decision|10|||
48825349|NCT01555762|157200781|FG000|Overall Study|Participant not wishing to continue|5|||
48825350|NCT01555762|157200781|FG000|Overall Study|Missing data|1|||
48825351|NCT01555762|157200781|FG000|Overall Study|Death linked to an adverse event|14|||
48825352|NCT05233085|157200782|FG000|Overall Study|Adverse Event|1|||
48825353|NCT05233085|157200783|FG001|Overall Study|Adverse Event|0|||
48825354|NCT05233085|157200784|FG002|Overall Study|Adverse Event|0|||
48825355|NCT05233085|157200785|FG003|Overall Study|Adverse Event|0|||
48825356|NCT00836810|157200786|FG000|Overall Study|New diagnosis|1|||
48825357|NCT00836810|157200787|FG001|Overall Study|New diagnosis|0|||
48825358|NCT04949399|157200788|FG000|Overall Study|Lost to Follow-up|11|||
48825359|NCT04949399|157200789|FG001|Overall Study|Lost to Follow-up|6|||
48825360|NCT04949399|157200788|FG000|Overall Study|Withdrawal by Subject|2|||
48825361|NCT04949399|157200789|FG001|Overall Study|Withdrawal by Subject|3|||
48921611|NCT02846532|157546431|FG000|Overall Study|Withdrawal by Subject|1|||
48921612|NCT02846532|157546432|FG001|Overall Study|Withdrawal by Subject|2|||
48921613|NCT02846532|157546433|FG002|Overall Study|Withdrawal by Subject|0|||
49151723|NCT02723955|158398714|FG020|Escalation Phase|Physician Decision|0|||
49151724|NCT02723955|158398715|FG021|Escalation Phase|Physician Decision|0|||
49151725|NCT02723955|158398716|FG022|Escalation Phase|Physician Decision|0|||
49151726|NCT02723955|158398717|FG023|Escalation Phase|Physician Decision|0|||
49151727|NCT02723955|158398718|FG024|Escalation Phase|Physician Decision|0|||
49151728|NCT02723955|158398719|FG025|Escalation Phase|Physician Decision|0|||
49151729|NCT02723955|158398720|FG026|Escalation Phase|Physician Decision|2|||
48825362|NCT02068885|157200790|FG000|Overall Study|Withdrew|3|||
48825363|NCT02068885|157200791|FG001|Overall Study|Withdrew|5|||
49151730|NCT02723955|158398721|FG027|Escalation Phase|Physician Decision|0|||
49151731|NCT02723955|158398722|FG028|Escalation Phase|Physician Decision|0|||
49151732|NCT02723955|158398723|FG029|Escalation Phase|Physician Decision|0|||
49151733|NCT02723955|158398724|FG030|Escalation Phase|Physician Decision|0|||
49151734|NCT02723955|158398725|FG031|Escalation Phase|Physician Decision|0|||
49151735|NCT02723955|158398726|FG032|Escalation Phase|Physician Decision|0|||
49151736|NCT02723955|158398727|FG033|Escalation Phase|Physician Decision|0|||
49151737|NCT02723955|158398728|FG034|Escalation Phase|Physician Decision|0|||
49151738|NCT02723955|158398729|FG035|Escalation Phase|Physician Decision|0|||
49151739|NCT02723955|158398730|FG036|Escalation Phase|Physician Decision|0|||
49151740|NCT02723955|158398731|FG037|Escalation Phase|Physician Decision|0|||
49151741|NCT02723955|158398732|FG038|Escalation Phase|Physician Decision|0|||
49151742|NCT02723955|158398733|FG039|Escalation Phase|Physician Decision|0|||
49151743|NCT02723955|158398734|FG040|Escalation Phase|Physician Decision|0|||
49151744|NCT02723955|158398735|FG041|Escalation Phase|Physician Decision|0|||
49151745|NCT02723955|158398736|FG042|Escalation Phase|Physician Decision|0|||
49151746|NCT02723955|158398694|FG000|Escalation Phase|Withdrawal by Subject|0|||
49151747|NCT02723955|158398695|FG001|Escalation Phase|Withdrawal by Subject|0|||
49151748|NCT02723955|158398696|FG002|Escalation Phase|Withdrawal by Subject|0|||
49151749|NCT02723955|158398697|FG003|Escalation Phase|Withdrawal by Subject|0|||
49151750|NCT02723955|158398698|FG004|Escalation Phase|Withdrawal by Subject|1|||
49151751|NCT02723955|158398699|FG005|Escalation Phase|Withdrawal by Subject|1|||
49151752|NCT02723955|158398700|FG006|Escalation Phase|Withdrawal by Subject|1|||
49151753|NCT02723955|158398701|FG007|Escalation Phase|Withdrawal by Subject|1|||
49151754|NCT02723955|158398702|FG008|Escalation Phase|Withdrawal by Subject|0|||
49151755|NCT02723955|158398703|FG009|Escalation Phase|Withdrawal by Subject|0|||
49151756|NCT02723955|158398704|FG010|Escalation Phase|Withdrawal by Subject|0|||
48921614|NCT01294579|157546434|FG000|Overall Study|Disease progression|12|||
49151757|NCT02723955|158398705|FG011|Escalation Phase|Withdrawal by Subject|0|||
49151758|NCT02723955|158398706|FG012|Escalation Phase|Withdrawal by Subject|1|||
49151759|NCT02723955|158398707|FG013|Escalation Phase|Withdrawal by Subject|0|||
49151760|NCT02723955|158398708|FG014|Escalation Phase|Withdrawal by Subject|0|||
49151761|NCT02723955|158398709|FG015|Escalation Phase|Withdrawal by Subject|0|||
48825364|NCT02068885|157200792|FG002|Overall Study|Withdrew|8|||
48921615|NCT01294579|157546434|FG000|Overall Study|Adverse Event|11|||
49151762|NCT02723955|158398710|FG016|Escalation Phase|Withdrawal by Subject|1|||
48825365|NCT01562743|157200793|FG000|Overall Study|Adverse Event|29|||
48921616|NCT01294579|157546434|FG000|Overall Study|Study closed/terminated|3|||
49151763|NCT02723955|158398711|FG017|Escalation Phase|Withdrawal by Subject|0|||
49151764|NCT02723955|158398712|FG018|Escalation Phase|Withdrawal by Subject|0|||
48825366|NCT01562743|157200793|FG000|Overall Study|Lack of Efficacy|3|||
48825367|NCT01562743|157200793|FG000|Overall Study|Withdrawal by Subject|13|||
48825368|NCT01562743|157200793|FG000|Overall Study|Protocol Violation|1|||
48825369|NCT01562743|157200793|FG000|Overall Study|Discontinuation criteria|2|||
48825370|NCT01562743|157200793|FG000|Overall Study|Lost to Follow-up|2|||
49151765|NCT02723955|158398713|FG019|Escalation Phase|Withdrawal by Subject|0|||
48825371|NCT01562743|157200793|FG000|Overall Study|Physician Decision|2|||
48825372|NCT00662909|157200795|FG000|Overall Study|Adverse Event|17|||
48825373|NCT00662909|157200796|FG001|Overall Study|Adverse Event|18|||
48825374|NCT00662909|157200797|FG002|Overall Study|Adverse Event|19|||
48825375|NCT00662909|157200795|FG000|Overall Study|Lack of Efficacy|9|||
48825376|NCT00662909|157200796|FG001|Overall Study|Lack of Efficacy|1|||
48825377|NCT00662909|157200797|FG002|Overall Study|Lack of Efficacy|5|||
48825378|NCT00662909|157200795|FG000|Overall Study|Withdrawal by Subject|29|||
48825379|NCT00662909|157200796|FG001|Overall Study|Withdrawal by Subject|22|||
48825380|NCT00662909|157200797|FG002|Overall Study|Withdrawal by Subject|16|||
48825381|NCT00662909|157200795|FG000|Overall Study|Lost to Follow-up|2|||
48825382|NCT00662909|157200796|FG001|Overall Study|Lost to Follow-up|9|||
48825383|NCT00662909|157200797|FG002|Overall Study|Lost to Follow-up|3|||
48825384|NCT00662909|157200795|FG000|Overall Study|Protocol Violation|7|||
48825385|NCT00662909|157200796|FG001|Overall Study|Protocol Violation|4|||
49151766|NCT02723955|158398714|FG020|Escalation Phase|Withdrawal by Subject|0|||
49151767|NCT02723955|158398715|FG021|Escalation Phase|Withdrawal by Subject|0|||
49151768|NCT02723955|158398716|FG022|Escalation Phase|Withdrawal by Subject|0|||
49151769|NCT02723955|158398717|FG023|Escalation Phase|Withdrawal by Subject|2|||
49151770|NCT02723955|158398718|FG024|Escalation Phase|Withdrawal by Subject|0|||
49151771|NCT02723955|158398719|FG025|Escalation Phase|Withdrawal by Subject|1|||
49151772|NCT02723955|158398720|FG026|Escalation Phase|Withdrawal by Subject|0|||
49151773|NCT02723955|158398721|FG027|Escalation Phase|Withdrawal by Subject|0|||
49151774|NCT02723955|158398722|FG028|Escalation Phase|Withdrawal by Subject|1|||
49151775|NCT02723955|158398723|FG029|Escalation Phase|Withdrawal by Subject|0|||
49151776|NCT02723955|158398724|FG030|Escalation Phase|Withdrawal by Subject|0|||
49151777|NCT02723955|158398725|FG031|Escalation Phase|Withdrawal by Subject|0|||
49151778|NCT02723955|158398726|FG032|Escalation Phase|Withdrawal by Subject|0|||
49151779|NCT02723955|158398727|FG033|Escalation Phase|Withdrawal by Subject|0|||
49151780|NCT02723955|158398728|FG034|Escalation Phase|Withdrawal by Subject|0|||
49151781|NCT02723955|158398729|FG035|Escalation Phase|Withdrawal by Subject|0|||
49151782|NCT02723955|158398730|FG036|Escalation Phase|Withdrawal by Subject|0|||
49151783|NCT02723955|158398731|FG037|Escalation Phase|Withdrawal by Subject|0|||
49151784|NCT02723955|158398732|FG038|Escalation Phase|Withdrawal by Subject|0|||
49151785|NCT02723955|158398733|FG039|Escalation Phase|Withdrawal by Subject|0|||
49151786|NCT02723955|158398734|FG040|Escalation Phase|Withdrawal by Subject|0|||
49151787|NCT02723955|158398735|FG041|Escalation Phase|Withdrawal by Subject|0|||
49151788|NCT02723955|158398736|FG042|Escalation Phase|Withdrawal by Subject|0|||
49151789|NCT02723955|158398694|FG000|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
49151790|NCT02723955|158398695|FG001|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
49151791|NCT02723955|158398696|FG002|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
49151792|NCT02723955|158398697|FG003|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
49151793|NCT02723955|158398698|FG004|Escalation Phase|Participants were crossed over OR were re-treated following progression|5|||
49151794|NCT02723955|158398699|FG005|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
49151795|NCT02723955|158398700|FG006|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
49151796|NCT02723955|158398701|FG007|Escalation Phase|Participants were crossed over OR were re-treated following progression|4|||
49151797|NCT02723955|158398702|FG008|Escalation Phase|Participants were crossed over OR were re-treated following progression|3|||
49151798|NCT02723955|158398703|FG009|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
49151799|NCT02723955|158398704|FG010|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
48825386|NCT00662909|157200797|FG002|Overall Study|Protocol Violation|5|||
48825387|NCT00662909|157200795|FG000|Overall Study|Randomized- never received study drug|1|||
48825388|NCT00662909|157200796|FG001|Overall Study|Randomized- never received study drug|0|||
48825389|NCT00662909|157200797|FG002|Overall Study|Randomized- never received study drug|0|||
48825390|NCT00662909|157200795|FG000|Overall Study|Non-compliance with study procedures|3|||
49151800|NCT02723955|158398705|FG011|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
49151801|NCT02723955|158398706|FG012|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
49151802|NCT02723955|158398707|FG013|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
49151803|NCT02723955|158398708|FG014|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
48825391|NCT00662909|157200796|FG001|Overall Study|Non-compliance with study procedures|3|||
48825392|NCT00662909|157200797|FG002|Overall Study|Non-compliance with study procedures|2|||
48825393|NCT00662909|157200795|FG000|Overall Study|Physician Decision|1|||
48825394|NCT00662909|157200796|FG001|Overall Study|Physician Decision|1|||
48825395|NCT00662909|157200797|FG002|Overall Study|Physician Decision|2|||
49151804|NCT02723955|158398709|FG015|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
49151805|NCT02723955|158398710|FG016|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
49151806|NCT02723955|158398711|FG017|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
49151807|NCT02723955|158398712|FG018|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
49151808|NCT02723955|158398713|FG019|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
49151809|NCT02723955|158398714|FG020|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
49151810|NCT02723955|158398715|FG021|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
49151811|NCT02723955|158398716|FG022|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
49151812|NCT02723955|158398717|FG023|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
49151813|NCT02723955|158398718|FG024|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
49151814|NCT02723955|158398719|FG025|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
49151815|NCT02723955|158398720|FG026|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
49151816|NCT02723955|158398721|FG027|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
49151817|NCT02723955|158398722|FG028|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
49151818|NCT02723955|158398723|FG029|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
49151819|NCT02723955|158398724|FG030|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
49151820|NCT02723955|158398725|FG031|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
49151821|NCT02723955|158398726|FG032|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
49151822|NCT02723955|158398727|FG033|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
49151823|NCT02723955|158398728|FG034|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
49151824|NCT02723955|158398729|FG035|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
49151825|NCT02723955|158398730|FG036|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
49151826|NCT02723955|158398731|FG037|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
49151827|NCT02723955|158398732|FG038|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
49151828|NCT02723955|158398733|FG039|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
49151829|NCT02723955|158398734|FG040|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
49151830|NCT02723955|158398735|FG041|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
49151831|NCT02723955|158398736|FG042|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
49151832|NCT02723955|158398694|FG000|Escalation Phase|Site Closed|0|||
49151833|NCT02723955|158398695|FG001|Escalation Phase|Site Closed|0|||
49151834|NCT02723955|158398696|FG002|Escalation Phase|Site Closed|0|||
49151835|NCT02723955|158398697|FG003|Escalation Phase|Site Closed|0|||
49151836|NCT02723955|158398698|FG004|Escalation Phase|Site Closed|0|||
49151837|NCT02723955|158398699|FG005|Escalation Phase|Site Closed|0|||
49151838|NCT02723955|158398700|FG006|Escalation Phase|Site Closed|0|||
49151839|NCT02723955|158398701|FG007|Escalation Phase|Site Closed|0|||
49151840|NCT02723955|158398702|FG008|Escalation Phase|Site Closed|0|||
49151841|NCT02723955|158398703|FG009|Escalation Phase|Site Closed|0|||
49151842|NCT02723955|158398704|FG010|Escalation Phase|Site Closed|0|||
49151843|NCT02723955|158398705|FG011|Escalation Phase|Site Closed|0|||
49151844|NCT02723955|158398706|FG012|Escalation Phase|Site Closed|0|||
49151845|NCT02723955|158398707|FG013|Escalation Phase|Site Closed|0|||
49151846|NCT02723955|158398708|FG014|Escalation Phase|Site Closed|0|||
49151847|NCT02723955|158398709|FG015|Escalation Phase|Site Closed|1|||
49151848|NCT02723955|158398710|FG016|Escalation Phase|Site Closed|0|||
49151849|NCT02723955|158398711|FG017|Escalation Phase|Site Closed|2|||
49151850|NCT02723955|158398712|FG018|Escalation Phase|Site Closed|0|||
49151851|NCT02723955|158398713|FG019|Escalation Phase|Site Closed|0|||
49151852|NCT02723955|158398714|FG020|Escalation Phase|Site Closed|1|||
49151853|NCT02723955|158398715|FG021|Escalation Phase|Site Closed|0|||
49151854|NCT02723955|158398716|FG022|Escalation Phase|Site Closed|0|||
49151855|NCT02723955|158398717|FG023|Escalation Phase|Site Closed|0|||
49151856|NCT02723955|158398718|FG024|Escalation Phase|Site Closed|3|||
49151857|NCT02723955|158398719|FG025|Escalation Phase|Site Closed|1|||
49151858|NCT02723955|158398720|FG026|Escalation Phase|Site Closed|3|||
49151859|NCT02723955|158398721|FG027|Escalation Phase|Site Closed|1|||
49151860|NCT02723955|158398722|FG028|Escalation Phase|Site Closed|1|||
49151861|NCT02723955|158398723|FG029|Escalation Phase|Site Closed|0|||
49151862|NCT02723955|158398724|FG030|Escalation Phase|Site Closed|0|||
48733193|NCT02247531|156876119|FG000|Overall Study|Adverse Event|3|||
49151863|NCT02723955|158398725|FG031|Escalation Phase|Site Closed|0|||
49151864|NCT02723955|158398726|FG032|Escalation Phase|Site Closed|0|||
49151865|NCT02723955|158398727|FG033|Escalation Phase|Site Closed|0|||
49151866|NCT02723955|158398728|FG034|Escalation Phase|Site Closed|0|||
49151867|NCT02723955|158398729|FG035|Escalation Phase|Site Closed|0|||
49151868|NCT02723955|158398730|FG036|Escalation Phase|Site Closed|0|||
49151869|NCT02723955|158398731|FG037|Escalation Phase|Site Closed|0|||
49151870|NCT02723955|158398732|FG038|Escalation Phase|Site Closed|0|||
49151871|NCT02723955|158398733|FG039|Escalation Phase|Site Closed|0|||
49151872|NCT02723955|158398734|FG040|Escalation Phase|Site Closed|0|||
49151873|NCT02723955|158398735|FG041|Escalation Phase|Site Closed|0|||
49151874|NCT02723955|158398736|FG042|Escalation Phase|Site Closed|0|||
49151875|NCT02723955|158398694|FG000|Expansion Phase|Death|0|||
48733194|NCT02247531|156876120|FG001|Overall Study|Adverse Event|4|||
48733195|NCT02247531|156876121|FG002|Overall Study|Adverse Event|9|||
48825396|NCT00662909|157200795|FG000|Overall Study|Eligibility criterion not met|0|||
48825397|NCT00662909|157200796|FG001|Overall Study|Eligibility criterion not met|1|||
48825398|NCT00662909|157200797|FG002|Overall Study|Eligibility criterion not met|1|||
48825399|NCT01174550|157202059|FG000|Overall Study|Death|75|||
48825400|NCT01174550|157202060|FG001|Overall Study|Death|74|||
49151876|NCT02723955|158398695|FG001|Expansion Phase|Death|0|||
49151877|NCT02723955|158398696|FG002|Expansion Phase|Death|0|||
48825401|NCT01174550|157202059|FG000|Overall Study|Lost to Follow-up|652|||
48825402|NCT01174550|157202060|FG001|Overall Study|Lost to Follow-up|510|||
49151878|NCT02723955|158398697|FG003|Expansion Phase|Death|0|||
49151879|NCT02723955|158398698|FG004|Expansion Phase|Death|0|||
49151880|NCT02723955|158398699|FG005|Expansion Phase|Death|0|||
49151881|NCT02723955|158398700|FG006|Expansion Phase|Death|0|||
49151882|NCT02723955|158398701|FG007|Expansion Phase|Death|0|||
49151883|NCT02723955|158398702|FG008|Expansion Phase|Death|0|||
49151884|NCT02723955|158398703|FG009|Expansion Phase|Death|25|||
49151885|NCT02723955|158398704|FG010|Expansion Phase|Death|69|||
49151886|NCT02723955|158398705|FG011|Expansion Phase|Death|48|||
49151887|NCT02723955|158398706|FG012|Expansion Phase|Death|0|||
49151888|NCT02723955|158398707|FG013|Expansion Phase|Death|0|||
49151889|NCT02723955|158398708|FG014|Expansion Phase|Death|0|||
49151890|NCT02723955|158398709|FG015|Expansion Phase|Death|0|||
49151891|NCT02723955|158398710|FG016|Expansion Phase|Death|0|||
49151892|NCT02723955|158398711|FG017|Expansion Phase|Death|0|||
49151893|NCT02723955|158398712|FG018|Expansion Phase|Death|0|||
49151894|NCT02723955|158398713|FG019|Expansion Phase|Death|0|||
49151895|NCT02723955|158398714|FG020|Expansion Phase|Death|0|||
49151896|NCT02723955|158398715|FG021|Expansion Phase|Death|0|||
49151897|NCT02723955|158398716|FG022|Expansion Phase|Death|0|||
49151898|NCT02723955|158398717|FG023|Expansion Phase|Death|0|||
49151899|NCT02723955|158398718|FG024|Expansion Phase|Death|0|||
49151900|NCT02723955|158398719|FG025|Expansion Phase|Death|0|||
49151901|NCT02723955|158398720|FG026|Expansion Phase|Death|0|||
49151902|NCT02723955|158398721|FG027|Expansion Phase|Death|0|||
49151903|NCT02723955|158398722|FG028|Expansion Phase|Death|0|||
49151904|NCT02723955|158398723|FG029|Expansion Phase|Death|12|||
49151905|NCT02723955|158398724|FG030|Expansion Phase|Death|202|||
49151906|NCT02723955|158398725|FG031|Expansion Phase|Death|31|||
49151907|NCT02723955|158398726|FG032|Expansion Phase|Death|17|||
48733196|NCT02247531|156876119|FG000|Overall Study|Death|8|||
48825403|NCT01174550|157202059|FG000|Overall Study|Withdrawal by Subject|543|||
48733197|NCT02247531|156876120|FG001|Overall Study|Death|9|||
48825404|NCT01174550|157202060|FG001|Overall Study|Withdrawal by Subject|289|||
48825405|NCT01789203|157202061|FG000|Overall Study|Adverse Event|2|||
48733198|NCT02247531|156876121|FG002|Overall Study|Death|5|||
48733199|NCT02247531|156876119|FG000|Overall Study|Lost to Follow-up|1|||
48733200|NCT02247531|156876120|FG001|Overall Study|Lost to Follow-up|8|||
48733201|NCT02247531|156876121|FG002|Overall Study|Lost to Follow-up|3|||
48733202|NCT02247531|156876119|FG000|Overall Study|Non-compliance|2|||
49151908|NCT02723955|158398727|FG033|Expansion Phase|Death|2|||
48733203|NCT02247531|156876120|FG001|Overall Study|Non-compliance|2|||
48733204|NCT02247531|156876121|FG002|Overall Study|Non-compliance|0|||
48733205|NCT02247531|156876119|FG000|Overall Study|Withdrawal by Subject|26|||
48733206|NCT02247531|156876120|FG001|Overall Study|Withdrawal by Subject|31|||
48825406|NCT01789203|157202062|FG001|Overall Study|Adverse Event|2|||
49151909|NCT02723955|158398728|FG034|Expansion Phase|Death|3|||
49151910|NCT02723955|158398729|FG035|Expansion Phase|Death|3|||
49151911|NCT02723955|158398730|FG036|Expansion Phase|Death|1|||
49151912|NCT02723955|158398731|FG037|Expansion Phase|Death|0|||
48733207|NCT02247531|156876121|FG002|Overall Study|Withdrawal by Subject|25|||
48733208|NCT02247531|156876119|FG000|Overall Study|Study Terminated by Sponsor|64|||
48733209|NCT02247531|156876120|FG001|Overall Study|Study Terminated by Sponsor|66|||
48733210|NCT02247531|156876121|FG002|Overall Study|Study Terminated by Sponsor|62|||
49151913|NCT02723955|158398732|FG038|Expansion Phase|Death|0|||
49151914|NCT02723955|158398733|FG039|Expansion Phase|Death|0|||
49151915|NCT02723955|158398734|FG040|Expansion Phase|Death|0|||
49151916|NCT02723955|158398735|FG041|Expansion Phase|Death|0|||
49151917|NCT02723955|158398736|FG042|Expansion Phase|Death|0|||
49151918|NCT02723955|158398694|FG000|Expansion Phase|Lost to Follow-up|0|||
48825407|NCT01789203|157202061|FG000|Overall Study|Withdrawal by Subject|1|||
48825408|NCT01789203|157202062|FG001|Overall Study|Withdrawal by Subject|0|||
48825409|NCT01789203|157202061|FG000|Overall Study|Death|1|||
48825410|NCT01789203|157202062|FG001|Overall Study|Death|0|||
48825411|NCT01789203|157202061|FG000|Overall Study|Protocol Violation|2|||
48825412|NCT01789203|157202062|FG001|Overall Study|Protocol Violation|1|||
48825413|NCT01789203|157202061|FG000|Overall Study|Other|1|||
48825414|NCT01789203|157202062|FG001|Overall Study|Other|1|||
48825415|NCT01789203|157202061|FG000|Overall Study|patient non-adherent|2|||
48825416|NCT01789203|157202062|FG001|Overall Study|patient non-adherent|0|||
48825417|NCT03070392|157202063|FG000|Overall Study|Not Treated|7|||
48825418|NCT03070392|157202064|FG001|Overall Study|Not Treated|0|||
48825419|NCT03070392|157202065|FG002|Overall Study|Not Treated|3|||
48825420|NCT03070392|157202066|FG003|Overall Study|Not Treated|12|||
48825421|NCT03070392|157202063|FG000|Overall Study|Death|3|||
48825422|NCT03070392|157202064|FG001|Overall Study|Death|0|||
48825423|NCT03070392|157202065|FG002|Overall Study|Death|0|||
48825424|NCT03070392|157202066|FG003|Overall Study|Death|1|||
48825425|NCT03070392|157202063|FG000|Overall Study|Withdrawal by Subject|7|||
48825426|NCT03070392|157202064|FG001|Overall Study|Withdrawal by Subject|0|||
48825427|NCT03070392|157202065|FG002|Overall Study|Withdrawal by Subject|0|||
48825428|NCT03070392|157202066|FG003|Overall Study|Withdrawal by Subject|3|||
48825429|NCT03070392|157202063|FG000|Overall Study|Physician Decision|1|||
48825430|NCT03070392|157202064|FG001|Overall Study|Physician Decision|0|||
48825431|NCT03070392|157202065|FG002|Overall Study|Physician Decision|0|||
48825432|NCT03070392|157202066|FG003|Overall Study|Physician Decision|2|||
48825433|NCT03070392|157202063|FG000|Overall Study|Progressive Disease|154|||
48825434|NCT03070392|157202064|FG001|Overall Study|Progressive Disease|6|||
48825435|NCT03070392|157202065|FG002|Overall Study|Progressive Disease|2|||
48825436|NCT03070392|157202066|FG003|Overall Study|Progressive Disease|70|||
48825437|NCT03070392|157202063|FG000|Overall Study|Adverse Event|6|||
48825438|NCT03070392|157202064|FG001|Overall Study|Adverse Event|1|||
48825439|NCT03070392|157202065|FG002|Overall Study|Adverse Event|1|||
48825440|NCT03070392|157202066|FG003|Overall Study|Adverse Event|3|||
48825441|NCT03070392|157202063|FG000|Overall Study|Alternate anticancer treatment|1|||
48825442|NCT03070392|157202064|FG001|Overall Study|Alternate anticancer treatment|0|||
48825443|NCT03070392|157202065|FG002|Overall Study|Alternate anticancer treatment|0|||
49014018|NCT00321711|157887267|FG001|Part A|Requirement for alternative therapy|2|||
49014019|NCT00321711|157887268|FG002|Part A|Requirement for alternative therapy|1|||
49014020|NCT00321711|157887269|FG003|Part A|Requirement for alternative therapy|0|||
49014021|NCT00321711|157887270|FG004|Part A|Requirement for alternative therapy|0|||
49014022|NCT00321711|157887266|FG000|Part A|Physician Decision|0|||
49014023|NCT00321711|157887267|FG001|Part A|Physician Decision|1|||
49014024|NCT00321711|157887268|FG002|Part A|Physician Decision|3|||
49014025|NCT00321711|157887269|FG003|Part A|Physician Decision|0|||
49014026|NCT00321711|157887270|FG004|Part A|Physician Decision|0|||
49014027|NCT00321711|157887266|FG000|Part A|Other|1|||
49014028|NCT00321711|157887267|FG001|Part A|Other|2|||
49014029|NCT00321711|157887268|FG002|Part A|Other|3|||
49014030|NCT00321711|157887269|FG003|Part A|Other|0|||
49014031|NCT00321711|157887270|FG004|Part A|Other|0|||
49014032|NCT00321711|157887266|FG000|Part A|Protocol deviation|0|||
49014033|NCT00321711|157887267|FG001|Part A|Protocol deviation|0|||
49014034|NCT00321711|157887268|FG002|Part A|Protocol deviation|1|||
49014035|NCT00321711|157887269|FG003|Part A|Protocol deviation|0|||
49014036|NCT00321711|157887270|FG004|Part A|Protocol deviation|0|||
49014037|NCT00321711|157887266|FG000|Part B|Noncompliance|0|||
49014038|NCT00321711|157887267|FG001|Part B|Noncompliance|0|||
49014039|NCT00321711|157887268|FG002|Part B|Noncompliance|0|||
49014040|NCT00321711|157887269|FG003|Part B|Noncompliance|0|||
49014041|NCT00321711|157887270|FG004|Part B|Noncompliance|1|||
49014042|NCT00321711|157887266|FG000|Part B|Adverse Event|0|||
49014043|NCT00321711|157887267|FG001|Part B|Adverse Event|0|||
49014044|NCT00321711|157887268|FG002|Part B|Adverse Event|0|||
49014045|NCT00321711|157887269|FG003|Part B|Adverse Event|2|||
49014046|NCT00321711|157887270|FG004|Part B|Adverse Event|1|||
49014047|NCT00321711|157887266|FG000|Part B|Disease progression|0|||
49014048|NCT00321711|157887267|FG001|Part B|Disease progression|0|||
49014049|NCT00321711|157887268|FG002|Part B|Disease progression|0|||
49014050|NCT00321711|157887269|FG003|Part B|Disease progression|1|||
49014051|NCT00321711|157887270|FG004|Part B|Disease progression|0|||
49014052|NCT00321711|157887266|FG000|Part B|Physician Decision|0|||
49014053|NCT00321711|157887267|FG001|Part B|Physician Decision|0|||
49014054|NCT00321711|157887268|FG002|Part B|Physician Decision|0|||
49014055|NCT00321711|157887269|FG003|Part B|Physician Decision|1|||
49014056|NCT00321711|157887270|FG004|Part B|Physician Decision|2|||
49014057|NCT00321711|157887266|FG000|Part B|Death|0|||
49014058|NCT00321711|157887267|FG001|Part B|Death|0|||
49014059|NCT00321711|157887268|FG002|Part B|Death|0|||
49014060|NCT00321711|157887269|FG003|Part B|Death|2|||
49014061|NCT00321711|157887270|FG004|Part B|Death|1|||
49014062|NCT03521999|157887271|FG000|Completed 1 Month Up|Lost to Follow-up|59|||
49014063|NCT03521999|157887272|FG001|Completed 1 Month Up|Lost to Follow-up|58|||
49014064|NCT03521999|157887271|FG000|Completed 3 Month Follow up|Lost to Follow-up|64|||
48921617|NCT01294579|157546434|FG000|Overall Study|Lost to Follow-up|1|||
48921618|NCT01294579|157546434|FG000|Overall Study|Physician Decision|3|||
48825444|NCT03070392|157202066|FG003|Overall Study|Alternate anticancer treatment|1|||
48825445|NCT03070392|157202063|FG000|Overall Study|Ongoing|73|||
48825446|NCT03070392|157202064|FG001|Overall Study|Ongoing|0|||
48825447|NCT03070392|157202065|FG002|Overall Study|Ongoing|0|||
48825448|NCT03070392|157202066|FG003|Overall Study|Ongoing|11|||
48825449|NCT00723294|157202067|FG000|Overall Study|Lobular histology|2|||
48825450|NCT00723294|157202067|FG000|Overall Study|>25% intraductal component|1|||
48825451|NCT00723294|157202067|FG000|Overall Study|No MRI tumor enhancement|1|||
48825452|NCT00723294|157202067|FG000|Overall Study|1.0-Tesla MRI|1|||
48825453|NCT00723294|157202067|FG000|Overall Study|No cryoabalation|2|||
48825454|NCT00723294|157202067|FG000|Overall Study|Did not undergo surgery|1|||
48825455|NCT00723294|157202067|FG000|Overall Study|Treated prior to registration|1|||
48825456|NCT00723294|157202067|FG000|Overall Study|Treated by non-credentialed surgeon|1|||
48825457|NCT00723294|157202067|FG000|Overall Study|Benign lesion|1|||
48825458|NCT00723294|157202067|FG000|Overall Study|Withdrawal by Subject|1|||
48825459|NCT00723294|157202067|FG000|Overall Study|No treatment due to probe failure|1|||
48825460|NCT05343455|157202068|FG000|Overall Study|Withdrawal by Subject|4|||
48825461|NCT05343455|157202069|FG001|Overall Study|Withdrawal by Subject|9|||
48825462|NCT05343455|157202070|FG002|Overall Study|Withdrawal by Subject|7|||
48825463|NCT05343455|157202068|FG000|Overall Study|Adverse Event|2|||
48825464|NCT05343455|157202069|FG001|Overall Study|Adverse Event|1|||
48825465|NCT05343455|157202070|FG002|Overall Study|Adverse Event|2|||
48825466|NCT05343455|157202068|FG000|Overall Study|Lost to Follow-up|1|||
48825467|NCT05343455|157202069|FG001|Overall Study|Lost to Follow-up|1|||
48825468|NCT05343455|157202070|FG002|Overall Study|Lost to Follow-up|3|||
48825469|NCT05343455|157202068|FG000|Overall Study|Pregnancy|1|||
48825470|NCT05343455|157202069|FG001|Overall Study|Pregnancy|0|||
48825471|NCT05343455|157202070|FG002|Overall Study|Pregnancy|0|||
48825472|NCT05343455|157202068|FG000|Overall Study|Physician Decision|0|||
48825473|NCT05343455|157202069|FG001|Overall Study|Physician Decision|0|||
48825474|NCT05343455|157202070|FG002|Overall Study|Physician Decision|1|||
48825475|NCT05343455|157202068|FG000|Overall Study|Protocol Violation|0|||
48825476|NCT05343455|157202069|FG001|Overall Study|Protocol Violation|1|||
48825477|NCT05343455|157202070|FG002|Overall Study|Protocol Violation|1|||
48921619|NCT01294579|157546434|FG000|Overall Study|Withdrawal by Subject|5|||
48921620|NCT00640328|157546435|FG000|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
48921621|NCT00640328|157546436|FG001|First Treatment Period (Weeks 0-24)|Adverse Event|1|||
48921622|NCT00640328|157546437|FG002|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
48921623|NCT00640328|157546438|FG003|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
48921624|NCT00640328|157546439|FG004|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
49014065|NCT03521999|157887272|FG001|Completed 3 Month Follow up|Lost to Follow-up|59|||
49014066|NCT03521999|157887271|FG000|Completed 3 Month Follow up|Death|0|||
49014067|NCT03521999|157887272|FG001|Completed 3 Month Follow up|Death|1|||
49014068|NCT03521999|157887271|FG000|Completed 6 Month Follow|Lost to Follow-up|66|||
49014069|NCT03521999|157887272|FG001|Completed 6 Month Follow|Lost to Follow-up|70|||
49014070|NCT02843074|157887273|FG000|Overall Study|Withdrawal by Subject|5|||
49014071|NCT02843074|157887273|FG000|Overall Study|Progressive disease|1|||
49014072|NCT02843074|157887273|FG000|Overall Study|Physician Decision|1|||
49014073|NCT02843074|157887273|FG000|Overall Study|Lost to Follow-up|1|||
49014074|NCT02843074|157887273|FG000|Overall Study|Death|9|||
49014075|NCT03361956|157887274|FG000|Overall Study|Adverse Event|1|||
49014076|NCT03361956|157887275|FG001|Overall Study|Adverse Event|0|||
49014077|NCT03361956|157887276|FG002|Overall Study|Adverse Event|1|||
49014078|NCT03361956|157887277|FG003|Overall Study|Adverse Event|1|||
49014079|NCT03361956|157887278|FG004|Overall Study|Adverse Event|0|||
49014080|NCT03361956|157887274|FG000|Overall Study|Other|0|||
49014081|NCT03361956|157887275|FG001|Overall Study|Other|0|||
49014082|NCT03361956|157887276|FG002|Overall Study|Other|0|||
49014083|NCT03361956|157887277|FG003|Overall Study|Other|1|||
49014084|NCT03361956|157887278|FG004|Overall Study|Other|0|||
49014085|NCT03361956|157887274|FG000|Overall Study|Withdrawal by Subject|2|||
49014086|NCT03361956|157887275|FG001|Overall Study|Withdrawal by Subject|2|||
49014087|NCT03361956|157887276|FG002|Overall Study|Withdrawal by Subject|2|||
49014088|NCT03361956|157887277|FG003|Overall Study|Withdrawal by Subject|0|||
49014089|NCT03361956|157887278|FG004|Overall Study|Withdrawal by Subject|3|||
49014090|NCT03361956|157887274|FG000|Overall Study|Disease Relapse|0|||
49014091|NCT03361956|157887275|FG001|Overall Study|Disease Relapse|0|||
49014092|NCT03361956|157887276|FG002|Overall Study|Disease Relapse|1|||
49014093|NCT03361956|157887277|FG003|Overall Study|Disease Relapse|0|||
49014094|NCT03361956|157887278|FG004|Overall Study|Disease Relapse|0|||
49014095|NCT03361956|157887274|FG000|Overall Study|Physician Decision|0|||
49014096|NCT03361956|157887275|FG001|Overall Study|Physician Decision|2|||
49014097|NCT03361956|157887276|FG002|Overall Study|Physician Decision|0|||
49014098|NCT03361956|157887277|FG003|Overall Study|Physician Decision|1|||
49014099|NCT03361956|157887278|FG004|Overall Study|Physician Decision|0|||
49014100|NCT03361956|157887274|FG000|Overall Study|Lost to Follow-up|0|||
49014101|NCT03361956|157887275|FG001|Overall Study|Lost to Follow-up|0|||
48825478|NCT00448864|157202071|FG000|Overall Study|Death|1|||
48825479|NCT00448864|157202072|FG001|Overall Study|Death|0|||
48825480|NCT00448864|157202073|FG002|Overall Study|Death|0|||
48825481|NCT00448864|157202071|FG000|Overall Study|Lost to Follow-up|3|||
48825482|NCT00448864|157202072|FG001|Overall Study|Lost to Follow-up|1|||
48825483|NCT00448864|157202073|FG002|Overall Study|Lost to Follow-up|0|||
48825484|NCT00448864|157202071|FG000|Overall Study|Physician Decision|1|||
49151919|NCT02723955|158398695|FG001|Expansion Phase|Lost to Follow-up|0|||
49151920|NCT02723955|158398696|FG002|Expansion Phase|Lost to Follow-up|0|||
49151921|NCT02723955|158398697|FG003|Expansion Phase|Lost to Follow-up|0|||
49151922|NCT02723955|158398698|FG004|Expansion Phase|Lost to Follow-up|0|||
49151923|NCT02723955|158398699|FG005|Expansion Phase|Lost to Follow-up|0|||
49151924|NCT02723955|158398700|FG006|Expansion Phase|Lost to Follow-up|0|||
49151925|NCT02723955|158398701|FG007|Expansion Phase|Lost to Follow-up|0|||
49151926|NCT02723955|158398702|FG008|Expansion Phase|Lost to Follow-up|0|||
49151927|NCT02723955|158398703|FG009|Expansion Phase|Lost to Follow-up|0|||
49151928|NCT02723955|158398704|FG010|Expansion Phase|Lost to Follow-up|4|||
49151929|NCT02723955|158398705|FG011|Expansion Phase|Lost to Follow-up|1|||
49151930|NCT02723955|158398706|FG012|Expansion Phase|Lost to Follow-up|0|||
49151931|NCT02723955|158398707|FG013|Expansion Phase|Lost to Follow-up|0|||
49151932|NCT02723955|158398708|FG014|Expansion Phase|Lost to Follow-up|0|||
49151933|NCT02723955|158398709|FG015|Expansion Phase|Lost to Follow-up|0|||
49151934|NCT02723955|158398710|FG016|Expansion Phase|Lost to Follow-up|0|||
49151935|NCT02723955|158398711|FG017|Expansion Phase|Lost to Follow-up|0|||
49151936|NCT02723955|158398712|FG018|Expansion Phase|Lost to Follow-up|0|||
49151937|NCT02723955|158398713|FG019|Expansion Phase|Lost to Follow-up|0|||
49151938|NCT02723955|158398714|FG020|Expansion Phase|Lost to Follow-up|0|||
49151939|NCT02723955|158398715|FG021|Expansion Phase|Lost to Follow-up|0|||
49151940|NCT02723955|158398716|FG022|Expansion Phase|Lost to Follow-up|0|||
49151941|NCT02723955|158398717|FG023|Expansion Phase|Lost to Follow-up|0|||
49151942|NCT02723955|158398718|FG024|Expansion Phase|Lost to Follow-up|0|||
49151943|NCT02723955|158398719|FG025|Expansion Phase|Lost to Follow-up|0|||
49151944|NCT02723955|158398720|FG026|Expansion Phase|Lost to Follow-up|0|||
49151945|NCT02723955|158398721|FG027|Expansion Phase|Lost to Follow-up|0|||
49151946|NCT02723955|158398722|FG028|Expansion Phase|Lost to Follow-up|0|||
49151947|NCT02723955|158398723|FG029|Expansion Phase|Lost to Follow-up|1|||
49151948|NCT02723955|158398724|FG030|Expansion Phase|Lost to Follow-up|19|||
49151949|NCT02723955|158398725|FG031|Expansion Phase|Lost to Follow-up|2|||
49151950|NCT02723955|158398726|FG032|Expansion Phase|Lost to Follow-up|1|||
49151951|NCT02723955|158398727|FG033|Expansion Phase|Lost to Follow-up|0|||
49151952|NCT02723955|158398728|FG034|Expansion Phase|Lost to Follow-up|0|||
49151953|NCT02723955|158398729|FG035|Expansion Phase|Lost to Follow-up|0|||
49151954|NCT02723955|158398730|FG036|Expansion Phase|Lost to Follow-up|0|||
49151955|NCT02723955|158398731|FG037|Expansion Phase|Lost to Follow-up|0|||
49151956|NCT02723955|158398732|FG038|Expansion Phase|Lost to Follow-up|0|||
49151957|NCT02723955|158398733|FG039|Expansion Phase|Lost to Follow-up|0|||
49151958|NCT02723955|158398734|FG040|Expansion Phase|Lost to Follow-up|0|||
49151959|NCT02723955|158398735|FG041|Expansion Phase|Lost to Follow-up|0|||
48825485|NCT00448864|157202072|FG001|Overall Study|Physician Decision|0|||
48825486|NCT00448864|157202073|FG002|Overall Study|Physician Decision|1|||
49151960|NCT02723955|158398736|FG042|Expansion Phase|Lost to Follow-up|0|||
49151961|NCT02723955|158398694|FG000|Expansion Phase|Physician Decision|0|||
49151962|NCT02723955|158398695|FG001|Expansion Phase|Physician Decision|0|||
49151963|NCT02723955|158398696|FG002|Expansion Phase|Physician Decision|0|||
49151964|NCT02723955|158398697|FG003|Expansion Phase|Physician Decision|0|||
49151965|NCT02723955|158398698|FG004|Expansion Phase|Physician Decision|0|||
49151966|NCT02723955|158398699|FG005|Expansion Phase|Physician Decision|0|||
49151967|NCT02723955|158398700|FG006|Expansion Phase|Physician Decision|0|||
49151968|NCT02723955|158398701|FG007|Expansion Phase|Physician Decision|0|||
48825487|NCT00448864|157202071|FG000|Overall Study|Withdrawal by Subject|0|||
49151969|NCT02723955|158398702|FG008|Expansion Phase|Physician Decision|0|||
49151970|NCT02723955|158398703|FG009|Expansion Phase|Physician Decision|0|||
49151971|NCT02723955|158398704|FG010|Expansion Phase|Physician Decision|0|||
48825488|NCT00448864|157202072|FG001|Overall Study|Withdrawal by Subject|2|||
49151972|NCT02723955|158398705|FG011|Expansion Phase|Physician Decision|0|||
48921625|NCT00640328|157546440|FG005|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
48825489|NCT00448864|157202073|FG002|Overall Study|Withdrawal by Subject|0|||
48825490|NCT00448864|157202071|FG000|Overall Study|Protocol Violation|0|||
48825491|NCT00448864|157202072|FG001|Overall Study|Protocol Violation|2|||
48825492|NCT00448864|157202073|FG002|Overall Study|Protocol Violation|0|||
49014102|NCT03361956|157887276|FG002|Overall Study|Lost to Follow-up|1|||
49151973|NCT02723955|158398706|FG012|Expansion Phase|Physician Decision|0|||
49151974|NCT02723955|158398707|FG013|Expansion Phase|Physician Decision|0|||
49151975|NCT02723955|158398708|FG014|Expansion Phase|Physician Decision|0|||
49151976|NCT02723955|158398709|FG015|Expansion Phase|Physician Decision|0|||
49151977|NCT02723955|158398710|FG016|Expansion Phase|Physician Decision|0|||
49151978|NCT02723955|158398711|FG017|Expansion Phase|Physician Decision|0|||
49151979|NCT02723955|158398712|FG018|Expansion Phase|Physician Decision|0|||
49151980|NCT02723955|158398713|FG019|Expansion Phase|Physician Decision|0|||
49151981|NCT02723955|158398714|FG020|Expansion Phase|Physician Decision|0|||
49151982|NCT02723955|158398715|FG021|Expansion Phase|Physician Decision|0|||
49151983|NCT02723955|158398716|FG022|Expansion Phase|Physician Decision|0|||
49151984|NCT02723955|158398717|FG023|Expansion Phase|Physician Decision|0|||
49151985|NCT02723955|158398718|FG024|Expansion Phase|Physician Decision|0|||
49151986|NCT02723955|158398719|FG025|Expansion Phase|Physician Decision|0|||
49151987|NCT02723955|158398720|FG026|Expansion Phase|Physician Decision|0|||
49151988|NCT02723955|158398721|FG027|Expansion Phase|Physician Decision|0|||
49151989|NCT02723955|158398722|FG028|Expansion Phase|Physician Decision|0|||
49151990|NCT02723955|158398723|FG029|Expansion Phase|Physician Decision|0|||
49151991|NCT02723955|158398724|FG030|Expansion Phase|Physician Decision|1|||
49151992|NCT02723955|158398725|FG031|Expansion Phase|Physician Decision|1|||
49151993|NCT02723955|158398726|FG032|Expansion Phase|Physician Decision|0|||
49151994|NCT02723955|158398727|FG033|Expansion Phase|Physician Decision|0|||
49151995|NCT02723955|158398728|FG034|Expansion Phase|Physician Decision|0|||
49151996|NCT02723955|158398729|FG035|Expansion Phase|Physician Decision|0|||
49151997|NCT02723955|158398730|FG036|Expansion Phase|Physician Decision|0|||
49151998|NCT02723955|158398731|FG037|Expansion Phase|Physician Decision|0|||
49151999|NCT02723955|158398732|FG038|Expansion Phase|Physician Decision|0|||
49152000|NCT02723955|158398733|FG039|Expansion Phase|Physician Decision|0|||
49152001|NCT02723955|158398734|FG040|Expansion Phase|Physician Decision|0|||
49152002|NCT02723955|158398735|FG041|Expansion Phase|Physician Decision|0|||
49152003|NCT02723955|158398736|FG042|Expansion Phase|Physician Decision|0|||
49152004|NCT02723955|158398694|FG000|Expansion Phase|Withdrawal by Subject|0|||
49152005|NCT02723955|158398695|FG001|Expansion Phase|Withdrawal by Subject|0|||
49152006|NCT02723955|158398696|FG002|Expansion Phase|Withdrawal by Subject|0|||
49152007|NCT02723955|158398697|FG003|Expansion Phase|Withdrawal by Subject|0|||
49152008|NCT02723955|158398698|FG004|Expansion Phase|Withdrawal by Subject|0|||
49152009|NCT02723955|158398699|FG005|Expansion Phase|Withdrawal by Subject|0|||
49152010|NCT02723955|158398700|FG006|Expansion Phase|Withdrawal by Subject|0|||
49152011|NCT02723955|158398701|FG007|Expansion Phase|Withdrawal by Subject|0|||
49152012|NCT02723955|158398702|FG008|Expansion Phase|Withdrawal by Subject|0|||
49152013|NCT02723955|158398703|FG009|Expansion Phase|Withdrawal by Subject|2|||
49152014|NCT02723955|158398704|FG010|Expansion Phase|Withdrawal by Subject|1|||
49152015|NCT02723955|158398705|FG011|Expansion Phase|Withdrawal by Subject|0|||
49152016|NCT02723955|158398706|FG012|Expansion Phase|Withdrawal by Subject|0|||
49152017|NCT02723955|158398707|FG013|Expansion Phase|Withdrawal by Subject|0|||
49152018|NCT02723955|158398708|FG014|Expansion Phase|Withdrawal by Subject|0|||
49152019|NCT02723955|158398709|FG015|Expansion Phase|Withdrawal by Subject|0|||
49152020|NCT02723955|158398710|FG016|Expansion Phase|Withdrawal by Subject|0|||
49152021|NCT02723955|158398711|FG017|Expansion Phase|Withdrawal by Subject|0|||
49152022|NCT02723955|158398712|FG018|Expansion Phase|Withdrawal by Subject|0|||
49152023|NCT02723955|158398713|FG019|Expansion Phase|Withdrawal by Subject|0|||
49152024|NCT02723955|158398714|FG020|Expansion Phase|Withdrawal by Subject|0|||
49152025|NCT02723955|158398715|FG021|Expansion Phase|Withdrawal by Subject|0|||
49152026|NCT02723955|158398716|FG022|Expansion Phase|Withdrawal by Subject|0|||
49152027|NCT02723955|158398717|FG023|Expansion Phase|Withdrawal by Subject|0|||
49152028|NCT02723955|158398718|FG024|Expansion Phase|Withdrawal by Subject|0|||
49152029|NCT02723955|158398719|FG025|Expansion Phase|Withdrawal by Subject|0|||
49152030|NCT02723955|158398720|FG026|Expansion Phase|Withdrawal by Subject|0|||
49152031|NCT02723955|158398721|FG027|Expansion Phase|Withdrawal by Subject|0|||
49152032|NCT02723955|158398722|FG028|Expansion Phase|Withdrawal by Subject|0|||
49152033|NCT02723955|158398723|FG029|Expansion Phase|Withdrawal by Subject|0|||
48733211|NCT02247531|156876119|FG000|Overall Study|Physician Decision|0|||
49152034|NCT02723955|158398724|FG030|Expansion Phase|Withdrawal by Subject|8|||
48733212|NCT02247531|156876120|FG001|Overall Study|Physician Decision|2|||
48921626|NCT00640328|157546435|FG000|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
49152035|NCT02723955|158398725|FG031|Expansion Phase|Withdrawal by Subject|4|||
49152036|NCT02723955|158398726|FG032|Expansion Phase|Withdrawal by Subject|0|||
49152037|NCT02723955|158398727|FG033|Expansion Phase|Withdrawal by Subject|0|||
49152038|NCT02723955|158398728|FG034|Expansion Phase|Withdrawal by Subject|0|||
49152039|NCT02723955|158398729|FG035|Expansion Phase|Withdrawal by Subject|1|||
49152040|NCT02723955|158398730|FG036|Expansion Phase|Withdrawal by Subject|0|||
49152041|NCT02723955|158398731|FG037|Expansion Phase|Withdrawal by Subject|0|||
49152042|NCT02723955|158398732|FG038|Expansion Phase|Withdrawal by Subject|0|||
49152043|NCT02723955|158398733|FG039|Expansion Phase|Withdrawal by Subject|0|||
49152044|NCT02723955|158398734|FG040|Expansion Phase|Withdrawal by Subject|0|||
49152045|NCT02723955|158398735|FG041|Expansion Phase|Withdrawal by Subject|0|||
49152046|NCT02723955|158398736|FG042|Expansion Phase|Withdrawal by Subject|0|||
49152047|NCT02723955|158398694|FG000|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
48825493|NCT02374957|157202079|FG000|Overall Study|Patient did not complete forms correctly|1|||
48825494|NCT02374957|157202080|FG001|Overall Study|Patient did not complete forms correctly|0|||
48825495|NCT00748969|157202081|FG000|Overall Study|Withdrawal by Subject|1|||
48825496|NCT00748969|157202082|FG001|Overall Study|Withdrawal by Subject|0|||
48825497|NCT00748969|157202081|FG000|Overall Study|Withdrawal by Subject|0|||
48733213|NCT02247531|156876121|FG002|Overall Study|Physician Decision|2|||
48733214|NCT02247531|156876119|FG000|Overall Study|Unspecified Reason|2|||
48733215|NCT02247531|156876120|FG001|Overall Study|Unspecified Reason|3|||
48733216|NCT02247531|156876121|FG002|Overall Study|Unspecified Reason|4|||
48733217|NCT03906461|156876122|FG000|Completed 12-month Follow-up|Withdrawal by Subject|4|||
48733218|NCT03906461|156876122|FG000|Completed 12-month Follow-up|Missed Visit|6|||
48733219|NCT00426231|156876123|FG000|Overall Study|Withdrawal by Subject|9|||
48733220|NCT00426231|156876124|FG001|Overall Study|Withdrawal by Subject|12|||
48733221|NCT03061097|156876125|FG000|Overall Study|Withdrawal by Subject|0|||
48825498|NCT00748969|157202082|FG001|Overall Study|Withdrawal by Subject|1|||
48825499|NCT04296942|157202083|FG000|Overall Study|Study closure by sponsor|1|||
48825500|NCT04296942|157202084|FG001|Overall Study|Study closure by sponsor|0|||
48921627|NCT00640328|157546436|FG001|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
48921628|NCT00640328|157546437|FG002|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
48921629|NCT00640328|157546438|FG003|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
49014103|NCT03361956|157887277|FG003|Overall Study|Lost to Follow-up|1|||
49014104|NCT03361956|157887278|FG004|Overall Study|Lost to Follow-up|2|||
49014105|NCT02115256|157887283|FG000|Overall Study|Withdrawal by Subject|0|||
49014106|NCT02115256|157887284|FG001|Overall Study|Withdrawal by Subject|1|||
49014107|NCT00566709|157887286|FG000|Overall Study|Protocol Violation|5|||
49014108|NCT00566709|157887287|FG001|Overall Study|Protocol Violation|0|||
49014109|NCT02330081|157887288|FG000|Overall Study|Adverse Event|1|||
49014110|NCT02330081|157887288|FG000|Overall Study|Donation did not meet criteria|1|||
49014111|NCT02330081|157887288|FG000|Overall Study|Protocol Violation|6|||
49014112|NCT02668302|157887293|FG000|Overall Study|Withdrawal by Subject|1|||
49014113|NCT02668302|157887294|FG001|Overall Study|Withdrawal by Subject|0|||
49014114|NCT01626885|157887295|FG000|Overall Study|Adverse Event|8|||
49014115|NCT01626885|157887295|FG000|Overall Study|Withdrawal by Subject|4|||
49014116|NCT02308111|157887296|FG000|Overall Study|Adverse Event|31|||
49014117|NCT02308111|157887297|FG001|Overall Study|Adverse Event|19|||
49014118|NCT02308111|157887296|FG000|Overall Study|Death|9|||
49014119|NCT02308111|157887297|FG001|Overall Study|Death|6|||
49014120|NCT02308111|157887296|FG000|Overall Study|Lost to Follow-up|2|||
49014121|NCT02308111|157887297|FG001|Overall Study|Lost to Follow-up|7|||
49014122|NCT02308111|157887296|FG000|Overall Study|Physician Decision|6|||
49014123|NCT02308111|157887297|FG001|Overall Study|Physician Decision|17|||
49014124|NCT02308111|157887296|FG000|Overall Study|Protocol Violation|0|||
49014125|NCT02308111|157887297|FG001|Overall Study|Protocol Violation|1|||
49014126|NCT02308111|157887296|FG000|Overall Study|Withdrawal by Subject|28|||
49014127|NCT02308111|157887297|FG001|Overall Study|Withdrawal by Subject|38|||
49014128|NCT02308111|157887296|FG000|Overall Study|Study Terminated by Sponsor|72|||
49014129|NCT02308111|157887297|FG001|Overall Study|Study Terminated by Sponsor|61|||
49014130|NCT02308111|157887296|FG000|Overall Study|Initiated Commercial OCALIVA|6|||
49014131|NCT02308111|157887297|FG001|Overall Study|Initiated Commercial OCALIVA|8|||
49014132|NCT02308111|157887296|FG000|Overall Study|Site Closure|3|||
49014133|NCT02308111|157887297|FG001|Overall Study|Site Closure|3|||
49014134|NCT02308111|157887296|FG000|Overall Study|Non-compliance with Study Drug|3|||
49014135|NCT02308111|157887297|FG001|Overall Study|Non-compliance with Study Drug|1|||
49014136|NCT02308111|157887296|FG000|Overall Study|COVID-19 Pandemic Limitation|2|||
49014137|NCT02308111|157887297|FG001|Overall Study|COVID-19 Pandemic Limitation|0|||
49014138|NCT02308111|157887296|FG000|Overall Study|Liver Transplant|3|||
49014139|NCT02308111|157887297|FG001|Overall Study|Liver Transplant|3|||
49014140|NCT02308111|157887296|FG000|Overall Study|Liver Transplant Waitlist|2|||
49014141|NCT02308111|157887297|FG001|Overall Study|Liver Transplant Waitlist|2|||
49014142|NCT02308111|157887296|FG000|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|1|||
49014143|NCT02308111|157887297|FG001|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|0|||
49014144|NCT01078090|157887298|FG000|Overall Study|Lost to Follow-up|2363|||
49014145|NCT01078090|157887298|FG000|Overall Study|Adverse drug reaction (ADR)|453|||
49014146|NCT01078090|157887298|FG000|Overall Study|Lack of Efficacy|1193|||
49014147|NCT01078090|157887298|FG000|Overall Study|ADR and lack of efficacy|61|||
49014148|NCT01078090|157887298|FG000|Overall Study|Other|523|||
49014149|NCT01688037|157887299|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
49014150|NCT01688037|157887300|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
49014151|NCT01688037|157887301|FG002|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
49014152|NCT01688037|157887299|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|1|||
49014153|NCT01688037|157887300|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
49014154|NCT01688037|157887301|FG002|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
49014155|NCT01688037|157887299|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4|||
49014156|NCT01688037|157887300|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0|||
49152048|NCT02723955|158398695|FG001|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
49152049|NCT02723955|158398696|FG002|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
49152050|NCT02723955|158398697|FG003|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
49152051|NCT02723955|158398698|FG004|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
49152052|NCT02723955|158398699|FG005|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
49152053|NCT02723955|158398700|FG006|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
49152054|NCT02723955|158398701|FG007|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
49152055|NCT02723955|158398702|FG008|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
49152056|NCT02723955|158398703|FG009|Expansion Phase|Participants were crossed over OR were re-treated following progression|10|||
49152057|NCT02723955|158398704|FG010|Expansion Phase|Participants were crossed over OR were re-treated following progression|36|||
49152058|NCT02723955|158398705|FG011|Expansion Phase|Participants were crossed over OR were re-treated following progression|1|||
49152059|NCT02723955|158398706|FG012|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
49152060|NCT02723955|158398707|FG013|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
49152061|NCT02723955|158398708|FG014|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
49152062|NCT02723955|158398709|FG015|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
49152063|NCT02723955|158398710|FG016|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
49152064|NCT02723955|158398711|FG017|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
49152065|NCT02723955|158398712|FG018|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
49152066|NCT02723955|158398713|FG019|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
49152067|NCT02723955|158398714|FG020|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
49152068|NCT02723955|158398715|FG021|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
49152069|NCT02723955|158398716|FG022|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
49152070|NCT02723955|158398717|FG023|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
49152071|NCT02723955|158398718|FG024|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
49152072|NCT02723955|158398719|FG025|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
49152073|NCT02723955|158398720|FG026|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
49152074|NCT02723955|158398721|FG027|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
49152075|NCT02723955|158398722|FG028|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
49152076|NCT02723955|158398723|FG029|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
49152077|NCT02723955|158398724|FG030|Expansion Phase|Participants were crossed over OR were re-treated following progression|3|||
49152078|NCT02723955|158398725|FG031|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
48733222|NCT03061097|156876126|FG001|Overall Study|Withdrawal by Subject|3|||
48733223|NCT02572388|156876129|FG000|Overall Study|Withdrawal by Subject|1|||
48733224|NCT02572388|156876130|FG001|Overall Study|Withdrawal by Subject|1|||
48733225|NCT02572388|156876131|FG002|Overall Study|Withdrawal by Subject|2|||
48733226|NCT02572388|156876132|FG003|Overall Study|Withdrawal by Subject|2|||
48733227|NCT02231918|156876133|FG000|Overall Study|Withdrawal by Subject|0|||
48733228|NCT02231918|156876134|FG001|Overall Study|Withdrawal by Subject|1|||
48733229|NCT02231918|156876135|FG002|Overall Study|Withdrawal by Subject|0|||
48733230|NCT02231918|156876133|FG000|Overall Study|Adverse Event|0|||
48733231|NCT02231918|156876134|FG001|Overall Study|Adverse Event|0|||
48733232|NCT02231918|156876135|FG002|Overall Study|Adverse Event|1|||
48733233|NCT02486302|156876138|FG000|Overall Study|Discontinued prematurely|410|||
48733234|NCT02486302|156876138|FG000|Overall Study|Documentation not completed|255|||
48733235|NCT02486302|156876138|FG000|Overall Study|Excluded due to legal reasons|8|||
48733236|NCT02486302|156876138|FG000|Overall Study|Not treated|3|||
48733237|NCT00598702|156876147|FG000|Overall Study|Other|0|||
48733238|NCT00598702|156876148|FG001|Overall Study|Other|2|||
48733239|NCT00598702|156876149|FG002|Overall Study|Other|0|||
48733240|NCT00598702|156876150|FG003|Overall Study|Other|0|||
48733241|NCT00598702|156876151|FG004|Overall Study|Other|0|||
48733242|NCT00598702|156876152|FG005|Overall Study|Other|1|||
48825501|NCT04296942|157202085|FG002|Overall Study|Study closure by sponsor|0|||
48733243|NCT00598702|156876153|FG006|Overall Study|Other|0|||
48825502|NCT03432533|157202086|FG000|Overall Study|Lost to Follow-up|1|||
48825503|NCT03432533|157202087|FG001|Overall Study|Lost to Follow-up|2|||
48733244|NCT00598702|156876154|FG007|Overall Study|Other|0|||
48733245|NCT00598702|156876147|FG000|Overall Study|Early discharge from hospital|0|||
48825504|NCT03432533|157202086|FG000|Overall Study|Withdrawal by Subject|14|||
48825505|NCT03432533|157202087|FG001|Overall Study|Withdrawal by Subject|9|||
48825506|NCT03582137|157202088|FG000|Overall Study|Adverse Event|1|||
48733246|NCT00598702|156876148|FG001|Overall Study|Early discharge from hospital|0|||
48733247|NCT00598702|156876149|FG002|Overall Study|Early discharge from hospital|2|||
48733248|NCT00598702|156876150|FG003|Overall Study|Early discharge from hospital|5|||
48733249|NCT00598702|156876151|FG004|Overall Study|Early discharge from hospital|0|||
48733250|NCT00598702|156876152|FG005|Overall Study|Early discharge from hospital|10|||
48733251|NCT00598702|156876153|FG006|Overall Study|Early discharge from hospital|1|||
49152079|NCT02723955|158398726|FG032|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
49152080|NCT02723955|158398727|FG033|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
49152081|NCT02723955|158398728|FG034|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
49152082|NCT02723955|158398729|FG035|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
49152083|NCT02723955|158398730|FG036|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
49152084|NCT02723955|158398731|FG037|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
49152085|NCT02723955|158398732|FG038|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
49152086|NCT02723955|158398733|FG039|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
49152087|NCT02723955|158398734|FG040|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
49152088|NCT02723955|158398735|FG041|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
49152089|NCT02723955|158398736|FG042|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
49152090|NCT02723955|158398694|FG000|Expansion Phase|Site Closed|0|||
49152091|NCT02723955|158398695|FG001|Expansion Phase|Site Closed|0|||
49152092|NCT02723955|158398696|FG002|Expansion Phase|Site Closed|0|||
49152093|NCT02723955|158398697|FG003|Expansion Phase|Site Closed|0|||
49152094|NCT02723955|158398698|FG004|Expansion Phase|Site Closed|0|||
49152095|NCT02723955|158398699|FG005|Expansion Phase|Site Closed|0|||
49152096|NCT02723955|158398700|FG006|Expansion Phase|Site Closed|0|||
49152097|NCT02723955|158398701|FG007|Expansion Phase|Site Closed|0|||
49152098|NCT02723955|158398702|FG008|Expansion Phase|Site Closed|0|||
49152099|NCT02723955|158398703|FG009|Expansion Phase|Site Closed|1|||
49152100|NCT02723955|158398704|FG010|Expansion Phase|Site Closed|2|||
49152101|NCT02723955|158398705|FG011|Expansion Phase|Site Closed|6|||
49152102|NCT02723955|158398706|FG012|Expansion Phase|Site Closed|0|||
49152103|NCT02723955|158398707|FG013|Expansion Phase|Site Closed|0|||
49152104|NCT02723955|158398708|FG014|Expansion Phase|Site Closed|0|||
49152105|NCT02723955|158398709|FG015|Expansion Phase|Site Closed|0|||
49152106|NCT02723955|158398710|FG016|Expansion Phase|Site Closed|0|||
49152107|NCT02723955|158398711|FG017|Expansion Phase|Site Closed|0|||
49152108|NCT02723955|158398712|FG018|Expansion Phase|Site Closed|0|||
48733252|NCT00598702|156876154|FG007|Overall Study|Early discharge from hospital|0|||
48733253|NCT00598702|156876147|FG000|Overall Study|Adverse Event|0|||
48733254|NCT00598702|156876148|FG001|Overall Study|Adverse Event|0|||
48733255|NCT00598702|156876149|FG002|Overall Study|Adverse Event|0|||
48733256|NCT00598702|156876150|FG003|Overall Study|Adverse Event|1|||
48733257|NCT00598702|156876151|FG004|Overall Study|Adverse Event|0|||
48733258|NCT00598702|156876152|FG005|Overall Study|Adverse Event|0|||
48733259|NCT00598702|156876153|FG006|Overall Study|Adverse Event|0|||
48733260|NCT00598702|156876154|FG007|Overall Study|Adverse Event|0|||
48733261|NCT00598702|156876147|FG000|Overall Study|Withdrawal by Subject|0|||
48733262|NCT00598702|156876148|FG001|Overall Study|Withdrawal by Subject|0|||
48733263|NCT00598702|156876149|FG002|Overall Study|Withdrawal by Subject|0|||
48733264|NCT00598702|156876150|FG003|Overall Study|Withdrawal by Subject|1|||
48733265|NCT00598702|156876151|FG004|Overall Study|Withdrawal by Subject|1|||
48733266|NCT00598702|156876152|FG005|Overall Study|Withdrawal by Subject|0|||
48733267|NCT00598702|156876153|FG006|Overall Study|Withdrawal by Subject|0|||
48733268|NCT00598702|156876154|FG007|Overall Study|Withdrawal by Subject|0|||
48733269|NCT00598702|156876147|FG000|Overall Study|Physician Decision|0|||
48733270|NCT00598702|156876148|FG001|Overall Study|Physician Decision|0|||
48733271|NCT00598702|156876149|FG002|Overall Study|Physician Decision|0|||
48733272|NCT00598702|156876150|FG003|Overall Study|Physician Decision|0|||
48733273|NCT00598702|156876151|FG004|Overall Study|Physician Decision|1|||
48733274|NCT00598702|156876152|FG005|Overall Study|Physician Decision|0|||
48733275|NCT00598702|156876153|FG006|Overall Study|Physician Decision|0|||
48733276|NCT00598702|156876154|FG007|Overall Study|Physician Decision|0|||
48733277|NCT00598702|156876147|FG000|Overall Study|Dose limiting toxicity|0|||
48733278|NCT00598702|156876148|FG001|Overall Study|Dose limiting toxicity|0|||
48733279|NCT00598702|156876149|FG002|Overall Study|Dose limiting toxicity|0|||
48733280|NCT00598702|156876150|FG003|Overall Study|Dose limiting toxicity|1|||
48733281|NCT00598702|156876151|FG004|Overall Study|Dose limiting toxicity|1|||
48733282|NCT00598702|156876152|FG005|Overall Study|Dose limiting toxicity|1|||
48733283|NCT00598702|156876153|FG006|Overall Study|Dose limiting toxicity|0|||
48733284|NCT00598702|156876154|FG007|Overall Study|Dose limiting toxicity|0|||
48733285|NCT02600351|156876155|FG000|Overall Study|Lack of Efficacy|3|||
48733286|NCT02600351|156876156|FG001|Overall Study|Lack of Efficacy|0|||
49152109|NCT02723955|158398713|FG019|Expansion Phase|Site Closed|0|||
48733287|NCT02600351|156876157|FG002|Overall Study|Lack of Efficacy|5|||
48733288|NCT02600351|156876158|FG003|Overall Study|Lack of Efficacy|2|||
48733289|NCT02600351|156876155|FG000|Overall Study|Lost to Follow-up|1|||
48733290|NCT02600351|156876156|FG001|Overall Study|Lost to Follow-up|0|||
48733291|NCT02600351|156876157|FG002|Overall Study|Lost to Follow-up|0|||
48733292|NCT02600351|156876158|FG003|Overall Study|Lost to Follow-up|0|||
48733293|NCT02600351|156876155|FG000|Overall Study|Randomized but Not Treated|1|||
48733294|NCT02600351|156876156|FG001|Overall Study|Randomized but Not Treated|0|||
48733295|NCT02600351|156876157|FG002|Overall Study|Randomized but Not Treated|1|||
48733296|NCT02600351|156876158|FG003|Overall Study|Randomized but Not Treated|3|||
48733297|NCT02413372|156876159|FG000|Treatment|Lost to Follow-up|0|||
48733298|NCT02413372|156876160|FG001|Treatment|Lost to Follow-up|2|||
48733299|NCT02413372|156876161|FG002|Treatment|Lost to Follow-up|1|||
48733300|NCT02413372|156876159|FG000|Treatment|Withdrawal by Subject|1|||
48733301|NCT02413372|156876160|FG001|Treatment|Withdrawal by Subject|0|||
48733302|NCT02413372|156876161|FG002|Treatment|Withdrawal by Subject|0|||
48733303|NCT02413372|156876159|FG000|Follow-up|Lost to Follow-up|1|||
48733304|NCT02413372|156876160|FG001|Follow-up|Lost to Follow-up|1|||
48825507|NCT03582137|157202089|FG001|Overall Study|Adverse Event|0|||
48825508|NCT01928940|157202092|FG000|Overall Study|Adverse Event|0|||
48825509|NCT01928940|157202093|FG001|Overall Study|Adverse Event|1|||
48825510|NCT02365298|157202094|FG000|Period 2|incorrect Rx dispensed|1|||
48825511|NCT02365298|157202095|FG001|Period 2|incorrect Rx dispensed|0|||
48825512|NCT02365298|157202094|FG000|Period 2|Discontinued at request of Sponsor|1|||
48825513|NCT02365298|157202095|FG001|Period 2|Discontinued at request of Sponsor|0|||
48825514|NCT02365298|157202094|FG000|Period 2|Test Article longer available|0|||
49152110|NCT02723955|158398714|FG020|Expansion Phase|Site Closed|0|||
49152111|NCT02723955|158398715|FG021|Expansion Phase|Site Closed|0|||
49152112|NCT02723955|158398716|FG022|Expansion Phase|Site Closed|0|||
49152113|NCT02723955|158398717|FG023|Expansion Phase|Site Closed|0|||
49152114|NCT02723955|158398718|FG024|Expansion Phase|Site Closed|0|||
49152115|NCT02723955|158398719|FG025|Expansion Phase|Site Closed|0|||
49152116|NCT02723955|158398720|FG026|Expansion Phase|Site Closed|0|||
48733305|NCT02413372|156876161|FG002|Follow-up|Lost to Follow-up|0|||
48733306|NCT02413372|156876159|FG000|Follow-up|Subject Withdrew Consent|1|||
48733307|NCT02413372|156876160|FG001|Follow-up|Subject Withdrew Consent|0|||
48733308|NCT02413372|156876161|FG002|Follow-up|Subject Withdrew Consent|1|||
48733309|NCT02413372|156876159|FG000|Follow-up|Subject unable to return for visit|0|||
48733310|NCT02413372|156876160|FG001|Follow-up|Subject unable to return for visit|0|||
48733311|NCT02413372|156876161|FG002|Follow-up|Subject unable to return for visit|1|||
48733312|NCT02556203|156876165|FG000|Overall Study|Withdrawal by Subject|21|||
48733313|NCT02556203|156876166|FG001|Overall Study|Withdrawal by Subject|21|||
48733314|NCT02556203|156876165|FG000|Overall Study|Lost to Follow-up|5|||
48733315|NCT02556203|156876166|FG001|Overall Study|Lost to Follow-up|5|||
48733316|NCT02556203|156876165|FG000|Overall Study|Adverse Event|1|||
48733317|NCT02556203|156876166|FG001|Overall Study|Adverse Event|0|||
48733318|NCT01810432|156876168|FG000|Washout|Protocol Violation|0|||
48733319|NCT01810432|156876169|FG001|Washout|Protocol Violation|1|||
48733320|NCT01810432|156876168|FG000|Washout|Adverse Event|1|||
48733321|NCT01810432|156876169|FG001|Washout|Adverse Event|0|||
48733322|NCT01810432|156876168|FG000|Period 2|Withdrawal by Subject|2|||
48733323|NCT01810432|156876169|FG001|Period 2|Withdrawal by Subject|1|||
48733324|NCT01810432|156876168|FG000|Period 2|Physician Decision|1|||
48733325|NCT01810432|156876169|FG001|Period 2|Physician Decision|0|||
48733326|NCT01810432|156876168|FG000|Period 2|Lost to Follow-up|1|||
48733327|NCT01810432|156876169|FG001|Period 2|Lost to Follow-up|1|||
48733328|NCT02497612|156876174|FG000|Overall Study|Met >=1 anti-malarial treatment criteria|57|||
48733329|NCT02497612|156876175|FG001|Overall Study|Met >=1 anti-malarial treatment criteria|51|||
48733330|NCT02497612|156876176|FG002|Overall Study|Met >=1 anti-malarial treatment criteria|39|||
48733331|NCT02497612|156876177|FG003|Overall Study|Met >=1 anti-malarial treatment criteria|41|||
48733332|NCT02497612|156876174|FG000|Overall Study|Participant's request|2|||
48733333|NCT02497612|156876175|FG001|Overall Study|Participant's request|3|||
48733334|NCT02497612|156876176|FG002|Overall Study|Participant's request|4|||
48733335|NCT02497612|156876177|FG003|Overall Study|Participant's request|1|||
48733336|NCT02497612|156876174|FG000|Overall Study|Investigator's judgement|1|||
48733337|NCT02497612|156876175|FG001|Overall Study|Investigator's judgement|0|||
48733338|NCT02497612|156876176|FG002|Overall Study|Investigator's judgement|0|||
48733339|NCT02497612|156876177|FG003|Overall Study|Investigator's judgement|2|||
48733340|NCT02497612|156876174|FG000|Overall Study|Adverse Event|3|||
48733341|NCT02497612|156876175|FG001|Overall Study|Adverse Event|1|||
48733342|NCT02497612|156876176|FG002|Overall Study|Adverse Event|4|||
48733343|NCT02497612|156876177|FG003|Overall Study|Adverse Event|1|||
48733344|NCT02497612|156876174|FG000|Overall Study|Lost to Follow-up|1|||
48733345|NCT02497612|156876175|FG001|Overall Study|Lost to Follow-up|1|||
48825515|NCT02365298|157202095|FG001|Period 2|Test Article longer available|1|||
49152117|NCT02723955|158398721|FG027|Expansion Phase|Site Closed|0|||
48733346|NCT02497612|156876176|FG002|Overall Study|Lost to Follow-up|0|||
49152118|NCT02723955|158398722|FG028|Expansion Phase|Site Closed|0|||
48733347|NCT02497612|156876177|FG003|Overall Study|Lost to Follow-up|1|||
48733348|NCT02497612|156876174|FG000|Overall Study|Other unspecified|1|||
48825516|NCT02365298|157202094|FG000|Period 2|Protocol Violation|0|||
48825517|NCT02365298|157202095|FG001|Period 2|Protocol Violation|1|||
48825518|NCT02498613|157202098|FG000|Overall Study|Tx Initiation Criteria Not Met|2|||
48825519|NCT02498613|157202099|FG001|Overall Study|Tx Initiation Criteria Not Met|1|||
48825520|NCT02498613|157202100|FG002|Overall Study|Tx Initiation Criteria Not Met|5|||
48825521|NCT02498613|157202101|FG003|Overall Study|Tx Initiation Criteria Not Met|1|||
48825522|NCT02498613|157202098|FG000|Overall Study|Withdrawal by Subject|3|||
48825523|NCT02498613|157202099|FG001|Overall Study|Withdrawal by Subject|1|||
48825524|NCT02498613|157202100|FG002|Overall Study|Withdrawal by Subject|0|||
48825525|NCT02498613|157202101|FG003|Overall Study|Withdrawal by Subject|0|||
48825526|NCT01872611|157202114|FG000|Overall Study|Adverse Event|3|||
48825527|NCT01872611|157202115|FG001|Overall Study|Adverse Event|1|||
48825528|NCT01872611|157202114|FG000|Overall Study|Adverse Event, prior to treatment|0|||
48825529|NCT01872611|157202115|FG001|Overall Study|Adverse Event, prior to treatment|1|||
48825530|NCT01872611|157202114|FG000|Overall Study|Death|0|||
48825531|NCT01872611|157202115|FG001|Overall Study|Death|1|||
48825532|NCT01872611|157202114|FG000|Overall Study|Death, prior to treatment|0|||
48825533|NCT01872611|157202115|FG001|Overall Study|Death, prior to treatment|1|||
48825534|NCT01872611|157202114|FG000|Overall Study|Lost to Follow-up|8|||
48825535|NCT01872611|157202115|FG001|Overall Study|Lost to Follow-up|1|||
48825536|NCT01872611|157202114|FG000|Overall Study|Physician Decision|1|||
48825537|NCT01872611|157202115|FG001|Overall Study|Physician Decision|0|||
48825538|NCT01872611|157202114|FG000|Overall Study|Withdrawal by Subject|6|||
48825539|NCT01872611|157202115|FG001|Overall Study|Withdrawal by Subject|1|||
48825540|NCT01872611|157202114|FG000|Overall Study|Reason not provided|6|||
48825541|NCT01872611|157202115|FG001|Overall Study|Reason not provided|6|||
48825542|NCT02403323|157202122|FG000|Part 1: Open Label Extension Period|Adverse Event|26|||
48825543|NCT02403323|157202123|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
48825544|NCT02403323|157202124|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
48825545|NCT02403323|157202122|FG000|Part 1: Open Label Extension Period|Death|3|||
48825546|NCT02403323|157202123|FG001|Part 1: Open Label Extension Period|Death|0|||
48825547|NCT02403323|157202124|FG002|Part 1: Open Label Extension Period|Death|0|||
48825548|NCT02403323|157202122|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|23|||
48825549|NCT02403323|157202123|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
48825550|NCT02403323|157202124|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
48825551|NCT02403323|157202122|FG000|Part 1: Open Label Extension Period|Non-Compliance|2|||
48825552|NCT02403323|157202123|FG001|Part 1: Open Label Extension Period|Non-Compliance|0|||
48825553|NCT02403323|157202124|FG002|Part 1: Open Label Extension Period|Non-Compliance|0|||
48825554|NCT02403323|157202122|FG000|Part 1: Open Label Extension Period|Reason Not Specified|59|||
48825555|NCT02403323|157202123|FG001|Part 1: Open Label Extension Period|Reason Not Specified|0|||
48825556|NCT02403323|157202124|FG002|Part 1: Open Label Extension Period|Reason Not Specified|0|||
48825557|NCT02403323|157202122|FG000|Part 1: Open Label Extension Period|Physician Decision|61|||
48825558|NCT02403323|157202123|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
48825559|NCT02403323|157202124|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
48825560|NCT02403323|157202122|FG000|Part 1: Open Label Extension Period|Study Terminated By Sponsor|19|||
48825561|NCT02403323|157202123|FG001|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
48825562|NCT02403323|157202124|FG002|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
48825563|NCT02403323|157202122|FG000|Part 1: Open Label Extension Period|Other|1|||
48825564|NCT02403323|157202123|FG001|Part 1: Open Label Extension Period|Other|0|||
48825565|NCT02403323|157202124|FG002|Part 1: Open Label Extension Period|Other|0|||
48825566|NCT02403323|157202122|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|232|||
48825567|NCT02403323|157202123|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
48825568|NCT02403323|157202124|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
48825569|NCT02403323|157202122|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
48825570|NCT02403323|157202123|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|4|||
48825571|NCT02403323|157202124|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
49152119|NCT02723955|158398723|FG029|Expansion Phase|Site Closed|0|||
49152120|NCT02723955|158398724|FG030|Expansion Phase|Site Closed|8|||
49152121|NCT02723955|158398725|FG031|Expansion Phase|Site Closed|4|||
49152122|NCT02723955|158398726|FG032|Expansion Phase|Site Closed|2|||
49152123|NCT02723955|158398727|FG033|Expansion Phase|Site Closed|2|||
49152124|NCT02723955|158398728|FG034|Expansion Phase|Site Closed|0|||
48825572|NCT02403323|157202122|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
48825573|NCT02403323|157202123|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
49152125|NCT02723955|158398729|FG035|Expansion Phase|Site Closed|0|||
48825574|NCT02403323|157202124|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
48825575|NCT02403323|157202122|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
48825576|NCT02403323|157202123|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|9|||
48825577|NCT02403323|157202124|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
48825578|NCT02403323|157202122|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
48825579|NCT02403323|157202123|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
49152126|NCT02723955|158398730|FG036|Expansion Phase|Site Closed|0|||
49152127|NCT02723955|158398731|FG037|Expansion Phase|Site Closed|0|||
49152128|NCT02723955|158398732|FG038|Expansion Phase|Site Closed|0|||
49152129|NCT02723955|158398733|FG039|Expansion Phase|Site Closed|0|||
49152130|NCT02723955|158398734|FG040|Expansion Phase|Site Closed|0|||
49152131|NCT02723955|158398735|FG041|Expansion Phase|Site Closed|0|||
49152132|NCT02723955|158398736|FG042|Expansion Phase|Site Closed|0|||
49152133|NCT02723955|158398694|FG000|Crossover/ Re-treatment Phase|Death|0|||
49152134|NCT02723955|158398695|FG001|Crossover/ Re-treatment Phase|Death|0|||
49152135|NCT02723955|158398696|FG002|Crossover/ Re-treatment Phase|Death|0|||
49152136|NCT02723955|158398697|FG003|Crossover/ Re-treatment Phase|Death|0|||
49152137|NCT02723955|158398698|FG004|Crossover/ Re-treatment Phase|Death|0|||
49152138|NCT02723955|158398699|FG005|Crossover/ Re-treatment Phase|Death|0|||
49152139|NCT02723955|158398700|FG006|Crossover/ Re-treatment Phase|Death|0|||
49152140|NCT02723955|158398701|FG007|Crossover/ Re-treatment Phase|Death|0|||
49152141|NCT02723955|158398702|FG008|Crossover/ Re-treatment Phase|Death|0|||
49152142|NCT02723955|158398703|FG009|Crossover/ Re-treatment Phase|Death|0|||
49152143|NCT02723955|158398704|FG010|Crossover/ Re-treatment Phase|Death|0|||
49152144|NCT02723955|158398705|FG011|Crossover/ Re-treatment Phase|Death|0|||
49152145|NCT02723955|158398706|FG012|Crossover/ Re-treatment Phase|Death|0|||
49152146|NCT02723955|158398707|FG013|Crossover/ Re-treatment Phase|Death|0|||
49152147|NCT02723955|158398708|FG014|Crossover/ Re-treatment Phase|Death|0|||
48825580|NCT02403323|157202124|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
48825581|NCT02403323|157202122|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
49152148|NCT02723955|158398709|FG015|Crossover/ Re-treatment Phase|Death|0|||
48825582|NCT02403323|157202123|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
48825583|NCT02403323|157202124|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|1|||
48825584|NCT02403323|157202122|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
48825585|NCT02403323|157202123|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|7|||
48825586|NCT02403323|157202124|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
48825587|NCT02403323|157202122|FG000|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
48825588|NCT02403323|157202123|FG001|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|167|||
48825589|NCT02403323|157202124|FG002|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
48825590|NCT02403323|157202122|FG000|Part 2: PML Safety Monitoring Period|Other|0|||
48825591|NCT02403323|157202123|FG001|Part 2: PML Safety Monitoring Period|Other|1|||
49152149|NCT02723955|158398710|FG016|Crossover/ Re-treatment Phase|Death|0|||
49152150|NCT02723955|158398711|FG017|Crossover/ Re-treatment Phase|Death|0|||
49152151|NCT02723955|158398712|FG018|Crossover/ Re-treatment Phase|Death|0|||
49152152|NCT02723955|158398713|FG019|Crossover/ Re-treatment Phase|Death|0|||
49152153|NCT02723955|158398714|FG020|Crossover/ Re-treatment Phase|Death|0|||
49152154|NCT02723955|158398715|FG021|Crossover/ Re-treatment Phase|Death|0|||
49152155|NCT02723955|158398716|FG022|Crossover/ Re-treatment Phase|Death|0|||
49152156|NCT02723955|158398717|FG023|Crossover/ Re-treatment Phase|Death|0|||
49152157|NCT02723955|158398718|FG024|Crossover/ Re-treatment Phase|Death|0|||
49152158|NCT02723955|158398719|FG025|Crossover/ Re-treatment Phase|Death|0|||
49152159|NCT02723955|158398720|FG026|Crossover/ Re-treatment Phase|Death|0|||
49152160|NCT02723955|158398721|FG027|Crossover/ Re-treatment Phase|Death|0|||
49152161|NCT02723955|158398722|FG028|Crossover/ Re-treatment Phase|Death|0|||
49152162|NCT02723955|158398723|FG029|Crossover/ Re-treatment Phase|Death|0|||
49152163|NCT02723955|158398724|FG030|Crossover/ Re-treatment Phase|Death|0|||
49152164|NCT02723955|158398725|FG031|Crossover/ Re-treatment Phase|Death|0|||
49152165|NCT02723955|158398726|FG032|Crossover/ Re-treatment Phase|Death|0|||
49152166|NCT02723955|158398727|FG033|Crossover/ Re-treatment Phase|Death|0|||
49152167|NCT02723955|158398728|FG034|Crossover/ Re-treatment Phase|Death|0|||
49152168|NCT02723955|158398729|FG035|Crossover/ Re-treatment Phase|Death|0|||
49152169|NCT02723955|158398730|FG036|Crossover/ Re-treatment Phase|Death|0|||
49152170|NCT02723955|158398731|FG037|Crossover/ Re-treatment Phase|Death|1|||
49152171|NCT02723955|158398732|FG038|Crossover/ Re-treatment Phase|Death|14|||
49152172|NCT02723955|158398733|FG039|Crossover/ Re-treatment Phase|Death|32|||
49152173|NCT02723955|158398734|FG040|Crossover/ Re-treatment Phase|Death|2|||
49152174|NCT02723955|158398735|FG041|Crossover/ Re-treatment Phase|Death|1|||
49152175|NCT02723955|158398736|FG042|Crossover/ Re-treatment Phase|Death|0|||
49152176|NCT02723955|158398694|FG000|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
49152177|NCT02723955|158398695|FG001|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
48825592|NCT02403323|157202124|FG002|Part 2: PML Safety Monitoring Period|Other|0|||
49152178|NCT02723955|158398696|FG002|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
49152179|NCT02723955|158398697|FG003|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
49152180|NCT02723955|158398698|FG004|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
49152181|NCT02723955|158398699|FG005|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
49152182|NCT02723955|158398700|FG006|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
49152183|NCT02723955|158398701|FG007|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
49152184|NCT02723955|158398702|FG008|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
49152185|NCT02723955|158398703|FG009|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
49152186|NCT02723955|158398704|FG010|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
49152187|NCT02723955|158398705|FG011|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
49152188|NCT02723955|158398706|FG012|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
49152189|NCT02723955|158398707|FG013|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
49152190|NCT02723955|158398708|FG014|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
49152191|NCT02723955|158398709|FG015|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
49152192|NCT02723955|158398710|FG016|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
49152193|NCT02723955|158398711|FG017|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
49152194|NCT02723955|158398712|FG018|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
49152195|NCT02723955|158398713|FG019|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
49152196|NCT02723955|158398714|FG020|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
49152197|NCT02723955|158398715|FG021|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
49152198|NCT02723955|158398716|FG022|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
49152199|NCT02723955|158398717|FG023|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
49152200|NCT02723955|158398718|FG024|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
49152201|NCT02723955|158398719|FG025|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
49152202|NCT02723955|158398720|FG026|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
49152203|NCT02723955|158398721|FG027|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
49152204|NCT02723955|158398722|FG028|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
49152205|NCT02723955|158398723|FG029|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
49152206|NCT02723955|158398724|FG030|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
49152207|NCT02723955|158398725|FG031|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
49152208|NCT02723955|158398726|FG032|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
49152209|NCT02723955|158398727|FG033|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
49152210|NCT02723955|158398728|FG034|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
49152211|NCT02723955|158398729|FG035|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
49152212|NCT02723955|158398730|FG036|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
49152213|NCT02723955|158398731|FG037|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
49152214|NCT02723955|158398732|FG038|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
49152215|NCT02723955|158398733|FG039|Crossover/ Re-treatment Phase|Lost to Follow-up|4|||
49152216|NCT02723955|158398734|FG040|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
49152217|NCT02723955|158398735|FG041|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
49152218|NCT02723955|158398736|FG042|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
49152219|NCT02723955|158398694|FG000|Crossover/ Re-treatment Phase|Physician Decision|0|||
49152220|NCT02723955|158398695|FG001|Crossover/ Re-treatment Phase|Physician Decision|0|||
49152221|NCT02723955|158398696|FG002|Crossover/ Re-treatment Phase|Physician Decision|0|||
49152222|NCT02723955|158398697|FG003|Crossover/ Re-treatment Phase|Physician Decision|0|||
49152223|NCT02723955|158398698|FG004|Crossover/ Re-treatment Phase|Physician Decision|0|||
49152224|NCT02723955|158398699|FG005|Crossover/ Re-treatment Phase|Physician Decision|0|||
49152225|NCT02723955|158398700|FG006|Crossover/ Re-treatment Phase|Physician Decision|0|||
49152226|NCT02723955|158398701|FG007|Crossover/ Re-treatment Phase|Physician Decision|0|||
49152227|NCT02723955|158398702|FG008|Crossover/ Re-treatment Phase|Physician Decision|0|||
49152228|NCT02723955|158398703|FG009|Crossover/ Re-treatment Phase|Physician Decision|0|||
49152229|NCT02723955|158398704|FG010|Crossover/ Re-treatment Phase|Physician Decision|0|||
49152230|NCT02723955|158398705|FG011|Crossover/ Re-treatment Phase|Physician Decision|0|||
49152231|NCT02723955|158398706|FG012|Crossover/ Re-treatment Phase|Physician Decision|0|||
49152232|NCT02723955|158398707|FG013|Crossover/ Re-treatment Phase|Physician Decision|0|||
49152233|NCT02723955|158398708|FG014|Crossover/ Re-treatment Phase|Physician Decision|0|||
49152234|NCT02723955|158398709|FG015|Crossover/ Re-treatment Phase|Physician Decision|0|||
49152235|NCT02723955|158398710|FG016|Crossover/ Re-treatment Phase|Physician Decision|0|||
49152236|NCT02723955|158398711|FG017|Crossover/ Re-treatment Phase|Physician Decision|0|||
49152237|NCT02723955|158398712|FG018|Crossover/ Re-treatment Phase|Physician Decision|0|||
49152238|NCT02723955|158398713|FG019|Crossover/ Re-treatment Phase|Physician Decision|0|||
49152239|NCT02723955|158398714|FG020|Crossover/ Re-treatment Phase|Physician Decision|0|||
49152240|NCT02723955|158398715|FG021|Crossover/ Re-treatment Phase|Physician Decision|0|||
49152241|NCT02723955|158398716|FG022|Crossover/ Re-treatment Phase|Physician Decision|0|||
49152242|NCT02723955|158398717|FG023|Crossover/ Re-treatment Phase|Physician Decision|0|||
48733349|NCT02497612|156876175|FG001|Overall Study|Other unspecified|1|||
48733350|NCT02497612|156876176|FG002|Overall Study|Other unspecified|2|||
48733351|NCT02497612|156876177|FG003|Overall Study|Other unspecified|0|||
48733352|NCT02497612|156876174|FG000|Overall Study|Not eligible|1|||
48733353|NCT02497612|156876175|FG001|Overall Study|Not eligible|0|||
48733354|NCT02497612|156876176|FG002|Overall Study|Not eligible|0|||
48733355|NCT02497612|156876177|FG003|Overall Study|Not eligible|1|||
48733356|NCT02180165|156876180|FG000|Overall Study|Not Treated|0|||
48733357|NCT02180165|156876181|FG001|Overall Study|Not Treated|0|||
48733358|NCT02180165|156876182|FG002|Overall Study|Not Treated|1|||
48733359|NCT02180165|156876183|FG003|Overall Study|Not Treated|0|||
48733360|NCT02180165|156876180|FG000|Overall Study|Adverse Event|7|||
48733361|NCT02180165|156876181|FG001|Overall Study|Adverse Event|0|||
48733362|NCT02180165|156876182|FG002|Overall Study|Adverse Event|18|||
48733363|NCT02180165|156876183|FG003|Overall Study|Adverse Event|3|||
48733364|NCT02180165|156876180|FG000|Overall Study|Lack of Efficacy|0|||
48733365|NCT02180165|156876181|FG001|Overall Study|Lack of Efficacy|1|||
48733366|NCT02180165|156876182|FG002|Overall Study|Lack of Efficacy|3|||
48733367|NCT02180165|156876183|FG003|Overall Study|Lack of Efficacy|2|||
48733368|NCT02180165|156876180|FG000|Overall Study|Physician Decision|1|||
48733369|NCT02180165|156876181|FG001|Overall Study|Physician Decision|0|||
48733370|NCT02180165|156876182|FG002|Overall Study|Physician Decision|5|||
48733371|NCT02180165|156876183|FG003|Overall Study|Physician Decision|0|||
48733372|NCT02180165|156876180|FG000|Overall Study|Withdrawal by Subject|3|||
48733373|NCT02180165|156876181|FG001|Overall Study|Withdrawal by Subject|0|||
48733374|NCT02180165|156876182|FG002|Overall Study|Withdrawal by Subject|2|||
48733375|NCT02180165|156876183|FG003|Overall Study|Withdrawal by Subject|1|||
48733376|NCT01200524|156876188|FG000|Overall Study|Withdrawal by Subject|1|||
48733377|NCT01200524|156876189|FG001|Overall Study|Withdrawal by Subject|1|||
48733378|NCT01200524|156876190|FG002|Overall Study|Withdrawal by Subject|3|||
48733379|NCT01200524|156876188|FG000|Overall Study|Adverse Event|1|||
48733380|NCT01200524|156876189|FG001|Overall Study|Adverse Event|0|||
48733381|NCT01200524|156876190|FG002|Overall Study|Adverse Event|0|||
48733382|NCT01200524|156876188|FG000|Overall Study|Non availability of study nurse|0|||
48733383|NCT01200524|156876189|FG001|Overall Study|Non availability of study nurse|0|||
48733384|NCT01200524|156876190|FG002|Overall Study|Non availability of study nurse|1|||
48733385|NCT01303861|156876191|FG000|Overall Study|Lost to Follow-up|34|||
48733386|NCT01303861|156876192|FG001|Overall Study|Lost to Follow-up|14|||
48733387|NCT01303861|156876193|FG002|Overall Study|Lost to Follow-up|27|||
48733388|NCT01303861|156876194|FG003|Overall Study|Lost to Follow-up|31|||
48733389|NCT01303861|156876191|FG000|Overall Study|Lack of Efficacy|3|||
48733390|NCT01303861|156876192|FG001|Overall Study|Lack of Efficacy|2|||
48733391|NCT01303861|156876193|FG002|Overall Study|Lack of Efficacy|1|||
48733392|NCT01303861|156876194|FG003|Overall Study|Lack of Efficacy|0|||
48733393|NCT01303861|156876191|FG000|Overall Study|Withdrawal by Subject|16|||
48733394|NCT01303861|156876192|FG001|Overall Study|Withdrawal by Subject|8|||
48733395|NCT01303861|156876193|FG002|Overall Study|Withdrawal by Subject|8|||
48733396|NCT01303861|156876194|FG003|Overall Study|Withdrawal by Subject|23|||
48733397|NCT01303861|156876191|FG000|Overall Study|Adverse Event|4|||
48733398|NCT01303861|156876192|FG001|Overall Study|Adverse Event|1|||
48733399|NCT01303861|156876193|FG002|Overall Study|Adverse Event|0|||
48733400|NCT01303861|156876194|FG003|Overall Study|Adverse Event|5|||
48733401|NCT01303861|156876191|FG000|Overall Study|Pregnancy|1|||
48733402|NCT01303861|156876192|FG001|Overall Study|Pregnancy|0|||
48733403|NCT01303861|156876193|FG002|Overall Study|Pregnancy|0|||
48733404|NCT01303861|156876194|FG003|Overall Study|Pregnancy|0|||
48733405|NCT03270644|156876198|FG000|Day 1 Lasmiditan Reference|Physician Decision|1|||
48733406|NCT03270644|156876198|FG000|Day 4 - 10 Propranolol Reference|Adverse Event|1|||
48733407|NCT04676412|156876199|FG000|Overall Study|Death|17|||
48733408|NCT04676412|156876200|FG001|Overall Study|Death|23|||
48733409|NCT04676412|156876199|FG000|Overall Study|Withdrawal by Subject|0|||
48733410|NCT04676412|156876200|FG001|Overall Study|Withdrawal by Subject|2|||
48733411|NCT04676412|156876199|FG000|Overall Study|Participants ongoing|32|||
48733412|NCT04676412|156876200|FG001|Overall Study|Participants ongoing|33|||
48733413|NCT00902668|156876201|FG000|Overall Study|Protocol stopped due to slow accrual.|3|||
48733414|NCT01914757|156876202|FG000|Overall Study|Severe non-compliance to protocol|3|||
48733415|NCT01914757|156876203|FG001|Overall Study|Severe non-compliance to protocol|1|||
48733416|NCT01914757|156876204|FG002|Overall Study|Severe non-compliance to protocol|2|||
48733417|NCT01914757|156876202|FG000|Overall Study|Lost to Follow-up|5|||
48733418|NCT01914757|156876203|FG001|Overall Study|Lost to Follow-up|8|||
48733419|NCT01914757|156876204|FG002|Overall Study|Lost to Follow-up|6|||
48733420|NCT01914757|156876202|FG000|Overall Study|Withdrawal by Subject|15|||
48733421|NCT01914757|156876203|FG001|Overall Study|Withdrawal by Subject|27|||
48733422|NCT01914757|156876204|FG002|Overall Study|Withdrawal by Subject|19|||
48733423|NCT01914757|156876202|FG000|Overall Study|Death|2|||
48733424|NCT01914757|156876203|FG001|Overall Study|Death|2|||
48733425|NCT01914757|156876204|FG002|Overall Study|Death|1|||
48733426|NCT01914757|156876202|FG000|Overall Study|Adverse Event|4|||
48733427|NCT01914757|156876203|FG001|Overall Study|Adverse Event|3|||
48733428|NCT01914757|156876204|FG002|Overall Study|Adverse Event|4|||
48733429|NCT01914757|156876202|FG000|Overall Study|Study specific withdrawal criteria|0|||
48733430|NCT01914757|156876203|FG001|Overall Study|Study specific withdrawal criteria|1|||
48733431|NCT01914757|156876204|FG002|Overall Study|Study specific withdrawal criteria|0|||
49014157|NCT01688037|157887301|FG002|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
49014158|NCT01688037|157887299|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
49014159|NCT01688037|157887300|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
49014160|NCT01688037|157887301|FG002|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
49014161|NCT01688037|157887299|FG000|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
49014162|NCT01688037|157887300|FG001|Double-Blind Period (Week 0 to 6)|Physician Decision|1|||
49014163|NCT01688037|157887301|FG002|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
48825593|NCT02403323|157202122|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
48825594|NCT02403323|157202123|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|12|||
48825595|NCT02403323|157202124|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|2|||
48825596|NCT04824131|157202125|FG000|CAB LA Oral Phase|Adverse Event|1|||
48825597|NCT04824131|157202125|FG000|CAB LA Oral Phase|Withdrawal by Subject|1|||
48825598|NCT04824131|157202125|FG000|Step 3|Withdrawal by Subject|2|||
48825599|NCT05489224|157202126|FG000|Treatment Period I|Withdrawal by Subject|6|||
48825600|NCT05489224|157202127|FG001|Treatment Period I|Withdrawal by Subject|5|||
48825601|NCT05489224|157202128|FG002|Treatment Period I|Withdrawal by Subject|0|||
48825602|NCT05489224|157202126|FG000|Treatment Period I|Adverse Event|3|||
48825603|NCT05489224|157202127|FG001|Treatment Period I|Adverse Event|11|||
48825604|NCT05489224|157202128|FG002|Treatment Period I|Adverse Event|0|||
48825605|NCT05489224|157202126|FG000|Treatment Period I|Lost to Follow-up|0|||
48825606|NCT05489224|157202127|FG001|Treatment Period I|Lost to Follow-up|1|||
48825607|NCT05489224|157202128|FG002|Treatment Period I|Lost to Follow-up|0|||
48825608|NCT05489224|157202126|FG000|Treatment Period I|Physician Decision|0|||
48825609|NCT05489224|157202127|FG001|Treatment Period I|Physician Decision|1|||
48825610|NCT05489224|157202128|FG002|Treatment Period I|Physician Decision|0|||
48825611|NCT05489224|157202126|FG000|Treatment Period II up to Week 32|Ongoing|222|||
48825612|NCT05489224|157202127|FG001|Treatment Period II up to Week 32|Ongoing|107|||
48825613|NCT05489224|157202128|FG002|Treatment Period II up to Week 32|Ongoing|107|||
48825614|NCT05489224|157202126|FG000|Treatment Period II up to Week 32|Adverse Event|3|||
48825615|NCT05489224|157202127|FG001|Treatment Period II up to Week 32|Adverse Event|0|||
48825616|NCT05489224|157202128|FG002|Treatment Period II up to Week 32|Adverse Event|1|||
48825617|NCT05489224|157202126|FG000|Treatment Period II up to Week 32|Withdrawal by Subject|0|||
48825618|NCT05489224|157202127|FG001|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
48825619|NCT05489224|157202128|FG002|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
48825620|NCT04887285|157202130|FG000|Overall Study|Lost to Follow-up|0|||
48825621|NCT04887285|157202131|FG001|Overall Study|Lost to Follow-up|2|||
48825622|NCT04887285|157202132|FG002|Overall Study|Lost to Follow-up|3|||
48825623|NCT04269889|157202133|FG000|Initial Phase (Day 0 to Month 6)|Lack of Efficacy|1|||
48825624|NCT04269889|157202133|FG000|Extended Phase (6 Months to Year 3)|Lack of Efficacy|13|||
48825625|NCT04530344|157202137|FG000|Overall Study|Lost to Follow-up|3|||
48825626|NCT04530344|157202138|FG001|Overall Study|Lost to Follow-up|3|||
49152243|NCT02723955|158398718|FG024|Crossover/ Re-treatment Phase|Physician Decision|0|||
49152244|NCT02723955|158398719|FG025|Crossover/ Re-treatment Phase|Physician Decision|0|||
49152245|NCT02723955|158398720|FG026|Crossover/ Re-treatment Phase|Physician Decision|0|||
49152246|NCT02723955|158398721|FG027|Crossover/ Re-treatment Phase|Physician Decision|0|||
49152247|NCT02723955|158398722|FG028|Crossover/ Re-treatment Phase|Physician Decision|0|||
49152248|NCT02723955|158398723|FG029|Crossover/ Re-treatment Phase|Physician Decision|0|||
49152249|NCT02723955|158398724|FG030|Crossover/ Re-treatment Phase|Physician Decision|0|||
49152250|NCT02723955|158398725|FG031|Crossover/ Re-treatment Phase|Physician Decision|0|||
49152251|NCT02723955|158398726|FG032|Crossover/ Re-treatment Phase|Physician Decision|0|||
49152252|NCT02723955|158398727|FG033|Crossover/ Re-treatment Phase|Physician Decision|0|||
49152253|NCT02723955|158398728|FG034|Crossover/ Re-treatment Phase|Physician Decision|0|||
49152254|NCT02723955|158398729|FG035|Crossover/ Re-treatment Phase|Physician Decision|0|||
49152255|NCT02723955|158398730|FG036|Crossover/ Re-treatment Phase|Physician Decision|0|||
49152256|NCT02723955|158398731|FG037|Crossover/ Re-treatment Phase|Physician Decision|0|||
49152257|NCT02723955|158398732|FG038|Crossover/ Re-treatment Phase|Physician Decision|1|||
49152258|NCT02723955|158398733|FG039|Crossover/ Re-treatment Phase|Physician Decision|1|||
49152259|NCT02723955|158398734|FG040|Crossover/ Re-treatment Phase|Physician Decision|0|||
49152260|NCT02723955|158398735|FG041|Crossover/ Re-treatment Phase|Physician Decision|0|||
49152261|NCT02723955|158398736|FG042|Crossover/ Re-treatment Phase|Physician Decision|1|||
49152262|NCT02723955|158398694|FG000|Crossover/ Re-treatment Phase|Site Closed|0|||
49152263|NCT02723955|158398695|FG001|Crossover/ Re-treatment Phase|Site Closed|0|||
49152264|NCT02723955|158398696|FG002|Crossover/ Re-treatment Phase|Site Closed|0|||
49152265|NCT02723955|158398697|FG003|Crossover/ Re-treatment Phase|Site Closed|0|||
49152266|NCT02723955|158398698|FG004|Crossover/ Re-treatment Phase|Site Closed|0|||
49152267|NCT02723955|158398699|FG005|Crossover/ Re-treatment Phase|Site Closed|0|||
49152268|NCT02723955|158398700|FG006|Crossover/ Re-treatment Phase|Site Closed|0|||
49152269|NCT02723955|158398701|FG007|Crossover/ Re-treatment Phase|Site Closed|0|||
49152270|NCT02723955|158398702|FG008|Crossover/ Re-treatment Phase|Site Closed|0|||
49152271|NCT02723955|158398703|FG009|Crossover/ Re-treatment Phase|Site Closed|0|||
49152272|NCT02723955|158398704|FG010|Crossover/ Re-treatment Phase|Site Closed|0|||
49152273|NCT02723955|158398705|FG011|Crossover/ Re-treatment Phase|Site Closed|0|||
48825627|NCT04530344|157202139|FG002|Overall Study|Lost to Follow-up|3|||
48825628|NCT04530344|157202140|FG003|Overall Study|Lost to Follow-up|10|||
48825629|NCT04530344|157202137|FG000|Overall Study|Withdrawal by Subject|14|||
48825630|NCT04530344|157202138|FG001|Overall Study|Withdrawal by Subject|5|||
48825631|NCT04530344|157202139|FG002|Overall Study|Withdrawal by Subject|18|||
48825632|NCT04530344|157202140|FG003|Overall Study|Withdrawal by Subject|33|||
49152274|NCT02723955|158398706|FG012|Crossover/ Re-treatment Phase|Site Closed|0|||
49152275|NCT02723955|158398707|FG013|Crossover/ Re-treatment Phase|Site Closed|0|||
48921630|NCT00640328|157546439|FG004|Second Treatment Period (Weeks 24-48)|Adverse Event|1|||
48921631|NCT00640328|157546440|FG005|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
48921632|NCT00640328|157546435|FG000|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
48921633|NCT00640328|157546436|FG001|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
48921634|NCT00640328|157546437|FG002|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1|||
48921635|NCT00640328|157546438|FG003|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
48921636|NCT00640328|157546439|FG004|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
49152276|NCT02723955|158398708|FG014|Crossover/ Re-treatment Phase|Site Closed|0|||
49152277|NCT02723955|158398709|FG015|Crossover/ Re-treatment Phase|Site Closed|0|||
49152278|NCT02723955|158398710|FG016|Crossover/ Re-treatment Phase|Site Closed|0|||
49152279|NCT02723955|158398711|FG017|Crossover/ Re-treatment Phase|Site Closed|0|||
49152280|NCT02723955|158398712|FG018|Crossover/ Re-treatment Phase|Site Closed|0|||
49152281|NCT02723955|158398713|FG019|Crossover/ Re-treatment Phase|Site Closed|0|||
49152282|NCT02723955|158398714|FG020|Crossover/ Re-treatment Phase|Site Closed|0|||
49152283|NCT02723955|158398715|FG021|Crossover/ Re-treatment Phase|Site Closed|0|||
49152284|NCT02723955|158398716|FG022|Crossover/ Re-treatment Phase|Site Closed|0|||
49152285|NCT02723955|158398717|FG023|Crossover/ Re-treatment Phase|Site Closed|0|||
49152286|NCT02723955|158398718|FG024|Crossover/ Re-treatment Phase|Site Closed|0|||
49152287|NCT02723955|158398719|FG025|Crossover/ Re-treatment Phase|Site Closed|0|||
49152288|NCT02723955|158398720|FG026|Crossover/ Re-treatment Phase|Site Closed|0|||
49152289|NCT02723955|158398721|FG027|Crossover/ Re-treatment Phase|Site Closed|0|||
49152290|NCT02723955|158398722|FG028|Crossover/ Re-treatment Phase|Site Closed|0|||
49152291|NCT02723955|158398723|FG029|Crossover/ Re-treatment Phase|Site Closed|0|||
49152292|NCT02723955|158398724|FG030|Crossover/ Re-treatment Phase|Site Closed|0|||
49152293|NCT02723955|158398725|FG031|Crossover/ Re-treatment Phase|Site Closed|0|||
49152294|NCT02723955|158398726|FG032|Crossover/ Re-treatment Phase|Site Closed|0|||
49152295|NCT02723955|158398727|FG033|Crossover/ Re-treatment Phase|Site Closed|0|||
49152296|NCT02723955|158398728|FG034|Crossover/ Re-treatment Phase|Site Closed|0|||
49152297|NCT02723955|158398729|FG035|Crossover/ Re-treatment Phase|Site Closed|0|||
49152298|NCT02723955|158398730|FG036|Crossover/ Re-treatment Phase|Site Closed|0|||
49152299|NCT02723955|158398731|FG037|Crossover/ Re-treatment Phase|Site Closed|0|||
49152300|NCT02723955|158398732|FG038|Crossover/ Re-treatment Phase|Site Closed|4|||
49152301|NCT02723955|158398733|FG039|Crossover/ Re-treatment Phase|Site Closed|2|||
49152302|NCT02723955|158398734|FG040|Crossover/ Re-treatment Phase|Site Closed|0|||
48733432|NCT01914757|156876202|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
48733433|NCT01914757|156876203|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
48733434|NCT01914757|156876204|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
48733435|NCT01914757|156876202|FG000|Overall Study|Other reasons|5|||
48733436|NCT01914757|156876203|FG001|Overall Study|Other reasons|9|||
48733437|NCT01914757|156876204|FG002|Overall Study|Other reasons|4|||
48733438|NCT05021081|156876205|FG000|Phase 2|Subject enrolled in error|1|||
48733439|NCT05021081|156876206|FG001|Phase 2|Subject enrolled in error|1|||
48733440|NCT05021081|156876207|FG002|Phase 2|Subject enrolled in error|0|||
48733441|NCT04697056|156876208|FG000|Overall Study|Termination of the participant participation by the Investigator or Sponsor|4|||
48733442|NCT04697056|156876209|FG001|Overall Study|Termination of the participant participation by the Investigator or Sponsor|1|||
48733443|NCT01925274|156876210|FG000|Overall Study|Death|1|||
48733444|NCT01925274|156876211|FG001|Overall Study|Death|0|||
48733445|NCT01925274|156876212|FG002|Overall Study|Death|0|||
48733446|NCT01925274|156876210|FG000|Overall Study|Lost to Follow-up|0|||
48733447|NCT01925274|156876211|FG001|Overall Study|Lost to Follow-up|1|||
48733448|NCT01925274|156876212|FG002|Overall Study|Lost to Follow-up|0|||
48733449|NCT01925274|156876210|FG000|Overall Study|Withdrawal by Subject|1|||
48733450|NCT01925274|156876211|FG001|Overall Study|Withdrawal by Subject|2|||
48733451|NCT01925274|156876212|FG002|Overall Study|Withdrawal by Subject|0|||
48733452|NCT01925274|156876210|FG000|Overall Study|Study terminated by sponsor|4|||
48733453|NCT01925274|156876211|FG001|Overall Study|Study terminated by sponsor|0|||
48733454|NCT01925274|156876212|FG002|Overall Study|Study terminated by sponsor|0|||
48733455|NCT01925274|156876210|FG000|Overall Study|Protocol amendment|1|||
48733456|NCT01925274|156876211|FG001|Overall Study|Protocol amendment|3|||
48733457|NCT01925274|156876212|FG002|Overall Study|Protocol amendment|6|||
48733458|NCT00057954|156876215|FG000|Overall Study|Death|1|||
48733459|NCT00057954|156876215|FG000|Overall Study|Disease progression|1|||
48733460|NCT00559754|156876217|FG000|Overall Study|Disease progression|1|||
48733461|NCT00559754|156876217|FG000|Overall Study|Adverse Event|5|||
48733462|NCT00559754|156876217|FG000|Overall Study|Protocol Violation|1|||
48733463|NCT00559754|156876217|FG000|Overall Study|Investigator criteria|2|||
48733464|NCT00559754|156876217|FG000|Overall Study|Withdrawal by Subject|2|||
48733465|NCT00369122|156876222|FG000|Overall Study|Ineligible|10|||
48733466|NCT00369122|156876222|FG000|Overall Study|No protocol treatment|1|||
48733467|NCT04327674|156876223|FG000|Overall Study|Protocol Violation|19|||
48733468|NCT01461980|156876226|FG000|Overall Study|Other|9|||
48733469|NCT01461980|156876227|FG001|Overall Study|Other|8|||
48733470|NCT01461980|156876228|FG002|Overall Study|Other|6|||
48733471|NCT01461980|156876226|FG000|Overall Study|Medication error|7|||
48733472|NCT01461980|156876227|FG001|Overall Study|Medication error|5|||
49152303|NCT02723955|158398735|FG041|Crossover/ Re-treatment Phase|Site Closed|0|||
49152304|NCT02723955|158398736|FG042|Crossover/ Re-treatment Phase|Site Closed|0|||
49152305|NCT01313676|158398737|FG000|Overall Study|Adverse Event|395|||
49152306|NCT01313676|158398738|FG001|Overall Study|Adverse Event|365|||
49152307|NCT01313676|158398739|FG002|Overall Study|Adverse Event|372|||
49152308|NCT01313676|158398740|FG003|Overall Study|Adverse Event|333|||
49152309|NCT01313676|158398737|FG000|Overall Study|Lack of Efficacy|98|||
49152310|NCT01313676|158398738|FG001|Overall Study|Lack of Efficacy|90|||
48733473|NCT01461980|156876228|FG002|Overall Study|Medication error|6|||
48733474|NCT01461980|156876226|FG000|Overall Study|Adverse Event|12|||
48733475|NCT01461980|156876227|FG001|Overall Study|Adverse Event|5|||
48733476|NCT01461980|156876228|FG002|Overall Study|Adverse Event|6|||
48733477|NCT01461980|156876226|FG000|Overall Study|Protocol Violation|12|||
48733478|NCT01461980|156876227|FG001|Overall Study|Protocol Violation|19|||
48825633|NCT04530344|157202137|FG000|Overall Study|Adverse Event|0|||
49152311|NCT01313676|158398739|FG002|Overall Study|Lack of Efficacy|65|||
49152312|NCT01313676|158398740|FG003|Overall Study|Lack of Efficacy|46|||
49152313|NCT01313676|158398737|FG000|Overall Study|Protocol Violation|37|||
49152314|NCT01313676|158398738|FG001|Overall Study|Protocol Violation|44|||
49152315|NCT01313676|158398739|FG002|Overall Study|Protocol Violation|46|||
48733479|NCT01461980|156876228|FG002|Overall Study|Protocol Violation|16|||
48733480|NCT01461980|156876226|FG000|Overall Study|No longer meets eligibility criteria|18|||
48733481|NCT01461980|156876227|FG001|Overall Study|No longer meets eligibility criteria|9|||
48825634|NCT04530344|157202138|FG001|Overall Study|Adverse Event|0|||
48825635|NCT04530344|157202139|FG002|Overall Study|Adverse Event|0|||
48825636|NCT04530344|157202140|FG003|Overall Study|Adverse Event|1|||
48825637|NCT04530344|157202137|FG000|Overall Study|Lack of Efficacy|0|||
48825638|NCT04530344|157202138|FG001|Overall Study|Lack of Efficacy|0|||
48825639|NCT04530344|157202139|FG002|Overall Study|Lack of Efficacy|0|||
49152316|NCT01313676|158398740|FG003|Overall Study|Protocol Violation|44|||
49152317|NCT01313676|158398737|FG000|Overall Study|Met Protocol-Defined Stopping Critera|3|||
49152318|NCT01313676|158398738|FG001|Overall Study|Met Protocol-Defined Stopping Critera|4|||
49152319|NCT01313676|158398739|FG002|Overall Study|Met Protocol-Defined Stopping Critera|2|||
49152320|NCT01313676|158398740|FG003|Overall Study|Met Protocol-Defined Stopping Critera|11|||
49152321|NCT01313676|158398737|FG000|Overall Study|Study Closed/terminated|7|||
49152322|NCT01313676|158398738|FG001|Overall Study|Study Closed/terminated|6|||
49152323|NCT01313676|158398739|FG002|Overall Study|Study Closed/terminated|9|||
49152324|NCT01313676|158398740|FG003|Overall Study|Study Closed/terminated|9|||
49152325|NCT01313676|158398737|FG000|Overall Study|Lost to Follow-up|0|||
49152326|NCT01313676|158398738|FG001|Overall Study|Lost to Follow-up|0|||
49152327|NCT01313676|158398739|FG002|Overall Study|Lost to Follow-up|1|||
49152328|NCT01313676|158398740|FG003|Overall Study|Lost to Follow-up|0|||
49152329|NCT01313676|158398737|FG000|Overall Study|Physician Decision|53|||
49152330|NCT01313676|158398738|FG001|Overall Study|Physician Decision|64|||
49152331|NCT01313676|158398739|FG002|Overall Study|Physician Decision|62|||
49152332|NCT01313676|158398740|FG003|Overall Study|Physician Decision|48|||
49152333|NCT01313676|158398737|FG000|Overall Study|Decision by Participant or Proxy|643|||
49152334|NCT01313676|158398738|FG001|Overall Study|Decision by Participant or Proxy|527|||
49152335|NCT01313676|158398739|FG002|Overall Study|Decision by Participant or Proxy|515|||
49152336|NCT01313676|158398740|FG003|Overall Study|Decision by Participant or Proxy|492|||
49152337|NCT01313676|158398737|FG000|Overall Study|Sponsor Terminated Study Treatment|1|||
49152338|NCT01313676|158398738|FG001|Overall Study|Sponsor Terminated Study Treatment|1|||
49152339|NCT01313676|158398739|FG002|Overall Study|Sponsor Terminated Study Treatment|0|||
49152340|NCT01313676|158398740|FG003|Overall Study|Sponsor Terminated Study Treatment|1|||
49152341|NCT01313676|158398737|FG000|Overall Study|Investigator Site Closed|12|||
49152342|NCT01313676|158398738|FG001|Overall Study|Investigator Site Closed|11|||
49152343|NCT01313676|158398739|FG002|Overall Study|Investigator Site Closed|15|||
49152344|NCT01313676|158398740|FG003|Overall Study|Investigator Site Closed|10|||
49152345|NCT01313676|158398737|FG000|Overall Study|Missing|1|||
49152346|NCT01313676|158398738|FG001|Overall Study|Missing|1|||
49152347|NCT01313676|158398739|FG002|Overall Study|Missing|1|||
49152348|NCT01313676|158398740|FG003|Overall Study|Missing|0|||
49152349|NCT03312114|158398741|FG000|Overall Study|All the five enrolled dropped out of the|5|||
49152350|NCT03345550|158398744|FG000|Overall Study|Withdrawal by Subject|1|||
49152351|NCT03345550|158398745|FG001|Overall Study|Withdrawal by Subject|0|||
49152352|NCT03345550|158398744|FG000|Overall Study|Lost to Follow-up|4|||
49152353|NCT03345550|158398745|FG001|Overall Study|Lost to Follow-up|5|||
49152354|NCT03701074|158398746|FG000|Overall Study|Physician Decision|1|||
49152355|NCT03701074|158398747|FG001|Overall Study|Physician Decision|0|||
49152356|NCT01998477|158398760|FG000|Overall Study|Lost to Follow-up|4|||
49152357|NCT01998477|158398761|FG001|Overall Study|Lost to Follow-up|5|||
48733482|NCT01461980|156876228|FG002|Overall Study|No longer meets eligibility criteria|19|||
48733483|NCT01461980|156876226|FG000|Overall Study|Lost to Follow-up|52|||
48825640|NCT04530344|157202140|FG003|Overall Study|Lack of Efficacy|1|||
48825641|NCT04530344|157202137|FG000|Overall Study|Physician Decision|0|||
48825642|NCT04530344|157202138|FG001|Overall Study|Physician Decision|0|||
48825643|NCT04530344|157202139|FG002|Overall Study|Physician Decision|1|||
49152358|NCT01998477|158398760|FG000|Overall Study|Withdrawal by Subject|6|||
49152359|NCT01998477|158398761|FG001|Overall Study|Withdrawal by Subject|0|||
49152360|NCT00480532|158398762|FG000|Overall Study|Withdrawal by Subject|2|||
48921637|NCT00640328|157546440|FG005|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
48921638|NCT00640328|157546435|FG000|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
48921639|NCT00640328|157546436|FG001|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
48921640|NCT00640328|157546437|FG002|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
48921641|NCT00640328|157546438|FG003|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
48921642|NCT00640328|157546439|FG004|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
48921643|NCT00640328|157546440|FG005|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
48921644|NCT04697628|157546441|FG000|Overall Study|Withdrawal by Subject|17|||
48921645|NCT04697628|157546442|FG001|Overall Study|Withdrawal by Subject|23|||
48921646|NCT04697628|157546441|FG000|Overall Study|Lost to Follow-up|0|||
48921647|NCT04697628|157546442|FG001|Overall Study|Lost to Follow-up|4|||
48921648|NCT04697628|157546441|FG000|Overall Study|On-going in study|122|||
48921649|NCT04697628|157546442|FG001|Overall Study|On-going in study|91|||
48921650|NCT01326546|157546443|FG000|Overall Study|Lost to Follow-up|8|||
48921651|NCT01326546|157546444|FG001|Overall Study|Lost to Follow-up|7|||
48921652|NCT01326546|157546443|FG000|Overall Study|Protocol Violation|3|||
48921653|NCT01326546|157546444|FG001|Overall Study|Protocol Violation|4|||
48921654|NCT01326546|157546443|FG000|Overall Study|Pregnancy|0|||
48921655|NCT01326546|157546444|FG001|Overall Study|Pregnancy|1|||
48921656|NCT01326546|157546443|FG000|Overall Study|Adverse Event|1|||
48921657|NCT01326546|157546444|FG001|Overall Study|Adverse Event|0|||
48921658|NCT01326546|157546443|FG000|Overall Study|Withdrawal by Subject|5|||
48921659|NCT01326546|157546444|FG001|Overall Study|Withdrawal by Subject|1|||
48921660|NCT03152019|157546445|FG000|Overall Study|Adverse Event|0|||
48921661|NCT03152019|157546446|FG001|Overall Study|Adverse Event|1|||
48921662|NCT01119248|157546447|FG000|Overall Study|Physician Decision|5|||
48921663|NCT01967550|157546448|FG000|Overall Study|Withdrawal by Subject|1|||
48921664|NCT01967550|157546449|FG001|Overall Study|Withdrawal by Subject|0|||
48921665|NCT01967550|157546448|FG000|Overall Study|Adverse Event|2|||
48921666|NCT01967550|157546449|FG001|Overall Study|Adverse Event|0|||
48921667|NCT01967550|157546448|FG000|Overall Study|Protocol Violation|2|||
48921668|NCT01967550|157546449|FG001|Overall Study|Protocol Violation|1|||
48921669|NCT01967550|157546448|FG000|Overall Study|Non Compliance|0|||
48921670|NCT01967550|157546449|FG001|Overall Study|Non Compliance|1|||
48921671|NCT04417894|157546450|FG000|Overall Study|Lost to Follow-up|3|||
48921672|NCT04417894|157546451|FG001|Overall Study|Lost to Follow-up|0|||
48921673|NCT04417894|157546450|FG000|Overall Study|Withdrawal by Subject|7|||
48921674|NCT04417894|157546451|FG001|Overall Study|Withdrawal by Subject|6|||
48921675|NCT04417894|157546450|FG000|Overall Study|Lack of Efficacy|3|||
48921676|NCT04417894|157546451|FG001|Overall Study|Lack of Efficacy|1|||
48921677|NCT01180660|157546452|FG000|Overall Study|Changed to open surgery|1|||
48921678|NCT01180660|157546453|FG001|Overall Study|Changed to open surgery|0|||
48921679|NCT01883635|157546454|FG000|Overall Study|Withdrawal by Subject|4|||
48921680|NCT01883635|157546455|FG001|Overall Study|Withdrawal by Subject|0|||
48921681|NCT00498173|157546456|FG000|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|2|||
48921682|NCT00498173|157546457|FG001|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|1|||
48921683|NCT00498173|157546458|FG002|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|0|||
48921684|NCT03499028|157546459|FG000|Overall Study|Lost to Follow-up|12|||
48921685|NCT03499028|157546460|FG001|Overall Study|Lost to Follow-up|9|||
48921686|NCT03499028|157546459|FG000|Overall Study|Withdrawal by Subject|5|||
48921687|NCT03499028|157546460|FG001|Overall Study|Withdrawal by Subject|8|||
48921688|NCT03499028|157546459|FG000|Overall Study|Unplanned SNF discharge|5|||
48921689|NCT03499028|157546460|FG001|Overall Study|Unplanned SNF discharge|8|||
48921690|NCT00720109|157546461|FG000|Induction Period|Did not meet eligibility criteria|3|||
48921691|NCT00720109|157546462|FG001|Induction Period|Did not meet eligibility criteria|0|||
49152361|NCT00480532|158398763|FG001|Overall Study|Withdrawal by Subject|4|||
48921692|NCT00720109|157546463|FG002|Induction Period|Did not meet eligibility criteria|0|||
48921693|NCT00720109|157546461|FG000|Induction Period|Bone Marrow Transplant|2|||
48921694|NCT00720109|157546462|FG001|Induction Period|Bone Marrow Transplant|0|||
48921695|NCT00720109|157546463|FG002|Induction Period|Bone Marrow Transplant|0|||
49152362|NCT00480532|158398764|FG002|Overall Study|Withdrawal by Subject|3|||
48921696|NCT00720109|157546461|FG000|Induction Period|Physician Decision|1|||
48921697|NCT00720109|157546462|FG001|Induction Period|Physician Decision|0|||
48921698|NCT00720109|157546463|FG002|Induction Period|Physician Decision|0|||
49152363|NCT00480532|158398765|FG003|Overall Study|Withdrawal by Subject|1|||
49152364|NCT00480532|158398762|FG000|Overall Study|Protocol Violation|0|||
49152365|NCT00480532|158398763|FG001|Overall Study|Protocol Violation|0|||
49152366|NCT00480532|158398764|FG002|Overall Study|Protocol Violation|1|||
48921699|NCT00720109|157546461|FG000|Risk Stratification Period|Adverse Event|0|||
48921700|NCT00720109|157546462|FG001|Risk Stratification Period|Adverse Event|1|||
48921701|NCT00720109|157546463|FG002|Risk Stratification Period|Adverse Event|0|||
49152367|NCT00480532|158398765|FG003|Overall Study|Protocol Violation|0|||
49152368|NCT01817777|158398766|FG000|Observational Phase (8 Weeks)|Lost to Follow-up|3|||
49152369|NCT01817777|158398767|FG001|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
49152370|NCT01817777|158398768|FG002|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
49152371|NCT01817777|158398766|FG000|Observational Phase (8 Weeks)|Early Study Termination|2|||
49152372|NCT01817777|158398767|FG001|Observational Phase (8 Weeks)|Early Study Termination|0|||
49152373|NCT01817777|158398768|FG002|Observational Phase (8 Weeks)|Early Study Termination|0|||
49152374|NCT01817777|158398766|FG000|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
49152375|NCT01817777|158398767|FG001|Interventional Phase (20 Weeks)|Withdrawal by Subject|3|||
49152376|NCT01817777|158398768|FG002|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
49152377|NCT01817777|158398766|FG000|Interventional Phase (20 Weeks)|Lost to Follow-up|0|||
49152378|NCT01817777|158398767|FG001|Interventional Phase (20 Weeks)|Lost to Follow-up|1|||
49152379|NCT01817777|158398768|FG002|Interventional Phase (20 Weeks)|Lost to Follow-up|2|||
49152380|NCT01817777|158398766|FG000|Interventional Phase (20 Weeks)|Early Study Termination|0|||
48921702|NCT00720109|157546461|FG000|Risk Stratification Period|Physician Decision|0|||
49152381|NCT01817777|158398767|FG001|Interventional Phase (20 Weeks)|Early Study Termination|1|||
49152382|NCT01817777|158398768|FG002|Interventional Phase (20 Weeks)|Early Study Termination|3|||
49152383|NCT03524157|158398769|FG000|Overall Study|cytology not readable|0|||
49152384|NCT03524157|158398770|FG001|Overall Study|cytology not readable|0|||
49152385|NCT03524157|158398771|FG002|Overall Study|cytology not readable|1|||
49152386|NCT03627468|158398773|FG000|Overall Study|Adverse Event|5|||
49152387|NCT03627468|158398774|FG001|Overall Study|Adverse Event|33|||
49152388|NCT03627468|158398773|FG000|Overall Study|Withdrawal by Subject|13|||
49152389|NCT03627468|158398774|FG001|Overall Study|Withdrawal by Subject|23|||
49152390|NCT03627468|158398773|FG000|Overall Study|Physician Decision|1|||
49152391|NCT03627468|158398774|FG001|Overall Study|Physician Decision|0|||
49152392|NCT03627468|158398773|FG000|Overall Study|Protocol Violation|0|||
49152393|NCT03627468|158398774|FG001|Overall Study|Protocol Violation|2|||
49152394|NCT03627468|158398773|FG000|Overall Study|Lost to Follow-up|10|||
49152395|NCT03627468|158398774|FG001|Overall Study|Lost to Follow-up|16|||
49152396|NCT03627468|158398773|FG000|Overall Study|Death|1|||
49152397|NCT03627468|158398774|FG001|Overall Study|Death|0|||
49152398|NCT03627468|158398773|FG000|Overall Study|Pregnancy|1|||
49152399|NCT03627468|158398774|FG001|Overall Study|Pregnancy|1|||
49152400|NCT03627468|158398773|FG000|Overall Study|Lack of Efficacy|0|||
49152401|NCT03627468|158398774|FG001|Overall Study|Lack of Efficacy|2|||
49152402|NCT03627468|158398773|FG000|Overall Study|Poor Compliance or Noncompliance|0|||
49152403|NCT03627468|158398774|FG001|Overall Study|Poor Compliance or Noncompliance|2|||
49152404|NCT01514357|158398775|FG000|Overall Study|Screen failure|2|||
49152405|NCT01514357|158398776|FG001|Overall Study|Screen failure|0|||
49152406|NCT01514357|158398775|FG000|Overall Study|Withdrawal by Subject|2|||
49152407|NCT01514357|158398776|FG001|Overall Study|Withdrawal by Subject|0|||
49152408|NCT00752219|158398777|FG000|Overall Study|Clinical failure|0|||
49152409|NCT00752219|158398778|FG001|Overall Study|Clinical failure|1|||
49152410|NCT00752219|158398777|FG000|Overall Study|Adverse Event|5|||
49152411|NCT00752219|158398778|FG001|Overall Study|Adverse Event|3|||
49152412|NCT00752219|158398777|FG000|Overall Study|Protocol deviation|1|||
49152413|NCT00752219|158398778|FG001|Overall Study|Protocol deviation|0|||
49152414|NCT00752219|158398777|FG000|Overall Study|Lost to Follow-up|1|||
49152415|NCT00752219|158398778|FG001|Overall Study|Lost to Follow-up|2|||
49152416|NCT00752219|158398777|FG000|Overall Study|Randomized but not treated|1|||
49152417|NCT00752219|158398778|FG001|Overall Study|Randomized but not treated|0|||
49152418|NCT00752219|158398777|FG000|Overall Study|Other|3|||
49152419|NCT00752219|158398778|FG001|Overall Study|Other|0|||
49152420|NCT01651208|158398782|FG000|Overall Study|Lost to Follow-up|14|||
49152421|NCT01651208|158398783|FG001|Overall Study|Lost to Follow-up|16|||
49152422|NCT00425555|158398784|FG000|Overall Study|Withdrawal by Subject|11|||
49152423|NCT00425555|158398785|FG001|Overall Study|Withdrawal by Subject|8|||
49152424|NCT00425555|158398784|FG000|Overall Study|Lost to Follow-up|0|||
48733484|NCT01461980|156876227|FG001|Overall Study|Lost to Follow-up|53|||
48733485|NCT01461980|156876228|FG002|Overall Study|Lost to Follow-up|51|||
48733486|NCT01461980|156876226|FG000|Overall Study|No longer willing to participate|52|||
48733487|NCT01461980|156876227|FG001|Overall Study|No longer willing to participate|38|||
48733488|NCT01461980|156876228|FG002|Overall Study|No longer willing to participate|54|||
48733489|NCT01461980|156876226|FG000|Overall Study|Randomized but not vaccinated|4|||
48733490|NCT01461980|156876227|FG001|Overall Study|Randomized but not vaccinated|8|||
48733491|NCT01461980|156876228|FG002|Overall Study|Randomized but not vaccinated|7|||
48733492|NCT00723398|156876233|FG000|Overall Study|Withdrawal by Subject|2|||
48733493|NCT00723398|156876234|FG001|Overall Study|Withdrawal by Subject|6|||
48733494|NCT00723398|156876235|FG002|Overall Study|Withdrawal by Subject|4|||
48733495|NCT00723398|156876236|FG003|Overall Study|Withdrawal by Subject|4|||
48733496|NCT00723398|156876237|FG004|Overall Study|Withdrawal by Subject|4|||
48733497|NCT00723398|156876233|FG000|Overall Study|Protocol Violation|2|||
48733498|NCT00723398|156876234|FG001|Overall Study|Protocol Violation|1|||
48733499|NCT00723398|156876235|FG002|Overall Study|Protocol Violation|5|||
48733500|NCT00723398|156876236|FG003|Overall Study|Protocol Violation|0|||
49152425|NCT00425555|158398785|FG001|Overall Study|Lost to Follow-up|1|||
49152426|NCT00425555|158398784|FG000|Overall Study|Administrative problems|3|||
49152427|NCT00425555|158398785|FG001|Overall Study|Administrative problems|0|||
49152428|NCT00425555|158398784|FG000|Overall Study|Death|1|||
49152429|NCT00425555|158398785|FG001|Overall Study|Death|2|||
49152430|NCT00425555|158398784|FG000|Overall Study|New cancer therapy|2|||
49152431|NCT00425555|158398785|FG001|Overall Study|New cancer therapy|1|||
49152432|NCT00425555|158398784|FG000|Overall Study|Disease progression|36|||
49152433|NCT00425555|158398785|FG001|Overall Study|Disease progression|33|||
49152434|NCT00425555|158398784|FG000|Overall Study|Adverse Event|25|||
49152435|NCT00425555|158398785|FG001|Overall Study|Adverse Event|15|||
49152436|NCT00425555|158398784|FG000|Overall Study|Protocol Violation|1|||
49152437|NCT00425555|158398785|FG001|Overall Study|Protocol Violation|0|||
49152438|NCT03880019|158398786|FG000|Overall Study|Competing disease|1|||
49152439|NCT05308004|158398787|FG000|Overall Study|Not seen by Palliative Care NP|0|||
49152440|NCT05308004|158398788|FG001|Overall Study|Not seen by Palliative Care NP|1|||
49152441|NCT01767987|158398793|FG000|Overall Study|Physician Decision|4|||
48733501|NCT00723398|156876237|FG004|Overall Study|Protocol Violation|0|||
48733502|NCT00723398|156876233|FG000|Overall Study|Physician Decision|2|||
48733503|NCT00723398|156876234|FG001|Overall Study|Physician Decision|2|||
48733504|NCT00723398|156876235|FG002|Overall Study|Physician Decision|5|||
48733505|NCT00723398|156876236|FG003|Overall Study|Physician Decision|0|||
48733506|NCT00723398|156876237|FG004|Overall Study|Physician Decision|1|||
48733507|NCT00723398|156876233|FG000|Overall Study|Adverse Event|0|||
48825644|NCT04530344|157202140|FG003|Overall Study|Physician Decision|1|||
48825645|NCT04530344|157202137|FG000|Overall Study|Pregnancy|0|||
48825646|NCT04530344|157202138|FG001|Overall Study|Pregnancy|0|||
48825647|NCT04530344|157202139|FG002|Overall Study|Pregnancy|2|||
49152442|NCT01767987|158398794|FG001|Overall Study|Physician Decision|1|||
49152443|NCT00829868|158398795|FG000|Washout|Physician Decision|1|||
49152444|NCT00829868|158398796|FG001|Washout|Physician Decision|0|||
49152445|NCT01362790|158398797|FG000|Pilot Phase & Phase 2|Changed treatment, too early to assess|1|||
49152446|NCT01362790|158398798|FG001|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
49152447|NCT01362790|158398799|FG002|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
48825648|NCT04530344|157202140|FG003|Overall Study|Pregnancy|1|||
48825649|NCT04530344|157202137|FG000|Overall Study|Protocol Violation|0|||
48825650|NCT04530344|157202138|FG001|Overall Study|Protocol Violation|0|||
48825651|NCT04530344|157202139|FG002|Overall Study|Protocol Violation|0|||
48825652|NCT04530344|157202140|FG003|Overall Study|Protocol Violation|1|||
48825653|NCT04530344|157202137|FG000|Overall Study|Site Closed Due to Noncompliance|0|||
48825654|NCT04530344|157202138|FG001|Overall Study|Site Closed Due to Noncompliance|0|||
48825655|NCT04530344|157202139|FG002|Overall Study|Site Closed Due to Noncompliance|0|||
48825656|NCT04530344|157202140|FG003|Overall Study|Site Closed Due to Noncompliance|1|||
48825657|NCT04530344|157202137|FG000|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
49152448|NCT01362790|158398800|FG003|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
49152449|NCT01362790|158398801|FG004|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
48825658|NCT04530344|157202138|FG001|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
48733508|NCT00723398|156876234|FG001|Overall Study|Adverse Event|5|||
48921703|NCT00720109|157546462|FG001|Risk Stratification Period|Physician Decision|2|||
49152450|NCT01362790|158398802|FG005|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
49152451|NCT01362790|158398803|FG006|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
48733509|NCT00723398|156876235|FG002|Overall Study|Adverse Event|3|||
49152452|NCT01362790|158398797|FG000|Pilot Phase & Phase 2|Adverse Event|0|||
49152453|NCT01362790|158398798|FG001|Pilot Phase & Phase 2|Adverse Event|1|||
48733510|NCT00723398|156876236|FG003|Overall Study|Adverse Event|1|||
49152454|NCT01362790|158398799|FG002|Pilot Phase & Phase 2|Adverse Event|0|||
49152455|NCT01362790|158398800|FG003|Pilot Phase & Phase 2|Adverse Event|1|||
49152456|NCT01362790|158398801|FG004|Pilot Phase & Phase 2|Adverse Event|0|||
49152457|NCT01362790|158398802|FG005|Pilot Phase & Phase 2|Adverse Event|2|||
49152458|NCT01362790|158398803|FG006|Pilot Phase & Phase 2|Adverse Event|0|||
49152459|NCT01362790|158398797|FG000|Pilot Phase & Phase 2|Physician Decision|0|||
49152460|NCT01362790|158398798|FG001|Pilot Phase & Phase 2|Physician Decision|0|||
49152461|NCT01362790|158398799|FG002|Pilot Phase & Phase 2|Physician Decision|0|||
49152462|NCT01362790|158398800|FG003|Pilot Phase & Phase 2|Physician Decision|1|||
49152463|NCT01362790|158398801|FG004|Pilot Phase & Phase 2|Physician Decision|0|||
49152464|NCT01362790|158398802|FG005|Pilot Phase & Phase 2|Physician Decision|0|||
49152465|NCT01362790|158398803|FG006|Pilot Phase & Phase 2|Physician Decision|0|||
49152466|NCT01362790|158398797|FG000|Pilot Phase & Phase 2|Developed antibodies|7|||
49152467|NCT01362790|158398798|FG001|Pilot Phase & Phase 2|Developed antibodies|2|||
49152468|NCT01362790|158398799|FG002|Pilot Phase & Phase 2|Developed antibodies|3|||
49152469|NCT01362790|158398800|FG003|Pilot Phase & Phase 2|Developed antibodies|8|||
49152470|NCT01362790|158398801|FG004|Pilot Phase & Phase 2|Developed antibodies|0|||
48733511|NCT00723398|156876237|FG004|Overall Study|Adverse Event|4|||
48733512|NCT00723398|156876233|FG000|Overall Study|Lost to Follow-up|0|||
48733513|NCT00723398|156876234|FG001|Overall Study|Lost to Follow-up|1|||
48733514|NCT00723398|156876235|FG002|Overall Study|Lost to Follow-up|0|||
48733515|NCT00723398|156876236|FG003|Overall Study|Lost to Follow-up|0|||
48733516|NCT00723398|156876237|FG004|Overall Study|Lost to Follow-up|0|||
48733517|NCT02147184|156876238|FG000|Overall Study|Lost to Follow-up|28|||
48733518|NCT02147184|156876239|FG001|Overall Study|Lost to Follow-up|15|||
48733519|NCT02147184|156876238|FG000|Overall Study|Study Burden|11|||
48733520|NCT02147184|156876239|FG001|Overall Study|Study Burden|7|||
48733521|NCT02147184|156876238|FG000|Overall Study|Pregnancy|6|||
48733522|NCT02147184|156876239|FG001|Overall Study|Pregnancy|0|||
48733523|NCT02147184|156876238|FG000|Overall Study|Moved out of state|3|||
48733524|NCT02147184|156876239|FG001|Overall Study|Moved out of state|3|||
48733525|NCT02147184|156876238|FG000|Overall Study|Physician Decision|0|||
48733526|NCT02147184|156876239|FG001|Overall Study|Physician Decision|2|||
48733527|NCT02147184|156876238|FG000|Overall Study|Other|1|||
48733528|NCT02147184|156876239|FG001|Overall Study|Other|0|||
48733529|NCT00191906|156876240|FG000|Study Period II|Adverse Event|0|||
48733530|NCT00191906|156876241|FG001|Study Period II|Adverse Event|1|||
48733531|NCT00191906|156876242|FG002|Study Period II|Adverse Event|0|||
48733532|NCT00191906|156876243|FG003|Study Period II|Adverse Event|0|||
48733533|NCT00191906|156876240|FG000|Study Period II|Withdrawal by Subject|0|||
48733534|NCT00191906|156876241|FG001|Study Period II|Withdrawal by Subject|3|||
48733535|NCT00191906|156876242|FG002|Study Period II|Withdrawal by Subject|0|||
48733536|NCT00191906|156876243|FG003|Study Period II|Withdrawal by Subject|0|||
48733537|NCT00191906|156876240|FG000|Study Period II|Parent/Caregiver Decision|0|||
48733538|NCT00191906|156876241|FG001|Study Period II|Parent/Caregiver Decision|1|||
48733539|NCT00191906|156876242|FG002|Study Period II|Parent/Caregiver Decision|0|||
48733540|NCT00191906|156876243|FG003|Study Period II|Parent/Caregiver Decision|0|||
48733541|NCT00191906|156876240|FG000|Study Period II|Entry Criteria Exclusion|0|||
48733542|NCT00191906|156876241|FG001|Study Period II|Entry Criteria Exclusion|0|||
48733543|NCT00191906|156876242|FG002|Study Period II|Entry Criteria Exclusion|1|||
48733544|NCT00191906|156876243|FG003|Study Period II|Entry Criteria Exclusion|0|||
48733545|NCT00191906|156876240|FG000|Study Period III|Adverse Event|1|||
48733546|NCT00191906|156876241|FG001|Study Period III|Adverse Event|0|||
48733547|NCT00191906|156876242|FG002|Study Period III|Adverse Event|0|||
48733548|NCT00191906|156876243|FG003|Study Period III|Adverse Event|0|||
48733549|NCT00191906|156876240|FG000|Study Period III|Lost to Follow-up|0|||
48733550|NCT00191906|156876241|FG001|Study Period III|Lost to Follow-up|1|||
48733551|NCT00191906|156876242|FG002|Study Period III|Lost to Follow-up|0|||
48733552|NCT00191906|156876243|FG003|Study Period III|Lost to Follow-up|0|||
48733553|NCT00191906|156876240|FG000|Study Period III|Parent/Caregiver Decision|1|||
48733554|NCT00191906|156876241|FG001|Study Period III|Parent/Caregiver Decision|0|||
48733555|NCT00191906|156876242|FG002|Study Period III|Parent/Caregiver Decision|0|||
48733556|NCT00191906|156876243|FG003|Study Period III|Parent/Caregiver Decision|0|||
48733557|NCT00191906|156876240|FG000|Study Period III|Lack of Efficacy|3|||
48733558|NCT00191906|156876241|FG001|Study Period III|Lack of Efficacy|3|||
48733559|NCT00191906|156876242|FG002|Study Period III|Lack of Efficacy|0|||
48733560|NCT00191906|156876243|FG003|Study Period III|Lack of Efficacy|0|||
48733561|NCT00333801|156876244|FG000|Overall Study|Moved to another state|5|||
48733562|NCT00333801|156876245|FG001|Overall Study|Moved to another state|3|||
48733563|NCT00333801|156876244|FG000|Overall Study|Lost to Follow-up|2|||
49152471|NCT01362790|158398802|FG005|Pilot Phase & Phase 2|Developed antibodies|0|||
48733564|NCT00333801|156876245|FG001|Overall Study|Lost to Follow-up|0|||
48733565|NCT00333801|156876244|FG000|Overall Study|Incarcerated|1|||
48733566|NCT00333801|156876245|FG001|Overall Study|Incarcerated|2|||
48733567|NCT00333801|156876244|FG000|Overall Study|Withdrawal by Subject|0|||
48733568|NCT00333801|156876245|FG001|Overall Study|Withdrawal by Subject|1|||
48733569|NCT04171765|156876246|FG000|Overall Study|Adverse Event|2|||
48733570|NCT04171765|156876247|FG001|Overall Study|Adverse Event|0|||
48733571|NCT04171765|156876248|FG002|Overall Study|Adverse Event|1|||
48733572|NCT04171765|156876249|FG003|Overall Study|Adverse Event|0|||
48733573|NCT04171765|156876246|FG000|Overall Study|Lost to Follow-up|0|||
48733574|NCT04171765|156876247|FG001|Overall Study|Lost to Follow-up|2|||
48733575|NCT04171765|156876248|FG002|Overall Study|Lost to Follow-up|2|||
48733576|NCT04171765|156876249|FG003|Overall Study|Lost to Follow-up|2|||
48733577|NCT04171765|156876246|FG000|Overall Study|Week 58 visit missed|0|||
48733578|NCT04171765|156876247|FG001|Overall Study|Week 58 visit missed|0|||
48733579|NCT04171765|156876248|FG002|Overall Study|Week 58 visit missed|1|||
48733580|NCT04171765|156876249|FG003|Overall Study|Week 58 visit missed|0|||
48733581|NCT04171765|156876246|FG000|Overall Study|Study terminated by sponsor|2|||
48733582|NCT04171765|156876247|FG001|Overall Study|Study terminated by sponsor|0|||
48733583|NCT04171765|156876248|FG002|Overall Study|Study terminated by sponsor|0|||
48733584|NCT04171765|156876249|FG003|Overall Study|Study terminated by sponsor|0|||
48733585|NCT04171765|156876246|FG000|Overall Study|Withdrawal by Subject|1|||
48733586|NCT04171765|156876247|FG001|Overall Study|Withdrawal by Subject|0|||
48733587|NCT04171765|156876248|FG002|Overall Study|Withdrawal by Subject|0|||
48733588|NCT04171765|156876249|FG003|Overall Study|Withdrawal by Subject|3|||
48733589|NCT00122109|156876250|FG000|Overall Study|Did not meet criteria|6|||
48733590|NCT00122109|156876251|FG001|Overall Study|Did not meet criteria|7|||
48733591|NCT03633617|156876252|FG000|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|1|||
48733592|NCT03633617|156876253|FG001|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|3|||
49014164|NCT01688037|157887299|FG000|Open-Label Period (Week 6 to 12)|Adverse Event|4|||
49014165|NCT01688037|157887300|FG001|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
49014166|NCT01688037|157887301|FG002|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
49014167|NCT01688037|157887299|FG000|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
49014168|NCT01688037|157887300|FG001|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
49014169|NCT01688037|157887301|FG002|Open-Label Period (Week 6 to 12)|Non-compliance|2|||
49014170|NCT01688037|157887299|FG000|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1|||
49014171|NCT01688037|157887300|FG001|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2|||
49014172|NCT01688037|157887301|FG002|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0|||
49014173|NCT01688037|157887299|FG000|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
49014174|NCT01688037|157887300|FG001|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
49014175|NCT01688037|157887301|FG002|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1|||
49014176|NCT01688037|157887299|FG000|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
49014177|NCT01688037|157887300|FG001|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1|||
49014178|NCT01688037|157887301|FG002|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
49014179|NCT00576199|157887302|FG000|Overall Study|Adverse Event|12|||
49014180|NCT00576199|157887302|FG000|Overall Study|Insufficient Therapeutic Response|14|||
49014181|NCT00576199|157887302|FG000|Overall Study|Refused Treatment|2|||
49014182|NCT00576199|157887302|FG000|Overall Study|Reason Unspecified|2|||
49014183|NCT00580983|157887303|FG000|Overall Study|Did not complete 12 mon post RT studies|7|||
49014184|NCT02102490|157887304|FG000|Overall Study|Death|6|||
49014185|NCT02102490|157887304|FG000|Overall Study|Lost to Follow-up|1|||
49014186|NCT04345471|157887305|FG000|Overall Study|Adverse Event|8|||
49014187|NCT04345471|157887306|FG001|Overall Study|Adverse Event|5|||
49014188|NCT04345471|157887307|FG002|Overall Study|Adverse Event|6|||
49014189|NCT04345471|157887305|FG000|Overall Study|Lack of Efficacy|1|||
49014190|NCT04345471|157887306|FG001|Overall Study|Lack of Efficacy|1|||
49014191|NCT04345471|157887307|FG002|Overall Study|Lack of Efficacy|0|||
49014192|NCT04345471|157887305|FG000|Overall Study|Protocol Violation|0|||
49014193|NCT04345471|157887306|FG001|Overall Study|Protocol Violation|1|||
48733593|NCT03633617|156876254|FG002|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
48733594|NCT03633617|156876255|FG003|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
48733595|NCT03633617|156876256|FG004|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
48733596|NCT03633617|156876257|FG005|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
48733597|NCT03633617|156876258|FG006|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
48733598|NCT03633617|156876259|FG007|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
48733599|NCT03633617|156876260|FG008|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
48733600|NCT03633617|156876261|FG009|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
48733601|NCT03633617|156876262|FG010|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
48825659|NCT04530344|157202139|FG002|Overall Study|Discontinued due to COVID-19 Pandemic|1|||
48825660|NCT04530344|157202140|FG003|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
48825661|NCT04530344|157202137|FG000|Overall Study|Missed Safety Follow-up Visit|0|||
48825662|NCT04530344|157202138|FG001|Overall Study|Missed Safety Follow-up Visit|0|||
48825663|NCT04530344|157202139|FG002|Overall Study|Missed Safety Follow-up Visit|1|||
48825664|NCT04530344|157202140|FG003|Overall Study|Missed Safety Follow-up Visit|0|||
49152472|NCT01362790|158398803|FG006|Pilot Phase & Phase 2|Developed antibodies|0|||
49152473|NCT01362790|158398797|FG000|Pilot Phase & Phase 2|Refused further treatment|0|||
49152474|NCT01362790|158398798|FG001|Pilot Phase & Phase 2|Refused further treatment|1|||
49152475|NCT01362790|158398799|FG002|Pilot Phase & Phase 2|Refused further treatment|0|||
49152476|NCT01362790|158398800|FG003|Pilot Phase & Phase 2|Refused further treatment|0|||
49152477|NCT01362790|158398801|FG004|Pilot Phase & Phase 2|Refused further treatment|0|||
49152478|NCT01362790|158398802|FG005|Pilot Phase & Phase 2|Refused further treatment|0|||
49152479|NCT01362790|158398803|FG006|Pilot Phase & Phase 2|Refused further treatment|0|||
49152480|NCT01362790|158398797|FG000|Pilot Phase & Phase 2|Progressive disease|1|||
49152481|NCT01362790|158398798|FG001|Pilot Phase & Phase 2|Progressive disease|2|||
49152482|NCT01362790|158398799|FG002|Pilot Phase & Phase 2|Progressive disease|2|||
49152483|NCT01362790|158398800|FG003|Pilot Phase & Phase 2|Progressive disease|3|||
49152484|NCT01362790|158398801|FG004|Pilot Phase & Phase 2|Progressive disease|0|||
49152485|NCT01362790|158398802|FG005|Pilot Phase & Phase 2|Progressive disease|2|||
49152486|NCT01362790|158398803|FG006|Pilot Phase & Phase 2|Progressive disease|0|||
49152487|NCT01362790|158398797|FG000|Pilot Phase & Phase 2|Treatment delay >3 weeks|1|||
49152488|NCT01362790|158398798|FG001|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
49152489|NCT01362790|158398799|FG002|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
49152490|NCT01362790|158398800|FG003|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
49152491|NCT01362790|158398801|FG004|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
49152492|NCT01362790|158398802|FG005|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
49152493|NCT01362790|158398803|FG006|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
49152494|NCT01362790|158398797|FG000|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
49152495|NCT01362790|158398798|FG001|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2|||
49152496|NCT01362790|158398799|FG002|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
49152497|NCT01362790|158398800|FG003|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
49152498|NCT01362790|158398801|FG004|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
49152499|NCT01362790|158398802|FG005|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
49152500|NCT01362790|158398803|FG006|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
49152501|NCT01362790|158398797|FG000|Pilot Phase & Phase 2|Death on study|0|||
49152502|NCT01362790|158398798|FG001|Pilot Phase & Phase 2|Death on study|0|||
49152503|NCT01362790|158398799|FG002|Pilot Phase & Phase 2|Death on study|0|||
49152504|NCT01362790|158398800|FG003|Pilot Phase & Phase 2|Death on study|1|||
49152505|NCT01362790|158398801|FG004|Pilot Phase & Phase 2|Death on study|0|||
49152506|NCT01362790|158398802|FG005|Pilot Phase & Phase 2|Death on study|0|||
49152507|NCT01362790|158398803|FG006|Pilot Phase & Phase 2|Death on study|0|||
49152508|NCT01362790|158398797|FG000|Dose De-escalation of Regimen A|Adverse Event|0|||
48825665|NCT04530344|157202137|FG000|Overall Study|Personal Reasons|0|||
48825666|NCT04530344|157202138|FG001|Overall Study|Personal Reasons|0|||
48825667|NCT04530344|157202139|FG002|Overall Study|Personal Reasons|0|||
48825668|NCT04530344|157202140|FG003|Overall Study|Personal Reasons|1|||
48825669|NCT04530344|157202137|FG000|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
48825670|NCT04530344|157202138|FG001|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
49152509|NCT01362790|158398798|FG001|Dose De-escalation of Regimen A|Adverse Event|0|||
49152510|NCT01362790|158398799|FG002|Dose De-escalation of Regimen A|Adverse Event|0|||
49152511|NCT01362790|158398800|FG003|Dose De-escalation of Regimen A|Adverse Event|0|||
49152512|NCT01362790|158398801|FG004|Dose De-escalation of Regimen A|Adverse Event|1|||
49152513|NCT01362790|158398802|FG005|Dose De-escalation of Regimen A|Adverse Event|0|||
49152514|NCT01362790|158398803|FG006|Dose De-escalation of Regimen A|Adverse Event|0|||
49152515|NCT01362790|158398797|FG000|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
49152516|NCT01362790|158398798|FG001|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
49152517|NCT01362790|158398799|FG002|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
49152518|NCT01362790|158398800|FG003|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
49152519|NCT01362790|158398801|FG004|Dose De-escalation of Regimen A|Deveoped antibodies|3|||
49152520|NCT01362790|158398802|FG005|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
49152521|NCT01362790|158398803|FG006|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
49152522|NCT01362790|158398797|FG000|Dose De-escalation of Regimen A|Progressive disease|0|||
49152523|NCT01362790|158398798|FG001|Dose De-escalation of Regimen A|Progressive disease|0|||
49152524|NCT01362790|158398799|FG002|Dose De-escalation of Regimen A|Progressive disease|0|||
49152525|NCT01362790|158398800|FG003|Dose De-escalation of Regimen A|Progressive disease|0|||
49152526|NCT01362790|158398801|FG004|Dose De-escalation of Regimen A|Progressive disease|2|||
49152527|NCT01362790|158398802|FG005|Dose De-escalation of Regimen A|Progressive disease|0|||
49152528|NCT01362790|158398803|FG006|Dose De-escalation of Regimen A|Progressive disease|0|||
49152529|NCT03163667|158398810|FG000|Overall Study|Death|15|||
49152530|NCT03163667|158398811|FG001|Overall Study|Death|27|||
49152531|NCT03163667|158398810|FG000|Overall Study|Study terminated by sponsor (after primary endpoint was met)|8|||
49152532|NCT03163667|158398811|FG001|Overall Study|Study terminated by sponsor (after primary endpoint was met)|19|||
49152533|NCT05360784|158398812|FG000|Overall Study|Discontinued|25|||
49152534|NCT05360784|158398813|FG001|Overall Study|Discontinued|11|||
49152535|NCT02706392|158398816|FG000|Overall Study|Death|1|||
49152536|NCT02706392|158398817|FG001|Overall Study|Death|0|||
49152537|NCT02706392|158398818|FG002|Overall Study|Death|2|||
49152538|NCT02706392|158398819|FG003|Overall Study|Death|2|||
48733602|NCT03633617|156876252|FG000|Part A|Unconfirmed early termination visit|1|||
48733603|NCT03633617|156876253|FG001|Part A|Unconfirmed early termination visit|0|||
48733604|NCT03633617|156876254|FG002|Part A|Unconfirmed early termination visit|0|||
48733605|NCT03633617|156876255|FG003|Part A|Unconfirmed early termination visit|0|||
48733606|NCT03633617|156876256|FG004|Part A|Unconfirmed early termination visit|0|||
48733607|NCT03633617|156876257|FG005|Part A|Unconfirmed early termination visit|0|||
48733608|NCT03633617|156876258|FG006|Part A|Unconfirmed early termination visit|0|||
48733609|NCT03633617|156876259|FG007|Part A|Unconfirmed early termination visit|0|||
48733610|NCT03633617|156876260|FG008|Part A|Unconfirmed early termination visit|0|||
48733611|NCT03633617|156876261|FG009|Part A|Unconfirmed early termination visit|0|||
48733612|NCT03633617|156876262|FG010|Part A|Unconfirmed early termination visit|0|||
48733613|NCT03633617|156876252|FG000|Part A|Adverse Event|0|||
48733614|NCT03633617|156876253|FG001|Part A|Adverse Event|1|||
48733615|NCT03633617|156876254|FG002|Part A|Adverse Event|0|||
48733616|NCT03633617|156876255|FG003|Part A|Adverse Event|0|||
48733617|NCT03633617|156876256|FG004|Part A|Adverse Event|0|||
48825671|NCT04530344|157202139|FG002|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
48825672|NCT04530344|157202140|FG003|Overall Study|Not Compliant with Protocol-specific Visit Window|1|||
48825673|NCT00832780|157202141|FG000|Overall Study|Death|16|||
48825674|NCT00832780|157202141|FG000|Overall Study|Lost to Follow-up|4|||
48825675|NCT00832780|157202141|FG000|Overall Study|no reason given|2|||
48825676|NCT00832780|157202141|FG000|Overall Study|other complicating condition|2|||
48825677|NCT00832780|157202141|FG000|Overall Study|Physician Decision|1|||
48825678|NCT05705167|157202146|FG000|Overall Study|Randomised but not Treated|0|||
48825679|NCT05705167|157202147|FG001|Overall Study|Randomised but not Treated|2|||
48825680|NCT05705167|157202148|FG002|Overall Study|Randomised but not Treated|0|||
48825681|NCT05705167|157202149|FG003|Overall Study|Randomised but not Treated|7|||
48825682|NCT05705167|157202150|FG004|Overall Study|Randomised but not Treated|0|||
48825683|NCT05705167|157202151|FG005|Overall Study|Randomised but not Treated|0|||
48825684|NCT05705167|157202152|FG006|Overall Study|Randomised but not Treated|0|||
48825685|NCT05705167|157202146|FG000|Overall Study|Death|0|||
48825686|NCT05705167|157202147|FG001|Overall Study|Death|0|||
48825687|NCT05705167|157202148|FG002|Overall Study|Death|3|||
48825688|NCT05705167|157202149|FG003|Overall Study|Death|0|||
48825689|NCT05705167|157202150|FG004|Overall Study|Death|1|||
48825690|NCT05705167|157202151|FG005|Overall Study|Death|1|||
48825691|NCT05705167|157202152|FG006|Overall Study|Death|1|||
48825692|NCT05705167|157202146|FG000|Overall Study|Discontinued Prior to FAS Eligibility|0|||
48825693|NCT05705167|157202147|FG001|Overall Study|Discontinued Prior to FAS Eligibility|0|||
48825694|NCT05705167|157202148|FG002|Overall Study|Discontinued Prior to FAS Eligibility|1|||
48825695|NCT05705167|157202149|FG003|Overall Study|Discontinued Prior to FAS Eligibility|1|||
48825696|NCT05705167|157202150|FG004|Overall Study|Discontinued Prior to FAS Eligibility|0|||
48825697|NCT05705167|157202151|FG005|Overall Study|Discontinued Prior to FAS Eligibility|0|||
48825698|NCT05705167|157202152|FG006|Overall Study|Discontinued Prior to FAS Eligibility|1|||
48825699|NCT01723774|157202153|FG000|Neoadjuvant|Ki67 > 10%|4|||
48825700|NCT01723774|157202154|FG001|Neoadjuvant|Ki67 > 10%|0|||
49152539|NCT02706392|158398820|FG004|Overall Study|Death|5|||
49152540|NCT02706392|158398821|FG005|Overall Study|Death|2|||
49152541|NCT00619866|158398822|FG000|Weeks 1 - 12|Adverse Event|0|||
49152542|NCT00619866|158398823|FG001|Weeks 1 - 12|Adverse Event|1|||
49152543|NCT00619866|158398824|FG002|Weeks 1 - 12|Adverse Event|2|||
49152544|NCT00619866|158398825|FG003|Weeks 1 - 12|Adverse Event|0|||
48733618|NCT03633617|156876257|FG005|Part A|Adverse Event|0|||
48733619|NCT03633617|156876258|FG006|Part A|Adverse Event|0|||
49152545|NCT00619866|158398826|FG004|Weeks 1 - 12|Adverse Event|0|||
49152546|NCT00619866|158398822|FG000|Weeks 1 - 12|Non-compliance|0|||
49152547|NCT00619866|158398823|FG001|Weeks 1 - 12|Non-compliance|0|||
49152548|NCT00619866|158398824|FG002|Weeks 1 - 12|Non-compliance|1|||
49152549|NCT00619866|158398825|FG003|Weeks 1 - 12|Non-compliance|0|||
49152550|NCT00619866|158398826|FG004|Weeks 1 - 12|Non-compliance|0|||
49152551|NCT00619866|158398822|FG000|Weeks 1 - 12|Withdrawal by Subject|7|||
49152552|NCT00619866|158398823|FG001|Weeks 1 - 12|Withdrawal by Subject|2|||
49152553|NCT00619866|158398824|FG002|Weeks 1 - 12|Withdrawal by Subject|4|||
49152554|NCT00619866|158398825|FG003|Weeks 1 - 12|Withdrawal by Subject|0|||
49152555|NCT00619866|158398826|FG004|Weeks 1 - 12|Withdrawal by Subject|0|||
49152556|NCT00619866|158398822|FG000|Weeks 1 - 12|Lack of Efficacy|3|||
49152557|NCT00619866|158398823|FG001|Weeks 1 - 12|Lack of Efficacy|2|||
49152558|NCT00619866|158398824|FG002|Weeks 1 - 12|Lack of Efficacy|1|||
49152559|NCT00619866|158398825|FG003|Weeks 1 - 12|Lack of Efficacy|0|||
49152560|NCT00619866|158398826|FG004|Weeks 1 - 12|Lack of Efficacy|0|||
49152561|NCT00619866|158398822|FG000|Weeks 1 - 12|Lost to Follow-up|4|||
49152562|NCT00619866|158398823|FG001|Weeks 1 - 12|Lost to Follow-up|0|||
49152563|NCT00619866|158398824|FG002|Weeks 1 - 12|Lost to Follow-up|2|||
49152564|NCT00619866|158398825|FG003|Weeks 1 - 12|Lost to Follow-up|0|||
49152565|NCT00619866|158398826|FG004|Weeks 1 - 12|Lost to Follow-up|0|||
49152566|NCT00619866|158398822|FG000|Weeks 1 - 12|Sponsor Decision|0|||
49152567|NCT00619866|158398823|FG001|Weeks 1 - 12|Sponsor Decision|1|||
49152568|NCT00619866|158398824|FG002|Weeks 1 - 12|Sponsor Decision|0|||
49152569|NCT00619866|158398825|FG003|Weeks 1 - 12|Sponsor Decision|0|||
49152570|NCT00619866|158398826|FG004|Weeks 1 - 12|Sponsor Decision|0|||
49152571|NCT00619866|158398822|FG000|Weeks 13 - 24|Adverse Event|0|||
49152572|NCT00619866|158398823|FG001|Weeks 13 - 24|Adverse Event|0|||
49152573|NCT00619866|158398824|FG002|Weeks 13 - 24|Adverse Event|2|||
49152574|NCT00619866|158398825|FG003|Weeks 13 - 24|Adverse Event|1|||
49152575|NCT00619866|158398826|FG004|Weeks 13 - 24|Adverse Event|0|||
49152576|NCT00619866|158398822|FG000|Weeks 13 - 24|Protocol Deviation|0|||
49152577|NCT00619866|158398823|FG001|Weeks 13 - 24|Protocol Deviation|0|||
49152578|NCT00619866|158398824|FG002|Weeks 13 - 24|Protocol Deviation|0|||
49152579|NCT00619866|158398825|FG003|Weeks 13 - 24|Protocol Deviation|1|||
49152580|NCT00619866|158398826|FG004|Weeks 13 - 24|Protocol Deviation|0|||
49152581|NCT00619866|158398822|FG000|Weeks 13 - 24|Withdrawal by Subject|0|||
49152582|NCT00619866|158398823|FG001|Weeks 13 - 24|Withdrawal by Subject|3|||
49152583|NCT00619866|158398824|FG002|Weeks 13 - 24|Withdrawal by Subject|2|||
49152584|NCT00619866|158398825|FG003|Weeks 13 - 24|Withdrawal by Subject|2|||
49152585|NCT00619866|158398826|FG004|Weeks 13 - 24|Withdrawal by Subject|2|||
49152586|NCT00619866|158398822|FG000|Weeks 13 - 24|Non-compliance|0|||
49152587|NCT00619866|158398823|FG001|Weeks 13 - 24|Non-compliance|1|||
49152588|NCT00619866|158398824|FG002|Weeks 13 - 24|Non-compliance|1|||
49152589|NCT00619866|158398825|FG003|Weeks 13 - 24|Non-compliance|0|||
49152590|NCT00619866|158398826|FG004|Weeks 13 - 24|Non-compliance|0|||
49152591|NCT00619866|158398822|FG000|Weeks 13 - 24|Lost to Follow-up|0|||
49152592|NCT00619866|158398823|FG001|Weeks 13 - 24|Lost to Follow-up|3|||
49152593|NCT00619866|158398824|FG002|Weeks 13 - 24|Lost to Follow-up|0|||
49152594|NCT00619866|158398825|FG003|Weeks 13 - 24|Lost to Follow-up|0|||
49152595|NCT00619866|158398826|FG004|Weeks 13 - 24|Lost to Follow-up|0|||
49152596|NCT00835367|158398827|FG000|Washout|Adverse Event|2|||
48825701|NCT01723774|157202155|FG002|Neoadjuvant|Ki67 > 10%|10|||
48825702|NCT01723774|157202156|FG003|Neoadjuvant|Ki67 > 10%|0|||
48825703|NCT01723774|157202153|FG000|Neoadjuvant|Withdrawal by Subject|3|||
48825704|NCT01723774|157202154|FG001|Neoadjuvant|Withdrawal by Subject|1|||
48825705|NCT01723774|157202155|FG002|Neoadjuvant|Withdrawal by Subject|0|||
48825706|NCT01723774|157202156|FG003|Neoadjuvant|Withdrawal by Subject|0|||
49152597|NCT00835367|158398828|FG001|Washout|Adverse Event|0|||
49152598|NCT00835367|158398827|FG000|Washout|Withdrawal by Subject|1|||
49152599|NCT00835367|158398828|FG001|Washout|Withdrawal by Subject|0|||
49152600|NCT00835367|158398827|FG000|Second Intervention|Adverse Event|1|||
49152601|NCT00835367|158398828|FG001|Second Intervention|Adverse Event|1|||
49152602|NCT00835172|158398829|FG000|Washout|Protocol Violation|0|||
49152603|NCT00835172|158398830|FG001|Washout|Protocol Violation|1|||
49152604|NCT00618787|158398837|FG000|Overall Study|Adverse Event|0|||
49152605|NCT00618787|158398838|FG001|Overall Study|Adverse Event|1|||
49152606|NCT00618787|158398837|FG000|Overall Study|Withdrawal by Subject|2|||
49152607|NCT00618787|158398838|FG001|Overall Study|Withdrawal by Subject|1|||
49152608|NCT00618787|158398837|FG000|Overall Study|Lost to Follow-up|1|||
49152609|NCT00618787|158398838|FG001|Overall Study|Lost to Follow-up|0|||
48825707|NCT01723774|157202153|FG000|Neoadjuvant|Disease progression|0|||
49152610|NCT03423979|158398839|FG000|Overall Study|Death|1|||
49152611|NCT03599713|158398840|FG000|Overall Study|Death|26|||
49152612|NCT03599713|158398841|FG001|Overall Study|Death|3|||
49152613|NCT03599713|158398840|FG000|Overall Study|Withdrawal by Subject|6|||
49152614|NCT03599713|158398841|FG001|Overall Study|Withdrawal by Subject|0|||
49152615|NCT03599713|158398840|FG000|Overall Study|Ongoing|69|||
49152616|NCT03599713|158398841|FG001|Overall Study|Ongoing|3|||
49152617|NCT00492050|158398842|FG000|Overall Study|Adverse Event|1|||
49152618|NCT00492050|158398842|FG000|Overall Study|Lack of Efficacy|1|||
48733620|NCT03633617|156876259|FG007|Part A|Adverse Event|0|||
48733621|NCT03633617|156876260|FG008|Part A|Adverse Event|0|||
48733622|NCT03633617|156876261|FG009|Part A|Adverse Event|0|||
48733623|NCT03633617|156876262|FG010|Part A|Adverse Event|0|||
48733624|NCT03633617|156876252|FG000|Part A|Pregnancy|1|||
48733625|NCT03633617|156876253|FG001|Part A|Pregnancy|0|||
48733626|NCT03633617|156876254|FG002|Part A|Pregnancy|0|||
48733627|NCT03633617|156876255|FG003|Part A|Pregnancy|0|||
48733628|NCT03633617|156876256|FG004|Part A|Pregnancy|0|||
48733629|NCT03633617|156876257|FG005|Part A|Pregnancy|0|||
48733630|NCT03633617|156876258|FG006|Part A|Pregnancy|0|||
48733631|NCT03633617|156876259|FG007|Part A|Pregnancy|0|||
48733632|NCT03633617|156876260|FG008|Part A|Pregnancy|0|||
48733633|NCT03633617|156876261|FG009|Part A|Pregnancy|0|||
48733634|NCT03633617|156876262|FG010|Part A|Pregnancy|0|||
48733635|NCT03633617|156876252|FG000|Part A|Withdrawal by Subject|0|||
48733636|NCT03633617|156876253|FG001|Part A|Withdrawal by Subject|1|||
48733637|NCT03633617|156876254|FG002|Part A|Withdrawal by Subject|0|||
48733638|NCT03633617|156876255|FG003|Part A|Withdrawal by Subject|0|||
48733639|NCT03633617|156876256|FG004|Part A|Withdrawal by Subject|0|||
48733640|NCT03633617|156876257|FG005|Part A|Withdrawal by Subject|0|||
48733641|NCT03633617|156876258|FG006|Part A|Withdrawal by Subject|0|||
48733642|NCT03633617|156876259|FG007|Part A|Withdrawal by Subject|0|||
48733643|NCT03633617|156876260|FG008|Part A|Withdrawal by Subject|0|||
48733644|NCT03633617|156876261|FG009|Part A|Withdrawal by Subject|0|||
48733645|NCT03633617|156876262|FG010|Part A|Withdrawal by Subject|0|||
48825708|NCT01723774|157202154|FG001|Neoadjuvant|Disease progression|1|||
48825709|NCT01723774|157202155|FG002|Neoadjuvant|Disease progression|1|||
48825710|NCT01723774|157202156|FG003|Neoadjuvant|Disease progression|0|||
48825711|NCT01723774|157202153|FG000|Neoadjuvant|Adverse Event|0|||
48825712|NCT01723774|157202154|FG001|Neoadjuvant|Adverse Event|1|||
48825713|NCT01723774|157202155|FG002|Neoadjuvant|Adverse Event|2|||
48825714|NCT01723774|157202156|FG003|Neoadjuvant|Adverse Event|0|||
48825715|NCT01723774|157202153|FG000|Neoadjuvant|High estradiol|0|||
48825716|NCT01723774|157202154|FG001|Neoadjuvant|High estradiol|1|||
48825717|NCT01723774|157202155|FG002|Neoadjuvant|High estradiol|0|||
48825718|NCT01723774|157202156|FG003|Neoadjuvant|High estradiol|0|||
48921704|NCT00720109|157546463|FG002|Risk Stratification Period|Physician Decision|1|||
48921705|NCT00720109|157546461|FG000|Risk Stratification Period|Bone marrow transplant|0|||
48921706|NCT00720109|157546462|FG001|Risk Stratification Period|Bone marrow transplant|9|||
48921707|NCT00720109|157546463|FG002|Risk Stratification Period|Bone marrow transplant|7|||
48921708|NCT00720109|157546461|FG000|Risk Stratification Period|Disease progression or relapse|0|||
48921709|NCT00720109|157546462|FG001|Risk Stratification Period|Disease progression or relapse|2|||
48825719|NCT05015478|157202157|FG000|Second Experimental Condition|Withdrawal by Subject|0|||
48921710|NCT00720109|157546463|FG002|Risk Stratification Period|Disease progression or relapse|0|||
48921711|NCT00720109|157546461|FG000|Risk Stratification Period|Development of second malignant neoplasm|0|||
48921712|NCT00720109|157546462|FG001|Risk Stratification Period|Development of second malignant neoplasm|1|||
48921713|NCT00720109|157546463|FG002|Risk Stratification Period|Development of second malignant neoplasm|0|||
48921714|NCT03595553|157546464|FG000|Overall Study|Withdrawal by Subject|20|||
48921715|NCT03595553|157546465|FG001|Overall Study|Withdrawal by Subject|8|||
48921716|NCT03595553|157546464|FG000|Overall Study|Physician Decision|3|||
48921717|NCT03595553|157546465|FG001|Overall Study|Physician Decision|2|||
48921718|NCT03595553|157546464|FG000|Overall Study|Adverse Event|2|||
48921719|NCT03595553|157546465|FG001|Overall Study|Adverse Event|5|||
48921720|NCT03595553|157546464|FG000|Overall Study|Death|24|||
48921721|NCT03595553|157546465|FG001|Overall Study|Death|22|||
48921722|NCT03595553|157546464|FG000|Overall Study|Lost to Follow-up|6|||
48921723|NCT03595553|157546465|FG001|Overall Study|Lost to Follow-up|7|||
48921724|NCT03595553|157546464|FG000|Overall Study|Other as indicated in CSR|3|||
48921725|NCT03595553|157546465|FG001|Overall Study|Other as indicated in CSR|3|||
48921726|NCT03595553|157546464|FG000|Overall Study|Sponsor Decision|0|||
48921727|NCT03595553|157546465|FG001|Overall Study|Sponsor Decision|1|||
48921728|NCT00903175|157546466|FG000|Period 1 - First Line|Adverse Event|36|||
48921729|NCT00903175|157546467|FG001|Period 1 - First Line|Adverse Event|50|||
48921730|NCT00903175|157546466|FG000|Period 1 - First Line|Abnormal lab value(s)|0|||
48921731|NCT00903175|157546467|FG001|Period 1 - First Line|Abnormal lab value(s)|1|||
48921732|NCT00903175|157546466|FG000|Period 1 - First Line|Abnormal test procedure result(s)|1|||
48921733|NCT00903175|157546467|FG001|Period 1 - First Line|Abnormal test procedure result(s)|0|||
48921734|NCT00903175|157546466|FG000|Period 1 - First Line|Protocol Violation|3|||
48921735|NCT00903175|157546467|FG001|Period 1 - First Line|Protocol Violation|3|||
48921736|NCT00903175|157546466|FG000|Period 1 - First Line|Withdrawal by Subject|8|||
48733646|NCT03633617|156876252|FG000|Part B|Adverse Event|0|||
48733647|NCT03633617|156876253|FG001|Part B|Adverse Event|0|||
48733648|NCT03633617|156876254|FG002|Part B|Adverse Event|2|||
48733649|NCT03633617|156876255|FG003|Part B|Adverse Event|2|||
48733650|NCT03633617|156876256|FG004|Part B|Adverse Event|1|||
48733651|NCT03633617|156876257|FG005|Part B|Adverse Event|0|||
48733652|NCT03633617|156876258|FG006|Part B|Adverse Event|0|||
48825720|NCT05015478|157202158|FG001|Second Experimental Condition|Withdrawal by Subject|0|||
48921737|NCT00903175|157546467|FG001|Period 1 - First Line|Withdrawal by Subject|12|||
49152619|NCT00492050|158398842|FG000|Overall Study|Withdrawal by Subject|3|||
49152620|NCT00492050|158398842|FG000|Overall Study|Unable to collect SCT|2|||
49152621|NCT00492050|158398842|FG000|Overall Study|Progressive Disease|2|||
49152622|NCT02371889|158400146|FG000|Overall Study|Adverse medication effect|11|||
49152623|NCT02371889|158400147|FG001|Overall Study|Adverse medication effect|2|||
49152624|NCT02371889|158400146|FG000|Overall Study|Lost to Follow-up|6|||
49152625|NCT02371889|158400147|FG001|Overall Study|Lost to Follow-up|5|||
49152626|NCT02371889|158400146|FG000|Overall Study|Personal time constraints|2|||
49152627|NCT02371889|158400147|FG001|Overall Study|Personal time constraints|4|||
49152628|NCT02371889|158400146|FG000|Overall Study|Lack of Efficacy|0|||
49152629|NCT02371889|158400147|FG001|Overall Study|Lack of Efficacy|2|||
49152630|NCT02371889|158400146|FG000|Overall Study|Relapse|0|||
49152631|NCT02371889|158400147|FG001|Overall Study|Relapse|1|||
49152632|NCT00833703|158400148|FG000|Overall Study|Parent(s)/guardian(s)'s request|0|||
49152633|NCT00833703|158400149|FG001|Overall Study|Parent(s)/guardian(s)'s request|1|||
49152634|NCT01661595|158400150|FG000|Phase 1: Week 0-4|Adverse Event|1|||
49152635|NCT01661595|158400151|FG001|Phase 1: Week 0-4|Adverse Event|0|||
49152636|NCT01661595|158400152|FG002|Phase 1: Week 0-4|Adverse Event|0|||
49152637|NCT01661595|158400153|FG003|Phase 1: Week 0-4|Adverse Event|0|||
49152638|NCT01661595|158400150|FG000|Phase 2: Week 5-8.|Protocol Violation|0|||
49152639|NCT01661595|158400151|FG001|Phase 2: Week 5-8.|Protocol Violation|0|||
49152640|NCT01661595|158400152|FG002|Phase 2: Week 5-8.|Protocol Violation|1|||
48825721|NCT05015478|157202159|FG002|Second Experimental Condition|Withdrawal by Subject|0|||
48825722|NCT05015478|157202160|FG003|Second Experimental Condition|Withdrawal by Subject|1|||
48825723|NCT04939428|157202161|FG000|Overall Study|Death|0|||
48825724|NCT04939428|157202162|FG001|Overall Study|Death|1|||
48825725|NCT04939428|157202163|FG002|Overall Study|Death|0|||
48825726|NCT04939428|157202161|FG000|Overall Study|Lost to Follow-up|0|||
48825727|NCT04939428|157202162|FG001|Overall Study|Lost to Follow-up|5|||
48825728|NCT04939428|157202163|FG002|Overall Study|Lost to Follow-up|0|||
48825729|NCT04939428|157202161|FG000|Overall Study|Physician Decision|1|||
48825730|NCT04939428|157202162|FG001|Overall Study|Physician Decision|0|||
48825731|NCT04939428|157202163|FG002|Overall Study|Physician Decision|0|||
48825732|NCT04939428|157202161|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
48825733|NCT04939428|157202162|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
48825734|NCT04939428|157202163|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
48825735|NCT04939428|157202161|FG000|Overall Study|Withdrawal by Subject|10|||
48825736|NCT04939428|157202162|FG001|Overall Study|Withdrawal by Subject|11|||
48825737|NCT04939428|157202163|FG002|Overall Study|Withdrawal by Subject|0|||
48825738|NCT04939428|157202161|FG000|Overall Study|Unkown|6|||
48825739|NCT04939428|157202162|FG001|Overall Study|Unkown|3|||
48825740|NCT04939428|157202163|FG002|Overall Study|Unkown|0|||
48825741|NCT04939428|157202161|FG000|Overall Study|Discotinued per protocol|0|||
48825742|NCT04939428|157202162|FG001|Overall Study|Discotinued per protocol|0|||
48825743|NCT04939428|157202163|FG002|Overall Study|Discotinued per protocol|902|||
48825744|NCT04639947|157202164|FG000|Overall Study|Screen fail|1|||
48825745|NCT00946192|157202172|FG000|Overall Study|Lost to Follow-up|6|||
48825746|NCT00946192|157202173|FG001|Overall Study|Lost to Follow-up|11|||
48825747|NCT00946192|157202174|FG002|Overall Study|Lost to Follow-up|9|||
48825748|NCT00946192|157202172|FG000|Overall Study|Withdrawal by Subject|10|||
48825749|NCT00946192|157202173|FG001|Overall Study|Withdrawal by Subject|7|||
49152641|NCT01661595|158400153|FG003|Phase 2: Week 5-8.|Protocol Violation|0|||
49152642|NCT03033784|158400155|FG000|Overall Study|Anxiety related to MRI scanner|0|||
49152643|NCT03033784|158400156|FG001|Overall Study|Anxiety related to MRI scanner|1|||
49152644|NCT03033784|158400157|FG002|Overall Study|Anxiety related to MRI scanner|0|||
49152645|NCT03033784|158400158|FG003|Overall Study|Anxiety related to MRI scanner|0|||
49152646|NCT03033784|158400159|FG004|Overall Study|Anxiety related to MRI scanner|0|||
49152647|NCT03033784|158400160|FG005|Overall Study|Anxiety related to MRI scanner|0|||
49152648|NCT03033784|158400161|FG006|Overall Study|Anxiety related to MRI scanner|0|||
49152649|NCT03033784|158400162|FG007|Overall Study|Anxiety related to MRI scanner|0|||
49152650|NCT03033784|158400163|FG008|Overall Study|Anxiety related to MRI scanner|0|||
49152651|NCT03033784|158400164|FG009|Overall Study|Anxiety related to MRI scanner|0|||
49152652|NCT03033784|158400165|FG010|Overall Study|Anxiety related to MRI scanner|0|||
49152653|NCT03033784|158400166|FG011|Overall Study|Anxiety related to MRI scanner|0|||
49152654|NCT03033784|158400167|FG012|Overall Study|Anxiety related to MRI scanner|0|||
49152655|NCT03033784|158400155|FG000|Overall Study|Withdrawal by Subject|0|||
49152656|NCT03033784|158400156|FG001|Overall Study|Withdrawal by Subject|0|||
48825750|NCT00946192|157202174|FG002|Overall Study|Withdrawal by Subject|3|||
48825751|NCT00946192|157202172|FG000|Overall Study|Did not start medication|2|||
48825752|NCT00946192|157202173|FG001|Overall Study|Did not start medication|0|||
48825753|NCT00946192|157202174|FG002|Overall Study|Did not start medication|0|||
48825754|NCT00477412|157202175|FG000|Overall Study|Death|0|||
49152657|NCT03033784|158400157|FG002|Overall Study|Withdrawal by Subject|0|||
49152658|NCT03033784|158400158|FG003|Overall Study|Withdrawal by Subject|0|||
49152659|NCT03033784|158400159|FG004|Overall Study|Withdrawal by Subject|0|||
49152660|NCT03033784|158400160|FG005|Overall Study|Withdrawal by Subject|0|||
48733653|NCT03633617|156876259|FG007|Part B|Adverse Event|0|||
48733654|NCT03633617|156876260|FG008|Part B|Adverse Event|0|||
48733655|NCT03633617|156876261|FG009|Part B|Adverse Event|0|||
48733656|NCT03633617|156876262|FG010|Part B|Adverse Event|0|||
48733657|NCT03633617|156876252|FG000|Part B|Withdrawal by Subject|0|||
48733658|NCT03633617|156876253|FG001|Part B|Withdrawal by Subject|0|||
48733659|NCT03633617|156876254|FG002|Part B|Withdrawal by Subject|1|||
48825755|NCT00477412|157202176|FG001|Overall Study|Death|0|||
49152661|NCT03033784|158400161|FG006|Overall Study|Withdrawal by Subject|0|||
49152662|NCT03033784|158400162|FG007|Overall Study|Withdrawal by Subject|0|||
49152663|NCT03033784|158400163|FG008|Overall Study|Withdrawal by Subject|0|||
49152664|NCT03033784|158400164|FG009|Overall Study|Withdrawal by Subject|0|||
49152665|NCT03033784|158400165|FG010|Overall Study|Withdrawal by Subject|0|||
49152666|NCT03033784|158400166|FG011|Overall Study|Withdrawal by Subject|0|||
48825756|NCT00477412|157202177|FG002|Overall Study|Death|0|||
48825757|NCT00477412|157202178|FG003|Overall Study|Death|4|||
48825758|NCT00477412|157202175|FG000|Overall Study|Lost to Follow-up|0|||
48733660|NCT03633617|156876255|FG003|Part B|Withdrawal by Subject|0|||
48825759|NCT00477412|157202176|FG001|Overall Study|Lost to Follow-up|0|||
48825760|NCT00477412|157202177|FG002|Overall Study|Lost to Follow-up|0|||
48825761|NCT00477412|157202178|FG003|Overall Study|Lost to Follow-up|1|||
48825762|NCT00477412|157202175|FG000|Overall Study|Withdrawal by Subject|0|||
48825763|NCT00477412|157202176|FG001|Overall Study|Withdrawal by Subject|0|||
48825764|NCT00477412|157202177|FG002|Overall Study|Withdrawal by Subject|0|||
48825765|NCT00477412|157202178|FG003|Overall Study|Withdrawal by Subject|2|||
48825766|NCT00477412|157202175|FG000|Overall Study|Second Malignancy|0|||
48825767|NCT00477412|157202176|FG001|Overall Study|Second Malignancy|0|||
48825768|NCT00477412|157202177|FG002|Overall Study|Second Malignancy|0|||
48825769|NCT00477412|157202178|FG003|Overall Study|Second Malignancy|1|||
48825770|NCT00477412|157202175|FG000|Overall Study|Adverse Event|1|||
48825771|NCT00477412|157202176|FG001|Overall Study|Adverse Event|0|||
48825772|NCT00477412|157202177|FG002|Overall Study|Adverse Event|1|||
48825773|NCT00477412|157202178|FG003|Overall Study|Adverse Event|0|||
48825774|NCT01140347|157202183|FG000|Overall Study|Lost to Follow-up|5|||
49152667|NCT03033784|158400167|FG012|Overall Study|Withdrawal by Subject|2|||
49152668|NCT00668642|158400178|FG000|First Off-cycle|Cancer progression|1|||
49152669|NCT00668642|158400179|FG001|First Off-cycle|Cancer progression|0|||
49152670|NCT00668642|158400178|FG000|Second AAT Treatment (On-cycle 2)|Cancer progression|2|||
48825775|NCT01140347|157202184|FG001|Overall Study|Lost to Follow-up|6|||
48825776|NCT01140347|157202183|FG000|Overall Study|Withdrawal by Subject|13|||
49152671|NCT00668642|158400179|FG001|Second AAT Treatment (On-cycle 2)|Cancer progression|1|||
49152672|NCT00836706|158400180|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
49152673|NCT00836706|158400181|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
49152674|NCT01537432|158400182|FG000|Overall Study|Lost to Follow-up|3|||
49152675|NCT01537432|158400183|FG001|Overall Study|Lost to Follow-up|1|||
49152676|NCT01537432|158400182|FG000|Overall Study|Withdrawal by Subject|0|||
49152677|NCT01537432|158400183|FG001|Overall Study|Withdrawal by Subject|1|||
49152678|NCT01537432|158400182|FG000|Overall Study|Administrative problems|1|||
49152679|NCT01537432|158400183|FG001|Overall Study|Administrative problems|0|||
49152680|NCT01537432|158400182|FG000|Overall Study|Adverse Event|1|||
49152681|NCT01537432|158400183|FG001|Overall Study|Adverse Event|0|||
49152682|NCT01537432|158400182|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
49152683|NCT01537432|158400183|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
49152684|NCT00095576|158400186|FG000|Overall Study|Adverse Event|5|||
49152685|NCT00095576|158400187|FG001|Overall Study|Adverse Event|3|||
49152686|NCT00095576|158400186|FG000|Overall Study|Lost to Follow-up|233|||
49152687|NCT00095576|158400187|FG001|Overall Study|Lost to Follow-up|229|||
49152688|NCT00095576|158400186|FG000|Overall Study|Protocol Violation|1|||
49152689|NCT00095576|158400187|FG001|Overall Study|Protocol Violation|0|||
49152690|NCT00095576|158400186|FG000|Overall Study|Withdrawal by Subject|34|||
49152691|NCT00095576|158400187|FG001|Overall Study|Withdrawal by Subject|47|||
49152692|NCT00095576|158400186|FG000|Overall Study|Option to switch to a rollover study|1097|||
49152693|NCT00095576|158400187|FG001|Overall Study|Option to switch to a rollover study|1099|||
49152694|NCT00095576|158400186|FG000|Overall Study|Site terminated|75|||
49152695|NCT00095576|158400187|FG001|Overall Study|Site terminated|67|||
49152696|NCT00095576|158400186|FG000|Overall Study|Subject moved|30|||
49152697|NCT00095576|158400187|FG001|Overall Study|Subject moved|36|||
49152698|NCT02276040|158400188|FG000|Overall Study|Physician Decision|15|||
49152699|NCT00505687|158400189|FG000|Overall Study|Important protocol violation|2|||
48825777|NCT01140347|157202184|FG001|Overall Study|Withdrawal by Subject|8|||
48825778|NCT01304147|157202185|FG000|Second Intervention (7days)|Withdrawal by Subject|1|||
48825779|NCT01304147|157202186|FG001|Second Intervention (7days)|Withdrawal by Subject|1|||
48825780|NCT01919619|157202187|FG000|Overall Study|Physician Decision|1|||
48825781|NCT01919619|157202188|FG001|Overall Study|Physician Decision|1|||
49152700|NCT00505687|158400189|FG000|Overall Study|Lack of Efficacy|15|||
49152701|NCT00505687|158400189|FG000|Overall Study|Adverse Event|48|||
48733661|NCT03633617|156876256|FG004|Part B|Withdrawal by Subject|2|||
48825782|NCT00798265|157202189|FG000|Overall Study|Lost to Follow-up|1|||
49152702|NCT00505687|158400189|FG000|Overall Study|Subject withdrew consent|15|||
49152703|NCT00505687|158400189|FG000|Overall Study|Lost to Follow-up|1|||
49152704|NCT00505687|158400189|FG000|Overall Study|Other: Underwent Implantation Of DBS|1|||
49152705|NCT00505687|158400189|FG000|Overall Study|Other: Scheduled DBS Surgery|1|||
49152706|NCT00505687|158400189|FG000|Overall Study|Other: Prolonged Hospitalization|1|||
49152707|NCT00505687|158400189|FG000|Overall Study|Other: Patches Would Not Stick D/T Sweat|1|||
49152708|NCT00505687|158400189|FG000|Overall Study|Other: Neupro Given In Hospital|1|||
49152709|NCT00505687|158400189|FG000|Overall Study|Other: Disease Progression|1|||
49152710|NCT00505687|158400189|FG000|Overall Study|Other: As Per Sponsor|8|||
49152711|NCT00567502|158400190|FG000|Overall Study|Lost to Follow-up|91|||
49152712|NCT00567502|158400191|FG001|Overall Study|Lost to Follow-up|14|||
49152713|NCT00567502|158400192|FG002|Overall Study|Lost to Follow-up|351|||
48825783|NCT00798265|157202190|FG001|Overall Study|Lost to Follow-up|10|||
48825784|NCT00798265|157202189|FG000|Overall Study|Study closing|7|||
48825785|NCT00798265|157202190|FG001|Overall Study|Study closing|6|||
48825786|NCT00798265|157202189|FG000|Overall Study|Withdrawal by Subject|0|||
48825787|NCT00798265|157202190|FG001|Overall Study|Withdrawal by Subject|1|||
48825788|NCT00798265|157202189|FG000|Overall Study|Screen failure|0|||
48825789|NCT00798265|157202190|FG001|Overall Study|Screen failure|1|||
48825790|NCT01021332|157204016|FG000|Overall Study|Not fulfilling incl./excl.criteria|5|||
48825791|NCT01021332|157204016|FG000|Overall Study|Adverse Event|43|||
48825792|NCT01021332|157204016|FG000|Overall Study|Lack of Efficacy|19|||
48825793|NCT01021332|157204016|FG000|Overall Study|Withdrawal of Consent|23|||
48825794|NCT01021332|157204016|FG000|Overall Study|Lost to Follow-up|4|||
48825795|NCT01021332|157204016|FG000|Overall Study|Protocol Violation|9|||
48825796|NCT01021332|157204016|FG000|Overall Study|Miscellaneous|3|||
48825797|NCT03487666|157204017|FG000|Overall Study|Disease progression|4|||
48825798|NCT03487666|157204018|FG001|Overall Study|Disease progression|2|||
48825799|NCT03487666|157204019|FG002|Overall Study|Disease progression|0|||
48825800|NCT03487666|157204017|FG000|Overall Study|Adverse Event|0|||
48825801|NCT03487666|157204018|FG001|Overall Study|Adverse Event|0|||
48825802|NCT03487666|157204019|FG002|Overall Study|Adverse Event|1|||
48825803|NCT01474538|157204020|FG000|Treatment Period 1|Death|1|||
49152714|NCT00567502|158400193|FG003|Overall Study|Lost to Follow-up|2|||
49152715|NCT00567502|158400190|FG000|Overall Study|Death|65|||
49152716|NCT00567502|158400191|FG001|Overall Study|Death|16|||
49152717|NCT00567502|158400192|FG002|Overall Study|Death|360|||
49152718|NCT00567502|158400193|FG003|Overall Study|Death|5|||
49152719|NCT00567502|158400190|FG000|Overall Study|Other|64|||
49152720|NCT00567502|158400191|FG001|Overall Study|Other|2|||
49152721|NCT00567502|158400192|FG002|Overall Study|Other|134|||
49152722|NCT00567502|158400193|FG003|Overall Study|Other|6|||
49152723|NCT00567502|158400190|FG000|Overall Study|Participant request|12|||
49152724|NCT00567502|158400191|FG001|Overall Study|Participant request|1|||
49152725|NCT00567502|158400192|FG002|Overall Study|Participant request|33|||
49152726|NCT00567502|158400193|FG003|Overall Study|Participant request|1|||
49152727|NCT00567502|158400190|FG000|Overall Study|Sponsor request|9|||
49152728|NCT00567502|158400191|FG001|Overall Study|Sponsor request|0|||
49152729|NCT00567502|158400192|FG002|Overall Study|Sponsor request|30|||
49152730|NCT00567502|158400193|FG003|Overall Study|Sponsor request|1|||
49152731|NCT00567502|158400190|FG000|Overall Study|Never Initiated Treatment|0|||
49152732|NCT00567502|158400191|FG001|Overall Study|Never Initiated Treatment|0|||
49152733|NCT00567502|158400192|FG002|Overall Study|Never Initiated Treatment|0|||
49152734|NCT00567502|158400193|FG003|Overall Study|Never Initiated Treatment|72|||
49152735|NCT03341936|158400194|FG000|Overall Study|Ineligible|1|||
49152736|NCT03341936|158400194|FG000|Overall Study|Disease Progression|2|||
49152737|NCT03341936|158400194|FG000|Overall Study|Withdrew Consent|4|||
49152738|NCT03341936|158400194|FG000|Overall Study|Non-Compliance|1|||
49152739|NCT03341936|158400194|FG000|Overall Study|Physician Decision|1|||
49152740|NCT03341936|158400194|FG000|Overall Study|Withdrawal by Subject|1|||
49152741|NCT03341936|158400194|FG000|Overall Study|Other|1|||
49152742|NCT03639935|158400195|FG000|Overall Study|Death|3|||
49152743|NCT03639935|158400195|FG000|Overall Study|Adverse Event|1|||
49152744|NCT00573768|158400196|FG000|Overall Study|Adverse Event|1|||
49152745|NCT00573768|158400197|FG001|Overall Study|Adverse Event|1|||
49152746|NCT00573768|158400198|FG002|Overall Study|Adverse Event|2|||
49152747|NCT00573768|158400196|FG000|Overall Study|Protocol Violation|1|||
49152748|NCT00573768|158400197|FG001|Overall Study|Protocol Violation|0|||
49152749|NCT00573768|158400198|FG002|Overall Study|Protocol Violation|1|||
48825804|NCT01474538|157204021|FG001|Treatment Period 1|Death|0|||
48825805|NCT01474538|157204020|FG000|Treatment Period 1|Physician Decision|1|||
48825806|NCT01474538|157204021|FG001|Treatment Period 1|Physician Decision|0|||
49152750|NCT00573768|158400196|FG000|Overall Study|Withdrawal by Subject|0|||
49152751|NCT00573768|158400197|FG001|Overall Study|Withdrawal by Subject|1|||
49152752|NCT00573768|158400198|FG002|Overall Study|Withdrawal by Subject|0|||
49152753|NCT00573768|158400196|FG000|Overall Study|Lost to Follow-up|0|||
49152754|NCT00573768|158400197|FG001|Overall Study|Lost to Follow-up|0|||
49152755|NCT00573768|158400198|FG002|Overall Study|Lost to Follow-up|1|||
49152756|NCT00160563|158400199|FG000|Overall Study|Adverse Event|1|||
49152757|NCT00160563|158400200|FG001|Overall Study|Adverse Event|1|||
49152758|NCT00160563|158400201|FG002|Overall Study|Adverse Event|1|||
49152759|NCT00160563|158400199|FG000|Overall Study|Lost to Follow-up|1|||
49152760|NCT00160563|158400200|FG001|Overall Study|Lost to Follow-up|1|||
49152761|NCT00160563|158400201|FG002|Overall Study|Lost to Follow-up|2|||
49152762|NCT00160563|158400199|FG000|Overall Study|Protocol Violation|0|||
49152763|NCT00160563|158400200|FG001|Overall Study|Protocol Violation|0|||
49152764|NCT00160563|158400201|FG002|Overall Study|Protocol Violation|3|||
49152765|NCT00160563|158400199|FG000|Overall Study|Withdrawal by Subject|1|||
49152766|NCT00160563|158400200|FG001|Overall Study|Withdrawal by Subject|2|||
49152767|NCT00160563|158400201|FG002|Overall Study|Withdrawal by Subject|3|||
49152768|NCT00160563|158400199|FG000|Overall Study|Other (listed in the study report)|48|||
49152769|NCT00160563|158400200|FG001|Overall Study|Other (listed in the study report)|40|||
49152770|NCT00160563|158400201|FG002|Overall Study|Other (listed in the study report)|81|||
49152771|NCT00160563|158400199|FG000|Overall Study|Missing reason|0|||
49152772|NCT00160563|158400200|FG001|Overall Study|Missing reason|1|||
49152773|NCT00160563|158400201|FG002|Overall Study|Missing reason|0|||
49152774|NCT00867334|158400203|FG000|Overall Study|Withdrawal by Subject|0|||
49152775|NCT00867334|158400204|FG001|Overall Study|Withdrawal by Subject|1|||
49152776|NCT00867334|158400203|FG000|Overall Study|Withdrawal by Subject|1|||
49152777|NCT00867334|158400204|FG001|Overall Study|Withdrawal by Subject|0|||
49152778|NCT00867334|158400203|FG000|Overall Study|Withdrawal by Subject|1|||
49152779|NCT00867334|158400204|FG001|Overall Study|Withdrawal by Subject|0|||
49152780|NCT03093415|158400209|FG000|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17|||
49152781|NCT03093415|158400210|FG001|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36|||
49152782|NCT03093415|158400211|FG002|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0|||
49152783|NCT03093415|158400209|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40|||
49152784|NCT03093415|158400210|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
49152785|NCT03093415|158400211|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
49152786|NCT03093415|158400209|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28|||
49152787|NCT03093415|158400210|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6|||
49152788|NCT03093415|158400211|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0|||
49152789|NCT03093415|158400209|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
49152790|NCT03093415|158400210|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12|||
49152791|NCT03093415|158400211|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
49152792|NCT03093415|158400209|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18|||
49152793|NCT03093415|158400210|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12|||
49152794|NCT03093415|158400211|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0|||
49152795|NCT03093415|158400209|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
49152796|NCT03093415|158400210|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
49152797|NCT03093415|158400211|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0|||
49152798|NCT03093415|158400209|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15|||
49152799|NCT03093415|158400210|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32|||
49152800|NCT03093415|158400211|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0|||
49152801|NCT03093415|158400209|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5|||
48825807|NCT01474538|157204020|FG000|Treatment Period 1|Withdrawal by Subject|1|||
48825808|NCT01474538|157204021|FG001|Treatment Period 1|Withdrawal by Subject|3|||
49152802|NCT03093415|158400210|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3|||
49152803|NCT03093415|158400211|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0|||
49152804|NCT03093415|158400209|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4|||
49152805|NCT03093415|158400210|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2|||
49152806|NCT03093415|158400211|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0|||
49152807|NCT03093415|158400209|FG000|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9|||
49152808|NCT03093415|158400210|FG001|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3|||
48825809|NCT01474538|157204020|FG000|Treatment Period 1|Protocol Violation|0|||
49152809|NCT03093415|158400211|FG002|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0|||
49152810|NCT03093415|158400209|FG000|Enrollment to SVR12 Results|Lost to Follow-up|1|||
49152811|NCT03093415|158400210|FG001|Enrollment to SVR12 Results|Lost to Follow-up|8|||
49152812|NCT03093415|158400211|FG002|Enrollment to SVR12 Results|Lost to Follow-up|3|||
49152813|NCT03331354|158400212|FG000|Overall Study|Withdrawal by Subject|1|||
49152814|NCT03331354|158400213|FG001|Overall Study|Withdrawal by Subject|3|||
49152815|NCT03331354|158400212|FG000|Overall Study|Lost to Follow-up|3|||
49152816|NCT03331354|158400213|FG001|Overall Study|Lost to Follow-up|3|||
49152817|NCT03331354|158400212|FG000|Overall Study|Found employment before initiated active intervention|0|||
49152818|NCT03331354|158400213|FG001|Overall Study|Found employment before initiated active intervention|4|||
49152819|NCT03685149|158400214|FG000|First Intervention (4 Weeks)|Adverse Event|0|||
49152820|NCT03685149|158400215|FG001|First Intervention (4 Weeks)|Adverse Event|2|||
49152821|NCT03685149|158400214|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
49152822|NCT03685149|158400215|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
49152823|NCT03685149|158400214|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
49152824|NCT03685149|158400215|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
49152825|NCT00113373|158400218|FG000|Overall Study|Ineligible: wrong primary|1|||
48825810|NCT01474538|157204021|FG001|Treatment Period 1|Protocol Violation|1|||
48921738|NCT00903175|157546466|FG000|Period 1 - First Line|Administrative problems|12|||
48921739|NCT00903175|157546467|FG001|Period 1 - First Line|Administrative problems|13|||
48921740|NCT00903175|157546466|FG000|Period 1 - First Line|Death|17|||
48921741|NCT00903175|157546467|FG001|Period 1 - First Line|Death|10|||
48921742|NCT00903175|157546466|FG000|Period 2 - Second Line|Missing|1|||
48921743|NCT00903175|157546467|FG001|Period 2 - Second Line|Missing|0|||
48921744|NCT00903175|157546466|FG000|Period 2 - Second Line|Adverse Event|16|||
48921745|NCT00903175|157546467|FG001|Period 2 - Second Line|Adverse Event|20|||
48921746|NCT00903175|157546466|FG000|Period 2 - Second Line|Withdrawal by Subject|7|||
48921747|NCT00903175|157546467|FG001|Period 2 - Second Line|Withdrawal by Subject|5|||
48921748|NCT00903175|157546466|FG000|Period 2 - Second Line|Lost to Follow-up|1|||
48825811|NCT01474538|157204020|FG000|Treatment Period 2|Death|1|||
48825812|NCT01474538|157204021|FG001|Treatment Period 2|Death|0|||
48825813|NCT01474538|157204020|FG000|Treatment Period 2|Adverse Event|1|||
48825814|NCT01474538|157204021|FG001|Treatment Period 2|Adverse Event|1|||
48825815|NCT01474538|157204020|FG000|Treatment Period 2|Withdrawal by Subject|2|||
48825816|NCT01474538|157204021|FG001|Treatment Period 2|Withdrawal by Subject|0|||
48825817|NCT01474538|157204020|FG000|Treatment Period 2|Sponsor decision|1|||
48825818|NCT01474538|157204021|FG001|Treatment Period 2|Sponsor decision|0|||
48825819|NCT01474538|157204020|FG000|Treatment Period 2|Physician Decision|0|||
48825820|NCT01474538|157204021|FG001|Treatment Period 2|Physician Decision|1|||
48825821|NCT01474538|157204020|FG000|Treatment Period 2|Protocol Violation|1|||
48825822|NCT01474538|157204021|FG001|Treatment Period 2|Protocol Violation|0|||
48825823|NCT01323660|157204023|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|6|||
48825824|NCT01323660|157204024|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
48825825|NCT01323660|157204025|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
48825826|NCT01323660|157204026|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
48825827|NCT01323660|157204027|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
48825828|NCT01323660|157204028|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|4|||
48825829|NCT01323660|157204023|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
48825830|NCT01323660|157204024|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
48825831|NCT01323660|157204025|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
48825832|NCT01323660|157204026|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
48825833|NCT01323660|157204027|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
48825834|NCT01323660|157204028|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3|||
48825835|NCT01323660|157204023|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
48825836|NCT01323660|157204024|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
48825837|NCT01323660|157204025|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
48825838|NCT01323660|157204026|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
48825839|NCT01323660|157204027|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
48825840|NCT01323660|157204028|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
48825841|NCT01323660|157204023|FG000|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
48825842|NCT01323660|157204024|FG001|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
48825843|NCT01323660|157204025|FG002|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
48825844|NCT01323660|157204026|FG003|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
48825845|NCT01323660|157204027|FG004|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1|||
48825846|NCT01323660|157204028|FG005|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
48825847|NCT01323660|157204023|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
48825848|NCT01323660|157204024|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
48921749|NCT00903175|157546467|FG001|Period 2 - Second Line|Lost to Follow-up|0|||
48921750|NCT00903175|157546466|FG000|Period 2 - Second Line|Administrative problems|19|||
49152826|NCT00113373|158400218|FG000|Overall Study|Ineligible: second primary|1|||
48825849|NCT01323660|157204025|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
48825850|NCT01323660|157204026|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
48825851|NCT01323660|157204027|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
48825852|NCT01323660|157204028|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
48825853|NCT01323660|157204023|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5|||
48825854|NCT01323660|157204024|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
48825855|NCT01323660|157204025|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
48825856|NCT01323660|157204026|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
48825857|NCT01323660|157204027|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3|||
48921751|NCT00903175|157546467|FG001|Period 2 - Second Line|Administrative problems|9|||
48921752|NCT00903175|157546466|FG000|Period 2 - Second Line|Death|5|||
49152827|NCT00113373|158400218|FG000|Overall Study|Never Treated|1|||
49152828|NCT02526290|158400223|FG000|Overall Study|Adverse Event|3|||
48825858|NCT01323660|157204028|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
48825859|NCT01323660|157204023|FG000|Washout Period (14 Days)|Adverse Event|0|||
48825860|NCT01323660|157204024|FG001|Washout Period (14 Days)|Adverse Event|0|||
48825861|NCT01323660|157204025|FG002|Washout Period (14 Days)|Adverse Event|0|||
48825862|NCT01323660|157204026|FG003|Washout Period (14 Days)|Adverse Event|0|||
48825863|NCT01323660|157204027|FG004|Washout Period (14 Days)|Adverse Event|1|||
48825864|NCT01323660|157204028|FG005|Washout Period (14 Days)|Adverse Event|0|||
48825865|NCT01323660|157204023|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
48825866|NCT01323660|157204024|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
48825867|NCT01323660|157204025|FG002|Washout Period (14 Days)|Lack of Efficacy|1|||
48825868|NCT01323660|157204026|FG003|Washout Period (14 Days)|Lack of Efficacy|3|||
48825869|NCT01323660|157204027|FG004|Washout Period (14 Days)|Lack of Efficacy|2|||
48825870|NCT01323660|157204028|FG005|Washout Period (14 Days)|Lack of Efficacy|2|||
48825871|NCT01323660|157204023|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
48825872|NCT01323660|157204024|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
48825873|NCT01323660|157204025|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
48825874|NCT01323660|157204026|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
48825875|NCT01323660|157204027|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
48825876|NCT01323660|157204028|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|2|||
48825877|NCT01323660|157204023|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9|||
48825878|NCT01323660|157204024|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
48825879|NCT01323660|157204025|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
48825880|NCT01323660|157204026|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
48825881|NCT01323660|157204027|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
48825882|NCT01323660|157204028|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
48825883|NCT01323660|157204023|FG000|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
48825884|NCT01323660|157204024|FG001|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
48825885|NCT01323660|157204025|FG002|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
48825886|NCT01323660|157204026|FG003|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
48825887|NCT01323660|157204027|FG004|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
48825888|NCT01323660|157204028|FG005|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1|||
48825889|NCT01323660|157204023|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
48825890|NCT01323660|157204024|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
48825891|NCT01323660|157204025|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
48825892|NCT01323660|157204026|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
48825893|NCT01323660|157204027|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
48825894|NCT01323660|157204028|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
48825895|NCT01323660|157204023|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
48825896|NCT01323660|157204024|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
48825897|NCT01323660|157204025|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
48825898|NCT01323660|157204026|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
48825899|NCT01323660|157204027|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
48825900|NCT01323660|157204028|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
48825901|NCT04531540|157204034|FG000|Overall Study|Adverse Event|1|||
48825902|NCT04531540|157204034|FG000|Overall Study|Protocol Violation|3|||
48825903|NCT04531540|157204034|FG000|Overall Study|Withdrawal by Subject|4|||
48825904|NCT04531540|157204034|FG000|Overall Study|Found to be Ineligible|1|||
48825905|NCT00984282|157204035|FG000|Double Blind Treatment|Adverse Event|40|||
48825906|NCT00984282|157204036|FG001|Double Blind Treatment|Adverse Event|6|||
48825907|NCT00984282|157204035|FG000|Double Blind Treatment|Progression, recurrence or relapse|25|||
48825908|NCT00984282|157204036|FG001|Double Blind Treatment|Progression, recurrence or relapse|3|||
48825909|NCT00984282|157204035|FG000|Double Blind Treatment|Physician Decision|1|||
48825910|NCT00984282|157204036|FG001|Double Blind Treatment|Physician Decision|2|||
48825911|NCT00984282|157204035|FG000|Double Blind Treatment|Noncompliance with study medication|3|||
49152829|NCT02526290|158400223|FG000|Overall Study|Withdrawal by Subject|4|||
49152830|NCT02526290|158400223|FG000|Overall Study|Physician Decision|1|||
48825912|NCT00984282|157204036|FG001|Double Blind Treatment|Noncompliance with study medication|0|||
48825913|NCT00984282|157204035|FG000|Double Blind Treatment|Progression by clinical judgment|2|||
49152831|NCT02082977|158400224|FG000|Part 1 (Up to 3.2 Years)|Death|1|||
49152832|NCT02082977|158400225|FG001|Part 1 (Up to 3.2 Years)|Death|0|||
49152833|NCT02082977|158400226|FG002|Part 1 (Up to 3.2 Years)|Death|0|||
49152834|NCT02082977|158400227|FG003|Part 1 (Up to 3.2 Years)|Death|0|||
49152835|NCT02082977|158400228|FG004|Part 1 (Up to 3.2 Years)|Death|0|||
49152836|NCT02082977|158400229|FG005|Part 1 (Up to 3.2 Years)|Death|1|||
49152837|NCT02082977|158400230|FG006|Part 1 (Up to 3.2 Years)|Death|2|||
48825914|NCT00984282|157204036|FG001|Double Blind Treatment|Progression by clinical judgment|0|||
49152838|NCT02082977|158400231|FG007|Part 1 (Up to 3.2 Years)|Death|0|||
48825915|NCT00984282|157204035|FG000|Double Blind Treatment|Withdrawal by Subject|13|||
48825916|NCT00984282|157204036|FG001|Double Blind Treatment|Withdrawal by Subject|18|||
48825917|NCT00984282|157204035|FG000|Double Blind Treatment|Lost to Follow-up|3|||
48825918|NCT00984282|157204036|FG001|Double Blind Treatment|Lost to Follow-up|0|||
49152839|NCT02082977|158400232|FG008|Part 1 (Up to 3.2 Years)|Death|1|||
48921753|NCT00903175|157546467|FG001|Period 2 - Second Line|Death|2|||
48921754|NCT03074474|157546470|FG000|Overall Study|Lost to Follow-up|10|||
48921755|NCT03074474|157546470|FG000|Overall Study|Withdrawal by Subject|10|||
49152840|NCT02082977|158400233|FG009|Part 1 (Up to 3.2 Years)|Death|0|||
49152841|NCT02082977|158400224|FG000|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
49152842|NCT02082977|158400225|FG001|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
49152843|NCT02082977|158400226|FG002|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
49152844|NCT02082977|158400227|FG003|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
49152845|NCT02082977|158400228|FG004|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
48921756|NCT03074474|157546470|FG000|Overall Study|Death|4|||
48921757|NCT03074474|157546470|FG000|Overall Study|1 exited due to recurrence and 2 exited due to mesh removal.|3|||
49152846|NCT02082977|158400229|FG005|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
48921758|NCT01681433|157546471|FG000|Overall Study|Lack of Efficacy|23|||
48921759|NCT01681433|157546472|FG001|Overall Study|Lack of Efficacy|23|||
48921760|NCT01681433|157546471|FG000|Overall Study|Withdrawal by Subject|5|||
48921761|NCT01681433|157546472|FG001|Overall Study|Withdrawal by Subject|5|||
48921762|NCT01681433|157546471|FG000|Overall Study|Protocol Violation|2|||
48921763|NCT01681433|157546472|FG001|Overall Study|Protocol Violation|0|||
48921764|NCT01681433|157546471|FG000|Overall Study|Adverse Event|2|||
48921765|NCT01681433|157546472|FG001|Overall Study|Adverse Event|4|||
48921766|NCT01681433|157546471|FG000|Overall Study|Lost to Follow-up|0|||
48921767|NCT01681433|157546472|FG001|Overall Study|Lost to Follow-up|1|||
49152847|NCT02082977|158400230|FG006|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
49152848|NCT02082977|158400231|FG007|Part 1 (Up to 3.2 Years)|Study closed/terminated|2|||
49152849|NCT02082977|158400232|FG008|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
49152850|NCT02082977|158400233|FG009|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
49152851|NCT02082977|158400224|FG000|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
49152852|NCT02082977|158400225|FG001|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
49152853|NCT02082977|158400226|FG002|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
49152854|NCT02082977|158400227|FG003|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
49152855|NCT02082977|158400228|FG004|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
49152856|NCT02082977|158400229|FG005|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1|||
49152857|NCT02082977|158400230|FG006|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
49152858|NCT02082977|158400231|FG007|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
49152859|NCT02082977|158400232|FG008|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
49152860|NCT02082977|158400233|FG009|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
49152861|NCT02082977|158400224|FG000|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
49152862|NCT02082977|158400225|FG001|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
49152863|NCT02082977|158400226|FG002|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
49152864|NCT02082977|158400227|FG003|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
49152865|NCT02082977|158400228|FG004|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
49152866|NCT02082977|158400229|FG005|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
49152867|NCT02082977|158400230|FG006|Part 1 (Up to 3.2 Years)|Physician Decision|4|||
49152868|NCT02082977|158400231|FG007|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
49152869|NCT02082977|158400232|FG008|Part 1 (Up to 3.2 Years)|Physician Decision|2|||
49152870|NCT02082977|158400233|FG009|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
49152871|NCT02082977|158400224|FG000|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
48921768|NCT02321436|157546479|FG000|Overall Study|Withdrawal by Subject|1|||
48921769|NCT02321436|157546480|FG001|Overall Study|Withdrawal by Subject|0|||
48921770|NCT02321436|157546479|FG000|Overall Study|Lost to Follow-up|0|||
48921771|NCT02321436|157546480|FG001|Overall Study|Lost to Follow-up|1|||
48921772|NCT00264238|157546481|FG000|Overall Study|Protocol Violation|1|||
48921773|NCT03124563|157546484|FG000|Overall Study|Lost to Follow-up|1|||
48921774|NCT03124563|157546485|FG001|Overall Study|Lost to Follow-up|1|||
48921775|NCT03124563|157546484|FG000|Overall Study|Withdrawal by Subject|1|||
48921776|NCT03124563|157546485|FG001|Overall Study|Withdrawal by Subject|1|||
48921777|NCT01534533|157546486|FG000|Overall Study|Lost to Follow-up|3|||
48921778|NCT01534533|157546487|FG001|Overall Study|Lost to Follow-up|0|||
48921779|NCT01534533|157546488|FG002|Overall Study|Lost to Follow-up|4|||
49152872|NCT02082977|158400225|FG001|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
49152873|NCT02082977|158400226|FG002|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
49152874|NCT02082977|158400227|FG003|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
49152875|NCT02082977|158400228|FG004|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
48733662|NCT03633617|156876257|FG005|Part B|Withdrawal by Subject|0|||
48733663|NCT03633617|156876258|FG006|Part B|Withdrawal by Subject|0|||
48733664|NCT03633617|156876259|FG007|Part B|Withdrawal by Subject|0|||
48733665|NCT03633617|156876260|FG008|Part B|Withdrawal by Subject|0|||
48733666|NCT03633617|156876261|FG009|Part B|Withdrawal by Subject|0|||
48733667|NCT03633617|156876262|FG010|Part B|Withdrawal by Subject|0|||
48733668|NCT03633617|156876252|FG000|Part B|Lost to Follow-up|0|||
48733669|NCT03633617|156876253|FG001|Part B|Lost to Follow-up|0|||
48733670|NCT03633617|156876254|FG002|Part B|Lost to Follow-up|0|||
48733671|NCT03633617|156876255|FG003|Part B|Lost to Follow-up|0|||
48733672|NCT03633617|156876256|FG004|Part B|Lost to Follow-up|1|||
49152876|NCT02082977|158400229|FG005|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
49152877|NCT02082977|158400230|FG006|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
49152878|NCT02082977|158400231|FG007|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2|||
49152879|NCT02082977|158400232|FG008|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
49152880|NCT02082977|158400233|FG009|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
49152881|NCT02495883|158400234|FG000|Overall Study|Excessive head motion|1|||
49152882|NCT02495883|158400235|FG001|Overall Study|Excessive head motion|0|||
49152883|NCT00105066|158400236|FG000|Overall Study|Adverse Event|2|||
49152884|NCT00105066|158400237|FG001|Overall Study|Adverse Event|5|||
49152885|NCT02796651|158400238|FG000|Overall Study|Adverse Event|6|||
48733673|NCT03633617|156876257|FG005|Part B|Lost to Follow-up|0|||
48733674|NCT03633617|156876258|FG006|Part B|Lost to Follow-up|0|||
48733675|NCT03633617|156876259|FG007|Part B|Lost to Follow-up|0|||
48733676|NCT03633617|156876260|FG008|Part B|Lost to Follow-up|0|||
49152886|NCT02796651|158400238|FG000|Overall Study|Lost to Follow-up|1|||
49152887|NCT02796651|158400238|FG000|Overall Study|Withdrawal by Subject|4|||
49152888|NCT02796651|158400238|FG000|Overall Study|Protocol Violation|4|||
49152889|NCT02796651|158400238|FG000|Overall Study|Lack of Efficacy|1|||
49152890|NCT02796651|158400238|FG000|Overall Study|Other|10|||
49152891|NCT05014919|158400239|FG000|Open-Label (12 Weeks)|Adverse Event|1|||
49152892|NCT05014919|158400240|FG001|Open-Label (12 Weeks)|Adverse Event|0|||
49152893|NCT05014919|158400241|FG002|Open-Label (12 Weeks)|Adverse Event|0|||
48733677|NCT03633617|156876261|FG009|Part B|Lost to Follow-up|0|||
48733678|NCT03633617|156876262|FG010|Part B|Lost to Follow-up|0|||
48733679|NCT03633617|156876252|FG000|Part B|Physician Decision|0|||
48733680|NCT03633617|156876253|FG001|Part B|Physician Decision|0|||
48733681|NCT03633617|156876254|FG002|Part B|Physician Decision|0|||
48733682|NCT03633617|156876255|FG003|Part B|Physician Decision|0|||
48733683|NCT03633617|156876256|FG004|Part B|Physician Decision|1|||
48733684|NCT03633617|156876257|FG005|Part B|Physician Decision|0|||
48733685|NCT03633617|156876258|FG006|Part B|Physician Decision|0|||
48733686|NCT03633617|156876259|FG007|Part B|Physician Decision|0|||
48733687|NCT03633617|156876260|FG008|Part B|Physician Decision|0|||
48733688|NCT03633617|156876261|FG009|Part B|Physician Decision|0|||
48733689|NCT03633617|156876262|FG010|Part B|Physician Decision|0|||
48733690|NCT03633617|156876252|FG000|Part B|COVID-19 Restrictions|0|||
48733691|NCT03633617|156876253|FG001|Part B|COVID-19 Restrictions|0|||
48733692|NCT03633617|156876254|FG002|Part B|COVID-19 Restrictions|1|||
48733693|NCT03633617|156876255|FG003|Part B|COVID-19 Restrictions|0|||
48733694|NCT03633617|156876256|FG004|Part B|COVID-19 Restrictions|0|||
48733695|NCT03633617|156876257|FG005|Part B|COVID-19 Restrictions|0|||
48733696|NCT03633617|156876258|FG006|Part B|COVID-19 Restrictions|0|||
48733697|NCT03633617|156876259|FG007|Part B|COVID-19 Restrictions|0|||
48733698|NCT03633617|156876260|FG008|Part B|COVID-19 Restrictions|0|||
48733699|NCT03633617|156876261|FG009|Part B|COVID-19 Restrictions|0|||
48733700|NCT03633617|156876262|FG010|Part B|COVID-19 Restrictions|0|||
48733701|NCT03633617|156876252|FG000|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
48733702|NCT03633617|156876253|FG001|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
48733703|NCT03633617|156876254|FG002|Part B|Subject randomized, but did not receive study drug; did not qualify for study|1|||
48733704|NCT03633617|156876255|FG003|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
48733705|NCT03633617|156876256|FG004|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
48733706|NCT03633617|156876257|FG005|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
48733707|NCT03633617|156876258|FG006|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
48733708|NCT03633617|156876259|FG007|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
48733709|NCT03633617|156876260|FG008|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
48733710|NCT03633617|156876261|FG009|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
48733711|NCT03633617|156876262|FG010|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
49152894|NCT05014919|158400239|FG000|Open-Label (12 Weeks)|Lack of Efficacy|1|||
49152895|NCT05014919|158400240|FG001|Open-Label (12 Weeks)|Lack of Efficacy|0|||
49152896|NCT05014919|158400241|FG002|Open-Label (12 Weeks)|Lack of Efficacy|0|||
49152897|NCT05014919|158400239|FG000|Open-Label (12 Weeks)|Withdrawal by Subject|2|||
48825919|NCT00984282|157204035|FG000|Double Blind Treatment|Death|8|||
48825920|NCT00984282|157204036|FG001|Double Blind Treatment|Death|4|||
48825921|NCT00984282|157204035|FG000|Double Blind Treatment|Not treated|0|||
49152898|NCT05014919|158400240|FG001|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
49152899|NCT05014919|158400241|FG002|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
49152900|NCT05014919|158400239|FG000|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|15|||
49152901|NCT05014919|158400240|FG001|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
49152902|NCT05014919|158400241|FG002|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
49152903|NCT05014919|158400239|FG000|Open-Label (12 Weeks)|Sponsor Decision|4|||
49152904|NCT05014919|158400240|FG001|Open-Label (12 Weeks)|Sponsor Decision|0|||
49152905|NCT05014919|158400241|FG002|Open-Label (12 Weeks)|Sponsor Decision|0|||
49152906|NCT05014919|158400239|FG000|Open-Label (12 Weeks)|Study Terminated by Sponsor|5|||
49152907|NCT05014919|158400240|FG001|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
49152908|NCT05014919|158400241|FG002|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
49152909|NCT05014919|158400239|FG000|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
49152910|NCT05014919|158400240|FG001|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
49152911|NCT05014919|158400241|FG002|Double-Blind (26 Weeks)|Study Terminated by Sponsor|1|||
49152912|NCT05014919|158400239|FG000|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
49152913|NCT05014919|158400240|FG001|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
48825922|NCT00984282|157204036|FG001|Double Blind Treatment|Not treated|1|||
48825923|NCT00984282|157204035|FG000|Double Blind Treatment|Switched to commercial drug|6|||
48825924|NCT00984282|157204036|FG001|Double Blind Treatment|Switched to commercial drug|1|||
48825925|NCT00984282|157204035|FG000|Double Blind Treatment|protocol driven decision point|1|||
48825926|NCT00984282|157204036|FG001|Double Blind Treatment|protocol driven decision point|1|||
48825927|NCT00984282|157204035|FG000|Double Blind Treatment|Radiological and clinical progression|0|||
48825928|NCT00984282|157204036|FG001|Double Blind Treatment|Radiological and clinical progression|1|||
48825929|NCT00984282|157204035|FG000|Double Blind Treatment|Transferred to treat. continuation study|2|||
48825930|NCT00984282|157204036|FG001|Double Blind Treatment|Transferred to treat. continuation study|1|||
48825931|NCT00984282|157204035|FG000|Open-label Treatment|Adverse Event|20|||
48825932|NCT00984282|157204036|FG001|Open-label Treatment|Adverse Event|30|||
48825933|NCT00984282|157204035|FG000|Open-label Treatment|Withdrawal by Subject|6|||
48825934|NCT00984282|157204036|FG001|Open-label Treatment|Withdrawal by Subject|21|||
48825935|NCT00984282|157204035|FG000|Open-label Treatment|Death|7|||
48825936|NCT00984282|157204036|FG001|Open-label Treatment|Death|15|||
48825937|NCT00984282|157204035|FG000|Open-label Treatment|Progression, recurrence or relapse|40|||
48825938|NCT00984282|157204036|FG001|Open-label Treatment|Progression, recurrence or relapse|82|||
48825939|NCT00984282|157204035|FG000|Open-label Treatment|Lost to Follow-up|1|||
48825940|NCT00984282|157204036|FG001|Open-label Treatment|Lost to Follow-up|1|||
48825941|NCT00984282|157204035|FG000|Open-label Treatment|Patient convenience|1|||
48825942|NCT00984282|157204036|FG001|Open-label Treatment|Patient convenience|0|||
48825943|NCT00984282|157204035|FG000|Open-label Treatment|Non-compliant with study medication|1|||
48825944|NCT00984282|157204036|FG001|Open-label Treatment|Non-compliant with study medication|0|||
48825945|NCT00984282|157204035|FG000|Open-label Treatment|Target lesion removed|0|||
48825946|NCT00984282|157204036|FG001|Open-label Treatment|Target lesion removed|1|||
48825947|NCT00984282|157204035|FG000|Open-label Treatment|Protocol driven decision point|1|||
48825948|NCT00984282|157204036|FG001|Open-label Treatment|Protocol driven decision point|1|||
48825949|NCT00984282|157204035|FG000|Open-label Treatment|Transferred to treat. continuation study|2|||
48825950|NCT00984282|157204036|FG001|Open-label Treatment|Transferred to treat. continuation study|3|||
48825951|NCT00984282|157204035|FG000|Open-label Treatment|Switched to commercial drug|6|||
48825952|NCT00984282|157204036|FG001|Open-label Treatment|Switched to commercial drug|7|||
48825953|NCT00984282|157204035|FG000|Open-label Treatment|Physician Decision|1|||
48825954|NCT00984282|157204036|FG001|Open-label Treatment|Physician Decision|0|||
48825955|NCT00984282|157204035|FG000|Long Term Follow-up|Withdrawal by Subject|8|||
48825956|NCT00984282|157204036|FG001|Long Term Follow-up|Withdrawal by Subject|14|||
48825957|NCT00984282|157204035|FG000|Long Term Follow-up|Death|27|||
48825958|NCT00984282|157204036|FG001|Long Term Follow-up|Death|68|||
48825959|NCT00984282|157204035|FG000|Long Term Follow-up|Lost to Follow-up|3|||
48825960|NCT00984282|157204036|FG001|Long Term Follow-up|Lost to Follow-up|6|||
48825961|NCT00984282|157204035|FG000|Long Term Follow-up|Protocol driven decision point|25|||
48825962|NCT00984282|157204036|FG001|Long Term Follow-up|Protocol driven decision point|26|||
48825963|NCT00984282|157204035|FG000|Long Term Follow-up|Transferred to treat. continuation study|2|||
49152914|NCT05014919|158400241|FG002|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
48825964|NCT00984282|157204036|FG001|Long Term Follow-up|Transferred to treat. continuation study|3|||
48825965|NCT00984282|157204035|FG000|Long Term Follow-up|Switched to commercial drug|4|||
48825966|NCT00984282|157204036|FG001|Long Term Follow-up|Switched to commercial drug|2|||
48825967|NCT00984282|157204035|FG000|Long Term Follow-up|Disease prog., recurrence or relapse|0|||
49152915|NCT02657343|158400246|FG000|Overall Study|Death|0|||
49152916|NCT02657343|158400247|FG001|Overall Study|Death|2|||
49152917|NCT02657343|158400248|FG002|Overall Study|Death|0|||
49152918|NCT02657343|158400249|FG003|Overall Study|Death|0|||
49152919|NCT02657343|158400250|FG004|Overall Study|Death|0|||
49152920|NCT02657343|158400251|FG005|Overall Study|Death|0|||
49152921|NCT02657343|158400246|FG000|Overall Study|Patient went to hospice|1|||
49152922|NCT02657343|158400247|FG001|Overall Study|Patient went to hospice|0|||
49152923|NCT02657343|158400248|FG002|Overall Study|Patient went to hospice|0|||
48825968|NCT00984282|157204036|FG001|Long Term Follow-up|Disease prog., recurrence or relapse|1|||
48825969|NCT02223793|157204037|FG000|Overall Study|Lost to Follow-up|10|||
48825970|NCT02223793|157204038|FG001|Overall Study|Lost to Follow-up|1|||
48825971|NCT02223793|157204039|FG002|Overall Study|Lost to Follow-up|2|||
48825972|NCT02223793|157204037|FG000|Overall Study|Withdrawal by Subject|3|||
48825973|NCT02223793|157204038|FG001|Overall Study|Withdrawal by Subject|2|||
48825974|NCT02223793|157204039|FG002|Overall Study|Withdrawal by Subject|3|||
48825975|NCT02223793|157204037|FG000|Overall Study|Moved/studycenter unable to participate|4|||
48825976|NCT02223793|157204038|FG001|Overall Study|Moved/studycenter unable to participate|6|||
48825977|NCT02223793|157204039|FG002|Overall Study|Moved/studycenter unable to participate|8|||
48825978|NCT01244984|157204040|FG000|Overall Study|Adverse Event|2|||
48825979|NCT01244984|157204041|FG001|Overall Study|Adverse Event|11|||
48825980|NCT01244984|157204042|FG002|Overall Study|Adverse Event|2|||
48825981|NCT01244984|157204040|FG000|Overall Study|Protocol Violation|1|||
48825982|NCT01244984|157204041|FG001|Overall Study|Protocol Violation|0|||
48825983|NCT01244984|157204042|FG002|Overall Study|Protocol Violation|0|||
48825984|NCT01244984|157204040|FG000|Overall Study|Protocol Defined Stopping Criteria|1|||
48825985|NCT01244984|157204041|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
48825986|NCT01244984|157204042|FG002|Overall Study|Protocol Defined Stopping Criteria|0|||
48825987|NCT01244984|157204040|FG000|Overall Study|Withdrawal by Subject|1|||
49152924|NCT02657343|158400249|FG003|Overall Study|Patient went to hospice|0|||
49152925|NCT02657343|158400250|FG004|Overall Study|Patient went to hospice|0|||
48825988|NCT01244984|157204041|FG001|Overall Study|Withdrawal by Subject|2|||
48825989|NCT01244984|157204042|FG002|Overall Study|Withdrawal by Subject|2|||
48825990|NCT04577183|157204043|FG000|Overall Study|Death|1|||
48825991|NCT04577183|157204043|FG000|Overall Study|Withdrawal by Subject|3|||
48825992|NCT04577183|157204043|FG000|Overall Study|Early termination|2|||
48825993|NCT03566680|157204045|FG000|Overall Study|Pregnancy|1|||
48825994|NCT03566680|157204045|FG000|Overall Study|Lost to Follow-up|13|||
48825995|NCT03566680|157204045|FG000|Overall Study|Withdrawal by Subject|3|||
48825996|NCT00991276|157204049|FG000|First Intervention Period|Adverse Event|0|||
48825997|NCT00991276|157204050|FG001|First Intervention Period|Adverse Event|1|||
48825998|NCT00991276|157204051|FG002|First Intervention Period|Adverse Event|0|||
48825999|NCT00991276|157204052|FG003|First Intervention Period|Adverse Event|1|||
48826000|NCT00991276|157204053|FG004|First Intervention Period|Adverse Event|0|||
48826001|NCT00991276|157204054|FG005|First Intervention Period|Adverse Event|0|||
48826002|NCT00991276|157204049|FG000|First Intervention Period|Protocol Violation|0|||
49152926|NCT02657343|158400251|FG005|Overall Study|Patient went to hospice|0|||
49152927|NCT02657343|158400246|FG000|Overall Study|Withdrawal by Subject|0|||
49152928|NCT02657343|158400247|FG001|Overall Study|Withdrawal by Subject|0|||
49152929|NCT02657343|158400248|FG002|Overall Study|Withdrawal by Subject|0|||
49152930|NCT02657343|158400249|FG003|Overall Study|Withdrawal by Subject|0|||
49152931|NCT02657343|158400250|FG004|Overall Study|Withdrawal by Subject|1|||
49152932|NCT02657343|158400251|FG005|Overall Study|Withdrawal by Subject|0|||
49152933|NCT01979185|158400260|FG000|Period 2|Other|0|||
48826003|NCT00991276|157204050|FG001|First Intervention Period|Protocol Violation|0|||
48826004|NCT00991276|157204051|FG002|First Intervention Period|Protocol Violation|0|||
48826005|NCT00991276|157204052|FG003|First Intervention Period|Protocol Violation|0|||
49152934|NCT01979185|158400261|FG001|Period 2|Other|1|||
49152935|NCT01380080|158400262|FG000|Overall Study|Death|36|||
48921780|NCT01534533|157546489|FG003|Overall Study|Lost to Follow-up|3|||
48921781|NCT01534533|157546486|FG000|Overall Study|Withdrawal by Subject|5|||
49152936|NCT01380080|158400263|FG001|Overall Study|Death|44|||
49152937|NCT01380080|158400262|FG000|Overall Study|Site is closing|28|||
49152938|NCT01380080|158400263|FG001|Overall Study|Site is closing|31|||
48826006|NCT00991276|157204053|FG004|First Intervention Period|Protocol Violation|2|||
49152939|NCT01380080|158400262|FG000|Overall Study|Not able to get to clinic|7|||
48826007|NCT00991276|157204054|FG005|First Intervention Period|Protocol Violation|0|||
48826008|NCT00991276|157204049|FG000|First Intervention Period|Insufficient clinical response|0|||
48826009|NCT00991276|157204050|FG001|First Intervention Period|Insufficient clinical response|0|||
48826010|NCT00991276|157204051|FG002|First Intervention Period|Insufficient clinical response|0|||
48826011|NCT00991276|157204052|FG003|First Intervention Period|Insufficient clinical response|0|||
48826012|NCT00991276|157204053|FG004|First Intervention Period|Insufficient clinical response|1|||
48826013|NCT00991276|157204054|FG005|First Intervention Period|Insufficient clinical response|0|||
48826014|NCT00991276|157204049|FG000|First Intervention Period|Other|0|||
48826015|NCT00991276|157204050|FG001|First Intervention Period|Other|0|||
48826016|NCT00991276|157204051|FG002|First Intervention Period|Other|0|||
48826017|NCT00991276|157204052|FG003|First Intervention Period|Other|1|||
48826018|NCT00991276|157204053|FG004|First Intervention Period|Other|1|||
48826019|NCT00991276|157204054|FG005|First Intervention Period|Other|0|||
48826020|NCT00991276|157204049|FG000|First Intervention Period|Withdrawal by Subject|0|||
48826021|NCT00991276|157204050|FG001|First Intervention Period|Withdrawal by Subject|1|||
48826022|NCT00991276|157204051|FG002|First Intervention Period|Withdrawal by Subject|0|||
48826023|NCT00991276|157204052|FG003|First Intervention Period|Withdrawal by Subject|1|||
48826024|NCT00991276|157204053|FG004|First Intervention Period|Withdrawal by Subject|0|||
48826025|NCT00991276|157204054|FG005|First Intervention Period|Withdrawal by Subject|1|||
48826026|NCT00991276|157204049|FG000|First Intervention Period|Lost to Follow-up|0|||
48826027|NCT00991276|157204050|FG001|First Intervention Period|Lost to Follow-up|1|||
48826028|NCT00991276|157204051|FG002|First Intervention Period|Lost to Follow-up|0|||
48826029|NCT00991276|157204052|FG003|First Intervention Period|Lost to Follow-up|1|||
49014194|NCT04345471|157887307|FG002|Overall Study|Protocol Violation|2|||
49014195|NCT04345471|157887305|FG000|Overall Study|Withdrawal by Subject|10|||
49014196|NCT04345471|157887306|FG001|Overall Study|Withdrawal by Subject|5|||
49014197|NCT04345471|157887307|FG002|Overall Study|Withdrawal by Subject|10|||
49014198|NCT02415959|157887308|FG000|Overall Study|Adverse Event|0|||
49014199|NCT02415959|157887309|FG001|Overall Study|Adverse Event|1|||
49014200|NCT02415959|157887310|FG002|Overall Study|Adverse Event|0|||
49014201|NCT02415959|157887311|FG003|Overall Study|Adverse Event|0|||
49014202|NCT02415959|157887312|FG004|Overall Study|Adverse Event|0|||
49014203|NCT02415959|157887308|FG000|Overall Study|Protocol Violation|0|||
49014204|NCT02415959|157887309|FG001|Overall Study|Protocol Violation|0|||
49014205|NCT02415959|157887310|FG002|Overall Study|Protocol Violation|0|||
49014206|NCT02415959|157887311|FG003|Overall Study|Protocol Violation|1|||
49014207|NCT02415959|157887312|FG004|Overall Study|Protocol Violation|0|||
49014208|NCT00669955|157887313|FG000|Overall Study|Adverse Event|3|||
49014209|NCT00669955|157887314|FG001|Overall Study|Adverse Event|5|||
49014210|NCT00669955|157887313|FG000|Overall Study|Death|0|||
49014211|NCT00669955|157887314|FG001|Overall Study|Death|1|||
49014212|NCT00669955|157887313|FG000|Overall Study|Withdrawal by Subject|2|||
49014213|NCT00669955|157887314|FG001|Overall Study|Withdrawal by Subject|3|||
49014214|NCT00669955|157887313|FG000|Overall Study|Lost to Follow-up|5|||
49014215|NCT00669955|157887314|FG001|Overall Study|Lost to Follow-up|7|||
49014216|NCT00669955|157887313|FG000|Overall Study|Protocol Violation|2|||
49014217|NCT00669955|157887314|FG001|Overall Study|Protocol Violation|7|||
49014218|NCT00669955|157887313|FG000|Overall Study|Investigator Sponsor Judgement|0|||
49014219|NCT00669955|157887314|FG001|Overall Study|Investigator Sponsor Judgement|1|||
49014220|NCT00669955|157887313|FG000|Overall Study|not compliant with study drug/visit|2|||
49014221|NCT00669955|157887314|FG001|Overall Study|not compliant with study drug/visit|3|||
49014222|NCT00752856|157887315|FG000|Overall Study|randomized but did not do viral kinetics|0|||
49014223|NCT00752856|157887316|FG001|Overall Study|randomized but did not do viral kinetics|1|||
49014224|NCT02260492|157887317|FG000|Overall Study|Adverse Event|6|||
49014225|NCT02260492|157887318|FG001|Overall Study|Adverse Event|1|||
49014226|NCT02260492|157887319|FG002|Overall Study|Adverse Event|2|||
49014227|NCT02260492|157887317|FG000|Overall Study|Death|0|||
49014228|NCT02260492|157887318|FG001|Overall Study|Death|1|||
49014229|NCT02260492|157887319|FG002|Overall Study|Death|0|||
49014230|NCT02260492|157887317|FG000|Overall Study|Lost to Follow-up|12|||
49014231|NCT02260492|157887318|FG001|Overall Study|Lost to Follow-up|9|||
49014232|NCT02260492|157887319|FG002|Overall Study|Lost to Follow-up|0|||
49014233|NCT02260492|157887317|FG000|Overall Study|Physician Decision|2|||
49014234|NCT02260492|157887318|FG001|Overall Study|Physician Decision|0|||
49014235|NCT02260492|157887319|FG002|Overall Study|Physician Decision|1|||
49014236|NCT02260492|157887317|FG000|Overall Study|Withdrawal by Subject|3|||
49014237|NCT02260492|157887318|FG001|Overall Study|Withdrawal by Subject|2|||
49014238|NCT02260492|157887319|FG002|Overall Study|Withdrawal by Subject|2|||
49014239|NCT03131999|157887320|FG000|Overall Study|Withdrawal by Subject|0|||
49014240|NCT03131999|157887321|FG001|Overall Study|Withdrawal by Subject|1|||
49014241|NCT01415921|157888771|FG000|Overall Study|Adverse Event|0|||
49014242|NCT01415921|157888772|FG001|Overall Study|Adverse Event|1|||
49014243|NCT01415921|157888771|FG000|Overall Study|Physician Decision|1|||
49014244|NCT01415921|157888772|FG001|Overall Study|Physician Decision|1|||
49014245|NCT01415921|157888771|FG000|Overall Study|Withdrawal by Subject|0|||
49014246|NCT01415921|157888772|FG001|Overall Study|Withdrawal by Subject|1|||
49014247|NCT01415921|157888771|FG000|Overall Study|Other|2|||
49014248|NCT01415921|157888772|FG001|Overall Study|Other|0|||
49014249|NCT01960816|157888795|FG000|Overall Study|Lost to Follow-up|1|||
49014250|NCT01703741|157888796|FG000|Overall Study|Withdrawal by Subject|6|||
49152940|NCT01380080|158400263|FG001|Overall Study|Not able to get to clinic|1|||
49152941|NCT01380080|158400262|FG000|Overall Study|Not willing to adhere to requirements|6|||
49152942|NCT01380080|158400263|FG001|Overall Study|Not willing to adhere to requirements|2|||
49152943|NCT01380080|158400262|FG000|Overall Study|Withdrawal by Subject|5|||
49152944|NCT01380080|158400263|FG001|Overall Study|Withdrawal by Subject|2|||
49152945|NCT01380080|158400262|FG000|Overall Study|Lost to Follow-up|3|||
49152946|NCT01380080|158400263|FG001|Overall Study|Lost to Follow-up|3|||
49152947|NCT02135133|158400264|FG000|Overall Study|Adverse Event|10|||
49152948|NCT02135133|158400264|FG000|Overall Study|regulatory mandate|5|||
49152949|NCT00847730|158400268|FG000|Overall Study|Multiple interruptions in therapy|8|||
48826030|NCT00991276|157204053|FG004|First Intervention Period|Lost to Follow-up|0|||
48826031|NCT00991276|157204054|FG005|First Intervention Period|Lost to Follow-up|0|||
48826032|NCT00991276|157204049|FG000|Second Intervention Period|Adverse Event|0|||
48826033|NCT00991276|157204050|FG001|Second Intervention Period|Adverse Event|2|||
49152950|NCT00071032|158400269|FG000|Overall Study|Lost to Follow-up|1|||
49152951|NCT00071032|158400270|FG001|Overall Study|Lost to Follow-up|1|||
49152952|NCT00071032|158400269|FG000|Overall Study|Withdrawal by Subject|8|||
48826034|NCT00991276|157204051|FG002|Second Intervention Period|Adverse Event|0|||
48826035|NCT00991276|157204052|FG003|Second Intervention Period|Adverse Event|1|||
48826036|NCT00991276|157204053|FG004|Second Intervention Period|Adverse Event|1|||
48826037|NCT00991276|157204054|FG005|Second Intervention Period|Adverse Event|0|||
48826038|NCT00991276|157204049|FG000|Second Intervention Period|Protocol Violation|1|||
48826039|NCT00991276|157204050|FG001|Second Intervention Period|Protocol Violation|0|||
48826040|NCT00991276|157204051|FG002|Second Intervention Period|Protocol Violation|0|||
48826041|NCT00991276|157204052|FG003|Second Intervention Period|Protocol Violation|0|||
49152953|NCT00071032|158400270|FG001|Overall Study|Withdrawal by Subject|6|||
49152954|NCT00071032|158400269|FG000|Overall Study|Missing Primary Outcome|0|||
49152955|NCT00071032|158400270|FG001|Overall Study|Missing Primary Outcome|1|||
49152956|NCT02185768|158400271|FG000|Overall Study|Patients were not treated|2|||
49152957|NCT01889251|158400273|FG000|Overall Study|Adverse Event|1|||
49152958|NCT01889251|158400274|FG001|Overall Study|Adverse Event|0|||
49152959|NCT02936323|158400275|FG000|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
49152960|NCT02936323|158400276|FG001|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
49152961|NCT02936323|158400277|FG002|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
49152962|NCT02936323|158400278|FG003|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
49152963|NCT02936323|158400279|FG004|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
49152964|NCT02936323|158400280|FG005|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
49152965|NCT02936323|158400281|FG006|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
49152966|NCT02936323|158400282|FG007|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
49152967|NCT02936323|158400283|FG008|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
49152968|NCT02936323|158400284|FG009|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
49152969|NCT02936323|158400275|FG000|Phase 1 Dose Escalation|Death|2|||
49152970|NCT02936323|158400276|FG001|Phase 1 Dose Escalation|Death|1|||
49152971|NCT02936323|158400277|FG002|Phase 1 Dose Escalation|Death|3|||
49152972|NCT02936323|158400278|FG003|Phase 1 Dose Escalation|Death|1|||
49152973|NCT02936323|158400279|FG004|Phase 1 Dose Escalation|Death|2|||
49152974|NCT02936323|158400280|FG005|Phase 1 Dose Escalation|Death|3|||
49152975|NCT02936323|158400281|FG006|Phase 1 Dose Escalation|Death|3|||
49152976|NCT02936323|158400282|FG007|Phase 1 Dose Escalation|Death|0|||
49152977|NCT02936323|158400283|FG008|Phase 1 Dose Escalation|Death|0|||
49152978|NCT02936323|158400284|FG009|Phase 1 Dose Escalation|Death|0|||
49152979|NCT02936323|158400275|FG000|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
49152980|NCT02936323|158400276|FG001|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
49152981|NCT02936323|158400277|FG002|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
48826042|NCT00991276|157204053|FG004|Second Intervention Period|Protocol Violation|0|||
48826043|NCT00991276|157204054|FG005|Second Intervention Period|Protocol Violation|0|||
48826044|NCT00991276|157204049|FG000|Second Intervention Period|Other|0|||
49152982|NCT02936323|158400278|FG003|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
49152983|NCT02936323|158400279|FG004|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
49152984|NCT02936323|158400280|FG005|Phase 1 Dose Escalation|Study Discontinued at Site|1|||
49152985|NCT02936323|158400281|FG006|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
49152986|NCT02936323|158400282|FG007|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
49152987|NCT02936323|158400283|FG008|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
49152988|NCT02936323|158400284|FG009|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
49152989|NCT02936323|158400275|FG000|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
49152990|NCT02936323|158400276|FG001|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
49152991|NCT02936323|158400277|FG002|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
49152992|NCT02936323|158400278|FG003|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
49152993|NCT02936323|158400279|FG004|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
49152994|NCT02936323|158400280|FG005|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
49152995|NCT02936323|158400281|FG006|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
49152996|NCT02936323|158400282|FG007|Phase 2a Dose Expansion|Informed Consent Withdrawn|11|||
49152997|NCT02936323|158400283|FG008|Phase 2a Dose Expansion|Informed Consent Withdrawn|4|||
49152998|NCT02936323|158400284|FG009|Phase 2a Dose Expansion|Informed Consent Withdrawn|2|||
49152999|NCT02936323|158400275|FG000|Phase 2a Dose Expansion|Physician Decision|0|||
49153000|NCT02936323|158400276|FG001|Phase 2a Dose Expansion|Physician Decision|0|||
49153001|NCT02936323|158400277|FG002|Phase 2a Dose Expansion|Physician Decision|0|||
49153002|NCT02936323|158400278|FG003|Phase 2a Dose Expansion|Physician Decision|0|||
49153003|NCT02936323|158400279|FG004|Phase 2a Dose Expansion|Physician Decision|0|||
49153004|NCT02936323|158400280|FG005|Phase 2a Dose Expansion|Physician Decision|0|||
49153005|NCT02936323|158400281|FG006|Phase 2a Dose Expansion|Physician Decision|0|||
49153006|NCT02936323|158400282|FG007|Phase 2a Dose Expansion|Physician Decision|0|||
49153007|NCT02936323|158400283|FG008|Phase 2a Dose Expansion|Physician Decision|0|||
49153008|NCT02936323|158400284|FG009|Phase 2a Dose Expansion|Physician Decision|1|||
49153009|NCT02936323|158400275|FG000|Phase 2a Dose Expansion|Lost to Follow-up|0|||
49153010|NCT02936323|158400276|FG001|Phase 2a Dose Expansion|Lost to Follow-up|0|||
49153011|NCT02936323|158400277|FG002|Phase 2a Dose Expansion|Lost to Follow-up|0|||
49153012|NCT02936323|158400278|FG003|Phase 2a Dose Expansion|Lost to Follow-up|0|||
49153013|NCT02936323|158400279|FG004|Phase 2a Dose Expansion|Lost to Follow-up|0|||
49153014|NCT02936323|158400280|FG005|Phase 2a Dose Expansion|Lost to Follow-up|0|||
49153015|NCT02936323|158400281|FG006|Phase 2a Dose Expansion|Lost to Follow-up|0|||
49153016|NCT02936323|158400282|FG007|Phase 2a Dose Expansion|Lost to Follow-up|2|||
49153017|NCT02936323|158400283|FG008|Phase 2a Dose Expansion|Lost to Follow-up|1|||
49153018|NCT02936323|158400284|FG009|Phase 2a Dose Expansion|Lost to Follow-up|0|||
49153019|NCT02936323|158400275|FG000|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
49153020|NCT02936323|158400276|FG001|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
49153021|NCT02936323|158400277|FG002|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
49153022|NCT02936323|158400278|FG003|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
49153023|NCT02936323|158400279|FG004|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
48826045|NCT00991276|157204050|FG001|Second Intervention Period|Other|0|||
48826046|NCT00991276|157204051|FG002|Second Intervention Period|Other|0|||
48826047|NCT00991276|157204052|FG003|Second Intervention Period|Other|1|||
48826048|NCT00991276|157204053|FG004|Second Intervention Period|Other|0|||
48826049|NCT00991276|157204054|FG005|Second Intervention Period|Other|1|||
48826050|NCT00991276|157204049|FG000|Third Intervention Period|Protocol Violation|1|||
48826051|NCT00991276|157204050|FG001|Third Intervention Period|Protocol Violation|0|||
48826052|NCT00991276|157204051|FG002|Third Intervention Period|Protocol Violation|0|||
48826053|NCT00991276|157204052|FG003|Third Intervention Period|Protocol Violation|0|||
48826054|NCT00991276|157204053|FG004|Third Intervention Period|Protocol Violation|0|||
48826055|NCT00991276|157204054|FG005|Third Intervention Period|Protocol Violation|0|||
48826056|NCT00991276|157204049|FG000|Third Intervention Period|Other|0|||
48826057|NCT00991276|157204050|FG001|Third Intervention Period|Other|0|||
48826058|NCT00991276|157204051|FG002|Third Intervention Period|Other|0|||
48826059|NCT00991276|157204052|FG003|Third Intervention Period|Other|0|||
48826060|NCT00991276|157204053|FG004|Third Intervention Period|Other|0|||
48826061|NCT00991276|157204054|FG005|Third Intervention Period|Other|1|||
48826062|NCT00991276|157204049|FG000|Third Intervention Period|Adverse Event|0|||
48826063|NCT00991276|157204050|FG001|Third Intervention Period|Adverse Event|0|||
48826064|NCT00991276|157204051|FG002|Third Intervention Period|Adverse Event|1|||
48826065|NCT00991276|157204052|FG003|Third Intervention Period|Adverse Event|0|||
48826066|NCT00991276|157204053|FG004|Third Intervention Period|Adverse Event|0|||
48826067|NCT00991276|157204054|FG005|Third Intervention Period|Adverse Event|0|||
48826068|NCT00991276|157204049|FG000|Third Intervention Period|Withdrawal by Subject|0|||
48826069|NCT00991276|157204050|FG001|Third Intervention Period|Withdrawal by Subject|0|||
48826070|NCT00991276|157204051|FG002|Third Intervention Period|Withdrawal by Subject|0|||
48826071|NCT00991276|157204052|FG003|Third Intervention Period|Withdrawal by Subject|1|||
48826072|NCT00991276|157204053|FG004|Third Intervention Period|Withdrawal by Subject|0|||
48826073|NCT00991276|157204054|FG005|Third Intervention Period|Withdrawal by Subject|0|||
48826074|NCT00425503|157204055|FG000|Overall Study|Adverse Event|2|||
48826075|NCT00425503|157204055|FG000|Overall Study|Protocol Violation|1|||
48826076|NCT01720043|157204060|FG000|Overall Study|Withdrawal by Subject|1|||
48826077|NCT01688973|157204061|FG000|Overall Study|Ineligible|2|||
48826078|NCT01688973|157204062|FG001|Overall Study|Ineligible|3|||
48733712|NCT03633617|156876252|FG000|Part C (& Follow-up)|Adverse Event|0|||
48733713|NCT03633617|156876253|FG001|Part C (& Follow-up)|Adverse Event|0|||
48733714|NCT03633617|156876254|FG002|Part C (& Follow-up)|Adverse Event|0|||
48733715|NCT03633617|156876255|FG003|Part C (& Follow-up)|Adverse Event|0|||
48733716|NCT03633617|156876256|FG004|Part C (& Follow-up)|Adverse Event|0|||
48733717|NCT03633617|156876257|FG005|Part C (& Follow-up)|Adverse Event|1|||
48733718|NCT03633617|156876258|FG006|Part C (& Follow-up)|Adverse Event|0|||
48733719|NCT03633617|156876259|FG007|Part C (& Follow-up)|Adverse Event|1|||
48733720|NCT03633617|156876260|FG008|Part C (& Follow-up)|Adverse Event|0|||
48733721|NCT03633617|156876261|FG009|Part C (& Follow-up)|Adverse Event|0|||
48733722|NCT03633617|156876262|FG010|Part C (& Follow-up)|Adverse Event|0|||
48733723|NCT03633617|156876252|FG000|Part C (& Follow-up)|Pregnancy|0|||
48733724|NCT03633617|156876253|FG001|Part C (& Follow-up)|Pregnancy|0|||
48733725|NCT03633617|156876254|FG002|Part C (& Follow-up)|Pregnancy|0|||
48733726|NCT03633617|156876255|FG003|Part C (& Follow-up)|Pregnancy|0|||
48733727|NCT03633617|156876256|FG004|Part C (& Follow-up)|Pregnancy|0|||
48733728|NCT03633617|156876257|FG005|Part C (& Follow-up)|Pregnancy|0|||
48733729|NCT03633617|156876258|FG006|Part C (& Follow-up)|Pregnancy|0|||
48733730|NCT03633617|156876259|FG007|Part C (& Follow-up)|Pregnancy|0|||
48733731|NCT03633617|156876260|FG008|Part C (& Follow-up)|Pregnancy|0|||
48733732|NCT03633617|156876261|FG009|Part C (& Follow-up)|Pregnancy|1|||
48733733|NCT03633617|156876262|FG010|Part C (& Follow-up)|Pregnancy|0|||
48733734|NCT03633617|156876252|FG000|Part C (& Follow-up)|Withdrawal by Subject|0|||
48826079|NCT00335153|157204063|FG000|Nasojejunal (NJ) Test Period|Adverse Event|5|||
48826080|NCT00335153|157204063|FG000|Nasojejunal (NJ) Test Period|Lack of Efficacy|5|||
48826081|NCT00335153|157204063|FG000|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12|||
48826082|NCT00335153|157204063|FG000|Nasojejunal (NJ) Test Period|Administrative|1|||
48826083|NCT00335153|157204063|FG000|Nasojejunal (NJ) Test Period|Protocol Violation|7|||
49153024|NCT02936323|158400280|FG005|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
49153025|NCT02936323|158400281|FG006|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
49153026|NCT02936323|158400282|FG007|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
49153027|NCT02936323|158400283|FG008|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
49153028|NCT02936323|158400284|FG009|Phase 2a Dose Expansion|Change(s) to patient's condition|1|||
48733735|NCT03633617|156876253|FG001|Part C (& Follow-up)|Withdrawal by Subject|0|||
48733736|NCT03633617|156876254|FG002|Part C (& Follow-up)|Withdrawal by Subject|0|||
48733737|NCT03633617|156876255|FG003|Part C (& Follow-up)|Withdrawal by Subject|0|||
48733738|NCT03633617|156876256|FG004|Part C (& Follow-up)|Withdrawal by Subject|0|||
48733739|NCT03633617|156876257|FG005|Part C (& Follow-up)|Withdrawal by Subject|2|||
48826084|NCT00335153|157204063|FG000|Post-PEG-J Long-Term Treatment Period|Adverse Event|22|||
48826085|NCT00335153|157204063|FG000|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2|||
48826086|NCT00335153|157204063|FG000|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13|||
48826087|NCT00335153|157204063|FG000|Post-PEG-J Long-Term Treatment Period|Administrative|13|||
48826088|NCT00335153|157204063|FG000|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2|||
48826089|NCT01417000|157204064|FG000|Overall Study|Death|59|||
48826090|NCT01417000|157204065|FG001|Overall Study|Death|28|||
48826091|NCT01417000|157204064|FG000|Overall Study|Lost to Follow-up|1|||
48826092|NCT01417000|157204065|FG001|Overall Study|Lost to Follow-up|0|||
48826093|NCT01417000|157204064|FG000|Overall Study|Study Terminated by Sponsor|1|||
48826094|NCT01417000|157204065|FG001|Overall Study|Study Terminated by Sponsor|1|||
48826095|NCT03111095|157204066|FG000|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|3|||
48826096|NCT03111095|157204067|FG001|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|0|||
48826097|NCT03111095|157204066|FG000|Aims 2-5: Intervention|Withdrawal by Subject|19|||
48826098|NCT03111095|157204067|FG001|Aims 2-5: Intervention|Withdrawal by Subject|0|||
48826099|NCT01648283|157204068|FG000|Overall Study|Withdrawal by Subject|14|||
48826100|NCT04889118|157204069|FG000|Overall Study|Death|33|||
48826101|NCT04889118|157204070|FG001|Overall Study|Death|37|||
48826102|NCT04889118|157204069|FG000|Overall Study|Ongoing in Study|31|||
48826103|NCT04889118|157204070|FG001|Overall Study|Ongoing in Study|30|||
48826104|NCT02825043|157204073|FG000|Overall Study|Lost to Follow-up|4|||
48826105|NCT00558753|157204078|FG000|Overall Study|Lost to Follow-up|5|||
48826106|NCT00558753|157204079|FG001|Overall Study|Lost to Follow-up|7|||
48826107|NCT00601640|157204082|FG000|Overall Study|Withdrawal by Subject|3|||
48826108|NCT00601640|157204083|FG001|Overall Study|Withdrawal by Subject|0|||
48826109|NCT00601640|157204084|FG002|Overall Study|Withdrawal by Subject|7|||
48826110|NCT00601640|157204082|FG000|Overall Study|Death|1|||
48826111|NCT00601640|157204083|FG001|Overall Study|Death|0|||
48826112|NCT00601640|157204084|FG002|Overall Study|Death|0|||
48826113|NCT00601640|157204082|FG000|Overall Study|Adverse Event|0|||
48826114|NCT00601640|157204083|FG001|Overall Study|Adverse Event|4|||
48826115|NCT00601640|157204084|FG002|Overall Study|Adverse Event|2|||
48826116|NCT00601640|157204082|FG000|Overall Study|intercurrent illness|1|||
48826117|NCT00601640|157204083|FG001|Overall Study|intercurrent illness|0|||
48826118|NCT00601640|157204084|FG002|Overall Study|intercurrent illness|0|||
48826119|NCT00601640|157204082|FG000|Overall Study|change in eligibility status|0|||
48826120|NCT00601640|157204083|FG001|Overall Study|change in eligibility status|1|||
48733740|NCT03633617|156876258|FG006|Part C (& Follow-up)|Withdrawal by Subject|2|||
48733741|NCT03633617|156876259|FG007|Part C (& Follow-up)|Withdrawal by Subject|0|||
48733742|NCT03633617|156876260|FG008|Part C (& Follow-up)|Withdrawal by Subject|1|||
48733743|NCT03633617|156876261|FG009|Part C (& Follow-up)|Withdrawal by Subject|1|||
48733744|NCT03633617|156876262|FG010|Part C (& Follow-up)|Withdrawal by Subject|6|||
48733745|NCT03633617|156876252|FG000|Part C (& Follow-up)|Lost to Follow-up|0|||
48733746|NCT03633617|156876253|FG001|Part C (& Follow-up)|Lost to Follow-up|0|||
48733747|NCT03633617|156876254|FG002|Part C (& Follow-up)|Lost to Follow-up|0|||
48733748|NCT03633617|156876255|FG003|Part C (& Follow-up)|Lost to Follow-up|0|||
48733749|NCT03633617|156876256|FG004|Part C (& Follow-up)|Lost to Follow-up|0|||
48733750|NCT03633617|156876257|FG005|Part C (& Follow-up)|Lost to Follow-up|3|||
48733751|NCT03633617|156876258|FG006|Part C (& Follow-up)|Lost to Follow-up|3|||
48733752|NCT03633617|156876259|FG007|Part C (& Follow-up)|Lost to Follow-up|1|||
48733753|NCT03633617|156876260|FG008|Part C (& Follow-up)|Lost to Follow-up|0|||
48826121|NCT00601640|157204084|FG002|Overall Study|change in eligibility status|1|||
48826122|NCT00530777|157204085|FG000|Overall Study|Lost to Follow-up|0|||
48826123|NCT00530777|157204086|FG001|Overall Study|Lost to Follow-up|1|||
48826124|NCT00530777|157204085|FG000|Overall Study|Death|1|||
48826125|NCT00530777|157204086|FG001|Overall Study|Death|2|||
48826126|NCT00530777|157204085|FG000|Overall Study|Physician Decision|1|||
48826127|NCT00530777|157204086|FG001|Overall Study|Physician Decision|0|||
48826128|NCT00530777|157204085|FG000|Overall Study|Withdrawal by Subject|0|||
48826129|NCT00530777|157204086|FG001|Overall Study|Withdrawal by Subject|1|||
48826130|NCT00530777|157204085|FG000|Overall Study|Unable to adhere to visit schedule|5|||
48826131|NCT00530777|157204086|FG001|Overall Study|Unable to adhere to visit schedule|1|||
48826132|NCT00282438|157204089|FG000|Overall Study|Lack of Efficacy|1|||
48826133|NCT00282438|157204090|FG001|Overall Study|Lack of Efficacy|0|||
48826134|NCT00282438|157204089|FG000|Overall Study|Death|0|||
48826135|NCT00282438|157204090|FG001|Overall Study|Death|1|||
48826136|NCT03686384|157204091|FG000|Overall Study|Lack of Efficacy|4|||
48826137|NCT03686384|157204092|FG001|Overall Study|Lack of Efficacy|13|||
48826138|NCT03686384|157204091|FG000|Overall Study|Lost to Follow-up|3|||
49153029|NCT02936323|158400275|FG000|Phase 2a Dose Expansion|Death|0|||
49153030|NCT02936323|158400276|FG001|Phase 2a Dose Expansion|Death|0|||
49153031|NCT02936323|158400277|FG002|Phase 2a Dose Expansion|Death|0|||
49153032|NCT02936323|158400278|FG003|Phase 2a Dose Expansion|Death|0|||
49153033|NCT02936323|158400279|FG004|Phase 2a Dose Expansion|Death|0|||
49153034|NCT02936323|158400280|FG005|Phase 2a Dose Expansion|Death|0|||
49153035|NCT02936323|158400281|FG006|Phase 2a Dose Expansion|Death|0|||
49153036|NCT02936323|158400282|FG007|Phase 2a Dose Expansion|Death|4|||
49153037|NCT02936323|158400283|FG008|Phase 2a Dose Expansion|Death|8|||
48733754|NCT03633617|156876261|FG009|Part C (& Follow-up)|Lost to Follow-up|7|||
48733755|NCT03633617|156876262|FG010|Part C (& Follow-up)|Lost to Follow-up|2|||
48733756|NCT03633617|156876252|FG000|Part C (& Follow-up)|Physician Decision|0|||
48733757|NCT03633617|156876253|FG001|Part C (& Follow-up)|Physician Decision|0|||
48733758|NCT03633617|156876254|FG002|Part C (& Follow-up)|Physician Decision|0|||
48733759|NCT03633617|156876255|FG003|Part C (& Follow-up)|Physician Decision|0|||
48733760|NCT03633617|156876256|FG004|Part C (& Follow-up)|Physician Decision|0|||
48733761|NCT03633617|156876257|FG005|Part C (& Follow-up)|Physician Decision|0|||
48733762|NCT03633617|156876258|FG006|Part C (& Follow-up)|Physician Decision|0|||
48733763|NCT03633617|156876259|FG007|Part C (& Follow-up)|Physician Decision|1|||
48733764|NCT03633617|156876260|FG008|Part C (& Follow-up)|Physician Decision|0|||
48733765|NCT03633617|156876261|FG009|Part C (& Follow-up)|Physician Decision|0|||
48733766|NCT03633617|156876262|FG010|Part C (& Follow-up)|Physician Decision|1|||
48733767|NCT03633617|156876252|FG000|Part C (& Follow-up)|COVID-19 related|0|||
48733768|NCT03633617|156876253|FG001|Part C (& Follow-up)|COVID-19 related|0|||
48733769|NCT03633617|156876254|FG002|Part C (& Follow-up)|COVID-19 related|0|||
48733770|NCT03633617|156876255|FG003|Part C (& Follow-up)|COVID-19 related|0|||
48733771|NCT03633617|156876256|FG004|Part C (& Follow-up)|COVID-19 related|0|||
48733772|NCT03633617|156876257|FG005|Part C (& Follow-up)|COVID-19 related|1|||
48733773|NCT03633617|156876258|FG006|Part C (& Follow-up)|COVID-19 related|0|||
48826139|NCT03686384|157204092|FG001|Overall Study|Lost to Follow-up|0|||
48826140|NCT03686384|157204091|FG000|Overall Study|Physician Decision|0|||
48826141|NCT03686384|157204092|FG001|Overall Study|Physician Decision|1|||
48826142|NCT03686384|157204091|FG000|Overall Study|Took prohibited medication|0|||
48826143|NCT03686384|157204092|FG001|Overall Study|Took prohibited medication|1|||
48826144|NCT03168438|157204094|FG000|Overall Study|Long term follow-up declined, study terminated by sponsor|0|||
48826145|NCT03168438|157204095|FG001|Overall Study|Long term follow-up declined, study terminated by sponsor|1|||
49153038|NCT02936323|158400284|FG009|Phase 2a Dose Expansion|Death|10|||
49153039|NCT05309291|158400287|FG000|Overall Study|Adverse Event|0|||
49153040|NCT05309291|158400288|FG001|Overall Study|Adverse Event|1|||
49153041|NCT02919618|158401927|FG000|Overall Study|Death|1|||
48733774|NCT03633617|156876259|FG007|Part C (& Follow-up)|COVID-19 related|0|||
48826146|NCT02939183|157204098|FG000|Overall Study|Death|0|||
49153042|NCT06136897|158401928|FG000|Overall Study|Ineligible|3|||
48733775|NCT03633617|156876260|FG008|Part C (& Follow-up)|COVID-19 related|0|||
48733776|NCT03633617|156876261|FG009|Part C (& Follow-up)|COVID-19 related|0|||
48733777|NCT03633617|156876262|FG010|Part C (& Follow-up)|COVID-19 related|0|||
48733778|NCT03633617|156876252|FG000|Part C (& Follow-up)|Protocol Violation|0|||
48733779|NCT03633617|156876253|FG001|Part C (& Follow-up)|Protocol Violation|0|||
48733780|NCT03633617|156876254|FG002|Part C (& Follow-up)|Protocol Violation|0|||
48733781|NCT03633617|156876255|FG003|Part C (& Follow-up)|Protocol Violation|0|||
48826147|NCT02939183|157204099|FG001|Overall Study|Death|0|||
48826148|NCT02939183|157204100|FG002|Overall Study|Death|1|||
48826149|NCT02939183|157204101|FG003|Overall Study|Death|0|||
48826150|NCT02939183|157204102|FG004|Overall Study|Death|0|||
48826151|NCT02939183|157204103|FG005|Overall Study|Death|2|||
48826152|NCT02939183|157204104|FG006|Overall Study|Death|1|||
48921782|NCT01534533|157546487|FG001|Overall Study|Withdrawal by Subject|3|||
48921783|NCT01534533|157546488|FG002|Overall Study|Withdrawal by Subject|4|||
48921784|NCT01534533|157546489|FG003|Overall Study|Withdrawal by Subject|1|||
48921785|NCT02484911|157548011|FG000|Overall Study|Withdrawal by Subject|2|||
48921786|NCT02484911|157548012|FG001|Overall Study|Withdrawal by Subject|1|||
48921787|NCT02484911|157548011|FG000|Overall Study|Protocol Violation|2|||
48921788|NCT02484911|157548012|FG001|Overall Study|Protocol Violation|1|||
48921789|NCT02325219|157548019|FG000|Controlled Period (Week 0 - 16)|Adverse Event|6|||
48921790|NCT02325219|157548020|FG001|Controlled Period (Week 0 - 16)|Adverse Event|1|||
48921791|NCT02325219|157548021|FG002|Controlled Period (Week 0 - 16)|Adverse Event|0|||
48921792|NCT02325219|157548022|FG003|Controlled Period (Week 0 - 16)|Adverse Event|0|||
48921793|NCT02325219|157548023|FG004|Controlled Period (Week 0 - 16)|Adverse Event|0|||
48921794|NCT02325219|157548019|FG000|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6|||
48921795|NCT02325219|157548020|FG001|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
48921796|NCT02325219|157548021|FG002|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
48921797|NCT02325219|157548022|FG003|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
48826153|NCT02939183|157204105|FG007|Overall Study|Death|0|||
48826154|NCT02939183|157204106|FG008|Overall Study|Death|0|||
48921798|NCT02325219|157548023|FG004|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
48921799|NCT02325219|157548019|FG000|Controlled Period (Week 0 - 16)|Other|0|||
48921800|NCT02325219|157548020|FG001|Controlled Period (Week 0 - 16)|Other|0|||
48921801|NCT02325219|157548021|FG002|Controlled Period (Week 0 - 16)|Other|1|||
48921802|NCT02325219|157548022|FG003|Controlled Period (Week 0 - 16)|Other|0|||
48921803|NCT02325219|157548023|FG004|Controlled Period (Week 0 - 16)|Other|0|||
48921804|NCT02325219|157548019|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
48921805|NCT02325219|157548020|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
48921806|NCT02325219|157548021|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
49153043|NCT06136897|158401928|FG000|Overall Study|Mutation status not confirmed|7|||
49153044|NCT06136897|158401928|FG000|Overall Study|Adverse Event|2|||
49153045|NCT06136897|158401928|FG000|Overall Study|Death|1|||
49153046|NCT06136897|158401928|FG000|Overall Study|Disease progression|18|||
49153047|NCT06136897|158401928|FG000|Overall Study|Other complicating disease|1|||
49153048|NCT06136897|158401928|FG000|Overall Study|Withdrawal by Subject|1|||
49153049|NCT06136897|158401928|FG000|Overall Study|Still on treatment|1|||
49153050|NCT06136897|158401928|FG000|Overall Study|Lost to Follow-up|1|||
48826155|NCT02939183|157204098|FG000|Overall Study|Sponsor decision|0|||
48826156|NCT02939183|157204099|FG001|Overall Study|Sponsor decision|1|||
48826157|NCT02939183|157204100|FG002|Overall Study|Sponsor decision|0|||
48826158|NCT02939183|157204101|FG003|Overall Study|Sponsor decision|1|||
48826159|NCT02939183|157204102|FG004|Overall Study|Sponsor decision|2|||
48826160|NCT02939183|157204103|FG005|Overall Study|Sponsor decision|0|||
48826161|NCT02939183|157204104|FG006|Overall Study|Sponsor decision|3|||
48826162|NCT02939183|157204105|FG007|Overall Study|Sponsor decision|1|||
48826163|NCT02939183|157204106|FG008|Overall Study|Sponsor decision|4|||
48826164|NCT02939183|157204098|FG000|Overall Study|Withdrawal by Subject|0|||
48826165|NCT02939183|157204099|FG001|Overall Study|Withdrawal by Subject|2|||
48826166|NCT02939183|157204100|FG002|Overall Study|Withdrawal by Subject|0|||
48826167|NCT02939183|157204101|FG003|Overall Study|Withdrawal by Subject|1|||
48826168|NCT02939183|157204102|FG004|Overall Study|Withdrawal by Subject|0|||
48826169|NCT02939183|157204103|FG005|Overall Study|Withdrawal by Subject|0|||
49153051|NCT04802967|158401931|FG000|Part B|Withdrawal by Subject|0|||
49153052|NCT04802967|158401932|FG001|Part B|Withdrawal by Subject|0|||
48733782|NCT03633617|156876256|FG004|Part C (& Follow-up)|Protocol Violation|0|||
48921807|NCT02325219|157548022|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
49153053|NCT04802967|158401933|FG002|Part B|Withdrawal by Subject|0|||
49153054|NCT04802967|158401934|FG003|Part B|Withdrawal by Subject|0|||
49153055|NCT04802967|158401935|FG004|Part B|Withdrawal by Subject|0|||
48733783|NCT03633617|156876257|FG005|Part C (& Follow-up)|Protocol Violation|0|||
48733784|NCT03633617|156876258|FG006|Part C (& Follow-up)|Protocol Violation|0|||
48921808|NCT02325219|157548023|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
48921809|NCT02325219|157548019|FG000|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
49153056|NCT04802967|158401936|FG005|Part B|Withdrawal by Subject|1|||
48826170|NCT02939183|157204104|FG006|Overall Study|Withdrawal by Subject|2|||
48826171|NCT02939183|157204105|FG007|Overall Study|Withdrawal by Subject|2|||
48826172|NCT02939183|157204106|FG008|Overall Study|Withdrawal by Subject|2|||
48733785|NCT03633617|156876259|FG007|Part C (& Follow-up)|Protocol Violation|0|||
48733786|NCT03633617|156876260|FG008|Part C (& Follow-up)|Protocol Violation|0|||
48733787|NCT03633617|156876261|FG009|Part C (& Follow-up)|Protocol Violation|3|||
48733788|NCT03633617|156876262|FG010|Part C (& Follow-up)|Protocol Violation|1|||
48826173|NCT02939183|157204098|FG000|Overall Study|Not treated due to adverse event|0|||
48826174|NCT02939183|157204099|FG001|Overall Study|Not treated due to adverse event|0|||
48826175|NCT02939183|157204100|FG002|Overall Study|Not treated due to adverse event|0|||
48826176|NCT02939183|157204101|FG003|Overall Study|Not treated due to adverse event|1|||
48826177|NCT02939183|157204102|FG004|Overall Study|Not treated due to adverse event|0|||
48826178|NCT02939183|157204103|FG005|Overall Study|Not treated due to adverse event|0|||
48826179|NCT02939183|157204104|FG006|Overall Study|Not treated due to adverse event|1|||
48826180|NCT02939183|157204105|FG007|Overall Study|Not treated due to adverse event|0|||
48826181|NCT02939183|157204106|FG008|Overall Study|Not treated due to adverse event|0|||
48826182|NCT04736056|157204107|FG000|Overall Study|Death|0|||
48826183|NCT04736056|157204108|FG001|Overall Study|Death|0|||
48826184|NCT04736056|157204109|FG002|Overall Study|Death|0|||
48826185|NCT04736056|157204110|FG003|Overall Study|Death|1|||
48826186|NCT04736056|157204107|FG000|Overall Study|Lost to Follow-up|1|||
48826187|NCT04736056|157204108|FG001|Overall Study|Lost to Follow-up|0|||
48826188|NCT04736056|157204109|FG002|Overall Study|Lost to Follow-up|1|||
48826189|NCT04736056|157204110|FG003|Overall Study|Lost to Follow-up|1|||
48826190|NCT04736056|157204107|FG000|Overall Study|Withdrawal by Subject|2|||
49153057|NCT04802967|158401937|FG006|Part B|Withdrawal by Subject|0|||
49153058|NCT04802967|158401938|FG007|Part B|Withdrawal by Subject|0|||
49153059|NCT04802967|158401939|FG008|Part B|Withdrawal by Subject|0|||
49153060|NCT04802967|158401940|FG009|Part B|Withdrawal by Subject|0|||
49153061|NCT00023595|158401941|FG000|5 Year Follow up|Lost to Follow-up|2|||
49153062|NCT00023595|158401942|FG001|5 Year Follow up|Lost to Follow-up|2|||
49153063|NCT00023595|158401943|FG002|5 Year Follow up|Lost to Follow-up|1|||
49153064|NCT00023595|158401944|FG003|5 Year Follow up|Lost to Follow-up|7|||
49153065|NCT00023595|158401945|FG004|5 Year Follow up|Lost to Follow-up|3|||
49153066|NCT00023595|158401941|FG000|10 Year Follow up|Lost to Follow-up|12|||
49153067|NCT00023595|158401942|FG001|10 Year Follow up|Lost to Follow-up|10|||
49153068|NCT00023595|158401943|FG002|10 Year Follow up|Lost to Follow-up|3|||
49153069|NCT00023595|158401944|FG003|10 Year Follow up|Lost to Follow-up|0|||
49153070|NCT00023595|158401945|FG004|10 Year Follow up|Lost to Follow-up|0|||
49153071|NCT02096354|158401946|FG000|Overall Study|Physician Decision|4|||
49153072|NCT02096354|158401947|FG001|Overall Study|Physician Decision|5|||
49153073|NCT02096354|158401948|FG002|Overall Study|Physician Decision|0|||
49153074|NCT02096354|158401946|FG000|Overall Study|Withdrawal by Subject|3|||
49153075|NCT02096354|158401947|FG001|Overall Study|Withdrawal by Subject|1|||
49153076|NCT02096354|158401948|FG002|Overall Study|Withdrawal by Subject|0|||
49014251|NCT01703741|157888796|FG000|Overall Study|Adverse Event|2|||
49153077|NCT02096354|158401946|FG000|Overall Study|Adverse Event|7|||
49153078|NCT02096354|158401947|FG001|Overall Study|Adverse Event|4|||
49153079|NCT02096354|158401948|FG002|Overall Study|Adverse Event|0|||
49153080|NCT02096354|158401946|FG000|Overall Study|Ineligible|0|||
49153081|NCT02096354|158401947|FG001|Overall Study|Ineligible|0|||
49153082|NCT02096354|158401948|FG002|Overall Study|Ineligible|11|||
49153083|NCT03900650|158401950|FG000|Overall Study|Withdrawal by Subject|1|||
49153084|NCT03900650|158401951|FG001|Overall Study|Withdrawal by Subject|1|||
49153085|NCT03900650|158401952|FG002|Overall Study|Withdrawal by Subject|0|||
49153086|NCT03900650|158401953|FG003|Overall Study|Withdrawal by Subject|0|||
49153087|NCT03900650|158401950|FG000|Overall Study|Withdrawn by staff|1|||
49153088|NCT03900650|158401951|FG001|Overall Study|Withdrawn by staff|0|||
49153089|NCT03900650|158401952|FG002|Overall Study|Withdrawn by staff|0|||
49153090|NCT03900650|158401953|FG003|Overall Study|Withdrawn by staff|0|||
49153091|NCT02014376|158401956|FG000|Overall Study|Adverse Event|1|||
49153092|NCT02014376|158401957|FG001|Overall Study|Adverse Event|1|||
49153093|NCT02014376|158401958|FG002|Overall Study|Adverse Event|0|||
49153094|NCT02014376|158401956|FG000|Overall Study|Lost to Follow-up|2|||
49153095|NCT02014376|158401957|FG001|Overall Study|Lost to Follow-up|0|||
49153096|NCT02014376|158401958|FG002|Overall Study|Lost to Follow-up|0|||
49153097|NCT03038087|158401959|FG000|Overall Study|lost data|1|||
49153098|NCT01051661|158401960|FG000|Overall Study|Adverse Event|1|||
49153099|NCT01051661|158401961|FG001|Overall Study|Adverse Event|1|||
49153100|NCT01051661|158401962|FG002|Overall Study|Adverse Event|1|||
49153101|NCT01051661|158401963|FG003|Overall Study|Adverse Event|1|||
49153102|NCT01051661|158401964|FG004|Overall Study|Adverse Event|0|||
49153103|NCT01051661|158401965|FG005|Overall Study|Adverse Event|0|||
49153104|NCT01051661|158401960|FG000|Overall Study|Lost to Follow-up|13|||
49153105|NCT01051661|158401961|FG001|Overall Study|Lost to Follow-up|22|||
49153106|NCT01051661|158401962|FG002|Overall Study|Lost to Follow-up|15|||
49153107|NCT01051661|158401963|FG003|Overall Study|Lost to Follow-up|17|||
49153108|NCT01051661|158401964|FG004|Overall Study|Lost to Follow-up|10|||
49153109|NCT01051661|158401965|FG005|Overall Study|Lost to Follow-up|24|||
49153110|NCT01051661|158401960|FG000|Overall Study|Migrated/moved from study area|1|||
48826191|NCT04736056|157204108|FG001|Overall Study|Withdrawal by Subject|0|||
48826192|NCT04736056|157204109|FG002|Overall Study|Withdrawal by Subject|0|||
49153111|NCT01051661|158401961|FG001|Overall Study|Migrated/moved from study area|6|||
49153112|NCT01051661|158401962|FG002|Overall Study|Migrated/moved from study area|6|||
49153113|NCT01051661|158401963|FG003|Overall Study|Migrated/moved from study area|8|||
49153114|NCT01051661|158401964|FG004|Overall Study|Migrated/moved from study area|7|||
49153115|NCT01051661|158401965|FG005|Overall Study|Migrated/moved from study area|3|||
49153116|NCT01051661|158401960|FG000|Overall Study|Refused blood sampling|0|||
49153117|NCT01051661|158401961|FG001|Overall Study|Refused blood sampling|0|||
49153118|NCT01051661|158401962|FG002|Overall Study|Refused blood sampling|0|||
49153119|NCT01051661|158401963|FG003|Overall Study|Refused blood sampling|0|||
49153120|NCT01051661|158401964|FG004|Overall Study|Refused blood sampling|0|||
49153121|NCT01051661|158401965|FG005|Overall Study|Refused blood sampling|1|||
49153122|NCT01051661|158401960|FG000|Overall Study|Data not reliable|1|||
49153123|NCT01051661|158401961|FG001|Overall Study|Data not reliable|0|||
49153124|NCT01051661|158401962|FG002|Overall Study|Data not reliable|0|||
49153125|NCT01051661|158401963|FG003|Overall Study|Data not reliable|0|||
49153126|NCT01051661|158401964|FG004|Overall Study|Data not reliable|0|||
49153127|NCT01051661|158401965|FG005|Overall Study|Data not reliable|1|||
49153128|NCT01051661|158401960|FG000|Overall Study|Unable to attend visit(s)|2|||
49153129|NCT01051661|158401961|FG001|Overall Study|Unable to attend visit(s)|4|||
49153130|NCT01051661|158401962|FG002|Overall Study|Unable to attend visit(s)|2|||
49153131|NCT01051661|158401963|FG003|Overall Study|Unable to attend visit(s)|1|||
49153132|NCT01051661|158401964|FG004|Overall Study|Unable to attend visit(s)|3|||
49153133|NCT01051661|158401965|FG005|Overall Study|Unable to attend visit(s)|2|||
49153134|NCT01051661|158401960|FG000|Overall Study|Consent not received from both parents|0|||
49153135|NCT01051661|158401961|FG001|Overall Study|Consent not received from both parents|0|||
49153136|NCT01051661|158401962|FG002|Overall Study|Consent not received from both parents|0|||
49153137|NCT01051661|158401963|FG003|Overall Study|Consent not received from both parents|0|||
49153138|NCT01051661|158401964|FG004|Overall Study|Consent not received from both parents|0|||
49153139|NCT01051661|158401965|FG005|Overall Study|Consent not received from both parents|1|||
49153140|NCT01051661|158401960|FG000|Overall Study|Failure to comply with protocol|0|||
49153141|NCT01051661|158401961|FG001|Overall Study|Failure to comply with protocol|0|||
49153142|NCT01051661|158401962|FG002|Overall Study|Failure to comply with protocol|2|||
48921810|NCT02325219|157548020|FG001|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2|||
49014252|NCT01703741|157888796|FG000|Overall Study|Physician Decision|2|||
49153143|NCT01051661|158401963|FG003|Overall Study|Failure to comply with protocol|0|||
49153144|NCT01051661|158401964|FG004|Overall Study|Failure to comply with protocol|0|||
49153145|NCT01051661|158401965|FG005|Overall Study|Failure to comply with protocol|0|||
49153146|NCT01051661|158401960|FG000|Overall Study|Subject lost legal representation|0|||
49153147|NCT01051661|158401961|FG001|Overall Study|Subject lost legal representation|0|||
49153148|NCT01051661|158401962|FG002|Overall Study|Subject lost legal representation|0|||
48733789|NCT03633617|156876252|FG000|Part C (& Follow-up)|Lack of Efficacy|0|||
48733790|NCT03633617|156876253|FG001|Part C (& Follow-up)|Lack of Efficacy|0|||
48733791|NCT03633617|156876254|FG002|Part C (& Follow-up)|Lack of Efficacy|0|||
48733792|NCT03633617|156876255|FG003|Part C (& Follow-up)|Lack of Efficacy|0|||
48733793|NCT03633617|156876256|FG004|Part C (& Follow-up)|Lack of Efficacy|0|||
48733794|NCT03633617|156876257|FG005|Part C (& Follow-up)|Lack of Efficacy|0|||
48733795|NCT03633617|156876258|FG006|Part C (& Follow-up)|Lack of Efficacy|0|||
48733796|NCT03633617|156876259|FG007|Part C (& Follow-up)|Lack of Efficacy|1|||
48733797|NCT03633617|156876260|FG008|Part C (& Follow-up)|Lack of Efficacy|0|||
48733798|NCT03633617|156876261|FG009|Part C (& Follow-up)|Lack of Efficacy|0|||
48733799|NCT03633617|156876262|FG010|Part C (& Follow-up)|Lack of Efficacy|0|||
48733800|NCT03595774|156876265|FG000|Overall Study|Adverse Event|1|||
48733801|NCT03595774|156876266|FG001|Overall Study|Adverse Event|0|||
48733802|NCT03595774|156876267|FG002|Overall Study|Adverse Event|1|||
48733803|NCT03595774|156876268|FG003|Overall Study|Adverse Event|0|||
48733804|NCT03595774|156876265|FG000|Overall Study|screen failure|0|||
48733805|NCT03595774|156876266|FG001|Overall Study|screen failure|1|||
48733806|NCT03595774|156876267|FG002|Overall Study|screen failure|0|||
48733807|NCT03595774|156876268|FG003|Overall Study|screen failure|1|||
48733808|NCT02477839|156876269|FG000|Overall Study|Adverse Event|0|||
48733809|NCT02477839|156876270|FG001|Overall Study|Adverse Event|1|||
48733810|NCT02477839|156876269|FG000|Overall Study|Protocol Violation|0|||
48733811|NCT02477839|156876270|FG001|Overall Study|Protocol Violation|2|||
48733812|NCT02477839|156876269|FG000|Overall Study|Withdrawal by Subject|3|||
48733813|NCT02477839|156876270|FG001|Overall Study|Withdrawal by Subject|3|||
48733814|NCT02477839|156876269|FG000|Overall Study|Participant had PGS during V6|0|||
48733815|NCT02477839|156876270|FG001|Overall Study|Participant had PGS during V6|1|||
48733816|NCT02477839|156876269|FG000|Overall Study|Parents decided to stop medication|0|||
48733817|NCT02477839|156876270|FG001|Overall Study|Parents decided to stop medication|1|||
48733818|NCT02477839|156876269|FG000|Overall Study|Lack of tolerability|0|||
48733819|NCT02477839|156876270|FG001|Overall Study|Lack of tolerability|1|||
48733820|NCT02477839|156876269|FG000|Overall Study|Exclusion criterion|0|||
48733821|NCT02477839|156876270|FG001|Overall Study|Exclusion criterion|1|||
48733822|NCT03198078|156876275|FG000|Overall Study|Adverse Event|0|||
48733823|NCT03198078|156876276|FG001|Overall Study|Adverse Event|1|||
48733824|NCT03198078|156876277|FG002|Overall Study|Adverse Event|2|||
48733825|NCT03198078|156876275|FG000|Overall Study|Lack of Efficacy|0|||
48733826|NCT03198078|156876276|FG001|Overall Study|Lack of Efficacy|0|||
48733827|NCT03198078|156876277|FG002|Overall Study|Lack of Efficacy|3|||
48733828|NCT03198078|156876275|FG000|Overall Study|Lost to Follow-up|1|||
48733829|NCT03198078|156876276|FG001|Overall Study|Lost to Follow-up|0|||
48733830|NCT03198078|156876277|FG002|Overall Study|Lost to Follow-up|0|||
48733831|NCT03198078|156876275|FG000|Overall Study|Pregnancy|0|||
48733832|NCT03198078|156876276|FG001|Overall Study|Pregnancy|1|||
48733833|NCT03198078|156876277|FG002|Overall Study|Pregnancy|0|||
48733834|NCT03198078|156876275|FG000|Overall Study|Withdrawal by Subject|1|||
48733835|NCT03198078|156876276|FG001|Overall Study|Withdrawal by Subject|0|||
48733836|NCT03198078|156876277|FG002|Overall Study|Withdrawal by Subject|2|||
48733837|NCT03198078|156876275|FG000|Overall Study|Withdrawal by Caregiver|1|||
48733838|NCT03198078|156876276|FG001|Overall Study|Withdrawal by Caregiver|3|||
48733839|NCT03198078|156876277|FG002|Overall Study|Withdrawal by Caregiver|5|||
48733840|NCT04137224|156876278|FG000|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|1|||
48733841|NCT04137224|156876279|FG001|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|0|||
48733842|NCT04137224|156876278|FG000|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|0|||
48733843|NCT04137224|156876279|FG001|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|1|||
48733844|NCT04137224|156876278|FG000|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|0|||
48733845|NCT04137224|156876279|FG001|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|1|||
48733846|NCT01147640|156876280|FG000|Overall Study|Adverse Event|2|||
48733847|NCT01147640|156876281|FG001|Overall Study|Adverse Event|0|||
48733848|NCT01147640|156876280|FG000|Overall Study|Physician Decision|1|||
48733849|NCT01147640|156876281|FG001|Overall Study|Physician Decision|0|||
48733850|NCT01147640|156876280|FG000|Overall Study|Withdrawal by Subject|1|||
48733851|NCT01147640|156876281|FG001|Overall Study|Withdrawal by Subject|0|||
48733852|NCT01147640|156876280|FG000|Overall Study|Lost to Follow-up|0|||
48733853|NCT01147640|156876281|FG001|Overall Study|Lost to Follow-up|1|||
48733854|NCT01147640|156876280|FG000|Overall Study|Didn't meet eligibility criteria|1|||
48733855|NCT01147640|156876281|FG001|Overall Study|Didn't meet eligibility criteria|0|||
48733856|NCT01856907|156876283|FG000|Overall Study|Pregnancy|0|||
48733857|NCT01856907|156876284|FG001|Overall Study|Pregnancy|1|||
48733858|NCT01856907|156876285|FG002|Overall Study|Pregnancy|0|||
48733859|NCT01856907|156876283|FG000|Overall Study|Pregnancy|0|||
49153149|NCT01051661|158401963|FG003|Overall Study|Subject lost legal representation|0|||
49153150|NCT01051661|158401964|FG004|Overall Study|Subject lost legal representation|1|||
49153151|NCT01051661|158401965|FG005|Overall Study|Subject lost legal representation|0|||
49153152|NCT01051661|158401960|FG000|Overall Study|Protocol Violation|0|||
49153153|NCT01051661|158401961|FG001|Overall Study|Protocol Violation|0|||
49153154|NCT01051661|158401962|FG002|Overall Study|Protocol Violation|0|||
49153155|NCT01051661|158401963|FG003|Overall Study|Protocol Violation|1|||
49153156|NCT01051661|158401964|FG004|Overall Study|Protocol Violation|2|||
49153157|NCT01051661|158401965|FG005|Overall Study|Protocol Violation|1|||
49153158|NCT01051661|158401960|FG000|Overall Study|Withdrawal by Subject|16|||
49153159|NCT01051661|158401961|FG001|Overall Study|Withdrawal by Subject|30|||
49153160|NCT01051661|158401962|FG002|Overall Study|Withdrawal by Subject|13|||
49153161|NCT01051661|158401963|FG003|Overall Study|Withdrawal by Subject|28|||
49153162|NCT01051661|158401964|FG004|Overall Study|Withdrawal by Subject|12|||
49153163|NCT01051661|158401965|FG005|Overall Study|Withdrawal by Subject|34|||
49153164|NCT00086515|158401966|FG000|Phase A (Weeks 0-24)|Adverse Event|17|||
49153165|NCT00086515|158401967|FG001|Phase A (Weeks 0-24)|Adverse Event|9|||
49153166|NCT00086515|158401966|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|7|||
48733860|NCT01856907|156876284|FG001|Overall Study|Pregnancy|1|||
48733861|NCT01856907|156876285|FG002|Overall Study|Pregnancy|0|||
48733862|NCT01856907|156876283|FG000|Overall Study|Withdrawal by Subject|0|||
48733863|NCT01856907|156876284|FG001|Overall Study|Withdrawal by Subject|1|||
48733864|NCT01856907|156876285|FG002|Overall Study|Withdrawal by Subject|0|||
48733865|NCT00285818|156876296|FG000|Overall Study|Withdrawal by Subject|3|||
48733866|NCT00285818|156876297|FG001|Overall Study|Withdrawal by Subject|2|||
48733867|NCT00285818|156876296|FG000|Overall Study|Lost to Follow-up|1|||
48733868|NCT00285818|156876297|FG001|Overall Study|Lost to Follow-up|0|||
48733869|NCT01528215|156876303|FG000|Enrollment to 1 Year Follow-up|Adverse Event|4|||
48733870|NCT01528215|156876304|FG001|Enrollment to 1 Year Follow-up|Adverse Event|1|||
48733871|NCT01528215|156876303|FG000|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
48733872|NCT01528215|156876304|FG001|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
48733873|NCT01528215|156876303|FG000|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10|||
48733874|NCT01528215|156876304|FG001|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13|||
48733875|NCT01528215|156876303|FG000|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3|||
48733876|NCT01528215|156876304|FG001|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0|||
48733877|NCT04251273|156876305|FG000|Overall Study|Lost to Follow-up|331|||
48733878|NCT04251273|156876306|FG001|Overall Study|Lost to Follow-up|290|||
48733879|NCT05182125|156876309|FG000|Overall Study|Withdrawal by Subject|0|||
48733880|NCT05182125|156876310|FG001|Overall Study|Withdrawal by Subject|0|||
48733881|NCT05182125|156876311|FG002|Overall Study|Withdrawal by Subject|0|||
48733882|NCT05182125|156876312|FG003|Overall Study|Withdrawal by Subject|0|||
48733883|NCT05182125|156876313|FG004|Overall Study|Withdrawal by Subject|2|||
48733884|NCT05182125|156876314|FG005|Overall Study|Withdrawal by Subject|0|||
48733885|NCT05182125|156876309|FG000|Overall Study|Participant unable to adhere Visit Schedule|0|||
48733886|NCT05182125|156876310|FG001|Overall Study|Participant unable to adhere Visit Schedule|0|||
48733887|NCT05182125|156876311|FG002|Overall Study|Participant unable to adhere Visit Schedule|0|||
48733888|NCT05182125|156876312|FG003|Overall Study|Participant unable to adhere Visit Schedule|1|||
48733889|NCT05182125|156876313|FG004|Overall Study|Participant unable to adhere Visit Schedule|0|||
48733890|NCT05182125|156876314|FG005|Overall Study|Participant unable to adhere Visit Schedule|0|||
48733891|NCT05182125|156876309|FG000|Overall Study|Death|0|||
48733892|NCT05182125|156876310|FG001|Overall Study|Death|0|||
48733893|NCT05182125|156876311|FG002|Overall Study|Death|0|||
48733894|NCT05182125|156876312|FG003|Overall Study|Death|0|||
48733895|NCT05182125|156876313|FG004|Overall Study|Death|1|||
48733896|NCT05182125|156876314|FG005|Overall Study|Death|0|||
48733897|NCT05182125|156876309|FG000|Overall Study|Health Contact Follow-up|5|||
48733898|NCT05182125|156876310|FG001|Overall Study|Health Contact Follow-up|5|||
48733899|NCT05182125|156876311|FG002|Overall Study|Health Contact Follow-up|2|||
48733900|NCT05182125|156876312|FG003|Overall Study|Health Contact Follow-up|9|||
48733901|NCT05182125|156876313|FG004|Overall Study|Health Contact Follow-up|7|||
48733902|NCT05182125|156876314|FG005|Overall Study|Health Contact Follow-up|2|||
48733903|NCT02919696|156876315|FG000|Overall Study|Adverse Event|1|||
48733904|NCT02919696|156876316|FG001|Overall Study|Adverse Event|2|||
48733905|NCT02919696|156876315|FG000|Overall Study|Withdrawal by Subject|2|||
48826193|NCT04736056|157204110|FG003|Overall Study|Withdrawal by Subject|0|||
48826194|NCT04736056|157204107|FG000|Overall Study|Physician Decision|1|||
48826195|NCT04736056|157204108|FG001|Overall Study|Physician Decision|0|||
48826196|NCT04736056|157204109|FG002|Overall Study|Physician Decision|1|||
48826197|NCT04736056|157204110|FG003|Overall Study|Physician Decision|0|||
48733906|NCT02919696|156876316|FG001|Overall Study|Withdrawal by Subject|1|||
48733907|NCT02919696|156876315|FG000|Overall Study|Sponsor Decision|1|||
48733908|NCT02919696|156876316|FG001|Overall Study|Sponsor Decision|1|||
48733909|NCT02919696|156876315|FG000|Overall Study|Never Treated|0|||
48733910|NCT02919696|156876316|FG001|Overall Study|Never Treated|1|||
48733911|NCT01104701|156877626|FG000|Overall Study|Withdrawal by Subject|0|||
48733912|NCT01104701|156877627|FG001|Overall Study|Withdrawal by Subject|1|||
48733913|NCT01104701|156877628|FG002|Overall Study|Withdrawal by Subject|2|||
48733914|NCT01104701|156877629|FG003|Overall Study|Withdrawal by Subject|1|||
48733915|NCT01104701|156877626|FG000|Overall Study|Adverse Event|0|||
48733916|NCT01104701|156877627|FG001|Overall Study|Adverse Event|0|||
48733917|NCT01104701|156877628|FG002|Overall Study|Adverse Event|0|||
48733918|NCT01104701|156877629|FG003|Overall Study|Adverse Event|1|||
48733919|NCT01104701|156877626|FG000|Overall Study|Physician Decision|0|||
48733920|NCT01104701|156877627|FG001|Overall Study|Physician Decision|2|||
48733921|NCT01104701|156877628|FG002|Overall Study|Physician Decision|0|||
48733922|NCT01104701|156877629|FG003|Overall Study|Physician Decision|0|||
48733923|NCT01683019|156877630|FG000|Overall Study|Withdrawal by Subject|2|||
48733924|NCT01683019|156877631|FG001|Overall Study|Withdrawal by Subject|1|||
48733925|NCT01683019|156877632|FG002|Overall Study|Withdrawal by Subject|4|||
48733926|NCT03437512|156877633|FG000|Randomized|Withdrawal by Subject|0|||
48733927|NCT03437512|156877634|FG001|Randomized|Withdrawal by Subject|2|||
48733928|NCT03437512|156877633|FG000|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2|||
48733929|NCT03437512|156877634|FG001|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1|||
48733930|NCT01863953|156877637|FG000|Overall Study|Adverse Event|0|||
48733931|NCT01863953|156877638|FG001|Overall Study|Adverse Event|0|||
48733932|NCT01863953|156877639|FG002|Overall Study|Adverse Event|1|||
48733933|NCT00958789|156877640|FG000|Overall Study|Death|5|||
48733934|NCT00958789|156877640|FG000|Overall Study|Lost to Follow-up|14|||
48733935|NCT00958789|156877640|FG000|Overall Study|Withdrawal by Subject|17|||
48733936|NCT00958789|156877640|FG000|Overall Study|No 2 yr. Knee Society Score data|4|||
48826198|NCT03003962|157204117|FG000|Overall Study|Withdrawal by Subject|5|||
48733937|NCT00958789|156877640|FG000|Overall Study|2 yr. Knee Society Score not calculable|1|||
48733938|NCT00958789|156877640|FG000|Overall Study|Subject terminated|2|||
48733939|NCT00958789|156877640|FG000|Overall Study|Revision|7|||
48733940|NCT00595465|156877641|FG000|Overall Study|Adverse Event|4|||
48733941|NCT00595465|156877642|FG001|Overall Study|Adverse Event|3|||
48733942|NCT00595465|156877643|FG002|Overall Study|Adverse Event|3|||
48826199|NCT03003962|157204118|FG001|Overall Study|Withdrawal by Subject|17|||
48826200|NCT03003962|157204117|FG000|Overall Study|Death|274|||
49014253|NCT01703741|157888796|FG000|Overall Study|Protocol Violation|1|||
48826201|NCT03003962|157204118|FG001|Overall Study|Death|277|||
48733943|NCT00595465|156877641|FG000|Overall Study|Pregnancy|0|||
48733944|NCT00595465|156877642|FG001|Overall Study|Pregnancy|0|||
48733945|NCT00595465|156877643|FG002|Overall Study|Pregnancy|1|||
48733946|NCT00595465|156877641|FG000|Overall Study|Protocol Violation|2|||
48733947|NCT00595465|156877642|FG001|Overall Study|Protocol Violation|1|||
48733948|NCT00595465|156877643|FG002|Overall Study|Protocol Violation|0|||
48733949|NCT00595465|156877641|FG000|Overall Study|Lost to Follow-up|0|||
48733950|NCT00595465|156877642|FG001|Overall Study|Lost to Follow-up|0|||
48733951|NCT00595465|156877643|FG002|Overall Study|Lost to Follow-up|2|||
48733952|NCT00595465|156877641|FG000|Overall Study|administrative reason|0|||
48733953|NCT00595465|156877642|FG001|Overall Study|administrative reason|0|||
48733954|NCT00595465|156877643|FG002|Overall Study|administrative reason|1|||
48733955|NCT02395666|156877653|FG000|Overall Study|Physician Decision|3|||
48733956|NCT02395666|156877654|FG001|Overall Study|Physician Decision|0|||
48733957|NCT02395666|156877653|FG000|Overall Study|Lost to Follow-up|1|||
48733958|NCT02395666|156877654|FG001|Overall Study|Lost to Follow-up|0|||
48733959|NCT02395666|156877653|FG000|Overall Study|Withdrawal by Subject|2|||
48733960|NCT02395666|156877654|FG001|Overall Study|Withdrawal by Subject|1|||
48733961|NCT05061966|156877655|FG000|Overall Study|Lost to Follow-up|13|||
48733962|NCT05061966|156877656|FG001|Overall Study|Lost to Follow-up|13|||
48733963|NCT00761579|156877657|FG000|Overall Study|Adverse Event|10|||
48733964|NCT00761579|156877657|FG000|Overall Study|Death|2|||
48733965|NCT00761579|156877657|FG000|Overall Study|Lack of Efficacy|21|||
48733966|NCT00761579|156877657|FG000|Overall Study|Lost to Follow-up|16|||
48733967|NCT00761579|156877657|FG000|Overall Study|Pregnancy|1|||
48733968|NCT00761579|156877657|FG000|Overall Study|Withdrawal by Subject|34|||
48733969|NCT00761579|156877657|FG000|Overall Study|Lack of compliance|2|||
48733970|NCT00761579|156877657|FG000|Overall Study|Protocol deviation|1|||
48733971|NCT00761579|156877657|FG000|Overall Study|Drug overdose|1|||
48733972|NCT00761579|156877657|FG000|Overall Study|Aggravation of depression|1|||
48733973|NCT00761579|156877657|FG000|Overall Study|Aggravation of symptoms by changing drug|1|||
48733974|NCT00761579|156877657|FG000|Overall Study|Lost survey form|1|||
48733975|NCT00761579|156877657|FG000|Overall Study|Intake of prohibited concomitant drug|1|||
48733976|NCT00611533|156877659|FG000|First Intervention (6 Weeks)|Never started study|0|||
48733977|NCT00611533|156877660|FG001|First Intervention (6 Weeks)|Never started study|1|||
48733978|NCT00611533|156877659|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
48733979|NCT00611533|156877660|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
48733980|NCT00611533|156877659|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
48733981|NCT00611533|156877660|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
48733982|NCT00100178|156877661|FG000|Overall Study|Lost to Follow-up|0|||
48733983|NCT00100178|156877662|FG001|Overall Study|Lost to Follow-up|6|||
48733984|NCT00100178|156877663|FG002|Overall Study|Lost to Follow-up|5|||
48733985|NCT00100178|156877661|FG000|Overall Study|Adverse Event|2|||
48733986|NCT00100178|156877662|FG001|Overall Study|Adverse Event|2|||
48733987|NCT00100178|156877663|FG002|Overall Study|Adverse Event|1|||
48733988|NCT00100178|156877661|FG000|Overall Study|Withdrawal by Subject|1|||
48733989|NCT00100178|156877662|FG001|Overall Study|Withdrawal by Subject|1|||
48733990|NCT00100178|156877663|FG002|Overall Study|Withdrawal by Subject|1|||
48733991|NCT00100178|156877661|FG000|Overall Study|Physician Decision|6|||
48733992|NCT00100178|156877662|FG001|Overall Study|Physician Decision|1|||
48733993|NCT00100178|156877663|FG002|Overall Study|Physician Decision|3|||
48733994|NCT00532155|156877672|FG000|Overall Study|Adverse Event|66|||
48733995|NCT00532155|156877673|FG001|Overall Study|Adverse Event|123|||
48733996|NCT00532155|156877672|FG000|Overall Study|Lack of Efficacy|332|||
48733997|NCT00532155|156877673|FG001|Overall Study|Lack of Efficacy|255|||
48733998|NCT00532155|156877672|FG000|Overall Study|Protocol Violation|1|||
48733999|NCT00532155|156877673|FG001|Overall Study|Protocol Violation|3|||
48734000|NCT00532155|156877672|FG000|Overall Study|Lost to Follow-up|2|||
48734001|NCT00532155|156877673|FG001|Overall Study|Lost to Follow-up|0|||
48734002|NCT00532155|156877672|FG000|Overall Study|Physician Decision|16|||
48734003|NCT00532155|156877673|FG001|Overall Study|Physician Decision|15|||
48921811|NCT02325219|157548021|FG002|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
48921812|NCT02325219|157548022|FG003|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
48921813|NCT02325219|157548023|FG004|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
48921814|NCT02325219|157548019|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
48921815|NCT02325219|157548020|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
48921816|NCT02325219|157548021|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
48921817|NCT02325219|157548022|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
48921818|NCT02325219|157548023|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
48921819|NCT02918864|157548024|FG000|Overall Study|Withdrawal by Subject|1|||
48734004|NCT00532155|156877672|FG000|Overall Study|Withdrawal by Subject|23|||
48734005|NCT00532155|156877673|FG001|Overall Study|Withdrawal by Subject|44|||
48734006|NCT00532155|156877672|FG000|Overall Study|Consent withdrawn|5|||
48734007|NCT00532155|156877673|FG001|Overall Study|Consent withdrawn|7|||
48734008|NCT00532155|156877672|FG000|Overall Study|Moved|1|||
48734009|NCT00532155|156877673|FG001|Overall Study|Moved|0|||
48734010|NCT00532155|156877672|FG000|Overall Study|Pre-existing brain metastasis (by MRI)|1|||
48734011|NCT00532155|156877673|FG001|Overall Study|Pre-existing brain metastasis (by MRI)|0|||
48734012|NCT00532155|156877672|FG000|Overall Study|Occurence of a second cancer|0|||
48734013|NCT00532155|156877673|FG001|Overall Study|Occurence of a second cancer|1|||
48734014|NCT00532155|156877672|FG000|Overall Study|Occurence of a secondary cancer|0|||
48734015|NCT00532155|156877673|FG001|Overall Study|Occurence of a secondary cancer|1|||
48921820|NCT02918864|157548025|FG001|Overall Study|Withdrawal by Subject|1|||
48734016|NCT00532155|156877672|FG000|Overall Study|Promotor ended study|1|||
49153167|NCT00086515|158401967|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|13|||
49153168|NCT00086515|158401966|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|4|||
49153169|NCT00086515|158401967|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
49153170|NCT00086515|158401966|FG000|Phase A (Weeks 0-24)|Protocol Violation|3|||
49153171|NCT00086515|158401967|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
48734017|NCT00532155|156877673|FG001|Overall Study|Promotor ended study|0|||
48734018|NCT00532155|156877672|FG000|Overall Study|Progressive disease (by incorrect scan)|0|||
48734019|NCT00532155|156877673|FG001|Overall Study|Progressive disease (by incorrect scan)|1|||
48734020|NCT00532155|156877672|FG000|Overall Study|Had brain metastasis, was mis-randomized|1|||
48734021|NCT00532155|156877673|FG001|Overall Study|Had brain metastasis, was mis-randomized|0|||
48734022|NCT00532155|156877672|FG000|Overall Study|Study stopped|1|||
48734023|NCT00532155|156877673|FG001|Overall Study|Study stopped|0|||
49153172|NCT00086515|158401966|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
49153173|NCT00086515|158401967|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
49153174|NCT00086515|158401966|FG000|Phase A (Weeks 0-24)|Patient Moved|2|||
49153175|NCT00086515|158401967|FG001|Phase A (Weeks 0-24)|Patient Moved|3|||
48734024|NCT00532155|156877672|FG000|Overall Study|Study terminated by sponsor|1|||
48734025|NCT00532155|156877673|FG001|Overall Study|Study terminated by sponsor|0|||
48826202|NCT03003962|157204117|FG000|Overall Study|Participants ongoing at DCO|55|||
48826203|NCT03003962|157204118|FG001|Overall Study|Participants ongoing at DCO|40|||
48826204|NCT00490555|157204119|FG000|Overall Study|noncompliant with drug administration|0|||
48826205|NCT00490555|157204120|FG001|Overall Study|noncompliant with drug administration|0|||
48826206|NCT00490555|157204121|FG002|Overall Study|noncompliant with drug administration|2|||
48826207|NCT00490555|157204122|FG003|Overall Study|noncompliant with drug administration|0|||
48826208|NCT02042443|157204123|FG000|Overall Study|Adverse Event|2|||
48826209|NCT02042443|157204124|FG001|Overall Study|Adverse Event|1|||
48826210|NCT02042443|157204123|FG000|Overall Study|Withdrawal by Subject|0|||
48826211|NCT02042443|157204124|FG001|Overall Study|Withdrawal by Subject|1|||
49153176|NCT00086515|158401966|FG000|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4|||
49153177|NCT00086515|158401967|FG001|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3|||
48734026|NCT00532155|156877672|FG000|Overall Study|Study termination stop further treatment|4|||
48734027|NCT00532155|156877673|FG001|Overall Study|Study termination stop further treatment|0|||
48826212|NCT02042443|157204123|FG000|Overall Study|Progression|21|||
48826213|NCT02042443|157204124|FG001|Overall Study|Progression|17|||
48826214|NCT02042443|157204123|FG000|Overall Study|not protocol specified|1|||
48826215|NCT02042443|157204124|FG001|Overall Study|not protocol specified|1|||
48826216|NCT02042443|157204123|FG000|Overall Study|Not eligible/not analyzable|3|||
48826217|NCT02042443|157204124|FG001|Overall Study|Not eligible/not analyzable|6|||
48826218|NCT00828945|157204126|FG000|Overall Study|Death|4|||
48826219|NCT00828945|157204126|FG000|Overall Study|Participant was missing|1|||
48826220|NCT00828945|157204126|FG000|Overall Study|Other|36|||
48826221|NCT00764868|157204131|FG000|Overall Study|Adverse Event|18|||
48826222|NCT00764868|157204131|FG000|Overall Study|Withdrawal by Subject|31|||
49153178|NCT00086515|158401966|FG000|Phase A (Weeks 0-24)|Poor compliance|1|||
49153179|NCT00086515|158401967|FG001|Phase A (Weeks 0-24)|Poor compliance|0|||
48734028|NCT00532155|156877672|FG000|Overall Study|Did not receive study medication|2|||
48734029|NCT00532155|156877673|FG001|Overall Study|Did not receive study medication|6|||
48734030|NCT03911154|156877676|FG000|Overall Study|Withdrawal by Subject|1|||
48734031|NCT02853344|156877677|FG000|Overall Study|Lost to Follow-up|1|||
48734032|NCT02853344|156877678|FG001|Overall Study|Lost to Follow-up|1|||
48734033|NCT02853344|156877677|FG000|Overall Study|Withdrawal by Subject|2|||
48734034|NCT02853344|156877678|FG001|Overall Study|Withdrawal by Subject|4|||
48734035|NCT02853344|156877677|FG000|Overall Study|Participation in Study Terminated by Sponsor|37|||
48734036|NCT02853344|156877678|FG001|Overall Study|Participation in Study Terminated by Sponsor|48|||
48734037|NCT02853344|156877677|FG000|Overall Study|Death|70|||
48734038|NCT02853344|156877678|FG001|Overall Study|Death|112|||
48734039|NCT00973674|156877679|FG000|Overall Study|Protocol Violation|2|||
48734040|NCT00973674|156877680|FG001|Overall Study|Protocol Violation|0|||
48734041|NCT01460368|156877681|FG000|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
48734042|NCT01460368|156877682|FG001|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
48734043|NCT01460368|156877683|FG002|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
48734044|NCT01460368|156877684|FG003|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
48734045|NCT01460368|156877685|FG004|Part B: First Intervention (Period 1)|Lost to Follow-up|1|||
48734046|NCT01460368|156877686|FG005|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
48734047|NCT01460368|156877687|FG006|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
48734048|NCT01460368|156877681|FG000|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
48734049|NCT01460368|156877682|FG001|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
48734050|NCT01460368|156877683|FG002|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
48734051|NCT01460368|156877684|FG003|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
48734052|NCT01460368|156877685|FG004|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
48734053|NCT01460368|156877686|FG005|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
48734054|NCT01460368|156877687|FG006|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
48734055|NCT01460368|156877681|FG000|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
48734056|NCT01460368|156877682|FG001|Part B: Second Intervention (Period 2)|Lost to Follow-up|1|||
48734057|NCT01460368|156877683|FG002|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
48734058|NCT01460368|156877684|FG003|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
48734059|NCT01460368|156877685|FG004|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
48734060|NCT01460368|156877686|FG005|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
48734061|NCT01460368|156877687|FG006|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
48734062|NCT01460368|156877681|FG000|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
48734063|NCT01460368|156877682|FG001|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
48734064|NCT01460368|156877683|FG002|Part B: Washout (up to 15 Days)|Protocol Violation|1|||
48734065|NCT01460368|156877684|FG003|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
48734066|NCT01460368|156877685|FG004|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
48734067|NCT01460368|156877686|FG005|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
48734068|NCT01460368|156877687|FG006|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
48734069|NCT01460368|156877681|FG000|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
48734070|NCT01460368|156877682|FG001|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
48734071|NCT01460368|156877683|FG002|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
48734072|NCT01460368|156877684|FG003|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
48826223|NCT00764868|157204131|FG000|Overall Study|Non-compliance|16|||
48826224|NCT00764868|157204131|FG000|Overall Study|Lost to Follow-up|25|||
48826225|NCT00764868|157204131|FG000|Overall Study|Lack of Efficacy|5|||
48826226|NCT00764868|157204131|FG000|Overall Study|Subject moved|7|||
48826227|NCT00764868|157204131|FG000|Overall Study|Pregnancy|3|||
48826228|NCT00764868|157204131|FG000|Overall Study|Prohibited medication|1|||
48826229|NCT00764868|157204131|FG000|Overall Study|Out of town|1|||
48826230|NCT00764868|157204131|FG000|Overall Study|Misuse and compliance of study drug|1|||
48826231|NCT00764868|157204131|FG000|Overall Study|Subject sent to boarding school|1|||
48826232|NCT00764868|157204131|FG000|Overall Study|Met an exclusion criteria|1|||
48826233|NCT00764868|157204131|FG000|Overall Study|Positive drug screen|2|||
48826234|NCT00764868|157204131|FG000|Overall Study|Sponsor requested withdrawal|1|||
48826235|NCT00462943|157204132|FG000|Overall Study|Failure to achieve a response|5|||
48826236|NCT00462943|157204133|FG001|Overall Study|Failure to achieve a response|5|||
48826237|NCT00462943|157204134|FG002|Overall Study|Failure to achieve a response|1|||
48826238|NCT00462943|157204132|FG000|Overall Study|Adverse Event|6|||
48826239|NCT00462943|157204133|FG001|Overall Study|Adverse Event|4|||
48826240|NCT00462943|157204134|FG002|Overall Study|Adverse Event|1|||
48826241|NCT00462943|157204132|FG000|Overall Study|Protocol Violation|1|||
48826242|NCT00462943|157204133|FG001|Overall Study|Protocol Violation|0|||
48826243|NCT00462943|157204134|FG002|Overall Study|Protocol Violation|0|||
48826244|NCT00462943|157204132|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|8|||
48826245|NCT00462943|157204133|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|2|||
48826246|NCT00462943|157204134|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|4|||
48826247|NCT00462943|157204132|FG000|Overall Study|Disease Progression|15|||
49153180|NCT00086515|158401966|FG000|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0|||
49153181|NCT00086515|158401967|FG001|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1|||
49153182|NCT00086515|158401966|FG000|Phase A (Weeks 0-24)|Personal Circumstance|1|||
49153183|NCT00086515|158401967|FG001|Phase A (Weeks 0-24)|Personal Circumstance|0|||
49153184|NCT00086515|158401966|FG000|Phase A to Phase B Transition Period|Adverse Event|2|||
49153185|NCT00086515|158401967|FG001|Phase A to Phase B Transition Period|Adverse Event|1|||
49153186|NCT00086515|158401966|FG000|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
49153187|NCT00086515|158401967|FG001|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
49153188|NCT00086515|158401966|FG000|Phase A to Phase B Transition Period|Withdrawal by Subject|1|||
49153189|NCT00086515|158401967|FG001|Phase A to Phase B Transition Period|Withdrawal by Subject|0|||
49153190|NCT00086515|158401966|FG000|Phase A to Phase B Transition Period|Protocol Violation|0|||
49153191|NCT00086515|158401967|FG001|Phase A to Phase B Transition Period|Protocol Violation|1|||
49153192|NCT00086515|158401966|FG000|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16|||
49153193|NCT00086515|158401967|FG001|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23|||
49153194|NCT00086515|158401966|FG000|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
49153195|NCT00086515|158401967|FG001|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
49153196|NCT00086515|158401966|FG000|Phase A to Phase B Transition Period|Poor compliance|1|||
49153197|NCT00086515|158401967|FG001|Phase A to Phase B Transition Period|Poor compliance|0|||
49153198|NCT00086515|158401966|FG000|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1|||
49153199|NCT00086515|158401967|FG001|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0|||
49153200|NCT00086515|158401966|FG000|Phase B (Weeks 24-104)|Adverse Event|16|||
49153201|NCT00086515|158401967|FG001|Phase B (Weeks 24-104)|Adverse Event|10|||
49153202|NCT00086515|158401966|FG000|Phase B (Weeks 24-104)|Lack of Efficacy|94|||
49153203|NCT00086515|158401967|FG001|Phase B (Weeks 24-104)|Lack of Efficacy|19|||
49153204|NCT00086515|158401966|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|13|||
49153205|NCT00086515|158401967|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|4|||
49153206|NCT00086515|158401966|FG000|Phase B (Weeks 24-104)|Physician Decision|3|||
49153207|NCT00086515|158401967|FG001|Phase B (Weeks 24-104)|Physician Decision|0|||
49153208|NCT00086515|158401966|FG000|Phase B (Weeks 24-104)|Protocol Violation|1|||
49153209|NCT00086515|158401967|FG001|Phase B (Weeks 24-104)|Protocol Violation|0|||
49153210|NCT00086515|158401966|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|15|||
49153211|NCT00086515|158401967|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|5|||
49153212|NCT00086515|158401966|FG000|Phase B (Weeks 24-104)|Patient Moved|2|||
49153213|NCT00086515|158401967|FG001|Phase B (Weeks 24-104)|Patient Moved|2|||
49153214|NCT00086515|158401966|FG000|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5|||
49153215|NCT00086515|158401967|FG001|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3|||
49153216|NCT00086515|158401966|FG000|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36|||
49153217|NCT00086515|158401967|FG001|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10|||
49153218|NCT00086515|158401966|FG000|Phase B (Weeks 24-104)|Patient Died|3|||
49153219|NCT00086515|158401967|FG001|Phase B (Weeks 24-104)|Patient Died|1|||
49153220|NCT00086515|158401966|FG000|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0|||
49153221|NCT00086515|158401967|FG001|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1|||
49153222|NCT00086515|158401966|FG000|Phase B (Weeks 24-104)|Personal Circumstance|1|||
49153223|NCT00086515|158401967|FG001|Phase B (Weeks 24-104)|Personal Circumstance|0|||
49153224|NCT00086515|158401966|FG000|Phase B (Weeks 24-104)|Discontinued in error|1|||
49153225|NCT00086515|158401967|FG001|Phase B (Weeks 24-104)|Discontinued in error|0|||
49153226|NCT00209131|158401968|FG000|Overall Study|Lack of personnel due to turnovers.|15|||
49153227|NCT00209131|158401969|FG001|Overall Study|Lack of personnel due to turnovers.|11|||
49153228|NCT03770286|158401984|FG000|Overall Study|Lost to Follow-up|6|||
49153229|NCT03770286|158401985|FG001|Overall Study|Lost to Follow-up|4|||
49153230|NCT03770286|158401986|FG002|Overall Study|Lost to Follow-up|3|||
49153231|NCT03770286|158401984|FG000|Overall Study|Protocol Violation|1|||
49153232|NCT03770286|158401985|FG001|Overall Study|Protocol Violation|0|||
49153233|NCT03770286|158401986|FG002|Overall Study|Protocol Violation|2|||
49153234|NCT03204812|158401989|FG000|Overall Study|Adverse Event|3|||
49153235|NCT04197583|158401991|FG000|Overall Study|Study Stent Replacement|34|||
49153236|NCT04197583|158401992|FG001|Overall Study|Study Stent Replacement|8|||
49153237|NCT04197583|158401991|FG000|Overall Study|Lost to Follow-up|14|||
49153238|NCT04197583|158401992|FG001|Overall Study|Lost to Follow-up|3|||
49153239|NCT04197583|158401991|FG000|Overall Study|Death|3|||
49153240|NCT04197583|158401992|FG001|Overall Study|Death|0|||
49153241|NCT04197583|158401991|FG000|Overall Study|Physician Decision|1|||
49153242|NCT04197583|158401992|FG001|Overall Study|Physician Decision|0|||
49153243|NCT04197583|158401991|FG000|Overall Study|Withdrawal by Subject|1|||
49153244|NCT04197583|158401992|FG001|Overall Study|Withdrawal by Subject|1|||
49153245|NCT04197583|158401991|FG000|Overall Study|Discontinued. Patient had disseminated metastatic condition|0|||
49153246|NCT04197583|158401992|FG001|Overall Study|Discontinued. Patient had disseminated metastatic condition|1|||
49153247|NCT04197583|158401991|FG000|Overall Study|Screen Failure|0|||
49153248|NCT04197583|158401992|FG001|Overall Study|Screen Failure|20|||
49153249|NCT04629196|158401993|FG000|Overall Study|Subject discontinued study drug|1|||
49153250|NCT04629196|158401994|FG001|Overall Study|Subject discontinued study drug|0|||
49153251|NCT04629196|158401993|FG000|Overall Study|Subject study drug dosing increased|1|||
49153252|NCT04629196|158401994|FG001|Overall Study|Subject study drug dosing increased|1|||
49153253|NCT04629196|158401993|FG000|Overall Study|Withdrawal by Subject|1|||
49153254|NCT04629196|158401994|FG001|Overall Study|Withdrawal by Subject|2|||
49153255|NCT00323622|158402001|FG000|Overall Study|Other|30|||
49153256|NCT00323622|158402002|FG001|Overall Study|Other|91|||
49153257|NCT00323622|158402003|FG002|Overall Study|Other|4|||
49153258|NCT00323622|158402004|FG003|Overall Study|Other|12|||
49153259|NCT00323622|158402005|FG004|Overall Study|Other|32|||
49153260|NCT00323622|158402006|FG005|Overall Study|Other|74|||
49153261|NCT00323622|158402007|FG006|Overall Study|Other|5|||
49153262|NCT00323622|158402008|FG007|Overall Study|Other|13|||
49153263|NCT00323622|158402001|FG000|Overall Study|Death|1|||
49153264|NCT00323622|158402002|FG001|Overall Study|Death|1|||
49153265|NCT00323622|158402003|FG002|Overall Study|Death|0|||
49153266|NCT00323622|158402004|FG003|Overall Study|Death|0|||
49153267|NCT00323622|158402005|FG004|Overall Study|Death|7|||
49153268|NCT00323622|158402006|FG005|Overall Study|Death|0|||
49153269|NCT00323622|158402007|FG006|Overall Study|Death|0|||
49153270|NCT00323622|158402008|FG007|Overall Study|Death|2|||
49153271|NCT05646355|158402016|FG000|Overall Study|Lost to Follow-up|1|||
49153272|NCT05646355|158402017|FG001|Overall Study|Lost to Follow-up|0|||
49153273|NCT05646355|158402016|FG000|Overall Study|translated materials not available for pilot|2|||
49153274|NCT05646355|158402017|FG001|Overall Study|translated materials not available for pilot|0|||
49153275|NCT05646355|158402016|FG000|Overall Study|no longer screen eligible (completed screening prior to intervention)|6|||
49153276|NCT05646355|158402017|FG001|Overall Study|no longer screen eligible (completed screening prior to intervention)|0|||
49153277|NCT03110562|158402018|FG000|Initial Treatment Period|Disease Progression|1|||
49153278|NCT03110562|158402019|FG001|Initial Treatment Period|Disease Progression|1|||
49153279|NCT03110562|158402020|FG002|Initial Treatment Period|Disease Progression|0|||
49153280|NCT03110562|158402021|FG003|Initial Treatment Period|Disease Progression|0|||
49153281|NCT03110562|158402018|FG000|Initial Treatment Period|Withdrawal by Subject|39|||
49153282|NCT03110562|158402019|FG001|Initial Treatment Period|Withdrawal by Subject|41|||
49153283|NCT03110562|158402020|FG002|Initial Treatment Period|Withdrawal by Subject|0|||
49153284|NCT03110562|158402021|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
49153285|NCT03110562|158402018|FG000|Initial Treatment Period|Adverse Event|1|||
49153286|NCT03110562|158402019|FG001|Initial Treatment Period|Adverse Event|0|||
49153287|NCT03110562|158402020|FG002|Initial Treatment Period|Adverse Event|0|||
49153288|NCT03110562|158402021|FG003|Initial Treatment Period|Adverse Event|0|||
49153289|NCT03110562|158402018|FG000|Initial Treatment Period|Death|74|||
49153290|NCT03110562|158402019|FG001|Initial Treatment Period|Death|82|||
49153291|NCT03110562|158402020|FG002|Initial Treatment Period|Death|0|||
49153292|NCT03110562|158402021|FG003|Initial Treatment Period|Death|0|||
49153293|NCT03110562|158402018|FG000|Initial Treatment Period|Lost to Follow-up|13|||
49153294|NCT03110562|158402019|FG001|Initial Treatment Period|Lost to Follow-up|8|||
49153295|NCT03110562|158402020|FG002|Initial Treatment Period|Lost to Follow-up|0|||
49153296|NCT03110562|158402021|FG003|Initial Treatment Period|Lost to Follow-up|0|||
49153297|NCT03110562|158402018|FG000|Initial Treatment Period|Protocol Deviation|1|||
49153298|NCT03110562|158402019|FG001|Initial Treatment Period|Protocol Deviation|0|||
49153299|NCT03110562|158402020|FG002|Initial Treatment Period|Protocol Deviation|0|||
49153300|NCT03110562|158402021|FG003|Initial Treatment Period|Protocol Deviation|0|||
49153301|NCT03110562|158402018|FG000|Initial Treatment Period|Physician Decision|2|||
49153302|NCT03110562|158402019|FG001|Initial Treatment Period|Physician Decision|1|||
49153303|NCT03110562|158402020|FG002|Initial Treatment Period|Physician Decision|0|||
49153304|NCT03110562|158402021|FG003|Initial Treatment Period|Physician Decision|0|||
48826248|NCT00462943|157204133|FG001|Overall Study|Disease Progression|15|||
48826249|NCT00462943|157204134|FG002|Overall Study|Disease Progression|9|||
48826250|NCT00462943|157204132|FG000|Overall Study|Death|5|||
49153305|NCT03110562|158402018|FG000|Initial Treatment Period|Participants withdrawn due to company goals|59|||
49153306|NCT03110562|158402019|FG001|Initial Treatment Period|Participants withdrawn due to company goals|67|||
49153307|NCT03110562|158402020|FG002|Initial Treatment Period|Participants withdrawn due to company goals|0|||
48826251|NCT00462943|157204133|FG001|Overall Study|Death|2|||
48826252|NCT00462943|157204134|FG002|Overall Study|Death|7|||
49153308|NCT03110562|158402021|FG003|Initial Treatment Period|Participants withdrawn due to company goals|0|||
49153309|NCT03110562|158402018|FG000|Initial Treatment Period|Other|5|||
49153310|NCT03110562|158402019|FG001|Initial Treatment Period|Other|4|||
49153311|NCT03110562|158402020|FG002|Initial Treatment Period|Other|0|||
49153312|NCT03110562|158402021|FG003|Initial Treatment Period|Other|0|||
49153313|NCT03110562|158402018|FG000|Initial Treatment Period|Randomized but never treated|0|||
49153314|NCT03110562|158402019|FG001|Initial Treatment Period|Randomized but never treated|3|||
49153315|NCT03110562|158402020|FG002|Initial Treatment Period|Randomized but never treated|0|||
48921821|NCT02918864|157548024|FG000|Overall Study|Lost to Follow-up|3|||
49153316|NCT03110562|158402021|FG003|Initial Treatment Period|Randomized but never treated|0|||
49153317|NCT03110562|158402018|FG000|Crossover Period|Disease Progression|0|||
49153318|NCT03110562|158402019|FG001|Crossover Period|Disease Progression|0|||
49153319|NCT03110562|158402020|FG002|Crossover Period|Disease Progression|1|||
49153320|NCT03110562|158402021|FG003|Crossover Period|Disease Progression|0|||
49153321|NCT03110562|158402018|FG000|Crossover Period|Withdrawal by Subject|0|||
49153322|NCT03110562|158402019|FG001|Crossover Period|Withdrawal by Subject|0|||
49153323|NCT03110562|158402020|FG002|Crossover Period|Withdrawal by Subject|8|||
49153324|NCT03110562|158402021|FG003|Crossover Period|Withdrawal by Subject|6|||
49153325|NCT03110562|158402018|FG000|Crossover Period|Death|0|||
49153326|NCT03110562|158402019|FG001|Crossover Period|Death|0|||
49153327|NCT03110562|158402020|FG002|Crossover Period|Death|37|||
49153328|NCT03110562|158402021|FG003|Crossover Period|Death|3|||
49153329|NCT03110562|158402018|FG000|Crossover Period|Lost to Follow-up|0|||
49153330|NCT03110562|158402019|FG001|Crossover Period|Lost to Follow-up|0|||
49153331|NCT03110562|158402020|FG002|Crossover Period|Lost to Follow-up|0|||
49153332|NCT03110562|158402021|FG003|Crossover Period|Lost to Follow-up|1|||
49153333|NCT03110562|158402018|FG000|Crossover Period|Other|0|||
49153334|NCT03110562|158402019|FG001|Crossover Period|Other|0|||
49153335|NCT03110562|158402020|FG002|Crossover Period|Other|1|||
49153336|NCT03110562|158402021|FG003|Crossover Period|Other|1|||
49153337|NCT03110562|158402018|FG000|Crossover Period|Participants withdrawn due to company goals|0|||
49153338|NCT03110562|158402019|FG001|Crossover Period|Participants withdrawn due to company goals|0|||
49153339|NCT03110562|158402020|FG002|Crossover Period|Participants withdrawn due to company goals|19|||
49153340|NCT03110562|158402021|FG003|Crossover Period|Participants withdrawn due to company goals|3|||
49153341|NCT01111552|158402022|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|9|||
49153342|NCT01111552|158402023|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
49153343|NCT01111552|158402024|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
49153344|NCT01111552|158402025|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
49153345|NCT01111552|158402026|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
49153346|NCT01111552|158402022|FG000|Phase B (Day 1 to Week 8)|Adverse Event|4|||
49153347|NCT01111552|158402023|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
49153348|NCT01111552|158402024|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
49153349|NCT01111552|158402025|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
49153350|NCT01111552|158402026|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
49153351|NCT01111552|158402022|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89|||
49153352|NCT01111552|158402023|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
49153353|NCT01111552|158402024|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
49153354|NCT01111552|158402025|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
49153355|NCT01111552|158402026|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
49153356|NCT01111552|158402022|FG000|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3|||
48826253|NCT00462943|157204132|FG000|Overall Study|Stem Cell Transplant|1|||
48826254|NCT00462943|157204133|FG001|Overall Study|Stem Cell Transplant|1|||
48826255|NCT00462943|157204134|FG002|Overall Study|Stem Cell Transplant|0|||
48826256|NCT00462943|157204132|FG000|Overall Study|Bone Marrow Transplant|1|||
48826257|NCT00462943|157204133|FG001|Overall Study|Bone Marrow Transplant|0|||
48826258|NCT00462943|157204134|FG002|Overall Study|Bone Marrow Transplant|0|||
48826259|NCT00462943|157204132|FG000|Overall Study|Required Lymphocyte Infusion|1|||
48826260|NCT00462943|157204133|FG001|Overall Study|Required Lymphocyte Infusion|0|||
48826261|NCT00462943|157204134|FG002|Overall Study|Required Lymphocyte Infusion|0|||
48826262|NCT00462943|157204132|FG000|Overall Study|Transplant - not specified|1|||
48826263|NCT00462943|157204133|FG001|Overall Study|Transplant - not specified|0|||
48921822|NCT02918864|157548025|FG001|Overall Study|Lost to Follow-up|2|||
48921823|NCT00082888|157548026|FG000|Overall Study|Ineligible|1|||
48921824|NCT00082888|157548027|FG001|Overall Study|Ineligible|0|||
48921825|NCT00082888|157548028|FG002|Overall Study|Ineligible|0|||
48921826|NCT01148537|157548034|FG000|Overall Study|Withdrawal by Subject|1|||
48921827|NCT01148537|157548035|FG001|Overall Study|Withdrawal by Subject|0|||
48921828|NCT01148537|157548036|FG002|Overall Study|Withdrawal by Subject|2|||
48921829|NCT01148537|157548034|FG000|Overall Study|Adverse Event|2|||
49153357|NCT01111552|158402023|FG001|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
48921830|NCT01148537|157548035|FG001|Overall Study|Adverse Event|0|||
48921831|NCT01148537|157548036|FG002|Overall Study|Adverse Event|1|||
49153358|NCT01111552|158402024|FG002|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
49153359|NCT01111552|158402025|FG003|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
49153360|NCT01111552|158402026|FG004|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
48826264|NCT00462943|157204134|FG002|Overall Study|Transplant - not specified|1|||
49153361|NCT01111552|158402022|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3|||
49153362|NCT01111552|158402023|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
49153363|NCT01111552|158402024|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
48826265|NCT00462943|157204132|FG000|Overall Study|Physician Decision|1|||
48921832|NCT00847912|157548037|FG000|Overall Study|Protocol Violation|6|||
48921833|NCT00847912|157548038|FG001|Overall Study|Protocol Violation|7|||
48921834|NCT00847912|157548037|FG000|Overall Study|Withdrawal by Subject|3|||
49153364|NCT01111552|158402025|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
49153365|NCT01111552|158402026|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
49153366|NCT01111552|158402022|FG000|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7|||
49153367|NCT01111552|158402023|FG001|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
49153368|NCT01111552|158402024|FG002|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
48826266|NCT00462943|157204133|FG001|Overall Study|Physician Decision|0|||
48734073|NCT01460368|156877685|FG004|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
48734074|NCT01460368|156877686|FG005|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
48734075|NCT01460368|156877687|FG006|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
48734076|NCT03452228|156877688|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
48734077|NCT03452228|156877689|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
48734078|NCT03452228|156877690|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
48826267|NCT00462943|157204134|FG002|Overall Study|Physician Decision|0|||
48826268|NCT00462943|157204132|FG000|Overall Study|Withdrawal by Subject|0|||
48734079|NCT03452228|156877688|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
48734080|NCT03452228|156877689|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
48734081|NCT03452228|156877690|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
48734082|NCT03452228|156877688|FG000|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|1|||
48826269|NCT00462943|157204133|FG001|Overall Study|Withdrawal by Subject|1|||
48826270|NCT00462943|157204134|FG002|Overall Study|Withdrawal by Subject|0|||
49153369|NCT01111552|158402025|FG003|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
49153370|NCT01111552|158402026|FG004|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
49153371|NCT01111552|158402022|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|1|||
49153372|NCT01111552|158402023|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
49153373|NCT01111552|158402024|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
49153374|NCT01111552|158402025|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
49153375|NCT01111552|158402026|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
49153376|NCT01111552|158402022|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1|||
49153377|NCT01111552|158402023|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
49153378|NCT01111552|158402024|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
49153379|NCT01111552|158402025|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
49153380|NCT01111552|158402026|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
49153381|NCT01111552|158402022|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
49153382|NCT01111552|158402023|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
48826271|NCT00819234|157204135|FG000|Overall Study|Withdrawal by Subject|8|||
48826272|NCT00819234|157204136|FG001|Overall Study|Withdrawal by Subject|13|||
48826273|NCT00819234|157204137|FG002|Overall Study|Withdrawal by Subject|6|||
48826274|NCT00819234|157204138|FG003|Overall Study|Withdrawal by Subject|3|||
48826275|NCT00819234|157204139|FG004|Overall Study|Withdrawal by Subject|0|||
48826276|NCT00819234|157204140|FG005|Overall Study|Withdrawal by Subject|4|||
48826277|NCT00819234|157204141|FG006|Overall Study|Withdrawal by Subject|4|||
48826278|NCT00819234|157204142|FG007|Overall Study|Withdrawal by Subject|8|||
48826279|NCT00819234|157204143|FG008|Overall Study|Withdrawal by Subject|5|||
48826280|NCT00819234|157204144|FG009|Overall Study|Withdrawal by Subject|3|||
48826281|NCT00819234|157204135|FG000|Overall Study|Adverse Event|0|||
48826282|NCT00819234|157204136|FG001|Overall Study|Adverse Event|0|||
48826283|NCT00819234|157204137|FG002|Overall Study|Adverse Event|1|||
48826284|NCT00819234|157204138|FG003|Overall Study|Adverse Event|0|||
48734083|NCT03452228|156877689|FG001|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
48826285|NCT00819234|157204139|FG004|Overall Study|Adverse Event|0|||
48826286|NCT00819234|157204140|FG005|Overall Study|Adverse Event|2|||
48826287|NCT00819234|157204141|FG006|Overall Study|Adverse Event|0|||
48826288|NCT00819234|157204142|FG007|Overall Study|Adverse Event|0|||
48826289|NCT00819234|157204143|FG008|Overall Study|Adverse Event|0|||
48826290|NCT00819234|157204144|FG009|Overall Study|Adverse Event|0|||
48826291|NCT00819234|157204135|FG000|Overall Study|Physician Decision|0|||
48826292|NCT00819234|157204136|FG001|Overall Study|Physician Decision|0|||
48826293|NCT00819234|157204137|FG002|Overall Study|Physician Decision|0|||
48826294|NCT00819234|157204138|FG003|Overall Study|Physician Decision|1|||
48826295|NCT00819234|157204139|FG004|Overall Study|Physician Decision|0|||
48921835|NCT00847912|157548038|FG001|Overall Study|Withdrawal by Subject|6|||
48921836|NCT01294670|157548042|FG000|Overall Study|Not treated|1|||
48921837|NCT01294670|157548043|FG001|Overall Study|Not treated|0|||
49153383|NCT01111552|158402024|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
49153384|NCT01111552|158402025|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
49153385|NCT01111552|158402026|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
48921838|NCT01294670|157548044|FG002|Overall Study|Not treated|0|||
48921839|NCT01294670|157548045|FG003|Overall Study|Not treated|0|||
48921840|NCT01294670|157548046|FG004|Overall Study|Not treated|0|||
48734084|NCT03452228|156877690|FG002|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
48734085|NCT03452228|156877688|FG000|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
48734086|NCT03452228|156877689|FG001|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
48734087|NCT03452228|156877690|FG002|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
48734088|NCT01986907|156877693|FG000|Overall Study|Adverse Event|11|||
48734089|NCT01986907|156877693|FG000|Overall Study|Unsatisfactory therapeutic effect|24|||
48734090|NCT01986907|156877693|FG000|Overall Study|Protocol Violation|4|||
48734091|NCT01986907|156877693|FG000|Overall Study|Withdrawal by Subject|76|||
48734092|NCT01986907|156877693|FG000|Overall Study|Lost to Follow-up|38|||
48734093|NCT01986907|156877693|FG000|Overall Study|Death|9|||
48734094|NCT01297920|156877694|FG000|Overall Study|Adverse Event|42|||
48734095|NCT01297920|156877695|FG001|Overall Study|Adverse Event|10|||
48734096|NCT01297920|156877696|FG002|Overall Study|Adverse Event|38|||
48734097|NCT01297920|156877694|FG000|Overall Study|Patient Decision Unrelated to AE|6|||
48734098|NCT01297920|156877695|FG001|Overall Study|Patient Decision Unrelated to AE|5|||
48734099|NCT01297920|156877696|FG002|Overall Study|Patient Decision Unrelated to AE|2|||
48734100|NCT01297920|156877694|FG000|Overall Study|Noncompliance|1|||
48734101|NCT01297920|156877695|FG001|Overall Study|Noncompliance|0|||
48734102|NCT01297920|156877696|FG002|Overall Study|Noncompliance|0|||
48734103|NCT01297920|156877694|FG000|Overall Study|Protocol Violation|1|||
49153386|NCT01111552|158402022|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
49153387|NCT01111552|158402023|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
49153388|NCT01111552|158402024|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
49153389|NCT01111552|158402025|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
49153390|NCT01111552|158402026|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
49153391|NCT01111552|158402022|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
49153392|NCT01111552|158402023|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2|||
49153393|NCT01111552|158402024|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
49153394|NCT01111552|158402025|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
49153395|NCT01111552|158402026|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
49153396|NCT01111552|158402022|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
49153397|NCT01111552|158402023|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1|||
49153398|NCT01111552|158402024|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
49153399|NCT01111552|158402025|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
49153400|NCT01111552|158402026|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
48734104|NCT01297920|156877695|FG001|Overall Study|Protocol Violation|3|||
48734105|NCT01297920|156877696|FG002|Overall Study|Protocol Violation|0|||
48734106|NCT01297920|156877694|FG000|Overall Study|Inadequate Control of IOP|7|||
49153401|NCT01111552|158402022|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
49153402|NCT01111552|158402023|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1|||
49153403|NCT01111552|158402024|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
49153404|NCT01111552|158402025|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
49153405|NCT01111552|158402026|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
49153406|NCT01111552|158402022|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
49153407|NCT01111552|158402023|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
49153408|NCT01111552|158402024|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
49153409|NCT01111552|158402025|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
49153410|NCT01111552|158402026|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
49153411|NCT03926130|158402027|FG000|Overall Study|Adverse Event|9|||
49153412|NCT03926130|158402028|FG001|Overall Study|Adverse Event|11|||
49153413|NCT03926130|158402029|FG002|Overall Study|Adverse Event|2|||
49153414|NCT03926130|158402030|FG003|Overall Study|Adverse Event|0|||
49153415|NCT03926130|158402027|FG000|Overall Study|Death|2|||
49153416|NCT03926130|158402028|FG001|Overall Study|Death|0|||
49153417|NCT03926130|158402029|FG002|Overall Study|Death|1|||
49153418|NCT03926130|158402030|FG003|Overall Study|Death|0|||
49153419|NCT03926130|158402027|FG000|Overall Study|Lack of Efficacy|14|||
49153420|NCT03926130|158402028|FG001|Overall Study|Lack of Efficacy|11|||
49153421|NCT03926130|158402029|FG002|Overall Study|Lack of Efficacy|7|||
49153422|NCT03926130|158402030|FG003|Overall Study|Lack of Efficacy|1|||
49153423|NCT03926130|158402027|FG000|Overall Study|Lost to Follow-up|0|||
49153424|NCT03926130|158402028|FG001|Overall Study|Lost to Follow-up|7|||
49153425|NCT03926130|158402029|FG002|Overall Study|Lost to Follow-up|1|||
49153426|NCT03926130|158402030|FG003|Overall Study|Lost to Follow-up|0|||
49153427|NCT03926130|158402027|FG000|Overall Study|As Reported by Investigator|2|||
49153428|NCT03926130|158402028|FG001|Overall Study|As Reported by Investigator|6|||
48734107|NCT01297920|156877695|FG001|Overall Study|Inadequate Control of IOP|9|||
48734108|NCT01297920|156877696|FG002|Overall Study|Inadequate Control of IOP|17|||
48734109|NCT01297920|156877694|FG000|Overall Study|Patient Did Not Meet Entrance Criteria|1|||
48826296|NCT00819234|157204140|FG005|Overall Study|Physician Decision|0|||
48734110|NCT01297920|156877695|FG001|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
48734111|NCT01297920|156877696|FG002|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
48734112|NCT01090973|156877697|FG000|Overall Study|Disease progression|1|||
48734113|NCT02507973|156877698|FG000|Overall Study|Adverse Event|1|||
48734114|NCT01565642|156877699|FG000|Overall Study|Withdrawal by Subject|2|||
48734115|NCT01565642|156877700|FG001|Overall Study|Withdrawal by Subject|1|||
48734116|NCT02770170|156877703|FG000|Overall Study|Withdrawal by Subject|0|||
48734117|NCT02770170|156877704|FG001|Overall Study|Withdrawal by Subject|0|||
48734118|NCT02770170|156877705|FG002|Overall Study|Withdrawal by Subject|0|||
48734119|NCT02770170|156877706|FG003|Overall Study|Withdrawal by Subject|2|||
48734120|NCT02770170|156877703|FG000|Overall Study|due to pregnancy|1|||
48734121|NCT02770170|156877704|FG001|Overall Study|due to pregnancy|0|||
48734122|NCT02770170|156877705|FG002|Overall Study|due to pregnancy|0|||
48734123|NCT02770170|156877706|FG003|Overall Study|due to pregnancy|0|||
48734124|NCT02770170|156877703|FG000|Overall Study|Lack of Efficacy|2|||
48734125|NCT02770170|156877704|FG001|Overall Study|Lack of Efficacy|0|||
48734126|NCT02770170|156877705|FG002|Overall Study|Lack of Efficacy|0|||
48734127|NCT02770170|156877706|FG003|Overall Study|Lack of Efficacy|1|||
48734128|NCT02770170|156877703|FG000|Overall Study|Adverse Event|4|||
48734129|NCT02770170|156877704|FG001|Overall Study|Adverse Event|3|||
48734130|NCT02770170|156877705|FG002|Overall Study|Adverse Event|5|||
48734131|NCT02770170|156877706|FG003|Overall Study|Adverse Event|3|||
48734132|NCT02770170|156877703|FG000|Overall Study|due to disease worsening|0|||
48734133|NCT02770170|156877704|FG001|Overall Study|due to disease worsening|0|||
48734134|NCT02770170|156877705|FG002|Overall Study|due to disease worsening|0|||
48734135|NCT02770170|156877706|FG003|Overall Study|due to disease worsening|1|||
48734136|NCT01710046|156877709|FG000|Overall Study|Lost to Follow-up|1|||
48734137|NCT01710046|156877710|FG001|Overall Study|Lost to Follow-up|0|||
48734138|NCT00467857|156877711|FG000|Overall Study|Adverse Event|1|||
48734139|NCT00467857|156877712|FG001|Overall Study|Adverse Event|0|||
48734140|NCT00467857|156877711|FG000|Overall Study|Withdrew consent|2|||
48734141|NCT00467857|156877712|FG001|Overall Study|Withdrew consent|0|||
48734142|NCT00467857|156877711|FG000|Overall Study|Death|0|||
48734143|NCT00467857|156877712|FG001|Overall Study|Death|1|||
48734144|NCT00467857|156877711|FG000|Overall Study|Discharged from court service|0|||
48734145|NCT00467857|156877712|FG001|Overall Study|Discharged from court service|1|||
48734146|NCT00467857|156877711|FG000|Overall Study|Emergency care required|0|||
48734147|NCT00467857|156877712|FG001|Overall Study|Emergency care required|1|||
48734148|NCT00467857|156877711|FG000|Overall Study|Did not meet inclusion/exclusion criteri|0|||
48734149|NCT00467857|156877712|FG001|Overall Study|Did not meet inclusion/exclusion criteri|2|||
48734150|NCT00467857|156877711|FG000|Overall Study|Discontinuation reason missing|0|||
48734151|NCT00467857|156877712|FG001|Overall Study|Discontinuation reason missing|3|||
48734152|NCT02349542|156877713|FG000|Overall Study|Withdrawal by Subject|5|||
48734153|NCT00543543|156877714|FG000|Base Study|Adverse Event|1|||
48734154|NCT00543543|156877715|FG001|Base Study|Adverse Event|11|||
48734155|NCT00543543|156877716|FG002|Base Study|Adverse Event|0|||
48734156|NCT00543543|156877717|FG003|Base Study|Adverse Event|5|||
48734157|NCT00543543|156877714|FG000|Base Study|Lost to Follow-up|12|||
48734158|NCT00543543|156877715|FG001|Base Study|Lost to Follow-up|749|||
48734159|NCT00543543|156877716|FG002|Base Study|Lost to Follow-up|9|||
48734160|NCT00543543|156877717|FG003|Base Study|Lost to Follow-up|701|||
48734161|NCT00543543|156877714|FG000|Base Study|Physician Decision|0|||
48734162|NCT00543543|156877715|FG001|Base Study|Physician Decision|4|||
48734163|NCT00543543|156877716|FG002|Base Study|Physician Decision|0|||
48734164|NCT00543543|156877717|FG003|Base Study|Physician Decision|7|||
48734165|NCT00543543|156877714|FG000|Base Study|Protocol Violation|0|||
48734166|NCT00543543|156877715|FG001|Base Study|Protocol Violation|6|||
48734167|NCT00543543|156877716|FG002|Base Study|Protocol Violation|0|||
48734168|NCT00543543|156877717|FG003|Base Study|Protocol Violation|6|||
48734169|NCT00543543|156877714|FG000|Base Study|Withdrawal by Subject|7|||
48734170|NCT00543543|156877715|FG001|Base Study|Withdrawal by Subject|482|||
48734171|NCT00543543|156877716|FG002|Base Study|Withdrawal by Subject|5|||
48734172|NCT00543543|156877717|FG003|Base Study|Withdrawal by Subject|503|||
48734173|NCT00543543|156877714|FG000|Extension Study|Adverse Event|0|||
48734174|NCT00543543|156877715|FG001|Extension Study|Adverse Event|0|||
48826297|NCT00819234|157204141|FG006|Overall Study|Physician Decision|0|||
48826298|NCT00819234|157204142|FG007|Overall Study|Physician Decision|0|||
48826299|NCT00819234|157204143|FG008|Overall Study|Physician Decision|0|||
48826300|NCT00819234|157204144|FG009|Overall Study|Physician Decision|2|||
48734175|NCT00543543|156877716|FG002|Extension Study|Adverse Event|0|||
48734176|NCT00543543|156877717|FG003|Extension Study|Adverse Event|5|||
48734177|NCT00543543|156877714|FG000|Extension Study|Lost to Follow-up|0|||
48734178|NCT00543543|156877715|FG001|Extension Study|Lost to Follow-up|0|||
48734179|NCT00543543|156877716|FG002|Extension Study|Lost to Follow-up|0|||
48734180|NCT00543543|156877717|FG003|Extension Study|Lost to Follow-up|77|||
48734181|NCT00543543|156877714|FG000|Extension Study|Physician Decision|0|||
48734182|NCT00543543|156877715|FG001|Extension Study|Physician Decision|0|||
48734183|NCT00543543|156877716|FG002|Extension Study|Physician Decision|0|||
48734184|NCT00543543|156877717|FG003|Extension Study|Physician Decision|7|||
48734185|NCT00543543|156877714|FG000|Extension Study|Pregnancy|0|||
48734186|NCT00543543|156877715|FG001|Extension Study|Pregnancy|0|||
48734187|NCT00543543|156877716|FG002|Extension Study|Pregnancy|0|||
48734188|NCT00543543|156877717|FG003|Extension Study|Pregnancy|6|||
48734189|NCT00543543|156877714|FG000|Extension Study|Protocol Violation|0|||
48734190|NCT00543543|156877715|FG001|Extension Study|Protocol Violation|0|||
48734191|NCT00543543|156877716|FG002|Extension Study|Protocol Violation|0|||
48734192|NCT00543543|156877717|FG003|Extension Study|Protocol Violation|11|||
48734193|NCT00543543|156877714|FG000|Extension Study|Withdrawal by Subject|0|||
48734194|NCT00543543|156877715|FG001|Extension Study|Withdrawal by Subject|0|||
48734195|NCT00543543|156877716|FG002|Extension Study|Withdrawal by Subject|0|||
48734196|NCT00543543|156877717|FG003|Extension Study|Withdrawal by Subject|120|||
48734197|NCT04122534|156877721|FG000|Overall Study|Lost to Follow-up|4|||
48734198|NCT02959983|156877726|FG000|Overall Study|Protocol Violation|0|||
48734199|NCT02959983|156877727|FG001|Overall Study|Protocol Violation|1|||
48734200|NCT02959983|156877726|FG000|Overall Study|Lack of Efficacy|0|||
48734201|NCT02959983|156877727|FG001|Overall Study|Lack of Efficacy|1|||
48734202|NCT02959983|156877726|FG000|Overall Study|Lost to Follow-up|12|||
48734203|NCT02959983|156877727|FG001|Overall Study|Lost to Follow-up|9|||
48826301|NCT00819234|157204135|FG000|Overall Study|Protocol Violation|0|||
48826302|NCT00819234|157204136|FG001|Overall Study|Protocol Violation|0|||
48826303|NCT00819234|157204137|FG002|Overall Study|Protocol Violation|1|||
48826304|NCT00819234|157204138|FG003|Overall Study|Protocol Violation|0|||
48826305|NCT00819234|157204139|FG004|Overall Study|Protocol Violation|0|||
48826306|NCT00819234|157204140|FG005|Overall Study|Protocol Violation|0|||
48826307|NCT00819234|157204141|FG006|Overall Study|Protocol Violation|0|||
48826308|NCT00819234|157204142|FG007|Overall Study|Protocol Violation|0|||
48826309|NCT00819234|157204143|FG008|Overall Study|Protocol Violation|0|||
48826310|NCT00819234|157204144|FG009|Overall Study|Protocol Violation|0|||
48826311|NCT00819234|157204135|FG000|Overall Study|Lost to Follow-up|2|||
48826312|NCT00819234|157204136|FG001|Overall Study|Lost to Follow-up|2|||
48826313|NCT00819234|157204137|FG002|Overall Study|Lost to Follow-up|0|||
48826314|NCT00819234|157204138|FG003|Overall Study|Lost to Follow-up|2|||
48826315|NCT00819234|157204139|FG004|Overall Study|Lost to Follow-up|1|||
48826316|NCT00819234|157204140|FG005|Overall Study|Lost to Follow-up|1|||
48826317|NCT00819234|157204141|FG006|Overall Study|Lost to Follow-up|1|||
48826318|NCT00819234|157204142|FG007|Overall Study|Lost to Follow-up|1|||
48826319|NCT00819234|157204143|FG008|Overall Study|Lost to Follow-up|1|||
48826320|NCT00819234|157204144|FG009|Overall Study|Lost to Follow-up|2|||
48826321|NCT01096056|157204145|FG000|Overall Study|Lost to Follow-up|0|||
48826322|NCT01096056|157204146|FG001|Overall Study|Lost to Follow-up|1|||
48826323|NCT04438785|157204147|FG000|Overall Study|change of weight, give up intervention|2|||
48826324|NCT04438785|157204148|FG001|Overall Study|change of weight, give up intervention|10|||
48826325|NCT02027935|157204152|FG000|Overall Study|Death|1|||
49153429|NCT03926130|158402029|FG002|Overall Study|As Reported by Investigator|6|||
49153430|NCT03926130|158402030|FG003|Overall Study|As Reported by Investigator|0|||
48734204|NCT02959983|156877726|FG000|Overall Study|Other|1|||
48734205|NCT02959983|156877727|FG001|Overall Study|Other|1|||
48734206|NCT02959983|156877726|FG000|Overall Study|Physician Decision|1|||
48734207|NCT02959983|156877727|FG001|Overall Study|Physician Decision|0|||
48734208|NCT02959983|156877726|FG000|Overall Study|Adverse Event|5|||
48734209|NCT02959983|156877727|FG001|Overall Study|Adverse Event|1|||
48734210|NCT02959983|156877726|FG000|Overall Study|Withdrawal by Subject|7|||
48734211|NCT02959983|156877727|FG001|Overall Study|Withdrawal by Subject|12|||
48734212|NCT02020577|156877728|FG000|Overall Study|Progressive disease|3|||
48826326|NCT02027935|157204152|FG000|Overall Study|Lack of Efficacy|5|||
48826327|NCT02027935|157204152|FG000|Overall Study|Study Closure|1|||
49153431|NCT03926130|158402027|FG000|Overall Study|Physician Decision|3|||
49153432|NCT03926130|158402028|FG001|Overall Study|Physician Decision|2|||
49153433|NCT03926130|158402029|FG002|Overall Study|Physician Decision|1|||
49153434|NCT03926130|158402030|FG003|Overall Study|Physician Decision|0|||
49153435|NCT03926130|158402027|FG000|Overall Study|Pregnancy|2|||
49153436|NCT03926130|158402028|FG001|Overall Study|Pregnancy|2|||
49153437|NCT03926130|158402029|FG002|Overall Study|Pregnancy|1|||
48734213|NCT02020577|156877729|FG001|Overall Study|Progressive disease|38|||
48734214|NCT02020577|156877728|FG000|Overall Study|Other AE or clinical progression|0|||
48734215|NCT02020577|156877729|FG001|Overall Study|Other AE or clinical progression|15|||
48734216|NCT02020577|156877728|FG000|Overall Study|Withdrawal by Subject|0|||
48826328|NCT03115346|157204153|FG000|Overall Study|Did not have AAA surgery|28|||
48734217|NCT02020577|156877729|FG001|Overall Study|Withdrawal by Subject|1|||
48734218|NCT02020577|156877728|FG000|Overall Study|Other than stated above|0|||
48826329|NCT03115346|157204154|FG001|Overall Study|Did not have AAA surgery|15|||
48826330|NCT03115346|157204153|FG000|Overall Study|Death|3|||
48826331|NCT03115346|157204154|FG001|Overall Study|Death|1|||
48826332|NCT03115346|157204153|FG000|Overall Study|Withdrawal by Subject|0|||
49153438|NCT03926130|158402030|FG003|Overall Study|Pregnancy|0|||
48826333|NCT03115346|157204154|FG001|Overall Study|Withdrawal by Subject|3|||
48826334|NCT03115346|157204153|FG000|Overall Study|Lost to Follow-up|0|||
49153439|NCT03926130|158402027|FG000|Overall Study|Withdrawal by Subject|20|||
48734219|NCT02020577|156877729|FG001|Overall Study|Other than stated above|1|||
48734220|NCT00484094|156877730|FG000|Overall Study|Discontinued|39|||
48734221|NCT00484094|156877730|FG000|Overall Study|Other|3|||
48734222|NCT00621959|156877734|FG000|Overall Study|Adverse Event|4|||
48734223|NCT00621959|156877735|FG001|Overall Study|Adverse Event|2|||
48734224|NCT00621959|156877734|FG000|Overall Study|Lack of Efficacy|1|||
48734225|NCT00621959|156877735|FG001|Overall Study|Lack of Efficacy|1|||
48734226|NCT00621959|156877734|FG000|Overall Study|Lost to Follow-up|0|||
48734227|NCT00621959|156877735|FG001|Overall Study|Lost to Follow-up|2|||
48734228|NCT00621959|156877734|FG000|Overall Study|Withdrawal by Subject|1|||
48734229|NCT00621959|156877735|FG001|Overall Study|Withdrawal by Subject|1|||
48734230|NCT00621959|156877734|FG000|Overall Study|Other|1|||
49153440|NCT03926130|158402028|FG001|Overall Study|Withdrawal by Subject|28|||
49153441|NCT03926130|158402029|FG002|Overall Study|Withdrawal by Subject|18|||
49153442|NCT03926130|158402030|FG003|Overall Study|Withdrawal by Subject|1|||
49153443|NCT03926130|158402027|FG000|Overall Study|Non-Compliance|1|||
49153444|NCT03926130|158402028|FG001|Overall Study|Non-Compliance|1|||
48734231|NCT00621959|156877735|FG001|Overall Study|Other|3|||
48734232|NCT00590135|156877736|FG000|Overall Study|Primary endpoint measure not obtainable|59|||
48734233|NCT01414608|156877737|FG000|Overall Study|Ineligible|5|||
48826335|NCT03115346|157204154|FG001|Overall Study|Lost to Follow-up|3|||
48826336|NCT00630864|157204156|FG000|Part 1 (up to Week 6)|Adverse Event|1|||
48826337|NCT00630864|157204156|FG000|Part 2 (After Week 6 up to Month 12)|Liver transplant|2|||
48826338|NCT02014558|157204157|FG000|Overall Study|Never Received Study Drug|0|||
48826339|NCT02014558|157204158|FG001|Overall Study|Never Received Study Drug|0|||
48826340|NCT02014558|157204159|FG002|Overall Study|Never Received Study Drug|0|||
48826341|NCT02014558|157204160|FG003|Overall Study|Never Received Study Drug|0|||
48826342|NCT02014558|157204161|FG004|Overall Study|Never Received Study Drug|1|||
48826343|NCT02014558|157204162|FG005|Overall Study|Never Received Study Drug|0|||
48826344|NCT02014558|157204163|FG006|Overall Study|Never Received Study Drug|1|||
48826345|NCT02014558|157204164|FG007|Overall Study|Never Received Study Drug|0|||
48826346|NCT02014558|157204165|FG008|Overall Study|Never Received Study Drug|2|||
48826347|NCT02014558|157204166|FG009|Overall Study|Never Received Study Drug|0|||
48826348|NCT02014558|157204167|FG010|Overall Study|Never Received Study Drug|2|||
48826349|NCT02014558|157204168|FG011|Overall Study|Never Received Study Drug|2|||
48826350|NCT02014558|157204169|FG012|Overall Study|Never Received Study Drug|0|||
48826351|NCT02014558|157204157|FG000|Overall Study|Adverse Event|0|||
48826352|NCT02014558|157204158|FG001|Overall Study|Adverse Event|0|||
48826353|NCT02014558|157204159|FG002|Overall Study|Adverse Event|0|||
48826354|NCT02014558|157204160|FG003|Overall Study|Adverse Event|0|||
48826355|NCT02014558|157204161|FG004|Overall Study|Adverse Event|1|||
48826356|NCT02014558|157204162|FG005|Overall Study|Adverse Event|0|||
48826357|NCT02014558|157204163|FG006|Overall Study|Adverse Event|0|||
48826358|NCT02014558|157204164|FG007|Overall Study|Adverse Event|0|||
48826359|NCT02014558|157204165|FG008|Overall Study|Adverse Event|2|||
48826360|NCT02014558|157204166|FG009|Overall Study|Adverse Event|2|||
48826361|NCT02014558|157204167|FG010|Overall Study|Adverse Event|5|||
48921841|NCT00661531|157548047|FG000|Overall Study|Withdrawal by Subject|3|||
48921842|NCT00838331|157548049|FG000|Aged Blood Transfusion|Withdrawal by Subject|9|||
48921843|NCT01309659|157548050|FG000|Overall Study|Protocol Violation|0|||
48921844|NCT01309659|157548051|FG001|Overall Study|Protocol Violation|1|||
48921845|NCT01650636|157548052|FG000|Washout up to 5 Months|Withdrawal by Subject|4|||
48921846|NCT01650636|157548053|FG001|Washout up to 5 Months|Withdrawal by Subject|8|||
48921847|NCT01650636|157548052|FG000|Washout up to 5 Months|Physician Decision|2|||
49014254|NCT01703741|157888796|FG000|Overall Study|Lost to Follow-up|3|||
49153445|NCT03926130|158402029|FG002|Overall Study|Non-Compliance|0|||
48826362|NCT02014558|157204168|FG011|Overall Study|Adverse Event|21|||
48826363|NCT02014558|157204169|FG012|Overall Study|Adverse Event|3|||
48826364|NCT02014558|157204157|FG000|Overall Study|Death|1|||
48826365|NCT02014558|157204158|FG001|Overall Study|Death|0|||
49153446|NCT03926130|158402030|FG003|Overall Study|Non-Compliance|0|||
49153447|NCT03926130|158402027|FG000|Overall Study|Disposition Not Captured|0|||
49153448|NCT03926130|158402028|FG001|Overall Study|Disposition Not Captured|2|||
49153449|NCT03926130|158402029|FG002|Overall Study|Disposition Not Captured|1|||
49153450|NCT03926130|158402030|FG003|Overall Study|Disposition Not Captured|0|||
49153451|NCT01969058|158402031|FG000|Overall Study|Withdrawal by Subject|2|||
49153452|NCT01969058|158402032|FG001|Overall Study|Withdrawal by Subject|0|||
49153453|NCT01969058|158402031|FG000|Overall Study|Adverse Event|1|||
48921848|NCT01650636|157548053|FG001|Washout up to 5 Months|Physician Decision|2|||
48921849|NCT01650636|157548052|FG000|Washout up to 5 Months|Death|1|||
49153454|NCT01969058|158402032|FG001|Overall Study|Adverse Event|0|||
49153455|NCT03913130|158402033|FG000|Overall Study|Sponsor Decision|1|||
49153456|NCT01587196|158402034|FG000|Overall Study|Lost to Follow-up|50|||
49153457|NCT01587196|158402034|FG000|Overall Study|Withdrawal by Subject|4|||
49153458|NCT01355627|158402036|FG000|Overall Study|Request By the Patient to Discontinue|5|||
49153459|NCT01355627|158402037|FG001|Overall Study|Request By the Patient to Discontinue|7|||
49153460|NCT01355627|158402036|FG000|Overall Study|Lost to Follow-up|8|||
49153461|NCT01355627|158402037|FG001|Overall Study|Lost to Follow-up|7|||
49153462|NCT01355627|158402036|FG000|Overall Study|Fatal Adverse Event|19|||
49153463|NCT01355627|158402037|FG001|Overall Study|Fatal Adverse Event|23|||
49153464|NCT01355627|158402036|FG000|Overall Study|Other|1|||
48734234|NCT01414608|156877738|FG001|Overall Study|Ineligible|2|||
48734235|NCT03331250|156877739|FG000|Overall Study|Withdrawal by Subject|1|||
48734236|NCT03344796|156877742|FG000|Overall Study|Lost to Follow-up|0|||
48734237|NCT03344796|156877743|FG001|Overall Study|Lost to Follow-up|0|||
48734238|NCT03344796|156877744|FG002|Overall Study|Lost to Follow-up|0|||
48734239|NCT03344796|156877745|FG003|Overall Study|Lost to Follow-up|0|||
48734240|NCT03344796|156877746|FG004|Overall Study|Lost to Follow-up|0|||
48734241|NCT03344796|156877747|FG005|Overall Study|Lost to Follow-up|2|||
48734242|NCT01736124|156877748|FG000|Post-intervention Assessment|Death|2|||
48734243|NCT01736124|156877749|FG001|Post-intervention Assessment|Death|2|||
48734244|NCT01736124|156877748|FG000|Post-intervention Assessment|lost computer access|1|||
48734245|NCT01736124|156877749|FG001|Post-intervention Assessment|lost computer access|1|||
48734246|NCT01736124|156877748|FG000|Post-intervention Assessment|Moved away|3|||
48734247|NCT01736124|156877749|FG001|Post-intervention Assessment|Moved away|1|||
48734248|NCT01736124|156877748|FG000|Post-intervention Assessment|Withdrawal by Subject|11|||
48734249|NCT01736124|156877749|FG001|Post-intervention Assessment|Withdrawal by Subject|9|||
48734250|NCT01736124|156877748|FG000|Post-intervention Assessment|Illness|3|||
48734251|NCT01736124|156877749|FG001|Post-intervention Assessment|Illness|2|||
48734252|NCT01736124|156877748|FG000|Post-intervention Assessment|Lost to Follow-up|8|||
48734253|NCT01736124|156877749|FG001|Post-intervention Assessment|Lost to Follow-up|5|||
48734254|NCT01736124|156877748|FG000|Post-intervention Assessment|Temporarily away|3|||
48734255|NCT01736124|156877749|FG001|Post-intervention Assessment|Temporarily away|1|||
48734256|NCT01736124|156877748|FG000|6 Mo. Post-Intervention Assessment|Death|0|||
48734257|NCT01736124|156877749|FG001|6 Mo. Post-Intervention Assessment|Death|1|||
48734258|NCT01736124|156877748|FG000|6 Mo. Post-Intervention Assessment|Moved away|0|||
48734259|NCT01736124|156877749|FG001|6 Mo. Post-Intervention Assessment|Moved away|2|||
48734260|NCT01736124|156877748|FG000|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
48734261|NCT01736124|156877749|FG001|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
48734262|NCT01736124|156877748|FG000|6 Mo. Post-Intervention Assessment|Illness|1|||
48734263|NCT01736124|156877749|FG001|6 Mo. Post-Intervention Assessment|Illness|2|||
48734264|NCT01736124|156877748|FG000|6 Mo. Post-Intervention Assessment|Temporarily away|1|||
48734265|NCT01736124|156877749|FG001|6 Mo. Post-Intervention Assessment|Temporarily away|4|||
48734266|NCT01736124|156877748|FG000|12 Mo. Post-Intervention Assessment|Death|1|||
48734267|NCT01736124|156877749|FG001|12 Mo. Post-Intervention Assessment|Death|0|||
48734268|NCT01736124|156877748|FG000|12 Mo. Post-Intervention Assessment|Moved away|1|||
48734269|NCT01736124|156877749|FG001|12 Mo. Post-Intervention Assessment|Moved away|0|||
48734270|NCT01736124|156877748|FG000|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0|||
48734271|NCT01736124|156877749|FG001|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2|||
48734272|NCT01736124|156877748|FG000|12 Mo. Post-Intervention Assessment|End of study|10|||
48734273|NCT01736124|156877749|FG001|12 Mo. Post-Intervention Assessment|End of study|10|||
48734274|NCT02130024|156877751|FG000|Overall Study|Adverse Event|10|||
48734275|NCT02130024|156877752|FG001|Overall Study|Adverse Event|11|||
48734276|NCT02130024|156877751|FG000|Overall Study|Death|2|||
48734277|NCT02130024|156877752|FG001|Overall Study|Death|2|||
48734278|NCT02130024|156877751|FG000|Overall Study|Lost to Follow-up|1|||
48734279|NCT02130024|156877752|FG001|Overall Study|Lost to Follow-up|1|||
48734280|NCT02130024|156877751|FG000|Overall Study|Physician Decision|1|||
48734281|NCT02130024|156877752|FG001|Overall Study|Physician Decision|3|||
48734282|NCT02130024|156877751|FG000|Overall Study|Protocol Deviation|4|||
48734283|NCT02130024|156877752|FG001|Overall Study|Protocol Deviation|0|||
48734284|NCT02130024|156877751|FG000|Overall Study|Site Administration Problems|1|||
48734285|NCT02130024|156877752|FG001|Overall Study|Site Administration Problems|0|||
48734286|NCT02130024|156877751|FG000|Overall Study|Subject Withdrew Consent|6|||
48734287|NCT02130024|156877752|FG001|Overall Study|Subject Withdrew Consent|14|||
48734288|NCT04526509|156877755|FG000|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|40|||
48734289|NCT04526509|156877756|FG001|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
48734290|NCT04526509|156877757|FG002|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
48743060|NCT00968201|156910496|FG002|Base Study - (Period II)|Lack of Efficacy|1|||
48734291|NCT04526509|156877758|FG003|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
48734292|NCT04526509|156877759|FG004|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
48734293|NCT04526509|156877760|FG005|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
48734294|NCT04526509|156877761|FG006|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
48734295|NCT04526509|156877755|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|9|||
48734296|NCT04526509|156877756|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
48734297|NCT04526509|156877757|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
48734298|NCT04526509|156877758|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
48734299|NCT04526509|156877759|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
48734300|NCT04526509|156877760|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
48734301|NCT04526509|156877761|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
48734302|NCT04526509|156877755|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|1|||
48734303|NCT04526509|156877756|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
48734304|NCT04526509|156877757|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
48734305|NCT04526509|156877758|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
48734306|NCT04526509|156877759|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
48734307|NCT04526509|156877760|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
48734308|NCT04526509|156877761|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
48826366|NCT02014558|157204159|FG002|Overall Study|Death|0|||
48826367|NCT02014558|157204160|FG003|Overall Study|Death|0|||
48826368|NCT02014558|157204161|FG004|Overall Study|Death|0|||
48826369|NCT02014558|157204162|FG005|Overall Study|Death|0|||
48826370|NCT02014558|157204163|FG006|Overall Study|Death|1|||
48826371|NCT02014558|157204164|FG007|Overall Study|Death|1|||
48826372|NCT02014558|157204165|FG008|Overall Study|Death|2|||
48826373|NCT02014558|157204166|FG009|Overall Study|Death|5|||
48826374|NCT02014558|157204167|FG010|Overall Study|Death|5|||
48826375|NCT02014558|157204168|FG011|Overall Study|Death|19|||
48826376|NCT02014558|157204169|FG012|Overall Study|Death|2|||
48921850|NCT01650636|157548053|FG001|Washout up to 5 Months|Death|0|||
48921851|NCT01650636|157548052|FG000|Washout up to 5 Months|Lost to Follow-up|2|||
48921852|NCT01650636|157548053|FG001|Washout up to 5 Months|Lost to Follow-up|8|||
48921853|NCT01650636|157548052|FG000|Washout up to 9 Months|Withdrawal by Subject|4|||
49153465|NCT01355627|158402037|FG001|Overall Study|Other|1|||
49153466|NCT02022202|158402038|FG000|Overall Study|Withdrawal by Subject|2|||
49153467|NCT02022202|158402038|FG000|Overall Study|Disease Progression|3|||
49153468|NCT02022202|158402038|FG000|Overall Study|Desire go to immediately to surgery|3|||
49153469|NCT00642759|158402040|FG000|Overall Study|Protocol Violation|1|||
49153470|NCT02038036|158402045|FG000|Core Study|Adverse Event|7|||
49153471|NCT02038036|158402046|FG001|Core Study|Adverse Event|7|||
49153472|NCT02038036|158402045|FG000|Core Study|Death|1|||
49153473|NCT02038036|158402046|FG001|Core Study|Death|1|||
49153474|NCT02038036|158402045|FG000|Core Study|Disease progression|2|||
49153475|NCT02038036|158402046|FG001|Core Study|Disease progression|2|||
49153476|NCT02038036|158402045|FG000|Core Study|Lost to Follow-up|0|||
49153477|NCT02038036|158402046|FG001|Core Study|Lost to Follow-up|1|||
49153478|NCT02038036|158402045|FG000|Core Study|Physician Decision|2|||
49153479|NCT02038036|158402046|FG001|Core Study|Physician Decision|1|||
49153480|NCT02038036|158402045|FG000|Core Study|Subject/guardian decision|0|||
49153481|NCT02038036|158402046|FG001|Core Study|Subject/guardian decision|1|||
49153482|NCT02038036|158402045|FG000|Core Study|Withdrawal by Subject|3|||
49153483|NCT02038036|158402046|FG001|Core Study|Withdrawal by Subject|1|||
49153484|NCT02038036|158402045|FG000|Crossover Period|Withdrawal by Subject|0|||
49153485|NCT02038036|158402046|FG001|Crossover Period|Withdrawal by Subject|3|||
49153486|NCT02038036|158402045|FG000|Crossover Period|Adverse Event|0|||
49153487|NCT02038036|158402046|FG001|Crossover Period|Adverse Event|9|||
49153488|NCT02038036|158402045|FG000|Crossover Period|Death|0|||
48734309|NCT04526509|156877755|FG000|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|131|||
48734310|NCT04526509|156877756|FG001|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
48734311|NCT04526509|156877757|FG002|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
48734312|NCT04526509|156877758|FG003|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
48734313|NCT04526509|156877759|FG004|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
48734314|NCT04526509|156877760|FG005|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
48734315|NCT04526509|156877761|FG006|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
48734316|NCT04526509|156877755|FG000|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|97|||
48734317|NCT04526509|156877756|FG001|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
48734318|NCT04526509|156877757|FG002|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
48734319|NCT04526509|156877758|FG003|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
48734320|NCT04526509|156877759|FG004|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
48734321|NCT04526509|156877760|FG005|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
48734322|NCT04526509|156877761|FG006|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
48734323|NCT04526509|156877755|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|23|||
48734324|NCT04526509|156877756|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
48734325|NCT04526509|156877757|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
48734326|NCT04526509|156877758|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
48734327|NCT04526509|156877759|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
48734328|NCT04526509|156877760|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
48734329|NCT04526509|156877761|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
48734330|NCT04526509|156877755|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|6|||
48734331|NCT04526509|156877756|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
48734332|NCT04526509|156877757|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
48734333|NCT04526509|156877758|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
48734334|NCT04526509|156877759|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
48734335|NCT04526509|156877760|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
48734336|NCT04526509|156877761|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
48734337|NCT04526509|156877755|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|4|||
48734338|NCT04526509|156877756|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
48734339|NCT04526509|156877757|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
48734340|NCT04526509|156877758|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
48734341|NCT04526509|156877759|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
48734342|NCT04526509|156877760|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
48734343|NCT04526509|156877761|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
48743061|NCT00968201|156910494|FG000|Base Study - (Period II)|Lost to Follow-up|2|||
48743062|NCT00968201|156910495|FG001|Base Study - (Period II)|Lost to Follow-up|0|||
48743063|NCT00968201|156910496|FG002|Base Study - (Period II)|Lost to Follow-up|7|||
48743064|NCT00968201|156910494|FG000|Base Study - (Period II)|Protocol Violation|12|||
48743065|NCT00968201|156910495|FG001|Base Study - (Period II)|Protocol Violation|0|||
48743066|NCT00968201|156910496|FG002|Base Study - (Period II)|Protocol Violation|12|||
48743067|NCT00968201|156910494|FG000|Base Study - (Period II)|Withdrawal by Subject|4|||
48743068|NCT00968201|156910495|FG001|Base Study - (Period II)|Withdrawal by Subject|0|||
48743069|NCT00968201|156910496|FG002|Base Study - (Period II)|Withdrawal by Subject|8|||
48743070|NCT00968201|156910494|FG000|Base Study - (Period II)|Site Error|0|||
48743071|NCT00968201|156910495|FG001|Base Study - (Period II)|Site Error|0|||
48743072|NCT00968201|156910496|FG002|Base Study - (Period II)|Site Error|1|||
48921854|NCT01650636|157548053|FG001|Washout up to 9 Months|Withdrawal by Subject|2|||
49153489|NCT02038036|158402046|FG001|Crossover Period|Death|2|||
49153490|NCT02038036|158402045|FG000|Crossover Period|Disease progression|0|||
49153491|NCT02038036|158402046|FG001|Crossover Period|Disease progression|3|||
49153492|NCT02038036|158402045|FG000|Crossover Period|Lost to Follow-up|0|||
49153493|NCT02038036|158402046|FG001|Crossover Period|Lost to Follow-up|1|||
48743073|NCT00968201|156910494|FG000|Extension Study - (Period III)|Adverse Event|0|||
48826377|NCT02014558|157204157|FG000|Overall Study|Lack of Efficacy|1|||
48826378|NCT02014558|157204158|FG001|Overall Study|Lack of Efficacy|2|||
48826379|NCT02014558|157204159|FG002|Overall Study|Lack of Efficacy|1|||
48826380|NCT02014558|157204160|FG003|Overall Study|Lack of Efficacy|1|||
48826381|NCT02014558|157204161|FG004|Overall Study|Lack of Efficacy|0|||
48826382|NCT02014558|157204162|FG005|Overall Study|Lack of Efficacy|0|||
48826383|NCT02014558|157204163|FG006|Overall Study|Lack of Efficacy|1|||
49153494|NCT02038036|158402045|FG000|Crossover Period|Physician Decision|0|||
49153495|NCT02038036|158402046|FG001|Crossover Period|Physician Decision|2|||
49153496|NCT04756531|158402047|FG000|Overall Study|Adverse Event|0|||
49153497|NCT04756531|158402048|FG001|Overall Study|Adverse Event|0|||
49153498|NCT04756531|158402049|FG002|Overall Study|Adverse Event|0|||
49153499|NCT04756531|158402050|FG003|Overall Study|Adverse Event|0|||
49153500|NCT04756531|158402051|FG004|Overall Study|Adverse Event|1|||
49153501|NCT04756531|158402052|FG005|Overall Study|Adverse Event|0|||
49153502|NCT04756531|158402053|FG006|Overall Study|Adverse Event|0|||
49153503|NCT04756531|158402054|FG007|Overall Study|Adverse Event|0|||
49153504|NCT04756531|158402055|FG008|Overall Study|Adverse Event|0|||
49153505|NCT04756531|158402056|FG009|Overall Study|Adverse Event|0|||
49153506|NCT04756531|158402057|FG010|Overall Study|Adverse Event|0|||
49153507|NCT04756531|158402058|FG011|Overall Study|Adverse Event|0|||
49153508|NCT04756531|158402059|FG012|Overall Study|Adverse Event|0|||
49153509|NCT04756531|158402060|FG013|Overall Study|Adverse Event|0|||
49153510|NCT04756531|158402061|FG014|Overall Study|Adverse Event|0|||
49153511|NCT04756531|158402062|FG015|Overall Study|Adverse Event|0|||
49153512|NCT04756531|158402063|FG016|Overall Study|Adverse Event|0|||
49153513|NCT04756531|158402064|FG017|Overall Study|Adverse Event|0|||
49153514|NCT04756531|158402047|FG000|Overall Study|Withdrawal by Subject|0|||
49153515|NCT04756531|158402048|FG001|Overall Study|Withdrawal by Subject|0|||
49153516|NCT04756531|158402049|FG002|Overall Study|Withdrawal by Subject|0|||
49153517|NCT04756531|158402050|FG003|Overall Study|Withdrawal by Subject|0|||
49153518|NCT04756531|158402051|FG004|Overall Study|Withdrawal by Subject|0|||
49153519|NCT04756531|158402052|FG005|Overall Study|Withdrawal by Subject|0|||
49153520|NCT04756531|158402053|FG006|Overall Study|Withdrawal by Subject|1|||
49153521|NCT04756531|158402054|FG007|Overall Study|Withdrawal by Subject|0|||
49153522|NCT04756531|158402055|FG008|Overall Study|Withdrawal by Subject|0|||
49153523|NCT04756531|158402056|FG009|Overall Study|Withdrawal by Subject|0|||
49153524|NCT04756531|158402057|FG010|Overall Study|Withdrawal by Subject|0|||
49153525|NCT04756531|158402058|FG011|Overall Study|Withdrawal by Subject|0|||
49153526|NCT04756531|158402059|FG012|Overall Study|Withdrawal by Subject|0|||
49153527|NCT04756531|158402060|FG013|Overall Study|Withdrawal by Subject|0|||
49153528|NCT04756531|158402061|FG014|Overall Study|Withdrawal by Subject|0|||
49153529|NCT04756531|158402062|FG015|Overall Study|Withdrawal by Subject|0|||
49153530|NCT04756531|158402063|FG016|Overall Study|Withdrawal by Subject|0|||
49153531|NCT04756531|158402064|FG017|Overall Study|Withdrawal by Subject|0|||
49153532|NCT04704193|158402067|FG000|Overall Study|Withdrawal by Subject|1|||
48734344|NCT04526509|156877755|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|3|||
48734345|NCT04526509|156877756|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
49153533|NCT04144517|158402068|FG000|Overall Study|Physician Decision|0|||
49153534|NCT04144517|158402069|FG001|Overall Study|Physician Decision|1|||
49153535|NCT04144517|158402068|FG000|Overall Study|Other|2|||
49153536|NCT04144517|158402069|FG001|Overall Study|Other|2|||
49153537|NCT04144517|158402068|FG000|Overall Study|Death|6|||
49153538|NCT04144517|158402069|FG001|Overall Study|Death|3|||
49153539|NCT03814044|158402074|FG000|Overall Study|Protocol deviation|1|||
49153540|NCT00381641|158402079|FG000|Overall Study|Withdrawal by Subject|0|||
49153541|NCT00381641|158402080|FG001|Overall Study|Withdrawal by Subject|2|||
49153542|NCT04890509|158402081|FG000|Overall Study|Death|4|||
49153543|NCT04890509|158402082|FG001|Overall Study|Death|4|||
49153544|NCT05788991|158402083|FG000|Overall Study|Not treated with study medication|1|||
48734346|NCT04526509|156877757|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
48734347|NCT04526509|156877758|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
48734348|NCT04526509|156877759|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
48734349|NCT04526509|156877760|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
48734350|NCT04526509|156877761|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
48734351|NCT04526509|156877755|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|1|||
48734352|NCT04526509|156877756|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
48734353|NCT04526509|156877757|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
48734354|NCT04526509|156877758|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
48734355|NCT04526509|156877759|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
48734356|NCT04526509|156877760|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
48734357|NCT04526509|156877761|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
48734358|NCT04526509|156877755|FG000|Enrolled|Study Terminated by Sponsor|0|||
48734359|NCT04526509|156877756|FG001|Enrolled|Study Terminated by Sponsor|0|||
48734360|NCT04526509|156877757|FG002|Enrolled|Study Terminated by Sponsor|0|||
48734361|NCT04526509|156877758|FG003|Enrolled|Study Terminated by Sponsor|0|||
48734362|NCT04526509|156877759|FG004|Enrolled|Study Terminated by Sponsor|0|||
48734363|NCT04526509|156877760|FG005|Enrolled|Study Terminated by Sponsor|0|||
48734364|NCT04526509|156877761|FG006|Enrolled|Study Terminated by Sponsor|1|||
48734365|NCT04526509|156877755|FG000|Enrolled|Death prior to lymphodepletion|0|||
48734366|NCT04526509|156877756|FG001|Enrolled|Death prior to lymphodepletion|0|||
48734367|NCT04526509|156877757|FG002|Enrolled|Death prior to lymphodepletion|0|||
48734368|NCT04526509|156877758|FG003|Enrolled|Death prior to lymphodepletion|1|||
48734369|NCT04526509|156877759|FG004|Enrolled|Death prior to lymphodepletion|0|||
48734370|NCT04526509|156877760|FG005|Enrolled|Death prior to lymphodepletion|0|||
48734371|NCT04526509|156877761|FG006|Enrolled|Death prior to lymphodepletion|0|||
48734372|NCT04526509|156877755|FG000|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
48734373|NCT04526509|156877756|FG001|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
48734374|NCT04526509|156877757|FG002|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
48734375|NCT04526509|156877758|FG003|Enrolled|Did not meet Inclusion/Exclusion Criteria|1|||
48734376|NCT04526509|156877759|FG004|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
48734377|NCT04526509|156877760|FG005|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
48734378|NCT04526509|156877761|FG006|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
48734379|NCT04526509|156877755|FG000|Enrolled|Physician Decision|0|||
48734380|NCT04526509|156877756|FG001|Enrolled|Physician Decision|1|||
49153545|NCT05788991|158402084|FG001|Overall Study|Not treated with study medication|3|||
49153546|NCT05788991|158402083|FG000|Overall Study|Withdrawal by Subject|1|||
49153547|NCT05788991|158402084|FG001|Overall Study|Withdrawal by Subject|0|||
48826384|NCT02014558|157204164|FG007|Overall Study|Lack of Efficacy|3|||
48826385|NCT02014558|157204165|FG008|Overall Study|Lack of Efficacy|3|||
48826386|NCT02014558|157204166|FG009|Overall Study|Lack of Efficacy|3|||
48826387|NCT02014558|157204167|FG010|Overall Study|Lack of Efficacy|16|||
48826388|NCT02014558|157204168|FG011|Overall Study|Lack of Efficacy|8|||
48826389|NCT02014558|157204169|FG012|Overall Study|Lack of Efficacy|5|||
48826390|NCT02014558|157204157|FG000|Overall Study|Lost to Follow-up|0|||
48826391|NCT02014558|157204158|FG001|Overall Study|Lost to Follow-up|0|||
48826392|NCT02014558|157204159|FG002|Overall Study|Lost to Follow-up|0|||
48826393|NCT02014558|157204160|FG003|Overall Study|Lost to Follow-up|0|||
48826394|NCT02014558|157204161|FG004|Overall Study|Lost to Follow-up|0|||
48826395|NCT02014558|157204162|FG005|Overall Study|Lost to Follow-up|0|||
48826396|NCT02014558|157204163|FG006|Overall Study|Lost to Follow-up|0|||
48826397|NCT02014558|157204164|FG007|Overall Study|Lost to Follow-up|0|||
48826398|NCT02014558|157204165|FG008|Overall Study|Lost to Follow-up|0|||
48826399|NCT02014558|157204166|FG009|Overall Study|Lost to Follow-up|0|||
48826400|NCT02014558|157204167|FG010|Overall Study|Lost to Follow-up|1|||
48826401|NCT02014558|157204168|FG011|Overall Study|Lost to Follow-up|0|||
48826402|NCT02014558|157204169|FG012|Overall Study|Lost to Follow-up|0|||
48826403|NCT02014558|157204157|FG000|Overall Study|Progressive Disease|1|||
48826404|NCT02014558|157204158|FG001|Overall Study|Progressive Disease|0|||
48826405|NCT02014558|157204159|FG002|Overall Study|Progressive Disease|1|||
48826406|NCT02014558|157204160|FG003|Overall Study|Progressive Disease|1|||
48826407|NCT02014558|157204161|FG004|Overall Study|Progressive Disease|1|||
48826408|NCT02014558|157204162|FG005|Overall Study|Progressive Disease|2|||
48826409|NCT02014558|157204163|FG006|Overall Study|Progressive Disease|1|||
48826410|NCT02014558|157204164|FG007|Overall Study|Progressive Disease|6|||
48826411|NCT02014558|157204165|FG008|Overall Study|Progressive Disease|5|||
48826412|NCT02014558|157204166|FG009|Overall Study|Progressive Disease|6|||
48826413|NCT02014558|157204167|FG010|Overall Study|Progressive Disease|22|||
48826414|NCT02014558|157204168|FG011|Overall Study|Progressive Disease|31|||
48826415|NCT02014558|157204169|FG012|Overall Study|Progressive Disease|6|||
48826416|NCT02014558|157204157|FG000|Overall Study|Withdrawal by Subject|0|||
48826417|NCT02014558|157204158|FG001|Overall Study|Withdrawal by Subject|0|||
48826418|NCT02014558|157204159|FG002|Overall Study|Withdrawal by Subject|0|||
48826419|NCT02014558|157204160|FG003|Overall Study|Withdrawal by Subject|0|||
48826420|NCT02014558|157204161|FG004|Overall Study|Withdrawal by Subject|1|||
48826421|NCT02014558|157204162|FG005|Overall Study|Withdrawal by Subject|0|||
48826422|NCT02014558|157204163|FG006|Overall Study|Withdrawal by Subject|0|||
48826423|NCT02014558|157204164|FG007|Overall Study|Withdrawal by Subject|0|||
48826424|NCT02014558|157204165|FG008|Overall Study|Withdrawal by Subject|0|||
48826425|NCT02014558|157204166|FG009|Overall Study|Withdrawal by Subject|2|||
48826426|NCT02014558|157204167|FG010|Overall Study|Withdrawal by Subject|6|||
48826427|NCT02014558|157204168|FG011|Overall Study|Withdrawal by Subject|10|||
48826428|NCT02014558|157204169|FG012|Overall Study|Withdrawal by Subject|0|||
48826429|NCT02014558|157204157|FG000|Overall Study|Miscellaneous|2|||
48826430|NCT02014558|157204158|FG001|Overall Study|Miscellaneous|1|||
48826431|NCT02014558|157204159|FG002|Overall Study|Miscellaneous|1|||
48826432|NCT02014558|157204160|FG003|Overall Study|Miscellaneous|1|||
48826433|NCT02014558|157204161|FG004|Overall Study|Miscellaneous|0|||
48826434|NCT02014558|157204162|FG005|Overall Study|Miscellaneous|1|||
48826435|NCT02014558|157204163|FG006|Overall Study|Miscellaneous|0|||
48826436|NCT02014558|157204164|FG007|Overall Study|Miscellaneous|1|||
48826437|NCT02014558|157204165|FG008|Overall Study|Miscellaneous|1|||
48826438|NCT02014558|157204166|FG009|Overall Study|Miscellaneous|3|||
48826439|NCT02014558|157204167|FG010|Overall Study|Miscellaneous|12|||
48826440|NCT02014558|157204168|FG011|Overall Study|Miscellaneous|11|||
48826441|NCT02014558|157204169|FG012|Overall Study|Miscellaneous|1|||
48826442|NCT04580407|157204170|FG000|Overall Study|Judged to be Required to Receive Prophylactic Treatment with Emicizumab|1|||
48826443|NCT05296629|157205669|FG000|Overall Study|Withdrawal by Subject|3|||
48921855|NCT01650636|157548052|FG000|Washout up to 9 Months|Lost to Follow-up|2|||
48826444|NCT05296629|157205670|FG001|Overall Study|Withdrawal by Subject|10|||
48826445|NCT05296629|157205671|FG002|Overall Study|Withdrawal by Subject|4|||
48921856|NCT01650636|157548053|FG001|Washout up to 9 Months|Lost to Follow-up|1|||
48826446|NCT05296629|157205669|FG000|Overall Study|Lost to Follow-up|2|||
48826447|NCT05296629|157205670|FG001|Overall Study|Lost to Follow-up|7|||
48921857|NCT00750737|157548054|FG000|Overall Study|Withdrawal by Subject|3|||
48921858|NCT00750737|157548055|FG001|Overall Study|Withdrawal by Subject|3|||
48826448|NCT05296629|157205671|FG002|Overall Study|Lost to Follow-up|1|||
48826449|NCT05296629|157205669|FG000|Overall Study|Adverse Event|0|||
48826450|NCT05296629|157205670|FG001|Overall Study|Adverse Event|4|||
48921859|NCT02192827|157548056|FG000|Overall Study|Lost to Follow-up|25|||
48826451|NCT05296629|157205671|FG002|Overall Study|Adverse Event|2|||
48826452|NCT05296629|157205669|FG000|Overall Study|Protocol Violation|0|||
48826453|NCT05296629|157205670|FG001|Overall Study|Protocol Violation|2|||
48826454|NCT05296629|157205671|FG002|Overall Study|Protocol Violation|0|||
48826455|NCT04034238|157205679|FG000|Dose Escalation Phase|Withdrawal by Subject|1|||
48826456|NCT04034238|157205680|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
48826457|NCT04034238|157205681|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
48826458|NCT04034238|157205682|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
48921860|NCT02192827|157548057|FG001|Overall Study|Lost to Follow-up|27|||
48921861|NCT02192827|157548056|FG000|Overall Study|Given additional steroids with admission|13|||
48921862|NCT02192827|157548057|FG001|Overall Study|Given additional steroids with admission|11|||
48921863|NCT03571646|157548061|FG000|Overall Study|Adverse Event|1|||
48921864|NCT03571646|157548062|FG001|Overall Study|Adverse Event|0|||
48921865|NCT03571646|157548061|FG000|Overall Study|Withdrawal by Subject|1|||
48921866|NCT03571646|157548062|FG001|Overall Study|Withdrawal by Subject|1|||
48921867|NCT01453855|157548063|FG000|Overall Study|Adverse Event|3|||
48921868|NCT01453855|157548064|FG001|Overall Study|Adverse Event|4|||
48921869|NCT01453855|157548063|FG000|Overall Study|Lost to Follow-up|2|||
48921870|NCT01453855|157548064|FG001|Overall Study|Lost to Follow-up|1|||
48921871|NCT01453855|157548063|FG000|Overall Study|Patient Decision Unrel to Adverse Event|3|||
48921872|NCT01453855|157548064|FG001|Overall Study|Patient Decision Unrel to Adverse Event|3|||
48921873|NCT01453855|157548063|FG000|Overall Study|Noncompliance|1|||
48921874|NCT01453855|157548064|FG001|Overall Study|Noncompliance|0|||
48921875|NCT01453855|157548063|FG000|Overall Study|Inadequate Control of IOP|1|||
48921876|NCT01453855|157548064|FG001|Overall Study|Inadequate Control of IOP|5|||
48921877|NCT01453855|157548063|FG000|Overall Study|Other|0|||
48921878|NCT01453855|157548064|FG001|Overall Study|Other|1|||
48921879|NCT01780662|157548067|FG000|Overall Study|Adverse Event|1|||
48921880|NCT01780662|157548068|FG001|Overall Study|Adverse Event|0|||
48921881|NCT01780662|157548069|FG002|Overall Study|Adverse Event|2|||
48921882|NCT01780662|157548067|FG000|Overall Study|Physician Decision|0|||
48921883|NCT01780662|157548068|FG001|Overall Study|Physician Decision|5|||
48921884|NCT01780662|157548069|FG002|Overall Study|Physician Decision|7|||
48921885|NCT01780662|157548067|FG000|Overall Study|Protocol Violation|0|||
48921886|NCT01780662|157548068|FG001|Overall Study|Protocol Violation|1|||
48921887|NCT01780662|157548069|FG002|Overall Study|Protocol Violation|0|||
48921888|NCT01780662|157548067|FG000|Overall Study|Ineligible|0|||
48921889|NCT01780662|157548068|FG001|Overall Study|Ineligible|0|||
48921890|NCT01780662|157548069|FG002|Overall Study|Ineligible|1|||
48921891|NCT01263639|157548070|FG000|Overall Study|Lost to Follow-up|66|||
48921892|NCT01263639|157548071|FG001|Overall Study|Lost to Follow-up|70|||
48826459|NCT04034238|157205679|FG000|Dose Escalation Phase|Screen failures|0|||
48826460|NCT04034238|157205680|FG001|Dose Escalation Phase|Screen failures|0|||
48826461|NCT04034238|157205681|FG002|Dose Escalation Phase|Screen failures|0|||
48826462|NCT04034238|157205682|FG003|Dose Escalation Phase|Screen failures|2|||
48826463|NCT04034238|157205679|FG000|Dose Expansion Phase|Not treated due to study hold.|0|||
48826464|NCT04034238|157205680|FG001|Dose Expansion Phase|Not treated due to study hold.|0|||
48826465|NCT04034238|157205681|FG002|Dose Expansion Phase|Not treated due to study hold.|0|||
48921893|NCT01263639|157548070|FG000|Overall Study|Exclusion =Admission greater than 7 days|7|||
48921894|NCT01263639|157548071|FG001|Overall Study|Exclusion =Admission greater than 7 days|9|||
49153548|NCT05788991|158402083|FG000|Overall Study|Lack of Efficacy|0|||
49153549|NCT05788991|158402084|FG001|Overall Study|Lack of Efficacy|1|||
48826466|NCT04034238|157205682|FG003|Dose Expansion Phase|Not treated due to study hold.|1|||
49153550|NCT05788991|158402083|FG000|Overall Study|Protocol Violation|1|||
49153551|NCT05788991|158402084|FG001|Overall Study|Protocol Violation|2|||
49153552|NCT03802396|158402085|FG000|Overall Study|Withdrawal by Subject|2|||
49153553|NCT03802396|158402086|FG001|Overall Study|Withdrawal by Subject|0|||
49153554|NCT03802396|158402085|FG000|Overall Study|Surgery Cancelled|1|||
49153555|NCT03802396|158402086|FG001|Overall Study|Surgery Cancelled|0|||
49153556|NCT00936936|158403232|FG000|Overall Study|Adverse Event|7|||
49153557|NCT00936936|158403233|FG001|Overall Study|Adverse Event|1|||
49153558|NCT00936936|158403232|FG000|Overall Study|Disease Progression|2|||
48826467|NCT04034238|157205679|FG000|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
48921895|NCT00252057|157548072|FG000|Overall Study|Withdrawal by Subject|2|||
48921896|NCT00252057|157548073|FG001|Overall Study|Withdrawal by Subject|5|||
48921897|NCT00252057|157548072|FG000|Overall Study|Death|1|||
48921898|NCT00252057|157548073|FG001|Overall Study|Death|2|||
48921899|NCT00252057|157548072|FG000|Overall Study|Participant previously enrolled|0|||
48921900|NCT00252057|157548073|FG001|Overall Study|Participant previously enrolled|1|||
48921901|NCT00253630|157548076|FG000|Overall Study|ineligible|2|||
49153559|NCT00936936|158403233|FG001|Overall Study|Disease Progression|2|||
49153560|NCT00936936|158403232|FG000|Overall Study|Unrelated|3|||
49153561|NCT00936936|158403233|FG001|Overall Study|Unrelated|1|||
49153562|NCT01394185|158403235|FG000|Overall Study|Withdrawal by Subject|2|||
49153563|NCT01394185|158403236|FG001|Overall Study|Withdrawal by Subject|0|||
49153564|NCT01394185|158403237|FG002|Overall Study|Withdrawal by Subject|0|||
49153565|NCT01394185|158403238|FG003|Overall Study|Withdrawal by Subject|0|||
48826468|NCT04034238|157205680|FG001|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
48826469|NCT04034238|157205681|FG002|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|1|||
48826470|NCT04034238|157205682|FG003|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
48826471|NCT05310084|157205683|FG000|Overall Study|Withdrawal by Subject|2|||
48826472|NCT05310084|157205684|FG001|Overall Study|Withdrawal by Subject|3|||
48826473|NCT05310084|157205683|FG000|Overall Study|Participant availability|0|||
48826474|NCT05310084|157205684|FG001|Overall Study|Participant availability|4|||
48826475|NCT05310084|157205683|FG000|Overall Study|Lost to Follow-up|1|||
48826476|NCT05310084|157205684|FG001|Overall Study|Lost to Follow-up|1|||
48826477|NCT05310084|157205683|FG000|Overall Study|Adverse Event|1|||
48826478|NCT05310084|157205684|FG001|Overall Study|Adverse Event|1|||
48826479|NCT05310084|157205683|FG000|Overall Study|Randomized but not vaccinated|4|||
48826480|NCT05310084|157205684|FG001|Overall Study|Randomized but not vaccinated|2|||
48826481|NCT01518257|157205687|FG000|Overall Study|Lost to Follow-up|1|||
48826482|NCT01518257|157205688|FG001|Overall Study|Lost to Follow-up|0|||
48826483|NCT01518257|157205687|FG000|Overall Study|Other Miscellaneous Reason|1|||
48826484|NCT01518257|157205688|FG001|Overall Study|Other Miscellaneous Reason|0|||
48826485|NCT00797862|157205689|FG000|Overall Study|Adverse Event|86|||
48826486|NCT00797862|157205690|FG001|Overall Study|Adverse Event|44|||
48826487|NCT00797862|157205691|FG002|Overall Study|Adverse Event|58|||
48826488|NCT00797862|157205689|FG000|Overall Study|Abnormal Test Procedure Result|0|||
49153566|NCT01394185|158403239|FG004|Overall Study|Withdrawal by Subject|1|||
49153567|NCT01394185|158403240|FG005|Overall Study|Withdrawal by Subject|0|||
49153568|NCT01394185|158403235|FG000|Overall Study|Change in protocol|3|||
49153569|NCT01394185|158403236|FG001|Overall Study|Change in protocol|0|||
49153570|NCT01394185|158403237|FG002|Overall Study|Change in protocol|0|||
49153571|NCT01394185|158403238|FG003|Overall Study|Change in protocol|0|||
49153572|NCT01394185|158403239|FG004|Overall Study|Change in protocol|3|||
49153573|NCT01394185|158403240|FG005|Overall Study|Change in protocol|0|||
49153574|NCT01394185|158403235|FG000|Overall Study|Protocol Violation|1|||
49153575|NCT01394185|158403236|FG001|Overall Study|Protocol Violation|0|||
49153576|NCT01394185|158403237|FG002|Overall Study|Protocol Violation|0|||
49153577|NCT01394185|158403238|FG003|Overall Study|Protocol Violation|1|||
49153578|NCT01394185|158403239|FG004|Overall Study|Protocol Violation|0|||
49153579|NCT01394185|158403240|FG005|Overall Study|Protocol Violation|1|||
49153580|NCT01585025|158403241|FG000|Overall Study|Withdrawal by Subject|0|||
49153581|NCT01585025|158403242|FG001|Overall Study|Withdrawal by Subject|3|||
49153582|NCT01585025|158403243|FG002|Overall Study|Withdrawal by Subject|4|||
49153583|NCT00939185|158403250|FG000|Overall Study|Adverse Event|3|||
49153584|NCT00939185|158403250|FG000|Overall Study|Lack of Efficacy|1|||
49153585|NCT00939185|158403250|FG000|Overall Study|Lost to Follow-up|6|||
49153586|NCT00939185|158403250|FG000|Overall Study|Other|3|||
49153587|NCT00939185|158403250|FG000|Overall Study|Withdrawal by Subject|2|||
49153588|NCT00939185|158403250|FG000|Overall Study|Randomized But Did Not Receive Treatment|10|||
49153589|NCT00363298|158403251|FG000|First Study Week|Lack of Efficacy|6|||
49153590|NCT00363298|158403252|FG001|First Study Week|Lack of Efficacy|5|||
49153591|NCT00363298|158403251|FG000|4-week Study Continuation Phase|Lack of Efficacy|1|||
49153592|NCT00363298|158403252|FG001|4-week Study Continuation Phase|Lack of Efficacy|0|||
49153593|NCT03552029|158403254|FG000|Overall Study|Death|3|||
49153594|NCT03552029|158403255|FG001|Overall Study|Death|0|||
49153595|NCT03552029|158403254|FG000|Overall Study|Adverse Event|1|||
49153596|NCT03552029|158403255|FG001|Overall Study|Adverse Event|0|||
49153597|NCT03552029|158403254|FG000|Overall Study|Lack of Efficacy|0|||
49153598|NCT03552029|158403255|FG001|Overall Study|Lack of Efficacy|2|||
49153599|NCT03552029|158403254|FG000|Overall Study|Physician Decision|0|||
49153600|NCT03552029|158403255|FG001|Overall Study|Physician Decision|1|||
49153601|NCT03552029|158403254|FG000|Overall Study|Study terminated by Sponsor|0|||
49153602|NCT03552029|158403255|FG001|Overall Study|Study terminated by Sponsor|1|||
49153603|NCT03552029|158403254|FG000|Overall Study|Other|0|||
49153604|NCT03552029|158403255|FG001|Overall Study|Other|2|||
49153605|NCT03332056|158403256|FG000|Overall Study|Incomplete questionnaires|8|||
49153606|NCT03332056|158403257|FG001|Overall Study|Incomplete questionnaires|9|||
49153607|NCT03332056|158403256|FG000|Overall Study|Passed stone prior to surgery date|1|||
49153608|NCT03332056|158403257|FG001|Overall Study|Passed stone prior to surgery date|0|||
49153609|NCT03332056|158403256|FG000|Overall Study|Did not require a ureteral stent|0|||
49153610|NCT03332056|158403257|FG001|Overall Study|Did not require a ureteral stent|1|||
49153611|NCT03014089|158403258|FG000|Overall Study|Withdrawal by Subject|0|||
48921902|NCT01780831|157548077|FG000|Overall Study|Withdrawal by Subject|0|||
48921903|NCT01780831|157548078|FG001|Overall Study|Withdrawal by Subject|0|||
48826489|NCT00797862|157205690|FG001|Overall Study|Abnormal Test Procedure Result|1|||
49153612|NCT03014089|158403259|FG001|Overall Study|Withdrawal by Subject|1|||
49153613|NCT03014089|158403260|FG002|Overall Study|Withdrawal by Subject|1|||
49153614|NCT03014089|158403261|FG003|Overall Study|Withdrawal by Subject|1|||
49153615|NCT03014089|158403258|FG000|Overall Study|Lost to Follow-up|1|||
49153616|NCT03014089|158403259|FG001|Overall Study|Lost to Follow-up|0|||
49153617|NCT03014089|158403260|FG002|Overall Study|Lost to Follow-up|0|||
48826490|NCT00797862|157205691|FG002|Overall Study|Abnormal Test Procedure Result|1|||
48826491|NCT00797862|157205689|FG000|Overall Study|Lack of Efficacy|1|||
48826492|NCT00797862|157205690|FG001|Overall Study|Lack of Efficacy|7|||
48826493|NCT00797862|157205691|FG002|Overall Study|Lack of Efficacy|6|||
48826494|NCT00797862|157205689|FG000|Overall Study|No longer required study medication|1|||
48826495|NCT00797862|157205690|FG001|Overall Study|No longer required study medication|0|||
48826496|NCT00797862|157205691|FG002|Overall Study|No longer required study medication|0|||
48826497|NCT00797862|157205689|FG000|Overall Study|Withdrawal by Subject|14|||
48826498|NCT00797862|157205690|FG001|Overall Study|Withdrawal by Subject|7|||
48826499|NCT00797862|157205691|FG002|Overall Study|Withdrawal by Subject|7|||
48826500|NCT00797862|157205689|FG000|Overall Study|Lost to Follow-up|11|||
48826501|NCT00797862|157205690|FG001|Overall Study|Lost to Follow-up|0|||
48826502|NCT00797862|157205691|FG002|Overall Study|Lost to Follow-up|5|||
48826503|NCT00797862|157205689|FG000|Overall Study|Administrative Problem|4|||
48826504|NCT00797862|157205690|FG001|Overall Study|Administrative Problem|0|||
48826505|NCT00797862|157205691|FG002|Overall Study|Administrative Problem|0|||
49153618|NCT03014089|158403261|FG003|Overall Study|Lost to Follow-up|0|||
49153619|NCT03014089|158403258|FG000|Overall Study|Adverse Event|1|||
49153620|NCT03014089|158403259|FG001|Overall Study|Adverse Event|0|||
49153621|NCT03014089|158403260|FG002|Overall Study|Adverse Event|1|||
49153622|NCT03014089|158403261|FG003|Overall Study|Adverse Event|0|||
49153623|NCT00321932|158403263|FG000|Overall Study|Death|3|||
49153624|NCT00321932|158403264|FG001|Overall Study|Death|6|||
49153625|NCT00321932|158403263|FG000|Overall Study|Withdrawal by Subject|3|||
48826506|NCT00797862|157205689|FG000|Overall Study|Protocol Violation|4|||
48826507|NCT00797862|157205690|FG001|Overall Study|Protocol Violation|6|||
48826508|NCT00797862|157205691|FG002|Overall Study|Protocol Violation|8|||
48826509|NCT00797862|157205689|FG000|Overall Study|Mis-randomized|3|||
48826510|NCT00797862|157205690|FG001|Overall Study|Mis-randomized|3|||
48826511|NCT00797862|157205691|FG002|Overall Study|Mis-randomized|1|||
48826512|NCT00531479|157205692|FG000|Overall Study|Death|68|||
48826513|NCT00531479|157205693|FG001|Overall Study|Death|71|||
48826514|NCT00531479|157205692|FG000|Overall Study|Lost to Follow-up|0|||
49153626|NCT00321932|158403264|FG001|Overall Study|Withdrawal by Subject|6|||
49153627|NCT00321932|158403263|FG000|Overall Study|Early relapse|2|||
49153628|NCT00321932|158403264|FG001|Overall Study|Early relapse|8|||
49153629|NCT00321932|158403263|FG000|Overall Study|Missing data|2|||
49153630|NCT00321932|158403264|FG001|Overall Study|Missing data|1|||
49153631|NCT00734032|158403265|FG000|Overall Study|Adverse Event|0|||
49153632|NCT00734032|158403266|FG001|Overall Study|Adverse Event|1|||
49153633|NCT00734032|158403267|FG002|Overall Study|Adverse Event|0|||
49153634|NCT00734032|158403268|FG003|Overall Study|Adverse Event|0|||
49153635|NCT01344356|158403275|FG000|Overall Study|Physician Decision|0|||
49153636|NCT01344356|158403276|FG001|Overall Study|Physician Decision|3|||
49153637|NCT01344356|158403275|FG000|Overall Study|Lost to Follow-up|0|||
49153638|NCT01344356|158403276|FG001|Overall Study|Lost to Follow-up|6|||
49153639|NCT03682367|158403279|FG000|Overall Study|Protocol Violation|2|||
49153640|NCT03682367|158403280|FG001|Overall Study|Protocol Violation|1|||
49153641|NCT03682367|158403279|FG000|Overall Study|Closed Study Early|0|||
49153642|NCT03682367|158403280|FG001|Overall Study|Closed Study Early|3|||
49153643|NCT03707821|158403281|FG000|Overall Study|Protocol Violation|0|||
49153644|NCT03707821|158403282|FG001|Overall Study|Protocol Violation|1|||
49153645|NCT03707821|158403281|FG000|Overall Study|Unsatisfactory Visual Response|1|||
49153646|NCT03707821|158403282|FG001|Overall Study|Unsatisfactory Visual Response|0|||
49153647|NCT03707821|158403281|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
49153648|NCT03707821|158403282|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
49153649|NCT01432444|158403283|FG000|Tolerability/Cross-titration Phase|Lost to Follow-up|10|||
49153650|NCT01432444|158403284|FG001|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
49153651|NCT01432444|158403285|FG002|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
49153652|NCT01432444|158403283|FG000|Tolerability/Cross-titration Phase|Adverse Event|16|||
49153653|NCT01432444|158403284|FG001|Tolerability/Cross-titration Phase|Adverse Event|0|||
49153654|NCT01432444|158403285|FG002|Tolerability/Cross-titration Phase|Adverse Event|0|||
49153655|NCT01432444|158403283|FG000|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5|||
49153656|NCT01432444|158403284|FG001|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
49153657|NCT01432444|158403285|FG002|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
49153658|NCT01432444|158403283|FG000|Tolerability/Cross-titration Phase|Physician Decision|8|||
49153659|NCT01432444|158403284|FG001|Tolerability/Cross-titration Phase|Physician Decision|0|||
49153660|NCT01432444|158403285|FG002|Tolerability/Cross-titration Phase|Physician Decision|0|||
49153661|NCT01432444|158403283|FG000|Tolerability/Cross-titration Phase|Withdrawal by Subject|15|||
48826515|NCT00531479|157205693|FG001|Overall Study|Lost to Follow-up|2|||
48826516|NCT00531479|157205692|FG000|Overall Study|Other|0|||
48826517|NCT00531479|157205693|FG001|Overall Study|Other|1|||
48826518|NCT00531479|157205692|FG000|Overall Study|Withdrawal by Subject|6|||
49153662|NCT01432444|158403284|FG001|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
49153663|NCT01432444|158403285|FG002|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
48826519|NCT00531479|157205693|FG001|Overall Study|Withdrawal by Subject|6|||
49153664|NCT01432444|158403283|FG000|Tolerability/Cross-titration Phase|Protocol Deviation|1|||
48826520|NCT00531479|157205692|FG000|Overall Study|Did not receive treatment|2|||
48826521|NCT00531479|157205693|FG001|Overall Study|Did not receive treatment|3|||
48826522|NCT03404960|157205698|FG000|Overall Study|Adverse Event|0|||
48826523|NCT03404960|157205699|FG001|Overall Study|Adverse Event|2|||
48826524|NCT03404960|157205698|FG000|Overall Study|Rapidly declined before 1st follow-up scan|0|||
48826525|NCT03404960|157205699|FG001|Overall Study|Rapidly declined before 1st follow-up scan|2|||
48826526|NCT03404960|157205698|FG000|Overall Study|Bowel obstruction|0|||
48826527|NCT03404960|157205699|FG001|Overall Study|Bowel obstruction|1|||
48826528|NCT03404960|157205698|FG000|Overall Study|Incorrect pathological diagnosis on internal review|2|||
48826529|NCT03404960|157205699|FG001|Overall Study|Incorrect pathological diagnosis on internal review|0|||
48826530|NCT01636362|157205702|FG000|Overall Study|Physician Decision|6|||
48826531|NCT01636362|157205702|FG000|Overall Study|Subject healed, not returning|1|||
48826532|NCT01636362|157205702|FG000|Overall Study|Withdrawal by Subject|1|||
48826533|NCT00498186|157205703|FG000|Overall Study|Protocol Violation|10|||
48826534|NCT00498186|157205703|FG000|Overall Study|Lack of Efficacy|31|||
48826535|NCT00498186|157205703|FG000|Overall Study|Adverse Event|89|||
48826536|NCT00498186|157205703|FG000|Overall Study|Unsatisfactory compliance of subject|12|||
48826537|NCT00498186|157205703|FG000|Overall Study|Withdrawal by Subject|18|||
48826538|NCT00498186|157205703|FG000|Overall Study|Lost to Follow-up|3|||
48826539|NCT00498186|157205703|FG000|Overall Study|Other|10|||
48826540|NCT00088465|157205704|FG000|Overall Study|Withdrawal by Subject|290|||
48826541|NCT00088465|157205704|FG000|Overall Study|Adverse Event|77|||
48826542|NCT00088465|157205704|FG000|Overall Study|Lost to Follow-up|57|||
48826543|NCT00088465|157205704|FG000|Overall Study|Physician Decision|45|||
48826544|NCT00088465|157205704|FG000|Overall Study|Sponsor Decision|37|||
48826545|NCT00088465|157205704|FG000|Overall Study|Lack of Efficacy|27|||
48826546|NCT00088465|157205704|FG000|Overall Study|Protocol Violation|17|||
48826547|NCT00088465|157205704|FG000|Overall Study|Death|11|||
48826548|NCT02459964|157205705|FG000|Overall Study|Withdrawal by Subject|0|||
48826549|NCT02459964|157205706|FG001|Overall Study|Withdrawal by Subject|0|||
48826550|NCT02459964|157205707|FG002|Overall Study|Withdrawal by Subject|1|||
48826551|NCT02459964|157205705|FG000|Overall Study|Abnormal EKG changes|0|||
48826552|NCT02459964|157205706|FG001|Overall Study|Abnormal EKG changes|0|||
48826553|NCT02459964|157205707|FG002|Overall Study|Abnormal EKG changes|1|||
48826554|NCT01456780|157205709|FG000|Overall Study|Lost to Follow-up|3|||
48826555|NCT01456780|157205710|FG001|Overall Study|Lost to Follow-up|3|||
48826556|NCT01456780|157205711|FG002|Overall Study|Lost to Follow-up|0|||
48826557|NCT00886613|157205718|FG000|Overall Study|Protocol deviation (Part B)|1|||
48826558|NCT00886613|157205719|FG001|Overall Study|Protocol deviation (Part B)|0|||
48826559|NCT00886613|157205720|FG002|Overall Study|Protocol deviation (Part B)|0|||
48826560|NCT00886613|157205718|FG000|Overall Study|Lost to follow-up (Part B)|1|||
48826561|NCT00886613|157205719|FG001|Overall Study|Lost to follow-up (Part B)|0|||
48826562|NCT00886613|157205720|FG002|Overall Study|Lost to follow-up (Part B)|1|||
48826563|NCT00886613|157205718|FG000|Overall Study|Subject withdrew consent (Part A)|0|||
48826564|NCT00886613|157205719|FG001|Overall Study|Subject withdrew consent (Part A)|0|||
48826565|NCT00886613|157205720|FG002|Overall Study|Subject withdrew consent (Part A)|2|||
48826566|NCT00751790|157205721|FG000|Overall Study|Lost to Follow-up|1|||
48826567|NCT00751790|157205721|FG000|Overall Study|Death|3|||
48826568|NCT00751790|157205721|FG000|Overall Study|Withdrawal by Subject|1|||
48826569|NCT00151996|157205722|FG000|Overall Study|Adverse Event|3|||
48826570|NCT00151996|157205723|FG001|Overall Study|Adverse Event|2|||
48826571|NCT00151996|157205722|FG000|Overall Study|Withdrawal by Subject|1|||
48826572|NCT00151996|157205723|FG001|Overall Study|Withdrawal by Subject|1|||
49153665|NCT01432444|158403284|FG001|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
49153666|NCT01432444|158403285|FG002|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
49153667|NCT01432444|158403283|FG000|Tolerability/Cross-titration Phase|Lack of Efficacy|5|||
49153668|NCT01432444|158403284|FG001|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
49153669|NCT01432444|158403285|FG002|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
49153670|NCT01432444|158403283|FG000|Treatment Phase|Lost to Follow-up|0|||
49153671|NCT01432444|158403284|FG001|Treatment Phase|Lost to Follow-up|33|||
49153672|NCT01432444|158403285|FG002|Treatment Phase|Lost to Follow-up|0|||
48826573|NCT00151996|157205722|FG000|Overall Study|Protocol Violation|1|||
48826574|NCT00151996|157205723|FG001|Overall Study|Protocol Violation|2|||
48826575|NCT00151996|157205722|FG000|Overall Study|Sponsor's decision|0|||
48826576|NCT00151996|157205723|FG001|Overall Study|Sponsor's decision|2|||
48826577|NCT01168401|157205725|FG000|Overall Study|Lost to Follow-up|1|||
48826578|NCT01168401|157205726|FG001|Overall Study|Lost to Follow-up|1|||
48826579|NCT01168401|157205727|FG002|Overall Study|Lost to Follow-up|2|||
48826580|NCT01168401|157205728|FG003|Overall Study|Lost to Follow-up|1|||
48826581|NCT01168401|157205729|FG004|Overall Study|Lost to Follow-up|0|||
48826582|NCT01168401|157205730|FG005|Overall Study|Lost to Follow-up|0|||
48826583|NCT01168401|157205731|FG006|Overall Study|Lost to Follow-up|0|||
48826584|NCT01168401|157205732|FG007|Overall Study|Lost to Follow-up|0|||
49153673|NCT01432444|158403283|FG000|Treatment Phase|Adverse Event|0|||
48826585|NCT01168401|157205733|FG008|Overall Study|Lost to Follow-up|0|||
48826586|NCT01168401|157205734|FG009|Overall Study|Lost to Follow-up|0|||
48826587|NCT01168401|157205735|FG010|Overall Study|Lost to Follow-up|0|||
48826588|NCT01168401|157205725|FG000|Overall Study|Withdrawal by Subject|0|||
48826589|NCT01168401|157205726|FG001|Overall Study|Withdrawal by Subject|0|||
48826590|NCT01168401|157205727|FG002|Overall Study|Withdrawal by Subject|0|||
48826591|NCT01168401|157205728|FG003|Overall Study|Withdrawal by Subject|1|||
48826592|NCT01168401|157205729|FG004|Overall Study|Withdrawal by Subject|0|||
48826593|NCT01168401|157205730|FG005|Overall Study|Withdrawal by Subject|0|||
48826594|NCT01168401|157205731|FG006|Overall Study|Withdrawal by Subject|0|||
48826595|NCT01168401|157205732|FG007|Overall Study|Withdrawal by Subject|0|||
48826596|NCT01168401|157205733|FG008|Overall Study|Withdrawal by Subject|0|||
48826597|NCT01168401|157205734|FG009|Overall Study|Withdrawal by Subject|0|||
48826598|NCT01168401|157205735|FG010|Overall Study|Withdrawal by Subject|0|||
48826599|NCT00303303|157205738|FG000|Overall Study|Withdrawal by Subject|0|||
48826600|NCT00303303|157205739|FG001|Overall Study|Withdrawal by Subject|0|||
48826601|NCT00303303|157205740|FG002|Overall Study|Withdrawal by Subject|1|||
48826602|NCT00672256|157205741|FG000|Overall Study|PI dropped, bad data|44|||
48826603|NCT00945477|157205757|FG000|Overall Study|Adverse Event|3|||
48826604|NCT00945477|157205757|FG000|Overall Study|Lack of Efficacy|2|||
48826605|NCT00945477|157205757|FG000|Overall Study|Withdrawal by Subject|1|||
48826606|NCT01878890|157205767|FG000|Overall Study|Protocol Violation|0|||
48826607|NCT01878890|157205768|FG001|Overall Study|Protocol Violation|1|||
48826608|NCT01878890|157205769|FG002|Overall Study|Protocol Violation|0|||
48826609|NCT01878890|157205770|FG003|Overall Study|Protocol Violation|0|||
48826610|NCT00916006|157205772|FG000|Overall Study|Adverse Event|1|||
48826611|NCT00916006|157205773|FG001|Overall Study|Adverse Event|1|||
48826612|NCT00916006|157205772|FG000|Overall Study|Withdrawal by Subject|2|||
48826613|NCT00916006|157205773|FG001|Overall Study|Withdrawal by Subject|5|||
48826614|NCT00916006|157205772|FG000|Overall Study|Protocol Violation|0|||
48826615|NCT00916006|157205773|FG001|Overall Study|Protocol Violation|1|||
48826616|NCT02929108|157205776|FG000|Overall Study|Hospice patient death|100|||
48826617|NCT02929108|157205777|FG001|Overall Study|Hospice patient death|64|||
48826618|NCT02929108|157205778|FG002|Overall Study|Hospice patient death|28|||
48826619|NCT02929108|157205779|FG003|Overall Study|Hospice patient death|46|||
48826620|NCT02929108|157205780|FG004|Overall Study|Hospice patient death|55|||
48826621|NCT02929108|157205781|FG005|Overall Study|Hospice patient death|28|||
48826622|NCT02929108|157205782|FG006|Overall Study|Hospice patient death|78|||
48826623|NCT03441984|157205783|FG000|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
48826624|NCT03441984|157205784|FG001|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
48826625|NCT03441984|157205785|FG002|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1|||
48826626|NCT03441984|157205786|FG003|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
48826627|NCT03441984|157205787|FG004|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
48826628|NCT03441984|157205788|FG005|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
48826629|NCT03441984|157205789|FG006|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
48826630|NCT03441984|157205790|FG007|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
48826631|NCT03441984|157205791|FG008|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
48826632|NCT03441984|157205792|FG009|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
49153674|NCT01432444|158403284|FG001|Treatment Phase|Adverse Event|37|||
49153675|NCT01432444|158403285|FG002|Treatment Phase|Adverse Event|0|||
49153676|NCT01432444|158403283|FG000|Treatment Phase|Met Withdrawal Criteria|0|||
49153677|NCT01432444|158403284|FG001|Treatment Phase|Met Withdrawal Criteria|11|||
49153678|NCT01432444|158403285|FG002|Treatment Phase|Met Withdrawal Criteria|0|||
48826633|NCT03441984|157205793|FG010|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
48826634|NCT03441984|157205794|FG011|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
48826635|NCT04088188|157205795|FG000|Overall Study|Withdrawal by Subject|2|||
48826636|NCT04088188|157205796|FG001|Overall Study|Withdrawal by Subject|0|||
48826637|NCT04088188|157205795|FG000|Overall Study|Adverse Event|2|||
48826638|NCT04088188|157205796|FG001|Overall Study|Adverse Event|0|||
48826639|NCT01414166|157205797|FG000|Overall Study|Adverse Event|10|||
49153679|NCT01432444|158403283|FG000|Treatment Phase|Physician Decision|0|||
48826640|NCT01414166|157205798|FG001|Overall Study|Adverse Event|2|||
48826641|NCT01414166|157205797|FG000|Overall Study|Lost to Follow-up|4|||
48826642|NCT01414166|157205798|FG001|Overall Study|Lost to Follow-up|1|||
48826643|NCT01414166|157205797|FG000|Overall Study|Non-compliance with study drug|2|||
48826644|NCT01414166|157205798|FG001|Overall Study|Non-compliance with study drug|0|||
48826645|NCT01414166|157205797|FG000|Overall Study|Physician Decision|2|||
48826646|NCT01414166|157205798|FG001|Overall Study|Physician Decision|0|||
48826647|NCT01414166|157205797|FG000|Overall Study|Protocol Violation|2|||
48826648|NCT01414166|157205798|FG001|Overall Study|Protocol Violation|0|||
48826649|NCT01414166|157205797|FG000|Overall Study|Study terminated by Sponsor|68|||
48826650|NCT01414166|157205798|FG001|Overall Study|Study terminated by Sponsor|75|||
49153680|NCT01432444|158403284|FG001|Treatment Phase|Physician Decision|5|||
48826651|NCT01414166|157205797|FG000|Overall Study|Withdrawal by Subject|3|||
48826652|NCT01414166|157205798|FG001|Overall Study|Withdrawal by Subject|5|||
48826653|NCT05027971|157205799|FG000|Overall Study|Physician Decision|7|||
48826654|NCT05027971|157205800|FG001|Overall Study|Physician Decision|3|||
48826655|NCT05027971|157205799|FG000|Overall Study|Lost to Follow-up|1|||
48826656|NCT05027971|157205800|FG001|Overall Study|Lost to Follow-up|1|||
48826657|NCT05027971|157205799|FG000|Overall Study|Withdrawal by Subject|0|||
48826658|NCT05027971|157205800|FG001|Overall Study|Withdrawal by Subject|2|||
48826659|NCT05027971|157205799|FG000|Overall Study|Non-study fiber used.|0|||
48826660|NCT05027971|157205800|FG001|Overall Study|Non-study fiber used.|1|||
48826661|NCT05027971|157205799|FG000|Overall Study|Protocol Violation|0|||
48826662|NCT05027971|157205800|FG001|Overall Study|Protocol Violation|2|||
48826663|NCT04423393|157207281|FG000|Overall Study|Withdrawal by Subject|0|||
48826664|NCT04423393|157207282|FG001|Overall Study|Withdrawal by Subject|0|||
48826665|NCT04423393|157207283|FG002|Overall Study|Withdrawal by Subject|0|||
48826666|NCT04423393|157207284|FG003|Overall Study|Withdrawal by Subject|0|||
48826667|NCT04423393|157207285|FG004|Overall Study|Withdrawal by Subject|0|||
49153681|NCT01432444|158403285|FG002|Treatment Phase|Physician Decision|0|||
49153682|NCT01432444|158403283|FG000|Treatment Phase|Withdrawal by Subject|0|||
49153683|NCT01432444|158403284|FG001|Treatment Phase|Withdrawal by Subject|41|||
49153684|NCT01432444|158403285|FG002|Treatment Phase|Withdrawal by Subject|0|||
49153685|NCT01432444|158403283|FG000|Treatment Phase|Protocol Deviation|0|||
49153686|NCT01432444|158403284|FG001|Treatment Phase|Protocol Deviation|3|||
49153687|NCT01432444|158403285|FG002|Treatment Phase|Protocol Deviation|0|||
49153688|NCT01432444|158403283|FG000|Treatment Phase|Lack of Efficacy|0|||
49153689|NCT01432444|158403284|FG001|Treatment Phase|Lack of Efficacy|10|||
49153690|NCT01432444|158403285|FG002|Treatment Phase|Lack of Efficacy|0|||
49153691|NCT01432444|158403283|FG000|Extension Phase|Lost to Follow-up|0|||
49153692|NCT01432444|158403284|FG001|Extension Phase|Lost to Follow-up|0|||
49153693|NCT01432444|158403285|FG002|Extension Phase|Lost to Follow-up|17|||
49153694|NCT01432444|158403283|FG000|Extension Phase|Adverse Event|0|||
49153695|NCT01432444|158403284|FG001|Extension Phase|Adverse Event|0|||
49153696|NCT01432444|158403285|FG002|Extension Phase|Adverse Event|10|||
49153697|NCT01432444|158403283|FG000|Extension Phase|Sponsor Discontinued Trial|0|||
49153698|NCT01432444|158403284|FG001|Extension Phase|Sponsor Discontinued Trial|0|||
49153699|NCT01432444|158403285|FG002|Extension Phase|Sponsor Discontinued Trial|7|||
49153700|NCT01432444|158403283|FG000|Extension Phase|Met Withdrawal Criteria|0|||
49153701|NCT01432444|158403284|FG001|Extension Phase|Met Withdrawal Criteria|0|||
49153702|NCT01432444|158403285|FG002|Extension Phase|Met Withdrawal Criteria|144|||
49153703|NCT01432444|158403283|FG000|Extension Phase|Physician Decision|0|||
49153704|NCT01432444|158403284|FG001|Extension Phase|Physician Decision|0|||
49153705|NCT01432444|158403285|FG002|Extension Phase|Physician Decision|1|||
49153706|NCT01432444|158403283|FG000|Extension Phase|Withdrawal by Subject|0|||
49153707|NCT01432444|158403284|FG001|Extension Phase|Withdrawal by Subject|0|||
49153708|NCT01432444|158403285|FG002|Extension Phase|Withdrawal by Subject|13|||
49153709|NCT02439957|158403286|FG000|Overall Study|Study Terminated|3|||
49153710|NCT02439957|158403287|FG001|Overall Study|Study Terminated|3|||
49153711|NCT00889005|158403288|FG000|Overall Study|Lost to Follow-up|4|||
49153712|NCT00889005|158403289|FG001|Overall Study|Lost to Follow-up|2|||
49153713|NCT00889005|158403288|FG000|Overall Study|Withdrawal by Subject|4|||
49153714|NCT00889005|158403289|FG001|Overall Study|Withdrawal by Subject|0|||
49153715|NCT01052779|158403291|FG000|Overall Study|Adverse Event|1|||
49153716|NCT01052779|158403292|FG001|Overall Study|Adverse Event|4|||
49153717|NCT01052779|158403291|FG000|Overall Study|Withdrawal by Subject|1|||
49153718|NCT01052779|158403292|FG001|Overall Study|Withdrawal by Subject|2|||
49153719|NCT01052779|158403291|FG000|Overall Study|Other-Protocol Violation|1|||
49153720|NCT01052779|158403292|FG001|Overall Study|Other-Protocol Violation|1|||
49153721|NCT01052779|158403291|FG000|Overall Study|Other-Surgery|0|||
49153722|NCT01052779|158403292|FG001|Overall Study|Other-Surgery|2|||
49153723|NCT01052779|158403291|FG000|Overall Study|Other-Missed Week 5 Visit|2|||
49153724|NCT01052779|158403292|FG001|Overall Study|Other-Missed Week 5 Visit|0|||
49153725|NCT05034952|158403294|FG000|Overall Study|Adverse Event|1|||
48826668|NCT04423393|157207286|FG005|Overall Study|Withdrawal by Subject|1|||
48826669|NCT04423393|157207287|FG006|Overall Study|Withdrawal by Subject|0|||
48826670|NCT04423393|157207288|FG007|Overall Study|Withdrawal by Subject|0|||
49153726|NCT05034952|158403295|FG001|Overall Study|Adverse Event|0|||
49153727|NCT05034952|158403296|FG002|Overall Study|Adverse Event|0|||
49153728|NCT05034952|158403297|FG003|Overall Study|Adverse Event|0|||
49153729|NCT05034952|158403294|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
48826671|NCT04423393|157207289|FG008|Overall Study|Withdrawal by Subject|0|||
49153730|NCT05034952|158403295|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
49153731|NCT05034952|158403296|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
49153732|NCT05034952|158403297|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
49153733|NCT05034952|158403294|FG000|Overall Study|Lost to Follow-up|1|||
48826672|NCT04423393|157207290|FG009|Overall Study|Withdrawal by Subject|0|||
48826673|NCT04423393|157207291|FG010|Overall Study|Withdrawal by Subject|0|||
48734381|NCT04526509|156877757|FG002|Enrolled|Physician Decision|0|||
48734382|NCT04526509|156877758|FG003|Enrolled|Physician Decision|0|||
48734383|NCT04526509|156877759|FG004|Enrolled|Physician Decision|0|||
48734384|NCT04526509|156877760|FG005|Enrolled|Physician Decision|0|||
48734385|NCT04526509|156877761|FG006|Enrolled|Physician Decision|0|||
48734386|NCT01066000|156877764|FG000|Overall Study|Protocol Violation|4|||
48734387|NCT01066000|156877764|FG000|Overall Study|Death|3|||
48734388|NCT01066000|156877764|FG000|Overall Study|Withdrawal by Subject|1|||
48734389|NCT01066000|156877764|FG000|Overall Study|Adverse Event|1|||
48734390|NCT03001882|156877765|FG000|Overall Study|Death|1|||
48734391|NCT03001882|156877766|FG001|Overall Study|Death|0|||
48734392|NCT03001882|156877767|FG002|Overall Study|Death|0|||
48734393|NCT03001882|156877768|FG003|Overall Study|Death|3|||
48734394|NCT03001882|156877765|FG000|Overall Study|Participant withdrew consent|0|||
48734395|NCT03001882|156877766|FG001|Overall Study|Participant withdrew consent|1|||
48734396|NCT03001882|156877767|FG002|Overall Study|Participant withdrew consent|0|||
48826674|NCT04423393|157207292|FG011|Overall Study|Withdrawal by Subject|0|||
48826675|NCT04423393|157207293|FG012|Overall Study|Withdrawal by Subject|0|||
48826676|NCT04423393|157207294|FG013|Overall Study|Withdrawal by Subject|1|||
48826677|NCT04423393|157207295|FG014|Overall Study|Withdrawal by Subject|0|||
48826678|NCT04423393|157207296|FG015|Overall Study|Withdrawal by Subject|0|||
48826679|NCT04423393|157207297|FG016|Overall Study|Withdrawal by Subject|0|||
48826680|NCT04423393|157207298|FG017|Overall Study|Withdrawal by Subject|0|||
48826681|NCT04423393|157207281|FG000|Overall Study|Sponsor Decision|0|||
48826682|NCT04423393|157207282|FG001|Overall Study|Sponsor Decision|0|||
48826683|NCT04423393|157207283|FG002|Overall Study|Sponsor Decision|0|||
48826684|NCT04423393|157207284|FG003|Overall Study|Sponsor Decision|0|||
48826685|NCT04423393|157207285|FG004|Overall Study|Sponsor Decision|0|||
48826686|NCT04423393|157207286|FG005|Overall Study|Sponsor Decision|0|||
48826687|NCT04423393|157207287|FG006|Overall Study|Sponsor Decision|0|||
48826688|NCT04423393|157207288|FG007|Overall Study|Sponsor Decision|0|||
48921904|NCT01780831|157548079|FG002|Overall Study|Withdrawal by Subject|4|||
48921905|NCT01780831|157548080|FG003|Overall Study|Withdrawal by Subject|0|||
48921906|NCT01780831|157548077|FG000|Overall Study|Lost to Follow-up|0|||
48921907|NCT01780831|157548078|FG001|Overall Study|Lost to Follow-up|0|||
48921908|NCT01780831|157548079|FG002|Overall Study|Lost to Follow-up|0|||
48921909|NCT01780831|157548080|FG003|Overall Study|Lost to Follow-up|1|||
48921910|NCT02918019|157548093|FG000|Overall Study|Death|0|||
48921911|NCT02918019|157548094|FG001|Overall Study|Death|0|||
48921912|NCT02918019|157548095|FG002|Overall Study|Death|1|||
48921913|NCT02918019|157548096|FG003|Overall Study|Death|0|||
49153734|NCT05034952|158403295|FG001|Overall Study|Lost to Follow-up|4|||
49153735|NCT05034952|158403296|FG002|Overall Study|Lost to Follow-up|3|||
49153736|NCT05034952|158403297|FG003|Overall Study|Lost to Follow-up|3|||
49153737|NCT05034952|158403294|FG000|Overall Study|Other|0|||
49153738|NCT05034952|158403295|FG001|Overall Study|Other|0|||
49153739|NCT05034952|158403296|FG002|Overall Study|Other|0|||
49153740|NCT05034952|158403297|FG003|Overall Study|Other|1|||
49153741|NCT01073293|158403298|FG000|Overall Study|Lost to Follow-up|0|||
48734397|NCT03001882|156877768|FG003|Overall Study|Participant withdrew consent|5|||
48734398|NCT03001882|156877765|FG000|Overall Study|Other reasons|1|||
48734399|NCT03001882|156877766|FG001|Overall Study|Other reasons|2|||
48734400|NCT03001882|156877767|FG002|Overall Study|Other reasons|0|||
48734401|NCT03001882|156877768|FG003|Overall Study|Other reasons|5|||
49153742|NCT01073293|158403299|FG001|Overall Study|Lost to Follow-up|1|||
49153743|NCT01073293|158403298|FG000|Overall Study|Withdrawal by Subject|5|||
49153744|NCT01073293|158403299|FG001|Overall Study|Withdrawal by Subject|10|||
49153745|NCT03427619|158403300|FG000|Overall Study|Physician Decision|3|||
49153746|NCT03427619|158403300|FG000|Overall Study|Withdrawal by Subject|4|||
49153747|NCT03427619|158403300|FG000|Overall Study|Lost to Follow-up|5|||
49153748|NCT03427619|158403300|FG000|Overall Study|Administrative|4|||
49153749|NCT03427619|158403300|FG000|Overall Study|Other|2|||
48734402|NCT03001882|156877765|FG000|Overall Study|Administrative reason by sponsor|0|||
48734403|NCT03001882|156877766|FG001|Overall Study|Administrative reason by sponsor|0|||
48734404|NCT03001882|156877767|FG002|Overall Study|Administrative reason by sponsor|0|||
48734405|NCT03001882|156877768|FG003|Overall Study|Administrative reason by sponsor|1|||
48826689|NCT04423393|157207289|FG008|Overall Study|Sponsor Decision|0|||
48826690|NCT04423393|157207290|FG009|Overall Study|Sponsor Decision|0|||
48826691|NCT04423393|157207291|FG010|Overall Study|Sponsor Decision|0|||
48921914|NCT02918019|157548093|FG000|Overall Study|Lost to Follow-up|1|||
48921915|NCT02918019|157548094|FG001|Overall Study|Lost to Follow-up|1|||
48826692|NCT04423393|157207292|FG011|Overall Study|Sponsor Decision|0|||
48921916|NCT02918019|157548095|FG002|Overall Study|Lost to Follow-up|0|||
49153750|NCT03427619|158403300|FG000|Overall Study|Unknown or Missing Completion Status|48|||
48734406|NCT03001882|156877765|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
48826693|NCT04423393|157207293|FG012|Overall Study|Sponsor Decision|0|||
49153751|NCT01948427|158403301|FG000|Overall Study|Serious Adverse Event|3|||
49153752|NCT01948427|158403302|FG001|Overall Study|Serious Adverse Event|0|||
49153753|NCT01948427|158403303|FG002|Overall Study|Serious Adverse Event|0|||
48921917|NCT02918019|157548096|FG003|Overall Study|Lost to Follow-up|1|||
48921918|NCT02918019|157548093|FG000|Overall Study|Principal investigator request|0|||
48921919|NCT02918019|157548094|FG001|Overall Study|Principal investigator request|0|||
48921920|NCT02918019|157548095|FG002|Overall Study|Principal investigator request|0|||
48921921|NCT02918019|157548096|FG003|Overall Study|Principal investigator request|1|||
48921922|NCT02918019|157548093|FG000|Overall Study|Physician Decision|1|||
48921923|NCT02918019|157548094|FG001|Overall Study|Physician Decision|3|||
48921924|NCT02918019|157548095|FG002|Overall Study|Physician Decision|2|||
48921925|NCT02918019|157548096|FG003|Overall Study|Physician Decision|0|||
48921926|NCT02918019|157548093|FG000|Overall Study|Protocol deviation|1|||
48921927|NCT02918019|157548094|FG001|Overall Study|Protocol deviation|1|||
48921928|NCT02918019|157548095|FG002|Overall Study|Protocol deviation|0|||
48921929|NCT02918019|157548096|FG003|Overall Study|Protocol deviation|2|||
48921930|NCT02918019|157548093|FG000|Overall Study|Withdrawal by Subject|3|||
48921931|NCT02918019|157548094|FG001|Overall Study|Withdrawal by Subject|4|||
48921932|NCT02918019|157548095|FG002|Overall Study|Withdrawal by Subject|6|||
48921933|NCT02918019|157548096|FG003|Overall Study|Withdrawal by Subject|4|||
48921934|NCT02918019|157548093|FG000|Overall Study|Adverse Event|0|||
48921935|NCT02918019|157548094|FG001|Overall Study|Adverse Event|1|||
48921936|NCT02918019|157548095|FG002|Overall Study|Adverse Event|0|||
48921937|NCT02918019|157548096|FG003|Overall Study|Adverse Event|1|||
48921938|NCT04041284|157548101|FG000|DB Phase (12 Weeks)|Adverse Event|0|||
48921939|NCT04041284|157548102|FG001|DB Phase (12 Weeks)|Adverse Event|3|||
48921940|NCT04041284|157548101|FG000|DB Phase (12 Weeks)|Withdrawal by Subject|6|||
48921941|NCT04041284|157548102|FG001|DB Phase (12 Weeks)|Withdrawal by Subject|4|||
48826694|NCT04423393|157207294|FG013|Overall Study|Sponsor Decision|1|||
48826695|NCT04423393|157207295|FG014|Overall Study|Sponsor Decision|0|||
48826696|NCT04423393|157207296|FG015|Overall Study|Sponsor Decision|0|||
48826697|NCT04423393|157207297|FG016|Overall Study|Sponsor Decision|0|||
48826698|NCT04423393|157207298|FG017|Overall Study|Sponsor Decision|0|||
48826699|NCT03531905|157207304|FG000|Overall Study|Withdrawal by Subject|3|||
48826700|NCT03531905|157207305|FG001|Overall Study|Withdrawal by Subject|3|||
48826701|NCT03531905|157207306|FG002|Overall Study|Withdrawal by Subject|2|||
48826702|NCT03531905|157207304|FG000|Overall Study|Lost to Follow-up|2|||
48826703|NCT03531905|157207305|FG001|Overall Study|Lost to Follow-up|2|||
48921942|NCT04041284|157548101|FG000|DB Phase (12 Weeks)|Protocol deviation|3|||
48921943|NCT04041284|157548102|FG001|DB Phase (12 Weeks)|Protocol deviation|3|||
48921944|NCT04041284|157548101|FG000|DB Phase (12 Weeks)|Lost to Follow-up|1|||
48826704|NCT03531905|157207306|FG002|Overall Study|Lost to Follow-up|1|||
48826705|NCT03531905|157207304|FG000|Overall Study|Participant was out of town|1|||
48826706|NCT03531905|157207305|FG001|Overall Study|Participant was out of town|0|||
48826707|NCT03531905|157207306|FG002|Overall Study|Participant was out of town|0|||
48921945|NCT04041284|157548102|FG001|DB Phase (12 Weeks)|Lost to Follow-up|0|||
48921946|NCT04041284|157548101|FG000|DB Phase (12 Weeks)|Lack of Efficacy|1|||
48921947|NCT04041284|157548102|FG001|DB Phase (12 Weeks)|Lack of Efficacy|1|||
49014255|NCT01703741|157888796|FG000|Overall Study|Subject did not want to continue|2|||
49014256|NCT01703741|157888796|FG000|Overall Study|Subject cannot comply with study visits|1|||
49014257|NCT01703741|157888796|FG000|Overall Study|Subject started testosterone injections|1|||
49014258|NCT01170364|157888805|FG000|Overall Study|Protocol Violation|4|||
49014259|NCT01170364|157888806|FG001|Overall Study|Protocol Violation|1|||
49014260|NCT03341273|157888808|FG000|Overall Study|Lost to Follow-up|7|||
49014261|NCT03341273|157888809|FG001|Overall Study|Lost to Follow-up|7|||
49014262|NCT03341273|157888808|FG000|Overall Study|Withdrawal by Subject|4|||
49014263|NCT03341273|157888809|FG001|Overall Study|Withdrawal by Subject|2|||
49014264|NCT03341273|157888808|FG000|Overall Study|Physician Decision|1|||
49014265|NCT03341273|157888809|FG001|Overall Study|Physician Decision|0|||
49014266|NCT03341273|157888808|FG000|Overall Study|Protocol Violation|0|||
49014267|NCT03341273|157888809|FG001|Overall Study|Protocol Violation|1|||
49014268|NCT03341273|157888808|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
49153754|NCT01948427|158403304|FG003|Overall Study|Serious Adverse Event|0|||
49153755|NCT01948427|158403305|FG004|Overall Study|Serious Adverse Event|1|||
49153756|NCT01948427|158403301|FG000|Overall Study|Investigator Request|0|||
49153757|NCT01948427|158403302|FG001|Overall Study|Investigator Request|8|||
49153758|NCT01948427|158403303|FG002|Overall Study|Investigator Request|0|||
49153759|NCT01948427|158403304|FG003|Overall Study|Investigator Request|0|||
49153760|NCT01948427|158403305|FG004|Overall Study|Investigator Request|6|||
49153761|NCT01948427|158403301|FG000|Overall Study|Lost to Follow-up|1|||
49153762|NCT01948427|158403302|FG001|Overall Study|Lost to Follow-up|0|||
49153763|NCT01948427|158403303|FG002|Overall Study|Lost to Follow-up|0|||
49153764|NCT01948427|158403304|FG003|Overall Study|Lost to Follow-up|0|||
49153765|NCT01948427|158403305|FG004|Overall Study|Lost to Follow-up|4|||
49153766|NCT01948427|158403301|FG000|Overall Study|Withdrawal by Subject|2|||
49153767|NCT01948427|158403302|FG001|Overall Study|Withdrawal by Subject|0|||
49153768|NCT01948427|158403303|FG002|Overall Study|Withdrawal by Subject|0|||
49153769|NCT01948427|158403304|FG003|Overall Study|Withdrawal by Subject|0|||
49153770|NCT01948427|158403305|FG004|Overall Study|Withdrawal by Subject|1|||
49153771|NCT01948427|158403301|FG000|Overall Study|Other, Not Specified|1|||
49153772|NCT01948427|158403302|FG001|Overall Study|Other, Not Specified|9|||
49153773|NCT01948427|158403303|FG002|Overall Study|Other, Not Specified|0|||
49153774|NCT01948427|158403304|FG003|Overall Study|Other, Not Specified|0|||
49153775|NCT01948427|158403305|FG004|Overall Study|Other, Not Specified|2|||
49153776|NCT02314923|158403308|FG000|Overall Study|Death|0|||
49153777|NCT02314923|158403309|FG001|Overall Study|Death|0|||
49153778|NCT02314923|158403310|FG002|Overall Study|Death|0|||
49153779|NCT02314923|158403311|FG003|Overall Study|Death|1|||
49153780|NCT02314923|158403312|FG004|Overall Study|Death|0|||
49153781|NCT02314923|158403313|FG005|Overall Study|Death|0|||
49153782|NCT02314923|158403314|FG006|Overall Study|Death|0|||
49153783|NCT02314923|158403315|FG007|Overall Study|Death|0|||
49153784|NCT02314923|158403316|FG008|Overall Study|Death|0|||
49153785|NCT02314923|158403317|FG009|Overall Study|Death|0|||
49153786|NCT02314923|158403308|FG000|Overall Study|Lost to Follow-up|2|||
49153787|NCT02314923|158403309|FG001|Overall Study|Lost to Follow-up|3|||
49153788|NCT02314923|158403310|FG002|Overall Study|Lost to Follow-up|1|||
49153789|NCT02314923|158403311|FG003|Overall Study|Lost to Follow-up|0|||
49153790|NCT02314923|158403312|FG004|Overall Study|Lost to Follow-up|0|||
49153791|NCT02314923|158403313|FG005|Overall Study|Lost to Follow-up|0|||
49153792|NCT02314923|158403314|FG006|Overall Study|Lost to Follow-up|3|||
49153793|NCT02314923|158403315|FG007|Overall Study|Lost to Follow-up|4|||
49153794|NCT02314923|158403316|FG008|Overall Study|Lost to Follow-up|2|||
49153795|NCT02314923|158403317|FG009|Overall Study|Lost to Follow-up|0|||
49153796|NCT02314923|158403308|FG000|Overall Study|Withdrawal by Subject|0|||
49153797|NCT02314923|158403309|FG001|Overall Study|Withdrawal by Subject|0|||
49153798|NCT02314923|158403310|FG002|Overall Study|Withdrawal by Subject|1|||
49153799|NCT02314923|158403311|FG003|Overall Study|Withdrawal by Subject|0|||
49153800|NCT02314923|158403312|FG004|Overall Study|Withdrawal by Subject|1|||
49153801|NCT02314923|158403313|FG005|Overall Study|Withdrawal by Subject|0|||
49153802|NCT02314923|158403314|FG006|Overall Study|Withdrawal by Subject|1|||
49153803|NCT02314923|158403315|FG007|Overall Study|Withdrawal by Subject|0|||
49153804|NCT02314923|158403316|FG008|Overall Study|Withdrawal by Subject|0|||
49153805|NCT02314923|158403317|FG009|Overall Study|Withdrawal by Subject|0|||
49153806|NCT02314923|158403308|FG000|Overall Study|Physician Decision|0|||
49153807|NCT02314923|158403309|FG001|Overall Study|Physician Decision|1|||
49153808|NCT02314923|158403310|FG002|Overall Study|Physician Decision|0|||
49153809|NCT02314923|158403311|FG003|Overall Study|Physician Decision|0|||
49153810|NCT02314923|158403312|FG004|Overall Study|Physician Decision|0|||
49153811|NCT02314923|158403313|FG005|Overall Study|Physician Decision|0|||
49153812|NCT02314923|158403314|FG006|Overall Study|Physician Decision|0|||
49153813|NCT02314923|158403315|FG007|Overall Study|Physician Decision|0|||
49153814|NCT02314923|158403316|FG008|Overall Study|Physician Decision|0|||
49153815|NCT02314923|158403317|FG009|Overall Study|Physician Decision|0|||
49153816|NCT02314923|158403308|FG000|Overall Study|Participant unavailable|0|||
49153817|NCT02314923|158403309|FG001|Overall Study|Participant unavailable|0|||
49153818|NCT02314923|158403310|FG002|Overall Study|Participant unavailable|0|||
49153819|NCT02314923|158403311|FG003|Overall Study|Participant unavailable|0|||
49153820|NCT02314923|158403312|FG004|Overall Study|Participant unavailable|0|||
49153821|NCT02314923|158403313|FG005|Overall Study|Participant unavailable|1|||
49153822|NCT02314923|158403314|FG006|Overall Study|Participant unavailable|0|||
49153823|NCT02314923|158403315|FG007|Overall Study|Participant unavailable|0|||
49153824|NCT02314923|158403316|FG008|Overall Study|Participant unavailable|0|||
49153825|NCT02314923|158403317|FG009|Overall Study|Participant unavailable|0|||
49153826|NCT02314923|158403308|FG000|Overall Study|Screen failure|0|||
49153827|NCT02314923|158403309|FG001|Overall Study|Screen failure|0|||
49153828|NCT02314923|158403310|FG002|Overall Study|Screen failure|0|||
49153829|NCT02314923|158403311|FG003|Overall Study|Screen failure|0|||
49153830|NCT02314923|158403312|FG004|Overall Study|Screen failure|0|||
49153831|NCT02314923|158403313|FG005|Overall Study|Screen failure|0|||
49153832|NCT02314923|158403314|FG006|Overall Study|Screen failure|1|||
49153833|NCT02314923|158403315|FG007|Overall Study|Screen failure|0|||
49153834|NCT02314923|158403316|FG008|Overall Study|Screen failure|0|||
49153835|NCT02314923|158403317|FG009|Overall Study|Screen failure|0|||
49153836|NCT02314923|158403308|FG000|Overall Study|Participant relocation|1|||
49153837|NCT02314923|158403309|FG001|Overall Study|Participant relocation|0|||
49153838|NCT02314923|158403310|FG002|Overall Study|Participant relocation|0|||
49153839|NCT02314923|158403311|FG003|Overall Study|Participant relocation|0|||
49153840|NCT02314923|158403312|FG004|Overall Study|Participant relocation|0|||
49153841|NCT02314923|158403313|FG005|Overall Study|Participant relocation|0|||
49153842|NCT02314923|158403314|FG006|Overall Study|Participant relocation|0|||
49153843|NCT02314923|158403315|FG007|Overall Study|Participant relocation|1|||
49153844|NCT02314923|158403316|FG008|Overall Study|Participant relocation|0|||
49153845|NCT02314923|158403317|FG009|Overall Study|Participant relocation|0|||
49153846|NCT04476784|158403318|FG000|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1|||
49153847|NCT04476784|158403319|FG001|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0|||
49153848|NCT00841815|158403320|FG000|Washout|Withdrawal by Subject|0|||
49153849|NCT00841815|158403321|FG001|Washout|Withdrawal by Subject|1|||
49153850|NCT00863304|158403327|FG000|Overall Study|Adverse Event|10|||
49153851|NCT00863304|158403328|FG001|Overall Study|Adverse Event|4|||
49153852|NCT00863304|158403329|FG002|Overall Study|Adverse Event|14|||
49153853|NCT00863304|158403330|FG003|Overall Study|Adverse Event|16|||
49153854|NCT00863304|158403327|FG000|Overall Study|Lost to Follow-up|1|||
49153855|NCT00863304|158403328|FG001|Overall Study|Lost to Follow-up|5|||
49153856|NCT00863304|158403329|FG002|Overall Study|Lost to Follow-up|4|||
49153857|NCT00863304|158403330|FG003|Overall Study|Lost to Follow-up|2|||
48734407|NCT03001882|156877766|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
48734408|NCT03001882|156877767|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
48734409|NCT03001882|156877768|FG003|Overall Study|Participant requested to discontinue study treatment|2|||
49153858|NCT00863304|158403327|FG000|Overall Study|Lack of Efficacy|57|||
49153859|NCT00863304|158403328|FG001|Overall Study|Lack of Efficacy|26|||
49153860|NCT00863304|158403329|FG002|Overall Study|Lack of Efficacy|30|||
49153861|NCT00863304|158403330|FG003|Overall Study|Lack of Efficacy|28|||
49153862|NCT00863304|158403327|FG000|Overall Study|Withdrawal by Subject|19|||
49153863|NCT00863304|158403328|FG001|Overall Study|Withdrawal by Subject|14|||
49153864|NCT00863304|158403329|FG002|Overall Study|Withdrawal by Subject|20|||
48734410|NCT03001882|156877765|FG000|Overall Study|Not reported|0|||
48734411|NCT03001882|156877766|FG001|Overall Study|Not reported|0|||
48734412|NCT03001882|156877767|FG002|Overall Study|Not reported|0|||
48734413|NCT03001882|156877768|FG003|Overall Study|Not reported|6|||
48734414|NCT03001882|156877765|FG000|Overall Study|Maximum clinical benefit|2|||
48734415|NCT03001882|156877766|FG001|Overall Study|Maximum clinical benefit|3|||
48734416|NCT03001882|156877767|FG002|Overall Study|Maximum clinical benefit|0|||
48734417|NCT03001882|156877768|FG003|Overall Study|Maximum clinical benefit|10|||
48734418|NCT03001882|156877765|FG000|Overall Study|AE unrelated to study drug|3|||
48734419|NCT03001882|156877766|FG001|Overall Study|AE unrelated to study drug|3|||
48734420|NCT03001882|156877767|FG002|Overall Study|AE unrelated to study drug|0|||
48734421|NCT03001882|156877768|FG003|Overall Study|AE unrelated to study drug|11|||
48734422|NCT03001882|156877765|FG000|Overall Study|Study Drug Toxicity|8|||
48734423|NCT03001882|156877766|FG001|Overall Study|Study Drug Toxicity|5|||
48734424|NCT03001882|156877767|FG002|Overall Study|Study Drug Toxicity|0|||
48734425|NCT03001882|156877768|FG003|Overall Study|Study Drug Toxicity|37|||
48734426|NCT03001882|156877765|FG000|Overall Study|Disease progression|16|||
48734427|NCT03001882|156877766|FG001|Overall Study|Disease progression|14|||
48734428|NCT03001882|156877767|FG002|Overall Study|Disease progression|1|||
48734429|NCT03001882|156877768|FG003|Overall Study|Disease progression|90|||
48734430|NCT01386008|156877769|FG000|Overall Study|exited w/o incident /study discontinued|17|||
48734431|NCT01386008|156877769|FG000|Overall Study|Adverse Event|3|||
48734432|NCT04449861|156877770|FG000|Overall Study|Withdrawal by Subject|4|||
48734433|NCT04449861|156877770|FG000|Overall Study|Lost to Follow-up|5|||
48734434|NCT04449861|156877770|FG000|Overall Study|Death|112|||
48734435|NCT04635059|156877771|FG000|Overall Study|Study terminated early.|4|||
48734436|NCT01083485|156879458|FG000|Overall Study|Adverse Event|0|||
48734437|NCT01083485|156879459|FG001|Overall Study|Adverse Event|1|||
49153865|NCT00863304|158403330|FG003|Overall Study|Withdrawal by Subject|18|||
49153866|NCT00863304|158403327|FG000|Overall Study|Other|1|||
49153867|NCT00863304|158403328|FG001|Overall Study|Other|0|||
49153868|NCT00863304|158403329|FG002|Overall Study|Other|0|||
49153869|NCT00863304|158403330|FG003|Overall Study|Other|1|||
49153870|NCT00863304|158403327|FG000|Overall Study|Protocol Violation|2|||
49153871|NCT00863304|158403328|FG001|Overall Study|Protocol Violation|6|||
49014269|NCT03341273|157888809|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
49014270|NCT03341273|157888808|FG000|Overall Study|Became ineligible after enrollment|1|||
49014271|NCT03341273|157888809|FG001|Overall Study|Became ineligible after enrollment|0|||
49014272|NCT03341273|157888808|FG000|Overall Study|Not Eligible at Enrollment|0|||
49014273|NCT03341273|157888809|FG001|Overall Study|Not Eligible at Enrollment|1|||
49153872|NCT00863304|158403329|FG002|Overall Study|Protocol Violation|2|||
49153873|NCT00863304|158403330|FG003|Overall Study|Protocol Violation|0|||
49153874|NCT00863304|158403327|FG000|Overall Study|Randomized, but not Treated|3|||
49153875|NCT00863304|158403328|FG001|Overall Study|Randomized, but not Treated|1|||
48734438|NCT01083485|156879458|FG000|Overall Study|Protocol Violation|1|||
48734439|NCT01083485|156879459|FG001|Overall Study|Protocol Violation|0|||
48734440|NCT01083485|156879458|FG000|Overall Study|Withdrawal by Subject|5|||
48734441|NCT01083485|156879459|FG001|Overall Study|Withdrawal by Subject|2|||
48734442|NCT01083485|156879458|FG000|Overall Study|Other|1|||
48734443|NCT01083485|156879459|FG001|Overall Study|Other|0|||
48734444|NCT04879225|156879460|FG000|Mint, Menthol, Tobacco|Lost to Follow-up|1|||
48734445|NCT04879225|156879460|FG000|Menthol and Tobacco|Lost to Follow-up|1|||
48734446|NCT01824342|156879464|FG000|Overall Study|Withdrawal by Subject|0|||
48734447|NCT01824342|156879465|FG001|Overall Study|Withdrawal by Subject|3|||
49014274|NCT03341273|157888808|FG000|Overall Study|Participant incarcerated|1|||
49014275|NCT03341273|157888809|FG001|Overall Study|Participant incarcerated|0|||
49014276|NCT01717456|157888812|FG000|End of Treatment|Physician Decision|0|||
49014277|NCT01717456|157888813|FG001|End of Treatment|Physician Decision|1|||
49014278|NCT01717456|157888812|FG000|End of Treatment|Lost to Follow-up|0|||
49014279|NCT01717456|157888813|FG001|End of Treatment|Lost to Follow-up|1|||
49014280|NCT01717456|157888812|FG000|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
49014281|NCT01717456|157888813|FG001|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
49014282|NCT00891774|157888814|FG000|Overall Study|Lost to Follow-up|5|||
49014283|NCT00891774|157888814|FG000|Overall Study|Illness (Self/Mother)|3|||
49014284|NCT00891774|157888814|FG000|Overall Study|Withdrawal by Subject|2|||
49014285|NCT00891774|157888814|FG000|Overall Study|Protocol Violation|4|||
49014286|NCT01333033|157888816|FG000|Overall Study|Ineligible|0|||
49014287|NCT01333033|157888817|FG001|Overall Study|Ineligible|0|||
49014288|NCT01333033|157888818|FG002|Overall Study|Ineligible|0|||
49014289|NCT01333033|157888819|FG003|Overall Study|Ineligible|0|||
49014290|NCT01333033|157888820|FG004|Overall Study|Ineligible|6|||
49014291|NCT01333033|157888821|FG005|Overall Study|Ineligible|8|||
49014292|NCT01333033|157888816|FG000|Overall Study|Withdrawal by Subject|0|||
49014293|NCT01333033|157888817|FG001|Overall Study|Withdrawal by Subject|0|||
49014294|NCT01333033|157888818|FG002|Overall Study|Withdrawal by Subject|0|||
49014295|NCT01333033|157888819|FG003|Overall Study|Withdrawal by Subject|0|||
49014296|NCT01333033|157888820|FG004|Overall Study|Withdrawal by Subject|4|||
49014297|NCT01333033|157888821|FG005|Overall Study|Withdrawal by Subject|2|||
49014298|NCT01333033|157888816|FG000|Overall Study|PET inevaluable|0|||
49014299|NCT01333033|157888817|FG001|Overall Study|PET inevaluable|0|||
49014300|NCT01333033|157888818|FG002|Overall Study|PET inevaluable|0|||
49014301|NCT01333033|157888819|FG003|Overall Study|PET inevaluable|0|||
49014302|NCT01333033|157888820|FG004|Overall Study|PET inevaluable|2|||
49014303|NCT01333033|157888821|FG005|Overall Study|PET inevaluable|4|||
49014304|NCT01333033|157888816|FG000|Overall Study|Adverse Event|0|||
49014305|NCT01333033|157888817|FG001|Overall Study|Adverse Event|0|||
49014306|NCT01333033|157888818|FG002|Overall Study|Adverse Event|0|||
49014307|NCT01333033|157888819|FG003|Overall Study|Adverse Event|0|||
49014308|NCT01333033|157888820|FG004|Overall Study|Adverse Event|2|||
49014309|NCT01333033|157888821|FG005|Overall Study|Adverse Event|1|||
49014310|NCT01333033|157888816|FG000|Overall Study|Progression|0|||
49014311|NCT01333033|157888817|FG001|Overall Study|Progression|0|||
49014312|NCT01333033|157888818|FG002|Overall Study|Progression|0|||
49014313|NCT01333033|157888819|FG003|Overall Study|Progression|0|||
49014314|NCT01333033|157888820|FG004|Overall Study|Progression|0|||
49014315|NCT01333033|157888821|FG005|Overall Study|Progression|1|||
49014316|NCT01333033|157888816|FG000|Overall Study|MD Decision|0|||
49014317|NCT01333033|157888817|FG001|Overall Study|MD Decision|0|||
49014318|NCT01333033|157888818|FG002|Overall Study|MD Decision|0|||
49014319|NCT01333033|157888819|FG003|Overall Study|MD Decision|0|||
49014320|NCT01333033|157888820|FG004|Overall Study|MD Decision|0|||
49014321|NCT01333033|157888821|FG005|Overall Study|MD Decision|2|||
49014322|NCT02006147|157888822|FG000|Overall Study|Protocol Violation|1|||
49014323|NCT02006147|157888823|FG001|Overall Study|Protocol Violation|1|||
49014324|NCT02006147|157888824|FG002|Overall Study|Protocol Violation|0|||
49014325|NCT02006147|157888825|FG003|Overall Study|Protocol Violation|0|||
49014326|NCT02006147|157888822|FG000|Overall Study|Withdrawal by Subject|0|||
49014327|NCT02006147|157888823|FG001|Overall Study|Withdrawal by Subject|1|||
49014328|NCT02006147|157888824|FG002|Overall Study|Withdrawal by Subject|0|||
49014329|NCT02006147|157888825|FG003|Overall Study|Withdrawal by Subject|0|||
49014330|NCT02006147|157888822|FG000|Overall Study|Withdrawal by Sponsor|1|||
49014331|NCT02006147|157888823|FG001|Overall Study|Withdrawal by Sponsor|0|||
49014332|NCT02006147|157888824|FG002|Overall Study|Withdrawal by Sponsor|0|||
49014333|NCT02006147|157888825|FG003|Overall Study|Withdrawal by Sponsor|0|||
48826708|NCT03531905|157207304|FG000|Overall Study|Could not speak with the participant|1|||
48826709|NCT03531905|157207305|FG001|Overall Study|Could not speak with the participant|0|||
48826710|NCT03531905|157207306|FG002|Overall Study|Could not speak with the participant|0|||
48826711|NCT04978363|157207309|FG000|Overall Study|Other medical issues unrelated to the study|0|||
48826712|NCT04978363|157207310|FG001|Overall Study|Other medical issues unrelated to the study|0|||
48826713|NCT04978363|157207311|FG002|Overall Study|Other medical issues unrelated to the study|0|||
48826714|NCT04978363|157207312|FG003|Overall Study|Other medical issues unrelated to the study|0|||
48826715|NCT04978363|157207313|FG004|Overall Study|Other medical issues unrelated to the study|1|||
48826716|NCT04978363|157207314|FG005|Overall Study|Other medical issues unrelated to the study|0|||
48826717|NCT04978363|157207315|FG006|Overall Study|Other medical issues unrelated to the study|0|||
48826718|NCT04978363|157207316|FG007|Overall Study|Other medical issues unrelated to the study|0|||
48826719|NCT04978363|157207317|FG008|Overall Study|Other medical issues unrelated to the study|0|||
48826720|NCT04978363|157207318|FG009|Overall Study|Other medical issues unrelated to the study|0|||
48826721|NCT04978363|157207319|FG010|Overall Study|Other medical issues unrelated to the study|0|||
48826722|NCT04978363|157207309|FG000|Overall Study|Unable to meet the necessary time commitment|0|||
48826723|NCT04978363|157207310|FG001|Overall Study|Unable to meet the necessary time commitment|0|||
48826724|NCT04978363|157207311|FG002|Overall Study|Unable to meet the necessary time commitment|1|||
48826725|NCT04978363|157207312|FG003|Overall Study|Unable to meet the necessary time commitment|0|||
48826726|NCT04978363|157207313|FG004|Overall Study|Unable to meet the necessary time commitment|0|||
48826727|NCT04978363|157207314|FG005|Overall Study|Unable to meet the necessary time commitment|0|||
48826728|NCT04978363|157207315|FG006|Overall Study|Unable to meet the necessary time commitment|0|||
48826729|NCT04978363|157207316|FG007|Overall Study|Unable to meet the necessary time commitment|0|||
48826730|NCT04978363|157207317|FG008|Overall Study|Unable to meet the necessary time commitment|0|||
48826731|NCT04978363|157207318|FG009|Overall Study|Unable to meet the necessary time commitment|0|||
48826732|NCT04978363|157207319|FG010|Overall Study|Unable to meet the necessary time commitment|0|||
48826733|NCT04978363|157207309|FG000|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
48826734|NCT04978363|157207310|FG001|Overall Study|Didn't feel safe and had pain with hands-free crutch|1|||
48826735|NCT04978363|157207311|FG002|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
48826736|NCT04978363|157207312|FG003|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
48826737|NCT04978363|157207313|FG004|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
48826738|NCT04978363|157207314|FG005|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
48826739|NCT04978363|157207315|FG006|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
48826740|NCT04978363|157207316|FG007|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
48826741|NCT04978363|157207317|FG008|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
48826742|NCT04978363|157207318|FG009|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
48826743|NCT04978363|157207319|FG010|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
48826744|NCT01251614|157207320|FG000|Overall Study|Adverse Event|1|||
48826745|NCT01251614|157207321|FG001|Overall Study|Adverse Event|0|||
48826746|NCT01251614|157207322|FG002|Overall Study|Adverse Event|1|||
48826747|NCT01251614|157207320|FG000|Overall Study|Lack of Efficacy|1|||
48826748|NCT01251614|157207321|FG001|Overall Study|Lack of Efficacy|9|||
48826749|NCT01251614|157207322|FG002|Overall Study|Lack of Efficacy|4|||
48826750|NCT01251614|157207320|FG000|Overall Study|Clearing of Psoriatic Lesions|1|||
48826751|NCT01251614|157207321|FG001|Overall Study|Clearing of Psoriatic Lesions|0|||
49153876|NCT00863304|158403329|FG002|Overall Study|Randomized, but not Treated|4|||
49153877|NCT00863304|158403330|FG003|Overall Study|Randomized, but not Treated|1|||
49153878|NCT00863304|158403327|FG000|Overall Study|Entered extension study|101|||
49153879|NCT00863304|158403328|FG001|Overall Study|Entered extension study|129|||
48921948|NCT04041284|157548101|FG000|DB Phase (12 Weeks)|Other than specified|1|||
48921949|NCT04041284|157548102|FG001|DB Phase (12 Weeks)|Other than specified|0|||
48921950|NCT04041284|157548101|FG000|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
48921951|NCT04041284|157548102|FG001|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
48921952|NCT04041284|157548101|FG000|OL Phase (12 Weeks)|Protocol deviation|0|||
49153880|NCT00863304|158403329|FG002|Overall Study|Entered extension study|113|||
49153881|NCT00863304|158403330|FG003|Overall Study|Entered extension study|125|||
49153882|NCT04617860|158403331|FG000|Overall Study|Adverse Event|0|||
49153883|NCT04617860|158403332|FG001|Overall Study|Adverse Event|2|||
49153884|NCT04617860|158403333|FG002|Overall Study|Adverse Event|2|||
49153885|NCT04617860|158403331|FG000|Overall Study|Withdrawal by Subject|0|||
49153886|NCT04617860|158403332|FG001|Overall Study|Withdrawal by Subject|0|||
49153887|NCT04617860|158403333|FG002|Overall Study|Withdrawal by Subject|2|||
49153888|NCT04617860|158403331|FG000|Overall Study|Physician Decision|0|||
49153889|NCT04617860|158403332|FG001|Overall Study|Physician Decision|1|||
49153890|NCT04617860|158403333|FG002|Overall Study|Physician Decision|0|||
49153891|NCT04617860|158403331|FG000|Overall Study|Sponsor Decision|0|||
49153892|NCT04617860|158403332|FG001|Overall Study|Sponsor Decision|3|||
49153893|NCT04617860|158403333|FG002|Overall Study|Sponsor Decision|1|||
49153894|NCT04617860|158403331|FG000|Overall Study|Termination of Study by Sponsor|8|||
49153895|NCT04617860|158403332|FG001|Overall Study|Termination of Study by Sponsor|4|||
49153896|NCT04617860|158403333|FG002|Overall Study|Termination of Study by Sponsor|13|||
49153897|NCT00478257|158403334|FG000|Overall Study|Withdrawal by Subject|8|||
49153898|NCT00478257|158403335|FG001|Overall Study|Withdrawal by Subject|3|||
48826752|NCT01251614|157207322|FG002|Overall Study|Clearing of Psoriatic Lesions|0|||
48826753|NCT01251614|157207320|FG000|Overall Study|Pregnancy|0|||
48826754|NCT01251614|157207321|FG001|Overall Study|Pregnancy|0|||
48826755|NCT01251614|157207322|FG002|Overall Study|Pregnancy|2|||
48826756|NCT01251614|157207320|FG000|Overall Study|Loss of Disease Control|0|||
48826757|NCT01251614|157207321|FG001|Overall Study|Loss of Disease Control|1|||
48826758|NCT01251614|157207322|FG002|Overall Study|Loss of Disease Control|0|||
48826759|NCT01251614|157207320|FG000|Overall Study|Withdrawal by Subject|0|||
49153899|NCT03931330|158403338|FG000|Overall Study|Physician Decision|1|||
49153900|NCT03738228|158403339|FG000|Overall Study|Never received study treatment|2|||
49153901|NCT03738228|158403340|FG001|Overall Study|Never received study treatment|2|||
49153902|NCT05473715|158403345|FG000|Overall Study|Trial terminate|2|||
49153903|NCT05473715|158403346|FG001|Overall Study|Trial terminate|1|||
49153904|NCT02496000|158403355|FG000|Overall Study|Withdrawal by Subject|1|||
49153905|NCT02496000|158403356|FG001|Overall Study|Withdrawal by Subject|2|||
49153906|NCT02496000|158403357|FG002|Overall Study|Withdrawal by Subject|0|||
49153907|NCT02496000|158403355|FG000|Overall Study|Lost to Follow-up|1|||
49153908|NCT02496000|158403356|FG001|Overall Study|Lost to Follow-up|0|||
49153909|NCT02496000|158403357|FG002|Overall Study|Lost to Follow-up|1|||
49153910|NCT02496000|158403355|FG000|Overall Study|Protocol Violation|0|||
49153911|NCT02496000|158403356|FG001|Overall Study|Protocol Violation|0|||
49153912|NCT02496000|158403357|FG002|Overall Study|Protocol Violation|1|||
49153913|NCT02496000|158403355|FG000|Overall Study|Non-compliance or lack of cooperation|0|||
49153914|NCT02496000|158403356|FG001|Overall Study|Non-compliance or lack of cooperation|2|||
49153915|NCT02496000|158403357|FG002|Overall Study|Non-compliance or lack of cooperation|0|||
49153916|NCT02496000|158403355|FG000|Overall Study|undetermined|0|||
49153917|NCT02496000|158403356|FG001|Overall Study|undetermined|1|||
49153918|NCT02496000|158403357|FG002|Overall Study|undetermined|0|||
49153919|NCT03636022|158403358|FG000|Overall Study|Withdrawal by Subject|1|||
49153920|NCT03636022|158403359|FG001|Overall Study|Withdrawal by Subject|3|||
49153921|NCT01174563|158403362|FG000|Overall Study|Progressive Disease|45|||
49153922|NCT01174563|158403362|FG000|Overall Study|Death|5|||
49153923|NCT01174563|158403362|FG000|Overall Study|Investigator's Discretion|5|||
49153924|NCT01174563|158403362|FG000|Overall Study|Participant Withdrew Consent|3|||
49153925|NCT01174563|158403362|FG000|Overall Study|Rash Adverse Event|1|||
49153926|NCT01174563|158403362|FG000|Overall Study|Sponsor's decision|1|||
49153927|NCT00643279|158403366|FG000|Overall Study|Death|13|||
49153928|NCT00643279|158403367|FG001|Overall Study|Death|11|||
49153929|NCT00643279|158403366|FG000|Overall Study|Withdrawal by Subject|3|||
49153930|NCT00643279|158403367|FG001|Overall Study|Withdrawal by Subject|0|||
49153931|NCT00643279|158403366|FG000|Overall Study|Lost to Follow-up|0|||
49153932|NCT00643279|158403367|FG001|Overall Study|Lost to Follow-up|1|||
49153933|NCT00643279|158403366|FG000|Overall Study|Physician Decision|0|||
49153934|NCT00643279|158403367|FG001|Overall Study|Physician Decision|1|||
49153935|NCT00404248|158403368|FG000|Overall Study|pts declining status|0|||
49153936|NCT00404248|158403369|FG001|Overall Study|pts declining status|1|||
49153937|NCT00404248|158403370|FG002|Overall Study|pts declining status|0|||
49153938|NCT00404248|158403371|FG003|Overall Study|pts declining status|0|||
49153939|NCT00404248|158403372|FG004|Overall Study|pts declining status|0|||
49153940|NCT00404248|158403373|FG005|Overall Study|pts declining status|0|||
49153941|NCT00404248|158403374|FG006|Overall Study|pts declining status|0|||
49153942|NCT00404248|158403375|FG007|Overall Study|pts declining status|0|||
49153943|NCT00404248|158403376|FG008|Overall Study|pts declining status|0|||
49153944|NCT01405196|158403377|FG000|Overall Study|Study Terminated by Sponsor|0|||
49153945|NCT01405196|158403378|FG001|Overall Study|Study Terminated by Sponsor|0|||
49153946|NCT01405196|158403379|FG002|Overall Study|Study Terminated by Sponsor|9|||
49153947|NCT01405196|158403380|FG003|Overall Study|Study Terminated by Sponsor|0|||
49153948|NCT01405196|158403377|FG000|Overall Study|Other|2|||
49153949|NCT01405196|158403378|FG001|Overall Study|Other|2|||
49153950|NCT01405196|158403379|FG002|Overall Study|Other|5|||
49153951|NCT01405196|158403380|FG003|Overall Study|Other|0|||
49153952|NCT01405196|158403377|FG000|Overall Study|Withdrawal by Subject|4|||
49153953|NCT01405196|158403378|FG001|Overall Study|Withdrawal by Subject|6|||
48826760|NCT01251614|157207321|FG001|Overall Study|Withdrawal by Subject|2|||
48826761|NCT01251614|157207322|FG002|Overall Study|Withdrawal by Subject|1|||
48826762|NCT01251614|157207320|FG000|Overall Study|Lost to Follow-up|0|||
49153954|NCT01405196|158403379|FG002|Overall Study|Withdrawal by Subject|3|||
49153955|NCT01405196|158403380|FG003|Overall Study|Withdrawal by Subject|6|||
49153956|NCT01405196|158403377|FG000|Overall Study|Adverse Event|2|||
49153957|NCT01405196|158403378|FG001|Overall Study|Adverse Event|2|||
48826763|NCT01251614|157207321|FG001|Overall Study|Lost to Follow-up|1|||
49153958|NCT01405196|158403379|FG002|Overall Study|Adverse Event|0|||
48734448|NCT01824342|156879464|FG000|Overall Study|Adverse Event|1|||
48734449|NCT01824342|156879465|FG001|Overall Study|Adverse Event|1|||
48734450|NCT01824342|156879464|FG000|Overall Study|Disease Progression|1|||
48734451|NCT01824342|156879465|FG001|Overall Study|Disease Progression|1|||
48826764|NCT01251614|157207322|FG002|Overall Study|Lost to Follow-up|0|||
48826765|NCT02153788|157207323|FG000|Overall Study|Physician Decision|2|||
48826766|NCT02153788|157207324|FG001|Overall Study|Physician Decision|1|||
48826767|NCT05305040|157207327|FG000|Overall Study|Not Dosed|37|||
48826768|NCT05305040|157207328|FG001|Overall Study|Not Dosed|37|||
48826769|NCT05305040|157207327|FG000|Overall Study|Study Closure|34|||
48826770|NCT05305040|157207328|FG001|Overall Study|Study Closure|46|||
48826771|NCT05305040|157207327|FG000|Overall Study|Death|14|||
48826772|NCT05305040|157207328|FG001|Overall Study|Death|13|||
48826773|NCT05305040|157207327|FG000|Overall Study|Withdrawal by Subject|15|||
48826774|NCT05305040|157207328|FG001|Overall Study|Withdrawal by Subject|10|||
48826775|NCT05305040|157207327|FG000|Overall Study|Other|13|||
48826776|NCT05305040|157207328|FG001|Overall Study|Other|10|||
48826777|NCT05305040|157207327|FG000|Overall Study|Primary Malignancy Relapse|3|||
48826778|NCT05305040|157207328|FG001|Overall Study|Primary Malignancy Relapse|4|||
49153959|NCT01405196|158403380|FG003|Overall Study|Adverse Event|2|||
49153960|NCT01405196|158403377|FG000|Overall Study|Death|1|||
49153961|NCT01405196|158403378|FG001|Overall Study|Death|0|||
49153962|NCT01405196|158403379|FG002|Overall Study|Death|3|||
49153963|NCT01405196|158403380|FG003|Overall Study|Death|0|||
49153964|NCT01405196|158403377|FG000|Overall Study|Lost to Follow-up|2|||
49153965|NCT01405196|158403378|FG001|Overall Study|Lost to Follow-up|2|||
49153966|NCT01405196|158403379|FG002|Overall Study|Lost to Follow-up|3|||
49153967|NCT01405196|158403380|FG003|Overall Study|Lost to Follow-up|1|||
49153968|NCT03189524|158404947|FG000|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7|||
49153969|NCT03189524|158404948|FG001|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5|||
49153970|NCT03189524|158404949|FG002|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11|||
49153971|NCT03189524|158404947|FG000|Overall Study|Death|2|||
49153972|NCT03189524|158404948|FG001|Overall Study|Death|2|||
49153973|NCT03189524|158404949|FG002|Overall Study|Death|1|||
49153974|NCT03189524|158404947|FG000|Overall Study|Lost to Follow-up|1|||
49153975|NCT03189524|158404948|FG001|Overall Study|Lost to Follow-up|0|||
49153976|NCT03189524|158404949|FG002|Overall Study|Lost to Follow-up|8|||
49153977|NCT03189524|158404947|FG000|Overall Study|Withdrawal by Subject|1|||
49153978|NCT03189524|158404948|FG001|Overall Study|Withdrawal by Subject|1|||
49153979|NCT03189524|158404949|FG002|Overall Study|Withdrawal by Subject|3|||
49153980|NCT03189524|158404947|FG000|Overall Study|Progressive Disease|0|||
49153981|NCT03189524|158404948|FG001|Overall Study|Progressive Disease|2|||
49153982|NCT03189524|158404949|FG002|Overall Study|Progressive Disease|0|||
49153983|NCT04038957|158404950|FG000|Overall Study|Withdrawal by Subject|1|||
49153984|NCT04038957|158404950|FG000|Overall Study|SUBJECT WAS WITHDRAWN DUE TO SAFETY REASON|1|||
49153985|NCT04129398|158404951|FG000|Overall Study|Physician Decision|2|||
49153986|NCT03058952|158404952|FG000|Overall Study|Adverse Event|1|||
49153987|NCT03058952|158404953|FG001|Overall Study|Adverse Event|0|||
49153988|NCT03058952|158404952|FG000|Overall Study|Lost to Follow-up|15|||
49153989|NCT03058952|158404953|FG001|Overall Study|Lost to Follow-up|15|||
49153990|NCT03058952|158404952|FG000|Overall Study|Withdrawal by Subject|7|||
49153991|NCT03058952|158404953|FG001|Overall Study|Withdrawal by Subject|11|||
49153992|NCT03271151|158404955|FG000|Overall Study|Lost to Follow-up|1|||
49153993|NCT03271151|158404956|FG001|Overall Study|Lost to Follow-up|3|||
49153994|NCT03271151|158404955|FG000|Overall Study|Withdrawal by Subject|1|||
49153995|NCT03271151|158404956|FG001|Overall Study|Withdrawal by Subject|0|||
48734452|NCT01824342|156879464|FG000|Overall Study|Physician Decision|5|||
48734453|NCT01824342|156879465|FG001|Overall Study|Physician Decision|0|||
48734454|NCT01824342|156879464|FG000|Overall Study|Death|2|||
48734455|NCT01824342|156879465|FG001|Overall Study|Death|0|||
48826779|NCT05305040|157207327|FG000|Overall Study|Adverse Event|3|||
48826780|NCT05305040|157207328|FG001|Overall Study|Adverse Event|3|||
48826781|NCT05305040|157207327|FG000|Overall Study|Lost to Follow-up|2|||
48826782|NCT05305040|157207328|FG001|Overall Study|Lost to Follow-up|1|||
48921953|NCT04041284|157548102|FG001|OL Phase (12 Weeks)|Protocol deviation|1|||
48921954|NCT04041284|157548101|FG000|OL Phase (12 Weeks)|Pregnancy|1|||
49153996|NCT04439253|158404957|FG000|Overall Study|Adverse Event|1|||
49153997|NCT04439253|158404957|FG000|Overall Study|Disease progression|2|||
49153998|NCT04439253|158404957|FG000|Overall Study|Complicating disease|1|||
49153999|NCT03433339|158404958|FG000|Overall Study|Lost to Follow-up|2|||
49154000|NCT03433339|158404959|FG001|Overall Study|Lost to Follow-up|0|||
49154001|NCT03433339|158404958|FG000|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|0|||
49154002|NCT03433339|158404959|FG001|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|2|||
48826783|NCT05305040|157207327|FG000|Overall Study|Graft versus host disease|2|||
49154003|NCT03433339|158404958|FG000|Overall Study|Withdrawal by Subject|0|||
49154004|NCT03433339|158404959|FG001|Overall Study|Withdrawal by Subject|2|||
48826784|NCT05305040|157207328|FG001|Overall Study|Graft versus host disease|0|||
49154005|NCT04123704|158404963|FG000|Overall Study|Disease progression|2|||
49154006|NCT02965716|158404964|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
49154007|NCT02965716|158404965|FG001|Overall Study|Refusal Unrelated to Adverse Event|5|||
49154008|NCT02965716|158404964|FG000|Overall Study|Progression/Relapse|8|||
49154009|NCT02965716|158404965|FG001|Overall Study|Progression/Relapse|16|||
49154010|NCT02965716|158404964|FG000|Overall Study|Death|1|||
49154011|NCT02965716|158404965|FG001|Overall Study|Death|0|||
49154012|NCT02965716|158404964|FG000|Overall Study|Not Protocol Specified|1|||
49154013|NCT02965716|158404965|FG001|Overall Study|Not Protocol Specified|3|||
49154014|NCT03360344|158404967|FG000|Overall Study|Withdrawal by Subject|0|||
48826785|NCT05305040|157207327|FG000|Overall Study|Investigator's Decision|1|||
48826786|NCT05305040|157207328|FG001|Overall Study|Investigator's Decision|1|||
48826787|NCT05305040|157207327|FG000|Overall Study|COVID-19 Reasons|1|||
48826788|NCT05305040|157207328|FG001|Overall Study|COVID-19 Reasons|0|||
48921955|NCT04041284|157548102|FG001|OL Phase (12 Weeks)|Pregnancy|1|||
48826789|NCT00049517|157207329|FG000|Induction|Disease progression|0|||
48826790|NCT00049517|157207330|FG001|Induction|Disease progression|0|||
48826791|NCT00049517|157207331|FG002|Induction|Disease progression|0|||
48826792|NCT00049517|157207332|FG003|Induction|Disease progression|0|||
48826793|NCT00049517|157207333|FG004|Induction|Disease progression|18|||
48826794|NCT00049517|157207334|FG005|Induction|Disease progression|11|||
48826795|NCT00049517|157207329|FG000|Induction|Adverse Event|0|||
48826796|NCT00049517|157207330|FG001|Induction|Adverse Event|0|||
48826797|NCT00049517|157207331|FG002|Induction|Adverse Event|0|||
48826798|NCT00049517|157207332|FG003|Induction|Adverse Event|0|||
48826799|NCT00049517|157207333|FG004|Induction|Adverse Event|5|||
48826800|NCT00049517|157207334|FG005|Induction|Adverse Event|7|||
48826801|NCT00049517|157207329|FG000|Induction|Death|0|||
48826802|NCT00049517|157207330|FG001|Induction|Death|0|||
48826803|NCT00049517|157207331|FG002|Induction|Death|0|||
48826804|NCT00049517|157207332|FG003|Induction|Death|0|||
48826805|NCT00049517|157207333|FG004|Induction|Death|9|||
48826806|NCT00049517|157207334|FG005|Induction|Death|6|||
48826807|NCT00049517|157207329|FG000|Induction|Withdrawal by Subject|0|||
48826808|NCT00049517|157207330|FG001|Induction|Withdrawal by Subject|0|||
48826809|NCT00049517|157207331|FG002|Induction|Withdrawal by Subject|0|||
48826810|NCT00049517|157207332|FG003|Induction|Withdrawal by Subject|0|||
48826811|NCT00049517|157207333|FG004|Induction|Withdrawal by Subject|1|||
48826812|NCT00049517|157207334|FG005|Induction|Withdrawal by Subject|3|||
48921956|NCT04041284|157548101|FG000|OL Phase (12 Weeks)|Other than specified|6|||
48921957|NCT04041284|157548102|FG001|OL Phase (12 Weeks)|Other than specified|2|||
48921958|NCT02595723|157548103|FG000|First Washout (21 Days)|Withdrawal by Subject|1|||
48921959|NCT02595723|157548104|FG001|First Washout (21 Days)|Withdrawal by Subject|0|||
48921960|NCT02595723|157548105|FG002|First Washout (21 Days)|Withdrawal by Subject|0|||
48921961|NCT02595723|157548103|FG000|First Washout (21 Days)|Lost to Follow-up|1|||
48921962|NCT02595723|157548104|FG001|First Washout (21 Days)|Lost to Follow-up|0|||
48921963|NCT02595723|157548105|FG002|First Washout (21 Days)|Lost to Follow-up|0|||
48921964|NCT04839380|157548106|FG000|Overall Study|Withdrawal by Subject|2|||
48921965|NCT04839380|157548106|FG000|Overall Study|Dosed, but Did Not Complete Run-in Period|3|||
48921966|NCT01058096|157548111|FG000|Double-blind Treatment Phase|Adverse Event|11|||
48921967|NCT01058096|157548112|FG001|Double-blind Treatment Phase|Adverse Event|15|||
48921968|NCT01058096|157548111|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|16|||
48921969|NCT01058096|157548112|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|7|||
48921970|NCT01058096|157548111|FG000|Double-blind Treatment Phase|Protocol Violation|2|||
48921971|NCT01058096|157548112|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
48921972|NCT01058096|157548111|FG000|Double-blind Treatment Phase|Withdrawal of Consent|17|||
48921973|NCT01058096|157548112|FG001|Double-blind Treatment Phase|Withdrawal of Consent|26|||
48921974|NCT01058096|157548111|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
48921975|NCT01058096|157548112|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
48921976|NCT01058096|157548111|FG000|Double-blind Treatment Phase|Other Unspecified|2|||
48921977|NCT01058096|157548112|FG001|Double-blind Treatment Phase|Other Unspecified|0|||
48921978|NCT00446511|157548118|FG000|Overall Study|Adverse Event|7|||
48921979|NCT00446511|157548119|FG001|Overall Study|Adverse Event|2|||
49154015|NCT03360344|158404968|FG001|Overall Study|Withdrawal by Subject|1|||
49154016|NCT03360344|158404969|FG002|Overall Study|Withdrawal by Subject|1|||
49154017|NCT03468998|158404970|FG000|Overall Study|Withdrawal by Subject|1|||
48921980|NCT00446511|157548120|FG002|Overall Study|Adverse Event|3|||
48921981|NCT00446511|157548121|FG003|Overall Study|Adverse Event|1|||
48826813|NCT00049517|157207329|FG000|Induction|Alternative therapy|0|||
48826814|NCT00049517|157207330|FG001|Induction|Alternative therapy|0|||
48826815|NCT00049517|157207331|FG002|Induction|Alternative therapy|0|||
48826816|NCT00049517|157207332|FG003|Induction|Alternative therapy|0|||
48826817|NCT00049517|157207333|FG004|Induction|Alternative therapy|2|||
48826818|NCT00049517|157207334|FG005|Induction|Alternative therapy|2|||
49154018|NCT03468998|158404971|FG001|Overall Study|Withdrawal by Subject|1|||
49154019|NCT03468998|158404972|FG002|Overall Study|Withdrawal by Subject|0|||
48826819|NCT00049517|157207329|FG000|Induction|Other complicating disease|0|||
48826820|NCT00049517|157207330|FG001|Induction|Other complicating disease|0|||
48826821|NCT00049517|157207331|FG002|Induction|Other complicating disease|0|||
48826822|NCT00049517|157207332|FG003|Induction|Other complicating disease|0|||
48826823|NCT00049517|157207333|FG004|Induction|Other complicating disease|3|||
48826824|NCT00049517|157207334|FG005|Induction|Other complicating disease|0|||
48826825|NCT00049517|157207329|FG000|Induction|Reasons not reported|0|||
48826826|NCT00049517|157207330|FG001|Induction|Reasons not reported|0|||
48826827|NCT00049517|157207331|FG002|Induction|Reasons not reported|0|||
48826828|NCT00049517|157207332|FG003|Induction|Reasons not reported|0|||
48826829|NCT00049517|157207333|FG004|Induction|Reasons not reported|22|||
48826830|NCT00049517|157207334|FG005|Induction|Reasons not reported|25|||
48826831|NCT00049517|157207329|FG000|Conditioning/Transplant|Disease progression|14|||
48826832|NCT00049517|157207330|FG001|Conditioning/Transplant|Disease progression|6|||
48826833|NCT00049517|157207331|FG002|Conditioning/Transplant|Disease progression|10|||
48826834|NCT00049517|157207332|FG003|Conditioning/Transplant|Disease progression|6|||
48826835|NCT00049517|157207333|FG004|Conditioning/Transplant|Disease progression|0|||
48826836|NCT00049517|157207334|FG005|Conditioning/Transplant|Disease progression|0|||
48826837|NCT00049517|157207329|FG000|Conditioning/Transplant|Adverse Event|2|||
48826838|NCT00049517|157207330|FG001|Conditioning/Transplant|Adverse Event|1|||
48826839|NCT00049517|157207331|FG002|Conditioning/Transplant|Adverse Event|4|||
48826840|NCT00049517|157207332|FG003|Conditioning/Transplant|Adverse Event|8|||
48826841|NCT00049517|157207333|FG004|Conditioning/Transplant|Adverse Event|0|||
48826842|NCT00049517|157207334|FG005|Conditioning/Transplant|Adverse Event|0|||
48826843|NCT00049517|157207329|FG000|Conditioning/Transplant|Death|1|||
48826844|NCT00049517|157207330|FG001|Conditioning/Transplant|Death|0|||
48826845|NCT00049517|157207331|FG002|Conditioning/Transplant|Death|0|||
48826846|NCT00049517|157207332|FG003|Conditioning/Transplant|Death|2|||
48826847|NCT00049517|157207333|FG004|Conditioning/Transplant|Death|0|||
48826848|NCT00049517|157207334|FG005|Conditioning/Transplant|Death|0|||
48826849|NCT00049517|157207329|FG000|Conditioning/Transplant|Withdrawal by Subject|4|||
48826850|NCT00049517|157207330|FG001|Conditioning/Transplant|Withdrawal by Subject|8|||
48826851|NCT00049517|157207331|FG002|Conditioning/Transplant|Withdrawal by Subject|4|||
48826852|NCT00049517|157207332|FG003|Conditioning/Transplant|Withdrawal by Subject|7|||
48826853|NCT00049517|157207333|FG004|Conditioning/Transplant|Withdrawal by Subject|0|||
48826854|NCT00049517|157207334|FG005|Conditioning/Transplant|Withdrawal by Subject|0|||
48826855|NCT00049517|157207329|FG000|Conditioning/Transplant|Alternative therapy|4|||
48826856|NCT00049517|157207330|FG001|Conditioning/Transplant|Alternative therapy|4|||
48826857|NCT00049517|157207331|FG002|Conditioning/Transplant|Alternative therapy|2|||
48826858|NCT00049517|157207332|FG003|Conditioning/Transplant|Alternative therapy|1|||
48826859|NCT00049517|157207333|FG004|Conditioning/Transplant|Alternative therapy|1|||
48826860|NCT00049517|157207334|FG005|Conditioning/Transplant|Alternative therapy|0|||
48826861|NCT00049517|157207329|FG000|Conditioning/Transplant|Other complicating disease|2|||
48826862|NCT00049517|157207330|FG001|Conditioning/Transplant|Other complicating disease|0|||
48826863|NCT00049517|157207331|FG002|Conditioning/Transplant|Other complicating disease|0|||
48826864|NCT00049517|157207332|FG003|Conditioning/Transplant|Other complicating disease|4|||
48826865|NCT00049517|157207333|FG004|Conditioning/Transplant|Other complicating disease|0|||
48826866|NCT00049517|157207334|FG005|Conditioning/Transplant|Other complicating disease|1|||
48826867|NCT00049517|157207329|FG000|Conditioning/Transplant|Reasons not reported|25|||
48826868|NCT00049517|157207330|FG001|Conditioning/Transplant|Reasons not reported|31|||
48826869|NCT00049517|157207331|FG002|Conditioning/Transplant|Reasons not reported|18|||
48826870|NCT00049517|157207332|FG003|Conditioning/Transplant|Reasons not reported|15|||
48826871|NCT00049517|157207333|FG004|Conditioning/Transplant|Reasons not reported|5|||
48826872|NCT00049517|157207334|FG005|Conditioning/Transplant|Reasons not reported|5|||
48826873|NCT00256308|157207335|FG000|Overall Study|Death|2|||
48826874|NCT02206685|157207336|FG000|Overall Study|Surgery cancelled/changed|2|||
48826875|NCT02206685|157207337|FG001|Overall Study|Surgery cancelled/changed|3|||
48826876|NCT02206685|157207336|FG000|Overall Study|Withdrawal by Subject|1|||
48826877|NCT02206685|157207337|FG001|Overall Study|Withdrawal by Subject|2|||
48826878|NCT02206685|157207336|FG000|Overall Study|Protocol Violation|2|||
48826879|NCT02206685|157207337|FG001|Overall Study|Protocol Violation|2|||
48826880|NCT01106287|157207338|FG000|Overall Study|Adverse Event|1|||
48921982|NCT00446511|157548118|FG000|Overall Study|Protocol Violation|0|||
48921983|NCT00446511|157548119|FG001|Overall Study|Protocol Violation|0|||
49154020|NCT03468998|158404973|FG003|Overall Study|Withdrawal by Subject|4|||
48826881|NCT01106287|157207339|FG001|Overall Study|Adverse Event|0|||
48826882|NCT01106287|157207340|FG002|Overall Study|Adverse Event|0|||
48826883|NCT01106287|157207341|FG003|Overall Study|Adverse Event|0|||
48826884|NCT00072475|157207342|FG000|Overall Study|Adverse Event|44|||
48826885|NCT00072475|157207342|FG000|Overall Study|Death|3|||
48826886|NCT00072475|157207342|FG000|Overall Study|Withdrawal by Subject|46|||
48826887|NCT00072475|157207342|FG000|Overall Study|Patient/Investigator Decision|4|||
48826888|NCT04730947|157207343|FG000|Overall Study|Withdrawal by Subject|0|||
48826889|NCT04730947|157207344|FG001|Overall Study|Withdrawal by Subject|1|||
48826890|NCT04476043|157207345|FG000|Overall Study|Withdrawal by Subject|1|||
48826891|NCT04476043|157207346|FG001|Overall Study|Withdrawal by Subject|3|||
49154021|NCT03468998|158404974|FG004|Overall Study|Withdrawal by Subject|1|||
49154022|NCT03468998|158404975|FG005|Overall Study|Withdrawal by Subject|0|||
49154023|NCT03257657|158404977|FG000|Overall Study|Lost to Follow-up|0|||
49154024|NCT03257657|158404978|FG001|Overall Study|Lost to Follow-up|3|||
49154025|NCT03257657|158404977|FG000|Overall Study|Withdrawn|0|||
49154026|NCT03257657|158404978|FG001|Overall Study|Withdrawn|1|||
49154027|NCT03257657|158404977|FG000|Overall Study|Noted not eligible right after enrolled|0|||
49154028|NCT03257657|158404978|FG001|Overall Study|Noted not eligible right after enrolled|1|||
49154029|NCT02989857|158404982|FG000|Randomization Phase|Not Treated|3|||
49154030|NCT02989857|158404983|FG001|Randomization Phase|Not Treated|2|||
49154031|NCT02989857|158404984|FG002|Randomization Phase|Not Treated|0|||
49154032|NCT02489279|158404985|FG000|Overall Study|Lost to Follow-up|12|||
49154033|NCT02489279|158404986|FG001|Overall Study|Lost to Follow-up|10|||
49154034|NCT04150718|158404987|FG000|Overall Study|Withdrawal by Subject|2|||
49154035|NCT04150718|158404988|FG001|Overall Study|Withdrawal by Subject|7|||
49154036|NCT04150718|158404989|FG002|Overall Study|Withdrawal by Subject|1|||
49154037|NCT04150718|158404987|FG000|Overall Study|Lost to Follow-up|1|||
49154038|NCT04150718|158404988|FG001|Overall Study|Lost to Follow-up|2|||
49154039|NCT04150718|158404989|FG002|Overall Study|Lost to Follow-up|0|||
49154040|NCT04150718|158404987|FG000|Overall Study|Ineligible|1|||
49154041|NCT04150718|158404988|FG001|Overall Study|Ineligible|0|||
49154042|NCT04150718|158404989|FG002|Overall Study|Ineligible|10|||
49154043|NCT01992757|158404990|FG000|Overall Study|2 patients excluded due to FFP given.|2|||
49154044|NCT04992273|158404991|FG000|Overall Study|Lost to Follow-up|0|||
49154045|NCT04992273|158404992|FG001|Overall Study|Lost to Follow-up|1|||
49154046|NCT03440411|158404993|FG000|Overall Study|Adverse Event|0|||
49154047|NCT03440411|158404994|FG001|Overall Study|Adverse Event|0|||
49154048|NCT03440411|158404995|FG002|Overall Study|Adverse Event|1|||
49154049|NCT03440411|158404996|FG003|Overall Study|Adverse Event|0|||
49154050|NCT03440411|158404993|FG000|Overall Study|PD|2|||
49154051|NCT03440411|158404994|FG001|Overall Study|PD|1|||
49154052|NCT03440411|158404995|FG002|Overall Study|PD|1|||
49154053|NCT03440411|158404996|FG003|Overall Study|PD|1|||
49154054|NCT03440411|158404993|FG000|Overall Study|Withdrawal by Subject|1|||
49154055|NCT03440411|158404994|FG001|Overall Study|Withdrawal by Subject|0|||
49154056|NCT03440411|158404995|FG002|Overall Study|Withdrawal by Subject|0|||
49154057|NCT03440411|158404996|FG003|Overall Study|Withdrawal by Subject|0|||
49154058|NCT03440411|158404993|FG000|Overall Study|Closed study by sponsor|0|||
49154059|NCT03440411|158404994|FG001|Overall Study|Closed study by sponsor|0|||
49154060|NCT03440411|158404995|FG002|Overall Study|Closed study by sponsor|0|||
49154061|NCT03440411|158404996|FG003|Overall Study|Closed study by sponsor|1|||
49154062|NCT02014467|158404999|FG000|Overall Study|Adverse Event|4|||
49154063|NCT02014467|158405000|FG001|Overall Study|Adverse Event|0|||
48734456|NCT01229371|156879470|FG000|Overall Study|Withdrawal by Subject|0|||
48734457|NCT01229371|156879471|FG001|Overall Study|Withdrawal by Subject|1|||
48734458|NCT01229371|156879472|FG002|Overall Study|Withdrawal by Subject|0|||
49154064|NCT02014467|158404999|FG000|Overall Study|Protocol Violation|3|||
49154065|NCT02014467|158405000|FG001|Overall Study|Protocol Violation|0|||
49154066|NCT02014467|158404999|FG000|Overall Study|Physician Decision|2|||
49154067|NCT02014467|158405000|FG001|Overall Study|Physician Decision|3|||
49154068|NCT02014467|158404999|FG000|Overall Study|Withdrawal by Subject|16|||
49154069|NCT02014467|158405000|FG001|Overall Study|Withdrawal by Subject|4|||
49154070|NCT01217892|158405001|FG000|Overall Study|Adverse Event|1|||
48734459|NCT01229371|156879473|FG003|Overall Study|Withdrawal by Subject|0|||
48734460|NCT03491215|156879480|FG000|Overall Study|Death|6|||
48734461|NCT03491215|156879481|FG001|Overall Study|Death|2|||
48734462|NCT03491215|156879482|FG002|Overall Study|Death|1|||
48734463|NCT03491215|156879483|FG003|Overall Study|Death|0|||
48826892|NCT04476043|157207347|FG002|Overall Study|Withdrawal by Subject|4|||
49154071|NCT01217892|158405002|FG001|Overall Study|Adverse Event|1|||
49154072|NCT01217892|158405003|FG002|Overall Study|Adverse Event|1|||
49154073|NCT01217892|158405004|FG003|Overall Study|Adverse Event|0|||
49154074|NCT01217892|158405001|FG000|Overall Study|Withdrawal by Subject|0|||
49154075|NCT01217892|158405002|FG001|Overall Study|Withdrawal by Subject|2|||
49154076|NCT01217892|158405003|FG002|Overall Study|Withdrawal by Subject|1|||
48826893|NCT04476043|157207348|FG003|Overall Study|Withdrawal by Subject|1|||
48826894|NCT04476043|157207345|FG000|Overall Study|Lost to Follow-up|1|||
48826895|NCT04476043|157207346|FG001|Overall Study|Lost to Follow-up|1|||
48826896|NCT04476043|157207347|FG002|Overall Study|Lost to Follow-up|2|||
48734464|NCT03491215|156879480|FG000|Overall Study|Physician Decision|1|||
49014334|NCT00770991|157888828|FG000|Overall Study|Physician Decision|2|||
48734465|NCT03491215|156879481|FG001|Overall Study|Physician Decision|0|||
48826897|NCT04476043|157207348|FG003|Overall Study|Lost to Follow-up|1|||
49154077|NCT01217892|158405004|FG003|Overall Study|Withdrawal by Subject|0|||
49154078|NCT01217892|158405001|FG000|Overall Study|Lab value|1|||
49154079|NCT01217892|158405002|FG001|Overall Study|Lab value|0|||
49154080|NCT01217892|158405003|FG002|Overall Study|Lab value|1|||
49154081|NCT01217892|158405004|FG003|Overall Study|Lab value|0|||
49154082|NCT01217892|158405001|FG000|Overall Study|Subject no longer meets study criteria|5|||
49154083|NCT01217892|158405002|FG001|Overall Study|Subject no longer meets study criteria|2|||
48734466|NCT03491215|156879482|FG002|Overall Study|Physician Decision|0|||
48734467|NCT03491215|156879483|FG003|Overall Study|Physician Decision|0|||
48734468|NCT00617851|156879484|FG000|Overall Study|Death|0|||
48734469|NCT00617851|156879485|FG001|Overall Study|Death|0|||
48734470|NCT00617851|156879486|FG002|Overall Study|Death|0|||
48734471|NCT00617851|156879487|FG003|Overall Study|Death|1|||
48734472|NCT00617851|156879484|FG000|Overall Study|Withdrawal by Subject|14|||
48734473|NCT00617851|156879485|FG001|Overall Study|Withdrawal by Subject|7|||
48734474|NCT00617851|156879486|FG002|Overall Study|Withdrawal by Subject|12|||
48734475|NCT00617851|156879487|FG003|Overall Study|Withdrawal by Subject|4|||
48734476|NCT00617851|156879484|FG000|Overall Study|Lost to Follow-up|27|||
48734477|NCT00617851|156879485|FG001|Overall Study|Lost to Follow-up|29|||
48734478|NCT00617851|156879486|FG002|Overall Study|Lost to Follow-up|31|||
48734479|NCT00617851|156879487|FG003|Overall Study|Lost to Follow-up|19|||
48734480|NCT00617851|156879484|FG000|Overall Study|Inappropriate Enrollment|5|||
48734481|NCT00617851|156879485|FG001|Overall Study|Inappropriate Enrollment|4|||
48734482|NCT00617851|156879486|FG002|Overall Study|Inappropriate Enrollment|1|||
48734483|NCT00617851|156879487|FG003|Overall Study|Inappropriate Enrollment|1|||
48734484|NCT00617851|156879484|FG000|Overall Study|Unable to classify|1|||
48734485|NCT00617851|156879485|FG001|Overall Study|Unable to classify|0|||
48734486|NCT00617851|156879486|FG002|Overall Study|Unable to classify|1|||
48734487|NCT00617851|156879487|FG003|Overall Study|Unable to classify|0|||
48734488|NCT05246397|156879488|FG000|Overall Study|3 were excluded due to protocol deviation|3|||
48734489|NCT01676727|156879501|FG000|Overall Study|Death|18|||
48734490|NCT01676727|156879501|FG000|Overall Study|Withdrawal by Subject|6|||
48734491|NCT01676727|156879501|FG000|Overall Study|Screening failure|5|||
48734492|NCT01676727|156879501|FG000|Overall Study|Not willing to attend 1-year visit|2|||
48734493|NCT01676727|156879501|FG000|Overall Study|Valve explanted|1|||
48734494|NCT01578330|156879502|FG000|Overall Study|Adverse Event|2|||
48734495|NCT01578330|156879502|FG000|Overall Study|Protocol Violation|5|||
48734496|NCT01134731|156879503|FG000|Overall Study|Adverse Event|3|||
48734497|NCT01134731|156879504|FG001|Overall Study|Adverse Event|2|||
48734498|NCT01134731|156879505|FG002|Overall Study|Adverse Event|1|||
48734499|NCT01134731|156879503|FG000|Overall Study|Physician Decision|2|||
48734500|NCT01134731|156879504|FG001|Overall Study|Physician Decision|2|||
48734501|NCT01134731|156879505|FG002|Overall Study|Physician Decision|2|||
48734502|NCT01134731|156879503|FG000|Overall Study|Lack of Efficacy|0|||
48734503|NCT01134731|156879504|FG001|Overall Study|Lack of Efficacy|0|||
48734504|NCT01134731|156879505|FG002|Overall Study|Lack of Efficacy|1|||
48734505|NCT01134731|156879503|FG000|Overall Study|Withdrawal by Subject|3|||
48734506|NCT01134731|156879504|FG001|Overall Study|Withdrawal by Subject|3|||
48734507|NCT01134731|156879505|FG002|Overall Study|Withdrawal by Subject|1|||
48734508|NCT01134731|156879503|FG000|Overall Study|Lost to Follow-up|5|||
48734509|NCT01134731|156879504|FG001|Overall Study|Lost to Follow-up|4|||
48734510|NCT01134731|156879505|FG002|Overall Study|Lost to Follow-up|3|||
48734511|NCT01050543|156879506|FG000|Overall Study|Withdrawal by Subject|0|||
48734512|NCT01050543|156879507|FG001|Overall Study|Withdrawal by Subject|2|||
48734513|NCT01050543|156879506|FG000|Overall Study|Protocol Violation|0|||
48734514|NCT01050543|156879507|FG001|Overall Study|Protocol Violation|1|||
48734515|NCT01050543|156879506|FG000|Overall Study|Administrative|4|||
48734516|NCT01050543|156879507|FG001|Overall Study|Administrative|1|||
48734517|NCT03161093|156879508|FG000|Overall Study|Protocol Violation|11|||
48734518|NCT03161093|156879509|FG001|Overall Study|Protocol Violation|14|||
48734519|NCT03161093|156879510|FG002|Overall Study|Protocol Violation|6|||
48734520|NCT03161093|156879511|FG003|Overall Study|Protocol Violation|13|||
48734521|NCT03161093|156879512|FG004|Overall Study|Protocol Violation|1|||
48734522|NCT03161093|156879513|FG005|Overall Study|Protocol Violation|0|||
48734523|NCT03161093|156879508|FG000|Overall Study|Adverse Event|5|||
48826898|NCT04476043|157207345|FG000|Overall Study|Adverse Event|2|||
48826899|NCT04476043|157207346|FG001|Overall Study|Adverse Event|0|||
48826900|NCT04476043|157207347|FG002|Overall Study|Adverse Event|1|||
49154084|NCT01217892|158405003|FG002|Overall Study|Subject no longer meets study criteria|4|||
49154085|NCT01217892|158405004|FG003|Overall Study|Subject no longer meets study criteria|8|||
48734524|NCT03161093|156879509|FG001|Overall Study|Adverse Event|21|||
48734525|NCT03161093|156879510|FG002|Overall Study|Adverse Event|16|||
48734526|NCT03161093|156879511|FG003|Overall Study|Adverse Event|35|||
48734527|NCT03161093|156879512|FG004|Overall Study|Adverse Event|2|||
48734528|NCT03161093|156879513|FG005|Overall Study|Adverse Event|1|||
48734529|NCT03161093|156879508|FG000|Overall Study|Lack of Efficacy|9|||
48734530|NCT03161093|156879509|FG001|Overall Study|Lack of Efficacy|13|||
48734531|NCT03161093|156879510|FG002|Overall Study|Lack of Efficacy|9|||
48734532|NCT03161093|156879511|FG003|Overall Study|Lack of Efficacy|24|||
48734533|NCT03161093|156879512|FG004|Overall Study|Lack of Efficacy|4|||
48734534|NCT03161093|156879513|FG005|Overall Study|Lack of Efficacy|1|||
48826901|NCT04476043|157207348|FG003|Overall Study|Adverse Event|0|||
48734535|NCT03161093|156879508|FG000|Overall Study|Physician Decision|0|||
48734536|NCT03161093|156879509|FG001|Overall Study|Physician Decision|1|||
48734537|NCT03161093|156879510|FG002|Overall Study|Physician Decision|0|||
48826902|NCT04476043|157207345|FG000|Overall Study|Protocol Violation|0|||
49154086|NCT01217892|158405001|FG000|Overall Study|Incorrect enrollment|0|||
49154087|NCT01217892|158405002|FG001|Overall Study|Incorrect enrollment|1|||
49154088|NCT01217892|158405003|FG002|Overall Study|Incorrect enrollment|1|||
49154089|NCT01217892|158405004|FG003|Overall Study|Incorrect enrollment|0|||
49154090|NCT01217892|158405001|FG000|Overall Study|Poor/Non-Compliance|0|||
48826903|NCT04476043|157207346|FG001|Overall Study|Protocol Violation|1|||
48826904|NCT04476043|157207347|FG002|Overall Study|Protocol Violation|0|||
48826905|NCT04476043|157207348|FG003|Overall Study|Protocol Violation|0|||
48826906|NCT00940017|157207349|FG000|Overall Study|did not meet entrance criteria|3|||
49154091|NCT01217892|158405002|FG001|Overall Study|Poor/Non-Compliance|0|||
49154092|NCT01217892|158405003|FG002|Overall Study|Poor/Non-Compliance|1|||
49154093|NCT01217892|158405004|FG003|Overall Study|Poor/Non-Compliance|0|||
49154094|NCT00183248|158405006|FG000|Overall Study|Lost to Follow-up|0|||
49154095|NCT00183248|158405007|FG001|Overall Study|Lost to Follow-up|1|||
49154096|NCT00183248|158405006|FG000|Overall Study|Focal glomerulosclerosis proteinuria|1|||
49154097|NCT00183248|158405007|FG001|Overall Study|Focal glomerulosclerosis proteinuria|0|||
49154098|NCT00779909|158405008|FG000|Overall Study|Lost to Follow-up|1|||
49154099|NCT00779909|158405009|FG001|Overall Study|Lost to Follow-up|0|||
49154100|NCT00779909|158405010|FG002|Overall Study|Lost to Follow-up|0|||
49154101|NCT00779909|158405011|FG003|Overall Study|Lost to Follow-up|1|||
49154102|NCT00779909|158405008|FG000|Overall Study|Withdrawal by Subject|0|||
49154103|NCT00779909|158405009|FG001|Overall Study|Withdrawal by Subject|1|||
49154104|NCT00779909|158405010|FG002|Overall Study|Withdrawal by Subject|0|||
49154105|NCT00779909|158405011|FG003|Overall Study|Withdrawal by Subject|0|||
49154106|NCT03896503|158405014|FG000|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
49154107|NCT03896503|158405015|FG001|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
49154108|NCT03896503|158405016|FG002|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
49154109|NCT03896503|158405017|FG003|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
49154110|NCT03896503|158405018|FG004|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
49154111|NCT03896503|158405019|FG005|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
49154112|NCT03896503|158405020|FG006|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
49154113|NCT03896503|158405021|FG007|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
49154114|NCT03896503|158405014|FG000|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
49154115|NCT03896503|158405015|FG001|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
49154116|NCT03896503|158405016|FG002|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
49154117|NCT03896503|158405017|FG003|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
49154118|NCT03896503|158405018|FG004|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
49154119|NCT03896503|158405019|FG005|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
49154120|NCT03896503|158405020|FG006|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
49154121|NCT03896503|158405021|FG007|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
49154122|NCT03896503|158405014|FG000|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
49154123|NCT03896503|158405015|FG001|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
49154124|NCT03896503|158405016|FG002|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
49154125|NCT03896503|158405017|FG003|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
49154126|NCT03896503|158405018|FG004|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
49154127|NCT03896503|158405019|FG005|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
49154128|NCT03896503|158405020|FG006|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
49154129|NCT03896503|158405021|FG007|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
49154130|NCT03896503|158405014|FG000|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
49154131|NCT03896503|158405015|FG001|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
49154132|NCT03896503|158405016|FG002|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
49154133|NCT03896503|158405017|FG003|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
49154134|NCT03896503|158405018|FG004|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
49154135|NCT03896503|158405019|FG005|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
49154136|NCT03896503|158405020|FG006|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
49154137|NCT03896503|158405021|FG007|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
49154138|NCT03896503|158405014|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
49154139|NCT03896503|158405015|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
49154140|NCT03896503|158405016|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|4|||
49154141|NCT03896503|158405017|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
48826907|NCT00940017|157207349|FG000|Overall Study|Adverse Event|1|||
48826908|NCT01450943|157207352|FG000|Overall Study|Screen failure, loss to follow-up|2|||
48826909|NCT01450943|157207353|FG001|Overall Study|Screen failure, loss to follow-up|7|||
48921984|NCT00446511|157548120|FG002|Overall Study|Protocol Violation|0|||
48826910|NCT01450943|157207354|FG002|Overall Study|Screen failure, loss to follow-up|6|||
49154142|NCT03896503|158405018|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
49154143|NCT03896503|158405019|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
49154144|NCT03896503|158405020|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|1|||
49154145|NCT03896503|158405021|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
49154146|NCT03896503|158405014|FG000|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
49154147|NCT03896503|158405015|FG001|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
48734538|NCT03161093|156879511|FG003|Overall Study|Physician Decision|2|||
48734539|NCT03161093|156879512|FG004|Overall Study|Physician Decision|17|||
48734540|NCT03161093|156879513|FG005|Overall Study|Physician Decision|15|||
48734541|NCT03161093|156879508|FG000|Overall Study|Withdrawal by Subject|24|||
48734542|NCT03161093|156879509|FG001|Overall Study|Withdrawal by Subject|73|||
48734543|NCT03161093|156879510|FG002|Overall Study|Withdrawal by Subject|44|||
48734544|NCT03161093|156879511|FG003|Overall Study|Withdrawal by Subject|97|||
48734545|NCT03161093|156879512|FG004|Overall Study|Withdrawal by Subject|11|||
48734546|NCT03161093|156879513|FG005|Overall Study|Withdrawal by Subject|10|||
48734547|NCT03161093|156879508|FG000|Overall Study|Lost to Follow-up|3|||
48734548|NCT03161093|156879509|FG001|Overall Study|Lost to Follow-up|12|||
48734549|NCT03161093|156879510|FG002|Overall Study|Lost to Follow-up|4|||
48734550|NCT03161093|156879511|FG003|Overall Study|Lost to Follow-up|7|||
48734551|NCT03161093|156879512|FG004|Overall Study|Lost to Follow-up|8|||
48734552|NCT03161093|156879513|FG005|Overall Study|Lost to Follow-up|13|||
48734553|NCT03161093|156879508|FG000|Overall Study|Death|3|||
48734554|NCT03161093|156879509|FG001|Overall Study|Death|9|||
48734555|NCT03161093|156879510|FG002|Overall Study|Death|7|||
48734556|NCT03161093|156879511|FG003|Overall Study|Death|9|||
48734557|NCT03161093|156879512|FG004|Overall Study|Death|0|||
48734558|NCT03161093|156879513|FG005|Overall Study|Death|0|||
48734559|NCT03161093|156879508|FG000|Overall Study|Unknown - Not reported|0|||
48734560|NCT03161093|156879509|FG001|Overall Study|Unknown - Not reported|1|||
48734561|NCT03161093|156879510|FG002|Overall Study|Unknown - Not reported|0|||
48734562|NCT03161093|156879511|FG003|Overall Study|Unknown - Not reported|0|||
48734563|NCT03161093|156879512|FG004|Overall Study|Unknown - Not reported|0|||
48734564|NCT03161093|156879513|FG005|Overall Study|Unknown - Not reported|1|||
48734565|NCT01031706|156879514|FG000|Overall Study|Adverse Event|1|||
48734566|NCT01031706|156879515|FG001|Overall Study|Adverse Event|0|||
48734567|NCT01031706|156879514|FG000|Overall Study|Withdrawal by Subject|1|||
48734568|NCT01031706|156879515|FG001|Overall Study|Withdrawal by Subject|1|||
48734569|NCT02758171|156879520|FG000|Wash-out|Withdrawal by Subject|1|||
48734570|NCT02758171|156879521|FG001|Wash-out|Withdrawal by Subject|0|||
48734571|NCT02758171|156879520|FG000|Wash-out|Other reason|1|||
48734572|NCT02758171|156879521|FG001|Wash-out|Other reason|0|||
48734573|NCT01309165|156879522|FG000|Overall Study|Lost to Follow-up|4|||
48734574|NCT01309165|156879523|FG001|Overall Study|Lost to Follow-up|3|||
48734575|NCT01309165|156879522|FG000|Overall Study|Return to work|1|||
48734576|NCT01309165|156879523|FG001|Overall Study|Return to work|2|||
48734577|NCT01309165|156879522|FG000|Overall Study|Left country|0|||
48734578|NCT01309165|156879523|FG001|Overall Study|Left country|1|||
48734579|NCT01309165|156879522|FG000|Overall Study|No transportation|0|||
48734580|NCT01309165|156879523|FG001|Overall Study|No transportation|1|||
48734581|NCT01309165|156879522|FG000|Overall Study|Admitted to hospital for second stroke|1|||
48734582|NCT01309165|156879523|FG001|Overall Study|Admitted to hospital for second stroke|0|||
48734583|NCT01497275|156879524|FG000|Overall Study|Death|1|||
48734584|NCT01497275|156879524|FG000|Overall Study|Adverse Event|1|||
48734585|NCT00437320|156879525|FG000|Overall Study|Participant request|2|||
48734586|NCT00437320|156879526|FG001|Overall Study|Participant request|1|||
48734587|NCT00437320|156879527|FG002|Overall Study|Participant request|4|||
48734588|NCT01495975|156879528|FG000|Overall Study|Lost to Follow-up|1|||
48734589|NCT01495975|156879529|FG001|Overall Study|Lost to Follow-up|0|||
48734590|NCT00808483|156879530|FG000|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
48734591|NCT00808483|156879531|FG001|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
48734592|NCT00808483|156879530|FG000|From 3 to 5 Months After Surgery|Lack of Efficacy|1|||
48734593|NCT00808483|156879531|FG001|From 3 to 5 Months After Surgery|Lack of Efficacy|0|||
48826911|NCT02790606|157207361|FG000|Overall Study|Death|27|||
48826912|NCT02790606|157207361|FG000|Overall Study|Lost to Follow-up|4|||
48734594|NCT00808483|156879530|FG000|From 5 Months to 12 Months|Lack of Efficacy|1|||
48734595|NCT00808483|156879531|FG001|From 5 Months to 12 Months|Lack of Efficacy|0|||
48734596|NCT02357979|156879532|FG000|Overall Study|Lost to Follow-up|5|||
48826913|NCT02790606|157207361|FG000|Overall Study|Physician Decision|3|||
48734597|NCT02357979|156879533|FG001|Overall Study|Lost to Follow-up|5|||
48734598|NCT04810481|156879538|FG000|Overall Study|Disqualified data sets|10|||
48734599|NCT04810481|156879539|FG001|Overall Study|Disqualified data sets|28|||
48734600|NCT01123850|156879540|FG000|Overall Study|Slow enrollment|45|||
48734601|NCT01024231|156879546|FG000|Overall Study|Other Reasons|1|||
48734602|NCT01024231|156879547|FG001|Overall Study|Other Reasons|2|||
48734603|NCT01024231|156879548|FG002|Overall Study|Other Reasons|0|||
48826914|NCT02790606|157207361|FG000|Overall Study|Withdrawal by Subject|1|||
48734604|NCT01024231|156879549|FG003|Overall Study|Other Reasons|0|||
48734605|NCT01024231|156879550|FG004|Overall Study|Other Reasons|2|||
48734606|NCT01024231|156879551|FG005|Overall Study|Other Reasons|0|||
48734607|NCT01024231|156879552|FG006|Overall Study|Other Reasons|1|||
48734608|NCT01024231|156879546|FG000|Overall Study|Maximum Clinical Benefit|1|||
48734609|NCT01024231|156879547|FG001|Overall Study|Maximum Clinical Benefit|2|||
48734610|NCT01024231|156879548|FG002|Overall Study|Maximum Clinical Benefit|0|||
48734611|NCT01024231|156879549|FG003|Overall Study|Maximum Clinical Benefit|1|||
48734612|NCT01024231|156879550|FG004|Overall Study|Maximum Clinical Benefit|1|||
48734613|NCT01024231|156879551|FG005|Overall Study|Maximum Clinical Benefit|0|||
48734614|NCT01024231|156879552|FG006|Overall Study|Maximum Clinical Benefit|0|||
48734615|NCT01024231|156879546|FG000|Overall Study|Disease Progression|3|||
48734616|NCT01024231|156879547|FG001|Overall Study|Disease Progression|1|||
48734617|NCT01024231|156879548|FG002|Overall Study|Disease Progression|3|||
48734618|NCT01024231|156879549|FG003|Overall Study|Disease Progression|0|||
48734619|NCT01024231|156879550|FG004|Overall Study|Disease Progression|4|||
48921985|NCT00446511|157548121|FG003|Overall Study|Protocol Violation|1|||
48921986|NCT00446511|157548118|FG000|Overall Study|Withdrawal by Subject|0|||
48921987|NCT00446511|157548119|FG001|Overall Study|Withdrawal by Subject|0|||
49154148|NCT03896503|158405016|FG002|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
49154149|NCT03896503|158405017|FG003|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
49154150|NCT03896503|158405018|FG004|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
49154151|NCT03896503|158405019|FG005|Initial Subgroup and Arm Enrollment|Not treated; screen failure|3|||
49154152|NCT03896503|158405020|FG006|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
49154153|NCT03896503|158405021|FG007|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
49154154|NCT03896503|158405014|FG000|Initial Subgroup and Arm Enrollment|Refused further treatment|2|||
49154155|NCT03896503|158405015|FG001|Initial Subgroup and Arm Enrollment|Refused further treatment|1|||
49154156|NCT03896503|158405016|FG002|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
49154157|NCT03896503|158405017|FG003|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
49154158|NCT03896503|158405018|FG004|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
49154159|NCT03896503|158405019|FG005|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
49154160|NCT03896503|158405020|FG006|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
49154161|NCT03896503|158405021|FG007|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
49154162|NCT03896503|158405014|FG000|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
49154163|NCT03896503|158405015|FG001|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|1|||
49154164|NCT03896503|158405016|FG002|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
49154165|NCT03896503|158405017|FG003|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
49154166|NCT03896503|158405018|FG004|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
49154167|NCT03896503|158405019|FG005|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
49154168|NCT03896503|158405020|FG006|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
49154169|NCT03896503|158405021|FG007|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
49154170|NCT03896503|158405014|FG000|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
49154171|NCT03896503|158405015|FG001|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
49154172|NCT03896503|158405016|FG002|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
49154173|NCT03896503|158405017|FG003|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
49154174|NCT03896503|158405018|FG004|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|1|||
49154175|NCT03896503|158405019|FG005|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
49154176|NCT03896503|158405020|FG006|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
49154177|NCT03896503|158405021|FG007|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
49154178|NCT03896503|158405014|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
49154179|NCT03896503|158405015|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
48734620|NCT01024231|156879551|FG005|Overall Study|Disease Progression|11|||
48734621|NCT01024231|156879552|FG006|Overall Study|Disease Progression|6|||
48734622|NCT01024231|156879546|FG000|Overall Study|AE unrelated to Study Drug|0|||
48734623|NCT01024231|156879547|FG001|Overall Study|AE unrelated to Study Drug|1|||
48734624|NCT01024231|156879548|FG002|Overall Study|AE unrelated to Study Drug|0|||
48734625|NCT01024231|156879549|FG003|Overall Study|AE unrelated to Study Drug|0|||
48734626|NCT01024231|156879550|FG004|Overall Study|AE unrelated to Study Drug|0|||
48734627|NCT01024231|156879551|FG005|Overall Study|AE unrelated to Study Drug|0|||
48734628|NCT01024231|156879552|FG006|Overall Study|AE unrelated to Study Drug|0|||
48734629|NCT01024231|156879546|FG000|Overall Study|No longer meets criteria|0|||
48734630|NCT01024231|156879547|FG001|Overall Study|No longer meets criteria|0|||
48734631|NCT01024231|156879548|FG002|Overall Study|No longer meets criteria|0|||
48734632|NCT01024231|156879549|FG003|Overall Study|No longer meets criteria|0|||
48734633|NCT01024231|156879550|FG004|Overall Study|No longer meets criteria|1|||
48734634|NCT01024231|156879551|FG005|Overall Study|No longer meets criteria|0|||
48734635|NCT01024231|156879552|FG006|Overall Study|No longer meets criteria|1|||
48734636|NCT01024231|156879546|FG000|Overall Study|Study Drug Toxicity|1|||
48734637|NCT01024231|156879547|FG001|Overall Study|Study Drug Toxicity|6|||
48734638|NCT01024231|156879548|FG002|Overall Study|Study Drug Toxicity|6|||
48734639|NCT01024231|156879549|FG003|Overall Study|Study Drug Toxicity|4|||
48734640|NCT01024231|156879550|FG004|Overall Study|Study Drug Toxicity|2|||
48734641|NCT01024231|156879551|FG005|Overall Study|Study Drug Toxicity|0|||
48734642|NCT01024231|156879552|FG006|Overall Study|Study Drug Toxicity|7|||
48734643|NCT01024231|156879546|FG000|Overall Study|Death|6|||
48734644|NCT01024231|156879547|FG001|Overall Study|Death|2|||
48734645|NCT01024231|156879548|FG002|Overall Study|Death|1|||
48734646|NCT01024231|156879549|FG003|Overall Study|Death|0|||
48734647|NCT01024231|156879550|FG004|Overall Study|Death|4|||
48734648|NCT01024231|156879551|FG005|Overall Study|Death|3|||
48734649|NCT01024231|156879552|FG006|Overall Study|Death|5|||
48734650|NCT01024231|156879546|FG000|Overall Study|Lost to Follow-up|0|||
48734651|NCT01024231|156879547|FG001|Overall Study|Lost to Follow-up|0|||
48734652|NCT01024231|156879548|FG002|Overall Study|Lost to Follow-up|0|||
48734653|NCT01024231|156879549|FG003|Overall Study|Lost to Follow-up|0|||
48734654|NCT01024231|156879550|FG004|Overall Study|Lost to Follow-up|0|||
48734655|NCT01024231|156879551|FG005|Overall Study|Lost to Follow-up|0|||
48734656|NCT01024231|156879552|FG006|Overall Study|Lost to Follow-up|1|||
48734657|NCT01024231|156879546|FG000|Overall Study|Withdrew Consent|0|||
48734658|NCT01024231|156879547|FG001|Overall Study|Withdrew Consent|1|||
48734659|NCT01024231|156879548|FG002|Overall Study|Withdrew Consent|0|||
48734660|NCT01024231|156879549|FG003|Overall Study|Withdrew Consent|0|||
48734661|NCT01024231|156879550|FG004|Overall Study|Withdrew Consent|0|||
48734662|NCT01024231|156879551|FG005|Overall Study|Withdrew Consent|0|||
48734663|NCT01024231|156879552|FG006|Overall Study|Withdrew Consent|0|||
48734664|NCT01024231|156879546|FG000|Overall Study|Continuing on Treatment|0|||
48734665|NCT01024231|156879547|FG001|Overall Study|Continuing on Treatment|0|||
48734666|NCT01024231|156879548|FG002|Overall Study|Continuing on Treatment|0|||
48734667|NCT01024231|156879549|FG003|Overall Study|Continuing on Treatment|0|||
48734668|NCT01024231|156879550|FG004|Overall Study|Continuing on Treatment|3|||
48734669|NCT01024231|156879551|FG005|Overall Study|Continuing on Treatment|2|||
48734670|NCT01024231|156879552|FG006|Overall Study|Continuing on Treatment|0|||
48734671|NCT02435147|156879553|FG000|Overall Study|non-evaluable DXA scan|11|||
48734672|NCT04439344|156879554|FG000|Overall Study|Never started threapy|3|||
48734673|NCT04439344|156879554|FG000|Overall Study|Ineligible|3|||
48734674|NCT04439344|156879554|FG000|Overall Study|Adverse Event|13|||
48734675|NCT04439344|156879554|FG000|Overall Study|Death|2|||
48734676|NCT04439344|156879554|FG000|Overall Study|Disease progression|29|||
48734677|NCT04439344|156879554|FG000|Overall Study|Withdrawal by Subject|2|||
48734678|NCT04439344|156879554|FG000|Overall Study|Alternative therapy|1|||
48734679|NCT01281137|156879557|FG000|Baseline Population|No samples assayed (excluded from all analyses)|0|||
48734680|NCT01281137|156879558|FG001|Baseline Population|No samples assayed (excluded from all analyses)|1|||
48734681|NCT01281137|156879557|FG000|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4|||
48734682|NCT01281137|156879558|FG001|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9|||
48734683|NCT01281137|156879557|FG000|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0|||
48734684|NCT01281137|156879558|FG001|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5|||
48734685|NCT01281137|156879557|FG000|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1|||
48826915|NCT02652130|157207362|FG000|Overall Study|Death|1|||
48826916|NCT01941316|157207363|FG000|Overall Study|Adverse Event|0|||
48826917|NCT01941316|157207364|FG001|Overall Study|Adverse Event|1|||
48826918|NCT01941316|157207365|FG002|Overall Study|Adverse Event|0|||
48826919|NCT01941316|157207366|FG003|Overall Study|Adverse Event|7|||
48826920|NCT01941316|157207363|FG000|Overall Study|Progressive Disease|3|||
48826921|NCT01941316|157207364|FG001|Overall Study|Progressive Disease|6|||
49154180|NCT03896503|158405016|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
48826922|NCT01941316|157207365|FG002|Overall Study|Progressive Disease|2|||
48826923|NCT01941316|157207366|FG003|Overall Study|Progressive Disease|29|||
48826924|NCT01941316|157207363|FG000|Overall Study|Withdrawal by Subject|0|||
48734686|NCT01281137|156879558|FG001|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0|||
49154181|NCT03896503|158405017|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
49154182|NCT03896503|158405018|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
49154183|NCT03896503|158405019|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|2|||
49154184|NCT03896503|158405020|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
49154185|NCT03896503|158405021|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
49154186|NCT03896503|158405014|FG000|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
49154187|NCT03896503|158405015|FG001|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
49154188|NCT03896503|158405016|FG002|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
49154189|NCT03896503|158405017|FG003|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
49154190|NCT03896503|158405018|FG004|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
49154191|NCT03896503|158405019|FG005|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
49154192|NCT03896503|158405020|FG006|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
49154193|NCT03896503|158405021|FG007|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
49154194|NCT02367456|158405022|FG000|Overall Study|Death|8|||
49154195|NCT02367456|158405023|FG001|Overall Study|Death|24|||
49154196|NCT02367456|158405024|FG002|Overall Study|Death|17|||
49154197|NCT02367456|158405022|FG000|Overall Study|Lost to Follow-up|1|||
49154198|NCT02367456|158405023|FG001|Overall Study|Lost to Follow-up|3|||
49154199|NCT02367456|158405024|FG002|Overall Study|Lost to Follow-up|1|||
49154200|NCT02367456|158405022|FG000|Overall Study|Other reason|3|||
49154201|NCT02367456|158405023|FG001|Overall Study|Other reason|3|||
49154202|NCT02367456|158405024|FG002|Overall Study|Other reason|9|||
49154203|NCT02367456|158405022|FG000|Overall Study|Study Participation Terminated by Sponsor|0|||
49154204|NCT02367456|158405023|FG001|Overall Study|Study Participation Terminated by Sponsor|0|||
49154205|NCT02367456|158405024|FG002|Overall Study|Study Participation Terminated by Sponsor|3|||
49154206|NCT00329420|158405025|FG000|Re-induction Phase|Lack of Efficacy|0|||
49154207|NCT00329420|158405026|FG001|Re-induction Phase|Lack of Efficacy|1|||
49154208|NCT00329420|158405027|FG002|Re-induction Phase|Lack of Efficacy|0|||
49154209|NCT00329420|158405025|FG000|Re-induction Phase|Withdrawal of Consent|0|||
49154210|NCT00329420|158405026|FG001|Re-induction Phase|Withdrawal of Consent|0|||
49154211|NCT00329420|158405027|FG002|Re-induction Phase|Withdrawal of Consent|1|||
49154212|NCT00329420|158405025|FG000|Re-induction Phase|Did not respond to re-induction|6|||
49154213|NCT00329420|158405026|FG001|Re-induction Phase|Did not respond to re-induction|5|||
49154214|NCT00329420|158405027|FG002|Re-induction Phase|Did not respond to re-induction|7|||
49154215|NCT00329420|158405025|FG000|4-weekly Dosing Phase (Responders Only)|Adverse Event|2|||
49154216|NCT00329420|158405026|FG001|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
49154217|NCT00329420|158405027|FG002|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
49154218|NCT00329420|158405025|FG000|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
49154219|NCT00329420|158405026|FG001|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
49154220|NCT00329420|158405027|FG002|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0|||
49154221|NCT00329420|158405025|FG000|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1|||
49154222|NCT00329420|158405026|FG001|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
49154223|NCT00329420|158405027|FG002|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
49154224|NCT01358734|158405028|FG000|Overall Study|Adverse Event|4|||
48734687|NCT01281137|156879557|FG000|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1|||
48734688|NCT01281137|156879558|FG001|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2|||
48734689|NCT00299182|156879559|FG000|Overall Study|Withdrawal by Subject|0|||
48734690|NCT00299182|156879560|FG001|Overall Study|Withdrawal by Subject|0|||
48734691|NCT00299182|156879561|FG002|Overall Study|Withdrawal by Subject|1|||
48734692|NCT00299182|156879562|FG003|Overall Study|Withdrawal by Subject|0|||
48734693|NCT00299182|156879563|FG004|Overall Study|Withdrawal by Subject|1|||
48734694|NCT00299182|156879564|FG005|Overall Study|Withdrawal by Subject|2|||
48734695|NCT00299182|156879565|FG006|Overall Study|Withdrawal by Subject|0|||
48734696|NCT00299182|156879559|FG000|Overall Study|Chemotherapy Changed|0|||
48734697|NCT00299182|156879560|FG001|Overall Study|Chemotherapy Changed|0|||
48734698|NCT00299182|156879561|FG002|Overall Study|Chemotherapy Changed|1|||
48734699|NCT00299182|156879562|FG003|Overall Study|Chemotherapy Changed|0|||
48734700|NCT00299182|156879563|FG004|Overall Study|Chemotherapy Changed|1|||
48734701|NCT00299182|156879564|FG005|Overall Study|Chemotherapy Changed|0|||
48734702|NCT00299182|156879565|FG006|Overall Study|Chemotherapy Changed|1|||
48734703|NCT00299182|156879559|FG000|Overall Study|Adverse Event|0|||
49154225|NCT01358734|158405029|FG001|Overall Study|Adverse Event|7|||
49154226|NCT01358734|158405030|FG002|Overall Study|Adverse Event|3|||
49154227|NCT01358734|158405028|FG000|Overall Study|Lack of Efficacy|0|||
49154228|NCT01358734|158405029|FG001|Overall Study|Lack of Efficacy|1|||
49154229|NCT01358734|158405030|FG002|Overall Study|Lack of Efficacy|3|||
49154230|NCT01358734|158405028|FG000|Overall Study|Withdrawal by Subject|1|||
49154231|NCT01358734|158405029|FG001|Overall Study|Withdrawal by Subject|6|||
49154232|NCT01358734|158405030|FG002|Overall Study|Withdrawal by Subject|3|||
48734704|NCT00299182|156879560|FG001|Overall Study|Adverse Event|0|||
48734705|NCT00299182|156879561|FG002|Overall Study|Adverse Event|0|||
48826925|NCT01941316|157207364|FG001|Overall Study|Withdrawal by Subject|2|||
48826926|NCT01941316|157207365|FG002|Overall Study|Withdrawal by Subject|1|||
48826927|NCT01941316|157207366|FG003|Overall Study|Withdrawal by Subject|8|||
48826928|NCT01941316|157207363|FG000|Overall Study|Death|0|||
48826929|NCT01941316|157207364|FG001|Overall Study|Death|0|||
48826930|NCT01941316|157207365|FG002|Overall Study|Death|0|||
48826931|NCT01941316|157207366|FG003|Overall Study|Death|3|||
48826932|NCT01941316|157207363|FG000|Overall Study|Physician Decision|0|||
48826933|NCT01941316|157207364|FG001|Overall Study|Physician Decision|0|||
48826934|NCT01941316|157207365|FG002|Overall Study|Physician Decision|0|||
48826935|NCT01941316|157207366|FG003|Overall Study|Physician Decision|3|||
48826936|NCT01941316|157207363|FG000|Overall Study|Protocol Violation|0|||
49154233|NCT01358734|158405028|FG000|Overall Study|Death|3|||
49154234|NCT01358734|158405029|FG001|Overall Study|Death|7|||
49154235|NCT01358734|158405030|FG002|Overall Study|Death|2|||
49154236|NCT01358734|158405028|FG000|Overall Study|Progressive Disease|5|||
49154237|NCT01358734|158405029|FG001|Overall Study|Progressive Disease|13|||
49154238|NCT01358734|158405030|FG002|Overall Study|Progressive Disease|16|||
49154239|NCT01358734|158405028|FG000|Overall Study|Non-compliance with study drug|0|||
49154240|NCT01358734|158405029|FG001|Overall Study|Non-compliance with study drug|0|||
49154241|NCT01358734|158405030|FG002|Overall Study|Non-compliance with study drug|1|||
49154242|NCT01358734|158405028|FG000|Overall Study|Other|2|||
49154243|NCT01358734|158405029|FG001|Overall Study|Other|5|||
49154244|NCT01358734|158405030|FG002|Overall Study|Other|4|||
49154245|NCT01358734|158405028|FG000|Overall Study|Protocol Violation|0|||
49154246|NCT01358734|158405029|FG001|Overall Study|Protocol Violation|0|||
49154247|NCT01358734|158405030|FG002|Overall Study|Protocol Violation|2|||
49154248|NCT02157610|158405033|FG000|Overall Study|Death|4|||
49154249|NCT02157610|158405034|FG001|Overall Study|Death|4|||
49154250|NCT05878067|158405035|FG000|Overall Study|Lost to Follow-up|2|||
49154251|NCT02853136|158405045|FG000|Wash-out|Adverse Event|0|||
49154252|NCT02853136|158405046|FG001|Wash-out|Adverse Event|0|||
49154253|NCT02853136|158405047|FG002|Wash-out|Adverse Event|0|||
49154254|NCT02853136|158405048|FG003|Wash-out|Adverse Event|1|||
48734706|NCT00299182|156879562|FG003|Overall Study|Adverse Event|0|||
48734707|NCT00299182|156879563|FG004|Overall Study|Adverse Event|0|||
48734708|NCT00299182|156879564|FG005|Overall Study|Adverse Event|1|||
48734709|NCT00299182|156879565|FG006|Overall Study|Adverse Event|0|||
48734710|NCT00299182|156879559|FG000|Overall Study|Not Eligible|0|||
48734711|NCT00299182|156879560|FG001|Overall Study|Not Eligible|0|||
48734712|NCT00299182|156879561|FG002|Overall Study|Not Eligible|0|||
48734713|NCT00299182|156879562|FG003|Overall Study|Not Eligible|0|||
48734714|NCT00299182|156879563|FG004|Overall Study|Not Eligible|1|||
48734715|NCT00299182|156879564|FG005|Overall Study|Not Eligible|0|||
48734716|NCT00299182|156879565|FG006|Overall Study|Not Eligible|0|||
48734717|NCT00669396|156879568|FG000|Overall Study|Lost to Follow-up|10|||
48734718|NCT00669396|156879569|FG001|Overall Study|Lost to Follow-up|12|||
48734719|NCT02635776|156879577|FG000|Overall Study|Physician Decision|1|||
48734720|NCT02635776|156879578|FG001|Overall Study|Physician Decision|0|||
48734721|NCT02635776|156879577|FG000|Overall Study|Adverse Event|51|||
48734722|NCT02635776|156879578|FG001|Overall Study|Adverse Event|3|||
48734723|NCT02635776|156879577|FG000|Overall Study|Withdrawal by Subject|41|||
48734724|NCT02635776|156879578|FG001|Overall Study|Withdrawal by Subject|7|||
48734725|NCT02635776|156879577|FG000|Overall Study|Lost to Follow-up|4|||
48734726|NCT02635776|156879578|FG001|Overall Study|Lost to Follow-up|0|||
48734727|NCT02635776|156879577|FG000|Overall Study|Other reasons|5|||
48734728|NCT02635776|156879578|FG001|Overall Study|Other reasons|1|||
48734729|NCT00910273|156879579|FG000|Overall Study|Lack of Efficacy|6|||
48734730|NCT00910273|156879580|FG001|Overall Study|Lack of Efficacy|9|||
48734731|NCT00910273|156879579|FG000|Overall Study|Adverse Event|1|||
48734732|NCT00910273|156879580|FG001|Overall Study|Adverse Event|1|||
48734733|NCT00910273|156879579|FG000|Overall Study|Withdrawal by Subject|1|||
48734734|NCT00910273|156879580|FG001|Overall Study|Withdrawal by Subject|0|||
48734735|NCT00910273|156879579|FG000|Overall Study|Discontinuation of study by sponsor|8|||
48734736|NCT00910273|156879580|FG001|Overall Study|Discontinuation of study by sponsor|2|||
48734737|NCT00910273|156879579|FG000|Overall Study|Protocol Violation|1|||
48826937|NCT01941316|157207364|FG001|Overall Study|Protocol Violation|0|||
48826938|NCT01941316|157207365|FG002|Overall Study|Protocol Violation|0|||
49154255|NCT01156844|158405050|FG000|Overall Study|Adverse Event|0|||
49154256|NCT01156844|158405051|FG001|Overall Study|Adverse Event|0|||
49154257|NCT01156844|158405052|FG002|Overall Study|Adverse Event|1|||
49154258|NCT01156844|158405053|FG003|Overall Study|Adverse Event|1|||
48734738|NCT00910273|156879580|FG001|Overall Study|Protocol Violation|0|||
48734739|NCT00910273|156879579|FG000|Overall Study|Lost to Follow-up|1|||
48734740|NCT00910273|156879580|FG001|Overall Study|Lost to Follow-up|1|||
48734741|NCT02030938|156879581|FG000|Overall Study|Lost to Follow-up|4|||
48734742|NCT02030938|156879581|FG000|Overall Study|Withdrawal by Subject|1|||
49154259|NCT01156844|158405050|FG000|Overall Study|Abnormal test procedure result(s)|0|||
49154260|NCT01156844|158405051|FG001|Overall Study|Abnormal test procedure result(s)|1|||
48826939|NCT01941316|157207366|FG003|Overall Study|Protocol Violation|3|||
48826940|NCT01941316|157207363|FG000|Overall Study|Intercurrent illness|0|||
48826941|NCT01941316|157207364|FG001|Overall Study|Intercurrent illness|0|||
48826942|NCT01941316|157207365|FG002|Overall Study|Intercurrent illness|0|||
49154261|NCT01156844|158405052|FG002|Overall Study|Abnormal test procedure result(s)|2|||
49154262|NCT01156844|158405053|FG003|Overall Study|Abnormal test procedure result(s)|2|||
49154263|NCT01156844|158405050|FG000|Overall Study|Withdrawal by Subject|0|||
49154264|NCT01156844|158405051|FG001|Overall Study|Withdrawal by Subject|0|||
49154265|NCT01156844|158405052|FG002|Overall Study|Withdrawal by Subject|2|||
49154266|NCT01156844|158405053|FG003|Overall Study|Withdrawal by Subject|2|||
49154267|NCT01156844|158405050|FG000|Overall Study|Lost to Follow-up|0|||
49154268|NCT01156844|158405051|FG001|Overall Study|Lost to Follow-up|0|||
49154269|NCT01156844|158405052|FG002|Overall Study|Lost to Follow-up|1|||
49154270|NCT01156844|158405053|FG003|Overall Study|Lost to Follow-up|0|||
49154271|NCT01156844|158405050|FG000|Overall Study|Administrative problems|0|||
49154272|NCT01156844|158405051|FG001|Overall Study|Administrative problems|1|||
49154273|NCT01156844|158405052|FG002|Overall Study|Administrative problems|0|||
49154274|NCT01156844|158405053|FG003|Overall Study|Administrative problems|1|||
49154275|NCT01156844|158405050|FG000|Overall Study|Protocol deviation|2|||
49154276|NCT01156844|158405051|FG001|Overall Study|Protocol deviation|0|||
49154277|NCT01156844|158405052|FG002|Overall Study|Protocol deviation|0|||
49154278|NCT01156844|158405053|FG003|Overall Study|Protocol deviation|0|||
49154279|NCT03232567|158405062|FG000|Overall Study|Withdrawal by Subject|0|||
49154280|NCT03232567|158405063|FG001|Overall Study|Withdrawal by Subject|1|||
49154281|NCT03232567|158405064|FG002|Overall Study|Withdrawal by Subject|0|||
49154282|NCT03232567|158405065|FG003|Overall Study|Withdrawal by Subject|0|||
49154283|NCT01153516|158405066|FG000|Overall Study|Both subjects refused surgery|2|||
49154284|NCT01153516|158405067|FG001|Overall Study|Both subjects refused surgery|0|||
49154285|NCT05837481|158405068|FG000|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|0|||
48826943|NCT01941316|157207366|FG003|Overall Study|Intercurrent illness|1|||
48826944|NCT01941316|157207363|FG000|Overall Study|Other, not specified|0|||
48826945|NCT01941316|157207364|FG001|Overall Study|Other, not specified|0|||
48826946|NCT01941316|157207365|FG002|Overall Study|Other, not specified|0|||
48826947|NCT01941316|157207366|FG003|Overall Study|Other, not specified|1|||
48826948|NCT02469064|157207367|FG000|Overall Study|Request not to receive intervention.|1|||
48826949|NCT02469064|157207368|FG001|Overall Study|Request not to receive intervention.|3|||
48826950|NCT05650333|157207369|FG000|Treatment Period (7 Days)|Adverse Event|1|||
48826951|NCT02616263|157207370|FG000|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|0|||
48826952|NCT02616263|157207371|FG001|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|3|||
48826953|NCT02616263|157207370|FG000|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|1|||
48826954|NCT02616263|157207371|FG001|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|0|||
48826955|NCT02616263|157207370|FG000|6 Month to 1.5 Year|Death|1|||
48826956|NCT02616263|157207371|FG001|6 Month to 1.5 Year|Death|0|||
48826957|NCT02616263|157207370|FG000|6 Month to 1.5 Year|Lost to Follow-up|0|||
48826958|NCT02616263|157207371|FG001|6 Month to 1.5 Year|Lost to Follow-up|2|||
48826959|NCT02616263|157207370|FG000|6 Month to 1.5 Year|Withdrawal by Subject|1|||
48826960|NCT02616263|157207371|FG001|6 Month to 1.5 Year|Withdrawal by Subject|1|||
48826961|NCT02616263|157207370|FG000|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|4|||
48826962|NCT02616263|157207371|FG001|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|2|||
48826963|NCT02820051|157207373|FG000|Overall Study|Lost to Follow-up|7|||
48826964|NCT02820051|157207374|FG001|Overall Study|Lost to Follow-up|4|||
48826965|NCT01018511|157207379|FG000|Overall Study|Not fulfilling eligibility criteria|6|||
48826966|NCT01018511|157207380|FG001|Overall Study|Not fulfilling eligibility criteria|7|||
48826967|NCT01018511|157207381|FG002|Overall Study|Not fulfilling eligibility criteria|7|||
48826968|NCT01018511|157207382|FG003|Overall Study|Not fulfilling eligibility criteria|3|||
48826969|NCT01018511|157207379|FG000|Overall Study|Adverse Event|5|||
48826970|NCT01018511|157207380|FG001|Overall Study|Adverse Event|9|||
48826971|NCT01018511|157207381|FG002|Overall Study|Adverse Event|13|||
48826972|NCT01018511|157207382|FG003|Overall Study|Adverse Event|10|||
48826973|NCT01018511|157207379|FG000|Overall Study|Lack of Efficacy|4|||
48826974|NCT01018511|157207380|FG001|Overall Study|Lack of Efficacy|1|||
49154286|NCT05837481|158405069|FG001|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|1|||
49154287|NCT02457065|158405071|FG000|Overall Study|Lost to Follow-up|9|||
48826975|NCT01018511|157207381|FG002|Overall Study|Lack of Efficacy|1|||
48826976|NCT01018511|157207382|FG003|Overall Study|Lack of Efficacy|2|||
49154288|NCT02457065|158405072|FG001|Overall Study|Lost to Follow-up|11|||
48826977|NCT01018511|157207379|FG000|Overall Study|Withdrawal by Subject|6|||
48826978|NCT01018511|157207380|FG001|Overall Study|Withdrawal by Subject|5|||
49154289|NCT00526799|158405075|FG000|Overall Study|Withdrawal by Subject|1|||
49154290|NCT00526799|158405076|FG001|Overall Study|Withdrawal by Subject|0|||
48826979|NCT01018511|157207381|FG002|Overall Study|Withdrawal by Subject|11|||
48826980|NCT01018511|157207382|FG003|Overall Study|Withdrawal by Subject|9|||
49154291|NCT00526799|158405075|FG000|Overall Study|Intercurrent Complicating Disease|0|||
49154292|NCT00526799|158405076|FG001|Overall Study|Intercurrent Complicating Disease|1|||
48921988|NCT00446511|157548120|FG002|Overall Study|Withdrawal by Subject|0|||
48921989|NCT00446511|157548121|FG003|Overall Study|Withdrawal by Subject|3|||
48921990|NCT00446511|157548118|FG000|Overall Study|Administrative Problems|3|||
48921991|NCT00446511|157548119|FG001|Overall Study|Administrative Problems|0|||
48921992|NCT00446511|157548120|FG002|Overall Study|Administrative Problems|4|||
49154293|NCT02278003|158406438|FG000|Overall Study|Withdrawal by Subject|11|||
49154294|NCT02278003|158406439|FG001|Overall Study|Withdrawal by Subject|0|||
48734743|NCT04308304|156879582|FG000|Overall Study|Withdrawal by Subject|4|||
48734744|NCT04308304|156879583|FG001|Overall Study|Withdrawal by Subject|0|||
48734745|NCT04308304|156879582|FG000|Overall Study|Protocol Violation|1|||
48734746|NCT04308304|156879583|FG001|Overall Study|Protocol Violation|0|||
48734747|NCT03181893|156879584|FG000|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
48734748|NCT03181893|156879585|FG001|Baseline to Week 12 (All Stages)|Withdrawal by Subject|1|||
48734749|NCT03181893|156879586|FG002|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
48734750|NCT03181893|156879587|FG003|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
48734751|NCT03181893|156879588|FG004|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
48734752|NCT03181893|156879589|FG005|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
48734753|NCT03181893|156879590|FG006|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
48734754|NCT03181893|156879591|FG007|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
48734755|NCT03181893|156879592|FG008|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
48734756|NCT03181893|156879593|FG009|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
48734757|NCT03181893|156879594|FG010|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
48734758|NCT03181893|156879584|FG000|Baseline to Week 12 (All Stages)|Adverse Event|1|||
48734759|NCT03181893|156879585|FG001|Baseline to Week 12 (All Stages)|Adverse Event|1|||
48734760|NCT03181893|156879586|FG002|Baseline to Week 12 (All Stages)|Adverse Event|0|||
48734761|NCT03181893|156879587|FG003|Baseline to Week 12 (All Stages)|Adverse Event|0|||
48734762|NCT03181893|156879588|FG004|Baseline to Week 12 (All Stages)|Adverse Event|0|||
48734763|NCT03181893|156879589|FG005|Baseline to Week 12 (All Stages)|Adverse Event|0|||
48734764|NCT03181893|156879590|FG006|Baseline to Week 12 (All Stages)|Adverse Event|0|||
48734765|NCT03181893|156879591|FG007|Baseline to Week 12 (All Stages)|Adverse Event|0|||
48734766|NCT03181893|156879592|FG008|Baseline to Week 12 (All Stages)|Adverse Event|0|||
48734767|NCT03181893|156879593|FG009|Baseline to Week 12 (All Stages)|Adverse Event|0|||
48734768|NCT03181893|156879594|FG010|Baseline to Week 12 (All Stages)|Adverse Event|0|||
48734769|NCT03181893|156879584|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
48734770|NCT03181893|156879585|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
48734771|NCT03181893|156879586|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
48734772|NCT03181893|156879587|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
48734773|NCT03181893|156879588|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
48734774|NCT03181893|156879589|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
48734775|NCT03181893|156879590|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
48734776|NCT03181893|156879591|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
48734777|NCT03181893|156879592|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
48734778|NCT03181893|156879593|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
48734779|NCT03181893|156879594|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
48734780|NCT03181893|156879584|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
48921993|NCT00446511|157548121|FG003|Overall Study|Administrative Problems|1|||
48921994|NCT02069899|157548124|FG000|Overall Study|Adverse Event|6|||
48921995|NCT02069899|157548125|FG001|Overall Study|Adverse Event|0|||
48921996|NCT02069899|157548126|FG002|Overall Study|Adverse Event|1|||
48921997|NCT02069899|157548124|FG000|Overall Study|Withdrawal by Participant|2|||
48921998|NCT02069899|157548125|FG001|Overall Study|Withdrawal by Participant|0|||
48921999|NCT02069899|157548126|FG002|Overall Study|Withdrawal by Participant|0|||
48922000|NCT02069899|157548124|FG000|Overall Study|Lost to Follow-up|1|||
48922001|NCT02069899|157548125|FG001|Overall Study|Lost to Follow-up|0|||
48922002|NCT02069899|157548126|FG002|Overall Study|Lost to Follow-up|1|||
48922003|NCT02069899|157548124|FG000|Overall Study|Other|4|||
48922004|NCT02069899|157548125|FG001|Overall Study|Other|0|||
48922005|NCT02069899|157548126|FG002|Overall Study|Other|0|||
48922006|NCT02069899|157548124|FG000|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
48922007|NCT02069899|157548125|FG001|Overall Study|Participant could not travel to the study site due to Covid restrictions|1|||
48922008|NCT02069899|157548126|FG002|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
48922009|NCT02069899|157548124|FG000|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
48922010|NCT02069899|157548125|FG001|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
48922011|NCT02069899|157548126|FG002|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|1|||
48922012|NCT04294719|157548129|FG000|Overall Study|Withdrawal by Subject|1|||
48922013|NCT02788747|157548134|FG000|Overall Study|Adverse Event|1|||
48922014|NCT02788747|157548135|FG001|Overall Study|Adverse Event|0|||
48922015|NCT02788747|157548136|FG002|Overall Study|Adverse Event|0|||
49154295|NCT02278003|158406438|FG000|Overall Study|Not Treated|1|||
49154296|NCT02278003|158406439|FG001|Overall Study|Not Treated|0|||
48826981|NCT01018511|157207379|FG000|Overall Study|Lost to Follow-up|0|||
48826982|NCT01018511|157207380|FG001|Overall Study|Lost to Follow-up|0|||
48922016|NCT03033875|157548137|FG000|Overall Study|Withdrawal by Subject|5|||
48922017|NCT03033875|157548138|FG001|Overall Study|Withdrawal by Subject|9|||
48922018|NCT03033875|157548139|FG002|Overall Study|Withdrawal by Subject|4|||
48826983|NCT01018511|157207381|FG002|Overall Study|Lost to Follow-up|1|||
48826984|NCT01018511|157207382|FG003|Overall Study|Lost to Follow-up|0|||
48826985|NCT01018511|157207379|FG000|Overall Study|Protocol Violation|5|||
48826986|NCT01018511|157207380|FG001|Overall Study|Protocol Violation|8|||
48826987|NCT01018511|157207381|FG002|Overall Study|Protocol Violation|7|||
48826988|NCT01018511|157207382|FG003|Overall Study|Protocol Violation|9|||
48826989|NCT01018511|157207379|FG000|Overall Study|Miscellaneous|0|||
48826990|NCT01018511|157207380|FG001|Overall Study|Miscellaneous|2|||
48826991|NCT01018511|157207381|FG002|Overall Study|Miscellaneous|0|||
48826992|NCT01018511|157207382|FG003|Overall Study|Miscellaneous|0|||
48826993|NCT03282123|157207383|FG000|Overall Study|Withdrawal by Subject|5|||
48826994|NCT03905135|157207387|FG000|Dose Escalation|Adverse Event|1|||
48826995|NCT03905135|157207388|FG001|Dose Escalation|Adverse Event|1|||
48826996|NCT03905135|157207387|FG000|Dose Escalation|Progressive disease|3|||
48826997|NCT03905135|157207388|FG001|Dose Escalation|Progressive disease|1|||
48826998|NCT03905135|157207387|FG000|Dose Escalation|Intercurrent illness|1|||
48826999|NCT03905135|157207388|FG001|Dose Escalation|Intercurrent illness|0|||
48827000|NCT04523181|157207390|FG000|Overall Study|Withdrawal by Subject|4|||
48827001|NCT04523181|157207391|FG001|Overall Study|Withdrawal by Subject|5|||
48827002|NCT04523181|157207390|FG000|Overall Study|Lost to Follow-up|2|||
48827003|NCT04523181|157207391|FG001|Overall Study|Lost to Follow-up|3|||
48827004|NCT04523181|157207390|FG000|Overall Study|Physician Decision|1|||
48922019|NCT03033875|157548137|FG000|Overall Study|Other|14|||
48922020|NCT03033875|157548138|FG001|Overall Study|Other|15|||
48922021|NCT03033875|157548139|FG002|Overall Study|Other|8|||
48922022|NCT03434379|157548140|FG000|Global Period|Lost to Follow-up|3|||
49014335|NCT00770991|157888829|FG001|Overall Study|Physician Decision|0|||
49014336|NCT00770991|157888828|FG000|Overall Study|Withdrawal by Subject|1|||
49014337|NCT00770991|157888829|FG001|Overall Study|Withdrawal by Subject|0|||
48734781|NCT03181893|156879585|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
48734782|NCT03181893|156879586|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
48734783|NCT03181893|156879587|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
48734784|NCT03181893|156879588|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
48734785|NCT03181893|156879589|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
48734786|NCT03181893|156879590|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
48734787|NCT03181893|156879591|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
48734788|NCT03181893|156879592|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
49014338|NCT00770991|157888828|FG000|Overall Study|Adverse Event|1|||
49014339|NCT00770991|157888829|FG001|Overall Study|Adverse Event|5|||
48734789|NCT03181893|156879593|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|1|||
48734790|NCT03181893|156879594|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
48734791|NCT03181893|156879584|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
48734792|NCT03181893|156879585|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
48734793|NCT03181893|156879586|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
48734794|NCT03181893|156879587|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
48734795|NCT03181893|156879588|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
48827005|NCT04523181|157207391|FG001|Overall Study|Physician Decision|0|||
48827006|NCT04523181|157207390|FG000|Overall Study|Transferred to external facility.|1|||
48827007|NCT04523181|157207391|FG001|Overall Study|Transferred to external facility.|1|||
48827008|NCT04391309|157207395|FG000|Overall Study|Death|1|||
48827009|NCT04391309|157207396|FG001|Overall Study|Death|1|||
48922023|NCT03434379|157548141|FG001|Global Period|Lost to Follow-up|6|||
48922024|NCT03434379|157548142|FG002|Global Period|Lost to Follow-up|0|||
49014340|NCT00770991|157888828|FG000|Overall Study|Pregnancy|1|||
49014341|NCT00770991|157888829|FG001|Overall Study|Pregnancy|0|||
49014342|NCT01992107|157888830|FG000|Overall Study|Administrative reasons|2|||
49014343|NCT01992107|157888831|FG001|Overall Study|Administrative reasons|0|||
49014344|NCT01992107|157888832|FG002|Overall Study|Administrative reasons|0|||
49014345|NCT01992107|157888830|FG000|Overall Study|Adverse Event|0|||
49014346|NCT01992107|157888831|FG001|Overall Study|Adverse Event|1|||
49014347|NCT01992107|157888832|FG002|Overall Study|Adverse Event|0|||
49014348|NCT01992107|157888830|FG000|Overall Study|Lost to Follow-up|46|||
49014349|NCT01992107|157888831|FG001|Overall Study|Lost to Follow-up|22|||
49014350|NCT01992107|157888832|FG002|Overall Study|Lost to Follow-up|26|||
49014351|NCT01992107|157888830|FG000|Overall Study|noncompliance and were unavailable|7|||
49014352|NCT01992107|157888831|FG001|Overall Study|noncompliance and were unavailable|3|||
49014353|NCT01992107|157888832|FG002|Overall Study|noncompliance and were unavailable|2|||
49014354|NCT01992107|157888830|FG000|Overall Study|Withdrawal by Subject|13|||
49014355|NCT01992107|157888831|FG001|Overall Study|Withdrawal by Subject|7|||
49154297|NCT02278003|158406438|FG000|Overall Study|Recognition task improperly completed|7|||
49154298|NCT02278003|158406439|FG001|Overall Study|Recognition task improperly completed|0|||
49154299|NCT03673176|158406440|FG000|Overall Study|Death prior to intervention|1|||
49154300|NCT03673176|158406440|FG000|Overall Study|Death following intervention|3|||
49154301|NCT03673176|158406440|FG000|Overall Study|Withdrawal by Subject|1|||
49154302|NCT00337168|158406441|FG000|Overall Study|Death|5|||
49154303|NCT00337168|158406441|FG000|Overall Study|Not protocol specified|2|||
49154304|NCT00337168|158406441|FG000|Overall Study|Did not start therapy|1|||
49154305|NCT03283241|158406442|FG000|Overall Study|Adverse Event|4|||
49154306|NCT03283241|158406443|FG001|Overall Study|Adverse Event|1|||
49154307|NCT03283241|158406442|FG000|Overall Study|Withdrawal by Subject|0|||
49154308|NCT03283241|158406443|FG001|Overall Study|Withdrawal by Subject|1|||
49154309|NCT03283241|158406442|FG000|Overall Study|Subject relocated to Finland|0|||
49154310|NCT03283241|158406443|FG001|Overall Study|Subject relocated to Finland|1|||
49154311|NCT03386773|158406450|FG000|Overall Study|Lost to Follow-up|24|||
49154312|NCT03386773|158406451|FG001|Overall Study|Lost to Follow-up|33|||
49154313|NCT03386773|158406450|FG000|Overall Study|Withdrawal by Subject|3|||
49154314|NCT03386773|158406451|FG001|Overall Study|Withdrawal by Subject|2|||
49154315|NCT02724839|158406452|FG000|Overall Study|Withdrawal by Subject|1|||
49154316|NCT02724839|158406453|FG001|Overall Study|Withdrawal by Subject|1|||
49154317|NCT02724839|158406454|FG002|Overall Study|Withdrawal by Subject|0|||
49154318|NCT02724839|158406452|FG000|Overall Study|Lost to Follow-up|0|||
49154319|NCT02724839|158406453|FG001|Overall Study|Lost to Follow-up|3|||
49154320|NCT02724839|158406454|FG002|Overall Study|Lost to Follow-up|2|||
49154321|NCT02724839|158406452|FG000|Overall Study|Physician Decision|0|||
49154322|NCT02724839|158406453|FG001|Overall Study|Physician Decision|0|||
49154323|NCT02724839|158406454|FG002|Overall Study|Physician Decision|3|||
49154324|NCT01155050|158406455|FG000|Overall Study|Lost to Follow-up|15|||
49154325|NCT01155050|158406456|FG001|Overall Study|Lost to Follow-up|20|||
49154326|NCT01155050|158406457|FG002|Overall Study|Lost to Follow-up|19|||
49154327|NCT01155050|158406458|FG003|Overall Study|Lost to Follow-up|22|||
49154328|NCT03322566|158406460|FG000|Overall Study|Death|34|||
49154329|NCT03322566|158406461|FG001|Overall Study|Death|35|||
49154330|NCT03322566|158406462|FG002|Overall Study|Death|23|||
49154331|NCT03322566|158406460|FG000|Overall Study|Physician Decision|6|||
49154332|NCT03322566|158406461|FG001|Overall Study|Physician Decision|7|||
49154333|NCT03322566|158406462|FG002|Overall Study|Physician Decision|2|||
49154334|NCT03322566|158406460|FG000|Overall Study|Withdrawal by Subject|4|||
49154335|NCT03322566|158406461|FG001|Overall Study|Withdrawal by Subject|3|||
49154336|NCT03322566|158406462|FG002|Overall Study|Withdrawal by Subject|6|||
49154337|NCT03322566|158406460|FG000|Overall Study|Lost to Follow-up|0|||
49154338|NCT03322566|158406461|FG001|Overall Study|Lost to Follow-up|0|||
49154339|NCT03322566|158406462|FG002|Overall Study|Lost to Follow-up|1|||
49154340|NCT03322566|158406460|FG000|Overall Study|Study terminated by sponsor|1|||
49154341|NCT03322566|158406461|FG001|Overall Study|Study terminated by sponsor|0|||
49154342|NCT03322566|158406462|FG002|Overall Study|Study terminated by sponsor|1|||
49154343|NCT00560417|158406463|FG000|Overall Study|Adverse Event|3|||
49154344|NCT00560417|158406464|FG001|Overall Study|Adverse Event|2|||
49154345|NCT00560417|158406463|FG000|Overall Study|Entry Criteria Not Met|1|||
49154346|NCT00560417|158406464|FG001|Overall Study|Entry Criteria Not Met|0|||
49154347|NCT00560417|158406463|FG000|Overall Study|Lost to Follow-up|0|||
49154348|NCT00560417|158406464|FG001|Overall Study|Lost to Follow-up|1|||
49154349|NCT00560417|158406463|FG000|Overall Study|Physician Decision|2|||
49154350|NCT00560417|158406464|FG001|Overall Study|Physician Decision|6|||
49154351|NCT00560417|158406463|FG000|Overall Study|Protocol Violation|6|||
49154352|NCT00560417|158406464|FG001|Overall Study|Protocol Violation|5|||
49154353|NCT00560417|158406463|FG000|Overall Study|Sponsor Decision|2|||
49154354|NCT00560417|158406464|FG001|Overall Study|Sponsor Decision|0|||
49154355|NCT00560417|158406463|FG000|Overall Study|Withdrawal by Subject|3|||
49154356|NCT00560417|158406464|FG001|Overall Study|Withdrawal by Subject|3|||
49154357|NCT00652834|158406465|FG000|Overall Study|Withdrawal by Subject|3|||
49154358|NCT00652834|158406465|FG000|Overall Study|Lost to Follow-up|2|||
49154359|NCT00553254|158406466|FG000|Overall Study|Death|3|||
49154360|NCT00553254|158406467|FG001|Overall Study|Death|6|||
49154361|NCT00553254|158406468|FG002|Overall Study|Death|25|||
48734796|NCT03181893|156879589|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
49154362|NCT00553254|158406466|FG000|Overall Study|Lost to Follow-up|0|||
49154363|NCT00553254|158406467|FG001|Overall Study|Lost to Follow-up|0|||
49154364|NCT00553254|158406468|FG002|Overall Study|Lost to Follow-up|2|||
49154365|NCT00553254|158406466|FG000|Overall Study|Withdrawal by Subject|2|||
49154366|NCT00553254|158406467|FG001|Overall Study|Withdrawal by Subject|0|||
49154367|NCT00553254|158406468|FG002|Overall Study|Withdrawal by Subject|2|||
49154368|NCT00553254|158406466|FG000|Overall Study|Study terminated by Sponsor|0|||
49154369|NCT00553254|158406467|FG001|Overall Study|Study terminated by Sponsor|0|||
49154370|NCT00553254|158406468|FG002|Overall Study|Study terminated by Sponsor|1|||
49154371|NCT00553254|158406466|FG000|Overall Study|Other|1|||
49154372|NCT00553254|158406467|FG001|Overall Study|Other|0|||
49154373|NCT00553254|158406468|FG002|Overall Study|Other|13|||
49154374|NCT02327169|158406474|FG000|Overall Study|Progressive Disease|1|||
49154375|NCT02327169|158406475|FG001|Overall Study|Progressive Disease|3|||
49154376|NCT02327169|158406476|FG002|Overall Study|Progressive Disease|4|||
49154377|NCT02327169|158406477|FG003|Overall Study|Progressive Disease|3|||
49154378|NCT02327169|158406478|FG004|Overall Study|Progressive Disease|4|||
49154379|NCT02327169|158406479|FG005|Overall Study|Progressive Disease|3|||
49154380|NCT02327169|158406480|FG006|Overall Study|Progressive Disease|3|||
49154381|NCT02327169|158406481|FG007|Overall Study|Progressive Disease|3|||
49154382|NCT02327169|158406482|FG008|Overall Study|Progressive Disease|4|||
49154383|NCT02327169|158406483|FG009|Overall Study|Progressive Disease|4|||
49154384|NCT02327169|158406484|FG010|Overall Study|Progressive Disease|4|||
49154385|NCT02327169|158406485|FG011|Overall Study|Progressive Disease|3|||
49154386|NCT02327169|158406486|FG012|Overall Study|Progressive Disease|1|||
49154387|NCT02327169|158406487|FG013|Overall Study|Progressive Disease|3|||
48734797|NCT03181893|156879590|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
49154388|NCT02327169|158406488|FG014|Overall Study|Progressive Disease|3|||
49154389|NCT02327169|158406474|FG000|Overall Study|Adverse Event|2|||
49154390|NCT02327169|158406475|FG001|Overall Study|Adverse Event|0|||
49154391|NCT02327169|158406476|FG002|Overall Study|Adverse Event|1|||
49154392|NCT02327169|158406477|FG003|Overall Study|Adverse Event|0|||
48734798|NCT03181893|156879591|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
48734799|NCT03181893|156879592|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
48734800|NCT03181893|156879593|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
48734801|NCT03181893|156879594|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|1|||
48734802|NCT02298023|156879595|FG000|Overall Study|Withdrawal by Subject|1|||
48734803|NCT02298023|156879596|FG001|Overall Study|Withdrawal by Subject|0|||
48734804|NCT02298023|156879597|FG002|Overall Study|Withdrawal by Subject|0|||
48734805|NCT03540030|156879600|FG000|Overall Study|Withdrawal by Subject|2|||
48734806|NCT03540030|156879601|FG001|Overall Study|Withdrawal by Subject|1|||
48734807|NCT03540030|156879600|FG000|Overall Study|screen fail|7|||
48734808|NCT03540030|156879601|FG001|Overall Study|screen fail|1|||
48734809|NCT03540030|156879600|FG000|Overall Study|never had surgery after signing consent|9|||
48734810|NCT03540030|156879601|FG001|Overall Study|never had surgery after signing consent|1|||
48734811|NCT03021304|156879602|FG000|Overall Study|Lack of Efficacy|1|||
48734812|NCT00569270|156879603|FG000|Period: First Intervention|Protocol Violation|0|||
48734813|NCT00569270|156879604|FG001|Period: First Intervention|Protocol Violation|1|||
48734814|NCT00451451|156880754|FG000|Overall Study|Adverse Event|11|||
48734815|NCT00451451|156880755|FG001|Overall Study|Adverse Event|21|||
48734816|NCT00451451|156880756|FG002|Overall Study|Adverse Event|26|||
48734817|NCT00451451|156880757|FG003|Overall Study|Adverse Event|10|||
48734818|NCT00451451|156880754|FG000|Overall Study|Lost to Follow-up|11|||
48734819|NCT00451451|156880755|FG001|Overall Study|Lost to Follow-up|9|||
48734820|NCT00451451|156880756|FG002|Overall Study|Lost to Follow-up|8|||
48734821|NCT00451451|156880757|FG003|Overall Study|Lost to Follow-up|11|||
48734822|NCT00451451|156880754|FG000|Overall Study|Consent Withdrawn|14|||
48734823|NCT00451451|156880755|FG001|Overall Study|Consent Withdrawn|9|||
48734824|NCT00451451|156880756|FG002|Overall Study|Consent Withdrawn|17|||
48734825|NCT00451451|156880757|FG003|Overall Study|Consent Withdrawn|17|||
48734826|NCT00451451|156880754|FG000|Overall Study|Investigator Decision|6|||
48734827|NCT00451451|156880755|FG001|Overall Study|Investigator Decision|2|||
48734828|NCT00451451|156880756|FG002|Overall Study|Investigator Decision|1|||
48734829|NCT00451451|156880757|FG003|Overall Study|Investigator Decision|2|||
48734830|NCT00451451|156880754|FG000|Overall Study|Subject Non-Compliance|8|||
48734831|NCT00451451|156880755|FG001|Overall Study|Subject Non-Compliance|4|||
48734832|NCT00451451|156880756|FG002|Overall Study|Subject Non-Compliance|3|||
48734833|NCT00451451|156880757|FG003|Overall Study|Subject Non-Compliance|3|||
48734834|NCT00451451|156880754|FG000|Overall Study|Death|1|||
48734835|NCT00451451|156880755|FG001|Overall Study|Death|0|||
48734836|NCT00451451|156880756|FG002|Overall Study|Death|0|||
48734837|NCT00451451|156880757|FG003|Overall Study|Death|1|||
48734838|NCT00451451|156880754|FG000|Overall Study|Other Reasons for Not Completing Study|34|||
48734839|NCT00451451|156880755|FG001|Overall Study|Other Reasons for Not Completing Study|30|||
48734840|NCT00451451|156880756|FG002|Overall Study|Other Reasons for Not Completing Study|17|||
48734841|NCT00451451|156880757|FG003|Overall Study|Other Reasons for Not Completing Study|14|||
48734842|NCT02095223|156880758|FG000|Overall Study|Withdrawal by Subject|1|||
48734843|NCT02095223|156880759|FG001|Overall Study|Withdrawal by Subject|0|||
48734844|NCT03911713|156880760|FG000|Overall Study|Lost to Follow-up|0|||
48734845|NCT03911713|156880761|FG001|Overall Study|Lost to Follow-up|2|||
49154393|NCT02327169|158406478|FG004|Overall Study|Adverse Event|1|||
48734846|NCT03911713|156880762|FG002|Overall Study|Lost to Follow-up|0|||
48734847|NCT03911713|156880763|FG003|Overall Study|Lost to Follow-up|0|||
48734848|NCT03911713|156880764|FG004|Overall Study|Lost to Follow-up|0|||
48734849|NCT03911713|156880760|FG000|Overall Study|Other|0|||
48734850|NCT03911713|156880761|FG001|Overall Study|Other|0|||
49154394|NCT02327169|158406479|FG005|Overall Study|Adverse Event|0|||
49154395|NCT02327169|158406480|FG006|Overall Study|Adverse Event|0|||
48827010|NCT04391309|157207395|FG000|Overall Study|Lost to Follow-up|3|||
48827011|NCT04391309|157207396|FG001|Overall Study|Lost to Follow-up|2|||
48827012|NCT04391309|157207395|FG000|Overall Study|Withdrawal by Subject|2|||
48827013|NCT04391309|157207396|FG001|Overall Study|Withdrawal by Subject|2|||
48827014|NCT05576662|157207397|FG000|Overall Study|Withdrawn by site within 15-day treatment period|0|||
48827015|NCT05576662|157207398|FG001|Overall Study|Withdrawn by site within 15-day treatment period|1|||
48827016|NCT05576662|157207397|FG000|Overall Study|Requested to withdraw within 15-day treatment period|0|||
48827017|NCT05576662|157207398|FG001|Overall Study|Requested to withdraw within 15-day treatment period|1|||
48827018|NCT05576662|157207397|FG000|Overall Study|Lost to follow-up within 15-day treatment period|2|||
48827019|NCT05576662|157207398|FG001|Overall Study|Lost to follow-up within 15-day treatment period|0|||
48827020|NCT05576662|157207397|FG000|Overall Study|Requested to withdraw after 15-day treatment period|2|||
48827021|NCT05576662|157207398|FG001|Overall Study|Requested to withdraw after 15-day treatment period|2|||
48827022|NCT04739423|157207403|FG000|Overall Study|Protocol Violation|0|||
48827023|NCT04739423|157207404|FG001|Overall Study|Protocol Violation|1|||
48827024|NCT04739423|157207405|FG002|Overall Study|Protocol Violation|0|||
48827025|NCT04739423|157207406|FG003|Overall Study|Protocol Violation|0|||
48827026|NCT04739423|157207407|FG004|Overall Study|Protocol Violation|0|||
48827027|NCT04739423|157207408|FG005|Overall Study|Protocol Violation|0|||
48827028|NCT04739423|157207403|FG000|Overall Study|Adverse Event|0|||
48827029|NCT04739423|157207404|FG001|Overall Study|Adverse Event|0|||
48827030|NCT04739423|157207405|FG002|Overall Study|Adverse Event|1|||
48827031|NCT04739423|157207406|FG003|Overall Study|Adverse Event|0|||
48827032|NCT04739423|157207407|FG004|Overall Study|Adverse Event|1|||
48827033|NCT04739423|157207408|FG005|Overall Study|Adverse Event|0|||
48827034|NCT04739423|157207403|FG000|Overall Study|Withdrawal by Subject|0|||
48827035|NCT04739423|157207404|FG001|Overall Study|Withdrawal by Subject|0|||
48922025|NCT03434379|157548143|FG003|Global Period|Lost to Follow-up|0|||
48922026|NCT03434379|157548140|FG000|Global Period|Death|115|||
48922027|NCT03434379|157548141|FG001|Global Period|Death|228|||
48922028|NCT03434379|157548142|FG002|Global Period|Death|0|||
48827036|NCT04739423|157207405|FG002|Overall Study|Withdrawal by Subject|0|||
48827037|NCT04739423|157207406|FG003|Overall Study|Withdrawal by Subject|0|||
48827038|NCT04739423|157207407|FG004|Overall Study|Withdrawal by Subject|0|||
48827039|NCT04739423|157207408|FG005|Overall Study|Withdrawal by Subject|1|||
48922029|NCT03434379|157548143|FG003|Global Period|Death|0|||
48922030|NCT03434379|157548140|FG000|Global Period|Withdrawal by Subject|20|||
48827040|NCT03971357|157207411|FG000|Overall Study|Lack of Efficacy|0|||
48827041|NCT03971357|157207412|FG001|Overall Study|Lack of Efficacy|1|||
48827042|NCT00124982|157207413|FG000|Short-term Period|Death|1|||
48827043|NCT00124982|157207414|FG001|Short-term Period|Death|1|||
48827044|NCT00124982|157207415|FG002|Short-term Period|Death|0|||
48827045|NCT00124982|157207413|FG000|Short-term Period|Adverse Event|17|||
48827046|NCT00124982|157207414|FG001|Short-term Period|Adverse Event|22|||
48922031|NCT03434379|157548141|FG001|Global Period|Withdrawal by Subject|21|||
48922032|NCT03434379|157548142|FG002|Global Period|Withdrawal by Subject|0|||
48922033|NCT03434379|157548143|FG003|Global Period|Withdrawal by Subject|0|||
48922034|NCT03434379|157548140|FG000|Global Period|Reason Unspecified|0|||
48922035|NCT03434379|157548141|FG001|Global Period|Reason Unspecified|1|||
48922036|NCT03434379|157548142|FG002|Global Period|Reason Unspecified|0|||
49154396|NCT02327169|158406481|FG007|Overall Study|Adverse Event|0|||
49154397|NCT02327169|158406482|FG008|Overall Study|Adverse Event|0|||
49154398|NCT02327169|158406483|FG009|Overall Study|Adverse Event|2|||
49154399|NCT02327169|158406484|FG010|Overall Study|Adverse Event|0|||
48922037|NCT03434379|157548143|FG003|Global Period|Reason Unspecified|0|||
48922038|NCT03434379|157548140|FG000|Global Period|Study Ended by Sponsor|26|||
48922039|NCT03434379|157548141|FG001|Global Period|Study Ended by Sponsor|80|||
48922040|NCT03434379|157548142|FG002|Global Period|Study Ended by Sponsor|0|||
48922041|NCT03434379|157548143|FG003|Global Period|Study Ended by Sponsor|0|||
48922042|NCT03434379|157548140|FG000|Global Period|Physician Decision|1|||
48922043|NCT03434379|157548141|FG001|Global Period|Physician Decision|0|||
48922044|NCT03434379|157548142|FG002|Global Period|Physician Decision|0|||
48922045|NCT03434379|157548143|FG003|Global Period|Physician Decision|0|||
48922046|NCT03434379|157548140|FG000|China Extension Period|Lost to Follow-up|0|||
48922047|NCT03434379|157548141|FG001|China Extension Period|Lost to Follow-up|0|||
48922048|NCT03434379|157548142|FG002|China Extension Period|Lost to Follow-up|2|||
49154400|NCT02327169|158406485|FG011|Overall Study|Adverse Event|3|||
49154401|NCT02327169|158406486|FG012|Overall Study|Adverse Event|0|||
49154402|NCT02327169|158406487|FG013|Overall Study|Adverse Event|2|||
48827047|NCT00124982|157207415|FG002|Short-term Period|Adverse Event|0|||
48827048|NCT00124982|157207413|FG000|Short-term Period|Lack of Efficacy|32|||
48827049|NCT00124982|157207414|FG001|Short-term Period|Lack of Efficacy|73|||
48827050|NCT00124982|157207415|FG002|Short-term Period|Lack of Efficacy|0|||
48827051|NCT00124982|157207413|FG000|Short-term Period|Lost to Follow-up|8|||
48827052|NCT00124982|157207414|FG001|Short-term Period|Lost to Follow-up|5|||
48827053|NCT00124982|157207415|FG002|Short-term Period|Lost to Follow-up|0|||
48922049|NCT03434379|157548143|FG003|China Extension Period|Lost to Follow-up|3|||
49154403|NCT02327169|158406488|FG014|Overall Study|Adverse Event|1|||
49154404|NCT02327169|158406474|FG000|Overall Study|Symptomatic Deterioration|0|||
49154405|NCT02327169|158406475|FG001|Overall Study|Symptomatic Deterioration|0|||
49154406|NCT02327169|158406476|FG002|Overall Study|Symptomatic Deterioration|1|||
49154407|NCT02327169|158406477|FG003|Overall Study|Symptomatic Deterioration|0|||
49154408|NCT02327169|158406478|FG004|Overall Study|Symptomatic Deterioration|1|||
49154409|NCT02327169|158406479|FG005|Overall Study|Symptomatic Deterioration|1|||
49154410|NCT02327169|158406480|FG006|Overall Study|Symptomatic Deterioration|0|||
49154411|NCT02327169|158406481|FG007|Overall Study|Symptomatic Deterioration|0|||
49154412|NCT02327169|158406482|FG008|Overall Study|Symptomatic Deterioration|2|||
49154413|NCT02327169|158406483|FG009|Overall Study|Symptomatic Deterioration|1|||
49154414|NCT02327169|158406484|FG010|Overall Study|Symptomatic Deterioration|0|||
49154415|NCT02327169|158406485|FG011|Overall Study|Symptomatic Deterioration|0|||
49154416|NCT02327169|158406486|FG012|Overall Study|Symptomatic Deterioration|0|||
49154417|NCT02327169|158406487|FG013|Overall Study|Symptomatic Deterioration|2|||
49154418|NCT02327169|158406488|FG014|Overall Study|Symptomatic Deterioration|1|||
49154419|NCT02327169|158406474|FG000|Overall Study|Reason Not Specified|0|||
49154420|NCT02327169|158406475|FG001|Overall Study|Reason Not Specified|0|||
49154421|NCT02327169|158406476|FG002|Overall Study|Reason Not Specified|1|||
49154422|NCT02327169|158406477|FG003|Overall Study|Reason Not Specified|0|||
49154423|NCT02327169|158406478|FG004|Overall Study|Reason Not Specified|0|||
49154424|NCT02327169|158406479|FG005|Overall Study|Reason Not Specified|0|||
49154425|NCT02327169|158406480|FG006|Overall Study|Reason Not Specified|0|||
49154426|NCT02327169|158406481|FG007|Overall Study|Reason Not Specified|0|||
49154427|NCT02327169|158406482|FG008|Overall Study|Reason Not Specified|0|||
49154428|NCT02327169|158406483|FG009|Overall Study|Reason Not Specified|1|||
49154429|NCT02327169|158406484|FG010|Overall Study|Reason Not Specified|2|||
49154430|NCT02327169|158406485|FG011|Overall Study|Reason Not Specified|1|||
49154431|NCT02327169|158406486|FG012|Overall Study|Reason Not Specified|0|||
49154432|NCT02327169|158406487|FG013|Overall Study|Reason Not Specified|0|||
49154433|NCT02327169|158406488|FG014|Overall Study|Reason Not Specified|2|||
49154434|NCT02327169|158406474|FG000|Overall Study|Withdrawal by Subject|1|||
49154435|NCT02327169|158406475|FG001|Overall Study|Withdrawal by Subject|0|||
49154436|NCT02327169|158406476|FG002|Overall Study|Withdrawal by Subject|0|||
49154437|NCT02327169|158406477|FG003|Overall Study|Withdrawal by Subject|0|||
49154438|NCT02327169|158406478|FG004|Overall Study|Withdrawal by Subject|1|||
49154439|NCT02327169|158406479|FG005|Overall Study|Withdrawal by Subject|0|||
49154440|NCT02327169|158406480|FG006|Overall Study|Withdrawal by Subject|0|||
49154441|NCT02327169|158406481|FG007|Overall Study|Withdrawal by Subject|1|||
48827054|NCT00124982|157207413|FG000|Short-term Period|Withdrawal of Consent|7|||
49154442|NCT02327169|158406482|FG008|Overall Study|Withdrawal by Subject|0|||
49154443|NCT02327169|158406483|FG009|Overall Study|Withdrawal by Subject|0|||
49154444|NCT02327169|158406484|FG010|Overall Study|Withdrawal by Subject|0|||
48827055|NCT00124982|157207414|FG001|Short-term Period|Withdrawal of Consent|9|||
48827056|NCT00124982|157207415|FG002|Short-term Period|Withdrawal of Consent|0|||
48827057|NCT00124982|157207413|FG000|Short-term Period|Poor/Non-compliance|3|||
48827058|NCT00124982|157207414|FG001|Short-term Period|Poor/Non-compliance|1|||
48827059|NCT00124982|157207415|FG002|Short-term Period|Poor/Non-compliance|0|||
48827060|NCT00124982|157207413|FG000|Short-term Period|No Longer Meets Study Criteria|1|||
48827061|NCT00124982|157207414|FG001|Short-term Period|No Longer Meets Study Criteria|2|||
48827062|NCT00124982|157207415|FG002|Short-term Period|No Longer Meets Study Criteria|0|||
48827063|NCT00124982|157207413|FG000|Short-term Period|Participant Decision|1|||
48827064|NCT00124982|157207414|FG001|Short-term Period|Participant Decision|0|||
48827065|NCT00124982|157207415|FG002|Short-term Period|Participant Decision|0|||
48827066|NCT00124982|157207413|FG000|Short-term Period|Participant Chose Own Doctor|0|||
48827067|NCT00124982|157207414|FG001|Short-term Period|Participant Chose Own Doctor|1|||
48827068|NCT00124982|157207415|FG002|Short-term Period|Participant Chose Own Doctor|0|||
48827069|NCT00124982|157207413|FG000|Short-term Period|Investigator Decision-No Specific AE|1|||
48827070|NCT00124982|157207414|FG001|Short-term Period|Investigator Decision-No Specific AE|0|||
48827071|NCT00124982|157207415|FG002|Short-term Period|Investigator Decision-No Specific AE|0|||
49154445|NCT02327169|158406485|FG011|Overall Study|Withdrawal by Subject|0|||
49154446|NCT02327169|158406486|FG012|Overall Study|Withdrawal by Subject|0|||
49154447|NCT02327169|158406487|FG013|Overall Study|Withdrawal by Subject|0|||
49154448|NCT02327169|158406488|FG014|Overall Study|Withdrawal by Subject|3|||
49154449|NCT02327169|158406474|FG000|Overall Study|Lost to Follow-up|0|||
49154450|NCT02327169|158406475|FG001|Overall Study|Lost to Follow-up|0|||
49154451|NCT02327169|158406476|FG002|Overall Study|Lost to Follow-up|0|||
49154452|NCT02327169|158406477|FG003|Overall Study|Lost to Follow-up|0|||
49154453|NCT02327169|158406478|FG004|Overall Study|Lost to Follow-up|1|||
49154454|NCT02327169|158406479|FG005|Overall Study|Lost to Follow-up|0|||
49154455|NCT02327169|158406480|FG006|Overall Study|Lost to Follow-up|0|||
49154456|NCT02327169|158406481|FG007|Overall Study|Lost to Follow-up|0|||
49154457|NCT02327169|158406482|FG008|Overall Study|Lost to Follow-up|0|||
48827072|NCT00124982|157207413|FG000|Short-term Period|Participant Had Lymphopenia|1|||
48827073|NCT00124982|157207414|FG001|Short-term Period|Participant Had Lymphopenia|0|||
49154458|NCT02327169|158406483|FG009|Overall Study|Lost to Follow-up|0|||
49154459|NCT02327169|158406484|FG010|Overall Study|Lost to Follow-up|0|||
49154460|NCT02327169|158406485|FG011|Overall Study|Lost to Follow-up|0|||
49154461|NCT02327169|158406486|FG012|Overall Study|Lost to Follow-up|0|||
49154462|NCT02327169|158406487|FG013|Overall Study|Lost to Follow-up|0|||
49154463|NCT02327169|158406488|FG014|Overall Study|Lost to Follow-up|0|||
49154464|NCT01047540|158406489|FG000|Overall Study|Protocol Violation|1|||
49154465|NCT01047540|158406490|FG001|Overall Study|Protocol Violation|0|||
49154466|NCT01047540|158406491|FG002|Overall Study|Protocol Violation|0|||
49154467|NCT01047540|158406492|FG003|Overall Study|Protocol Violation|0|||
48827074|NCT00124982|157207415|FG002|Short-term Period|Participant Had Lymphopenia|0|||
48827075|NCT00124982|157207413|FG000|Long-term Period|Death|0|||
48827076|NCT00124982|157207414|FG001|Long-term Period|Death|0|||
48827077|NCT00124982|157207415|FG002|Long-term Period|Death|1|||
48827078|NCT00124982|157207413|FG000|Long-term Period|Adverse Event|0|||
48827079|NCT00124982|157207414|FG001|Long-term Period|Adverse Event|0|||
48827080|NCT00124982|157207415|FG002|Long-term Period|Adverse Event|17|||
48827081|NCT00124982|157207413|FG000|Long-term Period|Lack of Efficacy|0|||
48827082|NCT00124982|157207414|FG001|Long-term Period|Lack of Efficacy|0|||
48827083|NCT00124982|157207415|FG002|Long-term Period|Lack of Efficacy|46|||
48827084|NCT00124982|157207413|FG000|Long-term Period|Lost to Follow-up|0|||
48827085|NCT00124982|157207414|FG001|Long-term Period|Lost to Follow-up|0|||
48827086|NCT00124982|157207415|FG002|Long-term Period|Lost to Follow-up|4|||
48827087|NCT00124982|157207413|FG000|Long-term Period|Withdrawal by Subject|0|||
49154468|NCT01047540|158406493|FG004|Overall Study|Protocol Violation|0|||
49154469|NCT01047540|158406489|FG000|Overall Study|Lost to Follow-up|1|||
49154470|NCT01047540|158406490|FG001|Overall Study|Lost to Follow-up|0|||
49154471|NCT01047540|158406491|FG002|Overall Study|Lost to Follow-up|0|||
49154472|NCT01047540|158406492|FG003|Overall Study|Lost to Follow-up|0|||
49154473|NCT01047540|158406493|FG004|Overall Study|Lost to Follow-up|0|||
49154474|NCT01047540|158406489|FG000|Overall Study|Withdrawal by Subject|1|||
49154475|NCT01047540|158406490|FG001|Overall Study|Withdrawal by Subject|0|||
49154476|NCT01047540|158406491|FG002|Overall Study|Withdrawal by Subject|3|||
49154477|NCT01047540|158406492|FG003|Overall Study|Withdrawal by Subject|0|||
49154478|NCT01047540|158406493|FG004|Overall Study|Withdrawal by Subject|1|||
49154479|NCT01047540|158406489|FG000|Overall Study|Pregnancy|1|||
49154480|NCT01047540|158406490|FG001|Overall Study|Pregnancy|0|||
49154481|NCT01047540|158406491|FG002|Overall Study|Pregnancy|0|||
49154482|NCT01047540|158406492|FG003|Overall Study|Pregnancy|0|||
49154483|NCT01047540|158406493|FG004|Overall Study|Pregnancy|0|||
49154484|NCT01047540|158406489|FG000|Overall Study|Adverse Event|1|||
49154485|NCT01047540|158406490|FG001|Overall Study|Adverse Event|0|||
49154486|NCT01047540|158406491|FG002|Overall Study|Adverse Event|0|||
49154487|NCT01047540|158406492|FG003|Overall Study|Adverse Event|0|||
49154488|NCT01047540|158406493|FG004|Overall Study|Adverse Event|0|||
49154489|NCT03787615|158406494|FG000|Overall Study|Withdrawal by Subject|2|||
49154490|NCT03787615|158406494|FG000|Overall Study|Lost to Follow-up|2|||
49154491|NCT01055028|158406496|FG000|Screening|Screen Failure|1|||
49154492|NCT01055028|158406497|FG001|Screening|Screen Failure|1|||
49154493|NCT01055028|158406496|FG000|Treatment Cycles 1 to 3|Adverse Event|0|||
49154494|NCT01055028|158406497|FG001|Treatment Cycles 1 to 3|Adverse Event|1|||
49154495|NCT01055028|158406496|FG000|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
49154496|NCT01055028|158406497|FG001|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
48827088|NCT00124982|157207414|FG001|Long-term Period|Withdrawal by Subject|0|||
49154497|NCT01055028|158406496|FG000|Inter-treatment Period|Did not start Cycle 4|0|||
49154498|NCT01055028|158406497|FG001|Inter-treatment Period|Did not start Cycle 4|3|||
48827089|NCT00124982|157207415|FG002|Long-term Period|Withdrawal by Subject|16|||
48827090|NCT00124982|157207413|FG000|Long-term Period|Pregnancy|0|||
48827091|NCT00124982|157207414|FG001|Long-term Period|Pregnancy|0|||
48827092|NCT00124982|157207415|FG002|Long-term Period|Pregnancy|1|||
48827093|NCT00124982|157207413|FG000|Long-term Period|Poor/Non-compliance|0|||
49154499|NCT03056040|158406500|FG000|Primary Evaluation Period|Withdrawal by Subject|1|||
49154500|NCT03056040|158406501|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
49154501|NCT03056040|158406500|FG000|Primary Evaluation Period|Lack of Efficacy|0|||
49154502|NCT03056040|158406501|FG001|Primary Evaluation Period|Lack of Efficacy|1|||
49154503|NCT03056040|158406500|FG000|Primary Evaluation Period|Pregnancy|0|||
49154504|NCT03056040|158406501|FG001|Primary Evaluation Period|Pregnancy|1|||
49154505|NCT03056040|158406500|FG000|Primary Evaluation Period|Randomized, not treated|1|||
49154506|NCT03056040|158406501|FG001|Primary Evaluation Period|Randomized, not treated|1|||
49154507|NCT03056040|158406500|FG000|Extension Period|Physician Decision|3|||
49154508|NCT03056040|158406501|FG001|Extension Period|Physician Decision|3|||
49154509|NCT03056040|158406500|FG000|Extension Period|Lost to Follow-up|0|||
48827094|NCT00124982|157207414|FG001|Long-term Period|Poor/Non-compliance|0|||
48827095|NCT00124982|157207415|FG002|Long-term Period|Poor/Non-compliance|2|||
48827096|NCT00124982|157207413|FG000|Long-term Period|Administrative Reason by Sponsor|0|||
48827097|NCT00124982|157207414|FG001|Long-term Period|Administrative Reason by Sponsor|0|||
48922050|NCT03434379|157548140|FG000|China Extension Period|Death|0|||
49154510|NCT03056040|158406501|FG001|Extension Period|Lost to Follow-up|1|||
49154511|NCT03056040|158406500|FG000|Extension Period|Death|0|||
49154512|NCT03056040|158406501|FG001|Extension Period|Death|3|||
49154513|NCT03056040|158406500|FG000|Extension Period|Withdrawal by Subject|1|||
49154514|NCT03056040|158406501|FG001|Extension Period|Withdrawal by Subject|0|||
49154515|NCT02836249|158406502|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
49154516|NCT02836249|158406503|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
49154517|NCT02836249|158406504|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
49154518|NCT02836249|158406505|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
49154519|NCT02836249|158406502|FG000|Double-Blind Treatment Phase|Pregnancy|3|||
49154520|NCT02836249|158406503|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
49154521|NCT02836249|158406504|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
49154522|NCT02836249|158406505|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
49154523|NCT02836249|158406502|FG000|Double-Blind Treatment Phase|Withdrew Consent|5|||
49154524|NCT02836249|158406503|FG001|Double-Blind Treatment Phase|Withdrew Consent|2|||
49154525|NCT02836249|158406504|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
49154526|NCT02836249|158406505|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
49154527|NCT02836249|158406502|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
49154528|NCT02836249|158406503|FG001|Double-Blind Treatment Phase|Lost to Follow-up|1|||
49154529|NCT02836249|158406504|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
49154530|NCT02836249|158406505|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
49154531|NCT02836249|158406502|FG000|Double-Blind Treatment Phase|Investigator's discretion|0|||
49154532|NCT02836249|158406503|FG001|Double-Blind Treatment Phase|Investigator's discretion|1|||
49154533|NCT02836249|158406504|FG002|Double-Blind Treatment Phase|Investigator's discretion|0|||
49154534|NCT02836249|158406505|FG003|Double-Blind Treatment Phase|Investigator's discretion|0|||
49154535|NCT02836249|158406502|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
49154536|NCT02836249|158406503|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
49154537|NCT02836249|158406504|FG002|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
49154538|NCT02836249|158406505|FG003|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
49154539|NCT02836249|158406502|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
49154540|NCT02836249|158406503|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
49154541|NCT02836249|158406504|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|6|||
49154542|NCT02836249|158406505|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
49154543|NCT02836249|158406502|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
49154544|NCT02836249|158406503|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
49154545|NCT02836249|158406504|FG002|Open-Label TAF Treatment Phase|Withdrew consent|4|||
49154546|NCT02836249|158406505|FG003|Open-Label TAF Treatment Phase|Withdrew consent|3|||
49154547|NCT02836249|158406502|FG000|Open-Label TAF Treatment Phase|Death|0|||
49154548|NCT02836249|158406503|FG001|Open-Label TAF Treatment Phase|Death|0|||
49154549|NCT02836249|158406504|FG002|Open-Label TAF Treatment Phase|Death|1|||
49154550|NCT02836249|158406505|FG003|Open-Label TAF Treatment Phase|Death|0|||
49154551|NCT02836249|158406502|FG000|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
49154552|NCT02836249|158406503|FG001|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
49154553|NCT02836249|158406504|FG002|Open-Label TAF Treatment Phase|Lack of Efficacy|1|||
49154554|NCT02836249|158406505|FG003|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
49154555|NCT02836249|158406502|FG000|Open-Label TAF Treatment Phase|Pregnancy|0|||
49154556|NCT02836249|158406503|FG001|Open-Label TAF Treatment Phase|Pregnancy|0|||
49154557|NCT02836249|158406504|FG002|Open-Label TAF Treatment Phase|Pregnancy|1|||
49154558|NCT02836249|158406505|FG003|Open-Label TAF Treatment Phase|Pregnancy|0|||
49154559|NCT03559530|158406507|FG000|Overall Study|non-location of medical records|44|||
49154560|NCT03559530|158406508|FG001|Overall Study|non-location of medical records|0|||
49154561|NCT03559530|158406507|FG000|Overall Study|culture results not considered for treat|29|||
49154562|NCT03559530|158406508|FG001|Overall Study|culture results not considered for treat|0|||
49154563|NCT03559530|158406507|FG000|Overall Study|duplicate cases|8|||
49154564|NCT03559530|158406508|FG001|Overall Study|duplicate cases|0|||
49154565|NCT03559530|158406507|FG000|Overall Study|other species of Acinetobacte|7|||
49154566|NCT03559530|158406508|FG001|Overall Study|other species of Acinetobacte|0|||
49154567|NCT03559530|158406507|FG000|Overall Study|contamination / colonization|3|||
49154568|NCT03559530|158406508|FG001|Overall Study|contamination / colonization|0|||
49154569|NCT01554904|158406524|FG000|Overall Study|Withdrawal by Subject|3|||
49154570|NCT01554904|158406524|FG000|Overall Study|Had sleep apnea on Home Study 1|1|||
49154571|NCT00654355|158406525|FG000|Overall Study|Lost to Follow-up|2|||
49154572|NCT00654355|158406526|FG001|Overall Study|Lost to Follow-up|2|||
49154573|NCT01911260|158406527|FG000|Supplementation Period|transference or evasion of school|7|||
49154574|NCT01911260|158406528|FG001|Supplementation Period|transference or evasion of school|9|||
49154575|NCT01911260|158406529|FG002|Supplementation Period|transference or evasion of school|7|||
49154576|NCT01911260|158406530|FG003|Supplementation Period|transference or evasion of school|6|||
49154577|NCT01911260|158406527|FG000|Supplementation Period|Adverse Event|2|||
49154578|NCT01911260|158406528|FG001|Supplementation Period|Adverse Event|0|||
49154579|NCT01911260|158406529|FG002|Supplementation Period|Adverse Event|1|||
49154580|NCT01911260|158406530|FG003|Supplementation Period|Adverse Event|0|||
49154581|NCT01911260|158406527|FG000|Supplementation Period|refused to receive supplement|1|||
49154582|NCT01911260|158406528|FG001|Supplementation Period|refused to receive supplement|0|||
49154583|NCT01911260|158406529|FG002|Supplementation Period|refused to receive supplement|1|||
49154584|NCT01911260|158406530|FG003|Supplementation Period|refused to receive supplement|0|||
49154585|NCT01911260|158406527|FG000|Supplementation Period|less than 12 weeks supplementation|0|||
49154586|NCT01911260|158406528|FG001|Supplementation Period|less than 12 weeks supplementation|3|||
49154587|NCT01911260|158406529|FG002|Supplementation Period|less than 12 weeks supplementation|1|||
49154588|NCT01911260|158406530|FG003|Supplementation Period|less than 12 weeks supplementation|2|||
48827098|NCT00124982|157207415|FG002|Long-term Period|Administrative Reason by Sponsor|1|||
48827099|NCT00124982|157207413|FG000|Long-term Period|Neurologist Recommendation|0|||
48827100|NCT00124982|157207414|FG001|Long-term Period|Neurologist Recommendation|0|||
48827101|NCT00124982|157207415|FG002|Long-term Period|Neurologist Recommendation|1|||
48827102|NCT01773122|157207416|FG000|Overall Study|Due to amended age eligibility criteria|3|||
48827103|NCT01773122|157207417|FG001|Overall Study|Due to amended age eligibility criteria|1|||
48827104|NCT01773122|157207418|FG002|Overall Study|Due to amended age eligibility criteria|0|||
48827105|NCT01773122|157207419|FG003|Overall Study|Due to amended age eligibility criteria|1|||
48827106|NCT00871429|157207420|FG000|Overall Study|Lost to Follow-up|6|||
48827107|NCT00871429|157207420|FG000|Overall Study|Withdrawal by Subject|17|||
48827108|NCT00871429|157207420|FG000|Overall Study|Questionnaire not completed|1|||
48827109|NCT03425539|157207421|FG000|Overall Study|Randomized but not treated|0|||
48827110|NCT03425539|157207422|FG001|Overall Study|Randomized but not treated|1|||
48827111|NCT03425539|157207421|FG000|Overall Study|Adverse Event|2|||
48827112|NCT03425539|157207422|FG001|Overall Study|Adverse Event|2|||
48827113|NCT03425539|157207421|FG000|Overall Study|Withdrawal by Subject|3|||
48827114|NCT03425539|157207422|FG001|Overall Study|Withdrawal by Subject|0|||
48827115|NCT03425539|157207421|FG000|Overall Study|Lost to Follow-up|0|||
48827116|NCT03425539|157207422|FG001|Overall Study|Lost to Follow-up|1|||
48827117|NCT02040844|157207423|FG000|Overall Study|Adverse Event|0|||
48827118|NCT02040844|157207424|FG001|Overall Study|Adverse Event|0|||
48827119|NCT02040844|157207425|FG002|Overall Study|Adverse Event|1|||
48827120|NCT02040844|157207423|FG000|Overall Study|Withdrawal by Subject|16|||
48827121|NCT02040844|157207424|FG001|Overall Study|Withdrawal by Subject|22|||
48827122|NCT02040844|157207425|FG002|Overall Study|Withdrawal by Subject|25|||
48827123|NCT02040844|157207423|FG000|Overall Study|Lost to Follow-up|12|||
48827124|NCT02040844|157207424|FG001|Overall Study|Lost to Follow-up|9|||
48827125|NCT02040844|157207425|FG002|Overall Study|Lost to Follow-up|13|||
48827126|NCT02040844|157207423|FG000|Overall Study|Missing|13|||
48827127|NCT02040844|157207424|FG001|Overall Study|Missing|3|||
48827128|NCT02040844|157207425|FG002|Overall Study|Missing|2|||
48827129|NCT02040844|157207423|FG000|Overall Study|Non-specified|8|||
48827130|NCT02040844|157207424|FG001|Overall Study|Non-specified|2|||
48827131|NCT02040844|157207425|FG002|Overall Study|Non-specified|5|||
48827132|NCT02040844|157207423|FG000|Overall Study|Concomitant medication|1|||
48827133|NCT02040844|157207424|FG001|Overall Study|Concomitant medication|3|||
48827134|NCT02040844|157207425|FG002|Overall Study|Concomitant medication|1|||
48827135|NCT01772719|157207426|FG000|Overall Study|Withdrawal by Subject|3|||
48827136|NCT01772719|157207426|FG000|Overall Study|Adverse Event|2|||
48827137|NCT01772719|157207426|FG000|Overall Study|Protocol Violation|1|||
48827138|NCT01772719|157207426|FG000|Overall Study|Lost to Follow-up|1|||
48827139|NCT04159506|157207427|FG000|Overall Study|Lost to Follow-up|2|||
48827140|NCT04159506|157207428|FG001|Overall Study|Lost to Follow-up|5|||
48827141|NCT02949271|157208846|FG000|Overall Study|Lack of Efficacy|5|||
48827142|NCT02949271|157208847|FG001|Overall Study|Lack of Efficacy|4|||
48827143|NCT02949271|157208846|FG000|Overall Study|Lost to Follow-up|3|||
48827144|NCT02949271|157208847|FG001|Overall Study|Lost to Follow-up|6|||
48827145|NCT02949271|157208846|FG000|Overall Study|Physician Decision|5|||
49154589|NCT01911260|158406527|FG000|Follow-up Period|transference or evasion of school|13|||
49154590|NCT01911260|158406528|FG001|Follow-up Period|transference or evasion of school|20|||
49154591|NCT01911260|158406529|FG002|Follow-up Period|transference or evasion of school|15|||
49154592|NCT01911260|158406530|FG003|Follow-up Period|transference or evasion of school|12|||
49154593|NCT00654732|158406531|FG000|Overall Study|Adverse Event|4|||
48827146|NCT02949271|157208847|FG001|Overall Study|Physician Decision|5|||
48827147|NCT02949271|157208846|FG000|Overall Study|Protocol Violation|6|||
48827148|NCT02949271|157208847|FG001|Overall Study|Protocol Violation|3|||
48827149|NCT02949271|157208846|FG000|Overall Study|Withdrawal by Subject|1|||
48827150|NCT02949271|157208847|FG001|Overall Study|Withdrawal by Subject|0|||
48922051|NCT03434379|157548141|FG001|China Extension Period|Death|0|||
48922052|NCT03434379|157548142|FG002|China Extension Period|Death|46|||
48827151|NCT02949271|157208846|FG000|Overall Study|Delivered prior to intervention|7|||
48827152|NCT02949271|157208847|FG001|Overall Study|Delivered prior to intervention|9|||
48827153|NCT02949271|157208846|FG000|Overall Study|Outside the window for cervical dilation|2|||
48922053|NCT03434379|157548143|FG003|China Extension Period|Death|88|||
49154594|NCT00654732|158406532|FG001|Overall Study|Adverse Event|6|||
49154595|NCT01463033|158406533|FG000|Overall Study|Lost to Follow-up|4|||
49154596|NCT01463033|158406534|FG001|Overall Study|Lost to Follow-up|4|||
49154597|NCT01463033|158406533|FG000|Overall Study|Death|3|||
49154598|NCT01463033|158406534|FG001|Overall Study|Death|2|||
49154599|NCT00982280|158406535|FG000|Observation Period|Not eligible to be dosed|19|||
49154600|NCT00982280|158406535|FG000|Titration and Optimal Dose Period|Adverse Event|5|||
49154601|NCT00982280|158406535|FG000|Titration and Optimal Dose Period|Lack of Efficacy|2|||
49154602|NCT00982280|158406535|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|1|||
49154603|NCT00982280|158406535|FG000|Maintenance Period|Adverse Event|1|||
49154604|NCT01121757|158406536|FG000|First Drug|Death|1|||
49154605|NCT01121757|158406537|FG001|First Drug|Death|0|||
49154606|NCT01121757|158406536|FG000|First Drug|Disease Progression|0|||
49154607|NCT01121757|158406537|FG001|First Drug|Disease Progression|2|||
49154608|NCT01121757|158406536|FG000|Combination|Physician Decision|0|||
49154609|NCT01121757|158406537|FG001|Combination|Physician Decision|1|||
49154610|NCT01121757|158406536|FG000|Combination|Disease Progression|2|||
49154611|NCT01121757|158406537|FG001|Combination|Disease Progression|0|||
49154612|NCT00829244|158406541|FG000|Overall Study|Adverse Event|1|||
49154613|NCT00829244|158406542|FG001|Overall Study|Adverse Event|3|||
49154614|NCT00829244|158406541|FG000|Overall Study|Protocol Violation|1|||
49154615|NCT00829244|158406542|FG001|Overall Study|Protocol Violation|0|||
49154616|NCT00829244|158406541|FG000|Overall Study|Lack of ovarian response to stimulation|9|||
49154617|NCT00829244|158406542|FG001|Overall Study|Lack of ovarian response to stimulation|5|||
48734851|NCT03911713|156880762|FG002|Overall Study|Other|0|||
48734852|NCT03911713|156880763|FG003|Overall Study|Other|1|||
48734853|NCT03911713|156880764|FG004|Overall Study|Other|0|||
48734854|NCT03911713|156880760|FG000|Overall Study|Randomized, Never Dosed|1|||
48734855|NCT03911713|156880761|FG001|Overall Study|Randomized, Never Dosed|0|||
48734856|NCT03911713|156880762|FG002|Overall Study|Randomized, Never Dosed|0|||
48734857|NCT03911713|156880763|FG003|Overall Study|Randomized, Never Dosed|1|||
48734858|NCT03911713|156880764|FG004|Overall Study|Randomized, Never Dosed|0|||
48734859|NCT04447417|156880765|FG000|Overall Study|Withdrawal by Subject|1|||
48734860|NCT04447417|156880766|FG001|Overall Study|Withdrawal by Subject|0|||
48734861|NCT04447417|156880765|FG000|Overall Study|Failure to meet inclusion criteria|1|||
48734862|NCT04447417|156880766|FG001|Overall Study|Failure to meet inclusion criteria|0|||
48734863|NCT04447417|156880765|FG000|Overall Study|Lost to Follow-up|1|||
48734864|NCT04447417|156880766|FG001|Overall Study|Lost to Follow-up|0|||
48734865|NCT02423109|156880768|FG000|Lens 1|Adverse Event|1|||
48734866|NCT02423109|156880769|FG001|Lens 1|Adverse Event|0|||
48734867|NCT02203071|156880770|FG000|Overall Study|Lost to Follow-up|3|||
48734868|NCT02203071|156880771|FG001|Overall Study|Lost to Follow-up|1|||
48734869|NCT02186873|156880772|FG000|Overall Study|Adverse Event|1|||
48827154|NCT02949271|157208847|FG001|Overall Study|Outside the window for cervical dilation|3|||
49154618|NCT00829244|158406541|FG000|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1|||
49154619|NCT00829244|158406542|FG001|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6|||
49154620|NCT00829244|158406541|FG000|Overall Study|No fertilization|2|||
49154621|NCT00829244|158406542|FG001|Overall Study|No fertilization|2|||
49154622|NCT00829244|158406541|FG000|Overall Study|All embryos discarded|0|||
49154623|NCT00829244|158406542|FG001|Overall Study|All embryos discarded|3|||
49154624|NCT00829244|158406541|FG000|Overall Study|No embryo cleavage|0|||
49154625|NCT00829244|158406542|FG001|Overall Study|No embryo cleavage|2|||
49154626|NCT01197378|158406547|FG000|Overall Study|Adverse Event|3|||
49154627|NCT01197378|158406547|FG000|Overall Study|Withdrawal by Subject|1|||
49154628|NCT01197378|158406547|FG000|Overall Study|Physician Decision|1|||
49154629|NCT01197378|158406547|FG000|Overall Study|Other|2|||
49154630|NCT03370276|158406549|FG000|Overall Study|Death|0|||
49154631|NCT03370276|158406550|FG001|Overall Study|Death|2|||
49154632|NCT03370276|158406551|FG002|Overall Study|Death|5|||
49154633|NCT01928394|158406554|FG000|Treatment Period|Disease progression|17|||
49154634|NCT01928394|158406555|FG001|Treatment Period|Disease progression|2|||
48734870|NCT02186873|156880773|FG001|Overall Study|Adverse Event|3|||
48734871|NCT02186873|156880772|FG000|Overall Study|Lack of Efficacy|0|||
48734872|NCT02186873|156880773|FG001|Overall Study|Lack of Efficacy|1|||
48734873|NCT02186873|156880772|FG000|Overall Study|Lost to Follow-up|1|||
48734874|NCT02186873|156880773|FG001|Overall Study|Lost to Follow-up|2|||
49154635|NCT01928394|158406556|FG002|Treatment Period|Disease progression|12|||
49154636|NCT01928394|158406557|FG003|Treatment Period|Disease progression|48|||
49154637|NCT01928394|158406558|FG004|Treatment Period|Disease progression|3|||
49154638|NCT01928394|158406559|FG005|Treatment Period|Disease progression|25|||
49154639|NCT01928394|158406560|FG006|Treatment Period|Disease progression|38|||
49154640|NCT01928394|158406561|FG007|Treatment Period|Disease progression|16|||
49154641|NCT01928394|158406562|FG008|Treatment Period|Disease progression|3|||
49154642|NCT01928394|158406563|FG009|Treatment Period|Disease progression|11|||
49154643|NCT01928394|158406564|FG010|Treatment Period|Disease progression|22|||
49154644|NCT01928394|158406565|FG011|Treatment Period|Disease progression|73|||
49154645|NCT01928394|158406566|FG012|Treatment Period|Disease progression|38|||
49154646|NCT01928394|158406567|FG013|Treatment Period|Disease progression|118|||
49154647|NCT01928394|158406568|FG014|Treatment Period|Disease progression|59|||
49154648|NCT01928394|158406569|FG015|Treatment Period|Disease progression|1|||
48734875|NCT02186873|156880772|FG000|Overall Study|Withdrawal by Subject|7|||
48734876|NCT02186873|156880773|FG001|Overall Study|Withdrawal by Subject|2|||
48734877|NCT01973569|156880777|FG000|Overall Study|Adverse Event|9|||
48734878|NCT01973569|156880778|FG001|Overall Study|Adverse Event|2|||
48734879|NCT01973569|156880779|FG002|Overall Study|Adverse Event|4|||
48734880|NCT01973569|156880777|FG000|Overall Study|Protocol Violation|2|||
48734881|NCT01973569|156880778|FG001|Overall Study|Protocol Violation|1|||
48734882|NCT01973569|156880779|FG002|Overall Study|Protocol Violation|3|||
48734883|NCT01973569|156880777|FG000|Overall Study|Withdrawal by Subject|7|||
48734884|NCT01973569|156880778|FG001|Overall Study|Withdrawal by Subject|5|||
48734885|NCT01973569|156880779|FG002|Overall Study|Withdrawal by Subject|2|||
48734886|NCT01973569|156880777|FG000|Overall Study|Invasive dental treatment|3|||
48734887|NCT01973569|156880778|FG001|Overall Study|Invasive dental treatment|5|||
48734888|NCT01973569|156880779|FG002|Overall Study|Invasive dental treatment|6|||
48734889|NCT01973569|156880777|FG000|Overall Study|Prohibited concomitant d|1|||
48734890|NCT01973569|156880778|FG001|Overall Study|Prohibited concomitant d|5|||
48734891|NCT01973569|156880779|FG002|Overall Study|Prohibited concomitant d|0|||
48734892|NCT01973569|156880777|FG000|Overall Study|Disease progression|0|||
48734893|NCT01973569|156880778|FG001|Overall Study|Disease progression|3|||
48734894|NCT01973569|156880779|FG002|Overall Study|Disease progression|0|||
48734895|NCT01973569|156880777|FG000|Overall Study|Other|1|||
48734896|NCT01973569|156880778|FG001|Overall Study|Other|1|||
48734897|NCT01973569|156880779|FG002|Overall Study|Other|0|||
48734898|NCT01973569|156880777|FG000|Overall Study|Did not receive study drug|6|||
48734899|NCT01973569|156880778|FG001|Overall Study|Did not receive study drug|3|||
48734900|NCT01973569|156880779|FG002|Overall Study|Did not receive study drug|3|||
48734901|NCT00137631|156880783|FG000|Overall Study|Lost to Follow-up|37|||
48734902|NCT00137631|156880784|FG001|Overall Study|Lost to Follow-up|41|||
48734903|NCT04087213|156880789|FG000|In-Facility Introduction|Withdrawal by Subject|1|||
48734904|NCT04087213|156880789|FG000|In-Facility Introduction|Adverse Event|1|||
48734905|NCT04087213|156880789|FG000|Assisted Evaluable Period|Withdrawal by Subject|2|||
48734906|NCT04087213|156880789|FG000|Assisted Evaluable Period|Personal reasons|3|||
48827155|NCT01460381|157208848|FG000|Period 2 (Days 8-15)|Lost to Follow-up|1|||
48827156|NCT01460381|157208849|FG001|Period 2 (Days 8-15)|Lost to Follow-up|0|||
48827157|NCT01097655|157208850|FG000|Overall Study|Withdrawal by Subject|1|||
48827158|NCT01097655|157208850|FG000|Overall Study|Subject Documented Twice|1|||
48827159|NCT01097655|157208850|FG000|Overall Study|Did Not Meet Inclusion Criteria|8|||
49154649|NCT01928394|158406570|FG016|Treatment Period|Disease progression|43|||
48734907|NCT04087213|156880789|FG000|Transition Period B|Renal Transplantation|1|||
48734908|NCT02024529|156880790|FG000|Overall Study|Withdrawal by Subject|11|||
48734909|NCT02024529|156880791|FG001|Overall Study|Withdrawal by Subject|21|||
48827160|NCT01345292|157208851|FG000|Overall Study|Withdrawal by Subject|2|||
48827161|NCT01345292|157208852|FG001|Overall Study|Withdrawal by Subject|0|||
49154650|NCT01928394|158406571|FG017|Treatment Period|Disease progression|56|||
49154651|NCT01928394|158406572|FG018|Treatment Period|Disease progression|50|||
49154652|NCT01928394|158406573|FG019|Treatment Period|Disease progression|71|||
49154653|NCT01928394|158406574|FG020|Treatment Period|Disease progression|30|||
49154654|NCT01928394|158406575|FG021|Treatment Period|Disease progression|31|||
49154655|NCT01928394|158406576|FG022|Treatment Period|Disease progression|31|||
49154656|NCT01928394|158406554|FG000|Treatment Period|Study drug toxicity|1|||
49154657|NCT01928394|158406555|FG001|Treatment Period|Study drug toxicity|1|||
49154658|NCT01928394|158406556|FG002|Treatment Period|Study drug toxicity|3|||
49154659|NCT01928394|158406557|FG003|Treatment Period|Study drug toxicity|3|||
49154660|NCT01928394|158406558|FG004|Treatment Period|Study drug toxicity|0|||
49154661|NCT01928394|158406559|FG005|Treatment Period|Study drug toxicity|9|||
49154662|NCT01928394|158406560|FG006|Treatment Period|Study drug toxicity|7|||
49154663|NCT01928394|158406561|FG007|Treatment Period|Study drug toxicity|1|||
49154664|NCT01928394|158406562|FG008|Treatment Period|Study drug toxicity|0|||
49154665|NCT01928394|158406563|FG009|Treatment Period|Study drug toxicity|5|||
49154666|NCT01928394|158406564|FG010|Treatment Period|Study drug toxicity|2|||
49154667|NCT01928394|158406565|FG011|Treatment Period|Study drug toxicity|3|||
49154668|NCT01928394|158406566|FG012|Treatment Period|Study drug toxicity|7|||
49154669|NCT01928394|158406567|FG013|Treatment Period|Study drug toxicity|5|||
49154670|NCT01928394|158406568|FG014|Treatment Period|Study drug toxicity|12|||
49154671|NCT01928394|158406569|FG015|Treatment Period|Study drug toxicity|0|||
49154672|NCT01928394|158406570|FG016|Treatment Period|Study drug toxicity|3|||
49154673|NCT01928394|158406571|FG017|Treatment Period|Study drug toxicity|3|||
49154674|NCT01928394|158406572|FG018|Treatment Period|Study drug toxicity|12|||
49154675|NCT01928394|158406573|FG019|Treatment Period|Study drug toxicity|15|||
49154676|NCT01928394|158406574|FG020|Treatment Period|Study drug toxicity|4|||
49154677|NCT01928394|158406575|FG021|Treatment Period|Study drug toxicity|7|||
49154678|NCT01928394|158406576|FG022|Treatment Period|Study drug toxicity|4|||
49154679|NCT01928394|158406554|FG000|Treatment Period|AE unrelated to study drug|0|||
49154680|NCT01928394|158406555|FG001|Treatment Period|AE unrelated to study drug|0|||
48734910|NCT02024529|156880790|FG000|Overall Study|Lost to Follow-up|2|||
49154681|NCT01928394|158406556|FG002|Treatment Period|AE unrelated to study drug|2|||
48734911|NCT02024529|156880791|FG001|Overall Study|Lost to Follow-up|4|||
48734912|NCT01788046|156880793|FG000|Overall Study|Withdrawal by Subject|12|||
48734913|NCT01788046|156880794|FG001|Overall Study|Withdrawal by Subject|12|||
48734914|NCT01788046|156880793|FG000|Overall Study|Lost to Follow-up|12|||
48734915|NCT01788046|156880794|FG001|Overall Study|Lost to Follow-up|19|||
48734916|NCT01788046|156880793|FG000|Overall Study|Death|7|||
48734917|NCT01788046|156880794|FG001|Overall Study|Death|5|||
48734918|NCT01788046|156880793|FG000|Overall Study|Protocol Specified Criteria|25|||
48734919|NCT01788046|156880794|FG001|Overall Study|Protocol Specified Criteria|1|||
48734920|NCT02124161|156880795|FG000|Overall Study|Other unspecified|0|||
48734921|NCT02124161|156880796|FG001|Overall Study|Other unspecified|1|||
48734922|NCT02124161|156880795|FG000|Overall Study|Death|1|||
48734923|NCT02124161|156880796|FG001|Overall Study|Death|0|||
48734924|NCT02124161|156880795|FG000|Overall Study|Protocol Violation|2|||
48734925|NCT02124161|156880796|FG001|Overall Study|Protocol Violation|1|||
48734926|NCT02124161|156880795|FG000|Overall Study|Withdrawal by Subject|1|||
48734927|NCT02124161|156880796|FG001|Overall Study|Withdrawal by Subject|2|||
48734928|NCT02124161|156880795|FG000|Overall Study|Adverse Event|2|||
48734929|NCT02124161|156880796|FG001|Overall Study|Adverse Event|0|||
48734930|NCT02124161|156880795|FG000|Overall Study|Does not meet entrance criteria|2|||
48734931|NCT02124161|156880796|FG001|Overall Study|Does not meet entrance criteria|3|||
48734932|NCT02124161|156880795|FG000|Overall Study|No longer meets eligibility criteria|5|||
48734933|NCT02124161|156880796|FG001|Overall Study|No longer meets eligibility criteria|4|||
48734934|NCT02124161|156880795|FG000|Overall Study|Lost to Follow-up|3|||
48734935|NCT02124161|156880796|FG001|Overall Study|Lost to Follow-up|4|||
48734936|NCT01332331|156880802|FG000|Overall Study|Lost to Follow-up|0|||
48734937|NCT01332331|156880803|FG001|Overall Study|Lost to Follow-up|1|||
48734938|NCT01332331|156880802|FG000|Overall Study|Adverse Event|1|||
48734939|NCT01332331|156880803|FG001|Overall Study|Adverse Event|1|||
48734940|NCT01332331|156880802|FG000|Overall Study|Physician Decision|1|||
48734941|NCT01332331|156880803|FG001|Overall Study|Physician Decision|0|||
48734942|NCT03605212|156880804|FG000|Treatment Period|Adverse Event|1|||
48734943|NCT03605212|156880805|FG001|Treatment Period|Adverse Event|0|||
48734944|NCT03605212|156880806|FG002|Treatment Period|Adverse Event|0|||
48734945|NCT03605212|156880807|FG003|Treatment Period|Adverse Event|0|||
48734946|NCT03605212|156880808|FG004|Treatment Period|Adverse Event|0|||
48734947|NCT03605212|156880804|FG000|Treatment Period|Physician Decision|0|||
48734948|NCT03605212|156880805|FG001|Treatment Period|Physician Decision|0|||
48734949|NCT03605212|156880806|FG002|Treatment Period|Physician Decision|0|||
48734950|NCT03605212|156880807|FG003|Treatment Period|Physician Decision|0|||
48734951|NCT03605212|156880808|FG004|Treatment Period|Physician Decision|1|||
48734952|NCT02019277|156880809|FG000|Overall Study|Withdrawal by Subject|3|||
48734953|NCT02019277|156880809|FG000|Overall Study|Death|7|||
48734954|NCT02019277|156880809|FG000|Overall Study|Did no Cooperate|1|||
48734955|NCT02019277|156880809|FG000|Overall Study|Adverse Event|1|||
48734956|NCT00071396|156880812|FG000|Overall Study|Withdrawal by Subject|1|||
48734957|NCT00071396|156880812|FG000|Overall Study|Physician Decision|2|||
48734958|NCT00839852|156880813|FG000|Overall Study|Adverse Event|10|||
48734959|NCT00839852|156880813|FG000|Overall Study|Insufficient Therapeutic Response|3|||
48734960|NCT00839852|156880813|FG000|Overall Study|Protocol Violation|9|||
48734961|NCT00839852|156880813|FG000|Overall Study|Withdrawal of Consent|16|||
48734962|NCT00839852|156880813|FG000|Overall Study|Lost to Follow-up|7|||
48734963|NCT00839852|156880813|FG000|Overall Study|Lack of Compliance While in Jail|1|||
48734964|NCT00839852|156880813|FG000|Overall Study|Pregnancy|1|||
48734965|NCT02149875|156880814|FG000|Overall Study|Lost to Follow-up|3|||
48734966|NCT02149875|156880815|FG001|Overall Study|Lost to Follow-up|4|||
48734967|NCT02149875|156880816|FG002|Overall Study|Lost to Follow-up|5|||
48734968|NCT02149875|156880814|FG000|Overall Study|Withdrawal by Subject|3|||
48734969|NCT02149875|156880815|FG001|Overall Study|Withdrawal by Subject|2|||
48922054|NCT03434379|157548140|FG000|China Extension Period|Withdrawal by Subject|0|||
48922055|NCT03434379|157548141|FG001|China Extension Period|Withdrawal by Subject|0|||
48734970|NCT02149875|156880816|FG002|Overall Study|Withdrawal by Subject|2|||
48734971|NCT02149875|156880814|FG000|Overall Study|Physician Decision|1|||
48734972|NCT02149875|156880815|FG001|Overall Study|Physician Decision|2|||
48734973|NCT02149875|156880816|FG002|Overall Study|Physician Decision|2|||
48734974|NCT00702689|156880829|FG000|Overall Study|Withdrawal by Subject|4|||
48734975|NCT00702689|156880829|FG000|Overall Study|Recurrent malignancy|1|||
48922056|NCT03434379|157548142|FG002|China Extension Period|Withdrawal by Subject|8|||
48734976|NCT00702689|156880829|FG000|Overall Study|Adverse Event|1|||
48922057|NCT03434379|157548143|FG003|China Extension Period|Withdrawal by Subject|6|||
48734977|NCT01262573|156880830|FG000|Overall Study|Withdrawal by Subject|0|||
48734978|NCT01262573|156880831|FG001|Overall Study|Withdrawal by Subject|1|||
48734979|NCT04043728|156880840|FG000|Overall Study|Lost to Follow-up|1|||
48734980|NCT04043728|156880841|FG001|Overall Study|Lost to Follow-up|2|||
48734981|NCT04043728|156880842|FG002|Overall Study|Lost to Follow-up|0|||
48734982|NCT00331422|156880845|FG000|Overall Study|Did not receive entire study regimen|5|||
48734983|NCT03643159|156880852|FG000|Overall Study|Adverse Event|1|||
48734984|NCT03643159|156880852|FG000|Overall Study|Withdrawal by Subject|1|||
48734985|NCT02081183|156880855|FG000|Overall Study|Lost to Follow-up|0|||
48734986|NCT02081183|156880856|FG001|Overall Study|Lost to Follow-up|1|||
48734987|NCT02081183|156880855|FG000|Overall Study|Protocol Violation|1|||
48734988|NCT02081183|156880856|FG001|Overall Study|Protocol Violation|0|||
48734989|NCT02081183|156880855|FG000|Overall Study|Other|3|||
48734990|NCT02081183|156880856|FG001|Overall Study|Other|3|||
48734991|NCT03386474|156880857|FG000|Overall Study|Death|1|||
48734992|NCT03386474|156880858|FG001|Overall Study|Death|0|||
48734993|NCT03386474|156880857|FG000|Overall Study|Adverse Event|0|||
48734994|NCT03386474|156880858|FG001|Overall Study|Adverse Event|1|||
48734995|NCT00788073|156880863|FG000|STX209 Then Placebo|Adverse Event|1|||
48734996|NCT00788073|156880864|FG001|STX209 Then Placebo|Adverse Event|0|||
48734997|NCT00788073|156880863|FG000|STX209 Then Placebo|Lost to Follow-up|0|||
48734998|NCT00788073|156880864|FG001|STX209 Then Placebo|Lost to Follow-up|1|||
48734999|NCT00788073|156880863|FG000|STX209 Then Placebo|Withdrawal by Subject|0|||
48735000|NCT00788073|156880864|FG001|STX209 Then Placebo|Withdrawal by Subject|1|||
48735001|NCT00788073|156880863|FG000|STX209 Then Placebo|unable to return due to travel|0|||
48735002|NCT00788073|156880864|FG001|STX209 Then Placebo|unable to return due to travel|1|||
48735003|NCT00788073|156880863|FG000|Placebo Then STX209|Adverse Event|2|||
48735004|NCT00788073|156880864|FG001|Placebo Then STX209|Adverse Event|0|||
48735005|NCT00788073|156880863|FG000|Placebo Then STX209|Protocol Violation|0|||
48735006|NCT00788073|156880864|FG001|Placebo Then STX209|Protocol Violation|1|||
48735007|NCT02282358|156880866|FG000|Overall Study|Nonevaluable|1|||
48735008|NCT02155881|156880867|FG000|Overall Study|Withdrawal by Subject|0|||
48735009|NCT02155881|156880868|FG001|Overall Study|Withdrawal by Subject|2|||
48735010|NCT02155881|156880867|FG000|Overall Study|Inappropriately randomized|2|||
49154682|NCT01928394|158406557|FG003|Treatment Period|AE unrelated to study drug|3|||
48735011|NCT02155881|156880868|FG001|Overall Study|Inappropriately randomized|2|||
48735012|NCT04357782|156880869|FG000|Overall Study|Discharged from hospital|1|||
48735013|NCT04357782|156880870|FG001|Overall Study|Discharged from hospital|0|||
48735014|NCT04357782|156880869|FG000|Overall Study|Death|0|||
48735015|NCT04357782|156880870|FG001|Overall Study|Death|2|||
48735016|NCT00579098|156880873|FG000|Overall Study|Lost to Follow-up|2|||
48735017|NCT00579098|156880874|FG001|Overall Study|Lost to Follow-up|0|||
48735018|NCT00579098|156880873|FG000|Overall Study|Adverse Event|2|||
48735019|NCT00579098|156880874|FG001|Overall Study|Adverse Event|3|||
48735020|NCT00579098|156880873|FG000|Overall Study|Withdrawal by Subject|2|||
48735021|NCT00579098|156880874|FG001|Overall Study|Withdrawal by Subject|3|||
48735022|NCT00579098|156880873|FG000|Overall Study|AF returned after ablation|3|||
48735023|NCT00579098|156880874|FG001|Overall Study|AF returned after ablation|2|||
48735024|NCT02436681|156880875|FG000|Overall Study|Lost to Follow-up|10|||
48735025|NCT02436681|156880875|FG000|Overall Study|Withdrawal by Subject|2|||
48735026|NCT02436681|156880875|FG000|Overall Study|Death|2|||
48735027|NCT00406718|156880878|FG000|Overall Study|Withdrawal by Subject|2|||
48735028|NCT00406718|156880879|FG001|Overall Study|Withdrawal by Subject|9|||
48735029|NCT00406718|156880880|FG002|Overall Study|Withdrawal by Subject|4|||
48735030|NCT00406718|156880878|FG000|Overall Study|Lost to Follow-up|2|||
48735031|NCT00406718|156880879|FG001|Overall Study|Lost to Follow-up|5|||
48735032|NCT00406718|156880880|FG002|Overall Study|Lost to Follow-up|4|||
48735033|NCT00287365|156880881|FG000|Overall Study|sample not acquired|13|||
48735034|NCT00447005|156880883|FG000|Overall Study|Adverse Event|1|||
48735035|NCT00447005|156880883|FG000|Overall Study|Lack of Efficacy|11|||
48735036|NCT02628938|156880884|FG000|Overall Study|Did not attend the follow up recall|2|||
49154683|NCT01928394|158406558|FG004|Treatment Period|AE unrelated to study drug|0|||
48735037|NCT02628938|156880885|FG001|Overall Study|Did not attend the follow up recall|2|||
48735038|NCT02628938|156880886|FG002|Overall Study|Did not attend the follow up recall|1|||
48735039|NCT02628938|156880884|FG000|Overall Study|Failure to comply with the instructions|3|||
48735040|NCT02628938|156880885|FG001|Overall Study|Failure to comply with the instructions|0|||
48735041|NCT02628938|156880886|FG002|Overall Study|Failure to comply with the instructions|3|||
48735042|NCT00165984|156880887|FG000|Overall Study|Death|15|||
48735043|NCT00398411|156882169|FG000|Overall Study|Death|0|||
48735044|NCT00398411|156882170|FG001|Overall Study|Death|1|||
48735045|NCT01614600|156882171|FG000|Overall Study|Unacceptable fit|1|||
48735046|NCT01614600|156882171|FG000|Overall Study|Discomfort|1|||
48735047|NCT01614600|156882171|FG000|Overall Study|Unable to remove lens at the end of day|1|||
48735048|NCT01614600|156882171|FG000|Overall Study|Protocol deviation|1|||
48735049|NCT01858376|156882172|FG000|Overall Study|Dropped d/t lab work not fitting criter|4|||
48735050|NCT01680965|156882173|FG000|Overall Study|Death|0|||
48735051|NCT01680965|156882174|FG001|Overall Study|Death|0|||
49154684|NCT01928394|158406559|FG005|Treatment Period|AE unrelated to study drug|5|||
48735052|NCT01680965|156882175|FG002|Overall Study|Death|0|||
48735053|NCT01680965|156882176|FG003|Overall Study|Death|6|||
48735054|NCT00195273|156882177|FG000|Overall Study|Adverse Event|9|||
48735055|NCT00195273|156882178|FG001|Overall Study|Adverse Event|9|||
48735056|NCT00195273|156882177|FG000|Overall Study|Protocol deviation|0|||
48735057|NCT00195273|156882178|FG001|Overall Study|Protocol deviation|1|||
48735058|NCT00195273|156882177|FG000|Overall Study|Lack of Efficacy|3|||
48735059|NCT00195273|156882178|FG001|Overall Study|Lack of Efficacy|1|||
48735060|NCT00195273|156882177|FG000|Overall Study|Procedural complications|9|||
48735061|NCT00195273|156882178|FG001|Overall Study|Procedural complications|3|||
48735062|NCT04587271|156882179|FG000|Overall Study|Lost to Follow-up|2|||
48735063|NCT04587271|156882180|FG001|Overall Study|Lost to Follow-up|2|||
48735064|NCT04587271|156882181|FG002|Overall Study|Lost to Follow-up|0|||
48735065|NCT04587271|156882182|FG003|Overall Study|Lost to Follow-up|2|||
48735066|NCT04587271|156882183|FG004|Overall Study|Lost to Follow-up|2|||
48735067|NCT04587271|156882184|FG005|Overall Study|Lost to Follow-up|0|||
48735068|NCT04587271|156882179|FG000|Overall Study|Caregiver brought child to visits|0|||
48735069|NCT04587271|156882180|FG001|Overall Study|Caregiver brought child to visits|0|||
48735070|NCT04587271|156882181|FG002|Overall Study|Caregiver brought child to visits|0|||
48735071|NCT04587271|156882182|FG003|Overall Study|Caregiver brought child to visits|1|||
48735072|NCT04587271|156882183|FG004|Overall Study|Caregiver brought child to visits|0|||
48735073|NCT04587271|156882184|FG005|Overall Study|Caregiver brought child to visits|0|||
48735074|NCT04622306|156882185|FG000|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
48735075|NCT04622306|156882186|FG001|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
48735076|NCT04622306|156882187|FG002|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
48735077|NCT04622306|156882188|FG003|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
48735078|NCT04622306|156882189|FG004|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
48735079|NCT04622306|156882190|FG005|Couples Used First Assigned Condom Set|Withdrawal by Subject|5|||
48735080|NCT04622306|156882185|FG000|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
48735081|NCT04622306|156882186|FG001|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
48735082|NCT04622306|156882187|FG002|Couples Used Third Assigned Condom Set|Withdrawal by Subject|2|||
48735083|NCT04622306|156882188|FG003|Couples Used Third Assigned Condom Set|Withdrawal by Subject|3|||
48735084|NCT04622306|156882189|FG004|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
48735085|NCT04622306|156882190|FG005|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
48735086|NCT00354614|156882191|FG000|Overall Study|Lack of Efficacy|28|||
48735087|NCT01601132|156882194|FG000|Overall Study|Patient withdrew consent|1|||
48735088|NCT01601132|156882194|FG000|Overall Study|Protocol deviation|1|||
48735089|NCT02601027|156882199|FG000|Registration to Surgery|Withdrawal by Subject|20|||
48735090|NCT02601027|156882200|FG001|Registration to Surgery|Withdrawal by Subject|10|||
48735091|NCT00737438|156882206|FG000|Overall Study|Withdrawal by Subject|2|||
48735092|NCT00737438|156882206|FG000|Overall Study|Patient ineligible|1|||
48735093|NCT03626168|156882207|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
48735094|NCT03626168|156882208|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
48827162|NCT01345292|157208853|FG002|Overall Study|Withdrawal by Subject|1|||
48827163|NCT05458102|157208854|FG000|Overall Study|Withdrew consent|2|||
48827164|NCT05458102|157208855|FG001|Overall Study|Withdrew consent|0|||
48827165|NCT05458102|157208854|FG000|Overall Study|Adverse Event|1|||
48827166|NCT05458102|157208855|FG001|Overall Study|Adverse Event|0|||
48827167|NCT05458102|157208854|FG000|Overall Study|Enrolled but never treated|1|||
48827168|NCT05458102|157208855|FG001|Overall Study|Enrolled but never treated|0|||
48827169|NCT05458102|157208854|FG000|Overall Study|Protocol Violation|1|||
48827170|NCT05458102|157208855|FG001|Overall Study|Protocol Violation|0|||
48827171|NCT04454567|157208862|FG000|Overall Study|Study Terminated by Sponsor|1|||
48827172|NCT04454567|157208863|FG001|Overall Study|Study Terminated by Sponsor|1|||
48827173|NCT01516892|157208865|FG000|Overall Study|Adverse Event|25|||
48827174|NCT01516892|157208865|FG000|Overall Study|Lack of Efficacy|35|||
48827175|NCT01516892|157208865|FG000|Overall Study|Pregnancy|5|||
48827176|NCT01516892|157208865|FG000|Overall Study|Lost to Follow-up|82|||
48827177|NCT01516892|157208865|FG000|Overall Study|Subject Withdrew Consent|92|||
48827178|NCT01516892|157208865|FG000|Overall Study|Protocol Violation|60|||
49154685|NCT01928394|158406560|FG006|Treatment Period|AE unrelated to study drug|1|||
49154686|NCT01928394|158406561|FG007|Treatment Period|AE unrelated to study drug|0|||
49154687|NCT01928394|158406562|FG008|Treatment Period|AE unrelated to study drug|0|||
49154688|NCT01928394|158406563|FG009|Treatment Period|AE unrelated to study drug|2|||
49154689|NCT01928394|158406564|FG010|Treatment Period|AE unrelated to study drug|0|||
49154690|NCT01928394|158406565|FG011|Treatment Period|AE unrelated to study drug|12|||
48735095|NCT03626168|156882207|FG000|First Intervention (4 Weeks)|Began a medication that precluded participation|0|||
48735096|NCT03626168|156882208|FG001|First Intervention (4 Weeks)|Began a medication that precluded participation|1|||
48735097|NCT03626168|156882207|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
48735098|NCT03626168|156882208|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
48735099|NCT04289623|156882209|FG000|Wave 1 Emails|Email was not delivered|268|||
48735100|NCT04289623|156882210|FG001|Wave 1 Emails|Email was not delivered|257|||
48735101|NCT04289623|156882211|FG002|Wave 1 Emails|Email was not delivered|0|||
48735102|NCT04289623|156882212|FG003|Wave 1 Emails|Email was not delivered|0|||
48735103|NCT04289623|156882213|FG004|Wave 1 Emails|Email was not delivered|0|||
48735104|NCT04289623|156882214|FG005|Wave 1 Emails|Email was not delivered|0|||
48735105|NCT03758443|156882215|FG000|Induction Period|Adverse Event|2|||
48735106|NCT03758443|156882216|FG001|Induction Period|Adverse Event|4|||
48922058|NCT03434379|157548140|FG000|China Extension Period|Study Ended by Sponsor|0|||
48922059|NCT03434379|157548141|FG001|China Extension Period|Study Ended by Sponsor|0|||
48922060|NCT03434379|157548142|FG002|China Extension Period|Study Ended by Sponsor|5|||
48922061|NCT03434379|157548143|FG003|China Extension Period|Study Ended by Sponsor|36|||
48922062|NCT03064841|157548144|FG000|Overall Study|Inclusion/exclusion criteria violation|4|||
48922063|NCT03064841|157548144|FG000|Overall Study|No glycated haemoglobinA1c measurement|11|||
48922064|NCT03064841|157548144|FG000|Overall Study|Screen failure|2|||
48922065|NCT03864653|157548147|FG000|Overall Study|Withdrawal by Subject|1|||
48922066|NCT03355300|157548148|FG000|Overall Study|Physician Decision|0|||
48922067|NCT03355300|157548149|FG001|Overall Study|Physician Decision|1|||
48922068|NCT03355300|157548148|FG000|Overall Study|Lack of Efficacy|2|||
48922069|NCT03355300|157548149|FG001|Overall Study|Lack of Efficacy|1|||
48922070|NCT03355300|157548148|FG000|Overall Study|Other reason|1|||
48922071|NCT03355300|157548149|FG001|Overall Study|Other reason|0|||
48922072|NCT03048422|157548150|FG000|Overall Study|Death|1|||
48922073|NCT03048422|157548151|FG001|Overall Study|Death|0|||
48922074|NCT03048422|157548152|FG002|Overall Study|Death|0|||
48922075|NCT03048422|157548150|FG000|Overall Study|Lost to Follow-up|5|||
48922076|NCT03048422|157548151|FG001|Overall Study|Lost to Follow-up|0|||
48922077|NCT03048422|157548152|FG002|Overall Study|Lost to Follow-up|1|||
48922078|NCT03048422|157548150|FG000|Overall Study|Withdrawal by Subject|5|||
48922079|NCT03048422|157548151|FG001|Overall Study|Withdrawal by Subject|7|||
48922080|NCT03048422|157548152|FG002|Overall Study|Withdrawal by Subject|4|||
48922081|NCT03048422|157548150|FG000|Overall Study|Moved|3|||
48922082|NCT03048422|157548151|FG001|Overall Study|Moved|2|||
48922083|NCT03048422|157548152|FG002|Overall Study|Moved|2|||
48922084|NCT03048422|157548150|FG000|Overall Study|Noncompliant with Study Requirements|2|||
48922085|NCT03048422|157548151|FG001|Overall Study|Noncompliant with Study Requirements|1|||
48922086|NCT03048422|157548152|FG002|Overall Study|Noncompliant with Study Requirements|2|||
48922087|NCT03048422|157548150|FG000|Overall Study|Not Able to Get to Clinic|1|||
48922088|NCT03048422|157548151|FG001|Overall Study|Not Able to Get to Clinic|0|||
48922089|NCT03048422|157548152|FG002|Overall Study|Not Able to Get to Clinic|0|||
48922090|NCT01984268|157548153|FG000|Overall Study|Study Terminated|15|||
48922091|NCT01634555|157548157|FG000|Overall Study|Adverse Event|3|||
48922092|NCT01634555|157548157|FG000|Overall Study|Physician Decision|1|||
48922093|NCT01411085|157548158|FG000|Overall Study|Physician Decision|1|||
49154691|NCT01928394|158406566|FG012|Treatment Period|AE unrelated to study drug|6|||
49154692|NCT01928394|158406567|FG013|Treatment Period|AE unrelated to study drug|13|||
48735107|NCT03758443|156882217|FG002|Induction Period|Adverse Event|2|||
48735108|NCT03758443|156882218|FG003|Induction Period|Adverse Event|3|||
48735109|NCT03758443|156882215|FG000|Induction Period|Physician Decision|1|||
48735110|NCT03758443|156882216|FG001|Induction Period|Physician Decision|1|||
48735111|NCT03758443|156882217|FG002|Induction Period|Physician Decision|3|||
48735112|NCT03758443|156882218|FG003|Induction Period|Physician Decision|0|||
48735113|NCT03758443|156882215|FG000|Induction Period|Protocol Violation|0|||
48735114|NCT03758443|156882216|FG001|Induction Period|Protocol Violation|0|||
48735115|NCT03758443|156882217|FG002|Induction Period|Protocol Violation|0|||
48735116|NCT03758443|156882218|FG003|Induction Period|Protocol Violation|1|||
48735117|NCT03758443|156882215|FG000|Induction Period|Withdrawal by Subject|3|||
48735118|NCT03758443|156882216|FG001|Induction Period|Withdrawal by Subject|2|||
48735119|NCT03758443|156882217|FG002|Induction Period|Withdrawal by Subject|2|||
48735120|NCT03758443|156882218|FG003|Induction Period|Withdrawal by Subject|4|||
48735121|NCT03758443|156882215|FG000|Extended Induction Period|Adverse Event|1|||
48735122|NCT03758443|156882216|FG001|Extended Induction Period|Adverse Event|1|||
48735123|NCT03758443|156882217|FG002|Extended Induction Period|Adverse Event|0|||
48735124|NCT03758443|156882218|FG003|Extended Induction Period|Adverse Event|1|||
48735125|NCT03758443|156882215|FG000|Extended Induction Period|Lost to Follow-up|1|||
48735126|NCT03758443|156882216|FG001|Extended Induction Period|Lost to Follow-up|0|||
48735127|NCT03758443|156882217|FG002|Extended Induction Period|Lost to Follow-up|0|||
48735128|NCT03758443|156882218|FG003|Extended Induction Period|Lost to Follow-up|0|||
48735129|NCT03758443|156882215|FG000|Extended Induction Period|Physician Decision|2|||
48735130|NCT03758443|156882216|FG001|Extended Induction Period|Physician Decision|1|||
48735131|NCT03758443|156882217|FG002|Extended Induction Period|Physician Decision|2|||
48735132|NCT03758443|156882218|FG003|Extended Induction Period|Physician Decision|2|||
48735133|NCT03758443|156882215|FG000|Extended Induction Period|Protocol Violation|0|||
48735134|NCT03758443|156882216|FG001|Extended Induction Period|Protocol Violation|0|||
48735135|NCT03758443|156882217|FG002|Extended Induction Period|Protocol Violation|0|||
48735136|NCT03758443|156882218|FG003|Extended Induction Period|Protocol Violation|1|||
48735137|NCT03758443|156882215|FG000|Extended Induction Period|Withdrawal by Subject|8|||
48735138|NCT03758443|156882216|FG001|Extended Induction Period|Withdrawal by Subject|1|||
48735139|NCT03758443|156882217|FG002|Extended Induction Period|Withdrawal by Subject|7|||
48735140|NCT03758443|156882218|FG003|Extended Induction Period|Withdrawal by Subject|3|||
48735141|NCT03758443|156882215|FG000|Extended Induction Period|Miscellaneous|1|||
48735142|NCT03758443|156882216|FG001|Extended Induction Period|Miscellaneous|0|||
48922094|NCT01411085|157548158|FG000|Overall Study|Protocol Violation|1|||
48922095|NCT01411085|157548158|FG000|Overall Study|Adverse Event|1|||
48922096|NCT02193074|157548161|FG000|Overall Study|Withdrawal by Subject|1|||
48922097|NCT02193074|157548162|FG001|Overall Study|Withdrawal by Subject|2|||
48922098|NCT02193074|157548161|FG000|Overall Study|Adverse Event|16|||
48922099|NCT02193074|157548162|FG001|Overall Study|Adverse Event|13|||
48922100|NCT01652885|157549953|FG000|Overall Study|Adverse Event|1|||
48922101|NCT01395394|157549954|FG000|Baseline Study Visit|Protocol Violation|1|||
48922102|NCT01395394|157549955|FG001|Baseline Study Visit|Protocol Violation|0|||
48922103|NCT01395394|157549956|FG002|Baseline Study Visit|Protocol Violation|0|||
48922104|NCT00980200|157549957|FG000|7-day Treatment Period 1|Withdrawal by Subject|0|||
48922105|NCT00980200|157549958|FG001|7-day Treatment Period 1|Withdrawal by Subject|1|||
48922106|NCT00980200|157549959|FG002|7-day Treatment Period 1|Withdrawal by Subject|0|||
48922107|NCT00980200|157549960|FG003|7-day Treatment Period 1|Withdrawal by Subject|0|||
48922108|NCT00980200|157549961|FG004|7-day Treatment Period 1|Withdrawal by Subject|0|||
48922109|NCT00980200|157549957|FG000|7-day Treatment Period 3|Lack of Efficacy|0|||
48922110|NCT00980200|157549958|FG001|7-day Treatment Period 3|Lack of Efficacy|1|||
48922111|NCT00980200|157549959|FG002|7-day Treatment Period 3|Lack of Efficacy|0|||
48922112|NCT00980200|157549960|FG003|7-day Treatment Period 3|Lack of Efficacy|0|||
48922113|NCT00980200|157549961|FG004|7-day Treatment Period 3|Lack of Efficacy|1|||
48922114|NCT01736579|157549964|FG000|Overall Study|Termination of Study by Sponsor|2|||
48922115|NCT01736579|157549965|FG001|Overall Study|Termination of Study by Sponsor|2|||
48922116|NCT03468855|157549966|FG000|Overall Study|Adverse Event|2|||
48922117|NCT03468855|157549966|FG000|Overall Study|Lost to Follow-up|5|||
48922118|NCT03468855|157549966|FG000|Overall Study|Withdrawal by Subject|3|||
48922119|NCT03468855|157549966|FG000|Overall Study|Inclusion/Exclusion Enrollment Violator|1|||
48922120|NCT03368170|157549971|FG000|Overall Study|Adverse Event|2|||
48922121|NCT03368170|157549972|FG001|Overall Study|Adverse Event|1|||
48922122|NCT03670953|157549973|FG000|Dose Adjustment (Weeks 1- 3)|Adverse Event|4|||
48922123|NCT03670953|157549974|FG001|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
48922124|NCT03670953|157549975|FG002|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
48922125|NCT03670953|157549976|FG003|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
48922126|NCT03670953|157549973|FG000|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|1|||
48922127|NCT03670953|157549974|FG001|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
48922128|NCT03670953|157549975|FG002|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
48922129|NCT03670953|157549976|FG003|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
48922130|NCT03670953|157549973|FG000|Dose Adjustment (Weeks 1- 3)|Protocol Violation|6|||
48922131|NCT03670953|157549974|FG001|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
48922132|NCT03670953|157549975|FG002|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
48922133|NCT03670953|157549976|FG003|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
48922134|NCT03670953|157549973|FG000|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|9|||
48922135|NCT03670953|157549974|FG001|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
48922136|NCT03670953|157549975|FG002|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
48922137|NCT03670953|157549976|FG003|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
48922138|NCT03670953|157549973|FG000|Dose Adjustment (Weeks 1- 3)|Miscellaneous|21|||
48922139|NCT03670953|157549974|FG001|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
48922140|NCT03670953|157549975|FG002|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
48922141|NCT03670953|157549976|FG003|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
48922142|NCT03670953|157549973|FG000|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
48922143|NCT03670953|157549974|FG001|Dose Conversion (Weeks 4 - 7)|Adverse Event|35|||
48922144|NCT03670953|157549975|FG002|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
48922145|NCT03670953|157549976|FG003|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
48922146|NCT03670953|157549973|FG000|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
48922147|NCT03670953|157549974|FG001|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|10|||
48922148|NCT03670953|157549975|FG002|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
48922149|NCT03670953|157549976|FG003|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
48922150|NCT03670953|157549973|FG000|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
48922151|NCT03670953|157549974|FG001|Dose Conversion (Weeks 4 - 7)|Protocol Violation|1|||
48922152|NCT03670953|157549975|FG002|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
48922153|NCT03670953|157549976|FG003|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
48922154|NCT03670953|157549973|FG000|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
48735143|NCT03758443|156882217|FG002|Extended Induction Period|Miscellaneous|0|||
48735144|NCT03758443|156882218|FG003|Extended Induction Period|Miscellaneous|0|||
48735145|NCT03758443|156882215|FG000|Maintenance Period|Adverse Event|1|||
48735146|NCT03758443|156882216|FG001|Maintenance Period|Adverse Event|2|||
48735147|NCT03758443|156882217|FG002|Maintenance Period|Adverse Event|0|||
48735148|NCT03758443|156882218|FG003|Maintenance Period|Adverse Event|0|||
48735149|NCT03758443|156882215|FG000|Maintenance Period|Lost to Follow-up|0|||
48735150|NCT03758443|156882216|FG001|Maintenance Period|Lost to Follow-up|0|||
48735151|NCT03758443|156882217|FG002|Maintenance Period|Lost to Follow-up|0|||
48922155|NCT03670953|157549974|FG001|Dose Conversion (Weeks 4 - 7)|Non compliance|2|||
49014356|NCT01992107|157888832|FG002|Overall Study|Withdrawal by Subject|8|||
48922156|NCT03670953|157549975|FG002|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
49014357|NCT02035137|157888833|FG000|Overall Study|Physician Decision|0|||
48735152|NCT03758443|156882218|FG003|Maintenance Period|Lost to Follow-up|1|||
48735153|NCT03758443|156882215|FG000|Maintenance Period|Persistent Loss of Response During Maintenance|3|||
48735154|NCT03758443|156882216|FG001|Maintenance Period|Persistent Loss of Response During Maintenance|1|||
48735155|NCT03758443|156882217|FG002|Maintenance Period|Persistent Loss of Response During Maintenance|2|||
48735156|NCT03758443|156882218|FG003|Maintenance Period|Persistent Loss of Response During Maintenance|0|||
48735157|NCT03758443|156882215|FG000|Maintenance Period|Protocol Violation|0|||
48735158|NCT03758443|156882216|FG001|Maintenance Period|Protocol Violation|1|||
48735159|NCT03758443|156882217|FG002|Maintenance Period|Protocol Violation|0|||
48735160|NCT03758443|156882218|FG003|Maintenance Period|Protocol Violation|0|||
48735161|NCT03758443|156882215|FG000|Maintenance Period|Study Terminated by Sponsor|11|||
48735162|NCT03758443|156882216|FG001|Maintenance Period|Study Terminated by Sponsor|16|||
48735163|NCT03758443|156882217|FG002|Maintenance Period|Study Terminated by Sponsor|9|||
48735164|NCT03758443|156882218|FG003|Maintenance Period|Study Terminated by Sponsor|11|||
48735165|NCT03758443|156882215|FG000|Maintenance Period|Withdrawal by Subject|1|||
48735166|NCT03758443|156882216|FG001|Maintenance Period|Withdrawal by Subject|0|||
48735167|NCT03758443|156882217|FG002|Maintenance Period|Withdrawal by Subject|1|||
48735168|NCT03758443|156882218|FG003|Maintenance Period|Withdrawal by Subject|1|||
48735169|NCT03758443|156882215|FG000|Maintenance Period|Miscellaneous|0|||
48735170|NCT03758443|156882216|FG001|Maintenance Period|Miscellaneous|0|||
48735171|NCT03758443|156882217|FG002|Maintenance Period|Miscellaneous|1|||
48735172|NCT03758443|156882218|FG003|Maintenance Period|Miscellaneous|0|||
48735173|NCT03080454|156882219|FG000|Baseline|Adverse Event|2|||
48735174|NCT03080454|156882219|FG000|Anodal Doublestim (5 Days)|Adverse Event|1|||
48735175|NCT03080454|156882219|FG000|Anodal FU (7 Days)|Lost to Follow-up|4|||
48735176|NCT01649804|156882221|FG000|Overall Study|Administrative/Other|8|||
48735177|NCT01772160|156882222|FG000|Overall Study|Death|3|||
48735178|NCT01772160|156882222|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
48735179|NCT01772160|156882222|FG000|Overall Study|Consent withdrawal|3|||
48735180|NCT01772160|156882222|FG000|Overall Study|Migrated / moved from the study area|4|||
48735181|NCT01772160|156882222|FG000|Overall Study|Lost to Follow-up|30|||
48735182|NCT01772160|156882222|FG000|Overall Study|Other|5|||
48735183|NCT01904058|156882227|FG000|Overall Study|Adverse Event|2|||
48735184|NCT01904058|156882228|FG001|Overall Study|Adverse Event|0|||
48735185|NCT01904058|156882229|FG002|Overall Study|Adverse Event|0|||
48735186|NCT01904058|156882230|FG003|Overall Study|Adverse Event|0|||
48735187|NCT01904058|156882227|FG000|Overall Study|Withdrawal by Subject|1|||
48735188|NCT01904058|156882228|FG001|Overall Study|Withdrawal by Subject|0|||
48735189|NCT01904058|156882229|FG002|Overall Study|Withdrawal by Subject|1|||
48735190|NCT01904058|156882230|FG003|Overall Study|Withdrawal by Subject|0|||
48735191|NCT01904058|156882227|FG000|Overall Study|Pregnancy|0|||
48735192|NCT01904058|156882228|FG001|Overall Study|Pregnancy|0|||
48735193|NCT01904058|156882229|FG002|Overall Study|Pregnancy|0|||
48735194|NCT01904058|156882230|FG003|Overall Study|Pregnancy|1|||
48735195|NCT03096483|156882232|FG000|Overall Study|Withdrawal by site|1|||
48735196|NCT00369707|156882233|FG000|Induction Part B (2 Cycles)|Adverse Event|3|||
48735197|NCT00369707|156882233|FG000|Induction Part B (2 Cycles)|Withdrawal by Subject|2|||
48827179|NCT01516892|157208865|FG000|Overall Study|Other Miscellaneous Reasons|43|||
48827180|NCT01516892|157208865|FG000|Overall Study|Missing|1|||
48827181|NCT02334306|157208866|FG000|Double-blind Period|Adverse Event|0|||
48827182|NCT02334306|157208867|FG001|Double-blind Period|Adverse Event|1|||
48827183|NCT02334306|157208866|FG000|Double-blind Period|Withdrawal by Subject|1|||
48827184|NCT02334306|157208867|FG001|Double-blind Period|Withdrawal by Subject|1|||
48827185|NCT00465985|157208868|FG000|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4|||
48827186|NCT00465985|157208869|FG001|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
48922157|NCT03670953|157549976|FG003|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
48922158|NCT03670953|157549973|FG000|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
48922159|NCT03670953|157549974|FG001|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|1|||
48922160|NCT03670953|157549975|FG002|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
48922161|NCT03670953|157549976|FG003|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
48922162|NCT03670953|157549973|FG000|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
48922163|NCT03670953|157549974|FG001|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|32|||
48735198|NCT00369707|156882233|FG000|Induction Part B (2 Cycles)|Inadequate response/MD decision|1|||
48735199|NCT00369707|156882233|FG000|Induction Part B (2 Cycles)|Progressive disease|1|||
48735200|NCT00369707|156882233|FG000|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2|||
48735201|NCT00369707|156882233|FG000|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2|||
48735202|NCT00369707|156882233|FG000|Maintenance Period (up to 4 Cycles)|Progressive disease|4|||
48735203|NCT00369707|156882233|FG000|Follow up for 2 Years After Treatment|Death|1|||
48735204|NCT00369707|156882233|FG000|Follow up for 2 Years After Treatment|Other|2|||
48735205|NCT02083081|156882236|FG000|Overall Study|Lost to Follow-up|31|||
48735206|NCT02083081|156882237|FG001|Overall Study|Lost to Follow-up|9|||
48922164|NCT03670953|157549975|FG002|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
48735207|NCT03277690|156882242|FG000|Dose Titration and Maintenance|Protocol Violation|3|||
48922165|NCT03670953|157549976|FG003|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
48735208|NCT03277690|156882243|FG001|Dose Titration and Maintenance|Protocol Violation|0|||
48827187|NCT00465985|157208868|FG000|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0|||
48827188|NCT00465985|157208869|FG001|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12|||
48827189|NCT00465985|157208868|FG000|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1|||
48827190|NCT00465985|157208869|FG001|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
48827191|NCT00465985|157208868|FG000|Part III - Open-label Treatment Period|Adverse Event|1|||
48827192|NCT00465985|157208869|FG001|Part III - Open-label Treatment Period|Adverse Event|0|||
48735209|NCT03277690|156882242|FG000|Dose Titration and Maintenance|Physician Decision|1|||
48735210|NCT03277690|156882243|FG001|Dose Titration and Maintenance|Physician Decision|0|||
48827193|NCT02534896|157208870|FG000|Overall Study|Adverse Event|2|||
48827194|NCT02534896|157208871|FG001|Overall Study|Adverse Event|1|||
48827195|NCT02534896|157208872|FG002|Overall Study|Adverse Event|1|||
48827196|NCT02534896|157208870|FG000|Overall Study|Insufficient therapeutic response|2|||
48827197|NCT02534896|157208871|FG001|Overall Study|Insufficient therapeutic response|0|||
48827198|NCT02534896|157208872|FG002|Overall Study|Insufficient therapeutic response|0|||
48827199|NCT01313182|157208873|FG000|Overall Study|Protocol Violation|66|||
48827200|NCT01313182|157208874|FG001|Overall Study|Protocol Violation|92|||
48827201|NCT03686683|157208878|FG000|Overall Study|Withdrawal by Subject|52|||
48827202|NCT03686683|157208879|FG001|Overall Study|Withdrawal by Subject|32|||
48827203|NCT03686683|157208878|FG000|Overall Study|Lost to Follow-up|23|||
48827204|NCT03686683|157208879|FG001|Overall Study|Lost to Follow-up|19|||
48827205|NCT03686683|157208878|FG000|Overall Study|Adverse Event|1|||
48827206|NCT03686683|157208879|FG001|Overall Study|Adverse Event|0|||
48827207|NCT03686683|157208878|FG000|Overall Study|Death|10|||
48827208|NCT03686683|157208879|FG001|Overall Study|Death|5|||
48827209|NCT03686683|157208878|FG000|Overall Study|Progressive Disease|1|||
48827210|NCT03686683|157208879|FG001|Overall Study|Progressive Disease|1|||
48827211|NCT03686683|157208878|FG000|Overall Study|Noncompliance|1|||
48735211|NCT03277690|156882242|FG000|Dose Titration and Maintenance|Sponsor decision - Randomization closed|4|||
48735212|NCT03277690|156882243|FG001|Dose Titration and Maintenance|Sponsor decision - Randomization closed|0|||
48735213|NCT03277690|156882242|FG000|Dose Titration and Maintenance|Lack of Efficacy|9|||
48735214|NCT03277690|156882243|FG001|Dose Titration and Maintenance|Lack of Efficacy|0|||
48735215|NCT03277690|156882242|FG000|Dose Titration and Maintenance|Adverse Event|15|||
48735216|NCT03277690|156882243|FG001|Dose Titration and Maintenance|Adverse Event|0|||
48735217|NCT03277690|156882242|FG000|Dose Titration and Maintenance|Withdrawal by Subject|8|||
48735218|NCT03277690|156882243|FG001|Dose Titration and Maintenance|Withdrawal by Subject|0|||
48735219|NCT03277690|156882242|FG000|Randomized Withdrawal|Withdrawal by Subject|1|||
48735220|NCT03277690|156882243|FG001|Randomized Withdrawal|Withdrawal by Subject|0|||
48735221|NCT01691898|156882244|FG000|Overall Study|Death|34|||
48735222|NCT01691898|156882245|FG001|Overall Study|Death|32|||
48735223|NCT01691898|156882246|FG002|Overall Study|Death|6|||
48735224|NCT01691898|156882247|FG003|Overall Study|Death|3|||
48735225|NCT01691898|156882248|FG004|Overall Study|Death|8|||
48735226|NCT01691898|156882249|FG005|Overall Study|Death|31|||
48735227|NCT01691898|156882244|FG000|Overall Study|Adverse Event|0|||
48735228|NCT01691898|156882245|FG001|Overall Study|Adverse Event|1|||
48735229|NCT01691898|156882246|FG002|Overall Study|Adverse Event|0|||
48735230|NCT01691898|156882247|FG003|Overall Study|Adverse Event|1|||
48735231|NCT01691898|156882248|FG004|Overall Study|Adverse Event|1|||
48735232|NCT01691898|156882249|FG005|Overall Study|Adverse Event|0|||
48735233|NCT01691898|156882244|FG000|Overall Study|Progression of Disease|1|||
48735234|NCT01691898|156882245|FG001|Overall Study|Progression of Disease|2|||
48735235|NCT01691898|156882246|FG002|Overall Study|Progression of Disease|1|||
48735236|NCT01691898|156882247|FG003|Overall Study|Progression of Disease|0|||
48735237|NCT01691898|156882248|FG004|Overall Study|Progression of Disease|0|||
48735238|NCT01691898|156882249|FG005|Overall Study|Progression of Disease|1|||
48735239|NCT01691898|156882244|FG000|Overall Study|Lost to Follow-up|3|||
48735240|NCT01691898|156882245|FG001|Overall Study|Lost to Follow-up|1|||
48735241|NCT01691898|156882246|FG002|Overall Study|Lost to Follow-up|0|||
48735242|NCT01691898|156882247|FG003|Overall Study|Lost to Follow-up|0|||
48735243|NCT01691898|156882248|FG004|Overall Study|Lost to Follow-up|1|||
48735244|NCT01691898|156882249|FG005|Overall Study|Lost to Follow-up|0|||
48735245|NCT01691898|156882244|FG000|Overall Study|Withdrawal by Subject|9|||
48735246|NCT01691898|156882245|FG001|Overall Study|Withdrawal by Subject|8|||
48735247|NCT01691898|156882246|FG002|Overall Study|Withdrawal by Subject|2|||
48827212|NCT03686683|157208879|FG001|Overall Study|Noncompliance|0|||
48827213|NCT03686683|157208878|FG000|Overall Study|Physician Decision|1|||
48827214|NCT03686683|157208879|FG001|Overall Study|Physician Decision|1|||
48735248|NCT01691898|156882247|FG003|Overall Study|Withdrawal by Subject|1|||
48735249|NCT01691898|156882248|FG004|Overall Study|Withdrawal by Subject|3|||
48735250|NCT01691898|156882249|FG005|Overall Study|Withdrawal by Subject|3|||
48735251|NCT01691898|156882244|FG000|Overall Study|Non-Compliance|0|||
48735252|NCT01691898|156882245|FG001|Overall Study|Non-Compliance|0|||
48735253|NCT01691898|156882246|FG002|Overall Study|Non-Compliance|0|||
48735254|NCT01691898|156882247|FG003|Overall Study|Non-Compliance|0|||
49014358|NCT02035137|157888834|FG001|Overall Study|Physician Decision|0|||
48922166|NCT03670953|157549973|FG000|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
48922167|NCT03670953|157549974|FG001|Dose Conversion (Weeks 4 - 7)|Miscellaneous|2|||
48922168|NCT03670953|157549975|FG002|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
48922169|NCT03670953|157549976|FG003|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
48922170|NCT03670953|157549973|FG000|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
48922171|NCT03670953|157549974|FG001|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
48922172|NCT03670953|157549975|FG002|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|14|||
48922173|NCT03670953|157549976|FG003|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|3|||
48922174|NCT03670953|157549973|FG000|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
48922175|NCT03670953|157549974|FG001|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
48922176|NCT03670953|157549975|FG002|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|5|||
48922177|NCT03670953|157549976|FG003|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|8|||
48922178|NCT03670953|157549973|FG000|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
48922179|NCT03670953|157549974|FG001|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
48922180|NCT03670953|157549975|FG002|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|3|||
48922181|NCT03670953|157549976|FG003|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|1|||
48922182|NCT03670953|157549973|FG000|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
48922183|NCT03670953|157549974|FG001|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
48922184|NCT03670953|157549975|FG002|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|1|||
48922185|NCT03670953|157549976|FG003|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
48922186|NCT03670953|157549973|FG000|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
48922187|NCT03670953|157549974|FG001|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
48922188|NCT03670953|157549975|FG002|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|10|||
48922189|NCT03670953|157549976|FG003|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|11|||
48922190|NCT03670953|157549973|FG000|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
48922191|NCT03670953|157549974|FG001|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
48922192|NCT03670953|157549975|FG002|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|1|||
48922193|NCT03670953|157549976|FG003|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
48922194|NCT00412750|157549978|FG000|Overall Study|Abnormal laboratory value(s)|1|||
48922195|NCT00412750|157549979|FG001|Overall Study|Abnormal laboratory value(s)|0|||
48922196|NCT00412750|157549980|FG002|Overall Study|Abnormal laboratory value(s)|0|||
48922197|NCT00412750|157549978|FG000|Overall Study|Administrative problems|21|||
48922198|NCT00412750|157549979|FG001|Overall Study|Administrative problems|17|||
48922199|NCT00412750|157549980|FG002|Overall Study|Administrative problems|14|||
48922200|NCT00412750|157549978|FG000|Overall Study|Adverse Event|8|||
48922201|NCT00412750|157549979|FG001|Overall Study|Adverse Event|3|||
48922202|NCT00412750|157549980|FG002|Overall Study|Adverse Event|3|||
48922203|NCT00412750|157549978|FG000|Overall Study|Lost to Follow-up|1|||
48922204|NCT00412750|157549979|FG001|Overall Study|Lost to Follow-up|0|||
48922205|NCT00412750|157549980|FG002|Overall Study|Lost to Follow-up|1|||
48922206|NCT00412750|157549978|FG000|Overall Study|Withdrawal by Subject|0|||
48922207|NCT00412750|157549979|FG001|Overall Study|Withdrawal by Subject|1|||
48922208|NCT00412750|157549980|FG002|Overall Study|Withdrawal by Subject|2|||
48922209|NCT00412750|157549978|FG000|Overall Study|Lack of Efficacy|0|||
48922210|NCT00412750|157549979|FG001|Overall Study|Lack of Efficacy|0|||
48922211|NCT00412750|157549980|FG002|Overall Study|Lack of Efficacy|3|||
49154693|NCT01928394|158406568|FG014|Treatment Period|AE unrelated to study drug|6|||
48735255|NCT01691898|156882248|FG004|Overall Study|Non-Compliance|1|||
48735256|NCT01691898|156882249|FG005|Overall Study|Non-Compliance|0|||
48827215|NCT03686683|157208878|FG000|Overall Study|Screen fail post-randomization|1|||
48827216|NCT03686683|157208879|FG001|Overall Study|Screen fail post-randomization|0|||
48827217|NCT03686683|157208878|FG000|Overall Study|Protocol Violation|3|||
48827218|NCT03686683|157208879|FG001|Overall Study|Protocol Violation|0|||
48827219|NCT03686683|157208878|FG000|Overall Study|No data available|1|||
48735257|NCT01013350|156882250|FG000|Overall Study|Lost to Follow-up|15|||
48735258|NCT01013350|156882251|FG001|Overall Study|Lost to Follow-up|95|||
48735259|NCT01013350|156882250|FG000|Overall Study|Adverse Event|0|||
48827220|NCT03686683|157208879|FG001|Overall Study|No data available|0|||
48827221|NCT01101165|157208882|FG000|Period 1|Adverse Event|1|||
48827222|NCT01101165|157208883|FG001|Period 1|Adverse Event|2|||
48735260|NCT01013350|156882251|FG001|Overall Study|Adverse Event|1|||
48735261|NCT01013350|156882250|FG000|Overall Study|Physician Decision|4|||
48735262|NCT01013350|156882251|FG001|Overall Study|Physician Decision|20|||
48735263|NCT01013350|156882250|FG000|Overall Study|Withdrawal by Subject|15|||
48735264|NCT01013350|156882251|FG001|Overall Study|Withdrawal by Subject|38|||
48827223|NCT01101165|157208882|FG000|Period 1|Withdrawal by Subject|0|||
48827224|NCT01101165|157208883|FG001|Period 1|Withdrawal by Subject|2|||
48922212|NCT00666458|157549981|FG000|Overall Study|Adverse Event|8|||
48922213|NCT00666458|157549982|FG001|Overall Study|Adverse Event|7|||
48922214|NCT00666458|157549981|FG000|Overall Study|Withdrawal by Subject|5|||
48922215|NCT00666458|157549982|FG001|Overall Study|Withdrawal by Subject|4|||
48827225|NCT01101165|157208882|FG000|Period 1|Positive Drug Screen|0|||
48827226|NCT01101165|157208883|FG001|Period 1|Positive Drug Screen|1|||
48827227|NCT01101165|157208882|FG000|Period 1|Lost to Follow-up|1|||
48827228|NCT01101165|157208883|FG001|Period 1|Lost to Follow-up|0|||
48827229|NCT01101165|157208882|FG000|Period 2|Withdrawal by Subject|3|||
48827230|NCT01101165|157208883|FG001|Period 2|Withdrawal by Subject|1|||
48827231|NCT01101165|157208882|FG000|Period 2|Adverse Event|1|||
48827232|NCT01101165|157208883|FG001|Period 2|Adverse Event|0|||
48827233|NCT02397889|157208894|FG000|Overall Study|Physician Decision|1|||
48922216|NCT00666458|157549981|FG000|Overall Study|Lost to Follow-up|0|||
48922217|NCT00666458|157549982|FG001|Overall Study|Lost to Follow-up|3|||
48922218|NCT00666458|157549981|FG000|Overall Study|Administrative reason by sponsor|1|||
48922219|NCT00666458|157549982|FG001|Overall Study|Administrative reason by sponsor|1|||
48922220|NCT00666458|157549981|FG000|Overall Study|Incorrect enrollment|7|||
48922221|NCT00666458|157549982|FG001|Overall Study|Incorrect enrollment|1|||
48922222|NCT00666458|157549981|FG000|Overall Study|Study specific discontinuation criteria|14|||
48922223|NCT00666458|157549982|FG001|Overall Study|Study specific discontinuation criteria|7|||
48922224|NCT00666458|157549981|FG000|Overall Study|Severe non-compliance to the protocol|1|||
48922225|NCT00666458|157549982|FG001|Overall Study|Severe non-compliance to the protocol|1|||
48922226|NCT00666458|157549981|FG000|Overall Study|Safety reasons|1|||
48922227|NCT00666458|157549982|FG001|Overall Study|Safety reasons|0|||
48922228|NCT00666458|157549981|FG000|Overall Study|Medical history of anemia|1|||
48922229|NCT00666458|157549982|FG001|Overall Study|Medical history of anemia|0|||
48922230|NCT02135692|157549988|FG000|Overall Study|Adverse Event|3|||
48922231|NCT02135692|157549988|FG000|Overall Study|Lack of Efficacy|2|||
48922232|NCT02135692|157549988|FG000|Overall Study|Protocol Violation|2|||
48922233|NCT02135692|157549988|FG000|Overall Study|Subject met Liver Stopping Criteria|1|||
48922234|NCT02135692|157549988|FG000|Overall Study|Product commercially available|159|||
48922235|NCT02135692|157549988|FG000|Overall Study|Study closed/terminated|153|||
48922236|NCT02135692|157549988|FG000|Overall Study|Lost to Follow-up|4|||
48922237|NCT02135692|157549988|FG000|Overall Study|Withdrawal by Subject|15|||
48922238|NCT01995071|157549989|FG000|Overall Study|Adverse Event|0|||
48922239|NCT01995071|157549990|FG001|Overall Study|Adverse Event|0|||
48922240|NCT01995071|157549991|FG002|Overall Study|Adverse Event|0|||
48922241|NCT01995071|157549992|FG003|Overall Study|Adverse Event|0|||
48922242|NCT01995071|157549993|FG004|Overall Study|Adverse Event|0|||
48922243|NCT01995071|157549994|FG005|Overall Study|Adverse Event|0|||
48922244|NCT01995071|157549995|FG006|Overall Study|Adverse Event|1|||
48922245|NCT01995071|157549996|FG007|Overall Study|Adverse Event|0|||
48922246|NCT01995071|157549997|FG008|Overall Study|Adverse Event|0|||
48922247|NCT01995071|157549998|FG009|Overall Study|Adverse Event|0|||
48922248|NCT01995071|157549999|FG010|Overall Study|Adverse Event|0|||
48922249|NCT01995071|157550000|FG011|Overall Study|Adverse Event|0|||
48922250|NCT01995071|157549989|FG000|Overall Study|Moved|0|||
48922251|NCT01995071|157549990|FG001|Overall Study|Moved|0|||
49154694|NCT01928394|158406569|FG015|Treatment Period|AE unrelated to study drug|1|||
49154695|NCT01928394|158406570|FG016|Treatment Period|AE unrelated to study drug|1|||
49154696|NCT01928394|158406571|FG017|Treatment Period|AE unrelated to study drug|6|||
49154697|NCT01928394|158406572|FG018|Treatment Period|AE unrelated to study drug|3|||
49154698|NCT01928394|158406573|FG019|Treatment Period|AE unrelated to study drug|5|||
49154699|NCT01928394|158406574|FG020|Treatment Period|AE unrelated to study drug|1|||
49154700|NCT01928394|158406575|FG021|Treatment Period|AE unrelated to study drug|1|||
48827234|NCT02397889|157208895|FG001|Overall Study|Physician Decision|0|||
48827235|NCT03670602|157208896|FG000|Overall Study|Lost to Follow-up|1|||
48827236|NCT03670602|157208897|FG001|Overall Study|Lost to Follow-up|0|||
48922252|NCT01995071|157549991|FG002|Overall Study|Moved|1|||
48922253|NCT01995071|157549992|FG003|Overall Study|Moved|0|||
48922254|NCT01995071|157549993|FG004|Overall Study|Moved|1|||
48922255|NCT01995071|157549994|FG005|Overall Study|Moved|0|||
48922256|NCT01995071|157549995|FG006|Overall Study|Moved|0|||
48922257|NCT01995071|157549996|FG007|Overall Study|Moved|0|||
48922258|NCT01995071|157549997|FG008|Overall Study|Moved|0|||
49154701|NCT01928394|158406576|FG022|Treatment Period|AE unrelated to study drug|0|||
49154702|NCT01928394|158406554|FG000|Treatment Period|Participant request to stop therapy|0|||
49154703|NCT01928394|158406555|FG001|Treatment Period|Participant request to stop therapy|0|||
49154704|NCT01928394|158406556|FG002|Treatment Period|Participant request to stop therapy|0|||
49154705|NCT01928394|158406557|FG003|Treatment Period|Participant request to stop therapy|0|||
49154706|NCT01928394|158406558|FG004|Treatment Period|Participant request to stop therapy|0|||
48922259|NCT01995071|157549998|FG009|Overall Study|Moved|0|||
48922260|NCT01995071|157549999|FG010|Overall Study|Moved|1|||
48922261|NCT01995071|157550000|FG011|Overall Study|Moved|0|||
48922262|NCT01995071|157549989|FG000|Overall Study|Lost to Follow-up|1|||
48922263|NCT01995071|157549990|FG001|Overall Study|Lost to Follow-up|0|||
48922264|NCT01995071|157549991|FG002|Overall Study|Lost to Follow-up|0|||
49154707|NCT01928394|158406559|FG005|Treatment Period|Participant request to stop therapy|3|||
49154708|NCT01928394|158406560|FG006|Treatment Period|Participant request to stop therapy|3|||
49154709|NCT01928394|158406561|FG007|Treatment Period|Participant request to stop therapy|0|||
49154710|NCT01928394|158406562|FG008|Treatment Period|Participant request to stop therapy|0|||
49154711|NCT01928394|158406563|FG009|Treatment Period|Participant request to stop therapy|0|||
49154712|NCT01928394|158406564|FG010|Treatment Period|Participant request to stop therapy|3|||
49154713|NCT01928394|158406565|FG011|Treatment Period|Participant request to stop therapy|2|||
49154714|NCT01928394|158406566|FG012|Treatment Period|Participant request to stop therapy|1|||
49154715|NCT01928394|158406567|FG013|Treatment Period|Participant request to stop therapy|2|||
49154716|NCT01928394|158406568|FG014|Treatment Period|Participant request to stop therapy|4|||
49154717|NCT01928394|158406569|FG015|Treatment Period|Participant request to stop therapy|0|||
49154718|NCT01928394|158406570|FG016|Treatment Period|Participant request to stop therapy|1|||
49154719|NCT01928394|158406571|FG017|Treatment Period|Participant request to stop therapy|3|||
49154720|NCT01928394|158406572|FG018|Treatment Period|Participant request to stop therapy|1|||
49154721|NCT01928394|158406573|FG019|Treatment Period|Participant request to stop therapy|1|||
49154722|NCT01928394|158406574|FG020|Treatment Period|Participant request to stop therapy|3|||
49154723|NCT01928394|158406575|FG021|Treatment Period|Participant request to stop therapy|1|||
49154724|NCT01928394|158406576|FG022|Treatment Period|Participant request to stop therapy|3|||
49154725|NCT01928394|158406554|FG000|Treatment Period|Participant withdrew consent|0|||
49154726|NCT01928394|158406555|FG001|Treatment Period|Participant withdrew consent|0|||
49154727|NCT01928394|158406556|FG002|Treatment Period|Participant withdrew consent|1|||
49154728|NCT01928394|158406557|FG003|Treatment Period|Participant withdrew consent|1|||
49154729|NCT01928394|158406558|FG004|Treatment Period|Participant withdrew consent|0|||
49154730|NCT01928394|158406559|FG005|Treatment Period|Participant withdrew consent|1|||
49154731|NCT01928394|158406560|FG006|Treatment Period|Participant withdrew consent|0|||
49154732|NCT01928394|158406561|FG007|Treatment Period|Participant withdrew consent|1|||
49154733|NCT01928394|158406562|FG008|Treatment Period|Participant withdrew consent|0|||
49154734|NCT01928394|158406563|FG009|Treatment Period|Participant withdrew consent|0|||
48735265|NCT01013350|156882250|FG000|Overall Study|Death|3|||
48735266|NCT01013350|156882251|FG001|Overall Study|Death|5|||
48735267|NCT01013350|156882250|FG000|Overall Study|Participant entered interventional study|0|||
48827237|NCT03670602|157208896|FG000|Overall Study|Withdrawal by Subject|0|||
49014359|NCT02035137|157888835|FG002|Overall Study|Physician Decision|1|||
49154735|NCT01928394|158406564|FG010|Treatment Period|Participant withdrew consent|1|||
49154736|NCT01928394|158406565|FG011|Treatment Period|Participant withdrew consent|1|||
49154737|NCT01928394|158406566|FG012|Treatment Period|Participant withdrew consent|1|||
49154738|NCT01928394|158406567|FG013|Treatment Period|Participant withdrew consent|0|||
49154739|NCT01928394|158406568|FG014|Treatment Period|Participant withdrew consent|2|||
49154740|NCT01928394|158406569|FG015|Treatment Period|Participant withdrew consent|0|||
49154741|NCT01928394|158406570|FG016|Treatment Period|Participant withdrew consent|2|||
49154742|NCT01928394|158406571|FG017|Treatment Period|Participant withdrew consent|1|||
48735268|NCT01013350|156882251|FG001|Overall Study|Participant entered interventional study|8|||
48735269|NCT01013350|156882250|FG000|Overall Study|Other|1|||
48735270|NCT01013350|156882251|FG001|Overall Study|Other|25|||
48735271|NCT00413244|156882252|FG000|Overall Study|Withdrawal by Subject|10|||
48735272|NCT00413244|156882253|FG001|Overall Study|Withdrawal by Subject|1|||
48735273|NCT02633501|156882255|FG000|Overall Study|Adverse Event|0|||
48735274|NCT02633501|156882256|FG001|Overall Study|Adverse Event|0|||
48735275|NCT02633501|156882257|FG002|Overall Study|Adverse Event|1|||
48735276|NCT02633501|156882258|FG003|Overall Study|Adverse Event|0|||
48735277|NCT02633501|156882259|FG004|Overall Study|Adverse Event|1|||
48735278|NCT02633501|156882260|FG005|Overall Study|Adverse Event|1|||
48735279|NCT02633501|156882255|FG000|Overall Study|Withdrawal by Subject|2|||
48735280|NCT02633501|156882256|FG001|Overall Study|Withdrawal by Subject|1|||
48735281|NCT02633501|156882257|FG002|Overall Study|Withdrawal by Subject|2|||
48735282|NCT02633501|156882258|FG003|Overall Study|Withdrawal by Subject|2|||
48922265|NCT01995071|157549992|FG003|Overall Study|Lost to Follow-up|0|||
48922266|NCT01995071|157549993|FG004|Overall Study|Lost to Follow-up|0|||
48922267|NCT01995071|157549994|FG005|Overall Study|Lost to Follow-up|0|||
48922268|NCT01995071|157549995|FG006|Overall Study|Lost to Follow-up|0|||
48922269|NCT01995071|157549996|FG007|Overall Study|Lost to Follow-up|1|||
48922270|NCT01995071|157549997|FG008|Overall Study|Lost to Follow-up|1|||
48922271|NCT01995071|157549998|FG009|Overall Study|Lost to Follow-up|0|||
48922272|NCT01995071|157549999|FG010|Overall Study|Lost to Follow-up|0|||
48922273|NCT01995071|157550000|FG011|Overall Study|Lost to Follow-up|0|||
48922274|NCT01995071|157549989|FG000|Overall Study|Incarcerated|0|||
48922275|NCT01995071|157549990|FG001|Overall Study|Incarcerated|0|||
48735283|NCT02633501|156882259|FG004|Overall Study|Withdrawal by Subject|1|||
48735284|NCT02633501|156882260|FG005|Overall Study|Withdrawal by Subject|3|||
48735285|NCT02633501|156882255|FG000|Overall Study|Various other reasons|0|||
48735286|NCT02633501|156882256|FG001|Overall Study|Various other reasons|2|||
48735287|NCT02633501|156882257|FG002|Overall Study|Various other reasons|4|||
48735288|NCT02633501|156882258|FG003|Overall Study|Various other reasons|1|||
48735289|NCT02633501|156882259|FG004|Overall Study|Various other reasons|7|||
48735290|NCT02633501|156882260|FG005|Overall Study|Various other reasons|11|||
48735291|NCT02633501|156882255|FG000|Overall Study|Lost to Follow-up|0|||
48735292|NCT02633501|156882256|FG001|Overall Study|Lost to Follow-up|0|||
48735293|NCT02633501|156882257|FG002|Overall Study|Lost to Follow-up|0|||
48735294|NCT02633501|156882258|FG003|Overall Study|Lost to Follow-up|1|||
48735295|NCT02633501|156882259|FG004|Overall Study|Lost to Follow-up|2|||
48735296|NCT02633501|156882260|FG005|Overall Study|Lost to Follow-up|0|||
48735297|NCT05055128|156882268|FG000|Overall Study|Adverse Event|0|||
48735298|NCT05055128|156882269|FG001|Overall Study|Adverse Event|0|||
48735299|NCT05055128|156882270|FG002|Overall Study|Adverse Event|0|||
48735300|NCT05055128|156882271|FG003|Overall Study|Adverse Event|1|||
48735301|NCT05055128|156882272|FG004|Overall Study|Adverse Event|1|||
48735302|NCT05055128|156882268|FG000|Overall Study|Protocol Violation|0|||
48735303|NCT05055128|156882269|FG001|Overall Study|Protocol Violation|0|||
48735304|NCT05055128|156882270|FG002|Overall Study|Protocol Violation|0|||
48735305|NCT05055128|156882271|FG003|Overall Study|Protocol Violation|1|||
48735306|NCT05055128|156882272|FG004|Overall Study|Protocol Violation|0|||
48735307|NCT05055128|156882268|FG000|Overall Study|Withdrawal by Subject|5|||
48735308|NCT05055128|156882269|FG001|Overall Study|Withdrawal by Subject|2|||
48735309|NCT05055128|156882270|FG002|Overall Study|Withdrawal by Subject|2|||
48735310|NCT05055128|156882271|FG003|Overall Study|Withdrawal by Subject|4|||
48735311|NCT05055128|156882272|FG004|Overall Study|Withdrawal by Subject|2|||
48735312|NCT05055128|156882268|FG000|Overall Study|Randomized By Mistake|0|||
48735313|NCT05055128|156882269|FG001|Overall Study|Randomized By Mistake|1|||
48735314|NCT05055128|156882270|FG002|Overall Study|Randomized By Mistake|0|||
48735315|NCT05055128|156882271|FG003|Overall Study|Randomized By Mistake|0|||
48735316|NCT05055128|156882272|FG004|Overall Study|Randomized By Mistake|0|||
48735317|NCT05055128|156882268|FG000|Overall Study|Other|1|||
48735318|NCT05055128|156882269|FG001|Overall Study|Other|0|||
48735319|NCT05055128|156882270|FG002|Overall Study|Other|0|||
48735320|NCT05055128|156882271|FG003|Overall Study|Other|0|||
48735321|NCT05055128|156882272|FG004|Overall Study|Other|0|||
48735322|NCT00753766|156882273|FG000|Overall Study|Physician Decision|1|||
48735323|NCT00753766|156882274|FG001|Overall Study|Physician Decision|0|||
48735324|NCT00747461|156882275|FG000|Overall Study|study terminated by sponsor|5|||
48735325|NCT02478372|156882276|FG000|Overall Study|Protocol Violation|12|||
48735326|NCT02478372|156882277|FG001|Overall Study|Protocol Violation|8|||
48735327|NCT02478372|156882276|FG000|Overall Study|Lost to Follow-up|1|||
48735328|NCT02478372|156882277|FG001|Overall Study|Lost to Follow-up|4|||
48735329|NCT02478372|156882276|FG000|Overall Study|Death|0|||
48735330|NCT02478372|156882277|FG001|Overall Study|Death|2|||
48735331|NCT04295772|156882278|FG000|Overall Study|Protocol Violation|1|||
48735332|NCT04295772|156882279|FG001|Overall Study|Protocol Violation|0|||
48735333|NCT04295772|156882278|FG000|Overall Study|Ongoing for safety monitoring|14|||
48922276|NCT01995071|157549991|FG002|Overall Study|Incarcerated|0|||
48922277|NCT01995071|157549992|FG003|Overall Study|Incarcerated|0|||
48922278|NCT01995071|157549993|FG004|Overall Study|Incarcerated|0|||
49154743|NCT01928394|158406572|FG018|Treatment Period|Participant withdrew consent|1|||
49154744|NCT01928394|158406573|FG019|Treatment Period|Participant withdrew consent|1|||
49154745|NCT01928394|158406574|FG020|Treatment Period|Participant withdrew consent|0|||
49154746|NCT01928394|158406575|FG021|Treatment Period|Participant withdrew consent|2|||
48827238|NCT03670602|157208897|FG001|Overall Study|Withdrawal by Subject|3|||
48922279|NCT01995071|157549994|FG005|Overall Study|Incarcerated|0|||
48922280|NCT01995071|157549995|FG006|Overall Study|Incarcerated|0|||
48922281|NCT01995071|157549996|FG007|Overall Study|Incarcerated|1|||
48922282|NCT01995071|157549997|FG008|Overall Study|Incarcerated|0|||
48922283|NCT01995071|157549998|FG009|Overall Study|Incarcerated|0|||
48922284|NCT01995071|157549999|FG010|Overall Study|Incarcerated|0|||
48922285|NCT01995071|157550000|FG011|Overall Study|Incarcerated|0|||
48922286|NCT03311711|157550001|FG000|Overall Study|Death|1|||
48922287|NCT03311711|157550002|FG001|Overall Study|Death|0|||
48922288|NCT03311711|157550003|FG002|Overall Study|Death|0|||
48922289|NCT03311711|157550004|FG003|Overall Study|Death|0|||
48922290|NCT03311711|157550005|FG004|Overall Study|Death|0|||
48922291|NCT03311711|157550006|FG005|Overall Study|Death|0|||
48922292|NCT03311711|157550007|FG006|Overall Study|Death|1|||
48922293|NCT03311711|157550008|FG007|Overall Study|Death|0|||
48922294|NCT03311711|157550009|FG008|Overall Study|Death|1|||
48922295|NCT03311711|157550010|FG009|Overall Study|Death|0|||
48922296|NCT03311711|157550001|FG000|Overall Study|Death of dyad partner|0|||
48922297|NCT03311711|157550002|FG001|Overall Study|Death of dyad partner|1|||
48922298|NCT03311711|157550003|FG002|Overall Study|Death of dyad partner|0|||
48922299|NCT03311711|157550004|FG003|Overall Study|Death of dyad partner|0|||
49154747|NCT01928394|158406576|FG022|Treatment Period|Participant withdrew consent|0|||
49154748|NCT01928394|158406554|FG000|Treatment Period|Poor/non-compliance|0|||
49154749|NCT01928394|158406555|FG001|Treatment Period|Poor/non-compliance|0|||
49154750|NCT01928394|158406556|FG002|Treatment Period|Poor/non-compliance|0|||
49154751|NCT01928394|158406557|FG003|Treatment Period|Poor/non-compliance|1|||
49154752|NCT01928394|158406558|FG004|Treatment Period|Poor/non-compliance|0|||
49154753|NCT01928394|158406559|FG005|Treatment Period|Poor/non-compliance|0|||
49154754|NCT01928394|158406560|FG006|Treatment Period|Poor/non-compliance|0|||
49154755|NCT01928394|158406561|FG007|Treatment Period|Poor/non-compliance|0|||
49154756|NCT01928394|158406562|FG008|Treatment Period|Poor/non-compliance|0|||
49154757|NCT01928394|158406563|FG009|Treatment Period|Poor/non-compliance|0|||
49154758|NCT01928394|158406564|FG010|Treatment Period|Poor/non-compliance|0|||
49154759|NCT01928394|158406565|FG011|Treatment Period|Poor/non-compliance|0|||
49154760|NCT01928394|158406566|FG012|Treatment Period|Poor/non-compliance|1|||
49154761|NCT01928394|158406567|FG013|Treatment Period|Poor/non-compliance|0|||
49154762|NCT01928394|158406568|FG014|Treatment Period|Poor/non-compliance|1|||
49154763|NCT01928394|158406569|FG015|Treatment Period|Poor/non-compliance|0|||
49154764|NCT01928394|158406570|FG016|Treatment Period|Poor/non-compliance|0|||
49154765|NCT01928394|158406571|FG017|Treatment Period|Poor/non-compliance|1|||
49154766|NCT01928394|158406572|FG018|Treatment Period|Poor/non-compliance|0|||
49154767|NCT01928394|158406573|FG019|Treatment Period|Poor/non-compliance|1|||
49154768|NCT01928394|158406574|FG020|Treatment Period|Poor/non-compliance|0|||
49154769|NCT01928394|158406575|FG021|Treatment Period|Poor/non-compliance|0|||
49154770|NCT01928394|158406576|FG022|Treatment Period|Poor/non-compliance|0|||
49154771|NCT01928394|158406554|FG000|Treatment Period|other reason|0|||
49154772|NCT01928394|158406555|FG001|Treatment Period|other reason|0|||
49154773|NCT01928394|158406556|FG002|Treatment Period|other reason|0|||
49154774|NCT01928394|158406557|FG003|Treatment Period|other reason|0|||
48827239|NCT00241644|157208898|FG000|First Efficacy Period (Year 1)|Adverse Event|46|||
48827240|NCT00241644|157208899|FG001|First Efficacy Period (Year 1)|Adverse Event|45|||
48827241|NCT00241644|157208900|FG002|First Efficacy Period (Year 1)|Adverse Event|45|||
48827242|NCT00241644|157208901|FG003|First Efficacy Period (Year 1)|Adverse Event|91|||
48827243|NCT00241644|157208898|FG000|First Efficacy Period (Year 1)|Protocol Violation|3|||
48827244|NCT00241644|157208899|FG001|First Efficacy Period (Year 1)|Protocol Violation|5|||
48827245|NCT00241644|157208900|FG002|First Efficacy Period (Year 1)|Protocol Violation|4|||
48827246|NCT00241644|157208901|FG003|First Efficacy Period (Year 1)|Protocol Violation|8|||
48827247|NCT00241644|157208898|FG000|First Efficacy Period (Year 1)|Withdrawal by Subject|59|||
48827248|NCT00241644|157208899|FG001|First Efficacy Period (Year 1)|Withdrawal by Subject|74|||
48827249|NCT00241644|157208900|FG002|First Efficacy Period (Year 1)|Withdrawal by Subject|81|||
48827250|NCT00241644|157208901|FG003|First Efficacy Period (Year 1)|Withdrawal by Subject|133|||
48827251|NCT00241644|157208898|FG000|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
48827252|NCT00241644|157208899|FG001|First Efficacy Period (Year 1)|Lost to Follow-up|142|||
48922300|NCT03311711|157550005|FG004|Overall Study|Death of dyad partner|0|||
48922301|NCT03311711|157550006|FG005|Overall Study|Death of dyad partner|0|||
48922302|NCT03311711|157550007|FG006|Overall Study|Death of dyad partner|0|||
48922303|NCT03311711|157550008|FG007|Overall Study|Death of dyad partner|1|||
48922304|NCT03311711|157550009|FG008|Overall Study|Death of dyad partner|0|||
48922305|NCT03311711|157550010|FG009|Overall Study|Death of dyad partner|1|||
48922306|NCT03311711|157550001|FG000|Overall Study|Lost to Follow-up|2|||
48922307|NCT03311711|157550002|FG001|Overall Study|Lost to Follow-up|2|||
49154775|NCT01928394|158406558|FG004|Treatment Period|other reason|0|||
49154776|NCT01928394|158406559|FG005|Treatment Period|other reason|0|||
49154777|NCT01928394|158406560|FG006|Treatment Period|other reason|0|||
49154778|NCT01928394|158406561|FG007|Treatment Period|other reason|0|||
49154779|NCT01928394|158406562|FG008|Treatment Period|other reason|0|||
49154780|NCT01928394|158406563|FG009|Treatment Period|other reason|0|||
48827253|NCT00241644|157208900|FG002|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
48827254|NCT00241644|157208901|FG003|First Efficacy Period (Year 1)|Lost to Follow-up|258|||
48827255|NCT00241644|157208898|FG000|First Efficacy Period (Year 1)|Non-compliance|2|||
48827256|NCT00241644|157208899|FG001|First Efficacy Period (Year 1)|Non-compliance|1|||
48827257|NCT00241644|157208900|FG002|First Efficacy Period (Year 1)|Non-compliance|2|||
48827258|NCT00241644|157208901|FG003|First Efficacy Period (Year 1)|Non-compliance|3|||
48827259|NCT00241644|157208898|FG000|First Efficacy Period (Year 1)|Return dates not reliable|1|||
49154781|NCT01928394|158406564|FG010|Treatment Period|other reason|1|||
48827260|NCT00241644|157208899|FG001|First Efficacy Period (Year 1)|Return dates not reliable|0|||
48827261|NCT00241644|157208900|FG002|First Efficacy Period (Year 1)|Return dates not reliable|0|||
48827262|NCT00241644|157208901|FG003|First Efficacy Period (Year 1)|Return dates not reliable|1|||
48827263|NCT00241644|157208898|FG000|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
48827264|NCT00241644|157208899|FG001|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
48827265|NCT00241644|157208900|FG002|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1|||
48827266|NCT00241644|157208901|FG003|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
48827267|NCT00241644|157208898|FG000|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
48827268|NCT00241644|157208899|FG001|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
49154782|NCT01928394|158406565|FG011|Treatment Period|other reason|1|||
49154783|NCT01928394|158406566|FG012|Treatment Period|other reason|1|||
49154784|NCT01928394|158406567|FG013|Treatment Period|other reason|0|||
49154785|NCT01928394|158406568|FG014|Treatment Period|other reason|1|||
49154786|NCT01928394|158406569|FG015|Treatment Period|other reason|0|||
49154787|NCT01928394|158406570|FG016|Treatment Period|other reason|0|||
49154788|NCT01928394|158406571|FG017|Treatment Period|other reason|0|||
48827269|NCT00241644|157208900|FG002|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
48827270|NCT00241644|157208901|FG003|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
48827271|NCT00241644|157208898|FG000|Second Efficacy Period (Year 2)|Adverse Event|11|||
48827272|NCT00241644|157208899|FG001|Second Efficacy Period (Year 2)|Adverse Event|9|||
48827273|NCT00241644|157208900|FG002|Second Efficacy Period (Year 2)|Adverse Event|12|||
48827274|NCT00241644|157208901|FG003|Second Efficacy Period (Year 2)|Adverse Event|20|||
48827275|NCT00241644|157208898|FG000|Second Efficacy Period (Year 2)|Protocol Violation|2|||
48827276|NCT00241644|157208899|FG001|Second Efficacy Period (Year 2)|Protocol Violation|1|||
48827277|NCT00241644|157208900|FG002|Second Efficacy Period (Year 2)|Protocol Violation|2|||
48827278|NCT00241644|157208901|FG003|Second Efficacy Period (Year 2)|Protocol Violation|3|||
49154789|NCT01928394|158406572|FG018|Treatment Period|other reason|2|||
49154790|NCT01928394|158406573|FG019|Treatment Period|other reason|2|||
49154791|NCT01928394|158406574|FG020|Treatment Period|other reason|0|||
49154792|NCT01928394|158406575|FG021|Treatment Period|other reason|0|||
49154793|NCT01928394|158406576|FG022|Treatment Period|other reason|0|||
49154794|NCT01928394|158406554|FG000|Treatment Period|Maximum clinical benefit|0|||
49154795|NCT01928394|158406555|FG001|Treatment Period|Maximum clinical benefit|0|||
49154796|NCT01928394|158406556|FG002|Treatment Period|Maximum clinical benefit|0|||
49154797|NCT01928394|158406557|FG003|Treatment Period|Maximum clinical benefit|0|||
49154798|NCT01928394|158406558|FG004|Treatment Period|Maximum clinical benefit|0|||
49154799|NCT01928394|158406559|FG005|Treatment Period|Maximum clinical benefit|0|||
49154800|NCT01928394|158406560|FG006|Treatment Period|Maximum clinical benefit|0|||
49154801|NCT01928394|158406561|FG007|Treatment Period|Maximum clinical benefit|0|||
49154802|NCT01928394|158406562|FG008|Treatment Period|Maximum clinical benefit|0|||
49154803|NCT01928394|158406563|FG009|Treatment Period|Maximum clinical benefit|0|||
49154804|NCT01928394|158406564|FG010|Treatment Period|Maximum clinical benefit|1|||
49154805|NCT01928394|158406565|FG011|Treatment Period|Maximum clinical benefit|1|||
49154806|NCT01928394|158406566|FG012|Treatment Period|Maximum clinical benefit|0|||
49154807|NCT01928394|158406567|FG013|Treatment Period|Maximum clinical benefit|0|||
49154808|NCT01928394|158406568|FG014|Treatment Period|Maximum clinical benefit|1|||
49154809|NCT01928394|158406569|FG015|Treatment Period|Maximum clinical benefit|0|||
49154810|NCT01928394|158406570|FG016|Treatment Period|Maximum clinical benefit|0|||
49154811|NCT01928394|158406571|FG017|Treatment Period|Maximum clinical benefit|1|||
48827279|NCT00241644|157208898|FG000|Second Efficacy Period (Year 2)|Withdrawal by Subject|4|||
49154812|NCT01928394|158406572|FG018|Treatment Period|Maximum clinical benefit|1|||
49154813|NCT01928394|158406573|FG019|Treatment Period|Maximum clinical benefit|0|||
49154814|NCT01928394|158406574|FG020|Treatment Period|Maximum clinical benefit|2|||
49154815|NCT01928394|158406575|FG021|Treatment Period|Maximum clinical benefit|0|||
49154816|NCT01928394|158406576|FG022|Treatment Period|Maximum clinical benefit|0|||
49154817|NCT01928394|158406554|FG000|Treatment Period|Lost to Follow-up|0|||
48827280|NCT00241644|157208899|FG001|Second Efficacy Period (Year 2)|Withdrawal by Subject|3|||
48827281|NCT00241644|157208900|FG002|Second Efficacy Period (Year 2)|Withdrawal by Subject|2|||
48827282|NCT00241644|157208901|FG003|Second Efficacy Period (Year 2)|Withdrawal by Subject|7|||
48827283|NCT00241644|157208898|FG000|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
48827284|NCT00241644|157208899|FG001|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
48827285|NCT00241644|157208900|FG002|Second Efficacy Period (Year 2)|Lost to Follow-up|46|||
48827286|NCT00241644|157208901|FG003|Second Efficacy Period (Year 2)|Lost to Follow-up|86|||
48827287|NCT00241644|157208898|FG000|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
48827288|NCT00241644|157208899|FG001|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
48827289|NCT00241644|157208900|FG002|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
48827290|NCT00241644|157208901|FG003|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
48827291|NCT02317705|157208902|FG000|Overall Study|Withdrawal by Subject|3|||
48827292|NCT02317705|157208902|FG000|Overall Study|Physician Decision|1|||
48827293|NCT02317705|157208902|FG000|Overall Study|Drug not usable|1|||
48827294|NCT00335556|157208903|FG000|Overall Study|Death|0|||
48827295|NCT00335556|157208904|FG001|Overall Study|Death|5|||
48827296|NCT00335556|157208905|FG002|Overall Study|Death|0|||
48827297|NCT00335556|157208906|FG003|Overall Study|Death|0|||
48827298|NCT00335556|157208907|FG004|Overall Study|Death|1|||
48827299|NCT00335556|157208908|FG005|Overall Study|Death|0|||
48827300|NCT00335556|157208903|FG000|Overall Study|Lack of Efficacy|0|||
48827301|NCT00335556|157208904|FG001|Overall Study|Lack of Efficacy|19|||
48827302|NCT00335556|157208905|FG002|Overall Study|Lack of Efficacy|3|||
48827303|NCT00335556|157208906|FG003|Overall Study|Lack of Efficacy|3|||
48827304|NCT00335556|157208907|FG004|Overall Study|Lack of Efficacy|0|||
48827305|NCT00335556|157208908|FG005|Overall Study|Lack of Efficacy|1|||
48827306|NCT00335556|157208903|FG000|Overall Study|Physician Decision|0|||
48827307|NCT00335556|157208904|FG001|Overall Study|Physician Decision|6|||
48827308|NCT00335556|157208905|FG002|Overall Study|Physician Decision|2|||
48827309|NCT00335556|157208906|FG003|Overall Study|Physician Decision|1|||
48827310|NCT00335556|157208907|FG004|Overall Study|Physician Decision|0|||
48827311|NCT00335556|157208908|FG005|Overall Study|Physician Decision|0|||
48827312|NCT00335556|157208903|FG000|Overall Study|Ineligible|2|||
48827313|NCT00335556|157208904|FG001|Overall Study|Ineligible|0|||
48827314|NCT00335556|157208905|FG002|Overall Study|Ineligible|0|||
48827315|NCT00335556|157208906|FG003|Overall Study|Ineligible|0|||
48827316|NCT00335556|157208907|FG004|Overall Study|Ineligible|0|||
48827317|NCT00335556|157208908|FG005|Overall Study|Ineligible|0|||
48827318|NCT00335556|157208903|FG000|Overall Study|Refusal of further protocol therapy|0|||
48827319|NCT00335556|157208904|FG001|Overall Study|Refusal of further protocol therapy|4|||
48827320|NCT00335556|157208905|FG002|Overall Study|Refusal of further protocol therapy|0|||
48827321|NCT00335556|157208906|FG003|Overall Study|Refusal of further protocol therapy|1|||
48827322|NCT00335556|157208907|FG004|Overall Study|Refusal of further protocol therapy|0|||
49154818|NCT01928394|158406555|FG001|Treatment Period|Lost to Follow-up|0|||
49154819|NCT01928394|158406556|FG002|Treatment Period|Lost to Follow-up|0|||
49154820|NCT01928394|158406557|FG003|Treatment Period|Lost to Follow-up|0|||
49154821|NCT01928394|158406558|FG004|Treatment Period|Lost to Follow-up|0|||
49154822|NCT01928394|158406559|FG005|Treatment Period|Lost to Follow-up|0|||
49154823|NCT01928394|158406560|FG006|Treatment Period|Lost to Follow-up|0|||
49154824|NCT01928394|158406561|FG007|Treatment Period|Lost to Follow-up|0|||
49154825|NCT01928394|158406562|FG008|Treatment Period|Lost to Follow-up|0|||
49154826|NCT01928394|158406563|FG009|Treatment Period|Lost to Follow-up|0|||
49154827|NCT01928394|158406564|FG010|Treatment Period|Lost to Follow-up|0|||
49154828|NCT01928394|158406565|FG011|Treatment Period|Lost to Follow-up|0|||
49154829|NCT01928394|158406566|FG012|Treatment Period|Lost to Follow-up|0|||
49154830|NCT01928394|158406567|FG013|Treatment Period|Lost to Follow-up|0|||
48827323|NCT00335556|157208908|FG005|Overall Study|Refusal of further protocol therapy|0|||
48827324|NCT01599325|157208911|FG000|Primary Parent Phase|Adverse Event|5|||
48827325|NCT01599325|157208911|FG000|Primary Parent Phase|Disease Progression|7|||
48827326|NCT01599325|157208911|FG000|Primary Parent Phase|Withdrawal by Subject|20|||
48827327|NCT01599325|157208911|FG000|Primary Parent Phase|Death|13|||
48827328|NCT01599325|157208911|FG000|Primary Parent Phase|Protocol Violation|1|||
48827329|NCT01599325|157208911|FG000|Primary Parent Phase|Lack of Therapeutic Effect|9|||
48827330|NCT01599325|157208911|FG000|Primary Parent Phase|Other|2|||
48827331|NCT01599325|157208911|FG000|Extension Phase|Study Closure|1|||
48827332|NCT01599325|157208911|FG000|Extension Phase|Stopped to Receive Stem Cell Transplant|1|||
48827333|NCT01599325|157208911|FG000|Extension Phase|Lack of Therapeutic Effect|4|||
48827334|NCT01599325|157208911|FG000|Extension Phase|Disease Progression|1|||
48827335|NCT01599325|157208911|FG000|Extension Phase|Withdrawal by Subject|8|||
48827336|NCT02952261|157208913|FG000|Overall Study|Withdrawal by Subject|4|||
48827337|NCT02952261|157208914|FG001|Overall Study|Withdrawal by Subject|5|||
49154831|NCT01928394|158406568|FG014|Treatment Period|Lost to Follow-up|0|||
49154832|NCT01928394|158406569|FG015|Treatment Period|Lost to Follow-up|0|||
49154833|NCT01928394|158406570|FG016|Treatment Period|Lost to Follow-up|0|||
49154834|NCT01928394|158406571|FG017|Treatment Period|Lost to Follow-up|0|||
49154835|NCT01928394|158406572|FG018|Treatment Period|Lost to Follow-up|0|||
49154836|NCT01928394|158406573|FG019|Treatment Period|Lost to Follow-up|0|||
49154837|NCT01928394|158406574|FG020|Treatment Period|Lost to Follow-up|0|||
49154838|NCT01928394|158406575|FG021|Treatment Period|Lost to Follow-up|0|||
49154839|NCT01928394|158406576|FG022|Treatment Period|Lost to Follow-up|1|||
49154840|NCT01928394|158406554|FG000|Treatment Period|Death|0|||
49154841|NCT01928394|158406555|FG001|Treatment Period|Death|0|||
49154842|NCT01928394|158406556|FG002|Treatment Period|Death|0|||
49154843|NCT01928394|158406557|FG003|Treatment Period|Death|0|||
49154844|NCT01928394|158406558|FG004|Treatment Period|Death|0|||
49154845|NCT01928394|158406559|FG005|Treatment Period|Death|0|||
49154846|NCT01928394|158406560|FG006|Treatment Period|Death|0|||
49154847|NCT01928394|158406561|FG007|Treatment Period|Death|0|||
49154848|NCT01928394|158406562|FG008|Treatment Period|Death|0|||
49154849|NCT01928394|158406563|FG009|Treatment Period|Death|0|||
49154850|NCT01928394|158406564|FG010|Treatment Period|Death|0|||
49154851|NCT01928394|158406565|FG011|Treatment Period|Death|0|||
49154852|NCT01928394|158406566|FG012|Treatment Period|Death|0|||
49154853|NCT01928394|158406567|FG013|Treatment Period|Death|1|||
49154854|NCT01928394|158406568|FG014|Treatment Period|Death|2|||
49154855|NCT01928394|158406569|FG015|Treatment Period|Death|0|||
49154856|NCT01928394|158406570|FG016|Treatment Period|Death|0|||
49154857|NCT01928394|158406571|FG017|Treatment Period|Death|0|||
49154858|NCT01928394|158406572|FG018|Treatment Period|Death|0|||
49154859|NCT01928394|158406573|FG019|Treatment Period|Death|0|||
49154860|NCT01928394|158406574|FG020|Treatment Period|Death|0|||
49154861|NCT01928394|158406575|FG021|Treatment Period|Death|0|||
49154862|NCT01928394|158406576|FG022|Treatment Period|Death|0|||
49154863|NCT01928394|158406554|FG000|Follow-up Period|Participant withdrew consent|3|||
49154864|NCT01928394|158406555|FG001|Follow-up Period|Participant withdrew consent|0|||
48827338|NCT02952261|157208913|FG000|Overall Study|Protocol Violation|1|||
48827339|NCT02952261|157208914|FG001|Overall Study|Protocol Violation|0|||
48827340|NCT01763047|157208915|FG000|Period 1|Test Article Not Available|4|||
48827341|NCT01763047|157208916|FG001|Period 1|Test Article Not Available|1|||
48827342|NCT01763047|157208915|FG000|Period 1|Protocol Violation|4|||
48827343|NCT01763047|157208916|FG001|Period 1|Protocol Violation|4|||
48827344|NCT01763047|157208915|FG000|Period 1|No Longer Meets Eligibility criteria|1|||
48827345|NCT01763047|157208916|FG001|Period 1|No Longer Meets Eligibility criteria|0|||
48827346|NCT01763047|157208915|FG000|Period 1|Adverse Event|0|||
48827347|NCT01763047|157208916|FG001|Period 1|Adverse Event|1|||
48827348|NCT01763047|157208915|FG000|Period 1|Unsatisfactory Visual Response|0|||
48827349|NCT01763047|157208916|FG001|Period 1|Unsatisfactory Visual Response|3|||
48827350|NCT01763047|157208915|FG000|Period 1|Lens Power Not Available|0|||
48827351|NCT01763047|157208916|FG001|Period 1|Lens Power Not Available|1|||
48827352|NCT01763047|157208915|FG000|Period 1|Study Site office Closed|0|||
48827353|NCT01763047|157208916|FG001|Period 1|Study Site office Closed|1|||
48827354|NCT01763047|157208915|FG000|Period 2|Lens Discomfort|1|||
48827355|NCT01763047|157208916|FG001|Period 2|Lens Discomfort|0|||
48827356|NCT01763047|157208915|FG000|Period 2|No longer meets Eligibility Criteria|1|||
48827357|NCT01763047|157208916|FG001|Period 2|No longer meets Eligibility Criteria|0|||
48922308|NCT03311711|157550003|FG002|Overall Study|Lost to Follow-up|0|||
48922309|NCT03311711|157550004|FG003|Overall Study|Lost to Follow-up|0|||
48922310|NCT03311711|157550005|FG004|Overall Study|Lost to Follow-up|0|||
48922311|NCT03311711|157550006|FG005|Overall Study|Lost to Follow-up|0|||
48922312|NCT03311711|157550007|FG006|Overall Study|Lost to Follow-up|1|||
48922313|NCT03311711|157550008|FG007|Overall Study|Lost to Follow-up|1|||
48922314|NCT03311711|157550009|FG008|Overall Study|Lost to Follow-up|0|||
48922315|NCT03311711|157550010|FG009|Overall Study|Lost to Follow-up|0|||
49154865|NCT01928394|158406556|FG002|Follow-up Period|Participant withdrew consent|1|||
49154866|NCT01928394|158406557|FG003|Follow-up Period|Participant withdrew consent|4|||
49154867|NCT01928394|158406558|FG004|Follow-up Period|Participant withdrew consent|0|||
49154868|NCT01928394|158406559|FG005|Follow-up Period|Participant withdrew consent|2|||
49154869|NCT01928394|158406560|FG006|Follow-up Period|Participant withdrew consent|5|||
49154870|NCT01928394|158406561|FG007|Follow-up Period|Participant withdrew consent|1|||
48827358|NCT01763047|157208915|FG000|Period 2|Study Site office Closed|1|||
48827359|NCT01763047|157208916|FG001|Period 2|Study Site office Closed|1|||
48827360|NCT01763047|157208915|FG000|Period 2|Unsatisfactory Visual Response|1|||
48827361|NCT01763047|157208916|FG001|Period 2|Unsatisfactory Visual Response|1|||
48827362|NCT01763047|157208915|FG000|Period 2|Protocol Violation|0|||
49154871|NCT01928394|158406562|FG008|Follow-up Period|Participant withdrew consent|0|||
48827363|NCT01763047|157208916|FG001|Period 2|Protocol Violation|2|||
48922316|NCT03311711|157550001|FG000|Overall Study|Withdrawal by Subject|1|||
48922317|NCT03311711|157550002|FG001|Overall Study|Withdrawal by Subject|1|||
49154872|NCT01928394|158406563|FG009|Follow-up Period|Participant withdrew consent|0|||
49154873|NCT01928394|158406564|FG010|Follow-up Period|Participant withdrew consent|5|||
49154874|NCT01928394|158406565|FG011|Follow-up Period|Participant withdrew consent|8|||
48827364|NCT01763047|157208915|FG000|Period 2|Unsatisfactory lens Fitting|0|||
48827365|NCT01763047|157208916|FG001|Period 2|Unsatisfactory lens Fitting|1|||
48827366|NCT03404843|157208917|FG000|Overall Study|Study difficulties unrelated to Tx|4|||
48827367|NCT03404843|157208918|FG001|Overall Study|Study difficulties unrelated to Tx|1|||
48827368|NCT01605136|157208926|FG000|Study Period|Withdrawal by Subject|2|||
49154875|NCT01928394|158406566|FG012|Follow-up Period|Participant withdrew consent|2|||
49154876|NCT01928394|158406567|FG013|Follow-up Period|Participant withdrew consent|12|||
49154877|NCT01928394|158406568|FG014|Follow-up Period|Participant withdrew consent|7|||
49154878|NCT01928394|158406569|FG015|Follow-up Period|Participant withdrew consent|0|||
49154879|NCT01928394|158406570|FG016|Follow-up Period|Participant withdrew consent|5|||
49154880|NCT01928394|158406571|FG017|Follow-up Period|Participant withdrew consent|3|||
49154881|NCT01928394|158406572|FG018|Follow-up Period|Participant withdrew consent|2|||
49154882|NCT01928394|158406573|FG019|Follow-up Period|Participant withdrew consent|7|||
49154883|NCT01928394|158406574|FG020|Follow-up Period|Participant withdrew consent|4|||
49154884|NCT01928394|158406575|FG021|Follow-up Period|Participant withdrew consent|6|||
49154885|NCT01928394|158406576|FG022|Follow-up Period|Participant withdrew consent|2|||
49154886|NCT01928394|158406554|FG000|Follow-up Period|Death|0|||
49154887|NCT01928394|158406555|FG001|Follow-up Period|Death|0|||
49154888|NCT01928394|158406556|FG002|Follow-up Period|Death|2|||
49154889|NCT01928394|158406557|FG003|Follow-up Period|Death|6|||
49154890|NCT01928394|158406558|FG004|Follow-up Period|Death|0|||
48827369|NCT01605136|157208927|FG001|Study Period|Withdrawal by Subject|0|||
48827370|NCT01605136|157208926|FG000|Study Period|Physician Decision|1|||
48827371|NCT01605136|157208927|FG001|Study Period|Physician Decision|1|||
48827372|NCT01605136|157208926|FG000|Study Period|Lost to Follow-up|0|||
48827373|NCT01605136|157208927|FG001|Study Period|Lost to Follow-up|2|||
48827374|NCT01605136|157208926|FG000|Safety Follow-Up Period|Withdrawal by Subject|1|||
48827375|NCT01605136|157208927|FG001|Safety Follow-Up Period|Withdrawal by Subject|2|||
48827376|NCT01093534|157208937|FG000|Overall Study|Adverse Event|2|||
48827377|NCT01093534|157208938|FG001|Overall Study|Adverse Event|5|||
48827378|NCT01093534|157208939|FG002|Overall Study|Adverse Event|2|||
48827379|NCT01093534|157208937|FG000|Overall Study|Lack of Efficacy|2|||
48827380|NCT01093534|157208938|FG001|Overall Study|Lack of Efficacy|1|||
48827381|NCT01093534|157208939|FG002|Overall Study|Lack of Efficacy|1|||
48827382|NCT01093534|157208937|FG000|Overall Study|Withdrawal by Subject|5|||
48827383|NCT01093534|157208938|FG001|Overall Study|Withdrawal by Subject|7|||
48827384|NCT01093534|157208939|FG002|Overall Study|Withdrawal by Subject|2|||
48827385|NCT01093534|157208937|FG000|Overall Study|Other|1|||
48827386|NCT01093534|157208938|FG001|Overall Study|Other|3|||
48827387|NCT01093534|157208939|FG002|Overall Study|Other|4|||
48827388|NCT04831775|157208943|FG000|Overall Study|Lost to Follow-up|11|||
48827389|NCT04831775|157208944|FG001|Overall Study|Lost to Follow-up|13|||
48827390|NCT03563053|157208945|FG000|Overall Study|Withdrawal by Subject|17|||
48827391|NCT03563053|157208945|FG000|Overall Study|Due to the COVID-19 pandemic|12|||
48827392|NCT03563053|157208945|FG000|Overall Study|Adverse Event|3|||
48827393|NCT03563053|157208945|FG000|Overall Study|Physician Decision|1|||
48827394|NCT03563053|157208945|FG000|Overall Study|study terminated by sponsor|71|||
48827395|NCT01729871|157208946|FG000|Overall Study|Adverse Event|7|||
48827396|NCT01729871|157208947|FG001|Overall Study|Adverse Event|7|||
48827397|NCT01729871|157208946|FG000|Overall Study|Death|0|||
49154891|NCT01928394|158406559|FG005|Follow-up Period|Death|6|||
49154892|NCT01928394|158406560|FG006|Follow-up Period|Death|6|||
49154893|NCT01928394|158406561|FG007|Follow-up Period|Death|2|||
48827398|NCT01729871|157208947|FG001|Overall Study|Death|1|||
48827399|NCT01729871|157208946|FG000|Overall Study|Lack of Efficacy|0|||
48827400|NCT01729871|157208947|FG001|Overall Study|Lack of Efficacy|1|||
48827401|NCT01729871|157208946|FG000|Overall Study|Physician Decision|0|||
48827402|NCT01729871|157208947|FG001|Overall Study|Physician Decision|2|||
48827403|NCT01729871|157208946|FG000|Overall Study|Protocol Violation|1|||
48827404|NCT01729871|157208947|FG001|Overall Study|Protocol Violation|0|||
49154894|NCT01928394|158406562|FG008|Follow-up Period|Death|1|||
48827405|NCT01729871|157208946|FG000|Overall Study|Withdrawal by Subject|0|||
49154895|NCT01928394|158406563|FG009|Follow-up Period|Death|2|||
49154896|NCT01928394|158406564|FG010|Follow-up Period|Death|4|||
48827406|NCT01729871|157208947|FG001|Overall Study|Withdrawal by Subject|3|||
48827407|NCT01729871|157208946|FG000|Overall Study|Other|4|||
48827408|NCT01729871|157208947|FG001|Overall Study|Other|9|||
48827409|NCT00819910|157208949|FG000|Overall Study|Adverse Event|0|||
48827410|NCT00819910|157208950|FG001|Overall Study|Adverse Event|0|||
48827411|NCT00819910|157208951|FG002|Overall Study|Adverse Event|2|||
48827412|NCT00819910|157208952|FG003|Overall Study|Adverse Event|1|||
48827413|NCT00819910|157208949|FG000|Overall Study|Withdrawal by Subject|1|||
48922318|NCT03311711|157550003|FG002|Overall Study|Withdrawal by Subject|0|||
49154897|NCT01928394|158406565|FG011|Follow-up Period|Death|12|||
49154898|NCT01928394|158406566|FG012|Follow-up Period|Death|11|||
49154899|NCT01928394|158406567|FG013|Follow-up Period|Death|25|||
49154900|NCT01928394|158406568|FG014|Follow-up Period|Death|18|||
49154901|NCT01928394|158406569|FG015|Follow-up Period|Death|0|||
49154902|NCT01928394|158406570|FG016|Follow-up Period|Death|6|||
49154903|NCT01928394|158406571|FG017|Follow-up Period|Death|5|||
49154904|NCT01928394|158406572|FG018|Follow-up Period|Death|13|||
49154905|NCT01928394|158406573|FG019|Follow-up Period|Death|13|||
49154906|NCT01928394|158406574|FG020|Follow-up Period|Death|5|||
49154907|NCT01928394|158406575|FG021|Follow-up Period|Death|3|||
49154908|NCT01928394|158406576|FG022|Follow-up Period|Death|2|||
48827414|NCT00819910|157208950|FG001|Overall Study|Withdrawal by Subject|1|||
48827415|NCT00819910|157208951|FG002|Overall Study|Withdrawal by Subject|1|||
48827416|NCT00819910|157208952|FG003|Overall Study|Withdrawal by Subject|0|||
48827417|NCT00819910|157208949|FG000|Overall Study|Lost to Follow-up|1|||
48827418|NCT00819910|157208950|FG001|Overall Study|Lost to Follow-up|0|||
48827419|NCT00819910|157208951|FG002|Overall Study|Lost to Follow-up|0|||
48827420|NCT00819910|157208952|FG003|Overall Study|Lost to Follow-up|0|||
48827421|NCT05273801|157208955|FG000|Overall Study|Physician Decision|1|||
48827422|NCT03820986|157208956|FG000|Overall Study|Death|177|||
48827423|NCT03820986|157208957|FG001|Overall Study|Death|156|||
48827424|NCT03820986|157208956|FG000|Overall Study|Lost to Follow-up|0|||
49154909|NCT01928394|158406554|FG000|Follow-up Period|other reason|0|||
49154910|NCT01928394|158406555|FG001|Follow-up Period|other reason|0|||
49154911|NCT01928394|158406556|FG002|Follow-up Period|other reason|0|||
49154912|NCT01928394|158406557|FG003|Follow-up Period|other reason|0|||
49154913|NCT01928394|158406558|FG004|Follow-up Period|other reason|0|||
49154914|NCT01928394|158406559|FG005|Follow-up Period|other reason|0|||
49154915|NCT01928394|158406560|FG006|Follow-up Period|other reason|1|||
48827425|NCT03820986|157208957|FG001|Overall Study|Lost to Follow-up|1|||
48827426|NCT03820986|157208956|FG000|Overall Study|Withdrawal by Subject|8|||
48827427|NCT03820986|157208957|FG001|Overall Study|Withdrawal by Subject|3|||
48827428|NCT03820986|157208956|FG000|Overall Study|Ongoing|149|||
48827429|NCT03820986|157208957|FG001|Overall Study|Ongoing|180|||
48827430|NCT00828919|157208958|FG000|Overall Study|Death|0|||
48827431|NCT00828919|157208959|FG001|Overall Study|Death|1|||
48827432|NCT00828919|157208960|FG002|Overall Study|Death|2|||
48827433|NCT00828919|157208961|FG003|Overall Study|Death|0|||
48827434|NCT00828919|157208962|FG004|Overall Study|Death|0|||
48827435|NCT00828919|157208958|FG000|Overall Study|Adverse Event|2|||
48827436|NCT00828919|157208959|FG001|Overall Study|Adverse Event|2|||
48827437|NCT00828919|157208960|FG002|Overall Study|Adverse Event|2|||
48827438|NCT00828919|157208961|FG003|Overall Study|Adverse Event|1|||
48827439|NCT00828919|157208962|FG004|Overall Study|Adverse Event|3|||
48827440|NCT00828919|157208958|FG000|Overall Study|Objective progression or relapse|4|||
48827441|NCT00828919|157208959|FG001|Overall Study|Objective progression or relapse|4|||
48827442|NCT00828919|157208960|FG002|Overall Study|Objective progression or relapse|11|||
48827443|NCT00828919|157208961|FG003|Overall Study|Objective progression or relapse|0|||
48827444|NCT00828919|157208962|FG004|Overall Study|Objective progression or relapse|5|||
48827445|NCT00828919|157208958|FG000|Overall Study|No longer willing to participate in study|0|||
48827446|NCT00828919|157208959|FG001|Overall Study|No longer willing to participate in study|0|||
48827447|NCT00828919|157208960|FG002|Overall Study|No longer willing to participate in study|2|||
48827448|NCT00828919|157208961|FG003|Overall Study|No longer willing to participate in study|0|||
48827449|NCT00828919|157208962|FG004|Overall Study|No longer willing to participate in study|0|||
48827450|NCT00828919|157208958|FG000|Overall Study|Insufficient Clinical Response|0|||
48827451|NCT00828919|157208959|FG001|Overall Study|Insufficient Clinical Response|1|||
48827452|NCT00828919|157208960|FG002|Overall Study|Insufficient Clinical Response|2|||
48827453|NCT00828919|157208961|FG003|Overall Study|Insufficient Clinical Response|0|||
48827454|NCT00828919|157208962|FG004|Overall Study|Insufficient Clinical Response|0|||
49154916|NCT01928394|158406561|FG007|Follow-up Period|other reason|3|||
49154917|NCT01928394|158406562|FG008|Follow-up Period|other reason|0|||
49154918|NCT01928394|158406563|FG009|Follow-up Period|other reason|0|||
49154919|NCT01928394|158406564|FG010|Follow-up Period|other reason|2|||
49154920|NCT01928394|158406565|FG011|Follow-up Period|other reason|1|||
48827455|NCT00828919|157208958|FG000|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
48827456|NCT00828919|157208959|FG001|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
49154921|NCT01928394|158406566|FG012|Follow-up Period|other reason|0|||
48827457|NCT00828919|157208960|FG002|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
48827458|NCT00828919|157208961|FG003|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
48827459|NCT00828919|157208962|FG004|Overall Study|Subject refused continued treatment for reason other than adverse event|3|||
48827460|NCT00828919|157208958|FG000|Overall Study|Other|1|||
48827461|NCT00828919|157208959|FG001|Overall Study|Other|0|||
48827462|NCT00828919|157208960|FG002|Overall Study|Other|1|||
48827463|NCT00828919|157208961|FG003|Overall Study|Other|1|||
48827464|NCT00828919|157208962|FG004|Overall Study|Other|0|||
49154922|NCT01928394|158406567|FG013|Follow-up Period|other reason|1|||
49154923|NCT01928394|158406568|FG014|Follow-up Period|other reason|4|||
49154924|NCT01928394|158406569|FG015|Follow-up Period|other reason|0|||
49154925|NCT01928394|158406570|FG016|Follow-up Period|other reason|2|||
49154926|NCT01928394|158406571|FG017|Follow-up Period|other reason|0|||
48827465|NCT00828919|157208958|FG000|Overall Study|Lost to Follow-up|0|||
49154927|NCT01928394|158406572|FG018|Follow-up Period|other reason|1|||
49154928|NCT01928394|158406573|FG019|Follow-up Period|other reason|1|||
49154929|NCT01928394|158406574|FG020|Follow-up Period|other reason|0|||
49154930|NCT01928394|158406575|FG021|Follow-up Period|other reason|0|||
49154931|NCT01928394|158406576|FG022|Follow-up Period|other reason|1|||
49154932|NCT01928394|158406554|FG000|Follow-up Period|Lost to Follow-up|0|||
49154933|NCT01928394|158406555|FG001|Follow-up Period|Lost to Follow-up|0|||
49154934|NCT01928394|158406556|FG002|Follow-up Period|Lost to Follow-up|0|||
49154935|NCT01928394|158406557|FG003|Follow-up Period|Lost to Follow-up|0|||
48827466|NCT00828919|157208959|FG001|Overall Study|Lost to Follow-up|1|||
48827467|NCT00828919|157208960|FG002|Overall Study|Lost to Follow-up|0|||
48827468|NCT00828919|157208961|FG003|Overall Study|Lost to Follow-up|0|||
48827469|NCT00828919|157208962|FG004|Overall Study|Lost to Follow-up|0|||
48827470|NCT05567159|157208963|FG000|Overall Study|Adverse Event|4|||
48827471|NCT05567159|157208963|FG000|Overall Study|Physician Decision|3|||
48827472|NCT05567159|157208963|FG000|Overall Study|Protocol deviation|1|||
48827473|NCT05355805|157208964|FG000|Overall Study|Lost to Follow-up|6|||
48827474|NCT05355805|157208965|FG001|Overall Study|Lost to Follow-up|5|||
48827475|NCT05355805|157208966|FG002|Overall Study|Lost to Follow-up|6|||
48827476|NCT05355805|157208967|FG003|Overall Study|Lost to Follow-up|2|||
48827477|NCT05355805|157208964|FG000|Overall Study|Decision by Sponsor|0|||
48827478|NCT05355805|157208965|FG001|Overall Study|Decision by Sponsor|0|||
48827479|NCT05355805|157208966|FG002|Overall Study|Decision by Sponsor|0|||
48827480|NCT05355805|157208967|FG003|Overall Study|Decision by Sponsor|1|||
48827481|NCT05355805|157208964|FG000|Overall Study|Withdrawal by Subject|7|||
48827482|NCT05355805|157208965|FG001|Overall Study|Withdrawal by Subject|10|||
48827483|NCT05355805|157208966|FG002|Overall Study|Withdrawal by Subject|9|||
48827484|NCT05355805|157208967|FG003|Overall Study|Withdrawal by Subject|2|||
48827485|NCT05355805|157208964|FG000|Overall Study|Missing|0|||
48827486|NCT05355805|157208965|FG001|Overall Study|Missing|0|||
48827487|NCT05355805|157208966|FG002|Overall Study|Missing|1|||
48827488|NCT05355805|157208967|FG003|Overall Study|Missing|0|||
48827489|NCT05355805|157208964|FG000|Overall Study|Ongoing|0|||
48827490|NCT05355805|157208965|FG001|Overall Study|Ongoing|41|||
48827491|NCT05355805|157208966|FG002|Overall Study|Ongoing|38|||
48827492|NCT05355805|157208967|FG003|Overall Study|Ongoing|48|||
48827493|NCT05052983|157208968|FG000|Overall Study|Lack of Efficacy|3|||
48827494|NCT05052983|157208969|FG001|Overall Study|Lack of Efficacy|12|||
48827495|NCT05052983|157208968|FG000|Overall Study|Adverse Event|1|||
48827496|NCT05052983|157208969|FG001|Overall Study|Adverse Event|0|||
48827497|NCT03425643|157208970|FG000|Overall Study|Withdrawal by Subject|10|||
48827498|NCT03425643|157208971|FG001|Overall Study|Withdrawal by Subject|12|||
48827499|NCT03425643|157208970|FG000|Overall Study|Lost to Follow-up|2|||
48827500|NCT03425643|157208971|FG001|Overall Study|Lost to Follow-up|0|||
48827501|NCT03425643|157208970|FG000|Overall Study|Death|109|||
48827502|NCT03425643|157208971|FG001|Overall Study|Death|141|||
48827503|NCT03425643|157208970|FG000|Overall Study|Ongoing in study|276|||
48827504|NCT03425643|157208971|FG001|Overall Study|Ongoing in study|247|||
48827505|NCT01304706|157210973|FG000|Overall Study|Adverse Event|2|||
48827506|NCT01304706|157210973|FG000|Overall Study|Lack of Efficacy|1|||
48827507|NCT01304706|157210973|FG000|Overall Study|Death|3|||
48827508|NCT01304706|157210973|FG000|Overall Study|Withdrawal by Subject|3|||
48827509|NCT01304706|157210973|FG000|Overall Study|Lost to Follow-up|7|||
49154936|NCT01928394|158406558|FG004|Follow-up Period|Lost to Follow-up|0|||
49154937|NCT01928394|158406559|FG005|Follow-up Period|Lost to Follow-up|0|||
49154938|NCT01928394|158406560|FG006|Follow-up Period|Lost to Follow-up|0|||
49154939|NCT01928394|158406561|FG007|Follow-up Period|Lost to Follow-up|0|||
49154940|NCT01928394|158406562|FG008|Follow-up Period|Lost to Follow-up|0|||
49154941|NCT01928394|158406563|FG009|Follow-up Period|Lost to Follow-up|0|||
49154942|NCT01928394|158406564|FG010|Follow-up Period|Lost to Follow-up|0|||
49154943|NCT01928394|158406565|FG011|Follow-up Period|Lost to Follow-up|1|||
49154944|NCT01928394|158406566|FG012|Follow-up Period|Lost to Follow-up|1|||
49154945|NCT01928394|158406567|FG013|Follow-up Period|Lost to Follow-up|0|||
49154946|NCT01928394|158406568|FG014|Follow-up Period|Lost to Follow-up|1|||
48827510|NCT01304706|157210973|FG000|Overall Study|Discontinued due to failed drug admin.|1|||
49154947|NCT01928394|158406569|FG015|Follow-up Period|Lost to Follow-up|0|||
48827511|NCT03303105|157210981|FG000|Overall Study|Adverse Event|0|||
48827512|NCT03303105|157210982|FG001|Overall Study|Adverse Event|2|||
48827513|NCT03303105|157210981|FG000|Overall Study|Lack of Efficacy|1|||
48827514|NCT03303105|157210982|FG001|Overall Study|Lack of Efficacy|0|||
48827515|NCT03303105|157210981|FG000|Overall Study|Protocol Violation|1|||
48827516|NCT03303105|157210982|FG001|Overall Study|Protocol Violation|0|||
48827517|NCT03303105|157210981|FG000|Overall Study|Withdrawal by Subject|0|||
48827518|NCT03303105|157210982|FG001|Overall Study|Withdrawal by Subject|2|||
48827519|NCT01240356|157210985|FG000|Overall Study|Withdrawal by Subject|2|||
48827520|NCT01240356|157210986|FG001|Overall Study|Withdrawal by Subject|0|||
49154948|NCT01928394|158406570|FG016|Follow-up Period|Lost to Follow-up|1|||
49154949|NCT01928394|158406571|FG017|Follow-up Period|Lost to Follow-up|0|||
49154950|NCT01928394|158406572|FG018|Follow-up Period|Lost to Follow-up|0|||
49154951|NCT01928394|158406573|FG019|Follow-up Period|Lost to Follow-up|0|||
49154952|NCT01928394|158406574|FG020|Follow-up Period|Lost to Follow-up|0|||
49154953|NCT01928394|158406575|FG021|Follow-up Period|Lost to Follow-up|0|||
49154954|NCT01928394|158406576|FG022|Follow-up Period|Lost to Follow-up|1|||
49154955|NCT04549454|158406578|FG000|T1 to T2|Lost to Follow-up|22|||
49154956|NCT04549454|158406579|FG001|T1 to T2|Lost to Follow-up|26|||
49154957|NCT04549454|158406578|FG000|T1 to T3|Lost to Follow-up|31|||
49154958|NCT04549454|158406579|FG001|T1 to T3|Lost to Follow-up|36|||
49154959|NCT01542788|158406590|FG000|Overall Study|Randomized but Not Treated|2|||
49154960|NCT01542788|158406591|FG001|Overall Study|Randomized but Not Treated|0|||
49154961|NCT01542788|158406590|FG000|Overall Study|Lack of Efficacy|41|||
49154962|NCT01542788|158406591|FG001|Overall Study|Lack of Efficacy|71|||
49154963|NCT01542788|158406590|FG000|Overall Study|Lost to Follow-up|5|||
49154964|NCT01542788|158406591|FG001|Overall Study|Lost to Follow-up|0|||
49154965|NCT01542788|158406590|FG000|Overall Study|Death|3|||
49154966|NCT01542788|158406591|FG001|Overall Study|Death|0|||
49154967|NCT01542788|158406590|FG000|Overall Study|Protocol Violation|2|||
49154968|NCT01542788|158406591|FG001|Overall Study|Protocol Violation|0|||
49154969|NCT01542788|158406590|FG000|Overall Study|Physician Decision|1|||
49154970|NCT01542788|158406591|FG001|Overall Study|Physician Decision|0|||
49154971|NCT01542788|158406590|FG000|Overall Study|Withdrawal by Subject|1|||
49154972|NCT01542788|158406591|FG001|Overall Study|Withdrawal by Subject|0|||
49154973|NCT01972659|158406592|FG000|Overall Study|Protocol Violation|2|||
49154974|NCT01972659|158406593|FG001|Overall Study|Protocol Violation|2|||
49154975|NCT01972659|158406592|FG000|Overall Study|problems realted to acceleromyograph|2|||
48735334|NCT04295772|156882279|FG001|Overall Study|Ongoing for safety monitoring|1|||
49154976|NCT01972659|158406593|FG001|Overall Study|problems realted to acceleromyograph|1|||
49154977|NCT01107886|158406610|FG000|Overall Study|Lost to Follow-up|15|||
49154978|NCT01107886|158406611|FG001|Overall Study|Lost to Follow-up|13|||
49154979|NCT01107886|158406610|FG000|Overall Study|Withdrawal by Subject|180|||
49154980|NCT01107886|158406611|FG001|Overall Study|Withdrawal by Subject|196|||
49154981|NCT01107886|158406610|FG000|Overall Study|Administrative withdrawal of consent|7|||
49154982|NCT01107886|158406611|FG001|Overall Study|Administrative withdrawal of consent|5|||
49154983|NCT04237584|158406613|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
49154984|NCT04237584|158406614|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
49154985|NCT04237584|158406615|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
49154986|NCT04237584|158406616|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
49154987|NCT04237584|158406613|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
49154988|NCT04237584|158406614|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
49154989|NCT04237584|158406615|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|0|||
49154990|NCT04237584|158406616|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
49154991|NCT04237584|158406613|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
49154992|NCT04237584|158406614|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
49154993|NCT04237584|158406615|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|2|||
48735335|NCT04295772|156882278|FG000|Overall Study|Excluded from results due to informed consent issue|2|||
48735336|NCT04295772|156882279|FG001|Overall Study|Excluded from results due to informed consent issue|0|||
48735337|NCT02805972|156882284|FG000|Washout Period|Lost to Follow-up|3|||
48735338|NCT02805972|156882285|FG001|Washout Period|Lost to Follow-up|0|||
48735339|NCT01927627|156882288|FG000|Overall Study|Adverse Event|3|||
48735340|NCT01927627|156882288|FG000|Overall Study|Lack of Efficacy|1|||
48735341|NCT01927627|156882288|FG000|Overall Study|Financial Concerns|1|||
48735342|NCT03608254|156882289|FG000|Overall Study|Blood sampling was not completed for 2 participants.|2|||
48735343|NCT03608254|156882289|FG000|Overall Study|One participant chose not to consume the entire 12-ounce dose of watermelon juice.|1|||
48735344|NCT03511664|156882290|FG000|Overall Study|Death|457|||
48735345|NCT03511664|156882291|FG001|Overall Study|Death|201|||
48827521|NCT01240356|157210985|FG000|Overall Study|MRI contraindication|1|||
48827522|NCT01240356|157210986|FG001|Overall Study|MRI contraindication|0|||
49154994|NCT04237584|158406616|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
49154995|NCT04237584|158406613|FG000|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
49154996|NCT04237584|158406614|FG001|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
49154997|NCT04237584|158406615|FG002|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|2|||
49154998|NCT04237584|158406616|FG003|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|3|||
49154999|NCT04237584|158406613|FG000|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
49155000|NCT04237584|158406614|FG001|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
48735346|NCT03511664|156882292|FG002|Overall Study|Death|21|||
48735347|NCT03511664|156882290|FG000|Overall Study|Withdrew consent|40|||
48735348|NCT03511664|156882291|FG001|Overall Study|Withdrew consent|63|||
48735349|NCT03511664|156882292|FG002|Overall Study|Withdrew consent|3|||
48735350|NCT03511664|156882290|FG000|Overall Study|Other protocol pre-specified reasons for discontinuation|15|||
48735351|NCT03511664|156882291|FG001|Overall Study|Other protocol pre-specified reasons for discontinuation|4|||
48735352|NCT03511664|156882292|FG002|Overall Study|Other protocol pre-specified reasons for discontinuation|2|||
48735353|NCT03511664|156882290|FG000|Overall Study|Lost to Follow-up|8|||
48735354|NCT03511664|156882291|FG001|Overall Study|Lost to Follow-up|5|||
48735355|NCT03511664|156882292|FG002|Overall Study|Lost to Follow-up|0|||
48735356|NCT03511664|156882290|FG000|Overall Study|Physician Decision|2|||
48735357|NCT03511664|156882291|FG001|Overall Study|Physician Decision|1|||
48735358|NCT03511664|156882292|FG002|Overall Study|Physician Decision|0|||
48735359|NCT03511664|156882290|FG000|Overall Study|Patient non-compliance|1|||
48735360|NCT03511664|156882291|FG001|Overall Study|Patient non-compliance|0|||
48735361|NCT03511664|156882292|FG002|Overall Study|Patient non-compliance|0|||
48735362|NCT01528033|156882293|FG000|Primary Endpoint Assessment ITT|Withdrawal by Subject|8|||
48735363|NCT01528033|156882294|FG001|Primary Endpoint Assessment ITT|Withdrawal by Subject|7|||
48735364|NCT01528033|156882293|FG000|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
48735365|NCT01528033|156882294|FG001|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
48735366|NCT01528033|156882293|FG000|Primary Endpoint Assessment ITT|Death|2|||
48735367|NCT01528033|156882294|FG001|Primary Endpoint Assessment ITT|Death|2|||
48735368|NCT01528033|156882293|FG000|Primary Endpoint Assessment ITT|Physician Decision|2|||
48735369|NCT01528033|156882294|FG001|Primary Endpoint Assessment ITT|Physician Decision|1|||
48735370|NCT01528033|156882293|FG000|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
48735371|NCT01528033|156882294|FG001|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
48735372|NCT01528033|156882293|FG000|Follow Up|No data available|46|||
48735373|NCT01528033|156882294|FG001|Follow Up|No data available|44|||
48735374|NCT02121522|156882295|FG000|Overall Study|Adverse Event|1|||
48735375|NCT00338104|156882297|FG000|Overall Study|Protocol Violation|2|||
48735376|NCT00338104|156882298|FG001|Overall Study|Protocol Violation|1|||
48735377|NCT00338104|156882299|FG002|Overall Study|Protocol Violation|3|||
48735378|NCT03855228|156882300|FG000|Overall Study|Adverse Event|2|||
49155001|NCT04237584|158406615|FG002|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|1|||
49155002|NCT04237584|158406616|FG003|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
49155003|NCT00590317|158408442|FG000|Overall Study|Lack of Efficacy|1|||
49155004|NCT00590317|158408443|FG001|Overall Study|Lack of Efficacy|5|||
49155005|NCT03837509|158408446|FG000|Phase 1|Death|5|||
49155006|NCT03837509|158408447|FG001|Phase 1|Death|2|||
49155007|NCT03837509|158408448|FG002|Phase 1|Death|0|||
49155008|NCT03837509|158408449|FG003|Phase 1|Death|0|||
49155009|NCT03837509|158408450|FG004|Phase 1|Death|0|||
49155010|NCT03837509|158408446|FG000|Phase 2|Death|0|||
49155011|NCT03837509|158408447|FG001|Phase 2|Death|0|||
49155012|NCT03837509|158408448|FG002|Phase 2|Death|0|||
49155013|NCT03837509|158408449|FG003|Phase 2|Death|1|||
49155014|NCT03837509|158408450|FG004|Phase 2|Death|1|||
49155015|NCT04110145|158408455|FG000|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
49155016|NCT04110145|158408456|FG001|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
49155017|NCT04110145|158408457|FG002|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
49155018|NCT04110145|158408458|FG003|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|1|||
49155019|NCT04110145|158408459|FG004|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
49155020|NCT00851084|158408465|FG000|Overall Study|Randomized but not treated|1|||
49155021|NCT00851084|158408466|FG001|Overall Study|Randomized but not treated|0|||
49155022|NCT00851084|158408465|FG000|Overall Study|Adverse Event|26|||
49155023|NCT00851084|158408466|FG001|Overall Study|Adverse Event|36|||
49155024|NCT00851084|158408465|FG000|Overall Study|Disease progression|52|||
49155025|NCT00851084|158408466|FG001|Overall Study|Disease progression|47|||
49155026|NCT00851084|158408465|FG000|Overall Study|Poor compliance to protocol|1|||
49155027|NCT00851084|158408466|FG001|Overall Study|Poor compliance to protocol|1|||
49155028|NCT00851084|158408465|FG000|Overall Study|Physician Decision|13|||
49155029|NCT00851084|158408466|FG001|Overall Study|Physician Decision|14|||
49155030|NCT00851084|158408465|FG000|Overall Study|Consent withdrawn|0|||
49155031|NCT00851084|158408466|FG001|Overall Study|Consent withdrawn|2|||
48735379|NCT03855228|156882301|FG001|Overall Study|Adverse Event|4|||
48735380|NCT03855228|156882302|FG002|Overall Study|Adverse Event|4|||
48735381|NCT03855228|156882303|FG003|Overall Study|Adverse Event|8|||
48735382|NCT03855228|156882300|FG000|Overall Study|Treatment Failure|1|||
48735383|NCT03855228|156882301|FG001|Overall Study|Treatment Failure|2|||
48735384|NCT03855228|156882302|FG002|Overall Study|Treatment Failure|1|||
48735385|NCT03855228|156882303|FG003|Overall Study|Treatment Failure|8|||
48735386|NCT03855228|156882300|FG000|Overall Study|Lost to Follow-up|0|||
48735387|NCT03855228|156882301|FG001|Overall Study|Lost to Follow-up|0|||
48735388|NCT03855228|156882302|FG002|Overall Study|Lost to Follow-up|0|||
48735389|NCT03855228|156882303|FG003|Overall Study|Lost to Follow-up|1|||
48735390|NCT03855228|156882300|FG000|Overall Study|Protocol Violation|0|||
48735391|NCT03855228|156882301|FG001|Overall Study|Protocol Violation|1|||
48735392|NCT03855228|156882302|FG002|Overall Study|Protocol Violation|2|||
48735393|NCT03855228|156882303|FG003|Overall Study|Protocol Violation|1|||
48735394|NCT03855228|156882300|FG000|Overall Study|Did Not Meet Entry Requirements|0|||
48735395|NCT03855228|156882301|FG001|Overall Study|Did Not Meet Entry Requirements|2|||
48735396|NCT03855228|156882302|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
48735397|NCT03855228|156882303|FG003|Overall Study|Did Not Meet Entry Requirements|1|||
48735398|NCT00761631|156882316|FG000|Overall Study|Parent/legal guardian request|8|||
48735399|NCT00761631|156882317|FG001|Overall Study|Parent/legal guardian request|3|||
48735400|NCT00761631|156882318|FG002|Overall Study|Parent/legal guardian request|8|||
48735401|NCT00761631|156882319|FG003|Overall Study|Parent/legal guardian request|0|||
48735402|NCT00761631|156882320|FG004|Overall Study|Parent/legal guardian request|5|||
48735403|NCT00761631|156882321|FG005|Overall Study|Parent/legal guardian request|0|||
48735404|NCT00761631|156882316|FG000|Overall Study|Lost to Follow-up|2|||
48735405|NCT00761631|156882317|FG001|Overall Study|Lost to Follow-up|4|||
48735406|NCT00761631|156882318|FG002|Overall Study|Lost to Follow-up|7|||
48735407|NCT00761631|156882319|FG003|Overall Study|Lost to Follow-up|1|||
48735408|NCT00761631|156882320|FG004|Overall Study|Lost to Follow-up|6|||
48827523|NCT02735915|157210996|FG000|Overall Study|Not vaccinated but subject ID assigned|8|||
48827524|NCT02735915|157210996|FG000|Overall Study|Withdrawal following SAE|2|||
48827525|NCT02735915|157210996|FG000|Overall Study|Withdrawal by Subject|1|||
48827526|NCT05328973|157210997|FG000|Overall Study|Withdrawal by Subject|0|||
48827527|NCT05328973|157210998|FG001|Overall Study|Withdrawal by Subject|1|||
48827528|NCT00515086|157210999|FG000|Overall Study|Adverse Event|1|||
48827529|NCT00515086|157211000|FG001|Overall Study|Adverse Event|1|||
48827530|NCT00515086|157211001|FG002|Overall Study|Adverse Event|2|||
48827531|NCT00515086|157211002|FG003|Overall Study|Adverse Event|3|||
48827532|NCT00515086|157210999|FG000|Overall Study|Administrative|1|||
48827533|NCT00515086|157211000|FG001|Overall Study|Administrative|1|||
48827534|NCT00515086|157211001|FG002|Overall Study|Administrative|0|||
48827535|NCT00515086|157211002|FG003|Overall Study|Administrative|0|||
48827536|NCT00515086|157210999|FG000|Overall Study|Withdrawal by Subject|1|||
48827537|NCT00515086|157211000|FG001|Overall Study|Withdrawal by Subject|0|||
48827538|NCT00515086|157211001|FG002|Overall Study|Withdrawal by Subject|0|||
48827539|NCT00515086|157211002|FG003|Overall Study|Withdrawal by Subject|1|||
48827540|NCT00515086|157210999|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
48827541|NCT00515086|157211000|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
48827542|NCT00515086|157211001|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
48827543|NCT00515086|157211002|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
48827544|NCT00515086|157210999|FG000|Overall Study|Lost to Follow-up|1|||
48827545|NCT00515086|157211000|FG001|Overall Study|Lost to Follow-up|0|||
48827546|NCT00515086|157211001|FG002|Overall Study|Lost to Follow-up|0|||
48827547|NCT00515086|157211002|FG003|Overall Study|Lost to Follow-up|0|||
48827548|NCT00515086|157210999|FG000|Overall Study|Study drug no longer required|0|||
48827549|NCT00515086|157211000|FG001|Overall Study|Study drug no longer required|1|||
48827550|NCT00515086|157211001|FG002|Overall Study|Study drug no longer required|0|||
48827551|NCT00515086|157211002|FG003|Overall Study|Study drug no longer required|0|||
48827552|NCT00515086|157210999|FG000|Overall Study|Death|2|||
48827553|NCT00515086|157211000|FG001|Overall Study|Death|0|||
48827554|NCT00515086|157211001|FG002|Overall Study|Death|0|||
48827555|NCT00515086|157211002|FG003|Overall Study|Death|0|||
48827556|NCT00868231|157211003|FG000|Treatment Period 1|Adverse Event|0|||
48827557|NCT00868231|157211004|FG001|Treatment Period 1|Adverse Event|0|||
48827558|NCT00868231|157211005|FG002|Treatment Period 1|Adverse Event|0|||
48827559|NCT00868231|157211006|FG003|Treatment Period 1|Adverse Event|0|||
48827560|NCT00868231|157211007|FG004|Treatment Period 1|Adverse Event|1|||
48827561|NCT00868231|157211008|FG005|Treatment Period 1|Adverse Event|0|||
48827562|NCT00868231|157211003|FG000|Treatment Period 2|Adverse Event|1|||
48827563|NCT00868231|157211004|FG001|Treatment Period 2|Adverse Event|0|||
48827564|NCT00868231|157211005|FG002|Treatment Period 2|Adverse Event|0|||
48827565|NCT00868231|157211006|FG003|Treatment Period 2|Adverse Event|0|||
48827566|NCT00868231|157211007|FG004|Treatment Period 2|Adverse Event|0|||
48827567|NCT00868231|157211008|FG005|Treatment Period 2|Adverse Event|0|||
48827568|NCT00868231|157211003|FG000|Treatment Period 3|Adverse Event|0|||
48827569|NCT00868231|157211004|FG001|Treatment Period 3|Adverse Event|0|||
48827570|NCT00868231|157211005|FG002|Treatment Period 3|Adverse Event|1|||
48827571|NCT00868231|157211006|FG003|Treatment Period 3|Adverse Event|0|||
48827572|NCT00868231|157211007|FG004|Treatment Period 3|Adverse Event|0|||
48827573|NCT00868231|157211008|FG005|Treatment Period 3|Adverse Event|0|||
48827574|NCT03120676|157211011|FG000|Overall Study|Not treated|1|||
48827575|NCT01107626|157211012|FG000|Step 1: Induction Therapy|Lack of Efficacy|167|||
48827576|NCT01107626|157211013|FG001|Step 1: Induction Therapy|Lack of Efficacy|0|||
48827577|NCT01107626|157211014|FG002|Step 1: Induction Therapy|Lack of Efficacy|0|||
48827578|NCT01107626|157211015|FG003|Step 1: Induction Therapy|Lack of Efficacy|0|||
48827579|NCT01107626|157211012|FG000|Step 1: Induction Therapy|Adverse Event|198|||
48827580|NCT01107626|157211013|FG001|Step 1: Induction Therapy|Adverse Event|0|||
48827581|NCT01107626|157211014|FG002|Step 1: Induction Therapy|Adverse Event|0|||
48827582|NCT01107626|157211015|FG003|Step 1: Induction Therapy|Adverse Event|0|||
48827583|NCT01107626|157211012|FG000|Step 1: Induction Therapy|Death|62|||
48827584|NCT01107626|157211013|FG001|Step 1: Induction Therapy|Death|0|||
48827585|NCT01107626|157211014|FG002|Step 1: Induction Therapy|Death|0|||
48827586|NCT01107626|157211015|FG003|Step 1: Induction Therapy|Death|0|||
48827587|NCT01107626|157211012|FG000|Step 1: Induction Therapy|Withdrawal by Subject|54|||
48827588|NCT01107626|157211013|FG001|Step 1: Induction Therapy|Withdrawal by Subject|0|||
48827589|NCT01107626|157211014|FG002|Step 1: Induction Therapy|Withdrawal by Subject|0|||
48827590|NCT01107626|157211015|FG003|Step 1: Induction Therapy|Withdrawal by Subject|0|||
48827591|NCT01107626|157211012|FG000|Step 1: Induction Therapy|Complicating disease|13|||
48827592|NCT01107626|157211013|FG001|Step 1: Induction Therapy|Complicating disease|0|||
49155032|NCT00851084|158408465|FG000|Overall Study|Withdrawal by Subject|11|||
49155033|NCT00851084|158408466|FG001|Overall Study|Withdrawal by Subject|12|||
49155034|NCT00851084|158408465|FG000|Overall Study|Metastatic surgery|6|||
49155035|NCT00851084|158408466|FG001|Overall Study|Metastatic surgery|6|||
49155036|NCT00851084|158408465|FG000|Overall Study|Other|7|||
49155037|NCT00851084|158408466|FG001|Overall Study|Other|1|||
49155038|NCT00730327|158408467|FG000|Overall Study|Lost to Follow-up|14|||
49155039|NCT00730327|158408468|FG001|Overall Study|Lost to Follow-up|16|||
49155040|NCT00730327|158408467|FG000|Overall Study|Adverse Event|8|||
49155041|NCT00730327|158408468|FG001|Overall Study|Adverse Event|1|||
49155042|NCT00730327|158408467|FG000|Overall Study|Withdrawal by Subject|3|||
49155043|NCT00730327|158408468|FG001|Overall Study|Withdrawal by Subject|13|||
49155044|NCT00730327|158408467|FG000|Overall Study|Subject withdrew (reason not specified)|2|||
49155045|NCT00730327|158408468|FG001|Overall Study|Subject withdrew (reason not specified)|7|||
49155046|NCT02552225|158408471|FG000|Overall Study|Withdrawal by Subject|1|||
49155047|NCT02552225|158408472|FG001|Overall Study|Withdrawal by Subject|0|||
49155048|NCT00688740|158408485|FG000|Overall Study|Adverse Event|45|||
49155049|NCT00688740|158408486|FG001|Overall Study|Adverse Event|8|||
48827593|NCT01107626|157211014|FG002|Step 1: Induction Therapy|Complicating disease|0|||
48827594|NCT01107626|157211015|FG003|Step 1: Induction Therapy|Complicating disease|0|||
48827595|NCT01107626|157211012|FG000|Step 1: Induction Therapy|Alternative therapy|12|||
48827596|NCT01107626|157211013|FG001|Step 1: Induction Therapy|Alternative therapy|0|||
48827597|NCT01107626|157211014|FG002|Step 1: Induction Therapy|Alternative therapy|0|||
48827598|NCT01107626|157211015|FG003|Step 1: Induction Therapy|Alternative therapy|0|||
48827599|NCT01107626|157211012|FG000|Step 1: Induction Therapy|Symptomatic deterioration|10|||
48827600|NCT01107626|157211013|FG001|Step 1: Induction Therapy|Symptomatic deterioration|0|||
48827601|NCT01107626|157211014|FG002|Step 1: Induction Therapy|Symptomatic deterioration|0|||
48827602|NCT01107626|157211015|FG003|Step 1: Induction Therapy|Symptomatic deterioration|0|||
48827603|NCT01107626|157211012|FG000|Step 1: Induction Therapy|Non-compliance|4|||
48827604|NCT01107626|157211013|FG001|Step 1: Induction Therapy|Non-compliance|0|||
48827605|NCT01107626|157211014|FG002|Step 1: Induction Therapy|Non-compliance|0|||
48827606|NCT01107626|157211015|FG003|Step 1: Induction Therapy|Non-compliance|0|||
48827607|NCT01107626|157211012|FG000|Step 1: Induction Therapy|Pain|4|||
48827608|NCT01107626|157211013|FG001|Step 1: Induction Therapy|Pain|0|||
48827609|NCT01107626|157211014|FG002|Step 1: Induction Therapy|Pain|0|||
49155050|NCT00688740|158408485|FG000|Overall Study|Death|2|||
49155051|NCT00688740|158408486|FG001|Overall Study|Death|2|||
48827610|NCT01107626|157211015|FG003|Step 1: Induction Therapy|Pain|0|||
48827611|NCT01107626|157211012|FG000|Step 1: Induction Therapy|Protocol Violation|1|||
49155052|NCT00688740|158408485|FG000|Overall Study|Lost to Follow-up|0|||
49155053|NCT00688740|158408486|FG001|Overall Study|Lost to Follow-up|1|||
49155054|NCT00688740|158408485|FG000|Overall Study|Consent Withdrawn|17|||
48827612|NCT01107626|157211013|FG001|Step 1: Induction Therapy|Protocol Violation|0|||
48827613|NCT01107626|157211014|FG002|Step 1: Induction Therapy|Protocol Violation|0|||
48827614|NCT01107626|157211015|FG003|Step 1: Induction Therapy|Protocol Violation|0|||
48827615|NCT01107626|157211012|FG000|Step 1: Induction Therapy|Hospice care|1|||
48827616|NCT01107626|157211013|FG001|Step 1: Induction Therapy|Hospice care|0|||
48827617|NCT01107626|157211014|FG002|Step 1: Induction Therapy|Hospice care|0|||
48827618|NCT01107626|157211015|FG003|Step 1: Induction Therapy|Hospice care|0|||
48827619|NCT01107626|157211012|FG000|Step 1: Induction Therapy|Physician Decision|1|||
48827620|NCT01107626|157211013|FG001|Step 1: Induction Therapy|Physician Decision|0|||
48827621|NCT01107626|157211014|FG002|Step 1: Induction Therapy|Physician Decision|0|||
49155055|NCT00688740|158408486|FG001|Overall Study|Consent Withdrawn|17|||
49155056|NCT00688740|158408485|FG000|Overall Study|Breast Cancer Relapse|1|||
49155057|NCT00688740|158408486|FG001|Overall Study|Breast Cancer Relapse|4|||
49155058|NCT00688740|158408485|FG000|Overall Study|Violation of Inclusion Criteria|1|||
48827622|NCT01107626|157211015|FG003|Step 1: Induction Therapy|Physician Decision|0|||
48827623|NCT01107626|157211012|FG000|Step 1: Induction Therapy|Off treatment reason not reported|50|||
48827624|NCT01107626|157211013|FG001|Step 1: Induction Therapy|Off treatment reason not reported|0|||
48827625|NCT01107626|157211014|FG002|Step 1: Induction Therapy|Off treatment reason not reported|0|||
48827626|NCT01107626|157211015|FG003|Step 1: Induction Therapy|Off treatment reason not reported|0|||
49155059|NCT00688740|158408486|FG001|Overall Study|Violation of Inclusion Criteria|3|||
49155060|NCT01168596|158408487|FG000|Overall Study|Withdrawal by Subject|3|||
49155061|NCT01168596|158408488|FG001|Overall Study|Withdrawal by Subject|1|||
49155062|NCT03090152|158408489|FG000|Overall Study|Withdrawal by Subject|0|||
49155063|NCT03090152|158408490|FG001|Overall Study|Withdrawal by Subject|2|||
49155064|NCT03090152|158408491|FG002|Overall Study|Withdrawal by Subject|1|||
48922319|NCT03311711|157550004|FG003|Overall Study|Withdrawal by Subject|0|||
49155065|NCT03090152|158408489|FG000|Overall Study|Surgery Canceled|1|||
49155066|NCT03090152|158408490|FG001|Overall Study|Surgery Canceled|0|||
49155067|NCT03090152|158408491|FG002|Overall Study|Surgery Canceled|0|||
49155068|NCT03090152|158408489|FG000|Overall Study|Epidural catheter could not be placed|0|||
49155069|NCT03090152|158408490|FG001|Overall Study|Epidural catheter could not be placed|2|||
49155070|NCT03090152|158408491|FG002|Overall Study|Epidural catheter could not be placed|0|||
49155071|NCT00856557|158408492|FG000|Overall Study|No patients with contextual flags|12|||
49155072|NCT00856557|158408493|FG001|Overall Study|No patients with contextual flags|16|||
49155073|NCT01230060|158408494|FG000|Overall Study|Withdrawal by Subject|1|||
49155074|NCT00565747|158408495|FG000|Overall Study|No embryo transfer|67|||
49155075|NCT00565747|158408496|FG001|Overall Study|No embryo transfer|73|||
49155076|NCT03309202|158408497|FG000|Overall Study|Lost to Follow-up|1|||
49155077|NCT03309202|158408498|FG001|Overall Study|Lost to Follow-up|0|||
49155078|NCT03309202|158408499|FG002|Overall Study|Lost to Follow-up|0|||
49155079|NCT03309202|158408500|FG003|Overall Study|Lost to Follow-up|0|||
49155080|NCT00415636|158408501|FG000|Overall Study|Symptomatic deterioration|1|||
49155081|NCT00415636|158408502|FG001|Overall Study|Symptomatic deterioration|0|||
49155082|NCT00415636|158408503|FG002|Overall Study|Symptomatic deterioration|1|||
49155083|NCT00415636|158408504|FG003|Overall Study|Symptomatic deterioration|2|||
49155084|NCT00415636|158408505|FG004|Overall Study|Symptomatic deterioration|0|||
49155085|NCT00415636|158408506|FG005|Overall Study|Symptomatic deterioration|1|||
49155086|NCT00415636|158408501|FG000|Overall Study|Adverse Event|0|||
49155087|NCT00415636|158408502|FG001|Overall Study|Adverse Event|0|||
49155088|NCT00415636|158408503|FG002|Overall Study|Adverse Event|0|||
49155089|NCT00415636|158408504|FG003|Overall Study|Adverse Event|1|||
49155090|NCT00415636|158408505|FG004|Overall Study|Adverse Event|1|||
49155091|NCT00415636|158408506|FG005|Overall Study|Adverse Event|0|||
49155092|NCT00415636|158408501|FG000|Overall Study|Withdrawal by Subject|0|||
49155093|NCT00415636|158408502|FG001|Overall Study|Withdrawal by Subject|0|||
49155094|NCT00415636|158408503|FG002|Overall Study|Withdrawal by Subject|0|||
49155095|NCT00415636|158408504|FG003|Overall Study|Withdrawal by Subject|0|||
49155096|NCT00415636|158408505|FG004|Overall Study|Withdrawal by Subject|1|||
49155097|NCT00415636|158408506|FG005|Overall Study|Withdrawal by Subject|0|||
49155098|NCT00415636|158408501|FG000|Overall Study|Disease progression|0|||
49155099|NCT00415636|158408502|FG001|Overall Study|Disease progression|0|||
49155100|NCT00415636|158408503|FG002|Overall Study|Disease progression|0|||
49155101|NCT00415636|158408504|FG003|Overall Study|Disease progression|3|||
49155102|NCT00415636|158408505|FG004|Overall Study|Disease progression|0|||
49155103|NCT00415636|158408506|FG005|Overall Study|Disease progression|1|||
49155104|NCT04507204|158408510|FG000|Overall Study|Adverse Event|8|||
49155105|NCT04507204|158408511|FG001|Overall Study|Adverse Event|13|||
49155106|NCT04507204|158408510|FG000|Overall Study|Death|0|||
49155107|NCT04507204|158408511|FG001|Overall Study|Death|1|||
49155108|NCT04507204|158408510|FG000|Overall Study|Lost to Follow-up|15|||
49155109|NCT04507204|158408511|FG001|Overall Study|Lost to Follow-up|14|||
49155110|NCT04507204|158408510|FG000|Overall Study|Poor Compliance with Protocol|2|||
49155111|NCT04507204|158408511|FG001|Overall Study|Poor Compliance with Protocol|4|||
49155112|NCT04507204|158408510|FG000|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|4|||
49155113|NCT04507204|158408511|FG001|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|3|||
49155114|NCT04507204|158408510|FG000|Overall Study|Withdrawal of Patient Consent|21|||
49155115|NCT04507204|158408511|FG001|Overall Study|Withdrawal of Patient Consent|13|||
49155116|NCT01702298|158408512|FG000|Overall Study|Withdrawal by Subject|1|||
49155117|NCT04388826|158408515|FG000|Overall Study|Lost to Follow-up|3|||
49155118|NCT04388826|158408516|FG001|Overall Study|Lost to Follow-up|2|||
49155119|NCT04388826|158408515|FG000|Overall Study|Adverse Event|1|||
49155120|NCT04388826|158408516|FG001|Overall Study|Adverse Event|0|||
49155121|NCT00443456|158408517|FG000|Overall Study|Adverse Event|16|||
49155122|NCT00443456|158408517|FG000|Overall Study|Move|1|||
49155123|NCT00443456|158408517|FG000|Overall Study|Withdrawal by Subject|1|||
49155124|NCT00557440|158408527|FG000|Treatment Period 1|Adverse Event|0|||
49155125|NCT00557440|158408528|FG001|Treatment Period 1|Adverse Event|0|||
48922320|NCT03311711|157550005|FG004|Overall Study|Withdrawal by Subject|0|||
48922321|NCT03311711|157550006|FG005|Overall Study|Withdrawal by Subject|0|||
49155126|NCT00557440|158408529|FG002|Treatment Period 1|Adverse Event|1|||
49155127|NCT02164864|158408531|FG000|Overall Study|Trial disease worsening|7|||
49155128|NCT02164864|158408532|FG001|Overall Study|Trial disease worsening|5|||
49155129|NCT02164864|158408533|FG002|Overall Study|Trial disease worsening|1|||
49155130|NCT02164864|158408531|FG000|Overall Study|Other pre-existing disease worsening|6|||
49155131|NCT02164864|158408532|FG001|Overall Study|Other pre-existing disease worsening|4|||
49155132|NCT02164864|158408533|FG002|Overall Study|Other pre-existing disease worsening|9|||
49155133|NCT02164864|158408531|FG000|Overall Study|Other Adverse Event (AE)|52|||
49155134|NCT02164864|158408532|FG001|Overall Study|Other Adverse Event (AE)|32|||
48827627|NCT01107626|157211012|FG000|Step 2: Maintenance Therapy|Lack of Efficacy|0|||
48827628|NCT01107626|157211013|FG001|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
48827629|NCT01107626|157211014|FG002|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
48827630|NCT01107626|157211015|FG003|Step 2: Maintenance Therapy|Lack of Efficacy|170|||
48827631|NCT01107626|157211012|FG000|Step 2: Maintenance Therapy|Adverse Event|0|||
48827632|NCT01107626|157211013|FG001|Step 2: Maintenance Therapy|Adverse Event|32|||
48827633|NCT01107626|157211014|FG002|Step 2: Maintenance Therapy|Adverse Event|29|||
48827634|NCT01107626|157211015|FG003|Step 2: Maintenance Therapy|Adverse Event|46|||
48827635|NCT01107626|157211012|FG000|Step 2: Maintenance Therapy|Death|0|||
48827636|NCT01107626|157211013|FG001|Step 2: Maintenance Therapy|Death|8|||
48827637|NCT01107626|157211014|FG002|Step 2: Maintenance Therapy|Death|2|||
48827638|NCT01107626|157211015|FG003|Step 2: Maintenance Therapy|Death|13|||
48827639|NCT01107626|157211012|FG000|Step 2: Maintenance Therapy|Withdrawal by Subject|0|||
48827640|NCT01107626|157211013|FG001|Step 2: Maintenance Therapy|Withdrawal by Subject|11|||
48827641|NCT01107626|157211014|FG002|Step 2: Maintenance Therapy|Withdrawal by Subject|21|||
48827642|NCT01107626|157211015|FG003|Step 2: Maintenance Therapy|Withdrawal by Subject|27|||
48827643|NCT01107626|157211012|FG000|Step 2: Maintenance Therapy|Alternative therapy|0|||
48827644|NCT01107626|157211013|FG001|Step 2: Maintenance Therapy|Alternative therapy|2|||
48827645|NCT01107626|157211014|FG002|Step 2: Maintenance Therapy|Alternative therapy|4|||
48827646|NCT01107626|157211015|FG003|Step 2: Maintenance Therapy|Alternative therapy|5|||
48827647|NCT01107626|157211012|FG000|Step 2: Maintenance Therapy|Other complicating disease|0|||
48827648|NCT01107626|157211013|FG001|Step 2: Maintenance Therapy|Other complicating disease|2|||
48827649|NCT01107626|157211014|FG002|Step 2: Maintenance Therapy|Other complicating disease|5|||
48827650|NCT01107626|157211015|FG003|Step 2: Maintenance Therapy|Other complicating disease|9|||
48827651|NCT01107626|157211012|FG000|Step 2: Maintenance Therapy|Symptomatic deterioration|0|||
48827652|NCT01107626|157211013|FG001|Step 2: Maintenance Therapy|Symptomatic deterioration|2|||
48827653|NCT01107626|157211014|FG002|Step 2: Maintenance Therapy|Symptomatic deterioration|4|||
48827654|NCT01107626|157211015|FG003|Step 2: Maintenance Therapy|Symptomatic deterioration|3|||
48827655|NCT01107626|157211012|FG000|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0|||
48827656|NCT01107626|157211013|FG001|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
48827657|NCT01107626|157211014|FG002|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
48827658|NCT01107626|157211015|FG003|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3|||
48827659|NCT01107626|157211012|FG000|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
48827660|NCT01107626|157211013|FG001|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
48827661|NCT01107626|157211014|FG002|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
48827662|NCT01107626|157211015|FG003|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
48827663|NCT01107626|157211012|FG000|Step 2: Maintenance Therapy|Financial reason|0|||
48827664|NCT01107626|157211013|FG001|Step 2: Maintenance Therapy|Financial reason|2|||
48827665|NCT01107626|157211014|FG002|Step 2: Maintenance Therapy|Financial reason|0|||
48827666|NCT01107626|157211015|FG003|Step 2: Maintenance Therapy|Financial reason|0|||
48827667|NCT01107626|157211012|FG000|Step 2: Maintenance Therapy|Physician Decision|0|||
48827668|NCT01107626|157211013|FG001|Step 2: Maintenance Therapy|Physician Decision|2|||
48827669|NCT01107626|157211014|FG002|Step 2: Maintenance Therapy|Physician Decision|3|||
48827670|NCT01107626|157211015|FG003|Step 2: Maintenance Therapy|Physician Decision|3|||
48827671|NCT01107626|157211012|FG000|Step 2: Maintenance Therapy|Hospice care|0|||
48827672|NCT01107626|157211013|FG001|Step 2: Maintenance Therapy|Hospice care|1|||
48827673|NCT01107626|157211014|FG002|Step 2: Maintenance Therapy|Hospice care|2|||
48827674|NCT01107626|157211015|FG003|Step 2: Maintenance Therapy|Hospice care|0|||
48827675|NCT01107626|157211012|FG000|Step 2: Maintenance Therapy|Non-compliance|0|||
48827676|NCT01107626|157211013|FG001|Step 2: Maintenance Therapy|Non-compliance|0|||
48827677|NCT01107626|157211014|FG002|Step 2: Maintenance Therapy|Non-compliance|0|||
48827678|NCT01107626|157211015|FG003|Step 2: Maintenance Therapy|Non-compliance|2|||
48827679|NCT01107626|157211012|FG000|Step 2: Maintenance Therapy|Pain|0|||
48827680|NCT01107626|157211013|FG001|Step 2: Maintenance Therapy|Pain|0|||
48827681|NCT01107626|157211014|FG002|Step 2: Maintenance Therapy|Pain|0|||
48827682|NCT01107626|157211015|FG003|Step 2: Maintenance Therapy|Pain|1|||
48827683|NCT01107626|157211012|FG000|Step 2: Maintenance Therapy|Off treatment reason not reported|0|||
48827684|NCT01107626|157211013|FG001|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
48827685|NCT01107626|157211014|FG002|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
48827686|NCT01107626|157211015|FG003|Step 2: Maintenance Therapy|Off treatment reason not reported|10|||
48827687|NCT00711646|157211016|FG000|Overall Study|Adverse Event|6|||
48827688|NCT00711646|157211017|FG001|Overall Study|Adverse Event|1|||
48827689|NCT00711646|157211016|FG000|Overall Study|Withdrawal by Subject|4|||
48827690|NCT00711646|157211017|FG001|Overall Study|Withdrawal by Subject|0|||
48827691|NCT00711646|157211016|FG000|Overall Study|Protocol Violation|0|||
48827692|NCT00711646|157211017|FG001|Overall Study|Protocol Violation|1|||
48827693|NCT00711646|157211016|FG000|Overall Study|Lost to Follow-up|1|||
48827694|NCT00711646|157211017|FG001|Overall Study|Lost to Follow-up|0|||
48827695|NCT00711646|157211016|FG000|Overall Study|administrative decision|0|||
49155135|NCT02164864|158408533|FG002|Overall Study|Other Adverse Event (AE)|49|||
49155136|NCT02164864|158408531|FG000|Overall Study|Protocol Violation|2|||
49155137|NCT02164864|158408532|FG001|Overall Study|Protocol Violation|4|||
49155138|NCT02164864|158408533|FG002|Overall Study|Protocol Violation|1|||
49155139|NCT02164864|158408531|FG000|Overall Study|Lost to Follow-up|4|||
49155140|NCT02164864|158408532|FG001|Overall Study|Lost to Follow-up|3|||
49155141|NCT02164864|158408533|FG002|Overall Study|Lost to Follow-up|2|||
49155142|NCT02164864|158408531|FG000|Overall Study|Consent withdrawn, not due to AE|21|||
48827696|NCT00711646|157211017|FG001|Overall Study|administrative decision|1|||
48827697|NCT00711646|157211016|FG000|Overall Study|patient non-compliance|1|||
48827698|NCT00711646|157211017|FG001|Overall Study|patient non-compliance|0|||
48827699|NCT03302156|157211018|FG000|Overall Study|no visible evidence of tumor on MRI|0|||
48827700|NCT03302156|157211019|FG001|Overall Study|no visible evidence of tumor on MRI|1|||
48827701|NCT03302156|157211020|FG002|Overall Study|no visible evidence of tumor on MRI|0|||
48827702|NCT01280591|157211021|FG000|Overall Study|Withdrawal by Subject|0|||
48827703|NCT01280591|157211022|FG001|Overall Study|Withdrawal by Subject|0|||
48827704|NCT01280591|157211023|FG002|Overall Study|Withdrawal by Subject|0|||
48827705|NCT01280591|157211024|FG003|Overall Study|Withdrawal by Subject|2|||
49155143|NCT02164864|158408532|FG001|Overall Study|Consent withdrawn, not due to AE|8|||
49155144|NCT02164864|158408533|FG002|Overall Study|Consent withdrawn, not due to AE|56|||
49155145|NCT02164864|158408531|FG000|Overall Study|Other than stated|3|||
49155146|NCT02164864|158408532|FG001|Overall Study|Other than stated|4|||
49155147|NCT02164864|158408533|FG002|Overall Study|Other than stated|14|||
49155148|NCT00261833|158408534|FG000|Overall Study|Death|1|||
49155149|NCT00261833|158408535|FG001|Overall Study|Death|3|||
49155150|NCT00261833|158408534|FG000|Overall Study|Adverse Event|1|||
49155151|NCT00261833|158408535|FG001|Overall Study|Adverse Event|4|||
49155152|NCT00261833|158408534|FG000|Overall Study|Withdrawal by Subject|5|||
49155153|NCT00261833|158408535|FG001|Overall Study|Withdrawal by Subject|7|||
49155154|NCT00261833|158408534|FG000|Overall Study|Protocol Violation|0|||
48827706|NCT01280591|157211021|FG000|Overall Study|Does not meet exclusion #27 criteria|0|||
49155155|NCT00261833|158408535|FG001|Overall Study|Protocol Violation|1|||
49155156|NCT00261833|158408534|FG000|Overall Study|Suspicion of pulmonary cancer|0|||
49155157|NCT00261833|158408535|FG001|Overall Study|Suspicion of pulmonary cancer|1|||
48827707|NCT01280591|157211022|FG001|Overall Study|Does not meet exclusion #27 criteria|0|||
48827708|NCT01280591|157211023|FG002|Overall Study|Does not meet exclusion #27 criteria|0|||
48827709|NCT01280591|157211024|FG003|Overall Study|Does not meet exclusion #27 criteria|1|||
48827710|NCT02390557|157211025|FG000|Wave 2|Survey non-respondent|72|||
48827711|NCT02390557|157211026|FG001|Wave 2|Survey non-respondent|41|||
48827712|NCT02390557|157211027|FG002|Wave 2|Survey non-respondent|23|||
48827713|NCT05419557|157211030|FG000|Overall Study|Lost to Follow-up|11|||
48827714|NCT05419557|157211031|FG001|Overall Study|Lost to Follow-up|4|||
48827715|NCT04582877|157211032|FG000|Overall Study|Did not use device measurement|5|||
48827716|NCT04582877|157211032|FG000|Overall Study|No fractional flow reserve test results|2|||
48827717|NCT04582877|157211032|FG000|Overall Study|Protocol Violation|1|||
48827718|NCT01833065|157211034|FG000|Overall Study|Adverse Event|6|||
48827719|NCT01833065|157211035|FG001|Overall Study|Adverse Event|1|||
48827720|NCT01833065|157211036|FG002|Overall Study|Adverse Event|0|||
48827721|NCT01833065|157211037|FG003|Overall Study|Adverse Event|2|||
48827722|NCT01833065|157211038|FG004|Overall Study|Adverse Event|3|||
48827723|NCT01833065|157211034|FG000|Overall Study|Protocol Violation|1|||
48827724|NCT01833065|157211035|FG001|Overall Study|Protocol Violation|0|||
48827725|NCT01833065|157211036|FG002|Overall Study|Protocol Violation|0|||
48827726|NCT01833065|157211037|FG003|Overall Study|Protocol Violation|0|||
48827727|NCT01833065|157211038|FG004|Overall Study|Protocol Violation|2|||
48827728|NCT01833065|157211034|FG000|Overall Study|Lost to Follow-up|1|||
48827729|NCT01833065|157211035|FG001|Overall Study|Lost to Follow-up|0|||
48827730|NCT01833065|157211036|FG002|Overall Study|Lost to Follow-up|0|||
48827731|NCT01833065|157211037|FG003|Overall Study|Lost to Follow-up|0|||
48827732|NCT01833065|157211038|FG004|Overall Study|Lost to Follow-up|3|||
48827733|NCT01833065|157211034|FG000|Overall Study|Withdrawal by Subject|6|||
48827734|NCT01833065|157211035|FG001|Overall Study|Withdrawal by Subject|2|||
48827735|NCT01833065|157211036|FG002|Overall Study|Withdrawal by Subject|4|||
48827736|NCT01833065|157211037|FG003|Overall Study|Withdrawal by Subject|3|||
48827737|NCT01833065|157211038|FG004|Overall Study|Withdrawal by Subject|11|||
48827738|NCT01833065|157211034|FG000|Overall Study|Subject's substantial non-compliance|0|||
48827739|NCT01833065|157211035|FG001|Overall Study|Subject's substantial non-compliance|1|||
48827740|NCT01833065|157211036|FG002|Overall Study|Subject's substantial non-compliance|0|||
48827741|NCT01833065|157211037|FG003|Overall Study|Subject's substantial non-compliance|0|||
48827742|NCT01833065|157211038|FG004|Overall Study|Subject's substantial non-compliance|0|||
49155158|NCT00261833|158408534|FG000|Overall Study|Lung transplantation|1|||
49155159|NCT00261833|158408535|FG001|Overall Study|Lung transplantation|1|||
49155160|NCT00261833|158408534|FG000|Overall Study|Missing reason|1|||
49155161|NCT00261833|158408535|FG001|Overall Study|Missing reason|0|||
49155162|NCT00261833|158408534|FG000|Overall Study|Not interested in being participant|0|||
48922322|NCT03311711|157550007|FG006|Overall Study|Withdrawal by Subject|3|||
48922323|NCT03311711|157550008|FG007|Overall Study|Withdrawal by Subject|3|||
48922324|NCT03311711|157550009|FG008|Overall Study|Withdrawal by Subject|0|||
48922325|NCT03311711|157550010|FG009|Overall Study|Withdrawal by Subject|0|||
48922326|NCT00975156|157550017|FG000|Overall Study|Protocol Violation|0|||
48922327|NCT00975156|157550018|FG001|Overall Study|Protocol Violation|1|||
48922328|NCT02646982|157550020|FG000|Overall Study|Adverse Event|1|||
48922329|NCT02646982|157550021|FG001|Overall Study|Adverse Event|1|||
48922330|NCT02646982|157550020|FG000|Overall Study|Withdrawal by Subject|2|||
48922331|NCT02646982|157550021|FG001|Overall Study|Withdrawal by Subject|1|||
48922332|NCT04169373|157550022|FG000|Week 1 to Week 14|Adverse Event|1|||
49155163|NCT00261833|158408535|FG001|Overall Study|Not interested in being participant|1|||
49155164|NCT01378195|158408536|FG000|Overall Study|Lost to Follow-up|29|||
49155165|NCT01378195|158408537|FG001|Overall Study|Lost to Follow-up|18|||
49155166|NCT02434081|158408538|FG000|Overall Study|Death (never started treatment)|2|||
49155167|NCT02434081|158408538|FG000|Overall Study|Death|2|||
49155168|NCT02434081|158408538|FG000|Overall Study|Progression|20|||
49155169|NCT02434081|158408538|FG000|Overall Study|Adverse Event|20|||
49155170|NCT02434081|158408538|FG000|Overall Study|Physician Decision|2|||
49155171|NCT02434081|158408538|FG000|Overall Study|Withdrawal by Subject|1|||
49155172|NCT02434081|158408538|FG000|Overall Study|Patient did not receive treatment for more than six weeks|1|||
48692901|NCT03137992|156724646|FG000|Washout Period 1|Principal Investigator Discretion|0|||
48827743|NCT01833065|157211034|FG000|Overall Study|Trial terminated by sponsor|8|||
48827744|NCT01833065|157211035|FG001|Overall Study|Trial terminated by sponsor|8|||
48827745|NCT01833065|157211036|FG002|Overall Study|Trial terminated by sponsor|7|||
48827746|NCT01833065|157211037|FG003|Overall Study|Trial terminated by sponsor|3|||
48827747|NCT01833065|157211038|FG004|Overall Study|Trial terminated by sponsor|13|||
48827748|NCT01833065|157211034|FG000|Overall Study|Others|2|||
48827749|NCT01833065|157211035|FG001|Overall Study|Others|1|||
48827750|NCT01833065|157211036|FG002|Overall Study|Others|1|||
48827751|NCT01833065|157211037|FG003|Overall Study|Others|1|||
48827752|NCT01833065|157211038|FG004|Overall Study|Others|4|||
48827753|NCT00567164|157211040|FG000|Overall Study|Withdrawal by Subject|171|||
48827754|NCT00567164|157211041|FG001|Overall Study|Withdrawal by Subject|21|||
48827755|NCT00567164|157211042|FG002|Overall Study|Withdrawal by Subject|17|||
48827756|NCT00567164|157211040|FG000|Overall Study|Protocol Violation|23|||
48827757|NCT00567164|157211041|FG001|Overall Study|Protocol Violation|4|||
48827758|NCT00567164|157211042|FG002|Overall Study|Protocol Violation|2|||
48827759|NCT00567164|157211040|FG000|Overall Study|Adverse Event|92|||
48827760|NCT00567164|157211041|FG001|Overall Study|Adverse Event|13|||
48827761|NCT00567164|157211042|FG002|Overall Study|Adverse Event|9|||
48827762|NCT00567164|157211040|FG000|Overall Study|Death|0|||
48922333|NCT04169373|157550023|FG001|Week 1 to Week 14|Adverse Event|0|||
48922334|NCT04169373|157550024|FG002|Week 1 to Week 14|Adverse Event|1|||
48922335|NCT04169373|157550025|FG003|Week 1 to Week 14|Adverse Event|2|||
48922336|NCT04169373|157550022|FG000|Week 1 to Week 14|Withdrawal by Subject|2|||
48922337|NCT04169373|157550023|FG001|Week 1 to Week 14|Withdrawal by Subject|0|||
48922338|NCT04169373|157550024|FG002|Week 1 to Week 14|Withdrawal by Subject|5|||
48922339|NCT04169373|157550025|FG003|Week 1 to Week 14|Withdrawal by Subject|6|||
48922340|NCT04169373|157550022|FG000|Week 1 to Week 14|Lost to Follow-up|1|||
48922341|NCT04169373|157550023|FG001|Week 1 to Week 14|Lost to Follow-up|1|||
48922342|NCT04169373|157550024|FG002|Week 1 to Week 14|Lost to Follow-up|0|||
48922343|NCT04169373|157550025|FG003|Week 1 to Week 14|Lost to Follow-up|1|||
48922344|NCT04169373|157550022|FG000|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
48922345|NCT04169373|157550023|FG001|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|1|||
48922346|NCT04169373|157550024|FG002|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
48922347|NCT04169373|157550025|FG003|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
48922348|NCT04169373|157550022|FG000|Week 1 to Week 14|Other|1|||
48922349|NCT04169373|157550023|FG001|Week 1 to Week 14|Other|3|||
48922350|NCT04169373|157550024|FG002|Week 1 to Week 14|Other|3|||
48922351|NCT04169373|157550025|FG003|Week 1 to Week 14|Other|5|||
48922352|NCT04169373|157550022|FG000|Week 14 to Week 52|Adverse Event|1|||
48922353|NCT04169373|157550023|FG001|Week 14 to Week 52|Adverse Event|0|||
48922354|NCT04169373|157550024|FG002|Week 14 to Week 52|Adverse Event|0|||
48922355|NCT04169373|157550025|FG003|Week 14 to Week 52|Adverse Event|1|||
48922356|NCT04169373|157550022|FG000|Week 14 to Week 52|Withdrawal by Subject|4|||
48922357|NCT04169373|157550023|FG001|Week 14 to Week 52|Withdrawal by Subject|5|||
48922358|NCT04169373|157550024|FG002|Week 14 to Week 52|Withdrawal by Subject|7|||
48922359|NCT04169373|157550025|FG003|Week 14 to Week 52|Withdrawal by Subject|2|||
48922360|NCT04169373|157550022|FG000|Week 14 to Week 52|Lost to Follow-up|2|||
48922361|NCT04169373|157550023|FG001|Week 14 to Week 52|Lost to Follow-up|1|||
48922362|NCT04169373|157550024|FG002|Week 14 to Week 52|Lost to Follow-up|0|||
48922363|NCT04169373|157550025|FG003|Week 14 to Week 52|Lost to Follow-up|1|||
49155173|NCT04164901|158408539|FG000|Overall Study|Withdrawal by Subject|4|||
49155174|NCT04164901|158408540|FG001|Overall Study|Withdrawal by Subject|4|||
49155175|NCT00725985|158408542|FG000|ITP- Treatment Disposition|Adverse Event|20|||
48827763|NCT00567164|157211041|FG001|Overall Study|Death|0|||
48827764|NCT00567164|157211042|FG002|Overall Study|Death|1|||
48735409|NCT00761631|156882321|FG005|Overall Study|Lost to Follow-up|1|||
48735410|NCT00761631|156882316|FG000|Overall Study|Protocol Violation|2|||
48735411|NCT00761631|156882317|FG001|Overall Study|Protocol Violation|0|||
48735412|NCT00761631|156882318|FG002|Overall Study|Protocol Violation|0|||
48735413|NCT00761631|156882319|FG003|Overall Study|Protocol Violation|1|||
48735414|NCT00761631|156882320|FG004|Overall Study|Protocol Violation|5|||
48735415|NCT00761631|156882321|FG005|Overall Study|Protocol Violation|1|||
48735416|NCT00761631|156882316|FG000|Overall Study|Randomized, not treated|1|||
48735417|NCT00761631|156882317|FG001|Overall Study|Randomized, not treated|0|||
48735418|NCT00761631|156882318|FG002|Overall Study|Randomized, not treated|0|||
48735419|NCT00761631|156882319|FG003|Overall Study|Randomized, not treated|0|||
48735420|NCT00761631|156882320|FG004|Overall Study|Randomized, not treated|0|||
48827765|NCT00567164|157211040|FG000|Overall Study|Lost to Follow-up|202|||
48827766|NCT00567164|157211041|FG001|Overall Study|Lost to Follow-up|23|||
48827767|NCT00567164|157211042|FG002|Overall Study|Lost to Follow-up|21|||
48827768|NCT00567164|157211040|FG000|Overall Study|Pregnancy|20|||
48827769|NCT00567164|157211041|FG001|Overall Study|Pregnancy|4|||
48827770|NCT00567164|157211042|FG002|Overall Study|Pregnancy|6|||
48827771|NCT00567164|157211040|FG000|Overall Study|Primary Reason coded as 'Other'|37|||
48827772|NCT00567164|157211041|FG001|Overall Study|Primary Reason coded as 'Other'|8|||
48827773|NCT00567164|157211042|FG002|Overall Study|Primary Reason coded as 'Other'|16|||
48827774|NCT00567164|157211040|FG000|Overall Study|Missing|1|||
48827775|NCT00567164|157211041|FG001|Overall Study|Missing|0|||
48827776|NCT00567164|157211042|FG002|Overall Study|Missing|0|||
48827777|NCT02282527|157211044|FG000|Overall Study|Lost to Follow-up|0|||
48827778|NCT02282527|157211045|FG001|Overall Study|Lost to Follow-up|1|||
48827779|NCT02282527|157211044|FG000|Overall Study|Lack of home health aid|1|||
48827780|NCT02282527|157211045|FG001|Overall Study|Lack of home health aid|0|||
48827781|NCT00941031|157211046|FG000|Induction Period|Lack of Efficacy|2|||
48827782|NCT00941031|157211047|FG001|Induction Period|Lack of Efficacy|1|||
48827783|NCT00941031|157211048|FG002|Induction Period|Lack of Efficacy|0|||
48827784|NCT00941031|157211049|FG003|Induction Period|Lack of Efficacy|5|||
48827785|NCT00941031|157211050|FG004|Induction Period|Lack of Efficacy|0|||
48827786|NCT00941031|157211051|FG005|Induction Period|Lack of Efficacy|0|||
48827787|NCT00941031|157211052|FG006|Induction Period|Lack of Efficacy|0|||
48827788|NCT00941031|157211046|FG000|Induction Period|Withdrawal by Subject|1|||
48827789|NCT00941031|157211047|FG001|Induction Period|Withdrawal by Subject|2|||
48827790|NCT00941031|157211048|FG002|Induction Period|Withdrawal by Subject|2|||
48827791|NCT00941031|157211049|FG003|Induction Period|Withdrawal by Subject|2|||
48827792|NCT00941031|157211050|FG004|Induction Period|Withdrawal by Subject|0|||
48827793|NCT00941031|157211051|FG005|Induction Period|Withdrawal by Subject|0|||
48827794|NCT00941031|157211052|FG006|Induction Period|Withdrawal by Subject|0|||
48827795|NCT00941031|157211046|FG000|Induction Period|Adminstative Problems|1|||
48827796|NCT00941031|157211047|FG001|Induction Period|Adminstative Problems|1|||
48827797|NCT00941031|157211048|FG002|Induction Period|Adminstative Problems|1|||
48827798|NCT00941031|157211049|FG003|Induction Period|Adminstative Problems|0|||
48827799|NCT00941031|157211050|FG004|Induction Period|Adminstative Problems|0|||
48827800|NCT00941031|157211051|FG005|Induction Period|Adminstative Problems|0|||
48827801|NCT00941031|157211052|FG006|Induction Period|Adminstative Problems|0|||
48827802|NCT00941031|157211046|FG000|Induction Period|Adverse Event|1|||
48827803|NCT00941031|157211047|FG001|Induction Period|Adverse Event|0|||
48827804|NCT00941031|157211048|FG002|Induction Period|Adverse Event|3|||
48827805|NCT00941031|157211049|FG003|Induction Period|Adverse Event|2|||
48827806|NCT00941031|157211050|FG004|Induction Period|Adverse Event|0|||
48827807|NCT00941031|157211051|FG005|Induction Period|Adverse Event|0|||
49014360|NCT02035137|157888833|FG000|Overall Study|Withdrawal by Subject|0|||
49014361|NCT02035137|157888834|FG001|Overall Study|Withdrawal by Subject|1|||
49014362|NCT02035137|157888835|FG002|Overall Study|Withdrawal by Subject|2|||
48827808|NCT00941031|157211052|FG006|Induction Period|Adverse Event|0|||
49014363|NCT02035137|157888833|FG000|Overall Study|Ineligible|0|||
49014364|NCT02035137|157888834|FG001|Overall Study|Ineligible|1|||
49014365|NCT02035137|157888835|FG002|Overall Study|Ineligible|2|||
49014366|NCT02035137|157888833|FG000|Overall Study|Disease progression prior to treatment start|2|||
49014367|NCT02035137|157888834|FG001|Overall Study|Disease progression prior to treatment start|0|||
49014368|NCT02035137|157888835|FG002|Overall Study|Disease progression prior to treatment start|0|||
49014369|NCT00903383|157888842|FG000|Overall Study|Adverse Event|1|||
49014370|NCT00903383|157888843|FG001|Overall Study|Adverse Event|2|||
49014371|NCT00903383|157888844|FG002|Overall Study|Adverse Event|3|||
49014372|NCT00903383|157888845|FG003|Overall Study|Adverse Event|1|||
49014373|NCT00903383|157888842|FG000|Overall Study|Physician Decision|1|||
49014374|NCT00903383|157888843|FG001|Overall Study|Physician Decision|2|||
49014375|NCT00903383|157888844|FG002|Overall Study|Physician Decision|0|||
49014376|NCT00903383|157888845|FG003|Overall Study|Physician Decision|0|||
49014377|NCT00903383|157888842|FG000|Overall Study|Lost to Follow-up|0|||
49014378|NCT00903383|157888843|FG001|Overall Study|Lost to Follow-up|0|||
49014379|NCT00903383|157888844|FG002|Overall Study|Lost to Follow-up|0|||
49155176|NCT00725985|158408543|FG001|ITP- Treatment Disposition|Adverse Event|10|||
49155177|NCT00725985|158408544|FG002|ITP- Treatment Disposition|Adverse Event|5|||
49155178|NCT00725985|158408545|FG003|ITP- Treatment Disposition|Adverse Event|0|||
49155179|NCT00725985|158408546|FG004|ITP- Treatment Disposition|Adverse Event|0|||
49155180|NCT00725985|158408547|FG005|ITP- Treatment Disposition|Adverse Event|0|||
49155181|NCT00725985|158408548|FG006|ITP- Treatment Disposition|Adverse Event|0|||
49155182|NCT00725985|158408549|FG007|ITP- Treatment Disposition|Adverse Event|0|||
49155183|NCT00725985|158408550|FG008|ITP- Treatment Disposition|Adverse Event|0|||
49155184|NCT00725985|158408551|FG009|ITP- Treatment Disposition|Adverse Event|0|||
49155185|NCT00725985|158408552|FG010|ITP- Treatment Disposition|Adverse Event|0|||
49155186|NCT00725985|158408553|FG011|ITP- Treatment Disposition|Adverse Event|0|||
48735421|NCT00761631|156882321|FG005|Overall Study|Randomized, not treated|0|||
48735422|NCT00761631|156882316|FG000|Overall Study|Failed to return|1|||
48735423|NCT00761631|156882317|FG001|Overall Study|Failed to return|0|||
48735424|NCT00761631|156882318|FG002|Overall Study|Failed to return|1|||
48735425|NCT00761631|156882319|FG003|Overall Study|Failed to return|1|||
48735426|NCT00761631|156882320|FG004|Overall Study|Failed to return|5|||
48735427|NCT00761631|156882321|FG005|Overall Study|Failed to return|2|||
48735428|NCT00761631|156882316|FG000|Overall Study|Physician Decision|1|||
48735429|NCT00761631|156882317|FG001|Overall Study|Physician Decision|0|||
48735430|NCT00761631|156882318|FG002|Overall Study|Physician Decision|0|||
48735431|NCT00761631|156882319|FG003|Overall Study|Physician Decision|0|||
48735432|NCT00761631|156882320|FG004|Overall Study|Physician Decision|0|||
48735433|NCT00761631|156882321|FG005|Overall Study|Physician Decision|0|||
48735434|NCT00761631|156882316|FG000|Overall Study|Other|0|||
48735435|NCT00761631|156882317|FG001|Overall Study|Other|0|||
48735436|NCT00761631|156882318|FG002|Overall Study|Other|0|||
48735437|NCT00761631|156882319|FG003|Overall Study|Other|0|||
48735438|NCT00761631|156882320|FG004|Overall Study|Other|1|||
48735439|NCT00761631|156882321|FG005|Overall Study|Other|1|||
48735440|NCT00289016|156882322|FG000|Overall Study|Disease Progression|29|||
48735441|NCT00289016|156882322|FG000|Overall Study|Death|2|||
48735442|NCT00289016|156882322|FG000|Overall Study|Unrelated Medical Condition or Accident|2|||
48735443|NCT00289016|156882322|FG000|Overall Study|Withdrawal by Subject|2|||
48735444|NCT00289016|156882322|FG000|Overall Study|Adverse Event|1|||
48735445|NCT00289016|156882322|FG000|Overall Study|Other|1|||
48735446|NCT01558739|156882325|FG000|Overall Study|Adverse Event|7|||
48735447|NCT01558739|156882325|FG000|Overall Study|Withdrawal by Subject|2|||
48735448|NCT01558739|156882325|FG000|Overall Study|Death|3|||
48735449|NCT01558739|156882325|FG000|Overall Study|Disease Progression|4|||
48735450|NCT01558739|156882325|FG000|Overall Study|Protocol Violation|1|||
48735451|NCT01759511|156882326|FG000|Overall Study|Adverse Event|4|||
48735452|NCT01759511|156882326|FG000|Overall Study|Death|2|||
48827809|NCT00941031|157211046|FG000|Maintenance Period|Withdrawal by Subject|0|||
48827810|NCT00941031|157211047|FG001|Maintenance Period|Withdrawal by Subject|0|||
48827811|NCT00941031|157211048|FG002|Maintenance Period|Withdrawal by Subject|0|||
48827812|NCT00941031|157211049|FG003|Maintenance Period|Withdrawal by Subject|0|||
48827813|NCT00941031|157211050|FG004|Maintenance Period|Withdrawal by Subject|6|||
48827814|NCT00941031|157211051|FG005|Maintenance Period|Withdrawal by Subject|2|||
48827815|NCT00941031|157211052|FG006|Maintenance Period|Withdrawal by Subject|13|||
48827816|NCT00941031|157211046|FG000|Maintenance Period|Administrative Problems|0|||
48827817|NCT00941031|157211047|FG001|Maintenance Period|Administrative Problems|0|||
48827818|NCT00941031|157211048|FG002|Maintenance Period|Administrative Problems|0|||
48827819|NCT00941031|157211049|FG003|Maintenance Period|Administrative Problems|0|||
48827820|NCT00941031|157211050|FG004|Maintenance Period|Administrative Problems|1|||
48827821|NCT00941031|157211051|FG005|Maintenance Period|Administrative Problems|0|||
48827822|NCT00941031|157211052|FG006|Maintenance Period|Administrative Problems|1|||
48827823|NCT00941031|157211046|FG000|Maintenance Period|Protocol Violation|0|||
48827824|NCT00941031|157211047|FG001|Maintenance Period|Protocol Violation|0|||
48827825|NCT00941031|157211048|FG002|Maintenance Period|Protocol Violation|0|||
48827826|NCT00941031|157211049|FG003|Maintenance Period|Protocol Violation|0|||
48827827|NCT00941031|157211050|FG004|Maintenance Period|Protocol Violation|0|||
48827828|NCT00941031|157211051|FG005|Maintenance Period|Protocol Violation|0|||
48827829|NCT00941031|157211052|FG006|Maintenance Period|Protocol Violation|1|||
48827830|NCT00941031|157211046|FG000|Maintenance Period|Adverse Event|0|||
48827831|NCT00941031|157211047|FG001|Maintenance Period|Adverse Event|0|||
48827832|NCT00941031|157211048|FG002|Maintenance Period|Adverse Event|0|||
48827833|NCT00941031|157211049|FG003|Maintenance Period|Adverse Event|0|||
49155187|NCT00725985|158408542|FG000|ITP- Treatment Disposition|Lost to Follow-up|0|||
49155188|NCT00725985|158408543|FG001|ITP- Treatment Disposition|Lost to Follow-up|0|||
49155189|NCT00725985|158408544|FG002|ITP- Treatment Disposition|Lost to Follow-up|2|||
48735453|NCT01759511|156882326|FG000|Overall Study|Lack of Efficacy|2|||
48735454|NCT01759511|156882326|FG000|Overall Study|Physician Decision|1|||
48827834|NCT00941031|157211050|FG004|Maintenance Period|Adverse Event|0|||
48827835|NCT00941031|157211051|FG005|Maintenance Period|Adverse Event|2|||
48827836|NCT00941031|157211052|FG006|Maintenance Period|Adverse Event|8|||
48827837|NCT00941031|157211046|FG000|Maintenance Period|Lost to Follow-up|0|||
48827838|NCT00941031|157211047|FG001|Maintenance Period|Lost to Follow-up|0|||
48827839|NCT00941031|157211048|FG002|Maintenance Period|Lost to Follow-up|0|||
48827840|NCT00941031|157211049|FG003|Maintenance Period|Lost to Follow-up|0|||
48827841|NCT00941031|157211050|FG004|Maintenance Period|Lost to Follow-up|2|||
48827842|NCT00941031|157211051|FG005|Maintenance Period|Lost to Follow-up|2|||
48827843|NCT00941031|157211052|FG006|Maintenance Period|Lost to Follow-up|7|||
48827844|NCT00941031|157211046|FG000|Maintenance Period|Lack of Efficacy|0|||
48827845|NCT00941031|157211047|FG001|Maintenance Period|Lack of Efficacy|0|||
48827846|NCT00941031|157211048|FG002|Maintenance Period|Lack of Efficacy|0|||
48827847|NCT00941031|157211049|FG003|Maintenance Period|Lack of Efficacy|0|||
48827848|NCT00941031|157211050|FG004|Maintenance Period|Lack of Efficacy|0|||
48827849|NCT00941031|157211051|FG005|Maintenance Period|Lack of Efficacy|0|||
48827850|NCT00941031|157211052|FG006|Maintenance Period|Lack of Efficacy|13|||
48827851|NCT03124108|157211054|FG000|Overall Study|Adverse Event|0|||
48827852|NCT03124108|157211055|FG001|Overall Study|Adverse Event|1|||
48827853|NCT03124108|157211056|FG002|Overall Study|Adverse Event|0|||
48827854|NCT00631917|157211059|FG000|Overall Study|Adverse Event|34|||
48827855|NCT00631917|157211060|FG001|Overall Study|Adverse Event|45|||
48827856|NCT00631917|157211059|FG000|Overall Study|Abnormal laboratory value(s)|2|||
48827857|NCT00631917|157211060|FG001|Overall Study|Abnormal laboratory value(s)|1|||
48827858|NCT00631917|157211059|FG000|Overall Study|Abnormal test procedure result(s)|3|||
48827859|NCT00631917|157211060|FG001|Overall Study|Abnormal test procedure result(s)|2|||
48827860|NCT00631917|157211059|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
48827861|NCT00631917|157211060|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
48827862|NCT00631917|157211059|FG000|Overall Study|No longer required study drug|0|||
48827863|NCT00631917|157211060|FG001|Overall Study|No longer required study drug|1|||
48827864|NCT00631917|157211059|FG000|Overall Study|Protocol deviation|6|||
48735455|NCT01759511|156882326|FG000|Overall Study|Progressive Disease|5|||
48735456|NCT01759511|156882326|FG000|Overall Study|Protocol-Specified Criteria for Withdraw|4|||
48735457|NCT01759511|156882326|FG000|Overall Study|Study Terminated by Sponsor|13|||
48735458|NCT01759511|156882326|FG000|Overall Study|Withdrawal by Subject|3|||
48735459|NCT02024555|156882327|FG000|Overall Study|Lost to Follow-up|1|||
48735460|NCT02024555|156882328|FG001|Overall Study|Lost to Follow-up|1|||
48735461|NCT02024555|156882327|FG000|Overall Study|Withdrawal by Subject|5|||
48735462|NCT02024555|156882328|FG001|Overall Study|Withdrawal by Subject|1|||
48735463|NCT00810108|156883616|FG000|Overall Study|Withdrawal by Subject|1|||
48735464|NCT00810108|156883617|FG001|Overall Study|Withdrawal by Subject|0|||
48735465|NCT04806503|156883618|FG000|Overall Study|Lost to Follow-up|0|||
48735466|NCT04806503|156883619|FG001|Overall Study|Lost to Follow-up|0|||
48735467|NCT04806503|156883620|FG002|Overall Study|Lost to Follow-up|1|||
48735468|NCT04806503|156883621|FG003|Overall Study|Lost to Follow-up|0|||
48735469|NCT04806503|156883622|FG004|Overall Study|Lost to Follow-up|0|||
48735470|NCT04806503|156883618|FG000|Overall Study|Withdrawal by Subject|1|||
48735471|NCT04806503|156883619|FG001|Overall Study|Withdrawal by Subject|0|||
48735472|NCT04806503|156883620|FG002|Overall Study|Withdrawal by Subject|1|||
48735473|NCT04806503|156883621|FG003|Overall Study|Withdrawal by Subject|1|||
48735474|NCT04806503|156883622|FG004|Overall Study|Withdrawal by Subject|1|||
48735475|NCT04806503|156883618|FG000|Overall Study|Adverse Event|1|||
48735476|NCT04806503|156883619|FG001|Overall Study|Adverse Event|1|||
48735477|NCT04806503|156883620|FG002|Overall Study|Adverse Event|0|||
48735478|NCT04806503|156883621|FG003|Overall Study|Adverse Event|1|||
48735479|NCT04806503|156883622|FG004|Overall Study|Adverse Event|0|||
48735480|NCT01871142|156883623|FG000|Overall Study|Adverse Event|1|||
48735481|NCT01409434|156883624|FG000|Overall Study|Protocol Violation|4|||
48735482|NCT02336373|156883629|FG000|Overall Study|Protocol closed early|4|||
48735483|NCT02336373|156883629|FG000|Overall Study|Physician Decision|14|||
48735484|NCT01031381|156883640|FG000|Overall Study|Physician Decision|3|||
48735485|NCT01031381|156883640|FG000|Overall Study|Withdrawal by Subject|6|||
48735486|NCT03257371|156883641|FG000|Overall Study|Lost to Follow-up|1|||
48735487|NCT00631696|156883642|FG000|Overall Study|Entered, not randomized to treatment|1|||
48735488|NCT00631696|156883643|FG001|Overall Study|Entered, not randomized to treatment|1|||
48735489|NCT00631696|156883642|FG000|Overall Study|Discontinued after database release date|1|||
48735490|NCT00631696|156883643|FG001|Overall Study|Discontinued after database release date|0|||
48735491|NCT00631696|156883642|FG000|Overall Study|Follow up after database release date|1|||
48735492|NCT00631696|156883643|FG001|Overall Study|Follow up after database release date|0|||
48735493|NCT00631696|156883642|FG000|Overall Study|Lost to Follow-up|7|||
48735494|NCT00631696|156883643|FG001|Overall Study|Lost to Follow-up|10|||
48735495|NCT00631696|156883642|FG000|Overall Study|Withdrawal by Subject|2|||
48735496|NCT00631696|156883643|FG001|Overall Study|Withdrawal by Subject|9|||
48827865|NCT00631917|157211060|FG001|Overall Study|Protocol deviation|5|||
48827866|NCT00631917|157211059|FG000|Overall Study|Subject withdrew consent|25|||
48827867|NCT00631917|157211060|FG001|Overall Study|Subject withdrew consent|33|||
48827868|NCT00631917|157211059|FG000|Overall Study|Lost to Follow-up|7|||
48827869|NCT00631917|157211060|FG001|Overall Study|Lost to Follow-up|7|||
48827870|NCT00631917|157211059|FG000|Overall Study|Administrative problems|2|||
48827871|NCT00631917|157211060|FG001|Overall Study|Administrative problems|0|||
48827872|NCT00631917|157211059|FG000|Overall Study|Death|1|||
48827873|NCT00631917|157211060|FG001|Overall Study|Death|0|||
48827874|NCT00502593|157211063|FG000|Overall Study|Withdrawn unspecified reason|1|||
48827875|NCT00502593|157211064|FG001|Overall Study|Withdrawn unspecified reason|1|||
48827876|NCT00502593|157211065|FG002|Overall Study|Withdrawn unspecified reason|3|||
48827877|NCT00502593|157211066|FG003|Overall Study|Withdrawn unspecified reason|1|||
48827878|NCT00502593|157211067|FG004|Overall Study|Withdrawn unspecified reason|2|||
48827879|NCT00502593|157211068|FG005|Overall Study|Withdrawn unspecified reason|0|||
48827880|NCT00502593|157211069|FG006|Overall Study|Withdrawn unspecified reason|2|||
48827881|NCT00502593|157211070|FG007|Overall Study|Withdrawn unspecified reason|0|||
48827882|NCT00502593|157211071|FG008|Overall Study|Withdrawn unspecified reason|0|||
48827883|NCT00502593|157211072|FG009|Overall Study|Withdrawn unspecified reason|0|||
48827884|NCT00502593|157211073|FG010|Overall Study|Withdrawn unspecified reason|0|||
48827885|NCT00502593|157211074|FG011|Overall Study|Withdrawn unspecified reason|0|||
48827886|NCT00502593|157211063|FG000|Overall Study|Withdrawal by Subject|0|||
48827887|NCT00502593|157211064|FG001|Overall Study|Withdrawal by Subject|0|||
48827888|NCT00502593|157211065|FG002|Overall Study|Withdrawal by Subject|6|||
48827889|NCT00502593|157211066|FG003|Overall Study|Withdrawal by Subject|2|||
48827890|NCT00502593|157211067|FG004|Overall Study|Withdrawal by Subject|2|||
48827891|NCT00502593|157211068|FG005|Overall Study|Withdrawal by Subject|0|||
48827892|NCT00502593|157211069|FG006|Overall Study|Withdrawal by Subject|3|||
48827893|NCT00502593|157211070|FG007|Overall Study|Withdrawal by Subject|0|||
48827894|NCT00502593|157211071|FG008|Overall Study|Withdrawal by Subject|3|||
48827895|NCT00502593|157211072|FG009|Overall Study|Withdrawal by Subject|0|||
48827896|NCT00502593|157211073|FG010|Overall Study|Withdrawal by Subject|1|||
48827897|NCT00502593|157211074|FG011|Overall Study|Withdrawal by Subject|0|||
48827898|NCT00502593|157211063|FG000|Overall Study|Lost to Follow-up|2|||
48827899|NCT00502593|157211064|FG001|Overall Study|Lost to Follow-up|1|||
48827900|NCT00502593|157211065|FG002|Overall Study|Lost to Follow-up|1|||
48827901|NCT00502593|157211066|FG003|Overall Study|Lost to Follow-up|1|||
48827902|NCT00502593|157211067|FG004|Overall Study|Lost to Follow-up|0|||
48827903|NCT00502593|157211068|FG005|Overall Study|Lost to Follow-up|0|||
48827904|NCT00502593|157211069|FG006|Overall Study|Lost to Follow-up|0|||
48827905|NCT00502593|157211070|FG007|Overall Study|Lost to Follow-up|0|||
48827906|NCT00502593|157211071|FG008|Overall Study|Lost to Follow-up|3|||
48827907|NCT00502593|157211072|FG009|Overall Study|Lost to Follow-up|0|||
48827908|NCT00502593|157211073|FG010|Overall Study|Lost to Follow-up|1|||
48827909|NCT00502593|157211074|FG011|Overall Study|Lost to Follow-up|0|||
48827910|NCT01664104|157211075|FG000|Overall Study|Adverse Event|6|||
48827911|NCT01664104|157211075|FG000|Overall Study|Lack of Efficacy|2|||
48827912|NCT01664104|157211075|FG000|Overall Study|Withdrawal by Subject|1|||
48827913|NCT01664104|157211075|FG000|Overall Study|Lost to Follow-up|4|||
48827914|NCT01664104|157211075|FG000|Overall Study|Other|1|||
48827915|NCT01664104|157211075|FG000|Overall Study|Unknown: Reason Unrelated to TCZ|2|||
48827916|NCT03761784|157211078|FG000|Overall Study|Adverse Event|4|||
48827917|NCT03761784|157211079|FG001|Overall Study|Adverse Event|0|||
48827918|NCT03761784|157211078|FG000|Overall Study|Lost to Follow-up|10|||
48827919|NCT03761784|157211079|FG001|Overall Study|Lost to Follow-up|7|||
48827920|NCT03761784|157211078|FG000|Overall Study|Pregnancy|1|||
48827921|NCT03761784|157211079|FG001|Overall Study|Pregnancy|0|||
49014380|NCT00903383|157888845|FG003|Overall Study|Lost to Follow-up|1|||
49014381|NCT00903383|157888842|FG000|Overall Study|Decision of Sponsor|1|||
49014382|NCT00903383|157888843|FG001|Overall Study|Decision of Sponsor|0|||
49014383|NCT00903383|157888844|FG002|Overall Study|Decision of Sponsor|0|||
49014384|NCT00903383|157888845|FG003|Overall Study|Decision of Sponsor|0|||
49014385|NCT00903383|157888842|FG000|Overall Study|Withdrawal by Subject|4|||
49014386|NCT00903383|157888843|FG001|Overall Study|Withdrawal by Subject|1|||
49014387|NCT00903383|157888844|FG002|Overall Study|Withdrawal by Subject|0|||
49014388|NCT00903383|157888845|FG003|Overall Study|Withdrawal by Subject|2|||
49014389|NCT00903383|157888842|FG000|Overall Study|Patient Decision - Lack of Efficacy|0|||
49014390|NCT00903383|157888843|FG001|Overall Study|Patient Decision - Lack of Efficacy|1|||
49014391|NCT00903383|157888844|FG002|Overall Study|Patient Decision - Lack of Efficacy|0|||
49014392|NCT00903383|157888845|FG003|Overall Study|Patient Decision - Lack of Efficacy|0|||
49014393|NCT00903383|157888842|FG000|Overall Study|Patient Decision|0|||
49014394|NCT00903383|157888843|FG001|Overall Study|Patient Decision|0|||
49014395|NCT00903383|157888844|FG002|Overall Study|Patient Decision|0|||
49014396|NCT00903383|157888845|FG003|Overall Study|Patient Decision|1|||
49014397|NCT02611752|157888847|FG000|Overall Study|Adverse Event|0|||
49014398|NCT02611752|157888848|FG001|Overall Study|Adverse Event|1|||
49014399|NCT00310856|157888849|FG000|Overall Study|Withdrawal by Subject|2|||
49155190|NCT00725985|158408545|FG003|ITP- Treatment Disposition|Lost to Follow-up|0|||
49155191|NCT00725985|158408546|FG004|ITP- Treatment Disposition|Lost to Follow-up|0|||
49155192|NCT00725985|158408547|FG005|ITP- Treatment Disposition|Lost to Follow-up|0|||
49155193|NCT00725985|158408548|FG006|ITP- Treatment Disposition|Lost to Follow-up|0|||
49155194|NCT00725985|158408549|FG007|ITP- Treatment Disposition|Lost to Follow-up|0|||
49155195|NCT00725985|158408550|FG008|ITP- Treatment Disposition|Lost to Follow-up|0|||
49155196|NCT00725985|158408551|FG009|ITP- Treatment Disposition|Lost to Follow-up|0|||
49155197|NCT00725985|158408552|FG010|ITP- Treatment Disposition|Lost to Follow-up|0|||
49155198|NCT00725985|158408553|FG011|ITP- Treatment Disposition|Lost to Follow-up|0|||
49155199|NCT00725985|158408542|FG000|ITP- Treatment Disposition|Randomized but not treated|1|||
49155200|NCT00725985|158408543|FG001|ITP- Treatment Disposition|Randomized but not treated|0|||
49155201|NCT00725985|158408544|FG002|ITP- Treatment Disposition|Randomized but not treated|0|||
49155202|NCT00725985|158408545|FG003|ITP- Treatment Disposition|Randomized but not treated|0|||
49155203|NCT00725985|158408546|FG004|ITP- Treatment Disposition|Randomized but not treated|0|||
49155204|NCT00725985|158408547|FG005|ITP- Treatment Disposition|Randomized but not treated|0|||
49155205|NCT00725985|158408548|FG006|ITP- Treatment Disposition|Randomized but not treated|0|||
49155206|NCT00725985|158408549|FG007|ITP- Treatment Disposition|Randomized but not treated|0|||
49155207|NCT00725985|158408550|FG008|ITP- Treatment Disposition|Randomized but not treated|0|||
49155208|NCT00725985|158408551|FG009|ITP- Treatment Disposition|Randomized but not treated|0|||
49155209|NCT00725985|158408552|FG010|ITP- Treatment Disposition|Randomized but not treated|0|||
49155210|NCT00725985|158408553|FG011|ITP- Treatment Disposition|Randomized but not treated|0|||
49155211|NCT00725985|158408542|FG000|ITP- Treatment Disposition|Converted to CDMS|30|||
49155212|NCT00725985|158408543|FG001|ITP- Treatment Disposition|Converted to CDMS|27|||
49155213|NCT00725985|158408544|FG002|ITP- Treatment Disposition|Converted to CDMS|71|||
49155214|NCT00725985|158408545|FG003|ITP- Treatment Disposition|Converted to CDMS|0|||
49155215|NCT00725985|158408546|FG004|ITP- Treatment Disposition|Converted to CDMS|0|||
49155216|NCT00725985|158408547|FG005|ITP- Treatment Disposition|Converted to CDMS|0|||
49155217|NCT00725985|158408548|FG006|ITP- Treatment Disposition|Converted to CDMS|0|||
49155218|NCT00725985|158408549|FG007|ITP- Treatment Disposition|Converted to CDMS|0|||
49155219|NCT00725985|158408550|FG008|ITP- Treatment Disposition|Converted to CDMS|0|||
49155220|NCT00725985|158408551|FG009|ITP- Treatment Disposition|Converted to CDMS|0|||
49155221|NCT00725985|158408552|FG010|ITP- Treatment Disposition|Converted to CDMS|0|||
49155222|NCT00725985|158408553|FG011|ITP- Treatment Disposition|Converted to CDMS|0|||
49155223|NCT00725985|158408542|FG000|ITP- Treatment Disposition|Other|50|||
49155224|NCT00725985|158408543|FG001|ITP- Treatment Disposition|Other|38|||
49155225|NCT00725985|158408544|FG002|ITP- Treatment Disposition|Other|24|||
49155226|NCT00725985|158408545|FG003|ITP- Treatment Disposition|Other|0|||
49155227|NCT00725985|158408546|FG004|ITP- Treatment Disposition|Other|0|||
49155228|NCT00725985|158408547|FG005|ITP- Treatment Disposition|Other|0|||
49155229|NCT00725985|158408548|FG006|ITP- Treatment Disposition|Other|0|||
49155230|NCT00725985|158408549|FG007|ITP- Treatment Disposition|Other|0|||
49155231|NCT00725985|158408550|FG008|ITP- Treatment Disposition|Other|0|||
49155232|NCT00725985|158408551|FG009|ITP- Treatment Disposition|Other|0|||
49155233|NCT00725985|158408552|FG010|ITP- Treatment Disposition|Other|0|||
49155234|NCT00725985|158408553|FG011|ITP- Treatment Disposition|Other|0|||
49155235|NCT00725985|158408542|FG000|OLMP (Up to 96 Weeks)|Adverse Event|0|||
49155236|NCT00725985|158408543|FG001|OLMP (Up to 96 Weeks)|Adverse Event|0|||
49155237|NCT00725985|158408544|FG002|OLMP (Up to 96 Weeks)|Adverse Event|0|||
49155238|NCT00725985|158408545|FG003|OLMP (Up to 96 Weeks)|Adverse Event|2|||
49155239|NCT00725985|158408546|FG004|OLMP (Up to 96 Weeks)|Adverse Event|2|||
49155240|NCT00725985|158408547|FG005|OLMP (Up to 96 Weeks)|Adverse Event|5|||
49155241|NCT00725985|158408548|FG006|OLMP (Up to 96 Weeks)|Adverse Event|0|||
49155242|NCT00725985|158408549|FG007|OLMP (Up to 96 Weeks)|Adverse Event|0|||
49155243|NCT00725985|158408550|FG008|OLMP (Up to 96 Weeks)|Adverse Event|0|||
49155244|NCT00725985|158408551|FG009|OLMP (Up to 96 Weeks)|Adverse Event|0|||
49155245|NCT00725985|158408552|FG010|OLMP (Up to 96 Weeks)|Adverse Event|0|||
49155246|NCT00725985|158408553|FG011|OLMP (Up to 96 Weeks)|Adverse Event|0|||
49155247|NCT00725985|158408542|FG000|OLMP (Up to 96 Weeks)|Death|0|||
49155248|NCT00725985|158408543|FG001|OLMP (Up to 96 Weeks)|Death|0|||
49155249|NCT00725985|158408544|FG002|OLMP (Up to 96 Weeks)|Death|0|||
49155250|NCT00725985|158408545|FG003|OLMP (Up to 96 Weeks)|Death|0|||
49155251|NCT00725985|158408546|FG004|OLMP (Up to 96 Weeks)|Death|1|||
49155252|NCT00725985|158408547|FG005|OLMP (Up to 96 Weeks)|Death|0|||
49155253|NCT00725985|158408548|FG006|OLMP (Up to 96 Weeks)|Death|0|||
49155254|NCT00725985|158408549|FG007|OLMP (Up to 96 Weeks)|Death|0|||
49155255|NCT00725985|158408550|FG008|OLMP (Up to 96 Weeks)|Death|0|||
49155256|NCT00725985|158408551|FG009|OLMP (Up to 96 Weeks)|Death|0|||
49155257|NCT00725985|158408552|FG010|OLMP (Up to 96 Weeks)|Death|0|||
49155258|NCT00725985|158408553|FG011|OLMP (Up to 96 Weeks)|Death|0|||
49155259|NCT00725985|158408542|FG000|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
49155260|NCT00725985|158408543|FG001|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
48735497|NCT00631696|156883642|FG000|Overall Study|Other|8|||
49155261|NCT00725985|158408544|FG002|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
49155262|NCT00725985|158408545|FG003|OLMP (Up to 96 Weeks)|Lost to Follow-up|1|||
49155263|NCT00725985|158408546|FG004|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
49155264|NCT00725985|158408547|FG005|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
49155265|NCT00725985|158408548|FG006|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
49155266|NCT00725985|158408549|FG007|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
49155267|NCT00725985|158408550|FG008|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
49155268|NCT00725985|158408551|FG009|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
49155269|NCT00725985|158408552|FG010|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
49155270|NCT00725985|158408553|FG011|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
49155271|NCT00725985|158408542|FG000|OLMP (Up to 96 Weeks)|Disease progression|0|||
49155272|NCT00725985|158408543|FG001|OLMP (Up to 96 Weeks)|Disease progression|0|||
49155273|NCT00725985|158408544|FG002|OLMP (Up to 96 Weeks)|Disease progression|0|||
49155274|NCT00725985|158408545|FG003|OLMP (Up to 96 Weeks)|Disease progression|0|||
49155275|NCT00725985|158408546|FG004|OLMP (Up to 96 Weeks)|Disease progression|0|||
49155276|NCT00725985|158408547|FG005|OLMP (Up to 96 Weeks)|Disease progression|4|||
49155277|NCT00725985|158408548|FG006|OLMP (Up to 96 Weeks)|Disease progression|0|||
49155278|NCT00725985|158408549|FG007|OLMP (Up to 96 Weeks)|Disease progression|0|||
49155279|NCT00725985|158408550|FG008|OLMP (Up to 96 Weeks)|Disease progression|0|||
49155280|NCT00725985|158408551|FG009|OLMP (Up to 96 Weeks)|Disease progression|0|||
49155281|NCT00725985|158408552|FG010|OLMP (Up to 96 Weeks)|Disease progression|0|||
49155282|NCT00725985|158408553|FG011|OLMP (Up to 96 Weeks)|Disease progression|0|||
49155283|NCT00725985|158408542|FG000|OLMP (Up to 96 Weeks)|Other|0|||
49155284|NCT00725985|158408543|FG001|OLMP (Up to 96 Weeks)|Other|0|||
49155285|NCT00725985|158408544|FG002|OLMP (Up to 96 Weeks)|Other|0|||
49155286|NCT00725985|158408545|FG003|OLMP (Up to 96 Weeks)|Other|15|||
49155287|NCT00725985|158408546|FG004|OLMP (Up to 96 Weeks)|Other|20|||
49155288|NCT00725985|158408547|FG005|OLMP (Up to 96 Weeks)|Other|44|||
49155289|NCT00725985|158408548|FG006|OLMP (Up to 96 Weeks)|Other|0|||
49155290|NCT00725985|158408549|FG007|OLMP (Up to 96 Weeks)|Other|0|||
49155291|NCT00725985|158408550|FG008|OLMP (Up to 96 Weeks)|Other|0|||
49155292|NCT00725985|158408551|FG009|OLMP (Up to 96 Weeks)|Other|0|||
49155293|NCT00725985|158408552|FG010|OLMP (Up to 96 Weeks)|Other|0|||
49155294|NCT00725985|158408553|FG011|OLMP (Up to 96 Weeks)|Other|0|||
49155295|NCT00725985|158408542|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
49155296|NCT00725985|158408543|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
49155297|NCT00725985|158408544|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
49155298|NCT00725985|158408545|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
49155299|NCT00725985|158408546|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
49155300|NCT00725985|158408547|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
49155301|NCT00725985|158408548|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
49155302|NCT00725985|158408549|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|1|||
49155303|NCT00725985|158408550|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
49155304|NCT00725985|158408551|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
48827922|NCT03761784|157211078|FG000|Overall Study|Protocol Violation|2|||
48827923|NCT03761784|157211079|FG001|Overall Study|Protocol Violation|0|||
48827924|NCT03761784|157211078|FG000|Overall Study|Withdrawal by Parent or Guardian|4|||
48827925|NCT03761784|157211079|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
48827926|NCT03761784|157211078|FG000|Overall Study|Withdrawal by Subject|9|||
48827927|NCT03761784|157211079|FG001|Overall Study|Withdrawal by Subject|4|||
48827928|NCT03761784|157211078|FG000|Overall Study|Physician Decision|1|||
48827929|NCT03761784|157211079|FG001|Overall Study|Physician Decision|0|||
48827930|NCT03761784|157211078|FG000|Overall Study|Other Than Specified|1|||
48827931|NCT03761784|157211079|FG001|Overall Study|Other Than Specified|0|||
48827932|NCT02596035|157211082|FG000|Overall Study|Disease Progression|64|||
48827933|NCT02596035|157211083|FG001|Overall Study|Disease Progression|32|||
48827934|NCT02596035|157211084|FG002|Overall Study|Disease Progression|1|||
48827935|NCT02596035|157211082|FG000|Overall Study|study drug toxicity|12|||
48827936|NCT02596035|157211083|FG001|Overall Study|study drug toxicity|3|||
48827937|NCT02596035|157211084|FG002|Overall Study|study drug toxicity|0|||
48827938|NCT02596035|157211082|FG000|Overall Study|AE unrelated to study drug|5|||
48827939|NCT02596035|157211083|FG001|Overall Study|AE unrelated to study drug|2|||
48827940|NCT02596035|157211084|FG002|Overall Study|AE unrelated to study drug|0|||
48827941|NCT02596035|157211082|FG000|Overall Study|participant request to discontinue study treatment|2|||
48827942|NCT02596035|157211083|FG001|Overall Study|participant request to discontinue study treatment|0|||
48827943|NCT02596035|157211084|FG002|Overall Study|participant request to discontinue study treatment|0|||
48827944|NCT02596035|157211082|FG000|Overall Study|participant withdrew consent|2|||
48827945|NCT02596035|157211083|FG001|Overall Study|participant withdrew consent|2|||
48827946|NCT02596035|157211084|FG002|Overall Study|participant withdrew consent|0|||
48827947|NCT02596035|157211082|FG000|Overall Study|Poor/Non Comlpiance|0|||
48827948|NCT02596035|157211083|FG001|Overall Study|Poor/Non Comlpiance|1|||
48827949|NCT02596035|157211084|FG002|Overall Study|Poor/Non Comlpiance|0|||
48827950|NCT02596035|157211082|FG000|Overall Study|participant no longer meets study criteria|1|||
48827951|NCT02596035|157211083|FG001|Overall Study|participant no longer meets study criteria|0|||
49155305|NCT00725985|158408552|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
49155306|NCT00725985|158408553|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
49155307|NCT00725985|158408542|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
49155308|NCT00725985|158408543|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
49155309|NCT00725985|158408544|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
49155310|NCT00725985|158408545|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
49155311|NCT00725985|158408546|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
49155312|NCT00725985|158408547|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
49155313|NCT00725985|158408548|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
49155314|NCT00725985|158408549|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
49155315|NCT00725985|158408550|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|1|||
49155316|NCT00725985|158408551|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
49155317|NCT00725985|158408552|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
49155318|NCT00725985|158408553|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
49155319|NCT00725985|158408542|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
49155320|NCT00725985|158408543|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
49155321|NCT00725985|158408544|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
49155322|NCT00725985|158408545|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
49155323|NCT00725985|158408546|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
49155324|NCT00725985|158408547|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
49155325|NCT00725985|158408548|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Other|9|||
49155326|NCT00725985|158408549|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Other|8|||
49155327|NCT00725985|158408550|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Other|16|||
49155328|NCT00725985|158408551|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
49155329|NCT00725985|158408552|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
49155330|NCT00725985|158408553|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
49155331|NCT00725985|158408542|FG000|LTFU (No Cladribine) (48 Weeks)|Other|0|||
49155332|NCT00725985|158408543|FG001|LTFU (No Cladribine) (48 Weeks)|Other|0|||
49155333|NCT00725985|158408544|FG002|LTFU (No Cladribine) (48 Weeks)|Other|0|||
49155334|NCT00725985|158408545|FG003|LTFU (No Cladribine) (48 Weeks)|Other|0|||
49155335|NCT00725985|158408546|FG004|LTFU (No Cladribine) (48 Weeks)|Other|0|||
49155336|NCT00725985|158408547|FG005|LTFU (No Cladribine) (48 Weeks)|Other|0|||
49155337|NCT00725985|158408548|FG006|LTFU (No Cladribine) (48 Weeks)|Other|0|||
49155338|NCT00725985|158408549|FG007|LTFU (No Cladribine) (48 Weeks)|Other|0|||
49155339|NCT00725985|158408550|FG008|LTFU (No Cladribine) (48 Weeks)|Other|0|||
49155340|NCT00725985|158408551|FG009|LTFU (No Cladribine) (48 Weeks)|Other|34|||
49155341|NCT00725985|158408552|FG010|LTFU (No Cladribine) (48 Weeks)|Other|36|||
49155342|NCT00725985|158408553|FG011|LTFU (No Cladribine) (48 Weeks)|Other|14|||
49155343|NCT02448381|158408554|FG000|Overall Study|Adverse Event|2|||
49155344|NCT02448381|158408555|FG001|Overall Study|Adverse Event|0|||
49155345|NCT02448381|158408554|FG000|Overall Study|Lost to Follow-up|16|||
49155346|NCT02448381|158408555|FG001|Overall Study|Lost to Follow-up|9|||
49155347|NCT02448381|158408554|FG000|Overall Study|Physician Decision|1|||
49155348|NCT02448381|158408555|FG001|Overall Study|Physician Decision|1|||
49155349|NCT02448381|158408554|FG000|Overall Study|Pregnancy|1|||
49155350|NCT02448381|158408555|FG001|Overall Study|Pregnancy|0|||
48827952|NCT02596035|157211084|FG002|Overall Study|participant no longer meets study criteria|0|||
48827953|NCT02596035|157211082|FG000|Overall Study|other reasons|11|||
48827954|NCT02596035|157211083|FG001|Overall Study|other reasons|4|||
49155351|NCT02448381|158408554|FG000|Overall Study|Withdrawal by Subject|13|||
49155352|NCT02448381|158408555|FG001|Overall Study|Withdrawal by Subject|9|||
49155353|NCT02448381|158408554|FG000|Overall Study|Noncompliance with Study Procedures|2|||
49155354|NCT02448381|158408555|FG001|Overall Study|Noncompliance with Study Procedures|0|||
49155355|NCT02090764|158408556|FG000|Overall Study|Adverse Event|1|||
49155356|NCT02090764|158408557|FG001|Overall Study|Adverse Event|3|||
49155357|NCT02090764|158408556|FG000|Overall Study|Lack of Efficacy|0|||
49155358|NCT02090764|158408557|FG001|Overall Study|Lack of Efficacy|13|||
49155359|NCT02090764|158408556|FG000|Overall Study|Withdrawal by Subject|2|||
49155360|NCT02090764|158408557|FG001|Overall Study|Withdrawal by Subject|1|||
49155361|NCT02090764|158408556|FG000|Overall Study|Intercurrent illness and other|1|||
49155362|NCT02090764|158408557|FG001|Overall Study|Intercurrent illness and other|1|||
49155363|NCT02090764|158408556|FG000|Overall Study|Lost to Follow-up|2|||
48827955|NCT02596035|157211084|FG002|Overall Study|other reasons|0|||
48827956|NCT03852433|157211085|FG000|Overall Study|Withdrawal of consent|5|||
49155364|NCT02090764|158408557|FG001|Overall Study|Lost to Follow-up|2|||
49155365|NCT03895372|158408564|FG000|Investigational Treatment Period|Adverse Event|1|||
49155366|NCT03895372|158408565|FG001|Investigational Treatment Period|Adverse Event|0|||
49155367|NCT03895372|158408566|FG002|Investigational Treatment Period|Adverse Event|0|||
49155368|NCT03895372|158408567|FG003|Investigational Treatment Period|Adverse Event|0|||
49155369|NCT03895372|158408568|FG004|Investigational Treatment Period|Adverse Event|0|||
49155370|NCT03895372|158408569|FG005|Investigational Treatment Period|Adverse Event|0|||
49155371|NCT03895372|158408570|FG006|Investigational Treatment Period|Adverse Event|4|||
49155372|NCT03895372|158408571|FG007|Investigational Treatment Period|Adverse Event|3|||
48827957|NCT03852433|157211086|FG001|Overall Study|Withdrawal of consent|8|||
48827958|NCT03852433|157211087|FG002|Overall Study|Withdrawal of consent|1|||
48827959|NCT03852433|157211088|FG003|Overall Study|Withdrawal of consent|1|||
48827960|NCT03852433|157211085|FG000|Overall Study|Adverse Event|1|||
48827961|NCT03852433|157211086|FG001|Overall Study|Adverse Event|1|||
48827962|NCT03852433|157211087|FG002|Overall Study|Adverse Event|1|||
48827963|NCT03852433|157211088|FG003|Overall Study|Adverse Event|1|||
48827964|NCT03852433|157211085|FG000|Overall Study|Lost to Follow-up|0|||
48827965|NCT03852433|157211086|FG001|Overall Study|Lost to Follow-up|1|||
48827966|NCT03852433|157211087|FG002|Overall Study|Lost to Follow-up|0|||
48827967|NCT03852433|157211088|FG003|Overall Study|Lost to Follow-up|1|||
48827968|NCT03852433|157211085|FG000|Overall Study|Pregnancy|0|||
48827969|NCT03852433|157211086|FG001|Overall Study|Pregnancy|1|||
48827970|NCT03852433|157211087|FG002|Overall Study|Pregnancy|1|||
48827971|NCT03852433|157211088|FG003|Overall Study|Pregnancy|0|||
48827972|NCT03852433|157211085|FG000|Overall Study|Protocol Violation|0|||
48827973|NCT03852433|157211086|FG001|Overall Study|Protocol Violation|0|||
48827974|NCT03852433|157211087|FG002|Overall Study|Protocol Violation|1|||
48827975|NCT03852433|157211088|FG003|Overall Study|Protocol Violation|1|||
48827976|NCT03852433|157211085|FG000|Overall Study|Death|0|||
48827977|NCT03852433|157211086|FG001|Overall Study|Death|0|||
48827978|NCT03852433|157211087|FG002|Overall Study|Death|1|||
48827979|NCT03852433|157211088|FG003|Overall Study|Death|0|||
49014400|NCT00310856|157888850|FG001|Overall Study|Withdrawal by Subject|2|||
49014401|NCT00310856|157888851|FG002|Overall Study|Withdrawal by Subject|2|||
49014402|NCT00310856|157888849|FG000|Overall Study|Lost to Follow-up|1|||
49014403|NCT00310856|157888850|FG001|Overall Study|Lost to Follow-up|2|||
49014404|NCT00310856|157888851|FG002|Overall Study|Lost to Follow-up|6|||
49014405|NCT00310856|157888849|FG000|Overall Study|Inappropriate enrollment|1|||
49014406|NCT00310856|157888850|FG001|Overall Study|Inappropriate enrollment|1|||
49014407|NCT00310856|157888851|FG002|Overall Study|Inappropriate enrollment|0|||
49014408|NCT00310856|157888849|FG000|Overall Study|Unable to classify|1|||
49014409|NCT00310856|157888850|FG001|Overall Study|Unable to classify|0|||
49014410|NCT00310856|157888851|FG002|Overall Study|Unable to classify|0|||
49014411|NCT01564758|157888858|FG000|Overall Study|Death|8|||
49014412|NCT01564758|157888858|FG000|Overall Study|Adverse Event|3|||
49014413|NCT01564758|157888858|FG000|Overall Study|Other|3|||
49014414|NCT01186978|157888861|FG000|Overall Study|Withdrawal by Subject|1|||
49014415|NCT00210626|157888862|FG000|Overall Study|Adverse Event|1|||
49014416|NCT00210626|157888863|FG001|Overall Study|Adverse Event|2|||
49014417|NCT00210626|157888862|FG000|Overall Study|Protocol Violation|1|||
49014418|NCT00210626|157888863|FG001|Overall Study|Protocol Violation|5|||
49014419|NCT00210626|157888862|FG000|Overall Study|Lost to Follow-up|11|||
49014420|NCT00210626|157888863|FG001|Overall Study|Lost to Follow-up|11|||
49014421|NCT00210626|157888862|FG000|Overall Study|Death|1|||
49014422|NCT00210626|157888863|FG001|Overall Study|Death|0|||
49014423|NCT00210626|157888862|FG000|Overall Study|Withdrawal by Subject|29|||
49014424|NCT00210626|157888863|FG001|Overall Study|Withdrawal by Subject|20|||
49014425|NCT00210626|157888862|FG000|Overall Study|Physician Decision|0|||
49014426|NCT00210626|157888863|FG001|Overall Study|Physician Decision|2|||
49014427|NCT00210626|157888862|FG000|Overall Study|Sponser Request|1|||
49014428|NCT00210626|157888863|FG001|Overall Study|Sponser Request|0|||
49014429|NCT00210626|157888862|FG000|Overall Study|Other|4|||
49014430|NCT00210626|157888863|FG001|Overall Study|Other|5|||
49014431|NCT01227668|157888864|FG000|Phase 1 (Stabilization Phase)|Adverse Event|12|||
49014432|NCT01227668|157888865|FG001|Phase 1 (Stabilization Phase)|Adverse Event|0|||
49014433|NCT01227668|157888864|FG000|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7|||
49014434|NCT01227668|157888865|FG001|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0|||
49014435|NCT01227668|157888864|FG000|Phase 1 (Stabilization Phase)|Lost to Follow-up|8|||
49014436|NCT01227668|157888865|FG001|Phase 1 (Stabilization Phase)|Lost to Follow-up|0|||
49014437|NCT01227668|157888864|FG000|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11|||
49014438|NCT01227668|157888865|FG001|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0|||
49014439|NCT01227668|157888864|FG000|Phase 1 (Stabilization Phase)|No longer meets study criteria|7|||
49014440|NCT01227668|157888865|FG001|Phase 1 (Stabilization Phase)|No longer meets study criteria|0|||
49014441|NCT01227668|157888864|FG000|Phase 1 (Stabilization Phase)|Lack of Efficacy|25|||
49014442|NCT01227668|157888865|FG001|Phase 1 (Stabilization Phase)|Lack of Efficacy|0|||
49014443|NCT01227668|157888864|FG000|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2|||
49014444|NCT01227668|157888865|FG001|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0|||
49014445|NCT01227668|157888864|FG000|Phase 2 (Randomization Phase)|Adverse Event|0|||
49014446|NCT01227668|157888865|FG001|Phase 2 (Randomization Phase)|Adverse Event|1|||
49014447|NCT01227668|157888864|FG000|Phase 2 (Randomization Phase)|Withdrawal by Subject|5|||
49014448|NCT01227668|157888865|FG001|Phase 2 (Randomization Phase)|Withdrawal by Subject|0|||
49014449|NCT01227668|157888864|FG000|Phase 2 (Randomization Phase)|Lost to Follow-up|1|||
49014450|NCT01227668|157888865|FG001|Phase 2 (Randomization Phase)|Lost to Follow-up|0|||
49014451|NCT01227668|157888864|FG000|Phase 2 (Randomization Phase)|Lack of Efficacy|13|||
49155373|NCT03895372|158408564|FG000|Investigational Treatment Period|Lack of Efficacy|1|||
49155374|NCT03895372|158408565|FG001|Investigational Treatment Period|Lack of Efficacy|0|||
49155375|NCT03895372|158408566|FG002|Investigational Treatment Period|Lack of Efficacy|0|||
49155376|NCT03895372|158408567|FG003|Investigational Treatment Period|Lack of Efficacy|0|||
49155377|NCT03895372|158408568|FG004|Investigational Treatment Period|Lack of Efficacy|0|||
49155378|NCT03895372|158408569|FG005|Investigational Treatment Period|Lack of Efficacy|0|||
49155379|NCT03895372|158408570|FG006|Investigational Treatment Period|Lack of Efficacy|0|||
49155380|NCT03895372|158408571|FG007|Investigational Treatment Period|Lack of Efficacy|0|||
49155381|NCT03895372|158408564|FG000|Investigational Treatment Period|Lost to Follow-up|0|||
48827980|NCT03852433|157211085|FG000|Overall Study|Lack of Efficacy|0|||
48827981|NCT03852433|157211086|FG001|Overall Study|Lack of Efficacy|1|||
49155382|NCT03895372|158408565|FG001|Investigational Treatment Period|Lost to Follow-up|0|||
49155383|NCT03895372|158408566|FG002|Investigational Treatment Period|Lost to Follow-up|0|||
49155384|NCT03895372|158408567|FG003|Investigational Treatment Period|Lost to Follow-up|0|||
49155385|NCT03895372|158408568|FG004|Investigational Treatment Period|Lost to Follow-up|0|||
49155386|NCT03895372|158408569|FG005|Investigational Treatment Period|Lost to Follow-up|0|||
49155387|NCT03895372|158408570|FG006|Investigational Treatment Period|Lost to Follow-up|1|||
49155388|NCT03895372|158408571|FG007|Investigational Treatment Period|Lost to Follow-up|0|||
49155389|NCT03895372|158408564|FG000|Investigational Treatment Period|Other|0|||
49155390|NCT03895372|158408565|FG001|Investigational Treatment Period|Other|0|||
49155391|NCT03895372|158408566|FG002|Investigational Treatment Period|Other|0|||
49155392|NCT03895372|158408567|FG003|Investigational Treatment Period|Other|0|||
49155393|NCT03895372|158408568|FG004|Investigational Treatment Period|Other|0|||
49155394|NCT03895372|158408569|FG005|Investigational Treatment Period|Other|1|||
49155395|NCT03895372|158408570|FG006|Investigational Treatment Period|Other|0|||
49155396|NCT03895372|158408571|FG007|Investigational Treatment Period|Other|2|||
49155397|NCT03895372|158408564|FG000|Investigational Treatment Period|Protocol Violation|0|||
49155398|NCT03895372|158408565|FG001|Investigational Treatment Period|Protocol Violation|0|||
49155399|NCT03895372|158408566|FG002|Investigational Treatment Period|Protocol Violation|0|||
49155400|NCT03895372|158408567|FG003|Investigational Treatment Period|Protocol Violation|1|||
49155401|NCT03895372|158408568|FG004|Investigational Treatment Period|Protocol Violation|0|||
49155402|NCT03895372|158408569|FG005|Investigational Treatment Period|Protocol Violation|0|||
49155403|NCT03895372|158408570|FG006|Investigational Treatment Period|Protocol Violation|0|||
49155404|NCT03895372|158408571|FG007|Investigational Treatment Period|Protocol Violation|0|||
49155405|NCT03895372|158408564|FG000|Investigational Treatment Period|Withdrawal by Subject|2|||
49155406|NCT03895372|158408565|FG001|Investigational Treatment Period|Withdrawal by Subject|3|||
49155407|NCT03895372|158408566|FG002|Investigational Treatment Period|Withdrawal by Subject|1|||
49155408|NCT03895372|158408567|FG003|Investigational Treatment Period|Withdrawal by Subject|1|||
49155409|NCT03895372|158408568|FG004|Investigational Treatment Period|Withdrawal by Subject|0|||
49155410|NCT03895372|158408569|FG005|Investigational Treatment Period|Withdrawal by Subject|1|||
49155411|NCT03895372|158408570|FG006|Investigational Treatment Period|Withdrawal by Subject|3|||
49155412|NCT03895372|158408571|FG007|Investigational Treatment Period|Withdrawal by Subject|0|||
49155413|NCT03895372|158408564|FG000|Extension Treatment Period|Adverse Event|0|||
49155414|NCT03895372|158408565|FG001|Extension Treatment Period|Adverse Event|1|||
49155415|NCT03895372|158408566|FG002|Extension Treatment Period|Adverse Event|0|||
48827982|NCT03852433|157211087|FG002|Overall Study|Lack of Efficacy|0|||
48827983|NCT03852433|157211088|FG003|Overall Study|Lack of Efficacy|0|||
48827984|NCT03852433|157211085|FG000|Overall Study|Non-compliance with study drug|0|||
48827985|NCT03852433|157211086|FG001|Overall Study|Non-compliance with study drug|0|||
48827986|NCT03852433|157211087|FG002|Overall Study|Non-compliance with study drug|0|||
48827987|NCT03852433|157211088|FG003|Overall Study|Non-compliance with study drug|1|||
48827988|NCT03852433|157211085|FG000|Overall Study|Physician Decision|1|||
49155416|NCT03895372|158408567|FG003|Extension Treatment Period|Adverse Event|1|||
49155417|NCT03895372|158408568|FG004|Extension Treatment Period|Adverse Event|0|||
48827989|NCT03852433|157211086|FG001|Overall Study|Physician Decision|0|||
48827990|NCT03852433|157211087|FG002|Overall Study|Physician Decision|0|||
48827991|NCT03852433|157211088|FG003|Overall Study|Physician Decision|0|||
48827992|NCT03852433|157211085|FG000|Overall Study|Randomized but never treated|1|||
49155418|NCT03895372|158408569|FG005|Extension Treatment Period|Adverse Event|0|||
49155419|NCT03895372|158408570|FG006|Extension Treatment Period|Adverse Event|3|||
49155420|NCT03895372|158408571|FG007|Extension Treatment Period|Adverse Event|3|||
49155421|NCT03895372|158408564|FG000|Extension Treatment Period|Other|1|||
49155422|NCT03895372|158408565|FG001|Extension Treatment Period|Other|3|||
49155423|NCT03895372|158408566|FG002|Extension Treatment Period|Other|0|||
49155424|NCT03895372|158408567|FG003|Extension Treatment Period|Other|0|||
48827993|NCT03852433|157211086|FG001|Overall Study|Randomized but never treated|0|||
48827994|NCT03852433|157211087|FG002|Overall Study|Randomized but never treated|0|||
49155425|NCT03895372|158408568|FG004|Extension Treatment Period|Other|1|||
48827995|NCT03852433|157211088|FG003|Overall Study|Randomized but never treated|0|||
49155426|NCT03895372|158408569|FG005|Extension Treatment Period|Other|0|||
49155427|NCT03895372|158408570|FG006|Extension Treatment Period|Other|0|||
49155428|NCT03895372|158408571|FG007|Extension Treatment Period|Other|2|||
49155429|NCT03895372|158408564|FG000|Extension Treatment Period|Pregnancy|0|||
49155430|NCT03895372|158408565|FG001|Extension Treatment Period|Pregnancy|0|||
49155431|NCT03895372|158408566|FG002|Extension Treatment Period|Pregnancy|0|||
49155432|NCT03895372|158408567|FG003|Extension Treatment Period|Pregnancy|0|||
49155433|NCT03895372|158408568|FG004|Extension Treatment Period|Pregnancy|1|||
49155434|NCT03895372|158408569|FG005|Extension Treatment Period|Pregnancy|0|||
49155435|NCT03895372|158408570|FG006|Extension Treatment Period|Pregnancy|0|||
49155436|NCT03895372|158408571|FG007|Extension Treatment Period|Pregnancy|0|||
49155437|NCT03895372|158408564|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
49155438|NCT03895372|158408565|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
49155439|NCT03895372|158408566|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
49155440|NCT03895372|158408567|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
49155441|NCT03895372|158408568|FG004|Extension Treatment Period|Withdrawal by Subject|1|||
49155442|NCT03895372|158408569|FG005|Extension Treatment Period|Withdrawal by Subject|1|||
49155443|NCT03895372|158408570|FG006|Extension Treatment Period|Withdrawal by Subject|1|||
49155444|NCT03895372|158408571|FG007|Extension Treatment Period|Withdrawal by Subject|1|||
49155445|NCT00928668|158408574|FG000|Overall Study|Adverse Event|1|||
49155446|NCT00928668|158408575|FG001|Overall Study|Adverse Event|0|||
49155447|NCT00928668|158408576|FG002|Overall Study|Adverse Event|0|||
49155448|NCT00928668|158408577|FG003|Overall Study|Adverse Event|0|||
49155449|NCT00928668|158408578|FG004|Overall Study|Adverse Event|0|||
49155450|NCT00928668|158408574|FG000|Overall Study|Protocol Violation|0|||
49155451|NCT00928668|158408575|FG001|Overall Study|Protocol Violation|0|||
49155452|NCT00928668|158408576|FG002|Overall Study|Protocol Violation|0|||
49155453|NCT00928668|158408577|FG003|Overall Study|Protocol Violation|0|||
49155454|NCT00928668|158408578|FG004|Overall Study|Protocol Violation|1|||
49155455|NCT00928668|158408574|FG000|Overall Study|Withdrawal by Subject|0|||
49155456|NCT00928668|158408575|FG001|Overall Study|Withdrawal by Subject|1|||
49155457|NCT00928668|158408576|FG002|Overall Study|Withdrawal by Subject|1|||
49155458|NCT00928668|158408577|FG003|Overall Study|Withdrawal by Subject|0|||
49155459|NCT00928668|158408578|FG004|Overall Study|Withdrawal by Subject|0|||
49155460|NCT00928668|158408574|FG000|Overall Study|Other reasons not listed above|0|||
49155461|NCT00928668|158408575|FG001|Overall Study|Other reasons not listed above|0|||
49155462|NCT00928668|158408576|FG002|Overall Study|Other reasons not listed above|0|||
49155463|NCT00928668|158408577|FG003|Overall Study|Other reasons not listed above|1|||
49155464|NCT00928668|158408578|FG004|Overall Study|Other reasons not listed above|0|||
49155465|NCT02303262|158408579|FG000|Overall Study|Withdrawal by Subject|2|||
49155466|NCT04881760|158408580|FG000|Overall Study|Adverse Event|0|||
49155467|NCT04881760|158408581|FG001|Overall Study|Adverse Event|1|||
49155468|NCT04881760|158408582|FG002|Overall Study|Adverse Event|1|||
49155469|NCT04881760|158408583|FG003|Overall Study|Adverse Event|0|||
49155470|NCT04881760|158408584|FG004|Overall Study|Adverse Event|1|||
49155471|NCT04881760|158408585|FG005|Overall Study|Adverse Event|1|||
49155472|NCT04881760|158408586|FG006|Overall Study|Adverse Event|2|||
49155473|NCT04881760|158408580|FG000|Overall Study|Death|0|||
49155474|NCT04881760|158408581|FG001|Overall Study|Death|0|||
49155475|NCT04881760|158408582|FG002|Overall Study|Death|0|||
49155476|NCT04881760|158408583|FG003|Overall Study|Death|1|||
49155477|NCT04881760|158408584|FG004|Overall Study|Death|0|||
49155478|NCT04881760|158408585|FG005|Overall Study|Death|0|||
48827996|NCT03199469|157211090|FG000|Overall Study|Randomized, not treated|0|||
49014452|NCT01227668|157888865|FG001|Phase 2 (Randomization Phase)|Lack of Efficacy|23|||
49014453|NCT01227668|157888864|FG000|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0|||
49014454|NCT01227668|157888865|FG001|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1|||
49014455|NCT00947856|157888867|FG000|Treatment Period|Progressive Disease|33|||
49014456|NCT00947856|157888868|FG001|Treatment Period|Progressive Disease|12|||
49014457|NCT00947856|157888867|FG000|Treatment Period|Adverse Event|15|||
49014458|NCT00947856|157888868|FG001|Treatment Period|Adverse Event|9|||
49014459|NCT00947856|157888867|FG000|Treatment Period|Physician Decision|14|||
49014460|NCT00947856|157888868|FG001|Treatment Period|Physician Decision|6|||
49014461|NCT00947856|157888867|FG000|Treatment Period|Study Stopped by Sponsor|4|||
49014462|NCT00947856|157888868|FG001|Treatment Period|Study Stopped by Sponsor|4|||
49014463|NCT00947856|157888867|FG000|Treatment Period|Withdrawal by Subject|12|||
49014464|NCT00947856|157888868|FG001|Treatment Period|Withdrawal by Subject|1|||
49014465|NCT00947856|157888867|FG000|Follow-up Period|Study Stopped by Sponsor|40|||
49014466|NCT00947856|157888868|FG001|Follow-up Period|Study Stopped by Sponsor|20|||
49014467|NCT00947856|157888867|FG000|Follow-up Period|Re-enrolled for Retreatment|2|||
49014468|NCT00947856|157888868|FG001|Follow-up Period|Re-enrolled for Retreatment|3|||
49014469|NCT00947856|157888867|FG000|Follow-up Period|Lost to Follow-up|7|||
49014470|NCT00947856|157888868|FG001|Follow-up Period|Lost to Follow-up|0|||
49014471|NCT00947856|157888867|FG000|Follow-up Period|Patient unavailable for site visits|1|||
49014472|NCT00947856|157888868|FG001|Follow-up Period|Patient unavailable for site visits|0|||
49155479|NCT04881760|158408586|FG006|Overall Study|Death|0|||
49155480|NCT04881760|158408580|FG000|Overall Study|Lost to Follow-up|5|||
49155481|NCT04881760|158408581|FG001|Overall Study|Lost to Follow-up|7|||
49155482|NCT04881760|158408582|FG002|Overall Study|Lost to Follow-up|5|||
49155483|NCT04881760|158408583|FG003|Overall Study|Lost to Follow-up|1|||
49155484|NCT04881760|158408584|FG004|Overall Study|Lost to Follow-up|2|||
49155485|NCT04881760|158408585|FG005|Overall Study|Lost to Follow-up|4|||
49155486|NCT04881760|158408586|FG006|Overall Study|Lost to Follow-up|4|||
49155487|NCT04881760|158408580|FG000|Overall Study|Withdrawal by Subject|13|||
49155488|NCT04881760|158408581|FG001|Overall Study|Withdrawal by Subject|1|||
49155489|NCT04881760|158408582|FG002|Overall Study|Withdrawal by Subject|1|||
49155490|NCT04881760|158408583|FG003|Overall Study|Withdrawal by Subject|4|||
49155491|NCT04881760|158408584|FG004|Overall Study|Withdrawal by Subject|2|||
49155492|NCT04881760|158408585|FG005|Overall Study|Withdrawal by Subject|1|||
49155493|NCT04881760|158408586|FG006|Overall Study|Withdrawal by Subject|2|||
49155494|NCT04881760|158408580|FG000|Overall Study|Randomized but Never Treated|0|||
49155495|NCT04881760|158408581|FG001|Overall Study|Randomized but Never Treated|0|||
49155496|NCT04881760|158408582|FG002|Overall Study|Randomized but Never Treated|0|||
49155497|NCT04881760|158408583|FG003|Overall Study|Randomized but Never Treated|1|||
49155498|NCT04881760|158408584|FG004|Overall Study|Randomized but Never Treated|0|||
49155499|NCT04881760|158408585|FG005|Overall Study|Randomized but Never Treated|0|||
49155500|NCT04881760|158408586|FG006|Overall Study|Randomized but Never Treated|0|||
49155501|NCT04881760|158408580|FG000|Overall Study|Inadvertent Enrollment|2|||
49155502|NCT04881760|158408581|FG001|Overall Study|Inadvertent Enrollment|0|||
49155503|NCT04881760|158408582|FG002|Overall Study|Inadvertent Enrollment|0|||
49155504|NCT04881760|158408583|FG003|Overall Study|Inadvertent Enrollment|0|||
49155505|NCT04881760|158408584|FG004|Overall Study|Inadvertent Enrollment|0|||
49155506|NCT04881760|158408585|FG005|Overall Study|Inadvertent Enrollment|0|||
49155507|NCT04881760|158408586|FG006|Overall Study|Inadvertent Enrollment|0|||
49155508|NCT04881760|158408580|FG000|Overall Study|Site Closure|0|||
49155509|NCT04881760|158408581|FG001|Overall Study|Site Closure|0|||
49155510|NCT04881760|158408582|FG002|Overall Study|Site Closure|0|||
49155511|NCT04881760|158408583|FG003|Overall Study|Site Closure|1|||
49155512|NCT04881760|158408584|FG004|Overall Study|Site Closure|0|||
49155513|NCT04881760|158408585|FG005|Overall Study|Site Closure|0|||
49155514|NCT04881760|158408586|FG006|Overall Study|Site Closure|0|||
49155515|NCT00787150|158408589|FG000|Overall Study|Adverse Event|4|||
49155516|NCT00787150|158408590|FG001|Overall Study|Adverse Event|4|||
49155517|NCT00787150|158408591|FG002|Overall Study|Adverse Event|4|||
49155518|NCT00787150|158408589|FG000|Overall Study|Physician Decision|1|||
49155519|NCT00787150|158408590|FG001|Overall Study|Physician Decision|2|||
49155520|NCT00787150|158408591|FG002|Overall Study|Physician Decision|1|||
49155521|NCT00787150|158408589|FG000|Overall Study|Withdrawal by Subject|2|||
49155522|NCT00787150|158408590|FG001|Overall Study|Withdrawal by Subject|1|||
49155523|NCT00787150|158408591|FG002|Overall Study|Withdrawal by Subject|0|||
49155524|NCT00787150|158408589|FG000|Overall Study|Dosing incorrect study durg|2|||
49155525|NCT00787150|158408590|FG001|Overall Study|Dosing incorrect study durg|0|||
49155526|NCT00787150|158408591|FG002|Overall Study|Dosing incorrect study durg|0|||
49155527|NCT03773484|158408594|FG000|Post-intervention|5 clinicians were excluded from analysis due to lack of prescribing data|5|||
49155528|NCT00967499|158408597|FG000|Overall Study|Adverse Event|0|||
49155529|NCT00967499|158408598|FG001|Overall Study|Adverse Event|1|||
49155530|NCT00967499|158408597|FG000|Overall Study|Protocol Violation|1|||
49155531|NCT00967499|158408598|FG001|Overall Study|Protocol Violation|0|||
49155532|NCT00967499|158408597|FG000|Overall Study|Sponsor Decision|1|||
49155533|NCT00967499|158408598|FG001|Overall Study|Sponsor Decision|0|||
49155534|NCT00967499|158408597|FG000|Overall Study|Randomized but not treated|63|||
49155535|NCT00967499|158408598|FG001|Overall Study|Randomized but not treated|59|||
49155536|NCT02460458|158408603|FG000|Confirmatory Phase|Patients excluded basing on phenotype central analysis|31|||
49155537|NCT02460458|158408603|FG000|Confirmatory Phase|Lack of sample to analyse|19|||
49155538|NCT02460458|158408603|FG000|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|5|||
49155539|NCT02460458|158408603|FG000|First Prospective Phase|Lost to Follow-up|84|||
49155540|NCT02460458|158408603|FG000|Confirmation of Clinical Phase Data|Lost to Follow-up|34|||
49155541|NCT03478956|158408608|FG000|Randomized Treatment Period|Adverse Event|1|||
49155542|NCT03478956|158408609|FG001|Randomized Treatment Period|Adverse Event|0|||
49155543|NCT03478956|158408610|FG002|Randomized Treatment Period|Adverse Event|0|||
49155544|NCT03478956|158408611|FG003|Randomized Treatment Period|Adverse Event|0|||
49155545|NCT03478956|158408608|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
49155546|NCT03478956|158408609|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
49155547|NCT03478956|158408610|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
49155548|NCT03478956|158408611|FG003|Randomized Treatment Period|Withdrawal by Subject|0|||
49155549|NCT03478956|158408608|FG000|Open Label Extension Period|Adverse Event|0|||
49155550|NCT03478956|158408609|FG001|Open Label Extension Period|Adverse Event|0|||
49155551|NCT03478956|158408610|FG002|Open Label Extension Period|Adverse Event|4|||
49155552|NCT03478956|158408611|FG003|Open Label Extension Period|Adverse Event|0|||
49155553|NCT03478956|158408608|FG000|Open Label Extension Period|Lack of Efficacy|0|||
49155554|NCT03478956|158408609|FG001|Open Label Extension Period|Lack of Efficacy|0|||
49155555|NCT03478956|158408610|FG002|Open Label Extension Period|Lack of Efficacy|8|||
49155556|NCT03478956|158408611|FG003|Open Label Extension Period|Lack of Efficacy|0|||
49155557|NCT03478956|158408608|FG000|Open Label Extension Period|Reason Not Provided|0|||
49155558|NCT03478956|158408609|FG001|Open Label Extension Period|Reason Not Provided|0|||
49155559|NCT03478956|158408610|FG002|Open Label Extension Period|Reason Not Provided|1|||
49155560|NCT03478956|158408611|FG003|Open Label Extension Period|Reason Not Provided|0|||
49155561|NCT03478956|158408608|FG000|Open Label Extension Period|Study Terminated by Sponsor|0|||
49155562|NCT03478956|158408609|FG001|Open Label Extension Period|Study Terminated by Sponsor|0|||
49155563|NCT03478956|158408610|FG002|Open Label Extension Period|Study Terminated by Sponsor|6|||
49155564|NCT03478956|158408611|FG003|Open Label Extension Period|Study Terminated by Sponsor|0|||
49155565|NCT03478956|158408608|FG000|Open Label Extension Period|Withdrawal by Subject|0|||
49155566|NCT03478956|158408609|FG001|Open Label Extension Period|Withdrawal by Subject|0|||
49155567|NCT03478956|158408610|FG002|Open Label Extension Period|Withdrawal by Subject|2|||
49155568|NCT03478956|158408611|FG003|Open Label Extension Period|Withdrawal by Subject|0|||
49155569|NCT03478956|158408608|FG000|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
49155570|NCT03478956|158408609|FG001|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
49155571|NCT03478956|158408610|FG002|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
49155572|NCT03478956|158408611|FG003|PML Safety Monitoring Period|Study Terminated by Sponsor|9|||
49155573|NCT00867035|158408612|FG000|Baseline to 1 Hour|Withdrawal by Subject|1|||
49155574|NCT00867035|158408613|FG001|Baseline to 1 Hour|Withdrawal by Subject|1|||
49155575|NCT00867035|158408612|FG000|Baseline to 1 Week|Withdrawal by Subject|1|||
49155576|NCT00867035|158408613|FG001|Baseline to 1 Week|Withdrawal by Subject|0|||
49155577|NCT02473445|158408615|FG000|Overall Study|Withdrawal by Subject|2|||
49155578|NCT02473445|158408615|FG000|Overall Study|Sponsor Decision|20|||
49155579|NCT01085214|158408617|FG000|Overall Study|Alternate treatment required|1|||
49155580|NCT00789555|158408618|FG000|Overall Study|Protocol Amendment|78|||
49155581|NCT00789555|158408619|FG001|Overall Study|Protocol Amendment|76|||
49155582|NCT00789555|158408620|FG002|Overall Study|Protocol Amendment|80|||
49155583|NCT00789555|158408618|FG000|Overall Study|Adverse Event|17|||
49155584|NCT00789555|158408619|FG001|Overall Study|Adverse Event|7|||
49155585|NCT00789555|158408620|FG002|Overall Study|Adverse Event|10|||
49155586|NCT00789555|158408618|FG000|Overall Study|Lost to Follow-up|9|||
49155587|NCT00789555|158408619|FG001|Overall Study|Lost to Follow-up|10|||
49155588|NCT00789555|158408620|FG002|Overall Study|Lost to Follow-up|18|||
49155589|NCT00789555|158408618|FG000|Overall Study|Patient decision unnrelated to adv event|38|||
49155590|NCT00789555|158408619|FG001|Overall Study|Patient decision unnrelated to adv event|29|||
48827997|NCT03199469|157211091|FG001|Overall Study|Randomized, not treated|3|||
49155591|NCT00789555|158408620|FG002|Overall Study|Patient decision unnrelated to adv event|26|||
49155592|NCT00789555|158408618|FG000|Overall Study|Treatment failure|11|||
49155593|NCT00789555|158408619|FG001|Overall Study|Treatment failure|8|||
48827998|NCT03199469|157211090|FG000|Overall Study|Withdrawal by Subject|1|||
48827999|NCT03199469|157211091|FG001|Overall Study|Withdrawal by Subject|0|||
48828000|NCT03199469|157211090|FG000|Overall Study|Death|1|||
48828001|NCT03199469|157211091|FG001|Overall Study|Death|3|||
48828002|NCT03199469|157211090|FG000|Overall Study|Ongoing|5|||
48828003|NCT03199469|157211091|FG001|Overall Study|Ongoing|14|||
48828004|NCT04109118|157211096|FG000|Overall Study|Lost to Follow-up|3|||
48828005|NCT01268566|157211100|FG000|Overall Study|Lost to Follow-up|1|||
48828006|NCT01268566|157211100|FG000|Overall Study|Withdrawal by Subject|12|||
48828007|NCT01268566|157211100|FG000|Overall Study|Death|30|||
48828008|NCT05824351|157211103|FG000|Overall Study|Adverse Event|6|||
48828009|NCT03568162|157211106|FG000|Overall Study|Adverse Event|0|||
48828010|NCT03568162|157211107|FG001|Overall Study|Adverse Event|1|||
48828011|NCT03568162|157211108|FG002|Overall Study|Adverse Event|2|||
48828012|NCT03568162|157211109|FG003|Overall Study|Adverse Event|0|||
48828013|NCT03568162|157211110|FG004|Overall Study|Adverse Event|0|||
48828014|NCT03568162|157211111|FG005|Overall Study|Adverse Event|1|||
48828015|NCT03568162|157211106|FG000|Overall Study|Death|0|||
48828016|NCT03568162|157211107|FG001|Overall Study|Death|0|||
48828017|NCT03568162|157211108|FG002|Overall Study|Death|0|||
48828018|NCT03568162|157211109|FG003|Overall Study|Death|0|||
48828019|NCT03568162|157211110|FG004|Overall Study|Death|1|||
48828020|NCT03568162|157211111|FG005|Overall Study|Death|0|||
48828021|NCT03568162|157211106|FG000|Overall Study|Lost to Follow-up|3|||
48828022|NCT03568162|157211107|FG001|Overall Study|Lost to Follow-up|2|||
48828023|NCT03568162|157211108|FG002|Overall Study|Lost to Follow-up|4|||
48828024|NCT03568162|157211109|FG003|Overall Study|Lost to Follow-up|2|||
48828025|NCT03568162|157211110|FG004|Overall Study|Lost to Follow-up|3|||
48828026|NCT03568162|157211111|FG005|Overall Study|Lost to Follow-up|2|||
48828027|NCT03568162|157211106|FG000|Overall Study|Physician Decision|0|||
48828028|NCT03568162|157211107|FG001|Overall Study|Physician Decision|1|||
48828029|NCT03568162|157211108|FG002|Overall Study|Physician Decision|1|||
48828030|NCT03568162|157211109|FG003|Overall Study|Physician Decision|0|||
48828031|NCT03568162|157211110|FG004|Overall Study|Physician Decision|1|||
48828032|NCT03568162|157211111|FG005|Overall Study|Physician Decision|0|||
48828033|NCT03568162|157211106|FG000|Overall Study|Pregnancy|0|||
48828034|NCT03568162|157211107|FG001|Overall Study|Pregnancy|0|||
48828035|NCT03568162|157211108|FG002|Overall Study|Pregnancy|0|||
48828036|NCT03568162|157211109|FG003|Overall Study|Pregnancy|1|||
48828037|NCT03568162|157211110|FG004|Overall Study|Pregnancy|0|||
48828038|NCT03568162|157211111|FG005|Overall Study|Pregnancy|0|||
48828039|NCT03568162|157211106|FG000|Overall Study|Protocol Violation|1|||
48828040|NCT03568162|157211107|FG001|Overall Study|Protocol Violation|0|||
48828041|NCT03568162|157211108|FG002|Overall Study|Protocol Violation|1|||
48828042|NCT03568162|157211109|FG003|Overall Study|Protocol Violation|1|||
48828043|NCT03568162|157211110|FG004|Overall Study|Protocol Violation|1|||
48828044|NCT03568162|157211111|FG005|Overall Study|Protocol Violation|1|||
48828045|NCT03568162|157211106|FG000|Overall Study|Withdrawal by Subject|15|||
48828046|NCT03568162|157211107|FG001|Overall Study|Withdrawal by Subject|15|||
48828047|NCT03568162|157211108|FG002|Overall Study|Withdrawal by Subject|26|||
48828048|NCT03568162|157211109|FG003|Overall Study|Withdrawal by Subject|22|||
48828049|NCT03568162|157211110|FG004|Overall Study|Withdrawal by Subject|6|||
48828050|NCT03568162|157211111|FG005|Overall Study|Withdrawal by Subject|9|||
48828051|NCT03568162|157211106|FG000|Overall Study|Others|3|||
48828052|NCT03568162|157211107|FG001|Overall Study|Others|4|||
48828053|NCT03568162|157211108|FG002|Overall Study|Others|1|||
48828054|NCT03568162|157211109|FG003|Overall Study|Others|4|||
48828055|NCT03568162|157211110|FG004|Overall Study|Others|2|||
48828056|NCT03568162|157211111|FG005|Overall Study|Others|1|||
48828057|NCT01838551|157211112|FG000|Overall Study|Adverse Event|16|||
48828058|NCT01838551|157211112|FG000|Overall Study|Death|1|||
48828059|NCT01838551|157211112|FG000|Overall Study|Lack of Efficacy|10|||
48828060|NCT01838551|157211112|FG000|Overall Study|Physician Decision|4|||
48828061|NCT01838551|157211112|FG000|Overall Study|Withdrawal by Subject|10|||
48828062|NCT01838551|157211112|FG000|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7|||
48828063|NCT03722446|157211113|FG000|Overall Study|Protocol Violation|15|||
48828064|NCT03722446|157211114|FG001|Overall Study|Protocol Violation|2|||
48828065|NCT02931396|157211115|FG000|Overall Study|Lost to Follow-up|3|||
48828066|NCT02931396|157211116|FG001|Overall Study|Lost to Follow-up|0|||
48828067|NCT02931396|157211115|FG000|Overall Study|Withdrawal by Subject|2|||
48828068|NCT02931396|157211116|FG001|Overall Study|Withdrawal by Subject|0|||
48828069|NCT00315055|157212377|FG000|Overall Study|Protocol Violation|2|||
48828070|NCT00315055|157212378|FG001|Overall Study|Protocol Violation|4|||
48828071|NCT00315055|157212377|FG000|Overall Study|Lost to Follow-up|1|||
48828072|NCT00315055|157212378|FG001|Overall Study|Lost to Follow-up|1|||
48828073|NCT00530335|157212379|FG000|Overall Study|Adverse Event|3|||
48828074|NCT00530335|157212379|FG000|Overall Study|Protocol Violation|1|||
48828075|NCT00530335|157212379|FG000|Overall Study|Withdrawal by Subject|1|||
48828076|NCT00530335|157212379|FG000|Overall Study|Physician Decision|1|||
48828077|NCT01649791|157212380|FG000|Overall Study|Disease Progression|2|||
48828078|NCT01649791|157212380|FG000|Overall Study|Adverse Event|1|||
48828079|NCT03646669|157212381|FG000|Overall Study|Withdrawal by Subject|5|||
48828080|NCT03646669|157212382|FG001|Overall Study|Withdrawal by Subject|0|||
49155594|NCT00789555|158408620|FG002|Overall Study|Treatment failure|12|||
49155595|NCT00789555|158408618|FG000|Overall Study|Protocol Violation|6|||
49155596|NCT00789555|158408619|FG001|Overall Study|Protocol Violation|9|||
49155597|NCT00789555|158408620|FG002|Overall Study|Protocol Violation|13|||
48828081|NCT02680756|157212386|FG000|Overall Study|Adverse Event|10|||
48828082|NCT02680756|157212387|FG001|Overall Study|Adverse Event|2|||
48828083|NCT02680756|157212386|FG000|Overall Study|Lost to Follow-up|7|||
49155598|NCT03612570|158408621|FG000|Overall Study|Lost to Follow-up|1|||
48828084|NCT02680756|157212387|FG001|Overall Study|Lost to Follow-up|6|||
48828085|NCT02680756|157212386|FG000|Overall Study|Withdrawal by Subject|5|||
48828086|NCT02680756|157212387|FG001|Overall Study|Withdrawal by Subject|5|||
48828087|NCT02680756|157212386|FG000|Overall Study|Physician Decision|4|||
48828088|NCT02680756|157212387|FG001|Overall Study|Physician Decision|1|||
48828089|NCT02680756|157212386|FG000|Overall Study|Hb ≤7.5 g/dL|0|||
48828090|NCT02680756|157212387|FG001|Overall Study|Hb ≤7.5 g/dL|2|||
48828091|NCT02680756|157212386|FG000|Overall Study|Blood transfusion for any reason|0|||
48828092|NCT02680756|157212387|FG001|Overall Study|Blood transfusion for any reason|1|||
48828093|NCT02680756|157212386|FG000|Overall Study|Death|1|||
48828094|NCT02680756|157212387|FG001|Overall Study|Death|0|||
48828095|NCT02680756|157212386|FG000|Overall Study|Protocol Violation|1|||
48828096|NCT02680756|157212387|FG001|Overall Study|Protocol Violation|0|||
48828097|NCT02680756|157212386|FG000|Overall Study|TSAT above 60% or a ferritin above 800 m|1|||
48828098|NCT02680756|157212387|FG001|Overall Study|TSAT above 60% or a ferritin above 800 m|0|||
48828099|NCT02680756|157212386|FG000|Overall Study|None of above or not recorded|3|||
48828100|NCT02680756|157212387|FG001|Overall Study|None of above or not recorded|2|||
48828101|NCT03681691|157212388|FG000|Overall Study|COVID|1|||
48828102|NCT03681691|157212389|FG001|Overall Study|COVID|0|||
48828103|NCT03681691|157212388|FG000|Overall Study|prolonged bleeding|1|||
48828104|NCT03681691|157212389|FG001|Overall Study|prolonged bleeding|0|||
48828105|NCT03681691|157212388|FG000|Overall Study|veins would not stay open during the PET scan.|0|||
48828106|NCT03681691|157212389|FG001|Overall Study|veins would not stay open during the PET scan.|1|||
48828107|NCT01670019|157212394|FG000|Overall Study|Adverse Event|3|||
48828108|NCT01670019|157212395|FG001|Overall Study|Adverse Event|0|||
48828109|NCT01670019|157212394|FG000|Overall Study|Withdrawal by Subject|6|||
48828110|NCT01670019|157212395|FG001|Overall Study|Withdrawal by Subject|0|||
48828111|NCT00371566|157212398|FG000|Treatment Phase|Withdrawal by Subject|0|||
48828112|NCT00371566|157212399|FG001|Treatment Phase|Withdrawal by Subject|1|||
48828113|NCT00371566|157212398|FG000|Treatment Phase|Adverse Event|0|||
48828114|NCT00371566|157212399|FG001|Treatment Phase|Adverse Event|1|||
48828115|NCT00371566|157212398|FG000|Treatment Phase|Protocol Violation|0|||
48828116|NCT00371566|157212399|FG001|Treatment Phase|Protocol Violation|1|||
48828117|NCT00371566|157212398|FG000|Chemoradiation Phase|Physician Decision|2|||
48828118|NCT00371566|157212399|FG001|Chemoradiation Phase|Physician Decision|0|||
48828119|NCT00371566|157212398|FG000|Chemoradiation Phase|Withdrawal by Subject|0|||
48828120|NCT00371566|157212399|FG001|Chemoradiation Phase|Withdrawal by Subject|1|||
48828121|NCT00371566|157212398|FG000|Chemoradiation Phase|Non compliant|0|||
48828122|NCT00371566|157212399|FG001|Chemoradiation Phase|Non compliant|1|||
48828123|NCT00371566|157212398|FG000|Chemoradiation Phase|Progressive Disease|1|||
48828124|NCT00371566|157212399|FG001|Chemoradiation Phase|Progressive Disease|1|||
48828125|NCT00371566|157212398|FG000|Chemoradiation Phase|Death|2|||
48828126|NCT00371566|157212399|FG001|Chemoradiation Phase|Death|0|||
48828127|NCT00371566|157212398|FG000|Follow Up Phase|Death|0|||
48828128|NCT00371566|157212399|FG001|Follow Up Phase|Death|5|||
48828129|NCT00371566|157212398|FG000|Follow Up Phase|Disease progression|1|||
48828130|NCT00371566|157212399|FG001|Follow Up Phase|Disease progression|0|||
48828131|NCT00371566|157212398|FG000|Follow Up Phase|Withdrawal by Subject|0|||
48828132|NCT00371566|157212399|FG001|Follow Up Phase|Withdrawal by Subject|1|||
48828133|NCT00371566|157212398|FG000|Follow Up Phase|Physician Decision|1|||
48828134|NCT00371566|157212399|FG001|Follow Up Phase|Physician Decision|1|||
48828135|NCT00371566|157212398|FG000|Follow Up Phase|Lost to Follow-up|1|||
48828136|NCT00371566|157212399|FG001|Follow Up Phase|Lost to Follow-up|0|||
48828137|NCT01467700|157212400|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
48828138|NCT01467700|157212401|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
48828139|NCT01467700|157212402|FG002|Overall Study|Pretreatment Event or Adverse Event|2|||
48828140|NCT01467700|157212403|FG003|Overall Study|Pretreatment Event or Adverse Event|3|||
49155599|NCT00829998|158408624|FG000|Washout|Adverse Event|0|||
48828141|NCT01467700|157212400|FG000|Overall Study|Major Protocol Deviation|3|||
48828142|NCT01467700|157212401|FG001|Overall Study|Major Protocol Deviation|3|||
48828143|NCT01467700|157212402|FG002|Overall Study|Major Protocol Deviation|2|||
48828144|NCT01467700|157212403|FG003|Overall Study|Major Protocol Deviation|3|||
48828145|NCT01467700|157212400|FG000|Overall Study|Lost to Follow-up|6|||
48828146|NCT01467700|157212401|FG001|Overall Study|Lost to Follow-up|5|||
48828147|NCT01467700|157212402|FG002|Overall Study|Lost to Follow-up|2|||
48828148|NCT01467700|157212403|FG003|Overall Study|Lost to Follow-up|3|||
49155600|NCT00829998|158408625|FG001|Washout|Adverse Event|1|||
48828149|NCT01467700|157212400|FG000|Overall Study|Voluntary Withdrawal|5|||
48828150|NCT01467700|157212401|FG001|Overall Study|Voluntary Withdrawal|7|||
49155601|NCT01088906|158408628|FG000|Overall Study|Inclusion error|1|||
49155602|NCT01088906|158408628|FG000|Overall Study|Did not receive study treatment|3|||
48828151|NCT01467700|157212402|FG002|Overall Study|Voluntary Withdrawal|6|||
48828152|NCT01467700|157212403|FG003|Overall Study|Voluntary Withdrawal|2|||
48828153|NCT01467700|157212400|FG000|Overall Study|Study Termination|6|||
48828154|NCT01467700|157212401|FG001|Overall Study|Study Termination|5|||
48828155|NCT01467700|157212402|FG002|Overall Study|Study Termination|10|||
48828156|NCT01467700|157212403|FG003|Overall Study|Study Termination|7|||
48828157|NCT01467700|157212400|FG000|Overall Study|Pregnancy|0|||
48828158|NCT01467700|157212401|FG001|Overall Study|Pregnancy|1|||
48828159|NCT01467700|157212402|FG002|Overall Study|Pregnancy|1|||
48828160|NCT01467700|157212403|FG003|Overall Study|Pregnancy|0|||
48828161|NCT01467700|157212400|FG000|Overall Study|Lack of Efficacy|2|||
48828162|NCT01467700|157212401|FG001|Overall Study|Lack of Efficacy|0|||
48828163|NCT01467700|157212402|FG002|Overall Study|Lack of Efficacy|2|||
48828164|NCT01467700|157212403|FG003|Overall Study|Lack of Efficacy|1|||
48828165|NCT01467700|157212400|FG000|Overall Study|Reason not Specified|1|||
48828166|NCT01467700|157212401|FG001|Overall Study|Reason not Specified|3|||
48828167|NCT01467700|157212402|FG002|Overall Study|Reason not Specified|2|||
48828168|NCT01467700|157212403|FG003|Overall Study|Reason not Specified|8|||
48828169|NCT03732820|157212404|FG000|Overall Study|Death|168|||
48828170|NCT03732820|157212405|FG001|Overall Study|Death|203|||
48828171|NCT03732820|157212404|FG000|Overall Study|Other|2|||
48828172|NCT03732820|157212405|FG001|Overall Study|Other|2|||
48828173|NCT03732820|157212404|FG000|Overall Study|Failure to meet randomisation criteria|1|||
48828174|NCT03732820|157212405|FG001|Overall Study|Failure to meet randomisation criteria|1|||
48828175|NCT03732820|157212404|FG000|Overall Study|Patient decision|14|||
48828176|NCT03732820|157212405|FG001|Overall Study|Patient decision|10|||
48828177|NCT03732820|157212404|FG000|Overall Study|Screen failure|0|||
48828178|NCT03732820|157212405|FG001|Overall Study|Screen failure|1|||
48828179|NCT03732820|157212404|FG000|Overall Study|Patients ongoing study at data cut off|210|||
48828180|NCT03732820|157212405|FG001|Overall Study|Patients ongoing study at data cut off|178|||
48828181|NCT03732820|157212404|FG000|Overall Study|Lost to Follow-up|4|||
48828182|NCT03732820|157212405|FG001|Overall Study|Lost to Follow-up|2|||
48828183|NCT05030311|157212406|FG000|Overall Study|Technical problems|0|||
48828184|NCT05030311|157212407|FG001|Overall Study|Technical problems|1|||
48828185|NCT05030311|157212406|FG000|Overall Study|Withdrawal by Subject|31|||
48828186|NCT05030311|157212407|FG001|Overall Study|Withdrawal by Subject|17|||
48828187|NCT05030311|157212406|FG000|Overall Study|Adverse Event|13|||
49155603|NCT01088906|158408628|FG000|Overall Study|Missing data|1|||
49155604|NCT03514134|158410091|FG000|Overall Study|Lost to Follow-up|0|||
49155605|NCT03514134|158410092|FG001|Overall Study|Lost to Follow-up|1|||
49155606|NCT00622726|158410096|FG000|March, 2008 to August, 2010|Death|5|||
49155607|NCT00622726|158410097|FG001|March, 2008 to August, 2010|Death|2|||
49155608|NCT00622726|158410096|FG000|August, 2010 to April, 2013|Death|1|||
49155609|NCT00622726|158410097|FG001|August, 2010 to April, 2013|Death|5|||
49155610|NCT00163189|158410098|FG000|Overall Study|Other|6|||
49155611|NCT00163189|158410098|FG000|Overall Study|Lost to Follow-up|1|||
49155612|NCT00163189|158410098|FG000|Overall Study|Protocol Violation|2|||
49155613|NCT00163189|158410098|FG000|Overall Study|Death|3|||
49155614|NCT00163189|158410098|FG000|Overall Study|Adverse Event|6|||
49155615|NCT00163189|158410098|FG000|Overall Study|Lack of Efficacy|7|||
49155616|NCT00163189|158410098|FG000|Overall Study|Study terminated by sponsor|11|||
49155617|NCT00163189|158410098|FG000|Overall Study|Withdrawal by Subject|11|||
49155618|NCT00163189|158410098|FG000|Overall Study|Did not meet continuation criterion|16|||
49155619|NCT02519842|158410100|FG000|Base Study: Cycle 1|Screening Failure|1|||
49155620|NCT02519842|158410101|FG001|Base Study: Cycle 1|Screening Failure|1|||
49155621|NCT02519842|158410102|FG002|Base Study: Cycle 1|Screening Failure|0|||
49155622|NCT02519842|158410100|FG000|Base Study: Cycle 1|Adverse Event|1|||
49155623|NCT02519842|158410101|FG001|Base Study: Cycle 1|Adverse Event|0|||
49155624|NCT02519842|158410102|FG002|Base Study: Cycle 1|Adverse Event|0|||
48828188|NCT05030311|157212407|FG001|Overall Study|Adverse Event|5|||
48922364|NCT04169373|157550022|FG000|Week 14 to Week 52|COVID-19 Logistical Restrictions|1|||
49155625|NCT02519842|158410100|FG000|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
49155626|NCT02519842|158410101|FG001|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1|||
49155627|NCT02519842|158410102|FG002|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
48828189|NCT05030311|157212406|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
48828190|NCT05030311|157212407|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
48828191|NCT05030311|157212406|FG000|Overall Study|Physician Decision|5|||
48828192|NCT05030311|157212407|FG001|Overall Study|Physician Decision|2|||
48828193|NCT05030311|157212406|FG000|Overall Study|Lost to Follow-up|5|||
48828194|NCT05030311|157212407|FG001|Overall Study|Lost to Follow-up|1|||
48828195|NCT05030311|157212406|FG000|Overall Study|Protocol Violation|4|||
49155628|NCT02519842|158410100|FG000|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
48922365|NCT04169373|157550023|FG001|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
48922366|NCT04169373|157550024|FG002|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
48922367|NCT04169373|157550025|FG003|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
48922368|NCT04169373|157550022|FG000|Week 14 to Week 52|Other|4|||
48922369|NCT04169373|157550023|FG001|Week 14 to Week 52|Other|5|||
48922370|NCT04169373|157550024|FG002|Week 14 to Week 52|Other|4|||
48922371|NCT04169373|157550025|FG003|Week 14 to Week 52|Other|5|||
48922372|NCT04169373|157550022|FG000|Week 14 to Week 52|Ongoing|0|||
48922373|NCT04169373|157550023|FG001|Week 14 to Week 52|Ongoing|1|||
48922374|NCT04169373|157550024|FG002|Week 14 to Week 52|Ongoing|0|||
48922375|NCT04169373|157550025|FG003|Week 14 to Week 52|Ongoing|0|||
48922376|NCT02669017|157550028|FG000|Overall Study|Death|1|||
48922377|NCT02669017|157550029|FG001|Overall Study|Death|2|||
48922378|NCT02669017|157550030|FG002|Overall Study|Death|2|||
48922379|NCT02669017|157550031|FG003|Overall Study|Death|3|||
48922380|NCT02669017|157550032|FG004|Overall Study|Death|8|||
48922381|NCT02669017|157550033|FG005|Overall Study|Death|18|||
48922382|NCT02669017|157550034|FG006|Overall Study|Death|10|||
48922383|NCT02669017|157550035|FG007|Overall Study|Death|47|||
48922384|NCT02669017|157550036|FG008|Overall Study|Death|20|||
48922385|NCT02669017|157550028|FG000|Overall Study|Withdrawal by Subject|0|||
48922386|NCT02669017|157550029|FG001|Overall Study|Withdrawal by Subject|0|||
48922387|NCT02669017|157550030|FG002|Overall Study|Withdrawal by Subject|0|||
48922388|NCT02669017|157550031|FG003|Overall Study|Withdrawal by Subject|1|||
48922389|NCT02669017|157550032|FG004|Overall Study|Withdrawal by Subject|2|||
48922390|NCT02669017|157550033|FG005|Overall Study|Withdrawal by Subject|0|||
48922391|NCT02669017|157550034|FG006|Overall Study|Withdrawal by Subject|0|||
48828196|NCT05030311|157212407|FG001|Overall Study|Protocol Violation|4|||
48922392|NCT02669017|157550035|FG007|Overall Study|Withdrawal by Subject|2|||
48922393|NCT02669017|157550036|FG008|Overall Study|Withdrawal by Subject|2|||
48922394|NCT02669017|157550028|FG000|Overall Study|Lost to Follow-up|0|||
48922395|NCT02669017|157550029|FG001|Overall Study|Lost to Follow-up|0|||
48922396|NCT02669017|157550030|FG002|Overall Study|Lost to Follow-up|0|||
48922397|NCT02669017|157550031|FG003|Overall Study|Lost to Follow-up|0|||
48922398|NCT02669017|157550032|FG004|Overall Study|Lost to Follow-up|0|||
48922399|NCT02669017|157550033|FG005|Overall Study|Lost to Follow-up|0|||
48922400|NCT02669017|157550034|FG006|Overall Study|Lost to Follow-up|0|||
48922401|NCT02669017|157550035|FG007|Overall Study|Lost to Follow-up|0|||
48922402|NCT02669017|157550036|FG008|Overall Study|Lost to Follow-up|1|||
48922403|NCT02669017|157550028|FG000|Overall Study|Miscellaneous|0|||
48922404|NCT02669017|157550029|FG001|Overall Study|Miscellaneous|0|||
48922405|NCT02669017|157550030|FG002|Overall Study|Miscellaneous|0|||
48922406|NCT02669017|157550031|FG003|Overall Study|Miscellaneous|0|||
48922407|NCT02669017|157550032|FG004|Overall Study|Miscellaneous|2|||
48922408|NCT02669017|157550033|FG005|Overall Study|Miscellaneous|1|||
48922409|NCT02669017|157550034|FG006|Overall Study|Miscellaneous|1|||
48922410|NCT02669017|157550035|FG007|Overall Study|Miscellaneous|13|||
48922411|NCT02669017|157550036|FG008|Overall Study|Miscellaneous|2|||
48922412|NCT01146873|157550039|FG000|Overall Study|Transfer out|0|||
48922413|NCT01146873|157550040|FG001|Overall Study|Transfer out|6|||
48922414|NCT01379274|157550041|FG000|Overall Study|funding withdrawn|1|||
48922415|NCT00811135|157550042|FG000|Overall Study|Adverse Event/Intercurrent Illness|8|||
48922416|NCT00811135|157550042|FG000|Overall Study|Death|3|||
48922417|NCT00811135|157550042|FG000|Overall Study|Protocol Violation|2|||
48922418|NCT00811135|157550042|FG000|Overall Study|Violation of Selection Criteria|1|||
48922419|NCT00811135|157550042|FG000|Overall Study|Refused Treatment|1|||
48922420|NCT00811135|157550042|FG000|Overall Study|Withdrawal by Subject|3|||
48922421|NCT00811135|157550042|FG000|Overall Study|Administrative/Other Unspecified|11|||
48922422|NCT00811135|157550042|FG000|Overall Study|Ongoing|59|||
48922423|NCT03655756|157550053|FG000|Overall Study|Death|1|||
48922424|NCT03031301|157550054|FG000|Overall Study|Protocol Violation|4|||
48922425|NCT03031301|157550055|FG001|Overall Study|Protocol Violation|8|||
48922426|NCT03031301|157550054|FG000|Overall Study|Withdrawal by Subject|7|||
48922427|NCT03031301|157550055|FG001|Overall Study|Withdrawal by Subject|4|||
48922428|NCT03031301|157550054|FG000|Overall Study|Lost to Follow-up|4|||
48922429|NCT03031301|157550055|FG001|Overall Study|Lost to Follow-up|12|||
48922430|NCT03031301|157550054|FG000|Overall Study|Noncompliance|1|||
48922431|NCT03031301|157550055|FG001|Overall Study|Noncompliance|3|||
48922432|NCT03031301|157550054|FG000|Overall Study|Technical issue|1|||
48922433|NCT03031301|157550055|FG001|Overall Study|Technical issue|1|||
48922434|NCT03031301|157550054|FG000|Overall Study|Adverse Event|1|||
48922435|NCT03031301|157550055|FG001|Overall Study|Adverse Event|0|||
48828209|NCT02734004|157212411|FG000|Overall Study|Death|36|||
48828210|NCT02734004|157212412|FG001|Overall Study|Death|24|||
48828211|NCT02734004|157212413|FG002|Overall Study|Death|26|||
48828212|NCT02734004|157212414|FG003|Overall Study|Death|35|||
48922436|NCT01784861|157550057|FG000|Overall Study|Adverse Event|0|||
48922437|NCT01784861|157550058|FG001|Overall Study|Adverse Event|0|||
48922438|NCT01784861|157550059|FG002|Overall Study|Adverse Event|1|||
48922439|NCT01784861|157550060|FG003|Overall Study|Adverse Event|2|||
48922440|NCT01784861|157550061|FG004|Overall Study|Adverse Event|1|||
48828213|NCT02734004|157212415|FG004|Overall Study|Death|13|||
48828214|NCT02734004|157212416|FG005|Overall Study|Death|17|||
48828215|NCT02734004|157212417|FG006|Overall Study|Death|20|||
48828216|NCT02734004|157212411|FG000|Overall Study|Lost to Follow-up|1|||
48828217|NCT02734004|157212412|FG001|Overall Study|Lost to Follow-up|1|||
48828218|NCT02734004|157212413|FG002|Overall Study|Lost to Follow-up|0|||
48828219|NCT02734004|157212414|FG003|Overall Study|Lost to Follow-up|0|||
48828220|NCT02734004|157212415|FG004|Overall Study|Lost to Follow-up|1|||
48828221|NCT02734004|157212416|FG005|Overall Study|Lost to Follow-up|0|||
48828222|NCT02734004|157212417|FG006|Overall Study|Lost to Follow-up|0|||
48828223|NCT02734004|157212411|FG000|Overall Study|Withdrawal by Subject|3|||
48828224|NCT02734004|157212412|FG001|Overall Study|Withdrawal by Subject|1|||
48828225|NCT02734004|157212413|FG002|Overall Study|Withdrawal by Subject|1|||
48828226|NCT02734004|157212414|FG003|Overall Study|Withdrawal by Subject|1|||
48828227|NCT02734004|157212415|FG004|Overall Study|Withdrawal by Subject|3|||
48828228|NCT02734004|157212416|FG005|Overall Study|Withdrawal by Subject|0|||
48828229|NCT02734004|157212417|FG006|Overall Study|Withdrawal by Subject|2|||
48828230|NCT02734004|157212411|FG000|Overall Study|Other|0|||
48828231|NCT02734004|157212412|FG001|Overall Study|Other|8|||
48828232|NCT02734004|157212413|FG002|Overall Study|Other|7|||
48828233|NCT02734004|157212414|FG003|Overall Study|Other|4|||
48828234|NCT02734004|157212415|FG004|Overall Study|Other|34|||
48828235|NCT02734004|157212416|FG005|Overall Study|Other|14|||
48828236|NCT02734004|157212417|FG006|Overall Study|Other|10|||
48828237|NCT03098030|157212418|FG000|Overall Study|Death|10|||
48828238|NCT03098030|157212419|FG001|Overall Study|Death|156|||
48828239|NCT03098030|157212420|FG002|Overall Study|Death|156|||
48828240|NCT03098030|157212421|FG003|Overall Study|Death|82|||
48828241|NCT03098030|157212418|FG000|Overall Study|Withdrawal by Subject|0|||
48828242|NCT03098030|157212419|FG001|Overall Study|Withdrawal by Subject|7|||
48828243|NCT03098030|157212420|FG002|Overall Study|Withdrawal by Subject|8|||
48828244|NCT03098030|157212421|FG003|Overall Study|Withdrawal by Subject|2|||
48828245|NCT03098030|157212418|FG000|Overall Study|Lost to Follow-up|0|||
48828246|NCT03098030|157212419|FG001|Overall Study|Lost to Follow-up|0|||
48828247|NCT03098030|157212420|FG002|Overall Study|Lost to Follow-up|2|||
48828248|NCT03098030|157212421|FG003|Overall Study|Lost to Follow-up|1|||
48828249|NCT02062827|157212422|FG000|Overall Study|Death|1|||
48828250|NCT02062827|157212423|FG001|Overall Study|Death|0|||
48828251|NCT02062827|157212424|FG002|Overall Study|Death|0|||
48828252|NCT02062827|157212425|FG003|Overall Study|Death|0|||
48828253|NCT02062827|157212426|FG004|Overall Study|Death|0|||
48828254|NCT02062827|157212427|FG005|Overall Study|Death|0|||
48828255|NCT02062827|157212428|FG006|Overall Study|Death|0|||
48828256|NCT02062827|157212429|FG007|Overall Study|Death|0|||
48828257|NCT02062827|157212422|FG000|Overall Study|Withdrawal by Subject|3|||
48828258|NCT02062827|157212423|FG001|Overall Study|Withdrawal by Subject|1|||
48828259|NCT02062827|157212424|FG002|Overall Study|Withdrawal by Subject|1|||
48828260|NCT02062827|157212425|FG003|Overall Study|Withdrawal by Subject|2|||
48828261|NCT02062827|157212426|FG004|Overall Study|Withdrawal by Subject|6|||
48828262|NCT02062827|157212427|FG005|Overall Study|Withdrawal by Subject|0|||
48828263|NCT02062827|157212428|FG006|Overall Study|Withdrawal by Subject|5|||
48828264|NCT02062827|157212429|FG007|Overall Study|Withdrawal by Subject|0|||
48828265|NCT02062827|157212422|FG000|Overall Study|Screen Fail|0|||
48828266|NCT02062827|157212423|FG001|Overall Study|Screen Fail|0|||
48828267|NCT02062827|157212424|FG002|Overall Study|Screen Fail|0|||
48828268|NCT02062827|157212425|FG003|Overall Study|Screen Fail|0|||
48828269|NCT02062827|157212426|FG004|Overall Study|Screen Fail|0|||
48828270|NCT02062827|157212427|FG005|Overall Study|Screen Fail|0|||
48828271|NCT02062827|157212428|FG006|Overall Study|Screen Fail|0|||
48828272|NCT02062827|157212429|FG007|Overall Study|Screen Fail|8|||
48828273|NCT03586544|157212433|FG000|First Intervention|Adverse Event|0|||
48828274|NCT03586544|157212434|FG001|First Intervention|Adverse Event|1|||
48828275|NCT03586544|157212433|FG000|Second Intervention|Withdrawal by Subject|0|||
48828276|NCT03586544|157212434|FG001|Second Intervention|Withdrawal by Subject|1|||
48828277|NCT02781584|157212435|FG000|Pre-treatment Phase|Investigator's Discretion|0|||
48828278|NCT02781584|157212436|FG001|Pre-treatment Phase|Investigator's Discretion|0|||
48828279|NCT02781584|157212437|FG002|Pre-treatment Phase|Investigator's Discretion|0|||
48828280|NCT02781584|157212438|FG003|Pre-treatment Phase|Investigator's Discretion|0|||
48828281|NCT02781584|157212439|FG004|Pre-treatment Phase|Investigator's Discretion|0|||
48828282|NCT02781584|157212440|FG005|Pre-treatment Phase|Investigator's Discretion|0|||
48828283|NCT02781584|157212441|FG006|Pre-treatment Phase|Investigator's Discretion|0|||
48828284|NCT02781584|157212442|FG007|Pre-treatment Phase|Investigator's Discretion|0|||
48828285|NCT02781584|157212443|FG008|Pre-treatment Phase|Investigator's Discretion|0|||
48828286|NCT02781584|157212444|FG009|Pre-treatment Phase|Investigator's Discretion|0|||
48828287|NCT02781584|157212445|FG010|Pre-treatment Phase|Investigator's Discretion|0|||
48828288|NCT02781584|157212446|FG011|Pre-treatment Phase|Investigator's Discretion|2|||
48828289|NCT02781584|157212447|FG012|Pre-treatment Phase|Investigator's Discretion|1|||
48828290|NCT02781584|157212435|FG000|Pre-treatment Phase|Adverse Event|0|||
48828291|NCT02781584|157212436|FG001|Pre-treatment Phase|Adverse Event|0|||
48828292|NCT02781584|157212437|FG002|Pre-treatment Phase|Adverse Event|0|||
48828293|NCT02781584|157212438|FG003|Pre-treatment Phase|Adverse Event|0|||
48828294|NCT02781584|157212439|FG004|Pre-treatment Phase|Adverse Event|0|||
48828295|NCT02781584|157212440|FG005|Pre-treatment Phase|Adverse Event|0|||
48828296|NCT02781584|157212441|FG006|Pre-treatment Phase|Adverse Event|0|||
48828297|NCT02781584|157212442|FG007|Pre-treatment Phase|Adverse Event|0|||
48828298|NCT02781584|157212443|FG008|Pre-treatment Phase|Adverse Event|0|||
48828299|NCT02781584|157212444|FG009|Pre-treatment Phase|Adverse Event|0|||
48828300|NCT02781584|157212445|FG010|Pre-treatment Phase|Adverse Event|0|||
48828301|NCT02781584|157212446|FG011|Pre-treatment Phase|Adverse Event|1|||
48828302|NCT02781584|157212447|FG012|Pre-treatment Phase|Adverse Event|0|||
48828303|NCT02781584|157212435|FG000|Treatment Phase|Withdrew Consent|0|||
48828304|NCT02781584|157212436|FG001|Treatment Phase|Withdrew Consent|0|||
48828305|NCT02781584|157212437|FG002|Treatment Phase|Withdrew Consent|0|||
48828306|NCT02781584|157212438|FG003|Treatment Phase|Withdrew Consent|0|||
48828307|NCT02781584|157212439|FG004|Treatment Phase|Withdrew Consent|0|||
48828308|NCT02781584|157212440|FG005|Treatment Phase|Withdrew Consent|1|||
48828309|NCT02781584|157212441|FG006|Treatment Phase|Withdrew Consent|0|||
48828310|NCT02781584|157212442|FG007|Treatment Phase|Withdrew Consent|0|||
48828311|NCT02781584|157212443|FG008|Treatment Phase|Withdrew Consent|0|||
48828312|NCT02781584|157212444|FG009|Treatment Phase|Withdrew Consent|0|||
48828313|NCT02781584|157212445|FG010|Treatment Phase|Withdrew Consent|1|||
48828314|NCT02781584|157212446|FG011|Treatment Phase|Withdrew Consent|2|||
48828315|NCT02781584|157212447|FG012|Treatment Phase|Withdrew Consent|0|||
48828316|NCT02781584|157212435|FG000|Treatment Phase|Adverse Event|0|||
48828317|NCT02781584|157212436|FG001|Treatment Phase|Adverse Event|0|||
48828318|NCT02781584|157212437|FG002|Treatment Phase|Adverse Event|0|||
48828319|NCT02781584|157212438|FG003|Treatment Phase|Adverse Event|0|||
48828320|NCT02781584|157212439|FG004|Treatment Phase|Adverse Event|0|||
48828321|NCT02781584|157212440|FG005|Treatment Phase|Adverse Event|0|||
48828322|NCT02781584|157212441|FG006|Treatment Phase|Adverse Event|0|||
48828323|NCT02781584|157212442|FG007|Treatment Phase|Adverse Event|1|||
48828324|NCT02781584|157212443|FG008|Treatment Phase|Adverse Event|0|||
48828325|NCT02781584|157212444|FG009|Treatment Phase|Adverse Event|0|||
48828326|NCT02781584|157212445|FG010|Treatment Phase|Adverse Event|0|||
48828327|NCT02781584|157212446|FG011|Treatment Phase|Adverse Event|0|||
48828328|NCT02781584|157212447|FG012|Treatment Phase|Adverse Event|0|||
48828329|NCT00881335|157212448|FG000|Overall Study|Lost to Follow-up|3|||
48828330|NCT00881335|157212449|FG001|Overall Study|Lost to Follow-up|2|||
48828331|NCT01007149|157212452|FG000|Overall Study|Administrative problems|0|||
48828332|NCT01007149|157212453|FG001|Overall Study|Administrative problems|1|||
48828333|NCT01348087|157212454|FG000|Overall Study|Unsatisfactory therapeutic effect|35|||
48828334|NCT01348087|157212454|FG000|Overall Study|Administrative problems|79|||
48828335|NCT01348087|157212454|FG000|Overall Study|protocol deviation|1|||
48828336|NCT01348087|157212454|FG000|Overall Study|Lost to Follow-up|1|||
48828337|NCT01348087|157212454|FG000|Overall Study|Subject withdrew consent|7|||
48828338|NCT01348087|157212454|FG000|Overall Study|Adverse Event|25|||
48828339|NCT04886596|157212457|FG000|Overall Study|Adverse Event|73|||
48828340|NCT04886596|157212458|FG001|Overall Study|Adverse Event|78|||
48828341|NCT04886596|157212457|FG000|Overall Study|Lost to Follow-up|104|||
48828342|NCT04886596|157212458|FG001|Overall Study|Lost to Follow-up|104|||
48828343|NCT04886596|157212457|FG000|Overall Study|Ongoing|12095|||
48828344|NCT04886596|157212458|FG001|Overall Study|Ongoing|12107|||
48828345|NCT04886596|157212457|FG000|Overall Study|Consent withdrawal, not due to an (S)AE|162|||
48828346|NCT04886596|157212458|FG001|Overall Study|Consent withdrawal, not due to an (S)AE|173|||
48828347|NCT04886596|157212457|FG000|Overall Study|Migrated / Moved from the study area|17|||
48828348|NCT04886596|157212458|FG001|Overall Study|Migrated / Moved from the study area|14|||
48828349|NCT04886596|157212457|FG000|Overall Study|Unknown reason|16|||
48828350|NCT04886596|157212458|FG001|Overall Study|Unknown reason|23|||
48828351|NCT00603538|157212459|FG000|Overall Study|Adverse Event|0|||
48828352|NCT00603538|157212460|FG001|Overall Study|Adverse Event|4|||
48828353|NCT00603538|157212461|FG002|Overall Study|Adverse Event|2|||
48828354|NCT00603538|157212459|FG000|Overall Study|Objective progression or relapse|3|||
48828355|NCT00603538|157212460|FG001|Overall Study|Objective progression or relapse|0|||
48828356|NCT00603538|157212461|FG002|Overall Study|Objective progression or relapse|0|||
48828357|NCT04771273|157212462|FG000|Dose Escalation Period|Not treated with trial medication|0|||
48828358|NCT04771273|157212463|FG001|Dose Escalation Period|Not treated with trial medication|1|||
48828359|NCT04771273|157212464|FG002|Dose Escalation Period|Not treated with trial medication|1|||
48828360|NCT04771273|157212465|FG003|Dose Escalation Period|Not treated with trial medication|0|||
48828361|NCT04771273|157212462|FG000|Dose Escalation Period|Other reasons than listed|2|||
48828362|NCT04771273|157212463|FG001|Dose Escalation Period|Other reasons than listed|0|||
48828363|NCT04771273|157212464|FG002|Dose Escalation Period|Other reasons than listed|2|||
48828364|NCT04771273|157212465|FG003|Dose Escalation Period|Other reasons than listed|1|||
48828365|NCT04771273|157212462|FG000|Dose Escalation Period|Protocol Violation|0|||
48828366|NCT04771273|157212463|FG001|Dose Escalation Period|Protocol Violation|0|||
48828367|NCT04771273|157212464|FG002|Dose Escalation Period|Protocol Violation|3|||
48828368|NCT04771273|157212465|FG003|Dose Escalation Period|Protocol Violation|1|||
48828369|NCT04771273|157212462|FG000|Dose Escalation Period|Burden of study procedures|1|||
48828370|NCT04771273|157212463|FG001|Dose Escalation Period|Burden of study procedures|0|||
48828371|NCT04771273|157212464|FG002|Dose Escalation Period|Burden of study procedures|0|||
48828372|NCT04771273|157212465|FG003|Dose Escalation Period|Burden of study procedures|0|||
48828373|NCT04771273|157212462|FG000|Dose Escalation Period|Change of residence|0|||
48828374|NCT04771273|157212463|FG001|Dose Escalation Period|Change of residence|0|||
48828375|NCT04771273|157212464|FG002|Dose Escalation Period|Change of residence|0|||
48828376|NCT04771273|157212465|FG003|Dose Escalation Period|Change of residence|1|||
48828377|NCT04771273|157212462|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
48828378|NCT04771273|157212463|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
48828379|NCT04771273|157212464|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
48828380|NCT04771273|157212465|FG003|Dose Escalation Period|Perceived lack of efficacy|1|||
48828381|NCT04771273|157212462|FG000|Dose Escalation Period|Adverse Event|8|||
48828382|NCT04771273|157212463|FG001|Dose Escalation Period|Adverse Event|9|||
48828383|NCT04771273|157212464|FG002|Dose Escalation Period|Adverse Event|12|||
48828384|NCT04771273|157212465|FG003|Dose Escalation Period|Adverse Event|2|||
48828385|NCT04771273|157212462|FG000|Maintenance Period|Other than listed|4|||
48828386|NCT04771273|157212463|FG001|Maintenance Period|Other than listed|2|||
48828387|NCT04771273|157212464|FG002|Maintenance Period|Other than listed|0|||
48828388|NCT04771273|157212465|FG003|Maintenance Period|Other than listed|3|||
48828389|NCT04771273|157212462|FG000|Maintenance Period|Burden of study procedures|1|||
48828390|NCT04771273|157212463|FG001|Maintenance Period|Burden of study procedures|0|||
48922441|NCT01784861|157550062|FG005|Overall Study|Adverse Event|0|||
48828391|NCT04771273|157212464|FG002|Maintenance Period|Burden of study procedures|0|||
48922442|NCT01784861|157550057|FG000|Overall Study|Withdrawal by Subject|0|||
48922443|NCT01784861|157550058|FG001|Overall Study|Withdrawal by Subject|0|||
48922444|NCT01784861|157550059|FG002|Overall Study|Withdrawal by Subject|0|||
48922445|NCT01784861|157550060|FG003|Overall Study|Withdrawal by Subject|1|||
48922446|NCT01784861|157550061|FG004|Overall Study|Withdrawal by Subject|0|||
48922447|NCT01784861|157550062|FG005|Overall Study|Withdrawal by Subject|0|||
48922448|NCT01784861|157550057|FG000|Overall Study|Physician Decision|0|||
48922449|NCT01784861|157550058|FG001|Overall Study|Physician Decision|0|||
48922450|NCT01784861|157550059|FG002|Overall Study|Physician Decision|0|||
48922451|NCT01784861|157550060|FG003|Overall Study|Physician Decision|2|||
48922452|NCT01784861|157550061|FG004|Overall Study|Physician Decision|0|||
48922453|NCT01784861|157550062|FG005|Overall Study|Physician Decision|1|||
48922454|NCT01662895|157550068|FG000|Overall Study|Lost to Follow-up|0|||
48922455|NCT01662895|157550069|FG001|Overall Study|Lost to Follow-up|1|||
48922456|NCT05098041|157550070|FG000|Period 1 (1 Day)|Withdrawal by Subject|1|||
48922457|NCT00464334|157550080|FG000|Overall Study|Adverse Event|0|||
48922458|NCT00464334|157550081|FG001|Overall Study|Adverse Event|0|||
48922459|NCT00464334|157550082|FG002|Overall Study|Adverse Event|0|||
48922460|NCT00464334|157550083|FG003|Overall Study|Adverse Event|1|||
48922461|NCT00464334|157550084|FG004|Overall Study|Adverse Event|1|||
48922462|NCT00464334|157550085|FG005|Overall Study|Adverse Event|1|||
48922463|NCT00464334|157550086|FG006|Overall Study|Adverse Event|0|||
48922464|NCT00464334|157550087|FG007|Overall Study|Adverse Event|0|||
48922465|NCT00464334|157550088|FG008|Overall Study|Adverse Event|2|||
48922466|NCT00464334|157550089|FG009|Overall Study|Adverse Event|1|||
48922467|NCT00464334|157550090|FG010|Overall Study|Adverse Event|2|||
48922468|NCT00464334|157550080|FG000|Overall Study|Lack of Efficacy|0|||
48922469|NCT00464334|157550081|FG001|Overall Study|Lack of Efficacy|1|||
49155629|NCT02519842|158410101|FG001|Base Study: Cycle 1|Non-compliance with Study Drug|1|||
49155630|NCT02519842|158410102|FG002|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
49155631|NCT02519842|158410100|FG000|Optional Extension: Cycles 2-6|Physician Decision|0|||
49155632|NCT02519842|158410101|FG001|Optional Extension: Cycles 2-6|Physician Decision|0|||
49155633|NCT02519842|158410102|FG002|Optional Extension: Cycles 2-6|Physician Decision|5|||
49155634|NCT02519842|158410100|FG000|Optional Extension: Cycles 2-6|Adverse Event|0|||
49155635|NCT02519842|158410101|FG001|Optional Extension: Cycles 2-6|Adverse Event|0|||
49155636|NCT02519842|158410102|FG002|Optional Extension: Cycles 2-6|Adverse Event|1|||
48828392|NCT04771273|157212465|FG003|Maintenance Period|Burden of study procedures|0|||
48828393|NCT04771273|157212462|FG000|Maintenance Period|Change of residence|0|||
48828394|NCT04771273|157212463|FG001|Maintenance Period|Change of residence|1|||
48922470|NCT00464334|157550082|FG002|Overall Study|Lack of Efficacy|0|||
48922471|NCT00464334|157550083|FG003|Overall Study|Lack of Efficacy|0|||
48922472|NCT00464334|157550084|FG004|Overall Study|Lack of Efficacy|0|||
48922473|NCT00464334|157550085|FG005|Overall Study|Lack of Efficacy|0|||
49155637|NCT02519842|158410100|FG000|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
48828395|NCT04771273|157212464|FG002|Maintenance Period|Change of residence|3|||
48828396|NCT04771273|157212465|FG003|Maintenance Period|Change of residence|0|||
48828397|NCT04771273|157212462|FG000|Maintenance Period|Perceived lack of efficacy|0|||
48828398|NCT04771273|157212463|FG001|Maintenance Period|Perceived lack of efficacy|0|||
48922474|NCT00464334|157550086|FG006|Overall Study|Lack of Efficacy|0|||
48922475|NCT00464334|157550087|FG007|Overall Study|Lack of Efficacy|0|||
48922476|NCT00464334|157550088|FG008|Overall Study|Lack of Efficacy|0|||
48922477|NCT00464334|157550089|FG009|Overall Study|Lack of Efficacy|0|||
48828399|NCT04771273|157212464|FG002|Maintenance Period|Perceived lack of efficacy|0|||
48828400|NCT04771273|157212465|FG003|Maintenance Period|Perceived lack of efficacy|1|||
48828401|NCT04771273|157212462|FG000|Maintenance Period|Adverse Event|4|||
48828402|NCT04771273|157212463|FG001|Maintenance Period|Adverse Event|5|||
48828403|NCT04771273|157212464|FG002|Maintenance Period|Adverse Event|5|||
48828404|NCT04771273|157212465|FG003|Maintenance Period|Adverse Event|0|||
48828405|NCT05096884|157212466|FG000|Overall Study|Excluded based on negative tilt table test|4|||
49155638|NCT02519842|158410101|FG001|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
49155639|NCT02519842|158410102|FG002|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3|||
49155640|NCT02519842|158410100|FG000|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
49155641|NCT02519842|158410101|FG001|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
48828406|NCT04011033|157212470|FG000|Overall Study|Physician Decision|2|||
48828407|NCT04011033|157212471|FG001|Overall Study|Physician Decision|3|||
49155642|NCT02519842|158410102|FG002|Optional Extension: Cycles 2-6|Withdrawal by Subject|1|||
49155643|NCT02519842|158410100|FG000|Optional Extension: Cycles 2-6|Death|0|||
48828408|NCT04011033|157212470|FG000|Overall Study|Withdrawal by Subject|1|||
48828409|NCT04011033|157212471|FG001|Overall Study|Withdrawal by Subject|0|||
48828410|NCT01333514|157212478|FG000|Overall Study|Withdrawal by Subject|1|||
48828411|NCT01333514|157212479|FG001|Overall Study|Withdrawal by Subject|0|||
48828412|NCT02289560|157212480|FG000|Overall Study|Lost to Follow-up|6|||
48828413|NCT02289560|157212480|FG000|Overall Study|Alternative Treatment|4|||
48828414|NCT02289560|157212480|FG000|Overall Study|Inadequate Treatment|2|||
48828415|NCT02289560|157212480|FG000|Overall Study|Withdrawal by Subject|23|||
48828416|NCT02540213|157212482|FG000|Overall Study|Death/adverse event|18|||
48828417|NCT02540213|157212482|FG000|Overall Study|Administrative reasons|3|||
48828418|NCT02540213|157212482|FG000|Overall Study|Kidney transplant|3|||
48828419|NCT02540213|157212482|FG000|Overall Study|Lack of Efficacy|6|||
48828420|NCT02540213|157212482|FG000|Overall Study|Consent withdrawn|7|||
48828421|NCT02540213|157212482|FG000|Overall Study|Enrolled but not treated|2|||
48828422|NCT00389519|157212483|FG000|Placebo Run-In|Did not meet blood pressure criteria|119|||
48828423|NCT00389519|157212484|FG001|Placebo Run-In|Did not meet blood pressure criteria|0|||
48828424|NCT00389519|157212485|FG002|Placebo Run-In|Did not meet blood pressure criteria|0|||
48828425|NCT00389519|157212486|FG003|Placebo Run-In|Did not meet blood pressure criteria|0|||
48828426|NCT00389519|157212483|FG000|Placebo Run-In|Withdrawal by Subject|19|||
48828427|NCT00389519|157212484|FG001|Placebo Run-In|Withdrawal by Subject|0|||
48828428|NCT00389519|157212485|FG002|Placebo Run-In|Withdrawal by Subject|0|||
48828429|NCT00389519|157212486|FG003|Placebo Run-In|Withdrawal by Subject|0|||
48828430|NCT00389519|157212483|FG000|Placebo Run-In|Reason not specified|40|||
48828431|NCT00389519|157212484|FG001|Placebo Run-In|Reason not specified|0|||
48828432|NCT00389519|157212485|FG002|Placebo Run-In|Reason not specified|0|||
48828433|NCT00389519|157212486|FG003|Placebo Run-In|Reason not specified|0|||
48828434|NCT00389519|157212483|FG000|Randomized|Did not receive study drug|2|||
48828435|NCT00389519|157212484|FG001|Randomized|Did not receive study drug|0|||
48828436|NCT00389519|157212485|FG002|Randomized|Did not receive study drug|0|||
48828437|NCT00389519|157212486|FG003|Randomized|Did not receive study drug|0|||
48828438|NCT00389519|157212483|FG000|Treated|Adverse Event|1|||
48828439|NCT00389519|157212484|FG001|Treated|Adverse Event|0|||
48828440|NCT00389519|157212485|FG002|Treated|Adverse Event|0|||
48828441|NCT00389519|157212486|FG003|Treated|Adverse Event|2|||
48828442|NCT00389519|157212483|FG000|Treated|Reason not specified|1|||
48828443|NCT00389519|157212484|FG001|Treated|Reason not specified|1|||
48828444|NCT00389519|157212485|FG002|Treated|Reason not specified|0|||
48828445|NCT00389519|157212486|FG003|Treated|Reason not specified|2|||
48828446|NCT01981356|157212493|FG000|Overall Study|Lost to Follow-up|4|||
48828447|NCT01981356|157212494|FG001|Overall Study|Lost to Follow-up|1|||
48828448|NCT01981356|157212493|FG000|Overall Study|Withdrawal by Subject|1|||
48828449|NCT01981356|157212494|FG001|Overall Study|Withdrawal by Subject|1|||
48828450|NCT01981356|157212493|FG000|Overall Study|Protocol Violation|2|||
48828451|NCT01981356|157212494|FG001|Overall Study|Protocol Violation|0|||
48828452|NCT00536380|157212495|FG000|Overall Study|Adverse Event|0|||
48828453|NCT00536380|157212496|FG001|Overall Study|Adverse Event|2|||
48828454|NCT00536380|157212497|FG002|Overall Study|Adverse Event|2|||
48828455|NCT00536380|157212495|FG000|Overall Study|Lost to Follow-up|0|||
48828456|NCT00536380|157212496|FG001|Overall Study|Lost to Follow-up|0|||
48828457|NCT00536380|157212497|FG002|Overall Study|Lost to Follow-up|1|||
48828458|NCT00536380|157212495|FG000|Overall Study|Withdrawal unrelated to study drug|2|||
48828459|NCT00536380|157212496|FG001|Overall Study|Withdrawal unrelated to study drug|0|||
48828460|NCT00536380|157212497|FG002|Overall Study|Withdrawal unrelated to study drug|1|||
48828461|NCT00536380|157212495|FG000|Overall Study|Withdrawal related to study drug|7|||
48828462|NCT00536380|157212496|FG001|Overall Study|Withdrawal related to study drug|5|||
48828463|NCT00536380|157212497|FG002|Overall Study|Withdrawal related to study drug|2|||
48828464|NCT00536380|157212495|FG000|Overall Study|Noncompliance with protocol|3|||
48828465|NCT00536380|157212496|FG001|Overall Study|Noncompliance with protocol|2|||
48828466|NCT00536380|157212497|FG002|Overall Study|Noncompliance with protocol|2|||
48828467|NCT00536380|157212495|FG000|Overall Study|Did not meet protocol eligibility|0|||
48828468|NCT00536380|157212496|FG001|Overall Study|Did not meet protocol eligibility|0|||
48828469|NCT00536380|157212497|FG002|Overall Study|Did not meet protocol eligibility|1|||
48828470|NCT00536380|157212495|FG000|Overall Study|Administrative|0|||
48828471|NCT00536380|157212496|FG001|Overall Study|Administrative|0|||
48828472|NCT00536380|157212497|FG002|Overall Study|Administrative|1|||
48828473|NCT00299702|157212498|FG000|Overall Study|Death|1|||
48828474|NCT00299702|157212499|FG001|Overall Study|Death|0|||
48828475|NCT00299702|157212498|FG000|Overall Study|Adverse Event|0|||
48828476|NCT00299702|157212499|FG001|Overall Study|Adverse Event|4|||
48828477|NCT00299702|157212498|FG000|Overall Study|Lost to Follow-up|18|||
48828478|NCT00299702|157212499|FG001|Overall Study|Lost to Follow-up|10|||
48828479|NCT00299702|157212498|FG000|Overall Study|Withdrawal by Subject|25|||
48828480|NCT00299702|157212499|FG001|Overall Study|Withdrawal by Subject|23|||
48828481|NCT00299702|157212498|FG000|Overall Study|Pregnancy|0|||
48828482|NCT00299702|157212499|FG001|Overall Study|Pregnancy|1|||
48828483|NCT00299702|157212498|FG000|Overall Study|Insufficient Response|4|||
48828484|NCT00299702|157212499|FG001|Overall Study|Insufficient Response|3|||
48828485|NCT00299702|157212498|FG000|Overall Study|Admin issues, sponsor decision, etc.|5|||
48828486|NCT00299702|157212499|FG001|Overall Study|Admin issues, sponsor decision, etc.|9|||
48828487|NCT02013037|157212501|FG000|Overall Study|Death|6|||
48828488|NCT02013037|157212501|FG000|Overall Study|Withdrawal by Subject|1|||
48828489|NCT02013037|157212501|FG000|Overall Study|Awaiting Transplantation|7|||
48828490|NCT02013037|157212501|FG000|Overall Study|Transplanted without DSA|2|||
48828491|NCT02465359|157212502|FG000|Overall Study|Lack of Efficacy|1|||
48828492|NCT02465359|157212502|FG000|Overall Study|Withdrawal by Subject|1|||
48828493|NCT02465359|157212502|FG000|Overall Study|Adverse Event|1|||
48828494|NCT03141788|157212506|FG000|Overall Study|Lost to Follow-up|1|||
48828495|NCT03141788|157212506|FG000|Overall Study|Protocol Violation|3|||
48828496|NCT03141788|157212506|FG000|Overall Study|Withdrawal by Subject|4|||
48828497|NCT02812966|157212507|FG000|Overall Study|Death|1|||
48828498|NCT02812966|157212508|FG001|Overall Study|Death|0|||
48828499|NCT03354390|157212509|FG000|Level 1|Death|2|||
48828500|NCT03354390|157212510|FG001|Level 1|Death|0|||
48828501|NCT03354390|157212511|FG002|Level 1|Death|0|||
48828502|NCT03354390|157212512|FG003|Level 1|Death|0|||
48828503|NCT03354390|157212509|FG000|Level 1|Physician Decision|1|||
48828504|NCT03354390|157212510|FG001|Level 1|Physician Decision|0|||
48828505|NCT03354390|157212511|FG002|Level 1|Physician Decision|0|||
48828506|NCT03354390|157212512|FG003|Level 1|Physician Decision|0|||
48828507|NCT03354390|157212509|FG000|Level 2|Physician Decision|0|||
48828508|NCT03354390|157212510|FG001|Level 2|Physician Decision|2|||
48828509|NCT03354390|157212511|FG002|Level 2|Physician Decision|0|||
48828510|NCT03354390|157212512|FG003|Level 2|Physician Decision|0|||
48828511|NCT03354390|157212509|FG000|Level 2|Lack of Efficacy|0|||
48828512|NCT03354390|157212510|FG001|Level 2|Lack of Efficacy|1|||
48828513|NCT03354390|157212511|FG002|Level 2|Lack of Efficacy|0|||
48828514|NCT03354390|157212512|FG003|Level 2|Lack of Efficacy|0|||
48828515|NCT03354390|157212509|FG000|Level 2|Lost to Follow-up|0|||
48828516|NCT03354390|157212510|FG001|Level 2|Lost to Follow-up|1|||
48828517|NCT03354390|157212511|FG002|Level 2|Lost to Follow-up|0|||
48828518|NCT03354390|157212512|FG003|Level 2|Lost to Follow-up|0|||
48828519|NCT03354390|157212509|FG000|Level 3|Death|0|||
48828520|NCT03354390|157212510|FG001|Level 3|Death|0|||
48828521|NCT03354390|157212511|FG002|Level 3|Death|1|||
48828522|NCT03354390|157212512|FG003|Level 3|Death|0|||
48828523|NCT03354390|157212509|FG000|Level 3|Physician Decision|0|||
48828524|NCT03354390|157212510|FG001|Level 3|Physician Decision|0|||
48828525|NCT03354390|157212511|FG002|Level 3|Physician Decision|2|||
48828526|NCT03354390|157212512|FG003|Level 3|Physician Decision|0|||
48828527|NCT03354390|157212509|FG000|Level 4|Death|0|||
48828528|NCT03354390|157212510|FG001|Level 4|Death|0|||
48828529|NCT03354390|157212511|FG002|Level 4|Death|0|||
48828530|NCT03354390|157212512|FG003|Level 4|Death|3|||
48828531|NCT03481777|157214016|FG000|Overall Study|Withdrawal by Subject|36|||
48828532|NCT03481777|157214017|FG001|Overall Study|Withdrawal by Subject|31|||
48828533|NCT03481777|157214016|FG000|Overall Study|Non stroke = non target population|277|||
48828534|NCT03481777|157214017|FG001|Overall Study|Non stroke = non target population|254|||
48828535|NCT04091672|157214019|FG000|Overall Study|Death|6|||
48828536|NCT04091672|157214020|FG001|Overall Study|Death|6|||
48828537|NCT04091672|157214019|FG000|Overall Study|Lost to Follow-up|7|||
48828538|NCT04091672|157214020|FG001|Overall Study|Lost to Follow-up|7|||
48828539|NCT04091672|157214019|FG000|Overall Study|Withdrawal by Subject|3|||
48828540|NCT04091672|157214020|FG001|Overall Study|Withdrawal by Subject|3|||
48828541|NCT04091672|157214019|FG000|Overall Study|Non-Compliance With Study Schedule|2|||
48828542|NCT04091672|157214020|FG001|Overall Study|Non-Compliance With Study Schedule|2|||
48828543|NCT01939158|157214021|FG000|Overall Study|Adverse Event|1|||
48828544|NCT01939158|157214022|FG001|Overall Study|Adverse Event|0|||
48828545|NCT01939158|157214023|FG002|Overall Study|Adverse Event|0|||
48828546|NCT01939158|157214024|FG003|Overall Study|Adverse Event|0|||
48828547|NCT01939158|157214021|FG000|Overall Study|Withdrawal by Subject|22|||
48828548|NCT01939158|157214022|FG001|Overall Study|Withdrawal by Subject|25|||
48828549|NCT01939158|157214023|FG002|Overall Study|Withdrawal by Subject|15|||
48828550|NCT01939158|157214024|FG003|Overall Study|Withdrawal by Subject|17|||
48828551|NCT01939158|157214021|FG000|Overall Study|Migrated/moved from study area|5|||
48828552|NCT01939158|157214022|FG001|Overall Study|Migrated/moved from study area|7|||
48828553|NCT01939158|157214023|FG002|Overall Study|Migrated/moved from study area|3|||
48828554|NCT01939158|157214024|FG003|Overall Study|Migrated/moved from study area|6|||
48828555|NCT01939158|157214021|FG000|Overall Study|Lost to Follow-up|18|||
48828556|NCT01939158|157214022|FG001|Overall Study|Lost to Follow-up|17|||
48828557|NCT01939158|157214023|FG002|Overall Study|Lost to Follow-up|17|||
48828558|NCT01939158|157214024|FG003|Overall Study|Lost to Follow-up|17|||
48828559|NCT01939158|157214021|FG000|Overall Study|Death|0|||
48828560|NCT01939158|157214022|FG001|Overall Study|Death|0|||
48828561|NCT01939158|157214023|FG002|Overall Study|Death|1|||
48828562|NCT01939158|157214024|FG003|Overall Study|Death|1|||
48828563|NCT01939158|157214021|FG000|Overall Study|No longer meets eligibility criteria|0|||
48828564|NCT01939158|157214022|FG001|Overall Study|No longer meets eligibility criteria|0|||
48828565|NCT01939158|157214023|FG002|Overall Study|No longer meets eligibility criteria|1|||
48828566|NCT01939158|157214024|FG003|Overall Study|No longer meets eligibility criteria|0|||
48828567|NCT01939158|157214021|FG000|Overall Study|Other|1|||
48828568|NCT01939158|157214022|FG001|Overall Study|Other|3|||
48828569|NCT01939158|157214023|FG002|Overall Study|Other|4|||
48828570|NCT01939158|157214024|FG003|Overall Study|Other|3|||
48828571|NCT01684046|157214025|FG000|Period 1, First 30 Days|Adverse Event|0|||
48828572|NCT01684046|157214026|FG001|Period 1, First 30 Days|Adverse Event|2|||
48828573|NCT05074498|157214027|FG000|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
48828574|NCT05074498|157214028|FG001|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
48828575|NCT05074498|157214029|FG002|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
48828576|NCT05074498|157214030|FG003|Part 1 (Upto Day 104)|Lost to Follow-up|1|||
48828577|NCT05074498|157214031|FG004|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
48828578|NCT05074498|157214032|FG005|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
48828579|NCT05074498|157214027|FG000|Part 1 (Upto Day 104)|Other|1|||
48828580|NCT05074498|157214028|FG001|Part 1 (Upto Day 104)|Other|0|||
48828581|NCT05074498|157214029|FG002|Part 1 (Upto Day 104)|Other|0|||
48828582|NCT05074498|157214030|FG003|Part 1 (Upto Day 104)|Other|0|||
48828583|NCT05074498|157214031|FG004|Part 1 (Upto Day 104)|Other|0|||
48828584|NCT05074498|157214032|FG005|Part 1 (Upto Day 104)|Other|0|||
48828585|NCT05074498|157214027|FG000|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
48828586|NCT05074498|157214028|FG001|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
48828587|NCT05074498|157214029|FG002|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
48828588|NCT05074498|157214030|FG003|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
48828589|NCT05074498|157214031|FG004|Part 2 (Upto Day 104)|Withdrawal by Subject|2|||
48828590|NCT05074498|157214032|FG005|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
48828591|NCT05074498|157214027|FG000|Part 2 (Upto Day 104)|Death|0|||
48828592|NCT05074498|157214028|FG001|Part 2 (Upto Day 104)|Death|0|||
48828593|NCT05074498|157214029|FG002|Part 2 (Upto Day 104)|Death|0|||
48828594|NCT05074498|157214030|FG003|Part 2 (Upto Day 104)|Death|0|||
48828595|NCT05074498|157214031|FG004|Part 2 (Upto Day 104)|Death|1|||
48828596|NCT05074498|157214032|FG005|Part 2 (Upto Day 104)|Death|0|||
48828597|NCT05074498|157214027|FG000|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
48828598|NCT05074498|157214028|FG001|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
48828599|NCT05074498|157214029|FG002|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
48828600|NCT05074498|157214030|FG003|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
48828601|NCT05074498|157214031|FG004|Part 2 (Upto Day 104)|Lost to Follow-up|1|||
48828602|NCT05074498|157214032|FG005|Part 2 (Upto Day 104)|Lost to Follow-up|2|||
48828603|NCT05074498|157214027|FG000|Part 2 (Upto Day 104)|Other|0|||
48828604|NCT05074498|157214028|FG001|Part 2 (Upto Day 104)|Other|0|||
48922478|NCT00464334|157550090|FG010|Overall Study|Lack of Efficacy|0|||
48922479|NCT00464334|157550080|FG000|Overall Study|Lost to Follow-up|0|||
48922480|NCT00464334|157550081|FG001|Overall Study|Lost to Follow-up|0|||
48922481|NCT00464334|157550082|FG002|Overall Study|Lost to Follow-up|1|||
48922482|NCT00464334|157550083|FG003|Overall Study|Lost to Follow-up|0|||
48922483|NCT00464334|157550084|FG004|Overall Study|Lost to Follow-up|1|||
48922484|NCT00464334|157550085|FG005|Overall Study|Lost to Follow-up|0|||
48922485|NCT00464334|157550086|FG006|Overall Study|Lost to Follow-up|1|||
48828605|NCT05074498|157214029|FG002|Part 2 (Upto Day 104)|Other|0|||
48828606|NCT05074498|157214030|FG003|Part 2 (Upto Day 104)|Other|0|||
48828607|NCT05074498|157214031|FG004|Part 2 (Upto Day 104)|Other|1|||
48828608|NCT05074498|157214032|FG005|Part 2 (Upto Day 104)|Other|0|||
48828609|NCT02028884|157214033|FG000|Double-blind Period|Adverse Event|5|||
48828610|NCT02028884|157214034|FG001|Double-blind Period|Adverse Event|3|||
48828611|NCT02028884|157214035|FG002|Double-blind Period|Adverse Event|0|||
48828612|NCT02028884|157214033|FG000|Double-blind Period|Eligibility Violation|1|||
48828613|NCT02028884|157214034|FG001|Double-blind Period|Eligibility Violation|0|||
48828614|NCT02028884|157214035|FG002|Double-blind Period|Eligibility Violation|0|||
48828615|NCT02028884|157214033|FG000|Double-blind Period|Non-Compliance With Study Drug|2|||
48828616|NCT02028884|157214034|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
48828617|NCT02028884|157214035|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
48922486|NCT00464334|157550087|FG007|Overall Study|Lost to Follow-up|0|||
49155644|NCT02519842|158410101|FG001|Optional Extension: Cycles 2-6|Death|0|||
49155645|NCT02519842|158410102|FG002|Optional Extension: Cycles 2-6|Death|1|||
49155646|NCT02519842|158410100|FG000|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
49155647|NCT02519842|158410101|FG001|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
49155648|NCT02519842|158410102|FG002|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2|||
49155649|NCT02519842|158410100|FG000|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
48828618|NCT02028884|157214033|FG000|Double-blind Period|Withdrawal by Subject|2|||
48828619|NCT02028884|157214034|FG001|Double-blind Period|Withdrawal by Subject|0|||
48828620|NCT02028884|157214035|FG002|Double-blind Period|Withdrawal by Subject|0|||
48828621|NCT02028884|157214033|FG000|Open-label Extension Period|Adverse Event|3|||
48828622|NCT02028884|157214034|FG001|Open-label Extension Period|Adverse Event|1|||
48828623|NCT02028884|157214035|FG002|Open-label Extension Period|Adverse Event|0|||
48828624|NCT02028884|157214033|FG000|Open-label Extension Period|Lack of Efficacy|3|||
48828625|NCT02028884|157214034|FG001|Open-label Extension Period|Lack of Efficacy|0|||
48828626|NCT02028884|157214035|FG002|Open-label Extension Period|Lack of Efficacy|0|||
48828627|NCT02028884|157214033|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
48828628|NCT02028884|157214034|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
48828629|NCT02028884|157214035|FG002|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
48828630|NCT02028884|157214033|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
48828631|NCT02028884|157214034|FG001|Open-label Extension Period|Withdrawal by Subject|6|||
48828632|NCT02028884|157214035|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
48828633|NCT02028884|157214033|FG000|Open-label Extension Period|Switched to another treatment option|3|||
48828634|NCT02028884|157214034|FG001|Open-label Extension Period|Switched to another treatment option|0|||
48828635|NCT02028884|157214035|FG002|Open-label Extension Period|Switched to another treatment option|0|||
48828636|NCT00849147|157214038|FG000|Overall Study|Withdrawal by Subject|1|||
48828637|NCT00849147|157214038|FG000|Overall Study|Protocol Violation|2|||
48828638|NCT00849147|157214038|FG000|Overall Study|Disease Relapse/Progression|2|||
48828639|NCT01257503|157214041|FG000|Overall Study|Lost to Follow-up|7|||
48828640|NCT01257503|157214042|FG001|Overall Study|Lost to Follow-up|10|||
48828641|NCT01257503|157214041|FG000|Overall Study|Over 5 years old at enrollment|0|||
48828642|NCT01257503|157214042|FG001|Overall Study|Over 5 years old at enrollment|1|||
48828643|NCT01257503|157214041|FG000|Overall Study|strep culture positive at enrollment|1|||
48828644|NCT01257503|157214042|FG001|Overall Study|strep culture positive at enrollment|0|||
48828645|NCT03201757|157214043|FG000|Overall Study|Withdrawal by Subject|133|||
48828646|NCT03201757|157214043|FG000|Overall Study|Adverse Event|44|||
48828647|NCT03201757|157214043|FG000|Overall Study|Lost to Follow-up|37|||
48828648|NCT03201757|157214043|FG000|Overall Study|Pregnancy|2|||
48828649|NCT03201757|157214043|FG000|Overall Study|Lack of Efficacy|1|||
48828650|NCT03201757|157214043|FG000|Overall Study|Protocol Violation|20|||
48828651|NCT03201757|157214043|FG000|Overall Study|Study Terminated at Site by Sponsor Due to Regional War|1|||
48828652|NCT03201757|157214043|FG000|Overall Study|Not Yet Determined|5|||
48828653|NCT03201757|157214043|FG000|Overall Study|Logistical Difficulties Due to Regional Wars & COVID-19|72|||
48828654|NCT03201757|157214043|FG000|Overall Study|Other|20|||
48828655|NCT00495469|157214046|FG000|Overall Study|Adverse Event|0|||
48828656|NCT00495469|157214047|FG001|Overall Study|Adverse Event|1|||
48828657|NCT00495469|157214048|FG002|Overall Study|Adverse Event|3|||
48828658|NCT00495469|157214049|FG003|Overall Study|Adverse Event|0|||
48828659|NCT00495469|157214050|FG004|Overall Study|Adverse Event|1|||
48828660|NCT00495469|157214051|FG005|Overall Study|Adverse Event|1|||
48828661|NCT00495469|157214052|FG006|Overall Study|Adverse Event|1|||
48828662|NCT00495469|157214046|FG000|Overall Study|Lost to Follow-up|1|||
48828663|NCT00495469|157214047|FG001|Overall Study|Lost to Follow-up|1|||
48828664|NCT00495469|157214048|FG002|Overall Study|Lost to Follow-up|3|||
48828665|NCT00495469|157214049|FG003|Overall Study|Lost to Follow-up|1|||
48828666|NCT00495469|157214050|FG004|Overall Study|Lost to Follow-up|0|||
48828667|NCT00495469|157214051|FG005|Overall Study|Lost to Follow-up|0|||
48828668|NCT00495469|157214052|FG006|Overall Study|Lost to Follow-up|0|||
48828669|NCT00495469|157214046|FG000|Overall Study|Protocol Violation|0|||
48828670|NCT00495469|157214047|FG001|Overall Study|Protocol Violation|0|||
48828671|NCT00495469|157214048|FG002|Overall Study|Protocol Violation|0|||
48828672|NCT00495469|157214049|FG003|Overall Study|Protocol Violation|0|||
48828673|NCT00495469|157214050|FG004|Overall Study|Protocol Violation|1|||
48828674|NCT00495469|157214051|FG005|Overall Study|Protocol Violation|2|||
48828675|NCT00495469|157214052|FG006|Overall Study|Protocol Violation|0|||
48828676|NCT00495469|157214046|FG000|Overall Study|Withdrawal by Subject|5|||
48828677|NCT00495469|157214047|FG001|Overall Study|Withdrawal by Subject|3|||
48828678|NCT00495469|157214048|FG002|Overall Study|Withdrawal by Subject|1|||
48922487|NCT00464334|157550088|FG008|Overall Study|Lost to Follow-up|0|||
48828679|NCT00495469|157214049|FG003|Overall Study|Withdrawal by Subject|3|||
48828680|NCT00495469|157214050|FG004|Overall Study|Withdrawal by Subject|3|||
48828681|NCT00495469|157214051|FG005|Overall Study|Withdrawal by Subject|2|||
48828682|NCT00495469|157214052|FG006|Overall Study|Withdrawal by Subject|3|||
48828683|NCT00495469|157214046|FG000|Overall Study|Lack of Efficacy|0|||
48828684|NCT00495469|157214047|FG001|Overall Study|Lack of Efficacy|0|||
48922488|NCT00464334|157550089|FG009|Overall Study|Lost to Follow-up|0|||
48922489|NCT00464334|157550090|FG010|Overall Study|Lost to Follow-up|2|||
49155650|NCT02519842|158410101|FG001|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
49155651|NCT02519842|158410102|FG002|Optional Extension: Cycles 2-6|Completed Chemotherapy|13|||
49155652|NCT02519842|158410100|FG000|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
49155653|NCT02519842|158410101|FG001|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
49155654|NCT02519842|158410102|FG002|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1|||
49155655|NCT02519842|158410100|FG000|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
49155656|NCT02519842|158410101|FG001|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
49155657|NCT02519842|158410102|FG002|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2|||
49155658|NCT00833690|158410103|FG000|Overall Study|Withdrawal by Subject|1|||
49155659|NCT00833690|158410104|FG001|Overall Study|Withdrawal by Subject|0|||
49155660|NCT00833690|158410105|FG002|Overall Study|Withdrawal by Subject|0|||
49155661|NCT00833690|158410103|FG000|Overall Study|Discontinued study drug|3|||
49155662|NCT00833690|158410104|FG001|Overall Study|Discontinued study drug|2|||
49155663|NCT00833690|158410105|FG002|Overall Study|Discontinued study drug|0|||
49155664|NCT01744782|158410106|FG000|Overall Study|Death|1|||
49155665|NCT04256941|158410111|FG000|Overall Study|Withdrawal by Subject|0|||
49155666|NCT04256941|158410112|FG001|Overall Study|Withdrawal by Subject|1|||
49155667|NCT04256941|158410111|FG000|Overall Study|Death|1|||
49155668|NCT04256941|158410112|FG001|Overall Study|Death|0|||
48735498|NCT00631696|156883643|FG001|Overall Study|Other|8|||
48735499|NCT00631696|156883642|FG000|Overall Study|Protocol Violation|9|||
48735500|NCT00631696|156883643|FG001|Overall Study|Protocol Violation|9|||
48735501|NCT00631696|156883642|FG000|Overall Study|Study terminated by sponsor|3|||
48735502|NCT00631696|156883643|FG001|Overall Study|Study terminated by sponsor|3|||
48735503|NCT00631696|156883642|FG000|Overall Study|Adverse Event|5|||
48735504|NCT00631696|156883643|FG001|Overall Study|Adverse Event|0|||
48735505|NCT01160211|156883644|FG000|Overall Study|ongoing|90|||
48735506|NCT01160211|156883645|FG001|Overall Study|ongoing|75|||
48735507|NCT01160211|156883646|FG002|Overall Study|ongoing|79|||
48735508|NCT01160211|156883644|FG000|Overall Study|Withdrawal by Subject|3|||
48735509|NCT01160211|156883645|FG001|Overall Study|Withdrawal by Subject|5|||
48735510|NCT01160211|156883646|FG002|Overall Study|Withdrawal by Subject|3|||
48735511|NCT01160211|156883644|FG000|Overall Study|Physician Decision|2|||
48735512|NCT01160211|156883645|FG001|Overall Study|Physician Decision|0|||
48735513|NCT01160211|156883646|FG002|Overall Study|Physician Decision|0|||
48735514|NCT01160211|156883644|FG000|Overall Study|Lost to Follow-up|4|||
48735515|NCT01160211|156883645|FG001|Overall Study|Lost to Follow-up|7|||
48735516|NCT01160211|156883646|FG002|Overall Study|Lost to Follow-up|5|||
48735517|NCT00676338|156883647|FG000|Overall Study|Adverse Event|6|||
48735518|NCT00676338|156883648|FG001|Overall Study|Adverse Event|6|||
48735519|NCT00676338|156883649|FG002|Overall Study|Adverse Event|5|||
48735520|NCT00676338|156883650|FG003|Overall Study|Adverse Event|1|||
48735521|NCT00676338|156883647|FG000|Overall Study|Lost to Follow-up|4|||
48735522|NCT00676338|156883648|FG001|Overall Study|Lost to Follow-up|1|||
48735523|NCT00676338|156883649|FG002|Overall Study|Lost to Follow-up|3|||
48735524|NCT00676338|156883650|FG003|Overall Study|Lost to Follow-up|4|||
48735525|NCT00676338|156883647|FG000|Overall Study|Physician Decision|3|||
48735526|NCT00676338|156883648|FG001|Overall Study|Physician Decision|3|||
48735527|NCT00676338|156883649|FG002|Overall Study|Physician Decision|2|||
48735528|NCT00676338|156883650|FG003|Overall Study|Physician Decision|3|||
48735529|NCT00676338|156883647|FG000|Overall Study|Protocol Violation|5|||
48735530|NCT00676338|156883648|FG001|Overall Study|Protocol Violation|9|||
49155669|NCT04256941|158410111|FG000|Overall Study|Disease Progession|0|||
49155670|NCT04256941|158410112|FG001|Overall Study|Disease Progession|2|||
49155671|NCT00645658|158410113|FG000|Overall Study|Withdrawal by Subject|1|||
48735531|NCT00676338|156883649|FG002|Overall Study|Protocol Violation|2|||
49155672|NCT00645658|158410114|FG001|Overall Study|Withdrawal by Subject|0|||
48828685|NCT00495469|157214048|FG002|Overall Study|Lack of Efficacy|0|||
48828686|NCT00495469|157214049|FG003|Overall Study|Lack of Efficacy|0|||
48828687|NCT00495469|157214050|FG004|Overall Study|Lack of Efficacy|0|||
48828688|NCT00495469|157214051|FG005|Overall Study|Lack of Efficacy|0|||
48828689|NCT00495469|157214052|FG006|Overall Study|Lack of Efficacy|1|||
48828690|NCT00495469|157214046|FG000|Overall Study|Liver function test abnormality|0|||
48828691|NCT00495469|157214047|FG001|Overall Study|Liver function test abnormality|1|||
48828692|NCT00495469|157214048|FG002|Overall Study|Liver function test abnormality|0|||
48828693|NCT00495469|157214049|FG003|Overall Study|Liver function test abnormality|0|||
48828694|NCT00495469|157214050|FG004|Overall Study|Liver function test abnormality|0|||
48828695|NCT00495469|157214051|FG005|Overall Study|Liver function test abnormality|0|||
48828696|NCT00495469|157214052|FG006|Overall Study|Liver function test abnormality|0|||
48828697|NCT00495469|157214046|FG000|Overall Study|ST depression at randomisation in ECG|0|||
48828698|NCT00495469|157214047|FG001|Overall Study|ST depression at randomisation in ECG|1|||
48828699|NCT00495469|157214048|FG002|Overall Study|ST depression at randomisation in ECG|0|||
48828700|NCT00495469|157214049|FG003|Overall Study|ST depression at randomisation in ECG|0|||
48828701|NCT00495469|157214050|FG004|Overall Study|ST depression at randomisation in ECG|0|||
48828702|NCT00495469|157214051|FG005|Overall Study|ST depression at randomisation in ECG|0|||
48828703|NCT00495469|157214052|FG006|Overall Study|ST depression at randomisation in ECG|0|||
48828704|NCT01390857|157214053|FG000|Overall Study|Protocol Violation|2|||
48828705|NCT01390857|157214053|FG000|Overall Study|Lost to Follow-up|1|||
48828706|NCT01390857|157214053|FG000|Overall Study|No Visit after the First Visit|7|||
48922490|NCT00464334|157550080|FG000|Overall Study|Progressive Disease|0|||
48922491|NCT00464334|157550081|FG001|Overall Study|Progressive Disease|0|||
48922492|NCT00464334|157550082|FG002|Overall Study|Progressive Disease|0|||
48922493|NCT00464334|157550083|FG003|Overall Study|Progressive Disease|0|||
48922494|NCT00464334|157550084|FG004|Overall Study|Progressive Disease|0|||
48922495|NCT00464334|157550085|FG005|Overall Study|Progressive Disease|1|||
48922496|NCT00464334|157550086|FG006|Overall Study|Progressive Disease|0|||
48922497|NCT00464334|157550087|FG007|Overall Study|Progressive Disease|0|||
48922498|NCT00464334|157550088|FG008|Overall Study|Progressive Disease|1|||
48922499|NCT00464334|157550089|FG009|Overall Study|Progressive Disease|0|||
48922500|NCT00464334|157550090|FG010|Overall Study|Progressive Disease|0|||
48922501|NCT00464334|157550080|FG000|Overall Study|Study Terminated by Sponsor|0|||
48922502|NCT00464334|157550081|FG001|Overall Study|Study Terminated by Sponsor|0|||
48922503|NCT00464334|157550082|FG002|Overall Study|Study Terminated by Sponsor|0|||
48922504|NCT00464334|157550083|FG003|Overall Study|Study Terminated by Sponsor|1|||
48922505|NCT00464334|157550084|FG004|Overall Study|Study Terminated by Sponsor|0|||
48922506|NCT00464334|157550085|FG005|Overall Study|Study Terminated by Sponsor|0|||
48922507|NCT00464334|157550086|FG006|Overall Study|Study Terminated by Sponsor|0|||
48922508|NCT00464334|157550087|FG007|Overall Study|Study Terminated by Sponsor|0|||
48922509|NCT00464334|157550088|FG008|Overall Study|Study Terminated by Sponsor|0|||
48922510|NCT00464334|157550089|FG009|Overall Study|Study Terminated by Sponsor|0|||
48828707|NCT00603447|157214054|FG000|Overall Study|Adverse Event|0|||
48828708|NCT00603447|157214055|FG001|Overall Study|Adverse Event|1|||
48828709|NCT00603447|157214056|FG002|Overall Study|Adverse Event|1|||
48828710|NCT00603447|157214057|FG003|Overall Study|Adverse Event|2|||
48828711|NCT00603447|157214058|FG004|Overall Study|Adverse Event|1|||
48828712|NCT00603447|157214059|FG005|Overall Study|Adverse Event|2|||
48828713|NCT00603447|157214060|FG006|Overall Study|Adverse Event|10|||
48828714|NCT00603447|157214054|FG000|Overall Study|Other|0|||
48828715|NCT00603447|157214055|FG001|Overall Study|Other|0|||
48828716|NCT00603447|157214056|FG002|Overall Study|Other|1|||
48828717|NCT00603447|157214057|FG003|Overall Study|Other|0|||
48828718|NCT00603447|157214058|FG004|Overall Study|Other|3|||
48828719|NCT00603447|157214059|FG005|Overall Study|Other|0|||
48828720|NCT00603447|157214060|FG006|Overall Study|Other|13|||
48828721|NCT00603447|157214054|FG000|Overall Study|Withdrew Consent|0|||
48828722|NCT00603447|157214055|FG001|Overall Study|Withdrew Consent|2|||
48828723|NCT00603447|157214056|FG002|Overall Study|Withdrew Consent|0|||
48828724|NCT00603447|157214057|FG003|Overall Study|Withdrew Consent|0|||
48828725|NCT00603447|157214058|FG004|Overall Study|Withdrew Consent|1|||
48828726|NCT00603447|157214059|FG005|Overall Study|Withdrew Consent|0|||
48828727|NCT00603447|157214060|FG006|Overall Study|Withdrew Consent|1|||
48828728|NCT01123161|157214061|FG000|Overall Study|Lost to Follow-up|1|||
48828729|NCT01123161|157214062|FG001|Overall Study|Lost to Follow-up|0|||
48828730|NCT01123161|157214061|FG000|Overall Study|Withdrawal by Subject|1|||
48828731|NCT01123161|157214062|FG001|Overall Study|Withdrawal by Subject|0|||
48828732|NCT03085017|157214067|FG000|Overall Study|Death|0|||
48828733|NCT03085017|157214068|FG001|Overall Study|Death|3|||
48828734|NCT01268891|157214071|FG000|Overall Study|Adverse Event|3|||
49155673|NCT00645658|158410113|FG000|Overall Study|Did not complete all assesments|0|||
49155674|NCT00645658|158410114|FG001|Overall Study|Did not complete all assesments|2|||
49155675|NCT03575897|158410115|FG000|Overall Study|Lost to Follow-up|12|||
49155676|NCT03575897|158410116|FG001|Overall Study|Lost to Follow-up|13|||
49155677|NCT05730335|158410117|FG000|Overall Study|Continuing in ongoing study|58|||
48828735|NCT01268891|157214072|FG001|Overall Study|Adverse Event|7|||
48828736|NCT01268891|157214071|FG000|Overall Study|Lack of Efficacy|1|||
48828737|NCT01268891|157214072|FG001|Overall Study|Lack of Efficacy|0|||
49155678|NCT05730335|158410117|FG000|Overall Study|Withdrawal by Subject|1|||
49155679|NCT04749615|158410118|FG000|Overall Study|Lost to Follow-up|6|||
49155680|NCT04749615|158410119|FG001|Overall Study|Lost to Follow-up|10|||
49155681|NCT02023866|158410120|FG000|Overall Study|Non-compliance|2|||
49155682|NCT02023866|158410120|FG000|Overall Study|Adverse Event|3|||
49155683|NCT02023866|158410120|FG000|Overall Study|Withdrawal by Subject|1|||
49155684|NCT02573493|158410123|FG000|Overall Study|Determined to not be eligible after enrollment|0|||
48828738|NCT01268891|157214071|FG000|Overall Study|Withdrawal of Consent|3|||
48828739|NCT01268891|157214072|FG001|Overall Study|Withdrawal of Consent|1|||
48828740|NCT01268891|157214071|FG000|Overall Study|Administrative or other reason(s)|1|||
48828741|NCT01268891|157214072|FG001|Overall Study|Administrative or other reason(s)|0|||
48828742|NCT03255018|157214075|FG000|Overall Study|Death on study|0|||
49155685|NCT02573493|158410124|FG001|Overall Study|Determined to not be eligible after enrollment|0|||
48828743|NCT03255018|157214076|FG001|Overall Study|Death on study|5|||
48828744|NCT03255018|157214075|FG000|Overall Study|Withdrawal by Subject|0|||
48828745|NCT03255018|157214076|FG001|Overall Study|Withdrawal by Subject|2|||
48828746|NCT04759131|157214077|FG000|Overall Study|Investigator's discretion|1|||
49155686|NCT02573493|158410125|FG002|Overall Study|Determined to not be eligible after enrollment|0|||
49155687|NCT02573493|158410126|FG003|Overall Study|Determined to not be eligible after enrollment|1|||
49155688|NCT04581395|158410127|FG000|Overall Study|Protocol Violation|4|||
49155689|NCT04581395|158410128|FG001|Overall Study|Protocol Violation|3|||
49155690|NCT04581395|158410129|FG002|Overall Study|Protocol Violation|2|||
49155691|NCT04581395|158410127|FG000|Overall Study|Physician Decision|0|||
49155692|NCT04581395|158410128|FG001|Overall Study|Physician Decision|1|||
49155693|NCT04581395|158410129|FG002|Overall Study|Physician Decision|0|||
48828747|NCT04759131|157214078|FG001|Overall Study|Investigator's discretion|0|||
48828748|NCT04759131|157214077|FG000|Overall Study|Subject withdrawal|1|||
48828749|NCT04759131|157214078|FG001|Overall Study|Subject withdrawal|0|||
48828750|NCT01124162|157214079|FG000|First Intervention|Adverse Event|2|||
48828751|NCT01124162|157214080|FG001|First Intervention|Adverse Event|0|||
48828752|NCT01124162|157214079|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
48828753|NCT01124162|157214080|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
49155694|NCT04064905|158410130|FG000|Overall Study|Lost to Follow-up|0|||
49155695|NCT04064905|158410131|FG001|Overall Study|Lost to Follow-up|3|||
49155696|NCT04064905|158410132|FG002|Overall Study|Lost to Follow-up|1|||
49155697|NCT04064905|158410133|FG003|Overall Study|Lost to Follow-up|4|||
48828754|NCT01360840|157214083|FG000|Overall Study|Ongoing at data cut-off|10|||
48922511|NCT00464334|157550090|FG010|Overall Study|Study Terminated by Sponsor|0|||
48922512|NCT00464334|157550080|FG000|Overall Study|Withdrawal by Subject|1|||
48922513|NCT00464334|157550081|FG001|Overall Study|Withdrawal by Subject|7|||
48922514|NCT00464334|157550082|FG002|Overall Study|Withdrawal by Subject|4|||
48922515|NCT00464334|157550083|FG003|Overall Study|Withdrawal by Subject|2|||
48922516|NCT00464334|157550084|FG004|Overall Study|Withdrawal by Subject|2|||
48922517|NCT00464334|157550085|FG005|Overall Study|Withdrawal by Subject|2|||
48922518|NCT00464334|157550086|FG006|Overall Study|Withdrawal by Subject|2|||
48922519|NCT00464334|157550087|FG007|Overall Study|Withdrawal by Subject|1|||
48922520|NCT00464334|157550088|FG008|Overall Study|Withdrawal by Subject|3|||
48922521|NCT00464334|157550089|FG009|Overall Study|Withdrawal by Subject|0|||
48922522|NCT00464334|157550090|FG010|Overall Study|Withdrawal by Subject|0|||
48922523|NCT00586495|157550091|FG000|Treatment Period|Adverse Event|11|||
48922524|NCT00586495|157550091|FG000|Treatment Period|Death|1|||
48922525|NCT00586495|157550091|FG000|Treatment Period|Protocol Violation|1|||
48922526|NCT00586495|157550091|FG000|Treatment Period|Withdrawal by Subject|1|||
48922527|NCT00586495|157550091|FG000|Treatment Period|Disease progression, recurrence/relapse|71|||
48922528|NCT00586495|157550091|FG000|Treatment Period|Switch to commercial drug|10|||
48922529|NCT00586495|157550091|FG000|Follow-up|Death|40|||
48922530|NCT00586495|157550091|FG000|Follow-up|Lost to Follow-up|1|||
48922531|NCT00586495|157550091|FG000|Follow-up|Withdrawal by Subject|4|||
48922532|NCT00586495|157550091|FG000|Follow-up|Protocol driven decision point|37|||
48922533|NCT00586495|157550091|FG000|Follow-up|Switch to commercial drug|10|||
48922534|NCT00705783|157550094|FG000|Conversion Phase|Sponsor Discontinued Study|54|||
48922535|NCT00705783|157550095|FG001|Conversion Phase|Sponsor Discontinued Study|0|||
48828755|NCT01360840|157214084|FG001|Overall Study|Ongoing at data cut-off|10|||
48828756|NCT01360840|157214085|FG002|Overall Study|Ongoing at data cut-off|9|||
48828757|NCT02846415|157214087|FG000|Overall Study|Lost to Follow-up|2|||
48828758|NCT02846415|157214088|FG001|Overall Study|Lost to Follow-up|0|||
48828759|NCT02846415|157214087|FG000|Overall Study|Withdrawal by Subject|1|||
48828760|NCT02846415|157214088|FG001|Overall Study|Withdrawal by Subject|1|||
48828761|NCT03736785|157214089|FG000|Overall Study|Adverse Event|1|||
48828762|NCT03736785|157214090|FG001|Overall Study|Adverse Event|1|||
48828763|NCT03736785|157214091|FG002|Overall Study|Adverse Event|1|||
48828764|NCT03736785|157214089|FG000|Overall Study|Death|1|||
48828765|NCT03736785|157214090|FG001|Overall Study|Death|0|||
48922536|NCT00705783|157550096|FG002|Conversion Phase|Sponsor Discontinued Study|0|||
48922537|NCT00705783|157550094|FG000|Conversion Phase|Lost to Follow-up|13|||
48922538|NCT00705783|157550095|FG001|Conversion Phase|Lost to Follow-up|0|||
48922539|NCT00705783|157550096|FG002|Conversion Phase|Lost to Follow-up|0|||
48922540|NCT00705783|157550094|FG000|Conversion Phase|Met Withdrawal Criteria|4|||
48922541|NCT00705783|157550095|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
48922542|NCT00705783|157550096|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
48922543|NCT00705783|157550094|FG000|Conversion Phase|Withdrawn by Investigator|4|||
48922544|NCT00705783|157550095|FG001|Conversion Phase|Withdrawn by Investigator|0|||
48828766|NCT03736785|157214091|FG002|Overall Study|Death|1|||
48828767|NCT03736785|157214089|FG000|Overall Study|Lost to Follow-up|0|||
48828768|NCT03736785|157214090|FG001|Overall Study|Lost to Follow-up|2|||
48828769|NCT03736785|157214091|FG002|Overall Study|Lost to Follow-up|3|||
48828770|NCT03736785|157214089|FG000|Overall Study|Non compliance with study drug|1|||
48828771|NCT03736785|157214090|FG001|Overall Study|Non compliance with study drug|1|||
48828772|NCT03736785|157214091|FG002|Overall Study|Non compliance with study drug|0|||
48828773|NCT03736785|157214089|FG000|Overall Study|Physician Decision|0|||
48828774|NCT03736785|157214090|FG001|Overall Study|Physician Decision|1|||
48828775|NCT03736785|157214091|FG002|Overall Study|Physician Decision|1|||
48922545|NCT00705783|157550096|FG002|Conversion Phase|Withdrawn by Investigator|0|||
48922546|NCT00705783|157550094|FG000|Conversion Phase|Withdrew Consent|24|||
48922547|NCT00705783|157550095|FG001|Conversion Phase|Withdrew Consent|0|||
49155698|NCT04064905|158410134|FG004|Overall Study|Lost to Follow-up|2|||
49155699|NCT01188967|158410137|FG000|Overall Study|Withdrawal by Subject|1|||
49155700|NCT01188967|158410138|FG001|Overall Study|Withdrawal by Subject|1|||
49155701|NCT01188967|158410137|FG000|Overall Study|Physician Decision|1|||
48922548|NCT00705783|157550096|FG002|Conversion Phase|Withdrew Consent|0|||
48922549|NCT00705783|157550094|FG000|Conversion Phase|Protocol Deviation|2|||
48922550|NCT00705783|157550095|FG001|Conversion Phase|Protocol Deviation|0|||
48922551|NCT00705783|157550096|FG002|Conversion Phase|Protocol Deviation|0|||
48922552|NCT00705783|157550094|FG000|Conversion Phase|Adverse Event|11|||
48922553|NCT00705783|157550095|FG001|Conversion Phase|Adverse Event|0|||
48922554|NCT00705783|157550096|FG002|Conversion Phase|Adverse Event|0|||
48922555|NCT00705783|157550094|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|13|||
48922556|NCT00705783|157550095|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
48922557|NCT00705783|157550096|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
48922558|NCT00705783|157550094|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|8|||
48922559|NCT00705783|157550095|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
48922560|NCT00705783|157550096|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
48922561|NCT00705783|157550094|FG000|Oral Stabilization Phase|Sponsor Discontinue Study|42|||
48922562|NCT00705783|157550095|FG001|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
48922563|NCT00705783|157550096|FG002|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
48922564|NCT00705783|157550094|FG000|Oral Stabilization Phase|Lost to Follow-up|7|||
48922565|NCT00705783|157550095|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
48922566|NCT00705783|157550096|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
48922567|NCT00705783|157550094|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|19|||
48922568|NCT00705783|157550095|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
48922569|NCT00705783|157550096|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
48922570|NCT00705783|157550094|FG000|Oral Stabilization Phase|Withdrawn by Investigator|12|||
48922571|NCT00705783|157550095|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
48922572|NCT00705783|157550096|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
48922573|NCT00705783|157550094|FG000|Oral Stabilization Phase|Withdrew Consent|29|||
48922574|NCT00705783|157550095|FG001|Oral Stabilization Phase|Withdrew Consent|0|||
48922575|NCT00705783|157550096|FG002|Oral Stabilization Phase|Withdrew Consent|0|||
48922576|NCT00705783|157550094|FG000|Oral Stabilization Phase|Adverse Event|14|||
48922577|NCT00705783|157550095|FG001|Oral Stabilization Phase|Adverse Event|0|||
48922578|NCT00705783|157550096|FG002|Oral Stabilization Phase|Adverse Event|0|||
48922579|NCT00705783|157550094|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7|||
48922580|NCT00705783|157550095|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
48922581|NCT00705783|157550096|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
48922582|NCT00705783|157550094|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4|||
48922583|NCT00705783|157550095|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
48922584|NCT00705783|157550096|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
48922585|NCT00705783|157550094|FG000|Depot Stabilization Phase|Sponsor Discontinued Study|86|||
48922586|NCT00705783|157550095|FG001|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
48922587|NCT00705783|157550096|FG002|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
48922588|NCT00705783|157550094|FG000|Depot Stabilization Phase|Lost to Follow-up|11|||
49155702|NCT01188967|158410138|FG001|Overall Study|Physician Decision|1|||
49155703|NCT01188967|158410137|FG000|Overall Study|Lost to Follow-up|3|||
48922589|NCT00705783|157550095|FG001|Depot Stabilization Phase|Lost to Follow-up|0|||
48922590|NCT00705783|157550096|FG002|Depot Stabilization Phase|Lost to Follow-up|0|||
49155704|NCT01188967|158410138|FG001|Overall Study|Lost to Follow-up|2|||
49155705|NCT01983111|158410147|FG000|Overall Study|Withdrawal by Subject|8|||
49155706|NCT01983111|158410148|FG001|Overall Study|Withdrawal by Subject|6|||
48922591|NCT00705783|157550094|FG000|Depot Stabilization Phase|Met Withdrawal Criteria|8|||
48922592|NCT00705783|157550095|FG001|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
48922593|NCT00705783|157550096|FG002|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
48922594|NCT00705783|157550094|FG000|Depot Stabilization Phase|Withdrawn by Investigator|9|||
48922595|NCT00705783|157550095|FG001|Depot Stabilization Phase|Withdrawn by Investigator|0|||
48922596|NCT00705783|157550096|FG002|Depot Stabilization Phase|Withdrawn by Investigator|0|||
48922597|NCT00705783|157550094|FG000|Depot Stabilization Phase|Withdrew Consent|29|||
49155707|NCT01983111|158410147|FG000|Overall Study|Adverse Event|4|||
49155708|NCT01983111|158410148|FG001|Overall Study|Adverse Event|0|||
49155709|NCT01983111|158410147|FG000|Overall Study|Protocol Violation|0|||
49155710|NCT01983111|158410148|FG001|Overall Study|Protocol Violation|1|||
49155711|NCT02191618|158410149|FG000|Overall Study|Withdrawal by Subject|3|||
49155712|NCT02191618|158410149|FG000|Overall Study|Missed Visit|4|||
48922598|NCT00705783|157550095|FG001|Depot Stabilization Phase|Withdrew Consent|0|||
49155713|NCT03038620|158410150|FG000|Overall Study|Lost to Follow-up|18|||
49155714|NCT03038620|158410151|FG001|Overall Study|Lost to Follow-up|23|||
49155715|NCT03038620|158410150|FG000|Overall Study|Withdrawal by Subject|0|||
49155716|NCT03038620|158410151|FG001|Overall Study|Withdrawal by Subject|15|||
49155717|NCT03038620|158410150|FG000|Overall Study|Uninterpretable Outcome (Imaging)|1|||
48922599|NCT00705783|157550096|FG002|Depot Stabilization Phase|Withdrew Consent|0|||
48922600|NCT00705783|157550094|FG000|Depot Stabilization Phase|Adverse Event|17|||
48922601|NCT00705783|157550095|FG001|Depot Stabilization Phase|Adverse Event|0|||
48922602|NCT00705783|157550096|FG002|Depot Stabilization Phase|Adverse Event|0|||
48922603|NCT00705783|157550094|FG000|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12|||
48922604|NCT00705783|157550095|FG001|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
48922605|NCT00705783|157550096|FG002|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
48922606|NCT00705783|157550094|FG000|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1|||
49155718|NCT03038620|158410151|FG001|Overall Study|Uninterpretable Outcome (Imaging)|0|||
49155719|NCT00759395|158410154|FG000|Overall Study|Adverse Event|1|||
49155720|NCT00759395|158410155|FG001|Overall Study|Adverse Event|0|||
49155721|NCT00759395|158410154|FG000|Overall Study|Withdrawal by Subject|1|||
49155722|NCT00759395|158410155|FG001|Overall Study|Withdrawal by Subject|0|||
49155723|NCT00759395|158410154|FG000|Overall Study|Lack of Efficacy|0|||
49155724|NCT00759395|158410155|FG001|Overall Study|Lack of Efficacy|2|||
49155725|NCT00049543|158410158|FG000|Overall Study|still on treatment|2|||
49155726|NCT00049543|158410159|FG001|Overall Study|still on treatment|9|||
49155727|NCT04380142|158410160|FG000|LD/CD Stabilization Period|Adverse Event|3|||
49155728|NCT04380142|158410161|FG001|LD/CD Stabilization Period|Adverse Event|0|||
49155729|NCT04380142|158410162|FG002|LD/CD Stabilization Period|Adverse Event|0|||
49155730|NCT04380142|158410160|FG000|LD/CD Stabilization Period|Withdrawal by Subject|4|||
49155731|NCT04380142|158410161|FG001|LD/CD Stabilization Period|Withdrawal by Subject|0|||
49155732|NCT04380142|158410162|FG002|LD/CD Stabilization Period|Withdrawal by Subject|0|||
49155733|NCT04380142|158410160|FG000|LD/CD Stabilization Period|Lost to Follow-up|1|||
49155734|NCT04380142|158410161|FG001|LD/CD Stabilization Period|Lost to Follow-up|0|||
49155735|NCT04380142|158410162|FG002|LD/CD Stabilization Period|Lost to Follow-up|0|||
49155736|NCT04380142|158410160|FG000|LD/CD Stabilization Period|Lack of Efficacy|1|||
49155737|NCT04380142|158410161|FG001|LD/CD Stabilization Period|Lack of Efficacy|0|||
48828776|NCT03736785|157214089|FG000|Overall Study|Protocol Violation|1|||
48828777|NCT03736785|157214090|FG001|Overall Study|Protocol Violation|4|||
48828778|NCT03736785|157214091|FG002|Overall Study|Protocol Violation|3|||
48828779|NCT03736785|157214089|FG000|Overall Study|Sponsor Decision|1|||
48828780|NCT03736785|157214090|FG001|Overall Study|Sponsor Decision|0|||
48828781|NCT03736785|157214091|FG002|Overall Study|Sponsor Decision|0|||
48828782|NCT03736785|157214089|FG000|Overall Study|Unknown/Missing data|3|||
48828783|NCT03736785|157214090|FG001|Overall Study|Unknown/Missing data|2|||
48828784|NCT03736785|157214091|FG002|Overall Study|Unknown/Missing data|1|||
48828785|NCT03736785|157214089|FG000|Overall Study|Withdrawal by Subject|9|||
48828786|NCT03736785|157214090|FG001|Overall Study|Withdrawal by Subject|6|||
48828787|NCT03736785|157214091|FG002|Overall Study|Withdrawal by Subject|4|||
48828788|NCT01744691|157214092|FG000|Overall Study|Progressive Disease|18|||
48828789|NCT01744691|157214092|FG000|Overall Study|Unacceptable toxicity, AE or death|18|||
49155738|NCT04380142|158410162|FG002|LD/CD Stabilization Period|Lack of Efficacy|0|||
49155739|NCT04380142|158410160|FG000|LD/CD Stabilization Period|Difficulty With Drug Delivery System|2|||
49155740|NCT04380142|158410161|FG001|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
49155741|NCT04380142|158410162|FG002|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
49155742|NCT04380142|158410160|FG000|LD/CD Stabilization Period|Other, Not Specified|18|||
49155743|NCT04380142|158410161|FG001|LD/CD Stabilization Period|Other, Not Specified|0|||
48735532|NCT00676338|156883650|FG003|Overall Study|Protocol Violation|5|||
48735533|NCT00676338|156883647|FG000|Overall Study|Withdrawal by Subject|17|||
48735534|NCT00676338|156883648|FG001|Overall Study|Withdrawal by Subject|9|||
48735535|NCT00676338|156883649|FG002|Overall Study|Withdrawal by Subject|12|||
48735536|NCT00676338|156883650|FG003|Overall Study|Withdrawal by Subject|6|||
48735537|NCT00676338|156883647|FG000|Overall Study|Entry Criteria Not Met|0|||
48735538|NCT00676338|156883648|FG001|Overall Study|Entry Criteria Not Met|2|||
48735539|NCT00676338|156883649|FG002|Overall Study|Entry Criteria Not Met|1|||
48735540|NCT00676338|156883650|FG003|Overall Study|Entry Criteria Not Met|1|||
48735541|NCT00676338|156883647|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
48735542|NCT00676338|156883648|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
48735543|NCT00676338|156883649|FG002|Overall Study|Lack of Efficacy-Loss of Glucose Control|5|||
48735544|NCT00676338|156883650|FG003|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
48735545|NCT00697788|156883651|FG000|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
48735546|NCT00697788|156883652|FG001|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2|||
48735547|NCT00697788|156883653|FG002|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
48735548|NCT00697788|156883654|FG003|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
48735549|NCT00697788|156883655|FG004|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
48735550|NCT00697788|156883656|FG005|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
48735551|NCT00697788|156883657|FG006|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
49155744|NCT04380142|158410162|FG002|LD/CD Stabilization Period|Other, Not Specified|0|||
49155745|NCT04380142|158410160|FG000|Double-Blind Treatment Period|Adverse Event|0|||
49155746|NCT04380142|158410161|FG001|Double-Blind Treatment Period|Adverse Event|1|||
49155747|NCT04380142|158410162|FG002|Double-Blind Treatment Period|Adverse Event|14|||
49155748|NCT04380142|158410160|FG000|Double-Blind Treatment Period|Withdrew Consent|0|||
49155749|NCT04380142|158410161|FG001|Double-Blind Treatment Period|Withdrew Consent|3|||
49155750|NCT04380142|158410162|FG002|Double-Blind Treatment Period|Withdrew Consent|6|||
49155751|NCT04380142|158410160|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
49155752|NCT04380142|158410161|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
49155753|NCT04380142|158410162|FG002|Double-Blind Treatment Period|Lack of Efficacy|2|||
49155754|NCT04380142|158410160|FG000|Double-Blind Treatment Period|Difficulty With Drug Delivery System|0|||
49155755|NCT04380142|158410161|FG001|Double-Blind Treatment Period|Difficulty With Drug Delivery System|1|||
48828790|NCT01744691|157214092|FG000|Overall Study|Withdrawal of consent for treatment|3|||
48828791|NCT01744691|157214092|FG000|Overall Study|Physician Decision|4|||
48828792|NCT02095158|157214094|FG000|Overall Study|Adverse Event|14|||
48828793|NCT02095158|157214094|FG000|Overall Study|Lack of Efficacy|3|||
48828794|NCT02095158|157214094|FG000|Overall Study|Pregnancy|1|||
48828795|NCT02095158|157214094|FG000|Overall Study|Lost to Follow-up|20|||
48828796|NCT02095158|157214094|FG000|Overall Study|Personal Reasons|35|||
48828797|NCT02095158|157214094|FG000|Overall Study|Protocol Violation|1|||
48828798|NCT02095158|157214094|FG000|Overall Study|Other Miscellaneous Reasons|1|||
48828799|NCT04555044|157214095|FG000|Overall Study|Adverse Event|0|||
48828800|NCT04555044|157214096|FG001|Overall Study|Adverse Event|1|||
48828801|NCT00542386|157214101|FG000|Overall Study|Adverse Event|1|||
48828802|NCT00542386|157214102|FG001|Overall Study|Adverse Event|7|||
48828803|NCT00542386|157214103|FG002|Overall Study|Adverse Event|7|||
48828804|NCT00542386|157214104|FG003|Overall Study|Adverse Event|8|||
48828805|NCT00542386|157214105|FG004|Overall Study|Adverse Event|13|||
48828806|NCT00542386|157214106|FG005|Overall Study|Adverse Event|4|||
48828807|NCT00542386|157214101|FG000|Overall Study|Death|0|||
48828808|NCT00542386|157214102|FG001|Overall Study|Death|0|||
48828809|NCT00542386|157214103|FG002|Overall Study|Death|1|||
48828810|NCT00542386|157214104|FG003|Overall Study|Death|2|||
48828811|NCT00542386|157214105|FG004|Overall Study|Death|1|||
48828812|NCT00542386|157214106|FG005|Overall Study|Death|2|||
48828813|NCT00542386|157214101|FG000|Overall Study|Lack of Efficacy|32|||
48828814|NCT00542386|157214102|FG001|Overall Study|Lack of Efficacy|12|||
49155756|NCT04380142|158410162|FG002|Double-Blind Treatment Period|Difficulty With Drug Delivery System|3|||
49155757|NCT04380142|158410160|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
49155758|NCT04380142|158410161|FG001|Double-Blind Treatment Period|Other, Not Specified|0|||
49155759|NCT04380142|158410162|FG002|Double-Blind Treatment Period|Other, Not Specified|1|||
49155760|NCT04380142|158410160|FG000|Double-Blind Treatment Period|Did Not Receive Study Drug|0|||
49155761|NCT04380142|158410161|FG001|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
49155762|NCT04380142|158410162|FG002|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
49155763|NCT02106832|158410171|FG000|Overall Study|Adverse Event|1|||
49155764|NCT02106832|158410172|FG001|Overall Study|Adverse Event|2|||
49155765|NCT02106832|158410173|FG002|Overall Study|Adverse Event|3|||
49155766|NCT02106832|158410174|FG003|Overall Study|Adverse Event|0|||
49155767|NCT02106832|158410171|FG000|Overall Study|Death|4|||
49155768|NCT02106832|158410172|FG001|Overall Study|Death|4|||
49155769|NCT02106832|158410173|FG002|Overall Study|Death|1|||
49155770|NCT02106832|158410174|FG003|Overall Study|Death|4|||
49155771|NCT02106832|158410171|FG000|Overall Study|Deterioration of general conditions|0|||
49155772|NCT02106832|158410172|FG001|Overall Study|Deterioration of general conditions|0|||
49155773|NCT02106832|158410173|FG002|Overall Study|Deterioration of general conditions|1|||
49155774|NCT02106832|158410174|FG003|Overall Study|Deterioration of general conditions|0|||
49155775|NCT02106832|158410171|FG000|Overall Study|Lost to Follow-up|0|||
49155776|NCT02106832|158410172|FG001|Overall Study|Lost to Follow-up|1|||
49155777|NCT02106832|158410173|FG002|Overall Study|Lost to Follow-up|1|||
49155778|NCT02106832|158410174|FG003|Overall Study|Lost to Follow-up|3|||
49155779|NCT02106832|158410171|FG000|Overall Study|Physician Decision|1|||
48828815|NCT00542386|157214103|FG002|Overall Study|Lack of Efficacy|10|||
48922607|NCT00705783|157550095|FG001|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
48828816|NCT00542386|157214104|FG003|Overall Study|Lack of Efficacy|13|||
48828817|NCT00542386|157214105|FG004|Overall Study|Lack of Efficacy|7|||
48828818|NCT00542386|157214106|FG005|Overall Study|Lack of Efficacy|31|||
48828819|NCT00542386|157214101|FG000|Overall Study|Physician Decision|1|||
48828820|NCT00542386|157214102|FG001|Overall Study|Physician Decision|0|||
49155780|NCT02106832|158410172|FG001|Overall Study|Physician Decision|0|||
49155781|NCT02106832|158410173|FG002|Overall Study|Physician Decision|0|||
49155782|NCT02106832|158410174|FG003|Overall Study|Physician Decision|0|||
49155783|NCT02106832|158410171|FG000|Overall Study|Protocol Violation|0|||
49155784|NCT02106832|158410172|FG001|Overall Study|Protocol Violation|0|||
49155785|NCT02106832|158410173|FG002|Overall Study|Protocol Violation|0|||
49155786|NCT02106832|158410174|FG003|Overall Study|Protocol Violation|1|||
49155787|NCT02106832|158410171|FG000|Overall Study|Withdrawal by Subject|17|||
49155788|NCT02106832|158410172|FG001|Overall Study|Withdrawal by Subject|17|||
49155789|NCT02106832|158410173|FG002|Overall Study|Withdrawal by Subject|10|||
49155790|NCT02106832|158410174|FG003|Overall Study|Withdrawal by Subject|7|||
49155791|NCT02106832|158410171|FG000|Overall Study|Technical problems|0|||
49155792|NCT02106832|158410172|FG001|Overall Study|Technical problems|1|||
49155793|NCT02106832|158410173|FG002|Overall Study|Technical problems|0|||
49155794|NCT02106832|158410174|FG003|Overall Study|Technical problems|0|||
49155795|NCT01734902|158410177|FG000|Overall Study|Other than listed|0|||
49155796|NCT01734902|158410178|FG001|Overall Study|Other than listed|2|||
49155797|NCT01959932|158410179|FG000|Overall Study|Withdrawal by Subject|1|||
49155798|NCT01959932|158410180|FG001|Overall Study|Withdrawal by Subject|0|||
49155799|NCT01959932|158410181|FG002|Overall Study|Withdrawal by Subject|0|||
49155800|NCT04025554|158410182|FG000|Overall Study|Adverse Event|3|||
49155801|NCT00397540|158410187|FG000|Overall Study|short follow-up duration < 12 months|1|||
49155802|NCT00397540|158410188|FG001|Overall Study|short follow-up duration < 12 months|0|||
49155803|NCT03485157|158410194|FG000|Double Blind Phase|Lost to Follow-up|4|||
49155804|NCT03485157|158410195|FG001|Double Blind Phase|Lost to Follow-up|4|||
49155805|NCT03485157|158410194|FG000|Double Blind Phase|Adverse Event|2|||
49155806|NCT03485157|158410195|FG001|Double Blind Phase|Adverse Event|1|||
49155807|NCT03485157|158410194|FG000|Double Blind Phase|Withdrawal by Subject|6|||
49155808|NCT03485157|158410195|FG001|Double Blind Phase|Withdrawal by Subject|9|||
49155809|NCT03485157|158410194|FG000|Double Blind Phase|Removal by PI|3|||
49155810|NCT03485157|158410195|FG001|Double Blind Phase|Removal by PI|7|||
48828821|NCT00542386|157214103|FG002|Overall Study|Physician Decision|0|||
48828822|NCT00542386|157214104|FG003|Overall Study|Physician Decision|1|||
48828823|NCT00542386|157214105|FG004|Overall Study|Physician Decision|0|||
48828824|NCT00542386|157214106|FG005|Overall Study|Physician Decision|0|||
48828825|NCT00542386|157214101|FG000|Overall Study|Protocol Violation|0|||
48828826|NCT00542386|157214102|FG001|Overall Study|Protocol Violation|0|||
48828827|NCT00542386|157214103|FG002|Overall Study|Protocol Violation|1|||
48828828|NCT00542386|157214104|FG003|Overall Study|Protocol Violation|0|||
48828829|NCT00542386|157214105|FG004|Overall Study|Protocol Violation|0|||
48828830|NCT00542386|157214106|FG005|Overall Study|Protocol Violation|4|||
48828831|NCT00542386|157214101|FG000|Overall Study|Withdrawal by Subject|5|||
48828832|NCT00542386|157214102|FG001|Overall Study|Withdrawal by Subject|8|||
48922608|NCT00705783|157550096|FG002|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
48922609|NCT00705783|157550094|FG000|Depot Maintenance Phase|Sponsor Discontinued Study|0|||
48922610|NCT00705783|157550095|FG001|Depot Maintenance Phase|Sponsor Discontinued Study|179|||
48922611|NCT00705783|157550096|FG002|Depot Maintenance Phase|Sponsor Discontinued Study|58|||
48922612|NCT00705783|157550094|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
48922613|NCT00705783|157550095|FG001|Depot Maintenance Phase|Lost to Follow-up|5|||
48922614|NCT00705783|157550096|FG002|Depot Maintenance Phase|Lost to Follow-up|3|||
48922615|NCT00705783|157550094|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
48922616|NCT00705783|157550095|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
48922617|NCT00705783|157550096|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
48922618|NCT00705783|157550094|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
48922619|NCT00705783|157550095|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
48922620|NCT00705783|157550096|FG002|Depot Maintenance Phase|Withdrawn by Investigator|6|||
48922621|NCT00705783|157550094|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
48922622|NCT00705783|157550095|FG001|Depot Maintenance Phase|Withdrew Consent|14|||
48922623|NCT00705783|157550096|FG002|Depot Maintenance Phase|Withdrew Consent|4|||
48922624|NCT00705783|157550094|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
48922625|NCT00705783|157550095|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
48922626|NCT00705783|157550096|FG002|Depot Maintenance Phase|Protocol Deviation|0|||
48922627|NCT00705783|157550094|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
48922628|NCT00705783|157550095|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|9|||
48922629|NCT00705783|157550096|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|5|||
48922630|NCT00705783|157550094|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
48922631|NCT00705783|157550095|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|11|||
48922632|NCT00705783|157550096|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
48922633|NCT00705783|157550094|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
48922634|NCT00705783|157550095|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|16|||
48922635|NCT00705783|157550096|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|40|||
48922636|NCT01965262|157550102|FG000|Second Intervention (7 Days)|Discontinued|0|||
49155811|NCT03485157|158410194|FG000|Open Label Phase|Lost to Follow-up|1|||
49155812|NCT03485157|158410195|FG001|Open Label Phase|Lost to Follow-up|2|||
49155813|NCT03485157|158410194|FG000|Open Label Phase|Adverse Event|0|||
49155814|NCT03485157|158410195|FG001|Open Label Phase|Adverse Event|1|||
49155815|NCT03485157|158410194|FG000|Open Label Phase|Withdrawal by Subject|1|||
49155816|NCT03485157|158410195|FG001|Open Label Phase|Withdrawal by Subject|2|||
49155817|NCT03485157|158410194|FG000|Open Label Phase|Removal by PI|2|||
49155818|NCT03485157|158410195|FG001|Open Label Phase|Removal by PI|0|||
49155819|NCT02626533|158410204|FG000|Overall Study|Protocol Violation|14|||
49155820|NCT02626533|158410204|FG000|Overall Study|Patients were found have meet criteria under the exclusion criterion|2|||
49155821|NCT02626533|158410204|FG000|Overall Study|Withdrawal by Subject|1|||
49155822|NCT03950856|158410205|FG000|Overall Study|Death|1|||
49155823|NCT03950856|158410206|FG001|Overall Study|Death|2|||
49155824|NCT03950856|158410207|FG002|Overall Study|Death|0|||
49155825|NCT03950856|158410208|FG003|Overall Study|Death|0|||
49155826|NCT03950856|158410205|FG000|Overall Study|Lost to Follow-up|5|||
49155827|NCT03950856|158410206|FG001|Overall Study|Lost to Follow-up|6|||
49155828|NCT03950856|158410207|FG002|Overall Study|Lost to Follow-up|8|||
49155829|NCT03950856|158410208|FG003|Overall Study|Lost to Follow-up|2|||
49155830|NCT03950856|158410205|FG000|Overall Study|Protocol Violation|2|||
49155831|NCT03950856|158410206|FG001|Overall Study|Protocol Violation|0|||
49155832|NCT03950856|158410207|FG002|Overall Study|Protocol Violation|0|||
49014473|NCT00947856|157888867|FG000|Follow-up Period|Withdrawal by Subject|1|||
49014474|NCT00947856|157888868|FG001|Follow-up Period|Withdrawal by Subject|0|||
49014475|NCT01211769|157888869|FG000|Overall Study|Lost to Follow-up|7|||
49014476|NCT01211769|157888870|FG001|Overall Study|Lost to Follow-up|9|||
49014477|NCT01211769|157888871|FG002|Overall Study|Lost to Follow-up|5|||
49014478|NCT01211769|157888872|FG003|Overall Study|Lost to Follow-up|9|||
49014479|NCT01211769|157888869|FG000|Overall Study|Physician Decision|2|||
49014480|NCT01211769|157888870|FG001|Overall Study|Physician Decision|0|||
49014481|NCT01211769|157888871|FG002|Overall Study|Physician Decision|2|||
49014482|NCT01211769|157888872|FG003|Overall Study|Physician Decision|1|||
49014483|NCT01211769|157888869|FG000|Overall Study|Adverse Event|0|||
49014484|NCT01211769|157888870|FG001|Overall Study|Adverse Event|1|||
49014485|NCT01211769|157888871|FG002|Overall Study|Adverse Event|1|||
49014486|NCT01211769|157888872|FG003|Overall Study|Adverse Event|1|||
49014487|NCT01214330|157888873|FG000|Overall Study|Withdrawal by Subject|2|||
49014488|NCT01214330|157888873|FG000|Overall Study|Withdrawal by Subject|2|||
49014489|NCT00905489|157888878|FG000|Pharmaco-kinetic (PK) Phase|Protocol Violation|2|||
49014490|NCT00905489|157888878|FG000|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3|||
49014491|NCT00905489|157888878|FG000|Optional Extension Phase (OEP)|Adverse Event|1|||
49014492|NCT01855126|157888881|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|4|||
49014493|NCT01855126|157888882|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|6|||
49014494|NCT01855126|157888881|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
49014495|NCT01855126|157888882|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
49014496|NCT00526890|157888883|FG000|Overall Study|Adverse Event|2|||
49014497|NCT04049552|157888885|FG000|Overall Study|Lost to Follow-up|1|||
49014498|NCT03271528|157888892|FG000|Medication Dispense/Exposure Period 1|Adverse Event|1|||
49014499|NCT03271528|157888893|FG001|Medication Dispense/Exposure Period 1|Adverse Event|0|||
49014500|NCT03271528|157888892|FG000|Medication Dispense/Exposure Period 1|Protocol Violation|1|||
49014501|NCT03271528|157888893|FG001|Medication Dispense/Exposure Period 1|Protocol Violation|0|||
49014502|NCT03271528|157888892|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
49014503|NCT03271528|157888893|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
49014504|NCT03271528|157888892|FG000|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0|||
49014505|NCT03271528|157888893|FG001|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1|||
49014506|NCT03271528|157888892|FG000|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
49014507|NCT03271528|157888893|FG001|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
49014508|NCT03271528|157888892|FG000|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1|||
49014509|NCT03271528|157888893|FG001|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0|||
49014510|NCT03271528|157888892|FG000|Medication Dispense/Exposure Period 2|Lost to Follow-up|1|||
49014511|NCT03271528|157888893|FG001|Medication Dispense/Exposure Period 2|Lost to Follow-up|0|||
49014512|NCT00745251|157888894|FG000|Overall Study|Adverse Event|1|||
49014513|NCT00745251|157888895|FG001|Overall Study|Adverse Event|2|||
49014514|NCT00745251|157888894|FG000|Overall Study|Withdrawal by Subject|1|||
49014515|NCT00745251|157888895|FG001|Overall Study|Withdrawal by Subject|1|||
49014516|NCT03035227|157888896|FG000|Overall Study|study stopped due to PI leaving institut|1|||
49014517|NCT03035227|157888897|FG001|Overall Study|study stopped due to PI leaving institut|1|||
49014518|NCT02100956|157888898|FG000|At Least One Week Between Injections|Adverse Event|0|||
49014519|NCT02100956|157888899|FG001|At Least One Week Between Injections|Adverse Event|1|||
49014520|NCT00859469|157888900|FG000|Overall Study|Adverse Event|2|||
49014521|NCT00859469|157888900|FG000|Overall Study|Lack of Efficacy|9|||
49014522|NCT00859469|157888900|FG000|Overall Study|Withdrawal by Subject|1|||
49014523|NCT00859469|157888900|FG000|Overall Study|Death|16|||
49155833|NCT03950856|158410208|FG003|Overall Study|Protocol Violation|1|||
49155834|NCT03950856|158410205|FG000|Overall Study|Withdrawal by Subject|4|||
49155835|NCT03950856|158410206|FG001|Overall Study|Withdrawal by Subject|1|||
49155836|NCT03950856|158410207|FG002|Overall Study|Withdrawal by Subject|3|||
48828833|NCT00542386|157214103|FG002|Overall Study|Withdrawal by Subject|10|||
48828834|NCT00542386|157214104|FG003|Overall Study|Withdrawal by Subject|11|||
48828835|NCT00542386|157214105|FG004|Overall Study|Withdrawal by Subject|15|||
48828836|NCT00542386|157214106|FG005|Overall Study|Withdrawal by Subject|7|||
48922637|NCT01965262|157550103|FG001|Second Intervention (7 Days)|Discontinued|1|||
48922638|NCT01965262|157550102|FG000|Second Intervention (7 Days)|Poor lens fit|0|||
48922639|NCT01965262|157550103|FG001|Second Intervention (7 Days)|Poor lens fit|9|||
48922640|NCT01965262|157550102|FG000|Second Intervention (7 Days)|Poor visual acuity|1|||
48922641|NCT01965262|157550103|FG001|Second Intervention (7 Days)|Poor visual acuity|0|||
48922642|NCT03728309|157550109|FG000|Overall Study|Randomized but not Treated|0|||
48922643|NCT03728309|157550110|FG001|Overall Study|Randomized but not Treated|1|||
48922644|NCT03728309|157550109|FG000|Overall Study|Adverse Event|0|||
48922645|NCT03728309|157550110|FG001|Overall Study|Adverse Event|1|||
48922646|NCT03728309|157550109|FG000|Overall Study|Withdrawal by Subject|2|||
48922647|NCT03728309|157550110|FG001|Overall Study|Withdrawal by Subject|8|||
49155837|NCT03950856|158410208|FG003|Overall Study|Withdrawal by Subject|1|||
49155838|NCT03950856|158410205|FG000|Overall Study|Unable to phone|7|||
49155839|NCT03950856|158410206|FG001|Overall Study|Unable to phone|6|||
49155840|NCT03950856|158410207|FG002|Overall Study|Unable to phone|7|||
49155841|NCT03950856|158410208|FG003|Overall Study|Unable to phone|2|||
49155842|NCT04971109|158410211|FG000|Overall Study|Adverse Event|4|||
48922648|NCT03728309|157550109|FG000|Overall Study|Lost to Follow-up|9|||
48922649|NCT03728309|157550110|FG001|Overall Study|Lost to Follow-up|10|||
48922650|NCT03728309|157550109|FG000|Overall Study|Protocol Deviation|0|||
48922651|NCT03728309|157550110|FG001|Overall Study|Protocol Deviation|1|||
48922652|NCT03728309|157550109|FG000|Overall Study|Due to COVID|1|||
48922653|NCT03728309|157550110|FG001|Overall Study|Due to COVID|3|||
48922654|NCT01265550|157550111|FG000|Pre Randomization|Withdrawal by Subject|0|||
48922655|NCT01265550|157550112|FG001|Pre Randomization|Withdrawal by Subject|0|||
48922656|NCT01265550|157550113|FG002|Pre Randomization|Withdrawal by Subject|0|||
49155843|NCT04971109|158410212|FG001|Overall Study|Adverse Event|3|||
49155844|NCT04971109|158410211|FG000|Overall Study|Failure to Meet Cont. Criteria|7|||
49155845|NCT04971109|158410212|FG001|Overall Study|Failure to Meet Cont. Criteria|0|||
49155846|NCT04971109|158410211|FG000|Overall Study|Lost to Follow-up|8|||
49155847|NCT04971109|158410212|FG001|Overall Study|Lost to Follow-up|2|||
49155848|NCT04971109|158410211|FG000|Overall Study|Physician Decision|5|||
49155849|NCT04971109|158410212|FG001|Overall Study|Physician Decision|0|||
49155850|NCT04971109|158410211|FG000|Overall Study|Protocol Violation|0|||
49155851|NCT04971109|158410212|FG001|Overall Study|Protocol Violation|1|||
49155852|NCT04971109|158410211|FG000|Overall Study|Withdrawal by Subject|18|||
49155853|NCT04971109|158410212|FG001|Overall Study|Withdrawal by Subject|3|||
49155854|NCT04971109|158410211|FG000|Overall Study|Subject was randomized in error|1|||
49155855|NCT04971109|158410212|FG001|Overall Study|Subject was randomized in error|0|||
49155856|NCT05270863|158410216|FG000|Visit 2 First Intervention|Randomization error|0|||
49155857|NCT05270863|158410217|FG001|Visit 2 First Intervention|Randomization error|0|||
49155858|NCT05270863|158410218|FG002|Visit 2 First Intervention|Randomization error|0|||
49155859|NCT05270863|158410219|FG003|Visit 2 First Intervention|Randomization error|1|||
49155860|NCT05270863|158410220|FG004|Visit 2 First Intervention|Randomization error|0|||
49155861|NCT05270863|158410221|FG005|Visit 2 First Intervention|Randomization error|0|||
49155862|NCT05270863|158410216|FG000|First Washout|Withdrawal by Subject|0|||
49155863|NCT05270863|158410217|FG001|First Washout|Withdrawal by Subject|0|||
49155864|NCT05270863|158410218|FG002|First Washout|Withdrawal by Subject|0|||
48828837|NCT00542386|157214101|FG000|Overall Study|Other Reasons|4|||
48828838|NCT00542386|157214102|FG001|Overall Study|Other Reasons|1|||
48922657|NCT01265550|157550114|FG003|Pre Randomization|Withdrawal by Subject|70|||
48828839|NCT00542386|157214103|FG002|Overall Study|Other Reasons|4|||
48828840|NCT00542386|157214104|FG003|Overall Study|Other Reasons|3|||
48828841|NCT00542386|157214105|FG004|Overall Study|Other Reasons|4|||
48828842|NCT00542386|157214106|FG005|Overall Study|Other Reasons|2|||
48828843|NCT01839877|157214113|FG000|Overall Study|Protocol Violation|1|||
48828844|NCT03593070|157214114|FG000|Overall Study|administrative withdrawal|1|||
48828845|NCT03593070|157214115|FG001|Overall Study|administrative withdrawal|1|||
48828846|NCT03643211|157214116|FG000|Overall Study|Contract violation/deficiency|12|||
48828847|NCT03643211|157214116|FG000|Overall Study|Invalid registration|3|||
48828848|NCT03643211|157214116|FG000|Overall Study|No treatment information|2|||
48828849|NCT03643211|157214116|FG000|Overall Study|No adverse event information - No revisit|4|||
48828850|NCT02197234|157214121|FG000|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1|||
48828851|NCT02197234|157214121|FG000|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1|||
48828852|NCT02197234|157214121|FG000|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1|||
48922658|NCT01265550|157550111|FG000|Pre Randomization|Technical Exclusions|0|||
49155865|NCT05270863|158410219|FG003|First Washout|Withdrawal by Subject|0|||
48828853|NCT02197234|157214121|FG000|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1|||
49155866|NCT05270863|158410220|FG004|First Washout|Withdrawal by Subject|1|||
49155867|NCT05270863|158410221|FG005|First Washout|Withdrawal by Subject|1|||
49155868|NCT05270863|158410216|FG000|First Washout|Lost to Follow-up|0|||
49155869|NCT05270863|158410217|FG001|First Washout|Lost to Follow-up|0|||
49155870|NCT05270863|158410218|FG002|First Washout|Lost to Follow-up|0|||
49155871|NCT05270863|158410219|FG003|First Washout|Lost to Follow-up|0|||
49155872|NCT05270863|158410220|FG004|First Washout|Lost to Follow-up|0|||
48828854|NCT02197234|157214121|FG000|Part B: Day 33 to End Part B (AZD9291)|Death|6|||
48828855|NCT02197234|157214121|FG000|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22|||
48828856|NCT01740557|157214123|FG000|Overall Study|Ineligible|1|||
48828857|NCT01740557|157214123|FG000|Overall Study|Screen failure|1|||
48828858|NCT05826431|157214124|FG000|Overall Study|Withdrawal by Subject|1|||
48828859|NCT01913340|157214125|FG000|Overall Study|Death|2|||
48828860|NCT01913340|157214126|FG001|Overall Study|Death|5|||
48828861|NCT01913340|157214125|FG000|Overall Study|Lost to Follow-up|1|||
48828862|NCT01913340|157214126|FG001|Overall Study|Lost to Follow-up|1|||
48828863|NCT01823341|157214127|FG000|Overall Study|Failed run-in|7|||
48828864|NCT01823341|157214127|FG000|Overall Study|Withdrawal by Subject|7|||
48828865|NCT01823341|157214127|FG000|Overall Study|Adverse Event|1|||
48828866|NCT00751036|157214128|FG000|Overall Study|Disease Progression|28|||
48828867|NCT00751036|157214129|FG001|Overall Study|Disease Progression|29|||
48828868|NCT00751036|157214128|FG000|Overall Study|Adverse Event|6|||
48828869|NCT00751036|157214129|FG001|Overall Study|Adverse Event|4|||
48828870|NCT00751036|157214128|FG000|Overall Study|Administrative Problems|3|||
48828871|NCT00751036|157214129|FG001|Overall Study|Administrative Problems|4|||
48828872|NCT00751036|157214128|FG000|Overall Study|Withdrawal by Subject|5|||
48828873|NCT00751036|157214129|FG001|Overall Study|Withdrawal by Subject|2|||
48828874|NCT00751036|157214128|FG000|Overall Study|Death|3|||
48828875|NCT00751036|157214129|FG001|Overall Study|Death|3|||
48828876|NCT00751036|157214128|FG000|Overall Study|Lost to Follow-up|0|||
48828877|NCT00751036|157214129|FG001|Overall Study|Lost to Follow-up|1|||
48828878|NCT00751036|157214128|FG000|Overall Study|Protocol Violation|1|||
48828879|NCT00751036|157214129|FG001|Overall Study|Protocol Violation|0|||
48828880|NCT00751036|157214128|FG000|Overall Study|Missing end of Treatment Page|2|||
48828881|NCT00751036|157214129|FG001|Overall Study|Missing end of Treatment Page|3|||
48828882|NCT04248829|157214130|FG000|Overall Study|Disease progression|44|||
48828883|NCT04248829|157214131|FG001|Overall Study|Disease progression|109|||
48828884|NCT04248829|157214130|FG000|Overall Study|Adverse Event|19|||
48828885|NCT04248829|157214131|FG001|Overall Study|Adverse Event|18|||
48828886|NCT04248829|157214130|FG000|Overall Study|Withdrawal by Subject|11|||
48828887|NCT04248829|157214131|FG001|Overall Study|Withdrawal by Subject|2|||
48828888|NCT04248829|157214130|FG000|Overall Study|Lost to Follow-up|0|||
48828889|NCT04248829|157214131|FG001|Overall Study|Lost to Follow-up|1|||
48828890|NCT04248829|157214130|FG000|Overall Study|Death|12|||
48828891|NCT04248829|157214131|FG001|Overall Study|Death|14|||
48828892|NCT04248829|157214130|FG000|Overall Study|Physician Decision|2|||
48828893|NCT04248829|157214131|FG001|Overall Study|Physician Decision|4|||
48828894|NCT04248829|157214130|FG000|Overall Study|Any reason not specifically recorded|0|||
48828895|NCT04248829|157214131|FG001|Overall Study|Any reason not specifically recorded|2|||
48828896|NCT05460663|157214132|FG000|Overall Study|Withdrawal by Subject|2|||
48828897|NCT05460663|157214133|FG001|Overall Study|Withdrawal by Subject|5|||
48828898|NCT01867580|157214134|FG000|Overall Study|Withdrawal by Subject|2|||
48828899|NCT01867580|157214135|FG001|Overall Study|Withdrawal by Subject|3|||
49155873|NCT05270863|158410221|FG005|First Washout|Lost to Follow-up|1|||
49155874|NCT05270863|158410216|FG000|Visit 3 Second Intervention|Inclusion Criteria|1|||
49155875|NCT05270863|158410217|FG001|Visit 3 Second Intervention|Inclusion Criteria|0|||
49155876|NCT05270863|158410218|FG002|Visit 3 Second Intervention|Inclusion Criteria|1|||
49155877|NCT05270863|158410219|FG003|Visit 3 Second Intervention|Inclusion Criteria|0|||
49155878|NCT05270863|158410220|FG004|Visit 3 Second Intervention|Inclusion Criteria|0|||
49155879|NCT05270863|158410221|FG005|Visit 3 Second Intervention|Inclusion Criteria|0|||
49155880|NCT05270863|158410216|FG000|Second Washout|Withdrawal by Subject|1|||
49155881|NCT05270863|158410217|FG001|Second Washout|Withdrawal by Subject|1|||
49155882|NCT05270863|158410218|FG002|Second Washout|Withdrawal by Subject|0|||
49155883|NCT05270863|158410219|FG003|Second Washout|Withdrawal by Subject|0|||
49155884|NCT05270863|158410220|FG004|Second Washout|Withdrawal by Subject|0|||
49155885|NCT05270863|158410221|FG005|Second Washout|Withdrawal by Subject|0|||
49155886|NCT05270863|158410216|FG000|Second Washout|Lost to Follow-up|0|||
49155887|NCT05270863|158410217|FG001|Second Washout|Lost to Follow-up|0|||
49155888|NCT05270863|158410218|FG002|Second Washout|Lost to Follow-up|0|||
49155889|NCT05270863|158410219|FG003|Second Washout|Lost to Follow-up|1|||
49155890|NCT05270863|158410220|FG004|Second Washout|Lost to Follow-up|0|||
49155891|NCT05270863|158410221|FG005|Second Washout|Lost to Follow-up|0|||
48828900|NCT01867580|157214134|FG000|Overall Study|Physician Decision|17|||
48828901|NCT01867580|157214135|FG001|Overall Study|Physician Decision|12|||
48828902|NCT01867580|157214134|FG000|Overall Study|Lost to Follow-up|3|||
48828903|NCT01867580|157214135|FG001|Overall Study|Lost to Follow-up|5|||
48828904|NCT01867580|157214134|FG000|Overall Study|Sponsor terminated study|1|||
49155892|NCT01365455|158410222|FG000|Induction Period|Adverse Event|5|||
49155893|NCT01365455|158410223|FG001|Induction Period|Adverse Event|3|||
49155894|NCT01365455|158410224|FG002|Induction Period|Adverse Event|4|||
49155895|NCT01365455|158410225|FG003|Induction Period|Adverse Event|0|||
48922659|NCT01265550|157550112|FG001|Pre Randomization|Technical Exclusions|0|||
48922660|NCT01265550|157550113|FG002|Pre Randomization|Technical Exclusions|0|||
48922661|NCT01265550|157550114|FG003|Pre Randomization|Technical Exclusions|54|||
48922662|NCT01265550|157550111|FG000|Pre Randomization|GERD, PPI-Responsive|0|||
48922663|NCT01265550|157550112|FG001|Pre Randomization|GERD, PPI-Responsive|0|||
48922664|NCT01265550|157550113|FG002|Pre Randomization|GERD, PPI-Responsive|0|||
48922665|NCT01265550|157550114|FG003|Pre Randomization|GERD, PPI-Responsive|42|||
48922666|NCT01265550|157550111|FG000|Pre Randomization|Non-GERD organic disorders|0|||
48922667|NCT01265550|157550112|FG001|Pre Randomization|Non-GERD organic disorders|0|||
48922668|NCT01265550|157550113|FG002|Pre Randomization|Non-GERD organic disorders|0|||
48922669|NCT01265550|157550114|FG003|Pre Randomization|Non-GERD organic disorders|23|||
48922670|NCT01265550|157550111|FG000|Pre Randomization|Functional heartburn|0|||
48922671|NCT01265550|157550112|FG001|Pre Randomization|Functional heartburn|0|||
48922672|NCT01265550|157550113|FG002|Pre Randomization|Functional heartburn|0|||
48922673|NCT01265550|157550114|FG003|Pre Randomization|Functional heartburn|99|||
48922674|NCT00408694|157550115|FG000|Overall Study|Ineligible|1|||
49155896|NCT01365455|158410226|FG004|Induction Period|Adverse Event|0|||
49155897|NCT01365455|158410222|FG000|Induction Period|Lack of Efficacy|1|||
49155898|NCT01365455|158410223|FG001|Induction Period|Lack of Efficacy|1|||
49155899|NCT01365455|158410224|FG002|Induction Period|Lack of Efficacy|0|||
49155900|NCT01365455|158410225|FG003|Induction Period|Lack of Efficacy|0|||
49155901|NCT01365455|158410226|FG004|Induction Period|Lack of Efficacy|0|||
49155902|NCT01365455|158410222|FG000|Induction Period|Pregnancy|0|||
49155903|NCT01365455|158410223|FG001|Induction Period|Pregnancy|1|||
49155904|NCT01365455|158410224|FG002|Induction Period|Pregnancy|0|||
49155905|NCT01365455|158410225|FG003|Induction Period|Pregnancy|0|||
49155906|NCT01365455|158410226|FG004|Induction Period|Pregnancy|0|||
49155907|NCT01365455|158410222|FG000|Induction Period|Protocol deviation|0|||
49155908|NCT01365455|158410223|FG001|Induction Period|Protocol deviation|1|||
49155909|NCT01365455|158410224|FG002|Induction Period|Protocol deviation|1|||
49155910|NCT01365455|158410225|FG003|Induction Period|Protocol deviation|0|||
49155911|NCT01365455|158410226|FG004|Induction Period|Protocol deviation|0|||
49155912|NCT01365455|158410222|FG000|Induction Period|Subject/guardian decision|9|||
48828905|NCT01867580|157214135|FG001|Overall Study|Sponsor terminated study|0|||
48828906|NCT01867580|157214134|FG000|Overall Study|Missed follow-up assessment|2|||
48828907|NCT01867580|157214135|FG001|Overall Study|Missed follow-up assessment|1|||
48828908|NCT01867580|157214134|FG000|Overall Study|Interruption to therapy|3|||
48828909|NCT01867580|157214135|FG001|Overall Study|Interruption to therapy|0|||
48828910|NCT01867580|157214134|FG000|Overall Study|Osteomyelitis|0|||
48828911|NCT01867580|157214135|FG001|Overall Study|Osteomyelitis|1|||
48828912|NCT01867580|157214134|FG000|Overall Study|Continuation of therapy|0|||
48828913|NCT01867580|157214135|FG001|Overall Study|Continuation of therapy|1|||
48828914|NCT01867580|157214134|FG000|Overall Study|Wound recurrence|0|||
48828915|NCT01867580|157214135|FG001|Overall Study|Wound recurrence|1|||
48828916|NCT02451943|157215863|FG000|Overall Study|On Treatment|4|||
48828917|NCT02451943|157215864|FG001|Overall Study|On Treatment|4|||
48828918|NCT02451943|157215863|FG000|Overall Study|Withdrawal by Subject|13|||
48828919|NCT02451943|157215864|FG001|Overall Study|Withdrawal by Subject|16|||
48828920|NCT02451943|157215863|FG000|Overall Study|Lost to Follow-up|3|||
48828921|NCT02451943|157215864|FG001|Overall Study|Lost to Follow-up|4|||
48828922|NCT02624778|157215865|FG000|Overall Study|Lost to Follow-up|0|||
48828923|NCT02624778|157215866|FG001|Overall Study|Lost to Follow-up|0|||
48828924|NCT02624778|157215867|FG002|Overall Study|Lost to Follow-up|1|||
48828925|NCT02624778|157215868|FG003|Overall Study|Lost to Follow-up|0|||
48828926|NCT02624778|157215869|FG004|Overall Study|Lost to Follow-up|0|||
48828927|NCT02624778|157215870|FG005|Overall Study|Lost to Follow-up|0|||
48828928|NCT02624778|157215871|FG006|Overall Study|Lost to Follow-up|0|||
48828929|NCT02624778|157215872|FG007|Overall Study|Lost to Follow-up|0|||
48828930|NCT02624778|157215873|FG008|Overall Study|Lost to Follow-up|0|||
48922675|NCT00408694|157550115|FG000|Overall Study|No protocol treatment|1|||
48922676|NCT01687712|157550119|FG000|Cycle 1|Not Biochemically Pregnant|386|||
48922677|NCT01687712|157550120|FG001|Cycle 1|Not Biochemically Pregnant|348|||
49155913|NCT01365455|158410223|FG001|Induction Period|Subject/guardian decision|1|||
48922678|NCT01687712|157550119|FG000|Cycle 1|Early Pregnancy Loss|43|||
48922679|NCT01687712|157550120|FG001|Cycle 1|Early Pregnancy Loss|60|||
48922680|NCT01687712|157550119|FG000|Cycle 1|Ectopic Pregnancy|5|||
49155914|NCT01365455|158410224|FG002|Induction Period|Subject/guardian decision|8|||
49155915|NCT01365455|158410225|FG003|Induction Period|Subject/guardian decision|0|||
48828931|NCT02624778|157215865|FG000|Overall Study|Withdrawal by Subject|0|||
49155916|NCT01365455|158410226|FG004|Induction Period|Subject/guardian decision|0|||
49155917|NCT01365455|158410222|FG000|Induction Period|Lost to Follow-up|0|||
48828932|NCT02624778|157215866|FG001|Overall Study|Withdrawal by Subject|1|||
48828933|NCT02624778|157215867|FG002|Overall Study|Withdrawal by Subject|0|||
48828934|NCT02624778|157215868|FG003|Overall Study|Withdrawal by Subject|0|||
48828935|NCT02624778|157215869|FG004|Overall Study|Withdrawal by Subject|0|||
48828936|NCT02624778|157215870|FG005|Overall Study|Withdrawal by Subject|1|||
48828937|NCT02624778|157215871|FG006|Overall Study|Withdrawal by Subject|1|||
49155918|NCT01365455|158410223|FG001|Induction Period|Lost to Follow-up|0|||
49155919|NCT01365455|158410224|FG002|Induction Period|Lost to Follow-up|3|||
49155920|NCT01365455|158410225|FG003|Induction Period|Lost to Follow-up|0|||
49155921|NCT01365455|158410226|FG004|Induction Period|Lost to Follow-up|0|||
49155922|NCT01365455|158410222|FG000|Maintenance Period|Adverse Event|12|||
49155923|NCT01365455|158410223|FG001|Maintenance Period|Adverse Event|5|||
49155924|NCT01365455|158410224|FG002|Maintenance Period|Adverse Event|1|||
49155925|NCT01365455|158410225|FG003|Maintenance Period|Adverse Event|2|||
49155926|NCT01365455|158410226|FG004|Maintenance Period|Adverse Event|4|||
49155927|NCT01365455|158410222|FG000|Maintenance Period|Lack of Efficacy|10|||
49155928|NCT01365455|158410223|FG001|Maintenance Period|Lack of Efficacy|2|||
49155929|NCT01365455|158410224|FG002|Maintenance Period|Lack of Efficacy|0|||
49155930|NCT01365455|158410225|FG003|Maintenance Period|Lack of Efficacy|2|||
49155931|NCT01365455|158410226|FG004|Maintenance Period|Lack of Efficacy|2|||
49155932|NCT01365455|158410222|FG000|Maintenance Period|Lost to Follow-up|2|||
49155933|NCT01365455|158410223|FG001|Maintenance Period|Lost to Follow-up|4|||
49155934|NCT01365455|158410224|FG002|Maintenance Period|Lost to Follow-up|0|||
49155935|NCT01365455|158410225|FG003|Maintenance Period|Lost to Follow-up|0|||
49155936|NCT01365455|158410226|FG004|Maintenance Period|Lost to Follow-up|3|||
49155937|NCT01365455|158410222|FG000|Maintenance Period|Non-compliance with study treatment|0|||
49155938|NCT01365455|158410223|FG001|Maintenance Period|Non-compliance with study treatment|0|||
49155939|NCT01365455|158410224|FG002|Maintenance Period|Non-compliance with study treatment|0|||
49155940|NCT01365455|158410225|FG003|Maintenance Period|Non-compliance with study treatment|1|||
49155941|NCT01365455|158410226|FG004|Maintenance Period|Non-compliance with study treatment|0|||
49155942|NCT01365455|158410222|FG000|Maintenance Period|Physician Decision|0|||
49155943|NCT01365455|158410223|FG001|Maintenance Period|Physician Decision|1|||
49155944|NCT01365455|158410224|FG002|Maintenance Period|Physician Decision|0|||
49155945|NCT01365455|158410225|FG003|Maintenance Period|Physician Decision|0|||
49155946|NCT01365455|158410226|FG004|Maintenance Period|Physician Decision|1|||
49155947|NCT01365455|158410222|FG000|Maintenance Period|Pregnancy|0|||
49155948|NCT01365455|158410223|FG001|Maintenance Period|Pregnancy|4|||
49155949|NCT01365455|158410224|FG002|Maintenance Period|Pregnancy|0|||
49155950|NCT01365455|158410225|FG003|Maintenance Period|Pregnancy|0|||
49155951|NCT01365455|158410226|FG004|Maintenance Period|Pregnancy|2|||
49155952|NCT01365455|158410222|FG000|Maintenance Period|Protocol deviation|1|||
49155953|NCT01365455|158410223|FG001|Maintenance Period|Protocol deviation|1|||
49155954|NCT01365455|158410224|FG002|Maintenance Period|Protocol deviation|0|||
49155955|NCT01365455|158410225|FG003|Maintenance Period|Protocol deviation|0|||
49155956|NCT01365455|158410226|FG004|Maintenance Period|Protocol deviation|0|||
49155957|NCT01365455|158410222|FG000|Maintenance Period|Subject/guardian decision|4|||
49155958|NCT01365455|158410223|FG001|Maintenance Period|Subject/guardian decision|6|||
49155959|NCT01365455|158410224|FG002|Maintenance Period|Subject/guardian decision|2|||
49155960|NCT01365455|158410225|FG003|Maintenance Period|Subject/guardian decision|4|||
49155961|NCT01365455|158410226|FG004|Maintenance Period|Subject/guardian decision|1|||
49155962|NCT01373281|158412354|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40|||
49155963|NCT01373281|158412355|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23|||
49155964|NCT01373281|158412354|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|5|||
49155965|NCT01373281|158412355|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|2|||
49155966|NCT01373281|158412354|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5|||
49155967|NCT01373281|158412355|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1|||
49155968|NCT01373281|158412354|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|4|||
49155969|NCT01373281|158412355|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|1|||
48828938|NCT02624778|157215872|FG007|Overall Study|Withdrawal by Subject|1|||
48828939|NCT02624778|157215873|FG008|Overall Study|Withdrawal by Subject|1|||
48828940|NCT02624778|157215865|FG000|Overall Study|Adverse Event|0|||
48828941|NCT02624778|157215866|FG001|Overall Study|Adverse Event|0|||
48828942|NCT02624778|157215867|FG002|Overall Study|Adverse Event|0|||
48828943|NCT02624778|157215868|FG003|Overall Study|Adverse Event|0|||
48828944|NCT02624778|157215869|FG004|Overall Study|Adverse Event|0|||
48828945|NCT02624778|157215870|FG005|Overall Study|Adverse Event|0|||
48828946|NCT02624778|157215871|FG006|Overall Study|Adverse Event|0|||
48828947|NCT02624778|157215872|FG007|Overall Study|Adverse Event|0|||
48828948|NCT02624778|157215873|FG008|Overall Study|Adverse Event|2|||
48828949|NCT02624778|157215865|FG000|Overall Study|Death|0|||
48828950|NCT02624778|157215866|FG001|Overall Study|Death|0|||
48828951|NCT02624778|157215867|FG002|Overall Study|Death|0|||
48828952|NCT02624778|157215868|FG003|Overall Study|Death|0|||
49155970|NCT01373281|158412354|FG000|Surveillance Expansion Period|Withdrawal by Subject|180|||
49155971|NCT01373281|158412355|FG001|Surveillance Expansion Period|Withdrawal by Subject|105|||
49155972|NCT01373281|158412354|FG000|Surveillance Expansion Period|Protocol Violation|9|||
48828953|NCT02624778|157215869|FG004|Overall Study|Death|0|||
48828954|NCT02624778|157215870|FG005|Overall Study|Death|0|||
48828955|NCT02624778|157215871|FG006|Overall Study|Death|1|||
48828956|NCT02624778|157215872|FG007|Overall Study|Death|0|||
48828957|NCT02624778|157215873|FG008|Overall Study|Death|0|||
48828958|NCT02624778|157215865|FG000|Overall Study|Physician Decision|0|||
48828959|NCT02624778|157215866|FG001|Overall Study|Physician Decision|0|||
48828960|NCT02624778|157215867|FG002|Overall Study|Physician Decision|0|||
48828961|NCT02624778|157215868|FG003|Overall Study|Physician Decision|0|||
48828962|NCT02624778|157215869|FG004|Overall Study|Physician Decision|0|||
48828963|NCT02624778|157215870|FG005|Overall Study|Physician Decision|0|||
48828964|NCT02624778|157215871|FG006|Overall Study|Physician Decision|0|||
48828965|NCT02624778|157215872|FG007|Overall Study|Physician Decision|3|||
48828966|NCT02624778|157215873|FG008|Overall Study|Physician Decision|3|||
49155973|NCT01373281|158412355|FG001|Surveillance Expansion Period|Protocol Violation|1|||
49155974|NCT01373281|158412354|FG000|Surveillance Expansion Period|Lost to Follow-up|10|||
49155975|NCT01373281|158412355|FG001|Surveillance Expansion Period|Lost to Follow-up|8|||
49155976|NCT01373281|158412354|FG000|Surveillance Expansion Period|Serious adverse event|3|||
49155977|NCT01373281|158412355|FG001|Surveillance Expansion Period|Serious adverse event|4|||
49155978|NCT01397253|158412356|FG000|Overall Study|Reviewed by only 1 pharmacist|126|||
49155979|NCT01397253|158412357|FG001|Overall Study|Reviewed by only 1 pharmacist|149|||
49155980|NCT00980044|158412358|FG000|Overall Study|Withdrawal by Subject|5|||
49155981|NCT00980044|158412359|FG001|Overall Study|Withdrawal by Subject|7|||
48828967|NCT03158948|157215874|FG000|Overall Study|Death|1|||
48828968|NCT03158948|157215875|FG001|Overall Study|Death|1|||
48828969|NCT03158948|157215876|FG002|Overall Study|Death|3|||
48828970|NCT03158948|157215877|FG003|Overall Study|Death|2|||
48828971|NCT03158948|157215874|FG000|Overall Study|Physician Decision|0|||
48828972|NCT03158948|157215875|FG001|Overall Study|Physician Decision|0|||
48828973|NCT03158948|157215876|FG002|Overall Study|Physician Decision|0|||
48828974|NCT03158948|157215877|FG003|Overall Study|Physician Decision|1|||
48828975|NCT05025449|157215880|FG000|Overall Study|Withdrawal by Subject|1|||
48828976|NCT05025449|157215880|FG000|Overall Study|Patient emergently taken to operating room|1|||
48828977|NCT00093795|157215881|FG000|Overall Study|No follow up data|20|||
48828978|NCT00093795|157215882|FG001|Overall Study|No follow up data|16|||
48828979|NCT00093795|157215883|FG002|Overall Study|No follow up data|17|||
48828980|NCT01195675|157215884|FG000|Overall Study|Adverse Event|1|||
48828981|NCT01195675|157215884|FG000|Overall Study|Withdrawal by Subject|2|||
48828982|NCT02501629|157215894|FG000|Overall Study|Death|0|||
48828983|NCT02501629|157215895|FG001|Overall Study|Death|1|||
48828984|NCT02501629|157215894|FG000|Overall Study|Withdrawn from study by sponsor|1|||
48828985|NCT02501629|157215895|FG001|Overall Study|Withdrawn from study by sponsor|0|||
48828986|NCT02501629|157215894|FG000|Overall Study|Early termination by sponsor|1|||
48828987|NCT02501629|157215895|FG001|Overall Study|Early termination by sponsor|0|||
48828988|NCT02501629|157215894|FG000|Overall Study|Withdrawal by Subject|3|||
48828989|NCT02501629|157215895|FG001|Overall Study|Withdrawal by Subject|5|||
48828990|NCT02501629|157215894|FG000|Overall Study|Subject did not return to site|0|||
48828991|NCT02501629|157215895|FG001|Overall Study|Subject did not return to site|1|||
48828992|NCT00349908|157215898|FG000|Overall Study|Withdrawal by Subject|0|||
48828993|NCT00349908|157215899|FG001|Overall Study|Withdrawal by Subject|4|||
48828994|NCT04565249|157215900|FG000|Overall Study|Death|0|||
48828995|NCT04565249|157215901|FG001|Overall Study|Death|0|||
48828996|NCT04565249|157215902|FG002|Overall Study|Death|0|||
48828997|NCT04565249|157215903|FG003|Overall Study|Death|1|||
48828998|NCT00926393|157215904|FG000|Overall Study|Withdrawal by Subject|1|||
48828999|NCT00926393|157215905|FG001|Overall Study|Withdrawal by Subject|2|||
48829000|NCT00926393|157215904|FG000|Overall Study|Adverse Event|1|||
48829001|NCT00926393|157215905|FG001|Overall Study|Adverse Event|1|||
48829002|NCT02333630|157215906|FG000|Overall Study|Lost to Follow-up|5|||
48829003|NCT02333630|157215907|FG001|Overall Study|Lost to Follow-up|2|||
48829004|NCT05349864|157215908|FG000|Period 2 (5 Days)|Withdrawal by Subject|1|||
48829005|NCT05349864|157215909|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
48829006|NCT01704846|157215910|FG000|Treatment Period 2|Withdrawal by Subject|0|||
48829007|NCT01704846|157215911|FG001|Treatment Period 2|Withdrawal by Subject|1|||
48829008|NCT00058058|157215912|FG000|Overall Study|Withdrawal by Subject|4|||
48829009|NCT00058058|157215912|FG000|Overall Study|Ineligible|20|||
48922681|NCT01687712|157550120|FG001|Cycle 1|Ectopic Pregnancy|5|||
48922682|NCT01687712|157550119|FG000|Cycle 1|Heterotropic Pregnancy|1|||
49155982|NCT00980044|158412360|FG002|Overall Study|Withdrawal by Subject|3|||
48829010|NCT00058058|157215912|FG000|Overall Study|Claustrophobic|5|||
48829011|NCT00058058|157215912|FG000|Overall Study|technical issues|6|||
48829012|NCT00058058|157215912|FG000|Overall Study|Poor positioning, illness,pain|3|||
48829013|NCT03613129|157215914|FG000|Pre-treatment Assessment|Protocol Violation|2|||
48829014|NCT03613129|157215915|FG001|Pre-treatment Assessment|Protocol Violation|0|||
48829015|NCT03613129|157215916|FG002|Pre-treatment Assessment|Protocol Violation|0|||
48829016|NCT03613129|157215917|FG003|Pre-treatment Assessment|Protocol Violation|0|||
48829017|NCT03613129|157215918|FG004|Pre-treatment Assessment|Protocol Violation|0|||
48829018|NCT03613129|157215914|FG000|Pre-treatment Assessment|Withdrawal by Subject|1|||
48829019|NCT03613129|157215915|FG001|Pre-treatment Assessment|Withdrawal by Subject|0|||
48829020|NCT03613129|157215916|FG002|Pre-treatment Assessment|Withdrawal by Subject|0|||
48829021|NCT03613129|157215917|FG003|Pre-treatment Assessment|Withdrawal by Subject|0|||
48829022|NCT03613129|157215918|FG004|Pre-treatment Assessment|Withdrawal by Subject|0|||
49155983|NCT00980044|158412358|FG000|Overall Study|Protocol Violation|0|||
49155984|NCT00980044|158412359|FG001|Overall Study|Protocol Violation|0|||
49155985|NCT00980044|158412360|FG002|Overall Study|Protocol Violation|2|||
49155986|NCT03502681|158412363|FG000|Overall Study|Adverse Event|1|||
49155987|NCT03502681|158412364|FG001|Overall Study|Adverse Event|1|||
49155988|NCT03502681|158412363|FG000|Overall Study|Disease Progression|2|||
49155989|NCT03502681|158412364|FG001|Overall Study|Disease Progression|1|||
49155990|NCT00442702|158412365|FG000|Titration Period|Adverse Event|2|||
49155991|NCT00442702|158412366|FG001|Titration Period|Adverse Event|0|||
49155992|NCT00442702|158412365|FG000|Titration Period|Death|3|||
49155993|NCT00442702|158412366|FG001|Titration Period|Death|2|||
49155994|NCT00442702|158412365|FG000|Titration Period|Insufficient Therapeutic Response|1|||
49155995|NCT00442702|158412366|FG001|Titration Period|Insufficient Therapeutic Response|0|||
49155996|NCT00442702|158412365|FG000|Titration Period|Refused Treatment|4|||
49155997|NCT00442702|158412366|FG001|Titration Period|Refused Treatment|1|||
49155998|NCT00442702|158412365|FG000|Titration Period|Failure to return|1|||
49155999|NCT00442702|158412366|FG001|Titration Period|Failure to return|0|||
49156000|NCT00442702|158412365|FG000|Titration Period|Hospitalized in another hospital|1|||
49156001|NCT00442702|158412366|FG001|Titration Period|Hospitalized in another hospital|0|||
49156002|NCT00442702|158412365|FG000|Evaluation Period|Adverse Event|1|||
49156003|NCT00442702|158412366|FG001|Evaluation Period|Adverse Event|0|||
49156004|NCT00442702|158412365|FG000|Evaluation Period|Death|1|||
49156005|NCT00442702|158412366|FG001|Evaluation Period|Death|1|||
49156006|NCT00442702|158412365|FG000|Evaluation Period|Insufficient Therapeutic Response|1|||
49156007|NCT00442702|158412366|FG001|Evaluation Period|Insufficient Therapeutic Response|0|||
49156008|NCT00442702|158412365|FG000|Evaluation Period|Refused treatment|1|||
49156009|NCT00442702|158412366|FG001|Evaluation Period|Refused treatment|1|||
49156010|NCT00442702|158412365|FG000|Evaluation Period|Renal transplant|0|||
49156011|NCT00442702|158412366|FG001|Evaluation Period|Renal transplant|1|||
49156012|NCT00442702|158412365|FG000|Evaluation Period|Failure to return|1|||
49156013|NCT00442702|158412366|FG001|Evaluation Period|Failure to return|0|||
49156014|NCT00442702|158412365|FG000|Evaluation Period|Site closure|0|||
49156015|NCT00442702|158412366|FG001|Evaluation Period|Site closure|1|||
49156016|NCT01444781|158412367|FG000|Overall Study|Lost to Follow-up|0|||
49156017|NCT01444781|158412368|FG001|Overall Study|Lost to Follow-up|3|||
49156018|NCT01444781|158412369|FG002|Overall Study|Lost to Follow-up|1|||
49156019|NCT01444781|158412367|FG000|Overall Study|Withdrawal by Subject|3|||
49156020|NCT01444781|158412368|FG001|Overall Study|Withdrawal by Subject|1|||
49156021|NCT01444781|158412369|FG002|Overall Study|Withdrawal by Subject|2|||
49156022|NCT02254291|158412370|FG000|Overall Study|Withdrawal by Subject|0|||
49156023|NCT02254291|158412371|FG001|Overall Study|Withdrawal by Subject|3|||
49156024|NCT02254291|158412372|FG002|Overall Study|Withdrawal by Subject|1|||
49156025|NCT02254291|158412370|FG000|Overall Study|Missing follow-up information|0|||
49156026|NCT02254291|158412371|FG001|Overall Study|Missing follow-up information|0|||
49156027|NCT02254291|158412372|FG002|Overall Study|Missing follow-up information|1|||
49156028|NCT05538728|158412375|FG000|Overall Study|Withdrawal by Subject|1|||
49156029|NCT05538728|158412376|FG001|Overall Study|Withdrawal by Subject|1|||
49156030|NCT00133705|158412377|FG000|Overall Study|Withdrawal by Subject|2|||
49156031|NCT00133705|158412378|FG001|Overall Study|Withdrawal by Subject|3|||
49156032|NCT03122184|158412382|FG000|Overall Study|Lost to Follow-up|4|||
49156033|NCT03122184|158412383|FG001|Overall Study|Lost to Follow-up|6|||
49156034|NCT03122184|158412382|FG000|Overall Study|Withdrawal by Subject|3|||
49156035|NCT03122184|158412383|FG001|Overall Study|Withdrawal by Subject|0|||
49156036|NCT03122184|158412382|FG000|Overall Study|Terminated due to cognitive problem|1|||
49156037|NCT03122184|158412383|FG001|Overall Study|Terminated due to cognitive problem|0|||
49156038|NCT00876447|158412392|FG000|Overall Study|Other miscellaneous reasons|3|||
49156039|NCT00876447|158412393|FG001|Overall Study|Other miscellaneous reasons|8|||
49156040|NCT00876447|158412392|FG000|Overall Study|Site closure|19|||
49156041|NCT00876447|158412393|FG001|Overall Study|Site closure|14|||
49156042|NCT00876447|158412392|FG000|Overall Study|Protocol Violation|9|||
49156043|NCT00876447|158412393|FG001|Overall Study|Protocol Violation|3|||
49156044|NCT00876447|158412392|FG000|Overall Study|Personal reasons|30|||
49156045|NCT00876447|158412393|FG001|Overall Study|Personal reasons|28|||
49156046|NCT00876447|158412392|FG000|Overall Study|Lost to Follow-up|6|||
49156047|NCT00876447|158412393|FG001|Overall Study|Lost to Follow-up|15|||
49156048|NCT00876447|158412392|FG000|Overall Study|Pregnancy|4|||
49156049|NCT00876447|158412393|FG001|Overall Study|Pregnancy|2|||
49156050|NCT00876447|158412392|FG000|Overall Study|Lack of Efficacy|5|||
49156051|NCT00876447|158412393|FG001|Overall Study|Lack of Efficacy|3|||
49156052|NCT00876447|158412392|FG000|Overall Study|Adverse Event|4|||
49156053|NCT00876447|158412393|FG001|Overall Study|Adverse Event|8|||
49156054|NCT03674281|158412394|FG000|Overall Study|screen failure|2|||
49156055|NCT03674281|158412395|FG001|Overall Study|screen failure|0|||
49156056|NCT03674281|158412396|FG002|Overall Study|screen failure|0|||
49156057|NCT03674281|158412394|FG000|Overall Study|Withdrawal by Subject|1|||
49156058|NCT03674281|158412395|FG001|Overall Study|Withdrawal by Subject|3|||
49156059|NCT03674281|158412396|FG002|Overall Study|Withdrawal by Subject|3|||
49156060|NCT02301897|158412397|FG000|Treatment Course 1|Non-Compliance|0|||
49156061|NCT02301897|158412398|FG001|Treatment Course 1|Non-Compliance|0|||
49156062|NCT02301897|158412399|FG002|Treatment Course 1|Non-Compliance|1|||
49156063|NCT02301897|158412397|FG000|Treatment Course 1|Adverse Event|1|||
49156064|NCT02301897|158412398|FG001|Treatment Course 1|Adverse Event|1|||
49156065|NCT02301897|158412399|FG002|Treatment Course 1|Adverse Event|0|||
49156066|NCT02301897|158412397|FG000|Treatment Course 1|Lost to Follow-up|1|||
49156067|NCT02301897|158412398|FG001|Treatment Course 1|Lost to Follow-up|2|||
49156068|NCT02301897|158412399|FG002|Treatment Course 1|Lost to Follow-up|1|||
49156069|NCT02301897|158412397|FG000|Treatment Course 1|Withdrawal by Sponsor|0|||
49156070|NCT02301897|158412398|FG001|Treatment Course 1|Withdrawal by Sponsor|0|||
49156071|NCT02301897|158412399|FG002|Treatment Course 1|Withdrawal by Sponsor|2|||
49156072|NCT02301897|158412397|FG000|Treatment Course 1|Withdrawal by Subject|0|||
49156073|NCT02301897|158412398|FG001|Treatment Course 1|Withdrawal by Subject|0|||
49156074|NCT02301897|158412399|FG002|Treatment Course 1|Withdrawal by Subject|2|||
49156075|NCT02301897|158412397|FG000|Treatment Course 1|Other Miscellaneous Reasons|1|||
49156076|NCT02301897|158412398|FG001|Treatment Course 1|Other Miscellaneous Reasons|0|||
49156077|NCT02301897|158412399|FG002|Treatment Course 1|Other Miscellaneous Reasons|0|||
49156078|NCT02301897|158412397|FG000|Treatment Course 2|Lost to Follow-up|0|||
49156079|NCT02301897|158412398|FG001|Treatment Course 2|Lost to Follow-up|2|||
49156080|NCT02301897|158412399|FG002|Treatment Course 2|Lost to Follow-up|0|||
49156081|NCT02301897|158412397|FG000|Treatment Course 2|Pregnancy|0|||
49156082|NCT02301897|158412398|FG001|Treatment Course 2|Pregnancy|1|||
49156083|NCT02301897|158412399|FG002|Treatment Course 2|Pregnancy|1|||
49156084|NCT02301897|158412397|FG000|Treatment Course 2|Withdrawal by Subject|0|||
49156085|NCT02301897|158412398|FG001|Treatment Course 2|Withdrawal by Subject|2|||
49156086|NCT02301897|158412399|FG002|Treatment Course 2|Withdrawal by Subject|0|||
49156087|NCT02301897|158412397|FG000|Treatment Course 2|Other Miscellaneous Reasons|1|||
49156088|NCT02301897|158412398|FG001|Treatment Course 2|Other Miscellaneous Reasons|0|||
49156089|NCT02301897|158412399|FG002|Treatment Course 2|Other Miscellaneous Reasons|0|||
48829023|NCT04381494|157215921|FG000|Overall Study|Early termination of trial|19|||
48829024|NCT04381494|157215921|FG000|Overall Study|Investigator's discretion|1|||
48829025|NCT04381494|157215921|FG000|Overall Study|Withdrawal by Subject|9|||
48829026|NCT04381494|157215921|FG000|Overall Study|NSCLC disease progression|4|||
48829027|NCT04381494|157215921|FG000|Overall Study|Device-Related Adverse Event|2|||
48829028|NCT03278028|157215924|FG000|Overall Study|Lost to Follow-up|1|||
48829029|NCT03278028|157215925|FG001|Overall Study|Lost to Follow-up|0|||
48829030|NCT03278028|157215924|FG000|Overall Study|Withdrawal by Subject|3|||
48829031|NCT03278028|157215925|FG001|Overall Study|Withdrawal by Subject|1|||
48829032|NCT03278028|157215924|FG000|Overall Study|Pregnancy|0|||
48829033|NCT03278028|157215925|FG001|Overall Study|Pregnancy|1|||
48829034|NCT03635567|157215926|FG000|Overall Study|Lost to Follow-up|0|||
48829035|NCT03635567|157215927|FG001|Overall Study|Lost to Follow-up|2|||
48829036|NCT03635567|157215926|FG000|Overall Study|Withdrawal by Subject|9|||
48829037|NCT03635567|157215927|FG001|Overall Study|Withdrawal by Subject|10|||
48829038|NCT03635567|157215926|FG000|Overall Study|Ongoing in Study|125|||
48829039|NCT03635567|157215927|FG001|Overall Study|Ongoing in Study|76|||
48829040|NCT03635567|157215926|FG000|Overall Study|Death|174|||
49156090|NCT02538614|158412403|FG000|Overall Study|Progressive Disease|2|||
49156091|NCT00666263|158412406|FG000|Study Part 1 (Stabilization Phase 1)|Adverse Event|0|||
49156092|NCT00666263|158412407|FG001|Study Part 1 (Stabilization Phase 1)|Adverse Event|1|||
49156093|NCT00666263|158412406|FG000|Study Part 4 (Cross-over Period 2)|Adverse Event|1|||
49156094|NCT00666263|158412407|FG001|Study Part 4 (Cross-over Period 2)|Adverse Event|0|||
49156095|NCT00666263|158412406|FG000|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0|||
49156096|NCT00666263|158412407|FG001|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1|||
49156097|NCT00189423|158412408|FG000|Overall Study|Death|746|||
49156098|NCT00189423|158412409|FG001|Overall Study|Death|747|||
49156099|NCT00189423|158412408|FG000|Overall Study|Withdrawal by Subject|9|||
49156100|NCT00189423|158412409|FG001|Overall Study|Withdrawal by Subject|9|||
49156101|NCT00189423|158412408|FG000|Overall Study|Lost to Follow-up|10|||
48922683|NCT01687712|157550120|FG001|Cycle 1|Heterotropic Pregnancy|0|||
49156102|NCT00189423|158412409|FG001|Overall Study|Lost to Follow-up|10|||
49156103|NCT00586157|158412411|FG000|First Intervention|Worsening behavior|1|||
49156104|NCT00586157|158412412|FG001|First Intervention|Worsening behavior|0|||
48829041|NCT03635567|157215927|FG001|Overall Study|Death|221|||
48829042|NCT01720446|157215928|FG000|Overall Study|Lost to Follow-up|12|||
49156105|NCT00586157|158412411|FG000|Second Intervention|Withdrawal by Subject|1|||
49156106|NCT00586157|158412412|FG001|Second Intervention|Withdrawal by Subject|0|||
49156107|NCT00586157|158412411|FG000|Second Intervention|Worsening behavior|1|||
48829043|NCT01720446|157215929|FG001|Overall Study|Lost to Follow-up|6|||
48829044|NCT01720446|157215930|FG002|Overall Study|Lost to Follow-up|16|||
48829045|NCT01720446|157215931|FG003|Overall Study|Lost to Follow-up|16|||
48829046|NCT01720446|157215928|FG000|Overall Study|Withdrawal by Subject|2|||
49156108|NCT00586157|158412412|FG001|Second Intervention|Worsening behavior|0|||
49156109|NCT00586157|158412411|FG000|Second Intervention|Adverse Event|0|||
49156110|NCT00586157|158412412|FG001|Second Intervention|Adverse Event|1|||
49156111|NCT04622592|158412413|FG000|Overall Study|Death|0|||
49156112|NCT04622592|158412414|FG001|Overall Study|Death|0|||
49156113|NCT04622592|158412415|FG002|Overall Study|Death|1|||
49156114|NCT04622592|158412416|FG003|Overall Study|Death|0|||
49156115|NCT04622592|158412417|FG004|Overall Study|Death|0|||
49156116|NCT04622592|158412418|FG005|Overall Study|Death|0|||
49156117|NCT04622592|158412419|FG006|Overall Study|Death|0|||
49156118|NCT04622592|158412420|FG007|Overall Study|Death|1|||
49156119|NCT04622592|158412413|FG000|Overall Study|Lost to Follow-up|0|||
49156120|NCT04622592|158412414|FG001|Overall Study|Lost to Follow-up|0|||
49156121|NCT04622592|158412415|FG002|Overall Study|Lost to Follow-up|0|||
49156122|NCT04622592|158412416|FG003|Overall Study|Lost to Follow-up|3|||
49156123|NCT04622592|158412417|FG004|Overall Study|Lost to Follow-up|1|||
49156124|NCT04622592|158412418|FG005|Overall Study|Lost to Follow-up|0|||
49156125|NCT04622592|158412419|FG006|Overall Study|Lost to Follow-up|2|||
49156126|NCT04622592|158412420|FG007|Overall Study|Lost to Follow-up|2|||
49156127|NCT04622592|158412413|FG000|Overall Study|Physician Decision|0|||
49156128|NCT04622592|158412414|FG001|Overall Study|Physician Decision|0|||
49156129|NCT04622592|158412415|FG002|Overall Study|Physician Decision|0|||
49156130|NCT04622592|158412416|FG003|Overall Study|Physician Decision|0|||
49156131|NCT04622592|158412417|FG004|Overall Study|Physician Decision|1|||
49156132|NCT04622592|158412418|FG005|Overall Study|Physician Decision|0|||
49156133|NCT04622592|158412419|FG006|Overall Study|Physician Decision|0|||
49156134|NCT04622592|158412420|FG007|Overall Study|Physician Decision|0|||
49156135|NCT04622592|158412413|FG000|Overall Study|Withdrawal by Subject|1|||
49156136|NCT04622592|158412414|FG001|Overall Study|Withdrawal by Subject|0|||
49156137|NCT04622592|158412415|FG002|Overall Study|Withdrawal by Subject|2|||
48829047|NCT01720446|157215929|FG001|Overall Study|Withdrawal by Subject|5|||
48829048|NCT01720446|157215930|FG002|Overall Study|Withdrawal by Subject|4|||
48829049|NCT01720446|157215931|FG003|Overall Study|Withdrawal by Subject|4|||
48829050|NCT00015457|157215935|FG000|First Intervention|Adverse Event|0|||
48829051|NCT00015457|157215936|FG001|First Intervention|Adverse Event|2|||
48829052|NCT00015457|157215935|FG000|First Intervention|Lack of Efficacy|0|||
48829053|NCT00015457|157215936|FG001|First Intervention|Lack of Efficacy|1|||
48829054|NCT00015457|157215935|FG000|Second Intervention|Withdrawal by Subject|1|||
48829055|NCT00015457|157215936|FG001|Second Intervention|Withdrawal by Subject|0|||
48829056|NCT01027286|157215937|FG000|Overall Study|Unable to Obtain Required Blood Volume|1|||
48829057|NCT01027286|157215938|FG001|Overall Study|Unable to Obtain Required Blood Volume|0|||
48829058|NCT01027286|157215937|FG000|Overall Study|Lost to Follow-up|0|||
48829059|NCT01027286|157215938|FG001|Overall Study|Lost to Follow-up|1|||
48829060|NCT03178201|157215939|FG000|Overall Study|Off study|5|||
48829061|NCT03201809|157215940|FG000|Overall Study|Lost to Follow-up|2|||
48829062|NCT03201809|157215941|FG001|Overall Study|Lost to Follow-up|0|||
48829063|NCT00864682|157215947|FG000|Overall Study|Protocol Violation|2|||
48829064|NCT00864682|157215948|FG001|Overall Study|Protocol Violation|1|||
48829065|NCT00864682|157215949|FG002|Overall Study|Protocol Violation|2|||
49156138|NCT04622592|158412416|FG003|Overall Study|Withdrawal by Subject|0|||
49156139|NCT04622592|158412417|FG004|Overall Study|Withdrawal by Subject|0|||
49156140|NCT04622592|158412418|FG005|Overall Study|Withdrawal by Subject|0|||
49156141|NCT04622592|158412419|FG006|Overall Study|Withdrawal by Subject|1|||
48829066|NCT00545844|157215950|FG000|Overall Study|Lost to Follow-up|9|||
48829067|NCT00545844|157215950|FG000|Overall Study|Protocol Violation|1|||
48829068|NCT00545844|157215950|FG000|Overall Study|Withdrawal by Subject|2|||
48829069|NCT00001575|157215951|FG000|Overall Study|Screening failures-Ph I portion|22|||
48829070|NCT00001575|157215951|FG000|Overall Study|Withdrawn/deaths|23|||
49156142|NCT04622592|158412420|FG007|Overall Study|Withdrawal by Subject|4|||
49156143|NCT04622592|158412413|FG000|Overall Study|Other than specified above|0|||
49156144|NCT04622592|158412414|FG001|Overall Study|Other than specified above|0|||
49156145|NCT04622592|158412415|FG002|Overall Study|Other than specified above|1|||
49156146|NCT04622592|158412416|FG003|Overall Study|Other than specified above|0|||
49156147|NCT04622592|158412417|FG004|Overall Study|Other than specified above|0|||
48829071|NCT01242085|157215952|FG000|Overall Study|Withdrawal by Subject|4|||
48922684|NCT01687712|157550119|FG000|Cycle 1|Miscarriage/Spontaneous Abortion|9|||
48922685|NCT01687712|157550120|FG001|Cycle 1|Miscarriage/Spontaneous Abortion|14|||
48829072|NCT01242085|157215953|FG001|Overall Study|Withdrawal by Subject|2|||
48829073|NCT01242085|157215954|FG002|Overall Study|Withdrawal by Subject|0|||
49156148|NCT04622592|158412418|FG005|Overall Study|Other than specified above|0|||
49156149|NCT04622592|158412419|FG006|Overall Study|Other than specified above|0|||
49156150|NCT04622592|158412420|FG007|Overall Study|Other than specified above|0|||
49156151|NCT04484857|158412421|FG000|Overall Study|Adverse Event|2|||
49156152|NCT04484857|158412421|FG000|Overall Study|Death|10|||
49156153|NCT04484857|158412421|FG000|Overall Study|Withdrawal by Subject|3|||
48829074|NCT01242085|157215952|FG000|Overall Study|medically unable to have surgery|4|||
48922686|NCT01687712|157550119|FG000|Cycle 1|Abortion|3|||
49156154|NCT04484857|158412421|FG000|Overall Study|Transferred/Relocation|5|||
49156155|NCT04484857|158412421|FG000|Overall Study|Kidney Transplant|7|||
48922687|NCT01687712|157550120|FG001|Cycle 1|Abortion|0|||
48922688|NCT01687712|157550119|FG000|Cycle 1|Intrauterine Fetal Death|0|||
49156156|NCT04484857|158412421|FG000|Overall Study|Other than specified|4|||
49156157|NCT04484857|158412421|FG000|Overall Study|Participants continued an Optional Extension of Roxadustat Treatment|216|||
49156158|NCT03663582|158412422|FG000|Overall Study|Physician Decision|1|||
49156159|NCT05201807|158412423|FG000|Overall Study|Adverse Event|1|||
49156160|NCT05201807|158412423|FG000|Overall Study|COVID-19 Related|1|||
49156161|NCT01209767|158412424|FG000|Overall Study|Withdrawal by Subject|1|||
49156162|NCT01209767|158412424|FG000|Overall Study|Lost to Follow-up|3|||
49156163|NCT00278161|158412426|FG000|Overall Study|Death|11|||
49156164|NCT03610048|158412432|FG000|Overall Study|Study terminated by sponsor|84|||
49156165|NCT03610048|158412432|FG000|Overall Study|Adverse Event|32|||
49156166|NCT03610048|158412432|FG000|Overall Study|Withdrawal by Subject|31|||
49156167|NCT03610048|158412432|FG000|Overall Study|Lost to Follow-up|8|||
49156168|NCT03610048|158412432|FG000|Overall Study|Other|4|||
49156169|NCT03610048|158412432|FG000|Overall Study|Physician Decision|1|||
49156170|NCT03610048|158412432|FG000|Overall Study|Pregnancy|1|||
49156171|NCT02743962|158412435|FG000|Overall Study|Atrophic vaginitis diagnosed|1|||
49156172|NCT02743962|158412436|FG001|Overall Study|Atrophic vaginitis diagnosed|0|||
48829075|NCT01242085|157215953|FG001|Overall Study|medically unable to have surgery|5|||
48829076|NCT01242085|157215954|FG002|Overall Study|medically unable to have surgery|0|||
48829077|NCT00094809|157215955|FG000|Overall Study|Protocol deviation|2|||
48829078|NCT00094809|157215956|FG001|Overall Study|Protocol deviation|2|||
48829079|NCT00094809|157215955|FG000|Overall Study|Noncompliance|1|||
48829080|NCT00094809|157215956|FG001|Overall Study|Noncompliance|0|||
48829081|NCT00094809|157215955|FG000|Overall Study|Adverse Event|3|||
48829082|NCT00094809|157215956|FG001|Overall Study|Adverse Event|1|||
48829083|NCT00094809|157215955|FG000|Overall Study|Withdrawal by Subject|8|||
48829084|NCT00094809|157215956|FG001|Overall Study|Withdrawal by Subject|9|||
48829085|NCT00094809|157215955|FG000|Overall Study|Disease progression|3|||
48829086|NCT00094809|157215956|FG001|Overall Study|Disease progression|3|||
48829087|NCT00094809|157215955|FG000|Overall Study|Physician Decision|3|||
48829088|NCT00094809|157215956|FG001|Overall Study|Physician Decision|5|||
48829089|NCT00094809|157215955|FG000|Overall Study|Lost to Follow-up|6|||
48829090|NCT00094809|157215956|FG001|Overall Study|Lost to Follow-up|6|||
48829091|NCT00094809|157215955|FG000|Overall Study|Death|19|||
48829092|NCT00094809|157215956|FG001|Overall Study|Death|25|||
48829093|NCT00094809|157215955|FG000|Overall Study|Protocol-specified criteria|1|||
48829094|NCT00094809|157215956|FG001|Overall Study|Protocol-specified criteria|1|||
48829095|NCT00094809|157215955|FG000|Overall Study|Other|2|||
48829096|NCT00094809|157215956|FG001|Overall Study|Other|4|||
48829097|NCT00094809|157215955|FG000|Overall Study|Informed consent signed after treatment|1|||
48829098|NCT00094809|157215956|FG001|Overall Study|Informed consent signed after treatment|0|||
48829099|NCT00094809|157215955|FG000|Overall Study|Study drug not received|2|||
48829100|NCT00094809|157215956|FG001|Overall Study|Study drug not received|8|||
48829101|NCT00094809|157215955|FG000|Overall Study|Other|1|||
48829102|NCT00094809|157215956|FG001|Overall Study|Other|1|||
48829103|NCT02430532|157215964|FG000|Overall Study|Sponsor Decision to Stop Study Early|30|||
48829104|NCT02430532|157215965|FG001|Overall Study|Sponsor Decision to Stop Study Early|25|||
48829105|NCT02430532|157215964|FG000|Overall Study|Consent Withdrawn|0|||
48829106|NCT02430532|157215965|FG001|Overall Study|Consent Withdrawn|2|||
48829107|NCT02430532|157215964|FG000|Overall Study|Adverse Event|0|||
48829108|NCT02430532|157215965|FG001|Overall Study|Adverse Event|1|||
48829109|NCT02750709|157215966|FG000|Treatment Period 1|Adverse Event|0|||
48829110|NCT02750709|157215967|FG001|Treatment Period 1|Adverse Event|0|||
48829111|NCT02750709|157215968|FG002|Treatment Period 1|Adverse Event|0|||
48829112|NCT02750709|157215969|FG003|Treatment Period 1|Adverse Event|0|||
48829113|NCT02750709|157215970|FG004|Treatment Period 1|Adverse Event|0|||
48829114|NCT02750709|157215971|FG005|Treatment Period 1|Adverse Event|1|||
48829115|NCT03256344|157215972|FG000|Overall Study|Death|6|||
48829116|NCT03256344|157215973|FG001|Overall Study|Death|22|||
48829117|NCT03256344|157215972|FG000|Overall Study|Withdrawal by Subject|3|||
48829118|NCT03256344|157215973|FG001|Overall Study|Withdrawal by Subject|3|||
48829119|NCT03256344|157215972|FG000|Overall Study|Sponsor Decision|1|||
48829120|NCT03256344|157215973|FG001|Overall Study|Sponsor Decision|0|||
48829121|NCT00404079|157215974|FG000|Overall Study|Lost to follow up, adverse event etc|22|||
48829122|NCT00404079|157215975|FG001|Overall Study|Lost to follow up, adverse event etc|20|||
48829123|NCT01120275|157215976|FG000|Overall Study|Adverse Event|3|||
48829124|NCT01120275|157215976|FG000|Overall Study|Progression|27|||
49156173|NCT00806585|158412441|FG000|Overall Study|Study terminated by Sponsor|0|||
48829125|NCT01120275|157215976|FG000|Overall Study|Ineligible|3|||
48829126|NCT01120275|157215976|FG000|Overall Study|Withdrawal by Subject|1|||
48829127|NCT01120275|157215976|FG000|Overall Study|Refusal|1|||
48829128|NCT01120275|157215976|FG000|Overall Study|Not specific|1|||
48829129|NCT04511650|157215982|FG000|Overall Study|Lost to Follow-up|1|||
48829130|NCT04511650|157215983|FG001|Overall Study|Lost to Follow-up|0|||
48829131|NCT04511650|157215984|FG002|Overall Study|Lost to Follow-up|0|||
48922689|NCT01687712|157550120|FG001|Cycle 1|Intrauterine Fetal Death|1|||
49156174|NCT00806585|158412442|FG001|Overall Study|Study terminated by Sponsor|0|||
48829132|NCT04511650|157215982|FG000|Overall Study|Withdrawal by Subject|1|||
48829133|NCT04511650|157215983|FG001|Overall Study|Withdrawal by Subject|0|||
48829134|NCT04511650|157215984|FG002|Overall Study|Withdrawal by Subject|0|||
48829135|NCT04511650|157215982|FG000|Overall Study|reason not provided|0|||
48829136|NCT04511650|157215983|FG001|Overall Study|reason not provided|0|||
48829137|NCT04511650|157215984|FG002|Overall Study|reason not provided|1|||
48829138|NCT04511650|157215982|FG000|Overall Study|Death|1|||
48829139|NCT04511650|157215983|FG001|Overall Study|Death|1|||
48829140|NCT04511650|157215984|FG002|Overall Study|Death|1|||
48829141|NCT02503202|157215986|FG000|Base Study: Up to Month 6|Death|1|||
48829142|NCT02503202|157215987|FG001|Base Study: Up to Month 6|Death|1|||
48829143|NCT02503202|157215988|FG002|Base Study: Up to Month 6|Death|0|||
48829144|NCT02503202|157215989|FG003|Base Study: Up to Month 6|Death|0|||
48829145|NCT02503202|157215990|FG004|Base Study: Up to Month 6|Death|0|||
48829146|NCT02503202|157215986|FG000|Base Study: Up to Month 6|Lost to Follow-up|11|||
48829147|NCT02503202|157215987|FG001|Base Study: Up to Month 6|Lost to Follow-up|8|||
48829148|NCT02503202|157215988|FG002|Base Study: Up to Month 6|Lost to Follow-up|10|||
48829149|NCT02503202|157215989|FG003|Base Study: Up to Month 6|Lost to Follow-up|5|||
48829150|NCT02503202|157215990|FG004|Base Study: Up to Month 6|Lost to Follow-up|1|||
48829151|NCT02503202|157215986|FG000|Base Study: Up to Month 6|Physician Decision|0|||
48829152|NCT02503202|157215987|FG001|Base Study: Up to Month 6|Physician Decision|0|||
48829153|NCT02503202|157215988|FG002|Base Study: Up to Month 6|Physician Decision|0|||
48829154|NCT02503202|157215989|FG003|Base Study: Up to Month 6|Physician Decision|0|||
48829155|NCT02503202|157215990|FG004|Base Study: Up to Month 6|Physician Decision|1|||
48829156|NCT02503202|157215986|FG000|Base Study: Up to Month 6|Withdrawal by Subject|6|||
48829157|NCT02503202|157215987|FG001|Base Study: Up to Month 6|Withdrawal by Subject|3|||
48922690|NCT01687712|157550119|FG000|Cycle 1|Lost to Follow-up|1|||
48829158|NCT02503202|157215988|FG002|Base Study: Up to Month 6|Withdrawal by Subject|4|||
48829159|NCT02503202|157215989|FG003|Base Study: Up to Month 6|Withdrawal by Subject|4|||
48829160|NCT02503202|157215990|FG004|Base Study: Up to Month 6|Withdrawal by Subject|1|||
48922691|NCT01687712|157550120|FG001|Cycle 1|Lost to Follow-up|1|||
48829161|NCT02503202|157215986|FG000|Base Study: Up to Month 6|Randomized not vaccinated|0|||
48829162|NCT02503202|157215987|FG001|Base Study: Up to Month 6|Randomized not vaccinated|0|||
48829163|NCT02503202|157215988|FG002|Base Study: Up to Month 6|Randomized not vaccinated|1|||
48829164|NCT02503202|157215989|FG003|Base Study: Up to Month 6|Randomized not vaccinated|2|||
48829165|NCT02503202|157215990|FG004|Base Study: Up to Month 6|Randomized not vaccinated|0|||
48829166|NCT02503202|157215986|FG000|Extension: Month 6 to 24|Protocol Violation|0|||
48829167|NCT02503202|157215987|FG001|Extension: Month 6 to 24|Protocol Violation|0|||
48829168|NCT02503202|157215988|FG002|Extension: Month 6 to 24|Protocol Violation|0|||
48829169|NCT02503202|157215989|FG003|Extension: Month 6 to 24|Protocol Violation|1|||
48829170|NCT02503202|157215990|FG004|Extension: Month 6 to 24|Protocol Violation|0|||
48829171|NCT02503202|157215986|FG000|Extension: Month 6 to 24|Death|1|||
48829172|NCT02503202|157215987|FG001|Extension: Month 6 to 24|Death|0|||
48829173|NCT02503202|157215988|FG002|Extension: Month 6 to 24|Death|0|||
48829174|NCT02503202|157215989|FG003|Extension: Month 6 to 24|Death|0|||
48829175|NCT02503202|157215990|FG004|Extension: Month 6 to 24|Death|0|||
48829176|NCT02503202|157215986|FG000|Extension: Month 6 to 24|Lost to Follow-up|4|||
48829177|NCT02503202|157215987|FG001|Extension: Month 6 to 24|Lost to Follow-up|8|||
48829178|NCT02503202|157215988|FG002|Extension: Month 6 to 24|Lost to Follow-up|6|||
48829179|NCT02503202|157215989|FG003|Extension: Month 6 to 24|Lost to Follow-up|10|||
48829180|NCT02503202|157215990|FG004|Extension: Month 6 to 24|Lost to Follow-up|1|||
48829181|NCT02503202|157215986|FG000|Extension: Month 6 to 24|Physician Decision|1|||
48829182|NCT02503202|157215987|FG001|Extension: Month 6 to 24|Physician Decision|0|||
48829183|NCT02503202|157215988|FG002|Extension: Month 6 to 24|Physician Decision|1|||
48829184|NCT02503202|157215989|FG003|Extension: Month 6 to 24|Physician Decision|3|||
48829185|NCT02503202|157215990|FG004|Extension: Month 6 to 24|Physician Decision|0|||
48829186|NCT02503202|157215986|FG000|Extension: Month 6 to 24|Withdrawal by Subject|5|||
48829187|NCT02503202|157215987|FG001|Extension: Month 6 to 24|Withdrawal by Subject|8|||
48829188|NCT02503202|157215988|FG002|Extension: Month 6 to 24|Withdrawal by Subject|2|||
48829189|NCT02503202|157215989|FG003|Extension: Month 6 to 24|Withdrawal by Subject|4|||
48829190|NCT02503202|157215990|FG004|Extension: Month 6 to 24|Withdrawal by Subject|0|||
48829191|NCT01549652|157215991|FG000|Overall Study|Did Not Receive Allocated Intervention|0|||
48829192|NCT01549652|157215992|FG001|Overall Study|Did Not Receive Allocated Intervention|0|||
48829193|NCT01549652|157215993|FG002|Overall Study|Did Not Receive Allocated Intervention|2|||
48829194|NCT01549652|157215994|FG003|Overall Study|Did Not Receive Allocated Intervention|0|||
48829195|NCT01549652|157215991|FG000|Overall Study|Study Drug Titration Failure|5|||
48829196|NCT01549652|157215992|FG001|Overall Study|Study Drug Titration Failure|6|||
48829197|NCT01549652|157215993|FG002|Overall Study|Study Drug Titration Failure|0|||
48829198|NCT01549652|157215994|FG003|Overall Study|Study Drug Titration Failure|0|||
48829199|NCT01549652|157215991|FG000|Overall Study|Withdrawal Effect|0|||
48829200|NCT01549652|157215992|FG001|Overall Study|Withdrawal Effect|2|||
48829201|NCT01549652|157215993|FG002|Overall Study|Withdrawal Effect|0|||
48829202|NCT01549652|157215994|FG003|Overall Study|Withdrawal Effect|0|||
48829203|NCT01549652|157215991|FG000|Overall Study|Did Not Return Due to Withdrawal Effect|5|||
48829204|NCT01549652|157215992|FG001|Overall Study|Did Not Return Due to Withdrawal Effect|1|||
48829205|NCT01549652|157215993|FG002|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
48829206|NCT01549652|157215994|FG003|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
48829207|NCT01549652|157215991|FG000|Overall Study|Problem with Infusion|1|||
48829208|NCT01549652|157215992|FG001|Overall Study|Problem with Infusion|0|||
48829209|NCT01549652|157215993|FG002|Overall Study|Problem with Infusion|0|||
48829210|NCT01549652|157215994|FG003|Overall Study|Problem with Infusion|0|||
48829211|NCT01549652|157215991|FG000|Overall Study|Titration Non-Compliance|1|||
48829212|NCT01549652|157215992|FG001|Overall Study|Titration Non-Compliance|3|||
48829213|NCT01549652|157215993|FG002|Overall Study|Titration Non-Compliance|4|||
48829214|NCT01549652|157215994|FG003|Overall Study|Titration Non-Compliance|5|||
48829215|NCT01549652|157215991|FG000|Overall Study|Titration Side Effects|0|||
48829216|NCT01549652|157215992|FG001|Overall Study|Titration Side Effects|0|||
48829217|NCT01549652|157215993|FG002|Overall Study|Titration Side Effects|6|||
48829218|NCT01549652|157215994|FG003|Overall Study|Titration Side Effects|3|||
48829219|NCT01549652|157215991|FG000|Overall Study|Withdrawal by Subject|0|||
48829220|NCT01549652|157215992|FG001|Overall Study|Withdrawal by Subject|0|||
48829221|NCT01549652|157215993|FG002|Overall Study|Withdrawal by Subject|5|||
48829222|NCT01549652|157215994|FG003|Overall Study|Withdrawal by Subject|3|||
48829223|NCT00586339|157215995|FG000|Overall Study|Withdrawal by Subject|1|||
48829224|NCT00586339|157215996|FG001|Overall Study|Withdrawal by Subject|3|||
48829225|NCT00586339|157215997|FG002|Overall Study|Withdrawal by Subject|1|||
48829226|NCT00586339|157215995|FG000|Overall Study|Migrated/moved from study area|3|||
48829227|NCT00586339|157215996|FG001|Overall Study|Migrated/moved from study area|2|||
48829228|NCT00586339|157215997|FG002|Overall Study|Migrated/moved from study area|4|||
48829229|NCT00586339|157215995|FG000|Overall Study|Lost to Follow-up|3|||
48829230|NCT00586339|157215996|FG001|Overall Study|Lost to Follow-up|2|||
48829231|NCT00586339|157215997|FG002|Overall Study|Lost to Follow-up|1|||
48829232|NCT01972152|157215998|FG000|First Treatment Visit|Lost to Follow-up|0|||
48829233|NCT01972152|157215999|FG001|First Treatment Visit|Lost to Follow-up|1|||
48829234|NCT01972152|157216000|FG002|First Treatment Visit|Lost to Follow-up|0|||
48829235|NCT01972152|157216001|FG003|First Treatment Visit|Lost to Follow-up|0|||
48829236|NCT01972152|157216002|FG004|First Treatment Visit|Lost to Follow-up|0|||
48829237|NCT01972152|157216003|FG005|First Treatment Visit|Lost to Follow-up|0|||
48829238|NCT01972152|157215998|FG000|Second Treatment Visit|Protocol Violation|0|||
48829239|NCT01972152|157215999|FG001|Second Treatment Visit|Protocol Violation|1|||
48829240|NCT01972152|157216000|FG002|Second Treatment Visit|Protocol Violation|0|||
48829241|NCT01972152|157216001|FG003|Second Treatment Visit|Protocol Violation|0|||
48829242|NCT01972152|157216002|FG004|Second Treatment Visit|Protocol Violation|0|||
48829243|NCT01972152|157216003|FG005|Second Treatment Visit|Protocol Violation|0|||
48829244|NCT01959412|157216004|FG000|Overall Study|Protocol deviation|1|||
48829245|NCT01959412|157216005|FG001|Overall Study|Protocol deviation|1|||
48829246|NCT01959412|157216006|FG002|Overall Study|Protocol deviation|0|||
48829247|NCT01959412|157216007|FG003|Overall Study|Protocol deviation|1|||
48829248|NCT01959412|157216008|FG004|Overall Study|Protocol deviation|3|||
48829249|NCT01959412|157216009|FG005|Overall Study|Protocol deviation|0|||
48829250|NCT01959412|157216004|FG000|Overall Study|Adverse Event|0|||
48829251|NCT01959412|157216005|FG001|Overall Study|Adverse Event|0|||
48829252|NCT01959412|157216006|FG002|Overall Study|Adverse Event|0|||
48829253|NCT01959412|157216007|FG003|Overall Study|Adverse Event|1|||
48829254|NCT01959412|157216008|FG004|Overall Study|Adverse Event|0|||
48829255|NCT01959412|157216009|FG005|Overall Study|Adverse Event|0|||
48829256|NCT04163458|157216010|FG000|Overall Study|Protocol Deviation|7|||
48829257|NCT04163458|157216011|FG001|Overall Study|Protocol Deviation|13|||
48829258|NCT04163458|157216010|FG000|Overall Study|Adverse Event|5|||
48829259|NCT04163458|157216011|FG001|Overall Study|Adverse Event|8|||
48829260|NCT04163458|157216010|FG000|Overall Study|Due to COVID-19 pandemic|4|||
48829261|NCT04163458|157216011|FG001|Overall Study|Due to COVID-19 pandemic|2|||
48829262|NCT04163458|157216010|FG000|Overall Study|Participant withdrew consent|2|||
48829263|NCT04163458|157216011|FG001|Overall Study|Participant withdrew consent|3|||
48829264|NCT04163458|157216010|FG000|Overall Study|Randomization failure|2|||
48829265|NCT04163458|157216011|FG001|Overall Study|Randomization failure|2|||
48829266|NCT04163458|157216010|FG000|Overall Study|Other|4|||
48829267|NCT04163458|157216011|FG001|Overall Study|Other|2|||
48829268|NCT05487703|157216013|FG000|Overall Study|Other|19|||
48829269|NCT05487703|157216013|FG000|Overall Study|Participant not well|5|||
48829270|NCT05487703|157216013|FG000|Overall Study|Insurance Reasons|6|||
48829271|NCT05487703|157216013|FG000|Overall Study|Physician Decision|19|||
48829272|NCT05487703|157216013|FG000|Overall Study|Lack of Efficacy|60|||
48829273|NCT03631199|157216014|FG000|Overall Study|Progressive disease|9|||
48829274|NCT03631199|157216015|FG001|Overall Study|Progressive disease|5|||
48829275|NCT03631199|157216016|FG002|Overall Study|Progressive disease|5|||
48829276|NCT03631199|157216017|FG003|Overall Study|Progressive disease|149|||
48922692|NCT01687712|157550119|FG000|Cycle 2|Not Biochemically Pregnant|74|||
48829277|NCT03631199|157216018|FG004|Overall Study|Progressive disease|148|||
48829278|NCT03631199|157216014|FG000|Overall Study|Physician Decision|0|||
48829279|NCT03631199|157216015|FG001|Overall Study|Physician Decision|2|||
48829280|NCT03631199|157216016|FG002|Overall Study|Physician Decision|3|||
48829281|NCT03631199|157216017|FG003|Overall Study|Physician Decision|19|||
48829282|NCT03631199|157216018|FG004|Overall Study|Physician Decision|13|||
48829283|NCT03631199|157216014|FG000|Overall Study|Adverse Event|1|||
48829284|NCT03631199|157216015|FG001|Overall Study|Adverse Event|1|||
48829285|NCT03631199|157216016|FG002|Overall Study|Adverse Event|0|||
48829286|NCT03631199|157216017|FG003|Overall Study|Adverse Event|28|||
48829287|NCT03631199|157216018|FG004|Overall Study|Adverse Event|29|||
48829288|NCT03631199|157216014|FG000|Overall Study|Death|0|||
48829289|NCT03631199|157216015|FG001|Overall Study|Death|1|||
48829290|NCT03631199|157216016|FG002|Overall Study|Death|0|||
48829291|NCT03631199|157216017|FG003|Overall Study|Death|35|||
48829292|NCT03631199|157216018|FG004|Overall Study|Death|48|||
48829293|NCT03631199|157216014|FG000|Overall Study|Subject decision|0|||
48829294|NCT03631199|157216015|FG001|Overall Study|Subject decision|1|||
48829295|NCT03631199|157216016|FG002|Overall Study|Subject decision|0|||
48829296|NCT03631199|157216017|FG003|Overall Study|Subject decision|12|||
48829297|NCT03631199|157216018|FG004|Overall Study|Subject decision|12|||
48829298|NCT03631199|157216014|FG000|Overall Study|No treated|0|||
48829299|NCT03631199|157216015|FG001|Overall Study|No treated|0|||
48829300|NCT03631199|157216016|FG002|Overall Study|No treated|0|||
48829301|NCT03631199|157216017|FG003|Overall Study|No treated|0|||
48829302|NCT03631199|157216018|FG004|Overall Study|No treated|1|||
48829303|NCT03631199|157216014|FG000|Overall Study|Treatment ongoing|0|||
48829304|NCT03631199|157216015|FG001|Overall Study|Treatment ongoing|1|||
48829305|NCT03631199|157216016|FG002|Overall Study|Treatment ongoing|1|||
48829306|NCT03631199|157216017|FG003|Overall Study|Treatment ongoing|76|||
48829307|NCT03631199|157216018|FG004|Overall Study|Treatment ongoing|71|||
48829308|NCT03631199|157216014|FG000|Overall Study|Guardian decision|0|||
48829309|NCT03631199|157216015|FG001|Overall Study|Guardian decision|0|||
48829310|NCT03631199|157216016|FG002|Overall Study|Guardian decision|0|||
48829311|NCT03631199|157216017|FG003|Overall Study|Guardian decision|1|||
48829312|NCT03631199|157216018|FG004|Overall Study|Guardian decision|1|||
48829313|NCT03310983|157216019|FG000|Overall Study|Lost to Follow-up|15|||
48829314|NCT03310983|157216020|FG001|Overall Study|Lost to Follow-up|17|||
48829315|NCT03368001|157216022|FG000|Allocation|Lost to Pretest|16|||
48829316|NCT03368001|157216023|FG001|Allocation|Lost to Pretest|25|||
48829317|NCT03368001|157216022|FG000|Allocation|Completed Pretest but 0 Intervention sessions|8|||
48829318|NCT03368001|157216023|FG001|Allocation|Completed Pretest but 0 Intervention sessions|9|||
48829319|NCT03368001|157216022|FG000|Posttest|Lost to Posttest|7|||
48829320|NCT03368001|157216023|FG001|Posttest|Lost to Posttest|11|||
48829321|NCT03368001|157216022|FG000|Posttest|Discontinued Intervention|6|||
48829322|NCT03368001|157216023|FG001|Posttest|Discontinued Intervention|19|||
48829323|NCT03368001|157216022|FG000|Follow-up|Lost to Follow-up|6|||
48829324|NCT03368001|157216023|FG001|Follow-up|Lost to Follow-up|3|||
48829325|NCT01656304|157216024|FG000|Overall Study|Ineligible, uncontrolled hypertension|1|||
48829326|NCT02824432|157216025|FG000|Overall Study|Major Protocol Deviation|1|||
48829327|NCT02824432|157216026|FG001|Overall Study|Major Protocol Deviation|0|||
48829328|NCT04436120|157216027|FG000|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
48829329|NCT04436120|157216028|FG001|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
48829330|NCT04436120|157216029|FG002|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
48829331|NCT04436120|157216030|FG003|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
48829332|NCT04436120|157216031|FG004|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
48829333|NCT04436120|157216032|FG005|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
48829334|NCT04436120|157216033|FG006|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
48829335|NCT01068249|157216034|FG000|Overall Study|Death|1|||
48829336|NCT01068249|157216034|FG000|Overall Study|Withdrawal by Subject|3|||
48829337|NCT03822351|157216035|FG000|Overall Study|Death|27|||
48829338|NCT03822351|157216036|FG001|Overall Study|Death|23|||
48829339|NCT03822351|157216037|FG002|Overall Study|Death|24|||
48829340|NCT03822351|157216035|FG000|Overall Study|Lost to Follow-up|6|||
48829341|NCT03822351|157216036|FG001|Overall Study|Lost to Follow-up|2|||
48829342|NCT03822351|157216037|FG002|Overall Study|Lost to Follow-up|1|||
48829343|NCT03822351|157216035|FG000|Overall Study|Withdrawal by Subject|10|||
48829344|NCT03822351|157216036|FG001|Overall Study|Withdrawal by Subject|4|||
49156175|NCT00806585|158412443|FG002|Overall Study|Study terminated by Sponsor|1|||
49156176|NCT00806585|158412444|FG003|Overall Study|Study terminated by Sponsor|2|||
49156177|NCT00806585|158412445|FG004|Overall Study|Study terminated by Sponsor|0|||
48829345|NCT03822351|157216037|FG002|Overall Study|Withdrawal by Subject|6|||
48829346|NCT03822351|157216035|FG000|Overall Study|Progressive Disease|2|||
48829347|NCT03822351|157216036|FG001|Overall Study|Progressive Disease|1|||
48829348|NCT03822351|157216037|FG002|Overall Study|Progressive Disease|0|||
48829349|NCT03822351|157216035|FG000|Overall Study|Not Treated|1|||
48829350|NCT03822351|157216036|FG001|Overall Study|Not Treated|1|||
48829351|NCT03822351|157216037|FG002|Overall Study|Not Treated|1|||
48829352|NCT01311713|157216038|FG000|Overall Study|Death|0|||
48829353|NCT01311713|157216039|FG001|Overall Study|Death|0|||
48829354|NCT01311713|157216040|FG002|Overall Study|Death|1|||
49156178|NCT00806585|158412441|FG000|Overall Study|Protocol Violation|3|||
48829355|NCT01311713|157216041|FG003|Overall Study|Death|1|||
48829356|NCT01311713|157216042|FG004|Overall Study|Death|0|||
48829357|NCT01311713|157216043|FG005|Overall Study|Death|1|||
48829358|NCT01311713|157216044|FG006|Overall Study|Death|0|||
48829359|NCT01311713|157216038|FG000|Overall Study|Adverse Event|0|||
48829360|NCT01311713|157216039|FG001|Overall Study|Adverse Event|1|||
48829361|NCT01311713|157216040|FG002|Overall Study|Adverse Event|0|||
48829362|NCT01311713|157216041|FG003|Overall Study|Adverse Event|2|||
48829363|NCT01311713|157216042|FG004|Overall Study|Adverse Event|0|||
48829364|NCT01311713|157216043|FG005|Overall Study|Adverse Event|0|||
49156179|NCT00806585|158412442|FG001|Overall Study|Protocol Violation|1|||
49156180|NCT00806585|158412443|FG002|Overall Study|Protocol Violation|2|||
49156181|NCT00806585|158412444|FG003|Overall Study|Protocol Violation|0|||
49156182|NCT00806585|158412445|FG004|Overall Study|Protocol Violation|0|||
49156183|NCT00806585|158412441|FG000|Overall Study|Physician Decision|0|||
49156184|NCT00806585|158412442|FG001|Overall Study|Physician Decision|2|||
49156185|NCT00806585|158412443|FG002|Overall Study|Physician Decision|3|||
49156186|NCT00806585|158412444|FG003|Overall Study|Physician Decision|0|||
49156187|NCT00806585|158412445|FG004|Overall Study|Physician Decision|1|||
49156188|NCT00806585|158412441|FG000|Overall Study|Lost to Follow-up|2|||
49156189|NCT00806585|158412442|FG001|Overall Study|Lost to Follow-up|1|||
49156190|NCT00806585|158412443|FG002|Overall Study|Lost to Follow-up|2|||
49156191|NCT00806585|158412444|FG003|Overall Study|Lost to Follow-up|2|||
49156192|NCT00806585|158412445|FG004|Overall Study|Lost to Follow-up|5|||
49156193|NCT00806585|158412441|FG000|Overall Study|Lack of Efficacy|1|||
49156194|NCT00806585|158412442|FG001|Overall Study|Lack of Efficacy|0|||
49156195|NCT00806585|158412443|FG002|Overall Study|Lack of Efficacy|0|||
49156196|NCT00806585|158412444|FG003|Overall Study|Lack of Efficacy|0|||
49156197|NCT00806585|158412445|FG004|Overall Study|Lack of Efficacy|0|||
49156198|NCT00806585|158412441|FG000|Overall Study|Adverse Event|1|||
49156199|NCT00806585|158412442|FG001|Overall Study|Adverse Event|5|||
49156200|NCT00806585|158412443|FG002|Overall Study|Adverse Event|3|||
49156201|NCT00806585|158412444|FG003|Overall Study|Adverse Event|4|||
49156202|NCT00806585|158412445|FG004|Overall Study|Adverse Event|2|||
49156203|NCT00806585|158412441|FG000|Overall Study|Withdrawal by Subject|10|||
49156204|NCT00806585|158412442|FG001|Overall Study|Withdrawal by Subject|8|||
49156205|NCT00806585|158412443|FG002|Overall Study|Withdrawal by Subject|9|||
49156206|NCT00806585|158412444|FG003|Overall Study|Withdrawal by Subject|3|||
49156207|NCT00806585|158412445|FG004|Overall Study|Withdrawal by Subject|11|||
49156208|NCT00806585|158412441|FG000|Overall Study|Completion status unknown|15|||
49156209|NCT00806585|158412442|FG001|Overall Study|Completion status unknown|14|||
49156210|NCT00806585|158412443|FG002|Overall Study|Completion status unknown|12|||
49156211|NCT00806585|158412444|FG003|Overall Study|Completion status unknown|4|||
49156212|NCT00806585|158412445|FG004|Overall Study|Completion status unknown|12|||
49156213|NCT01936831|158412446|FG000|Step 2: Arm Randomization|Withdrawal by Subject|0|||
49156214|NCT01936831|158412447|FG001|Step 2: Arm Randomization|Withdrawal by Subject|0|||
49156215|NCT01936831|158412448|FG002|Step 2: Arm Randomization|Withdrawal by Subject|0|||
49156216|NCT01936831|158412449|FG003|Step 2: Arm Randomization|Withdrawal by Subject|0|||
49156217|NCT01936831|158412450|FG004|Step 2: Arm Randomization|Withdrawal by Subject|0|||
49156218|NCT01936831|158412451|FG005|Step 2: Arm Randomization|Withdrawal by Subject|1|||
49156219|NCT01936831|158412452|FG006|Step 2: Arm Randomization|Withdrawal by Subject|0|||
49156220|NCT01936831|158412453|FG007|Step 2: Arm Randomization|Withdrawal by Subject|0|||
49156221|NCT01936831|158412454|FG008|Step 2: Arm Randomization|Withdrawal by Subject|0|||
49156222|NCT03435380|158412455|FG000|Overall Study|Death|1|||
49156223|NCT03435380|158412456|FG001|Overall Study|Death|2|||
49156224|NCT03435380|158412457|FG002|Overall Study|Death|1|||
49156225|NCT03435380|158412455|FG000|Overall Study|Lost to Follow-up|12|||
49156226|NCT03435380|158412456|FG001|Overall Study|Lost to Follow-up|8|||
49156227|NCT03435380|158412457|FG002|Overall Study|Lost to Follow-up|6|||
49156228|NCT03435380|158412455|FG000|Overall Study|Physician Decision|1|||
49156229|NCT03435380|158412456|FG001|Overall Study|Physician Decision|0|||
49156230|NCT03435380|158412457|FG002|Overall Study|Physician Decision|0|||
49156231|NCT03435380|158412455|FG000|Overall Study|Withdrawal by Subject|0|||
49156232|NCT03435380|158412456|FG001|Overall Study|Withdrawal by Subject|1|||
49156233|NCT03435380|158412457|FG002|Overall Study|Withdrawal by Subject|1|||
49156234|NCT03435380|158412455|FG000|Overall Study|Ineligible|0|||
49156235|NCT03435380|158412456|FG001|Overall Study|Ineligible|1|||
49156236|NCT03435380|158412457|FG002|Overall Study|Ineligible|1|||
49156237|NCT01170663|158412458|FG000|Overall Study|Lost to Follow-up|3|||
49156238|NCT01170663|158412459|FG001|Overall Study|Lost to Follow-up|9|||
49156239|NCT01170663|158412458|FG000|Overall Study|Withdrawal of consent without follow-up|11|||
49156240|NCT01170663|158412459|FG001|Overall Study|Withdrawal of consent without follow-up|11|||
49156241|NCT00744861|158412462|FG000|Feasibility Stage 1|Withdrawal by Subject|1|||
49156242|NCT00744861|158412463|FG001|Feasibility Stage 1|Withdrawal by Subject|1|||
49156243|NCT00744861|158412464|FG002|Feasibility Stage 1|Withdrawal by Subject|0|||
49156244|NCT00744861|158412465|FG003|Feasibility Stage 1|Withdrawal by Subject|0|||
49156245|NCT00744861|158412462|FG000|Feasibility Stage 1|Pregnancy|0|||
49156246|NCT00744861|158412463|FG001|Feasibility Stage 1|Pregnancy|1|||
49156247|NCT00744861|158412464|FG002|Feasibility Stage 1|Pregnancy|0|||
49156248|NCT00744861|158412465|FG003|Feasibility Stage 1|Pregnancy|0|||
49156249|NCT00744861|158412462|FG000|Pivotal Stage 2|Adverse Event|0|||
48829365|NCT01311713|157216044|FG006|Overall Study|Adverse Event|2|||
49156250|NCT00744861|158412463|FG001|Pivotal Stage 2|Adverse Event|0|||
49156251|NCT00744861|158412464|FG002|Pivotal Stage 2|Adverse Event|6|||
49156252|NCT00744861|158412465|FG003|Pivotal Stage 2|Adverse Event|11|||
49156253|NCT00744861|158412462|FG000|Pivotal Stage 2|Death|0|||
48829366|NCT01311713|157216038|FG000|Overall Study|Withdrawal by Subject|0|||
48829367|NCT01311713|157216039|FG001|Overall Study|Withdrawal by Subject|1|||
48829368|NCT01311713|157216040|FG002|Overall Study|Withdrawal by Subject|1|||
48829369|NCT01311713|157216041|FG003|Overall Study|Withdrawal by Subject|0|||
48829370|NCT01311713|157216042|FG004|Overall Study|Withdrawal by Subject|0|||
48829371|NCT01311713|157216043|FG005|Overall Study|Withdrawal by Subject|1|||
48829372|NCT01311713|157216044|FG006|Overall Study|Withdrawal by Subject|2|||
48829373|NCT01311713|157216038|FG000|Overall Study|Disease progression|3|||
48829374|NCT01311713|157216039|FG001|Overall Study|Disease progression|4|||
48829375|NCT01311713|157216040|FG002|Overall Study|Disease progression|3|||
48829376|NCT01311713|157216041|FG003|Overall Study|Disease progression|2|||
48829377|NCT01311713|157216042|FG004|Overall Study|Disease progression|4|||
48829378|NCT01311713|157216043|FG005|Overall Study|Disease progression|4|||
48829379|NCT01311713|157216044|FG006|Overall Study|Disease progression|5|||
48829380|NCT01311713|157216038|FG000|Overall Study|Lost to Follow-up|0|||
48829381|NCT01311713|157216039|FG001|Overall Study|Lost to Follow-up|0|||
48829382|NCT01311713|157216040|FG002|Overall Study|Lost to Follow-up|1|||
48829383|NCT01311713|157216041|FG003|Overall Study|Lost to Follow-up|0|||
48829384|NCT01311713|157216042|FG004|Overall Study|Lost to Follow-up|0|||
48829385|NCT01311713|157216043|FG005|Overall Study|Lost to Follow-up|0|||
48829386|NCT01311713|157216044|FG006|Overall Study|Lost to Follow-up|0|||
48829387|NCT01311713|157216038|FG000|Overall Study|Stopped taking study medication|0|||
48829388|NCT01311713|157216039|FG001|Overall Study|Stopped taking study medication|0|||
48829389|NCT01311713|157216040|FG002|Overall Study|Stopped taking study medication|0|||
48829390|NCT01311713|157216041|FG003|Overall Study|Stopped taking study medication|1|||
48829391|NCT01311713|157216042|FG004|Overall Study|Stopped taking study medication|1|||
48829392|NCT01311713|157216043|FG005|Overall Study|Stopped taking study medication|0|||
48829393|NCT01311713|157216044|FG006|Overall Study|Stopped taking study medication|0|||
48829394|NCT01311713|157216038|FG000|Overall Study|Enrolled but not treated|0|||
48829395|NCT01311713|157216039|FG001|Overall Study|Enrolled but not treated|0|||
48829396|NCT01311713|157216040|FG002|Overall Study|Enrolled but not treated|1|||
48829397|NCT01311713|157216041|FG003|Overall Study|Enrolled but not treated|0|||
48829398|NCT01311713|157216042|FG004|Overall Study|Enrolled but not treated|0|||
48829399|NCT01311713|157216043|FG005|Overall Study|Enrolled but not treated|0|||
48829400|NCT01311713|157216044|FG006|Overall Study|Enrolled but not treated|0|||
48829401|NCT01311713|157216038|FG000|Overall Study|Other than specified|0|||
48829402|NCT01311713|157216039|FG001|Overall Study|Other than specified|1|||
48829403|NCT01311713|157216040|FG002|Overall Study|Other than specified|2|||
48829404|NCT01311713|157216041|FG003|Overall Study|Other than specified|0|||
48829405|NCT01311713|157216042|FG004|Overall Study|Other than specified|0|||
48829406|NCT01311713|157216043|FG005|Overall Study|Other than specified|0|||
48829407|NCT01311713|157216044|FG006|Overall Study|Other than specified|0|||
48829408|NCT01560949|157216045|FG000|Systemic Phase: mFOLFIRINOX|Adverse Event|6|||
48829409|NCT01560949|157216045|FG000|Surgery Phase|Physician Decision|3|||
48829410|NCT05526911|157217448|FG000|Overall Study|Adverse Event|2|||
48829411|NCT00946114|157217454|FG000|Overall Study|Death|5|||
48829412|NCT00946114|157217455|FG001|Overall Study|Death|2|||
48829413|NCT00946114|157217454|FG000|Overall Study|Other|1|||
48829414|NCT00946114|157217455|FG001|Overall Study|Other|0|||
48829415|NCT00946114|157217454|FG000|Overall Study|Withdrawal by Subject|2|||
48829416|NCT00946114|157217455|FG001|Overall Study|Withdrawal by Subject|0|||
48829417|NCT02380742|157217456|FG000|Overall Study|Withdrawal by Subject|1|||
48829418|NCT02380742|157217457|FG001|Overall Study|Withdrawal by Subject|0|||
49014524|NCT01309919|157888901|FG000|Overall Study|Did not receive a postpartum IUD|17|||
49014525|NCT01309919|157888902|FG001|Overall Study|Did not receive a postpartum IUD|48|||
49014526|NCT00979628|157888903|FG000|Overall Study|received regimen < 24 hours|7|||
49014527|NCT00979628|157888904|FG001|Overall Study|received regimen < 24 hours|6|||
49014528|NCT00979628|157888905|FG002|Overall Study|received regimen < 24 hours|5|||
49014529|NCT00979628|157888903|FG000|Overall Study|received steroids|1|||
49014530|NCT00979628|157888904|FG001|Overall Study|received steroids|1|||
49014531|NCT00979628|157888905|FG002|Overall Study|received steroids|0|||
49014532|NCT00979628|157888903|FG000|Overall Study|transferred to ICU|1|||
49014533|NCT00979628|157888904|FG001|Overall Study|transferred to ICU|2|||
49014534|NCT00979628|157888905|FG002|Overall Study|transferred to ICU|1|||
49014535|NCT03896490|157888906|FG000|Overall Study|Withdrawal by Subject|1|||
49014536|NCT03896490|157888907|FG001|Overall Study|Withdrawal by Subject|1|||
49014537|NCT00634179|157888914|FG000|Phase II: Maintenance|Diagnosis changed after re-review|1|||
49014538|NCT00767325|157888915|FG000|Overall Study|Lack of Efficacy|2|||
49014539|NCT00767325|157888915|FG000|Overall Study|Adverse Event|7|||
49014540|NCT00767325|157888915|FG000|Overall Study|Lost to Follow-up|3|||
49014541|NCT00767325|157888915|FG000|Overall Study|No longer met study criteria|2|||
49014542|NCT00767325|157888915|FG000|Overall Study|Missed visit due to family reasons|1|||
49014543|NCT03538756|157888916|FG000|Long-Term Follow-up|Adverse Event|0|||
49014544|NCT03538756|157888917|FG001|Long-Term Follow-up|Adverse Event|0|||
49014545|NCT03538756|157888918|FG002|Long-Term Follow-up|Adverse Event|6|||
49014546|NCT03538756|157888916|FG000|Long-Term Follow-up|Death|0|||
49014547|NCT03538756|157888917|FG001|Long-Term Follow-up|Death|0|||
49156254|NCT00744861|158412463|FG001|Pivotal Stage 2|Death|0|||
49156255|NCT00744861|158412464|FG002|Pivotal Stage 2|Death|0|||
49156256|NCT00744861|158412465|FG003|Pivotal Stage 2|Death|1|||
49156257|NCT00744861|158412462|FG000|Pivotal Stage 2|Lost to Follow-up|0|||
49156258|NCT00744861|158412463|FG001|Pivotal Stage 2|Lost to Follow-up|0|||
49156259|NCT00744861|158412464|FG002|Pivotal Stage 2|Lost to Follow-up|13|||
49156260|NCT00744861|158412465|FG003|Pivotal Stage 2|Lost to Follow-up|14|||
49156261|NCT00744861|158412462|FG000|Pivotal Stage 2|Physician Decision|0|||
49156262|NCT00744861|158412463|FG001|Pivotal Stage 2|Physician Decision|0|||
49156263|NCT00744861|158412464|FG002|Pivotal Stage 2|Physician Decision|3|||
49156264|NCT00744861|158412465|FG003|Pivotal Stage 2|Physician Decision|1|||
49156265|NCT00744861|158412462|FG000|Pivotal Stage 2|Protocol Violation|0|||
49156266|NCT00744861|158412463|FG001|Pivotal Stage 2|Protocol Violation|0|||
49156267|NCT00744861|158412464|FG002|Pivotal Stage 2|Protocol Violation|0|||
49156268|NCT00744861|158412465|FG003|Pivotal Stage 2|Protocol Violation|1|||
49156269|NCT00744861|158412462|FG000|Pivotal Stage 2|Withdrawal by Subject|0|||
49156270|NCT00744861|158412463|FG001|Pivotal Stage 2|Withdrawal by Subject|0|||
49156271|NCT00744861|158412464|FG002|Pivotal Stage 2|Withdrawal by Subject|20|||
49156272|NCT00744861|158412465|FG003|Pivotal Stage 2|Withdrawal by Subject|14|||
49156273|NCT00744861|158412462|FG000|Pivotal Stage 2|Study Terminated by Sponsor|0|||
49156274|NCT00744861|158412463|FG001|Pivotal Stage 2|Study Terminated by Sponsor|0|||
49156275|NCT00744861|158412464|FG002|Pivotal Stage 2|Study Terminated by Sponsor|60|||
49156276|NCT00744861|158412465|FG003|Pivotal Stage 2|Study Terminated by Sponsor|63|||
49156277|NCT01561976|158412466|FG000|Period 1|Adverse Event|0|||
49156278|NCT01561976|158412467|FG001|Period 1|Adverse Event|0|||
49156279|NCT01561976|158412468|FG002|Period 1|Adverse Event|1|||
49156280|NCT01561976|158412469|FG003|Period 1|Adverse Event|0|||
49156281|NCT01561976|158412470|FG004|Period 1|Adverse Event|0|||
49156282|NCT01561976|158412471|FG005|Period 1|Adverse Event|0|||
49156283|NCT01561976|158412466|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
49156284|NCT01561976|158412467|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
49156285|NCT01561976|158412468|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
49156286|NCT01561976|158412469|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
49156287|NCT01561976|158412470|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
49156288|NCT01561976|158412471|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
49156289|NCT01561976|158412466|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
49156290|NCT01561976|158412467|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
49156291|NCT01561976|158412468|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
49156292|NCT01561976|158412469|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
49156293|NCT01561976|158412470|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
49156294|NCT01561976|158412471|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
49156295|NCT01561976|158412466|FG000|Washout Period 2 (7 Days)|Non-compliance|1|||
49156296|NCT01561976|158412467|FG001|Washout Period 2 (7 Days)|Non-compliance|0|||
49156297|NCT01561976|158412468|FG002|Washout Period 2 (7 Days)|Non-compliance|1|||
49156298|NCT01561976|158412469|FG003|Washout Period 2 (7 Days)|Non-compliance|0|||
49156299|NCT01561976|158412470|FG004|Washout Period 2 (7 Days)|Non-compliance|0|||
49156300|NCT01561976|158412471|FG005|Washout Period 2 (7 Days)|Non-compliance|0|||
49156301|NCT01307449|158412472|FG000|Overall Study|Adverse Event|1|||
49156302|NCT01307449|158412473|FG001|Overall Study|Adverse Event|0|||
49156303|NCT01307449|158412474|FG002|Overall Study|Adverse Event|0|||
49156304|NCT01307449|158412475|FG003|Overall Study|Adverse Event|0|||
49156305|NCT03412929|158412478|FG000|Overall Study|Protocol Violation|3|||
49156306|NCT01493414|158412479|FG000|Overall Study|Adverse Event|405|||
49156307|NCT01493414|158412479|FG000|Overall Study|Disease progression|204|||
49156308|NCT01493414|158412479|FG000|Overall Study|Death|101|||
49156309|NCT01493414|158412479|FG000|Overall Study|Physician Decision|93|||
49156310|NCT01493414|158412479|FG000|Overall Study|Withdrawal by Subject|79|||
49156311|NCT01493414|158412479|FG000|Overall Study|Protocol deviation|27|||
48829419|NCT02955069|157217461|FG000|Overall Study|Adverse Event|7|||
48829420|NCT02955069|157217462|FG001|Overall Study|Adverse Event|2|||
48829421|NCT02955069|157217461|FG000|Overall Study|Death|7|||
48829422|NCT02955069|157217462|FG001|Overall Study|Death|3|||
48829423|NCT02955069|157217461|FG000|Overall Study|Physician Decision|10|||
48829424|NCT02955069|157217462|FG001|Overall Study|Physician Decision|2|||
48829425|NCT02955069|157217461|FG000|Overall Study|Progressive disease|64|||
48829426|NCT02955069|157217462|FG001|Overall Study|Progressive disease|13|||
48829427|NCT02955069|157217461|FG000|Overall Study|Study terminated by sponsor|4|||
48829428|NCT02955069|157217462|FG001|Overall Study|Study terminated by sponsor|0|||
48829429|NCT02955069|157217461|FG000|Overall Study|Subject/Guardian decision|3|||
48829430|NCT02955069|157217462|FG001|Overall Study|Subject/Guardian decision|1|||
48829431|NCT01149681|157217464|FG000|Overall Study|Withdrawal by Subject|7|||
48829432|NCT01149681|157217464|FG000|Overall Study|Progressive disease|1|||
48829433|NCT01149681|157217464|FG000|Overall Study|Physician Decision|2|||
48829434|NCT01149681|157217464|FG000|Overall Study|adverse events nonrelated study drug|2|||
49156312|NCT01493414|158412479|FG000|Overall Study|Administrative problems|25|||
48829435|NCT02232178|157217465|FG000|Overall Study|Lost to Follow-up|0|||
49156313|NCT01493414|158412479|FG000|Overall Study|Lost to Follow-up|16|||
49156314|NCT05104476|158412480|FG000|Overall Study|Randomized But Not Treated|1|||
49156315|NCT05104476|158412481|FG001|Overall Study|Randomized But Not Treated|2|||
49156316|NCT05104476|158412480|FG000|Overall Study|Adverse Event|2|||
49156317|NCT05104476|158412481|FG001|Overall Study|Adverse Event|2|||
49156318|NCT05104476|158412480|FG000|Overall Study|Withdrawal by Subject|3|||
48829436|NCT02232178|157217466|FG001|Overall Study|Lost to Follow-up|1|||
48829437|NCT02232178|157217467|FG002|Overall Study|Lost to Follow-up|0|||
48829438|NCT02232178|157217465|FG000|Overall Study|ineligibility|0|||
48829439|NCT02232178|157217466|FG001|Overall Study|ineligibility|0|||
48829440|NCT02232178|157217467|FG002|Overall Study|ineligibility|1|||
48829441|NCT02232178|157217465|FG000|Overall Study|surgical complication|1|||
48829442|NCT02232178|157217466|FG001|Overall Study|surgical complication|0|||
48829443|NCT02232178|157217467|FG002|Overall Study|surgical complication|0|||
48829444|NCT03357341|157217468|FG000|Overall Study|Withdrawal by Subject|3|||
48829445|NCT03357341|157217469|FG001|Overall Study|Withdrawal by Subject|6|||
48829446|NCT03357341|157217468|FG000|Overall Study|Lost to Follow-up|4|||
48829447|NCT03357341|157217469|FG001|Overall Study|Lost to Follow-up|5|||
48829448|NCT03357341|157217468|FG000|Overall Study|Death|0|||
48829449|NCT03357341|157217469|FG001|Overall Study|Death|1|||
48829450|NCT03107611|157217470|FG000|Overall Study|Adverse Event|1|||
48829451|NCT03107611|157217471|FG001|Overall Study|Adverse Event|0|||
48829452|NCT03107611|157217472|FG002|Overall Study|Adverse Event|2|||
48829453|NCT03107611|157217470|FG000|Overall Study|Lost to Follow-up|3|||
48829454|NCT03107611|157217471|FG001|Overall Study|Lost to Follow-up|3|||
48829455|NCT03107611|157217472|FG002|Overall Study|Lost to Follow-up|3|||
48829456|NCT03107611|157217470|FG000|Overall Study|Protocol Violation|0|||
48829457|NCT03107611|157217471|FG001|Overall Study|Protocol Violation|0|||
48829458|NCT03107611|157217472|FG002|Overall Study|Protocol Violation|1|||
48829459|NCT03107611|157217470|FG000|Overall Study|Withdrawal by Subject|1|||
48829460|NCT03107611|157217471|FG001|Overall Study|Withdrawal by Subject|0|||
49156319|NCT05104476|158412481|FG001|Overall Study|Withdrawal by Subject|3|||
49156320|NCT05104476|158412480|FG000|Overall Study|Other Than Specified|0|||
49156321|NCT05104476|158412481|FG001|Overall Study|Other Than Specified|3|||
49156322|NCT03605693|158412484|FG000|Overall Study|Lost to Follow-up|4|||
49156323|NCT03605693|158412485|FG001|Overall Study|Lost to Follow-up|0|||
49156324|NCT03605693|158412484|FG000|Overall Study|Physician Decision|1|||
49156325|NCT03605693|158412485|FG001|Overall Study|Physician Decision|0|||
49156326|NCT03498716|158412486|FG000|Overall Study|Withdrawal by Subject|88|||
49156327|NCT03498716|158412487|FG001|Overall Study|Withdrawal by Subject|73|||
49156328|NCT03498716|158412486|FG000|Overall Study|Study Terminated By Sponsor|933|||
49156329|NCT03498716|158412487|FG001|Overall Study|Study Terminated By Sponsor|927|||
49156330|NCT03498716|158412486|FG000|Overall Study|Lost to Follow-up|15|||
49156331|NCT03498716|158412487|FG001|Overall Study|Lost to Follow-up|26|||
48829461|NCT03107611|157217472|FG002|Overall Study|Withdrawal by Subject|1|||
48829462|NCT03107611|157217470|FG000|Overall Study|Worsening signs/symptoms|2|||
48829463|NCT03107611|157217471|FG001|Overall Study|Worsening signs/symptoms|1|||
48829464|NCT03107611|157217472|FG002|Overall Study|Worsening signs/symptoms|2|||
48829465|NCT03635112|157217473|FG000|Overall Study|Adverse Event|5|||
48829466|NCT03635112|157217474|FG001|Overall Study|Adverse Event|9|||
48829467|NCT03635112|157217475|FG002|Overall Study|Adverse Event|14|||
48829468|NCT03635112|157217473|FG000|Overall Study|Lost to Follow-up|1|||
48829469|NCT03635112|157217474|FG001|Overall Study|Lost to Follow-up|0|||
48829470|NCT03635112|157217475|FG002|Overall Study|Lost to Follow-up|1|||
48829471|NCT03635112|157217473|FG000|Overall Study|Physician Decision|5|||
48829472|NCT03635112|157217474|FG001|Overall Study|Physician Decision|7|||
48829473|NCT03635112|157217475|FG002|Overall Study|Physician Decision|5|||
48829474|NCT03635112|157217473|FG000|Overall Study|Protocol Violation|0|||
48829475|NCT03635112|157217474|FG001|Overall Study|Protocol Violation|0|||
48829476|NCT03635112|157217475|FG002|Overall Study|Protocol Violation|1|||
48829477|NCT03635112|157217473|FG000|Overall Study|Study Terminated by Sponsor|11|||
48829478|NCT03635112|157217474|FG001|Overall Study|Study Terminated by Sponsor|17|||
48829479|NCT03635112|157217475|FG002|Overall Study|Study Terminated by Sponsor|21|||
48829480|NCT03635112|157217473|FG000|Overall Study|Withdrawal by Subject|4|||
48829481|NCT03635112|157217474|FG001|Overall Study|Withdrawal by Subject|9|||
48829482|NCT03635112|157217475|FG002|Overall Study|Withdrawal by Subject|7|||
48829483|NCT03635112|157217473|FG000|Overall Study|Miscellaneous|0|||
48829484|NCT03635112|157217474|FG001|Overall Study|Miscellaneous|0|||
48829485|NCT03635112|157217475|FG002|Overall Study|Miscellaneous|1|||
49156332|NCT03498716|158412486|FG000|Overall Study|Disease Relapse|0|||
48829486|NCT00930813|157217476|FG000|Overall Study|Death|4|||
48829487|NCT00930813|157217477|FG001|Overall Study|Death|5|||
48829488|NCT00930813|157217476|FG000|Overall Study|Withdrawal by Subject|2|||
48829489|NCT00930813|157217477|FG001|Overall Study|Withdrawal by Subject|5|||
48829490|NCT00930813|157217476|FG000|Overall Study|Lost to Follow-up|2|||
48829491|NCT00930813|157217477|FG001|Overall Study|Lost to Follow-up|4|||
48829492|NCT01876511|157217478|FG000|Overall Study|Disease Progression-clinical/radiologic|11|||
48829493|NCT01876511|157217479|FG001|Overall Study|Disease Progression-clinical/radiologic|24|||
48829494|NCT01876511|157217480|FG002|Overall Study|Disease Progression-clinical/radiologic|16|||
48829495|NCT01876511|157217478|FG000|Overall Study|Death (unrelated)|3|||
48829496|NCT01876511|157217479|FG001|Overall Study|Death (unrelated)|0|||
48829497|NCT01876511|157217480|FG002|Overall Study|Death (unrelated)|2|||
48829498|NCT01876511|157217478|FG000|Overall Study|Drug-related Toxicity|5|||
48829499|NCT01876511|157217479|FG001|Overall Study|Drug-related Toxicity|1|||
48829500|NCT01876511|157217480|FG002|Overall Study|Drug-related Toxicity|6|||
48829501|NCT01876511|157217478|FG000|Overall Study|Patient Decision|3|||
48829502|NCT01876511|157217479|FG001|Overall Study|Patient Decision|0|||
48829503|NCT01876511|157217480|FG002|Overall Study|Patient Decision|6|||
48829504|NCT01876511|157217478|FG000|Overall Study|Physician Decision|1|||
48829505|NCT01876511|157217479|FG001|Overall Study|Physician Decision|0|||
48829506|NCT01876511|157217480|FG002|Overall Study|Physician Decision|1|||
48829507|NCT02145182|157217485|FG000|Overall Study|Adverse Event|4|||
48829508|NCT02145182|157217486|FG001|Overall Study|Adverse Event|1|||
48829509|NCT02145182|157217485|FG000|Overall Study|Death|7|||
48829510|NCT02145182|157217486|FG001|Overall Study|Death|7|||
48829511|NCT02145182|157217485|FG000|Overall Study|Lost to Follow-up|2|||
48829512|NCT02145182|157217486|FG001|Overall Study|Lost to Follow-up|2|||
48829513|NCT02145182|157217485|FG000|Overall Study|Pre-transplant Withdrawal|0|||
48829514|NCT02145182|157217486|FG001|Overall Study|Pre-transplant Withdrawal|2|||
48829515|NCT02145182|157217485|FG000|Overall Study|Withdrawal by Subject|5|||
48829516|NCT02145182|157217486|FG001|Overall Study|Withdrawal by Subject|4|||
48829517|NCT03999554|157217488|FG000|Overall Study|Lost to Follow-up|4|||
48829518|NCT03999554|157217489|FG001|Overall Study|Lost to Follow-up|5|||
48829519|NCT03999554|157217490|FG002|Overall Study|Lost to Follow-up|4|||
48829520|NCT03999554|157217491|FG003|Overall Study|Lost to Follow-up|5|||
48829521|NCT03999554|157217492|FG004|Overall Study|Lost to Follow-up|8|||
48829522|NCT03999554|157217488|FG000|Overall Study|Protocol Violation|0|||
48829523|NCT03999554|157217489|FG001|Overall Study|Protocol Violation|0|||
48829524|NCT03999554|157217490|FG002|Overall Study|Protocol Violation|5|||
48829525|NCT03999554|157217491|FG003|Overall Study|Protocol Violation|0|||
48829526|NCT03999554|157217492|FG004|Overall Study|Protocol Violation|0|||
48829527|NCT03999554|157217488|FG000|Overall Study|Pregnancy|0|||
48829528|NCT03999554|157217489|FG001|Overall Study|Pregnancy|0|||
48829529|NCT03999554|157217490|FG002|Overall Study|Pregnancy|1|||
48829530|NCT03999554|157217491|FG003|Overall Study|Pregnancy|0|||
48829531|NCT03999554|157217492|FG004|Overall Study|Pregnancy|0|||
48829532|NCT03999554|157217488|FG000|Overall Study|Withdrawal by Subject|2|||
48829533|NCT03999554|157217489|FG001|Overall Study|Withdrawal by Subject|2|||
48829534|NCT03999554|157217490|FG002|Overall Study|Withdrawal by Subject|2|||
48829535|NCT03999554|157217491|FG003|Overall Study|Withdrawal by Subject|1|||
48829536|NCT03999554|157217492|FG004|Overall Study|Withdrawal by Subject|1|||
48829537|NCT03999554|157217488|FG000|Overall Study|failure to comply with protocol requirements|0|||
48829538|NCT03999554|157217489|FG001|Overall Study|failure to comply with protocol requirements|0|||
48829539|NCT03999554|157217490|FG002|Overall Study|failure to comply with protocol requirements|0|||
48829540|NCT03999554|157217491|FG003|Overall Study|failure to comply with protocol requirements|1|||
48829541|NCT03999554|157217492|FG004|Overall Study|failure to comply with protocol requirements|0|||
48829542|NCT03006341|157217493|FG000|Overall Study|Not linked in the EMR|25069|||
48829543|NCT03006341|157217494|FG001|Overall Study|Not linked in the EMR|67505|||
48829544|NCT03006341|157217495|FG002|Overall Study|Not linked in the EMR|30993|||
48829545|NCT03006341|157217496|FG003|Overall Study|Not linked in the EMR|10685|||
48829546|NCT04337489|157217497|FG000|Overall Study|Withdrawal by Subject|1|||
48829547|NCT01695317|157217498|FG000|Period 1 in the Cross-over Design|Withdrawal by Subject|2|||
49156333|NCT03498716|158412487|FG001|Overall Study|Disease Relapse|1|||
49156334|NCT03498716|158412486|FG000|Overall Study|Death|58|||
49156335|NCT03498716|158412487|FG001|Overall Study|Death|72|||
49156336|NCT03498716|158412486|FG000|Overall Study|Physician Decision|4|||
49156337|NCT03498716|158412487|FG001|Overall Study|Physician Decision|2|||
49156338|NCT02257684|158412488|FG000|Overall Study|Adverse Event|2|||
48829548|NCT01695317|157217499|FG001|Period 1 in the Cross-over Design|Withdrawal by Subject|1|||
48829549|NCT01695317|157217498|FG000|Cross-over to Period 2|Withdrawal by Subject|4|||
48829550|NCT01695317|157217499|FG001|Cross-over to Period 2|Withdrawal by Subject|34|||
48829551|NCT03055767|157217500|FG000|Open-Label Period|Lost to Follow-up|0|||
48829552|NCT03055767|157217501|FG001|Open-Label Period|Lost to Follow-up|0|||
48829553|NCT03055767|157217502|FG002|Open-Label Period|Lost to Follow-up|2|||
49156339|NCT02257684|158412488|FG000|Overall Study|Lack of Efficacy|1|||
49156340|NCT02257684|158412488|FG000|Overall Study|Sponsor's Decision|1|||
48829554|NCT03055767|157217503|FG003|Open-Label Period|Lost to Follow-up|0|||
48829555|NCT03055767|157217500|FG000|Open-Label Period|Withdrawal by Subject|0|||
48829556|NCT03055767|157217501|FG001|Open-Label Period|Withdrawal by Subject|0|||
48829557|NCT03055767|157217502|FG002|Open-Label Period|Withdrawal by Subject|0|||
48829558|NCT03055767|157217503|FG003|Open-Label Period|Withdrawal by Subject|1|||
48829559|NCT02759731|157217504|FG000|Overall Study|Did not complete treatment.|8|||
48829560|NCT00957229|157217508|FG000|Study Start|Adverse Event|0|||
48829561|NCT00957229|157217509|FG001|Study Start|Adverse Event|3|||
48829562|NCT00957229|157217508|FG000|Study Start|Disease Progression|1|||
48829563|NCT00957229|157217509|FG001|Study Start|Disease Progression|0|||
48829564|NCT00957229|157217508|FG000|Reallocated to or Continued Vismodegib|Death|1|||
49156341|NCT02921256|158412492|FG000|Arm 1a v. Arm II|Adverse Event|6|||
48829565|NCT00957229|157217509|FG001|Reallocated to or Continued Vismodegib|Death|1|||
48829566|NCT00957229|157217508|FG000|Reallocated to or Continued Vismodegib|Adverse Event|2|||
48829567|NCT00957229|157217509|FG001|Reallocated to or Continued Vismodegib|Adverse Event|1|||
48829568|NCT05193318|157217510|FG000|Acute Intervention (Weeks 1-9 of Study)|Physician Decision|1|||
49156342|NCT02921256|158412493|FG001|Arm 1a v. Arm II|Adverse Event|15|||
49156343|NCT02921256|158412494|FG002|Arm 1a v. Arm II|Adverse Event|0|||
48829569|NCT05193318|157217510|FG000|Follow-up Phase (Through Week 16)|Lost to Follow-up|1|||
48829570|NCT02299635|157217511|FG000|Overall Study|Adverse Event|2|||
48829571|NCT02299635|157217511|FG000|Overall Study|Death|1|||
48829572|NCT02299635|157217511|FG000|Overall Study|Global deterioration of health status|1|||
48829573|NCT02299635|157217511|FG000|Overall Study|Objective progression or relapse|10|||
48829574|NCT02299635|157217511|FG000|Overall Study|Withdrawal by Subject|2|||
48829575|NCT02299635|157217511|FG000|Overall Study|Other|3|||
49156344|NCT02921256|158412492|FG000|Arm 1a v. Arm II|Death|0|||
48829576|NCT00927823|157217512|FG000|Continuous Dosing Period|Death|0|||
48829577|NCT00927823|157217513|FG001|Continuous Dosing Period|Death|0|||
48829578|NCT00927823|157217514|FG002|Continuous Dosing Period|Death|6|||
49156345|NCT02921256|158412493|FG001|Arm 1a v. Arm II|Death|2|||
49156346|NCT02921256|158412494|FG002|Arm 1a v. Arm II|Death|0|||
49156347|NCT02921256|158412492|FG000|Arm 1a v. Arm II|Lack of Efficacy|2|||
49156348|NCT02921256|158412493|FG001|Arm 1a v. Arm II|Lack of Efficacy|0|||
49156349|NCT02921256|158412494|FG002|Arm 1a v. Arm II|Lack of Efficacy|0|||
49156350|NCT02921256|158412492|FG000|Arm 1a v. Arm II|Lost to Follow-up|2|||
49156351|NCT02921256|158412493|FG001|Arm 1a v. Arm II|Lost to Follow-up|9|||
49156352|NCT02921256|158412494|FG002|Arm 1a v. Arm II|Lost to Follow-up|0|||
49156353|NCT02921256|158412492|FG000|Arm 1a v. Arm II|Physician Decision|1|||
49156354|NCT02921256|158412493|FG001|Arm 1a v. Arm II|Physician Decision|1|||
49156355|NCT02921256|158412494|FG002|Arm 1a v. Arm II|Physician Decision|0|||
49156356|NCT02921256|158412492|FG000|Arm 1a v. Arm II|Withdrawal by Subject|5|||
49156357|NCT02921256|158412493|FG001|Arm 1a v. Arm II|Withdrawal by Subject|6|||
49156358|NCT02921256|158412494|FG002|Arm 1a v. Arm II|Withdrawal by Subject|0|||
49156359|NCT02921256|158412492|FG000|Arm Ib v Arm III|Adverse Event|9|||
49156360|NCT02921256|158412493|FG001|Arm Ib v Arm III|Adverse Event|0|||
48829579|NCT00927823|157217515|FG003|Continuous Dosing Period|Death|0|||
48829580|NCT00927823|157217512|FG000|Continuous Dosing Period|Lost to Follow-up|1|||
48829581|NCT00927823|157217513|FG001|Continuous Dosing Period|Lost to Follow-up|1|||
48829582|NCT00927823|157217514|FG002|Continuous Dosing Period|Lost to Follow-up|9|||
48829583|NCT00927823|157217515|FG003|Continuous Dosing Period|Lost to Follow-up|0|||
48829584|NCT00927823|157217512|FG000|Continuous Dosing Period|Withdrawal by Subject|1|||
48829585|NCT00927823|157217513|FG001|Continuous Dosing Period|Withdrawal by Subject|0|||
48829586|NCT00927823|157217514|FG002|Continuous Dosing Period|Withdrawal by Subject|2|||
48829587|NCT00927823|157217515|FG003|Continuous Dosing Period|Withdrawal by Subject|2|||
48829588|NCT00927823|157217512|FG000|Continuous Dosing Period|Other|1|||
48829589|NCT00927823|157217513|FG001|Continuous Dosing Period|Other|2|||
49156361|NCT02921256|158412494|FG002|Arm Ib v Arm III|Adverse Event|4|||
49156362|NCT02921256|158412492|FG000|Arm Ib v Arm III|Death|1|||
49156363|NCT02921256|158412493|FG001|Arm Ib v Arm III|Death|0|||
49156364|NCT02921256|158412494|FG002|Arm Ib v Arm III|Death|1|||
49156365|NCT02921256|158412492|FG000|Arm Ib v Arm III|Lack of Efficacy|2|||
48829590|NCT00927823|157217514|FG002|Continuous Dosing Period|Other|9|||
48829591|NCT00927823|157217515|FG003|Continuous Dosing Period|Other|3|||
48829592|NCT00543725|157217516|FG000|Overall Study|Adverse Event|18|||
48829593|NCT00543725|157217517|FG001|Overall Study|Adverse Event|27|||
49156366|NCT02921256|158412493|FG001|Arm Ib v Arm III|Lack of Efficacy|0|||
48829594|NCT00543725|157217516|FG000|Overall Study|Sponsor's Decision|0|||
48829595|NCT00543725|157217517|FG001|Overall Study|Sponsor's Decision|1|||
48829596|NCT00543725|157217516|FG000|Overall Study|Subject Non-Compliant|4|||
48829597|NCT00543725|157217517|FG001|Overall Study|Subject Non-Compliant|4|||
48829598|NCT00543725|157217516|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
48829599|NCT00543725|157217517|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
48829600|NCT00543725|157217516|FG000|Overall Study|Subject Reached A Virologic Endpoint|22|||
48829601|NCT00543725|157217517|FG001|Overall Study|Subject Reached A Virologic Endpoint|14|||
48829602|NCT00543725|157217516|FG000|Overall Study|Protocol Violation|0|||
48829603|NCT00543725|157217517|FG001|Overall Study|Protocol Violation|1|||
48829604|NCT00543725|157217516|FG000|Overall Study|Withdrawal by Subject|4|||
49156367|NCT02921256|158412494|FG002|Arm Ib v Arm III|Lack of Efficacy|2|||
49156368|NCT02921256|158412492|FG000|Arm Ib v Arm III|Lost to Follow-up|1|||
49156369|NCT02921256|158412493|FG001|Arm Ib v Arm III|Lost to Follow-up|0|||
49156370|NCT02921256|158412494|FG002|Arm Ib v Arm III|Lost to Follow-up|3|||
49156371|NCT02921256|158412492|FG000|Arm Ib v Arm III|Physician Decision|4|||
49156372|NCT02921256|158412493|FG001|Arm Ib v Arm III|Physician Decision|0|||
49156373|NCT02921256|158412494|FG002|Arm Ib v Arm III|Physician Decision|1|||
49156374|NCT02921256|158412492|FG000|Arm Ib v Arm III|Withdrawal by Subject|7|||
49156375|NCT02921256|158412493|FG001|Arm Ib v Arm III|Withdrawal by Subject|0|||
49156376|NCT02921256|158412494|FG002|Arm Ib v Arm III|Withdrawal by Subject|4|||
49156377|NCT00760552|158412495|FG000|Overall Study|Death|2|||
49156378|NCT00760552|158412496|FG001|Overall Study|Death|0|||
49156379|NCT00760552|158412495|FG000|Overall Study|Lost to Follow-up|11|||
49156380|NCT00760552|158412496|FG001|Overall Study|Lost to Follow-up|10|||
49156381|NCT01605097|158412497|FG000|Overall Study|Protocol Violation|1|||
49156382|NCT01728246|158412498|FG000|Overall Study|Participant needed rescue medication|1|||
49156383|NCT01728246|158412499|FG001|Overall Study|Participant needed rescue medication|5|||
49156384|NCT01728246|158412498|FG000|Overall Study|Protocol Violation|1|||
49156385|NCT01728246|158412499|FG001|Overall Study|Protocol Violation|0|||
49156386|NCT01728246|158412498|FG000|Overall Study|Withdrawal by Subject|2|||
49156387|NCT01728246|158412499|FG001|Overall Study|Withdrawal by Subject|3|||
49156388|NCT01728246|158412498|FG000|Overall Study|Lost to Follow-up|23|||
49156389|NCT01728246|158412499|FG001|Overall Study|Lost to Follow-up|22|||
49156390|NCT01728246|158412498|FG000|Overall Study|Lack of Efficacy|1|||
49156391|NCT01728246|158412499|FG001|Overall Study|Lack of Efficacy|1|||
49156392|NCT01728246|158412498|FG000|Overall Study|Adverse Event|8|||
49156393|NCT01728246|158412499|FG001|Overall Study|Adverse Event|5|||
49156394|NCT04194450|158412502|FG000|Overall Study|not eligible|1|||
49156395|NCT04194450|158412503|FG001|Overall Study|not eligible|0|||
49156396|NCT00518180|158412504|FG000|Overall Study|Withdrawal by Subject|29|||
49156397|NCT00518180|158412505|FG001|Overall Study|Withdrawal by Subject|30|||
49156398|NCT00518180|158412506|FG002|Overall Study|Withdrawal by Subject|42|||
49156399|NCT00518180|158412504|FG000|Overall Study|Lost to Follow-up|30|||
49156400|NCT00518180|158412505|FG001|Overall Study|Lost to Follow-up|28|||
49156401|NCT00518180|158412506|FG002|Overall Study|Lost to Follow-up|34|||
49156402|NCT00518180|158412504|FG000|Overall Study|Administrative reason|0|||
49156403|NCT00518180|158412505|FG001|Overall Study|Administrative reason|2|||
49156404|NCT00518180|158412506|FG002|Overall Study|Administrative reason|2|||
49156405|NCT00518180|158412504|FG000|Overall Study|Protocol Violation|5|||
49156406|NCT00518180|158412505|FG001|Overall Study|Protocol Violation|7|||
49156407|NCT00518180|158412506|FG002|Overall Study|Protocol Violation|4|||
49156408|NCT00518180|158412504|FG000|Overall Study|Unable to classify|0|||
49156409|NCT00518180|158412505|FG001|Overall Study|Unable to classify|2|||
49156410|NCT00518180|158412506|FG002|Overall Study|Unable to classify|0|||
48829605|NCT00543725|157217517|FG001|Overall Study|Withdrawal by Subject|13|||
48829606|NCT00543725|157217516|FG000|Overall Study|Lost to Follow-up|15|||
48829607|NCT00543725|157217517|FG001|Overall Study|Lost to Follow-up|11|||
48829608|NCT00543725|157217516|FG000|Overall Study|Other|3|||
48829609|NCT00543725|157217517|FG001|Overall Study|Other|3|||
48829610|NCT00906698|157217518|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
48829611|NCT00906698|157217519|FG001|Overall Study|Dose-limiting toxicity (DLT)|6|||
48829612|NCT00906698|157217520|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
48829613|NCT00906698|157217521|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
48829614|NCT00906698|157217522|FG004|Overall Study|Dose-limiting toxicity (DLT)|1|||
48829615|NCT00906698|157217523|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
48829616|NCT00906698|157217518|FG000|Overall Study|Adverse Event|0|||
48829617|NCT00906698|157217519|FG001|Overall Study|Adverse Event|0|||
48829618|NCT00906698|157217520|FG002|Overall Study|Adverse Event|2|||
48829619|NCT00906698|157217521|FG003|Overall Study|Adverse Event|0|||
48829620|NCT00906698|157217522|FG004|Overall Study|Adverse Event|4|||
48829621|NCT00906698|157217523|FG005|Overall Study|Adverse Event|1|||
48829622|NCT00906698|157217518|FG000|Overall Study|Disease progression|3|||
48829623|NCT00906698|157217519|FG001|Overall Study|Disease progression|12|||
48829624|NCT00906698|157217520|FG002|Overall Study|Disease progression|4|||
48829625|NCT00906698|157217521|FG003|Overall Study|Disease progression|4|||
48829626|NCT00906698|157217522|FG004|Overall Study|Disease progression|12|||
48829627|NCT00906698|157217523|FG005|Overall Study|Disease progression|4|||
48829628|NCT00906698|157217518|FG000|Overall Study|Withdrawal by Subject|0|||
48829629|NCT00906698|157217519|FG001|Overall Study|Withdrawal by Subject|0|||
48829630|NCT00906698|157217520|FG002|Overall Study|Withdrawal by Subject|0|||
48829631|NCT00906698|157217521|FG003|Overall Study|Withdrawal by Subject|0|||
48829632|NCT00906698|157217522|FG004|Overall Study|Withdrawal by Subject|1|||
48829633|NCT00906698|157217523|FG005|Overall Study|Withdrawal by Subject|0|||
48829634|NCT00906698|157217518|FG000|Overall Study|incl. non compliance, lost to follow-up|0|||
48829635|NCT00906698|157217519|FG001|Overall Study|incl. non compliance, lost to follow-up|1|||
48829636|NCT00906698|157217520|FG002|Overall Study|incl. non compliance, lost to follow-up|0|||
48829637|NCT00906698|157217521|FG003|Overall Study|incl. non compliance, lost to follow-up|0|||
48829638|NCT00906698|157217522|FG004|Overall Study|incl. non compliance, lost to follow-up|0|||
48829639|NCT00906698|157217523|FG005|Overall Study|incl. non compliance, lost to follow-up|0|||
48829640|NCT01250002|157217524|FG000|Overall Study|Change to open surgical procedure|4|||
48829641|NCT01250002|157217525|FG001|Overall Study|Change to open surgical procedure|3|||
48829642|NCT02219490|157217526|FG000|Overall Study|Adverse Event|24|||
48829643|NCT02219490|157217526|FG000|Overall Study|Withdrew consent|96|||
48829644|NCT02219490|157217526|FG000|Overall Study|Lost to Follow-up|126|||
48829645|NCT02219490|157217526|FG000|Overall Study|COVID-19 infection|2|||
48829646|NCT02219490|157217526|FG000|Overall Study|COVID-19 logistical restrictions|33|||
48829647|NCT02219490|157217526|FG000|Overall Study|Other, not specified|57|||
48829648|NCT01674569|157217527|FG000|Overall Study|Adverse Event|0|||
48829649|NCT01674569|157217528|FG001|Overall Study|Adverse Event|2|||
48829650|NCT01674569|157217529|FG002|Overall Study|Adverse Event|0|||
48829651|NCT01674569|157217530|FG003|Overall Study|Adverse Event|1|||
48829652|NCT01674569|157217531|FG004|Overall Study|Adverse Event|2|||
48829653|NCT01674569|157217532|FG005|Overall Study|Adverse Event|2|||
48829654|NCT01674569|157217527|FG000|Overall Study|Protocol Violation|0|||
48829655|NCT01674569|157217528|FG001|Overall Study|Protocol Violation|1|||
48829656|NCT01674569|157217529|FG002|Overall Study|Protocol Violation|1|||
48829657|NCT01674569|157217530|FG003|Overall Study|Protocol Violation|0|||
48829658|NCT01674569|157217531|FG004|Overall Study|Protocol Violation|0|||
48829659|NCT01674569|157217532|FG005|Overall Study|Protocol Violation|0|||
48829660|NCT01674569|157217527|FG000|Overall Study|Withdrawal by Subject|0|||
48829661|NCT01674569|157217528|FG001|Overall Study|Withdrawal by Subject|0|||
48829662|NCT01674569|157217529|FG002|Overall Study|Withdrawal by Subject|1|||
48829663|NCT01674569|157217530|FG003|Overall Study|Withdrawal by Subject|0|||
48829664|NCT01674569|157217531|FG004|Overall Study|Withdrawal by Subject|0|||
48829665|NCT01674569|157217532|FG005|Overall Study|Withdrawal by Subject|0|||
48829666|NCT01119703|157217535|FG000|Overall Study|Adverse Event|0|||
48829667|NCT01119703|157217536|FG001|Overall Study|Adverse Event|1|||
48829668|NCT02974010|157217538|FG000|Overall Study|Lost to Follow-up|3|||
48829669|NCT02974010|157217539|FG001|Overall Study|Lost to Follow-up|1|||
48829670|NCT02974010|157217540|FG002|Overall Study|Lost to Follow-up|0|||
48829671|NCT02974010|157217541|FG003|Overall Study|Lost to Follow-up|0|||
48829672|NCT02974010|157217538|FG000|Overall Study|Withdrawal by Subject|2|||
48829673|NCT02974010|157217539|FG001|Overall Study|Withdrawal by Subject|1|||
48829674|NCT02974010|157217540|FG002|Overall Study|Withdrawal by Subject|0|||
48829675|NCT02974010|157217541|FG003|Overall Study|Withdrawal by Subject|0|||
48829676|NCT02974010|157217538|FG000|Overall Study|Adverse Event|0|||
48829677|NCT02974010|157217539|FG001|Overall Study|Adverse Event|1|||
48829678|NCT02974010|157217540|FG002|Overall Study|Adverse Event|0|||
48829679|NCT02974010|157217541|FG003|Overall Study|Adverse Event|0|||
48829680|NCT02974010|157217538|FG000|Overall Study|Completed day 42 but did not return for day 70|1|||
48829681|NCT02974010|157217539|FG001|Overall Study|Completed day 42 but did not return for day 70|0|||
48829682|NCT02974010|157217540|FG002|Overall Study|Completed day 42 but did not return for day 70|1|||
48829683|NCT02974010|157217541|FG003|Overall Study|Completed day 42 but did not return for day 70|0|||
48829684|NCT02974010|157217538|FG000|Overall Study|Lack of Efficacy|0|||
48829685|NCT02974010|157217539|FG001|Overall Study|Lack of Efficacy|0|||
48829686|NCT02974010|157217540|FG002|Overall Study|Lack of Efficacy|1|||
48829687|NCT02974010|157217541|FG003|Overall Study|Lack of Efficacy|0|||
48829688|NCT01178762|157217542|FG000|Overall Study|Lost to Follow-up|15|||
48829689|NCT02377362|157217543|FG000|Part A Second Treatment|Protocol Violation|0|||
48829690|NCT02377362|157217544|FG001|Part A Second Treatment|Protocol Violation|0|||
48829691|NCT02377362|157217545|FG002|Part A Second Treatment|Protocol Violation|0|||
48829692|NCT02377362|157217546|FG003|Part A Second Treatment|Protocol Violation|0|||
48829693|NCT02377362|157217547|FG004|Part A Second Treatment|Protocol Violation|1|||
48829694|NCT02377362|157217548|FG005|Part A Second Treatment|Protocol Violation|0|||
48829695|NCT02377362|157217549|FG006|Part A Second Treatment|Protocol Violation|0|||
48829696|NCT02377362|157217550|FG007|Part A Second Treatment|Protocol Violation|0|||
48829697|NCT02377362|157217551|FG008|Part A Second Treatment|Protocol Violation|0|||
48829698|NCT02377362|157217552|FG009|Part A Second Treatment|Protocol Violation|0|||
48829699|NCT02377362|157217553|FG010|Part A Second Treatment|Protocol Violation|0|||
48829700|NCT02377362|157217554|FG011|Part A Second Treatment|Protocol Violation|0|||
48829701|NCT02377362|157217555|FG012|Part A Second Treatment|Protocol Violation|0|||
48829702|NCT02377362|157217543|FG000|Part A Third Treatment|Highest dose level 1200 not used|0|||
48829703|NCT02377362|157217544|FG001|Part A Third Treatment|Highest dose level 1200 not used|0|||
48829704|NCT02377362|157217545|FG002|Part A Third Treatment|Highest dose level 1200 not used|0|||
48829705|NCT02377362|157217546|FG003|Part A Third Treatment|Highest dose level 1200 not used|4|||
48829706|NCT02377362|157217547|FG004|Part A Third Treatment|Highest dose level 1200 not used|3|||
48829707|NCT02377362|157217548|FG005|Part A Third Treatment|Highest dose level 1200 not used|4|||
48829708|NCT02377362|157217549|FG006|Part A Third Treatment|Highest dose level 1200 not used|0|||
48829709|NCT02377362|157217550|FG007|Part A Third Treatment|Highest dose level 1200 not used|0|||
48829710|NCT02377362|157217551|FG008|Part A Third Treatment|Highest dose level 1200 not used|0|||
48829711|NCT02377362|157217552|FG009|Part A Third Treatment|Highest dose level 1200 not used|0|||
48829712|NCT02377362|157217553|FG010|Part A Third Treatment|Highest dose level 1200 not used|0|||
48829713|NCT02377362|157217554|FG011|Part A Third Treatment|Highest dose level 1200 not used|0|||
48829714|NCT02377362|157217555|FG012|Part A Third Treatment|Highest dose level 1200 not used|0|||
48829715|NCT02377362|157217543|FG000|Part B Overall|Protocol Violation|0|||
48829716|NCT02377362|157217544|FG001|Part B Overall|Protocol Violation|0|||
48829717|NCT02377362|157217545|FG002|Part B Overall|Protocol Violation|0|||
48829718|NCT02377362|157217546|FG003|Part B Overall|Protocol Violation|0|||
48829719|NCT02377362|157217547|FG004|Part B Overall|Protocol Violation|0|||
48829720|NCT02377362|157217548|FG005|Part B Overall|Protocol Violation|0|||
48829721|NCT02377362|157217549|FG006|Part B Overall|Protocol Violation|0|||
48829722|NCT02377362|157217550|FG007|Part B Overall|Protocol Violation|0|||
48829723|NCT02377362|157217551|FG008|Part B Overall|Protocol Violation|0|||
48829724|NCT02377362|157217552|FG009|Part B Overall|Protocol Violation|1|||
48829725|NCT02377362|157217553|FG010|Part B Overall|Protocol Violation|0|||
48829726|NCT02377362|157217554|FG011|Part B Overall|Protocol Violation|0|||
48829727|NCT02377362|157217555|FG012|Part B Overall|Protocol Violation|0|||
48829728|NCT02377362|157217543|FG000|Part B Overall|Adverse Event|0|||
48829729|NCT02377362|157217544|FG001|Part B Overall|Adverse Event|0|||
48829730|NCT02377362|157217545|FG002|Part B Overall|Adverse Event|0|||
48829731|NCT02377362|157217546|FG003|Part B Overall|Adverse Event|0|||
48829732|NCT02377362|157217547|FG004|Part B Overall|Adverse Event|0|||
48829733|NCT02377362|157217548|FG005|Part B Overall|Adverse Event|0|||
48829734|NCT02377362|157217549|FG006|Part B Overall|Adverse Event|1|||
48829735|NCT02377362|157217550|FG007|Part B Overall|Adverse Event|1|||
48829736|NCT02377362|157217551|FG008|Part B Overall|Adverse Event|0|||
48829737|NCT02377362|157217552|FG009|Part B Overall|Adverse Event|0|||
48829738|NCT02377362|157217553|FG010|Part B Overall|Adverse Event|0|||
48829739|NCT02377362|157217554|FG011|Part B Overall|Adverse Event|0|||
48829740|NCT02377362|157217555|FG012|Part B Overall|Adverse Event|0|||
48829741|NCT02377362|157217543|FG000|Part B Overall|Withdrawal by Subject|0|||
48829742|NCT02377362|157217544|FG001|Part B Overall|Withdrawal by Subject|0|||
48829743|NCT02377362|157217545|FG002|Part B Overall|Withdrawal by Subject|0|||
48829744|NCT02377362|157217546|FG003|Part B Overall|Withdrawal by Subject|0|||
48829745|NCT02377362|157217547|FG004|Part B Overall|Withdrawal by Subject|0|||
48829746|NCT02377362|157217548|FG005|Part B Overall|Withdrawal by Subject|0|||
48829747|NCT02377362|157217549|FG006|Part B Overall|Withdrawal by Subject|1|||
48829748|NCT02377362|157217550|FG007|Part B Overall|Withdrawal by Subject|0|||
48829749|NCT02377362|157217551|FG008|Part B Overall|Withdrawal by Subject|0|||
48829750|NCT02377362|157217552|FG009|Part B Overall|Withdrawal by Subject|0|||
48829751|NCT02377362|157217553|FG010|Part B Overall|Withdrawal by Subject|0|||
48829752|NCT02377362|157217554|FG011|Part B Overall|Withdrawal by Subject|1|||
48829753|NCT02377362|157217555|FG012|Part B Overall|Withdrawal by Subject|0|||
48829754|NCT02140554|157217557|FG000|Overall Study|Withdrawal of consent|1|||
48829755|NCT02140554|157217558|FG001|Overall Study|Withdrawal of consent|0|||
48829756|NCT02140554|157217559|FG002|Overall Study|Withdrawal of consent|4|||
48829757|NCT02140554|157217557|FG000|Overall Study|Physician Decision|1|||
48829758|NCT02140554|157217558|FG001|Overall Study|Physician Decision|0|||
48829759|NCT02140554|157217559|FG002|Overall Study|Physician Decision|2|||
48829760|NCT02140554|157217557|FG000|Overall Study|Death|0|||
48829761|NCT02140554|157217558|FG001|Overall Study|Death|0|||
48829762|NCT02140554|157217559|FG002|Overall Study|Death|1|||
48829763|NCT02140554|157217557|FG000|Overall Study|Discontinued due to failure to mobilize|0|||
48829764|NCT02140554|157217558|FG001|Overall Study|Discontinued due to failure to mobilize|0|||
48829765|NCT02140554|157217559|FG002|Overall Study|Discontinued due to failure to mobilize|1|||
48829766|NCT03601507|157217560|FG000|Overall Study|Adverse Event|1|||
49156411|NCT00518180|158412504|FG000|Overall Study|Adverse Event|1|||
49156412|NCT00518180|158412505|FG001|Overall Study|Adverse Event|0|||
49156413|NCT00518180|158412506|FG002|Overall Study|Adverse Event|0|||
49156414|NCT00575666|158412507|FG000|Overall Study|Withdrawal by Subject|3|||
49156415|NCT00575666|158412508|FG001|Overall Study|Withdrawal by Subject|2|||
49156416|NCT00575666|158412507|FG000|Overall Study|Physician Decision|1|||
49156417|NCT00575666|158412508|FG001|Overall Study|Physician Decision|1|||
49156418|NCT01368614|158412509|FG000|Screening Period|Screen Failure|58|||
49156419|NCT01368614|158412510|FG001|Screening Period|Screen Failure|0|||
49156420|NCT01368614|158412511|FG002|Screening Period|Screen Failure|0|||
49156421|NCT01368614|158412512|FG003|Screening Period|Screen Failure|0|||
49156422|NCT01368614|158412509|FG000|Study Period|Withdrawal by Subject|0|||
48829767|NCT03586167|157217561|FG000|Overall Study|Other|1|||
48829768|NCT03586167|157217562|FG001|Overall Study|Other|0|||
48829769|NCT00517933|157217563|FG000|Period 1|Death|2|||
49156423|NCT01368614|158412510|FG001|Study Period|Withdrawal by Subject|1|||
49156424|NCT01368614|158412511|FG002|Study Period|Withdrawal by Subject|1|||
49156425|NCT01368614|158412512|FG003|Study Period|Withdrawal by Subject|3|||
49156426|NCT01368614|158412509|FG000|Study Period|Lost to Follow-up|0|||
49156427|NCT01368614|158412510|FG001|Study Period|Lost to Follow-up|0|||
49156428|NCT01368614|158412511|FG002|Study Period|Lost to Follow-up|1|||
49156429|NCT01368614|158412512|FG003|Study Period|Lost to Follow-up|0|||
49156430|NCT03314454|158412517|FG000|Overall Study|Protocol Violation|1|||
49156431|NCT00485173|158412518|FG000|Overall Study|Death|4|||
49156432|NCT00485173|158412519|FG001|Overall Study|Death|3|||
49156433|NCT00485173|158412518|FG000|Overall Study|Lost to Follow-up|32|||
49156434|NCT00485173|158412519|FG001|Overall Study|Lost to Follow-up|61|||
49156435|NCT00746811|158412520|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
49156436|NCT00746811|158412521|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
49156437|NCT04016714|158412522|FG000|Overall Study|Death|1|||
48829770|NCT00517933|157217564|FG001|Period 1|Death|1|||
48829771|NCT00517933|157217563|FG000|Period 1|Adverse Event|4|||
48829772|NCT00517933|157217564|FG001|Period 1|Adverse Event|4|||
48829773|NCT00517933|157217563|FG000|Period 1|Lost to Follow-up|2|||
49156438|NCT04016714|158412523|FG001|Overall Study|Death|0|||
49156439|NCT04016714|158412522|FG000|Overall Study|Lost to Follow-up|3|||
49156440|NCT04016714|158412523|FG001|Overall Study|Lost to Follow-up|1|||
49156441|NCT04016714|158412522|FG000|Overall Study|Physician Decision|3|||
48829774|NCT00517933|157217564|FG001|Period 1|Lost to Follow-up|0|||
49156442|NCT04016714|158412523|FG001|Overall Study|Physician Decision|3|||
49156443|NCT04016714|158412522|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
49156444|NCT04016714|158412523|FG001|Overall Study|Withdrawal by Parent/Guardian|12|||
49156445|NCT05281562|158412527|FG000|Overall Study|Ineligible patient|1|||
49156446|NCT05281562|158412528|FG001|Overall Study|Ineligible patient|0|||
48829775|NCT00517933|157217563|FG000|Period 1|Underwent lung transplant|0|||
49156447|NCT00791648|158414130|FG000|Overall Study|Physician Decision|0|||
48829776|NCT00517933|157217564|FG001|Period 1|Underwent lung transplant|1|||
48829777|NCT00517933|157217563|FG000|Period 2|Death|2|||
48829778|NCT00517933|157217564|FG001|Period 2|Death|4|||
48829779|NCT00517933|157217563|FG000|Period 2|Adverse Event|2|||
48829780|NCT00517933|157217564|FG001|Period 2|Adverse Event|4|||
48829781|NCT00517933|157217563|FG000|Period 2|Physician Decision|1|||
48829782|NCT00517933|157217564|FG001|Period 2|Physician Decision|0|||
48829783|NCT00517933|157217563|FG000|Period 2|Withdrawal by Subject|1|||
48829784|NCT00517933|157217564|FG001|Period 2|Withdrawal by Subject|3|||
48829785|NCT00517933|157217563|FG000|Period 2|Underwent lung transplant|0|||
48829786|NCT00517933|157217564|FG001|Period 2|Underwent lung transplant|2|||
49156448|NCT00791648|158414131|FG001|Overall Study|Physician Decision|1|||
49156449|NCT00791648|158414130|FG000|Overall Study|Withdrawal by Subject|0|||
49156450|NCT00791648|158414131|FG001|Overall Study|Withdrawal by Subject|1|||
49156451|NCT03299049|158414132|FG000|Overall Study|On-going|486|||
49156452|NCT03299049|158414133|FG001|Overall Study|On-going|481|||
49156453|NCT03299049|158414132|FG000|Overall Study|Withdrawal by Subject|6|||
49156454|NCT03299049|158414133|FG001|Overall Study|Withdrawal by Subject|21|||
49156455|NCT03299049|158414132|FG000|Overall Study|Physician Decision|5|||
49156456|NCT03299049|158414133|FG001|Overall Study|Physician Decision|1|||
49156457|NCT03299049|158414132|FG000|Overall Study|Lost to Follow-up|2|||
49156458|NCT03299049|158414133|FG001|Overall Study|Lost to Follow-up|0|||
49156459|NCT03299049|158414132|FG000|Overall Study|Pregnancy|1|||
49156460|NCT03299049|158414133|FG001|Overall Study|Pregnancy|3|||
49156461|NCT03299049|158414132|FG000|Overall Study|Protocol Violation|1|||
49156462|NCT03299049|158414133|FG001|Overall Study|Protocol Violation|1|||
48829787|NCT03523962|157217565|FG000|Closed Fractures|Death|86|||
48829788|NCT03523962|157217566|FG001|Closed Fractures|Death|71|||
48829789|NCT03523962|157217567|FG002|Closed Fractures|Death|0|||
48829790|NCT03523962|157217568|FG003|Closed Fractures|Death|0|||
48829791|NCT03523962|157217565|FG000|Closed Fractures|Lost to Follow-up|62|||
48829792|NCT03523962|157217566|FG001|Closed Fractures|Lost to Follow-up|36|||
48829793|NCT03523962|157217567|FG002|Closed Fractures|Lost to Follow-up|0|||
48829794|NCT03523962|157217568|FG003|Closed Fractures|Lost to Follow-up|0|||
48829795|NCT03523962|157217565|FG000|Closed Fractures|Withdrawal by Subject|19|||
49156463|NCT03299049|158414132|FG000|Overall Study|Lack of Efficacy|9|||
49156464|NCT03299049|158414133|FG001|Overall Study|Lack of Efficacy|3|||
49156465|NCT03299049|158414132|FG000|Overall Study|Adverse Event|12|||
49156466|NCT03299049|158414133|FG001|Overall Study|Adverse Event|13|||
49156467|NCT03038672|158414134|FG000|Initial Treatment|Unacceptable chemistry|0|||
49156468|NCT03038672|158414135|FG001|Initial Treatment|Unacceptable chemistry|1|||
49156469|NCT03038672|158414134|FG000|Initial Treatment|Progression prior to treatment|1|||
49156470|NCT03038672|158414135|FG001|Initial Treatment|Progression prior to treatment|0|||
49156471|NCT03038672|158414134|FG000|Initial Treatment|No treatment per protocol|1|||
49156472|NCT03038672|158414135|FG001|Initial Treatment|No treatment per protocol|0|||
48829796|NCT03523962|157217566|FG001|Closed Fractures|Withdrawal by Subject|29|||
48829797|NCT03523962|157217567|FG002|Closed Fractures|Withdrawal by Subject|0|||
49156473|NCT01246960|158414136|FG000|Overall Study|Lost to Follow-up|3|||
49156474|NCT01246960|158414137|FG001|Overall Study|Lost to Follow-up|1|||
49156475|NCT01246960|158414136|FG000|Overall Study|Withdrawal (by participant or physician)|3|||
49156476|NCT01246960|158414137|FG001|Overall Study|Withdrawal (by participant or physician)|3|||
49156477|NCT01225952|158414139|FG000|Overall Study|Lost to Follow-up|1|||
49156478|NCT01225952|158414140|FG001|Overall Study|Lost to Follow-up|0|||
49156479|NCT01225952|158414141|FG002|Overall Study|Lost to Follow-up|0|||
49156480|NCT01225952|158414139|FG000|Overall Study|Study Eye Explanted|0|||
49156481|NCT01225952|158414140|FG001|Overall Study|Study Eye Explanted|0|||
49156482|NCT01225952|158414141|FG002|Overall Study|Study Eye Explanted|1|||
49156483|NCT01225952|158414139|FG000|Overall Study|Withdrawal by Subject|4|||
49156484|NCT01225952|158414140|FG001|Overall Study|Withdrawal by Subject|4|||
49156485|NCT01225952|158414141|FG002|Overall Study|Withdrawal by Subject|5|||
49156486|NCT01225952|158414139|FG000|Overall Study|Surgical complications|1|||
49156487|NCT01225952|158414140|FG001|Overall Study|Surgical complications|0|||
49156488|NCT01225952|158414141|FG002|Overall Study|Surgical complications|0|||
49156489|NCT02378480|158414142|FG000|Overall Study|Physician Decision|1|||
49156490|NCT02378480|158414143|FG001|Overall Study|Physician Decision|1|||
49156491|NCT02378480|158414142|FG000|Overall Study|Death|1|||
49156492|NCT02378480|158414143|FG001|Overall Study|Death|2|||
49156493|NCT02378480|158414142|FG000|Overall Study|Randomized, but Not Treated|6|||
49156494|NCT02378480|158414143|FG001|Overall Study|Randomized, but Not Treated|4|||
49156495|NCT02378480|158414142|FG000|Overall Study|Adverse Event|0|||
49156496|NCT02378480|158414143|FG001|Overall Study|Adverse Event|1|||
49156497|NCT02378480|158414142|FG000|Overall Study|Missed EOT/PTE Visit|1|||
49156498|NCT02378480|158414143|FG001|Overall Study|Missed EOT/PTE Visit|2|||
49156499|NCT02378480|158414142|FG000|Overall Study|Withdrawal by Subject|9|||
49156500|NCT02378480|158414143|FG001|Overall Study|Withdrawal by Subject|4|||
49156501|NCT02378480|158414142|FG000|Overall Study|Lost to Follow-up|10|||
49156502|NCT02378480|158414143|FG001|Overall Study|Lost to Follow-up|18|||
49156503|NCT00954447|158414145|FG000|Overall Study|Adverse Event|33|||
49156504|NCT00954447|158414146|FG001|Overall Study|Adverse Event|25|||
49156505|NCT00954447|158414145|FG000|Overall Study|Lack of Efficacy|17|||
49156506|NCT00954447|158414146|FG001|Overall Study|Lack of Efficacy|3|||
48829798|NCT03523962|157217568|FG003|Closed Fractures|Withdrawal by Subject|0|||
49156507|NCT00954447|158414145|FG000|Overall Study|Protocol Violation|5|||
49156508|NCT00954447|158414146|FG001|Overall Study|Protocol Violation|7|||
49156509|NCT00954447|158414145|FG000|Overall Study|Lost to Follow-up|8|||
49156510|NCT00954447|158414146|FG001|Overall Study|Lost to Follow-up|14|||
49156511|NCT00954447|158414145|FG000|Overall Study|Withdrawal by Subject|26|||
48829799|NCT03523962|157217565|FG000|Closed Fractures|Incarceration|1|||
48829800|NCT03523962|157217566|FG001|Closed Fractures|Incarceration|4|||
48829801|NCT03523962|157217567|FG002|Closed Fractures|Incarceration|0|||
48829802|NCT03523962|157217568|FG003|Closed Fractures|Incarceration|0|||
48829803|NCT03523962|157217565|FG000|Open Fractures|Death|0|||
48829804|NCT03523962|157217566|FG001|Open Fractures|Death|0|||
48829805|NCT03523962|157217567|FG002|Open Fractures|Death|11|||
48829806|NCT03523962|157217568|FG003|Open Fractures|Death|6|||
48829807|NCT03523962|157217565|FG000|Open Fractures|Lost to Follow-up|0|||
48829808|NCT03523962|157217566|FG001|Open Fractures|Lost to Follow-up|0|||
48829809|NCT03523962|157217567|FG002|Open Fractures|Lost to Follow-up|15|||
48829810|NCT03523962|157217568|FG003|Open Fractures|Lost to Follow-up|8|||
48829811|NCT03523962|157217565|FG000|Open Fractures|Withdrawal by Subject|0|||
49156512|NCT00954447|158414146|FG001|Overall Study|Withdrawal by Subject|21|||
49156513|NCT00954447|158414145|FG000|Overall Study|Other|21|||
49156514|NCT00954447|158414146|FG001|Overall Study|Other|18|||
49156515|NCT03580044|158414152|FG000|Overall Study|Death|2|||
49156516|NCT03580044|158414153|FG001|Overall Study|Death|1|||
48829812|NCT03523962|157217566|FG001|Open Fractures|Withdrawal by Subject|0|||
48829813|NCT03523962|157217567|FG002|Open Fractures|Withdrawal by Subject|6|||
48829814|NCT03523962|157217568|FG003|Open Fractures|Withdrawal by Subject|2|||
48829815|NCT03523962|157217565|FG000|Open Fractures|Incarceration|0|||
48829816|NCT03523962|157217566|FG001|Open Fractures|Incarceration|0|||
48829817|NCT03523962|157217567|FG002|Open Fractures|Incarceration|1|||
48829818|NCT03523962|157217568|FG003|Open Fractures|Incarceration|0|||
48829819|NCT01835899|157217569|FG000|Overall Study|Adverse Event|0|||
48829820|NCT01835899|157217570|FG001|Overall Study|Adverse Event|0|||
48829821|NCT01835899|157217571|FG002|Overall Study|Adverse Event|1|||
48829822|NCT01835899|157217569|FG000|Overall Study|Other than stated above|0|||
48829823|NCT01835899|157217570|FG001|Overall Study|Other than stated above|1|||
48829824|NCT01835899|157217571|FG002|Overall Study|Other than stated above|0|||
48829825|NCT04716933|157217574|FG000|Overall Study|Ongoing|46|||
48829826|NCT04716933|157217575|FG001|Overall Study|Ongoing|37|||
48829827|NCT04716933|157217574|FG000|Overall Study|Sponsor Decision|55|||
48829828|NCT04716933|157217575|FG001|Overall Study|Sponsor Decision|63|||
48829829|NCT05484726|157217576|FG000|Overall Study|Protocol Violation|3|||
49156517|NCT03580044|158414152|FG000|Overall Study|Withdrawal by Subject|1|||
49156518|NCT03580044|158414153|FG001|Overall Study|Withdrawal by Subject|1|||
49156519|NCT00129974|158414154|FG000|Overall Study|Other|1|||
49156520|NCT03983421|158414155|FG000|Overall Study|Lost to Follow-up|1|||
49156521|NCT04573972|158414156|FG000|Overall Study|Dyad partner did not join study or did not walk >0 steps|32|||
49156522|NCT04573972|158414157|FG001|Overall Study|Dyad partner did not join study or did not walk >0 steps|14|||
49156523|NCT02441218|158414159|FG000|Overall Study|Death|503|||
49156524|NCT02441218|158414160|FG001|Overall Study|Death|553|||
48829830|NCT05484726|157217577|FG001|Overall Study|Protocol Violation|3|||
48829831|NCT05484726|157217576|FG000|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|4|||
48829832|NCT05484726|157217577|FG001|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|2|||
48829833|NCT05484726|157217576|FG000|Overall Study|HsPDA requiring antifailure therapy|1|||
48829834|NCT05484726|157217577|FG001|Overall Study|HsPDA requiring antifailure therapy|2|||
48829835|NCT05484726|157217576|FG000|Overall Study|continued need of mechanical ventilation|2|||
48829836|NCT05484726|157217577|FG001|Overall Study|continued need of mechanical ventilation|3|||
48829837|NCT05484726|157217576|FG000|Overall Study|Withdrawal by Subject|2|||
48829838|NCT05484726|157217577|FG001|Overall Study|Withdrawal by Subject|3|||
48829839|NCT05484726|157217576|FG000|Overall Study|IVH (G III & IV)|2|||
48829840|NCT05484726|157217577|FG001|Overall Study|IVH (G III & IV)|1|||
48829841|NCT05484726|157217576|FG000|Overall Study|NEC (stage II & III)|2|||
48829842|NCT05484726|157217577|FG001|Overall Study|NEC (stage II & III)|3|||
48829843|NCT02357784|157217579|FG000|Overall Study|Withdrawal by Subject|1|||
48829844|NCT00768066|157217580|FG000|Overall Study|Did not receive study product injection.|3|||
48829845|NCT00768066|157217581|FG001|Overall Study|Did not receive study product injection.|3|||
48829846|NCT00768066|157217582|FG002|Overall Study|Did not receive study product injection.|0|||
48829847|NCT03538054|157217583|FG000|Baseline Phase (2 Weeks)|Physician Decision|1|||
49156525|NCT02441218|158414159|FG000|Overall Study|Withdrawal by Subject|73|||
48829848|NCT03538054|157217583|FG000|Placebo Phase (5 Weeks)|Withdrawal by Subject|2|||
48829849|NCT03538054|157217583|FG000|Dextromethorphan Phase (10 Weeks)|Withdrawal by Subject|2|||
49156526|NCT02441218|158414160|FG001|Overall Study|Withdrawal by Subject|58|||
49156527|NCT02441218|158414159|FG000|Overall Study|Lost to Follow-up|2|||
48829850|NCT02132702|157217587|FG000|Overall Study|Protocol Violation|2|||
49156528|NCT02441218|158414160|FG001|Overall Study|Lost to Follow-up|1|||
49156529|NCT00399529|158414161|FG000|Overall Study|Off Study Prior to Treatment|2|||
49156530|NCT02006927|158414167|FG000|Overall Study|Adverse Event|2|||
49156531|NCT02006927|158414167|FG000|Overall Study|Withdrawal by Subject|1|||
49156532|NCT02735200|158414168|FG000|Overall Study|Lost to Follow-up|0|||
49156533|NCT02735200|158414169|FG001|Overall Study|Lost to Follow-up|5|||
49156534|NCT02735200|158414168|FG000|Overall Study|Withdrawal by Subject|8|||
49156535|NCT02735200|158414169|FG001|Overall Study|Withdrawal by Subject|0|||
49156536|NCT02746809|158414170|FG000|Enrollment|Inclusion Exclusion not met|9|||
49156537|NCT02746809|158414170|FG000|Enrollment|Withdrawal by Subject|1|||
49156538|NCT02746809|158414170|FG000|Enrollment|Expected Enrollment Met|2|||
49156539|NCT02746809|158414170|FG000|Procedure|Death|1|||
49156540|NCT02746809|158414170|FG000|1-Month|Death|5|||
49156541|NCT02746809|158414170|FG000|6-Month|Death|2|||
49156542|NCT02746809|158414170|FG000|6-Month|Withdrawal by Subject|1|||
49156543|NCT02746809|158414170|FG000|12-Month|Death|3|||
49156544|NCT02746809|158414170|FG000|12-Month|Withdrawal by Subject|2|||
49156545|NCT02746809|158414170|FG000|24-Month|Death|1|||
49156546|NCT02746809|158414170|FG000|24-Month|Withdrawal by Subject|1|||
49156547|NCT02746809|158414170|FG000|36-Month|Death|8|||
49156548|NCT02746809|158414170|FG000|36-Month|Withdrawal by Subject|1|||
49156549|NCT02746809|158414170|FG000|48-Month|Death|7|||
49156550|NCT02746809|158414170|FG000|48-Month|Withdrawal by Subject|1|||
49156551|NCT02746809|158414170|FG000|60-Month|Death|1|||
49156552|NCT02746809|158414170|FG000|60-Month|Lost to Follow-up|2|||
49156553|NCT00673920|158414171|FG000|Baseline up to Week 48|Withdrew consent|1|||
49156554|NCT00673920|158414172|FG001|Baseline up to Week 48|Withdrew consent|0|||
48829851|NCT02132702|157217587|FG000|Overall Study|Adverse Event|3|||
48829852|NCT02132702|157217587|FG000|Overall Study|Withdrawal by Subject|3|||
48829853|NCT04697069|157217588|FG000|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|0|||
48829854|NCT04697069|157217589|FG001|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|1|||
48829855|NCT04697069|157217588|FG000|Overall Study|Study termination|2|||
48829856|NCT04697069|157217589|FG001|Overall Study|Study termination|1|||
48829857|NCT04133363|157217592|FG000|Overall Study|Lost to Follow-up|2|||
48829858|NCT04133363|157217593|FG001|Overall Study|Lost to Follow-up|1|||
48829859|NCT04133363|157217594|FG002|Overall Study|Lost to Follow-up|4|||
48829860|NCT01306331|157219344|FG000|Overall Study|Adverse Event|28|||
48829861|NCT01306331|157219345|FG001|Overall Study|Adverse Event|25|||
48829862|NCT01306331|157219344|FG000|Overall Study|Lost to Follow-up|321|||
48829863|NCT01306331|157219345|FG001|Overall Study|Lost to Follow-up|323|||
48829864|NCT01306331|157219344|FG000|Overall Study|Physician Decision|26|||
48829865|NCT01306331|157219345|FG001|Overall Study|Physician Decision|22|||
49156555|NCT00673920|158414173|FG002|Baseline up to Week 48|Withdrew consent|2|||
49156556|NCT00673920|158414174|FG003|Baseline up to Week 48|Withdrew consent|0|||
49156557|NCT00673920|158414175|FG004|Baseline up to Week 48|Withdrew consent|0|||
49156558|NCT00673920|158414176|FG005|Baseline up to Week 48|Withdrew consent|0|||
49156559|NCT00673920|158414177|FG006|Baseline up to Week 48|Withdrew consent|0|||
49156560|NCT00673920|158414178|FG007|Baseline up to Week 48|Withdrew consent|0|||
48829866|NCT01306331|157219344|FG000|Overall Study|Pregnancy|136|||
48829867|NCT01306331|157219345|FG001|Overall Study|Pregnancy|151|||
48829868|NCT01306331|157219344|FG000|Overall Study|Protocol Violation|154|||
48829869|NCT01306331|157219345|FG001|Overall Study|Protocol Violation|124|||
48829870|NCT01306331|157219344|FG000|Overall Study|Withdrawal by Subject|163|||
48829871|NCT01306331|157219345|FG001|Overall Study|Withdrawal by Subject|152|||
48829872|NCT01306331|157219344|FG000|Overall Study|Not sexually active|29|||
48829873|NCT01306331|157219345|FG001|Overall Study|Not sexually active|28|||
48829874|NCT01306331|157219344|FG000|Overall Study|Meth. no longer prim. meth. birth cntrl|10|||
49156561|NCT00673920|158414171|FG000|Baseline up to Week 48|Refused treatment|1|||
49156562|NCT00673920|158414172|FG001|Baseline up to Week 48|Refused treatment|0|||
49156563|NCT00673920|158414173|FG002|Baseline up to Week 48|Refused treatment|0|||
49156564|NCT00673920|158414174|FG003|Baseline up to Week 48|Refused treatment|0|||
48829875|NCT01306331|157219345|FG001|Overall Study|Meth. no longer prim. meth. birth cntrl|20|||
48829876|NCT01306331|157219344|FG000|Overall Study|Other|34|||
48829877|NCT01306331|157219345|FG001|Overall Study|Other|32|||
48829878|NCT01211665|157219346|FG000|Overall Study|Withdrawal by Subject|1|||
48829879|NCT01211665|157219347|FG001|Overall Study|Withdrawal by Subject|0|||
48829880|NCT01211665|157219346|FG000|Overall Study|Death|1|||
48829881|NCT01211665|157219347|FG001|Overall Study|Death|0|||
48829882|NCT00567879|157219348|FG000|Overall Study|Adverse Event|2|||
48829883|NCT00567879|157219349|FG001|Overall Study|Adverse Event|0|||
48829884|NCT00567879|157219350|FG002|Overall Study|Adverse Event|1|||
48829885|NCT00567879|157219351|FG003|Overall Study|Adverse Event|0|||
48829886|NCT00567879|157219352|FG004|Overall Study|Adverse Event|1|||
48829887|NCT00567879|157219353|FG005|Overall Study|Adverse Event|0|||
48829888|NCT00567879|157219348|FG000|Overall Study|Abnormal test procedure(s)|0|||
48829889|NCT00567879|157219349|FG001|Overall Study|Abnormal test procedure(s)|0|||
48829890|NCT00567879|157219350|FG002|Overall Study|Abnormal test procedure(s)|1|||
48829891|NCT00567879|157219351|FG003|Overall Study|Abnormal test procedure(s)|0|||
48829892|NCT00567879|157219352|FG004|Overall Study|Abnormal test procedure(s)|0|||
48829893|NCT00567879|157219353|FG005|Overall Study|Abnormal test procedure(s)|0|||
48829894|NCT00567879|157219348|FG000|Overall Study|Withdrawal by Subject|0|||
48829895|NCT00567879|157219349|FG001|Overall Study|Withdrawal by Subject|0|||
48829896|NCT00567879|157219350|FG002|Overall Study|Withdrawal by Subject|3|||
48829897|NCT00567879|157219351|FG003|Overall Study|Withdrawal by Subject|1|||
48829898|NCT00567879|157219352|FG004|Overall Study|Withdrawal by Subject|0|||
48829899|NCT00567879|157219353|FG005|Overall Study|Withdrawal by Subject|0|||
48829900|NCT00567879|157219348|FG000|Overall Study|New cancer therapy|0|||
48829901|NCT00567879|157219349|FG001|Overall Study|New cancer therapy|0|||
48829902|NCT00567879|157219350|FG002|Overall Study|New cancer therapy|1|||
48829903|NCT00567879|157219351|FG003|Overall Study|New cancer therapy|0|||
48829904|NCT00567879|157219352|FG004|Overall Study|New cancer therapy|0|||
48829905|NCT00567879|157219353|FG005|Overall Study|New cancer therapy|0|||
48829906|NCT00567879|157219348|FG000|Overall Study|Disease progression|5|||
48829907|NCT00567879|157219349|FG001|Overall Study|Disease progression|7|||
48829908|NCT00567879|157219350|FG002|Overall Study|Disease progression|15|||
48829909|NCT00567879|157219351|FG003|Overall Study|Disease progression|5|||
48829910|NCT00567879|157219352|FG004|Overall Study|Disease progression|11|||
48829911|NCT00567879|157219353|FG005|Overall Study|Disease progression|3|||
48829912|NCT00938340|157219355|FG000|Overall Study|Withdrawal by Subject|3|||
48829913|NCT00938340|157219355|FG000|Overall Study|Protocol Violation|1|||
48829914|NCT00938340|157219355|FG000|Overall Study|Adverse Event|1|||
48829915|NCT03396835|157219356|FG000|Overall Study|Withdrawn prior to completion|1|||
48829916|NCT03396835|157219356|FG000|Overall Study|Did not meet criteria for data analysis|1|||
48829917|NCT04310579|157219357|FG000|Overall Study|Adverse Event|0|||
48829918|NCT04310579|157219358|FG001|Overall Study|Adverse Event|0|||
48829919|NCT04310579|157219359|FG002|Overall Study|Adverse Event|0|||
48829920|NCT04310579|157219360|FG003|Overall Study|Adverse Event|0|||
48829921|NCT04310579|157219361|FG004|Overall Study|Adverse Event|0|||
48829922|NCT04310579|157219362|FG005|Overall Study|Adverse Event|0|||
48829923|NCT04310579|157219363|FG006|Overall Study|Adverse Event|2|||
48829924|NCT04310579|157219364|FG007|Overall Study|Adverse Event|0|||
48829925|NCT04310579|157219365|FG008|Overall Study|Adverse Event|1|||
48829926|NCT04310579|157219366|FG009|Overall Study|Adverse Event|1|||
48829927|NCT04310579|157219367|FG010|Overall Study|Adverse Event|0|||
48829928|NCT04310579|157219357|FG000|Overall Study|Withdrawal by Subject|0|||
48829929|NCT04310579|157219358|FG001|Overall Study|Withdrawal by Subject|0|||
48829930|NCT04310579|157219359|FG002|Overall Study|Withdrawal by Subject|0|||
48829931|NCT04310579|157219360|FG003|Overall Study|Withdrawal by Subject|0|||
48829932|NCT04310579|157219361|FG004|Overall Study|Withdrawal by Subject|0|||
48829933|NCT04310579|157219362|FG005|Overall Study|Withdrawal by Subject|1|||
48829934|NCT04310579|157219363|FG006|Overall Study|Withdrawal by Subject|0|||
48829935|NCT04310579|157219364|FG007|Overall Study|Withdrawal by Subject|0|||
48829936|NCT04310579|157219365|FG008|Overall Study|Withdrawal by Subject|0|||
48829937|NCT04310579|157219366|FG009|Overall Study|Withdrawal by Subject|0|||
48829938|NCT04310579|157219367|FG010|Overall Study|Withdrawal by Subject|0|||
48829939|NCT04310579|157219357|FG000|Overall Study|Positive COVID-19 test|0|||
48829940|NCT04310579|157219358|FG001|Overall Study|Positive COVID-19 test|0|||
48829941|NCT04310579|157219359|FG002|Overall Study|Positive COVID-19 test|0|||
49156565|NCT00673920|158414175|FG004|Baseline up to Week 48|Refused treatment|0|||
48829942|NCT04310579|157219360|FG003|Overall Study|Positive COVID-19 test|0|||
48829943|NCT04310579|157219361|FG004|Overall Study|Positive COVID-19 test|0|||
48829944|NCT04310579|157219362|FG005|Overall Study|Positive COVID-19 test|0|||
48829945|NCT04310579|157219363|FG006|Overall Study|Positive COVID-19 test|0|||
48829946|NCT04310579|157219364|FG007|Overall Study|Positive COVID-19 test|0|||
48829947|NCT04310579|157219365|FG008|Overall Study|Positive COVID-19 test|0|||
48829948|NCT04310579|157219366|FG009|Overall Study|Positive COVID-19 test|0|||
48829949|NCT04310579|157219367|FG010|Overall Study|Positive COVID-19 test|1|||
48829950|NCT03721016|157219370|FG000|Overall Study|Adverse Event|0|||
48829951|NCT03721016|157219371|FG001|Overall Study|Adverse Event|1|||
48829952|NCT03721016|157219372|FG002|Overall Study|Adverse Event|1|||
48829953|NCT03721016|157219370|FG000|Overall Study|Withdrawal by Subject|8|||
48829954|NCT03721016|157219371|FG001|Overall Study|Withdrawal by Subject|16|||
48829955|NCT03721016|157219372|FG002|Overall Study|Withdrawal by Subject|13|||
48829956|NCT03721016|157219370|FG000|Overall Study|Lost to Follow-up|4|||
48829957|NCT03721016|157219371|FG001|Overall Study|Lost to Follow-up|6|||
48829958|NCT03721016|157219372|FG002|Overall Study|Lost to Follow-up|5|||
48829959|NCT03721016|157219370|FG000|Overall Study|Physician Decision|0|||
48829960|NCT03721016|157219371|FG001|Overall Study|Physician Decision|1|||
48829961|NCT03721016|157219372|FG002|Overall Study|Physician Decision|2|||
48829962|NCT03721016|157219370|FG000|Overall Study|Protocol Violation|0|||
48829963|NCT03721016|157219371|FG001|Overall Study|Protocol Violation|1|||
48829964|NCT03721016|157219372|FG002|Overall Study|Protocol Violation|0|||
48829965|NCT03721016|157219370|FG000|Overall Study|Site terminated by sponsor|3|||
48829966|NCT03721016|157219371|FG001|Overall Study|Site terminated by sponsor|7|||
48829967|NCT03721016|157219372|FG002|Overall Study|Site terminated by sponsor|6|||
48829968|NCT03721016|157219370|FG000|Overall Study|Subject exited early due to COVID-19|1|||
48829969|NCT03721016|157219371|FG001|Overall Study|Subject exited early due to COVID-19|0|||
48829970|NCT03721016|157219372|FG002|Overall Study|Subject exited early due to COVID-19|0|||
48829971|NCT04148937|157219375|FG000|Overall Study|Withdrawal by Subject|0|||
48829972|NCT04148937|157219376|FG001|Overall Study|Withdrawal by Subject|0|||
48829973|NCT04148937|157219377|FG002|Overall Study|Withdrawal by Subject|0|||
48829974|NCT04148937|157219378|FG003|Overall Study|Withdrawal by Subject|1|||
48829975|NCT04148937|157219379|FG004|Overall Study|Withdrawal by Subject|0|||
48829976|NCT04148937|157219380|FG005|Overall Study|Withdrawal by Subject|1|||
48829977|NCT04148937|157219381|FG006|Overall Study|Withdrawal by Subject|1|||
48829978|NCT04148937|157219382|FG007|Overall Study|Withdrawal by Subject|0|||
48829979|NCT04148937|157219375|FG000|Overall Study|Lost to Follow-up|0|||
48829980|NCT04148937|157219376|FG001|Overall Study|Lost to Follow-up|0|||
48829981|NCT04148937|157219377|FG002|Overall Study|Lost to Follow-up|1|||
48829982|NCT04148937|157219378|FG003|Overall Study|Lost to Follow-up|0|||
48829983|NCT04148937|157219379|FG004|Overall Study|Lost to Follow-up|0|||
48829984|NCT04148937|157219380|FG005|Overall Study|Lost to Follow-up|2|||
48829985|NCT04148937|157219381|FG006|Overall Study|Lost to Follow-up|0|||
48829986|NCT04148937|157219382|FG007|Overall Study|Lost to Follow-up|0|||
48829987|NCT01803646|157219383|FG000|Overall Study|Protocol Violation|1|||
48829988|NCT01803646|157219384|FG001|Overall Study|Protocol Violation|0|||
48829989|NCT01803646|157219383|FG000|Overall Study|Adverse Event|1|||
48829990|NCT01803646|157219384|FG001|Overall Study|Adverse Event|1|||
48829991|NCT01803646|157219383|FG000|Overall Study|Withdrawal by Subject|9|||
48829992|NCT01803646|157219384|FG001|Overall Study|Withdrawal by Subject|6|||
48829993|NCT01803646|157219383|FG000|Overall Study|Randomization error|1|||
48829994|NCT01803646|157219384|FG001|Overall Study|Randomization error|2|||
48829995|NCT01803646|157219383|FG000|Overall Study|Lost to Follow-up|5|||
48829996|NCT01803646|157219384|FG001|Overall Study|Lost to Follow-up|1|||
48829997|NCT01020838|157219385|FG000|Overall Study|Death|90|||
48829998|NCT01020838|157219385|FG000|Overall Study|Adverse Event|1|||
48829999|NCT01020838|157219385|FG000|Overall Study|Withdrawal by Subject|9|||
48830000|NCT01020838|157219385|FG000|Overall Study|Lost to Follow-up|6|||
48830001|NCT01020838|157219385|FG000|Overall Study|Most common: Study ended by sponsor|77|||
48830002|NCT01167426|157219386|FG000|Overall Study|Lost to Follow-up|6|||
48830003|NCT01167426|157219386|FG000|Overall Study|Protocol Violation|1|||
48830004|NCT01167426|157219386|FG000|Overall Study|Withdrawal by Subject|2|||
48830005|NCT01167426|157219386|FG000|Overall Study|Sponsor Decision|1|||
48830006|NCT00003656|157219389|FG000|Overall Study|Adverse Event|0|||
48830007|NCT00003656|157219390|FG001|Overall Study|Adverse Event|1|||
48830008|NCT03095508|157219396|FG000|Overall Study|Adverse Event|0|||
48830009|NCT03095508|157219397|FG001|Overall Study|Adverse Event|1|||
49156566|NCT00673920|158414176|FG005|Baseline up to Week 48|Refused treatment|0|||
49156567|NCT00673920|158414177|FG006|Baseline up to Week 48|Refused treatment|0|||
49156568|NCT00673920|158414178|FG007|Baseline up to Week 48|Refused treatment|0|||
49156569|NCT00673920|158414171|FG000|Baseline up to Week 48|Insufficient therapeutic response|2|||
48830010|NCT02954055|157219407|FG000|Overall Study|Did not initiate therapy|6|||
48830011|NCT02954055|157219408|FG001|Overall Study|Did not initiate therapy|1|||
48830012|NCT01511250|157219409|FG000|Overall Study|Withdrawal of Consent|1|||
48830013|NCT01511250|157219410|FG001|Overall Study|Withdrawal of Consent|0|||
49156570|NCT00673920|158414172|FG001|Baseline up to Week 48|Insufficient therapeutic response|1|||
49156571|NCT00673920|158414173|FG002|Baseline up to Week 48|Insufficient therapeutic response|0|||
48830014|NCT01511250|157219411|FG002|Overall Study|Withdrawal of Consent|0|||
48830015|NCT01511250|157219412|FG003|Overall Study|Withdrawal of Consent|0|||
48830016|NCT01511250|157219413|FG004|Overall Study|Withdrawal of Consent|0|||
49156572|NCT00673920|158414174|FG003|Baseline up to Week 48|Insufficient therapeutic response|0|||
48830017|NCT01511250|157219414|FG005|Overall Study|Withdrawal of Consent|0|||
48830018|NCT01511250|157219415|FG006|Overall Study|Withdrawal of Consent|0|||
48830019|NCT01511250|157219416|FG007|Overall Study|Withdrawal of Consent|1|||
48830020|NCT01511250|157219417|FG008|Overall Study|Withdrawal of Consent|1|||
49014548|NCT03538756|157888918|FG002|Long-Term Follow-up|Death|1|||
48830021|NCT01511250|157219418|FG009|Overall Study|Withdrawal of Consent|0|||
48830022|NCT01511250|157219409|FG000|Overall Study|Sponsor/Investigator Decision|1|||
48830023|NCT01511250|157219410|FG001|Overall Study|Sponsor/Investigator Decision|0|||
48830024|NCT01511250|157219411|FG002|Overall Study|Sponsor/Investigator Decision|0|||
48830025|NCT01511250|157219412|FG003|Overall Study|Sponsor/Investigator Decision|0|||
48830026|NCT01511250|157219413|FG004|Overall Study|Sponsor/Investigator Decision|0|||
48830027|NCT01511250|157219414|FG005|Overall Study|Sponsor/Investigator Decision|0|||
48830028|NCT01511250|157219415|FG006|Overall Study|Sponsor/Investigator Decision|0|||
48830029|NCT01511250|157219416|FG007|Overall Study|Sponsor/Investigator Decision|0|||
48830030|NCT01511250|157219417|FG008|Overall Study|Sponsor/Investigator Decision|0|||
48830031|NCT01511250|157219418|FG009|Overall Study|Sponsor/Investigator Decision|0|||
48830032|NCT01511250|157219409|FG000|Overall Study|Lost to Follow-up|7|||
48830033|NCT01511250|157219410|FG001|Overall Study|Lost to Follow-up|3|||
48830034|NCT01511250|157219411|FG002|Overall Study|Lost to Follow-up|3|||
48830035|NCT01511250|157219412|FG003|Overall Study|Lost to Follow-up|3|||
48830036|NCT01511250|157219413|FG004|Overall Study|Lost to Follow-up|0|||
48830037|NCT01511250|157219414|FG005|Overall Study|Lost to Follow-up|0|||
48830038|NCT01511250|157219415|FG006|Overall Study|Lost to Follow-up|2|||
48830039|NCT01511250|157219416|FG007|Overall Study|Lost to Follow-up|3|||
48830040|NCT01511250|157219417|FG008|Overall Study|Lost to Follow-up|13|||
48830041|NCT01511250|157219418|FG009|Overall Study|Lost to Follow-up|5|||
48830042|NCT01511250|157219409|FG000|Overall Study|Protocol Violation|0|||
48830043|NCT01511250|157219410|FG001|Overall Study|Protocol Violation|2|||
48830044|NCT01511250|157219411|FG002|Overall Study|Protocol Violation|1|||
48830045|NCT01511250|157219412|FG003|Overall Study|Protocol Violation|0|||
48830046|NCT01511250|157219413|FG004|Overall Study|Protocol Violation|0|||
48830047|NCT01511250|157219414|FG005|Overall Study|Protocol Violation|0|||
48830048|NCT01511250|157219415|FG006|Overall Study|Protocol Violation|0|||
48830049|NCT01511250|157219416|FG007|Overall Study|Protocol Violation|0|||
48830050|NCT01511250|157219417|FG008|Overall Study|Protocol Violation|0|||
48830051|NCT01511250|157219418|FG009|Overall Study|Protocol Violation|0|||
48830052|NCT01710514|157219419|FG000|Overall Study|Adverse Event|6|||
48830053|NCT01710514|157219420|FG001|Overall Study|Adverse Event|7|||
48830054|NCT01710514|157219419|FG000|Overall Study|Withdrawal by Subject|1|||
48830055|NCT01710514|157219420|FG001|Overall Study|Withdrawal by Subject|0|||
48830056|NCT04044664|157219423|FG000|Stage 1|Adverse Event|3|||
48830057|NCT04044664|157219424|FG001|Stage 1|Adverse Event|3|||
48830058|NCT04044664|157219425|FG002|Stage 1|Adverse Event|1|||
48830059|NCT04044664|157219423|FG000|Stage 1|Lost to Follow-up|3|||
48830060|NCT04044664|157219424|FG001|Stage 1|Lost to Follow-up|2|||
48830061|NCT04044664|157219425|FG002|Stage 1|Lost to Follow-up|2|||
48830062|NCT04044664|157219423|FG000|Stage 1|Withdrawal by Subject|9|||
48830063|NCT04044664|157219424|FG001|Stage 1|Withdrawal by Subject|1|||
48830064|NCT04044664|157219425|FG002|Stage 1|Withdrawal by Subject|0|||
48830065|NCT04044664|157219423|FG000|Stage 1|noncompliance, personal reason|2|||
48830066|NCT04044664|157219424|FG001|Stage 1|noncompliance, personal reason|0|||
48830067|NCT04044664|157219425|FG002|Stage 1|noncompliance, personal reason|0|||
48830068|NCT04044664|157219423|FG000|Stage 1|randomization error|0|||
48830069|NCT04044664|157219424|FG001|Stage 1|randomization error|1|||
48830070|NCT04044664|157219425|FG002|Stage 1|randomization error|0|||
48830071|NCT04044664|157219423|FG000|Stage 2|Adverse Event|2|||
48830072|NCT04044664|157219424|FG001|Stage 2|Adverse Event|0|||
48830073|NCT04044664|157219425|FG002|Stage 2|Adverse Event|0|||
48830074|NCT04044664|157219423|FG000|Stage 2|Lost to Follow-up|3|||
48830075|NCT04044664|157219424|FG001|Stage 2|Lost to Follow-up|2|||
48830076|NCT04044664|157219425|FG002|Stage 2|Lost to Follow-up|1|||
48830077|NCT04044664|157219423|FG000|Stage 2|Withdrawal by Subject|3|||
48830078|NCT04044664|157219424|FG001|Stage 2|Withdrawal by Subject|0|||
48830079|NCT04044664|157219425|FG002|Stage 2|Withdrawal by Subject|0|||
48830080|NCT04044664|157219423|FG000|Stage 2|protocol deviation|1|||
48830081|NCT04044664|157219424|FG001|Stage 2|protocol deviation|0|||
48830082|NCT04044664|157219425|FG002|Stage 2|protocol deviation|0|||
48830083|NCT00320489|157219426|FG000|Overall Study|Adverse Event|26|||
48830084|NCT00320489|157219427|FG001|Overall Study|Adverse Event|25|||
48830085|NCT00320489|157219426|FG000|Overall Study|Clinical Relapse|26|||
48830086|NCT00320489|157219427|FG001|Overall Study|Clinical Relapse|20|||
48830087|NCT00320489|157219426|FG000|Overall Study|Death|0|||
48830088|NCT00320489|157219427|FG001|Overall Study|Death|2|||
48830089|NCT00320489|157219426|FG000|Overall Study|Entry Criteria Exclusion|2|||
48830090|NCT00320489|157219427|FG001|Overall Study|Entry Criteria Exclusion|4|||
48830091|NCT00320489|157219426|FG000|Overall Study|Lack of Efficacy|16|||
48830092|NCT00320489|157219427|FG001|Overall Study|Lack of Efficacy|7|||
48830093|NCT00320489|157219426|FG000|Overall Study|Lost to Follow-up|21|||
48830094|NCT00320489|157219427|FG001|Overall Study|Lost to Follow-up|22|||
48830095|NCT00320489|157219426|FG000|Overall Study|Physician Decision|8|||
48830096|NCT00320489|157219427|FG001|Overall Study|Physician Decision|8|||
48830097|NCT00320489|157219426|FG000|Overall Study|Protocol Violation|4|||
48830098|NCT00320489|157219427|FG001|Overall Study|Protocol Violation|4|||
48830099|NCT00320489|157219426|FG000|Overall Study|Sponsor Decision|3|||
48830100|NCT00320489|157219427|FG001|Overall Study|Sponsor Decision|3|||
48830101|NCT00320489|157219426|FG000|Overall Study|Withdrawal by Subject|39|||
49156573|NCT00673920|158414175|FG004|Baseline up to Week 48|Insufficient therapeutic response|0|||
49156574|NCT00673920|158414176|FG005|Baseline up to Week 48|Insufficient therapeutic response|0|||
48830102|NCT00320489|157219427|FG001|Overall Study|Withdrawal by Subject|41|||
49156575|NCT00673920|158414177|FG006|Baseline up to Week 48|Insufficient therapeutic response|0|||
49156576|NCT00673920|158414178|FG007|Baseline up to Week 48|Insufficient therapeutic response|0|||
49156577|NCT00673920|158414171|FG000|Baseline up to Week 48|Protocol Violation|0|||
49156578|NCT00673920|158414172|FG001|Baseline up to Week 48|Protocol Violation|0|||
49156579|NCT00673920|158414173|FG002|Baseline up to Week 48|Protocol Violation|1|||
49156580|NCT00673920|158414174|FG003|Baseline up to Week 48|Protocol Violation|0|||
49156581|NCT00673920|158414175|FG004|Baseline up to Week 48|Protocol Violation|0|||
49156582|NCT00673920|158414176|FG005|Baseline up to Week 48|Protocol Violation|0|||
49156583|NCT00673920|158414177|FG006|Baseline up to Week 48|Protocol Violation|0|||
49156584|NCT00673920|158414178|FG007|Baseline up to Week 48|Protocol Violation|0|||
49156585|NCT00673920|158414171|FG000|Baseline up to Week 48|Violation of selection criteria at entry|0|||
49156586|NCT00673920|158414172|FG001|Baseline up to Week 48|Violation of selection criteria at entry|0|||
49156587|NCT00673920|158414173|FG002|Baseline up to Week 48|Violation of selection criteria at entry|1|||
49156588|NCT00673920|158414174|FG003|Baseline up to Week 48|Violation of selection criteria at entry|0|||
49156589|NCT00673920|158414175|FG004|Baseline up to Week 48|Violation of selection criteria at entry|0|||
49156590|NCT00673920|158414176|FG005|Baseline up to Week 48|Violation of selection criteria at entry|0|||
49156591|NCT00673920|158414177|FG006|Baseline up to Week 48|Violation of selection criteria at entry|0|||
49156592|NCT00673920|158414178|FG007|Baseline up to Week 48|Violation of selection criteria at entry|0|||
49156593|NCT00673920|158414171|FG000|Baseline up to Week 48|Administrative/Other|0|||
49156594|NCT00673920|158414172|FG001|Baseline up to Week 48|Administrative/Other|1|||
49156595|NCT00673920|158414173|FG002|Baseline up to Week 48|Administrative/Other|2|||
49156596|NCT00673920|158414174|FG003|Baseline up to Week 48|Administrative/Other|0|||
49156597|NCT00673920|158414175|FG004|Baseline up to Week 48|Administrative/Other|0|||
49156598|NCT00673920|158414176|FG005|Baseline up to Week 48|Administrative/Other|0|||
49156599|NCT00673920|158414177|FG006|Baseline up to Week 48|Administrative/Other|0|||
49156600|NCT00673920|158414178|FG007|Baseline up to Week 48|Administrative/Other|0|||
49156601|NCT00673920|158414171|FG000|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
49156602|NCT00673920|158414172|FG001|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
49156603|NCT00673920|158414173|FG002|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
49156604|NCT00673920|158414174|FG003|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
49156605|NCT00673920|158414175|FG004|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
49156606|NCT00673920|158414176|FG005|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
49156607|NCT00673920|158414177|FG006|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
49156608|NCT00673920|158414178|FG007|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
49156609|NCT00673920|158414171|FG000|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
49156610|NCT00673920|158414172|FG001|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
49156611|NCT00673920|158414173|FG002|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
49156612|NCT00673920|158414174|FG003|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
49156613|NCT00673920|158414175|FG004|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
49156614|NCT00673920|158414176|FG005|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
49156615|NCT00673920|158414177|FG006|Week 24 to Week 48|Adverse event/intercurrent illness|1|||
49156616|NCT00673920|158414178|FG007|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
49156617|NCT00673920|158414171|FG000|Week 24 to Week 48|Failure to return|0|||
49156618|NCT00673920|158414172|FG001|Week 24 to Week 48|Failure to return|0|||
49156619|NCT00673920|158414173|FG002|Week 24 to Week 48|Failure to return|0|||
49156620|NCT00673920|158414174|FG003|Week 24 to Week 48|Failure to return|0|||
49156621|NCT00673920|158414175|FG004|Week 24 to Week 48|Failure to return|0|||
49156622|NCT00673920|158414176|FG005|Week 24 to Week 48|Failure to return|1|||
49156623|NCT00673920|158414177|FG006|Week 24 to Week 48|Failure to return|0|||
49156624|NCT00673920|158414178|FG007|Week 24 to Week 48|Failure to return|0|||
49156625|NCT00673920|158414171|FG000|Week 24 to Week 48|Insufficient therapeutic response|0|||
49156626|NCT00673920|158414172|FG001|Week 24 to Week 48|Insufficient therapeutic response|0|||
49156627|NCT00673920|158414173|FG002|Week 24 to Week 48|Insufficient therapeutic response|0|||
49156628|NCT00673920|158414174|FG003|Week 24 to Week 48|Insufficient therapeutic response|0|||
49156629|NCT00673920|158414175|FG004|Week 24 to Week 48|Insufficient therapeutic response|0|||
49156630|NCT00673920|158414176|FG005|Week 24 to Week 48|Insufficient therapeutic response|1|||
49156631|NCT00673920|158414177|FG006|Week 24 to Week 48|Insufficient therapeutic response|0|||
49156632|NCT00673920|158414178|FG007|Week 24 to Week 48|Insufficient therapeutic response|0|||
49156633|NCT00673920|158414171|FG000|Week 24 to Week 48|Death|0|||
49156634|NCT00673920|158414172|FG001|Week 24 to Week 48|Death|0|||
49156635|NCT00673920|158414173|FG002|Week 24 to Week 48|Death|0|||
49156636|NCT00673920|158414174|FG003|Week 24 to Week 48|Death|0|||
49156637|NCT00673920|158414175|FG004|Week 24 to Week 48|Death|0|||
49156638|NCT00673920|158414176|FG005|Week 24 to Week 48|Death|1|||
49156639|NCT00673920|158414177|FG006|Week 24 to Week 48|Death|0|||
49156640|NCT00673920|158414178|FG007|Week 24 to Week 48|Death|0|||
48830103|NCT02322216|157219430|FG000|Overall Study|Adverse Event|1|||
48830104|NCT02322216|157219431|FG001|Overall Study|Adverse Event|0|||
48830105|NCT02322216|157219430|FG000|Overall Study|Withdrawal by Subject|1|||
48830106|NCT02322216|157219431|FG001|Overall Study|Withdrawal by Subject|4|||
48830107|NCT02954848|157219434|FG000|Overall Study|Randomized but Not Treated|0|||
48830108|NCT02954848|157219435|FG001|Overall Study|Randomized but Not Treated|1|||
49156641|NCT00673920|158414171|FG000|Week 24 to Week 48|Adminstrative/Other|0|||
49156642|NCT00673920|158414172|FG001|Week 24 to Week 48|Adminstrative/Other|0|||
49156643|NCT00673920|158414173|FG002|Week 24 to Week 48|Adminstrative/Other|0|||
48830109|NCT02954848|157219434|FG000|Overall Study|Adverse Event|2|||
48830110|NCT02954848|157219435|FG001|Overall Study|Adverse Event|3|||
48830111|NCT02954848|157219434|FG000|Overall Study|Withdrawal by Participant|0|||
48830112|NCT02954848|157219435|FG001|Overall Study|Withdrawal by Participant|1|||
48830113|NCT01253226|157219437|FG000|Overall Study|Adverse Event|0|||
48830114|NCT01253226|157219438|FG001|Overall Study|Adverse Event|0|||
48830115|NCT01253226|157219439|FG002|Overall Study|Adverse Event|1|||
48830116|NCT01253226|157219440|FG003|Overall Study|Adverse Event|0|||
48830117|NCT01253226|157219441|FG004|Overall Study|Adverse Event|0|||
48830118|NCT01253226|157219437|FG000|Overall Study|Death|0|||
48830119|NCT01253226|157219438|FG001|Overall Study|Death|1|||
48830120|NCT01253226|157219439|FG002|Overall Study|Death|0|||
48830121|NCT01253226|157219440|FG003|Overall Study|Death|0|||
48830122|NCT01253226|157219441|FG004|Overall Study|Death|0|||
48830123|NCT01253226|157219437|FG000|Overall Study|Physician Decision|0|||
48830124|NCT01253226|157219438|FG001|Overall Study|Physician Decision|0|||
48830125|NCT01253226|157219439|FG002|Overall Study|Physician Decision|0|||
48830126|NCT01253226|157219440|FG003|Overall Study|Physician Decision|0|||
48830127|NCT01253226|157219441|FG004|Overall Study|Physician Decision|2|||
48830128|NCT01253226|157219437|FG000|Overall Study|Withdrawal by Subject|0|||
48830129|NCT01253226|157219438|FG001|Overall Study|Withdrawal by Subject|0|||
48830130|NCT01253226|157219439|FG002|Overall Study|Withdrawal by Subject|0|||
48830131|NCT01253226|157219440|FG003|Overall Study|Withdrawal by Subject|1|||
48830132|NCT01253226|157219441|FG004|Overall Study|Withdrawal by Subject|0|||
48830133|NCT03235349|157219442|FG000|Overall Study|Adverse Event|1|||
48830134|NCT03235349|157219442|FG000|Overall Study|Other|1|||
48830135|NCT01227707|157219443|FG000|Overall Study|Adverse Event|10|||
48830136|NCT01227707|157219443|FG000|Overall Study|Progression of disease|3|||
48830137|NCT01227707|157219443|FG000|Overall Study|Withdrawal by Subject|1|||
48830138|NCT01227707|157219443|FG000|Overall Study|Patient non-compliance|3|||
48830139|NCT01227707|157219443|FG000|Overall Study|Medical decision|6|||
48830140|NCT01227707|157219443|FG000|Overall Study|Death|1|||
48830141|NCT03210402|157219446|FG000|Overall Study|Withdrawal by Subject|0|||
48830142|NCT03210402|157219447|FG001|Overall Study|Withdrawal by Subject|1|||
48830143|NCT04858425|157219448|FG000|Overall Study|Adverse Event|2|||
48830144|NCT04858425|157219449|FG001|Overall Study|Adverse Event|2|||
48830145|NCT04858425|157219448|FG000|Overall Study|Withdrawal by Subject|3|||
48830146|NCT04858425|157219449|FG001|Overall Study|Withdrawal by Subject|1|||
48830147|NCT04858425|157219448|FG000|Overall Study|Lost to Follow-up|4|||
48830148|NCT04858425|157219449|FG001|Overall Study|Lost to Follow-up|2|||
48830149|NCT04858425|157219448|FG000|Overall Study|Lost to Follow-up|1|||
49156644|NCT00673920|158414174|FG003|Week 24 to Week 48|Adminstrative/Other|1|||
49156645|NCT00673920|158414175|FG004|Week 24 to Week 48|Adminstrative/Other|0|||
48830150|NCT04858425|157219449|FG001|Overall Study|Lost to Follow-up|0|||
49156646|NCT00673920|158414176|FG005|Week 24 to Week 48|Adminstrative/Other|0|||
49156647|NCT00673920|158414177|FG006|Week 24 to Week 48|Adminstrative/Other|0|||
49156648|NCT00673920|158414178|FG007|Week 24 to Week 48|Adminstrative/Other|0|||
49156649|NCT04856527|158414186|FG000|Overall Study|Unable to complete experimental task|2|||
48830151|NCT00823979|157219464|FG000|Overall Study|Lack of Efficacy|13|||
48830152|NCT00823979|157219465|FG001|Overall Study|Lack of Efficacy|16|||
48830153|NCT00823979|157219466|FG002|Overall Study|Lack of Efficacy|9|||
48830154|NCT00823979|157219464|FG000|Overall Study|Lost to Follow-up|2|||
48830155|NCT00823979|157219465|FG001|Overall Study|Lost to Follow-up|1|||
48830156|NCT00823979|157219466|FG002|Overall Study|Lost to Follow-up|0|||
48830157|NCT00823979|157219464|FG000|Overall Study|Withdrawal by Subject|2|||
48830158|NCT00823979|157219465|FG001|Overall Study|Withdrawal by Subject|3|||
49156650|NCT04856527|158414187|FG001|Overall Study|Unable to complete experimental task|0|||
48830159|NCT00823979|157219466|FG002|Overall Study|Withdrawal by Subject|2|||
48830160|NCT00823979|157219464|FG000|Overall Study|Protocol Violation|1|||
48830161|NCT00823979|157219465|FG001|Overall Study|Protocol Violation|1|||
48830162|NCT00823979|157219466|FG002|Overall Study|Protocol Violation|0|||
48830163|NCT00823979|157219464|FG000|Overall Study|Pregnancy|0|||
48830164|NCT00823979|157219465|FG001|Overall Study|Pregnancy|1|||
48830165|NCT00823979|157219466|FG002|Overall Study|Pregnancy|0|||
48830166|NCT00823979|157219464|FG000|Overall Study|Adverse Event|0|||
48830167|NCT00823979|157219465|FG001|Overall Study|Adverse Event|2|||
48830168|NCT00823979|157219466|FG002|Overall Study|Adverse Event|4|||
48830169|NCT00823979|157219464|FG000|Overall Study|Other|2|||
48830170|NCT00823979|157219465|FG001|Overall Study|Other|0|||
48830171|NCT00823979|157219466|FG002|Overall Study|Other|1|||
48830172|NCT00823979|157219464|FG000|Overall Study|Randomized but not Treated|4|||
48830173|NCT00823979|157219465|FG001|Overall Study|Randomized but not Treated|3|||
48830174|NCT00823979|157219466|FG002|Overall Study|Randomized but not Treated|1|||
48830175|NCT00823979|157219464|FG000|Overall Study|Study Terminated by Sponsor|5|||
48830176|NCT00823979|157219465|FG001|Overall Study|Study Terminated by Sponsor|5|||
48830177|NCT00823979|157219466|FG002|Overall Study|Study Terminated by Sponsor|7|||
48830178|NCT03396913|157219467|FG000|Overall Study|Lost to Follow-up|0|||
48830179|NCT03396913|157219468|FG001|Overall Study|Lost to Follow-up|6|||
48830180|NCT00554801|157219469|FG000|Overall Study|left area before completion|5|||
48830181|NCT00554801|157219470|FG001|Overall Study|left area before completion|0|||
48830182|NCT00554801|157219469|FG000|Overall Study|Withdrawal by Subject|14|||
48830183|NCT00554801|157219470|FG001|Overall Study|Withdrawal by Subject|0|||
48830184|NCT03503773|157219471|FG000|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|0|||
48830185|NCT03503773|157219472|FG001|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|2|||
48830186|NCT03503773|157219471|FG000|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|8|||
48830187|NCT03503773|157219472|FG001|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|4|||
48830188|NCT03503773|157219471|FG000|Overall Study|Not completing the primary ABPM|3|||
48830189|NCT03503773|157219472|FG001|Overall Study|Not completing the primary ABPM|1|||
48830190|NCT03503773|157219471|FG000|Overall Study|Not meeting inclusion/exclusion criteria|1|||
48830191|NCT03503773|157219472|FG001|Overall Study|Not meeting inclusion/exclusion criteria|0|||
48830192|NCT00117988|157219475|FG000|Overall Study|Death|3|||
48830193|NCT00117988|157219475|FG000|Overall Study|Adverse Event|1|||
48830194|NCT00995709|157219480|FG000|Overall Study|Adverse Event|4|||
48830195|NCT00995709|157219481|FG001|Overall Study|Adverse Event|2|||
48830196|NCT00995709|157219482|FG002|Overall Study|Adverse Event|0|||
48830197|NCT00995709|157219480|FG000|Overall Study|Lack of Efficacy|0|||
48830198|NCT00995709|157219481|FG001|Overall Study|Lack of Efficacy|1|||
48830199|NCT00995709|157219482|FG002|Overall Study|Lack of Efficacy|4|||
48830200|NCT00995709|157219480|FG000|Overall Study|Withdrawal by Subject|0|||
48830201|NCT00995709|157219481|FG001|Overall Study|Withdrawal by Subject|4|||
48830202|NCT00995709|157219482|FG002|Overall Study|Withdrawal by Subject|1|||
48830203|NCT00995709|157219480|FG000|Overall Study|Lost to Follow-up|1|||
48830204|NCT00995709|157219481|FG001|Overall Study|Lost to Follow-up|0|||
48830205|NCT00995709|157219482|FG002|Overall Study|Lost to Follow-up|0|||
48830206|NCT00995709|157219480|FG000|Overall Study|Death|0|||
49156651|NCT02325154|158414188|FG000|Overall Study|Physician Decision|1|||
49156652|NCT02936752|158414190|FG000|Overall Study|Death|2|||
49156653|NCT02936752|158414191|FG001|Overall Study|Death|1|||
48830207|NCT00995709|157219481|FG001|Overall Study|Death|1|||
48830208|NCT00995709|157219482|FG002|Overall Study|Death|0|||
48830209|NCT00995709|157219480|FG000|Overall Study|Protocol Violation|2|||
48830210|NCT00995709|157219481|FG001|Overall Study|Protocol Violation|1|||
48830211|NCT00995709|157219482|FG002|Overall Study|Protocol Violation|0|||
48830212|NCT03781804|157219483|FG000|Overall Study|Adverse Event|2|||
48830213|NCT03781804|157219484|FG001|Overall Study|Adverse Event|2|||
48830214|NCT03781804|157219485|FG002|Overall Study|Adverse Event|3|||
48830215|NCT03781804|157219483|FG000|Overall Study|Lost to Follow-up|1|||
48830216|NCT03781804|157219484|FG001|Overall Study|Lost to Follow-up|1|||
48830217|NCT03781804|157219485|FG002|Overall Study|Lost to Follow-up|2|||
49156654|NCT02936752|158414190|FG000|Overall Study|Physician Decision|4|||
49156655|NCT02936752|158414191|FG001|Overall Study|Physician Decision|0|||
49156656|NCT02936752|158414190|FG000|Overall Study|Withdrawal by Subject|0|||
49156657|NCT02936752|158414191|FG001|Overall Study|Withdrawal by Subject|2|||
49156658|NCT01538199|158414193|FG000|Overall Study|Lost to Follow-up|1|||
49156659|NCT01538199|158414194|FG001|Overall Study|Lost to Follow-up|2|||
49156660|NCT01538199|158414195|FG002|Overall Study|Lost to Follow-up|1|||
49156661|NCT01538199|158414196|FG003|Overall Study|Lost to Follow-up|0|||
49156662|NCT01538199|158414193|FG000|Overall Study|participant did not have time|1|||
49156663|NCT01538199|158414194|FG001|Overall Study|participant did not have time|0|||
49156664|NCT01538199|158414195|FG002|Overall Study|participant did not have time|0|||
49156665|NCT01538199|158414196|FG003|Overall Study|participant did not have time|2|||
49156666|NCT01538199|158414193|FG000|Overall Study|Lack of Efficacy|0|||
49156667|NCT01538199|158414194|FG001|Overall Study|Lack of Efficacy|1|||
49156668|NCT01538199|158414195|FG002|Overall Study|Lack of Efficacy|0|||
49156669|NCT01538199|158414196|FG003|Overall Study|Lack of Efficacy|0|||
49156670|NCT02081586|158414197|FG000|Overall Study|Lost to Follow-up|0|||
49156671|NCT02081586|158414198|FG001|Overall Study|Lost to Follow-up|1|||
49156672|NCT02081586|158414199|FG002|Overall Study|Lost to Follow-up|0|||
48830218|NCT03781804|157219483|FG000|Overall Study|Lack of Efficacy|4|||
48830219|NCT03781804|157219484|FG001|Overall Study|Lack of Efficacy|2|||
48830220|NCT03781804|157219485|FG002|Overall Study|Lack of Efficacy|9|||
48830221|NCT03781804|157219483|FG000|Overall Study|Protocol Violation|0|||
48830222|NCT03781804|157219484|FG001|Overall Study|Protocol Violation|0|||
48830223|NCT03781804|157219485|FG002|Overall Study|Protocol Violation|1|||
48830224|NCT03781804|157219483|FG000|Overall Study|Withdrawal by Subject|0|||
48830225|NCT03781804|157219484|FG001|Overall Study|Withdrawal by Subject|1|||
48830226|NCT03781804|157219485|FG002|Overall Study|Withdrawal by Subject|1|||
48830227|NCT03781804|157219483|FG000|Overall Study|Reason not provided|2|||
48830228|NCT03781804|157219484|FG001|Overall Study|Reason not provided|2|||
48830229|NCT03781804|157219485|FG002|Overall Study|Reason not provided|0|||
48830230|NCT00906282|157219493|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
48830231|NCT00906282|157219493|FG000|Preoperative Chemotherapy|Not surgical candidates, off study|10|||
48830232|NCT00906282|157219493|FG000|Preoperative Chemotherapy|Progressive disease|6|||
48830233|NCT00906282|157219493|FG000|Preoperative Chemotherapy|Toxicity|1|||
48830234|NCT00712166|157219494|FG000|Overall Study|Noncompliance|0|||
48830235|NCT00712166|157219495|FG001|Overall Study|Noncompliance|1|||
48830236|NCT03102242|157219496|FG000|Overall Study|Adverse Event|2|||
48830237|NCT01264718|157219497|FG000|Overall Study|Lost to Follow-up|3|||
48830238|NCT01264718|157219498|FG001|Overall Study|Lost to Follow-up|2|||
49156673|NCT02081586|158414200|FG003|Overall Study|Lost to Follow-up|1|||
49156674|NCT02081586|158414197|FG000|Overall Study|Head injury not related to study|0|||
49156675|NCT02081586|158414198|FG001|Overall Study|Head injury not related to study|0|||
49156676|NCT02081586|158414199|FG002|Overall Study|Head injury not related to study|1|||
49156677|NCT02081586|158414200|FG003|Overall Study|Head injury not related to study|0|||
49156678|NCT00659425|158414208|FG000|Overall Study|Disease progression|1|||
49156679|NCT00659425|158414209|FG001|Overall Study|Disease progression|0|||
49156680|NCT00659425|158414210|FG002|Overall Study|Disease progression|0|||
49156681|NCT00659425|158414211|FG003|Overall Study|Disease progression|1|||
49156682|NCT00659425|158414212|FG004|Overall Study|Disease progression|0|||
49156683|NCT00659425|158414213|FG005|Overall Study|Disease progression|2|||
49156684|NCT00659425|158414214|FG006|Overall Study|Disease progression|4|||
49156685|NCT00659425|158414215|FG007|Overall Study|Disease progression|3|||
49156686|NCT00659425|158414216|FG008|Overall Study|Disease progression|5|||
49156687|NCT00659425|158414217|FG009|Overall Study|Disease progression|3|||
49156688|NCT00659425|158414208|FG000|Overall Study|Death|0|||
49156689|NCT00659425|158414209|FG001|Overall Study|Death|0|||
49156690|NCT00659425|158414210|FG002|Overall Study|Death|0|||
49156691|NCT00659425|158414211|FG003|Overall Study|Death|1|||
48830239|NCT01264718|157219497|FG000|Overall Study|Withdrawal by Subject|9|||
48922693|NCT01687712|157550120|FG001|Cycle 2|Not Biochemically Pregnant|77|||
49156692|NCT00659425|158414212|FG004|Overall Study|Death|0|||
49156693|NCT00659425|158414213|FG005|Overall Study|Death|0|||
49156694|NCT00659425|158414214|FG006|Overall Study|Death|1|||
49156695|NCT00659425|158414215|FG007|Overall Study|Death|0|||
49156696|NCT00659425|158414216|FG008|Overall Study|Death|0|||
49156697|NCT00659425|158414217|FG009|Overall Study|Death|0|||
49156698|NCT00659425|158414208|FG000|Overall Study|Adverse Event|0|||
49156699|NCT00659425|158414209|FG001|Overall Study|Adverse Event|0|||
49156700|NCT00659425|158414210|FG002|Overall Study|Adverse Event|0|||
49156701|NCT00659425|158414211|FG003|Overall Study|Adverse Event|0|||
49156702|NCT00659425|158414212|FG004|Overall Study|Adverse Event|0|||
49156703|NCT00659425|158414213|FG005|Overall Study|Adverse Event|1|||
49156704|NCT00659425|158414214|FG006|Overall Study|Adverse Event|0|||
49156705|NCT00659425|158414215|FG007|Overall Study|Adverse Event|3|||
49156706|NCT00659425|158414216|FG008|Overall Study|Adverse Event|1|||
49156707|NCT00659425|158414217|FG009|Overall Study|Adverse Event|4|||
49156708|NCT00659425|158414208|FG000|Overall Study|Investigator Discretion|0|||
49156709|NCT00659425|158414209|FG001|Overall Study|Investigator Discretion|0|||
49156710|NCT00659425|158414210|FG002|Overall Study|Investigator Discretion|0|||
49156711|NCT00659425|158414211|FG003|Overall Study|Investigator Discretion|0|||
49156712|NCT00659425|158414212|FG004|Overall Study|Investigator Discretion|0|||
49156713|NCT00659425|158414213|FG005|Overall Study|Investigator Discretion|1|||
49156714|NCT00659425|158414214|FG006|Overall Study|Investigator Discretion|0|||
49156715|NCT00659425|158414215|FG007|Overall Study|Investigator Discretion|3|||
49156716|NCT00659425|158414216|FG008|Overall Study|Investigator Discretion|0|||
49156717|NCT00659425|158414217|FG009|Overall Study|Investigator Discretion|0|||
49156718|NCT00659425|158414208|FG000|Overall Study|Other|0|||
48830240|NCT01264718|157219498|FG001|Overall Study|Withdrawal by Subject|15|||
48830241|NCT01264718|157219497|FG000|Overall Study|Loss of Medicaid/CHIP eligibility|37|||
48830242|NCT01264718|157219498|FG001|Overall Study|Loss of Medicaid/CHIP eligibility|26|||
49156719|NCT00659425|158414209|FG001|Overall Study|Other|1|||
48830243|NCT02908464|157219499|FG000|Overall Study|Withdrawal by Subject|2|||
48830244|NCT02908464|157219500|FG001|Overall Study|Withdrawal by Subject|1|||
49156720|NCT00659425|158414210|FG002|Overall Study|Other|1|||
49156721|NCT00659425|158414211|FG003|Overall Study|Other|2|||
49156722|NCT00659425|158414212|FG004|Overall Study|Other|4|||
49156723|NCT00659425|158414213|FG005|Overall Study|Other|0|||
48830245|NCT02908464|157219499|FG000|Overall Study|Found ineligible after randomization|0|||
48830246|NCT02908464|157219500|FG001|Overall Study|Found ineligible after randomization|2|||
48830247|NCT04084769|157219501|FG000|Overall Study|Protocol Violation|1|||
48830248|NCT04084769|157219502|FG001|Overall Study|Protocol Violation|3|||
48830249|NCT04084769|157219503|FG002|Overall Study|Protocol Violation|0|||
48830250|NCT04084769|157219504|FG003|Overall Study|Protocol Violation|1|||
48830251|NCT04084769|157219501|FG000|Overall Study|Withdrawal by Subject|0|||
48830252|NCT04084769|157219502|FG001|Overall Study|Withdrawal by Subject|1|||
48830253|NCT04084769|157219503|FG002|Overall Study|Withdrawal by Subject|0|||
48830254|NCT04084769|157219504|FG003|Overall Study|Withdrawal by Subject|0|||
48830255|NCT04084769|157219501|FG000|Overall Study|Withdrawal by parent/guardian|1|||
48830256|NCT04084769|157219502|FG001|Overall Study|Withdrawal by parent/guardian|0|||
48830257|NCT04084769|157219503|FG002|Overall Study|Withdrawal by parent/guardian|0|||
48830258|NCT04084769|157219504|FG003|Overall Study|Withdrawal by parent/guardian|1|||
48830259|NCT04084769|157219501|FG000|Overall Study|Lost to Follow-up|2|||
48830260|NCT04084769|157219502|FG001|Overall Study|Lost to Follow-up|0|||
48830261|NCT04084769|157219503|FG002|Overall Study|Lost to Follow-up|0|||
48830262|NCT04084769|157219504|FG003|Overall Study|Lost to Follow-up|0|||
48830263|NCT01278862|157219505|FG000|Overall Study|Lost to Follow-up|1|||
48830264|NCT01278862|157219506|FG001|Overall Study|Lost to Follow-up|1|||
48830265|NCT05512949|157220661|FG000|Overall Study|Lost to Follow-up|4|||
48830266|NCT05512949|157220662|FG001|Overall Study|Lost to Follow-up|6|||
48830267|NCT05512949|157220663|FG002|Overall Study|Lost to Follow-up|2|||
48830268|NCT05512949|157220661|FG000|Overall Study|Protocol Violation|0|||
48830269|NCT05512949|157220662|FG001|Overall Study|Protocol Violation|0|||
48830270|NCT05512949|157220663|FG002|Overall Study|Protocol Violation|1|||
48830271|NCT05512949|157220661|FG000|Overall Study|Withdrawal by Subject|1|||
48830272|NCT05512949|157220662|FG001|Overall Study|Withdrawal by Subject|1|||
48830273|NCT05512949|157220663|FG002|Overall Study|Withdrawal by Subject|2|||
48830274|NCT05512949|157220661|FG000|Overall Study|Completion status unknown|1|||
48830275|NCT05512949|157220662|FG001|Overall Study|Completion status unknown|3|||
48830276|NCT05512949|157220663|FG002|Overall Study|Completion status unknown|0|||
48830277|NCT00777556|157220665|FG000|Overall Study|Inappropriate self-selection|34|||
48830278|NCT00777556|157220665|FG000|Overall Study|Dispensed but did not use product|12|||
48830279|NCT00777556|157220665|FG000|Overall Study|Did not complete all 3 follow-up visits|20|||
48830280|NCT01249092|157220666|FG000|Overall Study|Expected side effect of nausea/dyspepsia|1|||
48830281|NCT01249092|157220666|FG000|Overall Study|Unable to tolerate expected SE -nausea|1|||
48830282|NCT01729819|157220671|FG000|Overall Study|Adverse Event|2|||
48830283|NCT01729819|157220672|FG001|Overall Study|Adverse Event|4|||
48830284|NCT01729819|157220671|FG000|Overall Study|Lack of Efficacy|1|||
48830285|NCT01729819|157220672|FG001|Overall Study|Lack of Efficacy|0|||
48830286|NCT01729819|157220671|FG000|Overall Study|Lost to Follow-up|2|||
48830287|NCT01729819|157220672|FG001|Overall Study|Lost to Follow-up|0|||
48830288|NCT01729819|157220671|FG000|Overall Study|Other reason|1|||
48830289|NCT01729819|157220672|FG001|Overall Study|Other reason|0|||
48830290|NCT01729819|157220671|FG000|Overall Study|Protocol Violation|0|||
48830291|NCT01729819|157220672|FG001|Overall Study|Protocol Violation|1|||
48830292|NCT01729819|157220671|FG000|Overall Study|Withdrawal by Subject|0|||
48922694|NCT01687712|157550119|FG000|Cycle 2|Early Pregnancy Loss|18|||
48922695|NCT01687712|157550120|FG001|Cycle 2|Early Pregnancy Loss|16|||
48922696|NCT01687712|157550119|FG000|Cycle 2|Ectopic Pregnancy|0|||
48922697|NCT01687712|157550120|FG001|Cycle 2|Ectopic Pregnancy|1|||
49156724|NCT00659425|158414214|FG006|Overall Study|Other|3|||
49156725|NCT00659425|158414215|FG007|Overall Study|Other|2|||
49156726|NCT00659425|158414216|FG008|Overall Study|Other|0|||
49156727|NCT00659425|158414217|FG009|Overall Study|Other|6|||
49156728|NCT04540367|158414218|FG000|Overall Study|Withdrawal by Subject|0|||
49156729|NCT04540367|158414219|FG001|Overall Study|Withdrawal by Subject|0|||
49156730|NCT04540367|158414220|FG002|Overall Study|Withdrawal by Subject|0|||
49156731|NCT04540367|158414221|FG003|Overall Study|Withdrawal by Subject|2|||
48830293|NCT01729819|157220672|FG001|Overall Study|Withdrawal by Subject|2|||
48830294|NCT00309452|157220674|FG000|Overall Study|Withdrawal by Subject|3|||
48830295|NCT00309452|157220675|FG001|Overall Study|Withdrawal by Subject|0|||
48830296|NCT02943993|157220676|FG000|Overall Study|Withdrawal by Subject|52|||
48922698|NCT01687712|157550119|FG000|Cycle 2|Still Birth|1|||
49156732|NCT04540367|158414218|FG000|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
49156733|NCT04540367|158414219|FG001|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
49156734|NCT04540367|158414220|FG002|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|4|||
48830297|NCT02943993|157220676|FG000|Overall Study|Transfer to another institution|6|||
48830298|NCT02943993|157220676|FG000|Overall Study|Lost to Follow-up|135|||
48830299|NCT02943993|157220676|FG000|Overall Study|Death|98|||
48830300|NCT02943993|157220676|FG000|Overall Study|Other reason for premature termination|32|||
48830301|NCT02943993|157220676|FG000|Overall Study|Missing reason for termination|7|||
48830302|NCT00109967|157220677|FG000|Overall Study|Cancel Prior to Treatment|2|||
48830303|NCT00109967|157220678|FG001|Overall Study|Cancel Prior to Treatment|0|||
48922699|NCT01687712|157550120|FG001|Cycle 2|Still Birth|0|||
48830304|NCT00109967|157220677|FG000|Overall Study|Adverse Event|12|||
48830305|NCT00109967|157220678|FG001|Overall Study|Adverse Event|1|||
48830306|NCT00109967|157220677|FG000|Overall Study|Withdrawal by Subject|5|||
48830307|NCT00109967|157220678|FG001|Overall Study|Withdrawal by Subject|0|||
48830308|NCT00109967|157220677|FG000|Overall Study|Physician Decision|1|||
48830309|NCT00109967|157220678|FG001|Overall Study|Physician Decision|3|||
48830310|NCT00109967|157220677|FG000|Overall Study|Death|0|||
48830311|NCT00109967|157220678|FG001|Overall Study|Death|2|||
48830312|NCT02993471|157220679|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1|||
48830313|NCT02993471|157220679|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1|||
48830314|NCT01693614|157220680|FG000|Overall Study|Adverse Event|7|||
48830315|NCT01693614|157220681|FG001|Overall Study|Adverse Event|11|||
48830316|NCT01693614|157220682|FG002|Overall Study|Adverse Event|5|||
48830317|NCT01693614|157220680|FG000|Overall Study|Disease progression|11|||
48830318|NCT01693614|157220681|FG001|Overall Study|Disease progression|8|||
48830319|NCT01693614|157220682|FG002|Overall Study|Disease progression|7|||
48830320|NCT01693614|157220680|FG000|Overall Study|Protocol Violation|5|||
48830321|NCT01693614|157220681|FG001|Overall Study|Protocol Violation|2|||
48830322|NCT01693614|157220682|FG002|Overall Study|Protocol Violation|1|||
48830323|NCT01693614|157220680|FG000|Overall Study|Death|1|||
48830324|NCT01693614|157220681|FG001|Overall Study|Death|0|||
48830325|NCT01693614|157220682|FG002|Overall Study|Death|0|||
48830326|NCT01693614|157220680|FG000|Overall Study|Physician Decision|1|||
48830327|NCT01693614|157220681|FG001|Overall Study|Physician Decision|1|||
48830328|NCT01693614|157220682|FG002|Overall Study|Physician Decision|4|||
48830329|NCT01693614|157220680|FG000|Overall Study|Withdrawal by subject/guardian|0|||
48830330|NCT01693614|157220681|FG001|Overall Study|Withdrawal by subject/guardian|0|||
48830331|NCT01693614|157220682|FG002|Overall Study|Withdrawal by subject/guardian|2|||
48830332|NCT01693614|157220680|FG000|Overall Study|Withdrawal by Subject|1|||
48830333|NCT01693614|157220681|FG001|Overall Study|Withdrawal by Subject|0|||
48830334|NCT01693614|157220682|FG002|Overall Study|Withdrawal by Subject|5|||
48830335|NCT04649359|157220683|FG000|Overall Study|Withdrawal by Subject|7|||
48830336|NCT04649359|157220684|FG001|Overall Study|Withdrawal by Subject|7|||
48830337|NCT04649359|157220683|FG000|Overall Study|Death|41|||
48830338|NCT04649359|157220684|FG001|Overall Study|Death|26|||
48830339|NCT04649359|157220683|FG000|Overall Study|Ongoing in the study|75|||
48830340|NCT04649359|157220684|FG001|Overall Study|Ongoing in the study|31|||
48830341|NCT03383887|157220686|FG000|Overall Study|Lost to Follow-up|0|||
48830342|NCT03383887|157220687|FG001|Overall Study|Lost to Follow-up|1|||
48830343|NCT00831792|157220688|FG000|Overall Study|Not Eligible|3|||
48830344|NCT00831792|157220688|FG000|Overall Study|Adverse Event|1|||
48830345|NCT00831792|157220688|FG000|Overall Study|Death|1|||
48830346|NCT00831792|157220688|FG000|Overall Study|Lack of Efficacy|1|||
48830347|NCT01190150|157220699|FG000|First Treatment|Withdrawal by Subject|1|||
48830348|NCT01190150|157220700|FG001|First Treatment|Withdrawal by Subject|0|||
48830349|NCT01190150|157220699|FG000|Washout|Withdrawal by Subject|0|||
48830350|NCT01190150|157220700|FG001|Washout|Withdrawal by Subject|1|||
48830351|NCT01190150|157220699|FG000|Washout|Difficulty in adherence|0|||
48830352|NCT01190150|157220700|FG001|Washout|Difficulty in adherence|1|||
48830353|NCT00580801|157220702|FG000|Overall Study|Physician Decision|1|||
48830354|NCT00580801|157220703|FG001|Overall Study|Physician Decision|0|||
48830355|NCT00580801|157220704|FG002|Overall Study|Physician Decision|0|||
48830356|NCT00580801|157220702|FG000|Overall Study|Adverse Event|2|||
48922700|NCT01687712|157550119|FG000|Cycle 2|Miscarriage/Spontaneous Abortion|0|||
48922701|NCT01687712|157550120|FG001|Cycle 2|Miscarriage/Spontaneous Abortion|1|||
48922702|NCT01687712|157550119|FG000|Cycle 3|Not Biochemically Pregnant|21|||
48922703|NCT01687712|157550120|FG001|Cycle 3|Not Biochemically Pregnant|22|||
48922704|NCT01687712|157550119|FG000|Cycle 3|Early Pregnancy Loss|1|||
48922705|NCT01687712|157550120|FG001|Cycle 3|Early Pregnancy Loss|2|||
48922706|NCT01687712|157550119|FG000|Cycle 3|Ectopic Pregnancy|1|||
49156735|NCT04540367|158414221|FG003|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|1|||
49156736|NCT04540367|158414218|FG000|Overall Study|Adverse Event|0|||
49156737|NCT04540367|158414219|FG001|Overall Study|Adverse Event|0|||
48830357|NCT00580801|157220703|FG001|Overall Study|Adverse Event|0|||
48922707|NCT01687712|157550120|FG001|Cycle 3|Ectopic Pregnancy|0|||
49156738|NCT04540367|158414220|FG002|Overall Study|Adverse Event|1|||
48830358|NCT00580801|157220704|FG002|Overall Study|Adverse Event|0|||
48830359|NCT00580801|157220702|FG000|Overall Study|Lost to Follow-up|2|||
48830360|NCT00580801|157220703|FG001|Overall Study|Lost to Follow-up|0|||
48830361|NCT00580801|157220704|FG002|Overall Study|Lost to Follow-up|0|||
48830362|NCT00580801|157220702|FG000|Overall Study|Reached a virologic endpoint|0|||
48830363|NCT00580801|157220703|FG001|Overall Study|Reached a virologic endpoint|1|||
48830364|NCT00580801|157220704|FG002|Overall Study|Reached a virologic endpoint|2|||
48830365|NCT00580801|157220702|FG000|Overall Study|Participant non-compliant|0|||
48830366|NCT00580801|157220703|FG001|Overall Study|Participant non-compliant|0|||
48922708|NCT01687712|157550119|FG000|Cycle 3|Miscarriage/Spontaneous Abortion|1|||
48922709|NCT01687712|157550120|FG001|Cycle 3|Miscarriage/Spontaneous Abortion|0|||
48830367|NCT00580801|157220704|FG002|Overall Study|Participant non-compliant|1|||
48830368|NCT00580801|157220702|FG000|Overall Study|Travel|1|||
48830369|NCT00580801|157220703|FG001|Overall Study|Travel|0|||
48830370|NCT00580801|157220704|FG002|Overall Study|Travel|0|||
48830371|NCT01833832|157220705|FG000|Overall Study|Pt could not be cytoreduced for HIPEC|1|||
48830372|NCT01191788|157220709|FG000|Overall Study|Lost to Follow-up|21|||
48830373|NCT01191788|157220710|FG001|Overall Study|Lost to Follow-up|22|||
48830374|NCT02512042|157220713|FG000|Overall Study|Adverse Event|0|||
48830375|NCT02512042|157220714|FG001|Overall Study|Adverse Event|4|||
48830376|NCT02512042|157220713|FG000|Overall Study|Withdrawal by Subject|6|||
48830377|NCT02512042|157220714|FG001|Overall Study|Withdrawal by Subject|6|||
48830378|NCT02512042|157220713|FG000|Overall Study|Non-compliance with study drug|1|||
48830379|NCT02512042|157220714|FG001|Overall Study|Non-compliance with study drug|2|||
48830380|NCT02512042|157220713|FG000|Overall Study|Lost to Follow-up|5|||
48830381|NCT02512042|157220714|FG001|Overall Study|Lost to Follow-up|2|||
48830382|NCT02512042|157220713|FG000|Overall Study|Other|11|||
48830383|NCT02512042|157220714|FG001|Overall Study|Other|11|||
48830384|NCT01194258|157220717|FG000|Titration Period|Withdrawal by Subject|6|||
48830385|NCT01194258|157220718|FG001|Titration Period|Withdrawal by Subject|0|||
48830386|NCT01194258|157220719|FG002|Titration Period|Withdrawal by Subject|0|||
48830387|NCT01194258|157220720|FG003|Titration Period|Withdrawal by Subject|0|||
48830388|NCT01194258|157220721|FG004|Titration Period|Withdrawal by Subject|0|||
48830389|NCT01194258|157220717|FG000|Titration Period|Lost to Follow-up|2|||
48830390|NCT01194258|157220718|FG001|Titration Period|Lost to Follow-up|0|||
48830391|NCT01194258|157220719|FG002|Titration Period|Lost to Follow-up|0|||
48830392|NCT01194258|157220720|FG003|Titration Period|Lost to Follow-up|0|||
48830393|NCT01194258|157220721|FG004|Titration Period|Lost to Follow-up|0|||
48830394|NCT01194258|157220717|FG000|Titration Period|Titration failure|3|||
48830395|NCT01194258|157220718|FG001|Titration Period|Titration failure|0|||
48830396|NCT01194258|157220719|FG002|Titration Period|Titration failure|0|||
49156739|NCT04540367|158414221|FG003|Overall Study|Adverse Event|1|||
49156740|NCT00907621|158414222|FG000|Overall Study|Lost to Follow-up|6|||
49156741|NCT00907621|158414223|FG001|Overall Study|Lost to Follow-up|3|||
49156742|NCT00907621|158414222|FG000|Overall Study|intercurrent febrile illness|1|||
49156743|NCT00907621|158414223|FG001|Overall Study|intercurrent febrile illness|1|||
49156744|NCT03958331|158414224|FG000|Overall Study|Withdrawal by Subject|3|||
49156745|NCT03958331|158414225|FG001|Overall Study|Withdrawal by Subject|1|||
49156746|NCT03958331|158414226|FG002|Overall Study|Withdrawal by Subject|5|||
49156747|NCT03958331|158414224|FG000|Overall Study|Weaned from medicine|2|||
49156748|NCT03958331|158414225|FG001|Overall Study|Weaned from medicine|0|||
49156749|NCT03958331|158414226|FG002|Overall Study|Weaned from medicine|0|||
49156750|NCT03958331|158414224|FG000|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|2|||
49156751|NCT03958331|158414225|FG001|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|1|||
49156752|NCT03958331|158414226|FG002|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|12|||
49156753|NCT03213509|158414227|FG000|Overall Study|Did not consent for verbal autopsy|4|||
49156754|NCT03213509|158414228|FG001|Overall Study|Did not consent for verbal autopsy|5|||
49156755|NCT04290624|158414229|FG000|Overall Study|Adverse Event|1|||
49156756|NCT04290624|158414230|FG001|Overall Study|Adverse Event|0|||
49156757|NCT04079738|158414231|FG000|Study Treatment|Death|1|||
49156758|NCT04079738|158414232|FG001|Study Treatment|Death|0|||
49156759|NCT04079738|158414233|FG002|Study Treatment|Death|0|||
49156760|NCT04079738|158414234|FG003|Study Treatment|Death|0|||
49156761|NCT04079738|158414231|FG000|Study Treatment|Adverse Event|2|||
49156762|NCT04079738|158414232|FG001|Study Treatment|Adverse Event|0|||
49156763|NCT04079738|158414233|FG002|Study Treatment|Adverse Event|0|||
49156764|NCT04079738|158414234|FG003|Study Treatment|Adverse Event|0|||
49156765|NCT04079738|158414231|FG000|Study Treatment|withdrawal before treatment|1|||
49156766|NCT04079738|158414232|FG001|Study Treatment|withdrawal before treatment|0|||
49156767|NCT04079738|158414233|FG002|Study Treatment|withdrawal before treatment|0|||
49156768|NCT04079738|158414234|FG003|Study Treatment|withdrawal before treatment|0|||
49156769|NCT04079738|158414231|FG000|Study Treatment|symptomatic deterioration|2|||
49156770|NCT04079738|158414232|FG001|Study Treatment|symptomatic deterioration|0|||
49156771|NCT04079738|158414233|FG002|Study Treatment|symptomatic deterioration|0|||
49156772|NCT04079738|158414234|FG003|Study Treatment|symptomatic deterioration|0|||
48830397|NCT01194258|157220720|FG003|Titration Period|Titration failure|0|||
48830398|NCT01194258|157220721|FG004|Titration Period|Titration failure|0|||
48830399|NCT01194258|157220717|FG000|Period 1 (12 Weeks)|Death|0|||
49156773|NCT04079738|158414231|FG000|Study Treatment|Disease Progression|1|||
49156774|NCT04079738|158414232|FG001|Study Treatment|Disease Progression|0|||
49156775|NCT04079738|158414233|FG002|Study Treatment|Disease Progression|0|||
48830400|NCT01194258|157220718|FG001|Period 1 (12 Weeks)|Death|0|||
48830401|NCT01194258|157220719|FG002|Period 1 (12 Weeks)|Death|0|||
48830402|NCT01194258|157220720|FG003|Period 1 (12 Weeks)|Death|0|||
48830403|NCT01194258|157220721|FG004|Period 1 (12 Weeks)|Death|1|||
48830404|NCT01194258|157220717|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
48830405|NCT01194258|157220718|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
48830406|NCT01194258|157220719|FG002|Period 2 (12 Weeks)|Lost to Follow-up|0|||
49156776|NCT04079738|158414234|FG003|Study Treatment|Disease Progression|0|||
49156777|NCT04079738|158414231|FG000|Study Treatment|withdrawal after treatment|1|||
49156778|NCT04079738|158414232|FG001|Study Treatment|withdrawal after treatment|0|||
49156779|NCT04079738|158414233|FG002|Study Treatment|withdrawal after treatment|0|||
49156780|NCT04079738|158414234|FG003|Study Treatment|withdrawal after treatment|0|||
49156781|NCT04079738|158414231|FG000|Follow up|Withdrawal by Subject|3|||
49156782|NCT04079738|158414232|FG001|Follow up|Withdrawal by Subject|0|||
49156783|NCT04079738|158414233|FG002|Follow up|Withdrawal by Subject|0|||
49156784|NCT04079738|158414234|FG003|Follow up|Withdrawal by Subject|0|||
48830407|NCT01194258|157220720|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
49156785|NCT04079738|158414231|FG000|Follow up|Death|5|||
49156786|NCT04079738|158414232|FG001|Follow up|Death|0|||
49156787|NCT04079738|158414233|FG002|Follow up|Death|0|||
48830408|NCT01194258|157220721|FG004|Period 2 (12 Weeks)|Lost to Follow-up|2|||
48830409|NCT01194258|157220717|FG000|Period 2 (12 Weeks)|Adverse Event|0|||
48830410|NCT01194258|157220718|FG001|Period 2 (12 Weeks)|Adverse Event|1|||
48830411|NCT01194258|157220719|FG002|Period 2 (12 Weeks)|Adverse Event|0|||
48830412|NCT01194258|157220720|FG003|Period 2 (12 Weeks)|Adverse Event|0|||
48830413|NCT01194258|157220721|FG004|Period 2 (12 Weeks)|Adverse Event|0|||
49156788|NCT04079738|158414234|FG003|Follow up|Death|0|||
49156789|NCT01733316|158414236|FG000|RP103 Phase|Non-compliance|1|||
49156790|NCT01733316|158414236|FG000|Long Term Extension Phase|Adverse Event|1|||
49156791|NCT01733316|158414236|FG000|Long Term Extension Phase|Consent Withdrawn by Subject|2|||
49156792|NCT01733316|158414236|FG000|Long Term Extension Phase|Sponsor Decision|2|||
49156793|NCT00656370|158414242|FG000|Overall Study|Screen Failures|7|||
49156794|NCT00656370|158414242|FG000|Overall Study|Alternates|3|||
49156795|NCT03391882|158414245|FG000|Study Overall|Adverse Event|3|||
49156796|NCT03391882|158414246|FG001|Study Overall|Adverse Event|6|||
49156797|NCT03391882|158414247|FG002|Study Overall|Adverse Event|1|||
49156798|NCT03391882|158414248|FG003|Study Overall|Adverse Event|1|||
49156799|NCT03391882|158414249|FG004|Study Overall|Adverse Event|3|||
49156800|NCT03391882|158414250|FG005|Study Overall|Adverse Event|1|||
49156801|NCT03391882|158414245|FG000|Study Overall|Lack of Efficacy|13|||
48830414|NCT01194258|157220717|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
48830415|NCT01194258|157220718|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
48830416|NCT01194258|157220719|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
48830417|NCT01194258|157220720|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
48830418|NCT01194258|157220721|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
48830419|NCT00197236|157220722|FG000|Overall Study|Adverse Event|1|||
49156802|NCT03391882|158414246|FG001|Study Overall|Lack of Efficacy|9|||
49156803|NCT03391882|158414247|FG002|Study Overall|Lack of Efficacy|0|||
49156804|NCT03391882|158414248|FG003|Study Overall|Lack of Efficacy|0|||
49156805|NCT03391882|158414249|FG004|Study Overall|Lack of Efficacy|0|||
49156806|NCT03391882|158414250|FG005|Study Overall|Lack of Efficacy|0|||
49156807|NCT03391882|158414245|FG000|Study Overall|Withdrawal by Subject|3|||
49156808|NCT03391882|158414246|FG001|Study Overall|Withdrawal by Subject|3|||
49156809|NCT03391882|158414247|FG002|Study Overall|Withdrawal by Subject|2|||
49156810|NCT03391882|158414248|FG003|Study Overall|Withdrawal by Subject|2|||
48830420|NCT00197236|157220723|FG001|Overall Study|Adverse Event|0|||
48830421|NCT00197236|157220724|FG002|Overall Study|Adverse Event|1|||
48830422|NCT00197236|157220722|FG000|Overall Study|Lost to Follow-up|5|||
48830423|NCT00197236|157220723|FG001|Overall Study|Lost to Follow-up|14|||
48830424|NCT00197236|157220724|FG002|Overall Study|Lost to Follow-up|6|||
48830425|NCT00197236|157220722|FG000|Overall Study|Protocol Violation|0|||
48830426|NCT00197236|157220723|FG001|Overall Study|Protocol Violation|0|||
48830427|NCT00197236|157220724|FG002|Overall Study|Protocol Violation|1|||
48830428|NCT00197236|157220722|FG000|Overall Study|Withdrawal by Subject|7|||
48830429|NCT00197236|157220723|FG001|Overall Study|Withdrawal by Subject|3|||
48830430|NCT00197236|157220724|FG002|Overall Study|Withdrawal by Subject|11|||
48830431|NCT00197236|157220722|FG000|Overall Study|Study drug/medication expiration|1|||
48830432|NCT00197236|157220723|FG001|Overall Study|Study drug/medication expiration|0|||
48830433|NCT00197236|157220724|FG002|Overall Study|Study drug/medication expiration|3|||
48830434|NCT00197236|157220722|FG000|Overall Study|Returned out of specified time window|0|||
48830435|NCT00197236|157220723|FG001|Overall Study|Returned out of specified time window|0|||
48830436|NCT00197236|157220724|FG002|Overall Study|Returned out of specified time window|1|||
49156811|NCT03391882|158414249|FG004|Study Overall|Withdrawal by Subject|1|||
49156812|NCT03391882|158414250|FG005|Study Overall|Withdrawal by Subject|3|||
49156813|NCT03391882|158414245|FG000|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
49156814|NCT03391882|158414246|FG001|Study Overall|EARLY TERM AT SPONSOR REQUEST|1|||
49156815|NCT03391882|158414247|FG002|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
49156816|NCT03391882|158414248|FG003|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
49156817|NCT03391882|158414249|FG004|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
49156818|NCT03391882|158414250|FG005|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
49156819|NCT03391882|158414245|FG000|Study Overall|Protocol Violation|1|||
49156820|NCT03391882|158414246|FG001|Study Overall|Protocol Violation|0|||
49156821|NCT03391882|158414247|FG002|Study Overall|Protocol Violation|0|||
49156822|NCT03391882|158414248|FG003|Study Overall|Protocol Violation|0|||
49156823|NCT03391882|158414249|FG004|Study Overall|Protocol Violation|0|||
49156824|NCT03391882|158414250|FG005|Study Overall|Protocol Violation|0|||
49156825|NCT03391882|158414245|FG000|Part A - Titration Phase|Adverse Event|3|||
49156826|NCT03391882|158414246|FG001|Part A - Titration Phase|Adverse Event|6|||
49156827|NCT03391882|158414247|FG002|Part A - Titration Phase|Adverse Event|0|||
49156828|NCT03391882|158414248|FG003|Part A - Titration Phase|Adverse Event|0|||
49156829|NCT03391882|158414249|FG004|Part A - Titration Phase|Adverse Event|0|||
49156830|NCT03391882|158414250|FG005|Part A - Titration Phase|Adverse Event|0|||
49156831|NCT03391882|158414245|FG000|Part A - Titration Phase|Lack of Efficacy|12|||
49156832|NCT03391882|158414246|FG001|Part A - Titration Phase|Lack of Efficacy|6|||
49156833|NCT03391882|158414247|FG002|Part A - Titration Phase|Lack of Efficacy|0|||
49156834|NCT03391882|158414248|FG003|Part A - Titration Phase|Lack of Efficacy|0|||
49156835|NCT03391882|158414249|FG004|Part A - Titration Phase|Lack of Efficacy|0|||
49156836|NCT03391882|158414250|FG005|Part A - Titration Phase|Lack of Efficacy|0|||
49156837|NCT03391882|158414245|FG000|Part A - Titration Phase|Withdrawal by Subject|3|||
48830437|NCT03885596|157220725|FG000|Overall Study|Withdrawal by Subject|2|||
48830438|NCT03885596|157220726|FG001|Overall Study|Withdrawal by Subject|1|||
48830439|NCT03885596|157220727|FG002|Overall Study|Withdrawal by Subject|0|||
48830440|NCT03885596|157220728|FG003|Overall Study|Withdrawal by Subject|0|||
48830441|NCT00383188|157220729|FG000|Overall Study|Adverse Event|4|||
48830442|NCT00383188|157220730|FG001|Overall Study|Adverse Event|7|||
48830443|NCT00383188|157220731|FG002|Overall Study|Adverse Event|9|||
48830444|NCT00383188|157220732|FG003|Overall Study|Adverse Event|8|||
48830445|NCT00383188|157220733|FG004|Overall Study|Adverse Event|8|||
49156838|NCT03391882|158414246|FG001|Part A - Titration Phase|Withdrawal by Subject|3|||
49156839|NCT03391882|158414247|FG002|Part A - Titration Phase|Withdrawal by Subject|0|||
49156840|NCT03391882|158414248|FG003|Part A - Titration Phase|Withdrawal by Subject|0|||
49156841|NCT03391882|158414249|FG004|Part A - Titration Phase|Withdrawal by Subject|0|||
49156842|NCT03391882|158414250|FG005|Part A - Titration Phase|Withdrawal by Subject|0|||
49156843|NCT03391882|158414245|FG000|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
49156844|NCT03391882|158414246|FG001|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|1|||
49156845|NCT03391882|158414247|FG002|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
49156846|NCT03391882|158414248|FG003|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
48922710|NCT02573155|157550121|FG000|Washout Between Treatment Period 1 and 2|Physician Decision|0|||
48922711|NCT02573155|157550122|FG001|Washout Between Treatment Period 1 and 2|Physician Decision|1|||
48922712|NCT02573155|157550121|FG000|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0|||
48922713|NCT02573155|157550122|FG001|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1|||
48922714|NCT02573155|157550121|FG000|Washout Between Treatment Period 1 and 2|Adverse Event|0|||
48922715|NCT02573155|157550122|FG001|Washout Between Treatment Period 1 and 2|Adverse Event|3|||
48922716|NCT02573155|157550121|FG000|Washout Between Treatment Period 2 and 3|Sponsor's decision|1|||
48830446|NCT00383188|157220729|FG000|Overall Study|Lack of Efficacy|9|||
48830447|NCT00383188|157220730|FG001|Overall Study|Lack of Efficacy|3|||
48830448|NCT00383188|157220731|FG002|Overall Study|Lack of Efficacy|3|||
48830449|NCT00383188|157220732|FG003|Overall Study|Lack of Efficacy|2|||
48830450|NCT00383188|157220733|FG004|Overall Study|Lack of Efficacy|6|||
48830451|NCT00383188|157220729|FG000|Overall Study|Other|3|||
48922717|NCT02573155|157550122|FG001|Washout Between Treatment Period 2 and 3|Sponsor's decision|0|||
48922718|NCT02573155|157550121|FG000|Washout Between Treatment Period 2 and 3|Adverse Event|0|||
48922719|NCT02573155|157550122|FG001|Washout Between Treatment Period 2 and 3|Adverse Event|2|||
48922720|NCT02573155|157550121|FG000|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0|||
48922721|NCT02573155|157550122|FG001|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1|||
48922722|NCT02573155|157550121|FG000|Washout Between Treatment Period 3 and 4|Adverse Event|0|||
48922723|NCT02573155|157550122|FG001|Washout Between Treatment Period 3 and 4|Adverse Event|1|||
48922724|NCT02573155|157550121|FG000|Washout Between Treatment Period 4 and 5|Adverse Event|0|||
48922725|NCT02573155|157550122|FG001|Washout Between Treatment Period 4 and 5|Adverse Event|1|||
48922726|NCT00512798|157550125|FG000|Overall Study|Death|0|||
48922727|NCT00512798|157550126|FG001|Overall Study|Death|3|||
48830452|NCT00383188|157220730|FG001|Overall Study|Other|1|||
48922728|NCT00512798|157550125|FG000|Overall Study|Adverse Event|2|||
48830453|NCT00383188|157220731|FG002|Overall Study|Other|0|||
48830454|NCT00383188|157220732|FG003|Overall Study|Other|2|||
48830455|NCT00383188|157220733|FG004|Overall Study|Other|6|||
48830456|NCT00383188|157220729|FG000|Overall Study|No longer willing to participate|1|||
48830457|NCT00383188|157220730|FG001|Overall Study|No longer willing to participate|0|||
48830458|NCT00383188|157220731|FG002|Overall Study|No longer willing to participate|1|||
48830459|NCT00383188|157220732|FG003|Overall Study|No longer willing to participate|0|||
48830460|NCT00383188|157220733|FG004|Overall Study|No longer willing to participate|2|||
48830461|NCT00383188|157220729|FG000|Overall Study|Lost to Follow-up|0|||
48830462|NCT00383188|157220730|FG001|Overall Study|Lost to Follow-up|0|||
48830463|NCT00383188|157220731|FG002|Overall Study|Lost to Follow-up|0|||
48830464|NCT00383188|157220732|FG003|Overall Study|Lost to Follow-up|0|||
48830465|NCT00383188|157220733|FG004|Overall Study|Lost to Follow-up|1|||
48830466|NCT01076335|157220734|FG000|Overall Study|Withdrawal by Subject|3|||
48830467|NCT01076335|157220734|FG000|Overall Study|Withdrawal without treatment|1|||
48830468|NCT01582945|157220735|FG000|Overall Study|Intolerable side-effects|1|||
48830469|NCT01582945|157220735|FG000|Overall Study|Scheduling conflicts|1|||
48830470|NCT02784704|157220737|FG000|Overall Study|Adverse Event|4|||
48830471|NCT02784704|157220738|FG001|Overall Study|Adverse Event|2|||
48830472|NCT02784704|157220737|FG000|Overall Study|Lost to Follow-up|6|||
48830473|NCT02784704|157220738|FG001|Overall Study|Lost to Follow-up|4|||
48830474|NCT02784704|157220737|FG000|Overall Study|Withdrawal by Subject|1|||
48830475|NCT02784704|157220738|FG001|Overall Study|Withdrawal by Subject|3|||
48830476|NCT02784704|157220737|FG000|Overall Study|Subject Non Compliance|2|||
48830477|NCT02784704|157220738|FG001|Overall Study|Subject Non Compliance|0|||
48830478|NCT00741988|157220739|FG000|Overall Study|Adverse Event|2|||
48830479|NCT00741988|157220740|FG001|Overall Study|Adverse Event|4|||
48830480|NCT00741988|157220739|FG000|Overall Study|Lack of Efficacy|2|||
48922729|NCT00512798|157550126|FG001|Overall Study|Adverse Event|4|||
49156847|NCT03391882|158414249|FG004|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
49156848|NCT03391882|158414250|FG005|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
49156849|NCT03391882|158414245|FG000|Post Part A / Pre Part B|Lack of Efficacy|1|||
49156850|NCT03391882|158414246|FG001|Post Part A / Pre Part B|Lack of Efficacy|3|||
49156851|NCT03391882|158414247|FG002|Post Part A / Pre Part B|Lack of Efficacy|0|||
49156852|NCT03391882|158414248|FG003|Post Part A / Pre Part B|Lack of Efficacy|0|||
49156853|NCT03391882|158414249|FG004|Post Part A / Pre Part B|Lack of Efficacy|0|||
49156854|NCT03391882|158414250|FG005|Post Part A / Pre Part B|Lack of Efficacy|0|||
48830481|NCT00741988|157220740|FG001|Overall Study|Lack of Efficacy|0|||
48922730|NCT00512798|157550125|FG000|Overall Study|Progression of disease|14|||
49156855|NCT03391882|158414245|FG000|Post Part A / Pre Part B|Protocol Violation|1|||
48830482|NCT00768651|157220741|FG000|Overall Study|Withdrawal by Subject|1|||
49156856|NCT03391882|158414246|FG001|Post Part A / Pre Part B|Protocol Violation|0|||
48830483|NCT03523572|157220742|FG000|Dose Escalation|Progressive disease|1|||
48830484|NCT03523572|157220743|FG001|Dose Escalation|Progressive disease|0|||
48830485|NCT03523572|157220744|FG002|Dose Escalation|Progressive disease|0|||
48830486|NCT03523572|157220745|FG003|Dose Escalation|Progressive disease|0|||
48830487|NCT03523572|157220746|FG004|Dose Escalation|Progressive disease|0|||
48830488|NCT03523572|157220747|FG005|Dose Escalation|Progressive disease|0|||
48830489|NCT03523572|157220742|FG000|Dose Escalation|Clinical Progression|0|||
48830490|NCT03523572|157220743|FG001|Dose Escalation|Clinical Progression|1|||
48830491|NCT03523572|157220744|FG002|Dose Escalation|Clinical Progression|0|||
48830492|NCT03523572|157220745|FG003|Dose Escalation|Clinical Progression|0|||
48830493|NCT03523572|157220746|FG004|Dose Escalation|Clinical Progression|0|||
48830494|NCT03523572|157220747|FG005|Dose Escalation|Clinical Progression|0|||
48830495|NCT03523572|157220742|FG000|Dose Escalation|Adverse Event|2|||
48830496|NCT03523572|157220743|FG001|Dose Escalation|Adverse Event|0|||
48830497|NCT03523572|157220744|FG002|Dose Escalation|Adverse Event|0|||
48830498|NCT03523572|157220745|FG003|Dose Escalation|Adverse Event|0|||
48830499|NCT03523572|157220746|FG004|Dose Escalation|Adverse Event|0|||
48830500|NCT03523572|157220747|FG005|Dose Escalation|Adverse Event|0|||
48830501|NCT03523572|157220742|FG000|Dose Escalation|Physician Decision|1|||
48830502|NCT03523572|157220743|FG001|Dose Escalation|Physician Decision|1|||
48830503|NCT03523572|157220744|FG002|Dose Escalation|Physician Decision|0|||
48830504|NCT03523572|157220745|FG003|Dose Escalation|Physician Decision|0|||
48830505|NCT03523572|157220746|FG004|Dose Escalation|Physician Decision|0|||
48830506|NCT03523572|157220747|FG005|Dose Escalation|Physician Decision|0|||
48830507|NCT03523572|157220742|FG000|Dose Expansion|Progressive Disease|0|||
48830508|NCT03523572|157220743|FG001|Dose Expansion|Progressive Disease|0|||
48830509|NCT03523572|157220744|FG002|Dose Expansion|Progressive Disease|9|||
48830510|NCT03523572|157220745|FG003|Dose Expansion|Progressive Disease|11|||
48830511|NCT03523572|157220746|FG004|Dose Expansion|Progressive Disease|15|||
48830512|NCT03523572|157220747|FG005|Dose Expansion|Progressive Disease|2|||
48830513|NCT03523572|157220742|FG000|Dose Expansion|Clinical Progression|0|||
48830514|NCT03523572|157220743|FG001|Dose Expansion|Clinical Progression|0|||
48830515|NCT03523572|157220744|FG002|Dose Expansion|Clinical Progression|2|||
48830516|NCT03523572|157220745|FG003|Dose Expansion|Clinical Progression|2|||
48830517|NCT03523572|157220746|FG004|Dose Expansion|Clinical Progression|2|||
48830518|NCT03523572|157220747|FG005|Dose Expansion|Clinical Progression|0|||
48830519|NCT03523572|157220742|FG000|Dose Expansion|Adverse Event|0|||
48830520|NCT03523572|157220743|FG001|Dose Expansion|Adverse Event|0|||
48830521|NCT03523572|157220744|FG002|Dose Expansion|Adverse Event|10|||
48830522|NCT03523572|157220745|FG003|Dose Expansion|Adverse Event|1|||
48830523|NCT03523572|157220746|FG004|Dose Expansion|Adverse Event|5|||
48830524|NCT03523572|157220747|FG005|Dose Expansion|Adverse Event|2|||
48830525|NCT03523572|157220742|FG000|Dose Expansion|Withdrawal by Subject|0|||
48830526|NCT03523572|157220743|FG001|Dose Expansion|Withdrawal by Subject|0|||
48830527|NCT03523572|157220744|FG002|Dose Expansion|Withdrawal by Subject|1|||
48830528|NCT03523572|157220745|FG003|Dose Expansion|Withdrawal by Subject|1|||
48830529|NCT03523572|157220746|FG004|Dose Expansion|Withdrawal by Subject|0|||
48830530|NCT03523572|157220747|FG005|Dose Expansion|Withdrawal by Subject|0|||
48830531|NCT03523572|157220742|FG000|Dose Expansion|Physician Decision|0|||
49156857|NCT03391882|158414247|FG002|Post Part A / Pre Part B|Protocol Violation|0|||
48830532|NCT03523572|157220743|FG001|Dose Expansion|Physician Decision|0|||
48830533|NCT03523572|157220744|FG002|Dose Expansion|Physician Decision|1|||
48830534|NCT03523572|157220745|FG003|Dose Expansion|Physician Decision|0|||
48830535|NCT03523572|157220746|FG004|Dose Expansion|Physician Decision|1|||
48830536|NCT03523572|157220747|FG005|Dose Expansion|Physician Decision|0|||
48830537|NCT03523572|157220742|FG000|Dose Expansion|Miscellaneous|0|||
48830538|NCT03523572|157220743|FG001|Dose Expansion|Miscellaneous|0|||
48830539|NCT03523572|157220744|FG002|Dose Expansion|Miscellaneous|0|||
48830540|NCT03523572|157220745|FG003|Dose Expansion|Miscellaneous|0|||
48830541|NCT03523572|157220746|FG004|Dose Expansion|Miscellaneous|3|||
48830542|NCT03523572|157220747|FG005|Dose Expansion|Miscellaneous|0|||
48830543|NCT04888585|157220748|FG000|Placebo-Controlled (Baseline-Week 12)|Other|4|||
48830544|NCT04888585|157220749|FG001|Placebo-Controlled (Baseline-Week 12)|Other|4|||
48830545|NCT04888585|157220750|FG002|Placebo-Controlled (Baseline-Week 12)|Other|4|||
48830546|NCT04888585|157220751|FG003|Placebo-Controlled (Baseline-Week 12)|Other|2|||
48830547|NCT04888585|157220752|FG004|Placebo-Controlled (Baseline-Week 12)|Other|1|||
48830548|NCT04888585|157220753|FG005|Placebo-Controlled (Baseline-Week 12)|Other|0|||
48830549|NCT04888585|157220754|FG006|Placebo-Controlled (Baseline-Week 12)|Other|0|||
48830550|NCT04888585|157220755|FG007|Placebo-Controlled (Baseline-Week 12)|Other|0|||
48830551|NCT04888585|157220756|FG008|Placebo-Controlled (Baseline-Week 12)|Other|0|||
48830552|NCT04888585|157220757|FG009|Placebo-Controlled (Baseline-Week 12)|Other|0|||
48830553|NCT04888585|157220758|FG010|Placebo-Controlled (Baseline-Week 12)|Other|0|||
48830554|NCT04888585|157220748|FG000|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
49156858|NCT03391882|158414248|FG003|Post Part A / Pre Part B|Protocol Violation|0|||
49156859|NCT03391882|158414249|FG004|Post Part A / Pre Part B|Protocol Violation|0|||
49156860|NCT03391882|158414250|FG005|Post Part A / Pre Part B|Protocol Violation|0|||
49156861|NCT03391882|158414245|FG000|Part B - Treatment Phase|Adverse Event|0|||
49156862|NCT03391882|158414246|FG001|Part B - Treatment Phase|Adverse Event|0|||
49156863|NCT03391882|158414247|FG002|Part B - Treatment Phase|Adverse Event|1|||
49156864|NCT03391882|158414248|FG003|Part B - Treatment Phase|Adverse Event|1|||
49156865|NCT03391882|158414249|FG004|Part B - Treatment Phase|Adverse Event|3|||
48922731|NCT00512798|157550126|FG001|Overall Study|Progression of disease|20|||
48922732|NCT00512798|157550125|FG000|Overall Study|Withdrawal by Subject|3|||
48922733|NCT00512798|157550126|FG001|Overall Study|Withdrawal by Subject|0|||
48922734|NCT01314716|157550134|FG000|Double-Blind Phase|Randomized but not treated|1|||
48922735|NCT01314716|157550135|FG001|Double-Blind Phase|Randomized but not treated|1|||
48922736|NCT01314716|157550134|FG000|Double-Blind Phase|Adverse Event|10|||
48922737|NCT01314716|157550135|FG001|Double-Blind Phase|Adverse Event|4|||
48922738|NCT01314716|157550134|FG000|Double-Blind Phase|Withdrawal by Subject|5|||
48922739|NCT01314716|157550135|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
48922740|NCT01314716|157550134|FG000|Double-Blind Phase|Lost to Follow-up|0|||
48922741|NCT01314716|157550135|FG001|Double-Blind Phase|Lost to Follow-up|1|||
48922742|NCT01314716|157550134|FG000|Double-Blind Phase|Sponsor request|1|||
48922743|NCT01314716|157550135|FG001|Double-Blind Phase|Sponsor request|2|||
48922744|NCT01314716|157550134|FG000|Double-Blind Phase|Physician Decision|0|||
48922745|NCT01314716|157550135|FG001|Double-Blind Phase|Physician Decision|1|||
48922746|NCT01314716|157550134|FG000|Open-Label Phase|Adverse Event|4|||
48922747|NCT01314716|157550135|FG001|Open-Label Phase|Adverse Event|6|||
48922748|NCT01314716|157550134|FG000|Open-Label Phase|Withdrawal by Subject|1|||
48922749|NCT01314716|157550135|FG001|Open-Label Phase|Withdrawal by Subject|2|||
48922750|NCT01314716|157550134|FG000|Open-Label Phase|Physician Decision|5|||
48922751|NCT01314716|157550135|FG001|Open-Label Phase|Physician Decision|4|||
48830555|NCT04888585|157220749|FG001|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|1|||
48922752|NCT00700271|157550136|FG000|Overall Study|Adverse Event|4|||
48922753|NCT00700271|157550137|FG001|Overall Study|Adverse Event|6|||
49156866|NCT03391882|158414250|FG005|Part B - Treatment Phase|Adverse Event|1|||
49156867|NCT03391882|158414245|FG000|Part B - Treatment Phase|Withdrawal by Subject|0|||
49156868|NCT03391882|158414246|FG001|Part B - Treatment Phase|Withdrawal by Subject|0|||
49156869|NCT03391882|158414247|FG002|Part B - Treatment Phase|Withdrawal by Subject|2|||
48830556|NCT04888585|157220750|FG002|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|4|||
48830557|NCT04888585|157220751|FG003|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
48830558|NCT04888585|157220752|FG004|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
48830559|NCT04888585|157220753|FG005|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
48830560|NCT04888585|157220754|FG006|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
48830561|NCT04888585|157220755|FG007|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
48830562|NCT04888585|157220756|FG008|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
48830563|NCT04888585|157220757|FG009|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
48830564|NCT04888585|157220758|FG010|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
48830565|NCT04888585|157220748|FG000|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
48830566|NCT04888585|157220749|FG001|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
48830567|NCT04888585|157220750|FG002|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
48830568|NCT04888585|157220751|FG003|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
48830569|NCT04888585|157220752|FG004|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
48830570|NCT04888585|157220753|FG005|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
48830571|NCT04888585|157220754|FG006|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
48830572|NCT04888585|157220755|FG007|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
48830573|NCT04888585|157220756|FG008|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
48830574|NCT04888585|157220757|FG009|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
48830575|NCT04888585|157220758|FG010|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
48830576|NCT04888585|157220748|FG000|Long Term Extension (Wk 13-End of Study)|Death|0|||
48830577|NCT04888585|157220749|FG001|Long Term Extension (Wk 13-End of Study)|Death|0|||
48830578|NCT04888585|157220750|FG002|Long Term Extension (Wk 13-End of Study)|Death|0|||
48830579|NCT04888585|157220751|FG003|Long Term Extension (Wk 13-End of Study)|Death|0|||
48830580|NCT04888585|157220752|FG004|Long Term Extension (Wk 13-End of Study)|Death|0|||
48830581|NCT04888585|157220753|FG005|Long Term Extension (Wk 13-End of Study)|Death|0|||
48830582|NCT04888585|157220754|FG006|Long Term Extension (Wk 13-End of Study)|Death|0|||
48830583|NCT04888585|157220755|FG007|Long Term Extension (Wk 13-End of Study)|Death|1|||
48830584|NCT04888585|157220756|FG008|Long Term Extension (Wk 13-End of Study)|Death|0|||
48830585|NCT04888585|157220757|FG009|Long Term Extension (Wk 13-End of Study)|Death|0|||
48830586|NCT04888585|157220758|FG010|Long Term Extension (Wk 13-End of Study)|Death|3|||
48830587|NCT04888585|157220748|FG000|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
48830588|NCT04888585|157220749|FG001|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
48830589|NCT04888585|157220750|FG002|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
48922754|NCT00700271|157550136|FG000|Overall Study|Protocol Violation|1|||
48922755|NCT00700271|157550137|FG001|Overall Study|Protocol Violation|0|||
49156870|NCT03391882|158414248|FG003|Part B - Treatment Phase|Withdrawal by Subject|2|||
49156871|NCT03391882|158414249|FG004|Part B - Treatment Phase|Withdrawal by Subject|1|||
49156872|NCT03391882|158414250|FG005|Part B - Treatment Phase|Withdrawal by Subject|3|||
49156873|NCT01722669|158414251|FG000|Overall Study|Withdrawal by Subject|0|||
49156874|NCT01722669|158414252|FG001|Overall Study|Withdrawal by Subject|0|||
48830590|NCT04888585|157220751|FG003|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
48830591|NCT04888585|157220752|FG004|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
48830592|NCT04888585|157220753|FG005|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
48830593|NCT04888585|157220754|FG006|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
48830594|NCT04888585|157220755|FG007|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
48830595|NCT04888585|157220756|FG008|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
48830596|NCT04888585|157220757|FG009|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
48830597|NCT04888585|157220758|FG010|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|11|||
48830598|NCT04888585|157220748|FG000|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
48830599|NCT04888585|157220749|FG001|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
48830600|NCT04888585|157220750|FG002|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
48830601|NCT04888585|157220751|FG003|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
48830602|NCT04888585|157220752|FG004|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
48830603|NCT04888585|157220753|FG005|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|37|||
48830604|NCT04888585|157220754|FG006|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|36|||
48830605|NCT04888585|157220755|FG007|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|78|||
48830606|NCT04888585|157220756|FG008|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
48830607|NCT04888585|157220757|FG009|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
48830608|NCT04888585|157220758|FG010|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|72|||
48830609|NCT04888585|157220748|FG000|Long Term Extension (Wk 13-End of Study)|Other|0|||
48830610|NCT04888585|157220749|FG001|Long Term Extension (Wk 13-End of Study)|Other|0|||
48830611|NCT04888585|157220750|FG002|Long Term Extension (Wk 13-End of Study)|Other|0|||
48830612|NCT04888585|157220751|FG003|Long Term Extension (Wk 13-End of Study)|Other|0|||
48830613|NCT04888585|157220752|FG004|Long Term Extension (Wk 13-End of Study)|Other|0|||
48830614|NCT04888585|157220753|FG005|Long Term Extension (Wk 13-End of Study)|Other|3|||
48830615|NCT04888585|157220754|FG006|Long Term Extension (Wk 13-End of Study)|Other|1|||
48830616|NCT04888585|157220755|FG007|Long Term Extension (Wk 13-End of Study)|Other|4|||
48830617|NCT04888585|157220756|FG008|Long Term Extension (Wk 13-End of Study)|Other|5|||
48830618|NCT04888585|157220757|FG009|Long Term Extension (Wk 13-End of Study)|Other|5|||
48830619|NCT04888585|157220758|FG010|Long Term Extension (Wk 13-End of Study)|Other|3|||
48830620|NCT04888585|157220748|FG000|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
48830621|NCT04888585|157220749|FG001|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
48830622|NCT04888585|157220750|FG002|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
48830623|NCT04888585|157220751|FG003|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
48830624|NCT04888585|157220752|FG004|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
48830625|NCT04888585|157220753|FG005|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
48830626|NCT04888585|157220754|FG006|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|4|||
48830627|NCT04888585|157220755|FG007|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
48830628|NCT04888585|157220756|FG008|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
48830629|NCT04888585|157220757|FG009|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|1|||
48830630|NCT04888585|157220758|FG010|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
48830631|NCT04927975|157220759|FG000|Period 1 (Baseline-Week 24)|Withdrawal by Subject|2|||
48830632|NCT04927975|157220760|FG001|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
48830633|NCT04927975|157220761|FG002|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
48830634|NCT04927975|157220762|FG003|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
48830635|NCT04927975|157220763|FG004|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
49156875|NCT01722669|158414253|FG002|Overall Study|Withdrawal by Subject|0|||
49156876|NCT01722669|158414254|FG003|Overall Study|Withdrawal by Subject|0|||
49156877|NCT01722669|158414255|FG004|Overall Study|Withdrawal by Subject|0|||
49156878|NCT01722669|158414256|FG005|Overall Study|Withdrawal by Subject|2|||
49156879|NCT04660539|158414259|FG000|Overall Study|Adverse Event|10|||
49156880|NCT04660539|158414259|FG000|Overall Study|Lack of Efficacy|4|||
49156881|NCT04660539|158414259|FG000|Overall Study|Lost to Follow-up|5|||
49156882|NCT04660539|158414259|FG000|Overall Study|Non-Compliance With Study Drug|3|||
49156883|NCT04660539|158414259|FG000|Overall Study|Reason not Specified|12|||
49156884|NCT04660539|158414259|FG000|Overall Study|Pregnancy|2|||
49156885|NCT04660539|158414259|FG000|Overall Study|Protocol Violation|2|||
49156886|NCT04660539|158414259|FG000|Overall Study|Switch To Commercial Satralizumab|1|||
48830636|NCT04927975|157220764|FG005|Period 1 (Baseline-Week 24)|Withdrawal by Subject|4|||
48830637|NCT04927975|157220759|FG000|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
48830638|NCT04927975|157220760|FG001|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
48830639|NCT04927975|157220761|FG002|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
48830640|NCT04927975|157220762|FG003|Period 1 (Baseline-Week 24)|Lost to Follow-up|2|||
48830641|NCT04927975|157220763|FG004|Period 1 (Baseline-Week 24)|Lost to Follow-up|1|||
48830642|NCT04927975|157220764|FG005|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
48830643|NCT04927975|157220759|FG000|Period 1 (Baseline-Week 24)|Death|0|||
48830644|NCT04927975|157220760|FG001|Period 1 (Baseline-Week 24)|Death|0|||
48830645|NCT04927975|157220761|FG002|Period 1 (Baseline-Week 24)|Death|0|||
48830646|NCT04927975|157220762|FG003|Period 1 (Baseline-Week 24)|Death|0|||
48830647|NCT04927975|157220763|FG004|Period 1 (Baseline-Week 24)|Death|0|||
48830648|NCT04927975|157220764|FG005|Period 1 (Baseline-Week 24)|Death|1|||
48830649|NCT04927975|157220759|FG000|Period 2 (Week 24-52)|Lost to Follow-up|0|||
48830650|NCT04927975|157220760|FG001|Period 2 (Week 24-52)|Lost to Follow-up|1|||
48830651|NCT04927975|157220761|FG002|Period 2 (Week 24-52)|Lost to Follow-up|0|||
48830652|NCT04927975|157220762|FG003|Period 2 (Week 24-52)|Lost to Follow-up|2|||
48830653|NCT04927975|157220763|FG004|Period 2 (Week 24-52)|Lost to Follow-up|6|||
48830654|NCT04927975|157220764|FG005|Period 2 (Week 24-52)|Lost to Follow-up|2|||
48830655|NCT04927975|157220759|FG000|Period 2 (Week 24-52)|Withdrawal by Subject|0|||
48830656|NCT04927975|157220760|FG001|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
48830657|NCT04927975|157220761|FG002|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
48830658|NCT04927975|157220762|FG003|Period 2 (Week 24-52)|Withdrawal by Subject|4|||
48830659|NCT04927975|157220763|FG004|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
48830660|NCT04927975|157220764|FG005|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
48830661|NCT03213665|157220769|FG000|Overall Study|Adverse Event|1|||
48830662|NCT03213665|157220769|FG000|Overall Study|Physician Decision|2|||
48830663|NCT03213665|157220769|FG000|Overall Study|Withdrawal by Subject|3|||
48830664|NCT03213665|157220769|FG000|Overall Study|Progressive Disease|13|||
48830665|NCT01769391|157220771|FG000|Overall Study|Death|10|||
48830666|NCT01769391|157220772|FG001|Overall Study|Death|1|||
49156887|NCT04660539|158414259|FG000|Overall Study|Withdrawal by Subject|21|||
49156888|NCT03132467|158414267|FG000|Overall Study|Adverse Event|2|||
49156889|NCT03132467|158414267|FG000|Overall Study|Withdrawal by Subject|2|||
49156890|NCT00542178|158414268|FG000|Overall Study|did not complete year 4 follow-up|75|||
49156891|NCT00542178|158414269|FG001|Overall Study|did not complete year 4 follow-up|80|||
49156892|NCT00542178|158414270|FG002|Overall Study|did not complete year 4 follow-up|74|||
49156893|NCT00542178|158414271|FG003|Overall Study|did not complete year 4 follow-up|62|||
49156894|NCT00542178|158414272|FG004|Overall Study|did not complete year 4 follow-up|64|||
49156895|NCT00542178|158414273|FG005|Overall Study|did not complete year 4 follow-up|89|||
49156896|NCT00542178|158414274|FG006|Overall Study|did not complete year 4 follow-up|87|||
49156897|NCT00542178|158414275|FG007|Overall Study|did not complete year 4 follow-up|85|||
48830667|NCT01769391|157220771|FG000|Overall Study|Adverse Event|0|||
48830668|NCT01769391|157220772|FG001|Overall Study|Adverse Event|3|||
48830669|NCT01769391|157220771|FG000|Overall Study|Progressive Disease|1|||
48830670|NCT01769391|157220772|FG001|Overall Study|Progressive Disease|2|||
48830671|NCT01769391|157220771|FG000|Overall Study|Withdrawal by Subject|4|||
48830672|NCT01769391|157220772|FG001|Overall Study|Withdrawal by Subject|3|||
48830673|NCT01769391|157220771|FG000|Overall Study|Investigator Decision|2|||
48830674|NCT01769391|157220772|FG001|Overall Study|Investigator Decision|0|||
48830675|NCT03603717|157220773|FG000|Overall Study|Lost to Follow-up|20|||
48830676|NCT03603717|157220774|FG001|Overall Study|Lost to Follow-up|20|||
48830677|NCT03603717|157220773|FG000|Overall Study|Withdrawal by Subject|16|||
48830678|NCT03603717|157220774|FG001|Overall Study|Withdrawal by Subject|10|||
48830679|NCT00290706|157220777|FG000|Overall Study|Withdrawal by Subject|2|||
48830680|NCT00290706|157220778|FG001|Overall Study|Withdrawal by Subject|0|||
48830681|NCT00290706|157220779|FG002|Overall Study|Withdrawal by Subject|0|||
49156898|NCT03440385|158415871|FG000|Overall Study|Other Reason|4|||
49156899|NCT03440385|158415872|FG001|Overall Study|Other Reason|1|||
49156900|NCT03440385|158415871|FG000|Overall Study|Site Closed|1|||
49156901|NCT03440385|158415872|FG001|Overall Study|Site Closed|0|||
49156902|NCT03440385|158415871|FG000|Overall Study|Lost to Follow-up|2|||
48830682|NCT00290706|157220780|FG003|Overall Study|Withdrawal by Subject|0|||
48830683|NCT00290706|157220777|FG000|Overall Study|Progressive Disease|3|||
48830684|NCT00290706|157220778|FG001|Overall Study|Progressive Disease|5|||
48830685|NCT00290706|157220779|FG002|Overall Study|Progressive Disease|4|||
48830686|NCT00290706|157220780|FG003|Overall Study|Progressive Disease|10|||
48830687|NCT00290706|157220777|FG000|Overall Study|Adverse Event|0|||
48830688|NCT00290706|157220778|FG001|Overall Study|Adverse Event|1|||
48830689|NCT00290706|157220779|FG002|Overall Study|Adverse Event|2|||
48830690|NCT00290706|157220780|FG003|Overall Study|Adverse Event|0|||
49156903|NCT03440385|158415872|FG001|Overall Study|Lost to Follow-up|0|||
49156904|NCT03440385|158415871|FG000|Overall Study|Withdrawal by Subject|12|||
49156905|NCT03440385|158415872|FG001|Overall Study|Withdrawal by Subject|6|||
49156906|NCT03440385|158415871|FG000|Overall Study|Lack of Efficacy|9|||
49156907|NCT03440385|158415872|FG001|Overall Study|Lack of Efficacy|2|||
48830691|NCT00290706|157220777|FG000|Overall Study|Receive auto transplant or radiation|0|||
48830692|NCT00290706|157220778|FG001|Overall Study|Receive auto transplant or radiation|0|||
49156908|NCT03440385|158415871|FG000|Overall Study|Adverse Event|15|||
49156909|NCT03440385|158415872|FG001|Overall Study|Adverse Event|11|||
49156910|NCT02297516|158415877|FG000|Single Treatment Phase (6 Months)|Medical reason|1|||
49156911|NCT02297516|158415878|FG001|Single Treatment Phase (6 Months)|Medical reason|0|||
49156912|NCT02297516|158415877|FG000|Single Treatment Phase (6 Months)|Protocol Violation|0|||
49156913|NCT02297516|158415878|FG001|Single Treatment Phase (6 Months)|Protocol Violation|2|||
49156914|NCT02297516|158415877|FG000|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0|||
49156915|NCT02297516|158415878|FG001|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1|||
49156916|NCT01693367|158415887|FG000|Overall Study|Withdrawal by Subject|1|||
49156917|NCT01693367|158415888|FG001|Overall Study|Withdrawal by Subject|1|||
49156918|NCT01693367|158415887|FG000|Overall Study|Physician Decision|0|||
49156919|NCT01693367|158415888|FG001|Overall Study|Physician Decision|1|||
49156920|NCT01645176|158415889|FG000|Overall Study|Lack of Efficacy|4|||
49156921|NCT01645176|158415889|FG000|Overall Study|did not complete final MRI|1|||
49156922|NCT00949533|158415890|FG000|Overall Study|Lost to Follow-up|0|||
49156923|NCT00949533|158415891|FG001|Overall Study|Lost to Follow-up|1|||
49156924|NCT04507763|158415892|FG000|Overall Study|Participants did not meet entrance criteria|201|||
49156925|NCT03243084|158415893|FG000|Washout (1-3 Weeks)|Lost to Follow-up|1|||
49156926|NCT03243084|158415894|FG001|Washout (1-3 Weeks)|Lost to Follow-up|0|||
49156927|NCT04618471|158415903|FG000|Overall Study|Screen Failure|62|||
49156928|NCT04618471|158415903|FG000|Overall Study|Withdrawal by Subject|6|||
49156929|NCT04618471|158415903|FG000|Overall Study|Physician Decision|2|||
49156930|NCT04618471|158415903|FG000|Overall Study|Lost to Follow-up|1|||
49156931|NCT04618471|158415903|FG000|Overall Study|Various other reasons|2|||
49156932|NCT04618471|158415903|FG000|Overall Study|Pending study evaluation and completion of 3-Month post activation visit|84|||
48735552|NCT00697788|156883658|FG007|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
48830693|NCT00290706|157220779|FG002|Overall Study|Receive auto transplant or radiation|0|||
48830694|NCT00290706|157220780|FG003|Overall Study|Receive auto transplant or radiation|1|||
48830695|NCT00290706|157220777|FG000|Overall Study|Physician Decision|0|||
48830696|NCT00290706|157220778|FG001|Overall Study|Physician Decision|0|||
48830697|NCT00290706|157220779|FG002|Overall Study|Physician Decision|0|||
48830698|NCT00290706|157220780|FG003|Overall Study|Physician Decision|1|||
48735553|NCT00697788|156883651|FG000|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
48735554|NCT00697788|156883652|FG001|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
48735555|NCT00697788|156883653|FG002|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
48735556|NCT00697788|156883654|FG003|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
48735557|NCT00697788|156883655|FG004|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1|||
48735558|NCT00697788|156883656|FG005|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
48735559|NCT00697788|156883657|FG006|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
48735560|NCT00697788|156883658|FG007|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
48735561|NCT05447897|156883663|FG000|Overall Study|Did not participate in survey|2|||
48735562|NCT00850070|156883664|FG000|Overall Study|Lack of Efficacy|1|||
48735563|NCT00850070|156883665|FG001|Overall Study|Lack of Efficacy|1|||
48735564|NCT00850070|156883664|FG000|Overall Study|Adverse Event|2|||
48735565|NCT00850070|156883665|FG001|Overall Study|Adverse Event|0|||
48830699|NCT00546871|157220781|FG000|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1|||
48830700|NCT00546871|157220782|FG001|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0|||
48830701|NCT00546871|157220781|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1|||
48830702|NCT00546871|157220782|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2|||
48830703|NCT00546871|157220781|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0|||
48830704|NCT00546871|157220782|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1|||
48830705|NCT00546871|157220781|FG000|Study Extension Period|Protocol Violation|1|||
48830706|NCT00546871|157220782|FG001|Study Extension Period|Protocol Violation|0|||
48830707|NCT00546871|157220781|FG000|Study Extension Period|Withdrawal by Subject|0|||
48830708|NCT00546871|157220782|FG001|Study Extension Period|Withdrawal by Subject|1|||
48830709|NCT05567952|157221860|FG000|Overall Study|Lost to Follow-up|3|||
48830710|NCT05567952|157221861|FG001|Overall Study|Lost to Follow-up|2|||
48830711|NCT05567952|157221860|FG000|Overall Study|Withdrawal by Subject|6|||
49156933|NCT05136170|158415912|FG000|Overall Study|Withdrawal by Subject|2|||
49156934|NCT05136170|158415913|FG001|Overall Study|Withdrawal by Subject|2|||
48830712|NCT05567952|157221861|FG001|Overall Study|Withdrawal by Subject|3|||
48830713|NCT05567952|157221860|FG000|Overall Study|Other|3|||
48830714|NCT05567952|157221861|FG001|Overall Study|Other|1|||
48830715|NCT02152137|157221862|FG000|Overall Study|Withdrawal by Subject|1|||
48830716|NCT02152137|157221862|FG000|Overall Study|Originally assigned to Arm B|3|||
48830717|NCT01311648|157221863|FG000|Main Study|Protocol Violation|0|||
48830718|NCT01311648|157221864|FG001|Main Study|Protocol Violation|1|||
48830719|NCT01311648|157221863|FG000|Main Study|Adverse Event|0|||
48830720|NCT01311648|157221864|FG001|Main Study|Adverse Event|1|||
48830721|NCT01311648|157221863|FG000|Main Study|Inhibitor management|0|||
48830722|NCT01311648|157221864|FG001|Main Study|Inhibitor management|17|||
48830723|NCT01311648|157221863|FG000|Main Study|Withdrawal by Subject|0|||
48830724|NCT01311648|157221864|FG001|Main Study|Withdrawal by Subject|2|||
49156935|NCT05136170|158415912|FG000|Overall Study|Can no longer make office visits|1|||
49156936|NCT05136170|158415913|FG001|Overall Study|Can no longer make office visits|0|||
49156937|NCT03528902|158415921|FG000|Overall Study|Adverse Event|1|||
49156938|NCT03528902|158415922|FG001|Overall Study|Adverse Event|0|||
49156939|NCT04439266|158415925|FG000|Overall Study|Ineligible|1|||
49156940|NCT04439266|158415925|FG000|Overall Study|Adverse Event|1|||
49156941|NCT04439266|158415925|FG000|Overall Study|Death|1|||
49156942|NCT04439266|158415925|FG000|Overall Study|Disease progression|1|||
49156943|NCT04439266|158415925|FG000|Overall Study|Still on treatment|1|||
49156944|NCT01038323|158415930|FG000|Overall Study|Withdrawal by Subject|3|||
49156945|NCT01038323|158415931|FG001|Overall Study|Withdrawal by Subject|2|||
49156946|NCT01038323|158415932|FG002|Overall Study|Withdrawal by Subject|4|||
49156947|NCT02757430|158415933|FG000|Overall Study|Physician Decision|6|||
49156948|NCT02757430|158415933|FG000|Overall Study|Inclusion/Exclusion criteria not met|3|||
49156949|NCT02757430|158415933|FG000|Overall Study|No informed consent|1|||
49156950|NCT02757430|158415933|FG000|Overall Study|No procedure performed|2|||
49156951|NCT02394561|158415935|FG000|CORE Phase|Adverse Event|7|||
49156952|NCT02394561|158415936|FG001|CORE Phase|Adverse Event|9|||
49156953|NCT02394561|158415935|FG000|CORE Phase|Death|0|||
49156954|NCT02394561|158415936|FG001|CORE Phase|Death|1|||
49156955|NCT02394561|158415935|FG000|CORE Phase|Pregnancy|1|||
49156956|NCT02394561|158415936|FG001|CORE Phase|Pregnancy|0|||
49156957|NCT02394561|158415935|FG000|CORE Phase|Lost to Follow-up|1|||
49156958|NCT02394561|158415936|FG001|CORE Phase|Lost to Follow-up|0|||
49156959|NCT02394561|158415935|FG000|CORE Phase|Physician Decision|1|||
49156960|NCT02394561|158415936|FG001|CORE Phase|Physician Decision|1|||
48830725|NCT01311648|157221863|FG000|Extension Study|Physician Decision|0|||
48830726|NCT01311648|157221864|FG001|Extension Study|Physician Decision|1|||
49156961|NCT02394561|158415935|FG000|CORE Phase|Withdrawal by Subject|2|||
49156962|NCT02394561|158415936|FG001|CORE Phase|Withdrawal by Subject|2|||
49156963|NCT02394561|158415935|FG000|CORE Phase|Lack of Efficacy|1|||
49156964|NCT02394561|158415936|FG001|CORE Phase|Lack of Efficacy|6|||
49156965|NCT02394561|158415935|FG000|Extension Phase|Adverse Event|6|||
49156966|NCT02394561|158415936|FG001|Extension Phase|Adverse Event|1|||
49156967|NCT02394561|158415935|FG000|Extension Phase|Death|0|||
49156968|NCT02394561|158415936|FG001|Extension Phase|Death|1|||
49156969|NCT02394561|158415935|FG000|Extension Phase|Protocol Violation|1|||
49156970|NCT02394561|158415936|FG001|Extension Phase|Protocol Violation|0|||
49156971|NCT02394561|158415935|FG000|Extension Phase|Lost to Follow-up|1|||
49156972|NCT02394561|158415936|FG001|Extension Phase|Lost to Follow-up|0|||
49156973|NCT02394561|158415935|FG000|Extension Phase|Physician Decision|0|||
49156974|NCT02394561|158415936|FG001|Extension Phase|Physician Decision|2|||
49156975|NCT02394561|158415935|FG000|Extension Phase|Withdrawal by Subject|0|||
49156976|NCT02394561|158415936|FG001|Extension Phase|Withdrawal by Subject|5|||
49156977|NCT02394561|158415935|FG000|Extension Phase|Lack of Efficacy|3|||
49156978|NCT02394561|158415936|FG001|Extension Phase|Lack of Efficacy|3|||
48830727|NCT01311648|157221863|FG000|Extension Study|ITI therapy with marketed product|0|||
49156979|NCT03434834|158415937|FG000|Overall Study|unable to swallow OCT probe|16|||
49156980|NCT03047135|158415938|FG000|Overall Study|Still being treated|3|||
49156981|NCT01736917|158415939|FG000|Overall Study|Adverse Event|1|||
49156982|NCT01736917|158415939|FG000|Overall Study|Protocol Violation|10|||
49156983|NCT04138056|158415944|FG000|Primary Study|Lost to Follow-up|3|||
49156984|NCT04138056|158415945|FG001|Primary Study|Lost to Follow-up|4|||
49156985|NCT04138056|158415946|FG002|Primary Study|Lost to Follow-up|1|||
49156986|NCT04138056|158415947|FG003|Primary Study|Lost to Follow-up|1|||
49156987|NCT04138056|158415948|FG004|Primary Study|Lost to Follow-up|4|||
49156988|NCT04138056|158415944|FG000|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|3|||
49156989|NCT04138056|158415945|FG001|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|4|||
49156990|NCT04138056|158415946|FG002|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|2|||
49156991|NCT04138056|158415947|FG003|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|1|||
49156992|NCT04138056|158415948|FG004|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|0|||
49156993|NCT04138056|158415944|FG000|Extension Study|Lost to Follow-up|1|||
49156994|NCT04138056|158415945|FG001|Extension Study|Lost to Follow-up|2|||
48830728|NCT01311648|157221864|FG001|Extension Study|ITI therapy with marketed product|1|||
48830729|NCT01311648|157221863|FG000|Extension Study|Incorrect visit planning|0|||
48830730|NCT01311648|157221864|FG001|Extension Study|Incorrect visit planning|1|||
48830731|NCT01311648|157221863|FG000|Extension Study|Family's decision|0|||
48830732|NCT01311648|157221864|FG001|Extension Study|Family's decision|1|||
48830733|NCT01311648|157221863|FG000|Extension Study|Failure of ITI therapy|0|||
48830734|NCT01311648|157221864|FG001|Extension Study|Failure of ITI therapy|3|||
49156995|NCT04138056|158415946|FG002|Extension Study|Lost to Follow-up|1|||
49156996|NCT04138056|158415947|FG003|Extension Study|Lost to Follow-up|0|||
49156997|NCT04138056|158415948|FG004|Extension Study|Lost to Follow-up|1|||
48830735|NCT01311648|157221863|FG000|Extension Study|Long travel|0|||
48830736|NCT01311648|157221864|FG001|Extension Study|Long travel|1|||
48830737|NCT01311648|157221863|FG000|Extension Study|Diagnosed with von Willebrand disease|1|||
48830738|NCT01311648|157221864|FG001|Extension Study|Diagnosed with von Willebrand disease|0|||
48830739|NCT01311648|157221863|FG000|Extension Study|Withdrawal by Subject|0|||
48830740|NCT01311648|157221864|FG001|Extension Study|Withdrawal by Subject|1|||
48830741|NCT01311648|157221863|FG000|Extension Study|Inhibitor management|0|||
48830742|NCT01311648|157221864|FG001|Extension Study|Inhibitor management|2|||
48830743|NCT01645111|157221865|FG000|Overall Study|Did not require Clevidipine|15|||
48830744|NCT03103321|157221866|FG000|Overall Study|Protocol Violation|1|||
48830745|NCT03103321|157221867|FG001|Overall Study|Protocol Violation|1|||
48830746|NCT03103321|157221868|FG002|Overall Study|Protocol Violation|1|||
48830747|NCT03103321|157221869|FG003|Overall Study|Protocol Violation|0|||
48830748|NCT01419717|157221870|FG000|Overall Study|Protocol-specified Criteria|62|||
48830749|NCT01419717|157221870|FG000|Overall Study|Adverse Event|19|||
48830750|NCT01419717|157221870|FG000|Overall Study|Death|17|||
48830751|NCT01419717|157221870|FG000|Overall Study|Withdrawal by Subject|10|||
48830752|NCT01419717|157221870|FG000|Overall Study|Disease Progression|9|||
48830753|NCT01419717|157221870|FG000|Overall Study|Other|4|||
48830754|NCT01419717|157221870|FG000|Overall Study|Lost to Follow-up|2|||
48830755|NCT01419717|157221870|FG000|Overall Study|Administrative Decision|1|||
48830756|NCT01419717|157221870|FG000|Overall Study|Noncompliance|1|||
48830757|NCT02857283|157221871|FG000|First Exposure|Withdrawal by Subject|1|||
48830758|NCT02857283|157221872|FG001|First Exposure|Withdrawal by Subject|0|||
48830759|NCT02728557|157221873|FG000|Overall Study|Dissatisfaction with assigned treatment|1|||
48830760|NCT02728557|157221874|FG001|Overall Study|Dissatisfaction with assigned treatment|3|||
49156998|NCT04103450|158415949|FG000|Overall Study|Adverse Event|4|||
49156999|NCT04103450|158415950|FG001|Overall Study|Adverse Event|2|||
49157000|NCT04103450|158415949|FG000|Overall Study|Lack of Efficacy|3|||
49157001|NCT04103450|158415950|FG001|Overall Study|Lack of Efficacy|0|||
49157002|NCT04103450|158415949|FG000|Overall Study|Withdrawal by Subject|5|||
49157003|NCT04103450|158415950|FG001|Overall Study|Withdrawal by Subject|3|||
49157004|NCT04103450|158415949|FG000|Overall Study|Lost to Follow-up|1|||
49157005|NCT04103450|158415950|FG001|Overall Study|Lost to Follow-up|2|||
48830761|NCT02728557|157221873|FG000|Overall Study|Dissatisfaction with research tasks|0|||
48830762|NCT02728557|157221874|FG001|Overall Study|Dissatisfaction with research tasks|1|||
49157006|NCT04103450|158415949|FG000|Overall Study|Physician Decision|1|||
49157007|NCT04103450|158415950|FG001|Overall Study|Physician Decision|2|||
49157008|NCT04103450|158415949|FG000|Overall Study|Protocol Violation|1|||
49157009|NCT04103450|158415950|FG001|Overall Study|Protocol Violation|0|||
48830763|NCT02728557|157221873|FG000|Overall Study|Scheduling or change in availability|1|||
48830764|NCT02728557|157221874|FG001|Overall Study|Scheduling or change in availability|1|||
48830765|NCT01537133|157221875|FG000|Overall Study|Withdrawal by Subject|2|||
48830766|NCT01537133|157221876|FG001|Overall Study|Withdrawal by Subject|0|||
48830767|NCT01537133|157221877|FG002|Overall Study|Withdrawal by Subject|0|||
49157010|NCT04103450|158415949|FG000|Overall Study|Other|1|||
49157011|NCT04103450|158415950|FG001|Overall Study|Other|1|||
49157012|NCT01133847|158415964|FG000|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5|||
49157013|NCT01133847|158415965|FG001|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1|||
49157014|NCT01133847|158415966|FG002|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3|||
49157015|NCT01133847|158415964|FG000|Follow-Up Phase|Lost to Follow-up|1|||
49157016|NCT01133847|158415965|FG001|Follow-Up Phase|Lost to Follow-up|3|||
49157017|NCT01133847|158415966|FG002|Follow-Up Phase|Lost to Follow-up|7|||
49157018|NCT00940602|158415967|FG000|Overall Study|Administrative problems|1|||
49157019|NCT00940602|158415968|FG001|Overall Study|Administrative problems|1|||
49157020|NCT00940602|158415967|FG000|Overall Study|Patient/guardian decision|13|||
49157021|NCT00940602|158415968|FG001|Overall Study|Patient/guardian decision|28|||
48830768|NCT01537133|157221878|FG003|Overall Study|Withdrawal by Subject|0|||
48830769|NCT01537133|157221875|FG000|Overall Study|Lost to Follow-up|1|||
48830770|NCT01537133|157221876|FG001|Overall Study|Lost to Follow-up|0|||
49157022|NCT00940602|158415967|FG000|Overall Study|Physician Decision|8|||
49157023|NCT00940602|158415968|FG001|Overall Study|Physician Decision|5|||
49157024|NCT00940602|158415967|FG000|Overall Study|Pregnancy|1|||
49157025|NCT00940602|158415968|FG001|Overall Study|Pregnancy|0|||
49157026|NCT00940602|158415967|FG000|Overall Study|Protocol Deviation (untreated)|1|||
49157027|NCT00940602|158415968|FG001|Overall Study|Protocol Deviation (untreated)|0|||
49157028|NCT00940602|158415967|FG000|Overall Study|Disease progression|8|||
49157029|NCT00940602|158415968|FG001|Overall Study|Disease progression|2|||
49157030|NCT00940602|158415967|FG000|Overall Study|Death|38|||
49157031|NCT00940602|158415968|FG001|Overall Study|Death|19|||
49157032|NCT00940602|158415967|FG000|Overall Study|Lost to Follow-up|3|||
49157033|NCT00940602|158415968|FG001|Overall Study|Lost to Follow-up|1|||
49157034|NCT00940602|158415967|FG000|Overall Study|Patient withdrew consent|26|||
49157035|NCT00940602|158415968|FG001|Overall Study|Patient withdrew consent|13|||
49157036|NCT00940602|158415967|FG000|Overall Study|Adverse Event|7|||
49157037|NCT00940602|158415968|FG001|Overall Study|Adverse Event|2|||
49157038|NCT00940602|158415967|FG000|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43|||
49157039|NCT00940602|158415968|FG001|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5|||
49157040|NCT01854528|158415969|FG000|Overall Study|Adverse Event|0|||
49157041|NCT01854528|158415970|FG001|Overall Study|Adverse Event|4|||
49157042|NCT01854528|158415969|FG000|Overall Study|Withdrawal by Subject|0|||
49157043|NCT01854528|158415970|FG001|Overall Study|Withdrawal by Subject|2|||
49157044|NCT01854528|158415969|FG000|Overall Study|Virologic Failure|0|||
49157045|NCT01854528|158415970|FG001|Overall Study|Virologic Failure|9|||
49157046|NCT01696643|158415972|FG000|Overall Study|Adverse Event|15|||
49157047|NCT01696643|158415973|FG001|Overall Study|Adverse Event|7|||
49157048|NCT01696643|158415972|FG000|Overall Study|Death|1|||
49157049|NCT01696643|158415973|FG001|Overall Study|Death|2|||
49157050|NCT01696643|158415972|FG000|Overall Study|Lack of Efficacy|3|||
49157051|NCT01696643|158415973|FG001|Overall Study|Lack of Efficacy|0|||
48830771|NCT01537133|157221877|FG002|Overall Study|Lost to Follow-up|0|||
48830772|NCT01537133|157221878|FG003|Overall Study|Lost to Follow-up|0|||
48830773|NCT00613301|157221879|FG000|Overall Study|Adverse Event|49|||
48830774|NCT00613301|157221879|FG000|Overall Study|Lost to Follow-up|88|||
48830775|NCT00613301|157221879|FG000|Overall Study|Withdrawal by Subject|5|||
48830776|NCT00613301|157221879|FG000|Overall Study|Death|6|||
48830777|NCT00613301|157221879|FG000|Overall Study|Lack of Efficacy|13|||
48830778|NCT00613301|157221879|FG000|Overall Study|Physician Decision|2|||
48830779|NCT00613301|157221879|FG000|Overall Study|No data was collected|53|||
48830780|NCT00613301|157221879|FG000|Overall Study|Irregularly enrolled patients|12|||
48830781|NCT00762463|157221880|FG000|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
48830782|NCT00762463|157221881|FG001|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
48830783|NCT00762463|157221882|FG002|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
48830784|NCT00762463|157221883|FG003|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
48830785|NCT00762463|157221880|FG000|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3|||
48830786|NCT00762463|157221881|FG001|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4|||
48830787|NCT00762463|157221882|FG002|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
48830788|NCT00762463|157221883|FG003|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
48830789|NCT00762463|157221880|FG000|Double-blind Phase (Baseline to Week 6)|Adverse Event|2|||
48830790|NCT00762463|157221881|FG001|Double-blind Phase (Baseline to Week 6)|Adverse Event|4|||
48830791|NCT00762463|157221882|FG002|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
48830792|NCT00762463|157221883|FG003|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
48830793|NCT00762463|157221880|FG000|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4|||
48830794|NCT00762463|157221881|FG001|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1|||
48830795|NCT00762463|157221882|FG002|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
48830796|NCT00762463|157221883|FG003|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
48830797|NCT00762463|157221880|FG000|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
48830798|NCT00762463|157221881|FG001|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
48830799|NCT00762463|157221882|FG002|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
48830800|NCT00762463|157221883|FG003|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
49157052|NCT01696643|158415972|FG000|Overall Study|Lost to Follow-up|67|||
49157053|NCT01696643|158415973|FG001|Overall Study|Lost to Follow-up|67|||
49157054|NCT01696643|158415972|FG000|Overall Study|Physician Decision|3|||
49157055|NCT01696643|158415973|FG001|Overall Study|Physician Decision|2|||
49157056|NCT01696643|158415972|FG000|Overall Study|Pregnancy|0|||
49157057|NCT01696643|158415973|FG001|Overall Study|Pregnancy|1|||
49157058|NCT01696643|158415972|FG000|Overall Study|Protocol Violation|7|||
49157059|NCT01696643|158415973|FG001|Overall Study|Protocol Violation|7|||
49157060|NCT01696643|158415972|FG000|Overall Study|Study Terminated by Sponsor|286|||
49157061|NCT01696643|158415973|FG001|Overall Study|Study Terminated by Sponsor|294|||
49157062|NCT01696643|158415972|FG000|Overall Study|Withdrawal by Subject|142|||
49157063|NCT01696643|158415973|FG001|Overall Study|Withdrawal by Subject|149|||
48830801|NCT00762463|157221880|FG000|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
49157064|NCT01696643|158415972|FG000|Overall Study|Participant on Restricted Bed Rest|1|||
49157065|NCT01696643|158415973|FG001|Overall Study|Participant on Restricted Bed Rest|0|||
49157066|NCT01696643|158415972|FG000|Overall Study|Site Error|2|||
49157067|NCT01696643|158415973|FG001|Overall Study|Site Error|1|||
49157068|NCT01696643|158415972|FG000|Overall Study|Participant Incarcerated|0|||
49157069|NCT01696643|158415973|FG001|Overall Study|Participant Incarcerated|1|||
49157070|NCT01696643|158415972|FG000|Overall Study|Medical Monitor Decision|0|||
49157071|NCT01696643|158415973|FG001|Overall Study|Medical Monitor Decision|2|||
49157072|NCT01696643|158415972|FG000|Overall Study|Participant Did Not Receive Study Drug|2|||
49157073|NCT01696643|158415973|FG001|Overall Study|Participant Did Not Receive Study Drug|2|||
49157074|NCT00016354|158415974|FG000|Overall Study|Lack of Efficacy|0|||
49157075|NCT00016354|158415975|FG001|Overall Study|Lack of Efficacy|0|||
49157076|NCT00016354|158415976|FG002|Overall Study|Lack of Efficacy|0|||
49157077|NCT00016354|158415977|FG003|Overall Study|Lack of Efficacy|0|||
49157078|NCT00016354|158415978|FG004|Overall Study|Lack of Efficacy|0|||
49157079|NCT00016354|158415979|FG005|Overall Study|Lack of Efficacy|0|||
49157080|NCT00016354|158415980|FG006|Overall Study|Lack of Efficacy|0|||
49157081|NCT00016354|158415981|FG007|Overall Study|Lack of Efficacy|1|||
49157082|NCT01968980|158415982|FG000|Overall Study|Death|0|||
49157083|NCT01968980|158415983|FG001|Overall Study|Death|1|||
49157084|NCT01968980|158415982|FG000|Overall Study|Adverse Event|1|||
49157085|NCT01968980|158415983|FG001|Overall Study|Adverse Event|3|||
49157086|NCT01968980|158415982|FG000|Overall Study|Does not meet entry criteria|1|||
49157087|NCT01968980|158415983|FG001|Overall Study|Does not meet entry criteria|3|||
49157088|NCT01968980|158415982|FG000|Overall Study|Withdrawal by Subject|13|||
49157089|NCT01968980|158415983|FG001|Overall Study|Withdrawal by Subject|5|||
49157090|NCT01968980|158415982|FG000|Overall Study|Other unspecified|1|||
49157091|NCT01968980|158415983|FG001|Overall Study|Other unspecified|2|||
49157092|NCT01374425|158415984|FG000|Overall Study|Radiographic Disease Progression|86|||
49157093|NCT01374425|158415985|FG001|Overall Study|Radiographic Disease Progression|81|||
49157094|NCT01374425|158415984|FG000|Overall Study|Clinical Disease Progression|9|||
49157095|NCT01374425|158415985|FG001|Overall Study|Clinical Disease Progression|6|||
49157096|NCT01374425|158415984|FG000|Overall Study|Adverse Event|29|||
49157097|NCT01374425|158415985|FG001|Overall Study|Adverse Event|18|||
49157098|NCT01374425|158415984|FG000|Overall Study|Death (Progression of Disease)|1|||
49157099|NCT01374425|158415985|FG001|Overall Study|Death (Progression of Disease)|0|||
49157100|NCT01374425|158415984|FG000|Overall Study|Death (Adverse Event)|2|||
49157101|NCT01374425|158415985|FG001|Overall Study|Death (Adverse Event)|4|||
49157102|NCT01374425|158415984|FG000|Overall Study|Withdrawal by Subject|6|||
49157103|NCT01374425|158415985|FG001|Overall Study|Withdrawal by Subject|7|||
49157104|NCT01374425|158415984|FG000|Overall Study|Refused Treatment|10|||
49157105|NCT01374425|158415985|FG001|Overall Study|Refused Treatment|24|||
49157106|NCT01374425|158415984|FG000|Overall Study|Protocol Violation|2|||
49157107|NCT01374425|158415985|FG001|Overall Study|Protocol Violation|3|||
49157108|NCT01374425|158415984|FG000|Overall Study|Sponsor Decision|0|||
49157109|NCT01374425|158415985|FG001|Overall Study|Sponsor Decision|1|||
49157110|NCT01374425|158415984|FG000|Overall Study|Lost to Follow-up|2|||
48830802|NCT00762463|157221881|FG001|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
48830803|NCT00762463|157221882|FG002|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0|||
48830804|NCT00762463|157221883|FG003|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
49157111|NCT01374425|158415985|FG001|Overall Study|Lost to Follow-up|1|||
49157112|NCT01374425|158415984|FG000|Overall Study|Other|41|||
49157113|NCT01374425|158415985|FG001|Overall Study|Other|43|||
49157114|NCT03383666|158415986|FG000|Overall Study|Withdrawal by Subject|2|||
49157115|NCT03383666|158415986|FG000|Overall Study|Lost to Follow-up|2|||
49157116|NCT04046939|158415991|FG000|Primary Assessment Period|Adverse Event|1|||
49157117|NCT04046939|158415992|FG001|Primary Assessment Period|Adverse Event|0|||
49157118|NCT04046939|158415993|FG002|Primary Assessment Period|Adverse Event|0|||
49157119|NCT04046939|158415994|FG003|Primary Assessment Period|Adverse Event|0|||
49157120|NCT04046939|158415991|FG000|Primary Assessment Period|Withdrawal by Subject|1|||
49157121|NCT04046939|158415992|FG001|Primary Assessment Period|Withdrawal by Subject|0|||
49157122|NCT04046939|158415993|FG002|Primary Assessment Period|Withdrawal by Subject|1|||
49014549|NCT03538756|157888916|FG000|Long-Term Follow-up|Withdrawal by Subject|0|||
48830805|NCT00762463|157221880|FG000|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1|||
48830806|NCT00762463|157221881|FG001|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
48830807|NCT00762463|157221882|FG002|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3|||
48830808|NCT00762463|157221883|FG003|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
48830809|NCT00762463|157221880|FG000|Extension Phase (Week 6 to Week 12)|Other|0|||
48830810|NCT00762463|157221881|FG001|Extension Phase (Week 6 to Week 12)|Other|0|||
48830811|NCT00762463|157221882|FG002|Extension Phase (Week 6 to Week 12)|Other|0|||
48830812|NCT00762463|157221883|FG003|Extension Phase (Week 6 to Week 12)|Other|1|||
48830813|NCT03784963|157221884|FG000|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12|||
48830814|NCT03784963|157221885|FG001|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10|||
48830815|NCT03784963|157221886|FG002|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1|||
48830816|NCT03784963|157221887|FG003|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0|||
48830817|NCT01362491|157221888|FG000|Overall Study|Ineligible|1|||
48830818|NCT01362491|157221889|FG001|Overall Study|Ineligible|0|||
48830819|NCT01362491|157221890|FG002|Overall Study|Ineligible|0|||
48830820|NCT00149630|157221891|FG000|Overall Study|Incarceration|2|||
48830821|NCT00149630|157221892|FG001|Overall Study|Incarceration|0|||
48830822|NCT00149630|157221891|FG000|Overall Study|Treatment Programs|4|||
48830823|NCT00149630|157221892|FG001|Overall Study|Treatment Programs|5|||
48830824|NCT00149630|157221891|FG000|Overall Study|Adverse Event|2|||
48830825|NCT00149630|157221892|FG001|Overall Study|Adverse Event|0|||
48830826|NCT01175707|157221894|FG000|Overall Study|Adverse Event|4|||
48830827|NCT01175707|157221895|FG001|Overall Study|Adverse Event|6|||
48830828|NCT03771898|157221896|FG000|Overall Study|Adverse Event|1|||
48830829|NCT03771898|157221897|FG001|Overall Study|Adverse Event|0|||
48830830|NCT03771898|157221898|FG002|Overall Study|Adverse Event|0|||
48830831|NCT03771898|157221899|FG003|Overall Study|Adverse Event|0|||
48830832|NCT03771898|157221900|FG004|Overall Study|Adverse Event|0|||
48830833|NCT03771898|157221896|FG000|Overall Study|Lost to Follow-up|1|||
48830834|NCT03771898|157221897|FG001|Overall Study|Lost to Follow-up|1|||
48830835|NCT03771898|157221898|FG002|Overall Study|Lost to Follow-up|1|||
48830836|NCT03771898|157221899|FG003|Overall Study|Lost to Follow-up|0|||
48830837|NCT03771898|157221900|FG004|Overall Study|Lost to Follow-up|0|||
48830838|NCT03771898|157221896|FG000|Overall Study|Withdrawal by parent/guardian|1|||
48830839|NCT03771898|157221897|FG001|Overall Study|Withdrawal by parent/guardian|1|||
48830840|NCT03771898|157221898|FG002|Overall Study|Withdrawal by parent/guardian|0|||
48830841|NCT03771898|157221899|FG003|Overall Study|Withdrawal by parent/guardian|0|||
48830842|NCT03771898|157221900|FG004|Overall Study|Withdrawal by parent/guardian|0|||
48830843|NCT03771898|157221896|FG000|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
48830844|NCT03771898|157221897|FG001|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
48830845|NCT03771898|157221898|FG002|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
48830846|NCT03771898|157221899|FG003|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
48830847|NCT03771898|157221900|FG004|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|33|||
48830848|NCT02962674|157221901|FG000|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49|||
48830849|NCT01897233|157221902|FG000|Part B (24 Weeks)|Adverse Event|1|||
49014550|NCT03538756|157888917|FG001|Long-Term Follow-up|Withdrawal by Subject|0|||
49014551|NCT03538756|157888918|FG002|Long-Term Follow-up|Withdrawal by Subject|5|||
49014552|NCT03538756|157888916|FG000|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
49014553|NCT03538756|157888917|FG001|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
49014554|NCT03538756|157888918|FG002|Long-Term Follow-up|COVID-19 Disruptions at Sites|13|||
49014555|NCT03538756|157888916|FG000|Long-Term Follow-up|Device Dissatisfaction|0|||
49014556|NCT03538756|157888917|FG001|Long-Term Follow-up|Device Dissatisfaction|0|||
49014557|NCT03538756|157888918|FG002|Long-Term Follow-up|Device Dissatisfaction|8|||
49014558|NCT03495869|157888919|FG000|Overall Study|Lost to Follow-up|4|||
49014559|NCT03495869|157888920|FG001|Overall Study|Lost to Follow-up|17|||
49014560|NCT03495869|157888921|FG002|Overall Study|Lost to Follow-up|8|||
49014561|NCT03495869|157888922|FG003|Overall Study|Lost to Follow-up|14|||
49014562|NCT03495869|157888919|FG000|Overall Study|Withdrawal by Subject|0|||
49014563|NCT03495869|157888920|FG001|Overall Study|Withdrawal by Subject|3|||
49014564|NCT03495869|157888921|FG002|Overall Study|Withdrawal by Subject|0|||
49014565|NCT03495869|157888922|FG003|Overall Study|Withdrawal by Subject|3|||
49014566|NCT03495869|157888919|FG000|Overall Study|Dropped from study|0|||
49014567|NCT03495869|157888920|FG001|Overall Study|Dropped from study|7|||
49014568|NCT03495869|157888921|FG002|Overall Study|Dropped from study|2|||
49014569|NCT03495869|157888922|FG003|Overall Study|Dropped from study|4|||
49014570|NCT04634409|157888923|FG000|Overall Study|Death|0|||
49014571|NCT04634409|157888924|FG001|Overall Study|Death|0|||
49014572|NCT04634409|157888925|FG002|Overall Study|Death|0|||
49014573|NCT04634409|157888926|FG003|Overall Study|Death|0|||
49014574|NCT04634409|157888927|FG004|Overall Study|Death|0|||
49157123|NCT04046939|158415994|FG003|Primary Assessment Period|Withdrawal by Subject|0|||
49157124|NCT04046939|158415991|FG000|Primary Assessment Period|Physician Decision|0|||
49157125|NCT04046939|158415992|FG001|Primary Assessment Period|Physician Decision|0|||
49157126|NCT04046939|158415993|FG002|Primary Assessment Period|Physician Decision|1|||
49157127|NCT04046939|158415994|FG003|Primary Assessment Period|Physician Decision|0|||
49157128|NCT04046939|158415991|FG000|Eosinophil Recovery Period|Withdrawal by Subject|1|||
49157129|NCT04046939|158415992|FG001|Eosinophil Recovery Period|Withdrawal by Subject|0|||
49157130|NCT04046939|158415993|FG002|Eosinophil Recovery Period|Withdrawal by Subject|0|||
49157131|NCT04046939|158415994|FG003|Eosinophil Recovery Period|Withdrawal by Subject|1|||
49157132|NCT04614324|158415995|FG000|Overall Study|Lost to Follow-up|3|||
48830850|NCT01897233|157221902|FG000|Part B (24 Weeks)|Withdrawal by Subject|2|||
48830851|NCT01897233|157221902|FG000|Part B (24 Weeks)|Physician Decision|1|||
48830852|NCT00269399|157221903|FG000|Overall Study|Lack of Efficacy|27|||
48830853|NCT00269399|157221904|FG001|Overall Study|Lack of Efficacy|10|||
49157133|NCT04614324|158415995|FG000|Overall Study|Physician Decision|1|||
49157134|NCT04614324|158415995|FG000|Overall Study|Withdrawal by Subject|2|||
49157135|NCT04614324|158415995|FG000|Overall Study|Remaining in Follow up|123|||
49157136|NCT02561962|158415996|FG000|Overall Study|Withdrawal by Subject|1|||
49157137|NCT02561962|158415997|FG001|Overall Study|Withdrawal by Subject|0|||
49157138|NCT02561962|158415998|FG002|Overall Study|Withdrawal by Subject|0|||
49157139|NCT02561962|158415999|FG003|Overall Study|Withdrawal by Subject|0|||
49157140|NCT02561962|158416000|FG004|Overall Study|Withdrawal by Subject|1|||
49157141|NCT02561962|158416001|FG005|Overall Study|Withdrawal by Subject|1|||
49157142|NCT02561962|158416002|FG006|Overall Study|Withdrawal by Subject|2|||
49157143|NCT02561962|158416003|FG007|Overall Study|Withdrawal by Subject|1|||
49157144|NCT02561962|158416004|FG008|Overall Study|Withdrawal by Subject|0|||
49157145|NCT02561962|158415996|FG000|Overall Study|Decision by sponsor|0|||
49157146|NCT02561962|158415997|FG001|Overall Study|Decision by sponsor|0|||
49157147|NCT02561962|158415998|FG002|Overall Study|Decision by sponsor|0|||
49157148|NCT02561962|158415999|FG003|Overall Study|Decision by sponsor|0|||
49157149|NCT02561962|158416000|FG004|Overall Study|Decision by sponsor|1|||
49157150|NCT02561962|158416001|FG005|Overall Study|Decision by sponsor|1|||
49157151|NCT02561962|158416002|FG006|Overall Study|Decision by sponsor|0|||
49157152|NCT02561962|158416003|FG007|Overall Study|Decision by sponsor|3|||
49157153|NCT02561962|158416004|FG008|Overall Study|Decision by sponsor|0|||
49157154|NCT02561962|158415996|FG000|Overall Study|Lost to Follow-up|0|||
49157155|NCT02561962|158415997|FG001|Overall Study|Lost to Follow-up|0|||
49157156|NCT02561962|158415998|FG002|Overall Study|Lost to Follow-up|0|||
49157157|NCT02561962|158415999|FG003|Overall Study|Lost to Follow-up|0|||
49157158|NCT02561962|158416000|FG004|Overall Study|Lost to Follow-up|0|||
49157159|NCT02561962|158416001|FG005|Overall Study|Lost to Follow-up|1|||
49157160|NCT02561962|158416002|FG006|Overall Study|Lost to Follow-up|0|||
49157161|NCT02561962|158416003|FG007|Overall Study|Lost to Follow-up|0|||
49157162|NCT02561962|158416004|FG008|Overall Study|Lost to Follow-up|0|||
49157163|NCT00457626|158416005|FG000|Overall Study|Adverse Event|3|||
49157164|NCT00457626|158416005|FG000|Overall Study|Administrative Problems|2|||
49157165|NCT00457626|158416005|FG000|Overall Study|Participant's Condition No Longer Requires Study Drug|1|||
49157166|NCT03586973|158416008|FG000|Overall Study|Death|15|||
48830854|NCT00269399|157221903|FG000|Overall Study|Adverse Event|10|||
48830855|NCT00269399|157221904|FG001|Overall Study|Adverse Event|4|||
48830856|NCT00269399|157221903|FG000|Overall Study|Withdrawal by Subject|2|||
48830857|NCT00269399|157221904|FG001|Overall Study|Withdrawal by Subject|5|||
48830858|NCT00269399|157221903|FG000|Overall Study|Negative Lab Result for C. difficile|2|||
48830859|NCT00269399|157221904|FG001|Overall Study|Negative Lab Result for C. difficile|3|||
48830860|NCT00269399|157221903|FG000|Overall Study|Other|0|||
48830861|NCT00269399|157221904|FG001|Overall Study|Other|4|||
48830862|NCT00269399|157221903|FG000|Overall Study|Development of exclusion criteria|0|||
48830863|NCT00269399|157221904|FG001|Overall Study|Development of exclusion criteria|1|||
48830864|NCT01048788|157221905|FG000|Overall Study|Adverse Event|5|||
48830865|NCT01048788|157221906|FG001|Overall Study|Adverse Event|1|||
48830866|NCT01048788|157221907|FG002|Overall Study|Adverse Event|1|||
49157167|NCT03586973|158416009|FG001|Overall Study|Death|8|||
49157168|NCT03586973|158416008|FG000|Overall Study|Site Terminated by Sponsor|3|||
49157169|NCT03586973|158416009|FG001|Overall Study|Site Terminated by Sponsor|6|||
49157170|NCT03586973|158416008|FG000|Overall Study|Withdrawal by Subject|1|||
48830867|NCT01048788|157221905|FG000|Overall Study|Lack of Efficacy|0|||
48830868|NCT01048788|157221906|FG001|Overall Study|Lack of Efficacy|0|||
48830869|NCT01048788|157221907|FG002|Overall Study|Lack of Efficacy|1|||
49157171|NCT03586973|158416009|FG001|Overall Study|Withdrawal by Subject|0|||
49157172|NCT03586973|158416008|FG000|Overall Study|Lost to Follow-up|1|||
49157173|NCT03586973|158416009|FG001|Overall Study|Lost to Follow-up|0|||
49157174|NCT04976777|158417365|FG000|Overall Study|COVID-19 Infection|1|||
49157175|NCT04976777|158417366|FG001|Overall Study|COVID-19 Infection|0|||
49157176|NCT01441960|158417367|FG000|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6|||
49157177|NCT01441960|158417368|FG001|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5|||
49157178|NCT01441960|158417367|FG000|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
49157179|NCT01441960|158417368|FG001|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
49157180|NCT01441960|158417367|FG000|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1|||
49157181|NCT01441960|158417368|FG001|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0|||
49157182|NCT03801525|158417369|FG000|Overall Study|Adverse Event|17|||
49157183|NCT03801525|158417370|FG001|Overall Study|Adverse Event|1|||
49157184|NCT03801525|158417371|FG002|Overall Study|Adverse Event|0|||
49157185|NCT03801525|158417369|FG000|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|1|||
49157186|NCT03801525|158417370|FG001|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
49157187|NCT03801525|158417371|FG002|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
49157188|NCT03801525|158417369|FG000|Overall Study|Death|29|||
49157189|NCT03801525|158417370|FG001|Overall Study|Death|1|||
49157190|NCT03801525|158417371|FG002|Overall Study|Death|4|||
49157191|NCT03801525|158417369|FG000|Overall Study|Disease Progression|6|||
49157192|NCT03801525|158417370|FG001|Overall Study|Disease Progression|0|||
49157193|NCT03801525|158417371|FG002|Overall Study|Disease Progression|1|||
49157194|NCT03801525|158417369|FG000|Overall Study|Inability to Comply With Study Requirements|1|||
49157195|NCT03801525|158417370|FG001|Overall Study|Inability to Comply With Study Requirements|1|||
49157196|NCT03801525|158417371|FG002|Overall Study|Inability to Comply With Study Requirements|0|||
49157197|NCT03801525|158417369|FG000|Overall Study|Investigator Decision|18|||
49157198|NCT03801525|158417370|FG001|Overall Study|Investigator Decision|1|||
49157199|NCT03801525|158417371|FG002|Overall Study|Investigator Decision|0|||
49157200|NCT03801525|158417369|FG000|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|14|||
49157201|NCT03801525|158417370|FG001|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
49157202|NCT03801525|158417371|FG002|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
49157203|NCT03801525|158417369|FG000|Overall Study|Sponsor Discontinuation of the Study|24|||
49157204|NCT03801525|158417370|FG001|Overall Study|Sponsor Discontinuation of the Study|49|||
49157205|NCT03801525|158417371|FG002|Overall Study|Sponsor Discontinuation of the Study|43|||
48830870|NCT01048788|157221905|FG000|Overall Study|Withdrawal by Subject|0|||
49157206|NCT03801525|158417369|FG000|Overall Study|Started Non-protocol Anti-cancer Therapy|2|||
49157207|NCT03801525|158417370|FG001|Overall Study|Started Non-protocol Anti-cancer Therapy|1|||
49157208|NCT03801525|158417371|FG002|Overall Study|Started Non-protocol Anti-cancer Therapy|3|||
49157209|NCT03801525|158417369|FG000|Overall Study|Withdrawal of Subject Consent|38|||
49157210|NCT03801525|158417370|FG001|Overall Study|Withdrawal of Subject Consent|2|||
49157211|NCT03801525|158417371|FG002|Overall Study|Withdrawal of Subject Consent|1|||
49157212|NCT03801525|158417369|FG000|Overall Study|Reason not Specified|4|||
49157213|NCT03801525|158417370|FG001|Overall Study|Reason not Specified|0|||
49157214|NCT03801525|158417371|FG002|Overall Study|Reason not Specified|4|||
49157215|NCT02684461|158417373|FG000|Overall Study|Adverse Event|1|||
49157216|NCT02684461|158417374|FG001|Overall Study|Adverse Event|0|||
49157217|NCT02684461|158417375|FG002|Overall Study|Adverse Event|0|||
49157218|NCT02684461|158417373|FG000|Overall Study|Lack of Efficacy|1|||
49157219|NCT02684461|158417374|FG001|Overall Study|Lack of Efficacy|2|||
49157220|NCT02684461|158417375|FG002|Overall Study|Lack of Efficacy|0|||
49157221|NCT02138825|158417376|FG000|Main Study Treatment|Adverse Event|11|||
49157222|NCT02138825|158417377|FG001|Main Study Treatment|Adverse Event|3|||
49157223|NCT02138825|158417376|FG000|Main Study Treatment|Death|1|||
49157224|NCT02138825|158417377|FG001|Main Study Treatment|Death|2|||
49157225|NCT02138825|158417376|FG000|Main Study Treatment|Protocol Violation|2|||
49157226|NCT02138825|158417377|FG001|Main Study Treatment|Protocol Violation|2|||
49157227|NCT02138825|158417376|FG000|Main Study Treatment|Sponsor decision|12|||
49157228|NCT02138825|158417377|FG001|Main Study Treatment|Sponsor decision|18|||
49157229|NCT02138825|158417376|FG000|Main Study Treatment|Study terminated by sponsor|10|||
48830871|NCT01048788|157221906|FG001|Overall Study|Withdrawal by Subject|1|||
48830872|NCT01048788|157221907|FG002|Overall Study|Withdrawal by Subject|0|||
48830873|NCT01196988|157221908|FG000|Overall Study|Adverse Event|1|||
48830874|NCT01196988|157221909|FG001|Overall Study|Adverse Event|2|||
48830875|NCT01196988|157221910|FG002|Overall Study|Adverse Event|0|||
48830876|NCT01196988|157221911|FG003|Overall Study|Adverse Event|0|||
48830877|NCT01196988|157221908|FG000|Overall Study|Withdrawal by Subject|5|||
48830878|NCT01196988|157221909|FG001|Overall Study|Withdrawal by Subject|1|||
48830879|NCT01196988|157221910|FG002|Overall Study|Withdrawal by Subject|4|||
49157230|NCT02138825|158417377|FG001|Main Study Treatment|Study terminated by sponsor|9|||
49157231|NCT02138825|158417376|FG000|Main Study Treatment|Withdrawal by Subject|3|||
49157232|NCT02138825|158417377|FG001|Main Study Treatment|Withdrawal by Subject|1|||
49157233|NCT02138825|158417376|FG000|Main Study Treatment|Medical decision|1|||
49157234|NCT02138825|158417377|FG001|Main Study Treatment|Medical decision|0|||
49157235|NCT02138825|158417376|FG000|Long-term Extension|Study termination by sponsor|32|||
48830880|NCT01196988|157221911|FG003|Overall Study|Withdrawal by Subject|0|||
48830881|NCT01196988|157221908|FG000|Overall Study|Lost to Follow-up|16|||
48830882|NCT01196988|157221909|FG001|Overall Study|Lost to Follow-up|29|||
48830883|NCT01196988|157221910|FG002|Overall Study|Lost to Follow-up|21|||
48830884|NCT01196988|157221911|FG003|Overall Study|Lost to Follow-up|1|||
48830885|NCT01196988|157221908|FG000|Overall Study|Other|2|||
48830886|NCT01196988|157221909|FG001|Overall Study|Other|0|||
48830887|NCT01196988|157221910|FG002|Overall Study|Other|0|||
48830888|NCT01196988|157221911|FG003|Overall Study|Other|0|||
49014575|NCT04634409|157888928|FG005|Overall Study|Death|0|||
49157236|NCT02138825|158417377|FG001|Long-term Extension|Study termination by sponsor|38|||
49157237|NCT02138825|158417376|FG000|Safety Follow-up|Adverse Event|4|||
49157238|NCT02138825|158417377|FG001|Safety Follow-up|Adverse Event|3|||
49157239|NCT02138825|158417376|FG000|Safety Follow-up|Death|11|||
49157240|NCT02138825|158417377|FG001|Safety Follow-up|Death|5|||
49157241|NCT02138825|158417376|FG000|Safety Follow-up|Withdrawal by Subject|5|||
49157242|NCT02138825|158417377|FG001|Safety Follow-up|Withdrawal by Subject|3|||
49157243|NCT02138825|158417376|FG000|Safety Follow-up|clinic worsening|1|||
49157244|NCT02138825|158417377|FG001|Safety Follow-up|clinic worsening|0|||
49157245|NCT02138825|158417376|FG000|Safety Follow-up|withdrawal by PI|1|||
49157246|NCT02138825|158417377|FG001|Safety Follow-up|withdrawal by PI|0|||
49157247|NCT02138825|158417376|FG000|Safety Follow-up|logistical difficulties|0|||
49157248|NCT02138825|158417377|FG001|Safety Follow-up|logistical difficulties|1|||
49157249|NCT02138825|158417376|FG000|Safety Follow-up|progressive disease|0|||
49157250|NCT02138825|158417377|FG001|Safety Follow-up|progressive disease|2|||
49157251|NCT02138825|158417376|FG000|Safety Follow-up|too unwell to attend the visit|0|||
49157252|NCT02138825|158417377|FG001|Safety Follow-up|too unwell to attend the visit|1|||
49157253|NCT02138825|158417376|FG000|Safety Follow-up|treatment unblinded|0|||
49157254|NCT02138825|158417377|FG001|Safety Follow-up|treatment unblinded|1|||
49157255|NCT02138825|158417376|FG000|Safety Follow-up|withdrawn due to lung transplant|0|||
49157256|NCT02138825|158417377|FG001|Safety Follow-up|withdrawn due to lung transplant|1|||
49157257|NCT02415556|158417378|FG000|Overall Study|Adverse Event|3|||
49157258|NCT02415556|158417379|FG001|Overall Study|Adverse Event|4|||
49157259|NCT02415556|158417380|FG002|Overall Study|Adverse Event|2|||
49157260|NCT02415556|158417381|FG003|Overall Study|Adverse Event|4|||
49157261|NCT02415556|158417378|FG000|Overall Study|Lost to Follow-up|4|||
49157262|NCT02415556|158417379|FG001|Overall Study|Lost to Follow-up|5|||
49157263|NCT02415556|158417380|FG002|Overall Study|Lost to Follow-up|4|||
49157264|NCT02415556|158417381|FG003|Overall Study|Lost to Follow-up|1|||
49157265|NCT02415556|158417378|FG000|Overall Study|Withdrawal by Subject|13|||
49157266|NCT02415556|158417379|FG001|Overall Study|Withdrawal by Subject|4|||
49157267|NCT02415556|158417380|FG002|Overall Study|Withdrawal by Subject|14|||
49157268|NCT02415556|158417381|FG003|Overall Study|Withdrawal by Subject|12|||
49157269|NCT02415556|158417378|FG000|Overall Study|Physician Decision|1|||
49157270|NCT02415556|158417379|FG001|Overall Study|Physician Decision|3|||
49157271|NCT02415556|158417380|FG002|Overall Study|Physician Decision|1|||
49157272|NCT02415556|158417381|FG003|Overall Study|Physician Decision|2|||
49157273|NCT02415556|158417378|FG000|Overall Study|Censored - study completion|4|||
49157274|NCT02415556|158417379|FG001|Overall Study|Censored - study completion|5|||
49157275|NCT02415556|158417380|FG002|Overall Study|Censored - study completion|1|||
49157276|NCT02415556|158417381|FG003|Overall Study|Censored - study completion|0|||
49157277|NCT02415556|158417378|FG000|Overall Study|Family-related issues|0|||
48830889|NCT04304534|157221913|FG000|Overall Study|Subject decision COVID-19 pandemic related|1|||
48830890|NCT04304534|157221914|FG001|Overall Study|Subject decision COVID-19 pandemic related|0|||
48830891|NCT04304534|157221915|FG002|Overall Study|Subject decision COVID-19 pandemic related|1|||
48830892|NCT04304534|157221916|FG003|Overall Study|Subject decision COVID-19 pandemic related|0|||
48830893|NCT04304534|157221913|FG000|Overall Study|Non-Compliance with study drug|0|||
48830894|NCT04304534|157221914|FG001|Overall Study|Non-Compliance with study drug|1|||
48830895|NCT04304534|157221915|FG002|Overall Study|Non-Compliance with study drug|1|||
48830896|NCT04304534|157221916|FG003|Overall Study|Non-Compliance with study drug|1|||
48830897|NCT04304534|157221913|FG000|Overall Study|Lost to Follow-up|0|||
48830898|NCT04304534|157221914|FG001|Overall Study|Lost to Follow-up|1|||
48830899|NCT04304534|157221915|FG002|Overall Study|Lost to Follow-up|2|||
48830900|NCT04304534|157221916|FG003|Overall Study|Lost to Follow-up|3|||
48830901|NCT04304534|157221913|FG000|Overall Study|Unspecific|4|||
48830902|NCT04304534|157221914|FG001|Overall Study|Unspecific|2|||
48830903|NCT04304534|157221915|FG002|Overall Study|Unspecific|2|||
48830904|NCT04304534|157221916|FG003|Overall Study|Unspecific|2|||
48830905|NCT04304534|157221913|FG000|Overall Study|Technical Problems|2|||
48830906|NCT04304534|157221914|FG001|Overall Study|Technical Problems|2|||
48830907|NCT04304534|157221915|FG002|Overall Study|Technical Problems|3|||
48830908|NCT04304534|157221916|FG003|Overall Study|Technical Problems|4|||
48830909|NCT04304534|157221913|FG000|Overall Study|Death|7|||
48830910|NCT04304534|157221914|FG001|Overall Study|Death|2|||
49157278|NCT02415556|158417379|FG001|Overall Study|Family-related issues|0|||
49157279|NCT02415556|158417380|FG002|Overall Study|Family-related issues|0|||
49157280|NCT02415556|158417381|FG003|Overall Study|Family-related issues|1|||
49157281|NCT02390076|158417382|FG000|Overall Study|Lost to Follow-up|2|||
49157282|NCT02390076|158417383|FG001|Overall Study|Lost to Follow-up|1|||
49157283|NCT02390076|158417384|FG002|Overall Study|Lost to Follow-up|4|||
49157284|NCT03639610|158417387|FG000|Overall Study|Adverse Event|7|||
48830911|NCT04304534|157221915|FG002|Overall Study|Death|4|||
48830912|NCT04304534|157221916|FG003|Overall Study|Death|3|||
48830913|NCT04304534|157221913|FG000|Overall Study|Withdrawal by Subject|7|||
48830914|NCT04304534|157221914|FG001|Overall Study|Withdrawal by Subject|2|||
48830915|NCT04304534|157221915|FG002|Overall Study|Withdrawal by Subject|7|||
49157285|NCT03639610|158417388|FG001|Overall Study|Adverse Event|1|||
48830916|NCT04304534|157221916|FG003|Overall Study|Withdrawal by Subject|4|||
48830917|NCT04304534|157221913|FG000|Overall Study|Physician Decision|4|||
48830918|NCT04304534|157221914|FG001|Overall Study|Physician Decision|9|||
48830919|NCT04304534|157221915|FG002|Overall Study|Physician Decision|9|||
48830920|NCT04304534|157221916|FG003|Overall Study|Physician Decision|5|||
48830921|NCT04304534|157221913|FG000|Overall Study|Subject Decision|34|||
48830922|NCT04304534|157221914|FG001|Overall Study|Subject Decision|25|||
48830923|NCT04304534|157221915|FG002|Overall Study|Subject Decision|25|||
48830924|NCT04304534|157221916|FG003|Overall Study|Subject Decision|26|||
48830925|NCT04304534|157221913|FG000|Overall Study|Adverse Event|35|||
48830926|NCT04304534|157221914|FG001|Overall Study|Adverse Event|40|||
48830927|NCT04304534|157221915|FG002|Overall Study|Adverse Event|39|||
48830928|NCT04304534|157221916|FG003|Overall Study|Adverse Event|44|||
49157286|NCT03639610|158417389|FG002|Overall Study|Adverse Event|0|||
49157287|NCT03639610|158417387|FG000|Overall Study|Physician Decision|3|||
49157288|NCT03639610|158417388|FG001|Overall Study|Physician Decision|1|||
49157289|NCT03639610|158417389|FG002|Overall Study|Physician Decision|0|||
49157290|NCT03639610|158417387|FG000|Overall Study|Disease progression|8|||
49157291|NCT03639610|158417388|FG001|Overall Study|Disease progression|5|||
49157292|NCT03639610|158417389|FG002|Overall Study|Disease progression|3|||
49157293|NCT03639610|158417387|FG000|Overall Study|Study terminated by sponsor|2|||
49157294|NCT03639610|158417388|FG001|Overall Study|Study terminated by sponsor|1|||
49157295|NCT03639610|158417389|FG002|Overall Study|Study terminated by sponsor|1|||
49157296|NCT03639610|158417387|FG000|Overall Study|Patient request to stop treatment|1|||
49157297|NCT03639610|158417388|FG001|Overall Study|Patient request to stop treatment|2|||
49157298|NCT03639610|158417389|FG002|Overall Study|Patient request to stop treatment|0|||
48830929|NCT00763282|157221917|FG000|Overall Study|Withdrawal by Subject|6|||
48830930|NCT00763282|157221918|FG001|Overall Study|Withdrawal by Subject|5|||
48830931|NCT00763282|157221917|FG000|Overall Study|Death|4|||
48830932|NCT00763282|157221918|FG001|Overall Study|Death|3|||
48830933|NCT00763282|157221917|FG000|Overall Study|Lost to Follow-up|22|||
48830934|NCT00763282|157221918|FG001|Overall Study|Lost to Follow-up|26|||
48830935|NCT00828672|157221919|FG000|Study Treatment|Lost to Follow-up|1|||
48830936|NCT00828672|157221920|FG001|Study Treatment|Lost to Follow-up|0|||
48830937|NCT00828672|157221919|FG000|Study Treatment|Adverse Event|0|||
48830938|NCT00828672|157221920|FG001|Study Treatment|Adverse Event|1|||
48830939|NCT00828672|157221919|FG000|Study Treatment|Complete response, no surgery|1|||
48830940|NCT00828672|157221920|FG001|Study Treatment|Complete response, no surgery|1|||
48830941|NCT00828672|157221919|FG000|Post-surgery (<30 Days)|No central review materials|0|||
48830942|NCT00828672|157221920|FG001|Post-surgery (<30 Days)|No central review materials|1|||
48830943|NCT04107805|157221921|FG000|Overall Study|Adverse Event|0|||
48830944|NCT04107805|157221922|FG001|Overall Study|Adverse Event|0|||
48830945|NCT04107805|157221923|FG002|Overall Study|Adverse Event|0|||
48830946|NCT04107805|157221924|FG003|Overall Study|Adverse Event|1|||
48830947|NCT04107805|157221925|FG004|Overall Study|Adverse Event|0|||
48830948|NCT04107805|157221926|FG005|Overall Study|Adverse Event|1|||
48830949|NCT04107805|157221927|FG006|Overall Study|Adverse Event|0|||
48830950|NCT04107805|157221928|FG007|Overall Study|Adverse Event|0|||
48830951|NCT04107805|157221929|FG008|Overall Study|Adverse Event|1|||
48830952|NCT02057718|157221934|FG000|Completed Study Treatment Through Wk. 72|Progressive disease|0|||
48830953|NCT02057718|157221935|FG001|Completed Study Treatment Through Wk. 72|Progressive disease|2|||
48830954|NCT02057718|157221934|FG000|Completed Study Treatment Through Wk. 72|Physician Decision|1|||
48830955|NCT02057718|157221935|FG001|Completed Study Treatment Through Wk. 72|Physician Decision|0|||
48830956|NCT02057718|157221934|FG000|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0|||
48830957|NCT02057718|157221935|FG001|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1|||
48830958|NCT02057718|157221934|FG000|Completed Study Treatment Through Wk. 72|Adverse Event|0|||
48830959|NCT02057718|157221935|FG001|Completed Study Treatment Through Wk. 72|Adverse Event|3|||
48830960|NCT02057718|157221934|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
48830961|NCT02057718|157221935|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
49014576|NCT04634409|157888929|FG006|Overall Study|Death|0|||
49157299|NCT02660229|158417390|FG000|Overall Study|Adverse Event|2|||
49157300|NCT02660229|158417391|FG001|Overall Study|Adverse Event|0|||
49157301|NCT02660229|158417390|FG000|Overall Study|Withdrawal by Subject|0|||
48830962|NCT02057718|157221934|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0|||
48830963|NCT02057718|157221935|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1|||
48830964|NCT02057718|157221934|FG000|Completed Study Treatment Through Wk. 72|Liver Transplant|0|||
48830965|NCT02057718|157221935|FG001|Completed Study Treatment Through Wk. 72|Liver Transplant|1|||
49014577|NCT04634409|157888930|FG007|Overall Study|Death|0|||
49157302|NCT02660229|158417391|FG001|Overall Study|Withdrawal by Subject|1|||
48922756|NCT00700271|157550136|FG000|Overall Study|Administrative Reasons|1|||
48922757|NCT00700271|157550137|FG001|Overall Study|Administrative Reasons|0|||
48922758|NCT00700271|157550136|FG000|Overall Study|Withdrawal by Subject|6|||
48922759|NCT00700271|157550137|FG001|Overall Study|Withdrawal by Subject|4|||
48922760|NCT00700271|157550136|FG000|Overall Study|Lost to Follow-up|2|||
48922761|NCT00700271|157550137|FG001|Overall Study|Lost to Follow-up|2|||
48922762|NCT04428424|157550139|FG000|Overall Study|Does not meet entrance criteria|132|||
49157303|NCT01935947|158417392|FG000|Overall Study|Adverse Event|0|||
49157304|NCT01935947|158417393|FG001|Overall Study|Adverse Event|2|||
49157305|NCT01935947|158417394|FG002|Overall Study|Adverse Event|0|||
49157306|NCT01935947|158417392|FG000|Overall Study|Diease Progression|2|||
48830966|NCT02057718|157221934|FG000|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1|||
48830967|NCT02057718|157221935|FG001|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3|||
48830968|NCT02057718|157221934|FG000|Optional Follow-up Treatment Period|Progressive disease|0|||
48830969|NCT02057718|157221935|FG001|Optional Follow-up Treatment Period|Progressive disease|1|||
48830970|NCT02057718|157221934|FG000|Optional Follow-up Treatment Period|Adverse Event|1|||
48830971|NCT02057718|157221935|FG001|Optional Follow-up Treatment Period|Adverse Event|2|||
48830972|NCT02057718|157221934|FG000|Optional Follow-up Treatment Period|Liver Transplant|0|||
48830973|NCT02057718|157221935|FG001|Optional Follow-up Treatment Period|Liver Transplant|2|||
48830974|NCT01565928|157221938|FG000|Overall Study|Adverse Event|3|||
48830975|NCT01565928|157221938|FG000|Overall Study|Other|3|||
48830976|NCT01565928|157221938|FG000|Overall Study|Progressive Disease|13|||
48830977|NCT01565928|157221938|FG000|Overall Study|Withdrawal by Subject|1|||
48830978|NCT01565928|157221938|FG000|Overall Study|Death|2|||
49157307|NCT01935947|158417393|FG001|Overall Study|Diease Progression|2|||
49157308|NCT01935947|158417394|FG002|Overall Study|Diease Progression|2|||
49157309|NCT01935947|158417392|FG000|Overall Study|Death|1|||
49157310|NCT01935947|158417393|FG001|Overall Study|Death|0|||
49157311|NCT01935947|158417394|FG002|Overall Study|Death|0|||
49157312|NCT02037529|158417399|FG000|Overall Study|Withdrawal by Subject|1|||
49157313|NCT02037529|158417400|FG001|Overall Study|Withdrawal by Subject|3|||
49157314|NCT02037529|158417399|FG000|Overall Study|Adverse Event|0|||
49157315|NCT02037529|158417400|FG001|Overall Study|Adverse Event|1|||
49157316|NCT00718315|158417402|FG000|Overall Study|Adverse Event|1|||
49157317|NCT00718315|158417403|FG001|Overall Study|Adverse Event|2|||
49157318|NCT00718315|158417404|FG002|Overall Study|Adverse Event|3|||
49157319|NCT00718315|158417402|FG000|Overall Study|Death|6|||
49157320|NCT00718315|158417403|FG001|Overall Study|Death|6|||
49157321|NCT00718315|158417404|FG002|Overall Study|Death|5|||
49157322|NCT00718315|158417402|FG000|Overall Study|Lost to Follow-up|2|||
49157323|NCT00718315|158417403|FG001|Overall Study|Lost to Follow-up|3|||
49157324|NCT00718315|158417404|FG002|Overall Study|Lost to Follow-up|4|||
49157325|NCT00718315|158417402|FG000|Overall Study|Protocol Violation|5|||
49157326|NCT00718315|158417403|FG001|Overall Study|Protocol Violation|5|||
49157327|NCT00718315|158417404|FG002|Overall Study|Protocol Violation|3|||
49157328|NCT00718315|158417402|FG000|Overall Study|Erlotinib dose decreased|4|||
49157329|NCT00718315|158417403|FG001|Overall Study|Erlotinib dose decreased|3|||
49157330|NCT00718315|158417404|FG002|Overall Study|Erlotinib dose decreased|1|||
49157331|NCT00718315|158417402|FG000|Overall Study|Use of Minocyclin|1|||
49157332|NCT00718315|158417403|FG001|Overall Study|Use of Minocyclin|1|||
49157333|NCT00718315|158417404|FG002|Overall Study|Use of Minocyclin|1|||
49157334|NCT00718315|158417402|FG000|Overall Study|Disease progression|0|||
49157335|NCT00718315|158417403|FG001|Overall Study|Disease progression|1|||
49157336|NCT00718315|158417404|FG002|Overall Study|Disease progression|1|||
48830979|NCT00608907|157221939|FG000|Overall Study|Adverse Event|6|||
48830980|NCT00608907|157221940|FG001|Overall Study|Adverse Event|0|||
48922763|NCT04428424|157550139|FG000|Overall Study|Lost to Follow-up|115|||
49157337|NCT00718315|158417402|FG000|Overall Study|Other|0|||
49157338|NCT00718315|158417403|FG001|Overall Study|Other|0|||
49157339|NCT00718315|158417404|FG002|Overall Study|Other|1|||
49157340|NCT00718315|158417402|FG000|Overall Study|Use of ATB and Corticoids|0|||
49157341|NCT00718315|158417403|FG001|Overall Study|Use of ATB and Corticoids|1|||
49157342|NCT00718315|158417404|FG002|Overall Study|Use of ATB and Corticoids|2|||
49157343|NCT02154061|158417405|FG000|Overall Study|Pregnancy|1|||
49157344|NCT02154061|158417406|FG001|Overall Study|Pregnancy|0|||
49157345|NCT02154061|158417405|FG000|Overall Study|enrolled but not vaccinated|1|||
49157346|NCT02154061|158417406|FG001|Overall Study|enrolled but not vaccinated|0|||
49157347|NCT00427700|158417407|FG000|Overall Study|Lost to Follow-up|2|||
49157348|NCT00427700|158417408|FG001|Overall Study|Lost to Follow-up|5|||
48830981|NCT00608907|157221941|FG002|Overall Study|Adverse Event|1|||
48830982|NCT00608907|157221939|FG000|Overall Study|Death|1|||
48830983|NCT00608907|157221940|FG001|Overall Study|Death|0|||
48922764|NCT04818593|157550142|FG000|Overall Study|Low Oocyte Yield|8|||
48922765|NCT04818593|157550143|FG001|Overall Study|Low Oocyte Yield|8|||
49157349|NCT00427700|158417407|FG000|Overall Study|no induction of menses|1|||
49157350|NCT00427700|158417408|FG001|Overall Study|no induction of menses|4|||
49157351|NCT00427700|158417407|FG000|Overall Study|Pregnancy|0|||
49157352|NCT00427700|158417408|FG001|Overall Study|Pregnancy|2|||
49157353|NCT02284191|158417409|FG000|Overall Study|Withdrawal by Subject|1|||
48830984|NCT00608907|157221941|FG002|Overall Study|Death|0|||
48830985|NCT00608907|157221939|FG000|Overall Study|Withdrawal by Subject|4|||
48830986|NCT00608907|157221940|FG001|Overall Study|Withdrawal by Subject|0|||
48830987|NCT00608907|157221941|FG002|Overall Study|Withdrawal by Subject|0|||
48830988|NCT00608907|157221939|FG000|Overall Study|Progressive Disease|1|||
48830989|NCT00608907|157221940|FG001|Overall Study|Progressive Disease|0|||
48830990|NCT00608907|157221941|FG002|Overall Study|Progressive Disease|0|||
48830991|NCT00130637|157221942|FG000|Overall Study|Adverse Event|2|||
48830992|NCT00130637|157221942|FG000|Overall Study|Withdrawal by Subject|1|||
48830993|NCT02982213|157221944|FG000|Overall Study|Did not complete follow up questionnaire|5|||
48830994|NCT02982213|157221945|FG001|Overall Study|Did not complete follow up questionnaire|1|||
48830995|NCT03537651|157221946|FG000|Part A (Up to 96 Weeks)|Adverse Event|2|||
48830996|NCT03537651|157221946|FG000|Part A (Up to 96 Weeks)|Withdrawal of Consent (not due to AE)|2|||
48830997|NCT03537651|157221946|FG000|Part A (Up to 96 Weeks)|Commercial Drug is Available for Participant|56|||
49157354|NCT02284191|158417410|FG001|Overall Study|Withdrawal by Subject|3|||
49157355|NCT02284191|158417409|FG000|Overall Study|Lost to Follow-up|1|||
49157356|NCT02284191|158417410|FG001|Overall Study|Lost to Follow-up|0|||
49157357|NCT01448616|158417411|FG000|Lead-In (Observational Phase)|Collected no genital swabs|3|||
49157358|NCT01448616|158417412|FG001|Lead-In (Observational Phase)|Collected no genital swabs|0|||
49157359|NCT01448616|158417413|FG002|Lead-In (Observational Phase)|Collected no genital swabs|0|||
49157360|NCT01448616|158417414|FG003|Lead-In (Observational Phase)|Collected no genital swabs|0|||
49157361|NCT01448616|158417411|FG000|Lead-In (Observational Phase)|Collected <90% of required swabs|6|||
49157362|NCT01448616|158417412|FG001|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
49157363|NCT01448616|158417413|FG002|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
49157364|NCT01448616|158417414|FG003|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
49157365|NCT01448616|158417411|FG000|Study Drug (Treatment Phase)|Adverse Event|0|||
48830998|NCT03537651|157221946|FG000|Part A (Up to 96 Weeks)|Other|1|||
48830999|NCT03537651|157221946|FG000|Part B (Up to 192 Weeks)|Adverse Event|1|||
48831000|NCT03537651|157221946|FG000|Part B (Up to 192 Weeks)|Withdrawal of Consent (not due to AE)|1|||
48831001|NCT03537651|157221946|FG000|Part B (Up to 192 Weeks)|Commercial Drug is available for Participant|56|||
49157366|NCT01448616|158417412|FG001|Study Drug (Treatment Phase)|Adverse Event|1|||
49157367|NCT01448616|158417413|FG002|Study Drug (Treatment Phase)|Adverse Event|1|||
49157368|NCT01448616|158417414|FG003|Study Drug (Treatment Phase)|Adverse Event|0|||
49157369|NCT01448616|158417411|FG000|Study Drug (Treatment Phase)|Never initiated study drug|0|||
49157370|NCT01448616|158417412|FG001|Study Drug (Treatment Phase)|Never initiated study drug|0|||
49157371|NCT01448616|158417413|FG002|Study Drug (Treatment Phase)|Never initiated study drug|1|||
49157372|NCT01448616|158417414|FG003|Study Drug (Treatment Phase)|Never initiated study drug|2|||
49157373|NCT01448616|158417411|FG000|Study Drug (Treatment Phase)|Withdrawal by Subject|0|||
49157374|NCT01448616|158417412|FG001|Study Drug (Treatment Phase)|Withdrawal by Subject|1|||
49157375|NCT01448616|158417413|FG002|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
49157376|NCT01448616|158417414|FG003|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
49157377|NCT01570387|158417417|FG000|Overall Study|Adverse Event|1|||
49157378|NCT01570387|158417418|FG001|Overall Study|Adverse Event|0|||
49157379|NCT01570387|158417419|FG002|Overall Study|Adverse Event|0|||
49157380|NCT01570387|158417420|FG003|Overall Study|Adverse Event|0|||
49157381|NCT01570387|158417417|FG000|Overall Study|Death|0|||
49157382|NCT01570387|158417418|FG001|Overall Study|Death|0|||
49157383|NCT01570387|158417419|FG002|Overall Study|Death|0|||
49157384|NCT01570387|158417420|FG003|Overall Study|Death|1|||
49157385|NCT01570387|158417417|FG000|Overall Study|Withdrawal by Subject|0|||
49157386|NCT01570387|158417418|FG001|Overall Study|Withdrawal by Subject|0|||
49157387|NCT01570387|158417419|FG002|Overall Study|Withdrawal by Subject|0|||
49157388|NCT01570387|158417420|FG003|Overall Study|Withdrawal by Subject|1|||
49157389|NCT03139448|158417421|FG000|Overall Study|Lack of Efficacy|6|||
49157390|NCT03139448|158417422|FG001|Overall Study|Lack of Efficacy|7|||
49157391|NCT03139448|158417421|FG000|Overall Study|Location of procedure changed|2|||
49157392|NCT03139448|158417422|FG001|Overall Study|Location of procedure changed|8|||
49157393|NCT03139448|158417421|FG000|Overall Study|Withdrawal by Subject|3|||
49157394|NCT03139448|158417422|FG001|Overall Study|Withdrawal by Subject|6|||
49157395|NCT03139448|158417421|FG000|Overall Study|Screen fail|1|||
49157396|NCT03139448|158417422|FG001|Overall Study|Screen fail|3|||
49157397|NCT03139448|158417421|FG000|Overall Study|Physician Decision|0|||
49157398|NCT03139448|158417422|FG001|Overall Study|Physician Decision|2|||
49157399|NCT00523978|158417423|FG000|Overall Study|Withdrawal by Subject|3|||
49157400|NCT00523978|158417424|FG001|Overall Study|Withdrawal by Subject|7|||
49157401|NCT00523978|158417423|FG000|Overall Study|Screen Failures|5|||
49157402|NCT00523978|158417424|FG001|Overall Study|Screen Failures|1|||
49157403|NCT00523978|158417423|FG000|Overall Study|Death|1|||
49157404|NCT00523978|158417424|FG001|Overall Study|Death|0|||
49157405|NCT01832727|158417430|FG000|Overall Study|Adverse Event|4|||
48831002|NCT03537651|157221946|FG000|Part B (Up to 192 Weeks)|Other|1|||
48831003|NCT01186848|157221947|FG000|Overall Study|Lost to Follow-up|4|||
49157406|NCT01832727|158417431|FG001|Overall Study|Adverse Event|6|||
49157407|NCT01832727|158417432|FG002|Overall Study|Adverse Event|1|||
49157408|NCT01832727|158417433|FG003|Overall Study|Adverse Event|0|||
49157409|NCT01832727|158417434|FG004|Overall Study|Adverse Event|1|||
49157410|NCT01832727|158417435|FG005|Overall Study|Adverse Event|1|||
49157411|NCT01832727|158417436|FG006|Overall Study|Adverse Event|2|||
49157412|NCT01832727|158417437|FG007|Overall Study|Adverse Event|1|||
49157413|NCT01832727|158417438|FG008|Overall Study|Adverse Event|9|||
49157414|NCT01832727|158417430|FG000|Overall Study|Disease progression|3|||
49157415|NCT01832727|158417431|FG001|Overall Study|Disease progression|0|||
48922766|NCT04818593|157550142|FG000|Overall Study|Not ICSI Insemination|7|||
48922767|NCT04818593|157550143|FG001|Overall Study|Not ICSI Insemination|7|||
49157416|NCT01832727|158417432|FG002|Overall Study|Disease progression|2|||
49157417|NCT01832727|158417433|FG003|Overall Study|Disease progression|1|||
49157418|NCT01832727|158417434|FG004|Overall Study|Disease progression|3|||
49157419|NCT01832727|158417435|FG005|Overall Study|Disease progression|3|||
49157420|NCT01832727|158417436|FG006|Overall Study|Disease progression|6|||
49157421|NCT01832727|158417437|FG007|Overall Study|Disease progression|2|||
49157422|NCT01832727|158417438|FG008|Overall Study|Disease progression|7|||
49157423|NCT01832727|158417430|FG000|Overall Study|Lost to Follow-up|0|||
49157424|NCT01832727|158417431|FG001|Overall Study|Lost to Follow-up|0|||
49157425|NCT01832727|158417432|FG002|Overall Study|Lost to Follow-up|0|||
49157426|NCT01832727|158417433|FG003|Overall Study|Lost to Follow-up|1|||
49157427|NCT01832727|158417434|FG004|Overall Study|Lost to Follow-up|0|||
49157428|NCT01832727|158417435|FG005|Overall Study|Lost to Follow-up|0|||
49157429|NCT01832727|158417436|FG006|Overall Study|Lost to Follow-up|0|||
49157430|NCT01832727|158417437|FG007|Overall Study|Lost to Follow-up|0|||
49157431|NCT01832727|158417438|FG008|Overall Study|Lost to Follow-up|0|||
49157432|NCT01832727|158417430|FG000|Overall Study|Physician Decision|1|||
49157433|NCT01832727|158417431|FG001|Overall Study|Physician Decision|0|||
49157434|NCT01832727|158417432|FG002|Overall Study|Physician Decision|0|||
49157435|NCT01832727|158417433|FG003|Overall Study|Physician Decision|1|||
49157436|NCT01832727|158417434|FG004|Overall Study|Physician Decision|0|||
48735566|NCT04674644|156883668|FG000|Overall Study|with missing data|37|||
49157437|NCT01832727|158417435|FG005|Overall Study|Physician Decision|1|||
49157438|NCT01832727|158417436|FG006|Overall Study|Physician Decision|0|||
49157439|NCT01832727|158417437|FG007|Overall Study|Physician Decision|0|||
49157440|NCT01832727|158417438|FG008|Overall Study|Physician Decision|0|||
49157441|NCT01832727|158417430|FG000|Overall Study|Withdrawal by Subject|1|||
49157442|NCT01832727|158417431|FG001|Overall Study|Withdrawal by Subject|1|||
49157443|NCT01832727|158417432|FG002|Overall Study|Withdrawal by Subject|0|||
49157444|NCT01832727|158417433|FG003|Overall Study|Withdrawal by Subject|1|||
49157445|NCT01832727|158417434|FG004|Overall Study|Withdrawal by Subject|0|||
49157446|NCT01832727|158417435|FG005|Overall Study|Withdrawal by Subject|1|||
49157447|NCT01832727|158417436|FG006|Overall Study|Withdrawal by Subject|0|||
49157448|NCT01832727|158417437|FG007|Overall Study|Withdrawal by Subject|2|||
49157449|NCT01832727|158417438|FG008|Overall Study|Withdrawal by Subject|1|||
49157450|NCT01832727|158417430|FG000|Overall Study|Study terminated by sponsor|0|||
49157451|NCT01832727|158417431|FG001|Overall Study|Study terminated by sponsor|0|||
49157452|NCT01832727|158417432|FG002|Overall Study|Study terminated by sponsor|0|||
49157453|NCT01832727|158417433|FG003|Overall Study|Study terminated by sponsor|0|||
49157454|NCT01832727|158417434|FG004|Overall Study|Study terminated by sponsor|0|||
49157455|NCT01832727|158417435|FG005|Overall Study|Study terminated by sponsor|0|||
49157456|NCT01832727|158417436|FG006|Overall Study|Study terminated by sponsor|0|||
49157457|NCT01832727|158417437|FG007|Overall Study|Study terminated by sponsor|1|||
49157458|NCT01832727|158417438|FG008|Overall Study|Study terminated by sponsor|1|||
49157459|NCT02750930|158417447|FG000|Overall Study|Study closed/terminated|8|||
49157460|NCT03961308|158417448|FG000|Overall Study|Withdrawal by Subject|1|||
49157461|NCT03961308|158417449|FG001|Overall Study|Withdrawal by Subject|0|||
49157462|NCT03961308|158417448|FG000|Overall Study|Other|1|||
49157463|NCT03961308|158417449|FG001|Overall Study|Other|0|||
49157464|NCT03961308|158417448|FG000|Overall Study|Lost to Follow-up|0|||
49157465|NCT03961308|158417449|FG001|Overall Study|Lost to Follow-up|1|||
49157466|NCT03961308|158417448|FG000|Overall Study|Adverse Event|0|||
49157467|NCT03961308|158417449|FG001|Overall Study|Adverse Event|1|||
49157468|NCT01849276|158417453|FG000|Followed for Survival for 5 Years|Death|1|||
49157469|NCT01849276|158417453|FG000|Followed for Survival for 5 Years|Early termination of the study|1|||
49157470|NCT00271544|158417466|FG000|Overall Study|Subjects did not receive a 4196 lead|7|||
49157471|NCT00271544|158417466|FG000|Overall Study|Model 4196 lead not attempted|9|||
49157472|NCT00271544|158417466|FG000|Overall Study|Implant not attempted|4|||
49157473|NCT03342560|158417478|FG000|Overall Study|Lost to Follow-up|2|||
49157474|NCT02604511|158417483|FG000|Overall Study|Adverse Event|3|||
48735567|NCT00395733|156883669|FG000|Period 2|Withdrawal by Subject|1|||
49157475|NCT02604511|158417483|FG000|Overall Study|Disease Progression|4|||
49157476|NCT02604511|158417483|FG000|Overall Study|Withdrawal by Subject|3|||
49157477|NCT02604511|158417483|FG000|Overall Study|Participant ineligible|1|||
49157478|NCT02604511|158417483|FG000|Overall Study|Intercurrent illness|1|||
49157479|NCT01816984|158417484|FG000|Overall Study|declining health status|1|||
49157480|NCT00545779|158417492|FG000|Overall Study|Violation of selection criteria at entry|8|||
49157481|NCT00545779|158417492|FG000|Overall Study|Other protocol violation|1|||
49157482|NCT00545779|158417492|FG000|Overall Study|Did not cooperate|7|||
49157483|NCT00545779|158417492|FG000|Overall Study|Withdrawal by Subject|20|||
49157484|NCT00545779|158417492|FG000|Overall Study|Adverse Event/intercurrent illness|5|||
49157485|NCT00545779|158417492|FG000|Overall Study|Failure to return|3|||
49157486|NCT01152437|158417506|FG000|Overall Study|Other Adverse Event|8|||
49157487|NCT01152437|158417507|FG001|Overall Study|Other Adverse Event|1|||
49157488|NCT01152437|158417508|FG002|Overall Study|Other Adverse Event|7|||
48831004|NCT01186848|157221947|FG000|Overall Study|Withdrawal by Subject|2|||
48831005|NCT01186848|157221947|FG000|Overall Study|Adverse Event|2|||
49157489|NCT01152437|158417506|FG000|Overall Study|Not treated|0|||
49157490|NCT01152437|158417507|FG001|Overall Study|Not treated|1|||
48831006|NCT02698241|157221951|FG000|Overall Study|Inclusion/exclusion criteria not met|4|||
48831007|NCT02698241|157221951|FG000|Overall Study|Screening not met|7|||
48831008|NCT02698241|157221951|FG000|Overall Study|Withdrawal by Subject|7|||
48831009|NCT02698241|157221951|FG000|Overall Study|Physician Decision|2|||
48831010|NCT02698241|157221951|FG000|Overall Study|Subject underwent system modification|2|||
48831011|NCT02698241|157221951|FG000|Overall Study|Lost to Follow-up|3|||
48831012|NCT02698241|157221951|FG000|Overall Study|Subject on inodrip not safe to continue|6|||
48831013|NCT02698241|157221951|FG000|Overall Study|geographic and licensing issue|1|||
48831014|NCT02698241|157221951|FG000|Overall Study|Death|2|||
48831015|NCT01837641|157221952|FG000|Overall Study|Sponsor decision|1|||
48831016|NCT01837641|157221953|FG001|Overall Study|Sponsor decision|0|||
48831017|NCT01837641|157221954|FG002|Overall Study|Sponsor decision|0|||
48831018|NCT01837641|157221955|FG003|Overall Study|Sponsor decision|0|||
48831019|NCT01837641|157221956|FG004|Overall Study|Sponsor decision|0|||
48831020|NCT01837641|157221957|FG005|Overall Study|Sponsor decision|1|||
48831021|NCT01837641|157221958|FG006|Overall Study|Sponsor decision|0|||
48831022|NCT01837641|157221959|FG007|Overall Study|Sponsor decision|0|||
48831023|NCT01837641|157221952|FG000|Overall Study|Adverse Event|0|||
48831024|NCT01837641|157221953|FG001|Overall Study|Adverse Event|0|||
48831025|NCT01837641|157221954|FG002|Overall Study|Adverse Event|0|||
48831026|NCT01837641|157221955|FG003|Overall Study|Adverse Event|0|||
48831027|NCT01837641|157221956|FG004|Overall Study|Adverse Event|0|||
48831028|NCT01837641|157221957|FG005|Overall Study|Adverse Event|1|||
48831029|NCT01837641|157221958|FG006|Overall Study|Adverse Event|0|||
48831030|NCT01837641|157221959|FG007|Overall Study|Adverse Event|0|||
48831031|NCT01837641|157221952|FG000|Overall Study|Withdrawal by Subject|0|||
48831032|NCT01837641|157221953|FG001|Overall Study|Withdrawal by Subject|0|||
48831033|NCT01837641|157221954|FG002|Overall Study|Withdrawal by Subject|0|||
48831034|NCT01837641|157221955|FG003|Overall Study|Withdrawal by Subject|0|||
48831035|NCT01837641|157221956|FG004|Overall Study|Withdrawal by Subject|1|||
48831036|NCT01837641|157221957|FG005|Overall Study|Withdrawal by Subject|0|||
48831037|NCT01837641|157221958|FG006|Overall Study|Withdrawal by Subject|1|||
48831038|NCT01837641|157221959|FG007|Overall Study|Withdrawal by Subject|0|||
48831039|NCT03386929|157221964|FG000|Overall Study|Death|0|||
48831040|NCT03386929|157221965|FG001|Overall Study|Death|0|||
48831041|NCT03386929|157221966|FG002|Overall Study|Death|1|||
48831042|NCT03386929|157221964|FG000|Overall Study|Withdrawal by Subject|0|||
48831043|NCT03386929|157221965|FG001|Overall Study|Withdrawal by Subject|1|||
48831044|NCT03386929|157221966|FG002|Overall Study|Withdrawal by Subject|0|||
48831045|NCT03386929|157221964|FG000|Overall Study|Physician Decision|0|||
48831046|NCT03386929|157221965|FG001|Overall Study|Physician Decision|0|||
48831047|NCT03386929|157221966|FG002|Overall Study|Physician Decision|1|||
48831048|NCT03386929|157221964|FG000|Overall Study|Progression|4|||
48831049|NCT03386929|157221965|FG001|Overall Study|Progression|4|||
48831050|NCT03386929|157221966|FG002|Overall Study|Progression|0|||
48831051|NCT03386929|157221964|FG000|Overall Study|Clinical Monitoring Committee and physician choice|1|||
48831052|NCT03386929|157221965|FG001|Overall Study|Clinical Monitoring Committee and physician choice|1|||
48831053|NCT03386929|157221966|FG002|Overall Study|Clinical Monitoring Committee and physician choice|1|||
48922768|NCT04818593|157550142|FG000|Overall Study|Poor Sperm Quality|2|||
48831054|NCT03386929|157221964|FG000|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|1|||
48831055|NCT03386929|157221965|FG001|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
48831056|NCT03386929|157221966|FG002|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
48831057|NCT01137292|157221967|FG000|Overall Study|Death|30|||
48831058|NCT01137292|157221967|FG000|Overall Study|Adverse Event|3|||
48831059|NCT01137292|157221967|FG000|Overall Study|Lack of Efficacy|13|||
48831060|NCT01137292|157221967|FG000|Overall Study|Lost to Follow-up|1|||
48831061|NCT01137292|157221967|FG000|Overall Study|Other|7|||
49157491|NCT01152437|158417508|FG002|Overall Study|Not treated|2|||
49157492|NCT01152437|158417506|FG000|Overall Study|Progressive disease|27|||
49157493|NCT01152437|158417507|FG001|Overall Study|Progressive disease|13|||
49157494|NCT01152437|158417508|FG002|Overall Study|Progressive disease|32|||
49157495|NCT01152437|158417506|FG000|Overall Study|Refusal to continue taking trial medicat|1|||
49157496|NCT01152437|158417507|FG001|Overall Study|Refusal to continue taking trial medicat|0|||
49157497|NCT01152437|158417508|FG002|Overall Study|Refusal to continue taking trial medicat|2|||
49157498|NCT02317627|158417509|FG000|Overall Study|Withdrawal by Subject|0|||
49157499|NCT02317627|158417510|FG001|Overall Study|Withdrawal by Subject|1|||
49157500|NCT02317627|158417511|FG002|Overall Study|Withdrawal by Subject|1|||
49157501|NCT02317627|158417509|FG000|Overall Study|Lost to Follow-up|2|||
49157502|NCT02317627|158417510|FG001|Overall Study|Lost to Follow-up|0|||
49157503|NCT02317627|158417511|FG002|Overall Study|Lost to Follow-up|0|||
49157504|NCT02317627|158417509|FG000|Overall Study|Stopped by Investigator|0|||
49157505|NCT02317627|158417510|FG001|Overall Study|Stopped by Investigator|1|||
49157506|NCT02317627|158417511|FG002|Overall Study|Stopped by Investigator|0|||
49157507|NCT02317627|158417509|FG000|Overall Study|Adverse Event|0|||
49157508|NCT02317627|158417510|FG001|Overall Study|Adverse Event|2|||
49157509|NCT02317627|158417511|FG002|Overall Study|Adverse Event|3|||
49157510|NCT02317627|158417509|FG000|Overall Study|Non-compliance with study drug|0|||
49157511|NCT02317627|158417510|FG001|Overall Study|Non-compliance with study drug|1|||
49157512|NCT02317627|158417511|FG002|Overall Study|Non-compliance with study drug|0|||
49157513|NCT04743973|158417513|FG000|Overall Study|Withdrawal by Subject|5|||
49157514|NCT05489328|158419177|FG000|Overall Study|Lost to Follow-up|0|||
49157515|NCT05489328|158419178|FG001|Overall Study|Lost to Follow-up|0|||
49157516|NCT05489328|158419179|FG002|Overall Study|Lost to Follow-up|1|||
49157517|NCT05489328|158419180|FG003|Overall Study|Lost to Follow-up|0|||
49157518|NCT05489328|158419181|FG004|Overall Study|Lost to Follow-up|2|||
49157519|NCT05489328|158419182|FG005|Overall Study|Lost to Follow-up|0|||
49157520|NCT05489328|158419183|FG006|Overall Study|Lost to Follow-up|0|||
49157521|NCT05489328|158419184|FG007|Overall Study|Lost to Follow-up|1|||
49157522|NCT05489328|158419185|FG008|Overall Study|Lost to Follow-up|0|||
49157523|NCT05489328|158419177|FG000|Overall Study|Withdrawal by Subject|0|||
49157524|NCT05489328|158419178|FG001|Overall Study|Withdrawal by Subject|0|||
48922769|NCT04818593|157550143|FG001|Overall Study|Poor Sperm Quality|2|||
48922770|NCT04818593|157550142|FG000|Overall Study|Withdrawal by Subject|2|||
48922771|NCT04818593|157550143|FG001|Overall Study|Withdrawal by Subject|2|||
48922772|NCT04818593|157550142|FG000|Overall Study|Conversion to IUI due to low response|1|||
48922773|NCT04818593|157550143|FG001|Overall Study|Conversion to IUI due to low response|1|||
48922774|NCT01452152|157550144|FG000|Overall Study|Study termination by sponsor|5|||
49157525|NCT05489328|158419179|FG002|Overall Study|Withdrawal by Subject|0|||
49157526|NCT05489328|158419180|FG003|Overall Study|Withdrawal by Subject|0|||
49157527|NCT05489328|158419181|FG004|Overall Study|Withdrawal by Subject|0|||
49157528|NCT05489328|158419182|FG005|Overall Study|Withdrawal by Subject|0|||
49157529|NCT05489328|158419183|FG006|Overall Study|Withdrawal by Subject|1|||
49157530|NCT05489328|158419184|FG007|Overall Study|Withdrawal by Subject|1|||
48831062|NCT03264456|157221969|FG000|Overall Study|Withdrawal by Subject|3|||
48831063|NCT03264456|157221969|FG000|Overall Study|Lost to Follow-up|1|||
48831064|NCT00837616|157221975|FG000|Overall Study|Withdrawal by Subject|0|||
48831065|NCT00837616|157221976|FG001|Overall Study|Withdrawal by Subject|1|||
48831066|NCT03254394|157221977|FG000|Overall Study|Withdrawal by Subject|0|||
48831067|NCT03254394|157221978|FG001|Overall Study|Withdrawal by Subject|2|||
48831068|NCT02317016|157221979|FG000|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1|||
48831069|NCT02317016|157221979|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1|||
48831070|NCT02317016|157221979|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1|||
49157531|NCT05489328|158419185|FG008|Overall Study|Withdrawal by Subject|0|||
48735568|NCT00395733|156883670|FG001|Period 2|Withdrawal by Subject|2|||
48735569|NCT00395733|156883669|FG000|Period 2|Protocol Violation|0|||
48735570|NCT00395733|156883670|FG001|Period 2|Protocol Violation|1|||
48735571|NCT00395733|156883669|FG000|Period 2|Adverse Event|0|||
48735572|NCT00395733|156883670|FG001|Period 2|Adverse Event|2|||
48735573|NCT00395733|156883669|FG000|Period 2|Technical problems|1|||
48735574|NCT00395733|156883670|FG001|Period 2|Technical problems|0|||
48735575|NCT00471146|156883671|FG000|Overall Study|Adverse Event|32|||
48735576|NCT00471146|156883672|FG001|Overall Study|Adverse Event|33|||
48735577|NCT00471146|156883671|FG000|Overall Study|Withdrawal by Subject|14|||
48735578|NCT00471146|156883672|FG001|Overall Study|Withdrawal by Subject|11|||
48735579|NCT00471146|156883671|FG000|Overall Study|Death|11|||
48735580|NCT00471146|156883672|FG001|Overall Study|Death|12|||
48735581|NCT00471146|156883671|FG000|Overall Study|Lost to Follow-up|4|||
48735582|NCT00471146|156883672|FG001|Overall Study|Lost to Follow-up|2|||
48735583|NCT00471146|156883671|FG000|Overall Study|Protocol Violation|2|||
48735584|NCT00471146|156883672|FG001|Overall Study|Protocol Violation|2|||
48735585|NCT00471146|156883671|FG000|Overall Study|Objective progression or relapse|84|||
48735586|NCT00471146|156883672|FG001|Overall Study|Objective progression or relapse|87|||
48735587|NCT00471146|156883671|FG000|Overall Study|Global deterioration of health status|12|||
48831071|NCT02317016|157221979|FG000|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23|||
48831072|NCT02317016|157221979|FG000|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1|||
48831073|NCT02317016|157221979|FG000|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2|||
48831074|NCT02317016|157221979|FG000|Part B: Day 35 to End Part B (AZD9291)|Death|5|||
48831075|NCT03418324|157221980|FG000|Overall Study|Death|0|||
48831076|NCT03418324|157221981|FG001|Overall Study|Death|1|||
48831077|NCT03418324|157221980|FG000|Overall Study|Physician Decision|1|||
48831078|NCT03418324|157221981|FG001|Overall Study|Physician Decision|1|||
48831079|NCT00605033|157221983|FG000|Overall Study|Adverse Event|2|||
48831080|NCT00605033|157221984|FG001|Overall Study|Adverse Event|2|||
48831081|NCT00605033|157221983|FG000|Overall Study|Lost to Follow-up|1|||
48831082|NCT00605033|157221984|FG001|Overall Study|Lost to Follow-up|1|||
49157532|NCT05489328|158419177|FG000|Overall Study|Other|0|||
49157533|NCT05489328|158419178|FG001|Overall Study|Other|0|||
49157534|NCT05489328|158419179|FG002|Overall Study|Other|0|||
49157535|NCT05489328|158419180|FG003|Overall Study|Other|0|||
49157536|NCT05489328|158419181|FG004|Overall Study|Other|0|||
49157537|NCT05489328|158419182|FG005|Overall Study|Other|0|||
49157538|NCT05489328|158419183|FG006|Overall Study|Other|0|||
48831083|NCT00605033|157221983|FG000|Overall Study|Withdrawal by Subject|3|||
48831084|NCT00605033|157221984|FG001|Overall Study|Withdrawal by Subject|4|||
48831085|NCT00605033|157221983|FG000|Overall Study|Protocol Violation|1|||
48831086|NCT00605033|157221984|FG001|Overall Study|Protocol Violation|1|||
48831087|NCT02041104|157221985|FG000|Overall Study|Lost to Follow-up|1|||
48831088|NCT02041104|157221986|FG001|Overall Study|Lost to Follow-up|4|||
48831089|NCT02041104|157221985|FG000|Overall Study|discomfort during OGTT|0|||
48831090|NCT02041104|157221986|FG001|Overall Study|discomfort during OGTT|3|||
48831091|NCT04688450|157223532|FG000|Overall Study|Unable to start software due to serial communication failure|1|||
48831092|NCT04688450|157223532|FG000|Overall Study|Withdrawal by Subject|1|||
48831093|NCT05057897|157223533|FG000|Overall Study|Site closure|2|||
48831094|NCT05057897|157223534|FG001|Overall Study|Site closure|2|||
48831095|NCT05057897|157223533|FG000|Overall Study|Death|1|||
48831096|NCT05057897|157223534|FG001|Overall Study|Death|0|||
48831097|NCT02662062|157223535|FG000|Overall Study|Withdrawal by Subject|1|||
48831098|NCT02249949|157223536|FG000|Overall Study|Cancelled prior to treatment|2|||
48831099|NCT03653507|157223537|FG000|Overall Study|Miscellaneous|26|||
48831100|NCT03653507|157223538|FG001|Overall Study|Miscellaneous|16|||
48831101|NCT03653507|157223537|FG000|Overall Study|Withdrawal by Subject|35|||
48831102|NCT03653507|157223538|FG001|Overall Study|Withdrawal by Subject|23|||
48831103|NCT03653507|157223537|FG000|Overall Study|Protocol Deviation|2|||
48831104|NCT03653507|157223538|FG001|Overall Study|Protocol Deviation|1|||
48831105|NCT03653507|157223537|FG000|Overall Study|Progressive disease|102|||
48831106|NCT03653507|157223538|FG001|Overall Study|Progressive disease|157|||
48831107|NCT03653507|157223537|FG000|Overall Study|Lost to Follow-up|1|||
48831108|NCT03653507|157223538|FG001|Overall Study|Lost to Follow-up|1|||
48831109|NCT03653507|157223537|FG000|Overall Study|Death|24|||
48831110|NCT03653507|157223538|FG001|Overall Study|Death|22|||
48831111|NCT03653507|157223537|FG000|Overall Study|Adverse Event|34|||
48831112|NCT03653507|157223538|FG001|Overall Study|Adverse Event|15|||
48831113|NCT01090024|157223539|FG000|Period 1|Met exclusion criteria|0|||
48831114|NCT01090024|157223540|FG001|Period 1|Met exclusion criteria|0|||
48831115|NCT01090024|157223541|FG002|Period 1|Met exclusion criteria|0|||
48831116|NCT01090024|157223542|FG003|Period 1|Met exclusion criteria|0|||
48831117|NCT01090024|157223543|FG004|Period 1|Met exclusion criteria|0|||
48831118|NCT01090024|157223544|FG005|Period 1|Met exclusion criteria|0|||
48831119|NCT01090024|157223545|FG006|Period 1|Met exclusion criteria|0|||
48831120|NCT01090024|157223546|FG007|Period 1|Met exclusion criteria|0|||
48831121|NCT01090024|157223547|FG008|Period 1|Met exclusion criteria|0|||
48831122|NCT01090024|157223548|FG009|Period 1|Met exclusion criteria|0|||
48831123|NCT01090024|157223549|FG010|Period 1|Met exclusion criteria|0|||
48831124|NCT01090024|157223550|FG011|Period 1|Met exclusion criteria|0|||
48831125|NCT01090024|157223551|FG012|Period 1|Met exclusion criteria|0|||
48831126|NCT01090024|157223552|FG013|Period 1|Met exclusion criteria|0|||
48831127|NCT01090024|157223553|FG014|Period 1|Met exclusion criteria|1|||
48831128|NCT01090024|157223554|FG015|Period 1|Met exclusion criteria|0|||
48831129|NCT01090024|157223555|FG016|Period 1|Met exclusion criteria|0|||
48831130|NCT01090024|157223556|FG017|Period 1|Met exclusion criteria|0|||
48831131|NCT01090024|157223539|FG000|Period 1|Adverse Event|0|||
48831132|NCT01090024|157223540|FG001|Period 1|Adverse Event|0|||
48831133|NCT01090024|157223541|FG002|Period 1|Adverse Event|0|||
48831134|NCT01090024|157223542|FG003|Period 1|Adverse Event|0|||
48831135|NCT01090024|157223543|FG004|Period 1|Adverse Event|0|||
48831136|NCT01090024|157223544|FG005|Period 1|Adverse Event|0|||
48831137|NCT01090024|157223545|FG006|Period 1|Adverse Event|0|||
48831138|NCT01090024|157223546|FG007|Period 1|Adverse Event|0|||
48831139|NCT01090024|157223547|FG008|Period 1|Adverse Event|0|||
48831140|NCT01090024|157223548|FG009|Period 1|Adverse Event|1|||
48831141|NCT01090024|157223549|FG010|Period 1|Adverse Event|0|||
48831142|NCT01090024|157223550|FG011|Period 1|Adverse Event|1|||
49157539|NCT05489328|158419184|FG007|Overall Study|Other|1|||
49157540|NCT05489328|158419185|FG008|Overall Study|Other|1|||
48831143|NCT01090024|157223551|FG012|Period 1|Adverse Event|0|||
48831144|NCT01090024|157223552|FG013|Period 1|Adverse Event|0|||
48831145|NCT01090024|157223553|FG014|Period 1|Adverse Event|0|||
48831146|NCT01090024|157223554|FG015|Period 1|Adverse Event|0|||
48831147|NCT01090024|157223555|FG016|Period 1|Adverse Event|0|||
48831148|NCT01090024|157223556|FG017|Period 1|Adverse Event|1|||
48831149|NCT01090024|157223539|FG000|Period 1|Withdrawal by Subject|0|||
48831150|NCT01090024|157223540|FG001|Period 1|Withdrawal by Subject|0|||
48831151|NCT01090024|157223541|FG002|Period 1|Withdrawal by Subject|0|||
48831152|NCT01090024|157223542|FG003|Period 1|Withdrawal by Subject|1|||
48831153|NCT01090024|157223543|FG004|Period 1|Withdrawal by Subject|0|||
48831154|NCT01090024|157223544|FG005|Period 1|Withdrawal by Subject|0|||
48831155|NCT01090024|157223545|FG006|Period 1|Withdrawal by Subject|0|||
48831156|NCT01090024|157223546|FG007|Period 1|Withdrawal by Subject|0|||
48831157|NCT01090024|157223547|FG008|Period 1|Withdrawal by Subject|0|||
48831158|NCT01090024|157223548|FG009|Period 1|Withdrawal by Subject|0|||
48831159|NCT01090024|157223549|FG010|Period 1|Withdrawal by Subject|0|||
48831160|NCT01090024|157223550|FG011|Period 1|Withdrawal by Subject|0|||
48831161|NCT01090024|157223551|FG012|Period 1|Withdrawal by Subject|0|||
48831162|NCT01090024|157223552|FG013|Period 1|Withdrawal by Subject|0|||
48831163|NCT01090024|157223553|FG014|Period 1|Withdrawal by Subject|0|||
48831164|NCT01090024|157223554|FG015|Period 1|Withdrawal by Subject|0|||
48831165|NCT01090024|157223555|FG016|Period 1|Withdrawal by Subject|0|||
48831166|NCT01090024|157223556|FG017|Period 1|Withdrawal by Subject|0|||
48831167|NCT01090024|157223539|FG000|Period 1|Lost to Follow-up|0|||
48831168|NCT01090024|157223540|FG001|Period 1|Lost to Follow-up|1|||
48831169|NCT01090024|157223541|FG002|Period 1|Lost to Follow-up|0|||
48831170|NCT01090024|157223542|FG003|Period 1|Lost to Follow-up|0|||
48831171|NCT01090024|157223543|FG004|Period 1|Lost to Follow-up|0|||
48831172|NCT01090024|157223544|FG005|Period 1|Lost to Follow-up|0|||
49157541|NCT04795531|158419187|FG000|Overall Study|Withdrawal by Subject|4|||
49157542|NCT04795531|158419188|FG001|Overall Study|Withdrawal by Subject|4|||
49157543|NCT04795531|158419187|FG000|Overall Study|Lost to Follow-up|0|||
49157544|NCT04795531|158419188|FG001|Overall Study|Lost to Follow-up|1|||
49157545|NCT04795531|158419187|FG000|Overall Study|Physician Decision|0|||
49157546|NCT04795531|158419188|FG001|Overall Study|Physician Decision|2|||
49157547|NCT04795531|158419187|FG000|Overall Study|Death|2|||
49157548|NCT04795531|158419188|FG001|Overall Study|Death|1|||
49157549|NCT01323192|158419189|FG000|Overall Study|Adverse Event|6|||
49157550|NCT01323192|158419190|FG001|Overall Study|Adverse Event|1|||
49157551|NCT01323192|158419189|FG000|Overall Study|Withdrawal by Subject|3|||
49157552|NCT01323192|158419190|FG001|Overall Study|Withdrawal by Subject|1|||
49157553|NCT01323192|158419189|FG000|Overall Study|Noncompliance with study medication|0|||
49157554|NCT01323192|158419190|FG001|Overall Study|Noncompliance with study medication|3|||
49157555|NCT01323192|158419189|FG000|Overall Study|Nonmedical reasons|0|||
49157556|NCT01323192|158419190|FG001|Overall Study|Nonmedical reasons|1|||
49157557|NCT00805389|158419191|FG000|Overall Study|Adverse Event|0|||
49157558|NCT00805389|158419192|FG001|Overall Study|Adverse Event|0|||
49157559|NCT00805389|158419193|FG002|Overall Study|Adverse Event|1|||
49157560|NCT00805389|158419194|FG003|Overall Study|Adverse Event|2|||
49157561|NCT00805389|158419195|FG004|Overall Study|Adverse Event|0|||
49157562|NCT00805389|158419191|FG000|Overall Study|Lost to Follow-up|4|||
49157563|NCT00805389|158419192|FG001|Overall Study|Lost to Follow-up|3|||
49157564|NCT00805389|158419193|FG002|Overall Study|Lost to Follow-up|6|||
49157565|NCT00805389|158419194|FG003|Overall Study|Lost to Follow-up|10|||
49157566|NCT00805389|158419195|FG004|Overall Study|Lost to Follow-up|9|||
49157567|NCT00805389|158419191|FG000|Overall Study|Protocol Violation|0|||
49157568|NCT00805389|158419192|FG001|Overall Study|Protocol Violation|0|||
49157569|NCT00805389|158419193|FG002|Overall Study|Protocol Violation|1|||
49157570|NCT00805389|158419194|FG003|Overall Study|Protocol Violation|0|||
49157571|NCT00805389|158419195|FG004|Overall Study|Protocol Violation|0|||
49157572|NCT00805389|158419191|FG000|Overall Study|Withdrawal by Subject|3|||
49157573|NCT00805389|158419192|FG001|Overall Study|Withdrawal by Subject|2|||
49157574|NCT00805389|158419193|FG002|Overall Study|Withdrawal by Subject|4|||
48831173|NCT01090024|157223545|FG006|Period 1|Lost to Follow-up|0|||
49157575|NCT00805389|158419194|FG003|Overall Study|Withdrawal by Subject|5|||
48831174|NCT01090024|157223546|FG007|Period 1|Lost to Follow-up|0|||
49157576|NCT00805389|158419195|FG004|Overall Study|Withdrawal by Subject|4|||
48831175|NCT01090024|157223547|FG008|Period 1|Lost to Follow-up|0|||
48831176|NCT01090024|157223548|FG009|Period 1|Lost to Follow-up|0|||
49014578|NCT04634409|157888931|FG008|Overall Study|Death|0|||
48831177|NCT01090024|157223549|FG010|Period 1|Lost to Follow-up|0|||
48831178|NCT01090024|157223550|FG011|Period 1|Lost to Follow-up|0|||
48831179|NCT01090024|157223551|FG012|Period 1|Lost to Follow-up|0|||
48831180|NCT01090024|157223552|FG013|Period 1|Lost to Follow-up|0|||
48831181|NCT01090024|157223553|FG014|Period 1|Lost to Follow-up|0|||
48831182|NCT01090024|157223554|FG015|Period 1|Lost to Follow-up|0|||
48831183|NCT01090024|157223555|FG016|Period 1|Lost to Follow-up|0|||
49157577|NCT00633126|158419197|FG000|Overall Study|Did not receive full dose|1|||
49157578|NCT00140140|158419198|FG000|Overall Study|Unacceptable toxicity|1|||
49157579|NCT00140140|158419199|FG001|Overall Study|Unacceptable toxicity|1|||
48831184|NCT01090024|157223556|FG017|Period 1|Lost to Follow-up|0|||
48831185|NCT01090024|157223539|FG000|Period 2|Lost to Follow-up|0|||
48831186|NCT01090024|157223540|FG001|Period 2|Lost to Follow-up|0|||
48831187|NCT01090024|157223541|FG002|Period 2|Lost to Follow-up|0|||
48831188|NCT01090024|157223542|FG003|Period 2|Lost to Follow-up|1|||
48831189|NCT01090024|157223543|FG004|Period 2|Lost to Follow-up|0|||
48831190|NCT01090024|157223544|FG005|Period 2|Lost to Follow-up|0|||
48831191|NCT01090024|157223545|FG006|Period 2|Lost to Follow-up|0|||
48831192|NCT01090024|157223546|FG007|Period 2|Lost to Follow-up|0|||
48831193|NCT01090024|157223547|FG008|Period 2|Lost to Follow-up|0|||
48831194|NCT01090024|157223548|FG009|Period 2|Lost to Follow-up|0|||
48831195|NCT01090024|157223549|FG010|Period 2|Lost to Follow-up|0|||
48831196|NCT01090024|157223550|FG011|Period 2|Lost to Follow-up|0|||
48831197|NCT01090024|157223551|FG012|Period 2|Lost to Follow-up|0|||
48831198|NCT01090024|157223552|FG013|Period 2|Lost to Follow-up|0|||
48831199|NCT01090024|157223553|FG014|Period 2|Lost to Follow-up|0|||
48831200|NCT01090024|157223554|FG015|Period 2|Lost to Follow-up|0|||
48831201|NCT01090024|157223555|FG016|Period 2|Lost to Follow-up|0|||
48831202|NCT01090024|157223556|FG017|Period 2|Lost to Follow-up|0|||
48831203|NCT01090024|157223539|FG000|Period 2|Adverse Event|1|||
48831204|NCT01090024|157223540|FG001|Period 2|Adverse Event|0|||
48831205|NCT01090024|157223541|FG002|Period 2|Adverse Event|0|||
48831206|NCT01090024|157223542|FG003|Period 2|Adverse Event|0|||
48831207|NCT01090024|157223543|FG004|Period 2|Adverse Event|0|||
48831208|NCT01090024|157223544|FG005|Period 2|Adverse Event|0|||
48831209|NCT01090024|157223545|FG006|Period 2|Adverse Event|0|||
48831210|NCT01090024|157223546|FG007|Period 2|Adverse Event|0|||
48831211|NCT01090024|157223547|FG008|Period 2|Adverse Event|0|||
48831212|NCT01090024|157223548|FG009|Period 2|Adverse Event|0|||
48831213|NCT01090024|157223549|FG010|Period 2|Adverse Event|0|||
48831214|NCT01090024|157223550|FG011|Period 2|Adverse Event|0|||
48831215|NCT01090024|157223551|FG012|Period 2|Adverse Event|0|||
48831216|NCT01090024|157223552|FG013|Period 2|Adverse Event|0|||
48831217|NCT01090024|157223553|FG014|Period 2|Adverse Event|0|||
48831218|NCT01090024|157223554|FG015|Period 2|Adverse Event|0|||
48831219|NCT01090024|157223555|FG016|Period 2|Adverse Event|0|||
48831220|NCT01090024|157223556|FG017|Period 2|Adverse Event|0|||
48831221|NCT01090024|157223539|FG000|Period 3|Withdrawal by Subject|0|||
48831222|NCT01090024|157223540|FG001|Period 3|Withdrawal by Subject|0|||
48831223|NCT01090024|157223541|FG002|Period 3|Withdrawal by Subject|0|||
48831224|NCT01090024|157223542|FG003|Period 3|Withdrawal by Subject|0|||
48831225|NCT01090024|157223543|FG004|Period 3|Withdrawal by Subject|0|||
48831226|NCT01090024|157223544|FG005|Period 3|Withdrawal by Subject|0|||
48831227|NCT01090024|157223545|FG006|Period 3|Withdrawal by Subject|0|||
48831228|NCT01090024|157223546|FG007|Period 3|Withdrawal by Subject|0|||
48831229|NCT01090024|157223547|FG008|Period 3|Withdrawal by Subject|0|||
48831230|NCT01090024|157223548|FG009|Period 3|Withdrawal by Subject|0|||
48831231|NCT01090024|157223549|FG010|Period 3|Withdrawal by Subject|0|||
48831232|NCT01090024|157223550|FG011|Period 3|Withdrawal by Subject|0|||
49157580|NCT00140140|158419200|FG002|Overall Study|Unacceptable toxicity|2|||
49157581|NCT00140140|158419198|FG000|Overall Study|Physician Decision|1|||
49157582|NCT00140140|158419199|FG001|Overall Study|Physician Decision|1|||
49157583|NCT00140140|158419200|FG002|Overall Study|Physician Decision|0|||
48831233|NCT01090024|157223551|FG012|Period 3|Withdrawal by Subject|0|||
48831234|NCT01090024|157223552|FG013|Period 3|Withdrawal by Subject|0|||
49157584|NCT01276704|158419201|FG000|Overall Study|Lost to Follow-up|2|||
49157585|NCT01276704|158419202|FG001|Overall Study|Lost to Follow-up|3|||
49157586|NCT01276704|158419201|FG000|Overall Study|Non-compliant|2|||
49157587|NCT01276704|158419202|FG001|Overall Study|Non-compliant|2|||
49157588|NCT01276704|158419201|FG000|Overall Study|Withdrawal by Subject|7|||
49157589|NCT01276704|158419202|FG001|Overall Study|Withdrawal by Subject|1|||
49157590|NCT01276704|158419201|FG000|Overall Study|Physician Decision|3|||
49157591|NCT01276704|158419202|FG001|Overall Study|Physician Decision|5|||
49157592|NCT02835690|158419203|FG000|Overall Study|Death|12|||
49157593|NCT02835690|158419204|FG001|Overall Study|Death|11|||
49157594|NCT02835690|158419205|FG002|Overall Study|Death|13|||
49157595|NCT02835690|158419203|FG000|Overall Study|Transferred to Extension Study|2|||
48692902|NCT03137992|156724647|FG001|Washout Period 1|Principal Investigator Discretion|1|||
48831235|NCT01090024|157223553|FG014|Period 3|Withdrawal by Subject|0|||
48831236|NCT01090024|157223554|FG015|Period 3|Withdrawal by Subject|1|||
49157596|NCT02835690|158419204|FG001|Overall Study|Transferred to Extension Study|2|||
48831237|NCT01090024|157223555|FG016|Period 3|Withdrawal by Subject|0|||
48831238|NCT01090024|157223556|FG017|Period 3|Withdrawal by Subject|0|||
48831239|NCT01090024|157223539|FG000|Period 3|Protocol Violation|0|||
48831240|NCT01090024|157223540|FG001|Period 3|Protocol Violation|0|||
48831241|NCT01090024|157223541|FG002|Period 3|Protocol Violation|0|||
48831242|NCT01090024|157223542|FG003|Period 3|Protocol Violation|0|||
48831243|NCT01090024|157223543|FG004|Period 3|Protocol Violation|0|||
48831244|NCT01090024|157223544|FG005|Period 3|Protocol Violation|0|||
48831245|NCT01090024|157223545|FG006|Period 3|Protocol Violation|0|||
49157597|NCT02835690|158419205|FG002|Overall Study|Transferred to Extension Study|1|||
49157598|NCT02835690|158419203|FG000|Overall Study|Did Not Continue on Extension Study|0|||
49157599|NCT02835690|158419204|FG001|Overall Study|Did Not Continue on Extension Study|0|||
48831246|NCT01090024|157223546|FG007|Period 3|Protocol Violation|0|||
48831247|NCT01090024|157223547|FG008|Period 3|Protocol Violation|1|||
48831248|NCT01090024|157223548|FG009|Period 3|Protocol Violation|0|||
48831249|NCT01090024|157223549|FG010|Period 3|Protocol Violation|0|||
48831250|NCT01090024|157223550|FG011|Period 3|Protocol Violation|0|||
48831251|NCT01090024|157223551|FG012|Period 3|Protocol Violation|0|||
48831252|NCT01090024|157223552|FG013|Period 3|Protocol Violation|0|||
48831253|NCT01090024|157223553|FG014|Period 3|Protocol Violation|0|||
48831254|NCT01090024|157223554|FG015|Period 3|Protocol Violation|0|||
48831255|NCT01090024|157223555|FG016|Period 3|Protocol Violation|0|||
48831256|NCT01090024|157223556|FG017|Period 3|Protocol Violation|0|||
48831257|NCT01090024|157223539|FG000|Period 3|Adverse Event|0|||
48831258|NCT01090024|157223540|FG001|Period 3|Adverse Event|0|||
48831259|NCT01090024|157223541|FG002|Period 3|Adverse Event|0|||
48831260|NCT01090024|157223542|FG003|Period 3|Adverse Event|0|||
48831261|NCT01090024|157223543|FG004|Period 3|Adverse Event|0|||
48831262|NCT01090024|157223544|FG005|Period 3|Adverse Event|1|||
48831263|NCT01090024|157223545|FG006|Period 3|Adverse Event|0|||
48831264|NCT01090024|157223546|FG007|Period 3|Adverse Event|0|||
48831265|NCT01090024|157223547|FG008|Period 3|Adverse Event|0|||
48831266|NCT01090024|157223548|FG009|Period 3|Adverse Event|0|||
48831267|NCT01090024|157223549|FG010|Period 3|Adverse Event|0|||
48831268|NCT01090024|157223550|FG011|Period 3|Adverse Event|0|||
48831269|NCT01090024|157223551|FG012|Period 3|Adverse Event|0|||
48831270|NCT01090024|157223552|FG013|Period 3|Adverse Event|0|||
48831271|NCT01090024|157223553|FG014|Period 3|Adverse Event|0|||
48831272|NCT01090024|157223554|FG015|Period 3|Adverse Event|0|||
48831273|NCT01090024|157223555|FG016|Period 3|Adverse Event|0|||
48831274|NCT01090024|157223556|FG017|Period 3|Adverse Event|0|||
48831275|NCT02757885|157223557|FG000|Overall Study|Screen Failures|4|||
48831276|NCT00470626|157223560|FG000|Overall Study|Lost to Follow-up|10|||
48831277|NCT00470626|157223560|FG000|Overall Study|Withdrawal by Subject|7|||
48831278|NCT05298111|157223561|FG000|Washout (3 Days)|Withdrawal by Subject|3|||
48831279|NCT05298111|157223562|FG001|Washout (3 Days)|Withdrawal by Subject|3|||
48831280|NCT02689349|157223563|FG000|Overall Study|Not implanted|4|||
48831281|NCT02689349|157223564|FG001|Overall Study|Not implanted|0|||
48831282|NCT02689349|157223563|FG000|Overall Study|Withdrawal by Subject|9|||
48831283|NCT02689349|157223564|FG001|Overall Study|Withdrawal by Subject|0|||
48831284|NCT02987543|157223565|FG000|Overall Study|Ongoing study at data cut off|49|||
48831285|NCT02987543|157223566|FG001|Overall Study|Ongoing study at data cut off|21|||
48831286|NCT02987543|157223567|FG002|Overall Study|Ongoing study at data cut off|19|||
48831287|NCT02987543|157223568|FG003|Overall Study|Ongoing study at data cut off|12|||
48831288|NCT02987543|157223565|FG000|Overall Study|Death|88|||
48831289|NCT02987543|157223566|FG001|Overall Study|Death|54|||
48831290|NCT02987543|157223567|FG002|Overall Study|Death|67|||
48831291|NCT02987543|157223568|FG003|Overall Study|Death|28|||
48831292|NCT02987543|157223565|FG000|Overall Study|Lost to Follow-up|3|||
48831293|NCT02987543|157223566|FG001|Overall Study|Lost to Follow-up|0|||
48831294|NCT02987543|157223567|FG002|Overall Study|Lost to Follow-up|1|||
48831295|NCT02987543|157223568|FG003|Overall Study|Lost to Follow-up|0|||
48831296|NCT02987543|157223565|FG000|Overall Study|Screen failure|0|||
48831297|NCT02987543|157223566|FG001|Overall Study|Screen failure|0|||
48831298|NCT02987543|157223567|FG002|Overall Study|Screen failure|0|||
48831299|NCT02987543|157223568|FG003|Overall Study|Screen failure|1|||
49157600|NCT02835690|158419205|FG002|Overall Study|Did Not Continue on Extension Study|1|||
49157601|NCT02835690|158419203|FG000|Overall Study|Not Treated|0|||
49157602|NCT02835690|158419204|FG001|Overall Study|Not Treated|2|||
49157603|NCT02835690|158419205|FG002|Overall Study|Not Treated|0|||
49157604|NCT04490278|158419206|FG000|Overall Study|Lost to Follow-up|6|||
48831300|NCT02987543|157223565|FG000|Overall Study|Withdrawal by Subject|21|||
48831301|NCT02987543|157223566|FG001|Overall Study|Withdrawal by Subject|7|||
48831302|NCT02987543|157223567|FG002|Overall Study|Withdrawal by Subject|7|||
48831303|NCT02987543|157223568|FG003|Overall Study|Withdrawal by Subject|6|||
48831304|NCT02987543|157223565|FG000|Overall Study|Study terminated by sponsor|1|||
48831305|NCT02987543|157223566|FG001|Overall Study|Study terminated by sponsor|0|||
48831306|NCT02987543|157223567|FG002|Overall Study|Study terminated by sponsor|0|||
48831307|NCT02987543|157223568|FG003|Overall Study|Study terminated by sponsor|0|||
48831308|NCT02987543|157223565|FG000|Overall Study|Investigator decision|0|||
48831309|NCT02987543|157223566|FG001|Overall Study|Investigator decision|1|||
49157605|NCT01784029|158419207|FG000|Overall Study|Lost to Follow-up|19|||
48831310|NCT02987543|157223567|FG002|Overall Study|Investigator decision|0|||
48831311|NCT02987543|157223568|FG003|Overall Study|Investigator decision|0|||
48831312|NCT02987543|157223565|FG000|Overall Study|Disease progression|0|||
48831313|NCT02987543|157223566|FG001|Overall Study|Disease progression|0|||
48831314|NCT02987543|157223567|FG002|Overall Study|Disease progression|0|||
48831315|NCT02987543|157223568|FG003|Overall Study|Disease progression|1|||
48831316|NCT04012853|157223575|FG000|Overall Study|Withdrawal by Subject|1|||
48831317|NCT04012853|157223576|FG001|Overall Study|Withdrawal by Subject|1|||
49157606|NCT01784029|158419208|FG001|Overall Study|Lost to Follow-up|20|||
49157607|NCT01784029|158419209|FG002|Overall Study|Lost to Follow-up|22|||
49157608|NCT00366457|158419210|FG000|Overall Study|never began study therapy|2|||
49157609|NCT03235050|158419211|FG000|Overall Study|Adverse Event|0|||
49157610|NCT03235050|158419212|FG001|Overall Study|Adverse Event|0|||
49157611|NCT03235050|158419213|FG002|Overall Study|Adverse Event|1|||
49157612|NCT03235050|158419214|FG003|Overall Study|Adverse Event|4|||
49157613|NCT03235050|158419215|FG004|Overall Study|Adverse Event|1|||
49157614|NCT03235050|158419211|FG000|Overall Study|Death|0|||
49157615|NCT03235050|158419212|FG001|Overall Study|Death|0|||
49157616|NCT03235050|158419213|FG002|Overall Study|Death|0|||
49157617|NCT03235050|158419214|FG003|Overall Study|Death|2|||
49157618|NCT03235050|158419215|FG004|Overall Study|Death|1|||
49157619|NCT03235050|158419211|FG000|Overall Study|Lost to Follow-up|1|||
49157620|NCT03235050|158419212|FG001|Overall Study|Lost to Follow-up|2|||
49157621|NCT03235050|158419213|FG002|Overall Study|Lost to Follow-up|1|||
49157622|NCT03235050|158419214|FG003|Overall Study|Lost to Follow-up|2|||
49157623|NCT03235050|158419215|FG004|Overall Study|Lost to Follow-up|0|||
49157624|NCT03235050|158419211|FG000|Overall Study|Withdrawal by Subject|3|||
49157625|NCT03235050|158419212|FG001|Overall Study|Withdrawal by Subject|2|||
49157626|NCT03235050|158419213|FG002|Overall Study|Withdrawal by Subject|2|||
49157627|NCT03235050|158419214|FG003|Overall Study|Withdrawal by Subject|5|||
49157628|NCT03235050|158419215|FG004|Overall Study|Withdrawal by Subject|7|||
49157629|NCT03235050|158419211|FG000|Overall Study|Other reasons|0|||
49157630|NCT03235050|158419212|FG001|Overall Study|Other reasons|1|||
49157631|NCT03235050|158419213|FG002|Overall Study|Other reasons|0|||
49157632|NCT03235050|158419214|FG003|Overall Study|Other reasons|1|||
49157633|NCT03235050|158419215|FG004|Overall Study|Other reasons|2|||
49157634|NCT01425814|158419218|FG000|Period 1|Stability criteria not fulfilled|0|||
49157635|NCT01425814|158419219|FG001|Period 1|Stability criteria not fulfilled|1|||
49157636|NCT01425814|158419220|FG002|Period 1|Stability criteria not fulfilled|0|||
48831318|NCT04012853|157223575|FG000|Overall Study|Protocol Violation|1|||
48831319|NCT04012853|157223576|FG001|Overall Study|Protocol Violation|0|||
49157637|NCT01425814|158419221|FG003|Period 1|Stability criteria not fulfilled|0|||
49157638|NCT01425814|158419222|FG004|Period 1|Stability criteria not fulfilled|0|||
48831320|NCT04012853|157223575|FG000|Overall Study|Unable to tolerate target tDCS intensity|1|||
48831321|NCT04012853|157223576|FG001|Overall Study|Unable to tolerate target tDCS intensity|0|||
48831322|NCT04613375|157223577|FG000|Overall Study|Death|198|||
48831323|NCT04613375|157223577|FG000|Overall Study|Withdrawal by Subject|3|||
48831324|NCT00464672|157223580|FG000|Overall Study|withdrawal of consent|0|||
48831325|NCT00464672|157223581|FG001|Overall Study|withdrawal of consent|0|||
48831326|NCT00464672|157223582|FG002|Overall Study|withdrawal of consent|0|||
48831327|NCT00464672|157223583|FG003|Overall Study|withdrawal of consent|1|||
48831328|NCT00464672|157223584|FG004|Overall Study|withdrawal of consent|9|||
48831329|NCT00464672|157223585|FG005|Overall Study|withdrawal of consent|4|||
48831330|NCT00464672|157223580|FG000|Overall Study|Lost to Follow-up|25|||
48831331|NCT00464672|157223581|FG001|Overall Study|Lost to Follow-up|10|||
48831332|NCT00464672|157223582|FG002|Overall Study|Lost to Follow-up|0|||
48831333|NCT00464672|157223583|FG003|Overall Study|Lost to Follow-up|0|||
48831334|NCT00464672|157223584|FG004|Overall Study|Lost to Follow-up|1|||
48831335|NCT00464672|157223585|FG005|Overall Study|Lost to Follow-up|0|||
48831336|NCT00217672|157223586|FG000|Allocation|Ineligible|2|||
48831337|NCT00217672|157223587|FG001|Allocation|Ineligible|0|||
48831338|NCT00217672|157223586|FG000|Treatment|disease progression|33|||
48831339|NCT00217672|157223587|FG001|Treatment|disease progression|4|||
48831340|NCT00217672|157223586|FG000|Treatment|Adverse Event|18|||
48831341|NCT00217672|157223587|FG001|Treatment|Adverse Event|2|||
48831342|NCT00217672|157223586|FG000|Treatment|reqd treatment not permitted by protocol|6|||
48831343|NCT00217672|157223587|FG001|Treatment|reqd treatment not permitted by protocol|0|||
48831344|NCT00217672|157223586|FG000|Treatment|Physician Decision|6|||
48831345|NCT00217672|157223587|FG001|Treatment|Physician Decision|0|||
48831346|NCT00217672|157223586|FG000|Treatment|insurance issues|1|||
48831347|NCT00217672|157223587|FG001|Treatment|insurance issues|1|||
48831348|NCT00217672|157223586|FG000|Treatment|Death|2|||
48831349|NCT00217672|157223587|FG001|Treatment|Death|0|||
48831350|NCT00217672|157223586|FG000|Treatment|secondary malignancy|1|||
48831351|NCT00217672|157223587|FG001|Treatment|secondary malignancy|0|||
48831352|NCT00217672|157223586|FG000|Follow-up|Withdrawal by Subject|4|||
48831353|NCT00217672|157223587|FG001|Follow-up|Withdrawal by Subject|0|||
48831354|NCT00217672|157223586|FG000|Follow-up|Lost to Follow-up|1|||
48831355|NCT00217672|157223587|FG001|Follow-up|Lost to Follow-up|0|||
48831356|NCT01235949|157223591|FG000|Primary Phase|Migrated/moved from study area|1|||
48831357|NCT01235949|157223592|FG001|Primary Phase|Migrated/moved from study area|1|||
48831358|NCT01235949|157223593|FG002|Primary Phase|Migrated/moved from study area|0|||
48831359|NCT01235949|157223594|FG003|Primary Phase|Migrated/moved from study area|0|||
49157639|NCT01425814|158419223|FG005|Period 1|Stability criteria not fulfilled|0|||
49157640|NCT01425814|158419218|FG000|Period 2|Stability criteria not fulfilled|0|||
49157641|NCT01425814|158419219|FG001|Period 2|Stability criteria not fulfilled|1|||
49157642|NCT01425814|158419220|FG002|Period 2|Stability criteria not fulfilled|0|||
49157643|NCT01425814|158419221|FG003|Period 2|Stability criteria not fulfilled|0|||
49157644|NCT01425814|158419222|FG004|Period 2|Stability criteria not fulfilled|0|||
49157645|NCT01425814|158419223|FG005|Period 2|Stability criteria not fulfilled|0|||
49157646|NCT01425814|158419218|FG000|Period 3|Adverse Event|0|||
49157647|NCT01425814|158419219|FG001|Period 3|Adverse Event|0|||
49157648|NCT01425814|158419220|FG002|Period 3|Adverse Event|0|||
49157649|NCT01425814|158419221|FG003|Period 3|Adverse Event|0|||
49157650|NCT01425814|158419222|FG004|Period 3|Adverse Event|0|||
49157651|NCT01425814|158419223|FG005|Period 3|Adverse Event|1|||
49157652|NCT01425814|158419218|FG000|Period 4|Adverse Event|1|||
49157653|NCT01425814|158419219|FG001|Period 4|Adverse Event|0|||
49157654|NCT01425814|158419220|FG002|Period 4|Adverse Event|1|||
49157655|NCT01425814|158419221|FG003|Period 4|Adverse Event|0|||
49157656|NCT01425814|158419222|FG004|Period 4|Adverse Event|0|||
49157657|NCT01425814|158419223|FG005|Period 4|Adverse Event|0|||
49157658|NCT01425814|158419218|FG000|Period 5|Stability criteria not fulfilled|0|||
49157659|NCT01425814|158419219|FG001|Period 5|Stability criteria not fulfilled|0|||
49157660|NCT01425814|158419220|FG002|Period 5|Stability criteria not fulfilled|1|||
49157661|NCT01425814|158419221|FG003|Period 5|Stability criteria not fulfilled|0|||
49157662|NCT01425814|158419222|FG004|Period 5|Stability criteria not fulfilled|0|||
48831360|NCT01235949|157223595|FG004|Primary Phase|Migrated/moved from study area|1|||
49157663|NCT01425814|158419223|FG005|Period 5|Stability criteria not fulfilled|1|||
49157664|NCT00492557|158419232|FG000|Overall Study|Subject request|12|||
49157665|NCT00492557|158419233|FG001|Overall Study|Subject request|11|||
49157666|NCT00492557|158419232|FG000|Overall Study|Protocol Violation|7|||
49157667|NCT00492557|158419233|FG001|Overall Study|Protocol Violation|8|||
49157668|NCT00492557|158419232|FG000|Overall Study|Other|2|||
48831361|NCT01235949|157223596|FG005|Primary Phase|Migrated/moved from study area|2|||
48831362|NCT01235949|157223597|FG006|Primary Phase|Migrated/moved from study area|0|||
48831363|NCT01235949|157223598|FG007|Primary Phase|Migrated/moved from study area|0|||
48831364|NCT01235949|157223599|FG008|Primary Phase|Migrated/moved from study area|0|||
48831365|NCT01235949|157223600|FG009|Primary Phase|Migrated/moved from study area|0|||
48831366|NCT01235949|157223601|FG010|Primary Phase|Migrated/moved from study area|0|||
49157669|NCT00492557|158419233|FG001|Overall Study|Other|2|||
49157670|NCT00492557|158419232|FG000|Overall Study|Death|1|||
49157671|NCT00492557|158419233|FG001|Overall Study|Death|1|||
49157672|NCT00492557|158419232|FG000|Overall Study|Adverse Event|1|||
49157673|NCT00492557|158419233|FG001|Overall Study|Adverse Event|0|||
49157674|NCT00492557|158419232|FG000|Overall Study|Failed to return|1|||
49157675|NCT00492557|158419233|FG001|Overall Study|Failed to return|0|||
49157676|NCT00492557|158419232|FG000|Overall Study|Lost to Follow-up|0|||
48831367|NCT01235949|157223602|FG011|Primary Phase|Migrated/moved from study area|0|||
48831368|NCT01235949|157223603|FG012|Primary Phase|Migrated/moved from study area|0|||
48831369|NCT01235949|157223604|FG013|Primary Phase|Migrated/moved from study area|0|||
48831370|NCT01235949|157223605|FG014|Primary Phase|Migrated/moved from study area|0|||
48831371|NCT01235949|157223606|FG015|Primary Phase|Migrated/moved from study area|0|||
48831372|NCT01235949|157223607|FG016|Primary Phase|Migrated/moved from study area|0|||
48831373|NCT01235949|157223608|FG017|Primary Phase|Migrated/moved from study area|0|||
48831374|NCT01235949|157223591|FG000|Primary Phase|Adverse Event|0|||
48831375|NCT01235949|157223592|FG001|Primary Phase|Adverse Event|0|||
48831376|NCT01235949|157223593|FG002|Primary Phase|Adverse Event|0|||
48831377|NCT01235949|157223594|FG003|Primary Phase|Adverse Event|1|||
48831378|NCT01235949|157223595|FG004|Primary Phase|Adverse Event|0|||
48831379|NCT01235949|157223596|FG005|Primary Phase|Adverse Event|0|||
48831380|NCT01235949|157223597|FG006|Primary Phase|Adverse Event|0|||
48831381|NCT01235949|157223598|FG007|Primary Phase|Adverse Event|0|||
48831382|NCT01235949|157223599|FG008|Primary Phase|Adverse Event|0|||
48831383|NCT01235949|157223600|FG009|Primary Phase|Adverse Event|0|||
48831384|NCT01235949|157223601|FG010|Primary Phase|Adverse Event|0|||
48831385|NCT01235949|157223602|FG011|Primary Phase|Adverse Event|0|||
48922775|NCT01452152|157550145|FG001|Overall Study|Study termination by sponsor|0|||
48922776|NCT01452152|157550146|FG002|Overall Study|Study termination by sponsor|4|||
48922777|NCT01908101|157551444|FG000|Overall Study|Physician Decision|1|||
49157677|NCT00492557|158419233|FG001|Overall Study|Lost to Follow-up|1|||
49157678|NCT01664624|158419234|FG000|Overall Study|Adverse Event|0|||
49157679|NCT01664624|158419235|FG001|Overall Study|Adverse Event|1|||
49157680|NCT01664624|158419236|FG002|Overall Study|Adverse Event|0|||
49157681|NCT01664624|158419237|FG003|Overall Study|Adverse Event|0|||
49157682|NCT01517984|158419241|FG000|Overall Study|Lost to Follow-up|0|||
48831386|NCT01235949|157223603|FG012|Primary Phase|Adverse Event|0|||
48831387|NCT01235949|157223604|FG013|Primary Phase|Adverse Event|0|||
48922778|NCT01908101|157551444|FG000|Overall Study|Withdrawal by Subject|1|||
49157683|NCT01517984|158419242|FG001|Overall Study|Lost to Follow-up|1|||
49157684|NCT01517984|158419243|FG002|Overall Study|Lost to Follow-up|0|||
49157685|NCT01517984|158419244|FG003|Overall Study|Lost to Follow-up|0|||
49157686|NCT01517984|158419241|FG000|Overall Study|Withdrawal by Subject|1|||
49157687|NCT01517984|158419242|FG001|Overall Study|Withdrawal by Subject|8|||
49157688|NCT01517984|158419243|FG002|Overall Study|Withdrawal by Subject|4|||
49157689|NCT01517984|158419244|FG003|Overall Study|Withdrawal by Subject|1|||
49157690|NCT01517984|158419241|FG000|Overall Study|Screen Failure|4|||
49157691|NCT01517984|158419242|FG001|Overall Study|Screen Failure|0|||
49157692|NCT01517984|158419243|FG002|Overall Study|Screen Failure|0|||
49157693|NCT01517984|158419244|FG003|Overall Study|Screen Failure|0|||
48831388|NCT01235949|157223605|FG014|Primary Phase|Adverse Event|0|||
48831389|NCT01235949|157223606|FG015|Primary Phase|Adverse Event|0|||
48831390|NCT01235949|157223607|FG016|Primary Phase|Adverse Event|0|||
48831391|NCT01235949|157223608|FG017|Primary Phase|Adverse Event|0|||
49157694|NCT01517984|158419241|FG000|Overall Study|Ineligible for randomization|0|||
49157695|NCT01517984|158419242|FG001|Overall Study|Ineligible for randomization|14|||
49157696|NCT01517984|158419243|FG002|Overall Study|Ineligible for randomization|0|||
49157697|NCT01517984|158419244|FG003|Overall Study|Ineligible for randomization|0|||
49157698|NCT05067335|158419245|FG000|Double-blind Period: Day 1 - Month 6|Adverse Event|1|||
49157699|NCT05067335|158419246|FG001|Double-blind Period: Day 1 - Month 6|Adverse Event|2|||
49157700|NCT05067335|158419247|FG002|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
49157701|NCT05067335|158419248|FG003|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
49157702|NCT05067335|158419245|FG000|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
49157703|NCT05067335|158419246|FG001|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
49157704|NCT05067335|158419247|FG002|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
49157705|NCT05067335|158419248|FG003|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
49157706|NCT05067335|158419245|FG000|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|6|||
49157707|NCT05067335|158419246|FG001|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|10|||
49157708|NCT05067335|158419247|FG002|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
49157709|NCT05067335|158419248|FG003|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
49157710|NCT05067335|158419245|FG000|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|1|||
49157711|NCT05067335|158419246|FG001|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
49157712|NCT05067335|158419247|FG002|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
49157713|NCT05067335|158419248|FG003|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
48831392|NCT01235949|157223591|FG000|Primary Phase|Withdrawal by Subject|3|||
48831393|NCT01235949|157223592|FG001|Primary Phase|Withdrawal by Subject|2|||
48831394|NCT01235949|157223593|FG002|Primary Phase|Withdrawal by Subject|2|||
48831395|NCT01235949|157223594|FG003|Primary Phase|Withdrawal by Subject|0|||
48831396|NCT01235949|157223595|FG004|Primary Phase|Withdrawal by Subject|0|||
48831397|NCT01235949|157223596|FG005|Primary Phase|Withdrawal by Subject|3|||
48831398|NCT01235949|157223597|FG006|Primary Phase|Withdrawal by Subject|0|||
48831399|NCT01235949|157223598|FG007|Primary Phase|Withdrawal by Subject|0|||
48831400|NCT01235949|157223599|FG008|Primary Phase|Withdrawal by Subject|0|||
48831401|NCT01235949|157223600|FG009|Primary Phase|Withdrawal by Subject|0|||
48831402|NCT01235949|157223601|FG010|Primary Phase|Withdrawal by Subject|0|||
48831403|NCT01235949|157223602|FG011|Primary Phase|Withdrawal by Subject|0|||
48831404|NCT01235949|157223603|FG012|Primary Phase|Withdrawal by Subject|0|||
48831405|NCT01235949|157223604|FG013|Primary Phase|Withdrawal by Subject|0|||
48831406|NCT01235949|157223605|FG014|Primary Phase|Withdrawal by Subject|0|||
48831407|NCT01235949|157223606|FG015|Primary Phase|Withdrawal by Subject|0|||
48831408|NCT01235949|157223607|FG016|Primary Phase|Withdrawal by Subject|0|||
48831409|NCT01235949|157223608|FG017|Primary Phase|Withdrawal by Subject|0|||
48831410|NCT01235949|157223591|FG000|Primary Phase|Lost to Follow-up|0|||
48831411|NCT01235949|157223592|FG001|Primary Phase|Lost to Follow-up|0|||
48831412|NCT01235949|157223593|FG002|Primary Phase|Lost to Follow-up|1|||
48831413|NCT01235949|157223594|FG003|Primary Phase|Lost to Follow-up|1|||
48831414|NCT01235949|157223595|FG004|Primary Phase|Lost to Follow-up|0|||
48831415|NCT01235949|157223596|FG005|Primary Phase|Lost to Follow-up|2|||
48831416|NCT01235949|157223597|FG006|Primary Phase|Lost to Follow-up|0|||
48831417|NCT01235949|157223598|FG007|Primary Phase|Lost to Follow-up|0|||
48831418|NCT01235949|157223599|FG008|Primary Phase|Lost to Follow-up|0|||
48831419|NCT01235949|157223600|FG009|Primary Phase|Lost to Follow-up|0|||
48831420|NCT01235949|157223601|FG010|Primary Phase|Lost to Follow-up|0|||
48831421|NCT01235949|157223602|FG011|Primary Phase|Lost to Follow-up|0|||
48831422|NCT01235949|157223603|FG012|Primary Phase|Lost to Follow-up|0|||
48831423|NCT01235949|157223604|FG013|Primary Phase|Lost to Follow-up|0|||
48831424|NCT01235949|157223605|FG014|Primary Phase|Lost to Follow-up|0|||
48831425|NCT01235949|157223606|FG015|Primary Phase|Lost to Follow-up|0|||
49157714|NCT05067335|158419245|FG000|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
48831426|NCT01235949|157223607|FG016|Primary Phase|Lost to Follow-up|0|||
48831427|NCT01235949|157223608|FG017|Primary Phase|Lost to Follow-up|0|||
48831428|NCT01235949|157223591|FG000|Booster Phase|Migrated/moved from study area|0|||
48831429|NCT01235949|157223592|FG001|Booster Phase|Migrated/moved from study area|0|||
48831430|NCT01235949|157223593|FG002|Booster Phase|Migrated/moved from study area|0|||
48831431|NCT01235949|157223594|FG003|Booster Phase|Migrated/moved from study area|0|||
49157715|NCT05067335|158419246|FG001|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|1|||
49157716|NCT05067335|158419247|FG002|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
49157717|NCT05067335|158419248|FG003|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
49157718|NCT05067335|158419245|FG000|Open-label Period: Month 7 - 12|Adverse Event|0|||
49157719|NCT05067335|158419246|FG001|Open-label Period: Month 7 - 12|Adverse Event|0|||
49157720|NCT05067335|158419247|FG002|Open-label Period: Month 7 - 12|Adverse Event|3|||
49157721|NCT05067335|158419248|FG003|Open-label Period: Month 7 - 12|Adverse Event|2|||
49157722|NCT05067335|158419245|FG000|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
49157723|NCT05067335|158419246|FG001|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
49157724|NCT05067335|158419247|FG002|Open-label Period: Month 7 - 12|Lost to Follow-up|1|||
49157725|NCT05067335|158419248|FG003|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
49157726|NCT05067335|158419245|FG000|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
48831432|NCT01235949|157223595|FG004|Booster Phase|Migrated/moved from study area|0|||
49157727|NCT05067335|158419246|FG001|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
49157728|NCT05067335|158419247|FG002|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
49157729|NCT05067335|158419248|FG003|Open-label Period: Month 7 - 12|Withdrawal by Subject|3|||
49157730|NCT05067335|158419245|FG000|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
48831433|NCT01235949|157223596|FG005|Booster Phase|Migrated/moved from study area|0|||
48831434|NCT01235949|157223597|FG006|Booster Phase|Migrated/moved from study area|0|||
48831435|NCT01235949|157223598|FG007|Booster Phase|Migrated/moved from study area|0|||
48831436|NCT01235949|157223599|FG008|Booster Phase|Migrated/moved from study area|0|||
48831437|NCT01235949|157223600|FG009|Booster Phase|Migrated/moved from study area|0|||
48831438|NCT01235949|157223601|FG010|Booster Phase|Migrated/moved from study area|0|||
48831439|NCT01235949|157223602|FG011|Booster Phase|Migrated/moved from study area|1|||
48831440|NCT01235949|157223603|FG012|Booster Phase|Migrated/moved from study area|1|||
48831441|NCT01235949|157223604|FG013|Booster Phase|Migrated/moved from study area|0|||
48831442|NCT01235949|157223605|FG014|Booster Phase|Migrated/moved from study area|0|||
48831443|NCT01235949|157223606|FG015|Booster Phase|Migrated/moved from study area|0|||
48831444|NCT01235949|157223607|FG016|Booster Phase|Migrated/moved from study area|0|||
48831445|NCT01235949|157223608|FG017|Booster Phase|Migrated/moved from study area|1|||
48831446|NCT01235949|157223591|FG000|Booster Phase|Adverse Event|0|||
48831447|NCT01235949|157223592|FG001|Booster Phase|Adverse Event|0|||
48831448|NCT01235949|157223593|FG002|Booster Phase|Adverse Event|0|||
48831449|NCT01235949|157223594|FG003|Booster Phase|Adverse Event|0|||
48831450|NCT01235949|157223595|FG004|Booster Phase|Adverse Event|0|||
48831451|NCT01235949|157223596|FG005|Booster Phase|Adverse Event|0|||
48831452|NCT01235949|157223597|FG006|Booster Phase|Adverse Event|0|||
48831453|NCT01235949|157223598|FG007|Booster Phase|Adverse Event|0|||
48831454|NCT01235949|157223599|FG008|Booster Phase|Adverse Event|0|||
48831455|NCT01235949|157223600|FG009|Booster Phase|Adverse Event|0|||
48831456|NCT01235949|157223601|FG010|Booster Phase|Adverse Event|0|||
48831457|NCT01235949|157223602|FG011|Booster Phase|Adverse Event|0|||
48831458|NCT01235949|157223603|FG012|Booster Phase|Adverse Event|0|||
48831459|NCT01235949|157223604|FG013|Booster Phase|Adverse Event|0|||
48831460|NCT01235949|157223605|FG014|Booster Phase|Adverse Event|0|||
48831461|NCT01235949|157223606|FG015|Booster Phase|Adverse Event|1|||
48831462|NCT01235949|157223607|FG016|Booster Phase|Adverse Event|0|||
48831463|NCT01235949|157223608|FG017|Booster Phase|Adverse Event|0|||
49157731|NCT05067335|158419246|FG001|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
49157732|NCT05067335|158419247|FG002|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|1|||
49157733|NCT05067335|158419248|FG003|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
49157734|NCT05067335|158419245|FG000|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
49157735|NCT05067335|158419246|FG001|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
49157736|NCT05067335|158419247|FG002|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|1|||
48831464|NCT01235949|157223591|FG000|Booster Phase|Withdrawal by Subject|0|||
48831465|NCT01235949|157223592|FG001|Booster Phase|Withdrawal by Subject|0|||
48831466|NCT01235949|157223593|FG002|Booster Phase|Withdrawal by Subject|0|||
48831467|NCT01235949|157223594|FG003|Booster Phase|Withdrawal by Subject|0|||
48831468|NCT01235949|157223595|FG004|Booster Phase|Withdrawal by Subject|0|||
48831469|NCT01235949|157223596|FG005|Booster Phase|Withdrawal by Subject|0|||
48831470|NCT01235949|157223597|FG006|Booster Phase|Withdrawal by Subject|0|||
48831471|NCT01235949|157223598|FG007|Booster Phase|Withdrawal by Subject|1|||
48831472|NCT01235949|157223599|FG008|Booster Phase|Withdrawal by Subject|1|||
48831473|NCT01235949|157223600|FG009|Booster Phase|Withdrawal by Subject|0|||
49157737|NCT05067335|158419248|FG003|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
49157738|NCT00557193|158419249|FG000|Induction|Adverse Event|2|||
49157739|NCT00557193|158419250|FG001|Induction|Adverse Event|0|||
49157740|NCT00557193|158419251|FG002|Induction|Adverse Event|0|||
49157741|NCT00557193|158419252|FG003|Induction|Adverse Event|0|||
49157742|NCT00557193|158419253|FG004|Induction|Adverse Event|0|||
49157743|NCT00557193|158419254|FG005|Induction|Adverse Event|0|||
49157744|NCT00557193|158419249|FG000|Induction|Death|6|||
49157745|NCT00557193|158419250|FG001|Induction|Death|0|||
49157746|NCT00557193|158419251|FG002|Induction|Death|0|||
48831474|NCT01235949|157223601|FG010|Booster Phase|Withdrawal by Subject|1|||
48831475|NCT01235949|157223602|FG011|Booster Phase|Withdrawal by Subject|1|||
48831476|NCT01235949|157223603|FG012|Booster Phase|Withdrawal by Subject|2|||
48831477|NCT01235949|157223604|FG013|Booster Phase|Withdrawal by Subject|0|||
48831478|NCT01235949|157223605|FG014|Booster Phase|Withdrawal by Subject|2|||
48831479|NCT01235949|157223606|FG015|Booster Phase|Withdrawal by Subject|0|||
48831480|NCT01235949|157223607|FG016|Booster Phase|Withdrawal by Subject|0|||
48831481|NCT01235949|157223608|FG017|Booster Phase|Withdrawal by Subject|0|||
48831482|NCT01235949|157223591|FG000|Booster Phase|Lost to Follow-up|0|||
48831483|NCT01235949|157223592|FG001|Booster Phase|Lost to Follow-up|0|||
48831484|NCT01235949|157223593|FG002|Booster Phase|Lost to Follow-up|0|||
48831485|NCT01235949|157223594|FG003|Booster Phase|Lost to Follow-up|0|||
48831486|NCT01235949|157223595|FG004|Booster Phase|Lost to Follow-up|0|||
49157747|NCT00557193|158419252|FG003|Induction|Death|0|||
48831487|NCT01235949|157223596|FG005|Booster Phase|Lost to Follow-up|0|||
48831488|NCT01235949|157223597|FG006|Booster Phase|Lost to Follow-up|0|||
48831489|NCT01235949|157223598|FG007|Booster Phase|Lost to Follow-up|0|||
48831490|NCT01235949|157223599|FG008|Booster Phase|Lost to Follow-up|1|||
48831491|NCT01235949|157223600|FG009|Booster Phase|Lost to Follow-up|1|||
48831492|NCT01235949|157223601|FG010|Booster Phase|Lost to Follow-up|1|||
48831493|NCT01235949|157223602|FG011|Booster Phase|Lost to Follow-up|1|||
48831494|NCT01235949|157223603|FG012|Booster Phase|Lost to Follow-up|0|||
48831495|NCT01235949|157223604|FG013|Booster Phase|Lost to Follow-up|0|||
48831496|NCT01235949|157223605|FG014|Booster Phase|Lost to Follow-up|0|||
48831497|NCT01235949|157223606|FG015|Booster Phase|Lost to Follow-up|0|||
48831498|NCT01235949|157223607|FG016|Booster Phase|Lost to Follow-up|0|||
48831499|NCT01235949|157223608|FG017|Booster Phase|Lost to Follow-up|1|||
48831500|NCT04173572|157223609|FG000|Overall Study|Withdrawal by Subject|1|||
48831501|NCT04173572|157223610|FG001|Overall Study|Withdrawal by Subject|5|||
48831502|NCT04173572|157223609|FG000|Overall Study|Lost to Follow-up|3|||
48831503|NCT04173572|157223610|FG001|Overall Study|Lost to Follow-up|1|||
48831504|NCT04059484|157223621|FG000|Overall Study|Adverse Event|2|||
48831505|NCT04059484|157223622|FG001|Overall Study|Adverse Event|5|||
48831506|NCT04059484|157223621|FG000|Overall Study|Withdrawal by Subject|5|||
48831507|NCT04059484|157223622|FG001|Overall Study|Withdrawal by Subject|3|||
48831508|NCT04059484|157223621|FG000|Overall Study|Progressive disease|112|||
48831509|NCT04059484|157223622|FG001|Overall Study|Progressive disease|112|||
48831510|NCT04059484|157223621|FG000|Overall Study|Other|8|||
48831511|NCT04059484|157223622|FG001|Overall Study|Other|3|||
48831512|NCT04059484|157223621|FG000|Overall Study|Ongoing|20|||
48831513|NCT04059484|157223622|FG001|Overall Study|Ongoing|20|||
48831514|NCT05949788|157223625|FG000|Overall Study|severe birth deformity|2|||
48831515|NCT05949788|157223626|FG001|Overall Study|severe birth deformity|7|||
48831516|NCT05949788|157223625|FG000|Overall Study|twin-twin transfusion syndrome|2|||
48831517|NCT05949788|157223626|FG001|Overall Study|twin-twin transfusion syndrome|7|||
48831518|NCT05949788|157223625|FG000|Overall Study|neonatal hemolytic disease|3|||
48831519|NCT05949788|157223626|FG001|Overall Study|neonatal hemolytic disease|8|||
48831520|NCT05949788|157223625|FG000|Overall Study|death within 14 days after birth|2|||
48831521|NCT05949788|157223626|FG001|Overall Study|death within 14 days after birth|6|||
48831522|NCT05949788|157223625|FG000|Overall Study|transfer to another hospital|2|||
48831523|NCT05949788|157223626|FG001|Overall Study|transfer to another hospital|6|||
48831524|NCT06181760|157223635|FG000|First Intervention (Fasted)|Withdrawal by Subject|0|||
48831525|NCT06181760|157223636|FG001|First Intervention (Fasted)|Withdrawal by Subject|0|||
48831526|NCT06181760|157223637|FG002|First Intervention (Fasted)|Withdrawal by Subject|0|||
48831527|NCT06181760|157223638|FG003|First Intervention (Fasted)|Withdrawal by Subject|1|||
48831528|NCT05125679|157223645|FG000|Overall Study|Study Terminated by Sponsor|2|||
48831529|NCT05125679|157223646|FG001|Overall Study|Study Terminated by Sponsor|5|||
48831530|NCT03483038|157223647|FG000|Overall Study|Subjects still in follow-up|18|||
48831531|NCT01155869|157223648|FG000|Overall Study|Lost to Follow-up|3|||
48831532|NCT01155869|157223649|FG001|Overall Study|Lost to Follow-up|1|||
48831533|NCT04678830|157223652|FG000|Overall Study|Lack of Efficacy|2|||
48831534|NCT04678830|157223653|FG001|Overall Study|Lack of Efficacy|0|||
48831535|NCT04678830|157223652|FG000|Overall Study|Withdrawal by Subject|0|||
48831536|NCT04678830|157223653|FG001|Overall Study|Withdrawal by Subject|1|||
48831537|NCT00324038|157223658|FG000|Overall Study|Adverse Event|38|||
49157748|NCT00557193|158419253|FG004|Induction|Death|0|||
49157749|NCT00557193|158419254|FG005|Induction|Death|0|||
49157750|NCT00557193|158419249|FG000|Induction|Physician Decision|3|||
49157751|NCT00557193|158419250|FG001|Induction|Physician Decision|0|||
48831538|NCT00324038|157223659|FG001|Overall Study|Adverse Event|23|||
48831539|NCT00324038|157223658|FG000|Overall Study|Lack of Efficacy|5|||
48831540|NCT00324038|157223659|FG001|Overall Study|Lack of Efficacy|13|||
49157752|NCT00557193|158419251|FG002|Induction|Physician Decision|0|||
49157753|NCT00557193|158419252|FG003|Induction|Physician Decision|0|||
49157754|NCT00557193|158419253|FG004|Induction|Physician Decision|0|||
49157755|NCT00557193|158419254|FG005|Induction|Physician Decision|0|||
48831541|NCT00324038|157223658|FG000|Overall Study|Lost to Follow-up|0|||
48831542|NCT00324038|157223659|FG001|Overall Study|Lost to Follow-up|2|||
48831543|NCT00324038|157223658|FG000|Overall Study|Other|6|||
48831544|NCT00324038|157223659|FG001|Overall Study|Other|13|||
48831545|NCT00038103|157223662|FG000|Overall Study|Adverse Event|5|||
48831546|NCT00038103|157223663|FG001|Overall Study|Adverse Event|6|||
48831547|NCT00038103|157223662|FG000|Overall Study|Lack of Efficacy|48|||
48831548|NCT00038103|157223663|FG001|Overall Study|Lack of Efficacy|41|||
48831549|NCT00038103|157223662|FG000|Overall Study|Withdrawal by Subject|0|||
48831550|NCT00038103|157223663|FG001|Overall Study|Withdrawal by Subject|3|||
48831551|NCT00038103|157223662|FG000|Overall Study|Lost to Follow-up|0|||
48831552|NCT00038103|157223663|FG001|Overall Study|Lost to Follow-up|3|||
48831553|NCT00038103|157223662|FG000|Overall Study|Protocol Violation|0|||
48831554|NCT00038103|157223663|FG001|Overall Study|Protocol Violation|2|||
48831555|NCT00038103|157223662|FG000|Overall Study|Sponsor Decision|0|||
48831556|NCT00038103|157223663|FG001|Overall Study|Sponsor Decision|1|||
48831557|NCT00038103|157223662|FG000|Overall Study|Randomized/never treated|2|||
48831558|NCT00038103|157223663|FG001|Overall Study|Randomized/never treated|0|||
48831559|NCT01080131|157223666|FG000|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
48831560|NCT01080131|157223667|FG001|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
48831561|NCT01080131|157223666|FG000|Core Study (0- 12 Weeks)|Patient withdrew consent|6|||
48831562|NCT01080131|157223667|FG001|Core Study (0- 12 Weeks)|Patient withdrew consent|4|||
48831563|NCT01080131|157223666|FG000|Core Study (0- 12 Weeks)|Lost to Follow-up|5|||
48831564|NCT01080131|157223667|FG001|Core Study (0- 12 Weeks)|Lost to Follow-up|3|||
48831565|NCT01080131|157223666|FG000|Core Study (0- 12 Weeks)|Administrative problems|0|||
48831566|NCT01080131|157223667|FG001|Core Study (0- 12 Weeks)|Administrative problems|1|||
48831567|NCT01080131|157223666|FG000|Core Study (0- 12 Weeks)|Death|1|||
48831568|NCT01080131|157223667|FG001|Core Study (0- 12 Weeks)|Death|0|||
48831569|NCT01080131|157223666|FG000|Core Study (0- 12 Weeks)|Protocol deviation|0|||
48831570|NCT01080131|157223667|FG001|Core Study (0- 12 Weeks)|Protocol deviation|2|||
48831571|NCT01080131|157223666|FG000|Extension Study 1 (12 -24 Weeks)|Adverse Event|1|||
48831572|NCT01080131|157223667|FG001|Extension Study 1 (12 -24 Weeks)|Adverse Event|0|||
48831573|NCT01080131|157223666|FG000|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0|||
48831574|NCT01080131|157223667|FG001|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1|||
48831575|NCT01080131|157223666|FG000|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4|||
48831576|NCT01080131|157223667|FG001|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3|||
48831577|NCT01080131|157223666|FG000|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1|||
48831578|NCT01080131|157223667|FG001|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0|||
48831579|NCT01080131|157223666|FG000|Extension Study 2 (25-72 Weeks)|Adverse Event|1|||
48831580|NCT01080131|157223667|FG001|Extension Study 2 (25-72 Weeks)|Adverse Event|2|||
48831581|NCT01080131|157223666|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3|||
48831582|NCT01080131|157223667|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4|||
48831583|NCT01080131|157223666|FG000|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4|||
48831584|NCT01080131|157223667|FG001|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5|||
48831585|NCT00387465|157223668|FG000|Overall Study|Withdrawal by Subject|0|||
48831586|NCT00387465|157223669|FG001|Overall Study|Withdrawal by Subject|1|||
48831587|NCT00387465|157223670|FG002|Overall Study|Withdrawal by Subject|0|||
48831588|NCT03545984|157223671|FG000|Overall Study|CSF cases not present during rotation|11|||
48831589|NCT03545984|157223672|FG001|Overall Study|CSF cases not present during rotation|9|||
48831590|NCT03768206|157223674|FG000|Overall Study|Lost to Follow-up|2|||
48831591|NCT03768206|157223675|FG001|Overall Study|Lost to Follow-up|1|||
48831592|NCT03768206|157223674|FG000|Overall Study|Withdrawal by Subject|0|||
48831593|NCT03768206|157223675|FG001|Overall Study|Withdrawal by Subject|1|||
48831594|NCT01390402|157223676|FG000|Overall Study|Death|1|||
48831595|NCT01390402|157223676|FG000|Overall Study|Disease Progression|4|||
48831596|NCT03121950|157223677|FG000|Overall Study|Withdrawal by Subject|11|||
48831597|NCT03121950|157223678|FG001|Overall Study|Withdrawal by Subject|2|||
48831598|NCT04167553|157223681|FG000|Overall Study|Withdrawal by Subject|1|||
48831599|NCT04167553|157223682|FG001|Overall Study|Withdrawal by Subject|0|||
48831600|NCT04167553|157223683|FG002|Overall Study|Withdrawal by Subject|1|||
48831601|NCT04167553|157223684|FG003|Overall Study|Withdrawal by Subject|2|||
48831602|NCT04167553|157223685|FG004|Overall Study|Withdrawal by Subject|1|||
48831603|NCT04167553|157223686|FG005|Overall Study|Withdrawal by Subject|0|||
48831604|NCT04167553|157223687|FG006|Overall Study|Withdrawal by Subject|0|||
48831605|NCT04167553|157223681|FG000|Overall Study|Physician Decision|0|||
49157756|NCT00557193|158419249|FG000|Induction|Withdrawal by Subject|1|||
49157757|NCT00557193|158419250|FG001|Induction|Withdrawal by Subject|0|||
49157758|NCT00557193|158419251|FG002|Induction|Withdrawal by Subject|0|||
48831606|NCT04167553|157223682|FG001|Overall Study|Physician Decision|0|||
48831607|NCT04167553|157223683|FG002|Overall Study|Physician Decision|0|||
48831608|NCT04167553|157223684|FG003|Overall Study|Physician Decision|0|||
48831609|NCT04167553|157223685|FG004|Overall Study|Physician Decision|2|||
48831610|NCT04167553|157223686|FG005|Overall Study|Physician Decision|2|||
48831611|NCT04167553|157223687|FG006|Overall Study|Physician Decision|0|||
48831612|NCT04167553|157223681|FG000|Overall Study|Lost to Follow-up|0|||
48831613|NCT04167553|157223682|FG001|Overall Study|Lost to Follow-up|0|||
48831614|NCT04167553|157223683|FG002|Overall Study|Lost to Follow-up|2|||
48831615|NCT04167553|157223684|FG003|Overall Study|Lost to Follow-up|0|||
48831616|NCT04167553|157223685|FG004|Overall Study|Lost to Follow-up|0|||
48831617|NCT04167553|157223686|FG005|Overall Study|Lost to Follow-up|0|||
48831618|NCT04167553|157223687|FG006|Overall Study|Lost to Follow-up|0|||
48831619|NCT02685033|157223688|FG000|Overall Study|Withdrawal of Consent|0|||
48831620|NCT02685033|157223689|FG001|Overall Study|Withdrawal of Consent|1|||
48831621|NCT02685033|157223688|FG000|Overall Study|Lost to Follow-up|2|||
48831622|NCT02685033|157223689|FG001|Overall Study|Lost to Follow-up|1|||
48831623|NCT02685033|157223688|FG000|Overall Study|Adverse Event|1|||
48831624|NCT02685033|157223689|FG001|Overall Study|Adverse Event|0|||
48831625|NCT01212757|157223692|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
48831626|NCT01212757|157223693|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
48831627|NCT01212757|157223694|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
48831628|NCT01212757|157223695|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
48831629|NCT01212757|157223696|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
48831630|NCT01212757|157223697|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
48831631|NCT01212757|157223698|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
48831632|NCT01212757|157223699|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
48831633|NCT01212757|157223700|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
48831634|NCT01212757|157223692|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
48831635|NCT01212757|157223693|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
48831636|NCT01212757|157223694|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
48831637|NCT01212757|157223695|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
48831638|NCT01212757|157223696|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
48831639|NCT01212757|157223697|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
48831640|NCT01212757|157223698|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
48831641|NCT01212757|157223699|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
48831642|NCT01212757|157223700|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
48831643|NCT01212757|157223692|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7|||
48831644|NCT01212757|157223693|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9|||
48831645|NCT01212757|157223694|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
48831646|NCT01212757|157223695|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
48831647|NCT01212757|157223696|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
48831648|NCT01212757|157223697|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
48831649|NCT01212757|157223698|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
49157759|NCT00557193|158419252|FG003|Induction|Withdrawal by Subject|0|||
49157760|NCT00557193|158419253|FG004|Induction|Withdrawal by Subject|0|||
49157761|NCT00557193|158419254|FG005|Induction|Withdrawal by Subject|0|||
48831650|NCT01212757|157223699|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
48831651|NCT01212757|157223700|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
48831652|NCT01212757|157223692|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3|||
48831653|NCT01212757|157223693|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
48831654|NCT01212757|157223694|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
48831655|NCT01212757|157223695|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
48831656|NCT01212757|157223696|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
49157762|NCT00557193|158419249|FG000|Induction|Refusal of Further Protocol Therapy|2|||
49157763|NCT00557193|158419250|FG001|Induction|Refusal of Further Protocol Therapy|0|||
49157764|NCT00557193|158419251|FG002|Induction|Refusal of Further Protocol Therapy|0|||
49157765|NCT00557193|158419252|FG003|Induction|Refusal of Further Protocol Therapy|0|||
49157766|NCT00557193|158419253|FG004|Induction|Refusal of Further Protocol Therapy|0|||
49157767|NCT00557193|158419254|FG005|Induction|Refusal of Further Protocol Therapy|0|||
48831657|NCT01212757|157223697|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
48831658|NCT01212757|157223698|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
48831659|NCT01212757|157223699|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
48831660|NCT01212757|157223700|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
49157768|NCT00557193|158419249|FG000|Induction|Ineligible|8|||
49157769|NCT00557193|158419250|FG001|Induction|Ineligible|0|||
49157770|NCT00557193|158419251|FG002|Induction|Ineligible|0|||
49157771|NCT00557193|158419252|FG003|Induction|Ineligible|0|||
49157772|NCT00557193|158419253|FG004|Induction|Ineligible|0|||
49157773|NCT00557193|158419254|FG005|Induction|Ineligible|0|||
49157774|NCT00557193|158419249|FG000|Induction|Inevaluable for post Induction|2|||
49157775|NCT00557193|158419250|FG001|Induction|Inevaluable for post Induction|0|||
48831661|NCT01212757|157223692|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
48831662|NCT01212757|157223693|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
48831663|NCT01212757|157223694|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
49157776|NCT00557193|158419251|FG002|Induction|Inevaluable for post Induction|0|||
49157777|NCT00557193|158419252|FG003|Induction|Inevaluable for post Induction|0|||
49157778|NCT00557193|158419253|FG004|Induction|Inevaluable for post Induction|0|||
49157779|NCT00557193|158419254|FG005|Induction|Inevaluable for post Induction|0|||
49157780|NCT00557193|158419249|FG000|Induction|Unable to receive Lestaurtinib-Not in US|2|||
48831664|NCT01212757|157223695|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
49157781|NCT00557193|158419250|FG001|Induction|Unable to receive Lestaurtinib-Not in US|0|||
49157782|NCT00557193|158419251|FG002|Induction|Unable to receive Lestaurtinib-Not in US|0|||
49157783|NCT00557193|158419252|FG003|Induction|Unable to receive Lestaurtinib-Not in US|0|||
49157784|NCT00557193|158419253|FG004|Induction|Unable to receive Lestaurtinib-Not in US|0|||
49157785|NCT00557193|158419254|FG005|Induction|Unable to receive Lestaurtinib-Not in US|0|||
49157786|NCT00557193|158419249|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
49157787|NCT00557193|158419250|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
49157788|NCT00557193|158419251|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
49157789|NCT00557193|158419252|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
49157790|NCT00557193|158419253|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
49157791|NCT00557193|158419254|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|3|||
49157792|NCT00557193|158419249|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
49157793|NCT00557193|158419250|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
49157794|NCT00557193|158419251|FG002|Post Induction Therapy by Tx Assignment|Death|2|||
48831665|NCT01212757|157223696|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
48831666|NCT01212757|157223697|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
48831667|NCT01212757|157223698|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
48831668|NCT01212757|157223699|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
48831669|NCT01212757|157223700|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
48831670|NCT01212757|157223692|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
48831671|NCT01212757|157223693|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
48831672|NCT01212757|157223694|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
48831673|NCT01212757|157223695|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
48831674|NCT01212757|157223696|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
48831675|NCT01212757|157223697|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
48831676|NCT01212757|157223698|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
48831677|NCT01212757|157223699|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
48831678|NCT01212757|157223700|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
48831679|NCT01212757|157223692|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
48831680|NCT01212757|157223693|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
48831681|NCT01212757|157223694|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
48831682|NCT01212757|157223695|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
48831683|NCT01212757|157223696|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
48831684|NCT01212757|157223697|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
48831685|NCT01212757|157223698|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
48831686|NCT01212757|157223699|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
48831687|NCT01212757|157223700|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
48831688|NCT01212757|157223692|FG000|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
48831689|NCT01212757|157223693|FG001|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
48831690|NCT01212757|157223694|FG002|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3|||
48831691|NCT01212757|157223695|FG003|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1|||
48831692|NCT01212757|157223696|FG004|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
48831693|NCT01212757|157223697|FG005|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
48831694|NCT01212757|157223698|FG006|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
48831695|NCT01212757|157223699|FG007|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
48831696|NCT01212757|157223700|FG008|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
48831697|NCT01212757|157223692|FG000|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
48831698|NCT01212757|157223693|FG001|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5|||
48831699|NCT01212757|157223694|FG002|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7|||
48831700|NCT01212757|157223695|FG003|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4|||
48831701|NCT01212757|157223696|FG004|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
48831702|NCT01212757|157223697|FG005|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2|||
48831703|NCT01212757|157223698|FG006|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
48831704|NCT01212757|157223699|FG007|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
49157795|NCT00557193|158419252|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
49157796|NCT00557193|158419253|FG004|Post Induction Therapy by Tx Assignment|Death|2|||
49157797|NCT00557193|158419254|FG005|Post Induction Therapy by Tx Assignment|Death|2|||
49157798|NCT00557193|158419249|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
49157799|NCT00557193|158419250|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|3|||
49157800|NCT00557193|158419251|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|5|||
49157801|NCT00557193|158419252|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|1|||
49157802|NCT00557193|158419253|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
49157803|NCT00557193|158419254|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
49157804|NCT00557193|158419249|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
49157805|NCT00557193|158419250|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1|||
49157806|NCT00557193|158419251|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
49157807|NCT00557193|158419252|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
49157808|NCT00557193|158419253|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
49157809|NCT00557193|158419254|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5|||
49157810|NCT00557193|158419249|FG000|Post Induction Therapy by Tx Assignment|Relapse|0|||
49157811|NCT00557193|158419250|FG001|Post Induction Therapy by Tx Assignment|Relapse|5|||
48922779|NCT01908101|157551444|FG000|Overall Study|Incorrect Diagnosis|2|||
48922780|NCT01908101|157551444|FG000|Overall Study|Incorrect Starting Dose|1|||
49157812|NCT00557193|158419251|FG002|Post Induction Therapy by Tx Assignment|Relapse|16|||
49157813|NCT00557193|158419252|FG003|Post Induction Therapy by Tx Assignment|Relapse|3|||
49157814|NCT00557193|158419253|FG004|Post Induction Therapy by Tx Assignment|Relapse|1|||
49157815|NCT00557193|158419254|FG005|Post Induction Therapy by Tx Assignment|Relapse|20|||
49157816|NCT00557193|158419249|FG000|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
49157817|NCT00557193|158419250|FG001|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
49157818|NCT00557193|158419251|FG002|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1|||
48831705|NCT01212757|157223700|FG008|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
48831706|NCT01212757|157223692|FG000|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
48831707|NCT01212757|157223693|FG001|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
48831708|NCT01212757|157223694|FG002|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2|||
48831709|NCT01212757|157223695|FG003|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
48831710|NCT01212757|157223696|FG004|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
48831711|NCT01212757|157223697|FG005|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
48831712|NCT01212757|157223698|FG006|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
48831713|NCT01212757|157223699|FG007|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
48831714|NCT01212757|157223700|FG008|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
48831715|NCT01212757|157223692|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
48831716|NCT01212757|157223693|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
48831717|NCT01212757|157223694|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7|||
48831718|NCT01212757|157223695|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
48831719|NCT01212757|157223696|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1|||
48831720|NCT01212757|157223697|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
48831721|NCT01212757|157223698|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
48831722|NCT01212757|157223699|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
48831723|NCT01212757|157223700|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
48831724|NCT01212757|157223692|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
48922781|NCT01908101|157551444|FG000|Overall Study|Did not complete the first cycle|4|||
49157819|NCT00557193|158419252|FG003|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
49157820|NCT00557193|158419253|FG004|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
49157821|NCT00557193|158419254|FG005|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
49157822|NCT00557193|158419249|FG000|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
49157823|NCT00557193|158419250|FG001|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
49157824|NCT00557193|158419251|FG002|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2|||
49157825|NCT00557193|158419252|FG003|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
49157826|NCT00557193|158419253|FG004|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
49157827|NCT00557193|158419254|FG005|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
49157828|NCT00557193|158419249|FG000|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
49157829|NCT00557193|158419250|FG001|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
49157830|NCT00557193|158419251|FG002|Post Induction Therapy by Tx Assignment|Induction Failure|4|||
49157831|NCT00557193|158419252|FG003|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
49157832|NCT00557193|158419253|FG004|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
49157833|NCT00557193|158419254|FG005|Post Induction Therapy by Tx Assignment|Induction Failure|5|||
48692903|NCT03137992|156724648|FG002|Washout Period 1|Principal Investigator Discretion|0|||
49157834|NCT00320606|158419255|FG000|Overall Study|Adverse Event|1|||
49157835|NCT00320606|158419255|FG000|Overall Study|Protocol Violation|1|||
48922782|NCT01394939|157551447|FG000|Overall Study|Adverse Event|1|||
48922783|NCT01394939|157551448|FG001|Overall Study|Adverse Event|3|||
48922784|NCT01394939|157551449|FG002|Overall Study|Adverse Event|0|||
48922785|NCT01394939|157551450|FG003|Overall Study|Adverse Event|2|||
48922786|NCT01394939|157551447|FG000|Overall Study|Death|0|||
49157836|NCT00320606|158419255|FG000|Overall Study|Withdrawal by Subject|1|||
49157837|NCT03984825|158419256|FG000|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2|||
49157838|NCT03984825|158419256|FG000|Treatment Period 2 (Day 11 to 21)|Physician Decision|1|||
49157839|NCT03984825|158419256|FG000|Treatment Period 2 (Day 11 to 21)|Adverse Event|3|||
49157840|NCT01602484|158419257|FG000|Overall Study|Airway issues unrelated to study|0|||
49157841|NCT01602484|158419258|FG001|Overall Study|Airway issues unrelated to study|1|||
49157842|NCT00419744|158419259|FG000|Overall Study|Adverse Event|39|||
49157843|NCT00419744|158419260|FG001|Overall Study|Adverse Event|40|||
49157844|NCT00419744|158419261|FG002|Overall Study|Adverse Event|50|||
48831725|NCT01212757|157223693|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
48831726|NCT01212757|157223694|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
49157845|NCT00419744|158419259|FG000|Overall Study|Withdrawal by Subject|45|||
49157846|NCT00419744|158419260|FG001|Overall Study|Withdrawal by Subject|49|||
49157847|NCT00419744|158419261|FG002|Overall Study|Withdrawal by Subject|52|||
49157848|NCT00419744|158419259|FG000|Overall Study|Lost to Follow-up|8|||
49157849|NCT00419744|158419260|FG001|Overall Study|Lost to Follow-up|10|||
49157850|NCT00419744|158419261|FG002|Overall Study|Lost to Follow-up|6|||
49157851|NCT00419744|158419259|FG000|Overall Study|Protocol Violation|4|||
48831727|NCT01212757|157223695|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
48831728|NCT01212757|157223696|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
48831729|NCT01212757|157223697|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
48831730|NCT01212757|157223698|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
48831731|NCT01212757|157223699|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
48831732|NCT01212757|157223700|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
49157852|NCT00419744|158419260|FG001|Overall Study|Protocol Violation|7|||
49157853|NCT00419744|158419261|FG002|Overall Study|Protocol Violation|8|||
49157854|NCT00419744|158419259|FG000|Overall Study|Randomized in error|9|||
49157855|NCT00419744|158419260|FG001|Overall Study|Randomized in error|6|||
49157856|NCT00419744|158419261|FG002|Overall Study|Randomized in error|7|||
49157857|NCT00419744|158419259|FG000|Overall Study|Moving out of state|2|||
49157858|NCT00419744|158419260|FG001|Overall Study|Moving out of state|0|||
49157859|NCT00419744|158419261|FG002|Overall Study|Moving out of state|1|||
49157860|NCT00419744|158419259|FG000|Overall Study|Physician Decision|10|||
49157861|NCT00419744|158419260|FG001|Overall Study|Physician Decision|5|||
49157862|NCT00419744|158419261|FG002|Overall Study|Physician Decision|6|||
49157863|NCT00419744|158419259|FG000|Overall Study|Spirometry mouthpiece issues|0|||
49157864|NCT00419744|158419260|FG001|Overall Study|Spirometry mouthpiece issues|1|||
49157865|NCT00419744|158419261|FG002|Overall Study|Spirometry mouthpiece issues|2|||
49157866|NCT00419744|158419259|FG000|Overall Study|Incorrect medication kit dispensed|0|||
49157867|NCT00419744|158419260|FG001|Overall Study|Incorrect medication kit dispensed|0|||
49157868|NCT00419744|158419261|FG002|Overall Study|Incorrect medication kit dispensed|1|||
49157869|NCT02095106|158419262|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
49157870|NCT02095106|158419263|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
49157871|NCT03894891|158419270|FG000|Overall Study|Withdrawal by Subject|1|||
49157872|NCT03894891|158419270|FG000|Overall Study|Completed protocol treatment per protocol|5|||
49157873|NCT00862940|158419271|FG000|Overall Study|Adverse Event|15|||
49157874|NCT00862940|158419272|FG001|Overall Study|Adverse Event|12|||
49157875|NCT00862940|158419271|FG000|Overall Study|Lack of Efficacy|1|||
49157876|NCT00862940|158419272|FG001|Overall Study|Lack of Efficacy|3|||
48831733|NCT01212757|157223692|FG000|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
49157877|NCT00862940|158419271|FG000|Overall Study|Protocol Violation|2|||
48831734|NCT01212757|157223693|FG001|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
48831735|NCT01212757|157223694|FG002|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
48831736|NCT01212757|157223695|FG003|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
48922787|NCT01394939|157551448|FG001|Overall Study|Death|2|||
48922788|NCT01394939|157551449|FG002|Overall Study|Death|0|||
49157878|NCT00862940|158419272|FG001|Overall Study|Protocol Violation|5|||
49157879|NCT00862940|158419271|FG000|Overall Study|Withdrawal by Subject|4|||
49157880|NCT00862940|158419272|FG001|Overall Study|Withdrawal by Subject|6|||
49157881|NCT00862940|158419271|FG000|Overall Study|Non-compliance|4|||
49157882|NCT00862940|158419272|FG001|Overall Study|Non-compliance|0|||
49157883|NCT00862940|158419271|FG000|Overall Study|Lost to Follow-up|0|||
49157884|NCT00862940|158419272|FG001|Overall Study|Lost to Follow-up|1|||
48831737|NCT01212757|157223696|FG004|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
49157885|NCT00862940|158419271|FG000|Overall Study|Administrative or other reason(s)|4|||
49157886|NCT00862940|158419272|FG001|Overall Study|Administrative or other reason(s)|3|||
48831738|NCT01212757|157223697|FG005|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
48831739|NCT01212757|157223698|FG006|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
48831740|NCT01212757|157223699|FG007|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
48831741|NCT01212757|157223700|FG008|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
48831742|NCT01212757|157223692|FG000|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
48831743|NCT01212757|157223693|FG001|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
48831744|NCT01212757|157223694|FG002|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
48831745|NCT01212757|157223695|FG003|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
48831746|NCT01212757|157223696|FG004|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
48831747|NCT01212757|157223697|FG005|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
48831748|NCT01212757|157223698|FG006|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
48831749|NCT01212757|157223699|FG007|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
48831750|NCT01212757|157223700|FG008|Long-Term Safety Phase (Year 2)|Miscellaneous|1|||
48831751|NCT01212757|157223692|FG000|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
48831752|NCT01212757|157223693|FG001|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
48831753|NCT01212757|157223694|FG002|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
48831754|NCT01212757|157223695|FG003|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
48831755|NCT01212757|157223696|FG004|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
48831756|NCT01212757|157223697|FG005|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
48831757|NCT01212757|157223698|FG006|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
48831758|NCT01212757|157223699|FG007|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
49157887|NCT01677988|158419279|FG000|Overall Study|Lack of Efficacy|2|||
49157888|NCT02629861|158419280|FG000|Overall Study|Adverse Event|7|||
49157889|NCT02629861|158419281|FG001|Overall Study|Adverse Event|5|||
49157890|NCT02629861|158419282|FG002|Overall Study|Adverse Event|4|||
49157891|NCT02629861|158419280|FG000|Overall Study|Withdrawal by Subject|5|||
49157892|NCT02629861|158419281|FG001|Overall Study|Withdrawal by Subject|8|||
49157893|NCT02629861|158419282|FG002|Overall Study|Withdrawal by Subject|13|||
49157894|NCT02629861|158419280|FG000|Overall Study|Protocol Violation|2|||
49157895|NCT02629861|158419281|FG001|Overall Study|Protocol Violation|3|||
49157896|NCT02629861|158419282|FG002|Overall Study|Protocol Violation|7|||
49157897|NCT02629861|158419280|FG000|Overall Study|Lost to Follow-up|12|||
49157898|NCT02629861|158419281|FG001|Overall Study|Lost to Follow-up|9|||
49157899|NCT02629861|158419282|FG002|Overall Study|Lost to Follow-up|4|||
49157900|NCT02629861|158419280|FG000|Overall Study|Other|1|||
49157901|NCT02629861|158419281|FG001|Overall Study|Other|1|||
49157902|NCT02629861|158419282|FG002|Overall Study|Other|0|||
49157903|NCT02629861|158419280|FG000|Overall Study|Pregnancy|2|||
49157904|NCT02629861|158419281|FG001|Overall Study|Pregnancy|1|||
49157905|NCT02629861|158419282|FG002|Overall Study|Pregnancy|0|||
49157906|NCT03366337|158419283|FG000|Overall Study|Lost to Follow-up|1|||
49157907|NCT03366337|158419284|FG001|Overall Study|Lost to Follow-up|0|||
49157908|NCT03366337|158419285|FG002|Overall Study|Lost to Follow-up|1|||
49157909|NCT03366337|158419286|FG003|Overall Study|Lost to Follow-up|0|||
49157910|NCT03366337|158419283|FG000|Overall Study|Withdrawal by Subject|2|||
49157911|NCT03366337|158419284|FG001|Overall Study|Withdrawal by Subject|0|||
49157912|NCT03366337|158419285|FG002|Overall Study|Withdrawal by Subject|1|||
49157913|NCT03366337|158419286|FG003|Overall Study|Withdrawal by Subject|1|||
48831759|NCT01212757|157223700|FG008|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
49157914|NCT02709161|158419293|FG000|Overall Study|Withdrawal by Subject|1|||
49157915|NCT02709161|158419294|FG001|Overall Study|Withdrawal by Subject|0|||
49157916|NCT04089865|158419297|FG000|Overall Study|Withdrawal by Subject|2|||
49157917|NCT04089865|158419298|FG001|Overall Study|Withdrawal by Subject|2|||
49157918|NCT04089865|158419299|FG002|Overall Study|Withdrawal by Subject|7|||
49157919|NCT04089865|158419300|FG003|Overall Study|Withdrawal by Subject|2|||
49157920|NCT01729039|158419303|FG000|Overall Study|disqualified|2|||
49157921|NCT01729039|158419304|FG001|Overall Study|disqualified|5|||
49157922|NCT01729039|158419303|FG000|Overall Study|Withdrawal by Subject|8|||
49157923|NCT01729039|158419304|FG001|Overall Study|Withdrawal by Subject|7|||
49157924|NCT04570384|158419307|FG000|Overall Study|Adverse Event|2|||
49157925|NCT04570384|158419308|FG001|Overall Study|Adverse Event|1|||
49157926|NCT04570384|158419307|FG000|Overall Study|Death|2|||
49157927|NCT04570384|158419308|FG001|Overall Study|Death|5|||
49157928|NCT04570384|158419307|FG000|Overall Study|Lost to Follow-up|1|||
49157929|NCT04570384|158419308|FG001|Overall Study|Lost to Follow-up|0|||
49157930|NCT04570384|158419307|FG000|Overall Study|Other|1|||
49157931|NCT04570384|158419308|FG001|Overall Study|Other|0|||
49157932|NCT04570384|158419307|FG000|Overall Study|Protocol Violation|0|||
49157933|NCT04570384|158419308|FG001|Overall Study|Protocol Violation|1|||
49157934|NCT04570384|158419307|FG000|Overall Study|Sponsor Decision|1|||
49157935|NCT04570384|158419308|FG001|Overall Study|Sponsor Decision|0|||
49157936|NCT04570384|158419307|FG000|Overall Study|Withdrawal by Subject|4|||
49157937|NCT04570384|158419308|FG001|Overall Study|Withdrawal by Subject|2|||
49157938|NCT01673126|158419309|FG000|Overall Study|change of diagnosis|4|||
49157939|NCT01673126|158419310|FG001|Overall Study|change of diagnosis|3|||
49157940|NCT01404234|158419311|FG000|Overall Study|Withdrawal by Subject|2|||
49157941|NCT00698841|158419312|FG000|Overall Study|Withdrawal by Subject|2|||
49157942|NCT00698841|158419312|FG000|Overall Study|Adverse Event|3|||
49157943|NCT00698841|158419312|FG000|Overall Study|Disease progression|7|||
49157944|NCT00698841|158419312|FG000|Overall Study|Failure to meet eligibility criteria|2|||
49157945|NCT00698841|158419312|FG000|Overall Study|Study drug toxicity|2|||
49157946|NCT00698841|158419312|FG000|Overall Study|Other|2|||
49157947|NCT01280968|158419313|FG000|Overall Study|Lost to Follow-up|8|||
49157948|NCT01280968|158419314|FG001|Overall Study|Lost to Follow-up|2|||
49157949|NCT01280968|158419313|FG000|Overall Study|Unable to Follow Experimental Protocol|2|||
49157950|NCT01280968|158419314|FG001|Overall Study|Unable to Follow Experimental Protocol|0|||
49157951|NCT01280968|158419313|FG000|Overall Study|Commuting Problems|2|||
49157952|NCT01280968|158419314|FG001|Overall Study|Commuting Problems|0|||
49157953|NCT01280968|158419313|FG000|Overall Study|Anxiety|2|||
49157954|NCT01280968|158419314|FG001|Overall Study|Anxiety|0|||
49157955|NCT01280968|158419313|FG000|Overall Study|Adverse Event|1|||
49157956|NCT01280968|158419314|FG001|Overall Study|Adverse Event|0|||
49157957|NCT01280968|158419313|FG000|Overall Study|Scheduling Conflicts|1|||
49157958|NCT01280968|158419314|FG001|Overall Study|Scheduling Conflicts|1|||
49157959|NCT01280968|158419313|FG000|Overall Study|Pre-existing Neurological Condition|1|||
49157960|NCT01280968|158419314|FG001|Overall Study|Pre-existing Neurological Condition|0|||
49157961|NCT01280968|158419313|FG000|Overall Study|Unable to Smoke in Supine Position|1|||
49157962|NCT01280968|158419314|FG001|Overall Study|Unable to Smoke in Supine Position|0|||
49157963|NCT05870865|158419318|FG000|Randomized|Did not receive study treatment|2|||
49157964|NCT05870865|158419319|FG001|Randomized|Did not receive study treatment|4|||
49157965|NCT05870865|158419320|FG002|Randomized|Did not receive study treatment|4|||
49157966|NCT05870865|158419321|FG003|Randomized|Did not receive study treatment|3|||
49157967|NCT05870865|158419318|FG000|Treatment Period|Adverse Event|1|||
49157968|NCT05870865|158419319|FG001|Treatment Period|Adverse Event|1|||
49157969|NCT05870865|158419320|FG002|Treatment Period|Adverse Event|1|||
49157970|NCT05870865|158419321|FG003|Treatment Period|Adverse Event|1|||
49157971|NCT05870865|158419318|FG000|Treatment Period|Lost to Follow-up|0|||
48831760|NCT01212757|157223692|FG000|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
48831761|NCT01212757|157223693|FG001|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
48831762|NCT01212757|157223694|FG002|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2|||
48831763|NCT01212757|157223695|FG003|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
48831764|NCT01212757|157223696|FG004|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
48831765|NCT01212757|157223697|FG005|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
48831766|NCT01212757|157223698|FG006|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
48831767|NCT01212757|157223699|FG007|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
48831768|NCT01212757|157223700|FG008|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
48831769|NCT01212757|157223692|FG000|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
48831770|NCT01212757|157223693|FG001|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7|||
48831771|NCT01212757|157223694|FG002|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9|||
48831772|NCT01212757|157223695|FG003|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
48831773|NCT01212757|157223696|FG004|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
48831774|NCT01212757|157223697|FG005|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
48831775|NCT01212757|157223698|FG006|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
48831776|NCT01212757|157223699|FG007|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4|||
48831777|NCT01212757|157223700|FG008|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6|||
48831778|NCT01212757|157223692|FG000|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
48831779|NCT01212757|157223693|FG001|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
48831780|NCT01212757|157223694|FG002|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2|||
48831781|NCT01212757|157223695|FG003|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
48831782|NCT01212757|157223696|FG004|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
48831783|NCT01212757|157223697|FG005|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
48831784|NCT01212757|157223698|FG006|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
48831785|NCT01212757|157223699|FG007|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
48922789|NCT01394939|157551450|FG003|Overall Study|Death|0|||
48922790|NCT01394939|157551447|FG000|Overall Study|Physician Decision|0|||
48922791|NCT01394939|157551448|FG001|Overall Study|Physician Decision|1|||
48922792|NCT01394939|157551449|FG002|Overall Study|Physician Decision|0|||
49157972|NCT05870865|158419319|FG001|Treatment Period|Lost to Follow-up|1|||
49157973|NCT05870865|158419320|FG002|Treatment Period|Lost to Follow-up|2|||
49157974|NCT05870865|158419321|FG003|Treatment Period|Lost to Follow-up|0|||
49157975|NCT05870865|158419318|FG000|Treatment Period|Protocol Violation|0|||
49157976|NCT05870865|158419319|FG001|Treatment Period|Protocol Violation|0|||
49157977|NCT05870865|158419320|FG002|Treatment Period|Protocol Violation|0|||
49157978|NCT05870865|158419321|FG003|Treatment Period|Protocol Violation|1|||
49157979|NCT05870865|158419318|FG000|Treatment Period|Withdrawal by Subject|0|||
49157980|NCT05870865|158419319|FG001|Treatment Period|Withdrawal by Subject|1|||
49157981|NCT05870865|158419320|FG002|Treatment Period|Withdrawal by Subject|1|||
49157982|NCT05870865|158419321|FG003|Treatment Period|Withdrawal by Subject|1|||
49157983|NCT00027560|158419322|FG000|Overall Study|Withdrawal by Subject|1|||
48831786|NCT01212757|157223700|FG008|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
48831787|NCT01212757|157223692|FG000|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
48831788|NCT01212757|157223693|FG001|Long-Term Safety Phase (Year 3)|Adverse Event|4|||
48831789|NCT01212757|157223694|FG002|Long-Term Safety Phase (Year 3)|Adverse Event|1|||
48831790|NCT01212757|157223695|FG003|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
48831791|NCT01212757|157223696|FG004|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
48831792|NCT01212757|157223697|FG005|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
48831793|NCT01212757|157223698|FG006|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
48831794|NCT01212757|157223699|FG007|Long-Term Safety Phase (Year 3)|Adverse Event|2|||
48831795|NCT01212757|157223700|FG008|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
48831796|NCT01212757|157223692|FG000|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
48831797|NCT01212757|157223693|FG001|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8|||
48831798|NCT01212757|157223694|FG002|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5|||
48831799|NCT01212757|157223695|FG003|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
48831800|NCT01212757|157223696|FG004|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
48831801|NCT01212757|157223697|FG005|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
48831802|NCT01212757|157223698|FG006|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
48831803|NCT01212757|157223699|FG007|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3|||
48831804|NCT01212757|157223700|FG008|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1|||
48831805|NCT01212757|157223692|FG000|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
48831806|NCT01212757|157223693|FG001|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
48831807|NCT01212757|157223694|FG002|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1|||
48831808|NCT01212757|157223695|FG003|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
48831809|NCT01212757|157223696|FG004|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
48831810|NCT01212757|157223697|FG005|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
48831811|NCT01212757|157223698|FG006|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
48831812|NCT01212757|157223699|FG007|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
48831813|NCT01212757|157223700|FG008|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
48831814|NCT01212757|157223692|FG000|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
48831815|NCT01212757|157223693|FG001|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5|||
48831816|NCT01212757|157223694|FG002|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
48831817|NCT01212757|157223695|FG003|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
48831818|NCT01212757|157223696|FG004|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
48831819|NCT01212757|157223697|FG005|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
48831820|NCT01212757|157223698|FG006|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
48831821|NCT01212757|157223699|FG007|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
48831822|NCT01212757|157223700|FG008|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
48831823|NCT01212757|157223692|FG000|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
48831824|NCT01212757|157223693|FG001|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
48831825|NCT01212757|157223694|FG002|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
48831826|NCT01212757|157223695|FG003|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
48831827|NCT01212757|157223696|FG004|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
48831828|NCT01212757|157223697|FG005|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
48831829|NCT01212757|157223698|FG006|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
48831830|NCT01212757|157223699|FG007|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
48831831|NCT01212757|157223700|FG008|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1|||
48831832|NCT01212757|157223692|FG000|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
48831833|NCT01212757|157223693|FG001|Long-Term Safety Phase (Year 3)|Protocol Violation|1|||
48831834|NCT01212757|157223694|FG002|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
48831835|NCT01212757|157223695|FG003|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
48831836|NCT01212757|157223696|FG004|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
48831837|NCT01212757|157223697|FG005|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
48831838|NCT01212757|157223698|FG006|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
48831839|NCT01212757|157223699|FG007|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
48831840|NCT01212757|157223700|FG008|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
48831841|NCT01212757|157223692|FG000|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
48831842|NCT01212757|157223693|FG001|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
48831843|NCT01212757|157223694|FG002|Long-Term Safety Phase (Year 3)|Miscellaneous|3|||
48831844|NCT01212757|157223695|FG003|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
48831845|NCT01212757|157223696|FG004|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
48831846|NCT01212757|157223697|FG005|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
48831847|NCT01212757|157223698|FG006|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
48831848|NCT01212757|157223699|FG007|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
48922793|NCT01394939|157551450|FG003|Overall Study|Physician Decision|0|||
48922794|NCT01394939|157551447|FG000|Overall Study|Withdrawal by Subject|0|||
49014579|NCT04634409|157888932|FG009|Overall Study|Death|0|||
48831849|NCT01212757|157223700|FG008|Long-Term Safety Phase (Year 3)|Miscellaneous|2|||
48831850|NCT01212757|157223692|FG000|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
48831851|NCT01212757|157223693|FG001|Long-Term Safety Phase (Year 4)|Miscellaneous|2|||
48831852|NCT01212757|157223694|FG002|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
48831853|NCT01212757|157223695|FG003|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
48831854|NCT01212757|157223696|FG004|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
48831855|NCT01212757|157223697|FG005|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
48831856|NCT01212757|157223698|FG006|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
48831857|NCT01212757|157223699|FG007|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
48831858|NCT01212757|157223700|FG008|Long-Term Safety Phase (Year 4)|Miscellaneous|1|||
48831859|NCT01212757|157223692|FG000|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
48831860|NCT01212757|157223693|FG001|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
48831861|NCT01212757|157223694|FG002|Long-Term Safety Phase (Year 4)|Adverse Event|2|||
48831862|NCT01212757|157223695|FG003|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
48831863|NCT01212757|157223696|FG004|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
48831864|NCT01212757|157223697|FG005|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
48831865|NCT01212757|157223698|FG006|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
48831866|NCT01212757|157223699|FG007|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
48831867|NCT01212757|157223700|FG008|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
48831868|NCT01212757|157223692|FG000|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
48831869|NCT01212757|157223693|FG001|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
48831870|NCT01212757|157223694|FG002|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
48831871|NCT01212757|157223695|FG003|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
48831872|NCT01212757|157223696|FG004|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
48831873|NCT01212757|157223697|FG005|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
48831874|NCT01212757|157223698|FG006|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
48831875|NCT01212757|157223699|FG007|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
48831876|NCT01212757|157223700|FG008|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
48831877|NCT01212757|157223692|FG000|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
48831878|NCT01212757|157223693|FG001|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4|||
48831879|NCT01212757|157223694|FG002|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2|||
48831880|NCT01212757|157223695|FG003|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
48831881|NCT01212757|157223696|FG004|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
48831882|NCT01212757|157223697|FG005|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
48831883|NCT01212757|157223698|FG006|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
48831884|NCT01212757|157223699|FG007|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1|||
48922795|NCT01394939|157551448|FG001|Overall Study|Withdrawal by Subject|2|||
48922796|NCT01394939|157551449|FG002|Overall Study|Withdrawal by Subject|0|||
48922797|NCT01394939|157551450|FG003|Overall Study|Withdrawal by Subject|2|||
48922798|NCT01394939|157551447|FG000|Overall Study|Others|0|||
48922799|NCT01394939|157551448|FG001|Overall Study|Others|2|||
48922800|NCT01394939|157551449|FG002|Overall Study|Others|0|||
48922801|NCT01394939|157551450|FG003|Overall Study|Others|3|||
48922802|NCT01339559|157551453|FG000|Overall Study|Adverse Event|92|||
48922803|NCT01339559|157551453|FG000|Overall Study|Death|5|||
48922804|NCT01339559|157551453|FG000|Overall Study|Lack of Efficacy|164|||
48922805|NCT01339559|157551453|FG000|Overall Study|Lost to Follow-up|22|||
48922806|NCT01339559|157551453|FG000|Overall Study|Subject choice|89|||
48922807|NCT01339559|157551453|FG000|Overall Study|Protocol Violation|15|||
48922808|NCT01339559|157551453|FG000|Overall Study|Study closure at site|1|||
48922809|NCT01339559|157551453|FG000|Overall Study|Incarcerated|2|||
48922810|NCT01339559|157551453|FG000|Overall Study|Epilepsy surgery|1|||
48922811|NCT01339559|157551453|FG000|Overall Study|Pregnancy planned|2|||
48922812|NCT01339559|157551453|FG000|Overall Study|Left the country|1|||
48922813|NCT01339559|157551453|FG000|Overall Study|Investigator decision|2|||
48922814|NCT01339559|157551453|FG000|Overall Study|Patient didn't wish to continue|1|||
48922815|NCT01339559|157551453|FG000|Overall Study|PI decision|1|||
48922816|NCT01661140|157551454|FG000|Open-Label Period|Adverse Event|44|||
48922817|NCT01661140|157551455|FG001|Open-Label Period|Adverse Event|0|||
48922818|NCT01661140|157551456|FG002|Open-Label Period|Adverse Event|0|||
48922819|NCT01661140|157551454|FG000|Open-Label Period|Protocol Violation|3|||
48922820|NCT01661140|157551455|FG001|Open-Label Period|Protocol Violation|0|||
48922821|NCT01661140|157551456|FG002|Open-Label Period|Protocol Violation|0|||
49157984|NCT01346176|158419323|FG000|Recruited|Protocol Violation|1|||
48831885|NCT01212757|157223700|FG008|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3|||
48922822|NCT01661140|157551454|FG000|Open-Label Period|Withdrawal by Subject|5|||
48922823|NCT01661140|157551455|FG001|Open-Label Period|Withdrawal by Subject|0|||
48922824|NCT01661140|157551456|FG002|Open-Label Period|Withdrawal by Subject|0|||
48922825|NCT01661140|157551454|FG000|Open-Label Period|Investigator Decision|3|||
48922826|NCT01661140|157551455|FG001|Open-Label Period|Investigator Decision|0|||
49157985|NCT01346176|158419324|FG001|Recruited|Protocol Violation|0|||
48922827|NCT01661140|157551456|FG002|Open-Label Period|Investigator Decision|0|||
48922828|NCT01661140|157551454|FG000|Open-Label Period|Death|1|||
49157986|NCT01346176|158419325|FG002|Recruited|Protocol Violation|0|||
48831886|NCT01212757|157223692|FG000|Long-Term Safety Phase (Year 4)|Death|0|||
48831887|NCT01212757|157223693|FG001|Long-Term Safety Phase (Year 4)|Death|0|||
48831888|NCT01212757|157223694|FG002|Long-Term Safety Phase (Year 4)|Death|1|||
48831889|NCT01212757|157223695|FG003|Long-Term Safety Phase (Year 4)|Death|0|||
48831890|NCT01212757|157223696|FG004|Long-Term Safety Phase (Year 4)|Death|0|||
48831891|NCT01212757|157223697|FG005|Long-Term Safety Phase (Year 4)|Death|0|||
48831892|NCT01212757|157223698|FG006|Long-Term Safety Phase (Year 4)|Death|0|||
48831893|NCT01212757|157223699|FG007|Long-Term Safety Phase (Year 4)|Death|0|||
48831894|NCT01212757|157223700|FG008|Long-Term Safety Phase (Year 4)|Death|1|||
48831895|NCT01212757|157223692|FG000|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
49157987|NCT01346176|158419323|FG000|Completed Advance Directive|Death|3|||
49157988|NCT01346176|158419324|FG001|Completed Advance Directive|Death|2|||
49157989|NCT01346176|158419325|FG002|Completed Advance Directive|Death|2|||
49157990|NCT01346176|158419323|FG000|Completed Advance Directive|Became Ineligible|3|||
49157991|NCT01346176|158419324|FG001|Completed Advance Directive|Became Ineligible|0|||
49157992|NCT01346176|158419325|FG002|Completed Advance Directive|Became Ineligible|1|||
49157993|NCT01346176|158419323|FG000|Completed Advance Directive|Other reason did not complete AD|7|||
49157994|NCT01346176|158419324|FG001|Completed Advance Directive|Other reason did not complete AD|12|||
49157995|NCT01346176|158419325|FG002|Completed Advance Directive|Other reason did not complete AD|7|||
49157996|NCT01346176|158419323|FG000|Completed Satisfaction Survey|Death|3|||
49157997|NCT01346176|158419324|FG001|Completed Satisfaction Survey|Death|0|||
49157998|NCT01346176|158419325|FG002|Completed Satisfaction Survey|Death|2|||
49157999|NCT01346176|158419323|FG000|Completed Satisfaction Survey|Lost to Follow-up|3|||
49158000|NCT01346176|158419324|FG001|Completed Satisfaction Survey|Lost to Follow-up|4|||
49158001|NCT01346176|158419325|FG002|Completed Satisfaction Survey|Lost to Follow-up|4|||
49158002|NCT01994876|158419326|FG000|Test Period 1|Withdrawal by Subject|0|||
49158003|NCT01994876|158419327|FG001|Test Period 1|Withdrawal by Subject|1|||
49158004|NCT01994876|158419326|FG000|Test Period 1|Adverse Event|0|||
49158005|NCT01994876|158419327|FG001|Test Period 1|Adverse Event|1|||
49158006|NCT01994876|158419326|FG000|Test Period 2|Adverse Event|1|||
49158007|NCT01994876|158419327|FG001|Test Period 2|Adverse Event|0|||
49158008|NCT01994876|158419326|FG000|Test Period 2|Protocol Violation|0|||
49158009|NCT01994876|158419327|FG001|Test Period 2|Protocol Violation|1|||
49158010|NCT03556891|158419331|FG000|Overall Study|Adverse Event|4|||
49158011|NCT03556891|158419331|FG000|Overall Study|MRI Need|3|||
49158012|NCT03556891|158419331|FG000|Overall Study|Device Failure|1|||
49158013|NCT03556891|158419331|FG000|Overall Study|Death|1|||
48831896|NCT01212757|157223693|FG001|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
48831897|NCT01212757|157223694|FG002|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
48831898|NCT01212757|157223695|FG003|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
48831899|NCT01212757|157223696|FG004|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
48831900|NCT01212757|157223697|FG005|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
48831901|NCT01212757|157223698|FG006|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
48831902|NCT01212757|157223699|FG007|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1|||
48831903|NCT01212757|157223700|FG008|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
48831904|NCT01212757|157223692|FG000|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
48831905|NCT01212757|157223693|FG001|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
48831906|NCT01212757|157223694|FG002|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
48831907|NCT01212757|157223695|FG003|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
48831908|NCT01212757|157223696|FG004|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
48831909|NCT01212757|157223697|FG005|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
48831910|NCT01212757|157223698|FG006|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
48831911|NCT01212757|157223699|FG007|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
48831912|NCT01212757|157223700|FG008|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
48831913|NCT01212757|157223692|FG000|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
48831914|NCT01212757|157223693|FG001|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
48831915|NCT01212757|157223694|FG002|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
48831916|NCT01212757|157223695|FG003|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
48831917|NCT01212757|157223696|FG004|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
48831918|NCT01212757|157223697|FG005|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
48831919|NCT01212757|157223698|FG006|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
48831920|NCT01212757|157223699|FG007|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
48831921|NCT01212757|157223700|FG008|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
48831922|NCT01212757|157223692|FG000|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
48831923|NCT01212757|157223693|FG001|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
48831924|NCT01212757|157223694|FG002|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
48831925|NCT01212757|157223695|FG003|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
48922829|NCT01661140|157551455|FG001|Open-Label Period|Death|0|||
49158014|NCT03556891|158419331|FG000|Overall Study|Lost to Follow-up|1|||
49158015|NCT03556891|158419331|FG000|Overall Study|Missing at random|1|||
49158016|NCT03556891|158419331|FG000|Overall Study|Missing due to COVID|1|||
49158017|NCT03556891|158419331|FG000|Overall Study|Protocol Violation|1|||
49158018|NCT00276419|158420640|FG000|First Intervention|Adverse Event|1|||
49158019|NCT00276419|158420641|FG001|First Intervention|Adverse Event|0|||
49158020|NCT00276419|158420640|FG000|First Intervention|Withdrawal by Subject|0|||
49158021|NCT00276419|158420641|FG001|First Intervention|Withdrawal by Subject|2|||
49158022|NCT03186638|158420642|FG000|Overall Study|Withdrawal by Subject|4|||
49158023|NCT03186638|158420643|FG001|Overall Study|Withdrawal by Subject|4|||
49158024|NCT03186638|158420642|FG000|Overall Study|Withdrawn due to medical problem|3|||
49158025|NCT03186638|158420643|FG001|Overall Study|Withdrawn due to medical problem|2|||
49158026|NCT03186638|158420642|FG000|Overall Study|Lost to Follow-up|1|||
49158027|NCT03186638|158420643|FG001|Overall Study|Lost to Follow-up|0|||
49158028|NCT00688597|158420644|FG000|Overall Study|Adverse Event|2|||
49158029|NCT00688597|158420645|FG001|Overall Study|Adverse Event|0|||
49158030|NCT00688597|158420646|FG002|Overall Study|Adverse Event|0|||
49158031|NCT00688597|158420644|FG000|Overall Study|Physician Decision|1|||
49158032|NCT00688597|158420645|FG001|Overall Study|Physician Decision|0|||
49158033|NCT00688597|158420646|FG002|Overall Study|Physician Decision|0|||
49158034|NCT02546323|158420648|FG000|Overall Study|Withdrawal by Subject|36|||
49158035|NCT02546323|158420649|FG001|Overall Study|Withdrawal by Subject|33|||
49158036|NCT02546323|158420648|FG000|Overall Study|Eligibility Criteria not Fulfilled|0|||
49158037|NCT02546323|158420649|FG001|Overall Study|Eligibility Criteria not Fulfilled|1|||
49158038|NCT02546323|158420648|FG000|Overall Study|Adverse Event|17|||
49158039|NCT02546323|158420649|FG001|Overall Study|Adverse Event|11|||
49158040|NCT02546323|158420648|FG000|Overall Study|Patient Specific Reasons|1|||
48831926|NCT01212757|157223696|FG004|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
48831927|NCT01212757|157223697|FG005|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
48831928|NCT01212757|157223698|FG006|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
48831929|NCT01212757|157223699|FG007|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
48831930|NCT01212757|157223700|FG008|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
48831931|NCT01212757|157223692|FG000|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
48831932|NCT01212757|157223693|FG001|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1|||
48831933|NCT01212757|157223694|FG002|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
48831934|NCT01212757|157223695|FG003|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
48831935|NCT01212757|157223696|FG004|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
48831936|NCT01212757|157223697|FG005|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
48831937|NCT01212757|157223698|FG006|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
48831938|NCT01212757|157223699|FG007|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
48831939|NCT01212757|157223700|FG008|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
48831940|NCT01212757|157223692|FG000|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
48831941|NCT01212757|157223693|FG001|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
48831942|NCT01212757|157223694|FG002|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
48831943|NCT01212757|157223695|FG003|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
48831944|NCT01212757|157223696|FG004|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
48831945|NCT01212757|157223697|FG005|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
48831946|NCT01212757|157223698|FG006|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
48831947|NCT01212757|157223699|FG007|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
48831948|NCT01212757|157223700|FG008|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
48831949|NCT00359619|157224991|FG000|Overall Study|Adverse Event|0|||
48831950|NCT00359619|157224992|FG001|Overall Study|Adverse Event|0|||
48831951|NCT00359619|157224993|FG002|Overall Study|Adverse Event|1|||
48831952|NCT00359619|157224994|FG003|Overall Study|Adverse Event|0|||
48831953|NCT00359619|157224995|FG004|Overall Study|Adverse Event|0|||
48831954|NCT00359619|157224996|FG005|Overall Study|Adverse Event|0|||
48831955|NCT00359619|157224997|FG006|Overall Study|Adverse Event|1|||
48831956|NCT00359619|157224991|FG000|Overall Study|Withdrawal by Subject|3|||
48831957|NCT00359619|157224992|FG001|Overall Study|Withdrawal by Subject|1|||
48831958|NCT00359619|157224993|FG002|Overall Study|Withdrawal by Subject|4|||
48831959|NCT00359619|157224994|FG003|Overall Study|Withdrawal by Subject|2|||
48831960|NCT00359619|157224995|FG004|Overall Study|Withdrawal by Subject|2|||
48831961|NCT00359619|157224996|FG005|Overall Study|Withdrawal by Subject|0|||
48831962|NCT00359619|157224997|FG006|Overall Study|Withdrawal by Subject|3|||
48831963|NCT00359619|157224991|FG000|Overall Study|Other|1|||
49158041|NCT02546323|158420649|FG001|Overall Study|Patient Specific Reasons|2|||
49158042|NCT02546323|158420648|FG000|Overall Study|Lost to Follow-up|2|||
49158043|NCT02546323|158420649|FG001|Overall Study|Lost to Follow-up|3|||
49158044|NCT02546323|158420648|FG000|Overall Study|Non-compliance with Study Drug|2|||
48831964|NCT00359619|157224992|FG001|Overall Study|Other|0|||
48831965|NCT00359619|157224993|FG002|Overall Study|Other|0|||
48831966|NCT00359619|157224994|FG003|Overall Study|Other|0|||
48831967|NCT00359619|157224995|FG004|Overall Study|Other|0|||
48831968|NCT00359619|157224996|FG005|Overall Study|Other|0|||
48831969|NCT00359619|157224997|FG006|Overall Study|Other|0|||
48831970|NCT00359619|157224991|FG000|Overall Study|Lost to Follow-up|4|||
48831971|NCT00359619|157224992|FG001|Overall Study|Lost to Follow-up|4|||
48831972|NCT00359619|157224993|FG002|Overall Study|Lost to Follow-up|2|||
48831973|NCT00359619|157224994|FG003|Overall Study|Lost to Follow-up|1|||
48831974|NCT00359619|157224995|FG004|Overall Study|Lost to Follow-up|1|||
48831975|NCT00359619|157224996|FG005|Overall Study|Lost to Follow-up|5|||
48831976|NCT00359619|157224997|FG006|Overall Study|Lost to Follow-up|0|||
48831977|NCT00569946|157224998|FG000|Overall Study|Adverse Event|16|||
48831978|NCT00569946|157224998|FG000|Overall Study|Objective Progression or Relapse|42|||
48831979|NCT00569946|157224998|FG000|Overall Study|Global Deterioration of Health Status|1|||
48831980|NCT00587288|157225000|FG000|Overall Study|Adverse Event|0|||
48831981|NCT00587288|157225001|FG001|Overall Study|Adverse Event|1|||
48831982|NCT00587288|157225000|FG000|Overall Study|Lack of Efficacy|2|||
48831983|NCT00587288|157225001|FG001|Overall Study|Lack of Efficacy|8|||
48831984|NCT00587288|157225000|FG000|Overall Study|Protocol Violation|1|||
48831985|NCT00587288|157225001|FG001|Overall Study|Protocol Violation|0|||
48831986|NCT03584516|157225002|FG000|Part 1|Death|2|||
48831987|NCT03584516|157225003|FG001|Part 1|Death|3|||
48831988|NCT03584516|157225004|FG002|Part 1|Death|0|||
48831989|NCT03584516|157225005|FG003|Part 1|Death|0|||
48831990|NCT03584516|157225006|FG004|Part 1|Death|0|||
48831991|NCT03584516|157225007|FG005|Part 1|Death|0|||
48831992|NCT03584516|157225002|FG000|Part 1|Withdrawal by Subject|2|||
48831993|NCT03584516|157225003|FG001|Part 1|Withdrawal by Subject|0|||
48831994|NCT03584516|157225004|FG002|Part 1|Withdrawal by Subject|0|||
48831995|NCT03584516|157225005|FG003|Part 1|Withdrawal by Subject|0|||
48831996|NCT03584516|157225006|FG004|Part 1|Withdrawal by Subject|0|||
48831997|NCT03584516|157225007|FG005|Part 1|Withdrawal by Subject|0|||
49158045|NCT02546323|158420649|FG001|Overall Study|Non-compliance with Study Drug|2|||
49158046|NCT02546323|158420648|FG000|Overall Study|Met Withdrawal Criteria|2|||
49158047|NCT02546323|158420649|FG001|Overall Study|Met Withdrawal Criteria|14|||
49158048|NCT02271880|158420658|FG000|Overall Study|Premature discontinuation of study|3|||
49158049|NCT02271880|158420659|FG001|Overall Study|Premature discontinuation of study|4|||
49158050|NCT00474903|158420660|FG000|Overall Study|Protocol Violation|1|||
49158051|NCT00474903|158420661|FG001|Overall Study|Protocol Violation|5|||
48831998|NCT03584516|157225002|FG000|Part 1|Lost to Follow-up|1|||
48831999|NCT03584516|157225003|FG001|Part 1|Lost to Follow-up|0|||
48832000|NCT03584516|157225004|FG002|Part 1|Lost to Follow-up|0|||
48832001|NCT03584516|157225005|FG003|Part 1|Lost to Follow-up|0|||
48832002|NCT03584516|157225006|FG004|Part 1|Lost to Follow-up|0|||
48832003|NCT03584516|157225007|FG005|Part 1|Lost to Follow-up|0|||
48832004|NCT03584516|157225002|FG000|Part 1|Study Terminated by Sponsor|0|||
48832005|NCT03584516|157225003|FG001|Part 1|Study Terminated by Sponsor|2|||
48832006|NCT03584516|157225004|FG002|Part 1|Study Terminated by Sponsor|0|||
48832007|NCT03584516|157225005|FG003|Part 1|Study Terminated by Sponsor|0|||
48832008|NCT03584516|157225006|FG004|Part 1|Study Terminated by Sponsor|0|||
48832009|NCT03584516|157225007|FG005|Part 1|Study Terminated by Sponsor|0|||
48832010|NCT03584516|157225002|FG000|Part 1 Expansion|Death|0|||
48832011|NCT03584516|157225003|FG001|Part 1 Expansion|Death|0|||
48832012|NCT03584516|157225004|FG002|Part 1 Expansion|Death|9|||
48832013|NCT03584516|157225005|FG003|Part 1 Expansion|Death|8|||
48832014|NCT03584516|157225006|FG004|Part 1 Expansion|Death|4|||
48832015|NCT03584516|157225007|FG005|Part 1 Expansion|Death|5|||
48832016|NCT03584516|157225002|FG000|Part 1 Expansion|Lost to Follow-up|0|||
48832017|NCT03584516|157225003|FG001|Part 1 Expansion|Lost to Follow-up|0|||
48832018|NCT03584516|157225004|FG002|Part 1 Expansion|Lost to Follow-up|0|||
48832019|NCT03584516|157225005|FG003|Part 1 Expansion|Lost to Follow-up|1|||
48832020|NCT03584516|157225006|FG004|Part 1 Expansion|Lost to Follow-up|0|||
48832021|NCT03584516|157225007|FG005|Part 1 Expansion|Lost to Follow-up|0|||
48832022|NCT03584516|157225002|FG000|Part 1 Expansion|Physician Decision|0|||
48832023|NCT03584516|157225003|FG001|Part 1 Expansion|Physician Decision|0|||
48832024|NCT03584516|157225004|FG002|Part 1 Expansion|Physician Decision|4|||
48832025|NCT03584516|157225005|FG003|Part 1 Expansion|Physician Decision|3|||
48922830|NCT01661140|157551456|FG002|Open-Label Period|Death|0|||
48832026|NCT03584516|157225006|FG004|Part 1 Expansion|Physician Decision|2|||
48832027|NCT03584516|157225007|FG005|Part 1 Expansion|Physician Decision|3|||
48832028|NCT03584516|157225002|FG000|Part 1 Expansion|Study Terminated by Sponsor|0|||
48832029|NCT03584516|157225003|FG001|Part 1 Expansion|Study Terminated by Sponsor|0|||
48832030|NCT03584516|157225004|FG002|Part 1 Expansion|Study Terminated by Sponsor|17|||
48832031|NCT03584516|157225005|FG003|Part 1 Expansion|Study Terminated by Sponsor|20|||
48832032|NCT03584516|157225006|FG004|Part 1 Expansion|Study Terminated by Sponsor|20|||
48832033|NCT03584516|157225007|FG005|Part 1 Expansion|Study Terminated by Sponsor|23|||
48922831|NCT01661140|157551454|FG000|Open-Label Period|Administrative/Other|1|||
49158052|NCT00474903|158420662|FG002|Overall Study|Protocol Violation|2|||
48922832|NCT01661140|157551455|FG001|Open-Label Period|Administrative/Other|0|||
48922833|NCT01661140|157551456|FG002|Open-Label Period|Administrative/Other|0|||
49158053|NCT02133573|158420663|FG000|Overall Study|Withdrawal by Maternal Subjects|2|||
49158054|NCT02133573|158420664|FG001|Overall Study|Withdrawal by Maternal Subjects|1|||
49158055|NCT02133573|158420663|FG000|Overall Study|Child Deaths|3|||
49158056|NCT02133573|158420664|FG001|Overall Study|Child Deaths|5|||
49158057|NCT02133573|158420663|FG000|Overall Study|Child Declined Follow Ups|2|||
49158058|NCT02133573|158420664|FG001|Overall Study|Child Declined Follow Ups|1|||
49158059|NCT02133573|158420663|FG000|Overall Study|Child missing primary endpoint score due to child's inability to test|2|||
49158060|NCT02133573|158420664|FG001|Overall Study|Child missing primary endpoint score due to child's inability to test|1|||
49158061|NCT01917318|158420665|FG000|First Treatment|Withdrawal by Subject|0|||
49158062|NCT01917318|158420666|FG001|First Treatment|Withdrawal by Subject|1|||
49158063|NCT00945659|158420667|FG000|Overall Study|Lost to Follow-up|7|||
49158064|NCT00945659|158420668|FG001|Overall Study|Lost to Follow-up|20|||
49158065|NCT00945659|158420669|FG002|Overall Study|Lost to Follow-up|17|||
49158066|NCT01646827|158420671|FG000|Overall Study|Lost to Follow-up|0|||
49158067|NCT01646827|158420672|FG001|Overall Study|Lost to Follow-up|3|||
49158068|NCT01646827|158420671|FG000|Overall Study|Physician Decision|1|||
49158069|NCT01646827|158420672|FG001|Overall Study|Physician Decision|2|||
49158070|NCT01646827|158420671|FG000|Overall Study|Withdrawal by Subject|1|||
49158071|NCT01646827|158420672|FG001|Overall Study|Withdrawal by Subject|0|||
49158072|NCT05134649|158420673|FG000|Overall Study|Lost to Follow-up|12|||
49158073|NCT05134649|158420673|FG000|Overall Study|Withdrawal by Subject|14|||
49158074|NCT05134649|158420673|FG000|Overall Study|Pregnancy|1|||
49158075|NCT05134649|158420673|FG000|Overall Study|Other, not specified|3|||
49158076|NCT02958865|158420674|FG000|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
49158077|NCT02958865|158420675|FG001|Induction Period (Day 1 to Week 8)|Adverse Event|4|||
49158078|NCT02958865|158420676|FG002|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
49158079|NCT02958865|158420677|FG003|Induction Period (Day 1 to Week 8)|Adverse Event|5|||
49158080|NCT02958865|158420678|FG004|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
49158081|NCT02958865|158420679|FG005|Induction Period (Day 1 to Week 8)|Adverse Event|2|||
49158082|NCT02958865|158420680|FG006|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
49158083|NCT02958865|158420681|FG007|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
48922834|NCT01661140|157551454|FG000|Open-Label Period|Sponsor termination|16|||
48922835|NCT01661140|157551455|FG001|Open-Label Period|Sponsor termination|0|||
48922836|NCT01661140|157551456|FG002|Open-Label Period|Sponsor termination|0|||
48922837|NCT01661140|157551454|FG000|Open-Label Period|Did not meet EULAR criteria|1|||
48832034|NCT03584516|157225002|FG000|Part 1 Expansion|Withdrawal by Subject|0|||
48832035|NCT03584516|157225003|FG001|Part 1 Expansion|Withdrawal by Subject|0|||
48832036|NCT03584516|157225004|FG002|Part 1 Expansion|Withdrawal by Subject|2|||
48832037|NCT03584516|157225005|FG003|Part 1 Expansion|Withdrawal by Subject|4|||
48832038|NCT03584516|157225006|FG004|Part 1 Expansion|Withdrawal by Subject|2|||
48832039|NCT03584516|157225007|FG005|Part 1 Expansion|Withdrawal by Subject|3|||
48922838|NCT01661140|157551455|FG001|Open-Label Period|Did not meet EULAR criteria|0|||
48832040|NCT03584516|157225002|FG000|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
48922839|NCT01661140|157551456|FG002|Open-Label Period|Did not meet EULAR criteria|0|||
49158084|NCT02958865|158420682|FG008|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
49158085|NCT02958865|158420683|FG009|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
49158086|NCT02958865|158420684|FG010|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
49158087|NCT02958865|158420685|FG011|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
49158088|NCT02958865|158420686|FG012|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
49158089|NCT02958865|158420687|FG013|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
49158090|NCT02958865|158420688|FG014|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
49158091|NCT02958865|158420689|FG015|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
49158092|NCT02958865|158420674|FG000|Induction Period (Day 1 to Week 8)|Death|0|||
49158093|NCT02958865|158420675|FG001|Induction Period (Day 1 to Week 8)|Death|1|||
49158094|NCT02958865|158420676|FG002|Induction Period (Day 1 to Week 8)|Death|0|||
49158095|NCT02958865|158420677|FG003|Induction Period (Day 1 to Week 8)|Death|0|||
49158096|NCT02958865|158420678|FG004|Induction Period (Day 1 to Week 8)|Death|0|||
49158097|NCT02958865|158420679|FG005|Induction Period (Day 1 to Week 8)|Death|0|||
49158098|NCT02958865|158420680|FG006|Induction Period (Day 1 to Week 8)|Death|0|||
49158099|NCT02958865|158420681|FG007|Induction Period (Day 1 to Week 8)|Death|0|||
49158100|NCT02958865|158420682|FG008|Induction Period (Day 1 to Week 8)|Death|0|||
49158101|NCT02958865|158420683|FG009|Induction Period (Day 1 to Week 8)|Death|0|||
49158102|NCT02958865|158420684|FG010|Induction Period (Day 1 to Week 8)|Death|0|||
49158103|NCT02958865|158420685|FG011|Induction Period (Day 1 to Week 8)|Death|0|||
49158104|NCT02958865|158420686|FG012|Induction Period (Day 1 to Week 8)|Death|0|||
48922840|NCT01661140|157551454|FG000|Open-Label Period|Lost to Follow-up|2|||
49158105|NCT02958865|158420687|FG013|Induction Period (Day 1 to Week 8)|Death|0|||
49158106|NCT02958865|158420688|FG014|Induction Period (Day 1 to Week 8)|Death|0|||
49158107|NCT02958865|158420689|FG015|Induction Period (Day 1 to Week 8)|Death|0|||
49158108|NCT02958865|158420674|FG000|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
48832041|NCT03584516|157225003|FG001|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
48832042|NCT03584516|157225004|FG002|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
48832043|NCT03584516|157225005|FG003|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|1|||
48922841|NCT01661140|157551455|FG001|Open-Label Period|Lost to Follow-up|0|||
49158109|NCT02958865|158420675|FG001|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
49158110|NCT02958865|158420676|FG002|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
49158111|NCT02958865|158420677|FG003|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
49158112|NCT02958865|158420678|FG004|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
49158113|NCT02958865|158420679|FG005|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
49158114|NCT02958865|158420680|FG006|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
49158115|NCT02958865|158420681|FG007|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
49158116|NCT02958865|158420682|FG008|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
49158117|NCT02958865|158420683|FG009|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
49158118|NCT02958865|158420684|FG010|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
49158119|NCT02958865|158420685|FG011|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
49158120|NCT02958865|158420686|FG012|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
49158121|NCT02958865|158420687|FG013|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
49158122|NCT02958865|158420688|FG014|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
49158123|NCT02958865|158420689|FG015|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
49158124|NCT02958865|158420674|FG000|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|2|||
49158125|NCT02958865|158420675|FG001|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
49158126|NCT02958865|158420676|FG002|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|3|||
49158127|NCT02958865|158420677|FG003|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
49158128|NCT02958865|158420678|FG004|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
49158129|NCT02958865|158420679|FG005|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
49158130|NCT02958865|158420680|FG006|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
49158131|NCT02958865|158420681|FG007|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
49158132|NCT02958865|158420682|FG008|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
49158133|NCT02958865|158420683|FG009|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
49158134|NCT02958865|158420684|FG010|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
49158135|NCT02958865|158420685|FG011|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
49158136|NCT02958865|158420686|FG012|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
49158137|NCT02958865|158420687|FG013|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
49158138|NCT02958865|158420688|FG014|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
49158139|NCT02958865|158420689|FG015|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
49158140|NCT02958865|158420674|FG000|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
49158141|NCT02958865|158420675|FG001|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
49158142|NCT02958865|158420676|FG002|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
48832044|NCT03584516|157225006|FG004|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
48832045|NCT03584516|157225007|FG005|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
48832046|NCT03584516|157225002|FG000|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
48832047|NCT03584516|157225003|FG001|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
48832048|NCT03584516|157225004|FG002|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
48832049|NCT03584516|157225005|FG003|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
48832050|NCT03584516|157225006|FG004|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
48832051|NCT03584516|157225007|FG005|Part 1 Expansion|Disease Progression; cGVHD Flare|1|||
48832052|NCT04868110|157225008|FG000|Overall Study|Withdrawal by Subject|3|||
48832053|NCT04868110|157225009|FG001|Overall Study|Withdrawal by Subject|4|||
48832054|NCT03068468|157225010|FG000|Placebo-Controlled Period|Randomized but not Treated|1|||
48832055|NCT03068468|157225011|FG001|Placebo-Controlled Period|Randomized but not Treated|3|||
48832056|NCT03068468|157225012|FG002|Placebo-Controlled Period|Randomized but not Treated|0|||
48832057|NCT03068468|157225013|FG003|Placebo-Controlled Period|Randomized but not Treated|0|||
48832058|NCT03068468|157225010|FG000|Placebo-Controlled Period|Lack of Efficacy|0|||
48832059|NCT03068468|157225011|FG001|Placebo-Controlled Period|Lack of Efficacy|1|||
48832060|NCT03068468|157225012|FG002|Placebo-Controlled Period|Lack of Efficacy|0|||
48832061|NCT03068468|157225013|FG003|Placebo-Controlled Period|Lack of Efficacy|0|||
48832062|NCT03068468|157225010|FG000|Placebo-Controlled Period|Adverse Event|16|||
48832063|NCT03068468|157225011|FG001|Placebo-Controlled Period|Adverse Event|21|||
48832064|NCT03068468|157225012|FG002|Placebo-Controlled Period|Adverse Event|0|||
48832065|NCT03068468|157225013|FG003|Placebo-Controlled Period|Adverse Event|0|||
48832066|NCT03068468|157225010|FG000|Placebo-Controlled Period|Withdrawal by Subject|3|||
48832067|NCT03068468|157225011|FG001|Placebo-Controlled Period|Withdrawal by Subject|11|||
48832068|NCT03068468|157225012|FG002|Placebo-Controlled Period|Withdrawal by Subject|0|||
48922842|NCT01661140|157551456|FG002|Open-Label Period|Lost to Follow-up|0|||
48922843|NCT01661140|157551454|FG000|Double-Blind Period|Refused Treatment|0|||
48832069|NCT03068468|157225013|FG003|Placebo-Controlled Period|Withdrawal by Subject|0|||
48922844|NCT01661140|157551455|FG001|Double-Blind Period|Refused Treatment|0|||
48922845|NCT01661140|157551456|FG002|Double-Blind Period|Refused Treatment|1|||
48922846|NCT01661140|157551454|FG000|Double-Blind Period|Adverse Event|0|||
48922847|NCT01661140|157551455|FG001|Double-Blind Period|Adverse Event|16|||
48922848|NCT01661140|157551456|FG002|Double-Blind Period|Adverse Event|18|||
48922849|NCT01661140|157551454|FG000|Double-Blind Period|Protocol Violation|0|||
48832070|NCT03068468|157225010|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
48832071|NCT03068468|157225011|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2|||
48832072|NCT03068468|157225012|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
48832073|NCT03068468|157225013|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
48832074|NCT03068468|157225010|FG000|Placebo-Controlled Period|Reason Not Specified|1|||
48832075|NCT03068468|157225011|FG001|Placebo-Controlled Period|Reason Not Specified|6|||
48832076|NCT03068468|157225012|FG002|Placebo-Controlled Period|Reason Not Specified|0|||
48832077|NCT03068468|157225013|FG003|Placebo-Controlled Period|Reason Not Specified|0|||
48832078|NCT03068468|157225010|FG000|Placebo-Controlled Period|Death|0|||
48832079|NCT03068468|157225011|FG001|Placebo-Controlled Period|Death|1|||
48832080|NCT03068468|157225012|FG002|Placebo-Controlled Period|Death|0|||
48832081|NCT03068468|157225013|FG003|Placebo-Controlled Period|Death|0|||
48832082|NCT03068468|157225010|FG000|Open-Label Extension Period|Lack of Efficacy|0|||
48832083|NCT03068468|157225011|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
48832084|NCT03068468|157225012|FG002|Open-Label Extension Period|Lack of Efficacy|1|||
48832085|NCT03068468|157225013|FG003|Open-Label Extension Period|Lack of Efficacy|2|||
48832086|NCT03068468|157225010|FG000|Open-Label Extension Period|Adverse Event|0|||
48832087|NCT03068468|157225011|FG001|Open-Label Extension Period|Adverse Event|0|||
48832088|NCT03068468|157225012|FG002|Open-Label Extension Period|Adverse Event|13|||
48922850|NCT01661140|157551455|FG001|Double-Blind Period|Protocol Violation|2|||
48922851|NCT01661140|157551456|FG002|Double-Blind Period|Protocol Violation|3|||
48922852|NCT01661140|157551454|FG000|Double-Blind Period|Withdrawal by Subject|0|||
48922853|NCT01661140|157551455|FG001|Double-Blind Period|Withdrawal by Subject|1|||
48922854|NCT01661140|157551456|FG002|Double-Blind Period|Withdrawal by Subject|3|||
48922855|NCT01661140|157551454|FG000|Double-Blind Period|Investigator's Decision|0|||
48922856|NCT01661140|157551455|FG001|Double-Blind Period|Investigator's Decision|1|||
48922857|NCT01661140|157551456|FG002|Double-Blind Period|Investigator's Decision|2|||
48922858|NCT01661140|157551454|FG000|Double-Blind Period|Sponsor Termination|0|||
48922859|NCT01661140|157551455|FG001|Double-Blind Period|Sponsor Termination|14|||
48922860|NCT01661140|157551456|FG002|Double-Blind Period|Sponsor Termination|17|||
48922861|NCT01661140|157551454|FG000|Double-Blind Period|Administrative/Other|0|||
49158143|NCT02958865|158420677|FG003|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
49158144|NCT02958865|158420678|FG004|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
48832089|NCT03068468|157225013|FG003|Open-Label Extension Period|Adverse Event|17|||
48832090|NCT03068468|157225010|FG000|Open-Label Extension Period|Withdrawal by Subject|0|||
49158145|NCT02958865|158420679|FG005|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
49158146|NCT02958865|158420680|FG006|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
49158147|NCT02958865|158420681|FG007|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
49158148|NCT02958865|158420682|FG008|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
49158149|NCT02958865|158420683|FG009|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
49158150|NCT02958865|158420684|FG010|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
49158151|NCT02958865|158420685|FG011|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
49158152|NCT02958865|158420686|FG012|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
49158153|NCT02958865|158420687|FG013|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
49158154|NCT02958865|158420688|FG014|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
49158155|NCT02958865|158420689|FG015|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
49158156|NCT02958865|158420674|FG000|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
49158157|NCT02958865|158420675|FG001|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
49158158|NCT02958865|158420676|FG002|Induction Period (Day 1 to Week 8)|Protocol Violation|1|||
49158159|NCT02958865|158420677|FG003|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
49158160|NCT02958865|158420678|FG004|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
49158161|NCT02958865|158420679|FG005|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
49158162|NCT02958865|158420680|FG006|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
49158163|NCT02958865|158420681|FG007|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
49158164|NCT02958865|158420682|FG008|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
49158165|NCT02958865|158420683|FG009|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
48832091|NCT03068468|157225011|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
48832092|NCT03068468|157225012|FG002|Open-Label Extension Period|Withdrawal by Subject|7|||
48922862|NCT01661140|157551455|FG001|Double-Blind Period|Administrative/Other|7|||
48922863|NCT01661140|157551456|FG002|Double-Blind Period|Administrative/Other|6|||
48922864|NCT00746252|157551457|FG000|Overall Study|weight gain >7.5 %|1|||
48832093|NCT03068468|157225013|FG003|Open-Label Extension Period|Withdrawal by Subject|20|||
48832094|NCT03068468|157225010|FG000|Open-Label Extension Period|Death|0|||
48832095|NCT03068468|157225011|FG001|Open-Label Extension Period|Death|0|||
48832096|NCT03068468|157225012|FG002|Open-Label Extension Period|Death|0|||
48832097|NCT03068468|157225013|FG003|Open-Label Extension Period|Death|1|||
48832098|NCT03068468|157225010|FG000|Open-Label Extension Period|Lost to Follow-up|0|||
48832099|NCT03068468|157225011|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
48832100|NCT03068468|157225012|FG002|Open-Label Extension Period|Lost to Follow-up|1|||
48832101|NCT03068468|157225013|FG003|Open-Label Extension Period|Lost to Follow-up|0|||
48832102|NCT03068468|157225010|FG000|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
48832103|NCT03068468|157225011|FG001|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
48832104|NCT03068468|157225012|FG002|Open-Label Extension Period|Failure to Meet Randomization Criteria|2|||
48832105|NCT03068468|157225013|FG003|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
48832106|NCT03068468|157225010|FG000|Open-Label Extension Period|Withdrawal by Sponsor|0|||
48832107|NCT03068468|157225011|FG001|Open-Label Extension Period|Withdrawal by Sponsor|0|||
48832108|NCT03068468|157225012|FG002|Open-Label Extension Period|Withdrawal by Sponsor|115|||
49158166|NCT02958865|158420684|FG010|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
49158167|NCT02958865|158420685|FG011|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
49158168|NCT02958865|158420686|FG012|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
49158169|NCT02958865|158420687|FG013|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
49158170|NCT02958865|158420688|FG014|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
49158171|NCT02958865|158420689|FG015|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
49158172|NCT02958865|158420674|FG000|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
49158173|NCT02958865|158420675|FG001|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
49158174|NCT02958865|158420676|FG002|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
49158175|NCT02958865|158420677|FG003|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
49158176|NCT02958865|158420678|FG004|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
49158177|NCT02958865|158420679|FG005|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
49158178|NCT02958865|158420680|FG006|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
49158179|NCT02958865|158420681|FG007|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
49158180|NCT02958865|158420682|FG008|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
49158181|NCT02958865|158420683|FG009|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
49158182|NCT02958865|158420684|FG010|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
49158183|NCT02958865|158420685|FG011|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
49158184|NCT02958865|158420686|FG012|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
49158185|NCT02958865|158420687|FG013|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
49158186|NCT02958865|158420688|FG014|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
49158187|NCT02958865|158420689|FG015|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
49158188|NCT02958865|158420674|FG000|Induction Period (Day 1 to Week 8)|Other|0|||
49158189|NCT02958865|158420675|FG001|Induction Period (Day 1 to Week 8)|Other|0|||
49158190|NCT02958865|158420676|FG002|Induction Period (Day 1 to Week 8)|Other|1|||
49158191|NCT02958865|158420677|FG003|Induction Period (Day 1 to Week 8)|Other|2|||
49158192|NCT02958865|158420678|FG004|Induction Period (Day 1 to Week 8)|Other|0|||
49158193|NCT02958865|158420679|FG005|Induction Period (Day 1 to Week 8)|Other|1|||
49158194|NCT02958865|158420680|FG006|Induction Period (Day 1 to Week 8)|Other|0|||
49158195|NCT02958865|158420681|FG007|Induction Period (Day 1 to Week 8)|Other|0|||
49158196|NCT02958865|158420682|FG008|Induction Period (Day 1 to Week 8)|Other|0|||
49158197|NCT02958865|158420683|FG009|Induction Period (Day 1 to Week 8)|Other|0|||
49158198|NCT02958865|158420684|FG010|Induction Period (Day 1 to Week 8)|Other|0|||
49158199|NCT02958865|158420685|FG011|Induction Period (Day 1 to Week 8)|Other|0|||
49158200|NCT02958865|158420686|FG012|Induction Period (Day 1 to Week 8)|Other|0|||
49158201|NCT02958865|158420687|FG013|Induction Period (Day 1 to Week 8)|Other|0|||
49158202|NCT02958865|158420688|FG014|Induction Period (Day 1 to Week 8)|Other|0|||
49158203|NCT02958865|158420689|FG015|Induction Period (Day 1 to Week 8)|Other|0|||
49158204|NCT02958865|158420674|FG000|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
49158205|NCT02958865|158420675|FG001|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
49158206|NCT02958865|158420676|FG002|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
49158207|NCT02958865|158420677|FG003|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
49158208|NCT02958865|158420678|FG004|Induction Period (Day 1 to Week 8)|Lost to Follow-up|1|||
49158209|NCT02958865|158420679|FG005|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
49158210|NCT02958865|158420680|FG006|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
49158211|NCT02958865|158420681|FG007|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
49158212|NCT02958865|158420682|FG008|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
48832109|NCT03068468|157225013|FG003|Open-Label Extension Period|Withdrawal by Sponsor|228|||
48832110|NCT03068468|157225010|FG000|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
48922865|NCT00746252|157551458|FG001|Overall Study|weight gain >7.5 %|2|||
48832111|NCT03068468|157225011|FG001|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
48922866|NCT01391000|157551459|FG000|Overall Study|Lost to Follow-up|2|||
49158213|NCT02958865|158420683|FG009|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
49158214|NCT02958865|158420684|FG010|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
49158215|NCT02958865|158420685|FG011|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
49158216|NCT02958865|158420686|FG012|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
49158217|NCT02958865|158420687|FG013|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
49158218|NCT02958865|158420688|FG014|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
49158219|NCT02958865|158420689|FG015|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
49158220|NCT02958865|158420674|FG000|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
49158221|NCT02958865|158420675|FG001|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
49158222|NCT02958865|158420676|FG002|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
49158223|NCT02958865|158420677|FG003|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
49158224|NCT02958865|158420678|FG004|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
49158225|NCT02958865|158420679|FG005|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
49158226|NCT02958865|158420680|FG006|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
49158227|NCT02958865|158420681|FG007|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
49158228|NCT02958865|158420682|FG008|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
48832112|NCT03068468|157225012|FG002|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
48832113|NCT03068468|157225013|FG003|Open-Label Extension Period|Withdrawal by Parent/Guardian|4|||
48832114|NCT03068468|157225010|FG000|Open-Label Extension Period|Reason not Specified|0|||
48832115|NCT03068468|157225011|FG001|Open-Label Extension Period|Reason not Specified|0|||
48832116|NCT03068468|157225012|FG002|Open-Label Extension Period|Reason not Specified|1|||
49158229|NCT02958865|158420683|FG009|Chronic Period (Week 8 to Week 32)|Adverse Event|2|||
49158230|NCT02958865|158420684|FG010|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
49158231|NCT02958865|158420685|FG011|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
49158232|NCT02958865|158420686|FG012|Chronic Period (Week 8 to Week 32)|Adverse Event|4|||
49158233|NCT02958865|158420687|FG013|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
49158234|NCT02958865|158420688|FG014|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
49158235|NCT02958865|158420689|FG015|Chronic Period (Week 8 to Week 32)|Adverse Event|5|||
48922867|NCT01391000|157551460|FG001|Overall Study|Lost to Follow-up|0|||
48922868|NCT00789529|157551461|FG000|Overall Study|Withdrawal by Subject|0|||
48922869|NCT00789529|157551462|FG001|Overall Study|Withdrawal by Subject|1|||
48922870|NCT00789529|157551461|FG000|Overall Study|Other Reason|1|||
48922871|NCT00789529|157551462|FG001|Overall Study|Other Reason|0|||
48922872|NCT04623242|157551463|FG000|Overall Study|Withdrawal by Subject|7|||
48922873|NCT04623242|157551464|FG001|Overall Study|Withdrawal by Subject|12|||
48922874|NCT04623242|157551465|FG002|Overall Study|Withdrawal by Subject|5|||
48922875|NCT04623242|157551466|FG003|Overall Study|Withdrawal by Subject|7|||
48922876|NCT04623242|157551467|FG004|Overall Study|Withdrawal by Subject|0|||
48922877|NCT04623242|157551463|FG000|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|6|||
48922878|NCT04623242|157551464|FG001|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|4|||
49158236|NCT02958865|158420674|FG000|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
49158237|NCT02958865|158420675|FG001|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
49158238|NCT02958865|158420676|FG002|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
49158239|NCT02958865|158420677|FG003|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
49158240|NCT02958865|158420678|FG004|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
49158241|NCT02958865|158420679|FG005|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
49158242|NCT02958865|158420680|FG006|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
49158243|NCT02958865|158420681|FG007|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
49158244|NCT02958865|158420682|FG008|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
49158245|NCT02958865|158420683|FG009|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|1|||
49158246|NCT02958865|158420684|FG010|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
49158247|NCT02958865|158420685|FG011|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|5|||
49158248|NCT02958865|158420686|FG012|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
48832117|NCT03068468|157225013|FG003|Open-Label Extension Period|Reason not Specified|4|||
48832118|NCT00739102|157225015|FG000|Overall Study|Death|5|||
48832119|NCT00739102|157225015|FG000|Overall Study|Withdrawal by Subject|10|||
48832120|NCT00646451|157225016|FG000|Overall Study|Adverse Event|3|||
49158249|NCT02958865|158420687|FG013|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
49158250|NCT02958865|158420688|FG014|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
49158251|NCT02958865|158420689|FG015|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|8|||
48832121|NCT00646451|157225017|FG001|Overall Study|Adverse Event|0|||
49158252|NCT02958865|158420674|FG000|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
48832122|NCT00646451|157225016|FG000|Overall Study|Exacerbation of pre-existing condition|1|||
48832123|NCT00646451|157225017|FG001|Overall Study|Exacerbation of pre-existing condition|0|||
48922879|NCT04623242|157551465|FG002|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|5|||
48922880|NCT04623242|157551466|FG003|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|3|||
48922881|NCT04623242|157551467|FG004|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|0|||
48922882|NCT04623242|157551463|FG000|Overall Study|Subject unblinded to mutation status|0|||
48922883|NCT04623242|157551464|FG001|Overall Study|Subject unblinded to mutation status|0|||
48922884|NCT04623242|157551465|FG002|Overall Study|Subject unblinded to mutation status|0|||
48922885|NCT04623242|157551466|FG003|Overall Study|Subject unblinded to mutation status|13|||
48922886|NCT04623242|157551467|FG004|Overall Study|Subject unblinded to mutation status|0|||
48922887|NCT01262365|157551468|FG000|Overall Study|Lack of Efficacy|35|||
48922888|NCT01262365|157551469|FG001|Overall Study|Lack of Efficacy|30|||
48922889|NCT01262365|157551470|FG002|Overall Study|Lack of Efficacy|47|||
49158253|NCT02958865|158420675|FG001|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
49158254|NCT02958865|158420676|FG002|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
48832124|NCT01510912|157225018|FG000|Overall Study|Adverse Event|99|||
48832125|NCT01510912|157225018|FG000|Overall Study|Lack of Efficacy|12|||
48832126|NCT01510912|157225018|FG000|Overall Study|Non-compliance with trial drug|23|||
48832127|NCT01510912|157225018|FG000|Overall Study|Withdrawal by Subject|49|||
48832128|NCT01510912|157225018|FG000|Overall Study|Physician Decision|1|||
48832129|NCT01510912|157225018|FG000|Overall Study|Protocol Violation|27|||
48832130|NCT01510912|157225018|FG000|Overall Study|Lost to Follow-up|26|||
48832131|NCT01510912|157225018|FG000|Overall Study|Other, including joint replacement|5|||
48832132|NCT03179787|157225019|FG000|Overall Study|Lost to Follow-up|15|||
48832133|NCT03179787|157225019|FG000|Overall Study|Case report failures|2|||
48832134|NCT03179787|157225019|FG000|Overall Study|Treatment not administered|1|||
48832135|NCT04335591|157225023|FG000|Overall Study|Adverse Event|5|||
48832136|NCT04335591|157225024|FG001|Overall Study|Adverse Event|2|||
48832137|NCT04335591|157225025|FG002|Overall Study|Adverse Event|3|||
48832138|NCT04335591|157225026|FG003|Overall Study|Adverse Event|2|||
48832139|NCT04335591|157225023|FG000|Overall Study|Protocol Violation|1|||
48832140|NCT04335591|157225024|FG001|Overall Study|Protocol Violation|0|||
48832141|NCT04335591|157225025|FG002|Overall Study|Protocol Violation|0|||
48832142|NCT04335591|157225026|FG003|Overall Study|Protocol Violation|0|||
48832143|NCT04335591|157225023|FG000|Overall Study|Withdrawal by Subject|8|||
48832144|NCT04335591|157225024|FG001|Overall Study|Withdrawal by Subject|4|||
48832145|NCT04335591|157225025|FG002|Overall Study|Withdrawal by Subject|4|||
48832146|NCT04335591|157225026|FG003|Overall Study|Withdrawal by Subject|5|||
48832147|NCT04335591|157225023|FG000|Overall Study|Subject planning pregnancy|0|||
48832148|NCT04335591|157225024|FG001|Overall Study|Subject planning pregnancy|1|||
48832149|NCT04335591|157225025|FG002|Overall Study|Subject planning pregnancy|0|||
48832150|NCT04335591|157225026|FG003|Overall Study|Subject planning pregnancy|0|||
48832151|NCT04335591|157225023|FG000|Overall Study|Ukrainian Russian war conflict|4|||
48832152|NCT04335591|157225024|FG001|Overall Study|Ukrainian Russian war conflict|5|||
48832153|NCT04335591|157225025|FG002|Overall Study|Ukrainian Russian war conflict|2|||
48832154|NCT04335591|157225026|FG003|Overall Study|Ukrainian Russian war conflict|0|||
48832155|NCT03518112|157225029|FG000|Overall Study|Withdrawal by Subject|1|||
48832156|NCT01546155|157225030|FG000|Overall Study|could not tolerate long scan duration|3|||
48832157|NCT02930343|157225031|FG000|Overall Study|Lost to Follow-up|9|||
48832158|NCT02930343|157225032|FG001|Overall Study|Lost to Follow-up|7|||
48832159|NCT01289119|157225033|FG000|Overall Study|Adverse Event|2|||
48832160|NCT01289119|157225034|FG001|Overall Study|Adverse Event|1|||
48832161|NCT01289119|157225035|FG002|Overall Study|Adverse Event|0|||
48832162|NCT01289119|157225036|FG003|Overall Study|Adverse Event|2|||
48832163|NCT01289119|157225037|FG004|Overall Study|Adverse Event|1|||
48832164|NCT01289119|157225038|FG005|Overall Study|Adverse Event|0|||
48832165|NCT01289119|157225033|FG000|Overall Study|Major Protocol Deviation|2|||
48832166|NCT01289119|157225034|FG001|Overall Study|Major Protocol Deviation|1|||
48922890|NCT01262365|157551468|FG000|Overall Study|Protocol Violation|3|||
48922891|NCT01262365|157551469|FG001|Overall Study|Protocol Violation|1|||
49158255|NCT02958865|158420677|FG003|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
49158256|NCT02958865|158420678|FG004|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
49158257|NCT02958865|158420679|FG005|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
49158258|NCT02958865|158420680|FG006|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
49158259|NCT02958865|158420681|FG007|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
49158260|NCT02958865|158420682|FG008|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
49158261|NCT02958865|158420683|FG009|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
49158262|NCT02958865|158420684|FG010|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
49158263|NCT02958865|158420685|FG011|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
48832167|NCT01289119|157225035|FG002|Overall Study|Major Protocol Deviation|3|||
48832168|NCT01289119|157225036|FG003|Overall Study|Major Protocol Deviation|0|||
48832169|NCT01289119|157225037|FG004|Overall Study|Major Protocol Deviation|2|||
48832170|NCT01289119|157225038|FG005|Overall Study|Major Protocol Deviation|1|||
48832171|NCT01289119|157225033|FG000|Overall Study|Lost to Follow-up|0|||
48832172|NCT01289119|157225034|FG001|Overall Study|Lost to Follow-up|3|||
48832173|NCT01289119|157225035|FG002|Overall Study|Lost to Follow-up|0|||
48832174|NCT01289119|157225036|FG003|Overall Study|Lost to Follow-up|0|||
49158264|NCT02958865|158420686|FG012|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
49158265|NCT02958865|158420687|FG013|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
49158266|NCT02958865|158420688|FG014|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
49158267|NCT02958865|158420689|FG015|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
49158268|NCT02958865|158420674|FG000|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
49158269|NCT02958865|158420675|FG001|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
49158270|NCT02958865|158420676|FG002|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
49158271|NCT02958865|158420677|FG003|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
49158272|NCT02958865|158420678|FG004|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
48832175|NCT01289119|157225037|FG004|Overall Study|Lost to Follow-up|0|||
48832176|NCT01289119|157225038|FG005|Overall Study|Lost to Follow-up|1|||
48832177|NCT01289119|157225033|FG000|Overall Study|Withdrawal by Subject|4|||
48832178|NCT01289119|157225034|FG001|Overall Study|Withdrawal by Subject|2|||
48832179|NCT01289119|157225035|FG002|Overall Study|Withdrawal by Subject|4|||
48832180|NCT01289119|157225036|FG003|Overall Study|Withdrawal by Subject|3|||
48832181|NCT01289119|157225037|FG004|Overall Study|Withdrawal by Subject|1|||
48832182|NCT01289119|157225038|FG005|Overall Study|Withdrawal by Subject|1|||
48832183|NCT01289119|157225033|FG000|Overall Study|Pregnancy|0|||
48832184|NCT01289119|157225034|FG001|Overall Study|Pregnancy|1|||
48832185|NCT01289119|157225035|FG002|Overall Study|Pregnancy|0|||
48832186|NCT01289119|157225036|FG003|Overall Study|Pregnancy|0|||
48832187|NCT01289119|157225037|FG004|Overall Study|Pregnancy|0|||
48832188|NCT01289119|157225038|FG005|Overall Study|Pregnancy|0|||
48832189|NCT01289119|157225033|FG000|Overall Study|Lack of Efficacy|0|||
48832190|NCT01289119|157225034|FG001|Overall Study|Lack of Efficacy|1|||
48832191|NCT01289119|157225035|FG002|Overall Study|Lack of Efficacy|1|||
48832192|NCT01289119|157225036|FG003|Overall Study|Lack of Efficacy|1|||
48832193|NCT01289119|157225037|FG004|Overall Study|Lack of Efficacy|1|||
48832194|NCT01289119|157225038|FG005|Overall Study|Lack of Efficacy|1|||
48832195|NCT01289119|157225033|FG000|Overall Study|Other|1|||
48832196|NCT01289119|157225034|FG001|Overall Study|Other|0|||
48832197|NCT01289119|157225035|FG002|Overall Study|Other|1|||
48832198|NCT01289119|157225036|FG003|Overall Study|Other|0|||
48832199|NCT01289119|157225037|FG004|Overall Study|Other|0|||
48832200|NCT01289119|157225038|FG005|Overall Study|Other|0|||
48832201|NCT01801930|157225043|FG000|Overall Study|Clear progression of the primary disease is observed|6|||
48832202|NCT01801930|157225044|FG001|Overall Study|Clear progression of the primary disease is observed|5|||
48832203|NCT01801930|157225045|FG002|Overall Study|Clear progression of the primary disease is observed|6|||
48832204|NCT01801930|157225046|FG003|Overall Study|Clear progression of the primary disease is observed|6|||
48832205|NCT01801930|157225043|FG000|Overall Study|DLT occurs|0|||
48832206|NCT01801930|157225044|FG001|Overall Study|DLT occurs|1|||
48832207|NCT01801930|157225045|FG002|Overall Study|DLT occurs|0|||
48832208|NCT01801930|157225046|FG003|Overall Study|DLT occurs|0|||
48832209|NCT00377455|157225049|FG000|Overall Study|Withdrawal by Subject|1|||
48832210|NCT00771667|157225050|FG000|Induction Phase|Adverse Event|5|||
48832211|NCT00771667|157225051|FG001|Induction Phase|Adverse Event|2|||
48832212|NCT00771667|157225052|FG002|Induction Phase|Adverse Event|4|||
48832213|NCT00771667|157225053|FG003|Induction Phase|Adverse Event|1|||
48832214|NCT00771667|157225054|FG004|Induction Phase|Adverse Event|0|||
48832215|NCT00771667|157225055|FG005|Induction Phase|Adverse Event|0|||
48832216|NCT00771667|157225056|FG006|Induction Phase|Adverse Event|0|||
48832217|NCT00771667|157225057|FG007|Induction Phase|Adverse Event|0|||
48832218|NCT00771667|157225058|FG008|Induction Phase|Adverse Event|0|||
48832219|NCT00771667|157225059|FG009|Induction Phase|Adverse Event|0|||
48832220|NCT00771667|157225050|FG000|Induction Phase|Lack of Efficacy|9|||
48832221|NCT00771667|157225051|FG001|Induction Phase|Lack of Efficacy|2|||
48832222|NCT00771667|157225052|FG002|Induction Phase|Lack of Efficacy|4|||
48832223|NCT00771667|157225053|FG003|Induction Phase|Lack of Efficacy|3|||
48832224|NCT00771667|157225054|FG004|Induction Phase|Lack of Efficacy|0|||
48832225|NCT00771667|157225055|FG005|Induction Phase|Lack of Efficacy|0|||
48832226|NCT00771667|157225056|FG006|Induction Phase|Lack of Efficacy|0|||
48832227|NCT00771667|157225057|FG007|Induction Phase|Lack of Efficacy|0|||
48832228|NCT00771667|157225058|FG008|Induction Phase|Lack of Efficacy|0|||
48832229|NCT00771667|157225059|FG009|Induction Phase|Lack of Efficacy|0|||
48832230|NCT00771667|157225050|FG000|Induction Phase|Lost to Follow-up|1|||
48832231|NCT00771667|157225051|FG001|Induction Phase|Lost to Follow-up|0|||
48832232|NCT00771667|157225052|FG002|Induction Phase|Lost to Follow-up|1|||
48832233|NCT00771667|157225053|FG003|Induction Phase|Lost to Follow-up|0|||
48832234|NCT00771667|157225054|FG004|Induction Phase|Lost to Follow-up|0|||
48832235|NCT00771667|157225055|FG005|Induction Phase|Lost to Follow-up|0|||
48832236|NCT00771667|157225056|FG006|Induction Phase|Lost to Follow-up|0|||
48832237|NCT00771667|157225057|FG007|Induction Phase|Lost to Follow-up|0|||
48832238|NCT00771667|157225058|FG008|Induction Phase|Lost to Follow-up|0|||
48832239|NCT00771667|157225059|FG009|Induction Phase|Lost to Follow-up|0|||
48832240|NCT00771667|157225050|FG000|Induction Phase|Other|4|||
48832241|NCT00771667|157225051|FG001|Induction Phase|Other|6|||
48832242|NCT00771667|157225052|FG002|Induction Phase|Other|3|||
48832243|NCT00771667|157225053|FG003|Induction Phase|Other|4|||
48832244|NCT00771667|157225054|FG004|Induction Phase|Other|0|||
49158273|NCT02958865|158420679|FG005|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
49158274|NCT02958865|158420680|FG006|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
49158275|NCT02958865|158420681|FG007|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
49158276|NCT02958865|158420682|FG008|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
49158277|NCT02958865|158420683|FG009|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
48832245|NCT00771667|157225055|FG005|Induction Phase|Other|0|||
48832246|NCT00771667|157225056|FG006|Induction Phase|Other|0|||
48832247|NCT00771667|157225057|FG007|Induction Phase|Other|0|||
48832248|NCT00771667|157225058|FG008|Induction Phase|Other|0|||
48832249|NCT00771667|157225059|FG009|Induction Phase|Other|0|||
48832250|NCT00771667|157225050|FG000|Maintenance Phase|Adverse Event|0|||
48832251|NCT00771667|157225051|FG001|Maintenance Phase|Adverse Event|0|||
48832252|NCT00771667|157225052|FG002|Maintenance Phase|Adverse Event|0|||
48832253|NCT00771667|157225053|FG003|Maintenance Phase|Adverse Event|0|||
48832254|NCT00771667|157225054|FG004|Maintenance Phase|Adverse Event|1|||
48832255|NCT00771667|157225055|FG005|Maintenance Phase|Adverse Event|3|||
49158278|NCT02958865|158420684|FG010|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
49158279|NCT02958865|158420685|FG011|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|1|||
48832256|NCT00771667|157225056|FG006|Maintenance Phase|Adverse Event|5|||
48832257|NCT00771667|157225057|FG007|Maintenance Phase|Adverse Event|1|||
48832258|NCT00771667|157225058|FG008|Maintenance Phase|Adverse Event|8|||
48832259|NCT00771667|157225059|FG009|Maintenance Phase|Adverse Event|7|||
48832260|NCT00771667|157225050|FG000|Maintenance Phase|Lack of Efficacy|0|||
48832261|NCT00771667|157225051|FG001|Maintenance Phase|Lack of Efficacy|0|||
48832262|NCT00771667|157225052|FG002|Maintenance Phase|Lack of Efficacy|0|||
48832263|NCT00771667|157225053|FG003|Maintenance Phase|Lack of Efficacy|0|||
48832264|NCT00771667|157225054|FG004|Maintenance Phase|Lack of Efficacy|1|||
48832265|NCT00771667|157225055|FG005|Maintenance Phase|Lack of Efficacy|3|||
48832266|NCT00771667|157225056|FG006|Maintenance Phase|Lack of Efficacy|3|||
48832267|NCT00771667|157225057|FG007|Maintenance Phase|Lack of Efficacy|2|||
48832268|NCT00771667|157225058|FG008|Maintenance Phase|Lack of Efficacy|11|||
48832269|NCT00771667|157225059|FG009|Maintenance Phase|Lack of Efficacy|7|||
48832270|NCT00771667|157225050|FG000|Maintenance Phase|Other|0|||
48832271|NCT00771667|157225051|FG001|Maintenance Phase|Other|0|||
48832272|NCT00771667|157225052|FG002|Maintenance Phase|Other|0|||
48832273|NCT00771667|157225053|FG003|Maintenance Phase|Other|0|||
48832274|NCT00771667|157225054|FG004|Maintenance Phase|Other|0|||
48832275|NCT00771667|157225055|FG005|Maintenance Phase|Other|1|||
48832276|NCT00771667|157225056|FG006|Maintenance Phase|Other|2|||
48832277|NCT00771667|157225057|FG007|Maintenance Phase|Other|2|||
49158280|NCT02958865|158420686|FG012|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|6|||
49158281|NCT02958865|158420687|FG013|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
49158282|NCT02958865|158420688|FG014|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
49158283|NCT02958865|158420689|FG015|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|2|||
49158284|NCT02958865|158420674|FG000|Chronic Period (Week 8 to Week 32)|Other|0|||
49158285|NCT02958865|158420675|FG001|Chronic Period (Week 8 to Week 32)|Other|0|||
49158286|NCT02958865|158420676|FG002|Chronic Period (Week 8 to Week 32)|Other|0|||
49158287|NCT02958865|158420677|FG003|Chronic Period (Week 8 to Week 32)|Other|0|||
48832278|NCT00771667|157225058|FG008|Maintenance Phase|Other|3|||
48832279|NCT00771667|157225059|FG009|Maintenance Phase|Other|3|||
48832280|NCT03467724|157225060|FG000|Overall Study|Lost to Follow-up|5|||
49158288|NCT02958865|158420678|FG004|Chronic Period (Week 8 to Week 32)|Other|0|||
49158289|NCT02958865|158420679|FG005|Chronic Period (Week 8 to Week 32)|Other|0|||
49158290|NCT02958865|158420680|FG006|Chronic Period (Week 8 to Week 32)|Other|0|||
49158291|NCT02958865|158420681|FG007|Chronic Period (Week 8 to Week 32)|Other|1|||
49158292|NCT02958865|158420682|FG008|Chronic Period (Week 8 to Week 32)|Other|0|||
49158293|NCT02958865|158420683|FG009|Chronic Period (Week 8 to Week 32)|Other|1|||
49158294|NCT02958865|158420684|FG010|Chronic Period (Week 8 to Week 32)|Other|0|||
49158295|NCT02958865|158420685|FG011|Chronic Period (Week 8 to Week 32)|Other|0|||
49158296|NCT02958865|158420686|FG012|Chronic Period (Week 8 to Week 32)|Other|1|||
49158297|NCT02958865|158420687|FG013|Chronic Period (Week 8 to Week 32)|Other|0|||
49158298|NCT02958865|158420688|FG014|Chronic Period (Week 8 to Week 32)|Other|0|||
49158299|NCT02958865|158420689|FG015|Chronic Period (Week 8 to Week 32)|Other|1|||
48832281|NCT03467724|157225060|FG000|Overall Study|Withdrawal by Subject|1|||
48832282|NCT03467724|157225060|FG000|Overall Study|Protocol Violation|1|||
48922892|NCT01262365|157551470|FG002|Overall Study|Protocol Violation|1|||
48832283|NCT03467724|157225060|FG000|Overall Study|Adverse Event|1|||
48832284|NCT01368406|157225064|FG000|Overall Study|Lost to Follow-up|8|||
48922893|NCT01262365|157551468|FG000|Overall Study|Lost to Follow-up|3|||
48832285|NCT01368406|157225065|FG001|Overall Study|Lost to Follow-up|4|||
48832286|NCT01368406|157225064|FG000|Overall Study|Withdrawal by Subject|8|||
48832287|NCT01368406|157225065|FG001|Overall Study|Withdrawal by Subject|4|||
48922894|NCT01262365|157551469|FG001|Overall Study|Lost to Follow-up|7|||
49158300|NCT02958865|158420674|FG000|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
49158301|NCT02958865|158420675|FG001|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
48832288|NCT01368406|157225064|FG000|Overall Study|relapse of the disease|3|||
49158302|NCT02958865|158420676|FG002|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
49158303|NCT02958865|158420677|FG003|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
49158304|NCT02958865|158420678|FG004|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
49158305|NCT02958865|158420679|FG005|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
49158306|NCT02958865|158420680|FG006|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
49158307|NCT02958865|158420681|FG007|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
49158308|NCT02958865|158420682|FG008|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
49158309|NCT02958865|158420683|FG009|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
49158310|NCT02958865|158420684|FG010|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
49158311|NCT02958865|158420685|FG011|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
49158312|NCT02958865|158420686|FG012|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
49158313|NCT02958865|158420687|FG013|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|1|||
49158314|NCT02958865|158420688|FG014|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
49158315|NCT02958865|158420689|FG015|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
49158316|NCT02958865|158420674|FG000|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
49158317|NCT02958865|158420675|FG001|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
49158318|NCT02958865|158420676|FG002|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
49158319|NCT02958865|158420677|FG003|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
49158320|NCT02958865|158420678|FG004|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
48832289|NCT01368406|157225065|FG001|Overall Study|relapse of the disease|2|||
49158321|NCT02958865|158420679|FG005|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
49158322|NCT02958865|158420680|FG006|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
49158323|NCT02958865|158420681|FG007|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
49158324|NCT02958865|158420682|FG008|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
49158325|NCT02958865|158420683|FG009|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
49158326|NCT02958865|158420684|FG010|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
49158327|NCT02958865|158420685|FG011|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
49158328|NCT02958865|158420686|FG012|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
49158329|NCT02958865|158420687|FG013|Chronic Period (Week 8 to Week 32)|Protocol Violation|1|||
49158330|NCT02958865|158420688|FG014|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
49158331|NCT02958865|158420689|FG015|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
49158332|NCT02958865|158420674|FG000|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
49158333|NCT02958865|158420675|FG001|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
49158334|NCT02958865|158420676|FG002|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
49158335|NCT02958865|158420677|FG003|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
49158336|NCT02958865|158420678|FG004|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
49158337|NCT02958865|158420679|FG005|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
49158338|NCT02958865|158420680|FG006|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
49158339|NCT02958865|158420681|FG007|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
49158340|NCT02958865|158420682|FG008|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
49158341|NCT02958865|158420683|FG009|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|1|||
48832290|NCT01368406|157225064|FG000|Overall Study|started working|2|||
48832291|NCT01368406|157225065|FG001|Overall Study|started working|3|||
49158342|NCT02958865|158420684|FG010|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
49158343|NCT02958865|158420685|FG011|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
49158344|NCT02958865|158420686|FG012|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
49158345|NCT02958865|158420687|FG013|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
49158346|NCT02958865|158420688|FG014|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
49158347|NCT02958865|158420689|FG015|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
49158348|NCT01987557|158420690|FG000|Overall Study|Protocol Violation|1|||
48832292|NCT01806714|157225070|FG000|Overall Study|No functioning phone number|200|||
48832293|NCT01806714|157225071|FG001|Overall Study|No functioning phone number|170|||
48832294|NCT02155829|157225072|FG000|Overall Study|Adverse Event|1|||
48832295|NCT02155829|157225073|FG001|Overall Study|Adverse Event|0|||
48832296|NCT02155829|157225072|FG000|Overall Study|Withdrawal by Subject|3|||
48832297|NCT02155829|157225073|FG001|Overall Study|Withdrawal by Subject|3|||
48832298|NCT02155829|157225072|FG000|Overall Study|Protocol Violation|2|||
48832299|NCT02155829|157225073|FG001|Overall Study|Protocol Violation|0|||
48832300|NCT00678795|157225074|FG000|Overall Study|Adverse Event|7|||
48832301|NCT00678795|157225075|FG001|Overall Study|Adverse Event|3|||
48832302|NCT00678795|157225074|FG000|Overall Study|Withdrawal by Subject|3|||
48832303|NCT00678795|157225075|FG001|Overall Study|Withdrawal by Subject|0|||
48832304|NCT00678795|157225074|FG000|Overall Study|Protocol Violation|0|||
48832305|NCT00678795|157225075|FG001|Overall Study|Protocol Violation|1|||
48832306|NCT00678795|157225074|FG000|Overall Study|Lost to Follow-up|0|||
48832307|NCT00678795|157225075|FG001|Overall Study|Lost to Follow-up|1|||
48832308|NCT00678795|157225074|FG000|Overall Study|Lack of Efficacy|1|||
48832309|NCT00678795|157225075|FG001|Overall Study|Lack of Efficacy|1|||
48832310|NCT00197015|157225084|FG000|Overall Study|Adverse Event|3|||
48832311|NCT00197015|157225085|FG001|Overall Study|Adverse Event|0|||
48832312|NCT00197015|157225086|FG002|Overall Study|Adverse Event|1|||
48832313|NCT00197015|157225084|FG000|Overall Study|Protocol Violation|0|||
48832314|NCT00197015|157225085|FG001|Overall Study|Protocol Violation|3|||
48832315|NCT00197015|157225086|FG002|Overall Study|Protocol Violation|3|||
48832316|NCT00197015|157225084|FG000|Overall Study|Withdrawal by Subject|17|||
48832317|NCT00197015|157225085|FG001|Overall Study|Withdrawal by Subject|37|||
48832318|NCT00197015|157225086|FG002|Overall Study|Withdrawal by Subject|34|||
48832319|NCT00197015|157225084|FG000|Overall Study|Lost to Follow-up|28|||
48832320|NCT00197015|157225085|FG001|Overall Study|Lost to Follow-up|46|||
48832321|NCT00197015|157225086|FG002|Overall Study|Lost to Follow-up|37|||
48832322|NCT00197015|157225084|FG000|Overall Study|Other|2|||
48832323|NCT00197015|157225085|FG001|Overall Study|Other|3|||
48832324|NCT00197015|157225086|FG002|Overall Study|Other|2|||
48832325|NCT04011722|157225089|FG000|30 Days|Death|5|||
48832326|NCT04011722|157225090|FG001|30 Days|Death|1|||
48832327|NCT04011722|157225089|FG000|1 Year|Death|13|||
48832328|NCT04011722|157225090|FG001|1 Year|Death|5|||
48832329|NCT04011722|157225089|FG000|1 Year|Withdrawal by Subject|8|||
48832330|NCT04011722|157225090|FG001|1 Year|Withdrawal by Subject|2|||
48832331|NCT04011722|157225089|FG000|1 Year|Missed Visit|6|||
48832332|NCT04011722|157225090|FG001|1 Year|Missed Visit|1|||
48832333|NCT04011722|157225089|FG000|1 Year|Pending Visit|0|||
48832334|NCT04011722|157225090|FG001|1 Year|Pending Visit|11|||
48832335|NCT04011722|157225089|FG000|1 Year|Not Yet Due|0|||
48832336|NCT04011722|157225090|FG001|1 Year|Not Yet Due|9|||
48832337|NCT04011722|157225089|FG000|2 Year|Death|16|||
48832338|NCT04011722|157225090|FG001|2 Year|Death|1|||
48832339|NCT04011722|157225089|FG000|2 Year|Withdrawal by Subject|10|||
48832340|NCT04011722|157225090|FG001|2 Year|Withdrawal by Subject|1|||
48832341|NCT04011722|157225089|FG000|2 Year|Missed Visit|9|||
48832342|NCT04011722|157225090|FG001|2 Year|Missed Visit|0|||
48832343|NCT04011722|157225089|FG000|2 Year|Visit Pending|1|||
48832344|NCT04011722|157225090|FG001|2 Year|Visit Pending|3|||
48832345|NCT04011722|157225089|FG000|2 Year|Not Yet Due|43|||
48832346|NCT04011722|157225090|FG001|2 Year|Not Yet Due|54|||
48832347|NCT04011722|157225089|FG000|3 Year|Death|10|||
48832348|NCT04011722|157225090|FG001|3 Year|Death|0|||
48832349|NCT04011722|157225089|FG000|3 Year|Withdrawal by Subject|2|||
48832350|NCT04011722|157225090|FG001|3 Year|Withdrawal by Subject|0|||
48832351|NCT04011722|157225089|FG000|3 Year|Missed Visit|2|||
48832352|NCT04011722|157225090|FG001|3 Year|Missed Visit|0|||
48832353|NCT04011722|157225089|FG000|3 Year|Pending Visit|34|||
48832354|NCT04011722|157225090|FG001|3 Year|Pending Visit|0|||
48832355|NCT04011722|157225089|FG000|3 Year|Not Yet Due|99|||
48832356|NCT04011722|157225090|FG001|3 Year|Not Yet Due|0|||
48832357|NCT03220035|157225093|FG000|Overall Study|Adverse Event|1|||
48832358|NCT03220035|157225093|FG000|Overall Study|Protocol Violation|1|||
48832359|NCT03220035|157225093|FG000|Overall Study|Progressive Disease|2|||
48832360|NCT03523091|157225096|FG000|Overall Study|Lower dose due to elevated post void residual (PVR)|1|||
48832361|NCT03523091|157225097|FG001|Overall Study|Lower dose due to elevated post void residual (PVR)|0|||
48832362|NCT03523091|157225096|FG000|Overall Study|Withdrawal by Subject|0|||
48832363|NCT03523091|157225097|FG001|Overall Study|Withdrawal by Subject|3|||
48832364|NCT03523091|157225096|FG000|Overall Study|Increase Botox dose|0|||
48922895|NCT01262365|157551470|FG002|Overall Study|Lost to Follow-up|6|||
48922896|NCT01262365|157551468|FG000|Overall Study|Withdrawal by Subject|17|||
48922897|NCT01262365|157551469|FG001|Overall Study|Withdrawal by Subject|22|||
48832365|NCT03523091|157225097|FG001|Overall Study|Increase Botox dose|1|||
48922898|NCT01262365|157551470|FG002|Overall Study|Withdrawal by Subject|22|||
49158349|NCT01987557|158420691|FG001|Overall Study|Protocol Violation|0|||
49158350|NCT01987557|158420692|FG002|Overall Study|Protocol Violation|1|||
49158351|NCT01987557|158420690|FG000|Overall Study|Withdrawal by Subject|2|||
49158352|NCT01987557|158420691|FG001|Overall Study|Withdrawal by Subject|1|||
49158353|NCT01987557|158420692|FG002|Overall Study|Withdrawal by Subject|2|||
49158354|NCT01987557|158420690|FG000|Overall Study|Adverse Event|0|||
49158355|NCT01987557|158420691|FG001|Overall Study|Adverse Event|2|||
48832366|NCT04340362|157225098|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
48832367|NCT02711826|157225099|FG000|Overall Study|Physician Decision|0|||
49158356|NCT01987557|158420692|FG002|Overall Study|Adverse Event|0|||
49158357|NCT01567722|158420693|FG000|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|1|||
49158358|NCT01567722|158420694|FG001|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
49158359|NCT01567722|158420695|FG002|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
49158360|NCT01567722|158420693|FG000|Overall Study|Insufficient tissue available to satisfy the protocol requirements|2|||
49158361|NCT01567722|158420694|FG001|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
49158362|NCT01567722|158420695|FG002|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
49158363|NCT01567722|158420693|FG000|Overall Study|Protocol closure by the OCG|2|||
49158364|NCT01567722|158420694|FG001|Overall Study|Protocol closure by the OCG|0|||
49158365|NCT01567722|158420695|FG002|Overall Study|Protocol closure by the OCG|0|||
49158366|NCT01567722|158420693|FG000|Overall Study|Not enough tissue left for the tissue scrolls|1|||
49158367|NCT01567722|158420694|FG001|Overall Study|Not enough tissue left for the tissue scrolls|0|||
49158368|NCT01567722|158420695|FG002|Overall Study|Not enough tissue left for the tissue scrolls|0|||
49158369|NCT00431964|158420696|FG000|Overall Study|Adverse Event|1|||
48832368|NCT02711826|157225100|FG001|Overall Study|Physician Decision|0|||
48832369|NCT02711826|157225101|FG002|Overall Study|Physician Decision|0|||
48832370|NCT02711826|157225102|FG003|Overall Study|Physician Decision|1|||
48832371|NCT02711826|157225103|FG004|Overall Study|Physician Decision|0|||
48832372|NCT02711826|157225099|FG000|Overall Study|Withdrawal by Subject|0|||
48832373|NCT02711826|157225100|FG001|Overall Study|Withdrawal by Subject|1|||
48832374|NCT02711826|157225101|FG002|Overall Study|Withdrawal by Subject|0|||
48832375|NCT02711826|157225102|FG003|Overall Study|Withdrawal by Subject|4|||
48832376|NCT02711826|157225103|FG004|Overall Study|Withdrawal by Subject|0|||
48832377|NCT02711826|157225099|FG000|Overall Study|Failure to manufacture cellular product|0|||
48832378|NCT02711826|157225100|FG001|Overall Study|Failure to manufacture cellular product|0|||
48832379|NCT02711826|157225101|FG002|Overall Study|Failure to manufacture cellular product|5|||
48832380|NCT02711826|157225102|FG003|Overall Study|Failure to manufacture cellular product|0|||
48832381|NCT02711826|157225103|FG004|Overall Study|Failure to manufacture cellular product|0|||
48832382|NCT02711826|157225099|FG000|Overall Study|Infusion canceled for active infection|0|||
48832383|NCT02711826|157225100|FG001|Overall Study|Infusion canceled for active infection|1|||
48832384|NCT02711826|157225101|FG002|Overall Study|Infusion canceled for active infection|0|||
48832385|NCT02711826|157225102|FG003|Overall Study|Infusion canceled for active infection|0|||
48832386|NCT02711826|157225103|FG004|Overall Study|Infusion canceled for active infection|0|||
48832387|NCT02711826|157225099|FG000|Overall Study|Screen failures|0|||
48832388|NCT02711826|157225100|FG001|Overall Study|Screen failures|0|||
48832389|NCT02711826|157225101|FG002|Overall Study|Screen failures|0|||
48832390|NCT02711826|157225102|FG003|Overall Study|Screen failures|4|||
48832391|NCT02711826|157225103|FG004|Overall Study|Screen failures|0|||
48832392|NCT03952559|157225104|FG000|Double Blind Treatment Period|Adverse Event|0|||
48832393|NCT03952559|157225105|FG001|Double Blind Treatment Period|Adverse Event|2|||
48832394|NCT03952559|157225106|FG002|Double Blind Treatment Period|Adverse Event|1|||
48832395|NCT03952559|157225107|FG003|Double Blind Treatment Period|Adverse Event|0|||
48832396|NCT03952559|157225108|FG004|Double Blind Treatment Period|Adverse Event|1|||
48832397|NCT03952559|157225104|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
48832398|NCT03952559|157225105|FG001|Double Blind Treatment Period|Lack of Efficacy|4|||
48832399|NCT03952559|157225106|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
48832400|NCT03952559|157225107|FG003|Double Blind Treatment Period|Lack of Efficacy|1|||
48832401|NCT03952559|157225108|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
48832402|NCT03952559|157225104|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
48832403|NCT03952559|157225105|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
48832404|NCT03952559|157225106|FG002|Double Blind Treatment Period|Withdrawal by Subject|2|||
48922899|NCT01262365|157551468|FG000|Overall Study|Death|1|||
48832405|NCT03952559|157225107|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
48832406|NCT03952559|157225108|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
48832407|NCT03952559|157225104|FG000|Double Blind Treatment Period|Inadvertently randomized|0|||
48832408|NCT03952559|157225105|FG001|Double Blind Treatment Period|Inadvertently randomized|0|||
48832409|NCT03952559|157225106|FG002|Double Blind Treatment Period|Inadvertently randomized|1|||
48832410|NCT03952559|157225107|FG003|Double Blind Treatment Period|Inadvertently randomized|0|||
48832411|NCT03952559|157225108|FG004|Double Blind Treatment Period|Inadvertently randomized|0|||
48832412|NCT02968004|157227550|FG000|Overall Study|Adverse Event|1|||
48832413|NCT02968004|157227551|FG001|Overall Study|Adverse Event|0|||
48832414|NCT02968004|157227550|FG000|Overall Study|Withdrawal by Subject|0|||
48832415|NCT02968004|157227551|FG001|Overall Study|Withdrawal by Subject|1|||
48832416|NCT01838200|157227554|FG000|Overall Study|Adverse Event|0|||
48832417|NCT01838200|157227555|FG001|Overall Study|Adverse Event|2|||
48832418|NCT01838200|157227554|FG000|Overall Study|Progressive disease|3|||
48832419|NCT01838200|157227555|FG001|Overall Study|Progressive disease|0|||
48832420|NCT00686517|157227560|FG000|Treatment|Serious Adverse Event|1|||
48832421|NCT00686517|157227561|FG001|Treatment|Serious Adverse Event|2|||
48832422|NCT00686517|157227562|FG002|Treatment|Serious Adverse Event|1|||
48832423|NCT00686517|157227560|FG000|Treatment|Adverse Event|2|||
48832424|NCT00686517|157227561|FG001|Treatment|Adverse Event|0|||
48832425|NCT00686517|157227562|FG002|Treatment|Adverse Event|0|||
48832426|NCT00686517|157227560|FG000|Treatment|Poor Protocol Compliance|1|||
48832427|NCT00686517|157227561|FG001|Treatment|Poor Protocol Compliance|0|||
48832428|NCT00686517|157227562|FG002|Treatment|Poor Protocol Compliance|0|||
48832429|NCT00686517|157227560|FG000|Treatment|Protocol Violation|2|||
48832430|NCT00686517|157227561|FG001|Treatment|Protocol Violation|1|||
48832431|NCT00686517|157227562|FG002|Treatment|Protocol Violation|0|||
48832432|NCT03710564|157227563|FG000|Overall Study|Study Terminated by Sponsor|104|||
48832433|NCT03710564|157227564|FG001|Overall Study|Study Terminated by Sponsor|55|||
48832434|NCT03710564|157227563|FG000|Overall Study|Withdrawal by Subject|57|||
48832435|NCT03710564|157227564|FG001|Overall Study|Withdrawal by Subject|25|||
48832436|NCT03710564|157227563|FG000|Overall Study|Death|10|||
48832437|NCT03710564|157227564|FG001|Overall Study|Death|4|||
48832438|NCT03710564|157227563|FG000|Overall Study|Lost to Follow-up|5|||
48832439|NCT03710564|157227564|FG001|Overall Study|Lost to Follow-up|4|||
48832440|NCT03710564|157227563|FG000|Overall Study|Protocol Violation|3|||
48832441|NCT03710564|157227564|FG001|Overall Study|Protocol Violation|2|||
48832442|NCT03710564|157227563|FG000|Overall Study|Adverse Event|3|||
48832443|NCT03710564|157227564|FG001|Overall Study|Adverse Event|0|||
48832444|NCT03710564|157227563|FG000|Overall Study|Physician Decision|2|||
48832445|NCT03710564|157227564|FG001|Overall Study|Physician Decision|3|||
48832446|NCT01908634|157227565|FG000|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1|||
48832447|NCT01908634|157227565|FG000|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5|||
48832448|NCT04176458|157227566|FG000|Overall Study|Covid 19|4|||
48832449|NCT01072357|157227567|FG000|Overall Study|Lost to Follow-up|0|||
48832450|NCT01072357|157227568|FG001|Overall Study|Lost to Follow-up|1|||
48832451|NCT01352507|157227573|FG000|Treatment Period 1|Adverse Event|3|||
48832452|NCT01352507|157227574|FG001|Treatment Period 1|Adverse Event|0|||
48832453|NCT01352507|157227573|FG000|Treatment Period 1|Lost to Follow-up|3|||
48832454|NCT01352507|157227574|FG001|Treatment Period 1|Lost to Follow-up|4|||
48832455|NCT01352507|157227573|FG000|Treatment Period 1|Withdrawal by Subject|7|||
48832456|NCT01352507|157227574|FG001|Treatment Period 1|Withdrawal by Subject|5|||
48832457|NCT01352507|157227573|FG000|Treatment Period 1|Physician Decision|1|||
48832458|NCT01352507|157227574|FG001|Treatment Period 1|Physician Decision|0|||
48832459|NCT01352507|157227573|FG000|Washout Period|Withdrawal by Subject|0|||
48832460|NCT01352507|157227574|FG001|Washout Period|Withdrawal by Subject|1|||
48832461|NCT01352507|157227573|FG000|Treatment Period 2|Entry Criteria Not Met|1|||
48832462|NCT01352507|157227574|FG001|Treatment Period 2|Entry Criteria Not Met|0|||
48832463|NCT01352507|157227573|FG000|Treatment Period 2|Withdrawal by Subject|4|||
48832464|NCT01352507|157227574|FG001|Treatment Period 2|Withdrawal by Subject|3|||
48832465|NCT01352507|157227573|FG000|Treatment Period 2|Lack of Efficacy|1|||
48832466|NCT01352507|157227574|FG001|Treatment Period 2|Lack of Efficacy|0|||
48832467|NCT02701361|157227575|FG000|Overall Study|Lost to Follow-up|5|||
48832468|NCT02701361|157227576|FG001|Overall Study|Lost to Follow-up|2|||
48832469|NCT02701361|157227577|FG002|Overall Study|Lost to Follow-up|1|||
48832470|NCT02701361|157227575|FG000|Overall Study|Withdrawal by Subject|4|||
48832471|NCT02701361|157227576|FG001|Overall Study|Withdrawal by Subject|0|||
48832472|NCT02701361|157227577|FG002|Overall Study|Withdrawal by Subject|0|||
48832473|NCT02701361|157227575|FG000|Overall Study|timed out in rehab center|0|||
48832474|NCT02701361|157227576|FG001|Overall Study|timed out in rehab center|1|||
48832475|NCT02701361|157227577|FG002|Overall Study|timed out in rehab center|0|||
48832476|NCT02701361|157227575|FG000|Overall Study|incarceration|0|||
48832477|NCT02701361|157227576|FG001|Overall Study|incarceration|0|||
48832478|NCT02701361|157227577|FG002|Overall Study|incarceration|1|||
48832479|NCT00975806|157227578|FG000|Overall Study|Adverse Event|2|||
48832480|NCT00975806|157227579|FG001|Overall Study|Adverse Event|1|||
48832481|NCT00975806|157227580|FG002|Overall Study|Adverse Event|2|||
48922900|NCT01262365|157551469|FG001|Overall Study|Death|2|||
48922901|NCT01262365|157551470|FG002|Overall Study|Death|1|||
48922902|NCT01262365|157551468|FG000|Overall Study|Adverse Event|26|||
48922903|NCT01262365|157551469|FG001|Overall Study|Adverse Event|16|||
48922904|NCT01262365|157551470|FG002|Overall Study|Adverse Event|11|||
48922905|NCT01262365|157551468|FG000|Overall Study|sponsor decision|1|||
48922906|NCT01262365|157551469|FG001|Overall Study|sponsor decision|1|||
48922907|NCT01262365|157551470|FG002|Overall Study|sponsor decision|0|||
48922908|NCT01262365|157551468|FG000|Overall Study|Randomization error|1|||
48832482|NCT00975806|157227578|FG000|Overall Study|Disease Progression|1|||
48832483|NCT00975806|157227579|FG001|Overall Study|Disease Progression|5|||
48832484|NCT00975806|157227580|FG002|Overall Study|Disease Progression|1|||
48832485|NCT00975806|157227578|FG000|Overall Study|Withdrawal by Subject|1|||
48832486|NCT00975806|157227579|FG001|Overall Study|Withdrawal by Subject|0|||
48832487|NCT00975806|157227580|FG002|Overall Study|Withdrawal by Subject|0|||
48832488|NCT00975806|157227578|FG000|Overall Study|Death|0|||
48832489|NCT00975806|157227579|FG001|Overall Study|Death|1|||
48832490|NCT00975806|157227580|FG002|Overall Study|Death|0|||
48832491|NCT00975806|157227578|FG000|Overall Study|Physician decision and disease related|1|||
48832492|NCT00975806|157227579|FG001|Overall Study|Physician decision and disease related|0|||
48832493|NCT00975806|157227580|FG002|Overall Study|Physician decision and disease related|1|||
48832494|NCT00290732|157227583|FG000|Overall Study|Inability to instill drug intraductally.|0|||
48832495|NCT00290732|157227584|FG001|Overall Study|Inability to instill drug intraductally.|1|||
48832496|NCT00290732|157227585|FG002|Overall Study|Inability to instill drug intraductally.|1|||
48832497|NCT00290732|157227586|FG003|Overall Study|Inability to instill drug intraductally.|0|||
48832498|NCT00290732|157227587|FG004|Overall Study|Inability to instill drug intraductally.|0|||
48832499|NCT00964366|157227588|FG000|Overall Study|Did not qualify at Day 1|1|||
48832500|NCT00964366|157227589|FG001|Overall Study|Did not qualify at Day 1|0|||
48832501|NCT00964366|157227588|FG000|Overall Study|Withdrawal by Subject|0|||
48832502|NCT00964366|157227589|FG001|Overall Study|Withdrawal by Subject|1|||
48832503|NCT02046616|157227591|FG000|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1|||
48832504|NCT02046616|157227591|FG000|24-Week Treatment Period|Any Other Adverse Event|13|||
48832505|NCT02046616|157227591|FG000|24-Week Treatment Period|Insufficient Therapeutic Response|1|||
48832506|NCT02046616|157227591|FG000|24-Week Treatment Period|Physician Decision|3|||
48832507|NCT02046616|157227591|FG000|24-Week Treatment Period|Other|1|||
48832508|NCT02046616|157227591|FG000|8-Week FU Period|Lost to Follow-up|1|||
48832509|NCT00344019|157227592|FG000|Overall Study|did not meet final inclusion criteria|0|||
48832510|NCT00344019|157227593|FG001|Overall Study|did not meet final inclusion criteria|0|||
48832511|NCT00344019|157227594|FG002|Overall Study|did not meet final inclusion criteria|74|||
48832512|NCT00843193|157227595|FG000|Overall Study|Adverse Event|2|||
49158370|NCT00431964|158420697|FG001|Overall Study|Adverse Event|0|||
49158371|NCT00431964|158420696|FG000|Overall Study|Lost to Follow-up|1|||
49158372|NCT00431964|158420697|FG001|Overall Study|Lost to Follow-up|2|||
49158373|NCT00431964|158420696|FG000|Overall Study|Physician Decision|2|||
49158374|NCT00431964|158420697|FG001|Overall Study|Physician Decision|2|||
49158375|NCT00431964|158420696|FG000|Overall Study|Withdrawal by Subject|2|||
49158376|NCT00431964|158420697|FG001|Overall Study|Withdrawal by Subject|1|||
49158377|NCT00431964|158420696|FG000|Overall Study|Parental Consent Withdrawn|0|||
49158378|NCT00431964|158420697|FG001|Overall Study|Parental Consent Withdrawn|2|||
49158379|NCT00431964|158420696|FG000|Overall Study|Due to Unstable Health|0|||
49158380|NCT00431964|158420697|FG001|Overall Study|Due to Unstable Health|1|||
49158381|NCT03323164|158420698|FG000|Overall Study|Poor quality imaging/scans|2|||
49158382|NCT03323164|158420699|FG001|Overall Study|Poor quality imaging/scans|2|||
49158383|NCT01882465|158420703|FG000|Period 1|Lens Discomfort|0|||
49158384|NCT01882465|158420704|FG001|Period 1|Lens Discomfort|0|||
49158385|NCT01882465|158420705|FG002|Period 1|Lens Discomfort|0|||
49158386|NCT01882465|158420706|FG003|Period 1|Lens Discomfort|1|||
49158387|NCT01882465|158420707|FG004|Period 1|Lens Discomfort|0|||
49158388|NCT01882465|158420708|FG005|Period 1|Lens Discomfort|0|||
49158389|NCT01882465|158420709|FG006|Period 1|Lens Discomfort|0|||
49158390|NCT01882465|158420703|FG000|Period 1|Withdrawal by Subject|0|||
49158391|NCT01882465|158420704|FG001|Period 1|Withdrawal by Subject|0|||
49158392|NCT01882465|158420705|FG002|Period 1|Withdrawal by Subject|0|||
49158393|NCT01882465|158420706|FG003|Period 1|Withdrawal by Subject|0|||
49158394|NCT01882465|158420707|FG004|Period 1|Withdrawal by Subject|0|||
49158395|NCT01882465|158420708|FG005|Period 1|Withdrawal by Subject|0|||
49158396|NCT01882465|158420709|FG006|Period 1|Withdrawal by Subject|1|||
49158397|NCT01882465|158420703|FG000|Period 2|Protocol Violation|0|||
49158398|NCT01882465|158420704|FG001|Period 2|Protocol Violation|0|||
49158399|NCT01882465|158420705|FG002|Period 2|Protocol Violation|0|||
48832513|NCT00843193|157227596|FG001|Overall Study|Adverse Event|4|||
48832514|NCT00843193|157227595|FG000|Overall Study|Lack of Efficacy|1|||
48832515|NCT00843193|157227596|FG001|Overall Study|Lack of Efficacy|1|||
48922909|NCT01262365|157551469|FG001|Overall Study|Randomization error|0|||
48922910|NCT01262365|157551470|FG002|Overall Study|Randomization error|2|||
49158400|NCT01882465|158420706|FG003|Period 2|Protocol Violation|0|||
48922911|NCT01262365|157551468|FG000|Overall Study|Non-compliance|1|||
48922912|NCT01262365|157551469|FG001|Overall Study|Non-compliance|0|||
48922913|NCT01262365|157551470|FG002|Overall Study|Non-compliance|2|||
48922914|NCT01262365|157551468|FG000|Overall Study|Suspected pregnancy|1|||
48922915|NCT01262365|157551469|FG001|Overall Study|Suspected pregnancy|0|||
48922916|NCT01262365|157551470|FG002|Overall Study|Suspected pregnancy|0|||
48922917|NCT01262365|157551468|FG000|Overall Study|Patient pregnant|1|||
48922918|NCT01262365|157551469|FG001|Overall Study|Patient pregnant|0|||
48922919|NCT01262365|157551470|FG002|Overall Study|Patient pregnant|1|||
48922920|NCT01262365|157551468|FG000|Overall Study|Toxicity related to study drug|0|||
48922921|NCT01262365|157551469|FG001|Overall Study|Toxicity related to study drug|1|||
49158401|NCT01882465|158420707|FG004|Period 2|Protocol Violation|1|||
49158402|NCT01882465|158420708|FG005|Period 2|Protocol Violation|0|||
49158403|NCT01882465|158420709|FG006|Period 2|Protocol Violation|0|||
49158404|NCT04436744|158420710|FG000|Overall Study|Adverse Event|1|||
49158405|NCT04436744|158420711|FG001|Overall Study|Adverse Event|1|||
48922922|NCT01262365|157551470|FG002|Overall Study|Toxicity related to study drug|0|||
48922923|NCT01262365|157551468|FG000|Overall Study|Cannot tolerate the protocol|0|||
49158406|NCT04436744|158420710|FG000|Overall Study|Death|1|||
49158407|NCT04436744|158420711|FG001|Overall Study|Death|0|||
49158408|NCT04436744|158420710|FG000|Overall Study|Lost to Follow-up|0|||
49158409|NCT04436744|158420711|FG001|Overall Study|Lost to Follow-up|2|||
49158410|NCT04436744|158420710|FG000|Overall Study|Physician Decision|0|||
49158411|NCT04436744|158420711|FG001|Overall Study|Physician Decision|1|||
49158412|NCT04436744|158420710|FG000|Overall Study|Progressive Disease|0|||
49158413|NCT04436744|158420711|FG001|Overall Study|Progressive Disease|4|||
49158414|NCT04436744|158420710|FG000|Overall Study|Protocol Deviation|1|||
49158415|NCT04436744|158420711|FG001|Overall Study|Protocol Deviation|1|||
49158416|NCT04436744|158420710|FG000|Overall Study|Withdrawal by Subject|1|||
49158417|NCT04436744|158420711|FG001|Overall Study|Withdrawal by Subject|2|||
48832516|NCT00843193|157227595|FG000|Overall Study|Protocol Violation|1|||
48832517|NCT00843193|157227596|FG001|Overall Study|Protocol Violation|2|||
48832518|NCT00843193|157227595|FG000|Overall Study|Lost to Follow-up|1|||
48832519|NCT00843193|157227596|FG001|Overall Study|Lost to Follow-up|0|||
48832520|NCT00843193|157227595|FG000|Overall Study|Physician Decision|0|||
48832521|NCT00843193|157227596|FG001|Overall Study|Physician Decision|1|||
48832522|NCT00843193|157227595|FG000|Overall Study|Withdrawal by Subject|3|||
48832523|NCT00843193|157227596|FG001|Overall Study|Withdrawal by Subject|3|||
48832524|NCT01648140|157227597|FG000|Overall Study|Physician Decision|1|||
48832525|NCT01648140|157227598|FG001|Overall Study|Physician Decision|0|||
48832526|NCT01648140|157227599|FG002|Overall Study|Physician Decision|0|||
48832527|NCT01648140|157227600|FG003|Overall Study|Physician Decision|0|||
48832528|NCT01648140|157227597|FG000|Overall Study|Lack of Efficacy|4|||
48832529|NCT01648140|157227598|FG001|Overall Study|Lack of Efficacy|7|||
48832530|NCT01648140|157227599|FG002|Overall Study|Lack of Efficacy|1|||
48832531|NCT01648140|157227600|FG003|Overall Study|Lack of Efficacy|0|||
48832532|NCT01648140|157227597|FG000|Overall Study|Adverse Event|3|||
48832533|NCT01648140|157227598|FG001|Overall Study|Adverse Event|1|||
48832534|NCT01648140|157227599|FG002|Overall Study|Adverse Event|2|||
48832535|NCT01648140|157227600|FG003|Overall Study|Adverse Event|0|||
48832536|NCT01648140|157227597|FG000|Overall Study|Withdrawal by Subject|2|||
48832537|NCT01648140|157227598|FG001|Overall Study|Withdrawal by Subject|3|||
48832538|NCT01648140|157227599|FG002|Overall Study|Withdrawal by Subject|3|||
48832539|NCT01648140|157227600|FG003|Overall Study|Withdrawal by Subject|2|||
48832540|NCT01648140|157227597|FG000|Overall Study|Lost to Follow-up|2|||
48832541|NCT01648140|157227598|FG001|Overall Study|Lost to Follow-up|1|||
48832542|NCT01648140|157227599|FG002|Overall Study|Lost to Follow-up|2|||
48832543|NCT01648140|157227600|FG003|Overall Study|Lost to Follow-up|0|||
48832544|NCT00880906|157227601|FG000|Overall Study|Lost to Follow-up|0|||
48832545|NCT00880906|157227602|FG001|Overall Study|Lost to Follow-up|1|||
48832546|NCT00880906|157227601|FG000|Overall Study|Did not meet criteria following patholog|12|||
48832547|NCT00880906|157227602|FG001|Overall Study|Did not meet criteria following patholog|6|||
48832548|NCT01119950|157227603|FG000|Overall Study|Adverse Event|25|||
48832549|NCT01119950|157227603|FG000|Overall Study|Withdrawal by Subject|9|||
48832550|NCT01119950|157227603|FG000|Overall Study|Protocol Violation|5|||
48832551|NCT01119950|157227603|FG000|Overall Study|Lost to Follow-up|4|||
48832552|NCT01119950|157227603|FG000|Overall Study|Administrative|2|||
48832553|NCT01119950|157227603|FG000|Overall Study|Abnormal lab value|1|||
48832554|NCT01119950|157227603|FG000|Overall Study|Death|1|||
48832555|NCT00906035|157227606|FG000|Overall Study|Withdrawal by Subject|2|||
48832556|NCT00906035|157227607|FG001|Overall Study|Withdrawal by Subject|3|||
48832557|NCT00906035|157227608|FG002|Overall Study|Withdrawal by Subject|0|||
49158418|NCT02712788|158420712|FG000|Overall Study|Physician Decision|1|||
49158419|NCT02712788|158420713|FG001|Overall Study|Physician Decision|0|||
48832558|NCT03621761|157227609|FG000|Overall Study|Lost to Follow-up|1|||
48832559|NCT03621761|157227610|FG001|Overall Study|Lost to Follow-up|1|||
48832560|NCT03621761|157227611|FG002|Overall Study|Lost to Follow-up|2|||
48922924|NCT01262365|157551469|FG001|Overall Study|Cannot tolerate the protocol|1|||
49158420|NCT02712788|158420712|FG000|Overall Study|Protocol Violation|1|||
48832561|NCT03621761|157227609|FG000|Overall Study|Withdrawal by Subject|2|||
48832562|NCT03621761|157227610|FG001|Overall Study|Withdrawal by Subject|1|||
48832563|NCT03621761|157227611|FG002|Overall Study|Withdrawal by Subject|1|||
48832564|NCT03621761|157227609|FG000|Overall Study|Became Ineligible|0|||
48832565|NCT03621761|157227610|FG001|Overall Study|Became Ineligible|2|||
48832566|NCT03621761|157227611|FG002|Overall Study|Became Ineligible|0|||
48832567|NCT02107014|157227614|FG000|Overall Study|Withdrew before drug: moving interstate|1|||
48832568|NCT00591838|157227615|FG000|Overall Study|Withdrawal by Subject|0|||
48832569|NCT00591838|157227616|FG001|Overall Study|Withdrawal by Subject|0|||
48832570|NCT00591838|157227617|FG002|Overall Study|Withdrawal by Subject|0|||
48832571|NCT00591838|157227618|FG003|Overall Study|Withdrawal by Subject|1|||
48832572|NCT00591838|157227619|FG004|Overall Study|Withdrawal by Subject|0|||
48832573|NCT01591616|157227620|FG000|Overall Study|Withdrawal by Subject|1|||
48832574|NCT01909336|157227624|FG000|Overall Study|Lost to Follow-up|4|||
48832575|NCT01909336|157227625|FG001|Overall Study|Lost to Follow-up|2|||
48832576|NCT01909336|157227626|FG002|Overall Study|Lost to Follow-up|2|||
48832577|NCT01909336|157227624|FG000|Overall Study|Physician Decision|0|||
48832578|NCT01909336|157227625|FG001|Overall Study|Physician Decision|1|||
48832579|NCT01909336|157227626|FG002|Overall Study|Physician Decision|1|||
48832580|NCT00619645|157227627|FG000|Overall Study|Adverse Event|1|||
48832581|NCT04364269|157227628|FG000|Overall Study|Adverse Event|1|||
48832582|NCT04364269|157227629|FG001|Overall Study|Adverse Event|0|||
48832583|NCT04364269|157227630|FG002|Overall Study|Adverse Event|0|||
48832584|NCT04364269|157227628|FG000|Overall Study|Withdrawal by Subject|0|||
48832585|NCT04364269|157227629|FG001|Overall Study|Withdrawal by Subject|1|||
48832586|NCT04364269|157227630|FG002|Overall Study|Withdrawal by Subject|0|||
48832587|NCT02914522|157227633|FG000|Induction Study: Up to Week 11|Adverse Event|5|||
48832588|NCT02914522|157227634|FG001|Induction Study: Up to Week 11|Adverse Event|6|||
48832589|NCT02914522|157227635|FG002|Induction Study: Up to Week 11|Adverse Event|4|||
48832590|NCT02914522|157227636|FG003|Induction Study: Up to Week 11|Adverse Event|18|||
48832591|NCT02914522|157227637|FG004|Induction Study: Up to Week 11|Adverse Event|14|||
48832592|NCT02914522|157227638|FG005|Induction Study: Up to Week 11|Adverse Event|10|||
48832593|NCT02914522|157227639|FG006|Induction Study: Up to Week 11|Adverse Event|0|||
48832594|NCT02914522|157227640|FG007|Induction Study: Up to Week 11|Adverse Event|0|||
48832595|NCT02914522|157227641|FG008|Induction Study: Up to Week 11|Adverse Event|0|||
48832596|NCT02914522|157227642|FG009|Induction Study: Up to Week 11|Adverse Event|0|||
48832597|NCT02914522|157227643|FG010|Induction Study: Up to Week 11|Adverse Event|0|||
48832598|NCT02914522|157227633|FG000|Induction Study: Up to Week 11|Withdrew Consent|4|||
48922925|NCT01262365|157551470|FG002|Overall Study|Cannot tolerate the protocol|0|||
48922926|NCT01262365|157551468|FG000|Overall Study|Patient unavailable|0|||
48922927|NCT01262365|157551469|FG001|Overall Study|Patient unavailable|0|||
48922928|NCT01262365|157551470|FG002|Overall Study|Patient unavailable|1|||
48922929|NCT02095535|157551472|FG000|Recruitment|Protocol Violation|2|||
48922930|NCT01368835|157551473|FG000|Overall Study|Inclusion criteria/photography quality|22|||
48922931|NCT01368835|157551473|FG000|Overall Study|Lost to Follow-up|11|||
48922932|NCT01594853|157551474|FG000|Overall Study|Withdrawal by Subject|1|||
48922933|NCT01594853|157551475|FG001|Overall Study|Withdrawal by Subject|1|||
48922934|NCT01594853|157551474|FG000|Overall Study|Lost to Follow-up|1|||
48922935|NCT01594853|157551475|FG001|Overall Study|Lost to Follow-up|1|||
48922936|NCT01594853|157551474|FG000|Overall Study|noncompliance with exercise|0|||
48922937|NCT01594853|157551475|FG001|Overall Study|noncompliance with exercise|1|||
48922938|NCT01414257|157551476|FG000|Overall Study|No Visit After First Day of Treatment|12|||
48922939|NCT01414257|157551476|FG000|Overall Study|Protocol Violation|10|||
48922940|NCT00769002|157551479|FG000|Overall Study|Study was not completed, no data|9|||
48922941|NCT00769002|157551480|FG001|Overall Study|Study was not completed, no data|9|||
48922942|NCT03776175|157551482|FG000|Treatment Period (42 Days)|Adverse Event|0|||
48922943|NCT03776175|157551483|FG001|Treatment Period (42 Days)|Adverse Event|1|||
48922944|NCT03776175|157551484|FG002|Treatment Period (42 Days)|Adverse Event|1|||
48922945|NCT03776175|157551485|FG003|Treatment Period (42 Days)|Adverse Event|0|||
48922946|NCT03776175|157551482|FG000|Treatment Period (42 Days)|Lost to Follow-up|0|||
48922947|NCT03776175|157551483|FG001|Treatment Period (42 Days)|Lost to Follow-up|0|||
48922948|NCT03776175|157551484|FG002|Treatment Period (42 Days)|Lost to Follow-up|0|||
48922949|NCT03776175|157551485|FG003|Treatment Period (42 Days)|Lost to Follow-up|2|||
48922950|NCT03776175|157551482|FG000|Treatment Period (42 Days)|Participants screened at other site|0|||
48922951|NCT03776175|157551483|FG001|Treatment Period (42 Days)|Participants screened at other site|2|||
48922952|NCT03776175|157551484|FG002|Treatment Period (42 Days)|Participants screened at other site|0|||
48922953|NCT03776175|157551485|FG003|Treatment Period (42 Days)|Participants screened at other site|0|||
48922954|NCT03776175|157551482|FG000|Treatment Period (42 Days)|Withdrawal by Subject|1|||
48922955|NCT03776175|157551483|FG001|Treatment Period (42 Days)|Withdrawal by Subject|2|||
48922956|NCT03776175|157551484|FG002|Treatment Period (42 Days)|Withdrawal by Subject|3|||
48922957|NCT03776175|157551485|FG003|Treatment Period (42 Days)|Withdrawal by Subject|0|||
48832599|NCT02914522|157227634|FG001|Induction Study: Up to Week 11|Withdrew Consent|11|||
48832600|NCT02914522|157227635|FG002|Induction Study: Up to Week 11|Withdrew Consent|4|||
49158421|NCT02712788|158420713|FG001|Overall Study|Protocol Violation|0|||
49158422|NCT01378117|158420717|FG000|Overall Study|withdrawal|2|||
49158423|NCT01378117|158420718|FG001|Overall Study|withdrawal|1|||
49158424|NCT01378117|158420719|FG002|Overall Study|withdrawal|2|||
49158425|NCT01378117|158420717|FG000|Overall Study|discharged before med given|2|||
49158426|NCT01378117|158420718|FG001|Overall Study|discharged before med given|0|||
49158427|NCT01378117|158420719|FG002|Overall Study|discharged before med given|1|||
49158428|NCT02951780|158420724|FG000|Period 1|Adverse Event|0|||
49158429|NCT02951780|158420725|FG001|Period 1|Adverse Event|0|||
49158430|NCT02951780|158420726|FG002|Period 1|Adverse Event|0|||
49158431|NCT02951780|158420727|FG003|Period 1|Adverse Event|1|||
49158432|NCT02951780|158420728|FG004|Period 1|Adverse Event|0|||
49158433|NCT02951780|158420729|FG005|Period 1|Adverse Event|0|||
49158434|NCT02951780|158420730|FG006|Period 1|Adverse Event|0|||
49158435|NCT02951780|158420731|FG007|Period 1|Adverse Event|0|||
49158436|NCT02951780|158420732|FG008|Period 1|Adverse Event|0|||
49158437|NCT02951780|158420724|FG000|Period 1|Scheduling Conflicts|0|||
49158438|NCT02951780|158420725|FG001|Period 1|Scheduling Conflicts|0|||
49158439|NCT02951780|158420726|FG002|Period 1|Scheduling Conflicts|0|||
49158440|NCT02951780|158420727|FG003|Period 1|Scheduling Conflicts|0|||
49158441|NCT02951780|158420728|FG004|Period 1|Scheduling Conflicts|0|||
49158442|NCT02951780|158420729|FG005|Period 1|Scheduling Conflicts|0|||
49158443|NCT02951780|158420730|FG006|Period 1|Scheduling Conflicts|0|||
49158444|NCT02951780|158420731|FG007|Period 1|Scheduling Conflicts|1|||
49158445|NCT02951780|158420732|FG008|Period 1|Scheduling Conflicts|0|||
49158446|NCT02951780|158420724|FG000|Period 2|Scheduling Conflicts|0|||
48832601|NCT02914522|157227636|FG003|Induction Study: Up to Week 11|Withdrew Consent|6|||
48832602|NCT02914522|157227637|FG004|Induction Study: Up to Week 11|Withdrew Consent|3|||
48832603|NCT02914522|157227638|FG005|Induction Study: Up to Week 11|Withdrew Consent|3|||
48832604|NCT02914522|157227639|FG006|Induction Study: Up to Week 11|Withdrew Consent|0|||
48832605|NCT02914522|157227640|FG007|Induction Study: Up to Week 11|Withdrew Consent|0|||
48832606|NCT02914522|157227641|FG008|Induction Study: Up to Week 11|Withdrew Consent|0|||
48832607|NCT02914522|157227642|FG009|Induction Study: Up to Week 11|Withdrew Consent|0|||
48832608|NCT02914522|157227643|FG010|Induction Study: Up to Week 11|Withdrew Consent|0|||
48832609|NCT02914522|157227633|FG000|Induction Study: Up to Week 11|Protocol Violation|0|||
48832610|NCT02914522|157227634|FG001|Induction Study: Up to Week 11|Protocol Violation|2|||
48832611|NCT02914522|157227635|FG002|Induction Study: Up to Week 11|Protocol Violation|1|||
48832612|NCT02914522|157227636|FG003|Induction Study: Up to Week 11|Protocol Violation|3|||
48832613|NCT02914522|157227637|FG004|Induction Study: Up to Week 11|Protocol Violation|4|||
48832614|NCT02914522|157227638|FG005|Induction Study: Up to Week 11|Protocol Violation|2|||
48832615|NCT02914522|157227639|FG006|Induction Study: Up to Week 11|Protocol Violation|0|||
48832616|NCT02914522|157227640|FG007|Induction Study: Up to Week 11|Protocol Violation|0|||
48832617|NCT02914522|157227641|FG008|Induction Study: Up to Week 11|Protocol Violation|0|||
48832618|NCT02914522|157227642|FG009|Induction Study: Up to Week 11|Protocol Violation|0|||
48832619|NCT02914522|157227643|FG010|Induction Study: Up to Week 11|Protocol Violation|0|||
48832620|NCT02914522|157227633|FG000|Induction Study: Up to Week 11|Lost to Follow-up|0|||
48832621|NCT02914522|157227634|FG001|Induction Study: Up to Week 11|Lost to Follow-up|2|||
48832622|NCT02914522|157227635|FG002|Induction Study: Up to Week 11|Lost to Follow-up|1|||
48832623|NCT02914522|157227636|FG003|Induction Study: Up to Week 11|Lost to Follow-up|1|||
48832624|NCT02914522|157227637|FG004|Induction Study: Up to Week 11|Lost to Follow-up|0|||
48832625|NCT02914522|157227638|FG005|Induction Study: Up to Week 11|Lost to Follow-up|0|||
48832626|NCT02914522|157227639|FG006|Induction Study: Up to Week 11|Lost to Follow-up|0|||
49014580|NCT04634409|157888933|FG010|Overall Study|Death|1|||
49158447|NCT02951780|158420725|FG001|Period 2|Scheduling Conflicts|0|||
49158448|NCT02951780|158420726|FG002|Period 2|Scheduling Conflicts|0|||
49158449|NCT02951780|158420727|FG003|Period 2|Scheduling Conflicts|0|||
49158450|NCT02951780|158420728|FG004|Period 2|Scheduling Conflicts|0|||
49158451|NCT02951780|158420729|FG005|Period 2|Scheduling Conflicts|0|||
49158452|NCT02951780|158420730|FG006|Period 2|Scheduling Conflicts|0|||
49158453|NCT02951780|158420731|FG007|Period 2|Scheduling Conflicts|1|||
49158454|NCT02951780|158420732|FG008|Period 2|Scheduling Conflicts|0|||
49158455|NCT02359903|158420733|FG000|Overall Study|Adverse Event|0|||
48832627|NCT02914522|157227640|FG007|Induction Study: Up to Week 11|Lost to Follow-up|0|||
48832628|NCT02914522|157227641|FG008|Induction Study: Up to Week 11|Lost to Follow-up|0|||
48832629|NCT02914522|157227642|FG009|Induction Study: Up to Week 11|Lost to Follow-up|0|||
48832630|NCT02914522|157227643|FG010|Induction Study: Up to Week 11|Lost to Follow-up|0|||
48832631|NCT02914522|157227633|FG000|Induction Study: Up to Week 11|Investigator's Discretion|0|||
48832632|NCT02914522|157227634|FG001|Induction Study: Up to Week 11|Investigator's Discretion|0|||
48832633|NCT02914522|157227635|FG002|Induction Study: Up to Week 11|Investigator's Discretion|0|||
48832634|NCT02914522|157227636|FG003|Induction Study: Up to Week 11|Investigator's Discretion|0|||
48832635|NCT02914522|157227637|FG004|Induction Study: Up to Week 11|Investigator's Discretion|1|||
48832636|NCT02914522|157227638|FG005|Induction Study: Up to Week 11|Investigator's Discretion|0|||
48832637|NCT02914522|157227639|FG006|Induction Study: Up to Week 11|Investigator's Discretion|0|||
48922958|NCT03776175|157551482|FG000|Treatment Period (42 Days)|Unable to attend study visits|0|||
49158456|NCT02359903|158420734|FG001|Overall Study|Adverse Event|2|||
49158457|NCT01077063|158420735|FG000|Overall Study|Adverse Event|3|||
49158458|NCT01077063|158420736|FG001|Overall Study|Adverse Event|0|||
49158459|NCT01077063|158420735|FG000|Overall Study|Death|1|||
49158460|NCT01077063|158420736|FG001|Overall Study|Death|1|||
49158461|NCT01077063|158420735|FG000|Overall Study|Withdrawal by Subject|0|||
49158462|NCT01077063|158420736|FG001|Overall Study|Withdrawal by Subject|2|||
49158463|NCT04117347|158420739|FG000|Overall Study|Adverse Event|0|||
49158464|NCT04117347|158420740|FG001|Overall Study|Adverse Event|0|||
49158465|NCT04117347|158420741|FG002|Overall Study|Adverse Event|1|||
49158466|NCT04117347|158420739|FG000|Overall Study|No time for study|0|||
49158467|NCT04117347|158420740|FG001|Overall Study|No time for study|2|||
49158468|NCT04117347|158420741|FG002|Overall Study|No time for study|0|||
49158469|NCT04117347|158420739|FG000|Overall Study|Family emergency|1|||
49158470|NCT04117347|158420740|FG001|Overall Study|Family emergency|0|||
48832638|NCT02914522|157227640|FG007|Induction Study: Up to Week 11|Investigator's Discretion|0|||
49158471|NCT04117347|158420741|FG002|Overall Study|Family emergency|0|||
49158472|NCT02121509|158420745|FG000|Washout Period (35 Days)|Adverse Event|1|||
49158473|NCT02121509|158420746|FG001|Washout Period (35 Days)|Adverse Event|1|||
49158474|NCT02121509|158420747|FG002|Washout Period (35 Days)|Adverse Event|0|||
49158475|NCT02121509|158420748|FG003|Washout Period (35 Days)|Adverse Event|0|||
49158476|NCT02121509|158420745|FG000|Washout Period (35 Days)|Withdrawal by Subject|0|||
49158477|NCT02121509|158420746|FG001|Washout Period (35 Days)|Withdrawal by Subject|3|||
49158478|NCT02121509|158420747|FG002|Washout Period (35 Days)|Withdrawal by Subject|0|||
49158479|NCT02121509|158420748|FG003|Washout Period (35 Days)|Withdrawal by Subject|0|||
49158480|NCT02121509|158420745|FG000|Washout Period (35 Days)|elevated AST and ALT levels|1|||
49158481|NCT02121509|158420746|FG001|Washout Period (35 Days)|elevated AST and ALT levels|0|||
49158482|NCT02121509|158420747|FG002|Washout Period (35 Days)|elevated AST and ALT levels|0|||
49158483|NCT02121509|158420748|FG003|Washout Period (35 Days)|elevated AST and ALT levels|0|||
49158484|NCT03069716|158420749|FG000|Run-in Period (2 Weeks)|Adverse Event|1|||
49158485|NCT03069716|158420750|FG001|Run-in Period (2 Weeks)|Adverse Event|0|||
49158486|NCT03069716|158420751|FG002|Run-in Period (2 Weeks)|Adverse Event|0|||
48832639|NCT02914522|157227641|FG008|Induction Study: Up to Week 11|Investigator's Discretion|0|||
48832640|NCT02914522|157227642|FG009|Induction Study: Up to Week 11|Investigator's Discretion|0|||
48832641|NCT02914522|157227643|FG010|Induction Study: Up to Week 11|Investigator's Discretion|0|||
48832642|NCT02914522|157227633|FG000|Induction Study: Up to Week 11|Non-compliance With Study Drug|1|||
48832643|NCT02914522|157227634|FG001|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
48832644|NCT02914522|157227635|FG002|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
48832645|NCT02914522|157227636|FG003|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
48922959|NCT03776175|157551483|FG001|Treatment Period (42 Days)|Unable to attend study visits|2|||
48922960|NCT03776175|157551484|FG002|Treatment Period (42 Days)|Unable to attend study visits|0|||
48832646|NCT02914522|157227637|FG004|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
48832647|NCT02914522|157227638|FG005|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
48922961|NCT03776175|157551485|FG003|Treatment Period (42 Days)|Unable to attend study visits|0|||
48922962|NCT03776175|157551482|FG000|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
49158487|NCT03069716|158420749|FG000|Run-in Period (2 Weeks)|Protocol Violation|1|||
49158488|NCT03069716|158420750|FG001|Run-in Period (2 Weeks)|Protocol Violation|0|||
49158489|NCT03069716|158420751|FG002|Run-in Period (2 Weeks)|Protocol Violation|0|||
48922963|NCT03776175|157551483|FG001|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
48922964|NCT03776175|157551484|FG002|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
49158490|NCT03069716|158420749|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|5|||
49158491|NCT03069716|158420750|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
49158492|NCT03069716|158420751|FG002|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
49158493|NCT03069716|158420749|FG000|Randomized Treatment|Withdrawal by Subject|0|||
49158494|NCT03069716|158420750|FG001|Randomized Treatment|Withdrawal by Subject|2|||
49158495|NCT03069716|158420751|FG002|Randomized Treatment|Withdrawal by Subject|0|||
49158496|NCT02993263|158420752|FG000|Overall Study|Equipment Software failed and results were lost.|323|||
49158497|NCT00543985|158420753|FG000|Overall Study|Withdrawal by Subject|4|||
49158498|NCT01634152|158420754|FG000|Overall Study|Adverse Event|2|||
49158499|NCT01634152|158420755|FG001|Overall Study|Adverse Event|0|||
49158500|NCT01634152|158420756|FG002|Overall Study|Adverse Event|2|||
49158501|NCT01634152|158420754|FG000|Overall Study|Consent withdrawn not due to AE|1|||
49158502|NCT01634152|158420755|FG001|Overall Study|Consent withdrawn not due to AE|0|||
49158503|NCT01634152|158420756|FG002|Overall Study|Consent withdrawn not due to AE|1|||
49158504|NCT01634152|158420754|FG000|Overall Study|Not treated|0|||
49158505|NCT01634152|158420755|FG001|Overall Study|Not treated|1|||
49158506|NCT01634152|158420756|FG002|Overall Study|Not treated|0|||
49158507|NCT01634152|158420754|FG000|Overall Study|Other reason not defined above|1|||
49158508|NCT01634152|158420755|FG001|Overall Study|Other reason not defined above|0|||
49158509|NCT01634152|158420756|FG002|Overall Study|Other reason not defined above|1|||
49158510|NCT00279214|158420760|FG000|Overall Study|Physician Decision|3|||
48832648|NCT02914522|157227639|FG006|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
48832649|NCT02914522|157227640|FG007|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
48832650|NCT02914522|157227641|FG008|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
48832651|NCT02914522|157227642|FG009|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
48832652|NCT02914522|157227643|FG010|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
48832653|NCT02914522|157227633|FG000|Induction Study: Up to Week 11|Pregnancy|0|||
48832654|NCT02914522|157227634|FG001|Induction Study: Up to Week 11|Pregnancy|0|||
48832655|NCT02914522|157227635|FG002|Induction Study: Up to Week 11|Pregnancy|0|||
48832656|NCT02914522|157227636|FG003|Induction Study: Up to Week 11|Pregnancy|0|||
48832657|NCT02914522|157227637|FG004|Induction Study: Up to Week 11|Pregnancy|1|||
48832658|NCT02914522|157227638|FG005|Induction Study: Up to Week 11|Pregnancy|0|||
48832659|NCT02914522|157227639|FG006|Induction Study: Up to Week 11|Pregnancy|0|||
48832660|NCT02914522|157227640|FG007|Induction Study: Up to Week 11|Pregnancy|0|||
49158511|NCT00279214|158420761|FG001|Overall Study|Physician Decision|2|||
48832661|NCT02914522|157227641|FG008|Induction Study: Up to Week 11|Pregnancy|0|||
48832662|NCT02914522|157227642|FG009|Induction Study: Up to Week 11|Pregnancy|0|||
48832663|NCT02914522|157227643|FG010|Induction Study: Up to Week 11|Pregnancy|0|||
48832664|NCT02914522|157227633|FG000|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
48832665|NCT02914522|157227634|FG001|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
48832666|NCT02914522|157227635|FG002|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
48832667|NCT02914522|157227636|FG003|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
48832668|NCT02914522|157227637|FG004|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
48832669|NCT02914522|157227638|FG005|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
48832670|NCT02914522|157227639|FG006|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
48832671|NCT02914522|157227640|FG007|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
48832672|NCT02914522|157227641|FG008|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
48832673|NCT02914522|157227642|FG009|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
48832674|NCT02914522|157227643|FG010|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
48832675|NCT02914522|157227633|FG000|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
48832676|NCT02914522|157227634|FG001|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
48832677|NCT02914522|157227635|FG002|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
48832678|NCT02914522|157227636|FG003|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
48832679|NCT02914522|157227637|FG004|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
48832680|NCT02914522|157227638|FG005|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
49158512|NCT04749914|158420762|FG000|Period 1|Adverse Event|1|||
49158513|NCT04749914|158420763|FG001|Period 1|Adverse Event|0|||
49158514|NCT04749914|158420764|FG002|Period 1|Adverse Event|0|||
48832681|NCT02914522|157227639|FG006|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34|||
48832682|NCT02914522|157227640|FG007|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49|||
48832683|NCT02914522|157227641|FG008|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53|||
48832684|NCT02914522|157227642|FG009|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39|||
48832685|NCT02914522|157227643|FG010|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21|||
48832686|NCT02914522|157227633|FG000|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
48832687|NCT02914522|157227634|FG001|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
48832688|NCT02914522|157227635|FG002|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
48832689|NCT02914522|157227636|FG003|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
48832690|NCT02914522|157227637|FG004|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
48832691|NCT02914522|157227638|FG005|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
48832692|NCT02914522|157227639|FG006|Maintenance Study: Week 11 to Week 58|Adverse Event|7|||
48832693|NCT02914522|157227640|FG007|Maintenance Study: Week 11 to Week 58|Adverse Event|2|||
48832694|NCT02914522|157227641|FG008|Maintenance Study: Week 11 to Week 58|Adverse Event|10|||
48832695|NCT02914522|157227642|FG009|Maintenance Study: Week 11 to Week 58|Adverse Event|4|||
48832696|NCT02914522|157227643|FG010|Maintenance Study: Week 11 to Week 58|Adverse Event|3|||
48832697|NCT02914522|157227633|FG000|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
48832698|NCT02914522|157227634|FG001|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
48832699|NCT02914522|157227635|FG002|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
48832700|NCT02914522|157227636|FG003|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
48832701|NCT02914522|157227637|FG004|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
48832702|NCT02914522|157227638|FG005|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
48832703|NCT02914522|157227639|FG006|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
48832704|NCT02914522|157227640|FG007|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
48832705|NCT02914522|157227641|FG008|Maintenance Study: Week 11 to Week 58|Protocol Violation|3|||
48832706|NCT02914522|157227642|FG009|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
48832707|NCT02914522|157227643|FG010|Maintenance Study: Week 11 to Week 58|Protocol Violation|1|||
48832708|NCT02914522|157227633|FG000|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
48832709|NCT02914522|157227634|FG001|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
48832710|NCT02914522|157227635|FG002|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
48832711|NCT02914522|157227636|FG003|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
48832712|NCT02914522|157227637|FG004|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
48832713|NCT02914522|157227638|FG005|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
48832714|NCT02914522|157227639|FG006|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
48832715|NCT02914522|157227640|FG007|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1|||
48832716|NCT02914522|157227641|FG008|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6|||
48832717|NCT02914522|157227642|FG009|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3|||
48832718|NCT02914522|157227643|FG010|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
48832719|NCT02914522|157227633|FG000|Maintenance Study: Week 11 to Week 58|Death|0|||
48832720|NCT02914522|157227634|FG001|Maintenance Study: Week 11 to Week 58|Death|0|||
48832721|NCT02914522|157227635|FG002|Maintenance Study: Week 11 to Week 58|Death|0|||
48832722|NCT02914522|157227636|FG003|Maintenance Study: Week 11 to Week 58|Death|0|||
48832723|NCT02914522|157227637|FG004|Maintenance Study: Week 11 to Week 58|Death|0|||
48922965|NCT03776175|157551485|FG003|Follow-Up Period (35 Days)|Lost to Follow-up|2|||
48922966|NCT01784965|157551489|FG000|Overall Study|Withdrawal by Subject|6|||
49158515|NCT04749914|158420765|FG003|Period 1|Adverse Event|0|||
49158516|NCT04749914|158420762|FG000|Period 1|Withdrawal by Subject|1|||
49158517|NCT04749914|158420763|FG001|Period 1|Withdrawal by Subject|0|||
49158518|NCT04749914|158420764|FG002|Period 1|Withdrawal by Subject|1|||
49158519|NCT04749914|158420765|FG003|Period 1|Withdrawal by Subject|0|||
49158520|NCT00237042|158420770|FG000|Treatment|Became ineligible post-randomization|0|||
49158521|NCT00237042|158420771|FG001|Treatment|Became ineligible post-randomization|1|||
49158522|NCT00237042|158420772|FG002|Treatment|Became ineligible post-randomization|16|||
49158523|NCT00237042|158420770|FG000|Treatment|Moved out of state|1|||
49158524|NCT00237042|158420771|FG001|Treatment|Moved out of state|1|||
49158525|NCT00237042|158420772|FG002|Treatment|Moved out of state|1|||
49158526|NCT00237042|158420770|FG000|Treatment|Completed no treatment|5|||
49158527|NCT00237042|158420771|FG001|Treatment|Completed no treatment|5|||
49158528|NCT00237042|158420772|FG002|Treatment|Completed no treatment|21|||
49158529|NCT00237042|158420770|FG000|Short Term (6 Month) Follow up|Lost to Follow-up|9|||
49158530|NCT00237042|158420771|FG001|Short Term (6 Month) Follow up|Lost to Follow-up|8|||
49158531|NCT00237042|158420772|FG002|Short Term (6 Month) Follow up|Lost to Follow-up|11|||
49158532|NCT00237042|158420770|FG000|Long Term (12 Month) Follow up|Lost to Follow-up|11|||
49158533|NCT00237042|158420771|FG001|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
49158534|NCT00237042|158420772|FG002|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
49158535|NCT01074931|158420773|FG000|Overall Study|Economic reasons|1|||
49158536|NCT01074931|158420773|FG000|Overall Study|Death|5|||
49158537|NCT04466891|158420774|FG000|Overall Study|Death|52|||
49158538|NCT04466891|158420775|FG001|Overall Study|Death|5|||
48832724|NCT02914522|157227638|FG005|Maintenance Study: Week 11 to Week 58|Death|0|||
48832725|NCT02914522|157227639|FG006|Maintenance Study: Week 11 to Week 58|Death|2|||
48832726|NCT02914522|157227640|FG007|Maintenance Study: Week 11 to Week 58|Death|0|||
48832727|NCT02914522|157227641|FG008|Maintenance Study: Week 11 to Week 58|Death|0|||
48832728|NCT02914522|157227642|FG009|Maintenance Study: Week 11 to Week 58|Death|0|||
48832729|NCT02914522|157227643|FG010|Maintenance Study: Week 11 to Week 58|Death|0|||
48832730|NCT02914522|157227633|FG000|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
48832731|NCT02914522|157227634|FG001|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
48832732|NCT02914522|157227635|FG002|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
48832733|NCT02914522|157227636|FG003|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
48832734|NCT02914522|157227637|FG004|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
48832735|NCT02914522|157227638|FG005|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
48832736|NCT02914522|157227639|FG006|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
48832737|NCT02914522|157227640|FG007|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1|||
48832738|NCT02914522|157227641|FG008|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2|||
48832739|NCT02914522|157227642|FG009|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
48832740|NCT02914522|157227643|FG010|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
48832741|NCT02914522|157227633|FG000|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
48832742|NCT02914522|157227634|FG001|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
48832743|NCT02914522|157227635|FG002|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
48832744|NCT02914522|157227636|FG003|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
48832745|NCT02914522|157227637|FG004|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
49158539|NCT04466891|158420774|FG000|Overall Study|Withdrawal by Subject|8|||
49158540|NCT04466891|158420775|FG001|Overall Study|Withdrawal by Subject|1|||
49158541|NCT01214837|158420776|FG000|Overall Study|Death|0|||
49158542|NCT01214837|158420777|FG001|Overall Study|Death|0|||
48922967|NCT01784965|157551490|FG001|Overall Study|Withdrawal by Subject|3|||
48922968|NCT01784965|157551489|FG000|Overall Study|Adverse Event|0|||
48922969|NCT01784965|157551490|FG001|Overall Study|Adverse Event|8|||
48922970|NCT00783094|157551491|FG000|Randomized Double-Blind Treatment Period|Adverse Event|4|||
49158543|NCT01214837|158420778|FG002|Overall Study|Death|1|||
49158544|NCT01214837|158420776|FG000|Overall Study|Adverse Event|1|||
49158545|NCT01214837|158420777|FG001|Overall Study|Adverse Event|2|||
49158546|NCT01214837|158420778|FG002|Overall Study|Adverse Event|1|||
49158547|NCT01214837|158420776|FG000|Overall Study|Withdrawal by Subject|27|||
49158548|NCT01214837|158420777|FG001|Overall Study|Withdrawal by Subject|36|||
49158549|NCT01214837|158420778|FG002|Overall Study|Withdrawal by Subject|28|||
48832746|NCT02914522|157227638|FG005|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
48832747|NCT02914522|157227639|FG006|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
49158550|NCT01214837|158420776|FG000|Overall Study|Lost to Follow-up|20|||
49158551|NCT01214837|158420777|FG001|Overall Study|Lost to Follow-up|15|||
49158552|NCT01214837|158420778|FG002|Overall Study|Lost to Follow-up|21|||
49158553|NCT01214837|158420776|FG000|Overall Study|Inappropriate Enrolment|0|||
49158554|NCT01214837|158420777|FG001|Overall Study|Inappropriate Enrolment|1|||
49158555|NCT01214837|158420778|FG002|Overall Study|Inappropriate Enrolment|2|||
49158556|NCT01214837|158420776|FG000|Overall Study|Administrative Reason|2|||
49158557|NCT01214837|158420777|FG001|Overall Study|Administrative Reason|6|||
49158558|NCT01214837|158420778|FG002|Overall Study|Administrative Reason|4|||
49158559|NCT01214837|158420776|FG000|Overall Study|Protocol Violation|3|||
49158560|NCT01214837|158420777|FG001|Overall Study|Protocol Violation|1|||
49158561|NCT01214837|158420778|FG002|Overall Study|Protocol Violation|5|||
49158562|NCT01214837|158420776|FG000|Overall Study|Unable to Classify|1|||
49158563|NCT01214837|158420777|FG001|Overall Study|Unable to Classify|3|||
49158564|NCT01214837|158420778|FG002|Overall Study|Unable to Classify|0|||
49158565|NCT05223673|158420779|FG000|Overall Study|Protocol Violation|1|||
49158566|NCT05223673|158420779|FG000|Overall Study|Study termination|6|||
49158567|NCT02112656|158420780|FG000|Overall Study|Death|78|||
49158568|NCT02112656|158420781|FG001|Overall Study|Death|82|||
49158569|NCT02112656|158420780|FG000|Overall Study|Withdrawal by Subject|9|||
49158570|NCT02112656|158420781|FG001|Overall Study|Withdrawal by Subject|11|||
49158571|NCT02112656|158420780|FG000|Overall Study|Lost to Follow-up|2|||
49158572|NCT02112656|158420781|FG001|Overall Study|Lost to Follow-up|4|||
49158573|NCT02112656|158420780|FG000|Overall Study|Noncompliance|1|||
49158574|NCT02112656|158420781|FG001|Overall Study|Noncompliance|2|||
49158575|NCT04696146|158422076|FG000|Overall Study|Transplant Cancelled and did not proceed with study|0|||
49158576|NCT04696146|158422077|FG001|Overall Study|Transplant Cancelled and did not proceed with study|4|||
49158577|NCT04696146|158422076|FG000|Overall Study|Off hours issue with product|1|||
49158578|NCT04696146|158422077|FG001|Overall Study|Off hours issue with product|0|||
48832748|NCT02914522|157227640|FG007|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
49158579|NCT00529633|158422078|FG000|Overall Study|Withdrawal by Subject|1|||
49158580|NCT00529633|158422079|FG001|Overall Study|Withdrawal by Subject|1|||
49158581|NCT01334918|158422080|FG000|Overall Study|Did not receive study drug|6|||
49158582|NCT01334918|158422081|FG001|Overall Study|Did not receive study drug|0|||
48832749|NCT02914522|157227641|FG008|Maintenance Study: Week 11 to Week 58|Pregnancy|1|||
48832750|NCT02914522|157227642|FG009|Maintenance Study: Week 11 to Week 58|Pregnancy|2|||
48832751|NCT02914522|157227643|FG010|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
48832752|NCT02914522|157227633|FG000|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
48832753|NCT02914522|157227634|FG001|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
48832754|NCT02914522|157227635|FG002|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
48832755|NCT02914522|157227636|FG003|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
48832756|NCT02914522|157227637|FG004|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
48832757|NCT02914522|157227638|FG005|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
48832758|NCT02914522|157227639|FG006|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
48832759|NCT02914522|157227640|FG007|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
48832760|NCT02914522|157227641|FG008|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
48832761|NCT02914522|157227642|FG009|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1|||
48832762|NCT02914522|157227643|FG010|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
48832763|NCT02537522|157227644|FG000|Phase I - Contralateral|Subject no longer eligible|15|||
48832764|NCT02537522|157227645|FG001|Phase I - Contralateral|Subject no longer eligible|7|||
48832765|NCT02537522|157227646|FG002|Phase I - Contralateral|Subject no longer eligible|0|||
48832766|NCT02537522|157227647|FG003|Phase I - Contralateral|Subject no longer eligible|0|||
48832767|NCT02537522|157227644|FG000|Phase I - Contralateral|Withdrawal by Subject|0|||
48832768|NCT02537522|157227645|FG001|Phase I - Contralateral|Withdrawal by Subject|1|||
48832769|NCT02537522|157227646|FG002|Phase I - Contralateral|Withdrawal by Subject|0|||
48832770|NCT02537522|157227647|FG003|Phase I - Contralateral|Withdrawal by Subject|0|||
48832771|NCT02537522|157227644|FG000|Phase I - Contralateral|incorrect randomization|0|||
48832772|NCT02537522|157227645|FG001|Phase I - Contralateral|incorrect randomization|1|||
48832773|NCT02537522|157227646|FG002|Phase I - Contralateral|incorrect randomization|0|||
48832774|NCT02537522|157227647|FG003|Phase I - Contralateral|incorrect randomization|0|||
48832775|NCT02537522|157227644|FG000|Phase I - Contralateral|unsatisfactory lens fitting|0|||
48832776|NCT02537522|157227645|FG001|Phase I - Contralateral|unsatisfactory lens fitting|1|||
48832777|NCT02537522|157227646|FG002|Phase I - Contralateral|unsatisfactory lens fitting|0|||
48832778|NCT02537522|157227647|FG003|Phase I - Contralateral|unsatisfactory lens fitting|0|||
48832779|NCT02537522|157227644|FG000|Phase II - Period 1 Bilateral|Adverse Event|0|||
48832780|NCT02537522|157227645|FG001|Phase II - Period 1 Bilateral|Adverse Event|0|||
48832781|NCT02537522|157227646|FG002|Phase II - Period 1 Bilateral|Adverse Event|0|||
48832782|NCT02537522|157227647|FG003|Phase II - Period 1 Bilateral|Adverse Event|1|||
48832783|NCT01726023|157227654|FG000|Overall Study|Death|1|||
48832784|NCT01726023|157227655|FG001|Overall Study|Death|1|||
48832785|NCT01726023|157227654|FG000|Overall Study|Lost to Follow-up|5|||
48832786|NCT01726023|157227655|FG001|Overall Study|Lost to Follow-up|10|||
48832787|NCT01726023|157227654|FG000|Overall Study|Other Eligibility criteria|7|||
48832788|NCT01726023|157227655|FG001|Overall Study|Other Eligibility criteria|7|||
48832789|NCT01726023|157227654|FG000|Overall Study|Withdrawal by Subject|16|||
48832790|NCT01726023|157227655|FG001|Overall Study|Withdrawal by Subject|8|||
48832791|NCT04770402|157227662|FG000|Overall Study|Lost to Follow-up|1|||
48832792|NCT04770402|157227663|FG001|Overall Study|Lost to Follow-up|2|||
48832793|NCT04770402|157227662|FG000|Overall Study|Non-compliance|1|||
48832794|NCT04770402|157227663|FG001|Overall Study|Non-compliance|0|||
48832795|NCT04770402|157227662|FG000|Overall Study|Withdrawal by Subject|0|||
48832796|NCT04770402|157227663|FG001|Overall Study|Withdrawal by Subject|1|||
48832797|NCT04811040|157227664|FG000|Overall Study|Lost to Follow-up|2|||
48832798|NCT04811040|157227665|FG001|Overall Study|Lost to Follow-up|0|||
48832799|NCT04811040|157227666|FG002|Overall Study|Lost to Follow-up|0|||
48832800|NCT04811040|157227667|FG003|Overall Study|Lost to Follow-up|0|||
48832801|NCT04811040|157227664|FG000|Overall Study|Withdrew consent|1|||
48832802|NCT04811040|157227665|FG001|Overall Study|Withdrew consent|1|||
48832803|NCT04811040|157227666|FG002|Overall Study|Withdrew consent|0|||
48832804|NCT04811040|157227667|FG003|Overall Study|Withdrew consent|0|||
48832805|NCT03612804|157227668|FG000|Overall Study|Death|0|||
48832806|NCT03612804|157227669|FG001|Overall Study|Death|7|||
48832807|NCT03612804|157227670|FG002|Overall Study|Death|0|||
48832808|NCT03612804|157227671|FG003|Overall Study|Death|8|||
48832809|NCT03612804|157227668|FG000|Overall Study|Medication copay coverage issues|0|||
48832810|NCT03612804|157227669|FG001|Overall Study|Medication copay coverage issues|0|||
48832811|NCT03612804|157227670|FG002|Overall Study|Medication copay coverage issues|0|||
48832812|NCT03612804|157227671|FG003|Overall Study|Medication copay coverage issues|17|||
48832813|NCT03612804|157227668|FG000|Overall Study|Not current smoker at time of screening|0|||
48832814|NCT03612804|157227669|FG001|Overall Study|Not current smoker at time of screening|1|||
48832815|NCT03612804|157227670|FG002|Overall Study|Not current smoker at time of screening|0|||
48832816|NCT03612804|157227671|FG003|Overall Study|Not current smoker at time of screening|3|||
48832817|NCT03612804|157227668|FG000|Overall Study|Non-veteran status|0|||
48832818|NCT03612804|157227669|FG001|Overall Study|Non-veteran status|1|||
48832819|NCT03612804|157227670|FG002|Overall Study|Non-veteran status|0|||
49158583|NCT01334918|158422080|FG000|Overall Study|Adverse Event|2|||
49158584|NCT01334918|158422081|FG001|Overall Study|Adverse Event|0|||
49158585|NCT01334918|158422080|FG000|Overall Study|Withdrawal by Subject|0|||
49158586|NCT01334918|158422081|FG001|Overall Study|Withdrawal by Subject|1|||
49158587|NCT00462826|158422085|FG000|Overall Study|Ineligible - second primary|1|||
49158588|NCT00462826|158422085|FG000|Overall Study|Ineligible - wrong cell type|1|||
49158589|NCT00462826|158422085|FG000|Overall Study|Ineligible - wrong primary|2|||
49158590|NCT00462826|158422085|FG000|Overall Study|Never treated|1|||
49158591|NCT01083602|158422086|FG000|Overall Study|Adverse Event|11|||
49158592|NCT01083602|158422086|FG000|Overall Study|New Cancer Therapy|2|||
49158593|NCT01083602|158422086|FG000|Overall Study|Death|1|||
49158594|NCT01083602|158422086|FG000|Overall Study|Withdrawal by Subject|5|||
49158595|NCT01083602|158422086|FG000|Overall Study|Lack of Efficacy|36|||
49158596|NCT03545672|158422087|FG000|Overall Study|Uncertain diagnosis|2|||
48832820|NCT03612804|157227671|FG003|Overall Study|Non-veteran status|0|||
48832821|NCT03612804|157227668|FG000|Overall Study|Misassignment to a proactive arm provider|0|||
48832822|NCT03612804|157227669|FG001|Overall Study|Misassignment to a proactive arm provider|1|||
48922971|NCT00783094|157551492|FG001|Randomized Double-Blind Treatment Period|Adverse Event|5|||
48922972|NCT00783094|157551493|FG002|Randomized Double-Blind Treatment Period|Adverse Event|5|||
48922973|NCT00783094|157551491|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|0|||
48922974|NCT00783094|157551492|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|2|||
48922975|NCT00783094|157551493|FG002|Randomized Double-Blind Treatment Period|Lack of Efficacy|1|||
48922976|NCT00783094|157551491|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
48922977|NCT00783094|157551492|FG001|Randomized Double-Blind Treatment Period|Physician Decision|2|||
48922978|NCT00783094|157551493|FG002|Randomized Double-Blind Treatment Period|Physician Decision|0|||
48922979|NCT00783094|157551491|FG000|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
48922980|NCT00783094|157551492|FG001|Randomized Double-Blind Treatment Period|Protocol Violation|2|||
48922981|NCT00783094|157551493|FG002|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
48922982|NCT00783094|157551491|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
49158597|NCT03545672|158422088|FG001|Overall Study|Uncertain diagnosis|1|||
49158598|NCT03545672|158422087|FG000|Overall Study|Protocol Violation|2|||
49158599|NCT03545672|158422088|FG001|Overall Study|Protocol Violation|2|||
49158600|NCT01263119|158422091|FG000|Period 1|Protocol Violation|2|||
49158601|NCT01263119|158422091|FG000|Period 2|Adverse Event|2|||
49158602|NCT01621178|158422092|FG000|Overall Study|Adverse Event|5|||
49158603|NCT01621178|158422093|FG001|Overall Study|Adverse Event|2|||
48922983|NCT00783094|157551492|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1|||
48922984|NCT00783094|157551493|FG002|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
48922985|NCT00783094|157551491|FG000|Open-Label Extension Period|Adverse Event|12|||
48922986|NCT00783094|157551492|FG001|Open-Label Extension Period|Adverse Event|7|||
48922987|NCT00783094|157551493|FG002|Open-Label Extension Period|Adverse Event|16|||
48922988|NCT00783094|157551491|FG000|Open-Label Extension Period|Death|0|||
48922989|NCT00783094|157551492|FG001|Open-Label Extension Period|Death|0|||
48922990|NCT00783094|157551493|FG002|Open-Label Extension Period|Death|1|||
48922991|NCT00783094|157551491|FG000|Open-Label Extension Period|Protocol Violation|4|||
48922992|NCT00783094|157551492|FG001|Open-Label Extension Period|Protocol Violation|5|||
49158604|NCT01621178|158422094|FG002|Overall Study|Adverse Event|8|||
49158605|NCT01621178|158422092|FG000|Overall Study|Death|6|||
49158606|NCT01621178|158422093|FG001|Overall Study|Death|7|||
49158607|NCT01621178|158422094|FG002|Overall Study|Death|2|||
49158608|NCT01621178|158422092|FG000|Overall Study|Lost to Follow-up|1|||
49158609|NCT01621178|158422093|FG001|Overall Study|Lost to Follow-up|2|||
48832823|NCT03612804|157227670|FG002|Overall Study|Misassignment to a proactive arm provider|0|||
48832824|NCT03612804|157227671|FG003|Overall Study|Misassignment to a proactive arm provider|0|||
48832825|NCT03612804|157227668|FG000|Overall Study|Provider retired from VA|0|||
48832826|NCT03612804|157227669|FG001|Overall Study|Provider retired from VA|0|||
48832827|NCT03612804|157227670|FG002|Overall Study|Provider retired from VA|2|||
48832828|NCT03612804|157227671|FG003|Overall Study|Provider retired from VA|0|||
48832829|NCT03612804|157227668|FG000|Overall Study|Withdrawal by Subject|0|||
48832830|NCT03612804|157227669|FG001|Overall Study|Withdrawal by Subject|0|||
48832831|NCT03612804|157227670|FG002|Overall Study|Withdrawal by Subject|7|||
48832832|NCT03612804|157227671|FG003|Overall Study|Withdrawal by Subject|0|||
48832833|NCT03612804|157227668|FG000|Overall Study|Provider involved with study activities|1|||
48832834|NCT03612804|157227669|FG001|Overall Study|Provider involved with study activities|0|||
48832835|NCT03612804|157227670|FG002|Overall Study|Provider involved with study activities|0|||
48832836|NCT03612804|157227671|FG003|Overall Study|Provider involved with study activities|0|||
48922993|NCT00783094|157551493|FG002|Open-Label Extension Period|Protocol Violation|7|||
48922994|NCT00783094|157551491|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
48922995|NCT00783094|157551492|FG001|Open-Label Extension Period|Withdrawal by Subject|1|||
49158610|NCT01621178|158422094|FG002|Overall Study|Lost to Follow-up|1|||
49158611|NCT01621178|158422092|FG000|Overall Study|Withdrawal by Subject|14|||
49158612|NCT01621178|158422093|FG001|Overall Study|Withdrawal by Subject|17|||
48832837|NCT00256243|157227679|FG000|Overall Study|Lost to Follow-up|2|||
49158613|NCT01621178|158422094|FG002|Overall Study|Withdrawal by Subject|18|||
49158614|NCT01621178|158422092|FG000|Overall Study|Physician Decision|5|||
49158615|NCT01621178|158422093|FG001|Overall Study|Physician Decision|2|||
49158616|NCT01621178|158422094|FG002|Overall Study|Physician Decision|7|||
49158617|NCT03493958|158422095|FG000|Overall Study|Withdrawal by Subject|6|||
48832838|NCT00256243|157227679|FG000|Overall Study|Death|7|||
49158618|NCT03493958|158422095|FG000|Overall Study|Lost to Follow-up|7|||
49158619|NCT03493958|158422095|FG000|Overall Study|Did not complete all required study procedures|2|||
49158620|NCT02862574|158422102|FG000|Double-Blind Treatment Period|Adverse Event|0|||
49158621|NCT02862574|158422103|FG001|Double-Blind Treatment Period|Adverse Event|1|||
49158622|NCT02862574|158422104|FG002|Double-Blind Treatment Period|Adverse Event|0|||
49158623|NCT02862574|158422102|FG000|Double-Blind Treatment Period|Study Terminated by Sponsor|3|||
49158624|NCT02862574|158422103|FG001|Double-Blind Treatment Period|Study Terminated by Sponsor|1|||
49158625|NCT02862574|158422104|FG002|Double-Blind Treatment Period|Study Terminated by Sponsor|4|||
49158626|NCT02862574|158422102|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
49158627|NCT02862574|158422103|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|3|||
49158628|NCT02862574|158422104|FG002|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
49158629|NCT01822925|158422107|FG000|Overall Study|Adverse Event|1|||
49158630|NCT01822925|158422108|FG001|Overall Study|Adverse Event|1|||
49158631|NCT01822925|158422109|FG002|Overall Study|Adverse Event|1|||
49158632|NCT01822925|158422110|FG003|Overall Study|Adverse Event|1|||
49158633|NCT01822925|158422107|FG000|Overall Study|Lost to Follow-up|0|||
49158634|NCT01822925|158422108|FG001|Overall Study|Lost to Follow-up|1|||
49158635|NCT01822925|158422109|FG002|Overall Study|Lost to Follow-up|0|||
48832839|NCT00256243|157227679|FG000|Overall Study|Not treated|1|||
49158636|NCT01822925|158422110|FG003|Overall Study|Lost to Follow-up|0|||
49158637|NCT01822925|158422107|FG000|Overall Study|Protocol Violation|1|||
49158638|NCT01822925|158422108|FG001|Overall Study|Protocol Violation|0|||
49158639|NCT01822925|158422109|FG002|Overall Study|Protocol Violation|0|||
49158640|NCT01822925|158422110|FG003|Overall Study|Protocol Violation|1|||
49158641|NCT01822925|158422107|FG000|Overall Study|Withdrawal by Subject|2|||
49158642|NCT01822925|158422108|FG001|Overall Study|Withdrawal by Subject|0|||
48832840|NCT00811057|157227680|FG000|Overall Study|Protocol Violation|5|||
49158643|NCT01822925|158422109|FG002|Overall Study|Withdrawal by Subject|2|||
49158644|NCT01822925|158422110|FG003|Overall Study|Withdrawal by Subject|2|||
49158645|NCT01822925|158422107|FG000|Overall Study|Taking prohibited medication|2|||
49158646|NCT01822925|158422108|FG001|Overall Study|Taking prohibited medication|0|||
49158647|NCT01822925|158422109|FG002|Overall Study|Taking prohibited medication|0|||
49158648|NCT01822925|158422110|FG003|Overall Study|Taking prohibited medication|1|||
49158649|NCT02431325|158422114|FG000|Overall Study|Adverse Event|3|||
49158650|NCT02431325|158422115|FG001|Overall Study|Adverse Event|0|||
49158651|NCT02431325|158422114|FG000|Overall Study|Lost to Follow-up|0|||
49158652|NCT02431325|158422115|FG001|Overall Study|Lost to Follow-up|1|||
49158653|NCT02431325|158422114|FG000|Overall Study|Withdrawal by Subject|1|||
49158654|NCT02431325|158422115|FG001|Overall Study|Withdrawal by Subject|2|||
49158655|NCT02431325|158422114|FG000|Overall Study|Declined to take study medication|1|||
49158656|NCT02431325|158422115|FG001|Overall Study|Declined to take study medication|0|||
49158657|NCT02431325|158422114|FG000|Overall Study|Withdrew before starting study medication|1|||
49158658|NCT02431325|158422115|FG001|Overall Study|Withdrew before starting study medication|0|||
49158659|NCT02431325|158422114|FG000|Overall Study|Placebo shortage|2|||
49158660|NCT02431325|158422115|FG001|Overall Study|Placebo shortage|0|||
49158661|NCT01463527|158422121|FG000|Overall Study|Protocol Violation|1|||
49158662|NCT01463527|158422122|FG001|Overall Study|Protocol Violation|1|||
49158663|NCT01463527|158422121|FG000|Overall Study|Crying >20% of sedation|5|||
49158664|NCT01463527|158422122|FG001|Overall Study|Crying >20% of sedation|6|||
49158665|NCT01816295|158422125|FG000|Double Blind Phase|Adverse Event|11|||
49158666|NCT01816295|158422126|FG001|Double Blind Phase|Adverse Event|8|||
49158667|NCT01816295|158422125|FG000|Double Blind Phase|Entry Criteria Not Met|0|||
49158668|NCT01816295|158422126|FG001|Double Blind Phase|Entry Criteria Not Met|2|||
49158669|NCT01816295|158422125|FG000|Double Blind Phase|Lost to Follow-up|3|||
49158670|NCT01816295|158422126|FG001|Double Blind Phase|Lost to Follow-up|5|||
49158671|NCT01816295|158422125|FG000|Double Blind Phase|Physician Decision|2|||
49158672|NCT01816295|158422126|FG001|Double Blind Phase|Physician Decision|2|||
49158673|NCT01816295|158422125|FG000|Double Blind Phase|Protocol Violation|17|||
49158674|NCT01816295|158422126|FG001|Double Blind Phase|Protocol Violation|11|||
49158675|NCT01816295|158422125|FG000|Double Blind Phase|Sponsor Decision|8|||
49158676|NCT01816295|158422126|FG001|Double Blind Phase|Sponsor Decision|8|||
49158677|NCT01816295|158422125|FG000|Double Blind Phase|Withdrawal by Subject|22|||
49158678|NCT01816295|158422126|FG001|Double Blind Phase|Withdrawal by Subject|20|||
49158679|NCT01816295|158422125|FG000|OLE Phase|Adverse Event|17|||
49158680|NCT01816295|158422126|FG001|OLE Phase|Adverse Event|15|||
49158681|NCT01816295|158422125|FG000|OLE Phase|Death|1|||
49158682|NCT01816295|158422126|FG001|OLE Phase|Death|0|||
49158683|NCT01816295|158422125|FG000|OLE Phase|Entry Criteria Not Met|3|||
49158684|NCT01816295|158422126|FG001|OLE Phase|Entry Criteria Not Met|5|||
49158685|NCT01816295|158422125|FG000|OLE Phase|Lost to Follow-up|5|||
49158686|NCT01816295|158422126|FG001|OLE Phase|Lost to Follow-up|5|||
49158687|NCT01816295|158422125|FG000|OLE Phase|Physician Decision|3|||
49158688|NCT01816295|158422126|FG001|OLE Phase|Physician Decision|1|||
49158689|NCT01816295|158422125|FG000|OLE Phase|Protocol Violation|4|||
49158690|NCT01816295|158422126|FG001|OLE Phase|Protocol Violation|4|||
49158691|NCT01816295|158422125|FG000|OLE Phase|Sponsor Decision|7|||
49158692|NCT01816295|158422126|FG001|OLE Phase|Sponsor Decision|9|||
49158693|NCT01816295|158422125|FG000|OLE Phase|Withdrawal by Subject|10|||
49158694|NCT01816295|158422126|FG001|OLE Phase|Withdrawal by Subject|10|||
49158695|NCT01816295|158422125|FG000|OLE Phase|Lack of Efficacy|3|||
48832841|NCT00811057|157227681|FG001|Overall Study|Protocol Violation|10|||
48832842|NCT00811057|157227682|FG002|Overall Study|Protocol Violation|10|||
48832843|NCT02747004|157227688|FG000|Overall Study|Withdrawal by Subject|8|||
48832844|NCT02747004|157227689|FG001|Overall Study|Withdrawal by Subject|5|||
48832845|NCT02747004|157227690|FG002|Overall Study|Withdrawal by Subject|4|||
48832846|NCT02747004|157227688|FG000|Overall Study|Lost to Follow-up|1|||
48832847|NCT02747004|157227689|FG001|Overall Study|Lost to Follow-up|2|||
49158696|NCT01816295|158422126|FG001|OLE Phase|Lack of Efficacy|7|||
49158697|NCT01182350|158422127|FG000|Overall Study|Adverse Event|5|||
49158698|NCT01182350|158422128|FG001|Overall Study|Adverse Event|0|||
49158699|NCT01182350|158422129|FG002|Overall Study|Adverse Event|0|||
49158700|NCT01182350|158422130|FG003|Overall Study|Adverse Event|0|||
49158701|NCT01182350|158422131|FG004|Overall Study|Adverse Event|0|||
49158702|NCT01182350|158422127|FG000|Overall Study|Disease Progression|15|||
49158703|NCT01182350|158422128|FG001|Overall Study|Disease Progression|12|||
49158704|NCT01182350|158422129|FG002|Overall Study|Disease Progression|0|||
48832848|NCT02747004|157227690|FG002|Overall Study|Lost to Follow-up|2|||
49158705|NCT01182350|158422130|FG003|Overall Study|Disease Progression|1|||
49158706|NCT01182350|158422131|FG004|Overall Study|Disease Progression|0|||
49158707|NCT01182350|158422127|FG000|Overall Study|Death|0|||
49158708|NCT01182350|158422128|FG001|Overall Study|Death|1|||
49158709|NCT01182350|158422129|FG002|Overall Study|Death|1|||
49158710|NCT01182350|158422130|FG003|Overall Study|Death|0|||
49158711|NCT01182350|158422131|FG004|Overall Study|Death|0|||
49158712|NCT01182350|158422127|FG000|Overall Study|Withdrawal by Subject|3|||
49158713|NCT01182350|158422128|FG001|Overall Study|Withdrawal by Subject|1|||
49158714|NCT01182350|158422129|FG002|Overall Study|Withdrawal by Subject|0|||
49158715|NCT01182350|158422130|FG003|Overall Study|Withdrawal by Subject|1|||
48832849|NCT02747004|157227688|FG000|Overall Study|on study treatment/follow-up|48|||
48832850|NCT02747004|157227689|FG001|Overall Study|on study treatment/follow-up|42|||
48832851|NCT02747004|157227690|FG002|Overall Study|on study treatment/follow-up|41|||
48832852|NCT05019729|157227691|FG000|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
48832853|NCT05019729|157227692|FG001|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
48832854|NCT05019729|157227693|FG002|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
48832855|NCT05019729|157227694|FG003|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
48832856|NCT05019729|157227695|FG004|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|3|||
48832857|NCT05019729|157227696|FG005|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
48832858|NCT02482233|157227697|FG000|Overall Study|Lost to Follow-up|1|||
48832859|NCT02482233|157227698|FG001|Overall Study|Lost to Follow-up|1|||
48832860|NCT01144182|157227701|FG000|Overall Study|Death|5|||
48832861|NCT01144182|157227702|FG001|Overall Study|Death|6|||
49158716|NCT01182350|158422131|FG004|Overall Study|Withdrawal by Subject|0|||
49158717|NCT01182350|158422127|FG000|Overall Study|Alternative Therapy|2|||
49158718|NCT01182350|158422128|FG001|Overall Study|Alternative Therapy|0|||
49158719|NCT01182350|158422129|FG002|Overall Study|Alternative Therapy|1|||
49158720|NCT01182350|158422130|FG003|Overall Study|Alternative Therapy|0|||
49158721|NCT01182350|158422131|FG004|Overall Study|Alternative Therapy|0|||
49158722|NCT01182350|158422127|FG000|Overall Study|Travel Issue/Prefer Treatment at Home|2|||
49158723|NCT01182350|158422128|FG001|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
49158724|NCT01182350|158422129|FG002|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
49158725|NCT01182350|158422130|FG003|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
49158726|NCT01182350|158422131|FG004|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
49158727|NCT01182350|158422127|FG000|Overall Study|Unevaluable for Biopsy|0|||
49158728|NCT01182350|158422128|FG001|Overall Study|Unevaluable for Biopsy|0|||
49158729|NCT01182350|158422129|FG002|Overall Study|Unevaluable for Biopsy|0|||
49158730|NCT01182350|158422130|FG003|Overall Study|Unevaluable for Biopsy|0|||
49158731|NCT01182350|158422131|FG004|Overall Study|Unevaluable for Biopsy|3|||
49158732|NCT01088503|158422132|FG000|Overall Study|Withdrawal by Subject|118|||
49158733|NCT01088503|158422133|FG001|Overall Study|Withdrawal by Subject|327|||
49158734|NCT01088503|158422134|FG002|Overall Study|Withdrawal by Subject|10|||
49158735|NCT01088503|158422132|FG000|Overall Study|Death|64|||
49158736|NCT01088503|158422133|FG001|Overall Study|Death|358|||
49158737|NCT01088503|158422134|FG002|Overall Study|Death|7|||
49158738|NCT01076010|158422135|FG000|Overall Study|Death|15|||
49158739|NCT01076010|158422136|FG001|Overall Study|Death|1|||
49158740|NCT01076010|158422137|FG002|Overall Study|Death|0|||
49158741|NCT01076010|158422135|FG000|Overall Study|Adverse Event|7|||
49158742|NCT01076010|158422136|FG001|Overall Study|Adverse Event|2|||
49158743|NCT01076010|158422137|FG002|Overall Study|Adverse Event|0|||
49158744|NCT01076010|158422135|FG000|Overall Study|Progressive disease|90|||
49158745|NCT01076010|158422136|FG001|Overall Study|Progressive disease|30|||
49158746|NCT01076010|158422137|FG002|Overall Study|Progressive disease|1|||
49158747|NCT01076010|158422135|FG000|Overall Study|Lack of Efficacy|4|||
49158748|NCT01076010|158422136|FG001|Overall Study|Lack of Efficacy|0|||
49158749|NCT01076010|158422137|FG002|Overall Study|Lack of Efficacy|0|||
49158750|NCT01076010|158422135|FG000|Overall Study|Treatment Interruption for > 2 Weeks|0|||
49158751|NCT01076010|158422136|FG001|Overall Study|Treatment Interruption for > 2 Weeks|1|||
49158752|NCT01076010|158422137|FG002|Overall Study|Treatment Interruption for > 2 Weeks|0|||
49158753|NCT01076010|158422135|FG000|Overall Study|Significant Surgical Procedure|0|||
48832862|NCT01144182|157227701|FG000|Overall Study|Withdrawal by Subject|3|||
48832863|NCT01144182|157227702|FG001|Overall Study|Withdrawal by Subject|6|||
48832864|NCT01144182|157227701|FG000|Overall Study|Lost to Follow-up|9|||
48832865|NCT01144182|157227702|FG001|Overall Study|Lost to Follow-up|9|||
48832866|NCT02351180|157227709|FG000|Overall Study|Withdrawal by Subject|1|||
48832867|NCT02351180|157227710|FG001|Overall Study|Withdrawal by Subject|0|||
49158754|NCT01076010|158422136|FG001|Overall Study|Significant Surgical Procedure|1|||
49158755|NCT01076010|158422137|FG002|Overall Study|Significant Surgical Procedure|0|||
49158756|NCT01076010|158422135|FG000|Overall Study|Protocol Violation|0|||
49158757|NCT01076010|158422136|FG001|Overall Study|Protocol Violation|1|||
49158758|NCT01076010|158422137|FG002|Overall Study|Protocol Violation|0|||
49158759|NCT01076010|158422135|FG000|Overall Study|Noncompliance|1|||
49158760|NCT01076010|158422136|FG001|Overall Study|Noncompliance|1|||
49158761|NCT01076010|158422137|FG002|Overall Study|Noncompliance|0|||
49158762|NCT01076010|158422135|FG000|Overall Study|Withdrawal by Subject|3|||
49158763|NCT01076010|158422136|FG001|Overall Study|Withdrawal by Subject|0|||
49158764|NCT01076010|158422137|FG002|Overall Study|Withdrawal by Subject|1|||
49158765|NCT01076010|158422135|FG000|Overall Study|Other|5|||
49158766|NCT01076010|158422136|FG001|Overall Study|Other|2|||
49158767|NCT01076010|158422137|FG002|Overall Study|Other|0|||
49158768|NCT00181844|158422141|FG000|Signed Consent|Withdrawal by Subject|5|||
48832868|NCT02163915|157227717|FG000|Overall Study|Withdrawal by Subject|2|||
48832869|NCT02163915|157227718|FG001|Overall Study|Withdrawal by Subject|0|||
48832870|NCT02163915|157227719|FG002|Overall Study|Withdrawal by Subject|2|||
48832871|NCT02163915|157227720|FG003|Overall Study|Withdrawal by Subject|2|||
48832872|NCT02163915|157227721|FG004|Overall Study|Withdrawal by Subject|2|||
48832873|NCT02163915|157227717|FG000|Overall Study|Study termination|1|||
48832874|NCT02163915|157227718|FG001|Overall Study|Study termination|0|||
48832875|NCT02163915|157227719|FG002|Overall Study|Study termination|0|||
48832876|NCT02163915|157227720|FG003|Overall Study|Study termination|0|||
48832877|NCT02163915|157227721|FG004|Overall Study|Study termination|2|||
49158769|NCT00181844|158422141|FG000|Signed Consent|Did not meet entrance criteria|7|||
49158770|NCT00181844|158422141|FG000|Exposed to Study Medication|Adverse Event|10|||
49158771|NCT00181844|158422141|FG000|Exposed to Study Medication|Lack of Efficacy|2|||
49158772|NCT00181844|158422141|FG000|Exposed to Study Medication|Non-compliance|2|||
49158773|NCT00181844|158422141|FG000|Exposed to Study Medication|Withdrawal by Subject|1|||
49158774|NCT00181844|158422141|FG000|Exposed to Study Medication|Difficulty meeting study schedule|2|||
49158775|NCT01847443|158422143|FG000|Study Period 1|Withdrawal by Subject|0|||
49158776|NCT01847443|158422144|FG001|Study Period 1|Withdrawal by Subject|1|||
49158777|NCT01847443|158422145|FG002|Study Period 1|Withdrawal by Subject|0|||
49158778|NCT01847443|158422146|FG003|Study Period 1|Withdrawal by Subject|0|||
49158779|NCT01847443|158422143|FG000|Washout Period Before Study Period 2|Adverse Event|1|||
49158780|NCT01847443|158422144|FG001|Washout Period Before Study Period 2|Adverse Event|1|||
49158781|NCT01847443|158422145|FG002|Washout Period Before Study Period 2|Adverse Event|0|||
48832878|NCT02163915|157227717|FG000|Overall Study|Physician Decision|0|||
48832879|NCT02163915|157227718|FG001|Overall Study|Physician Decision|0|||
49158782|NCT01847443|158422146|FG003|Washout Period Before Study Period 2|Adverse Event|0|||
49158783|NCT01847443|158422143|FG000|Washout Period Before Study Period 2|Other reason|1|||
49158784|NCT01847443|158422144|FG001|Washout Period Before Study Period 2|Other reason|0|||
49158785|NCT01847443|158422145|FG002|Washout Period Before Study Period 2|Other reason|0|||
49158786|NCT01847443|158422146|FG003|Washout Period Before Study Period 2|Other reason|0|||
49158787|NCT01847443|158422143|FG000|Washout Period Before Study Period 3|Other reason|1|||
49158788|NCT01847443|158422144|FG001|Washout Period Before Study Period 3|Other reason|0|||
49158789|NCT01847443|158422145|FG002|Washout Period Before Study Period 3|Other reason|0|||
49158790|NCT01847443|158422146|FG003|Washout Period Before Study Period 3|Other reason|0|||
49158791|NCT01847443|158422143|FG000|Washout Period Before Study Period 4|Withdrawal by Subject|1|||
49158792|NCT01847443|158422144|FG001|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
49158793|NCT01847443|158422145|FG002|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
49158794|NCT01847443|158422146|FG003|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
49158795|NCT01847443|158422143|FG000|Washout Period Before Study Period 4|Positive alcohol test|1|||
49158796|NCT01847443|158422144|FG001|Washout Period Before Study Period 4|Positive alcohol test|0|||
49158797|NCT01847443|158422145|FG002|Washout Period Before Study Period 4|Positive alcohol test|0|||
49158798|NCT01847443|158422146|FG003|Washout Period Before Study Period 4|Positive alcohol test|0|||
49158799|NCT04447755|158422148|FG000|Overall Study|Death|8|||
49158800|NCT04447755|158422149|FG001|Overall Study|Death|14|||
49158801|NCT04447755|158422150|FG002|Overall Study|Death|8|||
49158802|NCT04447755|158422151|FG003|Overall Study|Death|9|||
49158803|NCT04447755|158422152|FG004|Overall Study|Death|7|||
49158804|NCT04447755|158422153|FG005|Overall Study|Death|7|||
49158805|NCT04447755|158422154|FG006|Overall Study|Death|40|||
49158806|NCT04447755|158422148|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
49158807|NCT04447755|158422149|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
48832880|NCT02163915|157227719|FG002|Overall Study|Physician Decision|0|||
48832881|NCT02163915|157227720|FG003|Overall Study|Physician Decision|1|||
48832882|NCT02163915|157227721|FG004|Overall Study|Physician Decision|0|||
48832883|NCT03395353|157227724|FG000|Overall Study|Adverse Event|20|||
49158808|NCT04447755|158422150|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
49158809|NCT04447755|158422151|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
49158810|NCT04447755|158422152|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
49158811|NCT04447755|158422153|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
49158812|NCT04447755|158422154|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
49158813|NCT04447755|158422148|FG000|Overall Study|Ongoing in Study|1|||
49158814|NCT04447755|158422149|FG001|Overall Study|Ongoing in Study|2|||
49158815|NCT04447755|158422150|FG002|Overall Study|Ongoing in Study|0|||
49158816|NCT04447755|158422151|FG003|Overall Study|Ongoing in Study|0|||
49158817|NCT04447755|158422152|FG004|Overall Study|Ongoing in Study|2|||
49158818|NCT04447755|158422153|FG005|Overall Study|Ongoing in Study|2|||
49158819|NCT04447755|158422154|FG006|Overall Study|Ongoing in Study|26|||
49158820|NCT01342094|158422157|FG000|Overall Study|Adverse Event|5|||
49158821|NCT01342094|158422158|FG001|Overall Study|Adverse Event|0|||
49158822|NCT01342094|158422157|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
49158823|NCT01342094|158422158|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
49158824|NCT01342094|158422157|FG000|Overall Study|Withdrawal by Subject|0|||
49158825|NCT01342094|158422158|FG001|Overall Study|Withdrawal by Subject|2|||
49158826|NCT05899829|158422159|FG000|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
49158827|NCT05899829|158422160|FG001|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
49158828|NCT05899829|158422159|FG000|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|0|||
49158829|NCT05899829|158422160|FG001|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|6|||
49158830|NCT05076045|158422170|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
49158831|NCT05076045|158422171|FG001|Washout (1 Week)|Withdrawal by Subject|3|||
49158832|NCT02268383|158422172|FG000|Overall Study|Death|12|||
49158833|NCT02268383|158422172|FG000|Overall Study|Lost to Follow-up|2|||
49158834|NCT02268383|158422172|FG000|Overall Study|Withdrawal by Subject|9|||
49158835|NCT02268383|158422172|FG000|Overall Study|Presence of ≥1% blasts in peripheral blood|1|||
49158836|NCT02268383|158422172|FG000|Overall Study|Protocol deviation|3|||
49158837|NCT02268383|158422172|FG000|Overall Study|Sponsor decision|22|||
49158838|NCT02268383|158422172|FG000|Overall Study|Not reported|12|||
49158839|NCT00714948|158422173|FG000|Overall Study|Adverse Event|2|||
49158840|NCT02891226|158422174|FG000|Period 1 (Weeks 0 to 12)|Adverse Event|4|||
49158841|NCT02891226|158422175|FG001|Period 1 (Weeks 0 to 12)|Adverse Event|1|||
49158842|NCT02891226|158422176|FG002|Period 1 (Weeks 0 to 12)|Adverse Event|3|||
49158843|NCT02891226|158422177|FG003|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
49158844|NCT02891226|158422178|FG004|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
49158845|NCT02891226|158422179|FG005|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
49158846|NCT02891226|158422180|FG006|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
49158847|NCT02891226|158422181|FG007|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
49158848|NCT02891226|158422182|FG008|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
49158849|NCT02891226|158422183|FG009|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
49158850|NCT02891226|158422184|FG010|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
49158851|NCT02891226|158422185|FG011|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
49158852|NCT02891226|158422186|FG012|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
49158853|NCT02891226|158422187|FG013|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
49158854|NCT02891226|158422188|FG014|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
49158855|NCT02891226|158422189|FG015|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
49158856|NCT02891226|158422174|FG000|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
49158857|NCT02891226|158422175|FG001|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
49158858|NCT02891226|158422176|FG002|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
49158859|NCT02891226|158422177|FG003|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
49158860|NCT02891226|158422178|FG004|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
49158861|NCT02891226|158422179|FG005|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
49158862|NCT02891226|158422180|FG006|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
49158863|NCT02891226|158422181|FG007|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
49158864|NCT02891226|158422182|FG008|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
49158865|NCT02891226|158422183|FG009|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
49158866|NCT02891226|158422184|FG010|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
49158867|NCT02891226|158422185|FG011|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
49158868|NCT02891226|158422186|FG012|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
49158869|NCT02891226|158422187|FG013|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
48832884|NCT03395353|157227724|FG000|Overall Study|Protocol Violation|1|||
48832885|NCT03395353|157227724|FG000|Overall Study|Lack of Efficacy|3|||
49158870|NCT02891226|158422188|FG014|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
49158871|NCT02891226|158422189|FG015|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
48832886|NCT03395353|157227724|FG000|Overall Study|Withdrawal by Subject|24|||
48832887|NCT03395353|157227724|FG000|Overall Study|Discontinued visit|1|||
48832888|NCT03395353|157227724|FG000|Overall Study|Refrain from visit due to COVID-19|1|||
48832889|NCT03395353|157227724|FG000|Overall Study|Physician Decision|4|||
48832890|NCT03395353|157227724|FG000|Overall Study|Early termination of overall study|33|||
49158872|NCT02891226|158422174|FG000|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
49158873|NCT02891226|158422175|FG001|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
49158874|NCT02891226|158422176|FG002|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
49158875|NCT02891226|158422177|FG003|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|2|||
49158876|NCT02891226|158422178|FG004|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
49158877|NCT02891226|158422179|FG005|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
49158878|NCT02891226|158422180|FG006|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
49158879|NCT02891226|158422181|FG007|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
49158880|NCT02891226|158422182|FG008|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
49158881|NCT02891226|158422183|FG009|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
49158882|NCT02891226|158422184|FG010|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
49158883|NCT02891226|158422185|FG011|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
49158884|NCT02891226|158422186|FG012|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
49158885|NCT02891226|158422187|FG013|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
49158886|NCT02891226|158422188|FG014|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
49158887|NCT02891226|158422189|FG015|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
49158888|NCT02891226|158422174|FG000|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
49158889|NCT02891226|158422175|FG001|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
49158890|NCT02891226|158422176|FG002|Period 1 (Weeks 0 to 12)|Enrollment Failure|1|||
49158891|NCT02891226|158422177|FG003|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
49158892|NCT02891226|158422178|FG004|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
49158893|NCT02891226|158422179|FG005|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
49158894|NCT02891226|158422180|FG006|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
49158895|NCT02891226|158422181|FG007|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
49158896|NCT02891226|158422182|FG008|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
49158897|NCT02891226|158422183|FG009|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
48832891|NCT03213678|157227726|FG000|Overall Study|Death|1|||
48832892|NCT03213678|157227726|FG000|Overall Study|Physician Decision|1|||
48832893|NCT03213678|157227726|FG000|Overall Study|Progressive disease|16|||
48832894|NCT04369911|157227727|FG000|Overall Study|Lost to Follow-up|3|||
48832895|NCT04369911|157227728|FG001|Overall Study|Lost to Follow-up|3|||
48832896|NCT04369911|157227727|FG000|Overall Study|Withdrawal by Subject|1|||
48832897|NCT04369911|157227728|FG001|Overall Study|Withdrawal by Subject|2|||
48832898|NCT03140176|157229205|FG000|Overall Study|Reason missing|23|||
48832899|NCT03140176|157229205|FG000|Overall Study|Death|33|||
48832900|NCT03140176|157229205|FG000|Overall Study|Disease progression|1|||
48832901|NCT03140176|157229205|FG000|Overall Study|Physician Decision|1|||
48832902|NCT03140176|157229205|FG000|Overall Study|Withdrawal by Subject|1|||
48832903|NCT03140176|157229205|FG000|Overall Study|Lost to Follow-up|15|||
48832904|NCT03181958|157229206|FG000|Overall Study|Lost to Follow-up|17|||
48832905|NCT03181958|157229207|FG001|Overall Study|Lost to Follow-up|21|||
48832906|NCT03181958|157229208|FG002|Overall Study|Lost to Follow-up|15|||
48832907|NCT00408928|157229209|FG000|Overall Study|Withdrawal by Subject|1|||
48832908|NCT00408928|157229209|FG000|Overall Study|Death|1|||
48832909|NCT00408928|157229209|FG000|Overall Study|Infection indistinguishable from GVHD|1|||
48832910|NCT02030028|157229210|FG000|Overall Study|Withdrawal by Subject|4|||
48832911|NCT02030028|157229210|FG000|Overall Study|lack of transportation|1|||
48832912|NCT01185522|157229211|FG000|Overall Study|Lack of Efficacy|28|||
48832913|NCT01185522|157229211|FG000|Overall Study|Lost to Follow-up|19|||
48832914|NCT01185522|157229211|FG000|Overall Study|Withdrawal by Subject|10|||
48832915|NCT01185522|157229211|FG000|Overall Study|Poor tolerance|39|||
48832916|NCT01185522|157229211|FG000|Overall Study|Other reasons|12|||
48832917|NCT00954707|157229212|FG000|Overall Study|Death|34|||
48832918|NCT00954707|157229212|FG000|Overall Study|Withdrawal by Subject|100|||
48832919|NCT00954707|157229212|FG000|Overall Study|Lost to Follow-up|33|||
48832920|NCT02072226|157229213|FG000|Overall Study|Lost to Follow-up|11|||
48832921|NCT02072226|157229214|FG001|Overall Study|Lost to Follow-up|7|||
48832922|NCT02072226|157229213|FG000|Overall Study|Patient Non-compliance|2|||
49158898|NCT02891226|158422184|FG010|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
49158899|NCT02891226|158422185|FG011|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
48832923|NCT02072226|157229214|FG001|Overall Study|Patient Non-compliance|3|||
48832924|NCT02072226|157229213|FG000|Overall Study|Death|1|||
48832925|NCT02072226|157229214|FG001|Overall Study|Death|0|||
48832926|NCT02072226|157229213|FG000|Overall Study|Patient Withdrawal of Consent|1|||
49158900|NCT02891226|158422186|FG012|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
48832927|NCT02072226|157229214|FG001|Overall Study|Patient Withdrawal of Consent|0|||
48832928|NCT03441360|157229227|FG000|Overall Study|Radiological disease progression|5|||
48832929|NCT03441360|157229228|FG001|Overall Study|Radiological disease progression|6|||
48922996|NCT00783094|157551493|FG002|Open-Label Extension Period|Withdrawal by Subject|3|||
49158901|NCT02891226|158422187|FG013|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
49158902|NCT02891226|158422188|FG014|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
49158903|NCT02891226|158422189|FG015|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
48832930|NCT03441360|157229229|FG002|Overall Study|Radiological disease progression|4|||
48832931|NCT03441360|157229227|FG000|Overall Study|Clinical disease progression|2|||
48832932|NCT03441360|157229228|FG001|Overall Study|Clinical disease progression|2|||
48832933|NCT03441360|157229229|FG002|Overall Study|Clinical disease progression|0|||
48832934|NCT03441360|157229227|FG000|Overall Study|Adverse Event|1|||
48832935|NCT03441360|157229228|FG001|Overall Study|Adverse Event|0|||
48832936|NCT03441360|157229229|FG002|Overall Study|Adverse Event|1|||
48832937|NCT01977612|157229230|FG000|Overall Study|Lost to Follow-up|1|||
48832938|NCT01977612|157229231|FG001|Overall Study|Lost to Follow-up|1|||
48832939|NCT02236559|157229238|FG000|Overall Study|Met Exclusion|3|||
48832940|NCT02236559|157229239|FG001|Overall Study|Met Exclusion|6|||
48832941|NCT02236559|157229238|FG000|Overall Study|Did not Meet Inclusion|3|||
48832942|NCT02236559|157229239|FG001|Overall Study|Did not Meet Inclusion|3|||
48832943|NCT02236559|157229238|FG000|Overall Study|Subject Did Not Consent|4|||
48832944|NCT02236559|157229239|FG001|Overall Study|Subject Did Not Consent|2|||
48832945|NCT02236559|157229238|FG000|Overall Study|Physician Decision|1|||
48832946|NCT02236559|157229239|FG001|Overall Study|Physician Decision|1|||
48832947|NCT02236559|157229238|FG000|Overall Study|Withdrawal by Subject|1|||
48832948|NCT02236559|157229239|FG001|Overall Study|Withdrawal by Subject|0|||
49158904|NCT02891226|158422174|FG000|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
49158905|NCT02891226|158422175|FG001|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
49158906|NCT02891226|158422176|FG002|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
49158907|NCT02891226|158422177|FG003|Period 1 (Weeks 0 to 12)|Sponsor Decision|1|||
49158908|NCT02891226|158422178|FG004|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
49158909|NCT02891226|158422179|FG005|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
48832949|NCT04860258|157229241|FG000|Overall Study|Withdrawal by Subject|0|||
48832950|NCT04860258|157229242|FG001|Overall Study|Withdrawal by Subject|0|||
48832951|NCT04860258|157229243|FG002|Overall Study|Withdrawal by Subject|4|||
48832952|NCT04860258|157229244|FG003|Overall Study|Withdrawal by Subject|1|||
48832953|NCT04860258|157229245|FG004|Overall Study|Withdrawal by Subject|4|||
48832954|NCT04860258|157229246|FG005|Overall Study|Withdrawal by Subject|1|||
48832955|NCT04860258|157229247|FG006|Overall Study|Withdrawal by Subject|0|||
48832956|NCT00420316|157229248|FG000|Overall Study|Withdrawal by Subject|0|||
48832957|NCT00420316|157229249|FG001|Overall Study|Withdrawal by Subject|1|||
48832958|NCT00420316|157229248|FG000|Overall Study|Lost to Follow-up|12|||
48832959|NCT00420316|157229249|FG001|Overall Study|Lost to Follow-up|8|||
48832960|NCT00588666|157229250|FG000|Overall Study|Adverse Event|4|||
48832961|NCT01233050|157229251|FG000|Overall Study|protocol deviation (inclusion/exclusion)|8|||
48832962|NCT01233050|157229252|FG001|Overall Study|protocol deviation (inclusion/exclusion)|6|||
48832963|NCT02174562|157229256|FG000|Overall Study|Withdrawal by Subject|7|||
48832964|NCT02174562|157229257|FG001|Overall Study|Withdrawal by Subject|2|||
48832965|NCT02174562|157229256|FG000|Overall Study|Death|2|||
48832966|NCT02174562|157229257|FG001|Overall Study|Death|0|||
48832967|NCT02174562|157229256|FG000|Overall Study|Lost to Follow-up|0|||
48832968|NCT02174562|157229257|FG001|Overall Study|Lost to Follow-up|3|||
48832969|NCT00606580|157229260|FG000|Overall Study|Lost to Follow-up|1|||
48832970|NCT00606580|157229261|FG001|Overall Study|Lost to Follow-up|1|||
48832971|NCT00606580|157229262|FG002|Overall Study|Lost to Follow-up|4|||
48832972|NCT00606580|157229260|FG000|Overall Study|Clinical failures|1|||
48832973|NCT00606580|157229261|FG001|Overall Study|Clinical failures|0|||
48832974|NCT00606580|157229262|FG002|Overall Study|Clinical failures|12|||
48832975|NCT00606580|157229260|FG000|Overall Study|Withdrawal by investigator|0|||
48832976|NCT00606580|157229261|FG001|Overall Study|Withdrawal by investigator|1|||
48832977|NCT00606580|157229262|FG002|Overall Study|Withdrawal by investigator|6|||
48832978|NCT00606580|157229260|FG000|Overall Study|Withdrawal by Subject|0|||
48832979|NCT00606580|157229261|FG001|Overall Study|Withdrawal by Subject|1|||
48832980|NCT00606580|157229262|FG002|Overall Study|Withdrawal by Subject|0|||
48832981|NCT00798096|157229263|FG000|Overall Study|Ongoing|2|||
48832982|NCT01156116|157229277|FG000|Overall Study|Withdrawal by Subject|3|||
48832983|NCT01156116|157229278|FG001|Overall Study|Withdrawal by Subject|1|||
49158910|NCT02891226|158422180|FG006|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
49158911|NCT02891226|158422181|FG007|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
48832984|NCT01156116|157229277|FG000|Overall Study|CPAP intolerance|2|||
48832985|NCT01156116|157229278|FG001|Overall Study|CPAP intolerance|0|||
48832986|NCT01193153|157229279|FG000|Open-label Lead in Period|Lost to Follow-up|32|||
48832987|NCT01193153|157229280|FG001|Open-label Lead in Period|Lost to Follow-up|0|||
48832988|NCT01193153|157229279|FG000|Open-label Lead in Period|Pregnancy|1|||
48832989|NCT01193153|157229280|FG001|Open-label Lead in Period|Pregnancy|0|||
48832990|NCT01193153|157229279|FG000|Open-label Lead in Period|Withdrawal by Subject|69|||
48832991|NCT01193153|157229280|FG001|Open-label Lead in Period|Withdrawal by Subject|0|||
48832992|NCT01193153|157229279|FG000|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4|||
48832993|NCT01193153|157229280|FG001|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0|||
48832994|NCT01193153|157229279|FG000|Open-label Lead in Period|Other|14|||
48832995|NCT01193153|157229280|FG001|Open-label Lead in Period|Other|0|||
49158912|NCT02891226|158422182|FG008|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
48832996|NCT01193153|157229279|FG000|Open-label Lead in Period|Subject Failed Stabilization Criteria|47|||
48832997|NCT01193153|157229280|FG001|Open-label Lead in Period|Subject Failed Stabilization Criteria|0|||
48922997|NCT00783094|157551491|FG000|Open-Label Extension Period|Physician Decision|4|||
48922998|NCT00783094|157551492|FG001|Open-Label Extension Period|Physician Decision|2|||
48922999|NCT00783094|157551493|FG002|Open-Label Extension Period|Physician Decision|3|||
48923000|NCT00783094|157551491|FG000|Open-Label Extension Period|Lack of Efficacy|1|||
48923001|NCT00783094|157551492|FG001|Open-Label Extension Period|Lack of Efficacy|4|||
49158913|NCT02891226|158422183|FG009|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
49158914|NCT02891226|158422184|FG010|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
49158915|NCT02891226|158422185|FG011|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
49158916|NCT02891226|158422186|FG012|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
49158917|NCT02891226|158422187|FG013|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
49158918|NCT02891226|158422188|FG014|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
49158919|NCT02891226|158422189|FG015|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
49158920|NCT02891226|158422174|FG000|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
49158921|NCT02891226|158422175|FG001|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
49158922|NCT02891226|158422176|FG002|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
49158923|NCT02891226|158422177|FG003|Period 1 (Weeks 0 to 12)|Lack of Efficacy|1|||
49158924|NCT02891226|158422178|FG004|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
49158925|NCT02891226|158422179|FG005|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
49158926|NCT02891226|158422180|FG006|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
49158927|NCT02891226|158422181|FG007|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
49158928|NCT02891226|158422182|FG008|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
49158929|NCT02891226|158422183|FG009|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
48832998|NCT01193153|157229279|FG000|Open-label Lead in Period|Adverse Event|41|||
48832999|NCT01193153|157229280|FG001|Open-label Lead in Period|Adverse Event|0|||
48833000|NCT01193153|157229279|FG000|Open-label Lead in Period|Death|1|||
48833001|NCT01193153|157229280|FG001|Open-label Lead in Period|Death|0|||
48833002|NCT01193153|157229279|FG000|Open-label Lead in Period|Lack of Efficacy|26|||
48833003|NCT01193153|157229280|FG001|Open-label Lead in Period|Lack of Efficacy|0|||
48833004|NCT01193153|157229279|FG000|Open-label Stabilization Period|Adverse Event|9|||
48833005|NCT01193153|157229280|FG001|Open-label Stabilization Period|Adverse Event|0|||
48833006|NCT01193153|157229279|FG000|Open-label Stabilization Period|Death|2|||
48833007|NCT01193153|157229280|FG001|Open-label Stabilization Period|Death|0|||
48833008|NCT01193153|157229279|FG000|Open-label Stabilization Period|Lost to Follow-up|10|||
48833009|NCT01193153|157229280|FG001|Open-label Stabilization Period|Lost to Follow-up|0|||
48833010|NCT01193153|157229279|FG000|Open-label Stabilization Period|Lack of Efficacy|5|||
48833011|NCT01193153|157229280|FG001|Open-label Stabilization Period|Lack of Efficacy|0|||
48833012|NCT01193153|157229279|FG000|Open-label Stabilization Period|Withdrawal by Subject|29|||
48833013|NCT01193153|157229280|FG001|Open-label Stabilization Period|Withdrawal by Subject|0|||
48833014|NCT01193153|157229279|FG000|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35|||
48833015|NCT01193153|157229280|FG001|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0|||
48833016|NCT01193153|157229279|FG000|Open-label Stabilization Period|Other|8|||
48833017|NCT01193153|157229280|FG001|Open-label Stabilization Period|Other|0|||
48833018|NCT01193153|157229279|FG000|Double Blind Relapse Prevention Period|Other|2|||
48833019|NCT01193153|157229280|FG001|Double Blind Relapse Prevention Period|Other|3|||
48833020|NCT01193153|157229279|FG000|Double Blind Relapse Prevention Period|Adverse Event|12|||
48833021|NCT01193153|157229280|FG001|Double Blind Relapse Prevention Period|Adverse Event|3|||
48833022|NCT01193153|157229279|FG000|Double Blind Relapse Prevention Period|Death|2|||
48833023|NCT01193153|157229280|FG001|Double Blind Relapse Prevention Period|Death|0|||
48833024|NCT01193153|157229279|FG000|Double Blind Relapse Prevention Period|Lost to Follow-up|2|||
48833025|NCT01193153|157229280|FG001|Double Blind Relapse Prevention Period|Lost to Follow-up|9|||
48833026|NCT01193153|157229279|FG000|Double Blind Relapse Prevention Period|Pregnancy|1|||
48833027|NCT01193153|157229280|FG001|Double Blind Relapse Prevention Period|Pregnancy|0|||
48833028|NCT01193153|157229279|FG000|Double Blind Relapse Prevention Period|Withdrawal by Subject|19|||
48833029|NCT01193153|157229280|FG001|Double Blind Relapse Prevention Period|Withdrawal by Subject|30|||
48833030|NCT01193153|157229279|FG000|Double Blind Relapse Prevention Period|Experienced Relapse|25|||
48833031|NCT01193153|157229280|FG001|Double Blind Relapse Prevention Period|Experienced Relapse|57|||
48833032|NCT01193153|157229279|FG000|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1|||
48833033|NCT01193153|157229280|FG001|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3|||
48833034|NCT01460342|157229281|FG000|Overall Study|Adverse Event|5|||
48833035|NCT01460342|157229282|FG001|Overall Study|Adverse Event|4|||
48833036|NCT01460342|157229281|FG000|Overall Study|Lost to Follow-up|1|||
48833037|NCT01460342|157229282|FG001|Overall Study|Lost to Follow-up|2|||
48833038|NCT01460342|157229281|FG000|Overall Study|Protocol Violation|0|||
48833039|NCT01460342|157229282|FG001|Overall Study|Protocol Violation|1|||
48833040|NCT01460342|157229281|FG000|Overall Study|Withdrawal by Subject|3|||
48833041|NCT01460342|157229282|FG001|Overall Study|Withdrawal by Subject|4|||
48833042|NCT01460342|157229281|FG000|Overall Study|Physician Decision|1|||
49158930|NCT02891226|158422184|FG010|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
49158931|NCT02891226|158422185|FG011|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
49158932|NCT02891226|158422186|FG012|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
49158933|NCT02891226|158422187|FG013|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
48833043|NCT01460342|157229282|FG001|Overall Study|Physician Decision|3|||
48833044|NCT01460342|157229281|FG000|Overall Study|Lack of Efficacy|1|||
48833045|NCT01460342|157229282|FG001|Overall Study|Lack of Efficacy|0|||
48833046|NCT01689519|157229283|FG000|Intent to Treat|Death|157|||
48833047|NCT01689519|157229284|FG001|Intent to Treat|Death|167|||
48833048|NCT01689519|157229283|FG000|Intent to Treat|Lost to Follow-up|4|||
48833049|NCT01689519|157229284|FG001|Intent to Treat|Lost to Follow-up|8|||
48833050|NCT01689519|157229283|FG000|Intent to Treat|Other|2|||
48833051|NCT01689519|157229284|FG001|Intent to Treat|Other|4|||
48833052|NCT01689519|157229283|FG000|Intent to Treat|Physician Decision|4|||
48833053|NCT01689519|157229284|FG001|Intent to Treat|Physician Decision|1|||
48923002|NCT00783094|157551493|FG002|Open-Label Extension Period|Lack of Efficacy|0|||
49158934|NCT02891226|158422188|FG014|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
49158935|NCT02891226|158422189|FG015|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
49158936|NCT02891226|158422174|FG000|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
49158937|NCT02891226|158422175|FG001|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
49158938|NCT02891226|158422176|FG002|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
49158939|NCT02891226|158422177|FG003|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
49158940|NCT02891226|158422178|FG004|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
49158941|NCT02891226|158422179|FG005|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
49158942|NCT02891226|158422180|FG006|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
49158943|NCT02891226|158422181|FG007|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
49158944|NCT02891226|158422182|FG008|Period 2 (Weeks 12 to 52)|Adverse Event|3|||
49158945|NCT02891226|158422183|FG009|Period 2 (Weeks 12 to 52)|Adverse Event|7|||
49158946|NCT02891226|158422184|FG010|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
49158947|NCT02891226|158422185|FG011|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
49158948|NCT02891226|158422186|FG012|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
49158949|NCT02891226|158422187|FG013|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
49158950|NCT02891226|158422188|FG014|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
49158951|NCT02891226|158422189|FG015|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
49158952|NCT02891226|158422174|FG000|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
49158953|NCT02891226|158422175|FG001|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
49158954|NCT02891226|158422176|FG002|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
49158955|NCT02891226|158422177|FG003|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
49158956|NCT02891226|158422178|FG004|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
49158957|NCT02891226|158422179|FG005|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
49158958|NCT02891226|158422180|FG006|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
49158959|NCT02891226|158422181|FG007|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
49158960|NCT02891226|158422182|FG008|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
49158961|NCT02891226|158422183|FG009|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
49158962|NCT02891226|158422184|FG010|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
49158963|NCT02891226|158422185|FG011|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
49158964|NCT02891226|158422186|FG012|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
49158965|NCT02891226|158422187|FG013|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
49158966|NCT02891226|158422188|FG014|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
49158967|NCT02891226|158422189|FG015|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
49158968|NCT02891226|158422174|FG000|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
49158969|NCT02891226|158422175|FG001|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
49158970|NCT02891226|158422176|FG002|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
49158971|NCT02891226|158422177|FG003|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
49158972|NCT02891226|158422178|FG004|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
49158973|NCT02891226|158422179|FG005|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
49158974|NCT02891226|158422180|FG006|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
49158975|NCT02891226|158422181|FG007|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|2|||
49158976|NCT02891226|158422182|FG008|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
49158977|NCT02891226|158422183|FG009|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|6|||
49158978|NCT02891226|158422184|FG010|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
49158979|NCT02891226|158422185|FG011|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
49158980|NCT02891226|158422186|FG012|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
49158981|NCT02891226|158422187|FG013|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
49158982|NCT02891226|158422188|FG014|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
49158983|NCT02891226|158422189|FG015|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
49158984|NCT02891226|158422174|FG000|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
49158985|NCT02891226|158422175|FG001|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
49158986|NCT02891226|158422176|FG002|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
48923003|NCT03313076|157551495|FG000|Overall Study|Withdrawal by Subject|2|||
48923004|NCT03313076|157551496|FG001|Overall Study|Withdrawal by Subject|0|||
48923005|NCT03313076|157551497|FG002|Overall Study|Withdrawal by Subject|0|||
48923006|NCT03313076|157551498|FG003|Overall Study|Withdrawal by Subject|0|||
48833054|NCT01689519|157229283|FG000|Intent to Treat|Study terminated by Spon6sor|59|||
48923007|NCT03313076|157551495|FG000|Overall Study|Lost to Follow-up|0|||
48833055|NCT01689519|157229284|FG001|Intent to Treat|Study terminated by Spon6sor|48|||
48923008|NCT03313076|157551496|FG001|Overall Study|Lost to Follow-up|2|||
49158987|NCT02891226|158422177|FG003|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
49158988|NCT02891226|158422178|FG004|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|1|||
49158989|NCT02891226|158422179|FG005|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
49158990|NCT02891226|158422180|FG006|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
48923009|NCT03313076|157551497|FG002|Overall Study|Lost to Follow-up|2|||
48923010|NCT03313076|157551498|FG003|Overall Study|Lost to Follow-up|2|||
48923011|NCT00915681|157551499|FG000|Overall Study|Screening failures|46|||
48923012|NCT01297270|157551502|FG000|Overall Study|Adverse Event|19|||
48923013|NCT01297270|157551503|FG001|Overall Study|Adverse Event|32|||
48923014|NCT01297270|157551504|FG002|Overall Study|Adverse Event|5|||
48923015|NCT01297270|157551502|FG000|Overall Study|Lack of Efficacy|15|||
48923016|NCT01297270|157551503|FG001|Overall Study|Lack of Efficacy|17|||
48923017|NCT01297270|157551504|FG002|Overall Study|Lack of Efficacy|15|||
48923018|NCT01297270|157551502|FG000|Overall Study|Lost to Follow-up|1|||
48923019|NCT01297270|157551503|FG001|Overall Study|Lost to Follow-up|2|||
48923020|NCT01297270|157551504|FG002|Overall Study|Lost to Follow-up|1|||
48923021|NCT01297270|157551502|FG000|Overall Study|Protocol Violation|0|||
48923022|NCT01297270|157551503|FG001|Overall Study|Protocol Violation|2|||
48923023|NCT01297270|157551504|FG002|Overall Study|Protocol Violation|0|||
48923024|NCT01297270|157551502|FG000|Overall Study|Withdrawal by Subject|7|||
48923025|NCT01297270|157551503|FG001|Overall Study|Withdrawal by Subject|15|||
48923026|NCT01297270|157551504|FG002|Overall Study|Withdrawal by Subject|7|||
48923027|NCT01297270|157551502|FG000|Overall Study|Other reason not defined above|3|||
48923028|NCT01297270|157551503|FG001|Overall Study|Other reason not defined above|3|||
48923029|NCT01297270|157551504|FG002|Overall Study|Other reason not defined above|1|||
48923030|NCT01297270|157551502|FG000|Overall Study|Not treated|0|||
48923031|NCT01297270|157551503|FG001|Overall Study|Not treated|1|||
48923032|NCT01297270|157551504|FG002|Overall Study|Not treated|0|||
48923033|NCT02706730|157551510|FG000|Overall Study|Adverse Event|3|||
48923034|NCT02706730|157551510|FG000|Overall Study|Lack of Efficacy|5|||
48923035|NCT02706730|157551510|FG000|Overall Study|Withdrawal by Subject|11|||
48923036|NCT02706730|157551510|FG000|Overall Study|Study Terminated by Sponsor|11|||
48923037|NCT02706730|157551510|FG000|Overall Study|Subject chose not to receive injection|3|||
48923038|NCT03021642|157551511|FG000|Washout Period (21 Days)|Adverse Event|1|||
48923039|NCT03021642|157551512|FG001|Washout Period (21 Days)|Adverse Event|1|||
48923040|NCT00094055|157551513|FG000|Overall Study|Adverse Event|11|||
48923041|NCT00094055|157551513|FG000|Overall Study|Death|4|||
48923042|NCT00094055|157551513|FG000|Overall Study|Lack of Efficacy|17|||
48923043|NCT00094055|157551513|FG000|Overall Study|Lost to Follow-up|2|||
48923044|NCT00094055|157551513|FG000|Overall Study|progressive disease|2|||
48923045|NCT00094055|157551513|FG000|Overall Study|clinical progression|1|||
48923046|NCT00094055|157551513|FG000|Overall Study|roll-over to another study|14|||
48923047|NCT00094055|157551513|FG000|Overall Study|Withdrawal by Subject|9|||
48923048|NCT03603496|157551516|FG000|Overall Study|Death|19|||
48923049|NCT03603496|157551517|FG001|Overall Study|Death|24|||
48923050|NCT03603496|157551516|FG000|Overall Study|Lost to Follow-up|141|||
48923051|NCT03603496|157551517|FG001|Overall Study|Lost to Follow-up|141|||
48923052|NCT03603496|157551516|FG000|Overall Study|Withdrawal by Subject|26|||
48923053|NCT03603496|157551517|FG001|Overall Study|Withdrawal by Subject|20|||
48833056|NCT01689519|157229283|FG000|Intent to Treat|Withdrawal by Subject|21|||
48833057|NCT01689519|157229284|FG001|Intent to Treat|Withdrawal by Subject|20|||
48833058|NCT01689519|157229283|FG000|Safety Population|Death|158|||
48833059|NCT01689519|157229284|FG001|Safety Population|Death|165|||
48833060|NCT01689519|157229283|FG000|Safety Population|Lost to Follow-up|4|||
48833061|NCT01689519|157229284|FG001|Safety Population|Lost to Follow-up|8|||
48923054|NCT00411554|157551520|FG000|Overall Study|Adverse Event|2|||
48923055|NCT00411554|157551521|FG001|Overall Study|Adverse Event|4|||
48923056|NCT00411554|157551520|FG000|Overall Study|Lack of Efficacy|2|||
48923057|NCT00411554|157551521|FG001|Overall Study|Lack of Efficacy|5|||
48923058|NCT00411554|157551520|FG000|Overall Study|Withdrawal by Subject|3|||
48923059|NCT00411554|157551521|FG001|Overall Study|Withdrawal by Subject|0|||
48923060|NCT00411554|157551520|FG000|Overall Study|Patient Moved|1|||
48833062|NCT01689519|157229283|FG000|Safety Population|Other|2|||
48833063|NCT01689519|157229284|FG001|Safety Population|Other|4|||
48923061|NCT00411554|157551521|FG001|Overall Study|Patient Moved|0|||
48923062|NCT04317274|157551530|FG000|Overall Study|participant did not provide enough information to calculate a shared decision making process score|2|||
48923063|NCT04317274|157551531|FG001|Overall Study|participant did not provide enough information to calculate a shared decision making process score|3|||
49158991|NCT02891226|158422181|FG007|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
49158992|NCT02891226|158422182|FG008|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
49158993|NCT02891226|158422183|FG009|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
48833064|NCT01689519|157229283|FG000|Safety Population|Physician Decision|4|||
48833065|NCT01689519|157229284|FG001|Safety Population|Physician Decision|1|||
48833066|NCT01689519|157229283|FG000|Safety Population|Study Terminated By Sponsor|60|||
48833067|NCT01689519|157229284|FG001|Safety Population|Study Terminated By Sponsor|47|||
48923064|NCT04317274|157551532|FG002|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
49158994|NCT02891226|158422184|FG010|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
49158995|NCT02891226|158422185|FG011|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
49158996|NCT02891226|158422186|FG012|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
49158997|NCT02891226|158422187|FG013|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
49158998|NCT02891226|158422188|FG014|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
49158999|NCT02891226|158422189|FG015|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
49159000|NCT02891226|158422174|FG000|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
48833068|NCT01689519|157229283|FG000|Safety Population|Withdrawal by Subject|20|||
48833069|NCT01689519|157229284|FG001|Safety Population|Withdrawal by Subject|20|||
48833070|NCT00612586|157229285|FG000|Overall Study|Adverse Event|6|||
48833071|NCT00612586|157229286|FG001|Overall Study|Adverse Event|2|||
48833072|NCT00612586|157229285|FG000|Overall Study|Death|1|||
48833073|NCT00612586|157229286|FG001|Overall Study|Death|0|||
48833074|NCT00612586|157229285|FG000|Overall Study|Entry Criteria Not Met|0|||
48833075|NCT00612586|157229286|FG001|Overall Study|Entry Criteria Not Met|2|||
48833076|NCT00612586|157229285|FG000|Overall Study|Withdrawal by Subject|7|||
48833077|NCT00612586|157229286|FG001|Overall Study|Withdrawal by Subject|9|||
48833078|NCT00612586|157229285|FG000|Overall Study|Physician Decision|1|||
48833079|NCT00612586|157229286|FG001|Overall Study|Physician Decision|2|||
48833080|NCT00612586|157229285|FG000|Overall Study|Sponsor Decision|1|||
48833081|NCT00612586|157229286|FG001|Overall Study|Sponsor Decision|1|||
48833082|NCT00612586|157229285|FG000|Overall Study|Progressive Disease|26|||
48833083|NCT00612586|157229286|FG001|Overall Study|Progressive Disease|24|||
48833084|NCT00612586|157229285|FG000|Overall Study|Randomized and Not Treated|1|||
48833085|NCT00612586|157229286|FG001|Overall Study|Randomized and Not Treated|1|||
48833086|NCT00762606|157229289|FG000|Overall Study|Lost to Follow-up|18|||
48833087|NCT00762606|157229290|FG001|Overall Study|Lost to Follow-up|13|||
48833088|NCT00436644|157229291|FG000|Overall Study|Adverse Event|2|||
48833089|NCT00436644|157229291|FG000|Overall Study|Death|1|||
48833090|NCT01596504|157229293|FG000|Overall Study|Participant's Private Reason|0|||
48833091|NCT01596504|157229294|FG001|Overall Study|Participant's Private Reason|1|||
48833092|NCT01596504|157229295|FG002|Overall Study|Participant's Private Reason|0|||
48833093|NCT01596504|157229293|FG000|Overall Study|Adverse Event|1|||
48833094|NCT01596504|157229294|FG001|Overall Study|Adverse Event|2|||
48833095|NCT01596504|157229295|FG002|Overall Study|Adverse Event|1|||
48833096|NCT01596504|157229293|FG000|Overall Study|Withdrawal by Subject|1|||
48833097|NCT01596504|157229294|FG001|Overall Study|Withdrawal by Subject|0|||
48833098|NCT01596504|157229295|FG002|Overall Study|Withdrawal by Subject|0|||
48833099|NCT01069341|157229296|FG000|Overall Study|Lost to Follow-up|1|||
48833100|NCT00922207|157229297|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
48833101|NCT00922207|157229298|FG001|Overall Study|Adverse Event/Intercurrent Illness|0|||
48833102|NCT00922207|157229299|FG002|Overall Study|Adverse Event/Intercurrent Illness|0|||
48833103|NCT00922207|157229297|FG000|Overall Study|Insufficient Therapeutic Response|0|||
48833104|NCT00922207|157229298|FG001|Overall Study|Insufficient Therapeutic Response|0|||
48833105|NCT00922207|157229299|FG002|Overall Study|Insufficient Therapeutic Response|1|||
48833106|NCT00922207|157229297|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
48833107|NCT00922207|157229298|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
48833108|NCT00922207|157229299|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
48833109|NCT00922207|157229297|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
48833110|NCT00922207|157229298|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
48833111|NCT00922207|157229299|FG002|Overall Study|Refused Treatment/Did Not Cooperate|0|||
48833112|NCT00922207|157229297|FG000|Overall Study|Withdrew Consent|2|||
48833113|NCT00922207|157229298|FG001|Overall Study|Withdrew Consent|5|||
48833114|NCT00922207|157229299|FG002|Overall Study|Withdrew Consent|2|||
48833115|NCT00922207|157229297|FG000|Overall Study|Abnormality of Laboratory Test|0|||
48833116|NCT00922207|157229298|FG001|Overall Study|Abnormality of Laboratory Test|1|||
48833117|NCT00922207|157229299|FG002|Overall Study|Abnormality of Laboratory Test|1|||
48833118|NCT03299816|157229304|FG000|Phase 1: 4-month Intervention Period|Withdrawal by Subject|1|||
48833119|NCT03299816|157229305|FG001|Phase 1: 4-month Intervention Period|Withdrawal by Subject|0|||
48833120|NCT03299816|157229304|FG000|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|1|||
49159001|NCT02891226|158422175|FG001|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
48833121|NCT03299816|157229305|FG001|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|0|||
48833122|NCT03299816|157229304|FG000|Phase 2: 12-month Follow-up Period|Lost to Follow-up|2|||
49159002|NCT02891226|158422176|FG002|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
49159003|NCT02891226|158422177|FG003|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
49159004|NCT02891226|158422178|FG004|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
48833123|NCT03299816|157229305|FG001|Phase 2: 12-month Follow-up Period|Lost to Follow-up|3|||
48833124|NCT04536077|157229310|FG000|Overall Study|Did not start treatment due to surgery needing to occur urgently|1|||
48833125|NCT04536077|157229311|FG001|Overall Study|Did not start treatment due to surgery needing to occur urgently|0|||
48833126|NCT04536077|157229310|FG000|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|0|||
48923065|NCT04317274|157551533|FG003|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
48923066|NCT01902290|157551534|FG000|Overall Study|Withdrawal by Subject|19|||
48923067|NCT01902290|157551535|FG001|Overall Study|Withdrawal by Subject|27|||
48923068|NCT01902290|157551534|FG000|Overall Study|Lost to Follow-up|2|||
48923069|NCT01902290|157551535|FG001|Overall Study|Lost to Follow-up|2|||
48923070|NCT01902290|157551534|FG000|Overall Study|Death|1|||
48923071|NCT01902290|157551535|FG001|Overall Study|Death|0|||
48923072|NCT01902290|157551534|FG000|Overall Study|Sponsor Decision|26|||
48923073|NCT01902290|157551535|FG001|Overall Study|Sponsor Decision|24|||
48923074|NCT01081795|157551536|FG000|Overall Study|Adverse Event|18|||
48923075|NCT01081795|157551537|FG001|Overall Study|Adverse Event|23|||
48923076|NCT01081795|157551538|FG002|Overall Study|Adverse Event|6|||
48923077|NCT01081795|157551536|FG000|Overall Study|Lack of Efficacy|7|||
48923078|NCT01081795|157551537|FG001|Overall Study|Lack of Efficacy|5|||
48923079|NCT01081795|157551538|FG002|Overall Study|Lack of Efficacy|19|||
48923080|NCT01081795|157551536|FG000|Overall Study|Subject's schedule|1|||
48923081|NCT01081795|157551537|FG001|Overall Study|Subject's schedule|1|||
48923082|NCT01081795|157551538|FG002|Overall Study|Subject's schedule|2|||
48923083|NCT01081795|157551536|FG000|Overall Study|Revocation of informed consent|2|||
48923084|NCT01081795|157551537|FG001|Overall Study|Revocation of informed consent|0|||
48923085|NCT01081795|157551538|FG002|Overall Study|Revocation of informed consent|0|||
48923086|NCT01081795|157551536|FG000|Overall Study|Ineligible for participation|1|||
48923087|NCT01081795|157551537|FG001|Overall Study|Ineligible for participation|0|||
48923088|NCT01081795|157551538|FG002|Overall Study|Ineligible for participation|0|||
48923089|NCT01081795|157551536|FG000|Overall Study|Use of a prohibited concomitant drug|1|||
48923090|NCT01081795|157551537|FG001|Overall Study|Use of a prohibited concomitant drug|1|||
48923091|NCT01081795|157551538|FG002|Overall Study|Use of a prohibited concomitant drug|1|||
48923092|NCT01081795|157551536|FG000|Overall Study|Using drug with restricted days of use|2|||
48923093|NCT01081795|157551537|FG001|Overall Study|Using drug with restricted days of use|3|||
48923094|NCT01081795|157551538|FG002|Overall Study|Using drug with restricted days of use|2|||
48923095|NCT01081795|157551536|FG000|Overall Study|Other|1|||
48923096|NCT01081795|157551537|FG001|Overall Study|Other|2|||
48923097|NCT01081795|157551538|FG002|Overall Study|Other|0|||
49159005|NCT02891226|158422179|FG005|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
49159006|NCT02891226|158422180|FG006|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|1|||
49159007|NCT02891226|158422181|FG007|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
49159008|NCT02891226|158422182|FG008|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
49159009|NCT02891226|158422183|FG009|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
49159010|NCT02891226|158422184|FG010|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
49159011|NCT02891226|158422185|FG011|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
49159012|NCT02891226|158422186|FG012|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
49159013|NCT02891226|158422187|FG013|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
49159014|NCT02891226|158422188|FG014|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
49159015|NCT02891226|158422189|FG015|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
49159016|NCT02891226|158422174|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
49159017|NCT02891226|158422175|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
49159018|NCT02891226|158422176|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
49159019|NCT02891226|158422177|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
49159020|NCT02891226|158422178|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
49159021|NCT02891226|158422179|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
48833127|NCT04536077|157229311|FG001|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|1|||
48833128|NCT03803774|157229312|FG000|Dose Escalation|Withdrawal by Subject|0|||
48833129|NCT03803774|157229313|FG001|Dose Escalation|Withdrawal by Subject|0|||
48833130|NCT03803774|157229314|FG002|Dose Escalation|Withdrawal by Subject|0|||
48833131|NCT03803774|157229315|FG003|Dose Escalation|Withdrawal by Subject|1|||
48833132|NCT03803774|157229316|FG004|Dose Escalation|Withdrawal by Subject|0|||
48833133|NCT00208767|157229318|FG000|Overall Study|Adverse Event|9|||
48833134|NCT00208767|157229319|FG001|Overall Study|Adverse Event|1|||
48833135|NCT00208767|157229318|FG000|Overall Study|Withdrawal by Subject|14|||
48833136|NCT00208767|157229319|FG001|Overall Study|Withdrawal by Subject|3|||
48833137|NCT00208767|157229318|FG000|Overall Study|Death|1|||
48833138|NCT00208767|157229319|FG001|Overall Study|Death|0|||
48833139|NCT00208767|157229318|FG000|Overall Study|Lost to Follow-up|3|||
48923098|NCT02161211|157551545|FG000|Overall Study|Lost to Follow-up|21|||
48923099|NCT02161211|157551546|FG001|Overall Study|Lost to Follow-up|27|||
48923100|NCT02161211|157551547|FG002|Overall Study|Lost to Follow-up|21|||
48923101|NCT02161211|157551545|FG000|Overall Study|Dropped|12|||
48923102|NCT02161211|157551546|FG001|Overall Study|Dropped|5|||
48923103|NCT02161211|157551547|FG002|Overall Study|Dropped|9|||
48923104|NCT01618214|157551548|FG000|Overall Study|Adverse Event|3|||
48833140|NCT00208767|157229319|FG001|Overall Study|Lost to Follow-up|3|||
48833141|NCT01751724|157229322|FG000|Overall Study|extubated bef.start assigned treatment|1|||
49159022|NCT02891226|158422180|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
49159023|NCT02891226|158422181|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
49159024|NCT02891226|158422182|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
49159025|NCT02891226|158422183|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
49159026|NCT02891226|158422184|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
49159027|NCT02891226|158422185|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
49159028|NCT02891226|158422186|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
49159029|NCT02891226|158422187|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
49159030|NCT02891226|158422188|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
49159031|NCT02891226|158422189|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
49159032|NCT02891226|158422174|FG000|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
49159033|NCT02891226|158422175|FG001|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
49159034|NCT02891226|158422176|FG002|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
49159035|NCT02891226|158422177|FG003|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
49159036|NCT02891226|158422178|FG004|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
49159037|NCT02891226|158422179|FG005|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
49159038|NCT02891226|158422180|FG006|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
49159039|NCT02891226|158422181|FG007|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|1|||
49159040|NCT02891226|158422182|FG008|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
49159041|NCT02891226|158422183|FG009|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
49159042|NCT02891226|158422184|FG010|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
49159043|NCT02891226|158422185|FG011|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
49159044|NCT02891226|158422186|FG012|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
49159045|NCT02891226|158422187|FG013|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
49159046|NCT02891226|158422188|FG014|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
49159047|NCT02891226|158422189|FG015|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
49159048|NCT02891226|158422174|FG000|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
49159049|NCT02891226|158422175|FG001|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
49159050|NCT02891226|158422176|FG002|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
49159051|NCT02891226|158422177|FG003|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
49159052|NCT02891226|158422178|FG004|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
48923105|NCT01618214|157551549|FG001|Overall Study|Adverse Event|1|||
48923106|NCT01618214|157551548|FG000|Overall Study|Lack of Efficacy|1|||
48923107|NCT01618214|157551549|FG001|Overall Study|Lack of Efficacy|1|||
48923108|NCT01618214|157551548|FG000|Overall Study|Protocol Violation|1|||
48923109|NCT01618214|157551549|FG001|Overall Study|Protocol Violation|4|||
48923110|NCT01618214|157551548|FG000|Overall Study|Withdrawal Criteria|1|||
48923111|NCT01618214|157551549|FG001|Overall Study|Withdrawal Criteria|2|||
48923112|NCT01618214|157551548|FG000|Overall Study|Unclassified|4|||
48923113|NCT01618214|157551549|FG001|Overall Study|Unclassified|5|||
48923114|NCT00835237|157551550|FG000|Overall Study|Lost to Follow-up|4|||
48923115|NCT00835237|157551551|FG001|Overall Study|Lost to Follow-up|0|||
48923116|NCT00835237|157551550|FG000|Overall Study|Withdrawal by Subject|2|||
49159053|NCT02891226|158422179|FG005|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
49159054|NCT02891226|158422180|FG006|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
49159055|NCT02891226|158422181|FG007|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
49159056|NCT02891226|158422182|FG008|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|1|||
49159057|NCT02891226|158422183|FG009|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
49159058|NCT02891226|158422184|FG010|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
49159059|NCT02891226|158422185|FG011|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
49159060|NCT02891226|158422186|FG012|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
49159061|NCT02891226|158422187|FG013|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
49159062|NCT02891226|158422188|FG014|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
49159063|NCT02891226|158422189|FG015|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
49159064|NCT02891226|158422174|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
49159065|NCT02891226|158422175|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
49159066|NCT02891226|158422176|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
49159067|NCT02891226|158422177|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
49159068|NCT02891226|158422178|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
49159069|NCT02891226|158422179|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
49159070|NCT02891226|158422180|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
48833142|NCT01751724|157229323|FG001|Overall Study|extubated bef.start assigned treatment|0|||
48833143|NCT01751724|157229322|FG000|Overall Study|withdrawn by parent|0|||
49159071|NCT02891226|158422181|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
48923117|NCT00835237|157551551|FG001|Overall Study|Withdrawal by Subject|0|||
49159072|NCT02891226|158422182|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
49159073|NCT02891226|158422183|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|1|||
49159074|NCT02891226|158422184|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
49159075|NCT02891226|158422185|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
49159076|NCT02891226|158422186|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
49159077|NCT02891226|158422187|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
49159078|NCT02891226|158422188|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
49159079|NCT02891226|158422189|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
49159080|NCT02891226|158422174|FG000|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
49159081|NCT02891226|158422175|FG001|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
49159082|NCT02891226|158422176|FG002|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
49159083|NCT02891226|158422177|FG003|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
49159084|NCT02891226|158422178|FG004|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
49159085|NCT02891226|158422179|FG005|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
48923118|NCT02370615|157551552|FG000|Overall Study|Adverse Event|1|||
48923119|NCT02370615|157551553|FG001|Overall Study|Adverse Event|0|||
48923120|NCT01536860|157551554|FG000|Washout Period (3 Days)|Lost to Follow-up|1|||
48923121|NCT01536860|157551555|FG001|Washout Period (3 Days)|Lost to Follow-up|0|||
48923122|NCT01536860|157551556|FG002|Washout Period (3 Days)|Lost to Follow-up|0|||
48923123|NCT00606086|157551564|FG000|Overall Study|Adverse Event|1|||
48923124|NCT00606086|157551565|FG001|Overall Study|Adverse Event|1|||
48923125|NCT00606086|157551564|FG000|Overall Study|Lost to Follow-up|4|||
48923126|NCT00606086|157551565|FG001|Overall Study|Lost to Follow-up|8|||
48923127|NCT00606086|157551564|FG000|Overall Study|Protocol Violation|1|||
48923128|NCT00606086|157551565|FG001|Overall Study|Protocol Violation|0|||
48923129|NCT00606086|157551564|FG000|Overall Study|Withdrawal by Subject|5|||
48923130|NCT00606086|157551565|FG001|Overall Study|Withdrawal by Subject|3|||
48923131|NCT00606086|157551564|FG000|Overall Study|Non-compliance|0|||
49159086|NCT02891226|158422180|FG006|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
48833144|NCT01751724|157229323|FG001|Overall Study|withdrawn by parent|2|||
48833145|NCT01690624|157229326|FG000|Overall Study|PD based on IWG criteria or clinical PD|8|||
49159087|NCT02891226|158422181|FG007|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
49159088|NCT02891226|158422182|FG008|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
49159089|NCT02891226|158422183|FG009|Period 2 (Weeks 12 to 52)|Sponsor Decision|1|||
49159090|NCT02891226|158422184|FG010|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
49159091|NCT02891226|158422185|FG011|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
49159092|NCT02891226|158422186|FG012|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
49159093|NCT02891226|158422187|FG013|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
49159094|NCT02891226|158422188|FG014|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
49159095|NCT02891226|158422189|FG015|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
49159096|NCT02891226|158422174|FG000|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
49159097|NCT02891226|158422175|FG001|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
49159098|NCT02891226|158422176|FG002|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
49159099|NCT02891226|158422177|FG003|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
49159100|NCT02891226|158422178|FG004|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
49159101|NCT02891226|158422179|FG005|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
49159102|NCT02891226|158422180|FG006|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
49159103|NCT02891226|158422181|FG007|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
49159104|NCT02891226|158422182|FG008|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
49159105|NCT02891226|158422183|FG009|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
49159106|NCT02891226|158422184|FG010|Period 3 (Weeks 52 to 208)|Adverse Event|5|||
49159107|NCT02891226|158422185|FG011|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
49159108|NCT02891226|158422186|FG012|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
49159109|NCT02891226|158422187|FG013|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
49159110|NCT02891226|158422188|FG014|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
48833146|NCT01690624|157229327|FG001|Overall Study|PD based on IWG criteria or clinical PD|5|||
49159111|NCT02891226|158422189|FG015|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
49159112|NCT02891226|158422174|FG000|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
49159113|NCT02891226|158422175|FG001|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
48833147|NCT01690624|157229328|FG002|Overall Study|PD based on IWG criteria or clinical PD|2|||
49159114|NCT02891226|158422176|FG002|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
49159115|NCT02891226|158422177|FG003|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
49159116|NCT02891226|158422178|FG004|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
49159117|NCT02891226|158422179|FG005|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
49159118|NCT02891226|158422180|FG006|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
49159119|NCT02891226|158422181|FG007|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
49159120|NCT02891226|158422182|FG008|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
48833148|NCT01690624|157229329|FG003|Overall Study|PD based on IWG criteria or clinical PD|0|||
49159121|NCT02891226|158422183|FG009|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
48923132|NCT00606086|157551565|FG001|Overall Study|Non-compliance|1|||
48923133|NCT00606086|157551564|FG000|Overall Study|Randomized, not treated|1|||
49159122|NCT02891226|158422184|FG010|Period 3 (Weeks 52 to 208)|Lost to Follow-up|1|||
49159123|NCT02891226|158422185|FG011|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
49159124|NCT02891226|158422186|FG012|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
49159125|NCT02891226|158422187|FG013|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
49159126|NCT02891226|158422188|FG014|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
49159127|NCT02891226|158422189|FG015|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
49159128|NCT02891226|158422174|FG000|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
49159129|NCT02891226|158422175|FG001|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
49159130|NCT02891226|158422176|FG002|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
49159131|NCT02891226|158422177|FG003|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
49159132|NCT02891226|158422178|FG004|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
49159133|NCT02891226|158422179|FG005|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
49159134|NCT02891226|158422180|FG006|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
49159135|NCT02891226|158422181|FG007|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
49159136|NCT02891226|158422182|FG008|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
49159137|NCT02891226|158422183|FG009|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
49159138|NCT02891226|158422184|FG010|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|14|||
49159139|NCT02891226|158422185|FG011|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
49159140|NCT02891226|158422186|FG012|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
49159141|NCT02891226|158422187|FG013|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
49159142|NCT02891226|158422188|FG014|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
49159143|NCT02891226|158422189|FG015|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
48833149|NCT01690624|157229326|FG000|Overall Study|Adverse event (other than DLT)|3|||
48833150|NCT01690624|157229327|FG001|Overall Study|Adverse event (other than DLT)|1|||
48833151|NCT01690624|157229328|FG002|Overall Study|Adverse event (other than DLT)|1|||
49159144|NCT02891226|158422174|FG000|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
49159145|NCT02891226|158422175|FG001|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
49159146|NCT02891226|158422176|FG002|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
49159147|NCT02891226|158422177|FG003|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
49159148|NCT02891226|158422178|FG004|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
49159149|NCT02891226|158422179|FG005|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
49159150|NCT02891226|158422180|FG006|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
49159151|NCT02891226|158422181|FG007|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
49159152|NCT02891226|158422182|FG008|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
49159153|NCT02891226|158422183|FG009|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
49159154|NCT02891226|158422184|FG010|Period 3 (Weeks 52 to 208)|Roll over to AMAX|108|||
49159155|NCT02891226|158422185|FG011|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
49159156|NCT02891226|158422186|FG012|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
49159157|NCT02891226|158422187|FG013|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
49159158|NCT02891226|158422188|FG014|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
49159159|NCT02891226|158422189|FG015|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
49159160|NCT02891226|158422174|FG000|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
49159161|NCT02891226|158422175|FG001|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
49159162|NCT02891226|158422176|FG002|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
49159163|NCT02891226|158422177|FG003|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
49159164|NCT02891226|158422178|FG004|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
49159165|NCT02891226|158422179|FG005|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
49159166|NCT02891226|158422180|FG006|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
49159167|NCT02891226|158422181|FG007|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
48833152|NCT01690624|157229329|FG003|Overall Study|Adverse event (other than DLT)|1|||
48833153|NCT01690624|157229326|FG000|Overall Study|Withdrawal by Subject|0|||
48833154|NCT01690624|157229327|FG001|Overall Study|Withdrawal by Subject|0|||
48833155|NCT01690624|157229328|FG002|Overall Study|Withdrawal by Subject|1|||
48833156|NCT01690624|157229329|FG003|Overall Study|Withdrawal by Subject|0|||
48833157|NCT01690624|157229326|FG000|Overall Study|Sponsor is ending trial|0|||
48833158|NCT01690624|157229327|FG001|Overall Study|Sponsor is ending trial|0|||
48833159|NCT01690624|157229328|FG002|Overall Study|Sponsor is ending trial|0|||
48833160|NCT01690624|157229329|FG003|Overall Study|Sponsor is ending trial|1|||
48833161|NCT01690624|157229326|FG000|Overall Study|Physician Decision|0|||
48833162|NCT01690624|157229327|FG001|Overall Study|Physician Decision|0|||
48833163|NCT01690624|157229328|FG002|Overall Study|Physician Decision|0|||
48833164|NCT01690624|157229329|FG003|Overall Study|Physician Decision|1|||
48833165|NCT01690624|157229326|FG000|Overall Study|Withdrawal by Subject|0|||
48833166|NCT01690624|157229327|FG001|Overall Study|Withdrawal by Subject|1|||
48833167|NCT01690624|157229328|FG002|Overall Study|Withdrawal by Subject|0|||
48833168|NCT01690624|157229329|FG003|Overall Study|Withdrawal by Subject|0|||
48833169|NCT01690624|157229326|FG000|Overall Study|Lack of Efficacy|1|||
48833170|NCT01690624|157229327|FG001|Overall Study|Lack of Efficacy|1|||
48833171|NCT01690624|157229328|FG002|Overall Study|Lack of Efficacy|3|||
48833172|NCT01690624|157229329|FG003|Overall Study|Lack of Efficacy|0|||
48833173|NCT05355116|157231024|FG000|Overall Study|Withdrawal by Subject|2|||
48833174|NCT01025843|157231028|FG000|Washout 4|Withdrawal by Subject|0|||
48833175|NCT01025843|157231029|FG001|Washout 4|Withdrawal by Subject|0|||
49159168|NCT02891226|158422182|FG008|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
49159169|NCT02891226|158422183|FG009|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
49159170|NCT02891226|158422184|FG010|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|2|||
49159171|NCT02891226|158422185|FG011|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
49159172|NCT02891226|158422186|FG012|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
49159173|NCT02891226|158422187|FG013|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
49159174|NCT02891226|158422188|FG014|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
49159175|NCT02891226|158422189|FG015|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
49159176|NCT02891226|158422174|FG000|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
49159177|NCT02891226|158422175|FG001|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
48833176|NCT01025843|157231030|FG002|Washout 4|Withdrawal by Subject|1|||
48833177|NCT01025843|157231031|FG003|Washout 4|Withdrawal by Subject|1|||
48833178|NCT01025843|157231032|FG004|Washout 4|Withdrawal by Subject|0|||
48833179|NCT01025843|157231033|FG005|Washout 4|Withdrawal by Subject|0|||
48833180|NCT01025843|157231034|FG006|Washout 4|Withdrawal by Subject|0|||
48833181|NCT01025843|157231035|FG007|Washout 4|Withdrawal by Subject|0|||
48833182|NCT01025843|157231036|FG008|Washout 4|Withdrawal by Subject|0|||
48833183|NCT01025843|157231037|FG009|Washout 4|Withdrawal by Subject|0|||
48833184|NCT01883492|157231040|FG000|Overall Study|Lost to Follow-up|3|||
48833185|NCT01883492|157231041|FG001|Overall Study|Lost to Follow-up|4|||
48833186|NCT01883492|157231040|FG000|Overall Study|Surgery on contra-lateral hip|0|||
48833187|NCT01883492|157231041|FG001|Overall Study|Surgery on contra-lateral hip|1|||
48833188|NCT01883492|157231040|FG000|Overall Study|Poor X-ray quality|7|||
48833189|NCT01883492|157231041|FG001|Overall Study|Poor X-ray quality|4|||
48833190|NCT01883492|157231040|FG000|Overall Study|Withdrawal by Subject|1|||
48833191|NCT01883492|157231041|FG001|Overall Study|Withdrawal by Subject|0|||
48833192|NCT01883492|157231040|FG000|Overall Study|inappropriate implant used|1|||
48833193|NCT01883492|157231041|FG001|Overall Study|inappropriate implant used|1|||
48833194|NCT01883492|157231040|FG000|Overall Study|bone anatomy did not meet study criteria|1|||
48833195|NCT01883492|157231041|FG001|Overall Study|bone anatomy did not meet study criteria|1|||
48833196|NCT03265210|157231042|FG000|Overall Study|Withdrawal by Subject|7|||
48833197|NCT03265210|157231043|FG001|Overall Study|Withdrawal by Subject|9|||
48833198|NCT03265210|157231042|FG000|Overall Study|Lost to Follow-up|2|||
48833199|NCT03265210|157231043|FG001|Overall Study|Lost to Follow-up|0|||
48833200|NCT03265210|157231042|FG000|Overall Study|Physician Decision|2|||
48833201|NCT03265210|157231043|FG001|Overall Study|Physician Decision|0|||
48833202|NCT03265210|157231042|FG000|Overall Study|Adverse Event|1|||
48833203|NCT03265210|157231043|FG001|Overall Study|Adverse Event|0|||
48833204|NCT04353037|157231046|FG000|Overall Study|Lost to Follow-up|0|||
48833205|NCT04353037|157231047|FG001|Overall Study|Lost to Follow-up|1|||
48833206|NCT04353037|157231048|FG002|Overall Study|Lost to Follow-up|2|||
48833207|NCT04353037|157231049|FG003|Overall Study|Lost to Follow-up|3|||
48833208|NCT04353037|157231046|FG000|Overall Study|Withdrawal by Subject|0|||
48833209|NCT04353037|157231047|FG001|Overall Study|Withdrawal by Subject|2|||
48833210|NCT04353037|157231048|FG002|Overall Study|Withdrawal by Subject|3|||
48833211|NCT04353037|157231049|FG003|Overall Study|Withdrawal by Subject|5|||
48833212|NCT04353037|157231046|FG000|Overall Study|Adverse Event|0|||
48833213|NCT04353037|157231047|FG001|Overall Study|Adverse Event|0|||
48833214|NCT04353037|157231048|FG002|Overall Study|Adverse Event|2|||
48833215|NCT04353037|157231049|FG003|Overall Study|Adverse Event|0|||
48833216|NCT04353037|157231046|FG000|Overall Study|Exposure Change|0|||
48833217|NCT04353037|157231047|FG001|Overall Study|Exposure Change|0|||
48833218|NCT04353037|157231048|FG002|Overall Study|Exposure Change|0|||
48833219|NCT04353037|157231049|FG003|Overall Study|Exposure Change|2|||
48833220|NCT00357396|157231051|FG000|Overall Study|Adverse Event|1|||
48833221|NCT00357396|157231052|FG001|Overall Study|Adverse Event|0|||
48833222|NCT02274493|157231053|FG000|Overall Study|Withdrawal by Subject|1|||
48833223|NCT00920686|157231054|FG000|Overall Study|Lost to Follow-up|2|||
48833224|NCT00920686|157231055|FG001|Overall Study|Lost to Follow-up|3|||
48833225|NCT00920686|157231056|FG002|Overall Study|Lost to Follow-up|1|||
48833226|NCT00920686|157231054|FG000|Overall Study|Study drug dosing criteria not met|17|||
48833227|NCT00920686|157231055|FG001|Overall Study|Study drug dosing criteria not met|19|||
48833228|NCT00920686|157231056|FG002|Overall Study|Study drug dosing criteria not met|12|||
48833229|NCT01494662|157231061|FG000|Overall Study|Withdrawal by Subject|0|||
48833230|NCT01494662|157231062|FG001|Overall Study|Withdrawal by Subject|0|||
48833231|NCT01494662|157231063|FG002|Overall Study|Withdrawal by Subject|1|||
48833232|NCT01494662|157231064|FG003|Overall Study|Withdrawal by Subject|0|||
48833233|NCT01494662|157231065|FG004|Overall Study|Withdrawal by Subject|0|||
49159178|NCT02891226|158422176|FG002|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
49159179|NCT02891226|158422177|FG003|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
49159180|NCT02891226|158422178|FG004|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
49159181|NCT02891226|158422179|FG005|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
49159182|NCT02891226|158422180|FG006|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
48833234|NCT01494662|157231066|FG005|Overall Study|Withdrawal by Subject|0|||
48833235|NCT01494662|157231067|FG006|Overall Study|Withdrawal by Subject|0|||
48833236|NCT01494662|157231061|FG000|Overall Study|Physician Decision|0|||
48833237|NCT01494662|157231062|FG001|Overall Study|Physician Decision|0|||
49159183|NCT02891226|158422181|FG007|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
49159184|NCT02891226|158422182|FG008|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
49159185|NCT02891226|158422183|FG009|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
49159186|NCT02891226|158422184|FG010|Period 3 (Weeks 52 to 208)|Lack of Efficacy|3|||
48833238|NCT01494662|157231063|FG002|Overall Study|Physician Decision|1|||
48833239|NCT01494662|157231064|FG003|Overall Study|Physician Decision|0|||
48833240|NCT01494662|157231065|FG004|Overall Study|Physician Decision|0|||
48833241|NCT01494662|157231066|FG005|Overall Study|Physician Decision|0|||
48833242|NCT01494662|157231067|FG006|Overall Study|Physician Decision|0|||
48833243|NCT01329328|157231068|FG000|Overall Study|Withdrawal by Subject|2|||
48833244|NCT01329328|157231069|FG001|Overall Study|Withdrawal by Subject|4|||
48833245|NCT01329328|157231070|FG002|Overall Study|Withdrawal by Subject|3|||
48833246|NCT01651949|157231071|FG000|Overall Study|Unknown status|4|||
48833247|NCT01651949|157231072|FG001|Overall Study|Unknown status|4|||
48833248|NCT01651949|157231073|FG002|Overall Study|Unknown status|0|||
48833249|NCT01651949|157231071|FG000|Overall Study|Lost to Follow-up|30|||
48833250|NCT01651949|157231072|FG001|Overall Study|Lost to Follow-up|56|||
48833251|NCT01651949|157231073|FG002|Overall Study|Lost to Follow-up|20|||
48833252|NCT01651949|157231071|FG000|Overall Study|Protocol Violation|0|||
48833253|NCT01651949|157231072|FG001|Overall Study|Protocol Violation|2|||
48833254|NCT01651949|157231073|FG002|Overall Study|Protocol Violation|1|||
48833255|NCT01651949|157231071|FG000|Overall Study|Physician Decision|0|||
48833256|NCT01651949|157231072|FG001|Overall Study|Physician Decision|2|||
48833257|NCT01651949|157231073|FG002|Overall Study|Physician Decision|0|||
48833258|NCT01651949|157231071|FG000|Overall Study|Adverse Event|0|||
48833259|NCT01651949|157231072|FG001|Overall Study|Adverse Event|2|||
48833260|NCT01651949|157231073|FG002|Overall Study|Adverse Event|1|||
48833261|NCT01651949|157231071|FG000|Overall Study|Screen failure|2|||
48833262|NCT01651949|157231072|FG001|Overall Study|Screen failure|2|||
48833263|NCT01651949|157231073|FG002|Overall Study|Screen failure|0|||
48833264|NCT01651949|157231071|FG000|Overall Study|Withdrawal by Subject|17|||
48833265|NCT01651949|157231072|FG001|Overall Study|Withdrawal by Subject|18|||
48833266|NCT01651949|157231073|FG002|Overall Study|Withdrawal by Subject|9|||
48833267|NCT02595398|157231074|FG000|Overall Study|Non-compliance|1|||
48833268|NCT02595398|157231075|FG001|Overall Study|Non-compliance|0|||
48833269|NCT02595398|157231074|FG000|Overall Study|Withdrawal by Subject|2|||
48833270|NCT02595398|157231075|FG001|Overall Study|Withdrawal by Subject|1|||
48833271|NCT02595398|157231074|FG000|Overall Study|Lost to Follow-up|1|||
48833272|NCT02595398|157231075|FG001|Overall Study|Lost to Follow-up|0|||
48833273|NCT00544440|157231076|FG000|Overall Study|Other|1|||
48833274|NCT00544440|157231076|FG000|Overall Study|Adverse Event|1|||
48833275|NCT00544440|157231076|FG000|Overall Study|Withdrawal by Subject|2|||
48833276|NCT00544440|157231076|FG000|Overall Study|Subject Non-compliance|1|||
48833277|NCT00544440|157231076|FG000|Overall Study|Progressive Disease|47|||
48833278|NCT00544440|157231076|FG000|Overall Study|Other|5|||
48833279|NCT03525119|157231078|FG000|Overall Study|Adverse Event|0|||
48833280|NCT03525119|157231079|FG001|Overall Study|Adverse Event|1|||
48833281|NCT03525119|157231080|FG002|Overall Study|Adverse Event|0|||
48833282|NCT03525119|157231078|FG000|Overall Study|Lost to Follow-up|32|||
48833283|NCT03525119|157231079|FG001|Overall Study|Lost to Follow-up|33|||
48833284|NCT03525119|157231080|FG002|Overall Study|Lost to Follow-up|37|||
48833285|NCT03525119|157231078|FG000|Overall Study|Withdrawal by Subject|5|||
48833286|NCT03525119|157231079|FG001|Overall Study|Withdrawal by Subject|4|||
48833287|NCT03525119|157231080|FG002|Overall Study|Withdrawal by Subject|2|||
48833288|NCT03525119|157231078|FG000|Overall Study|Reason not Specified|2|||
48833289|NCT03525119|157231079|FG001|Overall Study|Reason not Specified|1|||
49159187|NCT02891226|158422185|FG011|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
48833290|NCT03525119|157231080|FG002|Overall Study|Reason not Specified|2|||
48833291|NCT03525119|157231078|FG000|Overall Study|Randomized but not Vaccinated|1|||
48833292|NCT03525119|157231079|FG001|Overall Study|Randomized but not Vaccinated|0|||
48833293|NCT03525119|157231080|FG002|Overall Study|Randomized but not Vaccinated|2|||
48833294|NCT03987451|157231081|FG000|Overall Study|Lost to Follow-up|1|||
48833295|NCT03987451|157231082|FG001|Overall Study|Lost to Follow-up|0|||
48833296|NCT03987451|157231081|FG000|Overall Study|Withdrawal by Subject|1|||
48833297|NCT03987451|157231082|FG001|Overall Study|Withdrawal by Subject|1|||
48833298|NCT00770965|157231096|FG000|Safety Set|Withdrawal by Subject|0|||
48833299|NCT00770965|157231097|FG001|Safety Set|Withdrawal by Subject|0|||
48833300|NCT00770965|157231098|FG002|Safety Set|Withdrawal by Subject|0|||
49159188|NCT02891226|158422186|FG012|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
48833301|NCT00770965|157231099|FG003|Safety Set|Withdrawal by Subject|1|||
48833302|NCT00770965|157231096|FG000|Safety Set|Protocol deviation|0|||
48833303|NCT00770965|157231097|FG001|Safety Set|Protocol deviation|0|||
48833304|NCT00770965|157231098|FG002|Safety Set|Protocol deviation|1|||
48833305|NCT00770965|157231099|FG003|Safety Set|Protocol deviation|0|||
48833306|NCT00770965|157231096|FG000|Excluded Set|Administrative problems|14|||
48833307|NCT00770965|157231097|FG001|Excluded Set|Administrative problems|12|||
48833308|NCT00770965|157231098|FG002|Excluded Set|Administrative problems|12|||
48833309|NCT00770965|157231099|FG003|Excluded Set|Administrative problems|10|||
48833310|NCT00770965|157231096|FG000|Excluded Set|Withdrawal by Subject|1|||
48833311|NCT00770965|157231097|FG001|Excluded Set|Withdrawal by Subject|1|||
48833312|NCT00770965|157231098|FG002|Excluded Set|Withdrawal by Subject|2|||
48833313|NCT00770965|157231099|FG003|Excluded Set|Withdrawal by Subject|3|||
48833314|NCT00509769|157231100|FG000|Overall Study|Progressive disease|77|||
48833315|NCT00509769|157231100|FG000|Overall Study|Adverse Event|4|||
48833316|NCT00509769|157231100|FG000|Overall Study|Patient's decision|1|||
48833317|NCT00509769|157231100|FG000|Overall Study|Physician Decision|8|||
48833318|NCT00509769|157231100|FG000|Overall Study|Use of prohibited therapies during study|1|||
48833319|NCT02371746|157231101|FG000|Overall Study|Consent withdrawn|0|||
48833320|NCT02371746|157231102|FG001|Overall Study|Consent withdrawn|0|||
48833321|NCT02371746|157231103|FG002|Overall Study|Consent withdrawn|0|||
48833322|NCT02371746|157231104|FG003|Overall Study|Consent withdrawn|0|||
48833323|NCT02371746|157231105|FG004|Overall Study|Consent withdrawn|0|||
48833324|NCT02371746|157231106|FG005|Overall Study|Consent withdrawn|0|||
48833325|NCT02371746|157231107|FG006|Overall Study|Consent withdrawn|1|||
48833326|NCT00410124|157231109|FG000|Core Phase Double Blind (15 Months)|Adverse Event|36|||
48833327|NCT00410124|157231110|FG001|Core Phase Double Blind (15 Months)|Adverse Event|2|||
48833328|NCT00410124|157231109|FG000|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1|||
48833329|NCT00410124|157231110|FG001|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0|||
48833330|NCT00410124|157231109|FG000|Core Phase Double Blind (15 Months)|Protocol Violation|2|||
48833331|NCT00410124|157231110|FG001|Core Phase Double Blind (15 Months)|Protocol Violation|1|||
48833332|NCT00410124|157231109|FG000|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13|||
48833333|NCT00410124|157231110|FG001|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2|||
48833334|NCT00410124|157231109|FG000|Core Phase Double Blind (15 Months)|Lost to Follow-up|4|||
49159189|NCT02891226|158422187|FG013|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
48833335|NCT00410124|157231110|FG001|Core Phase Double Blind (15 Months)|Lost to Follow-up|0|||
48833336|NCT00410124|157231109|FG000|Core Phase Double Blind (15 Months)|Administrative Problems|2|||
48833337|NCT00410124|157231110|FG001|Core Phase Double Blind (15 Months)|Administrative Problems|0|||
48833338|NCT00410124|157231109|FG000|Core Phase Double Blind (15 Months)|Death|7|||
48833339|NCT00410124|157231110|FG001|Core Phase Double Blind (15 Months)|Death|4|||
48833340|NCT00410124|157231109|FG000|Core Phase Double Blind (15 Months)|Disease Progression|137|||
48833341|NCT00410124|157231110|FG001|Core Phase Double Blind (15 Months)|Disease Progression|124|||
48833342|NCT00410124|157231109|FG000|Extension Phase - Open Label (45 Months)|Adverse Event|7|||
48833343|NCT00410124|157231110|FG001|Extension Phase - Open Label (45 Months)|Adverse Event|19|||
48833344|NCT00410124|157231109|FG000|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0|||
48833345|NCT00410124|157231110|FG001|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1|||
48833346|NCT00410124|157231109|FG000|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0|||
49159190|NCT02891226|158422188|FG014|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
48833347|NCT00410124|157231110|FG001|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1|||
48833348|NCT00410124|157231109|FG000|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
48833349|NCT00410124|157231110|FG001|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
48833350|NCT00410124|157231109|FG000|Extension Phase - Open Label (45 Months)|Death|2|||
48833351|NCT00410124|157231110|FG001|Extension Phase - Open Label (45 Months)|Death|10|||
48833352|NCT00410124|157231109|FG000|Extension Phase - Open Label (45 Months)|Disease Progression|56|||
49014581|NCT04634409|157888934|FG011|Overall Study|Death|0|||
49159191|NCT02891226|158422189|FG015|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
49159192|NCT02891226|158422174|FG000|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
49159193|NCT02891226|158422175|FG001|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
49159194|NCT02891226|158422176|FG002|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
49159195|NCT02891226|158422177|FG003|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
49159196|NCT02891226|158422178|FG004|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
49159197|NCT02891226|158422179|FG005|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
49159198|NCT02891226|158422180|FG006|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
49159199|NCT02891226|158422181|FG007|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
48833353|NCT00410124|157231110|FG001|Extension Phase - Open Label (45 Months)|Disease Progression|78|||
48833354|NCT00410124|157231109|FG000|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1|||
48833355|NCT00410124|157231110|FG001|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0|||
48833356|NCT00410124|157231109|FG000|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0|||
48833357|NCT00410124|157231110|FG001|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1|||
48833358|NCT00909363|157231111|FG000|Overall Study|Withdrawal by Subject|1|||
48833359|NCT00909363|157231112|FG001|Overall Study|Withdrawal by Subject|0|||
48833360|NCT00909363|157231113|FG002|Overall Study|Withdrawal by Subject|0|||
48833361|NCT00909363|157231111|FG000|Overall Study|Lack of Efficacy|1|||
48833362|NCT00909363|157231112|FG001|Overall Study|Lack of Efficacy|0|||
48833363|NCT00909363|157231113|FG002|Overall Study|Lack of Efficacy|0|||
48833364|NCT05179837|157231115|FG000|Overall Study|Lesion turned out to be scar tissue and not a polyp|1|||
48833365|NCT05179837|157231115|FG000|Overall Study|Device malfunctioned|1|||
48833366|NCT05179837|157231115|FG000|Overall Study|Image quality too low|2|||
48833367|NCT01802632|157231116|FG000|Overall Study|Death|28|||
48833368|NCT01802632|157231117|FG001|Overall Study|Death|1|||
48833369|NCT01802632|157231118|FG002|Overall Study|Death|38|||
48833370|NCT01802632|157231119|FG003|Overall Study|Death|0|||
48833371|NCT01802632|157231120|FG004|Overall Study|Death|2|||
48833372|NCT01802632|157231121|FG005|Overall Study|Death|0|||
48833373|NCT01802632|157231116|FG000|Overall Study|Withdrawal by Subject|4|||
48833374|NCT01802632|157231117|FG001|Overall Study|Withdrawal by Subject|2|||
48833375|NCT01802632|157231118|FG002|Overall Study|Withdrawal by Subject|7|||
48833376|NCT01802632|157231119|FG003|Overall Study|Withdrawal by Subject|3|||
48833377|NCT01802632|157231120|FG004|Overall Study|Withdrawal by Subject|0|||
48833378|NCT01802632|157231121|FG005|Overall Study|Withdrawal by Subject|1|||
49159200|NCT02891226|158422182|FG008|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
49159201|NCT02891226|158422183|FG009|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
49159202|NCT02891226|158422184|FG010|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|2|||
49159203|NCT02891226|158422185|FG011|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
49159204|NCT02891226|158422186|FG012|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
49159205|NCT02891226|158422187|FG013|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
49159206|NCT02891226|158422188|FG014|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
49159207|NCT02891226|158422189|FG015|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
49159208|NCT02891226|158422174|FG000|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
49159209|NCT02891226|158422175|FG001|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
49159210|NCT02891226|158422176|FG002|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
49159211|NCT02891226|158422177|FG003|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
49159212|NCT02891226|158422178|FG004|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
49159213|NCT02891226|158422179|FG005|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
49159214|NCT02891226|158422180|FG006|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
48833379|NCT01802632|157231116|FG000|Overall Study|Objective Disease Progression|1|||
48833380|NCT01802632|157231117|FG001|Overall Study|Objective Disease Progression|12|||
48833381|NCT01802632|157231118|FG002|Overall Study|Objective Disease Progression|104|||
48833382|NCT01802632|157231119|FG003|Overall Study|Objective Disease Progression|6|||
48833383|NCT01802632|157231120|FG004|Overall Study|Objective Disease Progression|4|||
48833384|NCT01802632|157231121|FG005|Overall Study|Objective Disease Progression|4|||
49159215|NCT02891226|158422181|FG007|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
49159216|NCT02891226|158422182|FG008|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
49159217|NCT02891226|158422183|FG009|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
49159218|NCT02891226|158422184|FG010|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|2|||
49159219|NCT02891226|158422185|FG011|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
49159220|NCT02891226|158422186|FG012|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
49159221|NCT02891226|158422187|FG013|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
49159222|NCT02891226|158422188|FG014|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
49159223|NCT02891226|158422189|FG015|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
49159224|NCT02891226|158422174|FG000|Follow-up Period|Withdrawal by Subject|0|||
49159225|NCT02891226|158422175|FG001|Follow-up Period|Withdrawal by Subject|0|||
49159226|NCT02891226|158422176|FG002|Follow-up Period|Withdrawal by Subject|0|||
49159227|NCT02891226|158422177|FG003|Follow-up Period|Withdrawal by Subject|0|||
49159228|NCT02891226|158422178|FG004|Follow-up Period|Withdrawal by Subject|0|||
49159229|NCT02891226|158422179|FG005|Follow-up Period|Withdrawal by Subject|0|||
48833385|NCT01802632|157231116|FG000|Overall Study|Ongoing Study at Data Cut-off|168|||
48833386|NCT01802632|157231117|FG001|Overall Study|Ongoing Study at Data Cut-off|16|||
48833387|NCT01802632|157231118|FG002|Overall Study|Ongoing Study at Data Cut-off|115|||
48833388|NCT01802632|157231119|FG003|Overall Study|Ongoing Study at Data Cut-off|50|||
49159230|NCT02891226|158422180|FG006|Follow-up Period|Withdrawal by Subject|0|||
49159231|NCT02891226|158422181|FG007|Follow-up Period|Withdrawal by Subject|0|||
49159232|NCT02891226|158422182|FG008|Follow-up Period|Withdrawal by Subject|0|||
49159233|NCT02891226|158422183|FG009|Follow-up Period|Withdrawal by Subject|0|||
49159234|NCT02891226|158422184|FG010|Follow-up Period|Withdrawal by Subject|0|||
49159235|NCT02891226|158422185|FG011|Follow-up Period|Withdrawal by Subject|1|||
49159236|NCT02891226|158422186|FG012|Follow-up Period|Withdrawal by Subject|0|||
49159237|NCT02891226|158422187|FG013|Follow-up Period|Withdrawal by Subject|0|||
49159238|NCT02891226|158422188|FG014|Follow-up Period|Withdrawal by Subject|1|||
49159239|NCT02891226|158422189|FG015|Follow-up Period|Withdrawal by Subject|1|||
49159240|NCT03402841|158422190|FG000|Overall Study|Withdrawal by Subject|3|||
49159241|NCT03402841|158422190|FG000|Overall Study|Lost to Follow-up|2|||
49159242|NCT03402841|158422190|FG000|Overall Study|Death|146|||
49159243|NCT04442269|158422193|FG000|Overall Study|Adverse Event|1|||
49159244|NCT04442269|158422194|FG001|Overall Study|Adverse Event|0|||
49159245|NCT04442269|158422193|FG000|Overall Study|Death|0|||
49159246|NCT04442269|158422194|FG001|Overall Study|Death|1|||
49159247|NCT04442269|158422193|FG000|Overall Study|Decision by the Investigator/Sponsor|1|||
49159248|NCT04442269|158422194|FG001|Overall Study|Decision by the Investigator/Sponsor|1|||
49159249|NCT04442269|158422193|FG000|Overall Study|Lost to Follow-up|1|||
49159250|NCT04442269|158422194|FG001|Overall Study|Lost to Follow-up|0|||
49159251|NCT04442269|158422193|FG000|Overall Study|Withdrawal by Subject|3|||
49159252|NCT04442269|158422194|FG001|Overall Study|Withdrawal by Subject|2|||
49159253|NCT04442269|158422193|FG000|Overall Study|Protocol Deviation|0|||
49159254|NCT04442269|158422194|FG001|Overall Study|Protocol Deviation|1|||
49159255|NCT04442269|158422193|FG000|Overall Study|Travel Limitations|1|||
49159256|NCT04442269|158422194|FG001|Overall Study|Travel Limitations|1|||
49159257|NCT00710593|158423820|FG000|Overall Study|Incarceration|1|||
49159258|NCT00710593|158423821|FG001|Overall Study|Incarceration|0|||
49159259|NCT00710593|158423820|FG000|Overall Study|Unable to complete Wk 48 within window|2|||
49159260|NCT00710593|158423821|FG001|Overall Study|Unable to complete Wk 48 within window|0|||
49159261|NCT00710593|158423820|FG000|Overall Study|Lost to Follow-up|3|||
49159262|NCT00710593|158423821|FG001|Overall Study|Lost to Follow-up|1|||
49159263|NCT00710593|158423820|FG000|Overall Study|Moved out of area|1|||
49159264|NCT00710593|158423821|FG001|Overall Study|Moved out of area|0|||
49159265|NCT00710593|158423820|FG000|Overall Study|Failure to adhere or complete study eval|1|||
49159266|NCT00710593|158423821|FG001|Overall Study|Failure to adhere or complete study eval|1|||
49159267|NCT00710593|158423820|FG000|Overall Study|Protocol Violation|1|||
49159268|NCT00710593|158423821|FG001|Overall Study|Protocol Violation|1|||
49159269|NCT00710593|158423820|FG000|Overall Study|Prem disc vaccine, completed all visits|6|||
49159270|NCT00710593|158423821|FG001|Overall Study|Prem disc vaccine, completed all visits|2|||
49159271|NCT00069641|158423822|FG000|Overall Study|Death|1|||
49159272|NCT00069641|158423823|FG001|Overall Study|Death|0|||
49159273|NCT00069641|158423824|FG002|Overall Study|Death|1|||
49159274|NCT00105534|158423825|FG000|Overall Study|Adverse Event|2|||
49159275|NCT00105534|158423826|FG001|Overall Study|Adverse Event|5|||
49159276|NCT00105534|158423825|FG000|Overall Study|Protocol Violation|1|||
49159277|NCT00105534|158423826|FG001|Overall Study|Protocol Violation|4|||
48833389|NCT01802632|157231120|FG004|Overall Study|Ongoing Study at Data Cut-off|6|||
48833390|NCT01802632|157231121|FG005|Overall Study|Ongoing Study at Data Cut-off|22|||
48833391|NCT01802632|157231116|FG000|Overall Study|Other (not specified)|0|||
48833392|NCT01802632|157231117|FG001|Overall Study|Other (not specified)|0|||
48833393|NCT01802632|157231118|FG002|Overall Study|Other (not specified)|7|||
48833394|NCT01802632|157231119|FG003|Overall Study|Other (not specified)|1|||
48833395|NCT01802632|157231120|FG004|Overall Study|Other (not specified)|0|||
48833396|NCT01802632|157231121|FG005|Overall Study|Other (not specified)|1|||
48833397|NCT00545077|157231129|FG000|Overall Study|Treatment not received|5|||
48833398|NCT00545077|157231130|FG001|Overall Study|Treatment not received|1|||
48833399|NCT00545077|157231129|FG000|Overall Study|Disease Progression|131|||
48833400|NCT00545077|157231130|FG001|Overall Study|Disease Progression|98|||
48833401|NCT00545077|157231129|FG000|Overall Study|Withdrawal by Subject|3|||
48833402|NCT00545077|157231130|FG001|Overall Study|Withdrawal by Subject|14|||
48833403|NCT00545077|157231129|FG000|Overall Study|Physician Decision|6|||
48833404|NCT00545077|157231130|FG001|Overall Study|Physician Decision|3|||
48833405|NCT00545077|157231129|FG000|Overall Study|Lost to Follow-up|2|||
49014582|NCT04634409|157888935|FG012|Overall Study|Death|1|||
49159278|NCT00105534|158423825|FG000|Overall Study|Withdrawal by Subject|6|||
49159279|NCT00105534|158423826|FG001|Overall Study|Withdrawal by Subject|6|||
48833406|NCT00545077|157231130|FG001|Overall Study|Lost to Follow-up|0|||
48833407|NCT00545077|157231129|FG000|Overall Study|Protocol Violation|1|||
48833408|NCT00545077|157231130|FG001|Overall Study|Protocol Violation|0|||
49014583|NCT04634409|157888936|FG013|Overall Study|Death|0|||
49159280|NCT00105534|158423825|FG000|Overall Study|Lost to Follow-up|5|||
49159281|NCT00105534|158423826|FG001|Overall Study|Lost to Follow-up|1|||
49159282|NCT00105534|158423825|FG000|Overall Study|Lack of Efficacy|7|||
49159283|NCT00105534|158423826|FG001|Overall Study|Lack of Efficacy|15|||
49159284|NCT00105534|158423825|FG000|Overall Study|Treatment unmasked|1|||
49159285|NCT00105534|158423826|FG001|Overall Study|Treatment unmasked|0|||
49159286|NCT00105534|158423825|FG000|Overall Study|Other Reason|0|||
49159287|NCT00105534|158423826|FG001|Overall Study|Other Reason|2|||
49159288|NCT00831389|158423828|FG000|Overall Study|Withdrawal by Subject|0|||
49159289|NCT00831389|158423829|FG001|Overall Study|Withdrawal by Subject|1|||
49159290|NCT04778592|158423837|FG000|Overall Study|Adverse Event|1|||
49159291|NCT04778592|158423838|FG001|Overall Study|Adverse Event|2|||
49159292|NCT04778592|158423837|FG000|Overall Study|Withdrawal by Subject|1|||
49159293|NCT04778592|158423838|FG001|Overall Study|Withdrawal by Subject|2|||
49159294|NCT01029535|158423839|FG000|Overall Study|Lost to Follow-up|24|||
49159295|NCT01029535|158423839|FG000|Overall Study|Protocol Violation|2|||
49159296|NCT01029535|158423839|FG000|Overall Study|Participant Withdrew Consent|2|||
49159297|NCT01029535|158423839|FG000|Overall Study|Adverse Event|1|||
49159298|NCT01029535|158423839|FG000|Overall Study|Use of Another Treatment|1|||
49159299|NCT01029535|158423839|FG000|Overall Study|Death|1|||
49159300|NCT03257358|158423840|FG000|Overall Study|Adverse Event|25|||
49159301|NCT03257358|158423841|FG001|Overall Study|Adverse Event|12|||
49159302|NCT03257358|158423840|FG000|Overall Study|Lack of Efficacy|1|||
49159303|NCT03257358|158423841|FG001|Overall Study|Lack of Efficacy|1|||
49159304|NCT03257358|158423840|FG000|Overall Study|Lost to Follow-up|12|||
49159305|NCT03257358|158423841|FG001|Overall Study|Lost to Follow-up|4|||
49159306|NCT03257358|158423840|FG000|Overall Study|Non-compliance with fingolimod treatment|4|||
49159307|NCT03257358|158423841|FG001|Overall Study|Non-compliance with fingolimod treatment|2|||
49159308|NCT03257358|158423840|FG000|Overall Study|Physician Decision|2|||
49159309|NCT03257358|158423841|FG001|Overall Study|Physician Decision|2|||
49159310|NCT03257358|158423840|FG000|Overall Study|Protocol Violation|5|||
49159311|NCT03257358|158423841|FG001|Overall Study|Protocol Violation|3|||
49159312|NCT03257358|158423840|FG000|Overall Study|Technical problems|4|||
49159313|NCT03257358|158423841|FG001|Overall Study|Technical problems|1|||
49159314|NCT03257358|158423840|FG000|Overall Study|Withdrawal by Subject|8|||
49159315|NCT03257358|158423841|FG001|Overall Study|Withdrawal by Subject|3|||
49159316|NCT03257358|158423840|FG000|Overall Study|Withdrawal of informed consent|9|||
49159317|NCT03257358|158423841|FG001|Overall Study|Withdrawal of informed consent|5|||
49159318|NCT03257358|158423840|FG000|Overall Study|New therapy for study indication|1|||
49159319|NCT03257358|158423841|FG001|Overall Study|New therapy for study indication|0|||
49159320|NCT03257358|158423840|FG000|Overall Study|No longer requires treatment|0|||
49159321|NCT03257358|158423841|FG001|Overall Study|No longer requires treatment|1|||
49159322|NCT02410772|158423842|FG000|Overall Study|Death|3|||
49159323|NCT02410772|158423843|FG001|Overall Study|Death|4|||
49159324|NCT02410772|158423844|FG002|Overall Study|Death|8|||
49159325|NCT02410772|158423842|FG000|Overall Study|Lost to Follow-up|31|||
49159326|NCT02410772|158423843|FG001|Overall Study|Lost to Follow-up|23|||
49159327|NCT02410772|158423844|FG002|Overall Study|Lost to Follow-up|22|||
49159328|NCT02410772|158423842|FG000|Overall Study|Pregnancy|8|||
49159329|NCT02410772|158423843|FG001|Overall Study|Pregnancy|4|||
49159330|NCT02410772|158423844|FG002|Overall Study|Pregnancy|5|||
49159331|NCT02410772|158423842|FG000|Overall Study|Protocol Violation|8|||
49159332|NCT02410772|158423843|FG001|Overall Study|Protocol Violation|8|||
49159333|NCT02410772|158423844|FG002|Overall Study|Protocol Violation|4|||
49159334|NCT02410772|158423842|FG000|Overall Study|Baseline Drug Resistance|49|||
49159335|NCT02410772|158423843|FG001|Overall Study|Baseline Drug Resistance|40|||
49159336|NCT02410772|158423844|FG002|Overall Study|Baseline Drug Resistance|51|||
49159337|NCT02410772|158423842|FG000|Overall Study|No positive Mycobacterium tuberculosis culture|4|||
49159338|NCT02410772|158423843|FG001|Overall Study|No positive Mycobacterium tuberculosis culture|6|||
49159339|NCT02410772|158423844|FG002|Overall Study|No positive Mycobacterium tuberculosis culture|3|||
49159340|NCT02410772|158423842|FG000|Overall Study|Reinfection with a new strain of MTB|0|||
49159341|NCT02410772|158423843|FG001|Overall Study|Reinfection with a new strain of MTB|1|||
49159342|NCT02410772|158423844|FG002|Overall Study|Reinfection with a new strain of MTB|0|||
49159343|NCT01475721|158423846|FG000|Overall Study|Death|3|||
49159344|NCT01475721|158423847|FG001|Overall Study|Death|6|||
49159345|NCT01475721|158423846|FG000|Overall Study|Withdrawal by Subject|8|||
49159346|NCT01475721|158423847|FG001|Overall Study|Withdrawal by Subject|8|||
49159347|NCT01198587|158423850|FG000|Overall Study|Lost to Follow-up|8|||
49159348|NCT01198587|158423851|FG001|Overall Study|Lost to Follow-up|0|||
49159349|NCT01198587|158423852|FG002|Overall Study|Lost to Follow-up|9|||
49159350|NCT01198587|158423853|FG003|Overall Study|Lost to Follow-up|0|||
49159351|NCT01959529|158423854|FG000|Overall Study|Adverse event (not hypoglycaemia)|0|||
49159352|NCT01959529|158423855|FG001|Overall Study|Adverse event (not hypoglycaemia)|1|||
49159353|NCT01959529|158423854|FG000|Overall Study|Lost to Follow-up|4|||
49159354|NCT01959529|158423855|FG001|Overall Study|Lost to Follow-up|1|||
49159355|NCT01959529|158423854|FG000|Overall Study|Other|70|||
48923134|NCT00606086|157551565|FG001|Overall Study|Randomized, not treated|2|||
48833409|NCT00545077|157231129|FG000|Overall Study|Adverse Event|0|||
48833410|NCT00545077|157231130|FG001|Overall Study|Adverse Event|31|||
48833411|NCT00545077|157231129|FG000|Overall Study|Death|0|||
48833412|NCT00545077|157231130|FG001|Overall Study|Death|8|||
48833413|NCT00919763|157231136|FG000|Overall Study|Adverse Event|7|||
48833414|NCT00919763|157231137|FG001|Overall Study|Adverse Event|1|||
48833415|NCT00919763|157231136|FG000|Overall Study|Lost to Follow-up|1|||
48833416|NCT00919763|157231137|FG001|Overall Study|Lost to Follow-up|0|||
48833417|NCT00919763|157231136|FG000|Overall Study|Protocol Violation|1|||
48833418|NCT00919763|157231137|FG001|Overall Study|Protocol Violation|1|||
48833419|NCT00919763|157231136|FG000|Overall Study|Withdrawal by Subject|3|||
48833420|NCT00919763|157231137|FG001|Overall Study|Withdrawal by Subject|1|||
48833421|NCT00919763|157231136|FG000|Overall Study|Non-compliance|0|||
48833422|NCT00919763|157231137|FG001|Overall Study|Non-compliance|1|||
48833423|NCT02739035|157231138|FG000|6 Weeks Post-MUA|Withdrawal by Subject|1|||
48833424|NCT02739035|157231139|FG001|6 Weeks Post-MUA|Withdrawal by Subject|3|||
48833425|NCT02739035|157231138|FG000|6 Weeks Post-MUA|Lost to Follow-up|1|||
48833426|NCT02739035|157231139|FG001|6 Weeks Post-MUA|Lost to Follow-up|3|||
48833427|NCT02739035|157231138|FG000|6 Weeks Post-MUA|Protocol Violation|1|||
48833428|NCT02739035|157231139|FG001|6 Weeks Post-MUA|Protocol Violation|4|||
48833429|NCT02739035|157231138|FG000|1 Year Post-MUA|Lost to Follow-up|10|||
48833430|NCT02739035|157231139|FG001|1 Year Post-MUA|Lost to Follow-up|11|||
48833431|NCT00940992|157231140|FG000|Overall Study|Adverse Event|2|||
48833432|NCT00940992|157231141|FG001|Overall Study|Adverse Event|0|||
48833433|NCT00940992|157231142|FG002|Overall Study|Adverse Event|1|||
48833434|NCT00940992|157231140|FG000|Overall Study|subject request|2|||
48833435|NCT00940992|157231141|FG001|Overall Study|subject request|1|||
48833436|NCT00940992|157231142|FG002|Overall Study|subject request|0|||
48833437|NCT00940992|157231140|FG000|Overall Study|Lost to Follow-up|0|||
48833438|NCT00940992|157231141|FG001|Overall Study|Lost to Follow-up|1|||
48833439|NCT00940992|157231142|FG002|Overall Study|Lost to Follow-up|1|||
48833440|NCT01254864|157231145|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|4|||
48833441|NCT01254864|157231146|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
48833442|NCT01254864|157231147|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
48833443|NCT01254864|157231145|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Death|1|||
48833444|NCT01254864|157231146|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
48833445|NCT01254864|157231147|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
48833446|NCT01254864|157231145|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|24|||
48833447|NCT01254864|157231146|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
48833448|NCT01254864|157231147|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
48833449|NCT01254864|157231145|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|9|||
48833450|NCT01254864|157231146|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
48833451|NCT01254864|157231147|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
48833452|NCT01254864|157231145|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|2|||
48833453|NCT01254864|157231146|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
48833454|NCT01254864|157231147|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
48833455|NCT01254864|157231145|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|7|||
48833456|NCT01254864|157231146|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
48833457|NCT01254864|157231147|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
48833458|NCT01254864|157231145|FG000|Randomization Phase|Adverse Event|0|||
49159356|NCT01959529|158423855|FG001|Overall Study|Other|68|||
49159357|NCT01959529|158423854|FG000|Overall Study|Hypoglycaemia|1|||
49159358|NCT01959529|158423855|FG001|Overall Study|Hypoglycaemia|1|||
49159359|NCT01959529|158423854|FG000|Overall Study|Lack of glycaemic control|1|||
49159360|NCT01959529|158423855|FG001|Overall Study|Lack of glycaemic control|1|||
49159361|NCT00904371|158423857|FG000|Overall Study|Adverse Event|2|||
49159362|NCT00904371|158423857|FG000|Overall Study|Lost to Follow-up|4|||
49159363|NCT00904371|158423857|FG000|Overall Study|Discontinued at target blood pressure|2|||
49159364|NCT00904371|158423857|FG000|Overall Study|Continued with Tritace|1|||
49159365|NCT02569853|158423858|FG000|Overall Study|Adverse Event|2|||
48923135|NCT01929408|157551569|FG000|Overall Study|received HCT as initial treatment|8|||
49159366|NCT02569853|158423859|FG001|Overall Study|Adverse Event|0|||
49159367|NCT02569853|158423858|FG000|Overall Study|Withdrawal by Subject|3|||
49159368|NCT02569853|158423859|FG001|Overall Study|Withdrawal by Subject|2|||
48833459|NCT01254864|157231146|FG001|Randomization Phase|Adverse Event|5|||
48833460|NCT01254864|157231147|FG002|Randomization Phase|Adverse Event|17|||
48833461|NCT01254864|157231145|FG000|Randomization Phase|Death|0|||
48923136|NCT01325428|157551578|FG000|Part A|Progressive disease according to RECIST|9|||
49159369|NCT02569853|158423858|FG000|Overall Study|Lost to Follow-up|3|||
49159370|NCT02569853|158423859|FG001|Overall Study|Lost to Follow-up|3|||
49159371|NCT02569853|158423858|FG000|Overall Study|Protocol Violation|1|||
48833462|NCT01254864|157231146|FG001|Randomization Phase|Death|1|||
49159372|NCT02569853|158423859|FG001|Overall Study|Protocol Violation|1|||
49159373|NCT02569853|158423858|FG000|Overall Study|Did not experience migraine attack|10|||
49159374|NCT02569853|158423859|FG001|Overall Study|Did not experience migraine attack|7|||
49159375|NCT02569853|158423858|FG000|Overall Study|Physician Decision|1|||
49159376|NCT02569853|158423859|FG001|Overall Study|Physician Decision|1|||
49159377|NCT00002766|158423860|FG000|Overall Study|Withdrawal by Subject|0|||
49159378|NCT00002766|158423861|FG001|Overall Study|Withdrawal by Subject|1|||
49159379|NCT00002766|158423860|FG000|Overall Study|Patient Not Treated|1|||
49159380|NCT00002766|158423861|FG001|Overall Study|Patient Not Treated|2|||
49159381|NCT00002766|158423860|FG000|Overall Study|Adverse Event|1|||
49159382|NCT00002766|158423861|FG001|Overall Study|Adverse Event|1|||
49159383|NCT00002766|158423860|FG000|Overall Study|Protocol Violation|1|||
49159384|NCT00002766|158423861|FG001|Overall Study|Protocol Violation|0|||
49159385|NCT01668004|158423867|FG000|Overall Study|Adverse Event|7|||
49159386|NCT01668004|158423867|FG000|Overall Study|Withdrawal by Subject|2|||
49159387|NCT01668004|158423867|FG000|Overall Study|Lost to Follow-up|5|||
49159388|NCT01668004|158423867|FG000|Overall Study|Lack of Efficacy|9|||
49159389|NCT01668004|158423867|FG000|Overall Study|Non-compliance with treatment|2|||
49159390|NCT00454116|158423873|FG000|Overall Study|Adverse Event|5|||
49159391|NCT00454116|158423874|FG001|Overall Study|Adverse Event|11|||
49159392|NCT00454116|158423875|FG002|Overall Study|Adverse Event|9|||
49159393|NCT00454116|158423873|FG000|Overall Study|Condition under investigation worsened|17|||
49159394|NCT00454116|158423874|FG001|Overall Study|Condition under investigation worsened|13|||
49159395|NCT00454116|158423875|FG002|Overall Study|Condition under investigation worsened|18|||
49159396|NCT00454116|158423873|FG000|Overall Study|Withdrawal by Subject|3|||
49159397|NCT00454116|158423874|FG001|Overall Study|Withdrawal by Subject|3|||
49159398|NCT00454116|158423875|FG002|Overall Study|Withdrawal by Subject|1|||
49159399|NCT00454116|158423873|FG000|Overall Study|Other|2|||
49159400|NCT00454116|158423874|FG001|Overall Study|Other|2|||
49159401|NCT00454116|158423875|FG002|Overall Study|Other|0|||
49159402|NCT01128569|158423878|FG000|Washout Period 1|Adverse Event|0|||
49159403|NCT01128569|158423879|FG001|Washout Period 1|Adverse Event|0|||
49159404|NCT01128569|158423880|FG002|Washout Period 1|Adverse Event|1|||
49159405|NCT01128569|158423881|FG003|Washout Period 1|Adverse Event|0|||
49159406|NCT01128569|158423882|FG004|Washout Period 1|Adverse Event|0|||
49159407|NCT01128569|158423883|FG005|Washout Period 1|Adverse Event|0|||
49159408|NCT01128569|158423878|FG000|Treatment Period 2|Withdrawal by Subject|0|||
49159409|NCT01128569|158423879|FG001|Treatment Period 2|Withdrawal by Subject|1|||
49159410|NCT01128569|158423880|FG002|Treatment Period 2|Withdrawal by Subject|0|||
49159411|NCT01128569|158423881|FG003|Treatment Period 2|Withdrawal by Subject|0|||
49159412|NCT01128569|158423882|FG004|Treatment Period 2|Withdrawal by Subject|0|||
49159413|NCT01128569|158423883|FG005|Treatment Period 2|Withdrawal by Subject|0|||
49159414|NCT00894387|158423884|FG000|Overall Study|Adverse Event|44|||
49159415|NCT00894387|158423885|FG001|Overall Study|Adverse Event|45|||
49159416|NCT00894387|158423884|FG000|Overall Study|Abnormal Laboratory values|2|||
49159417|NCT00894387|158423885|FG001|Overall Study|Abnormal Laboratory values|2|||
49159418|NCT00894387|158423884|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
49159419|NCT00894387|158423885|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
49159420|NCT00894387|158423884|FG000|Overall Study|Lost to Follow-up|3|||
49159421|NCT00894387|158423885|FG001|Overall Study|Lost to Follow-up|5|||
49159422|NCT00894387|158423884|FG000|Overall Study|Administrative problems|2|||
49159423|NCT00894387|158423885|FG001|Overall Study|Administrative problems|2|||
49159424|NCT00894387|158423884|FG000|Overall Study|Death|77|||
49159425|NCT00894387|158423885|FG001|Overall Study|Death|76|||
49159426|NCT00894387|158423884|FG000|Overall Study|Protocol Deviation|4|||
49159427|NCT00894387|158423885|FG001|Overall Study|Protocol Deviation|0|||
49159428|NCT00894387|158423884|FG000|Overall Study|Patient's request|25|||
49159429|NCT00894387|158423885|FG001|Overall Study|Patient's request|30|||
49159430|NCT00894387|158423884|FG000|Overall Study|Other (Missing)|5|||
49159431|NCT00894387|158423885|FG001|Overall Study|Other (Missing)|3|||
49159432|NCT00894387|158423884|FG000|Overall Study|Mis-randomized|13|||
49159433|NCT00894387|158423885|FG001|Overall Study|Mis-randomized|9|||
49159434|NCT00894387|158423884|FG000|Overall Study|GCP non-compliance|0|||
48833463|NCT01254864|157231147|FG002|Randomization Phase|Death|0|||
48833464|NCT01254864|157231145|FG000|Randomization Phase|Lost to Follow-up|0|||
48833465|NCT01254864|157231146|FG001|Randomization Phase|Lost to Follow-up|0|||
49159435|NCT00894387|158423885|FG001|Overall Study|GCP non-compliance|2|||
49159436|NCT02300233|158423886|FG000|Overall Study|Adverse Event or Serious Adverse Event|3|||
49159437|NCT02300233|158423887|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
49159438|NCT02300233|158423888|FG002|Overall Study|Adverse Event or Serious Adverse Event|14|||
49159439|NCT02300233|158423886|FG000|Overall Study|Withdrawal by Subject|1|||
48833466|NCT01254864|157231147|FG002|Randomization Phase|Lost to Follow-up|1|||
48833467|NCT01254864|157231145|FG000|Randomization Phase|Physician Decision|0|||
49159440|NCT02300233|158423887|FG001|Overall Study|Withdrawal by Subject|0|||
49159441|NCT02300233|158423888|FG002|Overall Study|Withdrawal by Subject|3|||
49159442|NCT02300233|158423886|FG000|Overall Study|Investigator Judgement|0|||
49159443|NCT02300233|158423887|FG001|Overall Study|Investigator Judgement|0|||
49159444|NCT02300233|158423888|FG002|Overall Study|Investigator Judgement|1|||
49159445|NCT02300233|158423886|FG000|Overall Study|Reason Not Specified|0|||
49159446|NCT02300233|158423887|FG001|Overall Study|Reason Not Specified|0|||
49159447|NCT02300233|158423888|FG002|Overall Study|Reason Not Specified|5|||
49159448|NCT05525910|158423889|FG000|Period 4|Per sponsor due to study timelines|0|||
49159449|NCT05525910|158423890|FG001|Period 4|Per sponsor due to study timelines|0|||
49159450|NCT05525910|158423891|FG002|Period 4|Per sponsor due to study timelines|1|||
49159451|NCT05525910|158423892|FG003|Period 4|Per sponsor due to study timelines|1|||
49159452|NCT05525910|158423893|FG004|Period 4|Per sponsor due to study timelines|1|||
49159453|NCT05448950|158423894|FG000|Overall Study|Death|2|||
49159454|NCT05448950|158423894|FG000|Overall Study|Withdrawal by Subject|1|||
49159455|NCT05448950|158423894|FG000|Overall Study|AVG abandoned|4|||
49159456|NCT02412670|158423895|FG000|Overall Study|Adverse Event|4|||
49159457|NCT02412670|158423896|FG001|Overall Study|Adverse Event|1|||
49159458|NCT02412670|158423895|FG000|Overall Study|Physician Decision|1|||
49159459|NCT02412670|158423896|FG001|Overall Study|Physician Decision|0|||
49159460|NCT02412670|158423895|FG000|Overall Study|Withdrawal by Subject|1|||
49159461|NCT02412670|158423896|FG001|Overall Study|Withdrawal by Subject|0|||
49159462|NCT02412670|158423895|FG000|Overall Study|Ineligible|1|||
49159463|NCT02412670|158423896|FG001|Overall Study|Ineligible|0|||
49159464|NCT03440008|158423899|FG000|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|25|||
49159465|NCT03440008|158423900|FG001|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|7|||
49159466|NCT03440008|158423899|FG000|Overall Study|Withdrawal by Subject|1|||
49159467|NCT03440008|158423900|FG001|Overall Study|Withdrawal by Subject|0|||
49159468|NCT01876381|158423906|FG000|Overall Study|Lack of Efficacy|5|||
49159469|NCT01876381|158423906|FG000|Overall Study|Physician Decision|1|||
49159470|NCT01876381|158423906|FG000|Overall Study|Withdrawal by Subject|1|||
49159471|NCT00332696|158423907|FG000|Overall Study|Death|24|||
49159472|NCT00332696|158423908|FG001|Overall Study|Death|14|||
49159473|NCT00332696|158423907|FG000|Overall Study|Insufficient therapeutic effect|4|||
49159474|NCT00332696|158423908|FG001|Overall Study|Insufficient therapeutic effect|11|||
49159475|NCT00332696|158423907|FG000|Overall Study|Adverse Event|1|||
49159476|NCT00332696|158423908|FG001|Overall Study|Adverse Event|2|||
49159477|NCT00332696|158423907|FG000|Overall Study|Condition does not justify treatment|0|||
49159478|NCT00332696|158423908|FG001|Overall Study|Condition does not justify treatment|2|||
49159479|NCT00332696|158423907|FG000|Overall Study|Lost to Follow-up|0|||
49159480|NCT00332696|158423908|FG001|Overall Study|Lost to Follow-up|1|||
49159481|NCT00332696|158423907|FG000|Overall Study|Withdrawal by Subject|1|||
49159482|NCT00332696|158423908|FG001|Overall Study|Withdrawal by Subject|0|||
49159483|NCT00060944|158423916|FG000|Overall Study|Adverse Event|12|||
49159484|NCT00060944|158423917|FG001|Overall Study|Adverse Event|10|||
49159485|NCT00060944|158423916|FG000|Overall Study|Death|2|||
49159486|NCT00060944|158423917|FG001|Overall Study|Death|3|||
49159487|NCT00060944|158423916|FG000|Overall Study|Withdrawal by Subject|18|||
49159488|NCT00060944|158423917|FG001|Overall Study|Withdrawal by Subject|5|||
49159489|NCT00060944|158423916|FG000|Overall Study|Disease Progression|93|||
49159490|NCT00060944|158423917|FG001|Overall Study|Disease Progression|94|||
49159491|NCT00060944|158423916|FG000|Overall Study|Lost to Follow-up|1|||
49159492|NCT00060944|158423917|FG001|Overall Study|Lost to Follow-up|0|||
49159493|NCT00060944|158423916|FG000|Overall Study|Subject Ineligible To Continue|2|||
49159494|NCT00060944|158423917|FG001|Overall Study|Subject Ineligible To Continue|1|||
49159495|NCT00060944|158423916|FG000|Overall Study|Treatment Switch|0|||
49159496|NCT00060944|158423917|FG001|Overall Study|Treatment Switch|13|||
49159497|NCT00060944|158423916|FG000|Overall Study|Other|2|||
49159498|NCT00060944|158423917|FG001|Overall Study|Other|4|||
49159499|NCT00060944|158423916|FG000|Overall Study|randomized but not treated|6|||
49159500|NCT00060944|158423917|FG001|Overall Study|randomized but not treated|4|||
49159501|NCT01656161|158423919|FG000|Overall Study|Death|3|||
49159502|NCT01656161|158423919|FG000|Overall Study|Adverse Event|2|||
49159503|NCT01656161|158423919|FG000|Overall Study|Protocol Violation|1|||
48923137|NCT01325428|157551578|FG000|Part A|Clinical signs, symptoms of progression|2|||
48923138|NCT01325428|157551578|FG000|Part A|Other adverse event|1|||
49159504|NCT01656161|158423919|FG000|Overall Study|Withdrawal by Subject|1|||
48923139|NCT01325428|157551578|FG000|Part A|Refused continue taking trial medication|2|||
49159505|NCT00967616|158423920|FG000|Overall Study|Adverse Event or Serious Adverse Event|2|||
49159506|NCT00967616|158423921|FG001|Overall Study|Adverse Event or Serious Adverse Event|17|||
49159507|NCT00967616|158423920|FG000|Overall Study|Death|0|||
49159508|NCT00967616|158423921|FG001|Overall Study|Death|3|||
48923140|NCT01325428|157551578|FG000|Part A|Other reason not defined above|2|||
49159509|NCT00967616|158423920|FG000|Overall Study|Withdrawal by Subject|8|||
49159510|NCT00967616|158423921|FG001|Overall Study|Withdrawal by Subject|4|||
49159511|NCT00967616|158423920|FG000|Overall Study|Progressive Disease|31|||
49159512|NCT00967616|158423921|FG001|Overall Study|Progressive Disease|18|||
49159513|NCT00967616|158423920|FG000|Overall Study|Other|8|||
49159514|NCT00967616|158423921|FG001|Overall Study|Other|8|||
49159515|NCT00967616|158423920|FG000|Overall Study|Protocol Violation|1|||
49159516|NCT00967616|158423921|FG001|Overall Study|Protocol Violation|0|||
49159517|NCT00127855|158423922|FG000|Primary Vaccination Course|Adverse Event|0|||
49159518|NCT00127855|158423923|FG001|Primary Vaccination Course|Adverse Event|0|||
49159519|NCT00127855|158423924|FG002|Primary Vaccination Course|Adverse Event|1|||
49159520|NCT00127855|158423925|FG003|Primary Vaccination Course|Adverse Event|0|||
49159521|NCT00127855|158423926|FG004|Primary Vaccination Course|Adverse Event|0|||
49159522|NCT00127855|158423922|FG000|Primary Vaccination Course|Withdrawal by Subject|1|||
49159523|NCT00127855|158423923|FG001|Primary Vaccination Course|Withdrawal by Subject|0|||
49159524|NCT00127855|158423924|FG002|Primary Vaccination Course|Withdrawal by Subject|0|||
49159525|NCT00127855|158423925|FG003|Primary Vaccination Course|Withdrawal by Subject|0|||
49159526|NCT00127855|158423926|FG004|Primary Vaccination Course|Withdrawal by Subject|1|||
49159527|NCT00127855|158423922|FG000|Primary Vaccination Course|Lost to Follow-up|1|||
49159528|NCT00127855|158423923|FG001|Primary Vaccination Course|Lost to Follow-up|1|||
49159529|NCT00127855|158423924|FG002|Primary Vaccination Course|Lost to Follow-up|1|||
49159530|NCT00127855|158423925|FG003|Primary Vaccination Course|Lost to Follow-up|0|||
48923141|NCT01325428|157551578|FG000|Part B|Refused continue taking trial medication|2|||
48923142|NCT01325428|157551578|FG000|Part B|Other reason not defined above|1|||
48923143|NCT01344876|157551580|FG000|Overall Study|Adverse Event|0|||
48923144|NCT01344876|157551581|FG001|Overall Study|Adverse Event|0|||
48923145|NCT01344876|157551582|FG002|Overall Study|Adverse Event|0|||
48923146|NCT01344876|157551583|FG003|Overall Study|Adverse Event|0|||
48923147|NCT01344876|157551584|FG004|Overall Study|Adverse Event|1|||
48923148|NCT01344876|157551580|FG000|Overall Study|Withdrawal by Subject|0|||
48923149|NCT01344876|157551581|FG001|Overall Study|Withdrawal by Subject|0|||
48923150|NCT01344876|157551582|FG002|Overall Study|Withdrawal by Subject|1|||
49159531|NCT00127855|158423926|FG004|Primary Vaccination Course|Lost to Follow-up|2|||
49159532|NCT00127855|158423922|FG000|Primary Vaccination Course|Other|0|||
49159533|NCT00127855|158423923|FG001|Primary Vaccination Course|Other|0|||
49159534|NCT00127855|158423924|FG002|Primary Vaccination Course|Other|0|||
49159535|NCT00127855|158423925|FG003|Primary Vaccination Course|Other|0|||
49159536|NCT00127855|158423926|FG004|Primary Vaccination Course|Other|1|||
49159537|NCT01215851|158423930|FG000|Treatment Period|Adverse Event|1|||
49159538|NCT01215851|158423931|FG001|Treatment Period|Adverse Event|1|||
49159539|NCT01215851|158423932|FG002|Treatment Period|Adverse Event|1|||
49159540|NCT01215851|158423933|FG003|Treatment Period|Adverse Event|3|||
49159541|NCT01215851|158423934|FG004|Treatment Period|Adverse Event|0|||
49159542|NCT01215851|158423935|FG005|Treatment Period|Adverse Event|1|||
49159543|NCT01215851|158423930|FG000|Follow up Period|Lost to Follow-up|0|||
49159544|NCT01215851|158423931|FG001|Follow up Period|Lost to Follow-up|0|||
49159545|NCT01215851|158423932|FG002|Follow up Period|Lost to Follow-up|0|||
49159546|NCT01215851|158423933|FG003|Follow up Period|Lost to Follow-up|0|||
49159547|NCT01215851|158423934|FG004|Follow up Period|Lost to Follow-up|0|||
49159548|NCT01215851|158423935|FG005|Follow up Period|Lost to Follow-up|1|||
49159549|NCT00546481|158423938|FG000|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1|||
49159550|NCT00546481|158423939|FG001|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
49159551|NCT00546481|158423940|FG002|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
49159552|NCT00546481|158423938|FG000|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1|||
49159553|NCT00546481|158423939|FG001|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3|||
49159554|NCT00546481|158423940|FG002|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0|||
49159555|NCT00546481|158423938|FG000|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1|||
49159556|NCT00546481|158423939|FG001|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
49159557|NCT00546481|158423940|FG002|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
49159558|NCT00546481|158423938|FG000|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2|||
49159559|NCT00546481|158423939|FG001|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
49159560|NCT00546481|158423940|FG002|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
49159561|NCT00546481|158423938|FG000|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
49159562|NCT00546481|158423939|FG001|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
49159563|NCT00546481|158423940|FG002|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0|||
49159564|NCT00546481|158423938|FG000|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
49159565|NCT00546481|158423939|FG001|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1|||
48923151|NCT01344876|157551583|FG003|Overall Study|Withdrawal by Subject|0|||
48923152|NCT01344876|157551584|FG004|Overall Study|Withdrawal by Subject|0|||
48923153|NCT01344876|157551580|FG000|Overall Study|Definite progression of primary disease|1|||
49014584|NCT04634409|157888937|FG014|Overall Study|Death|0|||
49159566|NCT00546481|158423940|FG002|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
49159567|NCT00546481|158423938|FG000|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
49159568|NCT00546481|158423939|FG001|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
49159569|NCT00546481|158423940|FG002|Maintenance Phase (CERA)|Withdrawal by Subject|2|||
49159570|NCT00546481|158423938|FG000|Maintenance Phase (CERA)|Kidney transplantation|0|||
49159571|NCT00546481|158423939|FG001|Maintenance Phase (CERA)|Kidney transplantation|0|||
49159572|NCT00546481|158423940|FG002|Maintenance Phase (CERA)|Kidney transplantation|1|||
49159573|NCT00546481|158423938|FG000|Maintenance Phase (CERA)|Other Reason|0|||
49159574|NCT00546481|158423939|FG001|Maintenance Phase (CERA)|Other Reason|0|||
49159575|NCT00546481|158423940|FG002|Maintenance Phase (CERA)|Other Reason|1|||
49159576|NCT00613106|158423941|FG000|Overall Study|Adverse Event|3|||
49159577|NCT00613106|158423942|FG001|Overall Study|Adverse Event|1|||
49159578|NCT00613106|158423941|FG000|Overall Study|Withdrawal by Subject|6|||
49159579|NCT00613106|158423942|FG001|Overall Study|Withdrawal by Subject|3|||
49159580|NCT00613106|158423941|FG000|Overall Study|Lost to Follow-up|7|||
49159581|NCT00613106|158423942|FG001|Overall Study|Lost to Follow-up|2|||
48833468|NCT01254864|157231146|FG001|Randomization Phase|Physician Decision|20|||
48833469|NCT01254864|157231147|FG002|Randomization Phase|Physician Decision|25|||
48833470|NCT01254864|157231145|FG000|Randomization Phase|Withdrawal by Subject|0|||
48833471|NCT01254864|157231146|FG001|Randomization Phase|Withdrawal by Subject|4|||
48833472|NCT01254864|157231147|FG002|Randomization Phase|Withdrawal by Subject|2|||
48833473|NCT01254864|157231145|FG000|Randomization Phase|Non-Compliance|0|||
49159582|NCT00613106|158423941|FG000|Overall Study|misc|4|||
49159583|NCT00613106|158423942|FG001|Overall Study|misc|3|||
49159584|NCT02834819|158423943|FG000|Overall Study|Did not complete 7 day follow up call.|5|||
49159585|NCT02834819|158423944|FG001|Overall Study|Did not complete 7 day follow up call.|0|||
48833474|NCT01254864|157231146|FG001|Randomization Phase|Non-Compliance|1|||
48833475|NCT01254864|157231147|FG002|Randomization Phase|Non-Compliance|0|||
48833476|NCT01254864|157231145|FG000|Randomization Phase|Comorbidities|0|||
48833477|NCT01254864|157231146|FG001|Randomization Phase|Comorbidities|2|||
48833478|NCT01254864|157231147|FG002|Randomization Phase|Comorbidities|1|||
48833479|NCT00337818|157231148|FG000|Overall Study|Lost to Follow-up|289|||
48833480|NCT00337818|157231149|FG001|Overall Study|Lost to Follow-up|91|||
48833481|NCT00337818|157231150|FG002|Overall Study|Lost to Follow-up|107|||
48833482|NCT02770248|157231156|FG000|Overall Study|Adverse Event|0|||
48833483|NCT02770248|157231157|FG001|Overall Study|Adverse Event|1|||
49159586|NCT03508050|158423947|FG000|Overall Study|Pleural adhesions|1|||
49159587|NCT03508050|158423948|FG001|Overall Study|Pleural adhesions|0|||
49159588|NCT03508050|158423947|FG000|Overall Study|Mucus plug|1|||
49159589|NCT03508050|158423948|FG001|Overall Study|Mucus plug|0|||
49159590|NCT03508050|158423947|FG000|Overall Study|Negative biopsy, surgery cancelled|3|||
49159591|NCT03508050|158423948|FG001|Overall Study|Negative biopsy, surgery cancelled|1|||
49159592|NCT03508050|158423947|FG000|Overall Study|Sustained desaturation|0|||
49159593|NCT03508050|158423948|FG001|Overall Study|Sustained desaturation|1|||
49159594|NCT01242514|158423949|FG000|Overall Study|e.g., project closure|1042|||
48833484|NCT02770248|157231156|FG000|Overall Study|Randomized in error, prior to treatment|0|||
49159595|NCT01242514|158423950|FG001|Overall Study|e.g., project closure|305|||
49159596|NCT01242514|158423951|FG002|Overall Study|e.g., project closure|171|||
49159597|NCT01242514|158423949|FG000|Overall Study|Subject decision|33|||
48833485|NCT02770248|157231157|FG001|Overall Study|Randomized in error, prior to treatment|1|||
48833486|NCT00094575|157231165|FG000|Overall Study|Death|146|||
49159598|NCT01242514|158423950|FG001|Overall Study|Subject decision|8|||
49159599|NCT01242514|158423951|FG002|Overall Study|Subject decision|2|||
49159600|NCT01242514|158423949|FG000|Overall Study|Severe non-compliance to protocol|5|||
49159601|NCT01242514|158423950|FG001|Overall Study|Severe non-compliance to protocol|2|||
49159602|NCT01242514|158423951|FG002|Overall Study|Severe non-compliance to protocol|1|||
49159603|NCT01242514|158423949|FG000|Overall Study|Lack of therapeutic response|99|||
49159604|NCT01242514|158423950|FG001|Overall Study|Lack of therapeutic response|16|||
49159605|NCT01242514|158423951|FG002|Overall Study|Lack of therapeutic response|10|||
49159606|NCT01242514|158423949|FG000|Overall Study|Dev. of study specific discont. criteria|21|||
49159607|NCT01242514|158423950|FG001|Overall Study|Dev. of study specific discont. criteria|3|||
49159608|NCT01242514|158423951|FG002|Overall Study|Dev. of study specific discont. criteria|5|||
48833487|NCT00094575|157231166|FG001|Overall Study|Death|146|||
48833488|NCT04679935|157231170|FG000|Overall Study|Death|0|||
48833489|NCT04679935|157231171|FG001|Overall Study|Death|1|||
48833490|NCT00961636|157231172|FG000|Overall Study|Adverse Event|35|||
48833491|NCT00961636|157231173|FG001|Overall Study|Adverse Event|54|||
48833492|NCT00961636|157231174|FG002|Overall Study|Adverse Event|13|||
48735588|NCT00471146|156883672|FG001|Overall Study|Global deterioration of health status|14|||
48833493|NCT00961636|157231172|FG000|Overall Study|Flushing Symptoms|29|||
48833494|NCT00961636|157231173|FG001|Overall Study|Flushing Symptoms|46|||
48833495|NCT00961636|157231174|FG002|Overall Study|Flushing Symptoms|3|||
48735589|NCT00471146|156883671|FG000|Overall Study|Randomized but not treated|9|||
48735590|NCT00471146|156883672|FG001|Overall Study|Randomized but not treated|8|||
48735591|NCT00471146|156883671|FG000|Overall Study|Other|4|||
48735592|NCT00471146|156883672|FG001|Overall Study|Other|5|||
48735593|NCT03800173|156883684|FG000|Overall Study|Lost to Follow-up|0|||
48735594|NCT03800173|156883685|FG001|Overall Study|Lost to Follow-up|0|||
48735595|NCT03800173|156883686|FG002|Overall Study|Lost to Follow-up|0|||
48735596|NCT03800173|156883687|FG003|Overall Study|Lost to Follow-up|0|||
48735597|NCT03800173|156883688|FG004|Overall Study|Lost to Follow-up|1|||
48735598|NCT01934972|156883689|FG000|Overall Study|Withdrawal by Subject|9|||
48735599|NCT01934972|156883690|FG001|Overall Study|Withdrawal by Subject|6|||
48735600|NCT02345226|156883691|FG000|Double-Blind Phase|Adverse Event|5|||
49159609|NCT01242514|158423949|FG000|Overall Study|Lost to Follow-up|14|||
49159610|NCT01242514|158423950|FG001|Overall Study|Lost to Follow-up|5|||
49159611|NCT01242514|158423951|FG002|Overall Study|Lost to Follow-up|4|||
49159612|NCT01242514|158423949|FG000|Overall Study|Adverse Event|129|||
49159613|NCT01242514|158423950|FG001|Overall Study|Adverse Event|18|||
49159614|NCT01242514|158423951|FG002|Overall Study|Adverse Event|19|||
49159615|NCT02756403|158423952|FG000|Overall Study|Unable to swallow medication|0|||
49159616|NCT02756403|158423953|FG001|Overall Study|Unable to swallow medication|1|||
49159617|NCT02756403|158423954|FG002|Overall Study|Unable to swallow medication|1|||
49159618|NCT02756403|158423955|FG003|Overall Study|Unable to swallow medication|1|||
49159619|NCT02756403|158423952|FG000|Overall Study|Did not complete Procedure|0|||
49159620|NCT02756403|158423953|FG001|Overall Study|Did not complete Procedure|1|||
49159621|NCT02756403|158423954|FG002|Overall Study|Did not complete Procedure|0|||
48833496|NCT00961636|157231172|FG000|Overall Study|Lost to Follow-up|2|||
49159622|NCT02756403|158423955|FG003|Overall Study|Did not complete Procedure|0|||
49159623|NCT02756403|158423952|FG000|Overall Study|Changed Mind About Procedure|0|||
49159624|NCT02756403|158423953|FG001|Overall Study|Changed Mind About Procedure|0|||
49159625|NCT02756403|158423954|FG002|Overall Study|Changed Mind About Procedure|1|||
49159626|NCT02756403|158423955|FG003|Overall Study|Changed Mind About Procedure|0|||
49159627|NCT02756403|158423952|FG000|Overall Study|Protocol Violation|0|||
49159628|NCT02756403|158423953|FG001|Overall Study|Protocol Violation|1|||
49159629|NCT02756403|158423954|FG002|Overall Study|Protocol Violation|0|||
49159630|NCT02756403|158423955|FG003|Overall Study|Protocol Violation|1|||
49159631|NCT00776789|158423958|FG000|Overall Study|Consent refusal|2|||
49159632|NCT00776789|158423959|FG001|Overall Study|Consent refusal|2|||
49159633|NCT00776789|158423958|FG000|Overall Study|Poor quality video|1|||
49159634|NCT00776789|158423959|FG001|Overall Study|Poor quality video|1|||
49159635|NCT03358030|158423964|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|2|||
49159636|NCT03358030|158423965|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
49159637|NCT03358030|158423966|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
49159638|NCT03358030|158423967|FG003|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
49159639|NCT03358030|158423964|FG000|Overall Study|Ineligibility|0|||
49159640|NCT03358030|158423965|FG001|Overall Study|Ineligibility|0|||
49159641|NCT03358030|158423966|FG002|Overall Study|Ineligibility|0|||
49159642|NCT03358030|158423967|FG003|Overall Study|Ineligibility|2|||
49159643|NCT03358030|158423964|FG000|Overall Study|Voluntary Withdrawal|1|||
49159644|NCT03358030|158423965|FG001|Overall Study|Voluntary Withdrawal|1|||
49159645|NCT03358030|158423966|FG002|Overall Study|Voluntary Withdrawal|3|||
49159646|NCT03358030|158423967|FG003|Overall Study|Voluntary Withdrawal|1|||
49159647|NCT03358030|158423964|FG000|Overall Study|Other|0|||
48833497|NCT00961636|157231173|FG001|Overall Study|Lost to Follow-up|3|||
48833498|NCT00961636|157231174|FG002|Overall Study|Lost to Follow-up|1|||
48833499|NCT00961636|157231172|FG000|Overall Study|Physician Decision|3|||
48833500|NCT00961636|157231173|FG001|Overall Study|Physician Decision|1|||
48833501|NCT00961636|157231174|FG002|Overall Study|Physician Decision|1|||
48833502|NCT00961636|157231172|FG000|Overall Study|Protocol Violation|9|||
48833503|NCT00961636|157231173|FG001|Overall Study|Protocol Violation|5|||
48833504|NCT00961636|157231174|FG002|Overall Study|Protocol Violation|1|||
49159648|NCT03358030|158423965|FG001|Overall Study|Other|0|||
49159649|NCT03358030|158423966|FG002|Overall Study|Other|1|||
49159650|NCT03358030|158423967|FG003|Overall Study|Other|0|||
49159651|NCT00730886|158423969|FG000|Overall Study|Lost to Follow-up|1|||
49159652|NCT00730886|158423970|FG001|Overall Study|Lost to Follow-up|0|||
49159653|NCT00730886|158423969|FG000|Overall Study|Physician Decision|1|||
49159654|NCT00730886|158423970|FG001|Overall Study|Physician Decision|0|||
49159655|NCT01150357|158423971|FG000|Dose Response Phase (Phase 1)|Protocol Violation|0|||
49159656|NCT01150357|158423972|FG001|Dose Response Phase (Phase 1)|Protocol Violation|1|||
48833505|NCT00961636|157231172|FG000|Overall Study|Withdrawal by Subject|29|||
49159657|NCT01150357|158423973|FG002|Dose Response Phase (Phase 1)|Protocol Violation|1|||
49159658|NCT01150357|158423971|FG000|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1|||
49159659|NCT01150357|158423972|FG001|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
49159660|NCT01150357|158423973|FG002|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
49159661|NCT01150357|158423971|FG000|Dose Response Phase (Phase 1)|Adverse Event|0|||
49159662|NCT01150357|158423972|FG001|Dose Response Phase (Phase 1)|Adverse Event|0|||
49159663|NCT01150357|158423973|FG002|Dose Response Phase (Phase 1)|Adverse Event|1|||
49159664|NCT01150357|158423971|FG000|Dose Response Phase (Phase 1)|Withdrawal by Participants|0|||
49159665|NCT01150357|158423972|FG001|Dose Response Phase (Phase 1)|Withdrawal by Participants|2|||
49159666|NCT01150357|158423973|FG002|Dose Response Phase (Phase 1)|Withdrawal by Participants|1|||
49159667|NCT01150357|158423971|FG000|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
49159668|NCT01150357|158423972|FG001|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
49159669|NCT01150357|158423973|FG002|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2|||
48833506|NCT00961636|157231173|FG001|Overall Study|Withdrawal by Subject|22|||
48833507|NCT00961636|157231174|FG002|Overall Study|Withdrawal by Subject|13|||
48833508|NCT01768676|157231182|FG000|Overall Study|Adverse Event|3|||
49159670|NCT01150357|158423971|FG000|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2|||
49159671|NCT01150357|158423972|FG001|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
49159672|NCT01150357|158423973|FG002|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
49159673|NCT01150357|158423971|FG000|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1|||
49159674|NCT01150357|158423972|FG001|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
49159675|NCT01150357|158423973|FG002|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
49159676|NCT00657267|158423974|FG000|Overall Study|Progressive disease|45|||
49159677|NCT00657267|158423974|FG000|Overall Study|Adverse Event|9|||
49159678|NCT02297412|158423976|FG000|Overall Study|Canceled|1|||
49159679|NCT02297412|158423977|FG001|Overall Study|Canceled|1|||
49159680|NCT02031302|158423978|FG000|Overall Study|Death|115|||
48833509|NCT01768676|157231183|FG001|Overall Study|Adverse Event|3|||
48833510|NCT01768676|157231182|FG000|Overall Study|Lost to Follow-up|13|||
48833511|NCT01768676|157231183|FG001|Overall Study|Lost to Follow-up|16|||
49159681|NCT02031302|158423979|FG001|Overall Study|Death|0|||
49159682|NCT02031302|158423978|FG000|Overall Study|Not treated with study valve system|18|||
49159683|NCT02031302|158423979|FG001|Overall Study|Not treated with study valve system|0|||
49159684|NCT02031302|158423978|FG000|Overall Study|Missed Follow Up|27|||
49159685|NCT02031302|158423979|FG001|Overall Study|Missed Follow Up|0|||
49159686|NCT02031302|158423978|FG000|Overall Study|Lost to Follow-up|4|||
49159687|NCT02031302|158423979|FG001|Overall Study|Lost to Follow-up|0|||
49159688|NCT02806414|158423980|FG000|Overall Study|Lost to Follow-up|2|||
49159689|NCT03816176|158423983|FG000|Overall Study|Miscellaneous|5|||
49159690|NCT03816176|158423983|FG000|Overall Study|Lack of Efficacy|4|||
49159691|NCT03816176|158423983|FG000|Overall Study|Adverse Event|3|||
49159692|NCT02471144|158425919|FG000|Induction Period (Up to Week 12)|Adverse Event|0|||
49159693|NCT02471144|158425920|FG001|Induction Period (Up to Week 12)|Adverse Event|1|||
49159694|NCT02471144|158425921|FG002|Induction Period (Up to Week 12)|Adverse Event|1|||
49159695|NCT02471144|158425922|FG003|Induction Period (Up to Week 12)|Adverse Event|0|||
49159696|NCT02471144|158425923|FG004|Induction Period (Up to Week 12)|Adverse Event|0|||
49159697|NCT02471144|158425924|FG005|Induction Period (Up to Week 12)|Adverse Event|0|||
49159698|NCT02471144|158425925|FG006|Induction Period (Up to Week 12)|Adverse Event|0|||
49159699|NCT02471144|158425926|FG007|Induction Period (Up to Week 12)|Adverse Event|0|||
49159700|NCT02471144|158425927|FG008|Induction Period (Up to Week 12)|Adverse Event|0|||
49159701|NCT02471144|158425928|FG009|Induction Period (Up to Week 12)|Adverse Event|0|||
49159702|NCT02471144|158425929|FG010|Induction Period (Up to Week 12)|Adverse Event|0|||
49159703|NCT02471144|158425919|FG000|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
49159704|NCT02471144|158425920|FG001|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
49159705|NCT02471144|158425921|FG002|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
49159706|NCT02471144|158425922|FG003|Induction Period (Up to Week 12)|Lack of Efficacy|1|||
49159707|NCT02471144|158425923|FG004|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
49159708|NCT02471144|158425924|FG005|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
49159709|NCT02471144|158425925|FG006|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
49159710|NCT02471144|158425926|FG007|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
49159711|NCT02471144|158425927|FG008|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
49159712|NCT02471144|158425928|FG009|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
49159713|NCT02471144|158425929|FG010|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
49159714|NCT02471144|158425919|FG000|Induction Period (Up to Week 12)|Protocol Deviation|0|||
49159715|NCT02471144|158425920|FG001|Induction Period (Up to Week 12)|Protocol Deviation|0|||
49159716|NCT02471144|158425921|FG002|Induction Period (Up to Week 12)|Protocol Deviation|1|||
49159717|NCT02471144|158425922|FG003|Induction Period (Up to Week 12)|Protocol Deviation|0|||
49159718|NCT02471144|158425923|FG004|Induction Period (Up to Week 12)|Protocol Deviation|0|||
49159719|NCT02471144|158425924|FG005|Induction Period (Up to Week 12)|Protocol Deviation|0|||
49159720|NCT02471144|158425925|FG006|Induction Period (Up to Week 12)|Protocol Deviation|0|||
49159721|NCT02471144|158425926|FG007|Induction Period (Up to Week 12)|Protocol Deviation|0|||
49159722|NCT02471144|158425927|FG008|Induction Period (Up to Week 12)|Protocol Deviation|0|||
49159723|NCT02471144|158425928|FG009|Induction Period (Up to Week 12)|Protocol Deviation|0|||
48833512|NCT01768676|157231182|FG000|Overall Study|Protocol Violation|1|||
48833513|NCT01768676|157231183|FG001|Overall Study|Protocol Violation|1|||
49159724|NCT02471144|158425929|FG010|Induction Period (Up to Week 12)|Protocol Deviation|0|||
49159725|NCT02471144|158425919|FG000|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
49159726|NCT02471144|158425920|FG001|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
49159727|NCT02471144|158425921|FG002|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
49159728|NCT02471144|158425922|FG003|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
49159729|NCT02471144|158425923|FG004|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
48833514|NCT01768676|157231182|FG000|Overall Study|Physician Decision|4|||
48833515|NCT01768676|157231183|FG001|Overall Study|Physician Decision|1|||
48833516|NCT01768676|157231182|FG000|Overall Study|Withdrawal by Subject|3|||
48833517|NCT01768676|157231183|FG001|Overall Study|Withdrawal by Subject|10|||
48833518|NCT00457691|157231187|FG000|Overall Study|Adverse Event|4|||
49159730|NCT02471144|158425924|FG005|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
49159731|NCT02471144|158425925|FG006|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
49159732|NCT02471144|158425926|FG007|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
49159733|NCT02471144|158425927|FG008|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
49159734|NCT02471144|158425928|FG009|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
49159735|NCT02471144|158425929|FG010|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
49159736|NCT02471144|158425919|FG000|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
49159737|NCT02471144|158425920|FG001|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
49159738|NCT02471144|158425921|FG002|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
49159739|NCT02471144|158425922|FG003|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
49159740|NCT02471144|158425923|FG004|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
49159741|NCT02471144|158425924|FG005|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
49159742|NCT02471144|158425925|FG006|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
49159743|NCT02471144|158425926|FG007|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
49159744|NCT02471144|158425927|FG008|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
49159745|NCT02471144|158425928|FG009|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
49159746|NCT02471144|158425929|FG010|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
49159747|NCT02471144|158425919|FG000|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
49159748|NCT02471144|158425920|FG001|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
49159749|NCT02471144|158425921|FG002|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
48833519|NCT00457691|157231188|FG001|Overall Study|Adverse Event|1|||
48833520|NCT00457691|157231187|FG000|Overall Study|Death|163|||
48833521|NCT00457691|157231188|FG001|Overall Study|Death|148|||
48833522|NCT00457691|157231187|FG000|Overall Study|Protocol Violation|1|||
48833523|NCT00457691|157231188|FG001|Overall Study|Protocol Violation|3|||
48833524|NCT00457691|157231187|FG000|Overall Study|Lost to Follow-up|23|||
48833525|NCT00457691|157231188|FG001|Overall Study|Lost to Follow-up|14|||
48833526|NCT00457691|157231187|FG000|Overall Study|Study terminated by Sponsor|1|||
48833527|NCT00457691|157231188|FG001|Overall Study|Study terminated by Sponsor|1|||
48833528|NCT00457691|157231187|FG000|Overall Study|Subject refused (reason other than AE)|14|||
48833529|NCT00457691|157231188|FG001|Overall Study|Subject refused (reason other than AE)|19|||
48833530|NCT00457691|157231187|FG000|Overall Study|Disease progression, study terminated|180|||
48833531|NCT00457691|157231188|FG001|Overall Study|Disease progression, study terminated|196|||
48833532|NCT02486588|157231191|FG000|Overall Study|Randomized in error- ineligible|738|||
48833533|NCT02486588|157231192|FG001|Overall Study|Randomized in error- ineligible|750|||
48833534|NCT02486588|157231193|FG002|Overall Study|Randomized in error- ineligible|755|||
48833535|NCT02486588|157231194|FG003|Overall Study|Randomized in error- ineligible|738|||
48833536|NCT02486588|157231195|FG004|Overall Study|Randomized in error- ineligible|746|||
48833537|NCT02486588|157231196|FG005|Overall Study|Randomized in error- ineligible|746|||
48833538|NCT02551055|157231201|FG000|Overall Study|Death|2|||
48833539|NCT02551055|157231202|FG001|Overall Study|Death|4|||
48833540|NCT02551055|157231203|FG002|Overall Study|Death|2|||
48833541|NCT02551055|157231204|FG003|Overall Study|Death|2|||
48833542|NCT02551055|157231205|FG004|Overall Study|Death|2|||
48833543|NCT02551055|157231206|FG005|Overall Study|Death|1|||
49159750|NCT02471144|158425922|FG003|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
49159751|NCT02471144|158425923|FG004|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
49159752|NCT02471144|158425924|FG005|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1|||
49159753|NCT02471144|158425925|FG006|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
49159754|NCT02471144|158425926|FG007|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
49159755|NCT02471144|158425927|FG008|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3|||
49159756|NCT02471144|158425928|FG009|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
49159757|NCT02471144|158425929|FG010|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
49159758|NCT02471144|158425919|FG000|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
49159759|NCT02471144|158425920|FG001|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
49159760|NCT02471144|158425921|FG002|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
49159761|NCT02471144|158425922|FG003|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
49159762|NCT02471144|158425923|FG004|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
49159763|NCT02471144|158425924|FG005|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
49159764|NCT02471144|158425925|FG006|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
49159765|NCT02471144|158425926|FG007|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
49159766|NCT02471144|158425927|FG008|Maintenance Period (Week 12 to Week 52)|Pregnancy|1|||
49159767|NCT02471144|158425928|FG009|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
49159768|NCT02471144|158425929|FG010|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
49159769|NCT02471144|158425919|FG000|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
49159770|NCT02471144|158425920|FG001|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
49159771|NCT02471144|158425921|FG002|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
49159772|NCT02471144|158425922|FG003|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
49159773|NCT02471144|158425923|FG004|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
49159774|NCT02471144|158425924|FG005|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
49159775|NCT02471144|158425925|FG006|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
49159776|NCT02471144|158425926|FG007|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2|||
49159777|NCT02471144|158425927|FG008|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1|||
49159778|NCT02471144|158425928|FG009|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
49159779|NCT02471144|158425929|FG010|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
49159780|NCT02471144|158425919|FG000|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
49159781|NCT02471144|158425920|FG001|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
49159782|NCT02471144|158425921|FG002|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
49159783|NCT02471144|158425922|FG003|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
49159784|NCT02471144|158425923|FG004|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
49159785|NCT02471144|158425924|FG005|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
49159786|NCT02471144|158425925|FG006|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
49159787|NCT02471144|158425926|FG007|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
49159788|NCT02471144|158425927|FG008|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
49159789|NCT02471144|158425928|FG009|Extension Period (Week 52 to Week 236)|Lack of Efficacy|6|||
49159790|NCT02471144|158425929|FG010|Extension Period (Week 52 to Week 236)|Lack of Efficacy|3|||
49159791|NCT02471144|158425919|FG000|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
49159792|NCT02471144|158425920|FG001|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
49159793|NCT02471144|158425921|FG002|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
49159794|NCT02471144|158425922|FG003|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
49159795|NCT02471144|158425923|FG004|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
49159796|NCT02471144|158425924|FG005|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
49159797|NCT02471144|158425925|FG006|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
49159798|NCT02471144|158425926|FG007|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
49159799|NCT02471144|158425927|FG008|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
49159800|NCT02471144|158425928|FG009|Extension Period (Week 52 to Week 236)|Pregnancy|2|||
49159801|NCT02471144|158425929|FG010|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
49159802|NCT02471144|158425919|FG000|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
49159803|NCT02471144|158425920|FG001|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
49159804|NCT02471144|158425921|FG002|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
49159805|NCT02471144|158425922|FG003|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
49159806|NCT02471144|158425923|FG004|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
49159807|NCT02471144|158425924|FG005|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
49159808|NCT02471144|158425925|FG006|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
49159809|NCT02471144|158425926|FG007|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
49159810|NCT02471144|158425927|FG008|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
49159811|NCT02471144|158425928|FG009|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
49159812|NCT02471144|158425929|FG010|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2|||
49159813|NCT02471144|158425919|FG000|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
48833544|NCT02551055|157231207|FG006|Overall Study|Death|2|||
48833545|NCT02551055|157231208|FG007|Overall Study|Death|0|||
49159814|NCT02471144|158425920|FG001|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
49159815|NCT02471144|158425921|FG002|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
49159816|NCT02471144|158425922|FG003|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
49159817|NCT02471144|158425923|FG004|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
49159818|NCT02471144|158425924|FG005|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
49159819|NCT02471144|158425925|FG006|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
49159820|NCT02471144|158425926|FG007|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
49159821|NCT02471144|158425927|FG008|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
49159822|NCT02471144|158425928|FG009|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
49159823|NCT02471144|158425929|FG010|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
49159824|NCT02471144|158425919|FG000|Extension Period (Week 52 to Week 236)|Technical problems|0|||
49159825|NCT02471144|158425920|FG001|Extension Period (Week 52 to Week 236)|Technical problems|0|||
49159826|NCT02471144|158425921|FG002|Extension Period (Week 52 to Week 236)|Technical problems|0|||
49159827|NCT02471144|158425922|FG003|Extension Period (Week 52 to Week 236)|Technical problems|0|||
49159828|NCT02471144|158425923|FG004|Extension Period (Week 52 to Week 236)|Technical problems|0|||
49159829|NCT02471144|158425924|FG005|Extension Period (Week 52 to Week 236)|Technical problems|0|||
49159830|NCT02471144|158425925|FG006|Extension Period (Week 52 to Week 236)|Technical problems|0|||
49159831|NCT02471144|158425926|FG007|Extension Period (Week 52 to Week 236)|Technical problems|0|||
49159832|NCT02471144|158425927|FG008|Extension Period (Week 52 to Week 236)|Technical problems|0|||
49159833|NCT02471144|158425928|FG009|Extension Period (Week 52 to Week 236)|Technical problems|1|||
49159834|NCT02471144|158425929|FG010|Extension Period (Week 52 to Week 236)|Technical problems|0|||
49159835|NCT02471144|158425919|FG000|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
49159836|NCT02471144|158425920|FG001|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
48833546|NCT02551055|157231201|FG000|Overall Study|Study Terminated by Sponsor|1|||
48833547|NCT02551055|157231202|FG001|Overall Study|Study Terminated by Sponsor|1|||
48833548|NCT02551055|157231203|FG002|Overall Study|Study Terminated by Sponsor|0|||
49159837|NCT02471144|158425921|FG002|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
48833549|NCT02551055|157231204|FG003|Overall Study|Study Terminated by Sponsor|2|||
48833550|NCT02551055|157231205|FG004|Overall Study|Study Terminated by Sponsor|2|||
48833551|NCT02551055|157231206|FG005|Overall Study|Study Terminated by Sponsor|0|||
48833552|NCT02551055|157231207|FG006|Overall Study|Study Terminated by Sponsor|0|||
48833553|NCT02551055|157231208|FG007|Overall Study|Study Terminated by Sponsor|0|||
48833554|NCT02551055|157231201|FG000|Overall Study|Withdrawal by Subject|1|||
48833555|NCT02551055|157231202|FG001|Overall Study|Withdrawal by Subject|1|||
48833556|NCT02551055|157231203|FG002|Overall Study|Withdrawal by Subject|0|||
48833557|NCT02551055|157231204|FG003|Overall Study|Withdrawal by Subject|1|||
48833558|NCT02551055|157231205|FG004|Overall Study|Withdrawal by Subject|2|||
48833559|NCT02551055|157231206|FG005|Overall Study|Withdrawal by Subject|0|||
48833560|NCT02551055|157231207|FG006|Overall Study|Withdrawal by Subject|0|||
48833561|NCT02551055|157231208|FG007|Overall Study|Withdrawal by Subject|0|||
48833562|NCT02551055|157231201|FG000|Overall Study|Reason not specified|0|||
48833563|NCT02551055|157231202|FG001|Overall Study|Reason not specified|0|||
48833564|NCT02551055|157231203|FG002|Overall Study|Reason not specified|0|||
48833565|NCT02551055|157231204|FG003|Overall Study|Reason not specified|0|||
48833566|NCT02551055|157231205|FG004|Overall Study|Reason not specified|1|||
48833567|NCT02551055|157231206|FG005|Overall Study|Reason not specified|0|||
48833568|NCT02551055|157231207|FG006|Overall Study|Reason not specified|1|||
48833569|NCT02551055|157231208|FG007|Overall Study|Reason not specified|0|||
48833570|NCT00430300|157231209|FG000|Overall Study|Adverse Event|0|||
48833571|NCT00430300|157231210|FG001|Overall Study|Adverse Event|2|||
48833572|NCT00430300|157231211|FG002|Overall Study|Adverse Event|1|||
48833573|NCT00430300|157231212|FG003|Overall Study|Adverse Event|1|||
48833574|NCT00430300|157231209|FG000|Overall Study|Withdrawal by Subject|1|||
48833575|NCT00430300|157231210|FG001|Overall Study|Withdrawal by Subject|0|||
49159838|NCT02471144|158425922|FG003|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
49159839|NCT02471144|158425923|FG004|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
49159840|NCT02471144|158425924|FG005|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
49159841|NCT02471144|158425925|FG006|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
49159842|NCT02471144|158425926|FG007|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
49159843|NCT02471144|158425927|FG008|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
49159844|NCT02471144|158425928|FG009|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
49159845|NCT02471144|158425929|FG010|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
49159846|NCT03217266|158425932|FG000|Step 1: Dose Level 1|Did not start protocol treatment|1|||
49159847|NCT03217266|158425933|FG001|Step 1: Dose Level 1|Did not start protocol treatment|0|||
49159848|NCT03217266|158425934|FG002|Step 1: Dose Level 1|Did not start protocol treatment|0|||
48833576|NCT00430300|157231211|FG002|Overall Study|Withdrawal by Subject|5|||
48833577|NCT00430300|157231212|FG003|Overall Study|Withdrawal by Subject|0|||
48833578|NCT00430300|157231209|FG000|Overall Study|Laboratory abnormality|1|||
48833579|NCT00430300|157231210|FG001|Overall Study|Laboratory abnormality|0|||
48833580|NCT00430300|157231211|FG002|Overall Study|Laboratory abnormality|0|||
48833581|NCT00430300|157231212|FG003|Overall Study|Laboratory abnormality|0|||
48923154|NCT01344876|157551581|FG001|Overall Study|Definite progression of primary disease|0|||
48923155|NCT01344876|157551582|FG002|Overall Study|Definite progression of primary disease|0|||
48923156|NCT01344876|157551583|FG003|Overall Study|Definite progression of primary disease|3|||
48923157|NCT01344876|157551584|FG004|Overall Study|Definite progression of primary disease|0|||
48923158|NCT01564862|157551588|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
48923159|NCT01564862|157551589|FG001|Overall Study|Pretreatment Event or Adverse Event|12|||
48923160|NCT01564862|157551590|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
48923161|NCT01564862|157551588|FG000|Overall Study|Major Protocol Deviation|3|||
48923162|NCT01564862|157551589|FG001|Overall Study|Major Protocol Deviation|3|||
48923163|NCT01564862|157551590|FG002|Overall Study|Major Protocol Deviation|4|||
48923164|NCT01564862|157551588|FG000|Overall Study|Lost to Follow-up|10|||
48923165|NCT01564862|157551589|FG001|Overall Study|Lost to Follow-up|8|||
48923166|NCT01564862|157551590|FG002|Overall Study|Lost to Follow-up|6|||
48923167|NCT01564862|157551588|FG000|Overall Study|Voluntary Withdrawal|9|||
48923168|NCT01564862|157551589|FG001|Overall Study|Voluntary Withdrawal|6|||
48833582|NCT00430300|157231209|FG000|Overall Study|Other|0|||
48833583|NCT00430300|157231210|FG001|Overall Study|Other|0|||
48833584|NCT00430300|157231211|FG002|Overall Study|Other|0|||
48923169|NCT01564862|157551590|FG002|Overall Study|Voluntary Withdrawal|8|||
48833585|NCT00430300|157231212|FG003|Overall Study|Other|1|||
48833586|NCT02577523|157232642|FG000|Overall Study|Adverse Event|1|||
48833587|NCT02577523|157232643|FG001|Overall Study|Adverse Event|1|||
48833588|NCT02577523|157232642|FG000|Overall Study|Lack of Efficacy|1|||
48833589|NCT02577523|157232643|FG001|Overall Study|Lack of Efficacy|1|||
48833590|NCT02577523|157232642|FG000|Overall Study|Withdrawal by Subject|1|||
48833591|NCT02577523|157232643|FG001|Overall Study|Withdrawal by Subject|0|||
48833592|NCT00943605|157232644|FG000|Overall Study|Study termination|30|||
48833593|NCT00943605|157232645|FG001|Overall Study|Study termination|30|||
48833594|NCT03646123|157232648|FG000|Overall Study|Patient transferred and not able to get testing completed|0|||
48833595|NCT03646123|157232649|FG001|Overall Study|Patient transferred and not able to get testing completed|1|||
48833596|NCT03646123|157232650|FG002|Overall Study|Patient transferred and not able to get testing completed|0|||
48833597|NCT03646123|157232648|FG000|Overall Study|Participant no longer met inclusion criteria and never received treatment|1|||
48833598|NCT03646123|157232649|FG001|Overall Study|Participant no longer met inclusion criteria and never received treatment|0|||
48833599|NCT03646123|157232650|FG002|Overall Study|Participant no longer met inclusion criteria and never received treatment|0|||
48833600|NCT03646123|157232648|FG000|Overall Study|Non-compliance to study protocol|1|||
48833601|NCT03646123|157232649|FG001|Overall Study|Non-compliance to study protocol|0|||
48833602|NCT03646123|157232650|FG002|Overall Study|Non-compliance to study protocol|0|||
48833603|NCT03646123|157232648|FG000|Overall Study|Ineligible due to progression during screening|0|||
48833604|NCT03646123|157232649|FG001|Overall Study|Ineligible due to progression during screening|0|||
48833605|NCT03646123|157232650|FG002|Overall Study|Ineligible due to progression during screening|1|||
48833606|NCT03646123|157232648|FG000|Overall Study|Withdrawal by Subject|2|||
48833607|NCT03646123|157232649|FG001|Overall Study|Withdrawal by Subject|1|||
48833608|NCT03646123|157232650|FG002|Overall Study|Withdrawal by Subject|3|||
48833609|NCT03646123|157232648|FG000|Overall Study|Additional CT scan showed inclusion criteria were not met for Part C|0|||
48833610|NCT03646123|157232649|FG001|Overall Study|Additional CT scan showed inclusion criteria were not met for Part C|0|||
48833611|NCT03646123|157232650|FG002|Overall Study|Additional CT scan showed inclusion criteria were not met for Part C|1|||
48833612|NCT03646123|157232648|FG000|Overall Study|Death|2|||
48833613|NCT03646123|157232649|FG001|Overall Study|Death|1|||
48833614|NCT03646123|157232650|FG002|Overall Study|Death|1|||
48833615|NCT03646123|157232648|FG000|Overall Study|Lost to Follow-up|4|||
48833616|NCT03646123|157232649|FG001|Overall Study|Lost to Follow-up|7|||
48833617|NCT03646123|157232650|FG002|Overall Study|Lost to Follow-up|6|||
48833618|NCT03646123|157232648|FG000|Overall Study|Participants in long term follow-up|0|||
48833619|NCT03646123|157232649|FG001|Overall Study|Participants in long term follow-up|48|||
48833620|NCT03646123|157232650|FG002|Overall Study|Participants in long term follow-up|144|||
48833621|NCT01956669|157232652|FG000|Overall Study|Disease Progression|12|||
48833622|NCT01956669|157232653|FG001|Overall Study|Disease Progression|7|||
48833623|NCT01956669|157232654|FG002|Overall Study|Disease Progression|7|||
48833624|NCT01956669|157232655|FG003|Overall Study|Disease Progression|8|||
48923170|NCT01564862|157551588|FG000|Overall Study|Lack of Efficacy|1|||
48923171|NCT01564862|157551589|FG001|Overall Study|Lack of Efficacy|5|||
48923172|NCT01564862|157551590|FG002|Overall Study|Lack of Efficacy|6|||
48923173|NCT01564862|157551588|FG000|Overall Study|Other reason(s)|1|||
48923174|NCT01564862|157551589|FG001|Overall Study|Other reason(s)|0|||
48833625|NCT01956669|157232656|FG004|Overall Study|Disease Progression|4|||
48833626|NCT01956669|157232657|FG005|Overall Study|Disease Progression|3|||
48833627|NCT01956669|157232658|FG006|Overall Study|Disease Progression|5|||
48833628|NCT01956669|157232652|FG000|Overall Study|Adverse Event|0|||
48923175|NCT01564862|157551590|FG002|Overall Study|Other reason(s)|0|||
48923176|NCT00772668|157551591|FG000|Overall Study|Physician Decision|3|||
49014585|NCT04634409|157888938|FG015|Overall Study|Death|0|||
49159849|NCT03217266|158425935|FG003|Step 1: Dose Level 1|Did not start protocol treatment|0|||
49159850|NCT03217266|158425932|FG000|Step 1: Dose Level 2|Did not start protocol treatment|1|||
49159851|NCT03217266|158425933|FG001|Step 1: Dose Level 2|Did not start protocol treatment|2|||
49159852|NCT03217266|158425934|FG002|Step 1: Dose Level 2|Did not start protocol treatment|0|||
49159853|NCT03217266|158425935|FG003|Step 1: Dose Level 2|Did not start protocol treatment|0|||
49159854|NCT03217266|158425932|FG000|Step 1: Dose Level 3|Did not start treatment|1|||
49159855|NCT03217266|158425933|FG001|Step 1: Dose Level 3|Did not start treatment|0|||
49159856|NCT03217266|158425934|FG002|Step 1: Dose Level 3|Did not start treatment|0|||
49159857|NCT03217266|158425935|FG003|Step 1: Dose Level 3|Did not start treatment|0|||
48833629|NCT01956669|157232653|FG001|Overall Study|Adverse Event|2|||
48833630|NCT01956669|157232654|FG002|Overall Study|Adverse Event|2|||
48833631|NCT01956669|157232655|FG003|Overall Study|Adverse Event|1|||
48833632|NCT01956669|157232656|FG004|Overall Study|Adverse Event|0|||
48833633|NCT01956669|157232657|FG005|Overall Study|Adverse Event|0|||
48833634|NCT01956669|157232658|FG006|Overall Study|Adverse Event|0|||
48833635|NCT01956669|157232652|FG000|Overall Study|Physician Decision|0|||
48833636|NCT01956669|157232653|FG001|Overall Study|Physician Decision|2|||
48833637|NCT01956669|157232654|FG002|Overall Study|Physician Decision|0|||
48833638|NCT01956669|157232655|FG003|Overall Study|Physician Decision|0|||
48833639|NCT01956669|157232656|FG004|Overall Study|Physician Decision|0|||
48833640|NCT01956669|157232657|FG005|Overall Study|Physician Decision|1|||
48833641|NCT01956669|157232658|FG006|Overall Study|Physician Decision|0|||
49159858|NCT05523323|158425936|FG000|Overall Study|Death|26|||
49159859|NCT05523323|158425937|FG001|Overall Study|Death|21|||
49159860|NCT05523323|158425936|FG000|Overall Study|Ongoing participants|35|||
49159861|NCT05523323|158425937|FG001|Overall Study|Ongoing participants|30|||
49159862|NCT04047446|158425946|FG000|Overall Study|Physician Decision|1|||
49159863|NCT04047446|158425947|FG001|Overall Study|Physician Decision|0|||
49159864|NCT02234362|158425954|FG000|Overall Study|Not eligible after first screening visit|17|||
49159865|NCT02234362|158425954|FG000|Overall Study|Lost to Follow-up|6|||
48833642|NCT01956669|157232652|FG000|Overall Study|Withdrawal by Subject|0|||
48833643|NCT01956669|157232653|FG001|Overall Study|Withdrawal by Subject|0|||
48833644|NCT01956669|157232654|FG002|Overall Study|Withdrawal by Subject|1|||
49014586|NCT04634409|157888939|FG016|Overall Study|Death|0|||
49159866|NCT02234362|158425954|FG000|Overall Study|Withdrawal by Subject|3|||
49159867|NCT00329030|158425955|FG000|Overall Study|Withdrawal by Subject|1|||
48833645|NCT01956669|157232655|FG003|Overall Study|Withdrawal by Subject|1|||
48833646|NCT01956669|157232656|FG004|Overall Study|Withdrawal by Subject|0|||
48833647|NCT01956669|157232657|FG005|Overall Study|Withdrawal by Subject|0|||
48833648|NCT01956669|157232658|FG006|Overall Study|Withdrawal by Subject|1|||
48833649|NCT00891618|157232659|FG000|Overall Study|Withdrawal by Subject|1|||
48833650|NCT03125382|157232664|FG000|Randomization|screening failure|1|||
48833651|NCT03125382|157232665|FG001|Randomization|screening failure|4|||
48833652|NCT03125382|157232666|FG002|Randomization|screening failure|2|||
48833653|NCT03125382|157232667|FG003|Randomization|screening failure|0|||
48833654|NCT03125382|157232664|FG000|Follow-up|Death|1|||
48833655|NCT03125382|157232665|FG001|Follow-up|Death|2|||
48833656|NCT03125382|157232666|FG002|Follow-up|Death|1|||
48833657|NCT03125382|157232667|FG003|Follow-up|Death|2|||
48833658|NCT03125382|157232664|FG000|Follow-up|Lost to Follow-up|1|||
48833659|NCT03125382|157232665|FG001|Follow-up|Lost to Follow-up|4|||
48833660|NCT03125382|157232666|FG002|Follow-up|Lost to Follow-up|3|||
48833661|NCT03125382|157232667|FG003|Follow-up|Lost to Follow-up|1|||
48833662|NCT04889664|157232670|FG000|Screen|Lost to Follow-up|1|||
48833663|NCT04889664|157232670|FG000|Screen|Failed to meet screening criteria|1|||
48833664|NCT04889664|157232670|FG000|Study Treatment|Exited by study team due to inappropriate behavior|1|||
48833665|NCT01585038|157232671|FG000|Overall Study|Adverse Event|2|||
48833666|NCT01585038|157232672|FG001|Overall Study|Adverse Event|2|||
48833667|NCT01145885|157232673|FG000|Overall Study|Progressive Disease|7|||
48833668|NCT01988233|157232679|FG000|Overall Study|Lost to Follow-up|64|||
48833669|NCT01988233|157232680|FG001|Overall Study|Lost to Follow-up|51|||
48833670|NCT02613364|157232681|FG000|Overall Study|Other|19|||
48833671|NCT02613364|157232682|FG001|Overall Study|Other|29|||
48833672|NCT02613364|157232683|FG002|Overall Study|Other|17|||
48833673|NCT02613364|157232681|FG000|Overall Study|Too time consuming|21|||
48833674|NCT02613364|157232682|FG001|Overall Study|Too time consuming|26|||
48833675|NCT02613364|157232683|FG002|Overall Study|Too time consuming|26|||
48833676|NCT02613364|157232681|FG000|Overall Study|Withdrawal by Subject|13|||
48833677|NCT02613364|157232682|FG001|Overall Study|Withdrawal by Subject|18|||
48833678|NCT02613364|157232683|FG002|Overall Study|Withdrawal by Subject|17|||
48833679|NCT02613364|157232681|FG000|Overall Study|Medical|12|||
48833680|NCT02613364|157232682|FG001|Overall Study|Medical|13|||
48833681|NCT02613364|157232683|FG002|Overall Study|Medical|9|||
48833682|NCT02613364|157232681|FG000|Overall Study|Disliked Study Procedure|1|||
48833683|NCT02613364|157232682|FG001|Overall Study|Disliked Study Procedure|1|||
48833684|NCT02613364|157232683|FG002|Overall Study|Disliked Study Procedure|4|||
48833685|NCT02613364|157232681|FG000|Overall Study|Disliked Intervention|0|||
48833686|NCT02613364|157232682|FG001|Overall Study|Disliked Intervention|3|||
48833687|NCT02613364|157232683|FG002|Overall Study|Disliked Intervention|3|||
48833688|NCT03743246|157232684|FG000|Pre-Treatment Period|Failure to meet treatment criteria|0|||
48833689|NCT03743246|157232685|FG001|Pre-Treatment Period|Failure to meet treatment criteria|0|||
48833690|NCT03743246|157232686|FG002|Pre-Treatment Period|Failure to meet treatment criteria|2|||
48833691|NCT03743246|157232687|FG003|Pre-Treatment Period|Failure to meet treatment criteria|0|||
48833692|NCT03743246|157232684|FG000|Pre-Treatment Period|Death|0|||
48833693|NCT03743246|157232685|FG001|Pre-Treatment Period|Death|1|||
48833694|NCT03743246|157232686|FG002|Pre-Treatment Period|Death|0|||
48833695|NCT03743246|157232687|FG003|Pre-Treatment Period|Death|1|||
48833696|NCT03743246|157232684|FG000|Pre-Treatment Period|Study Drug Manufacturing Failure|1|||
48833697|NCT03743246|157232685|FG001|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
48833698|NCT03743246|157232686|FG002|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
48833699|NCT03743246|157232687|FG003|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
48833700|NCT03743246|157232684|FG000|Lymphodepleting Chemotherapy|Progressive Disease|1|||
48833701|NCT03743246|157232685|FG001|Lymphodepleting Chemotherapy|Progressive Disease|0|||
48833702|NCT03743246|157232686|FG002|Lymphodepleting Chemotherapy|Progressive Disease|0|||
48833703|NCT03743246|157232687|FG003|Lymphodepleting Chemotherapy|Progressive Disease|0|||
48833704|NCT03743246|157232684|FG000|Treatment Period (JCAR017 Infusion)|Other Reason|1|||
48833705|NCT03743246|157232685|FG001|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
48833706|NCT03743246|157232686|FG002|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
48833707|NCT03743246|157232687|FG003|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
48833708|NCT03743246|157232684|FG000|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
48923177|NCT03344003|157551592|FG000|Overall Study|Switched to alternative treatment|1|||
48923178|NCT03344003|157551593|FG001|Overall Study|Switched to alternative treatment|0|||
48923179|NCT03344003|157551592|FG000|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|1|||
48923180|NCT03344003|157551593|FG001|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|0|||
48923181|NCT03557281|157553155|FG000|Overall Study|Investigator discretion|0|||
48923182|NCT03557281|157553156|FG001|Overall Study|Investigator discretion|0|||
48923183|NCT03557281|157553157|FG002|Overall Study|Investigator discretion|1|||
48923184|NCT03557281|157553158|FG003|Overall Study|Investigator discretion|0|||
48833709|NCT03743246|157232685|FG001|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|1|||
48833710|NCT03743246|157232686|FG002|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
48833711|NCT03743246|157232687|FG003|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
48833712|NCT03743246|157232684|FG000|Treatment Period (JCAR017 Infusion)|Progressive Disease|1|||
48833713|NCT03743246|157232685|FG001|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
48833714|NCT03743246|157232686|FG002|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
48833715|NCT03743246|157232687|FG003|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
48833716|NCT03743246|157232684|FG000|Treatment Period (JCAR017 Infusion)|Death|1|||
48833717|NCT03743246|157232685|FG001|Treatment Period (JCAR017 Infusion)|Death|0|||
49159868|NCT00329030|158425956|FG001|Overall Study|Withdrawal by Subject|3|||
49159869|NCT00329030|158425955|FG000|Overall Study|Progressive Disease|6|||
49159870|NCT00329030|158425956|FG001|Overall Study|Progressive Disease|2|||
49159871|NCT00329030|158425955|FG000|Overall Study|Ineligible Pathology|1|||
49159872|NCT00329030|158425956|FG001|Overall Study|Ineligible Pathology|1|||
49159873|NCT02286895|158425957|FG000|Assessed for Measles Seroconversion|Protocol Violation|1|||
49159874|NCT02286895|158425958|FG001|Assessed for Measles Seroconversion|Protocol Violation|4|||
49159875|NCT02286895|158425957|FG000|Assessed for Measles Seroconversion|Missing measurement|6|||
49159876|NCT02286895|158425958|FG001|Assessed for Measles Seroconversion|Missing measurement|3|||
49159877|NCT02286895|158425957|FG000|Assessed for Measles Seroconversion|Baseline measure non-negative|41|||
49159878|NCT02286895|158425958|FG001|Assessed for Measles Seroconversion|Baseline measure non-negative|32|||
49159879|NCT00328172|158425965|FG000|Overall Study|Adverse Event|3|||
49159880|NCT00328172|158425966|FG001|Overall Study|Adverse Event|2|||
49159881|NCT00328172|158425967|FG002|Overall Study|Adverse Event|1|||
49159882|NCT00328172|158425968|FG003|Overall Study|Adverse Event|2|||
49159883|NCT00328172|158425969|FG004|Overall Study|Adverse Event|1|||
49159884|NCT00328172|158425965|FG000|Overall Study|Protocol Violation|0|||
49159885|NCT00328172|158425966|FG001|Overall Study|Protocol Violation|1|||
49159886|NCT00328172|158425967|FG002|Overall Study|Protocol Violation|1|||
49159887|NCT00328172|158425968|FG003|Overall Study|Protocol Violation|0|||
49159888|NCT00328172|158425969|FG004|Overall Study|Protocol Violation|0|||
49159889|NCT00328172|158425965|FG000|Overall Study|Lost to Follow-up|1|||
49159890|NCT00328172|158425966|FG001|Overall Study|Lost to Follow-up|1|||
49159891|NCT00328172|158425967|FG002|Overall Study|Lost to Follow-up|2|||
49159892|NCT00328172|158425968|FG003|Overall Study|Lost to Follow-up|1|||
49159893|NCT00328172|158425969|FG004|Overall Study|Lost to Follow-up|1|||
49159894|NCT00328172|158425965|FG000|Overall Study|Withdrawal by Subject|1|||
49159895|NCT00328172|158425966|FG001|Overall Study|Withdrawal by Subject|1|||
49159896|NCT00328172|158425967|FG002|Overall Study|Withdrawal by Subject|1|||
49159897|NCT00328172|158425968|FG003|Overall Study|Withdrawal by Subject|6|||
49159898|NCT00328172|158425969|FG004|Overall Study|Withdrawal by Subject|0|||
49159899|NCT00328172|158425965|FG000|Overall Study|Lack of Efficacy|14|||
49159900|NCT00328172|158425966|FG001|Overall Study|Lack of Efficacy|9|||
49159901|NCT00328172|158425967|FG002|Overall Study|Lack of Efficacy|4|||
49159902|NCT00328172|158425968|FG003|Overall Study|Lack of Efficacy|4|||
49159903|NCT00328172|158425969|FG004|Overall Study|Lack of Efficacy|3|||
49159904|NCT00328172|158425965|FG000|Overall Study|Other reason (not specified)|3|||
48833718|NCT03743246|157232686|FG002|Treatment Period (JCAR017 Infusion)|Death|0|||
48833719|NCT03743246|157232687|FG003|Treatment Period (JCAR017 Infusion)|Death|0|||
48833720|NCT03743246|157232684|FG000|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|1|||
48833721|NCT03743246|157232685|FG001|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
49159905|NCT00328172|158425966|FG001|Overall Study|Other reason (not specified)|0|||
49159906|NCT00328172|158425967|FG002|Overall Study|Other reason (not specified)|1|||
49159907|NCT00328172|158425968|FG003|Overall Study|Other reason (not specified)|0|||
49159908|NCT00328172|158425969|FG004|Overall Study|Other reason (not specified)|0|||
49159909|NCT00077974|158425970|FG000|Overall Study|Adverse Event|22|||
49159910|NCT00077974|158425970|FG000|Overall Study|Protocol Violation|1|||
49159911|NCT00077974|158425970|FG000|Overall Study|Withdrawal by Subject|3|||
49159912|NCT00077974|158425970|FG000|Overall Study|Lack of Efficacy|76|||
49159913|NCT00077974|158425970|FG000|Overall Study|Decision of Sponsor|2|||
48923185|NCT03557281|157553159|FG004|Overall Study|Investigator discretion|0|||
48923186|NCT03557281|157553155|FG000|Overall Study|Withdrawal by Subject|0|||
48923187|NCT03557281|157553156|FG001|Overall Study|Withdrawal by Subject|1|||
48923188|NCT03557281|157553157|FG002|Overall Study|Withdrawal by Subject|1|||
48923189|NCT03557281|157553158|FG003|Overall Study|Withdrawal by Subject|1|||
48923190|NCT03557281|157553159|FG004|Overall Study|Withdrawal by Subject|2|||
48923191|NCT03557281|157553155|FG000|Overall Study|Randomized, but did not receive treatment|0|||
48923192|NCT03557281|157553156|FG001|Overall Study|Randomized, but did not receive treatment|0|||
48923193|NCT03557281|157553157|FG002|Overall Study|Randomized, but did not receive treatment|0|||
48923194|NCT03557281|157553158|FG003|Overall Study|Randomized, but did not receive treatment|0|||
48923195|NCT03557281|157553159|FG004|Overall Study|Randomized, but did not receive treatment|1|||
48923196|NCT02229552|157553160|FG000|Baseline|Withdrawal by Subject|6|||
49159914|NCT01343888|158425971|FG000|Overall Study|Adverse Event|12|||
49159915|NCT01343888|158425972|FG001|Overall Study|Adverse Event|22|||
49159916|NCT01343888|158425973|FG002|Overall Study|Adverse Event|5|||
49159917|NCT01343888|158425971|FG000|Overall Study|Lack of Efficacy|9|||
49159918|NCT01343888|158425972|FG001|Overall Study|Lack of Efficacy|9|||
48923197|NCT02229552|157553160|FG000|1-year Follow up|Withdrawal by Subject|7|||
48923198|NCT02229552|157553160|FG000|1-year Follow up|Lost to Follow-up|18|||
48923199|NCT02229552|157553160|FG000|2-Year Follow up|Withdrawal by Subject|9|||
48923200|NCT02229552|157553160|FG000|2-Year Follow up|Lost to Follow-up|17|||
49159919|NCT01343888|158425973|FG002|Overall Study|Lack of Efficacy|13|||
49159920|NCT01343888|158425971|FG000|Overall Study|Lost to Follow-up|0|||
48923201|NCT04429061|157553161|FG000|Overall Study|Lost to Follow-up|62|||
48923202|NCT04429061|157553162|FG001|Overall Study|Lost to Follow-up|87|||
48923203|NCT04429061|157553161|FG000|Overall Study|Withdrawal by Subject|3|||
48923204|NCT04429061|157553162|FG001|Overall Study|Withdrawal by Subject|4|||
48923205|NCT00971945|157553167|FG000|Overall Study|Progressive Disease|3|||
48923206|NCT00971945|157553167|FG000|Overall Study|Change in treatment policy|1|||
48923207|NCT00971945|157553167|FG000|Overall Study|Other reasons|2|||
48923208|NCT01137773|157553168|FG000|Overall Study|Death|3|||
48923209|NCT01137773|157553169|FG001|Overall Study|Death|3|||
48923210|NCT01137773|157553168|FG000|Overall Study|Lost to Follow-up|6|||
48923211|NCT01137773|157553169|FG001|Overall Study|Lost to Follow-up|0|||
48923212|NCT03325673|157553170|FG000|Overall Study|Adverse Event|4|||
48923213|NCT03325673|157553171|FG001|Overall Study|Adverse Event|0|||
48923214|NCT00820898|157553175|FG000|Overall Study|Inelgible - wrong primary site|1|||
48923215|NCT03189446|157553176|FG000|Overall Study|Adverse Event|2|||
48923216|NCT03189446|157553176|FG000|Overall Study|Withdrawal by Subject|2|||
48923217|NCT03189446|157553176|FG000|Overall Study|Physician Decision|1|||
48923218|NCT02830880|157553177|FG000|Overall Study|Adverse reaction to chemotherapy|1|||
48923219|NCT02830880|157553177|FG000|Overall Study|Death|1|||
48923220|NCT02830880|157553177|FG000|Overall Study|Physician Decision|1|||
48923221|NCT01580488|157553178|FG000|Overall Study|Withdrawal by Subject|1|||
48923222|NCT02787863|157553179|FG000|Overall Study|Death|1|||
48923223|NCT02787863|157553180|FG001|Overall Study|Death|0|||
48923224|NCT02787863|157553181|FG002|Overall Study|Death|1|||
48923225|NCT02787863|157553182|FG003|Overall Study|Death|0|||
48923226|NCT02787863|157553183|FG004|Overall Study|Death|0|||
48923227|NCT02787863|157553184|FG005|Overall Study|Death|0|||
49159921|NCT01343888|158425972|FG001|Overall Study|Lost to Follow-up|2|||
49159922|NCT01343888|158425973|FG002|Overall Study|Lost to Follow-up|1|||
49159923|NCT01343888|158425971|FG000|Overall Study|Protocol Violation|0|||
48833722|NCT03743246|157232686|FG002|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
48833723|NCT03743246|157232687|FG003|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
48833724|NCT01490580|157232688|FG000|Overall Study|Parents withdrew consent|0|||
49159924|NCT01343888|158425972|FG001|Overall Study|Protocol Violation|2|||
49159925|NCT01343888|158425973|FG002|Overall Study|Protocol Violation|0|||
48833725|NCT01490580|157232689|FG001|Overall Study|Parents withdrew consent|2|||
48833726|NCT00972504|157232690|FG000|Overall Study|Adverse Event|2|||
49159926|NCT01343888|158425971|FG000|Overall Study|Withdrawal by Subject|4|||
48833727|NCT00972504|157232690|FG000|Overall Study|Investigator discretion|1|||
48833728|NCT03478696|157232703|FG000|Overall Study|Adverse Event|1|||
48833729|NCT03478696|157232704|FG001|Overall Study|Adverse Event|5|||
48833730|NCT03478696|157232703|FG000|Overall Study|Lost to Follow-up|1|||
48833731|NCT03478696|157232704|FG001|Overall Study|Lost to Follow-up|0|||
48833732|NCT03478696|157232703|FG000|Overall Study|Physician Decision|6|||
48833733|NCT03478696|157232704|FG001|Overall Study|Physician Decision|3|||
49159927|NCT01343888|158425972|FG001|Overall Study|Withdrawal by Subject|4|||
49159928|NCT01343888|158425973|FG002|Overall Study|Withdrawal by Subject|2|||
49159929|NCT01343888|158425971|FG000|Overall Study|other than stated above|0|||
49159930|NCT01343888|158425972|FG001|Overall Study|other than stated above|0|||
49159931|NCT01343888|158425973|FG002|Overall Study|other than stated above|1|||
49159932|NCT00402987|158425974|FG000|Overall Study|Lack of Efficacy|0|||
49159933|NCT00402987|158425975|FG001|Overall Study|Lack of Efficacy|0|||
49159934|NCT00402987|158425976|FG002|Overall Study|Lack of Efficacy|1|||
49159935|NCT00402987|158425977|FG003|Overall Study|Lack of Efficacy|0|||
49159936|NCT01990742|158425978|FG000|Overall Study|Withdrawal by facility|407|||
49159937|NCT01990742|158425979|FG001|Overall Study|Withdrawal by facility|1083|||
48833734|NCT03478696|157232703|FG000|Overall Study|Withdrawal by Subject|9|||
48833735|NCT03478696|157232704|FG001|Overall Study|Withdrawal by Subject|4|||
48833736|NCT04246762|157232705|FG000|Period 1: Cocktail Alone|Protocol Violation|1|||
48833737|NCT00597519|157232706|FG000|Overall Study|Death|1|||
48833738|NCT01981850|157232707|FG000|Main Phase Stage 1|Death|2|||
48833739|NCT01981850|157232708|FG001|Main Phase Stage 1|Death|0|||
48833740|NCT01981850|157232709|FG002|Main Phase Stage 1|Death|0|||
48833741|NCT01981850|157232710|FG003|Main Phase Stage 1|Death|0|||
48833742|NCT01981850|157232711|FG004|Main Phase Stage 1|Death|0|||
48833743|NCT01981850|157232712|FG005|Main Phase Stage 1|Death|0|||
48833744|NCT01981850|157232713|FG006|Main Phase Stage 1|Death|0|||
48833745|NCT01981850|157232714|FG007|Main Phase Stage 1|Death|0|||
48833746|NCT01981850|157232715|FG008|Main Phase Stage 1|Death|0|||
48833747|NCT01981850|157232716|FG009|Main Phase Stage 1|Death|0|||
48833748|NCT01981850|157232707|FG000|Main Phase Stage 1|Informed Consent Withdrawn|1|||
48833749|NCT01981850|157232708|FG001|Main Phase Stage 1|Informed Consent Withdrawn|0|||
48833750|NCT01981850|157232709|FG002|Main Phase Stage 1|Informed Consent Withdrawn|0|||
48833751|NCT01981850|157232710|FG003|Main Phase Stage 1|Informed Consent Withdrawn|0|||
48833752|NCT01981850|157232711|FG004|Main Phase Stage 1|Informed Consent Withdrawn|0|||
48833753|NCT01981850|157232712|FG005|Main Phase Stage 1|Informed Consent Withdrawn|0|||
48833754|NCT01981850|157232713|FG006|Main Phase Stage 1|Informed Consent Withdrawn|0|||
48833755|NCT01981850|157232714|FG007|Main Phase Stage 1|Informed Consent Withdrawn|0|||
48833756|NCT01981850|157232715|FG008|Main Phase Stage 1|Informed Consent Withdrawn|0|||
48833757|NCT01981850|157232716|FG009|Main Phase Stage 1|Informed Consent Withdrawn|0|||
48833758|NCT01981850|157232707|FG000|Main Phase Stage 1|Lack of Efficacy|0|||
48833759|NCT01981850|157232708|FG001|Main Phase Stage 1|Lack of Efficacy|2|||
48833760|NCT01981850|157232709|FG002|Main Phase Stage 1|Lack of Efficacy|0|||
48833761|NCT01981850|157232710|FG003|Main Phase Stage 1|Lack of Efficacy|0|||
48833762|NCT01981850|157232711|FG004|Main Phase Stage 1|Lack of Efficacy|0|||
48833763|NCT01981850|157232712|FG005|Main Phase Stage 1|Lack of Efficacy|0|||
48833764|NCT01981850|157232713|FG006|Main Phase Stage 1|Lack of Efficacy|0|||
48833765|NCT01981850|157232714|FG007|Main Phase Stage 1|Lack of Efficacy|0|||
48833766|NCT01981850|157232715|FG008|Main Phase Stage 1|Lack of Efficacy|0|||
48833767|NCT01981850|157232716|FG009|Main Phase Stage 1|Lack of Efficacy|0|||
48923228|NCT02787863|157553185|FG006|Overall Study|Death|0|||
48923229|NCT02787863|157553186|FG007|Overall Study|Death|0|||
49159938|NCT01990742|158425978|FG000|Overall Study|Facility closed|0|||
49159939|NCT01990742|158425979|FG001|Overall Study|Facility closed|270|||
48833768|NCT01981850|157232707|FG000|Main Phase Stage 1|Various reasons|0|||
48833769|NCT01981850|157232708|FG001|Main Phase Stage 1|Various reasons|0|||
48833770|NCT01981850|157232709|FG002|Main Phase Stage 1|Various reasons|2|||
48833771|NCT01981850|157232710|FG003|Main Phase Stage 1|Various reasons|0|||
48833772|NCT01981850|157232711|FG004|Main Phase Stage 1|Various reasons|0|||
48833773|NCT01981850|157232712|FG005|Main Phase Stage 1|Various reasons|0|||
48833774|NCT01981850|157232713|FG006|Main Phase Stage 1|Various reasons|0|||
48833775|NCT01981850|157232714|FG007|Main Phase Stage 1|Various reasons|0|||
48833776|NCT01981850|157232715|FG008|Main Phase Stage 1|Various reasons|0|||
48833777|NCT01981850|157232716|FG009|Main Phase Stage 1|Various reasons|0|||
48833778|NCT01981850|157232707|FG000|Main Phase Stage 2|Adverse Event|0|||
48833779|NCT01981850|157232708|FG001|Main Phase Stage 2|Adverse Event|0|||
48833780|NCT01981850|157232709|FG002|Main Phase Stage 2|Adverse Event|0|||
48833781|NCT01981850|157232710|FG003|Main Phase Stage 2|Adverse Event|0|||
48833782|NCT01981850|157232711|FG004|Main Phase Stage 2|Adverse Event|6|||
48833783|NCT01981850|157232712|FG005|Main Phase Stage 2|Adverse Event|5|||
48833784|NCT01981850|157232713|FG006|Main Phase Stage 2|Adverse Event|7|||
48833785|NCT01981850|157232714|FG007|Main Phase Stage 2|Adverse Event|0|||
48833786|NCT01981850|157232715|FG008|Main Phase Stage 2|Adverse Event|0|||
48833787|NCT01981850|157232716|FG009|Main Phase Stage 2|Adverse Event|0|||
48833788|NCT01981850|157232707|FG000|Main Phase Stage 2|Informed Consent Withdrawn|0|||
48833789|NCT01981850|157232708|FG001|Main Phase Stage 2|Informed Consent Withdrawn|0|||
48833790|NCT01981850|157232709|FG002|Main Phase Stage 2|Informed Consent Withdrawn|0|||
48833791|NCT01981850|157232710|FG003|Main Phase Stage 2|Informed Consent Withdrawn|0|||
48833792|NCT01981850|157232711|FG004|Main Phase Stage 2|Informed Consent Withdrawn|4|||
48833793|NCT01981850|157232712|FG005|Main Phase Stage 2|Informed Consent Withdrawn|3|||
48833794|NCT01981850|157232713|FG006|Main Phase Stage 2|Informed Consent Withdrawn|3|||
48833795|NCT01981850|157232714|FG007|Main Phase Stage 2|Informed Consent Withdrawn|0|||
48833796|NCT01981850|157232715|FG008|Main Phase Stage 2|Informed Consent Withdrawn|0|||
48833797|NCT01981850|157232716|FG009|Main Phase Stage 2|Informed Consent Withdrawn|0|||
48833798|NCT01981850|157232707|FG000|Main Phase Stage 2|Lack of Efficacy|0|||
48833799|NCT01981850|157232708|FG001|Main Phase Stage 2|Lack of Efficacy|0|||
48833800|NCT01981850|157232709|FG002|Main Phase Stage 2|Lack of Efficacy|0|||
48833801|NCT01981850|157232710|FG003|Main Phase Stage 2|Lack of Efficacy|0|||
48833802|NCT01981850|157232711|FG004|Main Phase Stage 2|Lack of Efficacy|1|||
48833803|NCT01981850|157232712|FG005|Main Phase Stage 2|Lack of Efficacy|2|||
48833804|NCT01981850|157232713|FG006|Main Phase Stage 2|Lack of Efficacy|0|||
48833805|NCT01981850|157232714|FG007|Main Phase Stage 2|Lack of Efficacy|0|||
48833806|NCT01981850|157232715|FG008|Main Phase Stage 2|Lack of Efficacy|0|||
48833807|NCT01981850|157232716|FG009|Main Phase Stage 2|Lack of Efficacy|0|||
48833808|NCT01981850|157232707|FG000|Main Phase Stage 2|Various reasons|0|||
48833809|NCT01981850|157232708|FG001|Main Phase Stage 2|Various reasons|0|||
48833810|NCT01981850|157232709|FG002|Main Phase Stage 2|Various reasons|0|||
48833811|NCT01981850|157232710|FG003|Main Phase Stage 2|Various reasons|0|||
48833812|NCT01981850|157232711|FG004|Main Phase Stage 2|Various reasons|2|||
48833813|NCT01981850|157232712|FG005|Main Phase Stage 2|Various reasons|0|||
49159940|NCT00976456|158425980|FG000|Overall Study|Adverse Event|17|||
49159941|NCT00976456|158425981|FG001|Overall Study|Adverse Event|22|||
49159942|NCT00976456|158425980|FG000|Overall Study|Death|7|||
49159943|NCT00976456|158425981|FG001|Overall Study|Death|9|||
49159944|NCT00976456|158425980|FG000|Overall Study|Lack of Efficacy|5|||
49159945|NCT00976456|158425981|FG001|Overall Study|Lack of Efficacy|2|||
49159946|NCT00976456|158425980|FG000|Overall Study|Withdrawal by Subject|3|||
48833814|NCT01981850|157232713|FG006|Main Phase Stage 2|Various reasons|1|||
49159947|NCT00976456|158425981|FG001|Overall Study|Withdrawal by Subject|1|||
49159948|NCT00976456|158425980|FG000|Overall Study|screening failure, unknown|11|||
49159949|NCT00976456|158425981|FG001|Overall Study|screening failure, unknown|4|||
49159950|NCT00335829|158425982|FG000|Overall Study|Withdrawal by Subject|1|||
49159951|NCT00335829|158425982|FG000|Overall Study|Lost to Follow-up|1|||
49159952|NCT00335829|158425982|FG000|Overall Study|Adverse Event|1|||
49159953|NCT00583219|158425983|FG000|Phase 2|Withdrawal by Subject|1|||
49159954|NCT00854360|158425984|FG000|Overall Study|Adverse Event|0|||
49159955|NCT00854360|158425985|FG001|Overall Study|Adverse Event|1|||
49159956|NCT00854360|158425986|FG002|Overall Study|Adverse Event|2|||
49159957|NCT00854360|158425987|FG003|Overall Study|Adverse Event|6|||
49159958|NCT00854360|158425984|FG000|Overall Study|Withdrawal by Subject|0|||
49159959|NCT00854360|158425985|FG001|Overall Study|Withdrawal by Subject|0|||
49159960|NCT00854360|158425986|FG002|Overall Study|Withdrawal by Subject|0|||
49159961|NCT00854360|158425987|FG003|Overall Study|Withdrawal by Subject|1|||
49159962|NCT00854360|158425984|FG000|Overall Study|Pregnancy|0|||
49159963|NCT00854360|158425985|FG001|Overall Study|Pregnancy|1|||
49159964|NCT00854360|158425986|FG002|Overall Study|Pregnancy|0|||
49159965|NCT00854360|158425987|FG003|Overall Study|Pregnancy|0|||
49159966|NCT00854360|158425984|FG000|Overall Study|Lack of Efficacy|2|||
49159967|NCT00854360|158425985|FG001|Overall Study|Lack of Efficacy|1|||
49014587|NCT04634409|157888940|FG017|Overall Study|Death|0|||
49159968|NCT00854360|158425986|FG002|Overall Study|Lack of Efficacy|0|||
49159969|NCT00854360|158425987|FG003|Overall Study|Lack of Efficacy|0|||
49159970|NCT00854360|158425984|FG000|Overall Study|Other|0|||
48833815|NCT01981850|157232714|FG007|Main Phase Stage 2|Various reasons|0|||
49014588|NCT04634409|157888941|FG018|Overall Study|Death|0|||
49159971|NCT00854360|158425985|FG001|Overall Study|Other|0|||
48833816|NCT01981850|157232715|FG008|Main Phase Stage 2|Various reasons|0|||
48833817|NCT01981850|157232716|FG009|Main Phase Stage 2|Various reasons|0|||
48833818|NCT01981850|157232707|FG000|Main Phase Stage 2|Progressive Disease|0|||
48833819|NCT01981850|157232708|FG001|Main Phase Stage 2|Progressive Disease|0|||
48833820|NCT01981850|157232709|FG002|Main Phase Stage 2|Progressive Disease|0|||
48833821|NCT01981850|157232710|FG003|Main Phase Stage 2|Progressive Disease|0|||
48833822|NCT01981850|157232711|FG004|Main Phase Stage 2|Progressive Disease|0|||
48833823|NCT01981850|157232712|FG005|Main Phase Stage 2|Progressive Disease|6|||
48833824|NCT01981850|157232713|FG006|Main Phase Stage 2|Progressive Disease|6|||
48833825|NCT01981850|157232714|FG007|Main Phase Stage 2|Progressive Disease|0|||
48833826|NCT01981850|157232715|FG008|Main Phase Stage 2|Progressive Disease|0|||
48833827|NCT01981850|157232716|FG009|Main Phase Stage 2|Progressive Disease|0|||
48833828|NCT01981850|157232707|FG000|Open Label Extension (OLE)|Adverse Event|0|||
48833829|NCT01981850|157232708|FG001|Open Label Extension (OLE)|Adverse Event|0|||
48833830|NCT01981850|157232709|FG002|Open Label Extension (OLE)|Adverse Event|0|||
48833831|NCT01981850|157232710|FG003|Open Label Extension (OLE)|Adverse Event|0|||
49159972|NCT00854360|158425986|FG002|Overall Study|Other|0|||
49159973|NCT00854360|158425987|FG003|Overall Study|Other|3|||
49159974|NCT02949011|158425988|FG000|Overall Study|Adverse Event|6|||
49159975|NCT02949011|158425989|FG001|Overall Study|Adverse Event|7|||
48833832|NCT01981850|157232711|FG004|Open Label Extension (OLE)|Adverse Event|0|||
48833833|NCT01981850|157232712|FG005|Open Label Extension (OLE)|Adverse Event|0|||
48833834|NCT01981850|157232713|FG006|Open Label Extension (OLE)|Adverse Event|0|||
48833835|NCT01981850|157232714|FG007|Open Label Extension (OLE)|Adverse Event|2|||
48833836|NCT01981850|157232715|FG008|Open Label Extension (OLE)|Adverse Event|1|||
48833837|NCT01981850|157232716|FG009|Open Label Extension (OLE)|Adverse Event|8|||
49159976|NCT02949011|158425990|FG002|Overall Study|Adverse Event|3|||
49159977|NCT02949011|158425988|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
49159978|NCT02949011|158425989|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
49159979|NCT02949011|158425990|FG002|Overall Study|Failed Inclusion/Exclusion Criteria|3|||
49159980|NCT02949011|158425988|FG000|Overall Study|Protocol Deviation|5|||
49159981|NCT02949011|158425989|FG001|Overall Study|Protocol Deviation|3|||
49159982|NCT02949011|158425990|FG002|Overall Study|Protocol Deviation|3|||
49159983|NCT02949011|158425988|FG000|Overall Study|Lack of Efficacy|0|||
49159984|NCT02949011|158425989|FG001|Overall Study|Lack of Efficacy|2|||
49159985|NCT02949011|158425990|FG002|Overall Study|Lack of Efficacy|0|||
49159986|NCT02949011|158425988|FG000|Overall Study|Withdrawal by Subject|13|||
49159987|NCT02949011|158425989|FG001|Overall Study|Withdrawal by Subject|13|||
49159988|NCT02949011|158425990|FG002|Overall Study|Withdrawal by Subject|21|||
49159989|NCT02949011|158425988|FG000|Overall Study|Lost to Follow-up|7|||
49159990|NCT02949011|158425989|FG001|Overall Study|Lost to Follow-up|5|||
49159991|NCT02949011|158425990|FG002|Overall Study|Lost to Follow-up|5|||
49159992|NCT02949011|158425988|FG000|Overall Study|Death|0|||
49159993|NCT02949011|158425989|FG001|Overall Study|Death|0|||
49159994|NCT02949011|158425990|FG002|Overall Study|Death|1|||
49159995|NCT02949011|158425988|FG000|Overall Study|Miscellaneous|2|||
49159996|NCT02949011|158425989|FG001|Overall Study|Miscellaneous|4|||
49159997|NCT02949011|158425990|FG002|Overall Study|Miscellaneous|6|||
49159998|NCT04108273|158425994|FG000|Overall Study|COVID Pandemic|1|||
49159999|NCT04108273|158425995|FG001|Overall Study|COVID Pandemic|0|||
49160000|NCT02131766|158425996|FG000|Overall Study|Withdrawal by Subject|4|||
49160001|NCT01541371|158425997|FG000|Overall Study|Withdrawal by Subject|14|||
49160002|NCT01541371|158425997|FG000|Overall Study|Lost to Follow-up|21|||
49160003|NCT01541371|158425997|FG000|Overall Study|Adverse Event|15|||
49160004|NCT01541371|158425997|FG000|Overall Study|Lack of Efficacy|12|||
49160005|NCT01541371|158425997|FG000|Overall Study|Protocol Violation|6|||
49160006|NCT01541371|158425997|FG000|Overall Study|Study medication non-compliance|3|||
49160007|NCT01541371|158425997|FG000|Overall Study|Other|6|||
49160008|NCT00800735|158426000|FG000|Overall Study|Administrative/Other|2|||
49160009|NCT00800735|158426000|FG000|Overall Study|Insufficient Therapeutic Response|2|||
49160010|NCT00800735|158426000|FG000|Overall Study|Violation of Selection Criteria at Entry|7|||
49160011|NCT00800735|158426000|FG000|Overall Study|Withdrew Consent|3|||
49160012|NCT00506142|158426001|FG000|Overall Study|Adverse Event|8|||
49160013|NCT00506142|158426002|FG001|Overall Study|Adverse Event|7|||
49160014|NCT00506142|158426001|FG000|Overall Study|Lack of Efficacy|21|||
48833838|NCT01981850|157232707|FG000|Open Label Extension (OLE)|Lack of Efficacy|0|||
48833839|NCT01981850|157232708|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
49160015|NCT00506142|158426002|FG001|Overall Study|Lack of Efficacy|7|||
49160016|NCT00506142|158426001|FG000|Overall Study|Withdrawal by Subject|4|||
49160017|NCT00506142|158426002|FG001|Overall Study|Withdrawal by Subject|5|||
49160018|NCT00506142|158426001|FG000|Overall Study|Physician Decision|1|||
49160019|NCT00506142|158426002|FG001|Overall Study|Physician Decision|0|||
49160020|NCT00506142|158426001|FG000|Overall Study|New health condition|1|||
49160021|NCT00506142|158426002|FG001|Overall Study|New health condition|0|||
49160022|NCT01164007|158426008|FG000|Overall Study|Adverse Event|5|||
49160023|NCT01164007|158426008|FG000|Overall Study|Progression of Disease|30|||
49160024|NCT01164007|158426008|FG000|Overall Study|Protocol Violation|1|||
49160025|NCT01164007|158426008|FG000|Overall Study|Withdrawal by Subject|1|||
49160026|NCT01164007|158426008|FG000|Overall Study|Medical Decision|3|||
49160027|NCT02115321|158426009|FG000|Overall Study|Death|1|||
49160028|NCT02115321|158426010|FG001|Overall Study|Death|0|||
49160029|NCT03218917|158426011|FG000|Overall Study|Adverse Event|3|||
49160030|NCT03218917|158426012|FG001|Overall Study|Adverse Event|3|||
49160031|NCT03218917|158426013|FG002|Overall Study|Adverse Event|2|||
49160032|NCT03218917|158426011|FG000|Overall Study|Subject withdrew consent|2|||
49160033|NCT03218917|158426012|FG001|Overall Study|Subject withdrew consent|4|||
49160034|NCT03218917|158426013|FG002|Overall Study|Subject withdrew consent|10|||
49160035|NCT03218917|158426011|FG000|Overall Study|Physician Decision|0|||
49160036|NCT03218917|158426012|FG001|Overall Study|Physician Decision|1|||
49160037|NCT03218917|158426013|FG002|Overall Study|Physician Decision|1|||
49160038|NCT03218917|158426011|FG000|Overall Study|Lost to Follow-up|1|||
49160039|NCT03218917|158426012|FG001|Overall Study|Lost to Follow-up|0|||
49160040|NCT03218917|158426013|FG002|Overall Study|Lost to Follow-up|0|||
49160041|NCT03218917|158426011|FG000|Overall Study|Reason Missing|0|||
49160042|NCT03218917|158426012|FG001|Overall Study|Reason Missing|2|||
49160043|NCT03218917|158426013|FG002|Overall Study|Reason Missing|0|||
49160044|NCT03218917|158426011|FG000|Overall Study|Death|0|||
49160045|NCT03218917|158426012|FG001|Overall Study|Death|1|||
49160046|NCT03218917|158426013|FG002|Overall Study|Death|0|||
49160047|NCT03218917|158426011|FG000|Overall Study|Non-Compliance with Study Drug|0|||
49160048|NCT03218917|158426012|FG001|Overall Study|Non-Compliance with Study Drug|1|||
48833840|NCT01981850|157232709|FG002|Open Label Extension (OLE)|Lack of Efficacy|0|||
48833841|NCT01981850|157232710|FG003|Open Label Extension (OLE)|Lack of Efficacy|0|||
48833842|NCT01981850|157232711|FG004|Open Label Extension (OLE)|Lack of Efficacy|0|||
48833843|NCT01981850|157232712|FG005|Open Label Extension (OLE)|Lack of Efficacy|0|||
48833844|NCT01981850|157232713|FG006|Open Label Extension (OLE)|Lack of Efficacy|0|||
48833845|NCT01981850|157232714|FG007|Open Label Extension (OLE)|Lack of Efficacy|4|||
48833846|NCT01981850|157232715|FG008|Open Label Extension (OLE)|Lack of Efficacy|1|||
48833847|NCT01981850|157232716|FG009|Open Label Extension (OLE)|Lack of Efficacy|19|||
48833848|NCT01981850|157232707|FG000|Open Label Extension (OLE)|Various reasons|0|||
48833849|NCT01981850|157232708|FG001|Open Label Extension (OLE)|Various reasons|0|||
48833850|NCT01981850|157232709|FG002|Open Label Extension (OLE)|Various reasons|0|||
48833851|NCT01981850|157232710|FG003|Open Label Extension (OLE)|Various reasons|0|||
48833852|NCT01981850|157232711|FG004|Open Label Extension (OLE)|Various reasons|0|||
48833853|NCT01981850|157232712|FG005|Open Label Extension (OLE)|Various reasons|0|||
48833854|NCT01981850|157232713|FG006|Open Label Extension (OLE)|Various reasons|0|||
48833855|NCT01981850|157232714|FG007|Open Label Extension (OLE)|Various reasons|3|||
48833856|NCT01981850|157232715|FG008|Open Label Extension (OLE)|Various reasons|1|||
48833857|NCT01981850|157232716|FG009|Open Label Extension (OLE)|Various reasons|3|||
48833858|NCT01981850|157232707|FG000|Open Label Extension (OLE)|Progressive Disease|0|||
48833859|NCT01981850|157232708|FG001|Open Label Extension (OLE)|Progressive Disease|0|||
48833860|NCT01981850|157232709|FG002|Open Label Extension (OLE)|Progressive Disease|0|||
48833861|NCT01981850|157232710|FG003|Open Label Extension (OLE)|Progressive Disease|0|||
48833862|NCT01981850|157232711|FG004|Open Label Extension (OLE)|Progressive Disease|0|||
48833863|NCT01981850|157232712|FG005|Open Label Extension (OLE)|Progressive Disease|0|||
48833864|NCT01981850|157232713|FG006|Open Label Extension (OLE)|Progressive Disease|0|||
48833865|NCT01981850|157232714|FG007|Open Label Extension (OLE)|Progressive Disease|3|||
48833866|NCT01981850|157232715|FG008|Open Label Extension (OLE)|Progressive Disease|2|||
48833867|NCT01981850|157232716|FG009|Open Label Extension (OLE)|Progressive Disease|9|||
48833868|NCT01981850|157232707|FG000|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
48833869|NCT01981850|157232708|FG001|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
48833870|NCT01981850|157232709|FG002|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
48833871|NCT01981850|157232710|FG003|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
48833872|NCT01981850|157232711|FG004|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
48833873|NCT01981850|157232712|FG005|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
48833874|NCT01981850|157232713|FG006|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
48833875|NCT01981850|157232714|FG007|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
48833876|NCT01981850|157232715|FG008|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
48833877|NCT01981850|157232716|FG009|Open Label Extension (OLE)|Informed Consent Withdrawn|8|||
48833878|NCT01981850|157232707|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
48833879|NCT01981850|157232708|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
48833880|NCT01981850|157232709|FG002|Open Label Extension (OLE)|Lost to Follow-up|0|||
48833881|NCT01981850|157232710|FG003|Open Label Extension (OLE)|Lost to Follow-up|0|||
49160049|NCT03218917|158426013|FG002|Overall Study|Non-Compliance with Study Drug|0|||
48833882|NCT01981850|157232711|FG004|Open Label Extension (OLE)|Lost to Follow-up|0|||
48833883|NCT01981850|157232712|FG005|Open Label Extension (OLE)|Lost to Follow-up|0|||
48833884|NCT01981850|157232713|FG006|Open Label Extension (OLE)|Lost to Follow-up|0|||
48833885|NCT01981850|157232714|FG007|Open Label Extension (OLE)|Lost to Follow-up|0|||
48833886|NCT01981850|157232715|FG008|Open Label Extension (OLE)|Lost to Follow-up|0|||
48833887|NCT01981850|157232716|FG009|Open Label Extension (OLE)|Lost to Follow-up|1|||
48833888|NCT05641311|157232721|FG000|Dosing Period 1|Adverse Event|1|||
48833889|NCT05641311|157232722|FG001|Dosing Period 1|Adverse Event|0|||
48833890|NCT02524288|157232725|FG000|Overall Study|Adverse Event|115|||
48833891|NCT02524288|157232725|FG000|Overall Study|Lost to Follow-up|216|||
48833892|NCT02524288|157232725|FG000|Overall Study|Non-Compliance With Protocol|32|||
48833893|NCT02524288|157232725|FG000|Overall Study|Non-Compliance With Study Drug|14|||
48833894|NCT02524288|157232725|FG000|Overall Study|Pregnancy Wish|6|||
48833895|NCT02524288|157232725|FG000|Overall Study|Protocol Violation|6|||
48833896|NCT02524288|157232725|FG000|Overall Study|Screen Failure|2|||
48833897|NCT02524288|157232725|FG000|Overall Study|Site Discontinued Study Participation|1|||
48833898|NCT02524288|157232725|FG000|Overall Study|Study Terminated By Sponsor|1417|||
48833899|NCT02524288|157232725|FG000|Overall Study|Subject Moved|32|||
48833900|NCT02524288|157232725|FG000|Overall Study|Withdrawal by Subject|76|||
48833901|NCT02524288|157232725|FG000|Overall Study|Pregnancy|22|||
48833902|NCT02524288|157232725|FG000|Overall Study|Physician Decision|2|||
48833903|NCT02459899|157232741|FG000|Overall Study|Adverse Event|1|||
48833904|NCT02459899|157232742|FG001|Overall Study|Adverse Event|1|||
48833905|NCT02459899|157232743|FG002|Overall Study|Adverse Event|0|||
48833906|NCT02459899|157232744|FG003|Overall Study|Adverse Event|0|||
48833907|NCT02459899|157232741|FG000|Overall Study|Lost to Follow-up|1|||
48833908|NCT02459899|157232742|FG001|Overall Study|Lost to Follow-up|2|||
48923230|NCT02787863|157553179|FG000|Overall Study|Withdrawal by Subject|0|||
48833909|NCT02459899|157232743|FG002|Overall Study|Lost to Follow-up|0|||
48833910|NCT02459899|157232744|FG003|Overall Study|Lost to Follow-up|1|||
48833911|NCT02459899|157232741|FG000|Overall Study|Non-compliance with the treatment|0|||
48833912|NCT02459899|157232742|FG001|Overall Study|Non-compliance with the treatment|0|||
48833913|NCT02459899|157232743|FG002|Overall Study|Non-compliance with the treatment|0|||
48833914|NCT02459899|157232744|FG003|Overall Study|Non-compliance with the treatment|1|||
48833915|NCT02459899|157232741|FG000|Overall Study|Withdrawal by Subject|1|||
49160050|NCT01977222|158426014|FG000|Overall Study|Withdrawal by Subject|1|||
49160051|NCT01612676|158426015|FG000|Overall Study|Adverse Event|2|||
49160052|NCT01612676|158426016|FG001|Overall Study|Adverse Event|3|||
49160053|NCT01612676|158426017|FG002|Overall Study|Adverse Event|1|||
49160054|NCT01612676|158426018|FG003|Overall Study|Adverse Event|3|||
49160055|NCT01612676|158426015|FG000|Overall Study|Protocol Violation|0|||
49160056|NCT01612676|158426016|FG001|Overall Study|Protocol Violation|1|||
49160057|NCT01612676|158426017|FG002|Overall Study|Protocol Violation|0|||
48833916|NCT02459899|157232742|FG001|Overall Study|Withdrawal by Subject|3|||
48833917|NCT02459899|157232743|FG002|Overall Study|Withdrawal by Subject|0|||
48833918|NCT02459899|157232744|FG003|Overall Study|Withdrawal by Subject|0|||
48833919|NCT03394027|157232747|FG000|Overall Study|Ineligible|3|||
48833920|NCT03394027|157232748|FG001|Overall Study|Ineligible|1|||
48833921|NCT03394027|157232749|FG002|Overall Study|Ineligible|3|||
48833922|NCT03394027|157232747|FG000|Overall Study|Participant declined to participate before treatment started|0|||
48833923|NCT03394027|157232748|FG001|Overall Study|Participant declined to participate before treatment started|0|||
48833924|NCT03394027|157232749|FG002|Overall Study|Participant declined to participate before treatment started|1|||
48833925|NCT02248480|157232753|FG000|Overall Study|Lack of Efficacy|4|||
48833926|NCT02248480|157232754|FG001|Overall Study|Lack of Efficacy|6|||
48833927|NCT02248480|157232753|FG000|Overall Study|Adverse Event|11|||
48833928|NCT02248480|157232754|FG001|Overall Study|Adverse Event|2|||
48833929|NCT02248480|157232753|FG000|Overall Study|Withdrawal by Subject|2|||
48833930|NCT02248480|157232754|FG001|Overall Study|Withdrawal by Subject|4|||
48833931|NCT02248480|157232753|FG000|Overall Study|Entry Criteria Not Met|0|||
48833932|NCT02248480|157232754|FG001|Overall Study|Entry Criteria Not Met|1|||
48833933|NCT02248480|157232753|FG000|Overall Study|Other:Physician Decision|0|||
49160058|NCT01612676|158426018|FG003|Overall Study|Protocol Violation|0|||
49160059|NCT01143402|158426033|FG000|Overall Study|Rapid clinical decline|1|||
49160060|NCT01143402|158426034|FG001|Overall Study|Rapid clinical decline|1|||
49160061|NCT01143402|158426035|FG002|Overall Study|Rapid clinical decline|0|||
48833934|NCT02248480|157232754|FG001|Overall Study|Other:Physician Decision|1|||
48833935|NCT03942042|157232755|FG000|Induction Dosing Period (12 Weeks)|Adverse Event|0|||
48833936|NCT03942042|157232756|FG001|Induction Dosing Period (12 Weeks)|Adverse Event|1|||
48833937|NCT03942042|157232755|FG000|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1|||
48833938|NCT03942042|157232756|FG001|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0|||
48833939|NCT01196429|157232757|FG000|Overall Study|Ineligible - inadequate pathology|1|||
48833940|NCT01196429|157232758|FG001|Overall Study|Ineligible - inadequate pathology|0|||
48833941|NCT01196429|157232757|FG000|Overall Study|Ineligible - wrong cell type|1|||
48833942|NCT01196429|157232758|FG001|Overall Study|Ineligible - wrong cell type|0|||
48833943|NCT01196429|157232757|FG000|Overall Study|Refused - Never Treated|1|||
48833944|NCT01196429|157232758|FG001|Overall Study|Refused - Never Treated|0|||
48833945|NCT01121549|157232759|FG000|Overall Study|Adverse Event|10|||
48833946|NCT01121549|157232759|FG000|Overall Study|Lack of Efficacy|11|||
48833947|NCT01121549|157232759|FG000|Overall Study|Lost to Follow-up|12|||
48833948|NCT01121549|157232759|FG000|Overall Study|Did not meet entrance criteria|9|||
48923231|NCT02787863|157553180|FG001|Overall Study|Withdrawal by Subject|1|||
48923232|NCT02787863|157553181|FG002|Overall Study|Withdrawal by Subject|1|||
48923233|NCT02787863|157553182|FG003|Overall Study|Withdrawal by Subject|0|||
48923234|NCT02787863|157553183|FG004|Overall Study|Withdrawal by Subject|0|||
48923235|NCT02787863|157553184|FG005|Overall Study|Withdrawal by Subject|0|||
49160062|NCT01143402|158426033|FG000|Overall Study|Not Treated|0|||
49160063|NCT01143402|158426034|FG001|Overall Study|Not Treated|0|||
49160064|NCT01143402|158426035|FG002|Overall Study|Not Treated|1|||
49160065|NCT02216526|158426044|FG000|Overall Study|Adverse Event|1|||
49160066|NCT02216526|158426045|FG001|Overall Study|Adverse Event|1|||
49160067|NCT02216526|158426046|FG002|Overall Study|Adverse Event|0|||
49160068|NCT02216526|158426044|FG000|Overall Study|Death|0|||
49160069|NCT02216526|158426045|FG001|Overall Study|Death|1|||
49160070|NCT02216526|158426046|FG002|Overall Study|Death|3|||
49160071|NCT02216526|158426044|FG000|Overall Study|Protocol Violation|2|||
49160072|NCT02216526|158426045|FG001|Overall Study|Protocol Violation|0|||
48833949|NCT01121549|157232759|FG000|Overall Study|Study terminated by sponsor|197|||
48923236|NCT02787863|157553185|FG006|Overall Study|Withdrawal by Subject|0|||
48923237|NCT02787863|157553186|FG007|Overall Study|Withdrawal by Subject|0|||
48923238|NCT01324232|157553187|FG000|Overall Study|Protocol Violation|0|||
48923239|NCT01324232|157553188|FG001|Overall Study|Protocol Violation|0|||
48833950|NCT01121549|157232759|FG000|Overall Study|Pregnancy|1|||
48833951|NCT01121549|157232759|FG000|Overall Study|Protocol Violation|33|||
48923240|NCT01324232|157553189|FG002|Overall Study|Protocol Violation|0|||
48923241|NCT01324232|157553190|FG003|Overall Study|Protocol Violation|2|||
48833952|NCT01121549|157232759|FG000|Overall Study|Withdrawal by Subject|16|||
48833953|NCT01121549|157232759|FG000|Overall Study|Other|58|||
49160073|NCT02216526|158426046|FG002|Overall Study|Protocol Violation|2|||
49160074|NCT02216526|158426044|FG000|Overall Study|Hospitalization|2|||
49160075|NCT02216526|158426045|FG001|Overall Study|Hospitalization|1|||
48833954|NCT02299336|157232762|FG000|Overall Study|Withdrawal by Subject|11|||
48833955|NCT02299336|157232762|FG000|Overall Study|Adverse Event|1|||
48833956|NCT02299336|157232762|FG000|Overall Study|Death|1|||
48833957|NCT02299336|157232762|FG000|Overall Study|Lost to Follow-up|1|||
48833958|NCT03993392|157232765|FG000|Overall Study|Withdrawal by Subject|3|||
48833959|NCT03993392|157232765|FG000|Overall Study|Lost to Follow-up|2|||
48833960|NCT03993392|157232765|FG000|Overall Study|Did not meet Day 1 check-in criteria|1|||
48833961|NCT00573833|157232766|FG000|Overall Study|Not Treated|2|||
48833962|NCT01451814|157234108|FG000|Overall Study|Withdrawal by Subject|1|||
49160076|NCT02216526|158426046|FG002|Overall Study|Hospitalization|3|||
49160077|NCT04409834|158426047|FG000|Overall Study|Death|55|||
49160078|NCT04409834|158426048|FG001|Overall Study|Death|62|||
49160079|NCT02170064|158426049|FG000|Overall Study|Withdrawal by Subject|5|||
49160080|NCT02170064|158426050|FG001|Overall Study|Withdrawal by Subject|1|||
49160081|NCT02170064|158426051|FG002|Overall Study|Withdrawal by Subject|1|||
49160082|NCT02170064|158426049|FG000|Overall Study|Physician Decision|1|||
49160083|NCT02170064|158426050|FG001|Overall Study|Physician Decision|1|||
49160084|NCT02170064|158426051|FG002|Overall Study|Physician Decision|0|||
49160085|NCT04211363|158426054|FG000|Overall Study|Adverse Event|5|||
49160086|NCT04211363|158426055|FG001|Overall Study|Adverse Event|2|||
49160087|NCT04211363|158426054|FG000|Overall Study|Physician Decision|0|||
49160088|NCT04211363|158426055|FG001|Overall Study|Physician Decision|1|||
49160089|NCT04211363|158426054|FG000|Overall Study|Protocol Violation|1|||
49160090|NCT04211363|158426055|FG001|Overall Study|Protocol Violation|0|||
49160091|NCT04211363|158426054|FG000|Overall Study|Pregnancy|1|||
49160092|NCT04211363|158426055|FG001|Overall Study|Pregnancy|0|||
49160093|NCT04211363|158426054|FG000|Overall Study|Lost to Follow-up|12|||
49160094|NCT04211363|158426055|FG001|Overall Study|Lost to Follow-up|4|||
48833963|NCT01451814|157234109|FG001|Overall Study|Withdrawal by Subject|1|||
48833964|NCT01451814|157234108|FG000|Overall Study|Lost to Follow-up|5|||
48833965|NCT01451814|157234109|FG001|Overall Study|Lost to Follow-up|4|||
48833966|NCT02049866|157234110|FG000|Overall Study|Withdrawal by Subject|1|||
48833967|NCT01570751|157234112|FG000|Period A (16 Weeks)|Protocol Violation|1|||
48833968|NCT01570751|157234113|FG001|Period A (16 Weeks)|Protocol Violation|1|||
48833969|NCT01570751|157234112|FG000|Period A (16 Weeks)|Withdrawal criteria|0|||
48833970|NCT01570751|157234113|FG001|Period A (16 Weeks)|Withdrawal criteria|1|||
48833971|NCT01570751|157234112|FG000|Period A (16 Weeks)|Unclassified|2|||
49160095|NCT04211363|158426054|FG000|Overall Study|Withdrawal by Subject|11|||
49160096|NCT04211363|158426055|FG001|Overall Study|Withdrawal by Subject|11|||
49160097|NCT04211363|158426054|FG000|Overall Study|Other|1|||
49160098|NCT04211363|158426055|FG001|Overall Study|Other|2|||
49160099|NCT00461708|158426056|FG000|Overall Study|Adverse Event|17|||
49160100|NCT00461708|158426057|FG001|Overall Study|Adverse Event|7|||
49160101|NCT00461708|158426056|FG000|Overall Study|Lack of Efficacy|68|||
49160102|NCT00461708|158426057|FG001|Overall Study|Lack of Efficacy|20|||
49160103|NCT00461708|158426056|FG000|Overall Study|Physician Decision|10|||
49160104|NCT00461708|158426057|FG001|Overall Study|Physician Decision|4|||
49160105|NCT00461708|158426056|FG000|Overall Study|Withdrawal by Subject|8|||
49160106|NCT00461708|158426057|FG001|Overall Study|Withdrawal by Subject|2|||
48923242|NCT01324232|157553187|FG000|Overall Study|Missing|0|||
48923243|NCT01324232|157553188|FG001|Overall Study|Missing|0|||
48923244|NCT01324232|157553189|FG002|Overall Study|Missing|1|||
48923245|NCT01324232|157553190|FG003|Overall Study|Missing|0|||
48833972|NCT01570751|157234113|FG001|Period A (16 Weeks)|Unclassified|3|||
48833973|NCT01570751|157234112|FG000|Period B (16 Weeks)|Adverse Event|1|||
48833974|NCT01570751|157234113|FG001|Period B (16 Weeks)|Adverse Event|0|||
48833975|NCT01570751|157234112|FG000|Period B (16 Weeks)|Protocol Violation|0|||
48833976|NCT01570751|157234113|FG001|Period B (16 Weeks)|Protocol Violation|1|||
48833977|NCT02131324|157234114|FG000|Overall Study|Withdrawal by Subject|1|||
48833978|NCT02131324|157234115|FG001|Overall Study|Withdrawal by Subject|2|||
48923246|NCT01324232|157553187|FG000|Overall Study|Participant's Personal Reason/Decision|0|||
49160107|NCT00461708|158426056|FG000|Overall Study|Other|4|||
49160108|NCT00461708|158426057|FG001|Overall Study|Other|4|||
49160109|NCT00461708|158426056|FG000|Overall Study|Death|8|||
49160110|NCT00461708|158426057|FG001|Overall Study|Death|1|||
49160111|NCT03097289|158426059|FG000|Overall Study|Adverse Event|1|||
49014589|NCT04634409|157888942|FG019|Overall Study|Death|0|||
49160112|NCT03097289|158426059|FG000|Overall Study|Equipment failure|2|||
49160113|NCT03097289|158426059|FG000|Overall Study|Collected platelet product unusable|3|||
49160114|NCT02750514|158426060|FG000|Track 1|Disease progression|20|||
49160115|NCT02750514|158426061|FG001|Track 1|Disease progression|1|||
49160116|NCT02750514|158426062|FG002|Track 1|Disease progression|0|||
49160117|NCT02750514|158426063|FG003|Track 1|Disease progression|1|||
49160118|NCT02750514|158426064|FG004|Track 1|Disease progression|0|||
49160119|NCT02750514|158426060|FG000|Track 1|Adverse event unrelated to study drug|1|||
49160120|NCT02750514|158426061|FG001|Track 1|Adverse event unrelated to study drug|0|||
49160121|NCT02750514|158426062|FG002|Track 1|Adverse event unrelated to study drug|0|||
49160122|NCT02750514|158426063|FG003|Track 1|Adverse event unrelated to study drug|0|||
49160123|NCT02750514|158426064|FG004|Track 1|Adverse event unrelated to study drug|0|||
49160124|NCT02750514|158426060|FG000|Track 1|Study drug toxicity|4|||
49160125|NCT02750514|158426061|FG001|Track 1|Study drug toxicity|1|||
48833979|NCT02131324|157234114|FG000|Overall Study|Lost to Follow-up|1|||
48833980|NCT02131324|157234115|FG001|Overall Study|Lost to Follow-up|1|||
48833981|NCT05790408|157234116|FG000|Overall Study|Did not undergo surgery or did not undergo imaging at the time of surgery|3|||
49160126|NCT02750514|158426062|FG002|Track 1|Study drug toxicity|0|||
49160127|NCT02750514|158426063|FG003|Track 1|Study drug toxicity|1|||
49160128|NCT02750514|158426064|FG004|Track 1|Study drug toxicity|0|||
49160129|NCT02750514|158426060|FG000|Track 1|Participant request to discontinue|1|||
49160130|NCT02750514|158426061|FG001|Track 1|Participant request to discontinue|0|||
48833982|NCT02281318|157234122|FG000|Overall Study|Adverse Event|2|||
48833983|NCT02281318|157234123|FG001|Overall Study|Adverse Event|2|||
48833984|NCT02281318|157234122|FG000|Overall Study|Lack of Efficacy|2|||
48833985|NCT02281318|157234123|FG001|Overall Study|Lack of Efficacy|0|||
48833986|NCT02281318|157234122|FG000|Overall Study|Lost to Follow-up|2|||
48833987|NCT02281318|157234123|FG001|Overall Study|Lost to Follow-up|1|||
48833988|NCT02281318|157234122|FG000|Overall Study|Physician Decision|2|||
48833989|NCT02281318|157234123|FG001|Overall Study|Physician Decision|0|||
48833990|NCT02281318|157234122|FG000|Overall Study|Withdrawal by Subject|6|||
48833991|NCT02281318|157234123|FG001|Overall Study|Withdrawal by Subject|2|||
48833992|NCT01281813|157234131|FG000|Overall Study|Adverse Event|0|||
48833993|NCT01281813|157234132|FG001|Overall Study|Adverse Event|0|||
48833994|NCT01281813|157234133|FG002|Overall Study|Adverse Event|10|||
48833995|NCT01281813|157234131|FG000|Overall Study|Lost to Follow-up|0|||
48833996|NCT01281813|157234132|FG001|Overall Study|Lost to Follow-up|0|||
48833997|NCT01281813|157234133|FG002|Overall Study|Lost to Follow-up|31|||
48833998|NCT01281813|157234131|FG000|Overall Study|Withdrawal by Subject|0|||
48833999|NCT01281813|157234132|FG001|Overall Study|Withdrawal by Subject|0|||
48834000|NCT01281813|157234133|FG002|Overall Study|Withdrawal by Subject|13|||
48834001|NCT01281813|157234131|FG000|Overall Study|Subject Non-Compliant|0|||
48834002|NCT01281813|157234132|FG001|Overall Study|Subject Non-Compliant|0|||
48834003|NCT01281813|157234133|FG002|Overall Study|Subject Non-Compliant|6|||
48834004|NCT01281813|157234131|FG000|Overall Study|Subject Reached A Virologic Endpoint|0|||
48834005|NCT01281813|157234132|FG001|Overall Study|Subject Reached A Virologic Endpoint|0|||
48834006|NCT01281813|157234133|FG002|Overall Study|Subject Reached A Virologic Endpoint|5|||
49160131|NCT02750514|158426062|FG002|Track 1|Participant request to discontinue|0|||
49160132|NCT02750514|158426063|FG003|Track 1|Participant request to discontinue|0|||
49160133|NCT02750514|158426064|FG004|Track 1|Participant request to discontinue|0|||
49160134|NCT02750514|158426060|FG000|Track 1|Other reasons|1|||
48834007|NCT01281813|157234131|FG000|Overall Study|Sponsor's Decision|4|||
48834008|NCT01281813|157234132|FG001|Overall Study|Sponsor's Decision|3|||
48834009|NCT01281813|157234133|FG002|Overall Study|Sponsor's Decision|7|||
48834010|NCT01281813|157234131|FG000|Overall Study|Switched to Commercially Available Medication|0|||
48834011|NCT01281813|157234132|FG001|Overall Study|Switched to Commercially Available Medication|0|||
49160135|NCT02750514|158426061|FG001|Track 1|Other reasons|0|||
49160136|NCT02750514|158426062|FG002|Track 1|Other reasons|0|||
49160137|NCT02750514|158426063|FG003|Track 1|Other reasons|0|||
49160138|NCT02750514|158426064|FG004|Track 1|Other reasons|0|||
49160139|NCT02750514|158426060|FG000|Track 2|Disease progression|4|||
49160140|NCT02750514|158426061|FG001|Track 2|Disease progression|5|||
49160141|NCT02750514|158426062|FG002|Track 2|Disease progression|2|||
49160142|NCT02750514|158426063|FG003|Track 2|Disease progression|5|||
49160143|NCT02750514|158426064|FG004|Track 2|Disease progression|0|||
49160144|NCT02750514|158426060|FG000|Track 2|Adverse event unrelated to study drug|1|||
49160145|NCT02750514|158426061|FG001|Track 2|Adverse event unrelated to study drug|0|||
49160146|NCT02750514|158426062|FG002|Track 2|Adverse event unrelated to study drug|0|||
49160147|NCT02750514|158426063|FG003|Track 2|Adverse event unrelated to study drug|0|||
49160148|NCT02750514|158426064|FG004|Track 2|Adverse event unrelated to study drug|0|||
49160149|NCT02750514|158426060|FG000|Track 2|Study drug toxicity|1|||
49160150|NCT02750514|158426061|FG001|Track 2|Study drug toxicity|2|||
49160151|NCT02750514|158426062|FG002|Track 2|Study drug toxicity|0|||
49160152|NCT02750514|158426063|FG003|Track 2|Study drug toxicity|2|||
49160153|NCT02750514|158426064|FG004|Track 2|Study drug toxicity|0|||
49160154|NCT02750514|158426060|FG000|Track 2|Participant withdrew consent|0|||
49160155|NCT02750514|158426061|FG001|Track 2|Participant withdrew consent|1|||
49160156|NCT02750514|158426062|FG002|Track 2|Participant withdrew consent|0|||
49160157|NCT02750514|158426063|FG003|Track 2|Participant withdrew consent|0|||
49160158|NCT02750514|158426064|FG004|Track 2|Participant withdrew consent|0|||
49160159|NCT02750514|158426060|FG000|Track 3|Disease progression|0|||
49160160|NCT02750514|158426061|FG001|Track 3|Disease progression|24|||
49160161|NCT02750514|158426062|FG002|Track 3|Disease progression|13|||
49160162|NCT02750514|158426063|FG003|Track 3|Disease progression|14|||
49160163|NCT02750514|158426064|FG004|Track 3|Disease progression|0|||
49160164|NCT02750514|158426060|FG000|Track 3|Adverse event unrelated to study drug|0|||
49160165|NCT02750514|158426061|FG001|Track 3|Adverse event unrelated to study drug|1|||
49160166|NCT02750514|158426062|FG002|Track 3|Adverse event unrelated to study drug|1|||
49160167|NCT02750514|158426063|FG003|Track 3|Adverse event unrelated to study drug|1|||
49160168|NCT02750514|158426064|FG004|Track 3|Adverse event unrelated to study drug|0|||
49160169|NCT02750514|158426060|FG000|Track 3|Study drug toxicity|0|||
49160170|NCT02750514|158426061|FG001|Track 3|Study drug toxicity|3|||
49160171|NCT02750514|158426062|FG002|Track 3|Study drug toxicity|0|||
49160172|NCT02750514|158426063|FG003|Track 3|Study drug toxicity|1|||
49160173|NCT02750514|158426064|FG004|Track 3|Study drug toxicity|0|||
49160174|NCT02750514|158426060|FG000|Track 3|Participant request to discontinue|0|||
49160175|NCT02750514|158426061|FG001|Track 3|Participant request to discontinue|2|||
49160176|NCT02750514|158426062|FG002|Track 3|Participant request to discontinue|0|||
49160177|NCT02750514|158426063|FG003|Track 3|Participant request to discontinue|0|||
49160178|NCT02750514|158426064|FG004|Track 3|Participant request to discontinue|0|||
49160179|NCT02750514|158426060|FG000|Track 3|Participant withdrew consent|0|||
49160180|NCT02750514|158426061|FG001|Track 3|Participant withdrew consent|3|||
49160181|NCT02750514|158426062|FG002|Track 3|Participant withdrew consent|1|||
49160182|NCT02750514|158426063|FG003|Track 3|Participant withdrew consent|0|||
49160183|NCT02750514|158426064|FG004|Track 3|Participant withdrew consent|0|||
49160184|NCT02750514|158426060|FG000|Track 3|Other reasons|0|||
48834012|NCT01281813|157234133|FG002|Overall Study|Switched to Commercially Available Medication|26|||
48834013|NCT01281813|157234131|FG000|Overall Study|Other|0|||
48834014|NCT01281813|157234132|FG001|Overall Study|Other|1|||
48834015|NCT01281813|157234133|FG002|Overall Study|Other|39|||
48834016|NCT00970307|157234134|FG000|Overall Study|Serious Adverse Event|1|||
48834017|NCT00970307|157234135|FG001|Overall Study|Serious Adverse Event|0|||
48834018|NCT00970307|157234136|FG002|Overall Study|Serious Adverse Event|0|||
48834019|NCT00970307|157234134|FG000|Overall Study|Withdrawal by Subject|2|||
49160185|NCT02750514|158426061|FG001|Track 3|Other reasons|3|||
49160186|NCT02750514|158426062|FG002|Track 3|Other reasons|0|||
49160187|NCT02750514|158426063|FG003|Track 3|Other reasons|0|||
49160188|NCT02750514|158426064|FG004|Track 3|Other reasons|0|||
48834020|NCT00970307|157234135|FG001|Overall Study|Withdrawal by Subject|3|||
49160189|NCT02750514|158426060|FG000|Track 4|Study drug toxicity|0|||
49160190|NCT02750514|158426061|FG001|Track 4|Study drug toxicity|6|||
48834021|NCT00970307|157234136|FG002|Overall Study|Withdrawal by Subject|2|||
49160191|NCT02750514|158426062|FG002|Track 4|Study drug toxicity|0|||
49160192|NCT02750514|158426063|FG003|Track 4|Study drug toxicity|5|||
49160193|NCT02750514|158426064|FG004|Track 4|Study drug toxicity|0|||
49160194|NCT02750514|158426060|FG000|Track 4|Participant request to discontinue|0|||
49160195|NCT02750514|158426061|FG001|Track 4|Participant request to discontinue|1|||
49160196|NCT02750514|158426062|FG002|Track 4|Participant request to discontinue|0|||
49160197|NCT02750514|158426063|FG003|Track 4|Participant request to discontinue|1|||
49160198|NCT02750514|158426064|FG004|Track 4|Participant request to discontinue|0|||
49160199|NCT02750514|158426060|FG000|Track 4|Participant withdrew consent|0|||
49160200|NCT02750514|158426061|FG001|Track 4|Participant withdrew consent|1|||
49160201|NCT02750514|158426062|FG002|Track 4|Participant withdrew consent|0|||
49160202|NCT02750514|158426063|FG003|Track 4|Participant withdrew consent|0|||
49160203|NCT02750514|158426064|FG004|Track 4|Participant withdrew consent|0|||
49160204|NCT02750514|158426060|FG000|Track 4|Other reasons|0|||
49160205|NCT02750514|158426061|FG001|Track 4|Other reasons|5|||
49160206|NCT02750514|158426062|FG002|Track 4|Other reasons|0|||
49160207|NCT02750514|158426063|FG003|Track 4|Other reasons|3|||
49160208|NCT02750514|158426064|FG004|Track 4|Other reasons|0|||
49160209|NCT02750514|158426060|FG000|Track 4|Disease progression|0|||
49160210|NCT02750514|158426061|FG001|Track 4|Disease progression|33|||
49160211|NCT02750514|158426062|FG002|Track 4|Disease progression|0|||
49160212|NCT02750514|158426063|FG003|Track 4|Disease progression|32|||
49160213|NCT02750514|158426064|FG004|Track 4|Disease progression|0|||
49160214|NCT02750514|158426060|FG000|Track 4|Adverse event unrelated to study drug|0|||
49160215|NCT02750514|158426061|FG001|Track 4|Adverse event unrelated to study drug|5|||
49160216|NCT02750514|158426062|FG002|Track 4|Adverse event unrelated to study drug|0|||
49160217|NCT02750514|158426063|FG003|Track 4|Adverse event unrelated to study drug|0|||
49160218|NCT02750514|158426064|FG004|Track 4|Adverse event unrelated to study drug|0|||
49160219|NCT02750514|158426060|FG000|Track 4|Death|0|||
49160220|NCT02750514|158426061|FG001|Track 4|Death|0|||
49160221|NCT02750514|158426062|FG002|Track 4|Death|0|||
49160222|NCT02750514|158426063|FG003|Track 4|Death|1|||
49160223|NCT02750514|158426064|FG004|Track 4|Death|0|||
49160224|NCT02750514|158426060|FG000|Track 5|Disease progression|0|||
49160225|NCT02750514|158426061|FG001|Track 5|Disease progression|0|||
49160226|NCT02750514|158426062|FG002|Track 5|Disease progression|0|||
49160227|NCT02750514|158426063|FG003|Track 5|Disease progression|0|||
49160228|NCT02750514|158426064|FG004|Track 5|Disease progression|34|||
49160229|NCT02750514|158426060|FG000|Track 5|Adverse event unrelated to study drug|0|||
49160230|NCT02750514|158426061|FG001|Track 5|Adverse event unrelated to study drug|0|||
49160231|NCT02750514|158426062|FG002|Track 5|Adverse event unrelated to study drug|0|||
49160232|NCT02750514|158426063|FG003|Track 5|Adverse event unrelated to study drug|0|||
49160233|NCT02750514|158426064|FG004|Track 5|Adverse event unrelated to study drug|2|||
49160234|NCT02750514|158426060|FG000|Track 5|Study drug toxicity|0|||
49160235|NCT02750514|158426061|FG001|Track 5|Study drug toxicity|0|||
49160236|NCT02750514|158426062|FG002|Track 5|Study drug toxicity|0|||
49160237|NCT02750514|158426063|FG003|Track 5|Study drug toxicity|0|||
49160238|NCT02750514|158426064|FG004|Track 5|Study drug toxicity|2|||
49160239|NCT02750514|158426060|FG000|Track 5|Participant request to discontinue|0|||
49160240|NCT02750514|158426061|FG001|Track 5|Participant request to discontinue|0|||
49160241|NCT02750514|158426062|FG002|Track 5|Participant request to discontinue|0|||
49160242|NCT02750514|158426063|FG003|Track 5|Participant request to discontinue|0|||
49160243|NCT02750514|158426064|FG004|Track 5|Participant request to discontinue|3|||
49160244|NCT02750514|158426060|FG000|Track 5|Other reasons|0|||
49160245|NCT02750514|158426061|FG001|Track 5|Other reasons|0|||
49160246|NCT02750514|158426062|FG002|Track 5|Other reasons|0|||
48735601|NCT02345226|156883692|FG001|Double-Blind Phase|Adverse Event|6|||
48735602|NCT02345226|156883691|FG000|Double-Blind Phase|Death|3|||
48735603|NCT02345226|156883692|FG001|Double-Blind Phase|Death|0|||
48735604|NCT02345226|156883691|FG000|Double-Blind Phase|Pregnancy|0|||
48735605|NCT02345226|156883692|FG001|Double-Blind Phase|Pregnancy|1|||
48735606|NCT02345226|156883691|FG000|Double-Blind Phase|Lack of Efficacy|1|||
48735607|NCT02345226|156883692|FG001|Double-Blind Phase|Lack of Efficacy|0|||
48735608|NCT02345226|156883691|FG000|Double-Blind Phase|Investigator's Discretion|4|||
48735609|NCT02345226|156883692|FG001|Double-Blind Phase|Investigator's Discretion|3|||
48735610|NCT02345226|156883691|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
48735611|NCT02345226|156883692|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
48735612|NCT02345226|156883691|FG000|Double-Blind Phase|Withdrew Consent|41|||
48735613|NCT02345226|156883692|FG001|Double-Blind Phase|Withdrew Consent|39|||
48735614|NCT02345226|156883691|FG000|Double-Blind Phase|Lost to Follow-up|12|||
48735615|NCT02345226|156883692|FG001|Double-Blind Phase|Lost to Follow-up|16|||
48735616|NCT02345226|156883691|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
48735617|NCT02345226|156883692|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
48735618|NCT02345226|156883691|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
48735619|NCT02345226|156883692|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
48735620|NCT00304239|156883693|FG000|Overall Study|Protocol Deviations/Violations|15|||
48735621|NCT00304239|156883694|FG001|Overall Study|Protocol Deviations/Violations|0|||
48735622|NCT00304239|156883693|FG000|Overall Study|Adverse Event|2|||
48834022|NCT02614560|157234137|FG000|Overall Study|Death|6|||
48834023|NCT02614560|157234138|FG001|Overall Study|Death|2|||
48834024|NCT00558363|157234139|FG000|Overall Study|Physician Decision|18|||
48834025|NCT00558363|157234140|FG001|Overall Study|Physician Decision|4|||
48834026|NCT00558363|157234139|FG000|Overall Study|Withdrawal by Subject|11|||
48834027|NCT00558363|157234140|FG001|Overall Study|Withdrawal by Subject|4|||
48834028|NCT00558363|157234139|FG000|Overall Study|Adverse Event|5|||
48834029|NCT00558363|157234140|FG001|Overall Study|Adverse Event|5|||
48834030|NCT00558363|157234139|FG000|Overall Study|Lack of Efficacy|2|||
48834031|NCT00558363|157234140|FG001|Overall Study|Lack of Efficacy|2|||
48834032|NCT00558363|157234139|FG000|Overall Study|Protocol Violation|2|||
48834033|NCT00558363|157234140|FG001|Overall Study|Protocol Violation|1|||
48834034|NCT00558363|157234139|FG000|Overall Study|Lost to Follow-up|0|||
48834035|NCT00558363|157234140|FG001|Overall Study|Lost to Follow-up|1|||
48834036|NCT00558363|157234139|FG000|Overall Study|Met Protocol-defined Stopping Criteria|32|||
48834037|NCT00558363|157234140|FG001|Overall Study|Met Protocol-defined Stopping Criteria|16|||
48834038|NCT00558363|157234139|FG000|Overall Study|Randomized in Error|1|||
48834039|NCT00558363|157234140|FG001|Overall Study|Randomized in Error|2|||
48834040|NCT00558363|157234139|FG000|Overall Study|Hospitalized; Unable to Continue|0|||
48834041|NCT00558363|157234140|FG001|Overall Study|Hospitalized; Unable to Continue|1|||
48834042|NCT03102710|157234141|FG000|Overall Study|Dental metal affected MRI scan quality|1|||
48834043|NCT03102710|157234142|FG001|Overall Study|Dental metal affected MRI scan quality|0|||
48834044|NCT03102710|157234143|FG002|Overall Study|Dental metal affected MRI scan quality|0|||
48834045|NCT03102710|157234141|FG000|Overall Study|Technical issues during final MRI scan|0|||
48834046|NCT03102710|157234142|FG001|Overall Study|Technical issues during final MRI scan|1|||
48834047|NCT03102710|157234143|FG002|Overall Study|Technical issues during final MRI scan|0|||
48834048|NCT03102710|157234141|FG000|Overall Study|Nausea during MRI scan|0|||
48834049|NCT03102710|157234142|FG001|Overall Study|Nausea during MRI scan|1|||
48834050|NCT03102710|157234143|FG002|Overall Study|Nausea during MRI scan|0|||
49160247|NCT02750514|158426063|FG003|Track 5|Other reasons|0|||
49160248|NCT02750514|158426064|FG004|Track 5|Other reasons|2|||
49160249|NCT02553629|158426065|FG000|Overall Study|Logistic reasons|3|||
49160250|NCT02553629|158426066|FG001|Overall Study|Logistic reasons|6|||
49160251|NCT01812057|158426071|FG000|Overall Study|Protocol Violation|1|||
48834051|NCT03102710|157234141|FG000|Overall Study|Subject unable to attend final session|0|||
48834052|NCT03102710|157234142|FG001|Overall Study|Subject unable to attend final session|1|||
48834053|NCT03102710|157234143|FG002|Overall Study|Subject unable to attend final session|0|||
48834054|NCT02517307|157234144|FG000|Overall Study|Withdrawal by Subject|1|||
48834055|NCT02517307|157234145|FG001|Overall Study|Withdrawal by Subject|0|||
48834056|NCT02517307|157234146|FG002|Overall Study|Withdrawal by Subject|1|||
48923247|NCT01324232|157553188|FG001|Overall Study|Participant's Personal Reason/Decision|1|||
48923248|NCT01324232|157553189|FG002|Overall Study|Participant's Personal Reason/Decision|0|||
48923249|NCT01324232|157553190|FG003|Overall Study|Participant's Personal Reason/Decision|0|||
48923250|NCT01324232|157553187|FG000|Overall Study|Lack of Efficacy|2|||
48923251|NCT01324232|157553188|FG001|Overall Study|Lack of Efficacy|1|||
48923252|NCT01324232|157553189|FG002|Overall Study|Lack of Efficacy|2|||
48923253|NCT01324232|157553190|FG003|Overall Study|Lack of Efficacy|2|||
48923254|NCT01324232|157553187|FG000|Overall Study|Participant Refused Medication|0|||
48923255|NCT01324232|157553188|FG001|Overall Study|Participant Refused Medication|1|||
48923256|NCT01324232|157553189|FG002|Overall Study|Participant Refused Medication|0|||
48923257|NCT01324232|157553190|FG003|Overall Study|Participant Refused Medication|0|||
48923258|NCT01324232|157553187|FG000|Overall Study|Intercurrent illness|0|||
48923259|NCT01324232|157553188|FG001|Overall Study|Intercurrent illness|0|||
48923260|NCT01324232|157553189|FG002|Overall Study|Intercurrent illness|0|||
48923261|NCT01324232|157553190|FG003|Overall Study|Intercurrent illness|1|||
48923262|NCT01324232|157553187|FG000|Overall Study|Adverse Event|2|||
48923263|NCT01324232|157553188|FG001|Overall Study|Adverse Event|5|||
48923264|NCT01324232|157553189|FG002|Overall Study|Adverse Event|6|||
48923265|NCT01324232|157553190|FG003|Overall Study|Adverse Event|6|||
49160252|NCT01812057|158426072|FG001|Overall Study|Protocol Violation|0|||
49160253|NCT01812057|158426071|FG000|Overall Study|Physician Decision|1|||
49160254|NCT01812057|158426072|FG001|Overall Study|Physician Decision|0|||
49160255|NCT04577781|158426073|FG000|Overall Study|Adverse Event|2|||
49160256|NCT04577781|158426074|FG001|Overall Study|Adverse Event|2|||
48834057|NCT02517307|157234147|FG003|Overall Study|Withdrawal by Subject|0|||
48834058|NCT02517307|157234144|FG000|Overall Study|Protocol Violation|0|||
48834059|NCT02517307|157234145|FG001|Overall Study|Protocol Violation|0|||
48834060|NCT02517307|157234146|FG002|Overall Study|Protocol Violation|1|||
48834061|NCT02517307|157234147|FG003|Overall Study|Protocol Violation|1|||
48834062|NCT03058991|157234154|FG000|Overall Study|Lost to Follow-up|17|||
48834063|NCT03058991|157234155|FG001|Overall Study|Lost to Follow-up|12|||
48834064|NCT03058991|157234156|FG002|Overall Study|Lost to Follow-up|12|||
48834065|NCT03058991|157234154|FG000|Overall Study|Withdrawal by Subject|1|||
48923266|NCT01324232|157553187|FG000|Overall Study|Withdrawal by Subject|0|||
48923267|NCT01324232|157553188|FG001|Overall Study|Withdrawal by Subject|3|||
49160257|NCT04577781|158426073|FG000|Overall Study|Physician Decision|1|||
48834066|NCT03058991|157234155|FG001|Overall Study|Withdrawal by Subject|0|||
48834067|NCT03058991|157234156|FG002|Overall Study|Withdrawal by Subject|0|||
48834068|NCT00139737|157234157|FG000|Overall Study|Withdrawal by Subject|190|||
48834069|NCT00139737|157234157|FG000|Overall Study|Adverse Event|58|||
48834070|NCT00139737|157234157|FG000|Overall Study|Lack of Efficacy|40|||
48834071|NCT00139737|157234157|FG000|Overall Study|Lost to Follow-up|8|||
48834072|NCT00139737|157234157|FG000|Overall Study|Death|3|||
48834073|NCT00139737|157234157|FG000|Overall Study|Laboratory Abnormality|2|||
48834074|NCT00139737|157234157|FG000|Overall Study|Protocol Violation|18|||
48834075|NCT00139737|157234157|FG000|Overall Study|Withdrew During Screening Phase|8|||
48834076|NCT00139737|157234157|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
48834077|NCT00139737|157234157|FG000|Overall Study|Screened, Not Treated|13|||
48834078|NCT00758602|157234165|FG000|Overall Study|Adverse Event|11|||
48834079|NCT00758602|157234166|FG001|Overall Study|Adverse Event|10|||
48834080|NCT00758602|157234165|FG000|Overall Study|Lost to Follow-up|4|||
48834081|NCT00758602|157234166|FG001|Overall Study|Lost to Follow-up|3|||
48834082|NCT00758602|157234165|FG000|Overall Study|Withdrawal by Subject|1|||
48834083|NCT00758602|157234166|FG001|Overall Study|Withdrawal by Subject|3|||
48834084|NCT00758602|157234165|FG000|Overall Study|Protocol Violation|0|||
48834085|NCT00758602|157234166|FG001|Overall Study|Protocol Violation|2|||
48834086|NCT00758602|157234165|FG000|Overall Study|Death|0|||
48834087|NCT00758602|157234166|FG001|Overall Study|Death|1|||
48834088|NCT00758602|157234165|FG000|Overall Study|Reason not specified|3|||
48834089|NCT00758602|157234166|FG001|Overall Study|Reason not specified|3|||
48834090|NCT04379713|157234174|FG000|Overall Study|Adverse Event|2|||
48834091|NCT04379713|157234175|FG001|Overall Study|Adverse Event|0|||
48834092|NCT04379713|157234174|FG000|Overall Study|Physician Decision|2|||
48834093|NCT04379713|157234175|FG001|Overall Study|Physician Decision|1|||
48834094|NCT04379713|157234174|FG000|Overall Study|Protocol Violation|11|||
48834095|NCT04379713|157234175|FG001|Overall Study|Protocol Violation|6|||
48834096|NCT04379713|157234174|FG000|Overall Study|No longer met eligibility criteria|14|||
48834097|NCT04379713|157234175|FG001|Overall Study|No longer met eligibility criteria|11|||
48834098|NCT04379713|157234174|FG000|Overall Study|Withdrawal by parent/guardian|36|||
48834099|NCT04379713|157234175|FG001|Overall Study|Withdrawal by parent/guardian|15|||
48834100|NCT04379713|157234174|FG000|Overall Study|Lost to Follow-up|31|||
48834101|NCT04379713|157234175|FG001|Overall Study|Lost to Follow-up|21|||
48834102|NCT02148133|157234176|FG000|Overall Study|Investigator discretion|1|||
48834103|NCT02148133|157234176|FG000|Overall Study|Lack of Efficacy|1|||
48834104|NCT02148133|157234176|FG000|Overall Study|Protocol deviation|1|||
49160258|NCT04577781|158426074|FG001|Overall Study|Physician Decision|0|||
49160259|NCT01464879|158426081|FG000|Overall Study|Physician Decision|1|||
49160260|NCT01464879|158426081|FG000|Overall Study|Non-compliance|1|||
49160261|NCT01657305|158426082|FG000|Overall Study|Lack of Wound Closure at Day 28|15|||
49160262|NCT01657305|158426082|FG000|Overall Study|Withdrawal by Subject|4|||
49160263|NCT01657305|158426082|FG000|Overall Study|Adverse Event|1|||
49160264|NCT01657305|158426082|FG000|Overall Study|Lost to Follow-up|1|||
49160265|NCT01657305|158426082|FG000|Overall Study|Did not Adhere to Protocol/Procedures|4|||
49160266|NCT03937479|158426084|FG000|Overall Study|Adverse Event|2|||
49160267|NCT03937479|158426085|FG001|Overall Study|Adverse Event|3|||
49160268|NCT03937479|158426086|FG002|Overall Study|Adverse Event|0|||
48834105|NCT02148133|157234176|FG000|Overall Study|Protocol-defined stopping criteria|2|||
48834106|NCT03808883|157234177|FG000|Overall Study|Withdrawal by Subject|2|||
48834107|NCT03808883|157234178|FG001|Overall Study|Withdrawal by Subject|0|||
49160269|NCT03937479|158426087|FG003|Overall Study|Adverse Event|0|||
48834108|NCT03808883|157234177|FG000|Overall Study|Did not complete pre test or post test survey|4|||
48834109|NCT03808883|157234178|FG001|Overall Study|Did not complete pre test or post test survey|3|||
48834110|NCT04567888|157234185|FG000|Overall Study|Did Not Create Happify for Teens Account|22|||
48834111|NCT04567888|157234186|FG001|Overall Study|Did Not Create Happify for Teens Account|0|||
49160270|NCT03937479|158426088|FG004|Overall Study|Adverse Event|1|||
49160271|NCT03937479|158426084|FG000|Overall Study|Withdrawal by Subject|3|||
48834112|NCT04567888|157234185|FG000|Overall Study|Did Not Complete Any Happify for Teens Activities|22|||
48834113|NCT04567888|157234186|FG001|Overall Study|Did Not Complete Any Happify for Teens Activities|0|||
48834114|NCT04567888|157234185|FG000|Overall Study|Reported Unusual Birth Year|2|||
48834115|NCT04567888|157234186|FG001|Overall Study|Reported Unusual Birth Year|3|||
48834116|NCT04567888|157234185|FG000|Overall Study|Duplicate Responses|0|||
48834117|NCT04567888|157234186|FG001|Overall Study|Duplicate Responses|1|||
48834118|NCT00414648|157234187|FG000|Overall Study|Adverse Event|5|||
48834119|NCT00414648|157234188|FG001|Overall Study|Adverse Event|5|||
48834120|NCT00414648|157234187|FG000|Overall Study|Death|0|||
48834121|NCT00414648|157234188|FG001|Overall Study|Death|1|||
48834122|NCT00414648|157234187|FG000|Overall Study|Lack of Efficacy|0|||
48834123|NCT00414648|157234188|FG001|Overall Study|Lack of Efficacy|2|||
48834124|NCT00414648|157234187|FG000|Overall Study|Withdrawal by Subject|0|||
48834125|NCT00414648|157234188|FG001|Overall Study|Withdrawal by Subject|1|||
48834126|NCT00746330|157234190|FG000|Period 1|Abnormal test procedure result|0|||
48834127|NCT00746330|157234191|FG001|Period 1|Abnormal test procedure result|0|||
48834128|NCT00746330|157234192|FG002|Period 1|Abnormal test procedure result|1|||
48834129|NCT00746330|157234193|FG003|Period 1|Abnormal test procedure result|0|||
48834130|NCT00949975|157234194|FG000|Overall Study|Voluntary discontinuation|6|||
48834131|NCT00949975|157234195|FG001|Overall Study|Voluntary discontinuation|5|||
48834132|NCT00949975|157234196|FG002|Overall Study|Voluntary discontinuation|3|||
48834133|NCT00949975|157234197|FG003|Overall Study|Voluntary discontinuation|6|||
48834134|NCT00949975|157234194|FG000|Overall Study|Adverse Event|11|||
48834135|NCT00949975|157234195|FG001|Overall Study|Adverse Event|11|||
48834136|NCT00949975|157234196|FG002|Overall Study|Adverse Event|10|||
48834137|NCT00949975|157234197|FG003|Overall Study|Adverse Event|10|||
48834138|NCT00949975|157234194|FG000|Overall Study|Safety reason|0|||
48834139|NCT00949975|157234195|FG001|Overall Study|Safety reason|1|||
48834140|NCT00949975|157234196|FG002|Overall Study|Safety reason|0|||
48834141|NCT00949975|157234197|FG003|Overall Study|Safety reason|0|||
48834142|NCT00949975|157234194|FG000|Overall Study|Study-specific criteria|0|||
48834143|NCT00949975|157234195|FG001|Overall Study|Study-specific criteria|1|||
48834144|NCT00949975|157234196|FG002|Overall Study|Study-specific criteria|1|||
48834145|NCT00949975|157234197|FG003|Overall Study|Study-specific criteria|0|||
48834146|NCT00949975|157234194|FG000|Overall Study|Incorrect enrolment|5|||
48834147|NCT00949975|157234195|FG001|Overall Study|Incorrect enrolment|10|||
48834148|NCT00949975|157234196|FG002|Overall Study|Incorrect enrolment|4|||
48834149|NCT00949975|157234197|FG003|Overall Study|Incorrect enrolment|7|||
48834150|NCT00949975|157234194|FG000|Overall Study|Severe non-compliance|3|||
48834151|NCT00949975|157234195|FG001|Overall Study|Severe non-compliance|1|||
48834152|NCT00949975|157234196|FG002|Overall Study|Severe non-compliance|0|||
48834153|NCT00949975|157234197|FG003|Overall Study|Severe non-compliance|2|||
48834154|NCT00949975|157234194|FG000|Overall Study|Lost to Follow-up|1|||
48834155|NCT00949975|157234195|FG001|Overall Study|Lost to Follow-up|0|||
48834156|NCT00949975|157234196|FG002|Overall Study|Lost to Follow-up|1|||
48834157|NCT00949975|157234197|FG003|Overall Study|Lost to Follow-up|3|||
48834158|NCT00949975|157234194|FG000|Overall Study|Other|1|||
48834159|NCT00949975|157234195|FG001|Overall Study|Other|0|||
48834160|NCT00949975|157234196|FG002|Overall Study|Other|0|||
48834161|NCT00949975|157234197|FG003|Overall Study|Other|0|||
48834162|NCT02873754|157234198|FG000|Overall Study|Lost to Follow-up|5|||
48834163|NCT02873754|157234198|FG000|Overall Study|Couldn't complete study procedures|1|||
48834164|NCT00082810|157234199|FG000|Overall Study|Adverse Event|3|||
48834165|NCT00082810|157234199|FG000|Overall Study|Progressive disease|24|||
48834166|NCT00082810|157234199|FG000|Overall Study|Withdrawal by Subject|4|||
48834167|NCT00367055|157234200|FG000|Overall Study|Adverse Event|6|||
48834168|NCT00367055|157234201|FG001|Overall Study|Adverse Event|3|||
48834169|NCT00367055|157234200|FG000|Overall Study|Patient's Willing|3|||
49160272|NCT03937479|158426085|FG001|Overall Study|Withdrawal by Subject|5|||
49160273|NCT03937479|158426086|FG002|Overall Study|Withdrawal by Subject|2|||
49160274|NCT03937479|158426087|FG003|Overall Study|Withdrawal by Subject|2|||
48834170|NCT00367055|157234201|FG001|Overall Study|Patient's Willing|2|||
48834171|NCT00367055|157234200|FG000|Overall Study|Lack of Efficacy|1|||
48834172|NCT00367055|157234201|FG001|Overall Study|Lack of Efficacy|2|||
48834173|NCT00367055|157234200|FG000|Overall Study|Lost to Follow-up|1|||
48834174|NCT00367055|157234201|FG001|Overall Study|Lost to Follow-up|1|||
48834175|NCT00367055|157234200|FG000|Overall Study|Protocol Violation|0|||
48834176|NCT00367055|157234201|FG001|Overall Study|Protocol Violation|1|||
48834177|NCT00367055|157234200|FG000|Overall Study|Stopping Criterion Met|0|||
48834178|NCT00367055|157234201|FG001|Overall Study|Stopping Criterion Met|1|||
48834179|NCT00367055|157234200|FG000|Overall Study|Participant Living too Far from Hospital|0|||
48834180|NCT00367055|157234201|FG001|Overall Study|Participant Living too Far from Hospital|1|||
48834181|NCT01585558|157234202|FG000|Overall Study|Withdrawal by Subject|4|||
48834182|NCT01585558|157234203|FG001|Overall Study|Withdrawal by Subject|5|||
48834183|NCT01585558|157234204|FG002|Overall Study|Withdrawal by Subject|8|||
49160275|NCT03937479|158426088|FG004|Overall Study|Withdrawal by Subject|1|||
49160276|NCT03937479|158426084|FG000|Overall Study|Protocol Violation|5|||
48834184|NCT01585558|157234202|FG000|Overall Study|Lost to Follow-up|2|||
48834185|NCT01585558|157234203|FG001|Overall Study|Lost to Follow-up|0|||
48834186|NCT01585558|157234204|FG002|Overall Study|Lost to Follow-up|3|||
48834187|NCT01585558|157234202|FG000|Overall Study|Adverse Event|3|||
48834188|NCT01585558|157234203|FG001|Overall Study|Adverse Event|4|||
48834189|NCT01585558|157234204|FG002|Overall Study|Adverse Event|1|||
48834190|NCT01585558|157234202|FG000|Overall Study|Protocol Violation|4|||
48834191|NCT01585558|157234203|FG001|Overall Study|Protocol Violation|3|||
48834192|NCT01585558|157234204|FG002|Overall Study|Protocol Violation|2|||
48834193|NCT01585558|157234202|FG000|Overall Study|Lack of Efficacy|0|||
48834194|NCT01585558|157234203|FG001|Overall Study|Lack of Efficacy|0|||
49160277|NCT03937479|158426085|FG001|Overall Study|Protocol Violation|6|||
49160278|NCT03937479|158426086|FG002|Overall Study|Protocol Violation|4|||
48834195|NCT01585558|157234204|FG002|Overall Study|Lack of Efficacy|1|||
48834196|NCT02994654|157234205|FG000|Overall Study|Lost to Follow-up|1|||
48834197|NCT01123083|157234210|FG000|Overall Study|Investigator recommendation|1|||
48834198|NCT01123083|157234211|FG001|Overall Study|Investigator recommendation|1|||
48834199|NCT01123083|157234210|FG000|Overall Study|Administrative reasons|0|||
48834200|NCT01123083|157234211|FG001|Overall Study|Administrative reasons|4|||
48834201|NCT01123083|157234210|FG000|Overall Study|Lost to Follow-up|2|||
48834202|NCT01123083|157234211|FG001|Overall Study|Lost to Follow-up|6|||
48834203|NCT01123083|157234210|FG000|Overall Study|Adverse Event|1|||
48834204|NCT01123083|157234211|FG001|Overall Study|Adverse Event|0|||
48834205|NCT01123083|157234210|FG000|Overall Study|Withdrew for another reason not covered|0|||
48834206|NCT01123083|157234211|FG001|Overall Study|Withdrew for another reason not covered|1|||
48834207|NCT01123083|157234210|FG000|Overall Study|Participant/legal representative request|7|||
48834208|NCT01123083|157234211|FG001|Overall Study|Participant/legal representative request|3|||
48834209|NCT02674750|157234214|FG000|Overall Study|Death|4|||
48834210|NCT02674750|157234215|FG001|Overall Study|Death|5|||
48834211|NCT02674750|157234216|FG002|Overall Study|Death|8|||
48834212|NCT02674750|157234214|FG000|Overall Study|Lost to Follow-up|0|||
48834213|NCT02674750|157234215|FG001|Overall Study|Lost to Follow-up|8|||
48834214|NCT02674750|157234216|FG002|Overall Study|Lost to Follow-up|0|||
48834215|NCT02674750|157234214|FG000|Overall Study|Lack of Efficacy|1|||
48834216|NCT02674750|157234215|FG001|Overall Study|Lack of Efficacy|17|||
48834217|NCT02674750|157234216|FG002|Overall Study|Lack of Efficacy|3|||
48834218|NCT02674750|157234214|FG000|Overall Study|Withdrawal by Subject|0|||
48834219|NCT02674750|157234215|FG001|Overall Study|Withdrawal by Subject|7|||
48834220|NCT02674750|157234216|FG002|Overall Study|Withdrawal by Subject|1|||
48834221|NCT02674750|157234214|FG000|Overall Study|Other|0|||
48834222|NCT02674750|157234215|FG001|Overall Study|Other|8|||
48834223|NCT02674750|157234216|FG002|Overall Study|Other|0|||
48834224|NCT01063517|157234219|FG000|Overall Study|Consent withdrawal|1|||
48834225|NCT01063517|157234220|FG001|Overall Study|Consent withdrawal|0|||
48834226|NCT01063517|157234219|FG000|Overall Study|Study reached data cut-off|19|||
49160279|NCT03937479|158426087|FG003|Overall Study|Protocol Violation|3|||
49160280|NCT03937479|158426088|FG004|Overall Study|Protocol Violation|2|||
49160281|NCT03937479|158426084|FG000|Overall Study|Lost to Follow-up|0|||
49160282|NCT03937479|158426085|FG001|Overall Study|Lost to Follow-up|1|||
49160283|NCT03937479|158426086|FG002|Overall Study|Lost to Follow-up|0|||
49160284|NCT03937479|158426087|FG003|Overall Study|Lost to Follow-up|1|||
49160285|NCT03937479|158426088|FG004|Overall Study|Lost to Follow-up|0|||
49160286|NCT03937479|158426084|FG000|Overall Study|Physician Decision|0|||
49160287|NCT03937479|158426085|FG001|Overall Study|Physician Decision|0|||
49160288|NCT03937479|158426086|FG002|Overall Study|Physician Decision|1|||
49160289|NCT03937479|158426087|FG003|Overall Study|Physician Decision|0|||
49160290|NCT03937479|158426088|FG004|Overall Study|Physician Decision|1|||
49160291|NCT01880957|158426089|FG000|Overall Study|Diagnosis: Unipolar Depression|12|||
49160292|NCT01880957|158426090|FG001|Overall Study|Diagnosis: Unipolar Depression|0|||
49160293|NCT01880957|158426089|FG000|Overall Study|Lost to Follow-up|11|||
49160294|NCT01880957|158426090|FG001|Overall Study|Lost to Follow-up|0|||
49160295|NCT01880957|158426089|FG000|Overall Study|Poor Tolerance to Lithium/Declined Treatment|5|||
49160296|NCT01880957|158426090|FG001|Overall Study|Poor Tolerance to Lithium/Declined Treatment|0|||
49160297|NCT01957865|158426091|FG000|Overall Study|Found HIV negative|0|||
49160298|NCT01957865|158426092|FG001|Overall Study|Found HIV negative|0|||
49160299|NCT01957865|158426093|FG002|Overall Study|Found HIV negative|1|||
49160300|NCT01957865|158426091|FG000|Overall Study|Lost to Follow-up|0|||
49160301|NCT01957865|158426092|FG001|Overall Study|Lost to Follow-up|2|||
49160302|NCT01957865|158426093|FG002|Overall Study|Lost to Follow-up|2|||
48834227|NCT01063517|157234220|FG001|Overall Study|Study reached data cut-off|7|||
48834228|NCT01063517|157234219|FG000|Overall Study|Lost to Follow-up|4|||
48834229|NCT01063517|157234220|FG001|Overall Study|Lost to Follow-up|3|||
48834230|NCT01063517|157234219|FG000|Overall Study|Withdrawal by Subject|1|||
49160303|NCT03559270|158426094|FG000|Overall Study|Adverse Event|6|||
49160304|NCT03559270|158426095|FG001|Overall Study|Adverse Event|5|||
49160305|NCT03559270|158426096|FG002|Overall Study|Adverse Event|3|||
49160306|NCT03559270|158426097|FG003|Overall Study|Adverse Event|0|||
49160307|NCT03559270|158426094|FG000|Overall Study|Lack of Efficacy|34|||
48834231|NCT01063517|157234220|FG001|Overall Study|Withdrawal by Subject|2|||
48834232|NCT01063517|157234219|FG000|Overall Study|Death|33|||
49160308|NCT03559270|158426095|FG001|Overall Study|Lack of Efficacy|52|||
49160309|NCT03559270|158426096|FG002|Overall Study|Lack of Efficacy|37|||
49160310|NCT03559270|158426097|FG003|Overall Study|Lack of Efficacy|2|||
49160311|NCT03559270|158426094|FG000|Overall Study|Death|0|||
49160312|NCT03559270|158426095|FG001|Overall Study|Death|2|||
49160313|NCT03559270|158426096|FG002|Overall Study|Death|0|||
49160314|NCT03559270|158426097|FG003|Overall Study|Death|0|||
49160315|NCT03559270|158426094|FG000|Overall Study|Lost to Follow-up|16|||
49160316|NCT03559270|158426095|FG001|Overall Study|Lost to Follow-up|4|||
49160317|NCT03559270|158426096|FG002|Overall Study|Lost to Follow-up|12|||
49160318|NCT03559270|158426097|FG003|Overall Study|Lost to Follow-up|3|||
49160319|NCT03559270|158426094|FG000|Overall Study|Sponsor Decision|38|||
49160320|NCT03559270|158426095|FG001|Overall Study|Sponsor Decision|31|||
49160321|NCT03559270|158426096|FG002|Overall Study|Sponsor Decision|35|||
49160322|NCT03559270|158426097|FG003|Overall Study|Sponsor Decision|18|||
48834233|NCT01063517|157234220|FG001|Overall Study|Death|48|||
48834234|NCT01239316|157234221|FG000|Overall Study|Progression/Relapse|11|||
48834235|NCT01239316|157234221|FG000|Overall Study|Adverse Event|1|||
48834236|NCT02106442|157234222|FG000|Overall Study|Case Report Forms Uncollected|7|||
48834237|NCT02106442|157234222|FG000|Overall Study|Protocol Deviation|30|||
48834238|NCT01331824|157235665|FG000|Overall Study|Adverse Event|2|||
49160323|NCT03559270|158426094|FG000|Overall Study|Withdrawal by Subject|19|||
49160324|NCT03559270|158426095|FG001|Overall Study|Withdrawal by Subject|21|||
49160325|NCT03559270|158426096|FG002|Overall Study|Withdrawal by Subject|18|||
49160326|NCT03559270|158426097|FG003|Overall Study|Withdrawal by Subject|7|||
49160327|NCT03559270|158426094|FG000|Overall Study|Physician Decision|3|||
49160328|NCT03559270|158426095|FG001|Overall Study|Physician Decision|2|||
49160329|NCT03559270|158426096|FG002|Overall Study|Physician Decision|1|||
49160330|NCT03559270|158426097|FG003|Overall Study|Physician Decision|0|||
48834239|NCT01331824|157235665|FG000|Overall Study|Death|1|||
48834240|NCT01331824|157235665|FG000|Overall Study|Disease Progression|9|||
48834241|NCT01331824|157235665|FG000|Overall Study|Withdrawal by Subject|1|||
48834242|NCT01393119|157235666|FG000|Overall Study|Adverse Event|1|||
49160331|NCT03559270|158426094|FG000|Overall Study|Pregnancy|0|||
49160332|NCT03559270|158426095|FG001|Overall Study|Pregnancy|1|||
49160333|NCT03559270|158426096|FG002|Overall Study|Pregnancy|0|||
49160334|NCT03559270|158426097|FG003|Overall Study|Pregnancy|0|||
49160335|NCT03559270|158426094|FG000|Overall Study|Protocol Violation|1|||
49160336|NCT03559270|158426095|FG001|Overall Study|Protocol Violation|0|||
49160337|NCT03559270|158426096|FG002|Overall Study|Protocol Violation|2|||
49160338|NCT03559270|158426097|FG003|Overall Study|Protocol Violation|0|||
49160339|NCT02803203|158427339|FG000|Overall Study|Adverse Event|4|||
49160340|NCT02803203|158427339|FG000|Overall Study|Death|4|||
49160341|NCT02803203|158427339|FG000|Overall Study|Progressive disease|29|||
49160342|NCT02803203|158427339|FG000|Overall Study|Withdrawal by Subject|8|||
49160343|NCT02803203|158427339|FG000|Overall Study|Complete resection of target disease|2|||
49160344|NCT02803203|158427339|FG000|Overall Study|Switched to commercial Osi|1|||
49160345|NCT02803203|158427339|FG000|Overall Study|Participant moved away|1|||
49160346|NCT00696878|158427342|FG000|Overall Study|Adverse Event|8|||
49160347|NCT00696878|158427342|FG000|Overall Study|Withdrawal by Subject|87|||
49160348|NCT00696878|158427342|FG000|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18|||
49160349|NCT00696878|158427342|FG000|Overall Study|Pregnant prior to Treat Cycle 3|304|||
49160350|NCT00696878|158427342|FG000|Overall Study|Trial stopped|32|||
49160351|NCT00696878|158427342|FG000|Overall Study|Other reason (not specified)|55|||
49160352|NCT01276106|158427343|FG000|Overall Study|Adverse Event|3|||
49160353|NCT01276106|158427344|FG001|Overall Study|Adverse Event|3|||
49160354|NCT01276106|158427345|FG002|Overall Study|Adverse Event|11|||
49160355|NCT01276106|158427346|FG003|Overall Study|Adverse Event|3|||
48834243|NCT01393119|157235667|FG001|Overall Study|Adverse Event|1|||
48834244|NCT01393119|157235668|FG002|Overall Study|Adverse Event|0|||
48834245|NCT01393119|157235669|FG003|Overall Study|Adverse Event|1|||
49014590|NCT04634409|157888943|FG020|Overall Study|Death|0|||
49160356|NCT01276106|158427343|FG000|Overall Study|Withdrawal by Subject|6|||
49160357|NCT01276106|158427344|FG001|Overall Study|Withdrawal by Subject|3|||
49160358|NCT01276106|158427345|FG002|Overall Study|Withdrawal by Subject|1|||
49160359|NCT01276106|158427346|FG003|Overall Study|Withdrawal by Subject|6|||
49160360|NCT01276106|158427343|FG000|Overall Study|Lack of Efficacy|0|||
49160361|NCT01276106|158427344|FG001|Overall Study|Lack of Efficacy|1|||
48834246|NCT01393119|157235666|FG000|Overall Study|Withdrawal by Subject|0|||
48834247|NCT01393119|157235667|FG001|Overall Study|Withdrawal by Subject|1|||
48834248|NCT01393119|157235668|FG002|Overall Study|Withdrawal by Subject|1|||
48834249|NCT01393119|157235669|FG003|Overall Study|Withdrawal by Subject|0|||
48834250|NCT01393119|157235666|FG000|Overall Study|Lack of Efficacy|1|||
48834251|NCT01393119|157235667|FG001|Overall Study|Lack of Efficacy|0|||
48834252|NCT01393119|157235668|FG002|Overall Study|Lack of Efficacy|2|||
48834253|NCT01393119|157235669|FG003|Overall Study|Lack of Efficacy|1|||
48834254|NCT01393119|157235666|FG000|Overall Study|Protocol Violation|0|||
48834255|NCT01393119|157235667|FG001|Overall Study|Protocol Violation|0|||
48834256|NCT01393119|157235668|FG002|Overall Study|Protocol Violation|1|||
48834257|NCT01393119|157235669|FG003|Overall Study|Protocol Violation|0|||
48834258|NCT01393119|157235666|FG000|Overall Study|Death|0|||
48834259|NCT01393119|157235667|FG001|Overall Study|Death|0|||
48834260|NCT01393119|157235668|FG002|Overall Study|Death|0|||
48834261|NCT01393119|157235669|FG003|Overall Study|Death|1|||
49160362|NCT01276106|158427345|FG002|Overall Study|Lack of Efficacy|0|||
49160363|NCT01276106|158427346|FG003|Overall Study|Lack of Efficacy|1|||
49160364|NCT01276106|158427343|FG000|Overall Study|Lost to Follow-up|2|||
49160365|NCT01276106|158427344|FG001|Overall Study|Lost to Follow-up|1|||
49160366|NCT01276106|158427345|FG002|Overall Study|Lost to Follow-up|1|||
49160367|NCT01276106|158427346|FG003|Overall Study|Lost to Follow-up|0|||
49160368|NCT01276106|158427343|FG000|Overall Study|Physician Decision|0|||
49160369|NCT01276106|158427344|FG001|Overall Study|Physician Decision|0|||
49160370|NCT01276106|158427345|FG002|Overall Study|Physician Decision|1|||
49160371|NCT01276106|158427346|FG003|Overall Study|Physician Decision|1|||
49160372|NCT01276106|158427343|FG000|Overall Study|Protocol Violation|1|||
49160373|NCT01276106|158427344|FG001|Overall Study|Protocol Violation|1|||
49160374|NCT01276106|158427345|FG002|Overall Study|Protocol Violation|0|||
49160375|NCT01276106|158427346|FG003|Overall Study|Protocol Violation|2|||
49160376|NCT01276106|158427343|FG000|Overall Study|Insufficient therapeutic effects|0|||
49160377|NCT01276106|158427344|FG001|Overall Study|Insufficient therapeutic effects|0|||
49160378|NCT01276106|158427345|FG002|Overall Study|Insufficient therapeutic effects|2|||
49160379|NCT01276106|158427346|FG003|Overall Study|Insufficient therapeutic effects|0|||
49160380|NCT04716894|158427347|FG000|Period 2: Itraconazole Alone|Not treated: positive alcohol test|1|||
49160381|NCT04716894|158427347|FG000|Period 2: Itraconazole Alone|COVID-19 related reason|1|||
49160382|NCT00846846|158427349|FG000|Overall Study|Death|56|||
49160383|NCT00846846|158427349|FG000|Overall Study|Withdrawal by Subject|19|||
49160384|NCT02850978|158427350|FG000|Overall Study|Uncollectable CRF|27|||
49160385|NCT02850978|158427350|FG000|Overall Study|No visit since the first visit|35|||
49160386|NCT02850978|158427350|FG000|Overall Study|Adverse Event|81|||
49160387|NCT02850978|158427350|FG000|Overall Study|Lack of Efficacy|40|||
49160388|NCT02850978|158427350|FG000|Overall Study|Improvement in condition|34|||
49160389|NCT02850978|158427350|FG000|Overall Study|Lost to Follow-up|121|||
49160390|NCT02850978|158427350|FG000|Overall Study|Reason not listed|88|||
49160391|NCT00881894|158427351|FG000|Overall Study|Consent withdrawn|0|||
49160392|NCT00881894|158427352|FG001|Overall Study|Consent withdrawn|1|||
49160393|NCT00881894|158427351|FG000|Overall Study|Other reasons for premature termination|1|||
49160394|NCT00881894|158427352|FG001|Overall Study|Other reasons for premature termination|2|||
49160395|NCT03289533|158427353|FG000|Overall Study|Death|12|||
49160396|NCT03289533|158427353|FG000|Overall Study|Terminated from study by sponsor|10|||
49160397|NCT01030822|158427354|FG000|Overall Study|Moved/migrated from study area|6|||
49160398|NCT01030822|158427355|FG001|Overall Study|Moved/migrated from study area|7|||
49160399|NCT01030822|158427356|FG002|Overall Study|Moved/migrated from study area|3|||
49160400|NCT01030822|158427354|FG000|Overall Study|Withdrawal by Subject|16|||
49160401|NCT01030822|158427355|FG001|Overall Study|Withdrawal by Subject|13|||
49160402|NCT01030822|158427356|FG002|Overall Study|Withdrawal by Subject|16|||
49160403|NCT01030822|158427354|FG000|Overall Study|Lost to Follow-up|9|||
49160404|NCT01030822|158427355|FG001|Overall Study|Lost to Follow-up|4|||
49160405|NCT01030822|158427356|FG002|Overall Study|Lost to Follow-up|7|||
49160406|NCT02765399|158427357|FG000|Overall Study|Nausea|1|||
49160407|NCT02765399|158427358|FG001|Overall Study|Nausea|0|||
49160408|NCT00363311|158427359|FG000|Overall Study|Adverse Event|6|||
49160409|NCT00363311|158427360|FG001|Overall Study|Adverse Event|4|||
49160410|NCT00363311|158427359|FG000|Overall Study|Lost to Follow-up|3|||
49160411|NCT00363311|158427360|FG001|Overall Study|Lost to Follow-up|0|||
49160412|NCT00363311|158427359|FG000|Overall Study|Protocol Violation|1|||
49160413|NCT00363311|158427360|FG001|Overall Study|Protocol Violation|2|||
49160414|NCT00363311|158427359|FG000|Overall Study|Withdrawal by Subject|12|||
49160415|NCT00363311|158427360|FG001|Overall Study|Withdrawal by Subject|6|||
49160416|NCT00363311|158427359|FG000|Overall Study|Physician Decision|1|||
49160417|NCT00363311|158427360|FG001|Overall Study|Physician Decision|1|||
49160418|NCT00363311|158427359|FG000|Overall Study|Sponsor Terminated Study|2|||
49160419|NCT00363311|158427360|FG001|Overall Study|Sponsor Terminated Study|2|||
49160420|NCT00363311|158427359|FG000|Overall Study|Disease Progression|46|||
48834262|NCT01393119|157235666|FG000|Overall Study|Randomized but Not treated|1|||
48834263|NCT01393119|157235667|FG001|Overall Study|Randomized but Not treated|0|||
48834264|NCT01393119|157235668|FG002|Overall Study|Randomized but Not treated|1|||
48834265|NCT01393119|157235669|FG003|Overall Study|Randomized but Not treated|1|||
48834266|NCT01393119|157235666|FG000|Overall Study|Sponsor Termination of Study|11|||
48834267|NCT01393119|157235667|FG001|Overall Study|Sponsor Termination of Study|12|||
48834268|NCT01393119|157235668|FG002|Overall Study|Sponsor Termination of Study|9|||
48834269|NCT01393119|157235669|FG003|Overall Study|Sponsor Termination of Study|12|||
48834270|NCT00817635|157235670|FG000|Overall Study|Adverse Event|1|||
48834271|NCT00817635|157235671|FG001|Overall Study|Adverse Event|0|||
48834272|NCT00817635|157235672|FG002|Overall Study|Adverse Event|0|||
48834273|NCT00817635|157235673|FG003|Overall Study|Adverse Event|1|||
48834274|NCT00817635|157235674|FG004|Overall Study|Adverse Event|1|||
48834275|NCT00817635|157235670|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
48834276|NCT00817635|157235671|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
48834277|NCT00817635|157235672|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
48834278|NCT00817635|157235673|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
48834279|NCT00817635|157235674|FG004|Overall Study|Abnormal Laboratory Value(s)|1|||
48834280|NCT00817635|157235670|FG000|Overall Study|Withdrawal by Subject|2|||
48834281|NCT00817635|157235671|FG001|Overall Study|Withdrawal by Subject|1|||
48834282|NCT00817635|157235672|FG002|Overall Study|Withdrawal by Subject|0|||
48834283|NCT00817635|157235673|FG003|Overall Study|Withdrawal by Subject|1|||
48834284|NCT00817635|157235674|FG004|Overall Study|Withdrawal by Subject|2|||
48834285|NCT00817635|157235670|FG000|Overall Study|Lost to Follow-up|0|||
48834286|NCT00817635|157235671|FG001|Overall Study|Lost to Follow-up|1|||
48834287|NCT00817635|157235672|FG002|Overall Study|Lost to Follow-up|0|||
48834288|NCT00817635|157235673|FG003|Overall Study|Lost to Follow-up|1|||
48834289|NCT00817635|157235674|FG004|Overall Study|Lost to Follow-up|0|||
48834290|NCT00817635|157235670|FG000|Overall Study|Administrative Problems|0|||
48834291|NCT00817635|157235671|FG001|Overall Study|Administrative Problems|0|||
49160421|NCT00363311|158427360|FG001|Overall Study|Disease Progression|26|||
49160422|NCT00363311|158427359|FG000|Overall Study|Non-Compliance|1|||
49160423|NCT00363311|158427360|FG001|Overall Study|Non-Compliance|1|||
49160424|NCT00363311|158427359|FG000|Overall Study|Participant Refused Biopsy|1|||
49160425|NCT00363311|158427360|FG001|Overall Study|Participant Refused Biopsy|0|||
49160426|NCT00363311|158427359|FG000|Overall Study|Prostate Volume/PSA Doubled|1|||
49160427|NCT00363311|158427360|FG001|Overall Study|Prostate Volume/PSA Doubled|0|||
49160428|NCT00363311|158427359|FG000|Overall Study|Participant Opted for Treatment|1|||
49160429|NCT00363311|158427360|FG001|Overall Study|Participant Opted for Treatment|0|||
49160430|NCT00363311|158427359|FG000|Overall Study|Participant Moved to Another Country|1|||
49160431|NCT00363311|158427360|FG001|Overall Study|Participant Moved to Another Country|0|||
49160432|NCT00363311|158427359|FG000|Overall Study|Participant Withdrew Waiting for Surgery|0|||
49160433|NCT00363311|158427360|FG001|Overall Study|Participant Withdrew Waiting for Surgery|1|||
49160434|NCT00363311|158427359|FG000|Overall Study|Withdrawn per Instructions of Monitor|0|||
48834292|NCT00817635|157235672|FG002|Overall Study|Administrative Problems|0|||
48834293|NCT00817635|157235673|FG003|Overall Study|Administrative Problems|0|||
48834294|NCT00817635|157235674|FG004|Overall Study|Administrative Problems|1|||
48834295|NCT00817635|157235670|FG000|Overall Study|Protocol Violation|5|||
49014591|NCT04634409|157888944|FG021|Overall Study|Death|0|||
49014592|NCT04634409|157888945|FG022|Overall Study|Death|0|||
49160435|NCT00363311|158427360|FG001|Overall Study|Withdrawn per Instructions of Monitor|1|||
49160436|NCT00363311|158427359|FG000|Overall Study|Participant Moved to Louisiana|0|||
48834296|NCT00817635|157235671|FG001|Overall Study|Protocol Violation|1|||
48834297|NCT00817635|157235672|FG002|Overall Study|Protocol Violation|3|||
48834298|NCT00817635|157235673|FG003|Overall Study|Protocol Violation|2|||
48834299|NCT00817635|157235674|FG004|Overall Study|Protocol Violation|3|||
48834300|NCT01131494|157235676|FG000|Overall Study|Withdrawal by Subject|2|||
48834301|NCT02385669|157235678|FG000|Overall Study|Adverse Event|2|||
48834302|NCT02082158|157235679|FG000|Overall Study|Withdrawal by Subject|0|||
48834303|NCT02082158|157235680|FG001|Overall Study|Withdrawal by Subject|0|||
48834304|NCT02082158|157235681|FG002|Overall Study|Withdrawal by Subject|0|||
48834305|NCT02082158|157235682|FG003|Overall Study|Withdrawal by Subject|0|||
48834306|NCT02082158|157235683|FG004|Overall Study|Withdrawal by Subject|1|||
48834307|NCT02082158|157235684|FG005|Overall Study|Withdrawal by Subject|0|||
48834308|NCT02082158|157235679|FG000|Overall Study|Failed Fit-testing|8|||
48834309|NCT02082158|157235680|FG001|Overall Study|Failed Fit-testing|8|||
48834310|NCT02082158|157235681|FG002|Overall Study|Failed Fit-testing|14|||
48834311|NCT02082158|157235682|FG003|Overall Study|Failed Fit-testing|4|||
48834312|NCT02082158|157235683|FG004|Overall Study|Failed Fit-testing|3|||
48834313|NCT02082158|157235684|FG005|Overall Study|Failed Fit-testing|7|||
48834314|NCT00868192|157235685|FG000|Overall Study|Ineligible|4|||
48834315|NCT01616654|157235686|FG000|Overall Study|Lack of Efficacy|1|||
48834316|NCT01616654|157235687|FG001|Overall Study|Lack of Efficacy|0|||
48834317|NCT01616654|157235688|FG002|Overall Study|Lack of Efficacy|0|||
48834318|NCT01616654|157235689|FG003|Overall Study|Lack of Efficacy|0|||
48834319|NCT01616654|157235690|FG004|Overall Study|Lack of Efficacy|1|||
48834320|NCT01616654|157235686|FG000|Overall Study|Adverse Event|0|||
48834321|NCT01616654|157235687|FG001|Overall Study|Adverse Event|1|||
48834322|NCT01616654|157235688|FG002|Overall Study|Adverse Event|2|||
48834323|NCT01616654|157235689|FG003|Overall Study|Adverse Event|1|||
48834324|NCT01616654|157235690|FG004|Overall Study|Adverse Event|0|||
48834325|NCT01616654|157235686|FG000|Overall Study|Withdrawal by Subject|2|||
48834326|NCT01616654|157235687|FG001|Overall Study|Withdrawal by Subject|2|||
48834327|NCT01616654|157235688|FG002|Overall Study|Withdrawal by Subject|3|||
48834328|NCT01616654|157235689|FG003|Overall Study|Withdrawal by Subject|1|||
48834329|NCT01616654|157235690|FG004|Overall Study|Withdrawal by Subject|5|||
48834330|NCT01616654|157235686|FG000|Overall Study|Protocol Violation|0|||
48834331|NCT01616654|157235687|FG001|Overall Study|Protocol Violation|5|||
48834332|NCT01616654|157235688|FG002|Overall Study|Protocol Violation|2|||
48834333|NCT01616654|157235689|FG003|Overall Study|Protocol Violation|4|||
48834334|NCT01616654|157235690|FG004|Overall Study|Protocol Violation|4|||
48834335|NCT01616654|157235686|FG000|Overall Study|Lost to Follow-up|1|||
48834336|NCT01616654|157235687|FG001|Overall Study|Lost to Follow-up|0|||
48834337|NCT01616654|157235688|FG002|Overall Study|Lost to Follow-up|3|||
48834338|NCT01616654|157235689|FG003|Overall Study|Lost to Follow-up|2|||
48834339|NCT01616654|157235690|FG004|Overall Study|Lost to Follow-up|1|||
48834340|NCT01616654|157235686|FG000|Overall Study|Pregnancy|1|||
48923268|NCT01324232|157553189|FG002|Overall Study|Withdrawal by Subject|4|||
48923269|NCT01324232|157553190|FG003|Overall Study|Withdrawal by Subject|0|||
48923270|NCT01324232|157553187|FG000|Overall Study|Lost to Follow-up|1|||
48834341|NCT01616654|157235687|FG001|Overall Study|Pregnancy|0|||
48923271|NCT01324232|157553188|FG001|Overall Study|Lost to Follow-up|0|||
48834342|NCT01616654|157235688|FG002|Overall Study|Pregnancy|0|||
48923272|NCT01324232|157553189|FG002|Overall Study|Lost to Follow-up|0|||
48834343|NCT01616654|157235689|FG003|Overall Study|Pregnancy|0|||
48923273|NCT01324232|157553190|FG003|Overall Study|Lost to Follow-up|0|||
48923274|NCT03286842|157553191|FG000|Overall Study|Patients rolled over to another study|80|||
48834344|NCT01616654|157235690|FG004|Overall Study|Pregnancy|1|||
48834345|NCT02057692|157235691|FG000|Overall Study|Adverse Event|1|||
48834346|NCT02057692|157235692|FG001|Overall Study|Adverse Event|0|||
48834347|NCT02057692|157235693|FG002|Overall Study|Adverse Event|0|||
48834348|NCT02057692|157235694|FG003|Overall Study|Adverse Event|0|||
48834349|NCT02057692|157235691|FG000|Overall Study|Lost to Follow-up|0|||
48834350|NCT02057692|157235692|FG001|Overall Study|Lost to Follow-up|0|||
48834351|NCT02057692|157235693|FG002|Overall Study|Lost to Follow-up|0|||
48834352|NCT02057692|157235694|FG003|Overall Study|Lost to Follow-up|1|||
48834353|NCT01466881|157235696|FG000|Overall Study|Ineligible|5|||
48834354|NCT01466881|157235696|FG000|Overall Study|Adverse Event|6|||
48834355|NCT01466881|157235696|FG000|Overall Study|Progression/relapse|20|||
49014593|NCT04634409|157888946|FG023|Overall Study|Death|0|||
48834356|NCT01466881|157235696|FG000|Overall Study|Death|4|||
48834357|NCT01466881|157235696|FG000|Overall Study|Other reason not protocol specified|5|||
48834358|NCT01456936|157235699|FG000|Overall Study|Other reason|41|||
48834359|NCT01456936|157235700|FG001|Overall Study|Other reason|30|||
48834360|NCT01456936|157235701|FG002|Overall Study|Other reason|36|||
48923275|NCT02797808|157553192|FG000|Overall Study|Withdrawal by Subject|1|||
48923276|NCT02797808|157553193|FG001|Overall Study|Withdrawal by Subject|1|||
48923277|NCT02797808|157553192|FG000|Overall Study|Physician Decision|6|||
48923278|NCT02797808|157553193|FG001|Overall Study|Physician Decision|2|||
48923279|NCT03509350|157553194|FG000|Overall Study|Withdrawal by Subject|0|||
48923280|NCT03509350|157553195|FG001|Overall Study|Withdrawal by Subject|2|||
48923281|NCT00290433|157553196|FG000|Overall Study|Disease Progression|13|||
48923282|NCT00290433|157553196|FG000|Overall Study|Adverse Event|14|||
48923283|NCT00290433|157553196|FG000|Overall Study|Withdrawal by Subject|1|||
48923284|NCT00290433|157553196|FG000|Overall Study|Non-Compliance|1|||
48923285|NCT00290433|157553196|FG000|Overall Study|Congestive Heart Failure|1|||
48923286|NCT00290433|157553196|FG000|Overall Study|Transplant in CR|5|||
48923287|NCT00290433|157553196|FG000|Overall Study|Unrelated Infection/Death|1|||
48923288|NCT00797732|157553202|FG000|Overall Study|Withdrawal by Subject|3|||
48923289|NCT00797732|157553203|FG001|Overall Study|Withdrawal by Subject|3|||
48923290|NCT00797732|157553204|FG002|Overall Study|Withdrawal by Subject|0|||
48923291|NCT00797732|157553202|FG000|Overall Study|Lost to Follow-up|1|||
48923292|NCT00797732|157553203|FG001|Overall Study|Lost to Follow-up|0|||
48923293|NCT00797732|157553204|FG002|Overall Study|Lost to Follow-up|0|||
48923294|NCT00797732|157553202|FG000|Overall Study|Death|1|||
48923295|NCT00797732|157553203|FG001|Overall Study|Death|0|||
48923296|NCT00797732|157553204|FG002|Overall Study|Death|0|||
48923297|NCT00797732|157553202|FG000|Overall Study|Not meet inclusion criteria|0|||
48923298|NCT00797732|157553203|FG001|Overall Study|Not meet inclusion criteria|0|||
48923299|NCT00797732|157553204|FG002|Overall Study|Not meet inclusion criteria|7|||
48923300|NCT00797732|157553202|FG000|Overall Study|Excluded due to time constraints|0|||
48923301|NCT00797732|157553203|FG001|Overall Study|Excluded due to time constraints|0|||
48923302|NCT00797732|157553204|FG002|Overall Study|Excluded due to time constraints|24|||
49160437|NCT00363311|158427360|FG001|Overall Study|Participant Moved to Louisiana|1|||
49160438|NCT04068922|158427361|FG000|Overall Study|Lost to Follow-up|5|||
49160439|NCT04068922|158427361|FG000|Overall Study|Withdrawal by Subject|7|||
48834361|NCT01456936|157235702|FG003|Overall Study|Other reason|33|||
48834362|NCT01456936|157235699|FG000|Overall Study|No longer meets eligibility criteria|4|||
48834363|NCT01456936|157235700|FG001|Overall Study|No longer meets eligibility criteria|8|||
48834364|NCT01456936|157235701|FG002|Overall Study|No longer meets eligibility criteria|6|||
48834365|NCT01456936|157235702|FG003|Overall Study|No longer meets eligibility criteria|5|||
48834366|NCT01456936|157235699|FG000|Overall Study|Protocol Violation|4|||
48834367|NCT01456936|157235700|FG001|Overall Study|Protocol Violation|2|||
48834368|NCT01456936|157235701|FG002|Overall Study|Protocol Violation|5|||
48834369|NCT01456936|157235702|FG003|Overall Study|Protocol Violation|5|||
48834370|NCT01456936|157235699|FG000|Overall Study|Pregnancy|1|||
48834371|NCT01456936|157235700|FG001|Overall Study|Pregnancy|0|||
48834372|NCT01456936|157235701|FG002|Overall Study|Pregnancy|0|||
48834373|NCT01456936|157235702|FG003|Overall Study|Pregnancy|1|||
48834374|NCT01456936|157235699|FG000|Overall Study|Insufficient clinical response|4|||
48834375|NCT01456936|157235700|FG001|Overall Study|Insufficient clinical response|4|||
48834376|NCT01456936|157235701|FG002|Overall Study|Insufficient clinical response|14|||
48834377|NCT01456936|157235702|FG003|Overall Study|Insufficient clinical response|13|||
48834378|NCT01456936|157235699|FG000|Overall Study|No longer willing to participate|195|||
48834379|NCT01456936|157235700|FG001|Overall Study|No longer willing to participate|218|||
48834380|NCT01456936|157235701|FG002|Overall Study|No longer willing to participate|224|||
48834381|NCT01456936|157235702|FG003|Overall Study|No longer willing to participate|248|||
48834382|NCT01456936|157235699|FG000|Overall Study|Lost to Follow-up|135|||
48834383|NCT01456936|157235700|FG001|Overall Study|Lost to Follow-up|126|||
48834384|NCT01456936|157235701|FG002|Overall Study|Lost to Follow-up|144|||
48834385|NCT01456936|157235702|FG003|Overall Study|Lost to Follow-up|127|||
48834386|NCT01456936|157235699|FG000|Overall Study|Medication error|0|||
48834387|NCT01456936|157235700|FG001|Overall Study|Medication error|1|||
48834388|NCT01456936|157235701|FG002|Overall Study|Medication error|0|||
48834389|NCT01456936|157235702|FG003|Overall Study|Medication error|1|||
48834390|NCT01456936|157235699|FG000|Overall Study|Adverse event (study drug)|25|||
48834391|NCT01456936|157235700|FG001|Overall Study|Adverse event (study drug)|21|||
48834392|NCT01456936|157235701|FG002|Overall Study|Adverse event (study drug)|26|||
48923303|NCT00797732|157553202|FG000|Overall Study|Refused to Participate|0|||
48923304|NCT00797732|157553203|FG001|Overall Study|Refused to Participate|0|||
48923305|NCT00797732|157553204|FG002|Overall Study|Refused to Participate|123|||
48923306|NCT01789970|157553205|FG000|Open-label Titration Period|Adverse Event|68|||
49014594|NCT04634409|157888947|FG024|Overall Study|Death|0|||
48834393|NCT01456936|157235702|FG003|Overall Study|Adverse event (study drug)|17|||
48923307|NCT01789970|157553206|FG001|Open-label Titration Period|Adverse Event|0|||
48923308|NCT01789970|157553207|FG002|Open-label Titration Period|Adverse Event|0|||
49160440|NCT04068922|158427361|FG000|Overall Study|Adverse Event|1|||
48834394|NCT01456936|157235699|FG000|Overall Study|Adverse event (study drug unrelated)|9|||
48834395|NCT01456936|157235700|FG001|Overall Study|Adverse event (study drug unrelated)|7|||
48834396|NCT01456936|157235701|FG002|Overall Study|Adverse event (study drug unrelated)|9|||
48834397|NCT01456936|157235702|FG003|Overall Study|Adverse event (study drug unrelated)|9|||
48834398|NCT01456936|157235699|FG000|Overall Study|Death|0|||
48834399|NCT01456936|157235700|FG001|Overall Study|Death|3|||
48834400|NCT01456936|157235701|FG002|Overall Study|Death|1|||
48834401|NCT01456936|157235702|FG003|Overall Study|Death|3|||
48834402|NCT01456936|157235699|FG000|Overall Study|Randomized but not treated|21|||
48834403|NCT01456936|157235700|FG001|Overall Study|Randomized but not treated|28|||
48834404|NCT01456936|157235701|FG002|Overall Study|Randomized but not treated|16|||
48834405|NCT01456936|157235702|FG003|Overall Study|Randomized but not treated|21|||
48834406|NCT01786564|157235703|FG000|Overall Study|Lost to Follow-up|47|||
48834407|NCT01786564|157235703|FG000|Overall Study|Ineligible|17|||
48834408|NCT00494442|157235704|FG000|Overall Study|Death|1|||
48834409|NCT00494442|157235705|FG001|Overall Study|Death|1|||
48834410|NCT00494442|157235704|FG000|Overall Study|Lack of Efficacy|16|||
48834411|NCT00494442|157235705|FG001|Overall Study|Lack of Efficacy|10|||
48834412|NCT00494442|157235704|FG000|Overall Study|Adverse Event|0|||
48834413|NCT00494442|157235705|FG001|Overall Study|Adverse Event|2|||
49160441|NCT00716274|158427368|FG000|Study Period II (16-Weeks)|Entry Criteria Not Met|2|||
49160442|NCT00716274|158427369|FG001|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
49160443|NCT00716274|158427370|FG002|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
49160444|NCT00716274|158427371|FG003|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
49160445|NCT00716274|158427372|FG004|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
49160446|NCT00716274|158427373|FG005|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
49160447|NCT00716274|158427368|FG000|Study Period II (16-Weeks)|Protocol Violation|0|||
49160448|NCT00716274|158427369|FG001|Study Period II (16-Weeks)|Protocol Violation|3|||
48834414|NCT00494442|157235704|FG000|Overall Study|Physician Decision|0|||
48834415|NCT00494442|157235705|FG001|Overall Study|Physician Decision|1|||
48834416|NCT00494442|157235704|FG000|Overall Study|Non-compliance|0|||
48834417|NCT00494442|157235705|FG001|Overall Study|Non-compliance|1|||
48834418|NCT00494442|157235704|FG000|Overall Study|Intercurrent illness|0|||
48834419|NCT00494442|157235705|FG001|Overall Study|Intercurrent illness|1|||
49160449|NCT00716274|158427370|FG002|Study Period II (16-Weeks)|Protocol Violation|0|||
49160450|NCT00716274|158427371|FG003|Study Period II (16-Weeks)|Protocol Violation|0|||
49160451|NCT00716274|158427372|FG004|Study Period II (16-Weeks)|Protocol Violation|0|||
49160452|NCT00716274|158427373|FG005|Study Period II (16-Weeks)|Protocol Violation|1|||
49160453|NCT00716274|158427368|FG000|Study Period II (16-Weeks)|Withdrawal by Subject|1|||
49160454|NCT00716274|158427369|FG001|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
49160455|NCT00716274|158427370|FG002|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
49160456|NCT00716274|158427371|FG003|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
49160457|NCT00716274|158427372|FG004|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
49160458|NCT00716274|158427373|FG005|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
49160459|NCT00716274|158427368|FG000|Study Period II (16-Weeks)|Physician Decision|3|||
49160460|NCT00716274|158427369|FG001|Study Period II (16-Weeks)|Physician Decision|1|||
49160461|NCT00716274|158427370|FG002|Study Period II (16-Weeks)|Physician Decision|0|||
49160462|NCT00716274|158427371|FG003|Study Period II (16-Weeks)|Physician Decision|0|||
49160463|NCT00716274|158427372|FG004|Study Period II (16-Weeks)|Physician Decision|0|||
49160464|NCT00716274|158427373|FG005|Study Period II (16-Weeks)|Physician Decision|1|||
49160465|NCT00716274|158427368|FG000|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
49160466|NCT00716274|158427369|FG001|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
49160467|NCT00716274|158427370|FG002|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
49160468|NCT00716274|158427371|FG003|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
49160469|NCT00716274|158427372|FG004|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
49160470|NCT00716274|158427373|FG005|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
48834420|NCT00486330|157235706|FG000|Overall Study|Adverse Event|2|||
48834421|NCT01241292|157235707|FG000|Overall Study|Administrative Reason by Sponsor|1|||
48834422|NCT01241292|157235708|FG001|Overall Study|Administrative Reason by Sponsor|0|||
48834423|NCT01241292|157235707|FG000|Overall Study|Disease Progression|2|||
48834424|NCT01241292|157235708|FG001|Overall Study|Disease Progression|0|||
49160471|NCT00716274|158427368|FG000|Study Period II (16-Weeks)|Lost to Follow-up|0|||
49160472|NCT00716274|158427369|FG001|Study Period II (16-Weeks)|Lost to Follow-up|2|||
49160473|NCT00716274|158427370|FG002|Study Period II (16-Weeks)|Lost to Follow-up|0|||
48834425|NCT01241292|157235707|FG000|Overall Study|Study Drug Toxicity|0|||
48834426|NCT01241292|157235708|FG001|Overall Study|Study Drug Toxicity|1|||
48834427|NCT01241292|157235707|FG000|Overall Study|Participant Discontinued Treatment|0|||
48834428|NCT01241292|157235708|FG001|Overall Study|Participant Discontinued Treatment|2|||
48834429|NCT03034915|157235709|FG000|Overall Study|Adverse Event|29|||
48834430|NCT03034915|157235710|FG001|Overall Study|Adverse Event|32|||
48834431|NCT03034915|157235711|FG002|Overall Study|Adverse Event|22|||
48923309|NCT01789970|157553205|FG000|Open-label Titration Period|Lack of Efficacy|31|||
48834432|NCT03034915|157235709|FG000|Overall Study|Lost to Follow-up|5|||
48834433|NCT03034915|157235710|FG001|Overall Study|Lost to Follow-up|13|||
49160474|NCT00716274|158427371|FG003|Study Period II (16-Weeks)|Lost to Follow-up|0|||
49160475|NCT00716274|158427372|FG004|Study Period II (16-Weeks)|Lost to Follow-up|0|||
49160476|NCT00716274|158427373|FG005|Study Period II (16-Weeks)|Lost to Follow-up|0|||
49160477|NCT00716274|158427368|FG000|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
49160478|NCT00716274|158427369|FG001|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
49160479|NCT00716274|158427370|FG002|Study Period III (16-Weeks)|Withdrawal by Subject|2|||
49160480|NCT00716274|158427371|FG003|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
49160481|NCT00716274|158427372|FG004|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
48834434|NCT03034915|157235711|FG002|Overall Study|Lost to Follow-up|3|||
48834435|NCT03034915|157235709|FG000|Overall Study|Withdrawal by Subject|29|||
48834436|NCT03034915|157235710|FG001|Overall Study|Withdrawal by Subject|46|||
48834437|NCT03034915|157235711|FG002|Overall Study|Withdrawal by Subject|41|||
48834438|NCT03034915|157235709|FG000|Overall Study|Protocol Deviation|2|||
48834439|NCT03034915|157235710|FG001|Overall Study|Protocol Deviation|14|||
48834440|NCT03034915|157235711|FG002|Overall Study|Protocol Deviation|7|||
48834441|NCT03034915|157235709|FG000|Overall Study|Lack of Efficacy|8|||
48834442|NCT03034915|157235710|FG001|Overall Study|Lack of Efficacy|16|||
48834443|NCT03034915|157235711|FG002|Overall Study|Lack of Efficacy|18|||
48834444|NCT03034915|157235709|FG000|Overall Study|Site closed|2|||
48834445|NCT03034915|157235710|FG001|Overall Study|Site closed|2|||
48834446|NCT03034915|157235711|FG002|Overall Study|Site closed|4|||
48834447|NCT03034915|157235709|FG000|Overall Study|Protocol-defined withdrawal criteria met|19|||
48834448|NCT03034915|157235710|FG001|Overall Study|Protocol-defined withdrawal criteria met|26|||
48923310|NCT01789970|157553206|FG001|Open-label Titration Period|Lack of Efficacy|0|||
48923311|NCT01789970|157553207|FG002|Open-label Titration Period|Lack of Efficacy|0|||
48923312|NCT01789970|157553205|FG000|Open-label Titration Period|Withdrawal by Subject|31|||
49160482|NCT00716274|158427373|FG005|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
49160483|NCT00716274|158427368|FG000|Study Period III (16-Weeks)|Physician Decision|0|||
49160484|NCT00716274|158427369|FG001|Study Period III (16-Weeks)|Physician Decision|0|||
49160485|NCT00716274|158427370|FG002|Study Period III (16-Weeks)|Physician Decision|0|||
49160486|NCT00716274|158427371|FG003|Study Period III (16-Weeks)|Physician Decision|0|||
49160487|NCT00716274|158427372|FG004|Study Period III (16-Weeks)|Physician Decision|1|||
49160488|NCT00716274|158427373|FG005|Study Period III (16-Weeks)|Physician Decision|0|||
49160489|NCT00716274|158427368|FG000|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
49160490|NCT00716274|158427369|FG001|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
49160491|NCT00716274|158427370|FG002|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
49160492|NCT00716274|158427371|FG003|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
49160493|NCT00716274|158427372|FG004|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
49160494|NCT00716274|158427373|FG005|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
49160495|NCT00716274|158427368|FG000|Study Period III (16-Weeks)|Adverse Event|0|||
49160496|NCT00716274|158427369|FG001|Study Period III (16-Weeks)|Adverse Event|0|||
49160497|NCT00716274|158427370|FG002|Study Period III (16-Weeks)|Adverse Event|0|||
49160498|NCT00716274|158427371|FG003|Study Period III (16-Weeks)|Adverse Event|0|||
49160499|NCT00716274|158427372|FG004|Study Period III (16-Weeks)|Adverse Event|1|||
49160500|NCT00716274|158427373|FG005|Study Period III (16-Weeks)|Adverse Event|0|||
49160501|NCT03571971|158427377|FG000|Overall Study|Lost to Follow-up|2|||
49160502|NCT03571971|158427378|FG001|Overall Study|Lost to Follow-up|2|||
49160503|NCT03571971|158427377|FG000|Overall Study|Protocol Violation|2|||
49160504|NCT03571971|158427378|FG001|Overall Study|Protocol Violation|3|||
49160505|NCT03571971|158427377|FG000|Overall Study|Withdrawal by Subject|2|||
49160506|NCT03571971|158427378|FG001|Overall Study|Withdrawal by Subject|0|||
49160507|NCT03571971|158427377|FG000|Overall Study|Incomplete primary outcome data|2|||
49160508|NCT03571971|158427378|FG001|Overall Study|Incomplete primary outcome data|0|||
48834449|NCT03034915|157235711|FG002|Overall Study|Protocol-defined withdrawal criteria met|29|||
48834450|NCT03034915|157235709|FG000|Overall Study|Physician Decision|1|||
48834451|NCT03034915|157235710|FG001|Overall Study|Physician Decision|5|||
48923313|NCT01789970|157553206|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
49014595|NCT04634409|157888948|FG025|Overall Study|Death|0|||
49160509|NCT04021290|158427382|FG000|Randomized Phase (Day1 to Week 52)|Adverse Event|4|||
49160510|NCT04021290|158427383|FG001|Randomized Phase (Day1 to Week 52)|Adverse Event|3|||
49160511|NCT04021290|158427384|FG002|Randomized Phase (Day1 to Week 52)|Adverse Event|0|||
49160512|NCT04021290|158427382|FG000|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
49160513|NCT04021290|158427383|FG001|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|3|||
48923314|NCT01789970|157553207|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
48923315|NCT01789970|157553205|FG000|Open-label Titration Period|Protocol Violation|18|||
48923316|NCT01789970|157553206|FG001|Open-label Titration Period|Protocol Violation|0|||
48923317|NCT01789970|157553207|FG002|Open-label Titration Period|Protocol Violation|0|||
48834452|NCT03034915|157235711|FG002|Overall Study|Physician Decision|2|||
48923318|NCT01789970|157553205|FG000|Open-label Titration Period|Lost to Follow-up|5|||
48923319|NCT01789970|157553206|FG001|Open-label Titration Period|Lost to Follow-up|0|||
49160514|NCT04021290|158427384|FG002|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
49160515|NCT04021290|158427382|FG000|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|2|||
49160516|NCT04021290|158427383|FG001|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|1|||
49160517|NCT04021290|158427384|FG002|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|0|||
49160518|NCT04021290|158427382|FG000|Randomized Phase (Day1 to Week 52)|Death|1|||
49160519|NCT04021290|158427383|FG001|Randomized Phase (Day1 to Week 52)|Death|0|||
49160520|NCT04021290|158427384|FG002|Randomized Phase (Day1 to Week 52)|Death|0|||
49160521|NCT04021290|158427382|FG000|Randomized Phase (Day1 to Week 52)|Physician Decision|1|||
49160522|NCT04021290|158427383|FG001|Randomized Phase (Day1 to Week 52)|Physician Decision|2|||
49160523|NCT04021290|158427384|FG002|Randomized Phase (Day1 to Week 52)|Physician Decision|0|||
48834453|NCT00957658|157235712|FG000|Overall Study|Death|1|||
48834454|NCT00957658|157235712|FG000|Overall Study|Lost to Follow-up|4|||
48834455|NCT00957658|157235712|FG000|Overall Study|Withdrawal by Subject|12|||
48834456|NCT00957658|157235712|FG000|Overall Study|Revision|1|||
48834457|NCT00957658|157235712|FG000|Overall Study|Incomplete 2 yr data|28|||
48834458|NCT00957658|157235712|FG000|Overall Study|Site termination|10|||
48834459|NCT00957658|157235712|FG000|Overall Study|unwilling/unable to return|2|||
48834460|NCT00957658|157235712|FG000|Overall Study|surgery cancelled|2|||
48834461|NCT00957658|157235712|FG000|Overall Study|Protocol Violation|5|||
49160524|NCT04021290|158427382|FG000|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|1|||
49160525|NCT04021290|158427383|FG001|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|5|||
49160526|NCT04021290|158427384|FG002|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|0|||
49160527|NCT04021290|158427382|FG000|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|96|||
49160528|NCT04021290|158427383|FG001|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
49160529|NCT04021290|158427384|FG002|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
49160530|NCT04021290|158427382|FG000|Randomized Phase (Day1 to Week 52)|Protocol Deviation|5|||
49160531|NCT04021290|158427383|FG001|Randomized Phase (Day1 to Week 52)|Protocol Deviation|4|||
49160532|NCT04021290|158427384|FG002|Randomized Phase (Day1 to Week 52)|Protocol Deviation|0|||
49160533|NCT04021290|158427382|FG000|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
49160534|NCT04021290|158427383|FG001|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
49160535|NCT04021290|158427384|FG002|Continuation Phase (Week 52 to Week 132)|Physician Decision|1|||
49160536|NCT04021290|158427382|FG000|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
49160537|NCT04021290|158427383|FG001|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
49160538|NCT04021290|158427384|FG002|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|1|||
49160539|NCT04021290|158427382|FG000|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
49160540|NCT04021290|158427383|FG001|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
49160541|NCT04021290|158427384|FG002|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|1|||
49160542|NCT04021290|158427382|FG000|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
49160543|NCT04021290|158427383|FG001|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
49160544|NCT04021290|158427384|FG002|Continuation Phase (Week 52 to Week 132)|Adverse Event|2|||
49160545|NCT01342926|158427386|FG000|Overall Study|Adverse Event|5|||
49160546|NCT01342926|158427387|FG001|Overall Study|Adverse Event|8|||
49160547|NCT01342926|158427388|FG002|Overall Study|Adverse Event|10|||
49160548|NCT01342926|158427389|FG003|Overall Study|Adverse Event|7|||
49160549|NCT01342926|158427386|FG000|Overall Study|Lost to Follow-up|0|||
49160550|NCT01342926|158427387|FG001|Overall Study|Lost to Follow-up|1|||
49160551|NCT01342926|158427388|FG002|Overall Study|Lost to Follow-up|1|||
48834462|NCT00424762|157235713|FG000|Overall Study|Withdrawal by Subject|18|||
49160552|NCT01342926|158427389|FG003|Overall Study|Lost to Follow-up|0|||
49160553|NCT01342926|158427386|FG000|Overall Study|Investigator Discretion|2|||
49160554|NCT01342926|158427387|FG001|Overall Study|Investigator Discretion|2|||
49160555|NCT01342926|158427388|FG002|Overall Study|Investigator Discretion|0|||
49160556|NCT01342926|158427389|FG003|Overall Study|Investigator Discretion|0|||
49160557|NCT01342926|158427386|FG000|Overall Study|Withdrawal by Subject|2|||
49160558|NCT01342926|158427387|FG001|Overall Study|Withdrawal by Subject|4|||
49160559|NCT01342926|158427388|FG002|Overall Study|Withdrawal by Subject|3|||
49160560|NCT01342926|158427389|FG003|Overall Study|Withdrawal by Subject|5|||
49160561|NCT03092479|158427390|FG000|Overall Study|Lost to Follow-up|3|||
49160562|NCT03092479|158427391|FG001|Overall Study|Lost to Follow-up|2|||
49160563|NCT03092479|158427390|FG000|Overall Study|Withdrawal by Subject|4|||
49160564|NCT03092479|158427391|FG001|Overall Study|Withdrawal by Subject|0|||
49160565|NCT03382912|158427392|FG000|Overall Study|Physician Decision|0|||
49160566|NCT03382912|158427393|FG001|Overall Study|Physician Decision|1|||
49160567|NCT03382912|158427392|FG000|Overall Study|Sponsor Decision|6|||
49160568|NCT03382912|158427393|FG001|Overall Study|Sponsor Decision|6|||
49160569|NCT03382912|158427392|FG000|Overall Study|Withdrawal by Subject|0|||
49160570|NCT03382912|158427393|FG001|Overall Study|Withdrawal by Subject|5|||
49160571|NCT04422431|158427399|FG000|Treatment Period (48 Weeks)|Adverse Event|3|||
49160572|NCT04422431|158427399|FG000|Treatment Period (48 Weeks)|Withdrawal by Subject|1|||
49160573|NCT04422431|158427399|FG000|Treatment Period (48 Weeks)|Other than specified|1|||
49160574|NCT04422431|158427399|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|1|||
49160575|NCT04422431|158427399|FG000|Extension Period (48 Weeks)|Lost to Follow-up|1|||
49160576|NCT04422431|158427399|FG000|Extension Period (48 Weeks)|Other than specified|2|||
49160577|NCT04288089|158427400|FG000|Overall Study|Ongoing Treatment|2|||
49160578|NCT04288089|158427401|FG001|Overall Study|Ongoing Treatment|1|||
49160579|NCT04288089|158427402|FG002|Overall Study|Ongoing Treatment|1|||
49160580|NCT04288089|158427403|FG003|Overall Study|Ongoing Treatment|4|||
49160581|NCT03929913|158427404|FG000|Overall Study|Death|4|||
49160582|NCT03929913|158427404|FG000|Overall Study|Lost to Follow-up|1|||
49160583|NCT03929913|158427404|FG000|Overall Study|Failed Procedure|2|||
49160584|NCT01928433|158427405|FG000|Overall Study|Adverse Event|5|||
49160585|NCT01928433|158427406|FG001|Overall Study|Adverse Event|2|||
49160586|NCT01928433|158427407|FG002|Overall Study|Adverse Event|5|||
49160587|NCT01928433|158427405|FG000|Overall Study|Protocol Violation|0|||
49160588|NCT01928433|158427406|FG001|Overall Study|Protocol Violation|0|||
49160589|NCT01928433|158427407|FG002|Overall Study|Protocol Violation|2|||
49160590|NCT01928433|158427405|FG000|Overall Study|Lack of Efficacy|5|||
49160591|NCT01928433|158427406|FG001|Overall Study|Lack of Efficacy|4|||
49160592|NCT01928433|158427407|FG002|Overall Study|Lack of Efficacy|4|||
49160593|NCT01928433|158427405|FG000|Overall Study|Withdrawal by Subject|0|||
49160594|NCT01928433|158427406|FG001|Overall Study|Withdrawal by Subject|4|||
49160595|NCT01928433|158427407|FG002|Overall Study|Withdrawal by Subject|0|||
49160596|NCT01928433|158427405|FG000|Overall Study|Negative screening urine culture|7|||
49160597|NCT01928433|158427406|FG001|Overall Study|Negative screening urine culture|6|||
49160598|NCT01928433|158427407|FG002|Overall Study|Negative screening urine culture|10|||
49160599|NCT01928433|158427405|FG000|Overall Study|Lost to Follow-up|0|||
49160600|NCT01928433|158427406|FG001|Overall Study|Lost to Follow-up|2|||
49160601|NCT01928433|158427407|FG002|Overall Study|Lost to Follow-up|3|||
49160602|NCT01928433|158427405|FG000|Overall Study|Other reasons|3|||
49160603|NCT01928433|158427406|FG001|Overall Study|Other reasons|3|||
49160604|NCT01928433|158427407|FG002|Overall Study|Other reasons|4|||
49160605|NCT00403130|158427411|FG000|2 Years From Start of Treatment|Not Eligible|3|||
49160606|NCT00403130|158427411|FG000|2 Years From Start of Treatment|Lost to Follow up|1|||
49160607|NCT00403130|158427411|FG000|2 Years From Start of Treatment|Withdrawal by Subject|1|||
49160608|NCT00403130|158427411|FG000|Survival Follow-up up to 6 Years|Lost to Follow-up|10|||
49160609|NCT01913327|158427414|FG000|Overall Study|Withdrawal by Subject|0|||
49160610|NCT01913327|158427415|FG001|Overall Study|Withdrawal by Subject|1|||
49160611|NCT01897532|158427416|FG000|Discontinuation From Treatment|Not Treated|7|||
49160612|NCT01897532|158427417|FG001|Discontinuation From Treatment|Not Treated|5|||
49160613|NCT01897532|158427416|FG000|Discontinuation From Treatment|Other reason than specified|196|||
49160614|NCT01897532|158427417|FG001|Discontinuation From Treatment|Other reason than specified|176|||
49160615|NCT01897532|158427416|FG000|Discontinuation From Treatment|Withdrawal by Subject|333|||
49160616|NCT01897532|158427417|FG001|Discontinuation From Treatment|Withdrawal by Subject|281|||
49160617|NCT01897532|158427416|FG000|Discontinuation From Treatment|Non compliance|24|||
49160618|NCT01897532|158427417|FG001|Discontinuation From Treatment|Non compliance|15|||
49160619|NCT01897532|158427416|FG000|Discontinuation From Treatment|Adverse event/ CV outcome event|402|||
49160620|NCT01897532|158427417|FG001|Discontinuation From Treatment|Adverse event/ CV outcome event|362|||
49160621|NCT01897532|158427416|FG000|Discontinuation From Trial|Not Treated|7|||
49160622|NCT01897532|158427417|FG001|Discontinuation From Trial|Not Treated|5|||
49160623|NCT01897532|158427416|FG000|Discontinuation From Trial|Patient lost to follow-up for MACE|55|||
49160624|NCT01897532|158427417|FG001|Discontinuation From Trial|Patient lost to follow-up for MACE|36|||
49160625|NCT00953706|158427418|FG000|Part A (16-Week Double-Blind Treatment)|Adverse Event|2|||
49160626|NCT00953706|158427419|FG001|Part A (16-Week Double-Blind Treatment)|Adverse Event|3|||
49160627|NCT00953706|158427420|FG002|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
49160628|NCT00953706|158427421|FG003|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
49160629|NCT00953706|158427418|FG000|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
49160630|NCT00953706|158427419|FG001|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1|||
49160631|NCT00953706|158427420|FG002|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
49160632|NCT00953706|158427421|FG003|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
49160633|NCT00953706|158427418|FG000|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
49160634|NCT00953706|158427419|FG001|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2|||
49160635|NCT00953706|158427420|FG002|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
49160636|NCT00953706|158427421|FG003|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
49160637|NCT00953706|158427418|FG000|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
49160638|NCT00953706|158427419|FG001|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1|||
48834463|NCT00424762|157235714|FG001|Overall Study|Withdrawal by Subject|19|||
48834464|NCT00424762|157235713|FG000|Overall Study|Lost to Follow-up|2|||
48834465|NCT00424762|157235714|FG001|Overall Study|Lost to Follow-up|3|||
48834466|NCT04588480|157235715|FG000|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
48834467|NCT04588480|157235716|FG001|Unblinded Phase: From 6 to 12 Months|Protocol Violation|1|||
48834468|NCT04588480|157235717|FG002|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
48834469|NCT04588480|157235715|FG000|Unblinded Phase: From 6 to 12 Months|Other|2|||
48834470|NCT04588480|157235716|FG001|Unblinded Phase: From 6 to 12 Months|Other|2|||
48834471|NCT04588480|157235717|FG002|Unblinded Phase: From 6 to 12 Months|Other|0|||
48834472|NCT01405924|157235718|FG000|Overall Study|Protocol Violation|8|||
48834473|NCT01405924|157235718|FG000|Overall Study|Missing/Incomplete Data|2|||
48834474|NCT01191086|157235720|FG000|Overall Study|Adverse Event|20|||
48834475|NCT01191086|157235720|FG000|Overall Study|Lack of Efficacy|10|||
48834476|NCT01191086|157235720|FG000|Overall Study|Lost to Follow-up|4|||
48834477|NCT01191086|157235720|FG000|Overall Study|Physician Decision|2|||
48834478|NCT01191086|157235720|FG000|Overall Study|Withdrawal by Subject|24|||
48834479|NCT01191086|157235720|FG000|Overall Study|Discontinuation criterion met|1|||
48834480|NCT01191086|157235720|FG000|Overall Study|Other|1|||
49160639|NCT00953706|158427420|FG002|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
49160640|NCT00953706|158427421|FG003|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
49160641|NCT00953706|158427418|FG000|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
49160642|NCT00953706|158427419|FG001|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1|||
49160643|NCT00953706|158427420|FG002|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
49160644|NCT00953706|158427421|FG003|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
49160645|NCT00953706|158427418|FG000|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
49160646|NCT00953706|158427419|FG001|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
49160647|NCT00953706|158427420|FG002|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
49160648|NCT00953706|158427421|FG003|Part B (96-Week Open-Label Extension)|Adverse Event|2|||
49160649|NCT00953706|158427418|FG000|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
49160650|NCT00953706|158427419|FG001|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
49160651|NCT00953706|158427420|FG002|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
49160652|NCT00953706|158427421|FG003|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1|||
49160653|NCT00953706|158427418|FG000|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
49160654|NCT00953706|158427419|FG001|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
48923320|NCT01789970|157553207|FG002|Open-label Titration Period|Lost to Follow-up|0|||
48923321|NCT01789970|157553205|FG000|Open-label Titration Period|Noncompliance to study drug admin|11|||
48923322|NCT01789970|157553206|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
48923323|NCT01789970|157553207|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
48923324|NCT01789970|157553205|FG000|Open-label Titration Period|Noncompliance with study rescue meds|2|||
49160655|NCT00953706|158427420|FG002|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
49160656|NCT00953706|158427421|FG003|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1|||
49160657|NCT00953706|158427418|FG000|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
49160658|NCT00953706|158427419|FG001|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
49160659|NCT00953706|158427420|FG002|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4|||
49160660|NCT00953706|158427421|FG003|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25|||
49160661|NCT00953706|158427418|FG000|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
49160662|NCT00953706|158427419|FG001|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
49160663|NCT00953706|158427420|FG002|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1|||
49160664|NCT00953706|158427421|FG003|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2|||
49160665|NCT00953706|158427418|FG000|Part B (96-Week Open-Label Extension)|Other|0|||
49160666|NCT00953706|158427419|FG001|Part B (96-Week Open-Label Extension)|Other|0|||
49160667|NCT00953706|158427420|FG002|Part B (96-Week Open-Label Extension)|Other|0|||
49160668|NCT00953706|158427421|FG003|Part B (96-Week Open-Label Extension)|Other|2|||
49160669|NCT02137070|158427422|FG000|Overall Study|Adverse Event|12|||
49160670|NCT02137070|158427423|FG001|Overall Study|Adverse Event|3|||
48834481|NCT03691428|157235721|FG000|Overall Study|Withdrawal by Subject|6|||
48834482|NCT03691428|157235722|FG001|Overall Study|Withdrawal by Subject|8|||
48834483|NCT00853827|157235723|FG000|Single Blind Period (1 Week)|Other|4|||
49160671|NCT02137070|158427422|FG000|Overall Study|Death|2|||
49160672|NCT02137070|158427423|FG001|Overall Study|Death|0|||
49160673|NCT02137070|158427422|FG000|Overall Study|Lost to Follow-up|24|||
49160674|NCT02137070|158427423|FG001|Overall Study|Lost to Follow-up|9|||
49160675|NCT02137070|158427422|FG000|Overall Study|Physician Decision|0|||
49160676|NCT02137070|158427423|FG001|Overall Study|Physician Decision|1|||
49160677|NCT02137070|158427422|FG000|Overall Study|Protocol Violation|18|||
49160678|NCT02137070|158427423|FG001|Overall Study|Protocol Violation|4|||
49160679|NCT02137070|158427422|FG000|Overall Study|Withdrawal by Subject|18|||
49160680|NCT02137070|158427423|FG001|Overall Study|Withdrawal by Subject|1|||
49160681|NCT00003645|158429091|FG000|Overall Study|Death|4|||
49160682|NCT00003645|158429092|FG001|Overall Study|Death|1|||
49160683|NCT00003645|158429091|FG000|Overall Study|Lost to Follow-up|7|||
49160684|NCT00003645|158429092|FG001|Overall Study|Lost to Follow-up|8|||
49160685|NCT00003645|158429091|FG000|Overall Study|Withdrawal by Subject|1|||
49160686|NCT00003645|158429092|FG001|Overall Study|Withdrawal by Subject|3|||
49160687|NCT01173679|158429093|FG000|Overall Study|Death|1|||
49160688|NCT01657370|158429095|FG000|Overall Study|Withdrawal by Subject|0|||
49160689|NCT01657370|158429096|FG001|Overall Study|Withdrawal by Subject|0|||
49160690|NCT01657370|158429097|FG002|Overall Study|Withdrawal by Subject|1|||
49160691|NCT01657370|158429098|FG003|Overall Study|Withdrawal by Subject|0|||
49160692|NCT01657370|158429099|FG004|Overall Study|Withdrawal by Subject|0|||
49160693|NCT01657370|158429100|FG005|Overall Study|Withdrawal by Subject|1|||
49160694|NCT01657370|158429095|FG000|Overall Study|Physician Decision|2|||
49160695|NCT01657370|158429096|FG001|Overall Study|Physician Decision|3|||
49160696|NCT01657370|158429097|FG002|Overall Study|Physician Decision|1|||
49160697|NCT01657370|158429098|FG003|Overall Study|Physician Decision|2|||
49160698|NCT01657370|158429099|FG004|Overall Study|Physician Decision|5|||
49160699|NCT01657370|158429100|FG005|Overall Study|Physician Decision|0|||
49160700|NCT01657370|158429095|FG000|Overall Study|Lack of Qualifying Event|1|||
49160701|NCT01657370|158429096|FG001|Overall Study|Lack of Qualifying Event|0|||
49160702|NCT01657370|158429097|FG002|Overall Study|Lack of Qualifying Event|3|||
49160703|NCT01657370|158429098|FG003|Overall Study|Lack of Qualifying Event|2|||
49160704|NCT01657370|158429099|FG004|Overall Study|Lack of Qualifying Event|1|||
49160705|NCT01657370|158429100|FG005|Overall Study|Lack of Qualifying Event|2|||
49160706|NCT01657370|158429095|FG000|Overall Study|Adverse Event|0|||
49160707|NCT01657370|158429096|FG001|Overall Study|Adverse Event|0|||
49160708|NCT01657370|158429097|FG002|Overall Study|Adverse Event|0|||
49160709|NCT01657370|158429098|FG003|Overall Study|Adverse Event|0|||
49160710|NCT01657370|158429099|FG004|Overall Study|Adverse Event|1|||
49160711|NCT01657370|158429100|FG005|Overall Study|Adverse Event|0|||
49160712|NCT01657370|158429095|FG000|Overall Study|Protocol Violation|1|||
49160713|NCT01657370|158429096|FG001|Overall Study|Protocol Violation|1|||
49160714|NCT01657370|158429097|FG002|Overall Study|Protocol Violation|1|||
49160715|NCT01657370|158429098|FG003|Overall Study|Protocol Violation|1|||
49160716|NCT01657370|158429099|FG004|Overall Study|Protocol Violation|0|||
49160717|NCT01657370|158429100|FG005|Overall Study|Protocol Violation|0|||
49160718|NCT01657370|158429095|FG000|Overall Study|Lost to Follow-up|2|||
49160719|NCT01657370|158429096|FG001|Overall Study|Lost to Follow-up|0|||
49160720|NCT01657370|158429097|FG002|Overall Study|Lost to Follow-up|1|||
49160721|NCT01657370|158429098|FG003|Overall Study|Lost to Follow-up|0|||
49160722|NCT01657370|158429099|FG004|Overall Study|Lost to Follow-up|0|||
49160723|NCT01657370|158429100|FG005|Overall Study|Lost to Follow-up|1|||
49160724|NCT01250054|158429101|FG000|Period 2, One Week of Wear|Unacceptable subjective vision|1|||
49160725|NCT01250054|158429102|FG001|Period 2, One Week of Wear|Unacceptable subjective vision|0|||
49160726|NCT04043286|158429103|FG000|Overall Study|Withdrawal by Subject|2|||
49160727|NCT04043286|158429104|FG001|Overall Study|Withdrawal by Subject|2|||
49160728|NCT00503984|158429105|FG000|Overall Study|Protocol Violation|0|||
49160729|NCT00503984|158429106|FG001|Overall Study|Protocol Violation|1|||
49160730|NCT00503984|158429107|FG002|Overall Study|Protocol Violation|0|||
48834484|NCT00853827|157235724|FG001|Single Blind Period (1 Week)|Other|0|||
48834485|NCT00853827|157235723|FG000|Single Blind Period (1 Week)|Adverse Event|9|||
48834486|NCT00853827|157235724|FG001|Single Blind Period (1 Week)|Adverse Event|0|||
48834487|NCT00853827|157235723|FG000|Single Blind Period (1 Week)|Abnormal laboratory value|3|||
49160731|NCT00503984|158429108|FG003|Overall Study|Protocol Violation|0|||
49160732|NCT00503984|158429109|FG004|Overall Study|Protocol Violation|0|||
49160733|NCT00503984|158429110|FG005|Overall Study|Protocol Violation|0|||
49160734|NCT00503984|158429105|FG000|Overall Study|Adverse Event|0|||
49160735|NCT00503984|158429106|FG001|Overall Study|Adverse Event|1|||
49160736|NCT00503984|158429107|FG002|Overall Study|Adverse Event|0|||
49160737|NCT00503984|158429108|FG003|Overall Study|Adverse Event|0|||
49160738|NCT00503984|158429109|FG004|Overall Study|Adverse Event|0|||
49160739|NCT00503984|158429110|FG005|Overall Study|Adverse Event|0|||
49160740|NCT00503984|158429105|FG000|Overall Study|Death|0|||
49160741|NCT00503984|158429106|FG001|Overall Study|Death|0|||
49160742|NCT00503984|158429107|FG002|Overall Study|Death|0|||
49160743|NCT00503984|158429108|FG003|Overall Study|Death|0|||
49160744|NCT00503984|158429109|FG004|Overall Study|Death|1|||
49160745|NCT00503984|158429110|FG005|Overall Study|Death|0|||
49160746|NCT03698279|158429114|FG000|Overall Study|Withdrawal by parent/guardian|1|||
49160747|NCT03698279|158429115|FG001|Overall Study|Withdrawal by parent/guardian|1|||
49160748|NCT03698279|158429116|FG002|Overall Study|Withdrawal by parent/guardian|1|||
49160749|NCT03698279|158429117|FG003|Overall Study|Withdrawal by parent/guardian|1|||
49160750|NCT03698279|158429118|FG004|Overall Study|Withdrawal by parent/guardian|0|||
49160751|NCT03698279|158429119|FG005|Overall Study|Withdrawal by parent/guardian|0|||
49160752|NCT03698279|158429114|FG000|Overall Study|Protocol deviation|1|||
49160753|NCT03698279|158429115|FG001|Overall Study|Protocol deviation|0|||
49160754|NCT03698279|158429116|FG002|Overall Study|Protocol deviation|1|||
49160755|NCT03698279|158429117|FG003|Overall Study|Protocol deviation|0|||
49160756|NCT03698279|158429118|FG004|Overall Study|Protocol deviation|0|||
49160757|NCT03698279|158429119|FG005|Overall Study|Protocol deviation|0|||
49160758|NCT03698279|158429114|FG000|Overall Study|Withdrawal by Subject|0|||
49160759|NCT03698279|158429115|FG001|Overall Study|Withdrawal by Subject|0|||
49160760|NCT03698279|158429116|FG002|Overall Study|Withdrawal by Subject|1|||
49160761|NCT03698279|158429117|FG003|Overall Study|Withdrawal by Subject|0|||
49160762|NCT03698279|158429118|FG004|Overall Study|Withdrawal by Subject|0|||
49160763|NCT03698279|158429119|FG005|Overall Study|Withdrawal by Subject|0|||
49160764|NCT03698279|158429114|FG000|Overall Study|Lost to Follow-up|3|||
49160765|NCT03698279|158429115|FG001|Overall Study|Lost to Follow-up|1|||
49160766|NCT03698279|158429116|FG002|Overall Study|Lost to Follow-up|4|||
49160767|NCT03698279|158429117|FG003|Overall Study|Lost to Follow-up|5|||
49160768|NCT03698279|158429118|FG004|Overall Study|Lost to Follow-up|0|||
49160769|NCT03698279|158429119|FG005|Overall Study|Lost to Follow-up|0|||
49160770|NCT00272792|158429120|FG000|Part 1: Responsiveness|Lost to Follow-up|1|||
49160771|NCT00272792|158429121|FG001|Part 1: Responsiveness|Lost to Follow-up|0|||
49160772|NCT00272792|158429120|FG000|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0|||
48834488|NCT00853827|157235724|FG001|Single Blind Period (1 Week)|Abnormal laboratory value|0|||
49160773|NCT00272792|158429121|FG001|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2|||
49160774|NCT00272792|158429120|FG000|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1|||
49160775|NCT00272792|158429121|FG001|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0|||
49160776|NCT00272792|158429120|FG000|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0|||
49160777|NCT00272792|158429121|FG001|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1|||
49160778|NCT01359956|158429130|FG000|Overall Study|Death|58|||
49160779|NCT01359956|158429131|FG001|Overall Study|Death|60|||
49160780|NCT01359956|158429132|FG002|Overall Study|Death|66|||
49160781|NCT01359956|158429133|FG003|Overall Study|Death|57|||
49160782|NCT01359956|158429130|FG000|Overall Study|Lost to Follow-up|3|||
49160783|NCT01359956|158429131|FG001|Overall Study|Lost to Follow-up|4|||
49160784|NCT01359956|158429132|FG002|Overall Study|Lost to Follow-up|1|||
49160785|NCT01359956|158429133|FG003|Overall Study|Lost to Follow-up|1|||
49160786|NCT03728933|158429134|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
49160787|NCT03728933|158429135|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
49160788|NCT03728933|158429136|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
49160789|NCT03728933|158429134|FG000|Overall Study|Withdrawal by Subject|0|||
49160790|NCT03728933|158429135|FG001|Overall Study|Withdrawal by Subject|0|||
49160791|NCT03728933|158429136|FG002|Overall Study|Withdrawal by Subject|1|||
49160792|NCT03728933|158429134|FG000|Overall Study|Lost to Follow-up|0|||
49160793|NCT03728933|158429135|FG001|Overall Study|Lost to Follow-up|1|||
49160794|NCT03728933|158429136|FG002|Overall Study|Lost to Follow-up|0|||
49160795|NCT03728933|158429134|FG000|Overall Study|Adverse Event|1|||
49160796|NCT03728933|158429135|FG001|Overall Study|Adverse Event|0|||
48834489|NCT00853827|157235723|FG000|Single Blind Period (1 Week)|Abnormal test procedure result|1|||
48834490|NCT00853827|157235724|FG001|Single Blind Period (1 Week)|Abnormal test procedure result|0|||
48834491|NCT00853827|157235723|FG000|Single Blind Period (1 Week)|Withdrawal by Subject|9|||
48834492|NCT00853827|157235724|FG001|Single Blind Period (1 Week)|Withdrawal by Subject|0|||
48834493|NCT00853827|157235723|FG000|Single Blind Period (1 Week)|Lost to Follow-up|1|||
48834494|NCT00853827|157235724|FG001|Single Blind Period (1 Week)|Lost to Follow-up|0|||
48834495|NCT00853827|157235723|FG000|Single Blind Period (1 Week)|Protocol Violation|12|||
48834496|NCT00853827|157235724|FG001|Single Blind Period (1 Week)|Protocol Violation|0|||
48834497|NCT00853827|157235723|FG000|Double Blind Period (103 Weeks)|Adverse Event|25|||
48834498|NCT00853827|157235724|FG001|Double Blind Period (103 Weeks)|Adverse Event|14|||
48834499|NCT00853827|157235723|FG000|Double Blind Period (103 Weeks)|Abnormal laboratory values|0|||
49014596|NCT04634409|157888949|FG026|Overall Study|Death|0|||
49160797|NCT03728933|158429136|FG002|Overall Study|Adverse Event|0|||
49160798|NCT00582907|158429137|FG000|1st Course|Withdrawal by Subject|1|||
49160799|NCT00582907|158429138|FG001|1st Course|Withdrawal by Subject|0|||
49160800|NCT00582907|158429139|FG002|1st Course|Withdrawal by Subject|0|||
49160801|NCT00582907|158429140|FG003|1st Course|Withdrawal by Subject|0|||
49160802|NCT00582907|158429137|FG000|1st Course|Lost to Follow-up|0|||
49160803|NCT00582907|158429138|FG001|1st Course|Lost to Follow-up|0|||
49160804|NCT00582907|158429139|FG002|1st Course|Lost to Follow-up|0|||
49160805|NCT00582907|158429140|FG003|1st Course|Lost to Follow-up|1|||
49160806|NCT00582907|158429137|FG000|2nd Course|Lack of Efficacy|1|||
49160807|NCT00582907|158429138|FG001|2nd Course|Lack of Efficacy|0|||
48834500|NCT00853827|157235724|FG001|Double Blind Period (103 Weeks)|Abnormal laboratory values|3|||
48834501|NCT00853827|157235723|FG000|Double Blind Period (103 Weeks)|Lack of Efficacy|1|||
48834502|NCT00853827|157235724|FG001|Double Blind Period (103 Weeks)|Lack of Efficacy|0|||
48834503|NCT00853827|157235723|FG000|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3|||
48834504|NCT00853827|157235724|FG001|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1|||
48834505|NCT00853827|157235723|FG000|Double Blind Period (103 Weeks)|Protocol Violation|2|||
48834506|NCT00853827|157235724|FG001|Double Blind Period (103 Weeks)|Protocol Violation|1|||
48834507|NCT00853827|157235723|FG000|Double Blind Period (103 Weeks)|Withdrawal by Subject|19|||
48834508|NCT00853827|157235724|FG001|Double Blind Period (103 Weeks)|Withdrawal by Subject|18|||
48834509|NCT00853827|157235723|FG000|Double Blind Period (103 Weeks)|Lost to Follow-up|8|||
48834510|NCT00853827|157235724|FG001|Double Blind Period (103 Weeks)|Lost to Follow-up|10|||
48834511|NCT00853827|157235723|FG000|Double Blind Period (103 Weeks)|Administrative problems|45|||
48834512|NCT00853827|157235724|FG001|Double Blind Period (103 Weeks)|Administrative problems|56|||
48834513|NCT00853827|157235723|FG000|Double Blind Period (103 Weeks)|Death|1|||
49160808|NCT00582907|158429139|FG002|2nd Course|Lack of Efficacy|0|||
48834514|NCT00853827|157235724|FG001|Double Blind Period (103 Weeks)|Death|6|||
48834515|NCT00771849|157235725|FG000|Overall Study|Lost to Follow-up|1|||
48834516|NCT00771849|157235726|FG001|Overall Study|Lost to Follow-up|2|||
48834517|NCT00771849|157235725|FG000|Overall Study|Withdrawal by Subject|1|||
48834518|NCT00771849|157235726|FG001|Overall Study|Withdrawal by Subject|1|||
49160809|NCT00582907|158429140|FG003|2nd Course|Lack of Efficacy|0|||
49160810|NCT02332928|158429145|FG000|Overall Study|Withdrawal by Subject|0|||
49160811|NCT02332928|158429146|FG001|Overall Study|Withdrawal by Subject|2|||
49160812|NCT02332928|158429145|FG000|Overall Study|Cronavirus disease (COVID-19) Precautions|1|||
49160813|NCT02332928|158429146|FG001|Overall Study|Cronavirus disease (COVID-19) Precautions|0|||
49160814|NCT00639457|158429147|FG000|Overall Study|Withdrawal by Subject|2|||
49160815|NCT00639457|158429148|FG001|Overall Study|Withdrawal by Subject|3|||
49160816|NCT00370292|158429149|FG000|Overall Study|Disease Progression|4|||
49160817|NCT00370292|158429149|FG000|Overall Study|Adverse Event|7|||
49160818|NCT00370292|158429149|FG000|Overall Study|Physician Decision|2|||
49160819|NCT02239926|158429151|FG000|Overall Study|Withdrawal by Subject|0|||
49160820|NCT02239926|158429152|FG001|Overall Study|Withdrawal by Subject|1|||
49160821|NCT02921789|158429153|FG000|Overall Study|Adverse Event|0|||
49160822|NCT02921789|158429154|FG001|Overall Study|Adverse Event|1|||
49160823|NCT02921789|158429153|FG000|Overall Study|Lost to Follow-up|1|||
49160824|NCT02921789|158429154|FG001|Overall Study|Lost to Follow-up|0|||
49160825|NCT02921789|158429153|FG000|Overall Study|Protocol Deviation|2|||
49160826|NCT02921789|158429154|FG001|Overall Study|Protocol Deviation|0|||
49160827|NCT02921789|158429153|FG000|Overall Study|Withdrawal by Subject|2|||
49160828|NCT02921789|158429154|FG001|Overall Study|Withdrawal by Subject|1|||
49160829|NCT02921789|158429153|FG000|Overall Study|Miscellaneous|3|||
49160830|NCT02921789|158429154|FG001|Overall Study|Miscellaneous|2|||
49160831|NCT01334554|158429155|FG000|Overall Study|Adverse Event|4|||
49160832|NCT01334554|158429156|FG001|Overall Study|Adverse Event|2|||
49160833|NCT02704208|158429157|FG000|Overall Study|Lost to Follow-up|42|||
49160834|NCT02704208|158429158|FG001|Overall Study|Lost to Follow-up|37|||
49160835|NCT04099277|158429159|FG000|Overall Study|Physician Decision|1|||
49160836|NCT04099277|158429159|FG000|Overall Study|Withdrawal by Subject|1|||
49160837|NCT02393859|158429160|FG000|Overall Study|Decision by Sponsor|2|||
49160838|NCT02393859|158429161|FG001|Overall Study|Decision by Sponsor|4|||
49160839|NCT02393859|158429160|FG000|Overall Study|Withdrawal by Subject|11|||
49160840|NCT02393859|158429161|FG001|Overall Study|Withdrawal by Subject|6|||
49160841|NCT02393859|158429160|FG000|Overall Study|Death|27|||
49160842|NCT02393859|158429161|FG001|Overall Study|Death|10|||
49160843|NCT02393859|158429160|FG000|Overall Study|Lost to Follow-up|1|||
49160844|NCT02393859|158429161|FG001|Overall Study|Lost to Follow-up|1|||
49160845|NCT00598650|158429162|FG000|Overall Study|Withdrawal by Subject|3|||
49160846|NCT00598650|158429162|FG000|Overall Study|Adverse Event|18|||
49160847|NCT00598650|158429162|FG000|Overall Study|No treatment for 3 weeks|1|||
49160848|NCT00598650|158429162|FG000|Overall Study|Not eligible|1|||
49160849|NCT00598650|158429162|FG000|Overall Study|Prohibited Concomitant Medication|2|||
49160850|NCT00598650|158429162|FG000|Overall Study|Physician Decision|2|||
49160851|NCT04592341|158429163|FG000|Overall Study|Physician Decision|5|||
48735623|NCT00304239|156883694|FG001|Overall Study|Adverse Event|0|||
48735624|NCT03576495|156883695|FG000|Period 1 (0 Months)|Lost to Follow-up|51|||
48735625|NCT03576495|156883696|FG001|Period 1 (0 Months)|Lost to Follow-up|40|||
48735626|NCT00961649|156883697|FG000|Overall Study|Adverse Event|4|||
48735627|NCT00961649|156883698|FG001|Overall Study|Adverse Event|0|||
48735628|NCT00961649|156883699|FG002|Overall Study|Adverse Event|0|||
48735629|NCT00961649|156883700|FG003|Overall Study|Adverse Event|2|||
48735630|NCT00961649|156883697|FG000|Overall Study|Inadequate control of IOP|0|||
48735631|NCT00961649|156883698|FG001|Overall Study|Inadequate control of IOP|0|||
48735632|NCT00961649|156883699|FG002|Overall Study|Inadequate control of IOP|0|||
48735633|NCT00961649|156883700|FG003|Overall Study|Inadequate control of IOP|1|||
48735634|NCT00961649|156883697|FG000|Overall Study|Patient has travel plans during holidays|0|||
48923325|NCT01789970|157553206|FG001|Open-label Titration Period|Noncompliance with study rescue meds|0|||
48923326|NCT01789970|157553207|FG002|Open-label Titration Period|Noncompliance with study rescue meds|0|||
48923327|NCT01789970|157553205|FG000|Open-label Titration Period|Noncompliance with study procedures|8|||
48923328|NCT01789970|157553206|FG001|Open-label Titration Period|Noncompliance with study procedures|0|||
48923329|NCT01789970|157553207|FG002|Open-label Titration Period|Noncompliance with study procedures|0|||
48923330|NCT01789970|157553205|FG000|Open-label Titration Period|Pregnancy|2|||
48923331|NCT01789970|157553206|FG001|Open-label Titration Period|Pregnancy|0|||
48923332|NCT01789970|157553207|FG002|Open-label Titration Period|Pregnancy|0|||
48923333|NCT01789970|157553205|FG000|Open-label Titration Period|Other|76|||
48834519|NCT00771849|157235725|FG000|Overall Study|Not vaccinated|0|||
48834520|NCT00771849|157235726|FG001|Overall Study|Not vaccinated|1|||
48834521|NCT01370694|157235727|FG000|Overall Study|Switched to rituximab|4|||
48834522|NCT01370694|157235727|FG000|Overall Study|Progressive disease|2|||
48834523|NCT02736799|157235728|FG000|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
48834524|NCT02736799|157235729|FG001|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
48834525|NCT02736799|157235730|FG002|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
48834526|NCT02736799|157235731|FG003|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|1|||
48834527|NCT04842604|157235735|FG000|Overall Study|Death|1|||
48834528|NCT04842604|157235736|FG001|Overall Study|Death|0|||
48834529|NCT04842604|157235735|FG000|Overall Study|Other|4|||
48834530|NCT04842604|157235736|FG001|Overall Study|Other|4|||
48834531|NCT04842604|157235735|FG000|Overall Study|Randomized but not treated|1|||
48834532|NCT04842604|157235736|FG001|Overall Study|Randomized but not treated|0|||
48834533|NCT05046132|157235738|FG000|Overall Study|Adverse Event|4|||
48834534|NCT05046132|157235739|FG001|Overall Study|Adverse Event|0|||
48834535|NCT05046132|157235740|FG002|Overall Study|Adverse Event|0|||
48834536|NCT05046132|157235738|FG000|Overall Study|Withdrawal by Subject|3|||
48834537|NCT05046132|157235739|FG001|Overall Study|Withdrawal by Subject|0|||
48834538|NCT05046132|157235740|FG002|Overall Study|Withdrawal by Subject|0|||
48834539|NCT05046132|157235738|FG000|Overall Study|Positive Covid19 Result.|0|||
48834540|NCT05046132|157235739|FG001|Overall Study|Positive Covid19 Result.|1|||
48834541|NCT05046132|157235740|FG002|Overall Study|Positive Covid19 Result.|0|||
48834542|NCT00559949|157235741|FG000|Overall Study|Progressive Disease during cycle 1|1|||
48834543|NCT00559949|157235741|FG000|Overall Study|Adverse Event|1|||
48834544|NCT00559949|157235741|FG000|Overall Study|Withdrawal by Subject|4|||
48834545|NCT00559949|157235741|FG000|Overall Study|No disease evaluation per protocol|1|||
48834546|NCT01183780|157235742|FG000|Overall Study|Withdrawal by Subject|25|||
48834547|NCT01183780|157235743|FG001|Overall Study|Withdrawal by Subject|14|||
48834548|NCT01183780|157235742|FG000|Overall Study|Lost to Follow-up|6|||
48834549|NCT01183780|157235743|FG001|Overall Study|Lost to Follow-up|11|||
48834550|NCT04493242|157235744|FG000|Overall Study|Death|10|||
48834551|NCT04493242|157235745|FG001|Overall Study|Death|14|||
48834552|NCT04493242|157235746|FG002|Overall Study|Death|16|||
48834553|NCT04493242|157235744|FG000|Overall Study|Lost to Follow-up|1|||
48834554|NCT04493242|157235745|FG001|Overall Study|Lost to Follow-up|1|||
48834555|NCT04493242|157235746|FG002|Overall Study|Lost to Follow-up|0|||
48834556|NCT04493242|157235744|FG000|Overall Study|Withdrawal by Subject|1|||
48923334|NCT01789970|157553206|FG001|Open-label Titration Period|Other|0|||
49014597|NCT04634409|157888923|FG000|Overall Study|Adverse Event|0|||
49014598|NCT04634409|157888924|FG001|Overall Study|Adverse Event|0|||
49014599|NCT04634409|157888925|FG002|Overall Study|Adverse Event|1|||
49014600|NCT04634409|157888926|FG003|Overall Study|Adverse Event|0|||
49014601|NCT04634409|157888927|FG004|Overall Study|Adverse Event|0|||
49014602|NCT04634409|157888928|FG005|Overall Study|Adverse Event|1|||
49014603|NCT04634409|157888929|FG006|Overall Study|Adverse Event|0|||
49014604|NCT04634409|157888930|FG007|Overall Study|Adverse Event|0|||
49014605|NCT04634409|157888931|FG008|Overall Study|Adverse Event|0|||
49014606|NCT04634409|157888932|FG009|Overall Study|Adverse Event|0|||
49014607|NCT04634409|157888933|FG010|Overall Study|Adverse Event|0|||
48834557|NCT04493242|157235745|FG001|Overall Study|Withdrawal by Subject|0|||
48834558|NCT04493242|157235746|FG002|Overall Study|Withdrawal by Subject|0|||
48834559|NCT04493242|157235744|FG000|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
48834560|NCT04493242|157235745|FG001|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
48834561|NCT04493242|157235746|FG002|Overall Study|Subjects Discharged from Hospital Prior to End of Study|0|||
48834562|NCT04493242|157235744|FG000|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
48834563|NCT04493242|157235745|FG001|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|2|||
48834564|NCT04493242|157235746|FG002|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
48834565|NCT00754936|157235749|FG000|Overall Study|Lost to Follow-up|3|||
48834566|NCT00754936|157235749|FG000|Overall Study|Physician Decision|1|||
48834567|NCT00754936|157235749|FG000|Overall Study|Withdrawal by Subject|2|||
48834568|NCT00754936|157235749|FG000|Overall Study|Side Effects|3|||
48834569|NCT00754936|157235749|FG000|Overall Study|Inter-current medical events|3|||
48834570|NCT00530842|157235752|FG000|Overall Study|Adverse Event|10|||
48834571|NCT00530842|157235753|FG001|Overall Study|Adverse Event|6|||
48834572|NCT00530842|157235752|FG000|Overall Study|Lack of Efficacy|2|||
48834573|NCT00530842|157235753|FG001|Overall Study|Lack of Efficacy|1|||
48834574|NCT00530842|157235752|FG000|Overall Study|Lost to Follow-up|0|||
48834575|NCT00530842|157235753|FG001|Overall Study|Lost to Follow-up|4|||
48834576|NCT00530842|157235752|FG000|Overall Study|Protocol Violation|3|||
48834577|NCT00530842|157235753|FG001|Overall Study|Protocol Violation|2|||
48834578|NCT00530842|157235752|FG000|Overall Study|Withdrawal by Subject|4|||
48834579|NCT00530842|157235753|FG001|Overall Study|Withdrawal by Subject|5|||
48834580|NCT00530842|157235752|FG000|Overall Study|Individual different reasons|4|||
48834581|NCT00530842|157235753|FG001|Overall Study|Individual different reasons|3|||
48834582|NCT00530842|157235752|FG000|Period 1|Adverse Event|7|||
48834583|NCT00530842|157235753|FG001|Period 1|Adverse Event|3|||
48834584|NCT00530842|157235752|FG000|Period 1|Lack of Efficacy|1|||
48834585|NCT00530842|157235753|FG001|Period 1|Lack of Efficacy|1|||
48834586|NCT00530842|157235752|FG000|Period 1|Protocol Violation|2|||
48834587|NCT00530842|157235753|FG001|Period 1|Protocol Violation|1|||
48834588|NCT00530842|157235752|FG000|Period 1|Withdrawal by Subject|2|||
48834589|NCT00530842|157235753|FG001|Period 1|Withdrawal by Subject|3|||
48834590|NCT00530842|157235752|FG000|Period 1|Individual different reasons|2|||
48834591|NCT00530842|157235753|FG001|Period 1|Individual different reasons|3|||
48834592|NCT00530842|157235752|FG000|Period 2|Adverse Event|3|||
48834593|NCT00530842|157235753|FG001|Period 2|Adverse Event|3|||
48834594|NCT00530842|157235752|FG000|Period 2|Lack of Efficacy|1|||
48834595|NCT00530842|157235753|FG001|Period 2|Lack of Efficacy|0|||
48834596|NCT00530842|157235752|FG000|Period 2|Lost to Follow-up|0|||
48834597|NCT00530842|157235753|FG001|Period 2|Lost to Follow-up|4|||
48834598|NCT00530842|157235752|FG000|Period 2|Protocol Violation|1|||
48834599|NCT00530842|157235753|FG001|Period 2|Protocol Violation|0|||
48834600|NCT00530842|157235752|FG000|Period 2|Withdrawal by Subject|1|||
48834601|NCT00530842|157235753|FG001|Period 2|Withdrawal by Subject|2|||
48834602|NCT00530842|157235752|FG000|Period 2|Individual different reasons|2|||
48834603|NCT00530842|157235753|FG001|Period 2|Individual different reasons|0|||
48834604|NCT00835380|157235756|FG000|Overall Study|Withdrawal by Subject|2|||
48834605|NCT02950558|157235758|FG000|Overall Study|Lost to Follow-up|2|||
48834606|NCT02950558|157235759|FG001|Overall Study|Lost to Follow-up|0|||
48834607|NCT00319436|157235762|FG000|Overall Study|Withdrawal by Subject|6|||
48834608|NCT00319436|157235763|FG001|Overall Study|Withdrawal by Subject|7|||
48834609|NCT02000817|157235768|FG000|Overall Study|Withdrawal by Subject|2|||
48834610|NCT02000817|157235769|FG001|Overall Study|Withdrawal by Subject|0|||
48834611|NCT02000817|157235770|FG002|Overall Study|Withdrawal by Subject|0|||
48834612|NCT02000817|157235771|FG003|Overall Study|Withdrawal by Subject|0|||
48834613|NCT02000817|157235768|FG000|Overall Study|Adverse Event|0|||
48834614|NCT02000817|157235769|FG001|Overall Study|Adverse Event|1|||
48834615|NCT02000817|157235770|FG002|Overall Study|Adverse Event|0|||
48834616|NCT02000817|157235771|FG003|Overall Study|Adverse Event|0|||
48834617|NCT02000817|157235768|FG000|Overall Study|Lost to Follow-up|0|||
48834618|NCT02000817|157235769|FG001|Overall Study|Lost to Follow-up|0|||
48834619|NCT02000817|157235770|FG002|Overall Study|Lost to Follow-up|1|||
49160852|NCT04592341|158429163|FG000|Overall Study|Study Terminated by Sponsor|5|||
48834620|NCT02000817|157235771|FG003|Overall Study|Lost to Follow-up|0|||
48834621|NCT01792830|157235775|FG000|Overall Study|Withdrawal by Subject|22|||
49160853|NCT04592341|158429163|FG000|Overall Study|Withdrawal by Subject|53|||
49160854|NCT04592341|158429163|FG000|Overall Study|Lost to Follow-up|3|||
49160855|NCT04592341|158429163|FG000|Overall Study|Death|1|||
49160856|NCT04592341|158429163|FG000|Overall Study|Adverse Event|5|||
49160857|NCT04592341|158429163|FG000|Overall Study|other|4|||
49160858|NCT03423121|158429164|FG000|Overall Study|Lost to Follow-up|2|||
49160859|NCT03423121|158429165|FG001|Overall Study|Lost to Follow-up|6|||
49160860|NCT03423121|158429164|FG000|Overall Study|Adverse Event|1|||
49160861|NCT03423121|158429165|FG001|Overall Study|Adverse Event|0|||
49160862|NCT01669902|158429166|FG000|Overall Study|Adverse Event|11|||
49160863|NCT01669902|158429166|FG000|Overall Study|Lack of Efficacy|10|||
49160864|NCT01669902|158429166|FG000|Overall Study|Other|8|||
49160865|NCT02332187|158429169|FG000|Overall Study|Withdrawal by Subject|2|||
49160866|NCT02332187|158429170|FG001|Overall Study|Withdrawal by Subject|2|||
48834622|NCT01792830|157235776|FG001|Overall Study|Withdrawal by Subject|0|||
48834623|NCT01792830|157235777|FG002|Overall Study|Withdrawal by Subject|0|||
48834624|NCT01792830|157235778|FG003|Overall Study|Withdrawal by Subject|2|||
48834625|NCT01792830|157235779|FG004|Overall Study|Withdrawal by Subject|1|||
48834626|NCT01792830|157235780|FG005|Overall Study|Withdrawal by Subject|1|||
48834627|NCT01792830|157235781|FG006|Overall Study|Withdrawal by Subject|1|||
48834628|NCT01792830|157235782|FG007|Overall Study|Withdrawal by Subject|1|||
48834629|NCT01792830|157235783|FG008|Overall Study|Withdrawal by Subject|7|||
48834630|NCT01792830|157235784|FG009|Overall Study|Withdrawal by Subject|0|||
48834631|NCT01792830|157235785|FG010|Overall Study|Withdrawal by Subject|2|||
49160867|NCT02332187|158429169|FG000|Overall Study|Adverse Event|0|||
49160868|NCT02332187|158429170|FG001|Overall Study|Adverse Event|1|||
49160869|NCT01114737|158429171|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
49160870|NCT01114737|158429172|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
49160871|NCT01114737|158429171|FG000|Randomized Treatment Period|Lost to Follow-up|1|||
49160872|NCT01114737|158429172|FG001|Randomized Treatment Period|Lost to Follow-up|1|||
49160873|NCT01114737|158429171|FG000|Randomized Treatment Period|Pregnancy|1|||
49160874|NCT01114737|158429172|FG001|Randomized Treatment Period|Pregnancy|0|||
48834632|NCT01792830|157235775|FG000|Overall Study|Death|3|||
48834633|NCT01792830|157235776|FG001|Overall Study|Death|0|||
48834634|NCT01792830|157235777|FG002|Overall Study|Death|0|||
48834635|NCT01792830|157235778|FG003|Overall Study|Death|1|||
48834636|NCT01792830|157235779|FG004|Overall Study|Death|0|||
48834637|NCT01792830|157235780|FG005|Overall Study|Death|0|||
48834638|NCT01792830|157235781|FG006|Overall Study|Death|1|||
48834639|NCT01792830|157235782|FG007|Overall Study|Death|0|||
48834640|NCT01792830|157235783|FG008|Overall Study|Death|1|||
48834641|NCT01792830|157235784|FG009|Overall Study|Death|0|||
48834642|NCT01792830|157235785|FG010|Overall Study|Death|1|||
48834643|NCT01792830|157235775|FG000|Overall Study|Adverse Event|0|||
48834644|NCT01792830|157235776|FG001|Overall Study|Adverse Event|0|||
48834645|NCT01792830|157235777|FG002|Overall Study|Adverse Event|0|||
48834646|NCT01792830|157235778|FG003|Overall Study|Adverse Event|0|||
48834647|NCT01792830|157235779|FG004|Overall Study|Adverse Event|0|||
48834648|NCT01792830|157235780|FG005|Overall Study|Adverse Event|0|||
48834649|NCT01792830|157235781|FG006|Overall Study|Adverse Event|0|||
48834650|NCT01792830|157235782|FG007|Overall Study|Adverse Event|0|||
48834651|NCT01792830|157235783|FG008|Overall Study|Adverse Event|1|||
48834652|NCT01792830|157235784|FG009|Overall Study|Adverse Event|0|||
48834653|NCT01792830|157235785|FG010|Overall Study|Adverse Event|0|||
48834654|NCT00547118|157235786|FG000|Overall Study|Did not qualify prior to starting drug|1|||
48834655|NCT00547118|157235787|FG001|Overall Study|Did not qualify prior to starting drug|1|||
48834656|NCT00547118|157235786|FG000|Overall Study|Study suspended|7|||
48834657|NCT00547118|157235787|FG001|Overall Study|Study suspended|8|||
48834658|NCT00539292|157235788|FG000|Overall Study|Physician Decision|1|||
48834659|NCT00539292|157235789|FG001|Overall Study|Physician Decision|0|||
48834660|NCT02685488|157235793|FG000|Overall Study|Withdrawal by Subject|0|||
48834661|NCT02685488|157235794|FG001|Overall Study|Withdrawal by Subject|1|||
48834662|NCT02621424|157235795|FG000|Overall Study|Withdrawal by Subject|1|||
48834663|NCT02621424|157235796|FG001|Overall Study|Withdrawal by Subject|2|||
48834664|NCT00305695|157235799|FG000|Overall Study|Withdrawal by subject prior to 18 month|40|||
48834665|NCT00305695|157235800|FG001|Overall Study|Withdrawal by subject prior to 18 month|26|||
48834666|NCT00305695|157235799|FG000|Overall Study|Did not have baseline scan|1|||
48834667|NCT00305695|157235800|FG001|Overall Study|Did not have baseline scan|1|||
48834668|NCT01697319|157235802|FG000|Primary Phase|Withdrawal by Subject|1|||
48834669|NCT01697319|157235802|FG000|Extension Phase|Terminated by Sponsor|15|||
48834670|NCT04222959|157235806|FG000|Overall Study|Lost to Follow-up|76|||
48834671|NCT04222959|157235807|FG001|Overall Study|Lost to Follow-up|28|||
48834672|NCT00794118|157235808|FG000|Overall Study|Lost to Follow-up|16|||
48834673|NCT00794118|157235808|FG000|Overall Study|Withdrawal by Subject|9|||
48834674|NCT00794118|157235808|FG000|Overall Study|Changed hospital center|2|||
48834675|NCT02918071|157235809|FG000|Overall Study|Withdrawal by Subject|2|||
48834676|NCT02918071|157235809|FG000|Overall Study|Lost to Follow-up|1|||
48834677|NCT01251354|157235816|FG000|Overall Study|Adverse Event|1|||
48834678|NCT01251354|157235816|FG000|Overall Study|Investigator's Decision|1|||
48834679|NCT01251354|157235816|FG000|Overall Study|Disease Progression|4|||
48834680|NCT04057196|157237042|FG000|Overall Study|Withdrawal by Subject|3|||
48834681|NCT04057196|157237042|FG000|Overall Study|Death|3|||
48834682|NCT03439124|157237043|FG000|Overall Study|Adverse Event|2|||
48834683|NCT03439124|157237044|FG001|Overall Study|Adverse Event|0|||
48834684|NCT03439124|157237043|FG000|Overall Study|Lost to Follow-up|1|||
48834685|NCT03439124|157237044|FG001|Overall Study|Lost to Follow-up|0|||
48834686|NCT03439124|157237043|FG000|Overall Study|Other reasons|1|||
48834687|NCT03439124|157237044|FG001|Overall Study|Other reasons|0|||
48834688|NCT00918957|157237047|FG000|Overall Study|Adverse Event|2|||
48834689|NCT00918957|157237048|FG001|Overall Study|Adverse Event|0|||
49160875|NCT01114737|158429171|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
49160876|NCT01114737|158429172|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
49160877|NCT01114737|158429171|FG000|Open-Label Treatment Period|Lost to Follow-up|3|||
49160878|NCT01114737|158429172|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
49160879|NCT01114737|158429171|FG000|Open-Label Treatment Period|Difficult Personal Events|1|||
49160880|NCT01114737|158429172|FG001|Open-Label Treatment Period|Difficult Personal Events|0|||
49160881|NCT00457392|158429173|FG000|Overall Study|Objective Progression or Relapse|229|||
48834690|NCT00918957|157237047|FG000|Overall Study|Withdrawal by Subject|1|||
48834691|NCT00918957|157237048|FG001|Overall Study|Withdrawal by Subject|0|||
49160882|NCT00457392|158429174|FG001|Overall Study|Objective Progression or Relapse|296|||
49160883|NCT00457392|158429173|FG000|Overall Study|Death|106|||
49160884|NCT00457392|158429174|FG001|Overall Study|Death|106|||
49160885|NCT00457392|158429173|FG000|Overall Study|Adverse Event|84|||
49160886|NCT00457392|158429174|FG001|Overall Study|Adverse Event|41|||
49160887|NCT00457392|158429173|FG000|Overall Study|Global Deterioration of Health Status|22|||
49160888|NCT00457392|158429174|FG001|Overall Study|Global Deterioration of Health Status|8|||
49160889|NCT00457392|158429173|FG000|Overall Study|Withdrawal by Subject|14|||
49160890|NCT00457392|158429174|FG001|Overall Study|Withdrawal by Subject|8|||
49160891|NCT00457392|158429173|FG000|Overall Study|Lost to Follow-up|6|||
49160892|NCT00457392|158429174|FG001|Overall Study|Lost to Follow-up|7|||
49160893|NCT00457392|158429173|FG000|Overall Study|Protocol Violation|4|||
48834692|NCT04464421|157237049|FG000|Overall Study|Lost to Follow-up|2|||
48834693|NCT04464421|157237050|FG001|Overall Study|Lost to Follow-up|2|||
48834694|NCT00487578|157237051|FG000|Overall Study|Adverse Event|1|||
48834695|NCT00487578|157237052|FG001|Overall Study|Adverse Event|2|||
48834696|NCT00487578|157237051|FG000|Overall Study|Lack of Efficacy|0|||
48834697|NCT00487578|157237052|FG001|Overall Study|Lack of Efficacy|1|||
48834698|NCT00487578|157237051|FG000|Overall Study|Lost to Follow-up|0|||
49160894|NCT00457392|158429174|FG001|Overall Study|Protocol Violation|3|||
49160895|NCT00457392|158429173|FG000|Overall Study|Other|7|||
48834699|NCT00487578|157237052|FG001|Overall Study|Lost to Follow-up|1|||
48834700|NCT00768664|157237053|FG000|Overall Study|Death|57|||
48834701|NCT00768664|157237053|FG000|Overall Study|Lost to Follow-up|2|||
49160896|NCT00457392|158429174|FG001|Overall Study|Other|4|||
49160897|NCT00457392|158429173|FG000|Overall Study|Study Terminated by Sponsor|1|||
49160898|NCT00457392|158429174|FG001|Overall Study|Study Terminated by Sponsor|4|||
48834702|NCT00768664|157237053|FG000|Overall Study|Other|9|||
48834703|NCT00768664|157237053|FG000|Overall Study|Participant refused|1|||
48834704|NCT00726999|157237058|FG000|Overall Study|Physician Decision|0|||
48834705|NCT00726999|157237059|FG001|Overall Study|Physician Decision|1|||
48834706|NCT00726999|157237058|FG000|Overall Study|Withdrawal by Subject|2|||
48834707|NCT00726999|157237059|FG001|Overall Study|Withdrawal by Subject|0|||
48834708|NCT00726999|157237058|FG000|Overall Study|Protocol Violation|1|||
48834709|NCT00726999|157237059|FG001|Overall Study|Protocol Violation|0|||
48834710|NCT04480827|157237060|FG000|Overall Study|Adverse Event|0|||
48834711|NCT04480827|157237061|FG001|Overall Study|Adverse Event|0|||
48834712|NCT04480827|157237062|FG002|Overall Study|Adverse Event|0|||
48834713|NCT04480827|157237063|FG003|Overall Study|Adverse Event|0|||
48834714|NCT04480827|157237064|FG004|Overall Study|Adverse Event|0|||
48834715|NCT04480827|157237065|FG005|Overall Study|Adverse Event|1|||
48834716|NCT04480827|157237066|FG006|Overall Study|Adverse Event|0|||
48834717|NCT05257798|157237067|FG000|Follow-up Phase|Lost to Follow-up|1|||
48834718|NCT05257798|157237068|FG001|Follow-up Phase|Lost to Follow-up|0|||
49160899|NCT00457392|158429173|FG000|Overall Study|Randomized, Not Treated|7|||
49160900|NCT00457392|158429174|FG001|Overall Study|Randomized, Not Treated|3|||
49160901|NCT01049373|158429175|FG000|Overall Study|Protocol Violation|9|||
49160902|NCT01049373|158429176|FG001|Overall Study|Protocol Violation|9|||
49160903|NCT01049373|158429175|FG000|Overall Study|Withdrawal by Subject|8|||
49160904|NCT01049373|158429176|FG001|Overall Study|Withdrawal by Subject|5|||
49160905|NCT01049373|158429175|FG000|Overall Study|Adverse Event|3|||
49160906|NCT01049373|158429176|FG001|Overall Study|Adverse Event|3|||
49160907|NCT01049373|158429175|FG000|Overall Study|Lost to Follow-up|9|||
49160908|NCT01049373|158429176|FG001|Overall Study|Lost to Follow-up|4|||
49160909|NCT01049373|158429175|FG000|Overall Study|no evaluable study values|9|||
49160910|NCT01049373|158429176|FG001|Overall Study|no evaluable study values|21|||
49160911|NCT01049373|158429175|FG000|Overall Study|Other|1|||
49160912|NCT01049373|158429176|FG001|Overall Study|Other|1|||
49160913|NCT01049373|158429175|FG000|Overall Study|Non-cooperation|0|||
49160914|NCT01049373|158429176|FG001|Overall Study|Non-cooperation|1|||
49160915|NCT00812955|158429177|FG000|Overall Study|Adverse Event|7|||
49160916|NCT00812955|158429178|FG001|Overall Study|Adverse Event|6|||
49160917|NCT00812955|158429179|FG002|Overall Study|Adverse Event|3|||
49160918|NCT00812955|158429180|FG003|Overall Study|Adverse Event|4|||
49160919|NCT00812955|158429177|FG000|Overall Study|Lost to Follow-up|2|||
49160920|NCT00812955|158429178|FG001|Overall Study|Lost to Follow-up|1|||
49160921|NCT00812955|158429179|FG002|Overall Study|Lost to Follow-up|1|||
49160922|NCT00812955|158429180|FG003|Overall Study|Lost to Follow-up|2|||
49160923|NCT00812955|158429177|FG000|Overall Study|Withdrawal by Subject|1|||
49160924|NCT00812955|158429178|FG001|Overall Study|Withdrawal by Subject|0|||
49160925|NCT00812955|158429179|FG002|Overall Study|Withdrawal by Subject|1|||
49160926|NCT00812955|158429180|FG003|Overall Study|Withdrawal by Subject|2|||
49160927|NCT00812955|158429177|FG000|Overall Study|randomized in error|0|||
49160928|NCT00812955|158429178|FG001|Overall Study|randomized in error|0|||
49160929|NCT00812955|158429179|FG002|Overall Study|randomized in error|1|||
49160930|NCT00812955|158429180|FG003|Overall Study|randomized in error|0|||
49160931|NCT01493089|158429181|FG000|Overall Study|Protocol Violation|2|||
49160932|NCT01493089|158429182|FG001|Overall Study|Protocol Violation|2|||
49160933|NCT01493089|158429181|FG000|Overall Study|Withdrawal by Subject|1|||
49160934|NCT01493089|158429182|FG001|Overall Study|Withdrawal by Subject|0|||
49160935|NCT01493089|158429181|FG000|Overall Study|Physician Decision|0|||
49160936|NCT01493089|158429182|FG001|Overall Study|Physician Decision|1|||
49160937|NCT01905540|158429183|FG000|Period 3|Other|1|||
49160938|NCT01905540|158429184|FG001|Period 3|Other|0|||
49160939|NCT01905540|158429185|FG002|Period 3|Other|1|||
49160940|NCT01905540|158429186|FG003|Period 3|Other|1|||
49160941|NCT04661033|158429187|FG000|Overall Study|Adverse Event|0|||
48834719|NCT00419094|157237072|FG000|Overall Study|Adverse Event|3|||
49160942|NCT04661033|158429188|FG001|Overall Study|Adverse Event|0|||
49160943|NCT04661033|158429189|FG002|Overall Study|Adverse Event|1|||
49160944|NCT04661033|158429190|FG003|Overall Study|Adverse Event|0|||
49160945|NCT04661033|158429187|FG000|Overall Study|Switch of cohort due to retreatment criteria met|1|||
49160946|NCT04661033|158429188|FG001|Overall Study|Switch of cohort due to retreatment criteria met|0|||
49160947|NCT04661033|158429189|FG002|Overall Study|Switch of cohort due to retreatment criteria met|0|||
49160948|NCT04661033|158429190|FG003|Overall Study|Switch of cohort due to retreatment criteria met|0|||
49160949|NCT04661033|158429187|FG000|Overall Study|As per Principal Investigator (PI) decision|1|||
48834720|NCT00419094|157237073|FG001|Overall Study|Adverse Event|7|||
48834721|NCT00419094|157237072|FG000|Overall Study|Lack of Efficacy|1|||
48834722|NCT00419094|157237073|FG001|Overall Study|Lack of Efficacy|0|||
48834723|NCT00419094|157237072|FG000|Overall Study|Lost to Follow-up|0|||
48834724|NCT00419094|157237073|FG001|Overall Study|Lost to Follow-up|2|||
48834725|NCT00419094|157237072|FG000|Overall Study|Protocol Violation|1|||
48834726|NCT00419094|157237073|FG001|Overall Study|Protocol Violation|14|||
49160950|NCT04661033|158429188|FG001|Overall Study|As per Principal Investigator (PI) decision|0|||
49160951|NCT04661033|158429189|FG002|Overall Study|As per Principal Investigator (PI) decision|0|||
49160952|NCT04661033|158429190|FG003|Overall Study|As per Principal Investigator (PI) decision|0|||
49160953|NCT04661033|158429187|FG000|Overall Study|Early discontinuation as per PI|1|||
49160954|NCT04661033|158429188|FG001|Overall Study|Early discontinuation as per PI|0|||
49160955|NCT04661033|158429189|FG002|Overall Study|Early discontinuation as per PI|0|||
49160956|NCT04661033|158429190|FG003|Overall Study|Early discontinuation as per PI|0|||
49160957|NCT04562116|158429191|FG000|Overall Study|Lost to Follow-up|1|||
49160958|NCT04562116|158429191|FG000|Overall Study|Withdrawal by Subject|3|||
49160959|NCT00448448|158429192|FG000|Overall Study|Withdrawal by Subject|13|||
49160960|NCT00448448|158429193|FG001|Overall Study|Withdrawal by Subject|2|||
49160961|NCT00448448|158429192|FG000|Overall Study|On protocol when study ended|83|||
49160962|NCT00448448|158429193|FG001|Overall Study|On protocol when study ended|36|||
49160963|NCT00448448|158429192|FG000|Overall Study|Lost to Follow-up|2|||
48834727|NCT00419094|157237072|FG000|Overall Study|Withdrawal of consent|1|||
48834728|NCT00419094|157237073|FG001|Overall Study|Withdrawal of consent|5|||
48834729|NCT00419094|157237072|FG000|Overall Study|Other: Error determining exit criteria|1|||
48834730|NCT00419094|157237073|FG001|Overall Study|Other: Error determining exit criteria|0|||
48834731|NCT00419094|157237072|FG000|Overall Study|Other: Patient non-compliant|0|||
48834732|NCT00419094|157237073|FG001|Overall Study|Other: Patient non-compliant|1|||
48834733|NCT00419094|157237072|FG000|Overall Study|Other: No contact for extended period|0|||
48834734|NCT00419094|157237073|FG001|Overall Study|Other: No contact for extended period|1|||
48834735|NCT00814346|157237074|FG000|Double-blind Phase (4 Weeks)|Adverse Event|0|||
48834736|NCT00814346|157237075|FG001|Double-blind Phase (4 Weeks)|Adverse Event|1|||
49160964|NCT00448448|158429193|FG001|Overall Study|Lost to Follow-up|1|||
49160965|NCT00448448|158429192|FG000|Overall Study|Wrong diagnosis (n=3) or other|2|||
49160966|NCT00448448|158429193|FG001|Overall Study|Wrong diagnosis (n=3) or other|1|||
49160967|NCT00448448|158429192|FG000|Overall Study|Signed consent lost|0|||
49160968|NCT00448448|158429193|FG001|Overall Study|Signed consent lost|1|||
49160969|NCT01071954|158429194|FG000|Overall Study|Noncompliance|4|||
49160970|NCT01071954|158429194|FG000|Overall Study|Adverse Event|1|||
49160971|NCT01071954|158429194|FG000|Overall Study|Withdrawal by Subject|11|||
49160972|NCT01071954|158429194|FG000|Overall Study|Requirement for Alternative Therapy|5|||
49160973|NCT01071954|158429194|FG000|Overall Study|Administrative Decision|5|||
49160974|NCT01071954|158429194|FG000|Overall Study|Protocol Specified Criteria|1|||
49160975|NCT01823289|158429195|FG000|Overall Study|Lost to Follow-up|5|||
49160976|NCT01823289|158429195|FG000|Overall Study|Adverse Event|5|||
49160977|NCT01823289|158429195|FG000|Overall Study|Lack of Efficacy|1|||
49160978|NCT01823289|158429195|FG000|Overall Study|Physician Decision|9|||
48834737|NCT00814346|157237074|FG000|Double-blind Phase (4 Weeks)|Not otherwise specified|0|||
48834738|NCT00814346|157237075|FG001|Double-blind Phase (4 Weeks)|Not otherwise specified|2|||
48834739|NCT00814346|157237074|FG000|Open Phase (17 Months)|Adverse Event|5|||
48834740|NCT00814346|157237075|FG001|Open Phase (17 Months)|Adverse Event|0|||
48834741|NCT00814346|157237074|FG000|Open Phase (17 Months)|Consent|2|||
48834742|NCT00814346|157237075|FG001|Open Phase (17 Months)|Consent|0|||
48834743|NCT00814346|157237074|FG000|Open Phase (17 Months)|Lost to Follow-up|2|||
48834744|NCT00814346|157237075|FG001|Open Phase (17 Months)|Lost to Follow-up|0|||
48834745|NCT00814346|157237074|FG000|Open Phase (17 Months)|Not otherwise specified|1|||
48834746|NCT00814346|157237075|FG001|Open Phase (17 Months)|Not otherwise specified|0|||
49160979|NCT01823289|158429195|FG000|Overall Study|Administered contraindicated medicine|1|||
49160980|NCT01823289|158429195|FG000|Overall Study|Transaminase increased more than 3 times|1|||
49160981|NCT01823289|158429195|FG000|Overall Study|Drug affected efficacy and safety|1|||
49160982|NCT01823289|158429195|FG000|Overall Study|Creatinine clearance<30milliliter/minute|1|||
49160983|NCT02259114|158429197|FG000|Overall Study|Progressive Disease|14|||
49160984|NCT02259114|158429198|FG001|Overall Study|Progressive Disease|2|||
49160985|NCT02259114|158429199|FG002|Overall Study|Progressive Disease|10|||
49160986|NCT02259114|158429200|FG003|Overall Study|Progressive Disease|2|||
49160987|NCT02259114|158429201|FG004|Overall Study|Progressive Disease|5|||
49160988|NCT02259114|158429197|FG000|Overall Study|Adverse Event|2|||
49160989|NCT02259114|158429198|FG001|Overall Study|Adverse Event|1|||
49160990|NCT02259114|158429199|FG002|Overall Study|Adverse Event|0|||
49160991|NCT02259114|158429200|FG003|Overall Study|Adverse Event|0|||
49160992|NCT02259114|158429201|FG004|Overall Study|Adverse Event|1|||
49160993|NCT02259114|158429197|FG000|Overall Study|Death|3|||
49160994|NCT02259114|158429198|FG001|Overall Study|Death|0|||
49160995|NCT02259114|158429199|FG002|Overall Study|Death|1|||
49160996|NCT02259114|158429200|FG003|Overall Study|Death|0|||
49160997|NCT02259114|158429201|FG004|Overall Study|Death|0|||
49160998|NCT02259114|158429197|FG000|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
49160999|NCT02259114|158429198|FG001|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
49161000|NCT02259114|158429199|FG002|Overall Study|Treatment Delay >2 wks: Adverse Event|1|||
49161001|NCT02259114|158429200|FG003|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
48834747|NCT05136443|157237078|FG000|Overall Study|Lost to Follow-up|2|||
48834748|NCT05136443|157237078|FG000|Overall Study|Adverse Event|2|||
48834749|NCT04580303|157237080|FG000|Overall Study|Adverse Event|0|||
49161002|NCT02259114|158429201|FG004|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
49161003|NCT02259114|158429197|FG000|Overall Study|Withdrawal by Subject|0|||
49161004|NCT02259114|158429198|FG001|Overall Study|Withdrawal by Subject|0|||
48834750|NCT04580303|157237081|FG001|Overall Study|Adverse Event|1|||
48834751|NCT04580303|157237082|FG002|Overall Study|Adverse Event|0|||
48834752|NCT04580303|157237083|FG003|Overall Study|Adverse Event|0|||
48834753|NCT04580303|157237080|FG000|Overall Study|Withdrawal by Subject|0|||
48834754|NCT04580303|157237081|FG001|Overall Study|Withdrawal by Subject|0|||
48834755|NCT04580303|157237082|FG002|Overall Study|Withdrawal by Subject|1|||
48834756|NCT04580303|157237083|FG003|Overall Study|Withdrawal by Subject|0|||
48834757|NCT00753012|157237084|FG000|Overall Study|Ineligible, abnormal cardiac histo|1|||
48834758|NCT00753012|157237085|FG001|Overall Study|Ineligible, abnormal cardiac histo|0|||
48834759|NCT00753012|157237084|FG000|Overall Study|Adverse Event|2|||
48834760|NCT00753012|157237085|FG001|Overall Study|Adverse Event|0|||
48834761|NCT00753012|157237084|FG000|Overall Study|Withdrawal by Subject|0|||
48834762|NCT00753012|157237085|FG001|Overall Study|Withdrawal by Subject|1|||
48834763|NCT00753012|157237084|FG000|Overall Study|Lost to Follow-up|4|||
48834764|NCT00753012|157237085|FG001|Overall Study|Lost to Follow-up|0|||
48834765|NCT00753012|157237084|FG000|Overall Study|Confounded endpoint data|1|||
48834766|NCT00753012|157237085|FG001|Overall Study|Confounded endpoint data|0|||
48834767|NCT01290224|157237086|FG000|Overall Study|Adverse Event|1|||
49161005|NCT02259114|158429199|FG002|Overall Study|Withdrawal by Subject|1|||
49161006|NCT02259114|158429200|FG003|Overall Study|Withdrawal by Subject|1|||
49161007|NCT02259114|158429201|FG004|Overall Study|Withdrawal by Subject|0|||
49161008|NCT02259114|158429197|FG000|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
49161009|NCT02259114|158429198|FG001|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
49161010|NCT02259114|158429199|FG002|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
49161011|NCT02259114|158429200|FG003|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
49161012|NCT02259114|158429201|FG004|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
49161013|NCT02259114|158429197|FG000|Overall Study|Not Treated|1|||
49161014|NCT02259114|158429198|FG001|Overall Study|Not Treated|0|||
49161015|NCT02259114|158429199|FG002|Overall Study|Not Treated|0|||
49161016|NCT02259114|158429200|FG003|Overall Study|Not Treated|0|||
49161017|NCT02259114|158429201|FG004|Overall Study|Not Treated|0|||
49161018|NCT03789292|158429204|FG000|Treatment Period I (Week 0 to Week 26)|Adverse Event|7|||
49161019|NCT03789292|158429205|FG001|Treatment Period I (Week 0 to Week 26)|Adverse Event|8|||
49161020|NCT03789292|158429206|FG002|Treatment Period I (Week 0 to Week 26)|Adverse Event|0|||
49161021|NCT03789292|158429204|FG000|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|2|||
49161022|NCT03789292|158429205|FG001|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
49161023|NCT03789292|158429206|FG002|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
49161024|NCT03789292|158429204|FG000|Treatment Period I (Week 0 to Week 26)|Physician Decision|1|||
49161025|NCT03789292|158429205|FG001|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
49161026|NCT03789292|158429206|FG002|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
49161027|NCT03789292|158429204|FG000|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
49161028|NCT03789292|158429205|FG001|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
49161029|NCT03789292|158429206|FG002|Treatment Period I (Week 0 to Week 26)|Protocol Violation|0|||
49161030|NCT03789292|158429204|FG000|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|9|||
49161031|NCT03789292|158429205|FG001|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|8|||
49161032|NCT03789292|158429206|FG002|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|0|||
49161033|NCT03789292|158429204|FG000|Treatment Period I (Week 0 to Week 26)|Significant dose delay|1|||
48923335|NCT01789970|157553207|FG002|Open-label Titration Period|Other|0|||
48923336|NCT01789970|157553205|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
48923337|NCT01789970|157553206|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
48923338|NCT01789970|157553207|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
48923339|NCT01789970|157553205|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
48923340|NCT01789970|157553206|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|9|||
48923341|NCT01789970|157553207|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|15|||
48923342|NCT01789970|157553205|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
48923343|NCT01789970|157553206|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
48923344|NCT01789970|157553207|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
48923345|NCT01789970|157553205|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
48923346|NCT01789970|157553206|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
48923347|NCT01789970|157553207|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
48923348|NCT01789970|157553205|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
48923349|NCT01789970|157553206|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
48923350|NCT01789970|157553207|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7|||
48923351|NCT01789970|157553205|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
48923352|NCT01789970|157553206|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
48834768|NCT01290224|157237086|FG000|Overall Study|Refused Further Treatment|4|||
48923353|NCT01789970|157553207|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
49014608|NCT04634409|157888934|FG011|Overall Study|Adverse Event|0|||
48834769|NCT03184558|157237087|FG000|Overall Study|Withdrawal by Subject|2|||
48834770|NCT03184558|157237087|FG000|Overall Study|Death|16|||
48923354|NCT01789970|157553205|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0|||
48923355|NCT01789970|157553206|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2|||
48923356|NCT01789970|157553207|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1|||
48923357|NCT01789970|157553205|FG000|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
48923358|NCT01789970|157553206|FG001|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
48923359|NCT01789970|157553207|FG002|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2|||
48923360|NCT01789970|157553205|FG000|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
48923361|NCT01789970|157553206|FG001|Double-blind Treatment Period (12 Weeks)|Pregnancy|1|||
48923362|NCT01789970|157553207|FG002|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
48834771|NCT03184558|157237087|FG000|Overall Study|Lost to Follow-up|2|||
48834772|NCT03184558|157237087|FG000|Overall Study|Other|9|||
48923363|NCT01789970|157553205|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
48923364|NCT01789970|157553206|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
48923365|NCT01789970|157553207|FG002|Double-blind Treatment Period (12 Weeks)|Other|3|||
48923366|NCT01789970|157553205|FG000|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
48923367|NCT01789970|157553206|FG001|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1|||
48923368|NCT01789970|157553207|FG002|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
48923369|NCT02432235|157553208|FG000|Overall Study|Death|1|||
48834773|NCT02393716|157237088|FG000|Overall Study|Death|29|||
48834774|NCT02393716|157237088|FG000|Overall Study|Withdrawal by Subject|8|||
48834775|NCT02393716|157237088|FG000|Overall Study|Device Explanted|8|||
48834776|NCT02393716|157237088|FG000|Overall Study|Missed visit|16|||
48834777|NCT02957539|157237089|FG000|Baseline to Week 16|Lost to Follow-up|8|||
48834778|NCT02957539|157237090|FG001|Baseline to Week 16|Lost to Follow-up|10|||
48834779|NCT02957539|157237091|FG002|Baseline to Week 16|Lost to Follow-up|16|||
48834780|NCT02957539|157237089|FG000|Baseline to Week 16|Withdrawal by Subject|14|||
48834781|NCT02957539|157237090|FG001|Baseline to Week 16|Withdrawal by Subject|4|||
48834782|NCT02957539|157237091|FG002|Baseline to Week 16|Withdrawal by Subject|5|||
48834783|NCT02957539|157237089|FG000|Week 16 to 32|Withdrawal by Subject|3|||
48834784|NCT02957539|157237090|FG001|Week 16 to 32|Withdrawal by Subject|3|||
48834785|NCT02957539|157237091|FG002|Week 16 to 32|Withdrawal by Subject|1|||
48834786|NCT02957539|157237089|FG000|Week 16 to 32|Lost to Follow-up|8|||
48834787|NCT02957539|157237090|FG001|Week 16 to 32|Lost to Follow-up|7|||
48834788|NCT02957539|157237091|FG002|Week 16 to 32|Lost to Follow-up|5|||
48834789|NCT02957539|157237089|FG000|Week 32 to Week 52|Lost to Follow-up|11|||
48834790|NCT02957539|157237090|FG001|Week 32 to Week 52|Lost to Follow-up|16|||
48834791|NCT02957539|157237091|FG002|Week 32 to Week 52|Lost to Follow-up|27|||
48834792|NCT02957539|157237089|FG000|Week 32 to Week 52|Withdrawal by Subject|0|||
48834793|NCT02957539|157237090|FG001|Week 32 to Week 52|Withdrawal by Subject|1|||
48834794|NCT02957539|157237091|FG002|Week 32 to Week 52|Withdrawal by Subject|0|||
48834795|NCT00079183|157237100|FG000|Overall Study|Withdrawal by Subject|4|||
48834796|NCT00079183|157237100|FG000|Overall Study|Study medication non-compliance|2|||
48834797|NCT00079183|157237100|FG000|Overall Study|Specimen collection non-compliance|1|||
48834798|NCT00878722|157237101|FG000|Overall Study|Progressive disease|3|||
48834799|NCT00878722|157237102|FG001|Overall Study|Progressive disease|3|||
48834800|NCT00878722|157237103|FG002|Overall Study|Progressive disease|3|||
48834801|NCT00878722|157237104|FG003|Overall Study|Progressive disease|7|||
48834802|NCT00878722|157237105|FG004|Overall Study|Progressive disease|7|||
48834803|NCT00878722|157237106|FG005|Overall Study|Progressive disease|1|||
48834804|NCT00878722|157237107|FG006|Overall Study|Progressive disease|4|||
48834805|NCT00878722|157237108|FG007|Overall Study|Progressive disease|3|||
48834806|NCT00878722|157237101|FG000|Overall Study|Death|0|||
48834807|NCT00878722|157237102|FG001|Overall Study|Death|0|||
48834808|NCT00878722|157237103|FG002|Overall Study|Death|0|||
48834809|NCT00878722|157237104|FG003|Overall Study|Death|1|||
48923370|NCT02432235|157553209|FG001|Overall Study|Death|1|||
48923371|NCT02432235|157553210|FG002|Overall Study|Death|2|||
48923372|NCT02432235|157553211|FG003|Overall Study|Death|2|||
48923373|NCT02432235|157553212|FG004|Overall Study|Death|1|||
48923374|NCT02432235|157553213|FG005|Overall Study|Death|3|||
48834810|NCT00878722|157237105|FG004|Overall Study|Death|0|||
48834811|NCT00878722|157237106|FG005|Overall Study|Death|1|||
48834812|NCT00878722|157237107|FG006|Overall Study|Death|0|||
48834813|NCT00878722|157237108|FG007|Overall Study|Death|2|||
48834814|NCT00878722|157237101|FG000|Overall Study|Adverse Event|0|||
48834815|NCT00878722|157237102|FG001|Overall Study|Adverse Event|0|||
48834816|NCT00878722|157237103|FG002|Overall Study|Adverse Event|0|||
48834817|NCT00878722|157237104|FG003|Overall Study|Adverse Event|0|||
48834818|NCT00878722|157237105|FG004|Overall Study|Adverse Event|0|||
48834819|NCT00878722|157237106|FG005|Overall Study|Adverse Event|0|||
48834820|NCT00878722|157237107|FG006|Overall Study|Adverse Event|2|||
48834821|NCT00878722|157237108|FG007|Overall Study|Adverse Event|0|||
48834822|NCT00878722|157237101|FG000|Overall Study|Withdrawal by Subject|0|||
48834823|NCT00878722|157237102|FG001|Overall Study|Withdrawal by Subject|0|||
48834824|NCT00878722|157237103|FG002|Overall Study|Withdrawal by Subject|0|||
48834825|NCT00878722|157237104|FG003|Overall Study|Withdrawal by Subject|0|||
48834826|NCT00878722|157237105|FG004|Overall Study|Withdrawal by Subject|0|||
48834827|NCT00878722|157237106|FG005|Overall Study|Withdrawal by Subject|0|||
48834828|NCT00878722|157237107|FG006|Overall Study|Withdrawal by Subject|0|||
48834829|NCT00878722|157237108|FG007|Overall Study|Withdrawal by Subject|2|||
48834830|NCT00878722|157237101|FG000|Overall Study|Relapse|0|||
48834831|NCT00878722|157237102|FG001|Overall Study|Relapse|0|||
48834832|NCT00878722|157237103|FG002|Overall Study|Relapse|0|||
48834833|NCT00878722|157237104|FG003|Overall Study|Relapse|1|||
48834834|NCT00878722|157237105|FG004|Overall Study|Relapse|0|||
48834835|NCT00878722|157237106|FG005|Overall Study|Relapse|0|||
48834836|NCT00878722|157237107|FG006|Overall Study|Relapse|0|||
48834837|NCT00878722|157237108|FG007|Overall Study|Relapse|0|||
48834838|NCT03920215|157237109|FG000|Overall Study|Lost to Follow-up|1|||
48834839|NCT03920215|157237110|FG001|Overall Study|Lost to Follow-up|2|||
48923375|NCT02432235|157553214|FG006|Overall Study|Death|11|||
48923376|NCT02432235|157553215|FG007|Overall Study|Death|15|||
48923377|NCT02432235|157553216|FG008|Overall Study|Death|15|||
48923378|NCT02432235|157553217|FG009|Overall Study|Death|3|||
48923379|NCT02432235|157553218|FG010|Overall Study|Death|1|||
48923380|NCT02432235|157553219|FG011|Overall Study|Death|0|||
48923381|NCT02432235|157553208|FG000|Overall Study|Withdrawal by Subject|0|||
48923382|NCT02432235|157553209|FG001|Overall Study|Withdrawal by Subject|1|||
48923383|NCT02432235|157553210|FG002|Overall Study|Withdrawal by Subject|0|||
48923384|NCT02432235|157553211|FG003|Overall Study|Withdrawal by Subject|0|||
48923385|NCT02432235|157553212|FG004|Overall Study|Withdrawal by Subject|0|||
48923386|NCT02432235|157553213|FG005|Overall Study|Withdrawal by Subject|2|||
48923387|NCT02432235|157553214|FG006|Overall Study|Withdrawal by Subject|5|||
48923388|NCT02432235|157553215|FG007|Overall Study|Withdrawal by Subject|3|||
48923389|NCT02432235|157553216|FG008|Overall Study|Withdrawal by Subject|1|||
48923390|NCT02432235|157553217|FG009|Overall Study|Withdrawal by Subject|0|||
48923391|NCT02432235|157553218|FG010|Overall Study|Withdrawal by Subject|0|||
48923392|NCT02432235|157553219|FG011|Overall Study|Withdrawal by Subject|0|||
48923393|NCT02432235|157553208|FG000|Overall Study|Lost to Follow-up|0|||
48923394|NCT02432235|157553209|FG001|Overall Study|Lost to Follow-up|0|||
48923395|NCT02432235|157553210|FG002|Overall Study|Lost to Follow-up|0|||
48923396|NCT02432235|157553211|FG003|Overall Study|Lost to Follow-up|0|||
48923397|NCT02432235|157553212|FG004|Overall Study|Lost to Follow-up|0|||
48923398|NCT02432235|157553213|FG005|Overall Study|Lost to Follow-up|1|||
48923399|NCT02432235|157553214|FG006|Overall Study|Lost to Follow-up|0|||
48923400|NCT02432235|157553215|FG007|Overall Study|Lost to Follow-up|0|||
48923401|NCT02432235|157553216|FG008|Overall Study|Lost to Follow-up|1|||
48834840|NCT03920215|157237111|FG002|Overall Study|Lost to Follow-up|0|||
48834841|NCT03920215|157237112|FG003|Overall Study|Lost to Follow-up|0|||
48834842|NCT03920215|157237109|FG000|Overall Study|Death|0|||
48834843|NCT03920215|157237110|FG001|Overall Study|Death|0|||
48834844|NCT03920215|157237111|FG002|Overall Study|Death|0|||
48834845|NCT03920215|157237112|FG003|Overall Study|Death|1|||
48834846|NCT03621696|157237117|FG000|Overall Study|Not eligible|0|||
48834847|NCT03621696|157237118|FG001|Overall Study|Not eligible|0|||
48834848|NCT03621696|157237119|FG002|Overall Study|Not eligible|0|||
48834849|NCT03621696|157237120|FG003|Overall Study|Not eligible|5|||
48923402|NCT02432235|157553217|FG009|Overall Study|Lost to Follow-up|0|||
48923403|NCT02432235|157553218|FG010|Overall Study|Lost to Follow-up|0|||
48923404|NCT02432235|157553219|FG011|Overall Study|Lost to Follow-up|0|||
48923405|NCT02432235|157553208|FG000|Overall Study|Miscellaneous|0|||
48923406|NCT02432235|157553209|FG001|Overall Study|Miscellaneous|0|||
48923407|NCT02432235|157553210|FG002|Overall Study|Miscellaneous|0|||
48923408|NCT02432235|157553211|FG003|Overall Study|Miscellaneous|0|||
48923409|NCT02432235|157553212|FG004|Overall Study|Miscellaneous|1|||
48923410|NCT02432235|157553213|FG005|Overall Study|Miscellaneous|6|||
48923411|NCT02432235|157553214|FG006|Overall Study|Miscellaneous|2|||
48923412|NCT02432235|157553215|FG007|Overall Study|Miscellaneous|2|||
48923413|NCT02432235|157553216|FG008|Overall Study|Miscellaneous|4|||
48923414|NCT02432235|157553217|FG009|Overall Study|Miscellaneous|0|||
48923415|NCT02432235|157553218|FG010|Overall Study|Miscellaneous|0|||
48923416|NCT02432235|157553219|FG011|Overall Study|Miscellaneous|1|||
48923417|NCT00401752|157553220|FG000|Overall Study|Adverse Event|2|||
48923418|NCT00401752|157553221|FG001|Overall Study|Adverse Event|5|||
48923419|NCT00401752|157553220|FG000|Overall Study|Withdrawal by Subject|2|||
48923420|NCT00401752|157553221|FG001|Overall Study|Withdrawal by Subject|6|||
48923421|NCT00401752|157553220|FG000|Overall Study|Lost to Follow-up|1|||
48923422|NCT00401752|157553221|FG001|Overall Study|Lost to Follow-up|4|||
48923423|NCT00401752|157553220|FG000|Overall Study|Development of any exclusion criteria|4|||
48923424|NCT00401752|157553221|FG001|Overall Study|Development of any exclusion criteria|2|||
48923425|NCT00401752|157553220|FG000|Overall Study|Physician Decision|1|||
48923426|NCT00401752|157553221|FG001|Overall Study|Physician Decision|1|||
48923427|NCT01121393|157553222|FG000|Overall Study|Progressive disease|201|||
48923428|NCT01121393|157553223|FG001|Overall Study|Progressive disease|20|||
48923429|NCT01121393|157553222|FG000|Overall Study|Other Adverse events|24|||
48923430|NCT01121393|157553223|FG001|Overall Study|Other Adverse events|45|||
48923431|NCT01121393|157553222|FG000|Overall Study|Non-compliant with protocol|0|||
48923432|NCT01121393|157553223|FG001|Overall Study|Non-compliant with protocol|3|||
48923433|NCT01121393|157553222|FG000|Overall Study|Lost to Follow-up|1|||
48923434|NCT01121393|157553223|FG001|Overall Study|Lost to Follow-up|0|||
48923435|NCT01121393|157553222|FG000|Overall Study|Refused cont. medication|7|||
48923436|NCT01121393|157553223|FG001|Overall Study|Refused cont. medication|7|||
48923437|NCT01121393|157553222|FG000|Overall Study|Not treated|3|||
48923438|NCT01121393|157553223|FG001|Overall Study|Not treated|9|||
48923439|NCT01121393|157553222|FG000|Overall Study|Other than listed|6|||
48923440|NCT01121393|157553223|FG001|Overall Study|Other than listed|0|||
48923441|NCT01046877|157553238|FG000|Overall Study|Exited voluntarily before tube extrusion|7|||
48923442|NCT01046877|157553238|FG000|Overall Study|Exited voluntarily after tube extrusion|11|||
48923443|NCT02450578|157553239|FG000|Overall Study|ECG abnormality so not treated|1|||
48923444|NCT02450578|157553240|FG001|Overall Study|ECG abnormality so not treated|0|||
48923445|NCT02450578|157553241|FG002|Overall Study|ECG abnormality so not treated|0|||
48923446|NCT02450578|157553242|FG003|Overall Study|ECG abnormality so not treated|0|||
48923447|NCT04016311|157553243|FG000|Overall Study|Withdrawal by Subject|1|||
48923448|NCT04016311|157553244|FG001|Overall Study|Withdrawal by Subject|0|||
48923449|NCT02436876|157553249|FG000|Overall Study|Lost to Follow-up|0|||
48923450|NCT02436876|157553250|FG001|Overall Study|Lost to Follow-up|1|||
48923451|NCT02436876|157553251|FG002|Overall Study|Lost to Follow-up|1|||
48923452|NCT02436876|157553252|FG003|Overall Study|Lost to Follow-up|1|||
48923453|NCT02436876|157553249|FG000|Overall Study|Withdrawal by Subject|1|||
48923454|NCT02436876|157553250|FG001|Overall Study|Withdrawal by Subject|0|||
48923455|NCT02436876|157553251|FG002|Overall Study|Withdrawal by Subject|0|||
48923456|NCT02436876|157553252|FG003|Overall Study|Withdrawal by Subject|1|||
48923457|NCT02436876|157553249|FG000|Overall Study|Physician Decision|0|||
48923458|NCT02436876|157553250|FG001|Overall Study|Physician Decision|2|||
48923459|NCT02436876|157553251|FG002|Overall Study|Physician Decision|1|||
48923460|NCT02436876|157553252|FG003|Overall Study|Physician Decision|0|||
48923461|NCT02436876|157553249|FG000|Overall Study|Inadequate amount of study drug available for randomization|0|||
48923462|NCT02436876|157553250|FG001|Overall Study|Inadequate amount of study drug available for randomization|1|||
48923463|NCT02436876|157553251|FG002|Overall Study|Inadequate amount of study drug available for randomization|0|||
48923464|NCT02436876|157553252|FG003|Overall Study|Inadequate amount of study drug available for randomization|0|||
48923465|NCT00075504|157553253|FG000|Overall Study|Withdrawal by Subject|9|||
48923466|NCT00075504|157553254|FG001|Overall Study|Withdrawal by Subject|7|||
48923467|NCT00927095|157553259|FG000|Overall Study|Adverse Event|3|||
48923468|NCT00927095|157553260|FG001|Overall Study|Adverse Event|1|||
48923469|NCT00927095|157553261|FG002|Overall Study|Adverse Event|0|||
48923470|NCT00927095|157553259|FG000|Overall Study|Withdrawal by Subject|2|||
48923471|NCT00927095|157553260|FG001|Overall Study|Withdrawal by Subject|1|||
48923472|NCT00927095|157553261|FG002|Overall Study|Withdrawal by Subject|1|||
48923473|NCT00927095|157553259|FG000|Overall Study|Physician Decision|1|||
48923474|NCT00927095|157553260|FG001|Overall Study|Physician Decision|2|||
48923475|NCT00927095|157553261|FG002|Overall Study|Physician Decision|1|||
48923476|NCT01290692|157553264|FG000|Overall Study|Lack of sufficient efficacy as patients were immunocompromised|7|||
48923477|NCT02867995|157553268|FG000|Overall Study|Withdrawal by Subject|0|||
48923478|NCT02867995|157553269|FG001|Overall Study|Withdrawal by Subject|1|||
48923479|NCT02867995|157553268|FG000|Overall Study|Lost to Follow-up|0|||
48923480|NCT02867995|157553269|FG001|Overall Study|Lost to Follow-up|2|||
48923481|NCT02926950|157553270|FG000|Overall Study|Adverse Event|4|||
48923482|NCT02926950|157553271|FG001|Overall Study|Adverse Event|6|||
48923483|NCT02926950|157553270|FG000|Overall Study|At the participant's own request|21|||
48923484|NCT02926950|157553271|FG001|Overall Study|At the participant's own request|25|||
48923485|NCT02926950|157553270|FG000|Overall Study|Reason not Specified|17|||
48923486|NCT02926950|157553271|FG001|Overall Study|Reason not Specified|9|||
48923487|NCT02926950|157553270|FG000|Overall Study|Lost to Follow-up|7|||
49161034|NCT03789292|158429205|FG001|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
49161035|NCT03789292|158429206|FG002|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
49161036|NCT03789292|158429204|FG000|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
49161037|NCT03789292|158429205|FG001|Treatment Period I (Week 0 to Week 26)|Patient decision|2|||
49161038|NCT03789292|158429206|FG002|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
49161039|NCT03789292|158429204|FG000|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
49161040|NCT03789292|158429205|FG001|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
49161041|NCT03789292|158429206|FG002|Treatment Period II (Week 26 to Week 52)|Adverse Event|6|||
49161042|NCT03789292|158429204|FG000|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
49161043|NCT03789292|158429205|FG001|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
49161044|NCT03789292|158429206|FG002|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|1|||
49161045|NCT03789292|158429204|FG000|Treatment Period II (Week 26 to Week 52)|Physician Decision|1|||
49161046|NCT03789292|158429205|FG001|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
49161047|NCT03789292|158429206|FG002|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
49161048|NCT03789292|158429204|FG000|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|9|||
49161049|NCT03789292|158429205|FG001|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
49161050|NCT03789292|158429206|FG002|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
49161051|NCT03789292|158429204|FG000|Treatment Period II (Week 26 to Week 52)|Significant dose delay|1|||
49161052|NCT03789292|158429205|FG001|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
49161053|NCT03789292|158429206|FG002|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
49161054|NCT03789292|158429204|FG000|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|2|||
49161055|NCT03789292|158429205|FG001|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|1|||
49161056|NCT03789292|158429206|FG002|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|0|||
49161057|NCT01240863|158429208|FG000|Open-label Titration Period|Adverse Event|47|||
49161058|NCT01240863|158429209|FG001|Open-label Titration Period|Adverse Event|0|||
49161059|NCT01240863|158429210|FG002|Open-label Titration Period|Adverse Event|0|||
49161060|NCT01240863|158429208|FG000|Open-label Titration Period|Lack of Efficacy|19|||
49161061|NCT01240863|158429209|FG001|Open-label Titration Period|Lack of Efficacy|0|||
49161062|NCT01240863|158429210|FG002|Open-label Titration Period|Lack of Efficacy|0|||
49161063|NCT01240863|158429208|FG000|Open-label Titration Period|Withdrawal by Subject|9|||
49161064|NCT01240863|158429209|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
49161065|NCT01240863|158429210|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
49161066|NCT01240863|158429208|FG000|Open-label Titration Period|Protocol Violation|7|||
49161067|NCT01240863|158429209|FG001|Open-label Titration Period|Protocol Violation|0|||
49161068|NCT01240863|158429210|FG002|Open-label Titration Period|Protocol Violation|0|||
49161069|NCT01240863|158429208|FG000|Open-label Titration Period|Noncompliance to study drug admin|3|||
49161070|NCT01240863|158429209|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
49161071|NCT01240863|158429210|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
49161072|NCT01240863|158429208|FG000|Open-label Titration Period|Noncompliance to study procedures|3|||
49161073|NCT01240863|158429209|FG001|Open-label Titration Period|Noncompliance to study procedures|0|||
49161074|NCT01240863|158429210|FG002|Open-label Titration Period|Noncompliance to study procedures|0|||
49161075|NCT01240863|158429208|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
49161076|NCT01240863|158429209|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
49161077|NCT01240863|158429210|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
49161078|NCT01240863|158429208|FG000|Open-label Titration Period|Other|7|||
49161079|NCT01240863|158429209|FG001|Open-label Titration Period|Other|0|||
49161080|NCT01240863|158429210|FG002|Open-label Titration Period|Other|0|||
49161081|NCT01240863|158429208|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
49161082|NCT01240863|158429209|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|4|||
49161083|NCT01240863|158429210|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|10|||
49161084|NCT01240863|158429208|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
49161085|NCT01240863|158429209|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
49161086|NCT01240863|158429210|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
49161087|NCT01240863|158429208|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
49161088|NCT01240863|158429209|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
49161089|NCT01240863|158429210|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
49161090|NCT01240863|158429208|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
49161091|NCT01240863|158429209|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
49161092|NCT01240863|158429210|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14|||
49161093|NCT01240863|158429208|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
49161094|NCT01240863|158429209|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9|||
49161095|NCT01240863|158429210|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11|||
48923488|NCT02926950|157553271|FG001|Overall Study|Lost to Follow-up|8|||
49161096|NCT01240863|158429208|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0|||
49161097|NCT01240863|158429209|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
49161098|NCT01240863|158429210|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
48834850|NCT03621696|157237117|FG000|Overall Study|Withdrawal by Subject|1|||
48834851|NCT03621696|157237118|FG001|Overall Study|Withdrawal by Subject|1|||
48834852|NCT03621696|157237119|FG002|Overall Study|Withdrawal by Subject|1|||
48834853|NCT03621696|157237120|FG003|Overall Study|Withdrawal by Subject|0|||
48834854|NCT03621696|157237117|FG000|Overall Study|Physician Decision|0|||
49161099|NCT01240863|158429208|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
49161100|NCT01240863|158429209|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
49161101|NCT01240863|158429210|FG002|Double-blind Treatment Period (12 Weeks)|Other|5|||
49161102|NCT01240863|158429208|FG000|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
49161103|NCT01240863|158429209|FG001|Double-blind Treatment Period (12 Weeks)|Physician Decision|1|||
49161104|NCT01240863|158429210|FG002|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
49161105|NCT02761642|158429211|FG000|Overall Study|Did not Receive Study Treatment|3|||
49161106|NCT02761642|158429211|FG000|Overall Study|Adverse Event|13|||
49161107|NCT02761642|158429211|FG000|Overall Study|Withdrawal by Subject|2|||
49161108|NCT02761642|158429211|FG000|Overall Study|Non-compliant|7|||
49161109|NCT02761642|158429211|FG000|Overall Study|Death|3|||
49161110|NCT02761642|158429211|FG000|Overall Study|Lack of Efficacy|20|||
49161111|NCT02761642|158429211|FG000|Overall Study|Physician Decision|1|||
49161112|NCT02761642|158429211|FG000|Overall Study|Reason Unspecified|21|||
49161113|NCT03710889|158429212|FG000|Overall Study|Adverse Event|2|||
49161114|NCT03710889|158429212|FG000|Overall Study|Protocol Deviation|1|||
49161115|NCT01644643|158429213|FG000|Overall Study|Death|1|||
49161116|NCT01644643|158429214|FG001|Overall Study|Death|0|||
49161117|NCT01644643|158429215|FG002|Overall Study|Death|3|||
49161118|NCT01644643|158429216|FG003|Overall Study|Death|3|||
49161119|NCT01644643|158429213|FG000|Overall Study|Lost to Follow-up|0|||
49161120|NCT01644643|158429214|FG001|Overall Study|Lost to Follow-up|0|||
49161121|NCT01644643|158429215|FG002|Overall Study|Lost to Follow-up|0|||
49161122|NCT01644643|158429216|FG003|Overall Study|Lost to Follow-up|4|||
49161123|NCT01644643|158429213|FG000|Overall Study|Withdrawal by Subject|1|||
49161124|NCT01644643|158429214|FG001|Overall Study|Withdrawal by Subject|0|||
49161125|NCT01644643|158429215|FG002|Overall Study|Withdrawal by Subject|2|||
49161126|NCT01644643|158429216|FG003|Overall Study|Withdrawal by Subject|1|||
49161127|NCT01644643|158429213|FG000|Overall Study|Other Eligibility criteria|0|||
49161128|NCT01644643|158429214|FG001|Overall Study|Other Eligibility criteria|0|||
49161129|NCT01644643|158429215|FG002|Overall Study|Other Eligibility criteria|0|||
49161130|NCT01644643|158429216|FG003|Overall Study|Other Eligibility criteria|2|||
49161131|NCT04940130|158429217|FG000|Overall Study|Travel|1|||
49161132|NCT04940130|158429218|FG001|Overall Study|Travel|0|||
49161133|NCT04940130|158429219|FG002|Overall Study|Travel|2|||
49161134|NCT04940130|158429217|FG000|Overall Study|Parent/Guardian withdrew consent|0|||
49161135|NCT04940130|158429218|FG001|Overall Study|Parent/Guardian withdrew consent|1|||
49161136|NCT04940130|158429219|FG002|Overall Study|Parent/Guardian withdrew consent|7|||
49161137|NCT04940130|158429217|FG000|Overall Study|Adverse Event|0|||
49161138|NCT04940130|158429218|FG001|Overall Study|Adverse Event|0|||
49161139|NCT04940130|158429219|FG002|Overall Study|Adverse Event|2|||
49161140|NCT04940130|158429217|FG000|Overall Study|Disease progression/treatment failure|0|||
49161141|NCT04940130|158429218|FG001|Overall Study|Disease progression/treatment failure|0|||
49161142|NCT04940130|158429219|FG002|Overall Study|Disease progression/treatment failure|1|||
49161143|NCT04940130|158429217|FG000|Overall Study|Participant refusal|0|||
49161144|NCT04940130|158429218|FG001|Overall Study|Participant refusal|0|||
49161145|NCT04940130|158429219|FG002|Overall Study|Participant refusal|1|||
49161146|NCT00539240|158429223|FG000|Overall Study|Withdrawal by Subject|0|||
49161147|NCT00539240|158429224|FG001|Overall Study|Withdrawal by Subject|2|||
49161148|NCT00539240|158429225|FG002|Overall Study|Withdrawal by Subject|0|||
49161149|NCT00539240|158429223|FG000|Overall Study|Protocol Violation|1|||
49161150|NCT00539240|158429224|FG001|Overall Study|Protocol Violation|1|||
49161151|NCT00539240|158429225|FG002|Overall Study|Protocol Violation|4|||
49161152|NCT00539240|158429223|FG000|Overall Study|Lost to Follow-up|2|||
49161153|NCT00539240|158429224|FG001|Overall Study|Lost to Follow-up|3|||
49161154|NCT00539240|158429225|FG002|Overall Study|Lost to Follow-up|1|||
49161155|NCT00539240|158429223|FG000|Overall Study|Adverse Event|3|||
49161156|NCT00539240|158429224|FG001|Overall Study|Adverse Event|1|||
49161157|NCT00539240|158429225|FG002|Overall Study|Adverse Event|10|||
48834855|NCT03621696|157237118|FG001|Overall Study|Physician Decision|0|||
48834856|NCT03621696|157237119|FG002|Overall Study|Physician Decision|1|||
48834857|NCT03621696|157237120|FG003|Overall Study|Physician Decision|0|||
48834858|NCT05149313|157237125|FG000|Overall Study|Adverse Event|2|||
49161158|NCT00636181|158429227|FG000|Overall Study|Withdrawal by Subject|8|||
49161159|NCT00636181|158429228|FG001|Overall Study|Withdrawal by Subject|6|||
49161160|NCT00636181|158429229|FG002|Overall Study|Withdrawal by Subject|10|||
49161161|NCT00943761|158429239|FG000|Overall Study|Lost to Follow-up|2|||
49161162|NCT00943761|158429240|FG001|Overall Study|Lost to Follow-up|0|||
48834859|NCT05149313|157237126|FG001|Overall Study|Adverse Event|2|||
48834860|NCT05149313|157237125|FG000|Overall Study|Lost to Follow-up|2|||
48834861|NCT05149313|157237126|FG001|Overall Study|Lost to Follow-up|3|||
48834862|NCT05149313|157237125|FG000|Overall Study|Pregnancy|1|||
48834863|NCT05149313|157237126|FG001|Overall Study|Pregnancy|0|||
48834864|NCT05149313|157237125|FG000|Overall Study|Withdrawal by Subject|2|||
48834865|NCT05149313|157237126|FG001|Overall Study|Withdrawal by Subject|5|||
48834866|NCT05149313|157237125|FG000|Overall Study|Physician Decision|1|||
48834867|NCT05149313|157237126|FG001|Overall Study|Physician Decision|0|||
48834868|NCT05149313|157237125|FG000|Overall Study|Other|0|||
48834869|NCT05149313|157237126|FG001|Overall Study|Other|1|||
49014609|NCT04634409|157888935|FG012|Overall Study|Adverse Event|0|||
49014610|NCT04634409|157888936|FG013|Overall Study|Adverse Event|0|||
49014611|NCT04634409|157888937|FG014|Overall Study|Adverse Event|0|||
49014612|NCT04634409|157888938|FG015|Overall Study|Adverse Event|0|||
49014613|NCT04634409|157888939|FG016|Overall Study|Adverse Event|0|||
49014614|NCT04634409|157888940|FG017|Overall Study|Adverse Event|0|||
49014615|NCT04634409|157888941|FG018|Overall Study|Adverse Event|0|||
49014616|NCT04634409|157888942|FG019|Overall Study|Adverse Event|0|||
49014617|NCT04634409|157888943|FG020|Overall Study|Adverse Event|0|||
49014618|NCT04634409|157888944|FG021|Overall Study|Adverse Event|0|||
49014619|NCT04634409|157888945|FG022|Overall Study|Adverse Event|0|||
49014620|NCT04634409|157888946|FG023|Overall Study|Adverse Event|0|||
49014621|NCT04634409|157888947|FG024|Overall Study|Adverse Event|0|||
49014622|NCT04634409|157888948|FG025|Overall Study|Adverse Event|0|||
49014623|NCT04634409|157888949|FG026|Overall Study|Adverse Event|0|||
49014624|NCT04634409|157888923|FG000|Overall Study|Lost to Follow-up|3|||
49014625|NCT04634409|157888924|FG001|Overall Study|Lost to Follow-up|1|||
49014626|NCT04634409|157888925|FG002|Overall Study|Lost to Follow-up|1|||
49014627|NCT04634409|157888926|FG003|Overall Study|Lost to Follow-up|3|||
49014628|NCT04634409|157888927|FG004|Overall Study|Lost to Follow-up|1|||
49014629|NCT04634409|157888928|FG005|Overall Study|Lost to Follow-up|1|||
49014630|NCT04634409|157888929|FG006|Overall Study|Lost to Follow-up|1|||
49014631|NCT04634409|157888930|FG007|Overall Study|Lost to Follow-up|3|||
49014632|NCT04634409|157888931|FG008|Overall Study|Lost to Follow-up|3|||
49014633|NCT04634409|157888932|FG009|Overall Study|Lost to Follow-up|11|||
49014634|NCT04634409|157888933|FG010|Overall Study|Lost to Follow-up|8|||
49014635|NCT04634409|157888934|FG011|Overall Study|Lost to Follow-up|15|||
49014636|NCT04634409|157888935|FG012|Overall Study|Lost to Follow-up|3|||
49014637|NCT04634409|157888936|FG013|Overall Study|Lost to Follow-up|2|||
49014638|NCT04634409|157888937|FG014|Overall Study|Lost to Follow-up|7|||
49014639|NCT04634409|157888938|FG015|Overall Study|Lost to Follow-up|0|||
49014640|NCT04634409|157888939|FG016|Overall Study|Lost to Follow-up|0|||
49014641|NCT04634409|157888940|FG017|Overall Study|Lost to Follow-up|0|||
49014642|NCT04634409|157888941|FG018|Overall Study|Lost to Follow-up|0|||
49014643|NCT04634409|157888942|FG019|Overall Study|Lost to Follow-up|0|||
49014644|NCT04634409|157888943|FG020|Overall Study|Lost to Follow-up|0|||
49014645|NCT04634409|157888944|FG021|Overall Study|Lost to Follow-up|0|||
49014646|NCT04634409|157888945|FG022|Overall Study|Lost to Follow-up|0|||
49014647|NCT04634409|157888946|FG023|Overall Study|Lost to Follow-up|0|||
49014648|NCT04634409|157888947|FG024|Overall Study|Lost to Follow-up|0|||
49014649|NCT04634409|157888948|FG025|Overall Study|Lost to Follow-up|0|||
49014650|NCT04634409|157888949|FG026|Overall Study|Lost to Follow-up|0|||
49014651|NCT04634409|157888923|FG000|Overall Study|Withdrawal by Subject|3|||
49014652|NCT04634409|157888924|FG001|Overall Study|Withdrawal by Subject|1|||
49014653|NCT04634409|157888925|FG002|Overall Study|Withdrawal by Subject|6|||
49014654|NCT04634409|157888926|FG003|Overall Study|Withdrawal by Subject|4|||
49014655|NCT04634409|157888927|FG004|Overall Study|Withdrawal by Subject|2|||
49014656|NCT04634409|157888928|FG005|Overall Study|Withdrawal by Subject|0|||
49014657|NCT04634409|157888929|FG006|Overall Study|Withdrawal by Subject|0|||
49014658|NCT04634409|157888930|FG007|Overall Study|Withdrawal by Subject|2|||
49014659|NCT04634409|157888931|FG008|Overall Study|Withdrawal by Subject|3|||
49014660|NCT04634409|157888932|FG009|Overall Study|Withdrawal by Subject|2|||
49014661|NCT04634409|157888933|FG010|Overall Study|Withdrawal by Subject|3|||
49014662|NCT04634409|157888934|FG011|Overall Study|Withdrawal by Subject|2|||
49014663|NCT04634409|157888935|FG012|Overall Study|Withdrawal by Subject|2|||
49014664|NCT04634409|157888936|FG013|Overall Study|Withdrawal by Subject|1|||
49014665|NCT04634409|157888937|FG014|Overall Study|Withdrawal by Subject|5|||
49014666|NCT04634409|157888938|FG015|Overall Study|Withdrawal by Subject|0|||
49014667|NCT04634409|157888939|FG016|Overall Study|Withdrawal by Subject|0|||
49014668|NCT04634409|157888940|FG017|Overall Study|Withdrawal by Subject|1|||
49014669|NCT04634409|157888941|FG018|Overall Study|Withdrawal by Subject|0|||
49014670|NCT04634409|157888942|FG019|Overall Study|Withdrawal by Subject|0|||
49014671|NCT04634409|157888943|FG020|Overall Study|Withdrawal by Subject|0|||
49014672|NCT04634409|157888944|FG021|Overall Study|Withdrawal by Subject|0|||
49014673|NCT04634409|157888945|FG022|Overall Study|Withdrawal by Subject|0|||
49014674|NCT04634409|157888946|FG023|Overall Study|Withdrawal by Subject|1|||
49014675|NCT04634409|157888947|FG024|Overall Study|Withdrawal by Subject|0|||
49014676|NCT04634409|157888948|FG025|Overall Study|Withdrawal by Subject|0|||
49014677|NCT04634409|157888949|FG026|Overall Study|Withdrawal by Subject|0|||
49014678|NCT04634409|157888923|FG000|Overall Study|Other - As reported by Investigator|1|||
49014679|NCT04634409|157888924|FG001|Overall Study|Other - As reported by Investigator|0|||
49014680|NCT04634409|157888925|FG002|Overall Study|Other - As reported by Investigator|0|||
49014681|NCT04634409|157888926|FG003|Overall Study|Other - As reported by Investigator|0|||
49014682|NCT04634409|157888927|FG004|Overall Study|Other - As reported by Investigator|0|||
49014683|NCT04634409|157888928|FG005|Overall Study|Other - As reported by Investigator|0|||
49014684|NCT04634409|157888929|FG006|Overall Study|Other - As reported by Investigator|0|||
49014685|NCT04634409|157888930|FG007|Overall Study|Other - As reported by Investigator|6|||
49161163|NCT00943761|158429239|FG000|Overall Study|Withdrawal by Subject|2|||
49161164|NCT00943761|158429240|FG001|Overall Study|Withdrawal by Subject|1|||
49161165|NCT00444106|158429245|FG000|Overall Study|Lost to Follow-up|2|||
49161166|NCT00444106|158429246|FG001|Overall Study|Lost to Follow-up|1|||
49161167|NCT00444106|158429247|FG002|Overall Study|Lost to Follow-up|0|||
49161168|NCT00444106|158429245|FG000|Overall Study|Abnormal Test Procedure Results|0|||
48834870|NCT01152190|157237127|FG000|Overall Study|Adverse Event|2|||
48834871|NCT01152190|157237128|FG001|Overall Study|Adverse Event|4|||
48834872|NCT01152190|157237127|FG000|Overall Study|Death|1|||
48834873|NCT01152190|157237128|FG001|Overall Study|Death|0|||
48834874|NCT01152190|157237127|FG000|Overall Study|Protocol Violation|1|||
48834875|NCT01152190|157237128|FG001|Overall Study|Protocol Violation|1|||
48834876|NCT01152190|157237127|FG000|Overall Study|Withdrawal by Subject|1|||
48834877|NCT01152190|157237128|FG001|Overall Study|Withdrawal by Subject|3|||
48834878|NCT01595321|157237129|FG000|Overall Study|Adverse Event|1|||
49161169|NCT00444106|158429246|FG001|Overall Study|Abnormal Test Procedure Results|0|||
49161170|NCT00444106|158429247|FG002|Overall Study|Abnormal Test Procedure Results|1|||
49161171|NCT00145626|158429248|FG000|Overall Study|Did not have NK infusions|2|||
49161172|NCT00145626|158429248|FG000|Overall Study|Turned 2 years old before treatment|1|||
49161173|NCT00145626|158429248|FG000|Overall Study|Death|1|||
49161174|NCT00145626|158429248|FG000|Overall Study|Withdrawal by Subject|1|||
49161175|NCT01870869|158430467|FG000|Overall Study|Implanted with nonstudy device|1|||
49161176|NCT01870869|158430468|FG001|Overall Study|Implanted with nonstudy device|3|||
49161177|NCT01870869|158430469|FG002|Overall Study|Implanted with nonstudy device|14|||
49161178|NCT01870869|158430470|FG003|Overall Study|Implanted with nonstudy device|4|||
49161179|NCT01870869|158430467|FG000|Overall Study|Death|0|||
49161180|NCT01870869|158430468|FG001|Overall Study|Death|0|||
48834879|NCT01595321|157237130|FG001|Overall Study|Adverse Event|1|||
48834880|NCT01595321|157237131|FG002|Overall Study|Adverse Event|1|||
48834881|NCT01595321|157237129|FG000|Overall Study|Lack of Efficacy|0|||
48834882|NCT01595321|157237130|FG001|Overall Study|Lack of Efficacy|0|||
49161181|NCT01870869|158430469|FG002|Overall Study|Death|7|||
49161182|NCT01870869|158430470|FG003|Overall Study|Death|1|||
49161183|NCT01870869|158430467|FG000|Overall Study|Subject choice|6|||
48834883|NCT01595321|157237131|FG002|Overall Study|Lack of Efficacy|4|||
48834884|NCT01943799|157237132|FG000|Overall Study|Lost to Follow-up|0|||
48834885|NCT01943799|157237133|FG001|Overall Study|Lost to Follow-up|1|||
48834886|NCT01943799|157237134|FG002|Overall Study|Lost to Follow-up|1|||
48834887|NCT01943799|157237135|FG003|Overall Study|Lost to Follow-up|0|||
48834888|NCT01943799|157237132|FG000|Overall Study|Protocol Violation|1|||
48834889|NCT01943799|157237133|FG001|Overall Study|Protocol Violation|0|||
48834890|NCT01943799|157237134|FG002|Overall Study|Protocol Violation|0|||
48834891|NCT01943799|157237135|FG003|Overall Study|Protocol Violation|0|||
48834892|NCT01943799|157237132|FG000|Overall Study|Withdrawal by Subject|4|||
48834893|NCT01943799|157237133|FG001|Overall Study|Withdrawal by Subject|2|||
48834894|NCT01943799|157237134|FG002|Overall Study|Withdrawal by Subject|1|||
48834895|NCT01943799|157237135|FG003|Overall Study|Withdrawal by Subject|0|||
48834896|NCT03070483|157237138|FG000|Overall Study|Lost to Follow-up|2|||
48834897|NCT03008915|157237148|FG000|Treatment 1|Withdrawal by Subject|0|||
48834898|NCT03008915|157237149|FG001|Treatment 1|Withdrawal by Subject|1|||
48834899|NCT00361283|157237150|FG000|Overall Study|Lost to Follow-up|27|||
48834900|NCT01810263|157237154|FG000|Overall Study|Lost to Follow-up|8|||
48834901|NCT01810263|157237155|FG001|Overall Study|Lost to Follow-up|7|||
48834902|NCT00688519|157237156|FG000|Overall Study|Adverse Event|2|||
48834903|NCT00688519|157237157|FG001|Overall Study|Adverse Event|3|||
48834904|NCT00688519|157237156|FG000|Overall Study|Lost to Follow-up|3|||
48834905|NCT00688519|157237157|FG001|Overall Study|Lost to Follow-up|3|||
48834906|NCT00688519|157237156|FG000|Overall Study|Lack of Efficacy|3|||
48834907|NCT00688519|157237157|FG001|Overall Study|Lack of Efficacy|1|||
48834908|NCT00688519|157237156|FG000|Overall Study|Withdrawal by Subject|7|||
48834909|NCT00688519|157237157|FG001|Overall Study|Withdrawal by Subject|6|||
48834910|NCT00688519|157237156|FG000|Overall Study|Prohibited medication|1|||
49161184|NCT01870869|158430468|FG001|Overall Study|Subject choice|2|||
49161185|NCT01870869|158430469|FG002|Overall Study|Subject choice|22|||
48834911|NCT00688519|157237157|FG001|Overall Study|Prohibited medication|0|||
48834912|NCT00688519|157237156|FG000|Overall Study|Non-compliance|0|||
48834913|NCT00688519|157237157|FG001|Overall Study|Non-compliance|1|||
48834914|NCT00688519|157237156|FG000|Overall Study|Subject moved out of state|1|||
48834915|NCT00688519|157237157|FG001|Overall Study|Subject moved out of state|0|||
48834916|NCT00688519|157237156|FG000|Overall Study|Investigator decision|1|||
48834917|NCT00688519|157237157|FG001|Overall Study|Investigator decision|0|||
48834918|NCT00688519|157237156|FG000|Overall Study|Subject moved out of area|1|||
48834919|NCT00688519|157237157|FG001|Overall Study|Subject moved out of area|0|||
48834920|NCT00688519|157237156|FG000|Overall Study|Pregnancy|0|||
48834921|NCT00688519|157237157|FG001|Overall Study|Pregnancy|1|||
48834922|NCT03512756|157237158|FG000|Part 1|Death|23|||
48834923|NCT03512756|157237159|FG001|Part 1|Death|18|||
48834924|NCT03512756|157237160|FG002|Part 1|Death|0|||
48834925|NCT03512756|157237161|FG003|Part 1|Death|0|||
48834926|NCT03512756|157237158|FG000|Part 1|Lost to Follow-up|0|||
48834927|NCT03512756|157237159|FG001|Part 1|Lost to Follow-up|3|||
48834928|NCT03512756|157237160|FG002|Part 1|Lost to Follow-up|0|||
48834929|NCT03512756|157237161|FG003|Part 1|Lost to Follow-up|0|||
48834930|NCT03512756|157237158|FG000|Part 1|Physician Decision|0|||
48834931|NCT03512756|157237159|FG001|Part 1|Physician Decision|1|||
48834932|NCT03512756|157237160|FG002|Part 1|Physician Decision|0|||
48834933|NCT03512756|157237161|FG003|Part 1|Physician Decision|0|||
48834934|NCT03512756|157237158|FG000|Part 1|Withdrawal by Subject|2|||
48834935|NCT03512756|157237159|FG001|Part 1|Withdrawal by Subject|2|||
48834936|NCT03512756|157237160|FG002|Part 1|Withdrawal by Subject|0|||
48834937|NCT03512756|157237161|FG003|Part 1|Withdrawal by Subject|0|||
48834938|NCT03512756|157237158|FG000|Part 2|Death|0|||
48834939|NCT03512756|157237159|FG001|Part 2|Death|0|||
48834940|NCT03512756|157237160|FG002|Part 2|Death|32|||
48834941|NCT03512756|157237161|FG003|Part 2|Death|21|||
48834942|NCT03512756|157237158|FG000|Part 2|Lost to Follow-up|0|||
48834943|NCT03512756|157237159|FG001|Part 2|Lost to Follow-up|0|||
48834944|NCT03512756|157237160|FG002|Part 2|Lost to Follow-up|1|||
48834945|NCT03512756|157237161|FG003|Part 2|Lost to Follow-up|0|||
49161186|NCT01870869|158430470|FG003|Overall Study|Subject choice|8|||
49161187|NCT01870869|158430467|FG000|Overall Study|Lost to Follow-up|10|||
49161188|NCT01870869|158430468|FG001|Overall Study|Lost to Follow-up|2|||
49161189|NCT01870869|158430469|FG002|Overall Study|Lost to Follow-up|25|||
49161190|NCT01870869|158430470|FG003|Overall Study|Lost to Follow-up|3|||
49161191|NCT01870869|158430467|FG000|Overall Study|Reason not Specified|1|||
49161192|NCT01870869|158430468|FG001|Overall Study|Reason not Specified|2|||
49161193|NCT01870869|158430469|FG002|Overall Study|Reason not Specified|20|||
49161194|NCT01870869|158430470|FG003|Overall Study|Reason not Specified|4|||
49161195|NCT01870869|158430467|FG000|Overall Study|Not evaluable|10|||
49161196|NCT01870869|158430468|FG001|Overall Study|Not evaluable|5|||
49161197|NCT01870869|158430469|FG002|Overall Study|Not evaluable|42|||
49161198|NCT01870869|158430470|FG003|Overall Study|Not evaluable|10|||
49161199|NCT00256126|158430471|FG000|Overall Study|Adverse Event|1|||
49161200|NCT00256126|158430472|FG001|Overall Study|Adverse Event|0|||
49161201|NCT00256126|158430471|FG000|Overall Study|Other|1|||
49161202|NCT00256126|158430472|FG001|Overall Study|Other|2|||
49161203|NCT00387088|158430477|FG000|Overall Study|Adverse Event|143|||
49161204|NCT00387088|158430478|FG001|Overall Study|Adverse Event|156|||
49161205|NCT00387088|158430477|FG000|Overall Study|Protocol Violation|47|||
49161206|NCT00387088|158430478|FG001|Overall Study|Protocol Violation|35|||
49161207|NCT00387088|158430477|FG000|Overall Study|Withdrawal by Subject|20|||
49161208|NCT00387088|158430478|FG001|Overall Study|Withdrawal by Subject|35|||
49161209|NCT00387088|158430477|FG000|Overall Study|Lack of Efficacy|28|||
49161210|NCT00387088|158430478|FG001|Overall Study|Lack of Efficacy|67|||
49161211|NCT00387088|158430477|FG000|Overall Study|Lost to Follow-up|22|||
49161212|NCT00387088|158430478|FG001|Overall Study|Lost to Follow-up|28|||
49161213|NCT00387088|158430477|FG000|Overall Study|Other|58|||
48834946|NCT03512756|157237158|FG000|Part 2|Physician Decision|0|||
48834947|NCT03512756|157237159|FG001|Part 2|Physician Decision|0|||
49161214|NCT00387088|158430478|FG001|Overall Study|Other|52|||
49161215|NCT00399035|158430479|FG000|Overall Study|Death|289|||
49161216|NCT00399035|158430480|FG001|Overall Study|Death|141|||
49161217|NCT00399035|158430481|FG002|Overall Study|Death|234|||
48834948|NCT03512756|157237160|FG002|Part 2|Physician Decision|2|||
48834949|NCT03512756|157237161|FG003|Part 2|Physician Decision|4|||
48834950|NCT03512756|157237158|FG000|Part 2|Study Terminated by Sponsor|0|||
48834951|NCT03512756|157237159|FG001|Part 2|Study Terminated by Sponsor|0|||
48834952|NCT03512756|157237160|FG002|Part 2|Study Terminated by Sponsor|2|||
49161218|NCT00399035|158430479|FG000|Overall Study|Lost to Follow-up|2|||
49161219|NCT00399035|158430480|FG001|Overall Study|Lost to Follow-up|1|||
48834953|NCT03512756|157237161|FG003|Part 2|Study Terminated by Sponsor|6|||
48834954|NCT03512756|157237158|FG000|Part 2|Protocol Violation|0|||
48834955|NCT03512756|157237159|FG001|Part 2|Protocol Violation|0|||
48834956|NCT03512756|157237160|FG002|Part 2|Protocol Violation|1|||
48834957|NCT03512756|157237161|FG003|Part 2|Protocol Violation|0|||
48834958|NCT03512756|157237158|FG000|Part 2|Withdrawal by Subject|0|||
48834959|NCT03512756|157237159|FG001|Part 2|Withdrawal by Subject|0|||
48834960|NCT03512756|157237160|FG002|Part 2|Withdrawal by Subject|3|||
48834961|NCT03512756|157237161|FG003|Part 2|Withdrawal by Subject|9|||
48834962|NCT00943735|157238646|FG000|Overall Study|Adverse Event|12|||
48834963|NCT00943735|157238646|FG000|Overall Study|Withdrawal by Subject|8|||
48834964|NCT00943735|157238646|FG000|Overall Study|Death|1|||
48834965|NCT00943735|157238646|FG000|Overall Study|Other|8|||
48834966|NCT00943735|157238646|FG000|Overall Study|Other|3|||
48834967|NCT00831415|157238649|FG000|Overall Study|Adverse Event|14|||
48834968|NCT00831415|157238649|FG000|Overall Study|Failed to return|3|||
48834969|NCT00831415|157238649|FG000|Overall Study|Physician Decision|6|||
48834970|NCT00831415|157238649|FG000|Overall Study|Lost to Follow-up|9|||
48834971|NCT00831415|157238649|FG000|Overall Study|Protocol Violation|3|||
48834972|NCT00831415|157238649|FG000|Overall Study|Withdrawal by Subject|35|||
48834973|NCT00831415|157238649|FG000|Overall Study|Unsatisfactory response - Efficacy|4|||
48834974|NCT00831415|157238649|FG000|Overall Study|Death|1|||
48834975|NCT00246012|157238651|FG000|Overall Study|Adverse Event|0|||
48834976|NCT00246012|157238652|FG001|Overall Study|Adverse Event|0|||
48834977|NCT00246012|157238653|FG002|Overall Study|Adverse Event|0|||
48834978|NCT00246012|157238654|FG003|Overall Study|Adverse Event|0|||
48834979|NCT00246012|157238655|FG004|Overall Study|Adverse Event|0|||
48834980|NCT00246012|157238656|FG005|Overall Study|Adverse Event|1|||
48834981|NCT00246012|157238657|FG006|Overall Study|Adverse Event|0|||
48834982|NCT00246012|157238658|FG007|Overall Study|Adverse Event|0|||
48834983|NCT00246012|157238659|FG008|Overall Study|Adverse Event|2|||
48834984|NCT00246012|157238651|FG000|Overall Study|Withdrawal by Subject|0|||
48834985|NCT00246012|157238652|FG001|Overall Study|Withdrawal by Subject|0|||
48834986|NCT00246012|157238653|FG002|Overall Study|Withdrawal by Subject|0|||
48834987|NCT00246012|157238654|FG003|Overall Study|Withdrawal by Subject|0|||
48834988|NCT00246012|157238655|FG004|Overall Study|Withdrawal by Subject|0|||
48834989|NCT00246012|157238656|FG005|Overall Study|Withdrawal by Subject|1|||
48834990|NCT00246012|157238657|FG006|Overall Study|Withdrawal by Subject|0|||
48834991|NCT00246012|157238658|FG007|Overall Study|Withdrawal by Subject|0|||
48834992|NCT00246012|157238659|FG008|Overall Study|Withdrawal by Subject|0|||
48834993|NCT00246012|157238651|FG000|Overall Study|Disease progression|3|||
48834994|NCT00246012|157238652|FG001|Overall Study|Disease progression|1|||
48834995|NCT00246012|157238653|FG002|Overall Study|Disease progression|2|||
48834996|NCT00246012|157238654|FG003|Overall Study|Disease progression|3|||
48834997|NCT00246012|157238655|FG004|Overall Study|Disease progression|3|||
48834998|NCT00246012|157238656|FG005|Overall Study|Disease progression|25|||
48834999|NCT00246012|157238657|FG006|Overall Study|Disease progression|30|||
48835000|NCT00246012|157238658|FG007|Overall Study|Disease progression|27|||
48835001|NCT00246012|157238659|FG008|Overall Study|Disease progression|26|||
48835002|NCT00246012|157238651|FG000|Overall Study|Other|0|||
48835003|NCT00246012|157238652|FG001|Overall Study|Other|0|||
48835004|NCT00246012|157238653|FG002|Overall Study|Other|0|||
48835005|NCT00246012|157238654|FG003|Overall Study|Other|0|||
48835006|NCT00246012|157238655|FG004|Overall Study|Other|0|||
48835007|NCT00246012|157238656|FG005|Overall Study|Other|0|||
48835008|NCT00246012|157238657|FG006|Overall Study|Other|0|||
48835009|NCT00246012|157238658|FG007|Overall Study|Other|1|||
48835010|NCT00246012|157238659|FG008|Overall Study|Other|0|||
48835011|NCT00246012|157238651|FG000|Overall Study|Randomly assigned but not treated|0|||
48835012|NCT00246012|157238652|FG001|Overall Study|Randomly assigned but not treated|0|||
48835013|NCT00246012|157238653|FG002|Overall Study|Randomly assigned but not treated|0|||
48835014|NCT00246012|157238654|FG003|Overall Study|Randomly assigned but not treated|0|||
48835015|NCT00246012|157238655|FG004|Overall Study|Randomly assigned but not treated|0|||
48835016|NCT00246012|157238656|FG005|Overall Study|Randomly assigned but not treated|1|||
48835017|NCT00246012|157238657|FG006|Overall Study|Randomly assigned but not treated|1|||
48835018|NCT00246012|157238658|FG007|Overall Study|Randomly assigned but not treated|0|||
48835019|NCT00246012|157238659|FG008|Overall Study|Randomly assigned but not treated|0|||
48835020|NCT00855465|157238670|FG000|Treatment Period|Adverse Event|4|||
48835021|NCT00855465|157238671|FG001|Treatment Period|Adverse Event|2|||
48835022|NCT00855465|157238670|FG000|Treatment Period|Death|2|||
48835023|NCT00855465|157238671|FG001|Treatment Period|Death|2|||
48835024|NCT00855465|157238670|FG000|Treatment Period|Lack of Efficacy|2|||
48835025|NCT00855465|157238671|FG001|Treatment Period|Lack of Efficacy|1|||
48835026|NCT00855465|157238670|FG000|Treatment Period|Non-compliance|1|||
48835027|NCT00855465|157238671|FG001|Treatment Period|Non-compliance|0|||
48835028|NCT00855465|157238670|FG000|Treatment Period|Protocol Violation|2|||
48835029|NCT00855465|157238671|FG001|Treatment Period|Protocol Violation|0|||
48835030|NCT00855465|157238670|FG000|Treatment Period|Withdrawal by Subject|2|||
48835031|NCT00855465|157238671|FG001|Treatment Period|Withdrawal by Subject|0|||
48835032|NCT00855465|157238670|FG000|Treatment Period|Not treated|1|||
49161220|NCT00399035|158430481|FG002|Overall Study|Lost to Follow-up|5|||
49161221|NCT00399035|158430479|FG000|Overall Study|Withdrawal by Subject|19|||
49161222|NCT00399035|158430480|FG001|Overall Study|Withdrawal by Subject|15|||
49161223|NCT00399035|158430481|FG002|Overall Study|Withdrawal by Subject|12|||
49161224|NCT00399035|158430479|FG000|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
49161225|NCT00399035|158430480|FG001|Overall Study|Incorrect enrolment/eligib not fulfilled|0|||
49161226|NCT00399035|158430481|FG002|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
49161227|NCT00399035|158430479|FG000|Overall Study|Severe non-compliance with protocol|2|||
49161228|NCT00399035|158430480|FG001|Overall Study|Severe non-compliance with protocol|1|||
49161229|NCT00399035|158430481|FG002|Overall Study|Severe non-compliance with protocol|0|||
49161230|NCT02805790|158430484|FG000|Second Intervention (4 Weeks)|Physician Decision|0|||
49161231|NCT02805790|158430485|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
49161232|NCT02493764|158430487|FG000|Overall Study|Adverse Event|2|||
49161233|NCT02493764|158430488|FG001|Overall Study|Adverse Event|2|||
49161234|NCT02493764|158430487|FG000|Overall Study|Death|44|||
49161235|NCT02493764|158430488|FG001|Overall Study|Death|58|||
49161236|NCT02493764|158430487|FG000|Overall Study|Lost to Follow-up|2|||
49161237|NCT02493764|158430488|FG001|Overall Study|Lost to Follow-up|1|||
49161238|NCT02493764|158430487|FG000|Overall Study|Protocol Violation|6|||
49161239|NCT02493764|158430488|FG001|Overall Study|Protocol Violation|7|||
49161240|NCT02493764|158430487|FG000|Overall Study|Physician Decision|1|||
49161241|NCT02493764|158430488|FG001|Overall Study|Physician Decision|1|||
49161242|NCT02493764|158430487|FG000|Overall Study|Participant moved|17|||
49161243|NCT02493764|158430488|FG001|Overall Study|Participant moved|5|||
49161244|NCT02493764|158430487|FG000|Overall Study|Withdrawal parent/guardian|0|||
49161245|NCT02493764|158430488|FG001|Overall Study|Withdrawal parent/guardian|1|||
49161246|NCT02493764|158430487|FG000|Overall Study|Withdrawal by Subject|11|||
49161247|NCT02493764|158430488|FG001|Overall Study|Withdrawal by Subject|7|||
49161248|NCT00186628|158430493|FG000|Overall Study|Death|2|||
49161249|NCT00186628|158430493|FG000|Overall Study|Withdrawal by subject (before treatment)|1|||
49161250|NCT02581891|158430494|FG000|Overall Study|Adverse Event|4|||
49161251|NCT02581891|158430495|FG001|Overall Study|Adverse Event|6|||
49161252|NCT02581891|158430494|FG000|Overall Study|Death|3|||
49161253|NCT02581891|158430495|FG001|Overall Study|Death|4|||
49161254|NCT02581891|158430494|FG000|Overall Study|Lost to Follow-up|1|||
49161255|NCT02581891|158430495|FG001|Overall Study|Lost to Follow-up|2|||
49161256|NCT02581891|158430494|FG000|Overall Study|Physician Decision|0|||
49161257|NCT02581891|158430495|FG001|Overall Study|Physician Decision|1|||
49161258|NCT02581891|158430494|FG000|Overall Study|Withdrawal by Subject|4|||
49161259|NCT02581891|158430495|FG001|Overall Study|Withdrawal by Subject|5|||
49161260|NCT02581891|158430494|FG000|Overall Study|Other Reasons|3|||
49161261|NCT02581891|158430495|FG001|Overall Study|Other Reasons|1|||
49161262|NCT02581891|158430494|FG000|Overall Study|Discontinued during followup|1|||
49161263|NCT02581891|158430495|FG001|Overall Study|Discontinued during followup|0|||
49161264|NCT03745768|158430498|FG000|Overall Study|discontinued study|2|||
49161265|NCT03745768|158430499|FG001|Overall Study|discontinued study|0|||
49161266|NCT01130337|158430500|FG000|Overall Study|Withdrawal by Subject|3|||
49161267|NCT01130337|158430500|FG000|Overall Study|Principal investigator decision|1|||
49161268|NCT01130337|158430500|FG000|Overall Study|Death|1|||
49161269|NCT01130337|158430500|FG000|Overall Study|Disease progression|1|||
49161270|NCT01130337|158430500|FG000|Overall Study|Toxicity, AE/intercurrent disease|7|||
49161271|NCT01130337|158430500|FG000|Overall Study|Surgical resection (R2)|1|||
49161272|NCT00616642|158430501|FG000|Overall Study|Withdrawal by Subject|0|||
49161273|NCT00616642|158430502|FG001|Overall Study|Withdrawal by Subject|1|||
49161274|NCT03064074|158430503|FG000|Overall Study|Physician Decision|0|||
49161275|NCT03064074|158430504|FG001|Overall Study|Physician Decision|0|||
49161276|NCT03064074|158430505|FG002|Overall Study|Physician Decision|0|||
49161277|NCT03064074|158430506|FG003|Overall Study|Physician Decision|1|||
48835033|NCT00855465|157238671|FG001|Treatment Period|Not treated|0|||
48835034|NCT00855465|157238670|FG000|Follow-up Period (FUP)|Adverse Event|0|||
48835035|NCT00855465|157238671|FG001|Follow-up Period (FUP)|Adverse Event|1|||
48835036|NCT00855465|157238670|FG000|Follow-up Period (FUP)|Death|0|||
48835037|NCT00855465|157238671|FG001|Follow-up Period (FUP)|Death|1|||
49161278|NCT01193101|158430508|FG000|Overall Study|Adverse Event|0|||
49161279|NCT01193101|158430509|FG001|Overall Study|Adverse Event|1|||
49161280|NCT01193101|158430510|FG002|Overall Study|Adverse Event|1|||
49161281|NCT01193101|158430511|FG003|Overall Study|Adverse Event|3|||
49161282|NCT01193101|158430508|FG000|Overall Study|Lack of Efficacy|3|||
49161283|NCT01193101|158430509|FG001|Overall Study|Lack of Efficacy|1|||
49161284|NCT01193101|158430510|FG002|Overall Study|Lack of Efficacy|0|||
49161285|NCT01193101|158430511|FG003|Overall Study|Lack of Efficacy|8|||
49161286|NCT01193101|158430508|FG000|Overall Study|Withdrawal by Subject|2|||
49161287|NCT01193101|158430509|FG001|Overall Study|Withdrawal by Subject|4|||
49161288|NCT01193101|158430510|FG002|Overall Study|Withdrawal by Subject|1|||
49161289|NCT01193101|158430511|FG003|Overall Study|Withdrawal by Subject|1|||
49161290|NCT01193101|158430508|FG000|Overall Study|Administrative problems|0|||
49161291|NCT01193101|158430509|FG001|Overall Study|Administrative problems|0|||
49161292|NCT01193101|158430510|FG002|Overall Study|Administrative problems|1|||
49161293|NCT01193101|158430511|FG003|Overall Study|Administrative problems|0|||
49161294|NCT01193101|158430508|FG000|Overall Study|Abnormal test procedure results|0|||
48835038|NCT00855465|157238670|FG000|Follow-up Period (FUP)|Lost to Follow-up|3|||
48835039|NCT00855465|157238671|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
49161295|NCT01193101|158430509|FG001|Overall Study|Abnormal test procedure results|1|||
49161296|NCT01193101|158430510|FG002|Overall Study|Abnormal test procedure results|0|||
48835040|NCT00855465|157238670|FG000|Follow-up Period (FUP)|Withdrawal by Subject|4|||
48835041|NCT00855465|157238671|FG001|Follow-up Period (FUP)|Withdrawal by Subject|0|||
48835042|NCT00855465|157238670|FG000|Follow-up Period (FUP)|Missing|1|||
48835043|NCT00855465|157238671|FG001|Follow-up Period (FUP)|Missing|0|||
48835044|NCT00880048|157238674|FG000|Overall Study|Adverse Event|2|||
48835045|NCT00880048|157238675|FG001|Overall Study|Adverse Event|3|||
48835046|NCT00880048|157238676|FG002|Overall Study|Adverse Event|5|||
48835047|NCT00880048|157238674|FG000|Overall Study|Lack of Efficacy|1|||
48835048|NCT00880048|157238675|FG001|Overall Study|Lack of Efficacy|2|||
48835049|NCT00880048|157238676|FG002|Overall Study|Lack of Efficacy|2|||
49161297|NCT01193101|158430511|FG003|Overall Study|Abnormal test procedure results|0|||
49161298|NCT02271529|158430512|FG000|Overall Study|Withdrawal by Subject|1|||
49161299|NCT05142306|158430513|FG000|Overall Study|Withdrawal by Subject|0|||
49161300|NCT05142306|158430514|FG001|Overall Study|Withdrawal by Subject|0|||
49161301|NCT05142306|158430515|FG002|Overall Study|Withdrawal by Subject|1|||
49161302|NCT01082614|158430516|FG000|Overall Study|Adverse Event|1|||
49161303|NCT01082614|158430517|FG001|Overall Study|Adverse Event|4|||
49161304|NCT01082614|158430516|FG000|Overall Study|Equipment Malfunction|0|||
49161305|NCT01082614|158430517|FG001|Overall Study|Equipment Malfunction|1|||
49161306|NCT01082614|158430516|FG000|Overall Study|Physician Decision|2|||
49161307|NCT01082614|158430517|FG001|Overall Study|Physician Decision|0|||
49161308|NCT00553631|158430522|FG000|Overall Study|Withdrawal by Subject|0|||
49161309|NCT00553631|158430523|FG001|Overall Study|Withdrawal by Subject|1|||
49161310|NCT00553631|158430522|FG000|Overall Study|Lost to Follow-up|1|||
49161311|NCT00553631|158430523|FG001|Overall Study|Lost to Follow-up|0|||
49161312|NCT00950651|158430524|FG000|Overall Study|Adverse Event|17|||
49161313|NCT00950651|158430525|FG001|Overall Study|Adverse Event|20|||
49161314|NCT00950651|158430524|FG000|Overall Study|Death|1|||
49161315|NCT00950651|158430525|FG001|Overall Study|Death|0|||
49161316|NCT00950651|158430524|FG000|Overall Study|Lack of Efficacy|2|||
49161317|NCT00950651|158430525|FG001|Overall Study|Lack of Efficacy|2|||
49161318|NCT00950651|158430524|FG000|Overall Study|Protocol Violation|3|||
49161319|NCT00950651|158430525|FG001|Overall Study|Protocol Violation|4|||
49161320|NCT00950651|158430524|FG000|Overall Study|Withdrawal by Subject|8|||
49161321|NCT00950651|158430525|FG001|Overall Study|Withdrawal by Subject|9|||
49161322|NCT03783780|158430528|FG000|Overall Study|Withdrawn prior to completion|1|||
49161323|NCT03768427|158430529|FG000|Overall Study|Death|0|||
49161324|NCT03768427|158430530|FG001|Overall Study|Death|0|||
49161325|NCT03768427|158430531|FG002|Overall Study|Death|1|||
49161326|NCT03768427|158430532|FG003|Overall Study|Death|0|||
49161327|NCT03768427|158430529|FG000|Overall Study|Lost to Follow-up|2|||
49161328|NCT03768427|158430530|FG001|Overall Study|Lost to Follow-up|0|||
48835050|NCT00880048|157238674|FG000|Overall Study|Protocol Violation|4|||
48835051|NCT00880048|157238675|FG001|Overall Study|Protocol Violation|6|||
48835052|NCT00880048|157238676|FG002|Overall Study|Protocol Violation|5|||
48835053|NCT00880048|157238674|FG000|Overall Study|Lost to Follow-up|6|||
48835054|NCT00880048|157238675|FG001|Overall Study|Lost to Follow-up|6|||
49161329|NCT03768427|158430531|FG002|Overall Study|Lost to Follow-up|0|||
49161330|NCT03768427|158430532|FG003|Overall Study|Lost to Follow-up|0|||
49161331|NCT03768427|158430529|FG000|Overall Study|Physician Decision|3|||
49161332|NCT03768427|158430530|FG001|Overall Study|Physician Decision|2|||
49161333|NCT03768427|158430531|FG002|Overall Study|Physician Decision|4|||
49161334|NCT03768427|158430532|FG003|Overall Study|Physician Decision|4|||
49161335|NCT03768427|158430529|FG000|Overall Study|Withdrawal by Subject|7|||
49161336|NCT03768427|158430530|FG001|Overall Study|Withdrawal by Subject|2|||
49161337|NCT03768427|158430531|FG002|Overall Study|Withdrawal by Subject|6|||
49161338|NCT03768427|158430532|FG003|Overall Study|Withdrawal by Subject|7|||
49161339|NCT00087698|158430536|FG000|Overall Study|Lack of Efficacy, Progressive Disease|14|||
49161340|NCT00087698|158430536|FG000|Overall Study|Death from Other Causes|3|||
48835055|NCT00880048|157238676|FG002|Overall Study|Lost to Follow-up|5|||
48835056|NCT00880048|157238674|FG000|Overall Study|Physician Decision|1|||
48835057|NCT00880048|157238675|FG001|Overall Study|Physician Decision|1|||
48835058|NCT00880048|157238676|FG002|Overall Study|Physician Decision|7|||
48835059|NCT00880048|157238674|FG000|Overall Study|Withdrawal by Subject|5|||
48835060|NCT00880048|157238675|FG001|Overall Study|Withdrawal by Subject|8|||
48835061|NCT00880048|157238676|FG002|Overall Study|Withdrawal by Subject|5|||
49161341|NCT00087698|158430536|FG000|Overall Study|Adverse Event|4|||
49161342|NCT00087698|158430536|FG000|Overall Study|Withdrawal by Subject|4|||
49161343|NCT00087698|158430536|FG000|Overall Study|Lack of Efficacy, Physician Perception|3|||
49161344|NCT00087698|158430536|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
49161345|NCT00087698|158430536|FG000|Overall Study|Clinical Relapse|1|||
49161346|NCT00087698|158430536|FG000|Overall Study|Death from Study Disease|2|||
49161347|NCT00087698|158430536|FG000|Overall Study|Death from Study Drug Toxicity|2|||
49161348|NCT00087698|158430536|FG000|Overall Study|Protocol Violation|1|||
49161349|NCT00326599|158430537|FG000|Overall Study|Withdrawal by Subject|1|||
49161350|NCT00326599|158430538|FG001|Overall Study|Withdrawal by Subject|0|||
49161351|NCT00326599|158430539|FG002|Overall Study|Withdrawal by Subject|5|||
49161352|NCT00326599|158430540|FG003|Overall Study|Withdrawal by Subject|2|||
49161353|NCT00326599|158430537|FG000|Overall Study|Adverse Event|1|||
49161354|NCT00326599|158430538|FG001|Overall Study|Adverse Event|0|||
49161355|NCT00326599|158430539|FG002|Overall Study|Adverse Event|32|||
49161356|NCT00326599|158430540|FG003|Overall Study|Adverse Event|3|||
49161357|NCT00326599|158430537|FG000|Overall Study|Disease Progression|3|||
49161358|NCT00326599|158430538|FG001|Overall Study|Disease Progression|1|||
49161359|NCT00326599|158430539|FG002|Overall Study|Disease Progression|13|||
49161360|NCT00326599|158430540|FG003|Overall Study|Disease Progression|11|||
48835062|NCT00880048|157238674|FG000|Overall Study|Study closed/terminated|9|||
48923489|NCT00993031|157553272|FG000|Overall Study|Death|0|||
49161361|NCT00326599|158430537|FG000|Overall Study|Alternate Treatment|1|||
49161362|NCT00326599|158430538|FG001|Overall Study|Alternate Treatment|0|||
49161363|NCT00326599|158430539|FG002|Overall Study|Alternate Treatment|0|||
48835063|NCT00880048|157238675|FG001|Overall Study|Study closed/terminated|7|||
48835064|NCT00880048|157238676|FG002|Overall Study|Study closed/terminated|6|||
48835065|NCT00367991|157238684|FG000|Overall Study|Withdrawal by Subject|1|||
48835066|NCT00367991|157238685|FG001|Overall Study|Withdrawal by Subject|1|||
48835067|NCT00367991|157238684|FG000|Overall Study|Adverse Event|1|||
48835068|NCT00367991|157238685|FG001|Overall Study|Adverse Event|1|||
48835069|NCT03247543|157238688|FG000|Overall Study|Adverse Event|3|||
48835070|NCT03247543|157238689|FG001|Overall Study|Adverse Event|6|||
48835071|NCT03247543|157238690|FG002|Overall Study|Adverse Event|4|||
48835072|NCT03247543|157238688|FG000|Overall Study|Lost to Follow-up|10|||
48835073|NCT03247543|157238689|FG001|Overall Study|Lost to Follow-up|7|||
48835074|NCT03247543|157238690|FG002|Overall Study|Lost to Follow-up|8|||
48835075|NCT03247543|157238688|FG000|Overall Study|Consent withdrawn by caregiver|2|||
48835076|NCT03247543|157238689|FG001|Overall Study|Consent withdrawn by caregiver|2|||
48835077|NCT03247543|157238690|FG002|Overall Study|Consent withdrawn by caregiver|9|||
48835078|NCT03247543|157238688|FG000|Overall Study|Withdrawal by Subject|0|||
48835079|NCT03247543|157238689|FG001|Overall Study|Withdrawal by Subject|0|||
48835080|NCT03247543|157238690|FG002|Overall Study|Withdrawal by Subject|1|||
48835081|NCT03247543|157238688|FG000|Overall Study|Failure to Follow study procedures|1|||
48835082|NCT03247543|157238689|FG001|Overall Study|Failure to Follow study procedures|3|||
48835083|NCT03247543|157238690|FG002|Overall Study|Failure to Follow study procedures|1|||
48835084|NCT03247543|157238688|FG000|Overall Study|Lack of Efficacy|1|||
48835085|NCT03247543|157238689|FG001|Overall Study|Lack of Efficacy|0|||
48835086|NCT03247543|157238690|FG002|Overall Study|Lack of Efficacy|0|||
48835087|NCT03247543|157238688|FG000|Overall Study|Non-compliance with study visits|0|||
48835088|NCT03247543|157238689|FG001|Overall Study|Non-compliance with study visits|1|||
48835089|NCT03247543|157238690|FG002|Overall Study|Non-compliance with study visits|0|||
48835090|NCT00790790|157238691|FG000|Study Period 2: Therapy Phase|Adverse Event|3|||
48835091|NCT00790790|157238692|FG001|Study Period 2: Therapy Phase|Adverse Event|16|||
48835092|NCT00790790|157238693|FG002|Study Period 2: Therapy Phase|Adverse Event|16|||
48835093|NCT00790790|157238691|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
48835094|NCT00790790|157238692|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
48835095|NCT00790790|157238693|FG002|Study Period 2: Therapy Phase|Protocol Violation|0|||
48835096|NCT00790790|157238691|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|7|||
48835097|NCT00790790|157238692|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
48835098|NCT00790790|157238693|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
48835099|NCT00790790|157238691|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
48835100|NCT00790790|157238692|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
49161364|NCT00326599|158430540|FG003|Overall Study|Alternate Treatment|0|||
49161365|NCT00326599|158430537|FG000|Overall Study|Death|0|||
49161366|NCT00326599|158430538|FG001|Overall Study|Death|0|||
49161367|NCT00326599|158430539|FG002|Overall Study|Death|1|||
49161368|NCT00326599|158430540|FG003|Overall Study|Death|2|||
49161369|NCT00326599|158430537|FG000|Overall Study|Other Unspecified Reason|0|||
49161370|NCT00326599|158430538|FG001|Overall Study|Other Unspecified Reason|0|||
49161371|NCT00326599|158430539|FG002|Overall Study|Other Unspecified Reason|2|||
49161372|NCT00326599|158430540|FG003|Overall Study|Other Unspecified Reason|1|||
49161373|NCT01508910|158430541|FG000|Treatment|Death|2|||
49161374|NCT01508910|158430542|FG001|Treatment|Death|3|||
49161375|NCT01508910|158430543|FG002|Treatment|Death|2|||
49161376|NCT01508910|158430544|FG003|Treatment|Death|0|||
49161377|NCT01508910|158430541|FG000|Treatment|Lost to Follow-up|0|||
49161378|NCT01508910|158430542|FG001|Treatment|Lost to Follow-up|0|||
49161379|NCT01508910|158430543|FG002|Treatment|Lost to Follow-up|2|||
49161380|NCT01508910|158430544|FG003|Treatment|Lost to Follow-up|1|||
49161381|NCT01508910|158430541|FG000|Treatment|Withdrawal by Subject|0|||
49161382|NCT01508910|158430542|FG001|Treatment|Withdrawal by Subject|1|||
49161383|NCT01508910|158430543|FG002|Treatment|Withdrawal by Subject|6|||
49161384|NCT01508910|158430544|FG003|Treatment|Withdrawal by Subject|1|||
49161385|NCT01508910|158430541|FG000|Treatment|Sponsor Decision|0|||
49161386|NCT01508910|158430542|FG001|Treatment|Sponsor Decision|0|||
49161387|NCT01508910|158430543|FG002|Treatment|Sponsor Decision|0|||
48835101|NCT00790790|157238693|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|3|||
48835102|NCT00790790|157238691|FG000|Study Period 2: Therapy Phase|Physician Decision|0|||
48835103|NCT00790790|157238692|FG001|Study Period 2: Therapy Phase|Physician Decision|1|||
48835104|NCT00790790|157238693|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
48835105|NCT02059980|157238700|FG000|Overall Study|Lost to Follow-up|2|||
48835106|NCT02059980|157238701|FG001|Overall Study|Lost to Follow-up|1|||
48835107|NCT01321606|157238702|FG000|Overall Study|Lost to Follow-up|0|||
48835108|NCT01321606|157238703|FG001|Overall Study|Lost to Follow-up|0|||
48835109|NCT01321606|157238704|FG002|Overall Study|Lost to Follow-up|0|||
48835110|NCT01321606|157238705|FG003|Overall Study|Lost to Follow-up|1|||
48835111|NCT02808338|157238706|FG000|Screening|Screen Failure|10|||
48835112|NCT02808338|157238706|FG000|Overnight In-lab Polysomonography|Withdrawal by Subject|1|||
48835113|NCT02808338|157238706|FG000|Overnight In-lab Polysomonography|Reason not given|1|||
48835114|NCT02194933|157238710|FG000|Overall Study|Lost to Follow-up|1|||
48835115|NCT02194933|157238711|FG001|Overall Study|Lost to Follow-up|2|||
48835116|NCT02194933|157238710|FG000|Overall Study|Participant met withdrawal criteria|1|||
48835117|NCT02194933|157238711|FG001|Overall Study|Participant met withdrawal criteria|3|||
48835118|NCT02194933|157238710|FG000|Overall Study|Withdrawal by Subject|0|||
48835119|NCT02194933|157238711|FG001|Overall Study|Withdrawal by Subject|2|||
48835120|NCT02194933|157238710|FG000|Overall Study|Lack of Efficacy|1|||
48835121|NCT02194933|157238711|FG001|Overall Study|Lack of Efficacy|2|||
48835122|NCT01104415|157238712|FG000|Core Phase|Consent withdrawn by subjects|1|||
48835123|NCT01104415|157238713|FG001|Core Phase|Consent withdrawn by subjects|0|||
48835124|NCT01104415|157238712|FG000|Extension Period|Progressive disease|0|||
48835125|NCT01104415|157238713|FG001|Extension Period|Progressive disease|4|||
48835126|NCT01104415|157238712|FG000|Extension Period|Death|0|||
48835127|NCT01104415|157238713|FG001|Extension Period|Death|1|||
48835128|NCT01104415|157238712|FG000|Extension Period|Physician Decision|0|||
48835129|NCT01104415|157238713|FG001|Extension Period|Physician Decision|1|||
48835130|NCT01104415|157238712|FG000|Extension Period|Transition to Study LX1606.302|0|||
48835131|NCT01104415|157238713|FG001|Extension Period|Transition to Study LX1606.302|4|||
48835132|NCT01104415|157238712|FG000|Extension Period|Heart surgery/feeling miserable|0|||
48835133|NCT01104415|157238713|FG001|Extension Period|Heart surgery/feeling miserable|1|||
48835134|NCT00057837|157238721|FG000|Overall Study|Progression/relapse|12|||
48923490|NCT00993031|157553273|FG001|Overall Study|Death|1|||
48923491|NCT00993031|157553272|FG000|Overall Study|Physician Decision|0|||
48923492|NCT00993031|157553273|FG001|Overall Study|Physician Decision|2|||
48835135|NCT00057837|157238722|FG001|Overall Study|Progression/relapse|14|||
48835136|NCT00057837|157238721|FG000|Overall Study|Adverse Event|2|||
49161388|NCT01508910|158430544|FG003|Treatment|Sponsor Decision|1|||
49161389|NCT00902330|158430547|FG000|Overall Study|Too overwhelmed by treatment|2|||
49161390|NCT00902330|158430548|FG001|Overall Study|Too overwhelmed by treatment|5|||
49161391|NCT00902330|158430547|FG000|Overall Study|Adverse Event|1|||
49161392|NCT00902330|158430548|FG001|Overall Study|Adverse Event|0|||
49161393|NCT00902330|158430547|FG000|Overall Study|No post baseline data|1|||
49161394|NCT00902330|158430548|FG001|Overall Study|No post baseline data|0|||
49161395|NCT01261975|158430549|FG000|Overall Study|Surgical complication|1|||
49161396|NCT01932788|158430551|FG000|Overall Study|Protocol Violation|18|||
48835137|NCT00057837|157238722|FG001|Overall Study|Adverse Event|12|||
48835138|NCT00057837|157238721|FG000|Overall Study|Death|5|||
48835139|NCT00057837|157238722|FG001|Overall Study|Death|4|||
48835140|NCT00057837|157238721|FG000|Overall Study|Withdrawal by Subject|5|||
48835141|NCT00057837|157238722|FG001|Overall Study|Withdrawal by Subject|3|||
48835142|NCT00057837|157238721|FG000|Overall Study|Alternative therapy|0|||
48835143|NCT00057837|157238722|FG001|Overall Study|Alternative therapy|1|||
48835144|NCT00057837|157238721|FG000|Overall Study|Other complicating disease|2|||
48835145|NCT00057837|157238722|FG001|Overall Study|Other complicating disease|1|||
48835146|NCT00057837|157238721|FG000|Overall Study|Physician Decision|1|||
48835147|NCT00057837|157238722|FG001|Overall Study|Physician Decision|0|||
48835148|NCT00057837|157238721|FG000|Overall Study|Ineligible|3|||
48835149|NCT00057837|157238722|FG001|Overall Study|Ineligible|3|||
48835150|NCT00057837|157238721|FG000|Overall Study|Never started treatment|1|||
48835151|NCT00057837|157238722|FG001|Overall Study|Never started treatment|1|||
48835152|NCT05001945|157238725|FG000|Overall Study|Adverse Event|0|||
48835153|NCT05001945|157238726|FG001|Overall Study|Adverse Event|0|||
48835154|NCT05001945|157238727|FG002|Overall Study|Adverse Event|0|||
48835155|NCT05001945|157238728|FG003|Overall Study|Adverse Event|1|||
48835156|NCT05001945|157238729|FG004|Overall Study|Adverse Event|0|||
48835157|NCT05001945|157238730|FG005|Overall Study|Adverse Event|0|||
48835158|NCT05001945|157238731|FG006|Overall Study|Adverse Event|0|||
48835159|NCT05001945|157238732|FG007|Overall Study|Adverse Event|0|||
48835160|NCT05001945|157238725|FG000|Overall Study|Lost to Follow-up|0|||
48835161|NCT05001945|157238726|FG001|Overall Study|Lost to Follow-up|1|||
48835162|NCT05001945|157238727|FG002|Overall Study|Lost to Follow-up|1|||
48835163|NCT05001945|157238728|FG003|Overall Study|Lost to Follow-up|2|||
48835164|NCT05001945|157238729|FG004|Overall Study|Lost to Follow-up|0|||
48835165|NCT05001945|157238730|FG005|Overall Study|Lost to Follow-up|1|||
48835166|NCT05001945|157238731|FG006|Overall Study|Lost to Follow-up|0|||
48835167|NCT05001945|157238732|FG007|Overall Study|Lost to Follow-up|0|||
48835168|NCT05001945|157238725|FG000|Overall Study|Protocol Violation|1|||
48835169|NCT05001945|157238726|FG001|Overall Study|Protocol Violation|0|||
48835170|NCT05001945|157238727|FG002|Overall Study|Protocol Violation|1|||
48835171|NCT05001945|157238728|FG003|Overall Study|Protocol Violation|1|||
48835172|NCT05001945|157238729|FG004|Overall Study|Protocol Violation|0|||
48835173|NCT05001945|157238730|FG005|Overall Study|Protocol Violation|1|||
48835174|NCT05001945|157238731|FG006|Overall Study|Protocol Violation|0|||
48835175|NCT05001945|157238732|FG007|Overall Study|Protocol Violation|0|||
48835176|NCT05001945|157238725|FG000|Overall Study|Withdrawal by Subject|0|||
48835177|NCT05001945|157238726|FG001|Overall Study|Withdrawal by Subject|0|||
48835178|NCT05001945|157238727|FG002|Overall Study|Withdrawal by Subject|0|||
48835179|NCT05001945|157238728|FG003|Overall Study|Withdrawal by Subject|1|||
48835180|NCT05001945|157238729|FG004|Overall Study|Withdrawal by Subject|1|||
48835181|NCT05001945|157238730|FG005|Overall Study|Withdrawal by Subject|1|||
49161397|NCT01932788|158430552|FG001|Overall Study|Protocol Violation|0|||
49161398|NCT01932788|158430551|FG000|Overall Study|Lost to Follow-up|18|||
49161399|NCT01932788|158430552|FG001|Overall Study|Lost to Follow-up|46|||
49161400|NCT01932788|158430551|FG000|Overall Study|Lack of Efficacy|2|||
49161401|NCT01932788|158430552|FG001|Overall Study|Lack of Efficacy|0|||
49161402|NCT01932788|158430551|FG000|Overall Study|Withdrawal by Subject|0|||
49161403|NCT01932788|158430552|FG001|Overall Study|Withdrawal by Subject|5|||
49161404|NCT02505425|158430553|FG000|Overall Study|Lost to Follow-up|41|||
49161405|NCT02505425|158430554|FG001|Overall Study|Lost to Follow-up|61|||
49161406|NCT02505425|158430555|FG002|Overall Study|Lost to Follow-up|31|||
49161407|NCT02505425|158430556|FG003|Overall Study|Lost to Follow-up|19|||
49161408|NCT02505425|158430553|FG000|Overall Study|Withdrawal by Subject|39|||
49161409|NCT02505425|158430554|FG001|Overall Study|Withdrawal by Subject|9|||
49161410|NCT02505425|158430555|FG002|Overall Study|Withdrawal by Subject|19|||
49161411|NCT02505425|158430556|FG003|Overall Study|Withdrawal by Subject|7|||
49161412|NCT02505425|158430553|FG000|Overall Study|Death|8|||
49161413|NCT02505425|158430554|FG001|Overall Study|Death|12|||
49161414|NCT02505425|158430555|FG002|Overall Study|Death|0|||
49161415|NCT02505425|158430556|FG003|Overall Study|Death|0|||
49161416|NCT04819113|158430557|FG000|Overall Study|Withdrawal by parent/guardian|3|||
49161417|NCT04819113|158430557|FG000|Overall Study|Lost to Follow-up|1|||
49161418|NCT04819113|158430557|FG000|Overall Study|Withdrawn before vaccination|2|||
48835182|NCT05001945|157238731|FG006|Overall Study|Withdrawal by Subject|0|||
48835183|NCT05001945|157238732|FG007|Overall Study|Withdrawal by Subject|1|||
48835184|NCT05001945|157238725|FG000|Overall Study|Not specified by Investigator|0|||
48835185|NCT05001945|157238726|FG001|Overall Study|Not specified by Investigator|3|||
48835186|NCT05001945|157238727|FG002|Overall Study|Not specified by Investigator|0|||
49161419|NCT00786422|158430560|FG000|Rivaroxaban Treatment|Death|2|||
49161420|NCT00786422|158430560|FG000|Rivaroxaban Treatment|Final visit earlier than planned|3|||
49161421|NCT00786422|158430560|FG000|Rivaroxaban Treatment|Lack of Efficacy|1|||
49161422|NCT00786422|158430560|FG000|Rivaroxaban Treatment|Physician Decision|1|||
49161423|NCT00786422|158430560|FG000|Rivaroxaban Treatment|Withdrawal by Subject|1|||
49161424|NCT00786422|158430560|FG000|Rivaroxaban Treatment|Non-compliance with study drug treatment|1|||
49161425|NCT00786422|158430560|FG000|Rivaroxaban Treatment|Adverse Event|2|||
49161426|NCT00786422|158430560|FG000|Follow-up Period|Death|1|||
49161427|NCT00786422|158430560|FG000|Follow-up Period|End-of-study done up to 4 days early|2|||
49161428|NCT02708680|158430563|FG000|Overall Study|Withdrawal by Subject|4|||
49161429|NCT02708680|158430564|FG001|Overall Study|Withdrawal by Subject|12|||
49161430|NCT02708680|158430565|FG002|Overall Study|Withdrawal by Subject|12|||
49161431|NCT02708680|158430563|FG000|Overall Study|Death|4|||
49161432|NCT02708680|158430564|FG001|Overall Study|Death|19|||
49161433|NCT02708680|158430565|FG002|Overall Study|Death|21|||
49161434|NCT02708680|158430563|FG000|Overall Study|Lost to Follow-up|0|||
48835187|NCT05001945|157238728|FG003|Overall Study|Not specified by Investigator|0|||
48835188|NCT05001945|157238729|FG004|Overall Study|Not specified by Investigator|1|||
48835189|NCT05001945|157238730|FG005|Overall Study|Not specified by Investigator|0|||
48835190|NCT05001945|157238731|FG006|Overall Study|Not specified by Investigator|0|||
49161435|NCT02708680|158430564|FG001|Overall Study|Lost to Follow-up|3|||
49161436|NCT02708680|158430565|FG002|Overall Study|Lost to Follow-up|3|||
49161437|NCT02708680|158430563|FG000|Overall Study|Study Terminated By Sponsor|0|||
49161438|NCT02708680|158430564|FG001|Overall Study|Study Terminated By Sponsor|5|||
49161439|NCT02708680|158430565|FG002|Overall Study|Study Terminated By Sponsor|4|||
49161440|NCT02708680|158430563|FG000|Overall Study|Other than Specified|0|||
49161441|NCT02708680|158430564|FG001|Overall Study|Other than Specified|0|||
49161442|NCT02708680|158430565|FG002|Overall Study|Other than Specified|1|||
49161443|NCT02708680|158430563|FG000|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
49161444|NCT02708680|158430564|FG001|Overall Study|Discontinued Treatment but Remained in Follow-up|1|||
49161445|NCT02708680|158430565|FG002|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
49161446|NCT05588440|158430566|FG000|Overall Study|Sponsor Decision|2|||
49161447|NCT05588440|158430567|FG001|Overall Study|Sponsor Decision|0|||
49161448|NCT05588440|158430568|FG002|Overall Study|Sponsor Decision|1|||
49161449|NCT05588440|158430566|FG000|Overall Study|Death|1|||
49161450|NCT05588440|158430567|FG001|Overall Study|Death|1|||
49161451|NCT05588440|158430568|FG002|Overall Study|Death|1|||
49161452|NCT05588440|158430566|FG000|Overall Study|Screen Fail|0|||
49161453|NCT05588440|158430567|FG001|Overall Study|Screen Fail|1|||
49161454|NCT05588440|158430568|FG002|Overall Study|Screen Fail|1|||
49161455|NCT05588440|158430566|FG000|Overall Study|Withdrawal by Subject|0|||
49161456|NCT05588440|158430567|FG001|Overall Study|Withdrawal by Subject|0|||
49161457|NCT05588440|158430568|FG002|Overall Study|Withdrawal by Subject|1|||
49161458|NCT04619004|158430569|FG000|Overall Study|Death|114|||
49161459|NCT04619004|158430570|FG001|Overall Study|Death|28|||
49161460|NCT04619004|158430569|FG000|Overall Study|Lost to Follow-up|1|||
49161461|NCT04619004|158430570|FG001|Overall Study|Lost to Follow-up|1|||
48835191|NCT05001945|157238732|FG007|Overall Study|Not specified by Investigator|0|||
48835192|NCT00756730|157238733|FG000|Overall Study|discontinued due to rash prior to week 4|0|||
48835193|NCT00756730|157238734|FG001|Overall Study|discontinued due to rash prior to week 4|1|||
48835194|NCT00756730|157238733|FG000|Overall Study|persistent low-level viremmia|0|||
48835195|NCT00756730|157238734|FG001|Overall Study|persistent low-level viremmia|1|||
48835196|NCT02798835|157238736|FG000|Overall Study|Protocol Violation|0|||
48835197|NCT02798835|157238737|FG001|Overall Study|Protocol Violation|0|||
48835198|NCT02798835|157238738|FG002|Overall Study|Protocol Violation|3|||
48835199|NCT01081145|157238739|FG000|Open-Label Phase|Lack of Efficacy|56|||
48835200|NCT01081145|157238740|FG001|Open-Label Phase|Lack of Efficacy|0|||
48835201|NCT01081145|157238739|FG000|Open-Label Phase|Response criteria not met|46|||
48835202|NCT01081145|157238740|FG001|Open-Label Phase|Response criteria not met|0|||
48835203|NCT01081145|157238739|FG000|Open-Label Phase|Adverse Event|42|||
48923493|NCT00993031|157553272|FG000|Overall Study|Withdrawal by Subject|3|||
48923494|NCT00993031|157553273|FG001|Overall Study|Withdrawal by Subject|3|||
48923495|NCT00993031|157553272|FG000|Overall Study|Lost to Follow-up|19|||
48923496|NCT00993031|157553273|FG001|Overall Study|Lost to Follow-up|13|||
48835204|NCT01081145|157238740|FG001|Open-Label Phase|Adverse Event|0|||
48835205|NCT01081145|157238739|FG000|Open-Label Phase|Withdrawal by Subject|41|||
48835206|NCT01081145|157238740|FG001|Open-Label Phase|Withdrawal by Subject|0|||
48835207|NCT01081145|157238739|FG000|Open-Label Phase|Other|12|||
48923497|NCT01777581|157553274|FG000|Overall Study|Lost to Follow-up|1|||
49161462|NCT04619004|158430569|FG000|Overall Study|Withdrawal by Subject|24|||
49161463|NCT04619004|158430570|FG001|Overall Study|Withdrawal by Subject|7|||
49161464|NCT04619004|158430569|FG000|Overall Study|Other - Not specified|0|||
49161465|NCT04619004|158430570|FG001|Overall Study|Other - Not specified|1|||
49161466|NCT03381287|158430571|FG000|Overall Study|Withdrawal by Subject|0|||
49161467|NCT03381287|158430572|FG001|Overall Study|Withdrawal by Subject|1|||
49161468|NCT03381287|158430573|FG002|Overall Study|Withdrawal by Subject|0|||
49161469|NCT03381287|158430574|FG003|Overall Study|Withdrawal by Subject|0|||
49161470|NCT03381287|158430571|FG000|Overall Study|Adverse Event|0|||
49161471|NCT03381287|158430572|FG001|Overall Study|Adverse Event|0|||
49161472|NCT03381287|158430573|FG002|Overall Study|Adverse Event|0|||
49161473|NCT03381287|158430574|FG003|Overall Study|Adverse Event|1|||
49161474|NCT03381287|158430571|FG000|Overall Study|Physician Decision|0|||
49161475|NCT03381287|158430572|FG001|Overall Study|Physician Decision|0|||
49161476|NCT03381287|158430573|FG002|Overall Study|Physician Decision|0|||
49161477|NCT03381287|158430574|FG003|Overall Study|Physician Decision|1|||
49161478|NCT03384875|158430578|FG000|Overall Study|Death|1|||
49161479|NCT03384875|158430579|FG001|Overall Study|Death|1|||
49161480|NCT03384875|158430580|FG002|Overall Study|Death|0|||
49161481|NCT03384875|158430578|FG000|Overall Study|Reason not provided|1|||
49161482|NCT03384875|158430579|FG001|Overall Study|Reason not provided|0|||
49161483|NCT03384875|158430580|FG002|Overall Study|Reason not provided|0|||
49161484|NCT03247829|158431897|FG000|Overall Study|Death|3|||
49161485|NCT03247829|158431898|FG001|Overall Study|Death|4|||
49161486|NCT03247829|158431897|FG000|Overall Study|Enter Hospice Care|1|||
49161487|NCT03247829|158431898|FG001|Overall Study|Enter Hospice Care|0|||
48923498|NCT01777581|157553275|FG001|Overall Study|Lost to Follow-up|1|||
48923499|NCT01777581|157553274|FG000|Overall Study|Adverse Event|2|||
48923500|NCT01777581|157553275|FG001|Overall Study|Adverse Event|0|||
48923501|NCT01777581|157553274|FG000|Overall Study|Lack of Efficacy|0|||
48923502|NCT01777581|157553275|FG001|Overall Study|Lack of Efficacy|1|||
48923503|NCT01568593|157553276|FG000|Overall Study|Lack of Efficacy|4|||
48923504|NCT01568593|157553277|FG001|Overall Study|Lack of Efficacy|1|||
48923505|NCT01568593|157553276|FG000|Overall Study|Adverse Event|3|||
48923506|NCT01568593|157553277|FG001|Overall Study|Adverse Event|2|||
48923507|NCT03461757|157553282|FG000|Overall Study|Adverse Event|1|||
48923508|NCT03461757|157553283|FG001|Overall Study|Adverse Event|0|||
48923509|NCT03461757|157553282|FG000|Overall Study|Lost to Follow-up|13|||
48923510|NCT03461757|157553283|FG001|Overall Study|Lost to Follow-up|7|||
48923511|NCT03461757|157553282|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|28|||
48923512|NCT03461757|157553283|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|25|||
48923513|NCT03461757|157553282|FG000|Overall Study|Non-compliance with study treatment|0|||
48923514|NCT03461757|157553283|FG001|Overall Study|Non-compliance with study treatment|1|||
48923515|NCT03461757|157553282|FG000|Overall Study|Pregnancy|2|||
48923516|NCT03461757|157553283|FG001|Overall Study|Pregnancy|0|||
48923517|NCT03461757|157553282|FG000|Overall Study|Protocol Violation|1|||
48923518|NCT03461757|157553283|FG001|Overall Study|Protocol Violation|1|||
48923519|NCT03461757|157553282|FG000|Overall Study|Withdrawal by Subject|7|||
48923520|NCT03461757|157553283|FG001|Overall Study|Withdrawal by Subject|7|||
48923521|NCT03461757|157553282|FG000|Overall Study|Other Reasons|1|||
48923522|NCT03461757|157553283|FG001|Overall Study|Other Reasons|4|||
48923523|NCT00357500|157553284|FG000|Overall Study|Adverse Event|3|||
48835208|NCT01081145|157238740|FG001|Open-Label Phase|Other|0|||
48835209|NCT01081145|157238739|FG000|Open-Label Phase|Lost to Follow-up|11|||
48923524|NCT00357500|157553284|FG000|Overall Study|Withdrawal by Subject|5|||
48923525|NCT00357500|157553284|FG000|Overall Study|Progressive Disease|65|||
48923526|NCT00357500|157553284|FG000|Overall Study|Not Started Protocol Therapy|4|||
48923527|NCT02425826|157553285|FG000|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5|||
48923528|NCT02425826|157553286|FG001|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2|||
48923529|NCT02425826|157553287|FG002|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0|||
48923530|NCT02425826|157553285|FG000|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
48923531|NCT02425826|157553286|FG001|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1|||
48923532|NCT02425826|157553287|FG002|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
48923533|NCT02425826|157553285|FG000|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9|||
49161488|NCT03247829|158431897|FG000|Overall Study|LVAD System Replaced / Exchange|1|||
49161489|NCT03247829|158431898|FG001|Overall Study|LVAD System Replaced / Exchange|0|||
49161490|NCT03247829|158431897|FG000|Overall Study|LVAD Explant|1|||
48835210|NCT01081145|157238740|FG001|Open-Label Phase|Lost to Follow-up|0|||
49161491|NCT03247829|158431898|FG001|Overall Study|LVAD Explant|1|||
49161492|NCT03247829|158431897|FG000|Overall Study|Transplant|1|||
49161493|NCT03247829|158431898|FG001|Overall Study|Transplant|1|||
49161494|NCT03376516|158431899|FG000|Overall Study|Not treated|1|||
49161495|NCT03376516|158431899|FG000|Overall Study|Consent withdrawn|1|||
49161496|NCT02465931|158431900|FG000|Overall Study|Lost to Follow-up|9|||
49161497|NCT02465931|158431901|FG001|Overall Study|Lost to Follow-up|11|||
49161498|NCT02465931|158431900|FG000|Overall Study|Protocol Violation|1|||
49161499|NCT02465931|158431901|FG001|Overall Study|Protocol Violation|0|||
49161500|NCT02465931|158431900|FG000|Overall Study|Withdrawal by Subject|1|||
49161501|NCT02465931|158431901|FG001|Overall Study|Withdrawal by Subject|0|||
49161502|NCT03423602|158431902|FG000|Overall Study|Death|1|||
49161503|NCT03423602|158431902|FG000|Overall Study|Lost to Follow-up|6|||
49161504|NCT03423602|158431902|FG000|Overall Study|Protocol Violation|1|||
49161505|NCT03423602|158431902|FG000|Overall Study|Withdrawal by Subject|4|||
49161506|NCT04749745|158431903|FG000|Overall Study|Withdrawal by Subject|1|||
48923534|NCT02425826|157553286|FG001|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1|||
48923535|NCT02425826|157553287|FG002|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0|||
48923536|NCT02425826|157553285|FG000|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10|||
48923537|NCT02425826|157553286|FG001|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4|||
48923538|NCT02425826|157553287|FG002|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0|||
48923539|NCT02425826|157553285|FG000|Placebo-controlled Phase (Week 0 - 16)|Other|3|||
48923540|NCT02425826|157553286|FG001|Placebo-controlled Phase (Week 0 - 16)|Other|1|||
48923541|NCT02425826|157553287|FG002|Placebo-controlled Phase (Week 0 - 16)|Other|0|||
48923542|NCT02425826|157553285|FG000|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7|||
48923543|NCT02425826|157553286|FG001|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0|||
48923544|NCT02425826|157553287|FG002|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2|||
48923545|NCT02425826|157553285|FG000|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8|||
48923546|NCT02425826|157553286|FG001|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0|||
48923547|NCT02425826|157553287|FG002|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6|||
48923548|NCT02425826|157553285|FG000|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12|||
48923549|NCT02425826|157553286|FG001|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0|||
48923550|NCT02425826|157553287|FG002|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4|||
49161507|NCT04749745|158431904|FG001|Overall Study|Withdrawal by Subject|0|||
49161508|NCT01500317|158431911|FG000|Overall Study|Withdrawal by Subject|3|||
49161509|NCT01500317|158431912|FG001|Overall Study|Withdrawal by Subject|2|||
49161510|NCT01500317|158431913|FG002|Overall Study|Withdrawal by Subject|0|||
49161511|NCT01865487|158431914|FG000|Overall Study|Lost to Follow-up|0|||
49161512|NCT01865487|158431915|FG001|Overall Study|Lost to Follow-up|0|||
49161513|NCT01865487|158431916|FG002|Overall Study|Lost to Follow-up|0|||
48835211|NCT01081145|157238739|FG000|Open-Label Phase|Protocol Violation|4|||
48835212|NCT01081145|157238740|FG001|Open-Label Phase|Protocol Violation|0|||
48835213|NCT01081145|157238739|FG000|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3|||
48835214|NCT01081145|157238740|FG001|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2|||
48835215|NCT01081145|157238739|FG000|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1|||
48835216|NCT01081145|157238740|FG001|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0|||
48835217|NCT01081145|157238739|FG000|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10|||
48835218|NCT01081145|157238740|FG001|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8|||
48835219|NCT01081145|157238739|FG000|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3|||
48835220|NCT01081145|157238740|FG001|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2|||
48835221|NCT01081145|157238739|FG000|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13|||
48835222|NCT01081145|157238740|FG001|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20|||
48835223|NCT01081145|157238739|FG000|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47|||
48835224|NCT01081145|157238740|FG001|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71|||
48835225|NCT01081145|157238739|FG000|Double-Blind Randomized-Withdrawal Phase|Other|4|||
48835226|NCT01081145|157238740|FG001|Double-Blind Randomized-Withdrawal Phase|Other|3|||
48835227|NCT00639002|157238744|FG000|Overall Study|Death|1|||
48835228|NCT00639002|157238744|FG000|Overall Study|Adverse Event|1|||
48835229|NCT00639002|157238744|FG000|Overall Study|Protocol Violation|1|||
48835230|NCT00639002|157238744|FG000|Overall Study|Disease progression|3|||
48835231|NCT00639002|157238744|FG000|Overall Study|Physician Decision|6|||
48835232|NCT00639002|157238744|FG000|Overall Study|Lack of Efficacy|1|||
48835233|NCT01430611|157238748|FG000|Overall Study|Adverse Event|0|||
48835234|NCT01430611|157238749|FG001|Overall Study|Adverse Event|1|||
48835235|NCT01430611|157238748|FG000|Overall Study|Protocol Violation|1|||
48835236|NCT01430611|157238749|FG001|Overall Study|Protocol Violation|0|||
48835237|NCT01430611|157238748|FG000|Overall Study|Lost to Follow-up|1|||
48835238|NCT01430611|157238749|FG001|Overall Study|Lost to Follow-up|0|||
48835239|NCT01430611|157238748|FG000|Overall Study|Withdrawal by Subject|15|||
48835240|NCT01430611|157238749|FG001|Overall Study|Withdrawal by Subject|14|||
48835241|NCT01968226|157238750|FG000|Overall Study|[F-18] RDG-K5 was not available|2|||
48835242|NCT01909778|157238753|FG000|Overall Study|failed screening|1|||
48835243|NCT04707313|157238754|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|4|||
48835244|NCT04707313|157238755|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|20|||
48835245|NCT04707313|157238756|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|23|||
48835246|NCT04707313|157238757|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|25|||
48835247|NCT04707313|157238758|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
48835248|NCT04707313|157238759|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|38|||
48835249|NCT04707313|157238760|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
48835250|NCT04707313|157238761|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|42|||
48835251|NCT04707313|157238762|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|16|||
48835252|NCT04707313|157238763|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
48835253|NCT04707313|157238764|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
48835254|NCT04707313|157238765|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
49161514|NCT01865487|158431917|FG003|Overall Study|Lost to Follow-up|1|||
48923551|NCT02425826|157553285|FG000|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8|||
48923552|NCT02425826|157553286|FG001|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0|||
48923553|NCT02425826|157553287|FG002|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1|||
48923554|NCT02425826|157553285|FG000|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
48923555|NCT02425826|157553286|FG001|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
48923556|NCT02425826|157553287|FG002|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1|||
49161515|NCT01865487|158431918|FG004|Overall Study|Lost to Follow-up|0|||
49161516|NCT01865487|158431919|FG005|Overall Study|Lost to Follow-up|0|||
49161517|NCT01865487|158431920|FG006|Overall Study|Lost to Follow-up|1|||
49161518|NCT01865487|158431921|FG007|Overall Study|Lost to Follow-up|0|||
49161519|NCT01865487|158431922|FG008|Overall Study|Lost to Follow-up|0|||
49161520|NCT01865487|158431923|FG009|Overall Study|Lost to Follow-up|0|||
49161521|NCT01865487|158431914|FG000|Overall Study|Withdrawal by Subject|0|||
49161522|NCT01865487|158431915|FG001|Overall Study|Withdrawal by Subject|0|||
49161523|NCT01865487|158431916|FG002|Overall Study|Withdrawal by Subject|0|||
49161524|NCT01865487|158431917|FG003|Overall Study|Withdrawal by Subject|0|||
49161525|NCT01865487|158431918|FG004|Overall Study|Withdrawal by Subject|1|||
49161526|NCT01865487|158431919|FG005|Overall Study|Withdrawal by Subject|0|||
49161527|NCT01865487|158431920|FG006|Overall Study|Withdrawal by Subject|0|||
49161528|NCT01865487|158431921|FG007|Overall Study|Withdrawal by Subject|0|||
49161529|NCT01865487|158431922|FG008|Overall Study|Withdrawal by Subject|0|||
49161530|NCT01865487|158431923|FG009|Overall Study|Withdrawal by Subject|0|||
49161531|NCT02639390|158431924|FG000|Overall Study|Subject unable to comply with treatment schedule.|0|||
49161532|NCT02639390|158431925|FG001|Overall Study|Subject unable to comply with treatment schedule.|2|||
49161533|NCT02013609|158431929|FG000|Overall Study|Withdrawal by Subject|9|||
49161534|NCT02013609|158431929|FG000|Overall Study|Lost to Follow-up|3|||
49161535|NCT02013609|158431929|FG000|Overall Study|Adverse Event|3|||
48835255|NCT04707313|157238766|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
48835256|NCT04707313|157238754|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|5|||
49161536|NCT02013609|158431929|FG000|Overall Study|Met Withdrawal Criteria|3|||
49161537|NCT01119287|158431930|FG000|Overall Study|Patient Decision, not related to AE|0|||
49161538|NCT01119287|158431931|FG001|Overall Study|Patient Decision, not related to AE|0|||
49161539|NCT01119287|158431932|FG002|Overall Study|Patient Decision, not related to AE|2|||
49161540|NCT01119287|158431933|FG003|Overall Study|Patient Decision, not related to AE|2|||
49161541|NCT01119287|158431934|FG004|Overall Study|Patient Decision, not related to AE|1|||
49161542|NCT01119287|158431935|FG005|Overall Study|Patient Decision, not related to AE|0|||
49161543|NCT03273907|158431945|FG000|Overall Study|Death|1|||
49161544|NCT03273907|158431945|FG000|Overall Study|Lost to Follow-up|4|||
48835257|NCT04707313|157238755|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
48835258|NCT04707313|157238756|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
48835259|NCT04707313|157238757|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
48835260|NCT04707313|157238758|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
48835261|NCT04707313|157238759|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
48835262|NCT04707313|157238760|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
48835263|NCT04707313|157238761|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
48835264|NCT04707313|157238762|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
48835265|NCT04707313|157238763|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
48835266|NCT04707313|157238764|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
48835267|NCT04707313|157238765|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
48835268|NCT04707313|157238766|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
48835269|NCT04707313|157238754|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
48835270|NCT04707313|157238755|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
48835271|NCT04707313|157238756|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
48835272|NCT04707313|157238757|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
48923557|NCT01464307|157553289|FG000|Main Period|Death|0|||
49161545|NCT03273907|158431945|FG000|Overall Study|Withdrawal by Subject|2|||
49161546|NCT03273907|158431945|FG000|Overall Study|COVID 19|2|||
49161547|NCT00775268|158431948|FG000|Baseline|Drug not synthesize dose|1|||
49161548|NCT00775268|158431949|FG001|Baseline|Drug not synthesize dose|0|||
49161549|NCT00775268|158431948|FG000|Baseline|Not treated-ineligible per CT|0|||
49161550|NCT00775268|158431949|FG001|Baseline|Not treated-ineligible per CT|1|||
48923558|NCT01464307|157553290|FG001|Main Period|Death|1|||
48923559|NCT01464307|157553289|FG000|Main Period|Adverse Event|6|||
48923560|NCT01464307|157553290|FG001|Main Period|Adverse Event|1|||
48923561|NCT01464307|157553289|FG000|Main Period|Lack of Efficacy|2|||
48923562|NCT01464307|157553290|FG001|Main Period|Lack of Efficacy|0|||
48923563|NCT01464307|157553289|FG000|Main Period|Withdrawal by Subject|5|||
48923564|NCT01464307|157553290|FG001|Main Period|Withdrawal by Subject|2|||
48923565|NCT01464307|157553289|FG000|Main Period|Predefined discontinuation criteria|2|||
48923566|NCT01464307|157553290|FG001|Main Period|Predefined discontinuation criteria|1|||
48923567|NCT01464307|157553289|FG000|Open-Label Extension Period|Adverse Event|15|||
48923568|NCT01464307|157553290|FG001|Open-Label Extension Period|Adverse Event|0|||
48923569|NCT01464307|157553289|FG000|Open-Label Extension Period|Withdrawal by Subject|14|||
48923570|NCT01464307|157553290|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
48923571|NCT01464307|157553289|FG000|Open-Label Extension Period|Lack of Efficacy|5|||
48923572|NCT01464307|157553290|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
48923573|NCT01464307|157553289|FG000|Open-Label Extension Period|Death|1|||
48923574|NCT01464307|157553290|FG001|Open-Label Extension Period|Death|0|||
48923575|NCT01464307|157553289|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
48923576|NCT01464307|157553290|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
48923577|NCT01464307|157553289|FG000|Open-Label Extension Period|Non-compliance|9|||
49161551|NCT00775268|158431948|FG000|After 2 Cycles|Participant refused to be scanned further|1|||
49161552|NCT00775268|158431949|FG001|After 2 Cycles|Participant refused to be scanned further|0|||
49161553|NCT00775268|158431948|FG000|After Completion|Participant missed scan appointment|1|||
49161554|NCT00775268|158431949|FG001|After Completion|Participant missed scan appointment|0|||
49161555|NCT01531998|158431950|FG000|Overall Study|Withdrawal by Subject|3|||
49161556|NCT02927795|158431955|FG000|Overall Study|Non-evaluable PF10 quest. at visit 2|19|||
49161557|NCT02927795|158431955|FG000|Overall Study|Not Treated|4|||
49161558|NCT00107276|158431960|FG000|Overall Study|Progression|46|||
49161559|NCT00107276|158431960|FG000|Overall Study|Adverse Event|6|||
49161560|NCT00107276|158431960|FG000|Overall Study|M.D. decision|2|||
49161561|NCT00107276|158431960|FG000|Overall Study|Patient refusal|1|||
49161562|NCT00107276|158431960|FG000|Overall Study|Death|1|||
49161563|NCT00107276|158431960|FG000|Overall Study|Ineligible|16|||
49161564|NCT01791517|158431961|FG000|Phase I: Period 1|Withdrawal by Subject|0|||
49161565|NCT01791517|158431962|FG001|Phase I: Period 1|Withdrawal by Subject|1|||
49161566|NCT01791517|158431963|FG002|Phase I: Period 1|Withdrawal by Subject|1|||
49161567|NCT01791517|158431964|FG003|Phase I: Period 1|Withdrawal by Subject|0|||
49161568|NCT01791517|158431965|FG004|Phase I: Period 1|Withdrawal by Subject|1|||
49161569|NCT01791517|158431966|FG005|Phase I: Period 1|Withdrawal by Subject|1|||
49161570|NCT01791517|158431967|FG006|Phase I: Period 1|Withdrawal by Subject|0|||
49161571|NCT01791517|158431968|FG007|Phase I: Period 1|Withdrawal by Subject|0|||
49161572|NCT01791517|158431969|FG008|Phase I: Period 1|Withdrawal by Subject|0|||
49161573|NCT01791517|158431970|FG009|Phase I: Period 1|Withdrawal by Subject|0|||
49161574|NCT01791517|158431971|FG010|Phase I: Period 1|Withdrawal by Subject|0|||
49161575|NCT01791517|158431972|FG011|Phase I: Period 1|Withdrawal by Subject|0|||
49161576|NCT01791517|158431961|FG000|Phase I: Period 1|Adverse Event|0|||
49161577|NCT01791517|158431962|FG001|Phase I: Period 1|Adverse Event|0|||
49161578|NCT01791517|158431963|FG002|Phase I: Period 1|Adverse Event|1|||
49161579|NCT01791517|158431964|FG003|Phase I: Period 1|Adverse Event|1|||
49161580|NCT01791517|158431965|FG004|Phase I: Period 1|Adverse Event|0|||
49161581|NCT01791517|158431966|FG005|Phase I: Period 1|Adverse Event|0|||
49161582|NCT01791517|158431967|FG006|Phase I: Period 1|Adverse Event|0|||
49161583|NCT01791517|158431968|FG007|Phase I: Period 1|Adverse Event|0|||
49161584|NCT01791517|158431969|FG008|Phase I: Period 1|Adverse Event|0|||
49161585|NCT01791517|158431970|FG009|Phase I: Period 1|Adverse Event|0|||
49161586|NCT01791517|158431971|FG010|Phase I: Period 1|Adverse Event|0|||
49161587|NCT01791517|158431972|FG011|Phase I: Period 1|Adverse Event|0|||
49161588|NCT01791517|158431961|FG000|Phase I: Period 1|Unsatisfactory Lens Fitting|1|||
49161589|NCT01791517|158431962|FG001|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
49161590|NCT01791517|158431963|FG002|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
48835273|NCT04707313|157238758|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
48835274|NCT04707313|157238759|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
48835275|NCT04707313|157238760|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
48835276|NCT04707313|157238761|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
48835277|NCT04707313|157238762|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
48835278|NCT04707313|157238763|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
49161591|NCT01791517|158431964|FG003|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
48835279|NCT04707313|157238764|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
49161592|NCT01791517|158431965|FG004|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
49161593|NCT01791517|158431966|FG005|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
49161594|NCT01791517|158431967|FG006|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
49161595|NCT01791517|158431968|FG007|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
49161596|NCT01791517|158431969|FG008|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
49161597|NCT01791517|158431970|FG009|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
49161598|NCT01791517|158431971|FG010|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
49161599|NCT01791517|158431972|FG011|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
49161600|NCT01791517|158431961|FG000|Phase I: Period 1|Protocol Violation|0|||
49161601|NCT01791517|158431962|FG001|Phase I: Period 1|Protocol Violation|1|||
49161602|NCT01791517|158431963|FG002|Phase I: Period 1|Protocol Violation|0|||
49161603|NCT01791517|158431964|FG003|Phase I: Period 1|Protocol Violation|0|||
49161604|NCT01791517|158431965|FG004|Phase I: Period 1|Protocol Violation|0|||
49161605|NCT01791517|158431966|FG005|Phase I: Period 1|Protocol Violation|0|||
48835280|NCT04707313|157238765|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
48835281|NCT04707313|157238766|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
48835282|NCT04707313|157238754|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
48835283|NCT04707313|157238755|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
48835284|NCT04707313|157238756|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|2|||
48835285|NCT04707313|157238757|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
48835286|NCT04707313|157238758|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
48835287|NCT04707313|157238759|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
48835288|NCT04707313|157238760|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
48835289|NCT04707313|157238761|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
48835290|NCT04707313|157238762|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
48835291|NCT04707313|157238763|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
48835292|NCT04707313|157238764|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
48835293|NCT04707313|157238765|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
48835294|NCT04707313|157238766|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
48835295|NCT04707313|157238754|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
48835296|NCT04707313|157238755|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Other|4|||
48835297|NCT04707313|157238756|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
48835298|NCT04707313|157238757|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
48835299|NCT04707313|157238758|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Other|2|||
48835300|NCT04707313|157238759|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
49161606|NCT01791517|158431967|FG006|Phase I: Period 1|Protocol Violation|0|||
49161607|NCT01791517|158431968|FG007|Phase I: Period 1|Protocol Violation|0|||
49161608|NCT01791517|158431969|FG008|Phase I: Period 1|Protocol Violation|0|||
49161609|NCT01791517|158431970|FG009|Phase I: Period 1|Protocol Violation|0|||
49161610|NCT01791517|158431971|FG010|Phase I: Period 1|Protocol Violation|0|||
49161611|NCT01791517|158431972|FG011|Phase I: Period 1|Protocol Violation|0|||
49161612|NCT01791517|158431961|FG000|Phase I: Period 1|Lost to Follow-up|0|||
49161613|NCT01791517|158431962|FG001|Phase I: Period 1|Lost to Follow-up|0|||
49161614|NCT01791517|158431963|FG002|Phase I: Period 1|Lost to Follow-up|0|||
49161615|NCT01791517|158431964|FG003|Phase I: Period 1|Lost to Follow-up|1|||
49161616|NCT01791517|158431965|FG004|Phase I: Period 1|Lost to Follow-up|0|||
49161617|NCT01791517|158431966|FG005|Phase I: Period 1|Lost to Follow-up|0|||
49161618|NCT01791517|158431967|FG006|Phase I: Period 1|Lost to Follow-up|1|||
49161619|NCT01791517|158431968|FG007|Phase I: Period 1|Lost to Follow-up|0|||
49161620|NCT01791517|158431969|FG008|Phase I: Period 1|Lost to Follow-up|1|||
49161621|NCT01791517|158431970|FG009|Phase I: Period 1|Lost to Follow-up|1|||
49161622|NCT01791517|158431971|FG010|Phase I: Period 1|Lost to Follow-up|0|||
49161623|NCT01791517|158431972|FG011|Phase I: Period 1|Lost to Follow-up|0|||
49161624|NCT01791517|158431961|FG000|Phase I: Period 1|Lens Handling DIfficulties|0|||
49161625|NCT01791517|158431962|FG001|Phase I: Period 1|Lens Handling DIfficulties|0|||
49161626|NCT01791517|158431963|FG002|Phase I: Period 1|Lens Handling DIfficulties|0|||
49161627|NCT01791517|158431964|FG003|Phase I: Period 1|Lens Handling DIfficulties|0|||
49161628|NCT01791517|158431965|FG004|Phase I: Period 1|Lens Handling DIfficulties|0|||
49161629|NCT01791517|158431966|FG005|Phase I: Period 1|Lens Handling DIfficulties|0|||
49161630|NCT01791517|158431967|FG006|Phase I: Period 1|Lens Handling DIfficulties|0|||
49161631|NCT01791517|158431968|FG007|Phase I: Period 1|Lens Handling DIfficulties|0|||
49161632|NCT01791517|158431969|FG008|Phase I: Period 1|Lens Handling DIfficulties|0|||
49161633|NCT01791517|158431970|FG009|Phase I: Period 1|Lens Handling DIfficulties|0|||
49161634|NCT01791517|158431971|FG010|Phase I: Period 1|Lens Handling DIfficulties|0|||
49161635|NCT01791517|158431972|FG011|Phase I: Period 1|Lens Handling DIfficulties|1|||
49161636|NCT01791517|158431961|FG000|Phase I: Period 2|Unsatisfactory Lens Fit|1|||
49161637|NCT01791517|158431962|FG001|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
49161638|NCT01791517|158431963|FG002|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
49161639|NCT01791517|158431964|FG003|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
48835301|NCT04707313|157238760|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
49161640|NCT01791517|158431965|FG004|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
49161641|NCT01791517|158431966|FG005|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
49161642|NCT01791517|158431967|FG006|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
49161643|NCT01791517|158431968|FG007|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
49161644|NCT01791517|158431969|FG008|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
49161645|NCT01791517|158431970|FG009|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
49161646|NCT01791517|158431971|FG010|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
49161647|NCT01791517|158431972|FG011|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
49161648|NCT01791517|158431961|FG000|Phase I: Period 2|Protocol Violation|0|||
49161649|NCT01791517|158431962|FG001|Phase I: Period 2|Protocol Violation|0|||
48835302|NCT04707313|157238761|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
48835303|NCT04707313|157238762|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
49161650|NCT01791517|158431963|FG002|Phase I: Period 2|Protocol Violation|0|||
49161651|NCT01791517|158431964|FG003|Phase I: Period 2|Protocol Violation|1|||
49161652|NCT01791517|158431965|FG004|Phase I: Period 2|Protocol Violation|0|||
49161653|NCT01791517|158431966|FG005|Phase I: Period 2|Protocol Violation|0|||
49161654|NCT01791517|158431967|FG006|Phase I: Period 2|Protocol Violation|0|||
49161655|NCT01791517|158431968|FG007|Phase I: Period 2|Protocol Violation|0|||
49161656|NCT01791517|158431969|FG008|Phase I: Period 2|Protocol Violation|0|||
49161657|NCT01791517|158431970|FG009|Phase I: Period 2|Protocol Violation|0|||
49161658|NCT01791517|158431971|FG010|Phase I: Period 2|Protocol Violation|0|||
49161659|NCT01791517|158431972|FG011|Phase I: Period 2|Protocol Violation|0|||
49161660|NCT01791517|158431961|FG000|Phase I: Period 2|Withdrawal by Subject|0|||
49161661|NCT01791517|158431962|FG001|Phase I: Period 2|Withdrawal by Subject|0|||
49161662|NCT01791517|158431963|FG002|Phase I: Period 2|Withdrawal by Subject|0|||
49161663|NCT01791517|158431964|FG003|Phase I: Period 2|Withdrawal by Subject|0|||
49161664|NCT01791517|158431965|FG004|Phase I: Period 2|Withdrawal by Subject|0|||
49161665|NCT01791517|158431966|FG005|Phase I: Period 2|Withdrawal by Subject|0|||
49161666|NCT01791517|158431967|FG006|Phase I: Period 2|Withdrawal by Subject|0|||
49161667|NCT01791517|158431968|FG007|Phase I: Period 2|Withdrawal by Subject|0|||
49161668|NCT01791517|158431969|FG008|Phase I: Period 2|Withdrawal by Subject|0|||
49161669|NCT01791517|158431970|FG009|Phase I: Period 2|Withdrawal by Subject|1|||
49161670|NCT01791517|158431971|FG010|Phase I: Period 2|Withdrawal by Subject|1|||
49161671|NCT01791517|158431972|FG011|Phase I: Period 2|Withdrawal by Subject|0|||
49161672|NCT01791517|158431961|FG000|Phase I: Period 2|Unsatisfactory Visual Response|0|||
49161673|NCT01791517|158431962|FG001|Phase I: Period 2|Unsatisfactory Visual Response|0|||
49161674|NCT01791517|158431963|FG002|Phase I: Period 2|Unsatisfactory Visual Response|0|||
49161675|NCT01791517|158431964|FG003|Phase I: Period 2|Unsatisfactory Visual Response|0|||
49161676|NCT01791517|158431965|FG004|Phase I: Period 2|Unsatisfactory Visual Response|0|||
49161677|NCT01791517|158431966|FG005|Phase I: Period 2|Unsatisfactory Visual Response|0|||
49161678|NCT01791517|158431967|FG006|Phase I: Period 2|Unsatisfactory Visual Response|0|||
49161679|NCT01791517|158431968|FG007|Phase I: Period 2|Unsatisfactory Visual Response|0|||
49161680|NCT01791517|158431969|FG008|Phase I: Period 2|Unsatisfactory Visual Response|0|||
49161681|NCT01791517|158431970|FG009|Phase I: Period 2|Unsatisfactory Visual Response|0|||
49161682|NCT01791517|158431971|FG010|Phase I: Period 2|Unsatisfactory Visual Response|1|||
49161683|NCT01791517|158431972|FG011|Phase I: Period 2|Unsatisfactory Visual Response|0|||
49161684|NCT01791517|158431961|FG000|Phase I: Period 2|Lens Discomfort|0|||
49161685|NCT01791517|158431962|FG001|Phase I: Period 2|Lens Discomfort|0|||
49161686|NCT01791517|158431963|FG002|Phase I: Period 2|Lens Discomfort|0|||
49161687|NCT01791517|158431964|FG003|Phase I: Period 2|Lens Discomfort|0|||
49161688|NCT01791517|158431965|FG004|Phase I: Period 2|Lens Discomfort|0|||
49161689|NCT01791517|158431966|FG005|Phase I: Period 2|Lens Discomfort|1|||
49161690|NCT01791517|158431967|FG006|Phase I: Period 2|Lens Discomfort|0|||
49161691|NCT01791517|158431968|FG007|Phase I: Period 2|Lens Discomfort|0|||
49161692|NCT01791517|158431969|FG008|Phase I: Period 2|Lens Discomfort|0|||
49161693|NCT01791517|158431970|FG009|Phase I: Period 2|Lens Discomfort|0|||
48835304|NCT04707313|157238763|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
48835305|NCT04707313|157238764|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
48835306|NCT04707313|157238765|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
48835307|NCT04707313|157238766|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
49161694|NCT01791517|158431971|FG010|Phase I: Period 2|Lens Discomfort|0|||
49161695|NCT01791517|158431972|FG011|Phase I: Period 2|Lens Discomfort|0|||
49161696|NCT01791517|158431961|FG000|Phase I: Period 2|Lost to Follow-up|0|||
49161697|NCT01791517|158431962|FG001|Phase I: Period 2|Lost to Follow-up|3|||
49161698|NCT01791517|158431963|FG002|Phase I: Period 2|Lost to Follow-up|2|||
49161699|NCT01791517|158431964|FG003|Phase I: Period 2|Lost to Follow-up|0|||
49161700|NCT01791517|158431965|FG004|Phase I: Period 2|Lost to Follow-up|0|||
48923578|NCT01464307|157553290|FG001|Open-Label Extension Period|Non-compliance|0|||
48923579|NCT01464307|157553289|FG000|Open-Label Extension Period|Predefined discontinuation criteria|6|||
49161701|NCT01791517|158431966|FG005|Phase I: Period 2|Lost to Follow-up|0|||
49161702|NCT01791517|158431967|FG006|Phase I: Period 2|Lost to Follow-up|0|||
49161703|NCT01791517|158431968|FG007|Phase I: Period 2|Lost to Follow-up|0|||
49161704|NCT01791517|158431969|FG008|Phase I: Period 2|Lost to Follow-up|0|||
49161705|NCT01791517|158431970|FG009|Phase I: Period 2|Lost to Follow-up|0|||
49161706|NCT01791517|158431971|FG010|Phase I: Period 2|Lost to Follow-up|0|||
49161707|NCT01791517|158431972|FG011|Phase I: Period 2|Lost to Follow-up|0|||
49161708|NCT01791517|158431961|FG000|Phase I: Period 3|Lens Discomfort|0|||
49161709|NCT01791517|158431962|FG001|Phase I: Period 3|Lens Discomfort|0|||
49161710|NCT01791517|158431963|FG002|Phase I: Period 3|Lens Discomfort|0|||
49161711|NCT01791517|158431964|FG003|Phase I: Period 3|Lens Discomfort|0|||
49161712|NCT01791517|158431965|FG004|Phase I: Period 3|Lens Discomfort|0|||
49161713|NCT01791517|158431966|FG005|Phase I: Period 3|Lens Discomfort|0|||
49161714|NCT01791517|158431967|FG006|Phase I: Period 3|Lens Discomfort|0|||
49161715|NCT01791517|158431968|FG007|Phase I: Period 3|Lens Discomfort|0|||
49161716|NCT01791517|158431969|FG008|Phase I: Period 3|Lens Discomfort|0|||
49161717|NCT01791517|158431970|FG009|Phase I: Period 3|Lens Discomfort|0|||
49161718|NCT01791517|158431971|FG010|Phase I: Period 3|Lens Discomfort|0|||
49161719|NCT01791517|158431972|FG011|Phase I: Period 3|Lens Discomfort|1|||
49161720|NCT01791517|158431961|FG000|Phase I: Period 3|Lost to Follow-up|0|||
49161721|NCT01791517|158431962|FG001|Phase I: Period 3|Lost to Follow-up|1|||
49161722|NCT01791517|158431963|FG002|Phase I: Period 3|Lost to Follow-up|0|||
49161723|NCT01791517|158431964|FG003|Phase I: Period 3|Lost to Follow-up|0|||
49161724|NCT01791517|158431965|FG004|Phase I: Period 3|Lost to Follow-up|1|||
49161725|NCT01791517|158431966|FG005|Phase I: Period 3|Lost to Follow-up|0|||
49161726|NCT01791517|158431967|FG006|Phase I: Period 3|Lost to Follow-up|0|||
49161727|NCT01791517|158431968|FG007|Phase I: Period 3|Lost to Follow-up|0|||
49161728|NCT01791517|158431969|FG008|Phase I: Period 3|Lost to Follow-up|0|||
49161729|NCT01791517|158431970|FG009|Phase I: Period 3|Lost to Follow-up|0|||
49161730|NCT01791517|158431971|FG010|Phase I: Period 3|Lost to Follow-up|0|||
49161731|NCT01791517|158431972|FG011|Phase I: Period 3|Lost to Follow-up|0|||
49161732|NCT01791517|158431961|FG000|Phase I: Period 3|Adverse Event|0|||
48923580|NCT01464307|157553290|FG001|Open-Label Extension Period|Predefined discontinuation criteria|0|||
49161733|NCT01791517|158431962|FG001|Phase I: Period 3|Adverse Event|0|||
49161734|NCT01791517|158431963|FG002|Phase I: Period 3|Adverse Event|0|||
49161735|NCT01791517|158431964|FG003|Phase I: Period 3|Adverse Event|1|||
49161736|NCT01791517|158431965|FG004|Phase I: Period 3|Adverse Event|0|||
49161737|NCT01791517|158431966|FG005|Phase I: Period 3|Adverse Event|0|||
49161738|NCT01791517|158431967|FG006|Phase I: Period 3|Adverse Event|0|||
49161739|NCT01791517|158431968|FG007|Phase I: Period 3|Adverse Event|0|||
49161740|NCT01791517|158431969|FG008|Phase I: Period 3|Adverse Event|0|||
49161741|NCT01791517|158431970|FG009|Phase I: Period 3|Adverse Event|0|||
49161742|NCT01791517|158431971|FG010|Phase I: Period 3|Adverse Event|0|||
49161743|NCT01791517|158431972|FG011|Phase I: Period 3|Adverse Event|0|||
49161744|NCT01791517|158431961|FG000|Phase II|Lost to Follow-up|1|||
49161745|NCT01791517|158431962|FG001|Phase II|Lost to Follow-up|0|||
49161746|NCT01791517|158431963|FG002|Phase II|Lost to Follow-up|1|||
49161747|NCT01791517|158431964|FG003|Phase II|Lost to Follow-up|0|||
49161748|NCT01791517|158431965|FG004|Phase II|Lost to Follow-up|1|||
49161749|NCT01791517|158431966|FG005|Phase II|Lost to Follow-up|2|||
49161750|NCT01791517|158431967|FG006|Phase II|Lost to Follow-up|0|||
49161751|NCT01791517|158431968|FG007|Phase II|Lost to Follow-up|1|||
49161752|NCT01791517|158431969|FG008|Phase II|Lost to Follow-up|1|||
49161753|NCT01791517|158431970|FG009|Phase II|Lost to Follow-up|1|||
49161754|NCT01791517|158431971|FG010|Phase II|Lost to Follow-up|0|||
49161755|NCT01791517|158431972|FG011|Phase II|Lost to Follow-up|0|||
49161756|NCT01791517|158431961|FG000|Phase II|Withdrawal by Subject|1|||
49161757|NCT01791517|158431962|FG001|Phase II|Withdrawal by Subject|0|||
49161758|NCT01791517|158431963|FG002|Phase II|Withdrawal by Subject|0|||
49161759|NCT01791517|158431964|FG003|Phase II|Withdrawal by Subject|0|||
49161760|NCT01791517|158431965|FG004|Phase II|Withdrawal by Subject|0|||
49161761|NCT01791517|158431966|FG005|Phase II|Withdrawal by Subject|2|||
49161762|NCT01791517|158431967|FG006|Phase II|Withdrawal by Subject|0|||
49161763|NCT01791517|158431968|FG007|Phase II|Withdrawal by Subject|1|||
49161764|NCT01791517|158431969|FG008|Phase II|Withdrawal by Subject|0|||
49161765|NCT01791517|158431970|FG009|Phase II|Withdrawal by Subject|0|||
49161766|NCT01791517|158431971|FG010|Phase II|Withdrawal by Subject|1|||
49161767|NCT01791517|158431972|FG011|Phase II|Withdrawal by Subject|0|||
49161768|NCT01791517|158431961|FG000|Phase II|Lack of Efficacy|0|||
49161769|NCT01791517|158431962|FG001|Phase II|Lack of Efficacy|0|||
49161770|NCT01791517|158431963|FG002|Phase II|Lack of Efficacy|0|||
49161771|NCT01791517|158431964|FG003|Phase II|Lack of Efficacy|0|||
49161772|NCT01791517|158431965|FG004|Phase II|Lack of Efficacy|1|||
49161773|NCT01791517|158431966|FG005|Phase II|Lack of Efficacy|0|||
49161774|NCT01791517|158431967|FG006|Phase II|Lack of Efficacy|0|||
49161775|NCT01791517|158431968|FG007|Phase II|Lack of Efficacy|0|||
49161776|NCT01791517|158431969|FG008|Phase II|Lack of Efficacy|0|||
49161777|NCT01791517|158431970|FG009|Phase II|Lack of Efficacy|0|||
49161778|NCT01791517|158431971|FG010|Phase II|Lack of Efficacy|0|||
49161779|NCT01791517|158431972|FG011|Phase II|Lack of Efficacy|0|||
49161780|NCT01791517|158431961|FG000|Phase II|Adverse Event|0|||
49161781|NCT01791517|158431962|FG001|Phase II|Adverse Event|0|||
49161782|NCT01791517|158431963|FG002|Phase II|Adverse Event|0|||
49161783|NCT01791517|158431964|FG003|Phase II|Adverse Event|0|||
49161784|NCT01791517|158431965|FG004|Phase II|Adverse Event|0|||
49161785|NCT01791517|158431966|FG005|Phase II|Adverse Event|0|||
49161786|NCT01791517|158431967|FG006|Phase II|Adverse Event|2|||
49161787|NCT01791517|158431968|FG007|Phase II|Adverse Event|1|||
49161788|NCT01791517|158431969|FG008|Phase II|Adverse Event|0|||
49161789|NCT01791517|158431970|FG009|Phase II|Adverse Event|1|||
49161790|NCT01791517|158431971|FG010|Phase II|Adverse Event|0|||
49161791|NCT01791517|158431972|FG011|Phase II|Adverse Event|0|||
49161792|NCT01791517|158431961|FG000|Phase II|Lens Handling Difficulties|0|||
49161793|NCT01791517|158431962|FG001|Phase II|Lens Handling Difficulties|0|||
49161794|NCT01791517|158431963|FG002|Phase II|Lens Handling Difficulties|0|||
49161795|NCT01791517|158431964|FG003|Phase II|Lens Handling Difficulties|0|||
49161796|NCT01791517|158431965|FG004|Phase II|Lens Handling Difficulties|0|||
48923581|NCT00866307|157553292|FG000|Induction|Adverse Event|5|||
48923582|NCT00866307|157553293|FG001|Induction|Adverse Event|0|||
48923583|NCT00866307|157553294|FG002|Induction|Adverse Event|0|||
48923584|NCT00866307|157553292|FG000|Induction|Death|2|||
49161797|NCT01791517|158431966|FG005|Phase II|Lens Handling Difficulties|0|||
49161798|NCT01791517|158431967|FG006|Phase II|Lens Handling Difficulties|0|||
48923585|NCT00866307|157553293|FG001|Induction|Death|0|||
48923586|NCT00866307|157553294|FG002|Induction|Death|0|||
48923587|NCT00866307|157553292|FG000|Induction|Physician Decision|5|||
48923588|NCT00866307|157553293|FG001|Induction|Physician Decision|0|||
48923589|NCT00866307|157553294|FG002|Induction|Physician Decision|0|||
48923590|NCT00866307|157553292|FG000|Induction|Progressive Disease|1|||
49161799|NCT01791517|158431968|FG007|Phase II|Lens Handling Difficulties|0|||
49161800|NCT01791517|158431969|FG008|Phase II|Lens Handling Difficulties|1|||
49161801|NCT01791517|158431970|FG009|Phase II|Lens Handling Difficulties|0|||
49161802|NCT01791517|158431971|FG010|Phase II|Lens Handling Difficulties|0|||
49161803|NCT01791517|158431972|FG011|Phase II|Lens Handling Difficulties|0|||
49161804|NCT01791517|158431961|FG000|Phase II|Unsatisfactory Lens Fitting|0|||
49161805|NCT01791517|158431962|FG001|Phase II|Unsatisfactory Lens Fitting|0|||
48923591|NCT00866307|157553293|FG001|Induction|Progressive Disease|0|||
48923592|NCT00866307|157553294|FG002|Induction|Progressive Disease|0|||
49161806|NCT01791517|158431963|FG002|Phase II|Unsatisfactory Lens Fitting|0|||
49161807|NCT01791517|158431964|FG003|Phase II|Unsatisfactory Lens Fitting|0|||
49161808|NCT01791517|158431965|FG004|Phase II|Unsatisfactory Lens Fitting|0|||
49161809|NCT01791517|158431966|FG005|Phase II|Unsatisfactory Lens Fitting|0|||
48835308|NCT04707313|157238754|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
48923593|NCT00866307|157553292|FG000|Induction|Identification of Patients with Day 29 M|3|||
48923594|NCT00866307|157553293|FG001|Induction|Identification of Patients with Day 29 M|0|||
48923595|NCT00866307|157553294|FG002|Induction|Identification of Patients with Day 29 M|0|||
48923596|NCT00866307|157553292|FG000|Induction|Inadequate cytognetic samples th|1|||
48923597|NCT00866307|157553293|FG001|Induction|Inadequate cytognetic samples th|0|||
48923598|NCT00866307|157553294|FG002|Induction|Inadequate cytognetic samples th|0|||
48923599|NCT00866307|157553292|FG000|Induction|Improper post-induction consent|2|||
49161810|NCT01791517|158431967|FG006|Phase II|Unsatisfactory Lens Fitting|0|||
49161811|NCT01791517|158431968|FG007|Phase II|Unsatisfactory Lens Fitting|0|||
49161812|NCT01791517|158431969|FG008|Phase II|Unsatisfactory Lens Fitting|0|||
49161813|NCT01791517|158431970|FG009|Phase II|Unsatisfactory Lens Fitting|1|||
49161814|NCT01791517|158431971|FG010|Phase II|Unsatisfactory Lens Fitting|0|||
49161815|NCT01791517|158431972|FG011|Phase II|Unsatisfactory Lens Fitting|0|||
48835309|NCT04707313|157238755|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
48835310|NCT04707313|157238756|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
48835311|NCT04707313|157238757|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
48835312|NCT04707313|157238758|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
48835313|NCT04707313|157238759|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
48835314|NCT04707313|157238760|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|2|||
48835315|NCT04707313|157238761|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
48835316|NCT04707313|157238762|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
48835317|NCT04707313|157238763|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
49161816|NCT01791517|158431961|FG000|Phase II|Pre-Existing Ocular Issue|0|||
48835318|NCT04707313|157238764|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
48835319|NCT04707313|157238765|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
48835320|NCT04707313|157238766|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
48835321|NCT04707313|157238754|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|11|||
48835322|NCT04707313|157238755|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|5|||
48835323|NCT04707313|157238756|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
48835324|NCT04707313|157238757|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|7|||
49161817|NCT01791517|158431962|FG001|Phase II|Pre-Existing Ocular Issue|0|||
49161818|NCT01791517|158431963|FG002|Phase II|Pre-Existing Ocular Issue|0|||
49161819|NCT01791517|158431964|FG003|Phase II|Pre-Existing Ocular Issue|0|||
49161820|NCT01791517|158431965|FG004|Phase II|Pre-Existing Ocular Issue|0|||
49161821|NCT01791517|158431966|FG005|Phase II|Pre-Existing Ocular Issue|0|||
49161822|NCT01791517|158431967|FG006|Phase II|Pre-Existing Ocular Issue|0|||
49161823|NCT01791517|158431968|FG007|Phase II|Pre-Existing Ocular Issue|0|||
49161824|NCT01791517|158431969|FG008|Phase II|Pre-Existing Ocular Issue|0|||
49161825|NCT01791517|158431970|FG009|Phase II|Pre-Existing Ocular Issue|0|||
49161826|NCT01791517|158431971|FG010|Phase II|Pre-Existing Ocular Issue|0|||
49161827|NCT01791517|158431972|FG011|Phase II|Pre-Existing Ocular Issue|1|||
49161828|NCT05518461|158431973|FG000|Overall Study|Lost to Follow-up|25|||
49161829|NCT03179761|158431974|FG000|Overall Study|Death|2|||
49161830|NCT03179761|158431975|FG001|Overall Study|Death|5|||
49161831|NCT03179761|158431974|FG000|Overall Study|Lost to Follow-up|2|||
49161832|NCT03179761|158431975|FG001|Overall Study|Lost to Follow-up|2|||
49161833|NCT03179761|158431974|FG000|Overall Study|Protocol Violation|1|||
49161834|NCT03179761|158431975|FG001|Overall Study|Protocol Violation|0|||
49161835|NCT03179761|158431974|FG000|Overall Study|Withdrawal by Subject|1|||
49161836|NCT03179761|158431975|FG001|Overall Study|Withdrawal by Subject|4|||
49161837|NCT03179761|158431974|FG000|Overall Study|Investigator Request|0|||
49161838|NCT03179761|158431975|FG001|Overall Study|Investigator Request|2|||
49161839|NCT03962855|158431976|FG000|Overall Study|Death|0|||
49161840|NCT03962855|158431977|FG001|Overall Study|Death|1|||
49161841|NCT03962855|158431976|FG000|Overall Study|Lost to Follow-up|0|||
49161842|NCT03962855|158431977|FG001|Overall Study|Lost to Follow-up|1|||
49161843|NCT03962855|158431976|FG000|Overall Study|Adverse Event|0|||
49161844|NCT03962855|158431977|FG001|Overall Study|Adverse Event|1|||
49161845|NCT03962855|158431976|FG000|Overall Study|Physician Decision|0|||
49161846|NCT03962855|158431977|FG001|Overall Study|Physician Decision|2|||
48835325|NCT04707313|157238758|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
48835326|NCT04707313|157238759|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
48835327|NCT04707313|157238760|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|6|||
48835328|NCT04707313|157238761|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
48835329|NCT04707313|157238762|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
48835330|NCT04707313|157238763|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
49161847|NCT02388906|158431978|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
49161848|NCT02388906|158431979|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
49161849|NCT02388906|158431978|FG000|Treatment Period|Disease progression|121|||
49161850|NCT02388906|158431979|FG001|Treatment Period|Disease progression|101|||
49161851|NCT02388906|158431978|FG000|Treatment Period|Study drug toxicity|41|||
49161852|NCT02388906|158431979|FG001|Treatment Period|Study drug toxicity|208|||
49161853|NCT02388906|158431978|FG000|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
49161854|NCT02388906|158431979|FG001|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
49161855|NCT02388906|158431978|FG000|Treatment Period|Participant request to stop treatment|5|||
49161856|NCT02388906|158431979|FG001|Treatment Period|Participant request to stop treatment|9|||
49161857|NCT02388906|158431978|FG000|Treatment Period|Participant withdrew consent|2|||
49161858|NCT02388906|158431979|FG001|Treatment Period|Participant withdrew consent|3|||
49161859|NCT02388906|158431978|FG000|Treatment Period|Poor/non-compliance|0|||
49161860|NCT02388906|158431979|FG001|Treatment Period|Poor/non-compliance|1|||
49161861|NCT02388906|158431978|FG000|Treatment Period|Participant no longer meets study criteria|0|||
49161862|NCT02388906|158431979|FG001|Treatment Period|Participant no longer meets study criteria|1|||
49161863|NCT02388906|158431978|FG000|Treatment Period|Other reasons|3|||
49161864|NCT02388906|158431979|FG001|Treatment Period|Other reasons|3|||
49161865|NCT00565409|158431980|FG000|Period 1 Open Label|Adverse Event|17|||
49161866|NCT00565409|158431981|FG001|Period 1 Open Label|Adverse Event|0|||
49161867|NCT00565409|158431982|FG002|Period 1 Open Label|Adverse Event|0|||
49161868|NCT00565409|158431983|FG003|Period 1 Open Label|Adverse Event|0|||
49161869|NCT00565409|158431980|FG000|Period 1 Open Label|Death|2|||
49161870|NCT00565409|158431981|FG001|Period 1 Open Label|Death|0|||
48835331|NCT04707313|157238764|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
48835332|NCT04707313|157238765|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
48835333|NCT04707313|157238766|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
48835334|NCT04707313|157238754|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
48835335|NCT04707313|157238755|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
48835336|NCT04707313|157238756|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
48835337|NCT04707313|157238757|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
48835338|NCT04707313|157238758|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
48835339|NCT04707313|157238759|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
48835340|NCT04707313|157238760|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
48835341|NCT04707313|157238761|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
48835342|NCT04707313|157238762|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
48835343|NCT04707313|157238763|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
48835344|NCT04707313|157238764|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
48835345|NCT04707313|157238765|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
48835346|NCT04707313|157238766|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
48835347|NCT04707313|157238754|FG000|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
48835348|NCT04707313|157238755|FG001|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
48835349|NCT04707313|157238756|FG002|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
48835350|NCT04707313|157238757|FG003|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
48835351|NCT04707313|157238758|FG004|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
48835352|NCT04707313|157238759|FG005|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
48835353|NCT04707313|157238760|FG006|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
48835354|NCT04707313|157238761|FG007|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
48835355|NCT04707313|157238762|FG008|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
48835356|NCT04707313|157238763|FG009|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
48835357|NCT04707313|157238764|FG010|Cohort 3 (Week 0 to Week 32)|Adverse Event|9|||
48835358|NCT04707313|157238765|FG011|Cohort 3 (Week 0 to Week 32)|Adverse Event|16|||
48835359|NCT04707313|157238766|FG012|Cohort 3 (Week 0 to Week 32)|Adverse Event|18|||
48835360|NCT04707313|157238754|FG000|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
48835361|NCT04707313|157238755|FG001|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
48835362|NCT04707313|157238756|FG002|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
48835363|NCT04707313|157238757|FG003|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
48835364|NCT04707313|157238758|FG004|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
48835365|NCT04707313|157238759|FG005|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
48835366|NCT04707313|157238760|FG006|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
48835367|NCT04707313|157238761|FG007|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
48835368|NCT04707313|157238762|FG008|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
48835369|NCT04707313|157238763|FG009|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|3|||
48835370|NCT04707313|157238764|FG010|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
48835371|NCT04707313|157238765|FG011|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
48835372|NCT04707313|157238766|FG012|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
48835373|NCT04707313|157238754|FG000|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
48835374|NCT04707313|157238755|FG001|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
48835375|NCT04707313|157238756|FG002|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
48835376|NCT04707313|157238757|FG003|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
49161871|NCT00565409|158431982|FG002|Period 1 Open Label|Death|0|||
49161872|NCT00565409|158431983|FG003|Period 1 Open Label|Death|0|||
49161873|NCT00565409|158431980|FG000|Period 1 Open Label|Lost to Follow-up|1|||
48835377|NCT04707313|157238758|FG004|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
48835378|NCT04707313|157238759|FG005|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
48923600|NCT00866307|157553293|FG001|Induction|Improper post-induction consent|0|||
48923601|NCT00866307|157553294|FG002|Induction|Improper post-induction consent|0|||
48923602|NCT00866307|157553292|FG000|Induction|Study was closed at the time|1|||
48923603|NCT00866307|157553293|FG001|Induction|Study was closed at the time|0|||
48923604|NCT00866307|157553294|FG002|Induction|Study was closed at the time|0|||
48923605|NCT00866307|157553292|FG000|Consolidation/Maintenance|Adverse Event|0|||
48923606|NCT00866307|157553293|FG001|Consolidation/Maintenance|Adverse Event|0|||
48923607|NCT00866307|157553294|FG002|Consolidation/Maintenance|Adverse Event|8|||
48923608|NCT00866307|157553292|FG000|Consolidation/Maintenance|Death|0|||
48923609|NCT00866307|157553293|FG001|Consolidation/Maintenance|Death|0|||
48923610|NCT00866307|157553294|FG002|Consolidation/Maintenance|Death|1|||
48923611|NCT00866307|157553292|FG000|Consolidation/Maintenance|Physician Decision|0|||
48923612|NCT00866307|157553293|FG001|Consolidation/Maintenance|Physician Decision|3|||
48923613|NCT00866307|157553294|FG002|Consolidation/Maintenance|Physician Decision|2|||
48923614|NCT00866307|157553292|FG000|Consolidation/Maintenance|Withdrawal by Subject|0|||
48923615|NCT00866307|157553293|FG001|Consolidation/Maintenance|Withdrawal by Subject|1|||
48923616|NCT00866307|157553294|FG002|Consolidation/Maintenance|Withdrawal by Subject|1|||
48923617|NCT00866307|157553292|FG000|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
48923618|NCT00866307|157553293|FG001|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
48923619|NCT00866307|157553294|FG002|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2|||
48923620|NCT00866307|157553292|FG000|Consolidation/Maintenance|Recurrent leukemia following remission|0|||
48923621|NCT00866307|157553293|FG001|Consolidation/Maintenance|Recurrent leukemia following remission|3|||
48923622|NCT00866307|157553294|FG002|Consolidation/Maintenance|Recurrent leukemia following remission|1|||
48923623|NCT00866307|157553292|FG000|Consolidation/Maintenance|Therapy error|0|||
48923624|NCT00866307|157553293|FG001|Consolidation/Maintenance|Therapy error|1|||
48923625|NCT00866307|157553294|FG002|Consolidation/Maintenance|Therapy error|0|||
48923626|NCT00866307|157553292|FG000|Consolidation/Maintenance|Non-compliance|0|||
48923627|NCT00866307|157553293|FG001|Consolidation/Maintenance|Non-compliance|0|||
48923628|NCT00866307|157553294|FG002|Consolidation/Maintenance|Non-compliance|1|||
48923629|NCT00866307|157553292|FG000|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
48923630|NCT00866307|157553293|FG001|Consolidation/Maintenance|Patient moved to non-participating inst|1|||
48923631|NCT00866307|157553294|FG002|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
48923632|NCT01031446|157553295|FG000|Overall Study|Disease Progression|38|||
48923633|NCT01031446|157553295|FG000|Overall Study|Adverse Event|9|||
48923634|NCT01031446|157553295|FG000|Overall Study|Physician Decision|4|||
48923635|NCT01031446|157553295|FG000|Overall Study|Withdrawal by Subject|3|||
48923636|NCT01031446|157553295|FG000|Overall Study|Still on treatment|1|||
48923637|NCT01623271|157555169|FG000|Overall Study|Withdrawal by Subject|2|||
48923638|NCT03354663|157555170|FG000|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4|||
48923639|NCT03354663|157555170|FG000|Enrollment to Catheter Insertion|Adverse Event|1|||
48923640|NCT03354663|157555170|FG000|Completed 30-day Visit|Withdrawal by Subject|1|||
48923641|NCT03354663|157555170|FG000|Completed 30-day Visit|Missed Visit|1|||
48923642|NCT01049035|157555171|FG000|Overall Study|Serious adverse event|0|||
48923643|NCT01049035|157555172|FG001|Overall Study|Serious adverse event|1|||
48923644|NCT01049035|157555173|FG002|Overall Study|Serious adverse event|1|||
48923645|NCT01049035|157555174|FG003|Overall Study|Serious adverse event|2|||
48923646|NCT01049035|157555175|FG004|Overall Study|Serious adverse event|0|||
48923647|NCT01049035|157555176|FG005|Overall Study|Serious adverse event|0|||
48923648|NCT01049035|157555177|FG006|Overall Study|Serious adverse event|0|||
48923649|NCT01049035|157555171|FG000|Overall Study|Other adverse event (AE)|0|||
48923650|NCT01049035|157555172|FG001|Overall Study|Other adverse event (AE)|0|||
48923651|NCT01049035|157555173|FG002|Overall Study|Other adverse event (AE)|0|||
48923652|NCT01049035|157555174|FG003|Overall Study|Other adverse event (AE)|1|||
48923653|NCT01049035|157555175|FG004|Overall Study|Other adverse event (AE)|0|||
48923654|NCT01049035|157555176|FG005|Overall Study|Other adverse event (AE)|0|||
48923655|NCT01049035|157555177|FG006|Overall Study|Other adverse event (AE)|0|||
48923656|NCT01049035|157555171|FG000|Overall Study|Non-compliance with the protocol|12|||
48923657|NCT01049035|157555172|FG001|Overall Study|Non-compliance with the protocol|6|||
48923658|NCT01049035|157555173|FG002|Overall Study|Non-compliance with the protocol|14|||
48923659|NCT01049035|157555174|FG003|Overall Study|Non-compliance with the protocol|5|||
48923660|NCT01049035|157555175|FG004|Overall Study|Non-compliance with the protocol|3|||
48923661|NCT01049035|157555176|FG005|Overall Study|Non-compliance with the protocol|4|||
48923662|NCT01049035|157555177|FG006|Overall Study|Non-compliance with the protocol|10|||
48923663|NCT01049035|157555171|FG000|Overall Study|Lost to Follow-up|5|||
49161874|NCT00565409|158431981|FG001|Period 1 Open Label|Lost to Follow-up|0|||
49161875|NCT00565409|158431982|FG002|Period 1 Open Label|Lost to Follow-up|0|||
48923664|NCT01049035|157555172|FG001|Overall Study|Lost to Follow-up|4|||
48923665|NCT01049035|157555173|FG002|Overall Study|Lost to Follow-up|4|||
48923666|NCT01049035|157555174|FG003|Overall Study|Lost to Follow-up|1|||
48923667|NCT01049035|157555175|FG004|Overall Study|Lost to Follow-up|0|||
48923668|NCT01049035|157555176|FG005|Overall Study|Lost to Follow-up|3|||
48923669|NCT01049035|157555177|FG006|Overall Study|Lost to Follow-up|3|||
49161876|NCT00565409|158431983|FG003|Period 1 Open Label|Lost to Follow-up|0|||
48835379|NCT04707313|157238760|FG006|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
48835380|NCT04707313|157238761|FG007|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
48835381|NCT04707313|157238762|FG008|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
48835382|NCT04707313|157238763|FG009|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
48835383|NCT04707313|157238764|FG010|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|5|||
48835384|NCT04707313|157238765|FG011|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|2|||
48835385|NCT04707313|157238766|FG012|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
48835386|NCT04707313|157238754|FG000|Cohort 3 (Week 0 to Week 32)|Other|0|||
48835387|NCT04707313|157238755|FG001|Cohort 3 (Week 0 to Week 32)|Other|0|||
48835388|NCT04707313|157238756|FG002|Cohort 3 (Week 0 to Week 32)|Other|0|||
48835389|NCT04707313|157238757|FG003|Cohort 3 (Week 0 to Week 32)|Other|0|||
48835390|NCT04707313|157238758|FG004|Cohort 3 (Week 0 to Week 32)|Other|0|||
48923670|NCT01049035|157555171|FG000|Overall Study|Voluntary withdrawal not due to an AE|16|||
48835391|NCT04707313|157238759|FG005|Cohort 3 (Week 0 to Week 32)|Other|0|||
48923671|NCT01049035|157555172|FG001|Overall Study|Voluntary withdrawal not due to an AE|10|||
48923672|NCT01049035|157555173|FG002|Overall Study|Voluntary withdrawal not due to an AE|8|||
48923673|NCT01049035|157555174|FG003|Overall Study|Voluntary withdrawal not due to an AE|2|||
48923674|NCT01049035|157555175|FG004|Overall Study|Voluntary withdrawal not due to an AE|1|||
48923675|NCT01049035|157555176|FG005|Overall Study|Voluntary withdrawal not due to an AE|5|||
48923676|NCT01049035|157555177|FG006|Overall Study|Voluntary withdrawal not due to an AE|2|||
48923677|NCT02239939|157555180|FG000|Overall Study|Adverse Event|1|||
48923678|NCT02239939|157555181|FG001|Overall Study|Adverse Event|0|||
48923679|NCT02239939|157555180|FG000|Overall Study|Withdrawal by Subject|1|||
48835392|NCT04707313|157238760|FG006|Cohort 3 (Week 0 to Week 32)|Other|0|||
48835393|NCT04707313|157238761|FG007|Cohort 3 (Week 0 to Week 32)|Other|0|||
48835394|NCT04707313|157238762|FG008|Cohort 3 (Week 0 to Week 32)|Other|0|||
48835395|NCT04707313|157238763|FG009|Cohort 3 (Week 0 to Week 32)|Other|0|||
48835396|NCT04707313|157238764|FG010|Cohort 3 (Week 0 to Week 32)|Other|1|||
49161877|NCT00565409|158431980|FG000|Period 1 Open Label|Other|21|||
49161878|NCT00565409|158431981|FG001|Period 1 Open Label|Other|0|||
49161879|NCT00565409|158431982|FG002|Period 1 Open Label|Other|0|||
49161880|NCT00565409|158431983|FG003|Period 1 Open Label|Other|0|||
49161881|NCT00565409|158431980|FG000|Period 1 Open Label|Protocol Violation|14|||
49161882|NCT00565409|158431981|FG001|Period 1 Open Label|Protocol Violation|0|||
49161883|NCT00565409|158431982|FG002|Period 1 Open Label|Protocol Violation|0|||
49161884|NCT00565409|158431983|FG003|Period 1 Open Label|Protocol Violation|0|||
49161885|NCT00565409|158431980|FG000|Period 1 Open Label|Unsatisfactory Response-Efficacy|22|||
49161886|NCT00565409|158431981|FG001|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
49161887|NCT00565409|158431982|FG002|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
49161888|NCT00565409|158431983|FG003|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
49161889|NCT00565409|158431980|FG000|Period 1 Open Label|no conclusion of participation record|1|||
49161890|NCT00565409|158431981|FG001|Period 1 Open Label|no conclusion of participation record|0|||
49161891|NCT00565409|158431982|FG002|Period 1 Open Label|no conclusion of participation record|0|||
49161892|NCT00565409|158431983|FG003|Period 1 Open Label|no conclusion of participation record|0|||
49161893|NCT00565409|158431980|FG000|After Period 1, Prior to Period 2|did not meet criteria|152|||
49161894|NCT00565409|158431981|FG001|After Period 1, Prior to Period 2|did not meet criteria|0|||
49161895|NCT00565409|158431982|FG002|After Period 1, Prior to Period 2|did not meet criteria|0|||
49161896|NCT00565409|158431983|FG003|After Period 1, Prior to Period 2|did not meet criteria|0|||
49161897|NCT00565409|158431980|FG000|Period 2 Double-Blind|Adverse Event|0|||
49161898|NCT00565409|158431981|FG001|Period 2 Double-Blind|Adverse Event|7|||
49161899|NCT00565409|158431982|FG002|Period 2 Double-Blind|Adverse Event|4|||
49161900|NCT00565409|158431983|FG003|Period 2 Double-Blind|Adverse Event|5|||
49161901|NCT00565409|158431980|FG000|Period 2 Double-Blind|Death|0|||
49161902|NCT00565409|158431981|FG001|Period 2 Double-Blind|Death|2|||
49161903|NCT00565409|158431982|FG002|Period 2 Double-Blind|Death|0|||
49161904|NCT00565409|158431983|FG003|Period 2 Double-Blind|Death|0|||
49161905|NCT00565409|158431980|FG000|Period 2 Double-Blind|Protocol Violation|0|||
49161906|NCT00565409|158431981|FG001|Period 2 Double-Blind|Protocol Violation|4|||
49161907|NCT00565409|158431982|FG002|Period 2 Double-Blind|Protocol Violation|6|||
49161908|NCT00565409|158431983|FG003|Period 2 Double-Blind|Protocol Violation|2|||
49161909|NCT00565409|158431980|FG000|Period 2 Double-Blind|Lost to Follow-up|0|||
49161910|NCT00565409|158431981|FG001|Period 2 Double-Blind|Lost to Follow-up|0|||
49161911|NCT00565409|158431982|FG002|Period 2 Double-Blind|Lost to Follow-up|1|||
49161912|NCT00565409|158431983|FG003|Period 2 Double-Blind|Lost to Follow-up|0|||
49161913|NCT00565409|158431980|FG000|Period 2 Double-Blind|Other|0|||
49161914|NCT00565409|158431981|FG001|Period 2 Double-Blind|Other|4|||
49161915|NCT00565409|158431982|FG002|Period 2 Double-Blind|Other|5|||
49161916|NCT00565409|158431983|FG003|Period 2 Double-Blind|Other|9|||
49161917|NCT00565409|158431980|FG000|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0|||
49161918|NCT00565409|158431981|FG001|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4|||
49161919|NCT00565409|158431982|FG002|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11|||
49161920|NCT00565409|158431983|FG003|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43|||
49161921|NCT00382174|158431984|FG000|Overall Study|Lost to Follow-up|1|||
49161922|NCT00382174|158431985|FG001|Overall Study|Lost to Follow-up|4|||
48835397|NCT04707313|157238765|FG011|Cohort 3 (Week 0 to Week 32)|Other|0|||
48835398|NCT04707313|157238766|FG012|Cohort 3 (Week 0 to Week 32)|Other|1|||
48835399|NCT04707313|157238754|FG000|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
48835400|NCT04707313|157238755|FG001|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
48835401|NCT04707313|157238756|FG002|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
48835402|NCT04707313|157238757|FG003|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
48835403|NCT04707313|157238758|FG004|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
48835404|NCT04707313|157238759|FG005|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
48835405|NCT04707313|157238760|FG006|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
48835406|NCT04707313|157238761|FG007|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
48835407|NCT04707313|157238762|FG008|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
48835408|NCT04707313|157238763|FG009|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
48835409|NCT04707313|157238764|FG010|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
48835410|NCT04707313|157238765|FG011|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
48835411|NCT04707313|157238766|FG012|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
48835412|NCT04707313|157238754|FG000|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
48835413|NCT04707313|157238755|FG001|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
49161923|NCT00382174|158431986|FG002|Overall Study|Lost to Follow-up|5|||
49161924|NCT00382174|158431984|FG000|Overall Study|Adverse Event|1|||
49161925|NCT00382174|158431985|FG001|Overall Study|Adverse Event|4|||
49161926|NCT00382174|158431986|FG002|Overall Study|Adverse Event|5|||
49161927|NCT00382174|158431984|FG000|Overall Study|Withdrawal by Subject|1|||
49161928|NCT00382174|158431985|FG001|Overall Study|Withdrawal by Subject|4|||
49161929|NCT00382174|158431986|FG002|Overall Study|Withdrawal by Subject|5|||
48835414|NCT04707313|157238756|FG002|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
48835415|NCT04707313|157238757|FG003|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
49161930|NCT00382174|158431984|FG000|Overall Study|Non compliance|1|||
49161931|NCT00382174|158431985|FG001|Overall Study|Non compliance|0|||
49161932|NCT00382174|158431986|FG002|Overall Study|Non compliance|1|||
49161933|NCT00382174|158431984|FG000|Overall Study|Physician Decision|0|||
49161934|NCT00382174|158431985|FG001|Overall Study|Physician Decision|2|||
49161935|NCT00382174|158431986|FG002|Overall Study|Physician Decision|2|||
49161936|NCT00382174|158431984|FG000|Overall Study|Failed to meet criteria|0|||
49161937|NCT00382174|158431985|FG001|Overall Study|Failed to meet criteria|1|||
49161938|NCT00382174|158431986|FG002|Overall Study|Failed to meet criteria|1|||
49161939|NCT00382174|158431984|FG000|Overall Study|Wounds merged|0|||
49161940|NCT00382174|158431985|FG001|Overall Study|Wounds merged|2|||
49161941|NCT00382174|158431986|FG002|Overall Study|Wounds merged|2|||
49161942|NCT00501644|158431987|FG000|Overall Study|Adverse Event|4|||
48835416|NCT04707313|157238758|FG004|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
49161943|NCT00501644|158431987|FG000|Overall Study|Withdrawal by Subject|1|||
49161944|NCT02379052|158431988|FG000|Overall Study|Protocol Violation|0|||
49161945|NCT02379052|158431989|FG001|Overall Study|Protocol Violation|1|||
49161946|NCT02379052|158431988|FG000|Overall Study|Adverse Event|0|||
49161947|NCT02379052|158431989|FG001|Overall Study|Adverse Event|1|||
48923680|NCT02239939|157555181|FG001|Overall Study|Withdrawal by Subject|1|||
48923681|NCT02239939|157555180|FG000|Overall Study|Lost to Follow-up|0|||
48923682|NCT02239939|157555181|FG001|Overall Study|Lost to Follow-up|1|||
48923683|NCT01535729|157555182|FG000|Overall Study|Withdrawal by Subject|2|||
48923684|NCT01535729|157555182|FG000|Overall Study|Disease progression|230|||
48923685|NCT01535729|157555182|FG000|Overall Study|Discontinued treatment|25|||
49161948|NCT02379052|158431988|FG000|Overall Study|Physician Decision|1|||
49161949|NCT02379052|158431989|FG001|Overall Study|Physician Decision|1|||
49161950|NCT02379052|158431988|FG000|Overall Study|Withdrawal by Subject|2|||
49161951|NCT02379052|158431989|FG001|Overall Study|Withdrawal by Subject|0|||
48835417|NCT04707313|157238759|FG005|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
48835418|NCT04707313|157238760|FG006|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
48835419|NCT04707313|157238761|FG007|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
48923686|NCT01535729|157555182|FG000|Overall Study|Lost to Follow-up|8|||
48923687|NCT01535729|157555182|FG000|Overall Study|Death|52|||
49161952|NCT02379052|158431988|FG000|Overall Study|Lost to Follow-up|2|||
49161953|NCT02379052|158431989|FG001|Overall Study|Lost to Follow-up|1|||
49161954|NCT02379052|158431988|FG000|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1|||
49161955|NCT02379052|158431989|FG001|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0|||
49161956|NCT02379052|158431988|FG000|Overall Study|Subject was Incarcerated|0|||
49161957|NCT02379052|158431989|FG001|Overall Study|Subject was Incarcerated|1|||
49161958|NCT02230189|158431990|FG000|Overall Study|Withdrawal by Subject|3|||
49161959|NCT02230189|158431991|FG001|Overall Study|Withdrawal by Subject|0|||
49161960|NCT02230189|158431992|FG002|Overall Study|Withdrawal by Subject|1|||
49161961|NCT02230189|158431990|FG000|Overall Study|Lost to Follow-up|1|||
49161962|NCT02230189|158431991|FG001|Overall Study|Lost to Follow-up|0|||
49161963|NCT02230189|158431992|FG002|Overall Study|Lost to Follow-up|0|||
49161964|NCT02230189|158431990|FG000|Overall Study|Physician Decision|1|||
49161965|NCT02230189|158431991|FG001|Overall Study|Physician Decision|0|||
49161966|NCT02230189|158431992|FG002|Overall Study|Physician Decision|0|||
49161967|NCT02343302|158431994|FG000|Overall Study|Physician Decision|1|||
49161968|NCT02343302|158431995|FG001|Overall Study|Physician Decision|1|||
49161969|NCT00776230|158431996|FG000|Overall Study|Lost to Follow-up|2|||
49161970|NCT00776230|158431997|FG001|Overall Study|Lost to Follow-up|1|||
48835420|NCT04707313|157238762|FG008|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
48835421|NCT04707313|157238763|FG009|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|1|||
48835422|NCT04707313|157238764|FG010|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|7|||
48835423|NCT04707313|157238765|FG011|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
48835424|NCT04707313|157238766|FG012|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
48835425|NCT03823911|157238769|FG000|Overall Study|Lost to Follow-up|1|||
48835426|NCT03823911|157238770|FG001|Overall Study|Lost to Follow-up|5|||
48835427|NCT03823911|157238771|FG002|Overall Study|Lost to Follow-up|2|||
48835428|NCT03823911|157238769|FG000|Overall Study|Did not meet eligibility criteria|13|||
48835429|NCT03823911|157238770|FG001|Overall Study|Did not meet eligibility criteria|7|||
48835430|NCT03823911|157238771|FG002|Overall Study|Did not meet eligibility criteria|4|||
48835431|NCT03823911|157238769|FG000|Overall Study|Death|0|||
48835432|NCT03823911|157238770|FG001|Overall Study|Death|1|||
48835433|NCT03823911|157238771|FG002|Overall Study|Death|0|||
48835434|NCT00834834|157238774|FG000|Overall Study|Withdrawal by Subject|4|||
48835435|NCT00834834|157238775|FG001|Overall Study|Withdrawal by Subject|3|||
48835436|NCT01692730|157238776|FG000|Overall Study|Lost to Follow-up|225|||
48835437|NCT01692730|157238777|FG001|Overall Study|Lost to Follow-up|227|||
48835438|NCT04199728|157240646|FG000|Overall Study|Adverse Event|1|||
48835439|NCT04199728|157240647|FG001|Overall Study|Adverse Event|0|||
48835440|NCT04199728|157240646|FG000|Overall Study|Withdrawal by Subject|8|||
48835441|NCT04199728|157240647|FG001|Overall Study|Withdrawal by Subject|3|||
48835442|NCT04199728|157240646|FG000|Overall Study|Screen fail after consent|0|||
48835443|NCT04199728|157240647|FG001|Overall Study|Screen fail after consent|1|||
48835444|NCT04199728|157240646|FG000|Overall Study|Early withdraw criteria met|0|||
48835445|NCT04199728|157240647|FG001|Overall Study|Early withdraw criteria met|1|||
48835446|NCT04199728|157240646|FG000|Overall Study|Non-compliance/difficulty with staff|2|||
48835447|NCT04199728|157240647|FG001|Overall Study|Non-compliance/difficulty with staff|0|||
48835448|NCT04048135|157240648|FG000|Overall Study|Withdrawal by Subject|1|||
48835449|NCT04048135|157240649|FG001|Overall Study|Withdrawal by Subject|1|||
48835450|NCT04048135|157240650|FG002|Overall Study|Withdrawal by Subject|1|||
48835451|NCT04048135|157240651|FG003|Overall Study|Withdrawal by Subject|2|||
48835452|NCT04048135|157240652|FG004|Overall Study|Withdrawal by Subject|0|||
48835453|NCT04048135|157240653|FG005|Overall Study|Withdrawal by Subject|0|||
48835454|NCT04048135|157240654|FG006|Overall Study|Withdrawal by Subject|1|||
48923688|NCT01535729|157555182|FG000|Overall Study|Other|19|||
48923689|NCT01535729|157555182|FG000|Overall Study|Did not sign informed consent|1|||
49161971|NCT00776230|158431998|FG002|Overall Study|Lost to Follow-up|5|||
49161972|NCT00776230|158431996|FG000|Overall Study|Not vaccinated at Day 0|1|||
49161973|NCT00776230|158431997|FG001|Overall Study|Not vaccinated at Day 0|0|||
49161974|NCT00776230|158431998|FG002|Overall Study|Not vaccinated at Day 0|0|||
49161975|NCT00776230|158431996|FG000|Overall Study|Withdrawal by Subject|0|||
48835455|NCT04048135|157240655|FG007|Overall Study|Withdrawal by Subject|1|||
48835456|NCT04048135|157240648|FG000|Overall Study|Adverse Event|0|||
49161976|NCT00776230|158431997|FG001|Overall Study|Withdrawal by Subject|1|||
49161977|NCT00776230|158431998|FG002|Overall Study|Withdrawal by Subject|0|||
49161978|NCT00776230|158431996|FG000|Overall Study|Subject missed Visit 4|0|||
49161979|NCT00776230|158431997|FG001|Overall Study|Subject missed Visit 4|1|||
49161980|NCT00776230|158431998|FG002|Overall Study|Subject missed Visit 4|0|||
49161981|NCT01887717|158431999|FG000|Overall Study|Withdrawal by Subject|1|||
49161982|NCT01887717|158432000|FG001|Overall Study|Withdrawal by Subject|7|||
49161983|NCT01887717|158431999|FG000|Overall Study|Physician Decision|0|||
49161984|NCT01887717|158432000|FG001|Overall Study|Physician Decision|2|||
49161985|NCT01887717|158431999|FG000|Overall Study|Administrative reasons|5|||
49161986|NCT01887717|158432000|FG001|Overall Study|Administrative reasons|2|||
49161987|NCT00508482|158432001|FG000|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9|||
49161988|NCT00508482|158432002|FG001|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7|||
49161989|NCT00508482|158432003|FG002|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4|||
49161990|NCT00508482|158432001|FG000|Over 4 Weeks of Treatment|Lost to Follow-up|12|||
49161991|NCT00508482|158432002|FG001|Over 4 Weeks of Treatment|Lost to Follow-up|10|||
49161992|NCT00508482|158432003|FG002|Over 4 Weeks of Treatment|Lost to Follow-up|16|||
49161993|NCT00508482|158432001|FG000|at the 4th Week of Follow-up|Lost to Follow-up|20|||
49161994|NCT00508482|158432002|FG001|at the 4th Week of Follow-up|Lost to Follow-up|6|||
49161995|NCT00508482|158432003|FG002|at the 4th Week of Follow-up|Lost to Follow-up|1|||
49161996|NCT02536664|158432007|FG000|Overall Study|Inadequate completion of documentation|2|||
49161997|NCT02536664|158432008|FG001|Overall Study|Inadequate completion of documentation|4|||
49161998|NCT02536664|158432007|FG000|Overall Study|Progression|13|||
49161999|NCT02536664|158432008|FG001|Overall Study|Progression|18|||
49162000|NCT02536664|158432007|FG000|Overall Study|Death due to lymphoma|2|||
49162001|NCT02536664|158432008|FG001|Overall Study|Death due to lymphoma|1|||
49162002|NCT02536664|158432007|FG000|Overall Study|Death due to other reason|3|||
49162003|NCT02536664|158432008|FG001|Overall Study|Death due to other reason|2|||
49162004|NCT02536664|158432007|FG000|Overall Study|Intolerability|8|||
49162005|NCT02536664|158432008|FG001|Overall Study|Intolerability|6|||
49162006|NCT02536664|158432007|FG000|Overall Study|Withdrawal by Subject|8|||
49162007|NCT02536664|158432008|FG001|Overall Study|Withdrawal by Subject|5|||
49162008|NCT02536664|158432007|FG000|Overall Study|Other|18|||
49162009|NCT02536664|158432008|FG001|Overall Study|Other|24|||
49162010|NCT02536664|158432007|FG000|Overall Study|Missing|53|||
49162011|NCT02536664|158432008|FG001|Overall Study|Missing|20|||
49162012|NCT02655887|158432009|FG000|Overall Study|Lost to Follow-up|3|||
49162013|NCT02655887|158432009|FG000|Overall Study|Death|4|||
49162014|NCT02655887|158432009|FG000|Overall Study|Withdrawal by Subject|3|||
49162015|NCT02655887|158432009|FG000|Overall Study|Missed 12-month follow-up visit|4|||
49162016|NCT00244621|158432010|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
49162017|NCT00244621|158432011|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
49162018|NCT00244621|158432012|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
49162019|NCT00244621|158432010|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
49162020|NCT00244621|158432011|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
49162021|NCT00244621|158432012|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
49162022|NCT00244621|158432010|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
49162023|NCT00244621|158432011|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
49162024|NCT00244621|158432012|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
48692904|NCT03137992|156724649|FG003|Washout Period 1|Principal Investigator Discretion|0|||
48835457|NCT04048135|157240649|FG001|Overall Study|Adverse Event|0|||
48835458|NCT04048135|157240650|FG002|Overall Study|Adverse Event|0|||
48835459|NCT04048135|157240651|FG003|Overall Study|Adverse Event|1|||
49162025|NCT00244621|158432010|FG000|Double-blind Treatment Period|Multiple Reasons|2|||
49162026|NCT00244621|158432011|FG001|Double-blind Treatment Period|Multiple Reasons|1|||
49162027|NCT00244621|158432012|FG002|Double-blind Treatment Period|Multiple Reasons|1|||
49162028|NCT00244621|158432010|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
49162029|NCT00244621|158432011|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
49162030|NCT00244621|158432012|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
49162031|NCT00244621|158432010|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
49162032|NCT00244621|158432011|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
49162033|NCT00244621|158432012|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
49162034|NCT00244621|158432010|FG000|Open-label Treatment Period|Adverse Event|0|||
49162035|NCT00244621|158432011|FG001|Open-label Treatment Period|Adverse Event|0|||
49162036|NCT00244621|158432012|FG002|Open-label Treatment Period|Adverse Event|1|||
49162037|NCT00244621|158432010|FG000|Open-label Treatment Period|Moved abroad|0|||
49162038|NCT00244621|158432011|FG001|Open-label Treatment Period|Moved abroad|0|||
49162039|NCT00244621|158432012|FG002|Open-label Treatment Period|Moved abroad|1|||
49162040|NCT01847755|158432016|FG000|Overall Study|Adverse Event|2|||
49162041|NCT01847755|158432016|FG000|Overall Study|Withdrawal by Subject|2|||
49162042|NCT01847755|158432016|FG000|Overall Study|Physician Decision|1|||
49162043|NCT00920556|158432017|FG000|Overall Study|Adverse Event|16|||
49162044|NCT00920556|158432017|FG000|Overall Study|Physician Decision|7|||
49162045|NCT00920556|158432017|FG000|Overall Study|Withdrawal by Subject|1|||
49162046|NCT01299389|158432018|FG000|Double-blind|Adverse Event|45|||
49162047|NCT01299389|158432019|FG001|Double-blind|Adverse Event|27|||
49162048|NCT01299389|158432020|FG002|Double-blind|Adverse Event|0|||
49162049|NCT01299389|158432021|FG003|Double-blind|Adverse Event|0|||
49162050|NCT01299389|158432018|FG000|Double-blind|Lack of Efficacy|45|||
49162051|NCT01299389|158432019|FG001|Double-blind|Lack of Efficacy|21|||
49162052|NCT01299389|158432020|FG002|Double-blind|Lack of Efficacy|0|||
49162053|NCT01299389|158432021|FG003|Double-blind|Lack of Efficacy|0|||
49162054|NCT01299389|158432018|FG000|Double-blind|Lost to Follow-up|2|||
49162055|NCT01299389|158432019|FG001|Double-blind|Lost to Follow-up|1|||
49162056|NCT01299389|158432020|FG002|Double-blind|Lost to Follow-up|0|||
49162057|NCT01299389|158432021|FG003|Double-blind|Lost to Follow-up|0|||
49162058|NCT01299389|158432018|FG000|Double-blind|Withdrawal by Subject|16|||
49162059|NCT01299389|158432019|FG001|Double-blind|Withdrawal by Subject|13|||
49162060|NCT01299389|158432020|FG002|Double-blind|Withdrawal by Subject|0|||
49162061|NCT01299389|158432021|FG003|Double-blind|Withdrawal by Subject|0|||
49162062|NCT01299389|158432018|FG000|Double-blind|Other|1|||
49162063|NCT01299389|158432019|FG001|Double-blind|Other|1|||
49162064|NCT01299389|158432020|FG002|Double-blind|Other|0|||
49162065|NCT01299389|158432021|FG003|Double-blind|Other|0|||
49162066|NCT01299389|158432018|FG000|Double-blind|"fail to meet study population criteria"|0|||
49162067|NCT01299389|158432019|FG001|Double-blind|"fail to meet study population criteria"|1|||
49162068|NCT01299389|158432020|FG002|Double-blind|"fail to meet study population criteria"|0|||
49162069|NCT01299389|158432021|FG003|Double-blind|"fail to meet study population criteria"|0|||
49162070|NCT01299389|158432018|FG000|Post-observational|Other|0|||
49162071|NCT01299389|158432019|FG001|Post-observational|Other|0|||
49162072|NCT01299389|158432020|FG002|Post-observational|Other|12|||
49162073|NCT01299389|158432021|FG003|Post-observational|Other|6|||
49162074|NCT02347085|158432022|FG000|Overall Study|Adverse Event|2|||
49162075|NCT02347085|158432022|FG000|Overall Study|Lack of Efficacy|1|||
49162076|NCT02347085|158432022|FG000|Overall Study|Withdrawal by Subject|4|||
49162077|NCT02347085|158432022|FG000|Overall Study|Lost to Follow-up|1|||
49162078|NCT02347085|158432022|FG000|Overall Study|Protocol Criteria|2|||
49162079|NCT03507127|158432025|FG000|Overall Study|Withdrawal by Subject|1|||
49162080|NCT03507127|158432026|FG001|Overall Study|Withdrawal by Subject|0|||
49162081|NCT03507127|158432025|FG000|Overall Study|Unable to meet smoking abstinence criterion|1|||
49162082|NCT03507127|158432026|FG001|Overall Study|Unable to meet smoking abstinence criterion|1|||
49162083|NCT03314935|158432027|FG000|Phase 1|Death|4|||
49162084|NCT03314935|158432028|FG001|Phase 1|Death|2|||
49162085|NCT03314935|158432029|FG002|Phase 1|Death|5|||
49162086|NCT03314935|158432030|FG003|Phase 1|Death|4|||
49162087|NCT03314935|158432031|FG004|Phase 1|Death|3|||
49162088|NCT03314935|158432032|FG005|Phase 1|Death|4|||
49162089|NCT03314935|158432033|FG006|Phase 1|Death|5|||
49162090|NCT03314935|158432034|FG007|Phase 1|Death|4|||
49162091|NCT03314935|158432035|FG008|Phase 1|Death|3|||
49162092|NCT03314935|158432036|FG009|Phase 1|Death|0|||
49162093|NCT03314935|158432037|FG010|Phase 1|Death|0|||
49162094|NCT03314935|158432038|FG011|Phase 1|Death|0|||
49162095|NCT03314935|158432039|FG012|Phase 1|Death|0|||
49162096|NCT03314935|158432040|FG013|Phase 1|Death|0|||
49162097|NCT03314935|158432041|FG014|Phase 1|Death|0|||
49162098|NCT03314935|158432027|FG000|Phase 1|Withdrawal by Subject|2|||
49162099|NCT03314935|158432028|FG001|Phase 1|Withdrawal by Subject|1|||
49162100|NCT03314935|158432029|FG002|Phase 1|Withdrawal by Subject|1|||
49162101|NCT03314935|158432030|FG003|Phase 1|Withdrawal by Subject|2|||
49162102|NCT03314935|158432031|FG004|Phase 1|Withdrawal by Subject|1|||
49162103|NCT03314935|158432032|FG005|Phase 1|Withdrawal by Subject|0|||
49162104|NCT03314935|158432033|FG006|Phase 1|Withdrawal by Subject|1|||
49162105|NCT03314935|158432034|FG007|Phase 1|Withdrawal by Subject|0|||
49162106|NCT03314935|158432035|FG008|Phase 1|Withdrawal by Subject|1|||
49162107|NCT03314935|158432036|FG009|Phase 1|Withdrawal by Subject|0|||
49162108|NCT03314935|158432037|FG010|Phase 1|Withdrawal by Subject|0|||
49162109|NCT03314935|158432038|FG011|Phase 1|Withdrawal by Subject|0|||
49162110|NCT03314935|158432039|FG012|Phase 1|Withdrawal by Subject|0|||
49162111|NCT03314935|158432040|FG013|Phase 1|Withdrawal by Subject|0|||
49162112|NCT03314935|158432041|FG014|Phase 1|Withdrawal by Subject|0|||
49162113|NCT03314935|158432027|FG000|Phase 1|Progressive Disease|2|||
49162114|NCT03314935|158432028|FG001|Phase 1|Progressive Disease|0|||
49162115|NCT03314935|158432029|FG002|Phase 1|Progressive Disease|0|||
49162116|NCT03314935|158432030|FG003|Phase 1|Progressive Disease|1|||
49162117|NCT03314935|158432031|FG004|Phase 1|Progressive Disease|0|||
49162118|NCT03314935|158432032|FG005|Phase 1|Progressive Disease|0|||
49162119|NCT03314935|158432033|FG006|Phase 1|Progressive Disease|0|||
49162120|NCT03314935|158432034|FG007|Phase 1|Progressive Disease|0|||
49162121|NCT03314935|158432035|FG008|Phase 1|Progressive Disease|0|||
49162122|NCT03314935|158432036|FG009|Phase 1|Progressive Disease|0|||
49162123|NCT03314935|158432037|FG010|Phase 1|Progressive Disease|0|||
49162124|NCT03314935|158432038|FG011|Phase 1|Progressive Disease|0|||
49162125|NCT03314935|158432039|FG012|Phase 1|Progressive Disease|0|||
49162126|NCT03314935|158432040|FG013|Phase 1|Progressive Disease|0|||
49162127|NCT03314935|158432041|FG014|Phase 1|Progressive Disease|0|||
49162128|NCT03314935|158432027|FG000|Phase 1|Study Terminated by Sponsor|0|||
49162129|NCT03314935|158432028|FG001|Phase 1|Study Terminated by Sponsor|1|||
49162130|NCT03314935|158432029|FG002|Phase 1|Study Terminated by Sponsor|0|||
48835460|NCT04048135|157240652|FG004|Overall Study|Adverse Event|1|||
48835461|NCT04048135|157240653|FG005|Overall Study|Adverse Event|0|||
48835462|NCT04048135|157240654|FG006|Overall Study|Adverse Event|0|||
49162131|NCT03314935|158432030|FG003|Phase 1|Study Terminated by Sponsor|0|||
49162132|NCT03314935|158432031|FG004|Phase 1|Study Terminated by Sponsor|0|||
49162133|NCT03314935|158432032|FG005|Phase 1|Study Terminated by Sponsor|0|||
49162134|NCT03314935|158432033|FG006|Phase 1|Study Terminated by Sponsor|0|||
49162135|NCT03314935|158432034|FG007|Phase 1|Study Terminated by Sponsor|0|||
49162136|NCT03314935|158432035|FG008|Phase 1|Study Terminated by Sponsor|1|||
49162137|NCT03314935|158432036|FG009|Phase 1|Study Terminated by Sponsor|0|||
49162138|NCT03314935|158432037|FG010|Phase 1|Study Terminated by Sponsor|0|||
48835463|NCT04048135|157240655|FG007|Overall Study|Adverse Event|0|||
48835464|NCT04048135|157240648|FG000|Overall Study|Protocol Violation|0|||
48835465|NCT04048135|157240649|FG001|Overall Study|Protocol Violation|0|||
48835466|NCT04048135|157240650|FG002|Overall Study|Protocol Violation|0|||
48835467|NCT04048135|157240651|FG003|Overall Study|Protocol Violation|0|||
48835468|NCT04048135|157240652|FG004|Overall Study|Protocol Violation|0|||
48835469|NCT04048135|157240653|FG005|Overall Study|Protocol Violation|1|||
48835470|NCT04048135|157240654|FG006|Overall Study|Protocol Violation|0|||
48835471|NCT04048135|157240655|FG007|Overall Study|Protocol Violation|0|||
48835472|NCT00172185|157240656|FG000|Overall Study|Adverse Event|0|||
48835473|NCT00172185|157240657|FG001|Overall Study|Adverse Event|1|||
48835474|NCT00172185|157240658|FG002|Overall Study|Adverse Event|3|||
48835475|NCT00172185|157240659|FG003|Overall Study|Adverse Event|4|||
48835476|NCT00172185|157240656|FG000|Overall Study|Physician Decision|0|||
48835477|NCT00172185|157240657|FG001|Overall Study|Physician Decision|0|||
48835478|NCT00172185|157240658|FG002|Overall Study|Physician Decision|1|||
48835479|NCT00172185|157240659|FG003|Overall Study|Physician Decision|0|||
48835480|NCT00172185|157240656|FG000|Overall Study|SPONSOR Decision|0|||
48835481|NCT00172185|157240657|FG001|Overall Study|SPONSOR Decision|1|||
48835482|NCT00172185|157240658|FG002|Overall Study|SPONSOR Decision|0|||
48835483|NCT00172185|157240659|FG003|Overall Study|SPONSOR Decision|0|||
48835484|NCT00172185|157240656|FG000|Overall Study|Withdrawal by Subject|0|||
48835485|NCT00172185|157240657|FG001|Overall Study|Withdrawal by Subject|0|||
48835486|NCT00172185|157240658|FG002|Overall Study|Withdrawal by Subject|1|||
48835487|NCT00172185|157240659|FG003|Overall Study|Withdrawal by Subject|0|||
48835488|NCT04358549|157240667|FG000|Overall Study|Adverse Event|0|||
48835489|NCT04358549|157240668|FG001|Overall Study|Adverse Event|1|||
48835490|NCT04358549|157240667|FG000|Overall Study|Death|1|||
49162139|NCT03314935|158432038|FG011|Phase 1|Study Terminated by Sponsor|0|||
49162140|NCT03314935|158432039|FG012|Phase 1|Study Terminated by Sponsor|0|||
49162141|NCT03314935|158432040|FG013|Phase 1|Study Terminated by Sponsor|0|||
49162142|NCT03314935|158432041|FG014|Phase 1|Study Terminated by Sponsor|0|||
49162143|NCT03314935|158432027|FG000|Phase 1|"Captured as Other in Database"|0|||
49162144|NCT03314935|158432028|FG001|Phase 1|"Captured as Other in Database"|2|||
49162145|NCT03314935|158432029|FG002|Phase 1|"Captured as Other in Database"|0|||
49162146|NCT03314935|158432030|FG003|Phase 1|"Captured as Other in Database"|0|||
49162147|NCT03314935|158432031|FG004|Phase 1|"Captured as Other in Database"|0|||
49162148|NCT03314935|158432032|FG005|Phase 1|"Captured as Other in Database"|0|||
49162149|NCT03314935|158432033|FG006|Phase 1|"Captured as Other in Database"|1|||
49162150|NCT03314935|158432034|FG007|Phase 1|"Captured as Other in Database"|1|||
49162151|NCT03314935|158432035|FG008|Phase 1|"Captured as Other in Database"|1|||
49162152|NCT03314935|158432036|FG009|Phase 1|"Captured as Other in Database"|0|||
49162153|NCT03314935|158432037|FG010|Phase 1|"Captured as Other in Database"|0|||
49162154|NCT03314935|158432038|FG011|Phase 1|"Captured as Other in Database"|0|||
49162155|NCT03314935|158432039|FG012|Phase 1|"Captured as Other in Database"|0|||
49162156|NCT03314935|158432040|FG013|Phase 1|"Captured as Other in Database"|0|||
49162157|NCT03314935|158432041|FG014|Phase 1|"Captured as Other in Database"|0|||
49162158|NCT03314935|158432027|FG000|Phase 1|Lost to Follow-up|0|||
49162159|NCT03314935|158432028|FG001|Phase 1|Lost to Follow-up|0|||
49162160|NCT03314935|158432029|FG002|Phase 1|Lost to Follow-up|0|||
49162161|NCT03314935|158432030|FG003|Phase 1|Lost to Follow-up|0|||
49162162|NCT03314935|158432031|FG004|Phase 1|Lost to Follow-up|0|||
49162163|NCT03314935|158432032|FG005|Phase 1|Lost to Follow-up|0|||
49162164|NCT03314935|158432033|FG006|Phase 1|Lost to Follow-up|0|||
49162165|NCT03314935|158432034|FG007|Phase 1|Lost to Follow-up|0|||
49162166|NCT03314935|158432035|FG008|Phase 1|Lost to Follow-up|1|||
49162167|NCT03314935|158432036|FG009|Phase 1|Lost to Follow-up|0|||
49162168|NCT03314935|158432037|FG010|Phase 1|Lost to Follow-up|0|||
49162169|NCT03314935|158432038|FG011|Phase 1|Lost to Follow-up|0|||
49162170|NCT03314935|158432039|FG012|Phase 1|Lost to Follow-up|0|||
49162171|NCT03314935|158432040|FG013|Phase 1|Lost to Follow-up|0|||
49162172|NCT03314935|158432041|FG014|Phase 1|Lost to Follow-up|0|||
49162173|NCT03314935|158432027|FG000|Phase 2|Death|0|||
49162174|NCT03314935|158432028|FG001|Phase 2|Death|0|||
49162175|NCT03314935|158432029|FG002|Phase 2|Death|0|||
49162176|NCT03314935|158432030|FG003|Phase 2|Death|0|||
49162177|NCT03314935|158432031|FG004|Phase 2|Death|0|||
49162178|NCT03314935|158432032|FG005|Phase 2|Death|0|||
49162179|NCT03314935|158432033|FG006|Phase 2|Death|0|||
49162180|NCT03314935|158432034|FG007|Phase 2|Death|0|||
49162181|NCT03314935|158432035|FG008|Phase 2|Death|0|||
49162182|NCT03314935|158432036|FG009|Phase 2|Death|5|||
49162183|NCT03314935|158432037|FG010|Phase 2|Death|20|||
49162184|NCT03314935|158432038|FG011|Phase 2|Death|6|||
49162185|NCT03314935|158432039|FG012|Phase 2|Death|7|||
49162186|NCT03314935|158432040|FG013|Phase 2|Death|6|||
49162187|NCT03314935|158432041|FG014|Phase 2|Death|17|||
49162188|NCT03314935|158432027|FG000|Phase 2|Withdrawal by Subject|0|||
49162189|NCT03314935|158432028|FG001|Phase 2|Withdrawal by Subject|0|||
49162190|NCT03314935|158432029|FG002|Phase 2|Withdrawal by Subject|0|||
49162191|NCT03314935|158432030|FG003|Phase 2|Withdrawal by Subject|0|||
49162192|NCT03314935|158432031|FG004|Phase 2|Withdrawal by Subject|0|||
49162193|NCT03314935|158432032|FG005|Phase 2|Withdrawal by Subject|0|||
49162194|NCT03314935|158432033|FG006|Phase 2|Withdrawal by Subject|0|||
49162195|NCT03314935|158432034|FG007|Phase 2|Withdrawal by Subject|0|||
49162196|NCT03314935|158432035|FG008|Phase 2|Withdrawal by Subject|0|||
49162197|NCT03314935|158432036|FG009|Phase 2|Withdrawal by Subject|1|||
49162198|NCT03314935|158432037|FG010|Phase 2|Withdrawal by Subject|4|||
49162199|NCT03314935|158432038|FG011|Phase 2|Withdrawal by Subject|0|||
49162200|NCT03314935|158432039|FG012|Phase 2|Withdrawal by Subject|1|||
49162201|NCT03314935|158432040|FG013|Phase 2|Withdrawal by Subject|0|||
49162202|NCT03314935|158432041|FG014|Phase 2|Withdrawal by Subject|1|||
49162203|NCT03314935|158432027|FG000|Phase 2|Progressive Disease|0|||
49162204|NCT03314935|158432028|FG001|Phase 2|Progressive Disease|0|||
49162205|NCT03314935|158432029|FG002|Phase 2|Progressive Disease|0|||
49162206|NCT03314935|158432030|FG003|Phase 2|Progressive Disease|0|||
49162207|NCT03314935|158432031|FG004|Phase 2|Progressive Disease|0|||
49162208|NCT03314935|158432032|FG005|Phase 2|Progressive Disease|0|||
49162209|NCT03314935|158432033|FG006|Phase 2|Progressive Disease|0|||
49162210|NCT03314935|158432034|FG007|Phase 2|Progressive Disease|0|||
49162211|NCT03314935|158432035|FG008|Phase 2|Progressive Disease|0|||
49162212|NCT03314935|158432036|FG009|Phase 2|Progressive Disease|1|||
49162213|NCT03314935|158432037|FG010|Phase 2|Progressive Disease|1|||
49162214|NCT03314935|158432038|FG011|Phase 2|Progressive Disease|1|||
49162215|NCT03314935|158432039|FG012|Phase 2|Progressive Disease|2|||
49162216|NCT03314935|158432040|FG013|Phase 2|Progressive Disease|0|||
49162217|NCT03314935|158432041|FG014|Phase 2|Progressive Disease|1|||
49162218|NCT03314935|158432027|FG000|Phase 2|Study Terminated by Sponsor|0|||
49162219|NCT03314935|158432028|FG001|Phase 2|Study Terminated by Sponsor|0|||
49162220|NCT03314935|158432029|FG002|Phase 2|Study Terminated by Sponsor|0|||
49162221|NCT03314935|158432030|FG003|Phase 2|Study Terminated by Sponsor|0|||
49162222|NCT03314935|158432031|FG004|Phase 2|Study Terminated by Sponsor|0|||
49162223|NCT03314935|158432032|FG005|Phase 2|Study Terminated by Sponsor|0|||
49162224|NCT03314935|158432033|FG006|Phase 2|Study Terminated by Sponsor|0|||
49162225|NCT03314935|158432034|FG007|Phase 2|Study Terminated by Sponsor|0|||
49162226|NCT03314935|158432035|FG008|Phase 2|Study Terminated by Sponsor|0|||
49162227|NCT03314935|158432036|FG009|Phase 2|Study Terminated by Sponsor|0|||
49162228|NCT03314935|158432037|FG010|Phase 2|Study Terminated by Sponsor|7|||
49162229|NCT03314935|158432038|FG011|Phase 2|Study Terminated by Sponsor|2|||
49162230|NCT03314935|158432039|FG012|Phase 2|Study Terminated by Sponsor|1|||
49162231|NCT03314935|158432040|FG013|Phase 2|Study Terminated by Sponsor|4|||
49162232|NCT03314935|158432041|FG014|Phase 2|Study Terminated by Sponsor|4|||
49162233|NCT03314935|158432027|FG000|Phase 2|Lost to Follow-up|0|||
49162234|NCT03314935|158432028|FG001|Phase 2|Lost to Follow-up|0|||
49162235|NCT03314935|158432029|FG002|Phase 2|Lost to Follow-up|0|||
49162236|NCT03314935|158432030|FG003|Phase 2|Lost to Follow-up|0|||
49162237|NCT03314935|158432031|FG004|Phase 2|Lost to Follow-up|0|||
49162238|NCT03314935|158432032|FG005|Phase 2|Lost to Follow-up|0|||
49162239|NCT03314935|158432033|FG006|Phase 2|Lost to Follow-up|0|||
49162240|NCT03314935|158432034|FG007|Phase 2|Lost to Follow-up|0|||
49162241|NCT03314935|158432035|FG008|Phase 2|Lost to Follow-up|0|||
49162242|NCT03314935|158432036|FG009|Phase 2|Lost to Follow-up|1|||
48835491|NCT04358549|157240668|FG001|Overall Study|Death|0|||
48835492|NCT04358549|157240667|FG000|Overall Study|Lost to Follow-up|2|||
48835493|NCT04358549|157240668|FG001|Overall Study|Lost to Follow-up|1|||
48835494|NCT04358549|157240667|FG000|Overall Study|Withdrawal by Subject|6|||
49162243|NCT03314935|158432037|FG010|Phase 2|Lost to Follow-up|0|||
49162244|NCT03314935|158432038|FG011|Phase 2|Lost to Follow-up|0|||
49162245|NCT03314935|158432039|FG012|Phase 2|Lost to Follow-up|0|||
49162246|NCT03314935|158432040|FG013|Phase 2|Lost to Follow-up|0|||
49162247|NCT03314935|158432041|FG014|Phase 2|Lost to Follow-up|1|||
49162248|NCT03314935|158432027|FG000|Phase 2|Physician Decision|0|||
49162249|NCT03314935|158432028|FG001|Phase 2|Physician Decision|0|||
49162250|NCT03314935|158432029|FG002|Phase 2|Physician Decision|0|||
49162251|NCT03314935|158432030|FG003|Phase 2|Physician Decision|0|||
49162252|NCT03314935|158432031|FG004|Phase 2|Physician Decision|0|||
49162253|NCT03314935|158432032|FG005|Phase 2|Physician Decision|0|||
48835495|NCT04358549|157240668|FG001|Overall Study|Withdrawal by Subject|6|||
49162254|NCT03314935|158432033|FG006|Phase 2|Physician Decision|0|||
49162255|NCT03314935|158432034|FG007|Phase 2|Physician Decision|0|||
49162256|NCT03314935|158432035|FG008|Phase 2|Physician Decision|0|||
49162257|NCT03314935|158432036|FG009|Phase 2|Physician Decision|0|||
49162258|NCT03314935|158432037|FG010|Phase 2|Physician Decision|1|||
49162259|NCT03314935|158432038|FG011|Phase 2|Physician Decision|0|||
49162260|NCT03314935|158432039|FG012|Phase 2|Physician Decision|0|||
49162261|NCT03314935|158432040|FG013|Phase 2|Physician Decision|0|||
49162262|NCT03314935|158432041|FG014|Phase 2|Physician Decision|0|||
49162263|NCT04781816|158432048|FG000|Overall Study|Adverse Event|0|||
49162264|NCT04781816|158432049|FG001|Overall Study|Adverse Event|1|||
49162265|NCT04781816|158432048|FG000|Overall Study|Withdrawal by Subject|1|||
49162266|NCT04781816|158432049|FG001|Overall Study|Withdrawal by Subject|1|||
49162267|NCT04781816|158432048|FG000|Overall Study|Not Related to Coronavirus Disease 2019|1|||
49162268|NCT04781816|158432049|FG001|Overall Study|Not Related to Coronavirus Disease 2019|1|||
49162269|NCT00165789|158432050|FG000|Overall Study|Adverse Event|0|||
49162270|NCT00165789|158432051|FG001|Overall Study|Adverse Event|3|||
49162271|NCT00165789|158432052|FG002|Overall Study|Adverse Event|0|||
49162272|NCT00165789|158432053|FG003|Overall Study|Adverse Event|12|||
49162273|NCT00165789|158432050|FG000|Overall Study|Withdrawal by Subject|0|||
49162274|NCT00165789|158432051|FG001|Overall Study|Withdrawal by Subject|1|||
49162275|NCT00165789|158432052|FG002|Overall Study|Withdrawal by Subject|1|||
49162276|NCT00165789|158432053|FG003|Overall Study|Withdrawal by Subject|2|||
49162277|NCT02737501|158432054|FG000|Randomized Phase|Died|41|||
49162278|NCT02737501|158432055|FG001|Randomized Phase|Died|29|||
49162279|NCT02737501|158432056|FG002|Randomized Phase|Died|0|||
49162280|NCT02737501|158432054|FG000|Randomized Phase|Withdrawal by Subject|16|||
49162281|NCT02737501|158432055|FG001|Randomized Phase|Withdrawal by Subject|6|||
49162282|NCT02737501|158432056|FG002|Randomized Phase|Withdrawal by Subject|0|||
49162283|NCT02737501|158432054|FG000|Randomized Phase|Lost to Follow-up|0|||
49162284|NCT02737501|158432055|FG001|Randomized Phase|Lost to Follow-up|1|||
49162285|NCT02737501|158432056|FG002|Randomized Phase|Lost to Follow-up|0|||
49162286|NCT02737501|158432054|FG000|Randomized Phase|Site Terminated by Sponsor|58|||
49162287|NCT02737501|158432055|FG001|Randomized Phase|Site Terminated by Sponsor|16|||
49162288|NCT02737501|158432056|FG002|Randomized Phase|Site Terminated by Sponsor|0|||
49162289|NCT02737501|158432054|FG000|Randomized Phase|Reason not Specified|1|||
49162290|NCT02737501|158432055|FG001|Randomized Phase|Reason not Specified|1|||
49162291|NCT02737501|158432056|FG002|Randomized Phase|Reason not Specified|0|||
49162292|NCT02737501|158432054|FG000|Randomized Phase|Never Treated|1|||
49162293|NCT02737501|158432055|FG001|Randomized Phase|Never Treated|1|||
49162294|NCT02737501|158432056|FG002|Randomized Phase|Never Treated|0|||
49162295|NCT02737501|158432054|FG000|Crossover Phase|Died|0|||
49162296|NCT02737501|158432055|FG001|Crossover Phase|Died|0|||
49162297|NCT02737501|158432056|FG002|Crossover Phase|Died|22|||
49162298|NCT02737501|158432054|FG000|Crossover Phase|Withdrew Consent|0|||
49162299|NCT02737501|158432055|FG001|Crossover Phase|Withdrew Consent|0|||
49162300|NCT02737501|158432056|FG002|Crossover Phase|Withdrew Consent|9|||
48835496|NCT04358549|157240667|FG000|Overall Study|Start remdesivir|1|||
48835497|NCT04358549|157240668|FG001|Overall Study|Start remdesivir|0|||
48835498|NCT03895034|157240669|FG000|Overall Study|Lost to Follow-up|2|||
48835499|NCT01118377|157240673|FG000|Overall Study|Did Not Receive Study Medication|1|||
49162301|NCT02737501|158432054|FG000|Crossover Phase|Physician Decision|0|||
49162302|NCT02737501|158432055|FG001|Crossover Phase|Physician Decision|0|||
49162303|NCT02737501|158432056|FG002|Crossover Phase|Physician Decision|1|||
49162304|NCT02737501|158432054|FG000|Crossover Phase|Site Terminated by Sponsor|0|||
49162305|NCT02737501|158432055|FG001|Crossover Phase|Site Terminated by Sponsor|0|||
49162306|NCT02737501|158432056|FG002|Crossover Phase|Site Terminated by Sponsor|23|||
48835500|NCT01118377|157240673|FG000|Overall Study|Death|38|||
48835501|NCT01118377|157240673|FG000|Overall Study|Failure to Return|3|||
49162307|NCT01445847|158432057|FG000|Overall Study|Protocol Violation|13|||
49162308|NCT01445847|158432058|FG001|Overall Study|Protocol Violation|14|||
49162309|NCT01445847|158432057|FG000|Overall Study|Missed Data|1|||
49162310|NCT01445847|158432058|FG001|Overall Study|Missed Data|0|||
49162311|NCT01900665|158432059|FG000|Placebo Controlled Period|Death|9|||
49162312|NCT01900665|158432060|FG001|Placebo Controlled Period|Death|16|||
49162313|NCT01900665|158432059|FG000|Placebo Controlled Period|Adverse Event|48|||
49162314|NCT01900665|158432060|FG001|Placebo Controlled Period|Adverse Event|39|||
49162315|NCT01900665|158432059|FG000|Placebo Controlled Period|Protocol Violation|1|||
49162316|NCT01900665|158432060|FG001|Placebo Controlled Period|Protocol Violation|7|||
49162317|NCT01900665|158432059|FG000|Placebo Controlled Period|Withdrawal by Subject|33|||
49162318|NCT01900665|158432060|FG001|Placebo Controlled Period|Withdrawal by Subject|45|||
49162319|NCT01900665|158432059|FG000|Placebo Controlled Period|Physician Decision|11|||
49162320|NCT01900665|158432060|FG001|Placebo Controlled Period|Physician Decision|7|||
49162321|NCT01900665|158432059|FG000|Placebo Controlled Period|Lost to Follow-up|3|||
49162322|NCT01900665|158432060|FG001|Placebo Controlled Period|Lost to Follow-up|0|||
49162323|NCT01900665|158432059|FG000|Placebo Controlled Period|Caregiver Decision|33|||
49162324|NCT01900665|158432060|FG001|Placebo Controlled Period|Caregiver Decision|41|||
49162325|NCT01900665|158432059|FG000|Placebo Controlled Period|Entry Criteria Not Met|5|||
49162326|NCT01900665|158432060|FG001|Placebo Controlled Period|Entry Criteria Not Met|9|||
49162327|NCT01900665|158432059|FG000|Open Label Period|Adverse Event|16|||
49162328|NCT01900665|158432060|FG001|Open Label Period|Adverse Event|20|||
49162329|NCT01900665|158432059|FG000|Open Label Period|Death|5|||
49162330|NCT01900665|158432060|FG001|Open Label Period|Death|6|||
49162331|NCT01900665|158432059|FG000|Open Label Period|Lost to Follow-up|1|||
49162332|NCT01900665|158432060|FG001|Open Label Period|Lost to Follow-up|1|||
49162333|NCT01900665|158432059|FG000|Open Label Period|Parent/Caregiver Decision|33|||
49162334|NCT01900665|158432060|FG001|Open Label Period|Parent/Caregiver Decision|34|||
49162335|NCT01900665|158432059|FG000|Open Label Period|Physician Decision|4|||
49162336|NCT01900665|158432060|FG001|Open Label Period|Physician Decision|4|||
49162337|NCT01900665|158432059|FG000|Open Label Period|Protocol Violation|0|||
49162338|NCT01900665|158432060|FG001|Open Label Period|Protocol Violation|1|||
49162339|NCT01900665|158432059|FG000|Open Label Period|Sponsor Decision|802|||
49162340|NCT01900665|158432060|FG001|Open Label Period|Sponsor Decision|765|||
49162341|NCT01900665|158432059|FG000|Open Label Period|Withdrawal by Subject|20|||
49162342|NCT01900665|158432060|FG001|Open Label Period|Withdrawal by Subject|28|||
49162343|NCT05414175|158432064|FG000|Overall Study|Withdrawal by Subject|1|||
49162344|NCT05414175|158432064|FG000|Overall Study|Other Reasons|1|||
49162345|NCT02701764|158432065|FG000|Overall Study|Lost to Follow-up|0|||
49162346|NCT02701764|158432066|FG001|Overall Study|Lost to Follow-up|1|||
49162347|NCT03960684|158432067|FG000|Overall Study|Did not proceed to surgery with MSS|1|||
49162348|NCT03761056|158432068|FG000|Overall Study|Death|8|||
49162349|NCT03761056|158432068|FG000|Overall Study|Enrolled but never treated|2|||
49162350|NCT03761056|158432068|FG000|Overall Study|Withdrawal of consent from further follow-up|2|||
49162351|NCT03761056|158432068|FG000|Overall Study|Investigator decision|1|||
49162352|NCT03965403|158432074|FG000|Overall Study|Subject not meeting eligibility criteria|1|||
49162353|NCT03783026|158433657|FG000|Treatment Phase|Adverse Event|15|||
49162354|NCT03783026|158433657|FG000|Treatment Phase|Lack of Efficacy|11|||
49162355|NCT03783026|158433657|FG000|Treatment Phase|Withdrawal by Subject|6|||
49162356|NCT03783026|158433657|FG000|Treatment Phase|Lost to Follow-up|2|||
49162357|NCT03783026|158433657|FG000|Treatment Phase|Protocol Deviation|8|||
49162358|NCT03783026|158433657|FG000|Treatment Phase|Did Not Receive Treatment|1|||
49162359|NCT03783026|158433657|FG000|Observational Follow-up Phase|Lost to Follow-up|3|||
49162360|NCT06194214|158433658|FG000|Overall Study|Adverse Event|1|||
49162361|NCT04218201|158433659|FG000|Overall Study|Death|0|||
49162362|NCT04218201|158433660|FG001|Overall Study|Death|0|||
49162363|NCT04218201|158433661|FG002|Overall Study|Death|2|||
49162364|NCT04218201|158433662|FG003|Overall Study|Death|0|||
49162365|NCT04218201|158433659|FG000|Overall Study|Unable to contact participant|4|||
49162366|NCT04218201|158433660|FG001|Overall Study|Unable to contact participant|0|||
49162367|NCT04218201|158433661|FG002|Overall Study|Unable to contact participant|3|||
49162368|NCT04218201|158433662|FG003|Overall Study|Unable to contact participant|0|||
49162369|NCT04218201|158433659|FG000|Overall Study|Practical problems (e.g., no childcare or transportation)|3|||
49162370|NCT04218201|158433660|FG001|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
49162371|NCT04218201|158433661|FG002|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
49162372|NCT04218201|158433662|FG003|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
49162373|NCT04218201|158433659|FG000|Overall Study|Withdrawal by Subject|2|||
49162374|NCT04218201|158433660|FG001|Overall Study|Withdrawal by Subject|0|||
49162375|NCT04218201|158433661|FG002|Overall Study|Withdrawal by Subject|0|||
49162376|NCT04218201|158433662|FG003|Overall Study|Withdrawal by Subject|0|||
49162377|NCT04218201|158433659|FG000|Overall Study|PCP plans to leave practice|0|||
49162378|NCT04218201|158433660|FG001|Overall Study|PCP plans to leave practice|8|||
49162379|NCT04218201|158433661|FG002|Overall Study|PCP plans to leave practice|0|||
49162380|NCT04218201|158433662|FG003|Overall Study|PCP plans to leave practice|5|||
49162381|NCT04218201|158433659|FG000|Overall Study|Reduced panel|0|||
49162382|NCT04218201|158433660|FG001|Overall Study|Reduced panel|0|||
49162383|NCT04218201|158433661|FG002|Overall Study|Reduced panel|0|||
49162384|NCT04218201|158433662|FG003|Overall Study|Reduced panel|1|||
49162385|NCT04218201|158433659|FG000|Overall Study|No longer interested in participating|0|||
49162386|NCT04218201|158433660|FG001|Overall Study|No longer interested in participating|1|||
49162387|NCT04218201|158433661|FG002|Overall Study|No longer interested in participating|0|||
49162388|NCT04218201|158433662|FG003|Overall Study|No longer interested in participating|0|||
49162389|NCT01631214|158433663|FG000|Overall Study|Withdrawal by Subject|276|||
49162390|NCT01631214|158433664|FG001|Overall Study|Withdrawal by Subject|290|||
49162391|NCT01631214|158433663|FG000|Overall Study|Death|113|||
49162392|NCT01631214|158433664|FG001|Overall Study|Death|106|||
49162393|NCT01631214|158433663|FG000|Overall Study|Lost to Follow-up|54|||
49162394|NCT01631214|158433664|FG001|Overall Study|Lost to Follow-up|40|||
49162395|NCT01631214|158433663|FG000|Overall Study|Adverse Event|45|||
49162396|NCT01631214|158433664|FG001|Overall Study|Adverse Event|45|||
49162397|NCT01631214|158433663|FG000|Overall Study|Other|22|||
49162398|NCT01631214|158433664|FG001|Overall Study|Other|19|||
49162399|NCT01631214|158433663|FG000|Overall Study|Noncompliance|16|||
49162400|NCT01631214|158433664|FG001|Overall Study|Noncompliance|15|||
49162401|NCT01631214|158433663|FG000|Overall Study|Requirement for Alternative Therapy|8|||
49162402|NCT01631214|158433664|FG001|Overall Study|Requirement for Alternative Therapy|3|||
49162403|NCT01631214|158433663|FG000|Overall Study|Protocol Deviation|4|||
49162404|NCT01631214|158433664|FG001|Overall Study|Protocol Deviation|3|||
49162405|NCT01631214|158433663|FG000|Overall Study|Ineligibility determined|5|||
49162406|NCT01631214|158433664|FG001|Overall Study|Ineligibility determined|2|||
49162407|NCT01631214|158433663|FG000|Overall Study|Administrative Decision|1|||
49162408|NCT01631214|158433664|FG001|Overall Study|Administrative Decision|0|||
49162409|NCT03857620|158433665|FG000|Overall Study|Death|4|||
49162410|NCT03857620|158433666|FG001|Overall Study|Death|5|||
49162411|NCT03857620|158433667|FG002|Overall Study|Death|7|||
49162412|NCT03857620|158433665|FG000|Overall Study|Lost to Follow-up|2|||
49162413|NCT03857620|158433666|FG001|Overall Study|Lost to Follow-up|5|||
49162414|NCT03857620|158433667|FG002|Overall Study|Lost to Follow-up|3|||
49162415|NCT03857620|158433665|FG000|Overall Study|Disease progression or relapse after study registration|1|||
49162416|NCT03857620|158433666|FG001|Overall Study|Disease progression or relapse after study registration|5|||
49162417|NCT03857620|158433667|FG002|Overall Study|Disease progression or relapse after study registration|1|||
49162418|NCT03857620|158433665|FG000|Overall Study|Ineligible|5|||
49162419|NCT03857620|158433666|FG001|Overall Study|Ineligible|0|||
49162420|NCT03857620|158433667|FG002|Overall Study|Ineligible|2|||
49162421|NCT03857620|158433665|FG000|Overall Study|No malignancy|1|||
49162422|NCT03857620|158433666|FG001|Overall Study|No malignancy|0|||
49162423|NCT03857620|158433667|FG002|Overall Study|No malignancy|1|||
49162424|NCT03857620|158433665|FG000|Overall Study|Patient withdrawal/refusal prior to surgery|2|||
49162425|NCT03857620|158433666|FG001|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
49162426|NCT03857620|158433667|FG002|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
49162427|NCT03857620|158433665|FG000|Overall Study|Patient withdrawal/refusal after surgery performed|4|||
49162428|NCT03857620|158433666|FG001|Overall Study|Patient withdrawal/refusal after surgery performed|7|||
49162429|NCT03857620|158433667|FG002|Overall Study|Patient withdrawal/refusal after surgery performed|2|||
49162430|NCT03857620|158433665|FG000|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
49162431|NCT03857620|158433666|FG001|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
49162432|NCT03857620|158433667|FG002|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|3|||
49162433|NCT03857620|158433665|FG000|Overall Study|Surgery not performed, patient decision|0|||
49162434|NCT03857620|158433666|FG001|Overall Study|Surgery not performed, patient decision|3|||
49162435|NCT03857620|158433667|FG002|Overall Study|Surgery not performed, patient decision|1|||
49162436|NCT03857620|158433665|FG000|Overall Study|Surgery not performed, other reason|3|||
49162437|NCT03857620|158433666|FG001|Overall Study|Surgery not performed, other reason|1|||
49162438|NCT03857620|158433667|FG002|Overall Study|Surgery not performed, other reason|4|||
49162439|NCT03857620|158433665|FG000|Overall Study|Worsening performance status after surgery performed|0|||
48835502|NCT01091454|157240677|FG000|Overall Study|Ineligible|1|||
48835503|NCT00157014|157240678|FG000|Overall Study|Death|4|||
48835504|NCT00157014|157240679|FG001|Overall Study|Death|2|||
48835505|NCT00157014|157240680|FG002|Overall Study|Death|1|||
48835506|NCT00157014|157240681|FG003|Overall Study|Death|1|||
49162440|NCT03857620|158433666|FG001|Overall Study|Worsening performance status after surgery performed|1|||
49162441|NCT03857620|158433667|FG002|Overall Study|Worsening performance status after surgery performed|1|||
49162442|NCT02296476|158433668|FG000|Overall Study|Disease Progression|6|||
48835507|NCT00157014|157240678|FG000|Overall Study|Physician Decision|0|||
49162443|NCT02296476|158433669|FG001|Overall Study|Disease Progression|4|||
49162444|NCT02296476|158433670|FG002|Overall Study|Disease Progression|2|||
48835508|NCT00157014|157240679|FG001|Overall Study|Physician Decision|1|||
48835509|NCT00157014|157240680|FG002|Overall Study|Physician Decision|0|||
49162445|NCT02122380|158433671|FG000|First Intervention (30 Days)|Adverse Event|1|||
48835510|NCT00157014|157240681|FG003|Overall Study|Physician Decision|0|||
49162446|NCT02122380|158433672|FG001|First Intervention (30 Days)|Adverse Event|0|||
49162447|NCT02122380|158433671|FG000|First Intervention (30 Days)|Physician Decision|0|||
49162448|NCT02122380|158433672|FG001|First Intervention (30 Days)|Physician Decision|1|||
49162449|NCT02122380|158433671|FG000|Washout (8 Weeks)|Lost to Follow-up|1|||
49162450|NCT02122380|158433672|FG001|Washout (8 Weeks)|Lost to Follow-up|0|||
49162451|NCT02122380|158433671|FG000|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0|||
49162452|NCT02122380|158433672|FG001|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2|||
49162453|NCT02122380|158433671|FG000|Second Intervention (30 Days)|2 did not complete all of inpatient day|0|||
49162454|NCT02122380|158433672|FG001|Second Intervention (30 Days)|2 did not complete all of inpatient day|2|||
49162455|NCT01783444|158433673|FG000|Treatment Phase|Adverse Event|9|||
49162456|NCT01783444|158433674|FG001|Treatment Phase|Adverse Event|20|||
49162457|NCT01783444|158433675|FG002|Treatment Phase|Adverse Event|19|||
49162458|NCT01783444|158433673|FG000|Treatment Phase|Disease Progression|76|||
49162459|NCT01783444|158433674|FG001|Treatment Phase|Disease Progression|66|||
49162460|NCT01783444|158433675|FG002|Treatment Phase|Disease Progression|64|||
49162461|NCT01783444|158433673|FG000|Treatment Phase|Death|2|||
49162462|NCT01783444|158433674|FG001|Treatment Phase|Death|2|||
49162463|NCT01783444|158433675|FG002|Treatment Phase|Death|2|||
48835511|NCT00157014|157240678|FG000|Overall Study|Medications withdrawn on family request|0|||
48835512|NCT00157014|157240679|FG001|Overall Study|Medications withdrawn on family request|1|||
48835513|NCT00157014|157240680|FG002|Overall Study|Medications withdrawn on family request|0|||
49162464|NCT01783444|158433673|FG000|Treatment Phase|Protocol Violation|1|||
49162465|NCT01783444|158433674|FG001|Treatment Phase|Protocol Violation|1|||
49162466|NCT01783444|158433675|FG002|Treatment Phase|Protocol Violation|2|||
48835514|NCT00157014|157240681|FG003|Overall Study|Medications withdrawn on family request|0|||
48835515|NCT00157014|157240678|FG000|Overall Study|Patient withdrawn by investigator|1|||
48835516|NCT00157014|157240679|FG001|Overall Study|Patient withdrawn by investigator|0|||
48835517|NCT00157014|157240680|FG002|Overall Study|Patient withdrawn by investigator|0|||
48835518|NCT00157014|157240681|FG003|Overall Study|Patient withdrawn by investigator|0|||
48835519|NCT00157014|157240678|FG000|Overall Study|Patient unable to return in nursing home|1|||
48835520|NCT00157014|157240679|FG001|Overall Study|Patient unable to return in nursing home|0|||
48835521|NCT00157014|157240680|FG002|Overall Study|Patient unable to return in nursing home|0|||
48835522|NCT00157014|157240681|FG003|Overall Study|Patient unable to return in nursing home|0|||
48835523|NCT00157014|157240678|FG000|Overall Study|Patient would not receive transplant|0|||
48835524|NCT00157014|157240679|FG001|Overall Study|Patient would not receive transplant|1|||
48835525|NCT00157014|157240680|FG002|Overall Study|Patient would not receive transplant|0|||
48835526|NCT00157014|157240681|FG003|Overall Study|Patient would not receive transplant|0|||
48835527|NCT00157014|157240678|FG000|Overall Study|Withdrawal by Subject|1|||
48835528|NCT00157014|157240679|FG001|Overall Study|Withdrawal by Subject|0|||
48835529|NCT00157014|157240680|FG002|Overall Study|Withdrawal by Subject|0|||
48835530|NCT00157014|157240681|FG003|Overall Study|Withdrawal by Subject|0|||
48835531|NCT00661778|157240686|FG000|Overall Study|Disease Progression|23|||
48835532|NCT00661778|157240686|FG000|Overall Study|Adverse Event|18|||
48835533|NCT00661778|157240686|FG000|Overall Study|Reason not Specified|6|||
48835534|NCT00661778|157240686|FG000|Overall Study|Protocol Violation|2|||
48835535|NCT00661778|157240686|FG000|Overall Study|Withdrawal of Consent|1|||
48835536|NCT00486759|157240692|FG000|Treatment|Adverse event/intercurrent illness|86|||
48835537|NCT00486759|157240693|FG001|Treatment|Adverse event/intercurrent illness|39|||
48835538|NCT00486759|157240692|FG000|Treatment|Insufficient therapeutic response|37|||
48835539|NCT00486759|157240693|FG001|Treatment|Insufficient therapeutic response|39|||
48835540|NCT00486759|157240692|FG000|Treatment|Death|17|||
48835541|NCT00486759|157240693|FG001|Treatment|Death|10|||
48835542|NCT00486759|157240692|FG000|Treatment|Withdrew consent|15|||
48835543|NCT00486759|157240693|FG001|Treatment|Withdrew consent|12|||
48835544|NCT00486759|157240692|FG000|Treatment|Administrative/reason not specified|17|||
48835545|NCT00486759|157240693|FG001|Treatment|Administrative/reason not specified|21|||
48835546|NCT00486759|157240692|FG000|Treatment|Refused treatment|10|||
48835547|NCT00486759|157240693|FG001|Treatment|Refused treatment|7|||
48835548|NCT00486759|157240692|FG000|Treatment|Violation of selection criteria at entry|3|||
48835549|NCT00486759|157240693|FG001|Treatment|Violation of selection criteria at entry|3|||
48835550|NCT00486759|157240692|FG000|Treatment|Other protocol violation|1|||
48835551|NCT00486759|157240693|FG001|Treatment|Other protocol violation|5|||
48835552|NCT00486759|157240692|FG000|Treatment|Failure to return|1|||
48835553|NCT00486759|157240693|FG001|Treatment|Failure to return|1|||
48835554|NCT00486759|157240692|FG000|Safety Follow-up|Insufficient therapeutic response|40|||
48835555|NCT00486759|157240693|FG001|Safety Follow-up|Insufficient therapeutic response|50|||
48835556|NCT00486759|157240692|FG000|Safety Follow-up|Death|40|||
48835557|NCT00486759|157240693|FG001|Safety Follow-up|Death|29|||
48835558|NCT00486759|157240692|FG000|Safety Follow-up|Withdrew consent|32|||
48835559|NCT00486759|157240693|FG001|Safety Follow-up|Withdrew consent|23|||
48835560|NCT00486759|157240692|FG000|Safety Follow-up|Failure to return|9|||
48835561|NCT00486759|157240693|FG001|Safety Follow-up|Failure to return|6|||
48835562|NCT00486759|157240692|FG000|Safety Follow-up|Administrative/not specified|8|||
48835563|NCT00486759|157240693|FG001|Safety Follow-up|Administrative/not specified|6|||
49162467|NCT01783444|158433673|FG000|Treatment Phase|Withdrawal by Subject|6|||
49162468|NCT01783444|158433674|FG001|Treatment Phase|Withdrawal by Subject|8|||
49162469|NCT01783444|158433675|FG002|Treatment Phase|Withdrawal by Subject|9|||
49162470|NCT01783444|158433673|FG000|Treatment Phase|Administrative problems|2|||
49162471|NCT01783444|158433674|FG001|Treatment Phase|Administrative problems|0|||
49162472|NCT01783444|158433675|FG002|Treatment Phase|Administrative problems|1|||
49162473|NCT01783444|158433673|FG000|Treatment Phase|Physician Decision|8|||
49162474|NCT01783444|158433674|FG001|Treatment Phase|Physician Decision|6|||
49162475|NCT01783444|158433675|FG002|Treatment Phase|Physician Decision|5|||
49162476|NCT01783444|158433673|FG000|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7|||
49162477|NCT01783444|158433674|FG001|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8|||
49162478|NCT01783444|158433675|FG002|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11|||
49162479|NCT01783444|158433673|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|9|||
49162480|NCT01783444|158433674|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|7|||
49162481|NCT01783444|158433675|FG002|Post-Treatment Efficacy Follow-Up Phase|Death|5|||
49162482|NCT01783444|158433673|FG000|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4|||
49162483|NCT01783444|158433674|FG001|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
49162484|NCT01783444|158433675|FG002|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
49162485|NCT01783444|158433673|FG000|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
49162486|NCT01783444|158433674|FG001|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1|||
48835564|NCT00486759|157240692|FG000|Safety Follow-up|Refused treatment/did not cooperate|6|||
48835565|NCT00486759|157240693|FG001|Safety Follow-up|Refused treatment/did not cooperate|4|||
48835566|NCT00486759|157240692|FG000|Safety Follow-up|Adverse event/intercurrent illness|4|||
48835567|NCT00486759|157240693|FG001|Safety Follow-up|Adverse event/intercurrent illness|0|||
48835568|NCT02496702|157240694|FG000|Overall Study|Lost to Follow-up|8|||
48835569|NCT02496702|157240695|FG001|Overall Study|Lost to Follow-up|6|||
48835570|NCT02496702|157240694|FG000|Overall Study|Only partially tested|0|||
48835571|NCT02496702|157240695|FG001|Overall Study|Only partially tested|2|||
48835572|NCT01499134|157240696|FG000|Overall Study|Withdrawal by Subject|0|||
48835573|NCT01499134|157240697|FG001|Overall Study|Withdrawal by Subject|1|||
48835574|NCT00708032|157240698|FG000|Overall Study|Adverse Event|0|||
48835575|NCT00708032|157240699|FG001|Overall Study|Adverse Event|2|||
48835576|NCT00708032|157240698|FG000|Overall Study|Lost to Follow-up|1|||
48835577|NCT00708032|157240699|FG001|Overall Study|Lost to Follow-up|2|||
48835578|NCT00708032|157240698|FG000|Overall Study|Pregnancy|0|||
48835579|NCT00708032|157240699|FG001|Overall Study|Pregnancy|1|||
48835580|NCT00708032|157240698|FG000|Overall Study|Poor vision|0|||
48835581|NCT00708032|157240699|FG001|Overall Study|Poor vision|6|||
48835582|NCT00708032|157240698|FG000|Overall Study|Visit out of range at month 12|4|||
48835583|NCT00708032|157240699|FG001|Overall Study|Visit out of range at month 12|1|||
48835584|NCT00708032|157240698|FG000|Overall Study|Did not meet protocol criteria|1|||
48835585|NCT00708032|157240699|FG001|Overall Study|Did not meet protocol criteria|2|||
48835586|NCT00708032|157240698|FG000|Overall Study|Protocol Violation|4|||
48835587|NCT00708032|157240699|FG001|Overall Study|Protocol Violation|1|||
48835588|NCT00708032|157240698|FG000|Overall Study|Withdrawal by Subject|0|||
48835589|NCT00708032|157240699|FG001|Overall Study|Withdrawal by Subject|1|||
48835590|NCT00516386|157240711|FG000|Overall Study|not interested in the study|4|||
48835591|NCT00516386|157240711|FG000|Overall Study|Lost to Follow-up|2|||
48835592|NCT04033432|157240712|FG000|Overall Study|Progressive Disease|8|||
48835593|NCT04033432|157240712|FG000|Overall Study|Adverse Event|4|||
48835594|NCT04033432|157240712|FG000|Overall Study|Death|1|||
48835595|NCT00854906|157240717|FG000|Overall Study|One person had no ocular history|1|||
48835596|NCT03804918|157240724|FG000|Overall Study|Participant did not use the app|1|||
48835597|NCT03861767|157240727|FG000|Overall Study|Withdrawal by Subject|2|||
48835598|NCT03861767|157240728|FG001|Overall Study|Withdrawal by Subject|1|||
48835599|NCT03861767|157240729|FG002|Overall Study|Withdrawal by Subject|0|||
48835600|NCT03861767|157240730|FG003|Overall Study|Withdrawal by Subject|5|||
48835601|NCT03861767|157240731|FG004|Overall Study|Withdrawal by Subject|2|||
48835602|NCT03861767|157240732|FG005|Overall Study|Withdrawal by Subject|1|||
48835603|NCT03861767|157240733|FG006|Overall Study|Withdrawal by Subject|3|||
48835604|NCT03861767|157240734|FG007|Overall Study|Withdrawal by Subject|1|||
48835605|NCT03861767|157240735|FG008|Overall Study|Withdrawal by Subject|0|||
48835606|NCT03861767|157240736|FG009|Overall Study|Withdrawal by Subject|5|||
48835607|NCT01460290|157240744|FG000|Overall Study|Adverse Event|3|||
48835608|NCT01460290|157240744|FG000|Overall Study|Elevated liver function|1|||
48835609|NCT02506257|157240745|FG000|Overall Study|Adverse Event|0|||
48835610|NCT02506257|157240746|FG001|Overall Study|Adverse Event|2|||
48835611|NCT02506257|157240747|FG002|Overall Study|Adverse Event|3|||
48835612|NCT02506257|157240748|FG003|Overall Study|Adverse Event|0|||
48835613|NCT02506257|157240745|FG000|Overall Study|Protocol Violation|0|||
48835614|NCT02506257|157240746|FG001|Overall Study|Protocol Violation|0|||
48923690|NCT01535729|157555182|FG000|Overall Study|No previous chemotherapy|33|||
48923691|NCT01535729|157555182|FG000|Overall Study|NSCLC grade IV histology not confirmed|20|||
48923692|NCT01535729|157555182|FG000|Overall Study|Protocol Violation|11|||
48923693|NCT01535729|157555182|FG000|Overall Study|Screening failure|1|||
48923694|NCT01535729|157555182|FG000|Overall Study|Not treated|9|||
48923695|NCT01535729|157555182|FG000|Overall Study|No participant record available|5|||
48923696|NCT02105454|157555190|FG000|Overall Study|Withdrawal by Subject|1|||
48923697|NCT04312009|157555193|FG000|Overall Study|Withdrawal by Subject|2|||
48923698|NCT04312009|157555194|FG001|Overall Study|Withdrawal by Subject|1|||
48923699|NCT01192022|157555195|FG000|Overall Study|Withdrawal of Consent|3|||
48835615|NCT02506257|157240747|FG002|Overall Study|Protocol Violation|1|||
48923700|NCT01192022|157555196|FG001|Overall Study|Withdrawal of Consent|1|||
49162487|NCT01783444|158433675|FG002|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
48835616|NCT02506257|157240748|FG003|Overall Study|Protocol Violation|0|||
48835617|NCT01924767|157240749|FG000|Overall Study|Adverse Event|1|||
48835618|NCT01924767|157240750|FG001|Overall Study|Adverse Event|0|||
48835619|NCT01924767|157240751|FG002|Overall Study|Adverse Event|1|||
48923701|NCT01192022|157555197|FG002|Overall Study|Withdrawal of Consent|0|||
48923702|NCT01192022|157555198|FG003|Overall Study|Withdrawal of Consent|0|||
48923703|NCT01192022|157555199|FG004|Overall Study|Withdrawal of Consent|0|||
48923704|NCT01192022|157555195|FG000|Overall Study|Lost to Follow-up|4|||
48835620|NCT01924767|157240752|FG003|Overall Study|Adverse Event|0|||
48835621|NCT01924767|157240753|FG004|Overall Study|Adverse Event|0|||
48835622|NCT01563354|157240754|FG000|Core Phase|Adverse Event|5|||
48835623|NCT01563354|157240755|FG001|Core Phase|Adverse Event|15|||
48835624|NCT01563354|157240756|FG002|Core Phase|Adverse Event|13|||
49162488|NCT01783444|158433673|FG000|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7|||
49162489|NCT01783444|158433674|FG001|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16|||
49162490|NCT01783444|158433675|FG002|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15|||
48835625|NCT01563354|157240754|FG000|Core Phase|Withdrawal by Subject|1|||
48835626|NCT01563354|157240755|FG001|Core Phase|Withdrawal by Subject|0|||
48835627|NCT01563354|157240756|FG002|Core Phase|Withdrawal by Subject|3|||
48835628|NCT01563354|157240754|FG000|Core Phase|Lost to Follow-up|1|||
49162491|NCT01783444|158433673|FG000|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69|||
49162492|NCT01783444|158433674|FG001|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53|||
49162493|NCT01783444|158433675|FG002|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52|||
49162494|NCT05111145|158433676|FG000|Overall Study|Commercial drug is available for participant|76|||
48835629|NCT01563354|157240755|FG001|Core Phase|Lost to Follow-up|0|||
48835630|NCT01563354|157240756|FG002|Core Phase|Lost to Follow-up|0|||
48835631|NCT01563354|157240754|FG000|Core Phase|Death|1|||
48835632|NCT01563354|157240755|FG001|Core Phase|Death|5|||
49162495|NCT05111145|158433676|FG000|Overall Study|Participant enrolled in another qualified Vertex study|10|||
49162496|NCT05246514|158433685|FG000|Overall Study|Ongoing in the study at data cut-off date|58|||
49162497|NCT05246514|158433685|FG000|Overall Study|Withdrawal by Subject|1|||
49162498|NCT05246514|158433685|FG000|Overall Study|Death|13|||
49162499|NCT04401267|158433686|FG000|Overall Study|Death|0|||
49162500|NCT04401267|158433687|FG001|Overall Study|Death|1|||
49162501|NCT04401267|158433686|FG000|Overall Study|Discontinuation of TOT17 therapy|4|||
49162502|NCT04401267|158433687|FG001|Overall Study|Discontinuation of TOT17 therapy|2|||
49162503|NCT04401267|158433686|FG000|Overall Study|Found to be Ineligible|1|||
49162504|NCT04401267|158433687|FG001|Overall Study|Found to be Ineligible|0|||
49162505|NCT01581684|158433688|FG000|Overall Study|Other reason not defined|0|||
49162506|NCT01581684|158433689|FG001|Overall Study|Other reason not defined|0|||
49162507|NCT01581684|158433690|FG002|Overall Study|Other reason not defined|0|||
49162508|NCT01581684|158433691|FG003|Overall Study|Other reason not defined|0|||
48835633|NCT01563354|157240756|FG002|Core Phase|Death|2|||
48835634|NCT01563354|157240754|FG000|Core Phase|Diseasse progression|18|||
48835635|NCT01563354|157240755|FG001|Core Phase|Diseasse progression|7|||
48835636|NCT01563354|157240756|FG002|Core Phase|Diseasse progression|8|||
48835637|NCT01563354|157240754|FG000|Core Phase|Protocol deviation|2|||
48835638|NCT01563354|157240755|FG001|Core Phase|Protocol deviation|0|||
49162509|NCT01581684|158433692|FG004|Overall Study|Other reason not defined|0|||
49162510|NCT01581684|158433693|FG005|Overall Study|Other reason not defined|0|||
49162511|NCT01581684|158433694|FG006|Overall Study|Other reason not defined|0|||
49162512|NCT01581684|158433695|FG007|Overall Study|Other reason not defined|0|||
49162513|NCT01581684|158433696|FG008|Overall Study|Other reason not defined|1|||
49162514|NCT01581684|158433697|FG009|Overall Study|Other reason not defined|0|||
49162515|NCT02986074|158433698|FG000|First Trial Period|Adverse Event|1|||
49162516|NCT02986074|158433699|FG001|First Trial Period|Adverse Event|0|||
49162517|NCT02986074|158433700|FG002|First Trial Period|Adverse Event|0|||
49162518|NCT02986074|158433701|FG003|First Trial Period|Adverse Event|0|||
49162519|NCT02986074|158433698|FG000|Follow up Period|system explant|0|||
49162520|NCT02986074|158433699|FG001|Follow up Period|system explant|0|||
49162521|NCT02986074|158433700|FG002|Follow up Period|system explant|1|||
49162522|NCT02986074|158433701|FG003|Follow up Period|system explant|2|||
48835639|NCT01563354|157240756|FG002|Core Phase|Protocol deviation|0|||
48835640|NCT01563354|157240754|FG000|Core Phase|PI decision - did not enter extension|0|||
48835641|NCT01563354|157240755|FG001|Core Phase|PI decision - did not enter extension|1|||
48835642|NCT01563354|157240756|FG002|Core Phase|PI decision - did not enter extension|0|||
48835643|NCT01563354|157240754|FG000|Core Phase|Worsening of clinical condition - did not enter extension|1|||
48835644|NCT01563354|157240755|FG001|Core Phase|Worsening of clinical condition - did not enter extension|0|||
48835645|NCT01563354|157240756|FG002|Core Phase|Worsening of clinical condition - did not enter extension|0|||
48835646|NCT01563354|157240754|FG000|Extension Phase|Adverse Event|0|||
48835647|NCT01563354|157240755|FG001|Extension Phase|Adverse Event|3|||
48835648|NCT01563354|157240756|FG002|Extension Phase|Adverse Event|2|||
48835649|NCT01563354|157240754|FG000|Extension Phase|Withdrawal by Subject|0|||
48835650|NCT01563354|157240755|FG001|Extension Phase|Withdrawal by Subject|1|||
48835651|NCT01563354|157240756|FG002|Extension Phase|Withdrawal by Subject|0|||
48835652|NCT01563354|157240754|FG000|Extension Phase|Administration problems|3|||
48835653|NCT01563354|157240755|FG001|Extension Phase|Administration problems|2|||
48835654|NCT01563354|157240756|FG002|Extension Phase|Administration problems|3|||
48835655|NCT01563354|157240754|FG000|Extension Phase|Disease progression|9|||
48835656|NCT01563354|157240755|FG001|Extension Phase|Disease progression|8|||
48835657|NCT01563354|157240756|FG002|Extension Phase|Disease progression|10|||
48835658|NCT01050569|157240760|FG000|Overall Study|Lost to Follow-up|20|||
48835659|NCT01050569|157240761|FG001|Overall Study|Lost to Follow-up|14|||
48835660|NCT01050569|157240762|FG002|Overall Study|Lost to Follow-up|16|||
48835661|NCT01050569|157240760|FG000|Overall Study|Withdrawal by Subject|9|||
48835662|NCT01050569|157240761|FG001|Overall Study|Withdrawal by Subject|3|||
48835663|NCT01050569|157240762|FG002|Overall Study|Withdrawal by Subject|11|||
49162523|NCT02986074|158433698|FG000|Follow up Period|Physician Decision|0|||
49162524|NCT02986074|158433699|FG001|Follow up Period|Physician Decision|0|||
49162525|NCT02986074|158433700|FG002|Follow up Period|Physician Decision|0|||
49162526|NCT02986074|158433701|FG003|Follow up Period|Physician Decision|1|||
49162527|NCT05227209|158433702|FG000|Overall Study|Adverse Event|11|||
49162528|NCT05227209|158433702|FG000|Overall Study|Lost to Follow-up|1|||
49162529|NCT05227209|158433702|FG000|Overall Study|Withdrawal by Subject|7|||
49162530|NCT05227209|158433702|FG000|Overall Study|Other Early Termination Reason (Not Listed on CRF)|36|||
49162531|NCT02896257|158433703|FG000|Providers|Without eligible patients|21|||
49162532|NCT02896257|158433704|FG001|Providers|Without eligible patients|28|||
49162533|NCT02896257|158433703|FG000|Patients|PFT entry criteria not met|43|||
49162534|NCT02896257|158433704|FG001|Patients|PFT entry criteria not met|50|||
49162535|NCT02896257|158433703|FG000|Patients|No capacity to review|8|||
49162536|NCT02896257|158433704|FG001|Patients|No capacity to review|11|||
49162537|NCT02896257|158433703|FG000|Patients|Appointment rescheduled/cancelled|5|||
49162538|NCT02896257|158433704|FG001|Patients|Appointment rescheduled/cancelled|7|||
49162539|NCT02896257|158433703|FG000|Patients|PCP not assigned a clinic|4|||
49162540|NCT02896257|158433704|FG001|Patients|PCP not assigned a clinic|0|||
48835664|NCT01050569|157240760|FG000|Overall Study|Lack of Efficacy|5|||
48835665|NCT01050569|157240761|FG001|Overall Study|Lack of Efficacy|4|||
48835666|NCT01050569|157240762|FG002|Overall Study|Lack of Efficacy|3|||
48835667|NCT01050569|157240760|FG000|Overall Study|Adverse Event|1|||
48835668|NCT01050569|157240761|FG001|Overall Study|Adverse Event|0|||
48835669|NCT01050569|157240762|FG002|Overall Study|Adverse Event|0|||
48835670|NCT01050569|157240760|FG000|Overall Study|Physician Decision|3|||
48835671|NCT01050569|157240761|FG001|Overall Study|Physician Decision|3|||
48835672|NCT01050569|157240762|FG002|Overall Study|Physician Decision|3|||
48835673|NCT01713530|157240767|FG000|Overall Study|Adverse Event|0|||
48835674|NCT01713530|157240768|FG001|Overall Study|Adverse Event|5|||
48835675|NCT01713530|157240767|FG000|Overall Study|Withdrawal criteria|21|||
48835676|NCT01713530|157240768|FG001|Overall Study|Withdrawal criteria|12|||
48835677|NCT01713530|157240767|FG000|Overall Study|Unclassified|4|||
48835678|NCT01713530|157240768|FG001|Overall Study|Unclassified|2|||
48835679|NCT03939819|157240769|FG000|Overall Study|Death|2|||
49162541|NCT02896257|158433703|FG000|Patients|No history of COPD|0|||
49162542|NCT02896257|158433704|FG001|Patients|No history of COPD|1|||
49162543|NCT02896257|158433703|FG000|Patients|Deceased between review and index date|0|||
49162544|NCT02896257|158433704|FG001|Patients|Deceased between review and index date|1|||
49162545|NCT02896257|158433703|FG000|Patients|No ICS Rx upon review|1|||
49162546|NCT02896257|158433704|FG001|Patients|No ICS Rx upon review|1|||
48835680|NCT03939819|157240770|FG001|Overall Study|Death|0|||
48835681|NCT03781336|157240771|FG000|Overall Study|Withdrawal by Subject|2|||
49162547|NCT02896257|158433703|FG000|Patients|Protocol Violation|2|||
49162548|NCT02896257|158433704|FG001|Patients|Protocol Violation|1|||
49162549|NCT02896257|158433703|FG000|Patients|Hospice care|0|||
49162550|NCT02896257|158433704|FG001|Patients|Hospice care|1|||
49162551|NCT01944020|158433705|FG000|Overall Study|Withdrawal by Subject|5|||
48835682|NCT03781336|157240772|FG001|Overall Study|Withdrawal by Subject|2|||
48835683|NCT01831791|157240773|FG000|Overall Study|Withdrawal by Subject|10|||
48835684|NCT00158054|157240776|FG000|Overall Study|Refused to continue|3|||
49162552|NCT01944020|158433706|FG001|Overall Study|Withdrawal by Subject|0|||
49162553|NCT01206517|158433707|FG000|Overall Study|Withdrawal by Subject|0|||
48835685|NCT00158054|157240777|FG001|Overall Study|Refused to continue|0|||
48835686|NCT00158054|157240776|FG000|Overall Study|Unavailable for follow up|7|||
48835687|NCT00158054|157240777|FG001|Overall Study|Unavailable for follow up|3|||
48835688|NCT03192046|157240778|FG000|Overall Study|Withdrawal by Subject|1|||
48835689|NCT03192046|157240779|FG001|Overall Study|Withdrawal by Subject|1|||
48835690|NCT01194154|157240782|FG000|Overall Study|Adverse Event|12|||
48835691|NCT01194154|157240783|FG001|Overall Study|Adverse Event|7|||
48835692|NCT01194154|157240782|FG000|Overall Study|Lost to Follow-up|2|||
48835693|NCT01194154|157240783|FG001|Overall Study|Lost to Follow-up|3|||
48835694|NCT01194154|157240782|FG000|Overall Study|Protocol Violation|0|||
48835695|NCT01194154|157240783|FG001|Overall Study|Protocol Violation|1|||
48835696|NCT01194154|157240782|FG000|Overall Study|Withdrawal by Subject|5|||
48835697|NCT01194154|157240783|FG001|Overall Study|Withdrawal by Subject|6|||
48835698|NCT01194154|157240782|FG000|Overall Study|Blood pressure increase|5|||
48835699|NCT01194154|157240783|FG001|Overall Study|Blood pressure increase|3|||
48835700|NCT01194154|157240782|FG000|Overall Study|Hemoglobin decrease|0|||
48835701|NCT01194154|157240783|FG001|Overall Study|Hemoglobin decrease|1|||
48835702|NCT01194154|157240782|FG000|Overall Study|Hemoglobin increase|12|||
48835703|NCT01194154|157240783|FG001|Overall Study|Hemoglobin increase|3|||
48835704|NCT01194154|157240782|FG000|Overall Study|Skipping of CERA treatment at two visits|3|||
48835705|NCT01194154|157240783|FG001|Overall Study|Skipping of CERA treatment at two visits|0|||
48835706|NCT01194154|157240782|FG000|Overall Study|Treatment with prohibited medication|4|||
48835707|NCT01194154|157240783|FG001|Overall Study|Treatment with prohibited medication|5|||
48835708|NCT01194154|157240782|FG000|Overall Study|Other|4|||
48835709|NCT01194154|157240783|FG001|Overall Study|Other|0|||
48835710|NCT01194154|157240782|FG000|Overall Study|Did not receive study medication|2|||
48835711|NCT01194154|157240783|FG001|Overall Study|Did not receive study medication|4|||
48835712|NCT01157182|157240788|FG000|Washout of 28 Days|Adverse Event|2|||
48835713|NCT01157182|157240789|FG001|Washout of 28 Days|Adverse Event|0|||
48835714|NCT01901276|157240790|FG000|No PPI: Week 0 to Week 4|Withdrawal by Subject|0|||
48835715|NCT01901276|157240791|FG001|No PPI: Week 0 to Week 4|Withdrawal by Subject|2|||
48835716|NCT02888080|157240792|FG000|Overall Study|Subject / Guardian decision|1|||
48835717|NCT02888080|157240793|FG001|Overall Study|Subject / Guardian decision|3|||
48835718|NCT02888080|157240792|FG000|Overall Study|New Therapy for study indication|1|||
48835719|NCT02888080|157240793|FG001|Overall Study|New Therapy for study indication|0|||
48835720|NCT02888080|157240792|FG000|Overall Study|Lack of Efficacy|0|||
48835721|NCT02888080|157240793|FG001|Overall Study|Lack of Efficacy|1|||
48835722|NCT02888080|157240792|FG000|Overall Study|Adverse Event|0|||
48835723|NCT02888080|157240793|FG001|Overall Study|Adverse Event|1|||
48835724|NCT00395018|157240794|FG000|On-Treatment|Death|4|||
48835725|NCT00395018|157240794|FG000|On-Treatment|Other Reason|2|||
48835726|NCT00395018|157240794|FG000|On-Treatment|Poor/non-compliance|2|||
48835727|NCT00395018|157240794|FG000|On-Treatment|Subject no longer meets study criteria|2|||
48835728|NCT00395018|157240794|FG000|Off-Treatment Follow-up|Followup no longer required per protocol|1|||
48835729|NCT00395018|157240794|FG000|Off-Treatment Follow-up|Lost to Follow-up|2|||
48835730|NCT00395018|157240794|FG000|Off-Treatment Follow-up|Poor/non-compliance|1|||
48835731|NCT02026258|157240795|FG000|Randomized|Did not start treatment|2|||
48835732|NCT02026258|157240796|FG001|Randomized|Did not start treatment|1|||
48835733|NCT02026258|157240795|FG000|Randomized|Change in treatment plan|1|||
48835734|NCT02026258|157240796|FG001|Randomized|Change in treatment plan|0|||
48835735|NCT02026258|157240795|FG000|Randomized|Presence of periodontal disease|1|||
48835736|NCT02026258|157240796|FG001|Randomized|Presence of periodontal disease|1|||
48835737|NCT02026258|157240795|FG000|Recieved Allocated Intervention|Withdrawal by Subject|1|||
48835738|NCT02026258|157240796|FG001|Recieved Allocated Intervention|Withdrawal by Subject|1|||
48835739|NCT02026258|157240795|FG000|Recieved Allocated Intervention|Lost to Follow-up|0|||
48835740|NCT02026258|157240796|FG001|Recieved Allocated Intervention|Lost to Follow-up|1|||
49162554|NCT01206517|158433708|FG001|Overall Study|Withdrawal by Subject|0|||
49162555|NCT01206517|158433709|FG002|Overall Study|Withdrawal by Subject|2|||
49162556|NCT01206517|158433710|FG003|Overall Study|Withdrawal by Subject|0|||
49162557|NCT01206517|158433711|FG004|Overall Study|Withdrawal by Subject|1|||
49162558|NCT01206517|158433712|FG005|Overall Study|Withdrawal by Subject|0|||
49162559|NCT00560508|158433714|FG000|12 Week Double-blind Period|Adverse Event|3|||
48835741|NCT04439799|157240797|FG000|Overall Study|Lost to Follow-up|6|||
48835742|NCT04439799|157240798|FG001|Overall Study|Lost to Follow-up|6|||
48835743|NCT04439799|157240797|FG000|Overall Study|Withdrawal by Subject|2|||
49162560|NCT00560508|158433715|FG001|12 Week Double-blind Period|Adverse Event|2|||
48835744|NCT04439799|157240798|FG001|Overall Study|Withdrawal by Subject|6|||
48835745|NCT04439799|157240797|FG000|Overall Study|Adverse Event|2|||
48835746|NCT04439799|157240798|FG001|Overall Study|Adverse Event|5|||
48835747|NCT00845832|157240799|FG000|Treatment Period|Adverse Event|0|||
48835748|NCT00845832|157240800|FG001|Treatment Period|Adverse Event|2|||
48835749|NCT00845832|157240801|FG002|Treatment Period|Adverse Event|0|||
48835750|NCT00845832|157240799|FG000|Treatment Period|Protocol Violation|1|||
48835751|NCT00845832|157240800|FG001|Treatment Period|Protocol Violation|1|||
49162561|NCT00560508|158433714|FG000|12 Week Double-blind Period|Protocol Violation|1|||
48835752|NCT00845832|157240801|FG002|Treatment Period|Protocol Violation|0|||
48835753|NCT00845832|157240799|FG000|Safety Follow-Up|Withdrawal by Subject|1|||
48835754|NCT00845832|157240800|FG001|Safety Follow-Up|Withdrawal by Subject|0|||
48835755|NCT00845832|157240801|FG002|Safety Follow-Up|Withdrawal by Subject|0|||
48835756|NCT00845832|157240799|FG000|Extended Safety Follow-Up|Withdrawal by Subject|0|||
48835757|NCT00845832|157240800|FG001|Extended Safety Follow-Up|Withdrawal by Subject|0|||
49162562|NCT00560508|158433715|FG001|12 Week Double-blind Period|Protocol Violation|0|||
49162563|NCT00560508|158433714|FG000|12 Week Double-blind Period|Withdrawal by Subject|1|||
49162564|NCT00560508|158433715|FG001|12 Week Double-blind Period|Withdrawal by Subject|1|||
49162565|NCT00560508|158433714|FG000|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
49162566|NCT00560508|158433715|FG001|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
48835758|NCT00845832|157240801|FG002|Extended Safety Follow-Up|Withdrawal by Subject|7|||
48835759|NCT01391130|157240803|FG000|Overall Study|Withdrawal by Subject|3|||
48835760|NCT01391130|157240804|FG001|Overall Study|Withdrawal by Subject|2|||
48835761|NCT01391130|157240803|FG000|Overall Study|Physician Decision|2|||
48835762|NCT01391130|157240804|FG001|Overall Study|Physician Decision|3|||
48835763|NCT01391130|157240803|FG000|Overall Study|Did not Receive Drug|1|||
49162567|NCT00560508|158433714|FG000|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
49162568|NCT00560508|158433715|FG001|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
49162569|NCT00560508|158433714|FG000|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0|||
49162570|NCT00560508|158433715|FG001|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3|||
49162571|NCT00560508|158433714|FG000|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
49162572|NCT00560508|158433715|FG001|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
49162573|NCT01192126|158433716|FG000|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1|||
49162574|NCT01192126|158433717|FG001|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0|||
49162575|NCT01192126|158433716|FG000|First Intervention (1 Week)|Lost to Follow-up|1|||
49162576|NCT01192126|158433717|FG001|First Intervention (1 Week)|Lost to Follow-up|1|||
49162577|NCT01354223|158433718|FG000|Overall Study|Withdrawal by Subject|3|||
49162578|NCT01354223|158433719|FG001|Overall Study|Withdrawal by Subject|1|||
49162579|NCT04102007|158433723|FG000|Overall Study|Adverse Event|4|||
49162580|NCT04102007|158433723|FG000|Overall Study|Lost to Follow-up|3|||
49162581|NCT04102007|158433723|FG000|Overall Study|Withdrawal by Subject|12|||
49162582|NCT04102007|158433723|FG000|Overall Study|Eligibility Violation|5|||
49162583|NCT04102007|158433723|FG000|Overall Study|Lack of Efficacy|6|||
49162584|NCT04102007|158433723|FG000|Overall Study|Protocol Deviation|5|||
49162585|NCT04102007|158433723|FG000|Overall Study|Protocol Compliance|1|||
49162586|NCT04102007|158433723|FG000|Overall Study|Withdrew Treatment|2|||
49162587|NCT04102007|158433723|FG000|Overall Study|Pregnancy|1|||
49162588|NCT00692003|158433726|FG000|Overall Study|Sponsor Decision|5|||
49162589|NCT00692003|158433727|FG001|Overall Study|Sponsor Decision|1|||
49162590|NCT03289143|158433728|FG000|Overall Study|Caregiver Unavailability|1|||
49162591|NCT03289143|158433729|FG001|Overall Study|Caregiver Unavailability|1|||
49162592|NCT03289143|158433730|FG002|Overall Study|Caregiver Unavailability|0|||
49162593|NCT03289143|158433731|FG003|Overall Study|Caregiver Unavailability|0|||
49162594|NCT03289143|158433728|FG000|Overall Study|Research Department Closure|0|||
49162595|NCT03289143|158433729|FG001|Overall Study|Research Department Closure|0|||
49162596|NCT03289143|158433730|FG002|Overall Study|Research Department Closure|1|||
49162597|NCT03289143|158433731|FG003|Overall Study|Research Department Closure|0|||
49162598|NCT03289143|158433728|FG000|Overall Study|Caregiver and Participant Withdrew Consent|0|||
49162599|NCT03289143|158433729|FG001|Overall Study|Caregiver and Participant Withdrew Consent|0|||
49162600|NCT03289143|158433730|FG002|Overall Study|Caregiver and Participant Withdrew Consent|1|||
49162601|NCT03289143|158433731|FG003|Overall Study|Caregiver and Participant Withdrew Consent|0|||
48835764|NCT01391130|157240804|FG001|Overall Study|Did not Receive Drug|1|||
48835765|NCT04347954|157240805|FG000|Overall Study|Did not present to study site for allocated intervention|3|||
48835766|NCT04347954|157240806|FG001|Overall Study|Did not present to study site for allocated intervention|0|||
48835767|NCT04347954|157240807|FG002|Overall Study|Did not present to study site for allocated intervention|3|||
48835768|NCT04347954|157240805|FG000|Overall Study|Lost to Follow-up|0|||
48835769|NCT04347954|157240806|FG001|Overall Study|Lost to Follow-up|1|||
48835770|NCT04347954|157240807|FG002|Overall Study|Lost to Follow-up|0|||
48835771|NCT02534350|157240808|FG000|Overall Study|Randomized But Not Treated|1|||
49162602|NCT03289143|158433728|FG000|Overall Study|Medical Monitor Decision|1|||
49162603|NCT03289143|158433729|FG001|Overall Study|Medical Monitor Decision|0|||
49162604|NCT03289143|158433730|FG002|Overall Study|Medical Monitor Decision|0|||
49162605|NCT03289143|158433731|FG003|Overall Study|Medical Monitor Decision|0|||
49162606|NCT03289143|158433728|FG000|Overall Study|Participant Non-Compliance|0|||
49162607|NCT03289143|158433729|FG001|Overall Study|Participant Non-Compliance|0|||
49162608|NCT03289143|158433730|FG002|Overall Study|Participant Non-Compliance|1|||
49162609|NCT03289143|158433731|FG003|Overall Study|Participant Non-Compliance|0|||
49162610|NCT03289143|158433728|FG000|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
49162611|NCT03289143|158433729|FG001|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
49162612|NCT03289143|158433730|FG002|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|1|||
48835772|NCT02534350|157240809|FG001|Overall Study|Randomized But Not Treated|0|||
49162613|NCT03289143|158433731|FG003|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
49162614|NCT03289143|158433728|FG000|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
49162615|NCT03289143|158433729|FG001|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
49162616|NCT03289143|158433730|FG002|Overall Study|Participant Non Compliance With Concomitant Medications|1|||
48835773|NCT02534350|157240808|FG000|Overall Study|Protocol Violation|1|||
48835774|NCT02534350|157240809|FG001|Overall Study|Protocol Violation|0|||
48835775|NCT02534350|157240808|FG000|Overall Study|Withdrew Consent|2|||
48835776|NCT02534350|157240809|FG001|Overall Study|Withdrew Consent|0|||
48835777|NCT00716144|157240813|FG000|Overall Study|Withdrawal by Subject|4|||
49162617|NCT03289143|158433731|FG003|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
49162618|NCT03289143|158433728|FG000|Overall Study|Caregiver Passed Away|1|||
49162619|NCT03289143|158433729|FG001|Overall Study|Caregiver Passed Away|0|||
49162620|NCT03289143|158433730|FG002|Overall Study|Caregiver Passed Away|0|||
48835778|NCT00716144|157240814|FG001|Overall Study|Withdrawal by Subject|2|||
49162621|NCT03289143|158433731|FG003|Overall Study|Caregiver Passed Away|0|||
49162622|NCT03289143|158433728|FG000|Overall Study|Physician Decision|0|||
49162623|NCT03289143|158433729|FG001|Overall Study|Physician Decision|2|||
48835779|NCT00716144|157240815|FG002|Overall Study|Withdrawal by Subject|6|||
48923705|NCT01192022|157555196|FG001|Overall Study|Lost to Follow-up|2|||
49162624|NCT03289143|158433730|FG002|Overall Study|Physician Decision|2|||
49162625|NCT03289143|158433731|FG003|Overall Study|Physician Decision|2|||
49162626|NCT03289143|158433728|FG000|Overall Study|Protocol Deviation|2|||
49162627|NCT03289143|158433729|FG001|Overall Study|Protocol Deviation|1|||
49162628|NCT03289143|158433730|FG002|Overall Study|Protocol Deviation|3|||
49162629|NCT03289143|158433731|FG003|Overall Study|Protocol Deviation|1|||
49162630|NCT03289143|158433728|FG000|Overall Study|Study Terminated By Sponsor|101|||
49162631|NCT03289143|158433729|FG001|Overall Study|Study Terminated By Sponsor|75|||
49162632|NCT03289143|158433730|FG002|Overall Study|Study Terminated By Sponsor|100|||
49162633|NCT03289143|158433731|FG003|Overall Study|Study Terminated By Sponsor|69|||
49162634|NCT03289143|158433728|FG000|Overall Study|Withdrawal by Subject|14|||
49162635|NCT03289143|158433729|FG001|Overall Study|Withdrawal by Subject|6|||
49162636|NCT03289143|158433730|FG002|Overall Study|Withdrawal by Subject|14|||
49162637|NCT03289143|158433731|FG003|Overall Study|Withdrawal by Subject|12|||
49162638|NCT03289143|158433728|FG000|Overall Study|Adverse Event|10|||
49162639|NCT03289143|158433729|FG001|Overall Study|Adverse Event|7|||
49162640|NCT03289143|158433730|FG002|Overall Study|Adverse Event|6|||
49162641|NCT03289143|158433731|FG003|Overall Study|Adverse Event|5|||
49162642|NCT03289143|158433728|FG000|Overall Study|Death|2|||
49162643|NCT03289143|158433729|FG001|Overall Study|Death|0|||
49162644|NCT03289143|158433730|FG002|Overall Study|Death|2|||
49162645|NCT03289143|158433731|FG003|Overall Study|Death|1|||
49162646|NCT03289143|158433728|FG000|Overall Study|Lost to Follow-up|2|||
49162647|NCT03289143|158433729|FG001|Overall Study|Lost to Follow-up|1|||
49162648|NCT03289143|158433730|FG002|Overall Study|Lost to Follow-up|1|||
49162649|NCT03289143|158433731|FG003|Overall Study|Lost to Follow-up|0|||
49162650|NCT03289143|158433728|FG000|Overall Study|Participant No Longer Has Study Partner|0|||
49162651|NCT03289143|158433729|FG001|Overall Study|Participant No Longer Has Study Partner|0|||
49162652|NCT03289143|158433730|FG002|Overall Study|Participant No Longer Has Study Partner|0|||
49162653|NCT03289143|158433731|FG003|Overall Study|Participant No Longer Has Study Partner|1|||
49162654|NCT03289143|158433728|FG000|Overall Study|Withdrawal by Caregiver|0|||
49162655|NCT03289143|158433729|FG001|Overall Study|Withdrawal by Caregiver|1|||
49162656|NCT03289143|158433730|FG002|Overall Study|Withdrawal by Caregiver|0|||
49162657|NCT03289143|158433731|FG003|Overall Study|Withdrawal by Caregiver|0|||
49162658|NCT03289143|158433728|FG000|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
49162659|NCT03289143|158433729|FG001|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
49162660|NCT03289143|158433730|FG002|Overall Study|Caregiver Passed Away & Family Moved Out of State|1|||
48923706|NCT01192022|157555197|FG002|Overall Study|Lost to Follow-up|1|||
49162661|NCT03289143|158433731|FG003|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
49162662|NCT03289143|158433728|FG000|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
49162663|NCT03289143|158433729|FG001|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
49162664|NCT03289143|158433730|FG002|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
49162665|NCT03289143|158433731|FG003|Overall Study|Absence of Consistent and Reliable Caregiver|1|||
49162666|NCT04950660|158433732|FG000|Overall Study|Protocol Violation|4|||
49162667|NCT04950660|158433733|FG001|Overall Study|Protocol Violation|2|||
49162668|NCT04950660|158433732|FG000|Overall Study|Poor pain control, switch to Oxycodone|1|||
49162669|NCT04950660|158433733|FG001|Overall Study|Poor pain control, switch to Oxycodone|1|||
49162670|NCT04950660|158433732|FG000|Overall Study|Withdrawal by Subject|0|||
49162671|NCT04950660|158433733|FG001|Overall Study|Withdrawal by Subject|1|||
49162672|NCT04950660|158433732|FG000|Overall Study|Hypotension|1|||
49162673|NCT04950660|158433733|FG001|Overall Study|Hypotension|0|||
49162674|NCT00339040|158433734|FG000|Stage I|Not able to attend clinic|1|||
49162675|NCT00339040|158433735|FG001|Stage I|Not able to attend clinic|0|||
49162676|NCT00339040|158433734|FG000|Stage I|Protocol Violation|1|||
49162677|NCT00339040|158433735|FG001|Stage I|Protocol Violation|1|||
49162678|NCT00339040|158433734|FG000|Stage II|Lost to Follow-up|3|||
49162679|NCT00339040|158433735|FG001|Stage II|Lost to Follow-up|0|||
49162680|NCT00339040|158433734|FG000|Stage II|Withdrawal by Subject|1|||
49162681|NCT00339040|158433735|FG001|Stage II|Withdrawal by Subject|2|||
49162682|NCT00339040|158433734|FG000|Stage II|Protocol Violation|3|||
49162683|NCT00339040|158433735|FG001|Stage II|Protocol Violation|0|||
49162684|NCT00339040|158433734|FG000|Stage II|Not able to attend clinic|1|||
49162685|NCT00339040|158433735|FG001|Stage II|Not able to attend clinic|0|||
49162686|NCT00339040|158433734|FG000|Stage II|Site closing|2|||
49162687|NCT00339040|158433735|FG001|Stage II|Site closing|0|||
49162688|NCT02136914|158433738|FG000|Overall Study|Sponsor's Decision to Stop the Study|7|||
49162689|NCT02136914|158433739|FG001|Overall Study|Sponsor's Decision to Stop the Study|7|||
49162690|NCT02136914|158433738|FG000|Overall Study|Withdrawal by Subject|3|||
49162691|NCT02136914|158433739|FG001|Overall Study|Withdrawal by Subject|10|||
49162692|NCT02136914|158433738|FG000|Overall Study|Subject Unwilling to Proceed|7|||
49162693|NCT02136914|158433739|FG001|Overall Study|Subject Unwilling to Proceed|2|||
49162694|NCT02136914|158433738|FG000|Overall Study|Lost to Follow-up|1|||
49162695|NCT02136914|158433739|FG001|Overall Study|Lost to Follow-up|1|||
49162696|NCT02136914|158433738|FG000|Overall Study|Did Not Receive Study Drug|2|||
49162697|NCT02136914|158433739|FG001|Overall Study|Did Not Receive Study Drug|0|||
49162698|NCT02136914|158433738|FG000|Overall Study|Lack of Efficacy|1|||
49162699|NCT02136914|158433739|FG001|Overall Study|Lack of Efficacy|0|||
49162700|NCT02136914|158433738|FG000|Overall Study|Death|0|||
49162701|NCT02136914|158433739|FG001|Overall Study|Death|1|||
49162702|NCT03692403|158433741|FG000|Overall Study|Withdrawal by Subject|1|||
49162703|NCT03692403|158433742|FG001|Overall Study|Withdrawal by Subject|0|||
49162704|NCT03692403|158433743|FG002|Overall Study|Withdrawal by Subject|1|||
49162705|NCT03692403|158433744|FG003|Overall Study|Withdrawal by Subject|0|||
49162706|NCT03692403|158433741|FG000|Overall Study|Adverse Event|0|||
49162707|NCT03692403|158433742|FG001|Overall Study|Adverse Event|0|||
49162708|NCT03692403|158433743|FG002|Overall Study|Adverse Event|0|||
49162709|NCT03692403|158433744|FG003|Overall Study|Adverse Event|1|||
49162710|NCT03692403|158433741|FG000|Overall Study|Pregnancy|0|||
49162711|NCT03692403|158433742|FG001|Overall Study|Pregnancy|1|||
49162712|NCT03692403|158433743|FG002|Overall Study|Pregnancy|0|||
49162713|NCT03692403|158433744|FG003|Overall Study|Pregnancy|0|||
49162714|NCT03692403|158433741|FG000|Overall Study|Other|0|||
49162715|NCT03692403|158433742|FG001|Overall Study|Other|0|||
49162716|NCT03692403|158433743|FG002|Overall Study|Other|1|||
49162717|NCT03692403|158433744|FG003|Overall Study|Other|0|||
49162718|NCT04567524|158433745|FG000|Overall Study|Adverse Event|1|||
49162719|NCT04567524|158433746|FG001|Overall Study|Adverse Event|1|||
49162720|NCT04567524|158433747|FG002|Overall Study|Adverse Event|0|||
49162721|NCT04567524|158433748|FG003|Overall Study|Adverse Event|0|||
49162722|NCT04567524|158433745|FG000|Overall Study|Withdrawal by Subject|2|||
49162723|NCT04567524|158433746|FG001|Overall Study|Withdrawal by Subject|0|||
49162724|NCT04567524|158433747|FG002|Overall Study|Withdrawal by Subject|0|||
49162725|NCT04567524|158433748|FG003|Overall Study|Withdrawal by Subject|1|||
49162726|NCT01008618|158433751|FG000|Period 1 (Titration Period)|Physician Decision|2|||
49162727|NCT01008618|158433752|FG001|Period 1 (Titration Period)|Physician Decision|0|||
49162728|NCT01008618|158433753|FG002|Period 1 (Titration Period)|Physician Decision|0|||
49162729|NCT01008618|158433751|FG000|Period 1 (Titration Period)|Adverse Event|33|||
49162730|NCT01008618|158433752|FG001|Period 1 (Titration Period)|Adverse Event|0|||
49162731|NCT01008618|158433753|FG002|Period 1 (Titration Period)|Adverse Event|0|||
49162732|NCT01008618|158433751|FG000|Period 1 (Titration Period)|Withdrawal by Subject|11|||
49162733|NCT01008618|158433752|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
49162734|NCT01008618|158433753|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
49162735|NCT01008618|158433751|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20|||
49162736|NCT01008618|158433752|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
49162737|NCT01008618|158433753|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
49162738|NCT01008618|158433751|FG000|Period 1 (Titration Period)|Aggravated symptom|2|||
49162739|NCT01008618|158433752|FG001|Period 1 (Titration Period)|Aggravated symptom|0|||
49162740|NCT01008618|158433753|FG002|Period 1 (Titration Period)|Aggravated symptom|0|||
49162741|NCT01008618|158433751|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
49162742|NCT01008618|158433752|FG001|Period 2 (Double-Blind Period)|Adverse Event|11|||
49162743|NCT01008618|158433753|FG002|Period 2 (Double-Blind Period)|Adverse Event|2|||
49162744|NCT01008618|158433751|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
49162745|NCT01008618|158433752|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|3|||
49162746|NCT01008618|158433753|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
49162747|NCT01008618|158433751|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
49162748|NCT01008618|158433752|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
49162749|NCT01008618|158433753|FG002|Period 2 (Double-Blind Period)|Physician Decision|0|||
49162750|NCT01008618|158433751|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
49162751|NCT01008618|158433752|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
49162752|NCT01008618|158433753|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3|||
49162753|NCT01008618|158433751|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
49162754|NCT01008618|158433752|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
49162755|NCT01008618|158433753|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
49162756|NCT01008618|158433751|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
49162757|NCT01008618|158433752|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21|||
48835780|NCT00716144|157240816|FG003|Overall Study|Withdrawal by Subject|6|||
48835781|NCT00716144|157240813|FG000|Overall Study|Lost to Follow-up|2|||
48835782|NCT00716144|157240814|FG001|Overall Study|Lost to Follow-up|2|||
48835783|NCT00716144|157240815|FG002|Overall Study|Lost to Follow-up|1|||
48835784|NCT00716144|157240816|FG003|Overall Study|Lost to Follow-up|2|||
48835785|NCT00716144|157240813|FG000|Overall Study|Adverse Event|0|||
48835786|NCT00716144|157240814|FG001|Overall Study|Adverse Event|0|||
48835787|NCT00716144|157240815|FG002|Overall Study|Adverse Event|0|||
48835788|NCT00716144|157240816|FG003|Overall Study|Adverse Event|2|||
48835789|NCT00716144|157240813|FG000|Overall Study|Non-compliance|1|||
48835790|NCT00716144|157240814|FG001|Overall Study|Non-compliance|0|||
48835791|NCT00716144|157240815|FG002|Overall Study|Non-compliance|0|||
48835792|NCT00716144|157240816|FG003|Overall Study|Non-compliance|0|||
48835793|NCT00716144|157240813|FG000|Overall Study|Protocol Violation|2|||
48835794|NCT00716144|157240814|FG001|Overall Study|Protocol Violation|0|||
48835795|NCT00716144|157240815|FG002|Overall Study|Protocol Violation|1|||
48835796|NCT00716144|157240816|FG003|Overall Study|Protocol Violation|0|||
48835797|NCT00716144|157240813|FG000|Overall Study|Physician Decision|0|||
48835798|NCT00716144|157240814|FG001|Overall Study|Physician Decision|1|||
48835799|NCT00716144|157240815|FG002|Overall Study|Physician Decision|2|||
48835800|NCT00716144|157240816|FG003|Overall Study|Physician Decision|2|||
48835801|NCT00716144|157240813|FG000|Overall Study|Intercurrent illness|0|||
49162758|NCT01008618|158433753|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29|||
49162759|NCT01008618|158433751|FG000|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
49162760|NCT01008618|158433752|FG001|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
49162761|NCT01008618|158433753|FG002|Period 2 (Double-Blind Period)|Not appropriate for this study|1|||
49162762|NCT00487981|158433754|FG000|Overall Study|Hypothyroidism diagnosis|1|||
49162763|NCT00698828|158433757|FG000|Overall Study|Adverse Event|3|||
49162764|NCT00698828|158433758|FG001|Overall Study|Adverse Event|4|||
49162765|NCT00698828|158433759|FG002|Overall Study|Adverse Event|4|||
49162766|NCT00698828|158433757|FG000|Overall Study|Death|0|||
48923707|NCT01192022|157555198|FG003|Overall Study|Lost to Follow-up|1|||
48923708|NCT01192022|157555199|FG004|Overall Study|Lost to Follow-up|0|||
48923709|NCT01192022|157555195|FG000|Overall Study|Adverse Event|1|||
48923710|NCT01192022|157555196|FG001|Overall Study|Adverse Event|0|||
48923711|NCT01192022|157555197|FG002|Overall Study|Adverse Event|0|||
48923712|NCT01192022|157555198|FG003|Overall Study|Adverse Event|0|||
48923713|NCT01192022|157555199|FG004|Overall Study|Adverse Event|0|||
48923714|NCT01192022|157555195|FG000|Overall Study|Fatal Adverse Event|4|||
48923715|NCT01192022|157555196|FG001|Overall Study|Fatal Adverse Event|6|||
48923716|NCT01192022|157555197|FG002|Overall Study|Fatal Adverse Event|0|||
48923717|NCT01192022|157555198|FG003|Overall Study|Fatal Adverse Event|0|||
48923718|NCT01192022|157555199|FG004|Overall Study|Fatal Adverse Event|1|||
48923719|NCT01192022|157555195|FG000|Overall Study|Physician withdrew-patient hardship|1|||
49162767|NCT00698828|158433758|FG001|Overall Study|Death|0|||
49162768|NCT00698828|158433759|FG002|Overall Study|Death|1|||
49162769|NCT00698828|158433757|FG000|Overall Study|Exacerbation of COPD|1|||
49162770|NCT00698828|158433758|FG001|Overall Study|Exacerbation of COPD|3|||
49162771|NCT00698828|158433759|FG002|Overall Study|Exacerbation of COPD|0|||
49162772|NCT00698828|158433757|FG000|Overall Study|Exacerbation of COPD (Not treated)|1|||
49162773|NCT00698828|158433758|FG001|Overall Study|Exacerbation of COPD (Not treated)|0|||
49162774|NCT00698828|158433759|FG002|Overall Study|Exacerbation of COPD (Not treated)|0|||
49162775|NCT00698828|158433757|FG000|Overall Study|Investigator/Sponsor decision|1|||
49162776|NCT00698828|158433758|FG001|Overall Study|Investigator/Sponsor decision|0|||
49162777|NCT00698828|158433759|FG002|Overall Study|Investigator/Sponsor decision|2|||
49162778|NCT00698828|158433757|FG000|Overall Study|Lost to Follow-up|1|||
49162779|NCT00698828|158433758|FG001|Overall Study|Lost to Follow-up|1|||
49162780|NCT00698828|158433759|FG002|Overall Study|Lost to Follow-up|0|||
49162781|NCT00698828|158433757|FG000|Overall Study|Withdrew consent|0|||
49162782|NCT00698828|158433758|FG001|Overall Study|Withdrew consent|7|||
48835802|NCT00716144|157240814|FG001|Overall Study|Intercurrent illness|0|||
49162783|NCT00698828|158433759|FG002|Overall Study|Withdrew consent|4|||
48835803|NCT00716144|157240815|FG002|Overall Study|Intercurrent illness|1|||
48835804|NCT00716144|157240816|FG003|Overall Study|Intercurrent illness|0|||
48835805|NCT00716144|157240813|FG000|Overall Study|Withdrew consent, allowed use of data|0|||
48835806|NCT00716144|157240814|FG001|Overall Study|Withdrew consent, allowed use of data|0|||
48835807|NCT00716144|157240815|FG002|Overall Study|Withdrew consent, allowed use of data|1|||
48835808|NCT00716144|157240816|FG003|Overall Study|Withdrew consent, allowed use of data|0|||
48835809|NCT00716144|157240813|FG000|Overall Study|Adverse event: left foot pain|0|||
48835810|NCT00716144|157240814|FG001|Overall Study|Adverse event: left foot pain|1|||
48835811|NCT00716144|157240815|FG002|Overall Study|Adverse event: left foot pain|0|||
48835812|NCT00716144|157240816|FG003|Overall Study|Adverse event: left foot pain|0|||
49162784|NCT00698828|158433757|FG000|Overall Study|Withdrew consent (not treated)|2|||
49162785|NCT00698828|158433758|FG001|Overall Study|Withdrew consent (not treated)|0|||
48835813|NCT00716144|157240813|FG000|Overall Study|Clinical Depression|0|||
48923720|NCT01192022|157555196|FG001|Overall Study|Physician withdrew-patient hardship|0|||
49162786|NCT00698828|158433759|FG002|Overall Study|Withdrew consent (not treated)|0|||
48923721|NCT01192022|157555197|FG002|Overall Study|Physician withdrew-patient hardship|0|||
48923722|NCT01192022|157555198|FG003|Overall Study|Physician withdrew-patient hardship|0|||
48923723|NCT01192022|157555199|FG004|Overall Study|Physician withdrew-patient hardship|0|||
49162787|NCT01788943|158433762|FG000|Overall Study|Withdrawal by Subject|1|||
49162788|NCT01788943|158433763|FG001|Overall Study|Withdrawal by Subject|0|||
48923724|NCT01192022|157555195|FG000|Overall Study|Patient too sick from chemotherapy|0|||
48835814|NCT00716144|157240814|FG001|Overall Study|Clinical Depression|1|||
48835815|NCT00716144|157240815|FG002|Overall Study|Clinical Depression|0|||
48835816|NCT00716144|157240816|FG003|Overall Study|Clinical Depression|0|||
48835817|NCT02425111|157240822|FG000|Part A: Treatment Period|Pretreatment Event/Adverse Event|2|||
48835818|NCT02425111|157240822|FG000|Part A: Treatment Period|Lack of Efficacy|15|||
48835819|NCT02425111|157240822|FG000|Part A: Treatment Period|Voluntary Withdrawal|4|||
48835820|NCT02425111|157240822|FG000|Part A: Treatment Period|Lost to Follow-up|2|||
48835821|NCT02425111|157240822|FG000|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3|||
48835822|NCT02425111|157240822|FG000|Part B: Treatment Extension Period|Lack of Efficacy|7|||
48835823|NCT03383146|157240823|FG000|Overall Study|Screen Failure|1|||
48835824|NCT03383146|157240824|FG001|Overall Study|Screen Failure|0|||
48835825|NCT03383146|157240823|FG000|Overall Study|Adverse Event|6|||
48835826|NCT03383146|157240824|FG001|Overall Study|Adverse Event|18|||
48835827|NCT03383146|157240823|FG000|Overall Study|Lack of Efficacy|0|||
48835828|NCT03383146|157240824|FG001|Overall Study|Lack of Efficacy|3|||
48835829|NCT03383146|157240823|FG000|Overall Study|Withdrawal by Subject|20|||
48835830|NCT03383146|157240824|FG001|Overall Study|Withdrawal by Subject|36|||
48835831|NCT03383146|157240823|FG000|Overall Study|Lost to Follow-up|5|||
48835832|NCT03383146|157240824|FG001|Overall Study|Lost to Follow-up|15|||
49014686|NCT04634409|157888931|FG008|Overall Study|Other - As reported by Investigator|4|||
49014687|NCT04634409|157888932|FG009|Overall Study|Other - As reported by Investigator|0|||
49014688|NCT04634409|157888933|FG010|Overall Study|Other - As reported by Investigator|1|||
49014689|NCT04634409|157888934|FG011|Overall Study|Other - As reported by Investigator|2|||
49014690|NCT04634409|157888935|FG012|Overall Study|Other - As reported by Investigator|2|||
49014691|NCT04634409|157888936|FG013|Overall Study|Other - As reported by Investigator|1|||
49014692|NCT04634409|157888937|FG014|Overall Study|Other - As reported by Investigator|0|||
49014693|NCT04634409|157888938|FG015|Overall Study|Other - As reported by Investigator|0|||
49014694|NCT04634409|157888939|FG016|Overall Study|Other - As reported by Investigator|0|||
49014695|NCT04634409|157888940|FG017|Overall Study|Other - As reported by Investigator|0|||
49014696|NCT04634409|157888941|FG018|Overall Study|Other - As reported by Investigator|0|||
49014697|NCT04634409|157888942|FG019|Overall Study|Other - As reported by Investigator|0|||
49014698|NCT04634409|157888943|FG020|Overall Study|Other - As reported by Investigator|0|||
49014699|NCT04634409|157888944|FG021|Overall Study|Other - As reported by Investigator|0|||
49014700|NCT04634409|157888945|FG022|Overall Study|Other - As reported by Investigator|0|||
49014701|NCT04634409|157888946|FG023|Overall Study|Other - As reported by Investigator|0|||
49014702|NCT04634409|157888947|FG024|Overall Study|Other - As reported by Investigator|0|||
49014703|NCT04634409|157888948|FG025|Overall Study|Other - As reported by Investigator|0|||
49162789|NCT04241068|158433769|FG000|Core Treatment Period|Adverse Event|91|||
49162790|NCT04241068|158433769|FG000|Core Treatment Period|Change of Treatment|4|||
49162791|NCT04241068|158433769|FG000|Core Treatment Period|Consent Withdrawn|143|||
49162792|NCT04241068|158433769|FG000|Core Treatment Period|Death|26|||
49162793|NCT04241068|158433769|FG000|Core Treatment Period|Disease Progression|67|||
49162794|NCT04241068|158433769|FG000|Core Treatment Period|Investigator Decision|40|||
49162795|NCT04241068|158433769|FG000|Core Treatment Period|Loss of Capacity|9|||
49162796|NCT04241068|158433769|FG000|Core Treatment Period|Lost to Follow-up|11|||
49162797|NCT04241068|158433769|FG000|Core Treatment Period|Relocation|4|||
49162798|NCT04241068|158433769|FG000|Core Treatment Period|Study Terminated by Sponsor|1|||
49162799|NCT04241068|158433769|FG000|Core Treatment Period|Study Visit Burden|40|||
49162800|NCT04241068|158433769|FG000|Core Treatment Period|Withdrawal by Guardian/caretaker|99|||
49162801|NCT04241068|158433769|FG000|Core Treatment Period|Missing|2|||
49162802|NCT04241068|158433769|FG000|Core Treatment Period|Reason Not Specified|41|||
49162803|NCT04241068|158433769|FG000|LTE Period|Adverse Event|19|||
49162804|NCT04241068|158433769|FG000|LTE Period|Change of Treatment|1|||
49162805|NCT04241068|158433769|FG000|LTE Period|Consent Withdrawn|71|||
48835833|NCT03383146|157240823|FG000|Overall Study|Death|0|||
48835834|NCT03383146|157240824|FG001|Overall Study|Death|2|||
48835835|NCT03383146|157240823|FG000|Overall Study|Physician Decision|0|||
48835836|NCT03383146|157240824|FG001|Overall Study|Physician Decision|1|||
48835837|NCT03383146|157240823|FG000|Overall Study|Protocol Deviation|1|||
49162806|NCT04241068|158433769|FG000|LTE Period|Death|8|||
49162807|NCT04241068|158433769|FG000|LTE Period|Disease Progression|11|||
49162808|NCT04241068|158433769|FG000|LTE Period|Investigator Decision|12|||
49162809|NCT04241068|158433769|FG000|LTE Period|Loss of Capacity|2|||
49162810|NCT04241068|158433769|FG000|LTE Period|Lost to Follow-up|7|||
49162811|NCT04241068|158433769|FG000|LTE Period|Relocation|6|||
49162812|NCT04241068|158433769|FG000|LTE Period|Site Terminated by Sponsor|26|||
49162813|NCT04241068|158433769|FG000|LTE Period|Study Terminated by Sponsor|276|||
49162814|NCT04241068|158433769|FG000|LTE Period|Study Visit Burden|10|||
49162815|NCT04241068|158433769|FG000|LTE Period|Withdrawal by Guardian/caretaker|19|||
49162816|NCT04241068|158433769|FG000|LTE Period|Reason Not Specified|65|||
49162817|NCT04610892|158433771|FG000|Overall Study|Adverse Event|1|||
49162818|NCT04610892|158433772|FG001|Overall Study|Adverse Event|0|||
49162819|NCT04610892|158433773|FG002|Overall Study|Adverse Event|0|||
49162820|NCT04610892|158433774|FG003|Overall Study|Adverse Event|1|||
49162821|NCT04610892|158433775|FG004|Overall Study|Adverse Event|3|||
49162822|NCT04610892|158433771|FG000|Overall Study|Death|0|||
49162823|NCT04610892|158433772|FG001|Overall Study|Death|1|||
48835838|NCT03383146|157240824|FG001|Overall Study|Protocol Deviation|8|||
48835839|NCT03383146|157240823|FG000|Overall Study|Study Terminated by the Sponsor|48|||
48835840|NCT03383146|157240824|FG001|Overall Study|Study Terminated by the Sponsor|95|||
48835841|NCT03383146|157240823|FG000|Overall Study|Reason not Specified|4|||
48835842|NCT03383146|157240824|FG001|Overall Study|Reason not Specified|6|||
48835843|NCT00988637|157240831|FG000|Overall Study|Lost to Follow-up|2|||
48835844|NCT00988637|157240832|FG001|Overall Study|Lost to Follow-up|1|||
48835845|NCT00988637|157240831|FG000|Overall Study|Withdrawal by Subject|1|||
48835846|NCT00988637|157240832|FG001|Overall Study|Withdrawal by Subject|1|||
48835847|NCT00988637|157240831|FG000|Overall Study|non-compliance with study drug|0|||
49162824|NCT04610892|158433773|FG002|Overall Study|Death|0|||
49162825|NCT04610892|158433774|FG003|Overall Study|Death|1|||
49162826|NCT04610892|158433775|FG004|Overall Study|Death|0|||
48835848|NCT00988637|157240832|FG001|Overall Study|non-compliance with study drug|1|||
48835849|NCT02104765|157240835|FG000|Overall Study|Lost to Follow-up|0|||
49162827|NCT04610892|158433771|FG000|Overall Study|Withdrawal by Subject|3|||
49162828|NCT04610892|158433772|FG001|Overall Study|Withdrawal by Subject|2|||
49162829|NCT04610892|158433773|FG002|Overall Study|Withdrawal by Subject|0|||
49162830|NCT04610892|158433774|FG003|Overall Study|Withdrawal by Subject|6|||
49162831|NCT04610892|158433775|FG004|Overall Study|Withdrawal by Subject|6|||
49162832|NCT04610892|158433771|FG000|Overall Study|Subjects who did not receive treatment|1|||
49162833|NCT04610892|158433772|FG001|Overall Study|Subjects who did not receive treatment|0|||
49162834|NCT04610892|158433773|FG002|Overall Study|Subjects who did not receive treatment|0|||
48835850|NCT02104765|157240836|FG001|Overall Study|Lost to Follow-up|0|||
48835851|NCT02104765|157240837|FG002|Overall Study|Lost to Follow-up|1|||
48835852|NCT02104765|157240838|FG003|Overall Study|Lost to Follow-up|0|||
48835853|NCT02104765|157240839|FG004|Overall Study|Lost to Follow-up|0|||
49162835|NCT04610892|158433774|FG003|Overall Study|Subjects who did not receive treatment|0|||
49162836|NCT04610892|158433775|FG004|Overall Study|Subjects who did not receive treatment|2|||
49162837|NCT02980107|158433776|FG000|Overall Study|Withdrawal by Subject|51|||
49162838|NCT02980107|158433777|FG001|Overall Study|Withdrawal by Subject|62|||
49162839|NCT01496976|158434745|FG000|Overall Study|Withdrew - received stem cell transplant|1|||
49162840|NCT00092534|158434746|FG000|Base Study Vaccination Period|Randomized not Vaccinated|5|||
49162841|NCT00092534|158434747|FG001|Base Study Vaccination Period|Randomized not Vaccinated|5|||
49162842|NCT00092534|158434748|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
49162843|NCT00092534|158434749|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
49162844|NCT00092534|158434750|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
49162845|NCT00092534|158434746|FG000|Base Study Vaccination Period|Adverse Event|3|||
49162846|NCT00092534|158434747|FG001|Base Study Vaccination Period|Adverse Event|1|||
49162847|NCT00092534|158434748|FG002|Base Study Vaccination Period|Adverse Event|0|||
49162848|NCT00092534|158434749|FG003|Base Study Vaccination Period|Adverse Event|0|||
48835854|NCT02104765|157240840|FG005|Overall Study|Lost to Follow-up|0|||
48835855|NCT02104765|157240841|FG006|Overall Study|Lost to Follow-up|0|||
48835856|NCT02104765|157240835|FG000|Overall Study|Withdrawal by Subject|0|||
48835857|NCT02104765|157240836|FG001|Overall Study|Withdrawal by Subject|0|||
48835858|NCT02104765|157240837|FG002|Overall Study|Withdrawal by Subject|0|||
48835859|NCT02104765|157240838|FG003|Overall Study|Withdrawal by Subject|1|||
49162849|NCT00092534|158434750|FG004|Base Study Vaccination Period|Adverse Event|0|||
49162850|NCT00092534|158434746|FG000|Base Study Vaccination Period|Death|5|||
49162851|NCT00092534|158434747|FG001|Base Study Vaccination Period|Death|4|||
49162852|NCT00092534|158434748|FG002|Base Study Vaccination Period|Death|0|||
49162853|NCT00092534|158434749|FG003|Base Study Vaccination Period|Death|0|||
49162854|NCT00092534|158434750|FG004|Base Study Vaccination Period|Death|0|||
49162855|NCT00092534|158434746|FG000|Base Study Vaccination Period|Lost to Follow-up|41|||
49162856|NCT00092534|158434747|FG001|Base Study Vaccination Period|Lost to Follow-up|37|||
49162857|NCT00092534|158434748|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
49162858|NCT00092534|158434749|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
49162859|NCT00092534|158434750|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
49162860|NCT00092534|158434746|FG000|Base Study Vaccination Period|Physician Decision|1|||
49162861|NCT00092534|158434747|FG001|Base Study Vaccination Period|Physician Decision|0|||
49162862|NCT00092534|158434748|FG002|Base Study Vaccination Period|Physician Decision|0|||
49162863|NCT00092534|158434749|FG003|Base Study Vaccination Period|Physician Decision|0|||
49162864|NCT00092534|158434750|FG004|Base Study Vaccination Period|Physician Decision|0|||
49162865|NCT00092534|158434746|FG000|Base Study Vaccination Period|Pregnancy|9|||
49162866|NCT00092534|158434747|FG001|Base Study Vaccination Period|Pregnancy|7|||
49162867|NCT00092534|158434748|FG002|Base Study Vaccination Period|Pregnancy|0|||
49162868|NCT00092534|158434749|FG003|Base Study Vaccination Period|Pregnancy|0|||
49162869|NCT00092534|158434750|FG004|Base Study Vaccination Period|Pregnancy|0|||
49162870|NCT00092534|158434746|FG000|Base Study Vaccination Period|Protocol Violation|2|||
49162871|NCT00092534|158434747|FG001|Base Study Vaccination Period|Protocol Violation|1|||
49162872|NCT00092534|158434748|FG002|Base Study Vaccination Period|Protocol Violation|0|||
49162873|NCT00092534|158434749|FG003|Base Study Vaccination Period|Protocol Violation|0|||
49162874|NCT00092534|158434750|FG004|Base Study Vaccination Period|Protocol Violation|0|||
49162875|NCT00092534|158434746|FG000|Base Study Vaccination Period|Withdrawal by Subject|85|||
49162876|NCT00092534|158434747|FG001|Base Study Vaccination Period|Withdrawal by Subject|58|||
49162877|NCT00092534|158434748|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
49162878|NCT00092534|158434749|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
49162879|NCT00092534|158434750|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
49162880|NCT00092534|158434746|FG000|Base Study Vaccination Period|Moved|14|||
48835860|NCT02104765|157240839|FG004|Overall Study|Withdrawal by Subject|1|||
48835861|NCT02104765|157240840|FG005|Overall Study|Withdrawal by Subject|0|||
49162881|NCT00092534|158434747|FG001|Base Study Vaccination Period|Moved|12|||
49162882|NCT00092534|158434748|FG002|Base Study Vaccination Period|Moved|0|||
49162883|NCT00092534|158434749|FG003|Base Study Vaccination Period|Moved|0|||
49162884|NCT00092534|158434750|FG004|Base Study Vaccination Period|Moved|0|||
49162885|NCT00092534|158434746|FG000|Base Study Vaccination Period|New Medical History (Not AEs)|5|||
49162886|NCT00092534|158434747|FG001|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
49162887|NCT00092534|158434748|FG002|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
49162888|NCT00092534|158434749|FG003|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
49162889|NCT00092534|158434750|FG004|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
49162890|NCT00092534|158434746|FG000|Base Study Vaccination Period|Travel|1|||
49162891|NCT00092534|158434747|FG001|Base Study Vaccination Period|Travel|0|||
49162892|NCT00092534|158434748|FG002|Base Study Vaccination Period|Travel|0|||
49162893|NCT00092534|158434749|FG003|Base Study Vaccination Period|Travel|0|||
49162894|NCT00092534|158434750|FG004|Base Study Vaccination Period|Travel|0|||
48835862|NCT02104765|157240841|FG006|Overall Study|Withdrawal by Subject|1|||
49162895|NCT00092534|158434746|FG000|Base Study Vaccination Period|Site Closed|0|||
49162896|NCT00092534|158434747|FG001|Base Study Vaccination Period|Site Closed|1|||
49162897|NCT00092534|158434748|FG002|Base Study Vaccination Period|Site Closed|0|||
49162898|NCT00092534|158434749|FG003|Base Study Vaccination Period|Site Closed|0|||
49162899|NCT00092534|158434750|FG004|Base Study Vaccination Period|Site Closed|0|||
49162900|NCT00092534|158434746|FG000|Base Study Follow-Up Period|Adverse Event|2|||
49162901|NCT00092534|158434747|FG001|Base Study Follow-Up Period|Adverse Event|4|||
49162902|NCT00092534|158434748|FG002|Base Study Follow-Up Period|Adverse Event|0|||
49162903|NCT00092534|158434749|FG003|Base Study Follow-Up Period|Adverse Event|0|||
49162904|NCT00092534|158434750|FG004|Base Study Follow-Up Period|Adverse Event|0|||
49162905|NCT00092534|158434746|FG000|Base Study Follow-Up Period|Death|2|||
49162906|NCT00092534|158434747|FG001|Base Study Follow-Up Period|Death|1|||
49162907|NCT00092534|158434748|FG002|Base Study Follow-Up Period|Death|0|||
49162908|NCT00092534|158434749|FG003|Base Study Follow-Up Period|Death|0|||
49162909|NCT00092534|158434750|FG004|Base Study Follow-Up Period|Death|0|||
49162910|NCT00092534|158434746|FG000|Base Study Follow-Up Period|Lost to Follow-up|120|||
49162911|NCT00092534|158434747|FG001|Base Study Follow-Up Period|Lost to Follow-up|146|||
49162912|NCT00092534|158434748|FG002|Base Study Follow-Up Period|Lost to Follow-up|0|||
49162913|NCT00092534|158434749|FG003|Base Study Follow-Up Period|Lost to Follow-up|0|||
49162914|NCT00092534|158434750|FG004|Base Study Follow-Up Period|Lost to Follow-up|0|||
49162915|NCT00092534|158434746|FG000|Base Study Follow-Up Period|Pregnancy|6|||
49162916|NCT00092534|158434747|FG001|Base Study Follow-Up Period|Pregnancy|10|||
49162917|NCT00092534|158434748|FG002|Base Study Follow-Up Period|Pregnancy|0|||
49162918|NCT00092534|158434749|FG003|Base Study Follow-Up Period|Pregnancy|0|||
48835863|NCT00442117|157240842|FG000|Overall Study|Adverse Event|3|||
48835864|NCT00442117|157240843|FG001|Overall Study|Adverse Event|2|||
49162919|NCT00092534|158434750|FG004|Base Study Follow-Up Period|Pregnancy|0|||
49162920|NCT00092534|158434746|FG000|Base Study Follow-Up Period|Protocol Violation|1|||
49162921|NCT00092534|158434747|FG001|Base Study Follow-Up Period|Protocol Violation|2|||
49162922|NCT00092534|158434748|FG002|Base Study Follow-Up Period|Protocol Violation|0|||
48835865|NCT00442117|157240842|FG000|Overall Study|Lack of Efficacy|2|||
48835866|NCT00442117|157240843|FG001|Overall Study|Lack of Efficacy|6|||
48835867|NCT00442117|157240842|FG000|Overall Study|Lost to Follow-up|1|||
48835868|NCT00442117|157240843|FG001|Overall Study|Lost to Follow-up|2|||
48835869|NCT00442117|157240842|FG000|Overall Study|Withdrawal by Subject|2|||
48835870|NCT00442117|157240843|FG001|Overall Study|Withdrawal by Subject|2|||
48835871|NCT00442117|157240842|FG000|Overall Study|Major Deviation|25|||
49162923|NCT00092534|158434749|FG003|Base Study Follow-Up Period|Protocol Violation|0|||
49162924|NCT00092534|158434750|FG004|Base Study Follow-Up Period|Protocol Violation|0|||
49162925|NCT00092534|158434746|FG000|Base Study Follow-Up Period|Withdrawal by Subject|71|||
49162926|NCT00092534|158434747|FG001|Base Study Follow-Up Period|Withdrawal by Subject|62|||
49162927|NCT00092534|158434748|FG002|Base Study Follow-Up Period|Withdrawal by Subject|0|||
49162928|NCT00092534|158434749|FG003|Base Study Follow-Up Period|Withdrawal by Subject|0|||
49162929|NCT00092534|158434750|FG004|Base Study Follow-Up Period|Withdrawal by Subject|0|||
49162930|NCT00092534|158434746|FG000|Base Study Follow-Up Period|Moved|62|||
49162931|NCT00092534|158434747|FG001|Base Study Follow-Up Period|Moved|58|||
49162932|NCT00092534|158434748|FG002|Base Study Follow-Up Period|Moved|0|||
49162933|NCT00092534|158434749|FG003|Base Study Follow-Up Period|Moved|0|||
49162934|NCT00092534|158434750|FG004|Base Study Follow-Up Period|Moved|0|||
49162935|NCT00092534|158434746|FG000|Base Study Follow-Up Period|Travel|10|||
49162936|NCT00092534|158434747|FG001|Base Study Follow-Up Period|Travel|7|||
49162937|NCT00092534|158434748|FG002|Base Study Follow-Up Period|Travel|0|||
49162938|NCT00092534|158434749|FG003|Base Study Follow-Up Period|Travel|0|||
49162939|NCT00092534|158434750|FG004|Base Study Follow-Up Period|Travel|0|||
49162940|NCT00092534|158434746|FG000|Base Study Follow-Up Period|Site Closed|0|||
49162941|NCT00092534|158434747|FG001|Base Study Follow-Up Period|Site Closed|2|||
49162942|NCT00092534|158434748|FG002|Base Study Follow-Up Period|Site Closed|0|||
49162943|NCT00092534|158434749|FG003|Base Study Follow-Up Period|Site Closed|0|||
49162944|NCT00092534|158434750|FG004|Base Study Follow-Up Period|Site Closed|0|||
49162945|NCT00092534|158434746|FG000|Base Study Follow-Up Period|Subjects continuing|27|||
49162946|NCT00092534|158434747|FG001|Base Study Follow-Up Period|Subjects continuing|31|||
49162947|NCT00092534|158434748|FG002|Base Study Follow-Up Period|Subjects continuing|0|||
49162948|NCT00092534|158434749|FG003|Base Study Follow-Up Period|Subjects continuing|0|||
49162949|NCT00092534|158434750|FG004|Base Study Follow-Up Period|Subjects continuing|0|||
49162950|NCT00092534|158434746|FG000|Base Study Follow-Up Period|Subjects in extension|15|||
49162951|NCT00092534|158434747|FG001|Base Study Follow-Up Period|Subjects in extension|371|||
49162952|NCT00092534|158434748|FG002|Base Study Follow-Up Period|Subjects in extension|0|||
49162953|NCT00092534|158434749|FG003|Base Study Follow-Up Period|Subjects in extension|0|||
49162954|NCT00092534|158434750|FG004|Base Study Follow-Up Period|Subjects in extension|0|||
49162955|NCT00092534|158434746|FG000|Base Study EXT|Lost to Follow-up|0|||
49162956|NCT00092534|158434747|FG001|Base Study EXT|Lost to Follow-up|0|||
49162957|NCT00092534|158434748|FG002|Base Study EXT|Lost to Follow-up|41|||
49162958|NCT00092534|158434749|FG003|Base Study EXT|Lost to Follow-up|0|||
49162959|NCT00092534|158434750|FG004|Base Study EXT|Lost to Follow-up|0|||
49162960|NCT00092534|158434746|FG000|Base Study EXT|Physician Decision|0|||
49162961|NCT00092534|158434747|FG001|Base Study EXT|Physician Decision|0|||
49162962|NCT00092534|158434748|FG002|Base Study EXT|Physician Decision|1|||
49162963|NCT00092534|158434749|FG003|Base Study EXT|Physician Decision|0|||
49162964|NCT00092534|158434750|FG004|Base Study EXT|Physician Decision|0|||
49162965|NCT00092534|158434746|FG000|Base Study EXT|Pregnancy|0|||
49162966|NCT00092534|158434747|FG001|Base Study EXT|Pregnancy|0|||
49162967|NCT00092534|158434748|FG002|Base Study EXT|Pregnancy|12|||
49162968|NCT00092534|158434749|FG003|Base Study EXT|Pregnancy|0|||
49162969|NCT00092534|158434750|FG004|Base Study EXT|Pregnancy|0|||
49162970|NCT00092534|158434746|FG000|Base Study EXT|Withdrawal by Subject|0|||
49162971|NCT00092534|158434747|FG001|Base Study EXT|Withdrawal by Subject|0|||
49162972|NCT00092534|158434748|FG002|Base Study EXT|Withdrawal by Subject|18|||
49162973|NCT00092534|158434749|FG003|Base Study EXT|Withdrawal by Subject|0|||
49162974|NCT00092534|158434750|FG004|Base Study EXT|Withdrawal by Subject|0|||
48835872|NCT00442117|157240843|FG001|Overall Study|Major Deviation|20|||
48835873|NCT00442117|157240842|FG000|Overall Study|Non compliance with protocol|3|||
49162975|NCT00092534|158434746|FG000|Base Study EXT|Participant moved|0|||
49162976|NCT00092534|158434747|FG001|Base Study EXT|Participant moved|0|||
48835874|NCT00442117|157240843|FG001|Overall Study|Non compliance with protocol|5|||
48835875|NCT00442117|157240842|FG000|Overall Study|Met Withdrawal Criteria|2|||
48835876|NCT00442117|157240843|FG001|Overall Study|Met Withdrawal Criteria|1|||
48835877|NCT03863834|157240844|FG000|Overall Study|Lost to Follow-up|3|||
48835878|NCT04009577|157240845|FG000|Core Study|Adverse Event|1|||
48835879|NCT04009577|157240846|FG001|Core Study|Adverse Event|0|||
48835880|NCT04009577|157240847|FG002|Core Study|Adverse Event|2|||
49162977|NCT00092534|158434748|FG002|Base Study EXT|Participant moved|6|||
49162978|NCT00092534|158434749|FG003|Base Study EXT|Participant moved|0|||
49162979|NCT00092534|158434750|FG004|Base Study EXT|Participant moved|0|||
49162980|NCT00092534|158434746|FG000|Base Study EXT|Travel|0|||
49162981|NCT00092534|158434747|FG001|Base Study EXT|Travel|0|||
49162982|NCT00092534|158434748|FG002|Base Study EXT|Travel|2|||
49162983|NCT00092534|158434749|FG003|Base Study EXT|Travel|0|||
49162984|NCT00092534|158434750|FG004|Base Study EXT|Travel|0|||
49162985|NCT00092534|158434746|FG000|Base Study EXT|Site closed|0|||
49162986|NCT00092534|158434747|FG001|Base Study EXT|Site closed|0|||
49162987|NCT00092534|158434748|FG002|Base Study EXT|Site closed|21|||
49162988|NCT00092534|158434749|FG003|Base Study EXT|Site closed|0|||
49162989|NCT00092534|158434750|FG004|Base Study EXT|Site closed|0|||
49162990|NCT00092534|158434746|FG000|Base Study EXT|Study ended|0|||
49162991|NCT00092534|158434747|FG001|Base Study EXT|Study ended|0|||
49162992|NCT00092534|158434748|FG002|Base Study EXT|Study ended|29|||
49162993|NCT00092534|158434749|FG003|Base Study EXT|Study ended|0|||
49162994|NCT00092534|158434750|FG004|Base Study EXT|Study ended|0|||
49162995|NCT00092534|158434746|FG000|Base Study EXT|Protocol Violation|0|||
49162996|NCT00092534|158434747|FG001|Base Study EXT|Protocol Violation|0|||
49162997|NCT00092534|158434748|FG002|Base Study EXT|Protocol Violation|15|||
49162998|NCT00092534|158434749|FG003|Base Study EXT|Protocol Violation|0|||
49162999|NCT00092534|158434750|FG004|Base Study EXT|Protocol Violation|0|||
49163000|NCT00092534|158434746|FG000|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
49163001|NCT00092534|158434747|FG001|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
49163002|NCT00092534|158434748|FG002|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
49163003|NCT00092534|158434749|FG003|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1|||
49163004|NCT00092534|158434750|FG004|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
49163005|NCT04732221|158434755|FG000|Base Period|Death|2|||
49163006|NCT04732221|158434756|FG001|Base Period|Death|0|||
49163007|NCT04732221|158434757|FG002|Base Period|Death|0|||
49163008|NCT04732221|158434758|FG003|Base Period|Death|0|||
49163009|NCT04732221|158434759|FG004|Base Period|Death|0|||
49163010|NCT04732221|158434760|FG005|Base Period|Death|0|||
49163011|NCT04732221|158434761|FG006|Base Period|Death|0|||
49163012|NCT04732221|158434755|FG000|Base Period|Withdrawal by Subject|0|||
49163013|NCT04732221|158434756|FG001|Base Period|Withdrawal by Subject|1|||
49163014|NCT04732221|158434757|FG002|Base Period|Withdrawal by Subject|1|||
49163015|NCT04732221|158434758|FG003|Base Period|Withdrawal by Subject|0|||
49163016|NCT04732221|158434759|FG004|Base Period|Withdrawal by Subject|0|||
49163017|NCT04732221|158434760|FG005|Base Period|Withdrawal by Subject|0|||
49163018|NCT04732221|158434761|FG006|Base Period|Withdrawal by Subject|0|||
49163019|NCT04732221|158434755|FG000|Extension Period|Adverse Event|0|||
49163020|NCT04732221|158434756|FG001|Extension Period|Adverse Event|0|||
49163021|NCT04732221|158434757|FG002|Extension Period|Adverse Event|0|||
49163022|NCT04732221|158434758|FG003|Extension Period|Adverse Event|0|||
49163023|NCT04732221|158434759|FG004|Extension Period|Adverse Event|0|||
49163024|NCT04732221|158434760|FG005|Extension Period|Adverse Event|1|||
49163025|NCT04732221|158434761|FG006|Extension Period|Adverse Event|0|||
49163026|NCT04732221|158434755|FG000|Extension Period|Death|0|||
49163027|NCT04732221|158434756|FG001|Extension Period|Death|0|||
49163028|NCT04732221|158434757|FG002|Extension Period|Death|0|||
49163029|NCT04732221|158434758|FG003|Extension Period|Death|0|||
49163030|NCT04732221|158434759|FG004|Extension Period|Death|1|||
49163031|NCT04732221|158434760|FG005|Extension Period|Death|0|||
49163032|NCT04732221|158434761|FG006|Extension Period|Death|2|||
49163033|NCT04732221|158434755|FG000|Extension Period|Pregnancy|0|||
49163034|NCT04732221|158434756|FG001|Extension Period|Pregnancy|0|||
49163035|NCT04732221|158434757|FG002|Extension Period|Pregnancy|0|||
49163036|NCT04732221|158434758|FG003|Extension Period|Pregnancy|0|||
49163037|NCT04732221|158434759|FG004|Extension Period|Pregnancy|1|||
49163038|NCT04732221|158434760|FG005|Extension Period|Pregnancy|0|||
49163039|NCT04732221|158434761|FG006|Extension Period|Pregnancy|0|||
49163040|NCT04732221|158434755|FG000|Extension Period|Sponsors Decision|0|||
49163041|NCT04732221|158434756|FG001|Extension Period|Sponsors Decision|0|||
49163042|NCT04732221|158434757|FG002|Extension Period|Sponsors Decision|0|||
49163043|NCT04732221|158434758|FG003|Extension Period|Sponsors Decision|0|||
49163044|NCT04732221|158434759|FG004|Extension Period|Sponsors Decision|41|||
49163045|NCT04732221|158434760|FG005|Extension Period|Sponsors Decision|40|||
49163046|NCT04732221|158434761|FG006|Extension Period|Sponsors Decision|40|||
49163047|NCT04732221|158434755|FG000|Extension Period|Withdrawal by Subject|0|||
49163048|NCT04732221|158434756|FG001|Extension Period|Withdrawal by Subject|0|||
48923725|NCT01192022|157555196|FG001|Overall Study|Patient too sick from chemotherapy|1|||
49163049|NCT04732221|158434757|FG002|Extension Period|Withdrawal by Subject|0|||
49163050|NCT04732221|158434758|FG003|Extension Period|Withdrawal by Subject|0|||
49163051|NCT04732221|158434759|FG004|Extension Period|Withdrawal by Subject|1|||
49163052|NCT04732221|158434760|FG005|Extension Period|Withdrawal by Subject|5|||
49163053|NCT04732221|158434761|FG006|Extension Period|Withdrawal by Subject|2|||
49163054|NCT00305877|158434764|FG000|Overall Study|Lack of Efficacy|6|||
49163055|NCT00305877|158434765|FG001|Overall Study|Lack of Efficacy|9|||
49163056|NCT00305877|158434764|FG000|Overall Study|Adverse Event|9|||
48835881|NCT04009577|157240848|FG003|Core Study|Adverse Event|4|||
48835882|NCT04009577|157240845|FG000|Core Study|Withdrawal by Subject|0|||
48835883|NCT04009577|157240846|FG001|Core Study|Withdrawal by Subject|0|||
48835884|NCT04009577|157240847|FG002|Core Study|Withdrawal by Subject|2|||
48835885|NCT04009577|157240848|FG003|Core Study|Withdrawal by Subject|0|||
48835886|NCT04009577|157240845|FG000|Core Study|Other|0|||
48835887|NCT04009577|157240846|FG001|Core Study|Other|0|||
48835888|NCT04009577|157240847|FG002|Core Study|Other|0|||
48835889|NCT04009577|157240848|FG003|Core Study|Other|1|||
48835890|NCT04009577|157240845|FG000|Extension Phase|Adverse Event|0|||
48835891|NCT04009577|157240846|FG001|Extension Phase|Adverse Event|0|||
48835892|NCT04009577|157240847|FG002|Extension Phase|Adverse Event|0|||
48835893|NCT04009577|157240848|FG003|Extension Phase|Adverse Event|1|||
48835894|NCT04009577|157240845|FG000|Extension Phase|Inadequate therapeutic effect|0|||
48835895|NCT04009577|157240846|FG001|Extension Phase|Inadequate therapeutic effect|0|||
48835896|NCT04009577|157240847|FG002|Extension Phase|Inadequate therapeutic effect|1|||
48835897|NCT04009577|157240848|FG003|Extension Phase|Inadequate therapeutic effect|0|||
48835898|NCT04009577|157240845|FG000|Extension Phase|Withdrawal by Subject|0|||
48835899|NCT04009577|157240846|FG001|Extension Phase|Withdrawal by Subject|0|||
48835900|NCT04009577|157240847|FG002|Extension Phase|Withdrawal by Subject|1|||
48835901|NCT04009577|157240848|FG003|Extension Phase|Withdrawal by Subject|0|||
48835902|NCT04009577|157240845|FG000|Extension Phase|Not Treated|0|||
48835903|NCT04009577|157240846|FG001|Extension Phase|Not Treated|0|||
48835904|NCT04009577|157240847|FG002|Extension Phase|Not Treated|2|||
48835905|NCT04009577|157240848|FG003|Extension Phase|Not Treated|0|||
48835906|NCT01685606|157240859|FG000|Overall Study|Withdrawal by Subject|1|||
48835907|NCT01787760|157240860|FG000|Overall Study|Anisometropia > -1.00D in spherical equi|1|||
48835908|NCT01787760|157240861|FG001|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
48835909|NCT01787760|157240862|FG002|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
48835910|NCT01787760|157240860|FG000|Overall Study|Decompensated on left exotropia|0|||
48835911|NCT01787760|157240861|FG001|Overall Study|Decompensated on left exotropia|0|||
48835912|NCT01787760|157240862|FG002|Overall Study|Decompensated on left exotropia|1|||
48835913|NCT01787760|157240860|FG000|Overall Study|Dryness|0|||
48835914|NCT01787760|157240861|FG001|Overall Study|Dryness|1|||
48835915|NCT01787760|157240862|FG002|Overall Study|Dryness|0|||
48835916|NCT01787760|157240860|FG000|Overall Study|Relocation|1|||
48835917|NCT01787760|157240861|FG001|Overall Study|Relocation|1|||
48835918|NCT01787760|157240862|FG002|Overall Study|Relocation|0|||
48835919|NCT01787760|157240860|FG000|Overall Study|Lens discomfort|3|||
48835920|NCT01787760|157240861|FG001|Overall Study|Lens discomfort|0|||
48835921|NCT01787760|157240862|FG002|Overall Study|Lens discomfort|0|||
48835922|NCT01787760|157240860|FG000|Overall Study|Lens handling difficulty|1|||
48835923|NCT01787760|157240861|FG001|Overall Study|Lens handling difficulty|2|||
48835924|NCT01787760|157240862|FG002|Overall Study|Lens handling difficulty|0|||
48835925|NCT01787760|157240860|FG000|Overall Study|Protocol Violation|6|||
48835926|NCT01787760|157240861|FG001|Overall Study|Protocol Violation|0|||
48835927|NCT01787760|157240862|FG002|Overall Study|Protocol Violation|1|||
48835928|NCT01787760|157240860|FG000|Overall Study|Withdrawal by Subject|5|||
48835929|NCT01787760|157240861|FG001|Overall Study|Withdrawal by Subject|1|||
48835930|NCT01787760|157240862|FG002|Overall Study|Withdrawal by Subject|2|||
48835931|NCT01787760|157240860|FG000|Overall Study|Lost to Follow-up|1|||
48835932|NCT01787760|157240861|FG001|Overall Study|Lost to Follow-up|0|||
48835933|NCT01787760|157240862|FG002|Overall Study|Lost to Follow-up|1|||
48835934|NCT01787760|157240860|FG000|Overall Study|Stroke|1|||
48835935|NCT01787760|157240861|FG001|Overall Study|Stroke|0|||
48835936|NCT01787760|157240862|FG002|Overall Study|Stroke|0|||
48835937|NCT01787760|157240860|FG000|Overall Study|Unsatisfactory lens fitting performance|3|||
48835938|NCT01787760|157240861|FG001|Overall Study|Unsatisfactory lens fitting performance|6|||
48835939|NCT01787760|157240862|FG002|Overall Study|Unsatisfactory lens fitting performance|0|||
48835940|NCT01787760|157240860|FG000|Overall Study|Unsatisfactory physiological response|2|||
48835941|NCT01787760|157240861|FG001|Overall Study|Unsatisfactory physiological response|4|||
48835942|NCT01787760|157240862|FG002|Overall Study|Unsatisfactory physiological response|0|||
48835943|NCT01787760|157240860|FG000|Overall Study|Unsatisfactory visual response|1|||
48835944|NCT01787760|157240861|FG001|Overall Study|Unsatisfactory visual response|1|||
48835945|NCT01787760|157240862|FG002|Overall Study|Unsatisfactory visual response|0|||
48835946|NCT01787760|157240860|FG000|Overall Study|Near vision blur|1|||
48835947|NCT01787760|157240861|FG001|Overall Study|Near vision blur|0|||
48835948|NCT01787760|157240862|FG002|Overall Study|Near vision blur|0|||
48835949|NCT02754479|157240863|FG000|Overall Study|Lost to Follow-up|1|||
48835950|NCT01199705|157240864|FG000|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1|||
48835951|NCT01849055|157240865|FG000|Overall Study|Withdrawal by Subject|0|||
48835952|NCT01849055|157240866|FG001|Overall Study|Withdrawal by Subject|0|||
48835953|NCT01849055|157240867|FG002|Overall Study|Withdrawal by Subject|1|||
48835954|NCT01849055|157240868|FG003|Overall Study|Withdrawal by Subject|0|||
48835955|NCT01849055|157240869|FG004|Overall Study|Withdrawal by Subject|0|||
48835956|NCT01849055|157240870|FG005|Overall Study|Withdrawal by Subject|0|||
48835957|NCT00223795|157240871|FG000|First Intervention - Eight Weeks|Lost to Follow-up|7|||
48835958|NCT00223795|157240872|FG001|First Intervention - Eight Weeks|Lost to Follow-up|9|||
48835959|NCT00223795|157240871|FG000|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
48835960|NCT00223795|157240872|FG001|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
48835961|NCT00801983|157240873|FG000|Period 1|Lost to Follow-up|2|||
48835962|NCT00801983|157240874|FG001|Period 1|Lost to Follow-up|0|||
48835963|NCT00801983|157240873|FG000|Period 1|Withdrawal by Subject|2|||
48835964|NCT00801983|157240874|FG001|Period 1|Withdrawal by Subject|8|||
48835965|NCT00801983|157240873|FG000|Period 2|Withdrawal by Subject|2|||
48835966|NCT00801983|157240874|FG001|Period 2|Withdrawal by Subject|1|||
48835967|NCT02999477|157240875|FG000|Overall Study|found ineligible after first dose|0|||
48835968|NCT02999477|157240876|FG001|Overall Study|found ineligible after first dose|1|||
48835969|NCT02999477|157240875|FG000|Overall Study|Withdrawal by Subject|1|||
48835970|NCT02999477|157240876|FG001|Overall Study|Withdrawal by Subject|1|||
48835971|NCT02738840|157242701|FG000|Overall Study|MRI Scan not Performed|5|||
48835972|NCT02738840|157242701|FG000|Overall Study|Lost to Follow-up|1|||
48835973|NCT02738840|157242701|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
48835974|NCT02738840|157242701|FG000|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1|||
48835975|NCT02960659|157242702|FG000|Overall Study|Withdrawal by Subject|1|||
48835976|NCT02960659|157242703|FG001|Overall Study|Withdrawal by Subject|0|||
48835977|NCT02960659|157242702|FG000|Overall Study|Poor compliance|0|||
48835978|NCT02960659|157242703|FG001|Overall Study|Poor compliance|1|||
48835979|NCT03712930|157242708|FG000|Overall Study|Death|7|||
48835980|NCT03712930|157242708|FG000|Overall Study|Physician Decision|1|||
48835981|NCT03712930|157242708|FG000|Overall Study|Study Terminated by Sponsor|3|||
48835982|NCT03712930|157242708|FG000|Overall Study|Progressive Disease|2|||
48835983|NCT01062126|157242711|FG000|Overall Study|Death|209|||
48835984|NCT01062126|157242711|FG000|Overall Study|All Withdrawals|324|||
48835985|NCT03837028|157242712|FG000|Overall Study|Lost to Follow-up|4|||
48835986|NCT03837028|157242713|FG001|Overall Study|Lost to Follow-up|0|||
48835987|NCT03837028|157242714|FG002|Overall Study|Lost to Follow-up|2|||
48835988|NCT03837028|157242715|FG003|Overall Study|Lost to Follow-up|0|||
48835989|NCT03837028|157242712|FG000|Overall Study|Withdrawal by Subject|12|||
48835990|NCT03837028|157242713|FG001|Overall Study|Withdrawal by Subject|11|||
48835991|NCT03837028|157242714|FG002|Overall Study|Withdrawal by Subject|11|||
48835992|NCT03837028|157242715|FG003|Overall Study|Withdrawal by Subject|7|||
48835993|NCT02001623|157242723|FG000|Overall Study|Disease Progression|2|||
48835994|NCT02001623|157242724|FG001|Overall Study|Disease Progression|2|||
48835995|NCT02001623|157242725|FG002|Overall Study|Disease Progression|3|||
48835996|NCT02001623|157242726|FG003|Overall Study|Disease Progression|2|||
48835997|NCT02001623|157242727|FG004|Overall Study|Disease Progression|3|||
48835998|NCT02001623|157242728|FG005|Overall Study|Disease Progression|2|||
48835999|NCT02001623|157242729|FG006|Overall Study|Disease Progression|3|||
48836000|NCT02001623|157242730|FG007|Overall Study|Disease Progression|3|||
48836001|NCT02001623|157242731|FG008|Overall Study|Disease Progression|7|||
48836002|NCT02001623|157242732|FG009|Overall Study|Disease Progression|40|||
48836003|NCT02001623|157242733|FG010|Overall Study|Disease Progression|5|||
48836004|NCT02001623|157242734|FG011|Overall Study|Disease Progression|9|||
48836005|NCT02001623|157242735|FG012|Overall Study|Disease Progression|9|||
48836006|NCT02001623|157242736|FG013|Overall Study|Disease Progression|20|||
48836007|NCT02001623|157242737|FG014|Overall Study|Disease Progression|9|||
48836008|NCT02001623|157242723|FG000|Overall Study|Physician Decision|0|||
48836009|NCT02001623|157242724|FG001|Overall Study|Physician Decision|0|||
48836010|NCT02001623|157242725|FG002|Overall Study|Physician Decision|0|||
48836011|NCT02001623|157242726|FG003|Overall Study|Physician Decision|0|||
48836012|NCT02001623|157242727|FG004|Overall Study|Physician Decision|0|||
48836013|NCT02001623|157242728|FG005|Overall Study|Physician Decision|0|||
48836014|NCT02001623|157242729|FG006|Overall Study|Physician Decision|0|||
48836015|NCT02001623|157242730|FG007|Overall Study|Physician Decision|0|||
48836016|NCT02001623|157242731|FG008|Overall Study|Physician Decision|3|||
48836017|NCT02001623|157242732|FG009|Overall Study|Physician Decision|2|||
49163057|NCT00305877|158434765|FG001|Overall Study|Adverse Event|14|||
49163058|NCT00305877|158434764|FG000|Overall Study|Death|0|||
49163059|NCT00305877|158434765|FG001|Overall Study|Death|1|||
48836018|NCT02001623|157242733|FG010|Overall Study|Physician Decision|3|||
48836019|NCT02001623|157242734|FG011|Overall Study|Physician Decision|3|||
48836020|NCT02001623|157242735|FG012|Overall Study|Physician Decision|1|||
48836021|NCT02001623|157242736|FG013|Overall Study|Physician Decision|2|||
48836022|NCT02001623|157242737|FG014|Overall Study|Physician Decision|1|||
48836023|NCT02001623|157242723|FG000|Overall Study|Death|0|||
48836024|NCT02001623|157242724|FG001|Overall Study|Death|1|||
48836025|NCT02001623|157242725|FG002|Overall Study|Death|0|||
48836026|NCT02001623|157242726|FG003|Overall Study|Death|0|||
48836027|NCT02001623|157242727|FG004|Overall Study|Death|0|||
48836028|NCT02001623|157242728|FG005|Overall Study|Death|0|||
48836029|NCT02001623|157242729|FG006|Overall Study|Death|0|||
48836030|NCT02001623|157242730|FG007|Overall Study|Death|0|||
48836031|NCT02001623|157242731|FG008|Overall Study|Death|0|||
48836032|NCT02001623|157242732|FG009|Overall Study|Death|0|||
49163060|NCT00305877|158434764|FG000|Overall Study|Withdrawal by Subject|4|||
48836033|NCT02001623|157242733|FG010|Overall Study|Death|0|||
48836034|NCT02001623|157242734|FG011|Overall Study|Death|0|||
48836035|NCT02001623|157242735|FG012|Overall Study|Death|0|||
48836036|NCT02001623|157242736|FG013|Overall Study|Death|0|||
48836037|NCT02001623|157242737|FG014|Overall Study|Death|0|||
48836038|NCT02001623|157242723|FG000|Overall Study|Adverse Event|0|||
48836039|NCT02001623|157242724|FG001|Overall Study|Adverse Event|0|||
48836040|NCT02001623|157242725|FG002|Overall Study|Adverse Event|0|||
48836041|NCT02001623|157242726|FG003|Overall Study|Adverse Event|0|||
48836042|NCT02001623|157242727|FG004|Overall Study|Adverse Event|0|||
48836043|NCT02001623|157242728|FG005|Overall Study|Adverse Event|1|||
48836044|NCT02001623|157242729|FG006|Overall Study|Adverse Event|0|||
48836045|NCT02001623|157242730|FG007|Overall Study|Adverse Event|3|||
49014704|NCT04634409|157888949|FG026|Overall Study|Other - As reported by Investigator|0|||
49014705|NCT00928252|157890345|FG000|Overall Study|Physician Decision|3|||
49014706|NCT02468557|157890346|FG000|Overall Study|Adverse Event|1|||
49014707|NCT02468557|157890346|FG000|Overall Study|Death|1|||
49014708|NCT02468557|157890346|FG000|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10|||
49014709|NCT02468557|157890346|FG000|Overall Study|All Enrolled but Never Dosed|4|||
49014710|NCT01830920|157890357|FG000|Overall Study|Adverse Event|1|||
49014711|NCT01830920|157890358|FG001|Overall Study|Adverse Event|0|||
49014712|NCT01830920|157890359|FG002|Overall Study|Adverse Event|1|||
49014713|NCT01830920|157890360|FG003|Overall Study|Adverse Event|0|||
49014714|NCT01830920|157890361|FG004|Overall Study|Adverse Event|0|||
49014715|NCT01830920|157890357|FG000|Overall Study|Withdrawal by Subject|2|||
49014716|NCT01830920|157890358|FG001|Overall Study|Withdrawal by Subject|2|||
49014717|NCT01830920|157890359|FG002|Overall Study|Withdrawal by Subject|1|||
49014718|NCT01830920|157890360|FG003|Overall Study|Withdrawal by Subject|7|||
49014719|NCT01830920|157890361|FG004|Overall Study|Withdrawal by Subject|1|||
49014720|NCT01830920|157890357|FG000|Overall Study|Death|3|||
49014721|NCT01830920|157890358|FG001|Overall Study|Death|3|||
49014722|NCT01830920|157890359|FG002|Overall Study|Death|5|||
49014723|NCT01830920|157890360|FG003|Overall Study|Death|4|||
49014724|NCT01830920|157890361|FG004|Overall Study|Death|4|||
49014725|NCT01830920|157890357|FG000|Overall Study|Other|15|||
49014726|NCT01830920|157890358|FG001|Overall Study|Other|1|||
49014727|NCT01830920|157890359|FG002|Overall Study|Other|1|||
49014728|NCT01830920|157890360|FG003|Overall Study|Other|5|||
49014729|NCT01830920|157890361|FG004|Overall Study|Other|3|||
48836046|NCT02001623|157242731|FG008|Overall Study|Adverse Event|4|||
48836047|NCT02001623|157242732|FG009|Overall Study|Adverse Event|6|||
48836048|NCT02001623|157242733|FG010|Overall Study|Adverse Event|4|||
48836049|NCT02001623|157242734|FG011|Overall Study|Adverse Event|0|||
48836050|NCT02001623|157242735|FG012|Overall Study|Adverse Event|3|||
48836051|NCT02001623|157242736|FG013|Overall Study|Adverse Event|5|||
48836052|NCT02001623|157242737|FG014|Overall Study|Adverse Event|6|||
48836053|NCT02001623|157242723|FG000|Overall Study|Other - Miscellaneous|0|||
48836054|NCT02001623|157242724|FG001|Overall Study|Other - Miscellaneous|0|||
48836055|NCT02001623|157242725|FG002|Overall Study|Other - Miscellaneous|0|||
48836056|NCT02001623|157242726|FG003|Overall Study|Other - Miscellaneous|0|||
48836057|NCT02001623|157242727|FG004|Overall Study|Other - Miscellaneous|0|||
48836058|NCT02001623|157242728|FG005|Overall Study|Other - Miscellaneous|0|||
48836059|NCT02001623|157242729|FG006|Overall Study|Other - Miscellaneous|0|||
48836060|NCT02001623|157242730|FG007|Overall Study|Other - Miscellaneous|0|||
48836061|NCT02001623|157242731|FG008|Overall Study|Other - Miscellaneous|0|||
48836062|NCT02001623|157242732|FG009|Overall Study|Other - Miscellaneous|1|||
48836063|NCT02001623|157242733|FG010|Overall Study|Other - Miscellaneous|0|||
48836064|NCT02001623|157242734|FG011|Overall Study|Other - Miscellaneous|0|||
48836065|NCT02001623|157242735|FG012|Overall Study|Other - Miscellaneous|0|||
48836066|NCT02001623|157242736|FG013|Overall Study|Other - Miscellaneous|1|||
48836067|NCT02001623|157242737|FG014|Overall Study|Other - Miscellaneous|0|||
49163061|NCT00305877|158434765|FG001|Overall Study|Withdrawal by Subject|2|||
49163062|NCT00305877|158434764|FG000|Overall Study|Physician Decision|1|||
49163063|NCT00305877|158434765|FG001|Overall Study|Physician Decision|1|||
49163064|NCT00305877|158434764|FG000|Overall Study|Never start treatment|2|||
49163065|NCT00305877|158434765|FG001|Overall Study|Never start treatment|5|||
49163066|NCT00305877|158434764|FG000|Overall Study|Ineligible|2|||
49163067|NCT00305877|158434765|FG001|Overall Study|Ineligible|1|||
49163068|NCT00305877|158434764|FG000|Overall Study|Transportation issue with daily RT|0|||
49163069|NCT00305877|158434765|FG001|Overall Study|Transportation issue with daily RT|1|||
49163070|NCT04784559|158434768|FG000|Overall Study|Withdrawal by Subject|3|||
49163071|NCT04784559|158434769|FG001|Overall Study|Withdrawal by Subject|2|||
49163072|NCT04784559|158434770|FG002|Overall Study|Withdrawal by Subject|1|||
49163073|NCT04784559|158434768|FG000|Overall Study|Death|2|||
49163074|NCT04784559|158434769|FG001|Overall Study|Death|1|||
49163075|NCT04784559|158434770|FG002|Overall Study|Death|2|||
49163076|NCT04784559|158434768|FG000|Overall Study|Lost to Follow-up|0|||
49163077|NCT04784559|158434769|FG001|Overall Study|Lost to Follow-up|0|||
49163078|NCT04784559|158434770|FG002|Overall Study|Lost to Follow-up|2|||
49163079|NCT04784559|158434768|FG000|Overall Study|Participant worsened, PI decision|1|||
49163080|NCT04784559|158434769|FG001|Overall Study|Participant worsened, PI decision|0|||
49163081|NCT04784559|158434770|FG002|Overall Study|Participant worsened, PI decision|0|||
49163082|NCT04784559|158434768|FG000|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|1|||
49163083|NCT04784559|158434769|FG001|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
49163084|NCT04784559|158434770|FG002|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
49163085|NCT04784559|158434768|FG000|Overall Study|Participant admitted in other hospital due to a serious adverse event|1|||
49163086|NCT04784559|158434769|FG001|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
49163087|NCT04784559|158434770|FG002|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
49163088|NCT04784559|158434768|FG000|Overall Study|Did not meet all inclusion criteria|0|||
49163089|NCT04784559|158434769|FG001|Overall Study|Did not meet all inclusion criteria|1|||
49163090|NCT04784559|158434770|FG002|Overall Study|Did not meet all inclusion criteria|0|||
49163091|NCT04784559|158434768|FG000|Overall Study|The participant was transferred to IRCU|0|||
49163092|NCT04784559|158434769|FG001|Overall Study|The participant was transferred to IRCU|1|||
49163093|NCT04784559|158434770|FG002|Overall Study|The participant was transferred to IRCU|0|||
49163094|NCT04784559|158434768|FG000|Overall Study|SAE|0|||
49163095|NCT04784559|158434769|FG001|Overall Study|SAE|1|||
49163096|NCT04784559|158434770|FG002|Overall Study|SAE|0|||
49163097|NCT04784559|158434768|FG000|Overall Study|Discontinued as was found to be ineligible|0|||
49163098|NCT04784559|158434769|FG001|Overall Study|Discontinued as was found to be ineligible|0|||
49163099|NCT04784559|158434770|FG002|Overall Study|Discontinued as was found to be ineligible|1|||
49163100|NCT02307565|158434771|FG000|Overall Study|Adverse Event|3|||
49163101|NCT02307565|158434772|FG001|Overall Study|Adverse Event|2|||
49163102|NCT02307565|158434771|FG000|Overall Study|Withdrawal by Subject|2|||
49163103|NCT02307565|158434772|FG001|Overall Study|Withdrawal by Subject|2|||
49163104|NCT03846505|158434773|FG000|Treatment Phase|Withdrawal by Subject|9|||
49163105|NCT03846505|158434774|FG001|Treatment Phase|Withdrawal by Subject|11|||
49163106|NCT03846505|158434773|FG000|Treatment Phase|Lost to Follow-up|6|||
49163107|NCT03846505|158434774|FG001|Treatment Phase|Lost to Follow-up|2|||
49163108|NCT03846505|158434773|FG000|Treatment Phase|Opted out of intervention but completed assessments|5|||
48836068|NCT02001623|157242723|FG000|Overall Study|Withdrawal by Subject|1|||
48836069|NCT02001623|157242724|FG001|Overall Study|Withdrawal by Subject|0|||
48836070|NCT02001623|157242725|FG002|Overall Study|Withdrawal by Subject|0|||
48836071|NCT02001623|157242726|FG003|Overall Study|Withdrawal by Subject|0|||
48836072|NCT02001623|157242727|FG004|Overall Study|Withdrawal by Subject|0|||
48836073|NCT02001623|157242728|FG005|Overall Study|Withdrawal by Subject|0|||
48836074|NCT02001623|157242729|FG006|Overall Study|Withdrawal by Subject|0|||
48836075|NCT02001623|157242730|FG007|Overall Study|Withdrawal by Subject|0|||
48836076|NCT02001623|157242731|FG008|Overall Study|Withdrawal by Subject|1|||
48836077|NCT02001623|157242732|FG009|Overall Study|Withdrawal by Subject|3|||
48836078|NCT02001623|157242733|FG010|Overall Study|Withdrawal by Subject|2|||
48836079|NCT02001623|157242734|FG011|Overall Study|Withdrawal by Subject|2|||
48836080|NCT02001623|157242735|FG012|Overall Study|Withdrawal by Subject|1|||
48836081|NCT02001623|157242736|FG013|Overall Study|Withdrawal by Subject|5|||
48836082|NCT02001623|157242737|FG014|Overall Study|Withdrawal by Subject|2|||
48836083|NCT02001623|157242723|FG000|Overall Study|Lost to Follow-up|0|||
48836084|NCT02001623|157242724|FG001|Overall Study|Lost to Follow-up|0|||
48836085|NCT02001623|157242725|FG002|Overall Study|Lost to Follow-up|0|||
48836086|NCT02001623|157242726|FG003|Overall Study|Lost to Follow-up|0|||
48836087|NCT02001623|157242727|FG004|Overall Study|Lost to Follow-up|0|||
48836088|NCT02001623|157242728|FG005|Overall Study|Lost to Follow-up|0|||
48836089|NCT02001623|157242729|FG006|Overall Study|Lost to Follow-up|0|||
48836090|NCT02001623|157242730|FG007|Overall Study|Lost to Follow-up|0|||
48836091|NCT02001623|157242731|FG008|Overall Study|Lost to Follow-up|0|||
48836092|NCT02001623|157242732|FG009|Overall Study|Lost to Follow-up|1|||
48836093|NCT02001623|157242733|FG010|Overall Study|Lost to Follow-up|0|||
48836094|NCT02001623|157242734|FG011|Overall Study|Lost to Follow-up|0|||
48836095|NCT02001623|157242735|FG012|Overall Study|Lost to Follow-up|0|||
48836096|NCT02001623|157242736|FG013|Overall Study|Lost to Follow-up|0|||
48836097|NCT02001623|157242737|FG014|Overall Study|Lost to Follow-up|0|||
48836098|NCT02001623|157242723|FG000|Overall Study|Start of New Anti-cancer Treatment|0|||
48836099|NCT02001623|157242724|FG001|Overall Study|Start of New Anti-cancer Treatment|0|||
48836100|NCT02001623|157242725|FG002|Overall Study|Start of New Anti-cancer Treatment|0|||
48836101|NCT02001623|157242726|FG003|Overall Study|Start of New Anti-cancer Treatment|0|||
48836102|NCT02001623|157242727|FG004|Overall Study|Start of New Anti-cancer Treatment|0|||
48836103|NCT02001623|157242728|FG005|Overall Study|Start of New Anti-cancer Treatment|0|||
48836104|NCT02001623|157242729|FG006|Overall Study|Start of New Anti-cancer Treatment|0|||
48836105|NCT02001623|157242730|FG007|Overall Study|Start of New Anti-cancer Treatment|0|||
48836106|NCT02001623|157242731|FG008|Overall Study|Start of New Anti-cancer Treatment|0|||
48836107|NCT02001623|157242732|FG009|Overall Study|Start of New Anti-cancer Treatment|0|||
48836108|NCT02001623|157242733|FG010|Overall Study|Start of New Anti-cancer Treatment|0|||
48836109|NCT02001623|157242734|FG011|Overall Study|Start of New Anti-cancer Treatment|1|||
48836110|NCT02001623|157242735|FG012|Overall Study|Start of New Anti-cancer Treatment|0|||
48836111|NCT02001623|157242736|FG013|Overall Study|Start of New Anti-cancer Treatment|1|||
48836112|NCT02001623|157242737|FG014|Overall Study|Start of New Anti-cancer Treatment|0|||
48836113|NCT02001623|157242723|FG000|Overall Study|Dose Delay Due to Toxicity|0|||
48836114|NCT02001623|157242724|FG001|Overall Study|Dose Delay Due to Toxicity|0|||
48836115|NCT02001623|157242725|FG002|Overall Study|Dose Delay Due to Toxicity|0|||
48836116|NCT02001623|157242726|FG003|Overall Study|Dose Delay Due to Toxicity|0|||
48836117|NCT02001623|157242727|FG004|Overall Study|Dose Delay Due to Toxicity|0|||
48836118|NCT02001623|157242728|FG005|Overall Study|Dose Delay Due to Toxicity|0|||
48836119|NCT02001623|157242729|FG006|Overall Study|Dose Delay Due to Toxicity|0|||
48836120|NCT02001623|157242730|FG007|Overall Study|Dose Delay Due to Toxicity|0|||
48836121|NCT02001623|157242731|FG008|Overall Study|Dose Delay Due to Toxicity|0|||
48836122|NCT02001623|157242732|FG009|Overall Study|Dose Delay Due to Toxicity|0|||
48836123|NCT02001623|157242733|FG010|Overall Study|Dose Delay Due to Toxicity|0|||
48836124|NCT02001623|157242734|FG011|Overall Study|Dose Delay Due to Toxicity|0|||
48836125|NCT02001623|157242735|FG012|Overall Study|Dose Delay Due to Toxicity|0|||
48836126|NCT02001623|157242736|FG013|Overall Study|Dose Delay Due to Toxicity|1|||
48836127|NCT02001623|157242737|FG014|Overall Study|Dose Delay Due to Toxicity|0|||
48836128|NCT01070888|157242738|FG000|First Intervention (14 Days)|Adverse Event|0|||
48836129|NCT01070888|157242739|FG001|First Intervention (14 Days)|Adverse Event|1|||
48836130|NCT01070888|157242738|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
48836131|NCT01070888|157242739|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
48836132|NCT01070888|157242738|FG000|Washout (14 Days)|Physician Decision|1|||
48836133|NCT01070888|157242739|FG001|Washout (14 Days)|Physician Decision|0|||
48836134|NCT00364286|157242740|FG000|Overall Study|Withdrawal by Subject|1|||
48836135|NCT00364286|157242740|FG000|Overall Study|Adverse Event|2|||
48836136|NCT00628862|157242741|FG000|Overall Study|Adverse Event|6|||
48836137|NCT00628862|157242742|FG001|Overall Study|Adverse Event|8|||
48836138|NCT00628862|157242743|FG002|Overall Study|Adverse Event|10|||
48836139|NCT00628862|157242741|FG000|Overall Study|Withdrawal by Subject|4|||
48836140|NCT00628862|157242742|FG001|Overall Study|Withdrawal by Subject|6|||
48836141|NCT00628862|157242743|FG002|Overall Study|Withdrawal by Subject|11|||
48836142|NCT00628862|157242741|FG000|Overall Study|Lost to Follow-up|0|||
48836143|NCT00628862|157242742|FG001|Overall Study|Lost to Follow-up|2|||
48836144|NCT00628862|157242743|FG002|Overall Study|Lost to Follow-up|1|||
48836145|NCT00628862|157242741|FG000|Overall Study|Protocol Violation|1|||
48836146|NCT00628862|157242742|FG001|Overall Study|Protocol Violation|0|||
48836147|NCT00628862|157242743|FG002|Overall Study|Protocol Violation|0|||
48836148|NCT00628862|157242741|FG000|Overall Study|COPD Exacerbation|0|||
48836149|NCT00628862|157242742|FG001|Overall Study|COPD Exacerbation|1|||
48836150|NCT00628862|157242743|FG002|Overall Study|COPD Exacerbation|0|||
48836151|NCT01063036|157242744|FG000|Participants Treated With Study Drug|Adverse Event|1|||
48836152|NCT01063036|157242744|FG000|Participants Treated With Study Drug|Protocol Violation|1|||
48836153|NCT01063036|157242744|FG000|Participants Treated With Study Drug|Withdrawal by Subject|2|||
48836154|NCT01063036|157242744|FG000|Participants Treated With Study Drug|Lost to Follow-up|1|||
48836155|NCT01063036|157242744|FG000|Participants Treated With Study Drug|Pregnancy|1|||
48836156|NCT01063036|157242744|FG000|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1|||
48836157|NCT01063036|157242744|FG000|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6|||
48836158|NCT01063036|157242744|FG000|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32|||
48836159|NCT02715258|157242745|FG000|Overall Study|Withdrawal by Subject|6|||
48836160|NCT02715258|157242746|FG001|Overall Study|Withdrawal by Subject|1|||
48836161|NCT02715258|157242745|FG000|Overall Study|Lost to Follow-up|7|||
48836162|NCT02715258|157242746|FG001|Overall Study|Lost to Follow-up|1|||
48836163|NCT02715258|157242745|FG000|Overall Study|Terminated by Sponsor|0|||
48836164|NCT02715258|157242746|FG001|Overall Study|Terminated by Sponsor|1|||
48836165|NCT02715258|157242745|FG000|Overall Study|Death|0|||
48836166|NCT02715258|157242746|FG001|Overall Study|Death|1|||
48836167|NCT02715258|157242745|FG000|Overall Study|Subject non-compliant|1|||
48836168|NCT02715258|157242746|FG001|Overall Study|Subject non-compliant|1|||
48836169|NCT02715258|157242745|FG000|Overall Study|GCP violation|2|||
48836170|NCT02715258|157242746|FG001|Overall Study|GCP violation|1|||
48836171|NCT00178399|157242747|FG000|Overall Study|Physician Decision|4|||
48836172|NCT00178399|157242747|FG000|Overall Study|Withdrawal by Subject|8|||
48836173|NCT00178399|157242747|FG000|Overall Study|Lost to Follow-up|1|||
48836174|NCT02814643|157242748|FG000|Overall Study|Lost to Follow-up|0|||
48836175|NCT02814643|157242749|FG001|Overall Study|Lost to Follow-up|1|||
48836176|NCT02814643|157242748|FG000|Overall Study|Withdrawal by Subject|1|||
48836177|NCT02814643|157242749|FG001|Overall Study|Withdrawal by Subject|2|||
48836178|NCT02631148|157242752|FG000|Overall Study|8 were ineligible|8|||
48836179|NCT02631148|157242753|FG001|Overall Study|8 were ineligible|0|||
48836180|NCT02631148|157242752|FG000|Overall Study|Withdrawal by Subject|1|||
48836181|NCT02631148|157242753|FG001|Overall Study|Withdrawal by Subject|0|||
48836182|NCT02631148|157242752|FG000|Overall Study|PAH not available to study participant|1|||
48836183|NCT02631148|157242753|FG001|Overall Study|PAH not available to study participant|0|||
48836184|NCT01134562|157242754|FG000|Overall Study|Adverse Event|0|||
48836185|NCT01134562|157242755|FG001|Overall Study|Adverse Event|1|||
48836186|NCT01134562|157242756|FG002|Overall Study|Adverse Event|0|||
48836187|NCT01134562|157242757|FG003|Overall Study|Adverse Event|0|||
48836188|NCT01134562|157242758|FG004|Overall Study|Adverse Event|0|||
48836189|NCT01400776|157242759|FG000|Overall Study|Adverse Event|7|||
48836190|NCT01400776|157242760|FG001|Overall Study|Adverse Event|2|||
48836191|NCT01400776|157242761|FG002|Overall Study|Adverse Event|9|||
48836192|NCT01400776|157242762|FG003|Overall Study|Adverse Event|2|||
48836193|NCT01400776|157242759|FG000|Overall Study|Lost to Follow-up|1|||
48836194|NCT01400776|157242760|FG001|Overall Study|Lost to Follow-up|0|||
48836195|NCT01400776|157242761|FG002|Overall Study|Lost to Follow-up|4|||
48836196|NCT01400776|157242762|FG003|Overall Study|Lost to Follow-up|1|||
48836197|NCT01400776|157242759|FG000|Overall Study|Withdrew Consent|4|||
49163109|NCT03846505|158434774|FG001|Treatment Phase|Opted out of intervention but completed assessments|3|||
49163110|NCT03846505|158434773|FG000|Completed Follow Up Phase (6-month)|Lost to Follow-up|6|||
49163111|NCT03846505|158434774|FG001|Completed Follow Up Phase (6-month)|Lost to Follow-up|1|||
48923726|NCT01192022|157555197|FG002|Overall Study|Patient too sick from chemotherapy|0|||
48836198|NCT01400776|157242760|FG001|Overall Study|Withdrew Consent|2|||
48836199|NCT01400776|157242761|FG002|Overall Study|Withdrew Consent|6|||
48836200|NCT01400776|157242762|FG003|Overall Study|Withdrew Consent|1|||
48836201|NCT01400776|157242759|FG000|Overall Study|Protocol Deviation|6|||
48836202|NCT01400776|157242760|FG001|Overall Study|Protocol Deviation|1|||
48836203|NCT01400776|157242761|FG002|Overall Study|Protocol Deviation|5|||
48836204|NCT01400776|157242762|FG003|Overall Study|Protocol Deviation|2|||
48836205|NCT01400776|157242759|FG000|Overall Study|Reason not Specified|3|||
48836206|NCT01400776|157242760|FG001|Overall Study|Reason not Specified|0|||
48836207|NCT01400776|157242761|FG002|Overall Study|Reason not Specified|4|||
48836208|NCT01400776|157242762|FG003|Overall Study|Reason not Specified|3|||
48836209|NCT02320123|157242763|FG000|Overall Study|Lost to Follow-up|4|||
48836210|NCT02320123|157242764|FG001|Overall Study|Lost to Follow-up|6|||
48836211|NCT02320123|157242763|FG000|Overall Study|Death|6|||
48836212|NCT02320123|157242764|FG001|Overall Study|Death|5|||
48836213|NCT02477670|157242768|FG000|Stage 1|Adverse Event|2|||
48836214|NCT02477670|157242769|FG001|Stage 1|Adverse Event|7|||
48836215|NCT02477670|157242770|FG002|Stage 1|Adverse Event|0|||
48836216|NCT02477670|157242771|FG003|Stage 1|Adverse Event|0|||
48836217|NCT02477670|157242772|FG004|Stage 1|Adverse Event|0|||
48836218|NCT02477670|157242773|FG005|Stage 1|Adverse Event|0|||
48836219|NCT02477670|157242774|FG006|Stage 1|Adverse Event|0|||
48836220|NCT02477670|157242768|FG000|Stage 1|Lost to Follow-up|0|||
48836221|NCT02477670|157242769|FG001|Stage 1|Lost to Follow-up|2|||
48836222|NCT02477670|157242770|FG002|Stage 1|Lost to Follow-up|0|||
48836223|NCT02477670|157242771|FG003|Stage 1|Lost to Follow-up|0|||
48836224|NCT02477670|157242772|FG004|Stage 1|Lost to Follow-up|0|||
48836225|NCT02477670|157242773|FG005|Stage 1|Lost to Follow-up|0|||
48836226|NCT02477670|157242774|FG006|Stage 1|Lost to Follow-up|0|||
48836227|NCT02477670|157242768|FG000|Stage 1|Withdrawal by Subject|1|||
48836228|NCT02477670|157242769|FG001|Stage 1|Withdrawal by Subject|2|||
48836229|NCT02477670|157242770|FG002|Stage 1|Withdrawal by Subject|0|||
48923727|NCT01192022|157555198|FG003|Overall Study|Patient too sick from chemotherapy|0|||
48836230|NCT02477670|157242771|FG003|Stage 1|Withdrawal by Subject|0|||
48836231|NCT02477670|157242772|FG004|Stage 1|Withdrawal by Subject|0|||
48836232|NCT02477670|157242773|FG005|Stage 1|Withdrawal by Subject|0|||
48836233|NCT02477670|157242774|FG006|Stage 1|Withdrawal by Subject|0|||
48836234|NCT02477670|157242768|FG000|Stage 1|Non-compliance with Study Drug|1|||
48836235|NCT02477670|157242769|FG001|Stage 1|Non-compliance with Study Drug|2|||
48836236|NCT02477670|157242770|FG002|Stage 1|Non-compliance with Study Drug|0|||
48836237|NCT02477670|157242771|FG003|Stage 1|Non-compliance with Study Drug|0|||
48836238|NCT02477670|157242772|FG004|Stage 1|Non-compliance with Study Drug|0|||
48836239|NCT02477670|157242773|FG005|Stage 1|Non-compliance with Study Drug|0|||
48836240|NCT02477670|157242774|FG006|Stage 1|Non-compliance with Study Drug|0|||
48836241|NCT02477670|157242768|FG000|Stage 2|Adverse Event|0|||
48836242|NCT02477670|157242769|FG001|Stage 2|Adverse Event|0|||
48836243|NCT02477670|157242770|FG002|Stage 2|Adverse Event|1|||
48836244|NCT02477670|157242771|FG003|Stage 2|Adverse Event|0|||
48836245|NCT02477670|157242772|FG004|Stage 2|Adverse Event|0|||
48836246|NCT02477670|157242773|FG005|Stage 2|Adverse Event|0|||
48836247|NCT02477670|157242774|FG006|Stage 2|Adverse Event|0|||
48836248|NCT02477670|157242768|FG000|Stage 2|Antipsychotic Medication Changed|0|||
48923728|NCT01192022|157555199|FG004|Overall Study|Patient too sick from chemotherapy|0|||
48923729|NCT01192022|157555195|FG000|Overall Study|Patient needed surgery|0|||
48836249|NCT02477670|157242769|FG001|Stage 2|Antipsychotic Medication Changed|0|||
48836250|NCT02477670|157242770|FG002|Stage 2|Antipsychotic Medication Changed|1|||
48836251|NCT02477670|157242771|FG003|Stage 2|Antipsychotic Medication Changed|0|||
48836252|NCT02477670|157242772|FG004|Stage 2|Antipsychotic Medication Changed|0|||
48836253|NCT02477670|157242773|FG005|Stage 2|Antipsychotic Medication Changed|0|||
48836254|NCT02477670|157242774|FG006|Stage 2|Antipsychotic Medication Changed|0|||
48836255|NCT02477670|157242768|FG000|Stage 2|Withdrawal by Subject|0|||
48836256|NCT02477670|157242769|FG001|Stage 2|Withdrawal by Subject|0|||
48836257|NCT02477670|157242770|FG002|Stage 2|Withdrawal by Subject|0|||
48836258|NCT02477670|157242771|FG003|Stage 2|Withdrawal by Subject|1|||
48836259|NCT02477670|157242772|FG004|Stage 2|Withdrawal by Subject|0|||
48836260|NCT02477670|157242773|FG005|Stage 2|Withdrawal by Subject|0|||
48836261|NCT02477670|157242774|FG006|Stage 2|Withdrawal by Subject|0|||
48836262|NCT00004124|157242775|FG000|Overall Study|Received no protocol therapy|12|||
48836263|NCT00004124|157242776|FG001|Overall Study|Received no protocol therapy|20|||
48836264|NCT02139046|157242780|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
48836265|NCT02139046|157242781|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
48923730|NCT01192022|157555196|FG001|Overall Study|Patient needed surgery|1|||
48923731|NCT01192022|157555197|FG002|Overall Study|Patient needed surgery|0|||
48923732|NCT01192022|157555198|FG003|Overall Study|Patient needed surgery|0|||
48923733|NCT01192022|157555199|FG004|Overall Study|Patient needed surgery|0|||
48923734|NCT01192022|157555195|FG000|Overall Study|Parents did not allow all follow up|0|||
48923735|NCT01192022|157555196|FG001|Overall Study|Parents did not allow all follow up|0|||
48923736|NCT01192022|157555197|FG002|Overall Study|Parents did not allow all follow up|0|||
48923737|NCT01192022|157555198|FG003|Overall Study|Parents did not allow all follow up|1|||
48923738|NCT01192022|157555199|FG004|Overall Study|Parents did not allow all follow up|0|||
48923739|NCT00179309|157555203|FG000|Treatment|Toxicity|2|||
48923740|NCT00179309|157555204|FG001|Treatment|Toxicity|3|||
48923741|NCT00179309|157555203|FG000|Treatment|Withdrawal by Subject|1|||
48923742|NCT00179309|157555204|FG001|Treatment|Withdrawal by Subject|2|||
48923743|NCT00179309|157555203|FG000|Treatment|Allergy|1|||
48923744|NCT00179309|157555204|FG001|Treatment|Allergy|0|||
48923745|NCT00623480|157555205|FG000|Overall Study|Lost to Follow-up|0|||
48923746|NCT00623480|157555206|FG001|Overall Study|Lost to Follow-up|1|||
48836266|NCT02139046|157242782|FG002|Overall Study|Pretreatment Event/Adverse Event|10|||
48836267|NCT02139046|157242783|FG003|Overall Study|Pretreatment Event/Adverse Event|13|||
48923747|NCT00623480|157555205|FG000|Overall Study|Withdrawal by Subject|2|||
48923748|NCT00623480|157555206|FG001|Overall Study|Withdrawal by Subject|4|||
48923749|NCT00623480|157555205|FG000|Overall Study|Lack of Efficacy|1|||
48923750|NCT00623480|157555206|FG001|Overall Study|Lack of Efficacy|0|||
48923751|NCT00623480|157555205|FG000|Overall Study|Non-compliant with study medication|4|||
48923752|NCT00623480|157555206|FG001|Overall Study|Non-compliant with study medication|0|||
48923753|NCT00623480|157555205|FG000|Overall Study|Protocol Violation|0|||
48923754|NCT00623480|157555206|FG001|Overall Study|Protocol Violation|1|||
48923755|NCT00623480|157555205|FG000|Overall Study|Site closed by sponsor|0|||
48836268|NCT02139046|157242784|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
48836269|NCT02139046|157242780|FG000|Overall Study|Major Protocol Deviation|9|||
48836270|NCT02139046|157242781|FG001|Overall Study|Major Protocol Deviation|10|||
48836271|NCT02139046|157242782|FG002|Overall Study|Major Protocol Deviation|16|||
48923756|NCT00623480|157555206|FG001|Overall Study|Site closed by sponsor|1|||
48923757|NCT00781456|157555207|FG000|Overall Study|Adverse Event|3|||
48923758|NCT00781456|157555208|FG001|Overall Study|Adverse Event|3|||
48923759|NCT00781456|157555207|FG000|Overall Study|Withdrawal by Subject|3|||
48923760|NCT00781456|157555208|FG001|Overall Study|Withdrawal by Subject|5|||
48923761|NCT00781456|157555207|FG000|Overall Study|Protocol Violation|4|||
48923762|NCT00781456|157555208|FG001|Overall Study|Protocol Violation|1|||
48923763|NCT00781456|157555207|FG000|Overall Study|Noncompliance With Protocol|1|||
48923764|NCT00781456|157555208|FG001|Overall Study|Noncompliance With Protocol|1|||
48923765|NCT00781456|157555207|FG000|Overall Study|Lost to Follow-up|10|||
48923766|NCT00781456|157555208|FG001|Overall Study|Lost to Follow-up|5|||
48923767|NCT00781456|157555207|FG000|Overall Study|Other Reason, Unknown|0|||
48836272|NCT02139046|157242783|FG003|Overall Study|Major Protocol Deviation|12|||
48836273|NCT02139046|157242784|FG004|Overall Study|Major Protocol Deviation|6|||
48836274|NCT02139046|157242780|FG000|Overall Study|Lost to Follow-up|13|||
48836275|NCT02139046|157242781|FG001|Overall Study|Lost to Follow-up|16|||
48836276|NCT02139046|157242782|FG002|Overall Study|Lost to Follow-up|16|||
48836277|NCT02139046|157242783|FG003|Overall Study|Lost to Follow-up|18|||
48836278|NCT02139046|157242784|FG004|Overall Study|Lost to Follow-up|13|||
48836279|NCT02139046|157242780|FG000|Overall Study|Voluntary Withdrawal|20|||
48836280|NCT02139046|157242781|FG001|Overall Study|Voluntary Withdrawal|8|||
48923768|NCT00781456|157555208|FG001|Overall Study|Other Reason, Unknown|1|||
48923769|NCT01902966|157555209|FG000|Overall Study|Death|1|||
48923770|NCT01902966|157555209|FG000|Overall Study|Physician Decision|1|||
48923771|NCT01902966|157555209|FG000|Overall Study|Withdrawal by Subject|1|||
48923772|NCT00711100|157555218|FG000|Overall Study|Lack of Efficacy|5|||
48923773|NCT00711100|157555218|FG000|Overall Study|Withdrawal by Subject|8|||
49163124|NCT03362502|158434778|FG000|Overall Study|Death|0|||
48923774|NCT03548558|157555219|FG000|Phase 1: 16 Total Fortnightly Sessions|Death|2|||
48923775|NCT03548558|157555220|FG001|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
48923776|NCT03548558|157555221|FG002|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
49163125|NCT03362502|158434779|FG001|Overall Study|Death|0|||
48923777|NCT03548558|157555222|FG003|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
48923778|NCT03548558|157555223|FG004|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
48923779|NCT03548558|157555224|FG005|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
49163126|NCT03362502|158434780|FG002|Overall Study|Death|1|||
48836281|NCT02139046|157242782|FG002|Overall Study|Voluntary Withdrawal|10|||
48836282|NCT02139046|157242783|FG003|Overall Study|Voluntary Withdrawal|15|||
48836283|NCT02139046|157242784|FG004|Overall Study|Voluntary Withdrawal|16|||
48836284|NCT02139046|157242780|FG000|Overall Study|Lack of Efficacy|0|||
48836285|NCT02139046|157242781|FG001|Overall Study|Lack of Efficacy|1|||
48836286|NCT02139046|157242782|FG002|Overall Study|Lack of Efficacy|2|||
48836287|NCT02139046|157242783|FG003|Overall Study|Lack of Efficacy|1|||
48836288|NCT02139046|157242784|FG004|Overall Study|Lack of Efficacy|2|||
48836289|NCT02139046|157242780|FG000|Overall Study|Withdrawal due to a Gout Flare|1|||
48836290|NCT02139046|157242781|FG001|Overall Study|Withdrawal due to a Gout Flare|1|||
48836291|NCT02139046|157242782|FG002|Overall Study|Withdrawal due to a Gout Flare|1|||
48836292|NCT02139046|157242783|FG003|Overall Study|Withdrawal due to a Gout Flare|0|||
48836293|NCT02139046|157242784|FG004|Overall Study|Withdrawal due to a Gout Flare|1|||
48836294|NCT02139046|157242780|FG000|Overall Study|Other Miscellaneous Reasons|10|||
48836295|NCT02139046|157242781|FG001|Overall Study|Other Miscellaneous Reasons|9|||
48836296|NCT02139046|157242782|FG002|Overall Study|Other Miscellaneous Reasons|4|||
48836297|NCT02139046|157242783|FG003|Overall Study|Other Miscellaneous Reasons|9|||
48836298|NCT02139046|157242784|FG004|Overall Study|Other Miscellaneous Reasons|12|||
48836299|NCT00244855|157242792|FG000|Overall Study|Withdrawal by Subject|0|||
48836300|NCT00244855|157242793|FG001|Overall Study|Withdrawal by Subject|1|||
48836301|NCT02441036|157242796|FG000|Overall Study|No tissue resected|0|||
48836302|NCT02441036|157242797|FG001|Overall Study|No tissue resected|1|||
48836303|NCT02441036|157242798|FG002|Overall Study|No tissue resected|0|||
48836304|NCT02441036|157242799|FG003|Overall Study|No tissue resected|1|||
48836305|NCT02441036|157242800|FG004|Overall Study|No tissue resected|0|||
48836306|NCT01254019|157242801|FG000|Overall Study|Adverse Event|0|||
48836307|NCT01254019|157242802|FG001|Overall Study|Adverse Event|2|||
48836308|NCT01254019|157242801|FG000|Overall Study|Protocol Violation|1|||
48836309|NCT01254019|157242802|FG001|Overall Study|Protocol Violation|0|||
48836310|NCT01254019|157242801|FG000|Overall Study|Withdrawal by Subject|0|||
48836311|NCT01254019|157242802|FG001|Overall Study|Withdrawal by Subject|2|||
48836312|NCT03061474|157242803|FG000|Overall Study|Adverse Event|2|||
48836313|NCT03061474|157242804|FG001|Overall Study|Adverse Event|0|||
48836314|NCT03061474|157242803|FG000|Overall Study|Safety Risk|0|||
48836315|NCT03061474|157242804|FG001|Overall Study|Safety Risk|1|||
48836316|NCT03061474|157242803|FG000|Overall Study|Participant unwilling or unable to participate|0|||
48836317|NCT03061474|157242804|FG001|Overall Study|Participant unwilling or unable to participate|2|||
48836318|NCT03061474|157242803|FG000|Overall Study|Lost to Follow-up|0|||
48836319|NCT03061474|157242804|FG001|Overall Study|Lost to Follow-up|1|||
48836320|NCT01505881|157242805|FG000|Overall Study|Adverse Event|0|||
48836321|NCT01505881|157242806|FG001|Overall Study|Adverse Event|1|||
48836322|NCT01505881|157242805|FG000|Overall Study|Lost to Follow-up|2|||
48836323|NCT01505881|157242806|FG001|Overall Study|Lost to Follow-up|0|||
48836324|NCT01505881|157242805|FG000|Overall Study|Withdrawal by Subject|2|||
48836325|NCT01505881|157242806|FG001|Overall Study|Withdrawal by Subject|0|||
48836326|NCT00842257|157242807|FG000|Overall Study|Adverse Event|1|||
48836327|NCT01147341|157242808|FG000|Double Blind Period|Lack of Efficacy|1|||
48836328|NCT01147341|157242809|FG001|Double Blind Period|Lack of Efficacy|1|||
48836329|NCT01147341|157242808|FG000|Double Blind Period|Withdrawal by Subject|0|||
48836330|NCT01147341|157242809|FG001|Double Blind Period|Withdrawal by Subject|1|||
48836331|NCT01147341|157242808|FG000|Open Label Period|Lack of Efficacy|3|||
48836332|NCT01147341|157242809|FG001|Open Label Period|Lack of Efficacy|0|||
48836333|NCT01147341|157242808|FG000|Open Label Period|Subject moved|1|||
48836334|NCT01147341|157242809|FG001|Open Label Period|Subject moved|0|||
48836335|NCT03257813|157242810|FG000|Overall Study|Protocol Violation|6|||
48836336|NCT03257813|157242811|FG001|Overall Study|Protocol Violation|3|||
48836337|NCT00177216|157242812|FG000|Overall Study|Withdrawal by Subject|6|||
48836338|NCT00177216|157242813|FG001|Overall Study|Withdrawal by Subject|3|||
48836339|NCT00177216|157242814|FG002|Overall Study|Withdrawal by Subject|1|||
48836340|NCT03024606|157242817|FG000|Overall Study|Withdrawal by Subject|9|||
48836341|NCT03024606|157242818|FG001|Overall Study|Withdrawal by Subject|10|||
48836342|NCT01161498|157242825|FG000|Overall Study|Disease Progression|0|||
48836343|NCT01161498|157242826|FG001|Overall Study|Disease Progression|1|||
48836344|NCT00258895|157242830|FG000|Overall Study|Lost to Follow-up|3|||
48836345|NCT00258895|157242831|FG001|Overall Study|Lost to Follow-up|1|||
48836346|NCT00258895|157242830|FG000|Overall Study|Protocol Violation|6|||
48836347|NCT00258895|157242831|FG001|Overall Study|Protocol Violation|2|||
48836348|NCT00258895|157242830|FG000|Overall Study|Withdrawal by Subject|1|||
48836349|NCT00258895|157242831|FG001|Overall Study|Withdrawal by Subject|0|||
48836350|NCT05609032|157242832|FG000|Overall Study|Lost to Follow-up|3|||
48836351|NCT05609032|157242833|FG001|Overall Study|Lost to Follow-up|1|||
48836352|NCT05609032|157242832|FG000|Overall Study|Withdrawal by Subject|1|||
48836353|NCT05609032|157242833|FG001|Overall Study|Withdrawal by Subject|0|||
48836354|NCT02031471|157242836|FG000|24 Week Treatment Period|Adverse Event|6|||
48836355|NCT02031471|157242836|FG000|24 Week Treatment Period|Participant Decision to Withdraw|2|||
48836356|NCT02031471|157242836|FG000|24 Week Treatment Period|Protocol Violation|1|||
48836357|NCT02031471|157242836|FG000|24 Week Treatment Period|Insufficient Therapeutic Response|1|||
49163139|NCT02883049|158434784|FG000|Induction|Adverse Event|52|||
49163140|NCT02883049|158434785|FG001|Induction|Adverse Event|2|||
49163141|NCT02883049|158434786|FG002|Induction|Adverse Event|0|||
49163142|NCT02883049|158434787|FG003|Induction|Adverse Event|0|||
49163143|NCT02883049|158434788|FG004|Induction|Adverse Event|0|||
49163144|NCT02883049|158434789|FG005|Induction|Adverse Event|0|||
49163145|NCT02883049|158434790|FG006|Induction|Adverse Event|0|||
49163146|NCT02883049|158434791|FG007|Induction|Adverse Event|0|||
49163147|NCT02883049|158434792|FG008|Induction|Adverse Event|0|||
49163148|NCT02883049|158434793|FG009|Induction|Adverse Event|0|||
49163149|NCT02883049|158434794|FG010|Induction|Adverse Event|0|||
49163150|NCT02883049|158434795|FG011|Induction|Adverse Event|0|||
49163151|NCT02883049|158434796|FG012|Induction|Adverse Event|0|||
49163152|NCT02883049|158434797|FG013|Induction|Adverse Event|0|||
49163153|NCT02883049|158434798|FG014|Induction|Adverse Event|0|||
49163154|NCT02883049|158434799|FG015|Induction|Adverse Event|0|||
49163155|NCT02883049|158434784|FG000|Induction|Death|76|||
49163156|NCT02883049|158434785|FG001|Induction|Death|8|||
49163157|NCT02883049|158434786|FG002|Induction|Death|0|||
49163158|NCT02883049|158434787|FG003|Induction|Death|0|||
49163159|NCT02883049|158434788|FG004|Induction|Death|0|||
49163160|NCT02883049|158434789|FG005|Induction|Death|0|||
49163161|NCT02883049|158434790|FG006|Induction|Death|0|||
49163162|NCT02883049|158434791|FG007|Induction|Death|0|||
49163163|NCT02883049|158434792|FG008|Induction|Death|0|||
48836358|NCT02031471|157242836|FG000|24 Week Treatment Period|Hypersensitivity Reaction|1|||
48836359|NCT02031471|157242836|FG000|Long Term Extension (LTE) Period|Adverse Event|1|||
48836360|NCT02031471|157242836|FG000|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1|||
48836361|NCT00732381|157242837|FG000|Overall Study|Adverse Event|1|||
48836362|NCT00732381|157242838|FG001|Overall Study|Adverse Event|0|||
48836363|NCT00732381|157242837|FG000|Overall Study|Treatment Failure|1|||
48836364|NCT00732381|157242838|FG001|Overall Study|Treatment Failure|1|||
48836365|NCT01353963|157242841|FG000|Overall Study|Adverse Event|2|||
48836366|NCT00617201|157242842|FG000|Overall Study|Lost to Follow-up|9|||
48836367|NCT00617201|157242843|FG001|Overall Study|Lost to Follow-up|13|||
48836368|NCT02670525|157242849|FG000|Overall Study|Death|94|||
48836369|NCT02670525|157242850|FG001|Overall Study|Death|14|||
48836370|NCT02670525|157242849|FG000|Overall Study|Lost to Follow-up|4|||
48836371|NCT02670525|157242850|FG001|Overall Study|Lost to Follow-up|1|||
48836372|NCT02670525|157242849|FG000|Overall Study|Subject withdrew consent|1|||
48836373|NCT02670525|157242850|FG001|Overall Study|Subject withdrew consent|0|||
48836374|NCT02670525|157242849|FG000|Overall Study|Unknown, data entry delayed|123|||
48836375|NCT02670525|157242850|FG001|Overall Study|Unknown, data entry delayed|78|||
48836376|NCT03227757|157244041|FG000|Overall Study|Death|25|||
48836377|NCT03227757|157244041|FG000|Overall Study|Withdrawal|10|||
48836378|NCT03227757|157244041|FG000|Overall Study|Missed visits|1|||
48836379|NCT03227757|157244041|FG000|Overall Study|Lost to Follow-up|2|||
48836380|NCT02263508|157244043|FG000|Overall Study|Withdrawal by Subject|1|||
49163164|NCT02883049|158434793|FG009|Induction|Death|0|||
49163165|NCT02883049|158434794|FG010|Induction|Death|0|||
49163166|NCT02883049|158434795|FG011|Induction|Death|0|||
49163167|NCT02883049|158434796|FG012|Induction|Death|0|||
49163168|NCT02883049|158434797|FG013|Induction|Death|0|||
49163169|NCT02883049|158434798|FG014|Induction|Death|0|||
49163170|NCT02883049|158434799|FG015|Induction|Death|0|||
49163171|NCT02883049|158434784|FG000|Induction|Lost to Follow-up|2|||
49163172|NCT02883049|158434785|FG001|Induction|Lost to Follow-up|0|||
49163173|NCT02883049|158434786|FG002|Induction|Lost to Follow-up|0|||
49163174|NCT02883049|158434787|FG003|Induction|Lost to Follow-up|0|||
49163175|NCT02883049|158434788|FG004|Induction|Lost to Follow-up|0|||
49163176|NCT02883049|158434789|FG005|Induction|Lost to Follow-up|0|||
48836381|NCT02263508|157244044|FG001|Overall Study|Withdrawal by Subject|23|||
48836382|NCT02263508|157244045|FG002|Overall Study|Withdrawal by Subject|17|||
48836383|NCT02263508|157244043|FG000|Overall Study|Sponsor Decision|12|||
48836384|NCT02263508|157244044|FG001|Overall Study|Sponsor Decision|165|||
48836385|NCT02263508|157244045|FG002|Overall Study|Sponsor Decision|182|||
48836386|NCT02263508|157244043|FG000|Overall Study|Lost to Follow-up|2|||
48836387|NCT02263508|157244044|FG001|Overall Study|Lost to Follow-up|7|||
48836388|NCT02263508|157244045|FG002|Overall Study|Lost to Follow-up|7|||
48836389|NCT02263508|157244043|FG000|Overall Study|Death|6|||
48836390|NCT02263508|157244044|FG001|Overall Study|Death|151|||
48836391|NCT02263508|157244045|FG002|Overall Study|Death|140|||
48836392|NCT01259102|157244046|FG000|Overall Study|Adverse Event|1|||
48836393|NCT01259102|157244047|FG001|Overall Study|Adverse Event|0|||
48836394|NCT01259102|157244048|FG002|Overall Study|Adverse Event|1|||
48836395|NCT01259102|157244049|FG003|Overall Study|Adverse Event|1|||
48836396|NCT01259102|157244050|FG004|Overall Study|Adverse Event|0|||
48836397|NCT01259102|157244046|FG000|Overall Study|Other|0|||
48836398|NCT01259102|157244047|FG001|Overall Study|Other|0|||
48836399|NCT01259102|157244048|FG002|Overall Study|Other|1|||
48836400|NCT01259102|157244049|FG003|Overall Study|Other|1|||
48836401|NCT01259102|157244050|FG004|Overall Study|Other|1|||
48836402|NCT02488980|157244053|FG000|Overall Study|Protocol Violation|2|||
48836403|NCT02488980|157244054|FG001|Overall Study|Protocol Violation|2|||
48836404|NCT02488980|157244055|FG002|Overall Study|Protocol Violation|2|||
48836405|NCT03546907|157244056|FG000|Overall Study|Lack of Efficacy|1|||
48836406|NCT03546907|157244057|FG001|Overall Study|Lack of Efficacy|1|||
48836407|NCT03546907|157244056|FG000|Overall Study|Withdrawal by Subject|8|||
48836408|NCT03546907|157244057|FG001|Overall Study|Withdrawal by Subject|9|||
48836409|NCT03546907|157244056|FG000|Overall Study|Adverse events (AEs)|7|||
48836410|NCT03546907|157244057|FG001|Overall Study|Adverse events (AEs)|10|||
48836411|NCT03546907|157244056|FG000|Overall Study|Other-unspecified|1|||
48836412|NCT03546907|157244057|FG001|Overall Study|Other-unspecified|1|||
48836413|NCT02810080|157244058|FG000|Overall Study|Adverse Event|3|||
48836414|NCT02810080|157244059|FG001|Overall Study|Adverse Event|0|||
48836415|NCT02810080|157244058|FG000|Overall Study|Death|0|||
48836416|NCT02810080|157244059|FG001|Overall Study|Death|2|||
48836417|NCT02810080|157244058|FG000|Overall Study|Physician Decision|4|||
48836418|NCT02810080|157244059|FG001|Overall Study|Physician Decision|0|||
48836419|NCT02810080|157244058|FG000|Overall Study|Withdrawal by Subject|0|||
48836420|NCT02810080|157244059|FG001|Overall Study|Withdrawal by Subject|2|||
48836421|NCT02027558|157244066|FG000|Overall Study|Death|0|||
48836422|NCT02027558|157244067|FG001|Overall Study|Death|1|||
48836423|NCT02027558|157244066|FG000|Overall Study|Withdrawal by Subject|2|||
48836424|NCT02027558|157244067|FG001|Overall Study|Withdrawal by Subject|0|||
48836425|NCT02027558|157244066|FG000|Overall Study|Lost to Follow-up|4|||
48836426|NCT02027558|157244067|FG001|Overall Study|Lost to Follow-up|1|||
48836427|NCT02027558|157244066|FG000|Overall Study|Refused assessment|3|||
48836428|NCT02027558|157244067|FG001|Overall Study|Refused assessment|0|||
48836429|NCT00114244|157244072|FG000|Overall Study|Adverse Event|2|||
48836430|NCT00114244|157244073|FG001|Overall Study|Adverse Event|5|||
48836431|NCT00114244|157244072|FG000|Overall Study|Withdrawal by Subject|0|||
48836432|NCT00114244|157244073|FG001|Overall Study|Withdrawal by Subject|2|||
48836433|NCT02698891|157244074|FG000|Overall Study|Withdrawal by Subject|2|||
48836434|NCT02698891|157244074|FG000|Overall Study|deemed ineligible|1|||
48836435|NCT02698891|157244074|FG000|Overall Study|Adverse Event|9|||
48836436|NCT00711958|157244075|FG000|Overall Study|Withdrawal by Subject|6|||
48836437|NCT00711958|157244076|FG001|Overall Study|Withdrawal by Subject|8|||
48836438|NCT00711958|157244075|FG000|Overall Study|Lack of Efficacy|3|||
48836439|NCT00711958|157244076|FG001|Overall Study|Lack of Efficacy|1|||
48836440|NCT00711958|157244075|FG000|Overall Study|Clinical deterioration|1|||
48836441|NCT00711958|157244076|FG001|Overall Study|Clinical deterioration|0|||
48836442|NCT00711958|157244075|FG000|Overall Study|Adverse Event|9|||
48836443|NCT00711958|157244076|FG001|Overall Study|Adverse Event|7|||
48836444|NCT00711958|157244075|FG000|Overall Study|Protocol Violation|1|||
48836445|NCT00711958|157244076|FG001|Overall Study|Protocol Violation|0|||
48836446|NCT00711958|157244075|FG000|Overall Study|Lost to Follow-up|2|||
48836447|NCT00711958|157244076|FG001|Overall Study|Lost to Follow-up|2|||
48836448|NCT00711958|157244075|FG000|Overall Study|Death|10|||
48836449|NCT00711958|157244076|FG001|Overall Study|Death|5|||
48836450|NCT00711958|157244075|FG000|Overall Study|Progression of disease|1|||
48836451|NCT00711958|157244076|FG001|Overall Study|Progression of disease|0|||
48836452|NCT00738699|157244077|FG000|Overall Study|Withdrawal by Subject|5|||
48836453|NCT00738699|157244078|FG001|Overall Study|Withdrawal by Subject|0|||
48836454|NCT00738699|157244077|FG000|Overall Study|Lost to Follow-up|1|||
48923780|NCT03548558|157555225|FG006|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
48836455|NCT00738699|157244078|FG001|Overall Study|Lost to Follow-up|0|||
48836456|NCT00738699|157244077|FG000|Overall Study|Death|144|||
48836457|NCT00738699|157244078|FG001|Overall Study|Death|68|||
48836458|NCT00738699|157244077|FG000|Overall Study|Discontinuation of study by Sponsor|123|||
48836459|NCT00738699|157244078|FG001|Overall Study|Discontinuation of study by Sponsor|72|||
48836460|NCT00738699|157244077|FG000|Overall Study|Other|2|||
48836461|NCT00738699|157244078|FG001|Overall Study|Other|0|||
48836462|NCT01458210|157244081|FG000|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2|||
48836463|NCT01458210|157244081|FG000|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2|||
48836464|NCT01458210|157244081|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2|||
48836465|NCT01458210|157244081|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1|||
48836466|NCT03020745|157244082|FG000|Part 2 (Up to 169 Days)|Adverse Event|0|||
48836467|NCT03020745|157244083|FG001|Part 2 (Up to 169 Days)|Adverse Event|0|||
48836468|NCT03020745|157244084|FG002|Part 2 (Up to 169 Days)|Adverse Event|0|||
48836469|NCT03020745|157244085|FG003|Part 2 (Up to 169 Days)|Adverse Event|0|||
48836470|NCT03020745|157244086|FG004|Part 2 (Up to 169 Days)|Adverse Event|0|||
48836471|NCT03020745|157244087|FG005|Part 2 (Up to 169 Days)|Adverse Event|0|||
48836472|NCT03020745|157244088|FG006|Part 2 (Up to 169 Days)|Adverse Event|0|||
48836473|NCT03020745|157244089|FG007|Part 2 (Up to 169 Days)|Adverse Event|0|||
48836474|NCT03020745|157244090|FG008|Part 2 (Up to 169 Days)|Adverse Event|1|||
48836475|NCT03020745|157244091|FG009|Part 2 (Up to 169 Days)|Adverse Event|0|||
48836476|NCT03020745|157244082|FG000|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
48836477|NCT03020745|157244083|FG001|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
48836478|NCT03020745|157244084|FG002|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
48836479|NCT03020745|157244085|FG003|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
48836480|NCT03020745|157244086|FG004|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
48836481|NCT03020745|157244087|FG005|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
48836482|NCT03020745|157244088|FG006|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
48836483|NCT03020745|157244089|FG007|Part 2 (Up to 169 Days)|Withdrawal by Subject|1|||
48836484|NCT03020745|157244090|FG008|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
48836485|NCT03020745|157244091|FG009|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
48836486|NCT03020745|157244082|FG000|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
48836487|NCT03020745|157244083|FG001|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
48836488|NCT03020745|157244084|FG002|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
48836489|NCT03020745|157244085|FG003|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
48836490|NCT03020745|157244086|FG004|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
48836491|NCT03020745|157244087|FG005|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
48836492|NCT03020745|157244088|FG006|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
48836493|NCT03020745|157244089|FG007|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
48836494|NCT03020745|157244090|FG008|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
48836495|NCT03020745|157244091|FG009|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
48836496|NCT03020745|157244082|FG000|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
48836497|NCT03020745|157244083|FG001|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
48836498|NCT03020745|157244084|FG002|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
48836499|NCT03020745|157244085|FG003|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
48836500|NCT03020745|157244086|FG004|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
48836501|NCT03020745|157244087|FG005|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
48836502|NCT03020745|157244088|FG006|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
48836503|NCT03020745|157244089|FG007|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
48836504|NCT03020745|157244090|FG008|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2|||
48836505|NCT03020745|157244091|FG009|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
49014730|NCT02585258|157890363|FG000|Overall Study|Adverse Event|28|||
48836506|NCT02296424|157244092|FG000|Part 1|New therapy for study indication|0|||
48836507|NCT02296424|157244093|FG001|Part 1|New therapy for study indication|1|||
48836508|NCT02296424|157244094|FG002|Part 1|New therapy for study indication|0|||
48836509|NCT02296424|157244095|FG003|Part 1|New therapy for study indication|0|||
48836510|NCT02296424|157244092|FG000|Part 1|Protocol Violation|0|||
48836511|NCT02296424|157244093|FG001|Part 1|Protocol Violation|1|||
48836512|NCT02296424|157244094|FG002|Part 1|Protocol Violation|0|||
48836513|NCT02296424|157244095|FG003|Part 1|Protocol Violation|0|||
48836514|NCT02296424|157244092|FG000|Part 1|Withdrawal by Subject|0|||
48836515|NCT02296424|157244093|FG001|Part 1|Withdrawal by Subject|2|||
48836516|NCT02296424|157244094|FG002|Part 1|Withdrawal by Subject|0|||
48836517|NCT02296424|157244095|FG003|Part 1|Withdrawal by Subject|0|||
48836518|NCT02296424|157244092|FG000|Part 1|Study terminated by sponsor|0|||
48836519|NCT02296424|157244093|FG001|Part 1|Study terminated by sponsor|1|||
48836520|NCT02296424|157244094|FG002|Part 1|Study terminated by sponsor|0|||
48836521|NCT02296424|157244095|FG003|Part 1|Study terminated by sponsor|0|||
48836522|NCT02296424|157244092|FG000|Part 1|Adverse Event|2|||
48836523|NCT02296424|157244093|FG001|Part 1|Adverse Event|11|||
48836524|NCT02296424|157244094|FG002|Part 1|Adverse Event|0|||
48836525|NCT02296424|157244095|FG003|Part 1|Adverse Event|0|||
48836526|NCT02296424|157244092|FG000|Part 1|Lack of Efficacy|5|||
48836527|NCT02296424|157244093|FG001|Part 1|Lack of Efficacy|17|||
48836528|NCT02296424|157244094|FG002|Part 1|Lack of Efficacy|0|||
48836529|NCT02296424|157244095|FG003|Part 1|Lack of Efficacy|0|||
48836530|NCT02296424|157244092|FG000|Part 1|16 directly started part II|16|||
48836531|NCT02296424|157244093|FG001|Part 1|16 directly started part II|0|||
48836532|NCT02296424|157244094|FG002|Part 1|16 directly started part II|0|||
48836533|NCT02296424|157244095|FG003|Part 1|16 directly started part II|0|||
48836534|NCT02296424|157244092|FG000|Part 2|Lack of Efficacy|0|||
48836535|NCT02296424|157244093|FG001|Part 2|Lack of Efficacy|0|||
48836536|NCT02296424|157244094|FG002|Part 2|Lack of Efficacy|1|||
48836537|NCT02296424|157244095|FG003|Part 2|Lack of Efficacy|0|||
48836538|NCT02296424|157244092|FG000|Part 2|Adverse Event|0|||
48836539|NCT02296424|157244093|FG001|Part 2|Adverse Event|0|||
48836540|NCT02296424|157244094|FG002|Part 2|Adverse Event|1|||
48836541|NCT02296424|157244095|FG003|Part 2|Adverse Event|0|||
48836542|NCT02296424|157244092|FG000|Part 2|Lost to Follow-up|0|||
48836543|NCT02296424|157244093|FG001|Part 2|Lost to Follow-up|0|||
48836544|NCT02296424|157244094|FG002|Part 2|Lost to Follow-up|1|||
48836545|NCT02296424|157244095|FG003|Part 2|Lost to Follow-up|0|||
48836546|NCT02613871|157244105|FG000|Overall Study|Death|2|||
48836547|NCT02613871|157244105|FG000|Overall Study|Withdrew Consent|1|||
48836548|NCT01930045|157244108|FG000|Pause (up to 37 Days)|Withdrawal by Subject|0|||
48836549|NCT01930045|157244109|FG001|Pause (up to 37 Days)|Withdrawal by Subject|0|||
48836550|NCT01930045|157244110|FG002|Pause (up to 37 Days)|Withdrawal by Subject|0|||
48836551|NCT01930045|157244111|FG003|Pause (up to 37 Days)|Withdrawal by Subject|0|||
48836552|NCT01930045|157244112|FG004|Pause (up to 37 Days)|Withdrawal by Subject|0|||
48836553|NCT01930045|157244113|FG005|Pause (up to 37 Days)|Withdrawal by Subject|1|||
48836554|NCT01930045|157244108|FG000|Pause (up to 37 Days)|Protocol Violation|0|||
48836555|NCT01930045|157244109|FG001|Pause (up to 37 Days)|Protocol Violation|0|||
48836556|NCT01930045|157244110|FG002|Pause (up to 37 Days)|Protocol Violation|0|||
48836557|NCT01930045|157244111|FG003|Pause (up to 37 Days)|Protocol Violation|0|||
48836558|NCT01930045|157244112|FG004|Pause (up to 37 Days)|Protocol Violation|0|||
48836559|NCT01930045|157244113|FG005|Pause (up to 37 Days)|Protocol Violation|1|||
48836560|NCT00813904|157244114|FG000|Overall Study|Death|1|||
48836561|NCT01140048|157244117|FG000|Overall Study|Physician Decision|1|||
48836562|NCT01140048|157244117|FG000|Overall Study|Withdrawal by Subject|13|||
48836563|NCT01140048|157244117|FG000|Overall Study|Lost to Follow-up|31|||
48836564|NCT03615924|157244120|FG000|Overall Study|Withdrawal by Subject|2|||
48836565|NCT03615924|157244121|FG001|Overall Study|Withdrawal by Subject|5|||
48836566|NCT03615924|157244120|FG000|Overall Study|Death|3|||
48836567|NCT03615924|157244121|FG001|Overall Study|Death|1|||
48836568|NCT03615924|157244120|FG000|Overall Study|Lost to Follow-up|1|||
48836569|NCT03615924|157244121|FG001|Overall Study|Lost to Follow-up|0|||
48836570|NCT03615924|157244120|FG000|Overall Study|Randomized in error|1|||
48836571|NCT03615924|157244121|FG001|Overall Study|Randomized in error|0|||
48836572|NCT03615924|157244120|FG000|Overall Study|Study termination by Sponsor|94|||
48836573|NCT03615924|157244121|FG001|Overall Study|Study termination by Sponsor|86|||
48836574|NCT02880241|157244122|FG000|Overall Study|Lack of Efficacy|1|||
48836575|NCT02880241|157244123|FG001|Overall Study|Lack of Efficacy|0|||
48836576|NCT02880241|157244124|FG002|Overall Study|Lack of Efficacy|0|||
48836577|NCT02880241|157244125|FG003|Overall Study|Lack of Efficacy|0|||
48836578|NCT02880241|157244126|FG004|Overall Study|Lack of Efficacy|0|||
48836579|NCT02880241|157244127|FG005|Overall Study|Lack of Efficacy|0|||
48836580|NCT00102063|157244129|FG000|Overall Study|Lack of Efficacy|5|||
48836581|NCT00102063|157244130|FG001|Overall Study|Lack of Efficacy|1|||
48836582|NCT00102063|157244131|FG002|Overall Study|Lack of Efficacy|1|||
48836583|NCT00102063|157244129|FG000|Overall Study|Adverse Event|7|||
48836584|NCT00102063|157244130|FG001|Overall Study|Adverse Event|4|||
48836585|NCT00102063|157244131|FG002|Overall Study|Adverse Event|2|||
48836586|NCT00102063|157244129|FG000|Overall Study|Withdrawal by Subject|4|||
48836587|NCT00102063|157244130|FG001|Overall Study|Withdrawal by Subject|12|||
48836588|NCT00102063|157244131|FG002|Overall Study|Withdrawal by Subject|5|||
48836589|NCT00102063|157244129|FG000|Overall Study|Lost to Follow-up|0|||
48836590|NCT00102063|157244130|FG001|Overall Study|Lost to Follow-up|0|||
48836591|NCT00102063|157244131|FG002|Overall Study|Lost to Follow-up|1|||
48836592|NCT00102063|157244129|FG000|Overall Study|Protocol Violation|0|||
48836593|NCT00102063|157244130|FG001|Overall Study|Protocol Violation|1|||
48836594|NCT00102063|157244131|FG002|Overall Study|Protocol Violation|1|||
48836595|NCT01692938|157244134|FG000|Overall Study|Protocol Deviation|1|||
48836596|NCT01692938|157244135|FG001|Overall Study|Protocol Deviation|1|||
48836597|NCT01692938|157244134|FG000|Overall Study|Study completed prior to site completion|3|||
48836598|NCT01692938|157244135|FG001|Overall Study|Study completed prior to site completion|3|||
48836599|NCT05686421|157244136|FG000|Overall Study|Screen failure|22|||
48836600|NCT05686421|157244137|FG001|Overall Study|Screen failure|0|||
48836601|NCT05686421|157244138|FG002|Overall Study|Screen failure|0|||
48836602|NCT05686421|157244139|FG003|Overall Study|Screen failure|0|||
48836603|NCT02471755|157244140|FG000|Overall Study|Withdrawal by Subject|1|||
48836604|NCT02471755|157244141|FG001|Overall Study|Withdrawal by Subject|0|||
48836605|NCT02471755|157244140|FG000|Overall Study|Lost to Follow-up|0|||
48836606|NCT02471755|157244141|FG001|Overall Study|Lost to Follow-up|1|||
48836607|NCT02020616|157244144|FG000|Overall Study|Adverse Event|0|||
48836608|NCT02020616|157244145|FG001|Overall Study|Adverse Event|0|||
48836609|NCT02020616|157244146|FG002|Overall Study|Adverse Event|0|||
48836610|NCT02020616|157244147|FG003|Overall Study|Adverse Event|0|||
48836611|NCT02020616|157244148|FG004|Overall Study|Adverse Event|0|||
48836612|NCT02020616|157244149|FG005|Overall Study|Adverse Event|1|||
48836613|NCT02020616|157244150|FG006|Overall Study|Adverse Event|1|||
48836614|NCT02020616|157244144|FG000|Overall Study|Physician Decision|0|||
48836615|NCT02020616|157244145|FG001|Overall Study|Physician Decision|0|||
48836616|NCT02020616|157244146|FG002|Overall Study|Physician Decision|0|||
48836617|NCT02020616|157244147|FG003|Overall Study|Physician Decision|0|||
48836618|NCT02020616|157244148|FG004|Overall Study|Physician Decision|0|||
48836619|NCT02020616|157244149|FG005|Overall Study|Physician Decision|1|||
49163177|NCT02883049|158434790|FG006|Induction|Lost to Follow-up|0|||
49163178|NCT02883049|158434791|FG007|Induction|Lost to Follow-up|0|||
48836620|NCT02020616|157244150|FG006|Overall Study|Physician Decision|2|||
48836621|NCT02020616|157244144|FG000|Overall Study|Withdrawal by Subject|0|||
48836622|NCT02020616|157244145|FG001|Overall Study|Withdrawal by Subject|0|||
48836623|NCT02020616|157244146|FG002|Overall Study|Withdrawal by Subject|1|||
48836624|NCT02020616|157244147|FG003|Overall Study|Withdrawal by Subject|0|||
48836625|NCT02020616|157244148|FG004|Overall Study|Withdrawal by Subject|0|||
48836626|NCT02020616|157244149|FG005|Overall Study|Withdrawal by Subject|1|||
48836627|NCT02020616|157244150|FG006|Overall Study|Withdrawal by Subject|1|||
48836628|NCT02020616|157244144|FG000|Overall Study|Lost to Follow-up|0|||
48836629|NCT02020616|157244145|FG001|Overall Study|Lost to Follow-up|1|||
48836630|NCT02020616|157244146|FG002|Overall Study|Lost to Follow-up|0|||
48836631|NCT02020616|157244147|FG003|Overall Study|Lost to Follow-up|1|||
48836632|NCT02020616|157244148|FG004|Overall Study|Lost to Follow-up|1|||
48923781|NCT03548558|157555219|FG000|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
48923782|NCT03548558|157555220|FG001|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
48923783|NCT03548558|157555221|FG002|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
48923784|NCT03548558|157555222|FG003|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
48923785|NCT03548558|157555223|FG004|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|2|||
48923786|NCT03548558|157555224|FG005|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
48923787|NCT03548558|157555225|FG006|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
48923788|NCT03548558|157555219|FG000|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|7|||
48923789|NCT03548558|157555220|FG001|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|15|||
48923790|NCT03548558|157555221|FG002|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|9|||
48923791|NCT03548558|157555222|FG003|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|13|||
48923792|NCT03548558|157555223|FG004|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|24|||
49163179|NCT02883049|158434792|FG008|Induction|Lost to Follow-up|0|||
48836633|NCT02020616|157244149|FG005|Overall Study|Lost to Follow-up|1|||
48836634|NCT02020616|157244150|FG006|Overall Study|Lost to Follow-up|0|||
48836635|NCT02020616|157244144|FG000|Overall Study|Early Termination Criteria Met|0|||
48836636|NCT02020616|157244145|FG001|Overall Study|Early Termination Criteria Met|0|||
48836637|NCT02020616|157244146|FG002|Overall Study|Early Termination Criteria Met|1|||
48836638|NCT02020616|157244147|FG003|Overall Study|Early Termination Criteria Met|0|||
48836639|NCT02020616|157244148|FG004|Overall Study|Early Termination Criteria Met|0|||
48836640|NCT02020616|157244149|FG005|Overall Study|Early Termination Criteria Met|1|||
48836641|NCT02020616|157244150|FG006|Overall Study|Early Termination Criteria Met|0|||
48836642|NCT02020616|157244144|FG000|Overall Study|Randomized in Error|0|||
48836643|NCT02020616|157244145|FG001|Overall Study|Randomized in Error|0|||
48836644|NCT02020616|157244146|FG002|Overall Study|Randomized in Error|0|||
48836645|NCT02020616|157244147|FG003|Overall Study|Randomized in Error|1|||
48836646|NCT02020616|157244148|FG004|Overall Study|Randomized in Error|0|||
48836647|NCT02020616|157244149|FG005|Overall Study|Randomized in Error|0|||
48836648|NCT02020616|157244150|FG006|Overall Study|Randomized in Error|0|||
48836649|NCT02020616|157244144|FG000|Overall Study|Lack of Efficacy|0|||
48836650|NCT02020616|157244145|FG001|Overall Study|Lack of Efficacy|0|||
48836651|NCT02020616|157244146|FG002|Overall Study|Lack of Efficacy|0|||
48836652|NCT02020616|157244147|FG003|Overall Study|Lack of Efficacy|0|||
48836653|NCT02020616|157244148|FG004|Overall Study|Lack of Efficacy|1|||
48836654|NCT02020616|157244149|FG005|Overall Study|Lack of Efficacy|0|||
48836655|NCT02020616|157244150|FG006|Overall Study|Lack of Efficacy|0|||
48836656|NCT01597258|157244151|FG000|Overall Study|No Drug Administration|1|||
48836657|NCT01580293|157245555|FG000|Part A_Main Trial|Adverse Event|0|||
48836658|NCT01580293|157245556|FG001|Part A_Main Trial|Adverse Event|2|||
48836659|NCT01580293|157245557|FG002|Part A_Main Trial|Adverse Event|0|||
48836660|NCT01580293|157245555|FG000|Part A_Main Trial|Withdrawal by Subject|1|||
48836661|NCT01580293|157245556|FG001|Part A_Main Trial|Withdrawal by Subject|4|||
48836662|NCT01580293|157245557|FG002|Part A_Main Trial|Withdrawal by Subject|0|||
48836663|NCT01580293|157245555|FG000|Part A_Main Trial|Non-adherence to the protocol|1|||
48836664|NCT01580293|157245556|FG001|Part A_Main Trial|Non-adherence to the protocol|0|||
48836665|NCT01580293|157245557|FG002|Part A_Main Trial|Non-adherence to the protocol|0|||
48836666|NCT01580293|157245555|FG000|Part A_Extension|Adverse Event|0|||
48836667|NCT01580293|157245556|FG001|Part A_Extension|Adverse Event|2|||
48836668|NCT01580293|157245557|FG002|Part A_Extension|Adverse Event|0|||
48836669|NCT01580293|157245555|FG000|Part A_Extension|Withdrawal by Subject|0|||
48836670|NCT01580293|157245556|FG001|Part A_Extension|Withdrawal by Subject|3|||
48836671|NCT01580293|157245557|FG002|Part A_Extension|Withdrawal by Subject|0|||
48836672|NCT01580293|157245555|FG000|Part A_Extension|Lost to Follow-up|0|||
48836673|NCT01580293|157245556|FG001|Part A_Extension|Lost to Follow-up|1|||
48836674|NCT01580293|157245557|FG002|Part A_Extension|Lost to Follow-up|0|||
48836675|NCT01580293|157245555|FG000|Part A_Extension|Other Reason|0|||
49163180|NCT02883049|158434793|FG009|Induction|Lost to Follow-up|0|||
49163181|NCT02883049|158434794|FG010|Induction|Lost to Follow-up|0|||
49163182|NCT02883049|158434795|FG011|Induction|Lost to Follow-up|0|||
49163183|NCT02883049|158434796|FG012|Induction|Lost to Follow-up|0|||
49163184|NCT02883049|158434797|FG013|Induction|Lost to Follow-up|0|||
49163185|NCT02883049|158434798|FG014|Induction|Lost to Follow-up|0|||
49163186|NCT02883049|158434799|FG015|Induction|Lost to Follow-up|0|||
49163187|NCT02883049|158434784|FG000|Induction|Physician Decision|1407|||
49163188|NCT02883049|158434785|FG001|Induction|Physician Decision|8|||
49163189|NCT02883049|158434786|FG002|Induction|Physician Decision|0|||
49163190|NCT02883049|158434787|FG003|Induction|Physician Decision|0|||
49163191|NCT02883049|158434788|FG004|Induction|Physician Decision|0|||
48836676|NCT01580293|157245556|FG001|Part A_Extension|Other Reason|1|||
48836677|NCT01580293|157245557|FG002|Part A_Extension|Other Reason|0|||
48836678|NCT01580293|157245555|FG000|Part A_Extension|Completed Japan only|0|||
48836679|NCT01580293|157245556|FG001|Part A_Extension|Completed Japan only|5|||
48836680|NCT01580293|157245557|FG002|Part A_Extension|Completed Japan only|0|||
48836681|NCT01580293|157245555|FG000|Part B|Withdrawal by Subject|0|||
48836682|NCT01580293|157245556|FG001|Part B|Withdrawal by Subject|0|||
48836683|NCT01580293|157245557|FG002|Part B|Withdrawal by Subject|1|||
48836684|NCT01580293|157245555|FG000|Part B|Other reason|0|||
48836685|NCT01580293|157245556|FG001|Part B|Other reason|0|||
48836686|NCT01580293|157245557|FG002|Part B|Other reason|1|||
48836687|NCT02525796|157245558|FG000|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
48836688|NCT02525796|157245559|FG001|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
48836689|NCT02525796|157245560|FG002|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
48836690|NCT02525796|157245558|FG000|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|1|||
48836691|NCT02525796|157245559|FG001|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
48836692|NCT02525796|157245560|FG002|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
48836693|NCT02525796|157245558|FG000|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
48836694|NCT02525796|157245559|FG001|Randomization to Monotherapy for 4 Weeks|Physician Decision|1|||
48836695|NCT02525796|157245560|FG002|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
48836696|NCT02525796|157245558|FG000|Open-label Addition of Cinacalcet|Withdrawal by Subject|2|||
48836697|NCT02525796|157245559|FG001|Open-label Addition of Cinacalcet|Withdrawal by Subject|0|||
48836698|NCT02525796|157245560|FG002|Open-label Addition of Cinacalcet|Withdrawal by Subject|1|||
48836699|NCT02525796|157245558|FG000|Open-label Addition of Cinacalcet|Adverse Event|2|||
48836700|NCT02525796|157245559|FG001|Open-label Addition of Cinacalcet|Adverse Event|2|||
48836701|NCT02525796|157245560|FG002|Open-label Addition of Cinacalcet|Adverse Event|2|||
48836702|NCT02937831|157245563|FG000|Overall Study|Protocol Violation|4|||
48836703|NCT02983617|157245564|FG000|Overall Study|Adverse Event|0|||
48836704|NCT02983617|157245565|FG001|Overall Study|Adverse Event|7|||
48836705|NCT02983617|157245564|FG000|Overall Study|Death|0|||
48836706|NCT02983617|157245565|FG001|Overall Study|Death|1|||
48836707|NCT02983617|157245564|FG000|Overall Study|Investigator's Discretion|0|||
48836708|NCT02983617|157245565|FG001|Overall Study|Investigator's Discretion|1|||
48836709|NCT03720210|157245566|FG000|Overall Study|Lost to Follow-up|1|||
48836710|NCT02013830|157245567|FG000|Overall Study|Adverse Event|3|||
48836711|NCT02013830|157245567|FG000|Overall Study|Death|1|||
48836712|NCT02013830|157245567|FG000|Overall Study|Insufficient therapeutic response|25|||
48836713|NCT02013830|157245567|FG000|Overall Study|Refused treatment|1|||
48836714|NCT00393848|157245568|FG000|Overall Study|Surgical schedule|0|||
48836715|NCT00393848|157245569|FG001|Overall Study|Surgical schedule|0|||
48836716|NCT00393848|157245570|FG002|Overall Study|Surgical schedule|0|||
48836717|NCT00393848|157245571|FG003|Overall Study|Surgical schedule|1|||
48836718|NCT00393848|157245568|FG000|Overall Study|Personal reasons|0|||
48836719|NCT00393848|157245569|FG001|Overall Study|Personal reasons|0|||
48836720|NCT00393848|157245570|FG002|Overall Study|Personal reasons|2|||
48836721|NCT00393848|157245571|FG003|Overall Study|Personal reasons|0|||
48836722|NCT01064817|157245573|FG000|Study Completion|Physician Decision|1|||
48836723|NCT01064817|157245574|FG001|Study Completion|Physician Decision|0|||
48836724|NCT01064817|157245573|FG000|Study Completion|Withdrawal by Subject|1|||
48836725|NCT01064817|157245574|FG001|Study Completion|Withdrawal by Subject|0|||
48836726|NCT02694978|157245577|FG000|Overall Study|Adverse Event|10|||
48836727|NCT02694978|157245578|FG001|Overall Study|Adverse Event|9|||
48836728|NCT02694978|157245577|FG000|Overall Study|Withdrawal by Subject|22|||
48836729|NCT02694978|157245578|FG001|Overall Study|Withdrawal by Subject|19|||
48836730|NCT02694978|157245577|FG000|Overall Study|Lost to Follow-up|14|||
48836731|NCT02694978|157245578|FG001|Overall Study|Lost to Follow-up|17|||
49163192|NCT02883049|158434789|FG005|Induction|Physician Decision|0|||
49163193|NCT02883049|158434790|FG006|Induction|Physician Decision|0|||
49163194|NCT02883049|158434791|FG007|Induction|Physician Decision|0|||
49163195|NCT02883049|158434792|FG008|Induction|Physician Decision|0|||
49163196|NCT02883049|158434793|FG009|Induction|Physician Decision|0|||
49163197|NCT02883049|158434794|FG010|Induction|Physician Decision|0|||
49163198|NCT02883049|158434795|FG011|Induction|Physician Decision|0|||
49163199|NCT02883049|158434796|FG012|Induction|Physician Decision|0|||
49163200|NCT02883049|158434797|FG013|Induction|Physician Decision|0|||
49163201|NCT02883049|158434798|FG014|Induction|Physician Decision|0|||
49163202|NCT02883049|158434799|FG015|Induction|Physician Decision|0|||
49163203|NCT02883049|158434784|FG000|Induction|Protocol Violation|6|||
49163204|NCT02883049|158434785|FG001|Induction|Protocol Violation|0|||
49163205|NCT02883049|158434786|FG002|Induction|Protocol Violation|0|||
49163206|NCT02883049|158434787|FG003|Induction|Protocol Violation|0|||
49163207|NCT02883049|158434788|FG004|Induction|Protocol Violation|0|||
49163208|NCT02883049|158434789|FG005|Induction|Protocol Violation|0|||
49163209|NCT02883049|158434790|FG006|Induction|Protocol Violation|0|||
49163210|NCT02883049|158434791|FG007|Induction|Protocol Violation|0|||
49163211|NCT02883049|158434792|FG008|Induction|Protocol Violation|0|||
49163212|NCT02883049|158434793|FG009|Induction|Protocol Violation|0|||
49163213|NCT02883049|158434794|FG010|Induction|Protocol Violation|0|||
49163214|NCT02883049|158434795|FG011|Induction|Protocol Violation|0|||
49163215|NCT02883049|158434796|FG012|Induction|Protocol Violation|0|||
49163216|NCT02883049|158434797|FG013|Induction|Protocol Violation|0|||
49163217|NCT02883049|158434798|FG014|Induction|Protocol Violation|0|||
48836732|NCT02694978|157245577|FG000|Overall Study|Death|4|||
48836733|NCT02694978|157245578|FG001|Overall Study|Death|1|||
49163218|NCT02883049|158434799|FG015|Induction|Protocol Violation|0|||
48836734|NCT02694978|157245577|FG000|Overall Study|Other-Decision of Participant|6|||
48836735|NCT02694978|157245578|FG001|Overall Study|Other-Decision of Participant|1|||
48836736|NCT02694978|157245577|FG000|Overall Study|Other-Investigator's decision|1|||
48836737|NCT02694978|157245578|FG001|Overall Study|Other-Investigator's decision|0|||
48836738|NCT02694978|157245577|FG000|Overall Study|Other-Unable to be reached|0|||
48836739|NCT02694978|157245578|FG001|Overall Study|Other-Unable to be reached|1|||
48836740|NCT02694978|157245577|FG000|Overall Study|Other-Protocol noncompliant|2|||
48836741|NCT02694978|157245578|FG001|Overall Study|Other-Protocol noncompliant|1|||
48836742|NCT02694978|157245577|FG000|Overall Study|Other-Personal reasons|3|||
48836743|NCT02694978|157245578|FG001|Overall Study|Other-Personal reasons|3|||
48836744|NCT02694978|157245577|FG000|Overall Study|Other-Withdrew prior to dosing|9|||
48836745|NCT02694978|157245578|FG001|Overall Study|Other-Withdrew prior to dosing|8|||
48836746|NCT03923491|157245580|FG000|Overall Study|Lost to Follow-up|5|||
48836747|NCT03923491|157245581|FG001|Overall Study|Lost to Follow-up|8|||
48836748|NCT03923491|157245580|FG000|Overall Study|Withdrawal by Subject|4|||
48836749|NCT03923491|157245581|FG001|Overall Study|Withdrawal by Subject|6|||
48836750|NCT03959241|157245582|FG000|Overall Study|Withdrawal by Subject|7|||
48836751|NCT03959241|157245583|FG001|Overall Study|Withdrawal by Subject|8|||
48836752|NCT03959241|157245582|FG000|Overall Study|Lost to Follow-up|1|||
48836753|NCT03959241|157245583|FG001|Overall Study|Lost to Follow-up|0|||
48836754|NCT03959241|157245582|FG000|Overall Study|Move to Hospice Care|1|||
48836755|NCT03959241|157245583|FG001|Overall Study|Move to Hospice Care|0|||
48836756|NCT03959241|157245582|FG000|Overall Study|Screen Failure|1|||
48836757|NCT03959241|157245583|FG001|Overall Study|Screen Failure|0|||
48836758|NCT03959241|157245582|FG000|Overall Study|Disease Relapse|0|||
48836759|NCT03959241|157245583|FG001|Overall Study|Disease Relapse|1|||
48836760|NCT03959241|157245582|FG000|Overall Study|Off Study|1|||
48836761|NCT03959241|157245583|FG001|Overall Study|Off Study|0|||
48836762|NCT04833855|157245586|FG000|Overall Study|Decision by sponsor|0|||
48836763|NCT04833855|157245587|FG001|Overall Study|Decision by sponsor|1|||
48836764|NCT04833855|157245588|FG002|Overall Study|Decision by sponsor|0|||
48836765|NCT04833855|157245589|FG003|Overall Study|Decision by sponsor|0|||
49163219|NCT02883049|158434784|FG000|Induction|Withdrawal by Subject|6|||
49163220|NCT02883049|158434785|FG001|Induction|Withdrawal by Subject|0|||
49163221|NCT02883049|158434786|FG002|Induction|Withdrawal by Subject|0|||
49163222|NCT02883049|158434787|FG003|Induction|Withdrawal by Subject|0|||
49163223|NCT02883049|158434788|FG004|Induction|Withdrawal by Subject|0|||
49163224|NCT02883049|158434789|FG005|Induction|Withdrawal by Subject|0|||
48836766|NCT04833855|157245586|FG000|Overall Study|Withdrawal by Subject|4|||
48836767|NCT04833855|157245587|FG001|Overall Study|Withdrawal by Subject|1|||
48836768|NCT04833855|157245588|FG002|Overall Study|Withdrawal by Subject|3|||
48836769|NCT04833855|157245589|FG003|Overall Study|Withdrawal by Subject|1|||
48836770|NCT04833855|157245586|FG000|Overall Study|Lost to Follow-up|1|||
48836771|NCT04833855|157245587|FG001|Overall Study|Lost to Follow-up|0|||
48836772|NCT04833855|157245588|FG002|Overall Study|Lost to Follow-up|2|||
48836773|NCT04833855|157245589|FG003|Overall Study|Lost to Follow-up|2|||
48836774|NCT04833855|157245586|FG000|Overall Study|Protocol specified criteria|0|||
48836775|NCT04833855|157245587|FG001|Overall Study|Protocol specified criteria|0|||
48836776|NCT04833855|157245588|FG002|Overall Study|Protocol specified criteria|2|||
48836777|NCT04833855|157245589|FG003|Overall Study|Protocol specified criteria|1|||
48836778|NCT03460756|157245596|FG000|Overall Study|Adverse Event|0|||
48836779|NCT03460756|157245597|FG001|Overall Study|Adverse Event|0|||
48836780|NCT03460756|157245598|FG002|Overall Study|Adverse Event|0|||
48836781|NCT03460756|157245599|FG003|Overall Study|Adverse Event|1|||
48836782|NCT03460756|157245596|FG000|Overall Study|Lack of Efficacy|0|||
48836783|NCT03460756|157245597|FG001|Overall Study|Lack of Efficacy|0|||
48836784|NCT03460756|157245598|FG002|Overall Study|Lack of Efficacy|0|||
48836785|NCT03460756|157245599|FG003|Overall Study|Lack of Efficacy|2|||
48836786|NCT03460756|157245596|FG000|Overall Study|Lost to Follow-up|0|||
48836787|NCT03460756|157245597|FG001|Overall Study|Lost to Follow-up|1|||
48836788|NCT03460756|157245598|FG002|Overall Study|Lost to Follow-up|2|||
48836789|NCT03460756|157245599|FG003|Overall Study|Lost to Follow-up|1|||
48836790|NCT03460756|157245596|FG000|Overall Study|Pregnancy|0|||
48836791|NCT03460756|157245597|FG001|Overall Study|Pregnancy|0|||
49163225|NCT02883049|158434790|FG006|Induction|Withdrawal by Subject|0|||
49163226|NCT02883049|158434791|FG007|Induction|Withdrawal by Subject|0|||
49163227|NCT02883049|158434792|FG008|Induction|Withdrawal by Subject|0|||
48836792|NCT03460756|157245598|FG002|Overall Study|Pregnancy|0|||
48836793|NCT03460756|157245599|FG003|Overall Study|Pregnancy|1|||
48836794|NCT03460756|157245596|FG000|Overall Study|Protocol Violation|0|||
48836795|NCT03460756|157245597|FG001|Overall Study|Protocol Violation|0|||
48836796|NCT03460756|157245598|FG002|Overall Study|Protocol Violation|0|||
48836797|NCT03460756|157245599|FG003|Overall Study|Protocol Violation|1|||
49163228|NCT02883049|158434793|FG009|Induction|Withdrawal by Subject|0|||
49163229|NCT02883049|158434794|FG010|Induction|Withdrawal by Subject|0|||
49163230|NCT02883049|158434795|FG011|Induction|Withdrawal by Subject|0|||
48836798|NCT03460756|157245596|FG000|Overall Study|Withdrawal by Subject|0|||
48836799|NCT03460756|157245597|FG001|Overall Study|Withdrawal by Subject|4|||
48836800|NCT03460756|157245598|FG002|Overall Study|Withdrawal by Subject|7|||
48836801|NCT03460756|157245599|FG003|Overall Study|Withdrawal by Subject|3|||
48836802|NCT02878330|157245601|FG000|Overall Study|Death|3|||
48836803|NCT02878330|157245602|FG001|Overall Study|Death|2|||
48836804|NCT02878330|157245601|FG000|Overall Study|Lost to Follow-up|11|||
49163231|NCT02883049|158434796|FG012|Induction|Withdrawal by Subject|0|||
49163232|NCT02883049|158434797|FG013|Induction|Withdrawal by Subject|0|||
49163233|NCT02883049|158434798|FG014|Induction|Withdrawal by Subject|0|||
49163234|NCT02883049|158434799|FG015|Induction|Withdrawal by Subject|0|||
49163235|NCT02883049|158434784|FG000|Induction|Ineligible|35|||
49163236|NCT02883049|158434785|FG001|Induction|Ineligible|1|||
49163237|NCT02883049|158434786|FG002|Induction|Ineligible|0|||
49163238|NCT02883049|158434787|FG003|Induction|Ineligible|0|||
49163239|NCT02883049|158434788|FG004|Induction|Ineligible|0|||
49163240|NCT02883049|158434789|FG005|Induction|Ineligible|0|||
49163241|NCT02883049|158434790|FG006|Induction|Ineligible|0|||
49163242|NCT02883049|158434791|FG007|Induction|Ineligible|0|||
49163243|NCT02883049|158434792|FG008|Induction|Ineligible|0|||
49163244|NCT02883049|158434793|FG009|Induction|Ineligible|0|||
49163245|NCT02883049|158434794|FG010|Induction|Ineligible|0|||
49163246|NCT02883049|158434795|FG011|Induction|Ineligible|0|||
49163247|NCT02883049|158434796|FG012|Induction|Ineligible|0|||
49163248|NCT02883049|158434797|FG013|Induction|Ineligible|0|||
49163249|NCT02883049|158434798|FG014|Induction|Ineligible|0|||
49163250|NCT02883049|158434799|FG015|Induction|Ineligible|0|||
49163251|NCT02883049|158434784|FG000|Induction|Refusal of further protocol therapy|466|||
49163252|NCT02883049|158434785|FG001|Induction|Refusal of further protocol therapy|2|||
49163253|NCT02883049|158434786|FG002|Induction|Refusal of further protocol therapy|0|||
49163254|NCT02883049|158434787|FG003|Induction|Refusal of further protocol therapy|0|||
49163255|NCT02883049|158434788|FG004|Induction|Refusal of further protocol therapy|0|||
49163256|NCT02883049|158434789|FG005|Induction|Refusal of further protocol therapy|0|||
49163257|NCT02883049|158434790|FG006|Induction|Refusal of further protocol therapy|0|||
48836805|NCT02878330|157245602|FG001|Overall Study|Lost to Follow-up|26|||
48836806|NCT02878330|157245601|FG000|Overall Study|Withdrawal by Subject|11|||
48836807|NCT02878330|157245602|FG001|Overall Study|Withdrawal by Subject|21|||
48836808|NCT02878330|157245601|FG000|Overall Study|Other|4|||
48836809|NCT02878330|157245602|FG001|Overall Study|Other|7|||
48836810|NCT00980330|157245603|FG000|Overall Study|Adverse Event|0|||
48836811|NCT00980330|157245604|FG001|Overall Study|Adverse Event|0|||
48836812|NCT00980330|157245605|FG002|Overall Study|Adverse Event|0|||
48836813|NCT00980330|157245606|FG003|Overall Study|Adverse Event|1|||
48836814|NCT00980330|157245607|FG004|Overall Study|Adverse Event|0|||
48836815|NCT00980330|157245608|FG005|Overall Study|Adverse Event|0|||
48836816|NCT00980330|157245609|FG006|Overall Study|Adverse Event|0|||
48836817|NCT00980330|157245603|FG000|Overall Study|Lost to Follow-up|1|||
48836818|NCT00980330|157245604|FG001|Overall Study|Lost to Follow-up|1|||
48836819|NCT00980330|157245605|FG002|Overall Study|Lost to Follow-up|4|||
48836820|NCT00980330|157245606|FG003|Overall Study|Lost to Follow-up|2|||
48836821|NCT00980330|157245607|FG004|Overall Study|Lost to Follow-up|1|||
48836822|NCT00980330|157245608|FG005|Overall Study|Lost to Follow-up|1|||
48836823|NCT00980330|157245609|FG006|Overall Study|Lost to Follow-up|2|||
48836824|NCT00980330|157245603|FG000|Overall Study|Withdrawal by Subject|2|||
48836825|NCT00980330|157245604|FG001|Overall Study|Withdrawal by Subject|4|||
48836826|NCT00980330|157245605|FG002|Overall Study|Withdrawal by Subject|4|||
48836827|NCT00980330|157245606|FG003|Overall Study|Withdrawal by Subject|1|||
49163258|NCT02883049|158434791|FG007|Induction|Refusal of further protocol therapy|0|||
49163259|NCT02883049|158434792|FG008|Induction|Refusal of further protocol therapy|0|||
49163260|NCT02883049|158434793|FG009|Induction|Refusal of further protocol therapy|0|||
49163261|NCT02883049|158434794|FG010|Induction|Refusal of further protocol therapy|0|||
49163262|NCT02883049|158434795|FG011|Induction|Refusal of further protocol therapy|0|||
49163263|NCT02883049|158434796|FG012|Induction|Refusal of further protocol therapy|0|||
49163264|NCT02883049|158434797|FG013|Induction|Refusal of further protocol therapy|0|||
49163265|NCT02883049|158434798|FG014|Induction|Refusal of further protocol therapy|0|||
48836828|NCT00980330|157245607|FG004|Overall Study|Withdrawal by Subject|3|||
48836829|NCT00980330|157245608|FG005|Overall Study|Withdrawal by Subject|2|||
48836830|NCT00980330|157245609|FG006|Overall Study|Withdrawal by Subject|5|||
48836831|NCT00980330|157245603|FG000|Overall Study|(not specified)|2|||
48836832|NCT00980330|157245604|FG001|Overall Study|(not specified)|0|||
48836833|NCT00980330|157245605|FG002|Overall Study|(not specified)|0|||
48836834|NCT00980330|157245606|FG003|Overall Study|(not specified)|1|||
48836835|NCT00980330|157245607|FG004|Overall Study|(not specified)|1|||
48836836|NCT00980330|157245608|FG005|Overall Study|(not specified)|1|||
48836837|NCT00980330|157245609|FG006|Overall Study|(not specified)|0|||
49163266|NCT02883049|158434799|FG015|Induction|Refusal of further protocol therapy|0|||
49163267|NCT02883049|158434784|FG000|Induction|Identified as Ph+ patients|279|||
49163268|NCT02883049|158434785|FG001|Induction|Identified as Ph+ patients|1|||
49163269|NCT02883049|158434786|FG002|Induction|Identified as Ph+ patients|0|||
49163270|NCT02883049|158434787|FG003|Induction|Identified as Ph+ patients|0|||
49163271|NCT02883049|158434788|FG004|Induction|Identified as Ph+ patients|0|||
49163272|NCT02883049|158434789|FG005|Induction|Identified as Ph+ patients|0|||
49163273|NCT02883049|158434790|FG006|Induction|Identified as Ph+ patients|0|||
49163274|NCT02883049|158434791|FG007|Induction|Identified as Ph+ patients|0|||
49163275|NCT02883049|158434792|FG008|Induction|Identified as Ph+ patients|0|||
48836838|NCT01039688|157245614|FG000|Overall Study|Adverse Event|38|||
48836839|NCT01039688|157245615|FG001|Overall Study|Adverse Event|39|||
48836840|NCT01039688|157245616|FG002|Overall Study|Adverse Event|24|||
48836841|NCT01039688|157245614|FG000|Overall Study|Lack of Efficacy|20|||
48836842|NCT01039688|157245615|FG001|Overall Study|Lack of Efficacy|11|||
48836843|NCT01039688|157245616|FG002|Overall Study|Lack of Efficacy|26|||
48836844|NCT01039688|157245614|FG000|Overall Study|Lost to Follow-up|11|||
48836845|NCT01039688|157245615|FG001|Overall Study|Lost to Follow-up|9|||
48836846|NCT01039688|157245616|FG002|Overall Study|Lost to Follow-up|5|||
48836847|NCT01039688|157245614|FG000|Overall Study|Other|13|||
49163276|NCT02883049|158434793|FG009|Induction|Identified as Ph+ patients|0|||
49163277|NCT02883049|158434794|FG010|Induction|Identified as Ph+ patients|0|||
48836848|NCT01039688|157245615|FG001|Overall Study|Other|25|||
48836849|NCT01039688|157245616|FG002|Overall Study|Other|12|||
48836850|NCT01039688|157245614|FG000|Overall Study|Withdrawal by Subject|23|||
48836851|NCT01039688|157245615|FG001|Overall Study|Withdrawal by Subject|27|||
48836852|NCT01039688|157245616|FG002|Overall Study|Withdrawal by Subject|13|||
48836853|NCT01039688|157245614|FG000|Overall Study|Death|2|||
48836854|NCT01039688|157245615|FG001|Overall Study|Death|0|||
48836855|NCT01039688|157245616|FG002|Overall Study|Death|0|||
48836856|NCT00346151|157245623|FG000|Overall Study|Withdrawal by Subject|3|||
49163278|NCT02883049|158434795|FG011|Induction|Identified as Ph+ patients|0|||
48836857|NCT02705586|157245630|FG000|Overall Study|Health Issues|2|||
49163279|NCT02883049|158434796|FG012|Induction|Identified as Ph+ patients|0|||
49163280|NCT02883049|158434797|FG013|Induction|Identified as Ph+ patients|0|||
48836858|NCT02705586|157245630|FG000|Overall Study|Transportation Difficulties|5|||
48836859|NCT02705586|157245630|FG000|Overall Study|Vacation/Planned Absence|1|||
48836860|NCT02448446|157245631|FG000|Overall Study|Withdrawal by Subject|1|||
48836861|NCT02448446|157245632|FG001|Overall Study|Withdrawal by Subject|0|||
49163281|NCT02883049|158434798|FG014|Induction|Identified as Ph+ patients|0|||
49163282|NCT02883049|158434799|FG015|Induction|Identified as Ph+ patients|0|||
48836862|NCT02547922|157245634|FG000|Overall Study|Withdrawal by Subject|9|||
48836863|NCT02547922|157245635|FG001|Overall Study|Withdrawal by Subject|6|||
48836864|NCT02547922|157245636|FG002|Overall Study|Withdrawal by Subject|10|||
48836865|NCT02547922|157245634|FG000|Overall Study|Adverse Event|3|||
48836866|NCT02547922|157245635|FG001|Overall Study|Adverse Event|1|||
48836867|NCT02547922|157245636|FG002|Overall Study|Adverse Event|2|||
48836868|NCT02547922|157245634|FG000|Overall Study|Lost to Follow-up|1|||
48836869|NCT02547922|157245635|FG001|Overall Study|Lost to Follow-up|0|||
48836870|NCT02547922|157245636|FG002|Overall Study|Lost to Follow-up|0|||
48836871|NCT02547922|157245634|FG000|Overall Study|Lack of Efficacy|5|||
48836872|NCT02547922|157245635|FG001|Overall Study|Lack of Efficacy|7|||
48836873|NCT02547922|157245636|FG002|Overall Study|Lack of Efficacy|4|||
48836874|NCT02547922|157245634|FG000|Overall Study|Death|1|||
48836875|NCT02547922|157245635|FG001|Overall Study|Death|0|||
48836876|NCT02547922|157245636|FG002|Overall Study|Death|0|||
48836877|NCT02547922|157245634|FG000|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|4|||
48836878|NCT02547922|157245635|FG001|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|8|||
48836879|NCT02547922|157245636|FG002|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|9|||
48836880|NCT02547922|157245634|FG000|Overall Study|TECHNICAL PROBLEMS|1|||
48836881|NCT02547922|157245635|FG001|Overall Study|TECHNICAL PROBLEMS|0|||
48836882|NCT02547922|157245636|FG002|Overall Study|TECHNICAL PROBLEMS|0|||
48836883|NCT02547922|157245634|FG000|Overall Study|PROGRESSIVE DISEASE|1|||
48836884|NCT02547922|157245635|FG001|Overall Study|PROGRESSIVE DISEASE|0|||
48836885|NCT02547922|157245636|FG002|Overall Study|PROGRESSIVE DISEASE|2|||
48836886|NCT02547922|157245634|FG000|Overall Study|Physician Decision|2|||
48836887|NCT02547922|157245635|FG001|Overall Study|Physician Decision|1|||
48836888|NCT02547922|157245636|FG002|Overall Study|Physician Decision|2|||
48836889|NCT02547922|157245634|FG000|Overall Study|Patients did not receive IP|1|||
48836890|NCT02547922|157245635|FG001|Overall Study|Patients did not receive IP|1|||
48836891|NCT02547922|157245636|FG002|Overall Study|Patients did not receive IP|0|||
48923793|NCT03548558|157555224|FG005|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
48923794|NCT03548558|157555225|FG006|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
48836892|NCT05283395|157245637|FG000|Overall Study|Adverse Event|4|||
48836893|NCT05283395|157245638|FG001|Overall Study|Adverse Event|4|||
48836894|NCT05283395|157245639|FG002|Overall Study|Adverse Event|0|||
48836895|NCT05283395|157245637|FG000|Overall Study|Patient Lost to Follow-Up|0|||
48923795|NCT03548558|157555219|FG000|Phase 2: Booster Sessions Every 2 Months|Death|0|||
48923796|NCT03548558|157555220|FG001|Phase 2: Booster Sessions Every 2 Months|Death|0|||
49163283|NCT02883049|158434784|FG000|Induction|M3 Marrow at Day29|8|||
49163284|NCT02883049|158434785|FG001|Induction|M3 Marrow at Day29|1|||
49163285|NCT02883049|158434786|FG002|Induction|M3 Marrow at Day29|0|||
49163286|NCT02883049|158434787|FG003|Induction|M3 Marrow at Day29|0|||
49163287|NCT02883049|158434788|FG004|Induction|M3 Marrow at Day29|0|||
49163288|NCT02883049|158434789|FG005|Induction|M3 Marrow at Day29|0|||
49163289|NCT02883049|158434790|FG006|Induction|M3 Marrow at Day29|0|||
49163290|NCT02883049|158434791|FG007|Induction|M3 Marrow at Day29|0|||
49163291|NCT02883049|158434792|FG008|Induction|M3 Marrow at Day29|0|||
49163292|NCT02883049|158434793|FG009|Induction|M3 Marrow at Day29|0|||
49163293|NCT02883049|158434794|FG010|Induction|M3 Marrow at Day29|0|||
49163294|NCT02883049|158434795|FG011|Induction|M3 Marrow at Day29|0|||
49163295|NCT02883049|158434796|FG012|Induction|M3 Marrow at Day29|0|||
49163296|NCT02883049|158434797|FG013|Induction|M3 Marrow at Day29|0|||
49163297|NCT02883049|158434798|FG014|Induction|M3 Marrow at Day29|0|||
49163298|NCT02883049|158434799|FG015|Induction|M3 Marrow at Day29|0|||
49163299|NCT02883049|158434784|FG000|Induction|Inevaluable|33|||
49163300|NCT02883049|158434785|FG001|Induction|Inevaluable|1|||
49163301|NCT02883049|158434786|FG002|Induction|Inevaluable|0|||
49163302|NCT02883049|158434787|FG003|Induction|Inevaluable|0|||
49163303|NCT02883049|158434788|FG004|Induction|Inevaluable|0|||
49163304|NCT02883049|158434789|FG005|Induction|Inevaluable|0|||
49163305|NCT02883049|158434790|FG006|Induction|Inevaluable|0|||
49163306|NCT02883049|158434791|FG007|Induction|Inevaluable|0|||
49163307|NCT02883049|158434792|FG008|Induction|Inevaluable|0|||
49163308|NCT02883049|158434793|FG009|Induction|Inevaluable|0|||
49163309|NCT02883049|158434794|FG010|Induction|Inevaluable|0|||
49163310|NCT02883049|158434795|FG011|Induction|Inevaluable|0|||
49163311|NCT02883049|158434796|FG012|Induction|Inevaluable|0|||
49163312|NCT02883049|158434797|FG013|Induction|Inevaluable|0|||
49163313|NCT02883049|158434798|FG014|Induction|Inevaluable|0|||
49163314|NCT02883049|158434799|FG015|Induction|Inevaluable|0|||
49163315|NCT02883049|158434784|FG000|Induction|Identified as VHR at end of Induction|244|||
49163316|NCT02883049|158434785|FG001|Induction|Identified as VHR at end of Induction|0|||
49163317|NCT02883049|158434786|FG002|Induction|Identified as VHR at end of Induction|0|||
49163318|NCT02883049|158434787|FG003|Induction|Identified as VHR at end of Induction|0|||
49163319|NCT02883049|158434788|FG004|Induction|Identified as VHR at end of Induction|0|||
48836896|NCT05283395|157245638|FG001|Overall Study|Patient Lost to Follow-Up|0|||
48836897|NCT05283395|157245639|FG002|Overall Study|Patient Lost to Follow-Up|1|||
49163320|NCT02883049|158434789|FG005|Induction|Identified as VHR at end of Induction|0|||
49163321|NCT02883049|158434790|FG006|Induction|Identified as VHR at end of Induction|0|||
48836898|NCT05283395|157245637|FG000|Overall Study|Patient Withdrawal|2|||
48836899|NCT05283395|157245638|FG001|Overall Study|Patient Withdrawal|4|||
48836900|NCT05283395|157245639|FG002|Overall Study|Patient Withdrawal|2|||
48836901|NCT05283395|157245637|FG000|Overall Study|Investigator Decision|1|||
48836902|NCT05283395|157245638|FG001|Overall Study|Investigator Decision|0|||
48836903|NCT05283395|157245639|FG002|Overall Study|Investigator Decision|1|||
48836904|NCT05283395|157245637|FG000|Overall Study|Enrolled in error|0|||
48836905|NCT05283395|157245638|FG001|Overall Study|Enrolled in error|0|||
48836906|NCT05283395|157245639|FG002|Overall Study|Enrolled in error|1|||
48836907|NCT00712335|157245640|FG000|Overall Study|Withdrawal by Subject|0|||
48836908|NCT00712335|157245641|FG001|Overall Study|Withdrawal by Subject|7|||
48836909|NCT00712335|157245642|FG002|Overall Study|Withdrawal by Subject|2|||
48836910|NCT00712335|157245643|FG003|Overall Study|Withdrawal by Subject|3|||
48836911|NCT00712335|157245644|FG004|Overall Study|Withdrawal by Subject|0|||
48836912|NCT00712335|157245640|FG000|Overall Study|Lost to Follow-up|2|||
48836913|NCT00712335|157245641|FG001|Overall Study|Lost to Follow-up|5|||
48836914|NCT00712335|157245642|FG002|Overall Study|Lost to Follow-up|0|||
48836915|NCT00712335|157245643|FG003|Overall Study|Lost to Follow-up|1|||
48836916|NCT00712335|157245644|FG004|Overall Study|Lost to Follow-up|0|||
48836917|NCT00712335|157245640|FG000|Overall Study|Protocol Violation|1|||
48836918|NCT00712335|157245641|FG001|Overall Study|Protocol Violation|2|||
48836919|NCT00712335|157245642|FG002|Overall Study|Protocol Violation|1|||
48836920|NCT00712335|157245643|FG003|Overall Study|Protocol Violation|0|||
48836921|NCT00712335|157245644|FG004|Overall Study|Protocol Violation|0|||
48836922|NCT00712335|157245640|FG000|Overall Study|Lack of Efficacy|0|||
48836923|NCT00712335|157245641|FG001|Overall Study|Lack of Efficacy|0|||
48836924|NCT00712335|157245642|FG002|Overall Study|Lack of Efficacy|1|||
48836925|NCT00712335|157245643|FG003|Overall Study|Lack of Efficacy|1|||
48836926|NCT00712335|157245644|FG004|Overall Study|Lack of Efficacy|0|||
48836927|NCT00712335|157245640|FG000|Overall Study|Other Reason|0|||
48836928|NCT00712335|157245641|FG001|Overall Study|Other Reason|3|||
48836929|NCT00712335|157245642|FG002|Overall Study|Other Reason|1|||
48836930|NCT00712335|157245643|FG003|Overall Study|Other Reason|0|||
48836931|NCT00712335|157245644|FG004|Overall Study|Other Reason|0|||
48836932|NCT03194958|157245649|FG000|Overall Study|Death|0|||
48836933|NCT03194958|157245650|FG001|Overall Study|Death|1|||
48836934|NCT03194958|157245651|FG002|Overall Study|Death|1|||
48836935|NCT03194958|157245652|FG003|Overall Study|Death|1|||
48836936|NCT03194958|157245649|FG000|Overall Study|Withdrawal by Subject|24|||
48836937|NCT03194958|157245650|FG001|Overall Study|Withdrawal by Subject|27|||
48836938|NCT03194958|157245651|FG002|Overall Study|Withdrawal by Subject|7|||
48836939|NCT03194958|157245652|FG003|Overall Study|Withdrawal by Subject|22|||
48836940|NCT03194958|157245649|FG000|Overall Study|Lost to Follow-up|168|||
48836941|NCT03194958|157245650|FG001|Overall Study|Lost to Follow-up|196|||
48836942|NCT03194958|157245651|FG002|Overall Study|Lost to Follow-up|174|||
48836943|NCT03194958|157245652|FG003|Overall Study|Lost to Follow-up|186|||
48836944|NCT00959946|157245654|FG000|Overall Study|Adverse Event|0|||
48836945|NCT00959946|157245655|FG001|Overall Study|Adverse Event|0|||
48836946|NCT00959946|157245656|FG002|Overall Study|Adverse Event|2|||
48836947|NCT00959946|157245657|FG003|Overall Study|Adverse Event|1|||
48836948|NCT00959946|157245658|FG004|Overall Study|Adverse Event|0|||
48836949|NCT00959946|157245659|FG005|Overall Study|Adverse Event|1|||
48836950|NCT00959946|157245660|FG006|Overall Study|Adverse Event|0|||
48836951|NCT00959946|157245661|FG007|Overall Study|Adverse Event|0|||
48836952|NCT00959946|157245654|FG000|Overall Study|Death|0|||
48836953|NCT00959946|157245655|FG001|Overall Study|Death|0|||
48836954|NCT00959946|157245656|FG002|Overall Study|Death|0|||
48836955|NCT00959946|157245657|FG003|Overall Study|Death|0|||
48836956|NCT00959946|157245658|FG004|Overall Study|Death|0|||
48836957|NCT00959946|157245659|FG005|Overall Study|Death|1|||
48836958|NCT00959946|157245660|FG006|Overall Study|Death|0|||
48836959|NCT00959946|157245661|FG007|Overall Study|Death|0|||
48836960|NCT00959946|157245654|FG000|Overall Study|Disease Progression|2|||
48836961|NCT00959946|157245655|FG001|Overall Study|Disease Progression|4|||
48836962|NCT00959946|157245656|FG002|Overall Study|Disease Progression|2|||
48836963|NCT00959946|157245657|FG003|Overall Study|Disease Progression|4|||
48923797|NCT03548558|157555221|FG002|Phase 2: Booster Sessions Every 2 Months|Death|0|||
48923798|NCT03548558|157555222|FG003|Phase 2: Booster Sessions Every 2 Months|Death|0|||
48923799|NCT03548558|157555223|FG004|Phase 2: Booster Sessions Every 2 Months|Death|3|||
48836964|NCT00959946|157245658|FG004|Overall Study|Disease Progression|4|||
48836965|NCT00959946|157245659|FG005|Overall Study|Disease Progression|6|||
48836966|NCT00959946|157245660|FG006|Overall Study|Disease Progression|2|||
48836967|NCT00959946|157245661|FG007|Overall Study|Disease Progression|2|||
48836968|NCT00959946|157245654|FG000|Overall Study|Withdrawal by Subject|0|||
48836969|NCT00959946|157245655|FG001|Overall Study|Withdrawal by Subject|0|||
48836970|NCT00959946|157245656|FG002|Overall Study|Withdrawal by Subject|0|||
48836971|NCT00959946|157245657|FG003|Overall Study|Withdrawal by Subject|0|||
48836972|NCT00959946|157245658|FG004|Overall Study|Withdrawal by Subject|0|||
48836973|NCT00959946|157245659|FG005|Overall Study|Withdrawal by Subject|1|||
48836974|NCT00959946|157245660|FG006|Overall Study|Withdrawal by Subject|0|||
48836975|NCT00959946|157245661|FG007|Overall Study|Withdrawal by Subject|0|||
48836976|NCT01202955|157245664|FG000|Period 1: 10 Days|Withdrawal by Subject|0|||
48836977|NCT01202955|157245665|FG001|Period 1: 10 Days|Withdrawal by Subject|2|||
48836978|NCT00159783|157245666|FG000|Overall Study|Adverse Event|5|||
48836979|NCT00159783|157245667|FG001|Overall Study|Adverse Event|7|||
48836980|NCT00159783|157245668|FG002|Overall Study|Adverse Event|9|||
48836981|NCT00159783|157245666|FG000|Overall Study|Lack of Efficacy|1|||
48836982|NCT00159783|157245667|FG001|Overall Study|Lack of Efficacy|2|||
48836983|NCT00159783|157245668|FG002|Overall Study|Lack of Efficacy|3|||
48836984|NCT00159783|157245666|FG000|Overall Study|Withdrawal by Subject|7|||
48836985|NCT00159783|157245667|FG001|Overall Study|Withdrawal by Subject|11|||
48836986|NCT00159783|157245668|FG002|Overall Study|Withdrawal by Subject|12|||
48836987|NCT00159783|157245666|FG000|Overall Study|Lost to Follow-up|6|||
48836988|NCT00159783|157245667|FG001|Overall Study|Lost to Follow-up|5|||
48836989|NCT00159783|157245668|FG002|Overall Study|Lost to Follow-up|11|||
48836990|NCT00159783|157245666|FG000|Overall Study|Other|0|||
48836991|NCT00159783|157245667|FG001|Overall Study|Other|2|||
48836992|NCT00159783|157245668|FG002|Overall Study|Other|4|||
48836993|NCT00658996|157245671|FG000|First Intervention|Positive slit lamp finding|1|||
48836994|NCT00658996|157245672|FG001|First Intervention|Positive slit lamp finding|0|||
48836995|NCT00658996|157245671|FG000|First Intervention|Lack of lenses|0|||
48836996|NCT00658996|157245672|FG001|First Intervention|Lack of lenses|1|||
48836997|NCT00658996|157245671|FG000|Crossover Period|Physician Decision|1|||
49163322|NCT02883049|158434791|FG007|Induction|Identified as VHR at end of Induction|0|||
48836998|NCT00658996|157245672|FG001|Crossover Period|Physician Decision|0|||
48836999|NCT00658996|157245671|FG000|Crossover Period|Ineligible|1|||
48837000|NCT00658996|157245672|FG001|Crossover Period|Ineligible|1|||
48837001|NCT00658996|157245671|FG000|Second Intervention|Developed a stye on upper lid|1|||
48837002|NCT00658996|157245672|FG001|Second Intervention|Developed a stye on upper lid|0|||
48837003|NCT00658996|157245671|FG000|Second Intervention|Positive slit lamp finding|0|||
48837004|NCT00658996|157245672|FG001|Second Intervention|Positive slit lamp finding|1|||
48837005|NCT00997386|157245673|FG000|Overall Study|Death|7|||
48837006|NCT01041417|157245674|FG000|Overall Study|Adverse Event|5|||
49163323|NCT02883049|158434792|FG008|Induction|Identified as VHR at end of Induction|0|||
49163324|NCT02883049|158434793|FG009|Induction|Identified as VHR at end of Induction|0|||
49163325|NCT02883049|158434794|FG010|Induction|Identified as VHR at end of Induction|0|||
49163326|NCT02883049|158434795|FG011|Induction|Identified as VHR at end of Induction|0|||
49163327|NCT02883049|158434796|FG012|Induction|Identified as VHR at end of Induction|0|||
49163328|NCT02883049|158434797|FG013|Induction|Identified as VHR at end of Induction|0|||
49163329|NCT02883049|158434798|FG014|Induction|Identified as VHR at end of Induction|0|||
49163330|NCT02883049|158434799|FG015|Induction|Identified as VHR at end of Induction|0|||
49163331|NCT02883049|158434784|FG000|Induction|Moved to another non-COG institution|3|||
48837007|NCT01041417|157245675|FG001|Overall Study|Adverse Event|2|||
49163332|NCT02883049|158434785|FG001|Induction|Moved to another non-COG institution|0|||
49163333|NCT02883049|158434786|FG002|Induction|Moved to another non-COG institution|0|||
49163334|NCT02883049|158434787|FG003|Induction|Moved to another non-COG institution|0|||
49163335|NCT02883049|158434788|FG004|Induction|Moved to another non-COG institution|0|||
49163336|NCT02883049|158434789|FG005|Induction|Moved to another non-COG institution|0|||
49163337|NCT02883049|158434790|FG006|Induction|Moved to another non-COG institution|0|||
49163338|NCT02883049|158434791|FG007|Induction|Moved to another non-COG institution|0|||
49163339|NCT02883049|158434792|FG008|Induction|Moved to another non-COG institution|0|||
49163340|NCT02883049|158434793|FG009|Induction|Moved to another non-COG institution|0|||
49163341|NCT02883049|158434794|FG010|Induction|Moved to another non-COG institution|0|||
49163342|NCT02883049|158434795|FG011|Induction|Moved to another non-COG institution|0|||
49163343|NCT02883049|158434796|FG012|Induction|Moved to another non-COG institution|0|||
49163344|NCT02883049|158434797|FG013|Induction|Moved to another non-COG institution|0|||
49163345|NCT02883049|158434798|FG014|Induction|Moved to another non-COG institution|0|||
49163346|NCT02883049|158434799|FG015|Induction|Moved to another non-COG institution|0|||
49163347|NCT02883049|158434784|FG000|Induction|Randomization closed|41|||
49163348|NCT02883049|158434785|FG001|Induction|Randomization closed|0|||
49163349|NCT02883049|158434786|FG002|Induction|Randomization closed|0|||
49163350|NCT02883049|158434787|FG003|Induction|Randomization closed|0|||
49163351|NCT02883049|158434788|FG004|Induction|Randomization closed|0|||
49163352|NCT02883049|158434789|FG005|Induction|Randomization closed|0|||
49163353|NCT02883049|158434790|FG006|Induction|Randomization closed|0|||
49163354|NCT02883049|158434791|FG007|Induction|Randomization closed|0|||
49163355|NCT02883049|158434792|FG008|Induction|Randomization closed|0|||
49163356|NCT02883049|158434793|FG009|Induction|Randomization closed|0|||
49163357|NCT02883049|158434794|FG010|Induction|Randomization closed|0|||
49163358|NCT02883049|158434795|FG011|Induction|Randomization closed|0|||
48837008|NCT01041417|157245674|FG000|Overall Study|Lost to Follow-up|1|||
48837009|NCT01041417|157245675|FG001|Overall Study|Lost to Follow-up|1|||
48837010|NCT01041417|157245674|FG000|Overall Study|Death|1|||
49163359|NCT02883049|158434796|FG012|Induction|Randomization closed|0|||
49163360|NCT02883049|158434797|FG013|Induction|Randomization closed|0|||
49163361|NCT02883049|158434798|FG014|Induction|Randomization closed|0|||
48837011|NCT01041417|157245675|FG001|Overall Study|Death|0|||
48837012|NCT03201562|157245678|FG000|Overall Study|Physician Decision|0|||
49163362|NCT02883049|158434799|FG015|Induction|Randomization closed|0|||
49163363|NCT02883049|158434784|FG000|Induction|MRD negative|36|||
49163364|NCT02883049|158434785|FG001|Induction|MRD negative|0|||
49163365|NCT02883049|158434786|FG002|Induction|MRD negative|0|||
49163366|NCT02883049|158434787|FG003|Induction|MRD negative|0|||
49163367|NCT02883049|158434788|FG004|Induction|MRD negative|0|||
49163368|NCT02883049|158434789|FG005|Induction|MRD negative|0|||
49163369|NCT02883049|158434790|FG006|Induction|MRD negative|0|||
49163370|NCT02883049|158434791|FG007|Induction|MRD negative|0|||
49163371|NCT02883049|158434792|FG008|Induction|MRD negative|0|||
49163372|NCT02883049|158434793|FG009|Induction|MRD negative|0|||
49163373|NCT02883049|158434794|FG010|Induction|MRD negative|0|||
49163374|NCT02883049|158434795|FG011|Induction|MRD negative|0|||
49163375|NCT02883049|158434796|FG012|Induction|MRD negative|0|||
49163376|NCT02883049|158434797|FG013|Induction|MRD negative|0|||
49163377|NCT02883049|158434798|FG014|Induction|MRD negative|0|||
49163378|NCT02883049|158434799|FG015|Induction|MRD negative|0|||
49163379|NCT02883049|158434784|FG000|Induction|Identified as HR patients|165|||
49163380|NCT02883049|158434785|FG001|Induction|Identified as HR patients|0|||
49163381|NCT02883049|158434786|FG002|Induction|Identified as HR patients|0|||
49163382|NCT02883049|158434787|FG003|Induction|Identified as HR patients|0|||
48837013|NCT03201562|157245679|FG001|Overall Study|Physician Decision|0|||
48837014|NCT03201562|157245680|FG002|Overall Study|Physician Decision|1|||
48837015|NCT03201562|157245678|FG000|Overall Study|Adverse Event|0|||
48837016|NCT03201562|157245679|FG001|Overall Study|Adverse Event|0|||
48837017|NCT03201562|157245680|FG002|Overall Study|Adverse Event|1|||
48837018|NCT03201562|157245678|FG000|Overall Study|Lost to Follow-up|0|||
48837019|NCT03201562|157245679|FG001|Overall Study|Lost to Follow-up|1|||
48837020|NCT03201562|157245680|FG002|Overall Study|Lost to Follow-up|2|||
49163383|NCT02883049|158434788|FG004|Induction|Identified as HR patients|0|||
49163384|NCT02883049|158434789|FG005|Induction|Identified as HR patients|0|||
49163385|NCT02883049|158434790|FG006|Induction|Identified as HR patients|0|||
49163386|NCT02883049|158434791|FG007|Induction|Identified as HR patients|0|||
49163387|NCT02883049|158434792|FG008|Induction|Identified as HR patients|0|||
49163388|NCT02883049|158434793|FG009|Induction|Identified as HR patients|0|||
49163389|NCT02883049|158434794|FG010|Induction|Identified as HR patients|0|||
49163390|NCT02883049|158434795|FG011|Induction|Identified as HR patients|0|||
49163391|NCT02883049|158434796|FG012|Induction|Identified as HR patients|0|||
49163392|NCT02883049|158434797|FG013|Induction|Identified as HR patients|0|||
49163393|NCT02883049|158434798|FG014|Induction|Identified as HR patients|0|||
49163394|NCT02883049|158434799|FG015|Induction|Identified as HR patients|0|||
49163395|NCT02883049|158434784|FG000|Induction|Developed SMN|0|||
49163396|NCT02883049|158434785|FG001|Induction|Developed SMN|1|||
48837021|NCT01117480|157247048|FG000|Overall Study|Protocol Violation|8|||
48837022|NCT01117480|157247048|FG000|Overall Study|Did Not Start Adalimumab Therapy|20|||
48837023|NCT01266265|157247049|FG000|Overall Study|Death|95|||
48837024|NCT01266265|157247050|FG001|Overall Study|Death|73|||
48837025|NCT01266265|157247049|FG000|Overall Study|Lost to Follow-up|23|||
48837026|NCT01266265|157247050|FG001|Overall Study|Lost to Follow-up|28|||
49163397|NCT02883049|158434786|FG002|Induction|Developed SMN|0|||
49163398|NCT02883049|158434787|FG003|Induction|Developed SMN|0|||
49163399|NCT02883049|158434788|FG004|Induction|Developed SMN|0|||
49163400|NCT02883049|158434789|FG005|Induction|Developed SMN|0|||
49163401|NCT02883049|158434790|FG006|Induction|Developed SMN|0|||
49163402|NCT02883049|158434791|FG007|Induction|Developed SMN|0|||
49163403|NCT02883049|158434792|FG008|Induction|Developed SMN|0|||
49163404|NCT02883049|158434793|FG009|Induction|Developed SMN|0|||
49163405|NCT02883049|158434794|FG010|Induction|Developed SMN|0|||
49163406|NCT02883049|158434795|FG011|Induction|Developed SMN|0|||
49163407|NCT02883049|158434796|FG012|Induction|Developed SMN|0|||
49163408|NCT02883049|158434797|FG013|Induction|Developed SMN|0|||
49163409|NCT02883049|158434798|FG014|Induction|Developed SMN|0|||
49163410|NCT02883049|158434799|FG015|Induction|Developed SMN|0|||
49163411|NCT02883049|158434784|FG000|Induction|Enrolled onto another COG study|72|||
49163412|NCT02883049|158434785|FG001|Induction|Enrolled onto another COG study|0|||
49163413|NCT02883049|158434786|FG002|Induction|Enrolled onto another COG study|0|||
49163414|NCT02883049|158434787|FG003|Induction|Enrolled onto another COG study|0|||
49163415|NCT02883049|158434788|FG004|Induction|Enrolled onto another COG study|0|||
49163416|NCT02883049|158434789|FG005|Induction|Enrolled onto another COG study|0|||
48837027|NCT01266265|157247049|FG000|Overall Study|Withdrawal by Subject|13|||
48837028|NCT01266265|157247050|FG001|Overall Study|Withdrawal by Subject|11|||
48837029|NCT01266265|157247049|FG000|Overall Study|Respiratory-related adverse event|2|||
49163417|NCT02883049|158434790|FG006|Induction|Enrolled onto another COG study|0|||
49163418|NCT02883049|158434791|FG007|Induction|Enrolled onto another COG study|0|||
49163419|NCT02883049|158434792|FG008|Induction|Enrolled onto another COG study|0|||
49163420|NCT02883049|158434793|FG009|Induction|Enrolled onto another COG study|0|||
49163421|NCT02883049|158434794|FG010|Induction|Enrolled onto another COG study|0|||
49163422|NCT02883049|158434795|FG011|Induction|Enrolled onto another COG study|0|||
49163423|NCT02883049|158434796|FG012|Induction|Enrolled onto another COG study|0|||
49163424|NCT02883049|158434797|FG013|Induction|Enrolled onto another COG study|0|||
49163425|NCT02883049|158434798|FG014|Induction|Enrolled onto another COG study|0|||
49163426|NCT02883049|158434799|FG015|Induction|Enrolled onto another COG study|0|||
49163427|NCT02883049|158434784|FG000|Induction|Incomplete induction data|17|||
49163428|NCT02883049|158434785|FG001|Induction|Incomplete induction data|0|||
49163429|NCT02883049|158434786|FG002|Induction|Incomplete induction data|0|||
49163430|NCT02883049|158434787|FG003|Induction|Incomplete induction data|0|||
49163431|NCT02883049|158434788|FG004|Induction|Incomplete induction data|0|||
49163432|NCT02883049|158434789|FG005|Induction|Incomplete induction data|0|||
49163433|NCT02883049|158434790|FG006|Induction|Incomplete induction data|0|||
49163434|NCT02883049|158434791|FG007|Induction|Incomplete induction data|0|||
49163435|NCT02883049|158434792|FG008|Induction|Incomplete induction data|0|||
49163436|NCT02883049|158434793|FG009|Induction|Incomplete induction data|0|||
49163437|NCT02883049|158434794|FG010|Induction|Incomplete induction data|0|||
49163438|NCT02883049|158434795|FG011|Induction|Incomplete induction data|0|||
49163439|NCT02883049|158434796|FG012|Induction|Incomplete induction data|0|||
48837030|NCT01266265|157247050|FG001|Overall Study|Respiratory-related adverse event|1|||
48837031|NCT01266265|157247049|FG000|Overall Study|Transferred care to another provider|22|||
49163440|NCT02883049|158434797|FG013|Induction|Incomplete induction data|0|||
49163441|NCT02883049|158434798|FG014|Induction|Incomplete induction data|0|||
49163442|NCT02883049|158434799|FG015|Induction|Incomplete induction data|0|||
49163443|NCT02883049|158434784|FG000|Post Induction|Adverse Event|0|||
49163444|NCT02883049|158434785|FG001|Post Induction|Adverse Event|0|||
49163445|NCT02883049|158434786|FG002|Post Induction|Adverse Event|0|||
49163446|NCT02883049|158434787|FG003|Post Induction|Adverse Event|7|||
49163447|NCT02883049|158434788|FG004|Post Induction|Adverse Event|8|||
49163448|NCT02883049|158434789|FG005|Post Induction|Adverse Event|3|||
49163449|NCT02883049|158434790|FG006|Post Induction|Adverse Event|4|||
49163450|NCT02883049|158434791|FG007|Post Induction|Adverse Event|5|||
49163451|NCT02883049|158434792|FG008|Post Induction|Adverse Event|6|||
49163452|NCT02883049|158434793|FG009|Post Induction|Adverse Event|7|||
49163453|NCT02883049|158434794|FG010|Post Induction|Adverse Event|2|||
49163454|NCT02883049|158434795|FG011|Post Induction|Adverse Event|2|||
49163455|NCT02883049|158434796|FG012|Post Induction|Adverse Event|0|||
49163456|NCT02883049|158434797|FG013|Post Induction|Adverse Event|0|||
49163457|NCT02883049|158434798|FG014|Post Induction|Adverse Event|5|||
49163458|NCT02883049|158434799|FG015|Post Induction|Adverse Event|2|||
49163459|NCT02883049|158434784|FG000|Post Induction|Death|0|||
49163460|NCT02883049|158434785|FG001|Post Induction|Death|0|||
49163461|NCT02883049|158434786|FG002|Post Induction|Death|0|||
49163462|NCT02883049|158434787|FG003|Post Induction|Death|9|||
49163463|NCT02883049|158434788|FG004|Post Induction|Death|9|||
49163464|NCT02883049|158434789|FG005|Post Induction|Death|0|||
49163465|NCT02883049|158434790|FG006|Post Induction|Death|1|||
49163466|NCT02883049|158434791|FG007|Post Induction|Death|6|||
49163467|NCT02883049|158434792|FG008|Post Induction|Death|5|||
49163468|NCT02883049|158434793|FG009|Post Induction|Death|3|||
49163469|NCT02883049|158434794|FG010|Post Induction|Death|1|||
49163470|NCT02883049|158434795|FG011|Post Induction|Death|0|||
48837032|NCT01266265|157247050|FG001|Overall Study|Transferred care to another provider|28|||
48837033|NCT01266265|157247049|FG000|Overall Study|Stopped/changed PAH medication(s)|16|||
49163471|NCT02883049|158434796|FG012|Post Induction|Death|1|||
49163472|NCT02883049|158434797|FG013|Post Induction|Death|1|||
49163473|NCT02883049|158434798|FG014|Post Induction|Death|10|||
49163474|NCT02883049|158434799|FG015|Post Induction|Death|2|||
49163475|NCT02883049|158434784|FG000|Post Induction|Lost to Follow-up|0|||
49163476|NCT02883049|158434785|FG001|Post Induction|Lost to Follow-up|0|||
49163477|NCT02883049|158434786|FG002|Post Induction|Lost to Follow-up|0|||
49163478|NCT02883049|158434787|FG003|Post Induction|Lost to Follow-up|0|||
49163479|NCT02883049|158434788|FG004|Post Induction|Lost to Follow-up|1|||
48837034|NCT01266265|157247050|FG001|Overall Study|Stopped/changed PAH medication(s)|9|||
48837035|NCT01266265|157247049|FG000|Overall Study|Enrolled in another clinical study|15|||
48837036|NCT01266265|157247050|FG001|Overall Study|Enrolled in another clinical study|26|||
49163480|NCT02883049|158434789|FG005|Post Induction|Lost to Follow-up|1|||
49163481|NCT02883049|158434790|FG006|Post Induction|Lost to Follow-up|0|||
49163482|NCT02883049|158434791|FG007|Post Induction|Lost to Follow-up|0|||
49163483|NCT02883049|158434792|FG008|Post Induction|Lost to Follow-up|3|||
49163484|NCT02883049|158434793|FG009|Post Induction|Lost to Follow-up|0|||
49163485|NCT02883049|158434794|FG010|Post Induction|Lost to Follow-up|1|||
49163486|NCT02883049|158434795|FG011|Post Induction|Lost to Follow-up|0|||
49163487|NCT02883049|158434796|FG012|Post Induction|Lost to Follow-up|0|||
49163488|NCT02883049|158434797|FG013|Post Induction|Lost to Follow-up|0|||
49163489|NCT02883049|158434798|FG014|Post Induction|Lost to Follow-up|0|||
49163490|NCT02883049|158434799|FG015|Post Induction|Lost to Follow-up|0|||
49163491|NCT02883049|158434784|FG000|Post Induction|Physician Decision|0|||
49163492|NCT02883049|158434785|FG001|Post Induction|Physician Decision|0|||
49163493|NCT02883049|158434786|FG002|Post Induction|Physician Decision|0|||
49163494|NCT02883049|158434787|FG003|Post Induction|Physician Decision|27|||
49163495|NCT02883049|158434788|FG004|Post Induction|Physician Decision|27|||
49163496|NCT02883049|158434789|FG005|Post Induction|Physician Decision|23|||
49163497|NCT02883049|158434790|FG006|Post Induction|Physician Decision|30|||
49163498|NCT02883049|158434791|FG007|Post Induction|Physician Decision|56|||
49163499|NCT02883049|158434792|FG008|Post Induction|Physician Decision|85|||
49163500|NCT02883049|158434793|FG009|Post Induction|Physician Decision|12|||
49163501|NCT02883049|158434794|FG010|Post Induction|Physician Decision|5|||
49163502|NCT02883049|158434795|FG011|Post Induction|Physician Decision|14|||
49163503|NCT02883049|158434796|FG012|Post Induction|Physician Decision|1|||
49163504|NCT02883049|158434797|FG013|Post Induction|Physician Decision|11|||
49163505|NCT02883049|158434798|FG014|Post Induction|Physician Decision|19|||
49163506|NCT02883049|158434799|FG015|Post Induction|Physician Decision|5|||
49163507|NCT02883049|158434784|FG000|Post Induction|Protocol Violation|0|||
49163508|NCT02883049|158434785|FG001|Post Induction|Protocol Violation|0|||
49163509|NCT02883049|158434786|FG002|Post Induction|Protocol Violation|0|||
49163510|NCT02883049|158434787|FG003|Post Induction|Protocol Violation|0|||
49163511|NCT02883049|158434788|FG004|Post Induction|Protocol Violation|0|||
49163512|NCT02883049|158434789|FG005|Post Induction|Protocol Violation|0|||
49163513|NCT02883049|158434790|FG006|Post Induction|Protocol Violation|0|||
49163514|NCT02883049|158434791|FG007|Post Induction|Protocol Violation|1|||
49163515|NCT02883049|158434792|FG008|Post Induction|Protocol Violation|0|||
49163516|NCT02883049|158434793|FG009|Post Induction|Protocol Violation|0|||
49163517|NCT02883049|158434794|FG010|Post Induction|Protocol Violation|0|||
49163518|NCT02883049|158434795|FG011|Post Induction|Protocol Violation|0|||
49163519|NCT02883049|158434796|FG012|Post Induction|Protocol Violation|0|||
49163520|NCT02883049|158434797|FG013|Post Induction|Protocol Violation|0|||
49163521|NCT02883049|158434798|FG014|Post Induction|Protocol Violation|0|||
49163522|NCT02883049|158434799|FG015|Post Induction|Protocol Violation|0|||
49163523|NCT02883049|158434784|FG000|Post Induction|Withdrawal by Subject|0|||
49163524|NCT02883049|158434785|FG001|Post Induction|Withdrawal by Subject|0|||
49163525|NCT02883049|158434786|FG002|Post Induction|Withdrawal by Subject|0|||
48837037|NCT01266265|157247049|FG000|Overall Study|Non-compliance|8|||
48837038|NCT01266265|157247050|FG001|Overall Study|Non-compliance|5|||
48837039|NCT01266265|157247049|FG000|Overall Study|Lung transplant|6|||
48837040|NCT01266265|157247050|FG001|Overall Study|Lung transplant|5|||
48837041|NCT01266265|157247049|FG000|Overall Study|Site closed early|4|||
48837042|NCT01266265|157247050|FG001|Overall Study|Site closed early|3|||
49163526|NCT02883049|158434787|FG003|Post Induction|Withdrawal by Subject|5|||
49163527|NCT02883049|158434788|FG004|Post Induction|Withdrawal by Subject|2|||
49163528|NCT02883049|158434789|FG005|Post Induction|Withdrawal by Subject|1|||
49163529|NCT02883049|158434790|FG006|Post Induction|Withdrawal by Subject|0|||
49163530|NCT02883049|158434791|FG007|Post Induction|Withdrawal by Subject|0|||
49163531|NCT02883049|158434792|FG008|Post Induction|Withdrawal by Subject|2|||
48837043|NCT01266265|157247049|FG000|Overall Study|Clinical worsening|1|||
48837044|NCT01266265|157247050|FG001|Overall Study|Clinical worsening|1|||
48923800|NCT03548558|157555224|FG005|Phase 2: Booster Sessions Every 2 Months|Death|1|||
49163532|NCT02883049|158434793|FG009|Post Induction|Withdrawal by Subject|0|||
49163533|NCT02883049|158434794|FG010|Post Induction|Withdrawal by Subject|1|||
49163534|NCT02883049|158434795|FG011|Post Induction|Withdrawal by Subject|1|||
49163535|NCT02883049|158434796|FG012|Post Induction|Withdrawal by Subject|0|||
49163536|NCT02883049|158434797|FG013|Post Induction|Withdrawal by Subject|0|||
49163537|NCT02883049|158434798|FG014|Post Induction|Withdrawal by Subject|1|||
49163538|NCT02883049|158434799|FG015|Post Induction|Withdrawal by Subject|0|||
48837045|NCT00028769|157247051|FG000|Overall Study|Adverse Event|2|||
48837046|NCT00028769|157247051|FG000|Overall Study|Refusal Unrelated to Adverse Events|1|||
49163539|NCT02883049|158434784|FG000|Post Induction|Ineligible|0|||
49163540|NCT02883049|158434785|FG001|Post Induction|Ineligible|0|||
49163541|NCT02883049|158434786|FG002|Post Induction|Ineligible|2|||
49163542|NCT02883049|158434787|FG003|Post Induction|Ineligible|0|||
49163543|NCT02883049|158434788|FG004|Post Induction|Ineligible|0|||
48837047|NCT00028769|157247051|FG000|Overall Study|Progression or Death|31|||
48837048|NCT00028769|157247051|FG000|Overall Study|Other - Not Protocol Specified|1|||
48837049|NCT00028769|157247051|FG000|Overall Study|Ineligible|5|||
48837050|NCT00028769|157247051|FG000|Overall Study|Not Analyzable|1|||
48837051|NCT02015546|157247058|FG000|Overall Study|Withdrawal by Subject|1|||
48837052|NCT02015546|157247059|FG001|Overall Study|Withdrawal by Subject|1|||
48837053|NCT02015546|157247060|FG002|Overall Study|Withdrawal by Subject|1|||
48837054|NCT02015546|157247058|FG000|Overall Study|Screem Failure|2|||
48837055|NCT02015546|157247059|FG001|Overall Study|Screem Failure|1|||
48837056|NCT02015546|157247060|FG002|Overall Study|Screem Failure|3|||
49163544|NCT02883049|158434789|FG005|Post Induction|Ineligible|0|||
49163545|NCT02883049|158434790|FG006|Post Induction|Ineligible|1|||
49163546|NCT02883049|158434791|FG007|Post Induction|Ineligible|0|||
49163547|NCT02883049|158434792|FG008|Post Induction|Ineligible|0|||
49163548|NCT02883049|158434793|FG009|Post Induction|Ineligible|0|||
49163549|NCT02883049|158434794|FG010|Post Induction|Ineligible|1|||
49163550|NCT02883049|158434795|FG011|Post Induction|Ineligible|0|||
49163551|NCT02883049|158434796|FG012|Post Induction|Ineligible|0|||
48837057|NCT00507689|157247065|FG000|Pre-Randomization Period|Adverse Event|1|||
48837058|NCT00507689|157247066|FG001|Pre-Randomization Period|Adverse Event|0|||
48837059|NCT00507689|157247065|FG000|Pre-Randomization Period|Physician Decision|1|||
48837060|NCT00507689|157247066|FG001|Pre-Randomization Period|Physician Decision|0|||
48837061|NCT00507689|157247065|FG000|Pre-Randomization Period|Withdrawal by Subject|1|||
48837062|NCT00507689|157247066|FG001|Pre-Randomization Period|Withdrawal by Subject|0|||
48837063|NCT00507689|157247065|FG000|Randomized Period|Adverse Event|1|||
48837064|NCT00507689|157247066|FG001|Randomized Period|Adverse Event|1|||
48837065|NCT00507689|157247065|FG000|Randomized Period|Withdrawal by Subject|0|||
48837066|NCT00507689|157247066|FG001|Randomized Period|Withdrawal by Subject|1|||
48837067|NCT00346333|157247067|FG000|Overall Study|Death|1|||
48837068|NCT00346333|157247068|FG001|Overall Study|Death|0|||
48837069|NCT00346333|157247067|FG000|Overall Study|unwilling or unable to continue|4|||
48837070|NCT00346333|157247068|FG001|Overall Study|unwilling or unable to continue|8|||
48837071|NCT00494780|157247069|FG000|Overall Study|Adverse Event|1|||
48837072|NCT00494780|157247070|FG001|Overall Study|Adverse Event|0|||
48837073|NCT00494780|157247069|FG000|Overall Study|Withdrew before Dosed|0|||
48837074|NCT00494780|157247070|FG001|Overall Study|Withdrew before Dosed|1|||
48837075|NCT00494780|157247069|FG000|Overall Study|Progression of Study Disease|7|||
48837076|NCT00494780|157247070|FG001|Overall Study|Progression of Study Disease|8|||
48837077|NCT00494780|157247069|FG000|Overall Study|New Treatment|2|||
48837078|NCT00494780|157247070|FG001|Overall Study|New Treatment|2|||
48837079|NCT00494780|157247069|FG000|Overall Study|Non-compliance|1|||
48837080|NCT00494780|157247070|FG001|Overall Study|Non-compliance|0|||
48837081|NCT00494780|157247069|FG000|Overall Study|Residual Tumour Mass|0|||
48837082|NCT00494780|157247070|FG001|Overall Study|Residual Tumour Mass|1|||
48837083|NCT00494780|157247069|FG000|Overall Study|Insurance Issues|0|||
48837084|NCT00494780|157247070|FG001|Overall Study|Insurance Issues|1|||
48923801|NCT03548558|157555225|FG006|Phase 2: Booster Sessions Every 2 Months|Death|1|||
49163552|NCT02883049|158434797|FG013|Post Induction|Ineligible|0|||
49163553|NCT02883049|158434798|FG014|Post Induction|Ineligible|0|||
49163554|NCT02883049|158434799|FG015|Post Induction|Ineligible|1|||
49163555|NCT02883049|158434784|FG000|Post Induction|Refusal of further protocol therapy|0|||
49163556|NCT02883049|158434785|FG001|Post Induction|Refusal of further protocol therapy|0|||
49163557|NCT02883049|158434786|FG002|Post Induction|Refusal of further protocol therapy|0|||
49163558|NCT02883049|158434787|FG003|Post Induction|Refusal of further protocol therapy|11|||
49163559|NCT02883049|158434788|FG004|Post Induction|Refusal of further protocol therapy|15|||
49163560|NCT02883049|158434789|FG005|Post Induction|Refusal of further protocol therapy|9|||
49163561|NCT02883049|158434790|FG006|Post Induction|Refusal of further protocol therapy|13|||
49163562|NCT02883049|158434791|FG007|Post Induction|Refusal of further protocol therapy|5|||
49163563|NCT02883049|158434792|FG008|Post Induction|Refusal of further protocol therapy|21|||
49163564|NCT02883049|158434793|FG009|Post Induction|Refusal of further protocol therapy|7|||
49163565|NCT02883049|158434794|FG010|Post Induction|Refusal of further protocol therapy|0|||
49163566|NCT02883049|158434795|FG011|Post Induction|Refusal of further protocol therapy|7|||
48837085|NCT00723450|157247071|FG000|Open-Label Phase|Adverse Event|26|||
48837086|NCT00723450|157247072|FG001|Open-Label Phase|Adverse Event|0|||
48837087|NCT00723450|157247073|FG002|Open-Label Phase|Adverse Event|0|||
48837088|NCT00723450|157247071|FG000|Open-Label Phase|Lack of Efficacy|18|||
48837089|NCT00723450|157247072|FG001|Open-Label Phase|Lack of Efficacy|0|||
48837090|NCT00723450|157247073|FG002|Open-Label Phase|Lack of Efficacy|0|||
48837091|NCT00723450|157247071|FG000|Open-Label Phase|Protocol Violation|35|||
48837092|NCT00723450|157247072|FG001|Open-Label Phase|Protocol Violation|0|||
48837093|NCT00723450|157247073|FG002|Open-Label Phase|Protocol Violation|0|||
48837094|NCT00723450|157247071|FG000|Open-Label Phase|Lost to Follow-up|7|||
48837095|NCT00723450|157247072|FG001|Open-Label Phase|Lost to Follow-up|0|||
49163567|NCT02883049|158434796|FG012|Post Induction|Refusal of further protocol therapy|3|||
48837096|NCT00723450|157247073|FG002|Open-Label Phase|Lost to Follow-up|0|||
48837097|NCT00723450|157247071|FG000|Open-Label Phase|Physician Decision|2|||
48837098|NCT00723450|157247072|FG001|Open-Label Phase|Physician Decision|0|||
48837099|NCT00723450|157247073|FG002|Open-Label Phase|Physician Decision|0|||
48837100|NCT00723450|157247071|FG000|Open-Label Phase|Withdrawal by Subject|37|||
48837101|NCT00723450|157247072|FG001|Open-Label Phase|Withdrawal by Subject|0|||
48837102|NCT00723450|157247073|FG002|Open-Label Phase|Withdrawal by Subject|0|||
48837103|NCT00723450|157247071|FG000|Randomized Phase|Adverse Event|0|||
48837104|NCT00723450|157247072|FG001|Randomized Phase|Adverse Event|26|||
48837105|NCT00723450|157247073|FG002|Randomized Phase|Adverse Event|17|||
48837106|NCT00723450|157247071|FG000|Randomized Phase|Lack of Efficacy|0|||
48837107|NCT00723450|157247072|FG001|Randomized Phase|Lack of Efficacy|11|||
48837108|NCT00723450|157247073|FG002|Randomized Phase|Lack of Efficacy|11|||
48837109|NCT00723450|157247071|FG000|Randomized Phase|Protocol Violation|0|||
48837110|NCT00723450|157247072|FG001|Randomized Phase|Protocol Violation|9|||
48837111|NCT00723450|157247073|FG002|Randomized Phase|Protocol Violation|13|||
48837112|NCT00723450|157247071|FG000|Randomized Phase|Lost to Follow-up|0|||
48837113|NCT00723450|157247072|FG001|Randomized Phase|Lost to Follow-up|2|||
48837114|NCT00723450|157247073|FG002|Randomized Phase|Lost to Follow-up|3|||
48837115|NCT00723450|157247071|FG000|Randomized Phase|Physician Decision|0|||
48837116|NCT00723450|157247072|FG001|Randomized Phase|Physician Decision|3|||
48837117|NCT00723450|157247073|FG002|Randomized Phase|Physician Decision|1|||
48837118|NCT00723450|157247071|FG000|Randomized Phase|Withdrawal by Subject|0|||
48837119|NCT00723450|157247072|FG001|Randomized Phase|Withdrawal by Subject|14|||
48837120|NCT00723450|157247073|FG002|Randomized Phase|Withdrawal by Subject|22|||
49163568|NCT02883049|158434797|FG013|Post Induction|Refusal of further protocol therapy|0|||
49163569|NCT02883049|158434798|FG014|Post Induction|Refusal of further protocol therapy|4|||
49163570|NCT02883049|158434799|FG015|Post Induction|Refusal of further protocol therapy|1|||
49163571|NCT02883049|158434784|FG000|Post Induction|Inevaluable|0|||
49163572|NCT02883049|158434785|FG001|Post Induction|Inevaluable|0|||
49163573|NCT02883049|158434786|FG002|Post Induction|Inevaluable|0|||
49163574|NCT02883049|158434787|FG003|Post Induction|Inevaluable|1|||
49163575|NCT02883049|158434788|FG004|Post Induction|Inevaluable|1|||
49163576|NCT02883049|158434789|FG005|Post Induction|Inevaluable|2|||
49163577|NCT02883049|158434790|FG006|Post Induction|Inevaluable|7|||
49163578|NCT02883049|158434791|FG007|Post Induction|Inevaluable|6|||
49163579|NCT02883049|158434792|FG008|Post Induction|Inevaluable|4|||
49163580|NCT02883049|158434793|FG009|Post Induction|Inevaluable|4|||
49163581|NCT02883049|158434794|FG010|Post Induction|Inevaluable|1|||
49163582|NCT02883049|158434795|FG011|Post Induction|Inevaluable|1|||
49163583|NCT02883049|158434796|FG012|Post Induction|Inevaluable|2|||
49163584|NCT02883049|158434797|FG013|Post Induction|Inevaluable|0|||
49163585|NCT02883049|158434798|FG014|Post Induction|Inevaluable|0|||
49163586|NCT02883049|158434799|FG015|Post Induction|Inevaluable|1|||
49163587|NCT02883049|158434784|FG000|Post Induction|Moved to another non-COG institution|0|||
49163588|NCT02883049|158434785|FG001|Post Induction|Moved to another non-COG institution|0|||
49163589|NCT02883049|158434786|FG002|Post Induction|Moved to another non-COG institution|0|||
49163590|NCT02883049|158434787|FG003|Post Induction|Moved to another non-COG institution|0|||
49163591|NCT02883049|158434788|FG004|Post Induction|Moved to another non-COG institution|0|||
49163592|NCT02883049|158434789|FG005|Post Induction|Moved to another non-COG institution|0|||
49163593|NCT02883049|158434790|FG006|Post Induction|Moved to another non-COG institution|0|||
49163594|NCT02883049|158434791|FG007|Post Induction|Moved to another non-COG institution|2|||
49163595|NCT02883049|158434792|FG008|Post Induction|Moved to another non-COG institution|2|||
49163596|NCT02883049|158434793|FG009|Post Induction|Moved to another non-COG institution|0|||
49163597|NCT02883049|158434794|FG010|Post Induction|Moved to another non-COG institution|0|||
49163598|NCT02883049|158434795|FG011|Post Induction|Moved to another non-COG institution|1|||
49163599|NCT02883049|158434796|FG012|Post Induction|Moved to another non-COG institution|0|||
49163600|NCT02883049|158434797|FG013|Post Induction|Moved to another non-COG institution|0|||
49163601|NCT02883049|158434798|FG014|Post Induction|Moved to another non-COG institution|0|||
49163602|NCT02883049|158434799|FG015|Post Induction|Moved to another non-COG institution|0|||
49163603|NCT02883049|158434784|FG000|Post Induction|Randomization closed|0|||
49163604|NCT02883049|158434785|FG001|Post Induction|Randomization closed|0|||
49163605|NCT02883049|158434786|FG002|Post Induction|Randomization closed|0|||
49163606|NCT02883049|158434787|FG003|Post Induction|Randomization closed|0|||
49163607|NCT02883049|158434788|FG004|Post Induction|Randomization closed|0|||
49163608|NCT02883049|158434789|FG005|Post Induction|Randomization closed|0|||
49163609|NCT02883049|158434790|FG006|Post Induction|Randomization closed|0|||
48837121|NCT02314117|157247074|FG000|Overall Study|Lost to Follow-up|9|||
48837122|NCT02314117|157247075|FG001|Overall Study|Lost to Follow-up|14|||
48837123|NCT02314117|157247074|FG000|Overall Study|Withdrawal by Subject|3|||
48837124|NCT02314117|157247075|FG001|Overall Study|Withdrawal by Subject|2|||
48837125|NCT00189202|157247076|FG000|Overall Study|Physician Decision|5|||
48837126|NCT00869323|157247077|FG000|Maintenance Therapy|concurrent illness|1|||
48837127|NCT04054635|157247078|FG000|Second Visit (First Follow-up)|Lost to Follow-up|0|||
49163610|NCT02883049|158434791|FG007|Post Induction|Randomization closed|20|||
49163611|NCT02883049|158434792|FG008|Post Induction|Randomization closed|0|||
48837128|NCT04054635|157247079|FG001|Second Visit (First Follow-up)|Lost to Follow-up|1|||
48837129|NCT04054635|157247080|FG002|Second Visit (First Follow-up)|Lost to Follow-up|0|||
48837130|NCT04054635|157247078|FG000|Third Visit (Second Follow-up)|Lost to Follow-up|1|||
48837131|NCT04054635|157247079|FG001|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
48837132|NCT04054635|157247080|FG002|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
48837133|NCT00566527|157247084|FG000|Overall Study|Reason not provided|3|||
48837134|NCT00566527|157247085|FG001|Overall Study|Reason not provided|11|||
48837135|NCT00566527|157247086|FG002|Overall Study|Reason not provided|10|||
48837136|NCT00566527|157247084|FG000|Overall Study|Adverse Event|2|||
48837137|NCT00566527|157247085|FG001|Overall Study|Adverse Event|0|||
48837138|NCT00566527|157247086|FG002|Overall Study|Adverse Event|1|||
48837139|NCT00566527|157247084|FG000|Overall Study|Physician Decision|3|||
48837140|NCT00566527|157247085|FG001|Overall Study|Physician Decision|8|||
48837141|NCT00566527|157247086|FG002|Overall Study|Physician Decision|20|||
48837142|NCT00566527|157247084|FG000|Overall Study|Lost to Follow-up|3|||
48837143|NCT00566527|157247085|FG001|Overall Study|Lost to Follow-up|4|||
48837144|NCT00566527|157247086|FG002|Overall Study|Lost to Follow-up|4|||
49014731|NCT02585258|157890364|FG001|Overall Study|Adverse Event|29|||
49014732|NCT02585258|157890363|FG000|Overall Study|Death|3|||
49014733|NCT02585258|157890364|FG001|Overall Study|Death|2|||
49014734|NCT02585258|157890363|FG000|Overall Study|Lack of Efficacy|7|||
49014735|NCT02585258|157890364|FG001|Overall Study|Lack of Efficacy|9|||
49014736|NCT02585258|157890363|FG000|Overall Study|includes covid-related access problems|42|||
49014737|NCT02585258|157890364|FG001|Overall Study|includes covid-related access problems|46|||
49014738|NCT02585258|157890363|FG000|Overall Study|Lost to Follow-up|5|||
49014739|NCT02585258|157890364|FG001|Overall Study|Lost to Follow-up|2|||
49014740|NCT01405950|157890365|FG000|Overall Study|Withdrawal by Subject|1|||
49014741|NCT01405950|157890366|FG001|Overall Study|Withdrawal by Subject|0|||
49014742|NCT01405950|157890367|FG002|Overall Study|Withdrawal by Subject|0|||
49014743|NCT01405950|157890368|FG003|Overall Study|Withdrawal by Subject|0|||
49014744|NCT00697112|157890371|FG000|Overall Study|Adverse Event|8|||
49014745|NCT00697112|157890371|FG000|Overall Study|Lost to Follow-up|1|||
49014746|NCT00697112|157890371|FG000|Overall Study|Did not meet inclusion criteria|1|||
49014747|NCT00447603|157890373|FG000|Screening|Withdrawal by Subject|1|||
49014748|NCT00447603|157890374|FG001|Screening|Withdrawal by Subject|0|||
49014749|NCT00447603|157890375|FG002|Screening|Withdrawal by Subject|0|||
49014750|NCT00447603|157890373|FG000|Screening|Protocol Violation|1|||
49014751|NCT00447603|157890374|FG001|Screening|Protocol Violation|0|||
49014752|NCT00447603|157890375|FG002|Screening|Protocol Violation|0|||
49014753|NCT00447603|157890373|FG000|Screening|Screen Failure|4|||
49014754|NCT00447603|157890374|FG001|Screening|Screen Failure|0|||
49014755|NCT00447603|157890375|FG002|Screening|Screen Failure|0|||
49014756|NCT00447603|157890373|FG000|Screening|Study Terminated by Sponsor|15|||
49014757|NCT00447603|157890374|FG001|Screening|Study Terminated by Sponsor|0|||
49014758|NCT00447603|157890375|FG002|Screening|Study Terminated by Sponsor|0|||
49014759|NCT00447603|157890373|FG000|Filter Period|Adverse Event|0|||
49014760|NCT00447603|157890374|FG001|Filter Period|Adverse Event|0|||
49014761|NCT00447603|157890375|FG002|Filter Period|Adverse Event|1|||
49014762|NCT00447603|157890373|FG000|Filter Period|Screen Failure|0|||
49014763|NCT00447603|157890374|FG001|Filter Period|Screen Failure|3|||
49014764|NCT00447603|157890375|FG002|Filter Period|Screen Failure|4|||
49014765|NCT00447603|157890373|FG000|Filter Period|Study terminated by Sponsor|0|||
49014766|NCT00447603|157890374|FG001|Filter Period|Study terminated by Sponsor|1|||
49014767|NCT00447603|157890375|FG002|Filter Period|Study terminated by Sponsor|10|||
49014768|NCT01381900|157890376|FG000|Overall Study|Subject meets glycemic withdrawal crit.|2|||
48923802|NCT03548558|157555219|FG000|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
48923803|NCT03548558|157555220|FG001|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
48923804|NCT03548558|157555221|FG002|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
48923805|NCT03548558|157555222|FG003|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
48923806|NCT03548558|157555223|FG004|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|4|||
48923807|NCT03548558|157555224|FG005|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
48923808|NCT03548558|157555225|FG006|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
48923809|NCT03548558|157555219|FG000|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
48923810|NCT03548558|157555220|FG001|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
48923811|NCT03548558|157555221|FG002|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
49014769|NCT01381900|157890377|FG001|Overall Study|Subject meets glycemic withdrawal crit.|0|||
49014770|NCT01381900|157890378|FG002|Overall Study|Subject meets glycemic withdrawal crit.|0|||
48837145|NCT00566527|157247084|FG000|Overall Study|Withdrawal by Subject|6|||
48837146|NCT00566527|157247085|FG001|Overall Study|Withdrawal by Subject|43|||
48837147|NCT00566527|157247086|FG002|Overall Study|Withdrawal by Subject|43|||
48837148|NCT00356265|157247087|FG000|Overall Study|Withdrawal by Subject|0|||
49014771|NCT01381900|157890376|FG000|Overall Study|Adverse Event|4|||
49014772|NCT01381900|157890377|FG001|Overall Study|Adverse Event|6|||
48837149|NCT00356265|157247088|FG001|Overall Study|Withdrawal by Subject|0|||
48837150|NCT00356265|157247089|FG002|Overall Study|Withdrawal by Subject|1|||
48837151|NCT02709655|157247090|FG000|Single-Blind Phase (4 Weeks)|Adverse Event|2|||
48837152|NCT02709655|157247091|FG001|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
48837153|NCT02709655|157247092|FG002|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
48837154|NCT02709655|157247093|FG003|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
48837155|NCT02709655|157247094|FG004|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
48837156|NCT02709655|157247090|FG000|Single-Blind Phase (4 Weeks)|Lack of Efficacy|8|||
48837157|NCT02709655|157247091|FG001|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
48837158|NCT02709655|157247092|FG002|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
48837159|NCT02709655|157247093|FG003|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
48837160|NCT02709655|157247094|FG004|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
48837161|NCT02709655|157247090|FG000|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|3|||
49014773|NCT01381900|157890378|FG002|Overall Study|Adverse Event|7|||
49014774|NCT01381900|157890376|FG000|Overall Study|Noncompliance with study drug|0|||
49014775|NCT01381900|157890377|FG001|Overall Study|Noncompliance with study drug|0|||
49014776|NCT01381900|157890378|FG002|Overall Study|Noncompliance with study drug|1|||
49014777|NCT01381900|157890376|FG000|Overall Study|Physician Decision|0|||
49014778|NCT01381900|157890377|FG001|Overall Study|Physician Decision|1|||
49014779|NCT01381900|157890378|FG002|Overall Study|Physician Decision|1|||
49014780|NCT01381900|157890376|FG000|Overall Study|Protocol Violation|0|||
49014781|NCT01381900|157890377|FG001|Overall Study|Protocol Violation|1|||
49014782|NCT01381900|157890378|FG002|Overall Study|Protocol Violation|1|||
49014783|NCT01381900|157890376|FG000|Overall Study|Withdrawal by Subject|0|||
49014784|NCT01381900|157890377|FG001|Overall Study|Withdrawal by Subject|0|||
49014785|NCT01381900|157890378|FG002|Overall Study|Withdrawal by Subject|1|||
49014786|NCT01381900|157890376|FG000|Overall Study|Early withdraw|3|||
48837162|NCT02709655|157247091|FG001|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
48837163|NCT02709655|157247092|FG002|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
48837164|NCT02709655|157247093|FG003|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
48837165|NCT02709655|157247094|FG004|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
49163612|NCT02883049|158434793|FG009|Post Induction|Randomization closed|0|||
49163613|NCT02883049|158434794|FG010|Post Induction|Randomization closed|0|||
48837166|NCT02709655|157247090|FG000|Single-Blind Phase (4 Weeks)|Protocol Violation|3|||
48837167|NCT02709655|157247091|FG001|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
48837168|NCT02709655|157247092|FG002|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
48837169|NCT02709655|157247093|FG003|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
48837170|NCT02709655|157247094|FG004|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
48837171|NCT02709655|157247090|FG000|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|15|||
48837172|NCT02709655|157247091|FG001|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
48837173|NCT02709655|157247092|FG002|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
48837174|NCT02709655|157247093|FG003|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
48837175|NCT02709655|157247094|FG004|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
48837176|NCT02709655|157247090|FG000|Single-Blind Phase (4 Weeks)|Lost to Follow-up|1|||
48837177|NCT02709655|157247091|FG001|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
48837178|NCT02709655|157247092|FG002|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
48837179|NCT02709655|157247093|FG003|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
48837180|NCT02709655|157247094|FG004|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
48837181|NCT02709655|157247090|FG000|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|85|||
48837182|NCT02709655|157247091|FG001|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
48837183|NCT02709655|157247092|FG002|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
48837184|NCT02709655|157247093|FG003|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
48837185|NCT02709655|157247094|FG004|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
48837186|NCT02709655|157247090|FG000|Single-Blind Phase (4 Weeks)|Other than specified|20|||
48837187|NCT02709655|157247091|FG001|Single-Blind Phase (4 Weeks)|Other than specified|0|||
48837188|NCT02709655|157247092|FG002|Single-Blind Phase (4 Weeks)|Other than specified|0|||
48837189|NCT02709655|157247093|FG003|Single-Blind Phase (4 Weeks)|Other than specified|0|||
49163614|NCT02883049|158434795|FG011|Post Induction|Randomization closed|0|||
49163615|NCT02883049|158434796|FG012|Post Induction|Randomization closed|0|||
49163616|NCT02883049|158434797|FG013|Post Induction|Randomization closed|0|||
49163617|NCT02883049|158434798|FG014|Post Induction|Randomization closed|0|||
49163618|NCT02883049|158434799|FG015|Post Induction|Randomization closed|0|||
49163619|NCT02883049|158434784|FG000|Post Induction|MRD negative|0|||
49163620|NCT02883049|158434785|FG001|Post Induction|MRD negative|0|||
49163621|NCT02883049|158434786|FG002|Post Induction|MRD negative|0|||
49163622|NCT02883049|158434787|FG003|Post Induction|MRD negative|0|||
48837190|NCT02709655|157247094|FG004|Single-Blind Phase (4 Weeks)|Other than specified|0|||
48837191|NCT02709655|157247090|FG000|Single-Blind Phase (4 Weeks)|Enrolled but not treated|6|||
48837192|NCT02709655|157247091|FG001|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
48837193|NCT02709655|157247092|FG002|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
48837194|NCT02709655|157247093|FG003|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
49163623|NCT02883049|158434788|FG004|Post Induction|MRD negative|0|||
48837195|NCT02709655|157247094|FG004|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
48837196|NCT02709655|157247090|FG000|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
48837197|NCT02709655|157247091|FG001|Double-Blind Phase (8 Weeks)|Adverse Event|1|||
48837198|NCT02709655|157247092|FG002|Double-Blind Phase (8 Weeks)|Adverse Event|2|||
48837199|NCT02709655|157247093|FG003|Double-Blind Phase (8 Weeks)|Adverse Event|3|||
48837200|NCT02709655|157247094|FG004|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
48837201|NCT02709655|157247090|FG000|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
48837202|NCT02709655|157247091|FG001|Double-Blind Phase (8 Weeks)|Lack of Efficacy|2|||
48837203|NCT02709655|157247092|FG002|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
48837204|NCT02709655|157247093|FG003|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
48837205|NCT02709655|157247094|FG004|Double-Blind Phase (8 Weeks)|Lack of Efficacy|1|||
48837206|NCT02709655|157247090|FG000|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|0|||
48837207|NCT02709655|157247091|FG001|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
48837208|NCT02709655|157247092|FG002|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|3|||
48837209|NCT02709655|157247093|FG003|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|6|||
48837210|NCT02709655|157247094|FG004|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
48837211|NCT02709655|157247090|FG000|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
48837212|NCT02709655|157247091|FG001|Double-Blind Phase (8 Weeks)|Protocol Violation|1|||
48837213|NCT02709655|157247092|FG002|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
48837214|NCT02709655|157247093|FG003|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
48837215|NCT02709655|157247094|FG004|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
48837216|NCT02709655|157247090|FG000|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|0|||
48837217|NCT02709655|157247091|FG001|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
48837218|NCT02709655|157247092|FG002|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
48837219|NCT02709655|157247093|FG003|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
48837220|NCT02709655|157247094|FG004|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|1|||
48837221|NCT02709655|157247090|FG000|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
48837222|NCT02709655|157247091|FG001|Double-Blind Phase (8 Weeks)|Lost to Follow-up|1|||
48837223|NCT02709655|157247092|FG002|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
48837224|NCT02709655|157247093|FG003|Double-Blind Phase (8 Weeks)|Lost to Follow-up|2|||
48837225|NCT02709655|157247094|FG004|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
48837226|NCT02709655|157247090|FG000|Double-Blind Phase (8 Weeks)|Other than specified|0|||
48837227|NCT02709655|157247091|FG001|Double-Blind Phase (8 Weeks)|Other than specified|5|||
49014787|NCT01381900|157890377|FG001|Overall Study|Early withdraw|1|||
48837228|NCT02709655|157247092|FG002|Double-Blind Phase (8 Weeks)|Other than specified|7|||
48837229|NCT02709655|157247093|FG003|Double-Blind Phase (8 Weeks)|Other than specified|5|||
48837230|NCT02709655|157247094|FG004|Double-Blind Phase (8 Weeks)|Other than specified|2|||
48837231|NCT04210180|157247095|FG000|Overall Study|Withdrawal by Subject|2|||
48837232|NCT00468910|157247096|FG000|Overall Study|Lost to Follow-up|2|||
48837233|NCT00468910|157247097|FG001|Overall Study|Lost to Follow-up|1|||
48837234|NCT00468910|157247096|FG000|Overall Study|Withdrawal by Subject|2|||
48837235|NCT00468910|157247097|FG001|Overall Study|Withdrawal by Subject|1|||
48837236|NCT00468910|157247096|FG000|Overall Study|Medical Contraindication|0|||
48837237|NCT00468910|157247097|FG001|Overall Study|Medical Contraindication|1|||
48837238|NCT05190419|157247098|FG000|Overall Study|Lack of Efficacy|8|||
48837239|NCT05190419|157247099|FG001|Overall Study|Lack of Efficacy|0|||
48837240|NCT05190419|157247100|FG002|Overall Study|Lack of Efficacy|1|||
48837241|NCT05190419|157247101|FG003|Overall Study|Lack of Efficacy|0|||
48837242|NCT05190419|157247098|FG000|Overall Study|Withdrawal by Subject|7|||
48837243|NCT05190419|157247099|FG001|Overall Study|Withdrawal by Subject|1|||
48837244|NCT05190419|157247100|FG002|Overall Study|Withdrawal by Subject|2|||
48837245|NCT05190419|157247101|FG003|Overall Study|Withdrawal by Subject|2|||
48837246|NCT05190419|157247098|FG000|Overall Study|Adverse Event|2|||
48837247|NCT05190419|157247099|FG001|Overall Study|Adverse Event|10|||
48837248|NCT05190419|157247100|FG002|Overall Study|Adverse Event|11|||
48837249|NCT05190419|157247101|FG003|Overall Study|Adverse Event|21|||
48837250|NCT05190419|157247098|FG000|Overall Study|Lost to Follow-up|1|||
48837251|NCT05190419|157247099|FG001|Overall Study|Lost to Follow-up|2|||
48837252|NCT05190419|157247100|FG002|Overall Study|Lost to Follow-up|3|||
48837253|NCT05190419|157247101|FG003|Overall Study|Lost to Follow-up|1|||
48837254|NCT05190419|157247098|FG000|Overall Study|Other|1|||
48837255|NCT05190419|157247099|FG001|Overall Study|Other|1|||
48837256|NCT05190419|157247100|FG002|Overall Study|Other|0|||
48837257|NCT05190419|157247101|FG003|Overall Study|Other|3|||
48837258|NCT01576484|157247104|FG000|Overall Study|Adverse Event|1|||
49163624|NCT02883049|158434789|FG005|Post Induction|MRD negative|0|||
48837259|NCT01576484|157247105|FG001|Overall Study|Adverse Event|1|||
48837260|NCT01576484|157247104|FG000|Overall Study|Protocol Violation|0|||
48837261|NCT01576484|157247105|FG001|Overall Study|Protocol Violation|2|||
48837262|NCT01576484|157247104|FG000|Overall Study|Sponsor Decision|2|||
48837263|NCT01576484|157247105|FG001|Overall Study|Sponsor Decision|8|||
48837264|NCT01576484|157247104|FG000|Overall Study|Withdrawal by Subject|0|||
48837265|NCT01576484|157247105|FG001|Overall Study|Withdrawal by Subject|3|||
48837266|NCT01576484|157247104|FG000|Overall Study|Other|2|||
48923812|NCT03548558|157555222|FG003|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
49163625|NCT02883049|158434790|FG006|Post Induction|MRD negative|0|||
49163626|NCT02883049|158434791|FG007|Post Induction|MRD negative|11|||
49163627|NCT02883049|158434792|FG008|Post Induction|MRD negative|0|||
49163628|NCT02883049|158434793|FG009|Post Induction|MRD negative|0|||
49163629|NCT02883049|158434794|FG010|Post Induction|MRD negative|0|||
49163630|NCT02883049|158434795|FG011|Post Induction|MRD negative|0|||
49163631|NCT02883049|158434796|FG012|Post Induction|MRD negative|0|||
49163632|NCT02883049|158434797|FG013|Post Induction|MRD negative|0|||
49163633|NCT02883049|158434798|FG014|Post Induction|MRD negative|0|||
49163634|NCT02883049|158434799|FG015|Post Induction|MRD negative|0|||
49163635|NCT02883049|158434784|FG000|Post Induction|Developed SMN|0|||
49163636|NCT02883049|158434785|FG001|Post Induction|Developed SMN|0|||
49163637|NCT02883049|158434786|FG002|Post Induction|Developed SMN|0|||
49163638|NCT02883049|158434787|FG003|Post Induction|Developed SMN|0|||
49163639|NCT02883049|158434788|FG004|Post Induction|Developed SMN|1|||
49163640|NCT02883049|158434789|FG005|Post Induction|Developed SMN|0|||
49163641|NCT02883049|158434790|FG006|Post Induction|Developed SMN|1|||
49163642|NCT02883049|158434791|FG007|Post Induction|Developed SMN|0|||
49163643|NCT02883049|158434792|FG008|Post Induction|Developed SMN|0|||
49163644|NCT02883049|158434793|FG009|Post Induction|Developed SMN|0|||
49163645|NCT02883049|158434794|FG010|Post Induction|Developed SMN|1|||
49163646|NCT02883049|158434795|FG011|Post Induction|Developed SMN|1|||
49163647|NCT02883049|158434796|FG012|Post Induction|Developed SMN|0|||
49163648|NCT02883049|158434797|FG013|Post Induction|Developed SMN|0|||
49163649|NCT02883049|158434798|FG014|Post Induction|Developed SMN|1|||
49163650|NCT02883049|158434799|FG015|Post Induction|Developed SMN|0|||
49163651|NCT02883049|158434784|FG000|Post Induction|Enrolled onto another COG study|0|||
49163652|NCT02883049|158434785|FG001|Post Induction|Enrolled onto another COG study|0|||
49163653|NCT02883049|158434786|FG002|Post Induction|Enrolled onto another COG study|0|||
49163654|NCT02883049|158434787|FG003|Post Induction|Enrolled onto another COG study|1|||
49163655|NCT02883049|158434788|FG004|Post Induction|Enrolled onto another COG study|1|||
49163656|NCT02883049|158434789|FG005|Post Induction|Enrolled onto another COG study|0|||
49163657|NCT02883049|158434790|FG006|Post Induction|Enrolled onto another COG study|0|||
49163658|NCT02883049|158434791|FG007|Post Induction|Enrolled onto another COG study|4|||
48837267|NCT01576484|157247105|FG001|Overall Study|Other|5|||
49163659|NCT02883049|158434792|FG008|Post Induction|Enrolled onto another COG study|0|||
48837268|NCT05274217|157247106|FG000|Overall Study|Study terminated.|11|||
48837269|NCT05274217|157247107|FG001|Overall Study|Study terminated.|0|||
48837270|NCT02261467|157247108|FG000|Overall Study|Enrolled in Error|1|||
48837271|NCT02261467|157247109|FG001|Overall Study|Enrolled in Error|0|||
48837272|NCT02261467|157247108|FG000|Overall Study|Protocol Violation|0|||
48837273|NCT02261467|157247109|FG001|Overall Study|Protocol Violation|1|||
48837274|NCT02261467|157247108|FG000|Overall Study|Personal Reasons|17|||
48837275|NCT02261467|157247109|FG001|Overall Study|Personal Reasons|22|||
48837276|NCT02261467|157247108|FG000|Overall Study|Lost to Follow-up|2|||
48837277|NCT02261467|157247109|FG001|Overall Study|Lost to Follow-up|13|||
48837278|NCT02261467|157247108|FG000|Overall Study|Adverse Event|1|||
48837279|NCT02261467|157247109|FG001|Overall Study|Adverse Event|1|||
48837280|NCT00841035|157247115|FG000|Phase 1 Overall Study|Physician Decision|13|||
48837281|NCT04305405|157247116|FG000|Overall Study|Withdrawal by parent/guardian|0|||
49163660|NCT02883049|158434793|FG009|Post Induction|Enrolled onto another COG study|0|||
49163661|NCT02883049|158434794|FG010|Post Induction|Enrolled onto another COG study|0|||
49163662|NCT02883049|158434795|FG011|Post Induction|Enrolled onto another COG study|2|||
49163663|NCT02883049|158434796|FG012|Post Induction|Enrolled onto another COG study|0|||
49163664|NCT02883049|158434797|FG013|Post Induction|Enrolled onto another COG study|1|||
49163665|NCT02883049|158434798|FG014|Post Induction|Enrolled onto another COG study|0|||
49163666|NCT02883049|158434799|FG015|Post Induction|Enrolled onto another COG study|0|||
49163667|NCT02883049|158434784|FG000|Post Induction|Recurrent leukemia|0|||
49163668|NCT02883049|158434785|FG001|Post Induction|Recurrent leukemia|0|||
49163669|NCT02883049|158434786|FG002|Post Induction|Recurrent leukemia|0|||
49163670|NCT02883049|158434787|FG003|Post Induction|Recurrent leukemia|17|||
49163671|NCT02883049|158434788|FG004|Post Induction|Recurrent leukemia|12|||
49163672|NCT02883049|158434789|FG005|Post Induction|Recurrent leukemia|4|||
49163673|NCT02883049|158434790|FG006|Post Induction|Recurrent leukemia|1|||
49163674|NCT02883049|158434791|FG007|Post Induction|Recurrent leukemia|13|||
49163675|NCT02883049|158434792|FG008|Post Induction|Recurrent leukemia|27|||
49163676|NCT02883049|158434793|FG009|Post Induction|Recurrent leukemia|5|||
49163677|NCT02883049|158434794|FG010|Post Induction|Recurrent leukemia|3|||
49163678|NCT02883049|158434795|FG011|Post Induction|Recurrent leukemia|12|||
49163679|NCT02883049|158434796|FG012|Post Induction|Recurrent leukemia|1|||
49163680|NCT02883049|158434797|FG013|Post Induction|Recurrent leukemia|1|||
49163681|NCT02883049|158434798|FG014|Post Induction|Recurrent leukemia|9|||
49163682|NCT02883049|158434799|FG015|Post Induction|Recurrent leukemia|3|||
49163683|NCT02883049|158434784|FG000|Post Induction|Induction Failure|0|||
49163684|NCT02883049|158434785|FG001|Post Induction|Induction Failure|0|||
49163685|NCT02883049|158434786|FG002|Post Induction|Induction Failure|0|||
49163686|NCT02883049|158434787|FG003|Post Induction|Induction Failure|0|||
49163687|NCT02883049|158434788|FG004|Post Induction|Induction Failure|0|||
49163688|NCT02883049|158434789|FG005|Post Induction|Induction Failure|0|||
49163689|NCT02883049|158434790|FG006|Post Induction|Induction Failure|0|||
49163690|NCT02883049|158434791|FG007|Post Induction|Induction Failure|2|||
49163691|NCT02883049|158434792|FG008|Post Induction|Induction Failure|2|||
49163692|NCT02883049|158434793|FG009|Post Induction|Induction Failure|0|||
49163693|NCT02883049|158434794|FG010|Post Induction|Induction Failure|0|||
49163694|NCT02883049|158434795|FG011|Post Induction|Induction Failure|0|||
49163695|NCT02883049|158434796|FG012|Post Induction|Induction Failure|0|||
49163696|NCT02883049|158434797|FG013|Post Induction|Induction Failure|2|||
49163697|NCT02883049|158434798|FG014|Post Induction|Induction Failure|0|||
49163698|NCT02883049|158434799|FG015|Post Induction|Induction Failure|0|||
49163699|NCT05319600|158434800|FG000|Overall Study|Withdrawal by Subject|1|||
49163700|NCT05319600|158434801|FG001|Overall Study|Withdrawal by Subject|0|||
49163701|NCT05319600|158434800|FG000|Overall Study|Lost to Follow-up|0|||
49163702|NCT05319600|158434801|FG001|Overall Study|Lost to Follow-up|4|||
49163703|NCT03916185|158434802|FG000|Overall Study|Lost to Follow-up|0|||
49163704|NCT03916185|158434803|FG001|Overall Study|Lost to Follow-up|1|||
49163705|NCT03916185|158434804|FG002|Overall Study|Lost to Follow-up|0|||
49163706|NCT03916185|158434805|FG003|Overall Study|Lost to Follow-up|0|||
49163707|NCT03916185|158434802|FG000|Overall Study|Moved|1|||
49163708|NCT03916185|158434803|FG001|Overall Study|Moved|0|||
49163709|NCT03916185|158434804|FG002|Overall Study|Moved|0|||
49163710|NCT03916185|158434805|FG003|Overall Study|Moved|1|||
49163711|NCT03916185|158434802|FG000|Overall Study|Not Able to Get to Clinic|1|||
49163712|NCT03916185|158434803|FG001|Overall Study|Not Able to Get to Clinic|0|||
49163713|NCT03916185|158434804|FG002|Overall Study|Not Able to Get to Clinic|0|||
49163714|NCT03916185|158434805|FG003|Overall Study|Not Able to Get to Clinic|0|||
49163715|NCT05477186|158434808|FG000|Overall Study|Vaccine not administered|0|||
49163716|NCT05477186|158434809|FG001|Overall Study|Vaccine not administered|2|||
48837282|NCT04305405|157247117|FG001|Overall Study|Withdrawal by parent/guardian|1|||
48837283|NCT00736853|157247121|FG000|Open-Label Period|Physician Decision|2|||
49163717|NCT05477186|158434810|FG002|Overall Study|Vaccine not administered|1|||
49163718|NCT05477186|158434811|FG003|Overall Study|Vaccine not administered|0|||
49163719|NCT05477186|158434812|FG004|Overall Study|Vaccine not administered|1|||
49163720|NCT05477186|158434813|FG005|Overall Study|Vaccine not administered|0|||
49163721|NCT05477186|158434814|FG006|Overall Study|Vaccine not administered|0|||
48837284|NCT00736853|157247122|FG001|Open-Label Period|Physician Decision|0|||
48837285|NCT00736853|157247123|FG002|Open-Label Period|Physician Decision|0|||
48837286|NCT00736853|157247121|FG000|Open-Label Period|Adverse Event|31|||
48837287|NCT00736853|157247122|FG001|Open-Label Period|Adverse Event|0|||
48837288|NCT00736853|157247123|FG002|Open-Label Period|Adverse Event|0|||
48837289|NCT00736853|157247121|FG000|Open-Label Period|Withdrawal by Subject|16|||
48837290|NCT00736853|157247122|FG001|Open-Label Period|Withdrawal by Subject|0|||
48837291|NCT00736853|157247123|FG002|Open-Label Period|Withdrawal by Subject|0|||
48837292|NCT00736853|157247121|FG000|Open-Label Period|Started but not treated|42|||
48837293|NCT00736853|157247122|FG001|Open-Label Period|Started but not treated|0|||
48837294|NCT00736853|157247123|FG002|Open-Label Period|Started but not treated|0|||
48837295|NCT00736853|157247121|FG000|Open-Label Period|Failed to meet the transfer criteria|40|||
48837296|NCT00736853|157247122|FG001|Open-Label Period|Failed to meet the transfer criteria|0|||
48837297|NCT00736853|157247123|FG002|Open-Label Period|Failed to meet the transfer criteria|0|||
48837298|NCT00736853|157247121|FG000|Open-Label Period|Unable to attend hospital appointments|1|||
48837299|NCT00736853|157247122|FG001|Open-Label Period|Unable to attend hospital appointments|0|||
48837300|NCT00736853|157247123|FG002|Open-Label Period|Unable to attend hospital appointments|0|||
48837301|NCT00736853|157247121|FG000|Double-Blind Period|Lack of Efficacy|0|||
48837302|NCT00736853|157247122|FG001|Double-Blind Period|Lack of Efficacy|19|||
48837303|NCT00736853|157247123|FG002|Double-Blind Period|Lack of Efficacy|42|||
48837304|NCT00736853|157247121|FG000|Double-Blind Period|Adverse Event|0|||
48837305|NCT00736853|157247122|FG001|Double-Blind Period|Adverse Event|3|||
48837306|NCT00736853|157247123|FG002|Double-Blind Period|Adverse Event|2|||
48837307|NCT00736853|157247121|FG000|Double-Blind Period|Withdrawal by Subject|0|||
48837308|NCT00736853|157247122|FG001|Double-Blind Period|Withdrawal by Subject|1|||
48837309|NCT00736853|157247123|FG002|Double-Blind Period|Withdrawal by Subject|4|||
48837310|NCT00736853|157247121|FG000|Double-Blind Period|Ineligible to participate the study|0|||
48837311|NCT00736853|157247122|FG001|Double-Blind Period|Ineligible to participate the study|1|||
48837312|NCT00736853|157247123|FG002|Double-Blind Period|Ineligible to participate the study|0|||
48837313|NCT01415349|157247128|FG000|Treatment Period 1|Adverse Event|0|||
48837314|NCT01415349|157247129|FG001|Treatment Period 1|Adverse Event|1|||
48837315|NCT01415349|157247128|FG000|Treatment Period 1|Withdrawal by Subject|0|||
48837316|NCT01415349|157247129|FG001|Treatment Period 1|Withdrawal by Subject|1|||
48837317|NCT01350804|157247130|FG000|Core Study|Withdrawal by Subject|11|||
48837318|NCT01350804|157247131|FG001|Core Study|Withdrawal by Subject|17|||
48837319|NCT01350804|157247132|FG002|Core Study|Withdrawal by Subject|16|||
48837320|NCT01350804|157247133|FG003|Core Study|Withdrawal by Subject|7|||
48837321|NCT01350804|157247130|FG000|Core Study|Study terminated by Sponsor|0|||
48837322|NCT01350804|157247131|FG001|Core Study|Study terminated by Sponsor|0|||
48837323|NCT01350804|157247132|FG002|Core Study|Study terminated by Sponsor|0|||
48837324|NCT01350804|157247133|FG003|Core Study|Study terminated by Sponsor|2|||
48837325|NCT01350804|157247130|FG000|Core Study|Protocol deviation|1|||
48837326|NCT01350804|157247131|FG001|Core Study|Protocol deviation|0|||
48837327|NCT01350804|157247132|FG002|Core Study|Protocol deviation|1|||
48837328|NCT01350804|157247133|FG003|Core Study|Protocol deviation|0|||
48837329|NCT01350804|157247130|FG000|Core Study|Physician Decision|1|||
48837330|NCT01350804|157247131|FG001|Core Study|Physician Decision|0|||
48837331|NCT01350804|157247132|FG002|Core Study|Physician Decision|1|||
48837332|NCT01350804|157247133|FG003|Core Study|Physician Decision|3|||
48837333|NCT01350804|157247130|FG000|Core Study|Lost to Follow-up|3|||
48837334|NCT01350804|157247131|FG001|Core Study|Lost to Follow-up|0|||
48837335|NCT01350804|157247132|FG002|Core Study|Lost to Follow-up|2|||
48837336|NCT01350804|157247133|FG003|Core Study|Lost to Follow-up|1|||
48837337|NCT01350804|157247130|FG000|Core Study|Lack of Efficacy|16|||
48837338|NCT01350804|157247131|FG001|Core Study|Lack of Efficacy|19|||
48837339|NCT01350804|157247132|FG002|Core Study|Lack of Efficacy|18|||
48837340|NCT01350804|157247133|FG003|Core Study|Lack of Efficacy|5|||
48837341|NCT01350804|157247130|FG000|Core Study|Death|1|||
48837342|NCT01350804|157247131|FG001|Core Study|Death|1|||
48837343|NCT01350804|157247132|FG002|Core Study|Death|1|||
48837344|NCT01350804|157247133|FG003|Core Study|Death|0|||
48837345|NCT01350804|157247130|FG000|Core Study|Adverse Event|8|||
48837346|NCT01350804|157247131|FG001|Core Study|Adverse Event|10|||
48837347|NCT01350804|157247132|FG002|Core Study|Adverse Event|8|||
48837348|NCT01350804|157247133|FG003|Core Study|Adverse Event|8|||
48837349|NCT01350804|157247130|FG000|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5|||
48837350|NCT01350804|157247131|FG001|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6|||
49014788|NCT01381900|157890378|FG002|Overall Study|Early withdraw|1|||
48837351|NCT01350804|157247132|FG002|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4|||
48837352|NCT01350804|157247133|FG003|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3|||
48837353|NCT01350804|157247130|FG000|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
48837354|NCT01350804|157247131|FG001|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
48837355|NCT01350804|157247132|FG002|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64|||
48837356|NCT01350804|157247133|FG003|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16|||
48837357|NCT01350804|157247130|FG000|Extension Study, Weeks 52 - 260|Physician Decision|1|||
48837358|NCT01350804|157247131|FG001|Extension Study, Weeks 52 - 260|Physician Decision|0|||
48837359|NCT01350804|157247132|FG002|Extension Study, Weeks 52 - 260|Physician Decision|2|||
48837360|NCT01350804|157247133|FG003|Extension Study, Weeks 52 - 260|Physician Decision|0|||
48837361|NCT01350804|157247130|FG000|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
48837362|NCT01350804|157247131|FG001|Extension Study, Weeks 52 - 260|Lost to Follow-up|1|||
48837363|NCT01350804|157247132|FG002|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
48837364|NCT01350804|157247133|FG003|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
48837365|NCT01350804|157247130|FG000|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
48837366|NCT01350804|157247131|FG001|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
48837367|NCT01350804|157247132|FG002|Extension Study, Weeks 52 - 260|Lack of Efficacy|0|||
48837368|NCT01350804|157247133|FG003|Extension Study, Weeks 52 - 260|Lack of Efficacy|1|||
48837369|NCT01350804|157247130|FG000|Extension Study, Weeks 52 - 260|Adverse Event|3|||
48837370|NCT01350804|157247131|FG001|Extension Study, Weeks 52 - 260|Adverse Event|1|||
48837371|NCT01350804|157247132|FG002|Extension Study, Weeks 52 - 260|Adverse Event|2|||
48837372|NCT01350804|157247133|FG003|Extension Study, Weeks 52 - 260|Adverse Event|3|||
48837373|NCT02139943|157247134|FG000|Overall Study|Adverse Event|0|||
48837374|NCT02139943|157247135|FG001|Overall Study|Adverse Event|1|||
48837375|NCT02139943|157247136|FG002|Overall Study|Adverse Event|2|||
48837376|NCT02139943|157247134|FG000|Overall Study|Lost to Follow-up|3|||
48837377|NCT02139943|157247135|FG001|Overall Study|Lost to Follow-up|2|||
48837378|NCT02139943|157247136|FG002|Overall Study|Lost to Follow-up|2|||
48837379|NCT02139943|157247134|FG000|Overall Study|Withdrawal by Subject|4|||
48837380|NCT02139943|157247135|FG001|Overall Study|Withdrawal by Subject|3|||
48837381|NCT02139943|157247136|FG002|Overall Study|Withdrawal by Subject|0|||
48837382|NCT02139943|157247134|FG000|Overall Study|Other|0|||
48837383|NCT02139943|157247135|FG001|Overall Study|Other|0|||
48837384|NCT02139943|157247136|FG002|Overall Study|Other|1|||
48837385|NCT02139943|157247134|FG000|Overall Study|Participant wishes to discontinue|2|||
48837386|NCT02139943|157247135|FG001|Overall Study|Participant wishes to discontinue|0|||
48837387|NCT02139943|157247136|FG002|Overall Study|Participant wishes to discontinue|0|||
48837388|NCT02139943|157247134|FG000|Overall Study|Participant in Poor Compliance|1|||
48837389|NCT02139943|157247135|FG001|Overall Study|Participant in Poor Compliance|0|||
48837390|NCT02139943|157247136|FG002|Overall Study|Participant in Poor Compliance|1|||
48837391|NCT02139943|157247134|FG000|Overall Study|eGFR Withdrawal Criteria|0|||
48837392|NCT02139943|157247135|FG001|Overall Study|eGFR Withdrawal Criteria|0|||
48837393|NCT02139943|157247136|FG002|Overall Study|eGFR Withdrawal Criteria|1|||
48837394|NCT01713946|157247139|FG000|Overall Study|Death|0|||
48837395|NCT01713946|157247140|FG001|Overall Study|Death|2|||
48837396|NCT01713946|157247141|FG002|Overall Study|Death|2|||
48837397|NCT01713946|157247139|FG000|Overall Study|Adverse Event|19|||
48837398|NCT01713946|157247140|FG001|Overall Study|Adverse Event|14|||
48837399|NCT01713946|157247141|FG002|Overall Study|Adverse Event|13|||
48837400|NCT01713946|157247139|FG000|Overall Study|Withdrawal by Subject|12|||
48837401|NCT01713946|157247140|FG001|Overall Study|Withdrawal by Subject|12|||
48837402|NCT01713946|157247141|FG002|Overall Study|Withdrawal by Subject|8|||
48837403|NCT01713946|157247139|FG000|Overall Study|Lack of Efficacy|8|||
48837404|NCT01713946|157247140|FG001|Overall Study|Lack of Efficacy|8|||
48837405|NCT01713946|157247141|FG002|Overall Study|Lack of Efficacy|14|||
48837406|NCT01713946|157247139|FG000|Overall Study|Protocol Violation|2|||
48837407|NCT01713946|157247140|FG001|Overall Study|Protocol Violation|4|||
48837408|NCT01713946|157247141|FG002|Overall Study|Protocol Violation|1|||
48837409|NCT01713946|157247139|FG000|Overall Study|Lost to Follow-up|0|||
48837410|NCT01713946|157247140|FG001|Overall Study|Lost to Follow-up|0|||
48837411|NCT01713946|157247141|FG002|Overall Study|Lost to Follow-up|1|||
48837412|NCT01713946|157247139|FG000|Overall Study|Administrative problems|1|||
48837413|NCT01713946|157247140|FG001|Overall Study|Administrative problems|0|||
48837414|NCT01713946|157247141|FG002|Overall Study|Administrative problems|0|||
48837415|NCT01713946|157247139|FG000|Overall Study|Did not continue in Ext|0|||
48837416|NCT01713946|157247140|FG001|Overall Study|Did not continue in Ext|3|||
48837417|NCT01713946|157247141|FG002|Overall Study|Did not continue in Ext|0|||
48837418|NCT01713946|157247139|FG000|Overall Study|Did not continue in Post-Ext. Phase|1|||
48837419|NCT01713946|157247140|FG001|Overall Study|Did not continue in Post-Ext. Phase|2|||
48837420|NCT01713946|157247141|FG002|Overall Study|Did not continue in Post-Ext. Phase|0|||
48837421|NCT01713946|157247139|FG000|Overall Study|Patients never switched to everolimus|0|||
48837422|NCT01713946|157247140|FG001|Overall Study|Patients never switched to everolimus|0|||
48837423|NCT01713946|157247141|FG002|Overall Study|Patients never switched to everolimus|5|||
48837424|NCT03183518|157247142|FG000|Overall Study|Other (Not specified)|2|||
48837425|NCT03183518|157247142|FG000|Overall Study|Other (Withdrawal of consent)|1|||
48837426|NCT01803555|157247145|FG000|Overall Study|Adverse Event|3|||
48837427|NCT01803555|157247146|FG001|Overall Study|Adverse Event|2|||
48837428|NCT01803555|157247145|FG000|Overall Study|Withdrawal by Subject|3|||
48837429|NCT01803555|157247146|FG001|Overall Study|Withdrawal by Subject|3|||
48837430|NCT01803555|157247145|FG000|Overall Study|Non-compliance|1|||
48837431|NCT01803555|157247146|FG001|Overall Study|Non-compliance|1|||
48837432|NCT01803555|157247145|FG000|Overall Study|Protocol Violation|3|||
48837433|NCT01803555|157247146|FG001|Overall Study|Protocol Violation|5|||
48837434|NCT01803555|157247145|FG000|Overall Study|Lost to Follow-up|0|||
48837435|NCT01803555|157247146|FG001|Overall Study|Lost to Follow-up|2|||
48837436|NCT01803555|157247145|FG000|Overall Study|Other than specified|3|||
48837437|NCT01803555|157247146|FG001|Overall Study|Other than specified|5|||
48837438|NCT00393484|157247147|FG000|Double-blind Period (Day 1 to Week 96)|Adverse Event|0|||
48837439|NCT00393484|157247148|FG001|Double-blind Period (Day 1 to Week 96)|Adverse Event|1|||
48837440|NCT00393484|157247147|FG000|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2|||
48837441|NCT00393484|157247148|FG001|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0|||
48837442|NCT00393484|157247147|FG000|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0|||
48837443|NCT00393484|157247148|FG001|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3|||
48837444|NCT00393484|157247147|FG000|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0|||
48837445|NCT00393484|157247148|FG001|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6|||
48837446|NCT00393484|157247147|FG000|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0|||
48837447|NCT00393484|157247148|FG001|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2|||
48837448|NCT00393484|157247147|FG000|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4|||
48837449|NCT00393484|157247148|FG001|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1|||
48837450|NCT00393484|157247147|FG000|Open-label Period (Weeks 96 to 240)|Death|1|||
48837451|NCT00393484|157247148|FG001|Open-label Period (Weeks 96 to 240)|Death|0|||
48837452|NCT00393484|157247147|FG000|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1|||
48837453|NCT00393484|157247148|FG001|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2|||
48837454|NCT00393484|157247147|FG000|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
48837455|NCT00393484|157247148|FG001|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
48837456|NCT00393484|157247147|FG000|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0|||
48837457|NCT00393484|157247148|FG001|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18|||
48837458|NCT01764464|157247149|FG000|First Intervention|Withdrawal by Subject|1|||
48837459|NCT01764464|157247150|FG001|First Intervention|Withdrawal by Subject|0|||
48837460|NCT01764464|157247149|FG000|First Intervention|Lost to Follow-up|1|||
48837461|NCT01764464|157247150|FG001|First Intervention|Lost to Follow-up|0|||
48837462|NCT01764464|157247149|FG000|First Intervention|Adverse Event|0|||
48837463|NCT01764464|157247150|FG001|First Intervention|Adverse Event|2|||
48837464|NCT01764464|157247149|FG000|First Intervention|did not receive study drug|0|||
48837465|NCT01764464|157247150|FG001|First Intervention|did not receive study drug|1|||
48837466|NCT01764464|157247149|FG000|Second Intervention (Cross-over)|Adverse Event|2|||
48837467|NCT01764464|157247150|FG001|Second Intervention (Cross-over)|Adverse Event|0|||
48837468|NCT00065260|157247151|FG000|Overall Study|Death|0|||
48837469|NCT00065260|157247152|FG001|Overall Study|Death|1|||
48837470|NCT03473340|157247158|FG000|Overall Study|Follow up not possible due to COVID restrictions|3|||
48837471|NCT03473340|157247159|FG001|Overall Study|Follow up not possible due to COVID restrictions|0|||
48837472|NCT03473340|157247158|FG000|Overall Study|Withdrawal by Subject|1|||
48837473|NCT03473340|157247159|FG001|Overall Study|Withdrawal by Subject|0|||
48837474|NCT03473340|157247158|FG000|Overall Study|Lost to Follow-up|1|||
48837475|NCT03473340|157247159|FG001|Overall Study|Lost to Follow-up|2|||
48837476|NCT01420549|157247160|FG000|Overall Study|Adverse Event|1|||
48837477|NCT01420549|157247161|FG001|Overall Study|Adverse Event|1|||
48837478|NCT01420549|157247160|FG000|Overall Study|Lost to Follow-up|2|||
48837479|NCT01420549|157247161|FG001|Overall Study|Lost to Follow-up|2|||
49163722|NCT05477186|158434808|FG000|Overall Study|Withdrawal by Subject|1|||
49163723|NCT05477186|158434809|FG001|Overall Study|Withdrawal by Subject|0|||
49163724|NCT05477186|158434810|FG002|Overall Study|Withdrawal by Subject|0|||
49163725|NCT05477186|158434811|FG003|Overall Study|Withdrawal by Subject|0|||
49163726|NCT05477186|158434812|FG004|Overall Study|Withdrawal by Subject|0|||
49163727|NCT05477186|158434813|FG005|Overall Study|Withdrawal by Subject|1|||
49163728|NCT05477186|158434814|FG006|Overall Study|Withdrawal by Subject|0|||
49163729|NCT05477186|158434808|FG000|Overall Study|Lost to Follow-up|1|||
49163730|NCT05477186|158434809|FG001|Overall Study|Lost to Follow-up|0|||
49163731|NCT05477186|158434810|FG002|Overall Study|Lost to Follow-up|2|||
49163732|NCT05477186|158434811|FG003|Overall Study|Lost to Follow-up|1|||
49163733|NCT05477186|158434812|FG004|Overall Study|Lost to Follow-up|1|||
49163734|NCT05477186|158434813|FG005|Overall Study|Lost to Follow-up|0|||
49163735|NCT05477186|158434814|FG006|Overall Study|Lost to Follow-up|2|||
49163736|NCT03829319|158434815|FG000|Overall Study|Ongoing|4|||
49163737|NCT03829319|158434816|FG001|Overall Study|Ongoing|125|||
49163738|NCT03829319|158434817|FG002|Overall Study|Ongoing|130|||
49163739|NCT03829319|158434815|FG000|Overall Study|Withdrawal by Subject|1|||
49163740|NCT03829319|158434816|FG001|Overall Study|Withdrawal by Subject|6|||
49163741|NCT03829319|158434817|FG002|Overall Study|Withdrawal by Subject|8|||
49163742|NCT03829319|158434815|FG000|Overall Study|Physician Decision|0|||
49163743|NCT03829319|158434816|FG001|Overall Study|Physician Decision|1|||
49163744|NCT03829319|158434817|FG002|Overall Study|Physician Decision|0|||
48837480|NCT01420549|157247160|FG000|Overall Study|Protocol Violation|0|||
48837481|NCT01420549|157247161|FG001|Overall Study|Protocol Violation|1|||
48837482|NCT01420549|157247160|FG000|Overall Study|Non-adherence to medication|4|||
48837483|NCT01420549|157247161|FG001|Overall Study|Non-adherence to medication|1|||
48837484|NCT01212991|157247162|FG000|Double-blind|Lost to Follow-up|8|||
48837485|NCT01212991|157247163|FG001|Double-blind|Lost to Follow-up|4|||
48837486|NCT01212991|157247164|FG002|Double-blind|Lost to Follow-up|0|||
49163745|NCT03829319|158434815|FG000|Overall Study|Lost to Follow-up|0|||
48837487|NCT01212991|157247162|FG000|Double-blind|Death|699|||
48837488|NCT01212991|157247163|FG001|Double-blind|Death|550|||
48923813|NCT03548558|157555223|FG004|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|62|||
49163746|NCT03829319|158434816|FG001|Overall Study|Lost to Follow-up|0|||
49163747|NCT03829319|158434817|FG002|Overall Study|Lost to Follow-up|1|||
49163748|NCT03829319|158434815|FG000|Overall Study|Death|8|||
49163749|NCT03829319|158434816|FG001|Overall Study|Death|243|||
49163750|NCT03829319|158434817|FG002|Overall Study|Death|234|||
49163751|NCT01615029|158434821|FG000|Overall Study|Adverse Event|0|||
48837489|NCT01212991|157247164|FG002|Double-blind|Death|0|||
48837490|NCT01212991|157247162|FG000|Double-blind|Withdrawal by Subject|16|||
48837491|NCT01212991|157247163|FG001|Double-blind|Withdrawal by Subject|19|||
48837492|NCT01212991|157247164|FG002|Double-blind|Withdrawal by Subject|0|||
48837493|NCT01212991|157247162|FG000|Double-blind|Other|7|||
48837494|NCT01212991|157247163|FG001|Double-blind|Other|0|||
48837495|NCT01212991|157247164|FG002|Double-blind|Other|0|||
48837496|NCT01212991|157247162|FG000|Double-blind|Sponsor decision|142|||
48837497|NCT01212991|157247163|FG001|Double-blind|Sponsor decision|38|||
48837498|NCT01212991|157247164|FG002|Double-blind|Sponsor decision|0|||
48837499|NCT01212991|157247162|FG000|Open-label|Death|0|||
48837500|NCT01212991|157247163|FG001|Open-label|Death|0|||
48837501|NCT01212991|157247164|FG002|Open-label|Death|166|||
48837502|NCT01212991|157247162|FG000|Open-label|Lost to Follow-up|0|||
48837503|NCT01212991|157247163|FG001|Open-label|Lost to Follow-up|0|||
48837504|NCT01212991|157247164|FG002|Open-label|Lost to Follow-up|5|||
48837505|NCT01212991|157247162|FG000|Open-label|Withdrawal by Subject|0|||
48837506|NCT01212991|157247163|FG001|Open-label|Withdrawal by Subject|0|||
48837507|NCT01212991|157247164|FG002|Open-label|Withdrawal by Subject|7|||
48837508|NCT01212991|157247162|FG000|Open-label|Sponsor decision|0|||
48837509|NCT01212991|157247163|FG001|Open-label|Sponsor decision|0|||
48837510|NCT01212991|157247164|FG002|Open-label|Sponsor decision|53|||
48837511|NCT01212991|157247162|FG000|Open-label|Other|0|||
48837512|NCT01212991|157247163|FG001|Open-label|Other|0|||
48837513|NCT01212991|157247164|FG002|Open-label|Other|3|||
48837514|NCT01677936|157248678|FG000|Overall Study|Lost to Follow-up|4|||
48837515|NCT01677936|157248679|FG001|Overall Study|Lost to Follow-up|1|||
48837516|NCT01677936|157248678|FG000|Overall Study|Protocol Violation|3|||
48837517|NCT01677936|157248679|FG001|Overall Study|Protocol Violation|0|||
48837518|NCT01677936|157248678|FG000|Overall Study|Adverse Event|1|||
48837519|NCT01677936|157248679|FG001|Overall Study|Adverse Event|0|||
48837520|NCT01677936|157248678|FG000|Overall Study|Lost to Follow-up|1|||
48837521|NCT01677936|157248679|FG001|Overall Study|Lost to Follow-up|0|||
48837522|NCT01677936|157248678|FG000|Overall Study|Protocol Violation|0|||
48837523|NCT01677936|157248679|FG001|Overall Study|Protocol Violation|4|||
48837524|NCT01359592|157248682|FG000|Initial Registration|Adverse Event|1|||
48837525|NCT01359592|157248683|FG001|Initial Registration|Adverse Event|0|||
48837526|NCT01359592|157248684|FG002|Initial Registration|Adverse Event|0|||
48837527|NCT01359592|157248685|FG003|Initial Registration|Adverse Event|0|||
48837528|NCT01359592|157248682|FG000|Initial Registration|Death|1|||
48837529|NCT01359592|157248683|FG001|Initial Registration|Death|0|||
48837530|NCT01359592|157248684|FG002|Initial Registration|Death|0|||
48837531|NCT01359592|157248685|FG003|Initial Registration|Death|0|||
48837532|NCT01359592|157248682|FG000|Initial Registration|Other reason not protocol specified|1|||
48837533|NCT01359592|157248683|FG001|Initial Registration|Other reason not protocol specified|0|||
48837534|NCT01359592|157248684|FG002|Initial Registration|Other reason not protocol specified|0|||
48837535|NCT01359592|157248685|FG003|Initial Registration|Other reason not protocol specified|0|||
48837536|NCT01359592|157248682|FG000|Initial Registration|Ineligible|26|||
48837537|NCT01359592|157248683|FG001|Initial Registration|Ineligible|0|||
48837538|NCT01359592|157248684|FG002|Initial Registration|Ineligible|0|||
48837539|NCT01359592|157248685|FG003|Initial Registration|Ineligible|0|||
48837540|NCT01359592|157248682|FG000|PET-Directed Therapy|Adverse Event|0|||
48837541|NCT01359592|157248683|FG001|PET-Directed Therapy|Adverse Event|0|||
48837542|NCT01359592|157248684|FG002|PET-Directed Therapy|Adverse Event|1|||
48837543|NCT01359592|157248685|FG003|PET-Directed Therapy|Adverse Event|0|||
48837544|NCT01359592|157248682|FG000|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
48837545|NCT01359592|157248683|FG001|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
48837546|NCT01359592|157248684|FG002|PET-Directed Therapy|Refusal unrelated to adverse event|1|||
48837547|NCT01359592|157248685|FG003|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
48837548|NCT01359592|157248682|FG000|PET-Directed Therapy|Ineligible|0|||
48837549|NCT01359592|157248683|FG001|PET-Directed Therapy|Ineligible|0|||
48837550|NCT01359592|157248684|FG002|PET-Directed Therapy|Ineligible|24|||
48837551|NCT01359592|157248685|FG003|PET-Directed Therapy|Ineligible|0|||
48837552|NCT00150176|157248690|FG000|Overall Study|Adverse Event|16|||
48837553|NCT00150176|157248691|FG001|Overall Study|Adverse Event|53|||
48837554|NCT00150176|157248690|FG000|Overall Study|Relapse/Impending relapse, non-AE|10|||
48837555|NCT00150176|157248691|FG001|Overall Study|Relapse/Impending relapse, non-AE|39|||
48837556|NCT00150176|157248690|FG000|Overall Study|Withdrawal by Subject|19|||
48837557|NCT00150176|157248691|FG001|Overall Study|Withdrawal by Subject|12|||
48837558|NCT00150176|157248690|FG000|Overall Study|Lost to Follow-up|3|||
48837559|NCT00150176|157248691|FG001|Overall Study|Lost to Follow-up|3|||
48837560|NCT00150176|157248690|FG000|Overall Study|OTHER|11|||
48837561|NCT00150176|157248691|FG001|Overall Study|OTHER|13|||
49163752|NCT01615029|158434822|FG001|Overall Study|Adverse Event|0|||
49163753|NCT01615029|158434823|FG002|Overall Study|Adverse Event|0|||
49163754|NCT01615029|158434824|FG003|Overall Study|Adverse Event|0|||
49163755|NCT01615029|158434825|FG004|Overall Study|Adverse Event|1|||
49163756|NCT01615029|158434821|FG000|Overall Study|Death|0|||
49163757|NCT01615029|158434822|FG001|Overall Study|Death|0|||
49163758|NCT01615029|158434823|FG002|Overall Study|Death|0|||
49163759|NCT01615029|158434824|FG003|Overall Study|Death|0|||
49163760|NCT01615029|158434825|FG004|Overall Study|Death|1|||
49163761|NCT01615029|158434821|FG000|Overall Study|Lost to Follow-up|0|||
49163762|NCT01615029|158434822|FG001|Overall Study|Lost to Follow-up|0|||
49163763|NCT01615029|158434823|FG002|Overall Study|Lost to Follow-up|0|||
49163764|NCT01615029|158434824|FG003|Overall Study|Lost to Follow-up|0|||
49163765|NCT01615029|158434825|FG004|Overall Study|Lost to Follow-up|1|||
49163766|NCT01615029|158434821|FG000|Overall Study|Progressive disease|2|||
49163767|NCT01615029|158434822|FG001|Overall Study|Progressive disease|1|||
49163768|NCT01615029|158434823|FG002|Overall Study|Progressive disease|1|||
49163769|NCT01615029|158434824|FG003|Overall Study|Progressive disease|1|||
49163770|NCT01615029|158434825|FG004|Overall Study|Progressive disease|5|||
49163771|NCT01615029|158434821|FG000|Overall Study|Physician Decision|0|||
49163772|NCT01615029|158434822|FG001|Overall Study|Physician Decision|0|||
49163773|NCT01615029|158434823|FG002|Overall Study|Physician Decision|0|||
49163774|NCT01615029|158434824|FG003|Overall Study|Physician Decision|0|||
48837562|NCT04035668|157248692|FG000|Overall Study|Adverse Event|3|||
48837563|NCT04035668|157248693|FG001|Overall Study|Adverse Event|4|||
49163775|NCT01615029|158434825|FG004|Overall Study|Physician Decision|1|||
49163776|NCT01615029|158434821|FG000|Overall Study|Ongoing|1|||
48837564|NCT04035668|157248694|FG002|Overall Study|Adverse Event|2|||
48837565|NCT04035668|157248692|FG000|Overall Study|Lost to Follow-up|0|||
48837566|NCT04035668|157248693|FG001|Overall Study|Lost to Follow-up|1|||
48837567|NCT04035668|157248694|FG002|Overall Study|Lost to Follow-up|0|||
48837568|NCT04035668|157248692|FG000|Overall Study|Physician Decision|2|||
48837569|NCT04035668|157248693|FG001|Overall Study|Physician Decision|1|||
48923814|NCT03548558|157555224|FG005|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|67|||
48923815|NCT03548558|157555225|FG006|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|61|||
48923816|NCT02792842|157555226|FG000|Overall Study|Adverse Event|4|||
48923817|NCT02792842|157555227|FG001|Overall Study|Adverse Event|2|||
48923818|NCT02792842|157555228|FG002|Overall Study|Adverse Event|3|||
48923819|NCT02792842|157555226|FG000|Overall Study|Withdrawal by Subject|0|||
48923820|NCT02792842|157555227|FG001|Overall Study|Withdrawal by Subject|1|||
48837570|NCT04035668|157248694|FG002|Overall Study|Physician Decision|1|||
48837571|NCT04035668|157248692|FG000|Overall Study|Subject Decision|2|||
48837572|NCT04035668|157248693|FG001|Overall Study|Subject Decision|2|||
48837573|NCT04035668|157248694|FG002|Overall Study|Subject Decision|0|||
48837574|NCT00703911|157248695|FG000|Overall Study|Death|1|||
49163777|NCT01615029|158434822|FG001|Overall Study|Ongoing|2|||
49163778|NCT01615029|158434823|FG002|Overall Study|Ongoing|3|||
49163779|NCT01615029|158434824|FG003|Overall Study|Ongoing|2|||
49163780|NCT01615029|158434825|FG004|Overall Study|Ongoing|23|||
49163781|NCT04630756|158434826|FG000|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|1|||
49163782|NCT04630756|158434827|FG001|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
49163783|NCT04630756|158434828|FG002|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
49163784|NCT03181516|158434833|FG000|Overall Study|Withdrawal by Subject|14|||
49163785|NCT03181516|158434834|FG001|Overall Study|Withdrawal by Subject|7|||
49163786|NCT03181516|158434833|FG000|Overall Study|Lost to Follow-up|2|||
49163787|NCT03181516|158434834|FG001|Overall Study|Lost to Follow-up|2|||
49163788|NCT03290079|158434835|FG000|Overall Study|Death|2|||
49163789|NCT04055012|158434836|FG000|Overall Study|Withdrawal by Subject|1|||
49163790|NCT04055012|158434837|FG001|Overall Study|Withdrawal by Subject|3|||
49163791|NCT04055012|158434838|FG002|Overall Study|Withdrawal by Subject|1|||
49163792|NCT04055012|158434839|FG003|Overall Study|Withdrawal by Subject|0|||
49163793|NCT04055012|158434836|FG000|Overall Study|Metformin Recall|1|||
49163794|NCT04055012|158434837|FG001|Overall Study|Metformin Recall|1|||
49163795|NCT04055012|158434838|FG002|Overall Study|Metformin Recall|1|||
49163796|NCT04055012|158434839|FG003|Overall Study|Metformin Recall|0|||
49163797|NCT05347485|158434840|FG000|Overall Study|Death|14|||
49163798|NCT05347485|158434840|FG000|Overall Study|Lost to Follow-up|2|||
49163799|NCT05347485|158434840|FG000|Overall Study|Withdrawal by Subject|13|||
49163800|NCT05347485|158434840|FG000|Overall Study|Progressive Disease|1|||
49163801|NCT05347485|158434840|FG000|Overall Study|Study Terminated by Sponsor|49|||
49163802|NCT05347485|158434840|FG000|Overall Study|Other|1|||
49163803|NCT05347485|158434840|FG000|Overall Study|Enrolled (consented) but not treated|4|||
49163804|NCT05347485|158434840|FG000|Overall Study|Disease Relapse|2|||
49163805|NCT00948688|158435662|FG000|Period 1: 200 mg Vorinostat|Adverse Event|1|||
49163806|NCT00948688|158435663|FG001|Period 1: 200 mg Vorinostat|Adverse Event|0|||
49163807|NCT00948688|158435662|FG000|Period 1: 200 mg Vorinostat|Protocol Violation|1|||
49163808|NCT00948688|158435663|FG001|Period 1: 200 mg Vorinostat|Protocol Violation|0|||
49163809|NCT00948688|158435662|FG000|Period 2: 100 mg Vorinostat|Adverse Event|0|||
49163810|NCT00948688|158435663|FG001|Period 2: 100 mg Vorinostat|Adverse Event|1|||
48837575|NCT00703911|157248695|FG000|Overall Study|Physician Decision|6|||
48837576|NCT00703911|157248695|FG000|Overall Study|Lost to Follow-up|1|||
48837577|NCT00703911|157248695|FG000|Overall Study|Withdrawal by Subject|2|||
48837578|NCT02192606|157248696|FG000|Overall Study|surgery type was changed|1|||
48837579|NCT02192606|157248697|FG001|Overall Study|surgery type was changed|1|||
48923821|NCT02792842|157555228|FG002|Overall Study|Withdrawal by Subject|2|||
48923822|NCT02792842|157555226|FG000|Overall Study|Lost to Follow-up|0|||
48923823|NCT02792842|157555227|FG001|Overall Study|Lost to Follow-up|0|||
48923824|NCT02792842|157555228|FG002|Overall Study|Lost to Follow-up|1|||
48923825|NCT02792842|157555226|FG000|Overall Study|Schedule delay|0|||
48923826|NCT02792842|157555227|FG001|Overall Study|Schedule delay|1|||
48923827|NCT02792842|157555228|FG002|Overall Study|Schedule delay|1|||
48923828|NCT00429858|157555235|FG000|Overall Study|Withdrawal by Subject|1|||
48923829|NCT00429858|157555235|FG000|Overall Study|Study Termination|1|||
49163811|NCT01248793|158435665|FG000|Overall Study|Lost to Follow-up|0|||
49163812|NCT01248793|158435666|FG001|Overall Study|Lost to Follow-up|1|||
49163813|NCT01248793|158435665|FG000|Overall Study|Adverse Event|1|||
49163814|NCT01248793|158435666|FG001|Overall Study|Adverse Event|1|||
49163815|NCT01248793|158435665|FG000|Overall Study|Protocol Violation|0|||
49163816|NCT01248793|158435666|FG001|Overall Study|Protocol Violation|1|||
49163817|NCT01248793|158435665|FG000|Overall Study|Withdrawal by Subject|3|||
49163818|NCT01248793|158435666|FG001|Overall Study|Withdrawal by Subject|3|||
48837580|NCT02192606|157248696|FG000|Overall Study|Physician Decision|1|||
48837581|NCT02192606|157248697|FG001|Overall Study|Physician Decision|2|||
48837582|NCT02192606|157248696|FG000|Overall Study|3D equipment rep unable to join|0|||
48837583|NCT02192606|157248697|FG001|Overall Study|3D equipment rep unable to join|1|||
48837584|NCT04956575|157248698|FG000|Overall Study|Death|1|||
48837585|NCT04956575|157248699|FG001|Overall Study|Death|0|||
48837586|NCT04956575|157248700|FG002|Overall Study|Death|0|||
48837587|NCT04956575|157248701|FG003|Overall Study|Death|0|||
48837588|NCT04956575|157248702|FG004|Overall Study|Death|0|||
48837589|NCT04956575|157248703|FG005|Overall Study|Death|0|||
48837590|NCT04956575|157248704|FG006|Overall Study|Death|0|||
49163819|NCT00517699|158435667|FG000|Overall Study|Withdrawal by Subject|1|||
49163820|NCT00517699|158435667|FG000|Overall Study|Lack of Efficacy|1|||
49163821|NCT00517699|158435667|FG000|Overall Study|Administrative error|1|||
49163822|NCT00517699|158435667|FG000|Overall Study|Study terminated by Sponsor|2|||
49163823|NCT02727322|158435668|FG000|Overall Study|Withdrawal by Subject|1|||
49163824|NCT02727322|158435669|FG001|Overall Study|Withdrawal by Subject|1|||
49163825|NCT02727322|158435668|FG000|Overall Study|Protocol Violation|1|||
49163826|NCT02727322|158435669|FG001|Overall Study|Protocol Violation|0|||
49163827|NCT00558636|158435670|FG000|Treatment|Adverse Event|9|||
49163828|NCT00558636|158435671|FG001|Treatment|Adverse Event|2|||
49163829|NCT00558636|158435670|FG000|Treatment|Withdrawal by Subject|2|||
49163830|NCT00558636|158435671|FG001|Treatment|Withdrawal by Subject|0|||
49163831|NCT00558636|158435670|FG000|Treatment|Premature termination of the study|35|||
49163832|NCT00558636|158435671|FG001|Treatment|Premature termination of the study|37|||
49163833|NCT00558636|158435670|FG000|Treatment|Disease progression|1|||
49163834|NCT00558636|158435671|FG001|Treatment|Disease progression|5|||
49163835|NCT00558636|158435670|FG000|Follow-up|Premature termination of the study|12|||
49163836|NCT00558636|158435671|FG001|Follow-up|Premature termination of the study|7|||
49163837|NCT01213082|158435672|FG000|Overall Study|Lost to Follow-up|6|||
48837591|NCT04956575|157248705|FG007|Overall Study|Death|1|||
48837592|NCT04956575|157248706|FG008|Overall Study|Death|0|||
48837593|NCT04956575|157248707|FG009|Overall Study|Death|1|||
48837594|NCT04956575|157248708|FG010|Overall Study|Death|0|||
48837595|NCT04956575|157248709|FG011|Overall Study|Death|0|||
49163838|NCT01213082|158435673|FG001|Overall Study|Lost to Follow-up|7|||
49163839|NCT01213082|158435674|FG002|Overall Study|Lost to Follow-up|4|||
49163840|NCT01213082|158435672|FG000|Overall Study|Physician Decision|0|||
49163841|NCT01213082|158435673|FG001|Overall Study|Physician Decision|0|||
49163842|NCT01213082|158435674|FG002|Overall Study|Physician Decision|1|||
49163843|NCT04403919|158435679|FG000|Overall Study|Lost to Follow-up|0|||
49163844|NCT04403919|158435680|FG001|Overall Study|Lost to Follow-up|0|||
49163845|NCT04403919|158435681|FG002|Overall Study|Lost to Follow-up|0|||
49163846|NCT04403919|158435682|FG003|Overall Study|Lost to Follow-up|1|||
49163847|NCT03886493|158435684|FG000|Overall Study|Adverse Event|1|||
49163848|NCT02639247|158435685|FG000|Overall Study|Lost to Follow-up|2|||
49163849|NCT02639247|158435686|FG001|Overall Study|Lost to Follow-up|1|||
49163850|NCT02639247|158435685|FG000|Overall Study|Death|2|||
49163851|NCT02639247|158435686|FG001|Overall Study|Death|0|||
49163852|NCT02639247|158435685|FG000|Overall Study|Withdrew Consent|0|||
49163853|NCT02639247|158435686|FG001|Overall Study|Withdrew Consent|1|||
49163854|NCT02639247|158435685|FG000|Overall Study|Protocol Violation|1|||
49163855|NCT02639247|158435686|FG001|Overall Study|Protocol Violation|0|||
49163856|NCT01881789|158435692|FG000|Overall Study|Withdrawal by Subject|0|||
49163857|NCT01881789|158435693|FG001|Overall Study|Withdrawal by Subject|2|||
49163858|NCT01881789|158435694|FG002|Overall Study|Withdrawal by Subject|1|||
49163859|NCT01881789|158435695|FG003|Overall Study|Withdrawal by Subject|0|||
48837596|NCT04956575|157248698|FG000|Overall Study|Lost to Follow-up|3|||
48837597|NCT04956575|157248699|FG001|Overall Study|Lost to Follow-up|4|||
48837598|NCT04956575|157248700|FG002|Overall Study|Lost to Follow-up|2|||
48837599|NCT04956575|157248701|FG003|Overall Study|Lost to Follow-up|3|||
48837600|NCT04956575|157248702|FG004|Overall Study|Lost to Follow-up|1|||
48837601|NCT04956575|157248703|FG005|Overall Study|Lost to Follow-up|10|||
48837602|NCT04956575|157248704|FG006|Overall Study|Lost to Follow-up|11|||
48837603|NCT04956575|157248705|FG007|Overall Study|Lost to Follow-up|7|||
48837604|NCT04956575|157248706|FG008|Overall Study|Lost to Follow-up|4|||
48923830|NCT03345472|157555240|FG000|Implant to 3 Months|Withdrawal by Subject|2|||
49163860|NCT01881789|158435696|FG004|Overall Study|Withdrawal by Subject|1|||
49163861|NCT01881789|158435697|FG005|Overall Study|Withdrawal by Subject|1|||
49163862|NCT01881789|158435692|FG000|Overall Study|Study Terminated by Sponsor|0|||
49163863|NCT01881789|158435693|FG001|Overall Study|Study Terminated by Sponsor|0|||
49163864|NCT01881789|158435694|FG002|Overall Study|Study Terminated by Sponsor|0|||
49163865|NCT01881789|158435695|FG003|Overall Study|Study Terminated by Sponsor|0|||
49163866|NCT01881789|158435696|FG004|Overall Study|Study Terminated by Sponsor|0|||
48837605|NCT04956575|157248707|FG009|Overall Study|Lost to Follow-up|2|||
48837606|NCT04956575|157248708|FG010|Overall Study|Lost to Follow-up|3|||
48837607|NCT04956575|157248709|FG011|Overall Study|Lost to Follow-up|8|||
48837608|NCT04956575|157248698|FG000|Overall Study|Withdrawal by Subject|1|||
49163867|NCT01881789|158435697|FG005|Overall Study|Study Terminated by Sponsor|1|||
48837609|NCT04956575|157248699|FG001|Overall Study|Withdrawal by Subject|2|||
49163868|NCT01881789|158435692|FG000|Overall Study|Other|3|||
49163869|NCT01881789|158435693|FG001|Overall Study|Other|5|||
48837610|NCT04956575|157248700|FG002|Overall Study|Withdrawal by Subject|1|||
48837611|NCT04956575|157248701|FG003|Overall Study|Withdrawal by Subject|4|||
48837612|NCT04956575|157248702|FG004|Overall Study|Withdrawal by Subject|2|||
48837613|NCT04956575|157248703|FG005|Overall Study|Withdrawal by Subject|8|||
48837614|NCT04956575|157248704|FG006|Overall Study|Withdrawal by Subject|5|||
48837615|NCT04956575|157248705|FG007|Overall Study|Withdrawal by Subject|1|||
48837616|NCT04956575|157248706|FG008|Overall Study|Withdrawal by Subject|1|||
48837617|NCT04956575|157248707|FG009|Overall Study|Withdrawal by Subject|0|||
48837618|NCT04956575|157248708|FG010|Overall Study|Withdrawal by Subject|3|||
48837619|NCT04956575|157248709|FG011|Overall Study|Withdrawal by Subject|1|||
48837620|NCT00668863|157248716|FG000|Overall Study|Objective Progression or Relapse|42|||
48837621|NCT00668863|157248716|FG000|Overall Study|Adverse Event|13|||
48837622|NCT00668863|157248716|FG000|Overall Study|Study Terminated by Sponsor|8|||
48837623|NCT00668863|157248716|FG000|Overall Study|Global Deterioration of Health Status|4|||
48837624|NCT00668863|157248716|FG000|Overall Study|Withdrawal by Subject|1|||
48837625|NCT00668863|157248716|FG000|Overall Study|Surgery|1|||
48837626|NCT00668863|157248716|FG000|Overall Study|Subject's work scheduling problem|1|||
48837627|NCT00668863|157248716|FG000|Overall Study|Physician Decision|1|||
48837628|NCT03520413|157248717|FG000|Overall Study|Lost to Follow-up|1|||
48837629|NCT03520413|157248718|FG001|Overall Study|Lost to Follow-up|1|||
48837630|NCT03520413|157248717|FG000|Overall Study|Withdrawal by Subject|1|||
48837631|NCT03520413|157248718|FG001|Overall Study|Withdrawal by Subject|2|||
48837632|NCT03520413|157248717|FG000|Overall Study|Death|0|||
48837633|NCT03520413|157248718|FG001|Overall Study|Death|1|||
49163870|NCT01881789|158435694|FG002|Overall Study|Other|2|||
48837634|NCT03520413|157248717|FG000|Overall Study|Physician Decision|3|||
48837635|NCT03520413|157248718|FG001|Overall Study|Physician Decision|3|||
49163871|NCT01881789|158435695|FG003|Overall Study|Other|3|||
49163872|NCT01881789|158435696|FG004|Overall Study|Other|1|||
48837636|NCT03520413|157248717|FG000|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
48837637|NCT03520413|157248718|FG001|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
48837638|NCT01184508|157248719|FG000|Overall Study|Adverse Event|4|||
49163873|NCT01881789|158435697|FG005|Overall Study|Other|1|||
49163874|NCT02961244|158435698|FG000|Overall Study|Protocol Violation|0|||
49163875|NCT02961244|158435699|FG001|Overall Study|Protocol Violation|1|||
49163876|NCT02961244|158435698|FG000|Overall Study|Withdrawal by Subject|1|||
49163877|NCT02961244|158435699|FG001|Overall Study|Withdrawal by Subject|2|||
49163878|NCT02961244|158435698|FG000|Overall Study|Surgery plan change after study approval|0|||
49163879|NCT02961244|158435699|FG001|Overall Study|Surgery plan change after study approval|2|||
49163880|NCT02961244|158435698|FG000|Overall Study|Lost to Follow-up|0|||
49163881|NCT02961244|158435699|FG001|Overall Study|Lost to Follow-up|2|||
49163882|NCT02961244|158435698|FG000|Overall Study|İnadequate data|0|||
48837639|NCT01184508|157248720|FG001|Overall Study|Adverse Event|6|||
48837640|NCT01184508|157248719|FG000|Overall Study|Lack of Efficacy|1|||
49163883|NCT02961244|158435699|FG001|Overall Study|İnadequate data|2|||
49163884|NCT03510273|158435700|FG000|Overall Study|Withdrawal by Subject|2|||
49163885|NCT03510273|158435700|FG000|Overall Study|Care outside study, ineligible to cont.|3|||
49163886|NCT03510273|158435700|FG000|Overall Study|Moved away from study area|4|||
49163887|NCT00956293|158435701|FG000|Main Period (Pre-randomization)|Not specified (data missing)|0|||
49163888|NCT00956293|158435702|FG001|Main Period (Pre-randomization)|Not specified (data missing)|0|||
49163889|NCT00956293|158435703|FG002|Main Period (Pre-randomization)|Not specified (data missing)|1|||
49163890|NCT00956293|158435701|FG000|Main Period (Pre-randomization)|Death|0|||
49163891|NCT00956293|158435702|FG001|Main Period (Pre-randomization)|Death|0|||
49163892|NCT00956293|158435703|FG002|Main Period (Pre-randomization)|Death|1|||
49163893|NCT00956293|158435701|FG000|Main Period (Pre-randomization)|Protocol Violation|0|||
49163894|NCT00956293|158435702|FG001|Main Period (Pre-randomization)|Protocol Violation|0|||
49163895|NCT00956293|158435703|FG002|Main Period (Pre-randomization)|Protocol Violation|1|||
48837641|NCT01184508|157248720|FG001|Overall Study|Lack of Efficacy|1|||
48837642|NCT01184508|157248719|FG000|Overall Study|Lost to Follow-up|1|||
48837643|NCT01184508|157248720|FG001|Overall Study|Lost to Follow-up|1|||
49163896|NCT00956293|158435701|FG000|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
49163897|NCT00956293|158435702|FG001|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
49163898|NCT00956293|158435703|FG002|Main Period (Pre-randomization)|Abnormal test procedure result|2|||
49163899|NCT00956293|158435701|FG000|Main Period (Pre-randomization)|Administrative problems|0|||
48837644|NCT01184508|157248719|FG000|Overall Study|Physician Decision|1|||
48837645|NCT01184508|157248720|FG001|Overall Study|Physician Decision|0|||
48837646|NCT01184508|157248719|FG000|Overall Study|Protocol Violation|3|||
48837647|NCT01184508|157248720|FG001|Overall Study|Protocol Violation|1|||
48837648|NCT01184508|157248719|FG000|Overall Study|Sponsor Decision|5|||
49163900|NCT00956293|158435702|FG001|Main Period (Pre-randomization)|Administrative problems|0|||
49163901|NCT00956293|158435703|FG002|Main Period (Pre-randomization)|Administrative problems|6|||
49163902|NCT00956293|158435701|FG000|Main Period (Pre-randomization)|Graft loss|0|||
49163903|NCT00956293|158435702|FG001|Main Period (Pre-randomization)|Graft loss|0|||
49163904|NCT00956293|158435703|FG002|Main Period (Pre-randomization)|Graft loss|7|||
49163905|NCT00956293|158435701|FG000|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
49163906|NCT00956293|158435702|FG001|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
49163907|NCT00956293|158435703|FG002|Main Period (Pre-randomization)|Withdrawal by Subject|12|||
49163908|NCT00956293|158435701|FG000|Main Period (Pre-randomization)|Lack of Efficacy|0|||
49163909|NCT00956293|158435702|FG001|Main Period (Pre-randomization)|Lack of Efficacy|0|||
49163910|NCT00956293|158435703|FG002|Main Period (Pre-randomization)|Lack of Efficacy|20|||
49163911|NCT00956293|158435701|FG000|Main Period (Pre-randomization)|Adverse Event|0|||
49163912|NCT00956293|158435702|FG001|Main Period (Pre-randomization)|Adverse Event|0|||
49163913|NCT00956293|158435703|FG002|Main Period (Pre-randomization)|Adverse Event|36|||
49163914|NCT00956293|158435701|FG000|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
49163915|NCT00956293|158435702|FG001|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
49163916|NCT00956293|158435703|FG002|Main Period (Pre-randomization)|Abnormal laboratory value|44|||
49163917|NCT00956293|158435701|FG000|Main Period (Randomization)|Abnormal laboratory value|0|||
49163918|NCT00956293|158435702|FG001|Main Period (Randomization)|Abnormal laboratory value|2|||
49163919|NCT00956293|158435703|FG002|Main Period (Randomization)|Abnormal laboratory value|0|||
49163920|NCT00956293|158435701|FG000|Main Period (Randomization)|Lack of Efficacy|1|||
49163921|NCT00956293|158435702|FG001|Main Period (Randomization)|Lack of Efficacy|10|||
49163922|NCT00956293|158435703|FG002|Main Period (Randomization)|Lack of Efficacy|0|||
49163923|NCT00956293|158435701|FG000|Main Period (Randomization)|Adverse Event|0|||
49163924|NCT00956293|158435702|FG001|Main Period (Randomization)|Adverse Event|15|||
49163925|NCT00956293|158435703|FG002|Main Period (Randomization)|Adverse Event|0|||
49163926|NCT00956293|158435701|FG000|Follow-up Period|Follow-up period was terminated.|20|||
49163927|NCT00956293|158435702|FG001|Follow-up Period|Follow-up period was terminated.|32|||
49163928|NCT00956293|158435703|FG002|Follow-up Period|Follow-up period was terminated.|0|||
49163929|NCT01904721|158435705|FG000|Overall Study|Other Reasons|0|||
49163930|NCT01904721|158435706|FG001|Overall Study|Other Reasons|0|||
49163931|NCT01904721|158435707|FG002|Overall Study|Other Reasons|1|||
49163932|NCT01904721|158435708|FG003|Overall Study|Other Reasons|1|||
49163933|NCT01904721|158435709|FG004|Overall Study|Other Reasons|2|||
49163934|NCT01904721|158435710|FG005|Overall Study|Other Reasons|2|||
49163935|NCT01904721|158435711|FG006|Overall Study|Other Reasons|2|||
49163936|NCT01904721|158435705|FG000|Overall Study|Personal Reasons|0|||
49163937|NCT01904721|158435706|FG001|Overall Study|Personal Reasons|0|||
49163938|NCT01904721|158435707|FG002|Overall Study|Personal Reasons|0|||
49163939|NCT01904721|158435708|FG003|Overall Study|Personal Reasons|0|||
49163940|NCT01904721|158435709|FG004|Overall Study|Personal Reasons|2|||
49163941|NCT01904721|158435710|FG005|Overall Study|Personal Reasons|3|||
49163942|NCT01904721|158435711|FG006|Overall Study|Personal Reasons|3|||
49163943|NCT01904721|158435705|FG000|Overall Study|Lost to Follow-up|0|||
49163944|NCT01904721|158435706|FG001|Overall Study|Lost to Follow-up|0|||
49163945|NCT01904721|158435707|FG002|Overall Study|Lost to Follow-up|0|||
49163946|NCT01904721|158435708|FG003|Overall Study|Lost to Follow-up|0|||
49163947|NCT01904721|158435709|FG004|Overall Study|Lost to Follow-up|1|||
49163948|NCT01904721|158435710|FG005|Overall Study|Lost to Follow-up|3|||
49163949|NCT01904721|158435711|FG006|Overall Study|Lost to Follow-up|1|||
49163950|NCT01904721|158435705|FG000|Overall Study|Lack of Efficacy|0|||
49163951|NCT01904721|158435706|FG001|Overall Study|Lack of Efficacy|0|||
49163952|NCT01904721|158435707|FG002|Overall Study|Lack of Efficacy|0|||
49163953|NCT01904721|158435708|FG003|Overall Study|Lack of Efficacy|0|||
49163954|NCT01904721|158435709|FG004|Overall Study|Lack of Efficacy|0|||
49163955|NCT01904721|158435710|FG005|Overall Study|Lack of Efficacy|0|||
49163956|NCT01904721|158435711|FG006|Overall Study|Lack of Efficacy|1|||
49163957|NCT01904721|158435705|FG000|Overall Study|Adverse Event|0|||
49163958|NCT01904721|158435706|FG001|Overall Study|Adverse Event|0|||
49163959|NCT01904721|158435707|FG002|Overall Study|Adverse Event|0|||
49163960|NCT01904721|158435708|FG003|Overall Study|Adverse Event|0|||
49163961|NCT01904721|158435709|FG004|Overall Study|Adverse Event|3|||
49163962|NCT01904721|158435710|FG005|Overall Study|Adverse Event|1|||
49163963|NCT01904721|158435711|FG006|Overall Study|Adverse Event|0|||
49163964|NCT00532844|158435712|FG000|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0|||
49163965|NCT00532844|158435713|FG001|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1|||
49163966|NCT00532844|158435712|FG000|Treatment Period - Day 15 to Day 28|Pregnancy|1|||
49163967|NCT00532844|158435713|FG001|Treatment Period - Day 15 to Day 28|Pregnancy|0|||
49163968|NCT00532844|158435712|FG000|Treatment Period - Day 15 to Day 28|Personal reasons|1|||
49163969|NCT00532844|158435713|FG001|Treatment Period - Day 15 to Day 28|Personal reasons|0|||
48837649|NCT01184508|157248720|FG001|Overall Study|Sponsor Decision|2|||
48837650|NCT01184508|157248719|FG000|Overall Study|Withdrawal by Subject|1|||
48837651|NCT01184508|157248720|FG001|Overall Study|Withdrawal by Subject|3|||
48837652|NCT01184508|157248719|FG000|Overall Study|Randomized, Not Treated|0|||
48837653|NCT01184508|157248720|FG001|Overall Study|Randomized, Not Treated|1|||
48837654|NCT01075217|157248721|FG000|Overall Study|Adverse Event|1|||
48837655|NCT01075217|157248722|FG001|Overall Study|Adverse Event|1|||
48837656|NCT01075217|157248721|FG000|Overall Study|Physician Decision|1|||
48837657|NCT01075217|157248722|FG001|Overall Study|Physician Decision|0|||
48837658|NCT00891930|157248727|FG000|Part 1 Panitumumab + Irinotecan|Full Consent Withdrawn|2|||
48837659|NCT00891930|157248727|FG000|Part 1 Panitumumab + Irinotecan|Death|66|||
48837660|NCT00891930|157248727|FG000|Part 1 Panitumumab + Irinotecan|Lost to Follow-up|1|||
48837661|NCT00891930|157248727|FG000|Part 2 Panitumumab + AMG479|Full Consent Withdrawn|1|||
48837662|NCT00891930|157248727|FG000|Part 2 Panitumumab + AMG479|Death|30|||
48837663|NCT02045836|157248728|FG000|Overall Study|Adverse Event|4|||
48837664|NCT02045836|157248729|FG001|Overall Study|Adverse Event|4|||
48837665|NCT02045836|157248728|FG000|Overall Study|Withdrawal by Subject|1|||
48837666|NCT02045836|157248729|FG001|Overall Study|Withdrawal by Subject|1|||
48837667|NCT02045836|157248728|FG000|Overall Study|Lost to Follow-up|4|||
48837668|NCT02045836|157248729|FG001|Overall Study|Lost to Follow-up|7|||
48837669|NCT02045836|157248728|FG000|Overall Study|Migrated from study area|0|||
48837670|NCT02045836|157248729|FG001|Overall Study|Migrated from study area|2|||
48837671|NCT02341625|157248730|FG000|Overall Study|Disease Progression|2|||
48837672|NCT02341625|157248731|FG001|Overall Study|Disease Progression|2|||
48837673|NCT02341625|157248732|FG002|Overall Study|Disease Progression|3|||
48837674|NCT02341625|157248733|FG003|Overall Study|Disease Progression|6|||
48837675|NCT02341625|157248734|FG004|Overall Study|Disease Progression|7|||
48837676|NCT02341625|157248735|FG005|Overall Study|Disease Progression|7|||
48837677|NCT02341625|157248736|FG006|Overall Study|Disease Progression|28|||
48837678|NCT02341625|157248737|FG007|Overall Study|Disease Progression|5|||
49163970|NCT00532844|158435712|FG000|Treatment Period - Day 15 to Day 28|Adverse Event|1|||
49163971|NCT00532844|158435713|FG001|Treatment Period - Day 15 to Day 28|Adverse Event|0|||
48837679|NCT02341625|157248738|FG008|Overall Study|Disease Progression|4|||
48837680|NCT02341625|157248739|FG009|Overall Study|Disease Progression|19|||
48837681|NCT02341625|157248730|FG000|Overall Study|Study Drug Toxicity|0|||
48837682|NCT02341625|157248731|FG001|Overall Study|Study Drug Toxicity|0|||
48837683|NCT02341625|157248732|FG002|Overall Study|Study Drug Toxicity|0|||
48923831|NCT03345472|157555240|FG000|Implant to 3 Months|Physician Decision|1|||
48923832|NCT03345472|157555240|FG000|Implant to 3 Months|Adverse Event|1|||
49014789|NCT02410252|157890379|FG000|Overall Study|Withdrawal by Subject|4|||
49163972|NCT00532844|158435712|FG000|Treatment Period - Day 15 to Day 28|withdrawal of consent|1|||
49163973|NCT00532844|158435713|FG001|Treatment Period - Day 15 to Day 28|withdrawal of consent|0|||
49163974|NCT03637491|158435714|FG000|Overall Study|Death|9|||
49163975|NCT03637491|158435715|FG001|Overall Study|Death|9|||
48837684|NCT02341625|157248733|FG003|Overall Study|Study Drug Toxicity|1|||
49014790|NCT02410252|157890379|FG000|Overall Study|Physician Decision|2|||
49014791|NCT04132232|157890380|FG000|Overall Study|Randomized but met exclusion criteria.|1|||
49014792|NCT04132232|157890381|FG001|Overall Study|Randomized but met exclusion criteria.|1|||
49014793|NCT04132232|157890380|FG000|Overall Study|Lost to Follow-up|6|||
49014794|NCT04132232|157890381|FG001|Overall Study|Lost to Follow-up|7|||
49014795|NCT01313728|157890382|FG000|Informed Consent to Baseline|Withdrawal by Subject|1|||
49014796|NCT00368537|157890388|FG000|Randomization|No study drug dosed|13|||
49014797|NCT00368537|157890389|FG001|Randomization|No study drug dosed|6|||
49014798|NCT00368537|157890388|FG000|Baseline Participants|Lost to Follow-up|16|||
49014799|NCT00368537|157890389|FG001|Baseline Participants|Lost to Follow-up|17|||
49014800|NCT00368537|157890388|FG000|Baseline Participants|Withdrawal by Subject|6|||
49014801|NCT00368537|157890389|FG001|Baseline Participants|Withdrawal by Subject|4|||
49014802|NCT00368537|157890388|FG000|Baseline Participants|Death|1|||
49014803|NCT00368537|157890389|FG001|Baseline Participants|Death|2|||
49014804|NCT00368537|157890388|FG000|Baseline Participants|No susceptibility|1|||
49014805|NCT00368537|157890389|FG001|Baseline Participants|No susceptibility|0|||
49014806|NCT00368537|157890388|FG000|Baseline Participants|Patient uncompliant|0|||
49014807|NCT00368537|157890389|FG001|Baseline Participants|Patient uncompliant|1|||
49014808|NCT01368276|157890410|FG000|Overall Study|Death|1|||
49014809|NCT01368276|157890411|FG001|Overall Study|Death|10|||
49014810|NCT01427920|157890412|FG000|Overall Study|Adverse Event|1|||
49014811|NCT01427920|157890413|FG001|Overall Study|Adverse Event|2|||
49014812|NCT01427920|157890412|FG000|Overall Study|Lack of Efficacy|1|||
49014813|NCT01427920|157890413|FG001|Overall Study|Lack of Efficacy|0|||
49014814|NCT01427920|157890412|FG000|Overall Study|Protocol Violation|1|||
49014815|NCT01427920|157890413|FG001|Overall Study|Protocol Violation|3|||
49014816|NCT01427920|157890412|FG000|Overall Study|Withdrawal Criteria|4|||
49014817|NCT01427920|157890413|FG001|Overall Study|Withdrawal Criteria|4|||
49014818|NCT01427920|157890412|FG000|Overall Study|Unclassified|2|||
49014819|NCT01427920|157890413|FG001|Overall Study|Unclassified|8|||
49014820|NCT02041494|157890414|FG000|Overall Study|Death|1|||
49014821|NCT02041494|157890415|FG001|Overall Study|Death|3|||
49014822|NCT02041494|157890414|FG000|Overall Study|Lost to Follow-up|2|||
48837685|NCT02341625|157248734|FG004|Overall Study|Study Drug Toxicity|0|||
48837686|NCT02341625|157248735|FG005|Overall Study|Study Drug Toxicity|3|||
48837687|NCT02341625|157248736|FG006|Overall Study|Study Drug Toxicity|10|||
48837688|NCT02341625|157248737|FG007|Overall Study|Study Drug Toxicity|0|||
48837689|NCT02341625|157248738|FG008|Overall Study|Study Drug Toxicity|0|||
48837690|NCT02341625|157248739|FG009|Overall Study|Study Drug Toxicity|3|||
48837691|NCT02341625|157248730|FG000|Overall Study|Adverse Event Unrelated to Study Drug|0|||
48837692|NCT02341625|157248731|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
48837693|NCT02341625|157248732|FG002|Overall Study|Adverse Event Unrelated to Study Drug|0|||
48837694|NCT02341625|157248733|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
48837695|NCT02341625|157248734|FG004|Overall Study|Adverse Event Unrelated to Study Drug|0|||
48837696|NCT02341625|157248735|FG005|Overall Study|Adverse Event Unrelated to Study Drug|0|||
48837697|NCT02341625|157248736|FG006|Overall Study|Adverse Event Unrelated to Study Drug|2|||
48837698|NCT02341625|157248737|FG007|Overall Study|Adverse Event Unrelated to Study Drug|1|||
48837699|NCT02341625|157248738|FG008|Overall Study|Adverse Event Unrelated to Study Drug|0|||
48837700|NCT02341625|157248739|FG009|Overall Study|Adverse Event Unrelated to Study Drug|2|||
48837701|NCT02341625|157248730|FG000|Overall Study|Participant Request to Discontinue Study Treatment|0|||
48837702|NCT02341625|157248731|FG001|Overall Study|Participant Request to Discontinue Study Treatment|0|||
48837703|NCT02341625|157248732|FG002|Overall Study|Participant Request to Discontinue Study Treatment|0|||
48837704|NCT02341625|157248733|FG003|Overall Study|Participant Request to Discontinue Study Treatment|0|||
48837705|NCT02341625|157248734|FG004|Overall Study|Participant Request to Discontinue Study Treatment|0|||
48837706|NCT02341625|157248735|FG005|Overall Study|Participant Request to Discontinue Study Treatment|0|||
48837707|NCT02341625|157248736|FG006|Overall Study|Participant Request to Discontinue Study Treatment|6|||
48837708|NCT02341625|157248737|FG007|Overall Study|Participant Request to Discontinue Study Treatment|2|||
48837709|NCT02341625|157248738|FG008|Overall Study|Participant Request to Discontinue Study Treatment|0|||
48837710|NCT02341625|157248739|FG009|Overall Study|Participant Request to Discontinue Study Treatment|0|||
48837711|NCT02341625|157248730|FG000|Overall Study|Participant Withdrew Consent|0|||
48837712|NCT02341625|157248731|FG001|Overall Study|Participant Withdrew Consent|0|||
48837713|NCT02341625|157248732|FG002|Overall Study|Participant Withdrew Consent|0|||
48837714|NCT02341625|157248733|FG003|Overall Study|Participant Withdrew Consent|1|||
48837715|NCT02341625|157248734|FG004|Overall Study|Participant Withdrew Consent|0|||
48837716|NCT02341625|157248735|FG005|Overall Study|Participant Withdrew Consent|0|||
48837717|NCT02341625|157248736|FG006|Overall Study|Participant Withdrew Consent|0|||
48837718|NCT02341625|157248737|FG007|Overall Study|Participant Withdrew Consent|0|||
48837719|NCT02341625|157248738|FG008|Overall Study|Participant Withdrew Consent|0|||
48837720|NCT02341625|157248739|FG009|Overall Study|Participant Withdrew Consent|0|||
48837721|NCT02341625|157248730|FG000|Overall Study|Completed Treatment as per Protocol|0|||
48837722|NCT02341625|157248731|FG001|Overall Study|Completed Treatment as per Protocol|0|||
48837723|NCT02341625|157248732|FG002|Overall Study|Completed Treatment as per Protocol|0|||
48837724|NCT02341625|157248733|FG003|Overall Study|Completed Treatment as per Protocol|0|||
48837725|NCT02341625|157248734|FG004|Overall Study|Completed Treatment as per Protocol|0|||
48837726|NCT02341625|157248735|FG005|Overall Study|Completed Treatment as per Protocol|0|||
48837727|NCT02341625|157248736|FG006|Overall Study|Completed Treatment as per Protocol|0|||
48837728|NCT02341625|157248737|FG007|Overall Study|Completed Treatment as per Protocol|0|||
48837729|NCT02341625|157248738|FG008|Overall Study|Completed Treatment as per Protocol|0|||
48837730|NCT02341625|157248739|FG009|Overall Study|Completed Treatment as per Protocol|1|||
48837731|NCT02341625|157248730|FG000|Overall Study|Other Reasons|0|||
48837732|NCT02341625|157248731|FG001|Overall Study|Other Reasons|0|||
48837733|NCT02341625|157248732|FG002|Overall Study|Other Reasons|0|||
48837734|NCT02341625|157248733|FG003|Overall Study|Other Reasons|0|||
48837735|NCT02341625|157248734|FG004|Overall Study|Other Reasons|1|||
48837736|NCT02341625|157248735|FG005|Overall Study|Other Reasons|0|||
48837737|NCT02341625|157248736|FG006|Overall Study|Other Reasons|5|||
48837738|NCT02341625|157248737|FG007|Overall Study|Other Reasons|0|||
48837739|NCT02341625|157248738|FG008|Overall Study|Other Reasons|0|||
48837740|NCT02341625|157248739|FG009|Overall Study|Other Reasons|2|||
48837741|NCT02341625|157248730|FG000|Overall Study|Not Reported|0|||
48837742|NCT02341625|157248731|FG001|Overall Study|Not Reported|0|||
48837743|NCT02341625|157248732|FG002|Overall Study|Not Reported|0|||
48837744|NCT02341625|157248733|FG003|Overall Study|Not Reported|0|||
48837745|NCT02341625|157248734|FG004|Overall Study|Not Reported|0|||
48837746|NCT02341625|157248735|FG005|Overall Study|Not Reported|0|||
49014823|NCT02041494|157890415|FG001|Overall Study|Lost to Follow-up|6|||
49014824|NCT02041494|157890414|FG000|Overall Study|study terminated|16|||
49014825|NCT02041494|157890415|FG001|Overall Study|study terminated|11|||
49014826|NCT03433001|157890416|FG000|Overall Study|Lack of Efficacy|109|||
49014827|NCT03433001|157890416|FG000|Overall Study|Adverse Event|69|||
49014828|NCT03433001|157890416|FG000|Overall Study|Withdrawal by Subject|10|||
49014829|NCT03433001|157890416|FG000|Overall Study|Death|12|||
49014830|NCT03433001|157890416|FG000|Overall Study|Lost to Follow-up|4|||
49014831|NCT03433001|157890416|FG000|Overall Study|Other|25|||
49014832|NCT00993616|157890417|FG000|Overall Study|No tumor at entry|1|||
48837747|NCT02341625|157248736|FG006|Overall Study|Not Reported|0|||
48837748|NCT02341625|157248737|FG007|Overall Study|Not Reported|0|||
48837749|NCT02341625|157248738|FG008|Overall Study|Not Reported|0|||
48837750|NCT02341625|157248739|FG009|Overall Study|Not Reported|3|||
48837751|NCT02570711|157248743|FG000|Overall Study|Death|1|||
48837752|NCT02570711|157248744|FG001|Overall Study|Death|0|||
48837753|NCT02570711|157248743|FG000|Overall Study|Early Termination of Study by Sponsor|0|||
48837754|NCT02570711|157248744|FG001|Overall Study|Early Termination of Study by Sponsor|2|||
48837755|NCT01490086|157248757|FG000|Overall Study|Consent withdrawn|4|||
48837756|NCT01490086|157248758|FG001|Overall Study|Consent withdrawn|4|||
48837757|NCT01490086|157248759|FG002|Overall Study|Consent withdrawn|3|||
48837758|NCT01490086|157248760|FG003|Overall Study|Consent withdrawn|0|||
48837759|NCT01490086|157248761|FG004|Overall Study|Consent withdrawn|1|||
48837760|NCT01490086|157248757|FG000|Overall Study|Non-compliance|0|||
48837761|NCT01490086|157248758|FG001|Overall Study|Non-compliance|1|||
48837762|NCT01490086|157248759|FG002|Overall Study|Non-compliance|0|||
48837763|NCT01490086|157248760|FG003|Overall Study|Non-compliance|0|||
48837764|NCT01490086|157248761|FG004|Overall Study|Non-compliance|0|||
48837765|NCT01490086|157248757|FG000|Overall Study|Abnormal laboratory findings|1|||
48837766|NCT01490086|157248758|FG001|Overall Study|Abnormal laboratory findings|0|||
48837767|NCT01490086|157248759|FG002|Overall Study|Abnormal laboratory findings|0|||
48837768|NCT01490086|157248760|FG003|Overall Study|Abnormal laboratory findings|0|||
48837769|NCT01490086|157248761|FG004|Overall Study|Abnormal laboratory findings|0|||
48837770|NCT01490086|157248757|FG000|Overall Study|Lost to Follow-up|0|||
48837771|NCT01490086|157248758|FG001|Overall Study|Lost to Follow-up|0|||
48837772|NCT01490086|157248759|FG002|Overall Study|Lost to Follow-up|0|||
48837773|NCT01490086|157248760|FG003|Overall Study|Lost to Follow-up|0|||
48837774|NCT01490086|157248761|FG004|Overall Study|Lost to Follow-up|1|||
48837775|NCT01490086|157248757|FG000|Overall Study|Physician Decision|3|||
48837776|NCT01490086|157248758|FG001|Overall Study|Physician Decision|4|||
48837777|NCT01490086|157248759|FG002|Overall Study|Physician Decision|2|||
48837778|NCT01490086|157248760|FG003|Overall Study|Physician Decision|3|||
48837779|NCT01490086|157248761|FG004|Overall Study|Physician Decision|1|||
48837780|NCT01490086|157248757|FG000|Overall Study|Adverse Event|0|||
48837781|NCT01490086|157248758|FG001|Overall Study|Adverse Event|0|||
48837782|NCT01490086|157248759|FG002|Overall Study|Adverse Event|1|||
48837783|NCT01490086|157248760|FG003|Overall Study|Adverse Event|2|||
48837784|NCT01490086|157248761|FG004|Overall Study|Adverse Event|0|||
48837785|NCT01490086|157248757|FG000|Overall Study|Lack of Efficacy|0|||
48837786|NCT01490086|157248758|FG001|Overall Study|Lack of Efficacy|3|||
48837787|NCT01490086|157248759|FG002|Overall Study|Lack of Efficacy|1|||
48837788|NCT01490086|157248760|FG003|Overall Study|Lack of Efficacy|0|||
48837789|NCT01490086|157248761|FG004|Overall Study|Lack of Efficacy|8|||
48837790|NCT01490086|157248757|FG000|Overall Study|Worsening of symptoms|0|||
48837791|NCT01490086|157248758|FG001|Overall Study|Worsening of symptoms|1|||
48837792|NCT01490086|157248759|FG002|Overall Study|Worsening of symptoms|0|||
48837793|NCT01490086|157248760|FG003|Overall Study|Worsening of symptoms|1|||
48837794|NCT01490086|157248761|FG004|Overall Study|Worsening of symptoms|0|||
48837795|NCT01490086|157248757|FG000|Overall Study|Subject uncontrollable and abusive|0|||
48837796|NCT01490086|157248758|FG001|Overall Study|Subject uncontrollable and abusive|1|||
48837797|NCT01490086|157248759|FG002|Overall Study|Subject uncontrollable and abusive|0|||
48837798|NCT01490086|157248760|FG003|Overall Study|Subject uncontrollable and abusive|0|||
48837799|NCT01490086|157248761|FG004|Overall Study|Subject uncontrollable and abusive|0|||
48837800|NCT01490086|157248757|FG000|Overall Study|Subject left hospital|0|||
48837801|NCT01490086|157248758|FG001|Overall Study|Subject left hospital|1|||
48923833|NCT03345472|157555240|FG000|3 Months to 12 Months|Physician Decision|3|||
48837802|NCT01490086|157248759|FG002|Overall Study|Subject left hospital|0|||
49163976|NCT03637491|158435716|FG002|Overall Study|Death|5|||
49163977|NCT03637491|158435717|FG003|Overall Study|Death|3|||
49163978|NCT03637491|158435714|FG000|Overall Study|Lost to Follow-up|0|||
49163979|NCT03637491|158435715|FG001|Overall Study|Lost to Follow-up|1|||
49163980|NCT03637491|158435716|FG002|Overall Study|Lost to Follow-up|0|||
48837803|NCT01490086|157248760|FG003|Overall Study|Subject left hospital|1|||
48837804|NCT01490086|157248761|FG004|Overall Study|Subject left hospital|0|||
48837805|NCT02549170|157248762|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|17|||
48837806|NCT02549170|157248763|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|4|||
48837807|NCT02549170|157248764|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
48923834|NCT03345472|157555240|FG000|3 Months to 12 Months|Lost to Follow-up|2|||
48837808|NCT02549170|157248765|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
48837809|NCT02549170|157248766|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
48837810|NCT02549170|157248762|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|5|||
48837811|NCT02549170|157248763|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|2|||
48837812|NCT02549170|157248764|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
49163981|NCT03637491|158435717|FG003|Overall Study|Lost to Follow-up|1|||
49163982|NCT03637491|158435714|FG000|Overall Study|Study Terminated By Sponsor|0|||
48837813|NCT02549170|157248765|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
48837814|NCT02549170|157248766|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
48837815|NCT02549170|157248762|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|2|||
48837816|NCT02549170|157248763|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|8|||
48837817|NCT02549170|157248764|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
48837818|NCT02549170|157248765|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
48837819|NCT02549170|157248766|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
48837820|NCT01124734|157248767|FG000|Overall Study|Disease progression|13|||
48837821|NCT01124734|157248767|FG000|Overall Study|Adverse Event|1|||
48837822|NCT01124734|157248767|FG000|Overall Study|Withdrawal by Subject|1|||
48837823|NCT01124734|157248767|FG000|Overall Study|Elected for alternative treatment|2|||
48837824|NCT02807493|157248769|FG000|Overall Study|Adverse Event|5|||
48837825|NCT02807493|157248770|FG001|Overall Study|Adverse Event|2|||
48837826|NCT02807493|157248769|FG000|Overall Study|Lost to Follow-up|6|||
48837827|NCT02807493|157248770|FG001|Overall Study|Lost to Follow-up|0|||
48837828|NCT02807493|157248769|FG000|Overall Study|Physician Decision|4|||
48837829|NCT02807493|157248770|FG001|Overall Study|Physician Decision|1|||
48837830|NCT02807493|157248769|FG000|Overall Study|Protocol Violation|7|||
48837831|NCT02807493|157248770|FG001|Overall Study|Protocol Violation|0|||
48837832|NCT02807493|157248769|FG000|Overall Study|Withdrawal by Subject|17|||
48837833|NCT02807493|157248770|FG001|Overall Study|Withdrawal by Subject|10|||
48837834|NCT02807493|157248769|FG000|Overall Study|Other withdrawal|17|||
48837835|NCT02807493|157248770|FG001|Overall Study|Other withdrawal|0|||
48837836|NCT02807493|157248769|FG000|Overall Study|C-Section Prior to Stage 2 of Labor|31|||
48837837|NCT02807493|157248770|FG001|Overall Study|C-Section Prior to Stage 2 of Labor|39|||
48837838|NCT04504916|157248771|FG000|Overall Study|Study terminated|7|||
48837839|NCT04504916|157248772|FG001|Overall Study|Study terminated|8|||
48837840|NCT04504916|157248771|FG000|Overall Study|Death|54|||
48837841|NCT04504916|157248772|FG001|Overall Study|Death|18|||
48837842|NCT04504916|157248771|FG000|Overall Study|Lost to Follow-up|1|||
48837843|NCT04504916|157248772|FG001|Overall Study|Lost to Follow-up|1|||
48837844|NCT04504916|157248771|FG000|Overall Study|Withdrawal by Subject|8|||
48837845|NCT04504916|157248772|FG001|Overall Study|Withdrawal by Subject|4|||
48837846|NCT04504916|157248771|FG000|Overall Study|Did not agree to follow-up|0|||
48837847|NCT04504916|157248772|FG001|Overall Study|Did not agree to follow-up|1|||
48837848|NCT04594759|157248773|FG000|Overall Study|Lost to Follow-up|3|||
48837849|NCT00311363|157248776|FG000|24-Week Single-Blind Treatment Period|Adverse Event|42|||
48837850|NCT00311363|157248777|FG001|24-Week Single-Blind Treatment Period|Adverse Event|0|||
48837851|NCT00311363|157248778|FG002|24-Week Single-Blind Treatment Period|Adverse Event|0|||
48837852|NCT00311363|157248776|FG000|24-Week Single-Blind Treatment Period|Lack of Efficacy|13|||
48837853|NCT00311363|157248777|FG001|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
48837854|NCT00311363|157248778|FG002|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
48837855|NCT00311363|157248776|FG000|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27|||
48837856|NCT00311363|157248777|FG001|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
48837857|NCT00311363|157248778|FG002|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
48837858|NCT00311363|157248776|FG000|24-Week Single-Blind Treatment Period|Lost to Follow-up|12|||
48837859|NCT00311363|157248777|FG001|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
48837860|NCT00311363|157248778|FG002|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
48837861|NCT00311363|157248776|FG000|24-Week Single-Blind Treatment Period|Protocol Violation|8|||
48837862|NCT00311363|157248777|FG001|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
48837863|NCT00311363|157248778|FG002|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
48837864|NCT00311363|157248776|FG000|24-Week Single-Blind Treatment Period|Elective Surgery|1|||
48837865|NCT00311363|157248777|FG001|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
49163983|NCT03637491|158435715|FG001|Overall Study|Study Terminated By Sponsor|2|||
49163984|NCT03637491|158435716|FG002|Overall Study|Study Terminated By Sponsor|1|||
49163985|NCT03637491|158435717|FG003|Overall Study|Study Terminated By Sponsor|0|||
49163986|NCT03637491|158435714|FG000|Overall Study|Withdrawal by Subject|1|||
49163987|NCT03637491|158435715|FG001|Overall Study|Withdrawal by Subject|0|||
49163988|NCT03637491|158435716|FG002|Overall Study|Withdrawal by Subject|1|||
49163989|NCT03637491|158435717|FG003|Overall Study|Withdrawal by Subject|2|||
49163990|NCT04141891|158435729|FG000|6 Month Follow-up (Drivers Only)|Missed interview|3|||
49163991|NCT04141891|158435730|FG001|6 Month Follow-up (Drivers Only)|Missed interview|8|||
49163992|NCT04141891|158435729|FG000|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
48837866|NCT00311363|157248778|FG002|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
49163993|NCT04141891|158435730|FG001|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
49163994|NCT04141891|158435729|FG000|12 Month Follow-up (Drivers + SPs)|Missed interview|9|||
49163995|NCT04141891|158435730|FG001|12 Month Follow-up (Drivers + SPs)|Missed interview|20|||
49163996|NCT04141891|158435729|FG000|12 Month Follow-up (Drivers + SPs)|Death|1|||
49163997|NCT04141891|158435730|FG001|12 Month Follow-up (Drivers + SPs)|Death|4|||
49163998|NCT04141891|158435729|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|11|||
49163999|NCT04141891|158435730|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|8|||
49164000|NCT04141891|158435729|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|0|||
48837867|NCT00311363|157248776|FG000|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1|||
48837868|NCT00311363|157248777|FG001|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
48837869|NCT00311363|157248778|FG002|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
48837870|NCT00311363|157248776|FG000|24-Week Single-Blind Treatment Period|Pregnancy|1|||
48837871|NCT00311363|157248777|FG001|24-Week Single-Blind Treatment Period|Pregnancy|0|||
48837872|NCT00311363|157248778|FG002|24-Week Single-Blind Treatment Period|Pregnancy|0|||
48837873|NCT00311363|157248776|FG000|24-Week Single-Blind Treatment Period|Death|1|||
48837874|NCT00311363|157248777|FG001|24-Week Single-Blind Treatment Period|Death|0|||
48837875|NCT00311363|157248778|FG002|24-Week Single-Blind Treatment Period|Death|0|||
48837876|NCT00311363|157248776|FG000|12-Week Double-Blind Treatment Period|Adverse Event|0|||
48837877|NCT00311363|157248777|FG001|12-Week Double-Blind Treatment Period|Adverse Event|3|||
48837878|NCT00311363|157248778|FG002|12-Week Double-Blind Treatment Period|Adverse Event|0|||
48837879|NCT00311363|157248776|FG000|12-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
48837880|NCT00311363|157248777|FG001|12-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
48837881|NCT00311363|157248778|FG002|12-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
48837882|NCT00311363|157248776|FG000|12-Week Double-Blind Treatment Period|Lack of Efficacy|0|||
48837883|NCT00311363|157248777|FG001|12-Week Double-Blind Treatment Period|Lack of Efficacy|6|||
48837884|NCT00311363|157248778|FG002|12-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
48837885|NCT00311363|157248776|FG000|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0|||
48837886|NCT00311363|157248777|FG001|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2|||
48837887|NCT00311363|157248778|FG002|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4|||
48837888|NCT00311363|157248776|FG000|12-Week Double-Blind Treatment Period|Protocol Violation|0|||
48837889|NCT00311363|157248777|FG001|12-Week Double-Blind Treatment Period|Protocol Violation|1|||
48837890|NCT00311363|157248778|FG002|12-Week Double-Blind Treatment Period|Protocol Violation|2|||
48837891|NCT00311363|157248776|FG000|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
48837892|NCT00311363|157248777|FG001|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1|||
48837893|NCT00311363|157248778|FG002|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
48837894|NCT00630786|157248779|FG000|Overall Study|Physician Decision|0|||
48837895|NCT00630786|157248780|FG001|Overall Study|Physician Decision|0|||
48837896|NCT00630786|157248781|FG002|Overall Study|Physician Decision|1|||
48837897|NCT00630786|157248779|FG000|Overall Study|Withdrawal by Subject|0|||
48837898|NCT00630786|157248780|FG001|Overall Study|Withdrawal by Subject|1|||
48837899|NCT00630786|157248781|FG002|Overall Study|Withdrawal by Subject|1|||
48837900|NCT00630786|157248779|FG000|Overall Study|Lost to Follow-up|0|||
48837901|NCT00630786|157248780|FG001|Overall Study|Lost to Follow-up|1|||
48837902|NCT00630786|157248781|FG002|Overall Study|Lost to Follow-up|0|||
48837903|NCT00630786|157248779|FG000|Overall Study|Other|1|||
48837904|NCT00630786|157248780|FG001|Overall Study|Other|0|||
48837905|NCT00630786|157248781|FG002|Overall Study|Other|0|||
48837906|NCT02568683|157248782|FG000|Overall Study|Death|0|||
48837907|NCT02568683|157248783|FG001|Overall Study|Death|2|||
48837908|NCT02568683|157248782|FG000|Overall Study|Withdrew Consent|1|||
48837909|NCT02568683|157248783|FG001|Overall Study|Withdrew Consent|0|||
48837910|NCT02568683|157248782|FG000|Overall Study|Study Terminated By Sponsor|5|||
48837911|NCT02568683|157248783|FG001|Overall Study|Study Terminated By Sponsor|2|||
48837912|NCT05510245|157248784|FG000|Overall Study|Withdrawal by Subject|1|||
48837913|NCT05510245|157248785|FG001|Overall Study|Withdrawal by Subject|0|||
48837914|NCT05510245|157248786|FG002|Overall Study|Withdrawal by Subject|0|||
48837915|NCT01373346|157248787|FG000|Overall Study|Death|1|||
48837916|NCT01395758|157248788|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
48837917|NCT01395758|157248789|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
48837918|NCT01395758|157248790|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
48837919|NCT00433199|157248791|FG000|Double-Blind Period|Adverse Event|0|||
48837920|NCT00433199|157248792|FG001|Double-Blind Period|Adverse Event|25|||
48837921|NCT00433199|157248791|FG000|Double-Blind Period|Lack of Efficacy|0|||
48837922|NCT00433199|157248792|FG001|Double-Blind Period|Lack of Efficacy|2|||
48837923|NCT00433199|157248791|FG000|Double-Blind Period|Lost to Follow-up|2|||
48837924|NCT00433199|157248792|FG001|Double-Blind Period|Lost to Follow-up|5|||
48837925|NCT00433199|157248791|FG000|Double-Blind Period|Withdrawal by Subject|8|||
48837926|NCT00433199|157248792|FG001|Double-Blind Period|Withdrawal by Subject|19|||
48837927|NCT00433199|157248791|FG000|Double-Blind Period|Protocol Violation|1|||
49164001|NCT04141891|158435730|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|2|||
49164002|NCT04141891|158435729|FG000|18 Month Follow-up (Drivers Only)|Missed interview|12|||
49164003|NCT04141891|158435730|FG001|18 Month Follow-up (Drivers Only)|Missed interview|14|||
48837928|NCT00433199|157248792|FG001|Double-Blind Period|Protocol Violation|10|||
48837929|NCT00433199|157248791|FG000|Double-Blind Period|Administrative|1|||
48837930|NCT00433199|157248792|FG001|Double-Blind Period|Administrative|5|||
48837931|NCT00433199|157248791|FG000|Open-Label Period|Adverse Event|0|||
48837932|NCT00433199|157248792|FG001|Open-Label Period|Adverse Event|19|||
48837933|NCT00433199|157248791|FG000|Open-Label Period|Lack of Efficacy|0|||
48837934|NCT00433199|157248792|FG001|Open-Label Period|Lack of Efficacy|2|||
48837935|NCT00433199|157248791|FG000|Open-Label Period|Lost to Follow-up|0|||
48837936|NCT00433199|157248792|FG001|Open-Label Period|Lost to Follow-up|3|||
48837937|NCT00433199|157248791|FG000|Open-Label Period|Withdrawal by Subject|0|||
48837938|NCT00433199|157248792|FG001|Open-Label Period|Withdrawal by Subject|7|||
48837939|NCT00433199|157248791|FG000|Open-Label Period|Protocol Violation|0|||
48837940|NCT00433199|157248792|FG001|Open-Label Period|Protocol Violation|2|||
48837941|NCT00433199|157248791|FG000|Open-Label Period|Administrative|0|||
48837942|NCT00433199|157248792|FG001|Open-Label Period|Administrative|1|||
48837943|NCT02794480|157248793|FG000|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
48837944|NCT02794480|157248794|FG001|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
48837945|NCT02794480|157248795|FG002|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1|||
48837946|NCT02794480|157248796|FG003|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
48837947|NCT02794480|157248793|FG000|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
48837948|NCT02794480|157248794|FG001|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
48837949|NCT02794480|157248795|FG002|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1|||
48837950|NCT02794480|157248796|FG003|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
48837951|NCT02794480|157248793|FG000|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48837952|NCT02794480|157248794|FG001|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48837953|NCT02794480|157248795|FG002|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48837954|NCT02794480|157248796|FG003|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2|||
48837955|NCT02794480|157248793|FG000|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
48837956|NCT02794480|157248794|FG001|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2|||
48837957|NCT02794480|157248795|FG002|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
48837958|NCT02794480|157248796|FG003|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
48837959|NCT02794480|157248793|FG000|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
48837960|NCT02794480|157248794|FG001|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
48837961|NCT02794480|157248795|FG002|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
48837962|NCT02794480|157248796|FG003|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
48837963|NCT00206375|157248798|FG000|Overall Study|Lost to Follow-up|1|||
48837964|NCT00206375|157248799|FG001|Overall Study|Lost to Follow-up|0|||
48837965|NCT00206375|157248800|FG002|Overall Study|Lost to Follow-up|0|||
48837966|NCT00206375|157248798|FG000|Overall Study|Withdrawal by Subject|2|||
49164004|NCT04141891|158435729|FG000|18 Month Follow-up (Drivers Only)|Death|1|||
49164005|NCT04141891|158435730|FG001|18 Month Follow-up (Drivers Only)|Death|2|||
48837967|NCT00206375|157248799|FG001|Overall Study|Withdrawal by Subject|1|||
48837968|NCT00206375|157248800|FG002|Overall Study|Withdrawal by Subject|3|||
48837969|NCT00206375|157248798|FG000|Overall Study|Study terminated due to lack of funds|0|||
48837970|NCT00206375|157248799|FG001|Overall Study|Study terminated due to lack of funds|1|||
48837971|NCT00206375|157248800|FG002|Overall Study|Study terminated due to lack of funds|1|||
48837972|NCT01170962|157248801|FG000|Treatment Period|Lack of Efficacy|96|||
48837973|NCT01170962|157248802|FG001|Treatment Period|Lack of Efficacy|91|||
48837974|NCT01170962|157248803|FG002|Treatment Period|Lack of Efficacy|7|||
48837975|NCT01170962|157248801|FG000|Treatment Period|Adverse Event|11|||
48837976|NCT01170962|157248802|FG001|Treatment Period|Adverse Event|12|||
48837977|NCT01170962|157248803|FG002|Treatment Period|Adverse Event|3|||
48837978|NCT01170962|157248801|FG000|Treatment Period|Withdrawal by Subject|2|||
48837979|NCT01170962|157248802|FG001|Treatment Period|Withdrawal by Subject|1|||
48923835|NCT03345472|157555240|FG000|3 Months to 12 Months|Withdrawal by Subject|1|||
49164006|NCT04141891|158435729|FG000|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|1|||
49164007|NCT04141891|158435730|FG001|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|3|||
49164008|NCT04141891|158435729|FG000|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|0|||
49164009|NCT04141891|158435730|FG001|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|1|||
49164010|NCT04141891|158435729|FG000|24 Month Follow-up (Drivers and SPs)|Missed interview|22|||
49164011|NCT04141891|158435730|FG001|24 Month Follow-up (Drivers and SPs)|Missed interview|18|||
49164012|NCT04141891|158435729|FG000|24 Month Follow-up (Drivers and SPs)|Death|2|||
49164013|NCT04141891|158435730|FG001|24 Month Follow-up (Drivers and SPs)|Death|3|||
49164014|NCT04141891|158435729|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|5|||
49164015|NCT04141891|158435730|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|6|||
49164016|NCT04141891|158435729|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|2|||
49164017|NCT04141891|158435730|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|0|||
49164018|NCT05856435|158435735|FG000|Overall Study|Lost to Follow-up|6|||
48837980|NCT01170962|157248803|FG002|Treatment Period|Withdrawal by Subject|0|||
48837981|NCT01170962|157248801|FG000|Treatment Period|Lost to Follow-up|1|||
48837982|NCT01170962|157248802|FG001|Treatment Period|Lost to Follow-up|1|||
48837983|NCT01170962|157248803|FG002|Treatment Period|Lost to Follow-up|1|||
48837984|NCT01170962|157248801|FG000|Treatment Period|Participant no longer meets criteria|0|||
48837985|NCT01170962|157248802|FG001|Treatment Period|Participant no longer meets criteria|1|||
48837986|NCT01170962|157248803|FG002|Treatment Period|Participant no longer meets criteria|0|||
48837987|NCT01170962|157248801|FG000|Treatment Period|Request to discontinue treatment|7|||
48837988|NCT01170962|157248802|FG001|Treatment Period|Request to discontinue treatment|3|||
48837989|NCT01170962|157248803|FG002|Treatment Period|Request to discontinue treatment|1|||
48837990|NCT01170962|157248801|FG000|Treatment Period|Completed 24 Week treatment period only|10|||
48837991|NCT01170962|157248802|FG001|Treatment Period|Completed 24 Week treatment period only|2|||
48837992|NCT01170962|157248803|FG002|Treatment Period|Completed 24 Week treatment period only|0|||
48837993|NCT01170962|157248801|FG000|Follow up Period|Withdrawal by Subject|14|||
48837994|NCT01170962|157248802|FG001|Follow up Period|Withdrawal by Subject|10|||
48837995|NCT01170962|157248803|FG002|Follow up Period|Withdrawal by Subject|2|||
48837996|NCT01170962|157248801|FG000|Follow up Period|Lost to Follow-up|13|||
48837997|NCT01170962|157248802|FG001|Follow up Period|Lost to Follow-up|8|||
48837998|NCT01170962|157248803|FG002|Follow up Period|Lost to Follow-up|1|||
48837999|NCT01170962|157248801|FG000|Follow up Period|Death|2|||
48838000|NCT01170962|157248802|FG001|Follow up Period|Death|2|||
48838001|NCT01170962|157248803|FG002|Follow up Period|Death|0|||
48838002|NCT01170962|157248801|FG000|Follow up Period|Others|10|||
48838003|NCT01170962|157248802|FG001|Follow up Period|Others|7|||
48838004|NCT01170962|157248803|FG002|Follow up Period|Others|3|||
48838005|NCT03887650|157248804|FG000|Preoperative-48 Hours Postoperative|Withdrawal by Subject|0|||
48838006|NCT03887650|157248805|FG001|Preoperative-48 Hours Postoperative|Withdrawal by Subject|1|||
48838007|NCT03887650|157248804|FG000|48-96 Hours Postoperative|Withdrawal by Subject|0|||
48838008|NCT03887650|157248805|FG001|48-96 Hours Postoperative|Withdrawal by Subject|2|||
48838009|NCT03887650|157248804|FG000|60 Postoperative Days|Withdrawal by Subject|1|||
48838010|NCT03887650|157248805|FG001|60 Postoperative Days|Withdrawal by Subject|0|||
48838011|NCT01579916|157248806|FG000|Overall Study|Lost to Follow-up|6|||
48838012|NCT01579916|157248807|FG001|Overall Study|Lost to Follow-up|1|||
48838013|NCT01579916|157248806|FG000|Overall Study|Withdrawal by Subject|1|||
48838014|NCT01579916|157248807|FG001|Overall Study|Withdrawal by Subject|1|||
48838015|NCT01579916|157248806|FG000|Overall Study|Death|1|||
48838016|NCT01579916|157248807|FG001|Overall Study|Death|0|||
48838017|NCT00933400|157248813|FG000|Overall Study|Withdrawal by Subject|21|||
48838018|NCT00933400|157248814|FG001|Overall Study|Withdrawal by Subject|1|||
48838019|NCT02299375|157248815|FG000|Overall Study|Adverse Event, serious fatal|1|||
48838020|NCT02299375|157248816|FG001|Overall Study|Adverse Event, serious fatal|3|||
48838021|NCT02299375|157248815|FG000|Overall Study|Adverse Event, non-fatal|8|||
48838022|NCT02299375|157248816|FG001|Overall Study|Adverse Event, non-fatal|9|||
48838023|NCT02299375|157248815|FG000|Overall Study|Lack of Efficacy|1|||
48838024|NCT02299375|157248816|FG001|Overall Study|Lack of Efficacy|3|||
48838025|NCT02299375|157248815|FG000|Overall Study|Protocol Violation|1|||
48838026|NCT02299375|157248816|FG001|Overall Study|Protocol Violation|3|||
48838027|NCT02299375|157248815|FG000|Overall Study|Other: Met stopping criteria|1|||
48838028|NCT02299375|157248816|FG001|Overall Study|Other: Met stopping criteria|0|||
48838029|NCT02299375|157248815|FG000|Overall Study|Other: Study closed/terminated|66|||
48838030|NCT02299375|157248816|FG001|Overall Study|Other: Study closed/terminated|55|||
49164019|NCT01985022|158435736|FG000|Overall Study|Lost to Follow-up|0|||
49164020|NCT01985022|158435737|FG001|Overall Study|Lost to Follow-up|1|||
49164021|NCT01985022|158435736|FG000|Overall Study|Protocol Violation|0|||
49164022|NCT01985022|158435737|FG001|Overall Study|Protocol Violation|1|||
49164023|NCT01985022|158435736|FG000|Overall Study|Withdrawal by Subject|4|||
49164024|NCT01985022|158435737|FG001|Overall Study|Withdrawal by Subject|1|||
49164025|NCT01740687|158435738|FG000|Overall Study|Lost to Follow-up|11|||
49164026|NCT01740687|158435738|FG000|Overall Study|Withdrawal by Subject|2|||
49164027|NCT01740687|158435738|FG000|Overall Study|other reason|22|||
49164028|NCT01740687|158435738|FG000|Overall Study|treatment not received|2|||
49164029|NCT03654274|158435744|FG000|Overall Study|Adverse Event|19|||
48838031|NCT02299375|157248815|FG000|Overall Study|Lost to Follow-up|0|||
48838032|NCT02299375|157248816|FG001|Overall Study|Lost to Follow-up|2|||
48838033|NCT02299375|157248815|FG000|Overall Study|Physician Decision|1|||
48838034|NCT02299375|157248816|FG001|Overall Study|Physician Decision|1|||
48838035|NCT02299375|157248815|FG000|Overall Study|Withdrawal by Subject|1|||
48838036|NCT02299375|157248816|FG001|Overall Study|Withdrawal by Subject|4|||
48838037|NCT02539225|157248817|FG000|Part A|Adverse Event|13|||
48838038|NCT02539225|157248818|FG001|Part A|Adverse Event|4|||
48838039|NCT02539225|157248817|FG000|Part A|Withdrawal by Subject|2|||
48838040|NCT02539225|157248818|FG001|Part A|Withdrawal by Subject|4|||
48838041|NCT02539225|157248817|FG000|Part A|Physician Decision|4|||
48838042|NCT02539225|157248818|FG001|Part A|Physician Decision|7|||
48838043|NCT02539225|157248817|FG000|Part A|Did Not Receive study Drug|1|||
48838044|NCT02539225|157248818|FG001|Part A|Did Not Receive study Drug|1|||
48838045|NCT02539225|157248817|FG000|Pre Treatment for Part B|Progressive disease|1|||
49164030|NCT03654274|158435745|FG001|Overall Study|Adverse Event|23|||
49164031|NCT03654274|158435746|FG002|Overall Study|Adverse Event|24|||
49164032|NCT03654274|158435744|FG000|Overall Study|Protocol Deviation|0|||
49164033|NCT03654274|158435745|FG001|Overall Study|Protocol Deviation|2|||
49164034|NCT03654274|158435746|FG002|Overall Study|Protocol Deviation|0|||
49164035|NCT03654274|158435744|FG000|Overall Study|Lost to Follow-up|8|||
49164036|NCT03654274|158435745|FG001|Overall Study|Lost to Follow-up|6|||
49164037|NCT03654274|158435746|FG002|Overall Study|Lost to Follow-up|5|||
49164038|NCT03654274|158435744|FG000|Overall Study|Withdrawal by Subject|46|||
49164039|NCT03654274|158435745|FG001|Overall Study|Withdrawal by Subject|25|||
49164040|NCT03654274|158435746|FG002|Overall Study|Withdrawal by Subject|33|||
49164041|NCT03654274|158435744|FG000|Overall Study|Lack of Efficacy|4|||
48838046|NCT02539225|157248818|FG001|Pre Treatment for Part B|Progressive disease|1|||
48838047|NCT02539225|157248817|FG000|Pre Treatment for Part B|Adverse Event|1|||
48838048|NCT02539225|157248818|FG001|Pre Treatment for Part B|Adverse Event|1|||
48838049|NCT02539225|157248817|FG000|Pre Treatment for Part B|Withdrawal by Subject|1|||
48838050|NCT02539225|157248818|FG001|Pre Treatment for Part B|Withdrawal by Subject|0|||
48838051|NCT02539225|157248817|FG000|Pre Treatment for Part B|Physician Decision|2|||
48838052|NCT02539225|157248818|FG001|Pre Treatment for Part B|Physician Decision|0|||
48838053|NCT02539225|157248817|FG000|Part B|Adverse Event|4|||
48838054|NCT02539225|157248818|FG001|Part B|Adverse Event|4|||
48838055|NCT02539225|157248817|FG000|Part B|Withdrawal by Subject|0|||
48838056|NCT02539225|157248818|FG001|Part B|Withdrawal by Subject|3|||
48838057|NCT02539225|157248817|FG000|Part B|Physician Decision|0|||
48838058|NCT02539225|157248818|FG001|Part B|Physician Decision|9|||
48838059|NCT01551355|157248819|FG000|Overall Study|Lost to Follow-up|51|||
48838060|NCT01551355|157248820|FG001|Overall Study|Lost to Follow-up|49|||
48838061|NCT01551355|157248821|FG002|Overall Study|Lost to Follow-up|34|||
48838062|NCT01551355|157248822|FG003|Overall Study|Lost to Follow-up|24|||
48838063|NCT01551355|157248823|FG004|Overall Study|Lost to Follow-up|9|||
48838064|NCT01551355|157248824|FG005|Overall Study|Lost to Follow-up|6|||
48838065|NCT01538719|157248829|FG000|Overall Study|Lost to Follow-up|2|||
48838066|NCT01538719|157248830|FG001|Overall Study|Lost to Follow-up|0|||
48838067|NCT03997916|157248831|FG000|Overall Study|Protocol Violation|35|||
49164042|NCT03654274|158435745|FG001|Overall Study|Lack of Efficacy|5|||
49164043|NCT03654274|158435746|FG002|Overall Study|Lack of Efficacy|7|||
49164044|NCT03654274|158435744|FG000|Overall Study|Pregnancy|2|||
49164045|NCT03654274|158435745|FG001|Overall Study|Pregnancy|2|||
49164046|NCT03654274|158435746|FG002|Overall Study|Pregnancy|1|||
49164047|NCT03654274|158435744|FG000|Overall Study|Other|27|||
49164048|NCT03654274|158435745|FG001|Overall Study|Other|29|||
49164049|NCT03654274|158435746|FG002|Overall Study|Other|32|||
49164050|NCT03654274|158435744|FG000|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
49164051|NCT03654274|158435745|FG001|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
49164052|NCT03654274|158435746|FG002|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|1|||
49164053|NCT02890329|158435752|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
49164054|NCT02890329|158435753|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|1|||
48923836|NCT03345472|157555240|FG000|3 Months to 12 Months|Adverse Event|1|||
49164055|NCT02890329|158435754|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
49164056|NCT02890329|158435755|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
49164057|NCT02890329|158435756|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
49164058|NCT02890329|158435757|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
49164059|NCT02890329|158435752|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
49164060|NCT02890329|158435753|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
49164061|NCT02890329|158435754|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
49164062|NCT02890329|158435755|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
49164063|NCT02890329|158435756|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
49164064|NCT02890329|158435757|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
49164065|NCT02890329|158435752|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
49164066|NCT02890329|158435753|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
49164067|NCT02890329|158435754|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
48923837|NCT03345472|157555240|FG000|3 Months to 12 Months|Death|1|||
48923838|NCT01926782|157555241|FG000|Overall Study|Participant moved|2|||
48923839|NCT01926782|157555242|FG001|Overall Study|Participant moved|0|||
48923840|NCT01926782|157555243|FG002|Overall Study|Participant moved|1|||
48923841|NCT01926782|157555244|FG003|Overall Study|Participant moved|1|||
48923842|NCT01926782|157555245|FG004|Overall Study|Participant moved|0|||
48923843|NCT01926782|157555246|FG005|Overall Study|Participant moved|3|||
49164068|NCT02890329|158435755|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|2|||
48923844|NCT01926782|157555241|FG000|Overall Study|Physician Decision|0|||
49164069|NCT02890329|158435756|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
49164070|NCT02890329|158435757|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
49164071|NCT02890329|158435752|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
49164072|NCT02890329|158435753|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
49164073|NCT02890329|158435754|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|1|||
49164074|NCT02890329|158435755|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
49164075|NCT02890329|158435756|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
49164076|NCT02890329|158435757|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
49164077|NCT05541484|158435758|FG000|Overall Study|Withdrawal by Subject|1|||
49164078|NCT05541484|158435759|FG001|Overall Study|Withdrawal by Subject|0|||
49164079|NCT02919917|158435760|FG000|Overall Study|Withdrawal by Subject|4|||
49164080|NCT02919917|158435761|FG001|Overall Study|Withdrawal by Subject|8|||
49164081|NCT05025384|158435762|FG000|Overall Study|Physician Decision|5|||
49164082|NCT05025384|158435763|FG001|Overall Study|Physician Decision|6|||
49164083|NCT04057131|158435764|FG000|Overall Study|Protocol Violation|24|||
49164084|NCT04577651|158435767|FG000|Overall Study|Screen Failure|7|||
49164085|NCT04577651|158435767|FG000|Overall Study|Adverse Event|1|||
49164086|NCT04577651|158435767|FG000|Overall Study|Death|1|||
49164087|NCT04577651|158435767|FG000|Overall Study|Physician Decision|1|||
49164088|NCT04577651|158435767|FG000|Overall Study|Withdrawal by Subject|3|||
49164089|NCT04459416|158437185|FG000|Overall Study|Lost to Follow-up|2|||
49164090|NCT04459416|158437186|FG001|Overall Study|Lost to Follow-up|0|||
48923845|NCT01926782|157555242|FG001|Overall Study|Physician Decision|2|||
49164091|NCT04459416|158437185|FG000|Overall Study|Withdrawal by Subject|8|||
49164092|NCT04459416|158437186|FG001|Overall Study|Withdrawal by Subject|10|||
49164093|NCT04459416|158437185|FG000|Overall Study|Disease progression|0|||
49164094|NCT04459416|158437186|FG001|Overall Study|Disease progression|3|||
49164095|NCT01576783|158437187|FG000|Overall Study|Change in Medical Care|1|||
49164096|NCT01576783|158437188|FG001|Overall Study|Change in Medical Care|0|||
49164097|NCT01576783|158437187|FG000|Overall Study|Lost to Follow-up|14|||
49164098|NCT01576783|158437188|FG001|Overall Study|Lost to Follow-up|16|||
49164099|NCT01576783|158437187|FG000|Overall Study|Withdrawal by Subject|5|||
49164100|NCT01576783|158437188|FG001|Overall Study|Withdrawal by Subject|1|||
49164101|NCT02114177|158437189|FG000|Overall Study|Lost to Follow-up|1|||
49164102|NCT02114177|158437190|FG001|Overall Study|Lost to Follow-up|2|||
49164103|NCT02114177|158437189|FG000|Overall Study|Withdrawal by Subject|6|||
49164104|NCT02114177|158437190|FG001|Overall Study|Withdrawal by Subject|1|||
49164105|NCT02114177|158437189|FG000|Overall Study|Other|2|||
49164106|NCT02114177|158437190|FG001|Overall Study|Other|1|||
49164107|NCT02026011|158437193|FG000|Allocation 1 (First Set of Medication)|Side Effects|6|||
49164108|NCT02026011|158437194|FG001|Allocation 1 (First Set of Medication)|Side Effects|0|||
49164109|NCT02026011|158437193|FG000|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1|||
49164110|NCT02026011|158437194|FG001|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2|||
49164111|NCT02026011|158437193|FG000|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1|||
49164112|NCT02026011|158437194|FG001|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0|||
49164113|NCT02026011|158437193|FG000|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1|||
49164114|NCT02026011|158437194|FG001|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2|||
49164115|NCT02777086|158437195|FG000|Overall Study|Lost to Follow-up|96|||
49164116|NCT02777086|158437196|FG001|Overall Study|Lost to Follow-up|99|||
49164117|NCT01770743|158437197|FG000|Overall Study|Adverse Event|1|||
49164118|NCT01770743|158437198|FG001|Overall Study|Adverse Event|0|||
49164119|NCT01770743|158437199|FG002|Overall Study|Adverse Event|0|||
49164120|NCT01770743|158437200|FG003|Overall Study|Adverse Event|0|||
49164121|NCT01770743|158437201|FG004|Overall Study|Adverse Event|0|||
49164122|NCT01770743|158437197|FG000|Overall Study|Withdrawal by Subject|0|||
49164123|NCT01770743|158437198|FG001|Overall Study|Withdrawal by Subject|0|||
49164124|NCT01770743|158437199|FG002|Overall Study|Withdrawal by Subject|1|||
49164125|NCT01770743|158437200|FG003|Overall Study|Withdrawal by Subject|1|||
49164126|NCT01770743|158437201|FG004|Overall Study|Withdrawal by Subject|1|||
49164127|NCT01770743|158437197|FG000|Overall Study|Lost to Follow-up|0|||
49164128|NCT01770743|158437198|FG001|Overall Study|Lost to Follow-up|2|||
49164129|NCT01770743|158437199|FG002|Overall Study|Lost to Follow-up|0|||
49164130|NCT01770743|158437200|FG003|Overall Study|Lost to Follow-up|0|||
49164131|NCT01770743|158437201|FG004|Overall Study|Lost to Follow-up|1|||
49164132|NCT01770743|158437197|FG000|Overall Study|Sponsor Terminated Subject|1|||
49164133|NCT01770743|158437198|FG001|Overall Study|Sponsor Terminated Subject|0|||
49164134|NCT01770743|158437199|FG002|Overall Study|Sponsor Terminated Subject|0|||
49164135|NCT01770743|158437200|FG003|Overall Study|Sponsor Terminated Subject|1|||
49164136|NCT01770743|158437201|FG004|Overall Study|Sponsor Terminated Subject|0|||
49164137|NCT01770743|158437197|FG000|Overall Study|Moving Out of State|0|||
49164138|NCT01770743|158437198|FG001|Overall Study|Moving Out of State|1|||
49164139|NCT01770743|158437199|FG002|Overall Study|Moving Out of State|0|||
49164140|NCT01770743|158437200|FG003|Overall Study|Moving Out of State|0|||
49164141|NCT01770743|158437201|FG004|Overall Study|Moving Out of State|0|||
49164142|NCT00937495|158437208|FG000|Overall Study|Protocol Violation|2|||
49164143|NCT00441272|158437209|FG000|Overall Study|Study terminated prior to enrollment|25|||
49164144|NCT00441272|158437210|FG001|Overall Study|Study terminated prior to enrollment|25|||
49164145|NCT01856322|158437211|FG000|Overall Study|off study due to lack of accrual|0|||
49164146|NCT01856322|158437212|FG001|Overall Study|off study due to lack of accrual|0|||
49164147|NCT01856322|158437213|FG002|Overall Study|off study due to lack of accrual|3|||
49164148|NCT00427011|158437214|FG000|Overall Study|Adverse Event|10|||
49164149|NCT00427011|158437214|FG000|Overall Study|Withdrawal by Subject|1|||
49164150|NCT00427011|158437214|FG000|Overall Study|Lack of Efficacy|2|||
49164151|NCT00427011|158437214|FG000|Overall Study|Other|12|||
49164152|NCT00952705|158437217|FG000|Overall Study|Lost to Follow-up|24|||
49164153|NCT00952705|158437218|FG001|Overall Study|Lost to Follow-up|8|||
49164154|NCT00952705|158437219|FG002|Overall Study|Lost to Follow-up|9|||
49164155|NCT00952705|158437217|FG000|Overall Study|Withdrawal by Subject|2|||
49164156|NCT00952705|158437218|FG001|Overall Study|Withdrawal by Subject|1|||
49164157|NCT00952705|158437219|FG002|Overall Study|Withdrawal by Subject|1|||
49164158|NCT00952705|158437217|FG000|Overall Study|Death|2|||
49164159|NCT00952705|158437218|FG001|Overall Study|Death|0|||
49164160|NCT00952705|158437219|FG002|Overall Study|Death|0|||
49164161|NCT00952705|158437217|FG000|Overall Study|Incarcerated post dose|5|||
49164162|NCT00952705|158437218|FG001|Overall Study|Incarcerated post dose|0|||
49164163|NCT00952705|158437219|FG002|Overall Study|Incarcerated post dose|0|||
49164164|NCT00952705|158437217|FG000|Overall Study|Exclusion criteria not met pre dose|0|||
49164165|NCT00952705|158437218|FG001|Overall Study|Exclusion criteria not met pre dose|1|||
49164166|NCT00952705|158437219|FG002|Overall Study|Exclusion criteria not met pre dose|0|||
49164167|NCT01497197|158437221|FG000|Overall Study|Lost to Follow-up|1|||
49164168|NCT01497197|158437222|FG001|Overall Study|Lost to Follow-up|0|||
49164169|NCT01497197|158437221|FG000|Overall Study|Protocol Violation|0|||
49164170|NCT01497197|158437222|FG001|Overall Study|Protocol Violation|2|||
49164171|NCT01497197|158437221|FG000|Overall Study|Withdrawal by Subject|2|||
49164172|NCT01497197|158437222|FG001|Overall Study|Withdrawal by Subject|1|||
49164173|NCT01497197|158437221|FG000|Overall Study|Excessive/lack of response to treatment|1|||
49164174|NCT01497197|158437222|FG001|Overall Study|Excessive/lack of response to treatment|0|||
49164175|NCT01497197|158437221|FG000|Overall Study|Risk of OHSS|1|||
49164176|NCT01497197|158437222|FG001|Overall Study|Risk of OHSS|0|||
49164177|NCT01497197|158437221|FG000|Overall Study|No oocytes retrieved|3|||
49164178|NCT01497197|158437222|FG001|Overall Study|No oocytes retrieved|2|||
49164179|NCT01497197|158437221|FG000|Overall Study|No fertilisation|6|||
49164180|NCT01497197|158437222|FG001|Overall Study|No fertilisation|5|||
49164181|NCT01497197|158437221|FG000|Overall Study|Intention to freeze all embryos|0|||
49164182|NCT01497197|158437222|FG001|Overall Study|Intention to freeze all embryos|1|||
49164183|NCT01497197|158437221|FG000|Overall Study|All embryos discarded|0|||
49164184|NCT01497197|158437222|FG001|Overall Study|All embryos discarded|3|||
49164185|NCT01497197|158437221|FG000|Overall Study|Other|3|||
49164186|NCT01497197|158437222|FG001|Overall Study|Other|1|||
49164187|NCT01628913|158437223|FG000|Overall Study|Adverse Event|12|||
49164188|NCT01628913|158437224|FG001|Overall Study|Adverse Event|5|||
49164189|NCT01628913|158437223|FG000|Overall Study|Disease Progression|11|||
49164190|NCT01628913|158437224|FG001|Overall Study|Disease Progression|14|||
49164191|NCT01628913|158437223|FG000|Overall Study|Protocol Violation|1|||
49164192|NCT01628913|158437224|FG001|Overall Study|Protocol Violation|0|||
49164193|NCT01628913|158437223|FG000|Overall Study|Death|1|||
49164194|NCT01628913|158437224|FG001|Overall Study|Death|0|||
49164195|NCT01628913|158437223|FG000|Overall Study|study terminated by Sponsor|4|||
49164196|NCT01628913|158437224|FG001|Overall Study|study terminated by Sponsor|9|||
49164197|NCT01628913|158437223|FG000|Overall Study|Withdrawal by Subject|1|||
49164198|NCT01628913|158437224|FG001|Overall Study|Withdrawal by Subject|0|||
49164199|NCT01628913|158437223|FG000|Overall Study|Physician Decision|1|||
49164200|NCT01628913|158437224|FG001|Overall Study|Physician Decision|3|||
49164201|NCT02935192|158437225|FG000|Overall Study|Withdrawal by Subject|8|||
49164202|NCT02935192|158437226|FG001|Overall Study|Withdrawal by Subject|4|||
49164203|NCT05173974|158437227|FG000|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
49164204|NCT05173974|158437228|FG001|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
49164205|NCT05173974|158437229|FG002|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
49164206|NCT05173974|158437230|FG003|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|1|||
49164207|NCT05173974|158437227|FG000|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
49164208|NCT05173974|158437228|FG001|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|1|||
49164209|NCT05173974|158437229|FG002|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
48923846|NCT01926782|157555243|FG002|Overall Study|Physician Decision|1|||
48923847|NCT01926782|157555244|FG003|Overall Study|Physician Decision|1|||
48923848|NCT01926782|157555245|FG004|Overall Study|Physician Decision|0|||
49164210|NCT05173974|158437230|FG003|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
49164211|NCT00661830|158437231|FG000|Overall Study|Death|37|||
49164212|NCT00661830|158437232|FG001|Overall Study|Death|33|||
49164213|NCT00661830|158437231|FG000|Overall Study|Lost to Follow-up|1|||
49164214|NCT00661830|158437232|FG001|Overall Study|Lost to Follow-up|3|||
49164215|NCT00661830|158437231|FG000|Overall Study|Withdrawal by Subject|1|||
49164216|NCT00661830|158437232|FG001|Overall Study|Withdrawal by Subject|1|||
49164217|NCT00661830|158437231|FG000|Overall Study|Other reason|1|||
49164218|NCT00661830|158437232|FG001|Overall Study|Other reason|5|||
49164219|NCT01979614|158437233|FG000|Overall Study|Adverse Event|1|||
49164220|NCT01979614|158437234|FG001|Overall Study|Adverse Event|1|||
49164221|NCT00488514|158437235|FG000|Overall Study|Adverse Event|41|||
49164222|NCT00488514|158437235|FG000|Overall Study|Lost to Follow-up|44|||
49164223|NCT00488514|158437235|FG000|Overall Study|Protocol Violation|32|||
49164224|NCT00488514|158437235|FG000|Overall Study|Withdrawal by Subject|106|||
49164225|NCT00488514|158437235|FG000|Overall Study|Lack of Efficacy|28|||
49164226|NCT00488514|158437235|FG000|Overall Study|Did not meet criteria for treatment|30|||
49164227|NCT00488514|158437235|FG000|Overall Study|Postive drug screen|1|||
49164228|NCT00488514|158437235|FG000|Overall Study|Withdrawn per medical monitor decision|2|||
49164229|NCT00488514|158437235|FG000|Overall Study|Investigator decision|1|||
48923849|NCT01926782|157555246|FG005|Overall Study|Physician Decision|0|||
48923850|NCT01926782|157555241|FG000|Overall Study|Other than specified|2|||
48923851|NCT01926782|157555242|FG001|Overall Study|Other than specified|3|||
48923852|NCT01926782|157555243|FG002|Overall Study|Other than specified|5|||
48923853|NCT01926782|157555244|FG003|Overall Study|Other than specified|12|||
48923854|NCT01926782|157555245|FG004|Overall Study|Other than specified|4|||
48923855|NCT01926782|157555246|FG005|Overall Study|Other than specified|11|||
48923856|NCT01926782|157555241|FG000|Overall Study|Adverse Event|13|||
48923857|NCT01926782|157555242|FG001|Overall Study|Adverse Event|4|||
49164230|NCT00488514|158437235|FG000|Overall Study|Participant had too few migraines|5|||
49164231|NCT00488514|158437235|FG000|Overall Study|Increase in number of migraines|2|||
49164232|NCT00488514|158437235|FG000|Overall Study|Increased use of concomitant medication|1|||
49164233|NCT00730756|158437236|FG000|Overall Study|Adverse Event|2|||
48923858|NCT01926782|157555243|FG002|Overall Study|Adverse Event|17|||
49164234|NCT00730756|158437237|FG001|Overall Study|Adverse Event|0|||
48923859|NCT01926782|157555244|FG003|Overall Study|Adverse Event|4|||
48923860|NCT01926782|157555245|FG004|Overall Study|Adverse Event|3|||
48923861|NCT01926782|157555246|FG005|Overall Study|Adverse Event|14|||
48923862|NCT01926782|157555241|FG000|Overall Study|Poor compliance to protocol|5|||
48923863|NCT01926782|157555242|FG001|Overall Study|Poor compliance to protocol|3|||
48923864|NCT01926782|157555243|FG002|Overall Study|Poor compliance to protocol|8|||
48923865|NCT01926782|157555244|FG003|Overall Study|Poor compliance to protocol|0|||
48923866|NCT01926782|157555245|FG004|Overall Study|Poor compliance to protocol|1|||
48923867|NCT01926782|157555246|FG005|Overall Study|Poor compliance to protocol|6|||
48923868|NCT01926782|157555241|FG000|Overall Study|Randomized and not treated|0|||
49164235|NCT00730756|158437236|FG000|Overall Study|Lack of Efficacy|1|||
48923869|NCT01926782|157555242|FG001|Overall Study|Randomized and not treated|0|||
49164236|NCT00730756|158437237|FG001|Overall Study|Lack of Efficacy|1|||
49164237|NCT00730756|158437236|FG000|Overall Study|Protocol Deviation|1|||
49164238|NCT00730756|158437237|FG001|Overall Study|Protocol Deviation|2|||
48923870|NCT01926782|157555243|FG002|Overall Study|Randomized and not treated|0|||
49164239|NCT00730756|158437236|FG000|Overall Study|Lost to Follow-up|0|||
48923871|NCT01926782|157555244|FG003|Overall Study|Randomized and not treated|1|||
48923872|NCT01926782|157555245|FG004|Overall Study|Randomized and not treated|0|||
48923873|NCT01926782|157555246|FG005|Overall Study|Randomized and not treated|0|||
48923874|NCT01926782|157555241|FG000|Overall Study|Withdrawal by Subject|6|||
48923875|NCT01926782|157555242|FG001|Overall Study|Withdrawal by Subject|1|||
48923876|NCT01926782|157555243|FG002|Overall Study|Withdrawal by Subject|8|||
49164240|NCT00730756|158437237|FG001|Overall Study|Lost to Follow-up|1|||
49164241|NCT00730756|158437236|FG000|Overall Study|Withdrew Consent|0|||
49164242|NCT00730756|158437237|FG001|Overall Study|Withdrew Consent|1|||
49164243|NCT01535287|158437238|FG000|Overall Study|drug not prepared in time|5|||
49164244|NCT01535287|158437239|FG001|Overall Study|drug not prepared in time|6|||
49164245|NCT00524121|158437244|FG000|Overall Study|Disease progression|6|||
49164246|NCT00524121|158437244|FG000|Overall Study|Adverse Event|4|||
49164247|NCT00524121|158437244|FG000|Overall Study|Patient refused|2|||
49014833|NCT00993616|157890417|FG000|Overall Study|Never treated|1|||
49164248|NCT00524121|158437244|FG000|Overall Study|Other|1|||
49164249|NCT00524121|158437244|FG000|Overall Study|Death|1|||
49164250|NCT00524121|158437244|FG000|Overall Study|Not treated (became ineligible)|4|||
49164251|NCT00524121|158437244|FG000|Overall Study|Not treated (changed mind)|1|||
49164252|NCT01840943|158437245|FG000|Overall Study|Withdrawal by Subject|5|||
49164253|NCT01840943|158437246|FG001|Overall Study|Withdrawal by Subject|6|||
49164254|NCT01840943|158437245|FG000|Overall Study|Physician Decision|4|||
49164255|NCT01840943|158437246|FG001|Overall Study|Physician Decision|2|||
49164256|NCT01840943|158437245|FG000|Overall Study|Lost to Follow-up|4|||
49164257|NCT01840943|158437246|FG001|Overall Study|Lost to Follow-up|4|||
49164258|NCT01446874|158437247|FG000|Overall Study|Not eligible|1|||
49164259|NCT01446874|158437248|FG001|Overall Study|Not eligible|0|||
49164260|NCT01446874|158437249|FG002|Overall Study|Not eligible|0|||
49164261|NCT01446874|158437247|FG000|Overall Study|No surgery/No qualifying surgery|1|||
49164262|NCT01446874|158437248|FG001|Overall Study|No surgery/No qualifying surgery|0|||
49164263|NCT01446874|158437249|FG002|Overall Study|No surgery/No qualifying surgery|12|||
49164264|NCT01446874|158437247|FG000|Overall Study|Non-compliance|0|||
49164265|NCT01446874|158437248|FG001|Overall Study|Non-compliance|4|||
49164266|NCT01446874|158437249|FG002|Overall Study|Non-compliance|0|||
49164267|NCT01446874|158437247|FG000|Overall Study|Antibiotics for pre-op infection|0|||
49164268|NCT01446874|158437248|FG001|Overall Study|Antibiotics for pre-op infection|0|||
49164269|NCT01446874|158437249|FG002|Overall Study|Antibiotics for pre-op infection|2|||
49164270|NCT01446874|158437247|FG000|Overall Study|Withdrawal by Subject|0|||
49164271|NCT01446874|158437248|FG001|Overall Study|Withdrawal by Subject|0|||
49164272|NCT01446874|158437249|FG002|Overall Study|Withdrawal by Subject|4|||
49164273|NCT01977898|158437250|FG000|Overall Study|Non functioning catheter|1|||
49164274|NCT01977898|158437251|FG001|Overall Study|Non functioning catheter|1|||
49164275|NCT02580877|158437253|FG000|Overall Study|Withdrawal by Subject|1|||
49164276|NCT02580877|158437254|FG001|Overall Study|Withdrawal by Subject|3|||
49164277|NCT02580877|158437253|FG000|Overall Study|Adverse Event|0|||
49164278|NCT02580877|158437254|FG001|Overall Study|Adverse Event|1|||
49164279|NCT00980148|158437255|FG000|Overall Study|Discharged from facility|89|||
49164280|NCT00980148|158437256|FG001|Overall Study|Discharged from facility|96|||
49164281|NCT00980148|158437255|FG000|Overall Study|Received other antichlamydia treatment|20|||
49164282|NCT00980148|158437256|FG001|Overall Study|Received other antichlamydia treatment|14|||
49164283|NCT00980148|158437255|FG000|Overall Study|Negative for chlamydia at enrollment|12|||
49164284|NCT00980148|158437256|FG001|Overall Study|Negative for chlamydia at enrollment|9|||
49164285|NCT00980148|158437255|FG000|Overall Study|Various other reasons|8|||
49164286|NCT00980148|158437256|FG001|Overall Study|Various other reasons|9|||
49164287|NCT02973997|158437257|FG000|Overall Study|Withdrawal by Subject|4|||
49164288|NCT02973997|158437258|FG001|Overall Study|Withdrawal by Subject|0|||
49164289|NCT02973997|158437257|FG000|Overall Study|Adverse Event|4|||
49164290|NCT02973997|158437258|FG001|Overall Study|Adverse Event|1|||
49164291|NCT02973997|158437257|FG000|Overall Study|Disease Progression|11|||
49164292|NCT02973997|158437258|FG001|Overall Study|Disease Progression|20|||
49164293|NCT02973997|158437257|FG000|Overall Study|Alternative Therapy|3|||
49164294|NCT02973997|158437258|FG001|Overall Study|Alternative Therapy|0|||
49164295|NCT02973997|158437257|FG000|Overall Study|Other complicating disease|0|||
49164296|NCT02973997|158437258|FG001|Overall Study|Other complicating disease|1|||
49164297|NCT02973997|158437257|FG000|Overall Study|Death|0|||
49164298|NCT02973997|158437258|FG001|Overall Study|Death|1|||
49164299|NCT03341637|158437261|FG000|Overall Study|Lost to Follow-up|1|||
49164300|NCT03341637|158437262|FG001|Overall Study|Lost to Follow-up|0|||
49164301|NCT03341637|158437261|FG000|Overall Study|Withdrawal by Subject|3|||
49164302|NCT03341637|158437262|FG001|Overall Study|Withdrawal by Subject|3|||
49164303|NCT03341637|158437261|FG000|Overall Study|Reason not Specified|1|||
49164304|NCT03341637|158437262|FG001|Overall Study|Reason not Specified|1|||
49164305|NCT00925002|158437263|FG000|Overall Study|Other|1|||
49164306|NCT00925002|158437264|FG001|Overall Study|Other|4|||
49164307|NCT00925002|158437265|FG002|Overall Study|Other|0|||
49164308|NCT00925002|158437263|FG000|Overall Study|Death|1|||
49164309|NCT00925002|158437264|FG001|Overall Study|Death|1|||
49164310|NCT00925002|158437265|FG002|Overall Study|Death|5|||
49164311|NCT00925002|158437263|FG000|Overall Study|Adverse Event|3|||
49164312|NCT00925002|158437264|FG001|Overall Study|Adverse Event|1|||
49164313|NCT00925002|158437265|FG002|Overall Study|Adverse Event|2|||
49164314|NCT00925002|158437263|FG000|Overall Study|Participant withdrew consent|1|||
49164315|NCT00925002|158437264|FG001|Overall Study|Participant withdrew consent|3|||
49164316|NCT00925002|158437265|FG002|Overall Study|Participant withdrew consent|3|||
49164317|NCT02808897|158437266|FG000|Overall Study|Lost to Follow-up|9|||
49164318|NCT02808897|158437267|FG001|Overall Study|Lost to Follow-up|11|||
49164319|NCT03443687|158437271|FG000|Overall Study|Lost to Follow-up|3|||
49164320|NCT03443687|158437272|FG001|Overall Study|Lost to Follow-up|5|||
49164321|NCT03443687|158437271|FG000|Overall Study|Withdrawal by Subject|1|||
49164322|NCT03443687|158437272|FG001|Overall Study|Withdrawal by Subject|0|||
49164323|NCT03443687|158437271|FG000|Overall Study|Discontinued intervention|1|||
49164324|NCT03443687|158437272|FG001|Overall Study|Discontinued intervention|1|||
49164325|NCT03500211|158437279|FG000|Overall Study|Withdrawal by Subject|1|||
49164326|NCT03500211|158437280|FG001|Overall Study|Withdrawal by Subject|1|||
49164327|NCT02897115|158437281|FG000|Overall Study|Early termination of study by sponsor|11|||
49164328|NCT02897115|158437282|FG001|Overall Study|Early termination of study by sponsor|8|||
49164329|NCT01061385|158437287|FG000|Overall Study|Lost to Follow-up|1|||
49164330|NCT01061385|158437288|FG001|Overall Study|Lost to Follow-up|0|||
49164331|NCT01061385|158437287|FG000|Overall Study|subject decision not related to AE|0|||
49164332|NCT01061385|158437288|FG001|Overall Study|subject decision not related to AE|1|||
49164333|NCT03824392|158437293|FG000|Overall Study|Adverse Event|1|||
49164334|NCT03824392|158437294|FG001|Overall Study|Adverse Event|0|||
49164335|NCT03824392|158437295|FG002|Overall Study|Adverse Event|0|||
49164336|NCT03824392|158437296|FG003|Overall Study|Adverse Event|0|||
49164337|NCT03824392|158437293|FG000|Overall Study|Investigator Decision|0|||
49164338|NCT03824392|158437294|FG001|Overall Study|Investigator Decision|1|||
49164339|NCT03824392|158437295|FG002|Overall Study|Investigator Decision|0|||
49164340|NCT03824392|158437296|FG003|Overall Study|Investigator Decision|0|||
49164341|NCT03824392|158437293|FG000|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|2|||
49164342|NCT03824392|158437294|FG001|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
49164343|NCT03824392|158437295|FG002|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|3|||
49164344|NCT03824392|158437296|FG003|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
49164345|NCT00800982|158437298|FG000|Overall Study|Lost to Follow-up|1|||
49164346|NCT00800982|158437299|FG001|Overall Study|Lost to Follow-up|2|||
49164347|NCT00800982|158437298|FG000|Overall Study|Withdrawal by Subject|0|||
49164348|NCT00800982|158437299|FG001|Overall Study|Withdrawal by Subject|1|||
49164349|NCT00800982|158437298|FG000|Overall Study|Patient moved out of state|1|||
49164350|NCT00800982|158437299|FG001|Overall Study|Patient moved out of state|0|||
49164351|NCT01824290|158437300|FG000|Period 1: Double Blind|Entry Criteria Not Met|1|||
49164352|NCT01824290|158437301|FG001|Period 1: Double Blind|Entry Criteria Not Met|0|||
49164353|NCT01824290|158437302|FG002|Period 1: Double Blind|Entry Criteria Not Met|0|||
49164354|NCT01824290|158437303|FG003|Period 1: Double Blind|Entry Criteria Not Met|0|||
49164355|NCT01824290|158437300|FG000|Period 1: Double Blind|Parent/Caregiver Decision|1|||
49164356|NCT01824290|158437301|FG001|Period 1: Double Blind|Parent/Caregiver Decision|1|||
49164357|NCT01824290|158437302|FG002|Period 1: Double Blind|Parent/Caregiver Decision|0|||
49164358|NCT01824290|158437303|FG003|Period 1: Double Blind|Parent/Caregiver Decision|0|||
49164359|NCT01824290|158437300|FG000|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
49164360|NCT01824290|158437301|FG001|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
49164361|NCT01824290|158437302|FG002|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
49164362|NCT01824290|158437303|FG003|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
49164363|NCT01824290|158437300|FG000|Period 2: Open-Label Treatment|Adverse Event|0|||
49164364|NCT01824290|158437301|FG001|Period 2: Open-Label Treatment|Adverse Event|0|||
49164365|NCT01824290|158437302|FG002|Period 2: Open-Label Treatment|Adverse Event|0|||
49164366|NCT01824290|158437303|FG003|Period 2: Open-Label Treatment|Adverse Event|1|||
49164367|NCT01824290|158437300|FG000|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
48923877|NCT01926782|157555244|FG003|Overall Study|Withdrawal by Subject|1|||
48923878|NCT01926782|157555245|FG004|Overall Study|Withdrawal by Subject|0|||
48923879|NCT01926782|157555246|FG005|Overall Study|Withdrawal by Subject|5|||
48923880|NCT01926782|157555241|FG000|Overall Study|Related to study drug administration|0|||
49164368|NCT01824290|158437301|FG001|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
48923881|NCT01926782|157555242|FG001|Overall Study|Related to study drug administration|0|||
49164369|NCT01824290|158437302|FG002|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
49164370|NCT01824290|158437303|FG003|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
49164371|NCT01824290|158437300|FG000|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
48923882|NCT01926782|157555243|FG002|Overall Study|Related to study drug administration|0|||
49164372|NCT01824290|158437301|FG001|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
49164373|NCT01824290|158437302|FG002|Period 2: Open-Label Treatment|Withdrawal by Subject|2|||
49164374|NCT01824290|158437303|FG003|Period 2: Open-Label Treatment|Withdrawal by Subject|1|||
49164375|NCT04419467|158437308|FG000|Overall Study|Not treated with IP|0|||
49164376|NCT04419467|158437309|FG001|Overall Study|Not treated with IP|0|||
49164377|NCT04419467|158437310|FG002|Overall Study|Not treated with IP|2|||
49164378|NCT04419467|158437308|FG000|Overall Study|Adverse Event|0|||
49164379|NCT04419467|158437309|FG001|Overall Study|Adverse Event|2|||
49164380|NCT04419467|158437310|FG002|Overall Study|Adverse Event|0|||
49164381|NCT04419467|158437308|FG000|Overall Study|Death|1|||
49164382|NCT04419467|158437309|FG001|Overall Study|Death|0|||
49164383|NCT04419467|158437310|FG002|Overall Study|Death|0|||
49164384|NCT04419467|158437308|FG000|Overall Study|Lost to Follow-up|0|||
49164385|NCT04419467|158437309|FG001|Overall Study|Lost to Follow-up|1|||
49164386|NCT04419467|158437310|FG002|Overall Study|Lost to Follow-up|2|||
49164387|NCT04419467|158437308|FG000|Overall Study|Withdrawal by Subject|0|||
49164388|NCT04419467|158437309|FG001|Overall Study|Withdrawal by Subject|0|||
49164389|NCT04419467|158437310|FG002|Overall Study|Withdrawal by Subject|4|||
49164390|NCT04419467|158437308|FG000|Overall Study|Pandemic related|0|||
49164391|NCT04419467|158437309|FG001|Overall Study|Pandemic related|0|||
49164392|NCT04419467|158437310|FG002|Overall Study|Pandemic related|1|||
49164393|NCT04419467|158437308|FG000|Overall Study|Reason not known|1|||
49164394|NCT04419467|158437309|FG001|Overall Study|Reason not known|0|||
49164395|NCT04419467|158437310|FG002|Overall Study|Reason not known|0|||
49164396|NCT03606486|158437320|FG000|Overall Study|Unable to collect sample|5|||
49164397|NCT01544348|158437323|FG000|Overall Study|Lost to Follow-up|1|||
49164398|NCT01544348|158437324|FG001|Overall Study|Lost to Follow-up|0|||
49164399|NCT01544348|158437325|FG002|Overall Study|Lost to Follow-up|0|||
49164400|NCT01544348|158437326|FG003|Overall Study|Lost to Follow-up|0|||
49164401|NCT01544348|158437327|FG004|Overall Study|Lost to Follow-up|0|||
49164402|NCT01544348|158437328|FG005|Overall Study|Lost to Follow-up|0|||
49164403|NCT01544348|158437329|FG006|Overall Study|Lost to Follow-up|1|||
49164404|NCT01544348|158437330|FG007|Overall Study|Lost to Follow-up|0|||
49164405|NCT01544348|158437323|FG000|Overall Study|Withdrawal by Subject|1|||
49164406|NCT01544348|158437324|FG001|Overall Study|Withdrawal by Subject|0|||
49164407|NCT01544348|158437325|FG002|Overall Study|Withdrawal by Subject|0|||
49164408|NCT01544348|158437326|FG003|Overall Study|Withdrawal by Subject|0|||
49164409|NCT01544348|158437327|FG004|Overall Study|Withdrawal by Subject|1|||
49164410|NCT01544348|158437328|FG005|Overall Study|Withdrawal by Subject|2|||
49164411|NCT01544348|158437329|FG006|Overall Study|Withdrawal by Subject|1|||
49164412|NCT01544348|158437330|FG007|Overall Study|Withdrawal by Subject|0|||
49164413|NCT01544348|158437323|FG000|Overall Study|Physician Decision|0|||
49164414|NCT01544348|158437324|FG001|Overall Study|Physician Decision|0|||
49164415|NCT01544348|158437325|FG002|Overall Study|Physician Decision|0|||
49164416|NCT01544348|158437326|FG003|Overall Study|Physician Decision|0|||
49164417|NCT01544348|158437327|FG004|Overall Study|Physician Decision|0|||
49164418|NCT01544348|158437328|FG005|Overall Study|Physician Decision|1|||
49164419|NCT01544348|158437329|FG006|Overall Study|Physician Decision|0|||
49164420|NCT01544348|158437330|FG007|Overall Study|Physician Decision|0|||
49164421|NCT01819272|158438505|FG000|Overall Study|Adverse Event|1|||
49164422|NCT01819272|158438506|FG001|Overall Study|Adverse Event|0|||
49164423|NCT01819272|158438507|FG002|Overall Study|Adverse Event|0|||
49164424|NCT01819272|158438508|FG003|Overall Study|Adverse Event|2|||
49164425|NCT01819272|158438509|FG004|Overall Study|Adverse Event|0|||
49164426|NCT01819272|158438510|FG005|Overall Study|Adverse Event|0|||
49164427|NCT01819272|158438505|FG000|Overall Study|Lost to Follow-up|3|||
49164428|NCT01819272|158438506|FG001|Overall Study|Lost to Follow-up|0|||
49164429|NCT01819272|158438507|FG002|Overall Study|Lost to Follow-up|1|||
49164430|NCT01819272|158438508|FG003|Overall Study|Lost to Follow-up|0|||
49164431|NCT01819272|158438509|FG004|Overall Study|Lost to Follow-up|0|||
49164432|NCT01819272|158438510|FG005|Overall Study|Lost to Follow-up|3|||
49164433|NCT01819272|158438505|FG000|Overall Study|Protocol Violation|0|||
49164434|NCT01819272|158438506|FG001|Overall Study|Protocol Violation|0|||
49164435|NCT01819272|158438507|FG002|Overall Study|Protocol Violation|0|||
49164436|NCT01819272|158438508|FG003|Overall Study|Protocol Violation|1|||
49164437|NCT01819272|158438509|FG004|Overall Study|Protocol Violation|2|||
49164438|NCT01819272|158438510|FG005|Overall Study|Protocol Violation|3|||
49164439|NCT01819272|158438505|FG000|Overall Study|Physician Decision|0|||
49164440|NCT01819272|158438506|FG001|Overall Study|Physician Decision|1|||
49164441|NCT01819272|158438507|FG002|Overall Study|Physician Decision|0|||
49164442|NCT01819272|158438508|FG003|Overall Study|Physician Decision|0|||
49164443|NCT01819272|158438509|FG004|Overall Study|Physician Decision|0|||
49164444|NCT01819272|158438510|FG005|Overall Study|Physician Decision|0|||
49164445|NCT01819272|158438505|FG000|Overall Study|Withdrawal of Consent|0|||
49164446|NCT01819272|158438506|FG001|Overall Study|Withdrawal of Consent|1|||
49164447|NCT01819272|158438507|FG002|Overall Study|Withdrawal of Consent|2|||
49164448|NCT01819272|158438508|FG003|Overall Study|Withdrawal of Consent|1|||
49164449|NCT01819272|158438509|FG004|Overall Study|Withdrawal of Consent|0|||
49164450|NCT01819272|158438510|FG005|Overall Study|Withdrawal of Consent|1|||
49164451|NCT01819272|158438505|FG000|Overall Study|Loss of Glucose Control|2|||
49164452|NCT01819272|158438506|FG001|Overall Study|Loss of Glucose Control|1|||
49164453|NCT01819272|158438507|FG002|Overall Study|Loss of Glucose Control|0|||
49164454|NCT01819272|158438508|FG003|Overall Study|Loss of Glucose Control|1|||
49164455|NCT01819272|158438509|FG004|Overall Study|Loss of Glucose Control|2|||
49164456|NCT01819272|158438510|FG005|Overall Study|Loss of Glucose Control|0|||
49164457|NCT04460183|158438513|FG000|Overall Study|Lost to Follow-up|3|||
49164458|NCT04460183|158438514|FG001|Overall Study|Lost to Follow-up|1|||
49164459|NCT04460183|158438513|FG000|Overall Study|Withdrawal by Subject|1|||
49164460|NCT04460183|158438514|FG001|Overall Study|Withdrawal by Subject|0|||
49164461|NCT02197572|158438515|FG000|Overall Study|Progressive Disease|28|||
49164462|NCT02197572|158438515|FG000|Overall Study|Withdrawal by Subject|9|||
49164463|NCT02197572|158438515|FG000|Overall Study|Adverse Event|3|||
49164464|NCT02197572|158438515|FG000|Overall Study|Reason Not Specified|4|||
49164465|NCT01627691|158438519|FG000|Overall Study|Death|11|||
49164466|NCT01627691|158438519|FG000|Overall Study|Lost to Follow-up|3|||
49164467|NCT01627691|158438519|FG000|Overall Study|Withdrawal by Subject|1|||
49164468|NCT01627691|158438519|FG000|Overall Study|Missed the visit|3|||
49164469|NCT00856323|158438522|FG000|Overall Study|Withdrawal by Subject|2|||
49164470|NCT03848416|158438523|FG000|Overall Study|Withdrawal by Subject|1|||
49164471|NCT03848416|158438524|FG001|Overall Study|Withdrawal by Subject|0|||
49164472|NCT03848416|158438525|FG002|Overall Study|Withdrawal by Subject|0|||
49164473|NCT03848416|158438523|FG000|Overall Study|Death|0|||
49164474|NCT03848416|158438524|FG001|Overall Study|Death|0|||
49164475|NCT03848416|158438525|FG002|Overall Study|Death|1|||
49014834|NCT03507439|157890418|FG000|Overall Study|Other|2|||
49014835|NCT03507439|157890419|FG001|Overall Study|Other|1|||
49014836|NCT03507439|157890418|FG000|Overall Study|Withdrawal by Subject|1|||
49014837|NCT03507439|157890419|FG001|Overall Study|Withdrawal by Subject|0|||
49014838|NCT03507439|157890418|FG000|Overall Study|Death|1|||
49014839|NCT03507439|157890419|FG001|Overall Study|Death|1|||
49014840|NCT00289458|157890420|FG000|Overall Study|Death|1|||
49014841|NCT00289458|157890421|FG001|Overall Study|Death|0|||
49014842|NCT00289458|157890422|FG002|Overall Study|Death|0|||
49014843|NCT00289458|157890420|FG000|Overall Study|Physician Decision|3|||
49014844|NCT00289458|157890421|FG001|Overall Study|Physician Decision|4|||
49014845|NCT00289458|157890422|FG002|Overall Study|Physician Decision|2|||
49014846|NCT00289458|157890420|FG000|Overall Study|Withdrawal by Subject|2|||
49014847|NCT00289458|157890421|FG001|Overall Study|Withdrawal by Subject|2|||
49014848|NCT00289458|157890422|FG002|Overall Study|Withdrawal by Subject|4|||
49014849|NCT01007916|157890423|FG000|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1|||
49014850|NCT01007916|157890424|FG001|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0|||
49014851|NCT01007916|157890423|FG000|Period 2, 4 Weeks of Wear|Relocation|1|||
49014852|NCT01007916|157890424|FG001|Period 2, 4 Weeks of Wear|Relocation|0|||
49014853|NCT04228302|157890425|FG000|Overall Study|Adverse Event|0|||
49014854|NCT04228302|157890426|FG001|Overall Study|Adverse Event|0|||
49014855|NCT04228302|157890427|FG002|Overall Study|Adverse Event|0|||
49014856|NCT04228302|157890428|FG003|Overall Study|Adverse Event|0|||
49014857|NCT04228302|157890429|FG004|Overall Study|Adverse Event|1|||
49014858|NCT04228302|157890430|FG005|Overall Study|Adverse Event|0|||
49014859|NCT01162499|157890442|FG000|Intervention 1 (4 Hours)|Unable to establish IV access|0|||
49014860|NCT01162499|157890443|FG001|Intervention 1 (4 Hours)|Unable to establish IV access|1|||
49014861|NCT01590433|157890444|FG000|Overall Study|Lost to Follow-up|20|||
49014862|NCT01590433|157890445|FG001|Overall Study|Lost to Follow-up|8|||
49014863|NCT01590433|157890444|FG000|Overall Study|Withdrawal by Subject|21|||
49014864|NCT01590433|157890445|FG001|Overall Study|Withdrawal by Subject|11|||
49014865|NCT01590433|157890444|FG000|Overall Study|Adverse Event|11|||
49014866|NCT01590433|157890445|FG001|Overall Study|Adverse Event|3|||
49014867|NCT01907737|157890452|FG000|Overall Study|Withdrawal by Subject|1|||
49014868|NCT00555009|157890457|FG000|Overall Study|Withdrawal by Subject|0|||
49014869|NCT00555009|157890458|FG001|Overall Study|Withdrawal by Subject|1|||
49014870|NCT00555009|157890457|FG000|Overall Study|Terminated by Sponsor|2|||
49014871|NCT00555009|157890458|FG001|Overall Study|Terminated by Sponsor|5|||
49014872|NCT02040428|157890460|FG000|Overall Study|Death|4|||
49014873|NCT02040428|157890461|FG001|Overall Study|Death|3|||
49014874|NCT02040428|157890460|FG000|Overall Study|Withdrawal by Subject|1|||
49014875|NCT02040428|157890461|FG001|Overall Study|Withdrawal by Subject|1|||
49014876|NCT01405820|157890462|FG000|Randomized Treatment Period|Adverse Event|3|||
49164476|NCT01147393|158438528|FG000|Dose Level 1|Dose limiting Toxicity|2|||
49164477|NCT01147393|158438528|FG000|Dose Level -1|Dose Limited Toxicity|1|||
49164478|NCT01428219|158438529|FG000|Overall Study|25 patients enrolled, 3 were not treated|3|||
49164479|NCT02071771|158438530|FG000|Period 1: First 10 Days|Unacceptable lens fit|1|||
49164480|NCT02071771|158438531|FG001|Period 1: First 10 Days|Unacceptable lens fit|0|||
49164481|NCT02071771|158438530|FG000|Period 1: First 10 Days|Unavailable lens power|1|||
49164482|NCT02071771|158438531|FG001|Period 1: First 10 Days|Unavailable lens power|0|||
49164483|NCT00783432|158438532|FG000|Overall Study|Adverse Event|22|||
49164484|NCT00783432|158438533|FG001|Overall Study|Adverse Event|17|||
49164485|NCT00783432|158438532|FG000|Overall Study|Lack of Efficacy|20|||
49164486|NCT00783432|158438533|FG001|Overall Study|Lack of Efficacy|21|||
49164487|NCT00783432|158438532|FG000|Overall Study|Lost to Follow-up|11|||
49164488|NCT00783432|158438533|FG001|Overall Study|Lost to Follow-up|6|||
49164489|NCT00783432|158438532|FG000|Overall Study|Withdrawal by Subject|23|||
49164490|NCT00783432|158438533|FG001|Overall Study|Withdrawal by Subject|20|||
49164491|NCT00783432|158438532|FG000|Overall Study|subject moved|3|||
49164492|NCT00783432|158438533|FG001|Overall Study|subject moved|5|||
49164493|NCT00783432|158438532|FG000|Overall Study|Protocol Violation|6|||
49164494|NCT00783432|158438533|FG001|Overall Study|Protocol Violation|9|||
49164495|NCT02479880|158438534|FG000|Overall Study|Study Terminated by Sponsor|13|||
49164496|NCT02479880|158438535|FG001|Overall Study|Study Terminated by Sponsor|12|||
49164497|NCT02479880|158438534|FG000|Overall Study|Pregnancy|0|||
49164498|NCT02479880|158438535|FG001|Overall Study|Pregnancy|1|||
49164499|NCT00355368|158438538|FG000|Overall Study|Protocol Violation|8|||
49164500|NCT00355368|158438539|FG001|Overall Study|Protocol Violation|7|||
49164501|NCT00355368|158438538|FG000|Overall Study|cardiac arrest prior to intubation|2|||
49164502|NCT00355368|158438539|FG001|Overall Study|cardiac arrest prior to intubation|2|||
49164503|NCT00110214|158438543|FG000|Overall Study|Never started treatment|21|||
49164504|NCT00110214|158438544|FG001|Overall Study|Never started treatment|20|||
49164505|NCT00110214|158438543|FG000|Overall Study|Disease progression or death|260|||
49164506|NCT00110214|158438544|FG001|Overall Study|Disease progression or death|151|||
49164507|NCT00110214|158438543|FG000|Overall Study|Adverse Event|115|||
49164508|NCT00110214|158438544|FG001|Overall Study|Adverse Event|192|||
49164509|NCT00110214|158438543|FG000|Overall Study|Refused further treatment|52|||
49164510|NCT00110214|158438544|FG001|Overall Study|Refused further treatment|65|||
49164511|NCT00110214|158438543|FG000|Overall Study|Other (not specified)|61|||
49164512|NCT00110214|158438544|FG001|Overall Study|Other (not specified)|75|||
49164513|NCT01534481|158438545|FG000|Overall Study|Lost to Follow-up|29|||
49164514|NCT01534481|158438546|FG001|Overall Study|Lost to Follow-up|24|||
49164515|NCT01534481|158438545|FG000|Overall Study|Incomplete Follow-up or No Study Data|6|||
49164516|NCT01534481|158438546|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
49164517|NCT04846231|158438547|FG000|Overall Study|Lost to Follow-up|1|||
49164518|NCT04846231|158438548|FG001|Overall Study|Lost to Follow-up|0|||
49164519|NCT04846231|158438549|FG002|Overall Study|Lost to Follow-up|0|||
49164520|NCT04846231|158438550|FG003|Overall Study|Lost to Follow-up|0|||
49164521|NCT04846231|158438551|FG004|Overall Study|Lost to Follow-up|0|||
49164522|NCT04846231|158438552|FG005|Overall Study|Lost to Follow-up|0|||
49164523|NCT04846231|158438553|FG006|Overall Study|Lost to Follow-up|0|||
49164524|NCT04846231|158438554|FG007|Overall Study|Lost to Follow-up|1|||
49164525|NCT04846231|158438547|FG000|Overall Study|Withdrawal by Subject|0|||
49164526|NCT04846231|158438548|FG001|Overall Study|Withdrawal by Subject|1|||
49164527|NCT04846231|158438549|FG002|Overall Study|Withdrawal by Subject|2|||
49164528|NCT04846231|158438550|FG003|Overall Study|Withdrawal by Subject|1|||
49164529|NCT04846231|158438551|FG004|Overall Study|Withdrawal by Subject|0|||
49164530|NCT04846231|158438552|FG005|Overall Study|Withdrawal by Subject|0|||
49164531|NCT04846231|158438553|FG006|Overall Study|Withdrawal by Subject|0|||
49164532|NCT04846231|158438554|FG007|Overall Study|Withdrawal by Subject|0|||
49164533|NCT04846231|158438547|FG000|Overall Study|Protocol Violation|0|||
49164534|NCT04846231|158438548|FG001|Overall Study|Protocol Violation|1|||
49164535|NCT04846231|158438549|FG002|Overall Study|Protocol Violation|0|||
49164536|NCT04846231|158438550|FG003|Overall Study|Protocol Violation|0|||
49164537|NCT04846231|158438551|FG004|Overall Study|Protocol Violation|0|||
49164538|NCT04846231|158438552|FG005|Overall Study|Protocol Violation|0|||
49164539|NCT04846231|158438553|FG006|Overall Study|Protocol Violation|0|||
49164540|NCT04846231|158438554|FG007|Overall Study|Protocol Violation|0|||
49164541|NCT04846231|158438547|FG000|Overall Study|Adverse Event|0|||
49164542|NCT04846231|158438548|FG001|Overall Study|Adverse Event|0|||
49164543|NCT04846231|158438549|FG002|Overall Study|Adverse Event|0|||
49164544|NCT04846231|158438550|FG003|Overall Study|Adverse Event|0|||
49164545|NCT04846231|158438551|FG004|Overall Study|Adverse Event|0|||
49164546|NCT04846231|158438552|FG005|Overall Study|Adverse Event|0|||
49164547|NCT04846231|158438553|FG006|Overall Study|Adverse Event|1|||
49164548|NCT04846231|158438554|FG007|Overall Study|Adverse Event|1|||
49164549|NCT00503425|158438557|FG000|Overall Study|Participant files lost|6|||
49164550|NCT00503425|158438557|FG000|Overall Study|Adverse Event|5|||
49164551|NCT00503425|158438557|FG000|Overall Study|Lack of Efficacy|25|||
49164552|NCT00503425|158438557|FG000|Overall Study|Withdrawal by Subject|8|||
49164553|NCT00503425|158438557|FG000|Overall Study|Lost to Follow-up|3|||
49164554|NCT00503425|158438557|FG000|Overall Study|Death|3|||
49164555|NCT00503425|158438557|FG000|Overall Study|Missing Data/Unknown|4|||
49164556|NCT01595529|158438558|FG000|Overall Study|Adverse Event|2|||
49164557|NCT01595529|158438559|FG001|Overall Study|Adverse Event|0|||
49164558|NCT01595529|158438558|FG000|Overall Study|Subject Non-Compliant|2|||
49164559|NCT01595529|158438559|FG001|Overall Study|Subject Non-Compliant|0|||
49164560|NCT01595529|158438558|FG000|Overall Study|Lost to Follow-up|8|||
49164561|NCT01595529|158438559|FG001|Overall Study|Lost to Follow-up|14|||
49164562|NCT01595529|158438558|FG000|Overall Study|Protocol Violation|1|||
49164563|NCT01595529|158438559|FG001|Overall Study|Protocol Violation|2|||
49164564|NCT01595529|158438558|FG000|Overall Study|Physician Decision|1|||
49164565|NCT01595529|158438559|FG001|Overall Study|Physician Decision|0|||
49164566|NCT01595529|158438558|FG000|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
49164567|NCT01595529|158438559|FG001|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
49164568|NCT01595529|158438558|FG000|Overall Study|Administrative Decision|1|||
49164569|NCT01595529|158438559|FG001|Overall Study|Administrative Decision|0|||
49164570|NCT01595529|158438558|FG000|Overall Study|Entry Failure/Screening Failure|6|||
49164571|NCT01595529|158438559|FG001|Overall Study|Entry Failure/Screening Failure|1|||
49164572|NCT01822665|158438560|FG000|Overall Study|Adverse Event|3|||
48923883|NCT01926782|157555244|FG003|Overall Study|Related to study drug administration|0|||
49164573|NCT01822665|158438560|FG000|Overall Study|Other Reason|5|||
49164574|NCT00414076|158438561|FG000|Overall Study|Progression|1|||
49164575|NCT00414076|158438562|FG001|Overall Study|Progression|2|||
49164576|NCT00414076|158438561|FG000|Overall Study|Withdrawal by Subject|1|||
49164577|NCT00414076|158438562|FG001|Overall Study|Withdrawal by Subject|3|||
49164578|NCT00414076|158438561|FG000|Overall Study|Adverse Event|1|||
49164579|NCT00414076|158438562|FG001|Overall Study|Adverse Event|0|||
49164580|NCT02030821|158438565|FG000|Overall Study|Physician Decision|2|||
49164581|NCT02030821|158438566|FG001|Overall Study|Physician Decision|2|||
49164582|NCT02030821|158438567|FG002|Overall Study|Physician Decision|5|||
49164583|NCT02030821|158438568|FG003|Overall Study|Physician Decision|2|||
49164584|NCT01816048|158438569|FG000|Overall Study|Adverse Event|1|||
49164585|NCT01816048|158438569|FG000|Overall Study|Death|1|||
49164586|NCT01816048|158438569|FG000|Overall Study|Withdrawal by Subject|1|||
49164587|NCT01816048|158438569|FG000|Overall Study|Disease Progression|3|||
49164588|NCT01171677|158438572|FG000|Overall Study|Withdrawal by Subject|0|||
49164589|NCT01171677|158438573|FG001|Overall Study|Withdrawal by Subject|3|||
49164590|NCT01171677|158438572|FG000|Overall Study|Adverse Event|1|||
49164591|NCT01171677|158438573|FG001|Overall Study|Adverse Event|0|||
49164592|NCT01171677|158438572|FG000|Overall Study|completed <70% IntenSati classes|5|||
49164593|NCT01171677|158438573|FG001|Overall Study|completed <70% IntenSati classes|0|||
49164594|NCT01070979|158438574|FG000|Overall Study|Adverse Event|2|||
49164595|NCT01070979|158438575|FG001|Overall Study|Adverse Event|3|||
49164596|NCT01070979|158438576|FG002|Overall Study|Adverse Event|3|||
49164597|NCT01070979|158438574|FG000|Overall Study|Lost to Follow-up|2|||
49164598|NCT01070979|158438575|FG001|Overall Study|Lost to Follow-up|1|||
49164599|NCT01070979|158438576|FG002|Overall Study|Lost to Follow-up|1|||
49164600|NCT01070979|158438574|FG000|Overall Study|Protocol Violation|0|||
49164601|NCT01070979|158438575|FG001|Overall Study|Protocol Violation|2|||
49164602|NCT01070979|158438576|FG002|Overall Study|Protocol Violation|6|||
49164603|NCT01070979|158438574|FG000|Overall Study|Surgery, moving, personal, abn. labs|4|||
49164604|NCT01070979|158438575|FG001|Overall Study|Surgery, moving, personal, abn. labs|4|||
49164605|NCT01070979|158438576|FG002|Overall Study|Surgery, moving, personal, abn. labs|2|||
49164606|NCT01070979|158438574|FG000|Overall Study|Withdrawal by Subject|3|||
49164607|NCT01070979|158438575|FG001|Overall Study|Withdrawal by Subject|1|||
49164608|NCT01070979|158438576|FG002|Overall Study|Withdrawal by Subject|1|||
49164609|NCT01070979|158438574|FG000|Overall Study|No study drug taken|0|||
49164610|NCT01070979|158438575|FG001|Overall Study|No study drug taken|1|||
49164611|NCT01070979|158438576|FG002|Overall Study|No study drug taken|0|||
49164612|NCT00444925|158438580|FG000|Randomized to Double-blind Treatment|Never returned after randomization|3|||
49164613|NCT00444925|158438581|FG001|Randomized to Double-blind Treatment|Never returned after randomization|6|||
49164614|NCT00444925|158438582|FG002|Randomized to Double-blind Treatment|Never returned after randomization|6|||
49164615|NCT00444925|158438580|FG000|Double-blind Treatment Period|Death|2|||
49164616|NCT00444925|158438581|FG001|Double-blind Treatment Period|Death|0|||
49164617|NCT00444925|158438582|FG002|Double-blind Treatment Period|Death|0|||
49164618|NCT00444925|158438580|FG000|Double-blind Treatment Period|Adverse Event|6|||
49164619|NCT00444925|158438581|FG001|Double-blind Treatment Period|Adverse Event|28|||
49164620|NCT00444925|158438582|FG002|Double-blind Treatment Period|Adverse Event|44|||
49164621|NCT00444925|158438580|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
49164622|NCT00444925|158438581|FG001|Double-blind Treatment Period|Lack of Efficacy|5|||
49164623|NCT00444925|158438582|FG002|Double-blind Treatment Period|Lack of Efficacy|13|||
49164624|NCT00444925|158438580|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
49164625|NCT00444925|158438581|FG001|Double-blind Treatment Period|Lost to Follow-up|8|||
49164626|NCT00444925|158438582|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
49164627|NCT00444925|158438580|FG000|Double-blind Treatment Period|Withdrawal by Subject|6|||
49164628|NCT00444925|158438581|FG001|Double-blind Treatment Period|Withdrawal by Subject|8|||
49164629|NCT00444925|158438582|FG002|Double-blind Treatment Period|Withdrawal by Subject|7|||
49164630|NCT00444925|158438580|FG000|Double-blind Treatment Period|Other|7|||
49164631|NCT00444925|158438581|FG001|Double-blind Treatment Period|Other|7|||
49164632|NCT00444925|158438582|FG002|Double-blind Treatment Period|Other|12|||
49164633|NCT03484429|158438585|FG000|Overall Study|Withdrawal by Subject|1|||
49164634|NCT03484429|158438586|FG001|Overall Study|Withdrawal by Subject|0|||
49164635|NCT03484429|158438585|FG000|Overall Study|Adverse Event|2|||
49164636|NCT03484429|158438586|FG001|Overall Study|Adverse Event|0|||
49164637|NCT01402869|158438591|FG000|Overall Study|Required Tooth Extraction|0|||
49164638|NCT01402869|158438592|FG001|Overall Study|Required Tooth Extraction|0|||
49164639|NCT01402869|158438593|FG002|Overall Study|Required Tooth Extraction|1|||
49164640|NCT01392573|158438596|FG000|Overall Study|Adverse Event|1|||
49164641|NCT01392573|158438597|FG001|Overall Study|Adverse Event|3|||
49164642|NCT01392573|158438596|FG000|Overall Study|Lack of Efficacy|1|||
49164643|NCT01392573|158438597|FG001|Overall Study|Lack of Efficacy|2|||
49164644|NCT01392573|158438596|FG000|Overall Study|Protocol Violation|0|||
49164645|NCT01392573|158438597|FG001|Overall Study|Protocol Violation|2|||
49164646|NCT01392573|158438596|FG000|Overall Study|Withdrawal Criteria|13|||
49164647|NCT01392573|158438597|FG001|Overall Study|Withdrawal Criteria|15|||
49164648|NCT01392573|158438596|FG000|Overall Study|Site closure|8|||
49164649|NCT01392573|158438597|FG001|Overall Study|Site closure|7|||
49164650|NCT01392573|158438596|FG000|Overall Study|Unclassified|9|||
49164651|NCT01392573|158438597|FG001|Overall Study|Unclassified|6|||
49164652|NCT00806260|158438598|FG000|Period 1 (1 Day)|Adverse Event|0|||
49164653|NCT00806260|158438599|FG001|Period 1 (1 Day)|Adverse Event|0|||
49164654|NCT00806260|158438600|FG002|Period 1 (1 Day)|Adverse Event|0|||
49164655|NCT00806260|158438601|FG003|Period 1 (1 Day)|Adverse Event|0|||
49164656|NCT00806260|158438602|FG004|Period 1 (1 Day)|Adverse Event|3|||
49164657|NCT00806260|158438603|FG005|Period 1 (1 Day)|Adverse Event|0|||
49164658|NCT00806260|158438598|FG000|Period 2|Adverse Event|0|||
49164659|NCT00806260|158438599|FG001|Period 2|Adverse Event|0|||
49164660|NCT00806260|158438600|FG002|Period 2|Adverse Event|0|||
49164661|NCT00806260|158438601|FG003|Period 2|Adverse Event|1|||
49164662|NCT00806260|158438602|FG004|Period 2|Adverse Event|0|||
49164663|NCT00806260|158438603|FG005|Period 2|Adverse Event|0|||
49164664|NCT00806260|158438598|FG000|Period 2|Protocol Violation|1|||
49164665|NCT00806260|158438599|FG001|Period 2|Protocol Violation|0|||
49164666|NCT00806260|158438600|FG002|Period 2|Protocol Violation|1|||
49164667|NCT00806260|158438601|FG003|Period 2|Protocol Violation|0|||
49164668|NCT00806260|158438602|FG004|Period 2|Protocol Violation|0|||
49164669|NCT00806260|158438603|FG005|Period 2|Protocol Violation|0|||
49164670|NCT00806260|158438598|FG000|Period 2|Need to take concomitant medication|1|||
49164671|NCT00806260|158438599|FG001|Period 2|Need to take concomitant medication|0|||
49164672|NCT00806260|158438600|FG002|Period 2|Need to take concomitant medication|0|||
49164673|NCT00806260|158438601|FG003|Period 2|Need to take concomitant medication|0|||
49164674|NCT00806260|158438602|FG004|Period 2|Need to take concomitant medication|0|||
49164675|NCT00806260|158438603|FG005|Period 2|Need to take concomitant medication|0|||
49164676|NCT00806260|158438598|FG000|Period 2|sponsor request|0|||
49164677|NCT00806260|158438599|FG001|Period 2|sponsor request|0|||
49164678|NCT00806260|158438600|FG002|Period 2|sponsor request|1|||
49164679|NCT00806260|158438601|FG003|Period 2|sponsor request|1|||
49164680|NCT00806260|158438602|FG004|Period 2|sponsor request|0|||
49164681|NCT00806260|158438603|FG005|Period 2|sponsor request|0|||
49164682|NCT00806260|158438598|FG000|Period 3|Protocol Violation|0|||
49164683|NCT00806260|158438599|FG001|Period 3|Protocol Violation|1|||
49164684|NCT00806260|158438600|FG002|Period 3|Protocol Violation|1|||
49164685|NCT00806260|158438601|FG003|Period 3|Protocol Violation|0|||
49164686|NCT00806260|158438602|FG004|Period 3|Protocol Violation|0|||
49164687|NCT00806260|158438603|FG005|Period 3|Protocol Violation|0|||
49164688|NCT00806260|158438598|FG000|Period 3|Pregnancy|1|||
49164689|NCT00806260|158438599|FG001|Period 3|Pregnancy|0|||
49164690|NCT00806260|158438600|FG002|Period 3|Pregnancy|0|||
49164691|NCT00806260|158438601|FG003|Period 3|Pregnancy|0|||
49164692|NCT00806260|158438602|FG004|Period 3|Pregnancy|0|||
49164693|NCT00806260|158438603|FG005|Period 3|Pregnancy|0|||
49164694|NCT00100802|158438605|FG000|Overall Study|Adverse Event|9|||
49164695|NCT00100802|158438605|FG000|Overall Study|Death|1|||
49164696|NCT00100802|158438605|FG000|Overall Study|Lack of Efficacy|47|||
49164697|NCT00100802|158438605|FG000|Overall Study|Physician Decision|5|||
49164698|NCT00100802|158438605|FG000|Overall Study|Protocol Violation|1|||
49164699|NCT00100802|158438605|FG000|Overall Study|Withdrawal by Subject|5|||
49164700|NCT00100802|158438605|FG000|Overall Study|Ineligible|12|||
49164701|NCT01451749|158438606|FG000|Overall Study|Protocol Violation|14|||
49164702|NCT01451749|158438607|FG001|Overall Study|Protocol Violation|7|||
49164703|NCT01451749|158438606|FG000|Overall Study|Lost to Follow-up|15|||
49164704|NCT01451749|158438607|FG001|Overall Study|Lost to Follow-up|5|||
49164705|NCT01451749|158438606|FG000|Overall Study|Meet the exclusion criteria,and|1|||
49164706|NCT01451749|158438607|FG001|Overall Study|Meet the exclusion criteria,and|1|||
49164707|NCT01451749|158438606|FG000|Overall Study|Adverse Event|2|||
49164708|NCT01451749|158438607|FG001|Overall Study|Adverse Event|0|||
49164709|NCT01451749|158438606|FG000|Overall Study|Withdrawal by Subject|0|||
49164710|NCT01451749|158438607|FG001|Overall Study|Withdrawal by Subject|1|||
49164711|NCT01837680|158438611|FG000|Overall Study|Lost to Follow-up|2|||
49164712|NCT01837680|158438612|FG001|Overall Study|Lost to Follow-up|2|||
49164713|NCT01837680|158438611|FG000|Overall Study|lack of insurance|0|||
49164714|NCT01837680|158438612|FG001|Overall Study|lack of insurance|2|||
49164715|NCT01837680|158438611|FG000|Overall Study|allergic reaction|6|||
49164716|NCT01837680|158438612|FG001|Overall Study|allergic reaction|0|||
49164717|NCT01837680|158438611|FG000|Overall Study|switched to oral hypoglycemic or diet|2|||
49164718|NCT01837680|158438612|FG001|Overall Study|switched to oral hypoglycemic or diet|4|||
49164719|NCT03110029|158438620|FG000|Overall Study|Withdrawal by Subject|1|||
49164720|NCT03110029|158438621|FG001|Overall Study|Withdrawal by Subject|1|||
49164721|NCT03154476|158438622|FG000|Overall Study|Lost to Follow-up|4|||
49164722|NCT03154476|158438623|FG001|Overall Study|Lost to Follow-up|4|||
49164723|NCT02685826|158438624|FG000|Overall Study|Adverse Event|2|||
49164724|NCT02685826|158438625|FG001|Overall Study|Adverse Event|0|||
49164725|NCT02685826|158438626|FG002|Overall Study|Adverse Event|1|||
49164726|NCT02685826|158438624|FG000|Overall Study|Progressive Disease|2|||
49164727|NCT02685826|158438625|FG001|Overall Study|Progressive Disease|1|||
49164728|NCT02685826|158438626|FG002|Overall Study|Progressive Disease|0|||
49164729|NCT02685826|158438624|FG000|Overall Study|Withdrawal by Subject|2|||
49164730|NCT02685826|158438625|FG001|Overall Study|Withdrawal by Subject|0|||
49164731|NCT02685826|158438626|FG002|Overall Study|Withdrawal by Subject|0|||
49164732|NCT02685826|158438624|FG000|Overall Study|Full Clinical Hold by FDA|19|||
49164733|NCT02685826|158438625|FG001|Overall Study|Full Clinical Hold by FDA|9|||
49164734|NCT02685826|158438626|FG002|Overall Study|Full Clinical Hold by FDA|20|||
49164735|NCT00670930|158438627|FG000|Overall Study|Adminstrative Problem|0|||
49164736|NCT00670930|158438628|FG001|Overall Study|Adminstrative Problem|1|||
49164737|NCT00670930|158438627|FG000|Overall Study|Lost to Follow-up|1|||
49164738|NCT00670930|158438628|FG001|Overall Study|Lost to Follow-up|0|||
49164739|NCT00200967|158438629|FG000|First Treatment Period|Withdrawal by Subject|5|||
49164740|NCT00200967|158438630|FG001|First Treatment Period|Withdrawal by Subject|1|||
49164741|NCT00200967|158438629|FG000|First Treatment Period|Pregnancy|1|||
49164742|NCT00200967|158438630|FG001|First Treatment Period|Pregnancy|0|||
49164743|NCT00200967|158438629|FG000|Wash-out Period|Lost to Follow-up|0|||
49164744|NCT00200967|158438630|FG001|Wash-out Period|Lost to Follow-up|1|||
49164745|NCT00200967|158438629|FG000|Second Treatment Period|Withdrawal by Subject|1|||
49164746|NCT00200967|158438630|FG001|Second Treatment Period|Withdrawal by Subject|2|||
49164747|NCT00200967|158438629|FG000|Run-out Period|Lost to Follow-up|1|||
49164748|NCT00200967|158438630|FG001|Run-out Period|Lost to Follow-up|0|||
49164749|NCT01444430|158438631|FG000|Overall Study|Withdrawal by Subject|53|||
49164750|NCT01444430|158438632|FG001|Overall Study|Withdrawal by Subject|72|||
49164751|NCT01444430|158438631|FG000|Overall Study|Death|6|||
49164752|NCT01444430|158438632|FG001|Overall Study|Death|8|||
49164753|NCT01444430|158438631|FG000|Overall Study|Lost to Follow-up|2|||
49164754|NCT01444430|158438632|FG001|Overall Study|Lost to Follow-up|0|||
49164755|NCT01444430|158438631|FG000|Overall Study|CRF termination module not completed.|0|||
49164756|NCT01444430|158438632|FG001|Overall Study|CRF termination module not completed.|1|||
49164757|NCT01732536|158440073|FG000|Overall Study|Withdrawal by Subject|1|||
49164758|NCT01732536|158440074|FG001|Overall Study|Withdrawal by Subject|1|||
49164759|NCT02808429|158440075|FG000|Overall Study|Lost to Follow-up|1|||
49164760|NCT02808429|158440076|FG001|Overall Study|Lost to Follow-up|0|||
49164761|NCT02808429|158440077|FG002|Overall Study|Lost to Follow-up|0|||
49164762|NCT02808429|158440075|FG000|Overall Study|Protocol Violation|0|||
49164763|NCT02808429|158440076|FG001|Overall Study|Protocol Violation|1|||
49164764|NCT02808429|158440077|FG002|Overall Study|Protocol Violation|0|||
49164765|NCT02808429|158440075|FG000|Overall Study|Premature study termination by sponsor|2|||
49164766|NCT02808429|158440076|FG001|Overall Study|Premature study termination by sponsor|0|||
49164767|NCT02808429|158440077|FG002|Overall Study|Premature study termination by sponsor|1|||
49164768|NCT02808429|158440075|FG000|Overall Study|Relocation|0|||
48923884|NCT01926782|157555245|FG004|Overall Study|Related to study drug administration|0|||
48923885|NCT01926782|157555246|FG005|Overall Study|Related to study drug administration|2|||
49164769|NCT02808429|158440076|FG001|Overall Study|Relocation|0|||
48923886|NCT04029519|157555252|FG000|Overall Study|Protocol Violation|1|||
49164770|NCT02808429|158440077|FG002|Overall Study|Relocation|1|||
49164771|NCT00473889|158440085|FG000|Overall Study|Did not receive study medication|1|||
49164772|NCT00473889|158440086|FG001|Overall Study|Did not receive study medication|4|||
49164773|NCT00473889|158440085|FG000|Overall Study|Adverse Event|30|||
49164774|NCT00473889|158440086|FG001|Overall Study|Adverse Event|17|||
49164775|NCT00473889|158440085|FG000|Overall Study|Protocol Violation|4|||
49164776|NCT00473889|158440086|FG001|Overall Study|Protocol Violation|2|||
49164777|NCT00473889|158440085|FG000|Overall Study|Lack of Efficacy|28|||
49164778|NCT00473889|158440086|FG001|Overall Study|Lack of Efficacy|29|||
49164779|NCT00473889|158440085|FG000|Overall Study|Lost to Follow-up|2|||
49164780|NCT00473889|158440086|FG001|Overall Study|Lost to Follow-up|1|||
48923887|NCT04029519|157555252|FG000|Overall Study|Withdrawal by Subject|3|||
48923888|NCT04029519|157555252|FG000|Overall Study|Lost to Follow-up|1|||
48923889|NCT02064387|157555253|FG000|Part 1 Max 23.5 Months Followup Duration|Death|0|||
48923890|NCT02064387|157555254|FG001|Part 1 Max 23.5 Months Followup Duration|Death|0|||
49164781|NCT00473889|158440085|FG000|Overall Study|Physician Decision|10|||
49164782|NCT00473889|158440086|FG001|Overall Study|Physician Decision|5|||
49164783|NCT00473889|158440085|FG000|Overall Study|Trial Terminated|3|||
49164784|NCT00473889|158440086|FG001|Overall Study|Trial Terminated|6|||
49164785|NCT00473889|158440085|FG000|Overall Study|Withdrawal by Subject|5|||
49164786|NCT00473889|158440086|FG001|Overall Study|Withdrawal by Subject|0|||
49164787|NCT00811954|158440087|FG000|Overall Study|Death|10|||
49164788|NCT00811954|158440088|FG001|Overall Study|Death|6|||
49164789|NCT00811954|158440089|FG002|Overall Study|Death|13|||
49164790|NCT00811954|158440087|FG000|Overall Study|Lost to Follow-up|29|||
49164791|NCT00811954|158440088|FG001|Overall Study|Lost to Follow-up|23|||
49164792|NCT00811954|158440089|FG002|Overall Study|Lost to Follow-up|34|||
49164793|NCT00811954|158440087|FG000|Overall Study|Not able to get to clinic|28|||
49164794|NCT00811954|158440088|FG001|Overall Study|Not able to get to clinic|35|||
49164795|NCT00811954|158440089|FG002|Overall Study|Not able to get to clinic|30|||
49164796|NCT00811954|158440087|FG000|Overall Study|Not willing to adhere to requirements|12|||
49164797|NCT00811954|158440088|FG001|Overall Study|Not willing to adhere to requirements|2|||
49164798|NCT00811954|158440089|FG002|Overall Study|Not willing to adhere to requirements|16|||
49164799|NCT00811954|158440087|FG000|Overall Study|Withdraw consent prior study completion|4|||
49164800|NCT00811954|158440088|FG001|Overall Study|Withdraw consent prior study completion|6|||
49164801|NCT00811954|158440089|FG002|Overall Study|Withdraw consent prior study completion|5|||
49164802|NCT00811954|158440087|FG000|Overall Study|Site Closure|4|||
49164803|NCT00811954|158440088|FG001|Overall Study|Site Closure|0|||
49164804|NCT00811954|158440089|FG002|Overall Study|Site Closure|1|||
49164805|NCT00811954|158440087|FG000|Overall Study|Severe Debilitation|2|||
49164806|NCT00811954|158440088|FG001|Overall Study|Severe Debilitation|0|||
49164807|NCT00811954|158440089|FG002|Overall Study|Severe Debilitation|1|||
49164808|NCT00811954|158440087|FG000|Overall Study|Complete Protocol: No follow-up|0|||
49164809|NCT00811954|158440088|FG001|Overall Study|Complete Protocol: No follow-up|0|||
49164810|NCT00811954|158440089|FG002|Overall Study|Complete Protocol: No follow-up|1|||
49164811|NCT03389308|158440097|FG000|Overall Study|Withdrawal by Subject|5|||
49164812|NCT03389308|158440097|FG000|Overall Study|Lost to Follow-up|3|||
49164813|NCT03389308|158440097|FG000|Overall Study|Adverse Event|2|||
49164814|NCT03389308|158440097|FG000|Overall Study|Sponsor Request|2|||
49164815|NCT02504372|158440099|FG000|Overall Study|Death|136|||
49164816|NCT02504372|158440100|FG001|Overall Study|Death|154|||
49164817|NCT02504372|158440099|FG000|Overall Study|Lost to Follow-up|0|||
49164818|NCT02504372|158440100|FG001|Overall Study|Lost to Follow-up|2|||
49164819|NCT02504372|158440099|FG000|Overall Study|Withdrawal of consent|25|||
49164820|NCT02504372|158440100|FG001|Overall Study|Withdrawal of consent|16|||
49164821|NCT02504372|158440099|FG000|Overall Study|Participants ongoing|429|||
49164822|NCT02504372|158440100|FG001|Overall Study|Participants ongoing|415|||
49164823|NCT01459666|158440102|FG000|Overall Study|PI left institution|5|||
49164824|NCT01459666|158440103|FG001|Overall Study|PI left institution|4|||
49164825|NCT00533429|158440104|FG000|Overall Study|Adverse Event|3|||
49164826|NCT00533429|158440105|FG001|Overall Study|Adverse Event|1|||
49164827|NCT00533429|158440104|FG000|Overall Study|Death|1|||
49164828|NCT00533429|158440105|FG001|Overall Study|Death|0|||
49164829|NCT00533429|158440104|FG000|Overall Study|Withdrawal by Subject|2|||
49164830|NCT00533429|158440105|FG001|Overall Study|Withdrawal by Subject|0|||
49164831|NCT00533429|158440104|FG000|Overall Study|Progressive Disease|12|||
49164832|NCT00533429|158440105|FG001|Overall Study|Progressive Disease|13|||
49164833|NCT00533429|158440104|FG000|Overall Study|Symptomatic deterioration|1|||
49164834|NCT00533429|158440105|FG001|Overall Study|Symptomatic deterioration|2|||
49164835|NCT04834726|158440112|FG000|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|82|||
49164836|NCT04834726|158440113|FG001|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|422|||
49164837|NCT04834726|158440114|FG002|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|404|||
49164838|NCT04834726|158440115|FG003|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|415|||
49164839|NCT04834726|158440116|FG004|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|428|||
49164840|NCT04834726|158440117|FG005|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|462|||
49164841|NCT04834726|158440118|FG006|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|447|||
49164842|NCT04834726|158440119|FG007|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|449|||
49164843|NCT04834726|158440120|FG008|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|400|||
49164844|NCT00889707|158440124|FG000|Overall Study|Adverse Event|1|||
49164845|NCT00889707|158440125|FG001|Overall Study|Adverse Event|0|||
49164846|NCT00889707|158440124|FG000|Overall Study|Withdrawal by Subject|4|||
49164847|NCT00889707|158440125|FG001|Overall Study|Withdrawal by Subject|3|||
49164848|NCT00889707|158440124|FG000|Overall Study|Lost to Follow-up|0|||
49164849|NCT00889707|158440125|FG001|Overall Study|Lost to Follow-up|2|||
49164850|NCT00889707|158440124|FG000|Overall Study|Lack of Efficacy|2|||
49164851|NCT00889707|158440125|FG001|Overall Study|Lack of Efficacy|5|||
49164852|NCT00600067|158440133|FG000|Overall Study|Adverse Event|0|||
49164853|NCT00600067|158440134|FG001|Overall Study|Adverse Event|1|||
49164854|NCT00600067|158440133|FG000|Overall Study|Lost to Follow-up|2|||
49164855|NCT00600067|158440134|FG001|Overall Study|Lost to Follow-up|3|||
49164856|NCT00600067|158440133|FG000|Overall Study|protocol non-compliance|0|||
49164857|NCT00600067|158440134|FG001|Overall Study|protocol non-compliance|3|||
49164858|NCT00600067|158440133|FG000|Overall Study|Lack of Efficacy|1|||
49164859|NCT00600067|158440134|FG001|Overall Study|Lack of Efficacy|0|||
49164860|NCT00469833|158440142|FG000|Overall Study|No IV access|2|||
49164861|NCT00295646|158440145|FG000|Overall Study|Protocol Violation|18|||
49164862|NCT00295646|158440146|FG001|Overall Study|Protocol Violation|20|||
49164863|NCT00295646|158440147|FG002|Overall Study|Protocol Violation|20|||
49164864|NCT00295646|158440148|FG003|Overall Study|Protocol Violation|18|||
49164865|NCT00295646|158440145|FG000|Overall Study|Withdrawal by Subject|8|||
49164866|NCT00295646|158440146|FG001|Overall Study|Withdrawal by Subject|9|||
49164867|NCT00295646|158440147|FG002|Overall Study|Withdrawal by Subject|11|||
49164868|NCT00295646|158440148|FG003|Overall Study|Withdrawal by Subject|14|||
49164869|NCT00295646|158440145|FG000|Overall Study|Lost to Follow-up|0|||
49164870|NCT00295646|158440146|FG001|Overall Study|Lost to Follow-up|5|||
49164871|NCT00295646|158440147|FG002|Overall Study|Lost to Follow-up|1|||
49164872|NCT00295646|158440148|FG003|Overall Study|Lost to Follow-up|5|||
49164873|NCT00295646|158440145|FG000|Overall Study|Death|9|||
49164874|NCT00295646|158440146|FG001|Overall Study|Death|7|||
49164875|NCT00295646|158440147|FG002|Overall Study|Death|18|||
49164876|NCT00295646|158440148|FG003|Overall Study|Death|8|||
49164877|NCT01603043|158440149|FG000|Overall Study|Study Futility|7|||
49164878|NCT01603043|158440150|FG001|Overall Study|Study Futility|3|||
49164879|NCT01284959|158440151|FG000|Overall Study|Withdrawal by Subject|1|||
49164880|NCT01284959|158440152|FG001|Overall Study|Withdrawal by Subject|0|||
49164881|NCT01284959|158440153|FG002|Overall Study|Withdrawal by Subject|0|||
49164882|NCT01284959|158440151|FG000|Overall Study|Adverse Event|0|||
49164883|NCT01284959|158440152|FG001|Overall Study|Adverse Event|0|||
49164884|NCT01284959|158440153|FG002|Overall Study|Adverse Event|1|||
49164885|NCT04179305|158440156|FG000|Overall Study|Death|1|||
49164886|NCT04179305|158440157|FG001|Overall Study|Death|1|||
49164887|NCT04179305|158440158|FG002|Overall Study|Death|0|||
49164888|NCT04179305|158440159|FG003|Overall Study|Death|0|||
49164889|NCT04179305|158440156|FG000|Overall Study|Lost to Follow-up|1|||
49164890|NCT04179305|158440157|FG001|Overall Study|Lost to Follow-up|1|||
49164891|NCT04179305|158440158|FG002|Overall Study|Lost to Follow-up|0|||
49164892|NCT04179305|158440159|FG003|Overall Study|Lost to Follow-up|0|||
49164893|NCT04179305|158440156|FG000|Overall Study|Withdrawal by Subject|0|||
49164894|NCT04179305|158440157|FG001|Overall Study|Withdrawal by Subject|1|||
49164895|NCT04179305|158440158|FG002|Overall Study|Withdrawal by Subject|0|||
49164896|NCT04179305|158440159|FG003|Overall Study|Withdrawal by Subject|0|||
49164897|NCT04179305|158440156|FG000|Overall Study|Did not have scan|1|||
49164898|NCT04179305|158440157|FG001|Overall Study|Did not have scan|0|||
49164899|NCT04179305|158440158|FG002|Overall Study|Did not have scan|0|||
49164900|NCT04179305|158440159|FG003|Overall Study|Did not have scan|0|||
49164901|NCT04179305|158440156|FG000|Overall Study|In hospice care|3|||
49164902|NCT04179305|158440157|FG001|Overall Study|In hospice care|0|||
49164903|NCT04179305|158440158|FG002|Overall Study|In hospice care|0|||
49164904|NCT04179305|158440159|FG003|Overall Study|In hospice care|0|||
49164905|NCT00401843|158440161|FG000|Overall Study|Achieved Complete Response|1|||
49164906|NCT00401843|158440162|FG001|Overall Study|Achieved Complete Response|5|||
49164907|NCT00401843|158440163|FG002|Overall Study|Achieved Complete Response|11|||
49164908|NCT00401843|158440161|FG000|Overall Study|Adverse Event|7|||
49164909|NCT00401843|158440162|FG001|Overall Study|Adverse Event|26|||
49164910|NCT00401843|158440163|FG002|Overall Study|Adverse Event|27|||
49164911|NCT00401843|158440161|FG000|Overall Study|Death|0|||
49164912|NCT00401843|158440162|FG001|Overall Study|Death|8|||
49164913|NCT00401843|158440163|FG002|Overall Study|Death|10|||
49164914|NCT00401843|158440161|FG000|Overall Study|Disease progression|10|||
49164915|NCT00401843|158440162|FG001|Overall Study|Disease progression|60|||
49164916|NCT00401843|158440163|FG002|Overall Study|Disease progression|49|||
49164917|NCT00401843|158440161|FG000|Overall Study|End of Study|1|||
49164918|NCT00401843|158440162|FG001|Overall Study|End of Study|1|||
49164919|NCT00401843|158440163|FG002|Overall Study|End of Study|2|||
49164920|NCT00401843|158440161|FG000|Overall Study|Lost to Follow-up|0|||
49164921|NCT00401843|158440162|FG001|Overall Study|Lost to Follow-up|0|||
49164922|NCT00401843|158440163|FG002|Overall Study|Lost to Follow-up|2|||
49164923|NCT00401843|158440161|FG000|Overall Study|Other Unspecified|0|||
49164924|NCT00401843|158440162|FG001|Overall Study|Other Unspecified|3|||
49164925|NCT00401843|158440163|FG002|Overall Study|Other Unspecified|5|||
49164926|NCT00401843|158440161|FG000|Overall Study|Physician Decision|0|||
49164927|NCT00401843|158440162|FG001|Overall Study|Physician Decision|16|||
49164928|NCT00401843|158440163|FG002|Overall Study|Physician Decision|10|||
49164929|NCT00401843|158440161|FG000|Overall Study|Protocol Violation|0|||
49164930|NCT00401843|158440162|FG001|Overall Study|Protocol Violation|0|||
49164931|NCT00401843|158440163|FG002|Overall Study|Protocol Violation|1|||
49164932|NCT00401843|158440161|FG000|Overall Study|Withdrawal by Subject|1|||
49164933|NCT00401843|158440162|FG001|Overall Study|Withdrawal by Subject|5|||
49164934|NCT00401843|158440163|FG002|Overall Study|Withdrawal by Subject|5|||
49164935|NCT00401843|158440161|FG000|Overall Study|Withdrawal of consent to study agent|1|||
49164936|NCT00401843|158440162|FG001|Overall Study|Withdrawal of consent to study agent|15|||
49164937|NCT00401843|158440163|FG002|Overall Study|Withdrawal of consent to study agent|17|||
49164938|NCT00401843|158440161|FG000|Overall Study|Randomized but not Treated|0|||
49164939|NCT00401843|158440162|FG001|Overall Study|Randomized but not Treated|2|||
49164940|NCT00401843|158440163|FG002|Overall Study|Randomized but not Treated|3|||
49164941|NCT00401843|158440161|FG000|Overall Study|Received incorrect treatment|0|||
49164942|NCT00401843|158440162|FG001|Overall Study|Received incorrect treatment|3|||
49164943|NCT00401843|158440163|FG002|Overall Study|Received incorrect treatment|0|||
49164944|NCT00003869|158440166|FG000|Overall Study|Adverse Event|14|||
49164945|NCT00003869|158440167|FG001|Overall Study|Adverse Event|3|||
49164946|NCT00003869|158440166|FG000|Overall Study|Withdrawal by Subject|21|||
49164947|NCT00003869|158440167|FG001|Overall Study|Withdrawal by Subject|3|||
49164948|NCT00003869|158440166|FG000|Overall Study|Death|1|||
49164949|NCT00003869|158440167|FG001|Overall Study|Death|2|||
49164950|NCT00003869|158440166|FG000|Overall Study|Alternative treatmnt, medical problems|5|||
49164951|NCT00003869|158440167|FG001|Overall Study|Alternative treatmnt, medical problems|4|||
49164952|NCT03364231|158440168|FG000|Overall Study|Adverse Event|1|||
49164953|NCT03364231|158440169|FG001|Overall Study|Adverse Event|4|||
49164954|NCT03364231|158440168|FG000|Overall Study|Death|1|||
49164955|NCT03364231|158440169|FG001|Overall Study|Death|0|||
49164956|NCT03364231|158440168|FG000|Overall Study|Investigator Decision|2|||
49164957|NCT03364231|158440169|FG001|Overall Study|Investigator Decision|2|||
49164958|NCT03364231|158440168|FG000|Overall Study|Sponsor Discontinuation of the Study|2|||
49164959|NCT03364231|158440169|FG001|Overall Study|Sponsor Discontinuation of the Study|1|||
49164960|NCT03364231|158440168|FG000|Overall Study|Withdrawal of Subject Consent|1|||
49164961|NCT03364231|158440169|FG001|Overall Study|Withdrawal of Subject Consent|0|||
49164962|NCT03364231|158440168|FG000|Overall Study|Reason Not Specified|1|||
49164963|NCT03364231|158440169|FG001|Overall Study|Reason Not Specified|0|||
49164964|NCT03364231|158440168|FG000|Overall Study|Disease Progression|0|||
49164965|NCT03364231|158440169|FG001|Overall Study|Disease Progression|6|||
49164966|NCT03386435|158440170|FG000|Overall Study|Protocol Violation|5|||
49164967|NCT03386435|158440171|FG001|Overall Study|Protocol Violation|7|||
49164968|NCT00506454|158440181|FG000|Overall Study|Withdrawal by Subject|1|||
49164969|NCT00506454|158440182|FG001|Overall Study|Withdrawal by Subject|1|||
49164970|NCT03666988|158440183|FG000|Part 1 (Up to 28 Months)|Adverse Event|0|||
49164971|NCT03666988|158440184|FG001|Part 1 (Up to 28 Months)|Adverse Event|1|||
49014877|NCT01405820|157890463|FG001|Randomized Treatment Period|Adverse Event|3|||
48923891|NCT02064387|157555255|FG002|Part 1 Max 23.5 Months Followup Duration|Death|0|||
48923892|NCT02064387|157555256|FG003|Part 1 Max 23.5 Months Followup Duration|Death|0|||
48923893|NCT02064387|157555257|FG004|Part 1 Max 23.5 Months Followup Duration|Death|0|||
48923894|NCT02064387|157555258|FG005|Part 1 Max 23.5 Months Followup Duration|Death|0|||
48923895|NCT02064387|157555259|FG006|Part 1 Max 23.5 Months Followup Duration|Death|0|||
48923896|NCT02064387|157555260|FG007|Part 1 Max 23.5 Months Followup Duration|Death|1|||
48923897|NCT02064387|157555261|FG008|Part 1 Max 23.5 Months Followup Duration|Death|0|||
48923898|NCT02064387|157555262|FG009|Part 1 Max 23.5 Months Followup Duration|Death|1|||
48923899|NCT02064387|157555263|FG010|Part 1 Max 23.5 Months Followup Duration|Death|0|||
48923900|NCT02064387|157555264|FG011|Part 1 Max 23.5 Months Followup Duration|Death|0|||
48923901|NCT02064387|157555253|FG000|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
48923902|NCT02064387|157555254|FG001|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
48923903|NCT02064387|157555255|FG002|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
48923904|NCT02064387|157555256|FG003|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
48923905|NCT02064387|157555257|FG004|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
48923906|NCT02064387|157555258|FG005|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
48923907|NCT02064387|157555259|FG006|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
48923908|NCT02064387|157555260|FG007|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1|||
48923909|NCT02064387|157555261|FG008|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
48923910|NCT02064387|157555262|FG009|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
48923911|NCT02064387|157555263|FG010|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
48923912|NCT02064387|157555264|FG011|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
48923913|NCT02064387|157555253|FG000|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
48923914|NCT02064387|157555254|FG001|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
48923915|NCT02064387|157555255|FG002|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
48923916|NCT02064387|157555256|FG003|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
48923917|NCT02064387|157555257|FG004|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
48923918|NCT02064387|157555258|FG005|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
48923919|NCT02064387|157555259|FG006|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
48923920|NCT02064387|157555260|FG007|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
48923921|NCT02064387|157555261|FG008|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1|||
48923922|NCT02064387|157555262|FG009|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
48923923|NCT02064387|157555263|FG010|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
48923924|NCT02064387|157555264|FG011|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
48923925|NCT02064387|157555253|FG000|Part 2 Max 35 Months Followup Duration|Death|0|||
48923926|NCT02064387|157555254|FG001|Part 2 Max 35 Months Followup Duration|Death|0|||
48923927|NCT02064387|157555255|FG002|Part 2 Max 35 Months Followup Duration|Death|0|||
48923928|NCT02064387|157555256|FG003|Part 2 Max 35 Months Followup Duration|Death|0|||
48923929|NCT02064387|157555257|FG004|Part 2 Max 35 Months Followup Duration|Death|0|||
48923930|NCT02064387|157555258|FG005|Part 2 Max 35 Months Followup Duration|Death|0|||
48923931|NCT02064387|157555259|FG006|Part 2 Max 35 Months Followup Duration|Death|0|||
48923932|NCT02064387|157555260|FG007|Part 2 Max 35 Months Followup Duration|Death|0|||
48923933|NCT02064387|157555261|FG008|Part 2 Max 35 Months Followup Duration|Death|0|||
48923934|NCT02064387|157555262|FG009|Part 2 Max 35 Months Followup Duration|Death|0|||
48923935|NCT02064387|157555263|FG010|Part 2 Max 35 Months Followup Duration|Death|5|||
48923936|NCT02064387|157555264|FG011|Part 2 Max 35 Months Followup Duration|Death|3|||
48923937|NCT02064387|157555253|FG000|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
48923938|NCT02064387|157555254|FG001|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
48923939|NCT02064387|157555255|FG002|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
48923940|NCT02064387|157555256|FG003|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
48923941|NCT02064387|157555257|FG004|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
48923942|NCT02064387|157555258|FG005|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
48923943|NCT02064387|157555259|FG006|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
48923944|NCT02064387|157555260|FG007|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
48923945|NCT02064387|157555261|FG008|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
48923946|NCT02064387|157555262|FG009|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
48923947|NCT02064387|157555263|FG010|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1|||
48923948|NCT02064387|157555264|FG011|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
48923949|NCT00749996|157555265|FG000|Overall Study|Lost to Follow-up|7|||
48923950|NCT00749996|157555266|FG001|Overall Study|Lost to Follow-up|4|||
48923951|NCT00749996|157555265|FG000|Overall Study|Withdrawal by Subject|5|||
48923952|NCT00749996|157555266|FG001|Overall Study|Withdrawal by Subject|4|||
48923953|NCT00749996|157555265|FG000|Overall Study|Protocol Violation|2|||
48923954|NCT00749996|157555266|FG001|Overall Study|Protocol Violation|3|||
48923955|NCT00749996|157555265|FG000|Overall Study|Physician Decision|2|||
48923956|NCT00749996|157555266|FG001|Overall Study|Physician Decision|0|||
49164972|NCT03666988|158440185|FG002|Part 1 (Up to 28 Months)|Adverse Event|3|||
49164973|NCT03666988|158440186|FG003|Part 1 (Up to 28 Months)|Adverse Event|0|||
49164974|NCT03666988|158440187|FG004|Part 1 (Up to 28 Months)|Adverse Event|0|||
49164975|NCT03666988|158440188|FG005|Part 1 (Up to 28 Months)|Adverse Event|0|||
49164976|NCT03666988|158440183|FG000|Part 1 (Up to 28 Months)|Other|0|||
49164977|NCT03666988|158440184|FG001|Part 1 (Up to 28 Months)|Other|1|||
49164978|NCT03666988|158440185|FG002|Part 1 (Up to 28 Months)|Other|1|||
49164979|NCT03666988|158440186|FG003|Part 1 (Up to 28 Months)|Other|0|||
49164980|NCT03666988|158440187|FG004|Part 1 (Up to 28 Months)|Other|0|||
48923957|NCT00749996|157555265|FG000|Overall Study|Pregnancy|0|||
48923958|NCT00749996|157555266|FG001|Overall Study|Pregnancy|2|||
48923959|NCT00749996|157555265|FG000|Overall Study|Adverse Event|1|||
48923960|NCT00749996|157555266|FG001|Overall Study|Adverse Event|0|||
48923961|NCT00749996|157555265|FG000|Overall Study|Death|1|||
48923962|NCT00749996|157555266|FG001|Overall Study|Death|0|||
48923963|NCT03436862|157555267|FG000|Overall Study|Adverse Event|4|||
48923964|NCT03436862|157555267|FG000|Overall Study|Progressive Disease|2|||
48923965|NCT01692301|157555268|FG000|Overall Study|Adverse Event|15|||
48923966|NCT01692301|157555269|FG001|Overall Study|Adverse Event|12|||
48923967|NCT01692301|157555268|FG000|Overall Study|Death|1|||
48923968|NCT01692301|157555269|FG001|Overall Study|Death|2|||
48923969|NCT01692301|157555268|FG000|Overall Study|Lack of Efficacy|0|||
48923970|NCT01692301|157555269|FG001|Overall Study|Lack of Efficacy|5|||
48923971|NCT01692301|157555268|FG000|Overall Study|Non-compliance with study treatment|1|||
48923972|NCT01692301|157555269|FG001|Overall Study|Non-compliance with study treatment|2|||
49164981|NCT03666988|158440188|FG005|Part 1 (Up to 28 Months)|Other|0|||
49164982|NCT03666988|158440183|FG000|Part 1 (Up to 28 Months)|Disease Progression|2|||
49164983|NCT03666988|158440184|FG001|Part 1 (Up to 28 Months)|Disease Progression|14|||
49164984|NCT03666988|158440185|FG002|Part 1 (Up to 28 Months)|Disease Progression|7|||
48923973|NCT01692301|157555268|FG000|Overall Study|Protocol deviation|9|||
48923974|NCT01692301|157555269|FG001|Overall Study|Protocol deviation|2|||
48923975|NCT01692301|157555268|FG000|Overall Study|Patient/guardian decision|16|||
49164985|NCT03666988|158440186|FG003|Part 1 (Up to 28 Months)|Disease Progression|0|||
49164986|NCT03666988|158440187|FG004|Part 1 (Up to 28 Months)|Disease Progression|0|||
48923976|NCT01692301|157555269|FG001|Overall Study|Patient/guardian decision|15|||
48923977|NCT01692301|157555268|FG000|Overall Study|Technical problems|0|||
48923978|NCT01692301|157555269|FG001|Overall Study|Technical problems|1|||
49164987|NCT03666988|158440188|FG005|Part 1 (Up to 28 Months)|Disease Progression|0|||
49164988|NCT03666988|158440183|FG000|Part 1 (Up to 28 Months)|Physician Decision|0|||
49164989|NCT03666988|158440184|FG001|Part 1 (Up to 28 Months)|Physician Decision|0|||
49164990|NCT03666988|158440185|FG002|Part 1 (Up to 28 Months)|Physician Decision|1|||
49164991|NCT03666988|158440186|FG003|Part 1 (Up to 28 Months)|Physician Decision|0|||
49164992|NCT03666988|158440187|FG004|Part 1 (Up to 28 Months)|Physician Decision|0|||
48923979|NCT01692301|157555268|FG000|Overall Study|Physician Decision|2|||
48923980|NCT01692301|157555269|FG001|Overall Study|Physician Decision|2|||
48923981|NCT01692301|157555268|FG000|Overall Study|Lost to Follow-up|1|||
48923982|NCT01692301|157555269|FG001|Overall Study|Lost to Follow-up|1|||
48923983|NCT02971670|157555276|FG000|Overall Study|Withdrawal by Subject|4|||
48923984|NCT02971670|157555277|FG001|Overall Study|Withdrawal by Subject|1|||
49164993|NCT03666988|158440188|FG005|Part 1 (Up to 28 Months)|Physician Decision|0|||
49164994|NCT03666988|158440183|FG000|Part 1 (Up to 28 Months)|Withdrawal by Subject|1|||
49164995|NCT03666988|158440184|FG001|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
49164996|NCT03666988|158440185|FG002|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
49164997|NCT03666988|158440186|FG003|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
49164998|NCT03666988|158440187|FG004|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
49164999|NCT03666988|158440188|FG005|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
49165000|NCT02131662|158440193|FG000|Overall Study|Protocol Violation|1|||
48923985|NCT02971670|157555278|FG002|Overall Study|Withdrawal by Subject|1|||
48923986|NCT02971670|157555279|FG003|Overall Study|Withdrawal by Subject|2|||
48923987|NCT05779072|157555281|FG000|Overall Study|Lost to Follow-up|0|||
48923988|NCT05779072|157555282|FG001|Overall Study|Lost to Follow-up|1|||
48923989|NCT05779072|157555281|FG000|Overall Study|Withdrawal by Subject|1|||
49165001|NCT02131662|158440194|FG001|Overall Study|Protocol Violation|0|||
49165002|NCT02131662|158440195|FG002|Overall Study|Protocol Violation|0|||
49165003|NCT02131662|158440196|FG003|Overall Study|Protocol Violation|0|||
49165004|NCT02131662|158440197|FG004|Overall Study|Protocol Violation|0|||
49165005|NCT02131662|158440193|FG000|Overall Study|Other|2|||
48923990|NCT05779072|157555282|FG001|Overall Study|Withdrawal by Subject|5|||
48923991|NCT00506883|157555283|FG000|Overall Study|Lost to Follow-up|1|||
48923992|NCT00506883|157555284|FG001|Overall Study|Lost to Follow-up|1|||
48923993|NCT00506883|157555285|FG002|Overall Study|Lost to Follow-up|1|||
48923994|NCT00506883|157555283|FG000|Overall Study|Withdrawal by Subject|1|||
48923995|NCT00506883|157555284|FG001|Overall Study|Withdrawal by Subject|0|||
48923996|NCT00506883|157555285|FG002|Overall Study|Withdrawal by Subject|1|||
48923997|NCT00506883|157555283|FG000|Overall Study|Lack of Efficacy|0|||
49165006|NCT02131662|158440194|FG001|Overall Study|Other|4|||
49165007|NCT02131662|158440195|FG002|Overall Study|Other|3|||
49165008|NCT02131662|158440196|FG003|Overall Study|Other|3|||
49165009|NCT02131662|158440197|FG004|Overall Study|Other|4|||
49165010|NCT02131662|158440193|FG000|Overall Study|Adverse Event|0|||
49165011|NCT02131662|158440194|FG001|Overall Study|Adverse Event|1|||
49165012|NCT02131662|158440195|FG002|Overall Study|Adverse Event|1|||
49165013|NCT02131662|158440196|FG003|Overall Study|Adverse Event|1|||
49165014|NCT02131662|158440197|FG004|Overall Study|Adverse Event|3|||
49165015|NCT02131662|158440193|FG000|Overall Study|Pregnancy|0|||
49165016|NCT02131662|158440194|FG001|Overall Study|Pregnancy|1|||
49165017|NCT02131662|158440195|FG002|Overall Study|Pregnancy|0|||
49165018|NCT02131662|158440196|FG003|Overall Study|Pregnancy|1|||
49165019|NCT02131662|158440197|FG004|Overall Study|Pregnancy|0|||
49165020|NCT02131662|158440193|FG000|Overall Study|Wish for pregnancy|0|||
49165021|NCT02131662|158440194|FG001|Overall Study|Wish for pregnancy|0|||
49165022|NCT02131662|158440195|FG002|Overall Study|Wish for pregnancy|0|||
49165023|NCT02131662|158440196|FG003|Overall Study|Wish for pregnancy|0|||
49165024|NCT02131662|158440197|FG004|Overall Study|Wish for pregnancy|1|||
49165025|NCT02131662|158440193|FG000|Overall Study|Lack of Efficacy|1|||
49165026|NCT02131662|158440194|FG001|Overall Study|Lack of Efficacy|0|||
49165027|NCT02131662|158440195|FG002|Overall Study|Lack of Efficacy|0|||
49165028|NCT02131662|158440196|FG003|Overall Study|Lack of Efficacy|0|||
49165029|NCT02131662|158440197|FG004|Overall Study|Lack of Efficacy|1|||
49165030|NCT02131662|158440193|FG000|Overall Study|Withdrawal by Subject|1|||
49165031|NCT02131662|158440194|FG001|Overall Study|Withdrawal by Subject|5|||
49165032|NCT02131662|158440195|FG002|Overall Study|Withdrawal by Subject|1|||
49165033|NCT02131662|158440196|FG003|Overall Study|Withdrawal by Subject|5|||
49165034|NCT02131662|158440197|FG004|Overall Study|Withdrawal by Subject|6|||
49165035|NCT02131662|158440193|FG000|Overall Study|Lost to Follow-up|1|||
49165036|NCT02131662|158440194|FG001|Overall Study|Lost to Follow-up|3|||
49165037|NCT02131662|158440195|FG002|Overall Study|Lost to Follow-up|0|||
49165038|NCT02131662|158440196|FG003|Overall Study|Lost to Follow-up|9|||
49165039|NCT02131662|158440197|FG004|Overall Study|Lost to Follow-up|0|||
49165040|NCT02131662|158440193|FG000|Overall Study|Not treated|2|||
49165041|NCT02131662|158440194|FG001|Overall Study|Not treated|0|||
49165042|NCT02131662|158440195|FG002|Overall Study|Not treated|2|||
49165043|NCT02131662|158440196|FG003|Overall Study|Not treated|2|||
49165044|NCT02131662|158440197|FG004|Overall Study|Not treated|3|||
49165045|NCT03554018|158440198|FG000|Overall Study|Lost to Follow-up|3|||
49165046|NCT03554018|158440199|FG001|Overall Study|Lost to Follow-up|7|||
49165047|NCT01154452|158440200|FG000|Phase Ib|Not Treated|1|||
49165048|NCT01154452|158440201|FG001|Phase Ib|Not Treated|0|||
49165049|NCT01154452|158440202|FG002|Phase Ib|Not Treated|0|||
49165050|NCT01154452|158440203|FG003|Phase Ib|Not Treated|0|||
49165051|NCT01154452|158440200|FG000|Phase Ib|Adverse Event|2|||
49165052|NCT01154452|158440201|FG001|Phase Ib|Adverse Event|1|||
49165053|NCT01154452|158440202|FG002|Phase Ib|Adverse Event|0|||
49165054|NCT01154452|158440203|FG003|Phase Ib|Adverse Event|0|||
49165055|NCT01154452|158440200|FG000|Phase II|Withdrawal by Subject|0|||
49165056|NCT01154452|158440201|FG001|Phase II|Withdrawal by Subject|0|||
49165057|NCT01154452|158440202|FG002|Phase II|Withdrawal by Subject|1|||
49165058|NCT01154452|158440203|FG003|Phase II|Withdrawal by Subject|2|||
49165059|NCT01154452|158440200|FG000|Phase II|Adverse Event|0|||
49165060|NCT01154452|158440201|FG001|Phase II|Adverse Event|0|||
49165061|NCT01154452|158440202|FG002|Phase II|Adverse Event|4|||
49165062|NCT01154452|158440203|FG003|Phase II|Adverse Event|4|||
49165063|NCT05653700|158440204|FG000|Overall Study|Non Responders|9|||
49165064|NCT05653700|158440205|FG001|Overall Study|Non Responders|0|||
49165065|NCT02015039|158440206|FG000|Overall Study|Not eligible|0|||
49165066|NCT02015039|158440207|FG001|Overall Study|Not eligible|1|||
49165067|NCT02670473|158440208|FG000|Overall Study|Withdrawal by Subject|1|||
49165068|NCT02573948|158440209|FG000|Longitudinal Cohort|Death|9|||
49165069|NCT02573948|158440209|FG000|Longitudinal Cohort|Lost to Follow-up|22|||
49165070|NCT02573948|158440209|FG000|Longitudinal Cohort|Incarcerated|25|||
49165071|NCT00707993|158440214|FG000|Overall Study|Adverse Event|16|||
49165072|NCT00707993|158440215|FG001|Overall Study|Adverse Event|20|||
49165073|NCT00707993|158440214|FG000|Overall Study|Protocol Violation|4|||
49165074|NCT00707993|158440215|FG001|Overall Study|Protocol Violation|7|||
49165075|NCT00707993|158440214|FG000|Overall Study|Lost to Follow-up|0|||
49165076|NCT00707993|158440215|FG001|Overall Study|Lost to Follow-up|4|||
49165077|NCT00707993|158440214|FG000|Overall Study|Withdrawal by Subject|12|||
49165078|NCT00707993|158440215|FG001|Overall Study|Withdrawal by Subject|16|||
49165079|NCT00707993|158440214|FG000|Overall Study|Hyperglycemic Rescue|55|||
49165080|NCT00707993|158440215|FG001|Overall Study|Hyperglycemic Rescue|47|||
49165081|NCT00707993|158440214|FG000|Overall Study|Other|2|||
49165082|NCT00707993|158440215|FG001|Overall Study|Other|0|||
49165083|NCT02712996|158440216|FG000|Second Intervention (Study Days 43-84)|Adverse Event|0|||
49165084|NCT02712996|158440217|FG001|Second Intervention (Study Days 43-84)|Adverse Event|1|||
49165085|NCT03533660|158440223|FG000|Overall Study|Withdrawal by Subject|2|||
49165086|NCT03533660|158440224|FG001|Overall Study|Withdrawal by Subject|2|||
49165087|NCT03533660|158440223|FG000|Overall Study|Death|2|||
49165088|NCT03533660|158440224|FG001|Overall Study|Death|4|||
49165089|NCT03533660|158440223|FG000|Overall Study|Adverse Event|0|||
49165090|NCT03533660|158440224|FG001|Overall Study|Adverse Event|2|||
49165091|NCT03941483|158440225|FG000|Overall Study|Miscellaneous|2|||
49165092|NCT03941483|158440226|FG001|Overall Study|Miscellaneous|3|||
49165093|NCT03941483|158440227|FG002|Overall Study|Miscellaneous|0|||
49165094|NCT03941483|158440225|FG000|Overall Study|Study Terminated by Sponsor|1|||
49165095|NCT03941483|158440226|FG001|Overall Study|Study Terminated by Sponsor|0|||
49165096|NCT03941483|158440227|FG002|Overall Study|Study Terminated by Sponsor|0|||
49165097|NCT03941483|158440225|FG000|Overall Study|Withdrawal by Subject|1|||
49165098|NCT03941483|158440226|FG001|Overall Study|Withdrawal by Subject|4|||
49165099|NCT03941483|158440227|FG002|Overall Study|Withdrawal by Subject|1|||
49165100|NCT03941483|158440225|FG000|Overall Study|Lost to Follow-up|2|||
49165101|NCT03941483|158440226|FG001|Overall Study|Lost to Follow-up|1|||
49165102|NCT03941483|158440227|FG002|Overall Study|Lost to Follow-up|8|||
49165103|NCT03941483|158440225|FG000|Overall Study|Death|3|||
49165104|NCT03941483|158440226|FG001|Overall Study|Death|2|||
49165105|NCT03941483|158440227|FG002|Overall Study|Death|6|||
49165106|NCT01897493|158441709|FG000|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1|||
49165107|NCT00552071|158441712|FG000|Overall Study|Adverse Event|1|||
49165108|NCT00552071|158441713|FG001|Overall Study|Adverse Event|0|||
49165109|NCT00552071|158441712|FG000|Overall Study|Lack of Efficacy|1|||
49165110|NCT00552071|158441713|FG001|Overall Study|Lack of Efficacy|0|||
49165111|NCT00552071|158441712|FG000|Overall Study|Physician Decision|1|||
49165112|NCT00552071|158441713|FG001|Overall Study|Physician Decision|0|||
49165113|NCT00552071|158441712|FG000|Overall Study|Pregnancy|1|||
49165114|NCT00552071|158441713|FG001|Overall Study|Pregnancy|0|||
49165115|NCT00552071|158441712|FG000|Overall Study|Death|0|||
49165116|NCT00552071|158441713|FG001|Overall Study|Death|1|||
49165117|NCT00552071|158441712|FG000|Overall Study|Withdrawal by Subject|0|||
49165118|NCT00552071|158441713|FG001|Overall Study|Withdrawal by Subject|1|||
49165119|NCT05219253|158441718|FG000|Overall Study|Withdrawal by Subject|1|||
49165120|NCT05219253|158441719|FG001|Overall Study|Withdrawal by Subject|2|||
49165121|NCT02628444|158441720|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1|||
49165122|NCT02628444|158441721|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
49165123|NCT02628444|158441722|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
49165124|NCT02628444|158441723|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
49165125|NCT02628444|158441724|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
49165126|NCT02628444|158441725|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
49165127|NCT02628444|158441726|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
49165128|NCT02628444|158441727|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
49165129|NCT02628444|158441728|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
49165130|NCT02628444|158441720|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
49165131|NCT02628444|158441721|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4|||
49165132|NCT02628444|158441722|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3|||
49165133|NCT02628444|158441723|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
49165134|NCT02628444|158441724|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
49165135|NCT02628444|158441725|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
49165136|NCT02628444|158441726|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
49165137|NCT02628444|158441727|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
49165138|NCT02628444|158441728|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
49165139|NCT02628444|158441720|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21|||
49165140|NCT02628444|158441721|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16|||
49165141|NCT02628444|158441722|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25|||
49165142|NCT02628444|158441723|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
49165143|NCT02628444|158441724|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
49165144|NCT02628444|158441725|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
49165145|NCT02628444|158441726|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
49165146|NCT02628444|158441727|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
49165147|NCT02628444|158441728|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
49165148|NCT02628444|158441720|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
49165149|NCT02628444|158441721|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16|||
49165150|NCT02628444|158441722|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
49165151|NCT02628444|158441723|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
49165152|NCT02628444|158441724|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
49165153|NCT02628444|158441725|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
49165154|NCT02628444|158441726|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
49165155|NCT02628444|158441727|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
49165156|NCT02628444|158441728|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
49165157|NCT02628444|158441720|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
49165158|NCT02628444|158441721|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3|||
49165159|NCT02628444|158441722|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
49165160|NCT02628444|158441723|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
49165161|NCT02628444|158441724|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
48856514|NCT01159600|157312865|FG004|Overall Study|Other reason not defined above|5|||
49165162|NCT02628444|158441725|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
49165163|NCT02628444|158441726|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
49165164|NCT02628444|158441727|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
49165165|NCT02628444|158441728|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
49165166|NCT02628444|158441720|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
49165167|NCT02628444|158441721|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
49165168|NCT02628444|158441722|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
49165169|NCT02628444|158441723|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1|||
49165170|NCT02628444|158441724|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
49165171|NCT02628444|158441725|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
49165172|NCT02628444|158441726|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
49165173|NCT02628444|158441727|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
49165174|NCT02628444|158441728|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
49165175|NCT02628444|158441720|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
49165176|NCT02628444|158441721|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
49165177|NCT02628444|158441722|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
49165178|NCT02628444|158441723|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
49165179|NCT02628444|158441724|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
49165180|NCT02628444|158441725|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
49165181|NCT02628444|158441726|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81|||
49165182|NCT02628444|158441727|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84|||
49165183|NCT02628444|158441728|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85|||
49165184|NCT02628444|158441720|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
49165185|NCT02628444|158441721|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
49165186|NCT02628444|158441722|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
49165187|NCT02628444|158441723|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5|||
49165188|NCT02628444|158441724|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6|||
49165189|NCT02628444|158441725|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10|||
49165190|NCT02628444|158441726|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12|||
49165191|NCT02628444|158441727|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11|||
49165192|NCT02628444|158441728|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9|||
49165193|NCT02628444|158441720|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
49165194|NCT02628444|158441721|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
49165195|NCT02628444|158441722|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
49165196|NCT02628444|158441723|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
49165197|NCT02628444|158441724|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
49165198|NCT02628444|158441725|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
49165199|NCT02628444|158441726|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
49165200|NCT02628444|158441727|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2|||
49165201|NCT02628444|158441728|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
49165202|NCT02628444|158441720|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
49165203|NCT02628444|158441721|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
49165204|NCT02628444|158441722|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
49165205|NCT02628444|158441723|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
49165206|NCT02628444|158441724|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
49165207|NCT02628444|158441725|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
49165208|NCT02628444|158441726|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3|||
49165209|NCT02628444|158441727|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
49165210|NCT02628444|158441728|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
49165211|NCT02336815|158441729|FG000|Overall Study|Disease Progression|45|||
49165212|NCT02336815|158441730|FG001|Overall Study|Disease Progression|70|||
49165213|NCT02336815|158441729|FG000|Overall Study|Adverse Event|18|||
49165214|NCT02336815|158441730|FG001|Overall Study|Adverse Event|39|||
49165215|NCT02336815|158441729|FG000|Overall Study|Physician Decision|11|||
49165216|NCT02336815|158441730|FG001|Overall Study|Physician Decision|4|||
49165217|NCT02336815|158441729|FG000|Overall Study|Withdrawal by Subject|3|||
49165218|NCT02336815|158441730|FG001|Overall Study|Withdrawal by Subject|2|||
49165219|NCT02336815|158441729|FG000|Overall Study|Lost to Follow-up|1|||
49165220|NCT02336815|158441730|FG001|Overall Study|Lost to Follow-up|3|||
49165221|NCT02336815|158441729|FG000|Overall Study|Other|1|||
49165222|NCT02336815|158441730|FG001|Overall Study|Other|5|||
49165223|NCT00784368|158441731|FG000|Overall Study|Physician Decision|0|||
49165224|NCT00784368|158441732|FG001|Overall Study|Physician Decision|0|||
49165225|NCT00784368|158441733|FG002|Overall Study|Physician Decision|6|||
49165226|NCT00784368|158441731|FG000|Overall Study|Lack of Efficacy|2|||
49165227|NCT00784368|158441732|FG001|Overall Study|Lack of Efficacy|0|||
49165228|NCT00784368|158441733|FG002|Overall Study|Lack of Efficacy|1|||
49165229|NCT00784368|158441731|FG000|Overall Study|Adverse Event|6|||
49165230|NCT00784368|158441732|FG001|Overall Study|Adverse Event|9|||
49165231|NCT00784368|158441733|FG002|Overall Study|Adverse Event|2|||
49165232|NCT00784368|158441731|FG000|Overall Study|Diagnosis of fever|0|||
49165233|NCT00784368|158441732|FG001|Overall Study|Diagnosis of fever|0|||
49165234|NCT00784368|158441733|FG002|Overall Study|Diagnosis of fever|1|||
49165235|NCT00784368|158441731|FG000|Overall Study|Worsening of complications|0|||
49165236|NCT00784368|158441732|FG001|Overall Study|Worsening of complications|0|||
49165237|NCT00784368|158441733|FG002|Overall Study|Worsening of complications|1|||
49165238|NCT00784368|158441731|FG000|Overall Study|Worsening of symptoms|0|||
49165239|NCT00784368|158441732|FG001|Overall Study|Worsening of symptoms|1|||
49165240|NCT00784368|158441733|FG002|Overall Study|Worsening of symptoms|0|||
49165241|NCT00784368|158441731|FG000|Overall Study|Withdrawal of informed consent|0|||
49165242|NCT00784368|158441732|FG001|Overall Study|Withdrawal of informed consent|1|||
49165243|NCT00784368|158441733|FG002|Overall Study|Withdrawal of informed consent|0|||
49165244|NCT02829996|158441734|FG000|Overall Study|Withdrawal by Subject|1|||
49165245|NCT02829996|158441735|FG001|Overall Study|Withdrawal by Subject|0|||
49165246|NCT02829996|158441736|FG002|Overall Study|Withdrawal by Subject|0|||
49165247|NCT02829996|158441737|FG003|Overall Study|Withdrawal by Subject|0|||
49165248|NCT02829996|158441738|FG004|Overall Study|Withdrawal by Subject|0|||
49165249|NCT01126190|158441741|FG000|Double-Blind Phase|Death|0|||
49165250|NCT01126190|158441742|FG001|Double-Blind Phase|Death|1|||
49165251|NCT01126190|158441743|FG002|Double-Blind Phase|Death|0|||
49165252|NCT01126190|158441741|FG000|Double-Blind Phase|Adverse Event|1|||
49165253|NCT01126190|158441742|FG001|Double-Blind Phase|Adverse Event|2|||
49165254|NCT01126190|158441743|FG002|Double-Blind Phase|Adverse Event|0|||
49165255|NCT01126190|158441741|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
49165256|NCT01126190|158441742|FG001|Double-Blind Phase|Withdrawal by Subject|5|||
49165257|NCT01126190|158441743|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
49165258|NCT01126190|158441741|FG000|Double-Blind Phase|Request of Investigator|1|||
49165259|NCT01126190|158441742|FG001|Double-Blind Phase|Request of Investigator|0|||
49165260|NCT01126190|158441743|FG002|Double-Blind Phase|Request of Investigator|0|||
49165261|NCT01126190|158441741|FG000|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
49165262|NCT01126190|158441742|FG001|Double-Blind Phase|Treatment Failure/Disease Progression|4|||
48923998|NCT00506883|157555284|FG001|Overall Study|Lack of Efficacy|1|||
48923999|NCT00506883|157555285|FG002|Overall Study|Lack of Efficacy|1|||
48924000|NCT00506883|157555283|FG000|Overall Study|Other|5|||
48924001|NCT00506883|157555284|FG001|Overall Study|Other|1|||
48924002|NCT00506883|157555285|FG002|Overall Study|Other|1|||
48924003|NCT03713944|157555286|FG000|Study Treatment|Patient non-compliance|1|||
48924004|NCT03713944|157555286|FG000|Study Treatment|Alternative Cancer Therapy|3|||
49165263|NCT01126190|158441743|FG002|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
49165264|NCT01126190|158441741|FG000|Double-Blind Phase|Non-compliance|1|||
49165265|NCT01126190|158441742|FG001|Double-Blind Phase|Non-compliance|0|||
49165266|NCT01126190|158441743|FG002|Double-Blind Phase|Non-compliance|0|||
49165267|NCT01126190|158441741|FG000|Double-Blind Phase|Lost to Follow-up|1|||
49165268|NCT01126190|158441742|FG001|Double-Blind Phase|Lost to Follow-up|3|||
49165269|NCT01126190|158441743|FG002|Double-Blind Phase|Lost to Follow-up|0|||
49165270|NCT01126190|158441741|FG000|Open-Label Phase|Death|0|||
49165271|NCT01126190|158441742|FG001|Open-Label Phase|Death|0|||
49165272|NCT01126190|158441743|FG002|Open-Label Phase|Death|1|||
49165273|NCT01126190|158441741|FG000|Open-Label Phase|Adverse Event|0|||
48924005|NCT03713944|157555286|FG000|Study Treatment|Disease Progression|18|||
48924006|NCT03713944|157555286|FG000|Study Treatment|AE/Side Effects/Complications|2|||
48924007|NCT03713944|157555286|FG000|Study Treatment|Death|2|||
48924008|NCT03713944|157555286|FG000|Study Treatment|Withdrawal by Subject|1|||
48924009|NCT03713944|157555286|FG000|Study Treatment|Subject decided to come off study due to hip replacement|1|||
49165274|NCT01126190|158441742|FG001|Open-Label Phase|Adverse Event|0|||
49165275|NCT01126190|158441743|FG002|Open-Label Phase|Adverse Event|4|||
49165276|NCT01126190|158441741|FG000|Open-Label Phase|Withdrawal by Subject|0|||
49165277|NCT01126190|158441742|FG001|Open-Label Phase|Withdrawal by Subject|0|||
49165278|NCT01126190|158441743|FG002|Open-Label Phase|Withdrawal by Subject|6|||
49165279|NCT00628446|158441744|FG000|Overall Study|Lost to Follow-up|3|||
49165280|NCT00628446|158441744|FG000|Overall Study|Withdrawal by Subject|1|||
49165281|NCT00628446|158441744|FG000|Overall Study|Protocol Violation|3|||
49165282|NCT01135992|158441745|FG000|Overall Study|Adverse Event|1|||
49165283|NCT01135992|158441745|FG000|Overall Study|Lack of Efficacy|1|||
48924010|NCT03713944|157555286|FG000|Study Treatment|Symptomatic Deterioration|2|||
48924011|NCT03713944|157555286|FG000|Follow up|Withdrawal by Subject|2|||
49165284|NCT01135992|158441745|FG000|Overall Study|Protocol Violation|2|||
49165285|NCT01135992|158441745|FG000|Overall Study|Withdrawal criteria|10|||
48924012|NCT03713944|157555286|FG000|Follow up|Death|11|||
48924013|NCT03713944|157555286|FG000|Follow up|Study Terminated|3|||
49165286|NCT01135992|158441745|FG000|Overall Study|Unclassified|7|||
48924014|NCT02004873|157555287|FG000|Overall Study|Implant unsuccessful|6|||
48924015|NCT02004873|157555287|FG000|Overall Study|Awaiting 6-month visit|390|||
48924016|NCT02004873|157555287|FG000|Overall Study|Missed 6-month visit|4|||
48924017|NCT02004873|157555287|FG000|Overall Study|Death|23|||
48924018|NCT02004873|157555287|FG000|Overall Study|Withdrawal by Subject|1|||
48924019|NCT01353703|157555288|FG000|Overall Study|Migrated/moved from study area|1|||
48924020|NCT01353703|157555289|FG001|Overall Study|Migrated/moved from study area|0|||
48924021|NCT00487539|157555292|FG000|Overall Study|Adverse Event|3|||
48924022|NCT00487539|157555293|FG001|Overall Study|Adverse Event|2|||
48924023|NCT00487539|157555294|FG002|Overall Study|Adverse Event|1|||
48924024|NCT00487539|157555295|FG003|Overall Study|Adverse Event|1|||
48924025|NCT00487539|157555292|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
48924026|NCT00487539|157555293|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
48924027|NCT00487539|157555294|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
48924028|NCT00487539|157555295|FG003|Overall Study|Unsatisfactory therapeutic effect|1|||
48924029|NCT00487539|157555292|FG000|Overall Study|Other|3|||
48924030|NCT00487539|157555293|FG001|Overall Study|Other|1|||
48924031|NCT00487539|157555294|FG002|Overall Study|Other|2|||
48924032|NCT00487539|157555295|FG003|Overall Study|Other|2|||
48924033|NCT02175680|157555299|FG000|Overall Study|non-compliance|1|||
48924034|NCT02175680|157555299|FG000|Overall Study|other non-medical reason|1|||
48924035|NCT01665144|157555300|FG000|Core Part|Withdrawal by Subject|96|||
48924036|NCT01665144|157555301|FG001|Core Part|Withdrawal by Subject|77|||
48924037|NCT01665144|157555302|FG002|Core Part|Withdrawal by Subject|0|||
48924038|NCT01665144|157555300|FG000|Core Part|Adverse Event|45|||
48924039|NCT01665144|157555301|FG001|Core Part|Adverse Event|18|||
48924040|NCT01665144|157555302|FG002|Core Part|Adverse Event|0|||
48924041|NCT01665144|157555300|FG000|Core Part|Lack of Efficacy|16|||
48924042|NCT01665144|157555301|FG001|Core Part|Lack of Efficacy|11|||
48924043|NCT01665144|157555302|FG002|Core Part|Lack of Efficacy|0|||
48924044|NCT01665144|157555300|FG000|Core Part|Lost to Follow-up|9|||
48924045|NCT01665144|157555301|FG001|Core Part|Lost to Follow-up|8|||
48924046|NCT01665144|157555302|FG002|Core Part|Lost to Follow-up|0|||
48924047|NCT01665144|157555300|FG000|Core Part|Physician Decision|13|||
48924048|NCT01665144|157555301|FG001|Core Part|Physician Decision|1|||
48924049|NCT01665144|157555302|FG002|Core Part|Physician Decision|0|||
48924050|NCT01665144|157555300|FG000|Core Part|Progressive disease|8|||
48924051|NCT01665144|157555301|FG001|Core Part|Progressive disease|4|||
48924052|NCT01665144|157555302|FG002|Core Part|Progressive disease|0|||
48924053|NCT01665144|157555300|FG000|Core Part|Non-compliance with study treatment|5|||
48924054|NCT01665144|157555301|FG001|Core Part|Non-compliance with study treatment|0|||
48924055|NCT01665144|157555302|FG002|Core Part|Non-compliance with study treatment|0|||
48924056|NCT01665144|157555300|FG000|Core Part|Death|3|||
48924057|NCT01665144|157555301|FG001|Core Part|Death|1|||
48924058|NCT01665144|157555302|FG002|Core Part|Death|0|||
48924059|NCT01665144|157555300|FG000|Core Part|Protocol deviation|3|||
48924060|NCT01665144|157555301|FG001|Core Part|Protocol deviation|1|||
48924061|NCT01665144|157555302|FG002|Core Part|Protocol deviation|0|||
48924062|NCT01665144|157555300|FG000|Core Part|New therapy for study indication|2|||
48924063|NCT01665144|157555301|FG001|Core Part|New therapy for study indication|1|||
48924064|NCT01665144|157555302|FG002|Core Part|New therapy for study indication|0|||
48924065|NCT01665144|157555300|FG000|Core Part|Technical problems|2|||
48924066|NCT01665144|157555301|FG001|Core Part|Technical problems|0|||
49165287|NCT04971967|158441746|FG000|Overall Study|Lost to Follow-up|6|||
49165288|NCT04971967|158441747|FG001|Overall Study|Lost to Follow-up|7|||
48924067|NCT01665144|157555302|FG002|Core Part|Technical problems|0|||
48924068|NCT01665144|157555300|FG000|Extension Part|Patient/guardian decision|180|||
48924069|NCT01665144|157555301|FG001|Extension Part|Patient/guardian decision|0|||
48924070|NCT01665144|157555302|FG002|Extension Part|Patient/guardian decision|98|||
48924071|NCT01665144|157555300|FG000|Extension Part|Adverse Event|104|||
48924072|NCT01665144|157555301|FG001|Extension Part|Adverse Event|0|||
48924073|NCT01665144|157555302|FG002|Extension Part|Adverse Event|59|||
48924074|NCT01665144|157555300|FG000|Extension Part|Study closed early|42|||
48924075|NCT01665144|157555301|FG001|Extension Part|Study closed early|0|||
48924076|NCT01665144|157555302|FG002|Extension Part|Study closed early|19|||
48924077|NCT01665144|157555300|FG000|Extension Part|Progressive disease|36|||
48924078|NCT01665144|157555301|FG001|Extension Part|Progressive disease|0|||
49165289|NCT01349673|158441751|FG000|Overall Study|Progression Of Disease Past 40 cm|1|||
49165290|NCT01349673|158441751|FG000|Overall Study|No Longer Qualified For Study|1|||
49165291|NCT01349673|158441751|FG000|Overall Study|Site Closure|10|||
49165292|NCT01349673|158441751|FG000|Overall Study|Withdrawal by Subject|21|||
49165293|NCT01349673|158441751|FG000|Overall Study|Lost to Follow-up|6|||
49165294|NCT01349673|158441751|FG000|Overall Study|Adverse Event|17|||
49165295|NCT01349673|158441751|FG000|Overall Study|Study Terminated By Sponsor|50|||
49165296|NCT01349673|158441751|FG000|Overall Study|Lack of Efficacy|8|||
49165297|NCT02383862|158441752|FG000|3 Month Follow up|Lost to Follow-up|23|||
49165298|NCT02383862|158441753|FG001|3 Month Follow up|Lost to Follow-up|21|||
49165299|NCT03801928|158441755|FG000|Overall Study|Adverse Event|1|||
49165300|NCT03801928|158441756|FG001|Overall Study|Adverse Event|0|||
49165301|NCT03801928|158441757|FG002|Overall Study|Adverse Event|1|||
49165302|NCT03801928|158441758|FG003|Overall Study|Adverse Event|2|||
49165303|NCT03801928|158441759|FG004|Overall Study|Adverse Event|0|||
49165304|NCT03801928|158441760|FG005|Overall Study|Adverse Event|2|||
48924079|NCT01665144|157555302|FG002|Extension Part|Progressive disease|14|||
48924080|NCT01665144|157555300|FG000|Extension Part|Lack of Efficacy|37|||
48924081|NCT01665144|157555301|FG001|Extension Part|Lack of Efficacy|0|||
49165305|NCT03801928|158441755|FG000|Overall Study|Lack of Efficacy|0|||
48924082|NCT01665144|157555302|FG002|Extension Part|Lack of Efficacy|12|||
49165306|NCT03801928|158441756|FG001|Overall Study|Lack of Efficacy|0|||
49165307|NCT03801928|158441757|FG002|Overall Study|Lack of Efficacy|1|||
49165308|NCT03801928|158441758|FG003|Overall Study|Lack of Efficacy|0|||
49165309|NCT03801928|158441759|FG004|Overall Study|Lack of Efficacy|0|||
49165310|NCT03801928|158441760|FG005|Overall Study|Lack of Efficacy|0|||
49165311|NCT03801928|158441755|FG000|Overall Study|Lost to Follow-up|5|||
49165312|NCT03801928|158441756|FG001|Overall Study|Lost to Follow-up|1|||
49165313|NCT03801928|158441757|FG002|Overall Study|Lost to Follow-up|1|||
49165314|NCT03801928|158441758|FG003|Overall Study|Lost to Follow-up|4|||
49165315|NCT03801928|158441759|FG004|Overall Study|Lost to Follow-up|4|||
49165316|NCT03801928|158441760|FG005|Overall Study|Lost to Follow-up|2|||
49165317|NCT03801928|158441755|FG000|Overall Study|Withdrawal by Subject|0|||
49165318|NCT03801928|158441756|FG001|Overall Study|Withdrawal by Subject|0|||
49165319|NCT03801928|158441757|FG002|Overall Study|Withdrawal by Subject|2|||
49165320|NCT03801928|158441758|FG003|Overall Study|Withdrawal by Subject|1|||
49165321|NCT03801928|158441759|FG004|Overall Study|Withdrawal by Subject|0|||
49165322|NCT03801928|158441760|FG005|Overall Study|Withdrawal by Subject|0|||
49165323|NCT03801928|158441755|FG000|Overall Study|Other|0|||
49165324|NCT03801928|158441756|FG001|Overall Study|Other|2|||
49165325|NCT03801928|158441757|FG002|Overall Study|Other|0|||
49165326|NCT03801928|158441758|FG003|Overall Study|Other|1|||
49165327|NCT03801928|158441759|FG004|Overall Study|Other|0|||
49165328|NCT03801928|158441760|FG005|Overall Study|Other|1|||
49165329|NCT03688919|158441761|FG000|Overall Study|Lost to Follow-up|2|||
49165330|NCT03688919|158441762|FG001|Overall Study|Lost to Follow-up|1|||
49165331|NCT03688919|158441761|FG000|Overall Study|withdrawn by study team due to poor data validity|1|||
49165332|NCT03688919|158441762|FG001|Overall Study|withdrawn by study team due to poor data validity|0|||
49165333|NCT04232943|158441767|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
48856515|NCT01159600|157312866|FG005|Overall Study|Other reason not defined above|7|||
49165334|NCT04232943|158441768|FG001|Overall Study|Enrolled but Treatment not Administered|3|||
48924083|NCT01665144|157555300|FG000|Extension Part|Physician Decision|29|||
48924084|NCT01665144|157555301|FG001|Extension Part|Physician Decision|0|||
48924085|NCT01665144|157555302|FG002|Extension Part|Physician Decision|13|||
48924086|NCT01665144|157555300|FG000|Extension Part|Technical problems|20|||
48924087|NCT01665144|157555301|FG001|Extension Part|Technical problems|0|||
48924088|NCT01665144|157555302|FG002|Extension Part|Technical problems|8|||
48924089|NCT01665144|157555300|FG000|Extension Part|Death|20|||
48924090|NCT01665144|157555301|FG001|Extension Part|Death|0|||
48924091|NCT01665144|157555302|FG002|Extension Part|Death|4|||
48924092|NCT01665144|157555300|FG000|Extension Part|Missing|12|||
48924093|NCT01665144|157555301|FG001|Extension Part|Missing|0|||
48924094|NCT01665144|157555302|FG002|Extension Part|Missing|6|||
48924095|NCT01665144|157555300|FG000|Extension Part|Lost to Follow-up|9|||
48924096|NCT01665144|157555301|FG001|Extension Part|Lost to Follow-up|0|||
48924097|NCT01665144|157555302|FG002|Extension Part|Lost to Follow-up|5|||
48924098|NCT01665144|157555300|FG000|Extension Part|New therapy for study indication|3|||
48924099|NCT01665144|157555301|FG001|Extension Part|New therapy for study indication|0|||
48924100|NCT01665144|157555302|FG002|Extension Part|New therapy for study indication|2|||
48924101|NCT01665144|157555300|FG000|Extension Part|Protocol deviation|3|||
48924102|NCT01665144|157555301|FG001|Extension Part|Protocol deviation|0|||
48924103|NCT01665144|157555302|FG002|Extension Part|Protocol deviation|0|||
48924104|NCT01060059|157555303|FG000|Overall Study|Adverse Event|1|||
48924105|NCT01060059|157555304|FG001|Overall Study|Adverse Event|1|||
48924106|NCT01060059|157555303|FG000|Overall Study|Death|2|||
48924107|NCT01060059|157555304|FG001|Overall Study|Death|3|||
48924108|NCT01060059|157555303|FG000|Overall Study|Lost to Follow-up|18|||
48924109|NCT01060059|157555304|FG001|Overall Study|Lost to Follow-up|34|||
48924110|NCT01060059|157555303|FG000|Overall Study|entry criteria not met|4|||
48924111|NCT01060059|157555304|FG001|Overall Study|entry criteria not met|3|||
48924112|NCT01060059|157555303|FG000|Overall Study|Withdrawal by Subject|35|||
48924113|NCT01060059|157555304|FG001|Overall Study|Withdrawal by Subject|23|||
48924114|NCT01060059|157555303|FG000|Overall Study|lack of glycemic control|2|||
48924115|NCT01060059|157555304|FG001|Overall Study|lack of glycemic control|1|||
48924116|NCT01060059|157555303|FG000|Overall Study|lack of compliance|5|||
48924117|NCT01060059|157555304|FG001|Overall Study|lack of compliance|2|||
48924118|NCT00903929|157555305|FG000|Overall Study|Withdrawal by Subject|0|||
48924119|NCT00903929|157555306|FG001|Overall Study|Withdrawal by Subject|0|||
48924120|NCT00903929|157555307|FG002|Overall Study|Withdrawal by Subject|1|||
48924121|NCT00903929|157555308|FG003|Overall Study|Withdrawal by Subject|2|||
48924122|NCT00903929|157555305|FG000|Overall Study|Adverse Event|0|||
48924123|NCT00903929|157555306|FG001|Overall Study|Adverse Event|0|||
48924124|NCT00903929|157555307|FG002|Overall Study|Adverse Event|0|||
48924125|NCT00903929|157555308|FG003|Overall Study|Adverse Event|1|||
48924126|NCT01913483|157555310|FG000|Overall Study|Withdrawal by Subject|1|||
48924127|NCT01913483|157555311|FG001|Overall Study|Withdrawal by Subject|2|||
48924128|NCT01913483|157555310|FG000|Overall Study|Lost to Follow-up|6|||
49165335|NCT04232943|158441769|FG002|Overall Study|Enrolled but Treatment not Administered|2|||
49165336|NCT04232943|158441767|FG000|Overall Study|Withdrawal by Subject|1|||
49165337|NCT04232943|158441768|FG001|Overall Study|Withdrawal by Subject|1|||
49165338|NCT04232943|158441769|FG002|Overall Study|Withdrawal by Subject|0|||
49165339|NCT00573391|158441770|FG000|Overall Study|study stopped|2|||
49165340|NCT00573391|158441771|FG001|Overall Study|study stopped|2|||
49165341|NCT00573391|158441770|FG000|Overall Study|Death|1|||
49165342|NCT00573391|158441771|FG001|Overall Study|Death|0|||
49165343|NCT01664247|158441773|FG000|Overall Study|Adverse Event|5|||
49165344|NCT01664247|158441774|FG001|Overall Study|Adverse Event|3|||
49165345|NCT01664247|158441773|FG000|Overall Study|Protocol Violation|3|||
49165346|NCT01664247|158441774|FG001|Overall Study|Protocol Violation|5|||
49165347|NCT01664247|158441773|FG000|Overall Study|Withdrawal Criteria|1|||
48924129|NCT01913483|157555311|FG001|Overall Study|Lost to Follow-up|3|||
48924130|NCT01913483|157555310|FG000|Overall Study|Death|14|||
48924131|NCT01913483|157555311|FG001|Overall Study|Death|17|||
48924132|NCT01035905|157555314|FG000|Overall Study|Lack of Efficacy|1|||
48924133|NCT01035905|157555315|FG001|Overall Study|Lack of Efficacy|1|||
48924134|NCT00091832|157555316|FG000|Overall Study|Physician Decision|1|||
48924135|NCT00091832|157555317|FG001|Overall Study|Physician Decision|0|||
48924136|NCT00091832|157555318|FG002|Overall Study|Physician Decision|0|||
48924137|NCT00091832|157555319|FG003|Overall Study|Physician Decision|0|||
48924138|NCT00091832|157555320|FG004|Overall Study|Physician Decision|0|||
48924139|NCT00091832|157555321|FG005|Overall Study|Physician Decision|0|||
48924140|NCT00091832|157555316|FG000|Overall Study|Adverse Event|0|||
48924141|NCT00091832|157555317|FG001|Overall Study|Adverse Event|0|||
49165348|NCT01664247|158441774|FG001|Overall Study|Withdrawal Criteria|4|||
49165349|NCT01664247|158441773|FG000|Overall Study|Unclassified|5|||
48924142|NCT00091832|157555318|FG002|Overall Study|Adverse Event|0|||
48924143|NCT00091832|157555319|FG003|Overall Study|Adverse Event|1|||
48924144|NCT00091832|157555320|FG004|Overall Study|Adverse Event|3|||
48924145|NCT00091832|157555321|FG005|Overall Study|Adverse Event|0|||
49165350|NCT01664247|158441774|FG001|Overall Study|Unclassified|29|||
49165351|NCT02553928|158441775|FG000|Overall Study|Adverse Event|2|||
48924146|NCT00091832|157555316|FG000|Overall Study|Withdrawal by Subject|4|||
48924147|NCT00091832|157555317|FG001|Overall Study|Withdrawal by Subject|5|||
48924148|NCT00091832|157555318|FG002|Overall Study|Withdrawal by Subject|0|||
48924149|NCT00091832|157555319|FG003|Overall Study|Withdrawal by Subject|1|||
48924150|NCT00091832|157555320|FG004|Overall Study|Withdrawal by Subject|3|||
48924151|NCT00091832|157555321|FG005|Overall Study|Withdrawal by Subject|1|||
48924152|NCT00091832|157555316|FG000|Overall Study|Death|6|||
48924153|NCT00091832|157555317|FG001|Overall Study|Death|4|||
48924154|NCT00091832|157555318|FG002|Overall Study|Death|5|||
48924155|NCT00091832|157555319|FG003|Overall Study|Death|8|||
48924156|NCT00091832|157555320|FG004|Overall Study|Death|5|||
48924157|NCT00091832|157555321|FG005|Overall Study|Death|6|||
48924158|NCT00091832|157555316|FG000|Overall Study|Disease Progression|2|||
48924159|NCT00091832|157555317|FG001|Overall Study|Disease Progression|0|||
48924160|NCT00091832|157555318|FG002|Overall Study|Disease Progression|0|||
48924161|NCT00091832|157555319|FG003|Overall Study|Disease Progression|1|||
48924162|NCT00091832|157555320|FG004|Overall Study|Disease Progression|1|||
48924163|NCT00091832|157555321|FG005|Overall Study|Disease Progression|2|||
48924164|NCT00091832|157555316|FG000|Overall Study|Ineligibility Determined|0|||
48924165|NCT00091832|157555317|FG001|Overall Study|Ineligibility Determined|0|||
48924166|NCT00091832|157555318|FG002|Overall Study|Ineligibility Determined|1|||
48924167|NCT00091832|157555319|FG003|Overall Study|Ineligibility Determined|0|||
48924168|NCT00091832|157555320|FG004|Overall Study|Ineligibility Determined|1|||
48924169|NCT00091832|157555321|FG005|Overall Study|Ineligibility Determined|0|||
48924170|NCT00091832|157555316|FG000|Overall Study|Lost to Follow-up|1|||
48924171|NCT00091832|157555317|FG001|Overall Study|Lost to Follow-up|0|||
48924172|NCT00091832|157555318|FG002|Overall Study|Lost to Follow-up|3|||
48924173|NCT00091832|157555319|FG003|Overall Study|Lost to Follow-up|3|||
48924174|NCT00091832|157555320|FG004|Overall Study|Lost to Follow-up|2|||
48924175|NCT00091832|157555321|FG005|Overall Study|Lost to Follow-up|1|||
48924176|NCT00091832|157555316|FG000|Overall Study|Noncompliance|0|||
48924177|NCT00091832|157555317|FG001|Overall Study|Noncompliance|1|||
48924178|NCT00091832|157555318|FG002|Overall Study|Noncompliance|0|||
48924179|NCT00091832|157555319|FG003|Overall Study|Noncompliance|0|||
48924180|NCT00091832|157555320|FG004|Overall Study|Noncompliance|0|||
48924181|NCT00091832|157555321|FG005|Overall Study|Noncompliance|0|||
48924182|NCT00091832|157555316|FG000|Overall Study|Other|0|||
48924183|NCT00091832|157555317|FG001|Overall Study|Other|1|||
48924184|NCT00091832|157555318|FG002|Overall Study|Other|2|||
48924185|NCT00091832|157555319|FG003|Overall Study|Other|0|||
48924186|NCT00091832|157555320|FG004|Overall Study|Other|0|||
48924187|NCT00091832|157555321|FG005|Overall Study|Other|0|||
48924188|NCT00091832|157555316|FG000|Overall Study|Protocol Violation|0|||
48924189|NCT00091832|157555317|FG001|Overall Study|Protocol Violation|0|||
48924190|NCT00091832|157555318|FG002|Overall Study|Protocol Violation|1|||
48924191|NCT00091832|157555319|FG003|Overall Study|Protocol Violation|0|||
48924192|NCT00091832|157555320|FG004|Overall Study|Protocol Violation|0|||
48924193|NCT00091832|157555321|FG005|Overall Study|Protocol Violation|1|||
48924194|NCT01972074|157555322|FG000|Overall Study|Adverse Event|4|||
48924195|NCT01972074|157555323|FG001|Overall Study|Adverse Event|1|||
48924196|NCT01972074|157555324|FG002|Overall Study|Adverse Event|0|||
48924197|NCT01972074|157555322|FG000|Overall Study|Lack of Efficacy|1|||
48924198|NCT01972074|157555323|FG001|Overall Study|Lack of Efficacy|1|||
48924199|NCT01972074|157555324|FG002|Overall Study|Lack of Efficacy|0|||
48924200|NCT01972074|157555322|FG000|Overall Study|Lost to Follow-up|0|||
48924201|NCT01972074|157555323|FG001|Overall Study|Lost to Follow-up|1|||
48924202|NCT01972074|157555324|FG002|Overall Study|Lost to Follow-up|1|||
48924203|NCT01972074|157555322|FG000|Overall Study|Withdrawal by Subject|1|||
49165352|NCT02553928|158441776|FG001|Overall Study|Adverse Event|1|||
49165353|NCT02553928|158441775|FG000|Overall Study|Lost to Follow-up|0|||
48924204|NCT01972074|157555323|FG001|Overall Study|Withdrawal by Subject|1|||
48924205|NCT01972074|157555324|FG002|Overall Study|Withdrawal by Subject|1|||
48924206|NCT01972074|157555322|FG000|Overall Study|Scanner Unavailable|0|||
48924207|NCT01972074|157555323|FG001|Overall Study|Scanner Unavailable|0|||
48924208|NCT01972074|157555324|FG002|Overall Study|Scanner Unavailable|1|||
48924209|NCT02508194|157555325|FG000|Overall Study|Death|5|||
48924210|NCT02508194|157555326|FG001|Overall Study|Death|3|||
48924211|NCT02508194|157555325|FG000|Overall Study|Lost to Follow-up|25|||
49165354|NCT02553928|158441776|FG001|Overall Study|Lost to Follow-up|1|||
48924212|NCT02508194|157555326|FG001|Overall Study|Lost to Follow-up|18|||
48924213|NCT02508194|157555325|FG000|Overall Study|Withdrawal by Subject|20|||
48924214|NCT02508194|157555326|FG001|Overall Study|Withdrawal by Subject|18|||
48924215|NCT02508194|157555325|FG000|Overall Study|Error in Randomization|1|||
48924216|NCT02508194|157555326|FG001|Overall Study|Error in Randomization|3|||
48924217|NCT02508194|157555325|FG000|Overall Study|Principal Investigator Decision|1|||
48924218|NCT02508194|157555326|FG001|Overall Study|Principal Investigator Decision|2|||
48924219|NCT03920670|157555329|FG000|Overall Study|Protocol Violation|2|||
48924220|NCT03920670|157555330|FG001|Overall Study|Protocol Violation|2|||
48924221|NCT03920670|157555329|FG000|Overall Study|Adverse Event|1|||
48924222|NCT03920670|157555330|FG001|Overall Study|Adverse Event|0|||
49165355|NCT02553928|158441775|FG000|Overall Study|Administrative reason(s)|0|||
49165356|NCT02553928|158441776|FG001|Overall Study|Administrative reason(s)|1|||
49165357|NCT01282866|158441781|FG000|Overall Study|Adverse Event|1|||
49165358|NCT02289469|158441782|FG000|Overall Study|Unable to match a control|6|||
49165359|NCT02289469|158441783|FG001|Overall Study|Unable to match a control|0|||
49165360|NCT00803361|158441784|FG000|Overall Study|Adverse Event|13|||
49165361|NCT00803361|158441785|FG001|Overall Study|Adverse Event|3|||
49165362|NCT00803361|158441784|FG000|Overall Study|Lack of Efficacy|4|||
48924223|NCT02937350|157555339|FG000|Overall Study|Withdrawal by Subject|0|||
48924224|NCT02937350|157555340|FG001|Overall Study|Withdrawal by Subject|1|||
48924225|NCT02937350|157555341|FG002|Overall Study|Withdrawal by Subject|0|||
48924226|NCT00488982|157557141|FG000|Course 1|Physician Decision|0|||
48924227|NCT00488982|157557142|FG001|Course 1|Physician Decision|2|||
48924228|NCT00488982|157557143|FG002|Course 1|Physician Decision|4|||
48924229|NCT00488982|157557141|FG000|Course 1|Withdrawal by Subject|0|||
48924230|NCT00488982|157557142|FG001|Course 1|Withdrawal by Subject|8|||
48924231|NCT00488982|157557143|FG002|Course 1|Withdrawal by Subject|2|||
48924232|NCT00488982|157557141|FG000|Course 1|nonprotocol therapy|0|||
48924233|NCT00488982|157557142|FG001|Course 1|nonprotocol therapy|2|||
48924234|NCT00488982|157557143|FG002|Course 1|nonprotocol therapy|2|||
48924235|NCT00488982|157557141|FG000|Course 1|Adverse Event|0|||
48924236|NCT00488982|157557142|FG001|Course 1|Adverse Event|0|||
48924237|NCT00488982|157557143|FG002|Course 1|Adverse Event|6|||
48924238|NCT04677712|157557147|FG000|Overall Study|Lost to Follow-up|0|||
48924239|NCT04677712|157557148|FG001|Overall Study|Lost to Follow-up|1|||
48924240|NCT04677712|157557149|FG002|Overall Study|Lost to Follow-up|0|||
48924241|NCT04677712|157557150|FG003|Overall Study|Lost to Follow-up|0|||
48924242|NCT04677712|157557151|FG004|Overall Study|Lost to Follow-up|0|||
48924243|NCT04677712|157557152|FG005|Overall Study|Lost to Follow-up|0|||
48924244|NCT02469090|157557161|FG000|Period 1: Dose Titration Phase|Adverse Event|12|||
48924245|NCT02469090|157557162|FG001|Period 1: Dose Titration Phase|Adverse Event|0|||
48924246|NCT02469090|157557163|FG002|Period 1: Dose Titration Phase|Adverse Event|0|||
48924247|NCT02469090|157557161|FG000|Period 1: Dose Titration Phase|Withdrawal by Subject|8|||
48924248|NCT02469090|157557162|FG001|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
48924249|NCT02469090|157557163|FG002|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
48924250|NCT02469090|157557161|FG000|Period 1: Dose Titration Phase|Lost to Follow-up|1|||
48924251|NCT02469090|157557162|FG001|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
48924252|NCT02469090|157557163|FG002|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
48924253|NCT02469090|157557161|FG000|Period 1: Dose Titration Phase|Lack of Efficacy|11|||
48924254|NCT02469090|157557162|FG001|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
48924255|NCT02469090|157557163|FG002|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
48924256|NCT02469090|157557161|FG000|Period 2: Maintenance Treatment Phase|Adverse Event|0|||
48924257|NCT02469090|157557162|FG001|Period 2: Maintenance Treatment Phase|Adverse Event|5|||
48924258|NCT02469090|157557163|FG002|Period 2: Maintenance Treatment Phase|Adverse Event|15|||
48924259|NCT02469090|157557161|FG000|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0|||
48924260|NCT02469090|157557162|FG001|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3|||
48924261|NCT02469090|157557163|FG002|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4|||
48924262|NCT02469090|157557161|FG000|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
48924263|NCT02469090|157557162|FG001|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1|||
48924264|NCT02469090|157557163|FG002|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
48924265|NCT02469090|157557161|FG000|Period 2: Maintenance Treatment Phase|Death|0|||
48924266|NCT02469090|157557162|FG001|Period 2: Maintenance Treatment Phase|Death|0|||
48924267|NCT02469090|157557163|FG002|Period 2: Maintenance Treatment Phase|Death|1|||
48924268|NCT02018822|157557166|FG000|Overall Study|filling replaced by crown|0|||
48924269|NCT02018822|157557167|FG001|Overall Study|filling replaced by crown|1|||
48924270|NCT02018822|157557168|FG002|Overall Study|filling replaced by crown|0|||
48924271|NCT02018822|157557166|FG000|Overall Study|Physician Decision|0|||
48924272|NCT02018822|157557167|FG001|Overall Study|Physician Decision|1|||
48924273|NCT02018822|157557168|FG002|Overall Study|Physician Decision|1|||
48924274|NCT02018822|157557166|FG000|Overall Study|Lost to Follow-up|6|||
48924275|NCT02018822|157557167|FG001|Overall Study|Lost to Follow-up|6|||
48924276|NCT02018822|157557168|FG002|Overall Study|Lost to Follow-up|5|||
48924277|NCT01425203|157557169|FG000|Treatment Phase|DC during PR Lead-in Phase|3|||
48924278|NCT01425203|157557170|FG001|Treatment Phase|DC during PR Lead-in Phase|1|||
48924279|NCT01425203|157557171|FG002|Treatment Phase|DC during PR Lead-in Phase|0|||
48924280|NCT01425203|157557169|FG000|Treatment Phase|Failure at futility timepoint|8|||
48924281|NCT01425203|157557170|FG001|Treatment Phase|Failure at futility timepoint|27|||
48924282|NCT01425203|157557171|FG002|Treatment Phase|Failure at futility timepoint|0|||
48924283|NCT01425203|157557169|FG000|Treatment Phase|Other virologic failure criteria|5|||
48924284|NCT01425203|157557170|FG001|Treatment Phase|Other virologic failure criteria|3|||
48924285|NCT01425203|157557171|FG002|Treatment Phase|Other virologic failure criteria|0|||
48924286|NCT01425203|157557169|FG000|Treatment Phase|Unidentified reasons|11|||
48924287|NCT01425203|157557170|FG001|Treatment Phase|Unidentified reasons|5|||
48924288|NCT01425203|157557171|FG002|Treatment Phase|Unidentified reasons|0|||
48924289|NCT01425203|157557169|FG000|Treatment Phase|Did not receive treatment|0|||
48924290|NCT01425203|157557170|FG001|Treatment Phase|Did not receive treatment|1|||
48924291|NCT01425203|157557171|FG002|Treatment Phase|Did not receive treatment|0|||
48924292|NCT01425203|157557169|FG000|Crossover Phase|Failure at futility timepoint|0|||
48924293|NCT01425203|157557170|FG001|Crossover Phase|Failure at futility timepoint|0|||
48924294|NCT01425203|157557171|FG002|Crossover Phase|Failure at futility timepoint|3|||
48924295|NCT01425203|157557169|FG000|Crossover Phase|Other virologic failure criteria|0|||
48924296|NCT01425203|157557170|FG001|Crossover Phase|Other virologic failure criteria|0|||
48924297|NCT01425203|157557171|FG002|Crossover Phase|Other virologic failure criteria|3|||
48924298|NCT00264875|157557172|FG000|Overall Study|Adverse Event|6|||
48924299|NCT00264875|157557172|FG000|Overall Study|Lost to Follow-up|6|||
48924300|NCT00264875|157557172|FG000|Overall Study|Protocol Violation|11|||
48924301|NCT00264875|157557172|FG000|Overall Study|Withdrawal by Subject|7|||
48924302|NCT00283595|157557173|FG000|Overall Study|Withdrawal by Subject|1|||
48924303|NCT00283595|157557174|FG001|Overall Study|Withdrawal by Subject|2|||
48924304|NCT00845728|157557179|FG000|Overall Study|Abnormal laboratory value (s)|2|||
48924305|NCT00845728|157557180|FG001|Overall Study|Abnormal laboratory value (s)|2|||
48924306|NCT00845728|157557179|FG000|Overall Study|Patient's inability to use the device|4|||
48924307|NCT00845728|157557180|FG001|Overall Study|Patient's inability to use the device|6|||
48924308|NCT00845728|157557179|FG000|Overall Study|Abnormal test procedure result (s)|7|||
48924309|NCT00845728|157557180|FG001|Overall Study|Abnormal test procedure result (s)|2|||
48924310|NCT00845728|157557179|FG000|Overall Study|Lost to Follow-up|22|||
48924311|NCT00845728|157557180|FG001|Overall Study|Lost to Follow-up|13|||
48924312|NCT00845728|157557179|FG000|Overall Study|Death|24|||
48924313|NCT00845728|157557180|FG001|Overall Study|Death|26|||
48924314|NCT00845728|157557179|FG000|Overall Study|Administrative Problems|34|||
48924315|NCT00845728|157557180|FG001|Overall Study|Administrative Problems|26|||
48924316|NCT00845728|157557179|FG000|Overall Study|Protocol Violation|36|||
48924317|NCT00845728|157557180|FG001|Overall Study|Protocol Violation|24|||
48924318|NCT00845728|157557179|FG000|Overall Study|Lack of Efficacy|51|||
48924319|NCT00845728|157557180|FG001|Overall Study|Lack of Efficacy|39|||
48924320|NCT00845728|157557179|FG000|Overall Study|Adverse Event|101|||
48924321|NCT00845728|157557180|FG001|Overall Study|Adverse Event|96|||
48924322|NCT00845728|157557179|FG000|Overall Study|Withdrawal by Subject|105|||
48924323|NCT00845728|157557180|FG001|Overall Study|Withdrawal by Subject|108|||
48924324|NCT02559687|157557181|FG000|Overall Study|Death|112|||
48924325|NCT02559687|157557181|FG000|Overall Study|Sponsor Decision|5|||
48924326|NCT02559687|157557181|FG000|Overall Study|Withdrawal by Subject|4|||
48924327|NCT03529773|157557182|FG000|Overall Study|Adverse Event|0|||
48924328|NCT03529773|157557183|FG001|Overall Study|Adverse Event|0|||
48924329|NCT03529773|157557184|FG002|Overall Study|Adverse Event|0|||
48924330|NCT03529773|157557185|FG003|Overall Study|Adverse Event|0|||
48924331|NCT03529773|157557186|FG004|Overall Study|Adverse Event|0|||
48924332|NCT03529773|157557187|FG005|Overall Study|Adverse Event|0|||
48924333|NCT03529773|157557188|FG006|Overall Study|Adverse Event|0|||
48924334|NCT03529773|157557189|FG007|Overall Study|Adverse Event|0|||
48924335|NCT03529773|157557190|FG008|Overall Study|Adverse Event|0|||
48924336|NCT03529773|157557191|FG009|Overall Study|Adverse Event|0|||
48924337|NCT03529773|157557192|FG010|Overall Study|Adverse Event|0|||
48924338|NCT03529773|157557193|FG011|Overall Study|Adverse Event|0|||
48924339|NCT03529773|157557194|FG012|Overall Study|Adverse Event|0|||
48924340|NCT03529773|157557195|FG013|Overall Study|Adverse Event|0|||
48924341|NCT03529773|157557196|FG014|Overall Study|Adverse Event|0|||
48924342|NCT03529773|157557197|FG015|Overall Study|Adverse Event|0|||
48924343|NCT03529773|157557198|FG016|Overall Study|Adverse Event|0|||
48924344|NCT03529773|157557199|FG017|Overall Study|Adverse Event|0|||
48924345|NCT03529773|157557200|FG018|Overall Study|Adverse Event|0|||
48924346|NCT03529773|157557201|FG019|Overall Study|Adverse Event|0|||
48924347|NCT03529773|157557202|FG020|Overall Study|Adverse Event|0|||
48924348|NCT03529773|157557203|FG021|Overall Study|Adverse Event|0|||
48924349|NCT03529773|157557204|FG022|Overall Study|Adverse Event|0|||
48924350|NCT03529773|157557205|FG023|Overall Study|Adverse Event|0|||
48924351|NCT03529773|157557206|FG024|Overall Study|Adverse Event|0|||
48924352|NCT03529773|157557207|FG025|Overall Study|Adverse Event|0|||
48924353|NCT03529773|157557208|FG026|Overall Study|Adverse Event|0|||
48924354|NCT03529773|157557209|FG027|Overall Study|Adverse Event|0|||
49165363|NCT00803361|158441785|FG001|Overall Study|Lack of Efficacy|13|||
49165364|NCT00803361|158441784|FG000|Overall Study|Lost to Follow-up|1|||
49165365|NCT00803361|158441785|FG001|Overall Study|Lost to Follow-up|2|||
49165366|NCT00803361|158441784|FG000|Overall Study|Physician Decision|1|||
49165367|NCT00803361|158441785|FG001|Overall Study|Physician Decision|0|||
48924355|NCT03529773|157557210|FG028|Overall Study|Adverse Event|0|||
48924356|NCT03529773|157557211|FG029|Overall Study|Adverse Event|0|||
48924357|NCT03529773|157557212|FG030|Overall Study|Adverse Event|1|||
48924358|NCT03529773|157557213|FG031|Overall Study|Adverse Event|0|||
49165368|NCT00803361|158441784|FG000|Overall Study|Protocol Violation|2|||
48924359|NCT03529773|157557214|FG032|Overall Study|Adverse Event|0|||
49165369|NCT00803361|158441785|FG001|Overall Study|Protocol Violation|4|||
48924360|NCT03529773|157557215|FG033|Overall Study|Adverse Event|0|||
48924361|NCT03529773|157557216|FG034|Overall Study|Adverse Event|0|||
48924362|NCT03529773|157557217|FG035|Overall Study|Adverse Event|1|||
48924363|NCT03529773|157557218|FG036|Overall Study|Adverse Event|0|||
48924364|NCT03529773|157557219|FG037|Overall Study|Adverse Event|0|||
48924365|NCT03529773|157557220|FG038|Overall Study|Adverse Event|1|||
48924366|NCT03529773|157557221|FG039|Overall Study|Adverse Event|1|||
49165370|NCT00803361|158441784|FG000|Overall Study|Withdrawal by Subject|5|||
48924367|NCT03529773|157557182|FG000|Overall Study|Death|0|||
49165371|NCT00803361|158441785|FG001|Overall Study|Withdrawal by Subject|6|||
49165372|NCT02185534|158441789|FG000|First Period|Withdrawal by Subject|0|||
49165373|NCT02185534|158441790|FG001|First Period|Withdrawal by Subject|0|||
49165374|NCT02185534|158441791|FG002|First Period|Withdrawal by Subject|0|||
49165375|NCT02185534|158441792|FG003|First Period|Withdrawal by Subject|1|||
49165376|NCT02185534|158441793|FG004|First Period|Withdrawal by Subject|0|||
49165377|NCT02185534|158441794|FG005|First Period|Withdrawal by Subject|0|||
49165378|NCT02185534|158441789|FG000|First Washout Period|Withdrawal by Subject|1|||
49165379|NCT02185534|158441790|FG001|First Washout Period|Withdrawal by Subject|0|||
49165380|NCT02185534|158441791|FG002|First Washout Period|Withdrawal by Subject|0|||
49165381|NCT02185534|158441792|FG003|First Washout Period|Withdrawal by Subject|0|||
49165382|NCT02185534|158441793|FG004|First Washout Period|Withdrawal by Subject|1|||
49165383|NCT02185534|158441794|FG005|First Washout Period|Withdrawal by Subject|0|||
49165384|NCT02185534|158441789|FG000|First Washout Period|Protocol Violation|0|||
49165385|NCT02185534|158441790|FG001|First Washout Period|Protocol Violation|0|||
49165386|NCT02185534|158441791|FG002|First Washout Period|Protocol Violation|0|||
49165387|NCT02185534|158441792|FG003|First Washout Period|Protocol Violation|0|||
49165388|NCT02185534|158441793|FG004|First Washout Period|Protocol Violation|0|||
49165389|NCT02185534|158441794|FG005|First Washout Period|Protocol Violation|1|||
49165390|NCT00363142|158441795|FG000|Overall Study|Adverse Event|2|||
49165391|NCT00363142|158441796|FG001|Overall Study|Adverse Event|0|||
49165392|NCT00363142|158441795|FG000|Overall Study|Lack of Efficacy|0|||
49165393|NCT00363142|158441796|FG001|Overall Study|Lack of Efficacy|1|||
49165394|NCT00363142|158441795|FG000|Overall Study|Lost to Follow-up|1|||
49165395|NCT00363142|158441796|FG001|Overall Study|Lost to Follow-up|0|||
49165396|NCT00363142|158441795|FG000|Overall Study|Non-compliance|1|||
49165397|NCT00363142|158441796|FG001|Overall Study|Non-compliance|1|||
49165398|NCT00363142|158441795|FG000|Overall Study|Withdrawal by Subject|3|||
49165399|NCT00363142|158441796|FG001|Overall Study|Withdrawal by Subject|1|||
49165400|NCT00527618|158441797|FG000|Week 1-12 (First Intervention)|Lost to Follow-up|3|||
49165401|NCT00527618|158441798|FG001|Week 1-12 (First Intervention)|Lost to Follow-up|1|||
49165402|NCT00527618|158441797|FG000|Week 1-12 (First Intervention)|Adverse Event|0|||
49165403|NCT00527618|158441798|FG001|Week 1-12 (First Intervention)|Adverse Event|1|||
49165404|NCT00527618|158441797|FG000|Week 13-14 (Washout)|Lost to Follow-up|1|||
49165405|NCT00527618|158441798|FG001|Week 13-14 (Washout)|Lost to Follow-up|0|||
49165406|NCT00527618|158441797|FG000|Week 15-18 (Second Intervention)|Lost to Follow-up|0|||
48924368|NCT03529773|157557183|FG001|Overall Study|Death|0|||
48924369|NCT03529773|157557184|FG002|Overall Study|Death|0|||
48924370|NCT03529773|157557185|FG003|Overall Study|Death|0|||
48924371|NCT03529773|157557186|FG004|Overall Study|Death|0|||
48924372|NCT03529773|157557187|FG005|Overall Study|Death|0|||
48924373|NCT03529773|157557188|FG006|Overall Study|Death|0|||
48924374|NCT03529773|157557189|FG007|Overall Study|Death|0|||
48924375|NCT03529773|157557190|FG008|Overall Study|Death|0|||
48924376|NCT03529773|157557191|FG009|Overall Study|Death|0|||
48924377|NCT03529773|157557192|FG010|Overall Study|Death|0|||
48924378|NCT03529773|157557193|FG011|Overall Study|Death|0|||
48924379|NCT03529773|157557194|FG012|Overall Study|Death|1|||
48924380|NCT03529773|157557195|FG013|Overall Study|Death|0|||
48924381|NCT03529773|157557196|FG014|Overall Study|Death|0|||
48924382|NCT03529773|157557197|FG015|Overall Study|Death|0|||
48924383|NCT03529773|157557198|FG016|Overall Study|Death|0|||
48924384|NCT03529773|157557199|FG017|Overall Study|Death|0|||
48924385|NCT03529773|157557200|FG018|Overall Study|Death|0|||
48924386|NCT03529773|157557201|FG019|Overall Study|Death|1|||
48924387|NCT03529773|157557202|FG020|Overall Study|Death|0|||
48924388|NCT03529773|157557203|FG021|Overall Study|Death|0|||
48924389|NCT03529773|157557204|FG022|Overall Study|Death|1|||
48924390|NCT03529773|157557205|FG023|Overall Study|Death|0|||
48924391|NCT03529773|157557206|FG024|Overall Study|Death|0|||
48924392|NCT03529773|157557207|FG025|Overall Study|Death|0|||
48924393|NCT03529773|157557208|FG026|Overall Study|Death|0|||
48924394|NCT03529773|157557209|FG027|Overall Study|Death|0|||
48924395|NCT03529773|157557210|FG028|Overall Study|Death|0|||
48924396|NCT03529773|157557211|FG029|Overall Study|Death|0|||
48924397|NCT03529773|157557212|FG030|Overall Study|Death|0|||
48924398|NCT03529773|157557213|FG031|Overall Study|Death|0|||
48924399|NCT03529773|157557214|FG032|Overall Study|Death|0|||
48924400|NCT03529773|157557215|FG033|Overall Study|Death|1|||
48924401|NCT03529773|157557216|FG034|Overall Study|Death|1|||
48924402|NCT03529773|157557217|FG035|Overall Study|Death|0|||
48924403|NCT03529773|157557218|FG036|Overall Study|Death|1|||
48924404|NCT03529773|157557219|FG037|Overall Study|Death|0|||
48924405|NCT03529773|157557220|FG038|Overall Study|Death|0|||
48924406|NCT03529773|157557221|FG039|Overall Study|Death|0|||
48924407|NCT03529773|157557182|FG000|Overall Study|Lost to Follow-up|0|||
48924408|NCT03529773|157557183|FG001|Overall Study|Lost to Follow-up|0|||
48924409|NCT03529773|157557184|FG002|Overall Study|Lost to Follow-up|1|||
48924410|NCT03529773|157557185|FG003|Overall Study|Lost to Follow-up|0|||
48924411|NCT03529773|157557186|FG004|Overall Study|Lost to Follow-up|1|||
48924412|NCT03529773|157557187|FG005|Overall Study|Lost to Follow-up|1|||
48924413|NCT03529773|157557188|FG006|Overall Study|Lost to Follow-up|0|||
48924414|NCT03529773|157557189|FG007|Overall Study|Lost to Follow-up|0|||
48924415|NCT03529773|157557190|FG008|Overall Study|Lost to Follow-up|0|||
48924416|NCT03529773|157557191|FG009|Overall Study|Lost to Follow-up|0|||
48924417|NCT03529773|157557192|FG010|Overall Study|Lost to Follow-up|0|||
48924418|NCT03529773|157557193|FG011|Overall Study|Lost to Follow-up|0|||
48924419|NCT03529773|157557194|FG012|Overall Study|Lost to Follow-up|0|||
48924420|NCT03529773|157557195|FG013|Overall Study|Lost to Follow-up|1|||
48924421|NCT03529773|157557196|FG014|Overall Study|Lost to Follow-up|4|||
48924422|NCT03529773|157557197|FG015|Overall Study|Lost to Follow-up|1|||
48924423|NCT03529773|157557198|FG016|Overall Study|Lost to Follow-up|1|||
48924424|NCT03529773|157557199|FG017|Overall Study|Lost to Follow-up|0|||
48924425|NCT03529773|157557200|FG018|Overall Study|Lost to Follow-up|1|||
48924426|NCT03529773|157557201|FG019|Overall Study|Lost to Follow-up|1|||
48924427|NCT03529773|157557202|FG020|Overall Study|Lost to Follow-up|2|||
48924428|NCT03529773|157557203|FG021|Overall Study|Lost to Follow-up|4|||
48924429|NCT03529773|157557204|FG022|Overall Study|Lost to Follow-up|3|||
48924430|NCT03529773|157557205|FG023|Overall Study|Lost to Follow-up|4|||
48924431|NCT03529773|157557206|FG024|Overall Study|Lost to Follow-up|3|||
48924432|NCT03529773|157557207|FG025|Overall Study|Lost to Follow-up|5|||
48924433|NCT03529773|157557208|FG026|Overall Study|Lost to Follow-up|5|||
48924434|NCT03529773|157557209|FG027|Overall Study|Lost to Follow-up|0|||
48924435|NCT03529773|157557210|FG028|Overall Study|Lost to Follow-up|0|||
48924436|NCT03529773|157557211|FG029|Overall Study|Lost to Follow-up|0|||
48924437|NCT03529773|157557212|FG030|Overall Study|Lost to Follow-up|1|||
48924438|NCT03529773|157557213|FG031|Overall Study|Lost to Follow-up|0|||
48924439|NCT03529773|157557214|FG032|Overall Study|Lost to Follow-up|0|||
48924440|NCT03529773|157557215|FG033|Overall Study|Lost to Follow-up|1|||
48924441|NCT03529773|157557216|FG034|Overall Study|Lost to Follow-up|1|||
48924442|NCT03529773|157557217|FG035|Overall Study|Lost to Follow-up|0|||
48924443|NCT03529773|157557218|FG036|Overall Study|Lost to Follow-up|0|||
48924444|NCT03529773|157557219|FG037|Overall Study|Lost to Follow-up|3|||
48924445|NCT03529773|157557220|FG038|Overall Study|Lost to Follow-up|1|||
48924446|NCT03529773|157557221|FG039|Overall Study|Lost to Follow-up|1|||
48924447|NCT03529773|157557182|FG000|Overall Study|No longer meets eligibility criteria|0|||
48924448|NCT03529773|157557183|FG001|Overall Study|No longer meets eligibility criteria|0|||
48924449|NCT03529773|157557184|FG002|Overall Study|No longer meets eligibility criteria|0|||
48924450|NCT03529773|157557185|FG003|Overall Study|No longer meets eligibility criteria|0|||
48924451|NCT03529773|157557186|FG004|Overall Study|No longer meets eligibility criteria|0|||
48924452|NCT03529773|157557187|FG005|Overall Study|No longer meets eligibility criteria|0|||
48924453|NCT03529773|157557188|FG006|Overall Study|No longer meets eligibility criteria|0|||
48924454|NCT03529773|157557189|FG007|Overall Study|No longer meets eligibility criteria|0|||
48924455|NCT03529773|157557190|FG008|Overall Study|No longer meets eligibility criteria|0|||
48924456|NCT03529773|157557191|FG009|Overall Study|No longer meets eligibility criteria|0|||
48924457|NCT03529773|157557192|FG010|Overall Study|No longer meets eligibility criteria|0|||
48924458|NCT03529773|157557193|FG011|Overall Study|No longer meets eligibility criteria|0|||
48924459|NCT03529773|157557194|FG012|Overall Study|No longer meets eligibility criteria|0|||
48924460|NCT03529773|157557195|FG013|Overall Study|No longer meets eligibility criteria|0|||
48924461|NCT03529773|157557196|FG014|Overall Study|No longer meets eligibility criteria|0|||
48924462|NCT03529773|157557197|FG015|Overall Study|No longer meets eligibility criteria|0|||
48924463|NCT03529773|157557198|FG016|Overall Study|No longer meets eligibility criteria|0|||
48924464|NCT03529773|157557199|FG017|Overall Study|No longer meets eligibility criteria|0|||
48924465|NCT03529773|157557200|FG018|Overall Study|No longer meets eligibility criteria|0|||
48924466|NCT03529773|157557201|FG019|Overall Study|No longer meets eligibility criteria|0|||
48924467|NCT03529773|157557202|FG020|Overall Study|No longer meets eligibility criteria|0|||
48924468|NCT03529773|157557203|FG021|Overall Study|No longer meets eligibility criteria|0|||
48924469|NCT03529773|157557204|FG022|Overall Study|No longer meets eligibility criteria|1|||
48924470|NCT03529773|157557205|FG023|Overall Study|No longer meets eligibility criteria|0|||
48924471|NCT03529773|157557206|FG024|Overall Study|No longer meets eligibility criteria|0|||
48924472|NCT03529773|157557207|FG025|Overall Study|No longer meets eligibility criteria|0|||
48924473|NCT03529773|157557208|FG026|Overall Study|No longer meets eligibility criteria|0|||
48924474|NCT03529773|157557209|FG027|Overall Study|No longer meets eligibility criteria|0|||
48924475|NCT03529773|157557210|FG028|Overall Study|No longer meets eligibility criteria|0|||
48924476|NCT03529773|157557211|FG029|Overall Study|No longer meets eligibility criteria|0|||
48924477|NCT03529773|157557212|FG030|Overall Study|No longer meets eligibility criteria|0|||
48924478|NCT03529773|157557213|FG031|Overall Study|No longer meets eligibility criteria|0|||
48924479|NCT03529773|157557214|FG032|Overall Study|No longer meets eligibility criteria|0|||
48924480|NCT03529773|157557215|FG033|Overall Study|No longer meets eligibility criteria|0|||
48924481|NCT03529773|157557216|FG034|Overall Study|No longer meets eligibility criteria|0|||
48924482|NCT03529773|157557217|FG035|Overall Study|No longer meets eligibility criteria|0|||
48924483|NCT03529773|157557218|FG036|Overall Study|No longer meets eligibility criteria|0|||
48924484|NCT03529773|157557219|FG037|Overall Study|No longer meets eligibility criteria|0|||
48924485|NCT03529773|157557220|FG038|Overall Study|No longer meets eligibility criteria|1|||
48924486|NCT03529773|157557221|FG039|Overall Study|No longer meets eligibility criteria|0|||
49165407|NCT00527618|158441798|FG001|Week 15-18 (Second Intervention)|Lost to Follow-up|1|||
49165408|NCT00527618|158441797|FG000|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0|||
49165409|NCT00527618|158441798|FG001|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1|||
49165410|NCT00527618|158441797|FG000|Week 15-18 (Second Intervention)|Withdrawal by Subject|0|||
48924487|NCT03529773|157557182|FG000|Overall Study|Other|0|||
48924488|NCT03529773|157557183|FG001|Overall Study|Other|0|||
48924489|NCT03529773|157557184|FG002|Overall Study|Other|0|||
48924490|NCT03529773|157557185|FG003|Overall Study|Other|0|||
48924491|NCT03529773|157557186|FG004|Overall Study|Other|0|||
48924492|NCT03529773|157557187|FG005|Overall Study|Other|0|||
49165411|NCT00527618|158441798|FG001|Week 15-18 (Second Intervention)|Withdrawal by Subject|1|||
48924493|NCT03529773|157557188|FG006|Overall Study|Other|0|||
48924494|NCT03529773|157557189|FG007|Overall Study|Other|0|||
48924495|NCT03529773|157557190|FG008|Overall Study|Other|0|||
48924496|NCT03529773|157557191|FG009|Overall Study|Other|0|||
48924497|NCT03529773|157557192|FG010|Overall Study|Other|0|||
48924498|NCT03529773|157557193|FG011|Overall Study|Other|0|||
48924499|NCT03529773|157557194|FG012|Overall Study|Other|1|||
48924500|NCT03529773|157557195|FG013|Overall Study|Other|0|||
48924501|NCT03529773|157557196|FG014|Overall Study|Other|2|||
48924502|NCT03529773|157557197|FG015|Overall Study|Other|0|||
48924503|NCT03529773|157557198|FG016|Overall Study|Other|0|||
48924504|NCT03529773|157557199|FG017|Overall Study|Other|3|||
48924505|NCT03529773|157557200|FG018|Overall Study|Other|0|||
48924506|NCT03529773|157557201|FG019|Overall Study|Other|0|||
48924507|NCT03529773|157557202|FG020|Overall Study|Other|1|||
48924508|NCT03529773|157557203|FG021|Overall Study|Other|0|||
48924509|NCT03529773|157557204|FG022|Overall Study|Other|1|||
48924510|NCT03529773|157557205|FG023|Overall Study|Other|0|||
48924511|NCT03529773|157557206|FG024|Overall Study|Other|3|||
48924512|NCT03529773|157557207|FG025|Overall Study|Other|2|||
48924513|NCT03529773|157557208|FG026|Overall Study|Other|2|||
48924514|NCT03529773|157557209|FG027|Overall Study|Other|0|||
48924515|NCT03529773|157557210|FG028|Overall Study|Other|0|||
48924516|NCT03529773|157557211|FG029|Overall Study|Other|0|||
48924517|NCT03529773|157557212|FG030|Overall Study|Other|0|||
48924518|NCT03529773|157557213|FG031|Overall Study|Other|0|||
48924519|NCT03529773|157557214|FG032|Overall Study|Other|0|||
48924520|NCT03529773|157557215|FG033|Overall Study|Other|0|||
48924521|NCT03529773|157557216|FG034|Overall Study|Other|1|||
48924522|NCT03529773|157557217|FG035|Overall Study|Other|1|||
48924523|NCT03529773|157557218|FG036|Overall Study|Other|0|||
48924524|NCT03529773|157557219|FG037|Overall Study|Other|0|||
48924525|NCT03529773|157557220|FG038|Overall Study|Other|0|||
48924526|NCT03529773|157557221|FG039|Overall Study|Other|0|||
48924527|NCT03529773|157557182|FG000|Overall Study|Physician Decision|0|||
49165412|NCT00648037|158441801|FG000|Overall Study|Not Treated|1|||
48924528|NCT03529773|157557183|FG001|Overall Study|Physician Decision|0|||
48924529|NCT03529773|157557184|FG002|Overall Study|Physician Decision|0|||
48924530|NCT03529773|157557185|FG003|Overall Study|Physician Decision|0|||
48924531|NCT03529773|157557186|FG004|Overall Study|Physician Decision|0|||
48924532|NCT03529773|157557187|FG005|Overall Study|Physician Decision|0|||
48924533|NCT03529773|157557188|FG006|Overall Study|Physician Decision|0|||
48924534|NCT03529773|157557189|FG007|Overall Study|Physician Decision|0|||
48924535|NCT03529773|157557190|FG008|Overall Study|Physician Decision|0|||
48924536|NCT03529773|157557191|FG009|Overall Study|Physician Decision|0|||
48924537|NCT03529773|157557192|FG010|Overall Study|Physician Decision|0|||
48924538|NCT03529773|157557193|FG011|Overall Study|Physician Decision|0|||
48924539|NCT03529773|157557194|FG012|Overall Study|Physician Decision|0|||
48924540|NCT03529773|157557195|FG013|Overall Study|Physician Decision|0|||
48924541|NCT03529773|157557196|FG014|Overall Study|Physician Decision|0|||
48924542|NCT03529773|157557197|FG015|Overall Study|Physician Decision|0|||
48924543|NCT03529773|157557198|FG016|Overall Study|Physician Decision|0|||
48924544|NCT03529773|157557199|FG017|Overall Study|Physician Decision|0|||
48924545|NCT03529773|157557200|FG018|Overall Study|Physician Decision|0|||
48924546|NCT03529773|157557201|FG019|Overall Study|Physician Decision|1|||
48924547|NCT03529773|157557202|FG020|Overall Study|Physician Decision|1|||
48924548|NCT03529773|157557203|FG021|Overall Study|Physician Decision|0|||
48924549|NCT03529773|157557204|FG022|Overall Study|Physician Decision|0|||
48924550|NCT03529773|157557205|FG023|Overall Study|Physician Decision|0|||
48924551|NCT03529773|157557206|FG024|Overall Study|Physician Decision|0|||
48924552|NCT03529773|157557207|FG025|Overall Study|Physician Decision|0|||
48924553|NCT03529773|157557208|FG026|Overall Study|Physician Decision|0|||
48924554|NCT03529773|157557209|FG027|Overall Study|Physician Decision|0|||
48924555|NCT03529773|157557210|FG028|Overall Study|Physician Decision|0|||
48924556|NCT03529773|157557211|FG029|Overall Study|Physician Decision|0|||
48924557|NCT03529773|157557212|FG030|Overall Study|Physician Decision|0|||
48924558|NCT03529773|157557213|FG031|Overall Study|Physician Decision|0|||
48924559|NCT03529773|157557214|FG032|Overall Study|Physician Decision|0|||
48924560|NCT03529773|157557215|FG033|Overall Study|Physician Decision|0|||
48924561|NCT03529773|157557216|FG034|Overall Study|Physician Decision|0|||
48924562|NCT03529773|157557217|FG035|Overall Study|Physician Decision|0|||
48924563|NCT03529773|157557218|FG036|Overall Study|Physician Decision|0|||
49165413|NCT00648037|158441801|FG000|Overall Study|Withdrawal by Subject|1|||
49165414|NCT00648037|158441801|FG000|Overall Study|Adverse Event|11|||
48924564|NCT03529773|157557219|FG037|Overall Study|Physician Decision|0|||
48924565|NCT03529773|157557220|FG038|Overall Study|Physician Decision|0|||
48924566|NCT03529773|157557221|FG039|Overall Study|Physician Decision|0|||
48924567|NCT03529773|157557182|FG000|Overall Study|Protocol Violation|0|||
48924568|NCT03529773|157557183|FG001|Overall Study|Protocol Violation|0|||
48924569|NCT03529773|157557184|FG002|Overall Study|Protocol Violation|0|||
48924570|NCT03529773|157557185|FG003|Overall Study|Protocol Violation|0|||
48924571|NCT03529773|157557186|FG004|Overall Study|Protocol Violation|0|||
49165415|NCT00648037|158441801|FG000|Overall Study|Relapse|2|||
49165416|NCT00648037|158441801|FG000|Overall Study|Other|1|||
49165417|NCT00251693|158441802|FG000|Overall Study|Adverse Event|17|||
49165418|NCT00251693|158441803|FG001|Overall Study|Adverse Event|9|||
49165419|NCT00251693|158441804|FG002|Overall Study|Adverse Event|9|||
49165420|NCT00251693|158441802|FG000|Overall Study|Protocol Violation|2|||
49165421|NCT00251693|158441803|FG001|Overall Study|Protocol Violation|0|||
49165422|NCT00251693|158441804|FG002|Overall Study|Protocol Violation|2|||
49165423|NCT00251693|158441802|FG000|Overall Study|Lost to Follow-up|12|||
49165424|NCT00251693|158441803|FG001|Overall Study|Lost to Follow-up|7|||
49165425|NCT00251693|158441804|FG002|Overall Study|Lost to Follow-up|8|||
49165426|NCT00251693|158441802|FG000|Overall Study|Withdrawal by Subject|11|||
49165427|NCT00251693|158441803|FG001|Overall Study|Withdrawal by Subject|17|||
49165428|NCT00251693|158441804|FG002|Overall Study|Withdrawal by Subject|14|||
49165429|NCT00251693|158441802|FG000|Overall Study|Lack of Efficacy|0|||
49165430|NCT00251693|158441803|FG001|Overall Study|Lack of Efficacy|1|||
49165431|NCT00251693|158441804|FG002|Overall Study|Lack of Efficacy|0|||
49165432|NCT00251693|158441802|FG000|Overall Study|Inclusion/exclusion criteria not met|5|||
49165433|NCT00251693|158441803|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
49165434|NCT00251693|158441804|FG002|Overall Study|Inclusion/exclusion criteria not met|8|||
49165435|NCT00251693|158441802|FG000|Overall Study|Noncompliant|0|||
49165436|NCT00251693|158441803|FG001|Overall Study|Noncompliant|0|||
49165437|NCT00251693|158441804|FG002|Overall Study|Noncompliant|2|||
49165438|NCT00251693|158441802|FG000|Overall Study|Possible Barrett's esophagus|3|||
48924572|NCT03529773|157557187|FG005|Overall Study|Protocol Violation|0|||
48924573|NCT03529773|157557188|FG006|Overall Study|Protocol Violation|0|||
48924574|NCT03529773|157557189|FG007|Overall Study|Protocol Violation|0|||
48924575|NCT03529773|157557190|FG008|Overall Study|Protocol Violation|0|||
48924576|NCT03529773|157557191|FG009|Overall Study|Protocol Violation|0|||
48924577|NCT03529773|157557192|FG010|Overall Study|Protocol Violation|0|||
48924578|NCT03529773|157557193|FG011|Overall Study|Protocol Violation|0|||
48924579|NCT03529773|157557194|FG012|Overall Study|Protocol Violation|0|||
49165439|NCT00251693|158441803|FG001|Overall Study|Possible Barrett's esophagus|5|||
49165440|NCT00251693|158441804|FG002|Overall Study|Possible Barrett's esophagus|2|||
49165441|NCT00251693|158441802|FG000|Overall Study|Subject request/subject unavailable|1|||
49014878|NCT01405820|157890464|FG002|Randomized Treatment Period|Adverse Event|3|||
49014879|NCT01405820|157890465|FG003|Randomized Treatment Period|Adverse Event|0|||
49014880|NCT01405820|157890466|FG004|Randomized Treatment Period|Adverse Event|2|||
48924580|NCT03529773|157557195|FG013|Overall Study|Protocol Violation|0|||
48924581|NCT03529773|157557196|FG014|Overall Study|Protocol Violation|0|||
48924582|NCT03529773|157557197|FG015|Overall Study|Protocol Violation|0|||
48924583|NCT03529773|157557198|FG016|Overall Study|Protocol Violation|0|||
48924584|NCT03529773|157557199|FG017|Overall Study|Protocol Violation|0|||
48924585|NCT03529773|157557200|FG018|Overall Study|Protocol Violation|0|||
48924586|NCT03529773|157557201|FG019|Overall Study|Protocol Violation|0|||
48924587|NCT03529773|157557202|FG020|Overall Study|Protocol Violation|0|||
48924588|NCT03529773|157557203|FG021|Overall Study|Protocol Violation|0|||
48924589|NCT03529773|157557204|FG022|Overall Study|Protocol Violation|0|||
48924590|NCT03529773|157557205|FG023|Overall Study|Protocol Violation|0|||
48924591|NCT03529773|157557206|FG024|Overall Study|Protocol Violation|0|||
48924592|NCT03529773|157557207|FG025|Overall Study|Protocol Violation|0|||
48924593|NCT03529773|157557208|FG026|Overall Study|Protocol Violation|0|||
49165442|NCT00251693|158441803|FG001|Overall Study|Subject request/subject unavailable|2|||
49165443|NCT00251693|158441804|FG002|Overall Study|Subject request/subject unavailable|0|||
49165444|NCT00251693|158441802|FG000|Overall Study|Abnormal laboratory findings|0|||
49165445|NCT00251693|158441803|FG001|Overall Study|Abnormal laboratory findings|0|||
49165446|NCT00251693|158441804|FG002|Overall Study|Abnormal laboratory findings|1|||
49165447|NCT00421148|158441807|FG000|Overall Study|Lost to Follow-up|0|||
49165448|NCT00421148|158441808|FG001|Overall Study|Lost to Follow-up|0|||
49165449|NCT00421148|158441809|FG002|Overall Study|Lost to Follow-up|0|||
49165450|NCT00421148|158441810|FG003|Overall Study|Lost to Follow-up|0|||
49165451|NCT00421148|158441811|FG004|Overall Study|Lost to Follow-up|0|||
49165452|NCT00421148|158441812|FG005|Overall Study|Lost to Follow-up|0|||
49165453|NCT00421148|158441813|FG006|Overall Study|Lost to Follow-up|0|||
49165454|NCT00421148|158441814|FG007|Overall Study|Lost to Follow-up|0|||
49165455|NCT00421148|158441815|FG008|Overall Study|Lost to Follow-up|0|||
49165456|NCT00421148|158441816|FG009|Overall Study|Lost to Follow-up|0|||
49165457|NCT00421148|158441817|FG010|Overall Study|Lost to Follow-up|0|||
49165458|NCT00421148|158441818|FG011|Overall Study|Lost to Follow-up|0|||
49165459|NCT00421148|158441819|FG012|Overall Study|Lost to Follow-up|0|||
49165460|NCT00421148|158441820|FG013|Overall Study|Lost to Follow-up|0|||
49165461|NCT00421148|158441821|FG014|Overall Study|Lost to Follow-up|0|||
49165462|NCT00421148|158441822|FG015|Overall Study|Lost to Follow-up|0|||
49165463|NCT00421148|158441823|FG016|Overall Study|Lost to Follow-up|0|||
49165464|NCT00421148|158441824|FG017|Overall Study|Lost to Follow-up|1|||
49165465|NCT00421148|158441825|FG018|Overall Study|Lost to Follow-up|0|||
49165466|NCT00421148|158441826|FG019|Overall Study|Lost to Follow-up|0|||
49165467|NCT00421148|158441807|FG000|Overall Study|Withdrawal by Subject|0|||
49165468|NCT00421148|158441808|FG001|Overall Study|Withdrawal by Subject|0|||
49165469|NCT00421148|158441809|FG002|Overall Study|Withdrawal by Subject|0|||
49165470|NCT00421148|158441810|FG003|Overall Study|Withdrawal by Subject|0|||
49165471|NCT00421148|158441811|FG004|Overall Study|Withdrawal by Subject|0|||
49165472|NCT00421148|158441812|FG005|Overall Study|Withdrawal by Subject|0|||
49165473|NCT00421148|158441813|FG006|Overall Study|Withdrawal by Subject|0|||
49165474|NCT00421148|158441814|FG007|Overall Study|Withdrawal by Subject|0|||
49165475|NCT00421148|158441815|FG008|Overall Study|Withdrawal by Subject|0|||
49165476|NCT00421148|158441816|FG009|Overall Study|Withdrawal by Subject|0|||
49165477|NCT00421148|158441817|FG010|Overall Study|Withdrawal by Subject|0|||
49165478|NCT00421148|158441818|FG011|Overall Study|Withdrawal by Subject|0|||
49165479|NCT00421148|158441819|FG012|Overall Study|Withdrawal by Subject|0|||
49165480|NCT00421148|158441820|FG013|Overall Study|Withdrawal by Subject|0|||
49165481|NCT00421148|158441821|FG014|Overall Study|Withdrawal by Subject|0|||
48924594|NCT03529773|157557209|FG027|Overall Study|Protocol Violation|0|||
48924595|NCT03529773|157557210|FG028|Overall Study|Protocol Violation|0|||
48924596|NCT03529773|157557211|FG029|Overall Study|Protocol Violation|0|||
48924597|NCT03529773|157557212|FG030|Overall Study|Protocol Violation|1|||
48924598|NCT03529773|157557213|FG031|Overall Study|Protocol Violation|0|||
48924599|NCT03529773|157557214|FG032|Overall Study|Protocol Violation|0|||
48924600|NCT03529773|157557215|FG033|Overall Study|Protocol Violation|0|||
48924601|NCT03529773|157557216|FG034|Overall Study|Protocol Violation|0|||
48924602|NCT03529773|157557217|FG035|Overall Study|Protocol Violation|0|||
48924603|NCT03529773|157557218|FG036|Overall Study|Protocol Violation|0|||
48924604|NCT03529773|157557219|FG037|Overall Study|Protocol Violation|0|||
48924605|NCT03529773|157557220|FG038|Overall Study|Protocol Violation|0|||
48924606|NCT03529773|157557221|FG039|Overall Study|Protocol Violation|0|||
48924607|NCT03529773|157557182|FG000|Overall Study|Withdrawal by Subject|0|||
48924608|NCT03529773|157557183|FG001|Overall Study|Withdrawal by Subject|0|||
48924609|NCT03529773|157557184|FG002|Overall Study|Withdrawal by Subject|0|||
49165482|NCT00421148|158441822|FG015|Overall Study|Withdrawal by Subject|0|||
49165483|NCT00421148|158441823|FG016|Overall Study|Withdrawal by Subject|0|||
49165484|NCT00421148|158441824|FG017|Overall Study|Withdrawal by Subject|1|||
49165485|NCT00421148|158441825|FG018|Overall Study|Withdrawal by Subject|0|||
49165486|NCT00421148|158441826|FG019|Overall Study|Withdrawal by Subject|0|||
49165487|NCT00421148|158441807|FG000|Overall Study|Protocol Violation|0|||
49165488|NCT00421148|158441808|FG001|Overall Study|Protocol Violation|0|||
49165489|NCT00421148|158441809|FG002|Overall Study|Protocol Violation|0|||
49165490|NCT00421148|158441810|FG003|Overall Study|Protocol Violation|0|||
49165491|NCT00421148|158441811|FG004|Overall Study|Protocol Violation|0|||
49165492|NCT00421148|158441812|FG005|Overall Study|Protocol Violation|1|||
49165493|NCT00421148|158441813|FG006|Overall Study|Protocol Violation|0|||
49165494|NCT00421148|158441814|FG007|Overall Study|Protocol Violation|0|||
49165495|NCT00421148|158441815|FG008|Overall Study|Protocol Violation|0|||
49165496|NCT00421148|158441816|FG009|Overall Study|Protocol Violation|0|||
49165497|NCT00421148|158441817|FG010|Overall Study|Protocol Violation|0|||
49165498|NCT00421148|158441818|FG011|Overall Study|Protocol Violation|0|||
49165499|NCT00421148|158441819|FG012|Overall Study|Protocol Violation|0|||
49165500|NCT00421148|158441820|FG013|Overall Study|Protocol Violation|0|||
49165501|NCT00421148|158441821|FG014|Overall Study|Protocol Violation|0|||
49165502|NCT00421148|158441822|FG015|Overall Study|Protocol Violation|0|||
49165503|NCT00421148|158441823|FG016|Overall Study|Protocol Violation|0|||
49165504|NCT00421148|158441824|FG017|Overall Study|Protocol Violation|0|||
49165505|NCT00421148|158441825|FG018|Overall Study|Protocol Violation|1|||
49165506|NCT00421148|158441826|FG019|Overall Study|Protocol Violation|0|||
49165507|NCT00997984|158441832|FG000|Overall Study|Adverse Event|1|||
49165508|NCT00997984|158441833|FG001|Overall Study|Adverse Event|8|||
49165509|NCT00997984|158441834|FG002|Overall Study|Adverse Event|8|||
49165510|NCT00997984|158441832|FG000|Overall Study|Protocol Violation|1|||
49165511|NCT00997984|158441833|FG001|Overall Study|Protocol Violation|3|||
49165512|NCT00997984|158441834|FG002|Overall Study|Protocol Violation|0|||
49165513|NCT00997984|158441832|FG000|Overall Study|Withdrawal by Subject|6|||
49165514|NCT00997984|158441833|FG001|Overall Study|Withdrawal by Subject|9|||
49165515|NCT00997984|158441834|FG002|Overall Study|Withdrawal by Subject|5|||
49165516|NCT00997984|158441832|FG000|Overall Study|Lost to Follow-up|8|||
49165517|NCT00997984|158441833|FG001|Overall Study|Lost to Follow-up|5|||
49165518|NCT00997984|158441834|FG002|Overall Study|Lost to Follow-up|4|||
49165519|NCT00997984|158441832|FG000|Overall Study|Lack of Efficacy|20|||
49165520|NCT00997984|158441833|FG001|Overall Study|Lack of Efficacy|6|||
49165521|NCT00997984|158441834|FG002|Overall Study|Lack of Efficacy|3|||
49165522|NCT00997984|158441832|FG000|Overall Study|Met exclusion criteria|1|||
49165523|NCT00997984|158441833|FG001|Overall Study|Met exclusion criteria|0|||
49165524|NCT00997984|158441834|FG002|Overall Study|Met exclusion criteria|0|||
49165525|NCT00997984|158441832|FG000|Overall Study|non-compliance|0|||
49165526|NCT00997984|158441833|FG001|Overall Study|non-compliance|2|||
49165527|NCT00997984|158441834|FG002|Overall Study|non-compliance|3|||
49165528|NCT00997984|158441832|FG000|Overall Study|Wrong medication dispensed|0|||
49165529|NCT00997984|158441833|FG001|Overall Study|Wrong medication dispensed|1|||
49165530|NCT00997984|158441834|FG002|Overall Study|Wrong medication dispensed|0|||
49165531|NCT00997984|158441832|FG000|Overall Study|Suicidal ideation|0|||
49165532|NCT00997984|158441833|FG001|Overall Study|Suicidal ideation|0|||
49165533|NCT00997984|158441834|FG002|Overall Study|Suicidal ideation|1|||
49165534|NCT00997984|158441832|FG000|Overall Study|Work schedule|0|||
49165535|NCT00997984|158441833|FG001|Overall Study|Work schedule|0|||
49165536|NCT00997984|158441834|FG002|Overall Study|Work schedule|2|||
49165537|NCT01182298|158441836|FG000|Overall Study|Lack of Efficacy|4|||
49165538|NCT01182298|158441836|FG000|Overall Study|Withdrawal by Subject|2|||
49165539|NCT04067492|158441837|FG000|Overall Study|Lost to Follow-up|0|||
49165540|NCT04067492|158441838|FG001|Overall Study|Lost to Follow-up|0|||
49165541|NCT04067492|158441839|FG002|Overall Study|Lost to Follow-up|0|||
49165542|NCT04067492|158441840|FG003|Overall Study|Lost to Follow-up|0|||
49165543|NCT04067492|158441841|FG004|Overall Study|Lost to Follow-up|0|||
49165544|NCT04067492|158441842|FG005|Overall Study|Lost to Follow-up|1|||
49165545|NCT04067492|158441837|FG000|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
49165546|NCT04067492|158441838|FG001|Overall Study|closure of city borders because of COVID-19 quarantine|1|||
49165547|NCT04067492|158441839|FG002|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
49165548|NCT04067492|158441840|FG003|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
49165549|NCT04067492|158441841|FG004|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
49165550|NCT04067492|158441842|FG005|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
49165551|NCT04067492|158441837|FG000|Overall Study|COVID-19 epidemiological situation|0|||
49165552|NCT04067492|158441838|FG001|Overall Study|COVID-19 epidemiological situation|0|||
49165553|NCT04067492|158441839|FG002|Overall Study|COVID-19 epidemiological situation|0|||
49165554|NCT04067492|158441840|FG003|Overall Study|COVID-19 epidemiological situation|1|||
49165555|NCT04067492|158441841|FG004|Overall Study|COVID-19 epidemiological situation|0|||
49165556|NCT04067492|158441842|FG005|Overall Study|COVID-19 epidemiological situation|0|||
49165557|NCT00437268|158441843|FG000|Overall Study|Adverse Event|1|||
49165558|NCT00437268|158441844|FG001|Overall Study|Adverse Event|1|||
49165559|NCT00437268|158441843|FG000|Overall Study|Withdrawal by Subject|2|||
49165560|NCT00437268|158441844|FG001|Overall Study|Withdrawal by Subject|2|||
49165561|NCT00437268|158441843|FG000|Overall Study|Progressive disease|9|||
49165562|NCT00437268|158441844|FG001|Overall Study|Progressive disease|9|||
49165563|NCT00437268|158441843|FG000|Overall Study|Physician Decision|1|||
49165564|NCT00437268|158441844|FG001|Overall Study|Physician Decision|0|||
49165565|NCT00437268|158441843|FG000|Overall Study|Death|0|||
49165566|NCT00437268|158441844|FG001|Overall Study|Death|1|||
49165567|NCT00038948|158441851|FG000|Overall Study|Adverse Event|131|||
49165568|NCT00038948|158441852|FG001|Overall Study|Adverse Event|43|||
49165569|NCT00038948|158441851|FG000|Overall Study|Lost to Follow-up|4|||
49165570|NCT00038948|158441852|FG001|Overall Study|Lost to Follow-up|4|||
49165571|NCT00038948|158441851|FG000|Overall Study|Nonmedical event|5|||
49165572|NCT00038948|158441852|FG001|Overall Study|Nonmedical event|7|||
49165573|NCT00038948|158441851|FG000|Overall Study|Withdrawal by Subject|23|||
49165574|NCT00038948|158441852|FG001|Overall Study|Withdrawal by Subject|10|||
49165575|NCT00038948|158441851|FG000|Overall Study|Protocol Violation|3|||
49165576|NCT00038948|158441852|FG001|Overall Study|Protocol Violation|7|||
49165577|NCT00038948|158441851|FG000|Overall Study|Lack of Efficacy|3|||
49165578|NCT00038948|158441852|FG001|Overall Study|Lack of Efficacy|6|||
49165579|NCT00755807|158443118|FG000|Acute Phase|Adverse Event|16|||
49165580|NCT00755807|158443119|FG001|Acute Phase|Adverse Event|5|||
49165581|NCT00755807|158443118|FG000|Acute Phase|Protocol Violation|1|||
49165582|NCT00755807|158443119|FG001|Acute Phase|Protocol Violation|3|||
49165583|NCT00755807|158443118|FG000|Acute Phase|Withdrawal by Subject|1|||
49165584|NCT00755807|158443119|FG001|Acute Phase|Withdrawal by Subject|2|||
49165585|NCT00755807|158443118|FG000|Acute Phase|Lack of Efficacy|0|||
49165586|NCT00755807|158443119|FG001|Acute Phase|Lack of Efficacy|1|||
49165587|NCT00755807|158443118|FG000|Acute Phase|Physician Decision|0|||
49165588|NCT00755807|158443119|FG001|Acute Phase|Physician Decision|1|||
49165589|NCT00755807|158443118|FG000|Open-label Extension Phase|Adverse Event|7|||
49165590|NCT00755807|158443119|FG001|Open-label Extension Phase|Adverse Event|7|||
49165591|NCT00755807|158443118|FG000|Open-label Extension Phase|Protocol Violation|5|||
49165592|NCT00755807|158443119|FG001|Open-label Extension Phase|Protocol Violation|2|||
49165593|NCT00755807|158443118|FG000|Open-label Extension Phase|Lack of Efficacy|3|||
49165594|NCT00755807|158443119|FG001|Open-label Extension Phase|Lack of Efficacy|3|||
49165595|NCT00755807|158443118|FG000|Open-label Extension Phase|Withdrawal by Subject|1|||
49165596|NCT00755807|158443119|FG001|Open-label Extension Phase|Withdrawal by Subject|3|||
49165597|NCT00755807|158443118|FG000|Open-label Extension Phase|Lost to Follow-up|2|||
49165598|NCT00755807|158443119|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
49165599|NCT00755807|158443118|FG000|Open-label Extension Phase|Sponsor Decision|0|||
49165600|NCT00755807|158443119|FG001|Open-label Extension Phase|Sponsor Decision|1|||
49165601|NCT03547908|158443120|FG000|Overall Study|Still On Study|115|||
49165602|NCT03547908|158443121|FG001|Overall Study|Still On Study|118|||
49165603|NCT03547908|158443120|FG000|Overall Study|Lost to Follow-up|2|||
49165604|NCT03547908|158443121|FG001|Overall Study|Lost to Follow-up|2|||
49165605|NCT03547908|158443120|FG000|Overall Study|Withdrew Consent|2|||
49165606|NCT03547908|158443121|FG001|Overall Study|Withdrew Consent|1|||
49165607|NCT03547908|158443120|FG000|Overall Study|Adverse Event|1|||
49165608|NCT03547908|158443121|FG001|Overall Study|Adverse Event|0|||
48924610|NCT03529773|157557185|FG003|Overall Study|Withdrawal by Subject|0|||
49165609|NCT03547908|158443120|FG000|Overall Study|Death|1|||
49165610|NCT03547908|158443121|FG001|Overall Study|Death|0|||
49165611|NCT03547908|158443120|FG000|Overall Study|Investigator's Discretion|0|||
49165612|NCT03547908|158443121|FG001|Overall Study|Investigator's Discretion|1|||
49165613|NCT03547908|158443120|FG000|Overall Study|Randomized But Never Treated|1|||
49165614|NCT03547908|158443121|FG001|Overall Study|Randomized But Never Treated|0|||
49165615|NCT05010070|158443122|FG000|Overall Study|Lost to Follow-up|1|||
49165616|NCT05010070|158443122|FG000|Overall Study|Withdrawal by Subject|1|||
49165617|NCT00939107|158443123|FG000|Overall Study|Lost to Follow-up|14|||
49165618|NCT00939107|158443124|FG001|Overall Study|Lost to Follow-up|12|||
49165619|NCT00066690|158443125|FG000|Overall Study|Adverse Event|145|||
49165620|NCT00066690|158443126|FG001|Overall Study|Adverse Event|58|||
49165621|NCT00066690|158443127|FG002|Overall Study|Adverse Event|126|||
49165622|NCT00066690|158443125|FG000|Overall Study|Death|3|||
49165623|NCT00066690|158443126|FG001|Overall Study|Death|0|||
49165624|NCT00066690|158443127|FG002|Overall Study|Death|2|||
49165625|NCT00066690|158443125|FG000|Overall Study|Lack of Efficacy|114|||
49165626|NCT00066690|158443126|FG001|Overall Study|Lack of Efficacy|110|||
49165627|NCT00066690|158443127|FG002|Overall Study|Lack of Efficacy|76|||
49165628|NCT00066690|158443125|FG000|Overall Study|Lost to Follow-up|40|||
49165629|NCT00066690|158443126|FG001|Overall Study|Lost to Follow-up|21|||
49165630|NCT00066690|158443127|FG002|Overall Study|Lost to Follow-up|29|||
49165631|NCT00066690|158443125|FG000|Overall Study|Withdrawal by Subject|50|||
49165632|NCT00066690|158443126|FG001|Overall Study|Withdrawal by Subject|55|||
49165633|NCT00066690|158443127|FG002|Overall Study|Withdrawal by Subject|49|||
49165634|NCT00066690|158443125|FG000|Overall Study|Treatment Ongoing|246|||
49165635|NCT00066690|158443126|FG001|Overall Study|Treatment Ongoing|278|||
49165636|NCT00066690|158443127|FG002|Overall Study|Treatment Ongoing|282|||
49165637|NCT00892008|158443128|FG000|Overall Study|Death|5|||
49165638|NCT00892008|158443128|FG000|Overall Study|Lack of Efficacy|3|||
49165639|NCT00892008|158443128|FG000|Overall Study|Lost to Follow-up|142|||
49165640|NCT00892008|158443128|FG000|Overall Study|Other|378|||
49165641|NCT00892008|158443128|FG000|Overall Study|Adverse Event|37|||
49165642|NCT00551031|158443129|FG000|Overall Study|Adverse Event|0|||
49165643|NCT00551031|158443130|FG001|Overall Study|Adverse Event|1|||
49165644|NCT00551031|158443131|FG002|Overall Study|Adverse Event|0|||
49165645|NCT00551031|158443132|FG003|Overall Study|Adverse Event|0|||
49165646|NCT00551031|158443133|FG004|Overall Study|Adverse Event|0|||
49165647|NCT00551031|158443129|FG000|Overall Study|Protocol Violation|1|||
49165648|NCT00551031|158443130|FG001|Overall Study|Protocol Violation|1|||
49165649|NCT00551031|158443131|FG002|Overall Study|Protocol Violation|0|||
49165650|NCT00551031|158443132|FG003|Overall Study|Protocol Violation|0|||
49165651|NCT00551031|158443133|FG004|Overall Study|Protocol Violation|0|||
49165652|NCT00551031|158443129|FG000|Overall Study|Lost to Follow-up|0|||
49165653|NCT00551031|158443130|FG001|Overall Study|Lost to Follow-up|1|||
49165654|NCT00551031|158443131|FG002|Overall Study|Lost to Follow-up|0|||
49165655|NCT00551031|158443132|FG003|Overall Study|Lost to Follow-up|1|||
49165656|NCT00551031|158443133|FG004|Overall Study|Lost to Follow-up|1|||
49165657|NCT00551031|158443129|FG000|Overall Study|Withdrawal by Subject|0|||
49165658|NCT00551031|158443130|FG001|Overall Study|Withdrawal by Subject|4|||
49165659|NCT00551031|158443131|FG002|Overall Study|Withdrawal by Subject|1|||
49165660|NCT00551031|158443132|FG003|Overall Study|Withdrawal by Subject|2|||
48924611|NCT03529773|157557186|FG004|Overall Study|Withdrawal by Subject|0|||
48924612|NCT03529773|157557187|FG005|Overall Study|Withdrawal by Subject|0|||
48924613|NCT03529773|157557188|FG006|Overall Study|Withdrawal by Subject|0|||
48924614|NCT03529773|157557189|FG007|Overall Study|Withdrawal by Subject|1|||
48924615|NCT03529773|157557190|FG008|Overall Study|Withdrawal by Subject|0|||
48924616|NCT03529773|157557191|FG009|Overall Study|Withdrawal by Subject|1|||
48924617|NCT03529773|157557192|FG010|Overall Study|Withdrawal by Subject|1|||
48924618|NCT03529773|157557193|FG011|Overall Study|Withdrawal by Subject|0|||
49165661|NCT00551031|158443133|FG004|Overall Study|Withdrawal by Subject|0|||
49165662|NCT00551031|158443129|FG000|Overall Study|Serious Adverse Event|0|||
49165663|NCT00551031|158443130|FG001|Overall Study|Serious Adverse Event|2|||
49165664|NCT00551031|158443131|FG002|Overall Study|Serious Adverse Event|1|||
49165665|NCT00551031|158443132|FG003|Overall Study|Serious Adverse Event|0|||
49165666|NCT00551031|158443133|FG004|Overall Study|Serious Adverse Event|0|||
49165667|NCT00551031|158443129|FG000|Overall Study|Did not receive vaccine|1|||
49165668|NCT00551031|158443130|FG001|Overall Study|Did not receive vaccine|2|||
49165669|NCT00551031|158443131|FG002|Overall Study|Did not receive vaccine|0|||
49165670|NCT00551031|158443132|FG003|Overall Study|Did not receive vaccine|0|||
48735635|NCT00961649|156883698|FG001|Overall Study|Patient has travel plans during holidays|0|||
48735636|NCT00961649|156883699|FG002|Overall Study|Patient has travel plans during holidays|1|||
49165671|NCT00551031|158443133|FG004|Overall Study|Did not receive vaccine|0|||
49165672|NCT02852967|158443134|FG000|Overall Study|Adverse Event|3|||
49165673|NCT02852967|158443135|FG001|Overall Study|Adverse Event|1|||
49165674|NCT02852967|158443136|FG002|Overall Study|Adverse Event|0|||
49165675|NCT02852967|158443137|FG003|Overall Study|Adverse Event|1|||
49165676|NCT02852967|158443138|FG004|Overall Study|Adverse Event|0|||
49165677|NCT02852967|158443134|FG000|Overall Study|Death|1|||
49165678|NCT02852967|158443135|FG001|Overall Study|Death|0|||
49165679|NCT02852967|158443136|FG002|Overall Study|Death|0|||
49165680|NCT02852967|158443137|FG003|Overall Study|Death|0|||
49165681|NCT02852967|158443138|FG004|Overall Study|Death|0|||
49165682|NCT02852967|158443134|FG000|Overall Study|Lost to Follow-up|1|||
49165683|NCT02852967|158443135|FG001|Overall Study|Lost to Follow-up|2|||
49165684|NCT02852967|158443136|FG002|Overall Study|Lost to Follow-up|3|||
49165685|NCT02852967|158443137|FG003|Overall Study|Lost to Follow-up|4|||
49165686|NCT02852967|158443138|FG004|Overall Study|Lost to Follow-up|4|||
49165687|NCT02852967|158443134|FG000|Overall Study|Withdrawal by Subject|6|||
49165688|NCT02852967|158443135|FG001|Overall Study|Withdrawal by Subject|12|||
48924619|NCT03529773|157557194|FG012|Overall Study|Withdrawal by Subject|0|||
48924620|NCT03529773|157557195|FG013|Overall Study|Withdrawal by Subject|0|||
48924621|NCT03529773|157557196|FG014|Overall Study|Withdrawal by Subject|0|||
48924622|NCT03529773|157557197|FG015|Overall Study|Withdrawal by Subject|3|||
48924623|NCT03529773|157557198|FG016|Overall Study|Withdrawal by Subject|0|||
48924624|NCT03529773|157557199|FG017|Overall Study|Withdrawal by Subject|2|||
48924625|NCT03529773|157557200|FG018|Overall Study|Withdrawal by Subject|3|||
48924626|NCT03529773|157557201|FG019|Overall Study|Withdrawal by Subject|1|||
48924627|NCT03529773|157557202|FG020|Overall Study|Withdrawal by Subject|3|||
48924628|NCT03529773|157557203|FG021|Overall Study|Withdrawal by Subject|1|||
48924629|NCT03529773|157557204|FG022|Overall Study|Withdrawal by Subject|1|||
48924630|NCT03529773|157557205|FG023|Overall Study|Withdrawal by Subject|2|||
48924631|NCT03529773|157557206|FG024|Overall Study|Withdrawal by Subject|2|||
48924632|NCT03529773|157557207|FG025|Overall Study|Withdrawal by Subject|4|||
48924633|NCT03529773|157557208|FG026|Overall Study|Withdrawal by Subject|2|||
48924634|NCT03529773|157557209|FG027|Overall Study|Withdrawal by Subject|1|||
48924635|NCT03529773|157557210|FG028|Overall Study|Withdrawal by Subject|1|||
48924636|NCT03529773|157557211|FG029|Overall Study|Withdrawal by Subject|0|||
49165689|NCT02852967|158443136|FG002|Overall Study|Withdrawal by Subject|7|||
49165690|NCT02852967|158443137|FG003|Overall Study|Withdrawal by Subject|10|||
49165691|NCT02852967|158443138|FG004|Overall Study|Withdrawal by Subject|10|||
49165692|NCT02852967|158443134|FG000|Overall Study|SAE|0|||
48924637|NCT03529773|157557212|FG030|Overall Study|Withdrawal by Subject|0|||
48924638|NCT03529773|157557213|FG031|Overall Study|Withdrawal by Subject|0|||
48924639|NCT03529773|157557214|FG032|Overall Study|Withdrawal by Subject|0|||
48924640|NCT03529773|157557215|FG033|Overall Study|Withdrawal by Subject|0|||
48924641|NCT03529773|157557216|FG034|Overall Study|Withdrawal by Subject|1|||
48924642|NCT03529773|157557217|FG035|Overall Study|Withdrawal by Subject|2|||
48924643|NCT03529773|157557218|FG036|Overall Study|Withdrawal by Subject|0|||
48924644|NCT03529773|157557219|FG037|Overall Study|Withdrawal by Subject|2|||
48924645|NCT03529773|157557220|FG038|Overall Study|Withdrawal by Subject|1|||
48924646|NCT03529773|157557221|FG039|Overall Study|Withdrawal by Subject|1|||
48924647|NCT03529773|157557182|FG000|Overall Study|Screen Failure|0|||
48924648|NCT03529773|157557183|FG001|Overall Study|Screen Failure|0|||
48924649|NCT03529773|157557184|FG002|Overall Study|Screen Failure|0|||
48924650|NCT03529773|157557185|FG003|Overall Study|Screen Failure|0|||
48924651|NCT03529773|157557186|FG004|Overall Study|Screen Failure|0|||
48924652|NCT03529773|157557187|FG005|Overall Study|Screen Failure|0|||
48924653|NCT03529773|157557188|FG006|Overall Study|Screen Failure|0|||
48924654|NCT03529773|157557189|FG007|Overall Study|Screen Failure|0|||
48924655|NCT03529773|157557190|FG008|Overall Study|Screen Failure|0|||
48924656|NCT03529773|157557191|FG009|Overall Study|Screen Failure|0|||
48924657|NCT03529773|157557192|FG010|Overall Study|Screen Failure|0|||
48924658|NCT03529773|157557193|FG011|Overall Study|Screen Failure|0|||
48924659|NCT03529773|157557194|FG012|Overall Study|Screen Failure|0|||
48924660|NCT03529773|157557195|FG013|Overall Study|Screen Failure|0|||
48924661|NCT03529773|157557196|FG014|Overall Study|Screen Failure|0|||
48924662|NCT03529773|157557197|FG015|Overall Study|Screen Failure|0|||
48924663|NCT03529773|157557198|FG016|Overall Study|Screen Failure|0|||
48924664|NCT03529773|157557199|FG017|Overall Study|Screen Failure|0|||
48924665|NCT03529773|157557200|FG018|Overall Study|Screen Failure|0|||
48924666|NCT03529773|157557201|FG019|Overall Study|Screen Failure|0|||
48924667|NCT03529773|157557202|FG020|Overall Study|Screen Failure|0|||
48924668|NCT03529773|157557203|FG021|Overall Study|Screen Failure|0|||
48924669|NCT03529773|157557204|FG022|Overall Study|Screen Failure|0|||
48924670|NCT03529773|157557205|FG023|Overall Study|Screen Failure|0|||
48924671|NCT03529773|157557206|FG024|Overall Study|Screen Failure|0|||
48924672|NCT03529773|157557207|FG025|Overall Study|Screen Failure|0|||
48924673|NCT03529773|157557208|FG026|Overall Study|Screen Failure|0|||
48924674|NCT03529773|157557209|FG027|Overall Study|Screen Failure|0|||
48924675|NCT03529773|157557210|FG028|Overall Study|Screen Failure|0|||
48924676|NCT03529773|157557211|FG029|Overall Study|Screen Failure|0|||
48924677|NCT03529773|157557212|FG030|Overall Study|Screen Failure|0|||
48924678|NCT03529773|157557213|FG031|Overall Study|Screen Failure|0|||
48924679|NCT03529773|157557214|FG032|Overall Study|Screen Failure|0|||
48924680|NCT03529773|157557215|FG033|Overall Study|Screen Failure|0|||
48924681|NCT03529773|157557216|FG034|Overall Study|Screen Failure|0|||
48924682|NCT03529773|157557217|FG035|Overall Study|Screen Failure|0|||
48924683|NCT03529773|157557218|FG036|Overall Study|Screen Failure|1|||
48924684|NCT03529773|157557219|FG037|Overall Study|Screen Failure|1|||
48924685|NCT03529773|157557220|FG038|Overall Study|Screen Failure|0|||
49165693|NCT02852967|158443135|FG001|Overall Study|SAE|0|||
48924686|NCT03529773|157557221|FG039|Overall Study|Screen Failure|1|||
48924687|NCT03529773|157557182|FG000|Overall Study|Randomized but not vaccinated|0|||
48924688|NCT03529773|157557183|FG001|Overall Study|Randomized but not vaccinated|0|||
48924689|NCT03529773|157557184|FG002|Overall Study|Randomized but not vaccinated|0|||
48924690|NCT03529773|157557185|FG003|Overall Study|Randomized but not vaccinated|0|||
48924691|NCT03529773|157557186|FG004|Overall Study|Randomized but not vaccinated|0|||
48924692|NCT03529773|157557187|FG005|Overall Study|Randomized but not vaccinated|0|||
48924693|NCT03529773|157557188|FG006|Overall Study|Randomized but not vaccinated|0|||
48924694|NCT03529773|157557189|FG007|Overall Study|Randomized but not vaccinated|0|||
48924695|NCT03529773|157557190|FG008|Overall Study|Randomized but not vaccinated|0|||
48924696|NCT03529773|157557191|FG009|Overall Study|Randomized but not vaccinated|0|||
48924697|NCT03529773|157557192|FG010|Overall Study|Randomized but not vaccinated|0|||
49165694|NCT02852967|158443136|FG002|Overall Study|SAE|0|||
49165695|NCT02852967|158443137|FG003|Overall Study|SAE|3|||
49165696|NCT02852967|158443138|FG004|Overall Study|SAE|0|||
49165697|NCT02852967|158443134|FG000|Overall Study|Elevated Liver Enzymes|2|||
48924698|NCT03529773|157557193|FG011|Overall Study|Randomized but not vaccinated|0|||
48924699|NCT03529773|157557194|FG012|Overall Study|Randomized but not vaccinated|0|||
48924700|NCT03529773|157557195|FG013|Overall Study|Randomized but not vaccinated|0|||
48924701|NCT03529773|157557196|FG014|Overall Study|Randomized but not vaccinated|0|||
48924702|NCT03529773|157557197|FG015|Overall Study|Randomized but not vaccinated|0|||
48924703|NCT03529773|157557198|FG016|Overall Study|Randomized but not vaccinated|0|||
48924704|NCT03529773|157557199|FG017|Overall Study|Randomized but not vaccinated|1|||
48924705|NCT03529773|157557200|FG018|Overall Study|Randomized but not vaccinated|0|||
48924706|NCT03529773|157557201|FG019|Overall Study|Randomized but not vaccinated|0|||
48924707|NCT03529773|157557202|FG020|Overall Study|Randomized but not vaccinated|0|||
48924708|NCT03529773|157557203|FG021|Overall Study|Randomized but not vaccinated|0|||
48924709|NCT03529773|157557204|FG022|Overall Study|Randomized but not vaccinated|0|||
48924710|NCT03529773|157557205|FG023|Overall Study|Randomized but not vaccinated|0|||
48924711|NCT03529773|157557206|FG024|Overall Study|Randomized but not vaccinated|0|||
48924712|NCT03529773|157557207|FG025|Overall Study|Randomized but not vaccinated|0|||
49165698|NCT02852967|158443135|FG001|Overall Study|Elevated Liver Enzymes|0|||
49165699|NCT02852967|158443136|FG002|Overall Study|Elevated Liver Enzymes|0|||
49165700|NCT02852967|158443137|FG003|Overall Study|Elevated Liver Enzymes|2|||
49165701|NCT02852967|158443138|FG004|Overall Study|Elevated Liver Enzymes|2|||
49165702|NCT02852967|158443134|FG000|Overall Study|Physician Decision|0|||
49165703|NCT02852967|158443135|FG001|Overall Study|Physician Decision|0|||
49165704|NCT02852967|158443136|FG002|Overall Study|Physician Decision|0|||
49165705|NCT02852967|158443137|FG003|Overall Study|Physician Decision|1|||
49165706|NCT02852967|158443138|FG004|Overall Study|Physician Decision|0|||
49165707|NCT02852967|158443134|FG000|Overall Study|Lack of Efficacy|0|||
49165708|NCT02852967|158443135|FG001|Overall Study|Lack of Efficacy|1|||
49165709|NCT02852967|158443136|FG002|Overall Study|Lack of Efficacy|0|||
49165710|NCT02852967|158443137|FG003|Overall Study|Lack of Efficacy|0|||
49165711|NCT02852967|158443138|FG004|Overall Study|Lack of Efficacy|0|||
49165712|NCT02852967|158443134|FG000|Overall Study|Non-compliance|0|||
49165713|NCT02852967|158443135|FG001|Overall Study|Non-compliance|0|||
49165714|NCT02852967|158443136|FG002|Overall Study|Non-compliance|1|||
49165715|NCT02852967|158443137|FG003|Overall Study|Non-compliance|1|||
49165716|NCT02852967|158443138|FG004|Overall Study|Non-compliance|0|||
49165717|NCT02852967|158443134|FG000|Overall Study|Dispensing Drug Violation|0|||
49165718|NCT02852967|158443135|FG001|Overall Study|Dispensing Drug Violation|0|||
49165719|NCT02852967|158443136|FG002|Overall Study|Dispensing Drug Violation|1|||
49165720|NCT02852967|158443137|FG003|Overall Study|Dispensing Drug Violation|0|||
49165721|NCT02852967|158443138|FG004|Overall Study|Dispensing Drug Violation|0|||
49165722|NCT02852967|158443134|FG000|Overall Study|Inclusion/Exclusion Violation|1|||
49165723|NCT02852967|158443135|FG001|Overall Study|Inclusion/Exclusion Violation|0|||
49165724|NCT02852967|158443136|FG002|Overall Study|Inclusion/Exclusion Violation|0|||
49165725|NCT02852967|158443137|FG003|Overall Study|Inclusion/Exclusion Violation|0|||
49165726|NCT02852967|158443138|FG004|Overall Study|Inclusion/Exclusion Violation|0|||
49165727|NCT02903823|158443139|FG000|Overall Study|Physician Decision|5|||
48924713|NCT03529773|157557208|FG026|Overall Study|Randomized but not vaccinated|0|||
48924714|NCT03529773|157557209|FG027|Overall Study|Randomized but not vaccinated|1|||
48924715|NCT03529773|157557210|FG028|Overall Study|Randomized but not vaccinated|0|||
48924716|NCT03529773|157557211|FG029|Overall Study|Randomized but not vaccinated|0|||
48924717|NCT03529773|157557212|FG030|Overall Study|Randomized but not vaccinated|0|||
48924718|NCT03529773|157557213|FG031|Overall Study|Randomized but not vaccinated|0|||
48924719|NCT03529773|157557214|FG032|Overall Study|Randomized but not vaccinated|0|||
48924720|NCT03529773|157557215|FG033|Overall Study|Randomized but not vaccinated|0|||
48924721|NCT03529773|157557216|FG034|Overall Study|Randomized but not vaccinated|0|||
48924722|NCT03529773|157557217|FG035|Overall Study|Randomized but not vaccinated|0|||
48924723|NCT03529773|157557218|FG036|Overall Study|Randomized but not vaccinated|0|||
48924724|NCT03529773|157557219|FG037|Overall Study|Randomized but not vaccinated|0|||
48924725|NCT03529773|157557220|FG038|Overall Study|Randomized but not vaccinated|0|||
48924726|NCT03529773|157557221|FG039|Overall Study|Randomized but not vaccinated|0|||
48924727|NCT01496066|157557223|FG000|Overall Study|Lost to Follow-up|8|||
48924728|NCT01496066|157557224|FG001|Overall Study|Lost to Follow-up|5|||
48924729|NCT01496066|157557223|FG000|Overall Study|Explant|3|||
48924730|NCT01496066|157557224|FG001|Overall Study|Explant|0|||
49165728|NCT02903823|158443139|FG000|Overall Study|Could not advance catheter|1|||
49165729|NCT02903823|158443139|FG000|Overall Study|Catheter dislodgement|1|||
49165730|NCT01123148|158443140|FG000|Overall Study|Coughing caused unacceptable EEG quality|1|||
48924731|NCT01496066|157557223|FG000|Overall Study|Death|1|||
48924732|NCT01496066|157557224|FG001|Overall Study|Death|4|||
48924733|NCT02926209|157557225|FG000|Study Cohort|Poor Bowel Preparation|1|||
48924734|NCT02926209|157557226|FG001|Study Cohort|Poor Bowel Preparation|0|||
48924735|NCT03237065|157557227|FG000|Overall Study|Adverse Event|0|||
48924736|NCT03237065|157557228|FG001|Overall Study|Adverse Event|2|||
48924737|NCT03237065|157557227|FG000|Overall Study|Protocol Violation|0|||
48924738|NCT03237065|157557228|FG001|Overall Study|Protocol Violation|1|||
48924739|NCT03237065|157557227|FG000|Overall Study|Withdrawal by Subject|3|||
48924740|NCT03237065|157557228|FG001|Overall Study|Withdrawal by Subject|0|||
48924741|NCT03237065|157557227|FG000|Overall Study|Lost to Follow-up|1|||
48924742|NCT03237065|157557228|FG001|Overall Study|Lost to Follow-up|0|||
48924743|NCT03237065|157557227|FG000|Overall Study|Unable to obtain venous access|0|||
48924744|NCT03237065|157557228|FG001|Overall Study|Unable to obtain venous access|1|||
48924745|NCT00267748|157557230|FG000|Non-randomized Period|Progressive disease|10|||
48924746|NCT00267748|157557231|FG001|Non-randomized Period|Progressive disease|0|||
48924747|NCT00267748|157557232|FG002|Non-randomized Period|Progressive disease|0|||
48924748|NCT00267748|157557230|FG000|Non-randomized Period|Adverse Event|8|||
49165731|NCT01123148|158443140|FG000|Overall Study|Didn't meet milestone criteria|1|||
49165732|NCT00355030|158443141|FG000|Study Period 1 Treatment|Adverse Event|1|||
49165733|NCT00355030|158443142|FG001|Study Period 1 Treatment|Adverse Event|1|||
49165734|NCT00355030|158443141|FG000|Study Period 1 Treatment|Lost to Follow-up|3|||
49165735|NCT00355030|158443142|FG001|Study Period 1 Treatment|Lost to Follow-up|0|||
49165736|NCT00355030|158443141|FG000|Study Period 1 Treatment|Withdrawal by Subject|4|||
49165737|NCT00355030|158443142|FG001|Study Period 1 Treatment|Withdrawal by Subject|1|||
49165738|NCT00355030|158443141|FG000|Study Period 1 Treatment|Parent/Caregiver Decision|1|||
48924749|NCT00267748|157557231|FG001|Non-randomized Period|Adverse Event|0|||
48924750|NCT00267748|157557232|FG002|Non-randomized Period|Adverse Event|0|||
48924751|NCT00267748|157557230|FG000|Non-randomized Period|Death|1|||
48924752|NCT00267748|157557231|FG001|Non-randomized Period|Death|0|||
48924753|NCT00267748|157557232|FG002|Non-randomized Period|Death|0|||
48924754|NCT00267748|157557230|FG000|Non-randomized Period|Participant not willing to participate|1|||
48924755|NCT00267748|157557231|FG001|Non-randomized Period|Participant not willing to participate|0|||
48924756|NCT00267748|157557232|FG002|Non-randomized Period|Participant not willing to participate|0|||
48924757|NCT00267748|157557230|FG000|Non-randomized Period|Other|3|||
48924758|NCT00267748|157557231|FG001|Non-randomized Period|Other|0|||
48924759|NCT00267748|157557232|FG002|Non-randomized Period|Other|0|||
48924760|NCT00267748|157557230|FG000|Randomized Period|Death|0|||
48924761|NCT00267748|157557231|FG001|Randomized Period|Death|2|||
48924762|NCT00267748|157557232|FG002|Randomized Period|Death|3|||
48924763|NCT00267748|157557230|FG000|Randomized Period|Adverse Event|0|||
48924764|NCT00267748|157557231|FG001|Randomized Period|Adverse Event|23|||
48924765|NCT00267748|157557232|FG002|Randomized Period|Adverse Event|25|||
48924766|NCT00267748|157557230|FG000|Randomized Period|Global deterioration of health status|0|||
48924767|NCT00267748|157557231|FG001|Randomized Period|Global deterioration of health status|6|||
48924768|NCT00267748|157557232|FG002|Randomized Period|Global deterioration of health status|7|||
48924769|NCT00267748|157557230|FG000|Randomized Period|Lost to Follow-up|0|||
48924770|NCT00267748|157557231|FG001|Randomized Period|Lost to Follow-up|1|||
48924771|NCT00267748|157557232|FG002|Randomized Period|Lost to Follow-up|0|||
48924772|NCT00267748|157557230|FG000|Randomized Period|Objective progression or relapse|0|||
48924773|NCT00267748|157557231|FG001|Randomized Period|Objective progression or relapse|77|||
48924774|NCT00267748|157557232|FG002|Randomized Period|Objective progression or relapse|86|||
48924775|NCT00267748|157557230|FG000|Randomized Period|Withdrawal by Subject|0|||
48924776|NCT00267748|157557231|FG001|Randomized Period|Withdrawal by Subject|9|||
48924777|NCT00267748|157557232|FG002|Randomized Period|Withdrawal by Subject|2|||
48924778|NCT00267748|157557230|FG000|Randomized Period|Other|0|||
48924779|NCT00267748|157557231|FG001|Randomized Period|Other|9|||
48924780|NCT00267748|157557232|FG002|Randomized Period|Other|6|||
48924781|NCT00267748|157557230|FG000|Randomized Period|randomized but not treated|0|||
48924782|NCT00267748|157557231|FG001|Randomized Period|randomized but not treated|0|||
48924783|NCT00267748|157557232|FG002|Randomized Period|randomized but not treated|3|||
48924784|NCT03245450|157557233|FG000|Overall Study|Radiological disease progression|3|||
48924785|NCT03245450|157557234|FG001|Overall Study|Radiological disease progression|3|||
48924786|NCT03245450|157557235|FG002|Overall Study|Radiological disease progression|2|||
48924787|NCT03245450|157557236|FG003|Overall Study|Radiological disease progression|2|||
49165739|NCT00355030|158443142|FG001|Study Period 1 Treatment|Parent/Caregiver Decision|2|||
49165740|NCT00355030|158443141|FG000|Study Period 1 Treatment|Physician Decision|0|||
49165741|NCT00355030|158443142|FG001|Study Period 1 Treatment|Physician Decision|1|||
49165742|NCT00355030|158443141|FG000|Study Period 1 Treatment|Sponsor Decision|34|||
49165743|NCT00355030|158443142|FG001|Study Period 1 Treatment|Sponsor Decision|32|||
49165744|NCT00355030|158443141|FG000|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0|||
49165745|NCT00355030|158443142|FG001|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1|||
49165746|NCT00355030|158443141|FG000|Study Period 1 Treatment|Other|2|||
49165747|NCT00355030|158443142|FG001|Study Period 1 Treatment|Other|6|||
49165748|NCT00355030|158443141|FG000|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0|||
49165749|NCT00355030|158443142|FG001|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1|||
49165750|NCT00355030|158443141|FG000|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
49165751|NCT00355030|158443142|FG001|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
49165752|NCT04240886|158443150|FG000|Treatment Phase|Death|4|||
49165753|NCT04240886|158443150|FG000|Treatment Phase|Discontinuation by Subject|1|||
49165754|NCT04240886|158443150|FG000|Treatment Phase|Adverse Event|5|||
49165755|NCT04240886|158443150|FG000|Follow-up Phase|Withdrawal by Subject|1|||
49165756|NCT04240886|158443150|FG000|Follow-up Phase|Discontinuation by Subject|1|||
49165757|NCT04240886|158443150|FG000|Follow-up Phase|Death|2|||
49165758|NCT01462929|158443151|FG000|Overall Study|Adverse Event|3|||
49165759|NCT01462929|158443152|FG001|Overall Study|Adverse Event|3|||
49165760|NCT01462929|158443153|FG002|Overall Study|Adverse Event|4|||
49165761|NCT01462929|158443151|FG000|Overall Study|Withdrawal by Subject|2|||
49165762|NCT01462929|158443152|FG001|Overall Study|Withdrawal by Subject|1|||
49165763|NCT01462929|158443153|FG002|Overall Study|Withdrawal by Subject|0|||
49165764|NCT01462929|158443151|FG000|Overall Study|Lack of Efficacy|0|||
49165765|NCT01462929|158443152|FG001|Overall Study|Lack of Efficacy|0|||
49165766|NCT01462929|158443153|FG002|Overall Study|Lack of Efficacy|1|||
49165767|NCT01146613|158443154|FG000|Overall Study|Lost to Follow-up|3|||
49165768|NCT01146613|158443155|FG001|Overall Study|Lost to Follow-up|8|||
49165769|NCT01146613|158443154|FG000|Overall Study|Lack of Efficacy|0|||
49165770|NCT01146613|158443155|FG001|Overall Study|Lack of Efficacy|1|||
49165771|NCT01146613|158443154|FG000|Overall Study|Death|1|||
49165772|NCT01146613|158443155|FG001|Overall Study|Death|0|||
49165773|NCT01146613|158443154|FG000|Overall Study|Physician Decision|1|||
49165774|NCT01146613|158443155|FG001|Overall Study|Physician Decision|0|||
49165775|NCT01146613|158443154|FG000|Overall Study|Withdrawal by Subject|0|||
49165776|NCT01146613|158443155|FG001|Overall Study|Withdrawal by Subject|3|||
49165777|NCT01146613|158443154|FG000|Overall Study|schedule conflict|1|||
49165778|NCT01146613|158443155|FG001|Overall Study|schedule conflict|0|||
49165779|NCT01146613|158443154|FG000|Overall Study|Outpatient detox|1|||
49165780|NCT01146613|158443155|FG001|Overall Study|Outpatient detox|0|||
49165781|NCT03046446|158443156|FG000|Overall Study|Lack of Efficacy|7|||
49165782|NCT03046446|158443156|FG000|Overall Study|Adverse Event|6|||
49165783|NCT03046446|158443156|FG000|Overall Study|Lost to Follow-up|3|||
49165784|NCT03046446|158443156|FG000|Overall Study|Withdrawal by Subject|14|||
49165785|NCT03046446|158443156|FG000|Overall Study|Withdrawn by Investigator/Sponsor|3|||
49165786|NCT03046446|158443156|FG000|Overall Study|Disease Progression (see caveats)|25|||
49165787|NCT03046446|158443156|FG000|Overall Study|Non OA related knee surgery|1|||
49165788|NCT03012334|158443159|FG000|Period 1|Withdrawal by Subject|0|||
49165789|NCT03012334|158443160|FG001|Period 1|Withdrawal by Subject|0|||
49165790|NCT03012334|158443161|FG002|Period 1|Withdrawal by Subject|0|||
49165791|NCT03012334|158443162|FG003|Period 1|Withdrawal by Subject|0|||
49165792|NCT03012334|158443163|FG004|Period 1|Withdrawal by Subject|0|||
49165793|NCT03012334|158443164|FG005|Period 1|Withdrawal by Subject|0|||
49165794|NCT03012334|158443165|FG006|Period 1|Withdrawal by Subject|0|||
49165795|NCT03012334|158443166|FG007|Period 1|Withdrawal by Subject|0|||
49165796|NCT03012334|158443167|FG008|Period 1|Withdrawal by Subject|0|||
49165797|NCT03012334|158443168|FG009|Period 1|Withdrawal by Subject|1|||
49165798|NCT03012334|158443159|FG000|Period 2|Withdrawal by Subject|0|||
49165799|NCT03012334|158443160|FG001|Period 2|Withdrawal by Subject|1|||
49165800|NCT03012334|158443161|FG002|Period 2|Withdrawal by Subject|0|||
49165801|NCT03012334|158443162|FG003|Period 2|Withdrawal by Subject|0|||
49165802|NCT03012334|158443163|FG004|Period 2|Withdrawal by Subject|0|||
49165803|NCT03012334|158443164|FG005|Period 2|Withdrawal by Subject|0|||
49165804|NCT03012334|158443165|FG006|Period 2|Withdrawal by Subject|0|||
49165805|NCT03012334|158443166|FG007|Period 2|Withdrawal by Subject|0|||
49165806|NCT03012334|158443167|FG008|Period 2|Withdrawal by Subject|0|||
49165807|NCT03012334|158443168|FG009|Period 2|Withdrawal by Subject|0|||
49165808|NCT03012334|158443159|FG000|Period 2|Protocol Violation|0|||
49165809|NCT03012334|158443160|FG001|Period 2|Protocol Violation|0|||
49165810|NCT03012334|158443161|FG002|Period 2|Protocol Violation|1|||
49165811|NCT03012334|158443162|FG003|Period 2|Protocol Violation|0|||
48924788|NCT03245450|157557237|FG004|Overall Study|Radiological disease progression|7|||
49165812|NCT03012334|158443163|FG004|Period 2|Protocol Violation|0|||
49165813|NCT03012334|158443164|FG005|Period 2|Protocol Violation|0|||
49165814|NCT03012334|158443165|FG006|Period 2|Protocol Violation|0|||
49165815|NCT03012334|158443166|FG007|Period 2|Protocol Violation|1|||
49165816|NCT03012334|158443167|FG008|Period 2|Protocol Violation|0|||
49165817|NCT03012334|158443168|FG009|Period 2|Protocol Violation|0|||
49165818|NCT03012334|158443159|FG000|Period 4|Non-Compliance|0|||
49165819|NCT03012334|158443160|FG001|Period 4|Non-Compliance|0|||
49165820|NCT03012334|158443161|FG002|Period 4|Non-Compliance|0|||
49165821|NCT03012334|158443162|FG003|Period 4|Non-Compliance|0|||
49165822|NCT03012334|158443163|FG004|Period 4|Non-Compliance|0|||
49165823|NCT03012334|158443164|FG005|Period 4|Non-Compliance|0|||
49165824|NCT03012334|158443165|FG006|Period 4|Non-Compliance|1|||
49165825|NCT03012334|158443166|FG007|Period 4|Non-Compliance|0|||
49165826|NCT03012334|158443167|FG008|Period 4|Non-Compliance|0|||
49165827|NCT03012334|158443168|FG009|Period 4|Non-Compliance|0|||
49165828|NCT03012334|158443159|FG000|Period 4|Adverse Event|0|||
49165829|NCT03012334|158443160|FG001|Period 4|Adverse Event|0|||
49165830|NCT03012334|158443161|FG002|Period 4|Adverse Event|0|||
49165831|NCT03012334|158443162|FG003|Period 4|Adverse Event|0|||
49165832|NCT03012334|158443163|FG004|Period 4|Adverse Event|0|||
49165833|NCT03012334|158443164|FG005|Period 4|Adverse Event|0|||
49165834|NCT03012334|158443165|FG006|Period 4|Adverse Event|0|||
49165835|NCT03012334|158443166|FG007|Period 4|Adverse Event|0|||
49165836|NCT03012334|158443167|FG008|Period 4|Adverse Event|1|||
49165837|NCT03012334|158443168|FG009|Period 4|Adverse Event|0|||
49165838|NCT00325143|158443169|FG000|Overall Study|Lost to follow-up(complete vacc. course)|13|||
49165839|NCT00325143|158443169|FG000|Overall Study|Migrated/moved from study area|1|||
49165840|NCT00325143|158443169|FG000|Overall Study|Lost to follow-up(incompl. vacc. course)|4|||
49165841|NCT00325143|158443169|FG000|Overall Study|Withdrawal by Subject|8|||
49165842|NCT03036852|158443170|FG000|Overall Study|Death|2|||
49165843|NCT03036852|158443170|FG000|Overall Study|Lack of Efficacy|2|||
49165844|NCT03036852|158443170|FG000|Overall Study|Adverse Event|1|||
49165845|NCT03036852|158443170|FG000|Overall Study|Lost to Follow-up|1|||
49165846|NCT00305448|158443171|FG000|Overall Study|Protocol Violation|0|||
49165847|NCT00305448|158443172|FG001|Overall Study|Protocol Violation|1|||
49165848|NCT00305448|158443173|FG002|Overall Study|Protocol Violation|0|||
49165849|NCT00305448|158443171|FG000|Overall Study|Withdrawal by Subject|2|||
49165850|NCT00305448|158443172|FG001|Overall Study|Withdrawal by Subject|0|||
49165851|NCT00305448|158443173|FG002|Overall Study|Withdrawal by Subject|1|||
49165852|NCT00305448|158443171|FG000|Overall Study|Adverse Event|1|||
49165853|NCT00305448|158443172|FG001|Overall Study|Adverse Event|0|||
49165854|NCT00305448|158443173|FG002|Overall Study|Adverse Event|1|||
49165855|NCT00305448|158443171|FG000|Overall Study|Disease Progression|27|||
49165856|NCT00305448|158443172|FG001|Overall Study|Disease Progression|31|||
49165857|NCT00305448|158443173|FG002|Overall Study|Disease Progression|28|||
49165858|NCT00305448|158443171|FG000|Overall Study|Subjective Disease Progression|1|||
49165859|NCT00305448|158443172|FG001|Overall Study|Subjective Disease Progression|2|||
49165860|NCT00305448|158443173|FG002|Overall Study|Subjective Disease Progression|2|||
49165861|NCT00305448|158443171|FG000|Overall Study|Tumor Marker Elevation|0|||
49165862|NCT00305448|158443172|FG001|Overall Study|Tumor Marker Elevation|0|||
49165863|NCT00305448|158443173|FG002|Overall Study|Tumor Marker Elevation|1|||
48692905|NCT03137992|156724650|FG004|Washout Period 1|Principal Investigator Discretion|0|||
48924789|NCT03245450|157557238|FG005|Overall Study|Radiological disease progression|6|||
49165864|NCT03073525|158443174|FG000|Overall Study|Withdrawal by Subject|0|||
49165865|NCT03073525|158443175|FG001|Overall Study|Withdrawal by Subject|0|||
49165866|NCT03073525|158443176|FG002|Overall Study|Withdrawal by Subject|3|||
49165867|NCT01273038|158443177|FG000|Second Intervention (14 Days)|Adverse Event|0|||
49165868|NCT01273038|158443178|FG001|Second Intervention (14 Days)|Adverse Event|1|||
49165869|NCT01273038|158443177|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
49165870|NCT01273038|158443178|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
49165871|NCT01976299|158443179|FG000|Overall Study|Withdrawal by Subject|3|||
49165872|NCT01976299|158443180|FG001|Overall Study|Withdrawal by Subject|1|||
49165873|NCT01976299|158443179|FG000|Overall Study|Death|4|||
49165874|NCT01976299|158443180|FG001|Overall Study|Death|2|||
49165875|NCT01976299|158443179|FG000|Overall Study|Lost to Follow-up|7|||
49165876|NCT01976299|158443180|FG001|Overall Study|Lost to Follow-up|1|||
49165877|NCT01976299|158443179|FG000|Overall Study|See clarification above in comments|9|||
49165878|NCT01976299|158443180|FG001|Overall Study|See clarification above in comments|2|||
49165879|NCT00742625|158443181|FG000|Remission Induction|Progression|6|||
49165880|NCT00742625|158443181|FG000|Remission Induction|Failed induction|8|||
49165881|NCT00742625|158443181|FG000|Remission Induction|Adverse Event|3|||
49165882|NCT00742625|158443181|FG000|Remission Induction|Death|10|||
49165883|NCT00742625|158443181|FG000|Remission Induction|Refusal|5|||
49165884|NCT00742625|158443181|FG000|Remission Induction|Non protocol treatment|17|||
49165885|NCT00742625|158443181|FG000|Remission Induction|Other, not specified|5|||
49165886|NCT00742625|158443181|FG000|Consolidation|Progression|5|||
49165887|NCT00742625|158443181|FG000|Consolidation|Adverse Event|1|||
49165888|NCT00742625|158443181|FG000|Consolidation|Death|1|||
49165889|NCT00742625|158443181|FG000|Consolidation|Refused|1|||
49165890|NCT00742625|158443181|FG000|Consolidation|Non protocol therapy|13|||
49165891|NCT01639469|158443182|FG000|Overall Study|Death|4|||
49165892|NCT01639469|158443183|FG001|Overall Study|Death|2|||
49165893|NCT01639469|158443182|FG000|Overall Study|Lost to Follow-up|1|||
49165894|NCT01639469|158443183|FG001|Overall Study|Lost to Follow-up|1|||
49165895|NCT01119443|158443184|FG000|Crossover Period 1 (5 Days)|Adverse Event|0|||
49165896|NCT01119443|158443185|FG001|Crossover Period 1 (5 Days)|Adverse Event|1|||
49165897|NCT00420381|158443186|FG000|Overall Study|Protocol Violation|1|||
49165898|NCT00856609|158443193|FG000|Overall Study|Adverse Event|1|||
49165899|NCT00856609|158443194|FG001|Overall Study|Adverse Event|0|||
49165900|NCT01436110|158443196|FG000|Overall Study|Lack of Efficacy|23|||
49165901|NCT01436110|158443197|FG001|Overall Study|Lack of Efficacy|14|||
49165902|NCT01436110|158443198|FG002|Overall Study|Lack of Efficacy|9|||
49165903|NCT01436110|158443196|FG000|Overall Study|Withdrawal by Subject|6|||
49165904|NCT01436110|158443197|FG001|Overall Study|Withdrawal by Subject|8|||
49165905|NCT01436110|158443198|FG002|Overall Study|Withdrawal by Subject|4|||
49165906|NCT01436110|158443196|FG000|Overall Study|Adverse Event|2|||
49165907|NCT01436110|158443197|FG001|Overall Study|Adverse Event|1|||
49165908|NCT01436110|158443198|FG002|Overall Study|Adverse Event|2|||
49165909|NCT01436110|158443196|FG000|Overall Study|Physician Decision|3|||
49165910|NCT01436110|158443197|FG001|Overall Study|Physician Decision|1|||
49165911|NCT01436110|158443198|FG002|Overall Study|Physician Decision|1|||
49165912|NCT01436110|158443196|FG000|Overall Study|Lost to Follow-up|1|||
49165913|NCT01436110|158443197|FG001|Overall Study|Lost to Follow-up|1|||
49165914|NCT01436110|158443198|FG002|Overall Study|Lost to Follow-up|3|||
49165915|NCT01436110|158443196|FG000|Overall Study|Protocol Violation|3|||
49165916|NCT01436110|158443197|FG001|Overall Study|Protocol Violation|1|||
49165917|NCT01436110|158443198|FG002|Overall Study|Protocol Violation|1|||
49165918|NCT01436110|158443196|FG000|Overall Study|Did Not Receive Trial Medication|1|||
49165919|NCT01436110|158443197|FG001|Overall Study|Did Not Receive Trial Medication|0|||
49165920|NCT01436110|158443198|FG002|Overall Study|Did Not Receive Trial Medication|3|||
49165921|NCT01847092|158443201|FG000|Overall Study|Adverse Event|12|||
49165922|NCT01847092|158443202|FG001|Overall Study|Adverse Event|3|||
49165923|NCT01847092|158443201|FG000|Overall Study|Withdrawal by Subject|5|||
49165924|NCT01847092|158443202|FG001|Overall Study|Withdrawal by Subject|5|||
49165925|NCT01847092|158443201|FG000|Overall Study|Protocol Specified|8|||
49165926|NCT01847092|158443202|FG001|Overall Study|Protocol Specified|0|||
49165927|NCT01847092|158443201|FG000|Overall Study|Physician Decision|1|||
49165928|NCT01847092|158443202|FG001|Overall Study|Physician Decision|1|||
49165929|NCT01847092|158443201|FG000|Overall Study|Protocol Violation|0|||
49165930|NCT01847092|158443202|FG001|Overall Study|Protocol Violation|2|||
49165931|NCT00825994|158443203|FG000|Overall Study|Withdrawal by Subject|2|||
49165932|NCT00825994|158443203|FG000|Overall Study|Lost to Follow-up|1|||
49165933|NCT00825994|158443203|FG000|Overall Study|Protocol Violation|1|||
49165934|NCT00825994|158443203|FG000|Overall Study|Placebo Responder at V2|1|||
49165935|NCT00443118|158443207|FG000|Overall Study|unknown primary outcome|3|||
49165936|NCT00443118|158443208|FG001|Overall Study|unknown primary outcome|1|||
49165937|NCT00443118|158443209|FG002|Overall Study|unknown primary outcome|0|||
49165938|NCT00443118|158443207|FG000|Overall Study|Withdrawal by Subject|1|||
49165939|NCT00443118|158443208|FG001|Overall Study|Withdrawal by Subject|0|||
49165940|NCT00443118|158443209|FG002|Overall Study|Withdrawal by Subject|0|||
49165941|NCT00506779|158443214|FG000|Overall Study|Withdrawal by Subject|1|||
49165942|NCT00506779|158443215|FG001|Overall Study|Withdrawal by Subject|0|||
49165943|NCT00506779|158443216|FG002|Overall Study|Withdrawal by Subject|1|||
49165944|NCT00506779|158443217|FG003|Overall Study|Withdrawal by Subject|0|||
49165945|NCT00506779|158443214|FG000|Overall Study|Adverse Event|0|||
49165946|NCT00506779|158443215|FG001|Overall Study|Adverse Event|1|||
49165947|NCT00506779|158443216|FG002|Overall Study|Adverse Event|1|||
49165948|NCT00506779|158443217|FG003|Overall Study|Adverse Event|1|||
49165949|NCT01194245|158443219|FG000|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5|||
49165950|NCT01194245|158443220|FG001|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
49165951|NCT01194245|158443221|FG002|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
49165952|NCT01194245|158443222|FG003|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
49165953|NCT01194245|158443223|FG004|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
49165954|NCT01194245|158443219|FG000|Titration Period (4 to 6 Weeks)|Physician Decision|3|||
49165955|NCT01194245|158443220|FG001|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
49165956|NCT01194245|158443221|FG002|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
49165957|NCT01194245|158443222|FG003|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
49165958|NCT01194245|158443223|FG004|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
49165959|NCT01194245|158443219|FG000|Titration Period (4 to 6 Weeks)|Titration Failure|3|||
49165960|NCT01194245|158443220|FG001|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
48924790|NCT03245450|157557239|FG006|Overall Study|Radiological disease progression|6|||
48924791|NCT03245450|157557233|FG000|Overall Study|Clinical disease progression|0|||
48924792|NCT03245450|157557234|FG001|Overall Study|Clinical disease progression|0|||
48924793|NCT03245450|157557235|FG002|Overall Study|Clinical disease progression|1|||
48924794|NCT03245450|157557236|FG003|Overall Study|Clinical disease progression|0|||
48924795|NCT03245450|157557237|FG004|Overall Study|Clinical disease progression|0|||
48924796|NCT03245450|157557238|FG005|Overall Study|Clinical disease progression|2|||
48924797|NCT03245450|157557239|FG006|Overall Study|Clinical disease progression|0|||
48924798|NCT03245450|157557233|FG000|Overall Study|Other|0|||
48924799|NCT03245450|157557234|FG001|Overall Study|Other|0|||
48924800|NCT03245450|157557235|FG002|Overall Study|Other|0|||
49165961|NCT01194245|158443221|FG002|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
49165962|NCT01194245|158443222|FG003|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
49165963|NCT01194245|158443223|FG004|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
48924801|NCT03245450|157557236|FG003|Overall Study|Other|1|||
48924802|NCT03245450|157557237|FG004|Overall Study|Other|1|||
48924803|NCT03245450|157557238|FG005|Overall Study|Other|1|||
48924804|NCT03245450|157557239|FG006|Overall Study|Other|1|||
48924805|NCT03245450|157557233|FG000|Overall Study|Withdrawal by Subject|0|||
48924806|NCT03245450|157557234|FG001|Overall Study|Withdrawal by Subject|1|||
48924807|NCT03245450|157557235|FG002|Overall Study|Withdrawal by Subject|0|||
48924808|NCT03245450|157557236|FG003|Overall Study|Withdrawal by Subject|0|||
49165964|NCT01194245|158443219|FG000|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7|||
49165965|NCT01194245|158443220|FG001|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
49165966|NCT01194245|158443221|FG002|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
49165967|NCT01194245|158443222|FG003|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
49165968|NCT01194245|158443223|FG004|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
49165969|NCT01194245|158443219|FG000|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
48924809|NCT03245450|157557237|FG004|Overall Study|Withdrawal by Subject|0|||
48924810|NCT03245450|157557238|FG005|Overall Study|Withdrawal by Subject|0|||
48924811|NCT03245450|157557239|FG006|Overall Study|Withdrawal by Subject|0|||
48924812|NCT03245450|157557233|FG000|Overall Study|Adverse Event|0|||
48924813|NCT03245450|157557234|FG001|Overall Study|Adverse Event|0|||
48924814|NCT03245450|157557235|FG002|Overall Study|Adverse Event|0|||
48924815|NCT03245450|157557236|FG003|Overall Study|Adverse Event|0|||
48924816|NCT03245450|157557237|FG004|Overall Study|Adverse Event|1|||
48924817|NCT03245450|157557238|FG005|Overall Study|Adverse Event|0|||
48924818|NCT03245450|157557239|FG006|Overall Study|Adverse Event|2|||
49014881|NCT01405820|157890467|FG005|Randomized Treatment Period|Adverse Event|1|||
49014882|NCT01405820|157890462|FG000|Randomized Treatment Period|Withdrawal by Subject|6|||
49014883|NCT01405820|157890463|FG001|Randomized Treatment Period|Withdrawal by Subject|2|||
49014884|NCT01405820|157890464|FG002|Randomized Treatment Period|Withdrawal by Subject|2|||
49014885|NCT01405820|157890465|FG003|Randomized Treatment Period|Withdrawal by Subject|2|||
49014886|NCT01405820|157890466|FG004|Randomized Treatment Period|Withdrawal by Subject|0|||
49014887|NCT01405820|157890467|FG005|Randomized Treatment Period|Withdrawal by Subject|0|||
49014888|NCT01405820|157890462|FG000|Randomized Treatment Period|Other|2|||
49014889|NCT01405820|157890463|FG001|Randomized Treatment Period|Other|2|||
49014890|NCT01405820|157890464|FG002|Randomized Treatment Period|Other|1|||
49014891|NCT01405820|157890465|FG003|Randomized Treatment Period|Other|1|||
49014892|NCT01405820|157890466|FG004|Randomized Treatment Period|Other|0|||
49014893|NCT01405820|157890467|FG005|Randomized Treatment Period|Other|0|||
49014894|NCT01405820|157890462|FG000|Randomized Treatment Period|Physician Decision|0|||
49014895|NCT01405820|157890463|FG001|Randomized Treatment Period|Physician Decision|2|||
49014896|NCT01405820|157890464|FG002|Randomized Treatment Period|Physician Decision|1|||
49014897|NCT01405820|157890465|FG003|Randomized Treatment Period|Physician Decision|0|||
49014898|NCT01405820|157890466|FG004|Randomized Treatment Period|Physician Decision|0|||
49014899|NCT01405820|157890467|FG005|Randomized Treatment Period|Physician Decision|0|||
49014900|NCT01405820|157890462|FG000|Randomized Treatment Period|Rescue|0|||
49014901|NCT01405820|157890463|FG001|Randomized Treatment Period|Rescue|1|||
49014902|NCT01405820|157890464|FG002|Randomized Treatment Period|Rescue|13|||
49014903|NCT01405820|157890465|FG003|Randomized Treatment Period|Rescue|10|||
49014904|NCT01405820|157890466|FG004|Randomized Treatment Period|Rescue|8|||
49014905|NCT01405820|157890467|FG005|Randomized Treatment Period|Rescue|8|||
49014906|NCT01405820|157890462|FG000|Randomized Treatment Period|Incorrect Study Treatment|0|||
49014907|NCT01405820|157890463|FG001|Randomized Treatment Period|Incorrect Study Treatment|0|||
49014908|NCT01405820|157890464|FG002|Randomized Treatment Period|Incorrect Study Treatment|3|||
49165970|NCT01194245|158443220|FG001|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
48924819|NCT02268058|157557240|FG000|Overall Study|Protocol Violation|1|||
48924820|NCT02268058|157557241|FG001|Overall Study|Protocol Violation|0|||
48924821|NCT02268058|157557242|FG002|Overall Study|Protocol Violation|0|||
48924822|NCT02268058|157557243|FG003|Overall Study|Protocol Violation|0|||
48924823|NCT01098071|157557244|FG000|Overall Study|Surgery (adenoidectomy)|2|||
48924824|NCT01098071|157557244|FG000|Overall Study|Lost to Follow-up|13|||
48924825|NCT00705939|157557246|FG000|Overall Study|Protocol Violation|0|||
48924826|NCT00705939|157557247|FG001|Overall Study|Protocol Violation|0|||
48924827|NCT00705939|157557248|FG002|Overall Study|Protocol Violation|1|||
48924828|NCT00705939|157557246|FG000|Overall Study|Withdrawal by Subject|0|||
48924829|NCT00705939|157557247|FG001|Overall Study|Withdrawal by Subject|1|||
48924830|NCT00705939|157557248|FG002|Overall Study|Withdrawal by Subject|3|||
48924831|NCT00705939|157557246|FG000|Overall Study|Physician Decision|0|||
48924832|NCT00705939|157557247|FG001|Overall Study|Physician Decision|1|||
48924833|NCT00705939|157557248|FG002|Overall Study|Physician Decision|0|||
48924834|NCT01537211|157557249|FG000|Overall Study|Lost to Follow-up|0|||
48924835|NCT01537211|157557250|FG001|Overall Study|Lost to Follow-up|1|||
48924836|NCT01857869|157557255|FG000|Primary/Challenge Phase|Lost to Follow-up|2|||
48924837|NCT01857869|157557256|FG001|Primary/Challenge Phase|Lost to Follow-up|0|||
48924838|NCT01857869|157557257|FG002|Primary/Challenge Phase|Lost to Follow-up|0|||
49165971|NCT01194245|158443221|FG002|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
49165972|NCT01194245|158443222|FG003|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
49165973|NCT01194245|158443223|FG004|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
49165974|NCT01194245|158443219|FG000|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
49165975|NCT01194245|158443220|FG001|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
49165976|NCT01194245|158443221|FG002|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
49165977|NCT01194245|158443222|FG003|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
49165978|NCT01194245|158443223|FG004|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
49165979|NCT01118780|158443224|FG000|Overall Study|Adverse Event|15|||
49165980|NCT01118780|158443225|FG001|Overall Study|Adverse Event|15|||
49165981|NCT01118780|158443224|FG000|Overall Study|Death|1|||
49165982|NCT01118780|158443225|FG001|Overall Study|Death|0|||
49165983|NCT01118780|158443224|FG000|Overall Study|Lack of Efficacy|2|||
49165984|NCT01118780|158443225|FG001|Overall Study|Lack of Efficacy|6|||
49165985|NCT01118780|158443224|FG000|Overall Study|Physician Decision|2|||
49165986|NCT01118780|158443225|FG001|Overall Study|Physician Decision|0|||
49165987|NCT01118780|158443224|FG000|Overall Study|Protocol Violation|3|||
49165988|NCT01118780|158443225|FG001|Overall Study|Protocol Violation|6|||
49165989|NCT01118780|158443224|FG000|Overall Study|Withdrawal by Subject|13|||
49165990|NCT01118780|158443225|FG001|Overall Study|Withdrawal by Subject|8|||
49165991|NCT02651116|158443226|FG000|Overall Study|Adverse Event|0|||
49165992|NCT02651116|158443227|FG001|Overall Study|Adverse Event|1|||
49165993|NCT02651116|158443226|FG000|Overall Study|No Longer Willing To Participate In Study|1|||
49165994|NCT02651116|158443227|FG001|Overall Study|No Longer Willing To Participate In Study|0|||
49165995|NCT00590967|158443228|FG000|Overall Study|Withdrawal by Subject|1|||
49165996|NCT00590967|158443229|FG001|Overall Study|Withdrawal by Subject|1|||
49165997|NCT00590967|158443228|FG000|Overall Study|Ineligible|1|||
49165998|NCT00590967|158443229|FG001|Overall Study|Ineligible|0|||
49165999|NCT00590967|158443228|FG000|Overall Study|Poor performance status|0|||
49166000|NCT00590967|158443229|FG001|Overall Study|Poor performance status|1|||
49166001|NCT00590967|158443228|FG000|Overall Study|Non-compliant|0|||
49166002|NCT00590967|158443229|FG001|Overall Study|Non-compliant|2|||
49166003|NCT00590967|158443228|FG000|Overall Study|Did not sign consent form|0|||
49166004|NCT00590967|158443229|FG001|Overall Study|Did not sign consent form|1|||
49166005|NCT00590967|158443228|FG000|Overall Study|Did not receive chemo per protocol|1|||
49166006|NCT00590967|158443229|FG001|Overall Study|Did not receive chemo per protocol|0|||
49166007|NCT01434654|158443230|FG000|Overall Study|Withdrawal by Subject|1|||
49166008|NCT01434654|158443231|FG001|Overall Study|Withdrawal by Subject|0|||
49166009|NCT01434654|158443230|FG000|Overall Study|Lost to Follow-up|1|||
49166010|NCT01434654|158443231|FG001|Overall Study|Lost to Follow-up|0|||
49166011|NCT03328832|158443232|FG000|Overall Study|Lost to Follow-up|0|||
49166012|NCT03328832|158443233|FG001|Overall Study|Lost to Follow-up|1|||
49166013|NCT00959907|158443234|FG000|Overall Study|Protocol Violation|0|||
49166014|NCT00959907|158443235|FG001|Overall Study|Protocol Violation|1|||
49166015|NCT00959907|158443234|FG000|Overall Study|Adverse Event|1|||
49166016|NCT00959907|158443235|FG001|Overall Study|Adverse Event|0|||
49166017|NCT00959907|158443234|FG000|Overall Study|Withdrawal by Subject|2|||
49166018|NCT00959907|158443235|FG001|Overall Study|Withdrawal by Subject|0|||
49166019|NCT01991483|158443236|FG000|Dose Level 600 mg|Withdrawal by Subject|0|||
49166020|NCT01991483|158443237|FG001|Dose Level 600 mg|Withdrawal by Subject|0|||
49166021|NCT01991483|158443238|FG002|Dose Level 600 mg|Withdrawal by Subject|1|||
49166022|NCT01991483|158443239|FG003|Dose Level 600 mg|Withdrawal by Subject|0|||
49166023|NCT01991483|158443236|FG000|Dose Level 600 mg|Physician Decision|0|||
48692906|NCT03137992|156724651|FG005|Washout Period 1|Principal Investigator Discretion|0|||
49166024|NCT01991483|158443237|FG001|Dose Level 600 mg|Physician Decision|0|||
48924839|NCT01857869|157557258|FG003|Primary/Challenge Phase|Lost to Follow-up|0|||
48924840|NCT01857869|157557259|FG004|Primary/Challenge Phase|Lost to Follow-up|0|||
49166025|NCT01991483|158443238|FG002|Dose Level 600 mg|Physician Decision|1|||
49166026|NCT01991483|158443239|FG003|Dose Level 600 mg|Physician Decision|0|||
48924841|NCT01857869|157557260|FG005|Primary/Challenge Phase|Lost to Follow-up|0|||
49166027|NCT01991483|158443236|FG000|Dose Level 1000 mg|Protocol Violation|0|||
49166028|NCT01991483|158443237|FG001|Dose Level 1000 mg|Protocol Violation|0|||
49166029|NCT01991483|158443238|FG002|Dose Level 1000 mg|Protocol Violation|0|||
49166030|NCT01991483|158443239|FG003|Dose Level 1000 mg|Protocol Violation|1|||
49166031|NCT01890265|158443241|FG000|Overall Study|Other (Unspecified reason)|0|||
49166032|NCT01890265|158443242|FG001|Overall Study|Other (Unspecified reason)|1|||
49166033|NCT01890265|158443243|FG002|Overall Study|Other (Unspecified reason)|0|||
49166034|NCT01890265|158443244|FG003|Overall Study|Other (Unspecified reason)|0|||
49166035|NCT01890265|158443245|FG004|Overall Study|Other (Unspecified reason)|0|||
49166036|NCT01890265|158443246|FG005|Overall Study|Other (Unspecified reason)|0|||
49166037|NCT01890265|158443241|FG000|Overall Study|Progressive disease|6|||
49166038|NCT01890265|158443242|FG001|Overall Study|Progressive disease|6|||
49166039|NCT01890265|158443243|FG002|Overall Study|Progressive disease|0|||
49166040|NCT01890265|158443244|FG003|Overall Study|Progressive disease|0|||
49166041|NCT01890265|158443245|FG004|Overall Study|Progressive disease|0|||
49166042|NCT01890265|158443246|FG005|Overall Study|Progressive disease|0|||
49166043|NCT01890265|158443241|FG000|Overall Study|Adverse Event|2|||
49166044|NCT01890265|158443242|FG001|Overall Study|Adverse Event|1|||
49166045|NCT01890265|158443243|FG002|Overall Study|Adverse Event|0|||
49166046|NCT01890265|158443244|FG003|Overall Study|Adverse Event|0|||
49166047|NCT01890265|158443245|FG004|Overall Study|Adverse Event|0|||
49166048|NCT01890265|158443246|FG005|Overall Study|Adverse Event|0|||
49166049|NCT01890265|158443241|FG000|Overall Study|Death|2|||
49166050|NCT01890265|158443242|FG001|Overall Study|Death|3|||
49166051|NCT01890265|158443243|FG002|Overall Study|Death|1|||
49166052|NCT01890265|158443244|FG003|Overall Study|Death|0|||
49166053|NCT01890265|158443245|FG004|Overall Study|Death|0|||
49166054|NCT01890265|158443246|FG005|Overall Study|Death|0|||
49166055|NCT01890265|158443241|FG000|Overall Study|Withdrawal by Subject|0|||
49166056|NCT01890265|158443242|FG001|Overall Study|Withdrawal by Subject|2|||
49166057|NCT01890265|158443243|FG002|Overall Study|Withdrawal by Subject|3|||
49166058|NCT01890265|158443244|FG003|Overall Study|Withdrawal by Subject|0|||
49166059|NCT01890265|158443245|FG004|Overall Study|Withdrawal by Subject|2|||
49166060|NCT01890265|158443246|FG005|Overall Study|Withdrawal by Subject|0|||
49166061|NCT00407602|158443247|FG000|Overall Study|Death - unrelated to device|1|||
49166062|NCT00407602|158443247|FG000|Overall Study|Device explanted|5|||
49166063|NCT00407602|158443247|FG000|Overall Study|Withdrawal by Subject|1|||
49166064|NCT04466384|158443248|FG000|First Phase|Protocol Violation|1|||
49166065|NCT04466384|158443249|FG001|First Phase|Protocol Violation|0|||
49166066|NCT04466384|158443248|FG000|First Phase|Missing data|1|||
49166067|NCT04466384|158443249|FG001|First Phase|Missing data|0|||
49166068|NCT04466384|158443248|FG000|Cross Over Phase|Physician Decision|1|||
49166069|NCT04466384|158443249|FG001|Cross Over Phase|Physician Decision|0|||
49166070|NCT04466384|158443248|FG000|Cross Over Phase|Withdrawal by Subject|0|||
49166071|NCT04466384|158443249|FG001|Cross Over Phase|Withdrawal by Subject|1|||
49166072|NCT00429182|158443254|FG000|Overall Study|Not evaluable, Disease Progression|2|||
49166073|NCT00429182|158443254|FG000|Overall Study|Not eligible|5|||
49166074|NCT04162470|158443258|FG000|Overall Study|Withdrawn due to sponsor's decision|24|||
49166075|NCT02146131|158443259|FG000|Overall Study|Physician Decision|61|||
49166076|NCT02146131|158443260|FG001|Overall Study|Physician Decision|56|||
49166077|NCT01466491|158444838|FG000|Overall Study|Protocol Violation|0|||
49166078|NCT01466491|158444839|FG001|Overall Study|Protocol Violation|3|||
49166079|NCT01466491|158444840|FG002|Overall Study|Protocol Violation|2|||
49166080|NCT01466491|158444841|FG003|Overall Study|Protocol Violation|0|||
49166081|NCT01466491|158444838|FG000|Overall Study|Missing Data|0|||
49166082|NCT01466491|158444839|FG001|Overall Study|Missing Data|0|||
49166083|NCT01466491|158444840|FG002|Overall Study|Missing Data|1|||
49166084|NCT01466491|158444841|FG003|Overall Study|Missing Data|0|||
49166085|NCT03374358|158444842|FG000|Overall Study|Withdrawal by Subject|0|||
49166086|NCT03374358|158444843|FG001|Overall Study|Withdrawal by Subject|2|||
49166087|NCT01306643|158444848|FG000|Overall Study|Adverse Event|5|||
49166088|NCT01306643|158444848|FG000|Overall Study|Disease Progression|7|||
49166089|NCT01306643|158444848|FG000|Overall Study|Other: Change in Eligibility Status|1|||
49166090|NCT02848092|158444852|FG000|1-month Post-training Follow-up|Lost to Follow-up|8|||
49166091|NCT02848092|158444853|FG001|1-month Post-training Follow-up|Lost to Follow-up|3|||
49166092|NCT02848092|158444852|FG000|1-month Post-training Follow-up|Adverse Event|2|||
49166093|NCT02848092|158444853|FG001|1-month Post-training Follow-up|Adverse Event|1|||
49166094|NCT02848092|158444852|FG000|1-month Post-training Follow-up|Withdrawal by Subject|1|||
49166095|NCT02848092|158444853|FG001|1-month Post-training Follow-up|Withdrawal by Subject|0|||
49166096|NCT02848092|158444852|FG000|1-month Post-training Follow-up|received new diagnosis of epilepsy|1|||
49166097|NCT02848092|158444853|FG001|1-month Post-training Follow-up|received new diagnosis of epilepsy|0|||
49166098|NCT02848092|158444852|FG000|1-month Post-training Follow-up|fatigue|0|||
49166099|NCT02848092|158444853|FG001|1-month Post-training Follow-up|fatigue|1|||
49166100|NCT02848092|158444852|FG000|6-month Post-training Follow-up|Lost to Follow-up|9|||
49166101|NCT02848092|158444853|FG001|6-month Post-training Follow-up|Lost to Follow-up|3|||
49166102|NCT02848092|158444852|FG000|6-month Post-training Follow-up|Adverse Event|1|||
49166103|NCT02848092|158444853|FG001|6-month Post-training Follow-up|Adverse Event|1|||
49166104|NCT02848092|158444852|FG000|6-month Post-training Follow-up|Withdrawal by Subject|1|||
49166105|NCT02848092|158444853|FG001|6-month Post-training Follow-up|Withdrawal by Subject|0|||
49166106|NCT02848092|158444852|FG000|6-month Post-training Follow-up|frustrated with task|1|||
49166107|NCT02848092|158444853|FG001|6-month Post-training Follow-up|frustrated with task|0|||
49166108|NCT02848092|158444852|FG000|6-month Post-training Follow-up|new diagnosis of epilepsy|1|||
49166109|NCT02848092|158444853|FG001|6-month Post-training Follow-up|new diagnosis of epilepsy|0|||
49166110|NCT02848092|158444852|FG000|12-month Naturalistic Driving|Did not have DriveCam installed in car|3|||
49166111|NCT02848092|158444853|FG001|12-month Naturalistic Driving|Did not have DriveCam installed in car|2|||
49166112|NCT01465386|158444854|FG000|Overall Study|Lack of Efficacy|3|||
49166113|NCT01465386|158444854|FG000|Overall Study|Adverse Event|1|||
49166114|NCT01908140|158444859|FG000|Overall Study|Other or Progressive Disease|5|||
49166115|NCT01908140|158444860|FG001|Overall Study|Other or Progressive Disease|12|||
49166116|NCT01908140|158444859|FG000|Overall Study|Lack of Efficacy|7|||
49166117|NCT01908140|158444860|FG001|Overall Study|Lack of Efficacy|5|||
49166118|NCT01908140|158444859|FG000|Overall Study|Withdrawal by Subject|23|||
48924842|NCT01857869|157557261|FG006|Primary/Challenge Phase|Lost to Follow-up|0|||
48924843|NCT01857869|157557262|FG007|Primary/Challenge Phase|Lost to Follow-up|0|||
48924844|NCT01857869|157557263|FG008|Primary/Challenge Phase|Lost to Follow-up|0|||
48924845|NCT01857869|157557264|FG009|Primary/Challenge Phase|Lost to Follow-up|0|||
48924846|NCT01857869|157557255|FG000|Primary/Challenge Phase|Pregnancy|1|||
48924847|NCT01857869|157557256|FG001|Primary/Challenge Phase|Pregnancy|0|||
48924848|NCT01857869|157557257|FG002|Primary/Challenge Phase|Pregnancy|0|||
48924849|NCT01857869|157557258|FG003|Primary/Challenge Phase|Pregnancy|0|||
48924850|NCT01857869|157557259|FG004|Primary/Challenge Phase|Pregnancy|0|||
48924851|NCT01857869|157557260|FG005|Primary/Challenge Phase|Pregnancy|0|||
49166119|NCT01908140|158444860|FG001|Overall Study|Withdrawal by Subject|24|||
49166120|NCT01908140|158444859|FG000|Overall Study|Lost to Follow-up|1|||
49166121|NCT01908140|158444860|FG001|Overall Study|Lost to Follow-up|6|||
49166122|NCT01908140|158444859|FG000|Overall Study|Protocol Violation|8|||
48924852|NCT01857869|157557261|FG006|Primary/Challenge Phase|Pregnancy|0|||
48924853|NCT01857869|157557262|FG007|Primary/Challenge Phase|Pregnancy|0|||
48924854|NCT01857869|157557263|FG008|Primary/Challenge Phase|Pregnancy|0|||
48924855|NCT01857869|157557264|FG009|Primary/Challenge Phase|Pregnancy|0|||
48924856|NCT01857869|157557255|FG000|Primary/Challenge Phase|Protocol Violation|1|||
48924857|NCT01857869|157557256|FG001|Primary/Challenge Phase|Protocol Violation|0|||
48924858|NCT01857869|157557257|FG002|Primary/Challenge Phase|Protocol Violation|0|||
48924859|NCT01857869|157557258|FG003|Primary/Challenge Phase|Protocol Violation|0|||
48924860|NCT01857869|157557259|FG004|Primary/Challenge Phase|Protocol Violation|0|||
48924861|NCT01857869|157557260|FG005|Primary/Challenge Phase|Protocol Violation|0|||
48924862|NCT01857869|157557261|FG006|Primary/Challenge Phase|Protocol Violation|0|||
48924863|NCT01857869|157557262|FG007|Primary/Challenge Phase|Protocol Violation|0|||
48924864|NCT01857869|157557263|FG008|Primary/Challenge Phase|Protocol Violation|0|||
48924865|NCT01857869|157557264|FG009|Primary/Challenge Phase|Protocol Violation|0|||
48924866|NCT01857869|157557255|FG000|Primary/Challenge Phase|Other|1|||
48924867|NCT01857869|157557256|FG001|Primary/Challenge Phase|Other|1|||
48924868|NCT01857869|157557257|FG002|Primary/Challenge Phase|Other|0|||
48924869|NCT01857869|157557258|FG003|Primary/Challenge Phase|Other|0|||
48924870|NCT01857869|157557259|FG004|Primary/Challenge Phase|Other|0|||
48924871|NCT01857869|157557260|FG005|Primary/Challenge Phase|Other|0|||
48924872|NCT01857869|157557261|FG006|Primary/Challenge Phase|Other|0|||
48924873|NCT01857869|157557262|FG007|Primary/Challenge Phase|Other|0|||
48924874|NCT01857869|157557263|FG008|Primary/Challenge Phase|Other|0|||
48924875|NCT01857869|157557264|FG009|Primary/Challenge Phase|Other|0|||
48924876|NCT01857869|157557255|FG000|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
48924877|NCT01857869|157557256|FG001|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
48924878|NCT01857869|157557257|FG002|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
48924879|NCT01857869|157557258|FG003|Booster/Rechallenge Phase|Withdrawal by Subject|1|||
48924880|NCT01857869|157557259|FG004|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
48924881|NCT01857869|157557260|FG005|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
48924882|NCT01857869|157557261|FG006|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
48924883|NCT01857869|157557262|FG007|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
48924884|NCT01857869|157557263|FG008|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
48924885|NCT01857869|157557264|FG009|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
48924886|NCT01857869|157557255|FG000|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
48924887|NCT01857869|157557256|FG001|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
48924888|NCT01857869|157557257|FG002|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
48924889|NCT01857869|157557258|FG003|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1|||
48924890|NCT01857869|157557259|FG004|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
48924891|NCT01857869|157557260|FG005|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
48924892|NCT01857869|157557261|FG006|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
48924893|NCT01857869|157557262|FG007|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
48924894|NCT01857869|157557263|FG008|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
48924895|NCT01857869|157557264|FG009|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
48924896|NCT01999582|157557267|FG000|Overall Study|Withdrawal by Subject|0|||
48924897|NCT01999582|157557268|FG001|Overall Study|Withdrawal by Subject|0|||
48924898|NCT01999582|157557269|FG002|Overall Study|Withdrawal by Subject|0|||
48924899|NCT01999582|157557270|FG003|Overall Study|Withdrawal by Subject|1|||
48924900|NCT01999582|157557271|FG004|Overall Study|Withdrawal by Subject|0|||
48924901|NCT01999582|157557272|FG005|Overall Study|Withdrawal by Subject|0|||
48924902|NCT01999582|157557267|FG000|Overall Study|Adverse Event|0|||
48924903|NCT01999582|157557268|FG001|Overall Study|Adverse Event|0|||
48924904|NCT01999582|157557269|FG002|Overall Study|Adverse Event|3|||
48924905|NCT01999582|157557270|FG003|Overall Study|Adverse Event|0|||
48924906|NCT01999582|157557271|FG004|Overall Study|Adverse Event|1|||
48924907|NCT01999582|157557272|FG005|Overall Study|Adverse Event|0|||
48924908|NCT01999582|157557267|FG000|Overall Study|Other Reasons|1|||
48924909|NCT01999582|157557268|FG001|Overall Study|Other Reasons|0|||
48924910|NCT01999582|157557269|FG002|Overall Study|Other Reasons|3|||
48924911|NCT01999582|157557270|FG003|Overall Study|Other Reasons|1|||
48924912|NCT01999582|157557271|FG004|Overall Study|Other Reasons|1|||
48924913|NCT01999582|157557272|FG005|Overall Study|Other Reasons|2|||
48924914|NCT01999582|157557267|FG000|Overall Study|Protocol Violation|1|||
48924915|NCT01999582|157557268|FG001|Overall Study|Protocol Violation|0|||
48924916|NCT01999582|157557269|FG002|Overall Study|Protocol Violation|0|||
49166123|NCT01908140|158444860|FG001|Overall Study|Protocol Violation|9|||
49166124|NCT01908140|158444859|FG000|Overall Study|Adverse Event|22|||
49166125|NCT01908140|158444860|FG001|Overall Study|Adverse Event|23|||
49166126|NCT02329743|158444864|FG000|Overall Study|Adverse Event|1|||
49166127|NCT02329743|158444865|FG001|Overall Study|Adverse Event|1|||
49166128|NCT02329743|158444866|FG002|Overall Study|Adverse Event|3|||
49166129|NCT02329743|158444864|FG000|Overall Study|Lost to Follow-up|1|||
49166130|NCT02329743|158444865|FG001|Overall Study|Lost to Follow-up|0|||
49166131|NCT02329743|158444866|FG002|Overall Study|Lost to Follow-up|1|||
49166132|NCT02329743|158444864|FG000|Overall Study|Withdrawal by Subject|4|||
49166133|NCT02329743|158444865|FG001|Overall Study|Withdrawal by Subject|4|||
49166134|NCT02329743|158444866|FG002|Overall Study|Withdrawal by Subject|1|||
48924917|NCT01999582|157557270|FG003|Overall Study|Protocol Violation|0|||
48924918|NCT01999582|157557271|FG004|Overall Study|Protocol Violation|0|||
48924919|NCT01999582|157557272|FG005|Overall Study|Protocol Violation|1|||
48924920|NCT01999582|157557267|FG000|Overall Study|Lack of Efficacy|1|||
49166135|NCT02329743|158444864|FG000|Overall Study|Other|0|||
49166136|NCT02329743|158444865|FG001|Overall Study|Other|2|||
49166137|NCT02329743|158444866|FG002|Overall Study|Other|3|||
49166138|NCT01016067|158444872|FG000|Overall Study|Lost to Follow-up|1|||
49166139|NCT01016067|158444873|FG001|Overall Study|Lost to Follow-up|2|||
49166140|NCT01016067|158444872|FG000|Overall Study|Physician Decision|1|||
49166141|NCT01016067|158444873|FG001|Overall Study|Physician Decision|1|||
49166142|NCT01016067|158444872|FG000|Overall Study|Withdrew due to Relocation|0|||
49166143|NCT01016067|158444873|FG001|Overall Study|Withdrew due to Relocation|1|||
49166144|NCT00592631|158444874|FG000|Overall Study|Lost to Follow-up|0|||
49166145|NCT00592631|158444875|FG001|Overall Study|Lost to Follow-up|2|||
49166146|NCT00570323|158444881|FG000|Started Treatment After Randomization|Withdrawal by Subject|0|||
49166147|NCT00570323|158444882|FG001|Started Treatment After Randomization|Withdrawal by Subject|1|||
49166148|NCT00570323|158444881|FG000|Started Treatment After Randomization|Protocol Violation|1|||
49166149|NCT00570323|158444882|FG001|Started Treatment After Randomization|Protocol Violation|0|||
49166150|NCT00570323|158444881|FG000|Started Treatment After Randomization|Physician Decision|1|||
49166151|NCT00570323|158444882|FG001|Started Treatment After Randomization|Physician Decision|0|||
49166152|NCT00570323|158444881|FG000|Complete Study After Start|Lost to Follow-up|0|||
49166153|NCT00570323|158444882|FG001|Complete Study After Start|Lost to Follow-up|1|||
49166154|NCT00570323|158444881|FG000|Complete Study After Start|Withdrawal by Subject|2|||
49166155|NCT00570323|158444882|FG001|Complete Study After Start|Withdrawal by Subject|0|||
49166156|NCT00570323|158444881|FG000|Complete Study After Start|Physician Decision|1|||
49166157|NCT00570323|158444882|FG001|Complete Study After Start|Physician Decision|0|||
49166158|NCT00310375|158444883|FG000|Primary Reporting Phase|Adverse Event|28|||
49166159|NCT00310375|158444884|FG001|Primary Reporting Phase|Adverse Event|22|||
49166160|NCT00310375|158444885|FG002|Primary Reporting Phase|Adverse Event|0|||
49166161|NCT00310375|158444883|FG000|Primary Reporting Phase|Lack of Efficacy|24|||
49166162|NCT00310375|158444884|FG001|Primary Reporting Phase|Lack of Efficacy|19|||
49166163|NCT00310375|158444885|FG002|Primary Reporting Phase|Lack of Efficacy|0|||
49166164|NCT00310375|158444883|FG000|Primary Reporting Phase|Pregnancy|2|||
49166165|NCT00310375|158444884|FG001|Primary Reporting Phase|Pregnancy|2|||
49166166|NCT00310375|158444885|FG002|Primary Reporting Phase|Pregnancy|0|||
48692907|NCT03137992|156724646|FG000|Washout Period 1|COPD Exacerbation|1|||
49166167|NCT00310375|158444883|FG000|Primary Reporting Phase|Withdrawal by Subject|10|||
49166168|NCT00310375|158444884|FG001|Primary Reporting Phase|Withdrawal by Subject|7|||
49166169|NCT00310375|158444885|FG002|Primary Reporting Phase|Withdrawal by Subject|0|||
49166170|NCT00310375|158444883|FG000|Primary Reporting Phase|Protocol Violation|8|||
49166171|NCT00310375|158444884|FG001|Primary Reporting Phase|Protocol Violation|5|||
49166172|NCT00310375|158444885|FG002|Primary Reporting Phase|Protocol Violation|0|||
48924921|NCT01999582|157557268|FG001|Overall Study|Lack of Efficacy|3|||
49166173|NCT00310375|158444883|FG000|Primary Reporting Phase|Change in Par medical condition|2|||
49166174|NCT00310375|158444884|FG001|Primary Reporting Phase|Change in Par medical condition|0|||
49166175|NCT00310375|158444885|FG002|Primary Reporting Phase|Change in Par medical condition|0|||
49166176|NCT00310375|158444883|FG000|Primary Reporting Phase|Transaminase >5 upper limit of normal|2|||
49166177|NCT00310375|158444884|FG001|Primary Reporting Phase|Transaminase >5 upper limit of normal|1|||
49166178|NCT00310375|158444885|FG002|Primary Reporting Phase|Transaminase >5 upper limit of normal|0|||
49166179|NCT00310375|158444883|FG000|Primary Reporting Phase|Physician Decision|5|||
49166180|NCT00310375|158444884|FG001|Primary Reporting Phase|Physician Decision|3|||
49166181|NCT00310375|158444885|FG002|Primary Reporting Phase|Physician Decision|0|||
49166182|NCT00310375|158444883|FG000|Primary Reporting Phase|Request of the sponsor|2|||
49166183|NCT00310375|158444884|FG001|Primary Reporting Phase|Request of the sponsor|2|||
49166184|NCT00310375|158444885|FG002|Primary Reporting Phase|Request of the sponsor|0|||
49166185|NCT00310375|158444883|FG000|Primary Reporting Phase|Failed to return|1|||
49166186|NCT00310375|158444884|FG001|Primary Reporting Phase|Failed to return|3|||
49166187|NCT00310375|158444885|FG002|Primary Reporting Phase|Failed to return|0|||
49166188|NCT00310375|158444883|FG000|Primary Reporting Phase|Participant request unrelated to study|1|||
49166189|NCT00310375|158444884|FG001|Primary Reporting Phase|Participant request unrelated to study|2|||
48924922|NCT01999582|157557269|FG002|Overall Study|Lack of Efficacy|0|||
48924923|NCT01999582|157557270|FG003|Overall Study|Lack of Efficacy|1|||
48924924|NCT01999582|157557271|FG004|Overall Study|Lack of Efficacy|0|||
48924925|NCT01999582|157557272|FG005|Overall Study|Lack of Efficacy|0|||
48924926|NCT02239263|157557273|FG000|Overall Study|Protocol Violation|6|||
48924927|NCT00797823|157557274|FG000|First Period (Initial Randomization)|Physician Decision|1|||
48924928|NCT00797823|157557275|FG001|First Period (Initial Randomization)|Physician Decision|0|||
48924929|NCT00797823|157557276|FG002|First Period (Initial Randomization)|Physician Decision|0|||
48924930|NCT01707693|157557277|FG000|Overall Study Allocation|Withdrawal by Subject|9|||
48924931|NCT01707693|157557278|FG001|Overall Study Allocation|Withdrawal by Subject|5|||
48924932|NCT01707693|157557277|FG000|Overall Study Allocation|Protocol Violation|4|||
48924933|NCT01707693|157557278|FG001|Overall Study Allocation|Protocol Violation|3|||
48924934|NCT01707693|157557277|FG000|Time 3 Measures @ 6 Mth|Lost to Follow-up|0|||
48924935|NCT01707693|157557278|FG001|Time 3 Measures @ 6 Mth|Lost to Follow-up|3|||
48924936|NCT01707693|157557277|FG000|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0|||
48924937|NCT01707693|157557278|FG001|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2|||
48924938|NCT00391222|157557280|FG000|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
48924939|NCT00391222|157557281|FG001|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
48924940|NCT00391222|157557282|FG002|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
48924941|NCT00391222|157557283|FG003|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26|||
48924942|NCT00391222|157557280|FG000|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
48924943|NCT00391222|157557281|FG001|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
48924944|NCT00391222|157557282|FG002|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
48924945|NCT00391222|157557283|FG003|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5|||
48924946|NCT00391222|157557280|FG000|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
48924947|NCT00391222|157557281|FG001|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
48924948|NCT00391222|157557282|FG002|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
48924949|NCT00391222|157557283|FG003|Period II (Open-label Risperidone LAI)|Adverse Event|10|||
48924950|NCT00391222|157557280|FG000|Period II (Open-label Risperidone LAI)|Non-responder|0|||
48924951|NCT00391222|157557281|FG001|Period II (Open-label Risperidone LAI)|Non-responder|0|||
48924952|NCT00391222|157557282|FG002|Period II (Open-label Risperidone LAI)|Non-responder|0|||
48924953|NCT00391222|157557283|FG003|Period II (Open-label Risperidone LAI)|Non-responder|97|||
48924954|NCT00391222|157557280|FG000|Period II (Open-label Risperidone LAI)|Other|0|||
48924955|NCT00391222|157557281|FG001|Period II (Open-label Risperidone LAI)|Other|0|||
48924956|NCT00391222|157557282|FG002|Period II (Open-label Risperidone LAI)|Other|0|||
48924957|NCT00391222|157557283|FG003|Period II (Open-label Risperidone LAI)|Other|24|||
48924958|NCT00391222|157557280|FG000|Period III (Double-Blind Treatment)|Withdrawal by Subject|15|||
49166190|NCT00310375|158444885|FG002|Primary Reporting Phase|Participant request unrelated to study|0|||
49166191|NCT00310375|158444883|FG000|Primary Reporting Phase|Going for temporal lobectomy|1|||
49166192|NCT00310375|158444884|FG001|Primary Reporting Phase|Going for temporal lobectomy|0|||
49166193|NCT00310375|158444885|FG002|Primary Reporting Phase|Going for temporal lobectomy|0|||
48924959|NCT00391222|157557281|FG001|Period III (Double-Blind Treatment)|Withdrawal by Subject|12|||
48924960|NCT00391222|157557282|FG002|Period III (Double-Blind Treatment)|Withdrawal by Subject|6|||
48924961|NCT00391222|157557283|FG003|Period III (Double-Blind Treatment)|Withdrawal by Subject|0|||
48924962|NCT00391222|157557280|FG000|Period III (Double-Blind Treatment)|Lost to Follow-up|2|||
48924963|NCT00391222|157557281|FG001|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
48924964|NCT00391222|157557282|FG002|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
48924965|NCT00391222|157557283|FG003|Period III (Double-Blind Treatment)|Lost to Follow-up|0|||
48924966|NCT00391222|157557280|FG000|Period III (Double-Blind Treatment)|Adverse Event|5|||
48924967|NCT00391222|157557281|FG001|Period III (Double-Blind Treatment)|Adverse Event|2|||
48924968|NCT00391222|157557282|FG002|Period III (Double-Blind Treatment)|Adverse Event|4|||
48924969|NCT00391222|157557283|FG003|Period III (Double-Blind Treatment)|Adverse Event|0|||
48924970|NCT00391222|157557280|FG000|Period III (Double-Blind Treatment)|Pregnancy|0|||
48924971|NCT00391222|157557281|FG001|Period III (Double-Blind Treatment)|Pregnancy|2|||
48924972|NCT00391222|157557282|FG002|Period III (Double-Blind Treatment)|Pregnancy|0|||
48924973|NCT00391222|157557283|FG003|Period III (Double-Blind Treatment)|Pregnancy|0|||
49014909|NCT01405820|157890465|FG003|Randomized Treatment Period|Incorrect Study Treatment|0|||
49014910|NCT01405820|157890466|FG004|Randomized Treatment Period|Incorrect Study Treatment|2|||
49014911|NCT01405820|157890467|FG005|Randomized Treatment Period|Incorrect Study Treatment|0|||
49014912|NCT01405820|157890462|FG000|Randomized Treatment Period|Treatment Arm Closed|0|||
49014913|NCT01405820|157890463|FG001|Randomized Treatment Period|Treatment Arm Closed|0|||
49014914|NCT01405820|157890464|FG002|Randomized Treatment Period|Treatment Arm Closed|20|||
49014915|NCT01405820|157890465|FG003|Randomized Treatment Period|Treatment Arm Closed|36|||
49014916|NCT01405820|157890466|FG004|Randomized Treatment Period|Treatment Arm Closed|33|||
49014917|NCT01405820|157890467|FG005|Randomized Treatment Period|Treatment Arm Closed|28|||
49014918|NCT01405820|157890462|FG000|Randomized Treatment Period|Death|0|||
49014919|NCT01405820|157890463|FG001|Randomized Treatment Period|Death|0|||
49014920|NCT01405820|157890464|FG002|Randomized Treatment Period|Death|0|||
49014921|NCT01405820|157890465|FG003|Randomized Treatment Period|Death|1|||
49014922|NCT01405820|157890466|FG004|Randomized Treatment Period|Death|0|||
49014923|NCT01405820|157890467|FG005|Randomized Treatment Period|Death|0|||
49014924|NCT01405820|157890462|FG000|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
49014925|NCT01405820|157890463|FG001|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
49014926|NCT01405820|157890464|FG002|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
48924974|NCT00391222|157557280|FG000|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
48924975|NCT00391222|157557281|FG001|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1|||
48924976|NCT00391222|157557282|FG002|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3|||
48924977|NCT00391222|157557283|FG003|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
48924978|NCT00391222|157557280|FG000|Period III (Double-Blind Treatment)|Other|6|||
48924979|NCT00391222|157557281|FG001|Period III (Double-Blind Treatment)|Other|1|||
48924980|NCT00391222|157557282|FG002|Period III (Double-Blind Treatment)|Other|6|||
48924981|NCT00391222|157557283|FG003|Period III (Double-Blind Treatment)|Other|0|||
48924982|NCT04849780|157557284|FG000|Period 1|Covid-19 Related|1|||
48924983|NCT04849780|157557285|FG001|Period 1|Covid-19 Related|0|||
48924984|NCT04849780|157557284|FG000|Period 1|Subject no longer meet eligibility criteria|3|||
48924985|NCT04849780|157557285|FG001|Period 1|Subject no longer meet eligibility criteria|0|||
48924986|NCT04849780|157557284|FG000|Period 2|Subject no longer meet eligibility criteria|2|||
48924987|NCT04849780|157557285|FG001|Period 2|Subject no longer meet eligibility criteria|0|||
48924988|NCT00725075|157557286|FG000|Overall Study|Use of Excluded Medication|0|||
48924989|NCT00725075|157557287|FG001|Overall Study|Use of Excluded Medication|1|||
48924990|NCT00725075|157557288|FG002|Overall Study|Use of Excluded Medication|0|||
48924991|NCT00725075|157557286|FG000|Overall Study|Protocol Violation|0|||
48924992|NCT00725075|157557287|FG001|Overall Study|Protocol Violation|0|||
48924993|NCT00725075|157557288|FG002|Overall Study|Protocol Violation|1|||
48924994|NCT00725075|157557286|FG000|Overall Study|Lost to Follow-up|1|||
48924995|NCT00725075|157557287|FG001|Overall Study|Lost to Follow-up|0|||
48924996|NCT00725075|157557288|FG002|Overall Study|Lost to Follow-up|0|||
48924997|NCT00725075|157557286|FG000|Overall Study|Withdrawal by Subject|4|||
48924998|NCT00725075|157557287|FG001|Overall Study|Withdrawal by Subject|5|||
48924999|NCT00725075|157557288|FG002|Overall Study|Withdrawal by Subject|4|||
48925000|NCT00725075|157557286|FG000|Overall Study|Adverse Event|2|||
48925001|NCT00725075|157557287|FG001|Overall Study|Adverse Event|1|||
48925002|NCT00725075|157557288|FG002|Overall Study|Adverse Event|1|||
48925003|NCT00725075|157557286|FG000|Overall Study|Worsening of Disease|2|||
48925004|NCT00725075|157557287|FG001|Overall Study|Worsening of Disease|1|||
48925005|NCT00725075|157557288|FG002|Overall Study|Worsening of Disease|2|||
48925006|NCT00725075|157557286|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
48925007|NCT00725075|157557287|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
48925008|NCT00725075|157557288|FG002|Overall Study|Inclusion/Exclusion Criteria|1|||
48925009|NCT00725075|157557286|FG000|Overall Study|Other|1|||
48925010|NCT00725075|157557287|FG001|Overall Study|Other|0|||
48925011|NCT00725075|157557288|FG002|Overall Study|Other|0|||
48925012|NCT03984305|157557289|FG000|Overall Study|Sponsor Request due to Study Discontinuation|19|||
48925013|NCT03984305|157557290|FG001|Overall Study|Sponsor Request due to Study Discontinuation|15|||
48925014|NCT03984305|157557289|FG000|Overall Study|Withdrawal by Subject|3|||
48925015|NCT03984305|157557290|FG001|Overall Study|Withdrawal by Subject|3|||
48925016|NCT03984305|157557289|FG000|Overall Study|Lost to Follow-up|1|||
48925017|NCT03984305|157557290|FG001|Overall Study|Lost to Follow-up|0|||
48925018|NCT02979431|157557291|FG000|Overall Study|Parent/guardian withdrew consent|2|||
48925019|NCT02979431|157557292|FG001|Overall Study|Parent/guardian withdrew consent|1|||
48925020|NCT02979431|157557293|FG002|Overall Study|Parent/guardian withdrew consent|1|||
48925021|NCT02979431|157557294|FG003|Overall Study|Parent/guardian withdrew consent|1|||
48925022|NCT02979431|157557291|FG000|Overall Study|Randomized but received no study drug|1|||
48925023|NCT02979431|157557292|FG001|Overall Study|Randomized but received no study drug|1|||
48925024|NCT02979431|157557293|FG002|Overall Study|Randomized but received no study drug|0|||
48925025|NCT02979431|157557294|FG003|Overall Study|Randomized but received no study drug|0|||
48925026|NCT02979431|157557291|FG000|Overall Study|Adverse Event|0|||
48925027|NCT02979431|157557292|FG001|Overall Study|Adverse Event|0|||
48925028|NCT02979431|157557293|FG002|Overall Study|Adverse Event|1|||
48925029|NCT02979431|157557294|FG003|Overall Study|Adverse Event|0|||
48925030|NCT02979431|157557291|FG000|Overall Study|Subject left country after Day14|1|||
48925031|NCT02979431|157557292|FG001|Overall Study|Subject left country after Day14|0|||
48925032|NCT02979431|157557293|FG002|Overall Study|Subject left country after Day14|0|||
48925033|NCT02979431|157557294|FG003|Overall Study|Subject left country after Day14|0|||
49166194|NCT00310375|158444883|FG000|Primary Reporting Phase|Missed study drug >5 days|1|||
49166195|NCT00310375|158444884|FG001|Primary Reporting Phase|Missed study drug >5 days|0|||
49166196|NCT00310375|158444885|FG002|Primary Reporting Phase|Missed study drug >5 days|0|||
48925034|NCT00796315|157557295|FG000|Overall Study|Protocol Violation|0|||
48925035|NCT00796315|157557296|FG001|Overall Study|Protocol Violation|1|||
48925036|NCT00796315|157557297|FG002|Overall Study|Protocol Violation|0|||
49166197|NCT00310375|158444883|FG000|Primary Reporting Phase|Site closure|3|||
49166198|NCT00310375|158444884|FG001|Primary Reporting Phase|Site closure|0|||
48925037|NCT02799069|157557299|FG000|Overall Study|Adverse Event|0|||
49166199|NCT00310375|158444885|FG002|Primary Reporting Phase|Site closure|0|||
48925038|NCT02799069|157557300|FG001|Overall Study|Adverse Event|2|||
48925039|NCT02799069|157557301|FG002|Overall Study|Adverse Event|2|||
48925040|NCT02799069|157557299|FG000|Overall Study|Lack of Efficacy|2|||
48925041|NCT02799069|157557300|FG001|Overall Study|Lack of Efficacy|0|||
48856516|NCT01159600|157312867|FG006|Overall Study|Other reason not defined above|3|||
48856517|NCT01159600|157312868|FG007|Overall Study|Other reason not defined above|3|||
48856518|NCT00983294|157312869|FG000|14 Day Washout Period|Withdrawal by Subject|2|||
48856519|NCT00983294|157312869|FG000|Colchicine With Azithromycin|Adverse Event|1|||
48856520|NCT00963924|157312870|FG000|Overall Study|Adverse Event|1|||
48856521|NCT00963924|157312871|FG001|Overall Study|Adverse Event|0|||
48856522|NCT00963924|157312870|FG000|Overall Study|Withdrawal by Subject|0|||
48856523|NCT00963924|157312871|FG001|Overall Study|Withdrawal by Subject|1|||
48856524|NCT00963924|157312870|FG000|Overall Study|Changed antipsychotic|0|||
48856525|NCT00963924|157312871|FG001|Overall Study|Changed antipsychotic|1|||
48856526|NCT00963924|157312870|FG000|Overall Study|Lost to Follow-up|0|||
48856527|NCT00963924|157312871|FG001|Overall Study|Lost to Follow-up|1|||
48856528|NCT00446095|157312872|FG000|Phase II (8 Weeks)|Lost to Follow-up|1|||
48856529|NCT00446095|157312873|FG001|Phase II (8 Weeks)|Lost to Follow-up|0|||
48856530|NCT00446095|157312874|FG002|Phase II (8 Weeks)|Lost to Follow-up|0|||
48856531|NCT00446095|157312875|FG003|Phase II (8 Weeks)|Lost to Follow-up|0|||
48856532|NCT00446095|157312876|FG004|Phase II (8 Weeks)|Lost to Follow-up|0|||
48856533|NCT00446095|157312872|FG000|Phase II (8 Weeks)|Adverse Event|0|||
48856534|NCT00446095|157312873|FG001|Phase II (8 Weeks)|Adverse Event|1|||
48856535|NCT00446095|157312874|FG002|Phase II (8 Weeks)|Adverse Event|1|||
48856536|NCT00446095|157312875|FG003|Phase II (8 Weeks)|Adverse Event|0|||
48856537|NCT00446095|157312876|FG004|Phase II (8 Weeks)|Adverse Event|0|||
48856538|NCT00446095|157312872|FG000|Phase II (8 Weeks)|Withdrawal by Subject|1|||
48856539|NCT00446095|157312873|FG001|Phase II (8 Weeks)|Withdrawal by Subject|0|||
48856540|NCT00446095|157312874|FG002|Phase II (8 Weeks)|Withdrawal by Subject|0|||
48856541|NCT00446095|157312875|FG003|Phase II (8 Weeks)|Withdrawal by Subject|0|||
48856542|NCT00446095|157312876|FG004|Phase II (8 Weeks)|Withdrawal by Subject|0|||
48856543|NCT00446095|157312872|FG000|Phase II (8 Weeks)|Physician Decision|1|||
48856544|NCT00446095|157312873|FG001|Phase II (8 Weeks)|Physician Decision|0|||
48856545|NCT00446095|157312874|FG002|Phase II (8 Weeks)|Physician Decision|0|||
48856546|NCT00446095|157312875|FG003|Phase II (8 Weeks)|Physician Decision|0|||
48856547|NCT00446095|157312876|FG004|Phase II (8 Weeks)|Physician Decision|0|||
48925042|NCT02799069|157557301|FG002|Overall Study|Lack of Efficacy|0|||
49014927|NCT01405820|157890465|FG003|Randomized Treatment Period|Withdrew Prior to Dosing|1|||
49014928|NCT01405820|157890466|FG004|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
49014929|NCT01405820|157890467|FG005|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
49014930|NCT01405820|157890462|FG000|Open-Label Treatment Period|Withdrawal by Subject|3|||
49014931|NCT01405820|157890463|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
49014932|NCT01405820|157890464|FG002|Open-Label Treatment Period|Withdrawal by Subject|1|||
49014933|NCT01405820|157890465|FG003|Open-Label Treatment Period|Withdrawal by Subject|1|||
49014934|NCT01405820|157890466|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
49014935|NCT01405820|157890467|FG005|Open-Label Treatment Period|Withdrawal by Subject|1|||
49014936|NCT01405820|157890462|FG000|Open-Label Treatment Period|Other|1|||
49014937|NCT01405820|157890463|FG001|Open-Label Treatment Period|Other|1|||
49014938|NCT01405820|157890464|FG002|Open-Label Treatment Period|Other|1|||
49014939|NCT01405820|157890465|FG003|Open-Label Treatment Period|Other|1|||
49166200|NCT00310375|158444883|FG000|Primary Reporting Phase|Missed study drug for 2 months|1|||
49166201|NCT00310375|158444884|FG001|Primary Reporting Phase|Missed study drug for 2 months|0|||
49166202|NCT00310375|158444885|FG002|Primary Reporting Phase|Missed study drug for 2 months|0|||
49166203|NCT00310375|158444883|FG000|Primary Reporting Phase|Par. switched to commercial product|0|||
49166204|NCT00310375|158444884|FG001|Primary Reporting Phase|Par. switched to commercial product|1|||
49166205|NCT00310375|158444885|FG002|Primary Reporting Phase|Par. switched to commercial product|0|||
49166206|NCT00310375|158444883|FG000|Primary Reporting Phase|Request of Ethics Committee|0|||
49166207|NCT00310375|158444884|FG001|Primary Reporting Phase|Request of Ethics Committee|1|||
49166208|NCT00310375|158444885|FG002|Primary Reporting Phase|Request of Ethics Committee|0|||
48925043|NCT02799069|157557299|FG000|Overall Study|Lost to Follow-up|1|||
48925044|NCT02799069|157557300|FG001|Overall Study|Lost to Follow-up|1|||
48925045|NCT02799069|157557301|FG002|Overall Study|Lost to Follow-up|0|||
48925046|NCT02799069|157557299|FG000|Overall Study|Withdrawal by Subject|4|||
48925047|NCT02799069|157557300|FG001|Overall Study|Withdrawal by Subject|4|||
48925048|NCT02799069|157557301|FG002|Overall Study|Withdrawal by Subject|3|||
48925049|NCT02799069|157557299|FG000|Overall Study|Protocol Violation|1|||
48925050|NCT02799069|157557300|FG001|Overall Study|Protocol Violation|0|||
48925051|NCT02799069|157557301|FG002|Overall Study|Protocol Violation|2|||
48925052|NCT03979274|157557302|FG000|Treatment Period 2|Withdrawal by Subject|0|||
48925053|NCT03979274|157557303|FG001|Treatment Period 2|Withdrawal by Subject|1|||
48925054|NCT02301403|157557304|FG000|Overall Study|Withdrawal by Subject|28|||
48925055|NCT02301403|157557305|FG001|Overall Study|Withdrawal by Subject|41|||
48925056|NCT01816243|157557306|FG000|Overall Study|Adverse Event|6|||
48925057|NCT01816243|157557306|FG000|Overall Study|Lost to Follow-up|1|||
48925058|NCT01816243|157557306|FG000|Overall Study|Lack of Efficacy|1|||
48925059|NCT01816243|157557306|FG000|Overall Study|Not eligible for the study|1|||
48925060|NCT01816243|157557306|FG000|Overall Study|Amputation|3|||
48925061|NCT01446419|157557307|FG000|Overall Study|Death|1|||
48925062|NCT01446419|157557308|FG001|Overall Study|Death|0|||
48925063|NCT01446419|157557307|FG000|Overall Study|Withdrawal by Subject|1|||
48925064|NCT01446419|157557308|FG001|Overall Study|Withdrawal by Subject|1|||
48925065|NCT01446419|157557307|FG000|Overall Study|Terminated per protocol|3|||
48925066|NCT01446419|157557308|FG001|Overall Study|Terminated per protocol|0|||
48925067|NCT00464178|157557309|FG000|Overall Study|Protocol Violation|1|||
48925068|NCT00464178|157557309|FG000|Overall Study|Withdrawal by Subject|1|||
48925069|NCT00915343|157557310|FG000|Part B - Open Label Period|Treatment switch|0|||
48925070|NCT00915343|157557311|FG001|Part B - Open Label Period|Treatment switch|0|||
48925071|NCT00915343|157557312|FG002|Part B - Open Label Period|Treatment switch|1|||
48925072|NCT00915343|157557310|FG000|Part B - Open Label Period|Did not attend the last visit|0|||
48925073|NCT00915343|157557311|FG001|Part B - Open Label Period|Did not attend the last visit|0|||
48925074|NCT00915343|157557312|FG002|Part B - Open Label Period|Did not attend the last visit|1|||
48925075|NCT03434977|157557315|FG000|Washout Period (at Least 6 Days)|Adverse Event|0|||
48925076|NCT03434977|157557316|FG001|Washout Period (at Least 6 Days)|Adverse Event|1|||
48925077|NCT01462266|157557318|FG000|Overall Study|Adverse Event|7|||
48925078|NCT01462266|157557319|FG001|Overall Study|Adverse Event|6|||
48925079|NCT01462266|157557318|FG000|Overall Study|Death|2|||
48925080|NCT01462266|157557319|FG001|Overall Study|Death|1|||
48925081|NCT01462266|157557318|FG000|Overall Study|Lack of Efficacy|0|||
48925082|NCT01462266|157557319|FG001|Overall Study|Lack of Efficacy|2|||
48925083|NCT01462266|157557318|FG000|Overall Study|Lost to Follow-up|4|||
48925084|NCT01462266|157557319|FG001|Overall Study|Lost to Follow-up|3|||
48925085|NCT01462266|157557318|FG000|Overall Study|Non-compliance with study drug|3|||
48925086|NCT01462266|157557319|FG001|Overall Study|Non-compliance with study drug|0|||
48925087|NCT01462266|157557318|FG000|Overall Study|Creatinine and eGFR, excluded medication|8|||
48925088|NCT01462266|157557319|FG001|Overall Study|Creatinine and eGFR, excluded medication|4|||
48925089|NCT01462266|157557318|FG000|Overall Study|Physician Decision|2|||
48925090|NCT01462266|157557319|FG001|Overall Study|Physician Decision|5|||
48925091|NCT01462266|157557318|FG000|Overall Study|Protocol Violation|1|||
48925092|NCT01462266|157557319|FG001|Overall Study|Protocol Violation|3|||
48925093|NCT01462266|157557318|FG000|Overall Study|Withdrawal by Subject|7|||
48925094|NCT01462266|157557319|FG001|Overall Study|Withdrawal by Subject|2|||
48925095|NCT01462266|157557318|FG000|Overall Study|Screen failure|1|||
48925096|NCT01462266|157557319|FG001|Overall Study|Screen failure|1|||
48925097|NCT00546052|157557320|FG000|Overall Study|Adverse Event|47|||
48925098|NCT00546052|157557320|FG000|Overall Study|Lost to Follow-up|144|||
48925099|NCT00546052|157557320|FG000|Overall Study|Protocol Violation|9|||
48925100|NCT00546052|157557320|FG000|Overall Study|Withdrawal by Subject|20|||
48925101|NCT00546052|157557320|FG000|Overall Study|Non Compliance|7|||
48925102|NCT01489527|157557321|FG000|Overall Study|Pregnancy|9|||
48925103|NCT01489527|157557322|FG001|Overall Study|Pregnancy|14|||
49166209|NCT00310375|158444883|FG000|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
49166210|NCT00310375|158444884|FG001|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
49166211|NCT00310375|158444885|FG002|Safety Follow-up Continuation Phase|Lost to Follow-up|1|||
49166212|NCT00413660|158444889|FG000|Up To Week 12|Adverse Event|1|||
49166213|NCT00413660|158444890|FG001|Up To Week 12|Adverse Event|3|||
49166214|NCT00413660|158444891|FG002|Up To Week 12|Adverse Event|1|||
49166215|NCT00413660|158444892|FG003|Up To Week 12|Adverse Event|4|||
49166216|NCT00413660|158444893|FG004|Up To Week 12|Adverse Event|6|||
49166217|NCT00413660|158444894|FG005|Up To Week 12|Adverse Event|4|||
49166218|NCT00413660|158444895|FG006|Up To Week 12|Adverse Event|1|||
49166219|NCT00413660|158444896|FG007|Up To Week 12|Adverse Event|0|||
49166220|NCT00413660|158444897|FG008|Up To Week 12|Adverse Event|0|||
49166221|NCT00413660|158444898|FG009|Up To Week 12|Adverse Event|0|||
49166222|NCT00413660|158444899|FG010|Up To Week 12|Adverse Event|0|||
49166223|NCT00413660|158444889|FG000|Up To Week 12|Lack of Efficacy|2|||
49166224|NCT00413660|158444890|FG001|Up To Week 12|Lack of Efficacy|0|||
49166225|NCT00413660|158444891|FG002|Up To Week 12|Lack of Efficacy|0|||
49166226|NCT00413660|158444892|FG003|Up To Week 12|Lack of Efficacy|0|||
49166227|NCT00413660|158444893|FG004|Up To Week 12|Lack of Efficacy|0|||
49166228|NCT00413660|158444894|FG005|Up To Week 12|Lack of Efficacy|0|||
49166229|NCT00413660|158444895|FG006|Up To Week 12|Lack of Efficacy|5|||
49166230|NCT00413660|158444896|FG007|Up To Week 12|Lack of Efficacy|0|||
49166231|NCT00413660|158444897|FG008|Up To Week 12|Lack of Efficacy|0|||
49166232|NCT00413660|158444898|FG009|Up To Week 12|Lack of Efficacy|0|||
49166233|NCT00413660|158444899|FG010|Up To Week 12|Lack of Efficacy|0|||
49166234|NCT00413660|158444889|FG000|Up To Week 12|Lost to Follow-up|0|||
49166235|NCT00413660|158444890|FG001|Up To Week 12|Lost to Follow-up|1|||
49166236|NCT00413660|158444891|FG002|Up To Week 12|Lost to Follow-up|0|||
49166237|NCT00413660|158444892|FG003|Up To Week 12|Lost to Follow-up|0|||
49166238|NCT00413660|158444893|FG004|Up To Week 12|Lost to Follow-up|1|||
49166239|NCT00413660|158444894|FG005|Up To Week 12|Lost to Follow-up|0|||
49166240|NCT00413660|158444895|FG006|Up To Week 12|Lost to Follow-up|0|||
49166241|NCT00413660|158444896|FG007|Up To Week 12|Lost to Follow-up|0|||
49166242|NCT00413660|158444897|FG008|Up To Week 12|Lost to Follow-up|0|||
49166243|NCT00413660|158444898|FG009|Up To Week 12|Lost to Follow-up|0|||
49166244|NCT00413660|158444899|FG010|Up To Week 12|Lost to Follow-up|0|||
49166245|NCT00413660|158444889|FG000|Up To Week 12|Withdrawal by Subject|0|||
49166246|NCT00413660|158444890|FG001|Up To Week 12|Withdrawal by Subject|2|||
49166247|NCT00413660|158444891|FG002|Up To Week 12|Withdrawal by Subject|0|||
49166248|NCT00413660|158444892|FG003|Up To Week 12|Withdrawal by Subject|2|||
49166249|NCT00413660|158444893|FG004|Up To Week 12|Withdrawal by Subject|0|||
49166250|NCT00413660|158444894|FG005|Up To Week 12|Withdrawal by Subject|2|||
49166251|NCT00413660|158444895|FG006|Up To Week 12|Withdrawal by Subject|2|||
49166252|NCT00413660|158444896|FG007|Up To Week 12|Withdrawal by Subject|0|||
49166253|NCT00413660|158444897|FG008|Up To Week 12|Withdrawal by Subject|0|||
49166254|NCT00413660|158444898|FG009|Up To Week 12|Withdrawal by Subject|0|||
49166255|NCT00413660|158444899|FG010|Up To Week 12|Withdrawal by Subject|0|||
49166256|NCT00413660|158444889|FG000|Up To Week 12|Randomized, Not Treated|1|||
49166257|NCT00413660|158444890|FG001|Up To Week 12|Randomized, Not Treated|0|||
49166258|NCT00413660|158444891|FG002|Up To Week 12|Randomized, Not Treated|0|||
49166259|NCT00413660|158444892|FG003|Up To Week 12|Randomized, Not Treated|1|||
49166260|NCT00413660|158444893|FG004|Up To Week 12|Randomized, Not Treated|0|||
49166261|NCT00413660|158444894|FG005|Up To Week 12|Randomized, Not Treated|0|||
49166262|NCT00413660|158444895|FG006|Up To Week 12|Randomized, Not Treated|0|||
49166263|NCT00413660|158444896|FG007|Up To Week 12|Randomized, Not Treated|0|||
49166264|NCT00413660|158444897|FG008|Up To Week 12|Randomized, Not Treated|0|||
49166265|NCT00413660|158444898|FG009|Up To Week 12|Randomized, Not Treated|0|||
49166266|NCT00413660|158444899|FG010|Up To Week 12|Randomized, Not Treated|0|||
49166267|NCT00413660|158444889|FG000|Up To Week 12|Other|3|||
49166268|NCT00413660|158444890|FG001|Up To Week 12|Other|1|||
49166269|NCT00413660|158444891|FG002|Up To Week 12|Other|6|||
49166270|NCT00413660|158444892|FG003|Up To Week 12|Other|1|||
49166271|NCT00413660|158444893|FG004|Up To Week 12|Other|2|||
49166272|NCT00413660|158444894|FG005|Up To Week 12|Other|4|||
49166273|NCT00413660|158444895|FG006|Up To Week 12|Other|3|||
49166274|NCT00413660|158444896|FG007|Up To Week 12|Other|0|||
49166275|NCT00413660|158444897|FG008|Up To Week 12|Other|0|||
49166276|NCT00413660|158444898|FG009|Up To Week 12|Other|0|||
49166277|NCT00413660|158444899|FG010|Up To Week 12|Other|0|||
48925104|NCT01489527|157557321|FG000|Overall Study|Participant moved|6|||
48925105|NCT01489527|157557322|FG001|Overall Study|Participant moved|7|||
48925106|NCT01489527|157557321|FG000|Overall Study|Withdrawal by Subject|0|||
48925107|NCT01489527|157557322|FG001|Overall Study|Withdrawal by Subject|4|||
48925108|NCT01489527|157557321|FG000|Overall Study|Lost to Follow-up|5|||
48925109|NCT01489527|157557322|FG001|Overall Study|Lost to Follow-up|1|||
48925110|NCT01489527|157557321|FG000|Overall Study|Procedures|1|||
48925111|NCT01489527|157557322|FG001|Overall Study|Procedures|0|||
48925112|NCT01489527|157557321|FG000|Overall Study|Not compliant|1|||
48925113|NCT01489527|157557322|FG001|Overall Study|Not compliant|0|||
48925114|NCT04899232|157557323|FG000|Screening Period|Physician Decision|1|||
48925115|NCT04899232|157557324|FG001|Screening Period|Physician Decision|0|||
48925116|NCT04899232|157557325|FG002|Screening Period|Physician Decision|0|||
48925117|NCT04899232|157557323|FG000|Screening Period|Withdrawal by Subject|1|||
48925118|NCT04899232|157557324|FG001|Screening Period|Withdrawal by Subject|0|||
48925119|NCT04899232|157557325|FG002|Screening Period|Withdrawal by Subject|0|||
48925120|NCT04899232|157557323|FG000|Screening Period|Participant discharged before receiving intervention|3|||
48925121|NCT04899232|157557324|FG001|Screening Period|Participant discharged before receiving intervention|0|||
48925122|NCT04899232|157557325|FG002|Screening Period|Participant discharged before receiving intervention|0|||
48925123|NCT01738971|157557329|FG000|Overall Study|Lost to Follow-up|19|||
48925124|NCT01738971|157557330|FG001|Overall Study|Lost to Follow-up|30|||
48925125|NCT01738971|157557331|FG002|Overall Study|Lost to Follow-up|17|||
48925126|NCT03505021|157557332|FG000|Overall Study|Protocol Violation|1|||
48925127|NCT03505021|157557333|FG001|Overall Study|Protocol Violation|0|||
49166278|NCT00413660|158444889|FG000|Post Week 12|Adverse Event|2|||
49166279|NCT00413660|158444890|FG001|Post Week 12|Adverse Event|0|||
49166280|NCT00413660|158444891|FG002|Post Week 12|Adverse Event|2|||
49166281|NCT00413660|158444892|FG003|Post Week 12|Adverse Event|1|||
49166282|NCT00413660|158444893|FG004|Post Week 12|Adverse Event|4|||
49166283|NCT00413660|158444894|FG005|Post Week 12|Adverse Event|2|||
49166284|NCT00413660|158444895|FG006|Post Week 12|Adverse Event|2|||
49166285|NCT00413660|158444896|FG007|Post Week 12|Adverse Event|0|||
49166286|NCT00413660|158444897|FG008|Post Week 12|Adverse Event|0|||
49166287|NCT00413660|158444898|FG009|Post Week 12|Adverse Event|0|||
49166288|NCT00413660|158444899|FG010|Post Week 12|Adverse Event|0|||
49166289|NCT00413660|158444889|FG000|Post Week 12|Lack of Efficacy|0|||
49166290|NCT00413660|158444890|FG001|Post Week 12|Lack of Efficacy|0|||
49166291|NCT00413660|158444891|FG002|Post Week 12|Lack of Efficacy|1|||
49166292|NCT00413660|158444892|FG003|Post Week 12|Lack of Efficacy|0|||
49166293|NCT00413660|158444893|FG004|Post Week 12|Lack of Efficacy|0|||
49166294|NCT00413660|158444894|FG005|Post Week 12|Lack of Efficacy|0|||
49166295|NCT00413660|158444895|FG006|Post Week 12|Lack of Efficacy|0|||
49166296|NCT00413660|158444896|FG007|Post Week 12|Lack of Efficacy|0|||
49166297|NCT00413660|158444897|FG008|Post Week 12|Lack of Efficacy|0|||
49166298|NCT00413660|158444898|FG009|Post Week 12|Lack of Efficacy|1|||
49166299|NCT00413660|158444899|FG010|Post Week 12|Lack of Efficacy|0|||
49166300|NCT00413660|158444889|FG000|Post Week 12|Lost to Follow-up|0|||
49166301|NCT00413660|158444890|FG001|Post Week 12|Lost to Follow-up|1|||
49166302|NCT00413660|158444891|FG002|Post Week 12|Lost to Follow-up|1|||
49166303|NCT00413660|158444892|FG003|Post Week 12|Lost to Follow-up|0|||
49166304|NCT00413660|158444893|FG004|Post Week 12|Lost to Follow-up|0|||
49166305|NCT00413660|158444894|FG005|Post Week 12|Lost to Follow-up|0|||
49166306|NCT00413660|158444895|FG006|Post Week 12|Lost to Follow-up|0|||
49166307|NCT00413660|158444896|FG007|Post Week 12|Lost to Follow-up|0|||
49166308|NCT00413660|158444897|FG008|Post Week 12|Lost to Follow-up|0|||
49166309|NCT00413660|158444898|FG009|Post Week 12|Lost to Follow-up|0|||
49166310|NCT00413660|158444899|FG010|Post Week 12|Lost to Follow-up|0|||
49166311|NCT00413660|158444889|FG000|Post Week 12|Withdrawal by Subject|0|||
49166312|NCT00413660|158444890|FG001|Post Week 12|Withdrawal by Subject|1|||
49166313|NCT00413660|158444891|FG002|Post Week 12|Withdrawal by Subject|1|||
49166314|NCT00413660|158444892|FG003|Post Week 12|Withdrawal by Subject|0|||
49166315|NCT00413660|158444893|FG004|Post Week 12|Withdrawal by Subject|1|||
49166316|NCT00413660|158444894|FG005|Post Week 12|Withdrawal by Subject|0|||
49166317|NCT00413660|158444895|FG006|Post Week 12|Withdrawal by Subject|0|||
48925128|NCT03505021|157557332|FG000|Overall Study|Death|9|||
49166318|NCT00413660|158444896|FG007|Post Week 12|Withdrawal by Subject|0|||
49166319|NCT00413660|158444897|FG008|Post Week 12|Withdrawal by Subject|0|||
49166320|NCT00413660|158444898|FG009|Post Week 12|Withdrawal by Subject|0|||
49166321|NCT00413660|158444899|FG010|Post Week 12|Withdrawal by Subject|1|||
48925129|NCT03505021|157557333|FG001|Overall Study|Death|8|||
49166322|NCT00413660|158444889|FG000|Post Week 12|Other|1|||
49166323|NCT00413660|158444890|FG001|Post Week 12|Other|2|||
49166324|NCT00413660|158444891|FG002|Post Week 12|Other|3|||
49166325|NCT00413660|158444892|FG003|Post Week 12|Other|0|||
48925130|NCT03505021|157557332|FG000|Overall Study|Consent withdrawn by subject|6|||
48925131|NCT03505021|157557333|FG001|Overall Study|Consent withdrawn by subject|1|||
48925132|NCT03505021|157557332|FG000|Overall Study|Lost to Follow-up|5|||
48925133|NCT03505021|157557333|FG001|Overall Study|Lost to Follow-up|3|||
48925134|NCT03505021|157557332|FG000|Overall Study|Adverse Event|26|||
49166326|NCT00413660|158444893|FG004|Post Week 12|Other|1|||
49166327|NCT00413660|158444894|FG005|Post Week 12|Other|1|||
49166328|NCT00413660|158444895|FG006|Post Week 12|Other|1|||
49166329|NCT00413660|158444896|FG007|Post Week 12|Other|0|||
49166330|NCT00413660|158444897|FG008|Post Week 12|Other|0|||
49166331|NCT00413660|158444898|FG009|Post Week 12|Other|0|||
49166332|NCT00413660|158444899|FG010|Post Week 12|Other|0|||
49166333|NCT03896477|158444902|FG000|Overall Study|Met Ineligibility Criteria During the Study|1|||
49166334|NCT03896477|158444903|FG001|Overall Study|Met Ineligibility Criteria During the Study|1|||
49166335|NCT03896477|158444904|FG002|Overall Study|Met Ineligibility Criteria During the Study|2|||
49166336|NCT03896477|158444902|FG000|Overall Study|Parent Requested Withdrawal|8|||
49166337|NCT03896477|158444903|FG001|Overall Study|Parent Requested Withdrawal|12|||
49166338|NCT03896477|158444904|FG002|Overall Study|Parent Requested Withdrawal|9|||
49166339|NCT03896477|158444902|FG000|Overall Study|Adverse Event|0|||
49166340|NCT03896477|158444903|FG001|Overall Study|Adverse Event|0|||
49166341|NCT03896477|158444904|FG002|Overall Study|Adverse Event|1|||
49166342|NCT03896477|158444902|FG000|Overall Study|Death|1|||
49166343|NCT03896477|158444903|FG001|Overall Study|Death|0|||
49166344|NCT03896477|158444904|FG002|Overall Study|Death|0|||
49166345|NCT03896477|158444902|FG000|Overall Study|Other|5|||
49166346|NCT03896477|158444903|FG001|Overall Study|Other|6|||
49166347|NCT03896477|158444904|FG002|Overall Study|Other|7|||
49166348|NCT03896477|158444902|FG000|Overall Study|Lost to Follow-up|2|||
49166349|NCT03896477|158444903|FG001|Overall Study|Lost to Follow-up|1|||
49166350|NCT03896477|158444904|FG002|Overall Study|Lost to Follow-up|1|||
49166351|NCT03369665|158444905|FG000|Overall Study|Adverse Event|3|||
49166352|NCT03369665|158444905|FG000|Overall Study|Lost to Follow-up|7|||
49166353|NCT03369665|158444905|FG000|Overall Study|Withdrawal by Subject|15|||
49166354|NCT03369665|158444905|FG000|Overall Study|Progression Disease|2|||
49166355|NCT03369665|158444905|FG000|Overall Study|Not classified|3|||
49166356|NCT00131352|158444906|FG000|Initial Treatment Period|Adverse Event|1|||
49166357|NCT00131352|158444907|FG001|Initial Treatment Period|Adverse Event|3|||
49166358|NCT00131352|158444906|FG000|Initial Treatment Period|Non-compliant|1|||
49166359|NCT00131352|158444907|FG001|Initial Treatment Period|Non-compliant|2|||
49166360|NCT00131352|158444906|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
48925135|NCT03505021|157557333|FG001|Overall Study|Adverse Event|9|||
48925136|NCT03505021|157557332|FG000|Overall Study|Disease progression|33|||
48925137|NCT03505021|157557333|FG001|Overall Study|Disease progression|17|||
48925138|NCT03505021|157557332|FG000|Overall Study|Other|11|||
48925139|NCT03505021|157557333|FG001|Overall Study|Other|5|||
48925140|NCT03505021|157557332|FG000|Overall Study|Personal reason|21|||
48925141|NCT03505021|157557333|FG001|Overall Study|Personal reason|12|||
48925142|NCT00105443|157559316|FG000|Double-Blind Treatment|Adverse Event|1|||
48925143|NCT00105443|157559317|FG001|Double-Blind Treatment|Adverse Event|0|||
48925144|NCT00105443|157559318|FG002|Double-Blind Treatment|Adverse Event|0|||
48925145|NCT00105443|157559319|FG003|Double-Blind Treatment|Adverse Event|0|||
48925146|NCT00105443|157559316|FG000|Double-Blind Treatment|Lost to Follow-up|0|||
48925147|NCT00105443|157559317|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
48925148|NCT00105443|157559318|FG002|Double-Blind Treatment|Lost to Follow-up|1|||
48925149|NCT00105443|157559319|FG003|Double-Blind Treatment|Lost to Follow-up|0|||
48925150|NCT00105443|157559316|FG000|Double-Blind Treatment|Withdrawal by Subject|8|||
48925151|NCT00105443|157559317|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
48925152|NCT00105443|157559318|FG002|Double-Blind Treatment|Withdrawal by Subject|7|||
48925153|NCT00105443|157559319|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
48925154|NCT00105443|157559316|FG000|Double-Blind Treatment|Physician Decision|1|||
48925155|NCT00105443|157559317|FG001|Double-Blind Treatment|Physician Decision|0|||
48925156|NCT00105443|157559318|FG002|Double-Blind Treatment|Physician Decision|2|||
48925157|NCT00105443|157559319|FG003|Double-Blind Treatment|Physician Decision|0|||
48925158|NCT00105443|157559316|FG000|Double-Blind Treatment|Radiological and symptomatic progression|4|||
48925159|NCT00105443|157559317|FG001|Double-Blind Treatment|Radiological and symptomatic progression|0|||
48925160|NCT00105443|157559318|FG002|Double-Blind Treatment|Radiological and symptomatic progression|1|||
48925161|NCT00105443|157559319|FG003|Double-Blind Treatment|Radiological and symptomatic progression|0|||
48925162|NCT00105443|157559316|FG000|Follow-up and/or Open Label Nexavar|Death|180|||
49166361|NCT00131352|158444907|FG001|Initial Treatment Period|Withdrawal by Subject|1|||
49166362|NCT00131352|158444906|FG000|Initial Treatment Period|Lack of Efficacy|6|||
49166363|NCT00131352|158444907|FG001|Initial Treatment Period|Lack of Efficacy|4|||
49166364|NCT00131352|158444906|FG000|Initial Treatment Period|Other|0|||
49166365|NCT00131352|158444907|FG001|Initial Treatment Period|Other|2|||
49166366|NCT00131352|158444906|FG000|Repeat Treatment Period|Adverse Event|1|||
48925163|NCT00105443|157559317|FG001|Follow-up and/or Open Label Nexavar|Death|7|||
48925164|NCT00105443|157559318|FG002|Follow-up and/or Open Label Nexavar|Death|219|||
48925165|NCT00105443|157559319|FG003|Follow-up and/or Open Label Nexavar|Death|4|||
49166367|NCT00131352|158444907|FG001|Repeat Treatment Period|Adverse Event|0|||
49166368|NCT00131352|158444906|FG000|Repeat Treatment Period|Other|1|||
49166369|NCT00131352|158444907|FG001|Repeat Treatment Period|Other|0|||
48925166|NCT00105443|157559316|FG000|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14|||
48925167|NCT00105443|157559317|FG001|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
49166370|NCT01023217|158444912|FG000|Overall Study|Withdrawal by Subject|1|||
48925168|NCT00105443|157559318|FG002|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10|||
48925169|NCT00105443|157559319|FG003|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
48925170|NCT00105443|157559316|FG000|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24|||
48925171|NCT00105443|157559317|FG001|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3|||
48925172|NCT00105443|157559318|FG002|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13|||
48925173|NCT00105443|157559319|FG003|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4|||
48925174|NCT00105443|157559316|FG000|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
48925175|NCT00105443|157559317|FG001|Follow-up and/or Open Label Nexavar|Adverse Event|14|||
48925176|NCT00105443|157559318|FG002|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
48925177|NCT00105443|157559319|FG003|Follow-up and/or Open Label Nexavar|Adverse Event|16|||
48925178|NCT00105443|157559316|FG000|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
48925179|NCT00105443|157559317|FG001|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
48925180|NCT00105443|157559318|FG002|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
48925181|NCT00105443|157559319|FG003|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
48925182|NCT00105443|157559316|FG000|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
48925183|NCT00105443|157559317|FG001|Follow-up and/or Open Label Nexavar|Protocol Violation|2|||
48925184|NCT00105443|157559318|FG002|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
48925185|NCT00105443|157559319|FG003|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
48925186|NCT00105443|157559316|FG000|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
48925187|NCT00105443|157559317|FG001|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2|||
48925188|NCT00105443|157559318|FG002|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
48925189|NCT00105443|157559319|FG003|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5|||
48925190|NCT00105443|157559316|FG000|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
48925191|NCT00105443|157559317|FG001|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
48925192|NCT00105443|157559318|FG002|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
48925193|NCT00105443|157559319|FG003|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
48925194|NCT00105443|157559316|FG000|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6|||
48925195|NCT00105443|157559317|FG001|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
48925196|NCT00105443|157559318|FG002|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1|||
48925197|NCT00105443|157559319|FG003|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
48925198|NCT00105443|157559316|FG000|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
48925199|NCT00105443|157559317|FG001|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
48925200|NCT00105443|157559318|FG002|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1|||
48925201|NCT00105443|157559319|FG003|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
48925202|NCT00105443|157559316|FG000|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1|||
48925203|NCT00105443|157559317|FG001|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
48925204|NCT00105443|157559318|FG002|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
48925205|NCT00105443|157559319|FG003|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
49166371|NCT01023217|158444913|FG001|Overall Study|Withdrawal by Subject|0|||
49166372|NCT00589797|158444914|FG000|Overall Study|Death|1|||
49166373|NCT00589797|158444915|FG001|Overall Study|Death|0|||
49166374|NCT00589797|158444914|FG000|Overall Study|Lost to Follow-up|12|||
49166375|NCT00589797|158444915|FG001|Overall Study|Lost to Follow-up|9|||
49166376|NCT00589797|158444914|FG000|Overall Study|Physician Decision|8|||
49166377|NCT00589797|158444915|FG001|Overall Study|Physician Decision|3|||
49166378|NCT00589797|158444914|FG000|Overall Study|Withdrawal by Subject|6|||
49166379|NCT00589797|158444915|FG001|Overall Study|Withdrawal by Subject|5|||
49166380|NCT00589797|158444914|FG000|Overall Study|Non-Randomized Training Subjects|46|||
49166381|NCT00589797|158444915|FG001|Overall Study|Non-Randomized Training Subjects|6|||
49166382|NCT04011735|158444916|FG000|Overall Study|Withdrawal by Subject|1|||
49166383|NCT04011735|158444917|FG001|Overall Study|Withdrawal by Subject|0|||
49166384|NCT04011735|158444918|FG002|Overall Study|Withdrawal by Subject|1|||
49166385|NCT04011735|158444916|FG000|Overall Study|Met exclusion criteria after study entry|0|||
49166386|NCT04011735|158444917|FG001|Overall Study|Met exclusion criteria after study entry|1|||
49166387|NCT04011735|158444918|FG002|Overall Study|Met exclusion criteria after study entry|0|||
49166388|NCT01000506|158444919|FG000|Overall Study|Adverse Event|6|||
49166389|NCT01000506|158444920|FG001|Overall Study|Adverse Event|5|||
49166390|NCT01000506|158444921|FG002|Overall Study|Adverse Event|8|||
48925206|NCT00105443|157559316|FG000|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
48925207|NCT00105443|157559317|FG001|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
49166391|NCT01000506|158444922|FG003|Overall Study|Adverse Event|9|||
49166392|NCT01000506|158444919|FG000|Overall Study|Lack of Efficacy|8|||
49166393|NCT01000506|158444920|FG001|Overall Study|Lack of Efficacy|6|||
49166394|NCT01000506|158444921|FG002|Overall Study|Lack of Efficacy|4|||
49166395|NCT01000506|158444922|FG003|Overall Study|Lack of Efficacy|4|||
49166396|NCT01000506|158444919|FG000|Overall Study|Protocol Violation|1|||
49166397|NCT01000506|158444920|FG001|Overall Study|Protocol Violation|1|||
49166398|NCT01000506|158444921|FG002|Overall Study|Protocol Violation|0|||
49166399|NCT01000506|158444922|FG003|Overall Study|Protocol Violation|0|||
49166400|NCT01000506|158444919|FG000|Overall Study|Lost to Follow-up|1|||
49166401|NCT01000506|158444920|FG001|Overall Study|Lost to Follow-up|1|||
49166402|NCT01000506|158444921|FG002|Overall Study|Lost to Follow-up|4|||
49166403|NCT01000506|158444922|FG003|Overall Study|Lost to Follow-up|0|||
49166404|NCT01000506|158444919|FG000|Overall Study|Physician Decision|1|||
49166405|NCT01000506|158444920|FG001|Overall Study|Physician Decision|3|||
49166406|NCT01000506|158444921|FG002|Overall Study|Physician Decision|3|||
49166407|NCT01000506|158444922|FG003|Overall Study|Physician Decision|3|||
49166408|NCT01000506|158444919|FG000|Overall Study|Withdrawal by Subject|11|||
49166409|NCT01000506|158444920|FG001|Overall Study|Withdrawal by Subject|8|||
49166410|NCT01000506|158444921|FG002|Overall Study|Withdrawal by Subject|2|||
49166411|NCT01000506|158444922|FG003|Overall Study|Withdrawal by Subject|7|||
49166412|NCT01485796|158444923|FG000|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1|||
49166413|NCT01485796|158444923|FG000|Period 2: Epoch 2|Withdrawal by Subject|6|||
49166414|NCT01485796|158444923|FG000|Period 2: Epoch 2|Adverse Event|3|||
49166415|NCT01485796|158444923|FG000|Period 2: Epoch 2|Switch to safety follow-up|26|||
49166416|NCT01485796|158444923|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1|||
49166417|NCT01485796|158444923|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6|||
49166418|NCT01485796|158444923|FG000|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3|||
49166419|NCT01485796|158444923|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2|||
49166420|NCT00658541|158444929|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
49166421|NCT00658541|158444930|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
49166422|NCT00658541|158444929|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
49166423|NCT00658541|158444930|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
49166424|NCT01063348|158444931|FG000|Overall Study|Lost to Follow-up|3|||
49166425|NCT01063348|158444932|FG001|Overall Study|Lost to Follow-up|10|||
49166426|NCT05384834|158444933|FG000|Overall Study|Lost to Follow-up|43|||
49166427|NCT05384834|158444933|FG000|Overall Study|Withdrawal by Subject|5|||
49166428|NCT04828707|158444934|FG000|Overall Study|Lost to Follow-up|3|||
49166429|NCT04828707|158444935|FG001|Overall Study|Lost to Follow-up|2|||
49166430|NCT04828707|158444934|FG000|Overall Study|Withdrawal by Subject|2|||
49166431|NCT04828707|158444935|FG001|Overall Study|Withdrawal by Subject|1|||
49166432|NCT01775553|158444936|FG000|Overall Study|Adverse Event|1|||
49166433|NCT01775553|158444936|FG000|Overall Study|Disease Progression|12|||
49166434|NCT02457247|158444937|FG000|Period 1|Pretreatment Event/Adverse Event|0|||
49166435|NCT02457247|158444938|FG001|Period 1|Pretreatment Event/Adverse Event|1|||
49166436|NCT02457247|158444939|FG002|Period 1|Pretreatment Event/Adverse Event|0|||
49166437|NCT02457247|158444940|FG003|Period 1|Pretreatment Event/Adverse Event|0|||
49166438|NCT02457247|158444937|FG000|Period 1|Significant Protocol Deviation|1|||
49166439|NCT02457247|158444938|FG001|Period 1|Significant Protocol Deviation|1|||
49166440|NCT02457247|158444939|FG002|Period 1|Significant Protocol Deviation|0|||
49166441|NCT02457247|158444940|FG003|Period 1|Significant Protocol Deviation|0|||
49166442|NCT02457247|158444937|FG000|Period 1|Voluntary Withdrawal|1|||
49166443|NCT02457247|158444938|FG001|Period 1|Voluntary Withdrawal|0|||
49166444|NCT02457247|158444939|FG002|Period 1|Voluntary Withdrawal|0|||
49166445|NCT02457247|158444940|FG003|Period 1|Voluntary Withdrawal|0|||
49166446|NCT02457247|158444937|FG000|Period 2|Pretreatment Event/Adverse Event|0|||
49166447|NCT02457247|158444938|FG001|Period 2|Pretreatment Event/Adverse Event|1|||
49166448|NCT02457247|158444939|FG002|Period 2|Pretreatment Event/Adverse Event|0|||
49166449|NCT02457247|158444940|FG003|Period 2|Pretreatment Event/Adverse Event|0|||
49166450|NCT02457247|158444937|FG000|Period 2|Significant Protocol Deviation|1|||
49166451|NCT02457247|158444938|FG001|Period 2|Significant Protocol Deviation|0|||
49166452|NCT02457247|158444939|FG002|Period 2|Significant Protocol Deviation|0|||
49166453|NCT02457247|158444940|FG003|Period 2|Significant Protocol Deviation|0|||
49166454|NCT02457247|158444937|FG000|Period 2|Lost to Follow-up|0|||
49166455|NCT02457247|158444938|FG001|Period 2|Lost to Follow-up|1|||
49166456|NCT02457247|158444939|FG002|Period 2|Lost to Follow-up|0|||
49166457|NCT02457247|158444940|FG003|Period 2|Lost to Follow-up|0|||
49166458|NCT02457247|158444937|FG000|Period 2|Voluntary Withdrawal|1|||
49166459|NCT02457247|158444938|FG001|Period 2|Voluntary Withdrawal|1|||
49166460|NCT02457247|158444939|FG002|Period 2|Voluntary Withdrawal|0|||
49166461|NCT02457247|158444940|FG003|Period 2|Voluntary Withdrawal|0|||
49166462|NCT01152788|158444949|FG000|Overall Study|Withdrawal by Subject|0|||
49166463|NCT01152788|158444950|FG001|Overall Study|Withdrawal by Subject|3|||
49166464|NCT01152788|158444949|FG000|Overall Study|No treatment|0|||
49166465|NCT01152788|158444950|FG001|Overall Study|No treatment|1|||
49166466|NCT04245709|158444951|FG000|Overall Study|Adverse Event|13|||
49166467|NCT04245709|158444951|FG000|Overall Study|Risk of travel during COVID19 pandemic|1|||
49166468|NCT00811720|158444953|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
49166469|NCT00811720|158444954|FG001|All Randomised Patients|Did not receive placebo/nalmefene|4|||
49166470|NCT00811720|158444953|FG000|All Treated Patients|Adverse Event|20|||
49166471|NCT00811720|158444954|FG001|All Treated Patients|Adverse Event|62|||
49166472|NCT00811720|158444953|FG000|All Treated Patients|Lack of Efficacy|22|||
49166473|NCT00811720|158444954|FG001|All Treated Patients|Lack of Efficacy|18|||
49166474|NCT00811720|158444953|FG000|All Treated Patients|Non-compliance|0|||
49166475|NCT00811720|158444954|FG001|All Treated Patients|Non-compliance|14|||
49166476|NCT00811720|158444953|FG000|All Treated Patients|Protocol Violation|9|||
49166477|NCT00811720|158444954|FG001|All Treated Patients|Protocol Violation|16|||
49166478|NCT00811720|158444953|FG000|All Treated Patients|Withdrawal by Subject|28|||
49166479|NCT00811720|158444954|FG001|All Treated Patients|Withdrawal by Subject|34|||
49166480|NCT00811720|158444953|FG000|All Treated Patients|Lost to Follow-up|10|||
49166481|NCT00811720|158444954|FG001|All Treated Patients|Lost to Follow-up|16|||
49166482|NCT00811720|158444953|FG000|All Treated Patients|Other Reason|7|||
49166483|NCT00811720|158444954|FG001|All Treated Patients|Other Reason|4|||
48925208|NCT00105443|157559318|FG002|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
48925209|NCT00105443|157559319|FG003|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1|||
48925210|NCT00105443|157559316|FG000|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
48925211|NCT00105443|157559317|FG001|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
48925212|NCT00105443|157559318|FG002|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
48925213|NCT00105443|157559319|FG003|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
48925214|NCT00105443|157559316|FG000|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
48925215|NCT00105443|157559317|FG001|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23|||
48925216|NCT00105443|157559318|FG002|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
48925217|NCT00105443|157559319|FG003|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11|||
48925218|NCT02164981|157559320|FG000|Started|Withdrawal by Subject|2|||
48925219|NCT02164981|157559321|FG001|Started|Withdrawal by Subject|1|||
48925220|NCT02164981|157559322|FG002|Started|Withdrawal by Subject|0|||
48925221|NCT02164981|157559320|FG000|Started|Protocol Violation|2|||
48925222|NCT02164981|157559321|FG001|Started|Protocol Violation|0|||
48925223|NCT02164981|157559322|FG002|Started|Protocol Violation|0|||
48925224|NCT02164981|157559320|FG000|Started|Adverse Event|1|||
48925225|NCT02164981|157559321|FG001|Started|Adverse Event|2|||
48925226|NCT02164981|157559322|FG002|Started|Adverse Event|0|||
48925227|NCT02164981|157559320|FG000|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
48925228|NCT02164981|157559321|FG001|Phase 1 (Day 0 - Day 14)|Adverse Event|2|||
48925229|NCT02164981|157559322|FG002|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
48925230|NCT02164981|157559320|FG000|Phase 2 (Day 14 - Day 28)|Adverse Event|2|||
48925231|NCT02164981|157559321|FG001|Phase 2 (Day 14 - Day 28)|Adverse Event|1|||
48925232|NCT02164981|157559322|FG002|Phase 2 (Day 14 - Day 28)|Adverse Event|0|||
48925233|NCT02164981|157559320|FG000|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
48925234|NCT02164981|157559321|FG001|Phase 2 (Day 14 - Day 28)|Protocol Violation|1|||
48925235|NCT02164981|157559322|FG002|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
48925236|NCT01157078|157559324|FG000|Overall Study|Withdrawal by Subject|12|||
48925237|NCT01157078|157559325|FG001|Overall Study|Withdrawal by Subject|14|||
48925238|NCT01157078|157559324|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
48925239|NCT01157078|157559325|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
48925240|NCT01157078|157559324|FG000|Overall Study|Adverse Event|6|||
48925241|NCT01157078|157559325|FG001|Overall Study|Adverse Event|6|||
48925242|NCT01157078|157559324|FG000|Overall Study|Severe non-compliance to protocol|2|||
48925243|NCT01157078|157559325|FG001|Overall Study|Severe non-compliance to protocol|4|||
48925244|NCT01157078|157559324|FG000|Overall Study|Condition under investigation worsened|0|||
48925245|NCT01157078|157559325|FG001|Overall Study|Condition under investigation worsened|1|||
48925246|NCT01157078|157559324|FG000|Overall Study|Lack of Efficacy|2|||
48925247|NCT01157078|157559325|FG001|Overall Study|Lack of Efficacy|0|||
48925248|NCT01157078|157559324|FG000|Overall Study|Study-specific withdrawal criteria|2|||
48925249|NCT01157078|157559325|FG001|Overall Study|Study-specific withdrawal criteria|2|||
48925250|NCT01157078|157559324|FG000|Overall Study|Lost to Follow-up|7|||
48925251|NCT01157078|157559325|FG001|Overall Study|Lost to Follow-up|5|||
48925252|NCT01157078|157559324|FG000|Overall Study|Other|2|||
48925253|NCT01157078|157559325|FG001|Overall Study|Other|4|||
48925254|NCT02600507|157559328|FG000|Overall Study|Adverse Event|3|||
48925255|NCT02600507|157559329|FG001|Overall Study|Adverse Event|15|||
48925256|NCT02600507|157559330|FG002|Overall Study|Adverse Event|5|||
48925257|NCT02600507|157559328|FG000|Overall Study|Lack of Efficacy|3|||
48925258|NCT02600507|157559329|FG001|Overall Study|Lack of Efficacy|8|||
48925259|NCT02600507|157559330|FG002|Overall Study|Lack of Efficacy|5|||
48925260|NCT02600507|157559328|FG000|Overall Study|Lost to Follow-up|3|||
48925261|NCT02600507|157559329|FG001|Overall Study|Lost to Follow-up|5|||
48925262|NCT02600507|157559330|FG002|Overall Study|Lost to Follow-up|2|||
48925263|NCT02600507|157559328|FG000|Overall Study|Protocol Violation|12|||
48925264|NCT02600507|157559329|FG001|Overall Study|Protocol Violation|4|||
48925265|NCT02600507|157559330|FG002|Overall Study|Protocol Violation|4|||
48925266|NCT02600507|157559328|FG000|Overall Study|Physician Decision|1|||
48925267|NCT02600507|157559329|FG001|Overall Study|Physician Decision|0|||
48925268|NCT02600507|157559330|FG002|Overall Study|Physician Decision|1|||
49166484|NCT03465722|158444955|FG000|Overall Study|Withdrawal by Subject|21|||
49166485|NCT03465722|158444956|FG001|Overall Study|Withdrawal by Subject|14|||
49166486|NCT03465722|158444955|FG000|Overall Study|Death|89|||
49166487|NCT03465722|158444956|FG001|Overall Study|Death|87|||
49166488|NCT03465722|158444955|FG000|Overall Study|Lost to Follow-up|5|||
49166489|NCT03465722|158444956|FG001|Overall Study|Lost to Follow-up|3|||
49166490|NCT03465722|158444955|FG000|Overall Study|Administrative/Other|33|||
49166491|NCT03465722|158444956|FG001|Overall Study|Administrative/Other|32|||
49166492|NCT03465722|158444955|FG000|Overall Study|Not treated|1|||
49166493|NCT03465722|158444956|FG001|Overall Study|Not treated|2|||
49166494|NCT03465722|158444955|FG000|Overall Study|Sponsor decision|91|||
49166495|NCT03465722|158444956|FG001|Overall Study|Sponsor decision|98|||
49166496|NCT00442416|158444962|FG000|Overall Study|Adverse Event|4|||
49166497|NCT00442416|158444963|FG001|Overall Study|Adverse Event|1|||
49166498|NCT00442416|158444962|FG000|Overall Study|Death|1|||
49166499|NCT00442416|158444963|FG001|Overall Study|Death|0|||
49166500|NCT00442416|158444962|FG000|Overall Study|Lack of Efficacy|2|||
49166501|NCT00442416|158444963|FG001|Overall Study|Lack of Efficacy|0|||
49166502|NCT00442416|158444962|FG000|Overall Study|Protocol Violation|2|||
49166503|NCT00442416|158444963|FG001|Overall Study|Protocol Violation|3|||
49166504|NCT00442416|158444962|FG000|Overall Study|Withdrew consent|1|||
49166505|NCT00442416|158444963|FG001|Overall Study|Withdrew consent|2|||
49166506|NCT00442416|158444962|FG000|Overall Study|Administrative/Other|27|||
49166507|NCT00442416|158444963|FG001|Overall Study|Administrative/Other|33|||
49166508|NCT00570713|158444964|FG000|Overall Study|Adverse Event|16|||
49166509|NCT00570713|158444965|FG001|Overall Study|Adverse Event|9|||
49166510|NCT00570713|158444964|FG000|Overall Study|Death|7|||
49166511|NCT00570713|158444965|FG001|Overall Study|Death|7|||
49166512|NCT00570713|158444964|FG000|Overall Study|Lack of Efficacy|40|||
49166513|NCT00570713|158444965|FG001|Overall Study|Lack of Efficacy|49|||
49166514|NCT00570713|158444964|FG000|Overall Study|Physician Decision|2|||
49166515|NCT00570713|158444965|FG001|Overall Study|Physician Decision|2|||
49166516|NCT00570713|158444964|FG000|Overall Study|Withdrawal by Subject|3|||
49166517|NCT00570713|158444965|FG001|Overall Study|Withdrawal by Subject|3|||
49166518|NCT00570713|158444964|FG000|Overall Study|Discontinuation of Study by the Sponsor|10|||
49166519|NCT00570713|158444965|FG001|Overall Study|Discontinuation of Study by the Sponsor|7|||
49166520|NCT02625220|158444966|FG000|Overall Study|Adverse Event|2|||
49166521|NCT02625220|158444966|FG000|Overall Study|Lost to Follow-up|2|||
49166522|NCT02625220|158444966|FG000|Overall Study|Protocol Violation|1|||
49166523|NCT02625220|158444966|FG000|Overall Study|Study discontinued at site|2|||
49166524|NCT02954458|158444969|FG000|Overall Study|Adverse Event|0|||
49166525|NCT02954458|158444970|FG001|Overall Study|Adverse Event|0|||
49166526|NCT02954458|158444971|FG002|Overall Study|Adverse Event|0|||
49166527|NCT02954458|158444972|FG003|Overall Study|Adverse Event|1|||
49166528|NCT02954458|158444969|FG000|Overall Study|Withdrawal by Subject|0|||
49166529|NCT02954458|158444970|FG001|Overall Study|Withdrawal by Subject|0|||
49166530|NCT02954458|158444971|FG002|Overall Study|Withdrawal by Subject|0|||
49166531|NCT02954458|158444972|FG003|Overall Study|Withdrawal by Subject|1|||
49166532|NCT02954458|158444969|FG000|Overall Study|Physician Decision|0|||
49166533|NCT02954458|158444970|FG001|Overall Study|Physician Decision|0|||
49166534|NCT02954458|158444971|FG002|Overall Study|Physician Decision|1|||
49166535|NCT02954458|158444972|FG003|Overall Study|Physician Decision|1|||
49166536|NCT02954458|158444969|FG000|Overall Study|Lost to Follow-up|1|||
49166537|NCT02954458|158444970|FG001|Overall Study|Lost to Follow-up|0|||
49166538|NCT02954458|158444971|FG002|Overall Study|Lost to Follow-up|0|||
49166539|NCT02954458|158444972|FG003|Overall Study|Lost to Follow-up|1|||
49166540|NCT02954458|158444969|FG000|Overall Study|Death|0|||
49166541|NCT02954458|158444970|FG001|Overall Study|Death|0|||
49166542|NCT02954458|158444971|FG002|Overall Study|Death|0|||
49166543|NCT02954458|158444972|FG003|Overall Study|Death|1|||
49166544|NCT02954458|158444969|FG000|Overall Study|Other|0|||
49166545|NCT02954458|158444970|FG001|Overall Study|Other|0|||
49166546|NCT02954458|158444971|FG002|Overall Study|Other|0|||
49166547|NCT02954458|158444972|FG003|Overall Study|Other|7|||
49166548|NCT01853462|158444975|FG000|Overall Study|Withdrawal by Subject|1|||
49166549|NCT01853462|158444976|FG001|Overall Study|Withdrawal by Subject|1|||
49166550|NCT00132301|158444978|FG000|Overall Study|Death|7|||
49166551|NCT00132301|158444979|FG001|Overall Study|Death|6|||
49166552|NCT00132301|158444978|FG000|Overall Study|Withdrawal by Subject|5|||
49166553|NCT00132301|158444979|FG001|Overall Study|Withdrawal by Subject|2|||
49166554|NCT00132301|158444978|FG000|Overall Study|Physician Decision|1|||
49166555|NCT00132301|158444979|FG001|Overall Study|Physician Decision|1|||
49166556|NCT00132301|158444978|FG000|Overall Study|Lost to Follow-up|5|||
49166557|NCT00132301|158444979|FG001|Overall Study|Lost to Follow-up|3|||
49166558|NCT00132301|158444978|FG000|Overall Study|Other|1|||
49166559|NCT00132301|158444979|FG001|Overall Study|Other|1|||
48841096|NCT02974634|157259283|FG000|Overall Study|Advanced disease|12|||
49166560|NCT00132301|158444978|FG000|Overall Study|Excluded by Data Monitoring Committee|1|||
49166561|NCT00132301|158444979|FG001|Overall Study|Excluded by Data Monitoring Committee|0|||
49166562|NCT04154605|158444980|FG000|Overall Study|Procedure Canceled|1|||
49166563|NCT04154605|158444981|FG001|Overall Study|Procedure Canceled|1|||
49166564|NCT04154605|158444980|FG000|Overall Study|Missed follow up|1|||
49166565|NCT04154605|158444981|FG001|Overall Study|Missed follow up|1|||
48841097|NCT02974634|157259284|FG001|Overall Study|Advanced disease|3|||
48841098|NCT02974634|157259283|FG000|Overall Study|Noncompliance|3|||
48841099|NCT02974634|157259284|FG001|Overall Study|Noncompliance|7|||
48841100|NCT02974634|157259283|FG000|Overall Study|intervention technology related issues|5|||
49166566|NCT04154605|158444980|FG000|Overall Study|Withdrawal by Subject|1|||
48841101|NCT02974634|157259284|FG001|Overall Study|intervention technology related issues|0|||
48925269|NCT02600507|157559328|FG000|Overall Study|Withdrawal by Subject|7|||
48925270|NCT02600507|157559329|FG001|Overall Study|Withdrawal by Subject|11|||
49166567|NCT04154605|158444981|FG001|Overall Study|Withdrawal by Subject|0|||
49166568|NCT02623205|158444982|FG000|Overall Study|Lost to Follow-Up or Discontinued Intervention|4|||
49166569|NCT02623205|158444983|FG001|Overall Study|Lost to Follow-Up or Discontinued Intervention|3|||
49166570|NCT00142792|158444984|FG000|Overall Study|Death|0|||
49166571|NCT00142792|158444985|FG001|Overall Study|Death|0|||
49166572|NCT00142792|158444986|FG002|Overall Study|Death|1|||
49166573|NCT00142792|158444984|FG000|Overall Study|Withdrawal by Subject|3|||
49166574|NCT00142792|158444985|FG001|Overall Study|Withdrawal by Subject|2|||
49166575|NCT00142792|158444986|FG002|Overall Study|Withdrawal by Subject|3|||
49166576|NCT00142792|158444984|FG000|Overall Study|Lost to Follow-up|8|||
48841102|NCT02974634|157259283|FG000|Overall Study|Death|8|||
48841103|NCT02974634|157259284|FG001|Overall Study|Death|11|||
48841104|NCT00774852|157259285|FG000|Overall Study|Adverse Event|9|||
48841105|NCT00774852|157259286|FG001|Overall Study|Adverse Event|6|||
48841106|NCT00774852|157259285|FG000|Overall Study|Death|2|||
48841107|NCT00774852|157259286|FG001|Overall Study|Death|1|||
48841108|NCT00774852|157259285|FG000|Overall Study|Lack of Efficacy|3|||
48841109|NCT00774852|157259286|FG001|Overall Study|Lack of Efficacy|7|||
48841110|NCT00774852|157259285|FG000|Overall Study|Lost to Follow-up|9|||
48841111|NCT00774852|157259286|FG001|Overall Study|Lost to Follow-up|5|||
48841112|NCT00774852|157259285|FG000|Overall Study|Physician Decision|2|||
48841113|NCT00774852|157259286|FG001|Overall Study|Physician Decision|6|||
48841114|NCT00774852|157259285|FG000|Overall Study|Pregnancy|1|||
48841115|NCT00774852|157259286|FG001|Overall Study|Pregnancy|2|||
48841116|NCT00774852|157259285|FG000|Overall Study|Withdrawal by Subject|2|||
48841117|NCT00774852|157259286|FG001|Overall Study|Withdrawal by Subject|2|||
48841118|NCT00774852|157259285|FG000|Overall Study|Non-responder|15|||
48841119|NCT00774852|157259286|FG001|Overall Study|Non-responder|11|||
48841120|NCT00774852|157259285|FG000|Overall Study|Subject non-compliance|0|||
48841121|NCT00774852|157259286|FG001|Overall Study|Subject non-compliance|1|||
48841122|NCT00774852|157259285|FG000|Overall Study|Protocol Violation|1|||
48841123|NCT00774852|157259286|FG001|Overall Study|Protocol Violation|0|||
48841124|NCT00774852|157259285|FG000|Overall Study|Subject received prohibited medication|1|||
48841125|NCT00774852|157259286|FG001|Overall Study|Subject received prohibited medication|0|||
48841126|NCT01662336|157259287|FG000|Overall Study|Adverse Event|1|||
48841127|NCT01662336|157259287|FG000|Overall Study|No longer on LPV/r|30|||
48841128|NCT01662336|157259287|FG000|Overall Study|Other|29|||
48841129|NCT01662336|157259287|FG000|Overall Study|Withdrawal by Subject|6|||
48841130|NCT04867902|157259288|FG000|Overall Study|Lost to Follow-up|1|||
48841131|NCT04867902|157259288|FG000|Overall Study|Withdrawal by Subject|2|||
48841132|NCT04867902|157259288|FG000|Overall Study|Protocol Violation|1|||
48841133|NCT03762668|157259290|FG000|Period 1, First Week of Wear|Withdrawal by Subject|0|||
48925271|NCT02600507|157559330|FG002|Overall Study|Withdrawal by Subject|7|||
48925272|NCT02600507|157559328|FG000|Overall Study|Other|0|||
49014940|NCT01405820|157890466|FG004|Open-Label Treatment Period|Other|1|||
49014941|NCT01405820|157890467|FG005|Open-Label Treatment Period|Other|1|||
49014942|NCT01405820|157890462|FG000|Open-Label Treatment Period|Physician Decision|0|||
49014943|NCT01405820|157890463|FG001|Open-Label Treatment Period|Physician Decision|0|||
49014944|NCT01405820|157890464|FG002|Open-Label Treatment Period|Physician Decision|1|||
49014945|NCT01405820|157890465|FG003|Open-Label Treatment Period|Physician Decision|2|||
49014946|NCT01405820|157890466|FG004|Open-Label Treatment Period|Physician Decision|1|||
49014947|NCT01405820|157890467|FG005|Open-Label Treatment Period|Physician Decision|0|||
49014948|NCT01405820|157890462|FG000|Open-Label Treatment Period|Adverse Event|0|||
49014949|NCT01405820|157890463|FG001|Open-Label Treatment Period|Adverse Event|0|||
49014950|NCT01405820|157890464|FG002|Open-Label Treatment Period|Adverse Event|0|||
49014951|NCT01405820|157890465|FG003|Open-Label Treatment Period|Adverse Event|1|||
49014952|NCT01405820|157890466|FG004|Open-Label Treatment Period|Adverse Event|0|||
49014953|NCT01405820|157890467|FG005|Open-Label Treatment Period|Adverse Event|0|||
49014954|NCT00947011|157890470|FG000|Overall Study|Study was terminated,PI left institution|12|||
49014955|NCT03687125|157890471|FG000|Overall Study|Progressive Disease|2|||
49014956|NCT03687125|157890472|FG001|Overall Study|Progressive Disease|1|||
49014957|NCT03687125|157890471|FG000|Overall Study|Protocol Violation|1|||
49014958|NCT03687125|157890472|FG001|Overall Study|Protocol Violation|0|||
49014959|NCT02022007|157890475|FG000|Overall Study|Withdrawal by Subject|1|||
49014960|NCT02022007|157890476|FG001|Overall Study|Withdrawal by Subject|1|||
49014961|NCT02022007|157890477|FG002|Overall Study|Withdrawal by Subject|1|||
49014962|NCT02022007|157890475|FG000|Overall Study|Noncompliant|0|||
49014963|NCT02022007|157890476|FG001|Overall Study|Noncompliant|0|||
49014964|NCT02022007|157890477|FG002|Overall Study|Noncompliant|1|||
49166577|NCT00142792|158444985|FG001|Overall Study|Lost to Follow-up|11|||
49166578|NCT00142792|158444986|FG002|Overall Study|Lost to Follow-up|7|||
49166579|NCT00142792|158444984|FG000|Overall Study|No category|1|||
49166580|NCT00142792|158444985|FG001|Overall Study|No category|2|||
49166581|NCT00142792|158444986|FG002|Overall Study|No category|1|||
49166582|NCT03089047|158444991|FG000|Overall Study|Lost to Follow-up|1|||
49166583|NCT03089047|158444992|FG001|Overall Study|Lost to Follow-up|0|||
49166584|NCT01492088|158446895|FG000|Overall Study|Withdrawal by Patient|0|||
49166585|NCT01492088|158446896|FG001|Overall Study|Withdrawal by Patient|2|||
49166586|NCT01492088|158446897|FG002|Overall Study|Withdrawal by Patient|0|||
49166587|NCT01492088|158446895|FG000|Overall Study|Death|1|||
49166588|NCT01492088|158446896|FG001|Overall Study|Death|6|||
49166589|NCT01492088|158446897|FG002|Overall Study|Death|2|||
49166590|NCT01492088|158446895|FG000|Overall Study|Completed Post Treatment Followup (PTFU)|2|||
49166591|NCT01492088|158446896|FG001|Overall Study|Completed Post Treatment Followup (PTFU)|0|||
49166592|NCT01492088|158446897|FG002|Overall Study|Completed Post Treatment Followup (PTFU)|1|||
49166593|NCT01492088|158446895|FG000|Overall Study|Alive at Last Follow-up|0|||
49166594|NCT01492088|158446896|FG001|Overall Study|Alive at Last Follow-up|6|||
49166595|NCT01492088|158446897|FG002|Overall Study|Alive at Last Follow-up|11|||
49166596|NCT00928187|158446904|FG000|Overall Study|Death|1|||
49166597|NCT00928187|158446905|FG001|Overall Study|Death|2|||
49166598|NCT00928187|158446906|FG002|Overall Study|Death|3|||
49166599|NCT00928187|158446904|FG000|Overall Study|Lost to Follow-up|1|||
49166600|NCT00928187|158446905|FG001|Overall Study|Lost to Follow-up|2|||
49166601|NCT00928187|158446906|FG002|Overall Study|Lost to Follow-up|1|||
49166602|NCT00928187|158446904|FG000|Overall Study|Withdrawal by Subject|0|||
49166603|NCT00928187|158446905|FG001|Overall Study|Withdrawal by Subject|1|||
49166604|NCT00928187|158446906|FG002|Overall Study|Withdrawal by Subject|1|||
48841134|NCT03762668|157259291|FG001|Period 1, First Week of Wear|Withdrawal by Subject|1|||
48841135|NCT00465816|157259293|FG000|Overall Study|Lost to Follow-up|0|||
49166605|NCT00928187|158446904|FG000|Overall Study|Protocol Violation|0|||
49166606|NCT00928187|158446905|FG001|Overall Study|Protocol Violation|1|||
49166607|NCT00928187|158446906|FG002|Overall Study|Protocol Violation|0|||
49166608|NCT02240121|158446909|FG000|Overall Study|Protocol Violation|1|||
49166609|NCT02240121|158446910|FG001|Overall Study|Protocol Violation|2|||
49166610|NCT02240121|158446909|FG000|Overall Study|Physician Decision|0|||
49166611|NCT02240121|158446910|FG001|Overall Study|Physician Decision|1|||
49166612|NCT02240121|158446909|FG000|Overall Study|Change in protocol interpretation|1|||
49166613|NCT02240121|158446910|FG001|Overall Study|Change in protocol interpretation|0|||
49166614|NCT02240121|158446909|FG000|Overall Study|Lack of Efficacy|2|||
49166615|NCT02240121|158446910|FG001|Overall Study|Lack of Efficacy|3|||
49166616|NCT02240121|158446909|FG000|Overall Study|Site closed|1|||
49166617|NCT02240121|158446910|FG001|Overall Study|Site closed|1|||
48841136|NCT00465816|157259294|FG001|Overall Study|Lost to Follow-up|0|||
48841137|NCT00465816|157259295|FG002|Overall Study|Lost to Follow-up|2|||
48841138|NCT04425629|157259300|FG000|Overall Study|Adverse Event|0|||
48841139|NCT04425629|157259301|FG001|Overall Study|Adverse Event|0|||
48841140|NCT04425629|157259302|FG002|Overall Study|Adverse Event|0|||
48841141|NCT04425629|157259303|FG003|Overall Study|Adverse Event|0|||
48841142|NCT04425629|157259304|FG004|Overall Study|Adverse Event|1|||
48841143|NCT04425629|157259305|FG005|Overall Study|Adverse Event|0|||
48841144|NCT04425629|157259306|FG006|Overall Study|Adverse Event|0|||
48841145|NCT04425629|157259307|FG007|Overall Study|Adverse Event|0|||
48841146|NCT04425629|157259308|FG008|Overall Study|Adverse Event|0|||
49166618|NCT02240121|158446909|FG000|Overall Study|Pregnancy|1|||
48841147|NCT04425629|157259309|FG009|Overall Study|Adverse Event|3|||
48841148|NCT04425629|157259310|FG010|Overall Study|Adverse Event|2|||
48841149|NCT04425629|157259311|FG011|Overall Study|Adverse Event|1|||
48841150|NCT04425629|157259312|FG012|Overall Study|Adverse Event|1|||
48841151|NCT04425629|157259313|FG013|Overall Study|Adverse Event|0|||
48841152|NCT04425629|157259314|FG014|Overall Study|Adverse Event|0|||
48841153|NCT04425629|157259315|FG015|Overall Study|Adverse Event|0|||
48841154|NCT04425629|157259316|FG016|Overall Study|Adverse Event|0|||
48841155|NCT04425629|157259317|FG017|Overall Study|Adverse Event|0|||
48841156|NCT04425629|157259318|FG018|Overall Study|Adverse Event|0|||
48841157|NCT04425629|157259300|FG000|Overall Study|Lost to Follow-up|1|||
48841158|NCT04425629|157259301|FG001|Overall Study|Lost to Follow-up|3|||
48841159|NCT04425629|157259302|FG002|Overall Study|Lost to Follow-up|1|||
48841160|NCT04425629|157259303|FG003|Overall Study|Lost to Follow-up|7|||
48841161|NCT04425629|157259304|FG004|Overall Study|Lost to Follow-up|1|||
48841162|NCT04425629|157259305|FG005|Overall Study|Lost to Follow-up|2|||
48841163|NCT04425629|157259306|FG006|Overall Study|Lost to Follow-up|1|||
48841164|NCT04425629|157259307|FG007|Overall Study|Lost to Follow-up|0|||
48841165|NCT04425629|157259308|FG008|Overall Study|Lost to Follow-up|1|||
48925273|NCT02600507|157559329|FG001|Overall Study|Other|1|||
49166619|NCT02240121|158446910|FG001|Overall Study|Pregnancy|0|||
49166620|NCT02240121|158446909|FG000|Overall Study|Adverse Event|2|||
49166621|NCT02240121|158446910|FG001|Overall Study|Adverse Event|4|||
49166622|NCT02240121|158446909|FG000|Overall Study|Withdrawal by Subject|6|||
49166623|NCT02240121|158446910|FG001|Overall Study|Withdrawal by Subject|2|||
49166624|NCT02240121|158446909|FG000|Overall Study|Lost to Follow-up|3|||
49166625|NCT02240121|158446910|FG001|Overall Study|Lost to Follow-up|4|||
49166626|NCT02240121|158446909|FG000|Overall Study|Other than specified|1|||
49166627|NCT02240121|158446910|FG001|Overall Study|Other than specified|3|||
49166628|NCT02041299|158446916|FG000|Overall Study|Adverse Event|9|||
49166629|NCT02041299|158446917|FG001|Overall Study|Adverse Event|3|||
49166630|NCT02041299|158446916|FG000|Overall Study|Lost to Follow-up|4|||
49166631|NCT02041299|158446917|FG001|Overall Study|Lost to Follow-up|1|||
49166632|NCT02041299|158446916|FG000|Overall Study|Physician Decision|1|||
49166633|NCT02041299|158446917|FG001|Overall Study|Physician Decision|1|||
49166634|NCT02041299|158446916|FG000|Overall Study|Withdrawal by Subject|13|||
49166635|NCT02041299|158446917|FG001|Overall Study|Withdrawal by Subject|7|||
49166636|NCT02041299|158446916|FG000|Overall Study|Protocol Violation|11|||
49166637|NCT02041299|158446917|FG001|Overall Study|Protocol Violation|4|||
49166638|NCT02041299|158446916|FG000|Overall Study|Termination of the study|7|||
49166639|NCT02041299|158446917|FG001|Overall Study|Termination of the study|3|||
49166640|NCT02041299|158446916|FG000|Overall Study|Required bone marrow transplant|0|||
49166641|NCT02041299|158446917|FG001|Overall Study|Required bone marrow transplant|1|||
49166642|NCT02041299|158446916|FG000|Overall Study|Patient stopped dosing on unknown date|1|||
49166643|NCT02041299|158446917|FG001|Overall Study|Patient stopped dosing on unknown date|0|||
49166644|NCT02389465|158446918|FG000|Overall Study|Lost to Follow-up|1|||
49166645|NCT02389465|158446919|FG001|Overall Study|Lost to Follow-up|3|||
48841166|NCT04425629|157259309|FG009|Overall Study|Lost to Follow-up|64|||
48841167|NCT04425629|157259310|FG010|Overall Study|Lost to Follow-up|70|||
48841168|NCT04425629|157259311|FG011|Overall Study|Lost to Follow-up|98|||
48925274|NCT02600507|157559330|FG002|Overall Study|Other|1|||
48841169|NCT04425629|157259312|FG012|Overall Study|Lost to Follow-up|30|||
48841170|NCT04425629|157259313|FG013|Overall Study|Lost to Follow-up|0|||
49166646|NCT02389465|158446920|FG002|Overall Study|Lost to Follow-up|3|||
48841171|NCT04425629|157259314|FG014|Overall Study|Lost to Follow-up|5|||
48841172|NCT04425629|157259315|FG015|Overall Study|Lost to Follow-up|4|||
48925275|NCT04541004|157559331|FG000|Overall Study|Adverse Event|2|||
48925276|NCT00706134|157559332|FG000|Overall Study|Adverse Event|8|||
48925277|NCT00706134|157559333|FG001|Overall Study|Adverse Event|7|||
48925278|NCT00706134|157559334|FG002|Overall Study|Adverse Event|2|||
48925279|NCT00706134|157559335|FG003|Overall Study|Adverse Event|3|||
48925280|NCT00706134|157559332|FG000|Overall Study|Lost to Follow-up|0|||
48925281|NCT00706134|157559333|FG001|Overall Study|Lost to Follow-up|1|||
48925282|NCT00706134|157559334|FG002|Overall Study|Lost to Follow-up|0|||
48925283|NCT00706134|157559335|FG003|Overall Study|Lost to Follow-up|0|||
49166647|NCT02389465|158446921|FG003|Overall Study|Lost to Follow-up|0|||
49166648|NCT02389465|158446918|FG000|Overall Study|Physician Decision|0|||
49166649|NCT02389465|158446919|FG001|Overall Study|Physician Decision|0|||
49166650|NCT02389465|158446920|FG002|Overall Study|Physician Decision|0|||
49166651|NCT02389465|158446921|FG003|Overall Study|Physician Decision|1|||
49166652|NCT02389465|158446918|FG000|Overall Study|Withdrawal by Subject|0|||
49166653|NCT02389465|158446919|FG001|Overall Study|Withdrawal by Subject|1|||
49166654|NCT02389465|158446920|FG002|Overall Study|Withdrawal by Subject|2|||
49166655|NCT02389465|158446921|FG003|Overall Study|Withdrawal by Subject|2|||
49166656|NCT00003631|158446924|FG000|Overall Study|Patient not treated|1|||
49166657|NCT00003631|158446925|FG001|Overall Study|Patient not treated|0|||
49166658|NCT00003631|158446926|FG002|Overall Study|Patient not treated|1|||
49166659|NCT00003631|158446924|FG000|Overall Study|Protocol Violation|1|||
49166660|NCT00003631|158446925|FG001|Overall Study|Protocol Violation|0|||
49166661|NCT00003631|158446926|FG002|Overall Study|Protocol Violation|0|||
49166662|NCT00003631|158446924|FG000|Overall Study|Adverse Event|1|||
49166663|NCT00003631|158446925|FG001|Overall Study|Adverse Event|1|||
49166664|NCT00003631|158446926|FG002|Overall Study|Adverse Event|5|||
49166665|NCT00003631|158446924|FG000|Overall Study|Death|0|||
49166666|NCT00003631|158446925|FG001|Overall Study|Death|0|||
49166667|NCT00003631|158446926|FG002|Overall Study|Death|1|||
49166668|NCT00003631|158446924|FG000|Overall Study|Evaluable for toxicity only|0|||
49166669|NCT00003631|158446925|FG001|Overall Study|Evaluable for toxicity only|0|||
49166670|NCT00003631|158446926|FG002|Overall Study|Evaluable for toxicity only|2|||
49166671|NCT00996658|158446927|FG000|Overall Study|Adverse Event|2|||
49166672|NCT00996658|158446928|FG001|Overall Study|Adverse Event|5|||
49166673|NCT00996658|158446927|FG000|Overall Study|Protocol Violation|0|||
49166674|NCT00996658|158446928|FG001|Overall Study|Protocol Violation|1|||
49166675|NCT00996658|158446927|FG000|Overall Study|Lost to Follow-up|2|||
49166676|NCT00996658|158446928|FG001|Overall Study|Lost to Follow-up|5|||
49166677|NCT00996658|158446927|FG000|Overall Study|Non-compliance issues|3|||
49166678|NCT00996658|158446928|FG001|Overall Study|Non-compliance issues|3|||
49166679|NCT00996658|158446927|FG000|Overall Study|Other|9|||
49166680|NCT00996658|158446928|FG001|Overall Study|Other|7|||
49166681|NCT04339413|158446930|FG000|Overall Study|Reason Not Specified|2|||
49166682|NCT04339413|158446931|FG001|Overall Study|Reason Not Specified|7|||
49166683|NCT04339413|158446930|FG000|Overall Study|Study Terminated by Sponsor|30|||
49166684|NCT04339413|158446931|FG001|Overall Study|Study Terminated by Sponsor|33|||
49166685|NCT04339413|158446930|FG000|Overall Study|Progressive Disease|9|||
49166686|NCT04339413|158446931|FG001|Overall Study|Progressive Disease|6|||
49166687|NCT04339413|158446930|FG000|Overall Study|Withdrawal by Subject|9|||
49166688|NCT04339413|158446931|FG001|Overall Study|Withdrawal by Subject|10|||
49166689|NCT04339413|158446930|FG000|Overall Study|Physician Decision|3|||
49166690|NCT04339413|158446931|FG001|Overall Study|Physician Decision|1|||
49166691|NCT04339413|158446930|FG000|Overall Study|Death|2|||
49166692|NCT04339413|158446931|FG001|Overall Study|Death|0|||
49166693|NCT04339413|158446930|FG000|Overall Study|Adverse Event|3|||
49166694|NCT04339413|158446931|FG001|Overall Study|Adverse Event|0|||
49166695|NCT02524145|158446932|FG000|Overall Study|Withdrawal by Subject|2|||
49166696|NCT02524145|158446933|FG001|Overall Study|Withdrawal by Subject|2|||
49166697|NCT02524145|158446934|FG002|Overall Study|Withdrawal by Subject|3|||
49166698|NCT00114127|158446943|FG000|Overall Study|Adverse Event|2|||
49166699|NCT00114127|158446944|FG001|Overall Study|Adverse Event|1|||
49166700|NCT00114127|158446943|FG000|Overall Study|Lost to Follow-up|1|||
49166701|NCT00114127|158446944|FG001|Overall Study|Lost to Follow-up|0|||
49166702|NCT00114127|158446943|FG000|Overall Study|Withdrawal by Subject|1|||
49166703|NCT00114127|158446944|FG001|Overall Study|Withdrawal by Subject|3|||
49166704|NCT03072043|158446945|FG000|Overall Study|Death|0|||
49166705|NCT03072043|158446946|FG001|Overall Study|Death|0|||
49166706|NCT03072043|158446947|FG002|Overall Study|Death|3|||
49166707|NCT03072043|158446945|FG000|Overall Study|Adverse Event|0|||
49166708|NCT03072043|158446946|FG001|Overall Study|Adverse Event|0|||
49166709|NCT03072043|158446947|FG002|Overall Study|Adverse Event|2|||
48925284|NCT00706134|157559332|FG000|Overall Study|Protocol Violation|0|||
49166710|NCT03072043|158446945|FG000|Overall Study|Withdrawal by Subject|0|||
49166711|NCT03072043|158446946|FG001|Overall Study|Withdrawal by Subject|0|||
49166712|NCT03072043|158446947|FG002|Overall Study|Withdrawal by Subject|4|||
49166713|NCT00645840|158446948|FG000|Overall Study|Protocol Violation|3|||
49166714|NCT00699413|158446951|FG000|Overall Study|Withdrawal by Subject|0|||
49166715|NCT00699413|158446952|FG001|Overall Study|Withdrawal by Subject|2|||
48925285|NCT00706134|157559333|FG001|Overall Study|Protocol Violation|6|||
49166716|NCT00699413|158446951|FG000|Overall Study|Study terminated by sponsor|4|||
49166717|NCT00699413|158446952|FG001|Overall Study|Study terminated by sponsor|2|||
49166718|NCT02779777|158446953|FG000|Overall Study|Disease Progression|1|||
49166719|NCT02779777|158446954|FG001|Overall Study|Disease Progression|0|||
49166720|NCT02779777|158446955|FG002|Overall Study|Disease Progression|0|||
48841173|NCT04425629|157259316|FG016|Overall Study|Lost to Follow-up|0|||
48841174|NCT04425629|157259317|FG017|Overall Study|Lost to Follow-up|3|||
48841175|NCT04425629|157259318|FG018|Overall Study|Lost to Follow-up|1|||
48841176|NCT04425629|157259300|FG000|Overall Study|Subject Decision|0|||
48841177|NCT04425629|157259301|FG001|Overall Study|Subject Decision|2|||
48841178|NCT04425629|157259302|FG002|Overall Study|Subject Decision|1|||
48841179|NCT04425629|157259303|FG003|Overall Study|Subject Decision|3|||
48841180|NCT04425629|157259304|FG004|Overall Study|Subject Decision|6|||
48841181|NCT04425629|157259305|FG005|Overall Study|Subject Decision|6|||
48841182|NCT04425629|157259306|FG006|Overall Study|Subject Decision|3|||
48841183|NCT04425629|157259307|FG007|Overall Study|Subject Decision|3|||
48841184|NCT04425629|157259308|FG008|Overall Study|Subject Decision|1|||
48841185|NCT04425629|157259309|FG009|Overall Study|Subject Decision|70|||
48841186|NCT04425629|157259310|FG010|Overall Study|Subject Decision|95|||
48841187|NCT04425629|157259311|FG011|Overall Study|Subject Decision|124|||
48841188|NCT04425629|157259312|FG012|Overall Study|Subject Decision|25|||
48841189|NCT04425629|157259313|FG013|Overall Study|Subject Decision|0|||
48841190|NCT04425629|157259314|FG014|Overall Study|Subject Decision|1|||
48841191|NCT04425629|157259315|FG015|Overall Study|Subject Decision|4|||
48841192|NCT04425629|157259316|FG016|Overall Study|Subject Decision|1|||
48841193|NCT04425629|157259317|FG017|Overall Study|Subject Decision|0|||
48841194|NCT04425629|157259318|FG018|Overall Study|Subject Decision|2|||
48841195|NCT04425629|157259300|FG000|Overall Study|Death|0|||
48841196|NCT04425629|157259301|FG001|Overall Study|Death|0|||
48925286|NCT00706134|157559334|FG002|Overall Study|Protocol Violation|0|||
49014965|NCT00814658|157890478|FG000|Overall Study|Lost to Follow-up|0|||
49166721|NCT02779777|158446953|FG000|Overall Study|Adverse Event|3|||
49166722|NCT02779777|158446954|FG001|Overall Study|Adverse Event|1|||
49166723|NCT02779777|158446955|FG002|Overall Study|Adverse Event|0|||
49166724|NCT02779777|158446953|FG000|Overall Study|Physician Decision|9|||
49166725|NCT02779777|158446954|FG001|Overall Study|Physician Decision|0|||
49166726|NCT02779777|158446955|FG002|Overall Study|Physician Decision|1|||
49166727|NCT02779777|158446953|FG000|Overall Study|Withdrawal by Subject|1|||
49166728|NCT02779777|158446954|FG001|Overall Study|Withdrawal by Subject|0|||
49166729|NCT02779777|158446955|FG002|Overall Study|Withdrawal by Subject|0|||
49166730|NCT04571060|158446956|FG000|Overall Study|Lost to Follow-up from Randomization to Treatment|17|||
49166731|NCT04571060|158446957|FG001|Overall Study|Lost to Follow-up from Randomization to Treatment|9|||
49166732|NCT04571060|158446956|FG000|Overall Study|Never treated migraine|47|||
49166733|NCT04571060|158446957|FG001|Overall Study|Never treated migraine|36|||
49166734|NCT04571060|158446956|FG000|Overall Study|Protocol Violation|4|||
49166735|NCT04571060|158446957|FG001|Overall Study|Protocol Violation|2|||
49166736|NCT04571060|158446956|FG000|Overall Study|Withdrawal by Subject|6|||
49166737|NCT04571060|158446957|FG001|Overall Study|Withdrawal by Subject|2|||
49166738|NCT04571060|158446956|FG000|Overall Study|Lost to Follow-up from Treatment to End of Study|7|||
49166739|NCT04571060|158446957|FG001|Overall Study|Lost to Follow-up from Treatment to End of Study|0|||
49166740|NCT03943290|158446958|FG000|Overall Study|Sponsor Terminated Study|6|||
49166741|NCT03943290|158446959|FG001|Overall Study|Sponsor Terminated Study|1|||
49166742|NCT03943290|158446960|FG002|Overall Study|Sponsor Terminated Study|11|||
49166743|NCT03943290|158446961|FG003|Overall Study|Sponsor Terminated Study|6|||
49166744|NCT03943290|158446962|FG004|Overall Study|Sponsor Terminated Study|7|||
49166745|NCT03943290|158446963|FG005|Overall Study|Sponsor Terminated Study|6|||
49166746|NCT03943290|158446964|FG006|Overall Study|Sponsor Terminated Study|6|||
49166747|NCT03943290|158446965|FG007|Overall Study|Sponsor Terminated Study|7|||
48841197|NCT04425629|157259302|FG002|Overall Study|Death|0|||
48841198|NCT04425629|157259303|FG003|Overall Study|Death|0|||
48841199|NCT04425629|157259304|FG004|Overall Study|Death|0|||
48841200|NCT04425629|157259305|FG005|Overall Study|Death|0|||
48841201|NCT04425629|157259306|FG006|Overall Study|Death|0|||
48841202|NCT04425629|157259307|FG007|Overall Study|Death|0|||
48841203|NCT04425629|157259308|FG008|Overall Study|Death|0|||
48841204|NCT04425629|157259309|FG009|Overall Study|Death|11|||
48841205|NCT04425629|157259310|FG010|Overall Study|Death|2|||
49014966|NCT00814658|157890479|FG001|Overall Study|Lost to Follow-up|1|||
49014967|NCT00814658|157890478|FG000|Overall Study|Physician Decision|1|||
49014968|NCT00814658|157890479|FG001|Overall Study|Physician Decision|0|||
49014969|NCT00814658|157890478|FG000|Overall Study|Adverse Event|3|||
49014970|NCT00814658|157890479|FG001|Overall Study|Adverse Event|3|||
49014971|NCT01326026|157890481|FG000|Overall Study|Adverse Event|4|||
49014972|NCT01326026|157890482|FG001|Overall Study|Adverse Event|3|||
49014973|NCT01326026|157890481|FG000|Overall Study|Withdrawal Criteria|5|||
49014974|NCT01326026|157890482|FG001|Overall Study|Withdrawal Criteria|7|||
49014975|NCT01326026|157890481|FG000|Overall Study|Other|3|||
49014976|NCT01326026|157890482|FG001|Overall Study|Other|3|||
49014977|NCT05266456|157890483|FG000|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
49014978|NCT05266456|157890484|FG001|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
49166748|NCT03943290|158446966|FG008|Overall Study|Sponsor Terminated Study|8|||
49166749|NCT03943290|158446958|FG000|Overall Study|Lost to Follow-up|1|||
49166750|NCT03943290|158446959|FG001|Overall Study|Lost to Follow-up|0|||
49166751|NCT03943290|158446960|FG002|Overall Study|Lost to Follow-up|1|||
49166752|NCT03943290|158446961|FG003|Overall Study|Lost to Follow-up|0|||
49166753|NCT03943290|158446962|FG004|Overall Study|Lost to Follow-up|0|||
49166754|NCT03943290|158446963|FG005|Overall Study|Lost to Follow-up|0|||
49166755|NCT03943290|158446964|FG006|Overall Study|Lost to Follow-up|0|||
49166756|NCT03943290|158446965|FG007|Overall Study|Lost to Follow-up|1|||
49166757|NCT03943290|158446966|FG008|Overall Study|Lost to Follow-up|0|||
49166758|NCT03943290|158446958|FG000|Overall Study|Withdrawal by Subject|0|||
49166759|NCT03943290|158446959|FG001|Overall Study|Withdrawal by Subject|0|||
49166760|NCT03943290|158446960|FG002|Overall Study|Withdrawal by Subject|1|||
49166761|NCT03943290|158446961|FG003|Overall Study|Withdrawal by Subject|0|||
49166762|NCT03943290|158446962|FG004|Overall Study|Withdrawal by Subject|0|||
49166763|NCT03943290|158446963|FG005|Overall Study|Withdrawal by Subject|0|||
49166764|NCT03943290|158446964|FG006|Overall Study|Withdrawal by Subject|0|||
49166765|NCT03943290|158446965|FG007|Overall Study|Withdrawal by Subject|0|||
49166766|NCT03943290|158446966|FG008|Overall Study|Withdrawal by Subject|0|||
49166767|NCT02441101|158446971|FG000|Overall Study|Withdrawal by Subject|1|||
49166768|NCT02441101|158446972|FG001|Overall Study|Withdrawal by Subject|0|||
49166769|NCT02441101|158446971|FG000|Overall Study|Lost to Follow-up|1|||
49166770|NCT02441101|158446972|FG001|Overall Study|Lost to Follow-up|0|||
49166771|NCT02441101|158446971|FG000|Overall Study|PI relocated and study terminated|1|||
49166772|NCT02441101|158446972|FG001|Overall Study|PI relocated and study terminated|0|||
49166773|NCT01369199|158446973|FG000|Overall Study|Withdrawal by Subject|1|||
49166774|NCT01369199|158446973|FG000|Overall Study|Lost to Follow-up|2|||
49166775|NCT00955474|158446974|FG000|Overall Study|Physician Decision|7|||
49166776|NCT00955474|158446975|FG001|Overall Study|Physician Decision|5|||
49166777|NCT01055613|158446976|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
49166778|NCT01055613|158446977|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
49166779|NCT01055613|158446976|FG000|Overall Study|Unacceptable lens fit|1|||
49166780|NCT01055613|158446977|FG001|Overall Study|Unacceptable lens fit|0|||
49166781|NCT01055613|158446976|FG000|Overall Study|Discomfort|2|||
49166782|NCT01055613|158446977|FG001|Overall Study|Discomfort|1|||
49166783|NCT01055613|158446976|FG000|Overall Study|Lost to Follow-up|1|||
49166784|NCT01055613|158446977|FG001|Overall Study|Lost to Follow-up|1|||
49166785|NCT01055613|158446976|FG000|Overall Study|Protocol Violation|1|||
49166786|NCT01055613|158446977|FG001|Overall Study|Protocol Violation|1|||
49166787|NCT01055613|158446976|FG000|Overall Study|Subject Disinterest|1|||
49166788|NCT01055613|158446977|FG001|Overall Study|Subject Disinterest|1|||
49166789|NCT01509846|158446981|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
49166790|NCT01509846|158446982|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
49166791|NCT01509846|158446983|FG002|Received Vaccination 2|Withdrawal by Subject|1|||
49166792|NCT01509846|158446984|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
49166793|NCT01509846|158446985|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
49166794|NCT01509846|158446981|FG000|Received Vaccination 2|Illness|0|||
49166795|NCT01509846|158446982|FG001|Received Vaccination 2|Illness|0|||
49166796|NCT01509846|158446983|FG002|Received Vaccination 2|Illness|0|||
49166797|NCT01509846|158446984|FG003|Received Vaccination 2|Illness|0|||
49166798|NCT01509846|158446985|FG004|Received Vaccination 2|Illness|1|||
49166799|NCT01509846|158446981|FG000|Received Vaccination 2|Not vaccinated per protocol|5|||
49166800|NCT01509846|158446982|FG001|Received Vaccination 2|Not vaccinated per protocol|0|||
49166801|NCT01509846|158446983|FG002|Received Vaccination 2|Not vaccinated per protocol|0|||
49166802|NCT01509846|158446984|FG003|Received Vaccination 2|Not vaccinated per protocol|0|||
49166803|NCT01509846|158446985|FG004|Received Vaccination 2|Not vaccinated per protocol|2|||
49166804|NCT01509846|158446981|FG000|Received Vaccination 3|Withdrawal by Subject|0|||
48841206|NCT04425629|157259311|FG011|Overall Study|Death|4|||
48841207|NCT04425629|157259312|FG012|Overall Study|Death|0|||
48841208|NCT04425629|157259313|FG013|Overall Study|Death|0|||
48841209|NCT04425629|157259314|FG014|Overall Study|Death|0|||
48841210|NCT04425629|157259315|FG015|Overall Study|Death|0|||
48841211|NCT04425629|157259316|FG016|Overall Study|Death|0|||
48841212|NCT04425629|157259317|FG017|Overall Study|Death|0|||
48841213|NCT04425629|157259318|FG018|Overall Study|Death|0|||
48841214|NCT04425629|157259300|FG000|Overall Study|Sponsor Request|0|||
48841215|NCT04425629|157259301|FG001|Overall Study|Sponsor Request|0|||
48841216|NCT04425629|157259302|FG002|Overall Study|Sponsor Request|0|||
48841217|NCT04425629|157259303|FG003|Overall Study|Sponsor Request|2|||
48841218|NCT04425629|157259304|FG004|Overall Study|Sponsor Request|2|||
48841219|NCT04425629|157259305|FG005|Overall Study|Sponsor Request|2|||
48841220|NCT04425629|157259306|FG006|Overall Study|Sponsor Request|1|||
48841221|NCT04425629|157259307|FG007|Overall Study|Sponsor Request|0|||
48841222|NCT04425629|157259308|FG008|Overall Study|Sponsor Request|0|||
48841223|NCT04425629|157259309|FG009|Overall Study|Sponsor Request|9|||
48841224|NCT04425629|157259310|FG010|Overall Study|Sponsor Request|9|||
48925287|NCT00706134|157559335|FG003|Overall Study|Protocol Violation|3|||
48925288|NCT00706134|157559332|FG000|Overall Study|Withdrawal by Subject|1|||
48925289|NCT00706134|157559333|FG001|Overall Study|Withdrawal by Subject|2|||
48925290|NCT00706134|157559334|FG002|Overall Study|Withdrawal by Subject|1|||
48925291|NCT00706134|157559335|FG003|Overall Study|Withdrawal by Subject|0|||
48925292|NCT00706134|157559332|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
48925293|NCT00706134|157559333|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
49166805|NCT01509846|158446982|FG001|Received Vaccination 3|Withdrawal by Subject|1|||
49166806|NCT01509846|158446983|FG002|Received Vaccination 3|Withdrawal by Subject|0|||
49166807|NCT01509846|158446984|FG003|Received Vaccination 3|Withdrawal by Subject|0|||
49166808|NCT01509846|158446985|FG004|Received Vaccination 3|Withdrawal by Subject|0|||
49166809|NCT01509846|158446981|FG000|Received Vaccination 3|Pregnancy|0|||
49166810|NCT01509846|158446982|FG001|Received Vaccination 3|Pregnancy|0|||
49166811|NCT01509846|158446983|FG002|Received Vaccination 3|Pregnancy|0|||
49166812|NCT01509846|158446984|FG003|Received Vaccination 3|Pregnancy|1|||
48925294|NCT00706134|157559334|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
48925295|NCT00706134|157559335|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
49166813|NCT01509846|158446985|FG004|Received Vaccination 3|Pregnancy|0|||
49166814|NCT01509846|158446981|FG000|Received Vaccination 3|Lost to Follow-up|0|||
49166815|NCT01509846|158446982|FG001|Received Vaccination 3|Lost to Follow-up|0|||
49166816|NCT01509846|158446983|FG002|Received Vaccination 3|Lost to Follow-up|1|||
49166817|NCT01509846|158446984|FG003|Received Vaccination 3|Lost to Follow-up|0|||
49166818|NCT01509846|158446985|FG004|Received Vaccination 3|Lost to Follow-up|0|||
49166819|NCT01964378|158446986|FG000|Overall Study|Disc. due to death before first dosing|0|||
49166820|NCT01964378|158446987|FG001|Overall Study|Disc. due to death before first dosing|1|||
49166821|NCT01964378|158446986|FG000|Overall Study|Disc. due to AE before first dosing|1|||
49166822|NCT01964378|158446987|FG001|Overall Study|Disc. due to AE before first dosing|0|||
49166823|NCT01964378|158446986|FG000|Overall Study|Death|3|||
49166824|NCT01964378|158446987|FG001|Overall Study|Death|2|||
49166825|NCT01964378|158446986|FG000|Overall Study|Adverse Event|12|||
49166826|NCT01964378|158446987|FG001|Overall Study|Adverse Event|5|||
49166827|NCT01964378|158446986|FG000|Overall Study|Lack of Efficacy|0|||
49166828|NCT01964378|158446987|FG001|Overall Study|Lack of Efficacy|1|||
49166829|NCT01964378|158446986|FG000|Overall Study|Protocol Violation|0|||
48925296|NCT00706134|157559332|FG000|Overall Study|Did not meet study criteria|2|||
49166830|NCT01964378|158446987|FG001|Overall Study|Protocol Violation|1|||
49166831|NCT01964378|158446986|FG000|Overall Study|Lost to Follow-up|0|||
48925297|NCT00706134|157559333|FG001|Overall Study|Did not meet study criteria|0|||
48925298|NCT00706134|157559334|FG002|Overall Study|Did not meet study criteria|0|||
48925299|NCT00706134|157559335|FG003|Overall Study|Did not meet study criteria|0|||
48925300|NCT03691974|157559336|FG000|Overall Study|Physician Decision|1|||
48925301|NCT03691974|157559337|FG001|Overall Study|Physician Decision|0|||
48925302|NCT03691974|157559336|FG000|Overall Study|Adverse Event|1|||
48925303|NCT03691974|157559337|FG001|Overall Study|Adverse Event|0|||
48925304|NCT03691974|157559336|FG000|Overall Study|Withdrawal by Subject|11|||
49166832|NCT01964378|158446987|FG001|Overall Study|Lost to Follow-up|1|||
49166833|NCT01964378|158446986|FG000|Overall Study|Withdrawal by Subject|7|||
49166834|NCT01964378|158446987|FG001|Overall Study|Withdrawal by Subject|5|||
49166835|NCT01964378|158446986|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
49166836|NCT01964378|158446987|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
49166837|NCT01964378|158446986|FG000|Overall Study|Other|1|||
49166838|NCT01964378|158446987|FG001|Overall Study|Other|2|||
49166839|NCT00120627|158446988|FG000|Overall Study|Withdrawal by Subject|5|||
49166840|NCT00120627|158446989|FG001|Overall Study|Withdrawal by Subject|5|||
49166841|NCT02544750|158446990|FG000|Overall Study|Physician Decision|3|||
49166842|NCT02544750|158446991|FG001|Overall Study|Physician Decision|1|||
49166843|NCT02544750|158446990|FG000|Overall Study|Other reasons|69|||
49166844|NCT02544750|158446991|FG001|Overall Study|Other reasons|39|||
49166845|NCT02544750|158446990|FG000|Overall Study|Met withdrawal criteria|2|||
49166846|NCT02544750|158446991|FG001|Overall Study|Met withdrawal criteria|2|||
49166847|NCT02544750|158446990|FG000|Overall Study|Transition To Commercial Product|1|||
49166848|NCT02544750|158446991|FG001|Overall Study|Transition To Commercial Product|0|||
49166849|NCT02544750|158446990|FG000|Overall Study|Withdrawal by Parent/Guardian|8|||
49166850|NCT02544750|158446991|FG001|Overall Study|Withdrawal by Parent/Guardian|7|||
49166851|NCT02544750|158446990|FG000|Overall Study|Adverse Event|8|||
49166852|NCT02544750|158446991|FG001|Overall Study|Adverse Event|10|||
49166853|NCT02544750|158446990|FG000|Overall Study|Withdrawal by Subject|10|||
48925305|NCT03691974|157559337|FG001|Overall Study|Withdrawal by Subject|9|||
48925306|NCT03691974|157559336|FG000|Overall Study|Protocol Violation|1|||
48925307|NCT03691974|157559337|FG001|Overall Study|Protocol Violation|0|||
49166854|NCT02544750|158446991|FG001|Overall Study|Withdrawal by Subject|4|||
49166855|NCT02544750|158446990|FG000|Overall Study|Lost to Follow-up|1|||
49166856|NCT02544750|158446991|FG001|Overall Study|Lost to Follow-up|0|||
49166857|NCT00625586|158446994|FG000|Overall Study|Adverse Event|1|||
49166858|NCT00625586|158446994|FG000|Overall Study|Progressive disease|1|||
49166859|NCT02484443|158446995|FG000|Overall Study|Lack of Efficacy|28|||
49166860|NCT02484443|158446995|FG000|Overall Study|Physician Decision|2|||
49166861|NCT02484443|158446995|FG000|Overall Study|Ineligible|2|||
49166862|NCT01393899|158446996|FG000|Overall Study|Study terminated by sponsor|1|||
49166863|NCT01393899|158446997|FG001|Overall Study|Study terminated by sponsor|0|||
49166864|NCT01393899|158446998|FG002|Overall Study|Study terminated by sponsor|1|||
49166865|NCT01393899|158446996|FG000|Overall Study|Other|1|||
49166866|NCT01393899|158446997|FG001|Overall Study|Other|0|||
49166867|NCT01393899|158446998|FG002|Overall Study|Other|0|||
49166868|NCT01393899|158446996|FG000|Overall Study|Withdrawal by Subject|2|||
49166869|NCT01393899|158446997|FG001|Overall Study|Withdrawal by Subject|2|||
49166870|NCT01393899|158446998|FG002|Overall Study|Withdrawal by Subject|1|||
48925308|NCT03691974|157559336|FG000|Overall Study|Lost to Follow-up|8|||
49166871|NCT01393899|158446996|FG000|Overall Study|Lost to Follow-up|0|||
49166872|NCT01393899|158446997|FG001|Overall Study|Lost to Follow-up|0|||
49166873|NCT01393899|158446998|FG002|Overall Study|Lost to Follow-up|1|||
49166874|NCT01393899|158446996|FG000|Overall Study|Does not meet entrance criteria|1|||
49166875|NCT01393899|158446997|FG001|Overall Study|Does not meet entrance criteria|0|||
49166876|NCT01393899|158446998|FG002|Overall Study|Does not meet entrance criteria|1|||
48925309|NCT03691974|157559337|FG001|Overall Study|Lost to Follow-up|7|||
48925310|NCT00691483|157559340|FG000|Overall Study|Adverse Event|14|||
48925311|NCT00691483|157559341|FG001|Overall Study|Adverse Event|6|||
48925312|NCT00691483|157559340|FG000|Overall Study|Lost to Follow-up|17|||
49166877|NCT01393899|158446996|FG000|Overall Study|Lack of Efficacy|26|||
49166878|NCT01393899|158446997|FG001|Overall Study|Lack of Efficacy|21|||
49166879|NCT01393899|158446998|FG002|Overall Study|Lack of Efficacy|16|||
49166880|NCT01393899|158446996|FG000|Overall Study|Adverse Event|1|||
49166881|NCT01393899|158446997|FG001|Overall Study|Adverse Event|5|||
49166882|NCT01393899|158446998|FG002|Overall Study|Adverse Event|3|||
49166883|NCT02503085|158446999|FG000|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
49166884|NCT02503085|158447000|FG001|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
49166885|NCT02503085|158447001|FG002|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
49166886|NCT02503085|158447002|FG003|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
49166887|NCT02122146|158447003|FG000|Part 1: Dose Escalation|Death|0|||
49166888|NCT02122146|158447004|FG001|Part 1: Dose Escalation|Death|1|||
49166889|NCT02122146|158447005|FG002|Part 1: Dose Escalation|Death|1|||
49166890|NCT02122146|158447006|FG003|Part 1: Dose Escalation|Death|0|||
49166891|NCT02122146|158447007|FG004|Part 1: Dose Escalation|Death|0|||
49166892|NCT02122146|158447008|FG005|Part 1: Dose Escalation|Death|0|||
49166893|NCT02122146|158447009|FG006|Part 1: Dose Escalation|Death|0|||
49166894|NCT02122146|158447010|FG007|Part 1: Dose Escalation|Death|0|||
49166895|NCT02122146|158447003|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
49166896|NCT02122146|158447004|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
49166897|NCT02122146|158447005|FG002|Part 1: Dose Escalation|Lost to Follow-up|1|||
49166898|NCT02122146|158447006|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
49166899|NCT02122146|158447007|FG004|Part 1: Dose Escalation|Lost to Follow-up|1|||
49166900|NCT02122146|158447008|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
49166901|NCT02122146|158447009|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
49166902|NCT02122146|158447010|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
49166903|NCT02122146|158447003|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
49166904|NCT02122146|158447004|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
49166905|NCT02122146|158447005|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
49166906|NCT02122146|158447006|FG003|Part 1: Dose Escalation|Withdrawal by Subject|1|||
49166907|NCT02122146|158447007|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
49166908|NCT02122146|158447008|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
49166909|NCT02122146|158447009|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
49166910|NCT02122146|158447010|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
49166911|NCT02122146|158447003|FG000|Part 1: Dose Escalation|Other|1|||
49166912|NCT02122146|158447004|FG001|Part 1: Dose Escalation|Other|0|||
49166913|NCT02122146|158447005|FG002|Part 1: Dose Escalation|Other|0|||
48925313|NCT00691483|157559341|FG001|Overall Study|Lost to Follow-up|10|||
49166914|NCT02122146|158447006|FG003|Part 1: Dose Escalation|Other|0|||
49166915|NCT02122146|158447007|FG004|Part 1: Dose Escalation|Other|0|||
49166916|NCT02122146|158447008|FG005|Part 1: Dose Escalation|Other|1|||
49166917|NCT02122146|158447009|FG006|Part 1: Dose Escalation|Other|1|||
49166918|NCT02122146|158447010|FG007|Part 1: Dose Escalation|Other|2|||
49166919|NCT00886769|158447013|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
49166920|NCT00886769|158447014|FG001|Overall Study|Unsatisfactory therapeutic effect|37|||
49166921|NCT00049257|158447015|FG000|Carboplatin, Paclitaxel|Withdrawal by Subject|10|||
49166922|NCT00049257|158447015|FG000|Carboplatin, Paclitaxel|Lost to Follow-up|1|||
49166923|NCT00049257|158447015|FG000|Carboplatin, Paclitaxel|Death|2|||
49166924|NCT00049257|158447015|FG000|Follow-up Period for Survival Status|Lost to Follow-up|4|||
48925314|NCT00691483|157559340|FG000|Overall Study|Withdrawal by Subject|24|||
48925315|NCT00691483|157559341|FG001|Overall Study|Withdrawal by Subject|7|||
48925316|NCT00691483|157559340|FG000|Overall Study|Other known cause|6|||
48925317|NCT00691483|157559341|FG001|Overall Study|Other known cause|1|||
48925318|NCT00691483|157559340|FG000|Overall Study|Randomized by not treated|7|||
48925319|NCT00691483|157559341|FG001|Overall Study|Randomized by not treated|1|||
48925320|NCT00049673|157559342|FG000|Overall Study|No receive treatment/lost to follow-up|1|||
48925321|NCT00049673|157559343|FG001|Overall Study|No receive treatment/lost to follow-up|3|||
48925322|NCT03927105|157559344|FG000|Overall Study|Death|1|||
48925323|NCT03927105|157559344|FG000|Overall Study|In observation for potential re-treatment|2|||
48925324|NCT03927105|157559344|FG000|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1|||
48925325|NCT00817531|157559346|FG000|Overall Study|Adverse Event|1|||
48925326|NCT00817531|157559346|FG000|Overall Study|Lack of Efficacy|1|||
48925327|NCT00812214|157559347|FG000|Overall Study|Lost to Follow-up|3|||
48925328|NCT00812214|157559348|FG001|Overall Study|Lost to Follow-up|1|||
49166925|NCT01558596|158447016|FG000|Overall Study|Withdrawal by Subject|1|||
48925329|NCT01659320|157559351|FG000|Overall Study|Withdrawal by Subject|2|||
48925330|NCT01659320|157559351|FG000|Overall Study|Physician Decision|1|||
48925331|NCT00590590|157559352|FG000|Overall Study|Lack of Efficacy|1|||
48925332|NCT00590590|157559353|FG001|Overall Study|Lack of Efficacy|2|||
48925333|NCT00590590|157559354|FG002|Overall Study|Lack of Efficacy|0|||
49166926|NCT01558596|158447017|FG001|Overall Study|Withdrawal by Subject|0|||
49166927|NCT01558596|158447016|FG000|Overall Study|surgery elsewhere or cancelled|1|||
49166928|NCT01558596|158447017|FG001|Overall Study|surgery elsewhere or cancelled|1|||
49166929|NCT01558596|158447016|FG000|Overall Study|Protocol Violation|1|||
49166930|NCT01558596|158447017|FG001|Overall Study|Protocol Violation|0|||
49166931|NCT03192137|158447018|FG000|Overall Study|Adverse Event|10|||
49166932|NCT03192137|158447019|FG001|Overall Study|Adverse Event|11|||
49166933|NCT03192137|158447018|FG000|Overall Study|Physician Decision|1|||
49166934|NCT03192137|158447019|FG001|Overall Study|Physician Decision|0|||
49166935|NCT03192137|158447018|FG000|Overall Study|Lack of Efficacy|20|||
49166936|NCT03192137|158447019|FG001|Overall Study|Lack of Efficacy|37|||
49166937|NCT03192137|158447018|FG000|Overall Study|Withdrawal by Subject|3|||
49166938|NCT03192137|158447019|FG001|Overall Study|Withdrawal by Subject|3|||
49166939|NCT03192137|158447018|FG000|Overall Study|Protocol Violation|4|||
49166940|NCT03192137|158447019|FG001|Overall Study|Protocol Violation|3|||
49166941|NCT03192137|158447018|FG000|Overall Study|Surgery Cancelled|4|||
49166942|NCT03192137|158447019|FG001|Overall Study|Surgery Cancelled|1|||
49166943|NCT03192137|158447018|FG000|Overall Study|Other - Various Administrative Reasons|8|||
49166944|NCT03192137|158447019|FG001|Overall Study|Other - Various Administrative Reasons|3|||
49166945|NCT02012218|158447021|FG000|Overall Study|Withdrawal by Subject|1|||
49166946|NCT02012218|158447022|FG001|Overall Study|Withdrawal by Subject|0|||
49166947|NCT02012218|158447023|FG002|Overall Study|Withdrawal by Subject|1|||
49166948|NCT02012218|158447024|FG003|Overall Study|Withdrawal by Subject|1|||
49166949|NCT02012218|158447025|FG004|Overall Study|Withdrawal by Subject|1|||
49166950|NCT02012218|158447021|FG000|Overall Study|Adverse Event|1|||
49166951|NCT02012218|158447022|FG001|Overall Study|Adverse Event|0|||
49166952|NCT02012218|158447023|FG002|Overall Study|Adverse Event|0|||
49166953|NCT02012218|158447024|FG003|Overall Study|Adverse Event|1|||
49166954|NCT02012218|158447025|FG004|Overall Study|Adverse Event|0|||
49166955|NCT02012218|158447021|FG000|Overall Study|Lost to Follow-up|0|||
49166956|NCT02012218|158447022|FG001|Overall Study|Lost to Follow-up|1|||
49166957|NCT02012218|158447023|FG002|Overall Study|Lost to Follow-up|1|||
49166958|NCT02012218|158447024|FG003|Overall Study|Lost to Follow-up|0|||
49166959|NCT02012218|158447025|FG004|Overall Study|Lost to Follow-up|0|||
49166960|NCT02012218|158447021|FG000|Overall Study|Protocol Specified|1|||
49166961|NCT02012218|158447022|FG001|Overall Study|Protocol Specified|0|||
49166962|NCT02012218|158447023|FG002|Overall Study|Protocol Specified|0|||
49166963|NCT02012218|158447024|FG003|Overall Study|Protocol Specified|0|||
49166964|NCT02012218|158447025|FG004|Overall Study|Protocol Specified|0|||
49166965|NCT02012218|158447021|FG000|Overall Study|Protocol Deviation|1|||
48925334|NCT00590590|157559352|FG000|Overall Study|Adverse Event|1|||
48925335|NCT00590590|157559353|FG001|Overall Study|Adverse Event|0|||
48925336|NCT00590590|157559354|FG002|Overall Study|Adverse Event|0|||
48925337|NCT00590590|157559352|FG000|Overall Study|Protocol Violation|0|||
49166966|NCT02012218|158447022|FG001|Overall Study|Protocol Deviation|0|||
49166967|NCT02012218|158447023|FG002|Overall Study|Protocol Deviation|0|||
49166968|NCT02012218|158447024|FG003|Overall Study|Protocol Deviation|0|||
49166969|NCT02012218|158447025|FG004|Overall Study|Protocol Deviation|0|||
49166970|NCT03082677|158447026|FG000|Overall Study|Not Treated|2|||
49166971|NCT04872569|158447027|FG000|Overall Study|Withdrawal by Subject|2|||
49166972|NCT00673231|158447029|FG000|Overall Study|Withdrawal by Subject|14|||
49166973|NCT00673231|158447030|FG001|Overall Study|Withdrawal by Subject|10|||
49166974|NCT00673231|158447031|FG002|Overall Study|Withdrawal by Subject|8|||
49166975|NCT00673231|158447032|FG003|Overall Study|Withdrawal by Subject|6|||
49166976|NCT00673231|158447029|FG000|Overall Study|Adverse Event|6|||
49166977|NCT00673231|158447030|FG001|Overall Study|Adverse Event|5|||
49166978|NCT00673231|158447031|FG002|Overall Study|Adverse Event|9|||
49166979|NCT00673231|158447032|FG003|Overall Study|Adverse Event|6|||
49166980|NCT00673231|158447029|FG000|Overall Study|Lost to Follow-up|1|||
49166981|NCT00673231|158447030|FG001|Overall Study|Lost to Follow-up|2|||
48925338|NCT00590590|157559353|FG001|Overall Study|Protocol Violation|0|||
48925339|NCT00590590|157559354|FG002|Overall Study|Protocol Violation|2|||
48925340|NCT00590590|157559352|FG000|Overall Study|Lost to Follow-up|4|||
49166982|NCT00673231|158447031|FG002|Overall Study|Lost to Follow-up|1|||
48925341|NCT00590590|157559353|FG001|Overall Study|Lost to Follow-up|1|||
48925342|NCT00590590|157559354|FG002|Overall Study|Lost to Follow-up|2|||
48925343|NCT00590590|157559352|FG000|Overall Study|Withdrawal by Subject|0|||
49166983|NCT00673231|158447032|FG003|Overall Study|Lost to Follow-up|2|||
48925344|NCT00590590|157559353|FG001|Overall Study|Withdrawal by Subject|1|||
48925345|NCT00590590|157559354|FG002|Overall Study|Withdrawal by Subject|1|||
48925346|NCT00590590|157559352|FG000|Overall Study|Did not complete due to study closure|1|||
48925347|NCT00590590|157559353|FG001|Overall Study|Did not complete due to study closure|1|||
48925348|NCT00590590|157559354|FG002|Overall Study|Did not complete due to study closure|1|||
48925349|NCT00590590|157559352|FG000|Overall Study|Did not complete study|0|||
48925350|NCT00590590|157559353|FG001|Overall Study|Did not complete study|1|||
48925351|NCT00590590|157559354|FG002|Overall Study|Did not complete study|0|||
48925352|NCT00132132|157559355|FG000|Overall Study|Lost to Follow-up|7|||
48925353|NCT00132132|157559356|FG001|Overall Study|Lost to Follow-up|2|||
48925354|NCT01870401|157559357|FG000|Overall Study|Death|48|||
48925355|NCT01870401|157559358|FG001|Overall Study|Death|24|||
48925356|NCT01870401|157559357|FG000|Overall Study|Withdrawal by Subject|39|||
48925357|NCT01870401|157559358|FG001|Overall Study|Withdrawal by Subject|26|||
49166984|NCT00673231|158447029|FG000|Overall Study|Death|0|||
49166985|NCT00673231|158447030|FG001|Overall Study|Death|0|||
49166986|NCT00673231|158447031|FG002|Overall Study|Death|1|||
49166987|NCT00673231|158447032|FG003|Overall Study|Death|0|||
49166988|NCT00673231|158447029|FG000|Overall Study|Study criteria,compliance,safety, other|8|||
49166989|NCT00673231|158447030|FG001|Overall Study|Study criteria,compliance,safety, other|5|||
49166990|NCT00673231|158447031|FG002|Overall Study|Study criteria,compliance,safety, other|7|||
49166991|NCT00673231|158447032|FG003|Overall Study|Study criteria,compliance,safety, other|4|||
49166992|NCT01016132|158447053|FG000|Overall Study|Discomfort|1|||
49166993|NCT02311881|158447054|FG000|Overall Study|Did not meet the study criteria|2|||
49166994|NCT02311881|158447055|FG001|Overall Study|Did not meet the study criteria|2|||
49166995|NCT02311881|158447056|FG002|Overall Study|Did not meet the study criteria|0|||
49166996|NCT02311881|158447054|FG000|Overall Study|Adverse Event|7|||
49166997|NCT02311881|158447055|FG001|Overall Study|Adverse Event|15|||
49166998|NCT02311881|158447056|FG002|Overall Study|Adverse Event|8|||
49166999|NCT02311881|158447054|FG000|Overall Study|Lost to Follow-up|3|||
49167000|NCT02311881|158447055|FG001|Overall Study|Lost to Follow-up|3|||
49167001|NCT02311881|158447056|FG002|Overall Study|Lost to Follow-up|2|||
49167002|NCT02311881|158447054|FG000|Overall Study|Protocol Violation|1|||
49167003|NCT02311881|158447055|FG001|Overall Study|Protocol Violation|2|||
49167004|NCT02311881|158447056|FG002|Overall Study|Protocol Violation|3|||
49167005|NCT02311881|158447054|FG000|Overall Study|Withdrawal of consent|14|||
49167006|NCT02311881|158447055|FG001|Overall Study|Withdrawal of consent|16|||
49167007|NCT02311881|158447056|FG002|Overall Study|Withdrawal of consent|17|||
49167008|NCT02311881|158447054|FG000|Overall Study|Other|0|||
49167009|NCT02311881|158447055|FG001|Overall Study|Other|0|||
49167010|NCT02311881|158447056|FG002|Overall Study|Other|1|||
49167011|NCT02311881|158447054|FG000|Overall Study|Lack of Efficacy|1|||
48925358|NCT01870401|157559357|FG000|Overall Study|Lost to Follow-up|19|||
48925359|NCT01870401|157559358|FG001|Overall Study|Lost to Follow-up|14|||
48925360|NCT01870401|157559357|FG000|Overall Study|Other|9|||
48925361|NCT01870401|157559358|FG001|Overall Study|Other|7|||
49167012|NCT02311881|158447055|FG001|Overall Study|Lack of Efficacy|2|||
49167013|NCT02311881|158447056|FG002|Overall Study|Lack of Efficacy|0|||
49167014|NCT02311881|158447054|FG000|Overall Study|Subject has border line pregnancy test|1|||
49167015|NCT02311881|158447055|FG001|Overall Study|Subject has border line pregnancy test|0|||
49167016|NCT02311881|158447056|FG002|Overall Study|Subject has border line pregnancy test|0|||
49167017|NCT02311881|158447054|FG000|Overall Study|Withdrawal by Subject|3|||
49167018|NCT02311881|158447055|FG001|Overall Study|Withdrawal by Subject|1|||
49167019|NCT02311881|158447056|FG002|Overall Study|Withdrawal by Subject|4|||
49167020|NCT02311881|158447054|FG000|Overall Study|Sponsor Decision|1|||
49167021|NCT02311881|158447055|FG001|Overall Study|Sponsor Decision|1|||
49167022|NCT02311881|158447056|FG002|Overall Study|Sponsor Decision|1|||
49167023|NCT02311881|158447054|FG000|Overall Study|Protocol Deviation|1|||
49167024|NCT02311881|158447055|FG001|Overall Study|Protocol Deviation|0|||
49167025|NCT02311881|158447056|FG002|Overall Study|Protocol Deviation|0|||
49167026|NCT02311881|158447054|FG000|Overall Study|Non-Compliance|1|||
49167027|NCT02311881|158447055|FG001|Overall Study|Non-Compliance|0|||
49167028|NCT02311881|158447056|FG002|Overall Study|Non-Compliance|2|||
49167029|NCT02311881|158447054|FG000|Overall Study|Physician Decision|0|||
49167030|NCT02311881|158447055|FG001|Overall Study|Physician Decision|0|||
49167031|NCT02311881|158447056|FG002|Overall Study|Physician Decision|1|||
49167032|NCT02311881|158447054|FG000|Overall Study|Medical Monitor Discretion|0|||
49167033|NCT02311881|158447055|FG001|Overall Study|Medical Monitor Discretion|0|||
49167034|NCT02311881|158447056|FG002|Overall Study|Medical Monitor Discretion|1|||
49167035|NCT02311881|158447054|FG000|Overall Study|Participant taking another medication|0|||
49167036|NCT02311881|158447055|FG001|Overall Study|Participant taking another medication|0|||
49167037|NCT02311881|158447056|FG002|Overall Study|Participant taking another medication|1|||
48841225|NCT04425629|157259311|FG011|Overall Study|Sponsor Request|10|||
49167038|NCT02311881|158447054|FG000|Overall Study|Serious Adverse Event|0|||
49167039|NCT02311881|158447055|FG001|Overall Study|Serious Adverse Event|1|||
49167040|NCT02311881|158447056|FG002|Overall Study|Serious Adverse Event|0|||
49167041|NCT01265992|158447057|FG000|Overall Study|Lost to Follow-up|1|||
49167042|NCT01265992|158447057|FG000|Overall Study|Withdrawal by Subject|1|||
49167043|NCT01265992|158447057|FG000|Overall Study|Adverse Event|1|||
49167044|NCT01265992|158447057|FG000|Overall Study|Administrative reasons|2|||
49167045|NCT01265992|158447057|FG000|Overall Study|Stopped treatment|3|||
48841226|NCT04425629|157259312|FG012|Overall Study|Sponsor Request|8|||
48841227|NCT04425629|157259313|FG013|Overall Study|Sponsor Request|0|||
48841228|NCT04425629|157259314|FG014|Overall Study|Sponsor Request|0|||
48841229|NCT04425629|157259315|FG015|Overall Study|Sponsor Request|1|||
48841230|NCT04425629|157259316|FG016|Overall Study|Sponsor Request|0|||
48841231|NCT04425629|157259317|FG017|Overall Study|Sponsor Request|0|||
48841232|NCT04425629|157259318|FG018|Overall Study|Sponsor Request|0|||
48841233|NCT04425629|157259300|FG000|Overall Study|Physician Decision|0|||
48841234|NCT04425629|157259301|FG001|Overall Study|Physician Decision|0|||
48841235|NCT04425629|157259302|FG002|Overall Study|Physician Decision|0|||
48841236|NCT04425629|157259303|FG003|Overall Study|Physician Decision|0|||
48841237|NCT04425629|157259304|FG004|Overall Study|Physician Decision|0|||
48925362|NCT01870401|157559357|FG000|Overall Study|On-going in the Study|35|||
48925363|NCT01870401|157559358|FG001|Overall Study|On-going in the Study|25|||
48925364|NCT01745146|157559359|FG000|Overall Study|Withdrawal by Subject|1|||
48925365|NCT01745146|157559360|FG001|Overall Study|Withdrawal by Subject|3|||
48925366|NCT01745146|157559359|FG000|Overall Study|Lost to Follow-up|2|||
48925367|NCT01745146|157559360|FG001|Overall Study|Lost to Follow-up|0|||
48925368|NCT02684981|157559361|FG000|Overall Study|Permanently discontinued the treatment|157|||
48925369|NCT02684981|157559362|FG001|Overall Study|Permanently discontinued the treatment|161|||
48925370|NCT02684981|157559363|FG002|Overall Study|Permanently discontinued the treatment|110|||
48925371|NCT02684981|157559361|FG000|Overall Study|Other|83|||
48925372|NCT02684981|157559362|FG001|Overall Study|Other|49|||
48925373|NCT02684981|157559363|FG002|Overall Study|Other|17|||
48925374|NCT00452699|157559364|FG000|Overall Study|Adverse Event|10|||
48925375|NCT00452699|157559365|FG001|Overall Study|Adverse Event|3|||
48925376|NCT00452699|157559364|FG000|Overall Study|Lack of Efficacy|6|||
48925377|NCT00452699|157559365|FG001|Overall Study|Lack of Efficacy|4|||
48925378|NCT00452699|157559364|FG000|Overall Study|Lost to Follow-up|6|||
48925379|NCT00452699|157559365|FG001|Overall Study|Lost to Follow-up|9|||
48925380|NCT00452699|157559364|FG000|Overall Study|Protocol Violation|21|||
48925381|NCT00452699|157559365|FG001|Overall Study|Protocol Violation|25|||
48925382|NCT00452699|157559364|FG000|Overall Study|Withdrawal by Subject|26|||
48925383|NCT00452699|157559365|FG001|Overall Study|Withdrawal by Subject|25|||
48925384|NCT00452699|157559364|FG000|Overall Study|Other|12|||
48925385|NCT00452699|157559365|FG001|Overall Study|Other|7|||
48925386|NCT02921971|157559366|FG000|Overall Study|Adverse Event|1|||
48925387|NCT02921971|157559367|FG001|Overall Study|Adverse Event|2|||
48925388|NCT02921971|157559366|FG000|Overall Study|Lack of Efficacy|3|||
48925389|NCT02921971|157559367|FG001|Overall Study|Lack of Efficacy|1|||
48925390|NCT02921971|157559366|FG000|Overall Study|Other than specified above|2|||
48925391|NCT02921971|157559367|FG001|Overall Study|Other than specified above|1|||
48925392|NCT00326898|157559368|FG000|Overall Study|Disease progression|52|||
48925393|NCT00326898|157559369|FG001|Overall Study|Disease progression|54|||
48925394|NCT00326898|157559370|FG002|Overall Study|Disease progression|102|||
48925395|NCT00326898|157559368|FG000|Overall Study|Adverse Event|124|||
48925396|NCT00326898|157559369|FG001|Overall Study|Adverse Event|128|||
48925397|NCT00326898|157559370|FG002|Overall Study|Adverse Event|33|||
48925398|NCT00326898|157559368|FG000|Overall Study|Death|2|||
48925399|NCT00326898|157559369|FG001|Overall Study|Death|0|||
48925400|NCT00326898|157559370|FG002|Overall Study|Death|0|||
48925401|NCT00326898|157559368|FG000|Overall Study|Withdrawal by Subject|134|||
48925402|NCT00326898|157559369|FG001|Overall Study|Withdrawal by Subject|128|||
48841238|NCT04425629|157259305|FG005|Overall Study|Physician Decision|0|||
48841239|NCT04425629|157259306|FG006|Overall Study|Physician Decision|0|||
48841240|NCT04425629|157259307|FG007|Overall Study|Physician Decision|0|||
48841241|NCT04425629|157259308|FG008|Overall Study|Physician Decision|0|||
48841242|NCT04425629|157259309|FG009|Overall Study|Physician Decision|4|||
48841243|NCT04425629|157259310|FG010|Overall Study|Physician Decision|3|||
48925403|NCT00326898|157559370|FG002|Overall Study|Withdrawal by Subject|32|||
48925404|NCT00326898|157559368|FG000|Overall Study|Alternative therapy|1|||
48925405|NCT00326898|157559369|FG001|Overall Study|Alternative therapy|0|||
48841244|NCT04425629|157259311|FG011|Overall Study|Physician Decision|5|||
48841245|NCT04425629|157259312|FG012|Overall Study|Physician Decision|1|||
48841246|NCT04425629|157259313|FG013|Overall Study|Physician Decision|0|||
48841247|NCT04425629|157259314|FG014|Overall Study|Physician Decision|0|||
48841248|NCT04425629|157259315|FG015|Overall Study|Physician Decision|1|||
48841249|NCT04425629|157259316|FG016|Overall Study|Physician Decision|0|||
48925406|NCT00326898|157559370|FG002|Overall Study|Alternative therapy|0|||
48925407|NCT00326898|157559368|FG000|Overall Study|Other complicating disease|5|||
48925408|NCT00326898|157559369|FG001|Overall Study|Other complicating disease|5|||
48925409|NCT00326898|157559370|FG002|Overall Study|Other complicating disease|4|||
48925410|NCT00326898|157559368|FG000|Overall Study|Other/Missing/Unknown|33|||
49167046|NCT01265992|158447057|FG000|Overall Study|Did not receive treatment|1|||
48841250|NCT04425629|157259317|FG017|Overall Study|Physician Decision|0|||
48841251|NCT04425629|157259318|FG018|Overall Study|Physician Decision|0|||
48841252|NCT04425629|157259300|FG000|Overall Study|Lack of Efficacy|0|||
48841253|NCT04425629|157259301|FG001|Overall Study|Lack of Efficacy|0|||
48841254|NCT04425629|157259302|FG002|Overall Study|Lack of Efficacy|0|||
48841255|NCT04425629|157259303|FG003|Overall Study|Lack of Efficacy|0|||
48841256|NCT04425629|157259304|FG004|Overall Study|Lack of Efficacy|0|||
48841257|NCT04425629|157259305|FG005|Overall Study|Lack of Efficacy|0|||
48841258|NCT04425629|157259306|FG006|Overall Study|Lack of Efficacy|0|||
48841259|NCT04425629|157259307|FG007|Overall Study|Lack of Efficacy|0|||
48841260|NCT04425629|157259308|FG008|Overall Study|Lack of Efficacy|0|||
48841261|NCT04425629|157259309|FG009|Overall Study|Lack of Efficacy|0|||
48841262|NCT04425629|157259310|FG010|Overall Study|Lack of Efficacy|1|||
48841263|NCT04425629|157259311|FG011|Overall Study|Lack of Efficacy|0|||
49167047|NCT01963767|158447058|FG000|Overall Study|Withdrawal by Subject|4|||
49167048|NCT01963767|158447059|FG001|Overall Study|Withdrawal by Subject|2|||
49167049|NCT01963767|158447058|FG000|Overall Study|Adverse Event|2|||
49167050|NCT01963767|158447059|FG001|Overall Study|Adverse Event|0|||
49167051|NCT02949024|158447060|FG000|Overall Study|Withdrawal by Subject|0|||
49167052|NCT02949024|158447061|FG001|Overall Study|Withdrawal by Subject|1|||
49167053|NCT03159468|158447064|FG000|Overall Study|Withdrawal by Subject|0|||
49167054|NCT03159468|158447065|FG001|Overall Study|Withdrawal by Subject|0|||
49167055|NCT03159468|158447066|FG002|Overall Study|Withdrawal by Subject|3|||
49167056|NCT03159468|158447067|FG003|Overall Study|Withdrawal by Subject|0|||
49167057|NCT03159468|158447068|FG004|Overall Study|Withdrawal by Subject|0|||
49167058|NCT03159468|158447069|FG005|Overall Study|Withdrawal by Subject|0|||
49167059|NCT02735421|158448226|FG000|Part A (Randomized): up to 24 Weeks|Adverse Event|2|||
49167060|NCT02735421|158448226|FG000|Part A (Randomized): up to 24 Weeks|Withdrawal by Subject|6|||
49167061|NCT02735421|158448226|FG000|Part A (Randomized): up to 24 Weeks|Lost to Follow-up|3|||
49167062|NCT02735421|158448226|FG000|Part A (Randomized): up to 24 Weeks|Inadequate compliance to treatment|1|||
49167063|NCT02735421|158448226|FG000|Part A (Randomized): up to 24 Weeks|Pregnancy|1|||
49167064|NCT02735421|158448226|FG000|Part 2 (Open Label): up to 48 Weeks|Withdrawal by Subject|1|||
49167065|NCT02735421|158448226|FG000|Part 2 (Open Label): up to 48 Weeks|Lost to Follow-up|3|||
48925411|NCT00326898|157559369|FG001|Overall Study|Other/Missing/Unknown|28|||
49167066|NCT01492426|158448227|FG000|Treatment|Death|0|||
49167067|NCT01492426|158448228|FG001|Treatment|Death|1|||
49167068|NCT01492426|158448227|FG000|Treatment|Other|1|||
49167069|NCT01492426|158448228|FG001|Treatment|Other|0|||
49167070|NCT01492426|158448227|FG000|Treatment|Adverse Event|25|||
49167071|NCT01492426|158448228|FG001|Treatment|Adverse Event|25|||
49167072|NCT01492426|158448227|FG000|Treatment|Lack of Efficacy|38|||
49167073|NCT01492426|158448228|FG001|Treatment|Lack of Efficacy|5|||
49167074|NCT01492426|158448227|FG000|Treatment|Participant withdrew consent|1|||
49167075|NCT01492426|158448228|FG001|Treatment|Participant withdrew consent|2|||
49167076|NCT01492426|158448227|FG000|Treatment|Poor compliance/noncompliance|1|||
49167077|NCT01492426|158448228|FG001|Treatment|Poor compliance/noncompliance|0|||
49167078|NCT01492426|158448227|FG000|Treatment|Subject requested discontinue study drug|7|||
49167079|NCT01492426|158448228|FG001|Treatment|Subject requested discontinue study drug|3|||
49167080|NCT01492426|158448227|FG000|Treatment|Lost to Follow-up|9|||
49167081|NCT01492426|158448228|FG001|Treatment|Lost to Follow-up|4|||
49167082|NCT01492426|158448227|FG000|Treatment|Participant does not meet study criteria|1|||
49167083|NCT01492426|158448228|FG001|Treatment|Participant does not meet study criteria|0|||
49167084|NCT01492426|158448227|FG000|Follow-Up|Protocol Requires no Follow-Up|2|||
49167085|NCT01492426|158448228|FG001|Follow-Up|Protocol Requires no Follow-Up|1|||
49167086|NCT01492426|158448227|FG000|Follow-Up|Death|1|||
49167087|NCT01492426|158448228|FG001|Follow-Up|Death|0|||
48925412|NCT00326898|157559370|FG002|Overall Study|Other/Missing/Unknown|32|||
49167088|NCT01492426|158448227|FG000|Follow-Up|Other|4|||
49167089|NCT01492426|158448228|FG001|Follow-Up|Other|2|||
49167090|NCT01492426|158448227|FG000|Follow-Up|Participant Withdrew Consent|6|||
49167091|NCT01492426|158448228|FG001|Follow-Up|Participant Withdrew Consent|1|||
49167092|NCT01492426|158448227|FG000|Follow-Up|Lost to Follow-up|12|||
49167093|NCT01492426|158448228|FG001|Follow-Up|Lost to Follow-up|6|||
49167094|NCT03549338|158448229|FG000|Overall Study|Progressive Disease|1|||
49167095|NCT03549338|158448230|FG001|Overall Study|Progressive Disease|0|||
49167096|NCT03549338|158448231|FG002|Overall Study|Progressive Disease|0|||
48841264|NCT04425629|157259312|FG012|Overall Study|Lack of Efficacy|0|||
48841265|NCT04425629|157259313|FG013|Overall Study|Lack of Efficacy|0|||
48925413|NCT00493870|157559372|FG000|Overall Study|Lost to Follow-up|12|||
48841266|NCT04425629|157259314|FG014|Overall Study|Lack of Efficacy|0|||
48841267|NCT04425629|157259315|FG015|Overall Study|Lack of Efficacy|0|||
49167097|NCT03549338|158448229|FG000|Overall Study|Clinical Progression|0|||
49014979|NCT05266456|157890485|FG002|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
49014980|NCT05266456|157890486|FG003|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
49014981|NCT05266456|157890483|FG000|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
49014982|NCT05266456|157890484|FG001|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
49014983|NCT05266456|157890485|FG002|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
49014984|NCT05266456|157890486|FG003|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|1|||
49014985|NCT05266456|157890483|FG000|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
49014986|NCT05266456|157890484|FG001|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
49014987|NCT05266456|157890485|FG002|Phase 2, Adults 50-64 Years|Lost to Follow-up|3|||
49014988|NCT05266456|157890486|FG003|Phase 2, Adults 50-64 Years|Lost to Follow-up|1|||
49014989|NCT05266456|157890483|FG000|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
49014990|NCT05266456|157890484|FG001|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
49014991|NCT05266456|157890485|FG002|Phase 2, Adults 50-64 Years|Withdrawal by Subject|2|||
49014992|NCT05266456|157890486|FG003|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
49014993|NCT05266456|157890483|FG000|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
49014994|NCT05266456|157890484|FG001|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
49014995|NCT05266456|157890485|FG002|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
49014996|NCT05266456|157890486|FG003|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
49014997|NCT02087046|157890496|FG000|Overall Study|Adverse Event|4|||
49014998|NCT02087046|157890496|FG000|Overall Study|Death|1|||
49014999|NCT02087046|157890496|FG000|Overall Study|Lost to Follow-up|3|||
49015000|NCT02087046|157890496|FG000|Overall Study|Withdrawal by Subject|2|||
49015001|NCT02087046|157890496|FG000|Overall Study|Physician Decision|1|||
49015002|NCT01618266|157890497|FG000|Overall Study|Lost to Follow-up|9|||
49015003|NCT01618266|157890497|FG000|Overall Study|Treatment satisfaction|10|||
49015004|NCT01618266|157890497|FG000|Overall Study|Other reasons|11|||
49015005|NCT01618266|157890497|FG000|Overall Study|Lack of Efficacy|23|||
49015006|NCT01618266|157890497|FG000|Overall Study|Protocol Violation|43|||
49015007|NCT00891293|157890498|FG000|Overall Study|Adverse Event|2|||
49015008|NCT00891293|157890498|FG000|Overall Study|Protocol Violation|2|||
49167098|NCT03549338|158448230|FG001|Overall Study|Clinical Progression|1|||
49167099|NCT03549338|158448231|FG002|Overall Study|Clinical Progression|0|||
49167100|NCT01133665|158448232|FG000|Overall Study|Physician Decision|2|||
49167101|NCT00529243|158448234|FG000|Overall Study|Adverse Event|1|||
49167102|NCT00529243|158448234|FG000|Overall Study|Death|1|||
49167103|NCT00529243|158448234|FG000|Overall Study|Relocated|1|||
49167104|NCT02549989|158448244|FG000|Overall Study|Adverse Event|4|||
49167105|NCT02549989|158448244|FG000|Overall Study|Death|1|||
49167106|NCT02549989|158448244|FG000|Overall Study|Lack of Efficacy|19|||
49167107|NCT02549989|158448244|FG000|Overall Study|Withdrawal by Subject|3|||
49167108|NCT00972023|158448245|FG000|Overall Study|Withdrawal by Subject|1|||
49167109|NCT00532129|158448246|FG000|Treatment Period|Adverse event/Serious adverse event|25|||
49167110|NCT00532129|158448246|FG000|Treatment Period|Physician Decision|15|||
49167111|NCT00532129|158448246|FG000|Treatment Period|Disease progression|3|||
49167112|NCT00532129|158448246|FG000|Treatment Period|Protocol Violation|1|||
49167113|NCT00532129|158448246|FG000|Treatment Period|Other|5|||
49167114|NCT00532129|158448246|FG000|Follow-up Period|Adverse event/Serious adverse event|1|||
49167115|NCT00532129|158448246|FG000|Follow-up Period|Disease progression|57|||
49167116|NCT00532129|158448246|FG000|Follow-up Period|Lost to Follow-up|1|||
49167117|NCT00532129|158448246|FG000|Follow-up Period|Other|6|||
49167118|NCT01333722|158448247|FG000|Overall Study|Lack of Efficacy|0|||
49167119|NCT01333722|158448248|FG001|Overall Study|Lack of Efficacy|2|||
49167120|NCT01333722|158448247|FG000|Overall Study|Withdrawal by Subject|0|||
49167121|NCT01333722|158448248|FG001|Overall Study|Withdrawal by Subject|1|||
49167122|NCT00443703|158448249|FG000|Overall Study|Never Treated|3|||
49167123|NCT00443703|158448250|FG001|Overall Study|Never Treated|1|||
49167124|NCT00443703|158448249|FG000|Overall Study|Adverse Event|7|||
49167125|NCT00443703|158448250|FG001|Overall Study|Adverse Event|3|||
49167126|NCT00443703|158448249|FG000|Overall Study|Lack of Efficacy|3|||
49167127|NCT00443703|158448250|FG001|Overall Study|Lack of Efficacy|1|||
49167128|NCT00443703|158448249|FG000|Overall Study|Lost to Follow-up|0|||
49167129|NCT00443703|158448250|FG001|Overall Study|Lost to Follow-up|4|||
49167130|NCT00443703|158448249|FG000|Overall Study|Physician Decision|4|||
49167131|NCT00443703|158448250|FG001|Overall Study|Physician Decision|2|||
49167132|NCT00443703|158448249|FG000|Overall Study|Protocol Violation|1|||
49167133|NCT00443703|158448250|FG001|Overall Study|Protocol Violation|1|||
49167134|NCT00443703|158448249|FG000|Overall Study|Withdrawal by Subject|9|||
49167135|NCT00443703|158448250|FG001|Overall Study|Withdrawal by Subject|6|||
49167136|NCT00443703|158448249|FG000|Overall Study|Progressive Disease|1|||
49167137|NCT00443703|158448250|FG001|Overall Study|Progressive Disease|0|||
49167138|NCT04776161|158448251|FG000|Overall Study|Withdrew after randomization but prior to intervention|1|||
49167139|NCT04776161|158448252|FG001|Overall Study|Withdrew after randomization but prior to intervention|3|||
49167140|NCT04776161|158448253|FG002|Overall Study|Withdrew after randomization but prior to intervention|2|||
49167141|NCT04776161|158448251|FG000|Overall Study|Withdrawal by Subject|1|||
49167142|NCT04776161|158448252|FG001|Overall Study|Withdrawal by Subject|0|||
49167143|NCT04776161|158448253|FG002|Overall Study|Withdrawal by Subject|1|||
49167144|NCT04776161|158448251|FG000|Overall Study|Adverse Event|0|||
49167145|NCT04776161|158448252|FG001|Overall Study|Adverse Event|1|||
49167146|NCT04776161|158448253|FG002|Overall Study|Adverse Event|1|||
49167147|NCT03759600|158448255|FG000|Overall Study|Adverse Event|2|||
49167148|NCT03759600|158448255|FG000|Overall Study|Progressive Disease|15|||
49167149|NCT03759600|158448255|FG000|Overall Study|Site Terminated by Sponsor|3|||
49167150|NCT00756275|158448256|FG000|Overall Study|Lost to Follow-up|25|||
49167151|NCT00756275|158448257|FG001|Overall Study|Lost to Follow-up|21|||
49167152|NCT00756275|158448256|FG000|Overall Study|Withdrawal by Subject|4|||
49167153|NCT00756275|158448257|FG001|Overall Study|Withdrawal by Subject|7|||
48841268|NCT04425629|157259316|FG016|Overall Study|Lack of Efficacy|0|||
48841269|NCT04425629|157259317|FG017|Overall Study|Lack of Efficacy|0|||
48841270|NCT04425629|157259318|FG018|Overall Study|Lack of Efficacy|0|||
48841271|NCT01111526|157259321|FG000|Overall Study|GVHD Disease Progression|0|||
48841272|NCT01111526|157259322|FG001|Overall Study|GVHD Disease Progression|1|||
48841273|NCT01111526|157259323|FG002|Overall Study|GVHD Disease Progression|2|||
49015009|NCT00891293|157890498|FG000|Overall Study|Laboratory abnormality|4|||
48841274|NCT04424641|157259324|FG000|Overall Study|Death|1|||
48841275|NCT04424641|157259325|FG001|Overall Study|Death|2|||
48841276|NCT04424641|157259326|FG002|Overall Study|Death|3|||
48841277|NCT04424641|157259327|FG003|Overall Study|Death|0|||
49015010|NCT00891293|157890498|FG000|Overall Study|Lost to Follow-up|7|||
49015011|NCT00891293|157890498|FG000|Overall Study|Subject withdrew consent|7|||
49015012|NCT00891293|157890498|FG000|Overall Study|Sponsor termination|62|||
49015013|NCT00982410|157892041|FG000|3-month Follow-up Assessment|Could not reach to schedule|8|||
49015014|NCT00982410|157892042|FG001|3-month Follow-up Assessment|Could not reach to schedule|9|||
49015015|NCT00982410|157892041|FG000|3-month Follow-up Assessment|Scheduled, no-show|1|||
49015016|NCT00982410|157892042|FG001|3-month Follow-up Assessment|Scheduled, no-show|2|||
49015017|NCT00982410|157892041|FG000|3-month Follow-up Assessment|Withdrawal by Subject|0|||
49015018|NCT00982410|157892042|FG001|3-month Follow-up Assessment|Withdrawal by Subject|2|||
49015019|NCT00982410|157892041|FG000|6-month Follow-up Assessment|Could not reach to schedule|5|||
49015020|NCT00982410|157892042|FG001|6-month Follow-up Assessment|Could not reach to schedule|7|||
49015021|NCT00982410|157892041|FG000|6-month Follow-up Assessment|participant no transportation|1|||
49015022|NCT00982410|157892042|FG001|6-month Follow-up Assessment|participant no transportation|0|||
49015023|NCT00982410|157892041|FG000|6-month Follow-up Assessment|incarceration|0|||
49015024|NCT00982410|157892042|FG001|6-month Follow-up Assessment|incarceration|2|||
49015025|NCT00982410|157892041|FG000|6-month Follow-up Assessment|patent surgery|0|||
49015026|NCT00982410|157892042|FG001|6-month Follow-up Assessment|patent surgery|1|||
49015027|NCT00982410|157892041|FG000|6-month Follow-up Assessment|scheduled, no-show|0|||
49015028|NCT00982410|157892042|FG001|6-month Follow-up Assessment|scheduled, no-show|1|||
49015029|NCT00982410|157892041|FG000|12-month Follow-up Assessment|Death|0|||
49015030|NCT00982410|157892042|FG001|12-month Follow-up Assessment|Death|2|||
49015031|NCT00982410|157892041|FG000|12-month Follow-up Assessment|could not reach to schedule|6|||
49015032|NCT00982410|157892042|FG001|12-month Follow-up Assessment|could not reach to schedule|5|||
49015033|NCT00982410|157892041|FG000|12-month Follow-up Assessment|Withdrawal by Subject|0|||
49015034|NCT00982410|157892042|FG001|12-month Follow-up Assessment|Withdrawal by Subject|1|||
49015035|NCT00982410|157892041|FG000|12-month Follow-up Assessment|incarceration|2|||
49015036|NCT00982410|157892042|FG001|12-month Follow-up Assessment|incarceration|1|||
49015037|NCT00982410|157892041|FG000|12-month Follow-up Assessment|scheduled, no-show|1|||
49015038|NCT00982410|157892042|FG001|12-month Follow-up Assessment|scheduled, no-show|0|||
49015039|NCT02919475|157892045|FG000|Overall Study|Adverse Event|3|||
49015040|NCT02919475|157892046|FG001|Overall Study|Adverse Event|3|||
49015041|NCT02919475|157892047|FG002|Overall Study|Adverse Event|3|||
49015042|NCT02919475|157892048|FG003|Overall Study|Adverse Event|9|||
49167154|NCT02257242|158448258|FG000|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|1|||
49167155|NCT02257242|158448259|FG001|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
49167156|NCT02257242|158448260|FG002|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
49167157|NCT02257242|158448261|FG003|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
49167158|NCT02257242|158448262|FG004|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
49167159|NCT02257242|158448263|FG005|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
49167160|NCT02257242|158448264|FG006|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
49167161|NCT02257242|158448265|FG007|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
49167162|NCT02257242|158448266|FG008|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
49167163|NCT01747915|158448267|FG000|Overall Study|Other|1|||
49167164|NCT01747915|158448268|FG001|Overall Study|Other|1|||
49167165|NCT01747915|158448269|FG002|Overall Study|Other|1|||
49167166|NCT01747915|158448267|FG000|Overall Study|Adverse Event|8|||
49167167|NCT01747915|158448268|FG001|Overall Study|Adverse Event|5|||
49167168|NCT01747915|158448269|FG002|Overall Study|Adverse Event|2|||
49167169|NCT01747915|158448267|FG000|Overall Study|Death|0|||
49167170|NCT01747915|158448268|FG001|Overall Study|Death|0|||
49167171|NCT01747915|158448269|FG002|Overall Study|Death|1|||
49167172|NCT01747915|158448267|FG000|Overall Study|Lack of Efficacy|0|||
49167173|NCT01747915|158448268|FG001|Overall Study|Lack of Efficacy|1|||
49167174|NCT01747915|158448269|FG002|Overall Study|Lack of Efficacy|0|||
49167175|NCT01747915|158448267|FG000|Overall Study|Lost to Follow-up|1|||
49167176|NCT01747915|158448268|FG001|Overall Study|Lost to Follow-up|0|||
49167177|NCT01747915|158448269|FG002|Overall Study|Lost to Follow-up|0|||
49167178|NCT01747915|158448267|FG000|Overall Study|Withdrawal by Subject|4|||
49015043|NCT02919475|157892049|FG004|Overall Study|Adverse Event|2|||
49015044|NCT02919475|157892045|FG000|Overall Study|Death|0|||
49015045|NCT02919475|157892046|FG001|Overall Study|Death|1|||
49015046|NCT02919475|157892047|FG002|Overall Study|Death|0|||
49015047|NCT02919475|157892048|FG003|Overall Study|Death|0|||
49015048|NCT02919475|157892049|FG004|Overall Study|Death|0|||
49015049|NCT02919475|157892045|FG000|Overall Study|Lost to Follow-up|0|||
49015050|NCT02919475|157892046|FG001|Overall Study|Lost to Follow-up|0|||
49015051|NCT02919475|157892047|FG002|Overall Study|Lost to Follow-up|0|||
49015052|NCT02919475|157892048|FG003|Overall Study|Lost to Follow-up|1|||
49015053|NCT02919475|157892049|FG004|Overall Study|Lost to Follow-up|0|||
49015054|NCT02919475|157892045|FG000|Overall Study|Withdrawal by Subject|2|||
49015055|NCT02919475|157892046|FG001|Overall Study|Withdrawal by Subject|3|||
49015056|NCT02919475|157892047|FG002|Overall Study|Withdrawal by Subject|1|||
49015057|NCT02919475|157892048|FG003|Overall Study|Withdrawal by Subject|2|||
49015058|NCT02919475|157892049|FG004|Overall Study|Withdrawal by Subject|2|||
49015059|NCT02919475|157892045|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
49015060|NCT02919475|157892046|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
49015061|NCT02919475|157892047|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
49015062|NCT02919475|157892048|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
49015063|NCT02919475|157892049|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
49015064|NCT04014959|157892050|FG000|Baseline MRI and Assessments|Physician Decision|2|||
49015065|NCT04014959|157892050|FG000|Targeting TMS Scan|Lost to Follow-up|1|||
49015066|NCT04014959|157892050|FG000|Mini TMS Sessions (3 Visits)|Withdrawal by Subject|1|||
49015067|NCT00827827|157892055|FG000|Overall Study|Lost to Follow-up|3|||
49015068|NCT00827827|157892056|FG001|Overall Study|Lost to Follow-up|0|||
49015069|NCT00827827|157892055|FG000|Overall Study|Fall at home- hospitalization|1|||
49015070|NCT00827827|157892056|FG001|Overall Study|Fall at home- hospitalization|0|||
49015071|NCT00827827|157892055|FG000|Overall Study|Another cerebrovascular accident (CVA)|1|||
49015072|NCT00827827|157892056|FG001|Overall Study|Another cerebrovascular accident (CVA)|0|||
49015073|NCT00827827|157892055|FG000|Overall Study|Gout|1|||
49015074|NCT00827827|157892056|FG001|Overall Study|Gout|0|||
49015075|NCT00827827|157892055|FG000|Overall Study|Transportation issues|1|||
49015076|NCT00827827|157892056|FG001|Overall Study|Transportation issues|0|||
49015077|NCT00827827|157892055|FG000|Overall Study|Burned with water at home|1|||
49015078|NCT00827827|157892056|FG001|Overall Study|Burned with water at home|0|||
49015079|NCT02742090|157892058|FG000|Overall Study|Adverse Event|10|||
49015080|NCT02742090|157892058|FG000|Overall Study|Death|3|||
49015081|NCT02742090|157892058|FG000|Overall Study|Disease Progression|25|||
49015082|NCT02742090|157892058|FG000|Overall Study|Investigator's Decision|1|||
49015083|NCT02742090|157892058|FG000|Overall Study|Lost to Follow-up|1|||
49015084|NCT02742090|157892058|FG000|Overall Study|Non-compliance with Study|1|||
49015085|NCT02742090|157892058|FG000|Overall Study|Sponsor Discontinuation of the Study|5|||
49015086|NCT02742090|157892058|FG000|Overall Study|Withdrawal by Subject|4|||
49015087|NCT02742090|157892058|FG000|Overall Study|Reason Not Specified|1|||
49015088|NCT02058628|157892059|FG000|Overall Study|Adverse Event|1|||
49015089|NCT02058628|157892060|FG001|Overall Study|Adverse Event|0|||
49015090|NCT02058628|157892059|FG000|Overall Study|Withdrawal by Subject|2|||
48841278|NCT04424641|157259328|FG004|Overall Study|Death|3|||
48841279|NCT04424641|157259329|FG005|Overall Study|Death|0|||
48841280|NCT04424641|157259330|FG006|Overall Study|Death|1|||
48841281|NCT04424641|157259331|FG007|Overall Study|Death|2|||
49167179|NCT01747915|158448268|FG001|Overall Study|Withdrawal by Subject|4|||
49167180|NCT01747915|158448269|FG002|Overall Study|Withdrawal by Subject|1|||
49167181|NCT01747915|158448267|FG000|Overall Study|Protocol Violation|1|||
49167182|NCT01747915|158448268|FG001|Overall Study|Protocol Violation|0|||
49167183|NCT01747915|158448269|FG002|Overall Study|Protocol Violation|0|||
49167184|NCT01747915|158448267|FG000|Overall Study|Pregnancy|0|||
49167185|NCT01747915|158448268|FG001|Overall Study|Pregnancy|0|||
49167186|NCT01747915|158448269|FG002|Overall Study|Pregnancy|1|||
49167187|NCT00803738|158448270|FG000|Overall Study|Adverse Event|3|||
49167188|NCT00803738|158448271|FG001|Overall Study|Adverse Event|5|||
49167189|NCT00803738|158448270|FG000|Overall Study|Lost to Follow-up|4|||
49167190|NCT00803738|158448271|FG001|Overall Study|Lost to Follow-up|4|||
49167191|NCT00803738|158448270|FG000|Overall Study|Protocol Violation|18|||
49167192|NCT00803738|158448271|FG001|Overall Study|Protocol Violation|10|||
49167193|NCT00803738|158448270|FG000|Overall Study|Withdrawal by Subject|1|||
48925414|NCT00493870|157559373|FG001|Overall Study|Lost to Follow-up|15|||
49167194|NCT00803738|158448271|FG001|Overall Study|Withdrawal by Subject|4|||
49167195|NCT00803738|158448270|FG000|Overall Study|Lack of Efficacy|10|||
49167196|NCT00803738|158448271|FG001|Overall Study|Lack of Efficacy|16|||
49167197|NCT00803738|158448270|FG000|Overall Study|Negative Baseline Culture of Candida|56|||
49167198|NCT00803738|158448271|FG001|Overall Study|Negative Baseline Culture of Candida|63|||
49167199|NCT00803738|158448270|FG000|Overall Study|Positive Results for STD or abnormal PAP|2|||
49167200|NCT00803738|158448271|FG001|Overall Study|Positive Results for STD or abnormal PAP|8|||
48841282|NCT04424641|157259324|FG000|Overall Study|Sponsor decision|0|||
48841283|NCT04424641|157259325|FG001|Overall Study|Sponsor decision|2|||
49167201|NCT00856635|158448275|FG000|Overall Study|Lost to Follow-up|2|||
49167202|NCT00856635|158448276|FG001|Overall Study|Lost to Follow-up|5|||
49167203|NCT00856635|158448275|FG000|Overall Study|Pregnancy|1|||
49167204|NCT00856635|158448276|FG001|Overall Study|Pregnancy|0|||
49167205|NCT00856635|158448275|FG000|Overall Study|Withdrawal by Subject|3|||
49167206|NCT00856635|158448276|FG001|Overall Study|Withdrawal by Subject|1|||
49167207|NCT00856635|158448275|FG000|Overall Study|Serious Adverse Event|1|||
49167208|NCT00856635|158448276|FG001|Overall Study|Serious Adverse Event|0|||
49167209|NCT00856635|158448275|FG000|Overall Study|Other|1|||
49167210|NCT00856635|158448276|FG001|Overall Study|Other|0|||
49167211|NCT00856635|158448275|FG000|Overall Study|Discontinued at Randomization|2|||
49167212|NCT00856635|158448276|FG001|Overall Study|Discontinued at Randomization|2|||
49167213|NCT01244035|158448277|FG000|Part 1: Period 1|Adverse Event|0|||
49167214|NCT01244035|158448278|FG001|Part 1: Period 1|Adverse Event|0|||
49167215|NCT01244035|158448279|FG002|Part 1: Period 1|Adverse Event|0|||
49167216|NCT01244035|158448280|FG003|Part 1: Period 1|Adverse Event|0|||
49167217|NCT01244035|158448281|FG004|Part 1: Period 1|Adverse Event|0|||
49167218|NCT01244035|158448282|FG005|Part 1: Period 1|Adverse Event|1|||
49167219|NCT01244035|158448277|FG000|Part 1: Period 1|Withdrawal by Subject|0|||
49167220|NCT01244035|158448278|FG001|Part 1: Period 1|Withdrawal by Subject|2|||
49167221|NCT01244035|158448279|FG002|Part 1: Period 1|Withdrawal by Subject|0|||
49167222|NCT01244035|158448280|FG003|Part 1: Period 1|Withdrawal by Subject|0|||
49167223|NCT01244035|158448281|FG004|Part 1: Period 1|Withdrawal by Subject|0|||
49167224|NCT01244035|158448282|FG005|Part 1: Period 1|Withdrawal by Subject|0|||
49167225|NCT01244035|158448277|FG000|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
49167226|NCT01244035|158448278|FG001|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
49167227|NCT01244035|158448279|FG002|Part 1: Period 1|Fulfilled Stopping Criteria|2|||
49167228|NCT01244035|158448280|FG003|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
49167229|NCT01244035|158448281|FG004|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
49167230|NCT01244035|158448282|FG005|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
49167231|NCT01244035|158448277|FG000|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
49167232|NCT01244035|158448278|FG001|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
49167233|NCT01244035|158448279|FG002|Part 1: Period 2|Fulfilled Stopping Criteria|1|||
49167234|NCT01244035|158448280|FG003|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
49167235|NCT01244035|158448281|FG004|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
49167236|NCT01244035|158448282|FG005|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
49167237|NCT01244035|158448277|FG000|Part 1: Period 3|Adverse Event|0|||
48841284|NCT04424641|157259326|FG002|Overall Study|Sponsor decision|3|||
48841285|NCT04424641|157259327|FG003|Overall Study|Sponsor decision|7|||
48841286|NCT04424641|157259328|FG004|Overall Study|Sponsor decision|2|||
48925415|NCT03733392|157559374|FG000|Overall Study|Withdrawal by Subject|11|||
49167238|NCT01244035|158448278|FG001|Part 1: Period 3|Adverse Event|0|||
49167239|NCT01244035|158448279|FG002|Part 1: Period 3|Adverse Event|0|||
49167240|NCT01244035|158448280|FG003|Part 1: Period 3|Adverse Event|0|||
49167241|NCT01244035|158448281|FG004|Part 1: Period 3|Adverse Event|0|||
49167242|NCT01244035|158448282|FG005|Part 1: Period 3|Adverse Event|1|||
49167243|NCT01244035|158448277|FG000|Part 1: Period 3|Withdrawal by Subject|0|||
49167244|NCT01244035|158448278|FG001|Part 1: Period 3|Withdrawal by Subject|0|||
49167245|NCT01244035|158448279|FG002|Part 1: Period 3|Withdrawal by Subject|0|||
49167246|NCT01244035|158448280|FG003|Part 1: Period 3|Withdrawal by Subject|0|||
49167247|NCT01244035|158448281|FG004|Part 1: Period 3|Withdrawal by Subject|1|||
49167248|NCT01244035|158448282|FG005|Part 1: Period 3|Withdrawal by Subject|0|||
49167249|NCT01244035|158448277|FG000|Part 1: Period 3|Protocol Deviation|0|||
49167250|NCT01244035|158448278|FG001|Part 1: Period 3|Protocol Deviation|1|||
49167251|NCT01244035|158448279|FG002|Part 1: Period 3|Protocol Deviation|0|||
49167252|NCT01244035|158448280|FG003|Part 1: Period 3|Protocol Deviation|0|||
49167253|NCT01244035|158448281|FG004|Part 1: Period 3|Protocol Deviation|0|||
49167254|NCT01244035|158448282|FG005|Part 1: Period 3|Protocol Deviation|0|||
49167255|NCT01694433|158448283|FG000|Overall Study|Adverse Event|7|||
49167256|NCT01694433|158448284|FG001|Overall Study|Adverse Event|0|||
49167257|NCT01694433|158448283|FG000|Overall Study|Physician Decision|1|||
49167258|NCT01694433|158448284|FG001|Overall Study|Physician Decision|0|||
49167259|NCT01694433|158448283|FG000|Overall Study|Withdrawal by Subject|3|||
49167260|NCT01694433|158448284|FG001|Overall Study|Withdrawal by Subject|4|||
49167261|NCT00374595|158448285|FG000|Overall Study|Death|23|||
49167262|NCT00374595|158448285|FG000|Overall Study|Withdrawal by Subject|39|||
49167263|NCT00374595|158448285|FG000|Overall Study|Lost to Follow-up|3|||
49167264|NCT00374595|158448285|FG000|Overall Study|too much time commitment|1|||
49167265|NCT00374595|158448285|FG000|Overall Study|transfer care to other clinical site|1|||
49167266|NCT00374595|158448285|FG000|Overall Study|relocation|3|||
49167267|NCT00375427|158448286|FG000|Overall Study|Adverse Event|21|||
49167268|NCT00375427|158448287|FG001|Overall Study|Adverse Event|27|||
49167269|NCT00375427|158448286|FG000|Overall Study|Abnormal test procedure result(s)|0|||
49167270|NCT00375427|158448287|FG001|Overall Study|Abnormal test procedure result(s)|1|||
49167271|NCT00375427|158448286|FG000|Overall Study|Abnormal laboratory value(s)|1|||
49167272|NCT00375427|158448287|FG001|Overall Study|Abnormal laboratory value(s)|2|||
48925416|NCT03733392|157559375|FG001|Overall Study|Withdrawal by Subject|1|||
48925417|NCT03733392|157559374|FG000|Overall Study|Death|1|||
49167273|NCT00375427|158448286|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
49167274|NCT00375427|158448287|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
49167275|NCT00375427|158448286|FG000|Overall Study|Patient no longer requires study drug|3|||
49167276|NCT00375427|158448287|FG001|Overall Study|Patient no longer requires study drug|7|||
49167277|NCT00375427|158448286|FG000|Overall Study|Protocol Violation|10|||
49167278|NCT00375427|158448287|FG001|Overall Study|Protocol Violation|8|||
49167279|NCT00375427|158448286|FG000|Overall Study|Withdrawal by Subject|9|||
49167280|NCT00375427|158448287|FG001|Overall Study|Withdrawal by Subject|13|||
48925418|NCT03733392|157559375|FG001|Overall Study|Death|0|||
48925419|NCT03733392|157559374|FG000|Overall Study|Lost to Follow-up|5|||
48925420|NCT03733392|157559375|FG001|Overall Study|Lost to Follow-up|0|||
48925421|NCT03733392|157559374|FG000|Overall Study|Protocol Violation|0|||
48925422|NCT03733392|157559375|FG001|Overall Study|Protocol Violation|1|||
49167281|NCT00375427|158448286|FG000|Overall Study|Lost to Follow-up|1|||
49167282|NCT00375427|158448287|FG001|Overall Study|Lost to Follow-up|1|||
49167283|NCT00375427|158448286|FG000|Overall Study|Administrative reasons|0|||
49167284|NCT00375427|158448287|FG001|Overall Study|Administrative reasons|1|||
49167285|NCT00375427|158448286|FG000|Overall Study|Death|11|||
49167286|NCT00375427|158448287|FG001|Overall Study|Death|10|||
49167287|NCT01106157|158448288|FG000|Overall Study|Withdrawal by Subject|1|||
49167288|NCT01106157|158448289|FG001|Overall Study|Withdrawal by Subject|0|||
49167289|NCT03230318|158448290|FG000|Overall Study|Radiographic disease progression|72|||
49167290|NCT03230318|158448291|FG001|Overall Study|Radiographic disease progression|19|||
49167291|NCT03230318|158448290|FG000|Overall Study|Clinical progression|17|||
49167292|NCT03230318|158448291|FG001|Overall Study|Clinical progression|7|||
49167293|NCT03230318|158448290|FG000|Overall Study|Adverse Event|5|||
48925423|NCT03733392|157559374|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
48925424|NCT03733392|157559375|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
48925425|NCT03733392|157559374|FG000|Overall Study|Incomplete Ablation or Ablation not done|0|||
48925426|NCT03733392|157559375|FG001|Overall Study|Incomplete Ablation or Ablation not done|5|||
48925427|NCT03733392|157559374|FG000|Overall Study|Patient Non-Compliance|2|||
48925428|NCT03733392|157559375|FG001|Overall Study|Patient Non-Compliance|1|||
48925429|NCT03733392|157559374|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|12|||
48951828|NCT00084682|157654907|FG000|Overall Study|Withdrawal by Subject|1|||
49167294|NCT03230318|158448291|FG001|Overall Study|Adverse Event|3|||
49167295|NCT03230318|158448290|FG000|Overall Study|Physician Decision|2|||
49167296|NCT03230318|158448291|FG001|Overall Study|Physician Decision|3|||
49167297|NCT03230318|158448290|FG000|Overall Study|Death|3|||
49167298|NCT03230318|158448291|FG001|Overall Study|Death|2|||
49167299|NCT03230318|158448290|FG000|Overall Study|Lost to Follow-up|1|||
49167300|NCT03230318|158448291|FG001|Overall Study|Lost to Follow-up|0|||
49167301|NCT03230318|158448290|FG000|Overall Study|Withdrawal by Subject|1|||
49167302|NCT03230318|158448291|FG001|Overall Study|Withdrawal by Subject|3|||
49167303|NCT03230318|158448290|FG000|Overall Study|Other|3|||
49167304|NCT03230318|158448291|FG001|Overall Study|Other|7|||
49167305|NCT01722994|158448292|FG000|Overall Study|Missing data|25|||
49167306|NCT01722994|158448293|FG001|Overall Study|Missing data|17|||
49167307|NCT00269087|158448295|FG000|Overall Study|Adverse Event|20|||
49167308|NCT00269087|158448295|FG000|Overall Study|Withdrawal by Subject|1|||
49167309|NCT00269087|158448295|FG000|Overall Study|Exacerbation of COPD|13|||
49167310|NCT00041470|158448296|FG000|Overall Study|Loss of Funding|38|||
49167311|NCT04389866|158448297|FG000|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
49167312|NCT04389866|158448298|FG001|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
49167313|NCT01541865|158448301|FG000|Overall Study|Lost to Follow-up|11|||
49167314|NCT01541865|158448301|FG000|Overall Study|Withdrawal by Subject|9|||
48925430|NCT03733392|157559375|FG001|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|0|||
48925431|NCT03733392|157559374|FG000|Overall Study|Withdrawal prior to procedure|5|||
48925432|NCT03733392|157559375|FG001|Overall Study|Withdrawal prior to procedure|2|||
48925433|NCT05594173|157559378|FG000|Overall Study|Adverse Event|1|||
48925434|NCT05594173|157559378|FG000|Overall Study|COVID-19 Pandemic|2|||
48925435|NCT00883337|157559379|FG000|Core Treatment Period|Adverse Event|9|||
48925436|NCT00883337|157559380|FG001|Core Treatment Period|Adverse Event|12|||
48925437|NCT00883337|157559381|FG002|Core Treatment Period|Adverse Event|22|||
48925438|NCT00883337|157559379|FG000|Core Treatment Period|Lack of Efficacy|7|||
48925439|NCT00883337|157559380|FG001|Core Treatment Period|Lack of Efficacy|4|||
48925440|NCT00883337|157559381|FG002|Core Treatment Period|Lack of Efficacy|2|||
48925441|NCT00883337|157559379|FG000|Core Treatment Period|Lost to Follow-up|1|||
48925442|NCT00883337|157559380|FG001|Core Treatment Period|Lost to Follow-up|1|||
48925443|NCT00883337|157559381|FG002|Core Treatment Period|Lost to Follow-up|0|||
48925444|NCT00883337|157559379|FG000|Core Treatment Period|Withdrawal by Subject|2|||
48925445|NCT00883337|157559380|FG001|Core Treatment Period|Withdrawal by Subject|2|||
48925446|NCT00883337|157559381|FG002|Core Treatment Period|Withdrawal by Subject|6|||
48925447|NCT00883337|157559379|FG000|Core Treatment Period|Wish to be pregnant|1|||
48925448|NCT00883337|157559380|FG001|Core Treatment Period|Wish to be pregnant|2|||
48925449|NCT00883337|157559381|FG002|Core Treatment Period|Wish to be pregnant|1|||
48925450|NCT00883337|157559379|FG000|Core Treatment Period|Poor compliance to protocol|0|||
48925451|NCT00883337|157559380|FG001|Core Treatment Period|Poor compliance to protocol|0|||
48925452|NCT00883337|157559381|FG002|Core Treatment Period|Poor compliance to protocol|1|||
48925453|NCT00883337|157559379|FG000|Core Treatment Period|Other than above|0|||
48925454|NCT00883337|157559380|FG001|Core Treatment Period|Other than above|1|||
48925455|NCT00883337|157559381|FG002|Core Treatment Period|Other than above|1|||
49167315|NCT01541865|158448301|FG000|Overall Study|Adverse Event|1|||
49167316|NCT01541865|158448301|FG000|Overall Study|Protocol Violation|1|||
49167317|NCT02967679|158448304|FG000|Overall Study|Adverse Event|1|||
49167318|NCT00703963|158448305|FG000|Overall Study|Withdrawal by Subject|7|||
49167319|NCT00703963|158448306|FG001|Overall Study|Withdrawal by Subject|13|||
49167320|NCT00703963|158448305|FG000|Overall Study|Physician Decision|0|||
49167321|NCT00703963|158448306|FG001|Overall Study|Physician Decision|1|||
49167322|NCT03768089|158448310|FG000|Part A|Lost to Follow-up|0|||
49167323|NCT03768089|158448311|FG001|Part A|Lost to Follow-up|0|||
49167324|NCT03768089|158448312|FG002|Part A|Lost to Follow-up|0|||
49167325|NCT03768089|158448313|FG003|Part A|Lost to Follow-up|0|||
49167326|NCT03768089|158448314|FG004|Part A|Lost to Follow-up|1|||
49167327|NCT03768089|158448315|FG005|Part A|Lost to Follow-up|0|||
49167328|NCT03768089|158448316|FG006|Part A|Lost to Follow-up|0|||
49167329|NCT03768089|158448317|FG007|Part A|Lost to Follow-up|0|||
49167330|NCT03768089|158448318|FG008|Part A|Lost to Follow-up|0|||
49167331|NCT03768089|158448319|FG009|Part A|Lost to Follow-up|0|||
49167332|NCT03768089|158448320|FG010|Part A|Lost to Follow-up|0|||
49167333|NCT03768089|158448321|FG011|Part A|Lost to Follow-up|0|||
49167334|NCT03768089|158448322|FG012|Part A|Lost to Follow-up|0|||
49167335|NCT03768089|158448323|FG013|Part A|Lost to Follow-up|0|||
49167336|NCT03768089|158448324|FG014|Part A|Lost to Follow-up|0|||
49167337|NCT03768089|158448325|FG015|Part A|Lost to Follow-up|0|||
49167338|NCT03768089|158448326|FG016|Part A|Lost to Follow-up|0|||
49167339|NCT03768089|158448327|FG017|Part A|Lost to Follow-up|0|||
48925456|NCT00883337|157559379|FG000|Extension Treatment Period|Adverse Event|8|||
48925457|NCT00883337|157559380|FG001|Extension Treatment Period|Adverse Event|5|||
48925458|NCT00883337|157559381|FG002|Extension Treatment Period|Adverse Event|5|||
48925459|NCT00883337|157559379|FG000|Extension Treatment Period|Lack of Efficacy|8|||
49167340|NCT03768089|158448310|FG000|Part C|Randomized, Never Dosed|0|||
49167341|NCT03768089|158448311|FG001|Part C|Randomized, Never Dosed|0|||
49167342|NCT03768089|158448312|FG002|Part C|Randomized, Never Dosed|0|||
49167343|NCT03768089|158448313|FG003|Part C|Randomized, Never Dosed|0|||
49167344|NCT03768089|158448314|FG004|Part C|Randomized, Never Dosed|0|||
49167345|NCT03768089|158448315|FG005|Part C|Randomized, Never Dosed|0|||
49167346|NCT03768089|158448316|FG006|Part C|Randomized, Never Dosed|0|||
49167347|NCT03768089|158448317|FG007|Part C|Randomized, Never Dosed|0|||
49167348|NCT03768089|158448318|FG008|Part C|Randomized, Never Dosed|0|||
49167349|NCT03768089|158448319|FG009|Part C|Randomized, Never Dosed|0|||
49167350|NCT03768089|158448320|FG010|Part C|Randomized, Never Dosed|0|||
49167351|NCT03768089|158448321|FG011|Part C|Randomized, Never Dosed|0|||
49167352|NCT03768089|158448322|FG012|Part C|Randomized, Never Dosed|0|||
49167353|NCT03768089|158448323|FG013|Part C|Randomized, Never Dosed|0|||
49167354|NCT03768089|158448324|FG014|Part C|Randomized, Never Dosed|1|||
49167355|NCT03768089|158448325|FG015|Part C|Randomized, Never Dosed|0|||
49167356|NCT03768089|158448326|FG016|Part C|Randomized, Never Dosed|0|||
49167357|NCT03768089|158448327|FG017|Part C|Randomized, Never Dosed|0|||
49167358|NCT02103062|158448328|FG000|Overall Study|Adverse Event|1|||
49167359|NCT02103062|158448329|FG001|Overall Study|Adverse Event|2|||
49167360|NCT02103062|158448328|FG000|Overall Study|Progressive Disease|17|||
49167361|NCT02103062|158448329|FG001|Overall Study|Progressive Disease|20|||
49167362|NCT02103062|158448328|FG000|Overall Study|Death|0|||
49167363|NCT02103062|158448329|FG001|Overall Study|Death|1|||
49167364|NCT03902392|158448330|FG000|Overall Study|Lost to Follow-up|7|||
49167365|NCT03902392|158448331|FG001|Overall Study|Lost to Follow-up|7|||
49167366|NCT02382991|158448338|FG000|Overall Study|Adverse Event|1|||
49167367|NCT02382991|158448339|FG001|Overall Study|Adverse Event|2|||
49167368|NCT02382991|158448338|FG000|Overall Study|Lost to Follow-up|1|||
49167369|NCT02382991|158448339|FG001|Overall Study|Lost to Follow-up|0|||
49167370|NCT02382991|158448338|FG000|Overall Study|Withdrawal by Subject|0|||
49167371|NCT02382991|158448339|FG001|Overall Study|Withdrawal by Subject|1|||
49167372|NCT00833027|158448340|FG000|Overall Study|Adverse Event|33|||
49167373|NCT00833027|158448340|FG000|Overall Study|Death|1|||
49167374|NCT00833027|158448340|FG000|Overall Study|Lack of Efficacy|12|||
49167375|NCT00833027|158448340|FG000|Overall Study|Lost to Follow-up|24|||
49167376|NCT00833027|158448340|FG000|Overall Study|Protocol Violation|115|||
49167377|NCT00833027|158448340|FG000|Overall Study|Withdrawal by Subject|16|||
49167378|NCT00833027|158448340|FG000|Overall Study|Missing|10|||
49167379|NCT01445613|158448344|FG000|30-day Follow-up|Withdrawal by Subject|6|||
49167380|NCT01445613|158448344|FG000|30-day Follow-up|Physician Decision|3|||
49167381|NCT01445613|158448344|FG000|30-day Follow-up|Missed visit|23|||
49167382|NCT01445613|158448344|FG000|30-day Follow-up|Death|3|||
49167383|NCT01445613|158448344|FG000|1-year Follow-up|Withdrawal by Subject|12|||
49167384|NCT01445613|158448344|FG000|1-year Follow-up|Missed visit|29|||
49167385|NCT01445613|158448344|FG000|1-year Follow-up|Lost to Follow-up|2|||
49167386|NCT01445613|158448344|FG000|1-year Follow-up|Death|30|||
49167387|NCT01445613|158448344|FG000|1-year Follow-up|Physician Decision|2|||
49167388|NCT01445613|158448344|FG000|1-year Follow-up|Received a non-study stent|2|||
49167389|NCT02063984|158448345|FG000|Overall Study|Lost to Follow-up|6|||
49167390|NCT02063984|158448346|FG001|Overall Study|Lost to Follow-up|5|||
49167391|NCT03599518|158448347|FG000|Overall Study|Clinical progression|0|||
49167392|NCT03599518|158448348|FG001|Overall Study|Clinical progression|0|||
49167393|NCT03599518|158448349|FG002|Overall Study|Clinical progression|0|||
49167394|NCT03599518|158448350|FG003|Overall Study|Clinical progression|0|||
49167395|NCT03599518|158448351|FG004|Overall Study|Clinical progression|1|||
49167396|NCT03599518|158448347|FG000|Overall Study|Adverse Event|0|||
49167397|NCT03599518|158448348|FG001|Overall Study|Adverse Event|0|||
49167398|NCT03599518|158448349|FG002|Overall Study|Adverse Event|0|||
49167399|NCT03599518|158448350|FG003|Overall Study|Adverse Event|0|||
49167400|NCT03599518|158448351|FG004|Overall Study|Adverse Event|1|||
49167401|NCT03599518|158448347|FG000|Overall Study|Progressive disease as per RECIST v1.1|5|||
49167402|NCT03599518|158448348|FG001|Overall Study|Progressive disease as per RECIST v1.1|4|||
49167403|NCT03599518|158448349|FG002|Overall Study|Progressive disease as per RECIST v1.1|5|||
49167404|NCT03599518|158448350|FG003|Overall Study|Progressive disease as per RECIST v1.1|1|||
49167405|NCT03599518|158448351|FG004|Overall Study|Progressive disease as per RECIST v1.1|2|||
48841287|NCT04424641|157259329|FG005|Overall Study|Sponsor decision|2|||
48841288|NCT04424641|157259330|FG006|Overall Study|Sponsor decision|3|||
48841289|NCT04424641|157259331|FG007|Overall Study|Sponsor decision|4|||
48841290|NCT04424641|157259324|FG000|Overall Study|Withdrawal by Subject|0|||
48841291|NCT04424641|157259325|FG001|Overall Study|Withdrawal by Subject|0|||
48841292|NCT04424641|157259326|FG002|Overall Study|Withdrawal by Subject|0|||
48841293|NCT04424641|157259327|FG003|Overall Study|Withdrawal by Subject|0|||
49167406|NCT03599518|158448347|FG000|Overall Study|Participant withdrawal from study treatment|0|||
49167407|NCT03599518|158448348|FG001|Overall Study|Participant withdrawal from study treatment|0|||
49167408|NCT03599518|158448349|FG002|Overall Study|Participant withdrawal from study treatment|1|||
49167409|NCT03599518|158448350|FG003|Overall Study|Participant withdrawal from study treatment|0|||
49167410|NCT03599518|158448351|FG004|Overall Study|Participant withdrawal from study treatment|0|||
49167411|NCT03497039|158448354|FG000|Overall Study|Withdrawal by Subject|1|||
49167412|NCT03497039|158448355|FG001|Overall Study|Withdrawal by Subject|0|||
49167413|NCT03497039|158448354|FG000|Overall Study|Protocol Violation|0|||
49167414|NCT03497039|158448355|FG001|Overall Study|Protocol Violation|1|||
48841294|NCT04424641|157259328|FG004|Overall Study|Withdrawal by Subject|1|||
49167415|NCT00436436|158448364|FG000|Overall Study|Progression|4|||
49167416|NCT00436436|158448364|FG000|Overall Study|Adverse Event|2|||
49167417|NCT00436436|158448364|FG000|Overall Study|Death|6|||
49167418|NCT00790582|158448366|FG000|Overall Study|Death|14|||
48841295|NCT04424641|157259329|FG005|Overall Study|Withdrawal by Subject|0|||
48841296|NCT04424641|157259330|FG006|Overall Study|Withdrawal by Subject|0|||
48841297|NCT04424641|157259331|FG007|Overall Study|Withdrawal by Subject|0|||
48841298|NCT04424641|157259324|FG000|Overall Study|Other|0|||
48841299|NCT04424641|157259325|FG001|Overall Study|Other|0|||
48841300|NCT04424641|157259326|FG002|Overall Study|Other|1|||
48841301|NCT04424641|157259327|FG003|Overall Study|Other|0|||
48841302|NCT04424641|157259328|FG004|Overall Study|Other|0|||
48925460|NCT00883337|157559380|FG001|Extension Treatment Period|Lack of Efficacy|8|||
48925461|NCT00883337|157559381|FG002|Extension Treatment Period|Lack of Efficacy|8|||
49167419|NCT00790582|158448367|FG001|Overall Study|Death|32|||
49167420|NCT00790582|158448366|FG000|Overall Study|Physician Decision|7|||
49167421|NCT00790582|158448367|FG001|Overall Study|Physician Decision|1|||
49167422|NCT00790582|158448366|FG000|Overall Study|Lost to Follow-up|3|||
49167423|NCT00790582|158448367|FG001|Overall Study|Lost to Follow-up|3|||
48841303|NCT04424641|157259329|FG005|Overall Study|Other|0|||
48841304|NCT04424641|157259330|FG006|Overall Study|Other|0|||
48925462|NCT00883337|157559379|FG000|Extension Treatment Period|Poor compliance to protocol|1|||
48925463|NCT00883337|157559380|FG001|Extension Treatment Period|Poor compliance to protocol|1|||
49167424|NCT00790582|158448366|FG000|Overall Study|Withdrawal by Subject|7|||
49167425|NCT00790582|158448367|FG001|Overall Study|Withdrawal by Subject|51|||
49167426|NCT03456700|158448368|FG000|Overall Study|Withdrawal by Subject|1|||
49167427|NCT01170273|158448369|FG000|Overall Study|Lost to Follow-up|6|||
49167428|NCT01170273|158448370|FG001|Overall Study|Lost to Follow-up|8|||
49167429|NCT01170273|158448369|FG000|Overall Study|Protocol Violation|1|||
48925464|NCT00883337|157559381|FG002|Extension Treatment Period|Poor compliance to protocol|1|||
48925465|NCT00883337|157559379|FG000|Extension Treatment Period|Lost to Follow-up|1|||
49167430|NCT01170273|158448370|FG001|Overall Study|Protocol Violation|0|||
49167431|NCT01170273|158448369|FG000|Overall Study|Death|1|||
49167432|NCT01170273|158448370|FG001|Overall Study|Death|0|||
49167433|NCT01170273|158448369|FG000|Overall Study|Adverse Event|0|||
49167434|NCT01170273|158448370|FG001|Overall Study|Adverse Event|1|||
49167435|NCT00347932|158450116|FG000|Overall Study|Adverse Event|4|||
49167436|NCT00347932|158450117|FG001|Overall Study|Adverse Event|5|||
49167437|NCT00347932|158450116|FG000|Overall Study|Lack of Efficacy|3|||
49167438|NCT00347932|158450117|FG001|Overall Study|Lack of Efficacy|14|||
49167439|NCT00347932|158450116|FG000|Overall Study|Lost to Follow-up|10|||
49167440|NCT00347932|158450117|FG001|Overall Study|Lost to Follow-up|9|||
49167441|NCT00347932|158450116|FG000|Overall Study|Withdrawal by Subject|10|||
49167442|NCT00347932|158450117|FG001|Overall Study|Withdrawal by Subject|16|||
48841305|NCT04424641|157259331|FG007|Overall Study|Other|0|||
48925466|NCT00883337|157559380|FG001|Extension Treatment Period|Lost to Follow-up|0|||
48925467|NCT00883337|157559381|FG002|Extension Treatment Period|Lost to Follow-up|0|||
48925468|NCT00883337|157559379|FG000|Extension Treatment Period|Other than above|10|||
48925469|NCT00883337|157559380|FG001|Extension Treatment Period|Other than above|9|||
48925470|NCT00883337|157559381|FG002|Extension Treatment Period|Other than above|5|||
48925471|NCT02615990|157559382|FG000|Overall Study|study terminated|1|||
48925472|NCT02615990|157559383|FG001|Overall Study|study terminated|1|||
48925473|NCT00130832|157559384|FG000|Overall Study|Adverse Event|1|||
49167443|NCT00347932|158450116|FG000|Overall Study|Did not meet inclusion criteria|4|||
49167444|NCT00347932|158450117|FG001|Overall Study|Did not meet inclusion criteria|8|||
49167445|NCT04512001|158450118|FG000|Week 0 to Week 24|Adverse Event|14|||
48841306|NCT00414544|157259334|FG000|Overall Study|Lost to Follow-up|14|||
48841307|NCT00186186|157259335|FG000|Overall Study|Lack of Efficacy|3|||
48841308|NCT00186186|157259335|FG000|Overall Study|Withdrawal by Subject|3|||
48925474|NCT00130832|157559385|FG001|Overall Study|Adverse Event|1|||
48925475|NCT00130832|157559384|FG000|Overall Study|Lost to Follow-up|1|||
49167446|NCT04512001|158450119|FG001|Week 0 to Week 24|Adverse Event|10|||
49167447|NCT04512001|158450120|FG002|Week 0 to Week 24|Adverse Event|0|||
49167448|NCT04512001|158450121|FG003|Week 0 to Week 24|Adverse Event|0|||
48925476|NCT00130832|157559385|FG001|Overall Study|Lost to Follow-up|2|||
48925477|NCT00130832|157559384|FG000|Overall Study|Protocol Violation|6|||
48925478|NCT00130832|157559385|FG001|Overall Study|Protocol Violation|8|||
48925479|NCT00130832|157559384|FG000|Overall Study|Withdrawal by Subject|6|||
48925480|NCT00130832|157559385|FG001|Overall Study|Withdrawal by Subject|1|||
48925481|NCT00130832|157559384|FG000|Overall Study|Moved|2|||
49167449|NCT04512001|158450122|FG004|Week 0 to Week 24|Adverse Event|0|||
49167450|NCT04512001|158450118|FG000|Week 0 to Week 24|Death|0|||
49167451|NCT04512001|158450119|FG001|Week 0 to Week 24|Death|2|||
49167452|NCT04512001|158450120|FG002|Week 0 to Week 24|Death|0|||
49167453|NCT04512001|158450121|FG003|Week 0 to Week 24|Death|0|||
49167454|NCT04512001|158450122|FG004|Week 0 to Week 24|Death|0|||
49167455|NCT04512001|158450118|FG000|Week 0 to Week 24|Withdrawal by Subject|16|||
49167456|NCT04512001|158450119|FG001|Week 0 to Week 24|Withdrawal by Subject|9|||
49167457|NCT04512001|158450120|FG002|Week 0 to Week 24|Withdrawal by Subject|0|||
49167458|NCT04512001|158450121|FG003|Week 0 to Week 24|Withdrawal by Subject|0|||
49167459|NCT04512001|158450122|FG004|Week 0 to Week 24|Withdrawal by Subject|0|||
49167460|NCT04512001|158450118|FG000|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
49167461|NCT04512001|158450119|FG001|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
49167462|NCT04512001|158450120|FG002|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
49167463|NCT04512001|158450121|FG003|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
49167464|NCT04512001|158450122|FG004|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
49167465|NCT04512001|158450118|FG000|Week 0 to Week 24|Withdrawal By Sponsor's Decision|1|||
49167466|NCT04512001|158450119|FG001|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
49167467|NCT04512001|158450120|FG002|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
49167468|NCT04512001|158450121|FG003|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
49167469|NCT04512001|158450122|FG004|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
49167470|NCT04512001|158450118|FG000|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
49167471|NCT04512001|158450119|FG001|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|1|||
49167472|NCT04512001|158450120|FG002|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
49167473|NCT04512001|158450121|FG003|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
49167474|NCT04512001|158450122|FG004|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
49167475|NCT04512001|158450118|FG000|Week 24 to Week 63|Adverse Event|0|||
49167476|NCT04512001|158450119|FG001|Week 24 to Week 63|Adverse Event|0|||
49167477|NCT04512001|158450120|FG002|Week 24 to Week 63|Adverse Event|13|||
49167478|NCT04512001|158450121|FG003|Week 24 to Week 63|Adverse Event|8|||
49167479|NCT04512001|158450122|FG004|Week 24 to Week 63|Adverse Event|6|||
49167480|NCT04512001|158450118|FG000|Week 24 to Week 63|Lost to Follow-up|0|||
49167481|NCT04512001|158450119|FG001|Week 24 to Week 63|Lost to Follow-up|0|||
49167482|NCT04512001|158450120|FG002|Week 24 to Week 63|Lost to Follow-up|1|||
49167483|NCT04512001|158450121|FG003|Week 24 to Week 63|Lost to Follow-up|1|||
49167484|NCT04512001|158450122|FG004|Week 24 to Week 63|Lost to Follow-up|1|||
49167485|NCT04512001|158450118|FG000|Week 24 to Week 63|Death|0|||
49167486|NCT04512001|158450119|FG001|Week 24 to Week 63|Death|0|||
49167487|NCT04512001|158450120|FG002|Week 24 to Week 63|Death|0|||
49167488|NCT04512001|158450121|FG003|Week 24 to Week 63|Death|1|||
49167489|NCT04512001|158450122|FG004|Week 24 to Week 63|Death|1|||
49167490|NCT04512001|158450118|FG000|Week 24 to Week 63|Withdrawal by Subject|0|||
49167491|NCT04512001|158450119|FG001|Week 24 to Week 63|Withdrawal by Subject|0|||
49167492|NCT04512001|158450120|FG002|Week 24 to Week 63|Withdrawal by Subject|6|||
49167493|NCT04512001|158450121|FG003|Week 24 to Week 63|Withdrawal by Subject|4|||
49167494|NCT04512001|158450122|FG004|Week 24 to Week 63|Withdrawal by Subject|6|||
48925482|NCT00130832|157559385|FG001|Overall Study|Moved|2|||
48925483|NCT00130832|157559384|FG000|Overall Study|Other|0|||
48925484|NCT00130832|157559385|FG001|Overall Study|Other|3|||
48925485|NCT02944448|157559386|FG000|Overall Study|Adverse Event|37|||
48925486|NCT02944448|157559387|FG001|Overall Study|Adverse Event|6|||
49167495|NCT04512001|158450118|FG000|Week 24 to Week 63|Miscellaneous|0|||
49167496|NCT04512001|158450119|FG001|Week 24 to Week 63|Miscellaneous|0|||
49167497|NCT04512001|158450120|FG002|Week 24 to Week 63|Miscellaneous|3|||
49167498|NCT04512001|158450121|FG003|Week 24 to Week 63|Miscellaneous|2|||
49167499|NCT04512001|158450122|FG004|Week 24 to Week 63|Miscellaneous|1|||
48925487|NCT02944448|157559386|FG000|Overall Study|Lack of Efficacy|8|||
49167500|NCT01724216|158450123|FG000|Overall Study|Scan was not completed|1|||
49167501|NCT01331681|158450124|FG000|Overall Study|Adverse Event|10|||
49167502|NCT01331681|158450125|FG001|Overall Study|Adverse Event|13|||
49167503|NCT01331681|158450126|FG002|Overall Study|Adverse Event|10|||
48925488|NCT02944448|157559387|FG001|Overall Study|Lack of Efficacy|5|||
49167504|NCT01331681|158450124|FG000|Overall Study|Death|6|||
49167505|NCT01331681|158450125|FG001|Overall Study|Death|6|||
49167506|NCT01331681|158450126|FG002|Overall Study|Death|2|||
49167507|NCT01331681|158450124|FG000|Overall Study|Lack of Efficacy|0|||
49167508|NCT01331681|158450125|FG001|Overall Study|Lack of Efficacy|1|||
49167509|NCT01331681|158450126|FG002|Overall Study|Lack of Efficacy|0|||
48925489|NCT02944448|157559386|FG000|Overall Study|Lost to Follow-up|3|||
48925490|NCT02944448|157559387|FG001|Overall Study|Lost to Follow-up|1|||
48925491|NCT02944448|157559386|FG000|Overall Study|Protocol Violation|25|||
48925492|NCT02944448|157559387|FG001|Overall Study|Protocol Violation|7|||
48925493|NCT02944448|157559386|FG000|Overall Study|Withdrawal by Subject|14|||
48925494|NCT02944448|157559387|FG001|Overall Study|Withdrawal by Subject|4|||
49167510|NCT01331681|158450124|FG000|Overall Study|Withdrawal by Subject|12|||
49167511|NCT01331681|158450125|FG001|Overall Study|Withdrawal by Subject|8|||
49167512|NCT01331681|158450126|FG002|Overall Study|Withdrawal by Subject|15|||
49167513|NCT01331681|158450124|FG000|Overall Study|Protocol Violation|1|||
49167514|NCT01331681|158450125|FG001|Overall Study|Protocol Violation|1|||
49167515|NCT01331681|158450126|FG002|Overall Study|Protocol Violation|0|||
49167516|NCT01331681|158450124|FG000|Overall Study|Lost to Follow-up|2|||
49167517|NCT01331681|158450125|FG001|Overall Study|Lost to Follow-up|4|||
49167518|NCT01331681|158450126|FG002|Overall Study|Lost to Follow-up|1|||
49167519|NCT01331681|158450124|FG000|Overall Study|Physician Decision|2|||
49167520|NCT01331681|158450125|FG001|Overall Study|Physician Decision|0|||
49167521|NCT01331681|158450126|FG002|Overall Study|Physician Decision|4|||
49167522|NCT01331681|158450124|FG000|Overall Study|Therapeutic procedure required|1|||
49167523|NCT01331681|158450125|FG001|Overall Study|Therapeutic procedure required|0|||
49167524|NCT01331681|158450126|FG002|Overall Study|Therapeutic procedure required|0|||
49167525|NCT01331681|158450124|FG000|Overall Study|Sponsor decision|1|||
49167526|NCT01331681|158450125|FG001|Overall Study|Sponsor decision|1|||
49167527|NCT01331681|158450126|FG002|Overall Study|Sponsor decision|0|||
49167528|NCT01331681|158450124|FG000|Overall Study|Switching to other therapy|0|||
49167529|NCT01331681|158450125|FG001|Overall Study|Switching to other therapy|0|||
49167530|NCT01331681|158450126|FG002|Overall Study|Switching to other therapy|1|||
49167531|NCT01331681|158450124|FG000|Overall Study|Not Received Study Treatment|0|||
49167532|NCT01331681|158450125|FG001|Overall Study|Not Received Study Treatment|0|||
49167533|NCT01331681|158450126|FG002|Overall Study|Not Received Study Treatment|2|||
49167534|NCT04703192|158450127|FG000|Overall Study|Withdrawal by Subject|2|||
49167535|NCT04703192|158450128|FG001|Overall Study|Withdrawal by Subject|0|||
49167536|NCT04703192|158450127|FG000|Overall Study|Death|3|||
49167537|NCT04703192|158450128|FG001|Overall Study|Death|1|||
49167538|NCT04703192|158450127|FG000|Overall Study|Adverse Event|13|||
49167539|NCT04703192|158450128|FG001|Overall Study|Adverse Event|2|||
49167540|NCT04703192|158450127|FG000|Overall Study|Progressive or Relapsed Disease|46|||
49167541|NCT04703192|158450128|FG001|Overall Study|Progressive or Relapsed Disease|7|||
48925495|NCT02944448|157559386|FG000|Overall Study|Sponsor did not supply drug in time|0|||
49167542|NCT04703192|158450127|FG000|Overall Study|Clinical Progression|19|||
49167543|NCT04703192|158450128|FG001|Overall Study|Clinical Progression|8|||
49167544|NCT04703192|158450127|FG000|Overall Study|Lost to Follow-up|1|||
49167545|NCT04703192|158450128|FG001|Overall Study|Lost to Follow-up|0|||
49167546|NCT04703192|158450127|FG000|Overall Study|Hematopoietic Cell Transplantation|12|||
49167547|NCT04703192|158450128|FG001|Overall Study|Hematopoietic Cell Transplantation|1|||
49167548|NCT04703192|158450127|FG000|Overall Study|Other|5|||
49167549|NCT04703192|158450128|FG001|Overall Study|Other|1|||
48925496|NCT02944448|157559387|FG001|Overall Study|Sponsor did not supply drug in time|1|||
48925497|NCT02944448|157559386|FG000|Overall Study|Noncompliant with dosing|1|||
48925498|NCT02944448|157559387|FG001|Overall Study|Noncompliant with dosing|0|||
48925499|NCT02944448|157559386|FG000|Overall Study|Abnormal laboratory values|1|||
49167550|NCT00540592|158450131|FG000|Overall Study|Adverse Event|0|||
49167551|NCT00540592|158450132|FG001|Overall Study|Adverse Event|1|||
49167552|NCT00540592|158450133|FG002|Overall Study|Adverse Event|0|||
49167553|NCT00540592|158450134|FG003|Overall Study|Adverse Event|0|||
49167554|NCT00540592|158450135|FG004|Overall Study|Adverse Event|1|||
49167555|NCT00540592|158450136|FG005|Overall Study|Adverse Event|0|||
49167556|NCT00540592|158450137|FG006|Overall Study|Adverse Event|0|||
49167557|NCT00540592|158450138|FG007|Overall Study|Adverse Event|1|||
49167558|NCT00540592|158450139|FG008|Overall Study|Adverse Event|1|||
49167559|NCT00540592|158450140|FG009|Overall Study|Adverse Event|2|||
49167560|NCT00540592|158450131|FG000|Overall Study|Lost to Follow-up|2|||
49167561|NCT00540592|158450132|FG001|Overall Study|Lost to Follow-up|0|||
49167562|NCT00540592|158450133|FG002|Overall Study|Lost to Follow-up|0|||
49167563|NCT00540592|158450134|FG003|Overall Study|Lost to Follow-up|0|||
49167564|NCT00540592|158450135|FG004|Overall Study|Lost to Follow-up|0|||
49167565|NCT00540592|158450136|FG005|Overall Study|Lost to Follow-up|0|||
49167566|NCT00540592|158450137|FG006|Overall Study|Lost to Follow-up|0|||
49167567|NCT00540592|158450138|FG007|Overall Study|Lost to Follow-up|0|||
49167568|NCT00540592|158450139|FG008|Overall Study|Lost to Follow-up|0|||
48925500|NCT02944448|157559387|FG001|Overall Study|Abnormal laboratory values|0|||
48925501|NCT03468309|157559388|FG000|Overall Study|Lost to Follow-up|4|||
49167569|NCT00540592|158450140|FG009|Overall Study|Lost to Follow-up|0|||
48925502|NCT03468309|157559388|FG000|Overall Study|Withdrawal by Subject|2|||
48925503|NCT02889796|157559389|FG000|Overall Study|Withdrew Consent|18|||
49167570|NCT00540592|158450131|FG000|Overall Study|Withdrawal by Subject|0|||
48841309|NCT00186186|157259335|FG000|Overall Study|Not reported as to reason|2|||
48841310|NCT02271854|157259336|FG000|Overall Study|Withdrawal by Subject|2|||
48841311|NCT02271854|157259336|FG000|Overall Study|Unable or unwilling to cooperate with st|1|||
48841312|NCT02271854|157259336|FG000|Overall Study|Lost to Follow-up|1|||
48841313|NCT01068743|157259338|FG000|Period 3|Adverse Event|0|||
48841314|NCT01068743|157259339|FG001|Period 3|Adverse Event|1|||
48925504|NCT02889796|157559390|FG001|Overall Study|Withdrew Consent|29|||
48841315|NCT01068743|157259340|FG002|Period 3|Adverse Event|0|||
48841316|NCT01068743|157259341|FG003|Period 3|Adverse Event|0|||
48841317|NCT00364013|157259342|FG000|Overall Study|Ineligibility determined|4|||
48841318|NCT00364013|157259343|FG001|Overall Study|Ineligibility determined|2|||
48841319|NCT00364013|157259342|FG000|Overall Study|Adverse Event|4|||
48841320|NCT00364013|157259343|FG001|Overall Study|Adverse Event|3|||
48841321|NCT00364013|157259342|FG000|Overall Study|Withdrawal by Subject|13|||
48841322|NCT00364013|157259343|FG001|Overall Study|Withdrawal by Subject|18|||
48841323|NCT00364013|157259342|FG000|Overall Study|Physician Decision|3|||
48841324|NCT00364013|157259343|FG001|Overall Study|Physician Decision|3|||
48841325|NCT00364013|157259342|FG000|Overall Study|Lost to Follow-up|10|||
48841326|NCT00364013|157259343|FG001|Overall Study|Lost to Follow-up|3|||
48841327|NCT00364013|157259342|FG000|Overall Study|Protocol-specified criteria|6|||
48841328|NCT00364013|157259343|FG001|Overall Study|Protocol-specified criteria|6|||
48841329|NCT00364013|157259342|FG000|Overall Study|Other|41|||
49167571|NCT00540592|158450132|FG001|Overall Study|Withdrawal by Subject|0|||
49167572|NCT00540592|158450133|FG002|Overall Study|Withdrawal by Subject|1|||
49167573|NCT00540592|158450134|FG003|Overall Study|Withdrawal by Subject|1|||
48841330|NCT00364013|157259343|FG001|Overall Study|Other|47|||
48841331|NCT00364013|157259342|FG000|Overall Study|Ongoing|20|||
48841332|NCT00364013|157259343|FG001|Overall Study|Ongoing|13|||
48841333|NCT02512965|157259344|FG000|Overall Study|Withdrawal by Subject|0|||
48841334|NCT02512965|157259345|FG001|Overall Study|Withdrawal by Subject|4|||
48841335|NCT00835770|157259346|FG000|Overall Study|MS Relapse|17|||
48841336|NCT00835770|157259347|FG001|Overall Study|MS Relapse|23|||
48841337|NCT00835770|157259346|FG000|Overall Study|MS Progression|14|||
48841338|NCT00835770|157259347|FG001|Overall Study|MS Progression|9|||
48841339|NCT00835770|157259346|FG000|Overall Study|Adverse Event|113|||
48841340|NCT00835770|157259347|FG001|Overall Study|Adverse Event|124|||
48841341|NCT00835770|157259346|FG000|Overall Study|Lost to Follow-up|22|||
48841342|NCT00835770|157259347|FG001|Overall Study|Lost to Follow-up|19|||
48841343|NCT00835770|157259346|FG000|Overall Study|Consent Withdrawn|144|||
48841344|NCT00835770|157259347|FG001|Overall Study|Consent Withdrawn|156|||
48841345|NCT00835770|157259346|FG000|Overall Study|Investigator Decision|42|||
48841346|NCT00835770|157259347|FG001|Overall Study|Investigator Decision|42|||
48841347|NCT00835770|157259346|FG000|Overall Study|Participant Non-Compliance|11|||
48841348|NCT00835770|157259347|FG001|Overall Study|Participant Non-Compliance|9|||
48841349|NCT00835770|157259346|FG000|Overall Study|Death|4|||
48841350|NCT00835770|157259347|FG001|Overall Study|Death|6|||
48841351|NCT00835770|157259346|FG000|Overall Study|Other|115|||
48841352|NCT00835770|157259347|FG001|Overall Study|Other|104|||
48841353|NCT00835770|157259346|FG000|Overall Study|Other|2|||
48841354|NCT00835770|157259347|FG001|Overall Study|Other|1|||
48841355|NCT02507752|157259351|FG000|Overall Study|Adverse Event|1|||
48841356|NCT02507752|157259351|FG000|Overall Study|Protocol Violation|6|||
48841357|NCT02507752|157259351|FG000|Overall Study|Lost to Follow-up|7|||
48841358|NCT02507752|157259351|FG000|Overall Study|Infusion reaction at first infusion|1|||
48841359|NCT02507752|157259351|FG000|Overall Study|Participant didn't perform visit Week 12|1|||
48841360|NCT02507752|157259351|FG000|Overall Study|Participant didn't perform visit Week 24|1|||
48841361|NCT02202499|157259352|FG000|Overall Study|Cancer diagnosis|0|||
48841362|NCT02202499|157259353|FG001|Overall Study|Cancer diagnosis|0|||
48841363|NCT02202499|157259354|FG002|Overall Study|Cancer diagnosis|1|||
48841364|NCT02202499|157259352|FG000|Overall Study|Moved from area|0|||
48841365|NCT02202499|157259353|FG001|Overall Study|Moved from area|0|||
48841366|NCT02202499|157259354|FG002|Overall Study|Moved from area|1|||
48841367|NCT02202499|157259352|FG000|Overall Study|Declined before randomization|1|||
49167574|NCT00540592|158450135|FG004|Overall Study|Withdrawal by Subject|0|||
48925505|NCT02889796|157559391|FG002|Overall Study|Withdrew Consent|20|||
48841368|NCT02202499|157259353|FG001|Overall Study|Declined before randomization|0|||
48925506|NCT02889796|157559392|FG003|Overall Study|Withdrew Consent|1|||
48925507|NCT02889796|157559393|FG004|Overall Study|Withdrew Consent|2|||
48841369|NCT02202499|157259354|FG002|Overall Study|Declined before randomization|0|||
48841370|NCT02202499|157259352|FG000|Overall Study|Auto accident|1|||
48841371|NCT02202499|157259353|FG001|Overall Study|Auto accident|0|||
48841372|NCT02202499|157259354|FG002|Overall Study|Auto accident|0|||
48841373|NCT00463788|157259355|FG000|Overall Study|Progressive Disease|86|||
48925508|NCT02889796|157559394|FG005|Overall Study|Withdrew Consent|35|||
48841374|NCT00463788|157259356|FG001|Overall Study|Progressive Disease|42|||
48841375|NCT00463788|157259355|FG000|Overall Study|Adverse Event|6|||
48841376|NCT00463788|157259356|FG001|Overall Study|Adverse Event|2|||
48841377|NCT00463788|157259355|FG000|Overall Study|Withdrawal by Subject|6|||
48841378|NCT00463788|157259356|FG001|Overall Study|Withdrawal by Subject|2|||
48951829|NCT01993329|157654908|FG000|Period 2|Adverse Event|0|||
49167575|NCT00540592|158450136|FG005|Overall Study|Withdrawal by Subject|0|||
49167576|NCT00540592|158450137|FG006|Overall Study|Withdrawal by Subject|0|||
49167577|NCT00540592|158450138|FG007|Overall Study|Withdrawal by Subject|0|||
49167578|NCT00540592|158450139|FG008|Overall Study|Withdrawal by Subject|0|||
48841379|NCT00463788|157259355|FG000|Overall Study|Death|4|||
48841380|NCT00463788|157259356|FG001|Overall Study|Death|3|||
48841381|NCT00463788|157259355|FG000|Overall Study|Symptomatic Deterioration|2|||
48841382|NCT00463788|157259356|FG001|Overall Study|Symptomatic Deterioration|3|||
48925509|NCT02889796|157559389|FG000|Overall Study|Investigator's Discretion|10|||
48925510|NCT02889796|157559390|FG001|Overall Study|Investigator's Discretion|9|||
48925511|NCT02889796|157559391|FG002|Overall Study|Investigator's Discretion|10|||
48925512|NCT02889796|157559392|FG003|Overall Study|Investigator's Discretion|3|||
48841383|NCT00463788|157259355|FG000|Overall Study|Lost to Follow-up|1|||
48841384|NCT00463788|157259356|FG001|Overall Study|Lost to Follow-up|0|||
48841385|NCT00463788|157259355|FG000|Overall Study|Protocol Violation|0|||
48841386|NCT00463788|157259356|FG001|Overall Study|Protocol Violation|1|||
48925513|NCT02889796|157559393|FG004|Overall Study|Investigator's Discretion|0|||
48925514|NCT02889796|157559394|FG005|Overall Study|Investigator's Discretion|15|||
49167579|NCT00540592|158450140|FG009|Overall Study|Withdrawal by Subject|0|||
49167580|NCT01456130|158450141|FG000|Overall Study|Adverse Event|4|||
49167581|NCT01456130|158450141|FG000|Overall Study|Voluntary Withdrawal|1|||
49167582|NCT01456130|158450141|FG000|Overall Study|Lack of Efficacy|4|||
49167583|NCT01456130|158450141|FG000|Overall Study|Other|1|||
49167584|NCT00700622|158450145|FG000|Overall Study|Adverse Event|4|||
49167585|NCT00700622|158450146|FG001|Overall Study|Adverse Event|0|||
49167586|NCT00700622|158450145|FG000|Overall Study|Lost to Follow-up|0|||
49167587|NCT00700622|158450146|FG001|Overall Study|Lost to Follow-up|1|||
49167588|NCT00700622|158450145|FG000|Overall Study|Physician Decision|2|||
49167589|NCT00700622|158450146|FG001|Overall Study|Physician Decision|1|||
49167590|NCT00700622|158450145|FG000|Overall Study|Protocol Violation|0|||
49167591|NCT00700622|158450146|FG001|Overall Study|Protocol Violation|1|||
49167592|NCT00700622|158450145|FG000|Overall Study|Withdrawal by Subject|4|||
49167593|NCT00700622|158450146|FG001|Overall Study|Withdrawal by Subject|1|||
49167594|NCT00700622|158450145|FG000|Overall Study|Other|3|||
49167595|NCT00700622|158450146|FG001|Overall Study|Other|1|||
49167596|NCT01673646|158450151|FG000|Overall Study|Adverse Event|2|||
49167597|NCT01673646|158450152|FG001|Overall Study|Adverse Event|1|||
49167598|NCT01673646|158450153|FG002|Overall Study|Adverse Event|1|||
49167599|NCT01673646|158450151|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
49167600|NCT01673646|158450152|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
49167601|NCT01673646|158450153|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
49167602|NCT01673646|158450151|FG000|Overall Study|Condition no longer requires study drug|0|||
49167603|NCT01673646|158450152|FG001|Overall Study|Condition no longer requires study drug|1|||
49167604|NCT01673646|158450153|FG002|Overall Study|Condition no longer requires study drug|0|||
49167605|NCT01673646|158450151|FG000|Overall Study|Withdrawal by Subject|0|||
49167606|NCT01673646|158450152|FG001|Overall Study|Withdrawal by Subject|2|||
49167607|NCT01673646|158450153|FG002|Overall Study|Withdrawal by Subject|2|||
49167608|NCT01673646|158450151|FG000|Overall Study|Completed Core/did not enter Ext.|2|||
49167609|NCT01673646|158450152|FG001|Overall Study|Completed Core/did not enter Ext.|1|||
49167610|NCT01673646|158450153|FG002|Overall Study|Completed Core/did not enter Ext.|1|||
49167611|NCT02141672|158450155|FG000|Overall Study|Adverse Event|0|||
49167612|NCT02141672|158450156|FG001|Overall Study|Adverse Event|1|||
49167613|NCT02141672|158450157|FG002|Overall Study|Adverse Event|0|||
49167614|NCT02141672|158450155|FG000|Overall Study|Death|10|||
49167615|NCT02141672|158450156|FG001|Overall Study|Death|2|||
49167616|NCT02141672|158450157|FG002|Overall Study|Death|1|||
49167617|NCT02141672|158450155|FG000|Overall Study|Lack of Efficacy|0|||
49167618|NCT02141672|158450156|FG001|Overall Study|Lack of Efficacy|0|||
49167619|NCT02141672|158450157|FG002|Overall Study|Lack of Efficacy|2|||
49167620|NCT02141672|158450155|FG000|Overall Study|Lost to Follow-up|1|||
49167621|NCT02141672|158450156|FG001|Overall Study|Lost to Follow-up|1|||
49167622|NCT02141672|158450157|FG002|Overall Study|Lost to Follow-up|3|||
49167623|NCT02141672|158450155|FG000|Overall Study|Physician Decision|1|||
49167624|NCT02141672|158450156|FG001|Overall Study|Physician Decision|2|||
49167625|NCT02141672|158450157|FG002|Overall Study|Physician Decision|5|||
49167626|NCT02141672|158450155|FG000|Overall Study|Protocol Violation|0|||
49167627|NCT02141672|158450156|FG001|Overall Study|Protocol Violation|0|||
49167628|NCT02141672|158450157|FG002|Overall Study|Protocol Violation|1|||
49167629|NCT02141672|158450155|FG000|Overall Study|Withdrawal by Subject|3|||
49167630|NCT02141672|158450156|FG001|Overall Study|Withdrawal by Subject|2|||
49167631|NCT02141672|158450157|FG002|Overall Study|Withdrawal by Subject|5|||
49167632|NCT02141672|158450155|FG000|Overall Study|refused to follow-up|1|||
49167633|NCT02141672|158450156|FG001|Overall Study|refused to follow-up|0|||
49167634|NCT02141672|158450157|FG002|Overall Study|refused to follow-up|1|||
48841387|NCT00463788|157259355|FG000|Overall Study|Other|3|||
49167635|NCT01194219|158450160|FG000|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23|||
49167636|NCT01194219|158450161|FG001|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5|||
49167637|NCT01194219|158450162|FG002|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
49167638|NCT01194219|158450163|FG003|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
49167639|NCT01194219|158450164|FG004|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
49167640|NCT01194219|158450165|FG005|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
49167641|NCT01194219|158450166|FG006|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
49167642|NCT01194219|158450167|FG007|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
49167643|NCT01194219|158450168|FG008|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
49167644|NCT01194219|158450169|FG009|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
49167645|NCT01194219|158450160|FG000|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2|||
49167646|NCT01194219|158450161|FG001|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7|||
49167647|NCT01194219|158450162|FG002|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
49167648|NCT01194219|158450163|FG003|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
49167649|NCT01194219|158450164|FG004|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
49167650|NCT01194219|158450165|FG005|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
49167651|NCT01194219|158450166|FG006|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
49167652|NCT01194219|158450167|FG007|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
49167653|NCT01194219|158450168|FG008|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
49167654|NCT01194219|158450169|FG009|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
49167655|NCT01194219|158450160|FG000|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7|||
49167656|NCT01194219|158450161|FG001|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
49167657|NCT01194219|158450162|FG002|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
49167658|NCT01194219|158450163|FG003|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
49167659|NCT01194219|158450164|FG004|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
48925515|NCT02889796|157559389|FG000|Overall Study|Adverse Event|17|||
48925516|NCT02889796|157559390|FG001|Overall Study|Adverse Event|8|||
48925517|NCT02889796|157559391|FG002|Overall Study|Adverse Event|8|||
48925518|NCT02889796|157559392|FG003|Overall Study|Adverse Event|4|||
48925519|NCT02889796|157559393|FG004|Overall Study|Adverse Event|1|||
48925520|NCT02889796|157559394|FG005|Overall Study|Adverse Event|7|||
48925521|NCT02889796|157559389|FG000|Overall Study|Lost to Follow-up|5|||
48925522|NCT02889796|157559390|FG001|Overall Study|Lost to Follow-up|7|||
48925523|NCT02889796|157559391|FG002|Overall Study|Lost to Follow-up|2|||
49167660|NCT01194219|158450165|FG005|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
49167661|NCT01194219|158450166|FG006|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
49167662|NCT01194219|158450167|FG007|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
49167663|NCT01194219|158450168|FG008|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
49167664|NCT01194219|158450169|FG009|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
49167665|NCT01194219|158450160|FG000|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12|||
49167666|NCT01194219|158450161|FG001|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9|||
49167667|NCT01194219|158450162|FG002|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
49167668|NCT01194219|158450163|FG003|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
49167669|NCT01194219|158450164|FG004|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
48925524|NCT02889796|157559392|FG003|Overall Study|Lost to Follow-up|0|||
48925525|NCT02889796|157559393|FG004|Overall Study|Lost to Follow-up|2|||
48925526|NCT02889796|157559394|FG005|Overall Study|Lost to Follow-up|6|||
48925527|NCT02889796|157559389|FG000|Overall Study|Protocol Violation|0|||
48925528|NCT02889796|157559390|FG001|Overall Study|Protocol Violation|1|||
48925529|NCT02889796|157559391|FG002|Overall Study|Protocol Violation|3|||
48925530|NCT02889796|157559392|FG003|Overall Study|Protocol Violation|0|||
48925531|NCT02889796|157559393|FG004|Overall Study|Protocol Violation|0|||
48925532|NCT02889796|157559394|FG005|Overall Study|Protocol Violation|4|||
48925533|NCT02889796|157559389|FG000|Overall Study|Non-compliance With Study Drug|0|||
48925534|NCT02889796|157559390|FG001|Overall Study|Non-compliance With Study Drug|2|||
49167670|NCT01194219|158450165|FG005|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
49167671|NCT01194219|158450166|FG006|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
49167672|NCT01194219|158450167|FG007|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
49167673|NCT01194219|158450168|FG008|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
49167674|NCT01194219|158450169|FG009|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
49167675|NCT01194219|158450160|FG000|Placebo-Controlled Phase Weeks 0-16|Death|0|||
49167676|NCT01194219|158450161|FG001|Placebo-Controlled Phase Weeks 0-16|Death|1|||
49167677|NCT01194219|158450162|FG002|Placebo-Controlled Phase Weeks 0-16|Death|0|||
49167678|NCT01194219|158450163|FG003|Placebo-Controlled Phase Weeks 0-16|Death|0|||
49167679|NCT01194219|158450164|FG004|Placebo-Controlled Phase Weeks 0-16|Death|0|||
48925535|NCT02889796|157559391|FG002|Overall Study|Non-compliance With Study Drug|0|||
48925536|NCT02889796|157559392|FG003|Overall Study|Non-compliance With Study Drug|0|||
48925537|NCT02889796|157559393|FG004|Overall Study|Non-compliance With Study Drug|1|||
48925538|NCT02889796|157559394|FG005|Overall Study|Non-compliance With Study Drug|2|||
49167680|NCT01194219|158450165|FG005|Placebo-Controlled Phase Weeks 0-16|Death|0|||
48925539|NCT02889796|157559389|FG000|Overall Study|Death|1|||
48925540|NCT02889796|157559390|FG001|Overall Study|Death|1|||
48841388|NCT00463788|157259356|FG001|Overall Study|Other|0|||
49167681|NCT01194219|158450166|FG006|Placebo-Controlled Phase Weeks 0-16|Death|0|||
49167682|NCT01194219|158450167|FG007|Placebo-Controlled Phase Weeks 0-16|Death|0|||
49167683|NCT01194219|158450168|FG008|Placebo-Controlled Phase Weeks 0-16|Death|0|||
49167684|NCT01194219|158450169|FG009|Placebo-Controlled Phase Weeks 0-16|Death|0|||
49167685|NCT01194219|158450160|FG000|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7|||
49167686|NCT01194219|158450161|FG001|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9|||
49167687|NCT01194219|158450162|FG002|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
49167688|NCT01194219|158450163|FG003|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
49167689|NCT01194219|158450164|FG004|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
49167690|NCT01194219|158450165|FG005|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
49167691|NCT01194219|158450166|FG006|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
49167692|NCT01194219|158450167|FG007|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
49167693|NCT01194219|158450168|FG008|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
49167694|NCT01194219|158450169|FG009|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
49167695|NCT01194219|158450160|FG000|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7|||
49167696|NCT01194219|158450161|FG001|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1|||
49167697|NCT01194219|158450162|FG002|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
49167698|NCT01194219|158450163|FG003|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
49167699|NCT01194219|158450164|FG004|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
49167700|NCT01194219|158450165|FG005|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
49167701|NCT01194219|158450166|FG006|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
49167702|NCT01194219|158450167|FG007|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
49167703|NCT01194219|158450168|FG008|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
49167704|NCT01194219|158450169|FG009|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
49167705|NCT01194219|158450160|FG000|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
49167706|NCT01194219|158450161|FG001|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
49167707|NCT01194219|158450162|FG002|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
49167708|NCT01194219|158450163|FG003|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
49167709|NCT01194219|158450164|FG004|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
49167710|NCT01194219|158450165|FG005|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
49167711|NCT01194219|158450166|FG006|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
49167712|NCT01194219|158450167|FG007|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
49167713|NCT01194219|158450168|FG008|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
49167714|NCT01194219|158450169|FG009|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
49167715|NCT01194219|158450160|FG000|Maintenance Phase Weeks16-32|Adverse Event|0|||
49167716|NCT01194219|158450161|FG001|Maintenance Phase Weeks16-32|Adverse Event|0|||
49167717|NCT01194219|158450162|FG002|Maintenance Phase Weeks16-32|Adverse Event|8|||
48841389|NCT00463788|157259355|FG000|Overall Study|Randomized but not treated|1|||
48841390|NCT00463788|157259356|FG001|Overall Study|Randomized but not treated|1|||
48841391|NCT00360698|157259357|FG000|Run-In|Physician Decision|0|||
48841392|NCT00360698|157259358|FG001|Run-In|Physician Decision|1|||
48841393|NCT00360698|157259357|FG000|Run-In|Withdrawal by Subject|0|||
48841394|NCT00360698|157259358|FG001|Run-In|Withdrawal by Subject|2|||
48841395|NCT00360698|157259357|FG000|Run-In|Non compliance with treatment procedure|0|||
48841396|NCT00360698|157259358|FG001|Run-In|Non compliance with treatment procedure|1|||
48841397|NCT00360698|157259357|FG000|Run-In|Sponsor request|0|||
48841398|NCT00360698|157259358|FG001|Run-In|Sponsor request|2|||
48841399|NCT00360698|157259357|FG000|Run-In|Patient did not meet inclusion criteria|0|||
48841400|NCT00360698|157259358|FG001|Run-In|Patient did not meet inclusion criteria|1|||
48841401|NCT00360698|157259357|FG000|Run-In|Patient personal reasons|0|||
48841402|NCT00360698|157259358|FG001|Run-In|Patient personal reasons|2|||
48841403|NCT00360698|157259357|FG000|Run-In|Need of insulin with meals|0|||
48841404|NCT00360698|157259358|FG001|Run-In|Need of insulin with meals|1|||
48841405|NCT00360698|157259357|FG000|Treatment Period|Non compliance with treatment procedure|1|||
48841406|NCT00360698|157259358|FG001|Treatment Period|Non compliance with treatment procedure|0|||
48841407|NCT00360698|157259357|FG000|Treatment Period|Early termination by error|0|||
48841408|NCT00360698|157259358|FG001|Treatment Period|Early termination by error|1|||
48841409|NCT02988817|157259359|FG000|Overall Study|Withdrawal by Subject|1|||
48841410|NCT02988817|157259360|FG001|Overall Study|Withdrawal by Subject|0|||
48841411|NCT02988817|157259361|FG002|Overall Study|Withdrawal by Subject|0|||
48841412|NCT02988817|157259362|FG003|Overall Study|Withdrawal by Subject|1|||
48841413|NCT02988817|157259363|FG004|Overall Study|Withdrawal by Subject|3|||
48841414|NCT02988817|157259364|FG005|Overall Study|Withdrawal by Subject|1|||
48841415|NCT02988817|157259365|FG006|Overall Study|Withdrawal by Subject|2|||
48841416|NCT02988817|157259366|FG007|Overall Study|Withdrawal by Subject|1|||
48841417|NCT02988817|157259367|FG008|Overall Study|Withdrawal by Subject|1|||
48841418|NCT02988817|157259368|FG009|Overall Study|Withdrawal by Subject|1|||
48841419|NCT02988817|157259369|FG010|Overall Study|Withdrawal by Subject|1|||
48841420|NCT02988817|157259370|FG011|Overall Study|Withdrawal by Subject|12|||
48841421|NCT02988817|157259371|FG012|Overall Study|Withdrawal by Subject|6|||
48841422|NCT02988817|157259372|FG013|Overall Study|Withdrawal by Subject|6|||
48841423|NCT02988817|157259373|FG014|Overall Study|Withdrawal by Subject|4|||
48841424|NCT02988817|157259374|FG015|Overall Study|Withdrawal by Subject|5|||
48841425|NCT02988817|157259375|FG016|Overall Study|Withdrawal by Subject|4|||
49167718|NCT01194219|158450163|FG003|Maintenance Phase Weeks16-32|Adverse Event|9|||
49167719|NCT01194219|158450164|FG004|Maintenance Phase Weeks16-32|Adverse Event|0|||
49167720|NCT01194219|158450165|FG005|Maintenance Phase Weeks16-32|Adverse Event|0|||
49167721|NCT01194219|158450166|FG006|Maintenance Phase Weeks16-32|Adverse Event|0|||
49167722|NCT01194219|158450167|FG007|Maintenance Phase Weeks16-32|Adverse Event|0|||
49167723|NCT01194219|158450168|FG008|Maintenance Phase Weeks16-32|Adverse Event|0|||
49167724|NCT01194219|158450169|FG009|Maintenance Phase Weeks16-32|Adverse Event|0|||
49167725|NCT01194219|158450160|FG000|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
49167726|NCT01194219|158450161|FG001|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
49167727|NCT01194219|158450162|FG002|Maintenance Phase Weeks16-32|Lack of Efficacy|37|||
49167728|NCT01194219|158450163|FG003|Maintenance Phase Weeks16-32|Lack of Efficacy|15|||
48925541|NCT02889796|157559391|FG002|Overall Study|Death|0|||
48841426|NCT02988817|157259376|FG017|Overall Study|Withdrawal by Subject|11|||
48841427|NCT02988817|157259377|FG018|Overall Study|Withdrawal by Subject|4|||
48841428|NCT02988817|157259378|FG019|Overall Study|Withdrawal by Subject|2|||
48841429|NCT02988817|157259359|FG000|Overall Study|Death|0|||
48841430|NCT02988817|157259360|FG001|Overall Study|Death|1|||
48841431|NCT02988817|157259361|FG002|Overall Study|Death|3|||
48841432|NCT02988817|157259362|FG003|Overall Study|Death|1|||
48841433|NCT02988817|157259363|FG004|Overall Study|Death|6|||
48841434|NCT02988817|157259364|FG005|Overall Study|Death|10|||
48841435|NCT02988817|157259365|FG006|Overall Study|Death|1|||
48841436|NCT02988817|157259366|FG007|Overall Study|Death|2|||
48841437|NCT02988817|157259367|FG008|Overall Study|Death|1|||
48841438|NCT02988817|157259368|FG009|Overall Study|Death|5|||
48841439|NCT02988817|157259369|FG010|Overall Study|Death|1|||
48841440|NCT02988817|157259370|FG011|Overall Study|Death|8|||
48925542|NCT02889796|157559392|FG003|Overall Study|Death|1|||
48925543|NCT02889796|157559393|FG004|Overall Study|Death|0|||
49167729|NCT01194219|158450164|FG004|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
49167730|NCT01194219|158450165|FG005|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
49167731|NCT01194219|158450166|FG006|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
49167732|NCT01194219|158450167|FG007|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
49167733|NCT01194219|158450168|FG008|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
49167734|NCT01194219|158450169|FG009|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
49167735|NCT01194219|158450160|FG000|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
49167736|NCT01194219|158450161|FG001|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
49167737|NCT01194219|158450162|FG002|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2|||
49167738|NCT01194219|158450163|FG003|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1|||
49167739|NCT01194219|158450164|FG004|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
49167740|NCT01194219|158450165|FG005|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
49167741|NCT01194219|158450166|FG006|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
49167742|NCT01194219|158450167|FG007|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
49167743|NCT01194219|158450168|FG008|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
49167744|NCT01194219|158450169|FG009|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
49167745|NCT01194219|158450160|FG000|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
48841441|NCT02988817|157259371|FG012|Overall Study|Death|9|||
49167746|NCT01194219|158450161|FG001|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
49167747|NCT01194219|158450162|FG002|Maintenance Phase Weeks16-32|Withdrawal by Subject|12|||
48841442|NCT02988817|157259372|FG013|Overall Study|Death|17|||
49167748|NCT01194219|158450163|FG003|Maintenance Phase Weeks16-32|Withdrawal by Subject|3|||
49167749|NCT01194219|158450164|FG004|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
49167750|NCT01194219|158450165|FG005|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
49167751|NCT01194219|158450166|FG006|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
49167752|NCT01194219|158450167|FG007|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
49167753|NCT01194219|158450168|FG008|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
49167754|NCT01194219|158450169|FG009|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
49167755|NCT01194219|158450160|FG000|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
49167756|NCT01194219|158450161|FG001|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
49167757|NCT01194219|158450162|FG002|Maintenance Phase Weeks16-32|Lost to Follow-up|9|||
49167758|NCT01194219|158450163|FG003|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
49167759|NCT01194219|158450164|FG004|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
49167760|NCT01194219|158450165|FG005|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
49167761|NCT01194219|158450166|FG006|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
49167762|NCT01194219|158450167|FG007|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
49167763|NCT01194219|158450168|FG008|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
49167764|NCT01194219|158450169|FG009|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
49167765|NCT01194219|158450160|FG000|Maintenance Phase Weeks16-32|Protocol Violation|0|||
49167766|NCT01194219|158450161|FG001|Maintenance Phase Weeks16-32|Protocol Violation|0|||
49167767|NCT01194219|158450162|FG002|Maintenance Phase Weeks16-32|Protocol Violation|0|||
49167768|NCT01194219|158450163|FG003|Maintenance Phase Weeks16-32|Protocol Violation|1|||
49167769|NCT01194219|158450164|FG004|Maintenance Phase Weeks16-32|Protocol Violation|0|||
49167770|NCT01194219|158450165|FG005|Maintenance Phase Weeks16-32|Protocol Violation|0|||
49167771|NCT01194219|158450166|FG006|Maintenance Phase Weeks16-32|Protocol Violation|0|||
49167772|NCT01194219|158450167|FG007|Maintenance Phase Weeks16-32|Protocol Violation|0|||
49167773|NCT01194219|158450168|FG008|Maintenance Phase Weeks16-32|Protocol Violation|0|||
49167774|NCT01194219|158450169|FG009|Maintenance Phase Weeks16-32|Protocol Violation|0|||
49167775|NCT01194219|158450160|FG000|Maintenance Phase Weeks16-32|Other|0|||
49167776|NCT01194219|158450161|FG001|Maintenance Phase Weeks16-32|Other|0|||
49167777|NCT01194219|158450162|FG002|Maintenance Phase Weeks16-32|Other|2|||
49167778|NCT01194219|158450163|FG003|Maintenance Phase Weeks16-32|Other|1|||
49167779|NCT01194219|158450164|FG004|Maintenance Phase Weeks16-32|Other|0|||
49167780|NCT01194219|158450165|FG005|Maintenance Phase Weeks16-32|Other|0|||
49167781|NCT01194219|158450166|FG006|Maintenance Phase Weeks16-32|Other|0|||
49167782|NCT01194219|158450167|FG007|Maintenance Phase Weeks16-32|Other|0|||
49167783|NCT01194219|158450168|FG008|Maintenance Phase Weeks16-32|Other|0|||
49167784|NCT01194219|158450169|FG009|Maintenance Phase Weeks16-32|Other|0|||
49167785|NCT01194219|158450160|FG000|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
49167786|NCT01194219|158450161|FG001|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
49167787|NCT01194219|158450162|FG002|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
49167788|NCT01194219|158450163|FG003|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
49167789|NCT01194219|158450164|FG004|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
49167790|NCT01194219|158450165|FG005|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1|||
48925544|NCT02889796|157559394|FG005|Overall Study|Death|1|||
49167791|NCT01194219|158450166|FG006|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6|||
49167792|NCT01194219|158450167|FG007|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5|||
49167793|NCT01194219|158450168|FG008|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
49167794|NCT01194219|158450169|FG009|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
49167795|NCT01194219|158450160|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
49167796|NCT01194219|158450161|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
48925545|NCT02889796|157559389|FG000|Overall Study|Pregnancy|0|||
48925546|NCT02889796|157559390|FG001|Overall Study|Pregnancy|1|||
48925547|NCT02889796|157559391|FG002|Overall Study|Pregnancy|1|||
48925548|NCT02889796|157559392|FG003|Overall Study|Pregnancy|0|||
48925549|NCT02889796|157559393|FG004|Overall Study|Pregnancy|0|||
48925550|NCT02889796|157559394|FG005|Overall Study|Pregnancy|0|||
48925551|NCT02889796|157559389|FG000|Overall Study|Randomized but not Dosed|2|||
48925552|NCT02889796|157559390|FG001|Overall Study|Randomized but not Dosed|0|||
48925553|NCT02889796|157559391|FG002|Overall Study|Randomized but not Dosed|0|||
48925554|NCT02889796|157559392|FG003|Overall Study|Randomized but not Dosed|0|||
48925555|NCT02889796|157559393|FG004|Overall Study|Randomized but not Dosed|0|||
48925556|NCT02889796|157559394|FG005|Overall Study|Randomized but not Dosed|2|||
49167797|NCT01194219|158450162|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
49167798|NCT01194219|158450163|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
49167799|NCT01194219|158450164|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
49167800|NCT01194219|158450165|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
49167801|NCT01194219|158450166|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35|||
49167802|NCT01194219|158450167|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33|||
48925557|NCT01678144|157559395|FG000|Stage 1: MAR Classic|Adverse Event|1|||
49167803|NCT01194219|158450168|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
49167804|NCT01194219|158450169|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
49167805|NCT01194219|158450160|FG000|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
49167806|NCT01194219|158450161|FG001|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
48925558|NCT02631200|157559396|FG000|First Period|Death|1|||
48925559|NCT02631200|157559397|FG001|First Period|Death|2|||
48925560|NCT02631200|157559396|FG000|First Period|Patient ill-health|2|||
48925561|NCT02631200|157559397|FG001|First Period|Patient ill-health|4|||
48925562|NCT02631200|157559396|FG000|First Period|Withdrawal by Subject|4|||
48925563|NCT02631200|157559397|FG001|First Period|Withdrawal by Subject|1|||
48925564|NCT02631200|157559396|FG000|Deferred Period|Death|0|||
48925565|NCT02631200|157559397|FG001|Deferred Period|Death|1|||
48925566|NCT02631200|157559396|FG000|Deferred Period|Received kidney transplant|0|||
48925567|NCT02631200|157559397|FG001|Deferred Period|Received kidney transplant|1|||
48925568|NCT02631200|157559396|FG000|Deferred Period|Withdrawal by Subject|0|||
48925569|NCT02631200|157559397|FG001|Deferred Period|Withdrawal by Subject|2|||
48925570|NCT02631200|157559396|FG000|Deferred Period|Lost to Follow-up|0|||
48925571|NCT02631200|157559397|FG001|Deferred Period|Lost to Follow-up|1|||
48925572|NCT01978093|157559400|FG000|Overall Study|Death|1|||
48925573|NCT01978093|157559401|FG001|Overall Study|Death|0|||
48925574|NCT01978093|157559400|FG000|Overall Study|Adverse Event|0|||
49167807|NCT01194219|158450162|FG002|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
49167808|NCT01194219|158450163|FG003|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
49167809|NCT01194219|158450164|FG004|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1|||
49167810|NCT01194219|158450165|FG005|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
49167811|NCT01194219|158450166|FG006|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2|||
49167812|NCT01194219|158450167|FG007|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
49167813|NCT01194219|158450168|FG008|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
49167814|NCT01194219|158450169|FG009|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
49167815|NCT01194219|158450160|FG000|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
49167816|NCT01194219|158450161|FG001|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
48925575|NCT01978093|157559401|FG001|Overall Study|Adverse Event|5|||
48925576|NCT01978093|157559400|FG000|Overall Study|Protocol Violation|8|||
48925577|NCT01978093|157559401|FG001|Overall Study|Protocol Violation|2|||
48925578|NCT01978093|157559400|FG000|Overall Study|Withdrawal by Subject|29|||
48925579|NCT01978093|157559401|FG001|Overall Study|Withdrawal by Subject|25|||
48925580|NCT01978093|157559400|FG000|Overall Study|Lost to Follow-up|11|||
48925581|NCT01978093|157559401|FG001|Overall Study|Lost to Follow-up|15|||
48925582|NCT01978093|157559400|FG000|Overall Study|Migrated/moved from study area|11|||
48925583|NCT01978093|157559401|FG001|Overall Study|Migrated/moved from study area|13|||
48925584|NCT01978093|157559400|FG000|Overall Study|Loss of kaiser coverage|4|||
48925585|NCT01978093|157559401|FG001|Overall Study|Loss of kaiser coverage|10|||
48925586|NCT01978093|157559400|FG000|Overall Study|Lost kaiser health plan unable to contac|1|||
48925587|NCT01978093|157559401|FG001|Overall Study|Lost kaiser health plan unable to contac|0|||
48925588|NCT01978093|157559400|FG000|Overall Study|Mother lost custody of child|0|||
48925589|NCT01978093|157559401|FG001|Overall Study|Mother lost custody of child|1|||
48925590|NCT01978093|157559400|FG000|Overall Study|Child was in care of grandmother|0|||
48925591|NCT01978093|157559401|FG001|Overall Study|Child was in care of grandmother|1|||
48925592|NCT01978093|157559400|FG000|Overall Study|N/A for vaccine administration|0|||
48925593|NCT01978093|157559401|FG001|Overall Study|N/A for vaccine administration|1|||
49167817|NCT01194219|158450162|FG002|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
49167818|NCT01194219|158450163|FG003|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
49167819|NCT01194219|158450164|FG004|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1|||
49167820|NCT01194219|158450165|FG005|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
49167821|NCT01194219|158450166|FG006|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12|||
49167822|NCT01194219|158450167|FG007|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6|||
49167823|NCT01194219|158450168|FG008|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
49167824|NCT01194219|158450169|FG009|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
49167825|NCT01194219|158450160|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
49167826|NCT01194219|158450161|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
49167827|NCT01194219|158450162|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
49167828|NCT01194219|158450163|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
49167829|NCT01194219|158450164|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1|||
49167830|NCT01194219|158450165|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2|||
49167831|NCT01194219|158450166|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5|||
49167832|NCT01194219|158450167|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
49167833|NCT01194219|158450168|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
48925594|NCT03124784|157559402|FG000|Overall Study|Adverse Event|1|||
48925595|NCT03124784|157559402|FG000|Overall Study|Computer/Equip Malfunction|1|||
48925596|NCT00424827|157559405|FG000|Overall Study|Adverse Event|1|||
48925597|NCT00957008|157559406|FG000|Overall Study|Withdrawal by Subject|13|||
48925598|NCT00957008|157559407|FG001|Overall Study|Withdrawal by Subject|10|||
48925599|NCT00957008|157559408|FG002|Overall Study|Withdrawal by Subject|12|||
48925600|NCT00957008|157559409|FG003|Overall Study|Withdrawal by Subject|16|||
48925601|NCT00957008|157559406|FG000|Overall Study|Lost to Follow-up|3|||
48925602|NCT00957008|157559407|FG001|Overall Study|Lost to Follow-up|1|||
48925603|NCT00957008|157559408|FG002|Overall Study|Lost to Follow-up|3|||
48925604|NCT00957008|157559409|FG003|Overall Study|Lost to Follow-up|4|||
48925605|NCT00957008|157559406|FG000|Overall Study|Physician Decision|1|||
48925606|NCT00957008|157559407|FG001|Overall Study|Physician Decision|0|||
48925607|NCT00957008|157559408|FG002|Overall Study|Physician Decision|1|||
48925608|NCT00957008|157559409|FG003|Overall Study|Physician Decision|1|||
48925609|NCT00957008|157559406|FG000|Overall Study|Relocated; Family conflict|4|||
48925610|NCT00957008|157559407|FG001|Overall Study|Relocated; Family conflict|1|||
48925611|NCT00957008|157559408|FG002|Overall Study|Relocated; Family conflict|1|||
48925612|NCT00957008|157559409|FG003|Overall Study|Relocated; Family conflict|3|||
48925613|NCT02275338|157559411|FG000|Overall Study|Adverse Event|15|||
48925614|NCT02275338|157559411|FG000|Overall Study|Lack of Efficacy|3|||
48925615|NCT02275338|157559411|FG000|Overall Study|Withdrawal by Subject|4|||
48925616|NCT02275338|157559411|FG000|Overall Study|Disease progression (death)|1|||
48925617|NCT02275338|157559411|FG000|Overall Study|Ineligible to start Phase 2|4|||
48925618|NCT02275338|157559411|FG000|Overall Study|Reason not specified|5|||
48925619|NCT02275338|157559411|FG000|Overall Study|Does not meet entry criteria|1|||
48925620|NCT04823949|157559412|FG000|Overall Study|Withdrawal by Subject|0|||
48925621|NCT04823949|157559413|FG001|Overall Study|Withdrawal by Subject|4|||
48925622|NCT04823949|157559412|FG000|Overall Study|Physician Decision|0|||
48925623|NCT04823949|157559413|FG001|Overall Study|Physician Decision|1|||
48925624|NCT02347176|157559414|FG000|Overall Study|Lost to Follow-up|2|||
48925625|NCT02347176|157559415|FG001|Overall Study|Lost to Follow-up|3|||
48925626|NCT02347176|157559416|FG002|Overall Study|Lost to Follow-up|1|||
48925627|NCT02347176|157559417|FG003|Overall Study|Lost to Follow-up|1|||
48925628|NCT02347176|157559414|FG000|Overall Study|Withdrawal by Subject|9|||
48925629|NCT02347176|157559415|FG001|Overall Study|Withdrawal by Subject|5|||
49167834|NCT01194219|158450169|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
49167835|NCT01194219|158450160|FG000|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
49167836|NCT01194219|158450161|FG001|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
49167837|NCT01194219|158450162|FG002|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
49167838|NCT01194219|158450163|FG003|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
49167839|NCT01194219|158450164|FG004|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
49167840|NCT01194219|158450165|FG005|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
49167841|NCT01194219|158450166|FG006|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
49167842|NCT01194219|158450167|FG007|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1|||
49167843|NCT01194219|158450168|FG008|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
49167844|NCT01194219|158450169|FG009|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
49167845|NCT01194219|158450160|FG000|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
49167846|NCT01194219|158450161|FG001|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
49167847|NCT01194219|158450162|FG002|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
49167848|NCT01194219|158450163|FG003|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
49167849|NCT01194219|158450164|FG004|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
49167850|NCT01194219|158450165|FG005|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
49167851|NCT01194219|158450166|FG006|Randomized Withdrawal Phase-Weeks 32-52|Other|1|||
49167852|NCT01194219|158450167|FG007|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
49167853|NCT01194219|158450168|FG008|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
49167854|NCT01194219|158450169|FG009|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
49167855|NCT01194219|158450160|FG000|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
49167856|NCT01194219|158450161|FG001|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
49167857|NCT01194219|158450162|FG002|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
49167858|NCT01194219|158450163|FG003|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
49167859|NCT01194219|158450164|FG004|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
49167860|NCT01194219|158450165|FG005|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
49167861|NCT01194219|158450166|FG006|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
49167862|NCT01194219|158450167|FG007|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
49167863|NCT01194219|158450168|FG008|Long-Term Extension Weeks 52 to 260|Adverse Event|25|||
48925630|NCT02347176|157559416|FG002|Overall Study|Withdrawal by Subject|5|||
48925631|NCT02347176|157559417|FG003|Overall Study|Withdrawal by Subject|3|||
48925632|NCT02347176|157559414|FG000|Overall Study|Other|1|||
48925633|NCT02347176|157559415|FG001|Overall Study|Other|2|||
48925634|NCT02347176|157559416|FG002|Overall Study|Other|2|||
48925635|NCT02347176|157559417|FG003|Overall Study|Other|0|||
48925636|NCT02435849|157559421|FG000|Overall Study|Death|23|||
48925637|NCT02435849|157559422|FG001|Overall Study|Death|0|||
48925638|NCT02435849|157559421|FG000|Overall Study|Lack of Efficacy|10|||
48925639|NCT02435849|157559422|FG001|Overall Study|Lack of Efficacy|0|||
48925640|NCT02435849|157559421|FG000|Overall Study|New therapy for study indication|8|||
48925641|NCT02435849|157559422|FG001|Overall Study|New therapy for study indication|0|||
48925642|NCT02435849|157559421|FG000|Overall Study|Subject/guardian decision|5|||
48925643|NCT02435849|157559422|FG001|Overall Study|Subject/guardian decision|1|||
48925644|NCT02435849|157559421|FG000|Overall Study|Lost to Follow-up|1|||
48925645|NCT02435849|157559422|FG001|Overall Study|Lost to Follow-up|0|||
48925646|NCT02435849|157559421|FG000|Overall Study|Physician Decision|1|||
48925647|NCT02435849|157559422|FG001|Overall Study|Physician Decision|0|||
48925648|NCT00293579|157559423|FG000|Overall Study|Withdrawal by Subject|1|||
48925649|NCT03099707|157559426|FG000|Overall Study|Withdrawal by Subject|0|||
48925650|NCT03099707|157559427|FG001|Overall Study|Withdrawal by Subject|3|||
48925651|NCT03099707|157559426|FG000|Overall Study|Lost to Follow-up|0|||
48925652|NCT03099707|157559427|FG001|Overall Study|Lost to Follow-up|1|||
48925653|NCT02302963|157559430|FG000|Overall Study|Withdrawal by Subject|2|||
48925654|NCT02302963|157559431|FG001|Overall Study|Withdrawal by Subject|1|||
48925655|NCT02302963|157559430|FG000|Overall Study|Steroid injection|0|||
48925656|NCT02302963|157559431|FG001|Overall Study|Steroid injection|1|||
48925657|NCT02302963|157559430|FG000|Overall Study|Physician Decision|1|||
48925658|NCT02302963|157559431|FG001|Overall Study|Physician Decision|0|||
48925659|NCT00516737|157559432|FG000|Overall Study|Lost to Follow-up|2|||
48925660|NCT00516737|157559433|FG001|Overall Study|Lost to Follow-up|0|||
48925661|NCT00516737|157559432|FG000|Overall Study|Physician Decision|0|||
48925662|NCT00516737|157559433|FG001|Overall Study|Physician Decision|1|||
48925663|NCT00516737|157559432|FG000|Overall Study|Withdrawal by Subject|0|||
48925664|NCT00516737|157559433|FG001|Overall Study|Withdrawal by Subject|1|||
48925665|NCT00516737|157559432|FG000|Overall Study|Lack of Qualifying Event|9|||
48925666|NCT00516737|157559433|FG001|Overall Study|Lack of Qualifying Event|6|||
48925667|NCT01920711|157559436|FG000|Overall Study|Death|347|||
48925668|NCT01920711|157559437|FG001|Overall Study|Death|356|||
48925669|NCT01920711|157559436|FG000|Overall Study|Lost to Follow-up|13|||
48925670|NCT01920711|157559437|FG001|Overall Study|Lost to Follow-up|14|||
48925671|NCT01920711|157559436|FG000|Overall Study|Withdrawal by Subject|4|||
48925672|NCT01920711|157559437|FG001|Overall Study|Withdrawal by Subject|3|||
48925673|NCT00511355|157559441|FG000|Overall Study|Adverse Event|4|||
48925674|NCT00511355|157559442|FG001|Overall Study|Adverse Event|4|||
48925675|NCT00511355|157559441|FG000|Overall Study|Pregnancy Wish|1|||
49167864|NCT01194219|158450169|FG009|Long-Term Extension Weeks 52 to 260|Adverse Event|14|||
49167865|NCT01194219|158450160|FG000|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
49167866|NCT01194219|158450161|FG001|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
49167867|NCT01194219|158450162|FG002|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
49167868|NCT01194219|158450163|FG003|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
49167869|NCT01194219|158450164|FG004|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
49167870|NCT01194219|158450165|FG005|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
49167871|NCT01194219|158450166|FG006|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
49167872|NCT01194219|158450167|FG007|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
49167873|NCT01194219|158450168|FG008|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81|||
49167874|NCT01194219|158450169|FG009|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49|||
49167875|NCT01194219|158450160|FG000|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
49167876|NCT01194219|158450161|FG001|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
49167877|NCT01194219|158450162|FG002|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
49167878|NCT01194219|158450163|FG003|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
49167879|NCT01194219|158450164|FG004|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
49167880|NCT01194219|158450165|FG005|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
49167881|NCT01194219|158450166|FG006|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
49167882|NCT01194219|158450167|FG007|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
49167883|NCT01194219|158450168|FG008|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9|||
49167884|NCT01194219|158450169|FG009|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4|||
49167885|NCT01194219|158450160|FG000|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
49167886|NCT01194219|158450161|FG001|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
49167887|NCT01194219|158450162|FG002|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
49167888|NCT01194219|158450163|FG003|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
49167889|NCT01194219|158450164|FG004|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
49167890|NCT01194219|158450165|FG005|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
49167891|NCT01194219|158450166|FG006|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
48925676|NCT00511355|157559442|FG001|Overall Study|Pregnancy Wish|0|||
48925677|NCT00511355|157559441|FG000|Overall Study|Lost to Follow-up|2|||
48925678|NCT00511355|157559442|FG001|Overall Study|Lost to Follow-up|1|||
48925679|NCT00511355|157559441|FG000|Overall Study|Other Reason|0|||
48925680|NCT00511355|157559442|FG001|Overall Study|Other Reason|1|||
48925681|NCT00511355|157559441|FG000|Overall Study|Pre-treatment (serious) adverse event|0|||
48925682|NCT00511355|157559442|FG001|Overall Study|Pre-treatment (serious) adverse event|1|||
48925683|NCT00511355|157559441|FG000|Overall Study|Withdrawal of informed consent|0|||
48925684|NCT00511355|157559442|FG001|Overall Study|Withdrawal of informed consent|1|||
48925685|NCT00511355|157559441|FG000|Overall Study|Other reason pre-treatment|0|||
48925686|NCT00511355|157559442|FG001|Overall Study|Other reason pre-treatment|1|||
49167892|NCT01194219|158450167|FG007|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
49167893|NCT01194219|158450168|FG008|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66|||
49167894|NCT01194219|158450169|FG009|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32|||
49167895|NCT01194219|158450160|FG000|Long-Term Extension Weeks 52 to 260|Death|0|||
49167896|NCT01194219|158450161|FG001|Long-Term Extension Weeks 52 to 260|Death|0|||
49167897|NCT01194219|158450162|FG002|Long-Term Extension Weeks 52 to 260|Death|0|||
49167898|NCT01194219|158450163|FG003|Long-Term Extension Weeks 52 to 260|Death|0|||
49167899|NCT01194219|158450164|FG004|Long-Term Extension Weeks 52 to 260|Death|0|||
49167900|NCT01194219|158450165|FG005|Long-Term Extension Weeks 52 to 260|Death|0|||
49167901|NCT01194219|158450166|FG006|Long-Term Extension Weeks 52 to 260|Death|0|||
49167902|NCT01194219|158450167|FG007|Long-Term Extension Weeks 52 to 260|Death|0|||
49167903|NCT01194219|158450168|FG008|Long-Term Extension Weeks 52 to 260|Death|1|||
49167904|NCT01194219|158450169|FG009|Long-Term Extension Weeks 52 to 260|Death|1|||
49167905|NCT01194219|158450160|FG000|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
49167906|NCT01194219|158450161|FG001|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
49167907|NCT01194219|158450162|FG002|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
49167908|NCT01194219|158450163|FG003|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
49167909|NCT01194219|158450164|FG004|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
49167910|NCT01194219|158450165|FG005|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
49167911|NCT01194219|158450166|FG006|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
49167912|NCT01194219|158450167|FG007|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
49167913|NCT01194219|158450168|FG008|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24|||
49167914|NCT01194219|158450169|FG009|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10|||
49167915|NCT01194219|158450160|FG000|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
49167916|NCT01194219|158450161|FG001|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
49167917|NCT01194219|158450162|FG002|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
49167918|NCT01194219|158450163|FG003|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
49167919|NCT01194219|158450164|FG004|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
49167920|NCT01194219|158450165|FG005|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
49167921|NCT01194219|158450166|FG006|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
49167922|NCT01194219|158450167|FG007|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
49167923|NCT01194219|158450168|FG008|Long-Term Extension Weeks 52 to 260|Protocol Violation|3|||
49167924|NCT01194219|158450169|FG009|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
49167925|NCT01194219|158450160|FG000|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
49167926|NCT01194219|158450161|FG001|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
49167927|NCT01194219|158450162|FG002|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
49167928|NCT01194219|158450163|FG003|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
49167929|NCT01194219|158450164|FG004|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
49167930|NCT01194219|158450165|FG005|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
49167931|NCT01194219|158450166|FG006|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
49167932|NCT01194219|158450167|FG007|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
49167933|NCT01194219|158450168|FG008|Long-Term Extension Weeks 52 to 260|Miscellaneous|11|||
48841443|NCT02988817|157259373|FG014|Overall Study|Death|18|||
48841444|NCT02988817|157259374|FG015|Overall Study|Death|30|||
48841445|NCT02988817|157259375|FG016|Overall Study|Death|17|||
48841446|NCT02988817|157259376|FG017|Overall Study|Death|38|||
48841447|NCT02988817|157259377|FG018|Overall Study|Death|14|||
48841448|NCT02988817|157259378|FG019|Overall Study|Death|16|||
48841449|NCT02988817|157259359|FG000|Overall Study|Other|0|||
48841450|NCT02988817|157259360|FG001|Overall Study|Other|0|||
48841451|NCT02988817|157259361|FG002|Overall Study|Other|0|||
48841452|NCT02988817|157259362|FG003|Overall Study|Other|1|||
48841453|NCT02988817|157259363|FG004|Overall Study|Other|1|||
48841454|NCT02988817|157259364|FG005|Overall Study|Other|0|||
48841455|NCT02988817|157259365|FG006|Overall Study|Other|0|||
48841456|NCT02988817|157259366|FG007|Overall Study|Other|0|||
48841457|NCT02988817|157259367|FG008|Overall Study|Other|0|||
48841458|NCT02988817|157259368|FG009|Overall Study|Other|0|||
48841459|NCT02988817|157259369|FG010|Overall Study|Other|0|||
48841460|NCT02988817|157259370|FG011|Overall Study|Other|0|||
48841461|NCT02988817|157259371|FG012|Overall Study|Other|0|||
48841462|NCT02988817|157259372|FG013|Overall Study|Other|0|||
48841463|NCT02988817|157259373|FG014|Overall Study|Other|0|||
48841464|NCT02988817|157259374|FG015|Overall Study|Other|1|||
48841465|NCT02988817|157259375|FG016|Overall Study|Other|0|||
48841466|NCT02988817|157259376|FG017|Overall Study|Other|0|||
48841467|NCT02988817|157259377|FG018|Overall Study|Other|0|||
48841468|NCT02988817|157259378|FG019|Overall Study|Other|0|||
48841469|NCT02988817|157259359|FG000|Overall Study|Lost to Follow-up|0|||
48841470|NCT02988817|157259360|FG001|Overall Study|Lost to Follow-up|0|||
48841471|NCT02988817|157259361|FG002|Overall Study|Lost to Follow-up|0|||
48841472|NCT02988817|157259362|FG003|Overall Study|Lost to Follow-up|0|||
48841473|NCT02988817|157259363|FG004|Overall Study|Lost to Follow-up|0|||
48925687|NCT00603915|157559443|FG000|Overall Study|Physician Decision|1|||
48925688|NCT00454805|157559444|FG000|Overall Study|Withdrawal by Subject|9|||
48925689|NCT00454805|157559445|FG001|Overall Study|Withdrawal by Subject|2|||
48925690|NCT00454805|157559444|FG000|Overall Study|Death|0|||
48925691|NCT00454805|157559445|FG001|Overall Study|Death|2|||
48925692|NCT00454805|157559444|FG000|Overall Study|Disease progression|16|||
48925693|NCT00454805|157559445|FG001|Overall Study|Disease progression|19|||
49167934|NCT01194219|158450169|FG009|Long-Term Extension Weeks 52 to 260|Miscellaneous|2|||
49167935|NCT03326063|158450172|FG000|Overall Study|COVID pandemic: subject recalled to her country|1|||
49167936|NCT03326063|158450173|FG001|Overall Study|COVID pandemic: subject recalled to her country|0|||
49167937|NCT01253369|158450178|FG000|Overall Study|Adverse Event|4|||
49167938|NCT01253369|158450178|FG000|Overall Study|Withdrawal by Subject|2|||
49167939|NCT01253369|158450178|FG000|Overall Study|Death|1|||
49167940|NCT01253369|158450178|FG000|Overall Study|Progressive disease|23|||
49167941|NCT01253369|158450178|FG000|Overall Study|Not Evaluable|3|||
49167942|NCT00690430|158450180|FG000|Core Phase|Abnormal Laboratory value|0|||
49167943|NCT00690430|158450181|FG001|Core Phase|Abnormal Laboratory value|1|||
49167944|NCT00690430|158450182|FG002|Core Phase|Abnormal Laboratory value|0|||
49167945|NCT00690430|158450180|FG000|Core Phase|Adverse Event|5|||
49167946|NCT00690430|158450181|FG001|Core Phase|Adverse Event|1|||
49167947|NCT00690430|158450182|FG002|Core Phase|Adverse Event|0|||
49167948|NCT00690430|158450180|FG000|Core Phase|Death|0|||
49167949|NCT00690430|158450181|FG001|Core Phase|Death|2|||
49167950|NCT00690430|158450182|FG002|Core Phase|Death|0|||
49167951|NCT00690430|158450180|FG000|Core Phase|Protocol Violation|1|||
49167952|NCT00690430|158450181|FG001|Core Phase|Protocol Violation|0|||
49167953|NCT00690430|158450182|FG002|Core Phase|Protocol Violation|0|||
49167954|NCT00690430|158450180|FG000|Core Phase|Withdrawal by Subject|3|||
49167955|NCT00690430|158450181|FG001|Core Phase|Withdrawal by Subject|3|||
49167956|NCT00690430|158450182|FG002|Core Phase|Withdrawal by Subject|0|||
49167957|NCT00690430|158450180|FG000|Core Phase|Subject no longer requires study drug|1|||
49167958|NCT00690430|158450181|FG001|Core Phase|Subject no longer requires study drug|0|||
49167959|NCT00690430|158450182|FG002|Core Phase|Subject no longer requires study drug|0|||
49167960|NCT00690430|158450180|FG000|Core Phase|Lack of Efficacy|8|||
49167961|NCT00690430|158450181|FG001|Core Phase|Lack of Efficacy|10|||
49167962|NCT00690430|158450182|FG002|Core Phase|Lack of Efficacy|0|||
49167963|NCT00690430|158450180|FG000|Core Phase|Administrative Problems|0|||
49167964|NCT00690430|158450181|FG001|Core Phase|Administrative Problems|1|||
49167965|NCT00690430|158450182|FG002|Core Phase|Administrative Problems|0|||
49167966|NCT00690430|158450180|FG000|Core Phase|Early Termination|0|||
49167967|NCT00690430|158450181|FG001|Core Phase|Early Termination|5|||
49167968|NCT00690430|158450182|FG002|Core Phase|Early Termination|0|||
49167969|NCT00690430|158450180|FG000|Extension Phase|Lack of Efficacy|3|||
49167970|NCT00690430|158450181|FG001|Extension Phase|Lack of Efficacy|1|||
49167971|NCT00690430|158450182|FG002|Extension Phase|Lack of Efficacy|4|||
49167972|NCT00690430|158450180|FG000|Extension Phase|Abnormal Lab Values|1|||
49167973|NCT00690430|158450181|FG001|Extension Phase|Abnormal Lab Values|0|||
49167974|NCT00690430|158450182|FG002|Extension Phase|Abnormal Lab Values|0|||
49167975|NCT00690430|158450180|FG000|Extension Phase|Abnormal test procedure results|1|||
49167976|NCT00690430|158450181|FG001|Extension Phase|Abnormal test procedure results|0|||
49167977|NCT00690430|158450182|FG002|Extension Phase|Abnormal test procedure results|0|||
49167978|NCT00690430|158450180|FG000|Extension Phase|Administrative Problems|0|||
49167979|NCT00690430|158450181|FG001|Extension Phase|Administrative Problems|1|||
49167980|NCT00690430|158450182|FG002|Extension Phase|Administrative Problems|1|||
49167981|NCT00690430|158450180|FG000|Extension Phase|Adverse Event|2|||
49167982|NCT00690430|158450181|FG001|Extension Phase|Adverse Event|1|||
49167983|NCT00690430|158450182|FG002|Extension Phase|Adverse Event|2|||
49167984|NCT00690430|158450180|FG000|Extension Phase|Death|1|||
49167985|NCT00690430|158450181|FG001|Extension Phase|Death|1|||
49167986|NCT00690430|158450182|FG002|Extension Phase|Death|1|||
48925694|NCT00454805|157559444|FG000|Overall Study|In order to begin radiotherapy|1|||
48925695|NCT00454805|157559445|FG001|Overall Study|In order to begin radiotherapy|0|||
48925696|NCT01609842|157559455|FG000|Concurrent Intervention Control|pharmacy data not available|2|||
49167987|NCT00690430|158450180|FG000|Extension Phase|Withdrawal by Subject|0|||
49167988|NCT00690430|158450181|FG001|Extension Phase|Withdrawal by Subject|0|||
49167989|NCT00690430|158450182|FG002|Extension Phase|Withdrawal by Subject|2|||
49167990|NCT00690430|158450180|FG000|Extension Phase|Early Termination|10|||
49167991|NCT00690430|158450181|FG001|Extension Phase|Early Termination|1|||
49167992|NCT00690430|158450182|FG002|Extension Phase|Early Termination|3|||
49167993|NCT00763256|158450183|FG000|Overall Study|Didn't return for appointments|7|||
49167994|NCT00763256|158450184|FG001|Overall Study|Didn't return for appointments|10|||
48925697|NCT01609842|157559456|FG001|Concurrent Intervention Control|pharmacy data not available|0|||
49167995|NCT04677543|158450185|FG000|Overall Study|Withdrawal by Subject|4|||
49167996|NCT04677543|158450186|FG001|Overall Study|Withdrawal by Subject|1|||
49167997|NCT04677543|158450185|FG000|Overall Study|Physician Decision|0|||
49167998|NCT04677543|158450186|FG001|Overall Study|Physician Decision|1|||
49167999|NCT04677543|158450185|FG000|Overall Study|Adverse Event|0|||
48925698|NCT01356589|157559457|FG000|Overall Study|Enrolled, but not treated|3|||
48925699|NCT01356589|157559457|FG000|Overall Study|Dose data not recorded|2|||
48925700|NCT02361216|157559458|FG000|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0|||
48925701|NCT02361216|157559459|FG001|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1|||
48925702|NCT02361216|157559458|FG000|3 Day Treatment and 8 Week Follow/up|Adverse Event|1|||
48925703|NCT02361216|157559459|FG001|3 Day Treatment and 8 Week Follow/up|Adverse Event|2|||
48925704|NCT02361216|157559458|FG000|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1|||
48925705|NCT02361216|157559459|FG001|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0|||
48925706|NCT02361216|157559458|FG000|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6|||
48925707|NCT02361216|157559459|FG001|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11|||
48925708|NCT02361216|157559458|FG000|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
48925709|NCT02361216|157559459|FG001|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
48925710|NCT02361216|157559458|FG000|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0|||
48925711|NCT02361216|157559459|FG001|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2|||
48925712|NCT00803179|157559460|FG000|Overall Study|Lost to Follow-up|3|||
48925713|NCT03110900|157559461|FG000|Overall Study|Sponsor withdrew|1|||
48925714|NCT03110900|157559462|FG001|Overall Study|Sponsor withdrew|1|||
48925715|NCT02482129|157559466|FG000|Overall Study|Adverse Event-prior to treatment|0|||
48925716|NCT02482129|157559467|FG001|Overall Study|Adverse Event-prior to treatment|1|||
48925717|NCT02482129|157559466|FG000|Overall Study|Withdrawal by subject-prior to treatment|0|||
48925718|NCT02482129|157559467|FG001|Overall Study|Withdrawal by subject-prior to treatment|1|||
48925719|NCT02482129|157559466|FG000|Overall Study|Unable to draw blood-prior to treatment|1|||
48925720|NCT02482129|157559467|FG001|Overall Study|Unable to draw blood-prior to treatment|0|||
48925721|NCT02482129|157559466|FG000|Overall Study|Criteria not met-prior to treatment|1|||
48925722|NCT02482129|157559467|FG001|Overall Study|Criteria not met-prior to treatment|0|||
48925723|NCT02482129|157559466|FG000|Overall Study|Adverse Event|1|||
48925724|NCT02482129|157559467|FG001|Overall Study|Adverse Event|0|||
48925725|NCT02482129|157559466|FG000|Overall Study|Withdrawal by Subject|2|||
48925726|NCT02482129|157559467|FG001|Overall Study|Withdrawal by Subject|0|||
48925727|NCT02482129|157559466|FG000|Overall Study|Criteria not met|1|||
48925728|NCT02482129|157559467|FG001|Overall Study|Criteria not met|0|||
48925729|NCT00490568|157561699|FG000|Overall Study|Adverse Event|116|||
48925730|NCT00490568|157561699|FG000|Overall Study|Lost to Follow-up|13|||
48925731|NCT00490568|157561699|FG000|Overall Study|Protocol Violation|45|||
48925732|NCT00490568|157561699|FG000|Overall Study|Withdrawal by Subject|135|||
48925733|NCT00490568|157561699|FG000|Overall Study|Still in the study at termination|974|||
48925734|NCT00490568|157561699|FG000|Overall Study|Other|1|||
49168000|NCT04677543|158450186|FG001|Overall Study|Adverse Event|1|||
49168001|NCT02534883|158450189|FG000|Overall Study|Early Termination|8|||
49168002|NCT02534883|158450190|FG001|Overall Study|Early Termination|3|||
49168003|NCT02473471|158450192|FG000|Overall Study|poor oral hygiene|2|||
49168004|NCT02473471|158450192|FG000|Overall Study|Lost to Follow-up|1|||
49168005|NCT03745638|158450193|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|4|||
49168006|NCT03745638|158450194|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|2|||
49168007|NCT03745638|158450195|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
49168008|NCT03745638|158450196|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
49168009|NCT03745638|158450197|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
49168010|NCT03745638|158450198|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
49168011|NCT03745638|158450199|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
49168012|NCT03745638|158450193|FG000|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|1|||
49168013|NCT03745638|158450194|FG001|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
49168014|NCT03745638|158450195|FG002|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
49168015|NCT03745638|158450196|FG003|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
49168016|NCT03745638|158450197|FG004|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
49168017|NCT03745638|158450198|FG005|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
49168018|NCT03745638|158450199|FG006|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
48925735|NCT00490568|157561699|FG000|Overall Study|Exclusion criteria met|1|||
48925736|NCT00490568|157561699|FG000|Overall Study|Caregiver related|20|||
48925737|NCT00490568|157561699|FG000|Overall Study|Abnormal ECG|25|||
48925738|NCT00490568|157561699|FG000|Overall Study|Participant refused follow-up|9|||
49168019|NCT03745638|158450193|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|5|||
49168020|NCT03745638|158450194|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|12|||
49168021|NCT03745638|158450195|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|8|||
48925739|NCT00490568|157561699|FG000|Overall Study|Legal representative withdrew consent|1|||
48925740|NCT00490568|157561699|FG000|Overall Study|Disease progression|4|||
48925741|NCT00490568|157561699|FG000|Overall Study|Unmet inclusion-exclusion criteria|5|||
48925742|NCT00490568|157561699|FG000|Overall Study|Investigator decision|3|||
48925743|NCT00490568|157561699|FG000|Overall Study|Non-Compliance|7|||
48925744|NCT00490568|157561699|FG000|Overall Study|Efficacy related|3|||
48925745|NCT00490568|157561699|FG000|Overall Study|Participant died|1|||
49168022|NCT03745638|158450196|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
49168023|NCT03745638|158450197|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
48925746|NCT00490568|157561699|FG000|Overall Study|Participant withdrawal due to surgery|1|||
48925747|NCT01964352|157561701|FG000|Overall Study|Adverse Event|13|||
48925748|NCT01964352|157561702|FG001|Overall Study|Adverse Event|3|||
48925749|NCT01964352|157561703|FG002|Overall Study|Adverse Event|4|||
48925750|NCT01964352|157561704|FG003|Overall Study|Adverse Event|3|||
48925751|NCT01964352|157561701|FG000|Overall Study|Lack of Efficacy|6|||
48925752|NCT01964352|157561702|FG001|Overall Study|Lack of Efficacy|0|||
48925753|NCT01964352|157561703|FG002|Overall Study|Lack of Efficacy|0|||
48925754|NCT01964352|157561704|FG003|Overall Study|Lack of Efficacy|0|||
48925755|NCT01964352|157561701|FG000|Overall Study|Protocol Violation|2|||
48925756|NCT01964352|157561702|FG001|Overall Study|Protocol Violation|4|||
49168024|NCT03745638|158450198|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
49168025|NCT03745638|158450199|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
49168026|NCT03745638|158450193|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
49168027|NCT03745638|158450194|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
49168028|NCT03745638|158450195|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
49168029|NCT03745638|158450196|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
49168030|NCT03745638|158450197|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
49168031|NCT03745638|158450198|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
49168032|NCT03745638|158450199|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
49168033|NCT03745638|158450193|FG000|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|1|||
49168034|NCT03745638|158450194|FG001|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
49168035|NCT03745638|158450195|FG002|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
49168036|NCT03745638|158450196|FG003|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
49168037|NCT03745638|158450197|FG004|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
49168038|NCT03745638|158450198|FG005|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
49168039|NCT03745638|158450199|FG006|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
49168040|NCT03745638|158450193|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
49168041|NCT03745638|158450194|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|3|||
49168042|NCT03745638|158450195|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
49168043|NCT03745638|158450196|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
49168044|NCT03745638|158450197|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
49168045|NCT03745638|158450198|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
49168046|NCT03745638|158450199|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
49168047|NCT03745638|158450193|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|17|||
49168048|NCT03745638|158450194|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
49168049|NCT03745638|158450195|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|19|||
49168050|NCT03745638|158450196|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
49168051|NCT03745638|158450197|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
49168052|NCT03745638|158450198|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
49168053|NCT03745638|158450199|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
49168054|NCT03745638|158450193|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|2|||
48925757|NCT01964352|157561703|FG002|Overall Study|Protocol Violation|0|||
48925758|NCT01964352|157561704|FG003|Overall Study|Protocol Violation|2|||
48925759|NCT01964352|157561701|FG000|Overall Study|Lost to Follow-up|1|||
48925760|NCT01964352|157561702|FG001|Overall Study|Lost to Follow-up|0|||
48925761|NCT01964352|157561703|FG002|Overall Study|Lost to Follow-up|0|||
48925762|NCT01964352|157561704|FG003|Overall Study|Lost to Follow-up|1|||
48925763|NCT01964352|157561701|FG000|Overall Study|Withdrawal by Subject|4|||
48925764|NCT01964352|157561702|FG001|Overall Study|Withdrawal by Subject|2|||
48925765|NCT01964352|157561703|FG002|Overall Study|Withdrawal by Subject|1|||
48925766|NCT01964352|157561704|FG003|Overall Study|Withdrawal by Subject|0|||
48925767|NCT01964352|157561701|FG000|Overall Study|Other than stated above|0|||
48925768|NCT01964352|157561702|FG001|Overall Study|Other than stated above|2|||
48925769|NCT01964352|157561703|FG002|Overall Study|Other than stated above|1|||
48925770|NCT01964352|157561704|FG003|Overall Study|Other than stated above|2|||
48925771|NCT03657043|157561705|FG000|Overall Study|Withdrawal by Subject|1|||
48925772|NCT03657043|157561706|FG001|Overall Study|Withdrawal by Subject|1|||
48925773|NCT03657043|157561707|FG002|Overall Study|Withdrawal by Subject|0|||
48925774|NCT03657043|157561708|FG003|Overall Study|Withdrawal by Subject|0|||
48925775|NCT03657043|157561709|FG004|Overall Study|Withdrawal by Subject|4|||
49168055|NCT03745638|158450194|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|1|||
49168056|NCT03745638|158450195|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
49168057|NCT03745638|158450196|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
49168058|NCT03745638|158450197|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
49168059|NCT03745638|158450198|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
49168060|NCT03745638|158450199|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
49168061|NCT03745638|158450193|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
49168062|NCT03745638|158450194|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
49168063|NCT03745638|158450195|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
49168064|NCT03745638|158450196|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
49168065|NCT03745638|158450197|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
49168066|NCT03745638|158450198|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|6|||
49168067|NCT03745638|158450199|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|1|||
49168068|NCT03745638|158450193|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
49168069|NCT03745638|158450194|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
49168070|NCT03745638|158450195|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
49168071|NCT03745638|158450196|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
49168072|NCT03745638|158450197|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
49168073|NCT03745638|158450198|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
49168074|NCT03745638|158450199|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
49168075|NCT03745638|158450193|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
49168076|NCT03745638|158450194|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
49168077|NCT03745638|158450195|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
49168078|NCT03745638|158450196|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|3|||
49168079|NCT03745638|158450197|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|5|||
48951830|NCT01993329|157654909|FG001|Period 2|Adverse Event|0|||
49168080|NCT03745638|158450198|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
49168081|NCT03745638|158450199|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|24|||
49168082|NCT03745638|158450193|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
49168083|NCT03745638|158450194|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
49168084|NCT03745638|158450195|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
49168085|NCT03745638|158450196|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
49168086|NCT03745638|158450197|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
49168087|NCT03745638|158450198|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|3|||
49168088|NCT03745638|158450199|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
49168089|NCT03745638|158450193|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
49168090|NCT03745638|158450194|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
49168091|NCT03745638|158450195|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
49168092|NCT03745638|158450196|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
49168093|NCT03745638|158450197|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
49168094|NCT03745638|158450198|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
49168095|NCT03745638|158450199|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
49168096|NCT03745638|158450193|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
48925776|NCT03657043|157561705|FG000|Overall Study|Study closure by Sponsor|0|||
48925777|NCT03657043|157561706|FG001|Overall Study|Study closure by Sponsor|2|||
48925778|NCT03657043|157561707|FG002|Overall Study|Study closure by Sponsor|0|||
49168097|NCT03745638|158450194|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
49168098|NCT03745638|158450195|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
49168099|NCT03745638|158450196|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|7|||
49168100|NCT03745638|158450197|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
49168101|NCT03745638|158450198|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|17|||
49168102|NCT03745638|158450199|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|21|||
49168103|NCT03745638|158450193|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
49168104|NCT03745638|158450194|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
49168105|NCT03745638|158450195|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
49168106|NCT03745638|158450196|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
49168107|NCT03745638|158450197|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
49168108|NCT03745638|158450198|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|4|||
49168109|NCT03745638|158450199|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|3|||
49168110|NCT02375373|158450202|FG000|Overall Study|Withdrawal by Subject|11|||
49168111|NCT00255723|158450203|FG000|Overall Study|Adverse Event|1|||
49168112|NCT00255723|158450204|FG001|Overall Study|Adverse Event|1|||
49168113|NCT00255723|158450203|FG000|Overall Study|Death|0|||
49168114|NCT00255723|158450204|FG001|Overall Study|Death|1|||
49168115|NCT00255723|158450203|FG000|Overall Study|Response Data Not Available|1|||
49168116|NCT00255723|158450204|FG001|Overall Study|Response Data Not Available|0|||
49168117|NCT02517398|158450205|FG000|Overall Study|Death|2|||
49168118|NCT02517398|158450206|FG001|Overall Study|Death|3|||
49168119|NCT02517398|158450207|FG002|Overall Study|Death|4|||
49168120|NCT02517398|158450208|FG003|Overall Study|Death|2|||
49168121|NCT02517398|158450209|FG004|Overall Study|Death|3|||
49168122|NCT02517398|158450210|FG005|Overall Study|Death|8|||
49168123|NCT02517398|158450211|FG006|Overall Study|Death|3|||
49168124|NCT02517398|158450212|FG007|Overall Study|Death|2|||
49168125|NCT02517398|158450213|FG008|Overall Study|Death|6|||
49168126|NCT02517398|158450214|FG009|Overall Study|Death|24|||
49168127|NCT02517398|158450215|FG010|Overall Study|Death|53|||
49168128|NCT02517398|158450216|FG011|Overall Study|Death|25|||
48925779|NCT03657043|157561708|FG003|Overall Study|Study closure by Sponsor|0|||
48925780|NCT03657043|157561709|FG004|Overall Study|Study closure by Sponsor|17|||
48925781|NCT03657043|157561705|FG000|Overall Study|Lost to Follow-up|0|||
48925782|NCT03657043|157561706|FG001|Overall Study|Lost to Follow-up|0|||
49168129|NCT02517398|158450217|FG012|Overall Study|Death|73|||
49168130|NCT02517398|158450218|FG013|Overall Study|Death|29|||
49168131|NCT02517398|158450219|FG014|Overall Study|Death|26|||
49168132|NCT02517398|158450220|FG015|Overall Study|Death|23|||
48925783|NCT03657043|157561707|FG002|Overall Study|Lost to Follow-up|0|||
49168133|NCT02517398|158450221|FG016|Overall Study|Death|26|||
49168134|NCT02517398|158450222|FG017|Overall Study|Death|25|||
49168135|NCT02517398|158450223|FG018|Overall Study|Death|22|||
49168136|NCT02517398|158450224|FG019|Overall Study|Death|7|||
48925784|NCT03657043|157561708|FG003|Overall Study|Lost to Follow-up|0|||
48925785|NCT03657043|157561709|FG004|Overall Study|Lost to Follow-up|4|||
49168137|NCT02517398|158450225|FG020|Overall Study|Death|26|||
49168138|NCT02517398|158450226|FG021|Overall Study|Death|30|||
49168139|NCT02517398|158450227|FG022|Overall Study|Death|20|||
49168140|NCT02517398|158450205|FG000|Overall Study|Other|0|||
49168141|NCT02517398|158450206|FG001|Overall Study|Other|0|||
49168142|NCT02517398|158450207|FG002|Overall Study|Other|0|||
49168143|NCT02517398|158450208|FG003|Overall Study|Other|1|||
49168144|NCT02517398|158450209|FG004|Overall Study|Other|0|||
49168145|NCT02517398|158450210|FG005|Overall Study|Other|0|||
49168146|NCT02517398|158450211|FG006|Overall Study|Other|0|||
48925786|NCT03657043|157561705|FG000|Overall Study|Death|6|||
48925787|NCT03657043|157561706|FG001|Overall Study|Death|5|||
48925788|NCT03657043|157561707|FG002|Overall Study|Death|0|||
48925789|NCT03657043|157561708|FG003|Overall Study|Death|0|||
49168147|NCT02517398|158450212|FG007|Overall Study|Other|0|||
49168148|NCT02517398|158450213|FG008|Overall Study|Other|0|||
49168149|NCT02517398|158450214|FG009|Overall Study|Other|1|||
49168150|NCT02517398|158450215|FG010|Overall Study|Other|0|||
49168151|NCT02517398|158450216|FG011|Overall Study|Other|0|||
49168152|NCT02517398|158450217|FG012|Overall Study|Other|0|||
49168153|NCT02517398|158450218|FG013|Overall Study|Other|1|||
49168154|NCT02517398|158450219|FG014|Overall Study|Other|0|||
49168155|NCT02517398|158450220|FG015|Overall Study|Other|1|||
49168156|NCT02517398|158450221|FG016|Overall Study|Other|1|||
49168157|NCT02517398|158450222|FG017|Overall Study|Other|0|||
49168158|NCT02517398|158450223|FG018|Overall Study|Other|0|||
49168159|NCT02517398|158450224|FG019|Overall Study|Other|1|||
49168160|NCT02517398|158450225|FG020|Overall Study|Other|0|||
49168161|NCT02517398|158450226|FG021|Overall Study|Other|0|||
49168162|NCT02517398|158450227|FG022|Overall Study|Other|0|||
49168163|NCT02517398|158450205|FG000|Overall Study|Lost to Follow-up|0|||
49168164|NCT02517398|158450206|FG001|Overall Study|Lost to Follow-up|0|||
49168165|NCT02517398|158450207|FG002|Overall Study|Lost to Follow-up|0|||
48925790|NCT03657043|157561709|FG004|Overall Study|Death|53|||
48925791|NCT03657043|157561705|FG000|Overall Study|Met exclusion criteria after enrollment|1|||
48925792|NCT03657043|157561706|FG001|Overall Study|Met exclusion criteria after enrollment|0|||
48925793|NCT03657043|157561707|FG002|Overall Study|Met exclusion criteria after enrollment|0|||
48925794|NCT03657043|157561708|FG003|Overall Study|Met exclusion criteria after enrollment|0|||
48925795|NCT03657043|157561709|FG004|Overall Study|Met exclusion criteria after enrollment|0|||
49168166|NCT02517398|158450208|FG003|Overall Study|Lost to Follow-up|0|||
49168167|NCT02517398|158450209|FG004|Overall Study|Lost to Follow-up|0|||
49168168|NCT02517398|158450210|FG005|Overall Study|Lost to Follow-up|0|||
49168169|NCT02517398|158450211|FG006|Overall Study|Lost to Follow-up|0|||
49168170|NCT02517398|158450212|FG007|Overall Study|Lost to Follow-up|0|||
49168171|NCT02517398|158450213|FG008|Overall Study|Lost to Follow-up|0|||
49168172|NCT02517398|158450214|FG009|Overall Study|Lost to Follow-up|1|||
49168173|NCT02517398|158450215|FG010|Overall Study|Lost to Follow-up|0|||
48925796|NCT03657043|157561705|FG000|Overall Study|Adverse Event|0|||
48925797|NCT03657043|157561706|FG001|Overall Study|Adverse Event|0|||
48925798|NCT03657043|157561707|FG002|Overall Study|Adverse Event|0|||
48925799|NCT03657043|157561708|FG003|Overall Study|Adverse Event|0|||
48925800|NCT03657043|157561709|FG004|Overall Study|Adverse Event|2|||
49168174|NCT02517398|158450216|FG011|Overall Study|Lost to Follow-up|2|||
49168175|NCT02517398|158450217|FG012|Overall Study|Lost to Follow-up|2|||
49168176|NCT02517398|158450218|FG013|Overall Study|Lost to Follow-up|0|||
48925801|NCT03657043|157561705|FG000|Overall Study|Withdrawal - subsequent treatment|0|||
48925802|NCT03657043|157561706|FG001|Overall Study|Withdrawal - subsequent treatment|0|||
48925803|NCT03657043|157561707|FG002|Overall Study|Withdrawal - subsequent treatment|0|||
49168177|NCT02517398|158450219|FG014|Overall Study|Lost to Follow-up|1|||
49168178|NCT02517398|158450220|FG015|Overall Study|Lost to Follow-up|1|||
49168179|NCT02517398|158450221|FG016|Overall Study|Lost to Follow-up|0|||
49168180|NCT02517398|158450222|FG017|Overall Study|Lost to Follow-up|3|||
48925804|NCT03657043|157561708|FG003|Overall Study|Withdrawal - subsequent treatment|0|||
49168181|NCT02517398|158450223|FG018|Overall Study|Lost to Follow-up|1|||
49168182|NCT02517398|158450224|FG019|Overall Study|Lost to Follow-up|0|||
49168183|NCT02517398|158450225|FG020|Overall Study|Lost to Follow-up|1|||
49168184|NCT02517398|158450226|FG021|Overall Study|Lost to Follow-up|0|||
49168185|NCT02517398|158450227|FG022|Overall Study|Lost to Follow-up|2|||
49168186|NCT02517398|158450205|FG000|Overall Study|Withdrew Consent|0|||
49168187|NCT02517398|158450206|FG001|Overall Study|Withdrew Consent|0|||
49168188|NCT02517398|158450207|FG002|Overall Study|Withdrew Consent|0|||
49168189|NCT02517398|158450208|FG003|Overall Study|Withdrew Consent|0|||
48925805|NCT03657043|157561709|FG004|Overall Study|Withdrawal - subsequent treatment|1|||
48925806|NCT03657043|157561705|FG000|Overall Study|Withdrawal - declined follow-up|0|||
49168190|NCT02517398|158450209|FG004|Overall Study|Withdrew Consent|0|||
49168191|NCT02517398|158450210|FG005|Overall Study|Withdrew Consent|0|||
49168192|NCT02517398|158450211|FG006|Overall Study|Withdrew Consent|1|||
49168193|NCT02517398|158450212|FG007|Overall Study|Withdrew Consent|0|||
49168194|NCT02517398|158450213|FG008|Overall Study|Withdrew Consent|0|||
49168195|NCT02517398|158450214|FG009|Overall Study|Withdrew Consent|2|||
49168196|NCT02517398|158450215|FG010|Overall Study|Withdrew Consent|7|||
49168197|NCT02517398|158450216|FG011|Overall Study|Withdrew Consent|1|||
49168198|NCT02517398|158450217|FG012|Overall Study|Withdrew Consent|5|||
49168199|NCT02517398|158450218|FG013|Overall Study|Withdrew Consent|4|||
49168200|NCT02517398|158450219|FG014|Overall Study|Withdrew Consent|2|||
49168201|NCT02517398|158450220|FG015|Overall Study|Withdrew Consent|5|||
49168202|NCT02517398|158450221|FG016|Overall Study|Withdrew Consent|4|||
49168203|NCT02517398|158450222|FG017|Overall Study|Withdrew Consent|2|||
49168204|NCT02517398|158450223|FG018|Overall Study|Withdrew Consent|3|||
49168205|NCT02517398|158450224|FG019|Overall Study|Withdrew Consent|2|||
49168206|NCT02517398|158450225|FG020|Overall Study|Withdrew Consent|9|||
49168207|NCT02517398|158450226|FG021|Overall Study|Withdrew Consent|3|||
49168208|NCT02517398|158450227|FG022|Overall Study|Withdrew Consent|1|||
49168209|NCT02567799|158450228|FG000|Concurrent Chemoradiotherapy|Death|1|||
49168210|NCT02567799|158450229|FG001|Concurrent Chemoradiotherapy|Death|0|||
49168211|NCT02567799|158450230|FG002|Concurrent Chemoradiotherapy|Death|0|||
49168212|NCT02567799|158450228|FG000|Concurrent Chemoradiotherapy|Adverse Event|0|||
49168213|NCT02567799|158450229|FG001|Concurrent Chemoradiotherapy|Adverse Event|1|||
49168214|NCT02567799|158450230|FG002|Concurrent Chemoradiotherapy|Adverse Event|0|||
49168215|NCT02567799|158450228|FG000|Concurrent Chemoradiotherapy|Progressive Disease|0|||
49168216|NCT02567799|158450229|FG001|Concurrent Chemoradiotherapy|Progressive Disease|2|||
49168217|NCT02567799|158450230|FG002|Concurrent Chemoradiotherapy|Progressive Disease|1|||
49168218|NCT02567799|158450228|FG000|Follow-up|Death|1|||
49168219|NCT02567799|158450229|FG001|Follow-up|Death|0|||
49168220|NCT02567799|158450230|FG002|Follow-up|Death|1|||
49168221|NCT02567799|158450228|FG000|Follow-up|Progressive Disease|1|||
49168222|NCT02567799|158450229|FG001|Follow-up|Progressive Disease|1|||
49168223|NCT02567799|158450230|FG002|Follow-up|Progressive Disease|3|||
49168224|NCT00465972|158450231|FG000|Overall Study|Withdrawal by Subject|2|||
49168225|NCT00465972|158450232|FG001|Overall Study|Withdrawal by Subject|1|||
49168226|NCT00642707|158450233|FG000|Overall Study|Adverse Event|0|||
49168227|NCT00642707|158450234|FG001|Overall Study|Adverse Event|0|||
49168228|NCT00642707|158450235|FG002|Overall Study|Adverse Event|0|||
49168229|NCT00642707|158450236|FG003|Overall Study|Adverse Event|2|||
49168230|NCT00642707|158450233|FG000|Overall Study|Withdrawal by Subject|1|||
49168231|NCT00642707|158450234|FG001|Overall Study|Withdrawal by Subject|0|||
49168232|NCT00642707|158450235|FG002|Overall Study|Withdrawal by Subject|0|||
49168233|NCT00642707|158450236|FG003|Overall Study|Withdrawal by Subject|0|||
49168234|NCT00130039|158450237|FG000|Overall Study|Withdrawal by Subject|15|||
49168235|NCT00130039|158450238|FG001|Overall Study|Withdrawal by Subject|11|||
49168236|NCT00130039|158450237|FG000|Overall Study|Lost to Follow-up|3|||
49168237|NCT00130039|158450238|FG001|Overall Study|Lost to Follow-up|1|||
48841474|NCT02988817|157259364|FG005|Overall Study|Lost to Follow-up|0|||
48841475|NCT02988817|157259365|FG006|Overall Study|Lost to Follow-up|0|||
48841476|NCT02988817|157259366|FG007|Overall Study|Lost to Follow-up|0|||
48841477|NCT02988817|157259367|FG008|Overall Study|Lost to Follow-up|1|||
48841478|NCT02988817|157259368|FG009|Overall Study|Lost to Follow-up|0|||
48841479|NCT02988817|157259369|FG010|Overall Study|Lost to Follow-up|1|||
49168238|NCT00130039|158450237|FG000|Overall Study|Adverse Event|4|||
49168239|NCT00130039|158450238|FG001|Overall Study|Adverse Event|2|||
49168240|NCT00130039|158450237|FG000|Overall Study|Physician Decision|3|||
49168241|NCT00130039|158450238|FG001|Overall Study|Physician Decision|0|||
48841480|NCT02988817|157259370|FG011|Overall Study|Lost to Follow-up|1|||
48841481|NCT02988817|157259371|FG012|Overall Study|Lost to Follow-up|0|||
48841482|NCT02988817|157259372|FG013|Overall Study|Lost to Follow-up|0|||
48841483|NCT02988817|157259373|FG014|Overall Study|Lost to Follow-up|1|||
49168242|NCT00130039|158450237|FG000|Overall Study|clinical events without follow up MRI|5|||
49168243|NCT00130039|158450238|FG001|Overall Study|clinical events without follow up MRI|4|||
49168244|NCT02709720|158450244|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
49168245|NCT02709720|158450244|FG000|Overall Study|Protocol Violation|1|||
48841484|NCT02988817|157259374|FG015|Overall Study|Lost to Follow-up|1|||
48841485|NCT02988817|157259375|FG016|Overall Study|Lost to Follow-up|2|||
48841486|NCT02988817|157259376|FG017|Overall Study|Lost to Follow-up|3|||
48925807|NCT03657043|157561706|FG001|Overall Study|Withdrawal - declined follow-up|0|||
48925808|NCT03657043|157561707|FG002|Overall Study|Withdrawal - declined follow-up|0|||
48925809|NCT03657043|157561708|FG003|Overall Study|Withdrawal - declined follow-up|0|||
49168246|NCT02709720|158450244|FG000|Overall Study|Not take study medication|1|||
48841487|NCT02988817|157259377|FG018|Overall Study|Lost to Follow-up|0|||
49168247|NCT03306433|158450245|FG000|Overall Study|Lost to Follow-up|3|||
49168248|NCT03306433|158450245|FG000|Overall Study|Patient did not have teeth extracted|1|||
49168249|NCT03306433|158450245|FG000|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3|||
49168250|NCT01198574|158450248|FG000|Overall Study|Resigned from schools|4|||
49168251|NCT01198574|158450249|FG001|Overall Study|Resigned from schools|1|||
49168252|NCT01198574|158450250|FG002|Overall Study|Resigned from schools|1|||
49168253|NCT01198574|158450251|FG003|Overall Study|Resigned from schools|4|||
49168254|NCT03135431|158450252|FG000|Overall Study|Study Surgeon not available|2|||
48841488|NCT02988817|157259378|FG019|Overall Study|Lost to Follow-up|0|||
48841489|NCT02988817|157259359|FG000|Overall Study|Sponsor decision|0|||
48841490|NCT02988817|157259360|FG001|Overall Study|Sponsor decision|0|||
48841491|NCT02988817|157259361|FG002|Overall Study|Sponsor decision|0|||
48841492|NCT02988817|157259362|FG003|Overall Study|Sponsor decision|0|||
48841493|NCT02988817|157259363|FG004|Overall Study|Sponsor decision|0|||
48841494|NCT02988817|157259364|FG005|Overall Study|Sponsor decision|0|||
48841495|NCT02988817|157259365|FG006|Overall Study|Sponsor decision|0|||
48841496|NCT02988817|157259366|FG007|Overall Study|Sponsor decision|0|||
48841497|NCT02988817|157259367|FG008|Overall Study|Sponsor decision|0|||
48841498|NCT02988817|157259368|FG009|Overall Study|Sponsor decision|0|||
48841499|NCT02988817|157259369|FG010|Overall Study|Sponsor decision|0|||
48841500|NCT02988817|157259370|FG011|Overall Study|Sponsor decision|1|||
48841501|NCT02988817|157259371|FG012|Overall Study|Sponsor decision|1|||
48841502|NCT02988817|157259372|FG013|Overall Study|Sponsor decision|2|||
48841503|NCT02988817|157259373|FG014|Overall Study|Sponsor decision|2|||
48841504|NCT02988817|157259374|FG015|Overall Study|Sponsor decision|6|||
48841505|NCT02988817|157259375|FG016|Overall Study|Sponsor decision|2|||
48841506|NCT02988817|157259376|FG017|Overall Study|Sponsor decision|3|||
48841507|NCT02988817|157259377|FG018|Overall Study|Sponsor decision|2|||
48841508|NCT02988817|157259378|FG019|Overall Study|Sponsor decision|7|||
48841509|NCT02988817|157259359|FG000|Overall Study|Physician Decision|0|||
48841510|NCT02988817|157259360|FG001|Overall Study|Physician Decision|0|||
48841511|NCT02988817|157259361|FG002|Overall Study|Physician Decision|0|||
48841512|NCT02988817|157259362|FG003|Overall Study|Physician Decision|0|||
49168255|NCT03135431|158450253|FG001|Overall Study|Study Surgeon not available|0|||
49168256|NCT00326001|158450254|FG000|Overall Study|Adverse Event|4|||
49168257|NCT00326001|158450255|FG001|Overall Study|Adverse Event|5|||
49168258|NCT00326001|158450254|FG000|Overall Study|Physician Decision|3|||
49168259|NCT00326001|158450255|FG001|Overall Study|Physician Decision|3|||
49168260|NCT00837161|158450256|FG000|Overall Study|refused hysterectomy|2|||
49168261|NCT02931838|158450257|FG000|Overall Study|Reason not provided by investigator|1|||
48841513|NCT02988817|157259363|FG004|Overall Study|Physician Decision|0|||
48841514|NCT02988817|157259364|FG005|Overall Study|Physician Decision|0|||
48841515|NCT02988817|157259365|FG006|Overall Study|Physician Decision|0|||
48841516|NCT02988817|157259366|FG007|Overall Study|Physician Decision|0|||
48841517|NCT02988817|157259367|FG008|Overall Study|Physician Decision|0|||
48841518|NCT02988817|157259368|FG009|Overall Study|Physician Decision|0|||
48841519|NCT02988817|157259369|FG010|Overall Study|Physician Decision|0|||
48841520|NCT02988817|157259370|FG011|Overall Study|Physician Decision|0|||
48841521|NCT02988817|157259371|FG012|Overall Study|Physician Decision|0|||
48841522|NCT02988817|157259372|FG013|Overall Study|Physician Decision|0|||
48841523|NCT02988817|157259373|FG014|Overall Study|Physician Decision|0|||
48841524|NCT02988817|157259374|FG015|Overall Study|Physician Decision|1|||
48841525|NCT02988817|157259375|FG016|Overall Study|Physician Decision|0|||
48841526|NCT02988817|157259376|FG017|Overall Study|Physician Decision|0|||
48841527|NCT02988817|157259377|FG018|Overall Study|Physician Decision|1|||
48841528|NCT02988817|157259378|FG019|Overall Study|Physician Decision|1|||
48841529|NCT03036813|157259380|FG000|Overall Study|Adverse Event|6|||
48841530|NCT03036813|157259381|FG001|Overall Study|Adverse Event|11|||
48841531|NCT03036813|157259382|FG002|Overall Study|Adverse Event|6|||
48841532|NCT03036813|157259380|FG000|Overall Study|Withdrawal by Subject|12|||
48841533|NCT03036813|157259381|FG001|Overall Study|Withdrawal by Subject|6|||
48841534|NCT03036813|157259382|FG002|Overall Study|Withdrawal by Subject|10|||
48841535|NCT03036813|157259380|FG000|Overall Study|Lost to Follow-up|1|||
48841536|NCT03036813|157259381|FG001|Overall Study|Lost to Follow-up|1|||
48841537|NCT03036813|157259382|FG002|Overall Study|Lost to Follow-up|0|||
48841538|NCT03036813|157259380|FG000|Overall Study|Physician Decision|2|||
48841539|NCT03036813|157259381|FG001|Overall Study|Physician Decision|1|||
48925810|NCT03657043|157561709|FG004|Overall Study|Withdrawal - declined follow-up|1|||
48925811|NCT02356562|157561710|FG000|Overall Study|Withdrawal by Subject|0|||
48925812|NCT02356562|157561711|FG001|Overall Study|Withdrawal by Subject|1|||
48841540|NCT03036813|157259382|FG002|Overall Study|Physician Decision|1|||
48925813|NCT02356562|157561710|FG000|Overall Study|Re-entered treatment in a previous study|1|||
48925814|NCT02356562|157561711|FG001|Overall Study|Re-entered treatment in a previous study|0|||
48925815|NCT02356562|157561710|FG000|Overall Study|site closure|1|||
48925816|NCT02356562|157561711|FG001|Overall Study|site closure|0|||
48841541|NCT03036813|157259380|FG000|Overall Study|Non-Compliance|1|||
48841542|NCT03036813|157259381|FG001|Overall Study|Non-Compliance|5|||
48841543|NCT03036813|157259382|FG002|Overall Study|Non-Compliance|3|||
48925817|NCT01514682|157561712|FG000|Overall Study|Withdrawal by Subject|2|||
48841544|NCT03036813|157259380|FG000|Overall Study|Pregnancy|0|||
48841545|NCT03036813|157259381|FG001|Overall Study|Pregnancy|0|||
48841546|NCT03036813|157259382|FG002|Overall Study|Pregnancy|1|||
48841547|NCT03036813|157259380|FG000|Overall Study|Other|0|||
48925818|NCT01514682|157561713|FG001|Overall Study|Withdrawal by Subject|3|||
49168262|NCT02931838|158450258|FG001|Overall Study|Reason not provided by investigator|0|||
48841548|NCT03036813|157259381|FG001|Overall Study|Other|3|||
48841549|NCT03036813|157259382|FG002|Overall Study|Other|5|||
48841550|NCT02928224|157259383|FG000|Overall Study|Lost to Follow-up|1|||
48841551|NCT02928224|157259384|FG001|Overall Study|Lost to Follow-up|1|||
48841552|NCT02928224|157259385|FG002|Overall Study|Lost to Follow-up|3|||
49168263|NCT02931838|158450259|FG002|Overall Study|Reason not provided by investigator|1|||
49168264|NCT02931838|158450260|FG003|Overall Study|Reason not provided by investigator|0|||
49168265|NCT02931838|158450261|FG004|Overall Study|Reason not provided by investigator|0|||
49168266|NCT02931838|158450262|FG005|Overall Study|Reason not provided by investigator|0|||
49168267|NCT02931838|158450257|FG000|Overall Study|Poor/non-compliance|0|||
49168268|NCT02931838|158450258|FG001|Overall Study|Poor/non-compliance|0|||
49168269|NCT02931838|158450259|FG002|Overall Study|Poor/non-compliance|1|||
49168270|NCT02931838|158450260|FG003|Overall Study|Poor/non-compliance|0|||
49168271|NCT02931838|158450261|FG004|Overall Study|Poor/non-compliance|0|||
48841553|NCT02928224|157259386|FG003|Overall Study|Lost to Follow-up|0|||
48841554|NCT02928224|157259383|FG000|Overall Study|Death|30|||
48841555|NCT02928224|157259384|FG001|Overall Study|Death|209|||
48841556|NCT02928224|157259385|FG002|Overall Study|Death|193|||
48841557|NCT02928224|157259386|FG003|Overall Study|Death|198|||
48841558|NCT02928224|157259383|FG000|Overall Study|Withdrawal by Subject|0|||
48841559|NCT02928224|157259384|FG001|Overall Study|Withdrawal by Subject|3|||
48841560|NCT02928224|157259385|FG002|Overall Study|Withdrawal by Subject|7|||
48841561|NCT02928224|157259386|FG003|Overall Study|Withdrawal by Subject|20|||
48841562|NCT02928224|157259383|FG000|Overall Study|Study participation terminated by sponsor|3|||
48841563|NCT02928224|157259384|FG001|Overall Study|Study participation terminated by sponsor|8|||
48841564|NCT02928224|157259385|FG002|Overall Study|Study participation terminated by sponsor|12|||
48841565|NCT02928224|157259386|FG003|Overall Study|Study participation terminated by sponsor|3|||
48841566|NCT02928224|157259383|FG000|Overall Study|Other|3|||
48841567|NCT02928224|157259384|FG001|Overall Study|Other|3|||
48841568|NCT02928224|157259385|FG002|Overall Study|Other|5|||
48841569|NCT02928224|157259386|FG003|Overall Study|Other|0|||
48841570|NCT01179334|157259387|FG000|Treatment Period|Adverse Event|1|||
48841571|NCT01179334|157259388|FG001|Treatment Period|Adverse Event|0|||
48841572|NCT01179334|157259387|FG000|Long-term Extension (LTE) Period|Study terminated by sponsor|6|||
48841573|NCT01179334|157259388|FG001|Long-term Extension (LTE) Period|Study terminated by sponsor|2|||
48841574|NCT01179334|157259387|FG000|Long-term Extension (LTE) Period|Death|3|||
48841575|NCT01179334|157259388|FG001|Long-term Extension (LTE) Period|Death|0|||
49168272|NCT02931838|158450262|FG005|Overall Study|Poor/non-compliance|0|||
49168273|NCT02931838|158450257|FG000|Overall Study|Lack of Efficacy|5|||
49168274|NCT02931838|158450258|FG001|Overall Study|Lack of Efficacy|4|||
49168275|NCT02931838|158450259|FG002|Overall Study|Lack of Efficacy|0|||
49168276|NCT02931838|158450260|FG003|Overall Study|Lack of Efficacy|0|||
49168277|NCT02931838|158450261|FG004|Overall Study|Lack of Efficacy|0|||
49168278|NCT02931838|158450262|FG005|Overall Study|Lack of Efficacy|1|||
49168279|NCT02931838|158450257|FG000|Overall Study|Lost to Follow-up|1|||
49168280|NCT02931838|158450258|FG001|Overall Study|Lost to Follow-up|0|||
49168281|NCT02931838|158450259|FG002|Overall Study|Lost to Follow-up|1|||
49168282|NCT02931838|158450260|FG003|Overall Study|Lost to Follow-up|1|||
49168283|NCT02931838|158450261|FG004|Overall Study|Lost to Follow-up|2|||
48841576|NCT01179334|157259387|FG000|Long-term Extension (LTE) Period|Adverse Event|2|||
48841577|NCT01179334|157259388|FG001|Long-term Extension (LTE) Period|Adverse Event|4|||
48841578|NCT02158091|157259389|FG000|Overall Study|DLT|2|||
48841579|NCT02158091|157259390|FG001|Overall Study|DLT|1|||
48841580|NCT02158091|157259391|FG002|Overall Study|DLT|0|||
48841581|NCT00396084|157259392|FG000|Overall Study|Adverse Event|0|||
48841582|NCT00396084|157259393|FG001|Overall Study|Adverse Event|0|||
48841583|NCT00396084|157259394|FG002|Overall Study|Adverse Event|0|||
48841584|NCT00396084|157259395|FG003|Overall Study|Adverse Event|0|||
48841585|NCT00396084|157259396|FG004|Overall Study|Adverse Event|1|||
48841586|NCT00396084|157259397|FG005|Overall Study|Adverse Event|2|||
48841587|NCT00396084|157259392|FG000|Overall Study|Withdrawal by Subject|0|||
48841588|NCT00396084|157259393|FG001|Overall Study|Withdrawal by Subject|0|||
48841589|NCT00396084|157259394|FG002|Overall Study|Withdrawal by Subject|0|||
48841590|NCT00396084|157259395|FG003|Overall Study|Withdrawal by Subject|1|||
48841591|NCT00396084|157259396|FG004|Overall Study|Withdrawal by Subject|0|||
49168284|NCT02931838|158450262|FG005|Overall Study|Lost to Follow-up|0|||
49168285|NCT02931838|158450257|FG000|Overall Study|Subject request to discontinue treatment|4|||
48841592|NCT00396084|157259397|FG005|Overall Study|Withdrawal by Subject|0|||
48841593|NCT00510887|157259398|FG000|Overall Study|Lost to Follow-up|1|||
48841594|NCT00970359|157259401|FG000|Overall Study|Not Treated|4|||
48841595|NCT01565148|157259404|FG000|Overall Study|Withdrawal by Subject|1|||
48841596|NCT01565148|157259405|FG001|Overall Study|Withdrawal by Subject|1|||
48841597|NCT01565148|157259406|FG002|Overall Study|Withdrawal by Subject|1|||
48841598|NCT01565148|157259407|FG003|Overall Study|Withdrawal by Subject|2|||
48841599|NCT01565148|157259404|FG000|Overall Study|Lost to Follow-up|4|||
48841600|NCT01565148|157259405|FG001|Overall Study|Lost to Follow-up|4|||
48841601|NCT01565148|157259406|FG002|Overall Study|Lost to Follow-up|0|||
48841602|NCT01565148|157259407|FG003|Overall Study|Lost to Follow-up|3|||
49168286|NCT02931838|158450258|FG001|Overall Study|Subject request to discontinue treatment|3|||
49168287|NCT02931838|158450259|FG002|Overall Study|Subject request to discontinue treatment|3|||
48841603|NCT01565148|157259404|FG000|Overall Study|Rescue Therapy|8|||
48841604|NCT01565148|157259405|FG001|Overall Study|Rescue Therapy|5|||
48841605|NCT01565148|157259406|FG002|Overall Study|Rescue Therapy|5|||
48841606|NCT01565148|157259407|FG003|Overall Study|Rescue Therapy|8|||
48841607|NCT01565148|157259404|FG000|Overall Study|Death|0|||
48841608|NCT01565148|157259405|FG001|Overall Study|Death|0|||
48841609|NCT01565148|157259406|FG002|Overall Study|Death|1|||
48841610|NCT01565148|157259407|FG003|Overall Study|Death|0|||
48841611|NCT01565148|157259404|FG000|Overall Study|Physician Decision|2|||
48841612|NCT01565148|157259405|FG001|Overall Study|Physician Decision|5|||
48841613|NCT01565148|157259406|FG002|Overall Study|Physician Decision|0|||
48841614|NCT01565148|157259407|FG003|Overall Study|Physician Decision|0|||
48841615|NCT01759771|157259409|FG000|Overall Study|Withdrawal by Subject|1|||
48841616|NCT01759771|157259410|FG001|Overall Study|Withdrawal by Subject|1|||
48841617|NCT00357097|157259411|FG000|Overall Study|Did not meet inclusion criteria|5|||
48841618|NCT00357097|157259412|FG001|Overall Study|Did not meet inclusion criteria|3|||
48841619|NCT00357097|157259411|FG000|Overall Study|Adverse Event|34|||
48841620|NCT00357097|157259412|FG001|Overall Study|Adverse Event|6|||
48841621|NCT00357097|157259411|FG000|Overall Study|Withdrawal by Subject|8|||
49168288|NCT02931838|158450260|FG003|Overall Study|Subject request to discontinue treatment|0|||
49168289|NCT02931838|158450261|FG004|Overall Study|Subject request to discontinue treatment|1|||
48841622|NCT00357097|157259412|FG001|Overall Study|Withdrawal by Subject|7|||
48841623|NCT00357097|157259411|FG000|Overall Study|Non-compliance|1|||
48841624|NCT00357097|157259412|FG001|Overall Study|Non-compliance|2|||
48841625|NCT00357097|157259411|FG000|Overall Study|Lack of Efficacy|2|||
48841626|NCT00357097|157259412|FG001|Overall Study|Lack of Efficacy|8|||
48841627|NCT00357097|157259411|FG000|Overall Study|Met Exclusion Criteria|3|||
48841628|NCT00357097|157259412|FG001|Overall Study|Met Exclusion Criteria|1|||
48841629|NCT00357097|157259411|FG000|Overall Study|Other|1|||
48841630|NCT00357097|157259412|FG001|Overall Study|Other|1|||
48841631|NCT00357097|157259411|FG000|Overall Study|Increase of RLS Symptoms|0|||
48841632|NCT00357097|157259412|FG001|Overall Study|Increase of RLS Symptoms|1|||
48841633|NCT02528188|157259413|FG000|Overall Study|Adverse Event|23|||
48841634|NCT02528188|157259414|FG001|Overall Study|Adverse Event|22|||
49168290|NCT02931838|158450262|FG005|Overall Study|Subject request to discontinue treatment|0|||
49168291|NCT02931838|158450257|FG000|Overall Study|Withdrawal by Subject|1|||
49168292|NCT02931838|158450258|FG001|Overall Study|Withdrawal by Subject|2|||
49168293|NCT02931838|158450259|FG002|Overall Study|Withdrawal by Subject|0|||
49168294|NCT02931838|158450260|FG003|Overall Study|Withdrawal by Subject|1|||
49168295|NCT02931838|158450261|FG004|Overall Study|Withdrawal by Subject|0|||
49168296|NCT02931838|158450262|FG005|Overall Study|Withdrawal by Subject|0|||
49168297|NCT02931838|158450257|FG000|Overall Study|Adverse Event|2|||
49168298|NCT02931838|158450258|FG001|Overall Study|Adverse Event|1|||
49168299|NCT02931838|158450259|FG002|Overall Study|Adverse Event|2|||
49168300|NCT02931838|158450260|FG003|Overall Study|Adverse Event|1|||
49168301|NCT02931838|158450261|FG004|Overall Study|Adverse Event|3|||
49168302|NCT02931838|158450262|FG005|Overall Study|Adverse Event|1|||
49168303|NCT01027650|158450263|FG000|Overall Study|Personal Reasons|0|||
49168304|NCT01027650|158450264|FG001|Overall Study|Personal Reasons|0|||
49168305|NCT01027650|158450265|FG002|Overall Study|Personal Reasons|0|||
49168306|NCT01027650|158450266|FG003|Overall Study|Personal Reasons|0|||
49168307|NCT01027650|158450267|FG004|Overall Study|Personal Reasons|2|||
49168308|NCT01027650|158450268|FG005|Overall Study|Personal Reasons|1|||
49168309|NCT01027650|158450269|FG006|Overall Study|Personal Reasons|0|||
49168310|NCT01027650|158450270|FG007|Overall Study|Personal Reasons|0|||
48841635|NCT02528188|157259415|FG002|Overall Study|Adverse Event|8|||
48841636|NCT02528188|157259413|FG000|Overall Study|Protocol Violation|4|||
48841637|NCT02528188|157259414|FG001|Overall Study|Protocol Violation|6|||
48841638|NCT02528188|157259415|FG002|Overall Study|Protocol Violation|4|||
48925819|NCT01514682|157561712|FG000|Overall Study|Physician Decision|4|||
49168311|NCT01027650|158450263|FG000|Overall Study|Lost to Follow-up|0|||
49168312|NCT01027650|158450264|FG001|Overall Study|Lost to Follow-up|0|||
49168313|NCT01027650|158450265|FG002|Overall Study|Lost to Follow-up|0|||
49168314|NCT01027650|158450266|FG003|Overall Study|Lost to Follow-up|0|||
49168315|NCT01027650|158450267|FG004|Overall Study|Lost to Follow-up|0|||
48841639|NCT02528188|157259413|FG000|Overall Study|Lack of Efficacy|19|||
48841640|NCT02528188|157259414|FG001|Overall Study|Lack of Efficacy|21|||
48841641|NCT02528188|157259415|FG002|Overall Study|Lack of Efficacy|22|||
48841642|NCT02528188|157259413|FG000|Overall Study|Withdrawal by Subject|97|||
48841643|NCT02528188|157259414|FG001|Overall Study|Withdrawal by Subject|104|||
48925820|NCT01514682|157561713|FG001|Overall Study|Physician Decision|3|||
48925821|NCT00527605|157561714|FG000|Overall Study|Adverse Event|3|||
48925822|NCT00527605|157561715|FG001|Overall Study|Adverse Event|0|||
48925823|NCT00527605|157561714|FG000|Overall Study|Withdrawal by Subject|3|||
48925824|NCT00527605|157561715|FG001|Overall Study|Withdrawal by Subject|7|||
48925825|NCT00527605|157561714|FG000|Overall Study|Lost to Follow-up|6|||
48925826|NCT00527605|157561715|FG001|Overall Study|Lost to Follow-up|2|||
48925827|NCT00527605|157561714|FG000|Overall Study|Protocol Violation|1|||
48925828|NCT00527605|157561715|FG001|Overall Study|Protocol Violation|2|||
48925829|NCT04316585|157561716|FG000|Overall Study|Adverse Event|2|||
48925830|NCT04316585|157561717|FG001|Overall Study|Adverse Event|1|||
48925831|NCT04316585|157561716|FG000|Overall Study|Lost to Follow-up|1|||
48925832|NCT04316585|157561717|FG001|Overall Study|Lost to Follow-up|0|||
48925833|NCT04316585|157561716|FG000|Overall Study|Withdrawal by Subject|2|||
48925834|NCT04316585|157561717|FG001|Overall Study|Withdrawal by Subject|3|||
48925835|NCT04316585|157561716|FG000|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
48925836|NCT04316585|157561717|FG001|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
49168316|NCT01027650|158450268|FG005|Overall Study|Lost to Follow-up|0|||
49168317|NCT01027650|158450269|FG006|Overall Study|Lost to Follow-up|1|||
49168318|NCT01027650|158450270|FG007|Overall Study|Lost to Follow-up|0|||
49168319|NCT01027650|158450263|FG000|Overall Study|Lack of Efficacy|0|||
49168320|NCT01027650|158450264|FG001|Overall Study|Lack of Efficacy|0|||
49168321|NCT01027650|158450265|FG002|Overall Study|Lack of Efficacy|0|||
49168322|NCT01027650|158450266|FG003|Overall Study|Lack of Efficacy|0|||
49168323|NCT01027650|158450267|FG004|Overall Study|Lack of Efficacy|0|||
49168324|NCT01027650|158450268|FG005|Overall Study|Lack of Efficacy|1|||
49168325|NCT01027650|158450269|FG006|Overall Study|Lack of Efficacy|0|||
49168326|NCT01027650|158450270|FG007|Overall Study|Lack of Efficacy|0|||
49168327|NCT03281629|158450271|FG000|Overall Study|The two participants dropped out due to COVID-19 lockdown.|2|||
49168328|NCT03281629|158450272|FG001|Overall Study|The two participants dropped out due to COVID-19 lockdown.|0|||
49168329|NCT03281629|158450271|FG000|Overall Study|Death|0|||
49168330|NCT03281629|158450272|FG001|Overall Study|Death|1|||
49168331|NCT03281629|158450271|FG000|Overall Study|Participant's schedule change and cannot participate in the study|0|||
49168332|NCT03281629|158450272|FG001|Overall Study|Participant's schedule change and cannot participate in the study|1|||
49168333|NCT01082081|158450273|FG000|Overall Study|Lost to Follow-up|0|||
49168334|NCT01082081|158450274|FG001|Overall Study|Lost to Follow-up|0|||
49168335|NCT01082081|158450275|FG002|Overall Study|Lost to Follow-up|1|||
49168336|NCT01082081|158450273|FG000|Overall Study|Withdrawal by Subject|0|||
49168337|NCT01082081|158450274|FG001|Overall Study|Withdrawal by Subject|0|||
49168338|NCT01082081|158450275|FG002|Overall Study|Withdrawal by Subject|1|||
49168339|NCT01082081|158450273|FG000|Overall Study|Other Reason|0|||
49168340|NCT01082081|158450274|FG001|Overall Study|Other Reason|1|||
49168341|NCT01082081|158450275|FG002|Overall Study|Other Reason|0|||
49168342|NCT02175277|158450276|FG000|Overall Study|Protocol-specified Criteria|1|||
49168343|NCT01042158|158450281|FG000|Overall Study|Physician Decision|1|||
49168344|NCT01575808|158450283|FG000|Overall Study|Death|2|||
49168345|NCT01575808|158450284|FG001|Overall Study|Death|0|||
49168346|NCT01575808|158450283|FG000|Overall Study|Withdrawal by Subject|1|||
49168347|NCT01575808|158450284|FG001|Overall Study|Withdrawal by Subject|0|||
49168348|NCT00375674|158450290|FG000|Overall Study|Other|26|||
49168349|NCT00375674|158450291|FG001|Overall Study|Other|18|||
49168350|NCT00375674|158450290|FG000|Overall Study|Death|67|||
49168351|NCT00375674|158450291|FG001|Overall Study|Death|76|||
49168352|NCT00375674|158450290|FG000|Overall Study|Participants refused further follow-up|31|||
49168353|NCT00375674|158450291|FG001|Overall Study|Participants refused further follow-up|30|||
49168354|NCT00375674|158450290|FG000|Overall Study|Lost to Follow-up|17|||
49168355|NCT00375674|158450291|FG001|Overall Study|Lost to Follow-up|15|||
49168356|NCT00375674|158450290|FG000|Overall Study|Enrolled but not treated|3|||
49168357|NCT00375674|158450291|FG001|Overall Study|Enrolled but not treated|2|||
49168358|NCT00912782|158450292|FG000|Overall Study|Death|2|||
49168359|NCT00912782|158450293|FG001|Overall Study|Death|1|||
49168360|NCT00912782|158450292|FG000|Overall Study|Lost to Follow-up|0|||
49168361|NCT00912782|158450293|FG001|Overall Study|Lost to Follow-up|1|||
49168362|NCT00912782|158450292|FG000|Overall Study|Did not receive vascular access type|1|||
49168363|NCT00912782|158450293|FG001|Overall Study|Did not receive vascular access type|2|||
49168364|NCT00912782|158450292|FG000|Overall Study|Relocated before study completion|0|||
49168365|NCT00912782|158450293|FG001|Overall Study|Relocated before study completion|1|||
49168366|NCT00288015|158451845|FG000|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1|||
49168367|NCT00288015|158451845|FG000|Bevacizumab Treatment Cycles 1-2|Physician Decision|1|||
49168368|NCT00288015|158451845|FG000|First Response Assessment|Withdrawal by Subject|1|||
49168369|NCT00288015|158451845|FG000|First Response Assessment|Death|1|||
49168370|NCT00288015|158451845|FG000|First Response Assessment|Physician Decision|2|||
49168371|NCT00288015|158451845|FG000|Continued Bevacizumab Cycle 3+|Disease progressed|7|||
49168372|NCT00288015|158451845|FG000|Follow up for Survival x 2 Years|Death|13|||
49168373|NCT00288015|158451845|FG000|Follow up for Survival x 2 Years|Lost to Follow-up|4|||
49168374|NCT00288015|158451845|FG000|Follow up for Survival x 2 Years|Other|9|||
48841644|NCT02528188|157259415|FG002|Overall Study|Withdrawal by Subject|100|||
48841645|NCT02528188|157259413|FG000|Overall Study|Lost to Follow-up|25|||
48841646|NCT02528188|157259414|FG001|Overall Study|Lost to Follow-up|21|||
48841647|NCT02528188|157259415|FG002|Overall Study|Lost to Follow-up|31|||
49168375|NCT01047007|158451848|FG000|Overall Study|Adverse Event|0|||
49168376|NCT01047007|158451849|FG001|Overall Study|Adverse Event|2|||
49168377|NCT01047007|158451850|FG002|Overall Study|Adverse Event|1|||
49168378|NCT01047007|158451851|FG003|Overall Study|Adverse Event|0|||
49168379|NCT01047007|158451848|FG000|Overall Study|Progressive Disease|2|||
49168380|NCT01047007|158451849|FG001|Overall Study|Progressive Disease|4|||
49168381|NCT01047007|158451850|FG002|Overall Study|Progressive Disease|1|||
49168382|NCT01047007|158451851|FG003|Overall Study|Progressive Disease|0|||
49168383|NCT00938912|158451860|FG000|Overall Study|Withdrawal by Subject|28|||
49168384|NCT00938912|158451860|FG000|Overall Study|Lost to Follow-up|4|||
49168385|NCT00938912|158451860|FG000|Overall Study|Lack of Efficacy|43|||
49168386|NCT00938912|158451860|FG000|Overall Study|Adverse event, non-fatal|24|||
49168387|NCT00938912|158451860|FG000|Overall Study|Adverse event, fatal|1|||
49168388|NCT00938912|158451860|FG000|Overall Study|Participant self adjusted antiepileptic medication|1|||
49168389|NCT00938912|158451860|FG000|Overall Study|Participant had a creatinine clearance less than 30 mL/min|1|||
49168390|NCT00938912|158451860|FG000|Overall Study|Participant needed prohibit medication|1|||
49168391|NCT00938912|158451860|FG000|Overall Study|Participant was scheduled for lobal resection|1|||
49168392|NCT00938912|158451860|FG000|Overall Study|Did not meet Eligibility criteria|1|||
49168393|NCT00938912|158451860|FG000|Overall Study|Participant relocated not related to AE|1|||
49168394|NCT00938912|158451860|FG000|Overall Study|Participant moved to another city|1|||
49168395|NCT00938912|158451860|FG000|Overall Study|Participant experienced break through seizures|1|||
49168396|NCT00938912|158451860|FG000|Overall Study|No longer wished to participate in the study|1|||
49168397|NCT00938912|158451860|FG000|Overall Study|Protocol Deviation|2|||
48925837|NCT04316585|157561716|FG000|Overall Study|INVESTIGATOR DISCRETION|1|||
48925838|NCT04316585|157561717|FG001|Overall Study|INVESTIGATOR DISCRETION|0|||
48925839|NCT00223496|157561718|FG000|Overall Study|screen failure|9|||
48925840|NCT00223496|157561718|FG000|Overall Study|Lost to Follow-up|4|||
48925841|NCT00223496|157561718|FG000|Overall Study|Lack of Efficacy|6|||
48925842|NCT00223496|157561718|FG000|Overall Study|Withdrawal by Subject|1|||
48925843|NCT00223496|157561718|FG000|Overall Study|Physician Decision|2|||
48925844|NCT00713700|157561719|FG000|Overall Study|Lost to Follow-up|3|||
48925845|NCT00713700|157561719|FG000|Overall Study|Withdrawal by Subject|1|||
48925846|NCT02814565|157561724|FG000|Overall Study|Lack of Efficacy|0|||
48925847|NCT02814565|157561725|FG001|Overall Study|Lack of Efficacy|1|||
48925848|NCT02814565|157561724|FG000|Overall Study|Subject decision, caused by AE Influenza|1|||
48841648|NCT02528188|157259413|FG000|Overall Study|Death|4|||
49168398|NCT01127633|158451865|FG000|Overall Study|Adverse Event|74|||
48841649|NCT02528188|157259414|FG001|Overall Study|Death|4|||
48841650|NCT02528188|157259415|FG002|Overall Study|Death|0|||
48841651|NCT02528188|157259413|FG000|Overall Study|Other|89|||
48841652|NCT02528188|157259414|FG001|Overall Study|Other|91|||
48841653|NCT02528188|157259415|FG002|Overall Study|Other|74|||
48841654|NCT02528188|157259413|FG000|Overall Study|Randomized but not treated|6|||
48841655|NCT02528188|157259414|FG001|Overall Study|Randomized but not treated|7|||
48841656|NCT02528188|157259415|FG002|Overall Study|Randomized but not treated|12|||
48925849|NCT02814565|157561725|FG001|Overall Study|Subject decision, caused by AE Influenza|1|||
48925850|NCT01701674|157561726|FG000|Overall Study|Unable to safely complete treatment|1|||
48925851|NCT03752619|157561727|FG000|Overall Study|Lost to Follow-up|2|||
48841657|NCT00529659|157259418|FG000|Overall Study|Adverse Event|8|||
48925852|NCT03752619|157561728|FG001|Overall Study|Lost to Follow-up|1|||
48841658|NCT00529659|157259419|FG001|Overall Study|Adverse Event|7|||
48925853|NCT03752619|157561727|FG000|Overall Study|Withdrawal by Subject|1|||
48925854|NCT03752619|157561728|FG001|Overall Study|Withdrawal by Subject|1|||
48925855|NCT03752619|157561727|FG000|Overall Study|Adverse Event|0|||
48925856|NCT03752619|157561728|FG001|Overall Study|Adverse Event|1|||
49168399|NCT01127633|158451866|FG001|Overall Study|Adverse Event|73|||
48841659|NCT00529659|157259418|FG000|Overall Study|Lost to Follow-up|0|||
49168400|NCT01127633|158451865|FG000|Overall Study|Death|40|||
49168401|NCT01127633|158451866|FG001|Overall Study|Death|43|||
49168402|NCT01127633|158451865|FG000|Overall Study|Lost to Follow-up|4|||
49168403|NCT01127633|158451866|FG001|Overall Study|Lost to Follow-up|0|||
49168404|NCT01127633|158451865|FG000|Overall Study|Parent/Caregiver Decision|246|||
49168405|NCT01127633|158451866|FG001|Overall Study|Parent/Caregiver Decision|228|||
49168406|NCT01127633|158451865|FG000|Overall Study|Physician Decision|60|||
49168407|NCT01127633|158451866|FG001|Overall Study|Physician Decision|45|||
49168408|NCT01127633|158451865|FG000|Overall Study|Withdrawal by Subject|57|||
49168409|NCT01127633|158451866|FG001|Overall Study|Withdrawal by Subject|72|||
49168410|NCT01127633|158451865|FG000|Overall Study|Sponsor Decision|163|||
49168411|NCT01127633|158451866|FG001|Overall Study|Sponsor Decision|195|||
49168412|NCT01127633|158451865|FG000|Overall Study|Protocol Violation|8|||
49168413|NCT01127633|158451866|FG001|Overall Study|Protocol Violation|16|||
49168414|NCT01127633|158451865|FG000|Overall Study|Abnormal Lab/ECG Result|0|||
49168415|NCT01127633|158451866|FG001|Overall Study|Abnormal Lab/ECG Result|1|||
49168416|NCT01127633|158451865|FG000|Overall Study|Not treated|1|||
49168417|NCT01127633|158451866|FG001|Overall Study|Not treated|0|||
49168418|NCT00688467|158451868|FG000|Treatment Period 1|Adverse Event|2|||
49168419|NCT00688467|158451869|FG001|Treatment Period 1|Adverse Event|1|||
49168420|NCT00688467|158451868|FG000|Treatment Period 1|Did not meet protocol eligibility|0|||
49168421|NCT00688467|158451869|FG001|Treatment Period 1|Did not meet protocol eligibility|1|||
49168422|NCT00688467|158451868|FG000|Treatment Period 2|Protocol Violation|0|||
49168423|NCT00688467|158451869|FG001|Treatment Period 2|Protocol Violation|1|||
49168424|NCT00688467|158451868|FG000|Treatment Period 2|Adverse Event|0|||
49168425|NCT00688467|158451869|FG001|Treatment Period 2|Adverse Event|1|||
49168426|NCT00078806|158451874|FG000|Part 1A|Adverse Event|2|||
49168427|NCT00078806|158451875|FG001|Part 1A|Adverse Event|0|||
49168428|NCT00078806|158451876|FG002|Part 1A|Adverse Event|0|||
49168429|NCT00078806|158451877|FG003|Part 1A|Adverse Event|0|||
49168430|NCT00078806|158451874|FG000|Part 1A|Lack of Efficacy|7|||
49168431|NCT00078806|158451875|FG001|Part 1A|Lack of Efficacy|0|||
49168432|NCT00078806|158451876|FG002|Part 1A|Lack of Efficacy|0|||
49168433|NCT00078806|158451877|FG003|Part 1A|Lack of Efficacy|0|||
49168434|NCT00078806|158451874|FG000|Part 1A|Other|1|||
49168435|NCT00078806|158451875|FG001|Part 1A|Other|0|||
49168436|NCT00078806|158451876|FG002|Part 1A|Other|0|||
49168437|NCT00078806|158451877|FG003|Part 1A|Other|0|||
49168438|NCT00078806|158451874|FG000|Part 1B|Adverse Event|1|||
49168439|NCT00078806|158451875|FG001|Part 1B|Adverse Event|0|||
49168440|NCT00078806|158451876|FG002|Part 1B|Adverse Event|0|||
49168441|NCT00078806|158451877|FG003|Part 1B|Adverse Event|0|||
49168442|NCT00078806|158451874|FG000|Part 1B|Lack of Efficacy|7|||
49168443|NCT00078806|158451875|FG001|Part 1B|Lack of Efficacy|0|||
49168444|NCT00078806|158451876|FG002|Part 1B|Lack of Efficacy|0|||
49168445|NCT00078806|158451877|FG003|Part 1B|Lack of Efficacy|0|||
49168446|NCT00078806|158451874|FG000|Part 2|Adverse Event|0|||
49168447|NCT00078806|158451875|FG001|Part 2|Adverse Event|1|||
49168448|NCT00078806|158451876|FG002|Part 2|Adverse Event|0|||
49168449|NCT00078806|158451877|FG003|Part 2|Adverse Event|0|||
49168450|NCT00690794|158451878|FG000|Overall Study|Adverse Event|12|||
49168451|NCT00690794|158451879|FG001|Overall Study|Adverse Event|10|||
49168452|NCT00690794|158451878|FG000|Overall Study|Lost to Follow-up|1|||
49168453|NCT00690794|158451879|FG001|Overall Study|Lost to Follow-up|4|||
49168454|NCT00690794|158451878|FG000|Overall Study|Withdrawal by Subject|0|||
49168455|NCT00690794|158451879|FG001|Overall Study|Withdrawal by Subject|9|||
49168456|NCT00690794|158451878|FG000|Overall Study|Protocol Violation|6|||
49168457|NCT00690794|158451879|FG001|Overall Study|Protocol Violation|7|||
49168458|NCT00690794|158451878|FG000|Overall Study|Noncompliance|1|||
49168459|NCT00690794|158451879|FG001|Overall Study|Noncompliance|2|||
49168460|NCT00690794|158451878|FG000|Overall Study|Other not specified|1|||
49168461|NCT00690794|158451879|FG001|Overall Study|Other not specified|3|||
49168462|NCT02078752|158451888|FG000|Overall Study|Death|0|||
49168463|NCT02078752|158451889|FG001|Overall Study|Death|3|||
49168464|NCT02078752|158451890|FG002|Overall Study|Death|0|||
49168465|NCT02078752|158451891|FG003|Overall Study|Death|0|||
49168466|NCT02078752|158451892|FG004|Overall Study|Death|0|||
49168467|NCT02078752|158451893|FG005|Overall Study|Death|1|||
48841660|NCT00529659|157259419|FG001|Overall Study|Lost to Follow-up|2|||
48841661|NCT00529659|157259418|FG000|Overall Study|Physician Decision|0|||
49168468|NCT02078752|158451894|FG006|Overall Study|Death|0|||
49168469|NCT02078752|158451895|FG007|Overall Study|Death|1|||
48841662|NCT00529659|157259419|FG001|Overall Study|Physician Decision|2|||
49168470|NCT02078752|158451896|FG008|Overall Study|Death|0|||
49168471|NCT02078752|158451897|FG009|Overall Study|Death|4|||
49168472|NCT02078752|158451888|FG000|Overall Study|Lost to Follow-up|1|||
49168473|NCT02078752|158451889|FG001|Overall Study|Lost to Follow-up|0|||
49168474|NCT02078752|158451890|FG002|Overall Study|Lost to Follow-up|0|||
49168475|NCT02078752|158451891|FG003|Overall Study|Lost to Follow-up|1|||
49168476|NCT02078752|158451892|FG004|Overall Study|Lost to Follow-up|0|||
49168477|NCT02078752|158451893|FG005|Overall Study|Lost to Follow-up|0|||
49168478|NCT02078752|158451894|FG006|Overall Study|Lost to Follow-up|0|||
49168479|NCT02078752|158451895|FG007|Overall Study|Lost to Follow-up|0|||
49168480|NCT02078752|158451896|FG008|Overall Study|Lost to Follow-up|0|||
49168481|NCT02078752|158451897|FG009|Overall Study|Lost to Follow-up|0|||
48841663|NCT00529659|157259418|FG000|Overall Study|Protocol Violation|2|||
48841664|NCT00529659|157259419|FG001|Overall Study|Protocol Violation|6|||
48841665|NCT00529659|157259418|FG000|Overall Study|Withdrawal by Subject|1|||
48841666|NCT00529659|157259419|FG001|Overall Study|Withdrawal by Subject|6|||
49168482|NCT02078752|158451888|FG000|Overall Study|Withdrawal by Subject|1|||
49168483|NCT02078752|158451889|FG001|Overall Study|Withdrawal by Subject|1|||
49168484|NCT02078752|158451890|FG002|Overall Study|Withdrawal by Subject|1|||
49168485|NCT02078752|158451891|FG003|Overall Study|Withdrawal by Subject|1|||
49168486|NCT02078752|158451892|FG004|Overall Study|Withdrawal by Subject|0|||
49168487|NCT02078752|158451893|FG005|Overall Study|Withdrawal by Subject|3|||
49168488|NCT02078752|158451894|FG006|Overall Study|Withdrawal by Subject|2|||
49168489|NCT02078752|158451895|FG007|Overall Study|Withdrawal by Subject|1|||
49168490|NCT02078752|158451896|FG008|Overall Study|Withdrawal by Subject|0|||
49168491|NCT02078752|158451897|FG009|Overall Study|Withdrawal by Subject|1|||
49168492|NCT02078752|158451888|FG000|Overall Study|Other|0|||
49168493|NCT02078752|158451889|FG001|Overall Study|Other|3|||
49168494|NCT02078752|158451890|FG002|Overall Study|Other|0|||
49168495|NCT02078752|158451891|FG003|Overall Study|Other|0|||
49168496|NCT02078752|158451892|FG004|Overall Study|Other|1|||
49168497|NCT02078752|158451893|FG005|Overall Study|Other|0|||
49168498|NCT02078752|158451894|FG006|Overall Study|Other|0|||
49168499|NCT02078752|158451895|FG007|Overall Study|Other|1|||
48841667|NCT03062358|157259420|FG000|Overall Study|Death|220|||
48841668|NCT03062358|157259421|FG001|Overall Study|Death|127|||
48841669|NCT03062358|157259420|FG000|Overall Study|Withdrawal by Subject|2|||
48841670|NCT03062358|157259421|FG001|Overall Study|Withdrawal by Subject|1|||
48841671|NCT03062358|157259420|FG000|Overall Study|Ongoing in Trial|78|||
48841672|NCT03062358|157259421|FG001|Overall Study|Ongoing in Trial|25|||
48841673|NCT00001277|157259429|FG000|Overall Study|Adverse Event|0|||
48841674|NCT00001277|157259430|FG001|Overall Study|Adverse Event|0|||
48841675|NCT00001277|157259431|FG002|Overall Study|Adverse Event|1|||
48841676|NCT00001277|157259429|FG000|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
48841677|NCT00001277|157259430|FG001|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
48841678|NCT00001277|157259431|FG002|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|2|||
48841679|NCT01616459|157259433|FG000|Overall Study|Adverse Event|1|||
48841680|NCT01616459|157259434|FG001|Overall Study|Adverse Event|1|||
49168500|NCT02078752|158451896|FG008|Overall Study|Other|0|||
48841681|NCT01616459|157259435|FG002|Overall Study|Adverse Event|2|||
49168501|NCT02078752|158451897|FG009|Overall Study|Other|0|||
49168502|NCT02078752|158451888|FG000|Overall Study|Study terminated by sponsor|0|||
49168503|NCT02078752|158451889|FG001|Overall Study|Study terminated by sponsor|0|||
49168504|NCT02078752|158451890|FG002|Overall Study|Study terminated by sponsor|0|||
49168505|NCT02078752|158451891|FG003|Overall Study|Study terminated by sponsor|0|||
49168506|NCT02078752|158451892|FG004|Overall Study|Study terminated by sponsor|0|||
49168507|NCT02078752|158451893|FG005|Overall Study|Study terminated by sponsor|0|||
49168508|NCT02078752|158451894|FG006|Overall Study|Study terminated by sponsor|0|||
49168509|NCT02078752|158451895|FG007|Overall Study|Study terminated by sponsor|0|||
49168510|NCT02078752|158451896|FG008|Overall Study|Study terminated by sponsor|0|||
49168511|NCT02078752|158451897|FG009|Overall Study|Study terminated by sponsor|5|||
49168512|NCT01408277|158451898|FG000|Overall Study|Adverse Event|3|||
49168513|NCT01408277|158451899|FG001|Overall Study|Adverse Event|4|||
49168514|NCT01408277|158451898|FG000|Overall Study|Lost to Follow-up|1|||
49168515|NCT01408277|158451899|FG001|Overall Study|Lost to Follow-up|0|||
49168516|NCT01408277|158451898|FG000|Overall Study|Withdrawal by Subject|2|||
49168517|NCT01408277|158451899|FG001|Overall Study|Withdrawal by Subject|0|||
49168518|NCT01408277|158451898|FG000|Overall Study|Protocol Violation|2|||
49168519|NCT01408277|158451899|FG001|Overall Study|Protocol Violation|0|||
49168520|NCT01582009|158451900|FG000|Overall Study|Withdrawal by Subject|1|||
49168521|NCT01582009|158451900|FG000|Overall Study|Physician Decision|1|||
49168522|NCT03432494|158451902|FG000|Overall Study|Death|1|||
49168523|NCT03432494|158451902|FG000|Overall Study|Noncompliance|1|||
49168524|NCT03604497|158451903|FG000|Overall Study|Protocol Violation|52|||
49168525|NCT01696773|158451908|FG000|Days 15-27, Washout|Adverse Event|1|||
49168526|NCT01696773|158451909|FG001|Days 15-27, Washout|Adverse Event|0|||
49168527|NCT00833469|158451912|FG000|Overall Study|Withdrawal by Subject|1|||
49168528|NCT00833469|158451912|FG000|Overall Study|Lost to Follow-up|1|||
49168529|NCT01665911|158451913|FG000|Overall Study|Protocol Violation|4|||
49168530|NCT01665911|158451913|FG000|Overall Study|Withdrawal by Subject|1|||
49168531|NCT01665911|158451913|FG000|Overall Study|Adverse Event|1|||
49168532|NCT02370368|158451914|FG000|Overall Study|Adverse Event|1|||
49168533|NCT02370368|158451915|FG001|Overall Study|Adverse Event|2|||
49168534|NCT02370368|158451914|FG000|Overall Study|Withdrawal by Subject|5|||
49168535|NCT02370368|158451915|FG001|Overall Study|Withdrawal by Subject|4|||
49168536|NCT00735553|158451918|FG000|Overall Study|Study prematurely terminated|77|||
49168537|NCT02776683|158451919|FG000|Pre-switch Period|Protocol Violation|1|||
49168538|NCT02776683|158451920|FG001|Pre-switch Period|Protocol Violation|0|||
49168539|NCT02776683|158451919|FG000|Pre-switch Period|Adverse Event|21|||
49168540|NCT02776683|158451920|FG001|Pre-switch Period|Adverse Event|0|||
49168541|NCT02776683|158451919|FG000|Pre-switch Period|Withdrawal by Subject|9|||
49168542|NCT02776683|158451920|FG001|Pre-switch Period|Withdrawal by Subject|0|||
49168543|NCT02776683|158451919|FG000|Pre-switch Period|Physician Decision|7|||
49168544|NCT02776683|158451920|FG001|Pre-switch Period|Physician Decision|0|||
49168545|NCT02776683|158451919|FG000|Pre-switch Period|Progressive disease|39|||
49168546|NCT02776683|158451920|FG001|Pre-switch Period|Progressive disease|0|||
49168547|NCT02776683|158451919|FG000|Pre-switch Period|Other than listed|3|||
49168548|NCT02776683|158451920|FG001|Pre-switch Period|Other than listed|0|||
49168549|NCT02776683|158451919|FG000|Post-switch Period|Adverse Event|0|||
49168550|NCT02776683|158451920|FG001|Post-switch Period|Adverse Event|3|||
49168551|NCT02776683|158451919|FG000|Post-switch Period|Withdrawal by Subject|0|||
49168552|NCT02776683|158451920|FG001|Post-switch Period|Withdrawal by Subject|2|||
49168553|NCT02776683|158451919|FG000|Post-switch Period|Physician Decision|0|||
49168554|NCT02776683|158451920|FG001|Post-switch Period|Physician Decision|3|||
49168555|NCT02776683|158451919|FG000|Post-switch Period|Progressive disease|0|||
49168556|NCT02776683|158451920|FG001|Post-switch Period|Progressive disease|20|||
49168557|NCT02776683|158451919|FG000|Post-switch Period|Other than listed|0|||
49168558|NCT02776683|158451920|FG001|Post-switch Period|Other than listed|15|||
49168559|NCT00175916|158451921|FG000|Overall Study|Death|19|||
49168560|NCT00175916|158451921|FG000|Overall Study|Adverse Event|81|||
49168561|NCT00175916|158451921|FG000|Overall Study|Lack of Efficacy|354|||
49168562|NCT00175916|158451921|FG000|Overall Study|Lost to Follow-up|17|||
49168563|NCT00175916|158451921|FG000|Overall Study|Subject Choice|98|||
49168564|NCT00175916|158451921|FG000|Overall Study|Lack of compliance|8|||
49168565|NCT00175916|158451921|FG000|Overall Study|Patient cannot record seizures|1|||
49168566|NCT00175916|158451921|FG000|Overall Study|Sponsor decision|17|||
49168567|NCT00175916|158451921|FG000|Overall Study|Vigabatrin intake|1|||
49168568|NCT00175916|158451921|FG000|Overall Study|Suicidal behaviour|1|||
49168569|NCT00175916|158451921|FG000|Overall Study|Withdrawal by Subject|1|||
49168570|NCT00175916|158451921|FG000|Overall Study|Seizure - free|4|||
49168571|NCT00175916|158451921|FG000|Overall Study|Administrative reason|1|||
49168572|NCT00175916|158451921|FG000|Overall Study|Pregnancy|1|||
49168573|NCT00175916|158451921|FG000|Overall Study|Patient's request|2|||
49168574|NCT00175916|158451921|FG000|Overall Study|Treating physiciant's choice|1|||
49168575|NCT00175916|158451921|FG000|Overall Study|Moved overseas|1|||
49168576|NCT00175916|158451921|FG000|Overall Study|Loss of job and economic burden|1|||
49168577|NCT00175916|158451921|FG000|Overall Study|Site was closed|9|||
49168578|NCT00175916|158451921|FG000|Overall Study|Patient went to prison|1|||
49168579|NCT01484496|158451924|FG000|Period 1|Protocol Violation|3|||
49168580|NCT01484496|158451925|FG001|Period 1|Protocol Violation|4|||
49168581|NCT01484496|158451926|FG002|Period 1|Protocol Violation|0|||
49168582|NCT01484496|158451927|FG003|Period 1|Protocol Violation|0|||
49168583|NCT01484496|158451924|FG000|Period 1|Physician Decision|5|||
49168584|NCT01484496|158451925|FG001|Period 1|Physician Decision|1|||
49168585|NCT01484496|158451926|FG002|Period 1|Physician Decision|0|||
49168586|NCT01484496|158451927|FG003|Period 1|Physician Decision|0|||
49168587|NCT01484496|158451924|FG000|Period 1|Lack of Efficacy|10|||
49168588|NCT01484496|158451925|FG001|Period 1|Lack of Efficacy|15|||
49168589|NCT01484496|158451926|FG002|Period 1|Lack of Efficacy|0|||
49168590|NCT01484496|158451927|FG003|Period 1|Lack of Efficacy|0|||
49168591|NCT01484496|158451924|FG000|Period 1|Adverse Event|25|||
49168592|NCT01484496|158451925|FG001|Period 1|Adverse Event|40|||
49168593|NCT01484496|158451926|FG002|Period 1|Adverse Event|0|||
49168594|NCT01484496|158451927|FG003|Period 1|Adverse Event|0|||
49168595|NCT01484496|158451924|FG000|Period 1|Withdrawal by Subject|15|||
49168596|NCT01484496|158451925|FG001|Period 1|Withdrawal by Subject|12|||
49168597|NCT01484496|158451926|FG002|Period 1|Withdrawal by Subject|0|||
49168598|NCT01484496|158451927|FG003|Period 1|Withdrawal by Subject|0|||
49168599|NCT01484496|158451924|FG000|Period 1|Lost to Follow-up|2|||
49168600|NCT01484496|158451925|FG001|Period 1|Lost to Follow-up|6|||
49168601|NCT01484496|158451926|FG002|Period 1|Lost to Follow-up|0|||
49168602|NCT01484496|158451927|FG003|Period 1|Lost to Follow-up|0|||
49168603|NCT01484496|158451924|FG000|Period 1|Positive Pregnancy|1|||
48925857|NCT04072822|157561731|FG000|Treatment|Adverse Event|9|||
49168604|NCT01484496|158451925|FG001|Period 1|Positive Pregnancy|6|||
49168605|NCT01484496|158451926|FG002|Period 1|Positive Pregnancy|0|||
49168606|NCT01484496|158451927|FG003|Period 1|Positive Pregnancy|0|||
49168607|NCT01484496|158451924|FG000|Period 1|Treatment Failure|3|||
49168608|NCT01484496|158451925|FG001|Period 1|Treatment Failure|6|||
49168609|NCT01484496|158451926|FG002|Period 1|Treatment Failure|0|||
49168610|NCT01484496|158451927|FG003|Period 1|Treatment Failure|0|||
49168611|NCT01484496|158451924|FG000|Period 1|Lack of Compliance|2|||
49168612|NCT01484496|158451925|FG001|Period 1|Lack of Compliance|1|||
49168613|NCT01484496|158451926|FG002|Period 1|Lack of Compliance|0|||
49168614|NCT01484496|158451927|FG003|Period 1|Lack of Compliance|0|||
49168615|NCT01484496|158451924|FG000|Period 1|Unable to Visit Site|0|||
49168616|NCT01484496|158451925|FG001|Period 1|Unable to Visit Site|2|||
49168617|NCT01484496|158451926|FG002|Period 1|Unable to Visit Site|0|||
49168618|NCT01484496|158451927|FG003|Period 1|Unable to Visit Site|0|||
49168619|NCT01484496|158451924|FG000|Period 2|Lack of Efficacy|0|||
49168620|NCT01484496|158451925|FG001|Period 2|Lack of Efficacy|0|||
49168621|NCT01484496|158451926|FG002|Period 2|Lack of Efficacy|1|||
49168622|NCT01484496|158451927|FG003|Period 2|Lack of Efficacy|3|||
49168623|NCT01484496|158451924|FG000|Period 2|Adverse Event|0|||
49168624|NCT01484496|158451925|FG001|Period 2|Adverse Event|0|||
49168625|NCT01484496|158451926|FG002|Period 2|Adverse Event|5|||
49168626|NCT01484496|158451927|FG003|Period 2|Adverse Event|13|||
49168627|NCT01484496|158451924|FG000|Period 2|Other|0|||
49168628|NCT01484496|158451925|FG001|Period 2|Other|0|||
49168629|NCT01484496|158451926|FG002|Period 2|Other|9|||
49168630|NCT01484496|158451927|FG003|Period 2|Other|6|||
48841682|NCT01616459|157259436|FG003|Overall Study|Adverse Event|0|||
49168631|NCT03462758|158451928|FG000|Overall Study|Chose no or other method of contraception|20|||
49168632|NCT03462758|158451929|FG001|Overall Study|Chose no or other method of contraception|23|||
49168633|NCT03462758|158451928|FG000|Overall Study|Lost to follow-up before IUD placement|14|||
48841683|NCT01616459|157259433|FG000|Overall Study|Lost to Follow-up|1|||
49168634|NCT03462758|158451929|FG001|Overall Study|Lost to follow-up before IUD placement|12|||
49168635|NCT03462758|158451928|FG000|Overall Study|Unsuccessful IUD placement attempt|3|||
49168636|NCT03462758|158451929|FG001|Overall Study|Unsuccessful IUD placement attempt|3|||
49168637|NCT03462758|158451928|FG000|Overall Study|Medical contraindication|2|||
49168638|NCT03462758|158451929|FG001|Overall Study|Medical contraindication|2|||
49168639|NCT03462758|158451928|FG000|Overall Study|Lost to follow-up after IUD placement|17|||
49168640|NCT03462758|158451929|FG001|Overall Study|Lost to follow-up after IUD placement|14|||
49168641|NCT00400517|158451933|FG000|Overall Study|Withdrawal by Subject|1|||
49168642|NCT00400517|158451933|FG000|Overall Study|Physician Decision|1|||
49168643|NCT02688192|158451934|FG000|Overall Study|Lost to Follow-up|11|||
49168644|NCT02688192|158451935|FG001|Overall Study|Lost to Follow-up|5|||
49168645|NCT02688192|158451934|FG000|Overall Study|Physician Decision|1|||
49168646|NCT02688192|158451935|FG001|Overall Study|Physician Decision|0|||
49168647|NCT00211172|158451937|FG000|Overall Study|Died or lost health plan eligibility|39|||
49168648|NCT00211172|158451938|FG001|Overall Study|Died or lost health plan eligibility|32|||
49168649|NCT01672879|158451939|FG000|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43|||
49168650|NCT01672879|158451940|FG001|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55|||
49168651|NCT01672879|158451941|FG002|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61|||
49168652|NCT01672879|158451939|FG000|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14|||
49168653|NCT01672879|158451940|FG001|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7|||
49168654|NCT01672879|158451941|FG002|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6|||
49168655|NCT01672879|158451939|FG000|Blinded Phase (Up to 240 Weeks)|Adverse Event|5|||
49168656|NCT01672879|158451940|FG001|Blinded Phase (Up to 240 Weeks)|Adverse Event|2|||
49168657|NCT01672879|158451941|FG002|Blinded Phase (Up to 240 Weeks)|Adverse Event|7|||
49168658|NCT01672879|158451939|FG000|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4|||
49168659|NCT01672879|158451940|FG001|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3|||
49168660|NCT01672879|158451941|FG002|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1|||
49168661|NCT01672879|158451939|FG000|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5|||
49168662|NCT01672879|158451940|FG001|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
49168663|NCT01672879|158451941|FG002|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2|||
49168664|NCT01672879|158451939|FG000|Blinded Phase (Up to 240 Weeks)|Death|0|||
49168665|NCT01672879|158451940|FG001|Blinded Phase (Up to 240 Weeks)|Death|2|||
49168666|NCT01672879|158451941|FG002|Blinded Phase (Up to 240 Weeks)|Death|0|||
49168667|NCT01672879|158451939|FG000|Blinded Phase (Up to 240 Weeks)|Missing|1|||
49168668|NCT01672879|158451940|FG001|Blinded Phase (Up to 240 Weeks)|Missing|0|||
49168669|NCT01672879|158451941|FG002|Blinded Phase (Up to 240 Weeks)|Missing|0|||
49168670|NCT01672879|158451939|FG000|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
49168671|NCT01672879|158451940|FG001|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
49168672|NCT01672879|158451941|FG002|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1|||
49168673|NCT01672879|158451939|FG000|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15|||
49168674|NCT01672879|158451940|FG001|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17|||
49168675|NCT01672879|158451941|FG002|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8|||
49168676|NCT01672879|158451939|FG000|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8|||
49168677|NCT01672879|158451940|FG001|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16|||
49168678|NCT01672879|158451941|FG002|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6|||
49168679|NCT01672879|158451939|FG000|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5|||
49168680|NCT01672879|158451940|FG001|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
49168681|NCT01672879|158451941|FG002|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
48841684|NCT01616459|157259434|FG001|Overall Study|Lost to Follow-up|11|||
49168682|NCT01672879|158451939|FG000|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
49168683|NCT01672879|158451940|FG001|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
49168684|NCT01672879|158451941|FG002|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
49168685|NCT01672879|158451939|FG000|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1|||
48841685|NCT01616459|157259435|FG002|Overall Study|Lost to Follow-up|3|||
49168686|NCT01672879|158451940|FG001|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
49168687|NCT01672879|158451941|FG002|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
49168688|NCT01871545|158451942|FG000|Overall Study|Death|2|||
49168689|NCT01871545|158451943|FG001|Overall Study|Death|0|||
49168690|NCT01871545|158451942|FG000|Overall Study|Lack of Efficacy|11|||
49168691|NCT01871545|158451943|FG001|Overall Study|Lack of Efficacy|2|||
49168692|NCT01871545|158451942|FG000|Overall Study|Physician Decision|4|||
49168693|NCT01871545|158451943|FG001|Overall Study|Physician Decision|0|||
49168694|NCT01871545|158451942|FG000|Overall Study|Withdrawal by Subject|0|||
49168695|NCT01871545|158451943|FG001|Overall Study|Withdrawal by Subject|1|||
49168696|NCT02954887|158451944|FG000|Overall Study|Withdrawal by Subject|3|||
49168697|NCT02954887|158451944|FG000|Overall Study|Lack of Efficacy|3|||
49168698|NCT02954887|158451944|FG000|Overall Study|Other|1|||
49168699|NCT01119066|158451947|FG000|Overall Study|Withdrawal by Subject|4|||
49168700|NCT01119066|158451948|FG001|Overall Study|Withdrawal by Subject|6|||
49168701|NCT01119066|158451949|FG002|Overall Study|Withdrawal by Subject|0|||
49168702|NCT01119066|158451950|FG003|Overall Study|Withdrawal by Subject|0|||
49168703|NCT01119066|158451947|FG000|Overall Study|Concern regarding adequacy of transplant cell dose|2|||
49168704|NCT01119066|158451948|FG001|Overall Study|Concern regarding adequacy of transplant cell dose|1|||
49168705|NCT01119066|158451949|FG002|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
49168706|NCT01119066|158451950|FG003|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
49168707|NCT01119066|158451947|FG000|Overall Study|Relapse identified before transplant|1|||
49168708|NCT01119066|158451948|FG001|Overall Study|Relapse identified before transplant|0|||
49168709|NCT01119066|158451949|FG002|Overall Study|Relapse identified before transplant|0|||
49168710|NCT01119066|158451950|FG003|Overall Study|Relapse identified before transplant|0|||
49168711|NCT01119066|158451947|FG000|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
49168712|NCT01119066|158451948|FG001|Overall Study|Intercurrent medication condition rendered patient ineligible|3|||
49168713|NCT01119066|158451949|FG002|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
49168714|NCT01119066|158451950|FG003|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
49168715|NCT01119066|158451947|FG000|Overall Study|Relapse identified before transplant|0|||
49168716|NCT01119066|158451948|FG001|Overall Study|Relapse identified before transplant|4|||
49168717|NCT01119066|158451949|FG002|Overall Study|Relapse identified before transplant|0|||
49168718|NCT01119066|158451950|FG003|Overall Study|Relapse identified before transplant|0|||
49168719|NCT04396795|158451951|FG000|Month 1|Lost to Follow-up|2|||
49168720|NCT04396795|158451952|FG001|Month 1|Lost to Follow-up|3|||
49168721|NCT04396795|158451951|FG000|Month 3|Lost to Follow-up|1|||
49168722|NCT04396795|158451952|FG001|Month 3|Lost to Follow-up|3|||
49168723|NCT04396795|158451951|FG000|Month 6|Lost to Follow-up|3|||
49168724|NCT04396795|158451952|FG001|Month 6|Lost to Follow-up|3|||
49168725|NCT01467466|158451953|FG000|Overall Study|Withdrawal by Subject|15|||
48925858|NCT04072822|157561732|FG001|Treatment|Adverse Event|5|||
48925859|NCT04072822|157561731|FG000|Treatment|Met Stopping Criteria|13|||
48925860|NCT04072822|157561732|FG001|Treatment|Met Stopping Criteria|24|||
48925861|NCT04072822|157561731|FG000|Treatment|Averse Event and Met Stopping Criteria|2|||
48925862|NCT04072822|157561732|FG001|Treatment|Averse Event and Met Stopping Criteria|9|||
48925863|NCT04072822|157561731|FG000|Treatment|Withdrawal by Subject|0|||
48925864|NCT04072822|157561732|FG001|Treatment|Withdrawal by Subject|2|||
48925865|NCT04072822|157561731|FG000|Treatment|Death|0|||
48925866|NCT04072822|157561732|FG001|Treatment|Death|2|||
48925867|NCT04072822|157561731|FG000|Treatment|Lost to Follow-up|11|||
48925868|NCT04072822|157561732|FG001|Treatment|Lost to Follow-up|3|||
48925869|NCT04072822|157561731|FG000|Treatment|Physician Decision|1|||
48925870|NCT04072822|157561732|FG001|Treatment|Physician Decision|0|||
48925871|NCT04072822|157561731|FG000|Treatment|Other|7|||
48925872|NCT04072822|157561732|FG001|Treatment|Other|9|||
48925873|NCT04072822|157561731|FG000|Follow-up|Withdrawal by Subject|1|||
48925874|NCT04072822|157561732|FG001|Follow-up|Withdrawal by Subject|0|||
48925875|NCT04072822|157561731|FG000|Follow-up|Lost to Follow-up|5|||
48925876|NCT04072822|157561732|FG001|Follow-up|Lost to Follow-up|4|||
48925877|NCT01391507|157561736|FG000|Overall Study|Death|0|||
48925878|NCT01391507|157561737|FG001|Overall Study|Death|0|||
48925879|NCT01391507|157561738|FG002|Overall Study|Death|0|||
48925880|NCT01391507|157561739|FG003|Overall Study|Death|1|||
48925881|NCT01391507|157561736|FG000|Overall Study|Adverse Event|1|||
48925882|NCT01391507|157561737|FG001|Overall Study|Adverse Event|1|||
48925883|NCT01391507|157561738|FG002|Overall Study|Adverse Event|2|||
48925884|NCT01391507|157561739|FG003|Overall Study|Adverse Event|2|||
49168726|NCT01467466|158451954|FG001|Overall Study|Withdrawal by Subject|18|||
49168727|NCT01467466|158451955|FG002|Overall Study|Withdrawal by Subject|13|||
49168728|NCT01467466|158451956|FG003|Overall Study|Withdrawal by Subject|11|||
49168729|NCT01467466|158451953|FG000|Overall Study|Revoked Consent Prior To Procedure|10|||
49168730|NCT01467466|158451954|FG001|Overall Study|Revoked Consent Prior To Procedure|9|||
49168731|NCT01467466|158451955|FG002|Overall Study|Revoked Consent Prior To Procedure|15|||
49168732|NCT01467466|158451956|FG003|Overall Study|Revoked Consent Prior To Procedure|5|||
49168733|NCT01467466|158451953|FG000|Overall Study|Procedure Cancelled|46|||
49168734|NCT01467466|158451954|FG001|Overall Study|Procedure Cancelled|45|||
49168735|NCT01467466|158451955|FG002|Overall Study|Procedure Cancelled|25|||
49168736|NCT01467466|158451956|FG003|Overall Study|Procedure Cancelled|29|||
49168737|NCT01467466|158451953|FG000|Overall Study|No Endpoint Blood Draw|38|||
49168738|NCT01467466|158451954|FG001|Overall Study|No Endpoint Blood Draw|32|||
48925885|NCT01391507|157561736|FG000|Overall Study|Withdrawal by Subject|1|||
48925886|NCT01391507|157561737|FG001|Overall Study|Withdrawal by Subject|2|||
48925887|NCT01391507|157561738|FG002|Overall Study|Withdrawal by Subject|1|||
49168739|NCT01467466|158451955|FG002|Overall Study|No Endpoint Blood Draw|51|||
49168740|NCT01467466|158451956|FG003|Overall Study|No Endpoint Blood Draw|43|||
49168741|NCT04721158|158451959|FG000|Overall Study|Lost to Follow-up|4|||
49168742|NCT04721158|158451959|FG000|Overall Study|Device did not connect|1|||
49168743|NCT00260832|158451960|FG000|Overall Study|Adverse Event|26|||
49168744|NCT00260832|158451961|FG001|Overall Study|Adverse Event|19|||
48925888|NCT01391507|157561739|FG003|Overall Study|Withdrawal by Subject|1|||
48925889|NCT01391507|157561736|FG000|Overall Study|Lack of Efficacy|0|||
48925890|NCT01391507|157561737|FG001|Overall Study|Lack of Efficacy|0|||
49168745|NCT00260832|158451960|FG000|Overall Study|Progression|116|||
49168746|NCT00260832|158451961|FG001|Overall Study|Progression|96|||
49168747|NCT00260832|158451960|FG000|Overall Study|Withdrawal by Subject|15|||
49168748|NCT00260832|158451961|FG001|Overall Study|Withdrawal by Subject|17|||
49168749|NCT00260832|158451960|FG000|Overall Study|Physician Decision|15|||
49168750|NCT00260832|158451961|FG001|Overall Study|Physician Decision|9|||
49168751|NCT00260832|158451960|FG000|Overall Study|Death|43|||
49168752|NCT00260832|158451961|FG001|Overall Study|Death|62|||
48925891|NCT01391507|157561738|FG002|Overall Study|Lack of Efficacy|0|||
48925892|NCT01391507|157561739|FG003|Overall Study|Lack of Efficacy|1|||
48925893|NCT01391507|157561736|FG000|Overall Study|Protocol Violation|2|||
48925894|NCT01391507|157561737|FG001|Overall Study|Protocol Violation|1|||
48925895|NCT01391507|157561738|FG002|Overall Study|Protocol Violation|1|||
48925896|NCT01391507|157561739|FG003|Overall Study|Protocol Violation|2|||
48925897|NCT00209339|157561742|FG000|At 12 Months Follow-up|Withdrawal by Subject|8|||
48925898|NCT00209339|157561742|FG000|At 12 Months Follow-up|Death|1|||
48925899|NCT00209339|157561742|FG000|At 12 Months Follow-up|No MitraClip Device Implanted|6|||
49168753|NCT00260832|158451960|FG000|Overall Study|Other|10|||
49168754|NCT00260832|158451961|FG001|Overall Study|Other|7|||
49168755|NCT00260832|158451960|FG000|Overall Study|Protocol Violation|3|||
49168756|NCT00260832|158451961|FG001|Overall Study|Protocol Violation|1|||
49168757|NCT00976716|158451962|FG000|Overall Study|Adverse Event|1|||
49168758|NCT03008070|158451991|FG000|Overall Study|Adverse Event|3|||
49168759|NCT03008070|158451992|FG001|Overall Study|Adverse Event|3|||
49168760|NCT03008070|158451993|FG002|Overall Study|Adverse Event|3|||
49168761|NCT03008070|158451991|FG000|Overall Study|Lost to Follow-up|1|||
49168762|NCT03008070|158451992|FG001|Overall Study|Lost to Follow-up|1|||
49168763|NCT03008070|158451993|FG002|Overall Study|Lost to Follow-up|0|||
49168764|NCT03008070|158451991|FG000|Overall Study|Non compliance|0|||
49168765|NCT03008070|158451992|FG001|Overall Study|Non compliance|1|||
49168766|NCT03008070|158451993|FG002|Overall Study|Non compliance|1|||
49168767|NCT03008070|158451991|FG000|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
49168768|NCT03008070|158451992|FG001|Overall Study|Withdrawal by patient and adverse event non fatal|1|||
49168769|NCT03008070|158451993|FG002|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
49168770|NCT03008070|158451991|FG000|Overall Study|Withdrawal by Subject|2|||
49168771|NCT03008070|158451992|FG001|Overall Study|Withdrawal by Subject|0|||
49168772|NCT03008070|158451993|FG002|Overall Study|Withdrawal by Subject|1|||
49168773|NCT03008070|158451991|FG000|Overall Study|Use of prohibited drug|0|||
49168774|NCT03008070|158451992|FG001|Overall Study|Use of prohibited drug|0|||
49168775|NCT03008070|158451993|FG002|Overall Study|Use of prohibited drug|2|||
49168776|NCT00556439|158451994|FG000|Study Entry to Week 12|Lack of Efficacy|5|||
49168777|NCT00556439|158451995|FG001|Study Entry to Week 12|Lack of Efficacy|0|||
49168778|NCT00556439|158451996|FG002|Study Entry to Week 12|Lack of Efficacy|6|||
49168779|NCT00556439|158451997|FG003|Study Entry to Week 12|Lack of Efficacy|0|||
49168780|NCT00556439|158451994|FG000|Study Entry to Week 12|Physician Decision|1|||
49168781|NCT00556439|158451995|FG001|Study Entry to Week 12|Physician Decision|0|||
49168782|NCT00556439|158451996|FG002|Study Entry to Week 12|Physician Decision|0|||
49168783|NCT00556439|158451997|FG003|Study Entry to Week 12|Physician Decision|0|||
49168784|NCT00556439|158451994|FG000|Study Entry to Week 12|Withdrawal by Subject|1|||
49168785|NCT00556439|158451995|FG001|Study Entry to Week 12|Withdrawal by Subject|0|||
49168786|NCT00556439|158451996|FG002|Study Entry to Week 12|Withdrawal by Subject|1|||
49168787|NCT00556439|158451997|FG003|Study Entry to Week 12|Withdrawal by Subject|0|||
49168788|NCT00556439|158451994|FG000|Study Entry to Week 12|Recurrent infection|1|||
49168789|NCT00556439|158451995|FG001|Study Entry to Week 12|Recurrent infection|0|||
49168790|NCT00556439|158451996|FG002|Study Entry to Week 12|Recurrent infection|0|||
49168791|NCT00556439|158451997|FG003|Study Entry to Week 12|Recurrent infection|0|||
49168792|NCT00556439|158451994|FG000|Study Entry to Week 12|Malignancy|0|||
49168793|NCT00556439|158451995|FG001|Study Entry to Week 12|Malignancy|0|||
49168794|NCT00556439|158451996|FG002|Study Entry to Week 12|Malignancy|1|||
49168795|NCT00556439|158451997|FG003|Study Entry to Week 12|Malignancy|0|||
49168796|NCT00556439|158451994|FG000|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1|||
49168797|NCT00556439|158451995|FG001|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3|||
49168798|NCT00556439|158451996|FG002|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
49168799|NCT00556439|158451997|FG003|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
49168800|NCT00556439|158451994|FG000|After Week 12 (Randomized Study Period)|Physician Decision|1|||
49168801|NCT00556439|158451995|FG001|After Week 12 (Randomized Study Period)|Physician Decision|0|||
49168802|NCT00556439|158451996|FG002|After Week 12 (Randomized Study Period)|Physician Decision|0|||
49168803|NCT00556439|158451997|FG003|After Week 12 (Randomized Study Period)|Physician Decision|0|||
49168804|NCT00556439|158451994|FG000|After Week 12 (Randomized Study Period)|Malignancy|0|||
49168805|NCT00556439|158451995|FG001|After Week 12 (Randomized Study Period)|Malignancy|1|||
49168806|NCT00556439|158451996|FG002|After Week 12 (Randomized Study Period)|Malignancy|0|||
49168807|NCT00556439|158451997|FG003|After Week 12 (Randomized Study Period)|Malignancy|1|||
49168808|NCT00556439|158451994|FG000|After Week 12 (Randomized Study Period)|Severe infection|1|||
49168809|NCT00556439|158451995|FG001|After Week 12 (Randomized Study Period)|Severe infection|0|||
49168810|NCT00556439|158451996|FG002|After Week 12 (Randomized Study Period)|Severe infection|0|||
49168811|NCT00556439|158451997|FG003|After Week 12 (Randomized Study Period)|Severe infection|0|||
49168812|NCT05005273|158451999|FG000|Overall Study|Study Terminated|1|||
49168813|NCT05005273|158452000|FG001|Overall Study|Study Terminated|0|||
49168814|NCT00652743|158453588|FG000|Months 12-18|Lost to Follow-up|1|||
49168815|NCT00652743|158453589|FG001|Months 12-18|Lost to Follow-up|2|||
49168816|NCT00652743|158453590|FG002|Months 12-18|Lost to Follow-up|7|||
49168817|NCT00652743|158453588|FG000|Months 24-30|Other|5|||
49168818|NCT00652743|158453589|FG001|Months 24-30|Other|1|||
49168819|NCT00652743|158453590|FG002|Months 24-30|Other|11|||
49168820|NCT00652743|158453588|FG000|Months 36-42|Serious Adverse Events|0|||
48925900|NCT00209339|157561742|FG000|At 24 Months Follow-up|Withdrawal by Subject|4|||
48925901|NCT00209339|157561742|FG000|At 24 Months Follow-up|Withdrawal because of other reasons|6|||
48925902|NCT00209339|157561742|FG000|At 24 Months Follow-up|Death|1|||
48925903|NCT00209339|157561742|FG000|At 3 Years Follow-up|Withdrawal by Subject|1|||
48925904|NCT00209339|157561742|FG000|At 4 Years Follow-up|Withdrawal by Subject|4|||
48925905|NCT00209339|157561742|FG000|At 4 Years Follow-up|Death|1|||
48925906|NCT00209339|157561742|FG000|At 5 Years Follow-up|Withdrawal by Subject|2|||
48925907|NCT00209339|157561742|FG000|At 5 Years Follow-up|Withdrawal because of other reasons|5|||
48925908|NCT00209339|157561742|FG000|At 5 Years Follow-up|Death|1|||
48925909|NCT01239160|157561748|FG000|Overall Study|Lost to Follow-up|3|||
48925910|NCT01239160|157561749|FG001|Overall Study|Lost to Follow-up|5|||
48925911|NCT01239160|157561750|FG002|Overall Study|Lost to Follow-up|0|||
48925912|NCT01239160|157561748|FG000|Overall Study|Withdrawal by Subject|17|||
48925913|NCT01239160|157561749|FG001|Overall Study|Withdrawal by Subject|6|||
48925914|NCT01239160|157561750|FG002|Overall Study|Withdrawal by Subject|2|||
48925915|NCT01239160|157561748|FG000|Overall Study|Physician Decision|5|||
48925916|NCT01239160|157561749|FG001|Overall Study|Physician Decision|7|||
48925917|NCT01239160|157561750|FG002|Overall Study|Physician Decision|2|||
48925918|NCT01239160|157561748|FG000|Overall Study|Early Termination Due to Study Closure|0|||
48925919|NCT01239160|157561749|FG001|Overall Study|Early Termination Due to Study Closure|1|||
48925920|NCT01239160|157561750|FG002|Overall Study|Early Termination Due to Study Closure|6|||
48925921|NCT00382993|157561751|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
48925922|NCT00382993|157561752|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|2|||
48925923|NCT00382993|157561751|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1|||
48925924|NCT00382993|157561752|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3|||
48925925|NCT00382993|157561751|FG000|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0|||
48925926|NCT00382993|157561752|FG001|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5|||
48925927|NCT00382993|157561751|FG000|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
48841686|NCT01616459|157259436|FG003|Overall Study|Lost to Follow-up|2|||
48841687|NCT01616459|157259433|FG000|Overall Study|Protocol Violation|0|||
48841688|NCT01616459|157259434|FG001|Overall Study|Protocol Violation|0|||
48841689|NCT01616459|157259435|FG002|Overall Study|Protocol Violation|0|||
48841690|NCT01616459|157259436|FG003|Overall Study|Protocol Violation|2|||
48841691|NCT01616459|157259433|FG000|Overall Study|Withdrawal by Subject|2|||
48841692|NCT01616459|157259434|FG001|Overall Study|Withdrawal by Subject|4|||
48841693|NCT01616459|157259435|FG002|Overall Study|Withdrawal by Subject|4|||
48841694|NCT01616459|157259436|FG003|Overall Study|Withdrawal by Subject|4|||
48841695|NCT01616459|157259433|FG000|Overall Study|Other reason|0|||
48841696|NCT01616459|157259434|FG001|Overall Study|Other reason|1|||
48841697|NCT01616459|157259435|FG002|Overall Study|Other reason|1|||
48841698|NCT01616459|157259436|FG003|Overall Study|Other reason|0|||
48841699|NCT02531113|157259437|FG000|Induction Period: Week 0 to 12|Adverse Event|4|||
49168821|NCT00652743|158453589|FG001|Months 36-42|Serious Adverse Events|1|||
49168822|NCT00652743|158453590|FG002|Months 36-42|Serious Adverse Events|1|||
49168823|NCT00652743|158453588|FG000|Months 36-42|Withdrawal by Subject|1|||
49168824|NCT00652743|158453589|FG001|Months 36-42|Withdrawal by Subject|1|||
49168825|NCT00652743|158453590|FG002|Months 36-42|Withdrawal by Subject|0|||
49168826|NCT00652743|158453588|FG000|Months 36-42|Lost to Follow-up|0|||
49168827|NCT00652743|158453589|FG001|Months 36-42|Lost to Follow-up|1|||
49168828|NCT00652743|158453590|FG002|Months 36-42|Lost to Follow-up|0|||
49168829|NCT00652743|158453588|FG000|Months 36-42|Migrated/moved from study area|1|||
49168830|NCT00652743|158453589|FG001|Months 36-42|Migrated/moved from study area|0|||
49168831|NCT00652743|158453590|FG002|Months 36-42|Migrated/moved from study area|0|||
49168832|NCT00652743|158453588|FG000|Months 36-42|Other|4|||
49168833|NCT00652743|158453589|FG001|Months 36-42|Other|2|||
49168834|NCT00652743|158453590|FG002|Months 36-42|Other|8|||
49168835|NCT01396187|158453603|FG000|Overall Study|Adverse Event|0|||
49168836|NCT01396187|158453604|FG001|Overall Study|Adverse Event|1|||
49168837|NCT01396187|158453605|FG002|Overall Study|Adverse Event|0|||
49168838|NCT01396187|158453606|FG003|Overall Study|Adverse Event|0|||
49168839|NCT01396187|158453607|FG004|Overall Study|Adverse Event|0|||
49168840|NCT01396187|158453603|FG000|Overall Study|Withdrawal by Subject|0|||
49168841|NCT01396187|158453604|FG001|Overall Study|Withdrawal by Subject|1|||
49168842|NCT01396187|158453605|FG002|Overall Study|Withdrawal by Subject|1|||
49168843|NCT01396187|158453606|FG003|Overall Study|Withdrawal by Subject|0|||
49168844|NCT01396187|158453607|FG004|Overall Study|Withdrawal by Subject|0|||
49168845|NCT01396187|158453603|FG000|Overall Study|Other|1|||
49168846|NCT01396187|158453604|FG001|Overall Study|Other|1|||
49168847|NCT01396187|158453605|FG002|Overall Study|Other|0|||
49168848|NCT01396187|158453606|FG003|Overall Study|Other|0|||
49168849|NCT01396187|158453607|FG004|Overall Study|Other|1|||
49168850|NCT01898286|158453608|FG000|Overall Study|Withdrawal by Subject|1|||
49168851|NCT01898286|158453608|FG000|Overall Study|Protocol Violation|1|||
49168852|NCT01898286|158453608|FG000|Overall Study|Lost to Follow-up|1|||
49168853|NCT00682929|158453612|FG000|Overall Study|Adverse Event|4|||
49168854|NCT00682929|158453613|FG001|Overall Study|Adverse Event|1|||
49168855|NCT00682929|158453614|FG002|Overall Study|Adverse Event|1|||
49168856|NCT00682929|158453612|FG000|Overall Study|Withdrawal by Subject|1|||
49168857|NCT00682929|158453613|FG001|Overall Study|Withdrawal by Subject|2|||
49168858|NCT00682929|158453614|FG002|Overall Study|Withdrawal by Subject|1|||
49168859|NCT00682929|158453612|FG000|Overall Study|dosing compliance < 80%|0|||
49168860|NCT00682929|158453613|FG001|Overall Study|dosing compliance < 80%|2|||
49168861|NCT00682929|158453614|FG002|Overall Study|dosing compliance < 80%|0|||
49168862|NCT00682929|158453612|FG000|Overall Study|lag in DEA renewal|1|||
49168863|NCT00682929|158453613|FG001|Overall Study|lag in DEA renewal|0|||
49168864|NCT00682929|158453614|FG002|Overall Study|lag in DEA renewal|0|||
49168865|NCT06164691|158453620|FG000|Overall Study|Withdrawal by Subject|2|||
49168866|NCT06164691|158453621|FG001|Overall Study|Withdrawal by Subject|0|||
49168867|NCT06164691|158453622|FG002|Overall Study|Withdrawal by Subject|0|||
49168868|NCT01048242|158453623|FG000|Overall Study|See study flow chart|4|||
49168869|NCT01048242|158453624|FG001|Overall Study|See study flow chart|2|||
49168870|NCT01815424|158453627|FG000|Week 0 to 16|Adverse Event|1|||
49168871|NCT01815424|158453628|FG001|Week 0 to 16|Adverse Event|3|||
49168872|NCT01815424|158453629|FG002|Week 0 to 16|Adverse Event|3|||
49168873|NCT01815424|158453630|FG003|Week 0 to 16|Adverse Event|0|||
49168874|NCT01815424|158453631|FG004|Week 0 to 16|Adverse Event|0|||
49168875|NCT01815424|158453627|FG000|Week 0 to 16|Does Not Meet Entrance Criteria|2|||
49168876|NCT01815424|158453628|FG001|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
49168877|NCT01815424|158453629|FG002|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
48925928|NCT00382993|157561752|FG001|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
48925929|NCT00382993|157561751|FG000|Migraine Attack 1 (Period 1)|Other (no additional data present)|3|||
48925930|NCT00382993|157561752|FG001|Migraine Attack 1 (Period 1)|Other (no additional data present)|5|||
49168878|NCT01815424|158453630|FG003|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
49168879|NCT01815424|158453631|FG004|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
49168880|NCT01815424|158453627|FG000|Week 0 to 16|Lost to Follow-up|0|||
49168881|NCT01815424|158453628|FG001|Week 0 to 16|Lost to Follow-up|1|||
49168882|NCT01815424|158453629|FG002|Week 0 to 16|Lost to Follow-up|0|||
48925931|NCT00382993|157561751|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
49168883|NCT01815424|158453630|FG003|Week 0 to 16|Lost to Follow-up|0|||
49168884|NCT01815424|158453631|FG004|Week 0 to 16|Lost to Follow-up|0|||
49168885|NCT01815424|158453627|FG000|Week 0 to 16|Withdrawal by Subject|0|||
49168886|NCT01815424|158453628|FG001|Week 0 to 16|Withdrawal by Subject|0|||
49168887|NCT01815424|158453629|FG002|Week 0 to 16|Withdrawal by Subject|1|||
49168888|NCT01815424|158453630|FG003|Week 0 to 16|Withdrawal by Subject|0|||
49168889|NCT01815424|158453631|FG004|Week 0 to 16|Withdrawal by Subject|0|||
49168890|NCT01815424|158453627|FG000|Week 0 to 16|Other|1|||
49168891|NCT01815424|158453628|FG001|Week 0 to 16|Other|0|||
49168892|NCT01815424|158453629|FG002|Week 0 to 16|Other|3|||
49168893|NCT01815424|158453630|FG003|Week 0 to 16|Other|0|||
49168894|NCT01815424|158453631|FG004|Week 0 to 16|Other|0|||
49168895|NCT01815424|158453627|FG000|Week 0 to 16|Protocol Violation|1|||
49168896|NCT01815424|158453628|FG001|Week 0 to 16|Protocol Violation|0|||
49168897|NCT01815424|158453629|FG002|Week 0 to 16|Protocol Violation|0|||
49168898|NCT01815424|158453630|FG003|Week 0 to 16|Protocol Violation|0|||
48841700|NCT02531113|157259437|FG000|Induction Period: Week 0 to 12|Lack of Efficacy|4|||
48841701|NCT02531113|157259437|FG000|Induction Period: Week 0 to 12|Withdrawal by Subject|3|||
48841702|NCT02531113|157259437|FG000|Extension Period: Week 12 up to Week 160|Physician Decision|2|||
48841703|NCT02531113|157259437|FG000|Extension Period: Week 12 up to Week 160|Adverse Event|5|||
48841704|NCT02531113|157259437|FG000|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19|||
48841705|NCT02531113|157259437|FG000|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11|||
48841706|NCT02531113|157259437|FG000|Extension Period: Week 12 up to Week 160|Pregnancy|1|||
48841707|NCT00482729|157260701|FG000|Overall Study|Adverse Event|29|||
48841708|NCT00482729|157260702|FG001|Overall Study|Adverse Event|33|||
48841709|NCT00482729|157260701|FG000|Overall Study|Creatinine/Creatinine Clearance Criteria|0|||
48841710|NCT00482729|157260702|FG001|Overall Study|Creatinine/Creatinine Clearance Criteria|2|||
48841711|NCT00482729|157260701|FG000|Overall Study|Hyperglycemia Criteria|7|||
48841712|NCT00482729|157260702|FG001|Overall Study|Hyperglycemia Criteria|5|||
48841713|NCT00482729|157260701|FG000|Overall Study|Lack of Efficacy|4|||
48841714|NCT00482729|157260702|FG001|Overall Study|Lack of Efficacy|16|||
48841715|NCT00482729|157260701|FG000|Overall Study|Lost to Follow-up|86|||
48841716|NCT00482729|157260702|FG001|Overall Study|Lost to Follow-up|66|||
48841717|NCT00482729|157260701|FG000|Overall Study|Physician Decision|10|||
48841718|NCT00482729|157260702|FG001|Overall Study|Physician Decision|7|||
48841719|NCT00482729|157260701|FG000|Overall Study|Pregnancy|4|||
48841720|NCT00482729|157260702|FG001|Overall Study|Pregnancy|2|||
48841721|NCT00482729|157260701|FG000|Overall Study|Protocol Violation|10|||
48841722|NCT00482729|157260702|FG001|Overall Study|Protocol Violation|18|||
48841723|NCT00482729|157260701|FG000|Overall Study|Withdrawal by Subject|67|||
48841724|NCT00482729|157260702|FG001|Overall Study|Withdrawal by Subject|69|||
48841725|NCT02396316|157260703|FG000|Overall Study|Physician Decision|1|||
48841726|NCT02396316|157260704|FG001|Overall Study|Physician Decision|0|||
48841727|NCT02396316|157260703|FG000|Overall Study|Progressive disease|6|||
48841728|NCT02396316|157260704|FG001|Overall Study|Progressive disease|3|||
48841729|NCT02396316|157260703|FG000|Overall Study|Protocol Violation|0|||
48841730|NCT02396316|157260704|FG001|Overall Study|Protocol Violation|1|||
48841731|NCT02396316|157260703|FG000|Overall Study|Treatment unblinded|0|||
48841732|NCT02396316|157260704|FG001|Overall Study|Treatment unblinded|1|||
49015091|NCT02058628|157892060|FG001|Overall Study|Withdrawal by Subject|2|||
49015092|NCT02058628|157892059|FG000|Overall Study|Lost to Follow-up|2|||
49015093|NCT02058628|157892060|FG001|Overall Study|Lost to Follow-up|4|||
49015094|NCT02058628|157892059|FG000|Overall Study|Not in time schedule|0|||
49015095|NCT02058628|157892060|FG001|Overall Study|Not in time schedule|1|||
49015096|NCT02058628|157892059|FG000|Overall Study|The visit date was not in timeline|0|||
49015097|NCT02058628|157892060|FG001|Overall Study|The visit date was not in timeline|1|||
49015098|NCT02058628|157892059|FG000|Overall Study|A lot of time for study for participant|1|||
49015099|NCT02058628|157892060|FG001|Overall Study|A lot of time for study for participant|0|||
49015100|NCT02058628|157892059|FG000|Overall Study|Non compliance|1|||
49168899|NCT01815424|158453631|FG004|Week 0 to 16|Protocol Violation|0|||
49168900|NCT01815424|158453627|FG000|Week 0 to 16|Insufficient Clinical Response|2|||
49168901|NCT01815424|158453628|FG001|Week 0 to 16|Insufficient Clinical Response|0|||
49168902|NCT01815424|158453629|FG002|Week 0 to 16|Insufficient Clinical Response|4|||
49168903|NCT01815424|158453630|FG003|Week 0 to 16|Insufficient Clinical Response|0|||
49168904|NCT01815424|158453631|FG004|Week 0 to 16|Insufficient Clinical Response|0|||
49168905|NCT01815424|158453627|FG000|Week 16 to 52|Other|0|||
49168906|NCT01815424|158453628|FG001|Week 16 to 52|Other|1|||
49168907|NCT01815424|158453629|FG002|Week 16 to 52|Other|0|||
49168908|NCT01815424|158453630|FG003|Week 16 to 52|Other|0|||
49168909|NCT01815424|158453631|FG004|Week 16 to 52|Other|0|||
49168910|NCT01815424|158453627|FG000|Week 16 to 52|Adverse Event|0|||
49168911|NCT01815424|158453628|FG001|Week 16 to 52|Adverse Event|0|||
48925932|NCT00382993|157561752|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
48925933|NCT00382993|157561751|FG000|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0|||
49168912|NCT01815424|158453629|FG002|Week 16 to 52|Adverse Event|0|||
49168913|NCT01815424|158453630|FG003|Week 16 to 52|Adverse Event|0|||
48925934|NCT00382993|157561752|FG001|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1|||
48925935|NCT00382993|157561751|FG000|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0|||
48925936|NCT00382993|157561752|FG001|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1|||
49168914|NCT01815424|158453631|FG004|Week 16 to 52|Adverse Event|1|||
49168915|NCT01815424|158453627|FG000|Week 16 to 52|Insufficient Clinical Response|1|||
49168916|NCT01815424|158453628|FG001|Week 16 to 52|Insufficient Clinical Response|0|||
49168917|NCT01815424|158453629|FG002|Week 16 to 52|Insufficient Clinical Response|0|||
48841733|NCT01875848|157260706|FG000|Overall Study|Withdrawal by Subject|2|||
49168918|NCT01815424|158453630|FG003|Week 16 to 52|Insufficient Clinical Response|1|||
49168919|NCT01815424|158453631|FG004|Week 16 to 52|Insufficient Clinical Response|1|||
49168920|NCT01815424|158453627|FG000|Week 16 to 52|Lost to Follow-up|0|||
49168921|NCT01815424|158453628|FG001|Week 16 to 52|Lost to Follow-up|2|||
49168922|NCT01815424|158453629|FG002|Week 16 to 52|Lost to Follow-up|0|||
49168923|NCT01815424|158453630|FG003|Week 16 to 52|Lost to Follow-up|2|||
49168924|NCT01815424|158453631|FG004|Week 16 to 52|Lost to Follow-up|1|||
49168925|NCT01815424|158453627|FG000|Week 16 to 52|Withdrawal by Subject|1|||
49168926|NCT01815424|158453628|FG001|Week 16 to 52|Withdrawal by Subject|2|||
49168927|NCT01815424|158453629|FG002|Week 16 to 52|Withdrawal by Subject|0|||
49168928|NCT01815424|158453630|FG003|Week 16 to 52|Withdrawal by Subject|0|||
49168929|NCT01815424|158453631|FG004|Week 16 to 52|Withdrawal by Subject|0|||
49168930|NCT01309204|158453632|FG000|Overall Study|Adverse Event|48|||
49168931|NCT01309204|158453633|FG001|Overall Study|Adverse Event|58|||
49168932|NCT01309204|158453632|FG000|Overall Study|Lost to Follow-up|2|||
49168933|NCT01309204|158453633|FG001|Overall Study|Lost to Follow-up|2|||
49168934|NCT01309204|158453632|FG000|Overall Study|Subject's decision unrelated to an AE|9|||
49168935|NCT01309204|158453633|FG001|Overall Study|Subject's decision unrelated to an AE|10|||
49168936|NCT01309204|158453632|FG000|Overall Study|Inadequate control of IOP|4|||
49168937|NCT01309204|158453633|FG001|Overall Study|Inadequate control of IOP|4|||
49168938|NCT01309204|158453632|FG000|Overall Study|Other|4|||
49168939|NCT01309204|158453633|FG001|Overall Study|Other|1|||
49168940|NCT03183063|158453634|FG000|Overall Study|Withdrawal by Subject|2|||
49168941|NCT03183063|158453635|FG001|Overall Study|Withdrawal by Subject|0|||
49168942|NCT03183063|158453636|FG002|Overall Study|Withdrawal by Subject|0|||
49168943|NCT03183063|158453634|FG000|Overall Study|Physician Decision|3|||
49168944|NCT03183063|158453635|FG001|Overall Study|Physician Decision|4|||
49168945|NCT03183063|158453636|FG002|Overall Study|Physician Decision|4|||
49168946|NCT03292874|158453637|FG000|Overall Study|Due to pandemic|5|||
49168947|NCT00161616|158453638|FG000|Overall Study|Withdrawal by Subject|6|||
49168948|NCT00161616|158453639|FG001|Overall Study|Withdrawal by Subject|5|||
49168949|NCT00161616|158453638|FG000|Overall Study|Physician Decision|1|||
49168950|NCT00161616|158453639|FG001|Overall Study|Physician Decision|0|||
49168951|NCT00161616|158453638|FG000|Overall Study|Death|1|||
49168952|NCT00161616|158453639|FG001|Overall Study|Death|1|||
48841734|NCT01875848|157260707|FG001|Overall Study|Withdrawal by Subject|0|||
48841735|NCT00925587|157260708|FG000|Overall Study|Protocol Specified Criteria|6|||
48841736|NCT00925587|157260709|FG001|Overall Study|Protocol Specified Criteria|6|||
48841737|NCT00925587|157260708|FG000|Overall Study|Physician Decision|4|||
48841738|NCT00925587|157260709|FG001|Overall Study|Physician Decision|1|||
49168953|NCT00161616|158453638|FG000|Overall Study|Lost to Follow-up|17|||
49168954|NCT00161616|158453639|FG001|Overall Study|Lost to Follow-up|13|||
49168955|NCT00161616|158453638|FG000|Overall Study|Protocol deviation|1|||
49168956|NCT00161616|158453639|FG001|Overall Study|Protocol deviation|0|||
49168957|NCT02477527|158453642|FG000|Overall Study|Lost to Follow-up|2|||
49168958|NCT02477527|158453642|FG000|Overall Study|Withdrawal by Subject|1|||
49168959|NCT02477527|158453642|FG000|Overall Study|Screen Failure|3|||
49168960|NCT03338400|158453643|FG000|Overall Study|Lost to Follow-up|1|||
49168961|NCT03338400|158453644|FG001|Overall Study|Lost to Follow-up|2|||
49168962|NCT02840253|158453646|FG000|Overall Study|Unsuccessful block|4|||
49168963|NCT01947283|158453650|FG000|Overall Study|Death|1|||
49168964|NCT01947283|158453651|FG001|Overall Study|Death|1|||
49168965|NCT01947283|158453652|FG002|Overall Study|Death|1|||
49168966|NCT01947283|158453653|FG003|Overall Study|Death|0|||
49168967|NCT01947283|158453654|FG004|Overall Study|Death|0|||
49168968|NCT01947283|158453655|FG005|Overall Study|Death|0|||
49168969|NCT01947283|158453656|FG006|Overall Study|Death|0|||
49168970|NCT01947283|158453650|FG000|Overall Study|Lost to Follow-up|4|||
48841739|NCT00925587|157260708|FG000|Overall Study|Protocol Violation|6|||
48841740|NCT00925587|157260709|FG001|Overall Study|Protocol Violation|4|||
48841741|NCT00925587|157260708|FG000|Overall Study|Withdrawal by Subject|9|||
48841742|NCT00925587|157260709|FG001|Overall Study|Withdrawal by Subject|6|||
49168971|NCT01947283|158453651|FG001|Overall Study|Lost to Follow-up|6|||
49168972|NCT01947283|158453652|FG002|Overall Study|Lost to Follow-up|5|||
49168973|NCT01947283|158453653|FG003|Overall Study|Lost to Follow-up|5|||
49168974|NCT01947283|158453654|FG004|Overall Study|Lost to Follow-up|0|||
49168975|NCT01947283|158453655|FG005|Overall Study|Lost to Follow-up|2|||
49168976|NCT01947283|158453656|FG006|Overall Study|Lost to Follow-up|5|||
49168977|NCT01947283|158453650|FG000|Overall Study|Withdrawal by Subject|10|||
49168978|NCT01947283|158453651|FG001|Overall Study|Withdrawal by Subject|8|||
49168979|NCT01947283|158453652|FG002|Overall Study|Withdrawal by Subject|4|||
49168980|NCT01947283|158453653|FG003|Overall Study|Withdrawal by Subject|1|||
49168981|NCT01947283|158453654|FG004|Overall Study|Withdrawal by Subject|0|||
49168982|NCT01947283|158453655|FG005|Overall Study|Withdrawal by Subject|0|||
49168983|NCT01947283|158453656|FG006|Overall Study|Withdrawal by Subject|2|||
49168984|NCT01947283|158453650|FG000|Overall Study|No Clinical Recording|12|||
48841743|NCT00925587|157260708|FG000|Overall Study|Death|5|||
48841744|NCT00925587|157260709|FG001|Overall Study|Death|5|||
49168985|NCT01947283|158453651|FG001|Overall Study|No Clinical Recording|6|||
49168986|NCT01947283|158453652|FG002|Overall Study|No Clinical Recording|8|||
49168987|NCT01947283|158453653|FG003|Overall Study|No Clinical Recording|10|||
49168988|NCT01947283|158453654|FG004|Overall Study|No Clinical Recording|0|||
49168989|NCT01947283|158453655|FG005|Overall Study|No Clinical Recording|0|||
49168990|NCT01947283|158453656|FG006|Overall Study|No Clinical Recording|0|||
49168991|NCT01947283|158453650|FG000|Overall Study|Non-coding Clinical Recording language|0|||
49168992|NCT01947283|158453651|FG001|Overall Study|Non-coding Clinical Recording language|0|||
49168993|NCT01947283|158453652|FG002|Overall Study|Non-coding Clinical Recording language|0|||
49168994|NCT01947283|158453653|FG003|Overall Study|Non-coding Clinical Recording language|1|||
49168995|NCT01947283|158453654|FG004|Overall Study|Non-coding Clinical Recording language|0|||
49168996|NCT01947283|158453655|FG005|Overall Study|Non-coding Clinical Recording language|0|||
49168997|NCT01947283|158453656|FG006|Overall Study|Non-coding Clinical Recording language|0|||
49168998|NCT01947283|158453650|FG000|Overall Study|Missing Follow-up Assessment|2|||
49168999|NCT01947283|158453651|FG001|Overall Study|Missing Follow-up Assessment|2|||
49169000|NCT01947283|158453652|FG002|Overall Study|Missing Follow-up Assessment|3|||
49169001|NCT01947283|158453653|FG003|Overall Study|Missing Follow-up Assessment|0|||
49169002|NCT01947283|158453654|FG004|Overall Study|Missing Follow-up Assessment|0|||
49169003|NCT01947283|158453655|FG005|Overall Study|Missing Follow-up Assessment|2|||
49169004|NCT01947283|158453656|FG006|Overall Study|Missing Follow-up Assessment|0|||
49169005|NCT01947283|158453650|FG000|Overall Study|No patients were enrolled in study|0|||
49169006|NCT01947283|158453651|FG001|Overall Study|No patients were enrolled in study|0|||
49169007|NCT01947283|158453652|FG002|Overall Study|No patients were enrolled in study|0|||
49169008|NCT01947283|158453653|FG003|Overall Study|No patients were enrolled in study|0|||
49169009|NCT01947283|158453654|FG004|Overall Study|No patients were enrolled in study|0|||
49169010|NCT01947283|158453655|FG005|Overall Study|No patients were enrolled in study|3|||
49169011|NCT01947283|158453656|FG006|Overall Study|No patients were enrolled in study|1|||
49169012|NCT00430989|158453657|FG000|Overall Study|Lost to Follow-up|2|||
49169013|NCT00430989|158453658|FG001|Overall Study|Lost to Follow-up|3|||
49169014|NCT00430989|158453657|FG000|Overall Study|Withdrawal by Subject|15|||
49169015|NCT00430989|158453658|FG001|Overall Study|Withdrawal by Subject|14|||
49169016|NCT00430989|158453657|FG000|Overall Study|Protocol Violation|30|||
49169017|NCT00430989|158453658|FG001|Overall Study|Protocol Violation|37|||
49169018|NCT00430989|158453657|FG000|Overall Study|Not eligible|13|||
49169019|NCT00430989|158453658|FG001|Overall Study|Not eligible|6|||
49169020|NCT01833494|158453659|FG000|Overall Study|Adverse Event|24|||
49169021|NCT01833494|158453659|FG000|Overall Study|Physician Decision|6|||
49169022|NCT01833494|158453659|FG000|Overall Study|Withdrawal by Subject|6|||
49169023|NCT01833494|158453659|FG000|Overall Study|Decrease in serum phosphorus|4|||
49169024|NCT01833494|158453659|FG000|Overall Study|Decrease in serum calcium|4|||
49169025|NCT01833494|158453659|FG000|Overall Study|Increase in serum ferritin|1|||
49169026|NCT04263766|158453660|FG000|Overall Study|Withdrawal by Subject|6|||
49169027|NCT04263766|158453661|FG001|Overall Study|Withdrawal by Subject|4|||
48841745|NCT00925587|157260708|FG000|Overall Study|Adverse Event|6|||
48841746|NCT00925587|157260709|FG001|Overall Study|Adverse Event|2|||
48841747|NCT00925587|157260708|FG000|Overall Study|Lost to Follow-up|0|||
49169028|NCT04263766|158453660|FG000|Overall Study|Lack of Efficacy|1|||
49169029|NCT04263766|158453661|FG001|Overall Study|Lack of Efficacy|3|||
49169030|NCT02266147|158453662|FG000|PART 1: Dose Escalation|Physician Decision|0|||
48841748|NCT00925587|157260709|FG001|Overall Study|Lost to Follow-up|1|||
48841749|NCT01198275|157260710|FG000|Overall Study|Adverse Event|2|||
48841750|NCT01198275|157260711|FG001|Overall Study|Adverse Event|3|||
48841751|NCT01198275|157260710|FG000|Overall Study|spontaneous return to sinus rhythm|4|||
48841752|NCT01198275|157260711|FG001|Overall Study|spontaneous return to sinus rhythm|2|||
48925937|NCT00382993|157561751|FG000|Migraine Attack 2 (Period 2)|Protocol Violation|0|||
48925938|NCT00382993|157561752|FG001|Migraine Attack 2 (Period 2)|Protocol Violation|1|||
48925939|NCT00382993|157561751|FG000|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
48951831|NCT01993329|157654910|FG002|Period 2|Adverse Event|0|||
49169031|NCT02266147|158453663|FG001|PART 1: Dose Escalation|Physician Decision|0|||
49169032|NCT02266147|158453664|FG002|PART 1: Dose Escalation|Physician Decision|1|||
49169033|NCT02266147|158453665|FG003|PART 1: Dose Escalation|Physician Decision|0|||
49169034|NCT02266147|158453662|FG000|PART 1: Dose Escalation|Lack of Efficacy|0|||
49169035|NCT02266147|158453663|FG001|PART 1: Dose Escalation|Lack of Efficacy|2|||
49169036|NCT02266147|158453664|FG002|PART 1: Dose Escalation|Lack of Efficacy|1|||
49169037|NCT02266147|158453665|FG003|PART 1: Dose Escalation|Lack of Efficacy|1|||
49169038|NCT02266147|158453662|FG000|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
49169039|NCT02266147|158453663|FG001|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
49169040|NCT02266147|158453664|FG002|PART 1: Dose Escalation|Study Terminated by Sponsor|1|||
49169041|NCT02266147|158453665|FG003|PART 1: Dose Escalation|Study Terminated by Sponsor|3|||
49169042|NCT02266147|158453662|FG000|PART 1: Dose Escalation|Other|1|||
49169043|NCT02266147|158453663|FG001|PART 1: Dose Escalation|Other|1|||
49169044|NCT02266147|158453664|FG002|PART 1: Dose Escalation|Other|0|||
49169045|NCT02266147|158453665|FG003|PART 1: Dose Escalation|Other|0|||
49169046|NCT02266147|158453662|FG000|PART 2: Dose Expansion|Lack of Efficacy|1|||
49169047|NCT02266147|158453663|FG001|PART 2: Dose Expansion|Lack of Efficacy|0|||
49169048|NCT02266147|158453664|FG002|PART 2: Dose Expansion|Lack of Efficacy|0|||
49169049|NCT02266147|158453665|FG003|PART 2: Dose Expansion|Lack of Efficacy|1|||
49169050|NCT02266147|158453662|FG000|PART 2: Dose Expansion|Study Terminated by Sponsor|6|||
49169051|NCT02266147|158453663|FG001|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
49169052|NCT02266147|158453664|FG002|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
49169053|NCT02266147|158453665|FG003|PART 2: Dose Expansion|Study Terminated by Sponsor|8|||
49169054|NCT02168101|158453666|FG000|Overall Study|Death|2|||
49169055|NCT02168101|158453667|FG001|Overall Study|Death|2|||
49169056|NCT02168101|158453668|FG002|Overall Study|Death|1|||
49169057|NCT01881009|158453672|FG000|Summer Camp Session (6 Days)|Unable to wear device|0|||
49169058|NCT01881009|158453673|FG001|Summer Camp Session (6 Days)|Unable to wear device|1|||
49169059|NCT01773967|158453677|FG000|Overall Study|Lost to Follow-up|15|||
49169060|NCT01773967|158453678|FG001|Overall Study|Lost to Follow-up|13|||
49169061|NCT01803880|158453679|FG000|Overall Study|Adverse Event|1|||
49169062|NCT01803880|158453680|FG001|Overall Study|Adverse Event|0|||
49169063|NCT01803880|158453681|FG002|Overall Study|Adverse Event|0|||
49169064|NCT01803880|158453679|FG000|Overall Study|Withdrawal by Subject|1|||
49169065|NCT01803880|158453680|FG001|Overall Study|Withdrawal by Subject|1|||
49169066|NCT01803880|158453681|FG002|Overall Study|Withdrawal by Subject|4|||
49169067|NCT01803880|158453679|FG000|Overall Study|Physician Decision|0|||
49169068|NCT01803880|158453680|FG001|Overall Study|Physician Decision|0|||
49169069|NCT01803880|158453681|FG002|Overall Study|Physician Decision|1|||
49169070|NCT01803880|158453679|FG000|Overall Study|Unable to return for follow-up visits|0|||
49169071|NCT01803880|158453680|FG001|Overall Study|Unable to return for follow-up visits|1|||
49169072|NCT01803880|158453681|FG002|Overall Study|Unable to return for follow-up visits|2|||
49169073|NCT01803880|158453679|FG000|Overall Study|Lost to Follow-up|1|||
49169074|NCT01803880|158453680|FG001|Overall Study|Lost to Follow-up|2|||
49169075|NCT01803880|158453681|FG002|Overall Study|Lost to Follow-up|3|||
49169076|NCT01803880|158453679|FG000|Overall Study|Protocol Violation|1|||
49169077|NCT01803880|158453680|FG001|Overall Study|Protocol Violation|0|||
49169078|NCT01803880|158453681|FG002|Overall Study|Protocol Violation|0|||
49169079|NCT01803880|158453679|FG000|Overall Study|Early study termination|0|||
49169080|NCT01803880|158453680|FG001|Overall Study|Early study termination|6|||
49169081|NCT01803880|158453681|FG002|Overall Study|Early study termination|5|||
49169082|NCT01803880|158453679|FG000|Overall Study|Incomplete data entry by sites|2|||
49169083|NCT01803880|158453680|FG001|Overall Study|Incomplete data entry by sites|0|||
49169084|NCT01803880|158453681|FG002|Overall Study|Incomplete data entry by sites|0|||
49169085|NCT01643408|158453682|FG000|Overall Study|Adverse Event|12|||
49169086|NCT01643408|158453682|FG000|Overall Study|Other|2|||
49169087|NCT01804049|158453683|FG000|Overall Study|Adverse Event|2|||
49169088|NCT01804049|158453684|FG001|Overall Study|Adverse Event|10|||
49169089|NCT01804049|158453683|FG000|Overall Study|Lost to Follow-up|2|||
48841753|NCT00941655|157260712|FG000|Overall Study|received some chemo, 4 and 9 cycles|1|||
49169090|NCT01804049|158453684|FG001|Overall Study|Lost to Follow-up|1|||
49169091|NCT01804049|158453683|FG000|Overall Study|Decreased interest/personal|4|||
49169092|NCT01804049|158453684|FG001|Overall Study|Decreased interest/personal|5|||
49169093|NCT01804049|158453683|FG000|Overall Study|Other health concerns|2|||
49169094|NCT01804049|158453684|FG001|Overall Study|Other health concerns|7|||
49169095|NCT01804049|158453683|FG000|Overall Study|Moved out of area|0|||
49169096|NCT01804049|158453684|FG001|Overall Study|Moved out of area|7|||
49169097|NCT01804049|158453683|FG000|Overall Study|other MD recommended|1|||
49169098|NCT01804049|158453684|FG001|Overall Study|other MD recommended|1|||
49169099|NCT01804049|158453683|FG000|Overall Study|Enrollment in dual studies|0|||
49169100|NCT01804049|158453684|FG001|Overall Study|Enrollment in dual studies|1|||
49169101|NCT00709319|158453685|FG000|Overall Study|Death|4|||
49169102|NCT00709319|158453685|FG000|Overall Study|Withdrawal by Subject|2|||
49169103|NCT02948582|158453688|FG000|Washout Period 1|Adverse Event|0|||
49169104|NCT02948582|158453689|FG001|Washout Period 1|Adverse Event|2|||
49169105|NCT02948582|158453690|FG002|Washout Period 1|Adverse Event|0|||
49169106|NCT02948582|158453691|FG003|Washout Period 1|Adverse Event|0|||
49169107|NCT02948582|158453692|FG004|Washout Period 1|Adverse Event|0|||
49169108|NCT02948582|158453693|FG005|Washout Period 1|Adverse Event|0|||
49169109|NCT02948582|158453688|FG000|Washout Period 1|Protocol Violation|0|||
49169110|NCT02948582|158453689|FG001|Washout Period 1|Protocol Violation|0|||
49169111|NCT02948582|158453690|FG002|Washout Period 1|Protocol Violation|0|||
49169112|NCT02948582|158453691|FG003|Washout Period 1|Protocol Violation|0|||
49169113|NCT02948582|158453692|FG004|Washout Period 1|Protocol Violation|0|||
49169114|NCT02948582|158453693|FG005|Washout Period 1|Protocol Violation|1|||
49169115|NCT02948582|158453688|FG000|Washout Period 2|Adverse Event|0|||
49169116|NCT02948582|158453689|FG001|Washout Period 2|Adverse Event|1|||
49169117|NCT02948582|158453690|FG002|Washout Period 2|Adverse Event|0|||
49169118|NCT02948582|158453691|FG003|Washout Period 2|Adverse Event|0|||
49169119|NCT02948582|158453692|FG004|Washout Period 2|Adverse Event|0|||
49169120|NCT02948582|158453693|FG005|Washout Period 2|Adverse Event|0|||
49169121|NCT02948582|158453688|FG000|Washout Period 2|personal reasons|0|||
49169122|NCT02948582|158453689|FG001|Washout Period 2|personal reasons|0|||
49169123|NCT02948582|158453690|FG002|Washout Period 2|personal reasons|0|||
49169124|NCT02948582|158453691|FG003|Washout Period 2|personal reasons|1|||
49169125|NCT02948582|158453692|FG004|Washout Period 2|personal reasons|0|||
49169126|NCT02948582|158453693|FG005|Washout Period 2|personal reasons|0|||
49169127|NCT02948582|158453688|FG000|Washout Period 4|Adverse Event|1|||
49169128|NCT02948582|158453689|FG001|Washout Period 4|Adverse Event|0|||
49169129|NCT02948582|158453690|FG002|Washout Period 4|Adverse Event|1|||
49169130|NCT02948582|158453691|FG003|Washout Period 4|Adverse Event|0|||
49169131|NCT02948582|158453692|FG004|Washout Period 4|Adverse Event|0|||
49169132|NCT02948582|158453693|FG005|Washout Period 4|Adverse Event|0|||
49169133|NCT01635998|158453694|FG000|Overall Study|Death|1|||
49169134|NCT01635998|158453695|FG001|Overall Study|Death|1|||
48841754|NCT00941655|157260713|FG001|Overall Study|received some chemo, 4 and 9 cycles|0|||
48841755|NCT00941655|157260712|FG000|Overall Study|not meet criteria for chemo foll surgery|4|||
49169135|NCT01635998|158453694|FG000|Overall Study|Lost to Follow-up|2|||
49169136|NCT01635998|158453695|FG001|Overall Study|Lost to Follow-up|1|||
49169137|NCT01635998|158453694|FG000|Overall Study|Withdrawal by Subject|1|||
49169138|NCT01635998|158453695|FG001|Overall Study|Withdrawal by Subject|5|||
48951832|NCT01993329|157654911|FG003|Period 2|Adverse Event|0|||
49169139|NCT01925768|158453696|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
49169140|NCT01925768|158453697|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
49169141|NCT01925768|158453696|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
49169142|NCT01925768|158453697|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2|||
49169143|NCT01925768|158453696|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
49169144|NCT01925768|158453697|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
49169145|NCT01925768|158453696|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
49169146|NCT01925768|158453697|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
49169147|NCT01925768|158453696|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
49169148|NCT01925768|158453697|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
49169149|NCT01925768|158453696|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0|||
49169150|NCT01925768|158453697|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1|||
49169151|NCT01925768|158453696|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
49169152|NCT01925768|158453697|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
49169153|NCT01925768|158453696|FG000|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7|||
49169154|NCT01925768|158453697|FG001|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9|||
49169155|NCT01925768|158453696|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2|||
49169156|NCT01925768|158453697|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1|||
49169157|NCT01925768|158453696|FG000|ActiveTreatment/Extension (Weeks 24-104)|Death|0|||
49169158|NCT01925768|158453697|FG001|ActiveTreatment/Extension (Weeks 24-104)|Death|1|||
49169159|NCT01925768|158453696|FG000|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5|||
49169160|NCT01925768|158453697|FG001|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1|||
49169161|NCT01340664|158453699|FG000|Overall Study|Adverse Event|0|||
49169162|NCT01340664|158453700|FG001|Overall Study|Adverse Event|1|||
49169163|NCT01340664|158453701|FG002|Overall Study|Adverse Event|7|||
49169164|NCT01340664|158453699|FG000|Overall Study|Lost to Follow-up|2|||
49169165|NCT01340664|158453700|FG001|Overall Study|Lost to Follow-up|0|||
49169166|NCT01340664|158453701|FG002|Overall Study|Lost to Follow-up|2|||
49169167|NCT01340664|158453699|FG000|Overall Study|Withdrawal by Subject|2|||
49169168|NCT01340664|158453700|FG001|Overall Study|Withdrawal by Subject|4|||
49169169|NCT01340664|158453701|FG002|Overall Study|Withdrawal by Subject|0|||
49169170|NCT01340664|158453699|FG000|Overall Study|Glycemic withdrawal criteria|2|||
49169171|NCT01340664|158453700|FG001|Overall Study|Glycemic withdrawal criteria|0|||
49169172|NCT01340664|158453701|FG002|Overall Study|Glycemic withdrawal criteria|0|||
49169173|NCT01340664|158453699|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|0|||
49169174|NCT01340664|158453700|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|1|||
49169175|NCT01340664|158453701|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|2|||
49169176|NCT01340664|158453699|FG000|Overall Study|Other|1|||
49169177|NCT01340664|158453700|FG001|Overall Study|Other|2|||
49169178|NCT01340664|158453701|FG002|Overall Study|Other|2|||
49169179|NCT00935493|158453703|FG000|Overall Study|Lost to Follow-up|1|||
49169180|NCT00935493|158453704|FG001|Overall Study|Lost to Follow-up|1|||
49169181|NCT00935493|158453705|FG002|Overall Study|Lost to Follow-up|1|||
49169182|NCT00935493|158453703|FG000|Overall Study|Treatment Discontinued|0|||
49169183|NCT00935493|158453704|FG001|Overall Study|Treatment Discontinued|1|||
49169184|NCT00935493|158453705|FG002|Overall Study|Treatment Discontinued|0|||
49169185|NCT01926444|158453706|FG000|Overall Study|Colonoscopy not performed|0|||
49169186|NCT01926444|158453707|FG001|Overall Study|Colonoscopy not performed|0|||
49169187|NCT01926444|158453708|FG002|Overall Study|Colonoscopy not performed|4|||
49169188|NCT01926444|158453709|FG003|Overall Study|Colonoscopy not performed|2|||
49169189|NCT01737762|158453720|FG000|Overall Study|Adverse Event|2|||
49169190|NCT01737762|158453721|FG001|Overall Study|Adverse Event|2|||
49169191|NCT01737762|158453720|FG000|Overall Study|Lost to Follow-up|1|||
49169192|NCT01737762|158453721|FG001|Overall Study|Lost to Follow-up|0|||
49169193|NCT01737762|158453720|FG000|Overall Study|Withdrawal by Subject|2|||
49169194|NCT01737762|158453721|FG001|Overall Study|Withdrawal by Subject|2|||
49169195|NCT01737762|158453720|FG000|Overall Study|Progressive disease|1|||
49169196|NCT01737762|158453721|FG001|Overall Study|Progressive disease|2|||
49169197|NCT01737762|158453720|FG000|Overall Study|Physician Decision|1|||
49169198|NCT01737762|158453721|FG001|Overall Study|Physician Decision|1|||
49169199|NCT01737762|158453720|FG000|Overall Study|Moved from area|2|||
49169200|NCT01737762|158453721|FG001|Overall Study|Moved from area|1|||
49169201|NCT01737762|158453720|FG000|Overall Study|Trial termination|11|||
49169202|NCT01737762|158453721|FG001|Overall Study|Trial termination|9|||
49169203|NCT02131311|158453727|FG000|Overall Study|Adverse Event|2|||
49169204|NCT02131311|158453727|FG000|Overall Study|Protocol Violation|1|||
49169205|NCT02131311|158453727|FG000|Overall Study|Lost to Follow-up|1|||
49169206|NCT00851890|158453729|FG000|Overall Study|Lost to Follow-up|0|||
49169207|NCT00851890|158453730|FG001|Overall Study|Lost to Follow-up|1|||
49169208|NCT00851890|158453731|FG002|Overall Study|Lost to Follow-up|0|||
49169209|NCT00851890|158453732|FG003|Overall Study|Lost to Follow-up|1|||
49169210|NCT03108521|158453736|FG000|Overall Study|Lost to Follow-up|3|||
49169211|NCT03108521|158453737|FG001|Overall Study|Lost to Follow-up|0|||
49169212|NCT03108521|158453736|FG000|Overall Study|Lack of Efficacy|2|||
49169213|NCT03108521|158453737|FG001|Overall Study|Lack of Efficacy|0|||
49169214|NCT03108521|158453736|FG000|Overall Study|Physician Decision|4|||
49169215|NCT03108521|158453737|FG001|Overall Study|Physician Decision|0|||
49169216|NCT03108521|158453736|FG000|Overall Study|Adverse Event|3|||
49169217|NCT03108521|158453737|FG001|Overall Study|Adverse Event|0|||
49169218|NCT00678288|158454752|FG000|Overall Study|Adverse Event|0|||
49169219|NCT00678288|158454753|FG001|Overall Study|Adverse Event|2|||
49169220|NCT00678288|158454752|FG000|Overall Study|Withdrawal by Subject|1|||
49169221|NCT00678288|158454753|FG001|Overall Study|Withdrawal by Subject|1|||
49169222|NCT00678288|158454752|FG000|Overall Study|Study terminated by the sponsor|2|||
49169223|NCT00678288|158454753|FG001|Overall Study|Study terminated by the sponsor|0|||
48841756|NCT00941655|157260713|FG001|Overall Study|not meet criteria for chemo foll surgery|0|||
48841757|NCT00941655|157260712|FG000|Overall Study|progressed while on chemo|0|||
48841758|NCT00941655|157260713|FG001|Overall Study|progressed while on chemo|2|||
48841759|NCT00941655|157260712|FG000|Overall Study|refused further treatment|0|||
48841760|NCT00941655|157260713|FG001|Overall Study|refused further treatment|1|||
48841761|NCT00941655|157260712|FG000|Overall Study|withdrew consent|0|||
48841762|NCT00941655|157260713|FG001|Overall Study|withdrew consent|1|||
48841763|NCT00941655|157260712|FG000|Overall Study|non-compliant|0|||
48841764|NCT00941655|157260713|FG001|Overall Study|non-compliant|1|||
48841765|NCT00002842|157260715|FG000|Overall Study|ineligible for surgical resection|27|||
49169224|NCT00678288|158454752|FG000|Overall Study|Not compliant with study medication|0|||
49169225|NCT00678288|158454753|FG001|Overall Study|Not compliant with study medication|1|||
49169226|NCT00678288|158454752|FG000|Overall Study|Switch to commercial drug|0|||
49169227|NCT00678288|158454753|FG001|Overall Study|Switch to commercial drug|1|||
49169228|NCT00678288|158454752|FG000|Overall Study|Reason not reported|1|||
49169229|NCT00678288|158454753|FG001|Overall Study|Reason not reported|0|||
49169230|NCT00678288|158454752|FG000|Overall Study|Disease progression/recurrence/relapse|6|||
49169231|NCT00678288|158454753|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
49169232|NCT00720356|158454756|FG000|Registration to Study|Determined to have methylated MGMT|67|||
49169233|NCT00720356|158454756|FG000|Reached 1st Response/2 Cycles|Progressive Disease|1|||
49169234|NCT00720356|158454756|FG000|Reached 1st Response/2 Cycles|Withdrawal by Subject|1|||
49169235|NCT00720356|158454756|FG000|Went on to be Treated Cycle 3|Adverse Event|1|||
49169236|NCT00720356|158454756|FG000|Went on to be Treated Cycle 3|Physician Decision|1|||
49169237|NCT00720356|158454756|FG000|Follow up Until Death|Withdrawal by Subject|1|||
49169238|NCT00720356|158454756|FG000|Follow up Until Death|Alive at last data collection|4|||
49169239|NCT01693250|158454757|FG000|Overall Study|Lost to Follow-up|2|||
49169240|NCT01693250|158454758|FG001|Overall Study|Lost to Follow-up|2|||
49169241|NCT01650831|158454761|FG000|Overall Study|Screen failure|1|||
49169242|NCT00887159|158454762|FG000|Overall Study|Disease progression|6|||
49169243|NCT00887159|158454763|FG001|Overall Study|Disease progression|39|||
49169244|NCT00887159|158454764|FG002|Overall Study|Disease progression|33|||
49169245|NCT00887159|158454762|FG000|Overall Study|Adverse Event|3|||
49169246|NCT00887159|158454763|FG001|Overall Study|Adverse Event|4|||
49169247|NCT00887159|158454764|FG002|Overall Study|Adverse Event|17|||
49169248|NCT00887159|158454762|FG000|Overall Study|Death|2|||
49169249|NCT00887159|158454763|FG001|Overall Study|Death|2|||
49169250|NCT00887159|158454764|FG002|Overall Study|Death|0|||
49169251|NCT00887159|158454762|FG000|Overall Study|Withdrawal by Subject|4|||
48841766|NCT01066923|157260716|FG000|Overall Study|Withdrawal by Subject|3|||
49169252|NCT00887159|158454763|FG001|Overall Study|Withdrawal by Subject|4|||
49169253|NCT00887159|158454764|FG002|Overall Study|Withdrawal by Subject|2|||
48925940|NCT00382993|157561752|FG001|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
48925941|NCT01100944|157561753|FG000|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2|||
48925942|NCT01100944|157561754|FG001|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
49169254|NCT00887159|158454762|FG000|Overall Study|Alternative therapy|2|||
49169255|NCT00887159|158454763|FG001|Overall Study|Alternative therapy|0|||
49169256|NCT00887159|158454764|FG002|Overall Study|Alternative therapy|0|||
49169257|NCT00887159|158454762|FG000|Overall Study|Physician Decision|1|||
49169258|NCT00887159|158454763|FG001|Overall Study|Physician Decision|1|||
49169259|NCT00887159|158454764|FG002|Overall Study|Physician Decision|0|||
49169260|NCT00887159|158454762|FG000|Overall Study|Sympomatic deterioration|1|||
49169261|NCT00887159|158454763|FG001|Overall Study|Sympomatic deterioration|0|||
49169262|NCT00887159|158454764|FG002|Overall Study|Sympomatic deterioration|0|||
49169263|NCT00887159|158454762|FG000|Overall Study|Treatment delayed|1|||
49169264|NCT00887159|158454763|FG001|Overall Study|Treatment delayed|1|||
49169265|NCT00887159|158454764|FG002|Overall Study|Treatment delayed|0|||
49169266|NCT00887159|158454762|FG000|Overall Study|Pt had PD but was SD when re-measured|0|||
48841767|NCT01066923|157260717|FG001|Overall Study|Withdrawal by Subject|3|||
48841768|NCT01066923|157260718|FG002|Overall Study|Withdrawal by Subject|8|||
48841769|NCT01066923|157260719|FG003|Overall Study|Withdrawal by Subject|8|||
48841770|NCT01171625|157260721|FG000|Overall Study|On-Protocol|67|||
48841771|NCT01171625|157260721|FG000|Overall Study|Death|38|||
48841772|NCT01171625|157260721|FG000|Overall Study|Withdrawal by Subject|31|||
48841773|NCT01171625|157260721|FG000|Overall Study|Explanted|10|||
48841774|NCT01171625|157260721|FG000|Overall Study|Lost to Follow-up|5|||
48841775|NCT01171625|157260721|FG000|Overall Study|Patient received valve-in-valve|3|||
48841776|NCT01171625|157260721|FG000|Overall Study|Other|1|||
48841777|NCT01171625|157260721|FG000|Overall Study|Consented but did not receive device|25|||
48841778|NCT03557008|157260727|FG000|Overall Study|Withdrawal by Subject|2|||
48841779|NCT03557008|157260728|FG001|Overall Study|Withdrawal by Subject|2|||
48841780|NCT03557008|157260727|FG000|Overall Study|Early termination from study|3|||
48841781|NCT03557008|157260728|FG001|Overall Study|Early termination from study|1|||
48841782|NCT03452189|157260729|FG000|First Intervention (3 Months)|Adverse Event|1|||
48841783|NCT03452189|157260730|FG001|First Intervention (3 Months)|Adverse Event|0|||
48841784|NCT03452189|157260729|FG000|First Intervention (3 Months)|insufficient samples of plasma and stool|4|||
48841785|NCT03452189|157260730|FG001|First Intervention (3 Months)|insufficient samples of plasma and stool|0|||
48841786|NCT00807144|157260731|FG000|Overall Study|Lost to Follow-up|0|||
48841787|NCT00807144|157260732|FG001|Overall Study|Lost to Follow-up|1|||
48841788|NCT01337635|157260739|FG000|Overall Study|Lost to Follow-up|0|||
48841789|NCT01337635|157260740|FG001|Overall Study|Lost to Follow-up|1|||
48841790|NCT03593213|157260749|FG000|Open-label Treatment Period (18 Weeks)|Adverse Event|39|||
48841791|NCT03593213|157260750|FG001|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
48841792|NCT03593213|157260751|FG002|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
48841793|NCT03593213|157260752|FG003|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
48841794|NCT03593213|157260749|FG000|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|14|||
48841795|NCT03593213|157260750|FG001|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
48841796|NCT03593213|157260751|FG002|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
48841797|NCT03593213|157260752|FG003|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
48841798|NCT03593213|157260749|FG000|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|85|||
48841799|NCT03593213|157260750|FG001|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
48841800|NCT03593213|157260751|FG002|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
48841801|NCT03593213|157260752|FG003|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
48841802|NCT03593213|157260749|FG000|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|51|||
48841803|NCT03593213|157260750|FG001|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
48841804|NCT03593213|157260751|FG002|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
49169267|NCT00887159|158454763|FG001|Overall Study|Pt had PD but was SD when re-measured|1|||
49169268|NCT00887159|158454764|FG002|Overall Study|Pt had PD but was SD when re-measured|0|||
49169269|NCT00887159|158454762|FG000|Overall Study|Received more tx instead of observation|1|||
49169270|NCT00887159|158454763|FG001|Overall Study|Received more tx instead of observation|0|||
49169271|NCT00887159|158454764|FG002|Overall Study|Received more tx instead of observation|0|||
49169272|NCT00887159|158454762|FG000|Overall Study|Ineligible|5|||
49169273|NCT00887159|158454763|FG001|Overall Study|Ineligible|1|||
49169274|NCT00887159|158454764|FG002|Overall Study|Ineligible|0|||
49169275|NCT00887159|158454762|FG000|Overall Study|Never started assigned therapy|3|||
49169276|NCT00887159|158454763|FG001|Overall Study|Never started assigned therapy|3|||
49169277|NCT00887159|158454764|FG002|Overall Study|Never started assigned therapy|4|||
49169278|NCT02391311|158454767|FG000|Overall Study|Lost to Follow-up|2|||
49169279|NCT02391311|158454768|FG001|Overall Study|Lost to Follow-up|1|||
49169280|NCT02391311|158454767|FG000|Overall Study|deemed ineligible after baseline|1|||
49169281|NCT02391311|158454768|FG001|Overall Study|deemed ineligible after baseline|1|||
49169282|NCT01772550|158454769|FG000|Overall Study|Unable to insert IV in antecubital vein|1|||
49169283|NCT01772550|158454770|FG001|Overall Study|Unable to insert IV in antecubital vein|1|||
49169284|NCT01772550|158454771|FG002|Overall Study|Unable to insert IV in antecubital vein|5|||
49169285|NCT01772550|158454769|FG000|Overall Study|Adverse Event|0|||
49169286|NCT01772550|158454770|FG001|Overall Study|Adverse Event|0|||
49169287|NCT01772550|158454771|FG002|Overall Study|Adverse Event|1|||
49169288|NCT04245449|158454776|FG000|Overall Study|COVID shutdown|7|||
49169289|NCT00861757|158454777|FG000|Overall Study|Adverse Event|1|||
49169290|NCT00861757|158454778|FG001|Overall Study|Adverse Event|5|||
49169291|NCT00861757|158454779|FG002|Overall Study|Adverse Event|7|||
49169292|NCT00861757|158454780|FG003|Overall Study|Adverse Event|2|||
49169293|NCT00861757|158454777|FG000|Overall Study|Entry Criteria Not Met|1|||
49169294|NCT00861757|158454778|FG001|Overall Study|Entry Criteria Not Met|2|||
49169295|NCT00861757|158454779|FG002|Overall Study|Entry Criteria Not Met|1|||
49169296|NCT00861757|158454780|FG003|Overall Study|Entry Criteria Not Met|1|||
49169297|NCT00861757|158454777|FG000|Overall Study|Lack of Efficacy|3|||
49169298|NCT00861757|158454778|FG001|Overall Study|Lack of Efficacy|1|||
49169299|NCT00861757|158454779|FG002|Overall Study|Lack of Efficacy|0|||
49169300|NCT00861757|158454780|FG003|Overall Study|Lack of Efficacy|1|||
48841805|NCT03593213|157260752|FG003|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
48841806|NCT03593213|157260749|FG000|Open-label Treatment Period (18 Weeks)|Death|1|||
48841807|NCT03593213|157260750|FG001|Open-label Treatment Period (18 Weeks)|Death|0|||
48841808|NCT03593213|157260751|FG002|Open-label Treatment Period (18 Weeks)|Death|0|||
49169301|NCT00861757|158454777|FG000|Overall Study|Lost to Follow-up|1|||
49169302|NCT00861757|158454778|FG001|Overall Study|Lost to Follow-up|0|||
48841809|NCT03593213|157260752|FG003|Open-label Treatment Period (18 Weeks)|Death|0|||
48841810|NCT03593213|157260749|FG000|Open-label Treatment Period (18 Weeks)|Protocol Deviation|5|||
48841811|NCT03593213|157260750|FG001|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
48841812|NCT03593213|157260751|FG002|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
48841813|NCT03593213|157260752|FG003|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
49169303|NCT00861757|158454779|FG002|Overall Study|Lost to Follow-up|1|||
49169304|NCT00861757|158454780|FG003|Overall Study|Lost to Follow-up|1|||
49169305|NCT00861757|158454777|FG000|Overall Study|Physician Decision|0|||
49169306|NCT00861757|158454778|FG001|Overall Study|Physician Decision|0|||
49169307|NCT00861757|158454779|FG002|Overall Study|Physician Decision|0|||
49169308|NCT00861757|158454780|FG003|Overall Study|Physician Decision|1|||
49169309|NCT00861757|158454777|FG000|Overall Study|Protocol Violation|2|||
49169310|NCT00861757|158454778|FG001|Overall Study|Protocol Violation|2|||
49169311|NCT00861757|158454779|FG002|Overall Study|Protocol Violation|4|||
49169312|NCT00861757|158454780|FG003|Overall Study|Protocol Violation|1|||
49169313|NCT00861757|158454777|FG000|Overall Study|Withdrawal by Subject|1|||
49169314|NCT00861757|158454778|FG001|Overall Study|Withdrawal by Subject|5|||
49169315|NCT00861757|158454779|FG002|Overall Study|Withdrawal by Subject|5|||
49169316|NCT00861757|158454780|FG003|Overall Study|Withdrawal by Subject|2|||
49169317|NCT03308968|158454781|FG000|Double-Blind Period (12 Weeks)|Adverse Event|3|||
49169318|NCT03308968|158454782|FG001|Double-Blind Period (12 Weeks)|Adverse Event|1|||
49169319|NCT03308968|158454783|FG002|Double-Blind Period (12 Weeks)|Adverse Event|4|||
49169320|NCT03308968|158454781|FG000|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
49169321|NCT03308968|158454782|FG001|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
49169322|NCT03308968|158454783|FG002|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3|||
49169323|NCT03308968|158454781|FG000|Double-Blind Period (12 Weeks)|Protocol Violation|6|||
49169324|NCT03308968|158454782|FG001|Double-Blind Period (12 Weeks)|Protocol Violation|0|||
49169325|NCT03308968|158454783|FG002|Double-Blind Period (12 Weeks)|Protocol Violation|2|||
49169326|NCT03308968|158454781|FG000|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
49169327|NCT03308968|158454782|FG001|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
49169328|NCT03308968|158454783|FG002|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0|||
49169329|NCT03308968|158454781|FG000|Double-Blind Period (12 Weeks)|Lost to Follow-up|1|||
49169330|NCT03308968|158454782|FG001|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
49169331|NCT03308968|158454783|FG002|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
49169332|NCT03308968|158454781|FG000|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
49169333|NCT03308968|158454782|FG001|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
49169334|NCT03308968|158454783|FG002|Double-Blind Period (12 Weeks)|Lack of Efficacy|0|||
49169335|NCT03308968|158454781|FG000|Double-Blind Period (12 Weeks)|Other than specified|1|||
49169336|NCT03308968|158454782|FG001|Double-Blind Period (12 Weeks)|Other than specified|0|||
49169337|NCT03308968|158454783|FG002|Double-Blind Period (12 Weeks)|Other than specified|2|||
49169338|NCT03308968|158454781|FG000|Open-Label Period (12 Weeks)|Other than specified|1|||
49169339|NCT03308968|158454782|FG001|Open-Label Period (12 Weeks)|Other than specified|2|||
49169340|NCT03308968|158454783|FG002|Open-Label Period (12 Weeks)|Other than specified|1|||
49169341|NCT03308968|158454781|FG000|Open-Label Period (12 Weeks)|Adverse Event|4|||
49169342|NCT03308968|158454782|FG001|Open-Label Period (12 Weeks)|Adverse Event|1|||
49169343|NCT03308968|158454783|FG002|Open-Label Period (12 Weeks)|Adverse Event|1|||
49169344|NCT03308968|158454781|FG000|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
49169345|NCT03308968|158454782|FG001|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
48841814|NCT03593213|157260749|FG000|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|23|||
48856548|NCT00446095|157312872|FG000|Phase II (8 Weeks)|Lack of Efficacy|9|||
48856549|NCT00446095|157312873|FG001|Phase II (8 Weeks)|Lack of Efficacy|2|||
48856550|NCT00446095|157312874|FG002|Phase II (8 Weeks)|Lack of Efficacy|1|||
48856551|NCT00446095|157312875|FG003|Phase II (8 Weeks)|Lack of Efficacy|0|||
48856552|NCT00446095|157312876|FG004|Phase II (8 Weeks)|Lack of Efficacy|0|||
48856553|NCT00446095|157312872|FG000|Phase II (8 Weeks)|Ongoing|0|||
48856554|NCT00446095|157312873|FG001|Phase II (8 Weeks)|Ongoing|0|||
48856555|NCT00446095|157312874|FG002|Phase II (8 Weeks)|Ongoing|1|||
48856556|NCT00446095|157312875|FG003|Phase II (8 Weeks)|Ongoing|0|||
48856557|NCT00446095|157312876|FG004|Phase II (8 Weeks)|Ongoing|0|||
48856558|NCT00446095|157312872|FG000|Phase I (28 Days)|Adverse Event|0|||
48856559|NCT00446095|157312873|FG001|Phase I (28 Days)|Adverse Event|0|||
48856560|NCT00446095|157312874|FG002|Phase I (28 Days)|Adverse Event|0|||
48856561|NCT00446095|157312875|FG003|Phase I (28 Days)|Adverse Event|1|||
48856562|NCT00446095|157312876|FG004|Phase I (28 Days)|Adverse Event|0|||
48856563|NCT00446095|157312872|FG000|Phase I (28 Days)|Lack of Efficacy|0|||
48856564|NCT00446095|157312873|FG001|Phase I (28 Days)|Lack of Efficacy|0|||
48841815|NCT03593213|157260750|FG001|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
48841816|NCT03593213|157260751|FG002|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
48841817|NCT03593213|157260752|FG003|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
48841818|NCT03593213|157260749|FG000|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|90|||
48841819|NCT03593213|157260750|FG001|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
48841820|NCT03593213|157260751|FG002|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
48841821|NCT03593213|157260752|FG003|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
48841822|NCT03593213|157260749|FG000|Open-label Treatment Period (18 Weeks)|Reason not Specified|13|||
48841823|NCT03593213|157260750|FG001|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
48841824|NCT03593213|157260751|FG002|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
48841825|NCT03593213|157260752|FG003|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
48841826|NCT03593213|157260749|FG000|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|104|||
48841827|NCT03593213|157260750|FG001|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
48841828|NCT03593213|157260751|FG002|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
48841829|NCT03593213|157260752|FG003|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
48841830|NCT03593213|157260749|FG000|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|0|||
49169346|NCT03308968|158454783|FG002|Open-Label Period (12 Weeks)|Withdrawal by Subject|7|||
49169347|NCT03308968|158454781|FG000|Open-Label Period (12 Weeks)|Protocol Violation|0|||
49169348|NCT03308968|158454782|FG001|Open-Label Period (12 Weeks)|Protocol Violation|1|||
49169349|NCT03308968|158454783|FG002|Open-Label Period (12 Weeks)|Protocol Violation|1|||
49169350|NCT03308968|158454781|FG000|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
49169351|NCT03308968|158454782|FG001|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
49169352|NCT03308968|158454783|FG002|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1|||
49169353|NCT03308968|158454781|FG000|Open-Label Period (12 Weeks)|Lost to Follow-up|0|||
49169354|NCT03308968|158454782|FG001|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
49169355|NCT03308968|158454783|FG002|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
49169356|NCT03308968|158454781|FG000|Open-Label Period (12 Weeks)|Lack of Efficacy|1|||
49169357|NCT03308968|158454782|FG001|Open-Label Period (12 Weeks)|Lack of Efficacy|2|||
49169358|NCT03308968|158454783|FG002|Open-Label Period (12 Weeks)|Lack of Efficacy|0|||
49169359|NCT01823107|158454784|FG000|Overall Study|Withdrawal by Subject|1|||
49169360|NCT03783962|158454785|FG000|Overall Study|Lost to Follow-up|3|||
49169361|NCT03783962|158454786|FG001|Overall Study|Lost to Follow-up|6|||
49169362|NCT03783962|158454785|FG000|Overall Study|Protocol Violation|0|||
49169363|NCT03783962|158454786|FG001|Overall Study|Protocol Violation|1|||
48841831|NCT03593213|157260750|FG001|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|15|||
48841832|NCT03593213|157260751|FG002|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|9|||
48841833|NCT03593213|157260752|FG003|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|8|||
48841834|NCT03593213|157260749|FG000|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
48841835|NCT03593213|157260750|FG001|Double-blind Treatment Period (26 Weeks)|Adverse Event|2|||
48841836|NCT03593213|157260751|FG002|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
48841837|NCT03593213|157260752|FG003|Double-blind Treatment Period (26 Weeks)|Adverse Event|4|||
48841838|NCT03593213|157260749|FG000|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|0|||
48841839|NCT03593213|157260750|FG001|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|4|||
48841840|NCT03593213|157260751|FG002|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|2|||
48841841|NCT03593213|157260752|FG003|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|3|||
48841842|NCT03593213|157260749|FG000|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|0|||
48841843|NCT03593213|157260750|FG001|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|5|||
48841844|NCT03593213|157260751|FG002|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|4|||
48841845|NCT03593213|157260752|FG003|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|1|||
48841846|NCT03593213|157260749|FG000|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
48841847|NCT03593213|157260750|FG001|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
48841848|NCT03593213|157260751|FG002|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
48841849|NCT03593213|157260752|FG003|Double-blind Treatment Period (26 Weeks)|Pregnancy|1|||
48841850|NCT03593213|157260749|FG000|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|0|||
48841851|NCT03593213|157260750|FG001|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|3|||
48841852|NCT03593213|157260751|FG002|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|2|||
49169364|NCT03458325|158454787|FG000|Overall Study|Withdrawal by Subject|1|||
49169365|NCT00603941|158454788|FG000|Overall Study|Disease progression|6|||
48841853|NCT03593213|157260752|FG003|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|5|||
48841854|NCT03593213|157260749|FG000|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
48841855|NCT03593213|157260750|FG001|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|1|||
48841856|NCT03593213|157260751|FG002|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|2|||
48951833|NCT01993329|157654912|FG004|Period 2|Adverse Event|0|||
48841857|NCT03593213|157260752|FG003|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
48841858|NCT03593213|157260749|FG000|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|0|||
48841859|NCT03593213|157260750|FG001|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|9|||
48841860|NCT03593213|157260751|FG002|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|11|||
48841861|NCT03593213|157260752|FG003|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|13|||
48841862|NCT03593213|157260749|FG000|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
48841863|NCT03593213|157260750|FG001|Double-blind Treatment Period (26 Weeks)|Reason not Specified|1|||
48841864|NCT03593213|157260751|FG002|Double-blind Treatment Period (26 Weeks)|Reason not Specified|3|||
48841865|NCT03593213|157260752|FG003|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
48841866|NCT00309907|157260753|FG000|Overall Study|Death|4|||
48841867|NCT00309907|157260753|FG000|Overall Study|Physician Decision|1|||
48841868|NCT00309907|157260753|FG000|Overall Study|Ineligible|11|||
48841869|NCT00309907|157260753|FG000|Overall Study|Major infectious event|4|||
48841870|NCT02969863|157260754|FG000|Overall Study|Physician Decision|1|||
48841871|NCT02969863|157260755|FG001|Overall Study|Physician Decision|0|||
48841872|NCT02969863|157260756|FG002|Overall Study|Physician Decision|0|||
48841873|NCT02969863|157260757|FG003|Overall Study|Physician Decision|0|||
48841874|NCT02969863|157260758|FG004|Overall Study|Physician Decision|0|||
48841875|NCT02969863|157260759|FG005|Overall Study|Physician Decision|0|||
48841876|NCT01135511|157260760|FG000|Overall Study|Adverse Event|0|||
48841877|NCT01135511|157260761|FG001|Overall Study|Adverse Event|1|||
48841878|NCT01135511|157260762|FG002|Overall Study|Adverse Event|2|||
48841879|NCT01135511|157260763|FG003|Overall Study|Adverse Event|0|||
48841880|NCT01135511|157260764|FG004|Overall Study|Adverse Event|0|||
48841881|NCT01135511|157260765|FG005|Overall Study|Adverse Event|1|||
48841882|NCT01135511|157260766|FG006|Overall Study|Adverse Event|0|||
48841883|NCT01135511|157260767|FG007|Overall Study|Adverse Event|1|||
48841884|NCT01135511|157260768|FG008|Overall Study|Adverse Event|0|||
48841885|NCT01135511|157260760|FG000|Overall Study|Lack of Efficacy|0|||
48841886|NCT01135511|157260761|FG001|Overall Study|Lack of Efficacy|1|||
48841887|NCT01135511|157260762|FG002|Overall Study|Lack of Efficacy|1|||
48841888|NCT01135511|157260763|FG003|Overall Study|Lack of Efficacy|2|||
48841889|NCT01135511|157260764|FG004|Overall Study|Lack of Efficacy|0|||
48841890|NCT01135511|157260765|FG005|Overall Study|Lack of Efficacy|0|||
48841891|NCT01135511|157260766|FG006|Overall Study|Lack of Efficacy|0|||
48841892|NCT01135511|157260767|FG007|Overall Study|Lack of Efficacy|0|||
48841893|NCT01135511|157260768|FG008|Overall Study|Lack of Efficacy|0|||
48841894|NCT01135511|157260760|FG000|Overall Study|Protocol Violation|0|||
48841895|NCT01135511|157260761|FG001|Overall Study|Protocol Violation|0|||
48841896|NCT01135511|157260762|FG002|Overall Study|Protocol Violation|3|||
48841897|NCT01135511|157260763|FG003|Overall Study|Protocol Violation|0|||
48841898|NCT01135511|157260764|FG004|Overall Study|Protocol Violation|0|||
48841899|NCT01135511|157260765|FG005|Overall Study|Protocol Violation|0|||
48925943|NCT01100944|157561755|FG002|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
48841900|NCT01135511|157260766|FG006|Overall Study|Protocol Violation|0|||
48841901|NCT01135511|157260767|FG007|Overall Study|Protocol Violation|0|||
48841902|NCT01135511|157260768|FG008|Overall Study|Protocol Violation|0|||
48841903|NCT01135511|157260760|FG000|Overall Study|Pregnancy|0|||
48841904|NCT01135511|157260761|FG001|Overall Study|Pregnancy|0|||
48841905|NCT01135511|157260762|FG002|Overall Study|Pregnancy|0|||
48841906|NCT01135511|157260763|FG003|Overall Study|Pregnancy|1|||
48841907|NCT01135511|157260764|FG004|Overall Study|Pregnancy|0|||
48841908|NCT01135511|157260765|FG005|Overall Study|Pregnancy|0|||
48925944|NCT01100944|157561753|FG000|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1|||
49169366|NCT00603941|158454789|FG001|Overall Study|Disease progression|7|||
49169367|NCT00603941|158454790|FG002|Overall Study|Disease progression|1|||
49169368|NCT00603941|158454788|FG000|Overall Study|Adverse Event|1|||
49169369|NCT00603941|158454789|FG001|Overall Study|Adverse Event|0|||
49169370|NCT00603941|158454790|FG002|Overall Study|Adverse Event|1|||
49169371|NCT00603941|158454788|FG000|Overall Study|Physician Decision|0|||
49169372|NCT00603941|158454789|FG001|Overall Study|Physician Decision|1|||
49169373|NCT00603941|158454790|FG002|Overall Study|Physician Decision|0|||
49169374|NCT00603941|158454788|FG000|Overall Study|Withdrawal by Subject|0|||
49169375|NCT00603941|158454789|FG001|Overall Study|Withdrawal by Subject|2|||
49169376|NCT00603941|158454790|FG002|Overall Study|Withdrawal by Subject|0|||
49169377|NCT01014767|158454791|FG000|Overall Study|PI left institution, data unavailable|12|||
49169378|NCT01014767|158454792|FG001|Overall Study|PI left institution, data unavailable|1|||
49169379|NCT01014767|158454793|FG002|Overall Study|PI left institution, data unavailable|4|||
49169380|NCT01014767|158454794|FG003|Overall Study|PI left institution, data unavailable|1|||
49169381|NCT00383331|158454795|FG000|Overall Study|Protocol Violation|0|||
48841909|NCT01135511|157260766|FG006|Overall Study|Pregnancy|0|||
48841910|NCT01135511|157260767|FG007|Overall Study|Pregnancy|0|||
48841911|NCT01135511|157260768|FG008|Overall Study|Pregnancy|0|||
48841912|NCT01135511|157260760|FG000|Overall Study|could not visit the clinic|0|||
48841913|NCT01135511|157260761|FG001|Overall Study|could not visit the clinic|1|||
48841914|NCT01135511|157260762|FG002|Overall Study|could not visit the clinic|2|||
48841915|NCT01135511|157260763|FG003|Overall Study|could not visit the clinic|0|||
48841916|NCT01135511|157260764|FG004|Overall Study|could not visit the clinic|0|||
48841917|NCT01135511|157260765|FG005|Overall Study|could not visit the clinic|0|||
48841918|NCT01135511|157260766|FG006|Overall Study|could not visit the clinic|0|||
48841919|NCT01135511|157260767|FG007|Overall Study|could not visit the clinic|0|||
48841920|NCT01135511|157260768|FG008|Overall Study|could not visit the clinic|0|||
48841921|NCT01135511|157260760|FG000|Overall Study|noncompliance with study drug taken|0|||
48841922|NCT01135511|157260761|FG001|Overall Study|noncompliance with study drug taken|0|||
48841923|NCT01135511|157260762|FG002|Overall Study|noncompliance with study drug taken|0|||
48841924|NCT01135511|157260763|FG003|Overall Study|noncompliance with study drug taken|0|||
49169382|NCT00383331|158454796|FG001|Overall Study|Protocol Violation|1|||
49169383|NCT01206140|158454799|FG000|Overall Study|Deemed ineligible due to incorrect diag.|1|||
49169384|NCT01206140|158454800|FG001|Overall Study|Deemed ineligible due to incorrect diag.|0|||
49169385|NCT01766037|158454801|FG000|Overall Study|Adverse Event|1|||
49169386|NCT01766037|158454802|FG001|Overall Study|Adverse Event|0|||
49169387|NCT01766037|158454801|FG000|Overall Study|Lack of Efficacy|1|||
49169388|NCT01766037|158454802|FG001|Overall Study|Lack of Efficacy|0|||
49169389|NCT01766037|158454801|FG000|Overall Study|Lost to Follow-up|0|||
49169390|NCT01766037|158454802|FG001|Overall Study|Lost to Follow-up|10|||
49169391|NCT01766037|158454801|FG000|Overall Study|Physician Decision|0|||
49169392|NCT01766037|158454802|FG001|Overall Study|Physician Decision|1|||
49169393|NCT01766037|158454801|FG000|Overall Study|Withdrawal by Subject|18|||
49169394|NCT01766037|158454802|FG001|Overall Study|Withdrawal by Subject|16|||
49169395|NCT01766037|158454801|FG000|Overall Study|Moved from area|5|||
49169396|NCT01766037|158454802|FG001|Overall Study|Moved from area|0|||
49169397|NCT01766037|158454801|FG000|Overall Study|medical - unrelated|1|||
49169398|NCT01766037|158454802|FG001|Overall Study|medical - unrelated|2|||
49169399|NCT01766037|158454801|FG000|Overall Study|nausea / discomfort|3|||
49169400|NCT01766037|158454802|FG001|Overall Study|nausea / discomfort|0|||
49169401|NCT00770562|158454805|FG000|Overall Study|Did not take treatment|1|||
49169402|NCT00770562|158454806|FG001|Overall Study|Did not take treatment|1|||
49169403|NCT00292045|158454808|FG000|Core Study (Through Week 13)|Adverse Event|1|||
49169404|NCT00292045|158454808|FG000|Core Study (Through Week 13)|Withdrawal by Subject|1|||
49169405|NCT03462641|158454809|FG000|Visit 1|Failed to complete dopaminergic PET scan|1|||
49169406|NCT03462641|158454810|FG001|Visit 1|Failed to complete dopaminergic PET scan|0|||
49169407|NCT03462641|158454809|FG000|Visit 2|Withdrawal by Subject|0|||
49169408|NCT03462641|158454810|FG001|Visit 2|Withdrawal by Subject|1|||
49169409|NCT02236572|158454811|FG000|Overall Study|Withdrawal by Subject|1|||
49169410|NCT02236572|158454811|FG000|Overall Study|Protocol Violation|1|||
49169411|NCT02236572|158454811|FG000|Overall Study|Lost to Follow-up|1|||
49169412|NCT02443337|158454812|FG000|Overall Study|Adverse Event|0|||
49169413|NCT02443337|158454813|FG001|Overall Study|Adverse Event|1|||
49169414|NCT02443337|158454812|FG000|Overall Study|Clinical Progressive Disease|3|||
49169415|NCT02443337|158454813|FG001|Overall Study|Clinical Progressive Disease|0|||
49169416|NCT02443337|158454812|FG000|Overall Study|Withdrawal by Subject|2|||
48841925|NCT01135511|157260764|FG004|Overall Study|noncompliance with study drug taken|1|||
48841926|NCT01135511|157260765|FG005|Overall Study|noncompliance with study drug taken|0|||
49169417|NCT02443337|158454813|FG001|Overall Study|Withdrawal by Subject|1|||
49169418|NCT00040742|158454814|FG000|Overall Study|Death|0|||
49169419|NCT00040742|158454815|FG001|Overall Study|Death|0|||
49169420|NCT00040742|158454816|FG002|Overall Study|Death|1|||
49169421|NCT00040742|158454817|FG003|Overall Study|Death|0|||
49169422|NCT00040742|158454814|FG000|Overall Study|Adverse Event|15|||
49169423|NCT00040742|158454815|FG001|Overall Study|Adverse Event|16|||
48841927|NCT01135511|157260766|FG006|Overall Study|noncompliance with study drug taken|0|||
48925945|NCT01100944|157561754|FG001|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
48925946|NCT01100944|157561755|FG002|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
48925947|NCT01100944|157561753|FG000|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1|||
48925948|NCT01100944|157561754|FG001|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
48925949|NCT01100944|157561755|FG002|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
48951834|NCT01993329|157654913|FG005|Period 2|Adverse Event|1|||
49169424|NCT00040742|158454816|FG002|Overall Study|Adverse Event|21|||
49169425|NCT00040742|158454817|FG003|Overall Study|Adverse Event|9|||
49169426|NCT00040742|158454814|FG000|Overall Study|Withdrawal by Subject|7|||
49169427|NCT00040742|158454815|FG001|Overall Study|Withdrawal by Subject|15|||
49169428|NCT00040742|158454816|FG002|Overall Study|Withdrawal by Subject|10|||
49169429|NCT00040742|158454817|FG003|Overall Study|Withdrawal by Subject|13|||
49169430|NCT00040742|158454814|FG000|Overall Study|Chemotoxicity|4|||
49169431|NCT00040742|158454815|FG001|Overall Study|Chemotoxicity|3|||
49169432|NCT00040742|158454816|FG002|Overall Study|Chemotoxicity|5|||
49169433|NCT00040742|158454817|FG003|Overall Study|Chemotoxicity|2|||
49169434|NCT00040742|158454814|FG000|Overall Study|Incomplete Forms|6|||
49169435|NCT00040742|158454815|FG001|Overall Study|Incomplete Forms|10|||
49169436|NCT00040742|158454816|FG002|Overall Study|Incomplete Forms|4|||
49169437|NCT00040742|158454817|FG003|Overall Study|Incomplete Forms|5|||
49169438|NCT00040742|158454814|FG000|Overall Study|Other medical|7|||
49169439|NCT00040742|158454815|FG001|Overall Study|Other medical|5|||
49169440|NCT00040742|158454816|FG002|Overall Study|Other medical|5|||
49169441|NCT00040742|158454817|FG003|Overall Study|Other medical|5|||
49169442|NCT00739310|158454822|FG000|Overall Study|Poor adherance to prescribed therapy|4|||
49169443|NCT00739310|158454822|FG000|Overall Study|Withdrawal by Subject|1|||
49169444|NCT00739310|158454822|FG000|Overall Study|Lost to Follow-up|2|||
49169445|NCT03782064|158454825|FG000|Overall Study|Lack of Efficacy|2|||
49169446|NCT03782064|158454825|FG000|Overall Study|Progression Prior to Starting Treatment|3|||
49169447|NCT01490918|158454826|FG000|Overall Study|Lost to Follow-up|2|||
49169448|NCT01490918|158454827|FG001|Overall Study|Lost to Follow-up|1|||
49169449|NCT01490918|158454828|FG002|Overall Study|Lost to Follow-up|0|||
49169450|NCT01490918|158454826|FG000|Overall Study|Withdrawal by Subject|7|||
49169451|NCT01490918|158454827|FG001|Overall Study|Withdrawal by Subject|8|||
49169452|NCT01490918|158454828|FG002|Overall Study|Withdrawal by Subject|3|||
49169453|NCT01490918|158454826|FG000|Overall Study|Adverse Event|0|||
49169454|NCT01490918|158454827|FG001|Overall Study|Adverse Event|0|||
49169455|NCT01490918|158454828|FG002|Overall Study|Adverse Event|1|||
49169456|NCT01490918|158454826|FG000|Overall Study|other cause|4|||
49169457|NCT01490918|158454827|FG001|Overall Study|other cause|5|||
49169458|NCT01490918|158454828|FG002|Overall Study|other cause|8|||
49169459|NCT01151020|158454829|FG000|Overall Study|Death|25|||
49169460|NCT01151020|158454829|FG000|Overall Study|Conversion to open repair|1|||
49169461|NCT01151020|158454829|FG000|Overall Study|Lost to Follow-up|4|||
49169462|NCT01151020|158454829|FG000|Overall Study|Withdrawal by Subject|22|||
49169463|NCT01151020|158454829|FG000|Overall Study|Patients did not receive the device|2|||
49169464|NCT00286091|158454835|FG000|Double-blind Treatment Phase|Withdrawal by Subject|103|||
49169465|NCT00286091|158454836|FG001|Double-blind Treatment Phase|Withdrawal by Subject|113|||
49169466|NCT00286091|158454835|FG000|Double-blind Treatment Phase|Protocol-Specified Criteria|307|||
49169467|NCT00286091|158454836|FG001|Double-blind Treatment Phase|Protocol-Specified Criteria|269|||
49169468|NCT00286091|158454835|FG000|Double-blind Treatment Phase|Death|58|||
49169469|NCT00286091|158454836|FG001|Double-blind Treatment Phase|Death|65|||
49169470|NCT00286091|158454835|FG000|Double-blind Treatment Phase|Adverse Event|28|||
49169471|NCT00286091|158454836|FG001|Double-blind Treatment Phase|Adverse Event|40|||
49169472|NCT00286091|158454835|FG000|Double-blind Treatment Phase|Disease Progression|22|||
49169473|NCT00286091|158454836|FG001|Double-blind Treatment Phase|Disease Progression|35|||
49169474|NCT00286091|158454835|FG000|Double-blind Treatment Phase|Other|25|||
49169475|NCT00286091|158454836|FG001|Double-blind Treatment Phase|Other|33|||
49169476|NCT00286091|158454835|FG000|Double-blind Treatment Phase|Administrative Decision|20|||
49169477|NCT00286091|158454836|FG001|Double-blind Treatment Phase|Administrative Decision|21|||
49169478|NCT00286091|158454835|FG000|Double-blind Treatment Phase|Noncompliance|8|||
49169479|NCT00286091|158454836|FG001|Double-blind Treatment Phase|Noncompliance|8|||
49169480|NCT00286091|158454835|FG000|Double-blind Treatment Phase|Lost to Follow-up|11|||
49169481|NCT00286091|158454836|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
49169482|NCT00286091|158454835|FG000|Double-blind Treatment Phase|Protocol Deviation|1|||
49169483|NCT00286091|158454836|FG001|Double-blind Treatment Phase|Protocol Deviation|3|||
49169484|NCT00286091|158454835|FG000|Double-blind Treatment Phase|Ineligibility Determined|1|||
49169485|NCT00286091|158454836|FG001|Double-blind Treatment Phase|Ineligibility Determined|2|||
49169486|NCT00286091|158454835|FG000|Open-label Treatment Phase|Physician Decision|24|||
49169487|NCT00286091|158454836|FG001|Open-label Treatment Phase|Physician Decision|21|||
49169488|NCT00286091|158454835|FG000|Open-label Treatment Phase|Adverse Event|5|||
49169489|NCT00286091|158454836|FG001|Open-label Treatment Phase|Adverse Event|16|||
49169490|NCT00286091|158454835|FG000|Open-label Treatment Phase|Other|11|||
49169491|NCT00286091|158454836|FG001|Open-label Treatment Phase|Other|11|||
48841928|NCT01135511|157260767|FG007|Overall Study|noncompliance with study drug taken|0|||
48841929|NCT01135511|157260768|FG008|Overall Study|noncompliance with study drug taken|0|||
48841930|NCT01135511|157260760|FG000|Overall Study|Withdrawal by Subject|0|||
48841931|NCT01135511|157260761|FG001|Overall Study|Withdrawal by Subject|0|||
48841932|NCT01135511|157260762|FG002|Overall Study|Withdrawal by Subject|0|||
48841933|NCT01135511|157260763|FG003|Overall Study|Withdrawal by Subject|0|||
48841934|NCT01135511|157260764|FG004|Overall Study|Withdrawal by Subject|0|||
48841935|NCT01135511|157260765|FG005|Overall Study|Withdrawal by Subject|0|||
48841936|NCT01135511|157260766|FG006|Overall Study|Withdrawal by Subject|1|||
48841937|NCT01135511|157260767|FG007|Overall Study|Withdrawal by Subject|0|||
48841938|NCT01135511|157260768|FG008|Overall Study|Withdrawal by Subject|1|||
48841939|NCT00585533|157260769|FG000|Overall Study|objective or symptomatic progression|9|||
48841940|NCT01254188|157260770|FG000|Overall Study|Disease Progression|6|||
48841941|NCT01254188|157260770|FG000|Overall Study|Protocol Violation|6|||
48841942|NCT01254188|157260770|FG000|Overall Study|Pregnancy|2|||
48841943|NCT01254188|157260770|FG000|Overall Study|Death|4|||
48841944|NCT01254188|157260770|FG000|Overall Study|Lost to Follow-up|5|||
48841945|NCT01254188|157260770|FG000|Overall Study|Withdrawal by Subject|7|||
48841946|NCT01254188|157260770|FG000|Overall Study|Adverse Event|43|||
49169492|NCT00286091|158454835|FG000|Open-label Treatment Phase|Withdrawal by Subject|14|||
49169493|NCT00286091|158454836|FG001|Open-label Treatment Phase|Withdrawal by Subject|10|||
49169494|NCT00286091|158454835|FG000|Open-label Treatment Phase|Death|10|||
49169495|NCT00286091|158454836|FG001|Open-label Treatment Phase|Death|7|||
49169496|NCT00286091|158454835|FG000|Open-label Treatment Phase|Disease Progression|9|||
49169497|NCT00286091|158454836|FG001|Open-label Treatment Phase|Disease Progression|3|||
49169498|NCT00286091|158454835|FG000|Open-label Treatment Phase|Noncompliance|3|||
49169499|NCT00286091|158454836|FG001|Open-label Treatment Phase|Noncompliance|1|||
49169500|NCT00286091|158454835|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
49169501|NCT00286091|158454836|FG001|Open-label Treatment Phase|Lost to Follow-up|1|||
49169502|NCT00286091|158454835|FG000|Open-label Treatment Phase|Protocol-specified Criteria|1|||
49169503|NCT00286091|158454836|FG001|Open-label Treatment Phase|Protocol-specified Criteria|0|||
49169504|NCT00286091|158454835|FG000|Open-label Treatment Phase|Missing End of Study Information|0|||
49169505|NCT00286091|158454836|FG001|Open-label Treatment Phase|Missing End of Study Information|1|||
49169506|NCT01295944|158454837|FG000|Overall Study|Switched to alternative treatment|1|||
49169507|NCT01295944|158454837|FG000|Overall Study|Ineligible|9|||
49169508|NCT01295944|158454837|FG000|Overall Study|Withdrawal by Subject|4|||
48841947|NCT01254188|157260770|FG000|Overall Study|per investigator discretion|20|||
48841948|NCT03740009|157260771|FG000|Overall Study|Physician Decision|9|||
48841949|NCT03740009|157260771|FG000|Overall Study|Lost to Follow-up|1|||
49169509|NCT01295944|158454837|FG000|Overall Study|Participant chose to be treated in Peru|1|||
48841950|NCT05082935|157260774|FG000|Overall Study|Lost to Follow-up|549|||
48841951|NCT05082935|157260775|FG001|Overall Study|Lost to Follow-up|631|||
49169510|NCT01295944|158454837|FG000|Overall Study|Participant wanting a local endoscopy surgery to remove more tumor|1|||
49169511|NCT01295944|158454837|FG000|Overall Study|Participant was diagnosed with stage 1 infiltrated ductal carcinoma of the right breast(10/03/2013).|1|||
49169512|NCT01295944|158454837|FG000|Overall Study|Participant decided to pursue other treatment before beginning protocol treatment|1|||
49169513|NCT02520388|158454838|FG000|Overall Study|Physician Decision|1|||
49169514|NCT02520388|158454839|FG001|Overall Study|Physician Decision|0|||
49169515|NCT02520388|158454838|FG000|Overall Study|Subject or parent/guardian request|0|||
49169516|NCT02520388|158454839|FG001|Overall Study|Subject or parent/guardian request|6|||
49169517|NCT02520388|158454838|FG000|Overall Study|Adverse Event|1|||
49169518|NCT02520388|158454839|FG001|Overall Study|Adverse Event|4|||
49169519|NCT02520388|158454838|FG000|Overall Study|Lost to Follow-up|3|||
49169520|NCT02520388|158454839|FG001|Overall Study|Lost to Follow-up|2|||
49169521|NCT02520388|158454838|FG000|Overall Study|Other (reason not defined)|4|||
49169522|NCT02520388|158454839|FG001|Overall Study|Other (reason not defined)|4|||
49169523|NCT01479764|158454843|FG000|Randomized|Adverse Event|1|||
49169524|NCT01479764|158454844|FG001|Randomized|Adverse Event|1|||
49169525|NCT01479764|158454843|FG000|Randomized|Withdrawal by Subject|1|||
49169526|NCT01479764|158454844|FG001|Randomized|Withdrawal by Subject|0|||
49169527|NCT01479764|158454843|FG000|Treated|Lost to Follow-up|0|||
49169528|NCT01479764|158454844|FG001|Treated|Lost to Follow-up|2|||
49169529|NCT03519997|158454845|FG000|Overall Study|Adverse Event|4|||
49169530|NCT03519997|158454845|FG000|Overall Study|Withdrawal by Subject|2|||
49169531|NCT03519997|158454845|FG000|Overall Study|Protocol Violation|1|||
49169532|NCT00923351|158454855|FG000|Overall Study|no apheresis/adequate tumor sample|0|||
49169533|NCT00923351|158454856|FG001|Overall Study|no apheresis/adequate tumor sample|0|||
49169534|NCT00923351|158454857|FG002|Overall Study|no apheresis/adequate tumor sample|12|||
49169535|NCT02454530|158454858|FG000|Overall Study|Other|8|||
49169536|NCT02454530|158454859|FG001|Overall Study|Other|13|||
49169537|NCT02454530|158454858|FG000|Overall Study|Missing information|56|||
49169538|NCT02454530|158454859|FG001|Overall Study|Missing information|69|||
49169539|NCT02454530|158454858|FG000|Overall Study|Death|2|||
49169540|NCT02454530|158454859|FG001|Overall Study|Death|41|||
49169541|NCT02454530|158454858|FG000|Overall Study|Lost to Follow-up|4|||
49169542|NCT02454530|158454859|FG001|Overall Study|Lost to Follow-up|4|||
49169543|NCT00451958|158454860|FG000|CS21A (NCT00451958)|Adverse Event|21|||
49169544|NCT00451958|158454861|FG001|CS21A (NCT00451958)|Adverse Event|34|||
49169545|NCT00451958|158454862|FG002|CS21A (NCT00451958)|Adverse Event|14|||
49169546|NCT00451958|158454863|FG003|CS21A (NCT00451958)|Adverse Event|17|||
49169547|NCT00451958|158454864|FG004|CS21A (NCT00451958)|Adverse Event|0|||
49169548|NCT00451958|158454860|FG000|CS21A (NCT00451958)|Lost to Follow-up|6|||
49169549|NCT00451958|158454861|FG001|CS21A (NCT00451958)|Lost to Follow-up|5|||
49169550|NCT00451958|158454862|FG002|CS21A (NCT00451958)|Lost to Follow-up|1|||
49169551|NCT00451958|158454863|FG003|CS21A (NCT00451958)|Lost to Follow-up|1|||
49169552|NCT00451958|158454864|FG004|CS21A (NCT00451958)|Lost to Follow-up|0|||
49169553|NCT00451958|158454860|FG000|CS21A (NCT00451958)|Protocol Violation|1|||
49169554|NCT00451958|158454861|FG001|CS21A (NCT00451958)|Protocol Violation|3|||
49169555|NCT00451958|158454862|FG002|CS21A (NCT00451958)|Protocol Violation|2|||
49169556|NCT00451958|158454863|FG003|CS21A (NCT00451958)|Protocol Violation|0|||
49169557|NCT00451958|158454864|FG004|CS21A (NCT00451958)|Protocol Violation|0|||
49169558|NCT00451958|158454860|FG000|CS21A (NCT00451958)|Physician Decision|2|||
49169559|NCT00451958|158454861|FG001|CS21A (NCT00451958)|Physician Decision|4|||
49169560|NCT00451958|158454862|FG002|CS21A (NCT00451958)|Physician Decision|4|||
49169561|NCT00451958|158454863|FG003|CS21A (NCT00451958)|Physician Decision|4|||
49169562|NCT00451958|158454864|FG004|CS21A (NCT00451958)|Physician Decision|0|||
49169563|NCT00451958|158454860|FG000|CS21A (NCT00451958)|Withdrawal by Subject|7|||
49169564|NCT00451958|158454861|FG001|CS21A (NCT00451958)|Withdrawal by Subject|4|||
49169565|NCT00451958|158454862|FG002|CS21A (NCT00451958)|Withdrawal by Subject|4|||
49169566|NCT00451958|158454863|FG003|CS21A (NCT00451958)|Withdrawal by Subject|3|||
49169567|NCT00451958|158454864|FG004|CS21A (NCT00451958)|Withdrawal by Subject|0|||
49169568|NCT00451958|158454860|FG000|CS21A (NCT00451958)|Miscellaneous reasons|28|||
49169569|NCT00451958|158454861|FG001|CS21A (NCT00451958)|Miscellaneous reasons|27|||
49169570|NCT00451958|158454862|FG002|CS21A (NCT00451958)|Miscellaneous reasons|17|||
48925950|NCT01100944|157561753|FG000|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
49169571|NCT00451958|158454863|FG003|CS21A (NCT00451958)|Miscellaneous reasons|14|||
49169572|NCT00451958|158454864|FG004|CS21A (NCT00451958)|Miscellaneous reasons|0|||
48925951|NCT01100944|157561754|FG001|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2|||
49169573|NCT00269113|158456109|FG000|Overall Study|Adverse Event|14|||
49169574|NCT00269113|158456110|FG001|Overall Study|Adverse Event|7|||
49169575|NCT00269113|158456109|FG000|Overall Study|Lack of Efficacy|35|||
49169576|NCT00269113|158456110|FG001|Overall Study|Lack of Efficacy|18|||
49169577|NCT00269113|158456109|FG000|Overall Study|Early Improvement|2|||
49169578|NCT00269113|158456110|FG001|Overall Study|Early Improvement|0|||
49169579|NCT00269113|158456109|FG000|Overall Study|Withdrawal by Subject|0|||
49169580|NCT00269113|158456110|FG001|Overall Study|Withdrawal by Subject|2|||
49169581|NCT00269113|158456109|FG000|Overall Study|Death|6|||
49169582|NCT00269113|158456110|FG001|Overall Study|Death|2|||
49169583|NCT00269113|158456109|FG000|Overall Study|Lost to Follow-up|2|||
49169584|NCT00269113|158456110|FG001|Overall Study|Lost to Follow-up|1|||
49169585|NCT00269113|158456109|FG000|Overall Study|Protocol Violation|15|||
49169586|NCT00269113|158456110|FG001|Overall Study|Protocol Violation|5|||
49169587|NCT00269113|158456109|FG000|Overall Study|Other|0|||
49169588|NCT00269113|158456110|FG001|Overall Study|Other|2|||
49169589|NCT01978145|158456111|FG000|Treatment Period 1|Adverse Event|1|||
49169590|NCT01978145|158456112|FG001|Treatment Period 1|Adverse Event|9|||
49169591|NCT01978145|158456111|FG000|Treatment Period 1|Physician Decision|1|||
49169592|NCT01978145|158456112|FG001|Treatment Period 1|Physician Decision|0|||
49169593|NCT01978145|158456111|FG000|Treatment Period 1|Withdrawal by Subject|5|||
49169594|NCT01978145|158456112|FG001|Treatment Period 1|Withdrawal by Subject|4|||
49169595|NCT01978145|158456111|FG000|Treatment Period 1|Par. reached defined stopping criteria|2|||
49169596|NCT01978145|158456112|FG001|Treatment Period 1|Par. reached defined stopping criteria|3|||
49169597|NCT01978145|158456111|FG000|Washout Period 1|Adverse Event|0|||
49169598|NCT01978145|158456112|FG001|Washout Period 1|Adverse Event|1|||
49169599|NCT01978145|158456111|FG000|Washout Period 1|Withdrawal by Subject|1|||
49169600|NCT01978145|158456112|FG001|Washout Period 1|Withdrawal by Subject|1|||
49169601|NCT01978145|158456111|FG000|Washout Period 1|Par. reached defined stopping criteria|0|||
49169602|NCT01978145|158456112|FG001|Washout Period 1|Par. reached defined stopping criteria|1|||
49169603|NCT01978145|158456111|FG000|Treatment Period 2|Adverse Event|3|||
49169604|NCT01978145|158456112|FG001|Treatment Period 2|Adverse Event|3|||
49169605|NCT01978145|158456111|FG000|Treatment Period 2|Protocol Violation|0|||
49169606|NCT01978145|158456112|FG001|Treatment Period 2|Protocol Violation|1|||
49169607|NCT01978145|158456111|FG000|Treatment Period 2|Lost to Follow-up|1|||
49169608|NCT01978145|158456112|FG001|Treatment Period 2|Lost to Follow-up|1|||
49169609|NCT01978145|158456111|FG000|Treatment Period 2|Withdrawal by Subject|7|||
49169610|NCT01978145|158456112|FG001|Treatment Period 2|Withdrawal by Subject|4|||
49169611|NCT01978145|158456111|FG000|Treatment Period 2|Par. reached defined stopping criteria|8|||
49169612|NCT01978145|158456112|FG001|Treatment Period 2|Par. reached defined stopping criteria|5|||
49169613|NCT03276728|158456115|FG000|Overall Study|Lost to Follow-up|0|||
49169614|NCT03276728|158456116|FG001|Overall Study|Lost to Follow-up|0|||
49169615|NCT03276728|158456117|FG002|Overall Study|Lost to Follow-up|2|||
49169616|NCT03276728|158456118|FG003|Overall Study|Lost to Follow-up|2|||
49169617|NCT03276728|158456119|FG004|Overall Study|Lost to Follow-up|0|||
48925952|NCT01100944|157561755|FG002|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
48925953|NCT01665807|157561777|FG000|Overall Study|Withdrawal by Subject|2|||
48925954|NCT01665807|157561778|FG001|Overall Study|Withdrawal by Subject|0|||
48925955|NCT01665807|157561779|FG002|Overall Study|Withdrawal by Subject|1|||
48925956|NCT01847885|157561783|FG000|Initial Enrollment (Consented)|Protocol Violation|1|||
48925957|NCT01847885|157561784|FG001|Initial Enrollment (Consented)|Protocol Violation|0|||
48925958|NCT01847885|157561785|FG002|Initial Enrollment (Consented)|Protocol Violation|0|||
48925959|NCT01847885|157561783|FG000|Initial Enrollment (Consented)|Withdrawal by Subject|2|||
48925960|NCT01847885|157561784|FG001|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
48925961|NCT01847885|157561785|FG002|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
48925962|NCT01847885|157561783|FG000|Initial Enrollment (Consented)|Screen failure|39|||
48925963|NCT01847885|157561784|FG001|Initial Enrollment (Consented)|Screen failure|0|||
48925964|NCT01847885|157561785|FG002|Initial Enrollment (Consented)|Screen failure|0|||
48925965|NCT01847885|157561783|FG000|Initial Enrollment (Consented)|Pending prior to enrollment stop|6|||
48925966|NCT01847885|157561784|FG001|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
48925967|NCT01847885|157561785|FG002|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
48925968|NCT01847885|157561783|FG000|Randomization|Protocol Violation|0|||
48925969|NCT01847885|157561784|FG001|Randomization|Protocol Violation|1|||
48925970|NCT01847885|157561785|FG002|Randomization|Protocol Violation|0|||
48925971|NCT01847885|157561783|FG000|Randomization|Withdrawal by Subject|0|||
49169618|NCT03276728|158456120|FG005|Overall Study|Lost to Follow-up|0|||
49169619|NCT03276728|158456121|FG006|Overall Study|Lost to Follow-up|0|||
49169620|NCT03276728|158456122|FG007|Overall Study|Lost to Follow-up|0|||
49169621|NCT03276728|158456115|FG000|Overall Study|Withdrawal by Subject|0|||
49169622|NCT03276728|158456116|FG001|Overall Study|Withdrawal by Subject|0|||
49169623|NCT03276728|158456117|FG002|Overall Study|Withdrawal by Subject|0|||
49169624|NCT03276728|158456118|FG003|Overall Study|Withdrawal by Subject|3|||
49169625|NCT03276728|158456119|FG004|Overall Study|Withdrawal by Subject|0|||
49169626|NCT03276728|158456120|FG005|Overall Study|Withdrawal by Subject|0|||
49169627|NCT03276728|158456121|FG006|Overall Study|Withdrawal by Subject|0|||
49169628|NCT03276728|158456122|FG007|Overall Study|Withdrawal by Subject|0|||
49169629|NCT03276728|158456115|FG000|Overall Study|Decision by sponsor|0|||
48735637|NCT00961649|156883700|FG003|Overall Study|Patient has travel plans during holidays|0|||
49169630|NCT03276728|158456116|FG001|Overall Study|Decision by sponsor|0|||
49169631|NCT03276728|158456117|FG002|Overall Study|Decision by sponsor|0|||
49169632|NCT03276728|158456118|FG003|Overall Study|Decision by sponsor|0|||
49169633|NCT03276728|158456119|FG004|Overall Study|Decision by sponsor|1|||
49169634|NCT03276728|158456120|FG005|Overall Study|Decision by sponsor|0|||
49169635|NCT03276728|158456121|FG006|Overall Study|Decision by sponsor|2|||
49169636|NCT03276728|158456122|FG007|Overall Study|Decision by sponsor|1|||
49169637|NCT02364037|158456124|FG000|Overall Study|Withdrawal by Subject|7|||
49169638|NCT02364037|158456125|FG001|Overall Study|Withdrawal by Subject|4|||
49169639|NCT02364037|158456124|FG000|Overall Study|Lost to Follow-up|37|||
49169640|NCT02364037|158456125|FG001|Overall Study|Lost to Follow-up|49|||
49169641|NCT00500357|158456128|FG000|Overall Study|Death|1|||
49169642|NCT02446769|158456131|FG000|Screening Period|Screen Failure|11|||
49169643|NCT02446769|158456132|FG001|Screening Period|Screen Failure|0|||
49169644|NCT02446769|158456133|FG002|Screening Period|Screen Failure|0|||
49169645|NCT02446769|158456131|FG000|Study Period|Randomized in Error|0|||
49169646|NCT02446769|158456132|FG001|Study Period|Randomized in Error|2|||
49169647|NCT02446769|158456133|FG002|Study Period|Randomized in Error|0|||
49169648|NCT00049322|158456134|FG000|Overall Study|disease burden|0|||
49169649|NCT00049322|158456135|FG001|Overall Study|disease burden|3|||
49169650|NCT00049322|158456134|FG000|Overall Study|Adverse Event|1|||
49169651|NCT00049322|158456135|FG001|Overall Study|Adverse Event|0|||
49169652|NCT00049322|158456134|FG000|Overall Study|refused angio|0|||
49169653|NCT00049322|158456135|FG001|Overall Study|refused angio|3|||
49169654|NCT02819297|158456136|FG000|Overall Study|Withdrawal by Subject|25|||
49169655|NCT02819297|158456137|FG001|Overall Study|Withdrawal by Subject|13|||
49169656|NCT02819297|158456136|FG000|Overall Study|Lost to Follow-up|12|||
49169657|NCT02819297|158456137|FG001|Overall Study|Lost to Follow-up|14|||
49169658|NCT02819297|158456136|FG000|Overall Study|Adverse Event|12|||
49169659|NCT02819297|158456137|FG001|Overall Study|Adverse Event|10|||
49169660|NCT02819297|158456136|FG000|Overall Study|Physician Decision|5|||
49169661|NCT02819297|158456137|FG001|Overall Study|Physician Decision|5|||
49169662|NCT02819297|158456136|FG000|Overall Study|Lack of Efficacy|5|||
49169663|NCT02819297|158456137|FG001|Overall Study|Lack of Efficacy|8|||
49169664|NCT02819297|158456136|FG000|Overall Study|Protocol Violation|1|||
49169665|NCT02819297|158456137|FG001|Overall Study|Protocol Violation|2|||
49169666|NCT02151903|158456138|FG000|Overall Study|Withdrawal by Subject|1|||
49169667|NCT02151903|158456139|FG001|Overall Study|Withdrawal by Subject|0|||
49169668|NCT02151903|158456138|FG000|Overall Study|Progressive disease|2|||
49169669|NCT02151903|158456139|FG001|Overall Study|Progressive disease|1|||
49169670|NCT03188263|158456140|FG000|Overall Study|Withdrawal by Subject|3|||
49169671|NCT03188263|158456141|FG001|Overall Study|Withdrawal by Subject|0|||
48925972|NCT01847885|157561784|FG001|Randomization|Withdrawal by Subject|0|||
48925973|NCT01847885|157561785|FG002|Randomization|Withdrawal by Subject|2|||
48925974|NCT01847885|157561783|FG000|Randomization|Screen Failure|0|||
48925975|NCT01847885|157561784|FG001|Randomization|Screen Failure|3|||
48925976|NCT01847885|157561785|FG002|Randomization|Screen Failure|0|||
48925977|NCT02574637|157561788|FG000|Double-blind Period|Adverse Event|1|||
49169672|NCT03188263|158456140|FG000|Overall Study|Physician Decision|1|||
49169673|NCT03188263|158456141|FG001|Overall Study|Physician Decision|0|||
49169674|NCT01277822|158456142|FG000|Overall Study|Adverse Event|2|||
49169675|NCT01277822|158456143|FG001|Overall Study|Adverse Event|1|||
49169676|NCT01277822|158456142|FG000|Overall Study|Withdrawal by Subject|6|||
49169677|NCT01277822|158456143|FG001|Overall Study|Withdrawal by Subject|7|||
49169678|NCT01277822|158456142|FG000|Overall Study|Physician Decision|1|||
49169679|NCT01277822|158456143|FG001|Overall Study|Physician Decision|1|||
49169680|NCT01277822|158456142|FG000|Overall Study|Protocol Violation|1|||
49169681|NCT01277822|158456143|FG001|Overall Study|Protocol Violation|0|||
49169682|NCT01277822|158456142|FG000|Overall Study|Lost to Follow-up|2|||
49169683|NCT01277822|158456143|FG001|Overall Study|Lost to Follow-up|1|||
49169684|NCT01277822|158456142|FG000|Overall Study|Contraindicated medication used|2|||
49169685|NCT01277822|158456143|FG001|Overall Study|Contraindicated medication used|1|||
49169686|NCT01277822|158456142|FG000|Overall Study|Participant moved|1|||
49169687|NCT01277822|158456143|FG001|Overall Study|Participant moved|0|||
49169688|NCT02923531|158456144|FG000|Overall Study|Adverse Event|4|||
49169689|NCT02923531|158456144|FG000|Overall Study|Clinical Deterioration|1|||
49169690|NCT02923531|158456144|FG000|Overall Study|Disease Progression|3|||
49169691|NCT02923531|158456144|FG000|Overall Study|Study Termination|1|||
49169692|NCT02997865|158456145|FG000|Overall Study|Death|2|||
49169693|NCT02997865|158456146|FG001|Overall Study|Death|1|||
49169694|NCT02997865|158456145|FG000|Overall Study|Lost to Follow-up|6|||
49169695|NCT02997865|158456146|FG001|Overall Study|Lost to Follow-up|3|||
49169696|NCT02997865|158456145|FG000|Overall Study|Withdrawal by Subject|5|||
49169697|NCT02997865|158456146|FG001|Overall Study|Withdrawal by Subject|0|||
49169698|NCT01945996|158456151|FG000|Overall Study|Lost to Follow-up|3|||
49169699|NCT01945996|158456152|FG001|Overall Study|Lost to Follow-up|5|||
49169700|NCT02148263|158456153|FG000|Overall Study|Withdrawal by Subject|3|||
49169701|NCT02148263|158456154|FG001|Overall Study|Withdrawal by Subject|2|||
49169702|NCT03542266|158456155|FG000|Treatment Phase|Withdrawal by Subject|1|||
49169703|NCT03542266|158456155|FG000|Treatment Phase|Adverse Event|1|||
49169704|NCT03542266|158456155|FG000|Treatment Phase|PD|1|||
49169705|NCT01637584|158456156|FG000|Overall Study|Withdrawal by Subject|1|||
49169706|NCT01637584|158456157|FG001|Overall Study|Withdrawal by Subject|3|||
49169707|NCT01721486|158456160|FG000|Overall Study|Protocol Violation|1|||
49169708|NCT01721486|158456161|FG001|Overall Study|Protocol Violation|0|||
49169709|NCT01721486|158456160|FG000|Overall Study|Physician Decision|0|||
49169710|NCT01721486|158456161|FG001|Overall Study|Physician Decision|1|||
49169711|NCT02125838|158456162|FG000|Overall Study|Lost to Follow-up|4|||
49169712|NCT02125838|158456163|FG001|Overall Study|Lost to Follow-up|4|||
48925978|NCT02574637|157561789|FG001|Double-blind Period|Adverse Event|0|||
48925979|NCT02574637|157561790|FG002|Double-blind Period|Adverse Event|0|||
48925980|NCT02574637|157561791|FG003|Double-blind Period|Adverse Event|0|||
48925981|NCT02574637|157561792|FG004|Double-blind Period|Adverse Event|0|||
48925982|NCT02574637|157561793|FG005|Double-blind Period|Adverse Event|0|||
48925983|NCT02574637|157561794|FG006|Double-blind Period|Adverse Event|0|||
48925984|NCT02574637|157561795|FG007|Double-blind Period|Adverse Event|0|||
48925985|NCT02574637|157561796|FG008|Double-blind Period|Adverse Event|0|||
48925986|NCT02574637|157561797|FG009|Double-blind Period|Adverse Event|0|||
48925987|NCT02574637|157561788|FG000|Double-blind Period|Lack of Efficacy|0|||
48925988|NCT02574637|157561789|FG001|Double-blind Period|Lack of Efficacy|0|||
48925989|NCT02574637|157561790|FG002|Double-blind Period|Lack of Efficacy|2|||
48925990|NCT02574637|157561791|FG003|Double-blind Period|Lack of Efficacy|0|||
48925991|NCT02574637|157561792|FG004|Double-blind Period|Lack of Efficacy|0|||
48925992|NCT02574637|157561793|FG005|Double-blind Period|Lack of Efficacy|0|||
48925993|NCT02574637|157561794|FG006|Double-blind Period|Lack of Efficacy|0|||
49169713|NCT00787839|158456164|FG000|Overall Study|Failure to have the OGTT was most common|404|||
49169714|NCT02969915|158456165|FG000|Overall Study|Death|104|||
49169715|NCT02969915|158456166|FG001|Overall Study|Death|125|||
48925994|NCT02574637|157561795|FG007|Double-blind Period|Lack of Efficacy|0|||
48925995|NCT02574637|157561796|FG008|Double-blind Period|Lack of Efficacy|0|||
48925996|NCT02574637|157561797|FG009|Double-blind Period|Lack of Efficacy|0|||
49169716|NCT02969915|158456165|FG000|Overall Study|Lost to Follow-up|108|||
49169717|NCT02969915|158456166|FG001|Overall Study|Lost to Follow-up|112|||
49169718|NCT02969915|158456165|FG000|Overall Study|Censored due to COVID-19|481|||
49169719|NCT02969915|158456166|FG001|Overall Study|Censored due to COVID-19|471|||
49169720|NCT02725476|158456173|FG000|Overall Study|Physician Decision|2|||
49169721|NCT02725476|158456174|FG001|Overall Study|Physician Decision|0|||
49169722|NCT02725476|158456173|FG000|Overall Study|Adverse Event|1|||
49169723|NCT02725476|158456174|FG001|Overall Study|Adverse Event|1|||
49169724|NCT01270880|158456178|FG000|Overall Study|Never rec'd treatment, but registered.|1|||
49169725|NCT01169701|158456185|FG000|Overall Study|Lost to Follow-up|1|||
49169726|NCT01169701|158456186|FG001|Overall Study|Lost to Follow-up|1|||
49169727|NCT01169701|158456185|FG000|Overall Study|Withdrawal by Subject|1|||
48925997|NCT02574637|157561788|FG000|Double-blind Period|Protocol Deviation|1|||
48925998|NCT02574637|157561789|FG001|Double-blind Period|Protocol Deviation|0|||
48925999|NCT02574637|157561790|FG002|Double-blind Period|Protocol Deviation|0|||
48926000|NCT02574637|157561791|FG003|Double-blind Period|Protocol Deviation|0|||
48926001|NCT02574637|157561792|FG004|Double-blind Period|Protocol Deviation|0|||
48926002|NCT02574637|157561793|FG005|Double-blind Period|Protocol Deviation|0|||
48926003|NCT02574637|157561794|FG006|Double-blind Period|Protocol Deviation|0|||
48926004|NCT02574637|157561795|FG007|Double-blind Period|Protocol Deviation|0|||
48926005|NCT02574637|157561796|FG008|Double-blind Period|Protocol Deviation|0|||
48926006|NCT02574637|157561797|FG009|Double-blind Period|Protocol Deviation|0|||
48926007|NCT02574637|157561788|FG000|Double-blind Period|Non-Compliance With Study Drug|0|||
48926008|NCT02574637|157561789|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
49015101|NCT02058628|157892060|FG001|Overall Study|Non compliance|0|||
49015102|NCT02884206|157892061|FG000|Valsartan Run-in Period|Death|1|||
49015103|NCT02884206|157892062|FG001|Valsartan Run-in Period|Death|0|||
49015104|NCT02884206|157892063|FG002|Valsartan Run-in Period|Death|0|||
49015105|NCT02884206|157892061|FG000|Valsartan Run-in Period|Adverse Event|31|||
49015106|NCT02884206|157892062|FG001|Valsartan Run-in Period|Adverse Event|0|||
49015107|NCT02884206|157892063|FG002|Valsartan Run-in Period|Adverse Event|0|||
49015108|NCT02884206|157892061|FG000|Valsartan Run-in Period|Patient/guardian decision|9|||
49015109|NCT02884206|157892062|FG001|Valsartan Run-in Period|Patient/guardian decision|0|||
49015110|NCT02884206|157892063|FG002|Valsartan Run-in Period|Patient/guardian decision|0|||
49015111|NCT02884206|157892061|FG000|Valsartan Run-in Period|Protocol deviation|4|||
49015112|NCT02884206|157892062|FG001|Valsartan Run-in Period|Protocol deviation|0|||
49015113|NCT02884206|157892063|FG002|Valsartan Run-in Period|Protocol deviation|0|||
49015114|NCT02884206|157892061|FG000|Valsartan Run-in Period|Non-compliance with study treatment|1|||
49015115|NCT02884206|157892062|FG001|Valsartan Run-in Period|Non-compliance with study treatment|0|||
49015116|NCT02884206|157892063|FG002|Valsartan Run-in Period|Non-compliance with study treatment|0|||
49015117|NCT02884206|157892061|FG000|Valsartan Run-in Period|Physician Decision|1|||
49015118|NCT02884206|157892062|FG001|Valsartan Run-in Period|Physician Decision|0|||
49015119|NCT02884206|157892063|FG002|Valsartan Run-in Period|Physician Decision|0|||
49015120|NCT02884206|157892061|FG000|LCZ696 Run-in Period|Adverse Event|38|||
49015121|NCT02884206|157892062|FG001|LCZ696 Run-in Period|Adverse Event|0|||
49015122|NCT02884206|157892063|FG002|LCZ696 Run-in Period|Adverse Event|0|||
48926009|NCT02574637|157561790|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
48926010|NCT02574637|157561791|FG003|Double-blind Period|Non-Compliance With Study Drug|1|||
48926011|NCT02574637|157561792|FG004|Double-blind Period|Non-Compliance With Study Drug|0|||
48926012|NCT02574637|157561793|FG005|Double-blind Period|Non-Compliance With Study Drug|0|||
48926013|NCT02574637|157561794|FG006|Double-blind Period|Non-Compliance With Study Drug|0|||
48926014|NCT02574637|157561795|FG007|Double-blind Period|Non-Compliance With Study Drug|0|||
48926015|NCT02574637|157561796|FG008|Double-blind Period|Non-Compliance With Study Drug|0|||
48926016|NCT02574637|157561797|FG009|Double-blind Period|Non-Compliance With Study Drug|0|||
48926017|NCT02574637|157561788|FG000|Double-blind Period|Study Terminated By Sponsor|1|||
48926018|NCT02574637|157561789|FG001|Double-blind Period|Study Terminated By Sponsor|1|||
48926019|NCT02574637|157561790|FG002|Double-blind Period|Study Terminated By Sponsor|5|||
48926020|NCT02574637|157561791|FG003|Double-blind Period|Study Terminated By Sponsor|2|||
48926021|NCT02574637|157561792|FG004|Double-blind Period|Study Terminated By Sponsor|2|||
48926022|NCT02574637|157561793|FG005|Double-blind Period|Study Terminated By Sponsor|0|||
48926023|NCT02574637|157561794|FG006|Double-blind Period|Study Terminated By Sponsor|0|||
48926024|NCT02574637|157561795|FG007|Double-blind Period|Study Terminated By Sponsor|0|||
48926025|NCT02574637|157561796|FG008|Double-blind Period|Study Terminated By Sponsor|0|||
48926026|NCT02574637|157561797|FG009|Double-blind Period|Study Terminated By Sponsor|0|||
48926027|NCT02574637|157561788|FG000|Double-blind Period|Reason Not Specified|0|||
48926028|NCT02574637|157561789|FG001|Double-blind Period|Reason Not Specified|0|||
48926029|NCT02574637|157561790|FG002|Double-blind Period|Reason Not Specified|0|||
48926030|NCT02574637|157561791|FG003|Double-blind Period|Reason Not Specified|1|||
48926031|NCT02574637|157561792|FG004|Double-blind Period|Reason Not Specified|0|||
48926032|NCT02574637|157561793|FG005|Double-blind Period|Reason Not Specified|0|||
48926033|NCT02574637|157561794|FG006|Double-blind Period|Reason Not Specified|0|||
48926034|NCT02574637|157561795|FG007|Double-blind Period|Reason Not Specified|0|||
48926035|NCT02574637|157561796|FG008|Double-blind Period|Reason Not Specified|0|||
48926036|NCT02574637|157561797|FG009|Double-blind Period|Reason Not Specified|0|||
48926037|NCT02574637|157561788|FG000|Open-label (OL) Period|Adverse Event|0|||
48926038|NCT02574637|157561789|FG001|Open-label (OL) Period|Adverse Event|0|||
48926039|NCT02574637|157561790|FG002|Open-label (OL) Period|Adverse Event|0|||
48926040|NCT02574637|157561791|FG003|Open-label (OL) Period|Adverse Event|0|||
48926041|NCT02574637|157561792|FG004|Open-label (OL) Period|Adverse Event|0|||
48926042|NCT02574637|157561793|FG005|Open-label (OL) Period|Adverse Event|0|||
48926043|NCT02574637|157561794|FG006|Open-label (OL) Period|Adverse Event|0|||
48926044|NCT02574637|157561795|FG007|Open-label (OL) Period|Adverse Event|0|||
48926045|NCT02574637|157561796|FG008|Open-label (OL) Period|Adverse Event|1|||
48926046|NCT02574637|157561797|FG009|Open-label (OL) Period|Adverse Event|0|||
48926047|NCT02574637|157561788|FG000|Open-label (OL) Period|Withdrawal by Subject|0|||
48926048|NCT02574637|157561789|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
48926049|NCT02574637|157561790|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
48926050|NCT02574637|157561791|FG003|Open-label (OL) Period|Withdrawal by Subject|0|||
48926051|NCT02574637|157561792|FG004|Open-label (OL) Period|Withdrawal by Subject|0|||
48926052|NCT02574637|157561793|FG005|Open-label (OL) Period|Withdrawal by Subject|1|||
48926053|NCT02574637|157561794|FG006|Open-label (OL) Period|Withdrawal by Subject|0|||
49169728|NCT01169701|158456186|FG001|Overall Study|Withdrawal by Subject|3|||
49169729|NCT01169701|158456185|FG000|Overall Study|Adverse Event|1|||
49169730|NCT01169701|158456186|FG001|Overall Study|Adverse Event|2|||
49169731|NCT01169701|158456185|FG000|Overall Study|Exclusion criteria|2|||
49169732|NCT01169701|158456186|FG001|Overall Study|Exclusion criteria|0|||
49169733|NCT01169701|158456185|FG000|Overall Study|Death|0|||
49169734|NCT01169701|158456186|FG001|Overall Study|Death|1|||
49169735|NCT01169701|158456185|FG000|Overall Study|Administrative problems|0|||
49169736|NCT01169701|158456186|FG001|Overall Study|Administrative problems|1|||
48926054|NCT02574637|157561795|FG007|Open-label (OL) Period|Withdrawal by Subject|0|||
48926055|NCT02574637|157561796|FG008|Open-label (OL) Period|Withdrawal by Subject|0|||
48926056|NCT02574637|157561797|FG009|Open-label (OL) Period|Withdrawal by Subject|1|||
48926057|NCT02574637|157561788|FG000|Open-label (OL) Period|Study Terminated By Sponsor|0|||
48926058|NCT02574637|157561789|FG001|Open-label (OL) Period|Study Terminated By Sponsor|0|||
48951835|NCT01993329|157654908|FG000|Wash-out|Personal reasons|0|||
49169737|NCT01169701|158456185|FG000|Overall Study|Serious adverse event|0|||
49169738|NCT01169701|158456186|FG001|Overall Study|Serious adverse event|1|||
49169739|NCT01169701|158456185|FG000|Overall Study|Sponsor decision|0|||
48841952|NCT05082935|157260774|FG000|Overall Study|Withdrawal by Subject|27|||
48841953|NCT05082935|157260775|FG001|Overall Study|Withdrawal by Subject|58|||
49169740|NCT01169701|158456186|FG001|Overall Study|Sponsor decision|1|||
49169741|NCT03146663|158456187|FG000|Overall Study|Did not receive study treatment|1|||
49169742|NCT03146663|158456188|FG001|Overall Study|Did not receive study treatment|1|||
49169743|NCT03583359|158456189|FG000|Overall Study|Withdrawal by Subject|15|||
49169744|NCT03583359|158456190|FG001|Overall Study|Withdrawal by Subject|6|||
49169745|NCT03583359|158456189|FG000|Overall Study|Lost to Follow-up|12|||
49169746|NCT03583359|158456190|FG001|Overall Study|Lost to Follow-up|3|||
49169747|NCT03583359|158456189|FG000|Overall Study|Adverse Event|0|||
49169748|NCT03583359|158456190|FG001|Overall Study|Adverse Event|1|||
49169749|NCT03583359|158456189|FG000|Overall Study|Protocol Violation|0|||
49169750|NCT03583359|158456190|FG001|Overall Study|Protocol Violation|1|||
49169751|NCT03583359|158456189|FG000|Overall Study|Other|2|||
49169752|NCT03583359|158456190|FG001|Overall Study|Other|1|||
49169753|NCT00809926|158456191|FG000|Overall Study|Adverse Event|18|||
49169754|NCT00809926|158456192|FG001|Overall Study|Adverse Event|10|||
48841954|NCT00439569|157260779|FG000|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1|||
49169755|NCT00809926|158456191|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
49169756|NCT00809926|158456192|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
48841955|NCT00439569|157260779|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3|||
48841956|NCT00439569|157260779|FG000|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
48841957|NCT01264679|157260785|FG000|Overall Study|Participation in Another Clinical Trial|1|||
48841958|NCT01264679|157260785|FG000|Overall Study|Physician Decision|1|||
48841959|NCT01264679|157260785|FG000|Overall Study|Sponsor's Suspension of Dosing|2|||
49169757|NCT00809926|158456191|FG000|Overall Study|Patient withdrew consent|8|||
49169758|NCT00809926|158456192|FG001|Overall Study|Patient withdrew consent|6|||
49169759|NCT00809926|158456191|FG000|Overall Study|Lost to Follow-up|2|||
49169760|NCT00809926|158456192|FG001|Overall Study|Lost to Follow-up|1|||
49169761|NCT00809926|158456191|FG000|Overall Study|Administrative Problems|0|||
49169762|NCT00809926|158456192|FG001|Overall Study|Administrative Problems|1|||
49169763|NCT00809926|158456191|FG000|Overall Study|Protocol deviation|0|||
49169764|NCT00809926|158456192|FG001|Overall Study|Protocol deviation|2|||
49169765|NCT00972517|158456204|FG000|Overall Study|Adverse Event|0|||
49169766|NCT00972517|158456205|FG001|Overall Study|Adverse Event|0|||
49169767|NCT00972517|158456206|FG002|Overall Study|Adverse Event|0|||
49169768|NCT00972517|158456207|FG003|Overall Study|Adverse Event|1|||
49169769|NCT00972517|158456208|FG004|Overall Study|Adverse Event|0|||
49169770|NCT00972517|158456209|FG005|Overall Study|Adverse Event|0|||
49169771|NCT00972517|158456204|FG000|Overall Study|Withdrawal by Subject|0|||
49169772|NCT00972517|158456205|FG001|Overall Study|Withdrawal by Subject|1|||
49169773|NCT00972517|158456206|FG002|Overall Study|Withdrawal by Subject|0|||
49169774|NCT00972517|158456207|FG003|Overall Study|Withdrawal by Subject|2|||
49169775|NCT00972517|158456208|FG004|Overall Study|Withdrawal by Subject|1|||
49169776|NCT00972517|158456209|FG005|Overall Study|Withdrawal by Subject|0|||
49169777|NCT01102491|158456212|FG000|Overall Study|Protocol Violation|11|||
49169778|NCT01102491|158456213|FG001|Overall Study|Protocol Violation|12|||
49169779|NCT00984594|158456216|FG000|Overall Study|Lost to Follow-up|1|||
49169780|NCT00984594|158456217|FG001|Overall Study|Lost to Follow-up|0|||
49169781|NCT00984594|158456216|FG000|Overall Study|Withdrawal by Subject|0|||
49169782|NCT00984594|158456217|FG001|Overall Study|Withdrawal by Subject|1|||
49169783|NCT02100423|158456219|FG000|Overall Study|Death|1|||
49169784|NCT02100423|158456219|FG000|Overall Study|Withdrawal by Subject|3|||
49169785|NCT02100423|158456219|FG000|Overall Study|Adverse Event|1|||
49169786|NCT02100423|158456219|FG000|Overall Study|Physician Decision|1|||
49169787|NCT00703846|158456222|FG000|Overall Study|Adverse Event|8|||
49169788|NCT00703846|158456222|FG000|Overall Study|Lost to Follow-up|55|||
49169789|NCT00703846|158456222|FG000|Overall Study|Lack of Efficacy|15|||
49169790|NCT00703846|158456222|FG000|Overall Study|Noncompliance with Study Treatment|2|||
49169791|NCT00703846|158456222|FG000|Overall Study|Withdrawal by Subject|40|||
49169792|NCT00703846|158456222|FG000|Overall Study|Death|1|||
49169793|NCT00703846|158456222|FG000|Overall Study|Other|14|||
49169794|NCT00703846|158456222|FG000|Overall Study|Did Not Receive Study Drug|2|||
49169795|NCT00325130|158456223|FG000|Overall Study|Lost to Follow-up|6|||
49169796|NCT00325130|158456224|FG001|Overall Study|Lost to Follow-up|14|||
49169797|NCT00325130|158456223|FG000|Overall Study|Withdrawal by Subject|12|||
49169798|NCT00325130|158456224|FG001|Overall Study|Withdrawal by Subject|14|||
49169799|NCT00325130|158456223|FG000|Overall Study|Protocol Deviation|0|||
49169800|NCT00325130|158456224|FG001|Overall Study|Protocol Deviation|1|||
49169801|NCT00325130|158456223|FG000|Overall Study|Moved|0|||
49169802|NCT00325130|158456224|FG001|Overall Study|Moved|1|||
49169803|NCT00325130|158456223|FG000|Overall Study|Patient Discontinued for Other|1|||
49169804|NCT00325130|158456224|FG001|Overall Study|Patient Discontinued for Other|0|||
49169805|NCT02015481|158456225|FG000|Overall Study|Death|1|||
49169806|NCT03265145|158456226|FG000|Overall Study|Protocol Violation|2|||
49169807|NCT03265145|158456227|FG001|Overall Study|Protocol Violation|0|||
49169808|NCT03265145|158456226|FG000|Overall Study|Adverse Event|1|||
49169809|NCT03265145|158456227|FG001|Overall Study|Adverse Event|0|||
49169810|NCT03265145|158456226|FG000|Overall Study|Withdrawal by Subject|23|||
49169811|NCT03265145|158456227|FG001|Overall Study|Withdrawal by Subject|19|||
49169812|NCT03265145|158456226|FG000|Overall Study|Death|12|||
49169813|NCT03265145|158456227|FG001|Overall Study|Death|12|||
49169814|NCT03265145|158456226|FG000|Overall Study|Lost to Follow-up|13|||
49169815|NCT03265145|158456227|FG001|Overall Study|Lost to Follow-up|9|||
49169816|NCT03265145|158456226|FG000|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|0|||
49169817|NCT03265145|158456227|FG001|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|1|||
49169818|NCT03265145|158456226|FG000|Overall Study|Switched back to previous medication|1|||
49169819|NCT03265145|158456227|FG001|Overall Study|Switched back to previous medication|0|||
49169820|NCT03265145|158456226|FG000|Overall Study|Did not want to take medication|1|||
48841960|NCT01264679|157260785|FG000|Overall Study|Withdrawal by Subject|1|||
49169821|NCT03265145|158456227|FG001|Overall Study|Did not want to take medication|0|||
49169822|NCT03265145|158456226|FG000|Overall Study|Subject could not afford medication|0|||
49169823|NCT03265145|158456227|FG001|Overall Study|Subject could not afford medication|1|||
49169824|NCT03265145|158456226|FG000|Overall Study|Site closed|2|||
49169825|NCT03265145|158456227|FG001|Overall Study|Site closed|3|||
49169826|NCT03265145|158456226|FG000|Overall Study|Incorrectly randomized|16|||
49169827|NCT03265145|158456227|FG001|Overall Study|Incorrectly randomized|6|||
49169828|NCT03265145|158456226|FG000|Overall Study|Entered into Electronic Data Capture in error|0|||
49169829|NCT03265145|158456227|FG001|Overall Study|Entered into Electronic Data Capture in error|1|||
49169830|NCT03265145|158456226|FG000|Overall Study|Physician Decision|0|||
49169831|NCT03265145|158456227|FG001|Overall Study|Physician Decision|3|||
49169832|NCT03265145|158456226|FG000|Overall Study|Subject transferred to another facility|0|||
49169833|NCT03265145|158456227|FG001|Overall Study|Subject transferred to another facility|1|||
49169834|NCT03122145|158456228|FG000|Overall Study|Concurrent respiratory disease|3|||
49169835|NCT03122145|158456229|FG001|Overall Study|Concurrent respiratory disease|0|||
49169836|NCT02628600|158456234|FG000|Overall Study|Death|2|||
49169837|NCT02628600|158456235|FG001|Overall Study|Death|1|||
49169838|NCT02628600|158456234|FG000|Overall Study|Adverse Event|3|||
49169839|NCT02628600|158456235|FG001|Overall Study|Adverse Event|20|||
49169840|NCT02628600|158456234|FG000|Overall Study|Protocol Violation|0|||
49169841|NCT02628600|158456235|FG001|Overall Study|Protocol Violation|1|||
49169842|NCT02628600|158456234|FG000|Overall Study|Lack of Efficacy|2|||
49169843|NCT02628600|158456235|FG001|Overall Study|Lack of Efficacy|0|||
49169844|NCT02628600|158456234|FG000|Overall Study|Withdrawal by Subject|13|||
49169845|NCT02628600|158456235|FG001|Overall Study|Withdrawal by Subject|8|||
49169846|NCT02628600|158456234|FG000|Overall Study|Lost to Follow-up|1|||
49169847|NCT02628600|158456235|FG001|Overall Study|Lost to Follow-up|0|||
49169848|NCT02628600|158456234|FG000|Overall Study|Physician Decision|2|||
49169849|NCT02628600|158456235|FG001|Overall Study|Physician Decision|2|||
49169850|NCT02628600|158456234|FG000|Overall Study|Other not specified|1|||
49169851|NCT02628600|158456235|FG001|Overall Study|Other not specified|0|||
48926059|NCT02574637|157561790|FG002|Open-label (OL) Period|Study Terminated By Sponsor|0|||
48926060|NCT02574637|157561791|FG003|Open-label (OL) Period|Study Terminated By Sponsor|0|||
48926061|NCT02574637|157561792|FG004|Open-label (OL) Period|Study Terminated By Sponsor|0|||
48926062|NCT02574637|157561793|FG005|Open-label (OL) Period|Study Terminated By Sponsor|1|||
48926063|NCT02574637|157561794|FG006|Open-label (OL) Period|Study Terminated By Sponsor|2|||
49169852|NCT02709577|158456238|FG000|Overall Study|non-accommodating anatomy|0|||
49169853|NCT02709577|158456239|FG001|Overall Study|non-accommodating anatomy|1|||
49169854|NCT02709577|158456240|FG002|Overall Study|non-accommodating anatomy|0|||
49169855|NCT02709577|158456241|FG003|Overall Study|non-accommodating anatomy|0|||
49169856|NCT02709577|158456238|FG000|Overall Study|procedural complication|0|||
49169857|NCT02709577|158456239|FG001|Overall Study|procedural complication|1|||
49169858|NCT02709577|158456240|FG002|Overall Study|procedural complication|0|||
49169859|NCT02709577|158456241|FG003|Overall Study|procedural complication|0|||
49169860|NCT02709577|158456238|FG000|Overall Study|Withdrawal by Subject|2|||
49169861|NCT02709577|158456239|FG001|Overall Study|Withdrawal by Subject|3|||
49169862|NCT02709577|158456240|FG002|Overall Study|Withdrawal by Subject|2|||
48926064|NCT02574637|157561795|FG007|Open-label (OL) Period|Study Terminated By Sponsor|1|||
48926065|NCT02574637|157561796|FG008|Open-label (OL) Period|Study Terminated By Sponsor|1|||
48926066|NCT02574637|157561797|FG009|Open-label (OL) Period|Study Terminated By Sponsor|0|||
48926067|NCT01212185|157561799|FG000|Overall Study|Protocol Violation|2|||
48926068|NCT01212185|157561800|FG001|Overall Study|Protocol Violation|1|||
48926069|NCT02474082|157561803|FG000|Overall Study|Adverse Event|2|||
48926070|NCT02474082|157561804|FG001|Overall Study|Adverse Event|32|||
48926071|NCT02474082|157561803|FG000|Overall Study|Withdrawal of informed consent|1|||
48926072|NCT02474082|157561804|FG001|Overall Study|Withdrawal of informed consent|11|||
48926073|NCT02474082|157561803|FG000|Overall Study|Lost to Follow-up|2|||
48926074|NCT02474082|157561804|FG001|Overall Study|Lost to Follow-up|2|||
48926075|NCT02474082|157561803|FG000|Overall Study|Dose tapering not achieved|0|||
48926076|NCT02474082|157561804|FG001|Overall Study|Dose tapering not achieved|4|||
49169863|NCT02709577|158456241|FG003|Overall Study|Withdrawal by Subject|0|||
49169864|NCT01059864|158456242|FG000|Open-Label Run-In Phase|Adverse Event|7|||
48926077|NCT02474082|157561803|FG000|Overall Study|Participant/guardian decision|1|||
48926078|NCT02474082|157561804|FG001|Overall Study|Participant/guardian decision|2|||
48926079|NCT02474082|157561803|FG000|Overall Study|Non-compliance with study treatment|0|||
48926080|NCT02474082|157561804|FG001|Overall Study|Non-compliance with study treatment|2|||
48926081|NCT02474082|157561803|FG000|Overall Study|Protocol deviation|0|||
48926082|NCT02474082|157561804|FG001|Overall Study|Protocol deviation|1|||
48926083|NCT01463098|157561809|FG000|Part A (11 Days)|Participant Choice|2|||
48926084|NCT01463098|157561810|FG001|Part A (11 Days)|Participant Choice|0|||
48926085|NCT01463098|157561811|FG002|Part A (11 Days)|Participant Choice|0|||
48926086|NCT01463098|157561812|FG003|Part A (11 Days)|Participant Choice|0|||
48926087|NCT01463098|157561813|FG004|Part A (11 Days)|Participant Choice|0|||
48926088|NCT01463098|157561814|FG005|Part A (11 Days)|Participant Choice|0|||
48926089|NCT01463098|157561815|FG006|Part A (11 Days)|Participant Choice|0|||
48926090|NCT01463098|157561816|FG007|Part A (11 Days)|Participant Choice|0|||
48926091|NCT01463098|157561817|FG008|Part A (11 Days)|Participant Choice|1|||
48926092|NCT01463098|157561818|FG009|Part A (11 Days)|Participant Choice|0|||
48926093|NCT01463098|157561819|FG010|Part A (11 Days)|Participant Choice|0|||
49169865|NCT01059864|158456243|FG001|Open-Label Run-In Phase|Adverse Event|0|||
49169866|NCT01059864|158456244|FG002|Open-Label Run-In Phase|Adverse Event|0|||
49169867|NCT01059864|158456242|FG000|Open-Label Run-In Phase|Lack of Efficacy|1|||
49169868|NCT01059864|158456243|FG001|Open-Label Run-In Phase|Lack of Efficacy|0|||
49169869|NCT01059864|158456244|FG002|Open-Label Run-In Phase|Lack of Efficacy|0|||
49169870|NCT01059864|158456242|FG000|Open-Label Run-In Phase|Lost to Follow-up|2|||
49169871|NCT01059864|158456243|FG001|Open-Label Run-In Phase|Lost to Follow-up|0|||
49169872|NCT01059864|158456244|FG002|Open-Label Run-In Phase|Lost to Follow-up|0|||
49169873|NCT01059864|158456242|FG000|Open-Label Run-In Phase|Withdrawal by Subject|1|||
49169874|NCT01059864|158456243|FG001|Open-Label Run-In Phase|Withdrawal by Subject|0|||
49169875|NCT01059864|158456244|FG002|Open-Label Run-In Phase|Withdrawal by Subject|0|||
49169876|NCT01059864|158456242|FG000|Open-Label Run-In Phase|Protocol Violation|2|||
49169877|NCT01059864|158456243|FG001|Open-Label Run-In Phase|Protocol Violation|0|||
49169878|NCT01059864|158456244|FG002|Open-Label Run-In Phase|Protocol Violation|0|||
49169879|NCT01059864|158456242|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
49169880|NCT01059864|158456243|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
49169881|NCT01059864|158456244|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
49169882|NCT00334737|158456251|FG000|Hospital Phase|Death|1|||
49169883|NCT00334737|158456252|FG001|Hospital Phase|Death|2|||
49169884|NCT00334737|158456253|FG002|Hospital Phase|Death|3|||
49169885|NCT00334737|158456251|FG000|Hospital Phase|Withdrawal by Subject|0|||
49169886|NCT00334737|158456252|FG001|Hospital Phase|Withdrawal by Subject|0|||
49169887|NCT00334737|158456253|FG002|Hospital Phase|Withdrawal by Subject|1|||
49169888|NCT00334737|158456251|FG000|Hospital Phase|Did not receive study drug|1|||
49169889|NCT00334737|158456252|FG001|Hospital Phase|Did not receive study drug|0|||
49169890|NCT00334737|158456253|FG002|Hospital Phase|Did not receive study drug|0|||
48926094|NCT01463098|157561820|FG011|Part A (11 Days)|Participant Choice|0|||
49169891|NCT00334737|158456251|FG000|Follow up Phase|Lost to Follow-up|5|||
49169892|NCT00334737|158456252|FG001|Follow up Phase|Lost to Follow-up|3|||
49169893|NCT00334737|158456253|FG002|Follow up Phase|Lost to Follow-up|6|||
49169894|NCT00322049|158458080|FG000|Overall Study|Moved out of area|0|||
49169895|NCT00322049|158458081|FG001|Overall Study|Moved out of area|0|||
49169896|NCT00322049|158458082|FG002|Overall Study|Moved out of area|0|||
49169897|NCT00322049|158458083|FG003|Overall Study|Moved out of area|1|||
49169898|NCT00322049|158458080|FG000|Overall Study|Infected with Dengue during study|0|||
49169899|NCT00322049|158458081|FG001|Overall Study|Infected with Dengue during study|1|||
49169900|NCT00322049|158458082|FG002|Overall Study|Infected with Dengue during study|0|||
49169901|NCT00322049|158458083|FG003|Overall Study|Infected with Dengue during study|0|||
49169902|NCT01496287|158458087|FG000|Overall Study|Lost to Follow-up|1|||
49169903|NCT01496287|158458087|FG000|Overall Study|Incomplete anesthesia|5|||
49169904|NCT01279044|158458088|FG000|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0|||
49169905|NCT01279044|158458089|FG001|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3|||
49169906|NCT01279044|158458090|FG002|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2|||
49169907|NCT01279044|158458088|FG000|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
49169908|NCT01279044|158458089|FG001|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8|||
49169909|NCT01279044|158458090|FG002|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
49169910|NCT01279044|158458088|FG000|PHASE 2 - Randmonized Controlled Trial|Death|0|||
49169911|NCT01279044|158458089|FG001|PHASE 2 - Randmonized Controlled Trial|Death|0|||
49169912|NCT01279044|158458090|FG002|PHASE 2 - Randmonized Controlled Trial|Death|1|||
49169913|NCT04294459|158458091|FG000|Overall Study|Adverse Event|0|||
49169914|NCT04294459|158458092|FG001|Overall Study|Adverse Event|1|||
49169915|NCT05002985|158458093|FG000|Overall Study|Withdrawal by Subject|1|||
49169916|NCT00590122|158458094|FG000|Overall Study|swallowed oral dissolving dose|1|||
49169917|NCT00590122|158458095|FG001|Overall Study|swallowed oral dissolving dose|0|||
49169918|NCT02705105|158458096|FG000|Treatment|Objective Disease Progression|1|||
49169919|NCT02705105|158458097|FG001|Treatment|Objective Disease Progression|50|||
49169920|NCT02705105|158458096|FG000|Treatment|Withdrawal by Subject|3|||
49169921|NCT02705105|158458097|FG001|Treatment|Withdrawal by Subject|5|||
49169922|NCT02705105|158458096|FG000|Treatment|Adverse Event|0|||
49169923|NCT02705105|158458097|FG001|Treatment|Adverse Event|17|||
49169924|NCT02705105|158458096|FG000|Treatment|Clinical Disease Progression|0|||
49169925|NCT02705105|158458097|FG001|Treatment|Clinical Disease Progression|32|||
49169926|NCT02705105|158458096|FG000|Treatment|Physician Decision|0|||
49169927|NCT02705105|158458097|FG001|Treatment|Physician Decision|3|||
49169928|NCT02705105|158458096|FG000|Treatment|Ongoing w/ Treatment at time of data cut|0|||
49169929|NCT02705105|158458097|FG001|Treatment|Ongoing w/ Treatment at time of data cut|2|||
49169930|NCT02705105|158458096|FG000|Follow-Up|Death|3|||
49169931|NCT02705105|158458097|FG001|Follow-Up|Death|68|||
49169932|NCT02705105|158458096|FG000|Follow-Up|Withdrawal by Subject|1|||
49169933|NCT02705105|158458097|FG001|Follow-Up|Withdrawal by Subject|14|||
49169934|NCT02705105|158458096|FG000|Follow-Up|Study Terminated|0|||
49169935|NCT02705105|158458097|FG001|Follow-Up|Study Terminated|26|||
49169936|NCT02705105|158458096|FG000|Follow-Up|Discontinued per Amendment 3|0|||
49169937|NCT02705105|158458097|FG001|Follow-Up|Discontinued per Amendment 3|2|||
49169938|NCT05559905|158458100|FG000|Overall Study|Withdrawal by Subject|1|||
49169939|NCT05559905|158458101|FG001|Overall Study|Withdrawal by Subject|0|||
49169940|NCT05559905|158458102|FG002|Overall Study|Withdrawal by Subject|0|||
49169941|NCT05559905|158458100|FG000|Overall Study|Not Reported|1|||
49169942|NCT05559905|158458101|FG001|Overall Study|Not Reported|0|||
49169943|NCT05559905|158458102|FG002|Overall Study|Not Reported|0|||
49169944|NCT01645735|158458103|FG000|Overall Study|Physician Decision|2|||
49169945|NCT01645735|158458104|FG001|Overall Study|Physician Decision|0|||
48841961|NCT03475316|157260786|FG000|6 Month Intervention|Adverse Event|2|||
48841962|NCT03475316|157260787|FG001|6 Month Intervention|Adverse Event|1|||
49169946|NCT01645735|158458103|FG000|Overall Study|Withdrawal by Subject|1|||
49169947|NCT01645735|158458104|FG001|Overall Study|Withdrawal by Subject|0|||
49169948|NCT01645735|158458103|FG000|Overall Study|Protocol Violation|1|||
49169949|NCT01645735|158458104|FG001|Overall Study|Protocol Violation|0|||
49169950|NCT01645735|158458103|FG000|Overall Study|Adverse Event|0|||
49169951|NCT01645735|158458104|FG001|Overall Study|Adverse Event|1|||
49169952|NCT01891396|158458106|FG000|Overall Study|Withdrawal by Subject|4|||
49169953|NCT01891396|158458107|FG001|Overall Study|Withdrawal by Subject|4|||
49169954|NCT01891396|158458108|FG002|Overall Study|Withdrawal by Subject|3|||
49169955|NCT01891396|158458106|FG000|Overall Study|Lost to Follow-up|0|||
49169956|NCT01891396|158458107|FG001|Overall Study|Lost to Follow-up|1|||
48841963|NCT03475316|157260786|FG000|6 Month Intervention|Withdrawal by Subject|2|||
48841964|NCT03475316|157260787|FG001|6 Month Intervention|Withdrawal by Subject|0|||
48841965|NCT03475316|157260786|FG000|6 Month Intervention|Study stopped due to COVID pandemic|1|||
48841966|NCT03475316|157260787|FG001|6 Month Intervention|Study stopped due to COVID pandemic|3|||
48841967|NCT03475316|157260786|FG000|9 Months|Study stopped due to COVID pandemic|3|||
48841968|NCT03475316|157260787|FG001|9 Months|Study stopped due to COVID pandemic|4|||
48841969|NCT03830866|157260788|FG000|Overall Study|Death|90|||
49169957|NCT01891396|158458108|FG002|Overall Study|Lost to Follow-up|0|||
49169958|NCT02820844|158458109|FG000|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1|||
49169959|NCT02820844|158458110|FG001|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3|||
49169960|NCT02820844|158458111|FG002|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
49169961|NCT02820844|158458112|FG003|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
49169962|NCT02820844|158458113|FG004|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
49169963|NCT02820844|158458114|FG005|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
49169964|NCT02820844|158458109|FG000|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1|||
49169965|NCT02820844|158458110|FG001|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2|||
49169966|NCT02820844|158458111|FG002|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
49169967|NCT02820844|158458112|FG003|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
49169968|NCT02820844|158458113|FG004|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
49169969|NCT02820844|158458114|FG005|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
49169970|NCT02820844|158458109|FG000|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
49169971|NCT02820844|158458110|FG001|Double-blinded (Up to 48 Weeks)|Protocol Violation|3|||
49169972|NCT02820844|158458111|FG002|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
49169973|NCT02820844|158458112|FG003|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
49169974|NCT02820844|158458113|FG004|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
49169975|NCT02820844|158458114|FG005|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
49169976|NCT02820844|158458109|FG000|Double-blinded (Up to 48 Weeks)|Adverse Event|2|||
49169977|NCT02820844|158458110|FG001|Double-blinded (Up to 48 Weeks)|Adverse Event|1|||
49169978|NCT02820844|158458111|FG002|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
49169979|NCT02820844|158458112|FG003|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
49169980|NCT02820844|158458113|FG004|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
49169981|NCT02820844|158458114|FG005|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
49169982|NCT02820844|158458109|FG000|Double-blinded (Up to 48 Weeks)|Investigator discretion|1|||
49169983|NCT02820844|158458110|FG001|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
49169984|NCT02820844|158458111|FG002|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
49169985|NCT02820844|158458112|FG003|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
49169986|NCT02820844|158458113|FG004|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
49169987|NCT02820844|158458114|FG005|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
49169988|NCT02820844|158458109|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
49169989|NCT02820844|158458110|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
49169990|NCT02820844|158458111|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1|||
49169991|NCT02820844|158458112|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2|||
49169992|NCT02820844|158458113|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
49169993|NCT02820844|158458114|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
49169994|NCT02820844|158458109|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
49169995|NCT02820844|158458110|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
49169996|NCT02820844|158458111|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1|||
49169997|NCT02820844|158458112|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
49169998|NCT02820844|158458113|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
49169999|NCT02820844|158458114|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
49170000|NCT02820844|158458109|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
49170001|NCT02820844|158458110|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
49170002|NCT02820844|158458111|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7|||
49170003|NCT02820844|158458112|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2|||
49170004|NCT02820844|158458113|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
49170005|NCT02820844|158458114|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
49170006|NCT02820844|158458109|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
49170007|NCT02820844|158458110|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
49170008|NCT02820844|158458111|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
49170009|NCT02820844|158458112|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
49170010|NCT02820844|158458113|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2|||
49170011|NCT02820844|158458114|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
49170012|NCT02820844|158458109|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
49170013|NCT02820844|158458110|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
49170014|NCT02820844|158458111|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
49170015|NCT02820844|158458112|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
49170016|NCT02820844|158458113|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
49170017|NCT02820844|158458114|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1|||
49170018|NCT01973231|158458115|FG000|Overall Study|Protocol Violation|1|||
49170019|NCT01973231|158458116|FG001|Overall Study|Protocol Violation|1|||
49170020|NCT01973231|158458115|FG000|Overall Study|Lost to Follow-up|1|||
49170021|NCT01973231|158458116|FG001|Overall Study|Lost to Follow-up|1|||
49170022|NCT01973231|158458115|FG000|Overall Study|unclassified|2|||
49170023|NCT01973231|158458116|FG001|Overall Study|unclassified|1|||
49170024|NCT01973231|158458115|FG000|Overall Study|Withdrawal by Subject|7|||
49170025|NCT01973231|158458116|FG001|Overall Study|Withdrawal by Subject|9|||
49170026|NCT02010593|158458121|FG000|Overall Study|Lost to Follow-up|1|||
49170027|NCT02010593|158458122|FG001|Overall Study|Lost to Follow-up|0|||
49170028|NCT02010593|158458121|FG000|Overall Study|Physician Decision|1|||
49170029|NCT02010593|158458122|FG001|Overall Study|Physician Decision|0|||
49170030|NCT02010593|158458121|FG000|Overall Study|Unable to adhere to visit schedule|0|||
49170031|NCT02010593|158458122|FG001|Overall Study|Unable to adhere to visit schedule|2|||
49170032|NCT01135459|158458123|FG000|Overall Study|Adverse Event|8|||
49170033|NCT01135459|158458124|FG001|Overall Study|Adverse Event|10|||
49170034|NCT01135459|158458123|FG000|Overall Study|Lack of Efficacy|3|||
49170035|NCT01135459|158458124|FG001|Overall Study|Lack of Efficacy|1|||
49170036|NCT01135459|158458123|FG000|Overall Study|Withdrawal by Subject|2|||
49170037|NCT01135459|158458124|FG001|Overall Study|Withdrawal by Subject|3|||
49170038|NCT01135459|158458123|FG000|Overall Study|Protocol Violation|5|||
49170039|NCT01135459|158458124|FG001|Overall Study|Protocol Violation|3|||
49170040|NCT01135459|158458123|FG000|Overall Study|Lost to Follow-up|2|||
49170041|NCT01135459|158458124|FG001|Overall Study|Lost to Follow-up|1|||
49170042|NCT01135459|158458123|FG000|Overall Study|Non-compliance to study procedures|0|||
49170043|NCT01135459|158458124|FG001|Overall Study|Non-compliance to study procedures|1|||
49170044|NCT01135459|158458123|FG000|Overall Study|Other than specified|1|||
49170045|NCT01135459|158458124|FG001|Overall Study|Other than specified|1|||
49170046|NCT01977729|158458125|FG000|Overall Study|Study terminated|1|||
49170047|NCT02229825|158458135|FG000|Overall Study|Personal Reasons|0|||
49170048|NCT02229825|158458136|FG001|Overall Study|Personal Reasons|1|||
49170049|NCT02229825|158458135|FG000|Overall Study|Refused continuing medication|7|||
49170050|NCT02229825|158458136|FG001|Overall Study|Refused continuing medication|6|||
49170051|NCT02229825|158458135|FG000|Overall Study|Lost to Follow-up|1|||
49170052|NCT02229825|158458136|FG001|Overall Study|Lost to Follow-up|2|||
49170053|NCT02229825|158458135|FG000|Overall Study|Protocol Violation|1|||
49170054|NCT02229825|158458136|FG001|Overall Study|Protocol Violation|1|||
49170055|NCT02229825|158458135|FG000|Overall Study|Lack of Efficacy|4|||
49170056|NCT02229825|158458136|FG001|Overall Study|Lack of Efficacy|10|||
48926095|NCT01463098|157561821|FG012|Part A (11 Days)|Participant Choice|0|||
48926096|NCT01463098|157561822|FG013|Part A (11 Days)|Participant Choice|0|||
48926097|NCT01463098|157561809|FG000|Part A (11 Days)|Lost to Follow-up|0|||
48926098|NCT01463098|157561810|FG001|Part A (11 Days)|Lost to Follow-up|0|||
48926099|NCT01463098|157561811|FG002|Part A (11 Days)|Lost to Follow-up|0|||
48926100|NCT01463098|157561812|FG003|Part A (11 Days)|Lost to Follow-up|0|||
48926101|NCT01463098|157561813|FG004|Part A (11 Days)|Lost to Follow-up|1|||
48926102|NCT01463098|157561814|FG005|Part A (11 Days)|Lost to Follow-up|0|||
48926103|NCT01463098|157561815|FG006|Part A (11 Days)|Lost to Follow-up|0|||
48926104|NCT01463098|157561816|FG007|Part A (11 Days)|Lost to Follow-up|0|||
48926105|NCT01463098|157561817|FG008|Part A (11 Days)|Lost to Follow-up|0|||
48926106|NCT01463098|157561818|FG009|Part A (11 Days)|Lost to Follow-up|0|||
48926107|NCT01463098|157561819|FG010|Part A (11 Days)|Lost to Follow-up|0|||
48926108|NCT01463098|157561820|FG011|Part A (11 Days)|Lost to Follow-up|0|||
48926109|NCT01463098|157561821|FG012|Part A (11 Days)|Lost to Follow-up|0|||
48926110|NCT01463098|157561822|FG013|Part A (11 Days)|Lost to Follow-up|0|||
49170057|NCT02229825|158458135|FG000|Overall Study|Adverse Event|11|||
49170058|NCT02229825|158458136|FG001|Overall Study|Adverse Event|9|||
49170059|NCT02229825|158458135|FG000|Overall Study|Not treated|0|||
49170060|NCT02229825|158458136|FG001|Overall Study|Not treated|1|||
49170061|NCT03226249|158458140|FG000|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1|||
49170062|NCT03226249|158458140|FG000|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29|||
49170063|NCT03226249|158458140|FG000|Survival Follow-up|Patients still in follow-up.|30|||
49170064|NCT04474197|158458141|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
49170065|NCT04474197|158458142|FG001|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
49170066|NCT04474197|158458143|FG002|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
49170067|NCT04474197|158458144|FG003|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
49170068|NCT01057693|158458145|FG000|Single-Blind Phase (Up to Week 6)|Adverse Event|45|||
49170069|NCT01057693|158458146|FG001|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
49170070|NCT01057693|158458147|FG002|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
48926111|NCT01463098|157561809|FG000|Part B (11 Days)|Participant Choice|0|||
48926112|NCT01463098|157561810|FG001|Part B (11 Days)|Participant Choice|0|||
48926113|NCT01463098|157561811|FG002|Part B (11 Days)|Participant Choice|0|||
48841970|NCT03830866|157260789|FG001|Overall Study|Death|111|||
49170071|NCT01057693|158458145|FG000|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7|||
49170072|NCT01057693|158458146|FG001|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
49170073|NCT01057693|158458147|FG002|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
49170074|NCT01057693|158458145|FG000|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14|||
49170075|NCT01057693|158458146|FG001|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
49170076|NCT01057693|158458147|FG002|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
49170077|NCT01057693|158458145|FG000|Single-Blind Phase (Up to Week 6)|Protocol Violation|9|||
49170078|NCT01057693|158458146|FG001|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
49170079|NCT01057693|158458147|FG002|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
49170080|NCT01057693|158458145|FG000|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22|||
49170081|NCT01057693|158458146|FG001|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
49170082|NCT01057693|158458147|FG002|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
49170083|NCT01057693|158458145|FG000|Single-Blind Phase (Up to Week 6)|Other|2|||
49170084|NCT01057693|158458146|FG001|Single-Blind Phase (Up to Week 6)|Other|0|||
49170085|NCT01057693|158458147|FG002|Single-Blind Phase (Up to Week 6)|Other|0|||
49170086|NCT01057693|158458145|FG000|Between Single-Blind and Double-Blind|Adverse Event|5|||
49170087|NCT01057693|158458146|FG001|Between Single-Blind and Double-Blind|Adverse Event|0|||
49170088|NCT01057693|158458147|FG002|Between Single-Blind and Double-Blind|Adverse Event|0|||
49170089|NCT01057693|158458145|FG000|Between Single-Blind and Double-Blind|Lack of Efficacy|247|||
49015123|NCT02884206|157892061|FG000|LCZ696 Run-in Period|Death|2|||
49015124|NCT02884206|157892062|FG001|LCZ696 Run-in Period|Death|0|||
49015125|NCT02884206|157892063|FG002|LCZ696 Run-in Period|Death|0|||
49015126|NCT02884206|157892061|FG000|LCZ696 Run-in Period|Patient/guardian decision|16|||
49015127|NCT02884206|157892062|FG001|LCZ696 Run-in Period|Patient/guardian decision|0|||
49015128|NCT02884206|157892063|FG002|LCZ696 Run-in Period|Patient/guardian decision|0|||
49015129|NCT02884206|157892061|FG000|LCZ696 Run-in Period|Protocol deviation|6|||
49015130|NCT02884206|157892062|FG001|LCZ696 Run-in Period|Protocol deviation|0|||
49015131|NCT02884206|157892063|FG002|LCZ696 Run-in Period|Protocol deviation|0|||
49015132|NCT02884206|157892061|FG000|LCZ696 Run-in Period|Non-compliance with study treatment|3|||
49015133|NCT02884206|157892062|FG001|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
49170090|NCT01057693|158458146|FG001|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
49170091|NCT01057693|158458147|FG002|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
49170092|NCT01057693|158458145|FG000|Between Single-Blind and Double-Blind|Lost to Follow-up|1|||
49170093|NCT01057693|158458146|FG001|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
49170094|NCT01057693|158458147|FG002|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
49170095|NCT01057693|158458145|FG000|Between Single-Blind and Double-Blind|Protocol Violation|7|||
49170096|NCT01057693|158458146|FG001|Between Single-Blind and Double-Blind|Protocol Violation|0|||
49170097|NCT01057693|158458147|FG002|Between Single-Blind and Double-Blind|Protocol Violation|0|||
49170098|NCT01057693|158458145|FG000|Between Single-Blind and Double-Blind|Withdrawal by Subject|4|||
49170099|NCT01057693|158458146|FG001|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
49170100|NCT01057693|158458147|FG002|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
49170101|NCT01057693|158458145|FG000|Between Single-Blind and Double-Blind|Other|6|||
49170102|NCT01057693|158458146|FG001|Between Single-Blind and Double-Blind|Other|0|||
49170103|NCT01057693|158458147|FG002|Between Single-Blind and Double-Blind|Other|0|||
49170104|NCT01057693|158458145|FG000|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0|||
49170105|NCT01057693|158458146|FG001|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8|||
49170106|NCT01057693|158458147|FG002|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11|||
49170107|NCT01057693|158458145|FG000|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0|||
49170108|NCT01057693|158458146|FG001|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3|||
49170109|NCT01057693|158458147|FG002|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8|||
49170110|NCT01057693|158458145|FG000|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0|||
49170111|NCT01057693|158458146|FG001|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2|||
49170112|NCT01057693|158458147|FG002|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5|||
49170113|NCT01057693|158458145|FG000|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
49170114|NCT01057693|158458146|FG001|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
49170115|NCT01057693|158458147|FG002|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4|||
49170116|NCT01057693|158458145|FG000|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0|||
49170117|NCT01057693|158458146|FG001|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8|||
49170118|NCT01057693|158458147|FG002|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6|||
49170119|NCT01057693|158458145|FG000|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
49170120|NCT01057693|158458146|FG001|Double-Blind Phase (Week 7 to Week 19)|Other|1|||
49170121|NCT01057693|158458147|FG002|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
49170122|NCT01057693|158458145|FG000|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
49170123|NCT01057693|158458146|FG001|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
49170124|NCT01057693|158458147|FG002|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2|||
49170125|NCT02413996|158458148|FG000|Overall Study|not comfortable with the intervention|9|||
49170126|NCT02413996|158458149|FG001|Overall Study|not comfortable with the intervention|2|||
49170127|NCT02526212|158458150|FG000|Overall Study|Incarceration|1|||
49170128|NCT02526212|158458151|FG001|Overall Study|Incarceration|0|||
49170129|NCT02526212|158458150|FG000|Overall Study|Lost to Follow-up|1|||
49170130|NCT02526212|158458151|FG001|Overall Study|Lost to Follow-up|0|||
49170131|NCT02526212|158458150|FG000|Overall Study|Death|0|||
49170132|NCT02526212|158458151|FG001|Overall Study|Death|1|||
49170133|NCT00606411|158458152|FG000|Overall Study|Adverse Event|1|||
49170134|NCT00606411|158458153|FG001|Overall Study|Adverse Event|2|||
49170135|NCT00606411|158458152|FG000|Overall Study|Lack of Adherence|1|||
49170136|NCT00606411|158458153|FG001|Overall Study|Lack of Adherence|1|||
49170137|NCT00606411|158458152|FG000|Overall Study|Lack of Efficacy|1|||
49170138|NCT00606411|158458153|FG001|Overall Study|Lack of Efficacy|1|||
49170139|NCT00606411|158458152|FG000|Overall Study|Withdrawal by Subject|2|||
49170140|NCT00606411|158458153|FG001|Overall Study|Withdrawal by Subject|0|||
49170141|NCT00606411|158458152|FG000|Overall Study|Lost to Follow-up|1|||
49170142|NCT00606411|158458153|FG001|Overall Study|Lost to Follow-up|2|||
49170143|NCT00606411|158458152|FG000|Overall Study|Move out of state|0|||
49170144|NCT00606411|158458153|FG001|Overall Study|Move out of state|1|||
49170145|NCT01390298|158458154|FG000|Overall Study|Death|1|||
49170146|NCT01390298|158458154|FG000|Overall Study|long term ICU admission|1|||
48841971|NCT03830866|157260788|FG000|Overall Study|Lost to Follow-up|7|||
48841972|NCT03830866|157260789|FG001|Overall Study|Lost to Follow-up|7|||
48841973|NCT03830866|157260788|FG000|Overall Study|Withdrawal by Subject|19|||
48841974|NCT03830866|157260789|FG001|Overall Study|Withdrawal by Subject|16|||
48841975|NCT03830866|157260788|FG000|Overall Study|No longer eligible due to additional cancer diagnosis|0|||
48841976|NCT03830866|157260789|FG001|Overall Study|No longer eligible due to additional cancer diagnosis|1|||
49170147|NCT01390298|158458154|FG000|Overall Study|Withdrawal by Subject|14|||
49170148|NCT01390298|158458154|FG000|Overall Study|Lost to Follow-up|7|||
49170149|NCT01390298|158458154|FG000|Overall Study|Surgery cancelled|1|||
49170150|NCT00579553|158458157|FG000|Overall Study|Lost to Follow-up|16|||
49170151|NCT00579553|158458158|FG001|Overall Study|Lost to Follow-up|13|||
49170152|NCT00412958|158458160|FG000|Overall Study|Withdrawal by Subject|3|||
49170153|NCT00412958|158458161|FG001|Overall Study|Withdrawal by Subject|0|||
49170154|NCT00412958|158458162|FG002|Overall Study|Withdrawal by Subject|0|||
49170155|NCT00412958|158458163|FG003|Overall Study|Withdrawal by Subject|1|||
49170156|NCT00412958|158458160|FG000|Overall Study|Adverse Event|0|||
49170157|NCT00412958|158458161|FG001|Overall Study|Adverse Event|1|||
49170158|NCT00412958|158458162|FG002|Overall Study|Adverse Event|0|||
49170159|NCT00412958|158458163|FG003|Overall Study|Adverse Event|0|||
49170160|NCT00412958|158458160|FG000|Overall Study|Lost to Follow-up|0|||
49170161|NCT00412958|158458161|FG001|Overall Study|Lost to Follow-up|1|||
49170162|NCT00412958|158458162|FG002|Overall Study|Lost to Follow-up|0|||
49170163|NCT00412958|158458163|FG003|Overall Study|Lost to Follow-up|0|||
49170164|NCT00412958|158458160|FG000|Overall Study|Death|0|||
49170165|NCT00412958|158458161|FG001|Overall Study|Death|1|||
49170166|NCT00412958|158458162|FG002|Overall Study|Death|0|||
49170167|NCT00412958|158458163|FG003|Overall Study|Death|0|||
49170168|NCT00412958|158458160|FG000|Overall Study|Transport issue|0|||
49170169|NCT00412958|158458161|FG001|Overall Study|Transport issue|1|||
49170170|NCT00412958|158458162|FG002|Overall Study|Transport issue|0|||
49170171|NCT00412958|158458163|FG003|Overall Study|Transport issue|0|||
49170172|NCT01318135|158458164|FG000|Enrolled - Long-Term Extension Study|Adverse Event|1|||
49170173|NCT01318135|158458165|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
49170174|NCT01318135|158458166|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
49170175|NCT01318135|158458167|FG003|Enrolled - Long-Term Extension Study|Adverse Event|0|||
49170176|NCT01318135|158458168|FG004|Enrolled - Long-Term Extension Study|Adverse Event|0|||
49170177|NCT01318135|158458169|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
49170178|NCT01318135|158458170|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
49170179|NCT01318135|158458171|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
49170180|NCT01318135|158458164|FG000|Enrolled - Long-Term Extension Study|Treatment Complications|1|||
49170181|NCT01318135|158458165|FG001|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
49170182|NCT01318135|158458166|FG002|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
49170183|NCT01318135|158458167|FG003|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
49170184|NCT01318135|158458168|FG004|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
49170185|NCT01318135|158458169|FG005|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
49170186|NCT01318135|158458170|FG006|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
49170187|NCT01318135|158458171|FG007|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
49170188|NCT01318135|158458164|FG000|Entered - Long-Term Extension Study|Adverse Event|9|||
49170189|NCT01318135|158458165|FG001|Entered - Long-Term Extension Study|Adverse Event|3|||
49170190|NCT01318135|158458166|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
49170191|NCT01318135|158458167|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
49170192|NCT01318135|158458168|FG004|Entered - Long-Term Extension Study|Adverse Event|4|||
49170193|NCT01318135|158458169|FG005|Entered - Long-Term Extension Study|Adverse Event|2|||
49170194|NCT01318135|158458170|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
49170195|NCT01318135|158458171|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
49170196|NCT01318135|158458164|FG000|Entered - Long-Term Extension Study|Protocol Violation|1|||
49170197|NCT01318135|158458165|FG001|Entered - Long-Term Extension Study|Protocol Violation|1|||
49170198|NCT01318135|158458166|FG002|Entered - Long-Term Extension Study|Protocol Violation|0|||
49170199|NCT01318135|158458167|FG003|Entered - Long-Term Extension Study|Protocol Violation|0|||
49170200|NCT01318135|158458168|FG004|Entered - Long-Term Extension Study|Protocol Violation|1|||
49170201|NCT01318135|158458169|FG005|Entered - Long-Term Extension Study|Protocol Violation|0|||
49170202|NCT01318135|158458170|FG006|Entered - Long-Term Extension Study|Protocol Violation|0|||
49170203|NCT01318135|158458171|FG007|Entered - Long-Term Extension Study|Protocol Violation|0|||
49170204|NCT01318135|158458164|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
49170205|NCT01318135|158458165|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
49170206|NCT01318135|158458166|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
49170207|NCT01318135|158458167|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
48841977|NCT03830866|157260788|FG000|Overall Study|Other|1|||
48841978|NCT03830866|157260789|FG001|Overall Study|Other|1|||
48841979|NCT03811574|157260795|FG000|Overall Study|Withdrawal by Subject|2|||
49170208|NCT01318135|158458168|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
49170209|NCT01318135|158458169|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
49170210|NCT01318135|158458170|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
49170211|NCT01318135|158458171|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
49170212|NCT01318135|158458164|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
49170213|NCT01318135|158458165|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|7|||
49170214|NCT01318135|158458166|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
49170215|NCT01318135|158458167|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
49170216|NCT01318135|158458168|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
49170217|NCT01318135|158458169|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
49170218|NCT01318135|158458170|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
48841980|NCT03811574|157260796|FG001|Overall Study|Withdrawal by Subject|4|||
48841981|NCT03811574|157260797|FG002|Overall Study|Withdrawal by Subject|0|||
49170219|NCT01318135|158458171|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
49170220|NCT01318135|158458164|FG000|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
49170221|NCT01318135|158458165|FG001|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
49170222|NCT01318135|158458166|FG002|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
49170223|NCT01318135|158458167|FG003|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
49170224|NCT01318135|158458168|FG004|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
49170225|NCT01318135|158458169|FG005|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
49170226|NCT01318135|158458170|FG006|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
49170227|NCT01318135|158458171|FG007|Entered - Long-Term Extension Study|Use of Excluded Medications|1|||
49170228|NCT00615719|158458184|FG000|Overall Study|Physician Decision|5|||
49170229|NCT03951766|158458185|FG000|Treatment Phase|Lost to Follow-up|1|||
49170230|NCT03951766|158458185|FG000|Follow-up Phase|Lost to Follow-up|10|||
49170231|NCT03810014|158458188|FG000|Overall Study|Pregnancy|2|||
49170232|NCT03810014|158458189|FG001|Overall Study|Pregnancy|2|||
49170233|NCT03810014|158458190|FG002|Overall Study|Pregnancy|0|||
49170234|NCT03810014|158458191|FG003|Overall Study|Pregnancy|2|||
49170235|NCT01220401|158458193|FG000|Overall Study|Withdrawal by Subject|2|||
49170236|NCT01220401|158458193|FG000|Overall Study|Protocol Violation|1|||
49170237|NCT02243371|158458205|FG000|Overall Study|Progressive Disease (clinic & radio)|35|||
49170238|NCT02243371|158458206|FG001|Overall Study|Progressive Disease (clinic & radio)|24|||
49170239|NCT02243371|158458205|FG000|Overall Study|Death (unrelated)|2|||
49170240|NCT02243371|158458206|FG001|Overall Study|Death (unrelated)|4|||
49170241|NCT02243371|158458205|FG000|Overall Study|Adverse Event (unrelated)|0|||
49170242|NCT02243371|158458206|FG001|Overall Study|Adverse Event (unrelated)|1|||
49170243|NCT02243371|158458205|FG000|Overall Study|Lack of Clinical Benefit|0|||
49170244|NCT02243371|158458206|FG001|Overall Study|Lack of Clinical Benefit|1|||
49170245|NCT02243371|158458205|FG000|Overall Study|Withdrawal by Subject|0|||
49170246|NCT02243371|158458206|FG001|Overall Study|Withdrawal by Subject|2|||
49170247|NCT02528942|158458210|FG000|Overall Study|Did not meet imaging criteria|9|||
49170248|NCT02528942|158458210|FG000|Overall Study|Lost to Follow-up|25|||
49170249|NCT03012828|158458211|FG000|Overall Study|Lost to Follow-up|1|||
49170250|NCT03012828|158458212|FG001|Overall Study|Lost to Follow-up|0|||
49170251|NCT03012828|158458213|FG002|Overall Study|Lost to Follow-up|1|||
49170252|NCT03012828|158458214|FG003|Overall Study|Lost to Follow-up|0|||
49170253|NCT03012828|158458215|FG004|Overall Study|Lost to Follow-up|1|||
49170254|NCT03012828|158458216|FG005|Overall Study|Lost to Follow-up|0|||
49170255|NCT03012828|158458211|FG000|Overall Study|Withdrawal by Subject|0|||
49170256|NCT03012828|158458212|FG001|Overall Study|Withdrawal by Subject|0|||
49170257|NCT03012828|158458213|FG002|Overall Study|Withdrawal by Subject|1|||
49170258|NCT03012828|158458214|FG003|Overall Study|Withdrawal by Subject|0|||
49170259|NCT03012828|158458215|FG004|Overall Study|Withdrawal by Subject|0|||
49170260|NCT03012828|158458216|FG005|Overall Study|Withdrawal by Subject|1|||
49170261|NCT03012828|158458211|FG000|Overall Study|Non-compliance with protocol|0|||
49170262|NCT03012828|158458212|FG001|Overall Study|Non-compliance with protocol|0|||
49170263|NCT03012828|158458213|FG002|Overall Study|Non-compliance with protocol|0|||
49170264|NCT03012828|158458214|FG003|Overall Study|Non-compliance with protocol|0|||
49170265|NCT03012828|158458215|FG004|Overall Study|Non-compliance with protocol|1|||
49170266|NCT03012828|158458216|FG005|Overall Study|Non-compliance with protocol|0|||
49170267|NCT03012828|158458211|FG000|Overall Study|Delay to last visit would delay DBL|0|||
49170268|NCT03012828|158458212|FG001|Overall Study|Delay to last visit would delay DBL|0|||
49170269|NCT03012828|158458213|FG002|Overall Study|Delay to last visit would delay DBL|0|||
49170270|NCT03012828|158458214|FG003|Overall Study|Delay to last visit would delay DBL|0|||
49170271|NCT03012828|158458215|FG004|Overall Study|Delay to last visit would delay DBL|0|||
49170272|NCT03012828|158458216|FG005|Overall Study|Delay to last visit would delay DBL|1|||
49170273|NCT00881530|158458217|FG000|Overall Study|Adverse Event|5|||
49170274|NCT00881530|158458218|FG001|Overall Study|Adverse Event|1|||
49170275|NCT00881530|158458219|FG002|Overall Study|Adverse Event|1|||
49170276|NCT00881530|158458220|FG003|Overall Study|Adverse Event|4|||
49170277|NCT00881530|158458221|FG004|Overall Study|Adverse Event|10|||
49170278|NCT00881530|158458222|FG005|Overall Study|Adverse Event|2|||
49170279|NCT00881530|158458217|FG000|Overall Study|Lack of Efficacy|1|||
49170280|NCT00881530|158458218|FG001|Overall Study|Lack of Efficacy|0|||
49170281|NCT00881530|158458219|FG002|Overall Study|Lack of Efficacy|0|||
49170282|NCT00881530|158458220|FG003|Overall Study|Lack of Efficacy|0|||
49170283|NCT00881530|158458221|FG004|Overall Study|Lack of Efficacy|1|||
49170284|NCT00881530|158458222|FG005|Overall Study|Lack of Efficacy|1|||
49170285|NCT00881530|158458217|FG000|Overall Study|Not compliant with the protocol|0|||
49170286|NCT00881530|158458218|FG001|Overall Study|Not compliant with the protocol|0|||
49170287|NCT00881530|158458219|FG002|Overall Study|Not compliant with the protocol|0|||
49170288|NCT00881530|158458220|FG003|Overall Study|Not compliant with the protocol|0|||
49170289|NCT00881530|158458221|FG004|Overall Study|Not compliant with the protocol|2|||
49170290|NCT00881530|158458222|FG005|Overall Study|Not compliant with the protocol|0|||
49170291|NCT00881530|158458217|FG000|Overall Study|Lost to Follow-up|0|||
49170292|NCT00881530|158458218|FG001|Overall Study|Lost to Follow-up|1|||
49170293|NCT00881530|158458219|FG002|Overall Study|Lost to Follow-up|1|||
49170294|NCT00881530|158458220|FG003|Overall Study|Lost to Follow-up|3|||
49170295|NCT00881530|158458221|FG004|Overall Study|Lost to Follow-up|1|||
49170296|NCT00881530|158458222|FG005|Overall Study|Lost to Follow-up|0|||
49170297|NCT00881530|158458217|FG000|Overall Study|Refused to continue medication|7|||
49170298|NCT00881530|158458218|FG001|Overall Study|Refused to continue medication|2|||
49170299|NCT00881530|158458219|FG002|Overall Study|Refused to continue medication|1|||
49170300|NCT00881530|158458220|FG003|Overall Study|Refused to continue medication|2|||
49170301|NCT00881530|158458221|FG004|Overall Study|Refused to continue medication|0|||
49170302|NCT00881530|158458222|FG005|Overall Study|Refused to continue medication|0|||
49170303|NCT00881530|158458217|FG000|Overall Study|Other reason not defined above|1|||
49170304|NCT00881530|158458218|FG001|Overall Study|Other reason not defined above|1|||
49170305|NCT00881530|158458219|FG002|Overall Study|Other reason not defined above|2|||
49170306|NCT00881530|158458220|FG003|Overall Study|Other reason not defined above|0|||
49170307|NCT00881530|158458221|FG004|Overall Study|Other reason not defined above|0|||
49170308|NCT00881530|158458222|FG005|Overall Study|Other reason not defined above|2|||
49170309|NCT03900728|158458223|FG000|Overall Study|No text responses|0|||
49170310|NCT03900728|158458224|FG001|Overall Study|No text responses|0|||
49170311|NCT03900728|158458225|FG002|Overall Study|No text responses|4|||
49170312|NCT05141175|158458236|FG000|Overall Study|Withdrawal by Subject|1|||
49170313|NCT02036580|158458239|FG000|Overall Study|Withdrawal by Subject|0|||
49170314|NCT02036580|158458240|FG001|Overall Study|Withdrawal by Subject|1|||
49170315|NCT02036580|158458241|FG002|Overall Study|Withdrawal by Subject|0|||
49170316|NCT02036580|158458239|FG000|Overall Study|Adverse Event|1|||
49170317|NCT02036580|158458240|FG001|Overall Study|Adverse Event|0|||
49170318|NCT02036580|158458241|FG002|Overall Study|Adverse Event|0|||
49170319|NCT00992056|158458242|FG000|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1|||
49170320|NCT00992056|158458243|FG001|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2|||
49170321|NCT00992056|158458242|FG000|Washout Period (2 Weeks)|Physician Decision|1|||
49170322|NCT00992056|158458243|FG001|Washout Period (2 Weeks)|Physician Decision|0|||
49170323|NCT01162473|158458244|FG000|Overall Study|Adverse Event|2|||
49170324|NCT01162473|158458245|FG001|Overall Study|Adverse Event|1|||
49170325|NCT01162473|158458244|FG000|Overall Study|Withdrawal by Subject|0|||
49170326|NCT01162473|158458245|FG001|Overall Study|Withdrawal by Subject|4|||
49170327|NCT01144416|158458246|FG000|Intervention Period|Adverse Event|5|||
49170328|NCT01144416|158458247|FG001|Intervention Period|Adverse Event|6|||
49170329|NCT01144416|158458246|FG000|Intervention Period|Insufficient ovarian response|11|||
49170330|NCT01144416|158458247|FG001|Intervention Period|Insufficient ovarian response|17|||
49170331|NCT01144416|158458246|FG000|Intervention Period|Risk of OHSS|0|||
49170332|NCT01144416|158458247|FG001|Intervention Period|Risk of OHSS|1|||
49170333|NCT01144416|158458246|FG000|Intervention Period|Too high ovarian response|4|||
49170334|NCT01144416|158458247|FG001|Intervention Period|Too high ovarian response|2|||
49170335|NCT01144416|158458246|FG000|Intervention Period|No/too few/bad oocytes|7|||
49170336|NCT01144416|158458247|FG001|Intervention Period|No/too few/bad oocytes|5|||
49170337|NCT01144416|158458246|FG000|Intervention Period|No or abnormal fertilization|25|||
49170338|NCT01144416|158458247|FG001|Intervention Period|No or abnormal fertilization|10|||
49170339|NCT01144416|158458246|FG000|Intervention Period|No/too few/bad quality embryos|3|||
49170340|NCT01144416|158458247|FG001|Intervention Period|No/too few/bad quality embryos|3|||
49170341|NCT01144416|158458246|FG000|Intervention Period|Other|7|||
49170342|NCT01144416|158458247|FG001|Intervention Period|Other|5|||
49170343|NCT01001767|158458248|FG000|Overall Study|no baseline study performed|1|||
49170344|NCT01001767|158458249|FG001|Overall Study|no baseline study performed|0|||
49170345|NCT01001767|158458248|FG000|Overall Study|Protocol Violation|1|||
49170346|NCT01001767|158458249|FG001|Overall Study|Protocol Violation|0|||
49170347|NCT01001767|158458248|FG000|Overall Study|Lost to Follow-up|1|||
49170348|NCT01001767|158458249|FG001|Overall Study|Lost to Follow-up|0|||
49170349|NCT01001767|158458248|FG000|Overall Study|Physician Decision|1|||
49170350|NCT01001767|158458249|FG001|Overall Study|Physician Decision|0|||
49170351|NCT01107392|158458250|FG000|Overall Study|Adverse Event|2|||
49170352|NCT01107392|158458251|FG001|Overall Study|Adverse Event|0|||
49170353|NCT01107392|158458250|FG000|Overall Study|Personal Reasons|2|||
49170354|NCT01107392|158458251|FG001|Overall Study|Personal Reasons|3|||
49170355|NCT01107392|158458250|FG000|Overall Study|Administrative decision|1|||
49170356|NCT01107392|158458251|FG001|Overall Study|Administrative decision|0|||
49170357|NCT02720523|158458252|FG000|Period 1: Placebo-controlled Period|Adverse Event|0|||
49170358|NCT02720523|158458253|FG001|Period 1: Placebo-controlled Period|Adverse Event|0|||
49170359|NCT02720523|158458254|FG002|Period 1: Placebo-controlled Period|Adverse Event|1|||
49170360|NCT02720523|158458255|FG003|Period 1: Placebo-controlled Period|Adverse Event|5|||
49170361|NCT02720523|158458256|FG004|Period 1: Placebo-controlled Period|Adverse Event|0|||
49170362|NCT02720523|158458257|FG005|Period 1: Placebo-controlled Period|Adverse Event|0|||
49170363|NCT02720523|158458258|FG006|Period 1: Placebo-controlled Period|Adverse Event|0|||
49170364|NCT02720523|158458252|FG000|Period 1: Placebo-controlled Period|Withdrawal by Subject|1|||
49170365|NCT02720523|158458253|FG001|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
49170366|NCT02720523|158458254|FG002|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
49170367|NCT02720523|158458255|FG003|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
49170368|NCT02720523|158458256|FG004|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
49170369|NCT02720523|158458257|FG005|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
49170370|NCT02720523|158458258|FG006|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
49170371|NCT02720523|158458252|FG000|Period 1: Placebo-controlled Period|Lack of Efficacy|1|||
49170372|NCT02720523|158458253|FG001|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
49170373|NCT02720523|158458254|FG002|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
49170374|NCT02720523|158458255|FG003|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
49170375|NCT02720523|158458256|FG004|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
49170376|NCT02720523|158458257|FG005|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
49170377|NCT02720523|158458258|FG006|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
49170378|NCT02720523|158458252|FG000|Period 1: Placebo-controlled Period|Other|0|||
49170379|NCT02720523|158458253|FG001|Period 1: Placebo-controlled Period|Other|0|||
49170380|NCT02720523|158458254|FG002|Period 1: Placebo-controlled Period|Other|1|||
49170381|NCT02720523|158458255|FG003|Period 1: Placebo-controlled Period|Other|1|||
49170382|NCT02720523|158458256|FG004|Period 1: Placebo-controlled Period|Other|0|||
49170383|NCT02720523|158458257|FG005|Period 1: Placebo-controlled Period|Other|0|||
49170384|NCT02720523|158458258|FG006|Period 1: Placebo-controlled Period|Other|0|||
49170385|NCT02720523|158458252|FG000|Period 2: Long-term Extension Period|Ongoing|0|||
49170386|NCT02720523|158458253|FG001|Period 2: Long-term Extension Period|Ongoing|0|||
49170387|NCT02720523|158458254|FG002|Period 2: Long-term Extension Period|Ongoing|0|||
49170388|NCT02720523|158458255|FG003|Period 2: Long-term Extension Period|Ongoing|0|||
49170389|NCT02720523|158458256|FG004|Period 2: Long-term Extension Period|Ongoing|57|||
49170390|NCT02720523|158458257|FG005|Period 2: Long-term Extension Period|Ongoing|54|||
49170391|NCT02720523|158458258|FG006|Period 2: Long-term Extension Period|Ongoing|45|||
48926114|NCT01463098|157561812|FG003|Part B (11 Days)|Participant Choice|0|||
48926115|NCT01463098|157561813|FG004|Part B (11 Days)|Participant Choice|0|||
49170392|NCT02720523|158458252|FG000|Period 2: Long-term Extension Period|Adverse Event|0|||
49170393|NCT02720523|158458253|FG001|Period 2: Long-term Extension Period|Adverse Event|0|||
49170394|NCT02720523|158458254|FG002|Period 2: Long-term Extension Period|Adverse Event|0|||
49170395|NCT02720523|158458255|FG003|Period 2: Long-term Extension Period|Adverse Event|0|||
49170396|NCT02720523|158458256|FG004|Period 2: Long-term Extension Period|Adverse Event|4|||
49170397|NCT02720523|158458257|FG005|Period 2: Long-term Extension Period|Adverse Event|7|||
49170398|NCT02720523|158458258|FG006|Period 2: Long-term Extension Period|Adverse Event|11|||
49170399|NCT02720523|158458252|FG000|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
49170400|NCT02720523|158458253|FG001|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
49170401|NCT02720523|158458254|FG002|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
49170402|NCT02720523|158458255|FG003|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
49170403|NCT02720523|158458256|FG004|Period 2: Long-term Extension Period|Withdrawal by Subject|2|||
49170404|NCT02720523|158458257|FG005|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
49170405|NCT02720523|158458258|FG006|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
49170406|NCT02720523|158458252|FG000|Period 2: Long-term Extension Period|Other|0|||
49170407|NCT02720523|158458253|FG001|Period 2: Long-term Extension Period|Other|0|||
49170408|NCT02720523|158458254|FG002|Period 2: Long-term Extension Period|Other|0|||
49170409|NCT02720523|158458255|FG003|Period 2: Long-term Extension Period|Other|0|||
49170410|NCT02720523|158458256|FG004|Period 2: Long-term Extension Period|Other|2|||
49170411|NCT02720523|158458257|FG005|Period 2: Long-term Extension Period|Other|0|||
49170412|NCT02720523|158458258|FG006|Period 2: Long-term Extension Period|Other|3|||
49170413|NCT00792740|158458261|FG000|Overall Study|Disease Worsening|3|||
49170414|NCT00792740|158458262|FG001|Overall Study|Disease Worsening|2|||
49170415|NCT00792740|158458261|FG000|Overall Study|Personal Reason|1|||
48841982|NCT03380390|157260798|FG000|Overall Study|Adverse Event|3|||
48841983|NCT01832480|157260799|FG000|Overall Study|Lost to Follow-up|33|||
48841984|NCT01832480|157260800|FG001|Overall Study|Lost to Follow-up|30|||
48841985|NCT01832480|157260799|FG000|Overall Study|Withdrawal by Subject|0|||
48841986|NCT01832480|157260800|FG001|Overall Study|Withdrawal by Subject|2|||
48841987|NCT01832480|157260799|FG000|Overall Study|post randomization ineligible|8|||
48841988|NCT01832480|157260800|FG001|Overall Study|post randomization ineligible|10|||
48841989|NCT02886286|157260802|FG000|Overall Study|pump motor stall|0|||
48841990|NCT02886286|157260803|FG001|Overall Study|pump motor stall|1|||
48841991|NCT00390299|157260805|FG000|Overall Study|Cancellation|1|||
48841992|NCT00390299|157260806|FG001|Overall Study|Cancellation|0|||
48841993|NCT00390299|157260807|FG002|Overall Study|Cancellation|0|||
48841994|NCT00390299|157260808|FG003|Overall Study|Cancellation|0|||
48841995|NCT00390299|157260809|FG004|Overall Study|Cancellation|0|||
48841996|NCT01198028|157260812|FG000|Overall Study|Adverse Event|5|||
48841997|NCT01198028|157260812|FG000|Overall Study|Death|3|||
48841998|NCT01198028|157260812|FG000|Overall Study|Physician Decision|2|||
48841999|NCT01875250|157262324|FG000|Overall Study|Adverse Event|2|||
49170416|NCT00792740|158458262|FG001|Overall Study|Personal Reason|0|||
48842000|NCT01875250|157262325|FG001|Overall Study|Adverse Event|0|||
48842001|NCT02466516|157262326|FG000|Overall Study|Adverse Event|1|||
48842002|NCT02466516|157262327|FG001|Overall Study|Adverse Event|1|||
48842003|NCT02466516|157262328|FG002|Overall Study|Adverse Event|0|||
48842004|NCT02466516|157262329|FG003|Overall Study|Adverse Event|0|||
48926116|NCT01463098|157561814|FG005|Part B (11 Days)|Participant Choice|0|||
49170417|NCT00792740|158458261|FG000|Overall Study|Adverse Event|1|||
49170418|NCT00792740|158458262|FG001|Overall Study|Adverse Event|3|||
48842005|NCT02466516|157262330|FG004|Overall Study|Adverse Event|0|||
48842006|NCT02466516|157262326|FG000|Overall Study|Withdrew Consent|1|||
48926117|NCT01463098|157561815|FG006|Part B (11 Days)|Participant Choice|0|||
49170419|NCT00792740|158458261|FG000|Overall Study|Patient's withdrawal of consent|0|||
48842007|NCT02466516|157262327|FG001|Overall Study|Withdrew Consent|0|||
48842008|NCT02466516|157262328|FG002|Overall Study|Withdrew Consent|0|||
48842009|NCT02466516|157262329|FG003|Overall Study|Withdrew Consent|0|||
48842010|NCT02466516|157262330|FG004|Overall Study|Withdrew Consent|0|||
48842011|NCT02466516|157262326|FG000|Overall Study|Lost to Follow-up|2|||
48842012|NCT02466516|157262327|FG001|Overall Study|Lost to Follow-up|0|||
48951836|NCT01993329|157654909|FG001|Wash-out|Personal reasons|1|||
49170420|NCT00792740|158458262|FG001|Overall Study|Patient's withdrawal of consent|1|||
49170421|NCT00792740|158458261|FG000|Overall Study|Termination of the trial by the Sponsor|2|||
49170422|NCT00792740|158458262|FG001|Overall Study|Termination of the trial by the Sponsor|0|||
49170423|NCT00792740|158458261|FG000|Overall Study|Other reasons|0|||
49170424|NCT00792740|158458262|FG001|Overall Study|Other reasons|1|||
49170425|NCT03559517|158458264|FG000|Overall Study|Withdrawal by Subject|1|||
49170426|NCT03559517|158458265|FG001|Overall Study|Withdrawal by Subject|0|||
49170427|NCT03559517|158458266|FG002|Overall Study|Withdrawal by Subject|0|||
49170428|NCT02079909|158460501|FG000|Overall Study|Adverse Event|23|||
49170429|NCT02079909|158460502|FG001|Overall Study|Adverse Event|23|||
49170430|NCT02079909|158460503|FG002|Overall Study|Adverse Event|7|||
49170431|NCT02079909|158460501|FG000|Overall Study|Withdrawal by Subject|9|||
49170432|NCT02079909|158460502|FG001|Overall Study|Withdrawal by Subject|17|||
49170433|NCT02079909|158460503|FG002|Overall Study|Withdrawal by Subject|4|||
49170434|NCT02079909|158460501|FG000|Overall Study|Lost to Follow-up|2|||
49170435|NCT02079909|158460502|FG001|Overall Study|Lost to Follow-up|3|||
49170436|NCT02079909|158460503|FG002|Overall Study|Lost to Follow-up|1|||
49170437|NCT02079909|158460501|FG000|Overall Study|Death|2|||
49170438|NCT02079909|158460502|FG001|Overall Study|Death|2|||
49170439|NCT02079909|158460503|FG002|Overall Study|Death|0|||
49170440|NCT02079909|158460501|FG000|Overall Study|Lack of Efficacy|0|||
49170441|NCT02079909|158460502|FG001|Overall Study|Lack of Efficacy|0|||
49170442|NCT02079909|158460503|FG002|Overall Study|Lack of Efficacy|1|||
49170443|NCT02079909|158460501|FG000|Overall Study|Protocol Violation|0|||
49170444|NCT02079909|158460502|FG001|Overall Study|Protocol Violation|1|||
49170445|NCT02079909|158460503|FG002|Overall Study|Protocol Violation|1|||
49170446|NCT02079909|158460501|FG000|Overall Study|Physician Decision|0|||
49170447|NCT02079909|158460502|FG001|Overall Study|Physician Decision|1|||
49170448|NCT02079909|158460503|FG002|Overall Study|Physician Decision|1|||
49170449|NCT02079909|158460501|FG000|Overall Study|Relocation etc.|2|||
49170450|NCT02079909|158460502|FG001|Overall Study|Relocation etc.|2|||
49170451|NCT02079909|158460503|FG002|Overall Study|Relocation etc.|3|||
49170452|NCT03846427|158460506|FG000|Overall Study|Death|13|||
49170453|NCT03846427|158460506|FG000|Overall Study|Withdrawal by Subject|3|||
49170454|NCT03846427|158460506|FG000|Overall Study|Physician Decision|1|||
48842013|NCT02466516|157262328|FG002|Overall Study|Lost to Follow-up|1|||
48842014|NCT02466516|157262329|FG003|Overall Study|Lost to Follow-up|0|||
48842015|NCT02466516|157262330|FG004|Overall Study|Lost to Follow-up|0|||
48842016|NCT00446550|157262333|FG000|Overall Study|Adverse Event|1|||
48842017|NCT00446550|157262334|FG001|Overall Study|Adverse Event|0|||
48842018|NCT01759264|157262335|FG000|Overall Study|Serious Adverse Events (SAEs)|1|||
48842019|NCT01759264|157262335|FG000|Overall Study|Adverse Event|1|||
48842020|NCT01759264|157262335|FG000|Overall Study|Other|2|||
48842021|NCT01759264|157262335|FG000|Overall Study|Lost to Follow-up|2|||
48842022|NCT01759264|157262335|FG000|Overall Study|Withdrawal by Subject|3|||
48842023|NCT01759264|157262335|FG000|Overall Study|Discontinued Humira Due to Business Trip|1|||
48842024|NCT00516321|157262336|FG000|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11|||
48842025|NCT00516321|157262337|FG001|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
48842026|NCT00516321|157262338|FG002|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
48842027|NCT00516321|157262336|FG000|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9|||
48842028|NCT00516321|157262337|FG001|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
48842029|NCT00516321|157262338|FG002|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
48842030|NCT00516321|157262336|FG000|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1|||
48842031|NCT00516321|157262337|FG001|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
48842032|NCT00516321|157262338|FG002|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
48842033|NCT00516321|157262336|FG000|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2|||
48842034|NCT00516321|157262337|FG001|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
48842035|NCT00516321|157262338|FG002|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
48842036|NCT00516321|157262336|FG000|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7|||
48842037|NCT00516321|157262337|FG001|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
48842038|NCT00516321|157262338|FG002|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
48842039|NCT00516321|157262336|FG000|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3|||
48842040|NCT00516321|157262337|FG001|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
48842041|NCT00516321|157262338|FG002|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
48842042|NCT00516321|157262336|FG000|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0|||
48842043|NCT00516321|157262337|FG001|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12|||
48842044|NCT00516321|157262338|FG002|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22|||
48842045|NCT00516321|157262336|FG000|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0|||
48842046|NCT00516321|157262337|FG001|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13|||
48842047|NCT00516321|157262338|FG002|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18|||
48842048|NCT00516321|157262336|FG000|Double-blind (DB) Antiviral Treatment|Adverse Event|0|||
48842049|NCT00516321|157262337|FG001|Double-blind (DB) Antiviral Treatment|Adverse Event|8|||
48735638|NCT00961649|156883697|FG000|Overall Study|Patient left to Mexico-family emergency|1|||
48842050|NCT00516321|157262338|FG002|Double-blind (DB) Antiviral Treatment|Adverse Event|13|||
48842051|NCT00516321|157262336|FG000|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
49015134|NCT02884206|157892063|FG002|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
49015135|NCT02884206|157892061|FG000|LCZ696 Run-in Period|Physician Decision|1|||
49015136|NCT02884206|157892062|FG001|LCZ696 Run-in Period|Physician Decision|0|||
49015137|NCT02884206|157892063|FG002|LCZ696 Run-in Period|Physician Decision|0|||
49015138|NCT02884206|157892061|FG000|LCZ696 Run-in Period|Lost to Follow-up|1|||
49015139|NCT02884206|157892062|FG001|LCZ696 Run-in Period|Lost to Follow-up|0|||
49015140|NCT02884206|157892063|FG002|LCZ696 Run-in Period|Lost to Follow-up|0|||
49015141|NCT02884206|157892061|FG000|Double-Blind Period|Death|0|||
49015142|NCT02884206|157892062|FG001|Double-Blind Period|Death|28|||
49015143|NCT02884206|157892063|FG002|Double-Blind Period|Death|39|||
49015144|NCT02884206|157892061|FG000|Double-Blind Period|Patient/guardian decision|0|||
49015145|NCT02884206|157892062|FG001|Double-Blind Period|Patient/guardian decision|10|||
49015146|NCT02884206|157892063|FG002|Double-Blind Period|Patient/guardian decision|13|||
49015147|NCT02884206|157892061|FG000|Double-Blind Period|Lost to Follow-up|0|||
49015148|NCT02884206|157892062|FG001|Double-Blind Period|Lost to Follow-up|4|||
49015149|NCT02884206|157892063|FG002|Double-Blind Period|Lost to Follow-up|4|||
49015150|NCT02884206|157892061|FG000|Double-Blind Period|Physician Decision|0|||
49015151|NCT02884206|157892062|FG001|Double-Blind Period|Physician Decision|2|||
49015152|NCT02884206|157892063|FG002|Double-Blind Period|Physician Decision|0|||
49015153|NCT02884206|157892061|FG000|Double-Blind Period|Adverse Event|0|||
49015154|NCT02884206|157892062|FG001|Double-Blind Period|Adverse Event|0|||
49015155|NCT02884206|157892063|FG002|Double-Blind Period|Adverse Event|3|||
49015156|NCT02884206|157892061|FG000|Double-Blind Period|Non-compliance with study treatment|0|||
49170455|NCT01897727|158460507|FG000|Overall Study|Exclusion: central sleep apnea|0|||
49170456|NCT01897727|158460508|FG001|Overall Study|Exclusion: central sleep apnea|1|||
49170457|NCT01558115|158460511|FG000|Overall Study|Withdrawal by Subject|3|||
49170458|NCT01558115|158460511|FG000|Overall Study|Study closed due to poor enrollment|4|||
49170459|NCT02140970|158460512|FG000|Overall Study|Lost to Follow-up|1|||
49170460|NCT02140970|158460513|FG001|Overall Study|Lost to Follow-up|2|||
49170461|NCT02140970|158460512|FG000|Overall Study|Misplaced consent, subject withdrawn|1|||
49170462|NCT02140970|158460513|FG001|Overall Study|Misplaced consent, subject withdrawn|0|||
49170463|NCT02140970|158460512|FG000|Overall Study|Did not meet inclusion criteria|0|||
49170464|NCT02140970|158460513|FG001|Overall Study|Did not meet inclusion criteria|1|||
49170465|NCT00460655|158460514|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
49170466|NCT00460655|158460515|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
49170467|NCT00460655|158460516|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
49170468|NCT00460655|158460517|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
49170469|NCT00460655|158460514|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3|||
49170470|NCT00460655|158460515|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
49170471|NCT00460655|158460516|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
49170472|NCT00460655|158460517|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
49170473|NCT00460655|158460514|FG000|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
49170474|NCT00460655|158460515|FG001|Double-Blind Phase (12 Weeks)|Protocol Violation|1|||
49170475|NCT00460655|158460516|FG002|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
49170476|NCT00460655|158460517|FG003|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
49170477|NCT00460655|158460514|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
49170478|NCT00460655|158460515|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
49170479|NCT00460655|158460516|FG002|Open-Label Phase (36 Weeks)|Adverse Event|1|||
49170480|NCT00460655|158460517|FG003|Open-Label Phase (36 Weeks)|Adverse Event|6|||
49170481|NCT00460655|158460514|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
49170482|NCT00460655|158460515|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
49170483|NCT00460655|158460516|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6|||
49170484|NCT00460655|158460517|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2|||
49170485|NCT00460655|158460514|FG000|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
49170486|NCT00460655|158460515|FG001|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
49170487|NCT00460655|158460516|FG002|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
49170488|NCT00460655|158460517|FG003|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1|||
49170489|NCT00466947|158460519|FG000|Primary Outcome Analysis Period|Other: study still ongoing|11875|||
49170490|NCT00466947|158460520|FG001|Primary Outcome Analysis Period|Other: study still ongoing|11863|||
49170491|NCT00466947|158460519|FG000|Study End Analysis Period|Adverse Event|35|||
49170492|NCT00466947|158460520|FG001|Study End Analysis Period|Adverse Event|43|||
49170493|NCT00466947|158460519|FG000|Study End Analysis Period|Lost to Follow-up|1137|||
49170494|NCT00466947|158460520|FG001|Study End Analysis Period|Lost to Follow-up|1167|||
49170495|NCT00466947|158460519|FG000|Study End Analysis Period|Physician Decision|29|||
49170496|NCT00466947|158460520|FG001|Study End Analysis Period|Physician Decision|29|||
49170497|NCT00466947|158460519|FG000|Study End Analysis Period|Protocol Violation|9|||
49170498|NCT00466947|158460520|FG001|Study End Analysis Period|Protocol Violation|17|||
49170499|NCT00466947|158460519|FG000|Study End Analysis Period|Withdrawal by Subject|1264|||
49170500|NCT00466947|158460520|FG001|Study End Analysis Period|Withdrawal by Subject|1267|||
49170501|NCT00466947|158460519|FG000|Study End Analysis Period|Other - Forbidden vaccination|21|||
49170502|NCT00466947|158460520|FG001|Study End Analysis Period|Other - Forbidden vaccination|10|||
49170503|NCT00466947|158460519|FG000|Study End Analysis Period|Other - Subject without a legal guardian|1|||
49170504|NCT00466947|158460520|FG001|Study End Analysis Period|Other - Subject without a legal guardian|0|||
49170505|NCT00466947|158460519|FG000|Study End Analysis Period|Other - Unconformity in team's treatment|0|||
49170506|NCT00466947|158460520|FG001|Study End Analysis Period|Other - Unconformity in team's treatment|1|||
49170507|NCT03726658|158460523|FG000|Overall Study|Lost to Follow-up|0|||
49170508|NCT03726658|158460524|FG001|Overall Study|Lost to Follow-up|0|||
49170509|NCT03726658|158460525|FG002|Overall Study|Lost to Follow-up|2|||
49170510|NCT03726658|158460526|FG003|Overall Study|Lost to Follow-up|0|||
49170511|NCT03726658|158460527|FG004|Overall Study|Lost to Follow-up|0|||
49170512|NCT03726658|158460528|FG005|Overall Study|Lost to Follow-up|1|||
49170513|NCT03726658|158460529|FG006|Overall Study|Lost to Follow-up|1|||
49170514|NCT03726658|158460523|FG000|Overall Study|Withdrawal by Subject|1|||
49170515|NCT03726658|158460524|FG001|Overall Study|Withdrawal by Subject|0|||
49170516|NCT03726658|158460525|FG002|Overall Study|Withdrawal by Subject|0|||
49170517|NCT03726658|158460526|FG003|Overall Study|Withdrawal by Subject|0|||
49170518|NCT03726658|158460527|FG004|Overall Study|Withdrawal by Subject|6|||
49170519|NCT03726658|158460528|FG005|Overall Study|Withdrawal by Subject|4|||
49170520|NCT03726658|158460529|FG006|Overall Study|Withdrawal by Subject|2|||
49170521|NCT03726658|158460523|FG000|Overall Study|Pregnancy|0|||
49170522|NCT03726658|158460524|FG001|Overall Study|Pregnancy|0|||
49170523|NCT03726658|158460525|FG002|Overall Study|Pregnancy|0|||
49170524|NCT03726658|158460526|FG003|Overall Study|Pregnancy|0|||
49170525|NCT03726658|158460527|FG004|Overall Study|Pregnancy|0|||
49170526|NCT03726658|158460528|FG005|Overall Study|Pregnancy|0|||
49170527|NCT03726658|158460529|FG006|Overall Study|Pregnancy|1|||
49170528|NCT03726658|158460523|FG000|Overall Study|Not Reported|0|||
49170529|NCT03726658|158460524|FG001|Overall Study|Not Reported|0|||
49170530|NCT03726658|158460525|FG002|Overall Study|Not Reported|0|||
49170531|NCT03726658|158460526|FG003|Overall Study|Not Reported|0|||
49170532|NCT03726658|158460527|FG004|Overall Study|Not Reported|0|||
49170533|NCT03726658|158460528|FG005|Overall Study|Not Reported|0|||
49170534|NCT03726658|158460529|FG006|Overall Study|Not Reported|1|||
49170535|NCT03248531|158460532|FG000|Overall Study|Adverse Event|0|||
49170536|NCT03248531|158460533|FG001|Overall Study|Adverse Event|0|||
49170537|NCT03248531|158460534|FG002|Overall Study|Adverse Event|1|||
49170538|NCT03248531|158460532|FG000|Overall Study|Lost to Follow-up|1|||
49170539|NCT03248531|158460533|FG001|Overall Study|Lost to Follow-up|0|||
49170540|NCT03248531|158460534|FG002|Overall Study|Lost to Follow-up|5|||
49170541|NCT03248531|158460532|FG000|Overall Study|Withdrawal by Subject|3|||
49170542|NCT03248531|158460533|FG001|Overall Study|Withdrawal by Subject|3|||
49170543|NCT03248531|158460534|FG002|Overall Study|Withdrawal by Subject|2|||
49170544|NCT03248531|158460532|FG000|Overall Study|Sponsor Request|0|||
49170545|NCT03248531|158460533|FG001|Overall Study|Sponsor Request|2|||
49170546|NCT03248531|158460534|FG002|Overall Study|Sponsor Request|0|||
49170547|NCT04860869|158460535|FG000|Overall Study|Withdrawal by Subject|1|||
49170548|NCT04860869|158460536|FG001|Overall Study|Withdrawal by Subject|0|||
49170549|NCT01864148|158460539|FG000|Overall Study|Other|2|||
49170550|NCT01864148|158460540|FG001|Overall Study|Other|1|||
49170551|NCT01864148|158460541|FG002|Overall Study|Other|1|||
49170552|NCT01864148|158460542|FG003|Overall Study|Other|3|||
49170553|NCT01864148|158460543|FG004|Overall Study|Other|1|||
49170554|NCT01864148|158460539|FG000|Overall Study|Death|0|||
49170555|NCT01864148|158460540|FG001|Overall Study|Death|0|||
49170556|NCT01864148|158460541|FG002|Overall Study|Death|0|||
48926118|NCT01463098|157561816|FG007|Part B (11 Days)|Participant Choice|0|||
48926119|NCT01463098|157561817|FG008|Part B (11 Days)|Participant Choice|0|||
48926120|NCT01463098|157561818|FG009|Part B (11 Days)|Participant Choice|0|||
48926121|NCT01463098|157561819|FG010|Part B (11 Days)|Participant Choice|0|||
49170557|NCT01864148|158460542|FG003|Overall Study|Death|1|||
49170558|NCT01864148|158460543|FG004|Overall Study|Death|0|||
49170559|NCT01864148|158460539|FG000|Overall Study|Investigator Decision|5|||
49170560|NCT01864148|158460540|FG001|Overall Study|Investigator Decision|0|||
49170561|NCT01864148|158460541|FG002|Overall Study|Investigator Decision|0|||
49170562|NCT01864148|158460542|FG003|Overall Study|Investigator Decision|4|||
49170563|NCT01864148|158460543|FG004|Overall Study|Investigator Decision|6|||
49170564|NCT01864148|158460539|FG000|Overall Study|Withdrawal by Subject|9|||
49170565|NCT01864148|158460540|FG001|Overall Study|Withdrawal by Subject|2|||
49170566|NCT01864148|158460541|FG002|Overall Study|Withdrawal by Subject|6|||
49170567|NCT01864148|158460542|FG003|Overall Study|Withdrawal by Subject|8|||
49170568|NCT01864148|158460543|FG004|Overall Study|Withdrawal by Subject|8|||
49170569|NCT01864148|158460539|FG000|Overall Study|Lost to Follow-up|0|||
49170570|NCT01864148|158460540|FG001|Overall Study|Lost to Follow-up|0|||
49170571|NCT01864148|158460541|FG002|Overall Study|Lost to Follow-up|0|||
49170572|NCT01864148|158460542|FG003|Overall Study|Lost to Follow-up|2|||
49170573|NCT01864148|158460543|FG004|Overall Study|Lost to Follow-up|1|||
49170574|NCT01864148|158460539|FG000|Overall Study|Adverse Event|4|||
49170575|NCT01864148|158460540|FG001|Overall Study|Adverse Event|2|||
49170576|NCT01864148|158460541|FG002|Overall Study|Adverse Event|4|||
49170577|NCT01864148|158460542|FG003|Overall Study|Adverse Event|7|||
49170578|NCT01864148|158460543|FG004|Overall Study|Adverse Event|7|||
49170579|NCT01864148|158460539|FG000|Overall Study|Not Dosed|0|||
49170580|NCT01864148|158460540|FG001|Overall Study|Not Dosed|0|||
49170581|NCT01864148|158460541|FG002|Overall Study|Not Dosed|0|||
49170582|NCT01864148|158460542|FG003|Overall Study|Not Dosed|1|||
49170583|NCT01864148|158460543|FG004|Overall Study|Not Dosed|0|||
49170584|NCT02702609|158460544|FG000|Overall Study|Lost to Follow-up|8|||
49170585|NCT02702609|158460545|FG001|Overall Study|Lost to Follow-up|4|||
49170586|NCT02702609|158460544|FG000|Overall Study|Physician Decision|1|||
49170587|NCT02702609|158460545|FG001|Overall Study|Physician Decision|0|||
49170588|NCT01823198|158460546|FG000|Overall Study|Physician Decision|0|||
49170589|NCT01823198|158460547|FG001|Overall Study|Physician Decision|1|||
49170590|NCT01823198|158460548|FG002|Overall Study|Physician Decision|0|||
49170591|NCT01823198|158460549|FG003|Overall Study|Physician Decision|0|||
49170592|NCT01823198|158460550|FG004|Overall Study|Physician Decision|0|||
49170593|NCT01823198|158460551|FG005|Overall Study|Physician Decision|3|||
49170594|NCT01823198|158460552|FG006|Overall Study|Physician Decision|3|||
49170595|NCT02674464|158460553|FG000|Overall Study|Death|10|||
49170596|NCT02674464|158460554|FG001|Overall Study|Death|21|||
49170597|NCT02674464|158460553|FG000|Overall Study|Withdrawal by Subject|24|||
49170598|NCT02674464|158460554|FG001|Overall Study|Withdrawal by Subject|44|||
49170599|NCT02674464|158460553|FG000|Overall Study|Lost to Follow-up|97|||
49170600|NCT02674464|158460554|FG001|Overall Study|Lost to Follow-up|92|||
49170601|NCT02674464|158460553|FG000|Overall Study|Outside survey window|6|||
49170602|NCT02674464|158460554|FG001|Overall Study|Outside survey window|3|||
49170603|NCT01500252|158460555|FG000|Overall Study|Death|4|||
49170604|NCT01500252|158460556|FG001|Overall Study|Death|2|||
49170605|NCT01500252|158460555|FG000|Overall Study|Lost to Follow-up|5|||
49170606|NCT01500252|158460556|FG001|Overall Study|Lost to Follow-up|4|||
49170607|NCT00470262|158460557|FG000|Overall Study|Withdrawal by Subject|2|||
49170608|NCT00470262|158460558|FG001|Overall Study|Withdrawal by Subject|0|||
49170609|NCT02466425|158460559|FG000|Overall Study|Adverse Event|3|||
49170610|NCT02466425|158460560|FG001|Overall Study|Adverse Event|11|||
49170611|NCT02466425|158460559|FG000|Overall Study|Lack of Efficacy|4|||
49170612|NCT02466425|158460560|FG001|Overall Study|Lack of Efficacy|1|||
49170613|NCT02466425|158460559|FG000|Overall Study|Lost to Follow-up|3|||
49170614|NCT02466425|158460560|FG001|Overall Study|Lost to Follow-up|0|||
49170615|NCT02466425|158460559|FG000|Overall Study|Protocol Violation|1|||
49170616|NCT02466425|158460560|FG001|Overall Study|Protocol Violation|0|||
49170617|NCT02466425|158460559|FG000|Overall Study|Withdrawal by Subject|0|||
49170618|NCT02466425|158460560|FG001|Overall Study|Withdrawal by Subject|1|||
49170619|NCT02466425|158460559|FG000|Overall Study|Other|1|||
49170620|NCT02466425|158460560|FG001|Overall Study|Other|3|||
49170621|NCT02466425|158460559|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
49170622|NCT02466425|158460560|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
49170623|NCT02366923|158460563|FG000|Overall Study|Withdrawal by Subject|1|||
49170624|NCT02366923|158460563|FG000|Overall Study|Positive Slit Lamp Findings|2|||
49170625|NCT02366923|158460563|FG000|Overall Study|High Astigmatism|3|||
49170626|NCT03083665|158460564|FG000|Double-Blind Period|Adverse Event|5|||
49170627|NCT03083665|158460565|FG001|Double-Blind Period|Adverse Event|4|||
49170628|NCT03083665|158460566|FG002|Double-Blind Period|Adverse Event|5|||
49170629|NCT03083665|158460567|FG003|Double-Blind Period|Adverse Event|0|||
49170630|NCT03083665|158460568|FG004|Double-Blind Period|Adverse Event|0|||
49170631|NCT03083665|158460569|FG005|Double-Blind Period|Adverse Event|0|||
49170632|NCT03083665|158460564|FG000|Double-Blind Period|Lack of Efficacy|0|||
49170633|NCT03083665|158460565|FG001|Double-Blind Period|Lack of Efficacy|0|||
49170634|NCT03083665|158460566|FG002|Double-Blind Period|Lack of Efficacy|1|||
49170635|NCT03083665|158460567|FG003|Double-Blind Period|Lack of Efficacy|0|||
49170636|NCT03083665|158460568|FG004|Double-Blind Period|Lack of Efficacy|0|||
49170637|NCT03083665|158460569|FG005|Double-Blind Period|Lack of Efficacy|0|||
49170638|NCT03083665|158460564|FG000|Double-Blind Period|Protocol Violation|1|||
49170639|NCT03083665|158460565|FG001|Double-Blind Period|Protocol Violation|0|||
49170640|NCT03083665|158460566|FG002|Double-Blind Period|Protocol Violation|1|||
49170641|NCT03083665|158460567|FG003|Double-Blind Period|Protocol Violation|0|||
49170642|NCT03083665|158460568|FG004|Double-Blind Period|Protocol Violation|0|||
49170643|NCT03083665|158460569|FG005|Double-Blind Period|Protocol Violation|0|||
49170644|NCT03083665|158460564|FG000|Double-Blind Period|Lost to Follow-up|1|||
49170645|NCT03083665|158460565|FG001|Double-Blind Period|Lost to Follow-up|0|||
48842052|NCT00516321|157262337|FG001|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
48842053|NCT00516321|157262338|FG002|Double-blind (DB) Antiviral Treatment|Protocol Violation|1|||
48842054|NCT00516321|157262336|FG000|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
48842055|NCT00516321|157262337|FG001|Double-blind (DB) Antiviral Treatment|Physician Decision|2|||
48842056|NCT00516321|157262338|FG002|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
48842057|NCT04218110|157262341|FG000|Overall Study|Withdrawal by Subject|0|||
48842058|NCT04218110|157262342|FG001|Overall Study|Withdrawal by Subject|0|||
48842059|NCT04218110|157262343|FG002|Overall Study|Withdrawal by Subject|0|||
48842060|NCT04218110|157262344|FG003|Overall Study|Withdrawal by Subject|1|||
48842061|NCT01811706|157262351|FG000|First Intervention ( 4 Weeks)|Adverse Event|1|||
48926122|NCT01463098|157561820|FG011|Part B (11 Days)|Participant Choice|1|||
48926123|NCT01463098|157561821|FG012|Part B (11 Days)|Participant Choice|0|||
48926124|NCT01463098|157561822|FG013|Part B (11 Days)|Participant Choice|0|||
49170646|NCT03083665|158460566|FG002|Double-Blind Period|Lost to Follow-up|1|||
49170647|NCT03083665|158460567|FG003|Double-Blind Period|Lost to Follow-up|0|||
48926125|NCT05099640|157561823|FG000|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|39|||
48926126|NCT05099640|157561824|FG001|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
48842062|NCT01811706|157262352|FG001|First Intervention ( 4 Weeks)|Adverse Event|0|||
48926127|NCT05099640|157561825|FG002|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
48951837|NCT01993329|157654910|FG002|Wash-out|Personal reasons|0|||
49170648|NCT03083665|158460568|FG004|Double-Blind Period|Lost to Follow-up|0|||
48842063|NCT01318382|157262354|FG000|Overall Study|Physician Decision|2|||
48842064|NCT01318382|157262354|FG000|Overall Study|Device Malfunction|10|||
48842065|NCT01318382|157262354|FG000|Overall Study|Protocol Violation|1|||
48842066|NCT01867216|157262355|FG000|Overall Study|Withdrawal by Subject|2|||
48842067|NCT01867216|157262356|FG001|Overall Study|Withdrawal by Subject|0|||
48842068|NCT01867216|157262357|FG002|Overall Study|Withdrawal by Subject|0|||
48842069|NCT01867216|157262358|FG003|Overall Study|Withdrawal by Subject|0|||
48842070|NCT01867216|157262359|FG004|Overall Study|Withdrawal by Subject|1|||
48842071|NCT01867216|157262360|FG005|Overall Study|Withdrawal by Subject|0|||
48842072|NCT01867216|157262361|FG006|Overall Study|Withdrawal by Subject|1|||
48842073|NCT01867216|157262355|FG000|Overall Study|Physician Decision|1|||
48842074|NCT01867216|157262356|FG001|Overall Study|Physician Decision|0|||
49170649|NCT03083665|158460569|FG005|Double-Blind Period|Lost to Follow-up|0|||
49170650|NCT03083665|158460564|FG000|Double-Blind Period|Withdrawal by Subject|3|||
49170651|NCT03083665|158460565|FG001|Double-Blind Period|Withdrawal by Subject|0|||
49170652|NCT03083665|158460566|FG002|Double-Blind Period|Withdrawal by Subject|0|||
49170653|NCT03083665|158460567|FG003|Double-Blind Period|Withdrawal by Subject|0|||
49170654|NCT03083665|158460568|FG004|Double-Blind Period|Withdrawal by Subject|0|||
48842075|NCT01867216|157262357|FG002|Overall Study|Physician Decision|0|||
48842076|NCT01867216|157262358|FG003|Overall Study|Physician Decision|0|||
48842077|NCT01867216|157262359|FG004|Overall Study|Physician Decision|0|||
48842078|NCT01867216|157262360|FG005|Overall Study|Physician Decision|0|||
48842079|NCT01867216|157262361|FG006|Overall Study|Physician Decision|0|||
48842080|NCT01867216|157262355|FG000|Overall Study|Unable to Place Catheter for Blood Draws|1|||
48842081|NCT01867216|157262356|FG001|Overall Study|Unable to Place Catheter for Blood Draws|0|||
48842082|NCT01867216|157262357|FG002|Overall Study|Unable to Place Catheter for Blood Draws|0|||
49170655|NCT03083665|158460569|FG005|Double-Blind Period|Withdrawal by Subject|0|||
49170656|NCT03083665|158460564|FG000|Double-Blind Period|Consent withdrawn by subject due to concern on AE|1|||
48842083|NCT01867216|157262358|FG003|Overall Study|Unable to Place Catheter for Blood Draws|0|||
48842084|NCT01867216|157262359|FG004|Overall Study|Unable to Place Catheter for Blood Draws|0|||
48842085|NCT01867216|157262360|FG005|Overall Study|Unable to Place Catheter for Blood Draws|0|||
49170657|NCT03083665|158460565|FG001|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
49170658|NCT03083665|158460566|FG002|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
49170659|NCT03083665|158460567|FG003|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
49170660|NCT03083665|158460568|FG004|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
49170661|NCT03083665|158460569|FG005|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
49170662|NCT03083665|158460564|FG000|Double-Blind Period|Subjects were able to never take a study drug|0|||
49170663|NCT03083665|158460565|FG001|Double-Blind Period|Subjects were able to never take a study drug|1|||
49170664|NCT03083665|158460566|FG002|Double-Blind Period|Subjects were able to never take a study drug|0|||
49170665|NCT03083665|158460567|FG003|Double-Blind Period|Subjects were able to never take a study drug|0|||
49170666|NCT03083665|158460568|FG004|Double-Blind Period|Subjects were able to never take a study drug|0|||
49170667|NCT03083665|158460569|FG005|Double-Blind Period|Subjects were able to never take a study drug|0|||
49170668|NCT03083665|158460564|FG000|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
49170669|NCT03083665|158460565|FG001|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
49170670|NCT03083665|158460566|FG002|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
49170671|NCT03083665|158460567|FG003|Open-Label Temporary Period (OLTP)|Adverse Event|2|||
49170672|NCT03083665|158460568|FG004|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
49170673|NCT03083665|158460569|FG005|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
49170674|NCT03083665|158460564|FG000|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
49170675|NCT03083665|158460565|FG001|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
49170676|NCT03083665|158460566|FG002|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
49170677|NCT03083665|158460567|FG003|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
49170678|NCT03083665|158460568|FG004|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
49170679|NCT03083665|158460569|FG005|Open-Label Temporary Period (OLTP)|Lack of Efficacy|2|||
49170680|NCT03083665|158460564|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
49170681|NCT03083665|158460565|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
49170682|NCT03083665|158460566|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
48842086|NCT01867216|157262361|FG006|Overall Study|Unable to Place Catheter for Blood Draws|0|||
48842087|NCT00743444|157262364|FG000|First Intervention|Catheter placement problems|0|||
48842088|NCT00743444|157262365|FG001|First Intervention|Catheter placement problems|1|||
48842089|NCT00743444|157262364|FG000|Washout Period|Adverse Event|0|||
48842090|NCT00743444|157262365|FG001|Washout Period|Adverse Event|1|||
49170683|NCT03083665|158460567|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
49170684|NCT03083665|158460568|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
49170685|NCT03083665|158460569|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
49170686|NCT03083665|158460564|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
49170687|NCT03083665|158460565|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
49170688|NCT03083665|158460566|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
49170689|NCT03083665|158460567|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
49170690|NCT03083665|158460568|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
49170691|NCT03083665|158460569|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|1|||
49170692|NCT03083665|158460564|FG000|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
49170693|NCT03083665|158460565|FG001|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
49170694|NCT03083665|158460566|FG002|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
49170695|NCT03083665|158460567|FG003|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|1|||
49170696|NCT03083665|158460568|FG004|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
49170697|NCT03083665|158460569|FG005|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
49170698|NCT03083665|158460564|FG000|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
49170699|NCT03083665|158460565|FG001|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
49170700|NCT03083665|158460566|FG002|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
49170701|NCT03083665|158460567|FG003|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
49170702|NCT03083665|158460568|FG004|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
49170703|NCT03083665|158460569|FG005|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|1|||
49170704|NCT03083665|158460564|FG000|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
49170705|NCT03083665|158460565|FG001|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
49170706|NCT03083665|158460566|FG002|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
49170707|NCT03083665|158460567|FG003|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
49170708|NCT03083665|158460568|FG004|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
49170709|NCT03083665|158460569|FG005|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|1|||
49170710|NCT02565147|158460570|FG000|Overall Study|Withdrawal by Subject|5|||
49170711|NCT02565147|158460571|FG001|Overall Study|Withdrawal by Subject|1|||
49170712|NCT02565147|158460570|FG000|Overall Study|Lost to Follow-up|0|||
49170713|NCT02565147|158460571|FG001|Overall Study|Lost to Follow-up|1|||
49170714|NCT02565147|158460570|FG000|Overall Study|Death|1|||
49170715|NCT02565147|158460571|FG001|Overall Study|Death|1|||
49170716|NCT00582712|158460573|FG000|Overall Study|Adverse Event|1|||
49170717|NCT00582712|158460573|FG000|Overall Study|Lack of Efficacy|1|||
49170718|NCT00582712|158460573|FG000|Overall Study|Withdrawal by Subject|1|||
49170719|NCT00582712|158460573|FG000|Overall Study|Complicating disease requiring treatment|1|||
49170720|NCT00244725|158460574|FG000|Overall Study|Lost to Follow-up|3|||
49170721|NCT00244725|158460575|FG001|Overall Study|Lost to Follow-up|4|||
49170722|NCT00244725|158460576|FG002|Overall Study|Lost to Follow-up|9|||
49170723|NCT00244725|158460577|FG003|Overall Study|Lost to Follow-up|2|||
49170724|NCT00244725|158460574|FG000|Overall Study|Withdrawal by Subject|9|||
49170725|NCT00244725|158460575|FG001|Overall Study|Withdrawal by Subject|7|||
49170726|NCT00244725|158460576|FG002|Overall Study|Withdrawal by Subject|7|||
49170727|NCT00244725|158460577|FG003|Overall Study|Withdrawal by Subject|8|||
49170728|NCT00244725|158460574|FG000|Overall Study|Not meet treatment eligibility criteria|1|||
49170729|NCT00244725|158460575|FG001|Overall Study|Not meet treatment eligibility criteria|2|||
49170730|NCT00244725|158460576|FG002|Overall Study|Not meet treatment eligibility criteria|0|||
49170731|NCT00244725|158460577|FG003|Overall Study|Not meet treatment eligibility criteria|0|||
49170732|NCT00244725|158460574|FG000|Overall Study|Physician Decision|3|||
49170733|NCT00244725|158460575|FG001|Overall Study|Physician Decision|0|||
49170734|NCT00244725|158460576|FG002|Overall Study|Physician Decision|1|||
49170735|NCT00244725|158460577|FG003|Overall Study|Physician Decision|2|||
49170736|NCT00244725|158460574|FG000|Overall Study|Adverse Events|3|||
49170737|NCT00244725|158460575|FG001|Overall Study|Adverse Events|1|||
49170738|NCT00244725|158460576|FG002|Overall Study|Adverse Events|4|||
49170739|NCT00244725|158460577|FG003|Overall Study|Adverse Events|4|||
49170740|NCT00244725|158460574|FG000|Overall Study|Withdrwal by participant|1|||
49170741|NCT00244725|158460575|FG001|Overall Study|Withdrwal by participant|0|||
49170742|NCT00244725|158460576|FG002|Overall Study|Withdrwal by participant|0|||
49170743|NCT00244725|158460577|FG003|Overall Study|Withdrwal by participant|1|||
49170744|NCT00244725|158460574|FG000|Overall Study|Liver function test abnormality|2|||
49170745|NCT00244725|158460575|FG001|Overall Study|Liver function test abnormality|0|||
49170746|NCT00244725|158460576|FG002|Overall Study|Liver function test abnormality|0|||
49170747|NCT00244725|158460577|FG003|Overall Study|Liver function test abnormality|1|||
49170748|NCT00244725|158460574|FG000|Overall Study|Sponsor withdrew the participant|1|||
49170749|NCT00244725|158460575|FG001|Overall Study|Sponsor withdrew the participant|0|||
49170750|NCT00244725|158460576|FG002|Overall Study|Sponsor withdrew the participant|0|||
49170751|NCT00244725|158460577|FG003|Overall Study|Sponsor withdrew the participant|1|||
49170752|NCT00244725|158460574|FG000|Overall Study|Mediciation Error|0|||
49170753|NCT00244725|158460575|FG001|Overall Study|Mediciation Error|1|||
49170754|NCT00244725|158460576|FG002|Overall Study|Mediciation Error|0|||
49170755|NCT00244725|158460577|FG003|Overall Study|Mediciation Error|0|||
49170756|NCT00244725|158460574|FG000|Overall Study|Rehab Refused to allow participantion|0|||
48842091|NCT00979992|157262369|FG000|Overall Study|Ineligible - inadequate pathology|1|||
48842092|NCT00979992|157262369|FG000|Overall Study|Ineligible - wrong cell type|2|||
48842093|NCT00979992|157262369|FG000|Overall Study|Refused - Never Treated|2|||
48842094|NCT00869258|157262370|FG000|Overall Study|Physician Decision|1|||
48842095|NCT00636207|157262371|FG000|Overall Study|Adverse Event|1|||
48842096|NCT00636207|157262372|FG001|Overall Study|Adverse Event|0|||
49170757|NCT00244725|158460575|FG001|Overall Study|Rehab Refused to allow participantion|1|||
49170758|NCT00244725|158460576|FG002|Overall Study|Rehab Refused to allow participantion|0|||
48842097|NCT00636207|157262373|FG002|Overall Study|Adverse Event|0|||
48842098|NCT00636207|157262374|FG003|Overall Study|Adverse Event|0|||
48842099|NCT00636207|157262375|FG004|Overall Study|Adverse Event|0|||
48842100|NCT00636207|157262376|FG005|Overall Study|Adverse Event|0|||
48842101|NCT00636207|157262377|FG006|Overall Study|Adverse Event|0|||
48842102|NCT00636207|157262371|FG000|Overall Study|Withdrawal by Subject|0|||
48842103|NCT00636207|157262372|FG001|Overall Study|Withdrawal by Subject|1|||
48842104|NCT00636207|157262373|FG002|Overall Study|Withdrawal by Subject|0|||
48842105|NCT00636207|157262374|FG003|Overall Study|Withdrawal by Subject|0|||
48842106|NCT00636207|157262375|FG004|Overall Study|Withdrawal by Subject|1|||
48842107|NCT00636207|157262376|FG005|Overall Study|Withdrawal by Subject|0|||
48842108|NCT00636207|157262377|FG006|Overall Study|Withdrawal by Subject|0|||
48842109|NCT00666276|157262381|FG000|Overall Study|Protocol Violation|34|||
48842110|NCT02529995|157262382|FG000|Part A|Ongoing Study at Data Cut-off|14|||
48842111|NCT02529995|157262383|FG001|Part A|Ongoing Study at Data Cut-off|16|||
48842112|NCT02529995|157262382|FG000|Part A|Discontinued Study|1|||
48842113|NCT02529995|157262383|FG001|Part A|Discontinued Study|0|||
48842114|NCT02529995|157262382|FG000|Part B|Ongoing Study at Data Cut-off|0|||
48842115|NCT02529995|157262383|FG001|Part B|Ongoing Study at Data Cut-off|7|||
48842116|NCT02529995|157262382|FG000|Part B|Discontinued Study|6|||
48842117|NCT02529995|157262383|FG001|Part B|Discontinued Study|5|||
49170759|NCT00244725|158460577|FG003|Overall Study|Rehab Refused to allow participantion|0|||
49170760|NCT00244725|158460574|FG000|Overall Study|Headache|0|||
49170761|NCT00244725|158460575|FG001|Overall Study|Headache|1|||
49170762|NCT00244725|158460576|FG002|Overall Study|Headache|0|||
49170763|NCT00244725|158460577|FG003|Overall Study|Headache|0|||
48842118|NCT03844269|157262386|FG000|Overall Study|Withdrawal pre-intervention|1|||
48842119|NCT03844269|157262386|FG000|Overall Study|Did not complete the intervention|2|||
48842120|NCT00665444|157262389|FG000|Overall Study|Physician Decision|1|||
49170764|NCT00244725|158460574|FG000|Overall Study|Received prohibited medication|0|||
49170765|NCT00244725|158460575|FG001|Overall Study|Received prohibited medication|1|||
49170766|NCT00244725|158460576|FG002|Overall Study|Received prohibited medication|0|||
49170767|NCT00244725|158460577|FG003|Overall Study|Received prohibited medication|1|||
49170768|NCT00244725|158460574|FG000|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
49170769|NCT00244725|158460575|FG001|Overall Study|Confirmed venous thromboembolism (VTE)|1|||
49170770|NCT00244725|158460576|FG002|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
49170771|NCT00244725|158460577|FG003|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
49170772|NCT00244725|158460574|FG000|Overall Study|Administrative reason|0|||
49170773|NCT00244725|158460575|FG001|Overall Study|Administrative reason|0|||
49170774|NCT00244725|158460576|FG002|Overall Study|Administrative reason|1|||
49170775|NCT00244725|158460577|FG003|Overall Study|Administrative reason|0|||
49170776|NCT00244725|158460574|FG000|Overall Study|Vomit|0|||
49170777|NCT00244725|158460575|FG001|Overall Study|Vomit|0|||
49170778|NCT00244725|158460576|FG002|Overall Study|Vomit|1|||
49170779|NCT00244725|158460577|FG003|Overall Study|Vomit|0|||
49170780|NCT00244725|158460574|FG000|Overall Study|Failed to follow-up|0|||
49170781|NCT00244725|158460575|FG001|Overall Study|Failed to follow-up|0|||
49170782|NCT00244725|158460576|FG002|Overall Study|Failed to follow-up|1|||
49170783|NCT00244725|158460577|FG003|Overall Study|Failed to follow-up|1|||
49170784|NCT02936869|158460578|FG000|Overall Study|Lost to Follow-up|1|||
49170785|NCT02936869|158460579|FG001|Overall Study|Lost to Follow-up|3|||
49170786|NCT02936869|158460578|FG000|Overall Study|Death|0|||
49170787|NCT02936869|158460579|FG001|Overall Study|Death|1|||
49170788|NCT02936869|158460578|FG000|Overall Study|Legal Case|0|||
49170789|NCT02936869|158460579|FG001|Overall Study|Legal Case|1|||
49170790|NCT02936869|158460578|FG000|Overall Study|Protocol Violation|1|||
49170791|NCT02936869|158460579|FG001|Overall Study|Protocol Violation|0|||
49170792|NCT03799952|158460580|FG000|Overall Study|Program was too easy, discontinued|1|||
49170793|NCT03799952|158460581|FG001|Overall Study|Program was too easy, discontinued|0|||
49170794|NCT03799952|158460580|FG000|Overall Study|Lost to Follow-up|0|||
49170795|NCT03799952|158460581|FG001|Overall Study|Lost to Follow-up|2|||
49170796|NCT00335738|158460582|FG000|Overall Study|Physician Decision|6|||
49170797|NCT00335738|158460583|FG001|Overall Study|Physician Decision|0|||
49170798|NCT00335738|158460582|FG000|Overall Study|Withdrawal by Subject|2|||
49170799|NCT00335738|158460583|FG001|Overall Study|Withdrawal by Subject|0|||
49170800|NCT00335738|158460582|FG000|Overall Study|Ineligible|3|||
49170801|NCT00335738|158460583|FG001|Overall Study|Ineligible|4|||
49170802|NCT03472495|158460584|FG000|Overall Study|Treatment no longer indicated|1|||
49170803|NCT03472495|158460585|FG001|Overall Study|Treatment no longer indicated|2|||
49170804|NCT03472495|158460584|FG000|Overall Study|Physician Decision|0|||
49170805|NCT03472495|158460585|FG001|Overall Study|Physician Decision|2|||
48735639|NCT00961649|156883698|FG001|Overall Study|Patient left to Mexico-family emergency|0|||
49170806|NCT00124072|158460588|FG000|Overall Study|Lost to Follow-up for Mortality|0|||
49170807|NCT00124072|158460589|FG001|Overall Study|Lost to Follow-up for Mortality|3|||
48842121|NCT00665444|157262389|FG000|Overall Study|Study Terminated by Study Sponsor|1|||
48842122|NCT00101010|157262390|FG000|Overall Study|Physician Decision|1|||
49170808|NCT00124072|158460590|FG002|Overall Study|Lost to Follow-up for Mortality|2|||
49170809|NCT00124072|158460591|FG003|Overall Study|Lost to Follow-up for Mortality|2|||
48926128|NCT05099640|157561823|FG000|Part 1: Open-label (14 Days)|Participant decision|3|||
48926129|NCT05099640|157561824|FG001|Part 1: Open-label (14 Days)|Participant decision|0|||
48926130|NCT05099640|157561825|FG002|Part 1: Open-label (14 Days)|Participant decision|0|||
48926131|NCT05099640|157561823|FG000|Part 1: Open-label (14 Days)|Adverse Event|1|||
48926132|NCT05099640|157561824|FG001|Part 1: Open-label (14 Days)|Adverse Event|0|||
48926133|NCT05099640|157561825|FG002|Part 1: Open-label (14 Days)|Adverse Event|0|||
48926134|NCT05099640|157561823|FG000|Part 1: Open-label (14 Days)|Withdrawal by Subject|1|||
48926135|NCT05099640|157561824|FG001|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
48926136|NCT05099640|157561825|FG002|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
48926137|NCT05099640|157561823|FG000|Part 1: Open-label (14 Days)|Other than specified|2|||
48926138|NCT05099640|157561824|FG001|Part 1: Open-label (14 Days)|Other than specified|0|||
48926139|NCT05099640|157561825|FG002|Part 1: Open-label (14 Days)|Other than specified|0|||
48926140|NCT05099640|157561823|FG000|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
48926141|NCT05099640|157561824|FG001|Part 2: Randomized Treatment (6 Weeks)|Participant decision|1|||
48926142|NCT05099640|157561825|FG002|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
48926143|NCT02462473|157561826|FG000|Overall Study|Death|1|||
48926144|NCT02462473|157561826|FG000|Overall Study|Other|3|||
48926145|NCT00953758|157561833|FG000|Overall Study|Death|2|||
48926146|NCT00953758|157561834|FG001|Overall Study|Death|0|||
48926147|NCT00953758|157561835|FG002|Overall Study|Death|1|||
48926148|NCT00953758|157561836|FG003|Overall Study|Death|1|||
48926149|NCT00953758|157561837|FG004|Overall Study|Death|1|||
48926150|NCT00953758|157561838|FG005|Overall Study|Death|1|||
48926151|NCT00953758|157561839|FG006|Overall Study|Death|1|||
48926152|NCT00953758|157561840|FG007|Overall Study|Death|3|||
48926153|NCT00953758|157561841|FG008|Overall Study|Death|1|||
49170810|NCT00124072|158460588|FG000|Overall Study|Lost to Follow-up for Morbidity|15|||
49170811|NCT00124072|158460589|FG001|Overall Study|Lost to Follow-up for Morbidity|25|||
49170812|NCT00124072|158460590|FG002|Overall Study|Lost to Follow-up for Morbidity|19|||
49170813|NCT00124072|158460591|FG003|Overall Study|Lost to Follow-up for Morbidity|18|||
49170814|NCT00124072|158460588|FG000|Overall Study|Death|499|||
49170815|NCT00124072|158460589|FG001|Overall Study|Death|484|||
49170816|NCT00124072|158460590|FG002|Overall Study|Death|471|||
49170817|NCT00124072|158460591|FG003|Overall Study|Death|480|||
49170818|NCT00995436|158460592|FG000|Overall Study|Withdrawal by Subject|2|||
49170819|NCT00995436|158460593|FG001|Overall Study|Withdrawal by Subject|5|||
49170820|NCT00995436|158460594|FG002|Overall Study|Withdrawal by Subject|0|||
49170821|NCT02689206|158460600|FG000|Overall Study|Adverse Event|0|||
49170822|NCT02689206|158460601|FG001|Overall Study|Adverse Event|0|||
49170823|NCT02689206|158460602|FG002|Overall Study|Adverse Event|1|||
49170824|NCT02689206|158460603|FG003|Overall Study|Adverse Event|0|||
49170825|NCT02689206|158460604|FG004|Overall Study|Adverse Event|2|||
49170826|NCT02689206|158460600|FG000|Overall Study|Protocol Violation|1|||
49170827|NCT02689206|158460601|FG001|Overall Study|Protocol Violation|0|||
49170828|NCT02689206|158460602|FG002|Overall Study|Protocol Violation|0|||
49170829|NCT02689206|158460603|FG003|Overall Study|Protocol Violation|1|||
49170830|NCT02689206|158460604|FG004|Overall Study|Protocol Violation|2|||
49170831|NCT02689206|158460600|FG000|Overall Study|Other: Reached stopping criteria|0|||
49170832|NCT02689206|158460601|FG001|Overall Study|Other: Reached stopping criteria|1|||
49170833|NCT02689206|158460602|FG002|Overall Study|Other: Reached stopping criteria|2|||
49170834|NCT02689206|158460603|FG003|Overall Study|Other: Reached stopping criteria|3|||
49170835|NCT02689206|158460604|FG004|Overall Study|Other: Reached stopping criteria|4|||
49170836|NCT02689206|158460600|FG000|Overall Study|Physician Decision|1|||
49170837|NCT02689206|158460601|FG001|Overall Study|Physician Decision|0|||
49170838|NCT02689206|158460602|FG002|Overall Study|Physician Decision|0|||
49170839|NCT02689206|158460603|FG003|Overall Study|Physician Decision|0|||
49170840|NCT02689206|158460604|FG004|Overall Study|Physician Decision|0|||
49170841|NCT02689206|158460600|FG000|Overall Study|Withdrawal by Subject|1|||
49170842|NCT02689206|158460601|FG001|Overall Study|Withdrawal by Subject|0|||
49170843|NCT02689206|158460602|FG002|Overall Study|Withdrawal by Subject|1|||
49170844|NCT02689206|158460603|FG003|Overall Study|Withdrawal by Subject|0|||
49170845|NCT02689206|158460604|FG004|Overall Study|Withdrawal by Subject|0|||
49170846|NCT02998671|158460605|FG000|Period 1|Study Terminated By Sponsor|2|||
49170847|NCT02998671|158460606|FG001|Period 1|Study Terminated By Sponsor|1|||
49170848|NCT02998671|158460607|FG002|Period 1|Study Terminated By Sponsor|0|||
49170849|NCT02998671|158460608|FG003|Period 1|Study Terminated By Sponsor|0|||
49170850|NCT02998671|158460609|FG004|Period 1|Study Terminated By Sponsor|1|||
49170851|NCT02998671|158460605|FG000|Period 1|Withdrawal by Subject|1|||
49170852|NCT02998671|158460606|FG001|Period 1|Withdrawal by Subject|2|||
48926154|NCT00953758|157561842|FG009|Overall Study|Death|0|||
48926155|NCT00953758|157561833|FG000|Overall Study|Participant refused further follow-up|0|||
49170853|NCT02998671|158460607|FG002|Period 1|Withdrawal by Subject|0|||
49170854|NCT02998671|158460608|FG003|Period 1|Withdrawal by Subject|0|||
49170855|NCT02998671|158460609|FG004|Period 1|Withdrawal by Subject|2|||
49170856|NCT02998671|158460605|FG000|Period 1|Pregnancy|1|||
49170857|NCT02998671|158460606|FG001|Period 1|Pregnancy|0|||
49170858|NCT02998671|158460607|FG002|Period 1|Pregnancy|0|||
49170859|NCT02998671|158460608|FG003|Period 1|Pregnancy|0|||
49170860|NCT02998671|158460609|FG004|Period 1|Pregnancy|0|||
49170861|NCT02998671|158460605|FG000|Period 1|Adverse Event|0|||
49170862|NCT02998671|158460606|FG001|Period 1|Adverse Event|0|||
49170863|NCT02998671|158460607|FG002|Period 1|Adverse Event|0|||
49170864|NCT02998671|158460608|FG003|Period 1|Adverse Event|0|||
49170865|NCT02998671|158460609|FG004|Period 1|Adverse Event|1|||
49170866|NCT02998671|158460605|FG000|Period 2|Adverse Event|0|||
49170867|NCT02998671|158460606|FG001|Period 2|Adverse Event|1|||
49170868|NCT02998671|158460607|FG002|Period 2|Adverse Event|0|||
49170869|NCT02998671|158460608|FG003|Period 2|Adverse Event|0|||
49170870|NCT02998671|158460609|FG004|Period 2|Adverse Event|0|||
49170871|NCT02998671|158460605|FG000|Period 2|Study Terminated By Sponsor|3|||
49170872|NCT02998671|158460606|FG001|Period 2|Study Terminated By Sponsor|5|||
49170873|NCT02998671|158460607|FG002|Period 2|Study Terminated By Sponsor|1|||
49170874|NCT02998671|158460608|FG003|Period 2|Study Terminated By Sponsor|3|||
49170875|NCT02998671|158460609|FG004|Period 2|Study Terminated By Sponsor|0|||
49170876|NCT02998671|158460605|FG000|Period 2|Withdrawal by Subject|0|||
49170877|NCT02998671|158460606|FG001|Period 2|Withdrawal by Subject|1|||
49170878|NCT02998671|158460607|FG002|Period 2|Withdrawal by Subject|0|||
49170879|NCT02998671|158460608|FG003|Period 2|Withdrawal by Subject|0|||
49170880|NCT02998671|158460609|FG004|Period 2|Withdrawal by Subject|0|||
49170881|NCT02998671|158460605|FG000|Period 2|Lost to Follow-up|0|||
49170882|NCT02998671|158460606|FG001|Period 2|Lost to Follow-up|0|||
49170883|NCT02998671|158460607|FG002|Period 2|Lost to Follow-up|0|||
49170884|NCT02998671|158460608|FG003|Period 2|Lost to Follow-up|1|||
49170885|NCT02998671|158460609|FG004|Period 2|Lost to Follow-up|0|||
49170886|NCT02038946|158460610|FG000|Overall Study|Death|5|||
49170887|NCT02038946|158460610|FG000|Overall Study|Withdrawal by Subject|3|||
49170888|NCT02038946|158460610|FG000|Overall Study|Lost to Follow-up|2|||
49170889|NCT02038946|158460610|FG000|Overall Study|Other reasons|2|||
49170890|NCT01232127|158460614|FG000|Period 1: Days 1-10|Discontinued due to dosing error|1|||
49170891|NCT01232127|158460615|FG001|Period 1: Days 1-10|Discontinued due to dosing error|0|||
49170892|NCT01232127|158460616|FG002|Period 1: Days 1-10|Discontinued due to dosing error|0|||
49170893|NCT03162796|158460618|FG000|Placebo Controlled Period: Week 0 - 24|Other|0|||
49170894|NCT03162796|158460619|FG001|Placebo Controlled Period: Week 0 - 24|Other|1|||
49170895|NCT03162796|158460620|FG002|Placebo Controlled Period: Week 0 - 24|Other|1|||
48926156|NCT00953758|157561834|FG001|Overall Study|Participant refused further follow-up|0|||
48926157|NCT00953758|157561835|FG002|Overall Study|Participant refused further follow-up|1|||
48926158|NCT00953758|157561836|FG003|Overall Study|Participant refused further follow-up|0|||
48926159|NCT00953758|157561837|FG004|Overall Study|Participant refused further follow-up|3|||
48926160|NCT00953758|157561838|FG005|Overall Study|Participant refused further follow-up|0|||
48926161|NCT00953758|157561839|FG006|Overall Study|Participant refused further follow-up|0|||
48926162|NCT00953758|157561840|FG007|Overall Study|Participant refused further follow-up|0|||
48926163|NCT00953758|157561841|FG008|Overall Study|Participant refused further follow-up|1|||
48926164|NCT00953758|157561842|FG009|Overall Study|Participant refused further follow-up|0|||
48926165|NCT00953758|157561833|FG000|Overall Study|Lost to Follow-up|0|||
48926166|NCT00953758|157561834|FG001|Overall Study|Lost to Follow-up|0|||
48926167|NCT00953758|157561835|FG002|Overall Study|Lost to Follow-up|0|||
48926168|NCT00953758|157561836|FG003|Overall Study|Lost to Follow-up|1|||
48926169|NCT00953758|157561837|FG004|Overall Study|Lost to Follow-up|0|||
48926170|NCT00953758|157561838|FG005|Overall Study|Lost to Follow-up|0|||
48735640|NCT00961649|156883699|FG002|Overall Study|Patient left to Mexico-family emergency|0|||
48926171|NCT00953758|157561839|FG006|Overall Study|Lost to Follow-up|0|||
48926172|NCT00953758|157561840|FG007|Overall Study|Lost to Follow-up|1|||
48926173|NCT00953758|157561841|FG008|Overall Study|Lost to Follow-up|0|||
48926174|NCT00953758|157561842|FG009|Overall Study|Lost to Follow-up|1|||
48926175|NCT00953758|157561833|FG000|Overall Study|Physician Decision|0|||
48926176|NCT00953758|157561834|FG001|Overall Study|Physician Decision|0|||
48926177|NCT00953758|157561835|FG002|Overall Study|Physician Decision|0|||
49170896|NCT03162796|158460618|FG000|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1|||
49170897|NCT03162796|158460619|FG001|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
49170898|NCT03162796|158460620|FG002|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
49170899|NCT03162796|158460618|FG000|Placebo Controlled Period: Week 0 - 24|Death|1|||
49170900|NCT03162796|158460619|FG001|Placebo Controlled Period: Week 0 - 24|Death|0|||
49170901|NCT03162796|158460620|FG002|Placebo Controlled Period: Week 0 - 24|Death|0|||
49170902|NCT03162796|158460618|FG000|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1|||
49170903|NCT03162796|158460619|FG001|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
49170904|NCT03162796|158460620|FG002|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
49170905|NCT03162796|158460618|FG000|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3|||
49170906|NCT03162796|158460619|FG001|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
49170907|NCT03162796|158460620|FG002|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
49170908|NCT03162796|158460618|FG000|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4|||
49170909|NCT03162796|158460619|FG001|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
49170910|NCT03162796|158460620|FG002|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
49170911|NCT03162796|158460618|FG000|Placebo Controlled Period: Week 0 - 24|Adverse Event|2|||
49170912|NCT03162796|158460619|FG001|Placebo Controlled Period: Week 0 - 24|Adverse Event|3|||
49170913|NCT03162796|158460620|FG002|Placebo Controlled Period: Week 0 - 24|Adverse Event|1|||
49170914|NCT03162796|158460618|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
49170915|NCT03162796|158460619|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
49170916|NCT03162796|158460620|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
49170917|NCT03162796|158460618|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
49170918|NCT03162796|158460619|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
49170919|NCT03162796|158460620|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1|||
49170920|NCT03162796|158460618|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
49170921|NCT03162796|158460619|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|2|||
49170922|NCT03162796|158460620|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
49170923|NCT03162796|158460618|FG000|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
49170924|NCT03162796|158460619|FG001|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2|||
49170925|NCT03162796|158460620|FG002|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
49170926|NCT00902850|158460621|FG000|Overall Study|Physician Decision|2|||
49170927|NCT00902850|158460622|FG001|Overall Study|Physician Decision|2|||
49170928|NCT03035864|158460623|FG000|Treatment Period|Adverse Event|1|||
49170929|NCT03035864|158460624|FG001|Treatment Period|Adverse Event|0|||
49170930|NCT03035864|158460623|FG000|Treatment Period|Other|3|||
49170931|NCT03035864|158460624|FG001|Treatment Period|Other|1|||
49170932|NCT03035864|158460623|FG000|Follow-up Period|Adverse Event|1|||
49170933|NCT03035864|158460624|FG001|Follow-up Period|Adverse Event|0|||
49170934|NCT03035864|158460623|FG000|Follow-up Period|Lost to Follow-up|6|||
49170935|NCT03035864|158460624|FG001|Follow-up Period|Lost to Follow-up|2|||
49170936|NCT03035864|158460623|FG000|Follow-up Period|Physician Decision|1|||
49170937|NCT03035864|158460624|FG001|Follow-up Period|Physician Decision|0|||
49170938|NCT03035864|158460623|FG000|Follow-up Period|Other|3|||
49170939|NCT03035864|158460624|FG001|Follow-up Period|Other|2|||
49170940|NCT03098433|158460625|FG000|Overall Study|Withdrawal by Subject|10|||
49170941|NCT01667133|158460626|FG000|Phase 1: Dose-escalation|Adverse Event|0|||
49170942|NCT01667133|158460627|FG001|Phase 1: Dose-escalation|Adverse Event|0|||
49170943|NCT01667133|158460628|FG002|Phase 1: Dose-escalation|Adverse Event|1|||
49170944|NCT01667133|158460629|FG003|Phase 1: Dose-escalation|Adverse Event|0|||
49170945|NCT01667133|158460630|FG004|Phase 1: Dose-escalation|Adverse Event|0|||
49170946|NCT01667133|158460631|FG005|Phase 1: Dose-escalation|Adverse Event|0|||
49170947|NCT01667133|158460632|FG006|Phase 1: Dose-escalation|Adverse Event|0|||
49170948|NCT01667133|158460633|FG007|Phase 1: Dose-escalation|Adverse Event|0|||
49170949|NCT01667133|158460634|FG008|Phase 1: Dose-escalation|Adverse Event|0|||
49170950|NCT01667133|158460635|FG009|Phase 1: Dose-escalation|Adverse Event|0|||
49170951|NCT01667133|158460636|FG010|Phase 1: Dose-escalation|Adverse Event|0|||
49170952|NCT01667133|158460637|FG011|Phase 1: Dose-escalation|Adverse Event|0|||
49170953|NCT01667133|158460626|FG000|Phase 1: Dose-escalation|Lack of Efficacy|0|||
49170954|NCT01667133|158460627|FG001|Phase 1: Dose-escalation|Lack of Efficacy|0|||
49170955|NCT01667133|158460628|FG002|Phase 1: Dose-escalation|Lack of Efficacy|1|||
49170956|NCT01667133|158460629|FG003|Phase 1: Dose-escalation|Lack of Efficacy|0|||
49170957|NCT01667133|158460630|FG004|Phase 1: Dose-escalation|Lack of Efficacy|0|||
49170958|NCT01667133|158460631|FG005|Phase 1: Dose-escalation|Lack of Efficacy|0|||
49170959|NCT01667133|158460632|FG006|Phase 1: Dose-escalation|Lack of Efficacy|0|||
49170960|NCT01667133|158460633|FG007|Phase 1: Dose-escalation|Lack of Efficacy|0|||
48926178|NCT00953758|157561836|FG003|Overall Study|Physician Decision|0|||
49170961|NCT01667133|158460634|FG008|Phase 1: Dose-escalation|Lack of Efficacy|0|||
49170962|NCT01667133|158460635|FG009|Phase 1: Dose-escalation|Lack of Efficacy|0|||
49170963|NCT01667133|158460636|FG010|Phase 1: Dose-escalation|Lack of Efficacy|0|||
49170964|NCT01667133|158460637|FG011|Phase 1: Dose-escalation|Lack of Efficacy|0|||
49170965|NCT01667133|158460626|FG000|Phase 1: Dose-escalation|Progressive Disease|0|||
49170966|NCT01667133|158460627|FG001|Phase 1: Dose-escalation|Progressive Disease|1|||
49170967|NCT01667133|158460628|FG002|Phase 1: Dose-escalation|Progressive Disease|2|||
49170968|NCT01667133|158460629|FG003|Phase 1: Dose-escalation|Progressive Disease|0|||
49170969|NCT01667133|158460630|FG004|Phase 1: Dose-escalation|Progressive Disease|1|||
49170970|NCT01667133|158460631|FG005|Phase 1: Dose-escalation|Progressive Disease|1|||
49170971|NCT01667133|158460632|FG006|Phase 1: Dose-escalation|Progressive Disease|1|||
49170972|NCT01667133|158460633|FG007|Phase 1: Dose-escalation|Progressive Disease|0|||
49170973|NCT01667133|158460634|FG008|Phase 1: Dose-escalation|Progressive Disease|0|||
49170974|NCT01667133|158460635|FG009|Phase 1: Dose-escalation|Progressive Disease|0|||
49170975|NCT01667133|158460636|FG010|Phase 1: Dose-escalation|Progressive Disease|0|||
49170976|NCT01667133|158460637|FG011|Phase 1: Dose-escalation|Progressive Disease|0|||
49170977|NCT01667133|158460626|FG000|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
49170978|NCT01667133|158460627|FG001|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
49170979|NCT01667133|158460628|FG002|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
49170980|NCT01667133|158460629|FG003|Phase 1: Dose-escalation|Withdrawal by Subject|1|||
49170981|NCT01667133|158460630|FG004|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
49170982|NCT01667133|158460631|FG005|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
49170983|NCT01667133|158460632|FG006|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
49170984|NCT01667133|158460633|FG007|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
49170985|NCT01667133|158460634|FG008|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
49170986|NCT01667133|158460635|FG009|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
49170987|NCT01667133|158460636|FG010|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
49170988|NCT01667133|158460637|FG011|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
49170989|NCT01667133|158460626|FG000|Phase 2: Dose-expansion|Adverse Event|0|||
49170990|NCT01667133|158460627|FG001|Phase 2: Dose-expansion|Adverse Event|0|||
49170991|NCT01667133|158460628|FG002|Phase 2: Dose-expansion|Adverse Event|0|||
49170992|NCT01667133|158460629|FG003|Phase 2: Dose-expansion|Adverse Event|0|||
49170993|NCT01667133|158460630|FG004|Phase 2: Dose-expansion|Adverse Event|0|||
49170994|NCT01667133|158460631|FG005|Phase 2: Dose-expansion|Adverse Event|0|||
49170995|NCT01667133|158460632|FG006|Phase 2: Dose-expansion|Adverse Event|0|||
48842123|NCT02706717|157262392|FG000|Overall Study|Withdrawal by Subject|1|||
48842124|NCT02706717|157262393|FG001|Overall Study|Withdrawal by Subject|8|||
48842125|NCT02706717|157262392|FG000|Overall Study|Lost to Follow-up|0|||
48842126|NCT02706717|157262393|FG001|Overall Study|Lost to Follow-up|1|||
48842127|NCT02706717|157262392|FG000|Overall Study|Physician Decision|0|||
48842128|NCT02706717|157262393|FG001|Overall Study|Physician Decision|1|||
48842129|NCT02706717|157262392|FG000|Overall Study|Death|0|||
48842130|NCT02706717|157262393|FG001|Overall Study|Death|1|||
48842131|NCT00293293|157262394|FG000|Overall Study|Withdrawal by Subject|1|||
48842132|NCT00293293|157262395|FG001|Overall Study|Withdrawal by Subject|1|||
48842133|NCT00293293|157262394|FG000|Overall Study|"Patient too anxious to complete trial"|1|||
48842134|NCT00293293|157262395|FG001|Overall Study|"Patient too anxious to complete trial"|0|||
48842135|NCT00293293|157262394|FG000|Overall Study|Patient discontinued chemotherapy|0|||
48842136|NCT00293293|157262395|FG001|Overall Study|Patient discontinued chemotherapy|1|||
48842137|NCT00638963|157262397|FG000|Overall Study|Withdrawal by Subject|1|||
48842138|NCT00638963|157262398|FG001|Overall Study|Withdrawal by Subject|0|||
48842139|NCT01185782|157262401|FG000|Overall Study|Adverse Event|0|||
48842140|NCT01185782|157262402|FG001|Overall Study|Adverse Event|1|||
48842141|NCT01185782|157262401|FG000|Overall Study|Protocol Violation|1|||
48842142|NCT01185782|157262402|FG001|Overall Study|Protocol Violation|0|||
48842143|NCT01185782|157262401|FG000|Overall Study|Poor Response to Treatment|3|||
49170996|NCT01667133|158460633|FG007|Phase 2: Dose-expansion|Adverse Event|2|||
49170997|NCT01667133|158460634|FG008|Phase 2: Dose-expansion|Adverse Event|1|||
49170998|NCT01667133|158460635|FG009|Phase 2: Dose-expansion|Adverse Event|1|||
49170999|NCT01667133|158460636|FG010|Phase 2: Dose-expansion|Adverse Event|0|||
49171000|NCT01667133|158460637|FG011|Phase 2: Dose-expansion|Adverse Event|0|||
49171001|NCT01667133|158460626|FG000|Phase 2: Dose-expansion|Lack of Efficacy|0|||
48926179|NCT00953758|157561837|FG004|Overall Study|Physician Decision|1|||
48926180|NCT00953758|157561838|FG005|Overall Study|Physician Decision|0|||
48926181|NCT00953758|157561839|FG006|Overall Study|Physician Decision|0|||
49171002|NCT01667133|158460627|FG001|Phase 2: Dose-expansion|Lack of Efficacy|0|||
49171003|NCT01667133|158460628|FG002|Phase 2: Dose-expansion|Lack of Efficacy|0|||
49171004|NCT01667133|158460629|FG003|Phase 2: Dose-expansion|Lack of Efficacy|0|||
49171005|NCT01667133|158460630|FG004|Phase 2: Dose-expansion|Lack of Efficacy|0|||
49171006|NCT01667133|158460631|FG005|Phase 2: Dose-expansion|Lack of Efficacy|0|||
48842144|NCT01185782|157262402|FG001|Overall Study|Poor Response to Treatment|1|||
48842145|NCT01185782|157262401|FG000|Overall Study|Other|2|||
48842146|NCT01185782|157262402|FG001|Overall Study|Other|5|||
48842147|NCT01185782|157262401|FG000|Overall Study|Randomized but not treated|0|||
48842148|NCT01185782|157262402|FG001|Overall Study|Randomized but not treated|4|||
48842149|NCT00444600|157262403|FG000|Overall Study|Death|7|||
48842150|NCT00444600|157262404|FG001|Overall Study|Death|5|||
48842151|NCT00444600|157262405|FG002|Overall Study|Death|3|||
48842152|NCT00444600|157262406|FG003|Overall Study|Death|2|||
48842153|NCT00444600|157262403|FG000|Overall Study|Dropped|11|||
48842154|NCT00444600|157262404|FG001|Overall Study|Dropped|11|||
48842155|NCT00444600|157262405|FG002|Overall Study|Dropped|7|||
48842156|NCT00444600|157262406|FG003|Overall Study|Dropped|7|||
48842157|NCT00444600|157262403|FG000|Overall Study|Missed visit|1|||
48842158|NCT00444600|157262404|FG001|Overall Study|Missed visit|0|||
48842159|NCT00444600|157262405|FG002|Overall Study|Missed visit|0|||
49171007|NCT01667133|158460632|FG006|Phase 2: Dose-expansion|Lack of Efficacy|0|||
49171008|NCT01667133|158460633|FG007|Phase 2: Dose-expansion|Lack of Efficacy|0|||
49171009|NCT01667133|158460634|FG008|Phase 2: Dose-expansion|Lack of Efficacy|0|||
49171010|NCT01667133|158460635|FG009|Phase 2: Dose-expansion|Lack of Efficacy|2|||
49171011|NCT01667133|158460636|FG010|Phase 2: Dose-expansion|Lack of Efficacy|0|||
49171012|NCT01667133|158460637|FG011|Phase 2: Dose-expansion|Lack of Efficacy|0|||
49171013|NCT01667133|158460626|FG000|Phase 2: Dose-expansion|Progressive Disease|0|||
49171014|NCT01667133|158460627|FG001|Phase 2: Dose-expansion|Progressive Disease|0|||
49171015|NCT01667133|158460628|FG002|Phase 2: Dose-expansion|Progressive Disease|0|||
49171016|NCT01667133|158460629|FG003|Phase 2: Dose-expansion|Progressive Disease|0|||
49171017|NCT01667133|158460630|FG004|Phase 2: Dose-expansion|Progressive Disease|0|||
49171018|NCT01667133|158460631|FG005|Phase 2: Dose-expansion|Progressive Disease|0|||
49171019|NCT01667133|158460632|FG006|Phase 2: Dose-expansion|Progressive Disease|0|||
49171020|NCT01667133|158460633|FG007|Phase 2: Dose-expansion|Progressive Disease|0|||
49171021|NCT01667133|158460634|FG008|Phase 2: Dose-expansion|Progressive Disease|0|||
49171022|NCT01667133|158460635|FG009|Phase 2: Dose-expansion|Progressive Disease|0|||
49171023|NCT01667133|158460636|FG010|Phase 2: Dose-expansion|Progressive Disease|3|||
49171024|NCT01667133|158460637|FG011|Phase 2: Dose-expansion|Progressive Disease|5|||
49171025|NCT01667133|158460626|FG000|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
49171026|NCT01667133|158460627|FG001|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
49171027|NCT01667133|158460628|FG002|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
49171028|NCT01667133|158460629|FG003|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
49171029|NCT01667133|158460630|FG004|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
49171030|NCT01667133|158460631|FG005|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
49171031|NCT01667133|158460632|FG006|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
49171032|NCT01667133|158460633|FG007|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
49171033|NCT01667133|158460634|FG008|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
49171034|NCT01667133|158460635|FG009|Phase 2: Dose-expansion|Withdrawal by Subject|2|||
49171035|NCT01667133|158460636|FG010|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
49171036|NCT01667133|158460637|FG011|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
49171037|NCT01667133|158460626|FG000|Phase 2: Dose-expansion|Death|0|||
49171038|NCT01667133|158460627|FG001|Phase 2: Dose-expansion|Death|0|||
49171039|NCT01667133|158460628|FG002|Phase 2: Dose-expansion|Death|0|||
49171040|NCT01667133|158460629|FG003|Phase 2: Dose-expansion|Death|0|||
49171041|NCT01667133|158460630|FG004|Phase 2: Dose-expansion|Death|0|||
49171042|NCT01667133|158460631|FG005|Phase 2: Dose-expansion|Death|0|||
49171043|NCT01667133|158460632|FG006|Phase 2: Dose-expansion|Death|0|||
49171044|NCT01667133|158460633|FG007|Phase 2: Dose-expansion|Death|0|||
49171045|NCT01667133|158460634|FG008|Phase 2: Dose-expansion|Death|0|||
49171046|NCT01667133|158460635|FG009|Phase 2: Dose-expansion|Death|1|||
49171047|NCT01667133|158460636|FG010|Phase 2: Dose-expansion|Death|0|||
49171048|NCT01667133|158460637|FG011|Phase 2: Dose-expansion|Death|0|||
49171049|NCT01667133|158460626|FG000|Phase 2: Dose-expansion|Other|0|||
49171050|NCT01667133|158460627|FG001|Phase 2: Dose-expansion|Other|0|||
49171051|NCT01667133|158460628|FG002|Phase 2: Dose-expansion|Other|0|||
49171052|NCT01667133|158460629|FG003|Phase 2: Dose-expansion|Other|0|||
49171053|NCT01667133|158460630|FG004|Phase 2: Dose-expansion|Other|0|||
49171054|NCT01667133|158460631|FG005|Phase 2: Dose-expansion|Other|0|||
49171055|NCT01667133|158460632|FG006|Phase 2: Dose-expansion|Other|0|||
48842160|NCT00444600|157262406|FG003|Overall Study|Missed visit|1|||
48842161|NCT05132478|157262407|FG000|Overall Study|did not complete survey after consent|1|||
49171056|NCT01667133|158460633|FG007|Phase 2: Dose-expansion|Other|0|||
49171057|NCT01667133|158460634|FG008|Phase 2: Dose-expansion|Other|0|||
48926182|NCT00953758|157561840|FG007|Overall Study|Physician Decision|0|||
48926183|NCT00953758|157561841|FG008|Overall Study|Physician Decision|0|||
48926184|NCT00953758|157561842|FG009|Overall Study|Physician Decision|0|||
48926185|NCT00953758|157561833|FG000|Overall Study|Disease progression|0|||
48926186|NCT00953758|157561834|FG001|Overall Study|Disease progression|0|||
48926187|NCT00953758|157561835|FG002|Overall Study|Disease progression|0|||
48926188|NCT00953758|157561836|FG003|Overall Study|Disease progression|0|||
48926189|NCT00953758|157561837|FG004|Overall Study|Disease progression|1|||
48926190|NCT00953758|157561838|FG005|Overall Study|Disease progression|0|||
48926191|NCT00953758|157561839|FG006|Overall Study|Disease progression|0|||
48926192|NCT00953758|157561840|FG007|Overall Study|Disease progression|0|||
48926193|NCT00953758|157561841|FG008|Overall Study|Disease progression|0|||
48926194|NCT00953758|157561842|FG009|Overall Study|Disease progression|0|||
48926195|NCT00953758|157561833|FG000|Overall Study|Participant went for transplant|0|||
48926196|NCT00953758|157561834|FG001|Overall Study|Participant went for transplant|0|||
48926197|NCT00953758|157561835|FG002|Overall Study|Participant went for transplant|0|||
48926198|NCT00953758|157561836|FG003|Overall Study|Participant went for transplant|0|||
48926199|NCT00953758|157561837|FG004|Overall Study|Participant went for transplant|0|||
48926200|NCT00953758|157561838|FG005|Overall Study|Participant went for transplant|0|||
48926201|NCT00953758|157561839|FG006|Overall Study|Participant went for transplant|0|||
49171058|NCT01667133|158460635|FG009|Phase 2: Dose-expansion|Other|0|||
49171059|NCT01667133|158460636|FG010|Phase 2: Dose-expansion|Other|0|||
49171060|NCT01667133|158460637|FG011|Phase 2: Dose-expansion|Other|1|||
49171061|NCT01916824|158460642|FG000|Overall Study|Lost to Follow-up|3|||
49171062|NCT01916824|158460643|FG001|Overall Study|Lost to Follow-up|6|||
49171063|NCT01916824|158460642|FG000|Overall Study|Physician Decision|2|||
49171064|NCT01916824|158460643|FG001|Overall Study|Physician Decision|0|||
49171065|NCT01916824|158460642|FG000|Overall Study|Withdrawal by Subject|2|||
49171066|NCT01916824|158460643|FG001|Overall Study|Withdrawal by Subject|3|||
49171067|NCT00771927|158460646|FG000|Overall Study|Adverse Event|100|||
49171068|NCT00771927|158460647|FG001|Overall Study|Adverse Event|105|||
49171069|NCT00771927|158460646|FG000|Overall Study|Lack of Efficacy|70|||
49171070|NCT00771927|158460647|FG001|Overall Study|Lack of Efficacy|42|||
48926202|NCT00953758|157561840|FG007|Overall Study|Participant went for transplant|0|||
49171071|NCT00771927|158460646|FG000|Overall Study|Lost to Follow-up|46|||
48926203|NCT00953758|157561841|FG008|Overall Study|Participant went for transplant|1|||
48926204|NCT00953758|157561842|FG009|Overall Study|Participant went for transplant|0|||
48926205|NCT02556255|157561843|FG000|Overall Study|Lost to Follow-up|4|||
48926206|NCT00744874|157561844|FG000|Overall Study|Lost to Follow-up|1|||
48926207|NCT00744874|157561844|FG000|Overall Study|Withdrawal by Subject|1|||
48926208|NCT00744874|157561844|FG000|Overall Study|Study Device not available at procedure|1|||
49171072|NCT00771927|158460647|FG001|Overall Study|Lost to Follow-up|46|||
49171073|NCT00771927|158460646|FG000|Overall Study|Withdrawal by Subject|16|||
49171074|NCT00771927|158460647|FG001|Overall Study|Withdrawal by Subject|17|||
49171075|NCT00771927|158460646|FG000|Overall Study|Other reason|23|||
49171076|NCT00771927|158460647|FG001|Overall Study|Other reason|27|||
49171077|NCT02676895|158460648|FG000|Overall Study|Administrative reason|1|||
49171078|NCT02676895|158460649|FG001|Overall Study|Administrative reason|0|||
49171079|NCT02676895|158460650|FG002|Overall Study|Administrative reason|0|||
49171080|NCT02676895|158460648|FG000|Overall Study|Protocol Violation|1|||
49171081|NCT02676895|158460649|FG001|Overall Study|Protocol Violation|0|||
49171082|NCT02676895|158460650|FG002|Overall Study|Protocol Violation|0|||
49171083|NCT02676895|158460648|FG000|Overall Study|Adverse Event|0|||
49171084|NCT02676895|158460649|FG001|Overall Study|Adverse Event|3|||
49171085|NCT02676895|158460650|FG002|Overall Study|Adverse Event|1|||
49171086|NCT02676895|158460648|FG000|Overall Study|Lost to Follow-up|0|||
49171087|NCT02676895|158460649|FG001|Overall Study|Lost to Follow-up|0|||
49171088|NCT02676895|158460650|FG002|Overall Study|Lost to Follow-up|1|||
49171089|NCT02676895|158460648|FG000|Overall Study|Withdrawal by Subject|0|||
49171090|NCT02676895|158460649|FG001|Overall Study|Withdrawal by Subject|0|||
49171091|NCT02676895|158460650|FG002|Overall Study|Withdrawal by Subject|1|||
49171092|NCT01221753|158460654|FG000|Overall Study|Adverse Event|1|||
49171093|NCT03299244|158460655|FG000|Overall Study|Withdrawal by Subject|34|||
49171094|NCT03299244|158460656|FG001|Overall Study|Withdrawal by Subject|29|||
49171095|NCT03299244|158460655|FG000|Overall Study|Decision by Sponsor|4|||
49171096|NCT03299244|158460656|FG001|Overall Study|Decision by Sponsor|5|||
49171097|NCT03299244|158460655|FG000|Overall Study|Death|9|||
49171098|NCT03299244|158460656|FG001|Overall Study|Death|4|||
49171099|NCT02467192|158460657|FG000|Overall Study|Death|1|||
49171100|NCT02467192|158460657|FG000|Overall Study|revealed to have pneumonia before|2|||
49171101|NCT00375505|158460665|FG000|Overall Study|Adverse Event|1|||
49171102|NCT00375505|158460666|FG001|Overall Study|Adverse Event|2|||
49171103|NCT02151786|158460671|FG000|Overall Study|Unavailability of Case Report Form|26|||
49171104|NCT02151786|158460671|FG000|Overall Study|Outside the Contract Period|1|||
49171105|NCT02151786|158460671|FG000|Overall Study|Randomized, not Treated|1|||
49171106|NCT02151786|158460671|FG000|Overall Study|Unavailability of Information|8|||
49171107|NCT00819156|158460672|FG000|Overall Study|Adverse Event|1|||
49171108|NCT00819156|158460673|FG001|Overall Study|Adverse Event|4|||
49171109|NCT00819156|158460674|FG002|Overall Study|Adverse Event|2|||
49171110|NCT00819156|158460675|FG003|Overall Study|Adverse Event|1|||
49171111|NCT00819156|158460676|FG004|Overall Study|Adverse Event|2|||
49171112|NCT00819156|158460677|FG005|Overall Study|Adverse Event|3|||
49171113|NCT00819156|158460672|FG000|Overall Study|Withdrawal by Subject|0|||
49171114|NCT00819156|158460673|FG001|Overall Study|Withdrawal by Subject|3|||
49171115|NCT00819156|158460674|FG002|Overall Study|Withdrawal by Subject|2|||
49171116|NCT00819156|158460675|FG003|Overall Study|Withdrawal by Subject|0|||
49171117|NCT00819156|158460676|FG004|Overall Study|Withdrawal by Subject|1|||
49171118|NCT00819156|158460677|FG005|Overall Study|Withdrawal by Subject|0|||
49171119|NCT00819156|158460672|FG000|Overall Study|Protocol Violation|1|||
49171120|NCT00819156|158460673|FG001|Overall Study|Protocol Violation|0|||
49171121|NCT00819156|158460674|FG002|Overall Study|Protocol Violation|1|||
49171122|NCT00819156|158460675|FG003|Overall Study|Protocol Violation|0|||
49171123|NCT00819156|158460676|FG004|Overall Study|Protocol Violation|0|||
49171124|NCT00819156|158460677|FG005|Overall Study|Protocol Violation|1|||
49171125|NCT00819156|158460672|FG000|Overall Study|Lost to Follow-up|0|||
49171126|NCT00819156|158460673|FG001|Overall Study|Lost to Follow-up|1|||
49171127|NCT00819156|158460674|FG002|Overall Study|Lost to Follow-up|0|||
49171128|NCT00819156|158460675|FG003|Overall Study|Lost to Follow-up|0|||
49171129|NCT00819156|158460676|FG004|Overall Study|Lost to Follow-up|0|||
49171130|NCT00819156|158460677|FG005|Overall Study|Lost to Follow-up|2|||
49171131|NCT00819156|158460672|FG000|Overall Study|Testosterone >1ng/ml from Day 28+|5|||
49171132|NCT00819156|158460673|FG001|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
49171133|NCT00819156|158460674|FG002|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
49171134|NCT00819156|158460675|FG003|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
49171135|NCT00819156|158460676|FG004|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
49171136|NCT00819156|158460677|FG005|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
49171137|NCT00819156|158460672|FG000|Overall Study|Testosterone >=.5ng/ml 2 visits|3|||
49171138|NCT00819156|158460673|FG001|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
49171139|NCT00819156|158460674|FG002|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
49171140|NCT00819156|158460675|FG003|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
49171141|NCT00819156|158460676|FG004|Overall Study|Testosterone >=.5ng/ml 2 visits|1|||
49171142|NCT00819156|158460677|FG005|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
49171143|NCT00819156|158460672|FG000|Overall Study|Prostate-specific antigen progression|0|||
49171144|NCT00819156|158460673|FG001|Overall Study|Prostate-specific antigen progression|0|||
49171145|NCT00819156|158460674|FG002|Overall Study|Prostate-specific antigen progression|0|||
49171146|NCT00819156|158460675|FG003|Overall Study|Prostate-specific antigen progression|0|||
49171147|NCT00819156|158460676|FG004|Overall Study|Prostate-specific antigen progression|1|||
49171148|NCT00819156|158460677|FG005|Overall Study|Prostate-specific antigen progression|0|||
49171149|NCT00803595|158460678|FG000|Overall Study|Adverse Event|3|||
49171150|NCT00803595|158460679|FG001|Overall Study|Adverse Event|4|||
49171151|NCT00803595|158460680|FG002|Overall Study|Adverse Event|1|||
49171152|NCT00803595|158460678|FG000|Overall Study|Protocol Violation|7|||
49171153|NCT00803595|158460679|FG001|Overall Study|Protocol Violation|2|||
48842162|NCT05132478|157262408|FG001|Overall Study|did not complete survey after consent|1|||
49171154|NCT00803595|158460680|FG002|Overall Study|Protocol Violation|12|||
49171155|NCT00803595|158460678|FG000|Overall Study|Withdrawal by Subject|5|||
49171156|NCT00803595|158460679|FG001|Overall Study|Withdrawal by Subject|2|||
49171157|NCT00803595|158460680|FG002|Overall Study|Withdrawal by Subject|3|||
49171158|NCT01248728|158460681|FG000|Overall Study|Adverse Event|1|||
49171159|NCT01248728|158460682|FG001|Overall Study|Adverse Event|1|||
49171160|NCT01248728|158460681|FG000|Overall Study|Withdrawal by Subject|2|||
49171161|NCT01248728|158460682|FG001|Overall Study|Withdrawal by Subject|1|||
49171162|NCT01248728|158460681|FG000|Overall Study|Lack of Efficacy|1|||
49171163|NCT01248728|158460682|FG001|Overall Study|Lack of Efficacy|0|||
49171164|NCT00104728|158460683|FG000|Overall Study|screen failures|19|||
49171165|NCT01673854|158460684|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7|||
49171166|NCT01673854|158460684|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6|||
49171167|NCT01673854|158460684|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2|||
49171168|NCT01673854|158460684|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1|||
49171169|NCT01673854|158460684|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1|||
49171170|NCT01673854|158460684|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1|||
49171171|NCT01673854|158460684|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2|||
49171172|NCT01673854|158460684|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7|||
49171173|NCT01673854|158460684|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12|||
49171174|NCT01673854|158460684|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5|||
49171175|NCT01673854|158460684|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1|||
48842163|NCT05132478|157262407|FG000|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
49171176|NCT01673854|158460684|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Death|1|||
49171177|NCT02297815|158462030|FG000|Overall Study|Lost to Follow-up|236|||
49171178|NCT02297815|158462031|FG001|Overall Study|Lost to Follow-up|140|||
49171179|NCT02522429|158462035|FG000|Overall Study|Lost to Follow-up|8|||
49171180|NCT02522429|158462035|FG000|Overall Study|Adverse Event|2|||
49171181|NCT02522429|158462035|FG000|Overall Study|Death|1|||
49171182|NCT02522429|158462035|FG000|Overall Study|Patient exceeded inclusion criteria after enrollment but prior to undergoing study procedures|1|||
49171183|NCT00294671|158462036|FG000|Overall Study|Lack of Efficacy|11|||
49171184|NCT00294671|158462037|FG001|Overall Study|Lack of Efficacy|23|||
49171185|NCT00294671|158462036|FG000|Overall Study|Liver transplant|7|||
49171186|NCT00294671|158462037|FG001|Overall Study|Liver transplant|9|||
49171187|NCT00294671|158462036|FG000|Overall Study|Drug related adverse event (AE)|4|||
49171188|NCT00294671|158462037|FG001|Overall Study|Drug related adverse event (AE)|2|||
49171189|NCT00294671|158462036|FG000|Overall Study|Non-drug related AE|3|||
49171190|NCT00294671|158462037|FG001|Overall Study|Non-drug related AE|2|||
49171191|NCT00294671|158462036|FG000|Overall Study|Lost to Follow-up|1|||
49171192|NCT00294671|158462037|FG001|Overall Study|Lost to Follow-up|3|||
49171193|NCT00294671|158462036|FG000|Overall Study|Non-compliance|1|||
49171194|NCT00294671|158462037|FG001|Overall Study|Non-compliance|0|||
49171195|NCT00294671|158462036|FG000|Overall Study|Death|0|||
49171196|NCT00294671|158462037|FG001|Overall Study|Death|1|||
49171197|NCT00456755|158462044|FG000|Overall Study|Lost to Follow-up|2|||
49171198|NCT00456755|158462045|FG001|Overall Study|Lost to Follow-up|1|||
49171199|NCT02964273|158462046|FG000|Phase A: Double-blind Period (12 Months)|Adverse Events|1|||
49171200|NCT02964273|158462047|FG001|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
49171201|NCT02964273|158462048|FG002|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
49171202|NCT02964273|158462049|FG003|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
49171203|NCT02964273|158462046|FG000|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
49171204|NCT02964273|158462047|FG001|Phase A: Double-blind Period (12 Months)|Physician Decision|2|||
49171205|NCT02964273|158462048|FG002|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
49171206|NCT02964273|158462049|FG003|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
49171207|NCT02964273|158462046|FG000|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|3|||
49171208|NCT02964273|158462047|FG001|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|1|||
49171209|NCT02964273|158462048|FG002|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
49171210|NCT02964273|158462049|FG003|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
49171211|NCT02964273|158462046|FG000|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
49171212|NCT02964273|158462047|FG001|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
49171213|NCT02964273|158462048|FG002|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
49171214|NCT02964273|158462049|FG003|Phase B: Open-label Period (24 Months)|Adverse Events|2|||
49171215|NCT02964273|158462046|FG000|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
49171216|NCT02964273|158462047|FG001|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
49171217|NCT02964273|158462048|FG002|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|4|||
49171218|NCT02964273|158462049|FG003|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|3|||
49171219|NCT02964273|158462046|FG000|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
49171220|NCT02964273|158462047|FG001|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
49171221|NCT02964273|158462048|FG002|Phase B: Open-label Period (24 Months)|Reason Not Specified|2|||
49171222|NCT02964273|158462049|FG003|Phase B: Open-label Period (24 Months)|Reason Not Specified|1|||
49171223|NCT01453036|158462053|FG000|Overall Study|Lost to Follow-up|26|||
49171224|NCT01453036|158462054|FG001|Overall Study|Lost to Follow-up|115|||
49171225|NCT01453036|158462055|FG002|Overall Study|Lost to Follow-up|31|||
49171226|NCT04723355|158462056|FG000|Overall Study|Issues with leads off, substantial ECG signal artefacts, and ECG data upload errors|50|||
49171227|NCT04723355|158462056|FG000|Overall Study|Errors in the informed consent form|2|||
49171228|NCT04072835|158462057|FG000|Overall Study|Overall trial ended|603|||
49171229|NCT04072835|158462057|FG000|Overall Study|Ablation|97|||
49171230|NCT04072835|158462057|FG000|Overall Study|Withdrawal of consent|66|||
49171231|NCT04072835|158462057|FG000|Overall Study|Physician Decision|50|||
49171232|NCT04072835|158462057|FG000|Overall Study|Lost to Follow-up|39|||
49171233|NCT04072835|158462057|FG000|Overall Study|Participant no longer meets the inclusion/exclusion criteria|38|||
49171234|NCT04072835|158462057|FG000|Overall Study|Participant wanted to try other therapy or treatment|34|||
49171235|NCT04072835|158462057|FG000|Overall Study|Adverse Event|25|||
49171236|NCT04072835|158462057|FG000|Overall Study|Participant non-compliance / Protocol violation(s)|25|||
49171237|NCT04072835|158462057|FG000|Overall Study|Death|11|||
49171238|NCT04072835|158462057|FG000|Overall Study|Participant felt the drug did not work|8|||
49171239|NCT04072835|158462057|FG000|Overall Study|Participant tolerability|5|||
49171240|NCT04072835|158462057|FG000|Overall Study|Missing|5|||
49171241|NCT04072835|158462057|FG000|Overall Study|Participant withdrawn due to COVID-19 situation|4|||
49171242|NCT04072835|158462057|FG000|Overall Study|Pregnancy|3|||
49171243|NCT01336712|158462058|FG000|Overall Study|Death|2|||
49171244|NCT01336712|158462058|FG000|Overall Study|Lack of Efficacy|1|||
49171245|NCT00620373|158462060|FG000|Overall Study|Unverified cancer status|33|||
49171246|NCT00399568|158462061|FG000|Overall Study|Adverse Event|1|||
49171247|NCT00399568|158462062|FG001|Overall Study|Adverse Event|2|||
49171248|NCT00399568|158462061|FG000|Overall Study|Withdrawal by Subject|7|||
49171249|NCT00399568|158462062|FG001|Overall Study|Withdrawal by Subject|3|||
49171250|NCT00399568|158462061|FG000|Overall Study|Protocol non-compliance|2|||
49171251|NCT00399568|158462062|FG001|Overall Study|Protocol non-compliance|2|||
48926209|NCT00744874|157561844|FG000|Overall Study|Unable to accomodate schedule|1|||
48951838|NCT01993329|157654911|FG003|Wash-out|Personal reasons|0|||
49171252|NCT00399568|158462061|FG000|Overall Study|Lost to Follow-up|2|||
49171253|NCT00399568|158462062|FG001|Overall Study|Lost to Follow-up|2|||
48842164|NCT05132478|157262408|FG001|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
48926210|NCT03115151|157561847|FG000|Overall Study|Intervention discontinue due to clinical condition|2|||
48842165|NCT05382104|157262410|FG000|Period 2 (2 Days)|Adverse Event|0|||
48842166|NCT05382104|157262411|FG001|Period 2 (2 Days)|Adverse Event|1|||
48842167|NCT05382104|157262412|FG002|Period 2 (2 Days)|Adverse Event|0|||
48842168|NCT05382104|157262413|FG003|Period 2 (2 Days)|Adverse Event|0|||
48842169|NCT05382104|157262414|FG004|Period 2 (2 Days)|Adverse Event|0|||
48842170|NCT05382104|157262415|FG005|Period 2 (2 Days)|Adverse Event|0|||
48842171|NCT02957136|157262416|FG000|Overall Study|Withdrawal by Subject|2|||
48842172|NCT02957136|157262417|FG001|Overall Study|Withdrawal by Subject|1|||
48842173|NCT02423291|157262419|FG000|Overall Study|Lack of Efficacy|14|||
48842174|NCT02423291|157262419|FG000|Overall Study|Adverse Event|1|||
48842175|NCT02115139|157262429|FG000|Overall Study|Protocol Violation|1|||
48926211|NCT03115151|157561848|FG001|Overall Study|Intervention discontinue due to clinical condition|2|||
48926212|NCT03115151|157561847|FG000|Overall Study|Epidural catheter removal|1|||
48926213|NCT03115151|157561848|FG001|Overall Study|Epidural catheter removal|0|||
48926214|NCT03115151|157561847|FG000|Overall Study|Withdrawal by Subject|0|||
48926215|NCT03115151|157561848|FG001|Overall Study|Withdrawal by Subject|1|||
48926216|NCT03115151|157561847|FG000|Overall Study|Intervention not received according to the protocol.|1|||
48926217|NCT03115151|157561848|FG001|Overall Study|Intervention not received according to the protocol.|1|||
48926218|NCT03115151|157561847|FG000|Overall Study|Physician Decision|1|||
48926219|NCT03115151|157561848|FG001|Overall Study|Physician Decision|0|||
48926220|NCT03115151|157561847|FG000|Overall Study|Randomization not applied|1|||
48926221|NCT03115151|157561848|FG001|Overall Study|Randomization not applied|1|||
48926222|NCT03403205|157561852|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|4|||
48926223|NCT03403205|157561853|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
48926224|NCT03403205|157561854|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
48926225|NCT03403205|157561855|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
48926226|NCT03403205|157561856|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
49171254|NCT00958360|158462063|FG000|Overall Study|Withdrawal by Subject|3|||
49171255|NCT00958360|158462064|FG001|Overall Study|Withdrawal by Subject|1|||
49171256|NCT00958360|158462063|FG000|Overall Study|Death|6|||
49171257|NCT00958360|158462064|FG001|Overall Study|Death|7|||
49171258|NCT00958360|158462063|FG000|Overall Study|Physician Decision|2|||
49171259|NCT00958360|158462064|FG001|Overall Study|Physician Decision|1|||
49171260|NCT00958360|158462063|FG000|Overall Study|Lost to Follow-up|0|||
49171261|NCT00958360|158462064|FG001|Overall Study|Lost to Follow-up|1|||
49171262|NCT01061723|158462065|FG000|Overall Study|Adverse Event|0|||
49171263|NCT01061723|158462066|FG001|Overall Study|Adverse Event|2|||
49171264|NCT01061723|158462067|FG002|Overall Study|Adverse Event|5|||
49171265|NCT01061723|158462068|FG003|Overall Study|Adverse Event|5|||
49171266|NCT01061723|158462069|FG004|Overall Study|Adverse Event|2|||
48842176|NCT02115139|157262429|FG000|Overall Study|treatment discontinuation|6|||
48842177|NCT03403413|157262430|FG000|Overall Study|Lack of Efficacy|2|||
49171267|NCT01061723|158462070|FG005|Overall Study|Adverse Event|6|||
49171268|NCT01061723|158462065|FG000|Overall Study|Lack of Efficacy|2|||
49171269|NCT01061723|158462066|FG001|Overall Study|Lack of Efficacy|3|||
48842178|NCT03684044|157262433|FG000|Overall Study|Adverse Event|3|||
48842179|NCT03684044|157262434|FG001|Overall Study|Adverse Event|0|||
48842180|NCT03684044|157262433|FG000|Overall Study|Death|4|||
48842181|NCT03684044|157262434|FG001|Overall Study|Death|7|||
48842182|NCT03684044|157262433|FG000|Overall Study|Lost to Follow-up|3|||
48926227|NCT03403205|157561857|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
48926228|NCT03403205|157561852|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|4|||
48926229|NCT03403205|157561853|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
48926230|NCT03403205|157561854|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
48926231|NCT03403205|157561855|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
48926232|NCT03403205|157561856|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
48926233|NCT03403205|157561857|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
48926234|NCT03403205|157561852|FG000|Primary Evaluation Period (48 Weeks)|Death|1|||
48926235|NCT03403205|157561853|FG001|Primary Evaluation Period (48 Weeks)|Death|0|||
48926236|NCT03403205|157561854|FG002|Primary Evaluation Period (48 Weeks)|Death|1|||
48926237|NCT03403205|157561855|FG003|Primary Evaluation Period (48 Weeks)|Death|0|||
48926238|NCT03403205|157561856|FG004|Primary Evaluation Period (48 Weeks)|Death|0|||
48926239|NCT03403205|157561857|FG005|Primary Evaluation Period (48 Weeks)|Death|0|||
48926240|NCT03403205|157561852|FG000|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
48926241|NCT03403205|157561853|FG001|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
48926242|NCT03403205|157561854|FG002|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
48926243|NCT03403205|157561855|FG003|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
48926244|NCT03403205|157561856|FG004|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
48926245|NCT03403205|157561857|FG005|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
49171270|NCT01061723|158462067|FG002|Overall Study|Lack of Efficacy|4|||
49171271|NCT01061723|158462068|FG003|Overall Study|Lack of Efficacy|2|||
49171272|NCT01061723|158462069|FG004|Overall Study|Lack of Efficacy|1|||
49171273|NCT01061723|158462070|FG005|Overall Study|Lack of Efficacy|1|||
49171274|NCT01061723|158462065|FG000|Overall Study|Randomized but not treated|0|||
49171275|NCT01061723|158462066|FG001|Overall Study|Randomized but not treated|0|||
49171276|NCT01061723|158462067|FG002|Overall Study|Randomized but not treated|0|||
49171277|NCT01061723|158462068|FG003|Overall Study|Randomized but not treated|0|||
49171278|NCT01061723|158462069|FG004|Overall Study|Randomized but not treated|0|||
49171279|NCT01061723|158462070|FG005|Overall Study|Randomized but not treated|1|||
49171280|NCT01061723|158462065|FG000|Overall Study|Other than specified above|2|||
48842183|NCT03684044|157262434|FG001|Overall Study|Lost to Follow-up|2|||
48842184|NCT03684044|157262433|FG000|Overall Study|Patient Not Available|0|||
48842185|NCT03684044|157262434|FG001|Overall Study|Patient Not Available|2|||
48842186|NCT03684044|157262433|FG000|Overall Study|Physician Decision|1|||
48951839|NCT01993329|157654912|FG004|Wash-out|Personal reasons|0|||
49171281|NCT01061723|158462066|FG001|Overall Study|Other than specified above|1|||
49171282|NCT01061723|158462067|FG002|Overall Study|Other than specified above|1|||
49171283|NCT01061723|158462068|FG003|Overall Study|Other than specified above|1|||
49171284|NCT01061723|158462069|FG004|Overall Study|Other than specified above|0|||
49171285|NCT01061723|158462070|FG005|Overall Study|Other than specified above|1|||
48842187|NCT03684044|157262434|FG001|Overall Study|Physician Decision|0|||
48842188|NCT03684044|157262433|FG000|Overall Study|Withdrawal by Subject|11|||
48842189|NCT03684044|157262434|FG001|Overall Study|Withdrawal by Subject|9|||
48842190|NCT03233633|157262435|FG000|Overall Study|Adverse Event|2|||
48842191|NCT03233633|157262435|FG000|Overall Study|Less Than 3 Days of Data|6|||
48842192|NCT04740164|157262436|FG000|Overall Study|Lack of Efficacy|4|||
48842193|NCT04740164|157262437|FG001|Overall Study|Lack of Efficacy|0|||
48842194|NCT04740164|157262436|FG000|Overall Study|Physician Decision|3|||
48842195|NCT04740164|157262437|FG001|Overall Study|Physician Decision|3|||
48842196|NCT02412748|157262440|FG000|Overall Study|Lost to Follow-up|38|||
48842197|NCT02412748|157262441|FG001|Overall Study|Lost to Follow-up|39|||
48842198|NCT02692417|157262444|FG000|Overall Study|Withdrawal by Subject|5|||
48842199|NCT02692417|157262445|FG001|Overall Study|Withdrawal by Subject|1|||
48842200|NCT02692417|157262444|FG000|Overall Study|Adverse Event|1|||
48842201|NCT02692417|157262445|FG001|Overall Study|Adverse Event|0|||
48842202|NCT01199575|157262450|FG000|Overall Study|Withdrawal by Subject|5|||
48842203|NCT00704184|157262452|FG000|Double-Blind Treatment|Withdrawal by Subject|1|||
48842204|NCT00704184|157262453|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
48842205|NCT00704184|157262454|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
48842206|NCT00704184|157262455|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
48842207|NCT00704184|157262456|FG004|Double-Blind Treatment|Withdrawal by Subject|0|||
48842208|NCT00704184|157262452|FG000|Open-Label Treatment|Adverse Event|0|||
48842209|NCT00704184|157262453|FG001|Open-Label Treatment|Adverse Event|0|||
48926246|NCT03403205|157561852|FG000|Primary Evaluation Period (48 Weeks)|Pregnancy|1|||
48926247|NCT03403205|157561853|FG001|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
48926248|NCT03403205|157561854|FG002|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
48926249|NCT03403205|157561855|FG003|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
48926250|NCT03403205|157561856|FG004|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
48926251|NCT03403205|157561857|FG005|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
48926252|NCT03403205|157561852|FG000|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
48926253|NCT03403205|157561853|FG001|Primary Evaluation Period (48 Weeks)|Protocol Deviation|1|||
48926254|NCT03403205|157561854|FG002|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
49171286|NCT00841776|158462071|FG000|Overall Study|Lack of Efficacy|0|||
49171287|NCT00841776|158462072|FG001|Overall Study|Lack of Efficacy|1|||
49171288|NCT00841776|158462071|FG000|Overall Study|Lost to Follow-up|2|||
49171289|NCT00841776|158462072|FG001|Overall Study|Lost to Follow-up|1|||
49171290|NCT00841776|158462071|FG000|Overall Study|Withdrawal by Subject|0|||
49171291|NCT00841776|158462072|FG001|Overall Study|Withdrawal by Subject|1|||
49171292|NCT00933608|158462073|FG000|Overall Study|Adverse Event|4|||
49171293|NCT00933608|158462074|FG001|Overall Study|Adverse Event|2|||
49171294|NCT00933608|158462073|FG000|Overall Study|Physician Decision|1|||
49171295|NCT00933608|158462074|FG001|Overall Study|Physician Decision|0|||
49171296|NCT01498692|158462081|FG000|Overall Study|Death|4|||
49171297|NCT01498692|158462081|FG000|Overall Study|Withdrawal by Subject|1|||
49171298|NCT01498692|158462081|FG000|Overall Study|Missed 12-month visit|3|||
49171299|NCT03050450|158462082|FG000|Overall Study|Physician Decision|1|||
49171300|NCT03050450|158462083|FG001|Overall Study|Physician Decision|0|||
49171301|NCT03050450|158462084|FG002|Overall Study|Physician Decision|0|||
49171302|NCT03050450|158462085|FG003|Overall Study|Physician Decision|0|||
49171303|NCT03050450|158462086|FG004|Overall Study|Physician Decision|0|||
49171304|NCT01642901|158462090|FG000|12-month Follow-up|Withdrawal by Subject|1|||
49171305|NCT01642901|158462091|FG001|12-month Follow-up|Withdrawal by Subject|0|||
49171306|NCT03592771|158462092|FG000|Overall Study|Adverse Event|2|||
49171307|NCT03592771|158462093|FG001|Overall Study|Adverse Event|0|||
49171308|NCT03592771|158462094|FG002|Overall Study|Adverse Event|1|||
49171309|NCT03592771|158462092|FG000|Overall Study|Death|0|||
49171310|NCT03592771|158462093|FG001|Overall Study|Death|1|||
49171311|NCT03592771|158462094|FG002|Overall Study|Death|1|||
49171312|NCT03592771|158462092|FG000|Overall Study|Lost to Follow-up|5|||
49171313|NCT03592771|158462093|FG001|Overall Study|Lost to Follow-up|11|||
49171314|NCT03592771|158462094|FG002|Overall Study|Lost to Follow-up|15|||
49171315|NCT03592771|158462092|FG000|Overall Study|Withdrawal by Subject|0|||
49171316|NCT03592771|158462093|FG001|Overall Study|Withdrawal by Subject|2|||
49171317|NCT03592771|158462094|FG002|Overall Study|Withdrawal by Subject|0|||
49171318|NCT02943070|158462095|FG000|Overall Study|Physician Decision|1|||
49171319|NCT02943070|158462095|FG000|Overall Study|Adverse Event|2|||
49171320|NCT02943070|158462095|FG000|Overall Study|Death|2|||
49171321|NCT02943070|158462095|FG000|Overall Study|Withdrawal by Subject|3|||
49171322|NCT02943070|158462095|FG000|Overall Study|Lost to Follow-up|4|||
49171323|NCT02943070|158462095|FG000|Overall Study|Retreatment or TURP|13|||
49171324|NCT02943070|158462095|FG000|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18|||
48842210|NCT00704184|157262454|FG002|Open-Label Treatment|Adverse Event|2|||
49171325|NCT01701362|158462096|FG000|Overall Study|Adverse events not related to study drug|1|||
49171326|NCT01701362|158462097|FG001|Overall Study|Adverse events not related to study drug|6|||
49171327|NCT01701362|158462096|FG000|Overall Study|Adverse events related to study drug|12|||
49171328|NCT01701362|158462097|FG001|Overall Study|Adverse events related to study drug|10|||
49171329|NCT01701362|158462096|FG000|Overall Study|Protocol Violation|5|||
49171330|NCT01701362|158462097|FG001|Overall Study|Protocol Violation|3|||
49171331|NCT01701362|158462096|FG000|Overall Study|No longer willing to participate|8|||
48842211|NCT00704184|157262455|FG003|Open-Label Treatment|Adverse Event|0|||
49171332|NCT01701362|158462097|FG001|Overall Study|No longer willing to participate|14|||
49171333|NCT01701362|158462096|FG000|Overall Study|Lost to Follow-up|6|||
49171334|NCT01701362|158462097|FG001|Overall Study|Lost to Follow-up|9|||
49171335|NCT01701362|158462096|FG000|Overall Study|Insufficient clinical response|6|||
49171336|NCT01701362|158462097|FG001|Overall Study|Insufficient clinical response|6|||
49171337|NCT01701362|158462096|FG000|Overall Study|Death|0|||
49171338|NCT01701362|158462097|FG001|Overall Study|Death|1|||
49171339|NCT01701362|158462096|FG000|Overall Study|Randomized but not treated|1|||
49171340|NCT01701362|158462097|FG001|Overall Study|Randomized but not treated|2|||
49171341|NCT01701362|158462096|FG000|Overall Study|Reasons other than those mentioned above|3|||
49171342|NCT01701362|158462097|FG001|Overall Study|Reasons other than those mentioned above|5|||
49171343|NCT03198767|158462098|FG000|Overall Study|Protocol Violation|0|||
49171344|NCT03198767|158462099|FG001|Overall Study|Protocol Violation|0|||
49171345|NCT03198767|158462100|FG002|Overall Study|Protocol Violation|0|||
49171346|NCT03198767|158462101|FG003|Overall Study|Protocol Violation|6|||
49171347|NCT03198767|158462102|FG004|Overall Study|Protocol Violation|0|||
49171348|NCT03198767|158462103|FG005|Overall Study|Protocol Violation|0|||
49171349|NCT03198767|158462104|FG006|Overall Study|Protocol Violation|0|||
49171350|NCT04556591|158462108|FG000|Overall Study|Lost to Follow-up|1|||
49171351|NCT04556591|158462109|FG001|Overall Study|Lost to Follow-up|0|||
49171352|NCT04556591|158462108|FG000|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|2|||
48842212|NCT00704184|157262456|FG004|Open-Label Treatment|Adverse Event|1|||
48842213|NCT00704184|157262452|FG000|Open-Label Treatment|Lack of Efficacy|0|||
48842214|NCT00704184|157262453|FG001|Open-Label Treatment|Lack of Efficacy|2|||
48842215|NCT00704184|157262454|FG002|Open-Label Treatment|Lack of Efficacy|2|||
48842216|NCT00704184|157262455|FG003|Open-Label Treatment|Lack of Efficacy|2|||
48842217|NCT00704184|157262456|FG004|Open-Label Treatment|Lack of Efficacy|1|||
48842218|NCT00704184|157262452|FG000|Open-Label Treatment|Physician Decision|0|||
48842219|NCT00704184|157262453|FG001|Open-Label Treatment|Physician Decision|0|||
48842220|NCT00704184|157262454|FG002|Open-Label Treatment|Physician Decision|0|||
48842221|NCT00704184|157262455|FG003|Open-Label Treatment|Physician Decision|0|||
48842222|NCT00704184|157262456|FG004|Open-Label Treatment|Physician Decision|1|||
49171353|NCT04556591|158462109|FG001|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|0|||
49171354|NCT04551963|158462110|FG000|Overall Study|Physician Decision|1|||
49171355|NCT04551963|158462111|FG001|Overall Study|Physician Decision|1|||
49171356|NCT04551963|158462110|FG000|Overall Study|Death|1|||
49171357|NCT04551963|158462111|FG001|Overall Study|Death|0|||
49171358|NCT03332173|158462112|FG000|Overall Study|Death|7|||
49171359|NCT03332173|158462112|FG000|Overall Study|Withdrawal by Subject|6|||
49171360|NCT03332173|158462112|FG000|Overall Study|Lost to Follow-up|2|||
49171361|NCT03332173|158462112|FG000|Overall Study|Transferred to long-term extension study|29|||
49171362|NCT00910910|158462113|FG000|Overall Study|Adverse Event|63|||
49171363|NCT00910910|158462114|FG001|Overall Study|Adverse Event|35|||
49171364|NCT00910910|158462113|FG000|Overall Study|PD without histologic change|27|||
49171365|NCT00910910|158462114|FG001|Overall Study|PD without histologic change|23|||
49171366|NCT00910910|158462113|FG000|Overall Study|PD with histologic change|0|||
49171367|NCT00910910|158462114|FG001|Overall Study|PD with histologic change|2|||
49171368|NCT00910910|158462113|FG000|Overall Study|Withdrawal by Subject|7|||
49171369|NCT00910910|158462114|FG001|Overall Study|Withdrawal by Subject|5|||
49171370|NCT00910910|158462113|FG000|Overall Study|Lost to Follow-up|2|||
49171371|NCT00910910|158462114|FG001|Overall Study|Lost to Follow-up|2|||
49171372|NCT00910910|158462113|FG000|Overall Study|Death|9|||
49171373|NCT00910910|158462114|FG001|Overall Study|Death|3|||
49171374|NCT00910910|158462113|FG000|Overall Study|Protocol Violation|2|||
49171375|NCT00910910|158462114|FG001|Overall Study|Protocol Violation|2|||
49171376|NCT00910910|158462113|FG000|Overall Study|Completed 13 cycles of treatment|0|||
49171377|NCT00910910|158462114|FG001|Overall Study|Completed 13 cycles of treatment|118|||
49171378|NCT00910910|158462113|FG000|Overall Study|Other|114|||
49171379|NCT00910910|158462114|FG001|Overall Study|Other|32|||
49171380|NCT00910910|158462113|FG000|Overall Study|Untreated before cycle 1|1|||
49171381|NCT00910910|158462114|FG001|Overall Study|Untreated before cycle 1|2|||
49171382|NCT01268046|158462116|FG000|Overall Study|Withdrawal by Subject|1|||
49171383|NCT01268046|158462117|FG001|Overall Study|Withdrawal by Subject|0|||
49171384|NCT01268046|158462118|FG002|Overall Study|Withdrawal by Subject|0|||
49171385|NCT01268046|158462119|FG003|Overall Study|Withdrawal by Subject|1|||
49171386|NCT01268046|158462116|FG000|Overall Study|Lost to Follow-up|0|||
49171387|NCT01268046|158462117|FG001|Overall Study|Lost to Follow-up|0|||
49171388|NCT01268046|158462118|FG002|Overall Study|Lost to Follow-up|1|||
49171389|NCT01268046|158462119|FG003|Overall Study|Lost to Follow-up|0|||
49171390|NCT02836717|158462129|FG000|Test Phase|Lack of Efficacy|14|||
49171391|NCT02836717|158462130|FG001|Test Phase|Lack of Efficacy|8|||
49171392|NCT02836717|158462131|FG002|Test Phase|Lack of Efficacy|0|||
49171393|NCT02836717|158462129|FG000|Study Phase|Adverse Event|2|||
49171394|NCT02836717|158462130|FG001|Study Phase|Adverse Event|0|||
49171395|NCT02836717|158462131|FG002|Study Phase|Adverse Event|0|||
48842223|NCT00704184|157262452|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
48842224|NCT00704184|157262453|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
48842225|NCT00704184|157262454|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
49171396|NCT02836717|158462129|FG000|Study Phase|Lack of Efficacy|8|||
48951840|NCT01993329|157654913|FG005|Wash-out|Personal reasons|0|||
49171397|NCT02836717|158462130|FG001|Study Phase|Lack of Efficacy|6|||
49171398|NCT02836717|158462131|FG002|Study Phase|Lack of Efficacy|1|||
49171399|NCT02836717|158462129|FG000|Study Phase|Withdrawal by Subject|1|||
49171400|NCT02836717|158462130|FG001|Study Phase|Withdrawal by Subject|0|||
49171401|NCT02836717|158462131|FG002|Study Phase|Withdrawal by Subject|0|||
49171402|NCT02836717|158462129|FG000|Study Phase|Death|1|||
49171403|NCT02836717|158462130|FG001|Study Phase|Death|0|||
49171404|NCT02836717|158462131|FG002|Study Phase|Death|0|||
49171405|NCT02836717|158462129|FG000|Study Phase|abdominal surgeries|2|||
49171406|NCT02836717|158462130|FG001|Study Phase|abdominal surgeries|1|||
49171407|NCT02836717|158462131|FG002|Study Phase|abdominal surgeries|0|||
49171408|NCT00758069|158462134|FG000|Overall Study|Lack of Efficacy|0|||
49171409|NCT00758069|158462135|FG001|Overall Study|Lack of Efficacy|0|||
49171410|NCT00758069|158462136|FG002|Overall Study|Lack of Efficacy|1|||
49171411|NCT00758069|158462134|FG000|Overall Study|Incorrect Study Drug|1|||
49171412|NCT00758069|158462135|FG001|Overall Study|Incorrect Study Drug|0|||
49171413|NCT00758069|158462136|FG002|Overall Study|Incorrect Study Drug|0|||
48926255|NCT03403205|157561855|FG003|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
48926256|NCT03403205|157561856|FG004|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
48926257|NCT03403205|157561857|FG005|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
48926258|NCT03403205|157561852|FG000|Primary Evaluation Period (48 Weeks)|Randomized but not treated|1|||
48926259|NCT03403205|157561853|FG001|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
48926260|NCT03403205|157561854|FG002|Primary Evaluation Period (48 Weeks)|Randomized but not treated|4|||
48926261|NCT03403205|157561855|FG003|Primary Evaluation Period (48 Weeks)|Randomized but not treated|2|||
48926262|NCT03403205|157561856|FG004|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
48926263|NCT03403205|157561857|FG005|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
48926264|NCT03403205|157561852|FG000|Extension Period (Up to 60 Months)|Withdrawal by Subject|6|||
48926265|NCT03403205|157561853|FG001|Extension Period (Up to 60 Months)|Withdrawal by Subject|7|||
49171414|NCT00588237|158462137|FG000|Overall Study|Evaluable for toxicity only|3|||
49171415|NCT00588237|158462137|FG000|Overall Study|Patien not treated|1|||
49171416|NCT02096952|158462138|FG000|Overall Study|Adverse Event|1|||
49171417|NCT03275246|158462139|FG000|Overall Study|Protocol Violation|5|||
49171418|NCT03275246|158462139|FG000|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1|||
49171419|NCT05059301|158462140|FG000|Overall Study|Adverse Event|0|||
49171420|NCT05059301|158462141|FG001|Overall Study|Adverse Event|2|||
49171421|NCT05059301|158462142|FG002|Overall Study|Adverse Event|2|||
49171422|NCT05059301|158462140|FG000|Overall Study|Lost to Follow-up|2|||
49171423|NCT05059301|158462141|FG001|Overall Study|Lost to Follow-up|3|||
49171424|NCT05059301|158462142|FG002|Overall Study|Lost to Follow-up|3|||
49171425|NCT00635349|158462143|FG000|Overall Study|Other|8|||
49171426|NCT00635349|158462144|FG001|Overall Study|Other|6|||
49171427|NCT00635349|158462143|FG000|Overall Study|Protocol Violation|18|||
49171428|NCT00635349|158462144|FG001|Overall Study|Protocol Violation|22|||
49171429|NCT00635349|158462143|FG000|Overall Study|Withdrawal by Subject|3|||
49171430|NCT00635349|158462144|FG001|Overall Study|Withdrawal by Subject|8|||
49171431|NCT00635349|158462143|FG000|Overall Study|Lost to Follow-up|4|||
49171432|NCT00635349|158462144|FG001|Overall Study|Lost to Follow-up|3|||
49171433|NCT00635349|158462143|FG000|Overall Study|Adverse Event|11|||
49171434|NCT00635349|158462144|FG001|Overall Study|Adverse Event|9|||
49171435|NCT03748706|158462151|FG000|Overall Study|Lost to Follow-up|1|||
49171436|NCT01345929|158462152|FG000|Overall Study|Withdrawal by Subject|9|||
49171437|NCT01345929|158462153|FG001|Overall Study|Withdrawal by Subject|8|||
49171438|NCT01345929|158462152|FG000|Overall Study|Lost to Follow-up|9|||
49171439|NCT01345929|158462153|FG001|Overall Study|Lost to Follow-up|9|||
49171440|NCT01345929|158462152|FG000|Overall Study|Adverse Event|0|||
49171441|NCT01345929|158462153|FG001|Overall Study|Adverse Event|1|||
49171442|NCT01345929|158462152|FG000|Overall Study|Didn't meet eligibility criteria|2|||
49171443|NCT01345929|158462153|FG001|Overall Study|Didn't meet eligibility criteria|0|||
49171444|NCT01345929|158462152|FG000|Overall Study|40,000 CFU/ML|1|||
49171445|NCT01345929|158462153|FG001|Overall Study|40,000 CFU/ML|0|||
49171446|NCT01345929|158462152|FG000|Overall Study|Patient withdrawal|0|||
49171447|NCT01345929|158462153|FG001|Overall Study|Patient withdrawal|1|||
49171448|NCT04482439|158462158|FG000|Overall Study|Lost to Follow-up|1|||
49171449|NCT04482439|158462158|FG000|Overall Study|Unrelated illness|1|||
49171450|NCT00402324|158462159|FG000|Overall Study|Lost to Follow-up|11|||
49171451|NCT00402324|158462160|FG001|Overall Study|Lost to Follow-up|11|||
49171452|NCT00402324|158462159|FG000|Overall Study|Protocol Entry Criteria Not Met|5|||
49171453|NCT00402324|158462160|FG001|Overall Study|Protocol Entry Criteria Not Met|4|||
49171454|NCT00402324|158462159|FG000|Overall Study|Protocol Violation|8|||
49171455|NCT00402324|158462160|FG001|Overall Study|Protocol Violation|7|||
49171456|NCT00402324|158462159|FG000|Overall Study|Withdrawal by Subject|5|||
49171457|NCT00402324|158462160|FG001|Overall Study|Withdrawal by Subject|2|||
49171458|NCT00402324|158462159|FG000|Overall Study|Physician Decision|2|||
49171459|NCT00402324|158462160|FG001|Overall Study|Physician Decision|4|||
49171460|NCT00402324|158462159|FG000|Overall Study|Sponsor Decision|4|||
49171461|NCT00402324|158462160|FG001|Overall Study|Sponsor Decision|5|||
49171462|NCT00402324|158462159|FG000|Overall Study|Lack of Efficacy|1|||
49171463|NCT00402324|158462160|FG001|Overall Study|Lack of Efficacy|4|||
49171464|NCT00402324|158462159|FG000|Overall Study|Adverse Event|6|||
49171465|NCT00402324|158462160|FG001|Overall Study|Adverse Event|4|||
49171466|NCT00402324|158462159|FG000|Overall Study|Death|1|||
49171467|NCT00402324|158462160|FG001|Overall Study|Death|0|||
49171468|NCT01670279|158462161|FG000|Overall Study|Adverse Event|0|||
49171469|NCT01670279|158462162|FG001|Overall Study|Adverse Event|1|||
49171470|NCT01670279|158462163|FG002|Overall Study|Adverse Event|0|||
49171471|NCT01670279|158462164|FG003|Overall Study|Adverse Event|0|||
49171472|NCT01670279|158462161|FG000|Overall Study|Physician Decision|0|||
49171473|NCT01670279|158462162|FG001|Overall Study|Physician Decision|1|||
49171474|NCT01670279|158462163|FG002|Overall Study|Physician Decision|0|||
49171475|NCT01670279|158462164|FG003|Overall Study|Physician Decision|0|||
49171476|NCT01670279|158462161|FG000|Overall Study|Participant met withdrawal criteria|0|||
49171477|NCT01670279|158462162|FG001|Overall Study|Participant met withdrawal criteria|0|||
49171478|NCT01670279|158462163|FG002|Overall Study|Participant met withdrawal criteria|0|||
49171479|NCT01670279|158462164|FG003|Overall Study|Participant met withdrawal criteria|1|||
49171480|NCT02318368|158462165|FG000|Overall Study|Withdrawal by Subject|2|||
49171481|NCT02318368|158462166|FG001|Overall Study|Withdrawal by Subject|0|||
49171482|NCT02318368|158462165|FG000|Overall Study|Study terminated by the sponsor|5|||
49171483|NCT02318368|158462166|FG001|Overall Study|Study terminated by the sponsor|2|||
49171484|NCT02318368|158462165|FG000|Overall Study|Death|0|||
49171485|NCT02318368|158462166|FG001|Overall Study|Death|1|||
49171486|NCT01901614|158462167|FG000|Overall Study|Adverse Event|0|||
49171487|NCT01901614|158462168|FG001|Overall Study|Adverse Event|1|||
49171488|NCT01901614|158462167|FG000|Overall Study|Lost to Follow-up|1|||
49171489|NCT01901614|158462168|FG001|Overall Study|Lost to Follow-up|0|||
49171490|NCT01901614|158462167|FG000|Overall Study|Screen Fail|1|||
49171491|NCT01901614|158462168|FG001|Overall Study|Screen Fail|0|||
49171492|NCT02201329|158462169|FG000|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3|||
49171493|NCT02201329|158462169|FG000|Overall Study|Withdrawal by Subject|2|||
49171494|NCT04153981|158462170|FG000|Overall Study|Death|1|||
49171495|NCT04153981|158462170|FG000|Overall Study|Withdrawal by Subject|24|||
49171496|NCT04153981|158462170|FG000|Overall Study|Lost to Follow-up|1|||
49171497|NCT04153981|158462170|FG000|Overall Study|Physician Decision|1|||
49171498|NCT04153981|158462170|FG000|Overall Study|Due to Unavailable Glucometer|1|||
49171499|NCT04153981|158462170|FG000|Overall Study|Covid 19|52|||
49171500|NCT04153981|158462170|FG000|Overall Study|Participant Dropped Out as Required Laboratory Test was Not Performed|5|||
49171501|NCT04153981|158462170|FG000|Overall Study|Due to Low Fasting Blood Sugar Levels|1|||
49171502|NCT00783835|158462171|FG000|Overall Study|Adverse Event|3|||
49171503|NCT00783835|158462171|FG000|Overall Study|Medical Criteria|1|||
49171504|NCT00783835|158462171|FG000|Overall Study|Withdrawal by Subject|2|||
49171505|NCT00783835|158462171|FG000|Overall Study|Lost to Follow-up|1|||
49171506|NCT00783835|158462171|FG000|Overall Study|Participant not Adherent|3|||
49171507|NCT03835481|158462175|FG000|Double-blind Period|Other not stated below|0|||
49171508|NCT03835481|158462176|FG001|Double-blind Period|Other not stated below|0|||
49171509|NCT03835481|158462177|FG002|Double-blind Period|Other not stated below|0|||
49171510|NCT03835481|158462178|FG003|Double-blind Period|Other not stated below|1|||
49171511|NCT03835481|158462179|FG004|Double-blind Period|Other not stated below|1|||
49171512|NCT03835481|158462175|FG000|Double-blind Period|Termination of treatment by sponsor|0|||
49171513|NCT03835481|158462176|FG001|Double-blind Period|Termination of treatment by sponsor|0|||
49171514|NCT03835481|158462177|FG002|Double-blind Period|Termination of treatment by sponsor|0|||
48842226|NCT00704184|157262455|FG003|Open-Label Treatment|Withdrawal by Subject|3|||
48842227|NCT00704184|157262456|FG004|Open-Label Treatment|Withdrawal by Subject|0|||
48842228|NCT04732338|157262457|FG000|Overall Study|Lost to Follow-up|3|||
49171515|NCT03835481|158462178|FG003|Double-blind Period|Termination of treatment by sponsor|0|||
48842229|NCT04732338|157262458|FG001|Overall Study|Lost to Follow-up|3|||
49171516|NCT03835481|158462179|FG004|Double-blind Period|Termination of treatment by sponsor|35|||
49171517|NCT03835481|158462175|FG000|Double-blind Period|Withdrawal by Subject|0|||
49171518|NCT03835481|158462176|FG001|Double-blind Period|Withdrawal by Subject|0|||
49171519|NCT03835481|158462177|FG002|Double-blind Period|Withdrawal by Subject|1|||
49171520|NCT03835481|158462178|FG003|Double-blind Period|Withdrawal by Subject|0|||
49171521|NCT03835481|158462179|FG004|Double-blind Period|Withdrawal by Subject|5|||
49171522|NCT03835481|158462175|FG000|Double-blind Period|Lost to Follow-up|0|||
49171523|NCT03835481|158462176|FG001|Double-blind Period|Lost to Follow-up|0|||
49171524|NCT03835481|158462177|FG002|Double-blind Period|Lost to Follow-up|0|||
49171525|NCT03835481|158462178|FG003|Double-blind Period|Lost to Follow-up|1|||
49171526|NCT03835481|158462179|FG004|Double-blind Period|Lost to Follow-up|0|||
49171527|NCT03835481|158462175|FG000|Double-blind Period|Protocol Violation|0|||
49171528|NCT03835481|158462176|FG001|Double-blind Period|Protocol Violation|2|||
49171529|NCT03835481|158462177|FG002|Double-blind Period|Protocol Violation|0|||
49171530|NCT03835481|158462178|FG003|Double-blind Period|Protocol Violation|1|||
49171531|NCT03835481|158462179|FG004|Double-blind Period|Protocol Violation|0|||
49171532|NCT03835481|158462175|FG000|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
49171533|NCT03835481|158462176|FG001|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
49171534|NCT03835481|158462177|FG002|Open Label Period (After Week 12)|Termination of treatment by Sponsor|23|||
49171535|NCT03835481|158462178|FG003|Open Label Period (After Week 12)|Termination of treatment by Sponsor|31|||
49171536|NCT03835481|158462179|FG004|Open Label Period (After Week 12)|Termination of treatment by Sponsor|35|||
49171537|NCT03835481|158462175|FG000|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
49171538|NCT03835481|158462176|FG001|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
49171539|NCT03835481|158462177|FG002|Open Label Period (After Week 12)|Withdrawal by Subject|7|||
49171540|NCT03835481|158462178|FG003|Open Label Period (After Week 12)|Withdrawal by Subject|9|||
49171541|NCT03835481|158462179|FG004|Open Label Period (After Week 12)|Withdrawal by Subject|1|||
49171542|NCT03835481|158462175|FG000|Open Label Period (After Week 12)|Lost to Follow-up|0|||
49171543|NCT03835481|158462176|FG001|Open Label Period (After Week 12)|Lost to Follow-up|0|||
49171544|NCT03835481|158462177|FG002|Open Label Period (After Week 12)|Lost to Follow-up|4|||
49171545|NCT03835481|158462178|FG003|Open Label Period (After Week 12)|Lost to Follow-up|3|||
48842230|NCT01976312|157262469|FG000|Overall Study|Pregnancy|0|||
49171546|NCT03835481|158462179|FG004|Open Label Period (After Week 12)|Lost to Follow-up|0|||
49171547|NCT03835481|158462175|FG000|Open Label Period (After Week 12)|Adverse Event|0|||
49171548|NCT03835481|158462176|FG001|Open Label Period (After Week 12)|Adverse Event|0|||
49171549|NCT03835481|158462177|FG002|Open Label Period (After Week 12)|Adverse Event|1|||
49171550|NCT03835481|158462178|FG003|Open Label Period (After Week 12)|Adverse Event|1|||
49171551|NCT03835481|158462179|FG004|Open Label Period (After Week 12)|Adverse Event|0|||
48926266|NCT03403205|157561854|FG002|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
48926267|NCT03403205|157561855|FG003|Extension Period (Up to 60 Months)|Withdrawal by Subject|1|||
48926268|NCT03403205|157561856|FG004|Extension Period (Up to 60 Months)|Withdrawal by Subject|0|||
48926269|NCT03403205|157561857|FG005|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
48926270|NCT03403205|157561852|FG000|Extension Period (Up to 60 Months)|Adverse Event|6|||
48926271|NCT03403205|157561853|FG001|Extension Period (Up to 60 Months)|Adverse Event|3|||
48926272|NCT03403205|157561854|FG002|Extension Period (Up to 60 Months)|Adverse Event|1|||
49171552|NCT03835481|158462175|FG000|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
49171553|NCT03835481|158462176|FG001|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
49171554|NCT03835481|158462177|FG002|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
49171555|NCT03835481|158462178|FG003|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|1|||
49171556|NCT03835481|158462179|FG004|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
49171557|NCT03835481|158462175|FG000|Open Label Period (After Week 12)|Other not stated above|0|||
49171558|NCT03835481|158462176|FG001|Open Label Period (After Week 12)|Other not stated above|0|||
49171559|NCT03835481|158462177|FG002|Open Label Period (After Week 12)|Other not stated above|0|||
49171560|NCT03835481|158462178|FG003|Open Label Period (After Week 12)|Other not stated above|1|||
49171561|NCT03835481|158462179|FG004|Open Label Period (After Week 12)|Other not stated above|1|||
49171562|NCT02574078|158463766|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
49171563|NCT02574078|158463767|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
49171564|NCT02574078|158463768|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
49171565|NCT02574078|158463769|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
49171566|NCT02574078|158463770|FG004|Pre-Treatment Period|Participant no longer meets study criteria|0|||
49171567|NCT02574078|158463771|FG005|Pre-Treatment Period|Participant no longer meets study criteria|1|||
49171568|NCT02574078|158463772|FG006|Pre-Treatment Period|Participant no longer meets study criteria|2|||
49171569|NCT02574078|158463773|FG007|Pre-Treatment Period|Participant no longer meets study criteria|0|||
49171570|NCT02574078|158463774|FG008|Pre-Treatment Period|Participant no longer meets study criteria|1|||
49171571|NCT02574078|158463775|FG009|Pre-Treatment Period|Participant no longer meets study criteria|0|||
49171572|NCT02574078|158463776|FG010|Pre-Treatment Period|Participant no longer meets study criteria|0|||
49171573|NCT02574078|158463777|FG011|Pre-Treatment Period|Participant no longer meets study criteria|0|||
49171574|NCT02574078|158463778|FG012|Pre-Treatment Period|Participant no longer meets study criteria|0|||
49171575|NCT02574078|158463766|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
49171576|NCT02574078|158463767|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
49171577|NCT02574078|158463768|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
49171578|NCT02574078|158463769|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
49171579|NCT02574078|158463770|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
49171580|NCT02574078|158463771|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
49171581|NCT02574078|158463772|FG006|Pre-Treatment Period|Participant withdrew consent|0|||
49171582|NCT02574078|158463773|FG007|Pre-Treatment Period|Participant withdrew consent|3|||
49171583|NCT02574078|158463774|FG008|Pre-Treatment Period|Participant withdrew consent|0|||
49171584|NCT02574078|158463775|FG009|Pre-Treatment Period|Participant withdrew consent|0|||
49171585|NCT02574078|158463776|FG010|Pre-Treatment Period|Participant withdrew consent|2|||
49171586|NCT02574078|158463777|FG011|Pre-Treatment Period|Participant withdrew consent|0|||
49171587|NCT02574078|158463778|FG012|Pre-Treatment Period|Participant withdrew consent|0|||
49171588|NCT02574078|158463766|FG000|Pre-Treatment Period|Other reasons|0|||
49171589|NCT02574078|158463767|FG001|Pre-Treatment Period|Other reasons|0|||
49171590|NCT02574078|158463768|FG002|Pre-Treatment Period|Other reasons|0|||
49171591|NCT02574078|158463769|FG003|Pre-Treatment Period|Other reasons|0|||
49171592|NCT02574078|158463770|FG004|Pre-Treatment Period|Other reasons|0|||
49171593|NCT02574078|158463771|FG005|Pre-Treatment Period|Other reasons|0|||
49171594|NCT02574078|158463772|FG006|Pre-Treatment Period|Other reasons|2|||
49171595|NCT02574078|158463773|FG007|Pre-Treatment Period|Other reasons|0|||
49171596|NCT02574078|158463774|FG008|Pre-Treatment Period|Other reasons|0|||
49171597|NCT02574078|158463775|FG009|Pre-Treatment Period|Other reasons|0|||
49171598|NCT02574078|158463776|FG010|Pre-Treatment Period|Other reasons|2|||
49171599|NCT02574078|158463777|FG011|Pre-Treatment Period|Other reasons|0|||
48926273|NCT03403205|157561855|FG003|Extension Period (Up to 60 Months)|Adverse Event|1|||
49171600|NCT02574078|158463778|FG012|Pre-Treatment Period|Other reasons|0|||
49171601|NCT02574078|158463766|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
49171602|NCT02574078|158463767|FG001|Pre-Treatment Period|Poor/non-compliance|0|||
49171603|NCT02574078|158463768|FG002|Pre-Treatment Period|Poor/non-compliance|0|||
49171604|NCT02574078|158463769|FG003|Pre-Treatment Period|Poor/non-compliance|0|||
49171605|NCT02574078|158463770|FG004|Pre-Treatment Period|Poor/non-compliance|0|||
49171606|NCT02574078|158463771|FG005|Pre-Treatment Period|Poor/non-compliance|0|||
49171607|NCT02574078|158463772|FG006|Pre-Treatment Period|Poor/non-compliance|0|||
49171608|NCT02574078|158463773|FG007|Pre-Treatment Period|Poor/non-compliance|0|||
49171609|NCT02574078|158463774|FG008|Pre-Treatment Period|Poor/non-compliance|0|||
49171610|NCT02574078|158463775|FG009|Pre-Treatment Period|Poor/non-compliance|0|||
49171611|NCT02574078|158463776|FG010|Pre-Treatment Period|Poor/non-compliance|0|||
49171612|NCT02574078|158463777|FG011|Pre-Treatment Period|Poor/non-compliance|1|||
49171613|NCT02574078|158463778|FG012|Pre-Treatment Period|Poor/non-compliance|0|||
49171614|NCT02574078|158463766|FG000|Treatment Period|Disease progression|6|||
49171615|NCT02574078|158463767|FG001|Treatment Period|Disease progression|4|||
49171616|NCT02574078|158463768|FG002|Treatment Period|Disease progression|7|||
49171617|NCT02574078|158463769|FG003|Treatment Period|Disease progression|18|||
49171618|NCT02574078|158463770|FG004|Treatment Period|Disease progression|16|||
49171619|NCT02574078|158463771|FG005|Treatment Period|Disease progression|26|||
49171620|NCT02574078|158463772|FG006|Treatment Period|Disease progression|5|||
49171621|NCT02574078|158463773|FG007|Treatment Period|Disease progression|9|||
49171622|NCT02574078|158463774|FG008|Treatment Period|Disease progression|8|||
49171623|NCT02574078|158463775|FG009|Treatment Period|Disease progression|5|||
49171624|NCT02574078|158463776|FG010|Treatment Period|Disease progression|20|||
49171625|NCT02574078|158463777|FG011|Treatment Period|Disease progression|29|||
49171626|NCT02574078|158463778|FG012|Treatment Period|Disease progression|2|||
49171627|NCT02574078|158463766|FG000|Treatment Period|Study drug toxicity|1|||
49171628|NCT02574078|158463767|FG001|Treatment Period|Study drug toxicity|1|||
48926274|NCT03403205|157561856|FG004|Extension Period (Up to 60 Months)|Adverse Event|0|||
48926275|NCT03403205|157561857|FG005|Extension Period (Up to 60 Months)|Adverse Event|0|||
49171629|NCT02574078|158463768|FG002|Treatment Period|Study drug toxicity|0|||
49171630|NCT02574078|158463769|FG003|Treatment Period|Study drug toxicity|5|||
49171631|NCT02574078|158463770|FG004|Treatment Period|Study drug toxicity|3|||
49171632|NCT02574078|158463771|FG005|Treatment Period|Study drug toxicity|1|||
49171633|NCT02574078|158463772|FG006|Treatment Period|Study drug toxicity|2|||
49171634|NCT02574078|158463773|FG007|Treatment Period|Study drug toxicity|0|||
49171635|NCT02574078|158463774|FG008|Treatment Period|Study drug toxicity|2|||
49171636|NCT02574078|158463775|FG009|Treatment Period|Study drug toxicity|1|||
49171637|NCT02574078|158463776|FG010|Treatment Period|Study drug toxicity|16|||
49171638|NCT02574078|158463777|FG011|Treatment Period|Study drug toxicity|2|||
49171639|NCT02574078|158463778|FG012|Treatment Period|Study drug toxicity|4|||
49171640|NCT02574078|158463766|FG000|Treatment Period|Death|2|||
49171641|NCT02574078|158463767|FG001|Treatment Period|Death|0|||
49171642|NCT02574078|158463768|FG002|Treatment Period|Death|0|||
49171643|NCT02574078|158463769|FG003|Treatment Period|Death|0|||
49171644|NCT02574078|158463770|FG004|Treatment Period|Death|1|||
49171645|NCT02574078|158463771|FG005|Treatment Period|Death|1|||
49171646|NCT02574078|158463772|FG006|Treatment Period|Death|1|||
49171647|NCT02574078|158463773|FG007|Treatment Period|Death|1|||
49171648|NCT02574078|158463774|FG008|Treatment Period|Death|7|||
49171649|NCT02574078|158463775|FG009|Treatment Period|Death|1|||
49171650|NCT02574078|158463776|FG010|Treatment Period|Death|0|||
49171651|NCT02574078|158463777|FG011|Treatment Period|Death|2|||
49171652|NCT02574078|158463778|FG012|Treatment Period|Death|1|||
49171653|NCT02574078|158463766|FG000|Treatment Period|Adverse event unrelated to drug|0|||
49171654|NCT02574078|158463767|FG001|Treatment Period|Adverse event unrelated to drug|0|||
49171655|NCT02574078|158463768|FG002|Treatment Period|Adverse event unrelated to drug|1|||
49171656|NCT02574078|158463769|FG003|Treatment Period|Adverse event unrelated to drug|0|||
49171657|NCT02574078|158463770|FG004|Treatment Period|Adverse event unrelated to drug|2|||
49171658|NCT02574078|158463771|FG005|Treatment Period|Adverse event unrelated to drug|3|||
49171659|NCT02574078|158463772|FG006|Treatment Period|Adverse event unrelated to drug|0|||
49171660|NCT02574078|158463773|FG007|Treatment Period|Adverse event unrelated to drug|0|||
49171661|NCT02574078|158463774|FG008|Treatment Period|Adverse event unrelated to drug|1|||
49171662|NCT02574078|158463775|FG009|Treatment Period|Adverse event unrelated to drug|2|||
49171663|NCT02574078|158463776|FG010|Treatment Period|Adverse event unrelated to drug|4|||
49171664|NCT02574078|158463777|FG011|Treatment Period|Adverse event unrelated to drug|1|||
49171665|NCT02574078|158463778|FG012|Treatment Period|Adverse event unrelated to drug|0|||
49171666|NCT02574078|158463766|FG000|Treatment Period|Administrative reason by Sponsor|0|||
49171667|NCT02574078|158463767|FG001|Treatment Period|Administrative reason by Sponsor|1|||
49171668|NCT02574078|158463768|FG002|Treatment Period|Administrative reason by Sponsor|0|||
49171669|NCT02574078|158463769|FG003|Treatment Period|Administrative reason by Sponsor|0|||
49171670|NCT02574078|158463770|FG004|Treatment Period|Administrative reason by Sponsor|0|||
49171671|NCT02574078|158463771|FG005|Treatment Period|Administrative reason by Sponsor|0|||
49171672|NCT02574078|158463772|FG006|Treatment Period|Administrative reason by Sponsor|1|||
49171673|NCT02574078|158463773|FG007|Treatment Period|Administrative reason by Sponsor|0|||
49171674|NCT02574078|158463774|FG008|Treatment Period|Administrative reason by Sponsor|0|||
49171675|NCT02574078|158463775|FG009|Treatment Period|Administrative reason by Sponsor|0|||
49171676|NCT02574078|158463776|FG010|Treatment Period|Administrative reason by Sponsor|0|||
49171677|NCT02574078|158463777|FG011|Treatment Period|Administrative reason by Sponsor|0|||
49171678|NCT02574078|158463778|FG012|Treatment Period|Administrative reason by Sponsor|3|||
49171679|NCT02574078|158463766|FG000|Treatment Period|Other reasons|1|||
49171680|NCT02574078|158463767|FG001|Treatment Period|Other reasons|0|||
49171681|NCT02574078|158463768|FG002|Treatment Period|Other reasons|1|||
49171682|NCT02574078|158463769|FG003|Treatment Period|Other reasons|3|||
49171683|NCT02574078|158463770|FG004|Treatment Period|Other reasons|3|||
49171684|NCT02574078|158463771|FG005|Treatment Period|Other reasons|1|||
49171685|NCT02574078|158463772|FG006|Treatment Period|Other reasons|2|||
49171686|NCT02574078|158463773|FG007|Treatment Period|Other reasons|1|||
49171687|NCT02574078|158463774|FG008|Treatment Period|Other reasons|3|||
49171688|NCT02574078|158463775|FG009|Treatment Period|Other reasons|1|||
49171689|NCT02574078|158463776|FG010|Treatment Period|Other reasons|1|||
49171690|NCT02574078|158463777|FG011|Treatment Period|Other reasons|3|||
49171691|NCT02574078|158463778|FG012|Treatment Period|Other reasons|1|||
49171692|NCT02574078|158463766|FG000|Treatment Period|Participant request to stop drug|0|||
49171693|NCT02574078|158463767|FG001|Treatment Period|Participant request to stop drug|0|||
49171694|NCT02574078|158463768|FG002|Treatment Period|Participant request to stop drug|0|||
49171695|NCT02574078|158463769|FG003|Treatment Period|Participant request to stop drug|2|||
49171696|NCT02574078|158463770|FG004|Treatment Period|Participant request to stop drug|4|||
49171697|NCT02574078|158463771|FG005|Treatment Period|Participant request to stop drug|0|||
49171698|NCT02574078|158463772|FG006|Treatment Period|Participant request to stop drug|1|||
49171699|NCT02574078|158463773|FG007|Treatment Period|Participant request to stop drug|0|||
49171700|NCT02574078|158463774|FG008|Treatment Period|Participant request to stop drug|3|||
49171701|NCT02574078|158463775|FG009|Treatment Period|Participant request to stop drug|2|||
49171702|NCT02574078|158463776|FG010|Treatment Period|Participant request to stop drug|2|||
49171703|NCT02574078|158463777|FG011|Treatment Period|Participant request to stop drug|4|||
49171704|NCT02574078|158463778|FG012|Treatment Period|Participant request to stop drug|1|||
49171705|NCT02574078|158463766|FG000|Treatment Period|Participant withdrew consent|0|||
49171706|NCT02574078|158463767|FG001|Treatment Period|Participant withdrew consent|0|||
49171707|NCT02574078|158463768|FG002|Treatment Period|Participant withdrew consent|0|||
49171708|NCT02574078|158463769|FG003|Treatment Period|Participant withdrew consent|0|||
49171709|NCT02574078|158463770|FG004|Treatment Period|Participant withdrew consent|1|||
49171710|NCT02574078|158463771|FG005|Treatment Period|Participant withdrew consent|1|||
49171711|NCT02574078|158463772|FG006|Treatment Period|Participant withdrew consent|0|||
49171712|NCT02574078|158463773|FG007|Treatment Period|Participant withdrew consent|1|||
49171713|NCT02574078|158463774|FG008|Treatment Period|Participant withdrew consent|0|||
49171714|NCT02574078|158463775|FG009|Treatment Period|Participant withdrew consent|2|||
49171715|NCT02574078|158463776|FG010|Treatment Period|Participant withdrew consent|1|||
49171716|NCT02574078|158463777|FG011|Treatment Period|Participant withdrew consent|4|||
49171717|NCT02574078|158463778|FG012|Treatment Period|Participant withdrew consent|1|||
49171718|NCT02574078|158463766|FG000|Treatment Period|Participant no longer meets criteria|0|||
49171719|NCT02574078|158463767|FG001|Treatment Period|Participant no longer meets criteria|0|||
49171720|NCT02574078|158463768|FG002|Treatment Period|Participant no longer meets criteria|0|||
49171721|NCT02574078|158463769|FG003|Treatment Period|Participant no longer meets criteria|0|||
49171722|NCT02574078|158463770|FG004|Treatment Period|Participant no longer meets criteria|1|||
49171723|NCT02574078|158463771|FG005|Treatment Period|Participant no longer meets criteria|0|||
49171724|NCT02574078|158463772|FG006|Treatment Period|Participant no longer meets criteria|0|||
49171725|NCT02574078|158463773|FG007|Treatment Period|Participant no longer meets criteria|0|||
49171726|NCT02574078|158463774|FG008|Treatment Period|Participant no longer meets criteria|0|||
49171727|NCT02574078|158463775|FG009|Treatment Period|Participant no longer meets criteria|1|||
49171728|NCT02574078|158463776|FG010|Treatment Period|Participant no longer meets criteria|1|||
49171729|NCT02574078|158463777|FG011|Treatment Period|Participant no longer meets criteria|1|||
49171730|NCT02574078|158463778|FG012|Treatment Period|Participant no longer meets criteria|0|||
49171731|NCT02574078|158463766|FG000|Treatment Period|Lost to Follow-up|0|||
49171732|NCT02574078|158463767|FG001|Treatment Period|Lost to Follow-up|0|||
48842231|NCT01976312|157262470|FG001|Overall Study|Pregnancy|1|||
48842232|NCT01976312|157262469|FG000|Overall Study|Lost to Follow-up|2|||
48842233|NCT01976312|157262470|FG001|Overall Study|Lost to Follow-up|0|||
48842234|NCT01976312|157262469|FG000|Overall Study|Withdrawal by Subject|7|||
48842235|NCT01976312|157262470|FG001|Overall Study|Withdrawal by Subject|2|||
48842236|NCT01976312|157262469|FG000|Overall Study|Adverse Event|6|||
48842237|NCT01976312|157262470|FG001|Overall Study|Adverse Event|6|||
48842238|NCT01976312|157262469|FG000|Overall Study|Protocol Violation|2|||
48842239|NCT01976312|157262470|FG001|Overall Study|Protocol Violation|0|||
48842240|NCT00411216|157262471|FG000|Overall Study|Ten participants were entered into the c|0|||
48842241|NCT00411216|157262472|FG001|Overall Study|Ten participants were entered into the c|2|||
48842242|NCT02556138|157262473|FG000|Overall Study|Withdrawal by Subject|1|||
48842243|NCT02079844|157262474|FG000|Treatment Period 1|Voluntary Withdrawal|0|||
49171733|NCT02574078|158463768|FG002|Treatment Period|Lost to Follow-up|0|||
49171734|NCT02574078|158463769|FG003|Treatment Period|Lost to Follow-up|0|||
49171735|NCT02574078|158463770|FG004|Treatment Period|Lost to Follow-up|0|||
49171736|NCT02574078|158463771|FG005|Treatment Period|Lost to Follow-up|0|||
49171737|NCT02574078|158463772|FG006|Treatment Period|Lost to Follow-up|0|||
49171738|NCT02574078|158463773|FG007|Treatment Period|Lost to Follow-up|0|||
49171739|NCT02574078|158463774|FG008|Treatment Period|Lost to Follow-up|0|||
49171740|NCT02574078|158463775|FG009|Treatment Period|Lost to Follow-up|1|||
49171741|NCT02574078|158463776|FG010|Treatment Period|Lost to Follow-up|0|||
49171742|NCT02574078|158463777|FG011|Treatment Period|Lost to Follow-up|1|||
49171743|NCT02574078|158463778|FG012|Treatment Period|Lost to Follow-up|0|||
49171744|NCT02574078|158463766|FG000|Treatment Period|Maximum clinical benefit|0|||
49171745|NCT02574078|158463767|FG001|Treatment Period|Maximum clinical benefit|0|||
49171746|NCT02574078|158463768|FG002|Treatment Period|Maximum clinical benefit|0|||
49171747|NCT02574078|158463769|FG003|Treatment Period|Maximum clinical benefit|0|||
49171748|NCT02574078|158463770|FG004|Treatment Period|Maximum clinical benefit|0|||
49171749|NCT02574078|158463771|FG005|Treatment Period|Maximum clinical benefit|0|||
49171750|NCT02574078|158463772|FG006|Treatment Period|Maximum clinical benefit|0|||
49171751|NCT02574078|158463773|FG007|Treatment Period|Maximum clinical benefit|0|||
49171752|NCT02574078|158463774|FG008|Treatment Period|Maximum clinical benefit|0|||
49171753|NCT02574078|158463775|FG009|Treatment Period|Maximum clinical benefit|1|||
49171754|NCT02574078|158463776|FG010|Treatment Period|Maximum clinical benefit|0|||
49171755|NCT02574078|158463777|FG011|Treatment Period|Maximum clinical benefit|0|||
49171756|NCT02574078|158463778|FG012|Treatment Period|Maximum clinical benefit|0|||
49171757|NCT00342628|158463779|FG000|Overall Study|Withdrawal by Subject|19|||
49171758|NCT00342628|158463780|FG001|Overall Study|Withdrawal by Subject|19|||
48842244|NCT02079844|157262475|FG001|Treatment Period 1|Voluntary Withdrawal|0|||
48842245|NCT02079844|157262476|FG002|Treatment Period 1|Voluntary Withdrawal|2|||
48842246|NCT02079844|157262474|FG000|Treatment Period 2|Voluntary Withdrawal|0|||
48842247|NCT02079844|157262475|FG001|Treatment Period 2|Voluntary Withdrawal|1|||
48842248|NCT02079844|157262476|FG002|Treatment Period 2|Voluntary Withdrawal|0|||
48842249|NCT01144468|157263781|FG000|Overall Study|Lost to Follow-up|4|||
48842250|NCT01144468|157263782|FG001|Overall Study|Lost to Follow-up|7|||
48842251|NCT01144468|157263781|FG000|Overall Study|Adverse Event|3|||
48842252|NCT01144468|157263782|FG001|Overall Study|Adverse Event|2|||
49171759|NCT00342628|158463781|FG002|Overall Study|Withdrawal by Subject|18|||
49171760|NCT00342628|158463779|FG000|Overall Study|Death|1|||
49171761|NCT00342628|158463780|FG001|Overall Study|Death|1|||
49171762|NCT00342628|158463781|FG002|Overall Study|Death|0|||
49171763|NCT00342628|158463779|FG000|Overall Study|moved residence|0|||
49171764|NCT00342628|158463780|FG001|Overall Study|moved residence|1|||
48842253|NCT01144468|157263781|FG000|Overall Study|did not reach 2 year follow up at time of clinical cut off|45|||
49171765|NCT00342628|158463781|FG002|Overall Study|moved residence|1|||
48842254|NCT01144468|157263782|FG001|Overall Study|did not reach 2 year follow up at time of clinical cut off|48|||
48842255|NCT04722003|157263785|FG000|Overall Study|Lost to Follow-up|2|||
48842256|NCT04722003|157263786|FG001|Overall Study|Lost to Follow-up|0|||
48842257|NCT04722003|157263785|FG000|Overall Study|Physician Decision|1|||
49171766|NCT03427814|158463782|FG000|Overall Study|Withdrawal by Subject|4|||
49171767|NCT03427814|158463783|FG001|Overall Study|Withdrawal by Subject|4|||
49171768|NCT03427814|158463782|FG000|Overall Study|Lost to Follow-up|0|||
49171769|NCT03427814|158463783|FG001|Overall Study|Lost to Follow-up|2|||
49171770|NCT03427814|158463782|FG000|Overall Study|Death|42|||
49171771|NCT03427814|158463783|FG001|Overall Study|Death|31|||
49171772|NCT03427814|158463782|FG000|Overall Study|Sponsor's Decision|1|||
49171773|NCT03427814|158463783|FG001|Overall Study|Sponsor's Decision|0|||
48842258|NCT04722003|157263786|FG001|Overall Study|Physician Decision|0|||
48842259|NCT00955825|157263790|FG000|Overall Study|Adverse Event|15|||
48842260|NCT00955825|157263791|FG001|Overall Study|Adverse Event|2|||
48842261|NCT00955825|157263790|FG000|Overall Study|Withdrawal by Subject|4|||
48842262|NCT00955825|157263791|FG001|Overall Study|Withdrawal by Subject|6|||
48842263|NCT00955825|157263790|FG000|Overall Study|Any other reason not above-mentioned|7|||
48842264|NCT00955825|157263791|FG001|Overall Study|Any other reason not above-mentioned|9|||
48842265|NCT02751580|157263792|FG000|Overall Study|Lost to Follow-up|4|||
49171774|NCT03427814|158463782|FG000|Overall Study|Investigator's Decision|1|||
49171775|NCT03427814|158463783|FG001|Overall Study|Investigator's Decision|2|||
49171776|NCT03427814|158463782|FG000|Overall Study|Disease progression|1|||
49171777|NCT03427814|158463783|FG001|Overall Study|Disease progression|0|||
49171778|NCT03427814|158463782|FG000|Overall Study|Treatment Completed|0|||
49171779|NCT03427814|158463783|FG001|Overall Study|Treatment Completed|1|||
49171780|NCT03427814|158463782|FG000|Overall Study|Sponsor's Decision to End study|21|||
49171781|NCT03427814|158463783|FG001|Overall Study|Sponsor's Decision to End study|25|||
49171782|NCT03427814|158463782|FG000|Overall Study|Transfer to Long Term Extension Study|1|||
49171783|NCT03427814|158463783|FG001|Overall Study|Transfer to Long Term Extension Study|0|||
49171784|NCT00662831|158463784|FG000|Overall Study|Death|4|||
49171785|NCT00662831|158463785|FG001|Overall Study|Death|1|||
49171786|NCT00662831|158463784|FG000|Overall Study|Lack of Efficacy|6|||
49171787|NCT00662831|158463785|FG001|Overall Study|Lack of Efficacy|6|||
49171788|NCT00662831|158463784|FG000|Overall Study|Lost to Follow-up|1|||
49171789|NCT00662831|158463785|FG001|Overall Study|Lost to Follow-up|0|||
49171790|NCT00662831|158463784|FG000|Overall Study|Withdrawal by Subject|2|||
49171791|NCT00662831|158463785|FG001|Overall Study|Withdrawal by Subject|1|||
48842266|NCT02751580|157263792|FG000|Overall Study|Death|2|||
48842267|NCT01227278|157263793|FG000|Overall Study|Withdrawal by Subject|4|||
48842268|NCT01227278|157263794|FG001|Overall Study|Withdrawal by Subject|4|||
48842269|NCT01227278|157263793|FG000|Overall Study|Death|0|||
48842270|NCT01227278|157263794|FG001|Overall Study|Death|2|||
48842271|NCT01227278|157263793|FG000|Overall Study|Other|1|||
48842272|NCT01227278|157263794|FG001|Overall Study|Other|2|||
48842273|NCT01460446|157263795|FG000|Overall Study|Non-compliance|2|||
48842274|NCT01460446|157263796|FG001|Overall Study|Non-compliance|9|||
48842275|NCT01460446|157263795|FG000|Overall Study|Consent Withdrawn|0|||
48842276|NCT01460446|157263796|FG001|Overall Study|Consent Withdrawn|4|||
48842277|NCT01460446|157263795|FG000|Overall Study|Non-compliance & Consent Withdrawn|1|||
48842278|NCT01460446|157263796|FG001|Overall Study|Non-compliance & Consent Withdrawn|3|||
48842279|NCT01460446|157263795|FG000|Overall Study|Surgery/Illness|1|||
48842280|NCT01460446|157263796|FG001|Overall Study|Surgery/Illness|1|||
48842281|NCT01460446|157263795|FG000|Overall Study|Pregnancy|1|||
48842282|NCT01460446|157263796|FG001|Overall Study|Pregnancy|0|||
48842283|NCT01460446|157263795|FG000|Overall Study|Other Reasons Incl. Lost for Follow-Up|0|||
48842284|NCT01460446|157263796|FG001|Overall Study|Other Reasons Incl. Lost for Follow-Up|3|||
48842285|NCT00549848|157263799|FG000|Overall Study|Death|1|||
48842286|NCT00549848|157263800|FG001|Overall Study|Death|4|||
48842287|NCT00549848|157263801|FG002|Overall Study|Death|13|||
48842288|NCT00549848|157263799|FG000|Overall Study|Physician Decision|0|||
49171792|NCT00662831|158463784|FG000|Overall Study|Other|62|||
48842289|NCT00549848|157263800|FG001|Overall Study|Physician Decision|0|||
48842290|NCT00549848|157263801|FG002|Overall Study|Physician Decision|4|||
48842291|NCT00549848|157263799|FG000|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|3|||
48842292|NCT00549848|157263800|FG001|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
48842293|NCT00549848|157263801|FG002|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
49171793|NCT00662831|158463785|FG001|Overall Study|Other|31|||
48842294|NCT00549848|157263799|FG000|Overall Study|Failure to achieve Complete Remission (CR)|1|||
48842295|NCT00549848|157263800|FG001|Overall Study|Failure to achieve Complete Remission (CR)|0|||
48842296|NCT00549848|157263801|FG002|Overall Study|Failure to achieve Complete Remission (CR)|1|||
49171794|NCT00662831|158463784|FG000|Overall Study|Protocol Violation|8|||
49171795|NCT00662831|158463785|FG001|Overall Study|Protocol Violation|4|||
49171796|NCT00662831|158463784|FG000|Overall Study|Adverse Event|23|||
49171797|NCT00662831|158463785|FG001|Overall Study|Adverse Event|16|||
49171798|NCT00600106|158463786|FG000|Overall Study|Withdrawal by Subject|1|||
48842297|NCT00549848|157263799|FG000|Overall Study|Participant/Family Withdraw|2|||
49171799|NCT00600106|158463787|FG001|Overall Study|Withdrawal by Subject|1|||
49171800|NCT00711594|158463788|FG000|Overall Study|Progressive disease|2|||
49171801|NCT00711594|158463789|FG001|Overall Study|Progressive disease|2|||
49171802|NCT00711594|158463790|FG002|Overall Study|Progressive disease|6|||
49171803|NCT00711594|158463791|FG003|Overall Study|Progressive disease|44|||
48926276|NCT03403205|157561852|FG000|Extension Period (Up to 60 Months)|Death|1|||
49171804|NCT00711594|158463788|FG000|Overall Study|Other Adverse Event|1|||
49171805|NCT00711594|158463789|FG001|Overall Study|Other Adverse Event|0|||
49171806|NCT00711594|158463790|FG002|Overall Study|Other Adverse Event|0|||
49171807|NCT00711594|158463791|FG003|Overall Study|Other Adverse Event|16|||
49171808|NCT00711594|158463788|FG000|Overall Study|Withdrawal by Subject|0|||
49171809|NCT00711594|158463789|FG001|Overall Study|Withdrawal by Subject|1|||
49171810|NCT00711594|158463790|FG002|Overall Study|Withdrawal by Subject|0|||
49171811|NCT00711594|158463791|FG003|Overall Study|Withdrawal by Subject|2|||
49171812|NCT00485758|158463794|FG000|Overall Study|Adverse Event|102|||
49171813|NCT00485758|158463795|FG001|Overall Study|Adverse Event|31|||
49171814|NCT00485758|158463794|FG000|Overall Study|Death|0|||
49171815|NCT00485758|158463795|FG001|Overall Study|Death|1|||
49171816|NCT00485758|158463794|FG000|Overall Study|Lost to Follow-up|5|||
49171817|NCT00485758|158463795|FG001|Overall Study|Lost to Follow-up|1|||
49171818|NCT00485758|158463794|FG000|Overall Study|Physician Decision|3|||
49171819|NCT00485758|158463795|FG001|Overall Study|Physician Decision|3|||
49171820|NCT00485758|158463794|FG000|Overall Study|Protocol Violation|11|||
49171821|NCT00485758|158463795|FG001|Overall Study|Protocol Violation|2|||
48842298|NCT00549848|157263800|FG001|Overall Study|Participant/Family Withdraw|3|||
48842299|NCT00549848|157263801|FG002|Overall Study|Participant/Family Withdraw|5|||
48842300|NCT00549848|157263799|FG000|Overall Study|Second Malignancy|1|||
48842301|NCT00549848|157263800|FG001|Overall Study|Second Malignancy|0|||
48842302|NCT00549848|157263801|FG002|Overall Study|Second Malignancy|0|||
48842303|NCT00549848|157263799|FG000|Overall Study|Transplant|3|||
48842304|NCT00549848|157263800|FG001|Overall Study|Transplant|3|||
49171822|NCT00485758|158463794|FG000|Overall Study|Withdrawal by Subject|32|||
49171823|NCT00485758|158463795|FG001|Overall Study|Withdrawal by Subject|27|||
49171824|NCT00485758|158463794|FG000|Overall Study|Study Terminated by Sponsor|3|||
49171825|NCT00485758|158463795|FG001|Overall Study|Study Terminated by Sponsor|0|||
49171826|NCT00135330|158463796|FG000|Overall Study|Adverse Event|2|||
49171827|NCT00135330|158463797|FG001|Overall Study|Adverse Event|5|||
49171828|NCT00135330|158463798|FG002|Overall Study|Adverse Event|1|||
48842305|NCT00549848|157263801|FG002|Overall Study|Transplant|18|||
48842306|NCT00549848|157263799|FG000|Overall Study|Unacceptable Toxicity|1|||
48842307|NCT00549848|157263800|FG001|Overall Study|Unacceptable Toxicity|6|||
48842308|NCT00549848|157263801|FG002|Overall Study|Unacceptable Toxicity|6|||
48842309|NCT02224924|157263802|FG000|Overall Study|Withdrawal by Subject|7|||
48842310|NCT02224924|157263803|FG001|Overall Study|Withdrawal by Subject|6|||
48842311|NCT02224924|157263802|FG000|Overall Study|Biopsy cancelled|20|||
48842312|NCT02224924|157263803|FG001|Overall Study|Biopsy cancelled|14|||
48842313|NCT02224924|157263802|FG000|Overall Study|Intra procedural exclusion - sealant deployed|23|||
48842314|NCT02224924|157263803|FG001|Overall Study|Intra procedural exclusion - sealant deployed|11|||
48842315|NCT02224924|157263802|FG000|Overall Study|Intra procedural exclusion - sealant not deployed|20|||
48842316|NCT02224924|157263803|FG001|Overall Study|Intra procedural exclusion - sealant not deployed|35|||
49171829|NCT00135330|158463796|FG000|Overall Study|Lost to Follow-up|0|||
49171830|NCT00135330|158463797|FG001|Overall Study|Lost to Follow-up|2|||
49171831|NCT00135330|158463798|FG002|Overall Study|Lost to Follow-up|3|||
49171832|NCT00135330|158463796|FG000|Overall Study|Physician Decision|1|||
49171833|NCT00135330|158463797|FG001|Overall Study|Physician Decision|1|||
49171834|NCT00135330|158463798|FG002|Overall Study|Physician Decision|0|||
49171835|NCT00135330|158463796|FG000|Overall Study|Protocol Violation|4|||
49171836|NCT00135330|158463797|FG001|Overall Study|Protocol Violation|3|||
49171837|NCT00135330|158463798|FG002|Overall Study|Protocol Violation|3|||
49171838|NCT00135330|158463796|FG000|Overall Study|Patient Decision|5|||
49171839|NCT00135330|158463797|FG001|Overall Study|Patient Decision|1|||
49171840|NCT00135330|158463798|FG002|Overall Study|Patient Decision|4|||
49171841|NCT00135330|158463796|FG000|Overall Study|Sponsor Decision|0|||
49171842|NCT00135330|158463797|FG001|Overall Study|Sponsor Decision|1|||
49171843|NCT00135330|158463798|FG002|Overall Study|Sponsor Decision|0|||
49171844|NCT04830215|158463799|FG000|Overall Study|Adverse Event|6|||
49171845|NCT04830215|158463799|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
49171846|NCT04830215|158463799|FG000|Overall Study|Withdrawal by Subject|3|||
49171847|NCT04830215|158463799|FG000|Overall Study|Protocol Deviation|1|||
49171848|NCT03367403|158463800|FG000|Overall Study|Adverse Event|20|||
49171849|NCT03367403|158463801|FG001|Overall Study|Adverse Event|6|||
49171850|NCT03367403|158463802|FG002|Overall Study|Adverse Event|2|||
49171851|NCT03367403|158463800|FG000|Overall Study|Withdrawal by Subject|12|||
49171852|NCT03367403|158463801|FG001|Overall Study|Withdrawal by Subject|13|||
49171853|NCT03367403|158463802|FG002|Overall Study|Withdrawal by Subject|1|||
49171854|NCT03367403|158463800|FG000|Overall Study|Death|1|||
49171855|NCT03367403|158463801|FG001|Overall Study|Death|2|||
49171856|NCT03367403|158463802|FG002|Overall Study|Death|0|||
49171857|NCT03367403|158463800|FG000|Overall Study|Physician Decision|0|||
49171858|NCT03367403|158463801|FG001|Overall Study|Physician Decision|1|||
49171859|NCT03367403|158463802|FG002|Overall Study|Physician Decision|0|||
49171860|NCT03367403|158463800|FG000|Overall Study|Protocol Violation|1|||
49171861|NCT03367403|158463801|FG001|Overall Study|Protocol Violation|1|||
49171862|NCT03367403|158463802|FG002|Overall Study|Protocol Violation|0|||
49171863|NCT03367403|158463800|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
49171864|NCT03367403|158463801|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|2|||
49171865|NCT03367403|158463802|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
49171866|NCT03367403|158463800|FG000|Overall Study|COVID-19|3|||
49171867|NCT03367403|158463801|FG001|Overall Study|COVID-19|6|||
49171868|NCT03367403|158463802|FG002|Overall Study|COVID-19|0|||
49171869|NCT03367403|158463800|FG000|Overall Study|Abuse of Alcohol Intake|0|||
49171870|NCT03367403|158463801|FG001|Overall Study|Abuse of Alcohol Intake|1|||
49171871|NCT03367403|158463802|FG002|Overall Study|Abuse of Alcohol Intake|0|||
49171872|NCT03367403|158463800|FG000|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
49171873|NCT03367403|158463801|FG001|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|1|||
49171874|NCT03367403|158463802|FG002|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
49171875|NCT02253433|158463805|FG000|Overall Study|Unable to Contact|9|||
49171876|NCT02253433|158463806|FG001|Overall Study|Unable to Contact|16|||
49171877|NCT02253433|158463805|FG000|Overall Study|Death|1|||
48842317|NCT01443845|157263806|FG000|Overall Study|Protocol Violation|43|||
48842318|NCT01443845|157263807|FG001|Overall Study|Protocol Violation|45|||
48842319|NCT01443845|157263806|FG000|Overall Study|Other reasons, such as COPD exacerbation|44|||
48842320|NCT01443845|157263807|FG001|Overall Study|Other reasons, such as COPD exacerbation|44|||
48842321|NCT01443845|157263806|FG000|Overall Study|Deterioration in pulmonary function|1|||
49171878|NCT02253433|158463806|FG001|Overall Study|Death|1|||
49171879|NCT02253433|158463805|FG000|Overall Study|No Longer Interested|3|||
49171880|NCT02253433|158463806|FG001|Overall Study|No Longer Interested|15|||
49171881|NCT02253433|158463805|FG000|Overall Study|Out of Study Area|2|||
49171882|NCT02253433|158463806|FG001|Overall Study|Out of Study Area|7|||
49171883|NCT02253433|158463805|FG000|Overall Study|Uncomfortable with home visitors|0|||
49171884|NCT02253433|158463806|FG001|Overall Study|Uncomfortable with home visitors|3|||
48842322|NCT01443845|157263807|FG001|Overall Study|Deterioration in pulmonary function|4|||
48842323|NCT01443845|157263806|FG000|Overall Study|Lack of Efficacy|10|||
49171885|NCT02253433|158463805|FG000|Overall Study|Unstable Housing/Homeless|0|||
49171886|NCT02253433|158463806|FG001|Overall Study|Unstable Housing/Homeless|7|||
49171887|NCT02253433|158463805|FG000|Overall Study|Too Busy|0|||
49171888|NCT02253433|158463806|FG001|Overall Study|Too Busy|4|||
49171889|NCT02253433|158463805|FG000|Overall Study|Medical or Other Concerns|1|||
49171890|NCT02253433|158463806|FG001|Overall Study|Medical or Other Concerns|2|||
49171891|NCT00759876|158463807|FG000|Overall Study|Sponsor terminated study early|36|||
49171892|NCT00224120|158463808|FG000|Overall Study|Adverse Event|10|||
49171893|NCT00224120|158463809|FG001|Overall Study|Adverse Event|4|||
49171894|NCT00224120|158463808|FG000|Overall Study|Protocol Violation|1|||
49171895|NCT00224120|158463809|FG001|Overall Study|Protocol Violation|0|||
49171896|NCT00224120|158463808|FG000|Overall Study|Withdrawal by Subject|5|||
49171897|NCT00224120|158463809|FG001|Overall Study|Withdrawal by Subject|10|||
49171898|NCT00224120|158463808|FG000|Overall Study|Lack of Efficacy|0|||
49171899|NCT00224120|158463809|FG001|Overall Study|Lack of Efficacy|2|||
49171900|NCT00224120|158463808|FG000|Overall Study|Lost to Follow-up|2|||
49171901|NCT00224120|158463809|FG001|Overall Study|Lost to Follow-up|3|||
49171902|NCT00224120|158463808|FG000|Overall Study|Other|4|||
49171903|NCT00224120|158463809|FG001|Overall Study|Other|5|||
48842324|NCT01443845|157263807|FG001|Overall Study|Lack of Efficacy|5|||
48842325|NCT01443845|157263806|FG000|Overall Study|Adverse Event|64|||
48842326|NCT01443845|157263807|FG001|Overall Study|Adverse Event|138|||
49171904|NCT03423238|158463812|FG000|Overall Study|Lost to Follow-up|1|||
49171905|NCT03423238|158463813|FG001|Overall Study|Lost to Follow-up|0|||
49171906|NCT03423238|158463812|FG000|Overall Study|Withdrawal by Subject|1|||
49171907|NCT03423238|158463813|FG001|Overall Study|Withdrawal by Subject|0|||
48842327|NCT01443845|157263806|FG000|Overall Study|Withdrawal by Subject|63|||
49171908|NCT03248167|158463816|FG000|Overall Study|Withdrawal by Subject|2|||
48842328|NCT01443845|157263807|FG001|Overall Study|Withdrawal by Subject|67|||
48842329|NCT01443845|157263806|FG000|Overall Study|Military Conflict - Site Terminated|20|||
48842330|NCT01443845|157263807|FG001|Overall Study|Military Conflict - Site Terminated|21|||
48842331|NCT01443845|157263806|FG000|Overall Study|Lost to Follow-up|9|||
48842332|NCT01443845|157263807|FG001|Overall Study|Lost to Follow-up|13|||
48842333|NCT00542789|157263809|FG000|Overall Study|Adverse Event|18|||
48842334|NCT00542789|157263810|FG001|Overall Study|Adverse Event|17|||
48842335|NCT00542789|157263809|FG000|Overall Study|Withdrawal by Subject|7|||
48926277|NCT03403205|157561853|FG001|Extension Period (Up to 60 Months)|Death|0|||
48926278|NCT03403205|157561854|FG002|Extension Period (Up to 60 Months)|Death|0|||
48842336|NCT00542789|157263810|FG001|Overall Study|Withdrawal by Subject|3|||
48926279|NCT03403205|157561855|FG003|Extension Period (Up to 60 Months)|Death|0|||
48926280|NCT03403205|157561856|FG004|Extension Period (Up to 60 Months)|Death|0|||
48926281|NCT03403205|157561857|FG005|Extension Period (Up to 60 Months)|Death|0|||
48926282|NCT03403205|157561852|FG000|Extension Period (Up to 60 Months)|Lost to Follow-up|1|||
48926283|NCT03403205|157561853|FG001|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
48926284|NCT03403205|157561854|FG002|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
48926285|NCT03403205|157561855|FG003|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
48926286|NCT03403205|157561856|FG004|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
48926287|NCT03403205|157561857|FG005|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
48926288|NCT03403205|157561852|FG000|Extension Period (Up to 60 Months)|Pregnancy|1|||
48926289|NCT03403205|157561853|FG001|Extension Period (Up to 60 Months)|Pregnancy|1|||
49171909|NCT03248167|158463817|FG001|Overall Study|Withdrawal by Subject|2|||
49171910|NCT03248167|158463816|FG000|Overall Study|Physician Decision|0|||
49171911|NCT03248167|158463817|FG001|Overall Study|Physician Decision|1|||
49171912|NCT03248167|158463816|FG000|Overall Study|Institution Mandated COVID-19 Research Pause|2|||
49171913|NCT03248167|158463817|FG001|Overall Study|Institution Mandated COVID-19 Research Pause|1|||
49171914|NCT03248167|158463816|FG000|Overall Study|Lost to Follow-up|1|||
49171915|NCT03248167|158463817|FG001|Overall Study|Lost to Follow-up|0|||
49171916|NCT01970241|158463818|FG000|Overall Study|Withdrawal by Subject|2|||
49171917|NCT01970241|158463819|FG001|Overall Study|Withdrawal by Subject|0|||
49171918|NCT01970241|158463818|FG000|Overall Study|Steroid d/c;discharge<48 hrs.|15|||
49171919|NCT01970241|158463819|FG001|Overall Study|Steroid d/c;discharge<48 hrs.|8|||
49171920|NCT01104545|158463826|FG000|Overall Study|Adverse Event|0|||
49171921|NCT01104545|158463827|FG001|Overall Study|Adverse Event|1|||
49171922|NCT01104545|158463828|FG002|Overall Study|Adverse Event|2|||
49171923|NCT03604172|158463829|FG000|Overall Study|Lost to Follow-up|1|||
49171924|NCT03604172|158463830|FG001|Overall Study|Lost to Follow-up|2|||
49171925|NCT03711370|158463831|FG000|Overall Study|Lost to Follow-up|16|||
49171926|NCT03711370|158463832|FG001|Overall Study|Lost to Follow-up|10|||
49171927|NCT03711370|158463831|FG000|Overall Study|Pre-test or Post-test visits were >2 weeks apart|0|||
49171928|NCT03711370|158463832|FG001|Overall Study|Pre-test or Post-test visits were >2 weeks apart|6|||
49171929|NCT00182078|158463839|FG000|Overall Study|Withdrawal by Subject|1|||
49171930|NCT00182078|158463840|FG001|Overall Study|Withdrawal by Subject|0|||
49171931|NCT04188834|158463842|FG000|Overall Study|Participants did not complete enough proportion of experiment(s) to be included in analysis|4|||
49171932|NCT00553436|158463843|FG000|Overall Study|Conversion to another procedure|1|||
49171933|NCT01814046|158463850|FG000|Drug Administration|Death due to complications of RSV|1|||
49171934|NCT01814046|158463851|FG001|Drug Administration|Death due to complications of RSV|0|||
49171935|NCT01814046|158463852|FG002|Drug Administration|Death due to complications of RSV|0|||
49171936|NCT01831466|158463858|FG000|Overall Study|Protocol Violation|1|||
49171937|NCT01831466|158463859|FG001|Overall Study|Protocol Violation|1|||
49171938|NCT01831466|158463860|FG002|Overall Study|Protocol Violation|2|||
49171939|NCT01831466|158463861|FG003|Overall Study|Protocol Violation|0|||
49171940|NCT01831466|158463862|FG004|Overall Study|Protocol Violation|0|||
49171941|NCT01831466|158463863|FG005|Overall Study|Protocol Violation|1|||
49171942|NCT01831466|158463864|FG006|Overall Study|Protocol Violation|0|||
49171943|NCT01831466|158463865|FG007|Overall Study|Protocol Violation|0|||
49171944|NCT01831466|158463866|FG008|Overall Study|Protocol Violation|0|||
49171945|NCT01831466|158463867|FG009|Overall Study|Protocol Violation|0|||
49171946|NCT01831466|158463868|FG010|Overall Study|Protocol Violation|0|||
49171947|NCT01831466|158463869|FG011|Overall Study|Protocol Violation|0|||
49171948|NCT01831466|158463858|FG000|Overall Study|Other|2|||
49171949|NCT01831466|158463859|FG001|Overall Study|Other|3|||
49171950|NCT01831466|158463860|FG002|Overall Study|Other|2|||
49171951|NCT01831466|158463861|FG003|Overall Study|Other|2|||
49171952|NCT01831466|158463862|FG004|Overall Study|Other|2|||
49171953|NCT01831466|158463863|FG005|Overall Study|Other|1|||
49171954|NCT01831466|158463864|FG006|Overall Study|Other|0|||
49171955|NCT01831466|158463865|FG007|Overall Study|Other|0|||
49171956|NCT01831466|158463866|FG008|Overall Study|Other|0|||
49171957|NCT01831466|158463867|FG009|Overall Study|Other|0|||
49171958|NCT01831466|158463868|FG010|Overall Study|Other|0|||
48842337|NCT00542789|157263809|FG000|Overall Study|Protocol Violation|8|||
49171959|NCT01831466|158463869|FG011|Overall Study|Other|0|||
49171960|NCT01831466|158463858|FG000|Overall Study|Non-compliance with study treatment|2|||
49171961|NCT01831466|158463859|FG001|Overall Study|Non-compliance with study treatment|1|||
49171962|NCT01831466|158463860|FG002|Overall Study|Non-compliance with study treatment|1|||
49171963|NCT01831466|158463861|FG003|Overall Study|Non-compliance with study treatment|0|||
49171964|NCT01831466|158463862|FG004|Overall Study|Non-compliance with study treatment|0|||
49171965|NCT01831466|158463863|FG005|Overall Study|Non-compliance with study treatment|1|||
49171966|NCT01831466|158463864|FG006|Overall Study|Non-compliance with study treatment|0|||
49171967|NCT01831466|158463865|FG007|Overall Study|Non-compliance with study treatment|0|||
49171968|NCT01831466|158463866|FG008|Overall Study|Non-compliance with study treatment|0|||
49171969|NCT01831466|158463867|FG009|Overall Study|Non-compliance with study treatment|0|||
49171970|NCT01831466|158463868|FG010|Overall Study|Non-compliance with study treatment|0|||
49171971|NCT01831466|158463869|FG011|Overall Study|Non-compliance with study treatment|0|||
49171972|NCT01831466|158463858|FG000|Overall Study|Death|0|||
49171973|NCT01831466|158463859|FG001|Overall Study|Death|1|||
49171974|NCT01831466|158463860|FG002|Overall Study|Death|0|||
49171975|NCT01831466|158463861|FG003|Overall Study|Death|0|||
49171976|NCT01831466|158463862|FG004|Overall Study|Death|0|||
49171977|NCT01831466|158463863|FG005|Overall Study|Death|0|||
49171978|NCT01831466|158463864|FG006|Overall Study|Death|0|||
49171979|NCT01831466|158463865|FG007|Overall Study|Death|0|||
49171980|NCT01831466|158463866|FG008|Overall Study|Death|0|||
49171981|NCT01831466|158463867|FG009|Overall Study|Death|0|||
49171982|NCT01831466|158463868|FG010|Overall Study|Death|0|||
49171983|NCT01831466|158463869|FG011|Overall Study|Death|0|||
49171984|NCT01831466|158463858|FG000|Overall Study|Withdrawal by Subject|6|||
49171985|NCT01831466|158463859|FG001|Overall Study|Withdrawal by Subject|3|||
49171986|NCT01831466|158463860|FG002|Overall Study|Withdrawal by Subject|3|||
49171987|NCT01831466|158463861|FG003|Overall Study|Withdrawal by Subject|3|||
49171988|NCT01831466|158463862|FG004|Overall Study|Withdrawal by Subject|3|||
49171989|NCT01831466|158463863|FG005|Overall Study|Withdrawal by Subject|5|||
49171990|NCT01831466|158463864|FG006|Overall Study|Withdrawal by Subject|0|||
49171991|NCT01831466|158463865|FG007|Overall Study|Withdrawal by Subject|0|||
49171992|NCT01831466|158463866|FG008|Overall Study|Withdrawal by Subject|0|||
49171993|NCT01831466|158463867|FG009|Overall Study|Withdrawal by Subject|1|||
49171994|NCT01831466|158463868|FG010|Overall Study|Withdrawal by Subject|0|||
49171995|NCT01831466|158463869|FG011|Overall Study|Withdrawal by Subject|1|||
49171996|NCT01831466|158463858|FG000|Overall Study|Lost to Follow-up|0|||
49171997|NCT01831466|158463859|FG001|Overall Study|Lost to Follow-up|1|||
49171998|NCT01831466|158463860|FG002|Overall Study|Lost to Follow-up|4|||
49171999|NCT01831466|158463861|FG003|Overall Study|Lost to Follow-up|2|||
49172000|NCT01831466|158463862|FG004|Overall Study|Lost to Follow-up|0|||
49172001|NCT01831466|158463863|FG005|Overall Study|Lost to Follow-up|3|||
49172002|NCT01831466|158463864|FG006|Overall Study|Lost to Follow-up|0|||
49172003|NCT01831466|158463865|FG007|Overall Study|Lost to Follow-up|0|||
49172004|NCT01831466|158463866|FG008|Overall Study|Lost to Follow-up|0|||
49172005|NCT01831466|158463867|FG009|Overall Study|Lost to Follow-up|1|||
49172006|NCT01831466|158463868|FG010|Overall Study|Lost to Follow-up|0|||
48842338|NCT00542789|157263810|FG001|Overall Study|Protocol Violation|1|||
49172007|NCT01831466|158463869|FG011|Overall Study|Lost to Follow-up|1|||
49172008|NCT01831466|158463858|FG000|Overall Study|Lack of Efficacy|5|||
49172009|NCT01831466|158463859|FG001|Overall Study|Lack of Efficacy|8|||
49172010|NCT01831466|158463860|FG002|Overall Study|Lack of Efficacy|7|||
49172011|NCT01831466|158463861|FG003|Overall Study|Lack of Efficacy|6|||
49172012|NCT01831466|158463862|FG004|Overall Study|Lack of Efficacy|9|||
49172013|NCT01831466|158463863|FG005|Overall Study|Lack of Efficacy|8|||
49172014|NCT01831466|158463864|FG006|Overall Study|Lack of Efficacy|1|||
49172015|NCT01831466|158463865|FG007|Overall Study|Lack of Efficacy|1|||
49172016|NCT01831466|158463866|FG008|Overall Study|Lack of Efficacy|2|||
49172017|NCT01831466|158463867|FG009|Overall Study|Lack of Efficacy|2|||
49172018|NCT01831466|158463868|FG010|Overall Study|Lack of Efficacy|2|||
49172019|NCT01831466|158463869|FG011|Overall Study|Lack of Efficacy|0|||
49172020|NCT01831466|158463858|FG000|Overall Study|Adverse Event|0|||
49172021|NCT01831466|158463859|FG001|Overall Study|Adverse Event|0|||
49172022|NCT01831466|158463860|FG002|Overall Study|Adverse Event|4|||
49172023|NCT01831466|158463861|FG003|Overall Study|Adverse Event|6|||
49172024|NCT01831466|158463862|FG004|Overall Study|Adverse Event|3|||
49172025|NCT01831466|158463863|FG005|Overall Study|Adverse Event|7|||
49172026|NCT01831466|158463864|FG006|Overall Study|Adverse Event|0|||
49172027|NCT01831466|158463865|FG007|Overall Study|Adverse Event|1|||
48842339|NCT00542789|157263809|FG000|Overall Study|Recurrence of Gastric Ulcer|8|||
48842340|NCT00542789|157263810|FG001|Overall Study|Recurrence of Gastric Ulcer|57|||
48842341|NCT01571596|157263811|FG000|Overall Study|Adverse Event|2|||
48842342|NCT01571596|157263812|FG001|Overall Study|Adverse Event|0|||
48842343|NCT01571596|157263813|FG002|Overall Study|Adverse Event|0|||
48842344|NCT01571596|157263811|FG000|Overall Study|Study Terminated by the Sponsor|0|||
48842345|NCT01571596|157263812|FG001|Overall Study|Study Terminated by the Sponsor|1|||
49172028|NCT01831466|158463866|FG008|Overall Study|Adverse Event|1|||
49172029|NCT01831466|158463867|FG009|Overall Study|Adverse Event|1|||
49172030|NCT01831466|158463868|FG010|Overall Study|Adverse Event|0|||
49172031|NCT01831466|158463869|FG011|Overall Study|Adverse Event|2|||
49172032|NCT01221623|158463870|FG000|Overall Study|Withdrawal by Subject|19|||
49172033|NCT01221623|158463871|FG001|Overall Study|Withdrawal by Subject|8|||
48842346|NCT01571596|157263813|FG002|Overall Study|Study Terminated by the Sponsor|1|||
48692908|NCT03137992|156724647|FG001|Washout Period 1|COPD Exacerbation|1|||
49172034|NCT01221623|158463870|FG000|Overall Study|Lost to Follow-up|7|||
49172035|NCT01221623|158463871|FG001|Overall Study|Lost to Follow-up|1|||
48842347|NCT01765543|157263822|FG000|Overall Study|Death|1|||
48842348|NCT01765543|157263822|FG000|Overall Study|Withdrawal by Subject|2|||
48842349|NCT03454529|157263823|FG000|Overall Study|Did not receive treatment|6|||
48842350|NCT03454529|157263823|FG000|Overall Study|Received < 80% doses|1|||
48842351|NCT04723394|157263829|FG000|Overall Study|Adverse Event|0|||
48842352|NCT04723394|157263830|FG001|Overall Study|Adverse Event|3|||
48842353|NCT04723394|157263829|FG000|Overall Study|Death|8|||
48842354|NCT04723394|157263830|FG001|Overall Study|Death|8|||
48842355|NCT04723394|157263829|FG000|Overall Study|Lost to Follow-up|20|||
48842356|NCT04723394|157263830|FG001|Overall Study|Lost to Follow-up|17|||
48842357|NCT04723394|157263829|FG000|Overall Study|Physician Decision|1|||
48842358|NCT04723394|157263830|FG001|Overall Study|Physician Decision|0|||
48842359|NCT04723394|157263829|FG000|Overall Study|Withdrawal by Subject|20|||
48842360|NCT04723394|157263830|FG001|Overall Study|Withdrawal by Subject|34|||
48842361|NCT04723394|157263829|FG000|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|0|||
48842362|NCT04723394|157263830|FG001|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|2|||
48842363|NCT00446459|157263831|FG000|8 Months|Protocol Violation|12|||
48842364|NCT00446459|157263831|FG000|12 Months|Protocol Violation|4|||
48842365|NCT00446459|157263831|FG000|12 Months|14 subjects to MMF + Rituximab Study|14|||
48842366|NCT00508924|157263833|FG000|Overall Study|Protocol Violation|0|||
48842367|NCT00508924|157263834|FG001|Overall Study|Protocol Violation|0|||
48842368|NCT00508924|157263835|FG002|Overall Study|Protocol Violation|1|||
48842369|NCT00508924|157263836|FG003|Overall Study|Protocol Violation|1|||
48842370|NCT02918279|157263842|FG000|Overall Study|Lost to Follow-up|3|||
48842371|NCT02918279|157263843|FG001|Overall Study|Lost to Follow-up|6|||
48842372|NCT02918279|157263842|FG000|Overall Study|Withdrawal by Subject|5|||
48842373|NCT02918279|157263843|FG001|Overall Study|Withdrawal by Subject|15|||
48842374|NCT02918279|157263842|FG000|Overall Study|Withdrawal by parent/guardian|2|||
49172036|NCT01221623|158463870|FG000|Overall Study|Adverse Event|6|||
49172037|NCT01221623|158463871|FG001|Overall Study|Adverse Event|3|||
49172038|NCT01221623|158463870|FG000|Overall Study|Death|1|||
49172039|NCT01221623|158463871|FG001|Overall Study|Death|0|||
49172040|NCT01221623|158463870|FG000|Overall Study|Other|5|||
49172041|NCT01221623|158463871|FG001|Overall Study|Other|2|||
49172042|NCT02952313|158463876|FG000|Primary Endpoint|Lost to Follow-up|4|||
49172043|NCT02952313|158463876|FG000|Primary Endpoint|Withdrawal by Subject|1|||
49172044|NCT02952313|158463876|FG000|Primary Endpoint|Lack of Efficacy|1|||
49172045|NCT02952313|158463876|FG000|Primary Endpoint|Missed visit|1|||
49172046|NCT02952313|158463876|FG000|Long-term Follow-up|Lost to Follow-up|12|||
49172047|NCT02952313|158463876|FG000|Long-term Follow-up|Did not reconsent for long-term FU|7|||
49172048|NCT02952313|158463876|FG000|Long-term Follow-up|Lack of Efficacy|6|||
49172049|NCT02952313|158463876|FG000|Long-term Follow-up|Withdrawal by Subject|5|||
49172050|NCT02952313|158463876|FG000|Long-term Follow-up|Physician Decision|1|||
49172051|NCT02952313|158463876|FG000|Long-term Follow-up|Death|1|||
49172052|NCT02798315|158463880|FG000|Overall Study|Failure to return|1|||
49172053|NCT02470585|158463883|FG000|Overall Study|Death|224|||
49172054|NCT02470585|158463884|FG001|Overall Study|Death|227|||
49172055|NCT02470585|158463885|FG002|Overall Study|Death|199|||
49172056|NCT02470585|158463883|FG000|Overall Study|Withdrew consent|21|||
49172057|NCT02470585|158463884|FG001|Overall Study|Withdrew consent|22|||
49172058|NCT02470585|158463885|FG002|Overall Study|Withdrew consent|31|||
49172059|NCT02470585|158463883|FG000|Overall Study|Lost to Follow-up|8|||
49172060|NCT02470585|158463884|FG001|Overall Study|Lost to Follow-up|15|||
49172061|NCT02470585|158463885|FG002|Overall Study|Lost to Follow-up|13|||
49172062|NCT02470585|158463883|FG000|Overall Study|Sponsor discontinued study|117|||
49172063|NCT02470585|158463884|FG001|Overall Study|Sponsor discontinued study|110|||
49172064|NCT02470585|158463885|FG002|Overall Study|Sponsor discontinued study|122|||
49172065|NCT02470585|158463883|FG000|Overall Study|Other, not specified|5|||
49172066|NCT02470585|158463884|FG001|Overall Study|Other, not specified|7|||
49172067|NCT02470585|158463885|FG002|Overall Study|Other, not specified|14|||
49172068|NCT02470585|158463883|FG000|Overall Study|Missing due to site non-compliance|0|||
49172069|NCT02470585|158463884|FG001|Overall Study|Missing due to site non-compliance|2|||
49172070|NCT02470585|158463885|FG002|Overall Study|Missing due to site non-compliance|3|||
49172071|NCT03335150|158463886|FG000|Overall Study|Withdrawal by Subject|10|||
49172072|NCT03335150|158463887|FG001|Overall Study|Withdrawal by Subject|4|||
49172073|NCT03335150|158463886|FG000|Overall Study|Adverse Event|0|||
49172074|NCT03335150|158463887|FG001|Overall Study|Adverse Event|1|||
49172075|NCT01063062|158463888|FG000|Overall Study|Patient withdrew consent|0|||
49172076|NCT01063062|158463889|FG001|Overall Study|Patient withdrew consent|1|||
49172077|NCT01063062|158463888|FG000|Overall Study|Adverse Event|2|||
49172078|NCT01063062|158463889|FG001|Overall Study|Adverse Event|4|||
49172079|NCT01063062|158463888|FG000|Overall Study|Protocol Violation|5|||
49172080|NCT01063062|158463889|FG001|Overall Study|Protocol Violation|4|||
49172081|NCT01063062|158463888|FG000|Overall Study|Investigator's request|1|||
49172082|NCT01063062|158463889|FG001|Overall Study|Investigator's request|0|||
48842375|NCT02918279|157263843|FG001|Overall Study|Withdrawal by parent/guardian|1|||
48842376|NCT02918279|157263842|FG000|Overall Study|Other|3|||
48842377|NCT02918279|157263843|FG001|Overall Study|Other|1|||
48842378|NCT01190007|157263844|FG000|Overall Study|Withdrawal by Subject|4|||
48842379|NCT01190007|157263844|FG000|Overall Study|Adverse Event|8|||
49172083|NCT01063062|158463888|FG000|Overall Study|Lost to Follow-up|0|||
49172084|NCT01063062|158463889|FG001|Overall Study|Lost to Follow-up|2|||
49172085|NCT01063062|158463888|FG000|Overall Study|Miscellaneous reason|0|||
49172086|NCT01063062|158463889|FG001|Overall Study|Miscellaneous reason|1|||
49172087|NCT02195700|158463892|FG000|Overall Study|Protocol Violation|0|||
49172088|NCT02195700|158463893|FG001|Overall Study|Protocol Violation|2|||
49172089|NCT02195700|158463892|FG000|Overall Study|Noncompliance|1|||
49172090|NCT02195700|158463893|FG001|Overall Study|Noncompliance|0|||
49172091|NCT02195700|158463892|FG000|Overall Study|Adverse Event|1|||
49172092|NCT02195700|158463893|FG001|Overall Study|Adverse Event|2|||
49172093|NCT02195700|158463892|FG000|Overall Study|Withdrawal by Subject|3|||
49172094|NCT02195700|158463893|FG001|Overall Study|Withdrawal by Subject|2|||
49172095|NCT02195700|158463892|FG000|Overall Study|Lost to Follow-up|1|||
49172096|NCT02195700|158463893|FG001|Overall Study|Lost to Follow-up|1|||
49172097|NCT03989349|158463894|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|3|||
49172098|NCT03989349|158463895|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
49172099|NCT03989349|158463896|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
49172100|NCT03989349|158463897|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
49172101|NCT03989349|158463898|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
49172102|NCT03989349|158463899|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
49172103|NCT03989349|158463894|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|17|||
49172104|NCT03989349|158463895|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|4|||
49172105|NCT03989349|158463896|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
49172106|NCT03989349|158463897|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
48842380|NCT01190007|157263844|FG000|Overall Study|Difficulty of visit for complications|1|||
49172107|NCT03989349|158463898|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
49172108|NCT03989349|158463899|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
48842381|NCT01190007|157263844|FG000|Overall Study|Participant was arrested|1|||
48842382|NCT01444417|157263851|FG000|Overall Study|Ineligibility Determined|0|||
48842383|NCT01444417|157263852|FG001|Overall Study|Ineligibility Determined|1|||
48842384|NCT01444417|157263851|FG000|Overall Study|Withdrawal by Subject|2|||
48842385|NCT01444417|157263852|FG001|Overall Study|Withdrawal by Subject|0|||
48842386|NCT02200770|157263853|FG000|Randomized-controlled Period (RCP)|Adverse Event|0|||
48842387|NCT02200770|157263854|FG001|Randomized-controlled Period (RCP)|Adverse Event|2|||
48842388|NCT02200770|157263853|FG000|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
48842389|NCT02200770|157263854|FG001|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
48842390|NCT02200770|157263853|FG000|Randomized-controlled Period (RCP)|Participants randomized, but not treated|0|||
48842391|NCT02200770|157263854|FG001|Randomized-controlled Period (RCP)|Participants randomized, but not treated|1|||
48842392|NCT02200770|157263853|FG000|Randomized-controlled Period (RCP)|Other|1|||
48842393|NCT02200770|157263854|FG001|Randomized-controlled Period (RCP)|Other|2|||
48842394|NCT02200770|157263853|FG000|Open-label Period (OLP)|Adverse Event|1|||
48842395|NCT02200770|157263854|FG001|Open-label Period (OLP)|Adverse Event|2|||
48842396|NCT02200770|157263853|FG000|Open-label Period (OLP)|Death|1|||
48842397|NCT02200770|157263854|FG001|Open-label Period (OLP)|Death|2|||
49172109|NCT03989349|158463894|FG000|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|24|||
49172110|NCT03989349|158463895|FG001|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|15|||
49172111|NCT03989349|158463896|FG002|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
49172112|NCT03989349|158463897|FG003|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
49172113|NCT03989349|158463898|FG004|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
49172114|NCT03989349|158463899|FG005|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
49172115|NCT03989349|158463894|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
49172116|NCT03989349|158463895|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
49172117|NCT03989349|158463896|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
49172118|NCT03989349|158463897|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
49172119|NCT03989349|158463898|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
49172120|NCT03989349|158463899|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
49172121|NCT03989349|158463894|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|3|||
49172122|NCT03989349|158463895|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|2|||
49172123|NCT03989349|158463896|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
49172124|NCT03989349|158463897|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
49172125|NCT03989349|158463898|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
49172126|NCT03989349|158463899|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
49172127|NCT03989349|158463894|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|1|||
49172128|NCT03989349|158463895|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
49172129|NCT03989349|158463896|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
49172130|NCT03989349|158463897|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
49172131|NCT03989349|158463898|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
49172132|NCT03989349|158463899|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
49172133|NCT03989349|158463894|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|3|||
49172134|NCT03989349|158463895|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|2|||
49172135|NCT03989349|158463896|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
49172136|NCT03989349|158463897|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
49172137|NCT03989349|158463898|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
49172138|NCT03989349|158463899|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
49172139|NCT03989349|158463894|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
49172140|NCT03989349|158463895|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
49172141|NCT03989349|158463896|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
49172142|NCT03989349|158463897|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
49172143|NCT03989349|158463898|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
49172144|NCT03989349|158463899|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
49172145|NCT03989349|158463894|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
49172146|NCT03989349|158463895|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
49172147|NCT03989349|158463896|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
49172148|NCT03989349|158463897|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
49172149|NCT03989349|158463898|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
49172150|NCT03989349|158463899|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
49172151|NCT03989349|158463894|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
49172152|NCT03989349|158463895|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
49172153|NCT03989349|158463896|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|2|||
49172154|NCT03989349|158463897|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|3|||
49172155|NCT03989349|158463898|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|1|||
49172156|NCT03989349|158463899|FG005|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
49172157|NCT03989349|158463894|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
49172158|NCT03989349|158463895|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
49172159|NCT03989349|158463896|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
49172160|NCT03989349|158463897|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
49172161|NCT03989349|158463898|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|3|||
49172162|NCT03989349|158463899|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
49172163|NCT03989349|158463894|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
49172164|NCT03989349|158463895|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
49172165|NCT03989349|158463896|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
49172166|NCT03989349|158463897|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
49172167|NCT03989349|158463898|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
49172168|NCT03989349|158463899|FG005|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
49172169|NCT03989349|158463894|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
49172170|NCT03989349|158463895|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
49172171|NCT03989349|158463896|FG002|Maintenance Period (Week 16-Week 48)|Other|4|||
49172172|NCT03989349|158463897|FG003|Maintenance Period (Week 16-Week 48)|Other|2|||
49172173|NCT03989349|158463898|FG004|Maintenance Period (Week 16-Week 48)|Other|2|||
49172174|NCT03989349|158463899|FG005|Maintenance Period (Week 16-Week 48)|Other|0|||
49172175|NCT03989349|158463894|FG000|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
49172176|NCT03989349|158463895|FG001|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
49172177|NCT03989349|158463896|FG002|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
49172178|NCT03989349|158463897|FG003|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
49172179|NCT03989349|158463898|FG004|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
49172180|NCT03989349|158463899|FG005|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
49172181|NCT00661726|158463904|FG000|Overall Study|Adverse Event|1|||
49172182|NCT02316353|158463905|FG000|Overall Study|Pregnancy|1|||
49172183|NCT02316353|158463906|FG001|Overall Study|Pregnancy|3|||
49172184|NCT02316353|158463905|FG000|Overall Study|Adverse Event|1|||
49172185|NCT02316353|158463906|FG001|Overall Study|Adverse Event|3|||
49172186|NCT02316353|158463905|FG000|Overall Study|Withdrawal by Subject|6|||
49172187|NCT02316353|158463906|FG001|Overall Study|Withdrawal by Subject|2|||
49172188|NCT02982772|158466361|FG000|Intervention|Lost to Follow-up|19|||
49172189|NCT02982772|158466362|FG001|Intervention|Lost to Follow-up|13|||
49172190|NCT02982772|158466361|FG000|1M Follow-Up|Lost to Follow-up|21|||
49172191|NCT02982772|158466362|FG001|1M Follow-Up|Lost to Follow-up|18|||
49172192|NCT02982772|158466361|FG000|3M Follow-Up|Lost to Follow-up|17|||
49172193|NCT02982772|158466362|FG001|3M Follow-Up|Lost to Follow-up|11|||
49172194|NCT02982772|158466361|FG000|6M Follow-Up|Lost to Follow-up|11|||
49172195|NCT02982772|158466362|FG001|6M Follow-Up|Lost to Follow-up|9|||
49172196|NCT02982772|158466361|FG000|12M Follow-Up|Lost to Follow-up|11|||
49172197|NCT02982772|158466362|FG001|12M Follow-Up|Lost to Follow-up|5|||
49172198|NCT01234480|158466363|FG000|Overall Study|Pregnancy|88|||
49172199|NCT01234480|158466363|FG000|Overall Study|>36/Normal History|50|||
49172200|NCT01234480|158466363|FG000|Overall Study|Age|3|||
49172201|NCT01234480|158466363|FG000|Overall Study|HPV Vaccine History|28|||
49172202|NCT01234480|158466363|FG000|Overall Study|HPV Vaccine after Enrollment|17|||
49172203|NCT01234480|158466363|FG000|Overall Study|Hysterectomy|2|||
49172204|NCT01234480|158466363|FG000|Overall Study|Hysterectomy post enrollment|1|||
49172205|NCT01234480|158466363|FG000|Overall Study|Inclusion/Exclusion Violation|3|||
49172206|NCT01234480|158466363|FG000|Overall Study|Informed Consent Form Violation|30|||
49172207|NCT01234480|158466363|FG000|Overall Study|Incorrect Visit|3|||
49172208|NCT01234480|158466363|FG000|Overall Study|No Florida Lab License|20|||
49172209|NCT01234480|158466363|FG000|Overall Study|Out of Window|42|||
49172210|NCT01234480|158466363|FG000|Overall Study|Sample Processing/Storage|92|||
49172211|NCT01234480|158466363|FG000|Overall Study|Site Amendment prohibited colposcopy|11|||
49172212|NCT01234480|158466363|FG000|Overall Study|Site/Subject non-compliance|44|||
49172213|NCT01234480|158466363|FG000|Overall Study|Missing Sample|9|||
49172214|NCT02974140|158466364|FG000|Overall Study|Adverse Event|2|||
49172215|NCT02974140|158466364|FG000|Overall Study|Lost to Follow-up|1|||
48926290|NCT03403205|157561854|FG002|Extension Period (Up to 60 Months)|Pregnancy|0|||
48926291|NCT03403205|157561855|FG003|Extension Period (Up to 60 Months)|Pregnancy|0|||
48926292|NCT03403205|157561856|FG004|Extension Period (Up to 60 Months)|Pregnancy|0|||
48926293|NCT03403205|157561857|FG005|Extension Period (Up to 60 Months)|Pregnancy|0|||
48926294|NCT03403205|157561852|FG000|Extension Period (Up to 60 Months)|Protocol Deviation|1|||
48926295|NCT03403205|157561853|FG001|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
48926296|NCT03403205|157561854|FG002|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
48926297|NCT03403205|157561855|FG003|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
48926298|NCT03403205|157561856|FG004|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
48926299|NCT03403205|157561857|FG005|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
48926300|NCT03403205|157561852|FG000|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|66|||
48926301|NCT03403205|157561853|FG001|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|32|||
48926302|NCT03403205|157561854|FG002|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|21|||
48926303|NCT03403205|157561855|FG003|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|10|||
48926304|NCT03403205|157561856|FG004|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|7|||
48926305|NCT03403205|157561857|FG005|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|8|||
48926306|NCT03403205|157561852|FG000|Extension Period (Up to 60 Months)|Other than specified|5|||
48926307|NCT03403205|157561853|FG001|Extension Period (Up to 60 Months)|Other than specified|5|||
48926308|NCT03403205|157561854|FG002|Extension Period (Up to 60 Months)|Other than specified|3|||
48926309|NCT03403205|157561855|FG003|Extension Period (Up to 60 Months)|Other than specified|0|||
48926310|NCT03403205|157561856|FG004|Extension Period (Up to 60 Months)|Other than specified|1|||
48926311|NCT03403205|157561857|FG005|Extension Period (Up to 60 Months)|Other than specified|0|||
48926312|NCT03403205|157561852|FG000|Extension Period (Up to 60 Months)|Physician Decision|2|||
48926313|NCT03403205|157561853|FG001|Extension Period (Up to 60 Months)|Physician Decision|1|||
48926314|NCT03403205|157561854|FG002|Extension Period (Up to 60 Months)|Physician Decision|1|||
48926315|NCT03403205|157561855|FG003|Extension Period (Up to 60 Months)|Physician Decision|0|||
48926316|NCT03403205|157561856|FG004|Extension Period (Up to 60 Months)|Physician Decision|0|||
48926317|NCT03403205|157561857|FG005|Extension Period (Up to 60 Months)|Physician Decision|0|||
48926318|NCT02111993|157561858|FG000|Overall Study|Physician Decision|5|||
48926319|NCT02111993|157561859|FG001|Overall Study|Physician Decision|4|||
48926320|NCT01422239|157561860|FG000|Overall Study|Lost to Follow-up|4|||
48926321|NCT01422239|157561861|FG001|Overall Study|Lost to Follow-up|3|||
48926322|NCT03167073|157561862|FG000|Overall Study|Stillbirth|1|||
48926323|NCT03167073|157561863|FG001|Overall Study|Stillbirth|0|||
48926324|NCT01627860|157561864|FG000|Overall Study|Adverse Event|9|||
48926325|NCT01627860|157561865|FG001|Overall Study|Adverse Event|4|||
48926326|NCT01627860|157561864|FG000|Overall Study|Withdrawal by Subject|2|||
48926327|NCT01627860|157561865|FG001|Overall Study|Withdrawal by Subject|1|||
48926328|NCT01627860|157561864|FG000|Overall Study|Seizure frequency doubled|0|||
48926329|NCT01627860|157561865|FG001|Overall Study|Seizure frequency doubled|1|||
48926330|NCT01627860|157561864|FG000|Overall Study|Protocol Violation|1|||
48926331|NCT01627860|157561865|FG001|Overall Study|Protocol Violation|0|||
48926332|NCT00044512|157561866|FG000|Follow Up|Lost to Follow-up|2|||
49172216|NCT02974140|158466364|FG000|Overall Study|Study Terminated by Sponsor|36|||
49172217|NCT00814580|158466365|FG000|Overall Study|Adverse Event|6|||
49172218|NCT00814580|158466366|FG001|Overall Study|Adverse Event|15|||
49172219|NCT00814580|158466365|FG000|Overall Study|Lack of Efficacy|18|||
49172220|NCT00814580|158466366|FG001|Overall Study|Lack of Efficacy|25|||
49172221|NCT00814580|158466365|FG000|Overall Study|Protocol Violation|2|||
49172222|NCT00814580|158466366|FG001|Overall Study|Protocol Violation|0|||
49172223|NCT00814580|158466365|FG000|Overall Study|Withdrawal by Subject|2|||
49172224|NCT00814580|158466366|FG001|Overall Study|Withdrawal by Subject|2|||
49172225|NCT00814580|158466365|FG000|Overall Study|Other|1|||
49172226|NCT00814580|158466366|FG001|Overall Study|Other|3|||
49172227|NCT00814580|158466365|FG000|Overall Study|Did Not Take Drug|2|||
49172228|NCT00814580|158466366|FG001|Overall Study|Did Not Take Drug|2|||
49172229|NCT01905943|158466367|FG000|Overall Study|Withdrawal of consent|90|||
49172230|NCT01905943|158466367|FG000|Overall Study|Lost to Follow-up|16|||
49172231|NCT01905943|158466367|FG000|Overall Study|Investigator discretion|7|||
49172232|NCT01905943|158466367|FG000|Overall Study|Death|186|||
49172233|NCT01905943|158466367|FG000|Overall Study|Adverse Event|3|||
49172234|NCT01905943|158466367|FG000|Overall Study|Other|12|||
49172235|NCT01238991|158466370|FG000|Overall Study|Adverse Event|1|||
49172236|NCT01238991|158466371|FG001|Overall Study|Adverse Event|0|||
49172237|NCT01238991|158466372|FG002|Overall Study|Adverse Event|3|||
49172238|NCT01238991|158466373|FG003|Overall Study|Adverse Event|1|||
49172239|NCT01238991|158466374|FG004|Overall Study|Adverse Event|1|||
49172240|NCT01238991|158466375|FG005|Overall Study|Adverse Event|0|||
49172241|NCT01238991|158466376|FG006|Overall Study|Adverse Event|1|||
49172242|NCT01238991|158466377|FG007|Overall Study|Adverse Event|1|||
49172243|NCT01238991|158466378|FG008|Overall Study|Adverse Event|0|||
49172244|NCT01238991|158466379|FG009|Overall Study|Adverse Event|0|||
49172245|NCT01238991|158466370|FG000|Overall Study|Death|0|||
49172246|NCT01238991|158466371|FG001|Overall Study|Death|0|||
49172247|NCT01238991|158466372|FG002|Overall Study|Death|0|||
49172248|NCT01238991|158466373|FG003|Overall Study|Death|1|||
49172249|NCT01238991|158466374|FG004|Overall Study|Death|0|||
49172250|NCT01238991|158466375|FG005|Overall Study|Death|0|||
49172251|NCT01238991|158466376|FG006|Overall Study|Death|0|||
49172252|NCT01238991|158466377|FG007|Overall Study|Death|0|||
49172253|NCT01238991|158466378|FG008|Overall Study|Death|0|||
49172254|NCT01238991|158466379|FG009|Overall Study|Death|0|||
49172255|NCT01238991|158466370|FG000|Overall Study|Lack of Efficacy|0|||
49172256|NCT01238991|158466371|FG001|Overall Study|Lack of Efficacy|0|||
49172257|NCT01238991|158466372|FG002|Overall Study|Lack of Efficacy|1|||
49172258|NCT01238991|158466373|FG003|Overall Study|Lack of Efficacy|0|||
49172259|NCT01238991|158466374|FG004|Overall Study|Lack of Efficacy|0|||
49172260|NCT01238991|158466375|FG005|Overall Study|Lack of Efficacy|0|||
49172261|NCT01238991|158466376|FG006|Overall Study|Lack of Efficacy|0|||
49172262|NCT01238991|158466377|FG007|Overall Study|Lack of Efficacy|0|||
49172263|NCT01238991|158466378|FG008|Overall Study|Lack of Efficacy|1|||
49172264|NCT01238991|158466379|FG009|Overall Study|Lack of Efficacy|0|||
49172265|NCT01238991|158466370|FG000|Overall Study|Withdrawal by Subject|0|||
49172266|NCT01238991|158466371|FG001|Overall Study|Withdrawal by Subject|0|||
49172267|NCT01238991|158466372|FG002|Overall Study|Withdrawal by Subject|1|||
49172268|NCT01238991|158466373|FG003|Overall Study|Withdrawal by Subject|0|||
49172269|NCT01238991|158466374|FG004|Overall Study|Withdrawal by Subject|0|||
49172270|NCT01238991|158466375|FG005|Overall Study|Withdrawal by Subject|0|||
49172271|NCT01238991|158466376|FG006|Overall Study|Withdrawal by Subject|0|||
49172272|NCT01238991|158466377|FG007|Overall Study|Withdrawal by Subject|0|||
49172273|NCT01238991|158466378|FG008|Overall Study|Withdrawal by Subject|0|||
49172274|NCT01238991|158466379|FG009|Overall Study|Withdrawal by Subject|0|||
49172275|NCT01238991|158466370|FG000|Overall Study|Study Terminated by Sponsor|0|||
49172276|NCT01238991|158466371|FG001|Overall Study|Study Terminated by Sponsor|0|||
49172277|NCT01238991|158466372|FG002|Overall Study|Study Terminated by Sponsor|0|||
49172278|NCT01238991|158466373|FG003|Overall Study|Study Terminated by Sponsor|0|||
49172279|NCT01238991|158466374|FG004|Overall Study|Study Terminated by Sponsor|1|||
49172280|NCT01238991|158466375|FG005|Overall Study|Study Terminated by Sponsor|0|||
49172281|NCT01238991|158466376|FG006|Overall Study|Study Terminated by Sponsor|7|||
49172282|NCT01238991|158466377|FG007|Overall Study|Study Terminated by Sponsor|4|||
49172283|NCT01238991|158466378|FG008|Overall Study|Study Terminated by Sponsor|2|||
49172284|NCT01238991|158466379|FG009|Overall Study|Study Terminated by Sponsor|2|||
49172285|NCT01238991|158466370|FG000|Overall Study|Caregiver's request|0|||
49172286|NCT01238991|158466371|FG001|Overall Study|Caregiver's request|0|||
49172287|NCT01238991|158466372|FG002|Overall Study|Caregiver's request|0|||
49172288|NCT01238991|158466373|FG003|Overall Study|Caregiver's request|0|||
49172289|NCT01238991|158466374|FG004|Overall Study|Caregiver's request|0|||
49172290|NCT01238991|158466375|FG005|Overall Study|Caregiver's request|0|||
49172291|NCT01238991|158466376|FG006|Overall Study|Caregiver's request|0|||
49172292|NCT01238991|158466377|FG007|Overall Study|Caregiver's request|0|||
49172293|NCT01238991|158466378|FG008|Overall Study|Caregiver's request|1|||
49172294|NCT01238991|158466379|FG009|Overall Study|Caregiver's request|0|||
49172295|NCT01238991|158466370|FG000|Overall Study|Admission to a nursing home|1|||
49172296|NCT01238991|158466371|FG001|Overall Study|Admission to a nursing home|0|||
49172297|NCT01238991|158466372|FG002|Overall Study|Admission to a nursing home|1|||
49172298|NCT01238991|158466373|FG003|Overall Study|Admission to a nursing home|0|||
49172299|NCT01238991|158466374|FG004|Overall Study|Admission to a nursing home|0|||
49172300|NCT01238991|158466375|FG005|Overall Study|Admission to a nursing home|0|||
49172301|NCT01238991|158466376|FG006|Overall Study|Admission to a nursing home|0|||
49172302|NCT01238991|158466377|FG007|Overall Study|Admission to a nursing home|0|||
49172303|NCT01238991|158466378|FG008|Overall Study|Admission to a nursing home|0|||
49172304|NCT01238991|158466379|FG009|Overall Study|Admission to a nursing home|0|||
49172305|NCT02237001|158466380|FG000|Overall Study|Lost to Follow-up|2|||
49172306|NCT02237001|158466380|FG000|Overall Study|Withdrawal by Subject|1|||
49172307|NCT02237001|158466380|FG000|Overall Study|Eligibility criteria/Late Screen Failure|3|||
49172308|NCT02237001|158466380|FG000|Overall Study|Re-operation|4|||
49172309|NCT02237001|158466380|FG000|Overall Study|Incarceration|1|||
49172310|NCT01713582|158466381|FG000|Overall Study|Disease progression|3|||
49172311|NCT01713582|158466382|FG001|Overall Study|Disease progression|3|||
49172312|NCT01713582|158466383|FG002|Overall Study|Disease progression|3|||
49172313|NCT01713582|158466384|FG003|Overall Study|Disease progression|2|||
49172314|NCT01713582|158466385|FG004|Overall Study|Disease progression|3|||
49172315|NCT01713582|158466386|FG005|Overall Study|Disease progression|3|||
49172316|NCT01713582|158466387|FG006|Overall Study|Disease progression|3|||
49172317|NCT01713582|158466388|FG007|Overall Study|Disease progression|3|||
49172318|NCT01713582|158466389|FG008|Overall Study|Disease progression|3|||
49172319|NCT01713582|158466390|FG009|Overall Study|Disease progression|11|||
49172320|NCT01713582|158466391|FG010|Overall Study|Disease progression|10|||
49172321|NCT01713582|158466392|FG011|Overall Study|Disease progression|5|||
49172322|NCT01713582|158466393|FG012|Overall Study|Disease progression|3|||
49172323|NCT01713582|158466394|FG013|Overall Study|Disease progression|3|||
49172324|NCT01713582|158466395|FG014|Overall Study|Disease progression|6|||
49172325|NCT01713582|158466396|FG015|Overall Study|Disease progression|6|||
49172326|NCT01713582|158466397|FG016|Overall Study|Disease progression|5|||
49172327|NCT01713582|158466398|FG017|Overall Study|Disease progression|2|||
49172328|NCT01713582|158466399|FG018|Overall Study|Disease progression|3|||
49172329|NCT01713582|158466400|FG019|Overall Study|Disease progression|5|||
49172330|NCT01713582|158466401|FG020|Overall Study|Disease progression|15|||
49172331|NCT01713582|158466381|FG000|Overall Study|Death|0|||
49172332|NCT01713582|158466382|FG001|Overall Study|Death|0|||
49172333|NCT01713582|158466383|FG002|Overall Study|Death|0|||
49172334|NCT01713582|158466384|FG003|Overall Study|Death|1|||
49172335|NCT01713582|158466385|FG004|Overall Study|Death|1|||
49172336|NCT01713582|158466386|FG005|Overall Study|Death|3|||
49172337|NCT01713582|158466387|FG006|Overall Study|Death|3|||
49172338|NCT01713582|158466388|FG007|Overall Study|Death|2|||
49172339|NCT01713582|158466389|FG008|Overall Study|Death|3|||
49172340|NCT01713582|158466390|FG009|Overall Study|Death|4|||
49172341|NCT01713582|158466391|FG010|Overall Study|Death|3|||
49172342|NCT01713582|158466392|FG011|Overall Study|Death|0|||
49172343|NCT01713582|158466393|FG012|Overall Study|Death|0|||
49172344|NCT01713582|158466394|FG013|Overall Study|Death|0|||
49172345|NCT01713582|158466395|FG014|Overall Study|Death|0|||
49172346|NCT01713582|158466396|FG015|Overall Study|Death|0|||
49172347|NCT01713582|158466397|FG016|Overall Study|Death|0|||
49172348|NCT01713582|158466398|FG017|Overall Study|Death|0|||
49172349|NCT01713582|158466399|FG018|Overall Study|Death|0|||
49172350|NCT01713582|158466400|FG019|Overall Study|Death|0|||
49172351|NCT01713582|158466401|FG020|Overall Study|Death|0|||
49172352|NCT01713582|158466381|FG000|Overall Study|Adverse event-related|0|||
49172353|NCT01713582|158466382|FG001|Overall Study|Adverse event-related|0|||
49172354|NCT01713582|158466383|FG002|Overall Study|Adverse event-related|0|||
49172355|NCT01713582|158466384|FG003|Overall Study|Adverse event-related|0|||
49172356|NCT01713582|158466385|FG004|Overall Study|Adverse event-related|0|||
49172357|NCT01713582|158466386|FG005|Overall Study|Adverse event-related|0|||
49172358|NCT01713582|158466387|FG006|Overall Study|Adverse event-related|0|||
49172359|NCT01713582|158466388|FG007|Overall Study|Adverse event-related|0|||
49172360|NCT01713582|158466389|FG008|Overall Study|Adverse event-related|0|||
49172361|NCT01713582|158466390|FG009|Overall Study|Adverse event-related|1|||
49172362|NCT01713582|158466391|FG010|Overall Study|Adverse event-related|1|||
49172363|NCT01713582|158466392|FG011|Overall Study|Adverse event-related|0|||
49172364|NCT01713582|158466393|FG012|Overall Study|Adverse event-related|0|||
49172365|NCT01713582|158466394|FG013|Overall Study|Adverse event-related|0|||
49172366|NCT01713582|158466395|FG014|Overall Study|Adverse event-related|0|||
49172367|NCT01713582|158466396|FG015|Overall Study|Adverse event-related|0|||
49172368|NCT01713582|158466397|FG016|Overall Study|Adverse event-related|0|||
49172369|NCT01713582|158466398|FG017|Overall Study|Adverse event-related|0|||
49172370|NCT01713582|158466399|FG018|Overall Study|Adverse event-related|1|||
49172371|NCT01713582|158466400|FG019|Overall Study|Adverse event-related|0|||
49172372|NCT01713582|158466401|FG020|Overall Study|Adverse event-related|0|||
49172373|NCT01713582|158466381|FG000|Overall Study|Adverse event-unrelated|0|||
49172374|NCT01713582|158466382|FG001|Overall Study|Adverse event-unrelated|0|||
49172375|NCT01713582|158466383|FG002|Overall Study|Adverse event-unrelated|0|||
49172376|NCT01713582|158466384|FG003|Overall Study|Adverse event-unrelated|0|||
49172377|NCT01713582|158466385|FG004|Overall Study|Adverse event-unrelated|0|||
49172378|NCT01713582|158466386|FG005|Overall Study|Adverse event-unrelated|1|||
49172379|NCT01713582|158466387|FG006|Overall Study|Adverse event-unrelated|1|||
48842398|NCT02200770|157263853|FG000|Open-label Period (OLP)|Lost to Follow-up|0|||
48842399|NCT02200770|157263854|FG001|Open-label Period (OLP)|Lost to Follow-up|1|||
49172380|NCT01713582|158466388|FG007|Overall Study|Adverse event-unrelated|1|||
49172381|NCT01713582|158466389|FG008|Overall Study|Adverse event-unrelated|0|||
49172382|NCT01713582|158466390|FG009|Overall Study|Adverse event-unrelated|0|||
49172383|NCT01713582|158466391|FG010|Overall Study|Adverse event-unrelated|0|||
49172384|NCT01713582|158466392|FG011|Overall Study|Adverse event-unrelated|0|||
49172385|NCT01713582|158466393|FG012|Overall Study|Adverse event-unrelated|0|||
49172386|NCT01713582|158466394|FG013|Overall Study|Adverse event-unrelated|1|||
49172387|NCT01713582|158466395|FG014|Overall Study|Adverse event-unrelated|1|||
49172388|NCT01713582|158466396|FG015|Overall Study|Adverse event-unrelated|0|||
49172389|NCT01713582|158466397|FG016|Overall Study|Adverse event-unrelated|0|||
49172390|NCT01713582|158466398|FG017|Overall Study|Adverse event-unrelated|0|||
49172391|NCT01713582|158466399|FG018|Overall Study|Adverse event-unrelated|0|||
49172392|NCT01713582|158466400|FG019|Overall Study|Adverse event-unrelated|0|||
49172393|NCT01713582|158466401|FG020|Overall Study|Adverse event-unrelated|0|||
49172394|NCT01713582|158466381|FG000|Overall Study|Withdrawal of consent|0|||
49172395|NCT01713582|158466382|FG001|Overall Study|Withdrawal of consent|0|||
49172396|NCT01713582|158466383|FG002|Overall Study|Withdrawal of consent|1|||
49172397|NCT01713582|158466384|FG003|Overall Study|Withdrawal of consent|0|||
48842400|NCT02200770|157263853|FG000|Open-label Period (OLP)|Withdrawal by Subject|0|||
48842401|NCT02200770|157263854|FG001|Open-label Period (OLP)|Withdrawal by Subject|14|||
48842402|NCT02200770|157263853|FG000|Open-label Period (OLP)|Other|6|||
48842403|NCT02200770|157263854|FG001|Open-label Period (OLP)|Other|15|||
48842404|NCT01414738|157263855|FG000|Overall Study|Death|26|||
48842405|NCT01414738|157263855|FG000|Overall Study|Refused testing|5|||
48842406|NCT01414738|157263855|FG000|Overall Study|Lost to Follow-up|2|||
48842407|NCT01414738|157263855|FG000|Overall Study|Refused, disease progression|8|||
48842408|NCT01414738|157263855|FG000|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3|||
48842409|NCT03950622|157263856|FG000|Overall Study|Withdrawal by Subject|1|||
49172398|NCT01713582|158466385|FG004|Overall Study|Withdrawal of consent|0|||
49172399|NCT01713582|158466386|FG005|Overall Study|Withdrawal of consent|1|||
49172400|NCT01713582|158466387|FG006|Overall Study|Withdrawal of consent|0|||
49172401|NCT01713582|158466388|FG007|Overall Study|Withdrawal of consent|0|||
49172402|NCT01713582|158466389|FG008|Overall Study|Withdrawal of consent|0|||
49172403|NCT01713582|158466390|FG009|Overall Study|Withdrawal of consent|1|||
49172404|NCT01713582|158466391|FG010|Overall Study|Withdrawal of consent|0|||
49172405|NCT01713582|158466392|FG011|Overall Study|Withdrawal of consent|0|||
49172406|NCT01713582|158466393|FG012|Overall Study|Withdrawal of consent|0|||
49172407|NCT01713582|158466394|FG013|Overall Study|Withdrawal of consent|0|||
49172408|NCT01713582|158466395|FG014|Overall Study|Withdrawal of consent|0|||
49172409|NCT01713582|158466396|FG015|Overall Study|Withdrawal of consent|0|||
48842410|NCT03950622|157263857|FG001|Overall Study|Withdrawal by Subject|0|||
48842411|NCT03950622|157263856|FG000|Overall Study|Protocol Deviation|0|||
48842412|NCT03950622|157263857|FG001|Overall Study|Protocol Deviation|1|||
48842413|NCT03950622|157263856|FG000|Overall Study|Physician Decision|1|||
49172410|NCT01713582|158466397|FG016|Overall Study|Withdrawal of consent|0|||
49172411|NCT01713582|158466398|FG017|Overall Study|Withdrawal of consent|0|||
48842414|NCT03950622|157263857|FG001|Overall Study|Physician Decision|0|||
48842415|NCT03950622|157263856|FG000|Overall Study|Lost to Follow-up|5|||
49172412|NCT01713582|158466399|FG018|Overall Study|Withdrawal of consent|1|||
49172413|NCT01713582|158466400|FG019|Overall Study|Withdrawal of consent|0|||
48842416|NCT03950622|157263857|FG001|Overall Study|Lost to Follow-up|5|||
48842417|NCT03950622|157263856|FG000|Overall Study|Death|1|||
48842418|NCT03950622|157263857|FG001|Overall Study|Death|1|||
48842419|NCT02423798|157263858|FG000|Overall Study|Withdrawal by Subject|3|||
48842420|NCT00457743|157263861|FG000|Overall Study|Adverse Event|0|||
48842421|NCT00457743|157263862|FG001|Overall Study|Adverse Event|4|||
48842422|NCT00457743|157263863|FG002|Overall Study|Adverse Event|0|||
48842423|NCT00457743|157263861|FG000|Overall Study|Lack of Efficacy|3|||
48842424|NCT00457743|157263862|FG001|Overall Study|Lack of Efficacy|23|||
48842425|NCT00457743|157263863|FG002|Overall Study|Lack of Efficacy|3|||
48842426|NCT01943916|157263868|FG000|Overall Study|Technically invalid images|10|||
48842427|NCT01943916|157263868|FG000|Overall Study|Enrollment Failure|23|||
48842428|NCT01943916|157263868|FG000|Overall Study|Pilot Phase exclusion|100|||
48842429|NCT01943916|157263868|FG000|Overall Study|Quality Assurance Reader Fail|130|||
48842430|NCT01943916|157263868|FG000|Overall Study|Technical Failure|39|||
49172414|NCT01713582|158466401|FG020|Overall Study|Withdrawal of consent|0|||
49172415|NCT01713582|158466381|FG000|Overall Study|Lack of Efficacy|0|||
49172416|NCT01713582|158466382|FG001|Overall Study|Lack of Efficacy|0|||
49172417|NCT01713582|158466383|FG002|Overall Study|Lack of Efficacy|0|||
49172418|NCT01713582|158466384|FG003|Overall Study|Lack of Efficacy|0|||
49172419|NCT01713582|158466385|FG004|Overall Study|Lack of Efficacy|0|||
49172420|NCT01713582|158466386|FG005|Overall Study|Lack of Efficacy|0|||
49172421|NCT01713582|158466387|FG006|Overall Study|Lack of Efficacy|0|||
49172422|NCT01713582|158466388|FG007|Overall Study|Lack of Efficacy|0|||
49172423|NCT01713582|158466389|FG008|Overall Study|Lack of Efficacy|0|||
49172424|NCT01713582|158466390|FG009|Overall Study|Lack of Efficacy|1|||
49172425|NCT01713582|158466391|FG010|Overall Study|Lack of Efficacy|2|||
49172426|NCT01713582|158466392|FG011|Overall Study|Lack of Efficacy|0|||
49172427|NCT01713582|158466393|FG012|Overall Study|Lack of Efficacy|0|||
49172428|NCT01713582|158466394|FG013|Overall Study|Lack of Efficacy|0|||
49172429|NCT01713582|158466395|FG014|Overall Study|Lack of Efficacy|0|||
49172430|NCT01713582|158466396|FG015|Overall Study|Lack of Efficacy|0|||
49172431|NCT01713582|158466397|FG016|Overall Study|Lack of Efficacy|0|||
49172432|NCT01713582|158466398|FG017|Overall Study|Lack of Efficacy|0|||
49172433|NCT01713582|158466399|FG018|Overall Study|Lack of Efficacy|0|||
49172434|NCT01713582|158466400|FG019|Overall Study|Lack of Efficacy|0|||
49172435|NCT01713582|158466401|FG020|Overall Study|Lack of Efficacy|0|||
49172436|NCT01713582|158466381|FG000|Overall Study|Withdrawal by Subject|0|||
49172437|NCT01713582|158466382|FG001|Overall Study|Withdrawal by Subject|0|||
49172438|NCT01713582|158466383|FG002|Overall Study|Withdrawal by Subject|0|||
49172439|NCT01713582|158466384|FG003|Overall Study|Withdrawal by Subject|0|||
49172440|NCT01713582|158466385|FG004|Overall Study|Withdrawal by Subject|0|||
49172441|NCT01713582|158466386|FG005|Overall Study|Withdrawal by Subject|0|||
49172442|NCT01713582|158466387|FG006|Overall Study|Withdrawal by Subject|0|||
49172443|NCT01713582|158466388|FG007|Overall Study|Withdrawal by Subject|0|||
49172444|NCT01713582|158466389|FG008|Overall Study|Withdrawal by Subject|0|||
49172445|NCT01713582|158466390|FG009|Overall Study|Withdrawal by Subject|0|||
49172446|NCT01713582|158466391|FG010|Overall Study|Withdrawal by Subject|0|||
49172447|NCT01713582|158466392|FG011|Overall Study|Withdrawal by Subject|0|||
49172448|NCT01713582|158466393|FG012|Overall Study|Withdrawal by Subject|0|||
49172449|NCT01713582|158466394|FG013|Overall Study|Withdrawal by Subject|0|||
49172450|NCT01713582|158466395|FG014|Overall Study|Withdrawal by Subject|0|||
49172451|NCT01713582|158466396|FG015|Overall Study|Withdrawal by Subject|0|||
49172452|NCT01713582|158466397|FG016|Overall Study|Withdrawal by Subject|0|||
49172453|NCT01713582|158466398|FG017|Overall Study|Withdrawal by Subject|1|||
49172454|NCT01713582|158466399|FG018|Overall Study|Withdrawal by Subject|0|||
49172455|NCT01713582|158466400|FG019|Overall Study|Withdrawal by Subject|0|||
49172456|NCT01713582|158466401|FG020|Overall Study|Withdrawal by Subject|0|||
48926333|NCT02551159|157561869|FG000|Overall Study|Death|352|||
49172457|NCT01713582|158466381|FG000|Overall Study|Stopped to receive bone marrow graft|0|||
49172458|NCT01713582|158466382|FG001|Overall Study|Stopped to receive bone marrow graft|0|||
49172459|NCT01713582|158466383|FG002|Overall Study|Stopped to receive bone marrow graft|0|||
49172460|NCT01713582|158466384|FG003|Overall Study|Stopped to receive bone marrow graft|0|||
48926334|NCT02551159|157561870|FG001|Overall Study|Death|174|||
48926335|NCT02551159|157561871|FG002|Overall Study|Death|161|||
48926336|NCT02551159|157561869|FG000|Overall Study|Withdrawal by Subject|8|||
48926337|NCT02551159|157561870|FG001|Overall Study|Withdrawal by Subject|5|||
48926338|NCT02551159|157561871|FG002|Overall Study|Withdrawal by Subject|16|||
48926339|NCT02551159|157561869|FG000|Overall Study|Patients alive or lost to follow-up at DCO|53|||
48926340|NCT02551159|157561870|FG001|Overall Study|Patients alive or lost to follow-up at DCO|25|||
48926341|NCT02551159|157561871|FG002|Overall Study|Patients alive or lost to follow-up at DCO|29|||
48926342|NCT00268242|157561872|FG000|Overall Study|Death|1|||
48926343|NCT02695628|157561879|FG000|Overall Study|Withdrawal by Subject|1|||
48926344|NCT01110200|157561880|FG000|Overall Study|Adverse Event|28|||
48926345|NCT01110200|157561881|FG001|Overall Study|Adverse Event|28|||
48926346|NCT01110200|157561880|FG000|Overall Study|Withdrawal by Subject|25|||
48926347|NCT01110200|157561881|FG001|Overall Study|Withdrawal by Subject|32|||
48926348|NCT01110200|157561880|FG000|Overall Study|Lack of Efficacy|16|||
48926349|NCT01110200|157561881|FG001|Overall Study|Lack of Efficacy|25|||
49172461|NCT01713582|158466385|FG004|Overall Study|Stopped to receive bone marrow graft|0|||
49172462|NCT01713582|158466386|FG005|Overall Study|Stopped to receive bone marrow graft|0|||
49172463|NCT01713582|158466387|FG006|Overall Study|Stopped to receive bone marrow graft|0|||
49172464|NCT01713582|158466388|FG007|Overall Study|Stopped to receive bone marrow graft|0|||
49172465|NCT01713582|158466389|FG008|Overall Study|Stopped to receive bone marrow graft|0|||
49172466|NCT01713582|158466390|FG009|Overall Study|Stopped to receive bone marrow graft|0|||
49172467|NCT01713582|158466391|FG010|Overall Study|Stopped to receive bone marrow graft|0|||
49172468|NCT01713582|158466392|FG011|Overall Study|Stopped to receive bone marrow graft|0|||
49172469|NCT01713582|158466393|FG012|Overall Study|Stopped to receive bone marrow graft|0|||
49172470|NCT01713582|158466394|FG013|Overall Study|Stopped to receive bone marrow graft|0|||
48926350|NCT01110200|157561880|FG000|Overall Study|Protocol Violation|14|||
48926351|NCT01110200|157561881|FG001|Overall Study|Protocol Violation|12|||
48926352|NCT01110200|157561880|FG000|Overall Study|Physician Decision|13|||
49172471|NCT01713582|158466395|FG014|Overall Study|Stopped to receive bone marrow graft|0|||
49172472|NCT01713582|158466396|FG015|Overall Study|Stopped to receive bone marrow graft|0|||
49172473|NCT01713582|158466397|FG016|Overall Study|Stopped to receive bone marrow graft|1|||
49172474|NCT01713582|158466398|FG017|Overall Study|Stopped to receive bone marrow graft|0|||
49172475|NCT01713582|158466399|FG018|Overall Study|Stopped to receive bone marrow graft|0|||
49172476|NCT01713582|158466400|FG019|Overall Study|Stopped to receive bone marrow graft|0|||
49172477|NCT01713582|158466401|FG020|Overall Study|Stopped to receive bone marrow graft|0|||
49172478|NCT01713582|158466381|FG000|Overall Study|Disease progression and adverse event|0|||
49172479|NCT01713582|158466382|FG001|Overall Study|Disease progression and adverse event|0|||
49172480|NCT01713582|158466383|FG002|Overall Study|Disease progression and adverse event|0|||
49172481|NCT01713582|158466384|FG003|Overall Study|Disease progression and adverse event|0|||
49172482|NCT01713582|158466385|FG004|Overall Study|Disease progression and adverse event|0|||
49172483|NCT01713582|158466386|FG005|Overall Study|Disease progression and adverse event|0|||
49172484|NCT01713582|158466387|FG006|Overall Study|Disease progression and adverse event|0|||
49172485|NCT01713582|158466388|FG007|Overall Study|Disease progression and adverse event|0|||
49172486|NCT01713582|158466389|FG008|Overall Study|Disease progression and adverse event|0|||
49172487|NCT01713582|158466390|FG009|Overall Study|Disease progression and adverse event|0|||
49172488|NCT01713582|158466391|FG010|Overall Study|Disease progression and adverse event|0|||
49172489|NCT01713582|158466392|FG011|Overall Study|Disease progression and adverse event|0|||
49172490|NCT01713582|158466393|FG012|Overall Study|Disease progression and adverse event|0|||
49172491|NCT01713582|158466394|FG013|Overall Study|Disease progression and adverse event|0|||
49172492|NCT01713582|158466395|FG014|Overall Study|Disease progression and adverse event|0|||
49172493|NCT01713582|158466396|FG015|Overall Study|Disease progression and adverse event|0|||
49172494|NCT01713582|158466397|FG016|Overall Study|Disease progression and adverse event|1|||
49172495|NCT01713582|158466398|FG017|Overall Study|Disease progression and adverse event|0|||
49172496|NCT01713582|158466399|FG018|Overall Study|Disease progression and adverse event|0|||
49172497|NCT01713582|158466400|FG019|Overall Study|Disease progression and adverse event|0|||
49172498|NCT01713582|158466401|FG020|Overall Study|Disease progression and adverse event|0|||
49172499|NCT00617084|158466402|FG000|Overall Study|Withdrawal by Subject|5|||
49172500|NCT00617084|158466403|FG001|Overall Study|Withdrawal by Subject|7|||
49172501|NCT00617084|158466402|FG000|Overall Study|Missed 12 Months visit|16|||
49172502|NCT00617084|158466403|FG001|Overall Study|Missed 12 Months visit|19|||
49172503|NCT03370419|158466405|FG000|Overall Study|Lost to Follow-up|16|||
49172504|NCT00809835|158466410|FG000|Overall Study|Lost to Follow-up|7|||
48842431|NCT01943916|157263868|FG000|Overall Study|Protocol Deviation No Biopsy|25|||
49172505|NCT00809835|158466411|FG001|Overall Study|Lost to Follow-up|6|||
48842432|NCT01943916|157263868|FG000|Overall Study|No Truth Panel Review|38|||
48842433|NCT01943916|157263868|FG000|Overall Study|Protocol Deviation|1|||
48842434|NCT00373529|157263870|FG000|Overall Study|Physician Decision|19|||
49172506|NCT00809835|158466412|FG002|Overall Study|Lost to Follow-up|10|||
49172507|NCT00809835|158466413|FG003|Overall Study|Lost to Follow-up|2|||
48842435|NCT00373529|157263870|FG000|Overall Study|Withdrawal by Subject|7|||
49172508|NCT00809835|158466410|FG000|Overall Study|Withdrawal by Subject|1|||
49172509|NCT00809835|158466411|FG001|Overall Study|Withdrawal by Subject|1|||
49172510|NCT00809835|158466412|FG002|Overall Study|Withdrawal by Subject|1|||
49172511|NCT00809835|158466413|FG003|Overall Study|Withdrawal by Subject|0|||
49172512|NCT00956007|158466414|FG000|Overall Study|Protocol Violation|27|||
49172513|NCT00956007|158466415|FG001|Overall Study|Protocol Violation|23|||
49172514|NCT04551898|158466418|FG000|Overall Study|Participant randomized but did not receive study drug|0|||
49172515|NCT04551898|158466419|FG001|Overall Study|Participant randomized but did not receive study drug|1|||
49172516|NCT04551898|158466420|FG002|Overall Study|Participant randomized but did not receive study drug|3|||
49172517|NCT04551898|158466421|FG003|Overall Study|Participant randomized but did not receive study drug|1|||
49172518|NCT04551898|158466418|FG000|Overall Study|Withdrawal by Subject|5|||
49172519|NCT04551898|158466419|FG001|Overall Study|Withdrawal by Subject|1|||
49172520|NCT04551898|158466420|FG002|Overall Study|Withdrawal by Subject|2|||
49172521|NCT04551898|158466421|FG003|Overall Study|Withdrawal by Subject|2|||
49172522|NCT04551898|158466418|FG000|Overall Study|Lost to Follow-up|2|||
49172523|NCT04551898|158466419|FG001|Overall Study|Lost to Follow-up|1|||
49172524|NCT04551898|158466420|FG002|Overall Study|Lost to Follow-up|2|||
49172525|NCT04551898|158466421|FG003|Overall Study|Lost to Follow-up|2|||
49172526|NCT04551898|158466418|FG000|Overall Study|Death|1|||
49172527|NCT04551898|158466419|FG001|Overall Study|Death|0|||
49172528|NCT04551898|158466420|FG002|Overall Study|Death|0|||
49172529|NCT04551898|158466421|FG003|Overall Study|Death|0|||
49172530|NCT04551898|158466418|FG000|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
49172531|NCT04551898|158466419|FG001|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
49172532|NCT04551898|158466420|FG002|Overall Study|Incorrectly randomized and screen failed due to administrative error|1|||
49172533|NCT04551898|158466421|FG003|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
49172534|NCT01681186|158466424|FG000|Washout Period From Second Intervention|Adverse Event|0|||
49172535|NCT01681186|158466425|FG001|Washout Period From Second Intervention|Adverse Event|0|||
49172536|NCT01681186|158466426|FG002|Washout Period From Second Intervention|Adverse Event|0|||
49172537|NCT01681186|158466427|FG003|Washout Period From Second Intervention|Adverse Event|0|||
49172538|NCT01681186|158466428|FG004|Washout Period From Second Intervention|Adverse Event|0|||
49172539|NCT01681186|158466429|FG005|Washout Period From Second Intervention|Adverse Event|0|||
49172540|NCT01681186|158466430|FG006|Washout Period From Second Intervention|Adverse Event|1|||
49172541|NCT01681186|158466431|FG007|Washout Period From Second Intervention|Adverse Event|0|||
49172542|NCT01681186|158466424|FG000|Washout Period From Second Intervention|Protocol Violation|0|||
49172543|NCT01681186|158466425|FG001|Washout Period From Second Intervention|Protocol Violation|0|||
49172544|NCT01681186|158466426|FG002|Washout Period From Second Intervention|Protocol Violation|0|||
49172545|NCT01681186|158466427|FG003|Washout Period From Second Intervention|Protocol Violation|0|||
49172546|NCT01681186|158466428|FG004|Washout Period From Second Intervention|Protocol Violation|0|||
49172547|NCT01681186|158466429|FG005|Washout Period From Second Intervention|Protocol Violation|0|||
49172548|NCT01681186|158466430|FG006|Washout Period From Second Intervention|Protocol Violation|0|||
49172549|NCT01681186|158466431|FG007|Washout Period From Second Intervention|Protocol Violation|1|||
49172550|NCT01681186|158466424|FG000|Washout Period From Third Intervention|Lost to Follow-up|0|||
49172551|NCT01681186|158466425|FG001|Washout Period From Third Intervention|Lost to Follow-up|0|||
49172552|NCT01681186|158466426|FG002|Washout Period From Third Intervention|Lost to Follow-up|0|||
49172553|NCT01681186|158466427|FG003|Washout Period From Third Intervention|Lost to Follow-up|0|||
49172554|NCT01681186|158466428|FG004|Washout Period From Third Intervention|Lost to Follow-up|0|||
49172555|NCT01681186|158466429|FG005|Washout Period From Third Intervention|Lost to Follow-up|0|||
49172556|NCT01681186|158466430|FG006|Washout Period From Third Intervention|Lost to Follow-up|1|||
49172557|NCT01681186|158466431|FG007|Washout Period From Third Intervention|Lost to Follow-up|0|||
49172558|NCT01681186|158466424|FG000|Fourth Intervention|Protocol Violation|0|||
49172559|NCT01681186|158466425|FG001|Fourth Intervention|Protocol Violation|0|||
49172560|NCT01681186|158466426|FG002|Fourth Intervention|Protocol Violation|0|||
49172561|NCT01681186|158466427|FG003|Fourth Intervention|Protocol Violation|0|||
49172562|NCT01681186|158466428|FG004|Fourth Intervention|Protocol Violation|0|||
49172563|NCT01681186|158466429|FG005|Fourth Intervention|Protocol Violation|0|||
49172564|NCT01681186|158466430|FG006|Fourth Intervention|Protocol Violation|0|||
49172565|NCT01681186|158466431|FG007|Fourth Intervention|Protocol Violation|1|||
49172566|NCT03333928|158466434|FG000|Initial Dosing Period (Period 1)|Protocol Violation|0|||
49172567|NCT03333928|158466435|FG001|Initial Dosing Period (Period 1)|Protocol Violation|0|||
49172568|NCT03333928|158466436|FG002|Initial Dosing Period (Period 1)|Protocol Violation|1|||
49172569|NCT03333928|158466434|FG000|Initial Dosing Period (Period 1)|Withdrawal by Subject|0|||
49172570|NCT03333928|158466435|FG001|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
49172571|NCT03333928|158466436|FG002|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
49172572|NCT03333928|158466434|FG000|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
49172573|NCT03333928|158466435|FG001|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|0|||
49172574|NCT03333928|158466436|FG002|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
49172575|NCT03333928|158466434|FG000|Initial Dosing Period (Period 1)|Adverse Event|0|||
48926353|NCT01110200|157561881|FG001|Overall Study|Physician Decision|17|||
48926354|NCT01110200|157561880|FG000|Overall Study|Lost to Follow-up|10|||
48926355|NCT01110200|157561881|FG001|Overall Study|Lost to Follow-up|7|||
48926356|NCT02025010|157561890|FG000|Overall Study|Symptomatic or radiographic progression|36|||
48926357|NCT02025010|157561890|FG000|Overall Study|Adverse Event|6|||
48926358|NCT02025010|157561890|FG000|Overall Study|Physician Decision|7|||
48926359|NCT02025010|157561890|FG000|Overall Study|Withdrawal by Subject|3|||
48926360|NCT02025010|157561890|FG000|Overall Study|Intercurrent illness|3|||
48926361|NCT02025010|157561890|FG000|Overall Study|Patients still on treatment|3|||
48926362|NCT02025010|157561890|FG000|Overall Study|Never initiate the treatment|2|||
48926363|NCT05076266|157561894|FG000|Overall Study|Survey not complete - Participant refusal|2|||
48926364|NCT05076266|157561895|FG001|Overall Study|Survey not complete - Participant refusal|0|||
48926365|NCT05425420|157561896|FG000|Overall Study|Physician Decision|1|||
48926366|NCT05425420|157561896|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
48926367|NCT05478525|157563217|FG000|Overall Study|Withdrawal by Subject|0|||
48926368|NCT05478525|157563218|FG001|Overall Study|Withdrawal by Subject|1|||
48926369|NCT05478525|157563219|FG002|Overall Study|Withdrawal by Subject|2|||
48926370|NCT05478525|157563220|FG003|Overall Study|Withdrawal by Subject|0|||
49172576|NCT03333928|158466435|FG001|Initial Dosing Period (Period 1)|Adverse Event|3|||
49172577|NCT03333928|158466436|FG002|Initial Dosing Period (Period 1)|Adverse Event|1|||
49172578|NCT03333928|158466434|FG000|Dose-controlled Extension (Period 2)|Adverse Event|2|||
49172579|NCT03333928|158466435|FG001|Dose-controlled Extension (Period 2)|Adverse Event|1|||
49172580|NCT03333928|158466436|FG002|Dose-controlled Extension (Period 2)|Adverse Event|0|||
49172581|NCT03333928|158466434|FG000|Dose-controlled Extension (Period 2)|Lost to Follow-up|1|||
49172582|NCT03333928|158466435|FG001|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
48926371|NCT05478525|157563217|FG000|Overall Study|COVID-19 Infection|2|||
48926372|NCT05478525|157563218|FG001|Overall Study|COVID-19 Infection|0|||
48926373|NCT05478525|157563219|FG002|Overall Study|COVID-19 Infection|1|||
48926374|NCT05478525|157563220|FG003|Overall Study|COVID-19 Infection|1|||
48926375|NCT03358875|157563223|FG000|Overall Study|Death|409|||
48926376|NCT03358875|157563224|FG001|Overall Study|Death|223|||
48926377|NCT03358875|157563223|FG000|Overall Study|Study Closed by Sponsor|66|||
48926378|NCT03358875|157563224|FG001|Overall Study|Study Closed by Sponsor|29|||
48926379|NCT03358875|157563223|FG000|Overall Study|Withdrawal by Subject|13|||
49172583|NCT03333928|158466436|FG002|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
49172584|NCT03333928|158466434|FG000|Randomized Withdrawal (Period 3)|Adverse Event|1|||
49172585|NCT03333928|158466435|FG001|Randomized Withdrawal (Period 3)|Adverse Event|0|||
49172586|NCT03333928|158466436|FG002|Randomized Withdrawal (Period 3)|Adverse Event|0|||
49172587|NCT03333928|158466434|FG000|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
49172588|NCT03333928|158466435|FG001|Randomized Withdrawal (Period 3)|Lost to Follow-up|0|||
49172589|NCT03333928|158466436|FG002|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
48926380|NCT03358875|157563224|FG001|Overall Study|Withdrawal by Subject|16|||
49172590|NCT03015363|158466445|FG000|Overall Study|Physician Decision|14|||
48842436|NCT00373529|157263870|FG000|Overall Study|Adverse Event|7|||
48842437|NCT00373529|157263870|FG000|Overall Study|Treatment failure|36|||
48842438|NCT00373529|157263870|FG000|Overall Study|Disease recurrence|10|||
48842439|NCT00373529|157263870|FG000|Overall Study|Death|16|||
48842440|NCT00373529|157263870|FG000|Overall Study|Need for treatment prohibited by study|1|||
48842441|NCT00373529|157263870|FG000|Overall Study|Other|8|||
48842442|NCT00373529|157263870|FG000|Overall Study|Failed independent confirmation of AML|3|||
48842443|NCT00373529|157263870|FG000|Overall Study|Consent violation|1|||
48842444|NCT02708108|157263871|FG000|Overall Study|Death|1|||
48842445|NCT02708108|157263872|FG001|Overall Study|Death|2|||
48842446|NCT02708108|157263871|FG000|Overall Study|Regimen change|1|||
49172591|NCT03015363|158466445|FG000|Overall Study|Withdrawal by Subject|3|||
49172592|NCT02263326|158466446|FG000|Overall Study|Lost to Follow-up|1|||
49172593|NCT02263326|158466447|FG001|Overall Study|Lost to Follow-up|1|||
49172594|NCT00301262|158466448|FG000|Double Blind Phase (DB)|Adverse Event|1|||
49172595|NCT00301262|158466449|FG001|Double Blind Phase (DB)|Adverse Event|0|||
49172596|NCT00301262|158466448|FG000|Double Blind Phase (DB)|Lack of Efficacy|0|||
49172597|NCT00301262|158466449|FG001|Double Blind Phase (DB)|Lack of Efficacy|1|||
49172598|NCT00301262|158466448|FG000|Double Blind Phase (DB)|Lost to Follow-up|3|||
49172599|NCT00301262|158466449|FG001|Double Blind Phase (DB)|Lost to Follow-up|3|||
49172600|NCT00301262|158466448|FG000|Double Blind Phase (DB)|Withdrawal by Subject|5|||
49172601|NCT00301262|158466449|FG001|Double Blind Phase (DB)|Withdrawal by Subject|5|||
49172602|NCT00301262|158466448|FG000|Double Blind Phase (DB)|Other|1|||
49172603|NCT00301262|158466449|FG001|Double Blind Phase (DB)|Other|4|||
49172604|NCT00301262|158466448|FG000|Open Label Phase (OL)|Adverse Event|1|||
49172605|NCT00301262|158466449|FG001|Open Label Phase (OL)|Adverse Event|0|||
49172606|NCT00301262|158466448|FG000|Open Label Phase (OL)|Lost to Follow-up|1|||
49172607|NCT00301262|158466449|FG001|Open Label Phase (OL)|Lost to Follow-up|2|||
49172608|NCT00301262|158466448|FG000|Open Label Phase (OL)|Other|2|||
49172609|NCT00301262|158466449|FG001|Open Label Phase (OL)|Other|0|||
49172610|NCT02397915|158466450|FG000|Period 1|Protocol Violation|0|||
49172611|NCT02397915|158466451|FG001|Period 1|Protocol Violation|1|||
49172612|NCT02397915|158466452|FG002|Period 1|Protocol Violation|0|||
49172613|NCT02397915|158466453|FG003|Period 1|Protocol Violation|0|||
49172614|NCT02397915|158466450|FG000|Period 1|Physician Decision|1|||
49172615|NCT02397915|158466451|FG001|Period 1|Physician Decision|0|||
49172616|NCT02397915|158466452|FG002|Period 1|Physician Decision|0|||
49172617|NCT02397915|158466453|FG003|Period 1|Physician Decision|0|||
49172618|NCT02013778|158466455|FG000|Overall Study|Death|4|||
49172619|NCT02013778|158466455|FG000|Overall Study|Withdrawal by Subject|1|||
49172620|NCT02013778|158466455|FG000|Overall Study|Physician Decision|1|||
49172621|NCT02013778|158466455|FG000|Overall Study|Adverse Event|1|||
49172622|NCT00293813|158466458|FG000|Overall Study|Physician Decision|0|||
49172623|NCT00293813|158466459|FG001|Overall Study|Physician Decision|1|||
49172624|NCT00293813|158466460|FG002|Overall Study|Physician Decision|0|||
49172625|NCT00293813|158466458|FG000|Overall Study|Adverse Event|3|||
49172626|NCT00293813|158466459|FG001|Overall Study|Adverse Event|1|||
49172627|NCT00293813|158466460|FG002|Overall Study|Adverse Event|1|||
49172628|NCT00293813|158466458|FG000|Overall Study|Withdrawal by Subject|7|||
49172629|NCT00293813|158466459|FG001|Overall Study|Withdrawal by Subject|4|||
49172630|NCT00293813|158466460|FG002|Overall Study|Withdrawal by Subject|4|||
49172631|NCT00293813|158466458|FG000|Overall Study|Lost to Follow-up|3|||
49172632|NCT00293813|158466459|FG001|Overall Study|Lost to Follow-up|2|||
49172633|NCT00293813|158466460|FG002|Overall Study|Lost to Follow-up|3|||
49172634|NCT00293813|158466458|FG000|Overall Study|Noncompliance|0|||
49172635|NCT00293813|158466459|FG001|Overall Study|Noncompliance|1|||
49172636|NCT00293813|158466460|FG002|Overall Study|Noncompliance|0|||
49172637|NCT01521923|158466461|FG000|Overall Study|AE, serious fatal|1|||
49172638|NCT01521923|158466462|FG001|Overall Study|AE, serious fatal|0|||
49172639|NCT01521923|158466463|FG002|Overall Study|AE, serious fatal|0|||
49172640|NCT01521923|158466464|FG003|Overall Study|AE, serious fatal|0|||
49172641|NCT01521923|158466461|FG000|Overall Study|SAE, non-fatal|0|||
49172642|NCT01521923|158466462|FG001|Overall Study|SAE, non-fatal|2|||
49172643|NCT01521923|158466463|FG002|Overall Study|SAE, non-fatal|2|||
49172644|NCT01521923|158466464|FG003|Overall Study|SAE, non-fatal|0|||
49172645|NCT01521923|158466461|FG000|Overall Study|AE, non-serious, non-fatal|1|||
49172646|NCT01521923|158466462|FG001|Overall Study|AE, non-serious, non-fatal|3|||
49172647|NCT01521923|158466463|FG002|Overall Study|AE, non-serious, non-fatal|6|||
49172648|NCT01521923|158466464|FG003|Overall Study|AE, non-serious, non-fatal|2|||
49172649|NCT01521923|158466461|FG000|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
49172650|NCT01521923|158466462|FG001|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
49172651|NCT01521923|158466463|FG002|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
49172652|NCT01521923|158466464|FG003|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1|||
49172653|NCT01521923|158466461|FG000|Overall Study|Lack of Efficacy|1|||
49172654|NCT01521923|158466462|FG001|Overall Study|Lack of Efficacy|1|||
49172655|NCT01521923|158466463|FG002|Overall Study|Lack of Efficacy|0|||
49172656|NCT01521923|158466464|FG003|Overall Study|Lack of Efficacy|0|||
49172657|NCT01521923|158466461|FG000|Overall Study|Protocol Violation|0|||
48842447|NCT02708108|157263872|FG001|Overall Study|Regimen change|0|||
48842448|NCT02708108|157263871|FG000|Overall Study|No MRD and no imaging available|0|||
48842449|NCT02708108|157263872|FG001|Overall Study|No MRD and no imaging available|1|||
49172658|NCT01521923|158466462|FG001|Overall Study|Protocol Violation|0|||
49172659|NCT01521923|158466463|FG002|Overall Study|Protocol Violation|1|||
48842450|NCT01736215|157263873|FG000|Overall Study|Early termination of erythropoietin use|1|||
48842451|NCT01736215|157263873|FG000|Overall Study|Adverse Event|4|||
48842452|NCT01736215|157263873|FG000|Overall Study|Progressive disease stop chemotherapy|1|||
48842453|NCT01736215|157263873|FG000|Overall Study|Insufficient data to perform analysis|8|||
49172660|NCT01521923|158466464|FG003|Overall Study|Protocol Violation|0|||
49172661|NCT01521923|158466461|FG000|Overall Study|Lost to Follow-up|1|||
49172662|NCT01521923|158466462|FG001|Overall Study|Lost to Follow-up|0|||
49172663|NCT01521923|158466463|FG002|Overall Study|Lost to Follow-up|2|||
49172664|NCT01521923|158466464|FG003|Overall Study|Lost to Follow-up|1|||
49172665|NCT01521923|158466461|FG000|Overall Study|Withdrawal by Subject|1|||
49172666|NCT01521923|158466462|FG001|Overall Study|Withdrawal by Subject|1|||
49172667|NCT01521923|158466463|FG002|Overall Study|Withdrawal by Subject|1|||
49172668|NCT01521923|158466464|FG003|Overall Study|Withdrawal by Subject|2|||
49172669|NCT01521923|158466461|FG000|Overall Study|Other|2|||
49172670|NCT01521923|158466462|FG001|Overall Study|Other|1|||
49172671|NCT01521923|158466463|FG002|Overall Study|Other|3|||
49172672|NCT01521923|158466464|FG003|Overall Study|Other|6|||
49172673|NCT01521923|158466461|FG000|Overall Study|AE, captured in Period 1|0|||
49172674|NCT01521923|158466462|FG001|Overall Study|AE, captured in Period 1|1|||
49172675|NCT01521923|158466463|FG002|Overall Study|AE, captured in Period 1|0|||
49172676|NCT01521923|158466464|FG003|Overall Study|AE, captured in Period 1|1|||
49172677|NCT02482298|158466465|FG000|Overall Study|Withdrawal by Subject|2|||
49172678|NCT02482298|158466466|FG001|Overall Study|Withdrawal by Subject|1|||
49172679|NCT02482298|158466467|FG002|Overall Study|Withdrawal by Subject|2|||
49172680|NCT02482298|158466465|FG000|Overall Study|Did Not Fulfill Randomization Criteria|0|||
49172681|NCT02482298|158466466|FG001|Overall Study|Did Not Fulfill Randomization Criteria|1|||
49172682|NCT02482298|158466467|FG002|Overall Study|Did Not Fulfill Randomization Criteria|0|||
49172683|NCT02482298|158466465|FG000|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
49172684|NCT02482298|158466466|FG001|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
49172685|NCT02482298|158466467|FG002|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1|||
49172686|NCT02482298|158466465|FG000|Overall Study|Lost to Follow-up|0|||
49172687|NCT02482298|158466466|FG001|Overall Study|Lost to Follow-up|1|||
49172688|NCT02482298|158466467|FG002|Overall Study|Lost to Follow-up|0|||
49172689|NCT00880269|158466469|FG000|Overall Study|Protocol Violation|1|||
49172690|NCT00880269|158466470|FG001|Overall Study|Protocol Violation|0|||
49172691|NCT00880269|158466469|FG000|Overall Study|Disease Progression|13|||
49172692|NCT00880269|158466470|FG001|Overall Study|Disease Progression|11|||
49172693|NCT00880269|158466469|FG000|Overall Study|New Cancer Therapy|1|||
49172694|NCT00880269|158466470|FG001|Overall Study|New Cancer Therapy|0|||
49172695|NCT00880269|158466469|FG000|Overall Study|Death|4|||
49172696|NCT00880269|158466470|FG001|Overall Study|Death|2|||
49172697|NCT00880269|158466469|FG000|Overall Study|Lost to Follow-up|0|||
49172698|NCT00880269|158466470|FG001|Overall Study|Lost to Follow-up|1|||
49172699|NCT00880269|158466469|FG000|Overall Study|Withdrawal by Subject|3|||
49172700|NCT00880269|158466470|FG001|Overall Study|Withdrawal by Subject|4|||
49172701|NCT00880269|158466469|FG000|Overall Study|Adverse Event|10|||
49172702|NCT00880269|158466470|FG001|Overall Study|Adverse Event|9|||
49172703|NCT02707965|158466471|FG000|Overall Study|Withdrawal by Subject|0|||
49172704|NCT02707965|158466472|FG001|Overall Study|Withdrawal by Subject|0|||
49172705|NCT02707965|158466473|FG002|Overall Study|Withdrawal by Subject|1|||
49172706|NCT02707965|158466474|FG003|Overall Study|Withdrawal by Subject|0|||
48692909|NCT03137992|156724648|FG002|Washout Period 1|COPD Exacerbation|1|||
48842454|NCT00068601|157263874|FG000|Overall Study|Ineligible|11|||
48842455|NCT00068601|157263875|FG001|Overall Study|Ineligible|13|||
48842456|NCT00068601|157263874|FG000|Overall Study|Not evaluable: withdrew consent|5|||
49172707|NCT02707965|158466475|FG004|Overall Study|Withdrawal by Subject|0|||
49172708|NCT02707965|158466476|FG005|Overall Study|Withdrawal by Subject|0|||
49172709|NCT02707965|158466477|FG006|Overall Study|Withdrawal by Subject|0|||
49172710|NCT02707965|158466478|FG007|Overall Study|Withdrawal by Subject|2|||
49172711|NCT02707965|158466479|FG008|Overall Study|Withdrawal by Subject|0|||
49172712|NCT02707965|158466480|FG009|Overall Study|Withdrawal by Subject|0|||
49172713|NCT02707965|158466481|FG010|Overall Study|Withdrawal by Subject|0|||
49172714|NCT02707965|158466482|FG011|Overall Study|Withdrawal by Subject|0|||
49172715|NCT02707965|158466483|FG012|Overall Study|Withdrawal by Subject|0|||
49172716|NCT02707965|158466484|FG013|Overall Study|Withdrawal by Subject|0|||
49172717|NCT02707965|158466485|FG014|Overall Study|Withdrawal by Subject|0|||
48926381|NCT03358875|157563223|FG000|Overall Study|Lost to Follow-up|13|||
48926382|NCT03358875|157563224|FG001|Overall Study|Lost to Follow-up|2|||
48926383|NCT03358875|157563223|FG000|Overall Study|Miscellaneous|33|||
48926384|NCT03358875|157563224|FG001|Overall Study|Miscellaneous|0|||
48926385|NCT03358875|157563223|FG000|Overall Study|Remained on Study|1|||
48926386|NCT03358875|157563224|FG001|Overall Study|Remained on Study|0|||
48926387|NCT04523207|157563225|FG000|Overall Study|Adverse Event|5|||
48926388|NCT04523207|157563226|FG001|Overall Study|Adverse Event|1|||
48926389|NCT04523207|157563225|FG000|Overall Study|Lost to Follow-up|2|||
48926390|NCT04523207|157563226|FG001|Overall Study|Lost to Follow-up|0|||
49172718|NCT02707965|158466486|FG015|Overall Study|Withdrawal by Subject|0|||
49172719|NCT02707965|158466471|FG000|Overall Study|PI decisions|0|||
48735641|NCT00961649|156883700|FG003|Overall Study|Patient left to Mexico-family emergency|0|||
48926391|NCT04523207|157563225|FG000|Overall Study|Withdrawal by Subject|2|||
48926392|NCT04523207|157563226|FG001|Overall Study|Withdrawal by Subject|0|||
48926393|NCT04523207|157563225|FG000|Overall Study|Progressive Disease|2|||
48926394|NCT04523207|157563226|FG001|Overall Study|Progressive Disease|1|||
48926395|NCT04523207|157563225|FG000|Overall Study|Other|7|||
48926396|NCT04523207|157563226|FG001|Overall Study|Other|1|||
48926397|NCT01408147|157563227|FG000|Overall Study|Withdrawal by Subject|0|||
48926398|NCT01408147|157563228|FG001|Overall Study|Withdrawal by Subject|1|||
48926399|NCT02489318|157563229|FG000|Randomized|Withdrawal by Subject|0|||
48926400|NCT02489318|157563230|FG001|Randomized|Withdrawal by Subject|1|||
48926401|NCT02489318|157563229|FG000|Treated|Adverse Event|19|||
48926402|NCT02489318|157563230|FG001|Treated|Adverse Event|62|||
48926403|NCT02489318|157563229|FG000|Treated|Death|13|||
48926404|NCT02489318|157563230|FG001|Treated|Death|11|||
48926405|NCT02489318|157563229|FG000|Treated|Physician Decision|4|||
48926406|NCT02489318|157563230|FG001|Treated|Physician Decision|6|||
48926407|NCT02489318|157563229|FG000|Treated|Protocol Violation|1|||
48926408|NCT02489318|157563230|FG001|Treated|Protocol Violation|2|||
48926409|NCT02489318|157563229|FG000|Treated|Withdrawal by Subject|37|||
48926410|NCT02489318|157563230|FG001|Treated|Withdrawal by Subject|36|||
48926411|NCT02489318|157563229|FG000|Treated|Other: Progressive Disease|245|||
48926412|NCT02489318|157563230|FG001|Treated|Other: Progressive Disease|138|||
48926413|NCT02489318|157563229|FG000|Treated|Other|0|||
48926414|NCT02489318|157563230|FG001|Treated|Other|2|||
48926415|NCT02489318|157563229|FG000|Treated|Ongoing|0|||
48926416|NCT02489318|157563230|FG001|Treated|Ongoing|267|||
48926417|NCT04833777|157563231|FG000|Overall Study|Lost to Follow-up|1|||
48926418|NCT04833777|157563232|FG001|Overall Study|Lost to Follow-up|0|||
48926419|NCT01171898|157563233|FG000|Overall Study|Death|0|||
48926420|NCT01171898|157563234|FG001|Overall Study|Death|0|||
48926421|NCT01171898|157563235|FG002|Overall Study|Death|2|||
48926422|NCT01171898|157563236|FG003|Overall Study|Death|0|||
49172720|NCT02707965|158466472|FG001|Overall Study|PI decisions|0|||
49172721|NCT02707965|158466473|FG002|Overall Study|PI decisions|0|||
49172722|NCT02707965|158466474|FG003|Overall Study|PI decisions|0|||
49172723|NCT02707965|158466475|FG004|Overall Study|PI decisions|0|||
49172724|NCT02707965|158466476|FG005|Overall Study|PI decisions|0|||
49172725|NCT02707965|158466477|FG006|Overall Study|PI decisions|0|||
49172726|NCT02707965|158466478|FG007|Overall Study|PI decisions|0|||
49172727|NCT02707965|158466479|FG008|Overall Study|PI decisions|0|||
49172728|NCT02707965|158466480|FG009|Overall Study|PI decisions|0|||
49172729|NCT02707965|158466481|FG010|Overall Study|PI decisions|0|||
49172730|NCT02707965|158466482|FG011|Overall Study|PI decisions|0|||
49172731|NCT02707965|158466483|FG012|Overall Study|PI decisions|0|||
49172732|NCT02707965|158466484|FG013|Overall Study|PI decisions|0|||
48926423|NCT01171898|157563233|FG000|Overall Study|Lost to Follow-up|0|||
48926424|NCT01171898|157563234|FG001|Overall Study|Lost to Follow-up|1|||
49172733|NCT02707965|158466485|FG014|Overall Study|PI decisions|2|||
49172734|NCT02707965|158466486|FG015|Overall Study|PI decisions|0|||
49172735|NCT02707965|158466471|FG000|Overall Study|Protocol deviation|1|||
49172736|NCT02707965|158466472|FG001|Overall Study|Protocol deviation|1|||
49172737|NCT02707965|158466473|FG002|Overall Study|Protocol deviation|0|||
49172738|NCT02707965|158466474|FG003|Overall Study|Protocol deviation|0|||
49172739|NCT02707965|158466475|FG004|Overall Study|Protocol deviation|0|||
49172740|NCT02707965|158466476|FG005|Overall Study|Protocol deviation|0|||
49172741|NCT02707965|158466477|FG006|Overall Study|Protocol deviation|0|||
49172742|NCT02707965|158466478|FG007|Overall Study|Protocol deviation|1|||
49172743|NCT02707965|158466479|FG008|Overall Study|Protocol deviation|0|||
49172744|NCT02707965|158466480|FG009|Overall Study|Protocol deviation|0|||
49172745|NCT02707965|158466481|FG010|Overall Study|Protocol deviation|0|||
49172746|NCT02707965|158466482|FG011|Overall Study|Protocol deviation|0|||
49172747|NCT02707965|158466483|FG012|Overall Study|Protocol deviation|0|||
49172748|NCT02707965|158466484|FG013|Overall Study|Protocol deviation|0|||
49172749|NCT02707965|158466485|FG014|Overall Study|Protocol deviation|0|||
49172750|NCT02707965|158466486|FG015|Overall Study|Protocol deviation|0|||
49172751|NCT00564733|158466487|FG000|Overall Study|Withdrawal by Subject|4|||
49172752|NCT00564733|158466487|FG000|Overall Study|Ineligible|5|||
49172753|NCT01995526|158466488|FG000|Overall Study|Physician Decision|1|||
49172754|NCT01822899|158466493|FG000|Overall Study|Adverse Event|6|||
49172755|NCT01822899|158466494|FG001|Overall Study|Adverse Event|5|||
49172756|NCT01822899|158466493|FG000|Overall Study|Lack of Efficacy|6|||
49172757|NCT01822899|158466494|FG001|Overall Study|Lack of Efficacy|3|||
49172758|NCT01822899|158466493|FG000|Overall Study|Protocol Violation|6|||
49172759|NCT01822899|158466494|FG001|Overall Study|Protocol Violation|3|||
49172760|NCT01822899|158466493|FG000|Overall Study|Lost to Follow-up|1|||
49172761|NCT01822899|158466494|FG001|Overall Study|Lost to Follow-up|0|||
49172762|NCT01822899|158466493|FG000|Overall Study|Withdrawal by Subject|5|||
49172763|NCT01822899|158466494|FG001|Overall Study|Withdrawal by Subject|7|||
49172764|NCT00988052|158466495|FG000|Overall Study|Missing|1|||
49172765|NCT00988052|158466496|FG001|Overall Study|Missing|0|||
48842457|NCT00068601|157263875|FG001|Overall Study|Not evaluable: withdrew consent|4|||
48842458|NCT00068601|157263874|FG000|Overall Study|Not evaluable: hysterectomy/oophorectomy|2|||
48842459|NCT00068601|157263875|FG001|Overall Study|Not evaluable: hysterectomy/oophorectomy|4|||
48842460|NCT00068601|157263874|FG000|Overall Study|Death|11|||
48842461|NCT00068601|157263875|FG001|Overall Study|Death|3|||
48842462|NCT00068601|157263874|FG000|Overall Study|Lost to Follow-up|3|||
48842463|NCT00068601|157263875|FG001|Overall Study|Lost to Follow-up|2|||
48842464|NCT00068601|157263874|FG000|Overall Study|Missing primary outcome data|30|||
48842465|NCT00068601|157263875|FG001|Overall Study|Missing primary outcome data|34|||
48842466|NCT03565315|157263876|FG000|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
48842467|NCT03565315|157263877|FG001|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
48842468|NCT03565315|157263878|FG002|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
48842469|NCT03565315|157263879|FG003|Overall Study|IND Sponsor/PI Voluntary Study Pause|1|||
49172766|NCT00988052|158466495|FG000|Overall Study|Teva requested subject withdrawal|3|||
49172767|NCT00988052|158466496|FG001|Overall Study|Teva requested subject withdrawal|1|||
49172768|NCT00988052|158466495|FG000|Overall Study|Death|1|||
49172769|NCT00988052|158466496|FG001|Overall Study|Death|3|||
49172770|NCT00988052|158466495|FG000|Overall Study|Protocol Violation|6|||
49172771|NCT00988052|158466496|FG001|Overall Study|Protocol Violation|5|||
49172772|NCT00988052|158466495|FG000|Overall Study|Pregnancy|6|||
49172773|NCT00988052|158466496|FG001|Overall Study|Pregnancy|6|||
49172774|NCT00988052|158466495|FG000|Overall Study|Lack of Efficacy|8|||
49172775|NCT00988052|158466496|FG001|Overall Study|Lack of Efficacy|7|||
49172776|NCT00988052|158466495|FG000|Overall Study|Lost to Follow-up|6|||
49172777|NCT00988052|158466496|FG001|Overall Study|Lost to Follow-up|11|||
49172778|NCT00988052|158466495|FG000|Overall Study|Physician Decision|27|||
49172779|NCT00988052|158466496|FG001|Overall Study|Physician Decision|28|||
49172780|NCT00988052|158466495|FG000|Overall Study|Adverse Event|35|||
49172781|NCT00988052|158466496|FG001|Overall Study|Adverse Event|28|||
49172782|NCT00988052|158466495|FG000|Overall Study|Withdrawal by Subject|90|||
49172783|NCT00988052|158466496|FG001|Overall Study|Withdrawal by Subject|91|||
49172784|NCT00988052|158466495|FG000|Overall Study|Study terminated by sponsor|240|||
49172785|NCT00988052|158466496|FG001|Overall Study|Study terminated by sponsor|236|||
48842470|NCT01017146|157263880|FG000|Overall Study|Adverse Event|11|||
48842471|NCT01017146|157263881|FG001|Overall Study|Adverse Event|1|||
48842472|NCT01017146|157263880|FG000|Overall Study|Lost to Follow-up|14|||
48842473|NCT01017146|157263881|FG001|Overall Study|Lost to Follow-up|14|||
48842474|NCT01017146|157263880|FG000|Overall Study|Noncompliance with Study Product|1|||
48842475|NCT01017146|157263881|FG001|Overall Study|Noncompliance with Study Product|1|||
48842476|NCT01017146|157263880|FG000|Overall Study|Withdrawal by Subject|32|||
48842477|NCT01017146|157263881|FG001|Overall Study|Withdrawal by Subject|16|||
48842478|NCT01017146|157263880|FG000|Overall Study|Relocation|0|||
48842479|NCT01017146|157263881|FG001|Overall Study|Relocation|4|||
48842480|NCT01017146|157263880|FG000|Overall Study|Pregnancy|2|||
48842481|NCT01017146|157263881|FG001|Overall Study|Pregnancy|1|||
48842482|NCT01017146|157263880|FG000|Overall Study|Protocol Violation|2|||
49172786|NCT02584452|158466497|FG000|Overall Study|Physician Decision|1|||
49172787|NCT02584452|158466498|FG001|Overall Study|Physician Decision|1|||
49172788|NCT02584452|158466497|FG000|Overall Study|Lost to Follow-up|1|||
49172789|NCT02584452|158466498|FG001|Overall Study|Lost to Follow-up|1|||
49172790|NCT03640507|158466501|FG000|Overall Study|Withdrawal by Subject|0|||
49172791|NCT03640507|158466502|FG001|Overall Study|Withdrawal by Subject|0|||
49172792|NCT03640507|158466503|FG002|Overall Study|Withdrawal by Subject|1|||
49172793|NCT03525600|158466504|FG000|Overall Study|Adverse Event|9|||
49172794|NCT03525600|158466505|FG001|Overall Study|Adverse Event|6|||
49172795|NCT03525600|158466506|FG002|Overall Study|Adverse Event|5|||
49172796|NCT03525600|158466507|FG003|Overall Study|Adverse Event|3|||
49172797|NCT03525600|158466504|FG000|Overall Study|Lost to Follow-up|2|||
49172798|NCT03525600|158466505|FG001|Overall Study|Lost to Follow-up|4|||
49172799|NCT03525600|158466506|FG002|Overall Study|Lost to Follow-up|4|||
49172800|NCT03525600|158466507|FG003|Overall Study|Lost to Follow-up|0|||
49172801|NCT03525600|158466504|FG000|Overall Study|Physician Decision|1|||
49172802|NCT03525600|158466505|FG001|Overall Study|Physician Decision|0|||
48926425|NCT01171898|157563235|FG002|Overall Study|Lost to Follow-up|1|||
48926426|NCT01171898|157563236|FG003|Overall Study|Lost to Follow-up|1|||
48926427|NCT01171898|157563233|FG000|Overall Study|Withdrawal by Subject|1|||
49172803|NCT03525600|158466506|FG002|Overall Study|Physician Decision|2|||
49172804|NCT03525600|158466507|FG003|Overall Study|Physician Decision|0|||
49172805|NCT03525600|158466504|FG000|Overall Study|Consent withdrawal|36|||
48842483|NCT01017146|157263881|FG001|Overall Study|Protocol Violation|0|||
48842484|NCT01017146|157263880|FG000|Overall Study|Took Excluded Medication|2|||
48842485|NCT01017146|157263881|FG001|Overall Study|Took Excluded Medication|0|||
48842486|NCT01017146|157263880|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
48842487|NCT01017146|157263881|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
48842488|NCT01017146|157263880|FG000|Overall Study|Change in Work Situation|1|||
48842489|NCT01017146|157263881|FG001|Overall Study|Change in Work Situation|0|||
48842490|NCT00440011|157263882|FG000|Overall Study|Adverse Event|2|||
48842491|NCT00440011|157263883|FG001|Overall Study|Adverse Event|0|||
48842492|NCT00440011|157263882|FG000|Overall Study|Lost to Follow-up|0|||
48842493|NCT00440011|157263883|FG001|Overall Study|Lost to Follow-up|2|||
48842494|NCT00440011|157263882|FG000|Overall Study|Protocol Violation|1|||
48842495|NCT00440011|157263883|FG001|Overall Study|Protocol Violation|1|||
48842496|NCT00440011|157263882|FG000|Overall Study|Withdrawal by Subject|1|||
48842497|NCT00440011|157263883|FG001|Overall Study|Withdrawal by Subject|0|||
48842498|NCT04200365|157263887|FG000|Overall Study|Adverse Event|2|||
48842499|NCT04200365|157263887|FG000|Overall Study|Progressive Disease|4|||
48842500|NCT04200365|157263887|FG000|Overall Study|Lack of Efficacy|1|||
48842501|NCT04200365|157263887|FG000|Overall Study|Study Closure|4|||
48842502|NCT04128319|157263891|FG000|Overall Study|Death|3|||
48842503|NCT00203411|157263900|FG000|Follow-up|Progressive Disease|4|||
48842504|NCT03482635|157263901|FG000|Overall Study|Lack of Efficacy|0|||
48842505|NCT03482635|157263902|FG001|Overall Study|Lack of Efficacy|0|||
48842506|NCT03482635|157263903|FG002|Overall Study|Lack of Efficacy|1|||
48842507|NCT03482635|157263904|FG003|Overall Study|Lack of Efficacy|3|||
48842508|NCT03482635|157263901|FG000|Overall Study|Adverse Event|2|||
48842509|NCT03482635|157263902|FG001|Overall Study|Adverse Event|2|||
48842510|NCT03482635|157263903|FG002|Overall Study|Adverse Event|0|||
48842511|NCT03482635|157263904|FG003|Overall Study|Adverse Event|3|||
48842512|NCT03482635|157263901|FG000|Overall Study|Withdrawal by Subject|2|||
48842513|NCT03482635|157263902|FG001|Overall Study|Withdrawal by Subject|1|||
49172806|NCT03525600|158466505|FG001|Overall Study|Consent withdrawal|20|||
49172807|NCT03525600|158466506|FG002|Overall Study|Consent withdrawal|6|||
49172808|NCT03525600|158466507|FG003|Overall Study|Consent withdrawal|13|||
49172809|NCT03525600|158466504|FG000|Overall Study|Death|7|||
49172810|NCT03525600|158466505|FG001|Overall Study|Death|6|||
49172811|NCT03525600|158466506|FG002|Overall Study|Death|4|||
49172812|NCT03525600|158466507|FG003|Overall Study|Death|3|||
49172813|NCT03525600|158466504|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
49172814|NCT03525600|158466505|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|10|||
49172815|NCT03525600|158466506|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
49172816|NCT03525600|158466507|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
49172817|NCT03525600|158466504|FG000|Overall Study|Other|0|||
49172818|NCT03525600|158466505|FG001|Overall Study|Other|1|||
49172819|NCT03525600|158466506|FG002|Overall Study|Other|0|||
49172820|NCT03525600|158466507|FG003|Overall Study|Other|0|||
49172821|NCT00289289|158466508|FG000|Overall Study|Withdrawal by Subject|5|||
49172822|NCT00289289|158466509|FG001|Overall Study|Withdrawal by Subject|3|||
49172823|NCT00289289|158466510|FG002|Overall Study|Withdrawal by Subject|15|||
49172824|NCT00289289|158466508|FG000|Overall Study|Lost to Follow-up|1|||
49172825|NCT00289289|158466509|FG001|Overall Study|Lost to Follow-up|0|||
49172826|NCT00289289|158466510|FG002|Overall Study|Lost to Follow-up|1|||
49172827|NCT00289289|158466508|FG000|Overall Study|Death|4|||
49172828|NCT00289289|158466509|FG001|Overall Study|Death|2|||
49172829|NCT00289289|158466510|FG002|Overall Study|Death|5|||
49172830|NCT00289289|158466508|FG000|Overall Study|No implant attempted|0|||
49172831|NCT00289289|158466509|FG001|Overall Study|No implant attempted|0|||
49172832|NCT00289289|158466510|FG002|Overall Study|No implant attempted|1|||
49172833|NCT00289289|158466508|FG000|Overall Study|Physician Decision|1|||
49172834|NCT00289289|158466509|FG001|Overall Study|Physician Decision|0|||
49172835|NCT00289289|158466510|FG002|Overall Study|Physician Decision|6|||
49172836|NCT00289289|158466508|FG000|Overall Study|Non-study device implanted|2|||
49172837|NCT00289289|158466509|FG001|Overall Study|Non-study device implanted|1|||
49172838|NCT00289289|158466510|FG002|Overall Study|Non-study device implanted|3|||
49172839|NCT00289289|158466508|FG000|Overall Study|Did not meet inclusion/exclusion|0|||
49172840|NCT00289289|158466509|FG001|Overall Study|Did not meet inclusion/exclusion|0|||
49172841|NCT00289289|158466510|FG002|Overall Study|Did not meet inclusion/exclusion|6|||
49172842|NCT00289289|158466508|FG000|Overall Study|Other Exit Reason|6|||
49172843|NCT00289289|158466509|FG001|Overall Study|Other Exit Reason|4|||
49172844|NCT00289289|158466510|FG002|Overall Study|Other Exit Reason|12|||
49172845|NCT01832493|158466517|FG000|Overall Study|Physician Decision|2|||
48842514|NCT03482635|157263903|FG002|Overall Study|Withdrawal by Subject|0|||
48842515|NCT03482635|157263904|FG003|Overall Study|Withdrawal by Subject|1|||
48842516|NCT03482635|157263901|FG000|Overall Study|Withdrawn by Principle Investigator|1|||
48842517|NCT03482635|157263902|FG001|Overall Study|Withdrawn by Principle Investigator|0|||
49172846|NCT01832493|158466517|FG000|Overall Study|Protocol Violation|4|||
49172847|NCT01832493|158466517|FG000|Overall Study|Unable to place LV lead|2|||
49172848|NCT01536561|158466518|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|40|||
48842518|NCT03482635|157263903|FG002|Overall Study|Withdrawn by Principle Investigator|0|||
48842519|NCT03482635|157263904|FG003|Overall Study|Withdrawn by Principle Investigator|0|||
48842520|NCT03482635|157263901|FG000|Overall Study|Not treated|0|||
48842521|NCT03482635|157263902|FG001|Overall Study|Not treated|0|||
48842522|NCT03482635|157263903|FG002|Overall Study|Not treated|0|||
48842523|NCT03482635|157263904|FG003|Overall Study|Not treated|1|||
48842524|NCT02769858|157263905|FG000|Overall Study|Withdrawal by Subject|2|||
48842525|NCT01049503|157265347|FG000|Overall Study|Lost to Follow-up|11|||
48842526|NCT01049503|157265348|FG001|Overall Study|Lost to Follow-up|12|||
48842527|NCT01049503|157265349|FG002|Overall Study|Lost to Follow-up|24|||
49172849|NCT01536561|158466518|FG000|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2|||
49172850|NCT01536561|158466518|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
49172851|NCT01536561|158466518|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1|||
49172852|NCT01536561|158466518|FG000|Dosimetric and Therapeutic Treatment|Death|2|||
49172853|NCT01536561|158466518|FG000|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13|||
49172854|NCT01939977|158466519|FG000|Overall Study|Adverse Event|4|||
49172855|NCT01939977|158466520|FG001|Overall Study|Adverse Event|3|||
49172856|NCT01939977|158466519|FG000|Overall Study|Lack of Efficacy|3|||
49172857|NCT01939977|158466520|FG001|Overall Study|Lack of Efficacy|0|||
49172858|NCT01939977|158466519|FG000|Overall Study|Physician Decision|1|||
49172859|NCT01939977|158466520|FG001|Overall Study|Physician Decision|1|||
49172860|NCT01939977|158466519|FG000|Overall Study|Withdrawal by Subject|0|||
49172861|NCT01939977|158466520|FG001|Overall Study|Withdrawal by Subject|2|||
49172862|NCT01939977|158466519|FG000|Overall Study|Did not meet inclusion criteria|1|||
49172863|NCT01939977|158466520|FG001|Overall Study|Did not meet inclusion criteria|0|||
49172864|NCT01939977|158466519|FG000|Overall Study|Did not receive study medication|0|||
49172865|NCT01939977|158466520|FG001|Overall Study|Did not receive study medication|1|||
49172866|NCT00577707|158466521|FG000|Overall Study|Withdrawal by Subject|3|||
49172867|NCT01262560|158466522|FG000|Overall Study|Protocol Violation|0|||
49172868|NCT01262560|158466523|FG001|Overall Study|Protocol Violation|1|||
49172869|NCT01262560|158466524|FG002|Overall Study|Protocol Violation|2|||
49172870|NCT00656058|158466525|FG000|Overall Study|Withdrawal by Subject|2|||
49172871|NCT00656058|158466525|FG000|Overall Study|Withdrawal by Subject|4|||
49172872|NCT02097719|158466527|FG000|Overall Study|Subject Withdrew Consent|1|||
49172873|NCT02097719|158466528|FG001|Overall Study|Subject Withdrew Consent|0|||
49172874|NCT02097719|158466527|FG000|Overall Study|Lost to Follow-up|0|||
49172875|NCT02097719|158466528|FG001|Overall Study|Lost to Follow-up|1|||
49172876|NCT02097719|158466527|FG000|Overall Study|Adverse Event|2|||
49172877|NCT02097719|158466528|FG001|Overall Study|Adverse Event|0|||
49172878|NCT00861692|158466529|FG000|Overall Study|Death|6|||
49172879|NCT04262882|158466530|FG000|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|14|||
49172880|NCT04262882|158466531|FG001|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|6|||
49172881|NCT04262882|158466530|FG000|Overall Study|Lost to Follow-up|1|||
49172882|NCT04262882|158466531|FG001|Overall Study|Lost to Follow-up|0|||
49172883|NCT03292640|158466532|FG000|Overall Study|Withdrawal by Subject|17|||
49172884|NCT03292640|158466533|FG001|Overall Study|Withdrawal by Subject|16|||
49172885|NCT03292640|158466532|FG000|Overall Study|Adverse Event|20|||
49172886|NCT03292640|158466533|FG001|Overall Study|Adverse Event|2|||
49172887|NCT03292640|158466532|FG000|Overall Study|Lost to Follow-up|24|||
49172888|NCT03292640|158466533|FG001|Overall Study|Lost to Follow-up|24|||
49172889|NCT02597452|158466536|FG000|Overall Study|testing incomplete|30|||
49172890|NCT00107900|158466539|FG000|Overall Study|Adverse Event|3|||
49172891|NCT00107900|158466540|FG001|Overall Study|Adverse Event|2|||
49172892|NCT00107900|158466541|FG002|Overall Study|Adverse Event|10|||
49172893|NCT00107900|158466542|FG003|Overall Study|Adverse Event|3|||
49172894|NCT00107900|158466543|FG004|Overall Study|Adverse Event|5|||
49172895|NCT00107900|158466544|FG005|Overall Study|Adverse Event|3|||
49172896|NCT00107900|158466539|FG000|Overall Study|Death|0|||
49172897|NCT00107900|158466540|FG001|Overall Study|Death|0|||
49172898|NCT00107900|158466541|FG002|Overall Study|Death|0|||
49172899|NCT00107900|158466542|FG003|Overall Study|Death|0|||
48842528|NCT01049503|157265350|FG003|Overall Study|Lost to Follow-up|26|||
48842529|NCT01049503|157265351|FG004|Overall Study|Lost to Follow-up|27|||
48842530|NCT01049503|157265352|FG005|Overall Study|Lost to Follow-up|8|||
48842531|NCT00726596|157265353|FG000|Overall Study|Adverse Event|2|||
48842532|NCT00726596|157265354|FG001|Overall Study|Adverse Event|1|||
48842533|NCT00726596|157265353|FG000|Overall Study|Withdrawal by Subject|3|||
48842534|NCT00726596|157265354|FG001|Overall Study|Withdrawal by Subject|3|||
49172900|NCT00107900|158466543|FG004|Overall Study|Death|1|||
49172901|NCT00107900|158466544|FG005|Overall Study|Death|0|||
49172902|NCT00107900|158466539|FG000|Overall Study|Lost to Follow-up|4|||
49172903|NCT00107900|158466540|FG001|Overall Study|Lost to Follow-up|1|||
49172904|NCT00107900|158466541|FG002|Overall Study|Lost to Follow-up|3|||
49172905|NCT00107900|158466542|FG003|Overall Study|Lost to Follow-up|2|||
49172906|NCT00107900|158466543|FG004|Overall Study|Lost to Follow-up|5|||
49172907|NCT00107900|158466544|FG005|Overall Study|Lost to Follow-up|5|||
49172908|NCT00107900|158466539|FG000|Overall Study|Protocol Violation|1|||
48842535|NCT00683696|157265355|FG000|Overall Study|Withdrawn due to study closure|337|||
48842536|NCT00683696|157265356|FG001|Overall Study|Withdrawn due to study closure|338|||
48842537|NCT00683696|157265355|FG000|Overall Study|Withdrawn prior to study closure|13|||
48842538|NCT00683696|157265356|FG001|Overall Study|Withdrawn prior to study closure|28|||
48842539|NCT00683696|157265355|FG000|Overall Study|Lost to Follow-up|5|||
48842540|NCT00683696|157265356|FG001|Overall Study|Lost to Follow-up|6|||
48842541|NCT00683696|157265355|FG000|Overall Study|Vital status follow-up only|3|||
48842542|NCT00683696|157265356|FG001|Overall Study|Vital status follow-up only|3|||
49172909|NCT00107900|158466540|FG001|Overall Study|Protocol Violation|0|||
49172910|NCT00107900|158466541|FG002|Overall Study|Protocol Violation|5|||
49172911|NCT00107900|158466542|FG003|Overall Study|Protocol Violation|5|||
49172912|NCT00107900|158466543|FG004|Overall Study|Protocol Violation|7|||
49172913|NCT00107900|158466544|FG005|Overall Study|Protocol Violation|0|||
49172914|NCT00107900|158466539|FG000|Overall Study|Withdrawal by Subject|1|||
49172915|NCT00107900|158466540|FG001|Overall Study|Withdrawal by Subject|0|||
49172916|NCT00107900|158466541|FG002|Overall Study|Withdrawal by Subject|5|||
49172917|NCT00107900|158466542|FG003|Overall Study|Withdrawal by Subject|0|||
49172918|NCT00107900|158466543|FG004|Overall Study|Withdrawal by Subject|1|||
49172919|NCT00107900|158466544|FG005|Overall Study|Withdrawal by Subject|1|||
49172920|NCT00107900|158466539|FG000|Overall Study|Administrative Reasons|1|||
49172921|NCT00107900|158466540|FG001|Overall Study|Administrative Reasons|0|||
49172922|NCT00107900|158466541|FG002|Overall Study|Administrative Reasons|2|||
49172923|NCT00107900|158466542|FG003|Overall Study|Administrative Reasons|2|||
49172924|NCT00107900|158466543|FG004|Overall Study|Administrative Reasons|2|||
49172925|NCT00107900|158466544|FG005|Overall Study|Administrative Reasons|0|||
49172926|NCT03053440|158468761|FG000|Overall Study|Sponsor's Decision to End the Study|20|||
49172927|NCT03053440|158468762|FG001|Overall Study|Sponsor's Decision to End the Study|13|||
49172928|NCT03053440|158468761|FG000|Overall Study|Death|18|||
49172929|NCT03053440|158468762|FG001|Overall Study|Death|14|||
49172930|NCT03053440|158468761|FG000|Overall Study|Withdrawal by Subject|9|||
49172931|NCT03053440|158468762|FG001|Overall Study|Withdrawal by Subject|8|||
49172932|NCT03053440|158468761|FG000|Overall Study|Lost to Follow-up|1|||
49172933|NCT03053440|158468762|FG001|Overall Study|Lost to Follow-up|0|||
49172934|NCT03053440|158468761|FG000|Overall Study|Enrolled in Long-term Extension Study|48|||
49172935|NCT03053440|158468762|FG001|Overall Study|Enrolled in Long-term Extension Study|66|||
49172936|NCT03053440|158468761|FG000|Overall Study|Physician Decision|2|||
49172937|NCT03053440|158468762|FG001|Overall Study|Physician Decision|1|||
49172938|NCT03053440|158468761|FG000|Overall Study|Participant Randomized but died before dosing|1|||
49172939|NCT03053440|158468762|FG001|Overall Study|Participant Randomized but died before dosing|0|||
49172940|NCT01188551|158468765|FG000|Overall Study|Pharmacy issues|1|||
49172941|NCT01188551|158468766|FG001|Overall Study|Pharmacy issues|0|||
49172942|NCT01188551|158468767|FG002|Overall Study|Pharmacy issues|0|||
49172943|NCT01188551|158468768|FG003|Overall Study|Pharmacy issues|0|||
49172944|NCT01436656|158468769|FG000|Dose Escalation|Death|1|||
49172945|NCT01436656|158468770|FG001|Dose Escalation|Death|3|||
49172946|NCT01436656|158468771|FG002|Dose Escalation|Death|1|||
49172947|NCT01436656|158468772|FG003|Dose Escalation|Death|0|||
49172948|NCT01436656|158468773|FG004|Dose Escalation|Death|2|||
49172949|NCT01436656|158468774|FG005|Dose Escalation|Death|1|||
49172950|NCT01436656|158468775|FG006|Dose Escalation|Death|1|||
49172951|NCT01436656|158468776|FG007|Dose Escalation|Death|1|||
49172952|NCT01436656|158468777|FG008|Dose Escalation|Death|1|||
49172953|NCT01436656|158468778|FG009|Dose Escalation|Death|0|||
49172954|NCT01436656|158468779|FG010|Dose Escalation|Death|0|||
49172955|NCT01436656|158468780|FG011|Dose Escalation|Death|0|||
49172956|NCT01436656|158468781|FG012|Dose Escalation|Death|0|||
49172957|NCT01436656|158468782|FG013|Dose Escalation|Death|0|||
49172958|NCT01436656|158468783|FG014|Dose Escalation|Death|0|||
49172959|NCT01436656|158468784|FG015|Dose Escalation|Death|0|||
49172960|NCT01436656|158468785|FG016|Dose Escalation|Death|0|||
49172961|NCT01436656|158468786|FG017|Dose Escalation|Death|0|||
49172962|NCT01436656|158468769|FG000|Dose Escalation|Protocol Violation|0|||
49172963|NCT01436656|158468770|FG001|Dose Escalation|Protocol Violation|0|||
49172964|NCT01436656|158468771|FG002|Dose Escalation|Protocol Violation|0|||
49172965|NCT01436656|158468772|FG003|Dose Escalation|Protocol Violation|0|||
49172966|NCT01436656|158468773|FG004|Dose Escalation|Protocol Violation|0|||
49172967|NCT01436656|158468774|FG005|Dose Escalation|Protocol Violation|1|||
49172968|NCT01436656|158468775|FG006|Dose Escalation|Protocol Violation|0|||
49172969|NCT01436656|158468776|FG007|Dose Escalation|Protocol Violation|0|||
49172970|NCT01436656|158468777|FG008|Dose Escalation|Protocol Violation|0|||
49172971|NCT01436656|158468778|FG009|Dose Escalation|Protocol Violation|0|||
49172972|NCT01436656|158468779|FG010|Dose Escalation|Protocol Violation|0|||
49172973|NCT01436656|158468780|FG011|Dose Escalation|Protocol Violation|0|||
49172974|NCT01436656|158468781|FG012|Dose Escalation|Protocol Violation|0|||
49172975|NCT01436656|158468782|FG013|Dose Escalation|Protocol Violation|0|||
49172976|NCT01436656|158468783|FG014|Dose Escalation|Protocol Violation|0|||
49172977|NCT01436656|158468784|FG015|Dose Escalation|Protocol Violation|0|||
49172978|NCT01436656|158468785|FG016|Dose Escalation|Protocol Violation|0|||
49172979|NCT01436656|158468786|FG017|Dose Escalation|Protocol Violation|0|||
49172980|NCT01436656|158468769|FG000|Dose Escalation|Withdrawal by Subject|0|||
49172981|NCT01436656|158468770|FG001|Dose Escalation|Withdrawal by Subject|0|||
49172982|NCT01436656|158468771|FG002|Dose Escalation|Withdrawal by Subject|0|||
49172983|NCT01436656|158468772|FG003|Dose Escalation|Withdrawal by Subject|0|||
49172984|NCT01436656|158468773|FG004|Dose Escalation|Withdrawal by Subject|1|||
49172985|NCT01436656|158468774|FG005|Dose Escalation|Withdrawal by Subject|0|||
48926428|NCT01171898|157563234|FG001|Overall Study|Withdrawal by Subject|4|||
48926429|NCT01171898|157563235|FG002|Overall Study|Withdrawal by Subject|6|||
48926430|NCT01171898|157563236|FG003|Overall Study|Withdrawal by Subject|3|||
48926431|NCT01171898|157563233|FG000|Overall Study|Terminated by Sponsor|1|||
48926432|NCT01171898|157563234|FG001|Overall Study|Terminated by Sponsor|0|||
48926433|NCT01171898|157563235|FG002|Overall Study|Terminated by Sponsor|0|||
48926434|NCT01171898|157563236|FG003|Overall Study|Terminated by Sponsor|0|||
48926435|NCT01171898|157563233|FG000|Overall Study|Ongoing|1|||
48926436|NCT01171898|157563234|FG001|Overall Study|Ongoing|9|||
48926437|NCT01171898|157563235|FG002|Overall Study|Ongoing|3|||
48926438|NCT01171898|157563236|FG003|Overall Study|Ongoing|0|||
48926439|NCT01171898|157563233|FG000|Overall Study|Other|1|||
48926440|NCT01171898|157563234|FG001|Overall Study|Other|5|||
48926441|NCT01171898|157563235|FG002|Overall Study|Other|0|||
48926442|NCT01171898|157563236|FG003|Overall Study|Other|2|||
48926443|NCT05418296|157563237|FG000|Overall Study|Withdrawal by Subject|4|||
48926444|NCT05418296|157563238|FG001|Overall Study|Withdrawal by Subject|1|||
48926445|NCT03548051|157563239|FG000|Overall Study|Death|1|||
48926446|NCT03548051|157563240|FG001|Overall Study|Death|1|||
49172986|NCT01436656|158468775|FG006|Dose Escalation|Withdrawal by Subject|0|||
49172987|NCT01436656|158468776|FG007|Dose Escalation|Withdrawal by Subject|2|||
49172988|NCT01436656|158468777|FG008|Dose Escalation|Withdrawal by Subject|0|||
49172989|NCT01436656|158468778|FG009|Dose Escalation|Withdrawal by Subject|1|||
49172990|NCT01436656|158468779|FG010|Dose Escalation|Withdrawal by Subject|1|||
49172991|NCT01436656|158468780|FG011|Dose Escalation|Withdrawal by Subject|0|||
49172992|NCT01436656|158468781|FG012|Dose Escalation|Withdrawal by Subject|0|||
49172993|NCT01436656|158468782|FG013|Dose Escalation|Withdrawal by Subject|0|||
49172994|NCT01436656|158468783|FG014|Dose Escalation|Withdrawal by Subject|0|||
49172995|NCT01436656|158468784|FG015|Dose Escalation|Withdrawal by Subject|0|||
49172996|NCT01436656|158468785|FG016|Dose Escalation|Withdrawal by Subject|0|||
49172997|NCT01436656|158468786|FG017|Dose Escalation|Withdrawal by Subject|0|||
49172998|NCT01436656|158468769|FG000|Dose Escalation|Administrative problems|0|||
49172999|NCT01436656|158468770|FG001|Dose Escalation|Administrative problems|1|||
49173000|NCT01436656|158468771|FG002|Dose Escalation|Administrative problems|0|||
49173001|NCT01436656|158468772|FG003|Dose Escalation|Administrative problems|0|||
49173002|NCT01436656|158468773|FG004|Dose Escalation|Administrative problems|0|||
49173003|NCT01436656|158468774|FG005|Dose Escalation|Administrative problems|0|||
49173004|NCT01436656|158468775|FG006|Dose Escalation|Administrative problems|0|||
49173005|NCT01436656|158468776|FG007|Dose Escalation|Administrative problems|0|||
49173006|NCT01436656|158468777|FG008|Dose Escalation|Administrative problems|0|||
49173007|NCT01436656|158468778|FG009|Dose Escalation|Administrative problems|0|||
49173008|NCT01436656|158468779|FG010|Dose Escalation|Administrative problems|0|||
49173009|NCT01436656|158468780|FG011|Dose Escalation|Administrative problems|0|||
49173010|NCT01436656|158468781|FG012|Dose Escalation|Administrative problems|0|||
49173011|NCT01436656|158468782|FG013|Dose Escalation|Administrative problems|0|||
49173012|NCT01436656|158468783|FG014|Dose Escalation|Administrative problems|0|||
49173013|NCT01436656|158468784|FG015|Dose Escalation|Administrative problems|0|||
49173014|NCT01436656|158468785|FG016|Dose Escalation|Administrative problems|0|||
49173015|NCT01436656|158468786|FG017|Dose Escalation|Administrative problems|0|||
49173016|NCT01436656|158468769|FG000|Dose Escalation|Lost to Follow-up|1|||
49173017|NCT01436656|158468770|FG001|Dose Escalation|Lost to Follow-up|0|||
49173018|NCT01436656|158468771|FG002|Dose Escalation|Lost to Follow-up|0|||
49173019|NCT01436656|158468772|FG003|Dose Escalation|Lost to Follow-up|0|||
49173020|NCT01436656|158468773|FG004|Dose Escalation|Lost to Follow-up|1|||
49173021|NCT01436656|158468774|FG005|Dose Escalation|Lost to Follow-up|0|||
49173022|NCT01436656|158468775|FG006|Dose Escalation|Lost to Follow-up|0|||
49173023|NCT01436656|158468776|FG007|Dose Escalation|Lost to Follow-up|0|||
49173024|NCT01436656|158468777|FG008|Dose Escalation|Lost to Follow-up|0|||
49173025|NCT01436656|158468778|FG009|Dose Escalation|Lost to Follow-up|0|||
48926447|NCT03548051|157563239|FG000|Overall Study|Withdrawal by Subject|1|||
48926448|NCT03548051|157563240|FG001|Overall Study|Withdrawal by Subject|0|||
48926449|NCT03847987|157563243|FG000|Overall Study|Lost to Follow-up|1|||
48926450|NCT03847987|157563244|FG001|Overall Study|Lost to Follow-up|0|||
48926451|NCT03847987|157563243|FG000|Overall Study|Adverse Event|2|||
48926452|NCT03847987|157563244|FG001|Overall Study|Adverse Event|0|||
48926453|NCT03605680|157563245|FG000|SB Placebo Run-in Period (1 Week)|Adverse Event|6|||
48926454|NCT03605680|157563246|FG001|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
48926455|NCT03605680|157563247|FG002|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
48926456|NCT03605680|157563248|FG003|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
49173026|NCT01436656|158468779|FG010|Dose Escalation|Lost to Follow-up|0|||
49173027|NCT01436656|158468780|FG011|Dose Escalation|Lost to Follow-up|0|||
49173028|NCT01436656|158468781|FG012|Dose Escalation|Lost to Follow-up|0|||
49173029|NCT01436656|158468782|FG013|Dose Escalation|Lost to Follow-up|0|||
49173030|NCT01436656|158468783|FG014|Dose Escalation|Lost to Follow-up|0|||
49173031|NCT01436656|158468784|FG015|Dose Escalation|Lost to Follow-up|0|||
49173032|NCT01436656|158468785|FG016|Dose Escalation|Lost to Follow-up|0|||
48926457|NCT03605680|157563245|FG000|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1|||
48842543|NCT00683696|157265355|FG000|Overall Study|Death|46|||
48926458|NCT03605680|157563246|FG001|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
48926459|NCT03605680|157563247|FG002|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
48926460|NCT03605680|157563248|FG003|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
48926461|NCT03605680|157563245|FG000|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9|||
48926462|NCT03605680|157563246|FG001|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
48926463|NCT03605680|157563247|FG002|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
48926464|NCT03605680|157563248|FG003|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
49173033|NCT01436656|158468786|FG017|Dose Escalation|Lost to Follow-up|0|||
49173034|NCT01436656|158468769|FG000|Dose Escalation|New anti-cancer therapy|1|||
49173035|NCT01436656|158468770|FG001|Dose Escalation|New anti-cancer therapy|0|||
49173036|NCT01436656|158468771|FG002|Dose Escalation|New anti-cancer therapy|0|||
49173037|NCT01436656|158468772|FG003|Dose Escalation|New anti-cancer therapy|0|||
48926465|NCT03605680|157563245|FG000|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3|||
48926466|NCT03605680|157563246|FG001|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
48926467|NCT03605680|157563247|FG002|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
48842544|NCT00683696|157265356|FG001|Overall Study|Death|30|||
48842545|NCT03648762|157265359|FG000|Overall Study|Lost to Follow-up|1|||
48842546|NCT03648762|157265360|FG001|Overall Study|Lost to Follow-up|2|||
48842547|NCT03648762|157265361|FG002|Overall Study|Lost to Follow-up|0|||
48842548|NCT03648762|157265359|FG000|Overall Study|Withdrawal by Subject|5|||
48842549|NCT03648762|157265360|FG001|Overall Study|Withdrawal by Subject|2|||
48842550|NCT03648762|157265361|FG002|Overall Study|Withdrawal by Subject|1|||
48842551|NCT03169244|157265362|FG000|Overall Study|Lost to Follow-up|1|||
48842552|NCT03169244|157265363|FG001|Overall Study|Lost to Follow-up|2|||
48842553|NCT03169244|157265362|FG000|Overall Study|Adverse Event|1|||
48842554|NCT03169244|157265363|FG001|Overall Study|Adverse Event|0|||
48842555|NCT03169244|157265362|FG000|Overall Study|Withdrawal by Subject|2|||
48842556|NCT03169244|157265363|FG001|Overall Study|Withdrawal by Subject|2|||
48842557|NCT03169244|157265362|FG000|Overall Study|Physician Decision|1|||
49173038|NCT01436656|158468773|FG004|Dose Escalation|New anti-cancer therapy|0|||
49173039|NCT01436656|158468774|FG005|Dose Escalation|New anti-cancer therapy|0|||
49173040|NCT01436656|158468775|FG006|Dose Escalation|New anti-cancer therapy|0|||
49173041|NCT01436656|158468776|FG007|Dose Escalation|New anti-cancer therapy|0|||
49173042|NCT01436656|158468777|FG008|Dose Escalation|New anti-cancer therapy|1|||
49173043|NCT01436656|158468778|FG009|Dose Escalation|New anti-cancer therapy|1|||
49173044|NCT01436656|158468779|FG010|Dose Escalation|New anti-cancer therapy|0|||
49173045|NCT01436656|158468780|FG011|Dose Escalation|New anti-cancer therapy|0|||
49173046|NCT01436656|158468781|FG012|Dose Escalation|New anti-cancer therapy|0|||
49173047|NCT01436656|158468782|FG013|Dose Escalation|New anti-cancer therapy|0|||
49173048|NCT01436656|158468783|FG014|Dose Escalation|New anti-cancer therapy|0|||
49173049|NCT01436656|158468784|FG015|Dose Escalation|New anti-cancer therapy|0|||
49173050|NCT01436656|158468785|FG016|Dose Escalation|New anti-cancer therapy|0|||
49173051|NCT01436656|158468786|FG017|Dose Escalation|New anti-cancer therapy|0|||
49173052|NCT01436656|158468769|FG000|Dose Expansion|Adverse Event|0|||
49173053|NCT01436656|158468770|FG001|Dose Expansion|Adverse Event|0|||
49173054|NCT01436656|158468771|FG002|Dose Expansion|Adverse Event|0|||
49173055|NCT01436656|158468772|FG003|Dose Expansion|Adverse Event|0|||
49173056|NCT01436656|158468773|FG004|Dose Expansion|Adverse Event|0|||
49173057|NCT01436656|158468774|FG005|Dose Expansion|Adverse Event|0|||
49173058|NCT01436656|158468775|FG006|Dose Expansion|Adverse Event|0|||
49173059|NCT01436656|158468776|FG007|Dose Expansion|Adverse Event|0|||
49173060|NCT01436656|158468777|FG008|Dose Expansion|Adverse Event|0|||
48842558|NCT03169244|157265363|FG001|Overall Study|Physician Decision|0|||
48842559|NCT02544152|157265364|FG000|Overall Study|Adverse Event|0|||
48842560|NCT02544152|157265365|FG001|Overall Study|Adverse Event|4|||
48926468|NCT03605680|157563248|FG003|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
48926469|NCT03605680|157563245|FG000|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13|||
48926470|NCT03605680|157563246|FG001|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
48926471|NCT03605680|157563247|FG002|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
49173061|NCT01436656|158468778|FG009|Dose Expansion|Adverse Event|0|||
49173062|NCT01436656|158468779|FG010|Dose Expansion|Adverse Event|0|||
49173063|NCT01436656|158468780|FG011|Dose Expansion|Adverse Event|1|||
49173064|NCT01436656|158468781|FG012|Dose Expansion|Adverse Event|0|||
49173065|NCT01436656|158468782|FG013|Dose Expansion|Adverse Event|0|||
49173066|NCT01436656|158468783|FG014|Dose Expansion|Adverse Event|0|||
49173067|NCT01436656|158468784|FG015|Dose Expansion|Adverse Event|0|||
49173068|NCT01436656|158468785|FG016|Dose Expansion|Adverse Event|0|||
49173069|NCT01436656|158468786|FG017|Dose Expansion|Adverse Event|0|||
49173070|NCT01436656|158468769|FG000|Dose Expansion|Withdrawal by Subject|0|||
49173071|NCT01436656|158468770|FG001|Dose Expansion|Withdrawal by Subject|0|||
49173072|NCT01436656|158468771|FG002|Dose Expansion|Withdrawal by Subject|0|||
49173073|NCT01436656|158468772|FG003|Dose Expansion|Withdrawal by Subject|0|||
49173074|NCT01436656|158468773|FG004|Dose Expansion|Withdrawal by Subject|0|||
49173075|NCT01436656|158468774|FG005|Dose Expansion|Withdrawal by Subject|0|||
49173076|NCT01436656|158468775|FG006|Dose Expansion|Withdrawal by Subject|0|||
49173077|NCT01436656|158468776|FG007|Dose Expansion|Withdrawal by Subject|0|||
49173078|NCT01436656|158468777|FG008|Dose Expansion|Withdrawal by Subject|0|||
49173079|NCT01436656|158468778|FG009|Dose Expansion|Withdrawal by Subject|0|||
49173080|NCT01436656|158468779|FG010|Dose Expansion|Withdrawal by Subject|0|||
49173081|NCT01436656|158468780|FG011|Dose Expansion|Withdrawal by Subject|1|||
49173082|NCT01436656|158468781|FG012|Dose Expansion|Withdrawal by Subject|3|||
49173083|NCT01436656|158468782|FG013|Dose Expansion|Withdrawal by Subject|1|||
49173084|NCT01436656|158468783|FG014|Dose Expansion|Withdrawal by Subject|2|||
49173085|NCT01436656|158468784|FG015|Dose Expansion|Withdrawal by Subject|0|||
49173086|NCT01436656|158468785|FG016|Dose Expansion|Withdrawal by Subject|1|||
49173087|NCT01436656|158468786|FG017|Dose Expansion|Withdrawal by Subject|1|||
49173088|NCT01436656|158468769|FG000|Dose Expansion|Death|0|||
49173089|NCT01436656|158468770|FG001|Dose Expansion|Death|0|||
49173090|NCT01436656|158468771|FG002|Dose Expansion|Death|0|||
49173091|NCT01436656|158468772|FG003|Dose Expansion|Death|0|||
49173092|NCT01436656|158468773|FG004|Dose Expansion|Death|0|||
49173093|NCT01436656|158468774|FG005|Dose Expansion|Death|0|||
49173094|NCT01436656|158468775|FG006|Dose Expansion|Death|0|||
49173095|NCT01436656|158468776|FG007|Dose Expansion|Death|0|||
49173096|NCT01436656|158468777|FG008|Dose Expansion|Death|0|||
49173097|NCT01436656|158468778|FG009|Dose Expansion|Death|0|||
49173098|NCT01436656|158468779|FG010|Dose Expansion|Death|0|||
49173099|NCT01436656|158468780|FG011|Dose Expansion|Death|0|||
49173100|NCT01436656|158468781|FG012|Dose Expansion|Death|1|||
49173101|NCT01436656|158468782|FG013|Dose Expansion|Death|0|||
49173102|NCT01436656|158468783|FG014|Dose Expansion|Death|3|||
49173103|NCT01436656|158468784|FG015|Dose Expansion|Death|0|||
48926472|NCT03605680|157563248|FG003|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
48842561|NCT02544152|157265364|FG000|Overall Study|Withdrawal by Subject|0|||
48842562|NCT02544152|157265365|FG001|Overall Study|Withdrawal by Subject|3|||
48842563|NCT02544152|157265364|FG000|Overall Study|Other|1|||
49173104|NCT01436656|158468785|FG016|Dose Expansion|Death|3|||
49173105|NCT01436656|158468786|FG017|Dose Expansion|Death|3|||
49173106|NCT01436656|158468769|FG000|Dose Expansion|Lost to Follow-up|0|||
49173107|NCT01436656|158468770|FG001|Dose Expansion|Lost to Follow-up|0|||
49173108|NCT01436656|158468771|FG002|Dose Expansion|Lost to Follow-up|0|||
49173109|NCT01436656|158468772|FG003|Dose Expansion|Lost to Follow-up|0|||
49173110|NCT01436656|158468773|FG004|Dose Expansion|Lost to Follow-up|0|||
49173111|NCT01436656|158468774|FG005|Dose Expansion|Lost to Follow-up|0|||
49173112|NCT01436656|158468775|FG006|Dose Expansion|Lost to Follow-up|0|||
49173113|NCT01436656|158468776|FG007|Dose Expansion|Lost to Follow-up|0|||
49173114|NCT01436656|158468777|FG008|Dose Expansion|Lost to Follow-up|0|||
49173115|NCT01436656|158468778|FG009|Dose Expansion|Lost to Follow-up|0|||
48842564|NCT02544152|157265365|FG001|Overall Study|Other|0|||
48926473|NCT03605680|157563245|FG000|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12|||
48842565|NCT02731755|157265369|FG000|First Intervention|Withdrawal by Subject|0|||
48842566|NCT02731755|157265370|FG001|First Intervention|Withdrawal by Subject|2|||
48842567|NCT00391846|157265371|FG000|Overall Study|Adverse Event|4|||
48842568|NCT00391846|157265372|FG001|Overall Study|Adverse Event|1|||
48842569|NCT00391846|157265371|FG000|Overall Study|Did not meet the required elig. crit|2|||
48842570|NCT00391846|157265372|FG001|Overall Study|Did not meet the required elig. crit|2|||
48842571|NCT00391846|157265371|FG000|Overall Study|Withdrawal by Subject|2|||
48842572|NCT00391846|157265372|FG001|Overall Study|Withdrawal by Subject|3|||
48842573|NCT00391846|157265371|FG000|Overall Study|Developed study specific DC criteria|0|||
48842574|NCT00391846|157265372|FG001|Overall Study|Developed study specific DC criteria|1|||
48842575|NCT00423098|157265373|FG000|Overall Study|Adverse Event|1|||
48842576|NCT00423098|157265374|FG001|Overall Study|Adverse Event|2|||
48842577|NCT00423098|157265373|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
48842578|NCT00423098|157265374|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
48926474|NCT03605680|157563246|FG001|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
49173116|NCT01436656|158468779|FG010|Dose Expansion|Lost to Follow-up|0|||
49173117|NCT01436656|158468780|FG011|Dose Expansion|Lost to Follow-up|0|||
49173118|NCT01436656|158468781|FG012|Dose Expansion|Lost to Follow-up|0|||
49173119|NCT01436656|158468782|FG013|Dose Expansion|Lost to Follow-up|0|||
49173120|NCT01436656|158468783|FG014|Dose Expansion|Lost to Follow-up|0|||
49173121|NCT01436656|158468784|FG015|Dose Expansion|Lost to Follow-up|0|||
49173122|NCT01436656|158468785|FG016|Dose Expansion|Lost to Follow-up|0|||
49173123|NCT01436656|158468786|FG017|Dose Expansion|Lost to Follow-up|3|||
49173124|NCT01436656|158468769|FG000|Dose Expansion|Disease progression|0|||
48926475|NCT03605680|157563247|FG002|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
48926476|NCT03605680|157563248|FG003|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
48842579|NCT00423098|157265373|FG000|Overall Study|Administrative problems|0|||
48842580|NCT00423098|157265374|FG001|Overall Study|Administrative problems|1|||
48842581|NCT00423098|157265373|FG000|Overall Study|Death|2|||
48842582|NCT00423098|157265374|FG001|Overall Study|Death|0|||
48842583|NCT01426269|157265378|FG000|Period 1: 12 Weeks|Adverse Event|5|||
48842584|NCT01426269|157265379|FG001|Period 1: 12 Weeks|Adverse Event|0|||
48842585|NCT01426269|157265380|FG002|Period 1: 12 Weeks|Adverse Event|0|||
48842586|NCT01426269|157265378|FG000|Period 1: 12 Weeks|Withdrawal by Subject|22|||
48842587|NCT01426269|157265379|FG001|Period 1: 12 Weeks|Withdrawal by Subject|0|||
48842588|NCT01426269|157265380|FG002|Period 1: 12 Weeks|Withdrawal by Subject|0|||
49173125|NCT01436656|158468770|FG001|Dose Expansion|Disease progression|0|||
49173126|NCT01436656|158468771|FG002|Dose Expansion|Disease progression|0|||
49173127|NCT01436656|158468772|FG003|Dose Expansion|Disease progression|0|||
49173128|NCT01436656|158468773|FG004|Dose Expansion|Disease progression|0|||
49173129|NCT01436656|158468774|FG005|Dose Expansion|Disease progression|0|||
49173130|NCT01436656|158468775|FG006|Dose Expansion|Disease progression|0|||
48842589|NCT01426269|157265378|FG000|Period 1: 12 Weeks|Protocol Violation|5|||
48842590|NCT01426269|157265379|FG001|Period 1: 12 Weeks|Protocol Violation|0|||
49173131|NCT01436656|158468776|FG007|Dose Expansion|Disease progression|0|||
49173132|NCT01436656|158468777|FG008|Dose Expansion|Disease progression|0|||
49173133|NCT01436656|158468778|FG009|Dose Expansion|Disease progression|0|||
49173134|NCT01436656|158468779|FG010|Dose Expansion|Disease progression|0|||
49173135|NCT01436656|158468780|FG011|Dose Expansion|Disease progression|3|||
49173136|NCT01436656|158468781|FG012|Dose Expansion|Disease progression|1|||
49173137|NCT01436656|158468782|FG013|Dose Expansion|Disease progression|0|||
49173138|NCT01436656|158468783|FG014|Dose Expansion|Disease progression|1|||
49173139|NCT01436656|158468784|FG015|Dose Expansion|Disease progression|0|||
49173140|NCT01436656|158468785|FG016|Dose Expansion|Disease progression|0|||
49173141|NCT01436656|158468786|FG017|Dose Expansion|Disease progression|1|||
49173142|NCT01436656|158468769|FG000|Dose Expansion|New cancer therapy|0|||
49173143|NCT01436656|158468770|FG001|Dose Expansion|New cancer therapy|0|||
49173144|NCT01436656|158468771|FG002|Dose Expansion|New cancer therapy|0|||
49173145|NCT01436656|158468772|FG003|Dose Expansion|New cancer therapy|0|||
49173146|NCT01436656|158468773|FG004|Dose Expansion|New cancer therapy|0|||
49173147|NCT01436656|158468774|FG005|Dose Expansion|New cancer therapy|0|||
49173148|NCT01436656|158468775|FG006|Dose Expansion|New cancer therapy|0|||
49173149|NCT01436656|158468776|FG007|Dose Expansion|New cancer therapy|0|||
49173150|NCT01436656|158468777|FG008|Dose Expansion|New cancer therapy|0|||
49173151|NCT01436656|158468778|FG009|Dose Expansion|New cancer therapy|0|||
49173152|NCT01436656|158468779|FG010|Dose Expansion|New cancer therapy|0|||
49173153|NCT01436656|158468780|FG011|Dose Expansion|New cancer therapy|1|||
49173154|NCT01436656|158468781|FG012|Dose Expansion|New cancer therapy|1|||
49173155|NCT01436656|158468782|FG013|Dose Expansion|New cancer therapy|0|||
49173156|NCT01436656|158468783|FG014|Dose Expansion|New cancer therapy|2|||
49173157|NCT01436656|158468784|FG015|Dose Expansion|New cancer therapy|0|||
49173158|NCT01436656|158468785|FG016|Dose Expansion|New cancer therapy|0|||
49173159|NCT01436656|158468786|FG017|Dose Expansion|New cancer therapy|0|||
49173160|NCT00391053|158468787|FG000|Overall Study|Serious Adverse Events|1|||
49173161|NCT00391053|158468788|FG001|Overall Study|Serious Adverse Events|0|||
49173162|NCT00391053|158468789|FG002|Overall Study|Serious Adverse Events|1|||
49173163|NCT00391053|158468790|FG003|Overall Study|Serious Adverse Events|4|||
48926477|NCT03605680|157563245|FG000|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|1|||
48926478|NCT03605680|157563246|FG001|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
49173164|NCT00391053|158468787|FG000|Overall Study|Protocol Violation|2|||
49173165|NCT00391053|158468788|FG001|Overall Study|Protocol Violation|0|||
49173166|NCT00391053|158468789|FG002|Overall Study|Protocol Violation|0|||
48842591|NCT01426269|157265380|FG002|Period 1: 12 Weeks|Protocol Violation|0|||
48842592|NCT01426269|157265378|FG000|Period 1: 12 Weeks|Lost to Follow-up|22|||
48842593|NCT01426269|157265379|FG001|Period 1: 12 Weeks|Lost to Follow-up|0|||
48842594|NCT01426269|157265380|FG002|Period 1: 12 Weeks|Lost to Follow-up|0|||
48842595|NCT01426269|157265378|FG000|Period 1: 12 Weeks|Pregnancy|1|||
48842596|NCT01426269|157265379|FG001|Period 1: 12 Weeks|Pregnancy|0|||
48842597|NCT01426269|157265380|FG002|Period 1: 12 Weeks|Pregnancy|0|||
49173167|NCT00391053|158468790|FG003|Overall Study|Protocol Violation|0|||
49173168|NCT00391053|158468787|FG000|Overall Study|Lost to Follow-up|1|||
49173169|NCT00391053|158468788|FG001|Overall Study|Lost to Follow-up|0|||
49173170|NCT00391053|158468789|FG002|Overall Study|Lost to Follow-up|0|||
48842598|NCT01426269|157265378|FG000|Eligibility for Period 2, Randomization|Did not qualify|42|||
48842599|NCT01426269|157265379|FG001|Eligibility for Period 2, Randomization|Did not qualify|0|||
48926479|NCT03605680|157563247|FG002|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
49173171|NCT00391053|158468790|FG003|Overall Study|Lost to Follow-up|5|||
49173172|NCT00391053|158468787|FG000|Overall Study|Withdrawal by Subject|5|||
49173173|NCT00391053|158468788|FG001|Overall Study|Withdrawal by Subject|1|||
49173174|NCT00391053|158468789|FG002|Overall Study|Withdrawal by Subject|1|||
49173175|NCT00391053|158468790|FG003|Overall Study|Withdrawal by Subject|1|||
49173176|NCT04644276|158468791|FG000|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
49173177|NCT04644276|158468792|FG001|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
49173178|NCT04644276|158468793|FG002|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|1|||
49173179|NCT03782259|158468796|FG000|Overall Study|Lost to Follow-up|1|||
49173180|NCT03782259|158468797|FG001|Overall Study|Lost to Follow-up|1|||
49173181|NCT03782259|158468796|FG000|Overall Study|Moved out of state|0|||
49173182|NCT03782259|158468797|FG001|Overall Study|Moved out of state|2|||
49173183|NCT03782259|158468796|FG000|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|0|||
49173184|NCT03782259|158468797|FG001|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|1|||
49173185|NCT03782259|158468796|FG000|Overall Study|Subject discontinued intervention|1|||
49173186|NCT03782259|158468797|FG001|Overall Study|Subject discontinued intervention|0|||
49173187|NCT01208324|158468798|FG000|Post-randomization of Patch|Withdrawal by Subject|1|||
49173188|NCT01208324|158468799|FG001|Post-randomization of Patch|Withdrawal by Subject|0|||
49173189|NCT01208324|158468800|FG002|Post-randomization of Patch|Withdrawal by Subject|0|||
49173190|NCT01208324|158468801|FG003|Post-randomization of Patch|Withdrawal by Subject|0|||
48735642|NCT00961649|156883697|FG000|Overall Study|Study terminated by sponsor|4|||
48735643|NCT00961649|156883698|FG001|Overall Study|Study terminated by sponsor|4|||
48735644|NCT00961649|156883699|FG002|Overall Study|Study terminated by sponsor|4|||
48735645|NCT00961649|156883700|FG003|Overall Study|Study terminated by sponsor|1|||
48735646|NCT02215096|156883705|FG000|Run-In Period (Up to Week 2)|Adverse Event|1|||
48842600|NCT01426269|157265380|FG002|Eligibility for Period 2, Randomization|Did not qualify|0|||
48842601|NCT01426269|157265378|FG000|Eligibility for Period 2, Randomization|Qualified, opted out|8|||
48842602|NCT01426269|157265379|FG001|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
48842603|NCT01426269|157265380|FG002|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
48842604|NCT01426269|157265378|FG000|Period 2: 40 Weeks|Adverse Event|0|||
48842605|NCT01426269|157265379|FG001|Period 2: 40 Weeks|Adverse Event|1|||
48842606|NCT01426269|157265380|FG002|Period 2: 40 Weeks|Adverse Event|2|||
48842607|NCT01426269|157265378|FG000|Period 2: 40 Weeks|Withdrawal by Subject|0|||
48842608|NCT01426269|157265379|FG001|Period 2: 40 Weeks|Withdrawal by Subject|9|||
48842609|NCT01426269|157265380|FG002|Period 2: 40 Weeks|Withdrawal by Subject|11|||
48926480|NCT03605680|157563248|FG003|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
48926481|NCT03605680|157563245|FG000|SB Placebo Run-in Period (1 Week)|Physician Decision|6|||
48926482|NCT03605680|157563246|FG001|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
48926483|NCT03605680|157563247|FG002|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
48926484|NCT03605680|157563248|FG003|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
48842610|NCT01426269|157265378|FG000|Period 2: 40 Weeks|Protocol Violation|0|||
48842611|NCT01426269|157265379|FG001|Period 2: 40 Weeks|Protocol Violation|5|||
48842612|NCT01426269|157265380|FG002|Period 2: 40 Weeks|Protocol Violation|5|||
48842613|NCT01426269|157265378|FG000|Period 2: 40 Weeks|Lost to Follow-up|0|||
48842614|NCT01426269|157265379|FG001|Period 2: 40 Weeks|Lost to Follow-up|8|||
48842615|NCT01426269|157265380|FG002|Period 2: 40 Weeks|Lost to Follow-up|6|||
48842616|NCT01426269|157265378|FG000|Period 2: 40 Weeks|Site closed|0|||
48842617|NCT01426269|157265379|FG001|Period 2: 40 Weeks|Site closed|6|||
48842618|NCT01426269|157265380|FG002|Period 2: 40 Weeks|Site closed|5|||
48842619|NCT01426269|157265378|FG000|Period 2: 40 Weeks|Relapsed|0|||
48842620|NCT01426269|157265379|FG001|Period 2: 40 Weeks|Relapsed|9|||
48842621|NCT01426269|157265380|FG002|Period 2: 40 Weeks|Relapsed|18|||
48842622|NCT00818454|157265381|FG000|Treatment Period 1|Adverse Event|0|||
48842623|NCT00818454|157265382|FG001|Treatment Period 1|Adverse Event|1|||
48842624|NCT00818454|157265383|FG002|Treatment Period 1|Adverse Event|0|||
48842625|NCT00818454|157265384|FG003|Treatment Period 1|Adverse Event|0|||
48842626|NCT00818454|157265381|FG000|Treatment Period 1|Other|3|||
48842627|NCT00818454|157265382|FG001|Treatment Period 1|Other|0|||
48842628|NCT00818454|157265383|FG002|Treatment Period 1|Other|0|||
48842629|NCT00818454|157265384|FG003|Treatment Period 1|Other|0|||
48842630|NCT00818454|157265381|FG000|Washout Period of 1 Week|Adverse Event|1|||
48842631|NCT00818454|157265382|FG001|Washout Period of 1 Week|Adverse Event|1|||
48842632|NCT00818454|157265383|FG002|Washout Period of 1 Week|Adverse Event|0|||
48842633|NCT00818454|157265384|FG003|Washout Period of 1 Week|Adverse Event|0|||
48842634|NCT00818454|157265381|FG000|Washout Period of 1 Week|Protocol Violation|2|||
48926485|NCT03605680|157563245|FG000|SB Placebo Run-in Period (1 Week)|Reason not Specified|87|||
48926486|NCT03605680|157563246|FG001|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
48926487|NCT03605680|157563247|FG002|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
48926488|NCT03605680|157563248|FG003|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
49173191|NCT05069597|158468802|FG000|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
49173192|NCT05069597|158468803|FG001|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
49173193|NCT03654040|158468804|FG000|Overall Study|Death|1|||
49173194|NCT03654040|158468805|FG001|Overall Study|Death|0|||
49173195|NCT03654040|158468804|FG000|Overall Study|Withdrawal by Subject|1|||
48926489|NCT03605680|157563245|FG000|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0|||
48926490|NCT03605680|157563246|FG001|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5|||
48926491|NCT03605680|157563247|FG002|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7|||
48926492|NCT03605680|157563248|FG003|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8|||
48926493|NCT03605680|157563245|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|0|||
49173196|NCT03654040|158468805|FG001|Overall Study|Withdrawal by Subject|0|||
49173197|NCT03654040|158468804|FG000|Overall Study|Study terminated by sponsor|8|||
49173198|NCT03654040|158468805|FG001|Overall Study|Study terminated by sponsor|2|||
48842635|NCT00818454|157265382|FG001|Washout Period of 1 Week|Protocol Violation|0|||
48842636|NCT00818454|157265383|FG002|Washout Period of 1 Week|Protocol Violation|0|||
48842637|NCT00818454|157265384|FG003|Washout Period of 1 Week|Protocol Violation|0|||
48842638|NCT00818454|157265381|FG000|Washout Period of 1 Week|Other|1|||
48926494|NCT03605680|157563246|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
48842639|NCT00818454|157265382|FG001|Washout Period of 1 Week|Other|2|||
48842640|NCT00818454|157265383|FG002|Washout Period of 1 Week|Other|0|||
48842641|NCT00818454|157265384|FG003|Washout Period of 1 Week|Other|0|||
48842642|NCT00818454|157265381|FG000|Treatment Period 2|Other|2|||
48842643|NCT00818454|157265382|FG001|Treatment Period 2|Other|1|||
48842644|NCT00818454|157265383|FG002|Treatment Period 2|Other|0|||
48842645|NCT00818454|157265384|FG003|Treatment Period 2|Other|0|||
48842646|NCT00818454|157265381|FG000|Treatment Period 3|Adverse Event|0|||
48842647|NCT00818454|157265382|FG001|Treatment Period 3|Adverse Event|0|||
48842648|NCT00818454|157265383|FG002|Treatment Period 3|Adverse Event|0|||
48842649|NCT00818454|157265384|FG003|Treatment Period 3|Adverse Event|1|||
48842650|NCT03262935|157265385|FG000|Overall Study|Withdrawal by Subject|6|||
48842651|NCT03262935|157265386|FG001|Overall Study|Withdrawal by Subject|7|||
48842652|NCT03262935|157265385|FG000|Overall Study|End Of Follow Up By Sponsor|90|||
48842653|NCT03262935|157265386|FG001|Overall Study|End Of Follow Up By Sponsor|41|||
48842654|NCT03262935|157265385|FG000|Overall Study|Death|181|||
48842655|NCT03262935|157265386|FG001|Overall Study|Death|94|||
48842656|NCT03262935|157265385|FG000|Overall Study|Lost to Follow-up|9|||
48842657|NCT03262935|157265386|FG001|Overall Study|Lost to Follow-up|4|||
48842658|NCT03262935|157265385|FG000|Overall Study|Other reason|5|||
48842659|NCT03262935|157265386|FG001|Overall Study|Other reason|0|||
48842660|NCT01149369|157265387|FG000|Overall Study|Adverse Event|6|||
48842661|NCT01149369|157265388|FG001|Overall Study|Adverse Event|3|||
48842662|NCT02034916|157265394|FG000|Overall Study|Death|39|||
48842663|NCT02034916|157265395|FG001|Overall Study|Death|28|||
48842664|NCT02034916|157265394|FG000|Overall Study|Withdrawal by Subject|2|||
48842665|NCT02034916|157265395|FG001|Overall Study|Withdrawal by Subject|1|||
48842666|NCT02034916|157265394|FG000|Overall Study|Lost to Follow-up|4|||
48842667|NCT02034916|157265395|FG001|Overall Study|Lost to Follow-up|1|||
48842668|NCT02034916|157265394|FG000|Overall Study|Study terminated by sponsor|4|||
48842669|NCT02034916|157265395|FG001|Overall Study|Study terminated by sponsor|5|||
48842670|NCT02015520|157265396|FG000|Overall Study|Lack of Efficacy|1|||
48842671|NCT02015520|157265397|FG001|Overall Study|Lack of Efficacy|0|||
48842672|NCT02015520|157265398|FG002|Overall Study|Lack of Efficacy|3|||
48842673|NCT02015520|157265399|FG003|Overall Study|Lack of Efficacy|2|||
48842674|NCT02015520|157265396|FG000|Overall Study|Adverse Event|0|||
48842675|NCT02015520|157265397|FG001|Overall Study|Adverse Event|0|||
48926495|NCT03605680|157563247|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
48926496|NCT03605680|157563248|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
48926497|NCT03605680|157563245|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
48842676|NCT02015520|157265398|FG002|Overall Study|Adverse Event|0|||
48842677|NCT02015520|157265399|FG003|Overall Study|Adverse Event|1|||
48842678|NCT02015520|157265396|FG000|Overall Study|Withdrawal by Subject|2|||
48842679|NCT02015520|157265397|FG001|Overall Study|Withdrawal by Subject|2|||
48842680|NCT02015520|157265398|FG002|Overall Study|Withdrawal by Subject|1|||
48842681|NCT02015520|157265399|FG003|Overall Study|Withdrawal by Subject|0|||
48842682|NCT02015520|157265396|FG000|Overall Study|Death|1|||
48842683|NCT02015520|157265397|FG001|Overall Study|Death|0|||
48842684|NCT02015520|157265398|FG002|Overall Study|Death|0|||
48842685|NCT02015520|157265399|FG003|Overall Study|Death|0|||
48842686|NCT02015520|157265396|FG000|Overall Study|Lost to Follow-up|0|||
48842687|NCT02015520|157265397|FG001|Overall Study|Lost to Follow-up|0|||
48842688|NCT02015520|157265398|FG002|Overall Study|Lost to Follow-up|1|||
49173199|NCT03654040|158468804|FG000|Overall Study|Failure to initiate study therapy|2|||
49173200|NCT03654040|158468805|FG001|Overall Study|Failure to initiate study therapy|0|||
48842689|NCT02015520|157265399|FG003|Overall Study|Lost to Follow-up|0|||
48842690|NCT02015520|157265396|FG000|Overall Study|Subject Request to Discontinue Study Treatment|1|||
48842691|NCT02015520|157265397|FG001|Overall Study|Subject Request to Discontinue Study Treatment|1|||
48842692|NCT02015520|157265398|FG002|Overall Study|Subject Request to Discontinue Study Treatment|2|||
48842693|NCT02015520|157265399|FG003|Overall Study|Subject Request to Discontinue Study Treatment|1|||
48842694|NCT02015520|157265396|FG000|Overall Study|Subject no Longer Meets Study Criteria|0|||
49173201|NCT03654040|158468804|FG000|Overall Study|Transplanted at another center|2|||
49173202|NCT03654040|158468805|FG001|Overall Study|Transplanted at another center|0|||
49173203|NCT03654040|158468804|FG000|Overall Study|Failure to meet eligibility criteria|14|||
49173204|NCT03654040|158468805|FG001|Overall Study|Failure to meet eligibility criteria|2|||
49173205|NCT03654040|158468804|FG000|Overall Study|No longer transplant candidate|1|||
49173206|NCT03654040|158468805|FG001|Overall Study|No longer transplant candidate|0|||
49173207|NCT03654040|158468804|FG000|Overall Study|Manufacturing unable to accept specimens|1|||
49173208|NCT03654040|158468805|FG001|Overall Study|Manufacturing unable to accept specimens|0|||
49173209|NCT03654040|158468804|FG000|Overall Study|Recipient ineligible|0|||
49173210|NCT03654040|158468805|FG001|Overall Study|Recipient ineligible|2|||
49173211|NCT03654040|158468804|FG000|Overall Study|Received deceased liver|0|||
49173212|NCT03654040|158468805|FG001|Overall Study|Received deceased liver|1|||
49173213|NCT01709110|158468806|FG000|Overall Study|Adverse Event|56|||
49173214|NCT01709110|158468807|FG001|Overall Study|Adverse Event|48|||
49173215|NCT01709110|158468806|FG000|Overall Study|Death|14|||
49173216|NCT01709110|158468807|FG001|Overall Study|Death|6|||
49173217|NCT01709110|158468806|FG000|Overall Study|Lost to Follow-up|7|||
49173218|NCT01709110|158468807|FG001|Overall Study|Lost to Follow-up|5|||
48842695|NCT02015520|157265397|FG001|Overall Study|Subject no Longer Meets Study Criteria|1|||
48926498|NCT03605680|157563246|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
48926499|NCT03605680|157563247|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
49173219|NCT01709110|158468806|FG000|Overall Study|Protocol Violation|4|||
49173220|NCT01709110|158468807|FG001|Overall Study|Protocol Violation|6|||
49173221|NCT01709110|158468806|FG000|Overall Study|Withdrawal by Subject|96|||
49173222|NCT01709110|158468807|FG001|Overall Study|Withdrawal by Subject|89|||
49173223|NCT01709110|158468806|FG000|Overall Study|Physician Decision|4|||
48842696|NCT02015520|157265398|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
48842697|NCT02015520|157265399|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
48842698|NCT02616900|157265400|FG000|Overall Study|Lack of Efficacy|7|||
48842699|NCT02616900|157265400|FG000|Overall Study|Lost to Follow-up|2|||
48842700|NCT02616900|157265400|FG000|Overall Study|Protocol Violation|5|||
48842701|NCT02616900|157265400|FG000|Overall Study|Withdrawal by Subject|3|||
48842702|NCT02616900|157265400|FG000|Overall Study|Incomplete data|6|||
48842703|NCT01087762|157265401|FG000|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2|||
48842704|NCT01087762|157265402|FG001|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
48842705|NCT01087762|157265403|FG002|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3|||
48842706|NCT01087762|157265404|FG003|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
48842707|NCT01087762|157265405|FG004|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
48842708|NCT01087762|157265401|FG000|Double Blind Period (Weeks 0-24)|Protocol Violation|6|||
48842709|NCT01087762|157265402|FG001|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
48842710|NCT01087762|157265403|FG002|Double Blind Period (Weeks 0-24)|Protocol Violation|1|||
48842711|NCT01087762|157265404|FG003|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
48842712|NCT01087762|157265405|FG004|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
48842713|NCT01087762|157265401|FG000|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
48842714|NCT01087762|157265402|FG001|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2|||
48842715|NCT01087762|157265403|FG002|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
48842716|NCT01087762|157265404|FG003|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
48842717|NCT01087762|157265405|FG004|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
48842718|NCT01087762|157265401|FG000|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
48842719|NCT01087762|157265402|FG001|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2|||
48842720|NCT01087762|157265403|FG002|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
48842721|NCT01087762|157265404|FG003|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
48842722|NCT01087762|157265405|FG004|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
48842723|NCT01087762|157265401|FG000|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
48842724|NCT01087762|157265402|FG001|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
48842725|NCT01087762|157265403|FG002|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3|||
48842726|NCT01087762|157265404|FG003|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
48842727|NCT01087762|157265405|FG004|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
48842728|NCT01087762|157265401|FG000|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
48842729|NCT01087762|157265402|FG001|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
48842730|NCT01087762|157265403|FG002|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
48842731|NCT01087762|157265404|FG003|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4|||
48842732|NCT01087762|157265405|FG004|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14|||
48842733|NCT01087762|157265401|FG000|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
48842734|NCT01087762|157265402|FG001|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
49173224|NCT01709110|158468807|FG001|Overall Study|Physician Decision|10|||
49173225|NCT01709110|158468806|FG000|Overall Study|Sponsor Decision|2|||
49173226|NCT01709110|158468807|FG001|Overall Study|Sponsor Decision|2|||
49173227|NCT01709110|158468806|FG000|Overall Study|Lack of Efficacy|1|||
49173228|NCT01709110|158468807|FG001|Overall Study|Lack of Efficacy|1|||
49173229|NCT01709110|158468806|FG000|Overall Study|Caregiver Decision|1|||
49173230|NCT01709110|158468807|FG001|Overall Study|Caregiver Decision|1|||
49173231|NCT02120781|158468810|FG000|Overall Study|Physician Decision|2|||
49173232|NCT02120781|158468811|FG001|Overall Study|Physician Decision|0|||
49173233|NCT02120781|158468810|FG000|Overall Study|Completion not documented|2|||
49173234|NCT02120781|158468811|FG001|Overall Study|Completion not documented|1|||
49173235|NCT02831855|158468812|FG000|Open Label Phase (24 Weeks)|Adverse Event|39|||
49173236|NCT02831855|158468813|FG001|Open Label Phase (24 Weeks)|Adverse Event|0|||
49173237|NCT02831855|158468814|FG002|Open Label Phase (24 Weeks)|Adverse Event|0|||
49173238|NCT02831855|158468812|FG000|Open Label Phase (24 Weeks)|Lost to Follow-up|8|||
49173239|NCT02831855|158468813|FG001|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
49173240|NCT02831855|158468814|FG002|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
49173241|NCT02831855|158468812|FG000|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7|||
49173242|NCT02831855|158468813|FG001|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
49173243|NCT02831855|158468814|FG002|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
49173244|NCT02831855|158468812|FG000|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2|||
49173245|NCT02831855|158468813|FG001|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
49173246|NCT02831855|158468814|FG002|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
49173247|NCT02831855|158468812|FG000|Open Label Phase (24 Weeks)|Protocol Violation|5|||
49173248|NCT02831855|158468813|FG001|Open Label Phase (24 Weeks)|Protocol Violation|0|||
49173249|NCT02831855|158468814|FG002|Open Label Phase (24 Weeks)|Protocol Violation|0|||
49173250|NCT02831855|158468812|FG000|Open Label Phase (24 Weeks)|Withdrawal by Subject|6|||
49173251|NCT02831855|158468813|FG001|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
49173252|NCT02831855|158468814|FG002|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
49173253|NCT02831855|158468812|FG000|Open Label Phase (24 Weeks)|Other|4|||
49173254|NCT02831855|158468813|FG001|Open Label Phase (24 Weeks)|Other|0|||
49173255|NCT02831855|158468814|FG002|Open Label Phase (24 Weeks)|Other|0|||
49173256|NCT02831855|158468812|FG000|Double Blind Phase (24 Weeks)|Adverse Event|0|||
49173257|NCT02831855|158468813|FG001|Double Blind Phase (24 Weeks)|Adverse Event|6|||
49173258|NCT02831855|158468814|FG002|Double Blind Phase (24 Weeks)|Adverse Event|6|||
49173259|NCT02831855|158468812|FG000|Double Blind Phase (24 Weeks)|Death|0|||
49173260|NCT02831855|158468813|FG001|Double Blind Phase (24 Weeks)|Death|0|||
49173261|NCT02831855|158468814|FG002|Double Blind Phase (24 Weeks)|Death|2|||
49173262|NCT02831855|158468812|FG000|Double Blind Phase (24 Weeks)|Lost to Follow-up|0|||
49173263|NCT02831855|158468813|FG001|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
49173264|NCT02831855|158468814|FG002|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
49173265|NCT02831855|158468812|FG000|Double Blind Phase (24 Weeks)|Screen Failure|0|||
49173266|NCT02831855|158468813|FG001|Double Blind Phase (24 Weeks)|Screen Failure|1|||
49173267|NCT02831855|158468814|FG002|Double Blind Phase (24 Weeks)|Screen Failure|0|||
49173268|NCT02831855|158468812|FG000|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0|||
49173269|NCT02831855|158468813|FG001|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5|||
49173270|NCT02831855|158468814|FG002|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2|||
49173271|NCT02831855|158468812|FG000|Double Blind Phase (24 Weeks)|Other|0|||
49173272|NCT02831855|158468813|FG001|Double Blind Phase (24 Weeks)|Other|2|||
49173273|NCT02831855|158468814|FG002|Double Blind Phase (24 Weeks)|Other|5|||
49173274|NCT02831855|158468812|FG000|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0|||
49173275|NCT02831855|158468813|FG001|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6|||
49173276|NCT02831855|158468814|FG002|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1|||
49173277|NCT02831855|158468812|FG000|Double Blind Phase (24 Weeks)|Protocol Violation|0|||
49173278|NCT02831855|158468813|FG001|Double Blind Phase (24 Weeks)|Protocol Violation|5|||
49173279|NCT02831855|158468814|FG002|Double Blind Phase (24 Weeks)|Protocol Violation|2|||
49173280|NCT02831855|158468812|FG000|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
49173281|NCT02831855|158468813|FG001|Double Blind Phase (24 Weeks)|Randomized but not Treated|3|||
49173282|NCT02831855|158468814|FG002|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
49173283|NCT02298868|158468815|FG000|Overall Study|Adverse Event|1|||
49173284|NCT02298868|158468815|FG000|Overall Study|Death|1|||
49173285|NCT02298868|158468815|FG000|Overall Study|Patient underwent transplant|1|||
49173286|NCT00075764|158468821|FG000|Overall Study|Adverse Event|5|||
49173287|NCT00075764|158468822|FG001|Overall Study|Adverse Event|12|||
49173288|NCT00075764|158468821|FG000|Overall Study|Death|4|||
49173289|NCT00075764|158468822|FG001|Overall Study|Death|8|||
49173290|NCT00075764|158468821|FG000|Overall Study|Withdrawal by Subject|28|||
49173291|NCT00075764|158468822|FG001|Overall Study|Withdrawal by Subject|18|||
49173292|NCT00075764|158468821|FG000|Overall Study|Progression|269|||
49173293|NCT00075764|158468822|FG001|Overall Study|Progression|274|||
49173294|NCT00075764|158468821|FG000|Overall Study|Still on treatment|8|||
49173295|NCT00075764|158468822|FG001|Overall Study|Still on treatment|15|||
49173296|NCT00075764|158468821|FG000|Overall Study|Delinquent|4|||
49173297|NCT00075764|158468822|FG001|Overall Study|Delinquent|2|||
49173298|NCT00075764|158468821|FG000|Overall Study|Not protocol specified|27|||
49173299|NCT00075764|158468822|FG001|Overall Study|Not protocol specified|19|||
49173300|NCT00075764|158468821|FG000|Overall Study|Under review|0|||
49173301|NCT00075764|158468822|FG001|Overall Study|Under review|1|||
49173302|NCT00194077|158468824|FG000|Overall Study|Lack of Efficacy|22|||
49173303|NCT00194077|158468825|FG001|Overall Study|Lack of Efficacy|29|||
49173304|NCT00194077|158468824|FG000|Overall Study|Study nonadherence|1|||
49173305|NCT00194077|158468825|FG001|Overall Study|Study nonadherence|0|||
49173306|NCT00194077|158468824|FG000|Overall Study|Withdrawal by Subject|1|||
49173307|NCT00194077|158468825|FG001|Overall Study|Withdrawal by Subject|1|||
49173308|NCT01309997|158468832|FG000|Overall Study|Adverse Event|1|||
49173309|NCT01309997|158468833|FG001|Overall Study|Adverse Event|0|||
49173310|NCT01309997|158468832|FG000|Overall Study|Death|1|||
49173311|NCT01309997|158468833|FG001|Overall Study|Death|3|||
49173312|NCT01309997|158468832|FG000|Overall Study|Lack of Efficacy|2|||
49173313|NCT01309997|158468833|FG001|Overall Study|Lack of Efficacy|2|||
49173314|NCT01309997|158468832|FG000|Overall Study|Withdrawal by Subject|1|||
49173315|NCT01309997|158468833|FG001|Overall Study|Withdrawal by Subject|1|||
49173316|NCT00282087|158468834|FG000|Overall Study|Death|1|||
49173317|NCT01147250|158468840|FG000|Overall Study|Lost to Follow-up|14|||
49173318|NCT01147250|158468841|FG001|Overall Study|Lost to Follow-up|11|||
49173319|NCT01147250|158468840|FG000|Overall Study|Withdrawal by Subject|83|||
49173320|NCT01147250|158468841|FG001|Overall Study|Withdrawal by Subject|88|||
49173321|NCT01147250|158468840|FG000|Overall Study|Site termination by sponsor|13|||
49173322|NCT01147250|158468841|FG001|Overall Study|Site termination by sponsor|5|||
49173323|NCT01147250|158468840|FG000|Overall Study|Other than specified|0|||
49173324|NCT01147250|158468841|FG001|Overall Study|Other than specified|1|||
49173325|NCT00624468|158468842|FG000|Double-blind Period|Early Termination Initiated by Sponsor|13|||
49173326|NCT00624468|158468843|FG001|Double-blind Period|Early Termination Initiated by Sponsor|12|||
49173327|NCT00624468|158468844|FG002|Double-blind Period|Early Termination Initiated by Sponsor|0|||
49173328|NCT00624468|158468845|FG003|Double-blind Period|Early Termination Initiated by Sponsor|0|||
49173329|NCT00624468|158468842|FG000|Double-blind Period|Withdrew Prematurely|1|||
49173330|NCT00624468|158468843|FG001|Double-blind Period|Withdrew Prematurely|1|||
49173331|NCT00624468|158468844|FG002|Double-blind Period|Withdrew Prematurely|0|||
49173332|NCT00624468|158468845|FG003|Double-blind Period|Withdrew Prematurely|0|||
49173333|NCT00624468|158468842|FG000|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
49173334|NCT00624468|158468843|FG001|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
49173335|NCT00624468|158468844|FG002|Safety Follow-up (SFU) Period|Lost to Follow-up|1|||
49173336|NCT00624468|158468845|FG003|Safety Follow-up (SFU) Period|Lost to Follow-up|2|||
49173337|NCT00624468|158468842|FG000|Safety Follow-up (SFU) Period|Other|0|||
49173338|NCT00624468|158468843|FG001|Safety Follow-up (SFU) Period|Other|0|||
49173339|NCT00624468|158468844|FG002|Safety Follow-up (SFU) Period|Other|1|||
49173340|NCT00624468|158468845|FG003|Safety Follow-up (SFU) Period|Other|1|||
49173341|NCT02249091|158468846|FG000|Overall Study|Lack of Efficacy|8|||
49173342|NCT02249091|158468847|FG001|Overall Study|Lack of Efficacy|3|||
49173343|NCT02249091|158468846|FG000|Overall Study|Physician Decision|4|||
49173344|NCT02249091|158468847|FG001|Overall Study|Physician Decision|1|||
49173345|NCT02249091|158468846|FG000|Overall Study|Withdrawal by Subject|2|||
49173346|NCT02249091|158468847|FG001|Overall Study|Withdrawal by Subject|2|||
49173347|NCT02249091|158468846|FG000|Overall Study|Death|3|||
49173348|NCT02249091|158468847|FG001|Overall Study|Death|4|||
49173349|NCT02249091|158468846|FG000|Overall Study|Adverse Event|1|||
49173350|NCT02249091|158468847|FG001|Overall Study|Adverse Event|0|||
49173351|NCT02249091|158468846|FG000|Overall Study|Stable disease with following SCT|0|||
49173352|NCT02249091|158468847|FG001|Overall Study|Stable disease with following SCT|1|||
49173353|NCT02249091|158468846|FG000|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0|||
49173354|NCT02249091|158468847|FG001|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1|||
49173355|NCT02249091|158468846|FG000|Overall Study|CR with subsequent donor lymphocyte infusion|1|||
49173356|NCT02249091|158468847|FG001|Overall Study|CR with subsequent donor lymphocyte infusion|0|||
49173357|NCT02249091|158468846|FG000|Overall Study|Refractory AML|1|||
49173358|NCT02249091|158468847|FG001|Overall Study|Refractory AML|1|||
49173359|NCT00372619|158468848|FG000|Overall Study|Ineligible|0|||
49173360|NCT00372619|158468849|FG001|Overall Study|Ineligible|0|||
49173361|NCT00372619|158468850|FG002|Overall Study|Ineligible|0|||
49173362|NCT00372619|158468851|FG003|Overall Study|Ineligible|0|||
49173363|NCT00372619|158468852|FG004|Overall Study|Ineligible|0|||
49173364|NCT00372619|158468853|FG005|Overall Study|Ineligible|2|||
49173365|NCT00372619|158468854|FG006|Overall Study|Ineligible|0|||
49173366|NCT00372619|158468848|FG000|Overall Study|Inevaluable|0|||
49173367|NCT00372619|158468849|FG001|Overall Study|Inevaluable|0|||
49173368|NCT00372619|158468850|FG002|Overall Study|Inevaluable|0|||
49173369|NCT00372619|158468851|FG003|Overall Study|Inevaluable|0|||
49173370|NCT00372619|158468852|FG004|Overall Study|Inevaluable|0|||
49173371|NCT00372619|158468853|FG005|Overall Study|Inevaluable|1|||
49173372|NCT00372619|158468854|FG006|Overall Study|Inevaluable|0|||
49173373|NCT04550832|158468857|FG000|Overall Study|Adverse Event|0|||
49173374|NCT04550832|158468858|FG001|Overall Study|Adverse Event|0|||
49173375|NCT04550832|158468859|FG002|Overall Study|Adverse Event|2|||
49173376|NCT04550832|158468860|FG003|Overall Study|Adverse Event|0|||
49173377|NCT04550832|158468861|FG004|Overall Study|Adverse Event|1|||
49173378|NCT05420961|158468862|FG000|Overall Study|Withdrawal by Subject|2|||
49173379|NCT05420961|158468863|FG001|Overall Study|Withdrawal by Subject|1|||
49173380|NCT05420961|158468864|FG002|Overall Study|Withdrawal by Subject|1|||
49173381|NCT05420961|158468865|FG003|Overall Study|Withdrawal by Subject|0|||
49173382|NCT05420961|158468866|FG004|Overall Study|Withdrawal by Subject|0|||
49173383|NCT05420961|158468862|FG000|Overall Study|Lost to Follow-up|0|||
49173384|NCT05420961|158468863|FG001|Overall Study|Lost to Follow-up|0|||
49173385|NCT05420961|158468864|FG002|Overall Study|Lost to Follow-up|1|||
49173386|NCT05420961|158468865|FG003|Overall Study|Lost to Follow-up|0|||
49173387|NCT05420961|158468866|FG004|Overall Study|Lost to Follow-up|0|||
49173388|NCT05420961|158468862|FG000|Overall Study|Randomized by mistake without study treatment|0|||
49173389|NCT05420961|158468863|FG001|Overall Study|Randomized by mistake without study treatment|0|||
49173390|NCT05420961|158468864|FG002|Overall Study|Randomized by mistake without study treatment|1|||
49173391|NCT05420961|158468865|FG003|Overall Study|Randomized by mistake without study treatment|0|||
49173392|NCT05420961|158468866|FG004|Overall Study|Randomized by mistake without study treatment|1|||
49173393|NCT03931382|158468867|FG000|Overall Study|Equipment malfunction|2|||
49173394|NCT03931382|158468868|FG001|Overall Study|Equipment malfunction|0|||
49173395|NCT03931382|158468869|FG002|Overall Study|Equipment malfunction|2|||
49173396|NCT03931382|158468867|FG000|Overall Study|Withdrawal by Subject|0|||
49173397|NCT03931382|158468868|FG001|Overall Study|Withdrawal by Subject|1|||
49173398|NCT03931382|158468869|FG002|Overall Study|Withdrawal by Subject|0|||
49173399|NCT01140867|158468875|FG000|Overall Study|Adverse Event|22|||
49173400|NCT01140867|158468875|FG000|Overall Study|Lack of Efficacy|3|||
49173401|NCT01140867|158468875|FG000|Overall Study|Lost to Follow-up|2|||
49173402|NCT01140867|158468875|FG000|Overall Study|Withdrawal by Subject|1|||
49173403|NCT01140867|158468875|FG000|Overall Study|Protocol Violation|1|||
49173404|NCT01140867|158468875|FG000|Overall Study|Uncooperative patient|2|||
49173405|NCT01140867|158468875|FG000|Overall Study|Medication Noncompliance|2|||
49173406|NCT03629223|158468876|FG000|Treatment Period 1 (21 Days)|Adverse Event|0|||
49173407|NCT03629223|158468877|FG001|Treatment Period 1 (21 Days)|Adverse Event|0|||
49173408|NCT03629223|158468878|FG002|Treatment Period 1 (21 Days)|Adverse Event|0|||
49173409|NCT03629223|158468879|FG003|Treatment Period 1 (21 Days)|Adverse Event|1|||
49173410|NCT03629223|158468880|FG004|Treatment Period 1 (21 Days)|Adverse Event|0|||
49173411|NCT03629223|158468881|FG005|Treatment Period 1 (21 Days)|Adverse Event|0|||
49173412|NCT03629223|158468876|FG000|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
49173413|NCT03629223|158468877|FG001|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
49173414|NCT03629223|158468878|FG002|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
49173415|NCT03629223|158468879|FG003|Treatment Period 1 (21 Days)|Lost to Follow-up|1|||
49173416|NCT03629223|158468880|FG004|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
49173417|NCT03629223|158468881|FG005|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
49173418|NCT03629223|158468876|FG000|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
48842735|NCT01087762|157265403|FG002|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
49173419|NCT03629223|158468877|FG001|Treatment Period 1 (21 Days)|Benzodiazepines positive|1|||
49173420|NCT03629223|158468878|FG002|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
49173421|NCT03629223|158468879|FG003|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
49173422|NCT03629223|158468880|FG004|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
49173423|NCT03629223|158468881|FG005|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
49173424|NCT03629223|158468876|FG000|Treatment Period 1 (21 Days)|Toothache treatment|0|||
49173425|NCT03629223|158468877|FG001|Treatment Period 1 (21 Days)|Toothache treatment|1|||
49173426|NCT03629223|158468878|FG002|Treatment Period 1 (21 Days)|Toothache treatment|0|||
49173427|NCT03629223|158468879|FG003|Treatment Period 1 (21 Days)|Toothache treatment|0|||
49173428|NCT03629223|158468880|FG004|Treatment Period 1 (21 Days)|Toothache treatment|0|||
49173429|NCT03629223|158468881|FG005|Treatment Period 1 (21 Days)|Toothache treatment|0|||
49173430|NCT03629223|158468876|FG000|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|1|||
49173431|NCT03629223|158468877|FG001|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
49173432|NCT03629223|158468878|FG002|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
49173433|NCT03629223|158468879|FG003|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
49173434|NCT03629223|158468880|FG004|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
49173435|NCT03629223|158468881|FG005|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
49173436|NCT01534351|158468882|FG000|Overall Study|Study Terminated Early|1|||
49173437|NCT01534351|158468883|FG001|Overall Study|Study Terminated Early|0|||
49173438|NCT01534351|158468884|FG002|Overall Study|Study Terminated Early|0|||
49173439|NCT03490292|158468889|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Death|0|||
49173440|NCT03490292|158468890|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Death|1|||
49173441|NCT03490292|158468889|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|0|||
49173442|NCT03490292|158468890|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|2|||
49173443|NCT03490292|158468889|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|0|||
49173444|NCT03490292|158468890|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|2|||
49173445|NCT03490292|158468889|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|0|||
49173446|NCT03490292|158468890|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|2|||
49173447|NCT03490292|158468889|FG000|1 Year Follow Up Post Last Dose|Death|1|||
49173448|NCT03490292|158468890|FG001|1 Year Follow Up Post Last Dose|Death|1|||
49173449|NCT03928418|158468891|FG000|Overall Study|Lost to Follow-up|5|||
49173450|NCT03928418|158468892|FG001|Overall Study|Lost to Follow-up|3|||
49173451|NCT03928418|158468893|FG002|Overall Study|Lost to Follow-up|5|||
49173452|NCT03928418|158468891|FG000|Overall Study|Pilot participant - excluded from analyses|1|||
49173453|NCT03928418|158468892|FG001|Overall Study|Pilot participant - excluded from analyses|1|||
49173454|NCT03928418|158468893|FG002|Overall Study|Pilot participant - excluded from analyses|1|||
49173455|NCT04599803|158468894|FG000|Overall Study|Withdrawal by Subject|5|||
49173456|NCT04599803|158468894|FG000|Overall Study|Lost to Follow-up|26|||
49173457|NCT01901289|158468897|FG000|Overall Study|Death|32|||
49173458|NCT01901289|158468897|FG000|Overall Study|Lost to Follow-up|16|||
49173459|NCT01901289|158468897|FG000|Overall Study|Withdrawal by Subject|35|||
49173460|NCT01901289|158468897|FG000|Overall Study|Other type of endpoint met|2|||
49173461|NCT02595866|158468898|FG000|Overall Study|Adverse Event|2|||
49173462|NCT02595866|158468899|FG001|Overall Study|Adverse Event|5|||
49173463|NCT02595866|158468898|FG000|Overall Study|Complicating Disease/Intercurrent Illness|1|||
49173464|NCT02595866|158468899|FG001|Overall Study|Complicating Disease/Intercurrent Illness|1|||
49173465|NCT02595866|158468898|FG000|Overall Study|Death|0|||
49173466|NCT02595866|158468899|FG001|Overall Study|Death|1|||
49173467|NCT02595866|158468898|FG000|Overall Study|Incarceration|1|||
49173468|NCT02595866|158468899|FG001|Overall Study|Incarceration|0|||
49173469|NCT02595866|158468898|FG000|Overall Study|Lack of Efficacy|17|||
49173470|NCT02595866|158468899|FG001|Overall Study|Lack of Efficacy|7|||
49173471|NCT02595866|158468898|FG000|Overall Study|Physician Decision|4|||
49173472|NCT02595866|158468899|FG001|Overall Study|Physician Decision|3|||
49173473|NCT02595866|158468898|FG000|Overall Study|Switched to Alternative Treatment|1|||
49173474|NCT02595866|158468899|FG001|Overall Study|Switched to Alternative Treatment|0|||
49173475|NCT02595866|158468898|FG000|Overall Study|Study Terminated|0|||
49173476|NCT02595866|158468899|FG001|Overall Study|Study Terminated|4|||
49173477|NCT02595866|158468898|FG000|Overall Study|Withdrawal by Subject|6|||
49173478|NCT02595866|158468899|FG001|Overall Study|Withdrawal by Subject|1|||
49173479|NCT00778336|158468900|FG000|Index Procedure-Discharge|Death|6|||
49173480|NCT00778336|158468901|FG001|Index Procedure-Discharge|Death|3|||
48842736|NCT01087762|157265404|FG003|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
48842737|NCT01087762|157265405|FG004|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
48842738|NCT01087762|157265401|FG000|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
49173481|NCT00778336|158468902|FG002|Index Procedure-Discharge|Death|2|||
48842739|NCT01087762|157265402|FG001|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
48842740|NCT01087762|157265403|FG002|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
48842741|NCT01087762|157265404|FG003|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5|||
48842742|NCT01087762|157265405|FG004|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2|||
48842743|NCT01087762|157265401|FG000|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
48842744|NCT01087762|157265402|FG001|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
48842745|NCT01087762|157265403|FG002|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
48842746|NCT01087762|157265404|FG003|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22|||
48842747|NCT01087762|157265405|FG004|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15|||
48842748|NCT01087762|157265401|FG000|Open-Label Period (Weeks 48-204)|Other|0|||
48842749|NCT01087762|157265402|FG001|Open-Label Period (Weeks 48-204)|Other|0|||
48926500|NCT03605680|157563248|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
48926501|NCT03605680|157563245|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
48926502|NCT03605680|157563246|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
48926503|NCT03605680|157563247|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4|||
49173482|NCT00778336|158468903|FG003|Index Procedure-Discharge|Death|0|||
49173483|NCT00778336|158468900|FG000|3 Month Follow Up|Lost to Follow-up|15|||
49173484|NCT00778336|158468901|FG001|3 Month Follow Up|Lost to Follow-up|20|||
49173485|NCT00778336|158468902|FG002|3 Month Follow Up|Lost to Follow-up|3|||
49173486|NCT00778336|158468903|FG003|3 Month Follow Up|Lost to Follow-up|0|||
49173487|NCT00778336|158468900|FG000|3 Month Follow Up|Death|8|||
49173488|NCT00778336|158468901|FG001|3 Month Follow Up|Death|3|||
49173489|NCT00778336|158468902|FG002|3 Month Follow Up|Death|2|||
49173490|NCT00778336|158468903|FG003|3 Month Follow Up|Death|0|||
49173491|NCT01437111|158468904|FG000|Overall Study|Adverse Event|2|||
49173492|NCT01437111|158468904|FG000|Overall Study|Withdrawal by Subject|4|||
49173493|NCT01437111|158468904|FG000|Overall Study|Not reported|5|||
49173494|NCT01437111|158468904|FG000|Overall Study|Physician Decision|1|||
49173495|NCT01437111|158468904|FG000|Overall Study|Lost to Follow-up|5|||
49173496|NCT01437111|158468904|FG000|Overall Study|Protocol Violation|1|||
49173497|NCT02342288|158468906|FG000|Overall Study|no protocol anesthesiologist available|3|||
49173498|NCT02342288|158468907|FG001|Overall Study|no protocol anesthesiologist available|2|||
49173499|NCT02342288|158468906|FG000|Overall Study|anesthesia leak in system|1|||
49173500|NCT02342288|158468907|FG001|Overall Study|anesthesia leak in system|0|||
49173501|NCT02342288|158468906|FG000|Overall Study|Withdrawal by Subject|1|||
49173502|NCT02342288|158468907|FG001|Overall Study|Withdrawal by Subject|0|||
49173503|NCT02342288|158468906|FG000|Overall Study|coordinator contaminated with blood|0|||
49173504|NCT02342288|158468907|FG001|Overall Study|coordinator contaminated with blood|1|||
49173505|NCT02342288|158468906|FG000|Overall Study|subject cannot tolerate numbing drops|0|||
48842750|NCT01087762|157265403|FG002|Open-Label Period (Weeks 48-204)|Other|0|||
48842751|NCT01087762|157265404|FG003|Open-Label Period (Weeks 48-204)|Other|2|||
48842752|NCT01087762|157265405|FG004|Open-Label Period (Weeks 48-204)|Other|4|||
48842753|NCT01087762|157265401|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
48842754|NCT01087762|157265402|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
48842755|NCT01087762|157265403|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
48842756|NCT01087762|157265404|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7|||
48926504|NCT03605680|157563248|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
49173506|NCT02342288|158468907|FG001|Overall Study|subject cannot tolerate numbing drops|1|||
49173507|NCT02342288|158468906|FG000|Overall Study|coordinator not available|0|||
49173508|NCT02342288|158468907|FG001|Overall Study|coordinator not available|2|||
49173509|NCT00191945|158468910|FG000|Double-Blind Acute Treatment|Parent's Decision|3|||
49173510|NCT00191945|158468911|FG001|Double-Blind Acute Treatment|Parent's Decision|0|||
49173511|NCT00191945|158468910|FG000|Double-Blind Acute Treatment|Lost to Follow-up|0|||
48842757|NCT01087762|157265405|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4|||
48842758|NCT01087762|157265401|FG000|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
48842759|NCT01087762|157265402|FG001|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
49173512|NCT00191945|158468911|FG001|Double-Blind Acute Treatment|Lost to Follow-up|1|||
49173513|NCT00191945|158468910|FG000|Double-Blind Acute Treatment|Non Protocol Compliance|3|||
49173514|NCT00191945|158468911|FG001|Double-Blind Acute Treatment|Non Protocol Compliance|0|||
49173515|NCT00191945|158468910|FG000|Double-Blind Acute Treatment|Physician Decision|0|||
49173516|NCT00191945|158468911|FG001|Double-Blind Acute Treatment|Physician Decision|2|||
49173517|NCT04731298|158468917|FG000|Follow-up (3 Years From HSCT)|Early termination of study.|0|||
49173518|NCT04731298|158468918|FG001|Follow-up (3 Years From HSCT)|Early termination of study.|2|||
49173519|NCT02455336|158468919|FG000|Overall Study|Withdrawal by Subject|0|||
49173520|NCT02455336|158468920|FG001|Overall Study|Withdrawal by Subject|2|||
49173521|NCT02455336|158468919|FG000|Overall Study|Adverse Event|3|||
49173522|NCT02455336|158468920|FG001|Overall Study|Adverse Event|0|||
49173523|NCT02455336|158468919|FG000|Overall Study|Non-responder to treatment|2|||
49173524|NCT02455336|158468920|FG001|Overall Study|Non-responder to treatment|0|||
49173525|NCT02308163|158468921|FG000|Overall Study|Not fulfill eligible criteria|1|||
49173526|NCT02308163|158468922|FG001|Overall Study|Not fulfill eligible criteria|2|||
49173527|NCT02308163|158468923|FG002|Overall Study|Not fulfill eligible criteria|0|||
49173528|NCT02308163|158468924|FG003|Overall Study|Not fulfill eligible criteria|1|||
49173529|NCT02308163|158468925|FG004|Overall Study|Not fulfill eligible criteria|1|||
49173530|NCT02308163|158468921|FG000|Overall Study|Adverse Event|9|||
49173531|NCT02308163|158468922|FG001|Overall Study|Adverse Event|5|||
49173532|NCT02308163|158468923|FG002|Overall Study|Adverse Event|2|||
49173533|NCT02308163|158468924|FG003|Overall Study|Adverse Event|2|||
49173534|NCT02308163|158468925|FG004|Overall Study|Adverse Event|11|||
49173535|NCT02308163|158468921|FG000|Overall Study|Lack of Efficacy|11|||
49173536|NCT02308163|158468922|FG001|Overall Study|Lack of Efficacy|3|||
49173537|NCT02308163|158468923|FG002|Overall Study|Lack of Efficacy|8|||
49173538|NCT02308163|158468924|FG003|Overall Study|Lack of Efficacy|4|||
49173539|NCT02308163|158468925|FG004|Overall Study|Lack of Efficacy|6|||
49173540|NCT02308163|158468921|FG000|Overall Study|Withdrawal of consent|2|||
49173541|NCT02308163|158468922|FG001|Overall Study|Withdrawal of consent|3|||
49173542|NCT02308163|158468923|FG002|Overall Study|Withdrawal of consent|0|||
49173543|NCT02308163|158468924|FG003|Overall Study|Withdrawal of consent|2|||
49173544|NCT02308163|158468925|FG004|Overall Study|Withdrawal of consent|6|||
49173545|NCT02308163|158468921|FG000|Overall Study|Protocol Violation|3|||
49173546|NCT02308163|158468922|FG001|Overall Study|Protocol Violation|3|||
49173547|NCT02308163|158468923|FG002|Overall Study|Protocol Violation|3|||
49173548|NCT02308163|158468924|FG003|Overall Study|Protocol Violation|2|||
49173549|NCT02308163|158468925|FG004|Overall Study|Protocol Violation|5|||
49173550|NCT02308163|158468921|FG000|Overall Study|Lab data met discontinuation criteria|3|||
49173551|NCT02308163|158468922|FG001|Overall Study|Lab data met discontinuation criteria|0|||
49173552|NCT02308163|158468923|FG002|Overall Study|Lab data met discontinuation criteria|0|||
49173553|NCT02308163|158468924|FG003|Overall Study|Lab data met discontinuation criteria|2|||
49173554|NCT02308163|158468925|FG004|Overall Study|Lab data met discontinuation criteria|0|||
49173555|NCT02308163|158468921|FG000|Overall Study|Miscellaneous|2|||
49173556|NCT02308163|158468922|FG001|Overall Study|Miscellaneous|2|||
48842760|NCT01087762|157265403|FG002|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
48842761|NCT01087762|157265404|FG003|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16|||
48842762|NCT01087762|157265405|FG004|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13|||
48842763|NCT01087762|157265401|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
48842764|NCT01087762|157265402|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
48842765|NCT01087762|157265403|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
48842766|NCT01087762|157265404|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2|||
48842767|NCT01087762|157265405|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4|||
48926505|NCT03605680|157563245|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0|||
48926506|NCT03605680|157563246|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3|||
48926507|NCT03605680|157563247|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1|||
48951841|NCT04760314|157654914|FG000|Induction Period|Withdrawal by Subject|0|||
49173557|NCT02308163|158468923|FG002|Overall Study|Miscellaneous|1|||
49173558|NCT02308163|158468924|FG003|Overall Study|Miscellaneous|0|||
49173559|NCT02308163|158468925|FG004|Overall Study|Miscellaneous|5|||
49173560|NCT03734016|158468926|FG000|Overall Study|Participants Remaining in the Study|260|||
49173561|NCT03734016|158468927|FG001|Overall Study|Participants Remaining in the Study|240|||
49173562|NCT03734016|158468926|FG000|Overall Study|Death|48|||
49173563|NCT03734016|158468927|FG001|Overall Study|Death|60|||
49173564|NCT03734016|158468926|FG000|Overall Study|Withdrawal by Subject|14|||
49173565|NCT03734016|158468927|FG001|Overall Study|Withdrawal by Subject|16|||
49173566|NCT03734016|158468926|FG000|Overall Study|Physician Decision|0|||
49173567|NCT03734016|158468927|FG001|Overall Study|Physician Decision|7|||
49173568|NCT03734016|158468926|FG000|Overall Study|Lost to Follow-up|3|||
49173569|NCT03734016|158468927|FG001|Overall Study|Lost to Follow-up|1|||
49173570|NCT03734016|158468926|FG000|Overall Study|Adverse Event|2|||
49173571|NCT03734016|158468927|FG001|Overall Study|Adverse Event|1|||
49173572|NCT03802630|158468928|FG000|Overall Study|Study terminated by sponsor|130|||
49173573|NCT03802630|158468929|FG001|Overall Study|Study terminated by sponsor|134|||
49173574|NCT03802630|158468928|FG000|Overall Study|Subject decision|16|||
49173575|NCT03802630|158468929|FG001|Overall Study|Subject decision|9|||
49173576|NCT03802630|158468928|FG000|Overall Study|Adverse Event|3|||
49173577|NCT03802630|158468929|FG001|Overall Study|Adverse Event|1|||
49173578|NCT03802630|158468928|FG000|Overall Study|Lost to Follow-up|2|||
49173579|NCT03802630|158468929|FG001|Overall Study|Lost to Follow-up|2|||
49173580|NCT03802630|158468928|FG000|Overall Study|Physician Decision|2|||
49173581|NCT03802630|158468929|FG001|Overall Study|Physician Decision|0|||
49173582|NCT03802630|158468928|FG000|Overall Study|Death|0|||
49173583|NCT03802630|158468929|FG001|Overall Study|Death|2|||
49173584|NCT02016716|158468930|FG000|Overall Study|Withdrawal by Subject|5|||
49173585|NCT02016716|158468931|FG001|Overall Study|Withdrawal by Subject|5|||
49173586|NCT02016716|158468932|FG002|Overall Study|Withdrawal by Subject|5|||
49173587|NCT02016716|158468930|FG000|Overall Study|Protocol-specified Criteria|0|||
49173588|NCT02016716|158468931|FG001|Overall Study|Protocol-specified Criteria|1|||
49173589|NCT02016716|158468932|FG002|Overall Study|Protocol-specified Criteria|0|||
49173590|NCT02016716|158468930|FG000|Overall Study|Lost to Follow-up|1|||
49173591|NCT02016716|158468931|FG001|Overall Study|Lost to Follow-up|2|||
49173592|NCT02016716|158468932|FG002|Overall Study|Lost to Follow-up|1|||
49173593|NCT02248649|158468933|FG000|Overall Study|Death|7|||
49173594|NCT02248649|158468934|FG001|Overall Study|Death|11|||
49173595|NCT02248649|158468933|FG000|Overall Study|Lost to Follow-up|14|||
49173596|NCT02248649|158468934|FG001|Overall Study|Lost to Follow-up|10|||
49173597|NCT01802580|158468935|FG000|Overall Study|Physician Decision|1|||
49173598|NCT01802580|158468936|FG001|Overall Study|Physician Decision|0|||
49173599|NCT01802580|158468935|FG000|Overall Study|Protocol Violation|2|||
49173600|NCT01802580|158468936|FG001|Overall Study|Protocol Violation|0|||
49173601|NCT01802580|158468935|FG000|Overall Study|Withdrawal by Subject|5|||
49173602|NCT01802580|158468936|FG001|Overall Study|Withdrawal by Subject|6|||
49173603|NCT01802580|158468935|FG000|Overall Study|Other|1|||
49173604|NCT01802580|158468936|FG001|Overall Study|Other|3|||
49173605|NCT01802580|158468935|FG000|Overall Study|Lack of Efficacy|0|||
49173606|NCT01802580|158468936|FG001|Overall Study|Lack of Efficacy|2|||
49173607|NCT00082368|158468947|FG000|Overall Study|Not treated-pt had poor IV access|1|||
49173608|NCT01846299|158468948|FG000|Overall Study|Physician Decision|4|||
49173609|NCT01846299|158468949|FG001|Overall Study|Physician Decision|2|||
49173610|NCT01846299|158468948|FG000|Overall Study|Protocol deviation|1|||
49173611|NCT01846299|158468949|FG001|Overall Study|Protocol deviation|0|||
49173612|NCT01846299|158468948|FG000|Overall Study|Death|1|||
49173613|NCT01846299|158468949|FG001|Overall Study|Death|2|||
48842768|NCT01641198|157265410|FG000|After 12 Months of Function|Lost to Follow-up|3|||
49173614|NCT01846299|158468948|FG000|Overall Study|Lost to Follow-up|3|||
49173615|NCT01846299|158468949|FG001|Overall Study|Lost to Follow-up|0|||
49173616|NCT01846299|158468948|FG000|Overall Study|Withdrawal by Subject|1|||
49173617|NCT01846299|158468949|FG001|Overall Study|Withdrawal by Subject|6|||
49173618|NCT01846299|158468948|FG000|Overall Study|Adverse Event|2|||
49173619|NCT01846299|158468949|FG001|Overall Study|Adverse Event|0|||
49173620|NCT02644096|158468950|FG000|Overall Study|Withdrawal by Subject|28|||
49173621|NCT02644096|158468951|FG001|Overall Study|Withdrawal by Subject|25|||
49173622|NCT02147197|158468952|FG000|Overall Study|Adverse Event|1|||
49173623|NCT02147197|158468953|FG001|Overall Study|Adverse Event|0|||
49173624|NCT02147197|158468954|FG002|Overall Study|Adverse Event|0|||
49173625|NCT02147197|158468952|FG000|Overall Study|Withdrawal of Consent|4|||
49173626|NCT02147197|158468953|FG001|Overall Study|Withdrawal of Consent|3|||
49173627|NCT02147197|158468954|FG002|Overall Study|Withdrawal of Consent|2|||
49173628|NCT02147197|158468952|FG000|Overall Study|Lost to Follow-up|2|||
49173629|NCT02147197|158468953|FG001|Overall Study|Lost to Follow-up|3|||
49173630|NCT02147197|158468954|FG002|Overall Study|Lost to Follow-up|1|||
49173631|NCT02147197|158468952|FG000|Overall Study|Protocol Violation|1|||
49173632|NCT02147197|158468953|FG001|Overall Study|Protocol Violation|0|||
49173633|NCT02147197|158468954|FG002|Overall Study|Protocol Violation|3|||
49173634|NCT02147197|158468952|FG000|Overall Study|Other Miscellaneous Reasons|1|||
49173635|NCT02147197|158468953|FG001|Overall Study|Other Miscellaneous Reasons|0|||
49173636|NCT02147197|158468954|FG002|Overall Study|Other Miscellaneous Reasons|3|||
49173637|NCT01700959|158468955|FG000|Overall Study|Adverse Event|0|||
49173638|NCT01700959|158468956|FG001|Overall Study|Adverse Event|1|||
48842769|NCT01641198|157265411|FG001|After 12 Months of Function|Lost to Follow-up|2|||
48842770|NCT01641198|157265412|FG002|After 12 Months of Function|Lost to Follow-up|2|||
48842771|NCT01641198|157265410|FG000|After 12 Months of Function|Protocol Violation|1|||
48842772|NCT01641198|157265411|FG001|After 12 Months of Function|Protocol Violation|0|||
48842773|NCT01641198|157265412|FG002|After 12 Months of Function|Protocol Violation|0|||
48842774|NCT01641198|157265410|FG000|After 12 Months of Function|Adverse Event|0|||
48842775|NCT01641198|157265411|FG001|After 12 Months of Function|Adverse Event|1|||
48842776|NCT01641198|157265412|FG002|After 12 Months of Function|Adverse Event|0|||
48842777|NCT01641198|157265410|FG000|After 24 Months of Function|Lost to Follow-up|4|||
48842778|NCT01641198|157265411|FG001|After 24 Months of Function|Lost to Follow-up|9|||
48842779|NCT01641198|157265412|FG002|After 24 Months of Function|Lost to Follow-up|6|||
48842780|NCT01641198|157265410|FG000|At 15-20 Years of Function|Lost to Follow-up|5|||
48842781|NCT01641198|157265411|FG001|At 15-20 Years of Function|Lost to Follow-up|1|||
48842782|NCT01641198|157265412|FG002|At 15-20 Years of Function|Lost to Follow-up|1|||
48842783|NCT01641198|157265410|FG000|At 15-20 Years of Function|Death|1|||
48842784|NCT01641198|157265411|FG001|At 15-20 Years of Function|Death|0|||
48842785|NCT01641198|157265412|FG002|At 15-20 Years of Function|Death|1|||
48842786|NCT03737240|157265413|FG000|Overall Study|Lost to Follow-up|16|||
48842787|NCT03737240|157265414|FG001|Overall Study|Lost to Follow-up|15|||
48842788|NCT01061151|157265416|FG000|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2|||
48842789|NCT01061151|157265417|FG001|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
48842790|NCT01061151|157265418|FG002|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
48926508|NCT03605680|157563248|FG003|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2|||
48926509|NCT03605680|157563245|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
49173639|NCT01700959|158468957|FG002|Overall Study|Adverse Event|1|||
49173640|NCT01700959|158468958|FG003|Overall Study|Adverse Event|2|||
49173641|NCT01700959|158468959|FG004|Overall Study|Adverse Event|0|||
49173642|NCT01700959|158468960|FG005|Overall Study|Adverse Event|2|||
49173643|NCT01700959|158468955|FG000|Overall Study|Withdrawal by Subject|15|||
49173644|NCT01700959|158468956|FG001|Overall Study|Withdrawal by Subject|9|||
49173645|NCT01700959|158468957|FG002|Overall Study|Withdrawal by Subject|12|||
49173646|NCT01700959|158468958|FG003|Overall Study|Withdrawal by Subject|11|||
49173647|NCT01700959|158468959|FG004|Overall Study|Withdrawal by Subject|8|||
49173648|NCT01700959|158468960|FG005|Overall Study|Withdrawal by Subject|12|||
49173649|NCT01700959|158468955|FG000|Overall Study|Ineligible|2|||
49173650|NCT01700959|158468956|FG001|Overall Study|Ineligible|1|||
49173651|NCT01700959|158468957|FG002|Overall Study|Ineligible|2|||
49173652|NCT01700959|158468958|FG003|Overall Study|Ineligible|0|||
49173653|NCT01700959|158468959|FG004|Overall Study|Ineligible|0|||
49173654|NCT01700959|158468960|FG005|Overall Study|Ineligible|1|||
49173655|NCT01700959|158468955|FG000|Overall Study|Noncompliant|9|||
49173656|NCT01700959|158468956|FG001|Overall Study|Noncompliant|9|||
49173657|NCT01700959|158468957|FG002|Overall Study|Noncompliant|17|||
48926510|NCT03605680|157563246|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14|||
49173658|NCT01700959|158468958|FG003|Overall Study|Noncompliant|18|||
49173659|NCT01700959|158468959|FG004|Overall Study|Noncompliant|15|||
49173660|NCT01700959|158468960|FG005|Overall Study|Noncompliant|9|||
49173661|NCT01700959|158468955|FG000|Overall Study|Side effects|1|||
49173662|NCT01700959|158468956|FG001|Overall Study|Side effects|4|||
49173663|NCT01700959|158468957|FG002|Overall Study|Side effects|8|||
48842791|NCT01061151|157265419|FG003|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1|||
48842792|NCT01061151|157265416|FG000|Protocol Version 2.0: 04/2011-09/2012|Death|6|||
48842793|NCT01061151|157265417|FG001|Protocol Version 2.0: 04/2011-09/2012|Death|9|||
48842794|NCT01061151|157265418|FG002|Protocol Version 2.0: 04/2011-09/2012|Death|1|||
48842795|NCT01061151|157265419|FG003|Protocol Version 2.0: 04/2011-09/2012|Death|2|||
48842796|NCT01061151|157265416|FG000|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89|||
48842797|NCT01061151|157265417|FG001|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82|||
48842798|NCT01061151|157265418|FG002|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2|||
48842799|NCT01061151|157265419|FG003|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10|||
48842800|NCT01061151|157265416|FG000|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73|||
48842801|NCT01061151|157265417|FG001|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65|||
48842802|NCT01061151|157265418|FG002|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2|||
48842803|NCT01061151|157265419|FG003|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10|||
48842804|NCT01061151|157265416|FG000|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15|||
48842805|NCT01061151|157265417|FG001|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19|||
48842806|NCT01061151|157265418|FG002|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1|||
48842807|NCT01061151|157265419|FG003|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0|||
48842808|NCT01061151|157265416|FG000|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44|||
48842809|NCT01061151|157265417|FG001|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61|||
48842810|NCT01061151|157265418|FG002|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2|||
48842811|NCT01061151|157265419|FG003|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5|||
48842812|NCT01061151|157265416|FG000|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3|||
48842813|NCT01061151|157265417|FG001|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5|||
48842814|NCT01061151|157265418|FG002|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1|||
48842815|NCT01061151|157265419|FG003|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0|||
48842816|NCT01061151|157265416|FG000|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
48842817|NCT01061151|157265417|FG001|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
48842818|NCT01061151|157265418|FG002|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2|||
48842819|NCT01061151|157265419|FG003|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4|||
48842820|NCT01061151|157265416|FG000|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1|||
48842821|NCT01061151|157265417|FG001|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
48842822|NCT01061151|157265418|FG002|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
48842823|NCT01061151|157265419|FG003|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
48842824|NCT01061151|157265416|FG000|Protocol Version 3.0: 10/2012-10/2014|Death|3|||
48842825|NCT01061151|157265417|FG001|Protocol Version 3.0: 10/2012-10/2014|Death|5|||
48842826|NCT01061151|157265418|FG002|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
48842827|NCT01061151|157265419|FG003|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
48842828|NCT01061151|157265416|FG000|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54|||
48842829|NCT01061151|157265417|FG001|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52|||
48842830|NCT01061151|157265418|FG002|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31|||
48842831|NCT01061151|157265419|FG003|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3|||
48842832|NCT01061151|157265416|FG000|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49|||
48842833|NCT01061151|157265417|FG001|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36|||
48842834|NCT01061151|157265418|FG002|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25|||
48842835|NCT01061151|157265419|FG003|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4|||
48842836|NCT01061151|157265416|FG000|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12|||
48842837|NCT01061151|157265417|FG001|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11|||
49173664|NCT01700959|158468958|FG003|Overall Study|Side effects|4|||
49173665|NCT01700959|158468959|FG004|Overall Study|Side effects|4|||
49173666|NCT01700959|158468960|FG005|Overall Study|Side effects|1|||
49173667|NCT00810277|158470315|FG000|Overall Study|Adverse Event|1|||
49173668|NCT04472650|158470316|FG000|Washout Period (Minimum 14 Days)|Adverse Event|1|||
49173669|NCT04472650|158470317|FG001|Washout Period (Minimum 14 Days)|Adverse Event|0|||
49173670|NCT00559104|158470327|FG000|Overall Study|Lack of Efficacy|9|||
49173671|NCT00559104|158470328|FG001|Overall Study|Lack of Efficacy|0|||
49173672|NCT03107052|158470329|FG000|Overall Study|Adverse Event|6|||
49173673|NCT03107052|158470330|FG001|Overall Study|Adverse Event|1|||
49173674|NCT03107052|158470331|FG002|Overall Study|Adverse Event|2|||
49173675|NCT03107052|158470329|FG000|Overall Study|Withdrawal by Subject|9|||
49173676|NCT03107052|158470330|FG001|Overall Study|Withdrawal by Subject|5|||
49173677|NCT03107052|158470331|FG002|Overall Study|Withdrawal by Subject|8|||
49173678|NCT03107052|158470329|FG000|Overall Study|Protocol Violation|6|||
49173679|NCT03107052|158470330|FG001|Overall Study|Protocol Violation|0|||
49173680|NCT03107052|158470331|FG002|Overall Study|Protocol Violation|3|||
49173681|NCT03107052|158470329|FG000|Overall Study|Lost to Follow-up|4|||
49173682|NCT03107052|158470330|FG001|Overall Study|Lost to Follow-up|0|||
49173683|NCT03107052|158470331|FG002|Overall Study|Lost to Follow-up|1|||
49173684|NCT03107052|158470329|FG000|Overall Study|Lack of Efficacy|23|||
49173685|NCT03107052|158470330|FG001|Overall Study|Lack of Efficacy|7|||
48842838|NCT01061151|157265418|FG002|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2|||
48842839|NCT01061151|157265419|FG003|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0|||
48842840|NCT01061151|157265416|FG000|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28|||
48842841|NCT01061151|157265417|FG001|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26|||
48842842|NCT01061151|157265418|FG002|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15|||
48842843|NCT01061151|157265419|FG003|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5|||
48842844|NCT01061151|157265416|FG000|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5|||
48842845|NCT01061151|157265417|FG001|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8|||
48842846|NCT01061151|157265418|FG002|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1|||
48842847|NCT01061151|157265419|FG003|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3|||
48842848|NCT00535145|157265422|FG000|Phase I|Adverse Event|3|||
48842849|NCT00535145|157265422|FG000|Phase I|Lost to Follow-up|7|||
48842850|NCT00535145|157265422|FG000|Phase I|Withdrawal by Subject|6|||
48842851|NCT00535145|157265422|FG000|Phase I|(eligibility)|8|||
48842852|NCT00535145|157265422|FG000|Phase I|(protocol violation)|1|||
48842853|NCT00535145|157265422|FG000|Phase I|(PI decision)|1|||
48842854|NCT00535145|157265422|FG000|Phase I|(diagnosis)|3|||
48842855|NCT00535145|157265422|FG000|Phase II|Adverse Event|2|||
48842856|NCT00535145|157265422|FG000|Phase II|Lack of Efficacy|1|||
48842857|NCT00535145|157265422|FG000|Phase II|Lost to Follow-up|5|||
48842858|NCT00535145|157265422|FG000|Phase II|Withdrawal by Subject|5|||
48842859|NCT00535145|157265422|FG000|Phase II|Subject non-compliance|2|||
48842860|NCT01236001|157265423|FG000|Overall Study|Adverse Event|5|||
48842861|NCT01236001|157265424|FG001|Overall Study|Adverse Event|14|||
48842862|NCT01236001|157265423|FG000|Overall Study|Lack of Efficacy|6|||
48842863|NCT01236001|157265424|FG001|Overall Study|Lack of Efficacy|6|||
48842864|NCT01236001|157265423|FG000|Overall Study|Lost to Follow-up|6|||
48842865|NCT01236001|157265424|FG001|Overall Study|Lost to Follow-up|1|||
48842866|NCT01236001|157265423|FG000|Overall Study|Incompliance|1|||
48842867|NCT01236001|157265424|FG001|Overall Study|Incompliance|0|||
48842868|NCT01236001|157265423|FG000|Overall Study|Planned Visit After End of Study|0|||
48842869|NCT01236001|157265424|FG001|Overall Study|Planned Visit After End of Study|1|||
48842870|NCT01198145|157265431|FG000|Overall Study|Withdrawal by Subject|1|||
48842871|NCT01198145|157265432|FG001|Overall Study|Withdrawal by Subject|1|||
48842872|NCT01697969|157265435|FG000|Overall Study|Did not meet inc/exc criteria|3|||
48842873|NCT01127373|157265436|FG000|Overall Study|Not Treated|3|||
48842874|NCT01127373|157265436|FG000|Overall Study|Lost to Follow-up|7|||
48842875|NCT01127373|157265436|FG000|Overall Study|Withdrawal by Subject|1|||
48842876|NCT01127373|157265436|FG000|Overall Study|Disease progression|1|||
48842877|NCT01248936|157265457|FG000|Overall Study|Sponsor Decision|259|||
48842878|NCT01248936|157265457|FG000|Overall Study|Progression of Disease|50|||
48842879|NCT01248936|157265457|FG000|Overall Study|Death|26|||
48842880|NCT01248936|157265457|FG000|Overall Study|Withdrawal of Consent|20|||
48842881|NCT01248936|157265457|FG000|Overall Study|Adverse Event|8|||
48842882|NCT01248936|157265457|FG000|Overall Study|Lost to Follow-up|7|||
48842883|NCT01248936|157265457|FG000|Overall Study|Refused Treatment|1|||
48842884|NCT01248936|157265457|FG000|Overall Study|Other reason|3|||
48842885|NCT03764475|157265458|FG000|Overall Study|Adverse Event|11|||
48842886|NCT03764475|157265459|FG001|Overall Study|Adverse Event|2|||
48842887|NCT03764475|157265458|FG000|Overall Study|Lost to Follow-up|24|||
48842888|NCT03764475|157265459|FG001|Overall Study|Lost to Follow-up|10|||
48842889|NCT03764475|157265458|FG000|Overall Study|Withdrawal by Subject|26|||
48842890|NCT03764475|157265459|FG001|Overall Study|Withdrawal by Subject|10|||
48842891|NCT03764475|157265458|FG000|Overall Study|Lack of Efficacy|3|||
49173686|NCT03107052|158470331|FG002|Overall Study|Lack of Efficacy|4|||
49173687|NCT03107052|158470329|FG000|Overall Study|Other than specified|4|||
49173688|NCT03107052|158470330|FG001|Overall Study|Other than specified|2|||
49173689|NCT03107052|158470331|FG002|Overall Study|Other than specified|0|||
49173690|NCT03107052|158470329|FG000|Overall Study|Study terminated due to futility|67|||
49173691|NCT03107052|158470330|FG001|Overall Study|Study terminated due to futility|31|||
49173692|NCT03107052|158470331|FG002|Overall Study|Study terminated due to futility|23|||
49173693|NCT01734785|158470332|FG000|Open-Label Period|Adverse Event|0|||
49173694|NCT01734785|158470333|FG001|Open-Label Period|Adverse Event|0|||
49173695|NCT01734785|158470334|FG002|Open-Label Period|Adverse Event|0|||
48842892|NCT03764475|157265459|FG001|Overall Study|Lack of Efficacy|0|||
48842893|NCT03764475|157265458|FG000|Overall Study|COVID-19 Disruption|2|||
48842894|NCT03764475|157265459|FG001|Overall Study|COVID-19 Disruption|0|||
49173696|NCT01734785|158470335|FG003|Open-Label Period|Adverse Event|9|||
49173697|NCT01734785|158470332|FG000|Open-Label Period|Lack of Efficacy|0|||
48842895|NCT02238483|157265460|FG000|Overall Study|Withdrawal by Subject|2|||
48842896|NCT02238483|157265461|FG001|Overall Study|Withdrawal by Subject|7|||
48842897|NCT02238483|157265460|FG000|Overall Study|Lost to Follow-up|1|||
48842898|NCT02238483|157265461|FG001|Overall Study|Lost to Follow-up|1|||
48842899|NCT02238483|157265460|FG000|Overall Study|Protocol Violation|1|||
48842900|NCT02238483|157265461|FG001|Overall Study|Protocol Violation|2|||
48842901|NCT02238483|157265460|FG000|Overall Study|Death|1|||
48842902|NCT02238483|157265461|FG001|Overall Study|Death|0|||
48842903|NCT02238483|157265460|FG000|Overall Study|Adverse Event|7|||
48842904|NCT02238483|157265461|FG001|Overall Study|Adverse Event|3|||
48842905|NCT02238483|157265460|FG000|Overall Study|Withdrawn due to physician decision|1|||
48842906|NCT02238483|157265461|FG001|Overall Study|Withdrawn due to physician decision|0|||
48842907|NCT02238483|157265460|FG000|Overall Study|Completion status not recorded|1|||
48842908|NCT02238483|157265461|FG001|Overall Study|Completion status not recorded|1|||
48842909|NCT02238483|157265460|FG000|Overall Study|Illness in family member|1|||
48842910|NCT02238483|157265461|FG001|Overall Study|Illness in family member|0|||
48842911|NCT01771731|157265466|FG000|Overall Study|Physician Decision|1|||
48842912|NCT01771731|157265467|FG001|Overall Study|Physician Decision|0|||
49173698|NCT01734785|158470333|FG001|Open-Label Period|Lack of Efficacy|0|||
48842913|NCT01771731|157265466|FG000|Overall Study|Protocol Violation|0|||
48842914|NCT01771731|157265467|FG001|Overall Study|Protocol Violation|1|||
48842915|NCT01771731|157265466|FG000|Overall Study|Adverse event: Pain Crisis|1|||
48842916|NCT01771731|157265467|FG001|Overall Study|Adverse event: Pain Crisis|1|||
48842917|NCT01499199|157265475|FG000|Overall Study|Adverse Event|1|||
48842918|NCT01499199|157265475|FG000|Overall Study|Lack of Efficacy|1|||
48842919|NCT03069313|157265476|FG000|Overall Study|Adverse Event|5|||
48842920|NCT00716859|157265477|FG000|Overall Study|Adverse Event|4|||
48842921|NCT00716859|157265478|FG001|Overall Study|Adverse Event|1|||
48842922|NCT00716859|157265477|FG000|Overall Study|Lack of Efficacy|3|||
48842923|NCT00716859|157265478|FG001|Overall Study|Lack of Efficacy|0|||
48842924|NCT00716859|157265477|FG000|Overall Study|Withdrawal by Subject|1|||
48842925|NCT00716859|157265478|FG001|Overall Study|Withdrawal by Subject|3|||
48842926|NCT00716859|157265477|FG000|Overall Study|Not treated|1|||
49173699|NCT01734785|158470334|FG002|Open-Label Period|Lack of Efficacy|0|||
49173700|NCT01734785|158470335|FG003|Open-Label Period|Lack of Efficacy|1|||
49173701|NCT01734785|158470332|FG000|Open-Label Period|Protocol Violation|0|||
49173702|NCT01734785|158470333|FG001|Open-Label Period|Protocol Violation|0|||
49173703|NCT01734785|158470334|FG002|Open-Label Period|Protocol Violation|0|||
49173704|NCT01734785|158470335|FG003|Open-Label Period|Protocol Violation|13|||
49173705|NCT01734785|158470332|FG000|Open-Label Period|Lost to Follow-up|0|||
49173706|NCT01734785|158470333|FG001|Open-Label Period|Lost to Follow-up|0|||
49173707|NCT01734785|158470334|FG002|Open-Label Period|Lost to Follow-up|0|||
49173708|NCT01734785|158470335|FG003|Open-Label Period|Lost to Follow-up|14|||
49173709|NCT01734785|158470332|FG000|Open-Label Period|Withdrawal by Subject|0|||
49173710|NCT01734785|158470333|FG001|Open-Label Period|Withdrawal by Subject|0|||
49173711|NCT01734785|158470334|FG002|Open-Label Period|Withdrawal by Subject|0|||
49173712|NCT01734785|158470335|FG003|Open-Label Period|Withdrawal by Subject|12|||
49173713|NCT01734785|158470332|FG000|Open-Label Period|Other Reasons|0|||
49173714|NCT01734785|158470333|FG001|Open-Label Period|Other Reasons|0|||
49173715|NCT01734785|158470334|FG002|Open-Label Period|Other Reasons|0|||
49173716|NCT01734785|158470335|FG003|Open-Label Period|Other Reasons|224|||
49173717|NCT01734785|158470332|FG000|Double-Blind Period|Adverse Event|0|||
49173718|NCT01734785|158470333|FG001|Double-Blind Period|Adverse Event|3|||
49173719|NCT01734785|158470334|FG002|Double-Blind Period|Adverse Event|2|||
49173720|NCT01734785|158470335|FG003|Double-Blind Period|Adverse Event|0|||
49173721|NCT01734785|158470332|FG000|Double-Blind Period|Lack of Efficacy|0|||
49173722|NCT01734785|158470333|FG001|Double-Blind Period|Lack of Efficacy|1|||
49173723|NCT01734785|158470334|FG002|Double-Blind Period|Lack of Efficacy|0|||
49173724|NCT01734785|158470335|FG003|Double-Blind Period|Lack of Efficacy|0|||
49173725|NCT01734785|158470332|FG000|Double-Blind Period|Protocol Violation|0|||
49173726|NCT01734785|158470333|FG001|Double-Blind Period|Protocol Violation|1|||
49173727|NCT01734785|158470334|FG002|Double-Blind Period|Protocol Violation|1|||
49173728|NCT01734785|158470335|FG003|Double-Blind Period|Protocol Violation|0|||
49173729|NCT01734785|158470332|FG000|Double-Blind Period|Lost to Follow-up|2|||
49173730|NCT01734785|158470333|FG001|Double-Blind Period|Lost to Follow-up|4|||
49173731|NCT01734785|158470334|FG002|Double-Blind Period|Lost to Follow-up|2|||
49173732|NCT01734785|158470335|FG003|Double-Blind Period|Lost to Follow-up|0|||
49173733|NCT01734785|158470332|FG000|Double-Blind Period|Withdrawal by Subject|2|||
49173734|NCT01734785|158470333|FG001|Double-Blind Period|Withdrawal by Subject|0|||
49173735|NCT01734785|158470334|FG002|Double-Blind Period|Withdrawal by Subject|0|||
49173736|NCT01734785|158470335|FG003|Double-Blind Period|Withdrawal by Subject|0|||
48842927|NCT00716859|157265478|FG001|Overall Study|Not treated|1|||
48842928|NCT01109524|157265483|FG000|Overall Study|Disease Progression|29|||
48842929|NCT01109524|157265483|FG000|Overall Study|Study Drug toxicity|6|||
49173737|NCT01734785|158470332|FG000|Double-Blind Period|Not treated|1|||
49173738|NCT01734785|158470333|FG001|Double-Blind Period|Not treated|0|||
49173739|NCT01734785|158470334|FG002|Double-Blind Period|Not treated|0|||
49173740|NCT01734785|158470335|FG003|Double-Blind Period|Not treated|0|||
48842930|NCT01109524|157265483|FG000|Overall Study|Adverse Event|4|||
49173741|NCT00576628|158470339|FG000|Overall Study|Adverse Event|11|||
49173742|NCT00576628|158470339|FG000|Overall Study|Death|2|||
48926511|NCT03605680|157563247|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7|||
48926512|NCT03605680|157563248|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5|||
48926513|NCT03605680|157563245|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0|||
48926514|NCT03605680|157563246|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
48926515|NCT03605680|157563247|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
48842931|NCT01109524|157265483|FG000|Overall Study|Withdrawal by Subject|2|||
48842932|NCT01109524|157265483|FG000|Overall Study|Maximum clinical benefit|3|||
48842933|NCT01109524|157265483|FG000|Overall Study|Death|2|||
48842934|NCT01109524|157265483|FG000|Overall Study|No longer meets criteria|2|||
48842935|NCT01109524|157265483|FG000|Overall Study|Participant requested to end treatment|4|||
48842936|NCT01109524|157265483|FG000|Overall Study|Other|5|||
48842937|NCT02759016|157265484|FG000|Overall Study|Not treated with BI 836826|1|||
48842938|NCT02759016|157265485|FG001|Overall Study|Not treated with BI 836826|0|||
48842939|NCT02759016|157265484|FG000|Overall Study|Progressive disease|1|||
48842940|NCT02759016|157265485|FG001|Overall Study|Progressive disease|0|||
48842941|NCT02759016|157265484|FG000|Overall Study|SD, PR-MRDpos or PR-L|0|||
48842942|NCT02759016|157265485|FG001|Overall Study|SD, PR-MRDpos or PR-L|2|||
48842943|NCT02759016|157265484|FG000|Overall Study|Other not defined above|2|||
48842944|NCT02759016|157265485|FG001|Overall Study|Other not defined above|1|||
48842945|NCT02318134|157265486|FG000|Overall Study|Withdrawal by Subject|2|||
48842946|NCT02318134|157265487|FG001|Overall Study|Withdrawal by Subject|1|||
48842947|NCT03892564|157265492|FG000|Overall Study|Withdrawal by Subject|2|||
48842948|NCT01037985|157265493|FG000|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3|||
48842949|NCT01037985|157265494|FG001|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0|||
48926516|NCT03605680|157563248|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7|||
48926517|NCT03605680|157563245|FG000|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
48926518|NCT03605680|157563246|FG001|Double-blind Treatment Period (6 Weeks)|Physician Decision|1|||
48926519|NCT03605680|157563247|FG002|Double-blind Treatment Period (6 Weeks)|Physician Decision|2|||
48926520|NCT03605680|157563248|FG003|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
48926521|NCT03605680|157563245|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
49173743|NCT00576628|158470339|FG000|Overall Study|Failure to return|1|||
49173744|NCT00576628|158470339|FG000|Overall Study|Refused Treatment|8|||
49173745|NCT00576628|158470339|FG000|Overall Study|Pregnancy|1|||
49173746|NCT00576628|158470339|FG000|Overall Study|RBC transfusion|1|||
49173747|NCT00576628|158470339|FG000|Overall Study|Progression of Kidney Disease|1|||
49173748|NCT00576628|158470339|FG000|Overall Study|Progression of Renal Failure|1|||
49173749|NCT00576628|158470339|FG000|Overall Study|The patient move into other town|1|||
49173750|NCT00576628|158470339|FG000|Overall Study|Transplantation|1|||
49173751|NCT00576628|158470339|FG000|Overall Study|Dialysis|15|||
49173752|NCT00570778|158470340|FG000|Overall Study|Protocol deviation|2|||
49173753|NCT00570778|158470341|FG001|Overall Study|Protocol deviation|1|||
49173754|NCT00570778|158470342|FG002|Overall Study|Protocol deviation|2|||
49173755|NCT00570778|158470343|FG003|Overall Study|Protocol deviation|2|||
49173756|NCT00570778|158470340|FG000|Overall Study|Adverse Event|0|||
49173757|NCT00570778|158470341|FG001|Overall Study|Adverse Event|1|||
49173758|NCT00570778|158470342|FG002|Overall Study|Adverse Event|4|||
49173759|NCT00570778|158470343|FG003|Overall Study|Adverse Event|1|||
49173760|NCT00570778|158470340|FG000|Overall Study|Subject withdrew consent|0|||
49173761|NCT00570778|158470341|FG001|Overall Study|Subject withdrew consent|1|||
49173762|NCT00570778|158470342|FG002|Overall Study|Subject withdrew consent|0|||
49173763|NCT00570778|158470343|FG003|Overall Study|Subject withdrew consent|1|||
49173764|NCT00570778|158470340|FG000|Overall Study|Abnormal test procedure|1|||
49173765|NCT00570778|158470341|FG001|Overall Study|Abnormal test procedure|0|||
49173766|NCT00570778|158470342|FG002|Overall Study|Abnormal test procedure|0|||
49173767|NCT00570778|158470343|FG003|Overall Study|Abnormal test procedure|0|||
49173768|NCT00570778|158470340|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
49173769|NCT00570778|158470341|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
49173770|NCT00570778|158470342|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
49173771|NCT00570778|158470343|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
49173772|NCT00570778|158470340|FG000|Overall Study|Lost to Follow-up|0|||
49173773|NCT00570778|158470341|FG001|Overall Study|Lost to Follow-up|0|||
49173774|NCT00570778|158470342|FG002|Overall Study|Lost to Follow-up|1|||
49173775|NCT00570778|158470343|FG003|Overall Study|Lost to Follow-up|0|||
49173776|NCT00570778|158470340|FG000|Overall Study|Subject no longer requires study drug|0|||
49173777|NCT00570778|158470341|FG001|Overall Study|Subject no longer requires study drug|1|||
49173778|NCT00570778|158470342|FG002|Overall Study|Subject no longer requires study drug|0|||
49173779|NCT00570778|158470343|FG003|Overall Study|Subject no longer requires study drug|0|||
49173780|NCT03650413|158470344|FG000|Overall Study|Adverse Event|1|||
49173781|NCT03650413|158470344|FG000|Overall Study|Lack of Efficacy|17|||
49173782|NCT03650413|158470344|FG000|Overall Study|Other|9|||
49173783|NCT03650413|158470344|FG000|Overall Study|Physician Decision|2|||
49173784|NCT03650413|158470344|FG000|Overall Study|Study Terminated By Sponsor|16|||
49173785|NCT03650413|158470344|FG000|Overall Study|Withdrawal by Subject|16|||
49173786|NCT02516982|158470345|FG000|Overall Study|Called in to antenatal appointment|32|||
49173787|NCT02516982|158470346|FG001|Overall Study|Called in to antenatal appointment|35|||
49173788|NCT02516982|158470347|FG002|Overall Study|Called in to antenatal appointment|0|||
49173789|NCT02516982|158470348|FG003|Overall Study|Called in to antenatal appointment|0|||
49173790|NCT02516982|158470345|FG000|Overall Study|Withdrawal by Subject|0|||
49173791|NCT02516982|158470346|FG001|Overall Study|Withdrawal by Subject|0|||
49173792|NCT02516982|158470347|FG002|Overall Study|Withdrawal by Subject|1|||
49173793|NCT02516982|158470348|FG003|Overall Study|Withdrawal by Subject|2|||
49173794|NCT02516982|158470345|FG000|Overall Study|Protocol Violation|0|||
49173795|NCT02516982|158470346|FG001|Overall Study|Protocol Violation|0|||
49173796|NCT02516982|158470347|FG002|Overall Study|Protocol Violation|1|||
49173797|NCT02516982|158470348|FG003|Overall Study|Protocol Violation|1|||
49173798|NCT02516982|158470345|FG000|Overall Study|Did not install the app|0|||
49173799|NCT02516982|158470346|FG001|Overall Study|Did not install the app|0|||
49173800|NCT02516982|158470347|FG002|Overall Study|Did not install the app|46|||
49173801|NCT02516982|158470348|FG003|Overall Study|Did not install the app|47|||
49173802|NCT05507567|158470353|FG000|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
49173803|NCT05507567|158470354|FG001|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
49173804|NCT05507567|158470355|FG002|Randomised and Received Challenge Virus|Lost to Follow-up|1|||
49173805|NCT05507567|158470353|FG000|Randomised and Received Challenge Virus|Physician Decision|1|||
49173806|NCT05507567|158470354|FG001|Randomised and Received Challenge Virus|Physician Decision|0|||
49173807|NCT05507567|158470355|FG002|Randomised and Received Challenge Virus|Physician Decision|0|||
49173808|NCT05507567|158470353|FG000|Randomised and Received Challenge Virus|Did not complete quarantine|1|||
49173809|NCT05507567|158470354|FG001|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
49173810|NCT05507567|158470355|FG002|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
49173811|NCT05507567|158470353|FG000|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
49173812|NCT05507567|158470354|FG001|From Challenge Virus to End of Study|Withdrawal by Subject|2|||
49173813|NCT05507567|158470355|FG002|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
49173814|NCT02817594|158470358|FG000|Overall Study|Withdrawal by Subject|1|||
49173815|NCT02817594|158470358|FG000|Overall Study|Other|1|||
49173816|NCT02817594|158470358|FG000|Overall Study|Did Not Receive Treatment|1|||
49173817|NCT03286543|158470359|FG000|Consented|Screen failure before randomization|2|||
49173818|NCT03286543|158470360|FG001|Consented|Screen failure before randomization|0|||
49173819|NCT03286543|158470361|FG002|Consented|Screen failure before randomization|0|||
49173820|NCT03286543|158470359|FG000|Consented|Screen failure before enrollment|4|||
49173821|NCT03286543|158470360|FG001|Consented|Screen failure before enrollment|0|||
49173822|NCT03286543|158470361|FG002|Consented|Screen failure before enrollment|0|||
49173823|NCT03286543|158470359|FG000|Consented|TKA cancelled after enrollment|1|||
49173824|NCT03286543|158470360|FG001|Consented|TKA cancelled after enrollment|0|||
49173825|NCT03286543|158470361|FG002|Consented|TKA cancelled after enrollment|0|||
49173826|NCT03286543|158470359|FG000|Consented|Withdrawn from study|12|||
49173827|NCT03286543|158470360|FG001|Consented|Withdrawn from study|0|||
49173828|NCT03286543|158470361|FG002|Consented|Withdrawn from study|0|||
49173829|NCT03286543|158470359|FG000|Study Enrollment|TKA cancelled after enrollment|0|||
49173830|NCT03286543|158470360|FG001|Study Enrollment|TKA cancelled after enrollment|0|||
49173831|NCT03286543|158470361|FG002|Study Enrollment|TKA cancelled after enrollment|1|||
49173832|NCT03286543|158470359|FG000|Study Enrollment|Withdrawn from study|0|||
49173833|NCT03286543|158470360|FG001|Study Enrollment|Withdrawn from study|6|||
49173834|NCT03286543|158470361|FG002|Study Enrollment|Withdrawn from study|6|||
49173835|NCT05332392|158470362|FG000|Overall Study|Did not meet inclusion criteria|25|||
49173836|NCT05332392|158470362|FG000|Overall Study|Principal Investigator's decision|17|||
49173837|NCT05332392|158470362|FG000|Overall Study|Adverse Event|1|||
49173838|NCT05332392|158470362|FG000|Overall Study|Subject's decision|1|||
49173839|NCT03850093|158470363|FG000|Overall Study|Withdrawal by Subject|1|||
49173840|NCT03850093|158470364|FG001|Overall Study|Withdrawal by Subject|0|||
49173841|NCT03850093|158470365|FG002|Overall Study|Withdrawal by Subject|2|||
49173842|NCT02314156|158470367|FG000|Overall Study|Adverse Event|1|||
49173843|NCT02314156|158470368|FG001|Overall Study|Adverse Event|0|||
49173844|NCT02314156|158470367|FG000|Overall Study|Withdrawal by Subject|1|||
49173845|NCT02314156|158470368|FG001|Overall Study|Withdrawal by Subject|0|||
49173846|NCT02752633|158470369|FG000|Overall Study|Withdrawal by Subject|1|||
49173847|NCT02277691|158470370|FG000|Overall Study|Pretreatment Event/Adverse Event|33|||
49173848|NCT02277691|158470370|FG000|Overall Study|Voluntary Withdrawal|7|||
49173849|NCT02277691|158470370|FG000|Overall Study|Lack of Efficacy|5|||
49173850|NCT02277691|158470370|FG000|Overall Study|Used Other Antihypertensive Drug|1|||
49173851|NCT00066222|158470375|FG000|Overall Study|No protocol treatment received|1|||
49173852|NCT00405392|158470376|FG000|Overall Study|Adverse Event|15|||
49173853|NCT00405392|158470377|FG001|Overall Study|Adverse Event|14|||
49173854|NCT00405392|158470376|FG000|Overall Study|Did not meet Eligibility criteria|7|||
49173855|NCT00405392|158470377|FG001|Overall Study|Did not meet Eligibility criteria|2|||
49173856|NCT00405392|158470376|FG000|Overall Study|Withdrawal by Subject|4|||
49173857|NCT00405392|158470377|FG001|Overall Study|Withdrawal by Subject|3|||
49173858|NCT00405392|158470376|FG000|Overall Study|Lost to Follow-up|1|||
49173859|NCT00405392|158470377|FG001|Overall Study|Lost to Follow-up|2|||
49173860|NCT00405392|158470376|FG000|Overall Study|Data missing|2|||
49173861|NCT00405392|158470377|FG001|Overall Study|Data missing|0|||
48926522|NCT03605680|157563246|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5|||
48926523|NCT03605680|157563247|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4|||
48926524|NCT03605680|157563248|FG003|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3|||
48926525|NCT03605680|157563245|FG000|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0|||
49173862|NCT00405392|158470376|FG000|Overall Study|Non-compliance|0|||
49173863|NCT00405392|158470377|FG001|Overall Study|Non-compliance|1|||
49173864|NCT00405392|158470376|FG000|Overall Study|Other|1|||
49173865|NCT00405392|158470377|FG001|Overall Study|Other|5|||
49173866|NCT02684617|158470378|FG000|Overall Study|Adverse Event|1|||
49173867|NCT02684617|158470379|FG001|Overall Study|Adverse Event|0|||
49173868|NCT02684617|158470380|FG002|Overall Study|Adverse Event|1|||
49173869|NCT02684617|158470378|FG000|Overall Study|Death|8|||
49173870|NCT02684617|158470379|FG001|Overall Study|Death|16|||
49173871|NCT02684617|158470380|FG002|Overall Study|Death|28|||
49173872|NCT02684617|158470378|FG000|Overall Study|Withdrawal by Subject|2|||
49173873|NCT02684617|158470379|FG001|Overall Study|Withdrawal by Subject|0|||
49173874|NCT02684617|158470380|FG002|Overall Study|Withdrawal by Subject|4|||
49173875|NCT02684617|158470378|FG000|Overall Study|Screen Failure|1|||
49173876|NCT02684617|158470379|FG001|Overall Study|Screen Failure|0|||
49173877|NCT02684617|158470380|FG002|Overall Study|Screen Failure|2|||
49173878|NCT02684617|158470378|FG000|Overall Study|Study Terminated by Sponsor|6|||
48926526|NCT03605680|157563246|FG001|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1|||
48926527|NCT03605680|157563247|FG002|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2|||
48926528|NCT03605680|157563248|FG003|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3|||
48926529|NCT00356278|157563249|FG000|Overall Study|Withdrawal by Subject|25|||
48926530|NCT00356278|157563250|FG001|Overall Study|Withdrawal by Subject|15|||
48926531|NCT00356278|157563251|FG002|Overall Study|Withdrawal by Subject|19|||
48926532|NCT00647556|157563252|FG000|Overall Study|Adverse Event|0|||
48926533|NCT00647556|157563253|FG001|Overall Study|Adverse Event|1|||
48926534|NCT00647556|157563252|FG000|Overall Study|Lost to Follow-up|1|||
48926535|NCT00647556|157563253|FG001|Overall Study|Lost to Follow-up|0|||
48926536|NCT00647556|157563252|FG000|Overall Study|Protocol Violation|0|||
48926537|NCT00647556|157563253|FG001|Overall Study|Protocol Violation|1|||
48926538|NCT00647556|157563252|FG000|Overall Study|Withdrawal by Subject|1|||
48926539|NCT00647556|157563253|FG001|Overall Study|Withdrawal by Subject|0|||
48926540|NCT00647556|157563252|FG000|Overall Study|Surgery for pre-existing neck pain|1|||
48926541|NCT00647556|157563253|FG001|Overall Study|Surgery for pre-existing neck pain|0|||
48926542|NCT00763139|157563260|FG000|Overall Study|Adverse Event|4|||
48926543|NCT00763139|157563261|FG001|Overall Study|Adverse Event|2|||
48926544|NCT00763139|157563260|FG000|Overall Study|Withdrawal by Subject|0|||
48926545|NCT00763139|157563261|FG001|Overall Study|Withdrawal by Subject|1|||
48926546|NCT00763139|157563260|FG000|Overall Study|med change not allowed by protocol|1|||
48926547|NCT00763139|157563261|FG001|Overall Study|med change not allowed by protocol|0|||
48926548|NCT01363986|157563264|FG000|Overall Study|Disease progression|1|||
48926549|NCT02927769|157563269|FG000|Induction Phase|Study drug toxicity|1|||
48926550|NCT02927769|157563270|FG001|Induction Phase|Study drug toxicity|1|||
48926551|NCT02927769|157563269|FG000|Induction Phase|Disease progression|0|||
48926552|NCT02927769|157563270|FG001|Induction Phase|Disease progression|1|||
49173879|NCT02684617|158470379|FG001|Overall Study|Study Terminated by Sponsor|1|||
49173880|NCT02684617|158470380|FG002|Overall Study|Study Terminated by Sponsor|5|||
49173881|NCT00090779|158470383|FG000|Step 1|Withdrawal by Subject|4|||
49173882|NCT00090779|158470384|FG001|Step 1|Withdrawal by Subject|2|||
49173883|NCT00090779|158470383|FG000|Step 1|Lost to Follow-up|3|||
48926553|NCT02927769|157563269|FG000|Intensification Phase|Study drug toxicity|1|||
48926554|NCT02927769|157563270|FG001|Intensification Phase|Study drug toxicity|0|||
48926555|NCT05633953|157563272|FG000|Overall Study|Adverse Event|7|||
48926556|NCT05633953|157563272|FG000|Overall Study|Death|30|||
48926557|NCT05633953|157563272|FG000|Overall Study|Lost to Follow-up|1|||
48926558|NCT05633953|157563272|FG000|Overall Study|Osilodrostat discontinued|4|||
48926559|NCT05633953|157563272|FG000|Overall Study|Physician Decision|1|||
48926560|NCT05633953|157563272|FG000|Overall Study|Planned surgery related to Cushing Syndrome (CS)|15|||
48926561|NCT05633953|157563272|FG000|Overall Study|Progressive disease|2|||
48926562|NCT05784662|157563273|FG000|Overall Study|Lost to Follow-up|21|||
48926563|NCT05784662|157563274|FG001|Overall Study|Lost to Follow-up|17|||
48926564|NCT03665597|157563275|FG000|Period 1|Adverse Event|1|||
48926565|NCT03665597|157563276|FG001|Period 1|Adverse Event|0|||
48926566|NCT03665597|157563277|FG002|Period 1|Adverse Event|0|||
48926567|NCT03665597|157563278|FG003|Period 1|Adverse Event|1|||
48926568|NCT03665597|157563279|FG004|Period 1|Adverse Event|0|||
48926569|NCT03665597|157563280|FG005|Period 1|Adverse Event|0|||
48926570|NCT03665597|157563281|FG006|Period 1|Adverse Event|0|||
48926571|NCT03665597|157563275|FG000|Period 1|Screen Failure|0|||
48926572|NCT03665597|157563276|FG001|Period 1|Screen Failure|0|||
48926573|NCT03665597|157563277|FG002|Period 1|Screen Failure|0|||
48926574|NCT03665597|157563278|FG003|Period 1|Screen Failure|1|||
48926575|NCT03665597|157563279|FG004|Period 1|Screen Failure|0|||
48926576|NCT03665597|157563280|FG005|Period 1|Screen Failure|0|||
49173884|NCT00090779|158470384|FG001|Step 1|Lost to Follow-up|2|||
49173885|NCT00090779|158470383|FG000|Step 1|Death|0|||
49173886|NCT00090779|158470384|FG001|Step 1|Death|2|||
49173887|NCT00090779|158470383|FG000|Step 1|Physician Decision|1|||
49173888|NCT00090779|158470384|FG001|Step 1|Physician Decision|0|||
49173889|NCT00090779|158470383|FG000|Step 1|Pregnancy|1|||
49173890|NCT00090779|158470384|FG001|Step 1|Pregnancy|0|||
49173891|NCT00090779|158470383|FG000|Step 1|Non-compliance to study requirements|0|||
49173892|NCT00090779|158470384|FG001|Step 1|Non-compliance to study requirements|1|||
49173893|NCT00090779|158470383|FG000|Step 1|Subject relocated|2|||
49173894|NCT00090779|158470384|FG001|Step 1|Subject relocated|8|||
49173895|NCT00090779|158470383|FG000|Step 2|Off study per study closure|6|||
49173896|NCT00090779|158470384|FG001|Step 2|Off study per study closure|16|||
49173897|NCT00090779|158470383|FG000|Step 2|Subject relocated|0|||
49173898|NCT00090779|158470384|FG001|Step 2|Subject relocated|1|||
49173899|NCT00090779|158470383|FG000|Step 2|Non-compliance to study requirements|0|||
49173900|NCT00090779|158470384|FG001|Step 2|Non-compliance to study requirements|1|||
49173901|NCT00090779|158470383|FG000|Step 3|Initiation of ART and off extended study|3|||
49173902|NCT00090779|158470384|FG001|Step 3|Initiation of ART and off extended study|2|||
49173903|NCT00090779|158470383|FG000|Step 3|Off extended study due to study closure|4|||
49173904|NCT00090779|158470384|FG001|Step 3|Off extended study due to study closure|3|||
49173905|NCT04075513|158470394|FG000|Overall Study|Withdrawal by Subject|2|||
49173906|NCT04075513|158470395|FG001|Overall Study|Withdrawal by Subject|2|||
49173907|NCT04075513|158470394|FG000|Overall Study|Lack of Efficacy|1|||
48926577|NCT03665597|157563281|FG006|Period 1|Screen Failure|0|||
48926578|NCT03665597|157563275|FG000|Period 1|Death|0|||
48926579|NCT03665597|157563276|FG001|Period 1|Death|0|||
48926580|NCT03665597|157563277|FG002|Period 1|Death|0|||
48926581|NCT03665597|157563278|FG003|Period 1|Death|0|||
48926582|NCT03665597|157563279|FG004|Period 1|Death|0|||
48926583|NCT03665597|157563280|FG005|Period 1|Death|0|||
48926584|NCT03665597|157563281|FG006|Period 1|Death|45|||
48926585|NCT03665597|157563275|FG000|Period 1|Withdrawal by Subject|0|||
48926586|NCT03665597|157563276|FG001|Period 1|Withdrawal by Subject|0|||
48926587|NCT03665597|157563277|FG002|Period 1|Withdrawal by Subject|0|||
48926588|NCT03665597|157563278|FG003|Period 1|Withdrawal by Subject|0|||
48926589|NCT03665597|157563279|FG004|Period 1|Withdrawal by Subject|0|||
49173908|NCT04075513|158470395|FG001|Overall Study|Lack of Efficacy|0|||
48926590|NCT03665597|157563280|FG005|Period 1|Withdrawal by Subject|0|||
49173909|NCT04075513|158470394|FG000|Overall Study|Lost to Follow-up|4|||
49173910|NCT04075513|158470395|FG001|Overall Study|Lost to Follow-up|2|||
48926591|NCT03665597|157563281|FG006|Period 1|Withdrawal by Subject|5|||
48926592|NCT03665597|157563275|FG000|Period 2|Adverse Event|0|||
48926593|NCT03665597|157563276|FG001|Period 2|Adverse Event|0|||
48926594|NCT03665597|157563277|FG002|Period 2|Adverse Event|0|||
48926595|NCT03665597|157563278|FG003|Period 2|Adverse Event|0|||
48926596|NCT03665597|157563279|FG004|Period 2|Adverse Event|0|||
48926597|NCT03665597|157563280|FG005|Period 2|Adverse Event|1|||
48926598|NCT03665597|157563281|FG006|Period 2|Adverse Event|0|||
48926599|NCT03665597|157563275|FG000|Period 3|Adverse Event|0|||
48926600|NCT03665597|157563276|FG001|Period 3|Adverse Event|1|||
48926601|NCT03665597|157563277|FG002|Period 3|Adverse Event|0|||
48926602|NCT03665597|157563278|FG003|Period 3|Adverse Event|0|||
48926603|NCT03665597|157563279|FG004|Period 3|Adverse Event|0|||
48926604|NCT03665597|157563280|FG005|Period 3|Adverse Event|0|||
48926605|NCT03665597|157563281|FG006|Period 3|Adverse Event|0|||
48926606|NCT03665597|157563275|FG000|Period 3|Death|0|||
48926607|NCT03665597|157563276|FG001|Period 3|Death|0|||
48926608|NCT03665597|157563277|FG002|Period 3|Death|0|||
48926609|NCT03665597|157563278|FG003|Period 3|Death|0|||
48926610|NCT03665597|157563279|FG004|Period 3|Death|1|||
48926611|NCT03665597|157563280|FG005|Period 3|Death|0|||
48926612|NCT03665597|157563281|FG006|Period 3|Death|0|||
48926613|NCT03665597|157563275|FG000|Period 4|Adverse Event|2|||
48926614|NCT03665597|157563276|FG001|Period 4|Adverse Event|2|||
48926615|NCT03665597|157563277|FG002|Period 4|Adverse Event|2|||
48926616|NCT03665597|157563278|FG003|Period 4|Adverse Event|2|||
48926617|NCT03665597|157563279|FG004|Period 4|Adverse Event|1|||
48926618|NCT03665597|157563280|FG005|Period 4|Adverse Event|0|||
48926619|NCT03665597|157563281|FG006|Period 4|Adverse Event|0|||
48926620|NCT03665597|157563275|FG000|Period 4|Death|0|||
48926621|NCT03665597|157563276|FG001|Period 4|Death|0|||
48926622|NCT03665597|157563277|FG002|Period 4|Death|2|||
48926623|NCT03665597|157563278|FG003|Period 4|Death|0|||
48926624|NCT03665597|157563279|FG004|Period 4|Death|0|||
48926625|NCT03665597|157563280|FG005|Period 4|Death|0|||
48926626|NCT03665597|157563281|FG006|Period 4|Death|0|||
48926627|NCT03665597|157563275|FG000|Period 4|Physician Decision|1|||
48926628|NCT03665597|157563276|FG001|Period 4|Physician Decision|2|||
48926629|NCT03665597|157563277|FG002|Period 4|Physician Decision|0|||
48926630|NCT03665597|157563278|FG003|Period 4|Physician Decision|0|||
48926631|NCT03665597|157563279|FG004|Period 4|Physician Decision|0|||
49173911|NCT04075513|158470394|FG000|Overall Study|Switch to insulin pump|1|||
49173912|NCT04075513|158470395|FG001|Overall Study|Switch to insulin pump|0|||
49173913|NCT01524224|158470400|FG000|Overall Study|Progressive Disease|1|||
49173914|NCT01524224|158470401|FG001|Overall Study|Progressive Disease|0|||
49173915|NCT01524224|158470402|FG002|Overall Study|Progressive Disease|2|||
49173916|NCT01524224|158470403|FG003|Overall Study|Progressive Disease|1|||
49173917|NCT01524224|158470404|FG004|Overall Study|Progressive Disease|2|||
49173918|NCT01524224|158470405|FG005|Overall Study|Progressive Disease|1|||
49173919|NCT01524224|158470406|FG006|Overall Study|Progressive Disease|1|||
49173920|NCT01524224|158470407|FG007|Overall Study|Progressive Disease|5|||
49173921|NCT01524224|158470400|FG000|Overall Study|Withdrawal by Subject|2|||
49173922|NCT01524224|158470401|FG001|Overall Study|Withdrawal by Subject|0|||
49173923|NCT01524224|158470402|FG002|Overall Study|Withdrawal by Subject|0|||
49173924|NCT01524224|158470403|FG003|Overall Study|Withdrawal by Subject|0|||
49173925|NCT01524224|158470404|FG004|Overall Study|Withdrawal by Subject|0|||
49173926|NCT01524224|158470405|FG005|Overall Study|Withdrawal by Subject|0|||
49173927|NCT01524224|158470406|FG006|Overall Study|Withdrawal by Subject|2|||
49173928|NCT01524224|158470407|FG007|Overall Study|Withdrawal by Subject|0|||
49173929|NCT01524224|158470400|FG000|Overall Study|Adverse Event|0|||
49173930|NCT01524224|158470401|FG001|Overall Study|Adverse Event|1|||
49173931|NCT01524224|158470402|FG002|Overall Study|Adverse Event|0|||
49173932|NCT01524224|158470403|FG003|Overall Study|Adverse Event|0|||
49173933|NCT01524224|158470404|FG004|Overall Study|Adverse Event|0|||
49173934|NCT01524224|158470405|FG005|Overall Study|Adverse Event|1|||
49173935|NCT01524224|158470406|FG006|Overall Study|Adverse Event|0|||
49173936|NCT01524224|158470407|FG007|Overall Study|Adverse Event|0|||
49173937|NCT01524224|158470400|FG000|Overall Study|Physician Decision|0|||
49173938|NCT01524224|158470401|FG001|Overall Study|Physician Decision|0|||
49173939|NCT01524224|158470402|FG002|Overall Study|Physician Decision|0|||
49173940|NCT01524224|158470403|FG003|Overall Study|Physician Decision|1|||
49173941|NCT01524224|158470404|FG004|Overall Study|Physician Decision|1|||
49173942|NCT01524224|158470405|FG005|Overall Study|Physician Decision|0|||
49173943|NCT01524224|158470406|FG006|Overall Study|Physician Decision|0|||
49173944|NCT01524224|158470407|FG007|Overall Study|Physician Decision|1|||
49173945|NCT01524224|158470400|FG000|Overall Study|Sponsor Decision|0|||
49173946|NCT01524224|158470401|FG001|Overall Study|Sponsor Decision|0|||
48926632|NCT03665597|157563280|FG005|Period 4|Physician Decision|0|||
48842950|NCT01037985|157265493|FG000|Part A: Skin Testing (50 Days)|Physician Decision|1|||
48842951|NCT01037985|157265494|FG001|Part A: Skin Testing (50 Days)|Physician Decision|0|||
48842952|NCT01037985|157265493|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0|||
48842953|NCT01037985|157265494|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1|||
48926633|NCT03665597|157563281|FG006|Period 4|Physician Decision|0|||
49173947|NCT01524224|158470402|FG002|Overall Study|Sponsor Decision|0|||
49173948|NCT01524224|158470403|FG003|Overall Study|Sponsor Decision|0|||
49173949|NCT01524224|158470404|FG004|Overall Study|Sponsor Decision|1|||
49173950|NCT01524224|158470405|FG005|Overall Study|Sponsor Decision|0|||
49173951|NCT01524224|158470406|FG006|Overall Study|Sponsor Decision|0|||
49173952|NCT01524224|158470407|FG007|Overall Study|Sponsor Decision|0|||
49173953|NCT01523743|158470411|FG000|Period 1|Adverse Event|1|||
49173954|NCT01523743|158470412|FG001|Period 1|Adverse Event|0|||
48842954|NCT01037985|157265493|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0|||
49173955|NCT01523743|158470411|FG000|Period 1|Withdrawal by Subject|6|||
48842955|NCT01037985|157265494|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4|||
48842956|NCT03664960|157265495|FG000|Overall Study|Adverse Event|0|||
48842957|NCT03664960|157265496|FG001|Overall Study|Adverse Event|3|||
49173956|NCT01523743|158470412|FG001|Period 1|Withdrawal by Subject|2|||
49173957|NCT01523743|158470411|FG000|Period 1|Lost to Follow-up|1|||
49173958|NCT01523743|158470412|FG001|Period 1|Lost to Follow-up|0|||
48926634|NCT03701399|157563282|FG000|Overall Study|Adverse Event|3|||
49173959|NCT01523743|158470411|FG000|Period 1|Lack of Efficacy|1|||
49173960|NCT01523743|158470412|FG001|Period 1|Lack of Efficacy|0|||
49173961|NCT01523743|158470411|FG000|Period 1|Felt unable to empty bladder|1|||
49173962|NCT01523743|158470412|FG001|Period 1|Felt unable to empty bladder|0|||
49173963|NCT01523743|158470411|FG000|Period 2|Withdrawal by Subject|0|||
49173964|NCT01523743|158470412|FG001|Period 2|Withdrawal by Subject|2|||
49173965|NCT01523743|158470411|FG000|Period 2|Adverse Event|1|||
49173966|NCT01523743|158470412|FG001|Period 2|Adverse Event|0|||
49173967|NCT02569476|158470414|FG000|Overall Study|Roll over to Long-Term Extension Study|73|||
49173968|NCT02569476|158470414|FG000|Overall Study|Death|33|||
49173969|NCT02569476|158470414|FG000|Overall Study|Withdrawal by Subject|9|||
49173970|NCT02569476|158470414|FG000|Overall Study|Progressive disease at study withdrawal and death by end of study|1|||
49173971|NCT02569476|158470414|FG000|Overall Study|Palliative care|1|||
49173972|NCT02569476|158470414|FG000|Overall Study|Transitioned to Long Term Follow Up Study|1|||
49173973|NCT02569476|158470414|FG000|Overall Study|Transitioned to Long Term Extension Study|1|||
49173974|NCT00395486|158470415|FG000|Overall Study|Adverse Event|1|||
49173975|NCT00395486|158470416|FG001|Overall Study|Adverse Event|2|||
49173976|NCT00395486|158470415|FG000|Overall Study|Withdrawal by Subject|5|||
49173977|NCT00395486|158470416|FG001|Overall Study|Withdrawal by Subject|2|||
49173978|NCT00395486|158470415|FG000|Overall Study|Lost to Follow-up|0|||
49173979|NCT00395486|158470416|FG001|Overall Study|Lost to Follow-up|1|||
49173980|NCT03594747|158470425|FG000|Overall Study|Death|78|||
49173981|NCT03594747|158470426|FG001|Overall Study|Death|86|||
49173982|NCT03594747|158470427|FG002|Overall Study|Death|87|||
49173983|NCT03594747|158470425|FG000|Overall Study|Withdrawal by Subject|5|||
49173984|NCT03594747|158470426|FG001|Overall Study|Withdrawal by Subject|2|||
49173985|NCT03594747|158470427|FG002|Overall Study|Withdrawal by Subject|11|||
49173986|NCT03594747|158470425|FG000|Overall Study|Lost to Follow-up|4|||
49173987|NCT03594747|158470426|FG001|Overall Study|Lost to Follow-up|1|||
49173988|NCT03594747|158470427|FG002|Overall Study|Lost to Follow-up|1|||
49173989|NCT03594747|158470425|FG000|Overall Study|Physician Decision|0|||
49173990|NCT03594747|158470426|FG001|Overall Study|Physician Decision|1|||
49173991|NCT03594747|158470427|FG002|Overall Study|Physician Decision|0|||
49173992|NCT03594747|158470425|FG000|Overall Study|Sponsor decision|23|||
49173993|NCT03594747|158470426|FG001|Overall Study|Sponsor decision|17|||
49173994|NCT03594747|158470427|FG002|Overall Study|Sponsor decision|16|||
49173995|NCT03594747|158470425|FG000|Overall Study|Did not meet inclusion criteria|0|||
49173996|NCT03594747|158470426|FG001|Overall Study|Did not meet inclusion criteria|0|||
49173997|NCT03594747|158470427|FG002|Overall Study|Did not meet inclusion criteria|1|||
49173998|NCT03594747|158470425|FG000|Overall Study|Transfer to long term extension study|10|||
49173999|NCT03594747|158470426|FG001|Overall Study|Transfer to long term extension study|12|||
49174000|NCT03594747|158470427|FG002|Overall Study|Transfer to long term extension study|5|||
49174001|NCT00005947|158470428|FG000|Overall Study|Death|54|||
49174002|NCT00005947|158470429|FG001|Overall Study|Death|40|||
49174003|NCT00005947|158470428|FG000|Overall Study|Patient Refused to Continue|2|||
49174004|NCT00005947|158470429|FG001|Overall Study|Patient Refused to Continue|1|||
49174005|NCT00005947|158470428|FG000|Overall Study|Site Closure|1|||
49174006|NCT00005947|158470429|FG001|Overall Study|Site Closure|0|||
49174007|NCT02265536|158470430|FG000|Overall Study|Adverse Event|1|||
49174008|NCT02265536|158470431|FG001|Overall Study|Adverse Event|0|||
49174009|NCT02265536|158470432|FG002|Overall Study|Adverse Event|0|||
49174010|NCT02265536|158470433|FG003|Overall Study|Adverse Event|0|||
49174011|NCT02265536|158470434|FG004|Overall Study|Adverse Event|1|||
49174012|NCT02265536|158470435|FG005|Overall Study|Adverse Event|0|||
49174013|NCT02265536|158470430|FG000|Overall Study|Physician Decision|0|||
49174014|NCT02265536|158470431|FG001|Overall Study|Physician Decision|0|||
49174015|NCT02265536|158470432|FG002|Overall Study|Physician Decision|0|||
49174016|NCT02265536|158470433|FG003|Overall Study|Physician Decision|0|||
49174017|NCT02265536|158470434|FG004|Overall Study|Physician Decision|2|||
49174018|NCT02265536|158470435|FG005|Overall Study|Physician Decision|0|||
49174019|NCT02265536|158470430|FG000|Overall Study|Withdrawal by Subject|0|||
49174020|NCT02265536|158470431|FG001|Overall Study|Withdrawal by Subject|3|||
49174021|NCT02265536|158470432|FG002|Overall Study|Withdrawal by Subject|0|||
49174022|NCT02265536|158470433|FG003|Overall Study|Withdrawal by Subject|0|||
49174023|NCT02265536|158470434|FG004|Overall Study|Withdrawal by Subject|0|||
49174024|NCT02265536|158470435|FG005|Overall Study|Withdrawal by Subject|0|||
49174025|NCT00349349|158470436|FG000|Overall Study|Adverse Event|5|||
49174026|NCT00349349|158470437|FG001|Overall Study|Adverse Event|6|||
49174027|NCT00349349|158470438|FG002|Overall Study|Adverse Event|2|||
49174028|NCT00349349|158470436|FG000|Overall Study|Withdrawal by Subject|5|||
49174029|NCT00349349|158470437|FG001|Overall Study|Withdrawal by Subject|2|||
49174030|NCT00349349|158470438|FG002|Overall Study|Withdrawal by Subject|1|||
49174031|NCT00349349|158470436|FG000|Overall Study|Withdrawn due to Disease Progression|27|||
49174032|NCT00349349|158470437|FG001|Overall Study|Withdrawn due to Disease Progression|37|||
49174033|NCT00349349|158470438|FG002|Overall Study|Withdrawn due to Disease Progression|1|||
49174034|NCT00349349|158470436|FG000|Overall Study|Death|13|||
49174035|NCT00349349|158470437|FG001|Overall Study|Death|10|||
49174036|NCT00349349|158470438|FG002|Overall Study|Death|1|||
49174037|NCT00349349|158470436|FG000|Overall Study|Other Treatment Selected|2|||
49174038|NCT00349349|158470437|FG001|Overall Study|Other Treatment Selected|0|||
49174039|NCT00349349|158470438|FG002|Overall Study|Other Treatment Selected|0|||
49174040|NCT00349349|158470436|FG000|Overall Study|Participant Reduced General Condition|0|||
49174041|NCT00349349|158470437|FG001|Overall Study|Participant Reduced General Condition|1|||
49174042|NCT00349349|158470438|FG002|Overall Study|Participant Reduced General Condition|0|||
49174043|NCT00349349|158470436|FG000|Overall Study|Physician Decision|1|||
49174044|NCT00349349|158470437|FG001|Overall Study|Physician Decision|2|||
49174045|NCT00349349|158470438|FG002|Overall Study|Physician Decision|1|||
49174046|NCT00349349|158470436|FG000|Overall Study|No Response|0|||
49174047|NCT00349349|158470437|FG001|Overall Study|No Response|3|||
49174048|NCT00349349|158470438|FG002|Overall Study|No Response|0|||
49174049|NCT00349349|158470436|FG000|Overall Study|New Malignancy (Bladder Cancer)|0|||
49174050|NCT00349349|158470437|FG001|Overall Study|New Malignancy (Bladder Cancer)|1|||
49174051|NCT00349349|158470438|FG002|Overall Study|New Malignancy (Bladder Cancer)|0|||
49174052|NCT03028415|158470439|FG000|Overall Study|Lost to Follow-up|6|||
49174053|NCT03028415|158470440|FG001|Overall Study|Lost to Follow-up|3|||
49174054|NCT03028415|158470439|FG000|Overall Study|Withdrawal by Subject|1|||
49174055|NCT03028415|158470440|FG001|Overall Study|Withdrawal by Subject|0|||
49174056|NCT03028415|158470439|FG000|Overall Study|Discontinued due to COVID-19|1|||
49174057|NCT03028415|158470440|FG001|Overall Study|Discontinued due to COVID-19|0|||
49174058|NCT02907216|158470441|FG000|Overall Study|No benefit to be obtained by continuing|0|||
49174059|NCT02907216|158470442|FG001|Overall Study|No benefit to be obtained by continuing|1|||
49174060|NCT02907216|158470441|FG000|Overall Study|Withdrawal by Subject|1|||
49174061|NCT02907216|158470442|FG001|Overall Study|Withdrawal by Subject|0|||
49174062|NCT04601532|158470445|FG000|Overall Study|Lost to Follow-up|1|||
49174063|NCT04601532|158470446|FG001|Overall Study|Lost to Follow-up|2|||
49174064|NCT04601532|158470445|FG000|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|1|||
49174065|NCT04601532|158470446|FG001|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|0|||
49174066|NCT02485639|158470447|FG000|Overall Study|8 participants did not complete study. Study halted due to CoronaVIrus Disease COVID-19 pandemic.|8|||
49174067|NCT02485639|158470447|FG000|Overall Study|Early termination|4|||
49174068|NCT02485639|158470447|FG000|Overall Study|Withdrawal by Subject|4|||
49174069|NCT03941964|158470448|FG000|Overall Study|Adverse Event|1|||
49174070|NCT03941964|158470449|FG001|Overall Study|Adverse Event|8|||
49174071|NCT03941964|158470448|FG000|Overall Study|Progressive disease|7|||
49174072|NCT03941964|158470449|FG001|Overall Study|Progressive disease|3|||
49174073|NCT03941964|158470448|FG000|Overall Study|Lack of Efficacy|0|||
49174074|NCT03941964|158470449|FG001|Overall Study|Lack of Efficacy|1|||
49174075|NCT03941964|158470448|FG000|Overall Study|Death|3|||
49174076|NCT03941964|158470449|FG001|Overall Study|Death|1|||
49174077|NCT03941964|158470448|FG000|Overall Study|Withdrew consent|1|||
49174078|NCT03941964|158470449|FG001|Overall Study|Withdrew consent|3|||
49174079|NCT03941964|158470448|FG000|Overall Study|Physician Decision|9|||
48842958|NCT03664960|157265495|FG000|Overall Study|Lost to Follow-up|3|||
48842959|NCT03664960|157265496|FG001|Overall Study|Lost to Follow-up|2|||
48842960|NCT03664960|157265495|FG000|Overall Study|Physician Decision|1|||
49174080|NCT03941964|158470449|FG001|Overall Study|Physician Decision|2|||
49174081|NCT03941964|158470448|FG000|Overall Study|Other, not specified|2|||
49174082|NCT03941964|158470449|FG001|Overall Study|Other, not specified|1|||
49015157|NCT02884206|157892062|FG001|Double-Blind Period|Non-compliance with study treatment|0|||
49015158|NCT02884206|157892063|FG002|Double-Blind Period|Non-compliance with study treatment|1|||
49015159|NCT01107535|157892071|FG000|Overall Study|Death|5|||
49015160|NCT01214603|157892081|FG000|Overall Study|Adverse Event|0|||
49015161|NCT01214603|157892082|FG001|Overall Study|Adverse Event|0|||
49015162|NCT01214603|157892083|FG002|Overall Study|Adverse Event|1|||
49015163|NCT01214603|157892081|FG000|Overall Study|Death|1|||
49015164|NCT01214603|157892082|FG001|Overall Study|Death|0|||
49015165|NCT01214603|157892083|FG002|Overall Study|Death|0|||
49015166|NCT01214603|157892081|FG000|Overall Study|Progressive Disease|4|||
49015167|NCT01214603|157892082|FG001|Overall Study|Progressive Disease|1|||
49015168|NCT01214603|157892083|FG002|Overall Study|Progressive Disease|3|||
49015169|NCT00384033|157892084|FG000|Overall Study|Adverse Event|10|||
49015170|NCT00384033|157892085|FG001|Overall Study|Adverse Event|8|||
49015171|NCT00384033|157892086|FG002|Overall Study|Adverse Event|11|||
49015172|NCT00384033|157892087|FG003|Overall Study|Adverse Event|20|||
49015173|NCT00384033|157892084|FG000|Overall Study|Failed to return|1|||
49015174|NCT00384033|157892085|FG001|Overall Study|Failed to return|3|||
48926635|NCT03701399|157563283|FG001|Overall Study|Adverse Event|5|||
48926636|NCT03701399|157563282|FG000|Overall Study|Withdrawal by Subject|6|||
48926637|NCT03701399|157563283|FG001|Overall Study|Withdrawal by Subject|3|||
48926638|NCT03701399|157563282|FG000|Overall Study|Investigators decision|1|||
48926639|NCT03701399|157563283|FG001|Overall Study|Investigators decision|2|||
48926640|NCT03701399|157563282|FG000|Overall Study|Lost to Follow-up|1|||
48926641|NCT03701399|157563283|FG001|Overall Study|Lost to Follow-up|2|||
48926642|NCT03701399|157563282|FG000|Overall Study|Death|1|||
48926643|NCT03701399|157563283|FG001|Overall Study|Death|1|||
48926644|NCT03701399|157563282|FG000|Overall Study|Randomized but not treated|1|||
48926645|NCT03701399|157563283|FG001|Overall Study|Randomized but not treated|0|||
48926646|NCT01842542|157563286|FG000|Overall Study|Withdrawal by Subject|2|||
48926647|NCT01842542|157563286|FG000|Overall Study|Lack of Efficacy|1|||
48926648|NCT01842542|157563286|FG000|Overall Study|Protocol Non-compliance|2|||
48926649|NCT01842542|157563286|FG000|Overall Study|Lost to Follow-up|1|||
48926650|NCT01562548|157563289|FG000|Overall Study|Lost to Follow-up|0|||
48926651|NCT01562548|157563290|FG001|Overall Study|Lost to Follow-up|0|||
48926652|NCT01562548|157563291|FG002|Overall Study|Lost to Follow-up|1|||
48926653|NCT01562548|157563292|FG003|Overall Study|Lost to Follow-up|0|||
48926654|NCT01587079|157563293|FG000|Overall Study|Protocol-specified criteria|9|||
48926655|NCT01587079|157563293|FG000|Overall Study|Protocol Violation|5|||
48926656|NCT01587079|157563293|FG000|Overall Study|Lost to Follow-up|2|||
48926657|NCT01587079|157563293|FG000|Overall Study|Physician Decision|2|||
48926658|NCT01587079|157563293|FG000|Overall Study|Withdrawal by Subject|7|||
48926659|NCT01587079|157563293|FG000|Overall Study|Adverse Event|14|||
49174083|NCT01659996|158470452|FG000|Overall Study|Protocol Violation|3|||
49174084|NCT01659996|158470453|FG001|Overall Study|Protocol Violation|3|||
49174085|NCT01659996|158470454|FG002|Overall Study|Protocol Violation|3|||
49174086|NCT01659996|158470452|FG000|Overall Study|Lost to Follow-up|1|||
49174087|NCT01659996|158470453|FG001|Overall Study|Lost to Follow-up|3|||
49174088|NCT01659996|158470454|FG002|Overall Study|Lost to Follow-up|2|||
49174089|NCT01659996|158470452|FG000|Overall Study|Adverse Event|0|||
49174090|NCT01659996|158470453|FG001|Overall Study|Adverse Event|0|||
49174091|NCT01659996|158470454|FG002|Overall Study|Adverse Event|1|||
49174092|NCT01659996|158470452|FG000|Overall Study|Withdrawal by Subject|4|||
49174093|NCT01659996|158470453|FG001|Overall Study|Withdrawal by Subject|1|||
49174094|NCT01659996|158470454|FG002|Overall Study|Withdrawal by Subject|5|||
49174095|NCT03206918|158470455|FG000|Overall Study|Death|11|||
49174096|NCT03206918|158470455|FG000|Overall Study|Withdrawal by Subject|5|||
49174097|NCT03206918|158470455|FG000|Overall Study|Study terminated by sponsor|12|||
49174098|NCT03206918|158470455|FG000|Overall Study|Lost to Follow-up|3|||
49174099|NCT03206918|158470455|FG000|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60|||
49174100|NCT04790279|158471743|FG000|Overall Study|Did not meet medication start criteria|27|||
49174101|NCT04790279|158471744|FG001|Overall Study|Did not meet medication start criteria|15|||
49174102|NCT04790279|158471743|FG000|Overall Study|Required long acting antihypertensive intrapartum|1|||
49174103|NCT04790279|158471744|FG001|Overall Study|Required long acting antihypertensive intrapartum|0|||
49174104|NCT04790279|158471743|FG000|Overall Study|Protocol Violation|8|||
49174105|NCT04790279|158471744|FG001|Overall Study|Protocol Violation|3|||
49174106|NCT04790279|158471743|FG000|Overall Study|Developed complication requiring alternative regimen|0|||
49174107|NCT04790279|158471744|FG001|Overall Study|Developed complication requiring alternative regimen|1|||
49174108|NCT00316706|158471745|FG000|Overall Study|Lost to Follow-up|38|||
49174109|NCT00316706|158471746|FG001|Overall Study|Lost to Follow-up|48|||
49174110|NCT03640325|158471747|FG000|Overall Study|Withdrawal by Subject|4|||
49174111|NCT03640325|158471748|FG001|Overall Study|Withdrawal by Subject|1|||
49174112|NCT03640325|158471749|FG002|Overall Study|Withdrawal by Subject|0|||
49174113|NCT03640325|158471747|FG000|Overall Study|Lost to Follow-up|4|||
49174114|NCT03640325|158471748|FG001|Overall Study|Lost to Follow-up|5|||
49174115|NCT03640325|158471749|FG002|Overall Study|Lost to Follow-up|21|||
49174116|NCT03640325|158471747|FG000|Overall Study|Death|5|||
49174117|NCT03640325|158471748|FG001|Overall Study|Death|5|||
49174118|NCT03640325|158471749|FG002|Overall Study|Death|0|||
49174119|NCT03493451|158471750|FG000|Overall Study|Death|11|||
49174120|NCT03493451|158471751|FG001|Overall Study|Death|26|||
49174121|NCT03493451|158471752|FG002|Overall Study|Death|3|||
49174122|NCT03493451|158471750|FG000|Overall Study|Lost to Follow-up|1|||
49174123|NCT03493451|158471751|FG001|Overall Study|Lost to Follow-up|4|||
49174124|NCT03493451|158471752|FG002|Overall Study|Lost to Follow-up|1|||
49174125|NCT03493451|158471750|FG000|Overall Study|Withdrawal by Subject|1|||
49174126|NCT03493451|158471751|FG001|Overall Study|Withdrawal by Subject|1|||
49174127|NCT03493451|158471752|FG002|Overall Study|Withdrawal by Subject|2|||
49174128|NCT03493451|158471750|FG000|Overall Study|Progressive Disease|1|||
49174129|NCT03493451|158471751|FG001|Overall Study|Progressive Disease|0|||
49174130|NCT03493451|158471752|FG002|Overall Study|Progressive Disease|0|||
49174131|NCT03493451|158471750|FG000|Overall Study|Transferred to long term extension study|8|||
49174132|NCT03493451|158471751|FG001|Overall Study|Transferred to long term extension study|13|||
49174133|NCT03493451|158471752|FG002|Overall Study|Transferred to long term extension study|5|||
49174134|NCT01133756|158471753|FG000|Overall Study|Adverse Event|1|||
49174135|NCT01133756|158471754|FG001|Overall Study|Adverse Event|2|||
49174136|NCT01133756|158471755|FG002|Overall Study|Adverse Event|1|||
49174137|NCT01133756|158471753|FG000|Overall Study|Investigator Decision|1|||
49174138|NCT01133756|158471754|FG001|Overall Study|Investigator Decision|0|||
49174139|NCT01133756|158471755|FG002|Overall Study|Investigator Decision|0|||
49174140|NCT01133756|158471753|FG000|Overall Study|Withdrawal by Subject|0|||
49174141|NCT01133756|158471754|FG001|Overall Study|Withdrawal by Subject|1|||
49174142|NCT01133756|158471755|FG002|Overall Study|Withdrawal by Subject|0|||
49174143|NCT01133756|158471753|FG000|Overall Study|Progression of Disease|0|||
49174144|NCT01133756|158471754|FG001|Overall Study|Progression of Disease|0|||
49174145|NCT01133756|158471755|FG002|Overall Study|Progression of Disease|1|||
49174146|NCT01566149|158471756|FG000|Overall Study|Adverse Event|0|||
49174147|NCT01566149|158471757|FG001|Overall Study|Adverse Event|1|||
49174148|NCT01566149|158471756|FG000|Overall Study|Non-compliance with study medication|2|||
49174149|NCT01566149|158471757|FG001|Overall Study|Non-compliance with study medication|0|||
49174150|NCT01566149|158471756|FG000|Overall Study|Protocol Violation|0|||
49174151|NCT01566149|158471757|FG001|Overall Study|Protocol Violation|1|||
49174152|NCT01566149|158471756|FG000|Overall Study|Withdrawal by Subject|1|||
49174153|NCT01566149|158471757|FG001|Overall Study|Withdrawal by Subject|0|||
49174154|NCT03430843|158471762|FG000|Overall Study|Death|233|||
49174155|NCT03430843|158471763|FG001|Overall Study|Death|233|||
49174156|NCT03430843|158471762|FG000|Overall Study|Sponsor Decision|17|||
49174157|NCT03430843|158471763|FG001|Overall Study|Sponsor Decision|6|||
49174158|NCT03430843|158471762|FG000|Overall Study|Withdrawal by Subject|5|||
49174159|NCT03430843|158471763|FG001|Overall Study|Withdrawal by Subject|14|||
49174160|NCT03430843|158471762|FG000|Overall Study|Lost to Follow-up|1|||
49174161|NCT03430843|158471763|FG001|Overall Study|Lost to Follow-up|3|||
49174162|NCT02222688|158471764|FG000|Overall Study|Withdrawal by Subject|0|||
49174163|NCT02222688|158471765|FG001|Overall Study|Withdrawal by Subject|0|||
49174164|NCT02222688|158471766|FG002|Overall Study|Withdrawal by Subject|0|||
49174165|NCT02222688|158471767|FG003|Overall Study|Withdrawal by Subject|2|||
49174166|NCT02222688|158471768|FG004|Overall Study|Withdrawal by Subject|1|||
49174167|NCT02222688|158471769|FG005|Overall Study|Withdrawal by Subject|0|||
49174168|NCT02222688|158471770|FG006|Overall Study|Withdrawal by Subject|1|||
49174169|NCT02222688|158471764|FG000|Overall Study|Disease progression|1|||
49174170|NCT02222688|158471765|FG001|Overall Study|Disease progression|0|||
49174171|NCT02222688|158471766|FG002|Overall Study|Disease progression|0|||
49174172|NCT02222688|158471767|FG003|Overall Study|Disease progression|0|||
48842961|NCT03664960|157265496|FG001|Overall Study|Physician Decision|0|||
49174173|NCT02222688|158471768|FG004|Overall Study|Disease progression|0|||
49174174|NCT02222688|158471769|FG005|Overall Study|Disease progression|0|||
49174175|NCT02222688|158471770|FG006|Overall Study|Disease progression|0|||
49174176|NCT03145064|158471773|FG000|Overall Study|Death|24|||
49174177|NCT03145064|158471773|FG000|Overall Study|Lost to Follow-up|3|||
48842962|NCT03664960|157265495|FG000|Overall Study|Withdrawal by Subject|3|||
48842963|NCT03664960|157265496|FG001|Overall Study|Withdrawal by Subject|14|||
48842964|NCT03664960|157265495|FG000|Overall Study|Sponsor Decision|1|||
48842965|NCT03664960|157265496|FG001|Overall Study|Sponsor Decision|1|||
48842966|NCT03664960|157265495|FG000|Overall Study|Other|1|||
49174178|NCT03145064|158471773|FG000|Overall Study|Withdrawal by Subject|6|||
49174179|NCT03145064|158471773|FG000|Overall Study|Study ended by sponsor once primary/ secondary analysis was complete and participants discontinued|4|||
49174180|NCT03145064|158471773|FG000|Overall Study|Other: Transferred to Long term Extension (LTE) study BGB-3111-LTE1 (NCT04170283)|4|||
49174181|NCT02543281|158471774|FG000|Overall Study|Lost to Follow-up|0|||
49174182|NCT02543281|158471775|FG001|Overall Study|Lost to Follow-up|0|||
49174183|NCT02543281|158471776|FG002|Overall Study|Lost to Follow-up|1|||
49174184|NCT01961297|158471777|FG000|Overall Study|unconfirmed diagnosis of SD|2|||
49174185|NCT01961297|158471778|FG001|Overall Study|unconfirmed diagnosis of SD|1|||
49174186|NCT02923830|158471779|FG000|Overall Study|Physician Decision|13|||
49174187|NCT02923830|158471780|FG001|Overall Study|Physician Decision|15|||
49174188|NCT00623233|158471781|FG000|Overall Study|Adverse Event|10|||
48842967|NCT03664960|157265496|FG001|Overall Study|Other|2|||
48842968|NCT01188655|157267237|FG000|Overall Study|Lack of Efficacy|1|||
48842969|NCT01188655|157267237|FG000|Overall Study|Lost to Follow-up|1|||
48842970|NCT01188655|157267237|FG000|Overall Study|Other|11|||
48842971|NCT00493649|157267238|FG000|Overall Study|Adverse Event|44|||
48842972|NCT00493649|157267238|FG000|Overall Study|Patient Request|21|||
48842973|NCT00493649|157267238|FG000|Overall Study|Investigator Request|2|||
48842974|NCT00493649|157267238|FG000|Overall Study|Disease Progression|1|||
48842975|NCT00493649|157267238|FG000|Overall Study|Lost to Follow-up|1|||
48842976|NCT00493649|157267238|FG000|Overall Study|Other|13|||
49174189|NCT00623233|158471781|FG000|Overall Study|Physician Decision|10|||
49174190|NCT00623233|158471781|FG000|Overall Study|Lost to Follow-up|1|||
48842977|NCT00925899|157267241|FG000|Part 1|Death|1|||
48842978|NCT00925899|157267242|FG001|Part 1|Death|2|||
48842979|NCT00925899|157267241|FG000|Part 1|Withdrawal by Subject|10|||
48842980|NCT00925899|157267242|FG001|Part 1|Withdrawal by Subject|9|||
48842981|NCT03287622|157267245|FG000|Overall Study|Withdrawal by Subject|1|||
48842982|NCT03287622|157267246|FG001|Overall Study|Withdrawal by Subject|0|||
48842983|NCT03287622|157267245|FG000|Overall Study|Lost to Follow-up|27|||
48842984|NCT03287622|157267246|FG001|Overall Study|Lost to Follow-up|15|||
48842985|NCT03287622|157267245|FG000|Overall Study|No prescripion after surgery|28|||
48842986|NCT03287622|157267246|FG001|Overall Study|No prescripion after surgery|31|||
48842987|NCT03287622|157267245|FG000|Overall Study|prolonged Length of stay|2|||
48842988|NCT03287622|157267246|FG001|Overall Study|prolonged Length of stay|0|||
48842989|NCT03287622|157267245|FG000|Overall Study|surgery related|0|||
48842990|NCT03287622|157267246|FG001|Overall Study|surgery related|2|||
48842991|NCT01078116|157267247|FG000|Overall Study|Lost to Follow-up|17|||
48842992|NCT01078116|157267247|FG000|Overall Study|Adverse Event|5|||
48842993|NCT01078116|157267247|FG000|Overall Study|Withdrawal by Subject|8|||
48842994|NCT01078116|157267247|FG000|Overall Study|Lack of effectiveness|15|||
48842995|NCT01078116|157267247|FG000|Overall Study|Case report form not completed|3|||
48842996|NCT00371787|157267250|FG000|Overall Study|Withdrawal by Subject|3|||
48842997|NCT00371787|157267251|FG001|Overall Study|Withdrawal by Subject|1|||
48842998|NCT02242487|157267253|FG000|Overall Study|Adverse Event|13|||
48842999|NCT02242487|157267254|FG001|Overall Study|Adverse Event|15|||
48843000|NCT02242487|157267253|FG000|Overall Study|Lack of Efficacy|4|||
48843001|NCT02242487|157267254|FG001|Overall Study|Lack of Efficacy|6|||
48843002|NCT02242487|157267253|FG000|Overall Study|Protocol Violation|2|||
48843003|NCT02242487|157267254|FG001|Overall Study|Protocol Violation|0|||
48843004|NCT02242487|157267253|FG000|Overall Study|Lost to Follow-up|2|||
48843005|NCT02242487|157267254|FG001|Overall Study|Lost to Follow-up|1|||
48843006|NCT02242487|157267253|FG000|Overall Study|Other - Miscellaneous|4|||
48843007|NCT02242487|157267254|FG001|Overall Study|Other - Miscellaneous|6|||
48843008|NCT02242487|157267253|FG000|Overall Study|Withdrawal by Subject|37|||
48843009|NCT02242487|157267254|FG001|Overall Study|Withdrawal by Subject|19|||
48843010|NCT03644849|157267257|FG000|Overall Study|Lost to Follow-up|1|||
48843011|NCT03644849|157267258|FG001|Overall Study|Lost to Follow-up|3|||
48843012|NCT02932579|157267259|FG000|Overall Study|Withdrawal by Subject|4|||
48843013|NCT02932579|157267260|FG001|Overall Study|Withdrawal by Subject|1|||
48843014|NCT01972724|157267263|FG000|Double-Blind|Rescue Criteria Met|1|||
48843015|NCT01972724|157267264|FG001|Double-Blind|Rescue Criteria Met|0|||
48843016|NCT01972724|157267265|FG002|Double-Blind|Rescue Criteria Met|0|||
48843017|NCT01972724|157267263|FG000|Double-Blind|Adverse Event|1|||
48843018|NCT01972724|157267264|FG001|Double-Blind|Adverse Event|0|||
48926660|NCT01294800|157563294|FG000|Overall Study|Adverse Event|7|||
48926661|NCT01294800|157563295|FG001|Overall Study|Adverse Event|6|||
48926662|NCT01294800|157563296|FG002|Overall Study|Adverse Event|12|||
48926663|NCT01294800|157563297|FG003|Overall Study|Adverse Event|5|||
48926664|NCT01294800|157563294|FG000|Overall Study|Subject Withdrew Consent|2|||
48926665|NCT01294800|157563295|FG001|Overall Study|Subject Withdrew Consent|2|||
48926666|NCT01294800|157563296|FG002|Overall Study|Subject Withdrew Consent|2|||
48926667|NCT01294800|157563297|FG003|Overall Study|Subject Withdrew Consent|11|||
48926668|NCT01294800|157563294|FG000|Overall Study|Lost to Follow-up|0|||
48926669|NCT01294800|157563295|FG001|Overall Study|Lost to Follow-up|0|||
48926670|NCT01294800|157563296|FG002|Overall Study|Lost to Follow-up|1|||
48926671|NCT01294800|157563297|FG003|Overall Study|Lost to Follow-up|0|||
48926672|NCT01294800|157563294|FG000|Overall Study|Non-compliance With Protocol|0|||
48926673|NCT01294800|157563295|FG001|Overall Study|Non-compliance With Protocol|1|||
49174191|NCT00623233|158471781|FG000|Overall Study|Withdrawal by Subject|3|||
49174192|NCT04908384|158471784|FG000|Overall Study|Lost to Follow-up|4|||
49174193|NCT04908384|158471785|FG001|Overall Study|Lost to Follow-up|4|||
49174194|NCT04908384|158471786|FG002|Overall Study|Lost to Follow-up|0|||
49174195|NCT04908384|158471787|FG003|Overall Study|Lost to Follow-up|0|||
49174196|NCT00249808|158471788|FG000|Overall Study|Other|27|||
49174197|NCT00249808|158471788|FG000|Overall Study|Protocol Violation|3|||
49174198|NCT00249808|158471788|FG000|Overall Study|Lost to Follow-up|8|||
49174199|NCT00249808|158471788|FG000|Overall Study|Adverse Event|81|||
49174200|NCT00249808|158471788|FG000|Overall Study|Lack of Efficacy|52|||
49174201|NCT00249808|158471788|FG000|Overall Study|Did Not Provide Post-Baseline Data|11|||
49174202|NCT01951586|158471789|FG000|Overall Study|Death|61|||
49174203|NCT01951586|158471790|FG001|Overall Study|Death|120|||
49174204|NCT01951586|158471789|FG000|Overall Study|Withdrawal by Subject|8|||
49174205|NCT01951586|158471790|FG001|Overall Study|Withdrawal by Subject|17|||
49174206|NCT01951586|158471789|FG000|Overall Study|Lost to Follow-up|0|||
49174207|NCT01951586|158471790|FG001|Overall Study|Lost to Follow-up|1|||
49174208|NCT01951586|158471789|FG000|Overall Study|Sponsor Decision|9|||
48843019|NCT01972724|157267265|FG002|Double-Blind|Adverse Event|0|||
48843020|NCT01972724|157267263|FG000|Double-Blind|Withdrawal of Consent|2|||
48843021|NCT01972724|157267264|FG001|Double-Blind|Withdrawal of Consent|1|||
48843022|NCT01972724|157267265|FG002|Double-Blind|Withdrawal of Consent|0|||
48926674|NCT01294800|157563296|FG002|Overall Study|Non-compliance With Protocol|1|||
48926675|NCT01294800|157563297|FG003|Overall Study|Non-compliance With Protocol|0|||
48843023|NCT01972724|157267263|FG000|Double-Blind|Significant Protocol Deviation|5|||
49174209|NCT01951586|158471790|FG001|Overall Study|Sponsor Decision|10|||
49174210|NCT00748618|158471791|FG000|Overall Study|Adverse Event|1|||
49174211|NCT00748618|158471792|FG001|Overall Study|Adverse Event|0|||
49174212|NCT00438360|158471794|FG000|Overall Study|Adverse Event|6|||
49174213|NCT00438360|158471795|FG001|Overall Study|Adverse Event|1|||
49174214|NCT00438360|158471794|FG000|Overall Study|Lack of Efficacy|42|||
48843024|NCT01972724|157267264|FG001|Double-Blind|Significant Protocol Deviation|8|||
48843025|NCT01972724|157267265|FG002|Double-Blind|Significant Protocol Deviation|0|||
48843026|NCT01972724|157267263|FG000|Open-Label|Withdrew Consent|0|||
48843027|NCT01972724|157267264|FG001|Open-Label|Withdrew Consent|0|||
48843028|NCT01972724|157267265|FG002|Open-Label|Withdrew Consent|3|||
48843029|NCT01972724|157267263|FG000|Open-Label|Significant Protocol Deviation|0|||
48843030|NCT01972724|157267264|FG001|Open-Label|Significant Protocol Deviation|0|||
48843031|NCT01972724|157267265|FG002|Open-Label|Significant Protocol Deviation|2|||
48843032|NCT01636687|157267267|FG000|Induction Period|Withdrawal by Subject|1|||
48843033|NCT01636687|157267268|FG001|Induction Period|Withdrawal by Subject|0|||
48843034|NCT01636687|157267269|FG002|Induction Period|Withdrawal by Subject|0|||
48843035|NCT01636687|157267270|FG003|Induction Period|Withdrawal by Subject|0|||
48843036|NCT01636687|157267271|FG004|Induction Period|Withdrawal by Subject|0|||
48843037|NCT01636687|157267267|FG000|Induction Period|Adverse Event|1|||
48843038|NCT01636687|157267268|FG001|Induction Period|Adverse Event|0|||
48843039|NCT01636687|157267269|FG002|Induction Period|Adverse Event|0|||
48843040|NCT01636687|157267270|FG003|Induction Period|Adverse Event|0|||
48843041|NCT01636687|157267271|FG004|Induction Period|Adverse Event|1|||
48843042|NCT01636687|157267267|FG000|Induction Period|Lack of Efficacy|0|||
48843043|NCT01636687|157267268|FG001|Induction Period|Lack of Efficacy|0|||
48843044|NCT01636687|157267269|FG002|Induction Period|Lack of Efficacy|0|||
48843045|NCT01636687|157267270|FG003|Induction Period|Lack of Efficacy|0|||
48843046|NCT01636687|157267271|FG004|Induction Period|Lack of Efficacy|1|||
48843047|NCT01636687|157267267|FG000|Induction Period|Physician Decision|1|||
48843048|NCT01636687|157267268|FG001|Induction Period|Physician Decision|0|||
48843049|NCT01636687|157267269|FG002|Induction Period|Physician Decision|0|||
48843050|NCT01636687|157267270|FG003|Induction Period|Physician Decision|0|||
48843051|NCT01636687|157267271|FG004|Induction Period|Physician Decision|0|||
48843052|NCT01636687|157267267|FG000|Maintenance Period|Withdrawal by Subject|2|||
48843053|NCT01636687|157267268|FG001|Maintenance Period|Withdrawal by Subject|0|||
48843054|NCT01636687|157267269|FG002|Maintenance Period|Withdrawal by Subject|2|||
48843055|NCT01636687|157267270|FG003|Maintenance Period|Withdrawal by Subject|0|||
48843056|NCT01636687|157267271|FG004|Maintenance Period|Withdrawal by Subject|0|||
49174215|NCT00438360|158471795|FG001|Overall Study|Lack of Efficacy|27|||
49174216|NCT00438360|158471794|FG000|Overall Study|Other|24|||
49174217|NCT00438360|158471795|FG001|Overall Study|Other|15|||
49174218|NCT00070109|158471798|FG000|Overall Study|Death|1|||
49174219|NCT00070109|158471799|FG001|Overall Study|Death|1|||
48843057|NCT01636687|157267267|FG000|Maintenance Period|Adverse Event|1|||
48843058|NCT01636687|157267268|FG001|Maintenance Period|Adverse Event|0|||
48843059|NCT01636687|157267269|FG002|Maintenance Period|Adverse Event|0|||
48843060|NCT01636687|157267270|FG003|Maintenance Period|Adverse Event|0|||
48843061|NCT01636687|157267271|FG004|Maintenance Period|Adverse Event|0|||
48843062|NCT01636687|157267267|FG000|Maintenance Period|Lack of Efficacy|4|||
48843063|NCT01636687|157267268|FG001|Maintenance Period|Lack of Efficacy|1|||
48843064|NCT01636687|157267269|FG002|Maintenance Period|Lack of Efficacy|0|||
48843065|NCT01636687|157267270|FG003|Maintenance Period|Lack of Efficacy|0|||
48843066|NCT01636687|157267271|FG004|Maintenance Period|Lack of Efficacy|0|||
48843067|NCT01636687|157267267|FG000|Maintenance Period|Lost to Follow-up|1|||
48843068|NCT01636687|157267268|FG001|Maintenance Period|Lost to Follow-up|1|||
48843069|NCT01636687|157267269|FG002|Maintenance Period|Lost to Follow-up|0|||
48843070|NCT01636687|157267270|FG003|Maintenance Period|Lost to Follow-up|0|||
48843071|NCT01636687|157267271|FG004|Maintenance Period|Lost to Follow-up|1|||
49174220|NCT00070109|158471800|FG002|Overall Study|Death|0|||
49174221|NCT00070109|158471801|FG003|Overall Study|Death|0|||
49174222|NCT00070109|158471802|FG004|Overall Study|Death|1|||
49174223|NCT00070109|158471798|FG000|Overall Study|Lack of Efficacy|6|||
49174224|NCT00070109|158471799|FG001|Overall Study|Lack of Efficacy|4|||
49174225|NCT00070109|158471800|FG002|Overall Study|Lack of Efficacy|5|||
49174226|NCT00070109|158471801|FG003|Overall Study|Lack of Efficacy|15|||
49174227|NCT00070109|158471802|FG004|Overall Study|Lack of Efficacy|5|||
49174228|NCT00070109|158471798|FG000|Overall Study|Physician Decision|1|||
49174229|NCT00070109|158471799|FG001|Overall Study|Physician Decision|0|||
49174230|NCT00070109|158471800|FG002|Overall Study|Physician Decision|0|||
49174231|NCT00070109|158471801|FG003|Overall Study|Physician Decision|0|||
49174232|NCT00070109|158471802|FG004|Overall Study|Physician Decision|0|||
49174233|NCT00070109|158471798|FG000|Overall Study|Withdrawal by Subject|0|||
49174234|NCT00070109|158471799|FG001|Overall Study|Withdrawal by Subject|1|||
49174235|NCT00070109|158471800|FG002|Overall Study|Withdrawal by Subject|1|||
49174236|NCT00070109|158471801|FG003|Overall Study|Withdrawal by Subject|0|||
49174237|NCT00070109|158471802|FG004|Overall Study|Withdrawal by Subject|0|||
49174238|NCT00070109|158471798|FG000|Overall Study|Adverse Event|0|||
48843072|NCT01636687|157267267|FG000|Maintenance Period|Physician Decision|0|||
48843073|NCT01636687|157267268|FG001|Maintenance Period|Physician Decision|0|||
48843074|NCT01636687|157267269|FG002|Maintenance Period|Physician Decision|0|||
48843075|NCT01636687|157267270|FG003|Maintenance Period|Physician Decision|0|||
48843076|NCT01636687|157267271|FG004|Maintenance Period|Physician Decision|1|||
48843077|NCT01636687|157267267|FG000|Extension Period|technical problems|0|||
48843078|NCT01636687|157267268|FG001|Extension Period|technical problems|1|||
48843079|NCT01636687|157267269|FG002|Extension Period|technical problems|2|||
48843080|NCT01636687|157267270|FG003|Extension Period|technical problems|1|||
48843081|NCT01636687|157267271|FG004|Extension Period|technical problems|0|||
48843082|NCT01636687|157267267|FG000|Extension Period|Adverse Event|4|||
48843083|NCT01636687|157267268|FG001|Extension Period|Adverse Event|3|||
48843084|NCT01636687|157267269|FG002|Extension Period|Adverse Event|2|||
48843085|NCT01636687|157267270|FG003|Extension Period|Adverse Event|1|||
48843086|NCT01636687|157267271|FG004|Extension Period|Adverse Event|0|||
48843087|NCT01636687|157267267|FG000|Extension Period|Lack of Efficacy|7|||
48843088|NCT01636687|157267268|FG001|Extension Period|Lack of Efficacy|0|||
48843089|NCT01636687|157267269|FG002|Extension Period|Lack of Efficacy|2|||
48843090|NCT01636687|157267270|FG003|Extension Period|Lack of Efficacy|1|||
48843091|NCT01636687|157267271|FG004|Extension Period|Lack of Efficacy|0|||
48843092|NCT01636687|157267267|FG000|Extension Period|Lost to Follow-up|1|||
48843093|NCT01636687|157267268|FG001|Extension Period|Lost to Follow-up|0|||
48843094|NCT01636687|157267269|FG002|Extension Period|Lost to Follow-up|1|||
48843095|NCT01636687|157267270|FG003|Extension Period|Lost to Follow-up|0|||
48843096|NCT01636687|157267271|FG004|Extension Period|Lost to Follow-up|0|||
48843097|NCT01636687|157267267|FG000|Extension Period|Physician Decision|1|||
48843098|NCT01636687|157267268|FG001|Extension Period|Physician Decision|0|||
48843099|NCT01636687|157267269|FG002|Extension Period|Physician Decision|0|||
48843100|NCT01636687|157267270|FG003|Extension Period|Physician Decision|1|||
48843101|NCT01636687|157267271|FG004|Extension Period|Physician Decision|0|||
48843102|NCT01636687|157267267|FG000|Extension Period|study terminated by sponsor|33|||
48843103|NCT01636687|157267268|FG001|Extension Period|study terminated by sponsor|50|||
48843104|NCT01636687|157267269|FG002|Extension Period|study terminated by sponsor|17|||
48843105|NCT01636687|157267270|FG003|Extension Period|study terminated by sponsor|23|||
48843106|NCT01636687|157267271|FG004|Extension Period|study terminated by sponsor|0|||
48843107|NCT01636687|157267267|FG000|Extension Period|Withdrawal by Subject|1|||
48843108|NCT01636687|157267268|FG001|Extension Period|Withdrawal by Subject|0|||
48843109|NCT01636687|157267269|FG002|Extension Period|Withdrawal by Subject|1|||
48843110|NCT01636687|157267270|FG003|Extension Period|Withdrawal by Subject|1|||
48843111|NCT01636687|157267271|FG004|Extension Period|Withdrawal by Subject|0|||
48843112|NCT01636687|157267267|FG000|Follow-up Period|Withdrawal by Subject|1|||
48843113|NCT01636687|157267268|FG001|Follow-up Period|Withdrawal by Subject|0|||
48843114|NCT01636687|157267269|FG002|Follow-up Period|Withdrawal by Subject|0|||
48843115|NCT01636687|157267270|FG003|Follow-up Period|Withdrawal by Subject|0|||
48843116|NCT01636687|157267271|FG004|Follow-up Period|Withdrawal by Subject|1|||
48843117|NCT02214160|157267272|FG000|Overall Study|Withdrawal by Subject|1|||
48843118|NCT02214160|157267273|FG001|Overall Study|Withdrawal by Subject|0|||
48843119|NCT02214160|157267274|FG002|Overall Study|Withdrawal by Subject|6|||
48843120|NCT02214160|157267272|FG000|Overall Study|Death|2|||
48843121|NCT02214160|157267273|FG001|Overall Study|Death|2|||
48843122|NCT02214160|157267274|FG002|Overall Study|Death|1|||
48843123|NCT02214160|157267272|FG000|Overall Study|Subject Non-Compliance|0|||
48843124|NCT02214160|157267273|FG001|Overall Study|Subject Non-Compliance|3|||
48843125|NCT02214160|157267274|FG002|Overall Study|Subject Non-Compliance|1|||
48843126|NCT02214160|157267272|FG000|Overall Study|Adverse Event|0|||
48843127|NCT02214160|157267273|FG001|Overall Study|Adverse Event|1|||
48843128|NCT02214160|157267274|FG002|Overall Study|Adverse Event|1|||
48843129|NCT02214160|157267272|FG000|Overall Study|Sponsor Decision|0|||
48843130|NCT02214160|157267273|FG001|Overall Study|Sponsor Decision|2|||
48843131|NCT02214160|157267274|FG002|Overall Study|Sponsor Decision|0|||
48843132|NCT02214160|157267272|FG000|Overall Study|Protocol Violation|1|||
48843133|NCT02214160|157267273|FG001|Overall Study|Protocol Violation|0|||
48843134|NCT02214160|157267274|FG002|Overall Study|Protocol Violation|0|||
48843135|NCT02214160|157267272|FG000|Overall Study|Physician Decision|0|||
48843136|NCT02214160|157267273|FG001|Overall Study|Physician Decision|0|||
48843137|NCT02214160|157267274|FG002|Overall Study|Physician Decision|1|||
48843138|NCT01063972|157267278|FG000|Overall Study|Death|12|||
48843139|NCT01063972|157267279|FG001|Overall Study|Death|11|||
48843140|NCT01063972|157267278|FG000|Overall Study|Incarcerated|2|||
48843141|NCT01063972|157267279|FG001|Overall Study|Incarcerated|1|||
48843142|NCT03051165|157267280|FG000|Overall Study|Withdrawal by Subject|1|||
48843143|NCT03051165|157267280|FG000|Overall Study|Early termination of study|12|||
48843144|NCT01610297|157267281|FG000|Overall Study|Lost to Follow-up|1|||
48843145|NCT02092116|157267284|FG000|Overall Study|Withdrawal by Subject|0|||
48843146|NCT02092116|157267285|FG001|Overall Study|Withdrawal by Subject|3|||
48843147|NCT02092116|157267284|FG000|Overall Study|Adverse Event|0|||
48843148|NCT02092116|157267285|FG001|Overall Study|Adverse Event|1|||
48843149|NCT00761605|157267287|FG000|Overall Study|Adverse Event|26|||
48843150|NCT00761605|157267287|FG000|Overall Study|Death|2|||
48843151|NCT00761605|157267287|FG000|Overall Study|Lack of Efficacy|26|||
48843152|NCT00761605|157267287|FG000|Overall Study|Lost to Follow-up|29|||
48843153|NCT00761605|157267287|FG000|Overall Study|Withdrawal by Subject|37|||
48843154|NCT00761605|157267287|FG000|Overall Study|Other|21|||
48843155|NCT03482011|157267288|FG000|Induction Period (16 Weeks)|Adverse Event|1|||
48843156|NCT03482011|157267289|FG001|Induction Period (16 Weeks)|Adverse Event|3|||
48843157|NCT03482011|157267290|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
48843158|NCT03482011|157267291|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
48926676|NCT01294800|157563294|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
48843159|NCT03482011|157267292|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
48843160|NCT03482011|157267293|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
48843161|NCT03482011|157267294|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
49174239|NCT00070109|158471799|FG001|Overall Study|Adverse Event|0|||
49174240|NCT00070109|158471800|FG002|Overall Study|Adverse Event|2|||
49174241|NCT00070109|158471801|FG003|Overall Study|Adverse Event|4|||
49174242|NCT00070109|158471802|FG004|Overall Study|Adverse Event|2|||
49174243|NCT00070109|158471798|FG000|Overall Study|removed from prot thpy prior to chemo|0|||
49174244|NCT00070109|158471799|FG001|Overall Study|removed from prot thpy prior to chemo|0|||
49174245|NCT00070109|158471800|FG002|Overall Study|removed from prot thpy prior to chemo|0|||
49174246|NCT00070109|158471801|FG003|Overall Study|removed from prot thpy prior to chemo|1|||
49174247|NCT00070109|158471802|FG004|Overall Study|removed from prot thpy prior to chemo|0|||
49174248|NCT05040971|158471808|FG000|Overall Study|Withdrawal by Subject|0|||
49174249|NCT05040971|158471809|FG001|Overall Study|Withdrawal by Subject|2|||
49174250|NCT05040971|158471808|FG000|Overall Study|Lost to Follow-up|8|||
49174251|NCT05040971|158471809|FG001|Overall Study|Lost to Follow-up|3|||
49174252|NCT05040971|158471808|FG000|Overall Study|Death|2|||
49174253|NCT05040971|158471809|FG001|Overall Study|Death|0|||
49174254|NCT00610857|158471811|FG000|Overall Study|Not evaluable for response|2|||
49174255|NCT02027311|158471815|FG000|Overall Study|Protocol Violation|3|||
49174256|NCT02027311|158471816|FG001|Overall Study|Protocol Violation|2|||
49174257|NCT00904670|158471817|FG000|Open Label Phase|Withdrawal by Subject|2|||
49174258|NCT00904670|158471818|FG001|Open Label Phase|Withdrawal by Subject|0|||
49174259|NCT00904670|158471817|FG000|Open Label Phase|Adverse Event|2|||
49174260|NCT00904670|158471818|FG001|Open Label Phase|Adverse Event|0|||
48843162|NCT03482011|157267295|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
48843163|NCT03482011|157267288|FG000|Induction Period (16 Weeks)|Lack of Efficacy|3|||
48843164|NCT03482011|157267289|FG001|Induction Period (16 Weeks)|Lack of Efficacy|1|||
48843165|NCT03482011|157267290|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
48843166|NCT03482011|157267291|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
48843167|NCT03482011|157267292|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
48843168|NCT03482011|157267293|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
48843169|NCT03482011|157267294|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
48843170|NCT03482011|157267295|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
48843171|NCT03482011|157267288|FG000|Induction Period (16 Weeks)|Lost to Follow-up|0|||
48843172|NCT03482011|157267289|FG001|Induction Period (16 Weeks)|Lost to Follow-up|1|||
48843173|NCT03482011|157267290|FG002|Induction Period (16 Weeks)|Lost to Follow-up|0|||
48843174|NCT03482011|157267291|FG003|Induction Period (16 Weeks)|Lost to Follow-up|0|||
48843175|NCT03482011|157267292|FG004|Induction Period (16 Weeks)|Lost to Follow-up|0|||
48843176|NCT03482011|157267293|FG005|Induction Period (16 Weeks)|Lost to Follow-up|0|||
48843177|NCT03482011|157267294|FG006|Induction Period (16 Weeks)|Lost to Follow-up|0|||
48843178|NCT03482011|157267295|FG007|Induction Period (16 Weeks)|Lost to Follow-up|0|||
48843179|NCT03482011|157267288|FG000|Induction Period (16 Weeks)|Screen Failure|0|||
48843180|NCT03482011|157267289|FG001|Induction Period (16 Weeks)|Screen Failure|1|||
48843181|NCT03482011|157267290|FG002|Induction Period (16 Weeks)|Screen Failure|0|||
48843182|NCT03482011|157267291|FG003|Induction Period (16 Weeks)|Screen Failure|0|||
48843183|NCT03482011|157267292|FG004|Induction Period (16 Weeks)|Screen Failure|0|||
48843184|NCT03482011|157267293|FG005|Induction Period (16 Weeks)|Screen Failure|0|||
48843185|NCT03482011|157267294|FG006|Induction Period (16 Weeks)|Screen Failure|0|||
48843186|NCT03482011|157267295|FG007|Induction Period (16 Weeks)|Screen Failure|0|||
49174261|NCT00904670|158471817|FG000|Open Label Phase|Lack of Efficacy|1|||
49174262|NCT00904670|158471818|FG001|Open Label Phase|Lack of Efficacy|0|||
49174263|NCT00904670|158471817|FG000|Open Label Phase|Lost to Follow-up|1|||
49174264|NCT00904670|158471818|FG001|Open Label Phase|Lost to Follow-up|0|||
49174265|NCT04154293|158471820|FG000|Overall Study|Withdrawal by Subject|2|||
49174266|NCT04154293|158471821|FG001|Overall Study|Withdrawal by Subject|3|||
49174267|NCT04154293|158471822|FG002|Overall Study|Withdrawal by Subject|1|||
49174268|NCT04154293|158471820|FG000|Overall Study|Physician Decision|0|||
49174269|NCT04154293|158471821|FG001|Overall Study|Physician Decision|0|||
49174270|NCT04154293|158471822|FG002|Overall Study|Physician Decision|1|||
49174271|NCT00564902|158471825|FG000|Overall Study|Withdrawal by Subject|0|||
49174272|NCT00564902|158471826|FG001|Overall Study|Withdrawal by Subject|3|||
49174273|NCT00564902|158471827|FG002|Overall Study|Withdrawal by Subject|4|||
49174274|NCT00564902|158471825|FG000|Overall Study|Death|1|||
49174275|NCT00564902|158471826|FG001|Overall Study|Death|1|||
49174276|NCT00564902|158471827|FG002|Overall Study|Death|0|||
49174277|NCT03783442|158471828|FG000|Overall Study|Remained on study (ongoing at time of DCO)|114|||
49174278|NCT03783442|158471829|FG001|Overall Study|Remained on study (ongoing at time of DCO)|77|||
49174279|NCT03783442|158471828|FG000|Overall Study|Death|196|||
48926677|NCT01294800|157563295|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
48926678|NCT01294800|157563296|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
48926679|NCT01294800|157563297|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
48926680|NCT02387580|157563300|FG000|Overall Study|Withdrawal by Subject|0|||
48926681|NCT02387580|157563301|FG001|Overall Study|Withdrawal by Subject|0|||
48926682|NCT02387580|157563302|FG002|Overall Study|Withdrawal by Subject|0|||
48926683|NCT02387580|157563303|FG003|Overall Study|Withdrawal by Subject|1|||
48926684|NCT02387580|157563304|FG004|Overall Study|Withdrawal by Subject|0|||
48926685|NCT02387580|157563305|FG005|Overall Study|Withdrawal by Subject|0|||
48926686|NCT03870555|157563306|FG000|Period 3 (2 Days)|Adverse Event|1|||
48926687|NCT03870555|157563307|FG001|Period 3 (2 Days)|Adverse Event|0|||
48926688|NCT03870555|157563308|FG002|Period 3 (2 Days)|Adverse Event|0|||
48926689|NCT01097863|157563309|FG000|Overall Study|Discomfort|1|||
48926690|NCT01097863|157563310|FG001|Overall Study|Discomfort|0|||
48926691|NCT01097863|157563311|FG002|Overall Study|Discomfort|1|||
48926692|NCT01097863|157563309|FG000|Overall Study|Did not return for final visit|0|||
48926693|NCT01097863|157563310|FG001|Overall Study|Did not return for final visit|0|||
48926694|NCT01097863|157563311|FG002|Overall Study|Did not return for final visit|1|||
48926695|NCT00352105|157563312|FG000|Overall Study|Death|5|||
48926696|NCT00352105|157563312|FG000|Overall Study|Withdrawal by Subject|5|||
48926697|NCT00352105|157563312|FG000|Overall Study|Lack of Efficacy|9|||
48926698|NCT00352105|157563312|FG000|Overall Study|Adverse Event|19|||
48926699|NCT00352105|157563312|FG000|Overall Study|Protocol Violation|2|||
48926700|NCT01580397|157563313|FG000|Overall Study|Lack of Efficacy|14|||
48926701|NCT02526550|157563314|FG000|Overall Study|Lost to Follow-up|1|||
48926702|NCT03463044|157563318|FG000|Overall Study|Lost to Follow-up|0|||
48926703|NCT03463044|157563319|FG001|Overall Study|Lost to Follow-up|0|||
48926704|NCT03463044|157563320|FG002|Overall Study|Lost to Follow-up|0|||
48926705|NCT03463044|157563321|FG003|Overall Study|Lost to Follow-up|0|||
49174280|NCT03783442|158471829|FG001|Overall Study|Death|226|||
49174281|NCT03783442|158471828|FG000|Overall Study|Withdrawal by Subject|14|||
49174282|NCT03783442|158471829|FG001|Overall Study|Withdrawal by Subject|17|||
49174283|NCT03783442|158471828|FG000|Overall Study|Lost to Follow-up|2|||
49174284|NCT03783442|158471829|FG001|Overall Study|Lost to Follow-up|3|||
49174285|NCT01932372|158471830|FG000|Overall Study|Not meeting eligibility criteria|33|||
49174286|NCT01932372|158471831|FG001|Overall Study|Not meeting eligibility criteria|179|||
49174287|NCT04532294|158471832|FG000|Overall Study|Withdrawal by Subject|0|||
49174288|NCT04532294|158471833|FG001|Overall Study|Withdrawal by Subject|0|||
49174289|NCT04532294|158471834|FG002|Overall Study|Withdrawal by Subject|1|||
49174290|NCT04532294|158471832|FG000|Overall Study|Participants Not Dosed|0|||
49174291|NCT04532294|158471833|FG001|Overall Study|Participants Not Dosed|0|||
49174292|NCT04532294|158471834|FG002|Overall Study|Participants Not Dosed|2|||
49174293|NCT04382586|158471835|FG000|Overall Study|Death|3|||
49174294|NCT04382586|158471836|FG001|Overall Study|Death|4|||
49174295|NCT04382586|158471835|FG000|Overall Study|Lost to Follow-up|11|||
49174296|NCT04382586|158471836|FG001|Overall Study|Lost to Follow-up|8|||
49174297|NCT04382586|158471835|FG000|Overall Study|Withdrawal by Subject|3|||
49174298|NCT04382586|158471836|FG001|Overall Study|Withdrawal by Subject|1|||
49174299|NCT04382586|158471835|FG000|Overall Study|Physician Decision|0|||
49174300|NCT04382586|158471836|FG001|Overall Study|Physician Decision|3|||
49174301|NCT02241733|158471840|FG000|Overall Study|Lost to Follow-up|9|||
49174302|NCT02241733|158471841|FG001|Overall Study|Lost to Follow-up|4|||
49174303|NCT02241733|158471840|FG000|Overall Study|Physician Decision|6|||
49174304|NCT02241733|158471841|FG001|Overall Study|Physician Decision|2|||
49174305|NCT02241733|158471840|FG000|Overall Study|Withdrawal by Subject|0|||
49174306|NCT02241733|158471841|FG001|Overall Study|Withdrawal by Subject|2|||
49174307|NCT02241733|158471840|FG000|Overall Study|Death|0|||
49174308|NCT02241733|158471841|FG001|Overall Study|Death|2|||
49174309|NCT02218697|158471842|FG000|Overall Study|Adverse Event|0|||
49174310|NCT02218697|158471843|FG001|Overall Study|Adverse Event|2|||
49174311|NCT02218697|158471842|FG000|Overall Study|Unwilling to be vaccinated in left arm|0|||
48926706|NCT03463044|157563322|FG004|Overall Study|Lost to Follow-up|0|||
48926707|NCT03463044|157563323|FG005|Overall Study|Lost to Follow-up|0|||
49174312|NCT02218697|158471843|FG001|Overall Study|Unwilling to be vaccinated in left arm|1|||
49174313|NCT02218697|158471842|FG000|Overall Study|Withdrawal by Subject|2|||
49174314|NCT02218697|158471843|FG001|Overall Study|Withdrawal by Subject|3|||
49174315|NCT01974206|158471844|FG000|Overall Study|Did Not Take Study Drug|0|||
48926708|NCT03463044|157563324|FG006|Overall Study|Lost to Follow-up|0|||
48926709|NCT03463044|157563325|FG007|Overall Study|Lost to Follow-up|1|||
48926710|NCT03463044|157563326|FG008|Overall Study|Lost to Follow-up|0|||
48926711|NCT05907174|157563327|FG000|3-Month Assessment|Withdrawal by Subject|0|||
48926712|NCT05907174|157563328|FG001|3-Month Assessment|Withdrawal by Subject|0|||
48926713|NCT05907174|157563329|FG002|3-Month Assessment|Withdrawal by Subject|0|||
48926714|NCT05907174|157563330|FG003|3-Month Assessment|Withdrawal by Subject|1|||
48926715|NCT05907174|157563327|FG000|3-Month Assessment|Lost to Follow-up|1|||
48926716|NCT05907174|157563328|FG001|3-Month Assessment|Lost to Follow-up|1|||
48926717|NCT05907174|157563329|FG002|3-Month Assessment|Lost to Follow-up|1|||
48926718|NCT05907174|157563330|FG003|3-Month Assessment|Lost to Follow-up|1|||
48926719|NCT05907174|157563327|FG000|6-Month Assessment|Death|0|||
48926720|NCT05907174|157563328|FG001|6-Month Assessment|Death|0|||
48926721|NCT05907174|157563329|FG002|6-Month Assessment|Death|3|||
48926722|NCT05907174|157563330|FG003|6-Month Assessment|Death|0|||
49174316|NCT01974206|158471845|FG001|Overall Study|Did Not Take Study Drug|1|||
49174317|NCT01974206|158471844|FG000|Overall Study|Physician Decision|1|||
49174318|NCT01974206|158471845|FG001|Overall Study|Physician Decision|0|||
49174319|NCT01974206|158471844|FG000|Overall Study|Withdrawal by Subject|3|||
49174320|NCT01974206|158471845|FG001|Overall Study|Withdrawal by Subject|0|||
49174321|NCT01974206|158471844|FG000|Overall Study|Lost to Follow-up|1|||
49174322|NCT01974206|158471845|FG001|Overall Study|Lost to Follow-up|0|||
49174323|NCT01974206|158471844|FG000|Overall Study|Death|1|||
49174324|NCT01974206|158471845|FG001|Overall Study|Death|0|||
49174325|NCT05111002|158471846|FG000|Primary Outcome|Negative Confirmatory Aptima MG Test|1|||
49174326|NCT05111002|158471847|FG001|Primary Outcome|Negative Confirmatory Aptima MG Test|0|||
48926723|NCT05907174|157563327|FG000|6-Month Assessment|Withdrawal by Subject|0|||
48926724|NCT05907174|157563328|FG001|6-Month Assessment|Withdrawal by Subject|0|||
48926725|NCT05907174|157563329|FG002|6-Month Assessment|Withdrawal by Subject|1|||
49174327|NCT05111002|158471846|FG000|Secondary Outcome|Lost to Follow-up|1|||
49174328|NCT05111002|158471847|FG001|Secondary Outcome|Lost to Follow-up|0|||
48926726|NCT05907174|157563330|FG003|6-Month Assessment|Withdrawal by Subject|1|||
48926727|NCT05907174|157563327|FG000|6-Month Assessment|Lost to Follow-up|0|||
49174329|NCT04776720|158471854|FG000|Overall Study|COVID Related|4|||
48926728|NCT05907174|157563328|FG001|6-Month Assessment|Lost to Follow-up|1|||
48926729|NCT05907174|157563329|FG002|6-Month Assessment|Lost to Follow-up|1|||
48926730|NCT05907174|157563330|FG003|6-Month Assessment|Lost to Follow-up|1|||
48926731|NCT04730739|157563331|FG000|Overall Study|Death|1|||
48926732|NCT02733159|157563332|FG000|Overall Study|Adverse Event|1|||
49174330|NCT04776720|158471855|FG001|Overall Study|COVID Related|2|||
49174331|NCT04776720|158471854|FG000|Overall Study|Adverse Event|2|||
49174332|NCT04776720|158471855|FG001|Overall Study|Adverse Event|0|||
49174333|NCT04776720|158471854|FG000|Overall Study|Serious Adverse Event|0|||
49174334|NCT04776720|158471855|FG001|Overall Study|Serious Adverse Event|1|||
49174335|NCT04776720|158471854|FG000|Overall Study|Too Busy|3|||
49174336|NCT04776720|158471855|FG001|Overall Study|Too Busy|1|||
49174337|NCT04776720|158471854|FG000|Overall Study|Lost to Follow-up|1|||
49174338|NCT04776720|158471855|FG001|Overall Study|Lost to Follow-up|2|||
49174339|NCT04776720|158471854|FG000|Overall Study|Family|2|||
49174340|NCT04776720|158471855|FG001|Overall Study|Family|2|||
49174341|NCT04776720|158471854|FG000|Overall Study|No remote technology access|0|||
49174342|NCT04776720|158471855|FG001|Overall Study|No remote technology access|1|||
49174343|NCT04776720|158471854|FG000|Overall Study|Withdrawal by Subject|1|||
49174344|NCT04776720|158471855|FG001|Overall Study|Withdrawal by Subject|0|||
49174345|NCT04776720|158471854|FG000|Overall Study|Cannot tolerate intervention|1|||
49174346|NCT04776720|158471855|FG001|Overall Study|Cannot tolerate intervention|0|||
49174347|NCT04776720|158471854|FG000|Overall Study|Incomplete outcome data|6|||
49174348|NCT04776720|158471855|FG001|Overall Study|Incomplete outcome data|1|||
49174349|NCT02684058|158471860|FG000|Treatment Period|Progressive disease|4|||
49174350|NCT02684058|158471861|FG001|Treatment Period|Progressive disease|10|||
49174351|NCT02684058|158471862|FG002|Treatment Period|Progressive disease|19|||
49174352|NCT02684058|158471860|FG000|Treatment Period|Adverse Event|3|||
49174353|NCT02684058|158471861|FG001|Treatment Period|Adverse Event|8|||
49174354|NCT02684058|158471862|FG002|Treatment Period|Adverse Event|1|||
49174355|NCT02684058|158471860|FG000|Treatment Period|Physician Decision|5|||
49174356|NCT02684058|158471861|FG001|Treatment Period|Physician Decision|1|||
49174357|NCT02684058|158471862|FG002|Treatment Period|Physician Decision|2|||
49174358|NCT02684058|158471860|FG000|Treatment Period|New therapy for study indication|1|||
49174359|NCT02684058|158471861|FG001|Treatment Period|New therapy for study indication|0|||
49174360|NCT02684058|158471862|FG002|Treatment Period|New therapy for study indication|0|||
49174361|NCT02684058|158471860|FG000|Treatment Period|Protocol deviation|0|||
49174362|NCT02684058|158471861|FG001|Treatment Period|Protocol deviation|1|||
49174363|NCT02684058|158471862|FG002|Treatment Period|Protocol deviation|0|||
49174364|NCT02684058|158471860|FG000|Treatment Period|Subject/guardian decision|4|||
49174365|NCT02684058|158471861|FG001|Treatment Period|Subject/guardian decision|3|||
48926733|NCT02733159|157563332|FG000|Overall Study|Lack of disease progression|1|||
49174366|NCT02684058|158471862|FG002|Treatment Period|Subject/guardian decision|0|||
48926734|NCT01298323|157563333|FG000|Overall Study|Adverse Event|2|||
49174367|NCT02684058|158471860|FG000|Treatment Period|Death|0|||
49174368|NCT02684058|158471861|FG001|Treatment Period|Death|0|||
49174369|NCT02684058|158471862|FG002|Treatment Period|Death|2|||
49174370|NCT02684058|158471860|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
49174371|NCT02684058|158471861|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
49174372|NCT02684058|158471862|FG002|Post-treatment Efficacy Follow-up|Physician Decision|0|||
49174373|NCT02684058|158471860|FG000|Post-treatment Efficacy Follow-up|Progressive disease|4|||
49174374|NCT02684058|158471861|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
49174375|NCT02684058|158471862|FG002|Post-treatment Efficacy Follow-up|Progressive disease|0|||
49174376|NCT02684058|158471860|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
49174377|NCT02684058|158471861|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
49174378|NCT02684058|158471862|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
49174379|NCT02684058|158471860|FG000|Post-treatment Efficacy Follow-up|Death|0|||
49174380|NCT02684058|158471861|FG001|Post-treatment Efficacy Follow-up|Death|0|||
49174381|NCT02684058|158471862|FG002|Post-treatment Efficacy Follow-up|Death|3|||
49174382|NCT02684058|158471860|FG000|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
49174383|NCT02684058|158471861|FG001|Post-treatment Efficacy Follow-up|New therapy for study indication|1|||
49174384|NCT02684058|158471862|FG002|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
49174385|NCT02684058|158471860|FG000|Post-treatment Survival Follow-up|Death|0|||
49174386|NCT02684058|158471861|FG001|Post-treatment Survival Follow-up|Death|0|||
49174387|NCT02684058|158471862|FG002|Post-treatment Survival Follow-up|Death|7|||
49174388|NCT02684058|158471860|FG000|Post-treatment Survival Follow-up|Lack of Efficacy|1|||
49174389|NCT02684058|158471861|FG001|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
49174390|NCT02684058|158471862|FG002|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
49174391|NCT02684058|158471860|FG000|Crossover Treatment Period|Progressive disease|0|||
49174392|NCT02684058|158471861|FG001|Crossover Treatment Period|Progressive disease|1|||
49174393|NCT02684058|158471862|FG002|Crossover Treatment Period|Progressive disease|0|||
49174394|NCT00443053|158471863|FG000|Overall Study|Adverse Event|2|||
49174395|NCT00443053|158471864|FG001|Overall Study|Adverse Event|1|||
49174396|NCT00443053|158471863|FG000|Overall Study|Withdrawal by Subject|9|||
49174397|NCT00443053|158471864|FG001|Overall Study|Withdrawal by Subject|18|||
49174398|NCT00443053|158471863|FG000|Overall Study|Lost to Follow-up|4|||
49174399|NCT00443053|158471864|FG001|Overall Study|Lost to Follow-up|5|||
49174400|NCT00443053|158471863|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
49174401|NCT00443053|158471864|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
49174402|NCT00443053|158471863|FG000|Overall Study|Noncompliance|2|||
49174403|NCT00443053|158471864|FG001|Overall Study|Noncompliance|1|||
49174404|NCT00443053|158471863|FG000|Overall Study|Other|3|||
49174405|NCT00443053|158471864|FG001|Overall Study|Other|4|||
49174406|NCT00443053|158471863|FG000|Overall Study|Physician Decision|0|||
49174407|NCT00443053|158471864|FG001|Overall Study|Physician Decision|4|||
49174408|NCT00281099|158471865|FG000|Overall Study|Death|46|||
48843187|NCT03482011|157267288|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
48843188|NCT03482011|157267289|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|5|||
48843189|NCT03482011|157267290|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
48926735|NCT01298323|157563334|FG001|Overall Study|Adverse Event|4|||
49174409|NCT00281099|158471866|FG001|Overall Study|Death|57|||
49174410|NCT00281099|158471865|FG000|Overall Study|Lost to Follow-up|10|||
49174411|NCT00281099|158471866|FG001|Overall Study|Lost to Follow-up|19|||
49174412|NCT00281099|158471865|FG000|Overall Study|Withdrawal by Subject|65|||
49174413|NCT00281099|158471866|FG001|Overall Study|Withdrawal by Subject|70|||
49174414|NCT00281099|158471865|FG000|Overall Study|Physician Decision|79|||
49174415|NCT00281099|158471866|FG001|Overall Study|Physician Decision|72|||
49174416|NCT00281099|158471865|FG000|Overall Study|Heart Transplant/Device Exit/Changeout|5|||
49174417|NCT00281099|158471866|FG001|Overall Study|Heart Transplant/Device Exit/Changeout|4|||
49174418|NCT02524275|158471867|FG000|Overall Study|not evaluable, completed less than 2 courses of chemotherapy.|5|||
49174419|NCT02438683|158471868|FG000|Overall Study|Adverse Event|1|||
49174420|NCT02438683|158471869|FG001|Overall Study|Adverse Event|0|||
49174421|NCT02438683|158471870|FG002|Overall Study|Adverse Event|0|||
49174422|NCT02438683|158471871|FG003|Overall Study|Adverse Event|0|||
49174423|NCT02438683|158471872|FG004|Overall Study|Adverse Event|0|||
49174424|NCT02438683|158471873|FG005|Overall Study|Adverse Event|0|||
49174425|NCT04621240|158471874|FG000|Overall Study|Withdrawal by Subject|36|||
49174426|NCT03763656|158471875|FG000|Overall Study|Physician Decision|1|||
49174427|NCT03763656|158471875|FG000|Overall Study|Protocol Violation|1|||
49174428|NCT03763656|158471875|FG000|Overall Study|Withdrawal by Subject|7|||
49174429|NCT00830375|158471876|FG000|Overall Study|Lost to Follow-up|1|||
49174430|NCT02461290|158471877|FG000|Overall Study|Withdrawn for Inadequate Clinical Stage|7|||
49174431|NCT02461290|158471877|FG000|Overall Study|Lost to Follow-up|3|||
49174432|NCT03315793|158471879|FG000|Overall Study|Adverse Event|4|||
49174433|NCT03315793|158471880|FG001|Overall Study|Adverse Event|2|||
49174434|NCT03315793|158471879|FG000|Overall Study|Protocol Deviation|1|||
49174435|NCT03315793|158471880|FG001|Overall Study|Protocol Deviation|0|||
49174436|NCT03315793|158471879|FG000|Overall Study|Difficult for regular visit|0|||
49174437|NCT03315793|158471880|FG001|Overall Study|Difficult for regular visit|1|||
49174438|NCT03941873|158473351|FG000|Overall Study|Death|0|||
49174439|NCT03941873|158473352|FG001|Overall Study|Death|12|||
49174440|NCT03941873|158473353|FG002|Overall Study|Death|2|||
49174441|NCT03941873|158473354|FG003|Overall Study|Death|53|||
49174442|NCT03941873|158473351|FG000|Overall Study|Withdrawal by Subject|1|||
49174443|NCT03941873|158473352|FG001|Overall Study|Withdrawal by Subject|1|||
49174444|NCT03941873|158473353|FG002|Overall Study|Withdrawal by Subject|0|||
49174445|NCT03941873|158473354|FG003|Overall Study|Withdrawal by Subject|5|||
49174446|NCT03941873|158473351|FG000|Overall Study|Lost to Follow-up|1|||
49174447|NCT03941873|158473352|FG001|Overall Study|Lost to Follow-up|2|||
49174448|NCT03941873|158473353|FG002|Overall Study|Lost to Follow-up|0|||
49174449|NCT03941873|158473354|FG003|Overall Study|Lost to Follow-up|0|||
49174450|NCT03941873|158473351|FG000|Overall Study|Sponsor Decision|0|||
49174451|NCT03941873|158473352|FG001|Overall Study|Sponsor Decision|6|||
49174452|NCT03941873|158473353|FG002|Overall Study|Sponsor Decision|0|||
49174453|NCT03941873|158473354|FG003|Overall Study|Sponsor Decision|15|||
49174454|NCT00368745|158473356|FG000|Double-blind Treatment Period|Adverse Event|6|||
49174455|NCT00368745|158473357|FG001|Double-blind Treatment Period|Adverse Event|6|||
49174456|NCT00368745|158473356|FG000|Double-blind Treatment Period|Lack of Efficacy|7|||
49174457|NCT00368745|158473357|FG001|Double-blind Treatment Period|Lack of Efficacy|16|||
49174458|NCT00368745|158473356|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
49174459|NCT00368745|158473357|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
49174460|NCT00368745|158473356|FG000|Double-blind Treatment Period|Withdrawal by Subject|5|||
49174461|NCT00368745|158473357|FG001|Double-blind Treatment Period|Withdrawal by Subject|3|||
49174462|NCT00368745|158473356|FG000|Double-blind Treatment Period|Other|7|||
49174463|NCT00368745|158473357|FG001|Double-blind Treatment Period|Other|6|||
49174464|NCT00854724|158473358|FG000|First Intervention|Withdrawal by Subject|1|||
49174465|NCT00854724|158473359|FG001|First Intervention|Withdrawal by Subject|1|||
49174466|NCT00854724|158473358|FG000|Washout|Protocol Violation|1|||
49174467|NCT00854724|158473359|FG001|Washout|Protocol Violation|0|||
49174468|NCT00854724|158473358|FG000|Washout|Withdrawal by Subject|0|||
49174469|NCT00854724|158473359|FG001|Washout|Withdrawal by Subject|1|||
49174470|NCT00854724|158473358|FG000|Second Intervention|Protocol Violation|1|||
49174471|NCT00854724|158473359|FG001|Second Intervention|Protocol Violation|0|||
49174472|NCT00854724|158473358|FG000|Second Intervention|Physician Decision|0|||
49174473|NCT00854724|158473359|FG001|Second Intervention|Physician Decision|1|||
49174474|NCT02388165|158473372|FG000|Overall Study|Study terminated by sponsor|5|||
49174475|NCT02388165|158473373|FG001|Overall Study|Study terminated by sponsor|5|||
49174476|NCT02388165|158473372|FG000|Overall Study|Other|11|||
49174477|NCT02388165|158473373|FG001|Overall Study|Other|13|||
49174478|NCT02388165|158473372|FG000|Overall Study|No longer meet eligibility criteria|40|||
49174479|NCT02388165|158473373|FG001|Overall Study|No longer meet eligibility criteria|43|||
49174480|NCT02388165|158473372|FG000|Overall Study|Withdrawal of consent|31|||
49174481|NCT02388165|158473373|FG001|Overall Study|Withdrawal of consent|32|||
49174482|NCT02388165|158473372|FG000|Overall Study|Lost to Follow-up|19|||
49174483|NCT02388165|158473373|FG001|Overall Study|Lost to Follow-up|20|||
49174484|NCT02388165|158473372|FG000|Overall Study|Death|13|||
49174485|NCT02388165|158473373|FG001|Overall Study|Death|10|||
49174486|NCT02388165|158473372|FG000|Overall Study|Adverse Event|3|||
49174487|NCT02388165|158473373|FG001|Overall Study|Adverse Event|5|||
49174488|NCT02388165|158473372|FG000|Overall Study|Did not meet entrance criteria|5|||
49174489|NCT02388165|158473373|FG001|Overall Study|Did not meet entrance criteria|2|||
49174490|NCT04560816|158473374|FG000|Overall Study|Withdrawal by Subject|1|||
49174491|NCT04560816|158473375|FG001|Overall Study|Withdrawal by Subject|1|||
49174492|NCT04560816|158473376|FG002|Overall Study|Withdrawal by Subject|1|||
49174493|NCT04560816|158473377|FG003|Overall Study|Withdrawal by Subject|0|||
49174494|NCT04560816|158473378|FG004|Overall Study|Withdrawal by Subject|3|||
49174495|NCT04560816|158473379|FG005|Overall Study|Withdrawal by Subject|0|||
49174496|NCT04560816|158473374|FG000|Overall Study|Lost to Follow-up|1|||
49174497|NCT04560816|158473375|FG001|Overall Study|Lost to Follow-up|0|||
49174498|NCT04560816|158473376|FG002|Overall Study|Lost to Follow-up|0|||
49174499|NCT04560816|158473377|FG003|Overall Study|Lost to Follow-up|0|||
49174500|NCT04560816|158473378|FG004|Overall Study|Lost to Follow-up|0|||
49174501|NCT04560816|158473379|FG005|Overall Study|Lost to Follow-up|0|||
49174502|NCT04560816|158473374|FG000|Overall Study|Protocol Violation|1|||
49174503|NCT04560816|158473375|FG001|Overall Study|Protocol Violation|0|||
49174504|NCT04560816|158473376|FG002|Overall Study|Protocol Violation|0|||
49174505|NCT04560816|158473377|FG003|Overall Study|Protocol Violation|0|||
49174506|NCT04560816|158473378|FG004|Overall Study|Protocol Violation|0|||
49174507|NCT04560816|158473379|FG005|Overall Study|Protocol Violation|0|||
49174508|NCT01532921|158473382|FG000|Overall Study|Death|3|||
49174509|NCT01532921|158473382|FG000|Overall Study|Withdrawal by Subject|2|||
49174510|NCT01532921|158473382|FG000|Overall Study|Lost to Follow-up|3|||
49174511|NCT01532921|158473382|FG000|Overall Study|Physician Decision|7|||
49174512|NCT01532921|158473382|FG000|Overall Study|Device was explanted during procedure|1|||
49174513|NCT03818607|158473383|FG000|Period 1 (Week 1 to Week 52)|Adverse Event|0|||
49174514|NCT03818607|158473384|FG001|Period 1 (Week 1 to Week 52)|Adverse Event|1|||
49174515|NCT03818607|158473383|FG000|Period 2 (Week 53 to Week 79)|Participant's personal needs|0|||
49174516|NCT03818607|158473384|FG001|Period 2 (Week 53 to Week 79)|Participant's personal needs|1|||
49174517|NCT03818607|158473383|FG000|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|1|||
49174518|NCT03818607|158473384|FG001|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|0|||
49174519|NCT00967694|158473385|FG000|Overall Study|Withdrawal by Subject|6|||
49174520|NCT02321319|158473386|FG000|Overall Study|Product discontinued|5|||
49174521|NCT03520920|158473397|FG000|Overall Study|Death|13|||
48843190|NCT03482011|157267291|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
48843191|NCT03482011|157267292|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
48843192|NCT03482011|157267293|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
48843193|NCT03482011|157267294|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
48843194|NCT03482011|157267295|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
48843195|NCT03482011|157267288|FG000|Maintenance Period (36 Weeks)|Adverse Event|0|||
48843196|NCT03482011|157267289|FG001|Maintenance Period (36 Weeks)|Adverse Event|0|||
48843197|NCT03482011|157267290|FG002|Maintenance Period (36 Weeks)|Adverse Event|0|||
48843198|NCT03482011|157267291|FG003|Maintenance Period (36 Weeks)|Adverse Event|0|||
48843199|NCT03482011|157267292|FG004|Maintenance Period (36 Weeks)|Adverse Event|0|||
48843200|NCT03482011|157267293|FG005|Maintenance Period (36 Weeks)|Adverse Event|1|||
48843201|NCT03482011|157267294|FG006|Maintenance Period (36 Weeks)|Adverse Event|1|||
48843202|NCT03482011|157267295|FG007|Maintenance Period (36 Weeks)|Adverse Event|4|||
48843203|NCT03482011|157267288|FG000|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
48843204|NCT03482011|157267289|FG001|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
48843205|NCT03482011|157267290|FG002|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
48843206|NCT03482011|157267291|FG003|Maintenance Period (36 Weeks)|Lack of Efficacy|2|||
48843207|NCT03482011|157267292|FG004|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
48843208|NCT03482011|157267293|FG005|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
48843209|NCT03482011|157267294|FG006|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
48843210|NCT03482011|157267295|FG007|Maintenance Period (36 Weeks)|Lack of Efficacy|9|||
48843211|NCT03482011|157267288|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
48843212|NCT03482011|157267289|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
48843213|NCT03482011|157267290|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
48843214|NCT03482011|157267291|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
48843215|NCT03482011|157267292|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|2|||
48843216|NCT03482011|157267293|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
48843217|NCT03482011|157267294|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
48843218|NCT03482011|157267295|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
48843219|NCT03482011|157267288|FG000|Maintenance Period (36 Weeks)|Physician Decision|0|||
48843220|NCT03482011|157267289|FG001|Maintenance Period (36 Weeks)|Physician Decision|0|||
48926736|NCT01298323|157563333|FG000|Overall Study|Death|11|||
48843221|NCT03482011|157267290|FG002|Maintenance Period (36 Weeks)|Physician Decision|0|||
48843222|NCT03482011|157267291|FG003|Maintenance Period (36 Weeks)|Physician Decision|1|||
48843223|NCT03482011|157267292|FG004|Maintenance Period (36 Weeks)|Physician Decision|0|||
48926737|NCT01298323|157563334|FG001|Overall Study|Death|16|||
48843224|NCT03482011|157267293|FG005|Maintenance Period (36 Weeks)|Physician Decision|1|||
48843225|NCT03482011|157267294|FG006|Maintenance Period (36 Weeks)|Physician Decision|1|||
48843226|NCT03482011|157267295|FG007|Maintenance Period (36 Weeks)|Physician Decision|1|||
48843227|NCT03482011|157267288|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
48843228|NCT03482011|157267289|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
48843229|NCT03482011|157267290|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
48843230|NCT03482011|157267291|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
49174522|NCT03520920|158473398|FG001|Overall Study|Death|1|||
49174523|NCT03520920|158473399|FG002|Overall Study|Death|0|||
49174524|NCT03520920|158473397|FG000|Overall Study|Withdrawal by Subject|2|||
49174525|NCT03520920|158473398|FG001|Overall Study|Withdrawal by Subject|1|||
49174526|NCT03520920|158473399|FG002|Overall Study|Withdrawal by Subject|0|||
49174527|NCT03520920|158473397|FG000|Overall Study|Study Terminated by the Sponsor|5|||
48843231|NCT03482011|157267292|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
48843232|NCT03482011|157267293|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
48843233|NCT03482011|157267294|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
48843234|NCT03482011|157267295|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
48843235|NCT03482011|157267288|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
48843236|NCT03482011|157267289|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
48843237|NCT03482011|157267290|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
48843238|NCT03482011|157267291|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|2|||
48843239|NCT03482011|157267292|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
48843240|NCT03482011|157267293|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
48843241|NCT03482011|157267294|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
48843242|NCT03482011|157267295|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|5|||
48843243|NCT03482011|157267288|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
48843244|NCT03482011|157267289|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
48843245|NCT03482011|157267290|FG002|Follow-up Period (12 Weeks)|Adverse Event|0|||
48843246|NCT03482011|157267291|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
48843247|NCT03482011|157267292|FG004|Follow-up Period (12 Weeks)|Adverse Event|0|||
48843248|NCT03482011|157267293|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
48843249|NCT03482011|157267294|FG006|Follow-up Period (12 Weeks)|Adverse Event|1|||
48843250|NCT03482011|157267295|FG007|Follow-up Period (12 Weeks)|Adverse Event|4|||
48843251|NCT03482011|157267288|FG000|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
48843252|NCT03482011|157267289|FG001|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
48843253|NCT03482011|157267290|FG002|Follow-up Period (12 Weeks)|Lack of Efficacy|1|||
48843254|NCT03482011|157267291|FG003|Follow-up Period (12 Weeks)|Lack of Efficacy|3|||
48843255|NCT03482011|157267292|FG004|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
48926738|NCT01298323|157563333|FG000|Overall Study|Lost to Follow-up|1|||
48926739|NCT01298323|157563334|FG001|Overall Study|Lost to Follow-up|0|||
48926740|NCT01298323|157563333|FG000|Overall Study|Withdrawal by Subject|6|||
48926741|NCT01298323|157563334|FG001|Overall Study|Withdrawal by Subject|3|||
48843256|NCT03482011|157267293|FG005|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
49174528|NCT03520920|158473398|FG001|Overall Study|Study Terminated by the Sponsor|14|||
49174529|NCT03520920|158473399|FG002|Overall Study|Study Terminated by the Sponsor|5|||
48843257|NCT03482011|157267294|FG006|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
48843258|NCT03482011|157267295|FG007|Follow-up Period (12 Weeks)|Lack of Efficacy|6|||
48843259|NCT03482011|157267288|FG000|Follow-up Period (12 Weeks)|Physician Decision|0|||
48843260|NCT03482011|157267289|FG001|Follow-up Period (12 Weeks)|Physician Decision|0|||
48926742|NCT01298323|157563333|FG000|Overall Study|Protocol Violation|1|||
49174530|NCT04952597|158473407|FG000|Overall Study|Death|12|||
48843261|NCT03482011|157267290|FG002|Follow-up Period (12 Weeks)|Physician Decision|0|||
48843262|NCT03482011|157267291|FG003|Follow-up Period (12 Weeks)|Physician Decision|0|||
48843263|NCT03482011|157267292|FG004|Follow-up Period (12 Weeks)|Physician Decision|0|||
48843264|NCT03482011|157267293|FG005|Follow-up Period (12 Weeks)|Physician Decision|0|||
48843265|NCT03482011|157267294|FG006|Follow-up Period (12 Weeks)|Physician Decision|0|||
48843266|NCT03482011|157267295|FG007|Follow-up Period (12 Weeks)|Physician Decision|1|||
48843267|NCT03482011|157267288|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
48843268|NCT03482011|157267289|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
48843269|NCT03482011|157267290|FG002|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
48843270|NCT03482011|157267291|FG003|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
48843271|NCT03482011|157267292|FG004|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
48843272|NCT03482011|157267293|FG005|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
48843273|NCT03482011|157267294|FG006|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
48843274|NCT03482011|157267295|FG007|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
48843275|NCT00424645|157267298|FG000|Overall Study|Death|1|||
48843276|NCT00424645|157267299|FG001|Overall Study|Death|0|||
48843277|NCT03074331|157267300|FG000|Overall Study|Enrolled but Not Treated|1|||
48843278|NCT03074331|157267300|FG000|Overall Study|Lost to Follow-up|5|||
48843279|NCT03074331|157267300|FG000|Overall Study|Withdrew Consent|1|||
48843280|NCT02555215|157267302|FG000|Overall Study|Other|1|||
49174531|NCT04952597|158473408|FG001|Overall Study|Death|13|||
49174532|NCT04952597|158473409|FG002|Overall Study|Death|14|||
49174533|NCT04952597|158473407|FG000|Overall Study|Withdrawal by Subject|1|||
49174534|NCT04952597|158473408|FG001|Overall Study|Withdrawal by Subject|0|||
49174535|NCT04952597|158473409|FG002|Overall Study|Withdrawal by Subject|3|||
49174536|NCT04952597|158473407|FG000|Overall Study|Lost to Follow-up|0|||
49174537|NCT04952597|158473408|FG001|Overall Study|Lost to Follow-up|1|||
49174538|NCT04952597|158473409|FG002|Overall Study|Lost to Follow-up|1|||
49174539|NCT01703091|158473410|FG000|Overall Study|Adverse Event|5|||
49174540|NCT01703091|158473411|FG001|Overall Study|Adverse Event|3|||
49174541|NCT01703091|158473410|FG000|Overall Study|Physician Decision|2|||
48843281|NCT02555215|157267302|FG000|Overall Study|Investigator Decision|2|||
48843282|NCT01000480|157267304|FG000|Induction Phase|Adverse Event|2|||
48926743|NCT01298323|157563334|FG001|Overall Study|Protocol Violation|0|||
48843283|NCT01000480|157267304|FG000|Induction Phase|Lost to Follow-up|1|||
48926744|NCT01298323|157563333|FG000|Overall Study|Other|10|||
49174542|NCT01703091|158473411|FG001|Overall Study|Physician Decision|1|||
49174543|NCT01703091|158473410|FG000|Overall Study|Withdrawal by Subject|1|||
48843284|NCT01000480|157267304|FG000|Induction Phase|Physician Decision|1|||
48843285|NCT01000480|157267304|FG000|Induction Phase|Entry Criteria Not Met|3|||
48843286|NCT01000480|157267304|FG000|Concurrent Therapy Phase|Adverse Event|4|||
48843287|NCT01000480|157267304|FG000|Concurrent Therapy Phase|Protocol Violation|2|||
48843288|NCT01000480|157267304|FG000|Concurrent Therapy Phase|Withdrawal by Subject|3|||
48843289|NCT01000480|157267304|FG000|Concurrent Therapy Phase|Physician Decision|1|||
48843290|NCT00520546|157267309|FG000|Overall Study|Withdrawal by Subject|1|||
48843291|NCT00520546|157267309|FG000|Overall Study|failed radiopharmaceut. synthesis of FEC|5|||
48843292|NCT04600752|157267310|FG000|Overall Study|Physician Decision|0|||
48843293|NCT04600752|157267311|FG001|Overall Study|Physician Decision|0|||
48843294|NCT04600752|157267312|FG002|Overall Study|Physician Decision|1|||
48843295|NCT04600752|157267310|FG000|Overall Study|Adverse Event|0|||
48843296|NCT04600752|157267311|FG001|Overall Study|Adverse Event|1|||
48843297|NCT04600752|157267312|FG002|Overall Study|Adverse Event|0|||
48843298|NCT04600752|157267310|FG000|Overall Study|Withdrawal by Subject|2|||
48843299|NCT04600752|157267311|FG001|Overall Study|Withdrawal by Subject|1|||
48843300|NCT04600752|157267312|FG002|Overall Study|Withdrawal by Subject|0|||
48843301|NCT04600752|157267310|FG000|Overall Study|Lack of Efficacy|1|||
48843302|NCT04600752|157267311|FG001|Overall Study|Lack of Efficacy|0|||
48843303|NCT04600752|157267312|FG002|Overall Study|Lack of Efficacy|0|||
48843304|NCT03988023|157267313|FG000|Overall Study|Non-compliance|3|||
48843305|NCT03988023|157267314|FG001|Overall Study|Non-compliance|0|||
48843306|NCT03988023|157267313|FG000|Overall Study|Withdrawal by Subject|39|||
48843307|NCT03988023|157267314|FG001|Overall Study|Withdrawal by Subject|37|||
48843308|NCT03988023|157267313|FG000|Overall Study|Adverse Event|0|||
48843309|NCT03988023|157267314|FG001|Overall Study|Adverse Event|2|||
48843310|NCT03988023|157267313|FG000|Overall Study|Physician Decision|0|||
48843311|NCT03988023|157267314|FG001|Overall Study|Physician Decision|1|||
48843312|NCT03988023|157267313|FG000|Overall Study|Lost to Follow-up|5|||
48843313|NCT03988023|157267314|FG001|Overall Study|Lost to Follow-up|8|||
48843314|NCT03988023|157267313|FG000|Overall Study|Sponsor decision to terminate follow up|10|||
48843315|NCT03988023|157267314|FG001|Overall Study|Sponsor decision to terminate follow up|12|||
48843316|NCT03988023|157267313|FG000|Overall Study|Lack of Efficacy|3|||
48843317|NCT03988023|157267314|FG001|Overall Study|Lack of Efficacy|1|||
48843318|NCT03988023|157267313|FG000|Overall Study|COVID-19 pandemic|225|||
48843319|NCT03988023|157267314|FG001|Overall Study|COVID-19 pandemic|227|||
48843320|NCT00174382|157267321|FG000|Overall Study|Death|2|||
48843321|NCT00174382|157267321|FG000|Overall Study|Adverse Event|19|||
48843322|NCT00174382|157267321|FG000|Overall Study|Withdrawal by Subject|6|||
48843323|NCT00174382|157267321|FG000|Overall Study|Protocol Violation|3|||
48843324|NCT00174382|157267321|FG000|Overall Study|Arrived early for last visit in error|1|||
48843325|NCT00174382|157267321|FG000|Overall Study|Subject felt pill not effective enough|1|||
48843326|NCT00174382|157267321|FG000|Overall Study|Lost to Follow-up|1|||
48843327|NCT01493778|157267322|FG000|Overall Study|Withdrawal by Subject|8|||
48843328|NCT03903822|157267323|FG000|Treatment Phase (6 Weeks)|Adverse Event|3|||
48843329|NCT03903822|157267324|FG001|Treatment Phase (6 Weeks)|Adverse Event|3|||
48843330|NCT03903822|157267325|FG002|Treatment Phase (6 Weeks)|Adverse Event|1|||
48843331|NCT03903822|157267326|FG003|Treatment Phase (6 Weeks)|Adverse Event|1|||
48843332|NCT03903822|157267327|FG004|Treatment Phase (6 Weeks)|Adverse Event|1|||
48843333|NCT03903822|157267328|FG005|Treatment Phase (6 Weeks)|Adverse Event|6|||
48843334|NCT03903822|157267329|FG006|Treatment Phase (6 Weeks)|Adverse Event|1|||
48843335|NCT03903822|157267330|FG007|Treatment Phase (6 Weeks)|Adverse Event|0|||
48843336|NCT03903822|157267323|FG000|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
48843337|NCT03903822|157267324|FG001|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
48843338|NCT03903822|157267325|FG002|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
48843339|NCT03903822|157267326|FG003|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
48843340|NCT03903822|157267327|FG004|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
48843341|NCT03903822|157267328|FG005|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
48843342|NCT03903822|157267329|FG006|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
48843343|NCT03903822|157267330|FG007|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
48843344|NCT03903822|157267323|FG000|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
48843345|NCT03903822|157267324|FG001|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
48843346|NCT03903822|157267325|FG002|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
48843347|NCT03903822|157267326|FG003|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
48843348|NCT03903822|157267327|FG004|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
48843349|NCT03903822|157267328|FG005|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
49015175|NCT00384033|157892086|FG002|Overall Study|Failed to return|2|||
48843350|NCT03903822|157267329|FG006|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
48843351|NCT03903822|157267330|FG007|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
48843352|NCT03903822|157267323|FG000|Treatment Phase (6 Weeks)|Physician Decision|0|||
48843353|NCT03903822|157267324|FG001|Treatment Phase (6 Weeks)|Physician Decision|2|||
48843354|NCT03903822|157267325|FG002|Treatment Phase (6 Weeks)|Physician Decision|0|||
48843355|NCT03903822|157267326|FG003|Treatment Phase (6 Weeks)|Physician Decision|0|||
48843356|NCT03903822|157267327|FG004|Treatment Phase (6 Weeks)|Physician Decision|0|||
48843357|NCT03903822|157267328|FG005|Treatment Phase (6 Weeks)|Physician Decision|0|||
48843358|NCT03903822|157267329|FG006|Treatment Phase (6 Weeks)|Physician Decision|0|||
48843359|NCT03903822|157267330|FG007|Treatment Phase (6 Weeks)|Physician Decision|0|||
49015176|NCT00384033|157892087|FG003|Overall Study|Failed to return|2|||
48843360|NCT03903822|157267323|FG000|Treatment Phase (6 Weeks)|Pregnancy|0|||
49015177|NCT00384033|157892084|FG000|Overall Study|Physician Decision|1|||
49015178|NCT00384033|157892085|FG001|Overall Study|Physician Decision|0|||
49015179|NCT00384033|157892086|FG002|Overall Study|Physician Decision|0|||
49015180|NCT00384033|157892087|FG003|Overall Study|Physician Decision|0|||
49015181|NCT00384033|157892084|FG000|Overall Study|Lost to Follow-up|6|||
49015182|NCT00384033|157892085|FG001|Overall Study|Lost to Follow-up|12|||
49015183|NCT00384033|157892086|FG002|Overall Study|Lost to Follow-up|7|||
49015184|NCT00384033|157892087|FG003|Overall Study|Lost to Follow-up|7|||
49015185|NCT00384033|157892084|FG000|Overall Study|Other|2|||
49015186|NCT00384033|157892085|FG001|Overall Study|Other|0|||
49015187|NCT00384033|157892086|FG002|Overall Study|Other|0|||
49015188|NCT00384033|157892087|FG003|Overall Study|Other|0|||
49015189|NCT00384033|157892084|FG000|Overall Study|Protocol Violation|5|||
49015190|NCT00384033|157892085|FG001|Overall Study|Protocol Violation|0|||
49015191|NCT00384033|157892086|FG002|Overall Study|Protocol Violation|5|||
49015192|NCT00384033|157892087|FG003|Overall Study|Protocol Violation|6|||
49015193|NCT00384033|157892084|FG000|Overall Study|Withdrawal by Subject|6|||
49015194|NCT00384033|157892085|FG001|Overall Study|Withdrawal by Subject|2|||
49015195|NCT00384033|157892086|FG002|Overall Study|Withdrawal by Subject|5|||
49015196|NCT00384033|157892087|FG003|Overall Study|Withdrawal by Subject|2|||
49015197|NCT00384033|157892084|FG000|Overall Study|Lack of Efficacy|7|||
49015198|NCT00384033|157892085|FG001|Overall Study|Lack of Efficacy|3|||
49015199|NCT00384033|157892086|FG002|Overall Study|Lack of Efficacy|3|||
49015200|NCT00384033|157892087|FG003|Overall Study|Lack of Efficacy|1|||
49015201|NCT00384033|157892084|FG000|Overall Study|Randomized but not treated|3|||
49015202|NCT00384033|157892085|FG001|Overall Study|Randomized but not treated|7|||
49015203|NCT00384033|157892086|FG002|Overall Study|Randomized but not treated|10|||
49015204|NCT00384033|157892087|FG003|Overall Study|Randomized but not treated|2|||
49015205|NCT02444533|157892088|FG000|Overall Study|Not able to complete forms|0|||
49015206|NCT02444533|157892089|FG001|Overall Study|Not able to complete forms|2|||
49015207|NCT02444533|157892088|FG000|Overall Study|Only gave post-procedure complications|2|||
49015208|NCT02444533|157892089|FG001|Overall Study|Only gave post-procedure complications|2|||
49015209|NCT03349333|157892090|FG000|Overall Study|Progression of Disease|36|||
49015210|NCT03349333|157892090|FG000|Overall Study|Adverse Event|11|||
49174544|NCT01703091|158473411|FG001|Overall Study|Withdrawal by Subject|0|||
48843361|NCT03903822|157267324|FG001|Treatment Phase (6 Weeks)|Pregnancy|0|||
49174545|NCT01703091|158473410|FG000|Overall Study|Sponsor Decision|1|||
48843362|NCT03903822|157267325|FG002|Treatment Phase (6 Weeks)|Pregnancy|0|||
48843363|NCT03903822|157267326|FG003|Treatment Phase (6 Weeks)|Pregnancy|1|||
48843364|NCT03903822|157267327|FG004|Treatment Phase (6 Weeks)|Pregnancy|1|||
48843365|NCT03903822|157267328|FG005|Treatment Phase (6 Weeks)|Pregnancy|0|||
48843366|NCT03903822|157267329|FG006|Treatment Phase (6 Weeks)|Pregnancy|0|||
48843367|NCT03903822|157267330|FG007|Treatment Phase (6 Weeks)|Pregnancy|0|||
49174546|NCT01703091|158473411|FG001|Overall Study|Sponsor Decision|0|||
49174547|NCT01092780|158473416|FG000|Washout Period 1|Adverse Event|0|||
49174548|NCT01092780|158473417|FG001|Washout Period 1|Adverse Event|1|||
49174549|NCT01092780|158473418|FG002|Washout Period 1|Adverse Event|0|||
49174550|NCT01092780|158473419|FG003|Washout Period 1|Adverse Event|0|||
49174551|NCT01092780|158473416|FG000|Washout Period 1|Noncompliance with nCPAP|1|||
49174552|NCT01092780|158473417|FG001|Washout Period 1|Noncompliance with nCPAP|0|||
49174553|NCT01092780|158473418|FG002|Washout Period 1|Noncompliance with nCPAP|0|||
49174554|NCT01092780|158473419|FG003|Washout Period 1|Noncompliance with nCPAP|0|||
49174555|NCT01092780|158473416|FG000|Washout Period 2|Adverse Event|0|||
49174556|NCT01092780|158473417|FG001|Washout Period 2|Adverse Event|1|||
49174557|NCT01092780|158473418|FG002|Washout Period 2|Adverse Event|1|||
49174558|NCT01092780|158473419|FG003|Washout Period 2|Adverse Event|0|||
49174559|NCT03994211|158473424|FG000|Core Phase|Adverse Event|0|||
49174560|NCT03994211|158473425|FG001|Core Phase|Adverse Event|1|||
49174561|NCT03994211|158473426|FG002|Core Phase|Adverse Event|0|||
49174562|NCT03994211|158473424|FG000|Extension Phase|Adverse Event|0|||
49174563|NCT03994211|158473425|FG001|Extension Phase|Adverse Event|0|||
49174564|NCT03994211|158473426|FG002|Extension Phase|Adverse Event|1|||
49174565|NCT03994211|158473424|FG000|Extension Phase|Physician Decision|0|||
49174566|NCT03994211|158473425|FG001|Extension Phase|Physician Decision|0|||
49174567|NCT03994211|158473426|FG002|Extension Phase|Physician Decision|1|||
49174568|NCT03994211|158473424|FG000|Extension Phase|Progressive Disease|0|||
49174569|NCT03994211|158473425|FG001|Extension Phase|Progressive Disease|0|||
49174570|NCT03994211|158473426|FG002|Extension Phase|Progressive Disease|20|||
49174571|NCT03994211|158473424|FG000|Extension Phase|Withdrawal by Subject|0|||
49174572|NCT03994211|158473425|FG001|Extension Phase|Withdrawal by Subject|0|||
49174573|NCT03994211|158473426|FG002|Extension Phase|Withdrawal by Subject|2|||
49174574|NCT01555073|158473431|FG000|Overall Study|Lost to Follow-up|1|||
49174575|NCT01555073|158473432|FG001|Overall Study|Lost to Follow-up|2|||
49174576|NCT01555073|158473433|FG002|Overall Study|Lost to Follow-up|0|||
49174577|NCT01555073|158473434|FG003|Overall Study|Lost to Follow-up|5|||
49174578|NCT01355679|158473435|FG000|Overall Study|benign tumor types found at biopsy|2|||
49174579|NCT01066104|158473436|FG000|Overall Study|Adverse Event|1|||
49174580|NCT01066104|158473437|FG001|Overall Study|Adverse Event|1|||
49174581|NCT01066104|158473436|FG000|Overall Study|Protocol Violation|1|||
49174582|NCT01066104|158473437|FG001|Overall Study|Protocol Violation|0|||
49174583|NCT04660552|158473438|FG000|Overall Study|Withdrawal by Subject|3|||
49174584|NCT04660552|158473439|FG001|Overall Study|Withdrawal by Subject|1|||
49174585|NCT00964002|158473444|FG000|Overall Study|Protocol Violation|8|||
49174586|NCT00271856|158473450|FG000|Overall Study|Withdrawal by Subject|1|||
49174587|NCT00271856|158473451|FG001|Overall Study|Withdrawal by Subject|7|||
49174588|NCT00271856|158473450|FG000|Overall Study|Lost to Follow-up|10|||
48843368|NCT03903822|157267323|FG000|Treatment Phase (6 Weeks)|Protocol Violation|0|||
48843369|NCT03903822|157267324|FG001|Treatment Phase (6 Weeks)|Protocol Violation|0|||
48843370|NCT03903822|157267325|FG002|Treatment Phase (6 Weeks)|Protocol Violation|0|||
48843371|NCT03903822|157267326|FG003|Treatment Phase (6 Weeks)|Protocol Violation|1|||
48843372|NCT03903822|157267327|FG004|Treatment Phase (6 Weeks)|Protocol Violation|0|||
48843373|NCT03903822|157267328|FG005|Treatment Phase (6 Weeks)|Protocol Violation|0|||
48843374|NCT03903822|157267329|FG006|Treatment Phase (6 Weeks)|Protocol Violation|0|||
48843375|NCT03903822|157267330|FG007|Treatment Phase (6 Weeks)|Protocol Violation|0|||
48843376|NCT03903822|157267323|FG000|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
48843377|NCT03903822|157267324|FG001|Treatment Phase (6 Weeks)|Withdrawal by Subject|4|||
48843378|NCT03903822|157267325|FG002|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
48843379|NCT03903822|157267326|FG003|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
48843380|NCT03903822|157267327|FG004|Treatment Phase (6 Weeks)|Withdrawal by Subject|1|||
48843381|NCT03903822|157267328|FG005|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
49174589|NCT00271856|158473451|FG001|Overall Study|Lost to Follow-up|11|||
49174590|NCT02091362|158473452|FG000|Period 1|Protocol Violation|1|||
49174591|NCT02091362|158473453|FG001|Period 1|Protocol Violation|0|||
49174592|NCT02091362|158473452|FG000|Period 1|Withdrawal by Subject|2|||
49174593|NCT02091362|158473453|FG001|Period 1|Withdrawal by Subject|3|||
49174594|NCT02091362|158473452|FG000|Period 1|Lost to Follow-up|0|||
49174595|NCT02091362|158473453|FG001|Period 1|Lost to Follow-up|1|||
49174596|NCT02091362|158473452|FG000|Period 1|Adverse Event|2|||
49174597|NCT02091362|158473453|FG001|Period 1|Adverse Event|0|||
49174598|NCT02091362|158473452|FG000|Wash-out|Lost to Follow-up|1|||
49174599|NCT02091362|158473453|FG001|Wash-out|Lost to Follow-up|1|||
49174600|NCT02091362|158473452|FG000|Wash-out|Withdrawal by Subject|0|||
49174601|NCT02091362|158473453|FG001|Wash-out|Withdrawal by Subject|2|||
49174602|NCT02091362|158473452|FG000|Period 2|Adverse Event|1|||
49174603|NCT02091362|158473453|FG001|Period 2|Adverse Event|0|||
49174604|NCT02091362|158473452|FG000|Period 2|Lost to Follow-up|0|||
49174605|NCT02091362|158473453|FG001|Period 2|Lost to Follow-up|1|||
49174606|NCT02091362|158473452|FG000|Period 2|Withdrawal by Subject|1|||
49174607|NCT02091362|158473453|FG001|Period 2|Withdrawal by Subject|1|||
49174608|NCT04004221|158473456|FG000|Overall Study|Death|89|||
49174609|NCT04004221|158473456|FG000|Overall Study|Withdrawal by Subject|5|||
49174610|NCT04004221|158473456|FG000|Overall Study|Participants transferred to Long-Term Extension (LTE) study|9|||
49174611|NCT04004221|158473456|FG000|Overall Study|Sponsor Decision|9|||
49174612|NCT04004221|158473456|FG000|Overall Study|Participant refused to enter LTE|1|||
49174613|NCT04470050|158473457|FG000|Double-blind Treatment Phase|Adverse Event|0|||
49174614|NCT04470050|158473458|FG001|Double-blind Treatment Phase|Adverse Event|0|||
49174615|NCT04470050|158473459|FG002|Double-blind Treatment Phase|Adverse Event|0|||
49174616|NCT04470050|158473460|FG003|Double-blind Treatment Phase|Adverse Event|1|||
49174617|NCT04470050|158473461|FG004|Double-blind Treatment Phase|Adverse Event|0|||
49174618|NCT04470050|158473462|FG005|Double-blind Treatment Phase|Adverse Event|0|||
49174619|NCT04470050|158473463|FG006|Double-blind Treatment Phase|Adverse Event|0|||
49174620|NCT04470050|158473457|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
49174621|NCT04470050|158473458|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
49174622|NCT04470050|158473459|FG002|Double-blind Treatment Phase|Lost to Follow-up|0|||
49174623|NCT04470050|158473460|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
49174624|NCT04470050|158473461|FG004|Double-blind Treatment Phase|Lost to Follow-up|1|||
49174625|NCT04470050|158473462|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
49174626|NCT04470050|158473463|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
49174627|NCT04470050|158473457|FG000|Double-blind Treatment Phase|Withdrawal by Subject|10|||
49174628|NCT04470050|158473458|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
49174629|NCT04470050|158473459|FG002|Double-blind Treatment Phase|Withdrawal by Subject|15|||
49174630|NCT04470050|158473460|FG003|Double-blind Treatment Phase|Withdrawal by Subject|11|||
49174631|NCT04470050|158473461|FG004|Double-blind Treatment Phase|Withdrawal by Subject|15|||
49174632|NCT04470050|158473462|FG005|Double-blind Treatment Phase|Withdrawal by Subject|9|||
49174633|NCT04470050|158473463|FG006|Double-blind Treatment Phase|Withdrawal by Subject|19|||
49174634|NCT01581021|158473466|FG000|Overall Study|Lost to Follow-up|4|||
49174635|NCT01581021|158473467|FG001|Overall Study|Lost to Follow-up|6|||
49174636|NCT01581021|158473466|FG000|Overall Study|More than 2 hooks in thoracic|3|||
49174637|NCT01581021|158473467|FG001|Overall Study|More than 2 hooks in thoracic|0|||
49174638|NCT01581021|158473466|FG000|Overall Study|Neuromuscular|2|||
49174639|NCT01581021|158473467|FG001|Overall Study|Neuromuscular|1|||
49174640|NCT01581021|158473466|FG000|Overall Study|Not Randomized|1|||
49174641|NCT01581021|158473467|FG001|Overall Study|Not Randomized|2|||
49174642|NCT01581021|158473466|FG000|Overall Study|Lenke 6 Classification|0|||
49174643|NCT01581021|158473467|FG001|Overall Study|Lenke 6 Classification|1|||
49174644|NCT01581021|158473466|FG000|Overall Study|Lack of Efficacy|0|||
49174645|NCT01581021|158473467|FG001|Overall Study|Lack of Efficacy|1|||
49174646|NCT00613327|158473476|FG000|Overall Study|Adverse Event|38|||
49174647|NCT00613327|158473476|FG000|Overall Study|Lost to Follow-up|8|||
49174648|NCT00613327|158473476|FG000|Overall Study|Withdrawal by Subject|6|||
49174649|NCT00613327|158473476|FG000|Overall Study|Protocol Violation|2|||
49174650|NCT00613327|158473476|FG000|Overall Study|Other|47|||
49174651|NCT03028129|158473477|FG000|Overall Study|Adverse Event|13|||
49174652|NCT03028129|158473478|FG001|Overall Study|Adverse Event|2|||
49174653|NCT03028129|158473477|FG000|Overall Study|Lost to Follow-up|50|||
49174654|NCT03028129|158473478|FG001|Overall Study|Lost to Follow-up|38|||
49174655|NCT03028129|158473477|FG000|Overall Study|Physician Decision|0|||
49174656|NCT03028129|158473478|FG001|Overall Study|Physician Decision|1|||
49174657|NCT03028129|158473477|FG000|Overall Study|Protocol Violation|1|||
49174658|NCT03028129|158473478|FG001|Overall Study|Protocol Violation|1|||
49174659|NCT03028129|158473477|FG000|Overall Study|Withdrawal by Subject|62|||
49174660|NCT03028129|158473478|FG001|Overall Study|Withdrawal by Subject|45|||
49174661|NCT04222699|158473481|FG000|Overall Study|Lost to Follow-up|2|||
49174662|NCT00700882|158473482|FG000|Overall Study|Never received treatment|6|||
49174663|NCT00700882|158473482|FG000|Overall Study|Ineligible|2|||
49174664|NCT00700882|158473482|FG000|Overall Study|No KIT mutation|51|||
49174665|NCT01076205|158473485|FG000|Overall Study|Adverse Drug Reaction|299|||
49174666|NCT01076205|158473485|FG000|Overall Study|Lack of Effectiveness|1423|||
49174667|NCT01076205|158473485|FG000|Overall Study|Other Reason|1075|||
49174668|NCT01076205|158473485|FG000|Overall Study|Unknown Reason|71|||
49174669|NCT01076205|158473485|FG000|Overall Study|Lost to Follow-up|3151|||
49174670|NCT00361231|158473486|FG000|Overall Study|Physician Decision|3|||
49174671|NCT00361231|158473486|FG000|Overall Study|Symptomatic deterioration|5|||
49174672|NCT00361231|158473486|FG000|Overall Study|Radiographic disease progression|16|||
48843382|NCT03903822|157267329|FG006|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
48843383|NCT03903822|157267330|FG007|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
48843384|NCT03903822|157267323|FG000|Treatment Phase (6 Weeks)|Refused Further Treatment|2|||
48843385|NCT03903822|157267324|FG001|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
49174673|NCT00361231|158473486|FG000|Overall Study|Withdrawal by Subject|4|||
49174674|NCT00361231|158473486|FG000|Overall Study|Adverse Event|6|||
49174675|NCT01030952|158473487|FG000|Overall Study|Protocol Violation|0|||
49174676|NCT01030952|158473488|FG001|Overall Study|Protocol Violation|1|||
49174677|NCT01030952|158473487|FG000|Overall Study|Informed consent withdrawal|1|||
49174678|NCT01030952|158473488|FG001|Overall Study|Informed consent withdrawal|0|||
49174679|NCT01030952|158473487|FG000|Overall Study|Lost to Follow-up|0|||
49174680|NCT01030952|158473488|FG001|Overall Study|Lost to Follow-up|1|||
49174681|NCT01030952|158473487|FG000|Overall Study|Unexplained|1|||
49174682|NCT01030952|158473488|FG001|Overall Study|Unexplained|1|||
49174683|NCT01732510|158473497|FG000|Overall Study|Adverse Event|0|||
49174684|NCT01732510|158473498|FG001|Overall Study|Adverse Event|1|||
49174685|NCT01732510|158473499|FG002|Overall Study|Adverse Event|1|||
49174686|NCT01732510|158473500|FG003|Overall Study|Adverse Event|0|||
49174687|NCT01732510|158473501|FG004|Overall Study|Adverse Event|0|||
49174688|NCT01732510|158473502|FG005|Overall Study|Adverse Event|0|||
49174689|NCT01732510|158473503|FG006|Overall Study|Adverse Event|1|||
49174690|NCT01732510|158473497|FG000|Overall Study|Protocol Violation|0|||
49174691|NCT01732510|158473498|FG001|Overall Study|Protocol Violation|0|||
49174692|NCT01732510|158473499|FG002|Overall Study|Protocol Violation|0|||
48843386|NCT03903822|157267325|FG002|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
48843387|NCT03903822|157267326|FG003|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
48843388|NCT03903822|157267327|FG004|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
49174693|NCT01732510|158473500|FG003|Overall Study|Protocol Violation|1|||
49174694|NCT01732510|158473501|FG004|Overall Study|Protocol Violation|0|||
49174695|NCT01732510|158473502|FG005|Overall Study|Protocol Violation|0|||
49174696|NCT01732510|158473503|FG006|Overall Study|Protocol Violation|0|||
49174697|NCT01732510|158473497|FG000|Overall Study|Withdrawal by Subject|1|||
49174698|NCT01732510|158473498|FG001|Overall Study|Withdrawal by Subject|3|||
49174699|NCT01732510|158473499|FG002|Overall Study|Withdrawal by Subject|2|||
49174700|NCT01732510|158473500|FG003|Overall Study|Withdrawal by Subject|1|||
49174701|NCT01732510|158473501|FG004|Overall Study|Withdrawal by Subject|5|||
49174702|NCT01732510|158473502|FG005|Overall Study|Withdrawal by Subject|0|||
49174703|NCT01732510|158473503|FG006|Overall Study|Withdrawal by Subject|1|||
49174704|NCT01732510|158473497|FG000|Overall Study|Lost to Follow-up|0|||
49174705|NCT01732510|158473498|FG001|Overall Study|Lost to Follow-up|0|||
49174706|NCT01732510|158473499|FG002|Overall Study|Lost to Follow-up|1|||
49174707|NCT01732510|158473500|FG003|Overall Study|Lost to Follow-up|1|||
49174708|NCT01732510|158473501|FG004|Overall Study|Lost to Follow-up|0|||
49174709|NCT01732510|158473502|FG005|Overall Study|Lost to Follow-up|1|||
49174710|NCT01732510|158473503|FG006|Overall Study|Lost to Follow-up|0|||
49174711|NCT01732510|158473497|FG000|Overall Study|Physician Decision|0|||
49174712|NCT01732510|158473498|FG001|Overall Study|Physician Decision|1|||
49174713|NCT01732510|158473499|FG002|Overall Study|Physician Decision|0|||
49174714|NCT01732510|158473500|FG003|Overall Study|Physician Decision|0|||
49174715|NCT01732510|158473501|FG004|Overall Study|Physician Decision|0|||
49174716|NCT01732510|158473502|FG005|Overall Study|Physician Decision|0|||
49174717|NCT01732510|158473503|FG006|Overall Study|Physician Decision|0|||
49174718|NCT01732510|158473497|FG000|Overall Study|Pregnancy|0|||
49174719|NCT01732510|158473498|FG001|Overall Study|Pregnancy|0|||
49174720|NCT01732510|158473499|FG002|Overall Study|Pregnancy|0|||
49174721|NCT01732510|158473500|FG003|Overall Study|Pregnancy|1|||
49174722|NCT01732510|158473501|FG004|Overall Study|Pregnancy|0|||
49174723|NCT01732510|158473502|FG005|Overall Study|Pregnancy|0|||
49174724|NCT01732510|158473503|FG006|Overall Study|Pregnancy|0|||
49174725|NCT01732510|158473497|FG000|Overall Study|Study Terminated By Sponsor|0|||
49174726|NCT01732510|158473498|FG001|Overall Study|Study Terminated By Sponsor|0|||
48843389|NCT03903822|157267328|FG005|Treatment Phase (6 Weeks)|Refused Further Treatment|1|||
48843390|NCT03903822|157267329|FG006|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
49174727|NCT01732510|158473499|FG002|Overall Study|Study Terminated By Sponsor|0|||
49174728|NCT01732510|158473500|FG003|Overall Study|Study Terminated By Sponsor|1|||
49174729|NCT01732510|158473501|FG004|Overall Study|Study Terminated By Sponsor|0|||
49174730|NCT01732510|158473502|FG005|Overall Study|Study Terminated By Sponsor|12|||
49174731|NCT01732510|158473503|FG006|Overall Study|Study Terminated By Sponsor|6|||
49174732|NCT00313144|158473504|FG000|Overall Study|Discontinue Aralast ≥4 consecutive doses|12|||
49174733|NCT00313144|158473504|FG000|Overall Study|Death|7|||
49174734|NCT00313144|158473504|FG000|Overall Study|Lost to Follow-up|5|||
49174735|NCT00313144|158473504|FG000|Overall Study|Withdrawal by Subject|4|||
49174736|NCT00313144|158473504|FG000|Overall Study|Terminated by sponsor/ homecare provider|4|||
49174737|NCT00313144|158473504|FG000|Overall Study|Physician Decision|4|||
49174738|NCT00313144|158473504|FG000|Overall Study|Adverse event - transient|5|||
49174739|NCT00313144|158473504|FG000|Overall Study|Liver transplant|1|||
49174740|NCT00313144|158473504|FG000|Overall Study|Insurance (homecare provider) change|1|||
49174741|NCT00313144|158473504|FG000|Overall Study|Change to different product|1|||
49174742|NCT00313144|158473504|FG000|Overall Study|Due to termination of the study|66|||
49174743|NCT00875485|158474984|FG000|Challenge Dose Epoch|Pregnancy|1|||
49174744|NCT00875485|158474985|FG001|Challenge Dose Epoch|Pregnancy|0|||
49174745|NCT02719691|158474992|FG000|Overall Study|Physician Decision|0|||
49174746|NCT02719691|158474993|FG001|Overall Study|Physician Decision|0|||
49174747|NCT02719691|158474994|FG002|Overall Study|Physician Decision|1|||
49174748|NCT02719691|158474995|FG003|Overall Study|Physician Decision|0|||
49174749|NCT02719691|158474996|FG004|Overall Study|Physician Decision|0|||
49174750|NCT02719691|158474997|FG005|Overall Study|Physician Decision|0|||
49174751|NCT02719691|158474998|FG006|Overall Study|Physician Decision|0|||
49174752|NCT02719691|158474992|FG000|Overall Study|Withdrawal by Subject|0|||
49174753|NCT02719691|158474993|FG001|Overall Study|Withdrawal by Subject|0|||
49174754|NCT02719691|158474994|FG002|Overall Study|Withdrawal by Subject|0|||
49174755|NCT02719691|158474995|FG003|Overall Study|Withdrawal by Subject|0|||
49174756|NCT02719691|158474996|FG004|Overall Study|Withdrawal by Subject|0|||
49174757|NCT02719691|158474997|FG005|Overall Study|Withdrawal by Subject|1|||
49174758|NCT02719691|158474998|FG006|Overall Study|Withdrawal by Subject|0|||
49174759|NCT01843673|158475004|FG000|Overall Study|Lack of Efficacy|2|||
49174760|NCT01843673|158475004|FG000|Overall Study|Withdrawal by Subject|4|||
49174761|NCT00022763|158475005|FG000|Overall Study|Adverse Event|1|||
49174762|NCT00022763|158475006|FG001|Overall Study|Adverse Event|2|||
49174763|NCT00022763|158475005|FG000|Overall Study|Injection Site Reactions|0|||
49174764|NCT00022763|158475006|FG001|Overall Study|Injection Site Reactions|2|||
49174765|NCT00022763|158475005|FG000|Overall Study|Death|0|||
49174766|NCT00022763|158475006|FG001|Overall Study|Death|1|||
49174767|NCT00022763|158475005|FG000|Overall Study|Lost to Follow-up|0|||
49174768|NCT00022763|158475006|FG001|Overall Study|Lost to Follow-up|3|||
49174769|NCT00022763|158475005|FG000|Overall Study|Withdrawal by Subject|4|||
49174770|NCT00022763|158475006|FG001|Overall Study|Withdrawal by Subject|7|||
49174771|NCT00022763|158475005|FG000|Overall Study|Insufficient Therapy|1|||
49174772|NCT00022763|158475006|FG001|Overall Study|Insufficient Therapy|0|||
49174773|NCT00022763|158475005|FG000|Overall Study|Admin|3|||
49174774|NCT00022763|158475006|FG001|Overall Study|Admin|2|||
49174775|NCT02550288|158475007|FG000|Overall Study|Adverse Event|0|||
49174776|NCT02550288|158475008|FG001|Overall Study|Adverse Event|1|||
49174777|NCT02550288|158475009|FG002|Overall Study|Adverse Event|0|||
49174778|NCT02550288|158475010|FG003|Overall Study|Adverse Event|0|||
49174779|NCT02550288|158475011|FG004|Overall Study|Adverse Event|0|||
49174780|NCT02550288|158475007|FG000|Overall Study|Physician Decision|0|||
49174781|NCT02550288|158475008|FG001|Overall Study|Physician Decision|0|||
49174782|NCT02550288|158475009|FG002|Overall Study|Physician Decision|0|||
49174783|NCT02550288|158475010|FG003|Overall Study|Physician Decision|1|||
49174784|NCT02550288|158475011|FG004|Overall Study|Physician Decision|0|||
49174785|NCT02550288|158475007|FG000|Overall Study|Protocol Violation|2|||
49174786|NCT02550288|158475008|FG001|Overall Study|Protocol Violation|2|||
49174787|NCT02550288|158475009|FG002|Overall Study|Protocol Violation|1|||
49174788|NCT02550288|158475010|FG003|Overall Study|Protocol Violation|0|||
49174789|NCT02550288|158475011|FG004|Overall Study|Protocol Violation|3|||
49174790|NCT02550288|158475007|FG000|Overall Study|Participant moved|0|||
49174791|NCT02550288|158475008|FG001|Overall Study|Participant moved|0|||
49174792|NCT02550288|158475009|FG002|Overall Study|Participant moved|0|||
49174793|NCT02550288|158475010|FG003|Overall Study|Participant moved|1|||
48926745|NCT01298323|157563334|FG001|Overall Study|Other|9|||
48926746|NCT01298323|157563333|FG000|Overall Study|Ongoing|55|||
49174794|NCT02550288|158475011|FG004|Overall Study|Participant moved|0|||
49174795|NCT02550288|158475007|FG000|Overall Study|Withdrawal by Subject|0|||
49174796|NCT02550288|158475008|FG001|Overall Study|Withdrawal by Subject|0|||
49174797|NCT02550288|158475009|FG002|Overall Study|Withdrawal by Subject|0|||
49174798|NCT02550288|158475010|FG003|Overall Study|Withdrawal by Subject|1|||
49174799|NCT02550288|158475011|FG004|Overall Study|Withdrawal by Subject|0|||
49174800|NCT01296711|158475012|FG000|Overall Study|Adverse Event|3|||
49174801|NCT01296711|158475013|FG001|Overall Study|Adverse Event|1|||
49174802|NCT01296711|158475014|FG002|Overall Study|Adverse Event|4|||
49174803|NCT01296711|158475015|FG003|Overall Study|Adverse Event|3|||
49174804|NCT01296711|158475016|FG004|Overall Study|Adverse Event|1|||
49174805|NCT01296711|158475017|FG005|Overall Study|Adverse Event|6|||
49174806|NCT01296711|158475018|FG006|Overall Study|Adverse Event|11|||
49174807|NCT01296711|158475019|FG007|Overall Study|Adverse Event|3|||
49174808|NCT01296711|158475012|FG000|Overall Study|Lack of Efficacy|1|||
49174809|NCT01296711|158475013|FG001|Overall Study|Lack of Efficacy|4|||
49174810|NCT01296711|158475014|FG002|Overall Study|Lack of Efficacy|1|||
49174811|NCT01296711|158475015|FG003|Overall Study|Lack of Efficacy|1|||
49174812|NCT01296711|158475016|FG004|Overall Study|Lack of Efficacy|1|||
49174813|NCT01296711|158475017|FG005|Overall Study|Lack of Efficacy|0|||
49174814|NCT01296711|158475018|FG006|Overall Study|Lack of Efficacy|2|||
49174815|NCT01296711|158475019|FG007|Overall Study|Lack of Efficacy|3|||
49174816|NCT01296711|158475012|FG000|Overall Study|Lost to Follow-up|0|||
49174817|NCT01296711|158475013|FG001|Overall Study|Lost to Follow-up|0|||
49174818|NCT01296711|158475014|FG002|Overall Study|Lost to Follow-up|1|||
49174819|NCT01296711|158475015|FG003|Overall Study|Lost to Follow-up|1|||
49174820|NCT01296711|158475016|FG004|Overall Study|Lost to Follow-up|2|||
49174821|NCT01296711|158475017|FG005|Overall Study|Lost to Follow-up|0|||
49174822|NCT01296711|158475018|FG006|Overall Study|Lost to Follow-up|4|||
49174823|NCT01296711|158475019|FG007|Overall Study|Lost to Follow-up|2|||
49174824|NCT01296711|158475012|FG000|Overall Study|Protocol Violation|0|||
49174825|NCT01296711|158475013|FG001|Overall Study|Protocol Violation|0|||
49174826|NCT01296711|158475014|FG002|Overall Study|Protocol Violation|0|||
49174827|NCT01296711|158475015|FG003|Overall Study|Protocol Violation|1|||
49174828|NCT01296711|158475016|FG004|Overall Study|Protocol Violation|1|||
49174829|NCT01296711|158475017|FG005|Overall Study|Protocol Violation|0|||
49174830|NCT01296711|158475018|FG006|Overall Study|Protocol Violation|0|||
49174831|NCT01296711|158475019|FG007|Overall Study|Protocol Violation|0|||
49174832|NCT01296711|158475012|FG000|Overall Study|Withdrawal by Subject|4|||
49174833|NCT01296711|158475013|FG001|Overall Study|Withdrawal by Subject|2|||
49174834|NCT01296711|158475014|FG002|Overall Study|Withdrawal by Subject|2|||
49174835|NCT01296711|158475015|FG003|Overall Study|Withdrawal by Subject|1|||
49174836|NCT01296711|158475016|FG004|Overall Study|Withdrawal by Subject|1|||
49174837|NCT01296711|158475017|FG005|Overall Study|Withdrawal by Subject|1|||
49174838|NCT01296711|158475018|FG006|Overall Study|Withdrawal by Subject|2|||
49174839|NCT01296711|158475019|FG007|Overall Study|Withdrawal by Subject|1|||
49174840|NCT01296711|158475012|FG000|Overall Study|Study termination|8|||
49174841|NCT01296711|158475013|FG001|Overall Study|Study termination|1|||
49174842|NCT01296711|158475014|FG002|Overall Study|Study termination|5|||
49174843|NCT01296711|158475015|FG003|Overall Study|Study termination|4|||
49174844|NCT01296711|158475016|FG004|Overall Study|Study termination|4|||
49174845|NCT01296711|158475017|FG005|Overall Study|Study termination|4|||
49174846|NCT01296711|158475018|FG006|Overall Study|Study termination|8|||
49174847|NCT01296711|158475019|FG007|Overall Study|Study termination|10|||
49174848|NCT01296711|158475012|FG000|Overall Study|Continued elevated liver enzymes|0|||
49174849|NCT01296711|158475013|FG001|Overall Study|Continued elevated liver enzymes|0|||
49174850|NCT01296711|158475014|FG002|Overall Study|Continued elevated liver enzymes|0|||
49174851|NCT01296711|158475015|FG003|Overall Study|Continued elevated liver enzymes|1|||
49174852|NCT01296711|158475016|FG004|Overall Study|Continued elevated liver enzymes|0|||
49174853|NCT01296711|158475017|FG005|Overall Study|Continued elevated liver enzymes|0|||
49174854|NCT01296711|158475018|FG006|Overall Study|Continued elevated liver enzymes|0|||
49174855|NCT01296711|158475019|FG007|Overall Study|Continued elevated liver enzymes|0|||
49174856|NCT01296711|158475012|FG000|Overall Study|Methotrexate discontinued|0|||
49174857|NCT01296711|158475013|FG001|Overall Study|Methotrexate discontinued|0|||
49174858|NCT01296711|158475014|FG002|Overall Study|Methotrexate discontinued|0|||
49174859|NCT01296711|158475015|FG003|Overall Study|Methotrexate discontinued|1|||
49174860|NCT01296711|158475016|FG004|Overall Study|Methotrexate discontinued|0|||
49174861|NCT01296711|158475017|FG005|Overall Study|Methotrexate discontinued|0|||
49174862|NCT01296711|158475018|FG006|Overall Study|Methotrexate discontinued|0|||
49174863|NCT01296711|158475019|FG007|Overall Study|Methotrexate discontinued|0|||
49174864|NCT01296711|158475012|FG000|Overall Study|Investigator discretion|0|||
48926747|NCT01298323|157563334|FG001|Overall Study|Ongoing|55|||
48926748|NCT01298323|157563333|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
48926749|NCT01298323|157563334|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
48926750|NCT04678856|157563335|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
48926751|NCT04678856|157563336|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|0|||
48926752|NCT04678856|157563335|FG000|Overall Study|Withdrawal by Subject|5|||
48926753|NCT04678856|157563336|FG001|Overall Study|Withdrawal by Subject|1|||
48926754|NCT04745676|157563337|FG000|Overall Study|Death|1|||
48926755|NCT04745676|157563338|FG001|Overall Study|Death|0|||
48926756|NCT04745676|157563339|FG002|Overall Study|Death|0|||
48926757|NCT03733899|157564742|FG000|Period 1|Protocol Violation|0|||
48926758|NCT03733899|157564743|FG001|Period 1|Protocol Violation|0|||
48926759|NCT03733899|157564744|FG002|Period 1|Protocol Violation|0|||
48926760|NCT03733899|157564745|FG003|Period 1|Protocol Violation|0|||
48926761|NCT03733899|157564746|FG004|Period 1|Protocol Violation|0|||
48926762|NCT03733899|157564747|FG005|Period 1|Protocol Violation|1|||
48926763|NCT03733899|157564742|FG000|Period 2|Unscuccessful Treatment|0|||
48926764|NCT03733899|157564743|FG001|Period 2|Unscuccessful Treatment|1|||
48926765|NCT03733899|157564744|FG002|Period 2|Unscuccessful Treatment|0|||
48926766|NCT03733899|157564745|FG003|Period 2|Unscuccessful Treatment|0|||
48926767|NCT03733899|157564746|FG004|Period 2|Unscuccessful Treatment|0|||
48926768|NCT03733899|157564747|FG005|Period 2|Unscuccessful Treatment|0|||
48926769|NCT03733899|157564742|FG000|Period 3|Withdrawal by Subject|1|||
48926770|NCT03733899|157564743|FG001|Period 3|Withdrawal by Subject|0|||
48926771|NCT03733899|157564744|FG002|Period 3|Withdrawal by Subject|0|||
48926772|NCT03733899|157564745|FG003|Period 3|Withdrawal by Subject|0|||
48926773|NCT03733899|157564746|FG004|Period 3|Withdrawal by Subject|0|||
48926774|NCT03733899|157564747|FG005|Period 3|Withdrawal by Subject|0|||
48926775|NCT01823679|157564748|FG000|Overall Study|Death|1|||
48926776|NCT04300231|157564749|FG000|Overall Study|Protocol Violation|4|||
48926777|NCT04300231|157564750|FG001|Overall Study|Protocol Violation|3|||
48926778|NCT04300231|157564751|FG002|Overall Study|Protocol Violation|0|||
48926779|NCT04300231|157564752|FG003|Overall Study|Protocol Violation|2|||
48926780|NCT01042600|157564753|FG000|Overall Study|Ineligible|1|||
48926781|NCT01042600|157564754|FG001|Overall Study|Ineligible|0|||
48926782|NCT02787850|157564755|FG000|Overall Study|Withdrawal by Subject|0|||
48926783|NCT02787850|157564756|FG001|Overall Study|Withdrawal by Subject|1|||
48926784|NCT00494091|157564757|FG000|Overall Study|Death|5|||
48926785|NCT00494091|157564758|FG001|Overall Study|Death|54|||
48926786|NCT00494091|157564757|FG000|Overall Study|Lost to Follow-up|0|||
48926787|NCT00494091|157564758|FG001|Overall Study|Lost to Follow-up|4|||
48926788|NCT00494091|157564757|FG000|Overall Study|Other|1|||
48926789|NCT00494091|157564758|FG001|Overall Study|Other|11|||
48926790|NCT00494091|157564757|FG000|Overall Study|Withdrawal by Subject|0|||
48926791|NCT00494091|157564758|FG001|Overall Study|Withdrawal by Subject|7|||
48926792|NCT03718143|157564761|FG000|Overall Study|Death|1|||
48926793|NCT03718143|157564762|FG001|Overall Study|Death|0|||
48926794|NCT03718143|157564763|FG002|Overall Study|Death|0|||
48926795|NCT03718143|157564761|FG000|Overall Study|Progression of Disease|1|||
48926796|NCT03718143|157564762|FG001|Overall Study|Progression of Disease|0|||
48926797|NCT03718143|157564763|FG002|Overall Study|Progression of Disease|0|||
48926798|NCT03718143|157564761|FG000|Overall Study|Withdrawal of Informed Consent|1|||
48926799|NCT03718143|157564762|FG001|Overall Study|Withdrawal of Informed Consent|2|||
48926800|NCT03718143|157564763|FG002|Overall Study|Withdrawal of Informed Consent|1|||
48926801|NCT04161131|157564766|FG000|Overall Study|Ineligible|2|||
48926802|NCT04161131|157564766|FG000|Overall Study|Lost to Follow-up|4|||
48926803|NCT02721355|157564767|FG000|Overall Study|Lost to Follow-up|6|||
48926804|NCT02721355|157564768|FG001|Overall Study|Lost to Follow-up|1|||
48926805|NCT05956002|157564772|FG000|Treatment Period 3|Adverse Event|0|||
48926806|NCT05956002|157564773|FG001|Treatment Period 3|Adverse Event|0|||
48926807|NCT05956002|157564774|FG002|Treatment Period 3|Adverse Event|1|||
48926808|NCT05956002|157564775|FG003|Treatment Period 3|Adverse Event|0|||
48926809|NCT03338790|157564779|FG000|Overall Study|Disease Progression|65|||
48926810|NCT03338790|157564780|FG001|Overall Study|Disease Progression|43|||
48926811|NCT03338790|157564781|FG002|Overall Study|Disease Progression|50|||
48926812|NCT03338790|157564782|FG003|Overall Study|Disease Progression|37|||
48926813|NCT03338790|157564779|FG000|Overall Study|Study Drug Toxicity|9|||
48926814|NCT03338790|157564780|FG001|Overall Study|Study Drug Toxicity|8|||
48926815|NCT03338790|157564781|FG002|Overall Study|Study Drug Toxicity|15|||
48926816|NCT03338790|157564782|FG003|Overall Study|Study Drug Toxicity|0|||
48926817|NCT03338790|157564779|FG000|Overall Study|Death|1|||
48926818|NCT03338790|157564780|FG001|Overall Study|Death|1|||
48926819|NCT03338790|157564781|FG002|Overall Study|Death|1|||
48926820|NCT03338790|157564782|FG003|Overall Study|Death|0|||
49174865|NCT01296711|158475013|FG001|Overall Study|Investigator discretion|0|||
49174866|NCT01296711|158475014|FG002|Overall Study|Investigator discretion|0|||
49174867|NCT01296711|158475015|FG003|Overall Study|Investigator discretion|0|||
49174868|NCT01296711|158475016|FG004|Overall Study|Investigator discretion|0|||
49174869|NCT01296711|158475017|FG005|Overall Study|Investigator discretion|0|||
49174870|NCT01296711|158475018|FG006|Overall Study|Investigator discretion|1|||
49174871|NCT01296711|158475019|FG007|Overall Study|Investigator discretion|0|||
49174872|NCT01296711|158475012|FG000|Overall Study|Other|0|||
49174873|NCT01296711|158475013|FG001|Overall Study|Other|0|||
49174874|NCT01296711|158475014|FG002|Overall Study|Other|0|||
49174875|NCT01296711|158475015|FG003|Overall Study|Other|0|||
49174876|NCT01296711|158475016|FG004|Overall Study|Other|0|||
49174877|NCT01296711|158475017|FG005|Overall Study|Other|0|||
49174878|NCT01296711|158475018|FG006|Overall Study|Other|1|||
49174879|NCT01296711|158475019|FG007|Overall Study|Other|0|||
49174880|NCT01296711|158475012|FG000|Overall Study|Required restricted steroid injections|0|||
49174881|NCT01296711|158475013|FG001|Overall Study|Required restricted steroid injections|0|||
49174882|NCT01296711|158475014|FG002|Overall Study|Required restricted steroid injections|0|||
48926821|NCT03338790|157564779|FG000|Overall Study|Adverse Event unrelated to Study Drug|4|||
48926822|NCT03338790|157564780|FG001|Overall Study|Adverse Event unrelated to Study Drug|4|||
48926823|NCT03338790|157564781|FG002|Overall Study|Adverse Event unrelated to Study Drug|6|||
48926824|NCT03338790|157564782|FG003|Overall Study|Adverse Event unrelated to Study Drug|4|||
48926825|NCT03338790|157564779|FG000|Overall Study|Participant request to discontinue study treatment|3|||
48926826|NCT03338790|157564780|FG001|Overall Study|Participant request to discontinue study treatment|3|||
48926827|NCT03338790|157564781|FG002|Overall Study|Participant request to discontinue study treatment|2|||
48926828|NCT03338790|157564782|FG003|Overall Study|Participant request to discontinue study treatment|1|||
48926829|NCT03338790|157564779|FG000|Overall Study|Poor/non-compliance|0|||
48926830|NCT03338790|157564780|FG001|Overall Study|Poor/non-compliance|1|||
48926831|NCT03338790|157564781|FG002|Overall Study|Poor/non-compliance|0|||
48926832|NCT03338790|157564782|FG003|Overall Study|Poor/non-compliance|0|||
48926833|NCT03338790|157564779|FG000|Overall Study|Participant withdrew consent|1|||
48926834|NCT03338790|157564780|FG001|Overall Study|Participant withdrew consent|0|||
48926835|NCT03338790|157564781|FG002|Overall Study|Participant withdrew consent|1|||
48926836|NCT03338790|157564782|FG003|Overall Study|Participant withdrew consent|1|||
48926837|NCT03338790|157564779|FG000|Overall Study|Other reasons|0|||
49174883|NCT01296711|158475015|FG003|Overall Study|Required restricted steroid injections|0|||
49174884|NCT01296711|158475016|FG004|Overall Study|Required restricted steroid injections|0|||
48926838|NCT03338790|157564780|FG001|Overall Study|Other reasons|5|||
49174885|NCT01296711|158475017|FG005|Overall Study|Required restricted steroid injections|0|||
49174886|NCT01296711|158475018|FG006|Overall Study|Required restricted steroid injections|1|||
49174887|NCT01296711|158475019|FG007|Overall Study|Required restricted steroid injections|0|||
49174888|NCT01296711|158475012|FG000|Overall Study|Ongoing missed appointments|0|||
49174889|NCT01296711|158475013|FG001|Overall Study|Ongoing missed appointments|0|||
49174890|NCT01296711|158475014|FG002|Overall Study|Ongoing missed appointments|0|||
49174891|NCT01296711|158475015|FG003|Overall Study|Ongoing missed appointments|0|||
49174892|NCT01296711|158475016|FG004|Overall Study|Ongoing missed appointments|0|||
49174893|NCT01296711|158475017|FG005|Overall Study|Ongoing missed appointments|0|||
49174894|NCT01296711|158475018|FG006|Overall Study|Ongoing missed appointments|1|||
49174895|NCT01296711|158475019|FG007|Overall Study|Ongoing missed appointments|0|||
49174896|NCT01296711|158475012|FG000|Overall Study|Failure to comply with visits|0|||
49174897|NCT01296711|158475013|FG001|Overall Study|Failure to comply with visits|0|||
49174898|NCT01296711|158475014|FG002|Overall Study|Failure to comply with visits|0|||
49174899|NCT01296711|158475015|FG003|Overall Study|Failure to comply with visits|0|||
49174900|NCT01296711|158475016|FG004|Overall Study|Failure to comply with visits|0|||
49174901|NCT01296711|158475017|FG005|Overall Study|Failure to comply with visits|0|||
49174902|NCT01296711|158475018|FG006|Overall Study|Failure to comply with visits|0|||
49174903|NCT01296711|158475019|FG007|Overall Study|Failure to comply with visits|1|||
49174904|NCT01296711|158475012|FG000|Overall Study|Patient decision due to transport|0|||
49174905|NCT01296711|158475013|FG001|Overall Study|Patient decision due to transport|0|||
49174906|NCT01296711|158475014|FG002|Overall Study|Patient decision due to transport|0|||
49174907|NCT01296711|158475015|FG003|Overall Study|Patient decision due to transport|0|||
49174908|NCT01296711|158475016|FG004|Overall Study|Patient decision due to transport|0|||
49174909|NCT01296711|158475017|FG005|Overall Study|Patient decision due to transport|0|||
49174910|NCT01296711|158475018|FG006|Overall Study|Patient decision due to transport|0|||
49174911|NCT01296711|158475019|FG007|Overall Study|Patient decision due to transport|1|||
49174912|NCT03249909|158475022|FG000|Overall Study|Withdrawal by Subject|3|||
49174913|NCT03249909|158475023|FG001|Overall Study|Withdrawal by Subject|0|||
49174914|NCT03249909|158475024|FG002|Overall Study|Withdrawal by Subject|0|||
49174915|NCT03249909|158475022|FG000|Overall Study|Adverse Event|3|||
49174916|NCT03249909|158475023|FG001|Overall Study|Adverse Event|0|||
49174917|NCT03249909|158475024|FG002|Overall Study|Adverse Event|0|||
49174918|NCT03249909|158475022|FG000|Overall Study|Lost to Follow-up|0|||
49174919|NCT03249909|158475023|FG001|Overall Study|Lost to Follow-up|1|||
49174920|NCT03249909|158475024|FG002|Overall Study|Lost to Follow-up|0|||
49174921|NCT01035463|158475026|FG000|Overall Study|Adverse Event|0|||
49174922|NCT01035463|158475027|FG001|Overall Study|Adverse Event|0|||
49174923|NCT01035463|158475028|FG002|Overall Study|Adverse Event|4|||
49174924|NCT01035463|158475029|FG003|Overall Study|Adverse Event|1|||
49174925|NCT01035463|158475030|FG004|Overall Study|Adverse Event|5|||
49174926|NCT01035463|158475031|FG005|Overall Study|Adverse Event|7|||
48926839|NCT03338790|157564781|FG002|Overall Study|Other reasons|0|||
48926840|NCT03338790|157564782|FG003|Overall Study|Other reasons|2|||
48926841|NCT03338790|157564779|FG000|Overall Study|Not reported|0|||
48926842|NCT03338790|157564780|FG001|Overall Study|Not reported|0|||
49174927|NCT01035463|158475026|FG000|Overall Study|Withdrawal by Subject|0|||
49174928|NCT01035463|158475027|FG001|Overall Study|Withdrawal by Subject|2|||
49174929|NCT01035463|158475028|FG002|Overall Study|Withdrawal by Subject|1|||
49174930|NCT01035463|158475029|FG003|Overall Study|Withdrawal by Subject|0|||
49174931|NCT01035463|158475030|FG004|Overall Study|Withdrawal by Subject|1|||
49174932|NCT01035463|158475031|FG005|Overall Study|Withdrawal by Subject|4|||
49174933|NCT01035463|158475026|FG000|Overall Study|Disease progression|0|||
49174934|NCT01035463|158475027|FG001|Overall Study|Disease progression|0|||
49174935|NCT01035463|158475028|FG002|Overall Study|Disease progression|0|||
49174936|NCT01035463|158475029|FG003|Overall Study|Disease progression|0|||
49174937|NCT01035463|158475030|FG004|Overall Study|Disease progression|0|||
49174938|NCT01035463|158475031|FG005|Overall Study|Disease progression|3|||
49174939|NCT01035463|158475026|FG000|Overall Study|Other Malignancy|0|||
49174940|NCT01035463|158475027|FG001|Overall Study|Other Malignancy|0|||
49174941|NCT01035463|158475028|FG002|Overall Study|Other Malignancy|0|||
49174942|NCT01035463|158475029|FG003|Overall Study|Other Malignancy|0|||
48926843|NCT03338790|157564781|FG002|Overall Study|Not reported|1|||
48926844|NCT03338790|157564782|FG003|Overall Study|Not reported|0|||
48926845|NCT03338790|157564779|FG000|Overall Study|Completed treatment period|1|||
48926846|NCT03338790|157564780|FG001|Overall Study|Completed treatment period|2|||
48926847|NCT03338790|157564781|FG002|Overall Study|Completed treatment period|0|||
48926848|NCT03338790|157564782|FG003|Overall Study|Completed treatment period|0|||
48926849|NCT02083380|157564783|FG000|Overall Study|Lack of Efficacy|68|||
48926850|NCT02083380|157564784|FG001|Overall Study|Lack of Efficacy|79|||
48926851|NCT02083380|157564785|FG002|Overall Study|Lack of Efficacy|64|||
48926852|NCT02083380|157564783|FG000|Overall Study|Withdrawal by Subject|9|||
48926853|NCT02083380|157564784|FG001|Overall Study|Withdrawal by Subject|3|||
48926854|NCT02083380|157564785|FG002|Overall Study|Withdrawal by Subject|7|||
48926855|NCT02083380|157564783|FG000|Overall Study|Physician Decision|1|||
48926856|NCT02083380|157564784|FG001|Overall Study|Physician Decision|6|||
48926857|NCT02083380|157564785|FG002|Overall Study|Physician Decision|3|||
48926858|NCT02083380|157564783|FG000|Overall Study|Adverse Event|0|||
48926859|NCT02083380|157564784|FG001|Overall Study|Adverse Event|0|||
48926860|NCT02083380|157564785|FG002|Overall Study|Adverse Event|1|||
48926861|NCT02083380|157564783|FG000|Overall Study|Lost to Follow-up|5|||
48926862|NCT02083380|157564784|FG001|Overall Study|Lost to Follow-up|3|||
49174943|NCT01035463|158475030|FG004|Overall Study|Other Malignancy|0|||
48926863|NCT02083380|157564785|FG002|Overall Study|Lost to Follow-up|3|||
48926864|NCT02083380|157564783|FG000|Overall Study|Other|8|||
49174944|NCT01035463|158475031|FG005|Overall Study|Other Malignancy|2|||
48843391|NCT03903822|157267330|FG007|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
48843392|NCT03903822|157267323|FG000|Treatment Phase (6 Weeks)|Other|2|||
48843393|NCT03903822|157267324|FG001|Treatment Phase (6 Weeks)|Other|1|||
48843394|NCT03903822|157267325|FG002|Treatment Phase (6 Weeks)|Other|0|||
48843395|NCT03903822|157267326|FG003|Treatment Phase (6 Weeks)|Other|0|||
48843396|NCT03903822|157267327|FG004|Treatment Phase (6 Weeks)|Other|1|||
48843397|NCT03903822|157267328|FG005|Treatment Phase (6 Weeks)|Other|1|||
48843398|NCT03903822|157267329|FG006|Treatment Phase (6 Weeks)|Other|0|||
48843399|NCT03903822|157267330|FG007|Treatment Phase (6 Weeks)|Other|0|||
48843400|NCT03903822|157267323|FG000|Follow up Phase (4 Weeks)|Adverse Event|3|||
48843401|NCT03903822|157267324|FG001|Follow up Phase (4 Weeks)|Adverse Event|2|||
48843402|NCT03903822|157267325|FG002|Follow up Phase (4 Weeks)|Adverse Event|1|||
48843403|NCT03903822|157267326|FG003|Follow up Phase (4 Weeks)|Adverse Event|1|||
48843404|NCT03903822|157267327|FG004|Follow up Phase (4 Weeks)|Adverse Event|0|||
48843405|NCT03903822|157267328|FG005|Follow up Phase (4 Weeks)|Adverse Event|5|||
48843406|NCT03903822|157267329|FG006|Follow up Phase (4 Weeks)|Adverse Event|1|||
48843407|NCT03903822|157267330|FG007|Follow up Phase (4 Weeks)|Adverse Event|0|||
48843408|NCT03903822|157267323|FG000|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
48843409|NCT03903822|157267324|FG001|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
48843410|NCT03903822|157267325|FG002|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
48843411|NCT03903822|157267326|FG003|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
48843412|NCT03903822|157267327|FG004|Follow up Phase (4 Weeks)|Lack of Efficacy|1|||
48843413|NCT03903822|157267328|FG005|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
48843414|NCT03903822|157267329|FG006|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
48843415|NCT03903822|157267330|FG007|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
48843416|NCT03903822|157267323|FG000|Follow up Phase (4 Weeks)|Lost to Follow-up|2|||
48843417|NCT03903822|157267324|FG001|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
48843418|NCT03903822|157267325|FG002|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
48843419|NCT03903822|157267326|FG003|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
48843420|NCT03903822|157267327|FG004|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
48843421|NCT03903822|157267328|FG005|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
48843422|NCT03903822|157267329|FG006|Follow up Phase (4 Weeks)|Lost to Follow-up|1|||
48843423|NCT03903822|157267330|FG007|Follow up Phase (4 Weeks)|Lost to Follow-up|3|||
48843424|NCT03903822|157267323|FG000|Follow up Phase (4 Weeks)|Pregnancy|0|||
48843425|NCT03903822|157267324|FG001|Follow up Phase (4 Weeks)|Pregnancy|0|||
48843426|NCT03903822|157267325|FG002|Follow up Phase (4 Weeks)|Pregnancy|0|||
48843427|NCT03903822|157267326|FG003|Follow up Phase (4 Weeks)|Pregnancy|1|||
48843428|NCT03903822|157267327|FG004|Follow up Phase (4 Weeks)|Pregnancy|1|||
48843429|NCT03903822|157267328|FG005|Follow up Phase (4 Weeks)|Pregnancy|0|||
48843430|NCT03903822|157267329|FG006|Follow up Phase (4 Weeks)|Pregnancy|0|||
48843431|NCT03903822|157267330|FG007|Follow up Phase (4 Weeks)|Pregnancy|0|||
48843432|NCT03903822|157267323|FG000|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
48843433|NCT03903822|157267324|FG001|Follow up Phase (4 Weeks)|Withdrawal by Subject|5|||
48843434|NCT03903822|157267325|FG002|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
48843435|NCT03903822|157267326|FG003|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
48843436|NCT03903822|157267327|FG004|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
48843437|NCT03903822|157267328|FG005|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
48843438|NCT03903822|157267329|FG006|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
48843439|NCT03903822|157267330|FG007|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
48843440|NCT03903822|157267323|FG000|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
48843441|NCT03903822|157267324|FG001|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
48843442|NCT03903822|157267325|FG002|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
48843443|NCT03903822|157267326|FG003|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
48843444|NCT03903822|157267327|FG004|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
48843445|NCT03903822|157267328|FG005|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1|||
49174945|NCT01035463|158475026|FG000|Overall Study|Other|0|||
49174946|NCT01035463|158475027|FG001|Overall Study|Other|0|||
49174947|NCT01035463|158475028|FG002|Overall Study|Other|0|||
49174948|NCT01035463|158475029|FG003|Overall Study|Other|1|||
49174949|NCT01035463|158475030|FG004|Overall Study|Other|0|||
49174950|NCT01035463|158475031|FG005|Overall Study|Other|2|||
49174951|NCT00313313|158475032|FG000|Overall Study|Lack of Efficacy|14|||
49174952|NCT00313313|158475033|FG001|Overall Study|Lack of Efficacy|9|||
49174953|NCT00313313|158475034|FG002|Overall Study|Lack of Efficacy|20|||
49174954|NCT00313313|158475032|FG000|Overall Study|Withdrawal of consent by subject|18|||
49174955|NCT00313313|158475033|FG001|Overall Study|Withdrawal of consent by subject|17|||
49174956|NCT00313313|158475034|FG002|Overall Study|Withdrawal of consent by subject|31|||
49174957|NCT00313313|158475032|FG000|Overall Study|Lost to Follow-up|10|||
49174958|NCT00313313|158475033|FG001|Overall Study|Lost to Follow-up|7|||
49174959|NCT00313313|158475034|FG002|Overall Study|Lost to Follow-up|9|||
49174960|NCT00313313|158475032|FG000|Overall Study|Adverse Event|15|||
48926865|NCT02083380|157564784|FG001|Overall Study|Other|4|||
48926866|NCT02083380|157564785|FG002|Overall Study|Other|6|||
49174961|NCT00313313|158475033|FG001|Overall Study|Adverse Event|16|||
48843446|NCT03903822|157267329|FG006|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
48843447|NCT03903822|157267330|FG007|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
48843448|NCT03903822|157267323|FG000|Follow up Phase (4 Weeks)|Other|1|||
48843449|NCT03903822|157267324|FG001|Follow up Phase (4 Weeks)|Other|1|||
48843450|NCT03903822|157267325|FG002|Follow up Phase (4 Weeks)|Other|0|||
48843451|NCT03903822|157267326|FG003|Follow up Phase (4 Weeks)|Other|0|||
48843452|NCT03903822|157267327|FG004|Follow up Phase (4 Weeks)|Other|0|||
48843453|NCT03903822|157267328|FG005|Follow up Phase (4 Weeks)|Other|0|||
48843454|NCT03903822|157267329|FG006|Follow up Phase (4 Weeks)|Other|0|||
48843455|NCT03903822|157267330|FG007|Follow up Phase (4 Weeks)|Other|0|||
48843456|NCT01278394|157267331|FG000|Overall Study|Lost to Follow-up|1|||
48843457|NCT00785512|157267332|FG000|Overall Study|Inclusion/Exclusion not meet|0|||
48843458|NCT00785512|157267333|FG001|Overall Study|Inclusion/Exclusion not meet|0|||
48843459|NCT00785512|157267332|FG000|Overall Study|Adverse Event|0|||
48843460|NCT00785512|157267333|FG001|Overall Study|Adverse Event|0|||
48843461|NCT00785512|157267332|FG000|Overall Study|Lack of Efficacy|0|||
48843462|NCT00785512|157267333|FG001|Overall Study|Lack of Efficacy|2|||
48843463|NCT00785512|157267332|FG000|Overall Study|Withdrawal by Subject|0|||
48843464|NCT00785512|157267333|FG001|Overall Study|Withdrawal by Subject|1|||
48843465|NCT00785512|157267332|FG000|Overall Study|Lost to Follow-up|3|||
48843466|NCT00785512|157267333|FG001|Overall Study|Lost to Follow-up|0|||
48843467|NCT00785512|157267332|FG000|Overall Study|Precedure Refused|0|||
48843468|NCT00785512|157267333|FG001|Overall Study|Precedure Refused|0|||
48843469|NCT00785512|157267332|FG000|Overall Study|IVRS Programing Error|0|||
48843470|NCT00785512|157267333|FG001|Overall Study|IVRS Programing Error|0|||
48843471|NCT00785512|157267332|FG000|Overall Study|Physician Decision|0|||
48843472|NCT00785512|157267333|FG001|Overall Study|Physician Decision|0|||
48843473|NCT00785512|157267332|FG000|Overall Study|Lack of compliance|0|||
48843474|NCT00785512|157267333|FG001|Overall Study|Lack of compliance|1|||
48843475|NCT00857649|157267334|FG000|Overall Study|Adverse Event|15|||
48843476|NCT00857649|157267335|FG001|Overall Study|Adverse Event|10|||
48843477|NCT00857649|157267334|FG000|Overall Study|Non-compliance|1|||
48843478|NCT00857649|157267335|FG001|Overall Study|Non-compliance|1|||
48843479|NCT00857649|157267334|FG000|Overall Study|Protocol Violation|2|||
48843480|NCT00857649|157267335|FG001|Overall Study|Protocol Violation|2|||
48843481|NCT00857649|157267334|FG000|Overall Study|Withdrawal of Consent|10|||
48843482|NCT00857649|157267335|FG001|Overall Study|Withdrawal of Consent|7|||
48843483|NCT00857649|157267334|FG000|Overall Study|Nursing Home Placement|2|||
48843484|NCT00857649|157267335|FG001|Overall Study|Nursing Home Placement|9|||
48843485|NCT00857649|157267334|FG000|Overall Study|Other Reasons|1|||
48843486|NCT00857649|157267335|FG001|Overall Study|Other Reasons|3|||
48843487|NCT02374307|157267336|FG000|3-months Follow-up|Lost to Follow-up|1|||
48843488|NCT02374307|157267337|FG001|3-months Follow-up|Lost to Follow-up|2|||
48843489|NCT02374307|157267336|FG000|3-months Follow-up|Withdrawal by Subject|1|||
48843490|NCT02374307|157267337|FG001|3-months Follow-up|Withdrawal by Subject|4|||
48843491|NCT02374307|157267336|FG000|3-months Follow-up|Death|1|||
48926867|NCT01790048|157564786|FG000|Overall Study|Incorrect Age|9|||
48843492|NCT02374307|157267337|FG001|3-months Follow-up|Death|2|||
48843493|NCT02374307|157267336|FG000|3-months Follow-up|Missed first follow-up|5|||
48843494|NCT02374307|157267337|FG001|3-months Follow-up|Missed first follow-up|1|||
48843495|NCT02374307|157267336|FG000|6-months Follow-up|Lost to Follow-up|1|||
48843496|NCT02374307|157267337|FG001|6-months Follow-up|Lost to Follow-up|2|||
48843497|NCT02374307|157267336|FG000|6-months Follow-up|Death|2|||
48843498|NCT02374307|157267337|FG001|6-months Follow-up|Death|1|||
48843499|NCT02374307|157267336|FG000|6-months Follow-up|Withdrawal by Subject|0|||
48843500|NCT02374307|157267337|FG001|6-months Follow-up|Withdrawal by Subject|3|||
49174962|NCT00313313|158475034|FG002|Overall Study|Adverse Event|12|||
49174963|NCT00313313|158475032|FG000|Overall Study|Physician Decision|2|||
48843501|NCT03703336|157267338|FG000|Overall Study|Parent withdrew consent|29|||
48843502|NCT03703336|157267339|FG001|Overall Study|Parent withdrew consent|8|||
48843503|NCT03703336|157267338|FG000|Overall Study|Migration|3|||
48843504|NCT03703336|157267339|FG001|Overall Study|Migration|3|||
48843505|NCT03703336|157267338|FG000|Overall Study|Protocol Violation|3|||
48843506|NCT03703336|157267339|FG001|Overall Study|Protocol Violation|1|||
49174964|NCT00313313|158475033|FG001|Overall Study|Physician Decision|6|||
48843507|NCT03703336|157267338|FG000|Overall Study|Physician Decision|2|||
48843508|NCT03703336|157267339|FG001|Overall Study|Physician Decision|0|||
48843509|NCT03703336|157267338|FG000|Overall Study|Adverse Event|0|||
48843510|NCT03703336|157267339|FG001|Overall Study|Adverse Event|2|||
49174965|NCT00313313|158475034|FG002|Overall Study|Physician Decision|4|||
49174966|NCT00313313|158475032|FG000|Overall Study|Poor/Noncompliance|3|||
48843511|NCT03703336|157267338|FG000|Overall Study|Lost to Follow-up|1|||
48843512|NCT03703336|157267339|FG001|Overall Study|Lost to Follow-up|0|||
48843513|NCT00595413|157267346|FG000|Overall Study|Adverse Event|0|||
48843514|NCT00595413|157267347|FG001|Overall Study|Adverse Event|2|||
48843515|NCT00595413|157267348|FG002|Overall Study|Adverse Event|1|||
48843516|NCT00595413|157267349|FG003|Overall Study|Adverse Event|1|||
48843517|NCT00595413|157267346|FG000|Overall Study|Lost to Follow-up|2|||
48843518|NCT00595413|157267347|FG001|Overall Study|Lost to Follow-up|2|||
48843519|NCT00595413|157267348|FG002|Overall Study|Lost to Follow-up|1|||
48843520|NCT00595413|157267349|FG003|Overall Study|Lost to Follow-up|3|||
48843521|NCT00595413|157267346|FG000|Overall Study|Death|0|||
48843522|NCT00595413|157267347|FG001|Overall Study|Death|0|||
48843523|NCT00595413|157267348|FG002|Overall Study|Death|1|||
48843524|NCT00595413|157267349|FG003|Overall Study|Death|0|||
48843525|NCT00595413|157267346|FG000|Overall Study|Other|5|||
48926868|NCT01790048|157564787|FG001|Overall Study|Incorrect Age|14|||
49174967|NCT00313313|158475033|FG001|Overall Study|Poor/Noncompliance|6|||
49174968|NCT00313313|158475034|FG002|Overall Study|Poor/Noncompliance|2|||
49174969|NCT00313313|158475032|FG000|Overall Study|Pregnancy|1|||
49174970|NCT00313313|158475033|FG001|Overall Study|Pregnancy|2|||
49174971|NCT00313313|158475034|FG002|Overall Study|Pregnancy|0|||
49174972|NCT00313313|158475032|FG000|Overall Study|Death|0|||
49174973|NCT00313313|158475033|FG001|Overall Study|Death|0|||
49174974|NCT00313313|158475034|FG002|Overall Study|Death|2|||
49174975|NCT00313313|158475032|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
49174976|NCT00313313|158475033|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
49174977|NCT00313313|158475034|FG002|Overall Study|Subject No Longer Meets Study Criteria|2|||
49174978|NCT03832322|158475043|FG000|Overall Study|Failed cecal intubation in 2nd exam|3|||
48843526|NCT00595413|157267347|FG001|Overall Study|Other|1|||
48843527|NCT00595413|157267348|FG002|Overall Study|Other|5|||
48843528|NCT00595413|157267349|FG003|Overall Study|Other|0|||
48843529|NCT04149002|157267356|FG000|Overall Study|Lost to Follow-up|1|||
48843530|NCT04149002|157267357|FG001|Overall Study|Lost to Follow-up|0|||
48843531|NCT04149002|157267356|FG000|Overall Study|Withdrawal by Subject|1|||
48843532|NCT04149002|157267357|FG001|Overall Study|Withdrawal by Subject|0|||
48843533|NCT00807937|157267358|FG000|Overall Study|Adverse Event|12|||
48843534|NCT00807937|157267359|FG001|Overall Study|Adverse Event|12|||
48843535|NCT00807937|157267360|FG002|Overall Study|Adverse Event|5|||
48843536|NCT00807937|157267361|FG003|Overall Study|Adverse Event|4|||
48843537|NCT00807937|157267358|FG000|Overall Study|Protocol Violation|4|||
48843538|NCT00807937|157267359|FG001|Overall Study|Protocol Violation|5|||
48843539|NCT00807937|157267360|FG002|Overall Study|Protocol Violation|3|||
48843540|NCT00807937|157267361|FG003|Overall Study|Protocol Violation|3|||
48843541|NCT00807937|157267358|FG000|Overall Study|Withdrawal by Subject|5|||
48843542|NCT00807937|157267359|FG001|Overall Study|Withdrawal by Subject|4|||
48843543|NCT00807937|157267360|FG002|Overall Study|Withdrawal by Subject|1|||
48843544|NCT00807937|157267361|FG003|Overall Study|Withdrawal by Subject|4|||
48843545|NCT00807937|157267358|FG000|Overall Study|Lost to Follow-up|4|||
48843546|NCT00807937|157267359|FG001|Overall Study|Lost to Follow-up|0|||
48843547|NCT00807937|157267360|FG002|Overall Study|Lost to Follow-up|2|||
48843548|NCT00807937|157267361|FG003|Overall Study|Lost to Follow-up|1|||
48843549|NCT00807937|157267358|FG000|Overall Study|Lack of Efficacy|0|||
48926869|NCT01790048|157564786|FG000|Overall Study|data entry error|0|||
48926870|NCT01790048|157564787|FG001|Overall Study|data entry error|1|||
48926871|NCT01790048|157564786|FG000|Overall Study|Other|0|||
48926872|NCT01790048|157564787|FG001|Overall Study|Other|2|||
48926873|NCT01790048|157564786|FG000|Overall Study|SAM at Enrollment|2|||
48843550|NCT00807937|157267359|FG001|Overall Study|Lack of Efficacy|0|||
48926874|NCT01790048|157564787|FG001|Overall Study|SAM at Enrollment|0|||
48843551|NCT00807937|157267360|FG002|Overall Study|Lack of Efficacy|1|||
48843552|NCT00807937|157267361|FG003|Overall Study|Lack of Efficacy|2|||
48926875|NCT01790048|157564786|FG000|Overall Study|Measurement error|1|||
48843553|NCT00807937|157267358|FG000|Overall Study|Intake of prohibited medicine|0|||
48843554|NCT00807937|157267359|FG001|Overall Study|Intake of prohibited medicine|0|||
48843555|NCT00807937|157267360|FG002|Overall Study|Intake of prohibited medicine|2|||
48843556|NCT00807937|157267361|FG003|Overall Study|Intake of prohibited medicine|0|||
48843557|NCT00807937|157267358|FG000|Overall Study|All other reasons (not provided)|2|||
48843558|NCT00807937|157267359|FG001|Overall Study|All other reasons (not provided)|4|||
48843559|NCT00807937|157267360|FG002|Overall Study|All other reasons (not provided)|0|||
48843560|NCT00807937|157267361|FG003|Overall Study|All other reasons (not provided)|1|||
48843561|NCT05512962|157267362|FG000|Overall Study|Withdrawal by Subject|1|||
48843562|NCT05512962|157267363|FG001|Overall Study|Withdrawal by Subject|0|||
48843563|NCT01561989|157267384|FG000|Overall Study|accural target not met.|5|||
48843564|NCT01561989|157267385|FG001|Overall Study|accural target not met.|6|||
48843565|NCT00522951|157267390|FG000|Period 1|body motion|0|||
48843566|NCT00522951|157267391|FG001|Period 1|body motion|1|||
48843567|NCT00522951|157267390|FG000|Washout Period|Adverse Event|0|||
48843568|NCT00522951|157267391|FG001|Washout Period|Adverse Event|1|||
48843569|NCT00522951|157267390|FG000|Washout Period|Death|0|||
48843570|NCT00522951|157267391|FG001|Washout Period|Death|1|||
48843571|NCT00522951|157267390|FG000|Period 2|Withdrawal by Subject|1|||
48843572|NCT00522951|157267391|FG001|Period 2|Withdrawal by Subject|0|||
48843573|NCT00522951|157267390|FG000|Period 2|residual contrast medium|1|||
48843574|NCT00522951|157267391|FG001|Period 2|residual contrast medium|1|||
48843575|NCT03447249|157267392|FG000|Overall Study|Adverse Event|1|||
48843576|NCT03447249|157267393|FG001|Overall Study|Adverse Event|0|||
48843577|NCT03447249|157267392|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
48843578|NCT03447249|157267393|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
48843579|NCT03447249|157267392|FG000|Overall Study|Other|3|||
48843580|NCT03447249|157267393|FG001|Overall Study|Other|0|||
48843581|NCT00566735|157269521|FG000|Overall Study|Withdrawal by Subject|0|||
48843582|NCT00566735|157269522|FG001|Overall Study|Withdrawal by Subject|1|||
48843583|NCT00566735|157269521|FG000|Overall Study|Refused neuropsychological testing|2|||
48843584|NCT00566735|157269522|FG001|Overall Study|Refused neuropsychological testing|5|||
48843585|NCT00566735|157269521|FG000|Overall Study|Switched into a manic episode|0|||
48843586|NCT00566735|157269522|FG001|Overall Study|Switched into a manic episode|1|||
48843587|NCT01613716|157269526|FG000|Overall Study|screen failures|3|||
48843588|NCT01613716|157269526|FG000|Overall Study|Lost to Follow-up|4|||
48843589|NCT01376089|157269527|FG000|Overall Study|Patient received no contrast media|3|||
48843590|NCT01376089|157269528|FG001|Overall Study|Patient received no contrast media|4|||
49174979|NCT03832322|158475044|FG001|Overall Study|Failed cecal intubation in 2nd exam|1|||
49174980|NCT01606176|158475046|FG000|Overall Study|Adverse Event|2|||
49174981|NCT01606176|158475047|FG001|Overall Study|Adverse Event|3|||
49174982|NCT01606176|158475046|FG000|Overall Study|Disease progression|1|||
49174983|NCT01606176|158475047|FG001|Overall Study|Disease progression|0|||
49174984|NCT01606176|158475046|FG000|Overall Study|Withdrawal by Subject|1|||
49174985|NCT01606176|158475047|FG001|Overall Study|Withdrawal by Subject|0|||
49174986|NCT02993822|158475055|FG000|Overall Study|Lack of Efficacy|1|||
49174987|NCT02993822|158475056|FG001|Overall Study|Lack of Efficacy|1|||
49174988|NCT02993822|158475057|FG002|Overall Study|Lack of Efficacy|0|||
49174989|NCT02993822|158475058|FG003|Overall Study|Lack of Efficacy|0|||
49174990|NCT02993822|158475055|FG000|Overall Study|Protocol Violation|1|||
49174991|NCT02993822|158475056|FG001|Overall Study|Protocol Violation|0|||
49174992|NCT02993822|158475057|FG002|Overall Study|Protocol Violation|0|||
49174993|NCT02993822|158475058|FG003|Overall Study|Protocol Violation|0|||
49174994|NCT02993822|158475055|FG000|Overall Study|Unable to attend follow-up due to illness|0|||
49174995|NCT02993822|158475056|FG001|Overall Study|Unable to attend follow-up due to illness|0|||
49174996|NCT02993822|158475057|FG002|Overall Study|Unable to attend follow-up due to illness|0|||
49174997|NCT02993822|158475058|FG003|Overall Study|Unable to attend follow-up due to illness|1|||
49174998|NCT02993822|158475055|FG000|Overall Study|Adverse Event|3|||
49174999|NCT02993822|158475056|FG001|Overall Study|Adverse Event|1|||
49175000|NCT02993822|158475057|FG002|Overall Study|Adverse Event|7|||
49175001|NCT02993822|158475058|FG003|Overall Study|Adverse Event|0|||
49175002|NCT02993822|158475055|FG000|Overall Study|Withdrawal by Subject|4|||
49175003|NCT02993822|158475056|FG001|Overall Study|Withdrawal by Subject|2|||
49175004|NCT02993822|158475057|FG002|Overall Study|Withdrawal by Subject|2|||
49175005|NCT02993822|158475058|FG003|Overall Study|Withdrawal by Subject|3|||
49175006|NCT02993822|158475055|FG000|Overall Study|Lost to Follow-up|1|||
49175007|NCT02993822|158475056|FG001|Overall Study|Lost to Follow-up|0|||
49175008|NCT02993822|158475057|FG002|Overall Study|Lost to Follow-up|1|||
49175009|NCT02993822|158475058|FG003|Overall Study|Lost to Follow-up|0|||
49175010|NCT01694121|158475059|FG000|Overall Study|Participant used false ID, was withdrawn|1|||
49175011|NCT01694121|158475060|FG001|Overall Study|Participant used false ID, was withdrawn|0|||
49175012|NCT01814397|158475063|FG000|Overall Study|Adverse Event|7|||
49175013|NCT01814397|158475063|FG000|Overall Study|Withdrawal by Subject|7|||
49175014|NCT00431444|158475066|FG000|Overall Study|Protocol Violation|1|||
49175015|NCT00431444|158475067|FG001|Overall Study|Protocol Violation|4|||
49175016|NCT00431444|158475066|FG000|Overall Study|Adverse Event|2|||
49175017|NCT00431444|158475067|FG001|Overall Study|Adverse Event|1|||
48843591|NCT01599104|157269531|FG000|Overall Study|Withdrawal by Subject|1|||
48843592|NCT01599104|157269532|FG001|Overall Study|Withdrawal by Subject|1|||
48843593|NCT01599104|157269533|FG002|Overall Study|Withdrawal by Subject|2|||
48843594|NCT01599104|157269531|FG000|Overall Study|Technical Problems|1|||
48843595|NCT01599104|157269532|FG001|Overall Study|Technical Problems|0|||
48843596|NCT01599104|157269533|FG002|Overall Study|Technical Problems|0|||
48843597|NCT01599104|157269531|FG000|Overall Study|Physician Decision|3|||
48843598|NCT01599104|157269532|FG001|Overall Study|Physician Decision|2|||
48843599|NCT01599104|157269533|FG002|Overall Study|Physician Decision|2|||
48843600|NCT01599104|157269531|FG000|Overall Study|Non-compliance with study treatment|0|||
48926876|NCT01790048|157564787|FG001|Overall Study|Measurement error|0|||
48926877|NCT01289015|157564788|FG000|Overall Study|Protocol Violation|12|||
49175018|NCT00431444|158475066|FG000|Overall Study|Withdrawal by Subject|1|||
49175019|NCT00431444|158475067|FG001|Overall Study|Withdrawal by Subject|1|||
49175020|NCT00431444|158475066|FG000|Overall Study|Lost to Follow-up|1|||
48843601|NCT01599104|157269532|FG001|Overall Study|Non-compliance with study treatment|1|||
48843602|NCT01599104|157269533|FG002|Overall Study|Non-compliance with study treatment|0|||
48843603|NCT01599104|157269531|FG000|Overall Study|Lack of Efficacy|4|||
48843604|NCT01599104|157269532|FG001|Overall Study|Lack of Efficacy|4|||
48843605|NCT01599104|157269533|FG002|Overall Study|Lack of Efficacy|10|||
48843606|NCT01599104|157269531|FG000|Overall Study|Adverse Event|7|||
48843607|NCT01599104|157269532|FG001|Overall Study|Adverse Event|6|||
48843608|NCT01599104|157269533|FG002|Overall Study|Adverse Event|12|||
48843609|NCT01303445|157269534|FG000|First Intervention (7 Days)|Withdrawal by Subject|1|||
48843610|NCT01303445|157269535|FG001|First Intervention (7 Days)|Withdrawal by Subject|0|||
48843611|NCT01303445|157269534|FG000|Second Intervention (7 Days)|Adverse Event|0|||
48843612|NCT01303445|157269535|FG001|Second Intervention (7 Days)|Adverse Event|2|||
48843613|NCT01303445|157269534|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
48843614|NCT01303445|157269535|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
48843615|NCT01303445|157269534|FG000|Washout (14 Days)|Protocol Violation|1|||
48843616|NCT01303445|157269535|FG001|Washout (14 Days)|Protocol Violation|0|||
48843617|NCT01303445|157269534|FG000|Washout (14 Days)|Lost to Follow-up|0|||
48843618|NCT01303445|157269535|FG001|Washout (14 Days)|Lost to Follow-up|2|||
48843619|NCT01303445|157269534|FG000|Fourth Intervention (7 Days)|Withdrawal by Subject|1|||
48843620|NCT01303445|157269535|FG001|Fourth Intervention (7 Days)|Withdrawal by Subject|0|||
48843621|NCT01303445|157269534|FG000|Follow-up Period (14 Days)|Withdrawal by Subject|0|||
48843622|NCT01303445|157269535|FG001|Follow-up Period (14 Days)|Withdrawal by Subject|1|||
48843623|NCT02567656|157269545|FG000|Overall Study|Premature discontinuation due to PD|1|||
49175021|NCT00431444|158475067|FG001|Overall Study|Lost to Follow-up|0|||
49175022|NCT00431444|158475066|FG000|Overall Study|Administrative Problems|0|||
49175023|NCT00431444|158475067|FG001|Overall Study|Administrative Problems|1|||
49175024|NCT03213938|158475068|FG000|Overall Study|Lost to Follow-up|4|||
48843624|NCT02567656|157269546|FG001|Overall Study|Premature discontinuation due to PD|1|||
48843625|NCT02567656|157269547|FG002|Overall Study|Premature discontinuation due to PD|2|||
48843626|NCT02567656|157269548|FG003|Overall Study|Premature discontinuation due to PD|0|||
48843627|NCT02567656|157269549|FG004|Overall Study|Premature discontinuation due to PD|0|||
49175025|NCT03213938|158475069|FG001|Overall Study|Lost to Follow-up|3|||
49175026|NCT03213938|158475068|FG000|Overall Study|Lack of Efficacy|1|||
49175027|NCT03213938|158475069|FG001|Overall Study|Lack of Efficacy|0|||
49175028|NCT03213938|158475068|FG000|Overall Study|Decline to participate|5|||
49175029|NCT03213938|158475069|FG001|Overall Study|Decline to participate|4|||
49175030|NCT03213938|158475068|FG000|Overall Study|Without reason|4|||
49175031|NCT03213938|158475069|FG001|Overall Study|Without reason|5|||
49175032|NCT03136497|158475070|FG000|Overall Study|Screen Failure|1|||
49175033|NCT03136497|158475071|FG001|Overall Study|Screen Failure|0|||
49175034|NCT03136497|158475072|FG002|Overall Study|Screen Failure|0|||
49175035|NCT02487654|158475073|FG000|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|0|||
49175036|NCT02487654|158475074|FG001|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|4|||
49175037|NCT02487654|158475073|FG000|Overall Study|Withdrawal by Subject|3|||
49175038|NCT02487654|158475074|FG001|Overall Study|Withdrawal by Subject|7|||
49175039|NCT04238481|158475077|FG000|Overall Study|Miscellaneous|0|||
49175040|NCT04238481|158475078|FG001|Overall Study|Miscellaneous|1|||
49175041|NCT04238481|158475079|FG002|Overall Study|Miscellaneous|0|||
49175042|NCT04238481|158475080|FG003|Overall Study|Miscellaneous|0|||
49175043|NCT00616018|158475082|FG000|Overall Study|Protocol Violation|3|||
49175044|NCT03718884|158475083|FG000|Period 2 (120 Days)|Withdrawal by Subject|0|||
49175045|NCT03718884|158475084|FG001|Period 2 (120 Days)|Withdrawal by Subject|1|||
49175046|NCT03718884|158475083|FG000|Period 2 (120 Days)|Lost to Follow-up|0|||
49175047|NCT03718884|158475084|FG001|Period 2 (120 Days)|Lost to Follow-up|2|||
49175048|NCT00350870|158475087|FG000|Overall Study|Withdrawal by Subject|21|||
49175049|NCT00350870|158475088|FG001|Overall Study|Withdrawal by Subject|17|||
49175050|NCT00350870|158475089|FG002|Overall Study|Withdrawal by Subject|15|||
49175051|NCT00350870|158475090|FG003|Overall Study|Withdrawal by Subject|14|||
49175052|NCT00350870|158475087|FG000|Overall Study|Physician Decision|1|||
49175053|NCT00350870|158475088|FG001|Overall Study|Physician Decision|0|||
49175054|NCT00350870|158475089|FG002|Overall Study|Physician Decision|1|||
49175055|NCT00350870|158475090|FG003|Overall Study|Physician Decision|1|||
49175056|NCT01301066|158475096|FG000|Overall Study|Lost to Follow-up|5|||
48843628|NCT02567656|157269550|FG005|Overall Study|Premature discontinuation due to PD|0|||
48843629|NCT01307267|157269553|FG000|Overall Study|Death|4|||
49175057|NCT01301066|158475097|FG001|Overall Study|Lost to Follow-up|11|||
49175058|NCT01301066|158475096|FG000|Overall Study|Protocol Violation|8|||
49175059|NCT01301066|158475097|FG001|Overall Study|Protocol Violation|7|||
49175060|NCT01301066|158475096|FG000|Overall Study|Withdrawal by Subject|4|||
49175061|NCT01301066|158475097|FG001|Overall Study|Withdrawal by Subject|9|||
49175062|NCT01301066|158475096|FG000|Overall Study|Adverse Event|6|||
48926878|NCT01289015|157564789|FG001|Overall Study|Protocol Violation|9|||
48926879|NCT01289015|157564788|FG000|Overall Study|Adverse Event|3|||
48926880|NCT01289015|157564789|FG001|Overall Study|Adverse Event|0|||
48926881|NCT01289015|157564788|FG000|Overall Study|Lost to Follow-up|33|||
48926882|NCT01289015|157564789|FG001|Overall Study|Lost to Follow-up|17|||
48926883|NCT01289015|157564788|FG000|Overall Study|Withdrawal by Subject|17|||
48926884|NCT01289015|157564789|FG001|Overall Study|Withdrawal by Subject|8|||
48926885|NCT01289015|157564788|FG000|Overall Study|Disease progression|1|||
48926886|NCT01289015|157564789|FG001|Overall Study|Disease progression|0|||
48926887|NCT01289015|157564788|FG000|Overall Study|Negative baseline culture and others|33|||
48926888|NCT01289015|157564789|FG001|Overall Study|Negative baseline culture and others|20|||
48926889|NCT01186367|157564790|FG000|Overall Study|Lost to Follow-up|7|||
48926890|NCT01186367|157564791|FG001|Overall Study|Lost to Follow-up|4|||
48926891|NCT01186367|157564792|FG002|Overall Study|Lost to Follow-up|7|||
48926892|NCT01186367|157564790|FG000|Overall Study|Did not receive study treatment|0|||
48926893|NCT01186367|157564791|FG001|Overall Study|Did not receive study treatment|1|||
48926894|NCT01186367|157564792|FG002|Overall Study|Did not receive study treatment|0|||
49175063|NCT01301066|158475097|FG001|Overall Study|Adverse Event|6|||
49175064|NCT01301066|158475096|FG000|Overall Study|Sponsor Decision|2|||
49175065|NCT01301066|158475097|FG001|Overall Study|Sponsor Decision|1|||
49175066|NCT01301066|158475096|FG000|Overall Study|Physician Decision|0|||
49175067|NCT01301066|158475097|FG001|Overall Study|Physician Decision|1|||
49175068|NCT01301066|158475096|FG000|Overall Study|Other|2|||
49175069|NCT01301066|158475097|FG001|Overall Study|Other|0|||
49175070|NCT04730635|158475100|FG000|Overall Study|Lost to Follow-up|1|||
49175071|NCT04730635|158475101|FG001|Overall Study|Lost to Follow-up|0|||
49175072|NCT04730635|158475100|FG000|Overall Study|Withdrawal by Subject|0|||
49175073|NCT04730635|158475101|FG001|Overall Study|Withdrawal by Subject|1|||
49175074|NCT00516906|158475102|FG000|Overall Study|Final Dressing Removal Data not captured|6|||
49175075|NCT00516906|158475103|FG001|Overall Study|Final Dressing Removal Data not captured|2|||
49175076|NCT03268954|158475106|FG000|Overall Study|Ongoing|23|||
49175077|NCT03268954|158475107|FG001|Overall Study|Ongoing|31|||
49175078|NCT03268954|158475106|FG000|Overall Study|Adverse Event|53|||
49175079|NCT03268954|158475107|FG001|Overall Study|Adverse Event|62|||
49175080|NCT03268954|158475106|FG000|Overall Study|Withdrawal by Subject|25|||
49175081|NCT03268954|158475107|FG001|Overall Study|Withdrawal by Subject|16|||
49175082|NCT03268954|158475106|FG000|Overall Study|Progressive Disease|61|||
49175083|NCT03268954|158475107|FG001|Overall Study|Progressive Disease|48|||
49175084|NCT03268954|158475106|FG000|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|25|||
49175085|NCT03268954|158475107|FG001|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|30|||
49175086|NCT03268954|158475106|FG000|Overall Study|Reason not Specified|40|||
49175087|NCT03268954|158475107|FG001|Overall Study|Reason not Specified|40|||
49175088|NCT01108731|158475108|FG000|Overall Study|Withdrawal by Subject|1|||
49175089|NCT01108731|158475109|FG001|Overall Study|Withdrawal by Subject|1|||
49175090|NCT01108731|158475108|FG000|Overall Study|Adverse Event|3|||
49175091|NCT01108731|158475109|FG001|Overall Study|Adverse Event|3|||
49175092|NCT04209634|158475114|FG000|Overall Study|Ongoing|10|||
49175093|NCT00780143|158475115|FG000|Overall Study|Progressive disease|1|||
49175094|NCT00780143|158475115|FG000|Overall Study|Toxicity|1|||
49175095|NCT00780143|158475115|FG000|Overall Study|Adverse Event|1|||
49175096|NCT00583752|158475116|FG000|Overall Study|Lost to Follow-up|5|||
49175097|NCT00583752|158475117|FG001|Overall Study|Lost to Follow-up|5|||
49175098|NCT01274338|158476607|FG000|Overall Study|Lack of Efficacy|72|||
49175099|NCT01274338|158476608|FG001|Overall Study|Lack of Efficacy|108|||
49175100|NCT01274338|158476609|FG002|Overall Study|Lack of Efficacy|116|||
49175101|NCT01274338|158476610|FG003|Overall Study|Lack of Efficacy|0|||
49175102|NCT01274338|158476611|FG004|Overall Study|Lack of Efficacy|0|||
49175103|NCT01274338|158476612|FG005|Overall Study|Lack of Efficacy|0|||
49175104|NCT01274338|158476607|FG000|Overall Study|Adverse Event|272|||
49175105|NCT01274338|158476608|FG001|Overall Study|Adverse Event|105|||
49175106|NCT01274338|158476609|FG002|Overall Study|Adverse Event|180|||
49175107|NCT01274338|158476610|FG003|Overall Study|Adverse Event|1|||
49175108|NCT01274338|158476611|FG004|Overall Study|Adverse Event|0|||
49175109|NCT01274338|158476612|FG005|Overall Study|Adverse Event|0|||
49175110|NCT01274338|158476607|FG000|Overall Study|Death|8|||
49175111|NCT01274338|158476608|FG001|Overall Study|Death|1|||
49175112|NCT01274338|158476609|FG002|Overall Study|Death|0|||
49175113|NCT01274338|158476610|FG003|Overall Study|Death|0|||
49175114|NCT01274338|158476611|FG004|Overall Study|Death|0|||
49175115|NCT01274338|158476612|FG005|Overall Study|Death|0|||
49175116|NCT01274338|158476607|FG000|Overall Study|Withdrawal by Subject|27|||
48926895|NCT04633122|157564793|FG000|Overall Study|Remained on treatment|19|||
48926896|NCT04633122|157564794|FG001|Overall Study|Remained on treatment|14|||
49175117|NCT01274338|158476608|FG001|Overall Study|Withdrawal by Subject|99|||
49175118|NCT01274338|158476609|FG002|Overall Study|Withdrawal by Subject|17|||
49175119|NCT01274338|158476610|FG003|Overall Study|Withdrawal by Subject|0|||
49175120|NCT01274338|158476611|FG004|Overall Study|Withdrawal by Subject|0|||
49175121|NCT01274338|158476612|FG005|Overall Study|Withdrawal by Subject|0|||
49175122|NCT01274338|158476607|FG000|Overall Study|Did not start treatment|8|||
49175123|NCT01274338|158476608|FG001|Overall Study|Did not start treatment|116|||
49175124|NCT01274338|158476609|FG002|Overall Study|Did not start treatment|7|||
49175125|NCT01274338|158476610|FG003|Overall Study|Did not start treatment|0|||
49175126|NCT01274338|158476611|FG004|Overall Study|Did not start treatment|0|||
49175127|NCT01274338|158476612|FG005|Overall Study|Did not start treatment|0|||
49175128|NCT01274338|158476607|FG000|Overall Study|Alternative therapy|0|||
49175129|NCT01274338|158476608|FG001|Overall Study|Alternative therapy|1|||
49175130|NCT01274338|158476609|FG002|Overall Study|Alternative therapy|0|||
49175131|NCT01274338|158476610|FG003|Overall Study|Alternative therapy|0|||
49175132|NCT01274338|158476611|FG004|Overall Study|Alternative therapy|0|||
49175133|NCT01274338|158476612|FG005|Overall Study|Alternative therapy|0|||
49175134|NCT01274338|158476607|FG000|Overall Study|Other complicating diseases|0|||
49175135|NCT01274338|158476608|FG001|Overall Study|Other complicating diseases|3|||
49175136|NCT01274338|158476609|FG002|Overall Study|Other complicating diseases|1|||
49175137|NCT01274338|158476610|FG003|Overall Study|Other complicating diseases|0|||
49175138|NCT01274338|158476611|FG004|Overall Study|Other complicating diseases|0|||
49175139|NCT01274338|158476612|FG005|Overall Study|Other complicating diseases|0|||
49175140|NCT01274338|158476607|FG000|Overall Study|Treatment arm was suspended due to toxicity|4|||
49175141|NCT01274338|158476608|FG001|Overall Study|Treatment arm was suspended due to toxicity|0|||
49175142|NCT01274338|158476609|FG002|Overall Study|Treatment arm was suspended due to toxicity|0|||
49175143|NCT01274338|158476610|FG003|Overall Study|Treatment arm was suspended due to toxicity|0|||
49175144|NCT01274338|158476611|FG004|Overall Study|Treatment arm was suspended due to toxicity|0|||
49175145|NCT01274338|158476612|FG005|Overall Study|Treatment arm was suspended due to toxicity|0|||
49175146|NCT01274338|158476607|FG000|Overall Study|Pregnancy|0|||
49175147|NCT01274338|158476608|FG001|Overall Study|Pregnancy|0|||
49175148|NCT01274338|158476609|FG002|Overall Study|Pregnancy|1|||
49175149|NCT01274338|158476610|FG003|Overall Study|Pregnancy|0|||
49175150|NCT01274338|158476611|FG004|Overall Study|Pregnancy|0|||
49175151|NCT01274338|158476612|FG005|Overall Study|Pregnancy|0|||
49175152|NCT01274338|158476607|FG000|Overall Study|Reason not reported|12|||
49175153|NCT01274338|158476608|FG001|Overall Study|Reason not reported|21|||
49175154|NCT01274338|158476609|FG002|Overall Study|Reason not reported|3|||
49175155|NCT01274338|158476610|FG003|Overall Study|Reason not reported|0|||
49175156|NCT01274338|158476611|FG004|Overall Study|Reason not reported|1|||
49175157|NCT01274338|158476612|FG005|Overall Study|Reason not reported|0|||
49175158|NCT01386385|158476613|FG000|Phase I 40mg: Concurrent CRT|Progression/relapse|1|||
49175159|NCT01386385|158476614|FG001|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
49175160|NCT01386385|158476615|FG002|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
49175161|NCT01386385|158476616|FG003|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
49175162|NCT01386385|158476617|FG004|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
49175163|NCT01386385|158476618|FG005|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
49175164|NCT01386385|158476619|FG006|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
49175165|NCT01386385|158476620|FG007|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
49175166|NCT01386385|158476613|FG000|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1|||
49175167|NCT01386385|158476614|FG001|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
49175168|NCT01386385|158476615|FG002|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
49175169|NCT01386385|158476616|FG003|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
49175170|NCT01386385|158476617|FG004|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
49175171|NCT01386385|158476618|FG005|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
49175172|NCT01386385|158476619|FG006|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
49175173|NCT01386385|158476620|FG007|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
49175174|NCT01386385|158476613|FG000|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
49175175|NCT01386385|158476614|FG001|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
49175176|NCT01386385|158476615|FG002|Phase I 80mg: Concurrent CRT|Adverse Event|2|||
49175177|NCT01386385|158476616|FG003|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
49175178|NCT01386385|158476617|FG004|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
49175179|NCT01386385|158476618|FG005|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
49175180|NCT01386385|158476619|FG006|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
49175181|NCT01386385|158476620|FG007|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
49175182|NCT01386385|158476613|FG000|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
49175183|NCT01386385|158476614|FG001|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
49175184|NCT01386385|158476615|FG002|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
49175185|NCT01386385|158476616|FG003|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
49175186|NCT01386385|158476617|FG004|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1|||
49175187|NCT01386385|158476618|FG005|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
49175188|NCT01386385|158476619|FG006|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
49175189|NCT01386385|158476620|FG007|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
49175190|NCT01386385|158476613|FG000|Phase II Concurrent CRT|Adverse Event|0|||
49175191|NCT01386385|158476614|FG001|Phase II Concurrent CRT|Adverse Event|0|||
49175192|NCT01386385|158476615|FG002|Phase II Concurrent CRT|Adverse Event|0|||
49175193|NCT01386385|158476616|FG003|Phase II Concurrent CRT|Adverse Event|0|||
49175194|NCT01386385|158476617|FG004|Phase II Concurrent CRT|Adverse Event|0|||
49175195|NCT01386385|158476618|FG005|Phase II Concurrent CRT|Adverse Event|0|||
49175196|NCT01386385|158476619|FG006|Phase II Concurrent CRT|Adverse Event|3|||
49175197|NCT01386385|158476620|FG007|Phase II Concurrent CRT|Adverse Event|3|||
49175198|NCT01386385|158476613|FG000|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
49175199|NCT01386385|158476614|FG001|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
49175200|NCT01386385|158476615|FG002|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
49175201|NCT01386385|158476616|FG003|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
49175202|NCT01386385|158476617|FG004|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
49175203|NCT01386385|158476618|FG005|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
49175204|NCT01386385|158476619|FG006|Phase II Concurrent CRT|Refusal unrelated to AE|3|||
49175205|NCT01386385|158476620|FG007|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
49175206|NCT01386385|158476613|FG000|Phase II: Consolidation Therapy|Adverse Event|0|||
49175207|NCT01386385|158476614|FG001|Phase II: Consolidation Therapy|Adverse Event|0|||
49175208|NCT01386385|158476615|FG002|Phase II: Consolidation Therapy|Adverse Event|0|||
49175209|NCT01386385|158476616|FG003|Phase II: Consolidation Therapy|Adverse Event|0|||
49175210|NCT01386385|158476617|FG004|Phase II: Consolidation Therapy|Adverse Event|0|||
49175211|NCT01386385|158476618|FG005|Phase II: Consolidation Therapy|Adverse Event|0|||
49175212|NCT01386385|158476619|FG006|Phase II: Consolidation Therapy|Adverse Event|2|||
49175213|NCT01386385|158476620|FG007|Phase II: Consolidation Therapy|Adverse Event|1|||
49175214|NCT01386385|158476613|FG000|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
49175215|NCT01386385|158476614|FG001|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
49175216|NCT01386385|158476615|FG002|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
49175217|NCT01386385|158476616|FG003|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
49175218|NCT01386385|158476617|FG004|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
49175219|NCT01386385|158476618|FG005|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
49175220|NCT01386385|158476619|FG006|Phase II: Consolidation Therapy|Refusal unrelated to AE|2|||
48926897|NCT04633122|157564793|FG000|Overall Study|Survival follow-up stopped|22|||
49015211|NCT03349333|157892090|FG000|Overall Study|Other|6|||
49015212|NCT03349333|157892090|FG000|Overall Study|Withdrawal by Subject|5|||
49015213|NCT03349333|157892090|FG000|Overall Study|Conditions interfere with participation|2|||
49015214|NCT03349333|157892090|FG000|Overall Study|Physician Decision|2|||
49015215|NCT03349333|157892090|FG000|Overall Study|3-week lapse between pralatrexate doses|1|||
49015216|NCT03349333|157892090|FG000|Overall Study|Patients in treatment less than 24 month|8|||
49015217|NCT01388647|157892091|FG000|Overall Study|Adverse Event|1|||
49015218|NCT01388647|157892092|FG001|Overall Study|Adverse Event|2|||
49015219|NCT01141283|157892093|FG000|Overall Study|Adverse Event|56|||
49015220|NCT01141283|157892093|FG000|Overall Study|Lost to Follow-up|4|||
49015221|NCT01141283|157892093|FG000|Overall Study|Withdrawal by Subject|14|||
49015222|NCT01141283|157892093|FG000|Overall Study|Administrative|4|||
49015223|NCT01141283|157892093|FG000|Overall Study|Lack of Efficacy|10|||
49015224|NCT00490061|157892094|FG000|Overall Study|Physician Decision|1|||
49015225|NCT01155583|157892095|FG000|Phase I|Screen failure - did not start treatment|0|||
49015226|NCT01155583|157892096|FG001|Phase I|Screen failure - did not start treatment|0|||
49015227|NCT01155583|157892097|FG002|Phase I|Screen failure - did not start treatment|0|||
49015228|NCT01155583|157892098|FG003|Phase I|Screen failure - did not start treatment|0|||
49015229|NCT01155583|157892099|FG004|Phase I|Screen failure - did not start treatment|1|||
49015230|NCT01155583|157892100|FG005|Phase I|Screen failure - did not start treatment|0|||
49015231|NCT01155583|157892101|FG006|Phase I|Screen failure - did not start treatment|0|||
49015232|NCT01155583|157892102|FG007|Phase I|Screen failure - did not start treatment|2|||
49015233|NCT01155583|157892103|FG008|Phase I|Screen failure - did not start treatment|0|||
49015234|NCT01155583|157892095|FG000|Phase I|Withdrawal by Subject|0|||
49015235|NCT01155583|157892096|FG001|Phase I|Withdrawal by Subject|0|||
49015236|NCT01155583|157892097|FG002|Phase I|Withdrawal by Subject|0|||
49015237|NCT01155583|157892098|FG003|Phase I|Withdrawal by Subject|0|||
49015238|NCT01155583|157892099|FG004|Phase I|Withdrawal by Subject|0|||
49015239|NCT01155583|157892100|FG005|Phase I|Withdrawal by Subject|0|||
49015240|NCT01155583|157892101|FG006|Phase I|Withdrawal by Subject|0|||
49015241|NCT01155583|157892102|FG007|Phase I|Withdrawal by Subject|1|||
49015242|NCT01155583|157892103|FG008|Phase I|Withdrawal by Subject|0|||
49015243|NCT02473510|157892110|FG000|Overall Study|Lost to Follow-up|1|||
49015244|NCT02473510|157892111|FG001|Overall Study|Lost to Follow-up|2|||
49015245|NCT01937364|157892116|FG000|Overall Study|Adverse Event|2|||
49015246|NCT01937364|157892117|FG001|Overall Study|Adverse Event|1|||
49015247|NCT04104646|157892124|FG000|Overall Study|Withdrawal by Subject|1|||
49015248|NCT04104646|157892125|FG001|Overall Study|Withdrawal by Subject|1|||
49015249|NCT04104646|157892124|FG000|Overall Study|Lost to Follow-up|1|||
49015250|NCT04104646|157892125|FG001|Overall Study|Lost to Follow-up|0|||
49015251|NCT04104646|157892124|FG000|Overall Study|Physician Decision|2|||
49015252|NCT04104646|157892125|FG001|Overall Study|Physician Decision|0|||
49015253|NCT01185288|157892126|FG000|Overall Study|Adverse Event|7|||
49015254|NCT01185288|157892127|FG001|Overall Study|Adverse Event|6|||
49015255|NCT01185288|157892126|FG000|Overall Study|Withdrawal by Subject|6|||
49015256|NCT01185288|157892127|FG001|Overall Study|Withdrawal by Subject|4|||
49015257|NCT01185288|157892126|FG000|Overall Study|Lost to Follow-up|2|||
49015258|NCT01185288|157892127|FG001|Overall Study|Lost to Follow-up|5|||
49015259|NCT01185288|157892126|FG000|Overall Study|Lack of Efficacy|2|||
49015260|NCT01185288|157892127|FG001|Overall Study|Lack of Efficacy|0|||
49015261|NCT01185288|157892126|FG000|Overall Study|Investigator discretion|1|||
49015262|NCT01185288|157892127|FG001|Overall Study|Investigator discretion|0|||
49015263|NCT01185288|157892126|FG000|Overall Study|Did not meet inclusion criteria|1|||
49015264|NCT01185288|157892127|FG001|Overall Study|Did not meet inclusion criteria|0|||
49015265|NCT01185288|157892126|FG000|Overall Study|Noncompliance|0|||
49015266|NCT01185288|157892127|FG001|Overall Study|Noncompliance|1|||
49015267|NCT03276975|157892128|FG000|Overall Study|Withdrawal by Subject|1|||
49015268|NCT03276975|157892129|FG001|Overall Study|Withdrawal by Subject|0|||
49015269|NCT01626859|157892132|FG000|Overall Study|Adverse Event|1|||
49015270|NCT01626859|157892133|FG001|Overall Study|Adverse Event|3|||
49015271|NCT01626859|157892134|FG002|Overall Study|Adverse Event|2|||
48926898|NCT04633122|157564794|FG001|Overall Study|Survival follow-up stopped|25|||
49175221|NCT01386385|158476620|FG007|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
48926899|NCT03694418|157564795|FG000|Overall Study|Lost to Follow-up|115|||
48926900|NCT03694418|157564796|FG001|Overall Study|Lost to Follow-up|23|||
48926901|NCT03694418|157564797|FG002|Overall Study|Lost to Follow-up|12|||
48926902|NCT03694418|157564798|FG003|Overall Study|Lost to Follow-up|12|||
48926903|NCT03694418|157564799|FG004|Overall Study|Lost to Follow-up|13|||
49175222|NCT01386385|158476613|FG000|Phase II: Consolidation Therapy|Progression/relapse|0|||
49175223|NCT01386385|158476614|FG001|Phase II: Consolidation Therapy|Progression/relapse|0|||
49175224|NCT01386385|158476615|FG002|Phase II: Consolidation Therapy|Progression/relapse|0|||
48843630|NCT01307267|157269554|FG001|Overall Study|Death|3|||
48843631|NCT01307267|157269555|FG002|Overall Study|Death|5|||
48843632|NCT01307267|157269556|FG003|Overall Study|Death|3|||
48843633|NCT01307267|157269557|FG004|Overall Study|Death|1|||
48843634|NCT01307267|157269558|FG005|Overall Study|Death|26|||
48843635|NCT01307267|157269559|FG006|Overall Study|Death|2|||
48843636|NCT01307267|157269560|FG007|Overall Study|Death|2|||
48843637|NCT01307267|157269561|FG008|Overall Study|Death|21|||
48843638|NCT01307267|157269562|FG009|Overall Study|Death|2|||
48843639|NCT01307267|157269563|FG010|Overall Study|Death|3|||
48843640|NCT01307267|157269564|FG011|Overall Study|Death|9|||
49175225|NCT01386385|158476616|FG003|Phase II: Consolidation Therapy|Progression/relapse|0|||
49175226|NCT01386385|158476617|FG004|Phase II: Consolidation Therapy|Progression/relapse|0|||
48843641|NCT01307267|157269565|FG012|Overall Study|Death|0|||
48843642|NCT01307267|157269566|FG013|Overall Study|Death|0|||
48843643|NCT01307267|157269567|FG014|Overall Study|Death|0|||
48843644|NCT01307267|157269568|FG015|Overall Study|Death|0|||
48843645|NCT01307267|157269569|FG016|Overall Study|Death|1|||
48843646|NCT01307267|157269570|FG017|Overall Study|Death|1|||
48843647|NCT01307267|157269571|FG018|Overall Study|Death|2|||
48843648|NCT01307267|157269572|FG019|Overall Study|Death|8|||
48843649|NCT01307267|157269573|FG020|Overall Study|Death|1|||
48843650|NCT01307267|157269574|FG021|Overall Study|Death|2|||
48843651|NCT01307267|157269575|FG022|Overall Study|Death|2|||
48843652|NCT01307267|157269553|FG000|Overall Study|Lost to Follow-up|0|||
48843653|NCT01307267|157269554|FG001|Overall Study|Lost to Follow-up|0|||
48843654|NCT01307267|157269555|FG002|Overall Study|Lost to Follow-up|0|||
48843655|NCT01307267|157269556|FG003|Overall Study|Lost to Follow-up|0|||
48843656|NCT01307267|157269557|FG004|Overall Study|Lost to Follow-up|0|||
48843657|NCT01307267|157269558|FG005|Overall Study|Lost to Follow-up|7|||
48843658|NCT01307267|157269559|FG006|Overall Study|Lost to Follow-up|0|||
49175227|NCT01386385|158476618|FG005|Phase II: Consolidation Therapy|Progression/relapse|0|||
49175228|NCT01386385|158476619|FG006|Phase II: Consolidation Therapy|Progression/relapse|1|||
48843659|NCT01307267|157269560|FG007|Overall Study|Lost to Follow-up|0|||
48843660|NCT01307267|157269561|FG008|Overall Study|Lost to Follow-up|1|||
48843661|NCT01307267|157269562|FG009|Overall Study|Lost to Follow-up|2|||
48843662|NCT01307267|157269563|FG010|Overall Study|Lost to Follow-up|1|||
48843663|NCT01307267|157269564|FG011|Overall Study|Lost to Follow-up|0|||
48843664|NCT01307267|157269565|FG012|Overall Study|Lost to Follow-up|0|||
48843665|NCT01307267|157269566|FG013|Overall Study|Lost to Follow-up|0|||
48843666|NCT01307267|157269567|FG014|Overall Study|Lost to Follow-up|0|||
48926904|NCT05399459|157564800|FG000|Overall Study|Randomized but not treated|29|||
48926905|NCT05399459|157564801|FG001|Overall Study|Randomized but not treated|30|||
48843667|NCT01307267|157269568|FG015|Overall Study|Lost to Follow-up|0|||
48843668|NCT01307267|157269569|FG016|Overall Study|Lost to Follow-up|0|||
49175229|NCT01386385|158476620|FG007|Phase II: Consolidation Therapy|Progression/relapse|1|||
49175230|NCT03889925|158476621|FG000|Overall Study|Lost to Follow-up|11|||
49175231|NCT03889925|158476622|FG001|Overall Study|Lost to Follow-up|10|||
49175232|NCT01643070|158476629|FG000|Overall Study|Withdrawal by Subject|3|||
49175233|NCT01643070|158476630|FG001|Overall Study|Withdrawal by Subject|1|||
49175234|NCT01643070|158476629|FG000|Overall Study|Death|1|||
49175235|NCT01643070|158476630|FG001|Overall Study|Death|0|||
49175236|NCT01643070|158476629|FG000|Overall Study|Pregressive disease|0|||
48843669|NCT01307267|157269570|FG017|Overall Study|Lost to Follow-up|0|||
49175237|NCT01643070|158476630|FG001|Overall Study|Pregressive disease|2|||
49175238|NCT01259401|158476631|FG000|4-month Follow-up|Death|0|||
49175239|NCT01259401|158476632|FG001|4-month Follow-up|Death|1|||
49175240|NCT01259401|158476631|FG000|4-month Follow-up|Lost to Follow-up|0|||
48843670|NCT01307267|157269571|FG018|Overall Study|Lost to Follow-up|0|||
48843671|NCT01307267|157269572|FG019|Overall Study|Lost to Follow-up|2|||
48843672|NCT01307267|157269573|FG020|Overall Study|Lost to Follow-up|0|||
48843673|NCT01307267|157269574|FG021|Overall Study|Lost to Follow-up|0|||
48843674|NCT01307267|157269575|FG022|Overall Study|Lost to Follow-up|0|||
48843675|NCT01307267|157269553|FG000|Overall Study|Withdrawal by Subject|0|||
48843676|NCT01307267|157269554|FG001|Overall Study|Withdrawal by Subject|0|||
48843677|NCT01307267|157269555|FG002|Overall Study|Withdrawal by Subject|0|||
48843678|NCT01307267|157269556|FG003|Overall Study|Withdrawal by Subject|0|||
48843679|NCT01307267|157269557|FG004|Overall Study|Withdrawal by Subject|0|||
48843680|NCT01307267|157269558|FG005|Overall Study|Withdrawal by Subject|1|||
48843681|NCT01307267|157269559|FG006|Overall Study|Withdrawal by Subject|0|||
48843682|NCT01307267|157269560|FG007|Overall Study|Withdrawal by Subject|1|||
48843683|NCT01307267|157269561|FG008|Overall Study|Withdrawal by Subject|5|||
48843684|NCT01307267|157269562|FG009|Overall Study|Withdrawal by Subject|1|||
49175241|NCT01259401|158476632|FG001|4-month Follow-up|Lost to Follow-up|1|||
49175242|NCT04770753|158476633|FG000|Overall Study|Randomized, never treated|1|||
49175243|NCT04770753|158476634|FG001|Overall Study|Randomized, never treated|1|||
49175244|NCT04770753|158476633|FG000|Overall Study|Withdrawal by Subject|3|||
49175245|NCT04770753|158476634|FG001|Overall Study|Withdrawal by Subject|1|||
49175246|NCT04770753|158476633|FG000|Overall Study|Adverse Event|2|||
48843685|NCT01307267|157269563|FG010|Overall Study|Withdrawal by Subject|1|||
48843686|NCT01307267|157269564|FG011|Overall Study|Withdrawal by Subject|1|||
48843687|NCT01307267|157269565|FG012|Overall Study|Withdrawal by Subject|0|||
48843688|NCT01307267|157269566|FG013|Overall Study|Withdrawal by Subject|0|||
48843689|NCT01307267|157269567|FG014|Overall Study|Withdrawal by Subject|0|||
48843690|NCT01307267|157269568|FG015|Overall Study|Withdrawal by Subject|0|||
48843691|NCT01307267|157269569|FG016|Overall Study|Withdrawal by Subject|0|||
48843692|NCT01307267|157269570|FG017|Overall Study|Withdrawal by Subject|0|||
48843693|NCT01307267|157269571|FG018|Overall Study|Withdrawal by Subject|0|||
48843694|NCT01307267|157269572|FG019|Overall Study|Withdrawal by Subject|3|||
48843695|NCT01307267|157269573|FG020|Overall Study|Withdrawal by Subject|0|||
48843696|NCT01307267|157269574|FG021|Overall Study|Withdrawal by Subject|0|||
48843697|NCT01307267|157269575|FG022|Overall Study|Withdrawal by Subject|0|||
48926906|NCT05399459|157564802|FG002|Overall Study|Randomized but not treated|38|||
48926907|NCT05399459|157564800|FG000|Overall Study|Lost to Follow-up|1|||
48926908|NCT05399459|157564801|FG001|Overall Study|Lost to Follow-up|0|||
49175247|NCT04770753|158476634|FG001|Overall Study|Adverse Event|0|||
49175248|NCT04770753|158476633|FG000|Overall Study|Pregnancy|1|||
49175249|NCT04770753|158476634|FG001|Overall Study|Pregnancy|0|||
49175250|NCT04770753|158476633|FG000|Overall Study|Other un-specified|1|||
49175251|NCT04770753|158476634|FG001|Overall Study|Other un-specified|0|||
49175252|NCT02775851|158476635|FG000|Overall Study|Adverse Event|1|||
49175253|NCT02775851|158476636|FG001|Overall Study|Adverse Event|10|||
49175254|NCT02775851|158476635|FG000|Overall Study|Refusal Unrelated to Adverse Event|0|||
49175255|NCT02775851|158476636|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
49175256|NCT02775851|158476635|FG000|Overall Study|Progression/Relapse|0|||
49175257|NCT02775851|158476636|FG001|Overall Study|Progression/Relapse|4|||
49175258|NCT02775851|158476635|FG000|Overall Study|Other - Not Protocol Specified|0|||
49175259|NCT02775851|158476636|FG001|Overall Study|Other - Not Protocol Specified|7|||
49175260|NCT02775851|158476635|FG000|Overall Study|Withdrawal by Subject|1|||
49175261|NCT02775851|158476636|FG001|Overall Study|Withdrawal by Subject|0|||
49175262|NCT05696080|158476639|FG000|Overall Study|Lost to Follow-up|2|||
49175263|NCT05696080|158476640|FG001|Overall Study|Lost to Follow-up|1|||
49175264|NCT05696080|158476639|FG000|Overall Study|Physician Decision|1|||
49175265|NCT05696080|158476640|FG001|Overall Study|Physician Decision|0|||
49175266|NCT05696080|158476639|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
49175267|NCT05696080|158476640|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
49175268|NCT05696080|158476639|FG000|Overall Study|Withdrawal by Subject|12|||
49175269|NCT05696080|158476640|FG001|Overall Study|Withdrawal by Subject|0|||
49175270|NCT05644002|158476641|FG000|Overall Study|Lost to Follow-up|1|||
49175271|NCT05644002|158476642|FG001|Overall Study|Lost to Follow-up|2|||
49175272|NCT05644002|158476641|FG000|Overall Study|Withdrawal by Subject|0|||
49175273|NCT05644002|158476642|FG001|Overall Study|Withdrawal by Subject|1|||
49175274|NCT03821844|158476645|FG000|Overall Study|Death|37|||
49175275|NCT03821844|158476646|FG001|Overall Study|Death|31|||
49175276|NCT03821844|158476645|FG000|Overall Study|Discharged|10|||
49175277|NCT03821844|158476646|FG001|Overall Study|Discharged|14|||
49175278|NCT03821844|158476645|FG000|Overall Study|Not present in facility at followup|2|||
49175279|NCT03821844|158476646|FG001|Overall Study|Not present in facility at followup|3|||
49175280|NCT04999085|158476647|FG000|Overall Study|Death|1|||
49175281|NCT05056246|158476650|FG000|Overall Study|Adverse Event|0|||
49175282|NCT05056246|158476651|FG001|Overall Study|Adverse Event|0|||
49175283|NCT05056246|158476652|FG002|Overall Study|Adverse Event|0|||
48843698|NCT01307267|157269553|FG000|Overall Study|Other|0|||
48843699|NCT01307267|157269554|FG001|Overall Study|Other|0|||
48926909|NCT05399459|157564802|FG002|Overall Study|Lost to Follow-up|0|||
48843700|NCT01307267|157269555|FG002|Overall Study|Other|0|||
48843701|NCT01307267|157269556|FG003|Overall Study|Other|0|||
48843702|NCT01307267|157269557|FG004|Overall Study|Other|0|||
48843703|NCT01307267|157269558|FG005|Overall Study|Other|7|||
48843704|NCT01307267|157269559|FG006|Overall Study|Other|0|||
48843705|NCT01307267|157269560|FG007|Overall Study|Other|1|||
48926910|NCT00774345|157564805|FG000|Pre-treatment|Other reasons|2|||
48926911|NCT00774345|157564806|FG001|Pre-treatment|Other reasons|0|||
48926912|NCT00774345|157564805|FG000|Treatment|Adverse Event|61|||
48926913|NCT00774345|157564806|FG001|Treatment|Adverse Event|15|||
48926914|NCT00774345|157564805|FG000|Treatment|Progressive Disease without histologic transformation|51|||
48926915|NCT00774345|157564806|FG001|Treatment|Progressive Disease without histologic transformation|111|||
48926916|NCT00774345|157564805|FG000|Treatment|Progressive Disease with histologic transformation|4|||
48926917|NCT00774345|157564806|FG001|Treatment|Progressive Disease with histologic transformation|2|||
48926918|NCT00774345|157564805|FG000|Treatment|Withdrawal by Subject|5|||
48926919|NCT00774345|157564806|FG001|Treatment|Withdrawal by Subject|2|||
48926920|NCT00774345|157564805|FG000|Treatment|Lost to Follow-up|1|||
48926921|NCT00774345|157564806|FG001|Treatment|Lost to Follow-up|1|||
48926922|NCT00774345|157564805|FG000|Treatment|Death|4|||
48926923|NCT00774345|157564806|FG001|Treatment|Death|0|||
48926924|NCT00774345|157564805|FG000|Treatment|Other Reasons|32|||
48926925|NCT00774345|157564806|FG001|Treatment|Other Reasons|26|||
48926926|NCT01127165|157564809|FG000|Overall Study|Adverse Event|2|||
48926927|NCT01127165|157564810|FG001|Overall Study|Adverse Event|2|||
48926928|NCT01127165|157564809|FG000|Overall Study|Lack of Efficacy|10|||
48926929|NCT01127165|157564810|FG001|Overall Study|Lack of Efficacy|8|||
48926930|NCT01127165|157564809|FG000|Overall Study|Lost to Follow-up|3|||
48926931|NCT01127165|157564810|FG001|Overall Study|Lost to Follow-up|5|||
48926932|NCT01127165|157564809|FG000|Overall Study|Withdrawal by Subject|1|||
48926933|NCT01127165|157564810|FG001|Overall Study|Withdrawal by Subject|3|||
48926934|NCT01127165|157564809|FG000|Overall Study|Protocol Violation|0|||
48926935|NCT01127165|157564810|FG001|Overall Study|Protocol Violation|1|||
48926936|NCT01400451|157564811|FG000|Combination Treatment (or Intended)|Withdrawal by Subject|2|||
49175284|NCT05056246|158476653|FG003|Overall Study|Adverse Event|0|||
49175285|NCT05056246|158476654|FG004|Overall Study|Adverse Event|1|||
49175286|NCT05056246|158476650|FG000|Overall Study|Lost to Follow-up|0|||
49175287|NCT05056246|158476651|FG001|Overall Study|Lost to Follow-up|0|||
49175288|NCT05056246|158476652|FG002|Overall Study|Lost to Follow-up|0|||
49175289|NCT05056246|158476653|FG003|Overall Study|Lost to Follow-up|2|||
49175290|NCT05056246|158476654|FG004|Overall Study|Lost to Follow-up|0|||
49175291|NCT05056246|158476650|FG000|Overall Study|Withdrawal by Subject|0|||
49175292|NCT05056246|158476651|FG001|Overall Study|Withdrawal by Subject|1|||
49175293|NCT05056246|158476652|FG002|Overall Study|Withdrawal by Subject|0|||
49175294|NCT05056246|158476653|FG003|Overall Study|Withdrawal by Subject|0|||
49175295|NCT05056246|158476654|FG004|Overall Study|Withdrawal by Subject|0|||
49175296|NCT05307978|158476657|FG000|Overall Study|Lost to Follow-up|0|||
49175297|NCT05307978|158476658|FG001|Overall Study|Lost to Follow-up|1|||
49175298|NCT05307978|158476659|FG002|Overall Study|Lost to Follow-up|0|||
49175299|NCT05307978|158476660|FG003|Overall Study|Lost to Follow-up|4|||
49175300|NCT05307978|158476661|FG004|Overall Study|Lost to Follow-up|0|||
49175301|NCT05307978|158476662|FG005|Overall Study|Lost to Follow-up|0|||
49175302|NCT05307978|158476663|FG006|Overall Study|Lost to Follow-up|1|||
49175303|NCT03324984|158476664|FG000|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|1|||
49175304|NCT03324984|158476665|FG001|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|4|||
49175305|NCT04023526|158476669|FG000|Overall Study|Ongoing treatment at data cutoff|5|||
49175306|NCT04023526|158476670|FG001|Overall Study|Ongoing treatment at data cutoff|9|||
49175307|NCT04023526|158476669|FG000|Overall Study|Randomized but did not receive assigned treatment|0|||
49175308|NCT04023526|158476670|FG001|Overall Study|Randomized but did not receive assigned treatment|1|||
49175309|NCT01353313|158476671|FG000|Overall Study|Lost to Follow-up|22|||
49175310|NCT01353313|158476672|FG001|Overall Study|Lost to Follow-up|23|||
49175311|NCT01353313|158476671|FG000|Overall Study|Incomplete Follow-up or No Study Data|12|||
49175312|NCT01353313|158476672|FG001|Overall Study|Incomplete Follow-up or No Study Data|15|||
49175313|NCT03737994|158476673|FG000|Overall Study|Withdrawal by Subject|0|||
49175314|NCT03737994|158476674|FG001|Overall Study|Withdrawal by Subject|0|||
49175315|NCT03737994|158476675|FG002|Overall Study|Withdrawal by Subject|0|||
49175316|NCT03737994|158476676|FG003|Overall Study|Withdrawal by Subject|0|||
48843706|NCT01307267|157269561|FG008|Overall Study|Other|3|||
48843707|NCT01307267|157269562|FG009|Overall Study|Other|0|||
48843708|NCT01307267|157269563|FG010|Overall Study|Other|1|||
48843709|NCT01307267|157269564|FG011|Overall Study|Other|1|||
48843710|NCT01307267|157269565|FG012|Overall Study|Other|1|||
48926937|NCT01400451|157564812|FG001|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
48926938|NCT01400451|157564813|FG002|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
48926939|NCT01400451|157564811|FG000|Combination Treatment (or Intended)|Drug Toxicity|0|||
48926940|NCT01400451|157564812|FG001|Combination Treatment (or Intended)|Drug Toxicity|1|||
49015272|NCT01626859|157892132|FG000|Overall Study|Physician Decision|0|||
49175317|NCT03737994|158476677|FG004|Overall Study|Withdrawal by Subject|0|||
49175318|NCT03737994|158476678|FG005|Overall Study|Withdrawal by Subject|0|||
49175319|NCT03737994|158476679|FG006|Overall Study|Withdrawal by Subject|1|||
49175320|NCT03382561|158476680|FG000|Overall Study|Disease progression|47|||
49175321|NCT03382561|158476681|FG001|Overall Study|Disease progression|6|||
49175322|NCT03382561|158476680|FG000|Overall Study|Adverse Event|10|||
48843711|NCT01307267|157269566|FG013|Overall Study|Other|0|||
48843712|NCT01307267|157269567|FG014|Overall Study|Other|2|||
48843713|NCT01307267|157269568|FG015|Overall Study|Other|1|||
48843714|NCT01307267|157269569|FG016|Overall Study|Other|0|||
48843715|NCT01307267|157269570|FG017|Overall Study|Other|0|||
49175323|NCT03382561|158476681|FG001|Overall Study|Adverse Event|2|||
49175324|NCT03382561|158476680|FG000|Overall Study|Death|8|||
49175325|NCT03382561|158476681|FG001|Overall Study|Death|3|||
49175326|NCT03382561|158476680|FG000|Overall Study|Withdrawal by Subject|6|||
49175327|NCT03382561|158476681|FG001|Overall Study|Withdrawal by Subject|5|||
49175328|NCT03382561|158476680|FG000|Overall Study|Alternative therapy|2|||
48843716|NCT01307267|157269571|FG018|Overall Study|Other|0|||
48843717|NCT01307267|157269572|FG019|Overall Study|Other|19|||
49175329|NCT03382561|158476681|FG001|Overall Study|Alternative therapy|8|||
48843718|NCT01307267|157269573|FG020|Overall Study|Other|2|||
49175330|NCT03382561|158476680|FG000|Overall Study|Never started treatment|3|||
48843719|NCT01307267|157269574|FG021|Overall Study|Other|3|||
48843720|NCT01307267|157269575|FG022|Overall Study|Other|2|||
48843721|NCT01582100|157269576|FG000|Overall Study|Adverse Event|1|||
48843722|NCT01582100|157269576|FG000|Overall Study|Withdrawal by Subject|1|||
48843723|NCT01424397|157269577|FG000|Period-2 (8 Days)|Withdrawal by Subject|0|||
48843724|NCT01424397|157269578|FG001|Period-2 (8 Days)|Withdrawal by Subject|0|||
48843725|NCT01424397|157269579|FG002|Period-2 (8 Days)|Withdrawal by Subject|1|||
48843726|NCT01424397|157269580|FG003|Period-2 (8 Days)|Withdrawal by Subject|0|||
48843727|NCT01424397|157269581|FG004|Period-2 (8 Days)|Withdrawal by Subject|0|||
48843728|NCT01424397|157269582|FG005|Period-2 (8 Days)|Withdrawal by Subject|0|||
48843729|NCT01424397|157269583|FG006|Period-2 (8 Days)|Withdrawal by Subject|0|||
48843730|NCT01424397|157269584|FG007|Period-2 (8 Days)|Withdrawal by Subject|0|||
48843731|NCT01424397|157269585|FG008|Period-2 (8 Days)|Withdrawal by Subject|0|||
48843732|NCT01424397|157269586|FG009|Period-2 (8 Days)|Withdrawal by Subject|0|||
48843733|NCT01424397|157269587|FG010|Period-2 (8 Days)|Withdrawal by Subject|0|||
48843734|NCT01424397|157269588|FG011|Period-2 (8 Days)|Withdrawal by Subject|0|||
48843735|NCT01808339|157269589|FG000|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
48843736|NCT01808339|157269590|FG001|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
48843737|NCT01808339|157269591|FG002|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
48843738|NCT01808339|157269592|FG003|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
48843739|NCT01808339|157269593|FG004|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2|||
48843740|NCT01808339|157269594|FG005|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
48843741|NCT01808339|157269589|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
48843742|NCT01808339|157269590|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
48843743|NCT01808339|157269591|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
48843744|NCT01808339|157269592|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
48843745|NCT01808339|157269593|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
48843746|NCT01808339|157269594|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
48843747|NCT01808339|157269589|FG000|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
48843748|NCT01808339|157269590|FG001|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
48843749|NCT01808339|157269591|FG002|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
48843750|NCT01808339|157269592|FG003|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
48843751|NCT01808339|157269593|FG004|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
48843752|NCT01808339|157269594|FG005|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
48843753|NCT03593876|157269601|FG000|Overall Study|Withdrawal by Subject|1|||
48926941|NCT01400451|157564813|FG002|Combination Treatment (or Intended)|Drug Toxicity|0|||
48843754|NCT03593876|157269601|FG000|Overall Study|Discharged home before intervention completion|2|||
48843755|NCT01040689|157269602|FG000|Overall Study|Adverse Event|0|||
48843756|NCT01040689|157269603|FG001|Overall Study|Adverse Event|0|||
48843757|NCT01040689|157269604|FG002|Overall Study|Adverse Event|2|||
48843758|NCT01040689|157269605|FG003|Overall Study|Adverse Event|4|||
48843759|NCT01040689|157269602|FG000|Overall Study|Lack of Efficacy|0|||
48843760|NCT01040689|157269603|FG001|Overall Study|Lack of Efficacy|0|||
48843761|NCT01040689|157269604|FG002|Overall Study|Lack of Efficacy|1|||
48843762|NCT01040689|157269605|FG003|Overall Study|Lack of Efficacy|0|||
48843763|NCT01040689|157269602|FG000|Overall Study|Lost to Follow-up|1|||
48843764|NCT01040689|157269603|FG001|Overall Study|Lost to Follow-up|0|||
48843765|NCT01040689|157269604|FG002|Overall Study|Lost to Follow-up|0|||
48843766|NCT01040689|157269605|FG003|Overall Study|Lost to Follow-up|0|||
48843767|NCT01040689|157269602|FG000|Overall Study|Withdrawal by Subject|2|||
48843768|NCT01040689|157269603|FG001|Overall Study|Withdrawal by Subject|1|||
48843769|NCT01040689|157269604|FG002|Overall Study|Withdrawal by Subject|1|||
48843770|NCT01040689|157269605|FG003|Overall Study|Withdrawal by Subject|0|||
48843771|NCT01040689|157269602|FG000|Overall Study|Other reasons not listed above|0|||
48843772|NCT01040689|157269603|FG001|Overall Study|Other reasons not listed above|1|||
49175331|NCT03382561|158476681|FG001|Overall Study|Never started treatment|6|||
49175332|NCT03382561|158476680|FG000|Overall Study|Lack of Efficacy|0|||
49175333|NCT03382561|158476681|FG001|Overall Study|Lack of Efficacy|1|||
49175334|NCT03382561|158476680|FG000|Overall Study|Physician Decision|0|||
49175335|NCT03382561|158476681|FG001|Overall Study|Physician Decision|1|||
49175336|NCT03382561|158476680|FG000|Overall Study|Other complicating disease|0|||
49175337|NCT03382561|158476681|FG001|Overall Study|Other complicating disease|1|||
49175338|NCT04468776|158476683|FG000|Overall Study|Lost to Follow-up|4|||
49175339|NCT04468776|158476684|FG001|Overall Study|Lost to Follow-up|3|||
49175340|NCT04468776|158476685|FG002|Overall Study|Lost to Follow-up|4|||
48843773|NCT01040689|157269604|FG002|Overall Study|Other reasons not listed above|0|||
48843774|NCT01040689|157269605|FG003|Overall Study|Other reasons not listed above|0|||
48843775|NCT00585052|157269610|FG000|Overall Study|Withdrawal by Subject|1|||
48843776|NCT01369498|157269613|FG000|Overall Study|Lack of Efficacy|9|||
48843777|NCT01369498|157269614|FG001|Overall Study|Lack of Efficacy|9|||
49175341|NCT04468776|158476683|FG000|Overall Study|Withdrawal by Subject|1|||
49175342|NCT04468776|158476684|FG001|Overall Study|Withdrawal by Subject|10|||
49175343|NCT04468776|158476685|FG002|Overall Study|Withdrawal by Subject|4|||
49175344|NCT04468776|158476683|FG000|Overall Study|Physician Decision|0|||
49175345|NCT04468776|158476684|FG001|Overall Study|Physician Decision|1|||
49175346|NCT04468776|158476685|FG002|Overall Study|Physician Decision|1|||
49175347|NCT02143414|158476686|FG000|Induction|Adverse Event|1|||
49175348|NCT02143414|158476687|FG001|Induction|Adverse Event|2|||
49175349|NCT02143414|158476686|FG000|Induction|Death|1|||
49175350|NCT02143414|158476687|FG001|Induction|Death|2|||
49175351|NCT02143414|158476686|FG000|Induction|Patient refusal|1|||
49175352|NCT02143414|158476687|FG001|Induction|Patient refusal|1|||
49175353|NCT02143414|158476686|FG000|Induction|Refractory|1|||
49175354|NCT02143414|158476687|FG001|Induction|Refractory|0|||
49175355|NCT02143414|158476686|FG000|Induction|Began alternative treatment|1|||
49175356|NCT02143414|158476687|FG001|Induction|Began alternative treatment|0|||
49175357|NCT02143414|158476686|FG000|Induction|Ineligible for postremission|5|||
49175358|NCT02143414|158476687|FG001|Induction|Ineligible for postremission|1|||
49175359|NCT02143414|158476686|FG000|Post-remission|Adverse Event|0|||
49175360|NCT02143414|158476687|FG001|Post-remission|Adverse Event|2|||
49175361|NCT02143414|158476686|FG000|Post-remission|Disease progression/relapse|5|||
49175362|NCT02143414|158476687|FG001|Post-remission|Disease progression/relapse|0|||
49175363|NCT02143414|158476686|FG000|Maintenance|Adverse Event|4|||
49175364|NCT02143414|158476687|FG001|Maintenance|Adverse Event|6|||
49175365|NCT02143414|158476686|FG000|Maintenance|Disease progression/relapse|3|||
49175366|NCT02143414|158476687|FG001|Maintenance|Disease progression/relapse|2|||
48843778|NCT01369498|157269615|FG002|Overall Study|Lack of Efficacy|1|||
48843779|NCT01369498|157269616|FG003|Overall Study|Lack of Efficacy|3|||
48843780|NCT01369498|157269613|FG000|Overall Study|Adverse Event|1|||
48843781|NCT01369498|157269614|FG001|Overall Study|Adverse Event|2|||
48843782|NCT01369498|157269615|FG002|Overall Study|Adverse Event|0|||
48843783|NCT01369498|157269616|FG003|Overall Study|Adverse Event|1|||
48843784|NCT01369498|157269613|FG000|Overall Study|Withdrawal of Consent|0|||
48843785|NCT01369498|157269614|FG001|Overall Study|Withdrawal of Consent|1|||
48843786|NCT01369498|157269615|FG002|Overall Study|Withdrawal of Consent|1|||
48843787|NCT01369498|157269616|FG003|Overall Study|Withdrawal of Consent|1|||
48843788|NCT01369498|157269613|FG000|Overall Study|Death|0|||
48843789|NCT01369498|157269614|FG001|Overall Study|Death|0|||
48843790|NCT01369498|157269615|FG002|Overall Study|Death|1|||
48843791|NCT01369498|157269616|FG003|Overall Study|Death|0|||
48843792|NCT01369498|157269613|FG000|Overall Study|Investigator's Discretion|1|||
48843793|NCT01369498|157269614|FG001|Overall Study|Investigator's Discretion|0|||
48843794|NCT01369498|157269615|FG002|Overall Study|Investigator's Discretion|1|||
48843795|NCT01369498|157269616|FG003|Overall Study|Investigator's Discretion|3|||
48843796|NCT01369498|157269613|FG000|Overall Study|Unknown Reason|1|||
48843797|NCT01369498|157269614|FG001|Overall Study|Unknown Reason|0|||
49175367|NCT02143414|158476686|FG000|Maintenance|Patient refusal|2|||
49175368|NCT02143414|158476687|FG001|Maintenance|Patient refusal|1|||
49175369|NCT02143414|158476686|FG000|Maintenance|Physician Decision|1|||
49175370|NCT02143414|158476687|FG001|Maintenance|Physician Decision|0|||
48843798|NCT01369498|157269615|FG002|Overall Study|Unknown Reason|11|||
48843799|NCT01369498|157269616|FG003|Overall Study|Unknown Reason|6|||
48843800|NCT01369498|157269613|FG000|Overall Study|Disease Progression|0|||
49175371|NCT02143414|158476686|FG000|Maintenance|Death|0|||
49175372|NCT02143414|158476687|FG001|Maintenance|Death|1|||
48843801|NCT01369498|157269614|FG001|Overall Study|Disease Progression|0|||
48843802|NCT01369498|157269615|FG002|Overall Study|Disease Progression|0|||
48843803|NCT01369498|157269616|FG003|Overall Study|Disease Progression|1|||
49175373|NCT02143414|158476686|FG000|Maintenance|On protocol treatment|0|||
49175374|NCT02143414|158476687|FG001|Maintenance|On protocol treatment|6|||
49175375|NCT04565990|158476692|FG000|Overall Study|Death|5|||
49175376|NCT04565990|158476692|FG000|Overall Study|Lost to Follow-up|1|||
48843804|NCT03260140|157269617|FG000|Overall Study|Death|4|||
48843805|NCT03260140|157269618|FG001|Overall Study|Death|1|||
48843806|NCT03260140|157269617|FG000|Overall Study|Withdrawal by Subject|1|||
48843807|NCT03260140|157269618|FG001|Overall Study|Withdrawal by Subject|4|||
48843808|NCT04530747|157269626|FG000|Overall Study|Withdrawal by Subject|1|||
48843809|NCT04530747|157269627|FG001|Overall Study|Withdrawal by Subject|0|||
48843810|NCT00421889|157269628|FG000|Overall Study|Adverse Event|1|||
48843811|NCT00421889|157269629|FG001|Overall Study|Adverse Event|0|||
48843812|NCT00421889|157269630|FG002|Overall Study|Adverse Event|1|||
48843813|NCT00421889|157269631|FG003|Overall Study|Adverse Event|1|||
48843814|NCT00421889|157269632|FG004|Overall Study|Adverse Event|1|||
48843815|NCT00421889|157269633|FG005|Overall Study|Adverse Event|4|||
48843816|NCT00421889|157269634|FG006|Overall Study|Adverse Event|1|||
48843817|NCT00421889|157269635|FG007|Overall Study|Adverse Event|0|||
48843818|NCT00421889|157269636|FG008|Overall Study|Adverse Event|2|||
48843819|NCT00421889|157269628|FG000|Overall Study|Withdrawal by Subject|1|||
48843820|NCT00421889|157269629|FG001|Overall Study|Withdrawal by Subject|3|||
48843821|NCT00421889|157269630|FG002|Overall Study|Withdrawal by Subject|0|||
48843822|NCT00421889|157269631|FG003|Overall Study|Withdrawal by Subject|0|||
48843823|NCT00421889|157269632|FG004|Overall Study|Withdrawal by Subject|2|||
48843824|NCT00421889|157269633|FG005|Overall Study|Withdrawal by Subject|0|||
48843825|NCT00421889|157269634|FG006|Overall Study|Withdrawal by Subject|0|||
48843826|NCT00421889|157269635|FG007|Overall Study|Withdrawal by Subject|0|||
48843827|NCT00421889|157269636|FG008|Overall Study|Withdrawal by Subject|0|||
48843828|NCT00421889|157269628|FG000|Overall Study|Death|0|||
48843829|NCT00421889|157269629|FG001|Overall Study|Death|0|||
48843830|NCT00421889|157269630|FG002|Overall Study|Death|0|||
48843831|NCT00421889|157269631|FG003|Overall Study|Death|0|||
48843832|NCT00421889|157269632|FG004|Overall Study|Death|1|||
48843833|NCT00421889|157269633|FG005|Overall Study|Death|1|||
48843834|NCT00421889|157269634|FG006|Overall Study|Death|0|||
48843835|NCT00421889|157269635|FG007|Overall Study|Death|0|||
48843836|NCT00421889|157269636|FG008|Overall Study|Death|0|||
48843837|NCT00421889|157269628|FG000|Overall Study|Progressive disease|3|||
49015273|NCT01626859|157892133|FG001|Overall Study|Physician Decision|1|||
48843838|NCT00421889|157269629|FG001|Overall Study|Progressive disease|2|||
48843839|NCT00421889|157269630|FG002|Overall Study|Progressive disease|2|||
49015274|NCT01626859|157892134|FG002|Overall Study|Physician Decision|0|||
49015275|NCT01626859|157892132|FG000|Overall Study|Withdrawal by Subject|1|||
49015276|NCT01626859|157892133|FG001|Overall Study|Withdrawal by Subject|4|||
49015277|NCT01626859|157892134|FG002|Overall Study|Withdrawal by Subject|2|||
49015278|NCT01446913|157892135|FG000|Overall Study|Significant illness|1|||
49015279|NCT01446913|157892136|FG001|Overall Study|Significant illness|1|||
49015280|NCT01446913|157892137|FG002|Overall Study|Significant illness|1|||
49015281|NCT01446913|157892135|FG000|Overall Study|Withdrawal by Subject|5|||
48843840|NCT00421889|157269631|FG003|Overall Study|Progressive disease|3|||
48843841|NCT00421889|157269632|FG004|Overall Study|Progressive disease|2|||
48843842|NCT00421889|157269633|FG005|Overall Study|Progressive disease|21|||
48843843|NCT00421889|157269634|FG006|Overall Study|Progressive disease|3|||
48843844|NCT00421889|157269635|FG007|Overall Study|Progressive disease|1|||
48843845|NCT00421889|157269636|FG008|Overall Study|Progressive disease|5|||
48843846|NCT00421889|157269628|FG000|Overall Study|Patient/Investigator request|0|||
48843847|NCT00421889|157269629|FG001|Overall Study|Patient/Investigator request|0|||
48843848|NCT00421889|157269630|FG002|Overall Study|Patient/Investigator request|0|||
48843849|NCT00421889|157269631|FG003|Overall Study|Patient/Investigator request|0|||
48843850|NCT00421889|157269632|FG004|Overall Study|Patient/Investigator request|0|||
48843851|NCT00421889|157269633|FG005|Overall Study|Patient/Investigator request|9|||
48843852|NCT00421889|157269634|FG006|Overall Study|Patient/Investigator request|0|||
48843853|NCT00421889|157269635|FG007|Overall Study|Patient/Investigator request|1|||
48843854|NCT00421889|157269636|FG008|Overall Study|Patient/Investigator request|3|||
48843855|NCT00421889|157269628|FG000|Overall Study|Lost to Follow-up|0|||
48843856|NCT00421889|157269629|FG001|Overall Study|Lost to Follow-up|0|||
48843857|NCT00421889|157269630|FG002|Overall Study|Lost to Follow-up|0|||
48843858|NCT00421889|157269631|FG003|Overall Study|Lost to Follow-up|0|||
48843859|NCT00421889|157269632|FG004|Overall Study|Lost to Follow-up|0|||
48843860|NCT00421889|157269633|FG005|Overall Study|Lost to Follow-up|0|||
48843861|NCT00421889|157269634|FG006|Overall Study|Lost to Follow-up|0|||
48843862|NCT00421889|157269635|FG007|Overall Study|Lost to Follow-up|0|||
48843863|NCT00421889|157269636|FG008|Overall Study|Lost to Follow-up|1|||
48843864|NCT00350792|157269637|FG000|Overall Study|Adverse Event|11|||
48843865|NCT00350792|157269637|FG000|Overall Study|Death from Study Disease|1|||
48843866|NCT00350792|157269637|FG000|Overall Study|Death from Study Drug Toxicity|1|||
48843867|NCT00350792|157269637|FG000|Overall Study|Death Not Study Drug Related|2|||
48843868|NCT00350792|157269637|FG000|Overall Study|Protocol Violation|1|||
48843869|NCT00350792|157269637|FG000|Overall Study|Withdrawal by Subject|4|||
48843870|NCT00350792|157269637|FG000|Overall Study|Physician Decision|2|||
48843871|NCT00350792|157269637|FG000|Overall Study|Lack of Efficacy|11|||
48843872|NCT01595061|157269642|FG000|Overall Study|Never Treated|3|||
48843873|NCT01595061|157269642|FG000|Overall Study|Inadequate Pathology|1|||
48843874|NCT02740231|157269645|FG000|Overall Study|Withdrawal by Subject|1|||
48843875|NCT02740231|157269646|FG001|Overall Study|Withdrawal by Subject|1|||
48843876|NCT02740231|157269647|FG002|Overall Study|Withdrawal by Subject|1|||
48843877|NCT02740231|157269648|FG003|Overall Study|Withdrawal by Subject|0|||
49175377|NCT04565990|158476692|FG000|Overall Study|Withdrawal by Subject|1|||
49175378|NCT04847999|158476693|FG000|Overall Study|Lost to Follow-up|0|||
49175379|NCT04847999|158476694|FG001|Overall Study|Lost to Follow-up|1|||
49175380|NCT02879448|158476695|FG000|Overall Study|Death|251|||
49175381|NCT02879448|158476696|FG001|Overall Study|Death|263|||
49175382|NCT02879448|158476695|FG000|Overall Study|Lost to Follow-up|23|||
49175383|NCT02879448|158476696|FG001|Overall Study|Lost to Follow-up|28|||
49175384|NCT02879448|158476695|FG000|Overall Study|Withdrawal by Subject|42|||
49175385|NCT02879448|158476696|FG001|Overall Study|Withdrawal by Subject|79|||
49175386|NCT02879448|158476695|FG000|Overall Study|Other Reasons|8|||
49175387|NCT02879448|158476696|FG001|Overall Study|Other Reasons|12|||
49175388|NCT01898494|158476698|FG000|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
49175389|NCT01898494|158476699|FG001|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
49175390|NCT01898494|158476700|FG002|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
49175391|NCT01898494|158476701|FG003|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
49175392|NCT01898494|158476702|FG004|Step 1 (Arm S - Transoral Surgery)|Physician Decision|2|||
49175393|NCT01898494|158476698|FG000|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
49175394|NCT01898494|158476699|FG001|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
49175395|NCT01898494|158476700|FG002|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
49175396|NCT01898494|158476701|FG003|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
49175397|NCT01898494|158476702|FG004|Step 1 (Arm S - Transoral Surgery)|Adverse Event|1|||
49175398|NCT01898494|158476698|FG000|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
49175399|NCT01898494|158476699|FG001|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
49175400|NCT01898494|158476700|FG002|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
49175401|NCT01898494|158476701|FG003|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
49175402|NCT01898494|158476702|FG004|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|7|||
49175403|NCT01898494|158476698|FG000|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
49175404|NCT01898494|158476699|FG001|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
49175405|NCT01898494|158476700|FG002|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
49175406|NCT01898494|158476701|FG003|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
49175407|NCT01898494|158476702|FG004|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|9|||
49175408|NCT01898494|158476698|FG000|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
49175409|NCT01898494|158476699|FG001|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
49175410|NCT01898494|158476700|FG002|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
49175411|NCT01898494|158476701|FG003|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
49175412|NCT01898494|158476702|FG004|Step 1 (Arm S - Transoral Surgery)|Disease progression|2|||
49175413|NCT01898494|158476698|FG000|Step 1 (Arm S - Transoral Surgery)|Death|0|||
49175414|NCT01898494|158476699|FG001|Step 1 (Arm S - Transoral Surgery)|Death|0|||
49175415|NCT01898494|158476700|FG002|Step 1 (Arm S - Transoral Surgery)|Death|0|||
49175416|NCT01898494|158476701|FG003|Step 1 (Arm S - Transoral Surgery)|Death|0|||
49175417|NCT01898494|158476702|FG004|Step 1 (Arm S - Transoral Surgery)|Death|1|||
49175418|NCT01898494|158476698|FG000|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
49175419|NCT01898494|158476699|FG001|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
48843878|NCT02740231|157269645|FG000|Overall Study|Lack of Efficacy|0|||
48843879|NCT02740231|157269646|FG001|Overall Study|Lack of Efficacy|1|||
48843880|NCT02740231|157269647|FG002|Overall Study|Lack of Efficacy|0|||
48843881|NCT02740231|157269648|FG003|Overall Study|Lack of Efficacy|4|||
48843882|NCT02740231|157269645|FG000|Overall Study|Lost to Follow-up|1|||
48843883|NCT02740231|157269646|FG001|Overall Study|Lost to Follow-up|3|||
48843884|NCT02740231|157269647|FG002|Overall Study|Lost to Follow-up|0|||
48843885|NCT02740231|157269648|FG003|Overall Study|Lost to Follow-up|3|||
48843886|NCT02740231|157269645|FG000|Overall Study|Adverse Event|0|||
48843887|NCT02740231|157269646|FG001|Overall Study|Adverse Event|1|||
48843888|NCT02740231|157269647|FG002|Overall Study|Adverse Event|0|||
48843889|NCT02740231|157269648|FG003|Overall Study|Adverse Event|1|||
48843890|NCT00243503|157269649|FG000|Overall Study|Adverse Event|11|||
48843891|NCT00243503|157269649|FG000|Overall Study|Withdrawal by Subject|1|||
48843892|NCT00243503|157269649|FG000|Overall Study|Lack of Efficacy|44|||
48843893|NCT00243503|157269649|FG000|Overall Study|Death|1|||
48843894|NCT00243503|157269649|FG000|Overall Study|Other|1|||
48843895|NCT00939510|157269650|FG000|Overall Study|Withdrawal by Subject|1|||
48843896|NCT00093015|157269651|FG000|Overall Study|Withdrawal by Subject|194|||
48843897|NCT00093015|157269652|FG001|Overall Study|Withdrawal by Subject|171|||
49175420|NCT01898494|158476700|FG002|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
48843898|NCT00093015|157269651|FG000|Overall Study|Lost to Follow-up|96|||
49175421|NCT01898494|158476701|FG003|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
49175422|NCT01898494|158476702|FG004|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|1|||
49175423|NCT01898494|158476698|FG000|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
49175424|NCT01898494|158476699|FG001|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
49175425|NCT01898494|158476700|FG002|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
49175426|NCT01898494|158476701|FG003|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
49175427|NCT01898494|158476702|FG004|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|1|||
49175428|NCT01898494|158476698|FG000|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
48843899|NCT00093015|157269652|FG001|Overall Study|Lost to Follow-up|108|||
48843900|NCT00093015|157269651|FG000|Overall Study|Death|375|||
48843901|NCT00093015|157269652|FG001|Overall Study|Death|385|||
48843902|NCT01747486|157269660|FG000|Stage 1|Physician Decision|3|||
48843903|NCT01747486|157269661|FG001|Stage 1|Physician Decision|0|||
48926942|NCT01400451|157564811|FG000|Combination Treatment (or Intended)|Adverse Event|1|||
48926943|NCT01400451|157564812|FG001|Combination Treatment (or Intended)|Adverse Event|0|||
48926944|NCT01400451|157564813|FG002|Combination Treatment (or Intended)|Adverse Event|0|||
48926945|NCT01400451|157564811|FG000|Combination Treatment (or Intended)|Disease Progression|3|||
48926946|NCT01400451|157564812|FG001|Combination Treatment (or Intended)|Disease Progression|1|||
48926947|NCT01400451|157564813|FG002|Combination Treatment (or Intended)|Disease Progression|1|||
48926948|NCT01400451|157564811|FG000|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
48926949|NCT01400451|157564812|FG001|Combination Treatment (or Intended)|Dose-limiting toxicity|1|||
48926950|NCT01400451|157564813|FG002|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
48926951|NCT01162421|157564814|FG000|Overall Study|Did not receive study drug|2|||
48926952|NCT01162421|157564815|FG001|Overall Study|Did not receive study drug|1|||
48926953|NCT01162421|157564814|FG000|Overall Study|Adverse Event|2|||
48843904|NCT01747486|157269660|FG000|Stage 1|Withdrawal by Subject|4|||
48843905|NCT01747486|157269661|FG001|Stage 1|Withdrawal by Subject|3|||
48843906|NCT01747486|157269660|FG000|Stage 1|Disease progression|4|||
48843907|NCT01747486|157269661|FG001|Stage 1|Disease progression|9|||
48843908|NCT01747486|157269660|FG000|Stage 1|Death|1|||
48843909|NCT01747486|157269661|FG001|Stage 1|Death|1|||
48843910|NCT01747486|157269660|FG000|Stage 2|Physician Decision|2|||
48843911|NCT01747486|157269661|FG001|Stage 2|Physician Decision|0|||
48843912|NCT01747486|157269660|FG000|Stage 2|Withdrawal by Subject|1|||
48843913|NCT01747486|157269661|FG001|Stage 2|Withdrawal by Subject|0|||
48843914|NCT01747486|157269660|FG000|Stage 2|New Cancer Therapy|3|||
48843915|NCT01747486|157269661|FG001|Stage 2|New Cancer Therapy|0|||
48843916|NCT01747486|157269660|FG000|Stage 2|Disease Progression|3|||
49175429|NCT01898494|158476699|FG001|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
49175430|NCT01898494|158476700|FG002|Step 2 (Adjuvant Treatment)|Adverse Event|2|||
49175431|NCT01898494|158476701|FG003|Step 2 (Adjuvant Treatment)|Adverse Event|3|||
49175432|NCT01898494|158476702|FG004|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
49175433|NCT01898494|158476698|FG000|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
49175434|NCT01898494|158476699|FG001|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
49175435|NCT01898494|158476700|FG002|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|6|||
49175436|NCT01898494|158476701|FG003|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|3|||
49175437|NCT01898494|158476702|FG004|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
49175438|NCT01898494|158476698|FG000|Step 2 (Adjuvant Treatment)|Death|0|||
49175439|NCT01898494|158476699|FG001|Step 2 (Adjuvant Treatment)|Death|0|||
49175440|NCT01898494|158476700|FG002|Step 2 (Adjuvant Treatment)|Death|0|||
49175441|NCT01898494|158476701|FG003|Step 2 (Adjuvant Treatment)|Death|1|||
49175442|NCT01898494|158476702|FG004|Step 2 (Adjuvant Treatment)|Death|0|||
48843917|NCT01747486|157269661|FG001|Stage 2|Disease Progression|0|||
48843918|NCT01084707|157269662|FG000|Overall Study|Withdrawal by Subject|6|||
48843919|NCT00901901|157269663|FG000|Treatment Period|Adverse Event|120|||
48843920|NCT00901901|157269664|FG001|Treatment Period|Adverse Event|128|||
48843921|NCT00901901|157269663|FG000|Treatment Period|Withdrawal by Subject|26|||
48843922|NCT00901901|157269664|FG001|Treatment Period|Withdrawal by Subject|24|||
48843923|NCT00901901|157269663|FG000|Treatment Period|Physician Decision|2|||
48843924|NCT00901901|157269664|FG001|Treatment Period|Physician Decision|2|||
48843925|NCT00901901|157269663|FG000|Treatment Period|Lost to Follow-up|3|||
48843926|NCT00901901|157269664|FG001|Treatment Period|Lost to Follow-up|5|||
48843927|NCT00901901|157269663|FG000|Treatment Period|Noncompliance with study medication|4|||
48843928|NCT00901901|157269664|FG001|Treatment Period|Noncompliance with study medication|1|||
48843929|NCT00901901|157269663|FG000|Treatment Period|Missing|1|||
48843930|NCT00901901|157269664|FG001|Treatment Period|Missing|0|||
48843931|NCT00901901|157269663|FG000|Treatment Period|Never treated|0|||
48843932|NCT00901901|157269664|FG001|Treatment Period|Never treated|3|||
48843933|NCT00901901|157269663|FG000|Treatment Period|Protocol driven decision point|0|||
48843934|NCT00901901|157269664|FG001|Treatment Period|Protocol driven decision point|2|||
48843935|NCT00901901|157269663|FG000|Treatment Period|Study terminated by sponsor|2|||
48843936|NCT00901901|157269664|FG001|Treatment Period|Study terminated by sponsor|0|||
48843937|NCT00901901|157269663|FG000|Treatment Period|Protocol Violation|5|||
48843938|NCT00901901|157269664|FG001|Treatment Period|Protocol Violation|9|||
48843939|NCT00901901|157269663|FG000|Treatment Period|Switch to commercial drug|1|||
48843940|NCT00901901|157269664|FG001|Treatment Period|Switch to commercial drug|1|||
48843941|NCT00901901|157269663|FG000|Treatment Period|Transfer to treatment continuation study|5|||
48926954|NCT01162421|157564815|FG001|Overall Study|Adverse Event|5|||
49175443|NCT01898494|158476698|FG000|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
49175444|NCT01898494|158476699|FG001|Step 2 (Adjuvant Treatment)|Physician Decision|1|||
49175445|NCT01898494|158476700|FG002|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
49175446|NCT01898494|158476701|FG003|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
49175447|NCT01898494|158476702|FG004|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
49175448|NCT01898494|158476698|FG000|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
49175449|NCT01898494|158476699|FG001|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
48926955|NCT01162421|157564814|FG000|Overall Study|Lost to Follow-up|0|||
48926956|NCT01162421|157564815|FG001|Overall Study|Lost to Follow-up|2|||
48926957|NCT01162421|157564814|FG000|Overall Study|Lack of Efficacy|2|||
48926958|NCT01162421|157564815|FG001|Overall Study|Lack of Efficacy|2|||
48926959|NCT01162421|157564814|FG000|Overall Study|Other|2|||
48926960|NCT01162421|157564815|FG001|Overall Study|Other|3|||
49175450|NCT01898494|158476700|FG002|Step 2 (Adjuvant Treatment)|Alternative therapy|1|||
49175451|NCT01898494|158476701|FG003|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
48843942|NCT00901901|157269664|FG001|Treatment Period|Transfer to treatment continuation study|2|||
48843943|NCT00901901|157269663|FG000|Follow-up Period|Death|181|||
48843944|NCT00901901|157269664|FG001|Follow-up Period|Death|208|||
48843945|NCT00901901|157269663|FG000|Follow-up Period|Protocol driven decision point|47|||
49175452|NCT01898494|158476702|FG004|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
49175453|NCT01898494|158476698|FG000|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
49175454|NCT01898494|158476699|FG001|Step 2 (Adjuvant Treatment)|Never started treatment|6|||
49175455|NCT01898494|158476700|FG002|Step 2 (Adjuvant Treatment)|Never started treatment|5|||
49175456|NCT01898494|158476701|FG003|Step 2 (Adjuvant Treatment)|Never started treatment|4|||
49175457|NCT01898494|158476702|FG004|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
49175458|NCT01286272|158476703|FG000|Overall Study|Ineligible after beginning treatment|1|||
49175459|NCT01286272|158476704|FG001|Overall Study|Ineligible after beginning treatment|3|||
49175460|NCT03713281|158476705|FG000|Overall Study|Lens handling difficuluties|2|||
49175461|NCT03713281|158476705|FG000|Overall Study|Subject was not dispensed enough lenses|1|||
49175462|NCT04052516|158476706|FG000|Overall Study|Withdrawal by Subject|4|||
49175463|NCT04052516|158476707|FG001|Overall Study|Withdrawal by Subject|5|||
49175464|NCT04052516|158476708|FG002|Overall Study|Withdrawal by Subject|6|||
49175465|NCT04052516|158476706|FG000|Overall Study|Adverse Event|3|||
49175466|NCT04052516|158476707|FG001|Overall Study|Adverse Event|2|||
49175467|NCT04052516|158476708|FG002|Overall Study|Adverse Event|8|||
49175468|NCT04052516|158476706|FG000|Overall Study|Lost to Follow-up|2|||
49175469|NCT04052516|158476707|FG001|Overall Study|Lost to Follow-up|5|||
49175470|NCT04052516|158476708|FG002|Overall Study|Lost to Follow-up|3|||
49175471|NCT04052516|158476706|FG000|Overall Study|Protocol Violation|1|||
49175472|NCT04052516|158476707|FG001|Overall Study|Protocol Violation|1|||
49175473|NCT04052516|158476708|FG002|Overall Study|Protocol Violation|0|||
49175474|NCT04052516|158476706|FG000|Overall Study|Death|1|||
49175475|NCT04052516|158476707|FG001|Overall Study|Death|0|||
49175476|NCT04052516|158476708|FG002|Overall Study|Death|0|||
49175477|NCT04052516|158476706|FG000|Overall Study|Physician Decision|0|||
49175478|NCT04052516|158476707|FG001|Overall Study|Physician Decision|1|||
49175479|NCT04052516|158476708|FG002|Overall Study|Physician Decision|0|||
49175480|NCT04052516|158476706|FG000|Overall Study|Pregnancy|1|||
49175481|NCT04052516|158476707|FG001|Overall Study|Pregnancy|0|||
49175482|NCT04052516|158476708|FG002|Overall Study|Pregnancy|0|||
49175483|NCT04052516|158476706|FG000|Overall Study|Requirement of prohibited concomitant medication|1|||
49175484|NCT04052516|158476707|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
49175485|NCT04052516|158476708|FG002|Overall Study|Requirement of prohibited concomitant medication|0|||
49175486|NCT04052516|158476706|FG000|Overall Study|Reason not recorded|0|||
49175487|NCT04052516|158476707|FG001|Overall Study|Reason not recorded|1|||
49175488|NCT04052516|158476708|FG002|Overall Study|Reason not recorded|0|||
49175489|NCT03818035|158476709|FG000|Part 1 (Up to 28 Weeks)|Death|1|||
49175490|NCT03818035|158476710|FG001|Part 1 (Up to 28 Weeks)|Death|0|||
49175491|NCT03818035|158476711|FG002|Part 1 (Up to 28 Weeks)|Death|0|||
49175492|NCT03818035|158476712|FG003|Part 1 (Up to 28 Weeks)|Death|0|||
49175493|NCT03818035|158476709|FG000|Part 1 (Up to 28 Weeks)|Lack of Efficacy|3|||
49175494|NCT03818035|158476710|FG001|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
49175495|NCT03818035|158476711|FG002|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
49175496|NCT03818035|158476712|FG003|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
49175497|NCT03818035|158476709|FG000|Part 1 (Up to 28 Weeks)|Lost to Follow-up|10|||
49175498|NCT03818035|158476710|FG001|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
49175499|NCT03818035|158476711|FG002|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
49175500|NCT03818035|158476712|FG003|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
49175501|NCT03818035|158476709|FG000|Part 1 (Up to 28 Weeks)|Protocol Violation|10|||
49175502|NCT03818035|158476710|FG001|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
49175503|NCT03818035|158476711|FG002|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
49175504|NCT03818035|158476712|FG003|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
49175505|NCT03818035|158476709|FG000|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|8|||
49175506|NCT03818035|158476710|FG001|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
49175507|NCT03818035|158476711|FG002|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
49175508|NCT03818035|158476712|FG003|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
49175509|NCT03818035|158476709|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|1|||
49175510|NCT03818035|158476710|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
49175511|NCT03818035|158476711|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
49175512|NCT03818035|158476712|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
49175513|NCT03818035|158476709|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Other|16|||
49175514|NCT03818035|158476710|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
49175515|NCT03818035|158476711|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
49175516|NCT03818035|158476712|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
49175517|NCT03818035|158476709|FG000|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|1|||
49175518|NCT03818035|158476710|FG001|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
49175519|NCT03818035|158476711|FG002|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
49175520|NCT03818035|158476712|FG003|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
49175521|NCT03818035|158476709|FG000|Part 1 (Up to 28 Weeks)|Other|7|||
49175522|NCT03818035|158476710|FG001|Part 1 (Up to 28 Weeks)|Other|0|||
49175523|NCT03818035|158476711|FG002|Part 1 (Up to 28 Weeks)|Other|0|||
49175524|NCT03818035|158476712|FG003|Part 1 (Up to 28 Weeks)|Other|0|||
49175525|NCT03818035|158476709|FG000|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
49175526|NCT03818035|158476710|FG001|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
49175527|NCT03818035|158476711|FG002|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
49175528|NCT03818035|158476712|FG003|Part 2 (Week 28 to Week 68)|Lack of Efficacy|4|||
49175529|NCT03818035|158476709|FG000|Part 2 (Week 28 to Week 68)|Lost to Follow-up|0|||
49175530|NCT03818035|158476710|FG001|Part 2 (Week 28 to Week 68)|Lost to Follow-up|6|||
49175531|NCT03818035|158476711|FG002|Part 2 (Week 28 to Week 68)|Lost to Follow-up|1|||
49175532|NCT03818035|158476712|FG003|Part 2 (Week 28 to Week 68)|Lost to Follow-up|9|||
49175533|NCT03818035|158476709|FG000|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
49175534|NCT03818035|158476710|FG001|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
49175535|NCT03818035|158476711|FG002|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
49175536|NCT03818035|158476712|FG003|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|8|||
49175537|NCT03818035|158476709|FG000|Part 2 (Week 28 to Week 68)|Other Adverse Events|0|||
49175538|NCT03818035|158476710|FG001|Part 2 (Week 28 to Week 68)|Other Adverse Events|3|||
49175539|NCT03818035|158476711|FG002|Part 2 (Week 28 to Week 68)|Other Adverse Events|4|||
49175540|NCT03818035|158476712|FG003|Part 2 (Week 28 to Week 68)|Other Adverse Events|7|||
49175541|NCT03818035|158476709|FG000|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
49175542|NCT03818035|158476710|FG001|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|1|||
49175543|NCT03818035|158476711|FG002|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|2|||
49175544|NCT03818035|158476712|FG003|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
49175545|NCT03818035|158476709|FG000|Part 2 (Week 28 to Week 68)|Other|0|||
49175546|NCT03818035|158476710|FG001|Part 2 (Week 28 to Week 68)|Other|1|||
49175547|NCT03818035|158476711|FG002|Part 2 (Week 28 to Week 68)|Other|1|||
49175548|NCT03818035|158476712|FG003|Part 2 (Week 28 to Week 68)|Other|1|||
49175549|NCT04905407|158476716|FG000|Part 1 and Part 2|Withdrawal by Subject|2|||
49175550|NCT04905407|158476717|FG001|Part 1 and Part 2|Withdrawal by Subject|1|||
49175551|NCT04905407|158476718|FG002|Part 1 and Part 2|Withdrawal by Subject|1|||
49175552|NCT04905407|158476719|FG003|Part 1 and Part 2|Withdrawal by Subject|0|||
49175553|NCT04905407|158476716|FG000|Part 1 and Part 2|Death|7|||
49175554|NCT04905407|158476717|FG001|Part 1 and Part 2|Death|7|||
49175555|NCT04905407|158476718|FG002|Part 1 and Part 2|Death|7|||
49175556|NCT04905407|158476719|FG003|Part 1 and Part 2|Death|0|||
49175557|NCT04905407|158476716|FG000|Part 1 and Part 2|Other than specified|0|||
49175558|NCT04905407|158476717|FG001|Part 1 and Part 2|Other than specified|0|||
49175559|NCT04905407|158476718|FG002|Part 1 and Part 2|Other than specified|1|||
49175560|NCT04905407|158476719|FG003|Part 1 and Part 2|Other than specified|0|||
49175561|NCT04905407|158476716|FG000|Part 3|Death|0|||
49175562|NCT04905407|158476717|FG001|Part 3|Death|0|||
49175563|NCT04905407|158476718|FG002|Part 3|Death|0|||
49175564|NCT04905407|158476719|FG003|Part 3|Death|2|||
49175565|NCT04683029|158476723|FG000|Overall Study|Withdrawal by Subject|1|||
49175566|NCT04683029|158476724|FG001|Overall Study|Withdrawal by Subject|0|||
49175567|NCT05320432|158476725|FG000|Overall Study|Withdrawal by Subject|0|||
49175568|NCT05320432|158476726|FG001|Overall Study|Withdrawal by Subject|2|||
49175569|NCT04850807|158476728|FG000|Overall Study|Death|50|||
49175570|NCT04850807|158476729|FG001|Overall Study|Death|55|||
49175571|NCT04850807|158476728|FG000|Overall Study|Discharged|17|||
49175572|NCT04850807|158476729|FG001|Overall Study|Discharged|13|||
49175573|NCT04850807|158476728|FG000|Overall Study|Incomplete baseline data|3|||
49175574|NCT04850807|158476729|FG001|Overall Study|Incomplete baseline data|2|||
49175575|NCT03261271|158476738|FG000|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
48843946|NCT00901901|157269664|FG001|Follow-up Period|Protocol driven decision point|36|||
49175576|NCT03261271|158476739|FG001|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
49175577|NCT02287311|158476743|FG000|Cohort 1: Dose Level 1|Death|2|||
49175578|NCT02287311|158476744|FG001|Cohort 1: Dose Level 1|Death|0|||
49175579|NCT02287311|158476745|FG002|Cohort 1: Dose Level 1|Death|0|||
49175580|NCT02287311|158476746|FG003|Cohort 1: Dose Level 1|Death|3|||
49175581|NCT02287311|158476747|FG004|Cohort 1: Dose Level 1|Death|0|||
49175582|NCT02287311|158476748|FG005|Cohort 1: Dose Level 1|Death|0|||
49175583|NCT02287311|158476749|FG006|Cohort 1: Dose Level 1|Death|1|||
49175584|NCT02287311|158476750|FG007|Cohort 1: Dose Level 1|Death|0|||
49175585|NCT02287311|158476751|FG008|Cohort 1: Dose Level 1|Death|0|||
49175586|NCT02287311|158476743|FG000|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
49175587|NCT02287311|158476744|FG001|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
49175588|NCT02287311|158476745|FG002|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
49175589|NCT02287311|158476746|FG003|Cohort 1: Dose Level 1|Lost to Follow-up|2|||
49175590|NCT02287311|158476747|FG004|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
49175591|NCT02287311|158476748|FG005|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
49175592|NCT02287311|158476749|FG006|Cohort 1: Dose Level 1|Lost to Follow-up|1|||
49175593|NCT02287311|158476750|FG007|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
49175594|NCT02287311|158476751|FG008|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
49175595|NCT02287311|158476743|FG000|Cohort 1: Dose Level 1|Physician Decision|1|||
49175596|NCT02287311|158476744|FG001|Cohort 1: Dose Level 1|Physician Decision|0|||
49175597|NCT02287311|158476745|FG002|Cohort 1: Dose Level 1|Physician Decision|0|||
49175598|NCT02287311|158476746|FG003|Cohort 1: Dose Level 1|Physician Decision|0|||
49175599|NCT02287311|158476747|FG004|Cohort 1: Dose Level 1|Physician Decision|0|||
49175600|NCT02287311|158476748|FG005|Cohort 1: Dose Level 1|Physician Decision|0|||
49175601|NCT02287311|158476749|FG006|Cohort 1: Dose Level 1|Physician Decision|0|||
49175602|NCT02287311|158476750|FG007|Cohort 1: Dose Level 1|Physician Decision|0|||
49175603|NCT02287311|158476751|FG008|Cohort 1: Dose Level 1|Physician Decision|0|||
49175604|NCT02287311|158476743|FG000|Cohort 2: Dose Level 2|Death|0|||
49175605|NCT02287311|158476744|FG001|Cohort 2: Dose Level 2|Death|2|||
49175606|NCT02287311|158476745|FG002|Cohort 2: Dose Level 2|Death|0|||
49175607|NCT02287311|158476746|FG003|Cohort 2: Dose Level 2|Death|0|||
49175608|NCT02287311|158476747|FG004|Cohort 2: Dose Level 2|Death|2|||
49175609|NCT02287311|158476748|FG005|Cohort 2: Dose Level 2|Death|0|||
49175610|NCT02287311|158476749|FG006|Cohort 2: Dose Level 2|Death|0|||
49175611|NCT02287311|158476750|FG007|Cohort 2: Dose Level 2|Death|2|||
49175612|NCT02287311|158476751|FG008|Cohort 2: Dose Level 2|Death|0|||
49175613|NCT02287311|158476743|FG000|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
49175614|NCT02287311|158476744|FG001|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
49175615|NCT02287311|158476745|FG002|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
49175616|NCT02287311|158476746|FG003|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
49175617|NCT02287311|158476747|FG004|Cohort 2: Dose Level 2|Lost to Follow-up|1|||
49175618|NCT02287311|158476748|FG005|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
49175619|NCT02287311|158476749|FG006|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
49175620|NCT02287311|158476750|FG007|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
49175621|NCT02287311|158476751|FG008|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
49175622|NCT02287311|158476743|FG000|Cohort 2: Dose Level 2|Refused follow-up|0|||
49175623|NCT02287311|158476744|FG001|Cohort 2: Dose Level 2|Refused follow-up|1|||
49175624|NCT02287311|158476745|FG002|Cohort 2: Dose Level 2|Refused follow-up|0|||
49175625|NCT02287311|158476746|FG003|Cohort 2: Dose Level 2|Refused follow-up|0|||
49175626|NCT02287311|158476747|FG004|Cohort 2: Dose Level 2|Refused follow-up|0|||
49175627|NCT02287311|158476748|FG005|Cohort 2: Dose Level 2|Refused follow-up|0|||
49175628|NCT02287311|158476749|FG006|Cohort 2: Dose Level 2|Refused follow-up|0|||
49175629|NCT02287311|158476750|FG007|Cohort 2: Dose Level 2|Refused follow-up|0|||
49175630|NCT02287311|158476751|FG008|Cohort 2: Dose Level 2|Refused follow-up|0|||
49175631|NCT02287311|158476743|FG000|Cohort 3: Dose Level 3|Death|0|||
49175632|NCT02287311|158476744|FG001|Cohort 3: Dose Level 3|Death|0|||
49175633|NCT02287311|158476745|FG002|Cohort 3: Dose Level 3|Death|4|||
49175634|NCT02287311|158476746|FG003|Cohort 3: Dose Level 3|Death|0|||
49175635|NCT02287311|158476747|FG004|Cohort 3: Dose Level 3|Death|0|||
49175636|NCT02287311|158476748|FG005|Cohort 3: Dose Level 3|Death|4|||
49175637|NCT02287311|158476749|FG006|Cohort 3: Dose Level 3|Death|0|||
49175638|NCT02287311|158476750|FG007|Cohort 3: Dose Level 3|Death|0|||
49175639|NCT02287311|158476751|FG008|Cohort 3: Dose Level 3|Death|2|||
49175640|NCT02287311|158476743|FG000|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
49175641|NCT02287311|158476744|FG001|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
49175642|NCT02287311|158476745|FG002|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
49175643|NCT02287311|158476746|FG003|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
49175644|NCT02287311|158476747|FG004|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
49175645|NCT02287311|158476748|FG005|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
49175646|NCT02287311|158476749|FG006|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
49175647|NCT02287311|158476750|FG007|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
49175648|NCT02287311|158476751|FG008|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
49175649|NCT02287311|158476743|FG000|Cohort 3: Dose Level 3|On long-term follow-up|0|||
49175650|NCT02287311|158476744|FG001|Cohort 3: Dose Level 3|On long-term follow-up|0|||
49175651|NCT02287311|158476745|FG002|Cohort 3: Dose Level 3|On long-term follow-up|0|||
49175652|NCT02287311|158476746|FG003|Cohort 3: Dose Level 3|On long-term follow-up|0|||
49175653|NCT02287311|158476747|FG004|Cohort 3: Dose Level 3|On long-term follow-up|0|||
49175654|NCT02287311|158476748|FG005|Cohort 3: Dose Level 3|On long-term follow-up|1|||
49175655|NCT02287311|158476749|FG006|Cohort 3: Dose Level 3|On long-term follow-up|0|||
49175656|NCT02287311|158476750|FG007|Cohort 3: Dose Level 3|On long-term follow-up|0|||
49175657|NCT02287311|158476751|FG008|Cohort 3: Dose Level 3|On long-term follow-up|1|||
49175658|NCT03648840|158476752|FG000|First IV Infusion Session|Adverse Event|0|||
48926961|NCT03691935|157564816|FG000|Overall Study|Physician Decision|2|||
49175659|NCT03648840|158476753|FG001|First IV Infusion Session|Adverse Event|2|||
49175660|NCT03648840|158476752|FG000|Session 1 to Session 2 Interval|Pandemic|0|||
49175661|NCT03648840|158476753|FG001|Session 1 to Session 2 Interval|Pandemic|1|||
49175662|NCT03648840|158476752|FG000|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|8|||
49175663|NCT03648840|158476753|FG001|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|11|||
49175664|NCT03648840|158476752|FG000|Session 2 to Imaging Interval|MRI exclusion (left handed)|3|||
49175665|NCT03648840|158476753|FG001|Session 2 to Imaging Interval|MRI exclusion (left handed)|5|||
49175666|NCT03055013|158476754|FG000|Overall Study|Adverse Event|78|||
49175667|NCT03055013|158476755|FG001|Overall Study|Adverse Event|0|||
49175668|NCT03055013|158476754|FG000|Overall Study|Death|6|||
49175669|NCT03055013|158476755|FG001|Overall Study|Death|0|||
49175670|NCT03055013|158476754|FG000|Overall Study|Disease relapse|33|||
49175671|NCT03055013|158476755|FG001|Overall Study|Disease relapse|0|||
49175672|NCT03055013|158476754|FG000|Overall Study|Withdrawal by Subject|28|||
49175673|NCT03055013|158476755|FG001|Overall Study|Withdrawal by Subject|0|||
49175674|NCT03055013|158476754|FG000|Overall Study|Other complicating disease|5|||
49175675|NCT03055013|158476755|FG001|Overall Study|Other complicating disease|0|||
49175676|NCT03055013|158476754|FG000|Overall Study|Physician Decision|1|||
49175677|NCT03055013|158476755|FG001|Overall Study|Physician Decision|0|||
49175678|NCT03055013|158476754|FG000|Overall Study|Benign mass/non-RCC|4|||
49175679|NCT03055013|158476755|FG001|Overall Study|Benign mass/non-RCC|0|||
49175680|NCT03055013|158476754|FG000|Overall Study|Enrolled in another trial|1|||
49175681|NCT03055013|158476755|FG001|Overall Study|Enrolled in another trial|0|||
49175682|NCT03055013|158476754|FG000|Overall Study|Non-protocol therapy|1|||
49175683|NCT03055013|158476755|FG001|Overall Study|Non-protocol therapy|0|||
49175684|NCT03055013|158476754|FG000|Overall Study|Incompliance|1|||
49175685|NCT03055013|158476755|FG001|Overall Study|Incompliance|0|||
49175686|NCT03055013|158476754|FG000|Overall Study|Insurance issues|1|||
49175687|NCT03055013|158476755|FG001|Overall Study|Insurance issues|0|||
49175688|NCT03055013|158476754|FG000|Overall Study|Did not receive nivolumab and surgery|38|||
49175689|NCT03055013|158476755|FG001|Overall Study|Did not receive nivolumab and surgery|0|||
49175690|NCT03055013|158476754|FG000|Overall Study|Did not receive nivolumab|10|||
49175691|NCT03055013|158476755|FG001|Overall Study|Did not receive nivolumab|0|||
49175692|NCT03055013|158476754|FG000|Overall Study|Did not receive surgery|0|||
49175693|NCT03055013|158476755|FG001|Overall Study|Did not receive surgery|28|||
49175694|NCT05063994|158476756|FG000|Cortef Run-In|Withdrawal of Consent|1|||
49175695|NCT05063994|158476757|FG001|Cortef Run-In|Withdrawal of Consent|0|||
49175696|NCT05063994|158476758|FG002|Cortef Run-In|Withdrawal of Consent|0|||
49175697|NCT05063994|158476756|FG000|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|1|||
49175698|NCT05063994|158476757|FG001|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
49175699|NCT05063994|158476758|FG002|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
49175700|NCT05063994|158476756|FG000|Treatment|Physician Decision|0|||
49175701|NCT05063994|158476757|FG001|Treatment|Physician Decision|0|||
49175702|NCT05063994|158476758|FG002|Treatment|Physician Decision|1|||
48926962|NCT03691935|157564817|FG001|Overall Study|Physician Decision|1|||
49175703|NCT05063994|158476756|FG000|Treatment|Withdrawal by Subject|0|||
49175704|NCT05063994|158476757|FG001|Treatment|Withdrawal by Subject|0|||
48843947|NCT00901901|157269663|FG000|Follow-up Period|Withdrawal by Subject|6|||
48843948|NCT00901901|157269664|FG001|Follow-up Period|Withdrawal by Subject|9|||
48843949|NCT00901901|157269663|FG000|Follow-up Period|Lost to Follow-up|12|||
49175705|NCT05063994|158476758|FG002|Treatment|Withdrawal by Subject|1|||
49175706|NCT05063994|158476756|FG000|Treatment|Withdrawal of Consent|0|||
49175707|NCT05063994|158476757|FG001|Treatment|Withdrawal of Consent|0|||
49175708|NCT05063994|158476758|FG002|Treatment|Withdrawal of Consent|1|||
49175709|NCT03101904|158476761|FG000|Wash Out (10 Days)|Adverse Event|1|||
49175710|NCT03101904|158476762|FG001|Wash Out (10 Days)|Adverse Event|0|||
49175711|NCT03101904|158476761|FG000|Wash Out (10 Days)|Lost to Follow-up|2|||
49175712|NCT03101904|158476762|FG001|Wash Out (10 Days)|Lost to Follow-up|0|||
49175713|NCT02107703|158476763|FG000|Overall Study|Withdrawal by Subject|46|||
49175714|NCT02107703|158476764|FG001|Overall Study|Withdrawal by Subject|21|||
49175715|NCT02107703|158476763|FG000|Overall Study|Lost to Follow-up|20|||
49175716|NCT02107703|158476764|FG001|Overall Study|Lost to Follow-up|9|||
49175717|NCT02107703|158476763|FG000|Overall Study|On study treatment/follow up|48|||
49175718|NCT02107703|158476764|FG001|Overall Study|On study treatment/follow up|5|||
49175719|NCT00861705|158478348|FG000|Overall Study|Never Began Treatment|7|||
49175720|NCT00861705|158478349|FG001|Overall Study|Never Began Treatment|3|||
49175721|NCT00861705|158478350|FG002|Overall Study|Never Began Treatment|0|||
49175722|NCT00861705|158478351|FG003|Overall Study|Never Began Treatment|1|||
49175723|NCT00616967|158478352|FG000|Overall Study|Withdrawal by Subject|0|||
49175724|NCT00616967|158478353|FG001|Overall Study|Withdrawal by Subject|0|||
48843950|NCT00901901|157269664|FG001|Follow-up Period|Lost to Follow-up|8|||
48843951|NCT00901901|157269663|FG000|Follow-up Period|Missing|94|||
48843952|NCT00901901|157269664|FG001|Follow-up Period|Missing|80|||
48843953|NCT02272816|157269665|FG000|Overall Study|Adverse Event|1|||
48843954|NCT00331136|157269666|FG000|Overall Study|Adverse Event|3|||
49175725|NCT00616967|158478354|FG002|Overall Study|Withdrawal by Subject|1|||
49175726|NCT05059262|158478355|FG000|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|3|||
49175727|NCT05059262|158478356|FG001|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|0|||
49175728|NCT05059262|158478355|FG000|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
49175729|NCT05059262|158478356|FG001|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
49175730|NCT05059262|158478355|FG000|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
49175731|NCT05059262|158478356|FG001|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
49175732|NCT05059262|158478355|FG000|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|0|||
49175733|NCT05059262|158478356|FG001|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|1|||
49175734|NCT05059262|158478355|FG000|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|1|||
49175735|NCT05059262|158478356|FG001|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|0|||
48926963|NCT03691935|157564816|FG000|Overall Study|Adverse Event|3|||
48926964|NCT03691935|157564817|FG001|Overall Study|Adverse Event|0|||
48926965|NCT04875195|157564818|FG000|Overall Study|Death|9|||
48926966|NCT04875195|157564819|FG001|Overall Study|Death|3|||
48926967|NCT04875195|157564818|FG000|Overall Study|Withdrawal by Subject|2|||
48926968|NCT04875195|157564819|FG001|Overall Study|Withdrawal by Subject|1|||
48926969|NCT04875195|157564818|FG000|Overall Study|Ongoing in study|49|||
48926970|NCT04875195|157564819|FG001|Overall Study|Ongoing in study|2|||
48926971|NCT03625115|157564820|FG000|Overall Study|Withdrawal by Subject|4|||
48926972|NCT03625115|157564821|FG001|Overall Study|Withdrawal by Subject|7|||
48926973|NCT03625115|157564820|FG000|Overall Study|Lost to Follow-up|17|||
48926974|NCT03625115|157564821|FG001|Overall Study|Lost to Follow-up|24|||
48926975|NCT05184452|157564822|FG000|Overall Study|Lost to Follow-up|0|||
48926976|NCT05184452|157564823|FG001|Overall Study|Lost to Follow-up|0|||
48926977|NCT05184452|157564824|FG002|Overall Study|Lost to Follow-up|0|||
48926978|NCT05184452|157564825|FG003|Overall Study|Lost to Follow-up|0|||
48926979|NCT05184452|157564826|FG004|Overall Study|Lost to Follow-up|0|||
48926980|NCT05184452|157564827|FG005|Overall Study|Lost to Follow-up|2|||
48926981|NCT05184452|157564828|FG006|Overall Study|Lost to Follow-up|0|||
48926982|NCT05184452|157564829|FG007|Overall Study|Lost to Follow-up|0|||
48926983|NCT05184452|157564830|FG008|Overall Study|Lost to Follow-up|0|||
48926984|NCT05184452|157564831|FG009|Overall Study|Lost to Follow-up|1|||
48926985|NCT05184452|157564822|FG000|Overall Study|Withdrawal by Subject|0|||
48926986|NCT05184452|157564823|FG001|Overall Study|Withdrawal by Subject|0|||
48926987|NCT05184452|157564824|FG002|Overall Study|Withdrawal by Subject|0|||
48926988|NCT05184452|157564825|FG003|Overall Study|Withdrawal by Subject|0|||
48926989|NCT05184452|157564826|FG004|Overall Study|Withdrawal by Subject|0|||
48926990|NCT05184452|157564827|FG005|Overall Study|Withdrawal by Subject|1|||
48926991|NCT05184452|157564828|FG006|Overall Study|Withdrawal by Subject|0|||
48926992|NCT05184452|157564829|FG007|Overall Study|Withdrawal by Subject|0|||
48926993|NCT05184452|157564830|FG008|Overall Study|Withdrawal by Subject|0|||
48926994|NCT05184452|157564831|FG009|Overall Study|Withdrawal by Subject|1|||
48926995|NCT04589650|157564832|FG000|Overall Study|Subject decision|6|||
48926996|NCT04589650|157564833|FG001|Overall Study|Subject decision|2|||
48926997|NCT04589650|157564834|FG002|Overall Study|Subject decision|2|||
48926998|NCT04589650|157564835|FG003|Overall Study|Subject decision|0|||
49175736|NCT05059262|158478355|FG000|Part 2: Open Label (Weeks 25 - EoS)|Death|1|||
49175737|NCT05059262|158478356|FG001|Part 2: Open Label (Weeks 25 - EoS)|Death|0|||
49175738|NCT05059262|158478355|FG000|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|0|||
48926999|NCT04589650|157564836|FG004|Overall Study|Subject decision|0|||
48927000|NCT04589650|157564837|FG005|Overall Study|Subject decision|0|||
48927001|NCT04589650|157564832|FG000|Overall Study|Adverse Event|3|||
48927002|NCT04589650|157564833|FG001|Overall Study|Adverse Event|1|||
48927003|NCT04589650|157564834|FG002|Overall Study|Adverse Event|1|||
48927004|NCT04589650|157564835|FG003|Overall Study|Adverse Event|1|||
48927005|NCT04589650|157564836|FG004|Overall Study|Adverse Event|0|||
48927006|NCT04589650|157564837|FG005|Overall Study|Adverse Event|1|||
48927007|NCT04589650|157564832|FG000|Overall Study|Physician Decision|1|||
48927008|NCT04589650|157564833|FG001|Overall Study|Physician Decision|1|||
48927009|NCT04589650|157564834|FG002|Overall Study|Physician Decision|0|||
49175739|NCT05059262|158478356|FG001|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|1|||
49175740|NCT05059262|158478355|FG000|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|0|||
49175741|NCT05059262|158478356|FG001|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|2|||
49175742|NCT05059262|158478355|FG000|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|73|||
49175743|NCT05059262|158478356|FG001|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|32|||
49175744|NCT05818137|158478357|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
49175745|NCT05818137|158478357|FG000|Extension Treatment Period|Ongoing participants|44|||
49175746|NCT02029443|158478358|FG000|Overall Study|Completed 30-Day safety follow-up visit|53|||
49175747|NCT02029443|158478359|FG001|Overall Study|Completed 30-Day safety follow-up visit|16|||
49175748|NCT02029443|158478360|FG002|Overall Study|Completed 30-Day safety follow-up visit|12|||
49175749|NCT02029443|158478361|FG003|Overall Study|Completed 30-Day safety follow-up visit|2|||
49175750|NCT02029443|158478362|FG004|Overall Study|Completed 30-Day safety follow-up visit|1|||
49175751|NCT02029443|158478358|FG000|Overall Study|Death|13|||
49175752|NCT02029443|158478359|FG001|Overall Study|Death|2|||
49175753|NCT02029443|158478360|FG002|Overall Study|Death|2|||
49175754|NCT02029443|158478361|FG003|Overall Study|Death|11|||
49175755|NCT02029443|158478362|FG004|Overall Study|Death|2|||
49175756|NCT02029443|158478358|FG000|Overall Study|Lost to Follow-up|1|||
49175757|NCT02029443|158478359|FG001|Overall Study|Lost to Follow-up|0|||
49175758|NCT02029443|158478360|FG002|Overall Study|Lost to Follow-up|1|||
49175759|NCT02029443|158478361|FG003|Overall Study|Lost to Follow-up|1|||
49175760|NCT02029443|158478362|FG004|Overall Study|Lost to Follow-up|0|||
49175761|NCT02029443|158478358|FG000|Overall Study|Started other anti-cancer therapy|17|||
49175762|NCT02029443|158478359|FG001|Overall Study|Started other anti-cancer therapy|4|||
49175763|NCT02029443|158478360|FG002|Overall Study|Started other anti-cancer therapy|7|||
49175764|NCT02029443|158478361|FG003|Overall Study|Started other anti-cancer therapy|9|||
49175765|NCT02029443|158478362|FG004|Overall Study|Started other anti-cancer therapy|3|||
49175766|NCT02029443|158478358|FG000|Overall Study|Withdrawal by Subject|3|||
49175767|NCT02029443|158478359|FG001|Overall Study|Withdrawal by Subject|1|||
49175768|NCT02029443|158478360|FG002|Overall Study|Withdrawal by Subject|1|||
49175769|NCT02029443|158478361|FG003|Overall Study|Withdrawal by Subject|1|||
49175770|NCT02029443|158478362|FG004|Overall Study|Withdrawal by Subject|0|||
49175771|NCT02029443|158478358|FG000|Overall Study|Other|6|||
49175772|NCT02029443|158478359|FG001|Overall Study|Other|6|||
49175773|NCT02029443|158478360|FG002|Overall Study|Other|4|||
49175774|NCT02029443|158478361|FG003|Overall Study|Other|2|||
49175775|NCT02029443|158478362|FG004|Overall Study|Other|0|||
49175776|NCT04737772|158478364|FG000|Phase 2 Study|Lost to Follow-up|15|||
49175777|NCT04737772|158478365|FG001|Phase 2 Study|Lost to Follow-up|15|||
49175778|NCT04737772|158478364|FG000|Phase 2 Study|Withdrawal by Subject|0|||
49175779|NCT04737772|158478365|FG001|Phase 2 Study|Withdrawal by Subject|1|||
49175780|NCT04737772|158478364|FG000|Phase 2 Study|Did not take any coaching calls|4|||
49175781|NCT04737772|158478365|FG001|Phase 2 Study|Did not take any coaching calls|0|||
49175782|NCT04737772|158478364|FG000|Pilot Phase 1 of Study|Withdrawal by Subject|0|||
49175783|NCT04737772|158478365|FG001|Pilot Phase 1 of Study|Withdrawal by Subject|1|||
49175784|NCT04737772|158478364|FG000|Pilot Phase 1 of Study|Randomized but ineligible|0|||
49175785|NCT04737772|158478365|FG001|Pilot Phase 1 of Study|Randomized but ineligible|1|||
49175786|NCT04083235|158478366|FG000|Overall Study|Death|252|||
49175787|NCT04083235|158478367|FG001|Overall Study|Death|277|||
49175788|NCT04083235|158478366|FG000|Overall Study|Withdrawal by Subject|13|||
49175789|NCT04083235|158478367|FG001|Overall Study|Withdrawal by Subject|17|||
49175790|NCT04083235|158478366|FG000|Overall Study|Lost to Follow-up|1|||
49175791|NCT04083235|158478367|FG001|Overall Study|Lost to Follow-up|1|||
49175792|NCT04083235|158478366|FG000|Overall Study|Does not meet entry criteria|1|||
49175793|NCT04083235|158478367|FG001|Overall Study|Does not meet entry criteria|0|||
49175794|NCT04083235|158478366|FG000|Overall Study|Did not receive treatment|13|||
49175795|NCT04083235|158478367|FG001|Overall Study|Did not receive treatment|8|||
49175796|NCT04083235|158478366|FG000|Overall Study|Ongoing at the time of DCO|44|||
48843955|NCT00331136|157269667|FG001|Overall Study|Adverse Event|5|||
49175797|NCT04083235|158478367|FG001|Overall Study|Ongoing at the time of DCO|7|||
49175798|NCT04270760|158478371|FG000|Overall Study|Withdrawal by Subject|0|||
49175799|NCT04270760|158478372|FG001|Overall Study|Withdrawal by Subject|1|||
48843956|NCT00331136|157269668|FG002|Overall Study|Adverse Event|0|||
48843957|NCT00331136|157269669|FG003|Overall Study|Adverse Event|1|||
48843958|NCT00331136|157269666|FG000|Overall Study|Withdrawal by Subject|0|||
48843959|NCT00331136|157269667|FG001|Overall Study|Withdrawal by Subject|1|||
49175800|NCT04270760|158478373|FG002|Overall Study|Withdrawal by Subject|3|||
49175801|NCT04270760|158478374|FG003|Overall Study|Withdrawal by Subject|0|||
49175802|NCT04270760|158478375|FG004|Overall Study|Withdrawal by Subject|0|||
49175803|NCT04270760|158478371|FG000|Overall Study|Lost to Follow-up|1|||
49175804|NCT04270760|158478372|FG001|Overall Study|Lost to Follow-up|2|||
49175805|NCT04270760|158478373|FG002|Overall Study|Lost to Follow-up|1|||
49175806|NCT04270760|158478374|FG003|Overall Study|Lost to Follow-up|0|||
49175807|NCT04270760|158478375|FG004|Overall Study|Lost to Follow-up|0|||
49175808|NCT04270760|158478371|FG000|Overall Study|Death|0|||
49175809|NCT04270760|158478372|FG001|Overall Study|Death|0|||
49175810|NCT04270760|158478373|FG002|Overall Study|Death|0|||
49175811|NCT04270760|158478374|FG003|Overall Study|Death|0|||
49175812|NCT04270760|158478375|FG004|Overall Study|Death|1|||
49175813|NCT00433511|158478376|FG000|Step 1|Adverse Event|50|||
49175814|NCT00433511|158478377|FG001|Step 1|Adverse Event|157|||
49175815|NCT00433511|158478378|FG002|Step 1|Adverse Event|153|||
49175816|NCT00433511|158478376|FG000|Step 1|Withdrawal by Subject|45|||
49175817|NCT00433511|158478377|FG001|Step 1|Withdrawal by Subject|143|||
49175818|NCT00433511|158478378|FG002|Step 1|Withdrawal by Subject|154|||
49175819|NCT00433511|158478376|FG000|Step 1|Death|3|||
49175820|NCT00433511|158478377|FG001|Step 1|Death|1|||
49175821|NCT00433511|158478378|FG002|Step 1|Death|1|||
49175822|NCT00433511|158478376|FG000|Step 1|Physician Decision|1|||
49175823|NCT00433511|158478377|FG001|Step 1|Physician Decision|4|||
49175824|NCT00433511|158478378|FG002|Step 1|Physician Decision|3|||
49175825|NCT00433511|158478376|FG000|Step 1|Never started protocol therapy|28|||
49175826|NCT00433511|158478377|FG001|Step 1|Never started protocol therapy|64|||
49175827|NCT00433511|158478378|FG002|Step 1|Never started protocol therapy|66|||
49175828|NCT00433511|158478376|FG000|Step 1|Alternative therapy|2|||
49175829|NCT00433511|158478377|FG001|Step 1|Alternative therapy|1|||
49175830|NCT00433511|158478378|FG002|Step 1|Alternative therapy|3|||
49175831|NCT00433511|158478376|FG000|Step 1|Disease progression, relapse|5|||
49175832|NCT00433511|158478377|FG001|Step 1|Disease progression, relapse|3|||
49175833|NCT00433511|158478378|FG002|Step 1|Disease progression, relapse|3|||
49175834|NCT00433511|158478376|FG000|Step 1|Other complicating disease|2|||
49175835|NCT00433511|158478377|FG001|Step 1|Other complicating disease|6|||
49175836|NCT00433511|158478378|FG002|Step 1|Other complicating disease|3|||
49175837|NCT00433511|158478376|FG000|Step 1|Non-breast cancer surgery/wound issues|0|||
49175838|NCT00433511|158478377|FG001|Step 1|Non-breast cancer surgery/wound issues|4|||
49175839|NCT00433511|158478378|FG002|Step 1|Non-breast cancer surgery/wound issues|1|||
49175840|NCT00433511|158478376|FG000|Step 1|Suspected recurrence|0|||
49175841|NCT00433511|158478377|FG001|Step 1|Suspected recurrence|1|||
49175842|NCT00433511|158478378|FG002|Step 1|Suspected recurrence|0|||
49175843|NCT00433511|158478376|FG000|Step 1|Insurance/drug distribution issues|0|||
49175844|NCT00433511|158478377|FG001|Step 1|Insurance/drug distribution issues|1|||
49175845|NCT00433511|158478378|FG002|Step 1|Insurance/drug distribution issues|2|||
49175846|NCT00433511|158478376|FG000|Step 1|Patient moved|0|||
49175847|NCT00433511|158478377|FG001|Step 1|Patient moved|0|||
49175848|NCT00433511|158478378|FG002|Step 1|Patient moved|1|||
49175849|NCT00433511|158478376|FG000|Step 2 (Arm D)|Adverse Event|0|||
49175850|NCT00433511|158478377|FG001|Step 2 (Arm D)|Adverse Event|0|||
49175851|NCT00433511|158478378|FG002|Step 2 (Arm D)|Adverse Event|135|||
49175852|NCT00433511|158478376|FG000|Step 2 (Arm D)|Withdrawal by Subject|0|||
49175853|NCT00433511|158478377|FG001|Step 2 (Arm D)|Withdrawal by Subject|0|||
49175854|NCT00433511|158478378|FG002|Step 2 (Arm D)|Withdrawal by Subject|181|||
49175855|NCT00433511|158478376|FG000|Step 2 (Arm D)|Never started protocol therapy|0|||
49175856|NCT00433511|158478377|FG001|Step 2 (Arm D)|Never started protocol therapy|0|||
49175857|NCT00433511|158478378|FG002|Step 2 (Arm D)|Never started protocol therapy|148|||
49175858|NCT00433511|158478376|FG000|Step 2 (Arm D)|Physician Decision|0|||
49175859|NCT00433511|158478377|FG001|Step 2 (Arm D)|Physician Decision|0|||
49175860|NCT00433511|158478378|FG002|Step 2 (Arm D)|Physician Decision|9|||
49175861|NCT00433511|158478376|FG000|Step 2 (Arm D)|Disease progression, relapse|0|||
49175862|NCT00433511|158478377|FG001|Step 2 (Arm D)|Disease progression, relapse|0|||
49175863|NCT00433511|158478378|FG002|Step 2 (Arm D)|Disease progression, relapse|7|||
49175864|NCT00433511|158478376|FG000|Step 2 (Arm D)|Other complicating disease|0|||
49175865|NCT00433511|158478377|FG001|Step 2 (Arm D)|Other complicating disease|0|||
49175866|NCT00433511|158478378|FG002|Step 2 (Arm D)|Other complicating disease|3|||
49175867|NCT00433511|158478376|FG000|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
49175868|NCT00433511|158478377|FG001|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
49175869|NCT00433511|158478378|FG002|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2|||
49175870|NCT00433511|158478376|FG000|Step 2 (Arm D)|Suspected recurrence|0|||
49175871|NCT00433511|158478377|FG001|Step 2 (Arm D)|Suspected recurrence|0|||
49175872|NCT00433511|158478378|FG002|Step 2 (Arm D)|Suspected recurrence|1|||
49175873|NCT00433511|158478376|FG000|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
49175874|NCT00433511|158478377|FG001|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
49175875|NCT00433511|158478378|FG002|Step 2 (Arm D)|Insurance/drug distribution issues|4|||
49175876|NCT00433511|158478376|FG000|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
49175877|NCT00433511|158478377|FG001|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
49175878|NCT00433511|158478378|FG002|Step 2 (Arm D)|Unknown (Missing off treatment form)|1|||
49175879|NCT00602641|158478383|FG000|Overall Study|Never started protocol therapy|6|||
49175880|NCT00602641|158478384|FG001|Overall Study|Never started protocol therapy|2|||
49175881|NCT00602641|158478383|FG000|Overall Study|Still on treatment at time of analysis|8|||
49175882|NCT00602641|158478384|FG001|Overall Study|Still on treatment at time of analysis|15|||
49175883|NCT00602641|158478383|FG000|Overall Study|Adverse Event|62|||
49175884|NCT00602641|158478384|FG001|Overall Study|Adverse Event|53|||
49175885|NCT00602641|158478383|FG000|Overall Study|Disease progression|38|||
49175886|NCT00602641|158478384|FG001|Overall Study|Disease progression|55|||
49175887|NCT00602641|158478383|FG000|Overall Study|Death|6|||
49175888|NCT00602641|158478384|FG001|Overall Study|Death|5|||
49175889|NCT00602641|158478383|FG000|Overall Study|Withdrawal by Subject|15|||
49175890|NCT00602641|158478384|FG001|Overall Study|Withdrawal by Subject|12|||
49175891|NCT00602641|158478383|FG000|Overall Study|Alternative therapy|5|||
49175892|NCT00602641|158478384|FG001|Overall Study|Alternative therapy|2|||
49175893|NCT00602641|158478383|FG000|Overall Study|Other Complicating Disease|5|||
49175894|NCT00602641|158478384|FG001|Overall Study|Other Complicating Disease|2|||
49175895|NCT00602641|158478383|FG000|Overall Study|Physician Decision|5|||
49175896|NCT00602641|158478384|FG001|Overall Study|Physician Decision|4|||
49175897|NCT00602641|158478383|FG000|Overall Study|Administrative Closure|1|||
49175898|NCT00602641|158478384|FG001|Overall Study|Administrative Closure|1|||
49175899|NCT00602641|158478383|FG000|Overall Study|Other|3|||
49175900|NCT00602641|158478384|FG001|Overall Study|Other|1|||
49175901|NCT02807636|158478387|FG000|Overall Study|Lost to Follow-up|10|||
49175902|NCT02807636|158478388|FG001|Overall Study|Lost to Follow-up|13|||
49175903|NCT02807636|158478389|FG002|Overall Study|Lost to Follow-up|6|||
49175904|NCT02807636|158478387|FG000|Overall Study|Protocol Deviation|1|||
49175905|NCT02807636|158478388|FG001|Overall Study|Protocol Deviation|0|||
49175906|NCT02807636|158478389|FG002|Overall Study|Protocol Deviation|0|||
49175907|NCT02807636|158478387|FG000|Overall Study|Symptomatic Deterioration|0|||
49175908|NCT02807636|158478388|FG001|Overall Study|Symptomatic Deterioration|1|||
49175909|NCT02807636|158478389|FG002|Overall Study|Symptomatic Deterioration|0|||
49175910|NCT02807636|158478387|FG000|Overall Study|Withdrawal by Subject|39|||
49175911|NCT02807636|158478388|FG001|Overall Study|Withdrawal by Subject|28|||
49175912|NCT02807636|158478389|FG002|Overall Study|Withdrawal by Subject|24|||
49175913|NCT02807636|158478387|FG000|Overall Study|Death|303|||
49175914|NCT02807636|158478388|FG001|Overall Study|Death|332|||
49175915|NCT02807636|158478389|FG002|Overall Study|Death|272|||
49175916|NCT02807636|158478387|FG000|Overall Study|Study Terminated By Sponsor|47|||
49175917|NCT02807636|158478388|FG001|Overall Study|Study Terminated By Sponsor|76|||
49175918|NCT02807636|158478389|FG002|Overall Study|Study Terminated By Sponsor|60|||
49175919|NCT02807636|158478387|FG000|Overall Study|Physician Decision|0|||
49175920|NCT02807636|158478388|FG001|Overall Study|Physician Decision|1|||
49175921|NCT02807636|158478389|FG002|Overall Study|Physician Decision|0|||
49175922|NCT02954341|158478390|FG000|Overall Study|Attempted Implant unsuccessful|5|||
49175923|NCT02954341|158478390|FG000|Overall Study|Death|90|||
49175924|NCT02954341|158478390|FG000|Overall Study|Withdrawal by Subject|4|||
49175925|NCT02954341|158478390|FG000|Overall Study|Physician Decision|13|||
49175926|NCT02954341|158478390|FG000|Overall Study|Not Implanted due to COVID restrictions|1|||
49175927|NCT02954341|158478390|FG000|Overall Study|Not implanted due to physician's decision|1|||
49175928|NCT02954341|158478390|FG000|Overall Study|Withdrawn Prior Implant Attempt|17|||
49175929|NCT04233879|158478397|FG000|Overall Study|Death|2|||
49175930|NCT04233879|158478398|FG001|Overall Study|Death|0|||
49175931|NCT04233879|158478397|FG000|Overall Study|Lost to Follow-up|3|||
49175932|NCT04233879|158478398|FG001|Overall Study|Lost to Follow-up|8|||
49175933|NCT04233879|158478397|FG000|Overall Study|Physician Decision|4|||
49175934|NCT04233879|158478398|FG001|Overall Study|Physician Decision|4|||
49175935|NCT04233879|158478397|FG000|Overall Study|Withdrawal by Subject|7|||
49175936|NCT04233879|158478398|FG001|Overall Study|Withdrawal by Subject|10|||
49175937|NCT04233879|158478397|FG000|Overall Study|Other|281|||
49175938|NCT04233879|158478398|FG001|Overall Study|Other|279|||
49175939|NCT01314118|158478401|FG000|Overall Study|Adverse Event|9|||
49175940|NCT01314118|158478401|FG000|Overall Study|Progressive disease|27|||
49175941|NCT01314118|158478401|FG000|Overall Study|Physician Decision|11|||
49175942|NCT01314118|158478401|FG000|Overall Study|Death|4|||
49175943|NCT01314118|158478401|FG000|Overall Study|Protocol Violation|5|||
49175944|NCT01314118|158478401|FG000|Overall Study|Withdrawal by Subject|11|||
49175945|NCT01314118|158478401|FG000|Overall Study|Other|2|||
49175946|NCT01314118|158478401|FG000|Overall Study|Ongoing|62|||
49175947|NCT04774926|158478402|FG000|Overall Study|Adverse Event|15|||
48843960|NCT00331136|157269668|FG002|Overall Study|Withdrawal by Subject|0|||
48843961|NCT00331136|157269669|FG003|Overall Study|Withdrawal by Subject|0|||
48843962|NCT00331136|157269666|FG000|Overall Study|Lost to Follow-up|0|||
48843963|NCT00331136|157269667|FG001|Overall Study|Lost to Follow-up|1|||
48843964|NCT00331136|157269668|FG002|Overall Study|Lost to Follow-up|0|||
48843965|NCT00331136|157269669|FG003|Overall Study|Lost to Follow-up|0|||
48843966|NCT00331136|157269666|FG000|Overall Study|Protocol Violation|1|||
48843967|NCT00331136|157269667|FG001|Overall Study|Protocol Violation|0|||
48843968|NCT00331136|157269668|FG002|Overall Study|Protocol Violation|0|||
48843969|NCT00331136|157269669|FG003|Overall Study|Protocol Violation|0|||
48843970|NCT00331136|157269666|FG000|Overall Study|Not treated|1|||
48927010|NCT04589650|157564835|FG003|Overall Study|Physician Decision|0|||
49175948|NCT04774926|158478402|FG000|Overall Study|Lost to Follow-up|3|||
49175949|NCT04774926|158478402|FG000|Overall Study|Physician Decision|6|||
49175950|NCT04774926|158478402|FG000|Overall Study|Withdrawal by Subject|3|||
49175951|NCT04774926|158478402|FG000|Overall Study|The original PI resigned and a new one could not be appointed|4|||
49175952|NCT03143153|158478405|FG000|Pre-Treatment|Participant request to discontinue study treatment|0|||
49175953|NCT03143153|158478406|FG001|Pre-Treatment|Participant request to discontinue study treatment|0|||
49175954|NCT03143153|158478407|FG002|Pre-Treatment|Participant request to discontinue study treatment|2|||
49175955|NCT03143153|158478405|FG000|Pre-Treatment|Participant withdrew consent|0|||
49175956|NCT03143153|158478406|FG001|Pre-Treatment|Participant withdrew consent|1|||
49175957|NCT03143153|158478407|FG002|Pre-Treatment|Participant withdrew consent|12|||
49175958|NCT03143153|158478405|FG000|Pre-Treatment|Participant no longer meets study criteria|0|||
49175959|NCT03143153|158478406|FG001|Pre-Treatment|Participant no longer meets study criteria|4|||
49175960|NCT03143153|158478407|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
49175961|NCT03143153|158478405|FG000|Pre-Treatment|Other Reasons|1|||
49175962|NCT03143153|158478406|FG001|Pre-Treatment|Other Reasons|2|||
49175963|NCT03143153|158478407|FG002|Pre-Treatment|Other Reasons|1|||
49175964|NCT03143153|158478405|FG000|Pre-Treatment|Disease Progression|1|||
49175965|NCT03143153|158478406|FG001|Pre-Treatment|Disease Progression|1|||
49175966|NCT03143153|158478407|FG002|Pre-Treatment|Disease Progression|2|||
49175967|NCT03143153|158478405|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
49175968|NCT03143153|158478406|FG001|Pre-Treatment|Adverse event unrelated to study drug|3|||
49175969|NCT03143153|158478407|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
49175970|NCT03143153|158478405|FG000|Treatment|Disease progression|174|||
49175971|NCT03143153|158478406|FG001|Treatment|Disease progression|184|||
49175972|NCT03143153|158478407|FG002|Treatment|Disease progression|193|||
49175973|NCT03143153|158478405|FG000|Treatment|Study drug toxicity|59|||
49175974|NCT03143153|158478406|FG001|Treatment|Study drug toxicity|33|||
49175975|NCT03143153|158478407|FG002|Treatment|Study drug toxicity|40|||
49175976|NCT03143153|158478405|FG000|Treatment|Death|5|||
49175977|NCT03143153|158478406|FG001|Treatment|Death|3|||
49175978|NCT03143153|158478407|FG002|Treatment|Death|4|||
49175979|NCT03143153|158478405|FG000|Treatment|Adverse event unrelated to study drug|19|||
48843971|NCT00331136|157269667|FG001|Overall Study|Not treated|0|||
48843972|NCT00331136|157269668|FG002|Overall Study|Not treated|0|||
48843973|NCT00331136|157269669|FG003|Overall Study|Not treated|0|||
48843974|NCT00632749|157269670|FG000|Overall Study|Progressive disease|3|||
48927011|NCT04589650|157564836|FG004|Overall Study|Physician Decision|0|||
49175980|NCT03143153|158478406|FG001|Treatment|Adverse event unrelated to study drug|28|||
49175981|NCT03143153|158478407|FG002|Treatment|Adverse event unrelated to study drug|12|||
49175982|NCT03143153|158478405|FG000|Treatment|Participant request to discontinue study treatment|13|||
49175983|NCT03143153|158478406|FG001|Treatment|Participant request to discontinue study treatment|15|||
48843975|NCT00632749|157269671|FG001|Overall Study|Progressive disease|2|||
48843976|NCT00632749|157269672|FG002|Overall Study|Progressive disease|2|||
48927012|NCT04589650|157564837|FG005|Overall Study|Physician Decision|0|||
48927013|NCT04589650|157564832|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
48927014|NCT04589650|157564833|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
48927015|NCT04589650|157564834|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
48927016|NCT04589650|157564835|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
48927017|NCT04589650|157564836|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
48927018|NCT04589650|157564837|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
48927019|NCT04589650|157564832|FG000|Overall Study|Death|0|||
48927020|NCT04589650|157564833|FG001|Overall Study|Death|0|||
48927021|NCT04589650|157564834|FG002|Overall Study|Death|0|||
48927022|NCT04589650|157564835|FG003|Overall Study|Death|1|||
48927023|NCT04589650|157564836|FG004|Overall Study|Death|0|||
48927024|NCT04589650|157564837|FG005|Overall Study|Death|0|||
48927025|NCT04589650|157564832|FG000|Overall Study|Guardian Decision|0|||
48927026|NCT04589650|157564833|FG001|Overall Study|Guardian Decision|0|||
48927027|NCT04589650|157564834|FG002|Overall Study|Guardian Decision|0|||
48927028|NCT04589650|157564835|FG003|Overall Study|Guardian Decision|1|||
48927029|NCT04589650|157564836|FG004|Overall Study|Guardian Decision|0|||
48927030|NCT04589650|157564837|FG005|Overall Study|Guardian Decision|0|||
48927031|NCT04675034|157564846|FG000|Overall Study|Lost to Follow-up|1|||
48927032|NCT04675034|157564847|FG001|Overall Study|Lost to Follow-up|1|||
48927033|NCT04675034|157564848|FG002|Overall Study|Lost to Follow-up|0|||
48927034|NCT04675034|157564849|FG003|Overall Study|Lost to Follow-up|2|||
48927035|NCT04675034|157564850|FG004|Overall Study|Lost to Follow-up|0|||
48927036|NCT04675034|157564846|FG000|Overall Study|Protocol Violation|1|||
48927037|NCT04675034|157564847|FG001|Overall Study|Protocol Violation|0|||
48927038|NCT04675034|157564848|FG002|Overall Study|Protocol Violation|0|||
48927039|NCT04675034|157564849|FG003|Overall Study|Protocol Violation|1|||
49175984|NCT03143153|158478407|FG002|Treatment|Participant request to discontinue study treatment|20|||
49175985|NCT03143153|158478405|FG000|Treatment|Participant withdrew consent|3|||
49175986|NCT03143153|158478406|FG001|Treatment|Participant withdrew consent|4|||
49175987|NCT03143153|158478407|FG002|Treatment|Participant withdrew consent|12|||
49175988|NCT03143153|158478405|FG000|Treatment|Pregnancy|1|||
49175989|NCT03143153|158478406|FG001|Treatment|Pregnancy|0|||
49175990|NCT03143153|158478407|FG002|Treatment|Pregnancy|0|||
49175991|NCT03143153|158478405|FG000|Treatment|Maximum clinical benefit|1|||
49175992|NCT03143153|158478406|FG001|Treatment|Maximum clinical benefit|3|||
49175993|NCT03143153|158478407|FG002|Treatment|Maximum clinical benefit|4|||
49175994|NCT03143153|158478405|FG000|Treatment|Completed treatment as per Protocol|13|||
49175995|NCT03143153|158478406|FG001|Treatment|Completed treatment as per Protocol|8|||
49175996|NCT03143153|158478407|FG002|Treatment|Completed treatment as per Protocol|0|||
49175997|NCT03143153|158478405|FG000|Treatment|Other reasons|12|||
49175998|NCT03143153|158478406|FG001|Treatment|Other reasons|7|||
49175999|NCT03143153|158478407|FG002|Treatment|Other reasons|15|||
49176000|NCT03143153|158478405|FG000|Treatment|Not reported|1|||
49176001|NCT03143153|158478406|FG001|Treatment|Not reported|0|||
48843977|NCT00632749|157269673|FG003|Overall Study|Progressive disease|2|||
48843978|NCT00632749|157269674|FG004|Overall Study|Progressive disease|4|||
48843979|NCT00632749|157269675|FG005|Overall Study|Progressive disease|4|||
48843980|NCT00632749|157269676|FG006|Overall Study|Progressive disease|3|||
49176002|NCT03143153|158478407|FG002|Treatment|Not reported|0|||
49176003|NCT04083976|158478411|FG000|Overall Study|Lost to Follow-up|3|||
49176004|NCT04083976|158478412|FG001|Overall Study|Lost to Follow-up|0|||
48843981|NCT00632749|157269677|FG007|Overall Study|Progressive disease|2|||
48843982|NCT00632749|157269678|FG008|Overall Study|Progressive disease|3|||
49176005|NCT04083976|158478413|FG002|Overall Study|Lost to Follow-up|0|||
49176006|NCT04083976|158478414|FG003|Overall Study|Lost to Follow-up|1|||
49176007|NCT04083976|158478411|FG000|Overall Study|Withdrawal by Subject|16|||
49176008|NCT04083976|158478412|FG001|Overall Study|Withdrawal by Subject|1|||
48843983|NCT00632749|157269679|FG009|Overall Study|Progressive disease|2|||
49176009|NCT04083976|158478413|FG002|Overall Study|Withdrawal by Subject|9|||
49176010|NCT04083976|158478414|FG003|Overall Study|Withdrawal by Subject|0|||
49176011|NCT04083976|158478411|FG000|Overall Study|Sponsor Decision|14|||
49176012|NCT04083976|158478412|FG001|Overall Study|Sponsor Decision|0|||
49176013|NCT04083976|158478413|FG002|Overall Study|Sponsor Decision|0|||
49176014|NCT04083976|158478414|FG003|Overall Study|Sponsor Decision|7|||
49176015|NCT04083976|158478411|FG000|Overall Study|Other|1|||
49176016|NCT04083976|158478412|FG001|Overall Study|Other|0|||
49176017|NCT04083976|158478413|FG002|Overall Study|Other|1|||
49176018|NCT04083976|158478414|FG003|Overall Study|Other|0|||
49176019|NCT04918147|158478415|FG000|Overall Study|Disease flare as defined in protocol|0|||
48843984|NCT00632749|157269680|FG010|Overall Study|Progressive disease|4|||
48843985|NCT00632749|157269681|FG011|Overall Study|Progressive disease|3|||
48843986|NCT00632749|157269682|FG012|Overall Study|Progressive disease|2|||
49176020|NCT04918147|158478416|FG001|Overall Study|Disease flare as defined in protocol|2|||
49176021|NCT04849416|158478420|FG000|Overall Study|Ongoing Treatment|12|||
49176022|NCT04849416|158478421|FG001|Overall Study|Ongoing Treatment|5|||
48843987|NCT00632749|157269683|FG013|Overall Study|Progressive disease|4|||
49176023|NCT04849416|158478422|FG002|Overall Study|Ongoing Treatment|3|||
49176024|NCT04849416|158478420|FG000|Overall Study|On Post-Treatment Follow-up|8|||
48927040|NCT04675034|157564850|FG004|Overall Study|Protocol Violation|3|||
49176025|NCT04849416|158478421|FG001|Overall Study|On Post-Treatment Follow-up|9|||
49176026|NCT04849416|158478422|FG002|Overall Study|On Post-Treatment Follow-up|10|||
49176027|NCT04849416|158478420|FG000|Overall Study|Withdrawal by Subject|0|||
49176028|NCT04849416|158478421|FG001|Overall Study|Withdrawal by Subject|0|||
49176029|NCT04849416|158478422|FG002|Overall Study|Withdrawal by Subject|1|||
49176030|NCT04849416|158478420|FG000|Overall Study|Lost to Follow-up|1|||
49176031|NCT04849416|158478421|FG001|Overall Study|Lost to Follow-up|0|||
49176032|NCT04849416|158478422|FG002|Overall Study|Lost to Follow-up|0|||
49176033|NCT02890355|158478428|FG000|Overall Study|Adverse Event|5|||
49176034|NCT02890355|158478429|FG001|Overall Study|Adverse Event|5|||
49176035|NCT02890355|158478428|FG000|Overall Study|Refusal unrelated to adverse event|5|||
49176036|NCT02890355|158478429|FG001|Overall Study|Refusal unrelated to adverse event|10|||
49176037|NCT02890355|158478428|FG000|Overall Study|Progression/relapse|46|||
49176038|NCT02890355|158478429|FG001|Overall Study|Progression/relapse|39|||
49176039|NCT02890355|158478428|FG000|Overall Study|Not protocol specified|3|||
49176040|NCT02890355|158478429|FG001|Overall Study|Not protocol specified|4|||
48927041|NCT04675034|157564846|FG000|Overall Study|Withdrawal by Subject|9|||
48927042|NCT04675034|157564847|FG001|Overall Study|Withdrawal by Subject|3|||
49176041|NCT03406780|158478431|FG000|Overall Study|Withdrawal by Subject|1|||
48843988|NCT00632749|157269670|FG000|Overall Study|Other Adverse event|1|||
48843989|NCT00632749|157269671|FG001|Overall Study|Other Adverse event|1|||
48843990|NCT00632749|157269672|FG002|Overall Study|Other Adverse event|1|||
48843991|NCT00632749|157269673|FG003|Overall Study|Other Adverse event|1|||
48843992|NCT00632749|157269674|FG004|Overall Study|Other Adverse event|2|||
48843993|NCT00632749|157269675|FG005|Overall Study|Other Adverse event|4|||
48843994|NCT00632749|157269676|FG006|Overall Study|Other Adverse event|1|||
48843995|NCT00632749|157269677|FG007|Overall Study|Other Adverse event|2|||
48843996|NCT00632749|157269678|FG008|Overall Study|Other Adverse event|2|||
48843997|NCT00632749|157269679|FG009|Overall Study|Other Adverse event|0|||
48843998|NCT00632749|157269680|FG010|Overall Study|Other Adverse event|1|||
48843999|NCT00632749|157269681|FG011|Overall Study|Other Adverse event|0|||
48844000|NCT00632749|157269682|FG012|Overall Study|Other Adverse event|1|||
48844001|NCT00632749|157269683|FG013|Overall Study|Other Adverse event|0|||
48844002|NCT00632749|157269670|FG000|Overall Study|Refuse to continue medication|0|||
48844003|NCT00632749|157269671|FG001|Overall Study|Refuse to continue medication|0|||
48844004|NCT00632749|157269672|FG002|Overall Study|Refuse to continue medication|0|||
48844005|NCT00632749|157269673|FG003|Overall Study|Refuse to continue medication|1|||
48844006|NCT00632749|157269674|FG004|Overall Study|Refuse to continue medication|0|||
48844007|NCT00632749|157269675|FG005|Overall Study|Refuse to continue medication|0|||
48844008|NCT00632749|157269676|FG006|Overall Study|Refuse to continue medication|0|||
48844009|NCT00632749|157269677|FG007|Overall Study|Refuse to continue medication|0|||
48844010|NCT00632749|157269678|FG008|Overall Study|Refuse to continue medication|0|||
48844011|NCT00632749|157269679|FG009|Overall Study|Refuse to continue medication|1|||
48844012|NCT00632749|157269680|FG010|Overall Study|Refuse to continue medication|0|||
48844013|NCT00632749|157269681|FG011|Overall Study|Refuse to continue medication|0|||
48844014|NCT00632749|157269682|FG012|Overall Study|Refuse to continue medication|0|||
48844015|NCT00632749|157269683|FG013|Overall Study|Refuse to continue medication|0|||
48844016|NCT00632749|157269670|FG000|Overall Study|Reason other than those specified above|0|||
48844017|NCT00632749|157269671|FG001|Overall Study|Reason other than those specified above|2|||
48844018|NCT00632749|157269672|FG002|Overall Study|Reason other than those specified above|0|||
48844019|NCT00632749|157269673|FG003|Overall Study|Reason other than those specified above|0|||
48844020|NCT00632749|157269674|FG004|Overall Study|Reason other than those specified above|1|||
48844021|NCT00632749|157269675|FG005|Overall Study|Reason other than those specified above|0|||
48844022|NCT00632749|157269676|FG006|Overall Study|Reason other than those specified above|1|||
48844023|NCT00632749|157269677|FG007|Overall Study|Reason other than those specified above|0|||
48844024|NCT00632749|157269678|FG008|Overall Study|Reason other than those specified above|0|||
48844025|NCT00632749|157269679|FG009|Overall Study|Reason other than those specified above|0|||
48844026|NCT00632749|157269680|FG010|Overall Study|Reason other than those specified above|2|||
48844027|NCT00632749|157269681|FG011|Overall Study|Reason other than those specified above|1|||
48844028|NCT00632749|157269682|FG012|Overall Study|Reason other than those specified above|0|||
48844029|NCT00632749|157269683|FG013|Overall Study|Reason other than those specified above|2|||
48844030|NCT00951379|157269684|FG000|Overall Study|Adverse Event|4|||
48844031|NCT00951379|157269685|FG001|Overall Study|Adverse Event|1|||
48844032|NCT00951379|157269684|FG000|Overall Study|Withdrawal by Subject|1|||
48844033|NCT00951379|157269685|FG001|Overall Study|Withdrawal by Subject|0|||
48844034|NCT00951379|157269684|FG000|Overall Study|Noncompliance|1|||
48844035|NCT00951379|157269685|FG001|Overall Study|Noncompliance|0|||
48844036|NCT00951379|157269684|FG000|Overall Study|Disease Progression|0|||
48844037|NCT00951379|157269685|FG001|Overall Study|Disease Progression|1|||
48844038|NCT00976937|157269686|FG000|Overall Study|Adverse Event|4|||
48927043|NCT04675034|157564848|FG002|Overall Study|Withdrawal by Subject|4|||
48927044|NCT04675034|157564849|FG003|Overall Study|Withdrawal by Subject|8|||
48927045|NCT04675034|157564850|FG004|Overall Study|Withdrawal by Subject|6|||
48844039|NCT00976937|157269687|FG001|Overall Study|Adverse Event|5|||
48844040|NCT00976937|157269686|FG000|Overall Study|Lost to Follow-up|2|||
48844041|NCT00976937|157269687|FG001|Overall Study|Lost to Follow-up|1|||
48844042|NCT00976937|157269686|FG000|Overall Study|Withdrawal by Subject|5|||
48844043|NCT00976937|157269687|FG001|Overall Study|Withdrawal by Subject|3|||
48844044|NCT00976937|157269686|FG000|Overall Study|Poor compliance to protocol|3|||
48844045|NCT00976937|157269687|FG001|Overall Study|Poor compliance to protocol|0|||
48844046|NCT00976937|157269686|FG000|Overall Study|Personal and Familial Reason|2|||
48844047|NCT00976937|157269687|FG001|Overall Study|Personal and Familial Reason|2|||
48844048|NCT02372253|157269696|FG000|Overall Study|Non Compliance|2|||
48844049|NCT02372253|157269697|FG001|Overall Study|Non Compliance|0|||
48844050|NCT04484935|157269698|FG000|Overall Study|Other|0|||
48844051|NCT04484935|157269699|FG001|Overall Study|Other|1|||
48844052|NCT04484935|157269698|FG000|Overall Study|Withdrawal by parent/guardian|0|||
48844053|NCT04484935|157269699|FG001|Overall Study|Withdrawal by parent/guardian|1|||
48844054|NCT04484935|157269698|FG000|Overall Study|Lost to Follow-up|1|||
48844055|NCT04484935|157269699|FG001|Overall Study|Lost to Follow-up|0|||
48927046|NCT02711553|157564851|FG000|Overall Study|Withdrawal by Subject|2|||
48844056|NCT04484935|157269698|FG000|Overall Study|Death|2|||
48844057|NCT04484935|157269699|FG001|Overall Study|Death|1|||
48844058|NCT02742519|157269700|FG000|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
48844059|NCT02742519|157269701|FG001|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
48844060|NCT02742519|157269702|FG002|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0|||
48844061|NCT02742519|157269700|FG000|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
48844062|NCT02742519|157269701|FG001|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
48844063|NCT02742519|157269702|FG002|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9|||
48844064|NCT02742519|157269700|FG000|Part 2 Open Label Period (32 Weeks)|Other|0|||
48844065|NCT02742519|157269701|FG001|Part 2 Open Label Period (32 Weeks)|Other|0|||
48844066|NCT02742519|157269702|FG002|Part 2 Open Label Period (32 Weeks)|Other|1|||
48844067|NCT01255670|157269708|FG000|Overall Study|Adverse Event|10|||
48844068|NCT01255670|157269709|FG001|Overall Study|Adverse Event|10|||
48844069|NCT01255670|157269708|FG000|Overall Study|Lost to Follow-up|16|||
48844070|NCT01255670|157269709|FG001|Overall Study|Lost to Follow-up|10|||
48844071|NCT00632424|157269715|FG000|Overall Study|Disease Progression|17|||
48844072|NCT00632424|157269715|FG000|Overall Study|Study Drug Toxicity|1|||
48844073|NCT00589667|157271224|FG000|Overall Study|Adverse Event|2|||
48844074|NCT00589667|157271224|FG000|Overall Study|Withdrawal by Subject|1|||
48844075|NCT00089544|157271227|FG000|Overall Study|Ineligible|1|||
48844076|NCT00089544|157271228|FG001|Overall Study|Ineligible|0|||
48844077|NCT02189252|157271229|FG000|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
49176042|NCT03406780|158478432|FG001|Overall Study|Withdrawal by Subject|1|||
48844078|NCT02189252|157271230|FG001|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1|||
48844079|NCT02189252|157271231|FG002|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
48844080|NCT02189252|157271232|FG003|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
48844081|NCT02189252|157271229|FG000|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
49176043|NCT03406780|158478431|FG000|Overall Study|Other|0|||
49176044|NCT03406780|158478432|FG001|Overall Study|Other|2|||
49176045|NCT04927065|158478433|FG000|First Booster|Adverse Event|1|||
49176046|NCT04927065|158478434|FG001|First Booster|Adverse Event|0|||
49176047|NCT04927065|158478435|FG002|First Booster|Adverse Event|0|||
49176048|NCT04927065|158478436|FG003|First Booster|Adverse Event|0|||
49176049|NCT04927065|158478437|FG004|First Booster|Adverse Event|0|||
48844082|NCT02189252|157271230|FG001|Period 1 (Visit 4b, Week 4)|Adverse Event|1|||
48844083|NCT02189252|157271231|FG002|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
48844084|NCT02189252|157271232|FG003|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
49176050|NCT04927065|158478438|FG005|First Booster|Adverse Event|0|||
49176051|NCT04927065|158478439|FG006|First Booster|Adverse Event|0|||
49176052|NCT04927065|158478440|FG007|First Booster|Adverse Event|1|||
49176053|NCT04927065|158478441|FG008|First Booster|Adverse Event|0|||
49176054|NCT04927065|158478442|FG009|First Booster|Adverse Event|0|||
49176055|NCT04927065|158478443|FG010|First Booster|Adverse Event|0|||
49176056|NCT04927065|158478444|FG011|First Booster|Adverse Event|0|||
49176057|NCT04927065|158478445|FG012|First Booster|Adverse Event|0|||
49176058|NCT04927065|158478446|FG013|First Booster|Adverse Event|0|||
49176059|NCT04927065|158478447|FG014|First Booster|Adverse Event|0|||
49176060|NCT04927065|158478448|FG015|First Booster|Adverse Event|0|||
49176061|NCT04927065|158478433|FG000|First Booster|Death|1|||
49176062|NCT04927065|158478434|FG001|First Booster|Death|0|||
49176063|NCT04927065|158478435|FG002|First Booster|Death|0|||
49176064|NCT04927065|158478436|FG003|First Booster|Death|1|||
49176065|NCT04927065|158478437|FG004|First Booster|Death|0|||
49176066|NCT04927065|158478438|FG005|First Booster|Death|1|||
49176067|NCT04927065|158478439|FG006|First Booster|Death|0|||
49176068|NCT04927065|158478440|FG007|First Booster|Death|0|||
49176069|NCT04927065|158478441|FG008|First Booster|Death|0|||
49176070|NCT04927065|158478442|FG009|First Booster|Death|0|||
49176071|NCT04927065|158478443|FG010|First Booster|Death|0|||
49176072|NCT04927065|158478444|FG011|First Booster|Death|0|||
49176073|NCT04927065|158478445|FG012|First Booster|Death|0|||
49176074|NCT04927065|158478446|FG013|First Booster|Death|0|||
49176075|NCT04927065|158478447|FG014|First Booster|Death|0|||
49176076|NCT04927065|158478448|FG015|First Booster|Death|0|||
49176077|NCT04927065|158478433|FG000|First Booster|Lost to Follow-up|8|||
49176078|NCT04927065|158478434|FG001|First Booster|Lost to Follow-up|20|||
49176079|NCT04927065|158478435|FG002|First Booster|Lost to Follow-up|0|||
49176080|NCT04927065|158478436|FG003|First Booster|Lost to Follow-up|11|||
49176081|NCT04927065|158478437|FG004|First Booster|Lost to Follow-up|43|||
49176082|NCT04927065|158478438|FG005|First Booster|Lost to Follow-up|30|||
49176083|NCT04927065|158478439|FG006|First Booster|Lost to Follow-up|28|||
49176084|NCT04927065|158478440|FG007|First Booster|Lost to Follow-up|23|||
49176085|NCT04927065|158478441|FG008|First Booster|Lost to Follow-up|4|||
49176086|NCT04927065|158478442|FG009|First Booster|Lost to Follow-up|15|||
49176087|NCT04927065|158478443|FG010|First Booster|Lost to Follow-up|0|||
49176088|NCT04927065|158478444|FG011|First Booster|Lost to Follow-up|0|||
49176089|NCT04927065|158478445|FG012|First Booster|Lost to Follow-up|0|||
49176090|NCT04927065|158478446|FG013|First Booster|Lost to Follow-up|0|||
49176091|NCT04927065|158478447|FG014|First Booster|Lost to Follow-up|0|||
49176092|NCT04927065|158478448|FG015|First Booster|Lost to Follow-up|0|||
49176093|NCT04927065|158478433|FG000|First Booster|Physician Decision|1|||
49176094|NCT04927065|158478434|FG001|First Booster|Physician Decision|0|||
49176095|NCT04927065|158478435|FG002|First Booster|Physician Decision|0|||
49176096|NCT04927065|158478436|FG003|First Booster|Physician Decision|3|||
49176097|NCT04927065|158478437|FG004|First Booster|Physician Decision|1|||
49176098|NCT04927065|158478438|FG005|First Booster|Physician Decision|1|||
49176099|NCT04927065|158478439|FG006|First Booster|Physician Decision|0|||
49176100|NCT04927065|158478440|FG007|First Booster|Physician Decision|3|||
49176101|NCT04927065|158478441|FG008|First Booster|Physician Decision|0|||
49176102|NCT04927065|158478442|FG009|First Booster|Physician Decision|0|||
49176103|NCT04927065|158478443|FG010|First Booster|Physician Decision|0|||
49176104|NCT04927065|158478444|FG011|First Booster|Physician Decision|0|||
49176105|NCT04927065|158478445|FG012|First Booster|Physician Decision|0|||
49176106|NCT04927065|158478446|FG013|First Booster|Physician Decision|0|||
49176107|NCT04927065|158478447|FG014|First Booster|Physician Decision|0|||
49176108|NCT04927065|158478448|FG015|First Booster|Physician Decision|0|||
49176109|NCT04927065|158478433|FG000|First Booster|Protocol Violation|4|||
49176110|NCT04927065|158478434|FG001|First Booster|Protocol Violation|4|||
49176111|NCT04927065|158478435|FG002|First Booster|Protocol Violation|0|||
49176112|NCT04927065|158478436|FG003|First Booster|Protocol Violation|3|||
49176113|NCT04927065|158478437|FG004|First Booster|Protocol Violation|0|||
49176114|NCT04927065|158478438|FG005|First Booster|Protocol Violation|0|||
49176115|NCT04927065|158478439|FG006|First Booster|Protocol Violation|0|||
49176116|NCT04927065|158478440|FG007|First Booster|Protocol Violation|2|||
49176117|NCT04927065|158478441|FG008|First Booster|Protocol Violation|0|||
49176118|NCT04927065|158478442|FG009|First Booster|Protocol Violation|0|||
49176119|NCT04927065|158478443|FG010|First Booster|Protocol Violation|0|||
49176120|NCT04927065|158478444|FG011|First Booster|Protocol Violation|0|||
49176121|NCT04927065|158478445|FG012|First Booster|Protocol Violation|0|||
49176122|NCT04927065|158478446|FG013|First Booster|Protocol Violation|0|||
49176123|NCT04927065|158478447|FG014|First Booster|Protocol Violation|0|||
49176124|NCT04927065|158478448|FG015|First Booster|Protocol Violation|0|||
49176125|NCT04927065|158478433|FG000|First Booster|Withdrawal by Subject|8|||
49176126|NCT04927065|158478434|FG001|First Booster|Withdrawal by Subject|23|||
49176127|NCT04927065|158478435|FG002|First Booster|Withdrawal by Subject|0|||
49176128|NCT04927065|158478436|FG003|First Booster|Withdrawal by Subject|19|||
49176129|NCT04927065|158478437|FG004|First Booster|Withdrawal by Subject|20|||
49176130|NCT04927065|158478438|FG005|First Booster|Withdrawal by Subject|15|||
49176131|NCT04927065|158478439|FG006|First Booster|Withdrawal by Subject|6|||
49176132|NCT04927065|158478440|FG007|First Booster|Withdrawal by Subject|24|||
49176133|NCT04927065|158478441|FG008|First Booster|Withdrawal by Subject|0|||
49176134|NCT04927065|158478442|FG009|First Booster|Withdrawal by Subject|4|||
49176135|NCT04927065|158478443|FG010|First Booster|Withdrawal by Subject|0|||
49176136|NCT04927065|158478444|FG011|First Booster|Withdrawal by Subject|0|||
49176137|NCT04927065|158478445|FG012|First Booster|Withdrawal by Subject|0|||
49176138|NCT04927065|158478446|FG013|First Booster|Withdrawal by Subject|0|||
49176139|NCT04927065|158478447|FG014|First Booster|Withdrawal by Subject|0|||
49176140|NCT04927065|158478448|FG015|First Booster|Withdrawal by Subject|0|||
49176141|NCT04927065|158478433|FG000|First Booster|Other Than Specified|1|||
49176142|NCT04927065|158478434|FG001|First Booster|Other Than Specified|1|||
49176143|NCT04927065|158478435|FG002|First Booster|Other Than Specified|0|||
49176144|NCT04927065|158478436|FG003|First Booster|Other Than Specified|1|||
49176145|NCT04927065|158478437|FG004|First Booster|Other Than Specified|2|||
49176146|NCT04927065|158478438|FG005|First Booster|Other Than Specified|3|||
49176147|NCT04927065|158478439|FG006|First Booster|Other Than Specified|2|||
49176148|NCT04927065|158478440|FG007|First Booster|Other Than Specified|6|||
49176149|NCT04927065|158478441|FG008|First Booster|Other Than Specified|0|||
49176150|NCT04927065|158478442|FG009|First Booster|Other Than Specified|4|||
49176151|NCT04927065|158478443|FG010|First Booster|Other Than Specified|0|||
49176152|NCT04927065|158478444|FG011|First Booster|Other Than Specified|0|||
49176153|NCT04927065|158478445|FG012|First Booster|Other Than Specified|0|||
49176154|NCT04927065|158478446|FG013|First Booster|Other Than Specified|0|||
49176155|NCT04927065|158478447|FG014|First Booster|Other Than Specified|0|||
49176156|NCT04927065|158478448|FG015|First Booster|Other Than Specified|0|||
49176157|NCT04927065|158478433|FG000|Second Booster|Death|0|||
49176158|NCT04927065|158478434|FG001|Second Booster|Death|0|||
49176159|NCT04927065|158478435|FG002|Second Booster|Death|0|||
49176160|NCT04927065|158478436|FG003|Second Booster|Death|0|||
49176161|NCT04927065|158478437|FG004|Second Booster|Death|0|||
49176162|NCT04927065|158478438|FG005|Second Booster|Death|0|||
49176163|NCT04927065|158478439|FG006|Second Booster|Death|0|||
49176164|NCT04927065|158478440|FG007|Second Booster|Death|0|||
49176165|NCT04927065|158478441|FG008|Second Booster|Death|0|||
49176166|NCT04927065|158478442|FG009|Second Booster|Death|0|||
49176167|NCT04927065|158478443|FG010|Second Booster|Death|2|||
49176168|NCT04927065|158478444|FG011|Second Booster|Death|0|||
49176169|NCT04927065|158478445|FG012|Second Booster|Death|2|||
49176170|NCT04927065|158478446|FG013|Second Booster|Death|2|||
48927047|NCT02711553|157564852|FG001|Overall Study|Withdrawal by Subject|1|||
48927048|NCT02711553|157564853|FG002|Overall Study|Withdrawal by Subject|1|||
48927049|NCT02711553|157564854|FG003|Overall Study|Withdrawal by Subject|0|||
48927050|NCT02711553|157564851|FG000|Overall Study|Lost to Follow-up|3|||
48927051|NCT02711553|157564852|FG001|Overall Study|Lost to Follow-up|3|||
48927052|NCT02711553|157564853|FG002|Overall Study|Lost to Follow-up|6|||
48927053|NCT02711553|157564854|FG003|Overall Study|Lost to Follow-up|3|||
48927054|NCT02711553|157564851|FG000|Overall Study|On Study Treatment at Study Conclusion|1|||
48927055|NCT02711553|157564852|FG001|Overall Study|On Study Treatment at Study Conclusion|1|||
48927056|NCT02711553|157564853|FG002|Overall Study|On Study Treatment at Study Conclusion|3|||
48927057|NCT02711553|157564854|FG003|Overall Study|On Study Treatment at Study Conclusion|1|||
48927058|NCT00687362|157566479|FG000|Overall Study|Protocol Violation|2|||
48927059|NCT00687362|157566479|FG000|Overall Study|Withdrawal by Subject|1|||
49176171|NCT04927065|158478447|FG014|Second Booster|Death|0|||
49176172|NCT04927065|158478448|FG015|Second Booster|Death|0|||
49176173|NCT04927065|158478433|FG000|Second Booster|Lost to Follow-up|0|||
49176174|NCT04927065|158478434|FG001|Second Booster|Lost to Follow-up|0|||
49176175|NCT04927065|158478435|FG002|Second Booster|Lost to Follow-up|3|||
49176176|NCT04927065|158478436|FG003|Second Booster|Lost to Follow-up|0|||
49176177|NCT04927065|158478437|FG004|Second Booster|Lost to Follow-up|0|||
49176178|NCT04927065|158478438|FG005|Second Booster|Lost to Follow-up|0|||
49176179|NCT04927065|158478439|FG006|Second Booster|Lost to Follow-up|0|||
49176180|NCT04927065|158478440|FG007|Second Booster|Lost to Follow-up|0|||
49176181|NCT04927065|158478441|FG008|Second Booster|Lost to Follow-up|0|||
49176182|NCT04927065|158478442|FG009|Second Booster|Lost to Follow-up|0|||
49176183|NCT04927065|158478443|FG010|Second Booster|Lost to Follow-up|14|||
49176184|NCT04927065|158478444|FG011|Second Booster|Lost to Follow-up|10|||
49176185|NCT04927065|158478445|FG012|Second Booster|Lost to Follow-up|13|||
49176186|NCT04927065|158478446|FG013|Second Booster|Lost to Follow-up|16|||
49176187|NCT04927065|158478447|FG014|Second Booster|Lost to Follow-up|0|||
49176188|NCT04927065|158478448|FG015|Second Booster|Lost to Follow-up|0|||
48927060|NCT01882907|157566480|FG000|Overall Study|Adverse Event|3|||
48927061|NCT01882907|157566481|FG001|Overall Study|Adverse Event|1|||
49176189|NCT04927065|158478433|FG000|Second Booster|Physician Decision|0|||
49176190|NCT04927065|158478434|FG001|Second Booster|Physician Decision|0|||
49176191|NCT04927065|158478435|FG002|Second Booster|Physician Decision|0|||
49176192|NCT04927065|158478436|FG003|Second Booster|Physician Decision|0|||
49176193|NCT04927065|158478437|FG004|Second Booster|Physician Decision|0|||
49176194|NCT04927065|158478438|FG005|Second Booster|Physician Decision|0|||
49176195|NCT04927065|158478439|FG006|Second Booster|Physician Decision|0|||
49176196|NCT04927065|158478440|FG007|Second Booster|Physician Decision|0|||
49176197|NCT04927065|158478441|FG008|Second Booster|Physician Decision|0|||
48927062|NCT01882907|157566480|FG000|Overall Study|Lack of Efficacy|0|||
49176198|NCT04927065|158478442|FG009|Second Booster|Physician Decision|0|||
49176199|NCT04927065|158478443|FG010|Second Booster|Physician Decision|0|||
49176200|NCT04927065|158478444|FG011|Second Booster|Physician Decision|3|||
49176201|NCT04927065|158478445|FG012|Second Booster|Physician Decision|0|||
49176202|NCT04927065|158478446|FG013|Second Booster|Physician Decision|1|||
49176203|NCT04927065|158478447|FG014|Second Booster|Physician Decision|0|||
49176204|NCT04927065|158478448|FG015|Second Booster|Physician Decision|0|||
49176205|NCT04927065|158478433|FG000|Second Booster|Withdrawal by Subject|0|||
49176206|NCT04927065|158478434|FG001|Second Booster|Withdrawal by Subject|0|||
49176207|NCT04927065|158478435|FG002|Second Booster|Withdrawal by Subject|4|||
49176208|NCT04927065|158478436|FG003|Second Booster|Withdrawal by Subject|0|||
49176209|NCT04927065|158478437|FG004|Second Booster|Withdrawal by Subject|0|||
49176210|NCT04927065|158478438|FG005|Second Booster|Withdrawal by Subject|0|||
49176211|NCT04927065|158478439|FG006|Second Booster|Withdrawal by Subject|0|||
49176212|NCT04927065|158478440|FG007|Second Booster|Withdrawal by Subject|0|||
49176213|NCT04927065|158478441|FG008|Second Booster|Withdrawal by Subject|0|||
49176214|NCT04927065|158478442|FG009|Second Booster|Withdrawal by Subject|0|||
49176215|NCT04927065|158478443|FG010|Second Booster|Withdrawal by Subject|3|||
49176216|NCT04927065|158478444|FG011|Second Booster|Withdrawal by Subject|16|||
49176217|NCT04927065|158478445|FG012|Second Booster|Withdrawal by Subject|13|||
49176218|NCT04927065|158478446|FG013|Second Booster|Withdrawal by Subject|9|||
49176219|NCT04927065|158478447|FG014|Second Booster|Withdrawal by Subject|0|||
49176220|NCT04927065|158478448|FG015|Second Booster|Withdrawal by Subject|0|||
49176221|NCT04927065|158478433|FG000|Second Booster|Other Than Specified|0|||
49176222|NCT04927065|158478434|FG001|Second Booster|Other Than Specified|0|||
49176223|NCT04927065|158478435|FG002|Second Booster|Other Than Specified|0|||
49176224|NCT04927065|158478436|FG003|Second Booster|Other Than Specified|0|||
49176225|NCT04927065|158478437|FG004|Second Booster|Other Than Specified|0|||
49176226|NCT04927065|158478438|FG005|Second Booster|Other Than Specified|0|||
49176227|NCT04927065|158478439|FG006|Second Booster|Other Than Specified|0|||
49176228|NCT04927065|158478440|FG007|Second Booster|Other Than Specified|0|||
49176229|NCT04927065|158478441|FG008|Second Booster|Other Than Specified|0|||
49176230|NCT04927065|158478442|FG009|Second Booster|Other Than Specified|0|||
49176231|NCT04927065|158478443|FG010|Second Booster|Other Than Specified|1|||
49176232|NCT04927065|158478444|FG011|Second Booster|Other Than Specified|1|||
49176233|NCT04927065|158478445|FG012|Second Booster|Other Than Specified|4|||
49176234|NCT04927065|158478446|FG013|Second Booster|Other Than Specified|0|||
49176235|NCT04927065|158478447|FG014|Second Booster|Other Than Specified|0|||
49176236|NCT04927065|158478448|FG015|Second Booster|Other Than Specified|0|||
49176237|NCT04927065|158478433|FG000|Third Booster|Lost to Follow-up|0|||
49176238|NCT04927065|158478434|FG001|Third Booster|Lost to Follow-up|0|||
49176239|NCT04927065|158478435|FG002|Third Booster|Lost to Follow-up|0|||
49176240|NCT04927065|158478436|FG003|Third Booster|Lost to Follow-up|0|||
48927063|NCT01882907|157566481|FG001|Overall Study|Lack of Efficacy|3|||
48927064|NCT01882907|157566480|FG000|Overall Study|Lost to Follow-up|1|||
48927065|NCT01882907|157566481|FG001|Overall Study|Lost to Follow-up|4|||
48927066|NCT01882907|157566480|FG000|Overall Study|Protocol Violation|10|||
48927067|NCT01882907|157566481|FG001|Overall Study|Protocol Violation|14|||
48927068|NCT01882907|157566480|FG000|Overall Study|Withdrawal by Subject|0|||
48927069|NCT01882907|157566481|FG001|Overall Study|Withdrawal by Subject|6|||
48927070|NCT01396005|157566482|FG000|Overall Study|Withdrawal by Subject|0|||
48927071|NCT01396005|157566483|FG001|Overall Study|Withdrawal by Subject|1|||
48927072|NCT01396005|157566482|FG000|Overall Study|Non-compliance with protocol|0|||
48927073|NCT01396005|157566483|FG001|Overall Study|Non-compliance with protocol|1|||
48927074|NCT05019131|157566484|FG000|Overall Study|Lost to Follow-up|0|||
48927075|NCT05019131|157566485|FG001|Overall Study|Lost to Follow-up|3|||
48927076|NCT01777152|157566486|FG000|Overall Study|Withdrawal by Subject|22|||
48927077|NCT01777152|157566487|FG001|Overall Study|Withdrawal by Subject|16|||
48927078|NCT01777152|157566486|FG000|Overall Study|Lost to Follow-up|3|||
49176241|NCT04927065|158478437|FG004|Third Booster|Lost to Follow-up|0|||
49176242|NCT04927065|158478438|FG005|Third Booster|Lost to Follow-up|0|||
49176243|NCT04927065|158478439|FG006|Third Booster|Lost to Follow-up|0|||
49176244|NCT04927065|158478440|FG007|Third Booster|Lost to Follow-up|0|||
49176245|NCT04927065|158478441|FG008|Third Booster|Lost to Follow-up|0|||
49176246|NCT04927065|158478442|FG009|Third Booster|Lost to Follow-up|0|||
49176247|NCT04927065|158478443|FG010|Third Booster|Lost to Follow-up|0|||
48844085|NCT03990649|157271240|FG000|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
48844086|NCT03990649|157271241|FG001|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1|||
48844087|NCT03990649|157271242|FG002|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
48844088|NCT03990649|157271240|FG000|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
48844089|NCT03990649|157271241|FG001|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1|||
48844090|NCT03990649|157271242|FG002|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
48844091|NCT03990649|157271240|FG000|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2|||
48844092|NCT03990649|157271241|FG001|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
48844093|NCT03990649|157271242|FG002|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
48844094|NCT03990649|157271240|FG000|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
48844095|NCT03990649|157271241|FG001|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
48844096|NCT03990649|157271242|FG002|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0|||
48844097|NCT03990649|157271240|FG000|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
48844098|NCT03990649|157271241|FG001|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
48844099|NCT03990649|157271242|FG002|Part B: OL Extension Period (14 Weeks)|Adverse Event|1|||
48844100|NCT03990649|157271240|FG000|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
48844101|NCT03990649|157271241|FG001|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
48844102|NCT03990649|157271242|FG002|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2|||
48844103|NCT03990649|157271240|FG000|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
48844104|NCT03990649|157271241|FG001|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
48844105|NCT03990649|157271242|FG002|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1|||
48844106|NCT02383472|157271243|FG000|Overall Study|Withdrawal by Subject|1|||
48844107|NCT02383472|157271244|FG001|Overall Study|Withdrawal by Subject|1|||
48844108|NCT03050814|157271249|FG000|Overall Study|Screen failures|0|||
48844109|NCT03050814|157271250|FG001|Overall Study|Screen failures|0|||
48844110|NCT03050814|157271251|FG002|Overall Study|Screen failures|4|||
48844111|NCT00304031|157271252|FG000|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144|||
48844112|NCT00304031|157271253|FG001|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
48844113|NCT00304031|157271254|FG002|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
48844114|NCT00304031|157271252|FG000|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48|||
48844115|NCT00304031|157271253|FG001|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
48844116|NCT00304031|157271254|FG002|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
48927079|NCT01777152|157566487|FG001|Overall Study|Lost to Follow-up|5|||
49176248|NCT04927065|158478444|FG011|Third Booster|Lost to Follow-up|0|||
49176249|NCT04927065|158478445|FG012|Third Booster|Lost to Follow-up|0|||
49176250|NCT04927065|158478446|FG013|Third Booster|Lost to Follow-up|0|||
49176251|NCT04927065|158478447|FG014|Third Booster|Lost to Follow-up|0|||
49176252|NCT04927065|158478448|FG015|Third Booster|Lost to Follow-up|1|||
49176253|NCT04927065|158478433|FG000|Third Booster|Withdrawal by Subject|0|||
49176254|NCT04927065|158478434|FG001|Third Booster|Withdrawal by Subject|0|||
49176255|NCT04927065|158478435|FG002|Third Booster|Withdrawal by Subject|0|||
49176256|NCT04927065|158478436|FG003|Third Booster|Withdrawal by Subject|0|||
49176257|NCT04927065|158478437|FG004|Third Booster|Withdrawal by Subject|0|||
49176258|NCT04927065|158478438|FG005|Third Booster|Withdrawal by Subject|0|||
49176259|NCT04927065|158478439|FG006|Third Booster|Withdrawal by Subject|0|||
49176260|NCT04927065|158478440|FG007|Third Booster|Withdrawal by Subject|0|||
49176261|NCT04927065|158478441|FG008|Third Booster|Withdrawal by Subject|0|||
49176262|NCT04927065|158478442|FG009|Third Booster|Withdrawal by Subject|0|||
49176263|NCT04927065|158478443|FG010|Third Booster|Withdrawal by Subject|0|||
49176264|NCT04927065|158478444|FG011|Third Booster|Withdrawal by Subject|0|||
49176265|NCT04927065|158478445|FG012|Third Booster|Withdrawal by Subject|0|||
49176266|NCT04927065|158478446|FG013|Third Booster|Withdrawal by Subject|0|||
49176267|NCT04927065|158478447|FG014|Third Booster|Withdrawal by Subject|0|||
49176268|NCT04927065|158478448|FG015|Third Booster|Withdrawal by Subject|1|||
49176269|NCT03898180|158478449|FG000|Overall Study|Ongoing in Study|133|||
49176270|NCT03898180|158478450|FG001|Overall Study|Ongoing in Study|134|||
49176271|NCT03898180|158478449|FG000|Overall Study|Withdrawal by Subject|3|||
49176272|NCT03898180|158478450|FG001|Overall Study|Withdrawal by Subject|2|||
49176273|NCT03898180|158478449|FG000|Overall Study|Death|109|||
49176274|NCT03898180|158478450|FG001|Overall Study|Death|106|||
49176275|NCT04005716|158478455|FG000|Overall Study|Death|175|||
49176276|NCT04005716|158478456|FG001|Overall Study|Death|196|||
49176277|NCT04005716|158478455|FG000|Overall Study|Withdrawal by Subject|1|||
49176278|NCT04005716|158478456|FG001|Overall Study|Withdrawal by Subject|6|||
49176279|NCT04005716|158478455|FG000|Overall Study|Lost to Follow-up|2|||
49176280|NCT04005716|158478456|FG001|Overall Study|Lost to Follow-up|2|||
49176281|NCT03892616|158478457|FG000|Washout Period 2|Met discontinuation criterion|0|||
49176282|NCT03892616|158478458|FG001|Washout Period 2|Met discontinuation criterion|0|||
49176283|NCT03892616|158478459|FG002|Washout Period 2|Met discontinuation criterion|0|||
49176284|NCT03892616|158478460|FG003|Washout Period 2|Met discontinuation criterion|0|||
49176285|NCT03892616|158478461|FG004|Washout Period 2|Met discontinuation criterion|0|||
48927080|NCT01777152|157566486|FG000|Overall Study|Death|68|||
48844117|NCT00304031|157271252|FG000|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19|||
48844118|NCT00304031|157271253|FG001|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
48844119|NCT00304031|157271254|FG002|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
48844120|NCT00304031|157271252|FG000|Concomitant RT+TMZ (Pre-randomization)|Death|18|||
48844121|NCT00304031|157271253|FG001|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
48844122|NCT00304031|157271254|FG002|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
48844123|NCT00304031|157271252|FG000|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15|||
48844124|NCT00304031|157271253|FG001|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
48844125|NCT00304031|157271254|FG002|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
48844126|NCT00304031|157271252|FG000|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10|||
48844127|NCT00304031|157271253|FG001|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
48844128|NCT00304031|157271254|FG002|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
48844129|NCT00304031|157271252|FG000|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1|||
48844130|NCT00304031|157271253|FG001|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
48844131|NCT00304031|157271254|FG002|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
48844132|NCT00304031|157271252|FG000|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37|||
48844133|NCT00304031|157271253|FG001|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
48844134|NCT00304031|157271254|FG002|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
48844135|NCT00304031|157271252|FG000|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
48844136|NCT00304031|157271253|FG001|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
48844137|NCT00304031|157271254|FG002|Randomization to Adjuvant TMZ Arm|No follow-up collected|2|||
48844138|NCT02374463|157271257|FG000|Overall Study|Withdrawal by Subject|3|||
48844139|NCT02374463|157271258|FG001|Overall Study|Withdrawal by Subject|3|||
48844140|NCT02767765|157271260|FG000|Overall Study|Adverse Event|4|||
48844141|NCT02767765|157271260|FG000|Overall Study|Death|1|||
48844142|NCT02767765|157271260|FG000|Overall Study|Insufficient response|1|||
48844143|NCT02767765|157271260|FG000|Overall Study|Lost to Follow-up|2|||
48844144|NCT02767765|157271260|FG000|Overall Study|Investigator decision|1|||
48844145|NCT02767765|157271260|FG000|Overall Study|Non-Compliance|1|||
48844146|NCT02767765|157271260|FG000|Overall Study|Withdrawal by Subject|1|||
48844147|NCT00858117|157271261|FG000|Treatment on Study|Adverse Event|2|||
48844148|NCT00858117|157271261|FG000|Follow up for 5 Years|Death|4|||
48844149|NCT00858117|157271261|FG000|Follow up for 5 Years|No further data collected for study|9|||
48844150|NCT03578536|157271262|FG000|Overall Study|Lost to Follow-up|1|||
48844151|NCT00468052|157271263|FG000|Overall Study|Protocol Violation|7|||
48844152|NCT00468052|157271264|FG001|Overall Study|Protocol Violation|8|||
48844153|NCT00529789|157271265|FG000|Study Period II/III|Parent/Caregiver Decision|9|||
48844154|NCT00529789|157271265|FG000|Study Period II/III|Adverse Event|3|||
48844155|NCT00529789|157271265|FG000|Study Period II/III|Lack of Efficacy|2|||
48844156|NCT00529789|157271265|FG000|Study Period II/III|Withdrawal by Subject|1|||
48844157|NCT00529789|157271265|FG000|Study Period II/III|Protocol Violation|3|||
48844158|NCT00529789|157271265|FG000|Study Period II/III|Physician Decision|3|||
48844159|NCT00529789|157271265|FG000|Study Period II/III|Lost to Follow-up|3|||
48844160|NCT00529789|157271265|FG000|Study Period IV|Parent/Caregiver Decision|1|||
48844161|NCT00529789|157271265|FG000|Study Period IV|Adverse Event|1|||
48844162|NCT00529789|157271265|FG000|Study Period IV|Lack of Efficacy|1|||
48844163|NCT00529789|157271265|FG000|Study Period IV|Lost to Follow-up|3|||
48844164|NCT04788641|157271266|FG000|Treatment Period 2 (4 Days)|Protocol Violation|0|||
48844165|NCT04788641|157271267|FG001|Treatment Period 2 (4 Days)|Protocol Violation|0|||
48844166|NCT04788641|157271268|FG002|Treatment Period 2 (4 Days)|Protocol Violation|1|||
48844167|NCT04788641|157271269|FG003|Treatment Period 2 (4 Days)|Protocol Violation|0|||
48844168|NCT04788641|157271266|FG000|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|1|||
48844169|NCT04788641|157271267|FG001|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
48844170|NCT04788641|157271268|FG002|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
48844171|NCT04788641|157271269|FG003|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
49176286|NCT03892616|158478462|FG005|Washout Period 2|Met discontinuation criterion|0|||
49176287|NCT03892616|158478463|FG006|Washout Period 2|Met discontinuation criterion|0|||
49176288|NCT03892616|158478464|FG007|Washout Period 2|Met discontinuation criterion|0|||
49176289|NCT03892616|158478465|FG008|Washout Period 2|Met discontinuation criterion|1|||
49176290|NCT03892616|158478466|FG009|Washout Period 2|Met discontinuation criterion|0|||
49176291|NCT03892616|158478467|FG010|Washout Period 2|Met discontinuation criterion|0|||
49176292|NCT03892616|158478468|FG011|Washout Period 2|Met discontinuation criterion|0|||
48844172|NCT04788641|157271266|FG000|Treatment Period 2 (4 Days)|Adverse Event|0|||
48844173|NCT04788641|157271267|FG001|Treatment Period 2 (4 Days)|Adverse Event|0|||
48844174|NCT04788641|157271268|FG002|Treatment Period 2 (4 Days)|Adverse Event|1|||
48844175|NCT04788641|157271269|FG003|Treatment Period 2 (4 Days)|Adverse Event|0|||
48927081|NCT01777152|157566487|FG001|Overall Study|Death|89|||
48927082|NCT01777152|157566486|FG000|Overall Study|Not eligible, no study drug received|1|||
48927083|NCT01777152|157566487|FG001|Overall Study|Not eligible, no study drug received|0|||
48927084|NCT01777152|157566486|FG000|Overall Study|Change of diagnosis|1|||
48927085|NCT01777152|157566487|FG001|Overall Study|Change of diagnosis|0|||
48927086|NCT02513329|157566488|FG000|Overall Study|Lost to Follow-up|5|||
48927087|NCT02513329|157566489|FG001|Overall Study|Lost to Follow-up|2|||
48927088|NCT01496885|157566490|FG000|Overall Study|Lost to Follow-up|13|||
48927089|NCT01496885|157566490|FG000|Overall Study|Withdrawal by Subject|7|||
48927090|NCT01496885|157566490|FG000|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2|||
48927091|NCT01496885|157566490|FG000|Overall Study|Death|1|||
48927092|NCT03273166|157566491|FG000|Overall Study|Withdrawn prior to Completion|31|||
48927093|NCT00168831|157566494|FG000|Overall Study|Adverse Event|36|||
48927094|NCT00168831|157566495|FG001|Overall Study|Adverse Event|47|||
48927095|NCT00168831|157566496|FG002|Overall Study|Adverse Event|74|||
48927096|NCT00168831|157566494|FG000|Overall Study|Lost to Follow-up|5|||
48927097|NCT00168831|157566495|FG001|Overall Study|Lost to Follow-up|6|||
48927098|NCT00168831|157566496|FG002|Overall Study|Lost to Follow-up|4|||
48927099|NCT00168831|157566494|FG000|Overall Study|Withdrawal by Subject|7|||
48927100|NCT00168831|157566495|FG001|Overall Study|Withdrawal by Subject|14|||
49176293|NCT00378105|158478469|FG000|Overall Study|Adverse Event|3|||
49176294|NCT00378105|158478470|FG001|Overall Study|Adverse Event|1|||
49176295|NCT00378105|158478469|FG000|Overall Study|Withdrawal by Subject|3|||
48927101|NCT00168831|157566496|FG002|Overall Study|Withdrawal by Subject|19|||
48927102|NCT00168831|157566494|FG000|Overall Study|Protocol Violation|6|||
48927103|NCT00168831|157566495|FG001|Overall Study|Protocol Violation|11|||
48927104|NCT00168831|157566496|FG002|Overall Study|Protocol Violation|11|||
48927105|NCT00168831|157566494|FG000|Overall Study|Other|6|||
48927106|NCT00168831|157566495|FG001|Overall Study|Other|3|||
48927107|NCT00168831|157566496|FG002|Overall Study|Other|6|||
48927108|NCT02450487|157566497|FG000|Overall Study|Lost to Follow-up|3|||
49176296|NCT00378105|158478470|FG001|Overall Study|Withdrawal by Subject|3|||
49176297|NCT00378105|158478469|FG000|Overall Study|Death|1|||
49176298|NCT00378105|158478470|FG001|Overall Study|Death|0|||
49176299|NCT00378105|158478469|FG000|Overall Study|Going to transplant|7|||
49176300|NCT00378105|158478470|FG001|Overall Study|Going to transplant|8|||
49176301|NCT00378105|158478469|FG000|Overall Study|Progressive disease|3|||
49176302|NCT00378105|158478470|FG001|Overall Study|Progressive disease|3|||
49176303|NCT00378105|158478469|FG000|Overall Study|remain on study|3|||
49176304|NCT00378105|158478470|FG001|Overall Study|remain on study|11|||
49176305|NCT00378105|158478469|FG000|Overall Study|Physician Decision|0|||
49176306|NCT00378105|158478470|FG001|Overall Study|Physician Decision|2|||
49176307|NCT00378105|158478469|FG000|Overall Study|Going non-protocol therapy|0|||
49176308|NCT00378105|158478470|FG001|Overall Study|Going non-protocol therapy|1|||
49176309|NCT00378105|158478469|FG000|Overall Study|necessity to increase lenalidomide dose|0|||
49176310|NCT00378105|158478470|FG001|Overall Study|necessity to increase lenalidomide dose|1|||
49176311|NCT00334815|158478473|FG000|Overall Study|Adverse Event|3|||
49176312|NCT00334815|158478474|FG001|Overall Study|Adverse Event|2|||
49176313|NCT00334815|158478473|FG000|Overall Study|Death|0|||
49176314|NCT00334815|158478474|FG001|Overall Study|Death|2|||
49176315|NCT00334815|158478473|FG000|Overall Study|Progression|1|||
49176316|NCT00334815|158478474|FG001|Overall Study|Progression|0|||
49176317|NCT00334815|158478473|FG000|Overall Study|ineligible|1|||
49176318|NCT00334815|158478474|FG001|Overall Study|ineligible|1|||
49176319|NCT00334815|158478473|FG000|Overall Study|patient refused treatment|0|||
49176320|NCT00334815|158478474|FG001|Overall Study|patient refused treatment|1|||
49176321|NCT00334815|158478473|FG000|Overall Study|Physician Decision|2|||
49176322|NCT00334815|158478474|FG001|Overall Study|Physician Decision|4|||
49176323|NCT02152982|158478476|FG000|Overall Study|Ineligible|4|||
49176324|NCT02152982|158478477|FG001|Overall Study|Ineligible|4|||
49176325|NCT02152982|158478476|FG000|Overall Study|Did not start treatment|12|||
49176326|NCT02152982|158478477|FG001|Overall Study|Did not start treatment|6|||
49176327|NCT01169337|158478478|FG000|Overall Study|Lack of Efficacy|5|||
49176328|NCT01169337|158478479|FG001|Overall Study|Lack of Efficacy|7|||
48927109|NCT04987320|157566498|FG000|Overall Study|Withdrawal by Subject|0|||
48927110|NCT04987320|157566499|FG001|Overall Study|Withdrawal by Subject|1|||
48927111|NCT05533632|157566501|FG000|Overall Study|Participant no longer wants to participate in study, has other priorities|1|||
48927112|NCT05533632|157566501|FG000|Overall Study|Participant moved to another city and will not come back to Santiago|1|||
48927113|NCT05533632|157566501|FG000|Overall Study|Lost to Follow-up|1|||
49176329|NCT01169337|158478480|FG002|Overall Study|Lack of Efficacy|0|||
49176330|NCT01169337|158478478|FG000|Overall Study|Adverse Event|12|||
49176331|NCT01169337|158478479|FG001|Overall Study|Adverse Event|18|||
49176332|NCT01169337|158478480|FG002|Overall Study|Adverse Event|0|||
49176333|NCT01169337|158478478|FG000|Overall Study|Death|2|||
49176334|NCT01169337|158478479|FG001|Overall Study|Death|0|||
49176335|NCT01169337|158478480|FG002|Overall Study|Death|0|||
49176336|NCT01169337|158478478|FG000|Overall Study|Withdrawal by Subject|11|||
49176337|NCT01169337|158478479|FG001|Overall Study|Withdrawal by Subject|11|||
49176338|NCT01169337|158478480|FG002|Overall Study|Withdrawal by Subject|6|||
49176339|NCT01169337|158478478|FG000|Overall Study|Noncompliance|2|||
49176340|NCT01169337|158478479|FG001|Overall Study|Noncompliance|0|||
49176341|NCT01169337|158478480|FG002|Overall Study|Noncompliance|0|||
49176342|NCT01169337|158478478|FG000|Overall Study|Other complicating disease|1|||
49176343|NCT01169337|158478479|FG001|Overall Study|Other complicating disease|1|||
49176344|NCT01169337|158478480|FG002|Overall Study|Other complicating disease|0|||
49176345|NCT01169337|158478478|FG000|Overall Study|Physician Decision|1|||
49176346|NCT01169337|158478479|FG001|Overall Study|Physician Decision|5|||
49176347|NCT01169337|158478480|FG002|Overall Study|Physician Decision|0|||
49176348|NCT01169337|158478478|FG000|Overall Study|Alternative therapy|0|||
49176349|NCT01169337|158478479|FG001|Overall Study|Alternative therapy|2|||
49176350|NCT01169337|158478480|FG002|Overall Study|Alternative therapy|0|||
49176351|NCT01169337|158478478|FG000|Overall Study|Changed hospital|0|||
49176352|NCT01169337|158478479|FG001|Overall Study|Changed hospital|1|||
49176353|NCT01169337|158478480|FG002|Overall Study|Changed hospital|0|||
48844176|NCT02204982|157271270|FG000|Overall Study|Patient ineligible-medical monitor|1|||
48844177|NCT02204982|157271271|FG001|Overall Study|Patient ineligible-medical monitor|0|||
48844178|NCT02204982|157271270|FG000|Overall Study|Withdrawal by Subject|1|||
49176354|NCT01169337|158478478|FG000|Overall Study|Never started treatment|0|||
49176355|NCT01169337|158478479|FG001|Overall Study|Never started treatment|2|||
49176356|NCT01169337|158478480|FG002|Overall Study|Never started treatment|0|||
49176357|NCT01169337|158478478|FG000|Overall Study|Reason not reported|1|||
49176358|NCT01169337|158478479|FG001|Overall Study|Reason not reported|0|||
49176359|NCT01169337|158478480|FG002|Overall Study|Reason not reported|0|||
49176360|NCT01169337|158478478|FG000|Overall Study|Continuing lenalidomide|9|||
49176361|NCT01169337|158478479|FG001|Overall Study|Continuing lenalidomide|43|||
49176362|NCT01169337|158478480|FG002|Overall Study|Continuing lenalidomide|0|||
48844179|NCT02204982|157271271|FG001|Overall Study|Withdrawal by Subject|0|||
48844180|NCT02204982|157271270|FG000|Overall Study|Adverse Event|1|||
48844181|NCT02204982|157271271|FG001|Overall Study|Adverse Event|0|||
48844182|NCT02204982|157271270|FG000|Overall Study|Adverse Event and Investigator decision|1|||
48844183|NCT02204982|157271271|FG001|Overall Study|Adverse Event and Investigator decision|0|||
48844184|NCT02204982|157271270|FG000|Overall Study|Physician Decision|0|||
48844185|NCT02204982|157271271|FG001|Overall Study|Physician Decision|2|||
48844186|NCT02204982|157271270|FG000|Overall Study|Protocol-Specified Disease Progression|0|||
48844187|NCT02204982|157271271|FG001|Overall Study|Protocol-Specified Disease Progression|4|||
48844188|NCT02204982|157271270|FG000|Overall Study|Termination of Study bySponsor|0|||
48844189|NCT02204982|157271271|FG001|Overall Study|Termination of Study bySponsor|1|||
48844190|NCT01546753|157271272|FG000|Overall Study|anxiety|1|||
48844191|NCT01546753|157271273|FG001|Overall Study|anxiety|1|||
48844192|NCT01546753|157271272|FG000|Overall Study|diagnosis of ulcerative colitis|1|||
48844193|NCT01546753|157271273|FG001|Overall Study|diagnosis of ulcerative colitis|0|||
48844194|NCT01837966|157271274|FG000|Overall Study|Withdrawal by Subject|2|||
48844195|NCT01837966|157271275|FG001|Overall Study|Withdrawal by Subject|1|||
48844196|NCT01102231|157271276|FG000|Overall Study|Protocol Violation|3|||
48844197|NCT01102231|157271276|FG000|Overall Study|Lack of Efficacy|2|||
48844198|NCT01102231|157271276|FG000|Overall Study|Death|2|||
48844199|NCT01102231|157271276|FG000|Overall Study|Adverse Event|3|||
48844200|NCT01102231|157271276|FG000|Overall Study|Withdrawal by Subject|1|||
48844201|NCT01102231|157271276|FG000|Overall Study|Did not received the treatment|4|||
48844202|NCT02538107|157271277|FG000|Overall Study|Did not receive any Mircera dose|11|||
48844203|NCT02538107|157271277|FG000|Overall Study|Missing|5|||
48844204|NCT02538107|157271277|FG000|Overall Study|Necessity of dialysis|20|||
48844205|NCT02538107|157271277|FG000|Overall Study|Administration of other ESA|11|||
48844206|NCT02538107|157271277|FG000|Overall Study|No further treatment necessary|18|||
48844207|NCT02538107|157271277|FG000|Overall Study|Withdrawal by Subject|17|||
48844208|NCT02538107|157271277|FG000|Overall Study|Death|4|||
48844209|NCT02538107|157271277|FG000|Overall Study|Administrative reason|5|||
48844210|NCT02538107|157271277|FG000|Overall Study|Adverse Event|4|||
48844211|NCT02538107|157271277|FG000|Overall Study|Surgery|1|||
48844212|NCT02538107|157271277|FG000|Overall Study|Other|7|||
48844213|NCT02538107|157271277|FG000|Overall Study|Not recorded|7|||
49176363|NCT02076113|158478481|FG000|Overall Study|Lost to Follow-up|4|||
49176364|NCT02076113|158478482|FG001|Overall Study|Lost to Follow-up|1|||
49176365|NCT02076113|158478481|FG000|Overall Study|Withdrawal by Subject|2|||
49176366|NCT02076113|158478482|FG001|Overall Study|Withdrawal by Subject|3|||
49176367|NCT02076113|158478481|FG000|Overall Study|Death|1|||
49176368|NCT02076113|158478482|FG001|Overall Study|Death|3|||
48927114|NCT05533632|157566501|FG000|Overall Study|Withdrawal by Subject|4|||
48927115|NCT05533632|157566501|FG000|Overall Study|Adverse Event|4|||
48927116|NCT00584194|157566502|FG000|Overall Study|Other|135|||
48927117|NCT01340209|157566504|FG000|Overall Study|Adverse Event|1|||
48927118|NCT01340209|157566505|FG001|Overall Study|Adverse Event|1|||
48927119|NCT01340209|157566506|FG002|Overall Study|Adverse Event|2|||
48927120|NCT01340209|157566504|FG000|Overall Study|Protocol Violation|1|||
48927121|NCT01340209|157566505|FG001|Overall Study|Protocol Violation|2|||
48927122|NCT01340209|157566506|FG002|Overall Study|Protocol Violation|1|||
48927123|NCT01340209|157566504|FG000|Overall Study|Withdrawal by Subject|0|||
48927124|NCT01340209|157566505|FG001|Overall Study|Withdrawal by Subject|0|||
48927125|NCT01340209|157566506|FG002|Overall Study|Withdrawal by Subject|1|||
48927126|NCT01340209|157566504|FG000|Overall Study|Other reason not defined above|3|||
48927127|NCT01340209|157566505|FG001|Overall Study|Other reason not defined above|5|||
48927128|NCT01340209|157566506|FG002|Overall Study|Other reason not defined above|4|||
48927129|NCT01903837|157566510|FG000|Part A|Withdrawal by Subject|4|||
48927130|NCT01903837|157566511|FG001|Part A|Withdrawal by Subject|9|||
48927131|NCT01903837|157566512|FG002|Part A|Withdrawal by Subject|8|||
48927132|NCT01903837|157566513|FG003|Part A|Withdrawal by Subject|5|||
48927133|NCT01903837|157566510|FG000|Part A|Adverse Event|3|||
48927134|NCT01903837|157566511|FG001|Part A|Adverse Event|6|||
48927135|NCT01903837|157566512|FG002|Part A|Adverse Event|9|||
48927136|NCT01903837|157566513|FG003|Part A|Adverse Event|6|||
48927137|NCT01903837|157566510|FG000|Part A|Lost to Follow-up|9|||
48927138|NCT01903837|157566511|FG001|Part A|Lost to Follow-up|7|||
48927139|NCT01903837|157566512|FG002|Part A|Lost to Follow-up|7|||
48927140|NCT01903837|157566513|FG003|Part A|Lost to Follow-up|2|||
48927141|NCT01903837|157566510|FG000|Part A|Non-compliance with study drug|1|||
48927142|NCT01903837|157566511|FG001|Part A|Non-compliance with study drug|4|||
48927143|NCT01903837|157566512|FG002|Part A|Non-compliance with study drug|4|||
48927144|NCT01903837|157566513|FG003|Part A|Non-compliance with study drug|0|||
48927145|NCT01903837|157566510|FG000|Part A|Physician Decision|1|||
48927146|NCT01903837|157566511|FG001|Part A|Physician Decision|1|||
48927147|NCT01903837|157566512|FG002|Part A|Physician Decision|0|||
48927148|NCT01903837|157566513|FG003|Part A|Physician Decision|0|||
49176369|NCT03836209|158478488|FG000|Overall Study|Adverse Event|5|||
49176370|NCT03836209|158478489|FG001|Overall Study|Adverse Event|2|||
49176371|NCT03836209|158478488|FG000|Overall Study|Death|4|||
49176372|NCT03836209|158478489|FG001|Overall Study|Death|1|||
48927149|NCT01903837|157566510|FG000|Part A|Protocol Violation|1|||
48927150|NCT01903837|157566511|FG001|Part A|Protocol Violation|1|||
48927151|NCT01903837|157566512|FG002|Part A|Protocol Violation|0|||
48927152|NCT01903837|157566513|FG003|Part A|Protocol Violation|0|||
48927153|NCT01903837|157566510|FG000|Part B|Lost to Follow-up|0|||
48927154|NCT01903837|157566511|FG001|Part B|Lost to Follow-up|3|||
49176373|NCT03836209|158478488|FG000|Overall Study|Lack of Efficacy|7|||
49176374|NCT03836209|158478489|FG001|Overall Study|Lack of Efficacy|10|||
49176375|NCT03836209|158478488|FG000|Overall Study|Physician Decision|7|||
49176376|NCT03836209|158478489|FG001|Overall Study|Physician Decision|11|||
49176377|NCT03836209|158478488|FG000|Overall Study|Protocol Violation|0|||
49176378|NCT03836209|158478489|FG001|Overall Study|Protocol Violation|3|||
49176379|NCT03836209|158478488|FG000|Overall Study|Withdrawal by Subject|2|||
49176380|NCT03836209|158478489|FG001|Overall Study|Withdrawal by Subject|10|||
49176381|NCT03836209|158478488|FG000|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|55|||
49176382|NCT03836209|158478489|FG001|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|44|||
49176383|NCT02306161|158478490|FG000|Overall Study|Death|1|||
49176384|NCT02306161|158478491|FG001|Overall Study|Death|3|||
49176385|NCT02306161|158478490|FG000|Overall Study|Lack of Efficacy|20|||
49176386|NCT02306161|158478491|FG001|Overall Study|Lack of Efficacy|43|||
49176387|NCT02306161|158478490|FG000|Overall Study|Physician Decision|30|||
49176388|NCT02306161|158478491|FG001|Overall Study|Physician Decision|18|||
49176389|NCT02306161|158478490|FG000|Overall Study|Withdrawal by Subject|4|||
49176390|NCT02306161|158478491|FG001|Overall Study|Withdrawal by Subject|0|||
49176391|NCT02306161|158478490|FG000|Overall Study|Ineligible|9|||
49176392|NCT02306161|158478491|FG001|Overall Study|Ineligible|5|||
49176393|NCT05197049|158478494|FG000|Overall Study|Death|0|||
49176394|NCT05197049|158478495|FG001|Overall Study|Death|1|||
49176395|NCT05197049|158478496|FG002|Overall Study|Death|0|||
49176396|NCT05197049|158478494|FG000|Overall Study|Lost to Follow-up|3|||
49176397|NCT05197049|158478495|FG001|Overall Study|Lost to Follow-up|1|||
49176398|NCT05197049|158478496|FG002|Overall Study|Lost to Follow-up|0|||
48927155|NCT01903837|157566512|FG002|Part B|Lost to Follow-up|3|||
48927156|NCT01903837|157566513|FG003|Part B|Lost to Follow-up|4|||
48927157|NCT01903837|157566510|FG000|Part B|Withdrawal by Subject|1|||
48927158|NCT01903837|157566511|FG001|Part B|Withdrawal by Subject|2|||
48927159|NCT01903837|157566512|FG002|Part B|Withdrawal by Subject|0|||
48927160|NCT01903837|157566513|FG003|Part B|Withdrawal by Subject|3|||
48927161|NCT01903837|157566510|FG000|Part B|Adverse Event|3|||
48927162|NCT01903837|157566511|FG001|Part B|Adverse Event|0|||
48927163|NCT01903837|157566512|FG002|Part B|Adverse Event|2|||
48927164|NCT01903837|157566513|FG003|Part B|Adverse Event|0|||
49176399|NCT05197049|158478494|FG000|Overall Study|Withdrawal by Subject|15|||
49176400|NCT05197049|158478495|FG001|Overall Study|Withdrawal by Subject|3|||
48844214|NCT00546754|157271278|FG000|Overall Study|Serious Adverse Event|1|||
49176401|NCT05197049|158478496|FG002|Overall Study|Withdrawal by Subject|1|||
49176402|NCT05197049|158478494|FG000|Overall Study|GCP non-compliance|1|||
49176403|NCT05197049|158478495|FG001|Overall Study|GCP non-compliance|2|||
49176404|NCT05197049|158478496|FG002|Overall Study|GCP non-compliance|0|||
49176405|NCT02921230|158478497|FG000|Overall Study|Withdrawal by Subject|20|||
49176406|NCT02921230|158478498|FG001|Overall Study|Withdrawal by Subject|8|||
49176407|NCT02921230|158478497|FG000|Overall Study|Death|12|||
49176408|NCT02921230|158478498|FG001|Overall Study|Death|3|||
49176409|NCT02921230|158478497|FG000|Overall Study|Protocol Violation|17|||
49176410|NCT02921230|158478498|FG001|Overall Study|Protocol Violation|6|||
49176411|NCT02921230|158478497|FG000|Overall Study|Early completion|5|||
49176412|NCT02921230|158478498|FG001|Overall Study|Early completion|1|||
49176413|NCT02921230|158478497|FG000|Overall Study|Pending data entry|1|||
49176414|NCT02921230|158478498|FG001|Overall Study|Pending data entry|0|||
49176415|NCT04130438|158478499|FG000|Overall Study|Lost to Follow-up|0|||
49176416|NCT04130438|158478500|FG001|Overall Study|Lost to Follow-up|0|||
49176417|NCT04130438|158478501|FG002|Overall Study|Lost to Follow-up|1|||
49176418|NCT05155306|158478502|FG000|Wash-out Period 1 to 2|Adverse Event|0|||
49176419|NCT05155306|158478503|FG001|Wash-out Period 1 to 2|Adverse Event|0|||
49176420|NCT05155306|158478504|FG002|Wash-out Period 1 to 2|Adverse Event|0|||
49176421|NCT05155306|158478505|FG003|Wash-out Period 1 to 2|Adverse Event|2|||
49176422|NCT05155306|158478502|FG000|Wash-out Period 3 to 4|Temporal availability|3|||
49176423|NCT05155306|158478503|FG001|Wash-out Period 3 to 4|Temporal availability|1|||
49176424|NCT05155306|158478504|FG002|Wash-out Period 3 to 4|Temporal availability|1|||
49176425|NCT05155306|158478505|FG003|Wash-out Period 3 to 4|Temporal availability|1|||
49176426|NCT04280081|158478506|FG000|Overall Study|Adverse Event|4|||
49176427|NCT04280081|158478506|FG000|Overall Study|Death|2|||
49176428|NCT04280081|158478506|FG000|Overall Study|Progressive Disease|6|||
49176429|NCT03396926|158480367|FG000|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|0|||
49176430|NCT03396926|158480368|FG001|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|4|||
49176431|NCT02476916|158480369|FG000|Core Period|Adverse Event|2|||
48844215|NCT00546754|157271279|FG001|Overall Study|Serious Adverse Event|1|||
48844216|NCT00546754|157271278|FG000|Overall Study|Adverse Event|11|||
48844217|NCT00546754|157271279|FG001|Overall Study|Adverse Event|16|||
48844218|NCT00546754|157271278|FG000|Overall Study|Lack of Efficacy|1|||
48844219|NCT00546754|157271279|FG001|Overall Study|Lack of Efficacy|1|||
49176432|NCT02476916|158480370|FG001|Core Period|Adverse Event|2|||
49176433|NCT02476916|158480369|FG000|Core Period|Investigator decision|1|||
49176434|NCT02476916|158480370|FG001|Core Period|Investigator decision|1|||
49176435|NCT02476916|158480369|FG000|Core Period|Withdrawal by Subject|3|||
48844220|NCT00546754|157271278|FG000|Overall Study|Lost to Follow-up|9|||
48844221|NCT00546754|157271279|FG001|Overall Study|Lost to Follow-up|15|||
48844222|NCT00546754|157271278|FG000|Overall Study|Protocol Violation|3|||
48844223|NCT00546754|157271279|FG001|Overall Study|Protocol Violation|0|||
48844224|NCT00546754|157271278|FG000|Overall Study|Withdrawal by Subject|6|||
48844225|NCT00546754|157271279|FG001|Overall Study|Withdrawal by Subject|7|||
48844226|NCT00546754|157271278|FG000|Overall Study|Dyspnea|1|||
49176436|NCT02476916|158480370|FG001|Core Period|Withdrawal by Subject|0|||
49176437|NCT02476916|158480369|FG000|Extension Period|Prematurely Discontinued Treatment|6|||
49176438|NCT02476916|158480370|FG001|Extension Period|Prematurely Discontinued Treatment|1|||
49176439|NCT02476916|158480369|FG000|Extension Period|On Treatment|12|||
49176440|NCT02476916|158480370|FG001|Extension Period|On Treatment|17|||
49176441|NCT04322643|158480375|FG000|Overall Study|Study halted prematurely therefore treatment halted.|4|||
49176442|NCT03904693|158480376|FG000|Overall Study|Death|0|||
49176443|NCT03904693|158480377|FG001|Overall Study|Death|0|||
49176444|NCT03904693|158480378|FG002|Overall Study|Death|3|||
49176445|NCT03904693|158480376|FG000|Overall Study|Physician Decision|0|||
49176446|NCT03904693|158480377|FG001|Overall Study|Physician Decision|0|||
49176447|NCT03904693|158480378|FG002|Overall Study|Physician Decision|2|||
49176448|NCT03904693|158480376|FG000|Overall Study|Withdrawal by Subject|0|||
49176449|NCT03904693|158480377|FG001|Overall Study|Withdrawal by Subject|1|||
49176450|NCT03904693|158480378|FG002|Overall Study|Withdrawal by Subject|4|||
49176451|NCT03232073|158480379|FG000|Overall Study|Death|1|||
49176452|NCT03232073|158480380|FG001|Overall Study|Death|0|||
49176453|NCT03232073|158480379|FG000|Overall Study|Adverse Event|7|||
49176454|NCT03232073|158480380|FG001|Overall Study|Adverse Event|12|||
49176455|NCT03232073|158480379|FG000|Overall Study|Lost to Follow-up|6|||
49176456|NCT03232073|158480380|FG001|Overall Study|Lost to Follow-up|6|||
49176457|NCT03232073|158480379|FG000|Overall Study|Lack of Efficacy|10|||
49176458|NCT03232073|158480380|FG001|Overall Study|Lack of Efficacy|8|||
49176459|NCT03232073|158480379|FG000|Overall Study|Physician Decision|9|||
49176460|NCT03232073|158480380|FG001|Overall Study|Physician Decision|2|||
49176461|NCT03232073|158480379|FG000|Overall Study|Withdrawal by Subject|54|||
49176462|NCT03232073|158480380|FG001|Overall Study|Withdrawal by Subject|39|||
48844227|NCT00546754|157271279|FG001|Overall Study|Dyspnea|0|||
48844228|NCT00546754|157271278|FG000|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1|||
48844229|NCT00546754|157271279|FG001|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0|||
48844230|NCT00546754|157271278|FG000|Overall Study|Hip Replacement|1|||
48844231|NCT00546754|157271279|FG001|Overall Study|Hip Replacement|0|||
48844232|NCT00546754|157271278|FG000|Overall Study|Suicide|1|||
48844233|NCT00546754|157271279|FG001|Overall Study|Suicide|0|||
48844234|NCT00546754|157271278|FG000|Overall Study|Missing Cooperation|1|||
48844235|NCT00546754|157271279|FG001|Overall Study|Missing Cooperation|0|||
48844236|NCT00546754|157271278|FG000|Overall Study|Elevated Creatinine and Potassium levels|0|||
48844237|NCT00546754|157271279|FG001|Overall Study|Elevated Creatinine and Potassium levels|1|||
48844238|NCT00546754|157271278|FG000|Overall Study|Patient's Decision|0|||
48844239|NCT00546754|157271279|FG001|Overall Study|Patient's Decision|1|||
48844240|NCT00546754|157271278|FG000|Overall Study|Missing|14|||
48844241|NCT00546754|157271279|FG001|Overall Study|Missing|7|||
48844242|NCT03485950|157271290|FG000|Overall Study|Adverse Event|1|||
48844243|NCT03485950|157271291|FG001|Overall Study|Adverse Event|0|||
48844244|NCT03485950|157271290|FG000|Overall Study|Death|3|||
48844245|NCT03485950|157271291|FG001|Overall Study|Death|2|||
48844246|NCT03485950|157271290|FG000|Overall Study|Withdrawal by Subject|3|||
48844247|NCT03485950|157271291|FG001|Overall Study|Withdrawal by Subject|0|||
48844248|NCT00988858|157271293|FG000|Overall Study|Adverse Event|7|||
48844249|NCT00988858|157271293|FG000|Overall Study|Death|1|||
48844250|NCT00988858|157271293|FG000|Overall Study|Physician Decision|1|||
48844251|NCT00988858|157271293|FG000|Overall Study|Sponsor Decision|1|||
48844252|NCT00609336|157271294|FG000|Overall Study|Protocol Violation|3|||
48844253|NCT00609336|157271294|FG000|Overall Study|Death|1|||
48844254|NCT00609336|157271294|FG000|Overall Study|LA or Met at Surgery|9|||
48844255|NCT02574455|157271295|FG000|Overall Study|Death|197|||
48844256|NCT02574455|157271296|FG001|Overall Study|Death|210|||
48844257|NCT02574455|157271295|FG000|Overall Study|Withdrawal of Consent|11|||
48844258|NCT02574455|157271296|FG001|Overall Study|Withdrawal of Consent|28|||
48844259|NCT02574455|157271295|FG000|Overall Study|Lost to Follow-up|4|||
48844260|NCT02574455|157271296|FG001|Overall Study|Lost to Follow-up|4|||
48844261|NCT02574455|157271295|FG000|Overall Study|Sponsor's Decision|55|||
48844262|NCT02574455|157271296|FG001|Overall Study|Sponsor's Decision|20|||
48844263|NCT02965846|157271299|FG000|Overall Study|Lost to Follow-up|1|||
48844264|NCT02965846|157271300|FG001|Overall Study|Lost to Follow-up|0|||
48844265|NCT02965846|157271301|FG002|Overall Study|Lost to Follow-up|0|||
48844266|NCT02965846|157271299|FG000|Overall Study|Withdrawal by Subject|0|||
48844267|NCT02965846|157271300|FG001|Overall Study|Withdrawal by Subject|1|||
48844268|NCT02965846|157271301|FG002|Overall Study|Withdrawal by Subject|0|||
48844269|NCT02965846|157271299|FG000|Overall Study|Study Terminated By Sponsor|4|||
48844270|NCT02965846|157271300|FG001|Overall Study|Study Terminated By Sponsor|4|||
48844271|NCT02965846|157271301|FG002|Overall Study|Study Terminated By Sponsor|0|||
48927165|NCT01903837|157566510|FG000|Part B|Non-compliance with study drug|2|||
48844272|NCT02965846|157271299|FG000|Overall Study|Participants not randomized|0|||
48844273|NCT02965846|157271300|FG001|Overall Study|Participants not randomized|0|||
48844274|NCT02965846|157271301|FG002|Overall Study|Participants not randomized|33|||
48844275|NCT01388361|157271302|FG000|Overall Study|Adverse Event|0|||
48844276|NCT01388361|157271303|FG001|Overall Study|Adverse Event|5|||
48844277|NCT01388361|157271304|FG002|Overall Study|Adverse Event|1|||
48844278|NCT01388361|157271302|FG000|Overall Study|Protocol Violation|0|||
48844279|NCT01388361|157271303|FG001|Overall Study|Protocol Violation|0|||
49176463|NCT04055090|158480384|FG000|Overall Study|screen failure|1|||
49176464|NCT04055090|158480385|FG001|Overall Study|screen failure|0|||
49176465|NCT04055090|158480384|FG000|Overall Study|Withdrawal by Subject|1|||
49176466|NCT04055090|158480385|FG001|Overall Study|Withdrawal by Subject|0|||
49176467|NCT05071807|158480386|FG000|Overall Study|Withdrawal by Subject|4|||
49176468|NCT05071807|158480387|FG001|Overall Study|Withdrawal by Subject|0|||
49176469|NCT05071807|158480386|FG000|Overall Study|Unrelated medical issues|3|||
49176470|NCT05071807|158480387|FG001|Overall Study|Unrelated medical issues|0|||
49176471|NCT05071807|158480386|FG000|Overall Study|Relocated|0|||
49176472|NCT05071807|158480387|FG001|Overall Study|Relocated|1|||
49176473|NCT03936322|158480388|FG000|Overall Study|Lost to Follow-up|1|||
49176474|NCT03936322|158480388|FG000|Overall Study|Infant Death after delivery; therefore, no further follow up occurred|1|||
49176475|NCT04033445|158480389|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|2|||
49176476|NCT04033445|158480390|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|1|||
49176477|NCT04033445|158480391|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
49176478|NCT04033445|158480392|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
49176479|NCT04033445|158480393|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
49176480|NCT04033445|158480394|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|9|||
49176481|NCT04033445|158480395|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|7|||
49176482|NCT04033445|158480396|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
49176483|NCT04033445|158480397|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
49176484|NCT04033445|158480398|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
49176485|NCT04033445|158480399|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
49176486|NCT04033445|158480400|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
49176487|NCT04033445|158480401|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
49176488|NCT04033445|158480402|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
49176489|NCT04033445|158480389|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
49176490|NCT04033445|158480390|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
49176491|NCT04033445|158480391|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
49176492|NCT04033445|158480392|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
49176493|NCT04033445|158480393|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
49176494|NCT04033445|158480394|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
49176495|NCT04033445|158480395|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
49176496|NCT04033445|158480396|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
49176497|NCT04033445|158480397|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
49176498|NCT04033445|158480398|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
49176499|NCT04033445|158480399|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
49176500|NCT04033445|158480400|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
49176501|NCT04033445|158480401|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
49176502|NCT04033445|158480402|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
49176503|NCT04033445|158480389|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
49176504|NCT04033445|158480390|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
49176505|NCT04033445|158480391|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
49176506|NCT04033445|158480392|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
49176507|NCT04033445|158480393|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
49176508|NCT04033445|158480394|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
49176509|NCT04033445|158480395|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
49176510|NCT04033445|158480396|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
49176511|NCT04033445|158480397|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
49176512|NCT04033445|158480398|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
49176513|NCT04033445|158480399|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
49176514|NCT04033445|158480400|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
49176515|NCT04033445|158480401|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
49176516|NCT04033445|158480402|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
49176517|NCT04033445|158480389|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
49176518|NCT04033445|158480390|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
49176519|NCT04033445|158480391|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
49176520|NCT04033445|158480392|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
49176521|NCT04033445|158480393|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
49176522|NCT04033445|158480394|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|2|||
49176523|NCT04033445|158480395|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|1|||
49176524|NCT04033445|158480396|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
49176525|NCT04033445|158480397|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
49176526|NCT04033445|158480398|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
49176527|NCT04033445|158480399|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
49176528|NCT04033445|158480400|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
49176529|NCT04033445|158480401|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
49176530|NCT04033445|158480402|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
49176531|NCT04033445|158480389|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
49176532|NCT04033445|158480390|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
49176533|NCT04033445|158480391|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
49176534|NCT04033445|158480392|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
49176535|NCT04033445|158480393|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
49176536|NCT04033445|158480394|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
49176537|NCT04033445|158480395|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|1|||
49176538|NCT04033445|158480396|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
49176539|NCT04033445|158480397|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
49176540|NCT04033445|158480398|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
49176541|NCT04033445|158480399|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
49176542|NCT04033445|158480400|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
49176543|NCT04033445|158480401|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
49176544|NCT04033445|158480402|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
49176545|NCT04033445|158480389|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
49176546|NCT04033445|158480390|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
49176547|NCT04033445|158480391|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
49176548|NCT04033445|158480392|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
49176549|NCT04033445|158480393|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
49176550|NCT04033445|158480394|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|12|||
49176551|NCT04033445|158480395|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|6|||
49176552|NCT04033445|158480396|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
49176553|NCT04033445|158480397|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
49176554|NCT04033445|158480398|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
49176555|NCT04033445|158480399|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
49176556|NCT04033445|158480400|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
49176557|NCT04033445|158480401|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
49176558|NCT04033445|158480402|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
49176559|NCT04033445|158480389|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
49176560|NCT04033445|158480390|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
49176561|NCT04033445|158480391|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
49176562|NCT04033445|158480392|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
49176563|NCT04033445|158480393|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
49176564|NCT04033445|158480394|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
49176565|NCT04033445|158480395|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
49176566|NCT04033445|158480396|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
49176567|NCT04033445|158480397|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
49176568|NCT04033445|158480398|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
49176569|NCT04033445|158480399|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
49176570|NCT04033445|158480400|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
49176571|NCT04033445|158480401|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
49176572|NCT04033445|158480402|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
49176573|NCT04033445|158480389|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
49176574|NCT04033445|158480390|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
49176575|NCT04033445|158480391|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
49176576|NCT04033445|158480392|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
49176577|NCT04033445|158480393|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
49176578|NCT04033445|158480394|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
49176579|NCT04033445|158480395|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
49176580|NCT04033445|158480396|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
49176581|NCT04033445|158480397|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
49176582|NCT04033445|158480398|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
49176583|NCT04033445|158480399|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
49176584|NCT04033445|158480400|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
49176585|NCT04033445|158480401|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
49176586|NCT04033445|158480402|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
49176587|NCT04033445|158480389|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
49176588|NCT04033445|158480390|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
49176589|NCT04033445|158480391|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
49176590|NCT04033445|158480392|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
49176591|NCT04033445|158480393|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
49176592|NCT04033445|158480394|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
49176593|NCT04033445|158480395|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
49176594|NCT04033445|158480396|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|4|||
49176595|NCT04033445|158480397|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|6|||
49176596|NCT04033445|158480398|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
49176597|NCT04033445|158480399|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
49176598|NCT04033445|158480400|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
49176599|NCT04033445|158480401|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
49176600|NCT04033445|158480402|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
49176601|NCT04033445|158480389|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
49176602|NCT04033445|158480390|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
49176603|NCT04033445|158480391|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
49176604|NCT04033445|158480392|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
49176605|NCT04033445|158480393|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
49176606|NCT04033445|158480394|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
49176607|NCT04033445|158480395|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
49176608|NCT04033445|158480396|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|1|||
49176609|NCT04033445|158480397|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|3|||
49176610|NCT04033445|158480398|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
49176611|NCT04033445|158480399|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
49176612|NCT04033445|158480400|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
49176613|NCT04033445|158480401|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
49176614|NCT04033445|158480402|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
49176615|NCT04033445|158480389|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
49176616|NCT04033445|158480390|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
49176617|NCT04033445|158480391|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
49176618|NCT04033445|158480392|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
49176619|NCT04033445|158480393|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
49176620|NCT04033445|158480394|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
49176621|NCT04033445|158480395|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
49176622|NCT04033445|158480396|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
49176623|NCT04033445|158480397|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|1|||
49176624|NCT04033445|158480398|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
49176625|NCT04033445|158480399|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
49176626|NCT04033445|158480400|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
49176627|NCT04033445|158480401|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
49176628|NCT04033445|158480402|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
49176629|NCT04033445|158480389|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
49176630|NCT04033445|158480390|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
49176631|NCT04033445|158480391|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
49176632|NCT04033445|158480392|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|1|||
49176633|NCT04033445|158480393|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
49176634|NCT04033445|158480394|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
49176635|NCT04033445|158480395|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
49176636|NCT04033445|158480396|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
49176637|NCT04033445|158480397|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
49176638|NCT04033445|158480398|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
49176639|NCT04033445|158480399|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
49176640|NCT04033445|158480400|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
49176641|NCT04033445|158480401|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
49176642|NCT04033445|158480402|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
49176643|NCT04033445|158480389|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
49176644|NCT04033445|158480390|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
49176645|NCT04033445|158480391|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
49176646|NCT04033445|158480392|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
49176647|NCT04033445|158480393|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
49176648|NCT04033445|158480394|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
49176649|NCT04033445|158480395|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
49176650|NCT04033445|158480396|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|3|||
49176651|NCT04033445|158480397|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|2|||
49176652|NCT04033445|158480398|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
49176653|NCT04033445|158480399|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
49176654|NCT04033445|158480400|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
49176655|NCT04033445|158480401|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
49176656|NCT04033445|158480402|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
49176657|NCT04033445|158480389|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
49176658|NCT04033445|158480390|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
49176659|NCT04033445|158480391|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
49176660|NCT04033445|158480392|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
49176661|NCT04033445|158480393|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
49176662|NCT04033445|158480394|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
49176663|NCT04033445|158480395|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
49176664|NCT04033445|158480396|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|1|||
49176665|NCT04033445|158480397|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
49176666|NCT04033445|158480398|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
49176667|NCT04033445|158480399|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
49176668|NCT04033445|158480400|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
49176669|NCT04033445|158480401|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
49176670|NCT04033445|158480402|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
49176671|NCT04033445|158480389|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
49176672|NCT04033445|158480390|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
48844280|NCT01388361|157271304|FG002|Overall Study|Protocol Violation|2|||
49176673|NCT04033445|158480391|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
49176674|NCT04033445|158480392|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
48844281|NCT01388361|157271302|FG000|Overall Study|Withdrawal criteria|12|||
48844282|NCT01388361|157271303|FG001|Overall Study|Withdrawal criteria|7|||
49176675|NCT04033445|158480393|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
49176676|NCT04033445|158480394|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
49176677|NCT04033445|158480395|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
49176678|NCT04033445|158480396|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|1|||
49176679|NCT04033445|158480397|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
49176680|NCT04033445|158480398|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
49176681|NCT04033445|158480399|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
49176682|NCT04033445|158480400|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
49176683|NCT04033445|158480401|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
49176684|NCT04033445|158480402|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
49176685|NCT04033445|158480389|FG000|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
49176686|NCT04033445|158480390|FG001|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
49176687|NCT04033445|158480391|FG002|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
49176688|NCT04033445|158480392|FG003|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
49176689|NCT04033445|158480393|FG004|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
49176690|NCT04033445|158480394|FG005|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
49176691|NCT04033445|158480395|FG006|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
49176692|NCT04033445|158480396|FG007|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
49176693|NCT04033445|158480397|FG008|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
49176694|NCT04033445|158480398|FG009|Maintenance Study (Week 0 to Week 44)|Adverse Event|12|||
49176695|NCT04033445|158480399|FG010|Maintenance Study (Week 0 to Week 44)|Adverse Event|9|||
49176696|NCT04033445|158480400|FG011|Maintenance Study (Week 0 to Week 44)|Adverse Event|10|||
49176697|NCT04033445|158480401|FG012|Maintenance Study (Week 0 to Week 44)|Adverse Event|11|||
49176698|NCT04033445|158480402|FG013|Maintenance Study (Week 0 to Week 44)|Adverse Event|5|||
49176699|NCT04033445|158480389|FG000|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
49176700|NCT04033445|158480390|FG001|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
49176701|NCT04033445|158480391|FG002|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
49176702|NCT04033445|158480392|FG003|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
49176703|NCT04033445|158480393|FG004|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
49176704|NCT04033445|158480394|FG005|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
49176705|NCT04033445|158480395|FG006|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
49176706|NCT04033445|158480396|FG007|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
49176707|NCT04033445|158480397|FG008|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
49176708|NCT04033445|158480398|FG009|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|6|||
49176709|NCT04033445|158480399|FG010|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
49176710|NCT04033445|158480400|FG011|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|1|||
49176711|NCT04033445|158480401|FG012|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|5|||
49176712|NCT04033445|158480402|FG013|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
49176713|NCT04033445|158480389|FG000|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
49176714|NCT04033445|158480390|FG001|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
49176715|NCT04033445|158480391|FG002|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
49176716|NCT04033445|158480392|FG003|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
49176717|NCT04033445|158480393|FG004|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
49176718|NCT04033445|158480394|FG005|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
49176719|NCT04033445|158480395|FG006|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
49176720|NCT04033445|158480396|FG007|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
49176721|NCT04033445|158480397|FG008|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
49176722|NCT04033445|158480398|FG009|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
48844283|NCT01388361|157271304|FG002|Overall Study|Withdrawal criteria|10|||
49176723|NCT04033445|158480399|FG010|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
49176724|NCT04033445|158480400|FG011|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
49176725|NCT04033445|158480401|FG012|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
49176726|NCT04033445|158480402|FG013|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
48844284|NCT01388361|157271302|FG000|Overall Study|Unclassified|0|||
48844285|NCT01388361|157271303|FG001|Overall Study|Unclassified|0|||
48844286|NCT01388361|157271304|FG002|Overall Study|Unclassified|1|||
48844287|NCT00539734|157271305|FG000|Overall Study|Protocol Violation|1|||
48844288|NCT01061671|157271307|FG000|Overall Study|Withdrawal by Subject|16|||
48844289|NCT01061671|157271308|FG001|Overall Study|Withdrawal by Subject|20|||
48844290|NCT01061671|157271307|FG000|Overall Study|Lost to Follow-up|3|||
48844291|NCT01061671|157271308|FG001|Overall Study|Lost to Follow-up|5|||
48844292|NCT01061671|157271307|FG000|Overall Study|Death|28|||
48844293|NCT01061671|157271308|FG001|Overall Study|Death|30|||
48844294|NCT01070069|157271311|FG000|Overall Study|Death|1|||
49176727|NCT04033445|158480389|FG000|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
49176728|NCT04033445|158480390|FG001|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
49176729|NCT04033445|158480391|FG002|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
49176730|NCT04033445|158480392|FG003|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
49176731|NCT04033445|158480393|FG004|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
49176732|NCT04033445|158480394|FG005|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
49176733|NCT04033445|158480395|FG006|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
49176734|NCT04033445|158480396|FG007|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
49176735|NCT04033445|158480397|FG008|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
49176736|NCT04033445|158480398|FG009|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
49176737|NCT04033445|158480399|FG010|Maintenance Study (Week 0 to Week 44)|Physician Decision|4|||
49176738|NCT04033445|158480400|FG011|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
49176739|NCT04033445|158480401|FG012|Maintenance Study (Week 0 to Week 44)|Physician Decision|2|||
49176740|NCT04033445|158480402|FG013|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
49176741|NCT04033445|158480389|FG000|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
49176742|NCT04033445|158480390|FG001|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
49176743|NCT04033445|158480391|FG002|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
49176744|NCT04033445|158480392|FG003|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
49176745|NCT04033445|158480393|FG004|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
49176746|NCT04033445|158480394|FG005|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
49176747|NCT04033445|158480395|FG006|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
49176748|NCT04033445|158480396|FG007|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
49176749|NCT04033445|158480397|FG008|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
49176750|NCT04033445|158480398|FG009|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|8|||
49176751|NCT04033445|158480399|FG010|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|4|||
49176752|NCT04033445|158480400|FG011|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|7|||
49176753|NCT04033445|158480401|FG012|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|6|||
49176754|NCT04033445|158480402|FG013|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|5|||
49176755|NCT04033445|158480389|FG000|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
49176756|NCT04033445|158480390|FG001|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
49176757|NCT04033445|158480391|FG002|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
49176758|NCT04033445|158480392|FG003|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
49176759|NCT04033445|158480393|FG004|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
49176760|NCT04033445|158480394|FG005|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
49176761|NCT04033445|158480395|FG006|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
49176762|NCT04033445|158480396|FG007|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
49176763|NCT04033445|158480397|FG008|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
49176764|NCT04033445|158480398|FG009|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
49176765|NCT04033445|158480399|FG010|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
49176766|NCT04033445|158480400|FG011|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
49176767|NCT04033445|158480401|FG012|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
49176768|NCT04033445|158480402|FG013|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|1|||
49176769|NCT04033445|158480389|FG000|Maintenance Study (Week 0 to Week 44)|Other|0|||
49176770|NCT04033445|158480390|FG001|Maintenance Study (Week 0 to Week 44)|Other|0|||
49176771|NCT04033445|158480391|FG002|Maintenance Study (Week 0 to Week 44)|Other|0|||
49176772|NCT04033445|158480392|FG003|Maintenance Study (Week 0 to Week 44)|Other|0|||
49176773|NCT04033445|158480393|FG004|Maintenance Study (Week 0 to Week 44)|Other|0|||
48927166|NCT01903837|157566511|FG001|Part B|Non-compliance with study drug|0|||
48927167|NCT01903837|157566512|FG002|Part B|Non-compliance with study drug|0|||
48927168|NCT01903837|157566513|FG003|Part B|Non-compliance with study drug|1|||
48927169|NCT01903837|157566510|FG000|Part B|Incarceration|2|||
48927170|NCT01903837|157566511|FG001|Part B|Incarceration|0|||
48927171|NCT01903837|157566512|FG002|Part B|Incarceration|0|||
48927172|NCT01903837|157566513|FG003|Part B|Incarceration|1|||
48927173|NCT01903837|157566510|FG000|Part B|Physician Decision|1|||
48927174|NCT01903837|157566511|FG001|Part B|Physician Decision|0|||
48927175|NCT01903837|157566512|FG002|Part B|Physician Decision|0|||
48927176|NCT01903837|157566513|FG003|Part B|Physician Decision|2|||
48927177|NCT01903837|157566510|FG000|Part B|Lack of Efficacy|0|||
48927178|NCT01903837|157566511|FG001|Part B|Lack of Efficacy|1|||
48927179|NCT01903837|157566512|FG002|Part B|Lack of Efficacy|0|||
48927180|NCT01903837|157566513|FG003|Part B|Lack of Efficacy|0|||
48927181|NCT02706873|157566514|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|15|||
48927182|NCT02706873|157566515|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|3|||
48927183|NCT02706873|157566516|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|18|||
48927184|NCT02706873|157566517|FG003|Period 1 (Weeks 1 to 48)|Adverse Event|11|||
48927185|NCT02706873|157566514|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|22|||
48927186|NCT02706873|157566515|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|0|||
48927187|NCT02706873|157566516|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|12|||
48927188|NCT02706873|157566517|FG003|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|20|||
48927189|NCT02706873|157566514|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|4|||
48927190|NCT02706873|157566515|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
48927191|NCT02706873|157566516|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|6|||
49176774|NCT04033445|158480394|FG005|Maintenance Study (Week 0 to Week 44)|Other|0|||
49176775|NCT04033445|158480395|FG006|Maintenance Study (Week 0 to Week 44)|Other|0|||
49176776|NCT04033445|158480396|FG007|Maintenance Study (Week 0 to Week 44)|Other|0|||
49176777|NCT04033445|158480397|FG008|Maintenance Study (Week 0 to Week 44)|Other|0|||
49176778|NCT04033445|158480398|FG009|Maintenance Study (Week 0 to Week 44)|Other|1|||
49176779|NCT04033445|158480399|FG010|Maintenance Study (Week 0 to Week 44)|Other|1|||
49176780|NCT04033445|158480400|FG011|Maintenance Study (Week 0 to Week 44)|Other|2|||
49176781|NCT04033445|158480401|FG012|Maintenance Study (Week 0 to Week 44)|Other|2|||
49176782|NCT04033445|158480402|FG013|Maintenance Study (Week 0 to Week 44)|Other|2|||
49176783|NCT04033445|158480389|FG000|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
49176784|NCT04033445|158480390|FG001|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
49176785|NCT04033445|158480391|FG002|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
49176786|NCT04033445|158480392|FG003|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
49176787|NCT04033445|158480393|FG004|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
49176788|NCT04033445|158480394|FG005|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
49176789|NCT04033445|158480395|FG006|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
49176790|NCT04033445|158480396|FG007|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
49176791|NCT04033445|158480397|FG008|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
49176792|NCT04033445|158480398|FG009|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
49176793|NCT04033445|158480399|FG010|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
49176794|NCT04033445|158480400|FG011|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
49176795|NCT04033445|158480401|FG012|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
49176796|NCT04033445|158480402|FG013|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
49176797|NCT03898960|158480403|FG000|Overall Study|Death|10|||
49176798|NCT04175912|158480404|FG000|Overall Study|Disease progression- relapse during active treatment|17|||
49176799|NCT04175912|158480405|FG001|Overall Study|Disease progression- relapse during active treatment|13|||
49176800|NCT04175912|158480404|FG000|Overall Study|Adverse Event|0|||
49176801|NCT04175912|158480405|FG001|Overall Study|Adverse Event|3|||
49176802|NCT04175912|158480404|FG000|Overall Study|Never started treatment|3|||
49176803|NCT04175912|158480405|FG001|Overall Study|Never started treatment|3|||
49176804|NCT04175912|158480404|FG000|Overall Study|Death|0|||
49176805|NCT04175912|158480405|FG001|Overall Study|Death|1|||
49176806|NCT04852302|158480406|FG000|Overall Study|Withdrawal by Subject|2|||
49176807|NCT04852302|158480406|FG000|Overall Study|Did not complete CALM therapy.|2|||
49176808|NCT04437511|158480407|FG000|Overall Study|Adverse Event|50|||
49176809|NCT04437511|158480408|FG001|Overall Study|Adverse Event|21|||
49176810|NCT04437511|158480407|FG000|Overall Study|Death|15|||
49176811|NCT04437511|158480408|FG001|Overall Study|Death|10|||
49176812|NCT04437511|158480407|FG000|Overall Study|Lost to Follow-up|11|||
49176813|NCT04437511|158480408|FG001|Overall Study|Lost to Follow-up|11|||
49176814|NCT04437511|158480407|FG000|Overall Study|Physician Decision|19|||
49176815|NCT04437511|158480408|FG001|Overall Study|Physician Decision|10|||
49176816|NCT04437511|158480407|FG000|Overall Study|Progressive Disease|4|||
49176817|NCT04437511|158480408|FG001|Overall Study|Progressive Disease|7|||
49176818|NCT04437511|158480407|FG000|Overall Study|Withdrawal by Subject|111|||
49176819|NCT04437511|158480408|FG001|Overall Study|Withdrawal by Subject|94|||
49176820|NCT04437511|158480407|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|21|||
49176821|NCT04437511|158480408|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|20|||
49176822|NCT04437511|158480407|FG000|Overall Study|Continuing Study|7|||
49176823|NCT04437511|158480408|FG001|Overall Study|Continuing Study|5|||
49176824|NCT02985957|158480409|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
49176825|NCT02985957|158480410|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
48927192|NCT02706873|157566517|FG003|Period 1 (Weeks 1 to 48)|Lost to Follow-up|5|||
49176826|NCT02985957|158480411|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
49176827|NCT02985957|158480412|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
49176828|NCT02985957|158480413|FG004|Pre-Treatment Period|Participant no longer meets study criteria|1|||
49176829|NCT02985957|158480414|FG005|Pre-Treatment Period|Participant no longer meets study criteria|0|||
49176830|NCT02985957|158480415|FG006|Pre-Treatment Period|Participant no longer meets study criteria|0|||
49176831|NCT02985957|158480409|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
49176832|NCT02985957|158480410|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
49176833|NCT02985957|158480411|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
49176834|NCT02985957|158480412|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
49176835|NCT02985957|158480413|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
49176836|NCT02985957|158480414|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
49176837|NCT02985957|158480415|FG006|Pre-Treatment Period|Participant withdrew consent|1|||
49176838|NCT02985957|158480409|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
49176839|NCT02985957|158480410|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
49176840|NCT02985957|158480411|FG002|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
49176841|NCT02985957|158480412|FG003|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
49176842|NCT02985957|158480413|FG004|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
49176843|NCT02985957|158480414|FG005|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
49176844|NCT02985957|158480415|FG006|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
49176845|NCT02985957|158480409|FG000|Treatment Period|Death|0|||
49176846|NCT02985957|158480410|FG001|Treatment Period|Death|0|||
49176847|NCT02985957|158480411|FG002|Treatment Period|Death|0|||
49176848|NCT02985957|158480412|FG003|Treatment Period|Death|0|||
49176849|NCT02985957|158480413|FG004|Treatment Period|Death|1|||
49176850|NCT02985957|158480414|FG005|Treatment Period|Death|0|||
49176851|NCT02985957|158480415|FG006|Treatment Period|Death|0|||
49176852|NCT02985957|158480409|FG000|Treatment Period|Participant withdrew consent|0|||
49176853|NCT02985957|158480410|FG001|Treatment Period|Participant withdrew consent|0|||
49176854|NCT02985957|158480411|FG002|Treatment Period|Participant withdrew consent|0|||
49176855|NCT02985957|158480412|FG003|Treatment Period|Participant withdrew consent|1|||
49176856|NCT02985957|158480413|FG004|Treatment Period|Participant withdrew consent|3|||
49176857|NCT02985957|158480414|FG005|Treatment Period|Participant withdrew consent|0|||
49176858|NCT02985957|158480415|FG006|Treatment Period|Participant withdrew consent|1|||
49176859|NCT02985957|158480409|FG000|Treatment Period|Lost to Follow-up|0|||
49176860|NCT02985957|158480410|FG001|Treatment Period|Lost to Follow-up|0|||
49176861|NCT02985957|158480411|FG002|Treatment Period|Lost to Follow-up|0|||
49176862|NCT02985957|158480412|FG003|Treatment Period|Lost to Follow-up|0|||
49176863|NCT02985957|158480413|FG004|Treatment Period|Lost to Follow-up|1|||
49176864|NCT02985957|158480414|FG005|Treatment Period|Lost to Follow-up|0|||
49176865|NCT02985957|158480415|FG006|Treatment Period|Lost to Follow-up|0|||
49176866|NCT02985957|158480409|FG000|Treatment Period|Other reasons|0|||
49176867|NCT02985957|158480410|FG001|Treatment Period|Other reasons|0|||
49176868|NCT02985957|158480411|FG002|Treatment Period|Other reasons|1|||
49176869|NCT02985957|158480412|FG003|Treatment Period|Other reasons|3|||
49176870|NCT02985957|158480413|FG004|Treatment Period|Other reasons|6|||
49176871|NCT02985957|158480414|FG005|Treatment Period|Other reasons|0|||
49176872|NCT02985957|158480415|FG006|Treatment Period|Other reasons|1|||
49176873|NCT02985957|158480409|FG000|Treatment Period|Not reported|0|||
49176874|NCT02985957|158480410|FG001|Treatment Period|Not reported|1|||
49176875|NCT02985957|158480411|FG002|Treatment Period|Not reported|2|||
49176876|NCT02985957|158480412|FG003|Treatment Period|Not reported|5|||
49176877|NCT02985957|158480413|FG004|Treatment Period|Not reported|0|||
49176878|NCT02985957|158480414|FG005|Treatment Period|Not reported|0|||
49176879|NCT02985957|158480415|FG006|Treatment Period|Not reported|0|||
49176880|NCT02985957|158480409|FG000|Treatment Period|Maximum clinical benefit|0|||
49176881|NCT02985957|158480410|FG001|Treatment Period|Maximum clinical benefit|0|||
49176882|NCT02985957|158480411|FG002|Treatment Period|Maximum clinical benefit|1|||
49176883|NCT02985957|158480412|FG003|Treatment Period|Maximum clinical benefit|1|||
49176884|NCT02985957|158480413|FG004|Treatment Period|Maximum clinical benefit|0|||
49176885|NCT02985957|158480414|FG005|Treatment Period|Maximum clinical benefit|0|||
49176886|NCT02985957|158480415|FG006|Treatment Period|Maximum clinical benefit|2|||
49176887|NCT02985957|158480409|FG000|Treatment Period|Adverse event unrelated to study drug|1|||
49176888|NCT02985957|158480410|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
49176889|NCT02985957|158480411|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
49176890|NCT02985957|158480412|FG003|Treatment Period|Adverse event unrelated to study drug|3|||
49176891|NCT02985957|158480413|FG004|Treatment Period|Adverse event unrelated to study drug|7|||
49176892|NCT02985957|158480414|FG005|Treatment Period|Adverse event unrelated to study drug|2|||
49176893|NCT02985957|158480415|FG006|Treatment Period|Adverse event unrelated to study drug|7|||
49176894|NCT02985957|158480409|FG000|Treatment Period|Study drug toxicity|1|||
49176895|NCT02985957|158480410|FG001|Treatment Period|Study drug toxicity|23|||
49176896|NCT02985957|158480411|FG002|Treatment Period|Study drug toxicity|20|||
49176897|NCT02985957|158480412|FG003|Treatment Period|Study drug toxicity|11|||
48927193|NCT02706873|157566514|FG000|Period 1 (Weeks 1 to 48)|Lack of Efficacy|12|||
48927194|NCT02706873|157566515|FG001|Period 1 (Weeks 1 to 48)|Lack of Efficacy|0|||
48927195|NCT02706873|157566516|FG002|Period 1 (Weeks 1 to 48)|Lack of Efficacy|2|||
48927196|NCT02706873|157566517|FG003|Period 1 (Weeks 1 to 48)|Lack of Efficacy|4|||
48927197|NCT02706873|157566514|FG000|Period 1 (Weeks 1 to 48)|Other|5|||
48927198|NCT02706873|157566515|FG001|Period 1 (Weeks 1 to 48)|Other|1|||
48927199|NCT02706873|157566516|FG002|Period 1 (Weeks 1 to 48)|Other|2|||
48927200|NCT02706873|157566517|FG003|Period 1 (Weeks 1 to 48)|Other|3|||
48927201|NCT02706873|157566514|FG000|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
48927202|NCT02706873|157566515|FG001|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
48927203|NCT02706873|157566516|FG002|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
48927204|NCT02706873|157566517|FG003|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
48927205|NCT02706873|157566514|FG000|Period 2 (Weeks 48 to 260)|Adverse Event|16|||
48927206|NCT02706873|157566515|FG001|Period 2 (Weeks 48 to 260)|Adverse Event|4|||
48927207|NCT02706873|157566516|FG002|Period 2 (Weeks 48 to 260)|Adverse Event|11|||
48927208|NCT02706873|157566517|FG003|Period 2 (Weeks 48 to 260)|Adverse Event|26|||
48927209|NCT02706873|157566514|FG000|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|32|||
48927210|NCT02706873|157566515|FG001|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|5|||
48927211|NCT02706873|157566516|FG002|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|23|||
48927212|NCT02706873|157566517|FG003|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|27|||
48927213|NCT02706873|157566514|FG000|Period 2 (Weeks 48 to 260)|Lost to Follow-up|17|||
48927214|NCT02706873|157566515|FG001|Period 2 (Weeks 48 to 260)|Lost to Follow-up|0|||
48927215|NCT02706873|157566516|FG002|Period 2 (Weeks 48 to 260)|Lost to Follow-up|10|||
48927216|NCT02706873|157566517|FG003|Period 2 (Weeks 48 to 260)|Lost to Follow-up|6|||
48927217|NCT02706873|157566514|FG000|Period 2 (Weeks 48 to 260)|Lack of Efficacy|11|||
48927218|NCT02706873|157566515|FG001|Period 2 (Weeks 48 to 260)|Lack of Efficacy|0|||
48927219|NCT02706873|157566516|FG002|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
48927220|NCT02706873|157566517|FG003|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
48927221|NCT02706873|157566514|FG000|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
48927222|NCT02706873|157566515|FG001|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
48927223|NCT02706873|157566516|FG002|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
48927224|NCT02706873|157566517|FG003|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|3|||
48927225|NCT02706873|157566514|FG000|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
48927226|NCT02706873|157566515|FG001|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
48927227|NCT02706873|157566516|FG002|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|2|||
48927228|NCT02706873|157566517|FG003|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|1|||
48927229|NCT02706873|157566514|FG000|Period 2 (Weeks 48 to 260)|Other|14|||
48927230|NCT02706873|157566515|FG001|Period 2 (Weeks 48 to 260)|Other|1|||
48927231|NCT02706873|157566516|FG002|Period 2 (Weeks 48 to 260)|Other|11|||
48927232|NCT02706873|157566517|FG003|Period 2 (Weeks 48 to 260)|Other|17|||
48927233|NCT02599961|157566518|FG000|Overall Study|Withdrawal by Subject|1|||
48927234|NCT02599961|157566518|FG000|Overall Study|Subject Non-Compliance|2|||
48927235|NCT02599961|157566518|FG000|Overall Study|Discontinuation of Study by Sponsor|9|||
48927236|NCT02599961|157566518|FG000|Overall Study|Other, Not Specified|3|||
48927237|NCT04142983|157566519|FG000|Overall Study|Lost to Follow-up|73|||
49176898|NCT02985957|158480413|FG004|Treatment Period|Study drug toxicity|19|||
49176899|NCT02985957|158480414|FG005|Treatment Period|Study drug toxicity|3|||
49176900|NCT02985957|158480415|FG006|Treatment Period|Study drug toxicity|5|||
49176901|NCT02985957|158480409|FG000|Treatment Period|Disease progression|0|||
49176902|NCT02985957|158480410|FG001|Treatment Period|Disease progression|16|||
49176903|NCT02985957|158480411|FG002|Treatment Period|Disease progression|20|||
49176904|NCT02985957|158480412|FG003|Treatment Period|Disease progression|39|||
49176905|NCT02985957|158480413|FG004|Treatment Period|Disease progression|29|||
49176906|NCT02985957|158480414|FG005|Treatment Period|Disease progression|11|||
49176907|NCT02985957|158480415|FG006|Treatment Period|Disease progression|28|||
49176908|NCT02985957|158480409|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
49176909|NCT02985957|158480410|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
48927238|NCT04142983|157566519|FG000|Overall Study|Withdrawal by Subject|10|||
48927239|NCT04142983|157566519|FG000|Overall Study|Physician Decision|1|||
48927240|NCT04142983|157566519|FG000|Overall Study|Adverse Event|1|||
48927241|NCT04142983|157566519|FG000|Overall Study|No longer eligible|4|||
48927242|NCT04142983|157566519|FG000|Overall Study|Screen Failure|10|||
48927243|NCT00608985|157566520|FG000|Overall Study|Adverse Event|2|||
48927244|NCT00608985|157566521|FG001|Overall Study|Adverse Event|7|||
48927245|NCT00608985|157566522|FG002|Overall Study|Adverse Event|4|||
49176910|NCT02985957|158480411|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
49176911|NCT02985957|158480412|FG003|Treatment Period|Participant request to discontinue study treatment|4|||
48927246|NCT00608985|157566523|FG003|Overall Study|Adverse Event|6|||
48927247|NCT00608985|157566520|FG000|Overall Study|Administrative/Other|7|||
48927248|NCT00608985|157566521|FG001|Overall Study|Administrative/Other|4|||
48927249|NCT00608985|157566522|FG002|Overall Study|Administrative/Other|1|||
49176912|NCT02985957|158480413|FG004|Treatment Period|Participant request to discontinue study treatment|2|||
48927250|NCT00608985|157566523|FG003|Overall Study|Administrative/Other|2|||
48927251|NCT00608985|157566520|FG000|Overall Study|Withdrawal of Consent|5|||
48927252|NCT00608985|157566521|FG001|Overall Study|Withdrawal of Consent|1|||
48927253|NCT00608985|157566522|FG002|Overall Study|Withdrawal of Consent|1|||
48927254|NCT00608985|157566523|FG003|Overall Study|Withdrawal of Consent|1|||
48927255|NCT00608985|157566520|FG000|Overall Study|Lost to Follow-up|2|||
48927256|NCT00608985|157566521|FG001|Overall Study|Lost to Follow-up|1|||
48927257|NCT00608985|157566522|FG002|Overall Study|Lost to Follow-up|0|||
48927258|NCT00608985|157566523|FG003|Overall Study|Lost to Follow-up|0|||
49176913|NCT02985957|158480414|FG005|Treatment Period|Participant request to discontinue study treatment|2|||
49176914|NCT02985957|158480415|FG006|Treatment Period|Participant request to discontinue study treatment|3|||
49176915|NCT02985957|158480409|FG000|Treatment Period|Poor/Non-Compliance|0|||
49176916|NCT02985957|158480410|FG001|Treatment Period|Poor/Non-Compliance|0|||
49176917|NCT02985957|158480411|FG002|Treatment Period|Poor/Non-Compliance|0|||
49176918|NCT02985957|158480412|FG003|Treatment Period|Poor/Non-Compliance|0|||
49176919|NCT02985957|158480413|FG004|Treatment Period|Poor/Non-Compliance|1|||
49176920|NCT02985957|158480414|FG005|Treatment Period|Poor/Non-Compliance|1|||
49176921|NCT02985957|158480415|FG006|Treatment Period|Poor/Non-Compliance|0|||
49176922|NCT02985957|158480409|FG000|Treatment Period|Continuing in Treatment Period|0|||
49176923|NCT02985957|158480410|FG001|Treatment Period|Continuing in Treatment Period|1|||
49176924|NCT02985957|158480411|FG002|Treatment Period|Continuing in Treatment Period|0|||
49176925|NCT02985957|158480412|FG003|Treatment Period|Continuing in Treatment Period|4|||
49176926|NCT02985957|158480413|FG004|Treatment Period|Continuing in Treatment Period|4|||
49176927|NCT02985957|158480414|FG005|Treatment Period|Continuing in Treatment Period|0|||
49176928|NCT02985957|158480415|FG006|Treatment Period|Continuing in Treatment Period|0|||
49176929|NCT04225039|158480416|FG000|Overall Study|Withdrawal by Subject|1|||
49176930|NCT04225039|158480417|FG001|Overall Study|Withdrawal by Subject|0|||
49176931|NCT04225039|158480418|FG002|Overall Study|Withdrawal by Subject|0|||
49176932|NCT04225039|158480419|FG003|Overall Study|Withdrawal by Subject|1|||
49176933|NCT04225039|158480416|FG000|Overall Study|Currently active on study treatment|0|||
49176934|NCT04225039|158480417|FG001|Overall Study|Currently active on study treatment|1|||
49176935|NCT04225039|158480418|FG002|Overall Study|Currently active on study treatment|0|||
49176936|NCT04225039|158480419|FG003|Overall Study|Currently active on study treatment|0|||
49176937|NCT04225039|158480416|FG000|Overall Study|Protocol deviation; data not analyzed for efficacy|2|||
49176938|NCT04225039|158480417|FG001|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
49176939|NCT04225039|158480418|FG002|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
49176940|NCT04225039|158480419|FG003|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
49176941|NCT04225039|158480416|FG000|Overall Study|Ineligible for treatment|0|||
49176942|NCT04225039|158480417|FG001|Overall Study|Ineligible for treatment|0|||
49176943|NCT04225039|158480418|FG002|Overall Study|Ineligible for treatment|0|||
49176944|NCT04225039|158480419|FG003|Overall Study|Ineligible for treatment|4|||
49176945|NCT01248130|158480420|FG000|Overall Study|Protocol Violation|1|||
48844295|NCT01070069|157271312|FG001|Overall Study|Death|0|||
49176946|NCT01248130|158480421|FG001|Overall Study|Protocol Violation|0|||
49176947|NCT01248130|158480420|FG000|Overall Study|Ineligible|1|||
49176948|NCT01248130|158480421|FG001|Overall Study|Ineligible|0|||
48927259|NCT00197054|157566524|FG000|Overall Study|Withdrawal by Subject|9|||
48927260|NCT00197054|157566525|FG001|Overall Study|Withdrawal by Subject|3|||
48927261|NCT00197054|157566526|FG002|Overall Study|Withdrawal by Subject|3|||
48927262|NCT00197054|157566524|FG000|Overall Study|Moved from area|7|||
48927263|NCT00197054|157566525|FG001|Overall Study|Moved from area|14|||
48927264|NCT00197054|157566526|FG002|Overall Study|Moved from area|9|||
48927265|NCT00197054|157566524|FG000|Overall Study|Lost to Follow-up|1|||
48927266|NCT00197054|157566525|FG001|Overall Study|Lost to Follow-up|4|||
48927267|NCT00197054|157566526|FG002|Overall Study|Lost to Follow-up|0|||
48927268|NCT00684515|157566527|FG000|Overall Study|Adverse Event|3|||
48927269|NCT00684515|157566528|FG001|Overall Study|Adverse Event|3|||
48927270|NCT00684515|157566529|FG002|Overall Study|Adverse Event|1|||
48927271|NCT00684515|157566527|FG000|Overall Study|Protocol-Defined Clinical Event|1|||
48927272|NCT00684515|157566528|FG001|Overall Study|Protocol-Defined Clinical Event|0|||
48927273|NCT00684515|157566529|FG002|Overall Study|Protocol-Defined Clinical Event|0|||
48927274|NCT00191451|157566530|FG000|Overall Study|Withdrawal by Subject|2|||
48927275|NCT00191451|157566531|FG001|Overall Study|Withdrawal by Subject|3|||
48927276|NCT00191451|157566532|FG002|Overall Study|Withdrawal by Subject|5|||
48927277|NCT00191451|157566530|FG000|Overall Study|Physician Decision|2|||
49176949|NCT04676022|158480422|FG000|Overall Study|Screen Failure/|1|||
49176950|NCT04676022|158480423|FG001|Overall Study|Screen Failure/|1|||
49176951|NCT04676022|158480424|FG002|Overall Study|Screen Failure/|85|||
49176952|NCT04676022|158480422|FG000|Overall Study|Lost to Follow-up|1|||
49176953|NCT04676022|158480423|FG001|Overall Study|Lost to Follow-up|1|||
49176954|NCT04676022|158480424|FG002|Overall Study|Lost to Follow-up|0|||
49176955|NCT04676022|158480422|FG000|Overall Study|Adverse Event|2|||
49176956|NCT04676022|158480423|FG001|Overall Study|Adverse Event|0|||
49176957|NCT04676022|158480424|FG002|Overall Study|Adverse Event|1|||
49176958|NCT04676022|158480422|FG000|Overall Study|Physician Decision|2|||
49176959|NCT04676022|158480423|FG001|Overall Study|Physician Decision|0|||
49176960|NCT04676022|158480424|FG002|Overall Study|Physician Decision|1|||
49176961|NCT04676022|158480422|FG000|Overall Study|Withdrawal by Subject|3|||
49176962|NCT04676022|158480423|FG001|Overall Study|Withdrawal by Subject|1|||
49176963|NCT04676022|158480424|FG002|Overall Study|Withdrawal by Subject|6|||
49176964|NCT04676022|158480422|FG000|Overall Study|Will not move forward with permanent implant|6|||
49176965|NCT04676022|158480423|FG001|Overall Study|Will not move forward with permanent implant|0|||
49176966|NCT04676022|158480424|FG002|Overall Study|Will not move forward with permanent implant|0|||
49176967|NCT04676022|158480422|FG000|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|7|||
49176968|NCT04676022|158480423|FG001|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
49176969|NCT04676022|158480424|FG002|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
49176970|NCT06161012|158480443|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
49176971|NCT06161012|158480444|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
49176972|NCT02763566|158480445|FG000|Overall Study|Lost to Follow-up|1|||
49176973|NCT02763566|158480446|FG001|Overall Study|Lost to Follow-up|4|||
49176974|NCT02763566|158480447|FG002|Overall Study|Lost to Follow-up|0|||
49176975|NCT02763566|158480448|FG003|Overall Study|Lost to Follow-up|1|||
49176976|NCT02763566|158480445|FG000|Overall Study|On study treatment at study conclusion|114|||
49176977|NCT02763566|158480446|FG001|Overall Study|On study treatment at study conclusion|34|||
49176978|NCT02763566|158480447|FG002|Overall Study|On study treatment at study conclusion|54|||
49176979|NCT02763566|158480448|FG003|Overall Study|On study treatment at study conclusion|13|||
49176980|NCT02763566|158480445|FG000|Overall Study|Withdrawal by Subject|3|||
49176981|NCT02763566|158480446|FG001|Overall Study|Withdrawal by Subject|1|||
49176982|NCT02763566|158480447|FG002|Overall Study|Withdrawal by Subject|0|||
49176983|NCT02763566|158480448|FG003|Overall Study|Withdrawal by Subject|0|||
49176984|NCT01522976|158480455|FG000|Overall Study|Ineligible|4|||
49176985|NCT01522976|158480456|FG001|Overall Study|Ineligible|0|||
49176986|NCT01522976|158480457|FG002|Overall Study|Ineligible|1|||
49176987|NCT01522976|158480455|FG000|Overall Study|Death|7|||
49176988|NCT01522976|158480456|FG001|Overall Study|Death|6|||
49176989|NCT01522976|158480457|FG002|Overall Study|Death|2|||
49176990|NCT01522976|158480455|FG000|Overall Study|Still on treatment|9|||
49176991|NCT01522976|158480456|FG001|Overall Study|Still on treatment|9|||
49176992|NCT01522976|158480457|FG002|Overall Study|Still on treatment|6|||
49176993|NCT01522976|158480455|FG000|Overall Study|Disease progression|28|||
49176994|NCT01522976|158480456|FG001|Overall Study|Disease progression|30|||
49176995|NCT01522976|158480457|FG002|Overall Study|Disease progression|25|||
48927278|NCT00191451|157566531|FG001|Overall Study|Physician Decision|9|||
49176996|NCT01522976|158480455|FG000|Overall Study|Adverse Event|17|||
49176997|NCT01522976|158480456|FG001|Overall Study|Adverse Event|7|||
49176998|NCT01522976|158480457|FG002|Overall Study|Adverse Event|18|||
49176999|NCT01522976|158480455|FG000|Overall Study|Refusal unrelated to adverse event|10|||
49177000|NCT01522976|158480456|FG001|Overall Study|Refusal unrelated to adverse event|13|||
49177001|NCT01522976|158480457|FG002|Overall Study|Refusal unrelated to adverse event|14|||
48844296|NCT01070069|157271313|FG002|Overall Study|Death|2|||
49177002|NCT01522976|158480455|FG000|Overall Study|Not protocol specified|22|||
49177003|NCT01522976|158480456|FG001|Overall Study|Not protocol specified|27|||
49177004|NCT01522976|158480457|FG002|Overall Study|Not protocol specified|27|||
49177005|NCT04963270|158480460|FG000|Double-Blind Period (24 Weeks)|Adverse Event|1|||
49177006|NCT04963270|158480461|FG001|Double-Blind Period (24 Weeks)|Adverse Event|2|||
49177007|NCT04963270|158480462|FG002|Double-Blind Period (24 Weeks)|Adverse Event|0|||
49177008|NCT04963270|158480463|FG003|Double-Blind Period (24 Weeks)|Adverse Event|0|||
49177009|NCT04963270|158480460|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
49177010|NCT04963270|158480461|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|1|||
49177011|NCT04963270|158480462|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
49177012|NCT04963270|158480463|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
49177013|NCT04963270|158480460|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
48927279|NCT00191451|157566532|FG002|Overall Study|Physician Decision|6|||
49177014|NCT04963270|158480461|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
49177015|NCT04963270|158480462|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
49177016|NCT04963270|158480463|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
49177017|NCT04963270|158480460|FG000|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|2|||
49177018|NCT04963270|158480461|FG001|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
49177019|NCT04963270|158480462|FG002|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
49177020|NCT04963270|158480463|FG003|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
49177021|NCT04963270|158480460|FG000|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
49177022|NCT04963270|158480461|FG001|Double-Blind Period (24 Weeks)|Reason Not Specified|1|||
49177023|NCT04963270|158480462|FG002|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
49177024|NCT04963270|158480463|FG003|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
49177025|NCT04963270|158480460|FG000|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
49177026|NCT04963270|158480461|FG001|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
49177027|NCT04963270|158480462|FG002|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
49177028|NCT04963270|158480463|FG003|Open Label Extension Period (92 Weeks)|Lack of Efficacy|1|||
49177029|NCT04963270|158480460|FG000|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
49177030|NCT04963270|158480461|FG001|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
49177031|NCT04963270|158480462|FG002|Open Label Extension Period (92 Weeks)|Lost to Follow-up|2|||
49177032|NCT04963270|158480463|FG003|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
49177033|NCT04963270|158480460|FG000|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
49177034|NCT04963270|158480461|FG001|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
49177035|NCT04963270|158480462|FG002|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|2|||
49177036|NCT04963270|158480463|FG003|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|6|||
49177037|NCT04963270|158480460|FG000|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
49177038|NCT04963270|158480461|FG001|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
49177039|NCT04963270|158480462|FG002|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
48927280|NCT00191451|157566530|FG000|Overall Study|Sponsor Decision|1|||
48927281|NCT00191451|157566531|FG001|Overall Study|Sponsor Decision|0|||
48927282|NCT00191451|157566532|FG002|Overall Study|Sponsor Decision|0|||
48927283|NCT00191451|157566530|FG000|Overall Study|Ineligible|0|||
48927284|NCT00191451|157566531|FG001|Overall Study|Ineligible|1|||
48927285|NCT00191451|157566532|FG002|Overall Study|Ineligible|0|||
48927286|NCT00191451|157566530|FG000|Overall Study|Reason Not Specified|2|||
48927287|NCT00191451|157566531|FG001|Overall Study|Reason Not Specified|1|||
48927288|NCT00191451|157566532|FG002|Overall Study|Reason Not Specified|3|||
48927289|NCT00272987|157566535|FG000|Overall Study|Adverse Event|1|||
48927290|NCT00272987|157566536|FG001|Overall Study|Adverse Event|0|||
48927291|NCT00272987|157566537|FG002|Overall Study|Adverse Event|0|||
48927292|NCT00272987|157566535|FG000|Overall Study|Lost to Follow-up|3|||
48927293|NCT00272987|157566536|FG001|Overall Study|Lost to Follow-up|1|||
49177040|NCT04963270|158480463|FG003|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
49177041|NCT04963270|158480460|FG000|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
49177042|NCT04963270|158480461|FG001|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
49177043|NCT04963270|158480462|FG002|Open Label Extension Period (92 Weeks)|Pregnancy|1|||
49177044|NCT04963270|158480463|FG003|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
49177045|NCT04963270|158480460|FG000|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
49177046|NCT04963270|158480461|FG001|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
49177047|NCT04963270|158480462|FG002|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|82|||
49177048|NCT04963270|158480463|FG003|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|81|||
49177049|NCT04963270|158480460|FG000|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
49177050|NCT04963270|158480461|FG001|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
49177051|NCT04963270|158480462|FG002|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
49177052|NCT04963270|158480463|FG003|Open Label Extension Period (92 Weeks)|Reason Not Specified|1|||
49177053|NCT04963270|158480460|FG000|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
49177054|NCT04963270|158480461|FG001|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
49177055|NCT04963270|158480462|FG002|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
49177056|NCT04963270|158480463|FG003|Open Label Extension Period (92 Weeks)|Reason Unknown|1|||
49177057|NCT04963270|158480460|FG000|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
49177058|NCT04963270|158480461|FG001|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
49177059|NCT04963270|158480462|FG002|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
49177060|NCT04963270|158480463|FG003|Open Label Extension Period (92 Weeks)|Adverse Event|1|||
49177061|NCT01798498|158480464|FG000|Overall Study|Lost to Follow-up|1|||
49177062|NCT04624633|158480467|FG000|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|0|||
49177063|NCT04624633|158480468|FG001|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|1|||
49177064|NCT04624633|158480467|FG000|Overall Study|Death|1|||
49177065|NCT04624633|158480468|FG001|Overall Study|Death|0|||
49177066|NCT01437709|158480469|FG000|Overall Study|Adverse Event|0|||
49177067|NCT01437709|158480470|FG001|Overall Study|Adverse Event|1|||
49177068|NCT01437709|158480471|FG002|Overall Study|Adverse Event|0|||
49177069|NCT01437709|158480469|FG000|Overall Study|Pt trasnferred care|0|||
49177070|NCT01437709|158480470|FG001|Overall Study|Pt trasnferred care|1|||
49177071|NCT01437709|158480471|FG002|Overall Study|Pt trasnferred care|0|||
49177072|NCT04091750|158480472|FG000|Overall Study|Adverse Event|4|||
49177073|NCT04091750|158480472|FG000|Overall Study|Withdrawal by Subject|1|||
49177074|NCT01776840|158480473|FG000|Overall Study|Lost to Follow-up|4|||
49177075|NCT01776840|158480474|FG001|Overall Study|Lost to Follow-up|4|||
49177076|NCT01776840|158480473|FG000|Overall Study|Withdrawal by Subject|42|||
49177077|NCT01776840|158480474|FG001|Overall Study|Withdrawal by Subject|22|||
49177078|NCT01776840|158480473|FG000|Overall Study|Ongoing|112|||
49177079|NCT01776840|158480474|FG001|Overall Study|Ongoing|129|||
49177080|NCT03698994|158480477|FG000|Overall Study|Adverse Event|2|||
49177081|NCT03698994|158480477|FG000|Overall Study|Death|1|||
49177082|NCT03698994|158480477|FG000|Overall Study|Physician Decision|1|||
49177083|NCT03698994|158480477|FG000|Overall Study|Withdrawal by Subject|3|||
49177084|NCT03698994|158480477|FG000|Overall Study|Progressive Disease|12|||
49177085|NCT02365597|158480478|FG000|Overall Study|Lost to Follow-up|0|||
49177086|NCT02365597|158480479|FG001|Overall Study|Lost to Follow-up|1|||
49177087|NCT02365597|158480480|FG002|Overall Study|Lost to Follow-up|0|||
49177088|NCT02365597|158480481|FG003|Overall Study|Lost to Follow-up|1|||
49177089|NCT02365597|158480478|FG000|Overall Study|Withdrawal by Subject|1|||
49177090|NCT02365597|158480479|FG001|Overall Study|Withdrawal by Subject|8|||
49177091|NCT02365597|158480480|FG002|Overall Study|Withdrawal by Subject|5|||
49177092|NCT02365597|158480481|FG003|Overall Study|Withdrawal by Subject|1|||
49177093|NCT02365597|158480478|FG000|Overall Study|Sponsor's decision|1|||
49177094|NCT02365597|158480479|FG001|Overall Study|Sponsor's decision|3|||
49177095|NCT02365597|158480480|FG002|Overall Study|Sponsor's decision|13|||
49177096|NCT02365597|158480481|FG003|Overall Study|Sponsor's decision|0|||
49177097|NCT02365597|158480478|FG000|Overall Study|Other|0|||
49177098|NCT02365597|158480479|FG001|Overall Study|Other|4|||
49177099|NCT02365597|158480480|FG002|Overall Study|Other|0|||
48927294|NCT00272987|157566537|FG002|Overall Study|Lost to Follow-up|1|||
49177100|NCT02365597|158480481|FG003|Overall Study|Other|0|||
49177101|NCT02365597|158480478|FG000|Overall Study|Enrolled but not treated|0|||
49177102|NCT02365597|158480479|FG001|Overall Study|Enrolled but not treated|1|||
49177103|NCT02365597|158480480|FG002|Overall Study|Enrolled but not treated|1|||
49177104|NCT02365597|158480481|FG003|Overall Study|Enrolled but not treated|0|||
49177105|NCT02365597|158480478|FG000|Overall Study|Ongoing|0|||
49177106|NCT02365597|158480479|FG001|Overall Study|Ongoing|0|||
49177107|NCT02365597|158480480|FG002|Overall Study|Ongoing|0|||
49177108|NCT02365597|158480481|FG003|Overall Study|Ongoing|17|||
49177109|NCT02567435|158480482|FG000|Overall Study|Death|1|||
49177110|NCT02567435|158480483|FG001|Overall Study|Death|1|||
49177111|NCT02567435|158480484|FG002|Overall Study|Death|0|||
49177112|NCT02567435|158480485|FG003|Overall Study|Death|0|||
49177113|NCT02567435|158480482|FG000|Overall Study|Ineligible|1|||
49177114|NCT02567435|158480483|FG001|Overall Study|Ineligible|3|||
49177115|NCT02567435|158480484|FG002|Overall Study|Ineligible|0|||
49177116|NCT02567435|158480485|FG003|Overall Study|Ineligible|0|||
49177117|NCT02567435|158480482|FG000|Overall Study|Withdrawal of consent for any further data submissions|4|||
49177118|NCT02567435|158480483|FG001|Overall Study|Withdrawal of consent for any further data submissions|5|||
49177119|NCT02567435|158480484|FG002|Overall Study|Withdrawal of consent for any further data submissions|0|||
49177120|NCT02567435|158480485|FG003|Overall Study|Withdrawal of consent for any further data submissions|1|||
49177121|NCT02166463|158480486|FG000|Overall Study|Lost to Follow-up|0|||
49177122|NCT02166463|158480487|FG001|Overall Study|Lost to Follow-up|1|||
49177123|NCT02166463|158480486|FG000|Overall Study|Physician Decision|10|||
49177124|NCT02166463|158480487|FG001|Overall Study|Physician Decision|10|||
49177125|NCT02166463|158480486|FG000|Overall Study|Ineligible|11|||
49177126|NCT02166463|158480487|FG001|Overall Study|Ineligible|2|||
49177127|NCT02166463|158480486|FG000|Overall Study|Progressive Disease|9|||
49177128|NCT02166463|158480487|FG001|Overall Study|Progressive Disease|6|||
49177129|NCT02166463|158480486|FG000|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
49177130|NCT02166463|158480487|FG001|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
49177131|NCT02166463|158480486|FG000|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|1|||
49177132|NCT02166463|158480487|FG001|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|0|||
49177133|NCT02166463|158480486|FG000|Overall Study|Refusal of further protocol therapy|5|||
49177134|NCT02166463|158480487|FG001|Overall Study|Refusal of further protocol therapy|6|||
49177135|NCT03452579|158480488|FG000|Overall Study|Death|0|||
49177136|NCT03452579|158480489|FG001|Overall Study|Death|1|||
49177137|NCT03452579|158480488|FG000|Overall Study|Withdrawal by Subject|2|||
49177138|NCT03452579|158480489|FG001|Overall Study|Withdrawal by Subject|0|||
49177139|NCT03452579|158480488|FG000|Overall Study|Disease progression, relapse during active treatment|38|||
49177140|NCT03452579|158480489|FG001|Overall Study|Disease progression, relapse during active treatment|37|||
49177141|NCT03452579|158480488|FG000|Overall Study|Physician Decision|1|||
49177142|NCT03452579|158480489|FG001|Overall Study|Physician Decision|1|||
49177143|NCT03452579|158480488|FG000|Overall Study|Adverse Event|1|||
49177144|NCT03452579|158480489|FG001|Overall Study|Adverse Event|4|||
49177145|NCT02101775|158480490|FG000|Overall Study|Adverse Event|4|||
49177146|NCT02101775|158480491|FG001|Overall Study|Adverse Event|0|||
49177147|NCT02101775|158480492|FG002|Overall Study|Adverse Event|0|||
49177148|NCT02101775|158480490|FG000|Overall Study|Admission to Hospital|0|||
49177149|NCT02101775|158480491|FG001|Overall Study|Admission to Hospital|1|||
49177150|NCT02101775|158480492|FG002|Overall Study|Admission to Hospital|0|||
49177151|NCT02242942|158480493|FG000|Overall Study|Death|17|||
49177152|NCT02242942|158480494|FG001|Overall Study|Death|20|||
49177153|NCT02242942|158480495|FG002|Overall Study|Death|2|||
49177154|NCT02242942|158480493|FG000|Overall Study|Physician Decision|1|||
49177155|NCT02242942|158480494|FG001|Overall Study|Physician Decision|0|||
49177156|NCT02242942|158480495|FG002|Overall Study|Physician Decision|0|||
49177157|NCT02242942|158480493|FG000|Overall Study|Withdrawal by Subject|8|||
49177158|NCT02242942|158480494|FG001|Overall Study|Withdrawal by Subject|10|||
49177159|NCT02242942|158480495|FG002|Overall Study|Withdrawal by Subject|0|||
49177160|NCT02242942|158480493|FG000|Overall Study|On-going in Study|190|||
49177161|NCT02242942|158480494|FG001|Overall Study|On-going in Study|186|||
49177162|NCT02242942|158480495|FG002|Overall Study|On-going in Study|11|||
49177163|NCT05006872|158480496|FG000|Overall Study|Lost to Follow-up|37|||
49177164|NCT05006872|158480497|FG001|Overall Study|Lost to Follow-up|31|||
49177165|NCT03668236|158480498|FG000|90-day Follow-up|Withdrawal by Subject|3|||
49177166|NCT03668236|158480499|FG001|90-day Follow-up|Withdrawal by Subject|2|||
49177167|NCT03668236|158480498|FG000|90-day Follow-up|Lost to Follow-up|3|||
49177168|NCT03668236|158480499|FG001|90-day Follow-up|Lost to Follow-up|1|||
49177169|NCT03668236|158480498|FG000|Baseline Characteristics|Lost to Follow-up|9|||
49177170|NCT03668236|158480499|FG001|Baseline Characteristics|Lost to Follow-up|5|||
49177171|NCT03668236|158480498|FG000|1-year Follow-up|Withdrawal by Subject|17|||
49177172|NCT03668236|158480499|FG001|1-year Follow-up|Withdrawal by Subject|15|||
49177173|NCT04788511|158480500|FG000|Overall Study|Withdrawal by Subject|2|||
49177174|NCT04788511|158480501|FG001|Overall Study|Withdrawal by Subject|1|||
49177175|NCT04788511|158480500|FG000|Overall Study|Lost to Follow-up|2|||
49177176|NCT04788511|158480501|FG001|Overall Study|Lost to Follow-up|7|||
49177177|NCT04788511|158480500|FG000|Overall Study|Death|3|||
49177178|NCT04788511|158480501|FG001|Overall Study|Death|4|||
49177179|NCT04458922|158480507|FG000|Overall Study|Withdrawal by Subject|1|||
49177180|NCT04458922|158480508|FG001|Overall Study|Withdrawal by Subject|0|||
49177181|NCT04458922|158480509|FG002|Overall Study|Withdrawal by Subject|2|||
49177182|NCT04458922|158480507|FG000|Overall Study|Protocol -specified withdrawal criterion met|0|||
49177183|NCT04458922|158480508|FG001|Overall Study|Protocol -specified withdrawal criterion met|0|||
49177184|NCT04458922|158480509|FG002|Overall Study|Protocol -specified withdrawal criterion met|1|||
49177185|NCT04458922|158480507|FG000|Overall Study|Adverse Event|1|||
49177186|NCT04458922|158480508|FG001|Overall Study|Adverse Event|0|||
49177187|NCT04458922|158480509|FG002|Overall Study|Adverse Event|0|||
49177188|NCT04458922|158480507|FG000|Overall Study|Started new study|0|||
49177189|NCT04458922|158480508|FG001|Overall Study|Started new study|0|||
49177190|NCT04458922|158480509|FG002|Overall Study|Started new study|1|||
49177191|NCT04458922|158480507|FG000|Overall Study|Progressive disease|6|||
49177192|NCT04458922|158480508|FG001|Overall Study|Progressive disease|8|||
49177193|NCT04458922|158480509|FG002|Overall Study|Progressive disease|2|||
49177194|NCT04458922|158480507|FG000|Overall Study|Death|1|||
49177195|NCT04458922|158480508|FG001|Overall Study|Death|0|||
49177196|NCT04458922|158480509|FG002|Overall Study|Death|2|||
49177197|NCT04458922|158480507|FG000|Overall Study|Participant started chemotherapy|0|||
49177198|NCT04458922|158480508|FG001|Overall Study|Participant started chemotherapy|1|||
49177199|NCT04458922|158480509|FG002|Overall Study|Participant started chemotherapy|0|||
49177200|NCT02003222|158480510|FG000|Induction|Never started treatment|0|||
49177201|NCT02003222|158480511|FG001|Induction|Never started treatment|0|||
49177202|NCT02003222|158480512|FG002|Induction|Never started treatment|0|||
49177203|NCT02003222|158480513|FG003|Induction|Never started treatment|0|||
49177204|NCT02003222|158480514|FG004|Induction|Never started treatment|8|||
49177205|NCT02003222|158480510|FG000|Induction|Complete remission or complete remission incomplete not achieved|0|||
49177206|NCT02003222|158480511|FG001|Induction|Complete remission or complete remission incomplete not achieved|0|||
49177207|NCT02003222|158480512|FG002|Induction|Complete remission or complete remission incomplete not achieved|0|||
49177208|NCT02003222|158480513|FG003|Induction|Complete remission or complete remission incomplete not achieved|0|||
49177209|NCT02003222|158480514|FG004|Induction|Complete remission or complete remission incomplete not achieved|67|||
49177210|NCT02003222|158480510|FG000|Induction|Adverse Event|0|||
49177211|NCT02003222|158480511|FG001|Induction|Adverse Event|0|||
49177212|NCT02003222|158480512|FG002|Induction|Adverse Event|0|||
49177213|NCT02003222|158480513|FG003|Induction|Adverse Event|0|||
49177214|NCT02003222|158480514|FG004|Induction|Adverse Event|13|||
49177215|NCT02003222|158480510|FG000|Induction|Alternative therapy|0|||
49177216|NCT02003222|158480511|FG001|Induction|Alternative therapy|0|||
49177217|NCT02003222|158480512|FG002|Induction|Alternative therapy|0|||
49177218|NCT02003222|158480513|FG003|Induction|Alternative therapy|0|||
49177219|NCT02003222|158480514|FG004|Induction|Alternative therapy|12|||
49177220|NCT02003222|158480510|FG000|Induction|Disease progression|0|||
49177221|NCT02003222|158480511|FG001|Induction|Disease progression|0|||
49177222|NCT02003222|158480512|FG002|Induction|Disease progression|0|||
49177223|NCT02003222|158480513|FG003|Induction|Disease progression|0|||
49177224|NCT02003222|158480514|FG004|Induction|Disease progression|22|||
49177225|NCT02003222|158480510|FG000|Induction|Death|0|||
49177226|NCT02003222|158480511|FG001|Induction|Death|0|||
49177227|NCT02003222|158480512|FG002|Induction|Death|0|||
49177228|NCT02003222|158480513|FG003|Induction|Death|0|||
49177229|NCT02003222|158480514|FG004|Induction|Death|3|||
49177230|NCT02003222|158480510|FG000|Induction|Withdrawal by Subject|0|||
49177231|NCT02003222|158480511|FG001|Induction|Withdrawal by Subject|0|||
49177232|NCT02003222|158480512|FG002|Induction|Withdrawal by Subject|0|||
49177233|NCT02003222|158480513|FG003|Induction|Withdrawal by Subject|0|||
49177234|NCT02003222|158480514|FG004|Induction|Withdrawal by Subject|8|||
49177235|NCT02003222|158480510|FG000|Induction|Other reasons|0|||
49177236|NCT02003222|158480511|FG001|Induction|Other reasons|0|||
49177237|NCT02003222|158480512|FG002|Induction|Other reasons|0|||
49177238|NCT02003222|158480513|FG003|Induction|Other reasons|0|||
49177239|NCT02003222|158480514|FG004|Induction|Other reasons|22|||
49177240|NCT02003222|158480510|FG000|Intensification|Never started treatment|0|||
49177241|NCT02003222|158480511|FG001|Intensification|Never started treatment|0|||
49177242|NCT02003222|158480512|FG002|Intensification|Never started treatment|0|||
49177243|NCT02003222|158480513|FG003|Intensification|Never started treatment|0|||
49177244|NCT02003222|158480514|FG004|Intensification|Never started treatment|2|||
49177245|NCT02003222|158480510|FG000|Intensification|Adverse Event|0|||
48927295|NCT00272987|157566535|FG000|Overall Study|Withdrawal by Subject|1|||
48927296|NCT00272987|157566536|FG001|Overall Study|Withdrawal by Subject|0|||
49177246|NCT02003222|158480511|FG001|Intensification|Adverse Event|0|||
49177247|NCT02003222|158480512|FG002|Intensification|Adverse Event|0|||
49177248|NCT02003222|158480513|FG003|Intensification|Adverse Event|0|||
49177249|NCT02003222|158480514|FG004|Intensification|Adverse Event|6|||
49177250|NCT02003222|158480510|FG000|Intensification|Alternative therapy|0|||
49177251|NCT02003222|158480511|FG001|Intensification|Alternative therapy|0|||
49177252|NCT02003222|158480512|FG002|Intensification|Alternative therapy|0|||
49177253|NCT02003222|158480513|FG003|Intensification|Alternative therapy|0|||
49177254|NCT02003222|158480514|FG004|Intensification|Alternative therapy|8|||
49177255|NCT02003222|158480510|FG000|Intensification|Disease progression|0|||
49177256|NCT02003222|158480511|FG001|Intensification|Disease progression|0|||
49177257|NCT02003222|158480512|FG002|Intensification|Disease progression|0|||
49177258|NCT02003222|158480513|FG003|Intensification|Disease progression|0|||
49177259|NCT02003222|158480514|FG004|Intensification|Disease progression|18|||
49177260|NCT02003222|158480510|FG000|Intensification|Withdrawal by Subject|0|||
49177261|NCT02003222|158480511|FG001|Intensification|Withdrawal by Subject|0|||
49177262|NCT02003222|158480512|FG002|Intensification|Withdrawal by Subject|0|||
49177263|NCT02003222|158480513|FG003|Intensification|Withdrawal by Subject|0|||
49177264|NCT02003222|158480514|FG004|Intensification|Withdrawal by Subject|5|||
49177265|NCT02003222|158480510|FG000|Intensification|Other reasons|0|||
49177266|NCT02003222|158480511|FG001|Intensification|Other reasons|0|||
49177267|NCT02003222|158480512|FG002|Intensification|Other reasons|0|||
49177268|NCT02003222|158480513|FG003|Intensification|Other reasons|0|||
49177269|NCT02003222|158480514|FG004|Intensification|Other reasons|8|||
49177270|NCT06019559|158480515|FG000|Overall Study|Withdrawal by Subject|7|||
49177271|NCT06019559|158480516|FG001|Overall Study|Withdrawal by Subject|6|||
49177272|NCT06019559|158480517|FG002|Overall Study|Withdrawal by Subject|5|||
49177273|NCT06019559|158480515|FG000|Overall Study|Lost to Follow-up|2|||
49177274|NCT06019559|158480516|FG001|Overall Study|Lost to Follow-up|0|||
49177275|NCT06019559|158480517|FG002|Overall Study|Lost to Follow-up|3|||
49177276|NCT03975647|158480518|FG000|Overall Study|Death|71|||
49177277|NCT03975647|158480519|FG001|Overall Study|Death|63|||
49177278|NCT03975647|158480518|FG000|Overall Study|Lost to Follow-up|2|||
49177279|NCT03975647|158480519|FG001|Overall Study|Lost to Follow-up|2|||
49177280|NCT03975647|158480518|FG000|Overall Study|Subject withdrawal of consent|7|||
49177281|NCT03975647|158480519|FG001|Overall Study|Subject withdrawal of consent|11|||
49177282|NCT03182244|158480520|FG000|Treatment Period (Upto 1917 Days)|Adverse Event|8|||
49177283|NCT03182244|158480521|FG001|Treatment Period (Upto 1917 Days)|Adverse Event|9|||
49177284|NCT03182244|158480520|FG000|Treatment Period (Upto 1917 Days)|Death|19|||
49177285|NCT03182244|158480521|FG001|Treatment Period (Upto 1917 Days)|Death|8|||
49177286|NCT03182244|158480520|FG000|Treatment Period (Upto 1917 Days)|Miscellaneous|12|||
49177287|NCT03182244|158480521|FG001|Treatment Period (Upto 1917 Days)|Miscellaneous|0|||
49177288|NCT03182244|158480520|FG000|Treatment Period (Upto 1917 Days)|Disease Relapse|41|||
49177289|NCT03182244|158480521|FG001|Treatment Period (Upto 1917 Days)|Disease Relapse|5|||
49177290|NCT03182244|158480520|FG000|Treatment Period (Upto 1917 Days)|Physician Decision|5|||
49177291|NCT03182244|158480521|FG001|Treatment Period (Upto 1917 Days)|Physician Decision|10|||
49177292|NCT03182244|158480520|FG000|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|10|||
49177293|NCT03182244|158480521|FG001|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|28|||
49177294|NCT03182244|158480520|FG000|Treatment Period (Upto 1917 Days)|Protocol Violation|4|||
49177295|NCT03182244|158480521|FG001|Treatment Period (Upto 1917 Days)|Protocol Violation|1|||
49177296|NCT03182244|158480520|FG000|Treatment Period (Upto 1917 Days)|Progressive Disease|18|||
49177297|NCT03182244|158480521|FG001|Treatment Period (Upto 1917 Days)|Progressive Disease|9|||
49177298|NCT03182244|158480520|FG000|Treatment Period (Upto 1917 Days)|Lack of Efficacy|20|||
49177299|NCT03182244|158480521|FG001|Treatment Period (Upto 1917 Days)|Lack of Efficacy|43|||
49177300|NCT03182244|158480520|FG000|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|4|||
49177301|NCT03182244|158480521|FG001|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|3|||
49177302|NCT03182244|158480520|FG000|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|5|||
49177303|NCT03182244|158480521|FG001|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|8|||
49177304|NCT03182244|158480520|FG000|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|6|||
49177305|NCT03182244|158480521|FG001|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|7|||
49177306|NCT03182244|158480520|FG000|Long Term Follow-up (Up to 1232 Days)|Death|76|||
49177307|NCT03182244|158480521|FG001|Long Term Follow-up (Up to 1232 Days)|Death|75|||
49177308|NCT05362487|158480522|FG000|Overall Study|Study was prematurely terminated as per Sponsor's decision|4|||
49177309|NCT06215521|158480523|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
49177310|NCT06215521|158480524|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
49177311|NCT06215521|158480525|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
49177312|NCT06215521|158480526|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
49177313|NCT06215521|158480527|FG004|Treatment Period 1 (Day 1)|Adverse Event|0|||
49177314|NCT06215521|158480528|FG005|Treatment Period 1 (Day 1)|Adverse Event|0|||
49177315|NCT04462471|158480529|FG000|Overall Study|Adverse Event|0|||
49177316|NCT04462471|158480530|FG001|Overall Study|Adverse Event|1|||
49177317|NCT04462471|158480531|FG002|Overall Study|Adverse Event|0|||
49177318|NCT04462471|158480532|FG003|Overall Study|Adverse Event|0|||
49177319|NCT04462471|158480529|FG000|Overall Study|Disease progression|1|||
49177320|NCT04462471|158480530|FG001|Overall Study|Disease progression|0|||
49177321|NCT04462471|158480531|FG002|Overall Study|Disease progression|0|||
49177322|NCT04462471|158480532|FG003|Overall Study|Disease progression|0|||
49177323|NCT05170009|158480533|FG000|Overall Study|Physician Decision|0|||
49177324|NCT05170009|158480534|FG001|Overall Study|Physician Decision|1|||
49177325|NCT02296125|158480537|FG000|Overall Study|Withdrawal by Subject|18|||
49177326|NCT02296125|158480538|FG001|Overall Study|Withdrawal by Subject|8|||
49177327|NCT02296125|158480539|FG002|Overall Study|Withdrawal by Subject|6|||
49177328|NCT02296125|158480540|FG003|Overall Study|Withdrawal by Subject|2|||
49177329|NCT02296125|158480537|FG000|Overall Study|Adverse Event|41|||
49177330|NCT02296125|158480538|FG001|Overall Study|Adverse Event|52|||
49177331|NCT02296125|158480539|FG002|Overall Study|Adverse Event|9|||
49177332|NCT02296125|158480540|FG003|Overall Study|Adverse Event|4|||
49177333|NCT02296125|158480537|FG000|Overall Study|Severe non-compliance to protocol|0|||
49177334|NCT02296125|158480538|FG001|Overall Study|Severe non-compliance to protocol|1|||
49177335|NCT02296125|158480539|FG002|Overall Study|Severe non-compliance to protocol|0|||
49177336|NCT02296125|158480540|FG003|Overall Study|Severe non-compliance to protocol|0|||
49177337|NCT02296125|158480537|FG000|Overall Study|Condition under investigation worsened|153|||
49177338|NCT02296125|158480538|FG001|Overall Study|Condition under investigation worsened|199|||
49177339|NCT02296125|158480539|FG002|Overall Study|Condition under investigation worsened|39|||
48927297|NCT00272987|157566537|FG002|Overall Study|Withdrawal by Subject|3|||
48927298|NCT00272987|157566535|FG000|Overall Study|Sponsor Terminated study|0|||
48927299|NCT00272987|157566536|FG001|Overall Study|Sponsor Terminated study|1|||
48927300|NCT00272987|157566537|FG002|Overall Study|Sponsor Terminated study|1|||
48927301|NCT00272987|157566535|FG000|Overall Study|Disease progression|1|||
48927302|NCT00272987|157566536|FG001|Overall Study|Disease progression|1|||
48927303|NCT00272987|157566537|FG002|Overall Study|Disease progression|2|||
48927304|NCT00272987|157566535|FG000|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2|||
48927305|NCT00272987|157566536|FG001|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1|||
48927306|NCT00272987|157566537|FG002|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4|||
48927307|NCT00272987|157566535|FG000|Overall Study|Death|1|||
48927308|NCT00272987|157566536|FG001|Overall Study|Death|0|||
48927309|NCT00272987|157566537|FG002|Overall Study|Death|0|||
48927310|NCT00662792|157566538|FG000|Period 1|Personal Reasons|0|||
48927311|NCT00662792|157566539|FG001|Period 1|Personal Reasons|0|||
48927312|NCT00662792|157566540|FG002|Period 1|Personal Reasons|1|||
48927313|NCT00662792|157566541|FG003|Period 1|Personal Reasons|0|||
48927314|NCT00662792|157566538|FG000|Period 1|Refused continuing medication|0|||
48927315|NCT00662792|157566539|FG001|Period 1|Refused continuing medication|1|||
48927316|NCT00662792|157566540|FG002|Period 1|Refused continuing medication|1|||
48927317|NCT00662792|157566541|FG003|Period 1|Refused continuing medication|0|||
48927318|NCT00662792|157566538|FG000|Period 1|Lost to Follow-up|1|||
48927319|NCT00662792|157566539|FG001|Period 1|Lost to Follow-up|0|||
48927320|NCT00662792|157566540|FG002|Period 1|Lost to Follow-up|0|||
48927321|NCT00662792|157566541|FG003|Period 1|Lost to Follow-up|0|||
48927322|NCT00662792|157566538|FG000|Period 1|Other adverse event (AE)|0|||
48927323|NCT00662792|157566539|FG001|Period 1|Other adverse event (AE)|2|||
48927324|NCT00662792|157566540|FG002|Period 1|Other adverse event (AE)|0|||
48927325|NCT00662792|157566541|FG003|Period 1|Other adverse event (AE)|0|||
48927326|NCT00662792|157566538|FG000|Period 1|Worsening of disease under study (AE)|1|||
48927327|NCT00662792|157566539|FG001|Period 1|Worsening of disease under study (AE)|3|||
48927328|NCT00662792|157566540|FG002|Period 1|Worsening of disease under study (AE)|2|||
48927329|NCT00662792|157566541|FG003|Period 1|Worsening of disease under study (AE)|0|||
48927330|NCT00662792|157566538|FG000|Period 1|Not treated|0|||
48927331|NCT00662792|157566539|FG001|Period 1|Not treated|1|||
48927332|NCT00662792|157566540|FG002|Period 1|Not treated|0|||
48927333|NCT00662792|157566541|FG003|Period 1|Not treated|0|||
48927334|NCT00662792|157566538|FG000|Period 2|Worsening of disease under study|1|||
48927335|NCT00662792|157566539|FG001|Period 2|Worsening of disease under study|0|||
48927336|NCT00662792|157566540|FG002|Period 2|Worsening of disease under study|0|||
48927337|NCT00662792|157566541|FG003|Period 2|Worsening of disease under study|3|||
48927338|NCT00662792|157566538|FG000|Period 3|Refused continuing medication|1|||
48927339|NCT00662792|157566539|FG001|Period 3|Refused continuing medication|0|||
48927340|NCT00662792|157566540|FG002|Period 3|Refused continuing medication|1|||
48927341|NCT00662792|157566541|FG003|Period 3|Refused continuing medication|0|||
48927342|NCT00662792|157566538|FG000|Period 3|Other adverse event (AE)|0|||
48927343|NCT00662792|157566539|FG001|Period 3|Other adverse event (AE)|0|||
48927344|NCT00662792|157566540|FG002|Period 3|Other adverse event (AE)|1|||
48927345|NCT00662792|157566541|FG003|Period 3|Other adverse event (AE)|1|||
48927346|NCT00662792|157566538|FG000|Period 4|Refused continuing medication|0|||
48927347|NCT00662792|157566539|FG001|Period 4|Refused continuing medication|1|||
48927348|NCT00662792|157566540|FG002|Period 4|Refused continuing medication|0|||
48927349|NCT00662792|157566541|FG003|Period 4|Refused continuing medication|0|||
48927350|NCT00662792|157566538|FG000|Period 4|Other adverse event (AE)|1|||
48927351|NCT00662792|157566539|FG001|Period 4|Other adverse event (AE)|0|||
48927352|NCT00662792|157566540|FG002|Period 4|Other adverse event (AE)|0|||
48927353|NCT00662792|157566541|FG003|Period 4|Other adverse event (AE)|0|||
48927354|NCT00662792|157566538|FG000|Period 4|Worsening of disease under study (AE)|0|||
48927355|NCT00662792|157566539|FG001|Period 4|Worsening of disease under study (AE)|0|||
48927356|NCT00662792|157566540|FG002|Period 4|Worsening of disease under study (AE)|0|||
48927357|NCT00662792|157566541|FG003|Period 4|Worsening of disease under study (AE)|1|||
48927358|NCT02499029|157566545|FG000|Overall Study|Lost to Follow-up|2|||
48927359|NCT02499029|157566546|FG001|Overall Study|Lost to Follow-up|2|||
48927360|NCT02499029|157566545|FG000|Overall Study|Physician Decision|2|||
48927361|NCT02499029|157566546|FG001|Overall Study|Physician Decision|1|||
48927362|NCT02499029|157566545|FG000|Overall Study|Death|1|||
48927363|NCT02499029|157566546|FG001|Overall Study|Death|0|||
48927364|NCT02809833|157566548|FG000|Overall Study|Death|3|||
48927365|NCT02809833|157566548|FG000|Overall Study|Intolerance|54|||
48927366|NCT02809833|157566548|FG000|Overall Study|Lack of Efficacy|89|||
48927367|NCT02809833|157566548|FG000|Overall Study|Remission/Treatment No Longer Needed|3|||
48927368|NCT02809833|157566548|FG000|Overall Study|Noncompliance|1|||
49177340|NCT02296125|158480540|FG003|Overall Study|Condition under investigation worsened|56|||
49177341|NCT02296125|158480537|FG000|Overall Study|Any reason not specifically recorded|6|||
48927369|NCT02809833|157566548|FG000|Overall Study|Withdrawal by Subject|34|||
49177342|NCT02296125|158480538|FG001|Overall Study|Any reason not specifically recorded|4|||
49177343|NCT02296125|158480539|FG002|Overall Study|Any reason not specifically recorded|2|||
49177344|NCT02296125|158480540|FG003|Overall Study|Any reason not specifically recorded|0|||
49177345|NCT03448107|158480541|FG000|Overall Study|Lost to Follow-up|229|||
49177346|NCT03448107|158480542|FG001|Overall Study|Lost to Follow-up|258|||
49177347|NCT05126433|158480543|FG000|Overall Study|Withdrawal by Subject|3|||
49177348|NCT05126433|158480544|FG001|Overall Study|Withdrawal by Subject|0|||
49177349|NCT05126433|158480545|FG002|Overall Study|Withdrawal by Subject|4|||
49177350|NCT05126433|158480543|FG000|Overall Study|Death|9|||
49177351|NCT05126433|158480544|FG001|Overall Study|Death|3|||
49177352|NCT05126433|158480545|FG002|Overall Study|Death|5|||
49177353|NCT05126433|158480543|FG000|Overall Study|Study Terminated by sponsor|0|||
49177354|NCT05126433|158480544|FG001|Overall Study|Study Terminated by sponsor|1|||
49177355|NCT05126433|158480545|FG002|Overall Study|Study Terminated by sponsor|2|||
49177356|NCT05126433|158480543|FG000|Overall Study|Progressive Disease|1|||
49177357|NCT05126433|158480544|FG001|Overall Study|Progressive Disease|4|||
49177358|NCT05126433|158480545|FG002|Overall Study|Progressive Disease|3|||
49177359|NCT05126433|158480543|FG000|Overall Study|Sponsor decision- no further OS follow up required|2|||
49177360|NCT05126433|158480544|FG001|Overall Study|Sponsor decision- no further OS follow up required|4|||
49177361|NCT05126433|158480545|FG002|Overall Study|Sponsor decision- no further OS follow up required|6|||
49177362|NCT03473743|158480546|FG000|Overall Study|Withdrawal by Subject|0|||
49177363|NCT03473743|158480547|FG001|Overall Study|Withdrawal by Subject|0|||
49177364|NCT03473743|158480548|FG002|Overall Study|Withdrawal by Subject|0|||
49177365|NCT03473743|158480549|FG003|Overall Study|Withdrawal by Subject|0|||
49177366|NCT03473743|158480550|FG004|Overall Study|Withdrawal by Subject|0|||
49177367|NCT03473743|158480551|FG005|Overall Study|Withdrawal by Subject|0|||
49177368|NCT03473743|158480552|FG006|Overall Study|Withdrawal by Subject|0|||
49177369|NCT03473743|158480553|FG007|Overall Study|Withdrawal by Subject|3|||
49177370|NCT03473743|158480546|FG000|Overall Study|Other|0|||
49177371|NCT03473743|158480547|FG001|Overall Study|Other|0|||
49177372|NCT03473743|158480548|FG002|Overall Study|Other|0|||
49177373|NCT03473743|158480549|FG003|Overall Study|Other|1|||
49177374|NCT03473743|158480550|FG004|Overall Study|Other|0|||
49177375|NCT03473743|158480551|FG005|Overall Study|Other|0|||
49177376|NCT03473743|158480552|FG006|Overall Study|Other|0|||
49177377|NCT03473743|158480553|FG007|Overall Study|Other|0|||
49177378|NCT03473743|158480546|FG000|Overall Study|Ongoing|0|||
49177379|NCT03473743|158480547|FG001|Overall Study|Ongoing|0|||
49177380|NCT03473743|158480548|FG002|Overall Study|Ongoing|6|||
49177381|NCT03473743|158480549|FG003|Overall Study|Ongoing|8|||
49177382|NCT03473743|158480550|FG004|Overall Study|Ongoing|1|||
49177383|NCT03473743|158480551|FG005|Overall Study|Ongoing|1|||
49177384|NCT03473743|158480552|FG006|Overall Study|Ongoing|22|||
49177385|NCT03473743|158480553|FG007|Overall Study|Ongoing|24|||
49177386|NCT03473743|158480546|FG000|Overall Study|Randomized but not treated|0|||
49177387|NCT03473743|158480547|FG001|Overall Study|Randomized but not treated|0|||
49177388|NCT03473743|158480548|FG002|Overall Study|Randomized but not treated|0|||
49177389|NCT03473743|158480549|FG003|Overall Study|Randomized but not treated|0|||
49177390|NCT03473743|158480550|FG004|Overall Study|Randomized but not treated|0|||
49177391|NCT03473743|158480551|FG005|Overall Study|Randomized but not treated|0|||
49177392|NCT03473743|158480552|FG006|Overall Study|Randomized but not treated|1|||
49177393|NCT03473743|158480553|FG007|Overall Study|Randomized but not treated|1|||
49177394|NCT01648023|158480554|FG000|Overall Study|Screen Fail Post Randomization|1|||
49177395|NCT01648023|158480555|FG001|Overall Study|Screen Fail Post Randomization|2|||
49177396|NCT05084508|158480556|FG000|Overall Study|Lost to Follow-up|6|||
49177397|NCT05084508|158480557|FG001|Overall Study|Lost to Follow-up|3|||
49177398|NCT05084508|158480558|FG002|Overall Study|Lost to Follow-up|7|||
49177399|NCT05084508|158480559|FG003|Overall Study|Lost to Follow-up|3|||
49177400|NCT05084508|158480556|FG000|Overall Study|Withdrawal by Subject|0|||
49177401|NCT05084508|158480557|FG001|Overall Study|Withdrawal by Subject|2|||
49177402|NCT05084508|158480558|FG002|Overall Study|Withdrawal by Subject|3|||
49177403|NCT05084508|158480559|FG003|Overall Study|Withdrawal by Subject|1|||
49177404|NCT05084508|158480556|FG000|Overall Study|Other|0|||
49177405|NCT05084508|158480557|FG001|Overall Study|Other|0|||
49177406|NCT05084508|158480558|FG002|Overall Study|Other|0|||
49177407|NCT05084508|158480559|FG003|Overall Study|Other|1|||
49177408|NCT01272037|158480560|FG000|Overall Study|Death|25|||
49177409|NCT01272037|158480561|FG001|Overall Study|Death|28|||
49177410|NCT01272037|158480560|FG000|Overall Study|Adverse Event|12|||
49177411|NCT01272037|158480561|FG001|Overall Study|Adverse Event|7|||
49177412|NCT01272037|158480560|FG000|Overall Study|Withdrawal by Subject|175|||
49177413|NCT01272037|158480561|FG001|Overall Study|Withdrawal by Subject|93|||
49177414|NCT01272037|158480560|FG000|Overall Study|Disease progression|70|||
49177415|NCT01272037|158480561|FG001|Overall Study|Disease progression|111|||
49177416|NCT01272037|158480560|FG000|Overall Study|Other reason|42|||
49177417|NCT01272037|158480561|FG001|Overall Study|Other reason|41|||
49177418|NCT01272037|158480560|FG000|Overall Study|Delinquent data|24|||
49177419|NCT01272037|158480561|FG001|Overall Study|Delinquent data|19|||
49177420|NCT01272037|158480560|FG000|Overall Study|Reason under review|33|||
49177421|NCT01272037|158480561|FG001|Overall Study|Reason under review|29|||
49177422|NCT01272037|158480560|FG000|Overall Study|On treatment|626|||
49177423|NCT01272037|158480561|FG001|Overall Study|On treatment|632|||
49177424|NCT04948697|158480564|FG000|Overall Study|Progressive disease|27|||
49177425|NCT04948697|158480565|FG001|Overall Study|Progressive disease|18|||
49177426|NCT04948697|158480564|FG000|Overall Study|Adverse Event|14|||
49177427|NCT04948697|158480565|FG001|Overall Study|Adverse Event|4|||
49177428|NCT04948697|158480564|FG000|Overall Study|Participant moved to long term extension study|7|||
49177429|NCT04948697|158480565|FG001|Overall Study|Participant moved to long term extension study|4|||
49177430|NCT04948697|158480564|FG000|Overall Study|Withdrawal by Subject|10|||
49177431|NCT04948697|158480565|FG001|Overall Study|Withdrawal by Subject|0|||
49177432|NCT04948697|158480564|FG000|Overall Study|Closed by Sponsor|3|||
49177433|NCT04948697|158480565|FG001|Overall Study|Closed by Sponsor|2|||
49177434|NCT04948697|158480564|FG000|Overall Study|Physician Decision|0|||
49177435|NCT04948697|158480565|FG001|Overall Study|Physician Decision|2|||
49177436|NCT04948697|158480564|FG000|Overall Study|Lost to Follow-up|0|||
49177437|NCT04948697|158480565|FG001|Overall Study|Lost to Follow-up|1|||
49177438|NCT04948697|158480564|FG000|Overall Study|Other-Miscellaneous|1|||
49177439|NCT04948697|158480565|FG001|Overall Study|Other-Miscellaneous|0|||
49177440|NCT04948697|158480564|FG000|Overall Study|Randomized but not treated|0|||
49177441|NCT04948697|158480565|FG001|Overall Study|Randomized but not treated|1|||
49177442|NCT05329220|158480570|FG000|Active Trial Period|Adverse Event|0|||
49177443|NCT05329220|158480571|FG001|Active Trial Period|Adverse Event|0|||
49177444|NCT05329220|158480572|FG002|Active Trial Period|Adverse Event|0|||
49177445|NCT05329220|158480573|FG003|Active Trial Period|Adverse Event|0|||
49177446|NCT05329220|158480574|FG004|Active Trial Period|Adverse Event|1|||
49177447|NCT05329220|158480575|FG005|Active Trial Period|Adverse Event|0|||
49177448|NCT05329220|158480570|FG000|Active Trial Period|Lost to Follow-up|0|||
49177449|NCT05329220|158480571|FG001|Active Trial Period|Lost to Follow-up|0|||
49177450|NCT05329220|158480572|FG002|Active Trial Period|Lost to Follow-up|0|||
49177451|NCT05329220|158480573|FG003|Active Trial Period|Lost to Follow-up|0|||
49177452|NCT05329220|158480574|FG004|Active Trial Period|Lost to Follow-up|32|||
49177453|NCT05329220|158480575|FG005|Active Trial Period|Lost to Follow-up|28|||
49177454|NCT05329220|158480570|FG000|Active Trial Period|Physician Decision|0|||
49177455|NCT05329220|158480571|FG001|Active Trial Period|Physician Decision|0|||
49177456|NCT05329220|158480572|FG002|Active Trial Period|Physician Decision|0|||
49177457|NCT05329220|158480573|FG003|Active Trial Period|Physician Decision|0|||
49177458|NCT05329220|158480574|FG004|Active Trial Period|Physician Decision|2|||
49177459|NCT05329220|158480575|FG005|Active Trial Period|Physician Decision|0|||
49177460|NCT05329220|158480570|FG000|Active Trial Period|Protocol Violation|0|||
49177461|NCT05329220|158480571|FG001|Active Trial Period|Protocol Violation|0|||
49177462|NCT05329220|158480572|FG002|Active Trial Period|Protocol Violation|0|||
49177463|NCT05329220|158480573|FG003|Active Trial Period|Protocol Violation|0|||
49177464|NCT05329220|158480574|FG004|Active Trial Period|Protocol Violation|1|||
49177465|NCT05329220|158480575|FG005|Active Trial Period|Protocol Violation|3|||
49177466|NCT05329220|158480570|FG000|Active Trial Period|Withdrawal by Subject|0|||
49177467|NCT05329220|158480571|FG001|Active Trial Period|Withdrawal by Subject|0|||
49177468|NCT05329220|158480572|FG002|Active Trial Period|Withdrawal by Subject|0|||
49177469|NCT05329220|158480573|FG003|Active Trial Period|Withdrawal by Subject|1|||
49177470|NCT05329220|158480574|FG004|Active Trial Period|Withdrawal by Subject|12|||
49177471|NCT05329220|158480575|FG005|Active Trial Period|Withdrawal by Subject|13|||
49177472|NCT05329220|158480570|FG000|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
49177473|NCT05329220|158480571|FG001|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
49177474|NCT05329220|158480572|FG002|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
49177475|NCT05329220|158480573|FG003|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
49177476|NCT05329220|158480574|FG004|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
49177477|NCT05329220|158480575|FG005|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|1|||
49177478|NCT05329220|158480570|FG000|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
49177479|NCT05329220|158480571|FG001|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
49177480|NCT05329220|158480572|FG002|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
49177481|NCT05329220|158480573|FG003|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
49177482|NCT05329220|158480574|FG004|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
48927370|NCT02809833|157566548|FG000|Overall Study|Lost to Follow-up|35|||
49177483|NCT05329220|158480575|FG005|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|1|||
49177484|NCT05329220|158480570|FG000|Active Trial Period|SUBJECT WAS OOW|0|||
48927371|NCT02809833|157566548|FG000|Overall Study|Adverse Event (AE)|24|||
49177485|NCT05329220|158480571|FG001|Active Trial Period|SUBJECT WAS OOW|0|||
49177486|NCT05329220|158480572|FG002|Active Trial Period|SUBJECT WAS OOW|0|||
48927372|NCT02809833|157566548|FG000|Overall Study|Other|5|||
49177487|NCT05329220|158480573|FG003|Active Trial Period|SUBJECT WAS OOW|0|||
49177488|NCT05329220|158480574|FG004|Active Trial Period|SUBJECT WAS OOW|0|||
49177489|NCT05329220|158480575|FG005|Active Trial Period|SUBJECT WAS OOW|1|||
49177490|NCT05329220|158480570|FG000|Follow-up Period|Adverse Event|0|||
49177491|NCT05329220|158480571|FG001|Follow-up Period|Adverse Event|0|||
49177492|NCT05329220|158480572|FG002|Follow-up Period|Adverse Event|0|||
49177493|NCT05329220|158480573|FG003|Follow-up Period|Adverse Event|0|||
49177494|NCT05329220|158480574|FG004|Follow-up Period|Adverse Event|2|||
49177495|NCT05329220|158480575|FG005|Follow-up Period|Adverse Event|1|||
49177496|NCT05329220|158480570|FG000|Follow-up Period|Death|0|||
49177497|NCT05329220|158480571|FG001|Follow-up Period|Death|0|||
49177498|NCT05329220|158480572|FG002|Follow-up Period|Death|1|||
49177499|NCT05329220|158480573|FG003|Follow-up Period|Death|1|||
49177500|NCT05329220|158480574|FG004|Follow-up Period|Death|0|||
49177501|NCT05329220|158480575|FG005|Follow-up Period|Death|1|||
49177502|NCT05329220|158480570|FG000|Follow-up Period|Lost to Follow-up|0|||
49177503|NCT05329220|158480571|FG001|Follow-up Period|Lost to Follow-up|1|||
49177504|NCT05329220|158480572|FG002|Follow-up Period|Lost to Follow-up|2|||
49177505|NCT05329220|158480573|FG003|Follow-up Period|Lost to Follow-up|2|||
49177506|NCT05329220|158480574|FG004|Follow-up Period|Lost to Follow-up|113|||
49177507|NCT05329220|158480575|FG005|Follow-up Period|Lost to Follow-up|89|||
49177508|NCT05329220|158480570|FG000|Follow-up Period|Physician Decision|0|||
49177509|NCT05329220|158480571|FG001|Follow-up Period|Physician Decision|0|||
49177510|NCT05329220|158480572|FG002|Follow-up Period|Physician Decision|0|||
49177511|NCT05329220|158480573|FG003|Follow-up Period|Physician Decision|0|||
49177512|NCT05329220|158480574|FG004|Follow-up Period|Physician Decision|2|||
49177513|NCT05329220|158480575|FG005|Follow-up Period|Physician Decision|2|||
49177514|NCT05329220|158480570|FG000|Follow-up Period|Protocol Violation|0|||
49177515|NCT05329220|158480571|FG001|Follow-up Period|Protocol Violation|0|||
49177516|NCT05329220|158480572|FG002|Follow-up Period|Protocol Violation|0|||
49177517|NCT05329220|158480573|FG003|Follow-up Period|Protocol Violation|0|||
49177518|NCT05329220|158480574|FG004|Follow-up Period|Protocol Violation|0|||
49177519|NCT05329220|158480575|FG005|Follow-up Period|Protocol Violation|1|||
49177520|NCT05329220|158480570|FG000|Follow-up Period|Withdrawal by Subject|0|||
49177521|NCT05329220|158480571|FG001|Follow-up Period|Withdrawal by Subject|0|||
49177522|NCT05329220|158480572|FG002|Follow-up Period|Withdrawal by Subject|1|||
49177523|NCT05329220|158480573|FG003|Follow-up Period|Withdrawal by Subject|1|||
49177524|NCT05329220|158480574|FG004|Follow-up Period|Withdrawal by Subject|34|||
49177525|NCT05329220|158480575|FG005|Follow-up Period|Withdrawal by Subject|35|||
49177526|NCT05329220|158480570|FG000|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
49177527|NCT05329220|158480571|FG001|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
49177528|NCT05329220|158480572|FG002|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|1|||
49177529|NCT05329220|158480573|FG003|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
49177530|NCT05329220|158480574|FG004|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
49177531|NCT05329220|158480575|FG005|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
49177532|NCT05329220|158480570|FG000|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
49177533|NCT05329220|158480571|FG001|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
49177534|NCT05329220|158480572|FG002|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
49177535|NCT05329220|158480573|FG003|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
49177536|NCT05329220|158480574|FG004|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|1|||
49177537|NCT05329220|158480575|FG005|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
49177538|NCT05329220|158480570|FG000|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
49177539|NCT05329220|158480571|FG001|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
49177540|NCT05329220|158480572|FG002|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
49177541|NCT05329220|158480573|FG003|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
49177542|NCT05329220|158480574|FG004|Follow-up Period|SUBJECT NON-COMPLIANCE|1|||
49177543|NCT05329220|158480575|FG005|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
49177544|NCT05329220|158480570|FG000|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
49177545|NCT05329220|158480571|FG001|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
49177546|NCT05329220|158480572|FG002|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
49177547|NCT05329220|158480573|FG003|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
49177548|NCT05329220|158480574|FG004|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
49177549|NCT05329220|158480575|FG005|Follow-up Period|SUBJECT MOVED OUT OF TOWN|1|||
49177550|NCT05329220|158480570|FG000|Follow-up Period|EARLY TERMINATION|0|||
49177551|NCT05329220|158480571|FG001|Follow-up Period|EARLY TERMINATION|0|||
49177552|NCT05329220|158480572|FG002|Follow-up Period|EARLY TERMINATION|0|||
49177553|NCT05329220|158480573|FG003|Follow-up Period|EARLY TERMINATION|0|||
49177554|NCT05329220|158480574|FG004|Follow-up Period|EARLY TERMINATION|0|||
49177555|NCT05329220|158480575|FG005|Follow-up Period|EARLY TERMINATION|1|||
49177556|NCT05329220|158480570|FG000|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
49177557|NCT05329220|158480571|FG001|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
49177558|NCT05329220|158480572|FG002|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
49177559|NCT05329220|158480573|FG003|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
49177560|NCT05329220|158480574|FG004|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
49177561|NCT05329220|158480575|FG005|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|2|||
49177562|NCT05329220|158480570|FG000|Follow-up Period|DROPPED|0|||
49177563|NCT05329220|158480571|FG001|Follow-up Period|DROPPED|0|||
49177564|NCT05329220|158480572|FG002|Follow-up Period|DROPPED|0|||
49177565|NCT05329220|158480573|FG003|Follow-up Period|DROPPED|0|||
49177566|NCT05329220|158480574|FG004|Follow-up Period|DROPPED|0|||
49177567|NCT05329220|158480575|FG005|Follow-up Period|DROPPED|1|||
49177568|NCT05329220|158480570|FG000|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
49177569|NCT05329220|158480571|FG001|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
49177570|NCT05329220|158480572|FG002|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
49177571|NCT05329220|158480573|FG003|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
49177572|NCT05329220|158480574|FG004|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
49177573|NCT05329220|158480575|FG005|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|1|||
49177574|NCT03504397|158480577|FG000|Overall Study|Progressive Disease|133|||
49177575|NCT03504397|158480578|FG001|Overall Study|Progressive Disease|177|||
49177576|NCT03504397|158480577|FG000|Overall Study|Withdrawal by Subject|29|||
49177577|NCT03504397|158480578|FG001|Overall Study|Withdrawal by Subject|18|||
49177578|NCT03504397|158480577|FG000|Overall Study|Lost to Follow-up|1|||
49177579|NCT03504397|158480578|FG001|Overall Study|Lost to Follow-up|0|||
49177580|NCT03504397|158480577|FG000|Overall Study|Death|13|||
49177581|NCT03504397|158480578|FG001|Overall Study|Death|16|||
49177582|NCT03504397|158480577|FG000|Overall Study|Adverse Event|42|||
49177583|NCT03504397|158480578|FG001|Overall Study|Adverse Event|14|||
49177584|NCT03504397|158480577|FG000|Overall Study|miscellaneous|17|||
49177585|NCT03504397|158480578|FG001|Overall Study|miscellaneous|15|||
49177586|NCT03504397|158480577|FG000|Overall Study|Protocol deviation|1|||
49177587|NCT03504397|158480578|FG001|Overall Study|Protocol deviation|0|||
49177588|NCT02427464|158480580|FG000|Overall Study|Adverse Event|6|||
49177589|NCT02427464|158480581|FG001|Overall Study|Adverse Event|1|||
49177590|NCT02427464|158480580|FG000|Overall Study|Lost to Follow-up|16|||
49177591|NCT02427464|158480581|FG001|Overall Study|Lost to Follow-up|5|||
49177592|NCT02427464|158480580|FG000|Overall Study|Physician Decision|2|||
49177593|NCT02427464|158480581|FG001|Overall Study|Physician Decision|0|||
49177594|NCT02427464|158480580|FG000|Overall Study|Withdrawal by Subject|10|||
48844297|NCT01070069|157271314|FG003|Overall Study|Death|0|||
48844298|NCT01070069|157271315|FG004|Overall Study|Death|1|||
49177595|NCT02427464|158480581|FG001|Overall Study|Withdrawal by Subject|8|||
49177596|NCT02427464|158480580|FG000|Overall Study|Noncompliance|16|||
49177597|NCT02427464|158480581|FG001|Overall Study|Noncompliance|10|||
49177598|NCT04103580|158480582|FG000|Phase 1 Active Caregiving|Lost to Follow-up|18|||
49177599|NCT04103580|158480583|FG001|Phase 1 Active Caregiving|Lost to Follow-up|45|||
49177600|NCT04103580|158480582|FG000|Phase 1 Active Caregiving|Withdrawal by Subject|5|||
49177601|NCT04103580|158480583|FG001|Phase 1 Active Caregiving|Withdrawal by Subject|14|||
49177602|NCT04103580|158480582|FG000|Phase 1 Active Caregiving|Decertified from Hospice|3|||
49177603|NCT04103580|158480583|FG001|Phase 1 Active Caregiving|Decertified from Hospice|1|||
49177604|NCT04103580|158480582|FG000|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|41|||
49177605|NCT04103580|158480583|FG001|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|35|||
49177606|NCT04103580|158480582|FG000|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|13|||
49177607|NCT04103580|158480583|FG001|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|19|||
49177608|NCT04103580|158480582|FG000|Phase 1 Active Caregiving|Other|3|||
49177609|NCT04103580|158480583|FG001|Phase 1 Active Caregiving|Other|3|||
49177610|NCT04103580|158480582|FG000|Phase 2 Bereavement|Lost to Follow-up|2|||
49177611|NCT04103580|158480583|FG001|Phase 2 Bereavement|Lost to Follow-up|6|||
49177612|NCT04103580|158480582|FG000|Phase 2 Bereavement|Withdrawal by Subject|1|||
49177613|NCT04103580|158480583|FG001|Phase 2 Bereavement|Withdrawal by Subject|4|||
49177614|NCT04103580|158480582|FG000|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|6|||
49177615|NCT04103580|158480583|FG001|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|7|||
49177616|NCT04103580|158480582|FG000|Phase 2 Bereavement|Other|8|||
49177617|NCT04103580|158480583|FG001|Phase 2 Bereavement|Other|6|||
49177618|NCT04145440|158480584|FG000|Overall Study|Physician Decision|3|||
49177619|NCT04145440|158480585|FG001|Overall Study|Physician Decision|0|||
49177620|NCT04145440|158480584|FG000|Overall Study|Use of prohibited therapy|2|||
49177621|NCT04145440|158480585|FG001|Overall Study|Use of prohibited therapy|3|||
49177622|NCT02927236|158480588|FG000|Characterization Phase|Physician Decision|0|||
49177623|NCT02927236|158480589|FG001|Characterization Phase|Physician Decision|3|||
49177624|NCT02927236|158480590|FG002|Characterization Phase|Physician Decision|0|||
49177625|NCT02927236|158480591|FG003|Characterization Phase|Physician Decision|2|||
49177626|NCT02927236|158480588|FG000|Characterization Phase|Lost to Follow-up|0|||
49177627|NCT02927236|158480589|FG001|Characterization Phase|Lost to Follow-up|0|||
49177628|NCT02927236|158480590|FG002|Characterization Phase|Lost to Follow-up|0|||
49177629|NCT02927236|158480591|FG003|Characterization Phase|Lost to Follow-up|3|||
49177630|NCT02927236|158480588|FG000|Characterization Phase|Withdrawal by Subject|1|||
49177631|NCT02927236|158480589|FG001|Characterization Phase|Withdrawal by Subject|0|||
49177632|NCT02927236|158480590|FG002|Characterization Phase|Withdrawal by Subject|0|||
49177633|NCT02927236|158480591|FG003|Characterization Phase|Withdrawal by Subject|1|||
49177634|NCT02927236|158480588|FG000|Treatment Phase|Adverse Event|1|||
49177635|NCT02927236|158480589|FG001|Treatment Phase|Adverse Event|0|||
49177636|NCT02927236|158480590|FG002|Treatment Phase|Adverse Event|1|||
49177637|NCT02927236|158480591|FG003|Treatment Phase|Adverse Event|1|||
49177638|NCT02927236|158480588|FG000|Treatment Phase|Protocol Violation|3|||
49177639|NCT02927236|158480589|FG001|Treatment Phase|Protocol Violation|0|||
49177640|NCT02927236|158480590|FG002|Treatment Phase|Protocol Violation|0|||
49177641|NCT02927236|158480591|FG003|Treatment Phase|Protocol Violation|1|||
49177642|NCT02927236|158480588|FG000|Treatment Phase|Lost to Follow-up|1|||
49177643|NCT02927236|158480589|FG001|Treatment Phase|Lost to Follow-up|0|||
49177644|NCT02927236|158480590|FG002|Treatment Phase|Lost to Follow-up|0|||
49177645|NCT02927236|158480591|FG003|Treatment Phase|Lost to Follow-up|0|||
49177646|NCT02927236|158480588|FG000|Follow-up Phase|Lost to Follow-up|1|||
49177647|NCT02927236|158480589|FG001|Follow-up Phase|Lost to Follow-up|0|||
49177648|NCT02927236|158480590|FG002|Follow-up Phase|Lost to Follow-up|1|||
49177649|NCT02927236|158480591|FG003|Follow-up Phase|Lost to Follow-up|0|||
49177650|NCT03698019|158480592|FG000|Step 1: Registration|Still receiving protocol therapy|0|||
49177651|NCT03698019|158480593|FG001|Step 1: Registration|Still receiving protocol therapy|10|||
49177652|NCT03698019|158480592|FG000|Step 1: Registration|Withdrawal by Subject|7|||
49177653|NCT03698019|158480593|FG001|Step 1: Registration|Withdrawal by Subject|2|||
49177654|NCT03698019|158480592|FG000|Step 1: Registration|Toxicity|0|||
49177655|NCT03698019|158480593|FG001|Step 1: Registration|Toxicity|1|||
49177656|NCT03698019|158480592|FG000|Step 1: Registration|Disease Progression|0|||
49177657|NCT03698019|158480593|FG001|Step 1: Registration|Disease Progression|12|||
49177658|NCT03698019|158480592|FG000|Step 1: Registration|Co-morbidities|0|||
49177659|NCT03698019|158480593|FG001|Step 1: Registration|Co-morbidities|1|||
49177660|NCT03698019|158480592|FG000|Step 1: Registration|Scheduling Issues|1|||
49177661|NCT03698019|158480593|FG001|Step 1: Registration|Scheduling Issues|0|||
49177662|NCT03698019|158480592|FG000|Step 1: Registration|Participant Refusal|0|||
49177663|NCT03698019|158480593|FG001|Step 1: Registration|Participant Refusal|1|||
49177664|NCT03698019|158480592|FG000|Step 2: Surgery|Participant Refusal|2|||
49177665|NCT03698019|158480593|FG001|Step 2: Surgery|Participant Refusal|1|||
49177666|NCT03698019|158480592|FG000|Step 2: Surgery|Neoadjuvant Toxicity|0|||
49177667|NCT03698019|158480593|FG001|Step 2: Surgery|Neoadjuvant Toxicity|3|||
48927373|NCT02809833|157566548|FG000|Overall Study|Missing Information|52|||
48927374|NCT03665285|157566549|FG000|Overall Study|Started New Anticancer Treatment|1|||
48927375|NCT03665285|157566550|FG001|Overall Study|Started New Anticancer Treatment|1|||
48927376|NCT03665285|157566551|FG002|Overall Study|Started New Anticancer Treatment|2|||
48927377|NCT03665285|157566552|FG003|Overall Study|Started New Anticancer Treatment|4|||
48927378|NCT03665285|157566553|FG004|Overall Study|Started New Anticancer Treatment|1|||
48927379|NCT03665285|157566554|FG005|Overall Study|Started New Anticancer Treatment|1|||
48927380|NCT03665285|157566555|FG006|Overall Study|Started New Anticancer Treatment|2|||
48927381|NCT03665285|157566556|FG007|Overall Study|Started New Anticancer Treatment|15|||
49177668|NCT03698019|158480592|FG000|Step 2: Surgery|Metastatic Disease|16|||
49177669|NCT03698019|158480593|FG001|Step 2: Surgery|Metastatic Disease|9|||
49177670|NCT03698019|158480592|FG000|Step 2: Surgery|Residual Disease|2|||
49177671|NCT03698019|158480593|FG001|Step 2: Surgery|Residual Disease|1|||
49177672|NCT03698019|158480592|FG000|Step 2: Surgery|Trial Closed due to Covid-19|0|||
49177673|NCT03698019|158480593|FG001|Step 2: Surgery|Trial Closed due to Covid-19|1|||
49177674|NCT03698019|158480592|FG000|Step 2: Surgery|Concerns about Exposure to Covid-19|0|||
49177675|NCT03698019|158480593|FG001|Step 2: Surgery|Concerns about Exposure to Covid-19|1|||
49177676|NCT03698019|158480592|FG000|Step 2: Surgery|Disease other than melanoma identified at surgery|0|||
49177677|NCT03698019|158480593|FG001|Step 2: Surgery|Disease other than melanoma identified at surgery|2|||
49177678|NCT03698019|158480592|FG000|Step 2: Surgery|Radiotherapy-related Delays|1|||
49177679|NCT03698019|158480593|FG001|Step 2: Surgery|Radiotherapy-related Delays|0|||
49177680|NCT03698019|158480592|FG000|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|41|||
49177681|NCT03698019|158480593|FG001|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|33|||
49177682|NCT03698019|158480592|FG000|Step 3: Adjuvant Pembrolizumab|Disease Progression|41|||
49177683|NCT03698019|158480593|FG001|Step 3: Adjuvant Pembrolizumab|Disease Progression|9|||
49177684|NCT03698019|158480592|FG000|Step 3: Adjuvant Pembrolizumab|Death|4|||
49177685|NCT03698019|158480593|FG001|Step 3: Adjuvant Pembrolizumab|Death|1|||
49177686|NCT03698019|158480592|FG000|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|6|||
49177687|NCT03698019|158480593|FG001|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|16|||
49177688|NCT00324805|158480594|FG000|Overall Study|Adverse Event|62|||
49177689|NCT00324805|158480595|FG001|Overall Study|Adverse Event|203|||
49177690|NCT00324805|158480594|FG000|Overall Study|Progression|7|||
49177691|NCT00324805|158480595|FG001|Overall Study|Progression|35|||
49177692|NCT00324805|158480594|FG000|Overall Study|Withdrawal by Subject|51|||
49177693|NCT00324805|158480595|FG001|Overall Study|Withdrawal by Subject|174|||
49177694|NCT00324805|158480594|FG000|Overall Study|Death|6|||
49177695|NCT00324805|158480595|FG001|Overall Study|Death|9|||
49177696|NCT00324805|158480594|FG000|Overall Study|Alternative therapy|4|||
49177697|NCT00324805|158480595|FG001|Overall Study|Alternative therapy|8|||
49177698|NCT00324805|158480594|FG000|Overall Study|Other complicating disease|1|||
49177699|NCT00324805|158480595|FG001|Overall Study|Other complicating disease|9|||
49177700|NCT00324805|158480594|FG000|Overall Study|Other reasons|7|||
48927382|NCT03665285|157566557|FG008|Overall Study|Started New Anticancer Treatment|1|||
48927383|NCT03665285|157566549|FG000|Overall Study|Disease Progression|0|||
48927384|NCT03665285|157566550|FG001|Overall Study|Disease Progression|0|||
49177701|NCT00324805|158480595|FG001|Overall Study|Other reasons|26|||
48927385|NCT03665285|157566551|FG002|Overall Study|Disease Progression|3|||
48927386|NCT03665285|157566552|FG003|Overall Study|Disease Progression|1|||
48927387|NCT03665285|157566553|FG004|Overall Study|Disease Progression|0|||
48927388|NCT03665285|157566554|FG005|Overall Study|Disease Progression|0|||
49177702|NCT00324805|158480594|FG000|Overall Study|Other|0|||
49177703|NCT00324805|158480595|FG001|Overall Study|Other|2|||
49177704|NCT00324805|158480594|FG000|Overall Study|Did not start therapy|12|||
49177705|NCT00324805|158480595|FG001|Overall Study|Did not start therapy|17|||
49177706|NCT01856192|158480596|FG000|Overall Study|Adverse Event|12|||
49177707|NCT01856192|158480597|FG001|Overall Study|Adverse Event|4|||
49177708|NCT01856192|158480596|FG000|Overall Study|Alternative therapy|0|||
49177709|NCT01856192|158480597|FG001|Overall Study|Alternative therapy|3|||
48927389|NCT03665285|157566555|FG006|Overall Study|Disease Progression|0|||
49177710|NCT01856192|158480596|FG000|Overall Study|Death|3|||
48927390|NCT03665285|157566556|FG007|Overall Study|Disease Progression|7|||
48927391|NCT03665285|157566557|FG008|Overall Study|Disease Progression|1|||
48927392|NCT03665285|157566549|FG000|Overall Study|Hospice|0|||
48927393|NCT03665285|157566550|FG001|Overall Study|Hospice|0|||
48927394|NCT03665285|157566551|FG002|Overall Study|Hospice|0|||
48927395|NCT03665285|157566552|FG003|Overall Study|Hospice|0|||
48927396|NCT03665285|157566553|FG004|Overall Study|Hospice|0|||
48927397|NCT03665285|157566554|FG005|Overall Study|Hospice|0|||
48927398|NCT03665285|157566555|FG006|Overall Study|Hospice|0|||
48927399|NCT03665285|157566556|FG007|Overall Study|Hospice|2|||
48927400|NCT03665285|157566557|FG008|Overall Study|Hospice|0|||
49177711|NCT01856192|158480597|FG001|Overall Study|Death|5|||
49177712|NCT01856192|158480596|FG000|Overall Study|Lack of Efficacy|0|||
49177713|NCT01856192|158480597|FG001|Overall Study|Lack of Efficacy|5|||
49177714|NCT01856192|158480596|FG000|Overall Study|Withdrawal by Subject|1|||
49177715|NCT01856192|158480597|FG001|Overall Study|Withdrawal by Subject|1|||
49177716|NCT01856192|158480596|FG000|Overall Study|Other diseases|1|||
48927401|NCT03665285|157566549|FG000|Overall Study|Withdrawal by Subject|0|||
48927402|NCT03665285|157566550|FG001|Overall Study|Withdrawal by Subject|0|||
48927403|NCT03665285|157566551|FG002|Overall Study|Withdrawal by Subject|0|||
48927404|NCT03665285|157566552|FG003|Overall Study|Withdrawal by Subject|0|||
48927405|NCT03665285|157566553|FG004|Overall Study|Withdrawal by Subject|1|||
48927406|NCT03665285|157566554|FG005|Overall Study|Withdrawal by Subject|0|||
48927407|NCT03665285|157566555|FG006|Overall Study|Withdrawal by Subject|0|||
48927408|NCT03665285|157566556|FG007|Overall Study|Withdrawal by Subject|2|||
48927409|NCT03665285|157566557|FG008|Overall Study|Withdrawal by Subject|0|||
48927410|NCT03665285|157566549|FG000|Overall Study|Physician Decision|0|||
48927411|NCT03665285|157566550|FG001|Overall Study|Physician Decision|0|||
48927412|NCT03665285|157566551|FG002|Overall Study|Physician Decision|0|||
48927413|NCT03665285|157566552|FG003|Overall Study|Physician Decision|0|||
48927414|NCT03665285|157566553|FG004|Overall Study|Physician Decision|0|||
49177717|NCT01856192|158480597|FG001|Overall Study|Other diseases|0|||
49177718|NCT01856192|158480596|FG000|Overall Study|Never started treatment|7|||
49177719|NCT01856192|158480597|FG001|Overall Study|Never started treatment|5|||
49177720|NCT01856192|158480596|FG000|Overall Study|Path ineligible|20|||
48927415|NCT03665285|157566554|FG005|Overall Study|Physician Decision|0|||
48927416|NCT03665285|157566555|FG006|Overall Study|Physician Decision|0|||
48927417|NCT03665285|157566556|FG007|Overall Study|Physician Decision|2|||
48927418|NCT03665285|157566557|FG008|Overall Study|Physician Decision|0|||
48927419|NCT01946204|157566558|FG000|Overall Study|Death|38|||
48927420|NCT01946204|157566559|FG001|Overall Study|Death|59|||
48927421|NCT01946204|157566558|FG000|Overall Study|Withdrawal by Subject|37|||
48927422|NCT01946204|157566559|FG001|Overall Study|Withdrawal by Subject|50|||
48927423|NCT01946204|157566558|FG000|Overall Study|Lost to Follow-up|3|||
48927424|NCT01946204|157566559|FG001|Overall Study|Lost to Follow-up|7|||
48927425|NCT01946204|157566558|FG000|Overall Study|Ongoing|316|||
48927426|NCT01946204|157566559|FG001|Overall Study|Ongoing|687|||
48927427|NCT01946204|157566558|FG000|Overall Study|Other|7|||
49177721|NCT01856192|158480597|FG001|Overall Study|Path ineligible|34|||
49177722|NCT01856192|158480596|FG000|Overall Study|Non-path ineligible|2|||
49177723|NCT01856192|158480597|FG001|Overall Study|Non-path ineligible|2|||
48927428|NCT01946204|157566559|FG001|Overall Study|Other|3|||
48927429|NCT01844895|157566560|FG000|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1|||
48927430|NCT01844895|157566560|FG000|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1|||
48927431|NCT01844895|157566560|FG000|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1|||
49177724|NCT01856192|158480596|FG000|Overall Study|Physician Decision|1|||
49177725|NCT01856192|158480597|FG001|Overall Study|Physician Decision|1|||
49177726|NCT01856192|158480596|FG000|Overall Study|Suspicion of progressive disease|1|||
49177727|NCT01856192|158480597|FG001|Overall Study|Suspicion of progressive disease|0|||
49177728|NCT01856192|158480596|FG000|Overall Study|Non-compliance|1|||
49177729|NCT01856192|158480597|FG001|Overall Study|Non-compliance|0|||
49177730|NCT05297565|158480598|FG000|Overall Study|Other Reasons|0|||
49177731|NCT05297565|158480599|FG001|Overall Study|Other Reasons|1|||
49177732|NCT05297565|158480598|FG000|Overall Study|Physician Decision|0|||
49177733|NCT05297565|158480599|FG001|Overall Study|Physician Decision|1|||
49177734|NCT05297565|158480598|FG000|Overall Study|Disease recurrence|1|||
49177735|NCT05297565|158480599|FG001|Overall Study|Disease recurrence|0|||
49177736|NCT05977530|158480600|FG000|Overall Study|Withdrawal by Subject|1|||
49177737|NCT05977530|158480600|FG000|Overall Study|injury unrelated to research participation. Unable to enter swimming pool to participate in protocol|1|||
49177738|NCT03375320|158480601|FG000|Overall Study|Adverse Event|34|||
49177739|NCT03375320|158480602|FG001|Overall Study|Adverse Event|9|||
49177740|NCT03375320|158480603|FG002|Overall Study|Adverse Event|10|||
49177741|NCT03375320|158480604|FG003|Overall Study|Adverse Event|0|||
49177742|NCT03375320|158480601|FG000|Overall Study|Death|6|||
49177743|NCT03375320|158480602|FG001|Overall Study|Death|3|||
49177744|NCT03375320|158480603|FG002|Overall Study|Death|0|||
49177745|NCT03375320|158480604|FG003|Overall Study|Death|0|||
49177746|NCT03375320|158480601|FG000|Overall Study|Withdrawal by Subject|7|||
49177747|NCT03375320|158480602|FG001|Overall Study|Withdrawal by Subject|4|||
49177748|NCT03375320|158480603|FG002|Overall Study|Withdrawal by Subject|5|||
49177749|NCT03375320|158480604|FG003|Overall Study|Withdrawal by Subject|4|||
49177750|NCT03375320|158480601|FG000|Overall Study|Progressive disease|55|||
49177751|NCT03375320|158480602|FG001|Overall Study|Progressive disease|41|||
49177752|NCT03375320|158480603|FG002|Overall Study|Progressive disease|29|||
49177753|NCT03375320|158480604|FG003|Overall Study|Progressive disease|24|||
49177754|NCT03375320|158480601|FG000|Overall Study|Alternative treatment|6|||
49177755|NCT03375320|158480602|FG001|Overall Study|Alternative treatment|1|||
49177756|NCT03375320|158480603|FG002|Overall Study|Alternative treatment|1|||
49177757|NCT03375320|158480604|FG003|Overall Study|Alternative treatment|0|||
49177758|NCT03375320|158480601|FG000|Overall Study|Other disease|1|||
49177759|NCT03375320|158480602|FG001|Overall Study|Other disease|1|||
49177760|NCT03375320|158480603|FG002|Overall Study|Other disease|3|||
49177761|NCT03375320|158480604|FG003|Overall Study|Other disease|0|||
49177762|NCT03375320|158480601|FG000|Overall Study|Withdrawal prior to initiation|2|||
49177763|NCT03375320|158480602|FG001|Overall Study|Withdrawal prior to initiation|2|||
49177764|NCT03375320|158480603|FG002|Overall Study|Withdrawal prior to initiation|1|||
49177765|NCT03375320|158480604|FG003|Overall Study|Withdrawal prior to initiation|0|||
49177766|NCT03375320|158480601|FG000|Overall Study|Physician Decision|1|||
49177767|NCT03375320|158480602|FG001|Overall Study|Physician Decision|1|||
49177768|NCT03375320|158480603|FG002|Overall Study|Physician Decision|1|||
49177769|NCT03375320|158480604|FG003|Overall Study|Physician Decision|1|||
49177770|NCT03375320|158480601|FG000|Overall Study|Non-compliance|1|||
49177771|NCT03375320|158480602|FG001|Overall Study|Non-compliance|0|||
49177772|NCT03375320|158480603|FG002|Overall Study|Non-compliance|0|||
49177773|NCT03375320|158480604|FG003|Overall Study|Non-compliance|0|||
49177774|NCT03058289|158482531|FG000|Overall Study|Radiographic Deterioration|0|||
49177775|NCT03058289|158482532|FG001|Overall Study|Radiographic Deterioration|3|||
49177776|NCT03058289|158482533|FG002|Overall Study|Radiographic Deterioration|1|||
49177777|NCT03058289|158482534|FG003|Overall Study|Radiographic Deterioration|2|||
49177778|NCT03058289|158482535|FG004|Overall Study|Radiographic Deterioration|6|||
49177779|NCT03058289|158482536|FG005|Overall Study|Radiographic Deterioration|3|||
49177780|NCT03058289|158482537|FG006|Overall Study|Radiographic Deterioration|0|||
49177781|NCT03058289|158482538|FG007|Overall Study|Radiographic Deterioration|4|||
49177782|NCT03058289|158482539|FG008|Overall Study|Radiographic Deterioration|2|||
49177783|NCT03058289|158482531|FG000|Overall Study|Adverse Event|2|||
49177784|NCT03058289|158482532|FG001|Overall Study|Adverse Event|0|||
49177785|NCT03058289|158482533|FG002|Overall Study|Adverse Event|1|||
49177786|NCT03058289|158482534|FG003|Overall Study|Adverse Event|3|||
49177787|NCT03058289|158482535|FG004|Overall Study|Adverse Event|1|||
49177788|NCT03058289|158482536|FG005|Overall Study|Adverse Event|0|||
49177789|NCT03058289|158482537|FG006|Overall Study|Adverse Event|1|||
49177790|NCT03058289|158482538|FG007|Overall Study|Adverse Event|3|||
49177791|NCT03058289|158482539|FG008|Overall Study|Adverse Event|0|||
49177792|NCT03058289|158482531|FG000|Overall Study|Withdrawal by Subject|0|||
49177793|NCT03058289|158482532|FG001|Overall Study|Withdrawal by Subject|0|||
49177794|NCT03058289|158482533|FG002|Overall Study|Withdrawal by Subject|0|||
49177795|NCT03058289|158482534|FG003|Overall Study|Withdrawal by Subject|2|||
49177796|NCT03058289|158482535|FG004|Overall Study|Withdrawal by Subject|0|||
49177797|NCT03058289|158482536|FG005|Overall Study|Withdrawal by Subject|2|||
49177798|NCT03058289|158482537|FG006|Overall Study|Withdrawal by Subject|0|||
49177799|NCT03058289|158482538|FG007|Overall Study|Withdrawal by Subject|4|||
49177800|NCT03058289|158482539|FG008|Overall Study|Withdrawal by Subject|1|||
49177801|NCT03058289|158482531|FG000|Overall Study|Physician Decision|1|||
49177802|NCT03058289|158482532|FG001|Overall Study|Physician Decision|0|||
49177803|NCT03058289|158482533|FG002|Overall Study|Physician Decision|0|||
49177804|NCT03058289|158482534|FG003|Overall Study|Physician Decision|2|||
49177805|NCT03058289|158482535|FG004|Overall Study|Physician Decision|1|||
49177806|NCT03058289|158482536|FG005|Overall Study|Physician Decision|0|||
49177807|NCT03058289|158482537|FG006|Overall Study|Physician Decision|2|||
49177808|NCT03058289|158482538|FG007|Overall Study|Physician Decision|3|||
49177809|NCT03058289|158482539|FG008|Overall Study|Physician Decision|0|||
49177810|NCT03058289|158482531|FG000|Overall Study|Clinical Deterioration|2|||
49177811|NCT03058289|158482532|FG001|Overall Study|Clinical Deterioration|0|||
49177812|NCT03058289|158482533|FG002|Overall Study|Clinical Deterioration|0|||
49177813|NCT03058289|158482534|FG003|Overall Study|Clinical Deterioration|2|||
49177814|NCT03058289|158482535|FG004|Overall Study|Clinical Deterioration|1|||
49177815|NCT03058289|158482536|FG005|Overall Study|Clinical Deterioration|1|||
49177816|NCT03058289|158482537|FG006|Overall Study|Clinical Deterioration|0|||
49177817|NCT03058289|158482538|FG007|Overall Study|Clinical Deterioration|3|||
49177818|NCT03058289|158482539|FG008|Overall Study|Clinical Deterioration|2|||
49177819|NCT03058289|158482531|FG000|Overall Study|Lost to Follow-up|0|||
49177820|NCT03058289|158482532|FG001|Overall Study|Lost to Follow-up|0|||
49177821|NCT03058289|158482533|FG002|Overall Study|Lost to Follow-up|0|||
49177822|NCT03058289|158482534|FG003|Overall Study|Lost to Follow-up|0|||
49177823|NCT03058289|158482535|FG004|Overall Study|Lost to Follow-up|1|||
49177824|NCT03058289|158482536|FG005|Overall Study|Lost to Follow-up|0|||
49177825|NCT03058289|158482537|FG006|Overall Study|Lost to Follow-up|0|||
49177826|NCT03058289|158482538|FG007|Overall Study|Lost to Follow-up|0|||
49177827|NCT03058289|158482539|FG008|Overall Study|Lost to Follow-up|0|||
49177828|NCT03058289|158482531|FG000|Overall Study|Refused Further Treatment|0|||
49177829|NCT03058289|158482532|FG001|Overall Study|Refused Further Treatment|0|||
49177830|NCT03058289|158482533|FG002|Overall Study|Refused Further Treatment|1|||
49177831|NCT03058289|158482534|FG003|Overall Study|Refused Further Treatment|0|||
49177832|NCT03058289|158482535|FG004|Overall Study|Refused Further Treatment|1|||
49177833|NCT03058289|158482536|FG005|Overall Study|Refused Further Treatment|0|||
49177834|NCT03058289|158482537|FG006|Overall Study|Refused Further Treatment|0|||
49177835|NCT03058289|158482538|FG007|Overall Study|Refused Further Treatment|0|||
49177836|NCT03058289|158482539|FG008|Overall Study|Refused Further Treatment|0|||
48927432|NCT01844895|157566560|FG000|Day 29 - Day113 - Autoinjector|Adverse Event|1|||
49177837|NCT03058289|158482531|FG000|Overall Study|Rapid Progression of Disease|0|||
48927433|NCT01844895|157566560|FG000|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1|||
48927434|NCT01844895|157566560|FG000|Day 29 - Day113 - Autoinjector|Difficulty using device|3|||
48927435|NCT01844895|157566560|FG000|Day 29 - Day113 - Autoinjector|planned surgery|1|||
49177838|NCT03058289|158482532|FG001|Overall Study|Rapid Progression of Disease|0|||
49177839|NCT03058289|158482533|FG002|Overall Study|Rapid Progression of Disease|0|||
49177840|NCT03058289|158482534|FG003|Overall Study|Rapid Progression of Disease|1|||
49177841|NCT03058289|158482535|FG004|Overall Study|Rapid Progression of Disease|0|||
49177842|NCT03058289|158482536|FG005|Overall Study|Rapid Progression of Disease|0|||
49177843|NCT03058289|158482537|FG006|Overall Study|Rapid Progression of Disease|0|||
49177844|NCT03058289|158482538|FG007|Overall Study|Rapid Progression of Disease|0|||
49177845|NCT03058289|158482539|FG008|Overall Study|Rapid Progression of Disease|0|||
49177846|NCT03462719|158482540|FG000|Overall Study|Withdrawal by Subject|4|||
49177847|NCT03462719|158482541|FG001|Overall Study|Withdrawal by Subject|3|||
49177848|NCT03462719|158482540|FG000|Overall Study|Ongoing|87|||
49177849|NCT03462719|158482541|FG001|Overall Study|Ongoing|72|||
49177850|NCT02319837|158482550|FG000|Study Treatment Phase|Centrally confirmed radiographic progression|26|||
49177851|NCT02319837|158482551|FG001|Study Treatment Phase|Centrally confirmed radiographic progression|66|||
49177852|NCT02319837|158482552|FG002|Study Treatment Phase|Centrally confirmed radiographic progression|37|||
49177853|NCT02319837|158482550|FG000|Study Treatment Phase|PSA progression notification from sponsor|2|||
49177854|NCT02319837|158482551|FG001|Study Treatment Phase|PSA progression notification from sponsor|20|||
49177855|NCT02319837|158482552|FG002|Study Treatment Phase|PSA progression notification from sponsor|5|||
49177856|NCT02319837|158482550|FG000|Study Treatment Phase|Adverse Event|73|||
49177857|NCT02319837|158482551|FG001|Study Treatment Phase|Adverse Event|36|||
49177858|NCT02319837|158482552|FG002|Study Treatment Phase|Adverse Event|63|||
49177859|NCT02319837|158482550|FG000|Study Treatment Phase|Development of castration resistance|0|||
49177860|NCT02319837|158482551|FG001|Study Treatment Phase|Development of castration resistance|2|||
49177861|NCT02319837|158482552|FG002|Study Treatment Phase|Development of castration resistance|0|||
49177862|NCT02319837|158482550|FG000|Study Treatment Phase|Withdrawal by Subject|26|||
49177863|NCT02319837|158482551|FG001|Study Treatment Phase|Withdrawal by Subject|32|||
49177864|NCT02319837|158482552|FG002|Study Treatment Phase|Withdrawal by Subject|25|||
49177865|NCT02319837|158482550|FG000|Study Treatment Phase|Protocol Violation|2|||
49177866|NCT02319837|158482551|FG001|Study Treatment Phase|Protocol Violation|2|||
49177867|NCT02319837|158482552|FG002|Study Treatment Phase|Protocol Violation|1|||
49177868|NCT02319837|158482550|FG000|Study Treatment Phase|Lost to Follow-up|0|||
49177869|NCT02319837|158482551|FG001|Study Treatment Phase|Lost to Follow-up|1|||
49177870|NCT02319837|158482552|FG002|Study Treatment Phase|Lost to Follow-up|0|||
49177871|NCT02319837|158482550|FG000|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|17|||
49177872|NCT02319837|158482551|FG001|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|41|||
49177873|NCT02319837|158482552|FG002|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|26|||
49177874|NCT02319837|158482550|FG000|Study Treatment Phase|Other|0|||
49177875|NCT02319837|158482551|FG001|Study Treatment Phase|Other|1|||
49177876|NCT02319837|158482552|FG002|Study Treatment Phase|Other|0|||
49177877|NCT02319837|158482550|FG000|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|207|||
49177878|NCT02319837|158482551|FG001|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|153|||
49177879|NCT02319837|158482552|FG002|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|197|||
49177880|NCT02319837|158482550|FG000|Study Treatment Phase|Participants did not receive treatment.|2|||
49177881|NCT02319837|158482551|FG001|Study Treatment Phase|Participants did not receive treatment.|4|||
49177882|NCT02319837|158482552|FG002|Study Treatment Phase|Participants did not receive treatment.|1|||
49177883|NCT02319837|158482550|FG000|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|67|||
49177884|NCT02319837|158482551|FG001|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|104|||
49177885|NCT02319837|158482552|FG002|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|62|||
49177886|NCT02319837|158482550|FG000|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|5|||
49177887|NCT02319837|158482551|FG001|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|8|||
49177888|NCT02319837|158482552|FG002|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|12|||
49177889|NCT02319837|158482550|FG000|Long-Term Follow-Up Phase|Withdrawal by Subject|40|||
49177890|NCT02319837|158482551|FG001|Long-Term Follow-Up Phase|Withdrawal by Subject|36|||
49177891|NCT02319837|158482552|FG002|Long-Term Follow-Up Phase|Withdrawal by Subject|38|||
49177892|NCT02319837|158482550|FG000|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
49177893|NCT02319837|158482551|FG001|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
49177894|NCT02319837|158482552|FG002|Long-Term Follow-Up Phase|Lost to Follow-up|4|||
49177895|NCT02319837|158482550|FG000|Long-Term Follow-Up Phase|Death|33|||
49177896|NCT02319837|158482551|FG001|Long-Term Follow-Up Phase|Death|54|||
49177897|NCT02319837|158482552|FG002|Long-Term Follow-Up Phase|Death|42|||
49177898|NCT04159415|158482553|FG000|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
49177899|NCT04159415|158482554|FG001|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
49177900|NCT04159415|158482555|FG002|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
49177901|NCT04159415|158482556|FG003|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
49177902|NCT04159415|158482557|FG004|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
49177903|NCT04159415|158482558|FG005|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
49177904|NCT04159415|158482559|FG006|Open-Label Treatment Period (OLTP) 4|Ongoing|2|||
49177905|NCT04159415|158482560|FG007|Open-Label Treatment Period (OLTP) 4|Ongoing|2|||
49177906|NCT03941860|158482561|FG000|Overall Study|Withdrawal by Subject|0|||
48927436|NCT00428597|157566565|FG000|Overall Study|Randomized but not treated|3|||
48927437|NCT00428597|157566566|FG001|Overall Study|Randomized but not treated|3|||
48927438|NCT00428597|157566565|FG000|Overall Study|Objective Progression or Relapse|19|||
48927439|NCT00428597|157566566|FG001|Overall Study|Objective Progression or Relapse|47|||
48927440|NCT00428597|157566565|FG000|Overall Study|Study Terminated by Sponsor|41|||
48927441|NCT00428597|157566566|FG001|Overall Study|Study Terminated by Sponsor|16|||
48927442|NCT00428597|157566565|FG000|Overall Study|Adverse Event|15|||
48927443|NCT00428597|157566566|FG001|Overall Study|Adverse Event|7|||
48927444|NCT00428597|157566565|FG000|Overall Study|Global Deterioration of Health Status|1|||
48927445|NCT00428597|157566566|FG001|Overall Study|Global Deterioration of Health Status|5|||
48927446|NCT00428597|157566565|FG000|Overall Study|Protocol Violation|2|||
48927447|NCT00428597|157566566|FG001|Overall Study|Protocol Violation|1|||
48927448|NCT00428597|157566565|FG000|Overall Study|Withdrawal by Subject|2|||
48927449|NCT00428597|157566566|FG001|Overall Study|Withdrawal by Subject|1|||
48927450|NCT00428597|157566565|FG000|Overall Study|Other|1|||
48927451|NCT00428597|157566566|FG001|Overall Study|Other|1|||
48927452|NCT00428597|157566565|FG000|Overall Study|Lost to Follow-up|0|||
49177907|NCT03941860|158482562|FG001|Overall Study|Withdrawal by Subject|1|||
49177908|NCT03783871|158482563|FG000|Overall Study|Withdrawal by Subject|15|||
49177909|NCT03783871|158482563|FG000|Overall Study|Death|13|||
49177910|NCT03783871|158482563|FG000|Overall Study|Lost to Follow-up|2|||
49177911|NCT05564052|158482566|FG000|Overall Study|Withdrawal by Subject|0|||
49177912|NCT05564052|158482567|FG001|Overall Study|Withdrawal by Subject|0|||
49177913|NCT05564052|158482568|FG002|Overall Study|Withdrawal by Subject|0|||
49177914|NCT05564052|158482569|FG003|Overall Study|Withdrawal by Subject|1|||
49177915|NCT05564052|158482566|FG000|Overall Study|Ongoing|8|||
49177916|NCT05564052|158482567|FG001|Overall Study|Ongoing|5|||
49177917|NCT05564052|158482568|FG002|Overall Study|Ongoing|4|||
49177918|NCT05564052|158482569|FG003|Overall Study|Ongoing|1|||
49177919|NCT05002088|158482570|FG000|Overall Study|Withdrawal by Subject|9|||
49177920|NCT05002088|158482571|FG001|Overall Study|Withdrawal by Subject|0|||
49177921|NCT05002088|158482570|FG000|Overall Study|Lost to Follow-up|0|||
49177922|NCT05002088|158482571|FG001|Overall Study|Lost to Follow-up|1|||
49177923|NCT05002088|158482570|FG000|Overall Study|Death|16|||
49177924|NCT05002088|158482571|FG001|Overall Study|Death|2|||
49177925|NCT05002088|158482570|FG000|Overall Study|Protocol Violation|25|||
49177926|NCT05002088|158482571|FG001|Overall Study|Protocol Violation|7|||
49177927|NCT05556265|158482574|FG000|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
49177928|NCT05556265|158482575|FG001|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|1|||
49177929|NCT05556265|158482576|FG002|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
49177930|NCT05556265|158482577|FG003|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
48927453|NCT00428597|157566566|FG001|Overall Study|Lost to Follow-up|1|||
48927454|NCT00428597|157566565|FG000|Overall Study|Pregnancy|1|||
48927455|NCT00428597|157566566|FG001|Overall Study|Pregnancy|0|||
49177931|NCT05556265|158482578|FG004|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
49177932|NCT05556265|158482574|FG000|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
49177933|NCT05556265|158482575|FG001|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|2|||
49177934|NCT05556265|158482576|FG002|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
49177935|NCT05556265|158482577|FG003|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
49177936|NCT05556265|158482578|FG004|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
49177937|NCT05556265|158482574|FG000|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
49177938|NCT05556265|158482575|FG001|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|2|||
49177939|NCT05556265|158482576|FG002|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
49177940|NCT05556265|158482577|FG003|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
49177941|NCT05556265|158482578|FG004|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
49177942|NCT05556265|158482574|FG000|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
49177943|NCT05556265|158482575|FG001|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
49177944|NCT05556265|158482576|FG002|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|0|||
49177945|NCT05556265|158482577|FG003|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|3|||
49177946|NCT05556265|158482578|FG004|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|1|||
49177947|NCT05556265|158482574|FG000|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
49177948|NCT05556265|158482575|FG001|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|3|||
49177949|NCT05556265|158482576|FG002|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
49177950|NCT05556265|158482577|FG003|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
48927456|NCT00428597|157566565|FG000|Overall Study|Death|1|||
48927457|NCT00428597|157566566|FG001|Overall Study|Death|3|||
48927458|NCT00950742|157566567|FG000|Overall Study|Other Adverse Event|1|||
48927459|NCT00950742|157566568|FG001|Overall Study|Other Adverse Event|0|||
48927460|NCT00950742|157566567|FG000|Overall Study|Withdrawal by Subject|3|||
48927461|NCT00950742|157566568|FG001|Overall Study|Withdrawal by Subject|0|||
49177951|NCT05556265|158482578|FG004|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
49177952|NCT05556265|158482574|FG000|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|19|||
49177953|NCT05556265|158482575|FG001|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|12|||
49177954|NCT05556265|158482576|FG002|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|0|||
49177955|NCT05556265|158482577|FG003|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|6|||
49177956|NCT05556265|158482578|FG004|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|9|||
49177957|NCT05556265|158482574|FG000|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
49177958|NCT05556265|158482575|FG001|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|2|||
49177959|NCT05556265|158482576|FG002|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
49177960|NCT05556265|158482577|FG003|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
49177961|NCT05556265|158482578|FG004|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|1|||
49177962|NCT05556265|158482574|FG000|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
49177963|NCT05556265|158482575|FG001|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
49177964|NCT05556265|158482576|FG002|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
49177965|NCT05556265|158482577|FG003|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
49177966|NCT05556265|158482578|FG004|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
49177967|NCT05556265|158482574|FG000|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
49177968|NCT05556265|158482575|FG001|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
49177969|NCT05556265|158482576|FG002|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
49177970|NCT05556265|158482577|FG003|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
49177971|NCT05556265|158482578|FG004|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
49177972|NCT02505984|158482581|FG000|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|1|||
49177973|NCT02505984|158482582|FG001|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|0|||
49177974|NCT02505984|158482581|FG000|Overall Study|Unreliable self-report data|1|||
49177975|NCT02505984|158482582|FG001|Overall Study|Unreliable self-report data|0|||
49177976|NCT02505984|158482581|FG000|Overall Study|Study blind opened during assessment|0|||
49177977|NCT02505984|158482582|FG001|Overall Study|Study blind opened during assessment|1|||
49177978|NCT02505984|158482581|FG000|Overall Study|Noncompliance with study protocol|0|||
49177979|NCT02505984|158482582|FG001|Overall Study|Noncompliance with study protocol|1|||
49177980|NCT02421939|158482592|FG000|Overall Study|Progressive disease|70|||
49177981|NCT02421939|158482593|FG001|Overall Study|Progressive disease|16|||
49177982|NCT02421939|158482592|FG000|Overall Study|Lack of Efficacy|21|||
49177983|NCT02421939|158482593|FG001|Overall Study|Lack of Efficacy|31|||
49177984|NCT02421939|158482592|FG000|Overall Study|Death|36|||
49177985|NCT02421939|158482593|FG001|Overall Study|Death|10|||
49177986|NCT02421939|158482592|FG000|Overall Study|Disease relapse|33|||
49177987|NCT02421939|158482593|FG001|Overall Study|Disease relapse|2|||
49177988|NCT02421939|158482592|FG000|Overall Study|Adverse Event|28|||
49177989|NCT02421939|158482593|FG001|Overall Study|Adverse Event|5|||
49177990|NCT02421939|158482592|FG000|Overall Study|Withdrawal by Subject|5|||
49177991|NCT02421939|158482593|FG001|Overall Study|Withdrawal by Subject|24|||
49177992|NCT02421939|158482592|FG000|Overall Study|Physician Decision|11|||
49177993|NCT02421939|158482593|FG001|Overall Study|Physician Decision|11|||
49177994|NCT02421939|158482592|FG000|Overall Study|Completed 1 or 2 chemo cycles with CRs|0|||
49177995|NCT02421939|158482593|FG001|Overall Study|Completed 1 or 2 chemo cycles with CRs|19|||
49177996|NCT02421939|158482592|FG000|Overall Study|Miscellaneous|4|||
49177997|NCT02421939|158482593|FG001|Overall Study|Miscellaneous|5|||
49177998|NCT02421939|158482592|FG000|Overall Study|Protocol deviation|1|||
49177999|NCT02421939|158482593|FG001|Overall Study|Protocol deviation|1|||
49178000|NCT05934942|158482594|FG000|Run-in Period|Not treated|1|||
49178001|NCT05934942|158482594|FG000|Run-in Period|Withdrawal by Subject|1|||
49178002|NCT04362254|158482597|FG000|Overall Study|Adverse Event|1|||
49178003|NCT04362254|158482597|FG000|Overall Study|Protocol Violation|1|||
49178004|NCT04362254|158482597|FG000|Overall Study|Due to early termination of the trial|10|||
49178005|NCT02003209|158482598|FG000|Overall Study|Patient not at risk for primary endpoint|5|||
49178006|NCT02003209|158482599|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
49178007|NCT00321048|158482602|FG000|Overall Study|Withdrawal by Subject|6|||
49178008|NCT00321048|158482603|FG001|Overall Study|Withdrawal by Subject|8|||
49178009|NCT04707625|158482604|FG000|Overall Study|IRB Required Early Termination Due to Safety Concerns|17|||
49178010|NCT02038777|158482605|FG000|Overall Study|Death|0|||
49178011|NCT02038777|158482606|FG001|Overall Study|Death|2|||
49178012|NCT02038777|158482607|FG002|Overall Study|Death|0|||
49178013|NCT02038777|158482608|FG003|Overall Study|Death|1|||
49178014|NCT02038777|158482609|FG004|Overall Study|Death|2|||
49178015|NCT02038777|158482610|FG005|Overall Study|Death|4|||
49178016|NCT02038777|158482611|FG006|Overall Study|Death|0|||
49178017|NCT02038777|158482612|FG007|Overall Study|Death|11|||
49178018|NCT02038777|158482605|FG000|Overall Study|Lost to Follow-up|0|||
49178019|NCT02038777|158482606|FG001|Overall Study|Lost to Follow-up|0|||
49178020|NCT02038777|158482607|FG002|Overall Study|Lost to Follow-up|0|||
49178021|NCT02038777|158482608|FG003|Overall Study|Lost to Follow-up|1|||
49178022|NCT02038777|158482609|FG004|Overall Study|Lost to Follow-up|0|||
49178023|NCT02038777|158482610|FG005|Overall Study|Lost to Follow-up|0|||
49178024|NCT02038777|158482611|FG006|Overall Study|Lost to Follow-up|0|||
49178025|NCT02038777|158482612|FG007|Overall Study|Lost to Follow-up|0|||
49178026|NCT02038777|158482605|FG000|Overall Study|Other|0|||
49178027|NCT02038777|158482606|FG001|Overall Study|Other|1|||
49178028|NCT02038777|158482607|FG002|Overall Study|Other|0|||
49178029|NCT02038777|158482608|FG003|Overall Study|Other|2|||
49178030|NCT02038777|158482609|FG004|Overall Study|Other|1|||
49178031|NCT02038777|158482610|FG005|Overall Study|Other|0|||
49178032|NCT02038777|158482611|FG006|Overall Study|Other|0|||
49178033|NCT02038777|158482612|FG007|Overall Study|Other|0|||
49178034|NCT02038777|158482605|FG000|Overall Study|Randomized but not treated|0|||
49178035|NCT02038777|158482606|FG001|Overall Study|Randomized but not treated|1|||
49178036|NCT02038777|158482607|FG002|Overall Study|Randomized but not treated|0|||
49178037|NCT02038777|158482608|FG003|Overall Study|Randomized but not treated|0|||
49178038|NCT02038777|158482609|FG004|Overall Study|Randomized but not treated|0|||
49178039|NCT02038777|158482610|FG005|Overall Study|Randomized but not treated|0|||
49178040|NCT02038777|158482611|FG006|Overall Study|Randomized but not treated|0|||
49178041|NCT02038777|158482612|FG007|Overall Study|Randomized but not treated|0|||
49178042|NCT02038777|158482605|FG000|Overall Study|Started Chemotherapy|1|||
49178043|NCT02038777|158482606|FG001|Overall Study|Started Chemotherapy|0|||
49178044|NCT02038777|158482607|FG002|Overall Study|Started Chemotherapy|3|||
49178045|NCT02038777|158482608|FG003|Overall Study|Started Chemotherapy|0|||
49178046|NCT02038777|158482609|FG004|Overall Study|Started Chemotherapy|0|||
49178047|NCT02038777|158482610|FG005|Overall Study|Started Chemotherapy|0|||
49178048|NCT02038777|158482611|FG006|Overall Study|Started Chemotherapy|0|||
49178049|NCT02038777|158482612|FG007|Overall Study|Started Chemotherapy|0|||
49178050|NCT02038777|158482605|FG000|Overall Study|participation terminated by sponsor|0|||
49178051|NCT02038777|158482606|FG001|Overall Study|participation terminated by sponsor|0|||
49178052|NCT02038777|158482607|FG002|Overall Study|participation terminated by sponsor|0|||
49178053|NCT02038777|158482608|FG003|Overall Study|participation terminated by sponsor|0|||
49178054|NCT02038777|158482609|FG004|Overall Study|participation terminated by sponsor|0|||
49178055|NCT02038777|158482610|FG005|Overall Study|participation terminated by sponsor|0|||
49178056|NCT02038777|158482611|FG006|Overall Study|participation terminated by sponsor|1|||
49178057|NCT02038777|158482612|FG007|Overall Study|participation terminated by sponsor|1|||
49178058|NCT02115282|158482615|FG000|Overall Study|Disease progression during treatment|216|||
49178059|NCT02115282|158482616|FG001|Overall Study|Disease progression during treatment|229|||
49178060|NCT02115282|158482615|FG000|Overall Study|Adverse Event|49|||
49178061|NCT02115282|158482616|FG001|Overall Study|Adverse Event|23|||
49178062|NCT02115282|158482615|FG000|Overall Study|Death|1|||
49178063|NCT02115282|158482616|FG001|Overall Study|Death|3|||
48927462|NCT00950742|157566567|FG000|Overall Study|Progressive Disease|6|||
48927463|NCT00950742|157566568|FG001|Overall Study|Progressive Disease|2|||
48927464|NCT00950742|157566567|FG000|Overall Study|Dose limiting toxicity|6|||
49178064|NCT02115282|158482615|FG000|Overall Study|Alternative therapy|1|||
49178065|NCT02115282|158482616|FG001|Overall Study|Alternative therapy|1|||
49178066|NCT02115282|158482615|FG000|Overall Study|Complicating disease|0|||
49178067|NCT02115282|158482616|FG001|Overall Study|Complicating disease|3|||
49178068|NCT02115282|158482615|FG000|Overall Study|Withdrawal by Subject|12|||
49178069|NCT02115282|158482616|FG001|Overall Study|Withdrawal by Subject|10|||
49178070|NCT02115282|158482615|FG000|Overall Study|Symptomatic progression/deterioration|7|||
49178071|NCT02115282|158482616|FG001|Overall Study|Symptomatic progression/deterioration|18|||
49178072|NCT02115282|158482615|FG000|Overall Study|Non-compliance|5|||
49178073|NCT02115282|158482616|FG001|Overall Study|Non-compliance|1|||
49178074|NCT02115282|158482615|FG000|Overall Study|Protocol Violation|2|||
49178075|NCT02115282|158482616|FG001|Overall Study|Protocol Violation|2|||
49178076|NCT02115282|158482615|FG000|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
49178077|NCT02115282|158482616|FG001|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
49178078|NCT02115282|158482615|FG000|Overall Study|Not start protocol therapy|9|||
49178079|NCT02115282|158482616|FG001|Overall Study|Not start protocol therapy|10|||
49178080|NCT04590963|158482617|FG000|Overall Study|Death|118|||
49178081|NCT04590963|158482618|FG001|Overall Study|Death|59|||
49178082|NCT04590963|158482617|FG000|Overall Study|Lost to Follow-up|1|||
49178083|NCT04590963|158482618|FG001|Overall Study|Lost to Follow-up|1|||
49178084|NCT04590963|158482617|FG000|Overall Study|Progressive disease|0|||
49178085|NCT04590963|158482618|FG001|Overall Study|Progressive disease|1|||
49178086|NCT04590963|158482617|FG000|Overall Study|Study terminated by sponsor|103|||
49178087|NCT04590963|158482618|FG001|Overall Study|Study terminated by sponsor|50|||
49178088|NCT04590963|158482617|FG000|Overall Study|Withdrawal by Subject|15|||
49178089|NCT04590963|158482618|FG001|Overall Study|Withdrawal by Subject|8|||
49178090|NCT04590963|158482617|FG000|Overall Study|Ongoing at data cut-off|9|||
49178091|NCT04590963|158482618|FG001|Overall Study|Ongoing at data cut-off|4|||
49178092|NCT04590963|158482617|FG000|Overall Study|Screen failure|1|||
49178093|NCT04590963|158482618|FG001|Overall Study|Screen failure|0|||
48927465|NCT00950742|157566568|FG001|Overall Study|Dose limiting toxicity|0|||
49178094|NCT02424617|158482619|FG000|Overall Study|Adverse Event|0|||
49178095|NCT02424617|158482620|FG001|Overall Study|Adverse Event|1|||
49178096|NCT02424617|158482621|FG002|Overall Study|Adverse Event|0|||
49178097|NCT02424617|158482622|FG003|Overall Study|Adverse Event|0|||
49178098|NCT02424617|158482619|FG000|Overall Study|Investigator Decision|0|||
49178099|NCT02424617|158482620|FG001|Overall Study|Investigator Decision|0|||
49178100|NCT02424617|158482621|FG002|Overall Study|Investigator Decision|0|||
49178101|NCT02424617|158482622|FG003|Overall Study|Investigator Decision|1|||
49178102|NCT02424617|158482619|FG000|Overall Study|Withdrawal by Subject|1|||
49178103|NCT02424617|158482620|FG001|Overall Study|Withdrawal by Subject|1|||
49178104|NCT02424617|158482621|FG002|Overall Study|Withdrawal by Subject|0|||
49178105|NCT02424617|158482622|FG003|Overall Study|Withdrawal by Subject|1|||
49178106|NCT02424617|158482619|FG000|Overall Study|Progressive Disease|7|||
49178107|NCT02424617|158482620|FG001|Overall Study|Progressive Disease|6|||
49178108|NCT02424617|158482621|FG002|Overall Study|Progressive Disease|11|||
49178109|NCT02424617|158482622|FG003|Overall Study|Progressive Disease|10|||
49178110|NCT02424617|158482619|FG000|Overall Study|Other|0|||
49178111|NCT02424617|158482620|FG001|Overall Study|Other|0|||
49178112|NCT02424617|158482621|FG002|Overall Study|Other|0|||
49178113|NCT02424617|158482622|FG003|Overall Study|Other|1|||
49178114|NCT04414722|158482623|FG000|Overall Study|Lost to Follow-up|3|||
49178115|NCT04414722|158482624|FG001|Overall Study|Lost to Follow-up|4|||
49178116|NCT04414722|158482625|FG002|Overall Study|Lost to Follow-up|3|||
49178117|NCT04414722|158482626|FG003|Overall Study|Lost to Follow-up|2|||
49178118|NCT04414722|158482627|FG004|Overall Study|Lost to Follow-up|3|||
49178119|NCT04414722|158482623|FG000|Overall Study|Withdrawal by Subject|6|||
49178120|NCT04414722|158482624|FG001|Overall Study|Withdrawal by Subject|3|||
49178121|NCT04414722|158482625|FG002|Overall Study|Withdrawal by Subject|1|||
49178122|NCT04414722|158482626|FG003|Overall Study|Withdrawal by Subject|5|||
49178123|NCT04414722|158482627|FG004|Overall Study|Withdrawal by Subject|1|||
49178124|NCT04414722|158482623|FG000|Overall Study|Physician Decision|0|||
49178125|NCT04414722|158482624|FG001|Overall Study|Physician Decision|1|||
49178126|NCT04414722|158482625|FG002|Overall Study|Physician Decision|2|||
49178127|NCT04414722|158482626|FG003|Overall Study|Physician Decision|0|||
49178128|NCT04414722|158482627|FG004|Overall Study|Physician Decision|0|||
49178129|NCT04414722|158482623|FG000|Overall Study|Non-participatory|0|||
49178130|NCT04414722|158482624|FG001|Overall Study|Non-participatory|1|||
49178131|NCT04414722|158482625|FG002|Overall Study|Non-participatory|1|||
49178132|NCT04414722|158482626|FG003|Overall Study|Non-participatory|0|||
49178133|NCT04414722|158482627|FG004|Overall Study|Non-participatory|0|||
49178134|NCT00769379|158482628|FG000|Overall Study|No follow up data mapped to Other.|3|||
49178135|NCT00769379|158482629|FG001|Overall Study|No follow up data mapped to Other.|13|||
49178136|NCT01275677|158482630|FG000|Overall Study|Not at risk for recurrence.|1|||
49178137|NCT01275677|158482631|FG001|Overall Study|Not at risk for recurrence.|1|||
49178138|NCT01275677|158482630|FG000|Overall Study|No follow-up|26|||
49178139|NCT01275677|158482631|FG001|Overall Study|No follow-up|37|||
49178140|NCT01275677|158482630|FG000|Overall Study|No clinical follow up.|1|||
49178141|NCT01275677|158482631|FG001|Overall Study|No clinical follow up.|4|||
49178142|NCT01627574|158482632|FG000|Overall Study|Withdrawal by Subject|8|||
49178143|NCT01627574|158482633|FG001|Overall Study|Withdrawal by Subject|5|||
49178144|NCT01627574|158482632|FG000|Overall Study|Lost to Follow-up|13|||
49178145|NCT01627574|158482633|FG001|Overall Study|Lost to Follow-up|13|||
49178146|NCT00792948|158482634|FG000|Overall Study|Adverse Event|6|||
49178147|NCT00792948|158482634|FG000|Overall Study|Death|4|||
49178148|NCT00792948|158482634|FG000|Overall Study|Withdrawal by Subject|3|||
49178149|NCT00792948|158482634|FG000|Overall Study|Ineligible|2|||
49178150|NCT00792948|158482634|FG000|Overall Study|Insurance denial - not treated|1|||
49178151|NCT00792948|158482634|FG000|Overall Study|Physician Decision|11|||
49178152|NCT00792948|158482634|FG000|Overall Study|Protocol Violation|1|||
49178153|NCT02446600|158482635|FG000|Overall Study|Never treated|20|||
49178154|NCT02446600|158482636|FG001|Overall Study|Never treated|2|||
49178155|NCT02446600|158482637|FG002|Overall Study|Never treated|6|||
49178156|NCT02446600|158482638|FG003|Overall Study|Never treated|0|||
49178157|NCT02446600|158482635|FG000|Overall Study|Withdrawal by Subject|19|||
49178158|NCT02446600|158482636|FG001|Overall Study|Withdrawal by Subject|5|||
49178159|NCT02446600|158482637|FG002|Overall Study|Withdrawal by Subject|17|||
49178160|NCT02446600|158482638|FG003|Overall Study|Withdrawal by Subject|0|||
49178161|NCT02446600|158482635|FG000|Overall Study|Ineligible|1|||
49178162|NCT02446600|158482636|FG001|Overall Study|Ineligible|4|||
49178163|NCT02446600|158482637|FG002|Overall Study|Ineligible|4|||
49178164|NCT02446600|158482638|FG003|Overall Study|Ineligible|1|||
49178165|NCT02446600|158482635|FG000|Overall Study|Duplicate Enrollment|0|||
49178166|NCT02446600|158482636|FG001|Overall Study|Duplicate Enrollment|1|||
49178167|NCT02446600|158482637|FG002|Overall Study|Duplicate Enrollment|0|||
49178168|NCT02446600|158482638|FG003|Overall Study|Duplicate Enrollment|0|||
49178169|NCT03211416|158482641|FG000|Overall Study|Adverse Event|7|||
49178170|NCT03211416|158482641|FG000|Overall Study|Lack of Efficacy|2|||
49178171|NCT03211416|158482641|FG000|Overall Study|Physician Decision|1|||
49178172|NCT02152995|158482642|FG000|Overall Study|Withdrawal by Subject|1|||
49178173|NCT02152995|158482643|FG001|Overall Study|Withdrawal by Subject|0|||
49178174|NCT03692052|158482649|FG000|Core Period (Day 1 to Week 24)|Adverse Event|1|||
49178175|NCT03692052|158482649|FG000|Extension Period (Week 25 to 10 Years)|Withdrawal of Consent|1|||
49178176|NCT03692052|158482649|FG000|Extension Period (Week 25 to 10 Years)|Physician Decision|1|||
49178177|NCT03692052|158482649|FG000|Extension Period (Week 25 to 10 Years)|Ongoing|17|||
49178178|NCT03442309|158482650|FG000|Overall Study|Lost to Follow-up|1676|||
49178179|NCT03442309|158482651|FG001|Overall Study|Lost to Follow-up|1642|||
49178180|NCT04428476|158482652|FG000|Overall Study|Withdrawal by Subject|1|||
49178181|NCT04428476|158482652|FG000|Overall Study|Still on treatment|12|||
49178182|NCT02466971|158482653|FG000|Overall Study|eligible and never treated|14|||
49178183|NCT02466971|158482654|FG001|Overall Study|eligible and never treated|20|||
49178184|NCT02466971|158482653|FG000|Overall Study|too early for evaluation of treatment and toxicity|3|||
49178185|NCT02466971|158482654|FG001|Overall Study|too early for evaluation of treatment and toxicity|2|||
49178186|NCT02466971|158482653|FG000|Overall Study|ineligible and treated|1|||
49178187|NCT02466971|158482654|FG001|Overall Study|ineligible and treated|0|||
49178188|NCT02466971|158482653|FG000|Overall Study|ineligible and never treated|0|||
49178189|NCT02466971|158482654|FG001|Overall Study|ineligible and never treated|1|||
49178190|NCT03362190|158482655|FG000|Overall Study|Adverse Event|0|||
49178191|NCT03362190|158482656|FG001|Overall Study|Adverse Event|0|||
49178192|NCT03362190|158482657|FG002|Overall Study|Adverse Event|0|||
49178193|NCT03362190|158482658|FG003|Overall Study|Adverse Event|1|||
49178194|NCT03362190|158482655|FG000|Overall Study|Withdrawal by Subject|0|||
49178195|NCT03362190|158482656|FG001|Overall Study|Withdrawal by Subject|0|||
49178196|NCT03362190|158482657|FG002|Overall Study|Withdrawal by Subject|0|||
49178197|NCT03362190|158482658|FG003|Overall Study|Withdrawal by Subject|1|||
49178198|NCT04295512|158482659|FG000|Overall Study|Lack of family response to schedule assessment|0|||
49178199|NCT04295512|158482660|FG001|Overall Study|Lack of family response to schedule assessment|0|||
49178200|NCT04295512|158482661|FG002|Overall Study|Lack of family response to schedule assessment|0|||
49178201|NCT04295512|158482662|FG003|Overall Study|Lack of family response to schedule assessment|2|||
49178202|NCT04295512|158482659|FG000|Overall Study|Therapist did not refer eligible family|7|||
49178203|NCT04295512|158482660|FG001|Overall Study|Therapist did not refer eligible family|7|||
49178204|NCT04295512|158482661|FG002|Overall Study|Therapist did not refer eligible family|0|||
49178205|NCT04295512|158482662|FG003|Overall Study|Therapist did not refer eligible family|0|||
49178206|NCT01309672|158482664|FG000|Overall Study|Lack of Efficacy|20|||
49178207|NCT01309672|158482664|FG000|Overall Study|Other|9|||
49178208|NCT01309672|158482664|FG000|Overall Study|Adverse Event|5|||
49178209|NCT01309672|158482664|FG000|Overall Study|Withdrawal by Subject|3|||
49178210|NCT04076059|158482665|FG000|Double Blind Phase|Progressive disease|22|||
49178211|NCT04076059|158482666|FG001|Double Blind Phase|Progressive disease|26|||
49178212|NCT04076059|158482667|FG002|Double Blind Phase|Progressive disease|0|||
49178213|NCT04076059|158482665|FG000|Double Blind Phase|Withdrawal by Subject|4|||
49178214|NCT04076059|158482666|FG001|Double Blind Phase|Withdrawal by Subject|11|||
49178215|NCT04076059|158482667|FG002|Double Blind Phase|Withdrawal by Subject|0|||
49178216|NCT04076059|158482665|FG000|Double Blind Phase|Death|1|||
49178217|NCT04076059|158482666|FG001|Double Blind Phase|Death|1|||
49178218|NCT04076059|158482667|FG002|Double Blind Phase|Death|0|||
49178219|NCT04076059|158482665|FG000|Double Blind Phase|Lost to Follow-up|1|||
49178220|NCT04076059|158482666|FG001|Double Blind Phase|Lost to Follow-up|0|||
49178221|NCT04076059|158482667|FG002|Double Blind Phase|Lost to Follow-up|0|||
49178222|NCT04076059|158482665|FG000|Double Blind Phase|Adverse Event|5|||
49178223|NCT04076059|158482666|FG001|Double Blind Phase|Adverse Event|1|||
49178224|NCT04076059|158482667|FG002|Double Blind Phase|Adverse Event|0|||
49178225|NCT04076059|158482665|FG000|Double Blind Phase|Ongoing Participants|82|||
49178226|NCT04076059|158482666|FG001|Double Blind Phase|Ongoing Participants|18|||
49178227|NCT04076059|158482667|FG002|Double Blind Phase|Ongoing Participants|0|||
49178228|NCT04076059|158482665|FG000|Double Blind Phase|Miscellaneous|3|||
49178229|NCT04076059|158482666|FG001|Double Blind Phase|Miscellaneous|1|||
49178230|NCT04076059|158482667|FG002|Double Blind Phase|Miscellaneous|0|||
49178231|NCT04076059|158482665|FG000|Double Blind Phase|Protocol Deviation|1|||
49178232|NCT04076059|158482666|FG001|Double Blind Phase|Protocol Deviation|1|||
49178233|NCT04076059|158482667|FG002|Double Blind Phase|Protocol Deviation|0|||
49178234|NCT04076059|158482665|FG000|Double Blind Phase|Did not take study drug|1|||
49178235|NCT04076059|158482666|FG001|Double Blind Phase|Did not take study drug|1|||
49178236|NCT04076059|158482667|FG002|Double Blind Phase|Did not take study drug|0|||
49178237|NCT04076059|158482665|FG000|Open Label Phase|Progressive disease|0|||
49178238|NCT04076059|158482666|FG001|Open Label Phase|Progressive disease|0|||
49178239|NCT04076059|158482667|FG002|Open Label Phase|Progressive disease|7|||
49178240|NCT04076059|158482665|FG000|Open Label Phase|Withdrawal by Subject|0|||
49178241|NCT04076059|158482666|FG001|Open Label Phase|Withdrawal by Subject|0|||
49178242|NCT04076059|158482667|FG002|Open Label Phase|Withdrawal by Subject|3|||
49178243|NCT04076059|158482665|FG000|Open Label Phase|Death|0|||
49178244|NCT04076059|158482666|FG001|Open Label Phase|Death|0|||
49178245|NCT04076059|158482667|FG002|Open Label Phase|Death|2|||
49178246|NCT04076059|158482665|FG000|Open Label Phase|Ongoing Participants|0|||
49178247|NCT04076059|158482666|FG001|Open Label Phase|Ongoing Participants|0|||
49178248|NCT04076059|158482667|FG002|Open Label Phase|Ongoing Participants|11|||
49178249|NCT04886154|158482668|FG000|Overall Study|Adverse Event|0|||
49178250|NCT04886154|158482669|FG001|Overall Study|Adverse Event|0|||
49178251|NCT04886154|158482670|FG002|Overall Study|Adverse Event|0|||
49178252|NCT04886154|158482671|FG003|Overall Study|Adverse Event|0|||
49178253|NCT04886154|158482672|FG004|Overall Study|Adverse Event|1|||
49178254|NCT04886154|158482673|FG005|Overall Study|Adverse Event|0|||
49178255|NCT04886154|158482674|FG006|Overall Study|Adverse Event|0|||
49178256|NCT04886154|158482675|FG007|Overall Study|Adverse Event|1|||
49178257|NCT04886154|158482676|FG008|Overall Study|Adverse Event|1|||
49178258|NCT04886154|158482677|FG009|Overall Study|Adverse Event|0|||
49178259|NCT04886154|158482678|FG010|Overall Study|Adverse Event|0|||
49178260|NCT04886154|158482679|FG011|Overall Study|Adverse Event|1|||
49178261|NCT04886154|158482680|FG012|Overall Study|Adverse Event|0|||
49178262|NCT04886154|158482681|FG013|Overall Study|Adverse Event|0|||
49178263|NCT04886154|158482682|FG014|Overall Study|Adverse Event|3|||
49178264|NCT04886154|158482668|FG000|Overall Study|Lost to Follow-up|1|||
49178265|NCT04886154|158482669|FG001|Overall Study|Lost to Follow-up|0|||
49178266|NCT04886154|158482670|FG002|Overall Study|Lost to Follow-up|2|||
49178267|NCT04886154|158482671|FG003|Overall Study|Lost to Follow-up|0|||
49178268|NCT04886154|158482672|FG004|Overall Study|Lost to Follow-up|17|||
49178269|NCT04886154|158482673|FG005|Overall Study|Lost to Follow-up|7|||
49178270|NCT04886154|158482674|FG006|Overall Study|Lost to Follow-up|8|||
49178271|NCT04886154|158482675|FG007|Overall Study|Lost to Follow-up|7|||
49178272|NCT04886154|158482676|FG008|Overall Study|Lost to Follow-up|8|||
49178273|NCT04886154|158482677|FG009|Overall Study|Lost to Follow-up|0|||
49178274|NCT04886154|158482678|FG010|Overall Study|Lost to Follow-up|2|||
49178275|NCT04886154|158482679|FG011|Overall Study|Lost to Follow-up|0|||
49178276|NCT04886154|158482680|FG012|Overall Study|Lost to Follow-up|0|||
49178277|NCT04886154|158482681|FG013|Overall Study|Lost to Follow-up|0|||
49178278|NCT04886154|158482682|FG014|Overall Study|Lost to Follow-up|0|||
49178279|NCT04886154|158482668|FG000|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
49178280|NCT04886154|158482669|FG001|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
49178281|NCT04886154|158482670|FG002|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
49178282|NCT04886154|158482671|FG003|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
49178283|NCT04886154|158482672|FG004|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
49178284|NCT04886154|158482673|FG005|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
49178285|NCT04886154|158482674|FG006|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|1|||
49178286|NCT04886154|158482675|FG007|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
49178287|NCT04886154|158482676|FG008|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
49178288|NCT04886154|158482677|FG009|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
49178289|NCT04886154|158482678|FG010|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
49178290|NCT04886154|158482679|FG011|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
49178291|NCT04886154|158482680|FG012|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
49178292|NCT04886154|158482681|FG013|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
49178293|NCT04886154|158482682|FG014|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
49178294|NCT04886154|158482668|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
49178295|NCT04886154|158482669|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
49178296|NCT04886154|158482670|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
49178297|NCT04886154|158482671|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
49178298|NCT04886154|158482672|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
49178299|NCT04886154|158482673|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
49178300|NCT04886154|158482674|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
49178301|NCT04886154|158482675|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
49178302|NCT04886154|158482676|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
49178303|NCT04886154|158482677|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
49178304|NCT04886154|158482678|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
49178305|NCT04886154|158482679|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
49178306|NCT04886154|158482680|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
49178307|NCT04886154|158482681|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
49178308|NCT04886154|158482682|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
48927466|NCT05290493|157566569|FG000|Overall Study|Withdrawal by Subject|2|||
48927467|NCT05290493|157566570|FG001|Overall Study|Withdrawal by Subject|2|||
49178309|NCT04886154|158482668|FG000|Overall Study|Other, Not Specified|0|||
49178310|NCT04886154|158482669|FG001|Overall Study|Other, Not Specified|0|||
49178311|NCT04886154|158482670|FG002|Overall Study|Other, Not Specified|0|||
49178312|NCT04886154|158482671|FG003|Overall Study|Other, Not Specified|0|||
49178313|NCT04886154|158482672|FG004|Overall Study|Other, Not Specified|11|||
49178314|NCT04886154|158482673|FG005|Overall Study|Other, Not Specified|8|||
49178315|NCT04886154|158482674|FG006|Overall Study|Other, Not Specified|9|||
49178316|NCT04886154|158482675|FG007|Overall Study|Other, Not Specified|10|||
49178317|NCT04886154|158482676|FG008|Overall Study|Other, Not Specified|6|||
49178318|NCT04886154|158482677|FG009|Overall Study|Other, Not Specified|1|||
49178319|NCT04886154|158482678|FG010|Overall Study|Other, Not Specified|1|||
49178320|NCT04886154|158482679|FG011|Overall Study|Other, Not Specified|2|||
49178321|NCT04886154|158482680|FG012|Overall Study|Other, Not Specified|1|||
49178322|NCT04886154|158482681|FG013|Overall Study|Other, Not Specified|2|||
49178323|NCT04886154|158482682|FG014|Overall Study|Other, Not Specified|3|||
49178324|NCT04308681|158482686|FG000|Pre-Treatment|Not reported|1|||
49178325|NCT04308681|158482687|FG001|Pre-Treatment|Not reported|1|||
49178326|NCT04308681|158482688|FG002|Pre-Treatment|Not reported|0|||
49178327|NCT04308681|158482689|FG003|Pre-Treatment|Not reported|0|||
49178328|NCT04308681|158482690|FG004|Pre-Treatment|Not reported|0|||
49178329|NCT04308681|158482691|FG005|Pre-Treatment|Not reported|2|||
49178330|NCT04308681|158482692|FG006|Pre-Treatment|Not reported|0|||
49178331|NCT04308681|158482693|FG007|Pre-Treatment|Not reported|0|||
49178332|NCT04308681|158482686|FG000|Treatment up to Week 26|Withdrawal by participant|2|||
49178333|NCT04308681|158482687|FG001|Treatment up to Week 26|Withdrawal by participant|1|||
49178334|NCT04308681|158482688|FG002|Treatment up to Week 26|Withdrawal by participant|1|||
49178335|NCT04308681|158482689|FG003|Treatment up to Week 26|Withdrawal by participant|0|||
49178336|NCT04308681|158482690|FG004|Treatment up to Week 26|Withdrawal by participant|0|||
49178337|NCT04308681|158482691|FG005|Treatment up to Week 26|Withdrawal by participant|1|||
49178338|NCT04308681|158482692|FG006|Treatment up to Week 26|Withdrawal by participant|1|||
49178339|NCT04308681|158482693|FG007|Treatment up to Week 26|Withdrawal by participant|0|||
49178340|NCT04308681|158482686|FG000|Treatment up to Week 26|Other reasons|2|||
49178341|NCT04308681|158482687|FG001|Treatment up to Week 26|Other reasons|0|||
49178342|NCT04308681|158482688|FG002|Treatment up to Week 26|Other reasons|0|||
49178343|NCT04308681|158482689|FG003|Treatment up to Week 26|Other reasons|0|||
49178344|NCT04308681|158482690|FG004|Treatment up to Week 26|Other reasons|1|||
49178345|NCT04308681|158482691|FG005|Treatment up to Week 26|Other reasons|1|||
49178346|NCT04308681|158482692|FG006|Treatment up to Week 26|Other reasons|0|||
49178347|NCT04308681|158482693|FG007|Treatment up to Week 26|Other reasons|0|||
49178348|NCT04308681|158482686|FG000|Treatment up to Week 26|Participant no longer meets study criteria|0|||
49178349|NCT04308681|158482687|FG001|Treatment up to Week 26|Participant no longer meets study criteria|1|||
49178350|NCT04308681|158482688|FG002|Treatment up to Week 26|Participant no longer meets study criteria|2|||
49178351|NCT04308681|158482689|FG003|Treatment up to Week 26|Participant no longer meets study criteria|0|||
49178352|NCT04308681|158482690|FG004|Treatment up to Week 26|Participant no longer meets study criteria|1|||
49178353|NCT04308681|158482691|FG005|Treatment up to Week 26|Participant no longer meets study criteria|0|||
49178354|NCT04308681|158482692|FG006|Treatment up to Week 26|Participant no longer meets study criteria|1|||
49178355|NCT04308681|158482693|FG007|Treatment up to Week 26|Participant no longer meets study criteria|0|||
49178356|NCT04308681|158482686|FG000|Treatment up to Week 26|Adverse Event|6|||
49178357|NCT04308681|158482687|FG001|Treatment up to Week 26|Adverse Event|5|||
49178358|NCT04308681|158482688|FG002|Treatment up to Week 26|Adverse Event|5|||
49178359|NCT04308681|158482689|FG003|Treatment up to Week 26|Adverse Event|0|||
49178360|NCT04308681|158482690|FG004|Treatment up to Week 26|Adverse Event|6|||
49178361|NCT04308681|158482691|FG005|Treatment up to Week 26|Adverse Event|1|||
49178362|NCT04308681|158482692|FG006|Treatment up to Week 26|Adverse Event|0|||
49178363|NCT04308681|158482693|FG007|Treatment up to Week 26|Adverse Event|0|||
49178364|NCT04308681|158482686|FG000|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
49178365|NCT04308681|158482687|FG001|Treatment up to Week 26|Adverse event unrelated to study drug|2|||
49178366|NCT04308681|158482688|FG002|Treatment up to Week 26|Adverse event unrelated to study drug|1|||
49178367|NCT04308681|158482689|FG003|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
49178368|NCT04308681|158482690|FG004|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
49178369|NCT04308681|158482691|FG005|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
49178370|NCT04308681|158482692|FG006|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
49178371|NCT04308681|158482693|FG007|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
49178372|NCT04308681|158482686|FG000|OTE - 26 Weeks|Withdrawal by participant|0|||
49178373|NCT04308681|158482687|FG001|OTE - 26 Weeks|Withdrawal by participant|0|||
49178374|NCT04308681|158482688|FG002|OTE - 26 Weeks|Withdrawal by participant|4|||
49178375|NCT04308681|158482689|FG003|OTE - 26 Weeks|Withdrawal by participant|0|||
49178376|NCT04308681|158482690|FG004|OTE - 26 Weeks|Withdrawal by participant|0|||
49178377|NCT04308681|158482691|FG005|OTE - 26 Weeks|Withdrawal by participant|0|||
49178378|NCT04308681|158482692|FG006|OTE - 26 Weeks|Withdrawal by participant|1|||
49178379|NCT04308681|158482693|FG007|OTE - 26 Weeks|Withdrawal by participant|0|||
49178380|NCT04308681|158482686|FG000|OTE - 26 Weeks|Death|0|||
49178381|NCT04308681|158482687|FG001|OTE - 26 Weeks|Death|1|||
49178382|NCT04308681|158482688|FG002|OTE - 26 Weeks|Death|0|||
49178383|NCT04308681|158482689|FG003|OTE - 26 Weeks|Death|0|||
49178384|NCT04308681|158482690|FG004|OTE - 26 Weeks|Death|0|||
49178385|NCT04308681|158482691|FG005|OTE - 26 Weeks|Death|0|||
49178386|NCT04308681|158482692|FG006|OTE - 26 Weeks|Death|1|||
49178387|NCT04308681|158482693|FG007|OTE - 26 Weeks|Death|0|||
49178388|NCT04308681|158482686|FG000|OTE - 26 Weeks|Adverse Event|0|||
49178389|NCT04308681|158482687|FG001|OTE - 26 Weeks|Adverse Event|2|||
49178390|NCT04308681|158482688|FG002|OTE - 26 Weeks|Adverse Event|8|||
49178391|NCT04308681|158482689|FG003|OTE - 26 Weeks|Adverse Event|3|||
49178392|NCT04308681|158482690|FG004|OTE - 26 Weeks|Adverse Event|0|||
49178393|NCT04308681|158482691|FG005|OTE - 26 Weeks|Adverse Event|1|||
49178394|NCT04308681|158482692|FG006|OTE - 26 Weeks|Adverse Event|2|||
49178395|NCT04308681|158482693|FG007|OTE - 26 Weeks|Adverse Event|0|||
49178396|NCT04308681|158482686|FG000|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
49178397|NCT04308681|158482687|FG001|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
49178398|NCT04308681|158482688|FG002|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
49178399|NCT04308681|158482689|FG003|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
49178400|NCT04308681|158482690|FG004|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
49178401|NCT04308681|158482691|FG005|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
49178402|NCT04308681|158482692|FG006|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
49178403|NCT04308681|158482693|FG007|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
49178404|NCT05565820|158482694|FG000|7 Day Treatment Effectiveness|Withdrawal by Subject|2|||
49178405|NCT05565820|158482695|FG001|7 Day Treatment Effectiveness|Withdrawal by Subject|0|||
49178406|NCT05565820|158482694|FG000|14 Day Treatment Effectiveness|Withdrawal by Subject|2|||
49178407|NCT05565820|158482695|FG001|14 Day Treatment Effectiveness|Withdrawal by Subject|0|||
49178408|NCT02257736|158482700|FG000|Overall Study|Progressive disease|365|||
49178409|NCT02257736|158482701|FG001|Overall Study|Progressive disease|327|||
49178410|NCT02257736|158482700|FG000|Overall Study|Adverse Event|45|||
49178411|NCT02257736|158482701|FG001|Overall Study|Adverse Event|56|||
49178412|NCT02257736|158482700|FG000|Overall Study|Withdrawal by Subject|21|||
49178413|NCT02257736|158482701|FG001|Overall Study|Withdrawal by Subject|38|||
49178414|NCT02257736|158482700|FG000|Overall Study|Death|11|||
49178415|NCT02257736|158482701|FG001|Overall Study|Death|6|||
49178416|NCT02257736|158482700|FG000|Overall Study|Physician Decision|5|||
49178417|NCT02257736|158482701|FG001|Overall Study|Physician Decision|9|||
49178418|NCT02257736|158482700|FG000|Overall Study|Non-Compliance with study drug|1|||
49178419|NCT02257736|158482701|FG001|Overall Study|Non-Compliance with study drug|2|||
49178420|NCT02257736|158482700|FG000|Overall Study|Protocol Violation|1|||
49178421|NCT02257736|158482701|FG001|Overall Study|Protocol Violation|0|||
49178422|NCT02257736|158482700|FG000|Overall Study|Other|1|||
49178423|NCT02257736|158482701|FG001|Overall Study|Other|7|||
49178424|NCT02257736|158482700|FG000|Overall Study|Randomized, not treated|1|||
49178425|NCT02257736|158482701|FG001|Overall Study|Randomized, not treated|2|||
49178426|NCT01796197|158482702|FG000|Overall Study|Lost to Follow-up|1|||
49178427|NCT01796197|158482702|FG000|Overall Study|Lack of Efficacy|1|||
49178428|NCT02142803|158482706|FG000|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
49178429|NCT02142803|158482707|FG001|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
49178430|NCT02142803|158482708|FG002|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
49178431|NCT02142803|158482709|FG003|Registration to Initiation of Therapy|Withdrawal by Subject|1|||
49178432|NCT04471428|158482710|FG000|Overall Study|Withdrawal by Subject|29|||
49178433|NCT04471428|158482711|FG001|Overall Study|Withdrawal by Subject|1|||
49178434|NCT04471428|158482710|FG000|Overall Study|Physician Decision|0|||
49178435|NCT04471428|158482711|FG001|Overall Study|Physician Decision|1|||
49178436|NCT04471428|158482710|FG000|Overall Study|Reason Not Specified|0|||
48844299|NCT01070069|157271311|FG000|Overall Study|Withdrawal by Subject|1|||
49178437|NCT04471428|158482711|FG001|Overall Study|Reason Not Specified|2|||
49178438|NCT04471428|158482710|FG000|Overall Study|Death|106|||
49178439|NCT04471428|158482711|FG001|Overall Study|Death|114|||
49178440|NCT04471428|158482710|FG000|Overall Study|Ongoing in the study|45|||
49178441|NCT04471428|158482711|FG001|Overall Study|Ongoing in the study|68|||
49178442|NCT05280574|158482712|FG000|Overall Study|Withdrawal by Subject|0|||
49178443|NCT05280574|158482713|FG001|Overall Study|Withdrawal by Subject|2|||
49178444|NCT05280574|158482714|FG002|Overall Study|Withdrawal by Subject|0|||
49178445|NCT02686658|158482715|FG000|Overall Study|Adverse Event|0|||
49178446|NCT02686658|158482716|FG001|Overall Study|Adverse Event|0|||
49178447|NCT02686658|158482717|FG002|Overall Study|Adverse Event|1|||
49178448|NCT02686658|158482718|FG003|Overall Study|Adverse Event|1|||
49178449|NCT02686658|158482719|FG004|Overall Study|Adverse Event|2|||
49178450|NCT02686658|158482720|FG005|Overall Study|Adverse Event|1|||
49178451|NCT02686658|158482715|FG000|Overall Study|Investigator decision|0|||
49178452|NCT02686658|158482716|FG001|Overall Study|Investigator decision|0|||
49178453|NCT02686658|158482717|FG002|Overall Study|Investigator decision|0|||
49178454|NCT02686658|158482718|FG003|Overall Study|Investigator decision|1|||
49178455|NCT02686658|158482719|FG004|Overall Study|Investigator decision|2|||
49178456|NCT02686658|158482720|FG005|Overall Study|Investigator decision|1|||
49178457|NCT02686658|158482715|FG000|Overall Study|Sponsor decision|1|||
49178458|NCT02686658|158482716|FG001|Overall Study|Sponsor decision|2|||
49178459|NCT02686658|158482717|FG002|Overall Study|Sponsor decision|1|||
49178460|NCT02686658|158482718|FG003|Overall Study|Sponsor decision|5|||
49178461|NCT02686658|158482719|FG004|Overall Study|Sponsor decision|13|||
49178462|NCT02686658|158482720|FG005|Overall Study|Sponsor decision|2|||
49178463|NCT02686658|158482715|FG000|Overall Study|Lost to Follow-up|0|||
49178464|NCT02686658|158482716|FG001|Overall Study|Lost to Follow-up|0|||
49178465|NCT02686658|158482717|FG002|Overall Study|Lost to Follow-up|2|||
49178466|NCT02686658|158482718|FG003|Overall Study|Lost to Follow-up|0|||
49178467|NCT02686658|158482719|FG004|Overall Study|Lost to Follow-up|0|||
49178468|NCT02686658|158482720|FG005|Overall Study|Lost to Follow-up|1|||
49178469|NCT02686658|158482715|FG000|Overall Study|Death|1|||
49178470|NCT02686658|158482716|FG001|Overall Study|Death|0|||
49178471|NCT02686658|158482717|FG002|Overall Study|Death|0|||
49178472|NCT02686658|158482718|FG003|Overall Study|Death|1|||
49178473|NCT02686658|158482719|FG004|Overall Study|Death|1|||
49178474|NCT02686658|158482720|FG005|Overall Study|Death|1|||
49178475|NCT02686658|158482715|FG000|Overall Study|Withdrawal by Subject|2|||
49178476|NCT02686658|158482716|FG001|Overall Study|Withdrawal by Subject|5|||
49178477|NCT02686658|158482717|FG002|Overall Study|Withdrawal by Subject|4|||
49178478|NCT02686658|158482718|FG003|Overall Study|Withdrawal by Subject|4|||
49178479|NCT02686658|158482719|FG004|Overall Study|Withdrawal by Subject|17|||
49178480|NCT02686658|158482720|FG005|Overall Study|Withdrawal by Subject|8|||
49178481|NCT02686658|158482715|FG000|Overall Study|Placed in hospice care|0|||
49178482|NCT02686658|158482716|FG001|Overall Study|Placed in hospice care|0|||
49178483|NCT02686658|158482717|FG002|Overall Study|Placed in hospice care|1|||
49178484|NCT02686658|158482718|FG003|Overall Study|Placed in hospice care|0|||
49178485|NCT02686658|158482719|FG004|Overall Study|Placed in hospice care|0|||
48927468|NCT05290493|157566569|FG000|Overall Study|Adverse Event|1|||
48927469|NCT05290493|157566570|FG001|Overall Study|Adverse Event|0|||
48927470|NCT04325828|157566571|FG000|Overall Study|Ongoing|26|||
48927471|NCT00695565|157566572|FG000|Overall Study|Lost to Follow-up|4|||
48927472|NCT00695565|157566573|FG001|Overall Study|Lost to Follow-up|4|||
48927473|NCT00695565|157566572|FG000|Overall Study|Adverse Event|3|||
48927474|NCT00695565|157566573|FG001|Overall Study|Adverse Event|1|||
48927475|NCT00695565|157566572|FG000|Overall Study|Protocol Violation|3|||
48927476|NCT00695565|157566573|FG001|Overall Study|Protocol Violation|1|||
48927477|NCT00695565|157566572|FG000|Overall Study|Withdrawal by Subject|1|||
48927478|NCT00695565|157566573|FG001|Overall Study|Withdrawal by Subject|1|||
48927479|NCT00695565|157566572|FG000|Overall Study|Lack of Efficacy|1|||
48927480|NCT00695565|157566573|FG001|Overall Study|Lack of Efficacy|1|||
48927481|NCT00695565|157566572|FG000|Overall Study|Subject did not follow instructions|1|||
48927482|NCT00695565|157566573|FG001|Overall Study|Subject did not follow instructions|1|||
48927483|NCT01106846|157566574|FG000|Overall Study|Change in surgical procedure|0|||
48927484|NCT01106846|157566575|FG001|Overall Study|Change in surgical procedure|1|||
48927485|NCT02447848|157566586|FG000|Overall Study|Patient discharged|3|||
48927486|NCT02447848|157566586|FG000|Overall Study|Lack of Efficacy|4|||
48927487|NCT02447848|157566586|FG000|Overall Study|Withdrawal by Subject|4|||
48927488|NCT01877083|157566587|FG000|Treatment Phase|Disease Progression|10|||
48927489|NCT01877083|157566587|FG000|Treatment Phase|Clinical Progression|1|||
48927490|NCT01877083|157566587|FG000|Treatment Phase|Adverse Event|6|||
48927491|NCT01877083|157566587|FG000|Treatment Phase|Withdrawal by Subject|2|||
48927492|NCT01877083|157566587|FG000|Treatment Phase|Lost to Follow-up|1|||
48927493|NCT01877083|157566587|FG000|Extension Phase|Disease Progression|3|||
48927494|NCT01877083|157566587|FG000|Extension Phase|Adverse Event|2|||
48927495|NCT00865020|157566590|FG000|Overall Study|Withdrawal by Subject|22|||
49178486|NCT02686658|158482720|FG005|Overall Study|Placed in hospice care|0|||
49178487|NCT02686658|158482715|FG000|Overall Study|Participant non-compliance|0|||
49178488|NCT02686658|158482716|FG001|Overall Study|Participant non-compliance|0|||
49178489|NCT02686658|158482717|FG002|Overall Study|Participant non-compliance|0|||
49178490|NCT02686658|158482718|FG003|Overall Study|Participant non-compliance|0|||
49178491|NCT02686658|158482719|FG004|Overall Study|Participant non-compliance|0|||
49178492|NCT02686658|158482720|FG005|Overall Study|Participant non-compliance|1|||
49178493|NCT02686658|158482715|FG000|Overall Study|Concern over coronavirus disease care|0|||
49178494|NCT02686658|158482716|FG001|Overall Study|Concern over coronavirus disease care|0|||
49178495|NCT02686658|158482717|FG002|Overall Study|Concern over coronavirus disease care|0|||
49178496|NCT02686658|158482718|FG003|Overall Study|Concern over coronavirus disease care|0|||
49178497|NCT02686658|158482719|FG004|Overall Study|Concern over coronavirus disease care|2|||
49178498|NCT02686658|158482720|FG005|Overall Study|Concern over coronavirus disease care|1|||
49178499|NCT05169567|158482721|FG000|Overall Study|On study treatment|116|||
49178500|NCT05169567|158482722|FG001|Overall Study|On study treatment|128|||
49178501|NCT05169567|158482721|FG000|Overall Study|Lost to Follow-up|1|||
49178502|NCT05169567|158482722|FG001|Overall Study|Lost to Follow-up|0|||
49178503|NCT05169567|158482721|FG000|Overall Study|Withdrawal by Subject|25|||
49178504|NCT05169567|158482722|FG001|Overall Study|Withdrawal by Subject|21|||
49178505|NCT03210714|158484445|FG000|Overall Study|Adverse Event|6|||
49178506|NCT03210714|158484445|FG000|Overall Study|Physician Decision|1|||
49178507|NCT03210714|158484445|FG000|Overall Study|Progressive disease|11|||
49178508|NCT03210714|158484445|FG000|Overall Study|Refusal by patient/parent/guardian|2|||
49178509|NCT04186845|158484456|FG000|Overall Study|Death|2|||
49178510|NCT04186845|158484456|FG000|Overall Study|Lost to Follow-up|1|||
49178511|NCT04186845|158484456|FG000|Overall Study|Physician Decision|1|||
49178512|NCT04186845|158484456|FG000|Overall Study|Protocol Violation|1|||
49178513|NCT04186845|158484456|FG000|Overall Study|Biopsy ordered but area too small to biopsy|1|||
49178514|NCT04186845|158484456|FG000|Overall Study|Biopsy ordered but not done|1|||
49178515|NCT04186845|158484456|FG000|Overall Study|It was previously confirmed|1|||
49178516|NCT04186845|158484456|FG000|Overall Study|Patient cancelled scheduled scans|2|||
48927496|NCT00865020|157566591|FG001|Overall Study|Withdrawal by Subject|16|||
48927497|NCT00865020|157566590|FG000|Overall Study|Adverse Event|9|||
48927498|NCT00865020|157566591|FG001|Overall Study|Adverse Event|14|||
48927499|NCT00865020|157566590|FG000|Overall Study|Abnormal test procedure result(s)|6|||
48927500|NCT00865020|157566591|FG001|Overall Study|Abnormal test procedure result(s)|8|||
48927501|NCT00865020|157566590|FG000|Overall Study|Lost to Follow-up|6|||
48927502|NCT00865020|157566591|FG001|Overall Study|Lost to Follow-up|4|||
48927503|NCT00865020|157566590|FG000|Overall Study|Protocol deviation|4|||
48927504|NCT00865020|157566591|FG001|Overall Study|Protocol deviation|1|||
48927505|NCT00865020|157566590|FG000|Overall Study|Administrative problems|0|||
48927506|NCT00865020|157566591|FG001|Overall Study|Administrative problems|2|||
48927507|NCT00865020|157566590|FG000|Overall Study|Abnormal laboratory value(s)|0|||
48927508|NCT00865020|157566591|FG001|Overall Study|Abnormal laboratory value(s)|1|||
49178517|NCT04186845|158484456|FG000|Overall Study|PSMA PET/CT scan show disease within previously Bx area|1|||
49178518|NCT04186845|158484456|FG000|Overall Study|Subject refused confirmatory imaging|1|||
49178519|NCT04186845|158484456|FG000|Overall Study|Too small to biopsy|1|||
49178520|NCT04086121|158484458|FG000|Overall Study|Other than listed|8|||
49178521|NCT04086121|158484458|FG000|Overall Study|Withdrawal by Subject|3|||
49178522|NCT04086121|158484458|FG000|Overall Study|Lost to Follow-up|2|||
49178523|NCT04086121|158484458|FG000|Overall Study|Adverse Event|1|||
49178524|NCT02246621|158484459|FG000|Overall Study|Withdrawal by Subject|28|||
49178525|NCT02246621|158484460|FG001|Overall Study|Withdrawal by Subject|16|||
49178526|NCT02246621|158484459|FG000|Overall Study|Lost to Follow-up|1|||
49178527|NCT02246621|158484460|FG001|Overall Study|Lost to Follow-up|0|||
49178528|NCT02246621|158484459|FG000|Overall Study|On Study Treatment/ Follow Up|236|||
49178529|NCT02246621|158484460|FG001|Overall Study|On Study Treatment/ Follow Up|119|||
49178530|NCT03201965|158484461|FG000|Overall Study|Death|5|||
49178531|NCT03201965|158484462|FG001|Overall Study|Death|27|||
49178532|NCT03201965|158484463|FG002|Overall Study|Death|27|||
49178533|NCT03201965|158484461|FG000|Overall Study|Lost to Follow-up|0|||
49178534|NCT03201965|158484462|FG001|Overall Study|Lost to Follow-up|1|||
49178535|NCT03201965|158484463|FG002|Overall Study|Lost to Follow-up|0|||
49178536|NCT03201965|158484461|FG000|Overall Study|Withdrawal by Subject|3|||
48927509|NCT00865020|157566590|FG000|Overall Study|Death|0|||
48927510|NCT00865020|157566591|FG001|Overall Study|Death|1|||
49178537|NCT03201965|158484462|FG001|Overall Study|Withdrawal by Subject|13|||
49178538|NCT03201965|158484463|FG002|Overall Study|Withdrawal by Subject|4|||
49178539|NCT03201965|158484461|FG000|Overall Study|Ongoing|20|||
49178540|NCT03201965|158484462|FG001|Overall Study|Ongoing|152|||
49178541|NCT03201965|158484463|FG002|Overall Study|Ongoing|164|||
49178542|NCT04880733|158484468|FG000|Participants in the RCT (Overall Study)|Data collection issue|3|||
49178543|NCT04880733|158484469|FG001|Participants in the RCT (Overall Study)|Data collection issue|5|||
49178544|NCT04880733|158484470|FG002|Participants in the RCT (Overall Study)|Data collection issue|0|||
49178545|NCT04880733|158484468|FG000|Participants in the RCT (Overall Study)|Withdrawal by Subject|3|||
49178546|NCT04880733|158484469|FG001|Participants in the RCT (Overall Study)|Withdrawal by Subject|1|||
49178547|NCT04880733|158484470|FG002|Participants in the RCT (Overall Study)|Withdrawal by Subject|0|||
49178548|NCT04880733|158484468|FG000|Participants in the RCT (Overall Study)|Delay due to ED imaging|1|||
49178549|NCT04880733|158484469|FG001|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
49178550|NCT04880733|158484470|FG002|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
49178551|NCT04880733|158484468|FG000|Participants in the RCT (Overall Study)|Early discharge|0|||
49178552|NCT04880733|158484469|FG001|Participants in the RCT (Overall Study)|Early discharge|1|||
49178553|NCT04880733|158484470|FG002|Participants in the RCT (Overall Study)|Early discharge|0|||
49178554|NCT04880733|158484468|FG000|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
49178555|NCT04880733|158484469|FG001|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
49178556|NCT04880733|158484470|FG002|ED Staff/Providers 6 Month Assessment|Skipped question 2|1|||
49178557|NCT04311632|158484471|FG000|Overall Study|Withdrawal by Subject|0|||
49178558|NCT04311632|158484472|FG001|Overall Study|Withdrawal by Subject|0|||
49178559|NCT04311632|158484473|FG002|Overall Study|Withdrawal by Subject|1|||
49178560|NCT04934072|158484474|FG000|Day 0 to Week 52|Withdrawal by Subject|17|||
49178561|NCT04934072|158484475|FG001|Day 0 to Week 52|Withdrawal by Subject|22|||
48927511|NCT00865020|157566590|FG000|Overall Study|Randomized but discontinued|2|||
48927512|NCT00865020|157566591|FG001|Overall Study|Randomized but discontinued|4|||
48927513|NCT01582308|157566596|FG000|Period 1|Withdrawal by Subject|0|||
48927514|NCT01582308|157566597|FG001|Period 1|Withdrawal by Subject|0|||
48927515|NCT01582308|157566598|FG002|Period 1|Withdrawal by Subject|0|||
48927516|NCT01582308|157566599|FG003|Period 1|Withdrawal by Subject|0|||
48927517|NCT01582308|157566600|FG004|Period 1|Withdrawal by Subject|0|||
48927518|NCT01582308|157566601|FG005|Period 1|Withdrawal by Subject|0|||
48927519|NCT01582308|157566602|FG006|Period 1|Withdrawal by Subject|1|||
48927520|NCT01582308|157566603|FG007|Period 1|Withdrawal by Subject|0|||
48927521|NCT01582308|157566604|FG008|Period 1|Withdrawal by Subject|0|||
48927522|NCT01582308|157566605|FG009|Period 1|Withdrawal by Subject|0|||
48927523|NCT01582308|157566596|FG000|10-day Washout Following Period 1|Physician Decision|0|||
48927524|NCT01582308|157566597|FG001|10-day Washout Following Period 1|Physician Decision|0|||
48927525|NCT01582308|157566598|FG002|10-day Washout Following Period 1|Physician Decision|0|||
48927526|NCT01582308|157566599|FG003|10-day Washout Following Period 1|Physician Decision|0|||
48927527|NCT01582308|157566600|FG004|10-day Washout Following Period 1|Physician Decision|1|||
48927528|NCT01582308|157566601|FG005|10-day Washout Following Period 1|Physician Decision|0|||
49178562|NCT04934072|158484476|FG002|Day 0 to Week 52|Withdrawal by Subject|0|||
49178563|NCT04934072|158484477|FG003|Day 0 to Week 52|Withdrawal by Subject|0|||
49178564|NCT04934072|158484478|FG004|Day 0 to Week 52|Withdrawal by Subject|0|||
49178565|NCT04934072|158484474|FG000|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|4|||
48927529|NCT01582308|157566602|FG006|10-day Washout Following Period 1|Physician Decision|0|||
48927530|NCT01582308|157566603|FG007|10-day Washout Following Period 1|Physician Decision|0|||
49178566|NCT04934072|158484475|FG001|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|1|||
49178567|NCT04934072|158484476|FG002|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
49178568|NCT04934072|158484477|FG003|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
49178569|NCT04934072|158484478|FG004|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
49178570|NCT04934072|158484474|FG000|Day 0 to Week 52|Other|3|||
49178571|NCT04934072|158484475|FG001|Day 0 to Week 52|Other|1|||
49178572|NCT04934072|158484476|FG002|Day 0 to Week 52|Other|0|||
49178573|NCT04934072|158484477|FG003|Day 0 to Week 52|Other|0|||
49178574|NCT04934072|158484478|FG004|Day 0 to Week 52|Other|0|||
49178575|NCT04934072|158484474|FG000|Day 0 to Week 52|Adverse Event|1|||
49178576|NCT04934072|158484475|FG001|Day 0 to Week 52|Adverse Event|3|||
49178577|NCT04934072|158484476|FG002|Day 0 to Week 52|Adverse Event|0|||
49178578|NCT04934072|158484477|FG003|Day 0 to Week 52|Adverse Event|0|||
49178579|NCT04934072|158484478|FG004|Day 0 to Week 52|Adverse Event|0|||
49178580|NCT04934072|158484474|FG000|Week 52 to Week 78|Adverse Event|0|||
49178581|NCT04934072|158484475|FG001|Week 52 to Week 78|Adverse Event|0|||
49178582|NCT04934072|158484476|FG002|Week 52 to Week 78|Adverse Event|0|||
49178583|NCT04934072|158484477|FG003|Week 52 to Week 78|Adverse Event|1|||
49178584|NCT04934072|158484478|FG004|Week 52 to Week 78|Adverse Event|1|||
49178585|NCT04934072|158484474|FG000|Week 52 to Week 78|Withdrawal by Subject|0|||
48927531|NCT01582308|157566604|FG008|10-day Washout Following Period 1|Physician Decision|0|||
48927532|NCT01582308|157566605|FG009|10-day Washout Following Period 1|Physician Decision|0|||
48927533|NCT01582308|157566596|FG000|Period 4|Physician Decision|1|||
48927534|NCT01582308|157566597|FG001|Period 4|Physician Decision|0|||
48927535|NCT01582308|157566598|FG002|Period 4|Physician Decision|0|||
48927536|NCT01582308|157566599|FG003|Period 4|Physician Decision|0|||
48927537|NCT01582308|157566600|FG004|Period 4|Physician Decision|0|||
48927538|NCT01582308|157566601|FG005|Period 4|Physician Decision|1|||
48927539|NCT01582308|157566602|FG006|Period 4|Physician Decision|0|||
48927540|NCT01582308|157566603|FG007|Period 4|Physician Decision|0|||
48927541|NCT01582308|157566604|FG008|Period 4|Physician Decision|0|||
48927542|NCT01582308|157566605|FG009|Period 4|Physician Decision|1|||
48927543|NCT04739800|157566606|FG000|Overall Study|Adverse Event|2|||
48927544|NCT04739800|157566607|FG001|Overall Study|Adverse Event|1|||
48927545|NCT04739800|157566608|FG002|Overall Study|Adverse Event|4|||
48927546|NCT04739800|157566609|FG003|Overall Study|Adverse Event|5|||
48927547|NCT04739800|157566606|FG000|Overall Study|Never Treated|2|||
48927548|NCT04739800|157566607|FG001|Overall Study|Never Treated|0|||
48927549|NCT04739800|157566608|FG002|Overall Study|Never Treated|1|||
49178586|NCT04934072|158484475|FG001|Week 52 to Week 78|Withdrawal by Subject|0|||
49178587|NCT04934072|158484476|FG002|Week 52 to Week 78|Withdrawal by Subject|6|||
49178588|NCT04934072|158484477|FG003|Week 52 to Week 78|Withdrawal by Subject|1|||
49178589|NCT04934072|158484478|FG004|Week 52 to Week 78|Withdrawal by Subject|2|||
49178590|NCT04934072|158484474|FG000|Week 52 to Week 78|Other|0|||
49178591|NCT04934072|158484475|FG001|Week 52 to Week 78|Other|0|||
49178592|NCT04934072|158484476|FG002|Week 52 to Week 78|Other|1|||
49178593|NCT04934072|158484477|FG003|Week 52 to Week 78|Other|0|||
49178594|NCT04934072|158484478|FG004|Week 52 to Week 78|Other|0|||
49178595|NCT02828358|158484479|FG000|Overall Study|Physician Decision|7|||
49178596|NCT02828358|158484480|FG001|Overall Study|Physician Decision|1|||
49178597|NCT02828358|158484479|FG000|Overall Study|Treatment Failure|6|||
49178598|NCT02828358|158484480|FG001|Overall Study|Treatment Failure|0|||
49178599|NCT02828358|158484479|FG000|Overall Study|Patients without KMT2A rearrangement|0|||
49178600|NCT02828358|158484480|FG001|Overall Study|Patients without KMT2A rearrangement|21|||
49178601|NCT02828358|158484479|FG000|Overall Study|Refusal of further protocol therapy|2|||
49178602|NCT02828358|158484480|FG001|Overall Study|Refusal of further protocol therapy|0|||
49178603|NCT02828358|158484479|FG000|Overall Study|Relapse|25|||
49178604|NCT02828358|158484480|FG001|Overall Study|Relapse|0|||
49178605|NCT02828358|158484479|FG000|Overall Study|Still on therapy|5|||
49178606|NCT02828358|158484480|FG001|Overall Study|Still on therapy|0|||
49178607|NCT05285137|158484483|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
49178608|NCT05285137|158484484|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
49178609|NCT05285137|158484485|FG002|Overall Study|Failure to Meet Continuation Criteria|0|||
49178610|NCT05285137|158484486|FG003|Overall Study|Failure to Meet Continuation Criteria|0|||
49178611|NCT05285137|158484487|FG004|Overall Study|Failure to Meet Continuation Criteria|0|||
49178612|NCT05285137|158484488|FG005|Overall Study|Failure to Meet Continuation Criteria|0|||
49178613|NCT05285137|158484489|FG006|Overall Study|Failure to Meet Continuation Criteria|2|||
49178614|NCT05285137|158484490|FG007|Overall Study|Failure to Meet Continuation Criteria|0|||
49178615|NCT05285137|158484491|FG008|Overall Study|Failure to Meet Continuation Criteria|1|||
49178616|NCT05285137|158484483|FG000|Overall Study|Lost to Follow-up|0|||
48927550|NCT04739800|157566609|FG003|Overall Study|Never Treated|1|||
49178617|NCT05285137|158484484|FG001|Overall Study|Lost to Follow-up|0|||
48927551|NCT04739800|157566606|FG000|Overall Study|On Treatment|5|||
48927552|NCT04739800|157566607|FG001|Overall Study|On Treatment|9|||
49178618|NCT05285137|158484485|FG002|Overall Study|Lost to Follow-up|1|||
48927553|NCT04739800|157566608|FG002|Overall Study|On Treatment|9|||
49178619|NCT05285137|158484486|FG003|Overall Study|Lost to Follow-up|3|||
49178620|NCT05285137|158484487|FG004|Overall Study|Lost to Follow-up|0|||
49178621|NCT05285137|158484488|FG005|Overall Study|Lost to Follow-up|0|||
49178622|NCT05285137|158484489|FG006|Overall Study|Lost to Follow-up|1|||
49178623|NCT05285137|158484490|FG007|Overall Study|Lost to Follow-up|0|||
49178624|NCT05285137|158484491|FG008|Overall Study|Lost to Follow-up|0|||
49178625|NCT05285137|158484483|FG000|Overall Study|Physician Decision|0|||
49178626|NCT05285137|158484484|FG001|Overall Study|Physician Decision|1|||
49178627|NCT05285137|158484485|FG002|Overall Study|Physician Decision|0|||
49178628|NCT05285137|158484486|FG003|Overall Study|Physician Decision|0|||
49178629|NCT05285137|158484487|FG004|Overall Study|Physician Decision|0|||
49178630|NCT05285137|158484488|FG005|Overall Study|Physician Decision|0|||
49178631|NCT05285137|158484489|FG006|Overall Study|Physician Decision|0|||
49178632|NCT05285137|158484490|FG007|Overall Study|Physician Decision|0|||
49178633|NCT05285137|158484491|FG008|Overall Study|Physician Decision|0|||
49178634|NCT05285137|158484483|FG000|Overall Study|Pregnancy|0|||
49178635|NCT05285137|158484484|FG001|Overall Study|Pregnancy|0|||
49178636|NCT05285137|158484485|FG002|Overall Study|Pregnancy|0|||
49178637|NCT05285137|158484486|FG003|Overall Study|Pregnancy|0|||
49178638|NCT05285137|158484487|FG004|Overall Study|Pregnancy|0|||
49178639|NCT05285137|158484488|FG005|Overall Study|Pregnancy|0|||
49178640|NCT05285137|158484489|FG006|Overall Study|Pregnancy|1|||
49178641|NCT05285137|158484490|FG007|Overall Study|Pregnancy|0|||
49178642|NCT05285137|158484491|FG008|Overall Study|Pregnancy|0|||
49178643|NCT05285137|158484483|FG000|Overall Study|Withdrawal by Subject|0|||
49178644|NCT05285137|158484484|FG001|Overall Study|Withdrawal by Subject|1|||
49178645|NCT05285137|158484485|FG002|Overall Study|Withdrawal by Subject|2|||
49178646|NCT05285137|158484486|FG003|Overall Study|Withdrawal by Subject|1|||
49178647|NCT05285137|158484487|FG004|Overall Study|Withdrawal by Subject|0|||
49178648|NCT05285137|158484488|FG005|Overall Study|Withdrawal by Subject|0|||
49178649|NCT05285137|158484489|FG006|Overall Study|Withdrawal by Subject|0|||
49178650|NCT05285137|158484490|FG007|Overall Study|Withdrawal by Subject|0|||
49178651|NCT05285137|158484491|FG008|Overall Study|Withdrawal by Subject|1|||
49178652|NCT04186819|158484493|FG000|Overall Study|Adverse Event|1|||
49178653|NCT04186819|158484493|FG000|Overall Study|Lost to Follow-up|1|||
49178654|NCT04186819|158484493|FG000|Overall Study|Opted for EBRT|1|||
49178655|NCT04186819|158484493|FG000|Overall Study|Opted SBRT|1|||
49178656|NCT04186819|158484493|FG000|Overall Study|Patient decided to have focal ablation and not surgery|2|||
49178657|NCT04186819|158484493|FG000|Overall Study|Physician Decision|1|||
49178658|NCT04186819|158484493|FG000|Overall Study|RP Delayed|1|||
49178659|NCT04186819|158484493|FG000|Overall Study|Sponsor Decision: Outdated FU Timeline|1|||
49178660|NCT04186819|158484493|FG000|Overall Study|Subject declined for financial reasons|1|||
49178661|NCT04186819|158484493|FG000|Overall Study|The subject declined any biopsy or surgery due to COVID-19 pandemic|1|||
49178662|NCT04186819|158484493|FG000|Overall Study|The subject declined for any biopsy or other imaging|2|||
49178663|NCT04186819|158484493|FG000|Overall Study|The subject opted for other treatment option|2|||
49178664|NCT04186819|158484493|FG000|Overall Study|The subject opted for other treatment options|1|||
49178665|NCT04186819|158484493|FG000|Overall Study|Withdrawal by Subject|3|||
49178666|NCT04186819|158484493|FG000|Overall Study|Reason not specified|1|||
49178667|NCT05013385|158484494|FG000|Overall Study|Sponsor's decision to terminate the trial|5|||
49178668|NCT04037891|158484495|FG000|Open-label Period|Withdrawal by Subject|1|||
49178669|NCT04037891|158484496|FG001|Open-label Period|Withdrawal by Subject|0|||
49178670|NCT04037891|158484497|FG002|Open-label Period|Withdrawal by Subject|0|||
49178671|NCT04037891|158484495|FG000|Randomized, Double-blind Period|Withdrawal by Subject|0|||
49178672|NCT04037891|158484496|FG001|Randomized, Double-blind Period|Withdrawal by Subject|1|||
49178673|NCT04037891|158484497|FG002|Randomized, Double-blind Period|Withdrawal by Subject|0|||
49178674|NCT03875235|158484498|FG000|Overall Study|Ongoing study treatment|63|||
49178675|NCT03875235|158484499|FG001|Overall Study|Ongoing study treatment|20|||
49178676|NCT03875235|158484498|FG000|Overall Study|Off treatment|77|||
49178677|NCT03875235|158484499|FG001|Overall Study|Off treatment|91|||
49178678|NCT03875235|158484498|FG000|Overall Study|Withdrawal by Subject|3|||
49178679|NCT03875235|158484499|FG001|Overall Study|Withdrawal by Subject|10|||
49178680|NCT03875235|158484498|FG000|Overall Study|Death|198|||
49178681|NCT03875235|158484499|FG001|Overall Study|Death|223|||
49178682|NCT04535544|158484504|FG000|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
49178683|NCT04535544|158484505|FG001|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
49178684|NCT04535544|158484506|FG002|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|1|||
49178685|NCT04535544|158484507|FG003|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
49178686|NCT04535544|158484504|FG000|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|1|||
49178687|NCT04535544|158484505|FG001|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
49178688|NCT04535544|158484506|FG002|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|2|||
49178689|NCT04535544|158484507|FG003|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
49178690|NCT04535544|158484504|FG000|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
49178691|NCT04535544|158484505|FG001|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
49178692|NCT04535544|158484506|FG002|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
49178693|NCT04535544|158484507|FG003|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
49178694|NCT04535544|158484504|FG000|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
49178695|NCT04535544|158484505|FG001|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
49178696|NCT04535544|158484506|FG002|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
49178697|NCT04535544|158484507|FG003|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
49178698|NCT04535544|158484504|FG000|Open-label (Week 52 up to Week 148)|Ongoing|0|||
49178699|NCT04535544|158484505|FG001|Open-label (Week 52 up to Week 148)|Ongoing|1|||
49178700|NCT04535544|158484506|FG002|Open-label (Week 52 up to Week 148)|Ongoing|14|||
49178701|NCT04535544|158484507|FG003|Open-label (Week 52 up to Week 148)|Ongoing|4|||
49178702|NCT04535544|158484504|FG000|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|5|||
49178703|NCT04535544|158484505|FG001|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
49178704|NCT04535544|158484506|FG002|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|4|||
49178705|NCT04535544|158484507|FG003|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
49178706|NCT04535544|158484504|FG000|Follow-up (Week 148 up to Week 161)|Ongoing|4|||
49178707|NCT04535544|158484505|FG001|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
49178708|NCT04535544|158484506|FG002|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
49178709|NCT04535544|158484507|FG003|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
49178710|NCT04535544|158484504|FG000|Follow-up (Week 148 up to Week 161)|Other|0|||
49178711|NCT04535544|158484505|FG001|Follow-up (Week 148 up to Week 161)|Other|0|||
49178712|NCT04535544|158484506|FG002|Follow-up (Week 148 up to Week 161)|Other|1|||
49178713|NCT04535544|158484507|FG003|Follow-up (Week 148 up to Week 161)|Other|0|||
49178714|NCT04211337|158484508|FG000|Overall Study|On Treatment|175|||
49178715|NCT04211337|158484509|FG001|Overall Study|On Treatment|40|||
49178716|NCT04211337|158484508|FG000|Overall Study|Withdrawal by Subject|0|||
49178717|NCT04211337|158484509|FG001|Overall Study|Withdrawal by Subject|2|||
49178718|NCT02101853|158484510|FG000|Block 1 Induction|Adverse Event|11|||
49178719|NCT02101853|158484511|FG001|Block 1 Induction|Adverse Event|0|||
49178720|NCT02101853|158484512|FG002|Block 1 Induction|Adverse Event|0|||
49178721|NCT02101853|158484513|FG003|Block 1 Induction|Adverse Event|0|||
49178722|NCT02101853|158484514|FG004|Block 1 Induction|Adverse Event|0|||
49178723|NCT02101853|158484515|FG005|Block 1 Induction|Adverse Event|0|||
49178724|NCT02101853|158484510|FG000|Block 1 Induction|Death|20|||
49178725|NCT02101853|158484511|FG001|Block 1 Induction|Death|0|||
49178726|NCT02101853|158484512|FG002|Block 1 Induction|Death|0|||
49178727|NCT02101853|158484513|FG003|Block 1 Induction|Death|0|||
49178728|NCT02101853|158484514|FG004|Block 1 Induction|Death|0|||
49178729|NCT02101853|158484515|FG005|Block 1 Induction|Death|0|||
49178730|NCT02101853|158484510|FG000|Block 1 Induction|Lack of Efficacy|6|||
49178731|NCT02101853|158484511|FG001|Block 1 Induction|Lack of Efficacy|0|||
49178732|NCT02101853|158484512|FG002|Block 1 Induction|Lack of Efficacy|0|||
49178733|NCT02101853|158484513|FG003|Block 1 Induction|Lack of Efficacy|0|||
49178734|NCT02101853|158484514|FG004|Block 1 Induction|Lack of Efficacy|0|||
49178735|NCT02101853|158484515|FG005|Block 1 Induction|Lack of Efficacy|0|||
49178736|NCT02101853|158484510|FG000|Block 1 Induction|Physician Decision|61|||
49178737|NCT02101853|158484511|FG001|Block 1 Induction|Physician Decision|0|||
49178738|NCT02101853|158484512|FG002|Block 1 Induction|Physician Decision|0|||
49178739|NCT02101853|158484513|FG003|Block 1 Induction|Physician Decision|0|||
49178740|NCT02101853|158484514|FG004|Block 1 Induction|Physician Decision|0|||
49178741|NCT02101853|158484515|FG005|Block 1 Induction|Physician Decision|0|||
49178742|NCT02101853|158484510|FG000|Block 1 Induction|Protocol Violation|2|||
49178743|NCT02101853|158484511|FG001|Block 1 Induction|Protocol Violation|0|||
49178744|NCT02101853|158484512|FG002|Block 1 Induction|Protocol Violation|0|||
49178745|NCT02101853|158484513|FG003|Block 1 Induction|Protocol Violation|0|||
49178746|NCT02101853|158484514|FG004|Block 1 Induction|Protocol Violation|0|||
49178747|NCT02101853|158484515|FG005|Block 1 Induction|Protocol Violation|0|||
49178748|NCT02101853|158484510|FG000|Block 1 Induction|Withdrawal by Subject|65|||
49178749|NCT02101853|158484511|FG001|Block 1 Induction|Withdrawal by Subject|0|||
49178750|NCT02101853|158484512|FG002|Block 1 Induction|Withdrawal by Subject|0|||
49178751|NCT02101853|158484513|FG003|Block 1 Induction|Withdrawal by Subject|0|||
49178752|NCT02101853|158484514|FG004|Block 1 Induction|Withdrawal by Subject|0|||
49178753|NCT02101853|158484515|FG005|Block 1 Induction|Withdrawal by Subject|0|||
49178754|NCT02101853|158484510|FG000|Block 1 Induction|Ineligible|8|||
49178755|NCT02101853|158484511|FG001|Block 1 Induction|Ineligible|0|||
49178756|NCT02101853|158484512|FG002|Block 1 Induction|Ineligible|0|||
49178757|NCT02101853|158484513|FG003|Block 1 Induction|Ineligible|0|||
49178758|NCT02101853|158484514|FG004|Block 1 Induction|Ineligible|0|||
49178759|NCT02101853|158484515|FG005|Block 1 Induction|Ineligible|0|||
49178760|NCT02101853|158484510|FG000|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|1|||
49178761|NCT02101853|158484511|FG001|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
49178762|NCT02101853|158484512|FG002|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
49178763|NCT02101853|158484513|FG003|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
49178764|NCT02101853|158484514|FG004|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
49178765|NCT02101853|158484515|FG005|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
49178766|NCT02101853|158484510|FG000|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|1|||
49178767|NCT02101853|158484511|FG001|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
49178768|NCT02101853|158484512|FG002|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
49178769|NCT02101853|158484513|FG003|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
49178770|NCT02101853|158484514|FG004|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
49178771|NCT02101853|158484515|FG005|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
49178772|NCT02101853|158484510|FG000|Post Induction Randomization|Adverse Event|0|||
49178773|NCT02101853|158484511|FG001|Post Induction Randomization|Adverse Event|3|||
49178774|NCT02101853|158484512|FG002|Post Induction Randomization|Adverse Event|8|||
49178775|NCT02101853|158484513|FG003|Post Induction Randomization|Adverse Event|4|||
49178776|NCT02101853|158484514|FG004|Post Induction Randomization|Adverse Event|4|||
49178777|NCT02101853|158484515|FG005|Post Induction Randomization|Adverse Event|0|||
49178778|NCT02101853|158484510|FG000|Post Induction Randomization|Death|0|||
49178779|NCT02101853|158484511|FG001|Post Induction Randomization|Death|9|||
49178780|NCT02101853|158484512|FG002|Post Induction Randomization|Death|2|||
49178781|NCT02101853|158484513|FG003|Post Induction Randomization|Death|2|||
49178782|NCT02101853|158484514|FG004|Post Induction Randomization|Death|0|||
49178783|NCT02101853|158484515|FG005|Post Induction Randomization|Death|0|||
49178784|NCT02101853|158484510|FG000|Post Induction Randomization|Lack of Efficacy|0|||
49178785|NCT02101853|158484511|FG001|Post Induction Randomization|Lack of Efficacy|14|||
49178786|NCT02101853|158484512|FG002|Post Induction Randomization|Lack of Efficacy|23|||
49178787|NCT02101853|158484513|FG003|Post Induction Randomization|Lack of Efficacy|18|||
49178788|NCT02101853|158484514|FG004|Post Induction Randomization|Lack of Efficacy|21|||
49178789|NCT02101853|158484515|FG005|Post Induction Randomization|Lack of Efficacy|0|||
49178790|NCT02101853|158484510|FG000|Post Induction Randomization|Physician Decision|0|||
49178791|NCT02101853|158484511|FG001|Post Induction Randomization|Physician Decision|43|||
49178792|NCT02101853|158484512|FG002|Post Induction Randomization|Physician Decision|23|||
49178793|NCT02101853|158484513|FG003|Post Induction Randomization|Physician Decision|14|||
49178794|NCT02101853|158484514|FG004|Post Induction Randomization|Physician Decision|14|||
49178795|NCT02101853|158484515|FG005|Post Induction Randomization|Physician Decision|0|||
49178796|NCT02101853|158484510|FG000|Post Induction Randomization|Protocol Violation|0|||
49178797|NCT02101853|158484511|FG001|Post Induction Randomization|Protocol Violation|3|||
49178798|NCT02101853|158484512|FG002|Post Induction Randomization|Protocol Violation|0|||
48927554|NCT04739800|157566609|FG003|Overall Study|On Treatment|9|||
49178799|NCT02101853|158484513|FG003|Post Induction Randomization|Protocol Violation|0|||
49178800|NCT02101853|158484514|FG004|Post Induction Randomization|Protocol Violation|0|||
49178801|NCT02101853|158484515|FG005|Post Induction Randomization|Protocol Violation|0|||
49178802|NCT02101853|158484510|FG000|Post Induction Randomization|Withdrawal by Subject|0|||
49178803|NCT02101853|158484511|FG001|Post Induction Randomization|Withdrawal by Subject|13|||
49178804|NCT02101853|158484512|FG002|Post Induction Randomization|Withdrawal by Subject|12|||
49178805|NCT02101853|158484513|FG003|Post Induction Randomization|Withdrawal by Subject|7|||
49178806|NCT02101853|158484514|FG004|Post Induction Randomization|Withdrawal by Subject|8|||
49178807|NCT02101853|158484515|FG005|Post Induction Randomization|Withdrawal by Subject|0|||
49178808|NCT02101853|158484510|FG000|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
49178809|NCT02101853|158484511|FG001|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
49178810|NCT02101853|158484512|FG002|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
49178811|NCT02101853|158484513|FG003|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|1|||
49178812|NCT02101853|158484514|FG004|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
49178813|NCT02101853|158484515|FG005|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
49178814|NCT02101853|158484510|FG000|Post Induction Randomization|Found to be ineligible for HSCT|0|||
49178815|NCT02101853|158484511|FG001|Post Induction Randomization|Found to be ineligible for HSCT|5|||
49178816|NCT02101853|158484512|FG002|Post Induction Randomization|Found to be ineligible for HSCT|8|||
49178817|NCT02101853|158484513|FG003|Post Induction Randomization|Found to be ineligible for HSCT|0|||
49178818|NCT02101853|158484514|FG004|Post Induction Randomization|Found to be ineligible for HSCT|0|||
49178819|NCT02101853|158484515|FG005|Post Induction Randomization|Found to be ineligible for HSCT|0|||
49178820|NCT02101853|158484510|FG000|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
49178821|NCT02101853|158484511|FG001|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|5|||
49178822|NCT02101853|158484512|FG002|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
49178823|NCT02101853|158484513|FG003|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
49178824|NCT02101853|158484514|FG004|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
49178825|NCT02101853|158484515|FG005|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
49178826|NCT02101853|158484510|FG000|Post Induction Randomization|Patient still receiving protocol therapy|0|||
49178827|NCT02101853|158484511|FG001|Post Induction Randomization|Patient still receiving protocol therapy|0|||
49178828|NCT02101853|158484512|FG002|Post Induction Randomization|Patient still receiving protocol therapy|0|||
49178829|NCT02101853|158484513|FG003|Post Induction Randomization|Patient still receiving protocol therapy|5|||
49178830|NCT02101853|158484514|FG004|Post Induction Randomization|Patient still receiving protocol therapy|1|||
49178831|NCT02101853|158484515|FG005|Post Induction Randomization|Patient still receiving protocol therapy|0|||
49178832|NCT02101853|158484510|FG000|Blinatumomab Salvage Therapy|Death|0|||
49178833|NCT02101853|158484511|FG001|Blinatumomab Salvage Therapy|Death|0|||
49178834|NCT02101853|158484512|FG002|Blinatumomab Salvage Therapy|Death|0|||
49178835|NCT02101853|158484513|FG003|Blinatumomab Salvage Therapy|Death|0|||
49178836|NCT02101853|158484514|FG004|Blinatumomab Salvage Therapy|Death|0|||
49178837|NCT02101853|158484515|FG005|Blinatumomab Salvage Therapy|Death|2|||
49178838|NCT02101853|158484510|FG000|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
49178839|NCT02101853|158484511|FG001|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
49178840|NCT02101853|158484512|FG002|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
49178841|NCT02101853|158484513|FG003|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
49178842|NCT02101853|158484514|FG004|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
49178843|NCT02101853|158484515|FG005|Blinatumomab Salvage Therapy|Lack of Efficacy|7|||
49178844|NCT02101853|158484510|FG000|Blinatumomab Salvage Therapy|Physician Decision|0|||
49178845|NCT02101853|158484511|FG001|Blinatumomab Salvage Therapy|Physician Decision|0|||
49178846|NCT02101853|158484512|FG002|Blinatumomab Salvage Therapy|Physician Decision|0|||
49178847|NCT02101853|158484513|FG003|Blinatumomab Salvage Therapy|Physician Decision|0|||
49178848|NCT02101853|158484514|FG004|Blinatumomab Salvage Therapy|Physician Decision|0|||
49178849|NCT02101853|158484515|FG005|Blinatumomab Salvage Therapy|Physician Decision|14|||
49178850|NCT02101853|158484510|FG000|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
49178851|NCT02101853|158484511|FG001|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
49178852|NCT02101853|158484512|FG002|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
49178853|NCT02101853|158484513|FG003|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
49178854|NCT02101853|158484514|FG004|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
49178855|NCT02101853|158484515|FG005|Blinatumomab Salvage Therapy|Withdrawal by Subject|2|||
49178856|NCT02112916|158484516|FG000|Overall Study|Adverse Event|6|||
49178857|NCT02112916|158484517|FG001|Overall Study|Adverse Event|9|||
49178858|NCT02112916|158484518|FG002|Overall Study|Adverse Event|3|||
49178859|NCT02112916|158484519|FG003|Overall Study|Adverse Event|2|||
49178860|NCT02112916|158484516|FG000|Overall Study|Death|9|||
49178861|NCT02112916|158484517|FG001|Overall Study|Death|9|||
49178862|NCT02112916|158484518|FG002|Overall Study|Death|3|||
49178863|NCT02112916|158484519|FG003|Overall Study|Death|4|||
49178864|NCT02112916|158484516|FG000|Overall Study|Lost to Follow-up|1|||
49178865|NCT02112916|158484517|FG001|Overall Study|Lost to Follow-up|0|||
49178866|NCT02112916|158484518|FG002|Overall Study|Lost to Follow-up|0|||
49178867|NCT02112916|158484519|FG003|Overall Study|Lost to Follow-up|0|||
49178868|NCT02112916|158484516|FG000|Overall Study|Physician Decision|94|||
49178869|NCT02112916|158484517|FG001|Overall Study|Physician Decision|72|||
49178870|NCT02112916|158484518|FG002|Overall Study|Physician Decision|24|||
49178871|NCT02112916|158484519|FG003|Overall Study|Physician Decision|15|||
49178872|NCT02112916|158484516|FG000|Overall Study|Withdrawal by Subject|5|||
49178873|NCT02112916|158484517|FG001|Overall Study|Withdrawal by Subject|3|||
49178874|NCT02112916|158484518|FG002|Overall Study|Withdrawal by Subject|1|||
49178875|NCT02112916|158484519|FG003|Overall Study|Withdrawal by Subject|1|||
49178876|NCT02112916|158484516|FG000|Overall Study|Ineligible|4|||
49178877|NCT02112916|158484517|FG001|Overall Study|Ineligible|8|||
49178878|NCT02112916|158484518|FG002|Overall Study|Ineligible|3|||
49178879|NCT02112916|158484519|FG003|Overall Study|Ineligible|8|||
49178880|NCT02112916|158484516|FG000|Overall Study|Inevaluable|6|||
49178881|NCT02112916|158484517|FG001|Overall Study|Inevaluable|4|||
49178882|NCT02112916|158484518|FG002|Overall Study|Inevaluable|5|||
49178883|NCT02112916|158484519|FG003|Overall Study|Inevaluable|5|||
49178884|NCT02112916|158484516|FG000|Overall Study|Refusal of further protocol therapy|19|||
49178885|NCT02112916|158484517|FG001|Overall Study|Refusal of further protocol therapy|16|||
49178886|NCT02112916|158484518|FG002|Overall Study|Refusal of further protocol therapy|1|||
49178887|NCT02112916|158484519|FG003|Overall Study|Refusal of further protocol therapy|7|||
49178888|NCT02112916|158484516|FG000|Overall Study|Development of SMN|1|||
49178889|NCT02112916|158484517|FG001|Overall Study|Development of SMN|0|||
49178890|NCT02112916|158484518|FG002|Overall Study|Development of SMN|0|||
49178891|NCT02112916|158484519|FG003|Overall Study|Development of SMN|1|||
49178892|NCT02112916|158484516|FG000|Overall Study|Relapse/Progression|10|||
49178893|NCT02112916|158484517|FG001|Overall Study|Relapse/Progression|18|||
49178894|NCT02112916|158484518|FG002|Overall Study|Relapse/Progression|15|||
49178895|NCT02112916|158484519|FG003|Overall Study|Relapse/Progression|2|||
49178896|NCT02112916|158484516|FG000|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
49178897|NCT02112916|158484517|FG001|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
49178898|NCT02112916|158484518|FG002|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
49178899|NCT02112916|158484519|FG003|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
49178900|NCT02112916|158484516|FG000|Overall Study|Still on Therapy|44|||
49178901|NCT02112916|158484517|FG001|Overall Study|Still on Therapy|47|||
49178902|NCT02112916|158484518|FG002|Overall Study|Still on Therapy|3|||
49178903|NCT02112916|158484519|FG003|Overall Study|Still on Therapy|2|||
49178904|NCT02112916|158484516|FG000|Overall Study|Identified to have Ph+ T-ALL|0|||
49178905|NCT02112916|158484517|FG001|Overall Study|Identified to have Ph+ T-ALL|1|||
49178906|NCT02112916|158484518|FG002|Overall Study|Identified to have Ph+ T-ALL|0|||
49178907|NCT02112916|158484519|FG003|Overall Study|Identified to have Ph+ T-ALL|0|||
49178908|NCT02112916|158484516|FG000|Overall Study|Identified to have Ph+ T-Lly|0|||
49178909|NCT02112916|158484517|FG001|Overall Study|Identified to have Ph+ T-Lly|0|||
49178910|NCT02112916|158484518|FG002|Overall Study|Identified to have Ph+ T-Lly|1|||
49178911|NCT02112916|158484519|FG003|Overall Study|Identified to have Ph+ T-Lly|0|||
49178912|NCT04194944|158484520|FG000|Overall Study|Lost to Follow-up|3|||
49178913|NCT04194944|158484521|FG001|Overall Study|Lost to Follow-up|0|||
49178914|NCT04194944|158484520|FG000|Overall Study|Withdrawal by Subject|2|||
49178915|NCT04194944|158484521|FG001|Overall Study|Withdrawal by Subject|2|||
49178916|NCT04194944|158484520|FG000|Overall Study|On Treatment|93|||
49178917|NCT04194944|158484521|FG001|Overall Study|On Treatment|30|||
49178918|NCT02577354|158484524|FG000|Overall Study|Lack of Efficacy|4|||
49178919|NCT02577354|158484525|FG001|Overall Study|Lack of Efficacy|4|||
49178920|NCT02577354|158484524|FG000|Overall Study|Lost to Follow-up|3|||
49178921|NCT02577354|158484525|FG001|Overall Study|Lost to Follow-up|1|||
49178922|NCT02577354|158484524|FG000|Overall Study|Missed Visit|4|||
49178923|NCT02577354|158484525|FG001|Overall Study|Missed Visit|3|||
49178924|NCT02577354|158484524|FG000|Overall Study|Adverse Event|4|||
49178925|NCT02577354|158484525|FG001|Overall Study|Adverse Event|5|||
49178926|NCT02254278|158484526|FG000|Overall Study|Protocol Violation|1|||
49178927|NCT02254278|158484527|FG001|Overall Study|Protocol Violation|1|||
49178928|NCT04631016|158484538|FG000|Overall Study|Adverse Event|3|||
49178929|NCT04631016|158484539|FG001|Overall Study|Adverse Event|0|||
49178930|NCT04631016|158484538|FG000|Overall Study|Withdrawal by Subject|5|||
49178931|NCT04631016|158484539|FG001|Overall Study|Withdrawal by Subject|4|||
49178932|NCT04631016|158484538|FG000|Overall Study|Reason unspecified|1|||
49178933|NCT04631016|158484539|FG001|Overall Study|Reason unspecified|0|||
49178934|NCT04631016|158484538|FG000|Overall Study|Failure to meet randomization criteria|2|||
49178935|NCT04631016|158484539|FG001|Overall Study|Failure to meet randomization criteria|1|||
49178936|NCT02611037|158484540|FG000|Overall Study|Withdrawal prior to treatment|2|||
49178937|NCT02611037|158484541|FG001|Overall Study|Withdrawal prior to treatment|0|||
49178938|NCT04526665|158484542|FG000|Overall Study|Withdrawal by Subject|6|||
49178939|NCT04526665|158484543|FG001|Overall Study|Withdrawal by Subject|3|||
49178940|NCT04526665|158484542|FG000|Overall Study|Adverse Event|4|||
49178941|NCT04526665|158484543|FG001|Overall Study|Adverse Event|1|||
49178942|NCT04526665|158484542|FG000|Overall Study|Physician Decision|2|||
49178943|NCT04526665|158484543|FG001|Overall Study|Physician Decision|2|||
49178944|NCT04526665|158484542|FG000|Overall Study|Death|2|||
49178945|NCT04526665|158484543|FG001|Overall Study|Death|0|||
49178946|NCT04526665|158484542|FG000|Overall Study|Other|0|||
49178947|NCT04526665|158484543|FG001|Overall Study|Other|1|||
49178948|NCT03372057|158484544|FG000|Dose Optimization Phase|Withdrawal by Subject|1|||
49178949|NCT03372057|158484545|FG001|Dose Optimization Phase|Withdrawal by Subject|1|||
49178950|NCT03372057|158484546|FG002|Dose Optimization Phase|Withdrawal by Subject|0|||
49178951|NCT03372057|158484544|FG000|Dose Optimization Phase|Closure Of The Study By The Sponsor|3|||
49178952|NCT03372057|158484545|FG001|Dose Optimization Phase|Closure Of The Study By The Sponsor|1|||
49178953|NCT03372057|158484546|FG002|Dose Optimization Phase|Closure Of The Study By The Sponsor|0|||
49178954|NCT03372057|158484544|FG000|Dose Optimization Phase|Death|16|||
49178955|NCT03372057|158484545|FG001|Dose Optimization Phase|Death|11|||
49178956|NCT03372057|158484546|FG002|Dose Optimization Phase|Death|0|||
49178957|NCT03372057|158484544|FG000|Expansion Phase|Withdrawal by Subject|0|||
49178958|NCT03372057|158484545|FG001|Expansion Phase|Withdrawal by Subject|0|||
49178959|NCT03372057|158484546|FG002|Expansion Phase|Withdrawal by Subject|4|||
49178960|NCT03372057|158484544|FG000|Expansion Phase|Closure Of The Study By The Sponsor|0|||
49178961|NCT03372057|158484545|FG001|Expansion Phase|Closure Of The Study By The Sponsor|0|||
49178962|NCT03372057|158484546|FG002|Expansion Phase|Closure Of The Study By The Sponsor|39|||
49178963|NCT03372057|158484544|FG000|Expansion Phase|Death|0|||
49178964|NCT03372057|158484545|FG001|Expansion Phase|Death|0|||
49178965|NCT03372057|158484546|FG002|Expansion Phase|Death|78|||
49178966|NCT03372057|158484544|FG000|Expansion Phase|Progressive Disease|0|||
49178967|NCT03372057|158484545|FG001|Expansion Phase|Progressive Disease|0|||
49178968|NCT03372057|158484546|FG002|Expansion Phase|Progressive Disease|1|||
49178969|NCT03372057|158484544|FG000|Expansion Phase|Adverse Event|0|||
49178970|NCT03372057|158484545|FG001|Expansion Phase|Adverse Event|0|||
49178971|NCT03372057|158484546|FG002|Expansion Phase|Adverse Event|1|||
49178972|NCT04283994|158484549|FG000|Overall Study|Death|11|||
49178973|NCT04283994|158484550|FG001|Overall Study|Death|20|||
49178974|NCT04283994|158484551|FG002|Overall Study|Death|11|||
49178975|NCT04283994|158484552|FG003|Overall Study|Death|0|||
49178976|NCT04283994|158484553|FG004|Overall Study|Death|0|||
49178977|NCT04283994|158484554|FG005|Overall Study|Death|0|||
49178978|NCT04283994|158484555|FG006|Overall Study|Death|0|||
49178979|NCT04283994|158484549|FG000|Overall Study|Withdrawal by Subject|16|||
49178980|NCT04283994|158484550|FG001|Overall Study|Withdrawal by Subject|4|||
49178981|NCT04283994|158484551|FG002|Overall Study|Withdrawal by Subject|6|||
49178982|NCT04283994|158484552|FG003|Overall Study|Withdrawal by Subject|1|||
49178983|NCT04283994|158484553|FG004|Overall Study|Withdrawal by Subject|0|||
49178984|NCT04283994|158484554|FG005|Overall Study|Withdrawal by Subject|1|||
49178985|NCT04283994|158484555|FG006|Overall Study|Withdrawal by Subject|0|||
49178986|NCT03744676|158484556|FG000|Pre-Treatment Phase|Disease related complications|2|||
49178987|NCT03744676|158484556|FG000|Pre-Treatment Phase|No longer meets study criteria|4|||
49178988|NCT03744676|158484556|FG000|Pre-Treatment Phase|Death|7|||
49178989|NCT03744676|158484556|FG000|Pre-Treatment Phase|Other Reasons|7|||
49178990|NCT03744676|158484556|FG000|Treatment Phase|Participant withdrew consent|8|||
49178991|NCT03744676|158484556|FG000|Treatment Phase|Death|33|||
49178992|NCT03744676|158484556|FG000|Treatment Phase|other reasons|6|||
49178993|NCT02510235|158484557|FG000|Overall Study|Withdrawal by Subject|1|||
49178994|NCT02510235|158484558|FG001|Overall Study|Withdrawal by Subject|0|||
49178995|NCT04206787|158484559|FG000|Overall Study|Other than listed|2|||
49178996|NCT04206787|158484559|FG000|Overall Study|Investigator decision|1|||
49178997|NCT04206787|158484559|FG000|Overall Study|Death|25|||
49178998|NCT04206787|158484559|FG000|Overall Study|Lost to Follow-up|9|||
49178999|NCT04206787|158484559|FG000|Overall Study|Withdrawal of consent|9|||
49179000|NCT04908930|158484560|FG000|Overall Study|Lost to Follow-up|1|||
49179001|NCT04908930|158484561|FG001|Overall Study|Lost to Follow-up|1|||
49179002|NCT04908930|158484562|FG002|Overall Study|Lost to Follow-up|0|||
49179003|NCT04908930|158484563|FG003|Overall Study|Lost to Follow-up|0|||
49179004|NCT04908930|158484564|FG004|Overall Study|Lost to Follow-up|0|||
49179005|NCT04908930|158484560|FG000|Overall Study|hardware in mouth|1|||
49179006|NCT04908930|158484561|FG001|Overall Study|hardware in mouth|1|||
49179007|NCT04908930|158484562|FG002|Overall Study|hardware in mouth|0|||
49179008|NCT04908930|158484563|FG003|Overall Study|hardware in mouth|0|||
49179009|NCT04908930|158484564|FG004|Overall Study|hardware in mouth|0|||
49179010|NCT04908930|158484560|FG000|Overall Study|wrong team|1|||
49179011|NCT04908930|158484561|FG001|Overall Study|wrong team|0|||
49179012|NCT04908930|158484562|FG002|Overall Study|wrong team|0|||
49179013|NCT04908930|158484563|FG003|Overall Study|wrong team|0|||
49179014|NCT04908930|158484564|FG004|Overall Study|wrong team|0|||
49179015|NCT04908930|158484560|FG000|Overall Study|quit team|2|||
49179016|NCT04908930|158484561|FG001|Overall Study|quit team|4|||
49179017|NCT04908930|158484562|FG002|Overall Study|quit team|0|||
49179018|NCT04908930|158484563|FG003|Overall Study|quit team|0|||
49179019|NCT04908930|158484564|FG004|Overall Study|quit team|0|||
49179020|NCT04908930|158484560|FG000|Overall Study|Withdrawal by Subject|1|||
49179021|NCT04908930|158484561|FG001|Overall Study|Withdrawal by Subject|2|||
49179022|NCT04908930|158484562|FG002|Overall Study|Withdrawal by Subject|0|||
49179023|NCT04908930|158484563|FG003|Overall Study|Withdrawal by Subject|0|||
49179024|NCT04908930|158484564|FG004|Overall Study|Withdrawal by Subject|0|||
49179025|NCT04908930|158484560|FG000|Overall Study|parent not liking program|0|||
49179026|NCT04908930|158484561|FG001|Overall Study|parent not liking program|1|||
49179027|NCT04908930|158484562|FG002|Overall Study|parent not liking program|0|||
49179028|NCT04908930|158484563|FG003|Overall Study|parent not liking program|0|||
49179029|NCT04908930|158484564|FG004|Overall Study|parent not liking program|0|||
49179030|NCT04505410|158484565|FG000|Overall Study|Adverse Event|2|||
49179031|NCT04505410|158484566|FG001|Overall Study|Adverse Event|0|||
49179032|NCT04505410|158484565|FG000|Overall Study|abdominal pain after starting tofacitinib|1|||
49179033|NCT04505410|158484566|FG001|Overall Study|abdominal pain after starting tofacitinib|1|||
49179034|NCT04505410|158484565|FG000|Overall Study|did not want to follow diet|1|||
49179035|NCT04505410|158484566|FG001|Overall Study|did not want to follow diet|0|||
49179036|NCT04505410|158484565|FG000|Overall Study|flare up of ulcerative colitis|0|||
49179037|NCT04505410|158484566|FG001|Overall Study|flare up of ulcerative colitis|1|||
49179038|NCT04505410|158484565|FG000|Overall Study|Lost to Follow-up|0|||
49179039|NCT04505410|158484566|FG001|Overall Study|Lost to Follow-up|2|||
49179040|NCT04505410|158484565|FG000|Overall Study|Lost to Follow-up|1|||
49179041|NCT04505410|158484566|FG001|Overall Study|Lost to Follow-up|0|||
49179042|NCT04505410|158484565|FG000|Overall Study|initiated another diet on their own|0|||
49179043|NCT04505410|158484566|FG001|Overall Study|initiated another diet on their own|2|||
49179044|NCT03807778|158484577|FG000|Overall Study|Adverse Event|0|||
49179045|NCT03807778|158484578|FG001|Overall Study|Adverse Event|0|||
49179046|NCT03807778|158484579|FG002|Overall Study|Adverse Event|3|||
49179047|NCT03807778|158484580|FG003|Overall Study|Adverse Event|5|||
49179048|NCT03807778|158484577|FG000|Overall Study|Progressive Disease|4|||
49179049|NCT03807778|158484578|FG001|Overall Study|Progressive Disease|2|||
49179050|NCT03807778|158484579|FG002|Overall Study|Progressive Disease|8|||
49179051|NCT03807778|158484580|FG003|Overall Study|Progressive Disease|15|||
49179052|NCT03807778|158484577|FG000|Overall Study|Symptomatic Deterioration|0|||
49179053|NCT03807778|158484578|FG001|Overall Study|Symptomatic Deterioration|1|||
49179054|NCT03807778|158484579|FG002|Overall Study|Symptomatic Deterioration|0|||
49179055|NCT03807778|158484580|FG003|Overall Study|Symptomatic Deterioration|1|||
49179056|NCT03807778|158484577|FG000|Overall Study|Withdrawal by Subject|0|||
49179057|NCT03807778|158484578|FG001|Overall Study|Withdrawal by Subject|1|||
49179058|NCT03807778|158484579|FG002|Overall Study|Withdrawal by Subject|0|||
49179059|NCT03807778|158484580|FG003|Overall Study|Withdrawal by Subject|1|||
49179060|NCT03807778|158484577|FG000|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
49179061|NCT03807778|158484578|FG001|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
49179062|NCT03807778|158484579|FG002|Overall Study|Ongoing at data cut- off date (08 November 2021)|1|||
49179063|NCT03807778|158484580|FG003|Overall Study|Ongoing at data cut- off date (08 November 2021)|11|||
49179064|NCT04647253|158484584|FG000|Overall Study|Death ≤ 365 Days|16|||
49179065|NCT04647253|158484585|FG001|Overall Study|Death ≤ 365 Days|7|||
49179066|NCT04647253|158484584|FG000|Overall Study|Physician Decision|0|||
49179067|NCT04647253|158484585|FG001|Overall Study|Physician Decision|1|||
49179068|NCT04647253|158484584|FG000|Overall Study|Withdrawal by Subject|7|||
49179069|NCT04647253|158484585|FG001|Overall Study|Withdrawal by Subject|2|||
49179070|NCT04647253|158484584|FG000|Overall Study|Missed 12-Month Visit|9|||
49179071|NCT04647253|158484585|FG001|Overall Study|Missed 12-Month Visit|7|||
49179072|NCT04647253|158484584|FG000|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
49179073|NCT04647253|158484585|FG001|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
49179074|NCT03250676|158484586|FG000|Overall Study|Adverse Event|0|||
48927555|NCT04739800|157566606|FG000|Overall Study|Symptomatic Deterioration|1|||
48927556|NCT04739800|157566607|FG001|Overall Study|Symptomatic Deterioration|1|||
48927557|NCT04739800|157566608|FG002|Overall Study|Symptomatic Deterioration|3|||
49179075|NCT03250676|158484587|FG001|Overall Study|Adverse Event|0|||
49179076|NCT03250676|158484588|FG002|Overall Study|Adverse Event|0|||
49179077|NCT03250676|158484589|FG003|Overall Study|Adverse Event|1|||
49179078|NCT03250676|158484590|FG004|Overall Study|Adverse Event|2|||
49179079|NCT03250676|158484591|FG005|Overall Study|Adverse Event|9|||
49179080|NCT03250676|158484586|FG000|Overall Study|Withdrawal by Subject|1|||
49179081|NCT03250676|158484587|FG001|Overall Study|Withdrawal by Subject|0|||
49179082|NCT03250676|158484588|FG002|Overall Study|Withdrawal by Subject|0|||
49179083|NCT03250676|158484589|FG003|Overall Study|Withdrawal by Subject|1|||
49179084|NCT03250676|158484590|FG004|Overall Study|Withdrawal by Subject|1|||
49179085|NCT03250676|158484591|FG005|Overall Study|Withdrawal by Subject|2|||
49179086|NCT03250676|158484586|FG000|Overall Study|Physician Decision|0|||
49179087|NCT03250676|158484587|FG001|Overall Study|Physician Decision|0|||
49179088|NCT03250676|158484588|FG002|Overall Study|Physician Decision|0|||
49179089|NCT03250676|158484589|FG003|Overall Study|Physician Decision|2|||
49179090|NCT03250676|158484590|FG004|Overall Study|Physician Decision|0|||
49179091|NCT03250676|158484591|FG005|Overall Study|Physician Decision|3|||
49179092|NCT03250676|158484586|FG000|Overall Study|Withdrawal of consent|0|||
49179093|NCT03250676|158484587|FG001|Overall Study|Withdrawal of consent|0|||
48927558|NCT04739800|157566609|FG003|Overall Study|Symptomatic Deterioration|0|||
48927559|NCT04739800|157566606|FG000|Overall Study|Withdrawal by Subject|1|||
48927560|NCT04739800|157566607|FG001|Overall Study|Withdrawal by Subject|2|||
49179094|NCT03250676|158484588|FG002|Overall Study|Withdrawal of consent|2|||
49179095|NCT03250676|158484589|FG003|Overall Study|Withdrawal of consent|0|||
49179096|NCT03250676|158484590|FG004|Overall Study|Withdrawal of consent|0|||
49179097|NCT03250676|158484591|FG005|Overall Study|Withdrawal of consent|2|||
49179098|NCT03250676|158484586|FG000|Overall Study|Other|1|||
49179099|NCT03250676|158484587|FG001|Overall Study|Other|0|||
49179100|NCT03250676|158484588|FG002|Overall Study|Other|0|||
49179101|NCT03250676|158484589|FG003|Overall Study|Other|0|||
49179102|NCT03250676|158484590|FG004|Overall Study|Other|0|||
49179103|NCT03250676|158484591|FG005|Overall Study|Other|0|||
49179104|NCT03250676|158484586|FG000|Overall Study|Disease progression|4|||
49179105|NCT03250676|158484587|FG001|Overall Study|Disease progression|12|||
49179106|NCT03250676|158484588|FG002|Overall Study|Disease progression|9|||
49179107|NCT03250676|158484589|FG003|Overall Study|Disease progression|7|||
49179108|NCT03250676|158484590|FG004|Overall Study|Disease progression|4|||
49179109|NCT03250676|158484591|FG005|Overall Study|Disease progression|88|||
49179110|NCT01560416|158484592|FG000|Randomized Phase|Crossover Participants|7|||
49179111|NCT01560416|158484593|FG001|Randomized Phase|Crossover Participants|0|||
49179112|NCT01366092|158484594|FG000|Overall Study|Progressive cGVHD|2|||
49179113|NCT01366092|158484594|FG000|Overall Study|Physician Decision|1|||
49179114|NCT01366092|158484594|FG000|Overall Study|Withdrawal by Subject|1|||
48927561|NCT04739800|157566608|FG002|Overall Study|Withdrawal by Subject|1|||
48927562|NCT04739800|157566609|FG003|Overall Study|Withdrawal by Subject|3|||
49179115|NCT00977574|158485395|FG000|Overall Study|Never Treated|4|||
49179116|NCT00977574|158485396|FG001|Overall Study|Never Treated|2|||
49179117|NCT00977574|158485397|FG002|Overall Study|Never Treated|4|||
49179118|NCT03414684|158485398|FG000|First-course Treatment|Complete response|0|||
49179119|NCT03414684|158485399|FG001|First-course Treatment|Complete response|1|||
49179120|NCT03414684|158485398|FG000|First-course Treatment|Intercurrent illness|1|||
49179121|NCT03414684|158485399|FG001|First-course Treatment|Intercurrent illness|0|||
49179122|NCT03414684|158485398|FG000|First-course Treatment|Progressive Disease|31|||
49179123|NCT03414684|158485399|FG001|First-course Treatment|Progressive Disease|32|||
49179124|NCT03414684|158485398|FG000|First-course Treatment|Adverse Event|1|||
49179125|NCT03414684|158485399|FG001|First-course Treatment|Adverse Event|2|||
49179126|NCT03414684|158485398|FG000|First-course Treatment|Physician Decision|0|||
49179127|NCT03414684|158485399|FG001|First-course Treatment|Physician Decision|1|||
49179128|NCT03414684|158485398|FG000|First-course Treatment|Withdrawal by Subject|0|||
49179129|NCT03414684|158485399|FG001|First-course Treatment|Withdrawal by Subject|1|||
49179130|NCT03414684|158485398|FG000|First-course Treatment|"Patient proceeded with chest wall excision"|1|||
49179131|NCT03414684|158485399|FG001|First-course Treatment|"Patient proceeded with chest wall excision"|0|||
49179132|NCT03414684|158485398|FG000|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|0|||
49179133|NCT03414684|158485399|FG001|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|1|||
49179134|NCT03414684|158485398|FG000|First-course Treatment|Still on treatment|3|||
49179135|NCT03414684|158485399|FG001|First-course Treatment|Still on treatment|0|||
49179136|NCT03414684|158485398|FG000|First-course Treatment|Never started protocol therapy|2|||
49179137|NCT03414684|158485399|FG001|First-course Treatment|Never started protocol therapy|1|||
49179138|NCT03414684|158485398|FG000|Crossover Treatment|Progressive disease|0|||
49179139|NCT03414684|158485399|FG001|Crossover Treatment|Progressive disease|12|||
49179140|NCT03414684|158485398|FG000|Crossover Treatment|Adverse Event|0|||
49179141|NCT03414684|158485399|FG001|Crossover Treatment|Adverse Event|3|||
49179142|NCT03414684|158485398|FG000|Crossover Treatment|Physician Decision|0|||
49179143|NCT03414684|158485399|FG001|Crossover Treatment|Physician Decision|1|||
49179144|NCT03414684|158485398|FG000|Crossover Treatment|Still on treatment|0|||
49179145|NCT03414684|158485399|FG001|Crossover Treatment|Still on treatment|2|||
49179146|NCT04303780|158485400|FG000|Overall Study|Death|104|||
49179147|NCT04303780|158485401|FG001|Overall Study|Death|85|||
49179148|NCT04303780|158485400|FG000|Overall Study|Lost to Follow-up|5|||
49179149|NCT04303780|158485401|FG001|Overall Study|Lost to Follow-up|2|||
49179150|NCT04303780|158485400|FG000|Overall Study|Withdrawal by Subject|12|||
49179151|NCT04303780|158485401|FG001|Overall Study|Withdrawal by Subject|39|||
49179152|NCT04303780|158485400|FG000|Overall Study|Ongoing in study|50|||
49179153|NCT04303780|158485401|FG001|Overall Study|Ongoing in study|45|||
49179154|NCT04899674|158485406|FG000|Test|Adverse Event|1|||
49179155|NCT03789110|158485407|FG000|Overall Study|Adverse Event|2|||
49179156|NCT03789110|158485407|FG000|Overall Study|Physician Decision|1|||
49179157|NCT03789110|158485407|FG000|Overall Study|Withdrawal by Subject|2|||
49179158|NCT03789110|158485407|FG000|Overall Study|Lack of Efficacy|22|||
49179159|NCT03789110|158485407|FG000|Overall Study|still on treatment|3|||
49179160|NCT03343704|158485408|FG000|Overall Study|Refused to complete follow up|0|||
49179161|NCT03343704|158485409|FG001|Overall Study|Refused to complete follow up|1|||
49179162|NCT03343704|158485408|FG000|Overall Study|Death|0|||
49179163|NCT03343704|158485409|FG001|Overall Study|Death|1|||
49179164|NCT03343704|158485408|FG000|Overall Study|Reluctant to collect blood and received telephone follow up|1|||
49179165|NCT03343704|158485409|FG001|Overall Study|Reluctant to collect blood and received telephone follow up|0|||
49179166|NCT05525572|158485410|FG000|Overall Study|Lost to Follow-up|2|||
49179167|NCT02761187|158485411|FG000|Overall Study|Too ill to Participate|13|||
49179168|NCT02761187|158485412|FG001|Overall Study|Too ill to Participate|8|||
49179169|NCT02761187|158485411|FG000|Overall Study|Patient declined participation and declined follow-up for survival|34|||
49179170|NCT02761187|158485412|FG001|Overall Study|Patient declined participation and declined follow-up for survival|26|||
49179171|NCT02761187|158485411|FG000|Overall Study|Patient withdrew consent|64|||
49179172|NCT02761187|158485412|FG001|Overall Study|Patient withdrew consent|58|||
49179173|NCT02761187|158485411|FG000|Overall Study|Physician discretion|4|||
49179174|NCT02761187|158485412|FG001|Overall Study|Physician discretion|8|||
49179175|NCT02761187|158485411|FG000|Overall Study|Change in physician or transferred to another treatment center|72|||
49179176|NCT02761187|158485412|FG001|Overall Study|Change in physician or transferred to another treatment center|62|||
49179177|NCT02761187|158485411|FG000|Overall Study|On Hospice|20|||
49179178|NCT02761187|158485412|FG001|Overall Study|On Hospice|26|||
49179179|NCT02761187|158485411|FG000|Overall Study|Deceased|474|||
49179180|NCT02761187|158485412|FG001|Overall Study|Deceased|642|||
49179181|NCT02761187|158485411|FG000|Overall Study|Lost to Follow-up|73|||
49179182|NCT02761187|158485412|FG001|Overall Study|Lost to Follow-up|63|||
49179183|NCT02761187|158485411|FG000|Overall Study|Due to study discontinued at site|100|||
49179184|NCT02761187|158485412|FG001|Overall Study|Due to study discontinued at site|85|||
49179185|NCT02761187|158485411|FG000|Overall Study|Reason not Specified|1484|||
49179186|NCT02761187|158485412|FG001|Overall Study|Reason not Specified|937|||
49179187|NCT02609048|158485413|FG000|Overall Study|Adverse Event|3|||
49179188|NCT02609048|158485414|FG001|Overall Study|Adverse Event|0|||
49179189|NCT02609048|158485415|FG002|Overall Study|Adverse Event|0|||
49179190|NCT02609048|158485413|FG000|Overall Study|Randomized but never treated|1|||
49179191|NCT02609048|158485414|FG001|Overall Study|Randomized but never treated|1|||
49179192|NCT02609048|158485415|FG002|Overall Study|Randomized but never treated|1|||
49179193|NCT02609048|158485413|FG000|Overall Study|Withdrawal of informed consent|1|||
49179194|NCT02609048|158485414|FG001|Overall Study|Withdrawal of informed consent|0|||
49179195|NCT02609048|158485415|FG002|Overall Study|Withdrawal of informed consent|0|||
49179196|NCT02609048|158485413|FG000|Overall Study|Reason not specified|6|||
49179197|NCT02609048|158485414|FG001|Overall Study|Reason not specified|9|||
49179198|NCT02609048|158485415|FG002|Overall Study|Reason not specified|9|||
49179199|NCT02830204|158485416|FG000|Overall Study|Death|9|||
49179200|NCT02830204|158485416|FG000|Overall Study|Withdrawal by Subject|1|||
49179201|NCT01950390|158485421|FG000|Overall Study|Never started treatment|3|||
49179202|NCT01950390|158485422|FG001|Overall Study|Never started treatment|2|||
49179203|NCT01950390|158485421|FG000|Overall Study|Disease progression|45|||
49179204|NCT01950390|158485422|FG001|Overall Study|Disease progression|52|||
49179205|NCT01950390|158485421|FG000|Overall Study|Adverse Event|22|||
49179206|NCT01950390|158485422|FG001|Overall Study|Adverse Event|16|||
49179207|NCT01950390|158485421|FG000|Overall Study|Death|5|||
49179208|NCT01950390|158485422|FG001|Overall Study|Death|3|||
49179209|NCT01950390|158485421|FG000|Overall Study|Withdrawal by Subject|5|||
49179210|NCT01950390|158485422|FG001|Overall Study|Withdrawal by Subject|1|||
49179211|NCT01950390|158485421|FG000|Overall Study|Alternative therapy|0|||
49179212|NCT01950390|158485422|FG001|Overall Study|Alternative therapy|3|||
49179213|NCT01950390|158485421|FG000|Overall Study|Complicating disease|1|||
49179214|NCT01950390|158485422|FG001|Overall Study|Complicating disease|0|||
49179215|NCT01950390|158485421|FG000|Overall Study|On treatment|1|||
49179216|NCT01950390|158485422|FG001|Overall Study|On treatment|0|||
49179217|NCT01950390|158485421|FG000|Overall Study|Symptomatic deterioration|2|||
49179218|NCT01950390|158485422|FG001|Overall Study|Symptomatic deterioration|1|||
49179219|NCT01950390|158485421|FG000|Overall Study|Physician Decision|0|||
49179220|NCT01950390|158485422|FG001|Overall Study|Physician Decision|4|||
49179221|NCT01950390|158485421|FG000|Overall Study|Lack of clinical benefit|0|||
49179222|NCT01950390|158485422|FG001|Overall Study|Lack of clinical benefit|1|||
49179223|NCT01950390|158485421|FG000|Overall Study|Maintained PR and moved to observation only|0|||
49179224|NCT01950390|158485422|FG001|Overall Study|Maintained PR and moved to observation only|1|||
49179225|NCT02180867|158485425|FG000|Overall Study|Adverse Event|3|||
49179226|NCT02180867|158485426|FG001|Overall Study|Adverse Event|4|||
49179227|NCT02180867|158485427|FG002|Overall Study|Adverse Event|1|||
49179228|NCT02180867|158485428|FG003|Overall Study|Adverse Event|5|||
49179229|NCT02180867|158485429|FG004|Overall Study|Adverse Event|0|||
49179230|NCT02180867|158485430|FG005|Overall Study|Adverse Event|0|||
49179231|NCT02180867|158485431|FG006|Overall Study|Adverse Event|0|||
49179232|NCT02180867|158485425|FG000|Overall Study|Death|0|||
49179233|NCT02180867|158485426|FG001|Overall Study|Death|0|||
49179234|NCT02180867|158485427|FG002|Overall Study|Death|0|||
49179235|NCT02180867|158485428|FG003|Overall Study|Death|0|||
49179236|NCT02180867|158485429|FG004|Overall Study|Death|1|||
49179237|NCT02180867|158485430|FG005|Overall Study|Death|0|||
49179238|NCT02180867|158485431|FG006|Overall Study|Death|0|||
49179239|NCT02180867|158485425|FG000|Overall Study|Lack of Efficacy|0|||
49179240|NCT02180867|158485426|FG001|Overall Study|Lack of Efficacy|2|||
49179241|NCT02180867|158485427|FG002|Overall Study|Lack of Efficacy|0|||
49179242|NCT02180867|158485428|FG003|Overall Study|Lack of Efficacy|1|||
49179243|NCT02180867|158485429|FG004|Overall Study|Lack of Efficacy|6|||
49179244|NCT02180867|158485430|FG005|Overall Study|Lack of Efficacy|0|||
49179245|NCT02180867|158485431|FG006|Overall Study|Lack of Efficacy|1|||
49179246|NCT02180867|158485425|FG000|Overall Study|Physician Decision|1|||
49179247|NCT02180867|158485426|FG001|Overall Study|Physician Decision|3|||
49179248|NCT02180867|158485427|FG002|Overall Study|Physician Decision|1|||
49179249|NCT02180867|158485428|FG003|Overall Study|Physician Decision|10|||
49179250|NCT02180867|158485429|FG004|Overall Study|Physician Decision|9|||
49179251|NCT02180867|158485430|FG005|Overall Study|Physician Decision|3|||
49179252|NCT02180867|158485431|FG006|Overall Study|Physician Decision|4|||
49179253|NCT02180867|158485425|FG000|Overall Study|Withdrawal by Subject|0|||
49179254|NCT02180867|158485426|FG001|Overall Study|Withdrawal by Subject|0|||
49179255|NCT02180867|158485427|FG002|Overall Study|Withdrawal by Subject|0|||
49179256|NCT02180867|158485428|FG003|Overall Study|Withdrawal by Subject|1|||
49179257|NCT02180867|158485429|FG004|Overall Study|Withdrawal by Subject|1|||
49179258|NCT02180867|158485430|FG005|Overall Study|Withdrawal by Subject|0|||
49179259|NCT02180867|158485431|FG006|Overall Study|Withdrawal by Subject|0|||
49179260|NCT02180867|158485425|FG000|Overall Study|Ineligible|1|||
49179261|NCT02180867|158485426|FG001|Overall Study|Ineligible|2|||
49179262|NCT02180867|158485427|FG002|Overall Study|Ineligible|0|||
49179263|NCT02180867|158485428|FG003|Overall Study|Ineligible|3|||
49179264|NCT02180867|158485429|FG004|Overall Study|Ineligible|5|||
49179265|NCT02180867|158485430|FG005|Overall Study|Ineligible|0|||
49179266|NCT02180867|158485431|FG006|Overall Study|Ineligible|0|||
49179267|NCT02180867|158485425|FG000|Overall Study|Repeat Eligibility Studies|0|||
49179268|NCT02180867|158485426|FG001|Overall Study|Repeat Eligibility Studies|0|||
49179269|NCT02180867|158485427|FG002|Overall Study|Repeat Eligibility Studies|0|||
49179270|NCT02180867|158485428|FG003|Overall Study|Repeat Eligibility Studies|0|||
49179271|NCT02180867|158485429|FG004|Overall Study|Repeat Eligibility Studies|1|||
49179272|NCT02180867|158485430|FG005|Overall Study|Repeat Eligibility Studies|0|||
49179273|NCT02180867|158485431|FG006|Overall Study|Repeat Eligibility Studies|0|||
49179274|NCT02180867|158485425|FG000|Overall Study|Refusal of further protocol therapy|1|||
49179275|NCT02180867|158485426|FG001|Overall Study|Refusal of further protocol therapy|0|||
49179276|NCT02180867|158485427|FG002|Overall Study|Refusal of further protocol therapy|2|||
49179277|NCT02180867|158485428|FG003|Overall Study|Refusal of further protocol therapy|6|||
49179278|NCT02180867|158485429|FG004|Overall Study|Refusal of further protocol therapy|4|||
49179279|NCT02180867|158485430|FG005|Overall Study|Refusal of further protocol therapy|0|||
49179280|NCT02180867|158485431|FG006|Overall Study|Refusal of further protocol therapy|0|||
49179281|NCT03570892|158485432|FG000|Overall Study|Death|51|||
49179282|NCT03570892|158485433|FG001|Overall Study|Death|45|||
49179283|NCT03570892|158485432|FG000|Overall Study|Subject decision|5|||
49179284|NCT03570892|158485433|FG001|Overall Study|Subject decision|3|||
49179285|NCT03570892|158485432|FG000|Overall Study|Protocol Violation|1|||
49179286|NCT03570892|158485433|FG001|Overall Study|Protocol Violation|4|||
49179287|NCT03570892|158485432|FG000|Overall Study|Physician Decision|0|||
49179288|NCT03570892|158485433|FG001|Overall Study|Physician Decision|2|||
49179289|NCT04218357|158485436|FG000|1st Allocation|Withdrawal by Subject|1|||
49179290|NCT04218357|158485437|FG001|1st Allocation|Withdrawal by Subject|0|||
49179291|NCT03581292|158485438|FG000|Overall Study|Physician Decision|9|||
49179292|NCT03581292|158485439|FG001|Overall Study|Physician Decision|5|||
49179293|NCT03581292|158485438|FG000|Overall Study|Withdrawal by Subject|3|||
49179294|NCT03581292|158485439|FG001|Overall Study|Withdrawal by Subject|0|||
49179295|NCT03581292|158485438|FG000|Overall Study|Withdrawal before Therapy Start|1|||
49179296|NCT03581292|158485439|FG001|Overall Study|Withdrawal before Therapy Start|0|||
49179297|NCT04701203|158485440|FG000|Blinded Period (Weeks 0 to 26)|Death|1|||
49179298|NCT04701203|158485441|FG001|Blinded Period (Weeks 0 to 26)|Death|0|||
49179299|NCT04701203|158485442|FG002|Blinded Period (Weeks 0 to 26)|Death|0|||
49179300|NCT04701203|158485440|FG000|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
49179301|NCT04701203|158485441|FG001|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|1|||
49179302|NCT04701203|158485442|FG002|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
49179303|NCT04701203|158485440|FG000|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
49179304|NCT04701203|158485441|FG001|Blinded Period (Weeks 0 to 26)|Adverse Event|1|||
49179305|NCT04701203|158485442|FG002|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
49179306|NCT04701203|158485440|FG000|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
49179307|NCT04701203|158485441|FG001|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
49179308|NCT04701203|158485442|FG002|Open-Label Period (Weeks 26 to 182)|Study Ongoing|79|||
49179309|NCT05529992|158485443|FG000|Overall Study|Withdrawal by Subject|1|||
49179310|NCT02798471|158485444|FG000|Overall Study|Adverse Event|7|||
49179311|NCT02798471|158485445|FG001|Overall Study|Adverse Event|2|||
49179312|NCT02798471|158485444|FG000|Overall Study|Physician Decision|3|||
49179313|NCT02798471|158485445|FG001|Overall Study|Physician Decision|7|||
49179314|NCT02798471|158485444|FG000|Overall Study|Death|2|||
49179315|NCT02798471|158485445|FG001|Overall Study|Death|3|||
49179316|NCT02798471|158485444|FG000|Overall Study|Lost to Follow-up|0|||
49179317|NCT02798471|158485445|FG001|Overall Study|Lost to Follow-up|1|||
49179318|NCT02798471|158485444|FG000|Overall Study|Other|5|||
49179319|NCT02798471|158485445|FG001|Overall Study|Other|3|||
49179320|NCT02798471|158485444|FG000|Overall Study|Subject withdrew consent|0|||
49179321|NCT02798471|158485445|FG001|Overall Study|Subject withdrew consent|6|||
49179322|NCT02798471|158485444|FG000|Overall Study|Data entry error (reported as study completion and study discontinuation)|2|||
49179323|NCT02798471|158485445|FG001|Overall Study|Data entry error (reported as study completion and study discontinuation)|0|||
48927563|NCT04739800|157566606|FG000|Overall Study|Other Reason|1|||
48927564|NCT04739800|157566607|FG001|Overall Study|Other Reason|3|||
48927565|NCT04739800|157566608|FG002|Overall Study|Other Reason|5|||
48927566|NCT04739800|157566609|FG003|Overall Study|Other Reason|4|||
48927567|NCT02779855|157566610|FG000|Overall Study|Withdrawal by patient prior to treatment|1|||
48927568|NCT02779855|157566611|FG001|Overall Study|Withdrawal by patient prior to treatment|0|||
48927569|NCT02779855|157566612|FG002|Overall Study|Withdrawal by patient prior to treatment|0|||
49179324|NCT02798471|158485444|FG000|Overall Study|Randomized, but not treated|0|||
49179325|NCT02798471|158485445|FG001|Overall Study|Randomized, but not treated|2|||
49179326|NCT05293717|158485450|FG000|Overall Study|Physician Decision|1|||
49179327|NCT03659136|158485454|FG000|Overall Study|Not treated|2|||
49179328|NCT03659136|158485455|FG001|Overall Study|Not treated|0|||
49179329|NCT03659136|158485454|FG000|Overall Study|Covid-19 related|1|||
49179330|NCT03659136|158485455|FG001|Overall Study|Covid-19 related|1|||
49179331|NCT03659136|158485454|FG000|Overall Study|Withdrawal by Subject|1|||
49179332|NCT03659136|158485455|FG001|Overall Study|Withdrawal by Subject|6|||
49179333|NCT03659136|158485454|FG000|Overall Study|Adverse Event|4|||
49179334|NCT03659136|158485455|FG001|Overall Study|Adverse Event|6|||
49179335|NCT03659136|158485454|FG000|Overall Study|Progressive disease|37|||
49179336|NCT03659136|158485455|FG001|Overall Study|Progressive disease|31|||
49179337|NCT03659136|158485454|FG000|Overall Study|Study closure|2|||
49179338|NCT03659136|158485455|FG001|Overall Study|Study closure|2|||
49179339|NCT03659136|158485454|FG000|Overall Study|Sponsor decision/recommendation|3|||
49179340|NCT03659136|158485455|FG001|Overall Study|Sponsor decision/recommendation|2|||
49179341|NCT03659136|158485454|FG000|Overall Study|Switched to other drug/therapy|2|||
49179342|NCT03659136|158485455|FG001|Overall Study|Switched to other drug/therapy|2|||
49179343|NCT03659136|158485454|FG000|Overall Study|Lack of clinical benefit|0|||
49179344|NCT03659136|158485455|FG001|Overall Study|Lack of clinical benefit|1|||
48927570|NCT04093531|157568001|FG000|Overall Study|failed screening|4|||
48927571|NCT01285908|157568002|FG000|Baseline Measurement|unable to insert catheter|1|||
48927572|NCT01285908|157568003|FG001|Baseline Measurement|unable to insert catheter|0|||
48927573|NCT01285908|157568004|FG002|Baseline Measurement|unable to insert catheter|0|||
48927574|NCT01285908|157568002|FG000|Baseline Measurement|History of stroke, exclusion criteria|1|||
48927575|NCT01285908|157568003|FG001|Baseline Measurement|History of stroke, exclusion criteria|0|||
48927576|NCT01285908|157568004|FG002|Baseline Measurement|History of stroke, exclusion criteria|0|||
48927577|NCT01285908|157568002|FG000|Baseline Measurement|unable to tolerate procedure|1|||
48927578|NCT01285908|157568003|FG001|Baseline Measurement|unable to tolerate procedure|0|||
48927579|NCT01285908|157568004|FG002|Baseline Measurement|unable to tolerate procedure|0|||
48927580|NCT03948178|157568007|FG000|Overall Study|Protocol Violation|1|||
48927581|NCT03948178|157568007|FG000|Overall Study|Lost to Follow-up|2|||
48927582|NCT03948178|157568007|FG000|Overall Study|Withdrawal by Subject|2|||
48927583|NCT03948178|157568007|FG000|Overall Study|Reason not known|2|||
48927584|NCT03948178|157568007|FG000|Overall Study|Personal reason|14|||
48927585|NCT03948178|157568007|FG000|Overall Study|Disease progression|30|||
48927586|NCT03948178|157568007|FG000|Overall Study|Adverse Event|12|||
48927587|NCT03948178|157568007|FG000|Overall Study|Sponsor terminated study|164|||
48927588|NCT02062658|157568008|FG000|Overall Study|Withdrawal by Subject|1|||
48927589|NCT02062658|157568008|FG000|Overall Study|Lack of Efficacy|1|||
48927590|NCT02475655|157568013|FG000|Overall Study|Lost to Follow-up|0|||
48927591|NCT02475655|157568014|FG001|Overall Study|Lost to Follow-up|1|||
48927592|NCT00699907|157568018|FG000|Overall Study|Withdrawal by Subject|2|||
48927593|NCT00699907|157568019|FG001|Overall Study|Withdrawal by Subject|1|||
48927594|NCT00699907|157568020|FG002|Overall Study|Withdrawal by Subject|0|||
48927595|NCT00699907|157568018|FG000|Overall Study|No usable sample|0|||
48927596|NCT00699907|157568019|FG001|Overall Study|No usable sample|9|||
48927597|NCT00699907|157568020|FG002|Overall Study|No usable sample|8|||
48927598|NCT00661271|157568021|FG000|Overall Study|Lost to Follow-up|28|||
48927599|NCT00661271|157568022|FG001|Overall Study|Lost to Follow-up|25|||
48927600|NCT00430508|157568023|FG000|Overall Study|Adverse Event|2|||
48927601|NCT00430508|157568024|FG001|Overall Study|Adverse Event|3|||
48927602|NCT00430508|157568025|FG002|Overall Study|Adverse Event|5|||
48927603|NCT00430508|157568026|FG003|Overall Study|Adverse Event|3|||
48927604|NCT00430508|157568023|FG000|Overall Study|Withdrawal by Subject|0|||
48927605|NCT00430508|157568024|FG001|Overall Study|Withdrawal by Subject|1|||
48927606|NCT00430508|157568025|FG002|Overall Study|Withdrawal by Subject|1|||
48927607|NCT00430508|157568026|FG003|Overall Study|Withdrawal by Subject|1|||
48927608|NCT00430508|157568023|FG000|Overall Study|responder at visit 4|0|||
48927609|NCT00430508|157568024|FG001|Overall Study|responder at visit 4|0|||
48927610|NCT00430508|157568025|FG002|Overall Study|responder at visit 4|2|||
48927611|NCT00430508|157568026|FG003|Overall Study|responder at visit 4|0|||
48927612|NCT00430508|157568023|FG000|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0|||
48927613|NCT00430508|157568024|FG001|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
48927614|NCT00430508|157568025|FG002|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2|||
48927615|NCT00430508|157568026|FG003|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
48927616|NCT00430508|157568023|FG000|Overall Study|Other|1|||
48927617|NCT00430508|157568024|FG001|Overall Study|Other|1|||
48927618|NCT00430508|157568025|FG002|Overall Study|Other|3|||
48927619|NCT00430508|157568026|FG003|Overall Study|Other|0|||
48927620|NCT01164722|157568030|FG000|Overall Study|Adverse Event|0|||
48927621|NCT01164722|157568031|FG001|Overall Study|Adverse Event|1|||
48927622|NCT01164722|157568030|FG000|Overall Study|Withdrawal by Subject|3|||
48927623|NCT01164722|157568031|FG001|Overall Study|Withdrawal by Subject|4|||
48927624|NCT01164722|157568030|FG000|Overall Study|Lost to Follow-up|3|||
48927625|NCT01164722|157568031|FG001|Overall Study|Lost to Follow-up|6|||
48927626|NCT01164722|157568030|FG000|Overall Study|met protocol criteria for non-treatment|11|||
48927627|NCT01164722|157568031|FG001|Overall Study|met protocol criteria for non-treatment|1|||
48927628|NCT01164722|157568030|FG000|Overall Study|enrolled on other study, concomitant med|1|||
48927629|NCT01164722|157568031|FG001|Overall Study|enrolled on other study, concomitant med|3|||
48927630|NCT00999908|157568032|FG000|Treatment Period 1|Subject withdrew consent|2|||
48927631|NCT00999908|157568033|FG001|Treatment Period 1|Subject withdrew consent|0|||
48927632|NCT00999908|157568034|FG002|Treatment Period 1|Subject withdrew consent|0|||
48927633|NCT00999908|157568032|FG000|Treatment Period 2|Protocol Violation|1|||
48927634|NCT00999908|157568033|FG001|Treatment Period 2|Protocol Violation|0|||
48927635|NCT00999908|157568034|FG002|Treatment Period 2|Protocol Violation|0|||
48927636|NCT02568046|157568035|FG000|Overall Study|Adverse Event|0|||
48927637|NCT02568046|157568036|FG001|Overall Study|Adverse Event|1|||
48927638|NCT02568046|157568035|FG000|Overall Study|Death|2|||
48927639|NCT02568046|157568036|FG001|Overall Study|Death|0|||
48927640|NCT02568046|157568035|FG000|Overall Study|Progressive Disease|1|||
48927641|NCT02568046|157568036|FG001|Overall Study|Progressive Disease|0|||
48927642|NCT02568046|157568035|FG000|Overall Study|Withdrawal by Subject|2|||
48927643|NCT02568046|157568036|FG001|Overall Study|Withdrawal by Subject|1|||
48927644|NCT02568046|157568035|FG000|Overall Study|Other Events|0|||
48927645|NCT02568046|157568036|FG001|Overall Study|Other Events|1|||
48927646|NCT04673786|157568039|FG000|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
48927647|NCT04673786|157568040|FG001|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
48927648|NCT04673786|157568041|FG002|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|0|||
48927649|NCT04673786|157568039|FG000|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
48927650|NCT04673786|157568040|FG001|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|1|||
48927651|NCT04673786|157568041|FG002|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
48927652|NCT04673786|157568039|FG000|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|9|||
48927653|NCT04673786|157568040|FG001|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|3|||
48927654|NCT04673786|157568041|FG002|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|1|||
48927655|NCT04673786|157568039|FG000|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|2|||
48927656|NCT04673786|157568040|FG001|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
48927657|NCT04673786|157568041|FG002|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
48927658|NCT04673786|157568039|FG000|Treatment Period II (Weeks 16 to 52)|Death|1|||
48927659|NCT04673786|157568040|FG001|Treatment Period II (Weeks 16 to 52)|Death|0|||
48927660|NCT04673786|157568041|FG002|Treatment Period II (Weeks 16 to 52)|Death|0|||
48927661|NCT04673786|157568039|FG000|Treatment Period II (Weeks 16 to 52)|Adverse Event|2|||
48927662|NCT04673786|157568040|FG001|Treatment Period II (Weeks 16 to 52)|Adverse Event|0|||
48927663|NCT04673786|157568041|FG002|Treatment Period II (Weeks 16 to 52)|Adverse Event|1|||
48927664|NCT02682901|157568042|FG000|Overall Study|Adverse Event|10|||
48927665|NCT02682901|157568043|FG001|Overall Study|Adverse Event|3|||
48927666|NCT02682901|157568042|FG000|Overall Study|Lack of Efficacy|0|||
48927667|NCT02682901|157568043|FG001|Overall Study|Lack of Efficacy|1|||
48927668|NCT01235962|157568044|FG000|Overall Study|Withdrawal by Subject|20|||
48927669|NCT01235962|157568045|FG001|Overall Study|Withdrawal by Subject|19|||
48927670|NCT01235962|157568046|FG002|Overall Study|Withdrawal by Subject|62|||
48927671|NCT01235962|157568047|FG003|Overall Study|Withdrawal by Subject|49|||
48927672|NCT01235962|157568044|FG000|Overall Study|Lost to Follow-up|21|||
48927673|NCT01235962|157568045|FG001|Overall Study|Lost to Follow-up|16|||
48927674|NCT01235962|157568046|FG002|Overall Study|Lost to Follow-up|47|||
48927675|NCT01235962|157568047|FG003|Overall Study|Lost to Follow-up|32|||
48927676|NCT01235962|157568044|FG000|Overall Study|Physician Decision|5|||
48927677|NCT01235962|157568045|FG001|Overall Study|Physician Decision|0|||
48927678|NCT01235962|157568046|FG002|Overall Study|Physician Decision|9|||
48927679|NCT01235962|157568047|FG003|Overall Study|Physician Decision|5|||
48927680|NCT03694925|157568048|FG000|Overall Study|Inadequate laboratory testing|0|||
48927681|NCT03694925|157568049|FG001|Overall Study|Inadequate laboratory testing|3|||
48927682|NCT03694925|157568050|FG002|Overall Study|Inadequate laboratory testing|0|||
48927683|NCT01276236|157568057|FG000|Overall Study|Lack of Efficacy|2|||
48927684|NCT01276236|157568057|FG000|Overall Study|Withdrawal by Subject|4|||
48927685|NCT00262873|157568058|FG000|Overall Study|Adverse Event|3|||
48927686|NCT00262873|157568058|FG000|Overall Study|Withdrawal by Subject|5|||
48927687|NCT04327388|157568059|FG000|Overall Study|Adverse Event|17|||
48927688|NCT04327388|157568060|FG001|Overall Study|Adverse Event|18|||
48927689|NCT04327388|157568061|FG002|Overall Study|Adverse Event|9|||
48927690|NCT04327388|157568059|FG000|Overall Study|Other|1|||
48927691|NCT04327388|157568060|FG001|Overall Study|Other|2|||
48927692|NCT04327388|157568061|FG002|Overall Study|Other|0|||
48927693|NCT04327388|157568059|FG000|Overall Study|Randomized and not treated|2|||
48927694|NCT04327388|157568060|FG001|Overall Study|Randomized and not treated|0|||
48927695|NCT04327388|157568061|FG002|Overall Study|Randomized and not treated|2|||
48927696|NCT03310970|157568062|FG000|Overall Study|Withdrawal by Subject|0|||
48927697|NCT03310970|157568063|FG001|Overall Study|Withdrawal by Subject|1|||
48927698|NCT01614093|157568070|FG000|Overall Study|Withdrawal by Subject|1|||
48927699|NCT00848354|157568071|FG000|Phase 1|Adverse Event|5|||
48927700|NCT00848354|157568072|FG001|Phase 1|Adverse Event|4|||
48927701|NCT00848354|157568071|FG000|Phase 1|Discontinuation of study by sponsor|2|||
48927702|NCT00848354|157568072|FG001|Phase 1|Discontinuation of study by sponsor|1|||
48927703|NCT00848354|157568071|FG000|Phase 1|Failed to return|0|||
48927704|NCT00848354|157568072|FG001|Phase 1|Failed to return|1|||
48927705|NCT00848354|157568071|FG000|Phase 1|Lost to Follow-up|1|||
48927706|NCT00848354|157568072|FG001|Phase 1|Lost to Follow-up|1|||
48927707|NCT00848354|157568071|FG000|Phase 1|Unspecified Reason|1|||
48927708|NCT00848354|157568072|FG001|Phase 1|Unspecified Reason|1|||
48927709|NCT00848354|157568071|FG000|Phase 1|Protocol Violation|1|||
48927710|NCT00848354|157568072|FG001|Phase 1|Protocol Violation|1|||
48927711|NCT00848354|157568071|FG000|Phase 1|Withdrawal by Subject|2|||
48927712|NCT00848354|157568072|FG001|Phase 1|Withdrawal by Subject|4|||
48927713|NCT00848354|157568071|FG000|Phase 1|Lack of Efficacy|0|||
48927714|NCT00848354|157568072|FG001|Phase 1|Lack of Efficacy|1|||
48927715|NCT00848354|157568071|FG000|Phase 2 Year 1|Adverse Event|7|||
48927716|NCT00848354|157568072|FG001|Phase 2 Year 1|Adverse Event|2|||
48927717|NCT00848354|157568071|FG000|Phase 2 Year 1|Death|1|||
48927718|NCT00848354|157568072|FG001|Phase 2 Year 1|Death|0|||
48927719|NCT00848354|157568071|FG000|Phase 2 Year 1|Failed to Return|1|||
48927720|NCT00848354|157568072|FG001|Phase 2 Year 1|Failed to Return|1|||
48927721|NCT00848354|157568071|FG000|Phase 2 Year 1|Lost to Follow-up|1|||
48927722|NCT00848354|157568072|FG001|Phase 2 Year 1|Lost to Follow-up|0|||
48927723|NCT00848354|157568071|FG000|Phase 2 Year 1|Unspecified Reason|3|||
48927724|NCT00848354|157568072|FG001|Phase 2 Year 1|Unspecified Reason|0|||
48927725|NCT00848354|157568071|FG000|Phase 2 Year 1|Protocol Violation|4|||
48927726|NCT00848354|157568072|FG001|Phase 2 Year 1|Protocol Violation|1|||
48927727|NCT00848354|157568071|FG000|Phase 2 Year 1|Subject Request|1|||
48927728|NCT00848354|157568072|FG001|Phase 2 Year 1|Subject Request|2|||
48927729|NCT00848354|157568071|FG000|Phase 2 Year 2|Adverse Event|12|||
48927730|NCT00848354|157568072|FG001|Phase 2 Year 2|Adverse Event|2|||
48927731|NCT00848354|157568071|FG000|Phase 2 Year 2|Death|2|||
48927732|NCT00848354|157568072|FG001|Phase 2 Year 2|Death|0|||
48927733|NCT00848354|157568071|FG000|Phase 2 Year 2|Failed to return|3|||
48927734|NCT00848354|157568072|FG001|Phase 2 Year 2|Failed to return|0|||
48927735|NCT00848354|157568071|FG000|Phase 2 Year 2|Lost to Follow-up|1|||
48927736|NCT00848354|157568072|FG001|Phase 2 Year 2|Lost to Follow-up|3|||
48927737|NCT00848354|157568071|FG000|Phase 2 Year 2|Unspecified Reason|1|||
48927738|NCT00848354|157568072|FG001|Phase 2 Year 2|Unspecified Reason|0|||
48927739|NCT00848354|157568071|FG000|Phase 2 Year 2|Protocol Violation|1|||
48927740|NCT00848354|157568072|FG001|Phase 2 Year 2|Protocol Violation|1|||
48927741|NCT00848354|157568071|FG000|Phase 2 Year 2|Subject Request|1|||
48927742|NCT00848354|157568072|FG001|Phase 2 Year 2|Subject Request|1|||
48927743|NCT00848354|157568071|FG000|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2|||
48927744|NCT00848354|157568072|FG001|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0|||
48927745|NCT00626093|157568075|FG000|Overall Study|Lost to Follow-up|5|||
48927746|NCT00626093|157568075|FG000|Overall Study|Death|1|||
48927747|NCT00626093|157568075|FG000|Overall Study|Physician Decision|4|||
48927748|NCT00626093|157568075|FG000|Overall Study|Withdrawal by Subject|6|||
48927749|NCT00626093|157568075|FG000|Overall Study|Protocol Violation|1|||
48927750|NCT00626093|157568075|FG000|Overall Study|One of the required devices not implante|6|||
48927751|NCT03891901|157568076|FG000|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|1|||
48927752|NCT03891901|157568077|FG001|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
48927753|NCT03891901|157568078|FG002|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
48927754|NCT03891901|157568079|FG003|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
48927755|NCT03891901|157568080|FG004|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
48927756|NCT03891901|157568081|FG005|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
48927757|NCT03891901|157568082|FG006|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
48927758|NCT03891901|157568083|FG007|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
48927759|NCT03891901|157568084|FG008|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
48927760|NCT03891901|157568076|FG000|Overall Study|Adverse Event|2|||
48927761|NCT03891901|157568077|FG001|Overall Study|Adverse Event|2|||
48927762|NCT03891901|157568078|FG002|Overall Study|Adverse Event|0|||
48927763|NCT03891901|157568079|FG003|Overall Study|Adverse Event|0|||
48927764|NCT03891901|157568080|FG004|Overall Study|Adverse Event|0|||
48927765|NCT03891901|157568081|FG005|Overall Study|Adverse Event|0|||
48927766|NCT03891901|157568082|FG006|Overall Study|Adverse Event|0|||
48927767|NCT03891901|157568083|FG007|Overall Study|Adverse Event|0|||
48927768|NCT03891901|157568084|FG008|Overall Study|Adverse Event|0|||
48927769|NCT03891901|157568076|FG000|Overall Study|Poor venous access|1|||
48927770|NCT03891901|157568077|FG001|Overall Study|Poor venous access|0|||
48927771|NCT03891901|157568078|FG002|Overall Study|Poor venous access|0|||
48927772|NCT03891901|157568079|FG003|Overall Study|Poor venous access|0|||
48927773|NCT03891901|157568080|FG004|Overall Study|Poor venous access|0|||
48927774|NCT03891901|157568081|FG005|Overall Study|Poor venous access|0|||
48927775|NCT03891901|157568082|FG006|Overall Study|Poor venous access|0|||
48927776|NCT03891901|157568083|FG007|Overall Study|Poor venous access|0|||
48927777|NCT03891901|157568084|FG008|Overall Study|Poor venous access|0|||
48927778|NCT03891901|157568076|FG000|Overall Study|Withdrawal by Subject|0|||
48927779|NCT03891901|157568077|FG001|Overall Study|Withdrawal by Subject|2|||
48927780|NCT03891901|157568078|FG002|Overall Study|Withdrawal by Subject|0|||
48927781|NCT03891901|157568079|FG003|Overall Study|Withdrawal by Subject|0|||
48927782|NCT03891901|157568080|FG004|Overall Study|Withdrawal by Subject|0|||
48927783|NCT03891901|157568081|FG005|Overall Study|Withdrawal by Subject|0|||
48927784|NCT03891901|157568082|FG006|Overall Study|Withdrawal by Subject|0|||
48927785|NCT03891901|157568083|FG007|Overall Study|Withdrawal by Subject|0|||
48927786|NCT03891901|157568084|FG008|Overall Study|Withdrawal by Subject|0|||
48927787|NCT00911989|157568085|FG000|Overall Study|Adverse Event|1|||
48927788|NCT02445586|157568086|FG000|Overall Study|Death|14|||
48927789|NCT02445586|157568086|FG000|Overall Study|Withdrawal by Subject|13|||
48927790|NCT02445586|157568086|FG000|Overall Study|Disease Progression|10|||
48927791|NCT02445586|157568086|FG000|Overall Study|Protocol Violation|1|||
48927792|NCT02445586|157568086|FG000|Overall Study|Medical Condition|1|||
48927793|NCT01145066|157568092|FG000|Overall Study|To resume NSAIDs|2|||
48927794|NCT01145066|157568093|FG001|Overall Study|To resume NSAIDs|2|||
48927795|NCT01145066|157568094|FG002|Overall Study|To resume NSAIDs|1|||
48927796|NCT01145066|157568092|FG000|Overall Study|Non-related surgery|0|||
48927797|NCT01145066|157568093|FG001|Overall Study|Non-related surgery|0|||
48927798|NCT01145066|157568094|FG002|Overall Study|Non-related surgery|1|||
48927799|NCT01145066|157568092|FG000|Overall Study|Withdrawal by Subject|0|||
48927800|NCT01145066|157568093|FG001|Overall Study|Withdrawal by Subject|0|||
48927801|NCT01145066|157568094|FG002|Overall Study|Withdrawal by Subject|2|||
48927802|NCT01145066|157568092|FG000|Overall Study|To start new med|1|||
48927803|NCT01145066|157568093|FG001|Overall Study|To start new med|0|||
48927804|NCT01145066|157568094|FG002|Overall Study|To start new med|0|||
48927805|NCT01145066|157568092|FG000|Overall Study|problems swallowing capsule|1|||
48927806|NCT01145066|157568093|FG001|Overall Study|problems swallowing capsule|0|||
48927807|NCT01145066|157568094|FG002|Overall Study|problems swallowing capsule|0|||
48927808|NCT01145066|157568092|FG000|Overall Study|Abdominal discomfort|0|||
48927809|NCT01145066|157568093|FG001|Overall Study|Abdominal discomfort|1|||
48927810|NCT01145066|157568094|FG002|Overall Study|Abdominal discomfort|0|||
48927811|NCT01145066|157568092|FG000|Overall Study|Low platelet count|0|||
48927812|NCT01145066|157568093|FG001|Overall Study|Low platelet count|1|||
48927813|NCT01145066|157568094|FG002|Overall Study|Low platelet count|0|||
48927814|NCT00217087|157568095|FG000|Overall Study|decided to have esophagectomy|1|||
48927815|NCT00217087|157568096|FG001|Overall Study|decided to have esophagectomy|2|||
48927816|NCT00217087|157568095|FG000|Overall Study|completed less than 12 months return|10|||
48927817|NCT00217087|157568096|FG001|Overall Study|completed less than 12 months return|18|||
48927818|NCT03208231|157568099|FG000|Overall Study|Death|1|||
48927819|NCT03208231|157568100|FG001|Overall Study|Death|2|||
48927820|NCT03208231|157568099|FG000|Overall Study|Moved and unable to get to clinic|1|||
48927821|NCT03208231|157568100|FG001|Overall Study|Moved and unable to get to clinic|0|||
48927822|NCT03208231|157568099|FG000|Overall Study|Unwilling to adhere to study requirements|0|||
48927823|NCT03208231|157568100|FG001|Overall Study|Unwilling to adhere to study requirements|1|||
48927824|NCT02474329|157568101|FG000|Overall Study|Withdraw or did not contribute data.|13|||
48927825|NCT02419508|157568102|FG000|Overall Study|Adverse Event|9|||
48927826|NCT02419508|157568103|FG001|Overall Study|Adverse Event|3|||
48927827|NCT02419508|157568102|FG000|Overall Study|Withdrawal by Subject|1|||
48927828|NCT02419508|157568103|FG001|Overall Study|Withdrawal by Subject|0|||
48927829|NCT02419508|157568102|FG000|Overall Study|Other - Reason not specified|0|||
48927830|NCT02419508|157568103|FG001|Overall Study|Other - Reason not specified|1|||
48927831|NCT01445678|157568106|FG000|Overall Study|Adverse Event|12|||
48927832|NCT01445678|157568107|FG001|Overall Study|Adverse Event|8|||
48927833|NCT01445678|157568106|FG000|Overall Study|Lack of Efficacy|0|||
48927834|NCT01445678|157568107|FG001|Overall Study|Lack of Efficacy|2|||
48927835|NCT01445678|157568106|FG000|Overall Study|Lost to Follow-up|8|||
48927836|NCT01445678|157568107|FG001|Overall Study|Lost to Follow-up|5|||
48927837|NCT01445678|157568106|FG000|Overall Study|Protocol Violation|1|||
48927838|NCT01445678|157568107|FG001|Overall Study|Protocol Violation|1|||
48927839|NCT01445678|157568106|FG000|Overall Study|Withdrawal by Subject|9|||
48927840|NCT01445678|157568107|FG001|Overall Study|Withdrawal by Subject|5|||
48927841|NCT01583374|157568111|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|6|||
48927842|NCT01583374|157568112|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|7|||
48927843|NCT01583374|157568113|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|12|||
48927844|NCT01583374|157568114|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
48927845|NCT01583374|157568115|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
48927846|NCT01583374|157568116|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
48927847|NCT01583374|157568117|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
48927848|NCT01583374|157568118|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
48927849|NCT01583374|157568119|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
48927850|NCT01583374|157568111|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3|||
48927851|NCT01583374|157568112|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2|||
48927852|NCT01583374|157568113|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
48927853|NCT01583374|157568114|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
48927854|NCT01583374|157568115|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
48927855|NCT01583374|157568116|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
48927856|NCT01583374|157568117|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
48927857|NCT01583374|157568118|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
48927858|NCT01583374|157568119|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
48927859|NCT01583374|157568111|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
48927860|NCT01583374|157568112|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
48927861|NCT01583374|157568113|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
48927862|NCT01583374|157568114|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
48927863|NCT01583374|157568115|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
48927864|NCT01583374|157568116|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
48927865|NCT01583374|157568117|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
48927866|NCT01583374|157568118|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
48927867|NCT01583374|157568119|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
48927868|NCT01583374|157568111|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8|||
48927869|NCT01583374|157568112|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
48927870|NCT01583374|157568113|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
48927871|NCT01583374|157568114|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
48927872|NCT01583374|157568115|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
48927873|NCT01583374|157568116|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
48927874|NCT01583374|157568117|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
48927875|NCT01583374|157568118|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
48927876|NCT01583374|157568119|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
48927877|NCT01583374|157568111|FG000|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1|||
48927878|NCT01583374|157568112|FG001|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2|||
48927879|NCT01583374|157568113|FG002|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
48927880|NCT01583374|157568114|FG003|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
48927881|NCT01583374|157568115|FG004|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
48927882|NCT01583374|157568116|FG005|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
48927883|NCT01583374|157568117|FG006|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
48927884|NCT01583374|157568118|FG007|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
48927885|NCT01583374|157568119|FG008|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
48927886|NCT01583374|157568111|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
48927887|NCT01583374|157568112|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
48927888|NCT01583374|157568113|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3|||
48927889|NCT01583374|157568114|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
48927890|NCT01583374|157568115|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
48927891|NCT01583374|157568116|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
48927892|NCT01583374|157568117|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
48927893|NCT01583374|157568118|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
48927894|NCT01583374|157568119|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
48927895|NCT01583374|157568111|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
48927896|NCT01583374|157568112|FG001|Placebo-controlled Phase (Week 0-24)|Other|1|||
48927897|NCT01583374|157568113|FG002|Placebo-controlled Phase (Week 0-24)|Other|0|||
48927898|NCT01583374|157568114|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
48927899|NCT01583374|157568115|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
48927900|NCT01583374|157568116|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
48927901|NCT01583374|157568117|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
48927902|NCT01583374|157568118|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
48927903|NCT01583374|157568119|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
48927904|NCT01583374|157568111|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
48927905|NCT01583374|157568112|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
48927906|NCT01583374|157568113|FG002|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
48927907|NCT01583374|157568114|FG003|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
48927908|NCT01583374|157568115|FG004|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
48927909|NCT01583374|157568116|FG005|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
48927910|NCT01583374|157568117|FG006|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
48927911|NCT01583374|157568118|FG007|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
48927912|NCT01583374|157568119|FG008|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
48927913|NCT01583374|157568111|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
48927914|NCT01583374|157568112|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
48927915|NCT01583374|157568113|FG002|Extension Phase (Weeks 24 to 52)|Adverse Event|2|||
48927916|NCT01583374|157568114|FG003|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
48927917|NCT01583374|157568115|FG004|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
48927918|NCT01583374|157568116|FG005|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
48927919|NCT01583374|157568117|FG006|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
48927920|NCT01583374|157568118|FG007|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
48927921|NCT01583374|157568119|FG008|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
48927922|NCT01583374|157568111|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
48927923|NCT01583374|157568112|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
48927924|NCT01583374|157568113|FG002|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
48927925|NCT01583374|157568114|FG003|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6|||
48927926|NCT01583374|157568115|FG004|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3|||
48927927|NCT01583374|157568116|FG005|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
48927928|NCT01583374|157568117|FG006|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5|||
48927929|NCT01583374|157568118|FG007|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
48927930|NCT01583374|157568119|FG008|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
48927931|NCT01583374|157568111|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
48927932|NCT01583374|157568112|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2|||
48927933|NCT01583374|157568113|FG002|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
48927934|NCT01583374|157568114|FG003|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
48927935|NCT01583374|157568115|FG004|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
48927936|NCT01583374|157568116|FG005|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
48927937|NCT01583374|157568117|FG006|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
48927938|NCT01583374|157568118|FG007|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
48927939|NCT01583374|157568119|FG008|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
48927940|NCT01583374|157568111|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
48927941|NCT01583374|157568112|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
48927942|NCT01583374|157568113|FG002|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
48927943|NCT01583374|157568114|FG003|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
48927944|NCT01583374|157568115|FG004|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
48927945|NCT01583374|157568116|FG005|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2|||
48927946|NCT01583374|157568117|FG006|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
48927947|NCT01583374|157568118|FG007|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
48927948|NCT01583374|157568119|FG008|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
48927949|NCT01583374|157568111|FG000|Long-Term Extension Phase Weeks 52-260|Adverse Event|0|||
48927950|NCT01583374|157568112|FG001|Long-Term Extension Phase Weeks 52-260|Adverse Event|5|||
48927951|NCT01583374|157568113|FG002|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
48927952|NCT01583374|157568114|FG003|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
48927953|NCT01583374|157568115|FG004|Long-Term Extension Phase Weeks 52-260|Adverse Event|6|||
48927954|NCT01583374|157568116|FG005|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
48927955|NCT01583374|157568117|FG006|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
48927956|NCT01583374|157568118|FG007|Long-Term Extension Phase Weeks 52-260|Adverse Event|3|||
48927957|NCT01583374|157568119|FG008|Long-Term Extension Phase Weeks 52-260|Adverse Event|1|||
48927958|NCT01583374|157568111|FG000|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0|||
48927959|NCT01583374|157568112|FG001|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
48927960|NCT01583374|157568113|FG002|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6|||
48927961|NCT01583374|157568114|FG003|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
48927962|NCT01583374|157568115|FG004|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10|||
48927963|NCT01583374|157568116|FG005|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
48927964|NCT01583374|157568117|FG006|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
48927965|NCT01583374|157568118|FG007|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2|||
48927966|NCT01583374|157568119|FG008|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
48927967|NCT01583374|157568111|FG000|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
48951842|NCT04760314|157654915|FG001|Induction Period|Withdrawal by Subject|1|||
48844300|NCT01070069|157271312|FG001|Overall Study|Withdrawal by Subject|1|||
48844301|NCT01070069|157271313|FG002|Overall Study|Withdrawal by Subject|4|||
48844302|NCT01070069|157271314|FG003|Overall Study|Withdrawal by Subject|0|||
48844303|NCT01070069|157271315|FG004|Overall Study|Withdrawal by Subject|0|||
48844304|NCT01070069|157271311|FG000|Overall Study|Lost to Follow-up|4|||
48844305|NCT01070069|157271312|FG001|Overall Study|Lost to Follow-up|1|||
48951843|NCT04760314|157654916|FG002|Induction Period|Withdrawal by Subject|1|||
48927968|NCT01583374|157568112|FG001|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
48927969|NCT01583374|157568113|FG002|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
48927970|NCT01583374|157568114|FG003|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
48927971|NCT01583374|157568115|FG004|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
48927972|NCT01583374|157568116|FG005|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
48927973|NCT01583374|157568117|FG006|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
48927974|NCT01583374|157568118|FG007|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
48927975|NCT01583374|157568119|FG008|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
48927976|NCT01583374|157568111|FG000|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0|||
48927977|NCT01583374|157568112|FG001|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
48927978|NCT01583374|157568113|FG002|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
48927979|NCT01583374|157568114|FG003|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1|||
48927980|NCT01583374|157568115|FG004|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12|||
48927981|NCT01583374|157568116|FG005|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7|||
48927982|NCT01583374|157568117|FG006|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5|||
48927983|NCT01583374|157568118|FG007|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
48927984|NCT01583374|157568119|FG008|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
48927985|NCT01583374|157568111|FG000|Long-Term Extension Phase Weeks 52-260|Death|0|||
48927986|NCT01583374|157568112|FG001|Long-Term Extension Phase Weeks 52-260|Death|0|||
48927987|NCT01583374|157568113|FG002|Long-Term Extension Phase Weeks 52-260|Death|0|||
48927988|NCT01583374|157568114|FG003|Long-Term Extension Phase Weeks 52-260|Death|0|||
48927989|NCT01583374|157568115|FG004|Long-Term Extension Phase Weeks 52-260|Death|1|||
48927990|NCT01583374|157568116|FG005|Long-Term Extension Phase Weeks 52-260|Death|0|||
48927991|NCT01583374|157568117|FG006|Long-Term Extension Phase Weeks 52-260|Death|1|||
48927992|NCT01583374|157568118|FG007|Long-Term Extension Phase Weeks 52-260|Death|0|||
48927993|NCT01583374|157568119|FG008|Long-Term Extension Phase Weeks 52-260|Death|0|||
48927994|NCT01583374|157568111|FG000|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
48927995|NCT01583374|157568112|FG001|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
48844306|NCT01070069|157271313|FG002|Overall Study|Lost to Follow-up|0|||
48844307|NCT01070069|157271314|FG003|Overall Study|Lost to Follow-up|0|||
48927996|NCT01583374|157568113|FG002|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
48927997|NCT01583374|157568114|FG003|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
48927998|NCT01583374|157568115|FG004|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
48927999|NCT01583374|157568116|FG005|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
48928000|NCT01583374|157568117|FG006|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
48928001|NCT01583374|157568118|FG007|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
48928002|NCT01583374|157568119|FG008|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
48928003|NCT01583374|157568111|FG000|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
48928004|NCT01583374|157568112|FG001|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
48928005|NCT01583374|157568113|FG002|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
48928006|NCT01583374|157568114|FG003|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2|||
48928007|NCT01583374|157568115|FG004|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
48928008|NCT01583374|157568116|FG005|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
48928009|NCT01583374|157568117|FG006|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
48928010|NCT01583374|157568118|FG007|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
48928011|NCT01583374|157568119|FG008|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
48928012|NCT01459614|157568120|FG000|Overall Study|Adverse Event|1|||
48928013|NCT01459614|157568121|FG001|Overall Study|Adverse Event|0|||
48928014|NCT00500682|157568124|FG000|Overall Study|Adverse Event|37|||
48928015|NCT00500682|157568125|FG001|Overall Study|Adverse Event|29|||
48928016|NCT00500682|157568124|FG000|Overall Study|Death|25|||
48928017|NCT00500682|157568125|FG001|Overall Study|Death|16|||
48928018|NCT00500682|157568124|FG000|Overall Study|Lost to Follow-up|11|||
48928019|NCT00500682|157568125|FG001|Overall Study|Lost to Follow-up|11|||
48928020|NCT00500682|157568124|FG000|Overall Study|Physician Decision|6|||
48928021|NCT00500682|157568125|FG001|Overall Study|Physician Decision|10|||
48928022|NCT00500682|157568124|FG000|Overall Study|Pregnancy|2|||
48928023|NCT00500682|157568125|FG001|Overall Study|Pregnancy|0|||
48928024|NCT00500682|157568124|FG000|Overall Study|Protocol Violation|1|||
48928025|NCT00500682|157568125|FG001|Overall Study|Protocol Violation|3|||
48928026|NCT00500682|157568124|FG000|Overall Study|Withdrawal by Subject|80|||
48928027|NCT00500682|157568125|FG001|Overall Study|Withdrawal by Subject|74|||
48928028|NCT00500682|157568124|FG000|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
48928029|NCT00500682|157568125|FG001|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
48928030|NCT02531646|157568128|FG000|Overall Study|equip. image processing issue|5|||
48928031|NCT02531646|157568129|FG001|Overall Study|equip. image processing issue|1|||
48928032|NCT02531646|157568130|FG002|Overall Study|equip. image processing issue|0|||
48928033|NCT01182428|157568131|FG000|Overall Study|Physician Decision|1|||
48928034|NCT01182428|157568132|FG001|Overall Study|Physician Decision|0|||
48928035|NCT01182428|157568131|FG000|Overall Study|Lost to Follow-up|9|||
48928036|NCT01182428|157568132|FG001|Overall Study|Lost to Follow-up|1|||
48928037|NCT01182428|157568131|FG000|Overall Study|Withdrawal by Subject|1|||
48928038|NCT01182428|157568132|FG001|Overall Study|Withdrawal by Subject|0|||
48928039|NCT02831673|157570016|FG000|Double-blind (Day 1 to Week 96)|Adverse Event|10|||
48928040|NCT02831673|157570017|FG001|Double-blind (Day 1 to Week 96)|Adverse Event|7|||
48928041|NCT02831673|157570018|FG002|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
48928042|NCT02831673|157570019|FG003|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
48928043|NCT02831673|157570020|FG004|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
48928044|NCT02831673|157570016|FG000|Double-blind (Day 1 to Week 96)|Lack of Efficacy|4|||
48928045|NCT02831673|157570017|FG001|Double-blind (Day 1 to Week 96)|Lack of Efficacy|2|||
48928046|NCT02831673|157570018|FG002|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
48928047|NCT02831673|157570019|FG003|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
48928048|NCT02831673|157570020|FG004|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
48928049|NCT02831673|157570016|FG000|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
48928050|NCT02831673|157570017|FG001|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
48928051|NCT02831673|157570018|FG002|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
48928052|NCT02831673|157570019|FG003|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
48928053|NCT02831673|157570020|FG004|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
48928054|NCT02831673|157570016|FG000|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|2|||
48928055|NCT02831673|157570017|FG001|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|6|||
48928056|NCT02831673|157570018|FG002|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
48928057|NCT02831673|157570019|FG003|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
48928058|NCT02831673|157570020|FG004|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
48928059|NCT02831673|157570016|FG000|Double-blind (Day 1 to Week 96)|Lost to Follow-up|13|||
48928060|NCT02831673|157570017|FG001|Double-blind (Day 1 to Week 96)|Lost to Follow-up|7|||
48928061|NCT02831673|157570018|FG002|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
48928062|NCT02831673|157570019|FG003|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
48928063|NCT02831673|157570020|FG004|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
48928064|NCT02831673|157570016|FG000|Double-blind (Day 1 to Week 96)|Physician Decision|9|||
48928065|NCT02831673|157570017|FG001|Double-blind (Day 1 to Week 96)|Physician Decision|4|||
48928066|NCT02831673|157570018|FG002|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
48928067|NCT02831673|157570019|FG003|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
48928068|NCT02831673|157570020|FG004|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
48928069|NCT02831673|157570016|FG000|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|11|||
48928070|NCT02831673|157570017|FG001|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|6|||
48928071|NCT02831673|157570018|FG002|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
48928072|NCT02831673|157570019|FG003|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
48928073|NCT02831673|157570020|FG004|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
48928074|NCT02831673|157570016|FG000|Double-blind (Day 1 to Week 96)|Randomized but not treated|3|||
48928075|NCT02831673|157570017|FG001|Double-blind (Day 1 to Week 96)|Randomized but not treated|2|||
48928076|NCT02831673|157570018|FG002|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
48928077|NCT02831673|157570019|FG003|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
48928078|NCT02831673|157570020|FG004|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
48928079|NCT02831673|157570016|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
48928080|NCT02831673|157570017|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
48928081|NCT02831673|157570018|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|3|||
48928082|NCT02831673|157570019|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
48928083|NCT02831673|157570020|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
48928084|NCT02831673|157570016|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
48928085|NCT02831673|157570017|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
48928086|NCT02831673|157570018|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|1|||
48928087|NCT02831673|157570019|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
48928088|NCT02831673|157570020|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
48928089|NCT02831673|157570016|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
48928090|NCT02831673|157570017|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
48928091|NCT02831673|157570018|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
48928092|NCT02831673|157570019|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|1|||
48928093|NCT02831673|157570020|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
48928094|NCT02831673|157570016|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
48928095|NCT02831673|157570017|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
48928096|NCT02831673|157570018|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|2|||
48928097|NCT02831673|157570019|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|1|||
48928098|NCT02831673|157570020|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
48928099|NCT02831673|157570016|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
48928100|NCT02831673|157570017|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
48928101|NCT02831673|157570018|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
48928102|NCT02831673|157570019|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|6|||
48928103|NCT02831673|157570020|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
48928104|NCT02831673|157570016|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
48928105|NCT02831673|157570017|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
48928106|NCT02831673|157570018|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
48928107|NCT02831673|157570019|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|4|||
48928108|NCT02831673|157570020|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
48928109|NCT02831673|157570016|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
48928110|NCT02831673|157570017|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
48928111|NCT02831673|157570018|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|6|||
48928112|NCT02831673|157570019|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|5|||
48928113|NCT02831673|157570020|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
48928114|NCT02831673|157570016|FG000|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
48928115|NCT02831673|157570017|FG001|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
48928116|NCT02831673|157570018|FG002|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
48928117|NCT02831673|157570019|FG003|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
48928118|NCT02831673|157570020|FG004|Continuation Phase(Week 148 to Week 280)|Adverse Event|1|||
48928119|NCT02831673|157570016|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
48928120|NCT02831673|157570017|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
48928121|NCT02831673|157570018|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
48928122|NCT02831673|157570019|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
48928123|NCT02831673|157570020|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
48928124|NCT02831673|157570016|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
48928125|NCT02831673|157570017|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
48928126|NCT02831673|157570018|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
48928127|NCT02831673|157570019|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
48928128|NCT02831673|157570020|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|10|||
48928129|NCT02831673|157570016|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
48928130|NCT02831673|157570017|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
48928131|NCT02831673|157570018|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
48928132|NCT02831673|157570019|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
48928133|NCT02831673|157570020|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|2|||
48928134|NCT02831673|157570016|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
48928135|NCT02831673|157570017|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
48928136|NCT02831673|157570018|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
48928137|NCT02831673|157570019|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
48928138|NCT02831673|157570020|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|7|||
48928139|NCT03047980|157570021|FG000|Overall Study|Adverse Event|1|||
48928140|NCT00874120|157570022|FG000|First Intervention|Adverse Event|0|||
48928141|NCT00874120|157570023|FG001|First Intervention|Adverse Event|1|||
48928142|NCT00874120|157570022|FG000|First Intervention|Withdrawal by Subject|2|||
48928143|NCT00874120|157570023|FG001|First Intervention|Withdrawal by Subject|0|||
48928144|NCT00874120|157570022|FG000|First Intervention|Lost to Follow-up|0|||
48928145|NCT00874120|157570023|FG001|First Intervention|Lost to Follow-up|1|||
48928146|NCT00874120|157570022|FG000|First Intervention|Protocol Violation|3|||
48928147|NCT00874120|157570023|FG001|First Intervention|Protocol Violation|0|||
48928148|NCT00874120|157570022|FG000|First Intervention|positive drug test|1|||
48928149|NCT00874120|157570023|FG001|First Intervention|positive drug test|0|||
48928150|NCT00874120|157570022|FG000|Second Intervention|Withdrawal by Subject|1|||
48928151|NCT00874120|157570023|FG001|Second Intervention|Withdrawal by Subject|0|||
48928152|NCT00874120|157570022|FG000|Second Intervention|Protocol Violation|1|||
48928153|NCT00874120|157570023|FG001|Second Intervention|Protocol Violation|0|||
48928154|NCT00477165|157570024|FG000|Overall Study|Adverse Event|7|||
48928155|NCT00477165|157570025|FG001|Overall Study|Adverse Event|2|||
48928156|NCT00621504|157570027|FG000|Overall Study|Adverse Event|1|||
48928157|NCT00621504|157570028|FG001|Overall Study|Adverse Event|3|||
48928158|NCT00621504|157570027|FG000|Overall Study|At the request of sponsor/investigator|1|||
48928159|NCT00621504|157570028|FG001|Overall Study|At the request of sponsor/investigator|0|||
48928160|NCT00621504|157570027|FG000|Overall Study|Withdrew consent|9|||
48928161|NCT00621504|157570028|FG001|Overall Study|Withdrew consent|6|||
48928162|NCT00621504|157570027|FG000|Overall Study|Lost to Follow-up|8|||
48928163|NCT00621504|157570028|FG001|Overall Study|Lost to Follow-up|10|||
48928164|NCT00621504|157570027|FG000|Overall Study|Other|1|||
48928165|NCT00621504|157570028|FG001|Overall Study|Other|0|||
48928166|NCT00621504|157570027|FG000|Overall Study|Death|6|||
48928167|NCT00621504|157570028|FG001|Overall Study|Death|6|||
48928168|NCT03839459|157570029|FG000|Overall Study|Withdrawal by Subject|2|||
48928169|NCT03839459|157570029|FG000|Overall Study|progression of disease|3|||
48928170|NCT01430442|157570031|FG000|Overall Study|Subject Withdrew Consent|3|||
48928171|NCT01430442|157570032|FG001|Overall Study|Subject Withdrew Consent|0|||
48928172|NCT01430442|157570033|FG002|Overall Study|Subject Withdrew Consent|1|||
48928173|NCT01430442|157570034|FG003|Overall Study|Subject Withdrew Consent|0|||
48928174|NCT01430442|157570035|FG004|Overall Study|Subject Withdrew Consent|2|||
48928175|NCT01430442|157570036|FG005|Overall Study|Subject Withdrew Consent|1|||
48928176|NCT01430442|157570037|FG006|Overall Study|Subject Withdrew Consent|5|||
48928177|NCT01430442|157570038|FG007|Overall Study|Subject Withdrew Consent|2|||
48928178|NCT01430442|157570031|FG000|Overall Study|Lost to Follow-up|2|||
48928179|NCT01430442|157570032|FG001|Overall Study|Lost to Follow-up|0|||
48928180|NCT01430442|157570033|FG002|Overall Study|Lost to Follow-up|1|||
48928181|NCT01430442|157570034|FG003|Overall Study|Lost to Follow-up|2|||
48928182|NCT01430442|157570035|FG004|Overall Study|Lost to Follow-up|2|||
48928183|NCT01430442|157570036|FG005|Overall Study|Lost to Follow-up|1|||
48928184|NCT01430442|157570037|FG006|Overall Study|Lost to Follow-up|5|||
48928185|NCT01430442|157570038|FG007|Overall Study|Lost to Follow-up|1|||
48928186|NCT01430442|157570031|FG000|Overall Study|Pregnancy|1|||
48928187|NCT01430442|157570032|FG001|Overall Study|Pregnancy|0|||
48928188|NCT01430442|157570033|FG002|Overall Study|Pregnancy|0|||
48928189|NCT01430442|157570034|FG003|Overall Study|Pregnancy|0|||
48928190|NCT01430442|157570035|FG004|Overall Study|Pregnancy|0|||
48928191|NCT01430442|157570036|FG005|Overall Study|Pregnancy|1|||
48928192|NCT01430442|157570037|FG006|Overall Study|Pregnancy|0|||
48928193|NCT01430442|157570038|FG007|Overall Study|Pregnancy|0|||
48928194|NCT01430442|157570031|FG000|Overall Study|Patient No Longer Meets Study Criteria|7|||
48928195|NCT01430442|157570032|FG001|Overall Study|Patient No Longer Meets Study Criteria|6|||
48928196|NCT01430442|157570033|FG002|Overall Study|Patient No Longer Meets Study Criteria|3|||
48928197|NCT01430442|157570034|FG003|Overall Study|Patient No Longer Meets Study Criteria|2|||
48928198|NCT01430442|157570035|FG004|Overall Study|Patient No Longer Meets Study Criteria|5|||
48928199|NCT01430442|157570036|FG005|Overall Study|Patient No Longer Meets Study Criteria|5|||
48928200|NCT01430442|157570037|FG006|Overall Study|Patient No Longer Meets Study Criteria|9|||
48928201|NCT01430442|157570038|FG007|Overall Study|Patient No Longer Meets Study Criteria|6|||
48928202|NCT00559507|157570039|FG000|Overall Study|Not treated, patient ineligible|3|||
48928203|NCT01407926|157570043|FG000|Overall Study|Lost to Follow-up|55|||
48928204|NCT03472560|157570044|FG000|Overall Study|Subject transfer to continuation protocol|0|||
48928205|NCT03472560|157570045|FG001|Overall Study|Subject transfer to continuation protocol|1|||
48928206|NCT03472560|157570044|FG000|Overall Study|Withdrawal by Subject|4|||
48928207|NCT03472560|157570045|FG001|Overall Study|Withdrawal by Subject|0|||
48928208|NCT03472560|157570044|FG000|Overall Study|Progressive disease|24|||
48928209|NCT03472560|157570045|FG001|Overall Study|Progressive disease|8|||
48928210|NCT03472560|157570044|FG000|Overall Study|Physician Decision|1|||
48928211|NCT03472560|157570045|FG001|Overall Study|Physician Decision|0|||
48928212|NCT03472560|157570044|FG000|Overall Study|Death|7|||
48928213|NCT03472560|157570045|FG001|Overall Study|Death|4|||
48928214|NCT03472560|157570044|FG000|Overall Study|Adverse Event|5|||
48928215|NCT03472560|157570045|FG001|Overall Study|Adverse Event|3|||
48928216|NCT03472560|157570044|FG000|Overall Study|Global deterioration of health status|0|||
48928217|NCT03472560|157570045|FG001|Overall Study|Global deterioration of health status|4|||
48928218|NCT01534676|157570046|FG000|Overall Study|Study closed due to poor enrollment|2|||
48928219|NCT01534676|157570047|FG001|Overall Study|Study closed due to poor enrollment|1|||
48928220|NCT02479802|157570049|FG000|Overall Study|Lost to Follow-up|1|||
48928221|NCT02479802|157570049|FG000|Overall Study|Adverse Event|1|||
48928222|NCT03178487|157570050|FG000|Period 1|Adverse Event|1|||
48928223|NCT03178487|157570051|FG001|Period 1|Adverse Event|2|||
48928224|NCT03178487|157570050|FG000|Period 1|Withdrawal by Subject|2|||
48928225|NCT03178487|157570051|FG001|Period 1|Withdrawal by Subject|1|||
48928226|NCT03178487|157570050|FG000|Period 1|Lost to Follow-up|1|||
48928227|NCT03178487|157570051|FG001|Period 1|Lost to Follow-up|0|||
48928228|NCT03178487|157570050|FG000|Period 1|Other|0|||
48928229|NCT03178487|157570051|FG001|Period 1|Other|1|||
48928230|NCT03178487|157570050|FG000|Period 2|Adverse Event|4|||
48928231|NCT03178487|157570051|FG001|Period 2|Adverse Event|4|||
48928232|NCT03178487|157570050|FG000|Period 2|Withdrawal by Subject|6|||
48928233|NCT03178487|157570051|FG001|Period 2|Withdrawal by Subject|6|||
48928234|NCT03178487|157570050|FG000|Period 2|Lost to Follow-up|2|||
48928235|NCT03178487|157570051|FG001|Period 2|Lost to Follow-up|2|||
48928236|NCT03178487|157570050|FG000|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|1|||
48928237|NCT03178487|157570051|FG001|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|0|||
48928238|NCT03178487|157570050|FG000|Period 2|Other|8|||
48928239|NCT03178487|157570051|FG001|Period 2|Other|7|||
48928240|NCT00323557|157570055|FG000|Overall Study|Physician Decision|1|||
48928241|NCT00323557|157570056|FG001|Overall Study|Physician Decision|0|||
48928242|NCT02614079|157570057|FG000|Overall Study|Withdrawal by Subject|1|||
48928243|NCT03555266|157570058|FG000|Overall Study|Protocol Violation|6|||
48692910|NCT03137992|156724649|FG003|Washout Period 1|COPD Exacerbation|0|||
48928244|NCT03555266|157570059|FG001|Overall Study|Protocol Violation|4|||
48928245|NCT00523991|157570063|FG000|Overall Study|Adverse Event|6|||
48928246|NCT00523991|157570064|FG001|Overall Study|Adverse Event|5|||
48928247|NCT00523991|157570063|FG000|Overall Study|Protocol Violation|1|||
48928248|NCT00523991|157570064|FG001|Overall Study|Protocol Violation|4|||
48928249|NCT00523991|157570063|FG000|Overall Study|Lost to Follow-up|4|||
48928250|NCT00523991|157570064|FG001|Overall Study|Lost to Follow-up|1|||
48928251|NCT00523991|157570063|FG000|Overall Study|Withdrawal by Subject|7|||
48928252|NCT00523991|157570064|FG001|Overall Study|Withdrawal by Subject|17|||
48928253|NCT00523991|157570063|FG000|Overall Study|Other reason (not specified)|3|||
48928254|NCT00523991|157570064|FG001|Overall Study|Other reason (not specified)|0|||
48928255|NCT03261531|157570065|FG000|Overall Study|Withdrawal by Subject|4|||
48928256|NCT01142726|157570066|FG000|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
48928257|NCT01142726|157570067|FG001|Treatment Phase: Day 1 Through Month 12|Adverse Event|8|||
48928258|NCT01142726|157570068|FG002|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
48928259|NCT01142726|157570066|FG000|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4|||
48928260|NCT01142726|157570067|FG001|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9|||
48928261|NCT01142726|157570068|FG002|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3|||
48844308|NCT01070069|157271315|FG004|Overall Study|Lost to Follow-up|3|||
48844309|NCT05368831|157271316|FG000|200 mg NST-1024 (QD)|Adverse Event|3|||
48844310|NCT03101930|157271317|FG000|Overall Study|Withdrawal by Subject|2|||
48844311|NCT03101930|157271318|FG001|Overall Study|Withdrawal by Subject|1|||
48844312|NCT03101930|157271319|FG002|Overall Study|Withdrawal by Subject|2|||
48844313|NCT00262301|157271320|FG000|Double-blind Phase|Lost to Follow-up|1|||
48844314|NCT00262301|157271321|FG001|Double-blind Phase|Lost to Follow-up|0|||
48844315|NCT00262301|157271322|FG002|Double-blind Phase|Lost to Follow-up|0|||
48844316|NCT00262301|157271320|FG000|Double-blind Phase|"worsening of HAE symptoms"|0|||
48844317|NCT00262301|157271321|FG001|Double-blind Phase|"worsening of HAE symptoms"|1|||
48844318|NCT00262301|157271322|FG002|Double-blind Phase|"worsening of HAE symptoms"|0|||
48844319|NCT00087139|157271324|FG000|Overall Study|Adverse Event|18|||
48928262|NCT01142726|157570066|FG000|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
48928263|NCT01142726|157570067|FG001|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2|||
48928264|NCT01142726|157570068|FG002|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
48928265|NCT01142726|157570066|FG000|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1|||
48928266|NCT01142726|157570067|FG001|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
48928267|NCT01142726|157570068|FG002|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
48928268|NCT01142726|157570066|FG000|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5|||
48928269|NCT01142726|157570067|FG001|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6|||
48928270|NCT01142726|157570068|FG002|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11|||
48928271|NCT01142726|157570066|FG000|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
48928272|NCT01142726|157570067|FG001|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
48928273|NCT01142726|157570068|FG002|Withdrawal Phase: Months 12 up to 24|Adverse Event|1|||
48928274|NCT01142726|157570066|FG000|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
48928275|NCT01142726|157570067|FG001|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
48928276|NCT01142726|157570068|FG002|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2|||
48928277|NCT01142726|157570066|FG000|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
48928278|NCT01142726|157570067|FG001|Withdrawal Phase: Months 12 up to 24|Pregnancy|0|||
48928279|NCT01142726|157570068|FG002|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
48928280|NCT01142726|157570066|FG000|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2|||
48928281|NCT01142726|157570067|FG001|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
48928282|NCT01142726|157570068|FG002|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
48928283|NCT01142726|157570066|FG000|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1|||
48928284|NCT01142726|157570067|FG001|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
48928285|NCT01142726|157570068|FG002|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
48928286|NCT01142726|157570066|FG000|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65|||
48928287|NCT01142726|157570067|FG001|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54|||
48928288|NCT01142726|157570068|FG002|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53|||
48928289|NCT01142726|157570066|FG000|Withdrawal Phase: Months 12 up to 24|non-specified|0|||
48928290|NCT01142726|157570067|FG001|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
48928291|NCT01142726|157570068|FG002|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
48928292|NCT01142726|157570066|FG000|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
48928293|NCT01142726|157570067|FG001|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
48928294|NCT01142726|157570068|FG002|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1|||
48928295|NCT01142726|157570066|FG000|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
48928296|NCT01142726|157570067|FG001|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
48928297|NCT01142726|157570068|FG002|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
48928298|NCT01142726|157570066|FG000|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
48928299|NCT01142726|157570067|FG001|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
48928300|NCT01142726|157570068|FG002|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1|||
48928301|NCT01142726|157570066|FG000|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
48928302|NCT01142726|157570067|FG001|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1|||
48928303|NCT01142726|157570068|FG002|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
48928304|NCT01731678|157570069|FG000|Overall Study|Withdrawal by Subject|3|||
48928305|NCT01731678|157570069|FG000|Overall Study|Did not meet inclusion criteria|1|||
48928306|NCT01731678|157570069|FG000|Overall Study|RMT too high, making TMS difficult|3|||
48928307|NCT01834729|157570072|FG000|Overall Study|Did not return bowel diaries|0|||
48928308|NCT01834729|157570073|FG001|Overall Study|Did not return bowel diaries|0|||
48928309|NCT01834729|157570074|FG002|Overall Study|Did not return bowel diaries|3|||
48928310|NCT01834729|157570075|FG003|Overall Study|Did not return bowel diaries|0|||
48928311|NCT01834729|157570072|FG000|Overall Study|Withdrawal by Subject|1|||
48928312|NCT01834729|157570073|FG001|Overall Study|Withdrawal by Subject|1|||
48928313|NCT01834729|157570074|FG002|Overall Study|Withdrawal by Subject|0|||
48928314|NCT01834729|157570075|FG003|Overall Study|Withdrawal by Subject|0|||
48928315|NCT01834729|157570072|FG000|Overall Study|Adverse Event|0|||
48928316|NCT01834729|157570073|FG001|Overall Study|Adverse Event|0|||
48928317|NCT01834729|157570074|FG002|Overall Study|Adverse Event|0|||
48928318|NCT01834729|157570075|FG003|Overall Study|Adverse Event|2|||
48928319|NCT00288080|157570076|FG000|Overall Study|Withdrawal by Subject|1|||
48928320|NCT00288080|157570077|FG001|Overall Study|Withdrawal by Subject|3|||
48928321|NCT00288080|157570076|FG000|Overall Study|Protocol Violation|25|||
48928322|NCT00288080|157570077|FG001|Overall Study|Protocol Violation|20|||
48928323|NCT01543087|157570078|FG000|Stage 1 (48 Months)|Lost to Follow-up|3|||
48928324|NCT01543087|157570079|FG001|Stage 1 (48 Months)|Lost to Follow-up|4|||
48928325|NCT01543087|157570080|FG002|Stage 1 (48 Months)|Lost to Follow-up|12|||
48928326|NCT01543087|157570081|FG003|Stage 1 (48 Months)|Lost to Follow-up|0|||
48928327|NCT01543087|157570082|FG004|Stage 1 (48 Months)|Lost to Follow-up|0|||
48928328|NCT01543087|157570083|FG005|Stage 1 (48 Months)|Lost to Follow-up|0|||
48928329|NCT01543087|157570078|FG000|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
48928330|NCT01543087|157570079|FG001|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
48928331|NCT01543087|157570080|FG002|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
48928332|NCT01543087|157570081|FG003|Stage 1 (48 Months)|No longer met eligibility criteria|2|||
48928333|NCT01543087|157570082|FG004|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
48928334|NCT01543087|157570083|FG005|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
48693062|NCT01400698|156724660|FG002|Overall Study|Adverse Event|0|||
48928335|NCT01543087|157570078|FG000|Stage 1 (48 Months)|No longer willing to participate|5|||
48928336|NCT01543087|157570079|FG001|Stage 1 (48 Months)|No longer willing to participate|3|||
48928337|NCT01543087|157570080|FG002|Stage 1 (48 Months)|No longer willing to participate|18|||
48928338|NCT01543087|157570081|FG003|Stage 1 (48 Months)|No longer willing to participate|6|||
48928339|NCT01543087|157570082|FG004|Stage 1 (48 Months)|No longer willing to participate|3|||
48928340|NCT01543087|157570083|FG005|Stage 1 (48 Months)|No longer willing to participate|0|||
48928341|NCT01543087|157570078|FG000|Stage 1 (48 Months)|Other than specified|5|||
48928342|NCT01543087|157570079|FG001|Stage 1 (48 Months)|Other than specified|0|||
48928343|NCT01543087|157570080|FG002|Stage 1 (48 Months)|Other than specified|9|||
48928344|NCT01543087|157570081|FG003|Stage 1 (48 Months)|Other than specified|0|||
48928345|NCT01543087|157570082|FG004|Stage 1 (48 Months)|Other than specified|0|||
48928346|NCT01543087|157570083|FG005|Stage 1 (48 Months)|Other than specified|0|||
48928347|NCT01543087|157570078|FG000|Stage 1 (48 Months)|Protocol Violation|0|||
48928348|NCT01543087|157570079|FG001|Stage 1 (48 Months)|Protocol Violation|3|||
48928349|NCT01543087|157570080|FG002|Stage 1 (48 Months)|Protocol Violation|0|||
48928350|NCT01543087|157570081|FG003|Stage 1 (48 Months)|Protocol Violation|0|||
48928351|NCT01543087|157570082|FG004|Stage 1 (48 Months)|Protocol Violation|0|||
48928352|NCT01543087|157570083|FG005|Stage 1 (48 Months)|Protocol Violation|0|||
48928353|NCT01543087|157570078|FG000|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
48928354|NCT01543087|157570079|FG001|Booster Stage (26 Months)|Withdrawal before booster vaccination|1|||
48928355|NCT01543087|157570080|FG002|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
48928356|NCT01543087|157570081|FG003|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
48928357|NCT01543087|157570082|FG004|Booster Stage (26 Months)|Withdrawal before booster vaccination|2|||
48928358|NCT01543087|157570083|FG005|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
48928359|NCT01543087|157570078|FG000|Booster Stage (26 Months)|Lost to Follow-up|0|||
48928360|NCT01543087|157570079|FG001|Booster Stage (26 Months)|Lost to Follow-up|0|||
48928361|NCT01543087|157570080|FG002|Booster Stage (26 Months)|Lost to Follow-up|1|||
48928362|NCT01543087|157570081|FG003|Booster Stage (26 Months)|Lost to Follow-up|0|||
48928363|NCT01543087|157570082|FG004|Booster Stage (26 Months)|Lost to Follow-up|0|||
48928364|NCT01543087|157570083|FG005|Booster Stage (26 Months)|Lost to Follow-up|0|||
48928365|NCT00379795|157570084|FG000|Overall Study|Death|31|||
48928366|NCT00379795|157570085|FG001|Overall Study|Death|8|||
48928367|NCT00379795|157570086|FG002|Overall Study|Death|6|||
48928368|NCT00379795|157570087|FG003|Overall Study|Death|4|||
48928369|NCT00379795|157570088|FG004|Overall Study|Death|7|||
48928370|NCT00379795|157570084|FG000|Overall Study|Adverse Event|17|||
48928371|NCT00379795|157570085|FG001|Overall Study|Adverse Event|3|||
48928372|NCT00379795|157570086|FG002|Overall Study|Adverse Event|3|||
48928373|NCT00379795|157570087|FG003|Overall Study|Adverse Event|1|||
48928374|NCT00379795|157570088|FG004|Overall Study|Adverse Event|4|||
48928375|NCT00379795|157570084|FG000|Overall Study|Lost to Follow-up|8|||
48928376|NCT00379795|157570085|FG001|Overall Study|Lost to Follow-up|1|||
48928377|NCT00379795|157570086|FG002|Overall Study|Lost to Follow-up|2|||
48928378|NCT00379795|157570087|FG003|Overall Study|Lost to Follow-up|1|||
48928379|NCT00379795|157570088|FG004|Overall Study|Lost to Follow-up|4|||
48928380|NCT00379795|157570084|FG000|Overall Study|Physician Decision|25|||
48928381|NCT00379795|157570085|FG001|Overall Study|Physician Decision|0|||
48928382|NCT00379795|157570086|FG002|Overall Study|Physician Decision|2|||
48928383|NCT00379795|157570087|FG003|Overall Study|Physician Decision|2|||
48928384|NCT00379795|157570088|FG004|Overall Study|Physician Decision|2|||
48928385|NCT00379795|157570084|FG000|Overall Study|Withdrawal by Subject|94|||
48928386|NCT00379795|157570085|FG001|Overall Study|Withdrawal by Subject|11|||
48928387|NCT00379795|157570086|FG002|Overall Study|Withdrawal by Subject|19|||
48928388|NCT00379795|157570087|FG003|Overall Study|Withdrawal by Subject|7|||
48928389|NCT00379795|157570088|FG004|Overall Study|Withdrawal by Subject|14|||
48928390|NCT00379795|157570084|FG000|Overall Study|Subject non-compliance|7|||
48928391|NCT00379795|157570085|FG001|Overall Study|Subject non-compliance|2|||
48928392|NCT00379795|157570086|FG002|Overall Study|Subject non-compliance|0|||
48928393|NCT00379795|157570087|FG003|Overall Study|Subject non-compliance|0|||
48928394|NCT00379795|157570088|FG004|Overall Study|Subject non-compliance|1|||
48928395|NCT00379795|157570084|FG000|Overall Study|Verteporfin photodynamic therapy in eye|3|||
48928396|NCT00379795|157570085|FG001|Overall Study|Verteporfin photodynamic therapy in eye|0|||
48928397|NCT00379795|157570086|FG002|Overall Study|Verteporfin photodynamic therapy in eye|0|||
48928398|NCT00379795|157570087|FG003|Overall Study|Verteporfin photodynamic therapy in eye|1|||
48928399|NCT00379795|157570088|FG004|Overall Study|Verteporfin photodynamic therapy in eye|0|||
48928400|NCT00379795|157570084|FG000|Overall Study|Subjects condition mandated intervention|34|||
48928401|NCT00379795|157570085|FG001|Overall Study|Subjects condition mandated intervention|9|||
48844320|NCT00087139|157271325|FG001|Overall Study|Adverse Event|17|||
48693063|NCT01400698|156724661|FG003|Overall Study|Adverse Event|0|||
48844321|NCT00087139|157271326|FG002|Overall Study|Adverse Event|13|||
48844322|NCT00087139|157271324|FG000|Overall Study|Death|2|||
48844323|NCT00087139|157271325|FG001|Overall Study|Death|1|||
48844324|NCT00087139|157271326|FG002|Overall Study|Death|0|||
48928402|NCT00379795|157570086|FG002|Overall Study|Subjects condition mandated intervention|7|||
48928403|NCT00379795|157570087|FG003|Overall Study|Subjects condition mandated intervention|5|||
48928404|NCT00379795|157570088|FG004|Overall Study|Subjects condition mandated intervention|7|||
48928405|NCT00379795|157570084|FG000|Overall Study|Sponsor's decision|257|||
48928406|NCT00379795|157570085|FG001|Overall Study|Sponsor's decision|17|||
48928407|NCT00379795|157570086|FG002|Overall Study|Sponsor's decision|54|||
48928408|NCT00379795|157570087|FG003|Overall Study|Sponsor's decision|47|||
48928409|NCT00379795|157570088|FG004|Overall Study|Sponsor's decision|10|||
48928410|NCT03175549|157570089|FG000|Overall Study|Lost to Follow-up|2|||
48928411|NCT03175549|157570090|FG001|Overall Study|Lost to Follow-up|2|||
48928412|NCT03175549|157570089|FG000|Overall Study|Medication non-compliance|2|||
48928413|NCT03175549|157570090|FG001|Overall Study|Medication non-compliance|2|||
48928414|NCT02486757|157570091|FG000|Overall Study|Lost to Follow-up|1|||
48928415|NCT02793232|157570092|FG000|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
48928416|NCT02793232|157570093|FG001|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
48928417|NCT02793232|157570094|FG002|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
48928418|NCT02793232|157570095|FG003|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
48928419|NCT02793232|157570096|FG004|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
48928420|NCT02793232|157570097|FG005|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
48928421|NCT02793232|157570098|FG006|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
48928422|NCT02793232|157570099|FG007|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
48928423|NCT02793232|157570100|FG008|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
48928424|NCT03847610|157570101|FG000|Overall Study|Withdrawal by Subject|1|||
48928425|NCT00087646|157570102|FG000|Overall Study|Adverse Event|37|||
48928426|NCT00087646|157570103|FG001|Overall Study|Adverse Event|6|||
48928427|NCT00087646|157570104|FG002|Overall Study|Adverse Event|18|||
48928428|NCT00087646|157570105|FG003|Overall Study|Adverse Event|20|||
48928429|NCT00087646|157570102|FG000|Overall Study|Death|0|||
48928430|NCT00087646|157570103|FG001|Overall Study|Death|1|||
48928431|NCT00087646|157570104|FG002|Overall Study|Death|0|||
48928432|NCT00087646|157570105|FG003|Overall Study|Death|0|||
48928433|NCT00087646|157570102|FG000|Overall Study|Withdrawal by Subject|6|||
48928434|NCT00087646|157570103|FG001|Overall Study|Withdrawal by Subject|1|||
48928435|NCT00087646|157570104|FG002|Overall Study|Withdrawal by Subject|2|||
48928436|NCT00087646|157570105|FG003|Overall Study|Withdrawal by Subject|2|||
48928437|NCT00087646|157570102|FG000|Overall Study|Insufficient therapeutic response|64|||
48928438|NCT00087646|157570103|FG001|Overall Study|Insufficient therapeutic response|24|||
48928439|NCT00087646|157570104|FG002|Overall Study|Insufficient therapeutic response|38|||
48928440|NCT00087646|157570105|FG003|Overall Study|Insufficient therapeutic response|51|||
48928441|NCT00087646|157570102|FG000|Overall Study|Refused Treatment/Did Not Cooperate|13|||
48928442|NCT00087646|157570103|FG001|Overall Study|Refused Treatment/Did Not Cooperate|6|||
48928443|NCT00087646|157570104|FG002|Overall Study|Refused Treatment/Did Not Cooperate|4|||
48928444|NCT00087646|157570105|FG003|Overall Study|Refused Treatment/Did Not Cooperate|5|||
48928445|NCT00087646|157570102|FG000|Overall Study|Failure to Return|5|||
48928446|NCT00087646|157570103|FG001|Overall Study|Failure to Return|2|||
48928447|NCT00087646|157570104|FG002|Overall Study|Failure to Return|2|||
48928448|NCT00087646|157570105|FG003|Overall Study|Failure to Return|3|||
48928449|NCT00087646|157570102|FG000|Overall Study|Administrative/Other|6|||
48928450|NCT00087646|157570103|FG001|Overall Study|Administrative/Other|1|||
48928451|NCT00087646|157570104|FG002|Overall Study|Administrative/Other|1|||
48928452|NCT00087646|157570105|FG003|Overall Study|Administrative/Other|2|||
48928453|NCT00087646|157570102|FG000|Overall Study|Other Protocol Violation|3|||
48928454|NCT00087646|157570103|FG001|Overall Study|Other Protocol Violation|1|||
48928455|NCT00087646|157570104|FG002|Overall Study|Other Protocol Violation|0|||
48928456|NCT00087646|157570105|FG003|Overall Study|Other Protocol Violation|0|||
48928457|NCT00087646|157570102|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
48928458|NCT00087646|157570103|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
48928459|NCT00087646|157570104|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
48928460|NCT00087646|157570105|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
48928461|NCT01486199|157570106|FG000|Two Year Period Between Study Days|Physician Decision|1|||
48928462|NCT01486199|157570107|FG001|Two Year Period Between Study Days|Physician Decision|0|||
48928463|NCT01445769|157570109|FG000|Overall Study|Consent Withdrawn|2|||
48928464|NCT01445769|157570109|FG000|Overall Study|Disease Progression|1|||
48928465|NCT01445769|157570109|FG000|Overall Study|Lost to Follow-up|5|||
48928466|NCT01405053|157570114|FG000|Overall Study|Adverse Event|3|||
48928467|NCT01405053|157570115|FG001|Overall Study|Adverse Event|0|||
48928468|NCT01405053|157570114|FG000|Overall Study|Lost to Follow-up|0|||
48928469|NCT01405053|157570115|FG001|Overall Study|Lost to Follow-up|1|||
48928470|NCT01405053|157570114|FG000|Overall Study|Participant choice|2|||
48928471|NCT01405053|157570115|FG001|Overall Study|Participant choice|1|||
48928472|NCT01405053|157570114|FG000|Overall Study|Inadequate therapeutic effect|2|||
48928473|NCT01405053|157570115|FG001|Overall Study|Inadequate therapeutic effect|1|||
48928474|NCT01405053|157570114|FG000|Overall Study|Withdrawal by Subject|3|||
48928475|NCT01405053|157570115|FG001|Overall Study|Withdrawal by Subject|4|||
48928476|NCT01405053|157570114|FG000|Overall Study|Other|0|||
48928477|NCT01405053|157570115|FG001|Overall Study|Other|1|||
48928478|NCT03604445|157570116|FG000|Overall Study|Death|0|||
48928479|NCT03604445|157570117|FG001|Overall Study|Death|0|||
48928480|NCT03604445|157570118|FG002|Overall Study|Death|0|||
48928481|NCT03604445|157570119|FG003|Overall Study|Death|0|||
48928482|NCT03604445|157570120|FG004|Overall Study|Death|0|||
48928483|NCT03604445|157570121|FG005|Overall Study|Death|0|||
48928484|NCT03604445|157570122|FG006|Overall Study|Death|0|||
48928485|NCT03604445|157570123|FG007|Overall Study|Death|0|||
48928486|NCT03604445|157570124|FG008|Overall Study|Death|1|||
48928487|NCT03604445|157570116|FG000|Overall Study|Withdrawal by Subject|0|||
48928488|NCT03604445|157570117|FG001|Overall Study|Withdrawal by Subject|0|||
48928489|NCT03604445|157570118|FG002|Overall Study|Withdrawal by Subject|0|||
48928490|NCT03604445|157570119|FG003|Overall Study|Withdrawal by Subject|0|||
48928491|NCT03604445|157570120|FG004|Overall Study|Withdrawal by Subject|0|||
48928492|NCT03604445|157570121|FG005|Overall Study|Withdrawal by Subject|0|||
48928493|NCT03604445|157570122|FG006|Overall Study|Withdrawal by Subject|1|||
48928494|NCT03604445|157570123|FG007|Overall Study|Withdrawal by Subject|0|||
48928495|NCT03604445|157570124|FG008|Overall Study|Withdrawal by Subject|0|||
48928496|NCT03604445|157570116|FG000|Overall Study|Missing visit|0|||
48928497|NCT03604445|157570117|FG001|Overall Study|Missing visit|0|||
48928498|NCT03604445|157570118|FG002|Overall Study|Missing visit|0|||
48928499|NCT03604445|157570119|FG003|Overall Study|Missing visit|0|||
48928500|NCT03604445|157570120|FG004|Overall Study|Missing visit|0|||
48928501|NCT03604445|157570121|FG005|Overall Study|Missing visit|1|||
48928502|NCT03604445|157570122|FG006|Overall Study|Missing visit|0|||
48928503|NCT03604445|157570123|FG007|Overall Study|Missing visit|1|||
48928504|NCT03604445|157570124|FG008|Overall Study|Missing visit|0|||
48928505|NCT03604445|157570116|FG000|Overall Study|Adverse Event|0|||
48928506|NCT03604445|157570117|FG001|Overall Study|Adverse Event|0|||
48928507|NCT03604445|157570118|FG002|Overall Study|Adverse Event|0|||
48928508|NCT03604445|157570119|FG003|Overall Study|Adverse Event|1|||
48928509|NCT03604445|157570120|FG004|Overall Study|Adverse Event|0|||
48928510|NCT03604445|157570121|FG005|Overall Study|Adverse Event|0|||
48928511|NCT03604445|157570122|FG006|Overall Study|Adverse Event|0|||
48928512|NCT03604445|157570123|FG007|Overall Study|Adverse Event|0|||
48928513|NCT03604445|157570124|FG008|Overall Study|Adverse Event|1|||
48928514|NCT02154425|157570131|FG000|Screening Period|Adverse Event|1|||
48928515|NCT04178772|157570132|FG000|Overall Study|Unsatisfacotry VIsual Response|1|||
48928516|NCT04178772|157570132|FG000|Overall Study|study terminated early due to COVID-19|7|||
48928517|NCT02817087|157570136|FG000|Overall Study|Withdrawal by Subject|2|||
48928518|NCT02817087|157570137|FG001|Overall Study|Withdrawal by Subject|0|||
48928519|NCT01327651|157570138|FG000|Self-administered Dosing Period|Lost to Follow-up|3|||
48928520|NCT01327651|157570139|FG001|Self-administered Dosing Period|Lost to Follow-up|2|||
48928521|NCT01327651|157570140|FG002|Self-administered Dosing Period|Lost to Follow-up|4|||
48928522|NCT01327651|157570141|FG003|Self-administered Dosing Period|Lost to Follow-up|2|||
48928523|NCT01327651|157570142|FG004|Self-administered Dosing Period|Lost to Follow-up|3|||
48928524|NCT01327651|157570143|FG005|Self-administered Dosing Period|Lost to Follow-up|0|||
48928525|NCT01327651|157570144|FG006|Self-administered Dosing Period|Lost to Follow-up|8|||
48928526|NCT01327651|157570145|FG007|Self-administered Dosing Period|Lost to Follow-up|9|||
48928527|NCT01327651|157570146|FG008|Self-administered Dosing Period|Lost to Follow-up|10|||
48928528|NCT01327651|157570138|FG000|Self-administered Dosing Period|Ineligible (retrospective result)|1|||
48928529|NCT01327651|157570139|FG001|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
48928530|NCT01327651|157570140|FG002|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
48928531|NCT01327651|157570141|FG003|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
48928532|NCT01327651|157570142|FG004|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
48928533|NCT01327651|157570143|FG005|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
48928534|NCT01327651|157570144|FG006|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
48928535|NCT01327651|157570145|FG007|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
48928536|NCT01327651|157570146|FG008|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
48928537|NCT01327651|157570138|FG000|Self-administered Dosing Period|Withdrawal by Subject|0|||
48928538|NCT01327651|157570139|FG001|Self-administered Dosing Period|Withdrawal by Subject|1|||
48928539|NCT01327651|157570140|FG002|Self-administered Dosing Period|Withdrawal by Subject|0|||
48928540|NCT01327651|157570141|FG003|Self-administered Dosing Period|Withdrawal by Subject|1|||
48928541|NCT01327651|157570142|FG004|Self-administered Dosing Period|Withdrawal by Subject|0|||
48928542|NCT01327651|157570143|FG005|Self-administered Dosing Period|Withdrawal by Subject|0|||
48928543|NCT01327651|157570144|FG006|Self-administered Dosing Period|Withdrawal by Subject|2|||
48928544|NCT01327651|157570145|FG007|Self-administered Dosing Period|Withdrawal by Subject|1|||
48928545|NCT01327651|157570146|FG008|Self-administered Dosing Period|Withdrawal by Subject|1|||
48928546|NCT01327651|157570138|FG000|Post Study Follow-up|Lost to Follow-up|0|||
48928547|NCT01327651|157570139|FG001|Post Study Follow-up|Lost to Follow-up|1|||
48928548|NCT01327651|157570140|FG002|Post Study Follow-up|Lost to Follow-up|1|||
48928549|NCT01327651|157570141|FG003|Post Study Follow-up|Lost to Follow-up|0|||
48928550|NCT01327651|157570142|FG004|Post Study Follow-up|Lost to Follow-up|0|||
48928551|NCT01327651|157570143|FG005|Post Study Follow-up|Lost to Follow-up|0|||
48928552|NCT01327651|157570144|FG006|Post Study Follow-up|Lost to Follow-up|4|||
48928553|NCT01327651|157570145|FG007|Post Study Follow-up|Lost to Follow-up|1|||
48928554|NCT01327651|157570146|FG008|Post Study Follow-up|Lost to Follow-up|2|||
48928555|NCT01890421|157570153|FG000|Overall Study|Adverse Event|1|||
48928556|NCT01890421|157570153|FG000|Overall Study|Other reason|10|||
48928557|NCT01282229|157570157|FG000|Overall Study|Protocol Violation|2|||
48928558|NCT02154087|157570158|FG000|Overall Study|Study Termination|1|||
48928559|NCT01724528|157570163|FG000|Overall Study|Death|3|||
48928560|NCT01724528|157570164|FG001|Overall Study|Death|0|||
48928561|NCT01724528|157570163|FG000|Overall Study|Withdrawal by Subject|0|||
48928562|NCT01724528|157570164|FG001|Overall Study|Withdrawal by Subject|2|||
48928563|NCT01724528|157570163|FG000|Overall Study|Protocol Violation|0|||
48928564|NCT01724528|157570164|FG001|Overall Study|Protocol Violation|1|||
48928565|NCT01724528|157570163|FG000|Overall Study|Patient refused to attend last visit|1|||
48928566|NCT01724528|157570164|FG001|Overall Study|Patient refused to attend last visit|0|||
48928567|NCT00654498|157570170|FG000|Overall Study|Not Treated|1|||
48928568|NCT00654498|157570171|FG001|Overall Study|Not Treated|0|||
48928569|NCT00654498|157570170|FG000|Overall Study|Adverse Event|6|||
48928570|NCT00654498|157570171|FG001|Overall Study|Adverse Event|1|||
48928571|NCT00654498|157570170|FG000|Overall Study|Protocol Violation|1|||
48928572|NCT00654498|157570171|FG001|Overall Study|Protocol Violation|1|||
48928573|NCT00654498|157570170|FG000|Overall Study|Lost to Follow-up|1|||
48928574|NCT00654498|157570171|FG001|Overall Study|Lost to Follow-up|5|||
48928575|NCT00654498|157570170|FG000|Overall Study|Withdrawal by Subject|1|||
48928576|NCT00654498|157570171|FG001|Overall Study|Withdrawal by Subject|0|||
48928577|NCT00654498|157570170|FG000|Overall Study|Other reason not defined above|4|||
48928578|NCT00654498|157570171|FG001|Overall Study|Other reason not defined above|5|||
48928579|NCT01292057|157570173|FG000|Overall Study|Protocol Violation|1|||
48928580|NCT01292057|157570174|FG001|Overall Study|Protocol Violation|1|||
48928581|NCT01292057|157570173|FG000|Overall Study|Lost to Follow-up|1|||
48928582|NCT01292057|157570174|FG001|Overall Study|Lost to Follow-up|1|||
48928583|NCT02320487|157570179|FG000|Overall Study|Reason not Specified|1|||
48928584|NCT02320487|157570179|FG000|Overall Study|Physician Decision|5|||
48928585|NCT02320487|157570179|FG000|Overall Study|Withdrawal by Subject|1|||
48928586|NCT02320487|157570179|FG000|Overall Study|Death|3|||
48928587|NCT02320487|157570179|FG000|Overall Study|Adverse Event|11|||
48928588|NCT01227902|157571438|FG000|Overall Study|Adverse Event|12|||
48928589|NCT01227902|157571439|FG001|Overall Study|Adverse Event|8|||
48928590|NCT01227902|157571440|FG002|Overall Study|Adverse Event|11|||
48928591|NCT01227902|157571441|FG003|Overall Study|Adverse Event|4|||
48928592|NCT01227902|157571438|FG000|Overall Study|Lack of Efficacy|1|||
48928593|NCT01227902|157571439|FG001|Overall Study|Lack of Efficacy|2|||
48928594|NCT01227902|157571440|FG002|Overall Study|Lack of Efficacy|2|||
48928595|NCT01227902|157571441|FG003|Overall Study|Lack of Efficacy|1|||
48928596|NCT01227902|157571438|FG000|Overall Study|Protocol Violation|1|||
48928597|NCT01227902|157571439|FG001|Overall Study|Protocol Violation|0|||
48928598|NCT01227902|157571440|FG002|Overall Study|Protocol Violation|0|||
48928599|NCT01227902|157571441|FG003|Overall Study|Protocol Violation|0|||
48928600|NCT01227902|157571438|FG000|Overall Study|Lost to Follow-up|0|||
48928601|NCT01227902|157571439|FG001|Overall Study|Lost to Follow-up|0|||
48928602|NCT01227902|157571440|FG002|Overall Study|Lost to Follow-up|1|||
48928603|NCT01227902|157571441|FG003|Overall Study|Lost to Follow-up|2|||
48928604|NCT01227902|157571438|FG000|Overall Study|Physician Decision|0|||
48928605|NCT01227902|157571439|FG001|Overall Study|Physician Decision|1|||
48928606|NCT01227902|157571440|FG002|Overall Study|Physician Decision|1|||
48928607|NCT01227902|157571441|FG003|Overall Study|Physician Decision|0|||
48928608|NCT01227902|157571438|FG000|Overall Study|Withdrawal by Subject|4|||
48928609|NCT01227902|157571439|FG001|Overall Study|Withdrawal by Subject|2|||
48928610|NCT01227902|157571440|FG002|Overall Study|Withdrawal by Subject|4|||
48928611|NCT01227902|157571441|FG003|Overall Study|Withdrawal by Subject|3|||
48928612|NCT02068547|157571442|FG000|Overall Study|Lost to Follow-up|3|||
48928613|NCT02068547|157571443|FG001|Overall Study|Lost to Follow-up|3|||
48928614|NCT02068547|157571442|FG000|Overall Study|Physician Decision|1|||
48928615|NCT02068547|157571443|FG001|Overall Study|Physician Decision|0|||
48928616|NCT00150592|157571444|FG000|Overall Study|Adverse Event|4|||
48928617|NCT00150592|157571445|FG001|Overall Study|Adverse Event|1|||
48928618|NCT00150592|157571444|FG000|Overall Study|Protocol Violation|1|||
48928619|NCT00150592|157571445|FG001|Overall Study|Protocol Violation|0|||
48928620|NCT00150592|157571444|FG000|Overall Study|Withdrawal by Subject|1|||
48928621|NCT00150592|157571445|FG001|Overall Study|Withdrawal by Subject|2|||
48928622|NCT00150592|157571444|FG000|Overall Study|Non-compliance|1|||
48928623|NCT00150592|157571445|FG001|Overall Study|Non-compliance|0|||
48928624|NCT02627495|157571446|FG000|Overall Study|Withdrawal by Subject|4|||
48928625|NCT00880893|157571447|FG000|Overall Study|Protocol Violation|13|||
48928626|NCT00880893|157571448|FG001|Overall Study|Protocol Violation|1|||
48928627|NCT00880893|157571447|FG000|Overall Study|Withdrawal by Subject|15|||
48928628|NCT00880893|157571448|FG001|Overall Study|Withdrawal by Subject|11|||
48928629|NCT00880893|157571447|FG000|Overall Study|Lost to Follow-up|76|||
48928630|NCT00880893|157571448|FG001|Overall Study|Lost to Follow-up|33|||
48928631|NCT00880893|157571447|FG000|Overall Study|Serious adverse event|3|||
48928632|NCT00880893|157571448|FG001|Overall Study|Serious adverse event|0|||
48928633|NCT00482014|157571452|FG000|Overall Study|Withdrawal by Subject|1|||
48928634|NCT00482014|157571453|FG001|Overall Study|Withdrawal by Subject|2|||
48928635|NCT00482014|157571454|FG002|Overall Study|Withdrawal by Subject|3|||
48928636|NCT00482014|157571455|FG003|Overall Study|Withdrawal by Subject|4|||
48928637|NCT00482014|157571452|FG000|Overall Study|Adverse Event|3|||
48928638|NCT00482014|157571453|FG001|Overall Study|Adverse Event|0|||
48928639|NCT00482014|157571454|FG002|Overall Study|Adverse Event|2|||
48928640|NCT00482014|157571455|FG003|Overall Study|Adverse Event|8|||
48928641|NCT00482014|157571452|FG000|Overall Study|Death|1|||
48928642|NCT00482014|157571453|FG001|Overall Study|Death|2|||
48928643|NCT00482014|157571454|FG002|Overall Study|Death|1|||
48928644|NCT00482014|157571455|FG003|Overall Study|Death|4|||
48928645|NCT00482014|157571452|FG000|Overall Study|Lack of Efficacy|1|||
48928646|NCT00482014|157571453|FG001|Overall Study|Lack of Efficacy|0|||
48928647|NCT00482014|157571454|FG002|Overall Study|Lack of Efficacy|4|||
48928648|NCT00482014|157571455|FG003|Overall Study|Lack of Efficacy|6|||
48928649|NCT00482014|157571452|FG000|Overall Study|Sponsor Decision|1|||
48928650|NCT00482014|157571453|FG001|Overall Study|Sponsor Decision|2|||
48928651|NCT00482014|157571454|FG002|Overall Study|Sponsor Decision|1|||
48928652|NCT00482014|157571455|FG003|Overall Study|Sponsor Decision|1|||
48928653|NCT01783678|157571458|FG000|Overall Study|Randomized but Not Treated|0|||
48928654|NCT01783678|157571459|FG001|Overall Study|Randomized but Not Treated|0|||
48928655|NCT01783678|157571460|FG002|Overall Study|Randomized but Not Treated|0|||
48928656|NCT01783678|157571461|FG003|Overall Study|Randomized but Not Treated|1|||
48928657|NCT01783678|157571462|FG004|Overall Study|Randomized but Not Treated|0|||
48928658|NCT01783678|157571463|FG005|Overall Study|Randomized but Not Treated|0|||
48928659|NCT01783678|157571458|FG000|Overall Study|Lack of Efficacy|1|||
48928660|NCT01783678|157571459|FG001|Overall Study|Lack of Efficacy|13|||
48928661|NCT01783678|157571460|FG002|Overall Study|Lack of Efficacy|1|||
48928662|NCT01783678|157571461|FG003|Overall Study|Lack of Efficacy|3|||
48928663|NCT01783678|157571462|FG004|Overall Study|Lack of Efficacy|6|||
48928664|NCT01783678|157571463|FG005|Overall Study|Lack of Efficacy|5|||
48928665|NCT01783678|157571458|FG000|Overall Study|Lost to Follow-up|0|||
48928666|NCT01783678|157571459|FG001|Overall Study|Lost to Follow-up|4|||
48928667|NCT01783678|157571460|FG002|Overall Study|Lost to Follow-up|0|||
48928668|NCT01783678|157571461|FG003|Overall Study|Lost to Follow-up|2|||
48928669|NCT01783678|157571462|FG004|Overall Study|Lost to Follow-up|1|||
48928670|NCT01783678|157571463|FG005|Overall Study|Lost to Follow-up|0|||
48928671|NCT01783678|157571458|FG000|Overall Study|Withdrew Consent|1|||
48928672|NCT01783678|157571459|FG001|Overall Study|Withdrew Consent|1|||
48928673|NCT01783678|157571460|FG002|Overall Study|Withdrew Consent|0|||
48928674|NCT01783678|157571461|FG003|Overall Study|Withdrew Consent|2|||
48928675|NCT01783678|157571462|FG004|Overall Study|Withdrew Consent|0|||
48928676|NCT01783678|157571463|FG005|Overall Study|Withdrew Consent|0|||
48928677|NCT02543528|157571464|FG000|Adaptation Period|Unsatisfactory Lens Fitting|0|||
48928678|NCT02543528|157571465|FG001|Adaptation Period|Unsatisfactory Lens Fitting|0|||
48928679|NCT02543528|157571466|FG002|Adaptation Period|Unsatisfactory Lens Fitting|0|||
48928680|NCT02543528|157571467|FG003|Adaptation Period|Unsatisfactory Lens Fitting|0|||
48928681|NCT02543528|157571468|FG004|Adaptation Period|Unsatisfactory Lens Fitting|2|||
48928682|NCT02543528|157571464|FG000|Adaptation Period|Lens Handling Difficultes|0|||
48928683|NCT02543528|157571465|FG001|Adaptation Period|Lens Handling Difficultes|0|||
48928684|NCT02543528|157571466|FG002|Adaptation Period|Lens Handling Difficultes|0|||
48928685|NCT02543528|157571467|FG003|Adaptation Period|Lens Handling Difficultes|0|||
48928686|NCT02543528|157571468|FG004|Adaptation Period|Lens Handling Difficultes|8|||
48928687|NCT02543528|157571464|FG000|Adaptation Period|Lost to Follow-up|0|||
48928688|NCT02543528|157571465|FG001|Adaptation Period|Lost to Follow-up|0|||
48928689|NCT02543528|157571466|FG002|Adaptation Period|Lost to Follow-up|0|||
48928690|NCT02543528|157571467|FG003|Adaptation Period|Lost to Follow-up|0|||
48928691|NCT02543528|157571468|FG004|Adaptation Period|Lost to Follow-up|14|||
48928692|NCT02543528|157571464|FG000|Adaptation Period|Adverse Event|0|||
48928693|NCT02543528|157571465|FG001|Adaptation Period|Adverse Event|0|||
48928694|NCT02543528|157571466|FG002|Adaptation Period|Adverse Event|0|||
48928695|NCT02543528|157571467|FG003|Adaptation Period|Adverse Event|0|||
48928696|NCT02543528|157571468|FG004|Adaptation Period|Adverse Event|2|||
48928697|NCT02543528|157571464|FG000|Extended Wear Period|Adverse Event|17|||
48928698|NCT02543528|157571465|FG001|Extended Wear Period|Adverse Event|11|||
48928699|NCT02543528|157571466|FG002|Extended Wear Period|Adverse Event|16|||
48928700|NCT02543528|157571467|FG003|Extended Wear Period|Adverse Event|3|||
48928701|NCT02543528|157571468|FG004|Extended Wear Period|Adverse Event|0|||
48928702|NCT02543528|157571464|FG000|Extended Wear Period|Missed too many scheduled visits|0|||
48928703|NCT02543528|157571465|FG001|Extended Wear Period|Missed too many scheduled visits|0|||
48928704|NCT02543528|157571466|FG002|Extended Wear Period|Missed too many scheduled visits|1|||
48928705|NCT02543528|157571467|FG003|Extended Wear Period|Missed too many scheduled visits|3|||
48928706|NCT02543528|157571468|FG004|Extended Wear Period|Missed too many scheduled visits|0|||
48928707|NCT02543528|157571464|FG000|Extended Wear Period|Unsatisfactory Lens Fitting|1|||
48928708|NCT02543528|157571465|FG001|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
48928709|NCT02543528|157571466|FG002|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
48928710|NCT02543528|157571467|FG003|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
48928711|NCT02543528|157571468|FG004|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
48693064|NCT01400698|156724662|FG004|Overall Study|Adverse Event|0|||
48928712|NCT02543528|157571464|FG000|Extended Wear Period|Lost to Follow-up|0|||
48928713|NCT02543528|157571465|FG001|Extended Wear Period|Lost to Follow-up|1|||
48928714|NCT02543528|157571466|FG002|Extended Wear Period|Lost to Follow-up|2|||
48928715|NCT02543528|157571467|FG003|Extended Wear Period|Lost to Follow-up|1|||
48928716|NCT02543528|157571468|FG004|Extended Wear Period|Lost to Follow-up|0|||
48928717|NCT02543528|157571464|FG000|Extended Wear Period|Withdrawal by Subject|10|||
48928718|NCT02543528|157571465|FG001|Extended Wear Period|Withdrawal by Subject|9|||
48928719|NCT02543528|157571466|FG002|Extended Wear Period|Withdrawal by Subject|4|||
48928720|NCT02543528|157571467|FG003|Extended Wear Period|Withdrawal by Subject|5|||
48928721|NCT02543528|157571468|FG004|Extended Wear Period|Withdrawal by Subject|0|||
48928722|NCT04682405|157571469|FG000|Overall Study|Adverse Event|0|||
48928723|NCT04682405|157571470|FG001|Overall Study|Adverse Event|1|||
48928724|NCT00272038|157571483|FG000|Overall Study|withdrew before they received 2 cycles|7|||
48928725|NCT02740478|157571487|FG000|Overall Study|Withdrawal by Subject|1|||
48928726|NCT01592760|157571488|FG000|24-hour Follow-Up|Lost to Follow-up|4|||
48928727|NCT01592760|157571489|FG001|24-hour Follow-Up|Lost to Follow-up|3|||
48928728|NCT01592760|157571490|FG002|24-hour Follow-Up|Lost to Follow-up|2|||
48928729|NCT02549339|157571491|FG000|3-day Treatment and 8-week Follow-up|Protocol Violation|2|||
48928730|NCT02549339|157571492|FG001|3-day Treatment and 8-week Follow-up|Protocol Violation|0|||
48928731|NCT02549339|157571491|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1|||
48928732|NCT02549339|157571492|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
48928733|NCT02549339|157571491|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
48928734|NCT02549339|157571492|FG001|3-day Treatment and 8-week Follow-up|Other|0|||
48928735|NCT02549339|157571491|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
48928736|NCT02549339|157571492|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2|||
48928737|NCT02549339|157571491|FG000|12-month Follow-up|Lack of Efficacy|0|||
48928738|NCT02549339|157571492|FG001|12-month Follow-up|Lack of Efficacy|2|||
48928739|NCT02549339|157571491|FG000|12-month Follow-up|Withdrawal by Subject|8|||
48928740|NCT02549339|157571492|FG001|12-month Follow-up|Withdrawal by Subject|3|||
48928741|NCT02549339|157571491|FG000|12-month Follow-up|Lost to Follow-up|1|||
48928742|NCT02549339|157571492|FG001|12-month Follow-up|Lost to Follow-up|3|||
48928743|NCT02549339|157571491|FG000|12-month Follow-up|Other|0|||
48928744|NCT02549339|157571492|FG001|12-month Follow-up|Other|3|||
48928745|NCT02415712|157571498|FG000|Overall Study|Protocol Violation|16|||
48928746|NCT03011333|157571503|FG000|Overall Study|Lost to Follow-up|0|||
48928747|NCT03011333|157571504|FG001|Overall Study|Lost to Follow-up|1|||
48928748|NCT03011333|157571505|FG002|Overall Study|Lost to Follow-up|0|||
48928749|NCT03011333|157571506|FG003|Overall Study|Lost to Follow-up|1|||
48928750|NCT03011333|157571507|FG004|Overall Study|Lost to Follow-up|4|||
48928751|NCT03011333|157571508|FG005|Overall Study|Lost to Follow-up|4|||
48928752|NCT03011333|157571509|FG006|Overall Study|Lost to Follow-up|5|||
48928753|NCT04372927|157571511|FG000|Overall Study|Death|1|||
48928754|NCT01639833|157571512|FG000|Overall Study|Death|4|||
48928755|NCT01639833|157571513|FG001|Overall Study|Death|2|||
48928756|NCT01639833|157571512|FG000|Overall Study|Withdrawal by Subject|2|||
48928757|NCT01639833|157571513|FG001|Overall Study|Withdrawal by Subject|2|||
48928758|NCT03033745|157571516|FG000|Overall Study|Protocol Violation|0|||
48928759|NCT03033745|157571517|FG001|Overall Study|Protocol Violation|0|||
48928760|NCT03033745|157571518|FG002|Overall Study|Protocol Violation|1|||
48928761|NCT03033745|157571516|FG000|Overall Study|Adverse Event|1|||
48928762|NCT03033745|157571517|FG001|Overall Study|Adverse Event|0|||
48928763|NCT03033745|157571518|FG002|Overall Study|Adverse Event|1|||
48928764|NCT03033745|157571516|FG000|Overall Study|Withdrawal by Subject|0|||
48928765|NCT03033745|157571517|FG001|Overall Study|Withdrawal by Subject|1|||
48928766|NCT03033745|157571518|FG002|Overall Study|Withdrawal by Subject|0|||
48928767|NCT00343512|157571519|FG000|Overall Study|Withdrawal by Subject|2|||
48928768|NCT00684957|157571520|FG000|Overall Study|Withdrawal by Subject|1|||
48928769|NCT00684957|157571521|FG001|Overall Study|Withdrawal by Subject|1|||
48844325|NCT00087139|157271324|FG000|Overall Study|Withdrawal by Subject|3|||
48844326|NCT00087139|157271325|FG001|Overall Study|Withdrawal by Subject|2|||
48844327|NCT00087139|157271326|FG002|Overall Study|Withdrawal by Subject|2|||
48844328|NCT00087139|157271324|FG000|Overall Study|Physician Decision|1|||
48844329|NCT00087139|157271325|FG001|Overall Study|Physician Decision|1|||
48844330|NCT00087139|157271326|FG002|Overall Study|Physician Decision|1|||
48928770|NCT00684957|157571520|FG000|Overall Study|Lost to Follow-up|1|||
48928771|NCT00684957|157571521|FG001|Overall Study|Lost to Follow-up|0|||
48928772|NCT01114529|157571523|FG000|Completed Study Medication at Month 24|Adverse Event|87|||
48928773|NCT01114529|157571524|FG001|Completed Study Medication at Month 24|Adverse Event|18|||
48928774|NCT01114529|157571525|FG002|Completed Study Medication at Month 24|Adverse Event|17|||
48928775|NCT01114529|157571523|FG000|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6|||
48928776|NCT01114529|157571524|FG001|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0|||
48928777|NCT01114529|157571525|FG002|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1|||
48928778|NCT01114529|157571523|FG000|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3|||
48928779|NCT01114529|157571524|FG001|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0|||
48928780|NCT01114529|157571525|FG002|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1|||
48928781|NCT01114529|157571523|FG000|Completed Study Medication at Month 24|Lack of Efficacy|2|||
48928782|NCT01114529|157571524|FG001|Completed Study Medication at Month 24|Lack of Efficacy|1|||
48928783|NCT01114529|157571525|FG002|Completed Study Medication at Month 24|Lack of Efficacy|2|||
48928784|NCT01114529|157571523|FG000|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
48928785|NCT01114529|157571524|FG001|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
48928786|NCT01114529|157571525|FG002|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
48928787|NCT01114529|157571523|FG000|Completed Study Medication at Month 24|Withdrawal by Subject|18|||
48928788|NCT01114529|157571524|FG001|Completed Study Medication at Month 24|Withdrawal by Subject|8|||
48928789|NCT01114529|157571525|FG002|Completed Study Medication at Month 24|Withdrawal by Subject|2|||
48928790|NCT01114529|157571523|FG000|Completed Study Medication at Month 24|Lost to Follow-up|1|||
48928791|NCT01114529|157571524|FG001|Completed Study Medication at Month 24|Lost to Follow-up|4|||
48928792|NCT01114529|157571525|FG002|Completed Study Medication at Month 24|Lost to Follow-up|2|||
48928793|NCT01114529|157571523|FG000|Completed Study Medication at Month 24|Administrative problems|2|||
48928794|NCT01114529|157571524|FG001|Completed Study Medication at Month 24|Administrative problems|1|||
48928795|NCT01114529|157571525|FG002|Completed Study Medication at Month 24|Administrative problems|2|||
48928796|NCT01114529|157571523|FG000|Completed Study Medication at Month 24|Death|2|||
48928797|NCT01114529|157571524|FG001|Completed Study Medication at Month 24|Death|1|||
48928798|NCT01114529|157571525|FG002|Completed Study Medication at Month 24|Death|2|||
48928799|NCT01114529|157571523|FG000|Completed Study Medication at Month 24|Graft loss|0|||
48928800|NCT01114529|157571524|FG001|Completed Study Medication at Month 24|Graft loss|2|||
48928801|NCT01114529|157571525|FG002|Completed Study Medication at Month 24|Graft loss|0|||
48928802|NCT01114529|157571523|FG000|Completed Study Medication at Month 24|Protocol Violation|0|||
48928803|NCT01114529|157571524|FG001|Completed Study Medication at Month 24|Protocol Violation|5|||
48928804|NCT01114529|157571525|FG002|Completed Study Medication at Month 24|Protocol Violation|2|||
48928805|NCT01114529|157571523|FG000|Completed Study Medication at Month 24|Missing|2|||
48928806|NCT01114529|157571524|FG001|Completed Study Medication at Month 24|Missing|0|||
48928807|NCT01114529|157571525|FG002|Completed Study Medication at Month 24|Missing|0|||
48928808|NCT01114529|157571523|FG000|Completed Study Phase at Month 24|Withdrawal by Subject|18|||
48928809|NCT01114529|157571524|FG001|Completed Study Phase at Month 24|Withdrawal by Subject|6|||
48928810|NCT01114529|157571525|FG002|Completed Study Phase at Month 24|Withdrawal by Subject|3|||
48928811|NCT01114529|157571523|FG000|Completed Study Phase at Month 24|Lost to Follow-up|10|||
48928812|NCT01114529|157571524|FG001|Completed Study Phase at Month 24|Lost to Follow-up|5|||
48928813|NCT01114529|157571525|FG002|Completed Study Phase at Month 24|Lost to Follow-up|7|||
48928814|NCT01114529|157571523|FG000|Completed Study Phase at Month 24|Death|8|||
48928815|NCT01114529|157571524|FG001|Completed Study Phase at Month 24|Death|5|||
48928816|NCT01114529|157571525|FG002|Completed Study Phase at Month 24|Death|4|||
48928817|NCT01114529|157571523|FG000|Completed Study Phase at Month 24|Other|2|||
48928818|NCT01114529|157571524|FG001|Completed Study Phase at Month 24|Other|0|||
48928819|NCT01114529|157571525|FG002|Completed Study Phase at Month 24|Other|0|||
48928820|NCT01114529|157571523|FG000|Completed Study Phase at Month 24|Missing|2|||
48928821|NCT01114529|157571524|FG001|Completed Study Phase at Month 24|Missing|0|||
48928822|NCT01114529|157571525|FG002|Completed Study Phase at Month 24|Missing|0|||
48928823|NCT00331409|157571526|FG000|Overall Study|Lack of Efficacy|4|||
48928824|NCT03222349|157571527|FG000|Overall Study|Treatment B not done|5|||
48928825|NCT03222349|157571528|FG001|Overall Study|Treatment B not done|0|||
48928826|NCT03222349|157571527|FG000|Overall Study|Lost to Follow-up|1|||
48928827|NCT03222349|157571528|FG001|Overall Study|Lost to Follow-up|2|||
48928828|NCT03222349|157571527|FG000|Overall Study|Withdrawal by Subject|1|||
48928829|NCT03222349|157571528|FG001|Overall Study|Withdrawal by Subject|0|||
48928830|NCT03222349|157571527|FG000|Overall Study|Treatment A not done|0|||
48928831|NCT03222349|157571528|FG001|Overall Study|Treatment A not done|5|||
48928832|NCT03222349|157571527|FG000|Overall Study|Study terminated by sponsor|1|||
48928833|NCT03222349|157571528|FG001|Overall Study|Study terminated by sponsor|0|||
48928834|NCT01699087|157571529|FG000|Overall Study|Lost to Follow-up|7|||
48928835|NCT01699087|157571529|FG000|Overall Study|Screen failure (prior to treatment)|15|||
48928836|NCT01699087|157571529|FG000|Overall Study|Unable to make future visits|2|||
48928837|NCT02623335|157571530|FG000|Overall Study|Death|8|||
48928838|NCT02623335|157571531|FG001|Overall Study|Death|7|||
48928839|NCT02623335|157571530|FG000|Overall Study|Lost to Follow-up|15|||
48928840|NCT02623335|157571531|FG001|Overall Study|Lost to Follow-up|23|||
48928841|NCT02623335|157571530|FG000|Overall Study|Withdrawal by Subject|2|||
48928842|NCT02623335|157571531|FG001|Overall Study|Withdrawal by Subject|5|||
48928843|NCT02623335|157571530|FG000|Overall Study|Protocol Violation|2|||
48928844|NCT02623335|157571531|FG001|Overall Study|Protocol Violation|1|||
48928845|NCT00820755|157571534|FG000|Period 1: Combination Therapy Phase|Adverse Event|77|||
48844331|NCT00087139|157271324|FG000|Overall Study|Disease progression|9|||
48844332|NCT00087139|157271325|FG001|Overall Study|Disease progression|19|||
48844333|NCT00087139|157271326|FG002|Overall Study|Disease progression|12|||
48844334|NCT00087139|157271324|FG000|Overall Study|Ineligible|4|||
48844335|NCT00087139|157271325|FG001|Overall Study|Ineligible|7|||
48844336|NCT00087139|157271326|FG002|Overall Study|Ineligible|4|||
48844337|NCT00087139|157271324|FG000|Overall Study|Symptomatic deterioration|1|||
48844338|NCT00087139|157271325|FG001|Overall Study|Symptomatic deterioration|1|||
48844339|NCT00087139|157271326|FG002|Overall Study|Symptomatic deterioration|3|||
48844340|NCT00087139|157271324|FG000|Overall Study|Use of coumadin|1|||
48844341|NCT00087139|157271325|FG001|Overall Study|Use of coumadin|0|||
48928846|NCT00820755|157571535|FG001|Period 1: Combination Therapy Phase|Adverse Event|0|||
48928847|NCT00820755|157571536|FG002|Period 1: Combination Therapy Phase|Adverse Event|0|||
48928848|NCT00820755|157571534|FG000|Period 1: Combination Therapy Phase|Death|28|||
48928849|NCT00820755|157571535|FG001|Period 1: Combination Therapy Phase|Death|0|||
48928850|NCT00820755|157571536|FG002|Period 1: Combination Therapy Phase|Death|0|||
48928851|NCT00820755|157571534|FG000|Period 1: Combination Therapy Phase|Protocol Violation|4|||
48928852|NCT00820755|157571535|FG001|Period 1: Combination Therapy Phase|Protocol Violation|0|||
48928853|NCT00820755|157571536|FG002|Period 1: Combination Therapy Phase|Protocol Violation|0|||
48928854|NCT00820755|157571534|FG000|Period 1: Combination Therapy Phase|Lost to Follow-up|1|||
48928855|NCT00820755|157571535|FG001|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
48928856|NCT00820755|157571536|FG002|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
48928857|NCT00820755|157571534|FG000|Period 1: Combination Therapy Phase|Withdrawal by Subject|21|||
48928858|NCT00820755|157571535|FG001|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
48928859|NCT00820755|157571536|FG002|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
48928860|NCT00820755|157571534|FG000|Period 1: Combination Therapy Phase|Progressive disease|114|||
48928861|NCT00820755|157571535|FG001|Period 1: Combination Therapy Phase|Progressive disease|0|||
48928862|NCT00820755|157571536|FG002|Period 1: Combination Therapy Phase|Progressive disease|0|||
48928863|NCT00820755|157571534|FG000|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14|||
48928864|NCT00820755|157571535|FG001|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
48928865|NCT00820755|157571536|FG002|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
48928866|NCT00820755|157571534|FG000|Period 1: Combination Therapy Phase|Other|11|||
48928867|NCT00820755|157571535|FG001|Period 1: Combination Therapy Phase|Other|0|||
48928868|NCT00820755|157571536|FG002|Period 1: Combination Therapy Phase|Other|0|||
48928869|NCT00820755|157571534|FG000|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0|||
48928870|NCT00820755|157571535|FG001|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
48928871|NCT00820755|157571536|FG002|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
48928872|NCT01014585|157571537|FG000|Overall Study|Adverse Event|0|||
48928873|NCT01014585|157571538|FG001|Overall Study|Adverse Event|2|||
48928874|NCT01014585|157571539|FG002|Overall Study|Adverse Event|0|||
48928875|NCT01014585|157571540|FG003|Overall Study|Adverse Event|3|||
48928876|NCT01014585|157571537|FG000|Overall Study|Withdrawal by Subject|2|||
48928877|NCT01014585|157571538|FG001|Overall Study|Withdrawal by Subject|0|||
48928878|NCT01014585|157571539|FG002|Overall Study|Withdrawal by Subject|1|||
48928879|NCT01014585|157571540|FG003|Overall Study|Withdrawal by Subject|3|||
48928880|NCT01014585|157571537|FG000|Overall Study|Lost to Follow-up|0|||
48928881|NCT01014585|157571538|FG001|Overall Study|Lost to Follow-up|0|||
48928882|NCT01014585|157571539|FG002|Overall Study|Lost to Follow-up|0|||
48928883|NCT01014585|157571540|FG003|Overall Study|Lost to Follow-up|2|||
48928884|NCT01014585|157571537|FG000|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18|||
48928885|NCT01014585|157571538|FG001|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23|||
48928886|NCT01014585|157571539|FG002|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
48693065|NCT01400698|156724663|FG005|Overall Study|Adverse Event|0|||
48928887|NCT01014585|157571540|FG003|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
48928888|NCT01465659|157571546|FG000|Completed 1 Cycle of Treatment|Death|0|||
48928889|NCT01465659|157571547|FG001|Completed 1 Cycle of Treatment|Death|1|||
48928890|NCT01465659|157571548|FG002|Completed 1 Cycle of Treatment|Death|0|||
48928891|NCT01465659|157571549|FG003|Completed 1 Cycle of Treatment|Death|0|||
48928892|NCT01465659|157571546|FG000|Completed 1 Cycle of Treatment|Adverse Event|0|||
48928893|NCT01465659|157571547|FG001|Completed 1 Cycle of Treatment|Adverse Event|0|||
48928894|NCT01465659|157571548|FG002|Completed 1 Cycle of Treatment|Adverse Event|0|||
48928895|NCT01465659|157571549|FG003|Completed 1 Cycle of Treatment|Adverse Event|1|||
48928896|NCT01465659|157571546|FG000|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
48928897|NCT01465659|157571547|FG001|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0|||
48928898|NCT01465659|157571548|FG002|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
48928899|NCT01465659|157571549|FG003|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
48928900|NCT01465659|157571546|FG000|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
48928901|NCT01465659|157571547|FG001|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
48928902|NCT01465659|157571548|FG002|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
48928903|NCT01465659|157571549|FG003|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
48928904|NCT01465659|157571546|FG000|Completed Follow for 1 Year|Death|6|||
48928905|NCT01465659|157571547|FG001|Completed Follow for 1 Year|Death|3|||
48693066|NCT01400698|156724658|FG000|Overall Study|Other|4|||
48844342|NCT00087139|157271326|FG002|Overall Study|Use of coumadin|0|||
48844343|NCT00087139|157271324|FG000|Overall Study|Response achieved|0|||
48844344|NCT00087139|157271325|FG001|Overall Study|Response achieved|1|||
48844345|NCT00087139|157271326|FG002|Overall Study|Response achieved|0|||
48844346|NCT00087139|157271324|FG000|Overall Study|Extradural disease|0|||
48844347|NCT00087139|157271325|FG001|Overall Study|Extradural disease|0|||
48844348|NCT00087139|157271326|FG002|Overall Study|Extradural disease|1|||
48844349|NCT00419341|157271329|FG000|Wash in/Wash Out Period|Withdrawal by Subject|8|||
48844350|NCT00419341|157271329|FG000|Wash in/Wash Out Period|Adverse Event|2|||
48844351|NCT00419341|157271329|FG000|Wash in/Wash Out Period|Disqualifying laboratory results|1|||
48844352|NCT00419341|157271329|FG000|Efficacy Period|Withdrawal by Subject|6|||
48844353|NCT00419341|157271329|FG000|Efficacy Period|Protocol Violation|1|||
48844354|NCT00419341|157271329|FG000|Efficacy Period|Lost to Follow-up|1|||
48844355|NCT00419341|157271329|FG000|Efficacy Period|Non-compliance|1|||
48844356|NCT00419341|157271329|FG000|Efficacy Period|Termination of study site|1|||
48844357|NCT02178098|157271333|FG000|Overall Study|Withdrawal by Subject|0|||
48844358|NCT02178098|157271334|FG001|Overall Study|Withdrawal by Subject|6|||
48844359|NCT02178098|157271333|FG000|Overall Study|Adverse Event|1|||
48844360|NCT02178098|157271334|FG001|Overall Study|Adverse Event|2|||
48844361|NCT02178098|157271333|FG000|Overall Study|Protocol Violation|1|||
48844362|NCT02178098|157271334|FG001|Overall Study|Protocol Violation|1|||
48844363|NCT02178098|157271333|FG000|Overall Study|Lost to Follow-up|0|||
48844364|NCT02178098|157271334|FG001|Overall Study|Lost to Follow-up|1|||
48844365|NCT02178098|157271333|FG000|Overall Study|Sponsor Request|1|||
48844366|NCT02178098|157271334|FG001|Overall Study|Sponsor Request|0|||
48844367|NCT02178098|157271333|FG000|Overall Study|Other|2|||
48844368|NCT02178098|157271334|FG001|Overall Study|Other|2|||
48844369|NCT01044303|157271336|FG000|Overall Study|Lost to Follow-up|2|||
48844370|NCT00761189|157271339|FG000|Overall Study|Adverse Event|42|||
48844371|NCT00761189|157271339|FG000|Overall Study|Lack of Efficacy|45|||
48844372|NCT00761189|157271339|FG000|Overall Study|Lost to Follow-up|36|||
48844373|NCT00761189|157271339|FG000|Overall Study|Withdrawal by Subject|49|||
48844374|NCT00761189|157271339|FG000|Overall Study|Other|13|||
48844375|NCT03101371|157271352|FG000|Overall Study|Physician Decision|0|||
48844376|NCT03101371|157271353|FG001|Overall Study|Physician Decision|1|||
48844377|NCT03101371|157271352|FG000|Overall Study|Lost to Follow-up|1|||
48844378|NCT03101371|157271353|FG001|Overall Study|Lost to Follow-up|4|||
48844379|NCT03101371|157271352|FG000|Overall Study|Did not meet eligibility criteria|2|||
48844380|NCT03101371|157271353|FG001|Overall Study|Did not meet eligibility criteria|1|||
48844381|NCT01494922|157271354|FG000|Overall Study|Adverse Event|1|||
48844382|NCT00031694|157271355|FG000|Overall Study|Adverse Event|12|||
48844383|NCT00031694|157271355|FG000|Overall Study|Death|2|||
48844384|NCT00031694|157271355|FG000|Overall Study|Withdrawal by Subject|5|||
48844385|NCT01925339|157271356|FG000|Overall Study|Adverse Event|2|||
48844386|NCT01925339|157271357|FG001|Overall Study|Adverse Event|0|||
48844387|NCT03527160|157271364|FG000|Overall Study|No urine collected|13|||
48928906|NCT01465659|157571548|FG002|Completed Follow for 1 Year|Death|2|||
48928907|NCT01465659|157571549|FG003|Completed Follow for 1 Year|Death|4|||
48928908|NCT02658812|157571550|FG000|Overall Study|Disease Progression|7|||
48928909|NCT02658812|157571550|FG000|Overall Study|Unrelated to study treatment|1|||
48928910|NCT02658812|157571550|FG000|Overall Study|Adverse Event|1|||
48928911|NCT01194440|157571551|FG000|Baseline (First Dose)|Reason not specified|4|||
48928912|NCT01194440|157571551|FG000|Baseline (First Dose)|Lack of Efficacy|1|||
48928913|NCT01194440|157571551|FG000|Baseline (First Dose)|Change in therapy|1|||
48928914|NCT01194440|157571551|FG000|Baseline (First Dose)|Adverse Event|1|||
48928915|NCT01194440|157571551|FG000|6-months (2nd Dose)|Change in therapy|4|||
48928916|NCT00686647|157571558|FG000|Overall Study|Lost to Follow-up|1|||
48928917|NCT00686647|157571558|FG000|Overall Study|Death|1|||
48928918|NCT01116544|157571561|FG000|Overall Study|Protocol Violation|1|||
48928919|NCT01116544|157571562|FG001|Overall Study|Protocol Violation|0|||
48928920|NCT01116544|157571561|FG000|Overall Study|Withdrawal by Subject|1|||
48928921|NCT01116544|157571562|FG001|Overall Study|Withdrawal by Subject|1|||
48928922|NCT02183519|157571566|FG000|Overall Study|computer error|3|||
48928923|NCT02183519|157571567|FG001|Overall Study|computer error|0|||
48928924|NCT02183519|157571566|FG000|Overall Study|Did not respond to cough inducter|0|||
48928925|NCT02183519|157571567|FG001|Overall Study|Did not respond to cough inducter|3|||
48928926|NCT02899156|157571568|FG000|Overall Study|Death|1|||
48928927|NCT02899156|157571569|FG001|Overall Study|Death|0|||
48928928|NCT02899156|157571568|FG000|Overall Study|Physician Decision|0|||
48928929|NCT02899156|157571569|FG001|Overall Study|Physician Decision|1|||
48928930|NCT02901431|157571570|FG000|PK Part|Adverse Event|0|||
48928931|NCT02901431|157571571|FG001|PK Part|Adverse Event|1|||
48928932|NCT02901431|157571572|FG002|PK Part|Adverse Event|0|||
48928933|NCT02901431|157571573|FG003|PK Part|Adverse Event|0|||
48928934|NCT02901431|157571574|FG004|PK Part|Adverse Event|0|||
48928935|NCT02901431|157571575|FG005|PK Part|Adverse Event|0|||
48928936|NCT02901431|157571576|FG006|PK Part|Adverse Event|0|||
48928937|NCT02901431|157571577|FG007|PK Part|Adverse Event|0|||
48928938|NCT02901431|157571578|FG008|PK Part|Adverse Event|0|||
48928939|NCT02901431|157571579|FG009|PK Part|Adverse Event|0|||
48928940|NCT02901431|157571580|FG010|PK Part|Adverse Event|0|||
48928941|NCT02901431|157571581|FG011|PK Part|Adverse Event|0|||
48928942|NCT02901431|157571582|FG012|PK Part|Adverse Event|0|||
48928943|NCT02901431|157571570|FG000|PK Part|Lost to Follow-up|0|||
48928944|NCT02901431|157571571|FG001|PK Part|Lost to Follow-up|0|||
48928945|NCT02901431|157571572|FG002|PK Part|Lost to Follow-up|1|||
48928946|NCT02901431|157571573|FG003|PK Part|Lost to Follow-up|0|||
48928947|NCT02901431|157571574|FG004|PK Part|Lost to Follow-up|0|||
48928948|NCT02901431|157571575|FG005|PK Part|Lost to Follow-up|0|||
48928949|NCT02901431|157571576|FG006|PK Part|Lost to Follow-up|0|||
48928950|NCT02901431|157571577|FG007|PK Part|Lost to Follow-up|0|||
48928951|NCT02901431|157571578|FG008|PK Part|Lost to Follow-up|0|||
48928952|NCT02901431|157571579|FG009|PK Part|Lost to Follow-up|0|||
48928953|NCT02901431|157571580|FG010|PK Part|Lost to Follow-up|0|||
48928954|NCT02901431|157571581|FG011|PK Part|Lost to Follow-up|0|||
48928955|NCT02901431|157571582|FG012|PK Part|Lost to Follow-up|0|||
48928956|NCT02901431|157571570|FG000|PK Part|Pending IMC/SOC Dose Confirmation|2|||
48928957|NCT02901431|157571571|FG001|PK Part|Pending IMC/SOC Dose Confirmation|0|||
48928958|NCT02901431|157571572|FG002|PK Part|Pending IMC/SOC Dose Confirmation|0|||
48928959|NCT02901431|157571573|FG003|PK Part|Pending IMC/SOC Dose Confirmation|0|||
48928960|NCT02901431|157571574|FG004|PK Part|Pending IMC/SOC Dose Confirmation|0|||
48928961|NCT02901431|157571575|FG005|PK Part|Pending IMC/SOC Dose Confirmation|0|||
48928962|NCT02901431|157571576|FG006|PK Part|Pending IMC/SOC Dose Confirmation|0|||
48928963|NCT02901431|157571577|FG007|PK Part|Pending IMC/SOC Dose Confirmation|0|||
48928964|NCT02901431|157571578|FG008|PK Part|Pending IMC/SOC Dose Confirmation|0|||
48928965|NCT02901431|157571579|FG009|PK Part|Pending IMC/SOC Dose Confirmation|0|||
48928966|NCT02901431|157571580|FG010|PK Part|Pending IMC/SOC Dose Confirmation|0|||
48928967|NCT02901431|157571581|FG011|PK Part|Pending IMC/SOC Dose Confirmation|0|||
48928968|NCT02901431|157571582|FG012|PK Part|Pending IMC/SOC Dose Confirmation|0|||
48928969|NCT02901431|157571570|FG000|PK Part|Pending dose confirmation|0|||
48928970|NCT02901431|157571571|FG001|PK Part|Pending dose confirmation|1|||
48928971|NCT02901431|157571572|FG002|PK Part|Pending dose confirmation|0|||
48928972|NCT02901431|157571573|FG003|PK Part|Pending dose confirmation|0|||
48928973|NCT02901431|157571574|FG004|PK Part|Pending dose confirmation|0|||
48928974|NCT02901431|157571575|FG005|PK Part|Pending dose confirmation|0|||
48928975|NCT02901431|157571576|FG006|PK Part|Pending dose confirmation|0|||
48928976|NCT02901431|157571577|FG007|PK Part|Pending dose confirmation|0|||
48928977|NCT02901431|157571578|FG008|PK Part|Pending dose confirmation|0|||
48928978|NCT02901431|157571579|FG009|PK Part|Pending dose confirmation|0|||
48928979|NCT02901431|157571580|FG010|PK Part|Pending dose confirmation|0|||
48928980|NCT02901431|157571581|FG011|PK Part|Pending dose confirmation|0|||
48928981|NCT02901431|157571582|FG012|PK Part|Pending dose confirmation|0|||
48928982|NCT02901431|157571570|FG000|PK Part|8 weeks of treatment ran out|2|||
48928983|NCT02901431|157571571|FG001|PK Part|8 weeks of treatment ran out|0|||
48928984|NCT02901431|157571572|FG002|PK Part|8 weeks of treatment ran out|0|||
48928985|NCT02901431|157571573|FG003|PK Part|8 weeks of treatment ran out|0|||
48928986|NCT02901431|157571574|FG004|PK Part|8 weeks of treatment ran out|0|||
48928987|NCT02901431|157571575|FG005|PK Part|8 weeks of treatment ran out|0|||
48928988|NCT02901431|157571576|FG006|PK Part|8 weeks of treatment ran out|0|||
48928989|NCT02901431|157571577|FG007|PK Part|8 weeks of treatment ran out|0|||
48928990|NCT02901431|157571578|FG008|PK Part|8 weeks of treatment ran out|0|||
48928991|NCT02901431|157571579|FG009|PK Part|8 weeks of treatment ran out|0|||
48928992|NCT02901431|157571580|FG010|PK Part|8 weeks of treatment ran out|0|||
48928993|NCT02901431|157571581|FG011|PK Part|8 weeks of treatment ran out|0|||
48928994|NCT02901431|157571582|FG012|PK Part|8 weeks of treatment ran out|0|||
48928995|NCT02901431|157571570|FG000|PK Part|Stopped treatment after 8 weeks|1|||
48928996|NCT02901431|157571571|FG001|PK Part|Stopped treatment after 8 weeks|0|||
48928997|NCT02901431|157571572|FG002|PK Part|Stopped treatment after 8 weeks|1|||
48928998|NCT02901431|157571573|FG003|PK Part|Stopped treatment after 8 weeks|0|||
48928999|NCT02901431|157571574|FG004|PK Part|Stopped treatment after 8 weeks|0|||
48929000|NCT02901431|157571575|FG005|PK Part|Stopped treatment after 8 weeks|0|||
48929001|NCT02901431|157571576|FG006|PK Part|Stopped treatment after 8 weeks|0|||
48929002|NCT02901431|157571577|FG007|PK Part|Stopped treatment after 8 weeks|0|||
48929003|NCT02901431|157571578|FG008|PK Part|Stopped treatment after 8 weeks|0|||
48929004|NCT02901431|157571579|FG009|PK Part|Stopped treatment after 8 weeks|0|||
48929005|NCT02901431|157571580|FG010|PK Part|Stopped treatment after 8 weeks|0|||
48929006|NCT02901431|157571581|FG011|PK Part|Stopped treatment after 8 weeks|0|||
48929007|NCT02901431|157571582|FG012|PK Part|Stopped treatment after 8 weeks|0|||
48929008|NCT02901431|157571570|FG000|PK Part|Stopped on Sponsor instruction pending dose confirmation|1|||
48929009|NCT02901431|157571571|FG001|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
48929010|NCT02901431|157571572|FG002|PK Part|Stopped on Sponsor instruction pending dose confirmation|4|||
48929011|NCT02901431|157571573|FG003|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
48929012|NCT02901431|157571574|FG004|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
48929013|NCT02901431|157571575|FG005|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
48929014|NCT02901431|157571576|FG006|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
48929015|NCT02901431|157571577|FG007|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
48929016|NCT02901431|157571578|FG008|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
48929017|NCT02901431|157571579|FG009|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
48929018|NCT02901431|157571580|FG010|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
48929019|NCT02901431|157571581|FG011|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
48929020|NCT02901431|157571582|FG012|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
48929021|NCT02901431|157571570|FG000|PK Part|Discontinued per Sponsor|0|||
48929022|NCT02901431|157571571|FG001|PK Part|Discontinued per Sponsor|3|||
48929023|NCT02901431|157571572|FG002|PK Part|Discontinued per Sponsor|0|||
48929024|NCT02901431|157571573|FG003|PK Part|Discontinued per Sponsor|0|||
48929025|NCT02901431|157571574|FG004|PK Part|Discontinued per Sponsor|0|||
48929026|NCT02901431|157571575|FG005|PK Part|Discontinued per Sponsor|0|||
48929027|NCT02901431|157571576|FG006|PK Part|Discontinued per Sponsor|0|||
48929028|NCT02901431|157571577|FG007|PK Part|Discontinued per Sponsor|0|||
48929029|NCT02901431|157571578|FG008|PK Part|Discontinued per Sponsor|0|||
48929030|NCT02901431|157571579|FG009|PK Part|Discontinued per Sponsor|0|||
48929031|NCT02901431|157571580|FG010|PK Part|Discontinued per Sponsor|0|||
48929032|NCT02901431|157571581|FG011|PK Part|Discontinued per Sponsor|0|||
48929033|NCT02901431|157571582|FG012|PK Part|Discontinued per Sponsor|0|||
48929034|NCT02901431|157571570|FG000|PK Part|Withdrawal by Subject|1|||
48929035|NCT02901431|157571571|FG001|PK Part|Withdrawal by Subject|1|||
48929036|NCT02901431|157571572|FG002|PK Part|Withdrawal by Subject|3|||
48929037|NCT02901431|157571573|FG003|PK Part|Withdrawal by Subject|0|||
48929038|NCT02901431|157571574|FG004|PK Part|Withdrawal by Subject|0|||
48929039|NCT02901431|157571575|FG005|PK Part|Withdrawal by Subject|0|||
48929040|NCT02901431|157571576|FG006|PK Part|Withdrawal by Subject|0|||
48929041|NCT02901431|157571577|FG007|PK Part|Withdrawal by Subject|0|||
48929042|NCT02901431|157571578|FG008|PK Part|Withdrawal by Subject|0|||
48929043|NCT02901431|157571579|FG009|PK Part|Withdrawal by Subject|0|||
48929044|NCT02901431|157571580|FG010|PK Part|Withdrawal by Subject|0|||
48929045|NCT02901431|157571581|FG011|PK Part|Withdrawal by Subject|0|||
48929046|NCT02901431|157571582|FG012|PK Part|Withdrawal by Subject|0|||
48929047|NCT02901431|157571570|FG000|Main Treatment Part|Adverse Event|0|||
48929048|NCT02901431|157571571|FG001|Main Treatment Part|Adverse Event|0|||
48929049|NCT02901431|157571572|FG002|Main Treatment Part|Adverse Event|0|||
48929050|NCT02901431|157571573|FG003|Main Treatment Part|Adverse Event|3|||
48929051|NCT02901431|157571574|FG004|Main Treatment Part|Adverse Event|3|||
48929052|NCT02901431|157571575|FG005|Main Treatment Part|Adverse Event|4|||
48929053|NCT02901431|157571576|FG006|Main Treatment Part|Adverse Event|1|||
48929054|NCT02901431|157571577|FG007|Main Treatment Part|Adverse Event|0|||
48929055|NCT02901431|157571578|FG008|Main Treatment Part|Adverse Event|0|||
48929056|NCT02901431|157571579|FG009|Main Treatment Part|Adverse Event|0|||
48929057|NCT02901431|157571580|FG010|Main Treatment Part|Adverse Event|0|||
48929058|NCT02901431|157571581|FG011|Main Treatment Part|Adverse Event|0|||
48929059|NCT02901431|157571582|FG012|Main Treatment Part|Adverse Event|0|||
48929060|NCT02901431|157571570|FG000|Main Treatment Part|Lack of Efficacy|0|||
48929061|NCT02901431|157571571|FG001|Main Treatment Part|Lack of Efficacy|0|||
48929062|NCT02901431|157571572|FG002|Main Treatment Part|Lack of Efficacy|0|||
48929063|NCT02901431|157571573|FG003|Main Treatment Part|Lack of Efficacy|1|||
48929064|NCT02901431|157571574|FG004|Main Treatment Part|Lack of Efficacy|0|||
48929065|NCT02901431|157571575|FG005|Main Treatment Part|Lack of Efficacy|0|||
48929066|NCT02901431|157571576|FG006|Main Treatment Part|Lack of Efficacy|0|||
48929067|NCT02901431|157571577|FG007|Main Treatment Part|Lack of Efficacy|0|||
48929068|NCT02901431|157571578|FG008|Main Treatment Part|Lack of Efficacy|0|||
48929069|NCT02901431|157571579|FG009|Main Treatment Part|Lack of Efficacy|0|||
48929070|NCT02901431|157571580|FG010|Main Treatment Part|Lack of Efficacy|0|||
48693067|NCT01400698|156724659|FG001|Overall Study|Other|2|||
48929071|NCT02901431|157571581|FG011|Main Treatment Part|Lack of Efficacy|0|||
48929072|NCT02901431|157571582|FG012|Main Treatment Part|Lack of Efficacy|0|||
48929073|NCT02901431|157571570|FG000|Main Treatment Part|Lost to Follow-up|0|||
48929074|NCT02901431|157571571|FG001|Main Treatment Part|Lost to Follow-up|0|||
48929075|NCT02901431|157571572|FG002|Main Treatment Part|Lost to Follow-up|0|||
48929076|NCT02901431|157571573|FG003|Main Treatment Part|Lost to Follow-up|3|||
48929077|NCT02901431|157571574|FG004|Main Treatment Part|Lost to Follow-up|1|||
48929078|NCT02901431|157571575|FG005|Main Treatment Part|Lost to Follow-up|2|||
48929079|NCT02901431|157571576|FG006|Main Treatment Part|Lost to Follow-up|3|||
48929080|NCT02901431|157571577|FG007|Main Treatment Part|Lost to Follow-up|0|||
48929081|NCT02901431|157571578|FG008|Main Treatment Part|Lost to Follow-up|0|||
48929082|NCT02901431|157571579|FG009|Main Treatment Part|Lost to Follow-up|0|||
48929083|NCT02901431|157571580|FG010|Main Treatment Part|Lost to Follow-up|0|||
48929084|NCT02901431|157571581|FG011|Main Treatment Part|Lost to Follow-up|0|||
48929085|NCT02901431|157571582|FG012|Main Treatment Part|Lost to Follow-up|0|||
48929086|NCT02901431|157571570|FG000|Main Treatment Part|Withdrawal by Caregiver|0|||
48929087|NCT02901431|157571571|FG001|Main Treatment Part|Withdrawal by Caregiver|0|||
48929088|NCT02901431|157571572|FG002|Main Treatment Part|Withdrawal by Caregiver|0|||
48929089|NCT02901431|157571573|FG003|Main Treatment Part|Withdrawal by Caregiver|0|||
48929090|NCT02901431|157571574|FG004|Main Treatment Part|Withdrawal by Caregiver|0|||
48929091|NCT02901431|157571575|FG005|Main Treatment Part|Withdrawal by Caregiver|1|||
48844388|NCT03527160|157271364|FG000|Overall Study|No clinical serum creatinine collected|6|||
48844389|NCT03527160|157271364|FG000|Overall Study|Did not meet inclusion|2|||
48844390|NCT04048382|157271365|FG000|3-Month Follow Up|Enrolled but did not complete survey|2|||
48844391|NCT04048382|157271366|FG001|3-Month Follow Up|Enrolled but did not complete survey|0|||
48844392|NCT04048382|157271365|FG000|3-Month Follow Up|Withdrawal by Subject|0|||
48844393|NCT04048382|157271366|FG001|3-Month Follow Up|Withdrawal by Subject|1|||
48844394|NCT04048382|157271365|FG000|6-Month Follow up|Enrolled but did not complete survey|2|||
48844395|NCT04048382|157271366|FG001|6-Month Follow up|Enrolled but did not complete survey|0|||
48929092|NCT02901431|157571576|FG006|Main Treatment Part|Withdrawal by Caregiver|0|||
48929093|NCT02901431|157571577|FG007|Main Treatment Part|Withdrawal by Caregiver|0|||
48929094|NCT02901431|157571578|FG008|Main Treatment Part|Withdrawal by Caregiver|0|||
48929095|NCT02901431|157571579|FG009|Main Treatment Part|Withdrawal by Caregiver|0|||
48929096|NCT02901431|157571580|FG010|Main Treatment Part|Withdrawal by Caregiver|0|||
48929097|NCT02901431|157571581|FG011|Main Treatment Part|Withdrawal by Caregiver|0|||
48929098|NCT02901431|157571582|FG012|Main Treatment Part|Withdrawal by Caregiver|0|||
48929099|NCT02901431|157571570|FG000|Main Treatment Part|Physician Decision|0|||
48929100|NCT02901431|157571571|FG001|Main Treatment Part|Physician Decision|0|||
48929101|NCT02901431|157571572|FG002|Main Treatment Part|Physician Decision|0|||
48929102|NCT02901431|157571573|FG003|Main Treatment Part|Physician Decision|1|||
48929103|NCT02901431|157571574|FG004|Main Treatment Part|Physician Decision|0|||
48929104|NCT02901431|157571575|FG005|Main Treatment Part|Physician Decision|0|||
48929105|NCT02901431|157571576|FG006|Main Treatment Part|Physician Decision|1|||
48929106|NCT02901431|157571577|FG007|Main Treatment Part|Physician Decision|0|||
48929107|NCT02901431|157571578|FG008|Main Treatment Part|Physician Decision|0|||
48929108|NCT02901431|157571579|FG009|Main Treatment Part|Physician Decision|0|||
48929109|NCT02901431|157571580|FG010|Main Treatment Part|Physician Decision|0|||
48929110|NCT02901431|157571581|FG011|Main Treatment Part|Physician Decision|0|||
48929111|NCT02901431|157571582|FG012|Main Treatment Part|Physician Decision|0|||
48929112|NCT02901431|157571570|FG000|Main Treatment Part|Withdrawal by Subject|0|||
48929113|NCT02901431|157571571|FG001|Main Treatment Part|Withdrawal by Subject|0|||
48929114|NCT02901431|157571572|FG002|Main Treatment Part|Withdrawal by Subject|0|||
48929115|NCT02901431|157571573|FG003|Main Treatment Part|Withdrawal by Subject|18|||
48929116|NCT02901431|157571574|FG004|Main Treatment Part|Withdrawal by Subject|3|||
48929117|NCT02901431|157571575|FG005|Main Treatment Part|Withdrawal by Subject|5|||
48929118|NCT02901431|157571576|FG006|Main Treatment Part|Withdrawal by Subject|6|||
48929119|NCT02901431|157571577|FG007|Main Treatment Part|Withdrawal by Subject|0|||
48929120|NCT02901431|157571578|FG008|Main Treatment Part|Withdrawal by Subject|0|||
48929121|NCT02901431|157571579|FG009|Main Treatment Part|Withdrawal by Subject|0|||
48929122|NCT02901431|157571580|FG010|Main Treatment Part|Withdrawal by Subject|0|||
48929123|NCT02901431|157571581|FG011|Main Treatment Part|Withdrawal by Subject|0|||
48929124|NCT02901431|157571582|FG012|Main Treatment Part|Withdrawal by Subject|0|||
48929125|NCT02901431|157571570|FG000|Open Label Part|Adverse Event|0|||
48929126|NCT02901431|157571571|FG001|Open Label Part|Adverse Event|0|||
48929127|NCT02901431|157571572|FG002|Open Label Part|Adverse Event|0|||
48929128|NCT02901431|157571573|FG003|Open Label Part|Adverse Event|0|||
48929129|NCT02901431|157571574|FG004|Open Label Part|Adverse Event|0|||
48929130|NCT02901431|157571575|FG005|Open Label Part|Adverse Event|0|||
48929131|NCT02901431|157571576|FG006|Open Label Part|Adverse Event|0|||
48929132|NCT02901431|157571577|FG007|Open Label Part|Adverse Event|0|||
48929133|NCT02901431|157571578|FG008|Open Label Part|Adverse Event|4|||
48929134|NCT02901431|157571579|FG009|Open Label Part|Adverse Event|4|||
48844396|NCT02730871|157271369|FG000|Overall Study|Adverse Event|6|||
48844397|NCT02730871|157271370|FG001|Overall Study|Adverse Event|0|||
48844398|NCT00332241|157272731|FG000|Overall Study|Lack of Efficacy|6|||
48844399|NCT00332241|157272732|FG001|Overall Study|Lack of Efficacy|1|||
48844400|NCT00332241|157272731|FG000|Overall Study|Adverse Event|3|||
48844401|NCT00332241|157272732|FG001|Overall Study|Adverse Event|5|||
48844402|NCT00332241|157272731|FG000|Overall Study|Withdrawal by Subject|2|||
48844403|NCT00332241|157272732|FG001|Overall Study|Withdrawal by Subject|1|||
48844404|NCT00332241|157272731|FG000|Overall Study|Lost to Follow-up|4|||
48844405|NCT00332241|157272732|FG001|Overall Study|Lost to Follow-up|1|||
48844406|NCT02724592|157272733|FG000|Overall Study|Lost to Follow-up|4|||
48844407|NCT02724592|157272734|FG001|Overall Study|Lost to Follow-up|1|||
48844408|NCT02584829|157272738|FG000|Overall Study|Physician Decision|1|||
48844409|NCT02584829|157272739|FG001|Overall Study|Physician Decision|0|||
48844410|NCT02584829|157272738|FG000|Overall Study|Withdrawal by Subject|0|||
48844411|NCT02584829|157272739|FG001|Overall Study|Withdrawal by Subject|1|||
48844412|NCT02584829|157272738|FG000|Overall Study|Progressive Disease|0|||
48844413|NCT02584829|157272739|FG001|Overall Study|Progressive Disease|3|||
48844414|NCT00802464|157272740|FG000|Month 0 - Month 8|Adverse Event|0|||
48929135|NCT02901431|157571580|FG010|Open Label Part|Adverse Event|0|||
48929136|NCT02901431|157571581|FG011|Open Label Part|Adverse Event|4|||
48929137|NCT02901431|157571582|FG012|Open Label Part|Adverse Event|1|||
48929138|NCT02901431|157571570|FG000|Open Label Part|Lost to Follow-up|0|||
48929139|NCT02901431|157571571|FG001|Open Label Part|Lost to Follow-up|0|||
48929140|NCT02901431|157571572|FG002|Open Label Part|Lost to Follow-up|0|||
48929141|NCT02901431|157571573|FG003|Open Label Part|Lost to Follow-up|0|||
48929142|NCT02901431|157571574|FG004|Open Label Part|Lost to Follow-up|0|||
48929143|NCT02901431|157571575|FG005|Open Label Part|Lost to Follow-up|0|||
48929144|NCT02901431|157571576|FG006|Open Label Part|Lost to Follow-up|0|||
48929145|NCT02901431|157571577|FG007|Open Label Part|Lost to Follow-up|0|||
48929146|NCT02901431|157571578|FG008|Open Label Part|Lost to Follow-up|2|||
48929147|NCT02901431|157571579|FG009|Open Label Part|Lost to Follow-up|2|||
48929148|NCT02901431|157571580|FG010|Open Label Part|Lost to Follow-up|1|||
48929149|NCT02901431|157571581|FG011|Open Label Part|Lost to Follow-up|1|||
48929150|NCT02901431|157571582|FG012|Open Label Part|Lost to Follow-up|1|||
48929151|NCT02901431|157571570|FG000|Open Label Part|Physician Decision|0|||
48929152|NCT02901431|157571571|FG001|Open Label Part|Physician Decision|0|||
48929153|NCT02901431|157571572|FG002|Open Label Part|Physician Decision|0|||
48929154|NCT02901431|157571573|FG003|Open Label Part|Physician Decision|0|||
48929155|NCT02901431|157571574|FG004|Open Label Part|Physician Decision|0|||
48929156|NCT02901431|157571575|FG005|Open Label Part|Physician Decision|0|||
48929157|NCT02901431|157571576|FG006|Open Label Part|Physician Decision|0|||
48929158|NCT02901431|157571577|FG007|Open Label Part|Physician Decision|0|||
48929159|NCT02901431|157571578|FG008|Open Label Part|Physician Decision|1|||
48929160|NCT02901431|157571579|FG009|Open Label Part|Physician Decision|1|||
48929161|NCT02901431|157571580|FG010|Open Label Part|Physician Decision|0|||
48929162|NCT02901431|157571581|FG011|Open Label Part|Physician Decision|0|||
48929163|NCT02901431|157571582|FG012|Open Label Part|Physician Decision|0|||
48929164|NCT02901431|157571570|FG000|Open Label Part|Study Terminated By Sponsor|0|||
48929165|NCT02901431|157571571|FG001|Open Label Part|Study Terminated By Sponsor|0|||
48929166|NCT02901431|157571572|FG002|Open Label Part|Study Terminated By Sponsor|0|||
48929167|NCT02901431|157571573|FG003|Open Label Part|Study Terminated By Sponsor|0|||
48929168|NCT02901431|157571574|FG004|Open Label Part|Study Terminated By Sponsor|0|||
48929169|NCT02901431|157571575|FG005|Open Label Part|Study Terminated By Sponsor|0|||
48929170|NCT02901431|157571576|FG006|Open Label Part|Study Terminated By Sponsor|0|||
48929171|NCT02901431|157571577|FG007|Open Label Part|Study Terminated By Sponsor|0|||
48929172|NCT02901431|157571578|FG008|Open Label Part|Study Terminated By Sponsor|35|||
48929173|NCT02901431|157571579|FG009|Open Label Part|Study Terminated By Sponsor|12|||
48929174|NCT02901431|157571580|FG010|Open Label Part|Study Terminated By Sponsor|21|||
48929175|NCT02901431|157571581|FG011|Open Label Part|Study Terminated By Sponsor|31|||
48929176|NCT02901431|157571582|FG012|Open Label Part|Study Terminated By Sponsor|0|||
48929177|NCT02901431|157571570|FG000|Open Label Part|Withdrawal by Subject|0|||
48929178|NCT02901431|157571571|FG001|Open Label Part|Withdrawal by Subject|0|||
48929179|NCT02901431|157571572|FG002|Open Label Part|Withdrawal by Subject|0|||
48929180|NCT02901431|157571573|FG003|Open Label Part|Withdrawal by Subject|0|||
48929181|NCT02901431|157571574|FG004|Open Label Part|Withdrawal by Subject|0|||
48929182|NCT02901431|157571575|FG005|Open Label Part|Withdrawal by Subject|0|||
48929183|NCT02901431|157571576|FG006|Open Label Part|Withdrawal by Subject|0|||
48929184|NCT02901431|157571577|FG007|Open Label Part|Withdrawal by Subject|0|||
48929185|NCT02901431|157571578|FG008|Open Label Part|Withdrawal by Subject|6|||
48929186|NCT02901431|157571579|FG009|Open Label Part|Withdrawal by Subject|5|||
48929187|NCT02901431|157571580|FG010|Open Label Part|Withdrawal by Subject|7|||
48929188|NCT02901431|157571581|FG011|Open Label Part|Withdrawal by Subject|3|||
48929189|NCT02901431|157571582|FG012|Open Label Part|Withdrawal by Subject|1|||
48929190|NCT02307370|157571588|FG000|Overall Study|Death|5|||
48929191|NCT02307370|157571588|FG000|Overall Study|Lost to Follow-up|1|||
48929192|NCT02307370|157571588|FG000|Overall Study|Withdrawal by Subject|1|||
48929193|NCT02307370|157571588|FG000|Overall Study|Declined Addendum ICF|6|||
48929194|NCT02307370|157571588|FG000|Overall Study|No response during telephone contact|5|||
48929195|NCT02307370|157571588|FG000|Overall Study|Protocol Violation|1|||
48929196|NCT01986062|157571591|FG000|Overall Study|Lost to Follow-up|1|||
48929197|NCT01986062|157571592|FG001|Overall Study|Lost to Follow-up|0|||
48929198|NCT01986062|157571591|FG000|Overall Study|Withdrawal by Subject|0|||
48929199|NCT01986062|157571592|FG001|Overall Study|Withdrawal by Subject|1|||
48929200|NCT02425098|157571594|FG000|Overall Study|Lost to Follow-up|7|||
48929201|NCT02425098|157571595|FG001|Overall Study|Lost to Follow-up|7|||
48929202|NCT02425098|157571594|FG000|Overall Study|Withdrawal by Subject|4|||
48929203|NCT02425098|157571595|FG001|Overall Study|Withdrawal by Subject|8|||
48929204|NCT02425098|157571594|FG000|Overall Study|Pregnancy|2|||
48929205|NCT02425098|157571595|FG001|Overall Study|Pregnancy|0|||
48929206|NCT02425098|157571594|FG000|Overall Study|Reason not Specified|0|||
48929207|NCT02425098|157571595|FG001|Overall Study|Reason not Specified|1|||
48929208|NCT03686397|157574903|FG000|Overall Study|Lack of Efficacy|3|||
48929209|NCT03686397|157574904|FG001|Overall Study|Lack of Efficacy|5|||
48929210|NCT03686397|157574903|FG000|Overall Study|Adverse Event|0|||
48929211|NCT03686397|157574904|FG001|Overall Study|Adverse Event|1|||
48929212|NCT03686397|157574903|FG000|Overall Study|Protocol Violation|0|||
48929213|NCT03686397|157574904|FG001|Overall Study|Protocol Violation|1|||
48929214|NCT03686397|157574903|FG000|Overall Study|Withdrawal by Subject|0|||
48929215|NCT03686397|157574904|FG001|Overall Study|Withdrawal by Subject|1|||
48929216|NCT03686397|157574903|FG000|Overall Study|covid pandemic, bacterial ear culture|2|||
48929217|NCT03686397|157574904|FG001|Overall Study|covid pandemic, bacterial ear culture|0|||
48929218|NCT00328627|157574905|FG000|Overall Study|Hyperglycemic Rescue|41|||
48929219|NCT00328627|157574906|FG001|Overall Study|Hyperglycemic Rescue|18|||
48929220|NCT00328627|157574907|FG002|Overall Study|Hyperglycemic Rescue|16|||
48929221|NCT00328627|157574908|FG003|Overall Study|Hyperglycemic Rescue|13|||
48929222|NCT00328627|157574909|FG004|Overall Study|Hyperglycemic Rescue|6|||
48929223|NCT00328627|157574910|FG005|Overall Study|Hyperglycemic Rescue|5|||
48929224|NCT00328627|157574911|FG006|Overall Study|Hyperglycemic Rescue|19|||
48929225|NCT00328627|157574912|FG007|Overall Study|Hyperglycemic Rescue|6|||
48929226|NCT00328627|157574913|FG008|Overall Study|Hyperglycemic Rescue|6|||
48929227|NCT00328627|157574914|FG009|Overall Study|Hyperglycemic Rescue|11|||
48929228|NCT00328627|157574915|FG010|Overall Study|Hyperglycemic Rescue|3|||
48929229|NCT00328627|157574916|FG011|Overall Study|Hyperglycemic Rescue|2|||
48929230|NCT00328627|157574905|FG000|Overall Study|Adverse Event|3|||
48929231|NCT00328627|157574906|FG001|Overall Study|Adverse Event|1|||
48929232|NCT00328627|157574907|FG002|Overall Study|Adverse Event|2|||
48929233|NCT00328627|157574908|FG003|Overall Study|Adverse Event|3|||
48929234|NCT00328627|157574909|FG004|Overall Study|Adverse Event|1|||
48929235|NCT00328627|157574910|FG005|Overall Study|Adverse Event|2|||
48929236|NCT00328627|157574911|FG006|Overall Study|Adverse Event|1|||
48929237|NCT00328627|157574912|FG007|Overall Study|Adverse Event|2|||
48929238|NCT00328627|157574913|FG008|Overall Study|Adverse Event|0|||
48929239|NCT00328627|157574914|FG009|Overall Study|Adverse Event|7|||
48929240|NCT00328627|157574915|FG010|Overall Study|Adverse Event|5|||
48929241|NCT00328627|157574916|FG011|Overall Study|Adverse Event|4|||
48929242|NCT00328627|157574905|FG000|Overall Study|Protocol Violation|2|||
48929243|NCT00328627|157574906|FG001|Overall Study|Protocol Violation|2|||
48929244|NCT00328627|157574907|FG002|Overall Study|Protocol Violation|2|||
48929245|NCT00328627|157574908|FG003|Overall Study|Protocol Violation|8|||
48929246|NCT00328627|157574909|FG004|Overall Study|Protocol Violation|5|||
48929247|NCT00328627|157574910|FG005|Overall Study|Protocol Violation|5|||
48929248|NCT00328627|157574911|FG006|Overall Study|Protocol Violation|6|||
48929249|NCT00328627|157574912|FG007|Overall Study|Protocol Violation|2|||
48929250|NCT00328627|157574913|FG008|Overall Study|Protocol Violation|1|||
48929251|NCT00328627|157574914|FG009|Overall Study|Protocol Violation|4|||
48929252|NCT00328627|157574915|FG010|Overall Study|Protocol Violation|6|||
48929253|NCT00328627|157574916|FG011|Overall Study|Protocol Violation|2|||
48929254|NCT00328627|157574905|FG000|Overall Study|Lost to Follow-up|4|||
48929255|NCT00328627|157574906|FG001|Overall Study|Lost to Follow-up|2|||
48929256|NCT00328627|157574907|FG002|Overall Study|Lost to Follow-up|2|||
48929257|NCT00328627|157574908|FG003|Overall Study|Lost to Follow-up|4|||
48929258|NCT00328627|157574909|FG004|Overall Study|Lost to Follow-up|0|||
48929259|NCT00328627|157574910|FG005|Overall Study|Lost to Follow-up|2|||
48929260|NCT00328627|157574911|FG006|Overall Study|Lost to Follow-up|3|||
48929261|NCT00328627|157574912|FG007|Overall Study|Lost to Follow-up|0|||
48929262|NCT00328627|157574913|FG008|Overall Study|Lost to Follow-up|3|||
48929263|NCT00328627|157574914|FG009|Overall Study|Lost to Follow-up|2|||
48929264|NCT00328627|157574915|FG010|Overall Study|Lost to Follow-up|0|||
48929265|NCT00328627|157574916|FG011|Overall Study|Lost to Follow-up|1|||
48929266|NCT00328627|157574905|FG000|Overall Study|Withdrawal by Subject|5|||
48929267|NCT00328627|157574906|FG001|Overall Study|Withdrawal by Subject|4|||
48929268|NCT00328627|157574907|FG002|Overall Study|Withdrawal by Subject|5|||
48929269|NCT00328627|157574908|FG003|Overall Study|Withdrawal by Subject|6|||
48929270|NCT00328627|157574909|FG004|Overall Study|Withdrawal by Subject|2|||
48929271|NCT00328627|157574910|FG005|Overall Study|Withdrawal by Subject|5|||
48929272|NCT00328627|157574911|FG006|Overall Study|Withdrawal by Subject|4|||
48929273|NCT00328627|157574912|FG007|Overall Study|Withdrawal by Subject|4|||
48929274|NCT00328627|157574913|FG008|Overall Study|Withdrawal by Subject|4|||
48929275|NCT00328627|157574914|FG009|Overall Study|Withdrawal by Subject|5|||
48929276|NCT00328627|157574915|FG010|Overall Study|Withdrawal by Subject|2|||
48929277|NCT00328627|157574916|FG011|Overall Study|Withdrawal by Subject|7|||
48929278|NCT00328627|157574905|FG000|Overall Study|Pregnancy|0|||
48929279|NCT00328627|157574906|FG001|Overall Study|Pregnancy|1|||
48929280|NCT00328627|157574907|FG002|Overall Study|Pregnancy|0|||
48929281|NCT00328627|157574908|FG003|Overall Study|Pregnancy|0|||
48929282|NCT00328627|157574909|FG004|Overall Study|Pregnancy|0|||
48929283|NCT00328627|157574910|FG005|Overall Study|Pregnancy|0|||
48929284|NCT00328627|157574911|FG006|Overall Study|Pregnancy|0|||
48929285|NCT00328627|157574912|FG007|Overall Study|Pregnancy|0|||
48929286|NCT00328627|157574913|FG008|Overall Study|Pregnancy|0|||
48929287|NCT00328627|157574914|FG009|Overall Study|Pregnancy|0|||
48929288|NCT00328627|157574915|FG010|Overall Study|Pregnancy|0|||
48929289|NCT00328627|157574916|FG011|Overall Study|Pregnancy|0|||
48929290|NCT00328627|157574905|FG000|Overall Study|Physician Decision|4|||
48929291|NCT00328627|157574906|FG001|Overall Study|Physician Decision|3|||
48929292|NCT00328627|157574907|FG002|Overall Study|Physician Decision|1|||
48929293|NCT00328627|157574908|FG003|Overall Study|Physician Decision|2|||
48929294|NCT00328627|157574909|FG004|Overall Study|Physician Decision|1|||
48929295|NCT00328627|157574910|FG005|Overall Study|Physician Decision|1|||
48929296|NCT00328627|157574911|FG006|Overall Study|Physician Decision|1|||
48929297|NCT00328627|157574912|FG007|Overall Study|Physician Decision|0|||
48929298|NCT00328627|157574913|FG008|Overall Study|Physician Decision|3|||
48929299|NCT00328627|157574914|FG009|Overall Study|Physician Decision|2|||
48929300|NCT00328627|157574915|FG010|Overall Study|Physician Decision|1|||
48929301|NCT00328627|157574916|FG011|Overall Study|Physician Decision|0|||
48929302|NCT00328627|157574905|FG000|Overall Study|Other|0|||
48929303|NCT00328627|157574906|FG001|Overall Study|Other|0|||
48929304|NCT00328627|157574907|FG002|Overall Study|Other|0|||
48929305|NCT00328627|157574908|FG003|Overall Study|Other|1|||
48929306|NCT00328627|157574909|FG004|Overall Study|Other|0|||
48929307|NCT00328627|157574910|FG005|Overall Study|Other|0|||
48929308|NCT00328627|157574911|FG006|Overall Study|Other|1|||
48929309|NCT00328627|157574912|FG007|Overall Study|Other|0|||
48929310|NCT00328627|157574913|FG008|Overall Study|Other|0|||
48929311|NCT00328627|157574914|FG009|Overall Study|Other|1|||
48929312|NCT00328627|157574915|FG010|Overall Study|Other|1|||
48929313|NCT00328627|157574916|FG011|Overall Study|Other|0|||
48929314|NCT04002310|157574919|FG000|Overall Study|Sponsor put on hold on treatment plan.|0|||
48929315|NCT04002310|157574920|FG001|Overall Study|Sponsor put on hold on treatment plan.|0|||
48844415|NCT00802464|157272741|FG001|Month 0 - Month 8|Adverse Event|1|||
48844416|NCT00802464|157272742|FG002|Month 0 - Month 8|Adverse Event|1|||
48844417|NCT00802464|157272743|FG003|Month 0 - Month 8|Adverse Event|2|||
48844418|NCT00802464|157272740|FG000|Month 0 - Month 8|Protocol Violation|0|||
48844419|NCT00802464|157272741|FG001|Month 0 - Month 8|Protocol Violation|0|||
48844420|NCT00802464|157272742|FG002|Month 0 - Month 8|Protocol Violation|1|||
48844421|NCT00802464|157272743|FG003|Month 0 - Month 8|Protocol Violation|0|||
48844422|NCT00802464|157272740|FG000|Month 0 - Month 8|Withdrawal by Subject|0|||
48844423|NCT00802464|157272741|FG001|Month 0 - Month 8|Withdrawal by Subject|1|||
48844424|NCT00802464|157272742|FG002|Month 0 - Month 8|Withdrawal by Subject|2|||
48844425|NCT00802464|157272743|FG003|Month 0 - Month 8|Withdrawal by Subject|5|||
48844426|NCT00802464|157272740|FG000|Month 0 - Month 8|Lost to Follow-up|0|||
48844427|NCT00802464|157272741|FG001|Month 0 - Month 8|Lost to Follow-up|1|||
48844428|NCT00802464|157272742|FG002|Month 0 - Month 8|Lost to Follow-up|2|||
48844429|NCT00802464|157272743|FG003|Month 0 - Month 8|Lost to Follow-up|2|||
48844430|NCT00802464|157272740|FG000|Month 0 - Month 8|Other|0|||
48844431|NCT00802464|157272741|FG001|Month 0 - Month 8|Other|0|||
48844432|NCT00802464|157272742|FG002|Month 0 - Month 8|Other|1|||
48844433|NCT00802464|157272743|FG003|Month 0 - Month 8|Other|0|||
48844434|NCT00802464|157272740|FG000|Month 8 - Month 14|Adverse Event|0|||
48844435|NCT00802464|157272741|FG001|Month 8 - Month 14|Adverse Event|1|||
48844436|NCT00802464|157272742|FG002|Month 8 - Month 14|Adverse Event|0|||
48844437|NCT00802464|157272743|FG003|Month 8 - Month 14|Adverse Event|0|||
48844438|NCT00802464|157272740|FG000|Month 8 - Month 14|Withdrawal by Subject|1|||
48844439|NCT00802464|157272741|FG001|Month 8 - Month 14|Withdrawal by Subject|1|||
48844440|NCT00802464|157272742|FG002|Month 8 - Month 14|Withdrawal by Subject|0|||
48844441|NCT00802464|157272743|FG003|Month 8 - Month 14|Withdrawal by Subject|0|||
48844442|NCT00802464|157272740|FG000|Month 8 - Month 14|Lost to Follow-up|0|||
48844443|NCT00802464|157272741|FG001|Month 8 - Month 14|Lost to Follow-up|0|||
48844444|NCT00802464|157272742|FG002|Month 8 - Month 14|Lost to Follow-up|1|||
48844445|NCT00802464|157272743|FG003|Month 8 - Month 14|Lost to Follow-up|0|||
48844446|NCT00434304|157272744|FG000|Overall Study|Adverse Event|14|||
48844447|NCT00434304|157272744|FG000|Overall Study|Lack of Efficacy|2|||
48844448|NCT00434304|157272744|FG000|Overall Study|Withdrawal by Subject|4|||
48844449|NCT01113931|157272746|FG000|Overall Study|Adverse Event|2|||
48844450|NCT01113931|157272747|FG001|Overall Study|Adverse Event|2|||
48844451|NCT01113931|157272746|FG000|Overall Study|Physician Decision|0|||
48844452|NCT01113931|157272747|FG001|Overall Study|Physician Decision|2|||
48844453|NCT01113931|157272746|FG000|Overall Study|Lost to Follow-up|12|||
48844454|NCT01113931|157272747|FG001|Overall Study|Lost to Follow-up|9|||
48844455|NCT01113931|157272746|FG000|Overall Study|Various|2|||
48844456|NCT01113931|157272747|FG001|Overall Study|Various|4|||
48844457|NCT01113931|157272746|FG000|Overall Study|Withdrawal by Subject|3|||
48929316|NCT04002310|157574921|FG002|Overall Study|Sponsor put on hold on treatment plan.|0|||
48929317|NCT04002310|157574922|FG003|Overall Study|Sponsor put on hold on treatment plan.|0|||
48929318|NCT04002310|157574923|FG004|Overall Study|Sponsor put on hold on treatment plan.|1|||
48929319|NCT00112905|157574924|FG000|Overall Study|Adverse Event|4|||
48929320|NCT00112905|157574924|FG000|Overall Study|Death|1|||
48929321|NCT00112905|157574924|FG000|Overall Study|Ineligibility|5|||
48929322|NCT00112905|157574924|FG000|Overall Study|Alternative treatment|1|||
48929323|NCT00112905|157574924|FG000|Overall Study|performance status was deteiorating|1|||
48929324|NCT01765673|157574925|FG000|Overall Study|No transportation for 2nd/3rd visits|1|||
48929325|NCT03905863|157574931|FG000|Overall Study|Adverse Event|2|||
48929326|NCT03905863|157574932|FG001|Overall Study|Adverse Event|4|||
48929327|NCT03905863|157574931|FG000|Overall Study|Withdrawal by Subject|2|||
48693068|NCT01400698|156724660|FG002|Overall Study|Other|0|||
48929328|NCT03905863|157574932|FG001|Overall Study|Withdrawal by Subject|2|||
48929329|NCT03905863|157574931|FG000|Overall Study|Physician Decision|0|||
48929330|NCT03905863|157574932|FG001|Overall Study|Physician Decision|3|||
48929331|NCT03905863|157574931|FG000|Overall Study|Lost to Follow-up|1|||
48929332|NCT03905863|157574932|FG001|Overall Study|Lost to Follow-up|0|||
48929333|NCT03905863|157574931|FG000|Overall Study|Protocol Violation|0|||
48929334|NCT03905863|157574932|FG001|Overall Study|Protocol Violation|2|||
48929335|NCT03905863|157574931|FG000|Overall Study|Death|0|||
48929336|NCT03905863|157574932|FG001|Overall Study|Death|1|||
48929337|NCT05162066|157574933|FG000|Overall Study|Adverse Event|1|||
48929338|NCT05162066|157574934|FG001|Overall Study|Adverse Event|0|||
48929339|NCT05162066|157574935|FG002|Overall Study|Adverse Event|0|||
48929340|NCT05162066|157574933|FG000|Overall Study|Perceived lack of efficacy|1|||
48929341|NCT05162066|157574934|FG001|Overall Study|Perceived lack of efficacy|0|||
48929342|NCT05162066|157574935|FG002|Overall Study|Perceived lack of efficacy|0|||
48929343|NCT01072344|157574936|FG000|Overall Study|Relasped-reached end point|7|||
48929344|NCT01072344|157574937|FG001|Overall Study|Relasped-reached end point|12|||
48929345|NCT01072344|157574936|FG000|Overall Study|Protocol Violation|1|||
48929346|NCT01072344|157574937|FG001|Overall Study|Protocol Violation|2|||
48929347|NCT01072344|157574936|FG000|Overall Study|Lost to Follow-up|3|||
48929348|NCT01072344|157574937|FG001|Overall Study|Lost to Follow-up|4|||
48929349|NCT02605642|157574938|FG000|Overall Study|Other|11|||
48929350|NCT02605642|157574939|FG001|Overall Study|Other|1|||
48929351|NCT02605642|157574938|FG000|Overall Study|Participant non-compliance|2|||
48929352|NCT02605642|157574939|FG001|Overall Study|Participant non-compliance|4|||
48929353|NCT02605642|157574938|FG000|Overall Study|Physician Decision|10|||
48929354|NCT02605642|157574939|FG001|Overall Study|Physician Decision|0|||
48929355|NCT02605642|157574938|FG000|Overall Study|Lost to Follow-up|12|||
48929356|NCT02605642|157574939|FG001|Overall Study|Lost to Follow-up|1|||
48929357|NCT02605642|157574938|FG000|Overall Study|Adverse Event|14|||
48929358|NCT02605642|157574939|FG001|Overall Study|Adverse Event|2|||
48929359|NCT02605642|157574938|FG000|Overall Study|Withdrawal by Subject|23|||
48929360|NCT02605642|157574939|FG001|Overall Study|Withdrawal by Subject|2|||
48929361|NCT02605642|157574938|FG000|Overall Study|Lack of response|24|||
48929362|NCT02605642|157574939|FG001|Overall Study|Lack of response|11|||
48929363|NCT02111564|157574940|FG000|Overall Study|Death|109|||
48929364|NCT02111564|157574941|FG001|Overall Study|Death|120|||
48929365|NCT02111564|157574940|FG000|Overall Study|Lost to Follow-up|2|||
48929366|NCT02111564|157574941|FG001|Overall Study|Lost to Follow-up|3|||
48929367|NCT02111564|157574940|FG000|Overall Study|Withdrawal by Subject|20|||
48929368|NCT02111564|157574941|FG001|Overall Study|Withdrawal by Subject|20|||
48929369|NCT02354703|157574942|FG000|Overall Study|Withdrawal by Subject|1|||
48929370|NCT02354703|157574943|FG001|Overall Study|Withdrawal by Subject|1|||
48929371|NCT02354703|157574944|FG002|Overall Study|Withdrawal by Subject|1|||
48929372|NCT02354703|157574945|FG003|Overall Study|Withdrawal by Subject|1|||
48929373|NCT02354703|157574942|FG000|Overall Study|Lost to Follow-up|2|||
48929374|NCT02354703|157574943|FG001|Overall Study|Lost to Follow-up|7|||
48929375|NCT02354703|157574944|FG002|Overall Study|Lost to Follow-up|9|||
48929376|NCT02354703|157574945|FG003|Overall Study|Lost to Follow-up|2|||
48929377|NCT02354703|157574942|FG000|Overall Study|Adverse Event|0|||
48929378|NCT02354703|157574943|FG001|Overall Study|Adverse Event|0|||
48929379|NCT02354703|157574944|FG002|Overall Study|Adverse Event|1|||
48929380|NCT02354703|157574945|FG003|Overall Study|Adverse Event|0|||
48929381|NCT00122135|157574948|FG000|Overall Study|Withdrawal by Subject|3|||
48929382|NCT00122135|157574949|FG001|Overall Study|Withdrawal by Subject|0|||
48929383|NCT03269344|157574950|FG000|Overall Study|Protocol Violation|4|||
48929384|NCT03269344|157574951|FG001|Overall Study|Protocol Violation|3|||
48844458|NCT01113931|157272747|FG001|Overall Study|Withdrawal by Subject|0|||
48844459|NCT00894543|157272750|FG000|Baseline to Week 4|No diary or lost or withdrew|3|||
48844460|NCT00894543|157272751|FG001|Baseline to Week 4|No diary or lost or withdrew|2|||
48844461|NCT00894543|157272750|FG000|Week 4 to Week 8|No diary or lost or withdrew|4|||
48844462|NCT00894543|157272751|FG001|Week 4 to Week 8|No diary or lost or withdrew|2|||
48844463|NCT00077675|157272754|FG000|Overall Study|Adverse Event|1|||
48844464|NCT00077675|157272755|FG001|Overall Study|Adverse Event|2|||
48844465|NCT00077675|157272754|FG000|Overall Study|Lost to Follow-up|6|||
48844466|NCT00077675|157272755|FG001|Overall Study|Lost to Follow-up|3|||
48844467|NCT00077675|157272754|FG000|Overall Study|Withdrawal by Subject|1|||
48844468|NCT00077675|157272755|FG001|Overall Study|Withdrawal by Subject|0|||
48844469|NCT00077675|157272754|FG000|Overall Study|Other|0|||
48844470|NCT00077675|157272755|FG001|Overall Study|Other|1|||
48844471|NCT00077675|157272754|FG000|Overall Study|Never received study treatment|3|||
48844472|NCT00077675|157272755|FG001|Overall Study|Never received study treatment|3|||
48844473|NCT02601820|157272756|FG000|Early On-Treatment (T2)|Missing T2 Record|51|||
48844474|NCT02601820|157272756|FG000|Late On-Treatment (T3)|missing T3 Record|49|||
48929385|NCT00700180|157574956|FG000|Overall Study|Death|99|||
48929386|NCT00700180|157574957|FG001|Overall Study|Death|114|||
48929387|NCT00700180|157574956|FG000|Overall Study|Alive on treatment|5|||
48929388|NCT00700180|157574957|FG001|Overall Study|Alive on treatment|3|||
48929389|NCT00700180|157574956|FG000|Overall Study|Alive in follow-up|46|||
48929390|NCT00700180|157574957|FG001|Overall Study|Alive in follow-up|27|||
48929391|NCT00700180|157574956|FG000|Overall Study|Lost to Follow-up|4|||
48929392|NCT00700180|157574957|FG001|Overall Study|Lost to Follow-up|5|||
48929393|NCT01613326|157574958|FG000|Overall Study|Adverse Event|7|||
48929394|NCT01613326|157574959|FG001|Overall Study|Adverse Event|5|||
48929395|NCT01613326|157574958|FG000|Overall Study|Withdrawal by Subject|3|||
48929396|NCT01613326|157574959|FG001|Overall Study|Withdrawal by Subject|4|||
48929397|NCT01613326|157574958|FG000|Overall Study|Abnormal test procedure result(s)|2|||
48929398|NCT01613326|157574959|FG001|Overall Study|Abnormal test procedure result(s)|0|||
48929399|NCT01613326|157574958|FG000|Overall Study|inability to use device|1|||
48929400|NCT01613326|157574959|FG001|Overall Study|inability to use device|0|||
48929401|NCT01613326|157574958|FG000|Overall Study|Lack of Efficacy|0|||
48929402|NCT01613326|157574959|FG001|Overall Study|Lack of Efficacy|1|||
48929403|NCT01613326|157574958|FG000|Overall Study|Lost to Follow-up|0|||
48929404|NCT01613326|157574959|FG001|Overall Study|Lost to Follow-up|1|||
48929405|NCT01613326|157574958|FG000|Overall Study|Administrative|0|||
48929406|NCT01613326|157574959|FG001|Overall Study|Administrative|2|||
48929407|NCT01613326|157574958|FG000|Overall Study|Protocol Violation|0|||
48929408|NCT01613326|157574959|FG001|Overall Study|Protocol Violation|1|||
48929409|NCT02468648|157574960|FG000|Overall Study|Death|1|||
48929410|NCT02634580|157574961|FG000|Double-blind Treatment Period|Subject Request|1|||
48929411|NCT02634580|157574962|FG001|Double-blind Treatment Period|Subject Request|0|||
48929412|NCT02634580|157574963|FG002|Double-blind Treatment Period|Subject Request|1|||
48929413|NCT02634580|157574964|FG003|Double-blind Treatment Period|Subject Request|1|||
48929414|NCT02634580|157574961|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
48929415|NCT02634580|157574962|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
48929416|NCT02634580|157574963|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
48929417|NCT02634580|157574964|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
48929418|NCT03118297|157574965|FG000|Overall Study|Lost to Follow-up|0|||
48929419|NCT03118297|157574966|FG001|Overall Study|Lost to Follow-up|2|||
48929420|NCT03757988|157574969|FG000|Overall Study|Withdrawal by Subject|1|||
48929421|NCT04418765|157574978|FG000|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
48929422|NCT04418765|157574979|FG001|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
48929423|NCT04418765|157574980|FG002|Placebo-controlled Period (24 Weeks)|Adverse Event|6|||
48929424|NCT04418765|157574978|FG000|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|1|||
48929425|NCT04418765|157574979|FG001|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|3|||
48929426|NCT04418765|157574980|FG002|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|0|||
48929427|NCT04418765|157574978|FG000|Placebo-controlled Period (24 Weeks)|Protocol Violation|0|||
48929428|NCT04418765|157574979|FG001|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
48929429|NCT04418765|157574980|FG002|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
48929430|NCT04418765|157574978|FG000|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|1|||
48929431|NCT04418765|157574979|FG001|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|5|||
48929432|NCT04418765|157574980|FG002|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|2|||
48929433|NCT04418765|157574978|FG000|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
48929434|NCT04418765|157574979|FG001|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|1|||
48929435|NCT04418765|157574980|FG002|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
48929436|NCT04418765|157574978|FG000|Placebo-controlled Period (24 Weeks)|Other than specified|2|||
48929437|NCT04418765|157574979|FG001|Placebo-controlled Period (24 Weeks)|Other than specified|0|||
48929438|NCT04418765|157574980|FG002|Placebo-controlled Period (24 Weeks)|Other than specified|1|||
48929439|NCT04418765|157574978|FG000|Placebo-controlled Period (24 Weeks)|Randomized but not treated|1|||
48929440|NCT04418765|157574979|FG001|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
48929441|NCT04418765|157574980|FG002|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
48929442|NCT04418765|157574978|FG000|Extension Period (48 Weeks)|Adverse Event|0|||
48693069|NCT01400698|156724661|FG003|Overall Study|Other|2|||
48929443|NCT04418765|157574979|FG001|Extension Period (48 Weeks)|Adverse Event|2|||
48929444|NCT04418765|157574980|FG002|Extension Period (48 Weeks)|Adverse Event|9|||
48929445|NCT04418765|157574978|FG000|Extension Period (48 Weeks)|Lack of Efficacy|0|||
48929446|NCT04418765|157574979|FG001|Extension Period (48 Weeks)|Lack of Efficacy|13|||
48929447|NCT04418765|157574980|FG002|Extension Period (48 Weeks)|Lack of Efficacy|13|||
48929448|NCT04418765|157574978|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|0|||
48929449|NCT04418765|157574979|FG001|Extension Period (48 Weeks)|Withdrawal by Subject|21|||
48929450|NCT04418765|157574980|FG002|Extension Period (48 Weeks)|Withdrawal by Subject|14|||
48929451|NCT04418765|157574978|FG000|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
48929452|NCT04418765|157574979|FG001|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
48929453|NCT04418765|157574980|FG002|Extension Period (48 Weeks)|Non-compliance with study drug|2|||
48929454|NCT04418765|157574978|FG000|Extension Period (48 Weeks)|Protocol Violation|0|||
48929455|NCT04418765|157574979|FG001|Extension Period (48 Weeks)|Protocol Violation|0|||
48929456|NCT04418765|157574980|FG002|Extension Period (48 Weeks)|Protocol Violation|2|||
48929457|NCT04418765|157574978|FG000|Extension Period (48 Weeks)|Other than specified|0|||
48929458|NCT04418765|157574979|FG001|Extension Period (48 Weeks)|Other than specified|5|||
48929459|NCT04418765|157574980|FG002|Extension Period (48 Weeks)|Other than specified|2|||
48929460|NCT02217566|157575005|FG000|Overall Study|Lost to Follow-up|2|||
48929461|NCT02217566|157575005|FG000|Overall Study|Death|3|||
48929462|NCT02217566|157575005|FG000|Overall Study|Early study termination|6|||
48929463|NCT00090545|157575006|FG000|Overall Study|Disease progression on study|21|||
48929464|NCT00090545|157575007|FG001|Overall Study|Disease progression on study|17|||
48929465|NCT00090545|157575006|FG000|Overall Study|Refused further treatment|1|||
48929466|NCT00090545|157575007|FG001|Overall Study|Refused further treatment|4|||
48929467|NCT00090545|157575006|FG000|Overall Study|Death|0|||
48929468|NCT00090545|157575007|FG001|Overall Study|Death|1|||
48929469|NCT00090545|157575006|FG000|Overall Study|Adverse Event|0|||
48929470|NCT00090545|157575007|FG001|Overall Study|Adverse Event|2|||
48929471|NCT02769624|157575008|FG000|Overall Study|Lost to Follow-up|0|||
48929472|NCT02769624|157575009|FG001|Overall Study|Lost to Follow-up|1|||
48929473|NCT01298492|157575013|FG000|Overall Study|Death|2|||
48929474|NCT01298492|157575013|FG000|Overall Study|Insufficient Clinical Response|22|||
48929475|NCT01298492|157575013|FG000|Overall Study|Lost to Follow-up|12|||
48929476|NCT01298492|157575013|FG000|Overall Study|Withdrawal by Subject|47|||
48929477|NCT01298492|157575013|FG000|Overall Study|Other (Unspecified)|7|||
48929478|NCT01298492|157575013|FG000|Overall Study|Withdrawn Due to Pregnancy|1|||
48929479|NCT01298492|157575013|FG000|Overall Study|Protocol Violation|2|||
48929480|NCT01298492|157575013|FG000|Overall Study|Adverse Event(Related to Study Drug)|8|||
48929481|NCT01298492|157575013|FG000|Overall Study|Adverse Event(Not Related to Study Drug)|18|||
48929482|NCT02340663|157575015|FG000|Overall Study|Lost to Follow-up|1|||
48929483|NCT02340663|157575016|FG001|Overall Study|Lost to Follow-up|0|||
48929484|NCT02340663|157575015|FG000|Overall Study|Protocol Violation|1|||
48929485|NCT02340663|157575016|FG001|Overall Study|Protocol Violation|0|||
48929486|NCT02340663|157575015|FG000|Overall Study|Withdrawal by Subject|3|||
48929487|NCT02340663|157575016|FG001|Overall Study|Withdrawal by Subject|1|||
48929488|NCT01078805|157575017|FG000|Overall Study|Clinically significant abnormal lab|5|||
48929489|NCT01078805|157575017|FG000|Overall Study|Death|134|||
48929490|NCT01078805|157575017|FG000|Overall Study|Lost to Follow-up|676|||
48929491|NCT01078805|157575017|FG000|Overall Study|Physician Decision|169|||
48929492|NCT01078805|157575017|FG000|Overall Study|Serious adverse event|26|||
48929493|NCT01078805|157575017|FG000|Overall Study|Sponsor decision|46|||
48929494|NCT01078805|157575017|FG000|Overall Study|Withdrawal by Subject|739|||
48929495|NCT01078805|157575017|FG000|Overall Study|Other|173|||
48929496|NCT01078805|157575017|FG000|Overall Study|Didn't take study drug|82|||
48929497|NCT01656434|157575021|FG000|Overall Study|Adverse Event|199|||
48929498|NCT01656434|157575022|FG001|Overall Study|Adverse Event|63|||
48929499|NCT01656434|157575021|FG000|Overall Study|Enrollment terminated at trial site|2|||
48929500|NCT01656434|157575022|FG001|Overall Study|Enrollment terminated at trial site|0|||
48929501|NCT01656434|157575021|FG000|Overall Study|Lost to Follow-up|309|||
48929502|NCT01656434|157575022|FG001|Overall Study|Lost to Follow-up|76|||
48929503|NCT01656434|157575021|FG000|Overall Study|Site discontinued study participation|24|||
48929504|NCT01656434|157575022|FG001|Overall Study|Site discontinued study participation|9|||
48929505|NCT01656434|157575021|FG000|Overall Study|Screen failure|2|||
48929506|NCT01656434|157575022|FG001|Overall Study|Screen failure|0|||
48929507|NCT01656434|157575021|FG000|Overall Study|Protocol Violation|7|||
48929508|NCT01656434|157575022|FG001|Overall Study|Protocol Violation|0|||
48929509|NCT01656434|157575021|FG000|Overall Study|Pregnancy wish|18|||
48929510|NCT01656434|157575022|FG001|Overall Study|Pregnancy wish|6|||
48929511|NCT01656434|157575021|FG000|Overall Study|Pregnancy|45|||
48929512|NCT01656434|157575022|FG001|Overall Study|Pregnancy|10|||
48929513|NCT01656434|157575021|FG000|Overall Study|Physician Decision|7|||
48929514|NCT01656434|157575022|FG001|Overall Study|Physician Decision|2|||
48929515|NCT01656434|157575021|FG000|Overall Study|Non-compliance with study drug|48|||
48929516|NCT01656434|157575022|FG001|Overall Study|Non-compliance with study drug|9|||
48929517|NCT01656434|157575021|FG000|Overall Study|Study terminated by sponsor|1501|||
48929518|NCT01656434|157575022|FG001|Overall Study|Study terminated by sponsor|348|||
48929519|NCT01656434|157575021|FG000|Overall Study|Participant discontinued; drug related|13|||
48929520|NCT01656434|157575022|FG001|Overall Study|Participant discontinued; drug related|4|||
48929521|NCT01656434|157575021|FG000|Overall Study|Part. discontinued; unrelated to drug|55|||
48929522|NCT01656434|157575022|FG001|Overall Study|Part. discontinued; unrelated to drug|10|||
48929523|NCT01656434|157575021|FG000|Overall Study|Non-compliance with protocol|39|||
48929524|NCT01656434|157575022|FG001|Overall Study|Non-compliance with protocol|15|||
48929525|NCT01656434|157575021|FG000|Overall Study|Participant moved|40|||
48929526|NCT01656434|157575022|FG001|Overall Study|Participant moved|12|||
48929527|NCT01656434|157575021|FG000|Overall Study|Participant withdrew consent|28|||
48929528|NCT01656434|157575022|FG001|Overall Study|Participant withdrew consent|9|||
48929529|NCT01656434|157575021|FG000|Overall Study|Withdrawal by Subject|64|||
48929530|NCT01656434|157575022|FG001|Overall Study|Withdrawal by Subject|7|||
48929531|NCT03213366|157575023|FG000|Overall Study|Lost to Follow-up|9|||
48929532|NCT03213366|157575024|FG001|Overall Study|Lost to Follow-up|4|||
48929533|NCT02292771|157575025|FG000|Overall Study|Withdrawal by Subject|2|||
48929534|NCT02292771|157575026|FG001|Overall Study|Withdrawal by Subject|1|||
48929535|NCT02292771|157575025|FG000|Overall Study|Lost to Follow-up|2|||
48929536|NCT02292771|157575026|FG001|Overall Study|Lost to Follow-up|1|||
48929537|NCT02629159|157575029|FG000|Overall Study|Adverse Event|17|||
48929538|NCT02629159|157575030|FG001|Overall Study|Adverse Event|20|||
48929539|NCT02629159|157575031|FG002|Overall Study|Adverse Event|22|||
48929540|NCT02629159|157575029|FG000|Overall Study|Withdrawal by Subject|22|||
48929541|NCT02629159|157575030|FG001|Overall Study|Withdrawal by Subject|11|||
48929542|NCT02629159|157575031|FG002|Overall Study|Withdrawal by Subject|15|||
48929543|NCT02629159|157575029|FG000|Overall Study|Lost to Follow-up|7|||
48929544|NCT02629159|157575030|FG001|Overall Study|Lost to Follow-up|4|||
48929545|NCT02629159|157575031|FG002|Overall Study|Lost to Follow-up|5|||
48929546|NCT02629159|157575029|FG000|Overall Study|Lack of Efficacy|4|||
48929547|NCT02629159|157575030|FG001|Overall Study|Lack of Efficacy|0|||
48929548|NCT02629159|157575031|FG002|Overall Study|Lack of Efficacy|1|||
48929549|NCT02629159|157575029|FG000|Overall Study|Other|6|||
48929550|NCT02629159|157575030|FG001|Overall Study|Other|4|||
48929551|NCT02629159|157575031|FG002|Overall Study|Other|8|||
48929552|NCT00243659|157575032|FG000|Overall Study|Withdrawal by Subject|1|||
48929553|NCT00243659|157575033|FG001|Overall Study|Withdrawal by Subject|1|||
48929554|NCT00243659|157575032|FG000|Overall Study|Protocol Violation|1|||
48929555|NCT00243659|157575033|FG001|Overall Study|Protocol Violation|2|||
48929556|NCT01375764|157575035|FG000|Overall Study|Lost to Follow-up|0|||
48929557|NCT01375764|157575036|FG001|Overall Study|Lost to Follow-up|1|||
48929558|NCT01375764|157575037|FG002|Overall Study|Lost to Follow-up|0|||
48929559|NCT01375764|157575038|FG003|Overall Study|Lost to Follow-up|0|||
48929560|NCT01375764|157575039|FG004|Overall Study|Lost to Follow-up|0|||
48929561|NCT01375764|157575035|FG000|Overall Study|Withdrawal by Subject|2|||
48929562|NCT01375764|157575036|FG001|Overall Study|Withdrawal by Subject|0|||
48929563|NCT01375764|157575037|FG002|Overall Study|Withdrawal by Subject|0|||
48929564|NCT01375764|157575038|FG003|Overall Study|Withdrawal by Subject|0|||
48929565|NCT01375764|157575039|FG004|Overall Study|Withdrawal by Subject|1|||
48929566|NCT01375764|157575035|FG000|Overall Study|Other|0|||
48929567|NCT01375764|157575036|FG001|Overall Study|Other|0|||
48929568|NCT01375764|157575037|FG002|Overall Study|Other|0|||
48929569|NCT01375764|157575038|FG003|Overall Study|Other|1|||
48929570|NCT01375764|157575039|FG004|Overall Study|Other|0|||
48929571|NCT02867761|157575040|FG000|Overall Study|Participant withdrawn by investigator|0|||
48929572|NCT02867761|157575041|FG001|Overall Study|Participant withdrawn by investigator|1|||
48929573|NCT02867761|157575040|FG000|Overall Study|Lost to Follow-up|25|||
48929574|NCT02867761|157575041|FG001|Overall Study|Lost to Follow-up|18|||
48929575|NCT02867761|157575040|FG000|Overall Study|Unable to complete protocol|3|||
48929576|NCT02867761|157575041|FG001|Overall Study|Unable to complete protocol|7|||
48929577|NCT04506294|157575042|FG000|Overall Study|Lost to Follow-up|70|||
48929578|NCT04506294|157575043|FG001|Overall Study|Lost to Follow-up|20|||
48929579|NCT04506294|157575042|FG000|Overall Study|Withdrawal by Subject|16|||
48929580|NCT04506294|157575043|FG001|Overall Study|Withdrawal by Subject|2|||
48929581|NCT02319044|157575046|FG000|Overall Study|Death, PI/sponsor decision, med history|0|||
48929582|NCT02319044|157575047|FG001|Overall Study|Death, PI/sponsor decision, med history|1|||
48929583|NCT02319044|157575048|FG002|Overall Study|Death, PI/sponsor decision, med history|4|||
48929584|NCT02319044|157575046|FG000|Overall Study|Withdrawal by Subject|3|||
48929585|NCT02319044|157575047|FG001|Overall Study|Withdrawal by Subject|3|||
48929586|NCT02319044|157575048|FG002|Overall Study|Withdrawal by Subject|6|||
48929587|NCT02319044|157575046|FG000|Overall Study|Condition under investigation worsened|100|||
48929588|NCT02319044|157575047|FG001|Overall Study|Condition under investigation worsened|50|||
48929589|NCT02319044|157575048|FG002|Overall Study|Condition under investigation worsened|46|||
48929590|NCT02319044|157575046|FG000|Overall Study|Adverse Event|17|||
48929591|NCT02319044|157575047|FG001|Overall Study|Adverse Event|2|||
48929592|NCT02319044|157575048|FG002|Overall Study|Adverse Event|8|||
48929593|NCT02319044|157575046|FG000|Overall Study|Study specific discontinuation criteria|2|||
48929594|NCT02319044|157575047|FG001|Overall Study|Study specific discontinuation criteria|2|||
48929595|NCT02319044|157575048|FG002|Overall Study|Study specific discontinuation criteria|1|||
48929596|NCT02319044|157575046|FG000|Overall Study|Not treated|0|||
48929597|NCT02319044|157575047|FG001|Overall Study|Not treated|2|||
48929598|NCT02319044|157575048|FG002|Overall Study|Not treated|2|||
48929599|NCT02317562|157575049|FG000|Overall Study|Physician Decision|1|||
48929600|NCT02317562|157575049|FG000|Overall Study|early termination of the study|8|||
48929601|NCT02317562|157575049|FG000|Overall Study|Lack of Efficacy|4|||
48929602|NCT02317562|157575049|FG000|Overall Study|Withdrawal by Subject|1|||
48929603|NCT03551743|157575050|FG000|Overall Study|Adverse Event|1|||
48929604|NCT03551743|157575051|FG001|Overall Study|Adverse Event|0|||
48929605|NCT03551743|157575052|FG002|Overall Study|Adverse Event|0|||
48929606|NCT03551743|157575053|FG003|Overall Study|Adverse Event|0|||
48929607|NCT03551743|157575050|FG000|Overall Study|Withdrawal by Subject|1|||
48929608|NCT03551743|157575051|FG001|Overall Study|Withdrawal by Subject|0|||
48929609|NCT03551743|157575052|FG002|Overall Study|Withdrawal by Subject|0|||
48929610|NCT03551743|157575053|FG003|Overall Study|Withdrawal by Subject|0|||
48929611|NCT01512264|157575054|FG000|Overall Study|Lost to Follow-up|0|||
48929612|NCT01512264|157575055|FG001|Overall Study|Lost to Follow-up|0|||
48929613|NCT01512264|157575056|FG002|Overall Study|Lost to Follow-up|0|||
48929614|NCT01512264|157575057|FG003|Overall Study|Lost to Follow-up|1|||
48929615|NCT03742037|157575058|FG000|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
48929616|NCT03742037|157575059|FG001|Treatment Period 1 (1st Dose - Month 6)|Death|1|||
48929617|NCT03742037|157575060|FG002|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
48929618|NCT03742037|157575061|FG003|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
48929619|NCT03742037|157575062|FG004|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
48929620|NCT03742037|157575063|FG005|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
48929621|NCT03742037|157575064|FG006|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
48929622|NCT03742037|157575058|FG000|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
48929623|NCT03742037|157575059|FG001|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|1|||
48929624|NCT03742037|157575060|FG002|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|4|||
48929625|NCT03742037|157575061|FG003|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
48929626|NCT03742037|157575062|FG004|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
48929627|NCT03742037|157575063|FG005|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|3|||
48929628|NCT03742037|157575064|FG006|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|2|||
48929629|NCT03742037|157575058|FG000|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
48929630|NCT03742037|157575059|FG001|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|1|||
48929631|NCT03742037|157575060|FG002|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
48929632|NCT03742037|157575061|FG003|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
48929633|NCT03742037|157575062|FG004|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
48929634|NCT03742037|157575063|FG005|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
48929635|NCT03742037|157575064|FG006|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
48929636|NCT03742037|157575058|FG000|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
48929637|NCT03742037|157575059|FG001|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
48929638|NCT03742037|157575060|FG002|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
48929639|NCT03742037|157575061|FG003|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
48929640|NCT03742037|157575062|FG004|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
48929641|NCT03742037|157575063|FG005|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
48929642|NCT03742037|157575064|FG006|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
48929643|NCT03742037|157575058|FG000|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
48929644|NCT03742037|157575059|FG001|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|3|||
48929645|NCT03742037|157575060|FG002|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|7|||
48929646|NCT03742037|157575061|FG003|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
48929647|NCT03742037|157575062|FG004|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
48929648|NCT03742037|157575063|FG005|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|6|||
48929649|NCT03742037|157575064|FG006|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
48929650|NCT03742037|157575058|FG000|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
48929651|NCT03742037|157575059|FG001|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
48929652|NCT03742037|157575060|FG002|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
48929653|NCT03742037|157575061|FG003|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
48929654|NCT03742037|157575062|FG004|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
48929655|NCT03742037|157575063|FG005|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|1|||
48929656|NCT03742037|157575064|FG006|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
48929657|NCT03742037|157575058|FG000|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
48929658|NCT03742037|157575059|FG001|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
48929659|NCT03742037|157575060|FG002|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
48929660|NCT03742037|157575061|FG003|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
48929661|NCT03742037|157575062|FG004|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
48929662|NCT03742037|157575063|FG005|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
48929663|NCT03742037|157575064|FG006|Treatment Period 1 (1st Dose - Month 6)|Other reasons|1|||
48929664|NCT03742037|157575058|FG000|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
48929665|NCT03742037|157575059|FG001|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
48929666|NCT03742037|157575060|FG002|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
48929667|NCT03742037|157575061|FG003|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
48929668|NCT03742037|157575062|FG004|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
48929669|NCT03742037|157575063|FG005|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
48929670|NCT03742037|157575064|FG006|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|1|||
48929671|NCT03742037|157575058|FG000|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
48929672|NCT03742037|157575059|FG001|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|2|||
48929673|NCT03742037|157575060|FG002|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|3|||
48929674|NCT03742037|157575061|FG003|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
48929675|NCT03742037|157575062|FG004|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
48929676|NCT03742037|157575063|FG005|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
48929677|NCT03742037|157575064|FG006|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|4|||
48929678|NCT03742037|157575058|FG000|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
48929679|NCT03742037|157575059|FG001|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
48929680|NCT03742037|157575060|FG002|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
48929681|NCT03742037|157575061|FG003|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
48929682|NCT03742037|157575062|FG004|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
48929683|NCT03742037|157575063|FG005|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
48929684|NCT03742037|157575064|FG006|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|1|||
48929685|NCT03742037|157575058|FG000|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
48929686|NCT03742037|157575059|FG001|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|1|||
48929687|NCT03742037|157575060|FG002|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|2|||
48929688|NCT03742037|157575061|FG003|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
48929689|NCT03742037|157575062|FG004|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
48929690|NCT03742037|157575063|FG005|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
48929691|NCT03742037|157575064|FG006|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
48929692|NCT03742037|157575058|FG000|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
48929693|NCT03742037|157575059|FG001|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
48929694|NCT03742037|157575060|FG002|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
48929695|NCT03742037|157575061|FG003|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
48929696|NCT03742037|157575062|FG004|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
48929697|NCT03742037|157575063|FG005|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
48929698|NCT03742037|157575064|FG006|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
48929699|NCT03742037|157575058|FG000|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
48929700|NCT03742037|157575059|FG001|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|1|||
48929701|NCT03742037|157575060|FG002|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|3|||
48929702|NCT03742037|157575061|FG003|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
48929703|NCT03742037|157575062|FG004|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
48929704|NCT03742037|157575063|FG005|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
48929705|NCT03742037|157575064|FG006|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
48929706|NCT03742037|157575058|FG000|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
48929707|NCT03742037|157575059|FG001|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
48929708|NCT03742037|157575060|FG002|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
48929709|NCT03742037|157575061|FG003|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
48929710|NCT03742037|157575062|FG004|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
48929711|NCT03742037|157575063|FG005|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
48929712|NCT03742037|157575064|FG006|Treatment Period 2 (Month 6 - Month 12)|Other reasons|1|||
48929713|NCT03742037|157575058|FG000|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
48929714|NCT03742037|157575059|FG001|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
48929715|NCT03742037|157575060|FG002|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|1|||
48929716|NCT03742037|157575061|FG003|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
48929717|NCT03742037|157575062|FG004|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
48929718|NCT03742037|157575063|FG005|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
48929719|NCT03742037|157575064|FG006|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
48929720|NCT02026063|157575068|FG000|Overall Study|Physician Decision|0|||
48929721|NCT02026063|157575069|FG001|Overall Study|Physician Decision|10|||
48929722|NCT02026063|157575068|FG000|Overall Study|Noncompliance with Study Drug|1|||
48929723|NCT02026063|157575069|FG001|Overall Study|Noncompliance with Study Drug|1|||
48929724|NCT02026063|157575068|FG000|Overall Study|Withdrawal of Consent|1|||
48929725|NCT02026063|157575069|FG001|Overall Study|Withdrawal of Consent|6|||
48929726|NCT02026063|157575068|FG000|Overall Study|Adverse Event|5|||
48929727|NCT02026063|157575069|FG001|Overall Study|Adverse Event|20|||
48929728|NCT02026063|157575068|FG000|Overall Study|Lack of Efficacy|0|||
48929729|NCT02026063|157575069|FG001|Overall Study|Lack of Efficacy|4|||
48929730|NCT02026063|157575068|FG000|Overall Study|Lost to Follow-up|0|||
48929731|NCT02026063|157575069|FG001|Overall Study|Lost to Follow-up|1|||
48929732|NCT02026063|157575068|FG000|Overall Study|Reason not Specified|2|||
48929733|NCT02026063|157575069|FG001|Overall Study|Reason not Specified|7|||
48929734|NCT00413959|157575071|FG000|Overall Study|Pt had only one cycle.|1|||
48929735|NCT00821678|157575073|FG000|Overall Study|Withdrawal by Subject|8|||
48929736|NCT00821678|157575074|FG001|Overall Study|Withdrawal by Subject|0|||
48929737|NCT00821678|157575073|FG000|Overall Study|Lost to Follow-up|13|||
48929738|NCT00821678|157575074|FG001|Overall Study|Lost to Follow-up|12|||
48929739|NCT00821678|157575073|FG000|Overall Study|Death|0|||
48929740|NCT00821678|157575074|FG001|Overall Study|Death|2|||
48929741|NCT00429585|157575075|FG000|Overall Study|Death|1|||
48929742|NCT00429585|157575076|FG001|Overall Study|Death|0|||
48929743|NCT00429585|157575075|FG000|Overall Study|Lost to Follow-up|27|||
48929744|NCT00429585|157575076|FG001|Overall Study|Lost to Follow-up|20|||
48929745|NCT00429585|157575075|FG000|Overall Study|Physician Decision|2|||
48929746|NCT00429585|157575076|FG001|Overall Study|Physician Decision|0|||
48929747|NCT03313050|157575081|FG000|Stage 2: 12 Months|Adverse Event|0|||
48929748|NCT03313050|157575082|FG001|Stage 2: 12 Months|Adverse Event|0|||
48929749|NCT03313050|157575083|FG002|Stage 2: 12 Months|Adverse Event|0|||
48929750|NCT03313050|157575084|FG003|Stage 2: 12 Months|Adverse Event|1|||
48929751|NCT03313050|157575081|FG000|Stage 2: 12 Months|Death|0|||
48929752|NCT03313050|157575082|FG001|Stage 2: 12 Months|Death|0|||
48929753|NCT03313050|157575083|FG002|Stage 2: 12 Months|Death|3|||
48929754|NCT03313050|157575084|FG003|Stage 2: 12 Months|Death|0|||
48929755|NCT03313050|157575081|FG000|Stage 2: 12 Months|Lost to Follow-up|0|||
48929756|NCT03313050|157575082|FG001|Stage 2: 12 Months|Lost to Follow-up|0|||
48929757|NCT03313050|157575083|FG002|Stage 2: 12 Months|Lost to Follow-up|1|||
48929758|NCT03313050|157575084|FG003|Stage 2: 12 Months|Lost to Follow-up|5|||
48929759|NCT03313050|157575081|FG000|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
48929760|NCT03313050|157575082|FG001|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
48929761|NCT03313050|157575083|FG002|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
48929762|NCT03313050|157575084|FG003|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3|||
48929763|NCT03313050|157575081|FG000|Stage 2: 12 Months|Protocol deviation|0|||
48929764|NCT03313050|157575082|FG001|Stage 2: 12 Months|Protocol deviation|0|||
48929765|NCT03313050|157575083|FG002|Stage 2: 12 Months|Protocol deviation|7|||
48929766|NCT03313050|157575084|FG003|Stage 2: 12 Months|Protocol deviation|7|||
48929767|NCT03313050|157575081|FG000|Stage 2: 12 Months|Withdrawal by Subject|0|||
48929768|NCT03313050|157575082|FG001|Stage 2: 12 Months|Withdrawal by Subject|0|||
48929769|NCT03313050|157575083|FG002|Stage 2: 12 Months|Withdrawal by Subject|0|||
48929770|NCT03313050|157575084|FG003|Stage 2: 12 Months|Withdrawal by Subject|3|||
48929771|NCT03313050|157575081|FG000|Stage 2: 12 Months|Other|0|||
48929772|NCT03313050|157575082|FG001|Stage 2: 12 Months|Other|0|||
48929773|NCT03313050|157575083|FG002|Stage 2: 12 Months|Other|0|||
48929774|NCT03313050|157575084|FG003|Stage 2: 12 Months|Other|1|||
48929775|NCT01291017|157575085|FG000|Overall Study|Lost to Follow-up|2|||
48929776|NCT01291017|157575085|FG000|Overall Study|Withdrawal by Subject|3|||
48929777|NCT02847598|157575086|FG000|Overall Study|Adverse Event|0|||
48929778|NCT02847598|157575087|FG001|Overall Study|Adverse Event|0|||
48929779|NCT02847598|157575088|FG002|Overall Study|Adverse Event|0|||
48929780|NCT02847598|157575089|FG003|Overall Study|Adverse Event|0|||
48929781|NCT02847598|157575090|FG004|Overall Study|Adverse Event|0|||
48929782|NCT02847598|157575091|FG005|Overall Study|Adverse Event|0|||
48929783|NCT02847598|157575092|FG006|Overall Study|Adverse Event|0|||
48929784|NCT02847598|157575093|FG007|Overall Study|Adverse Event|1|||
48929785|NCT02847598|157575086|FG000|Overall Study|Consent withdrawn|2|||
48929786|NCT02847598|157575087|FG001|Overall Study|Consent withdrawn|0|||
48929787|NCT02847598|157575088|FG002|Overall Study|Consent withdrawn|0|||
48929788|NCT02847598|157575089|FG003|Overall Study|Consent withdrawn|4|||
48929789|NCT02847598|157575090|FG004|Overall Study|Consent withdrawn|3|||
48929790|NCT02847598|157575091|FG005|Overall Study|Consent withdrawn|2|||
48929791|NCT02847598|157575092|FG006|Overall Study|Consent withdrawn|1|||
48929792|NCT02847598|157575093|FG007|Overall Study|Consent withdrawn|3|||
48929793|NCT02847598|157575086|FG000|Overall Study|Death|3|||
48929794|NCT02847598|157575087|FG001|Overall Study|Death|0|||
48929795|NCT02847598|157575088|FG002|Overall Study|Death|0|||
48929796|NCT02847598|157575089|FG003|Overall Study|Death|0|||
48929797|NCT02847598|157575090|FG004|Overall Study|Death|0|||
48929798|NCT02847598|157575091|FG005|Overall Study|Death|0|||
48929799|NCT02847598|157575092|FG006|Overall Study|Death|0|||
48929800|NCT02847598|157575093|FG007|Overall Study|Death|0|||
48929801|NCT02847598|157575086|FG000|Overall Study|Lost to Follow-up|0|||
48929802|NCT02847598|157575087|FG001|Overall Study|Lost to Follow-up|0|||
48929803|NCT02847598|157575088|FG002|Overall Study|Lost to Follow-up|0|||
48929804|NCT02847598|157575089|FG003|Overall Study|Lost to Follow-up|0|||
48929805|NCT02847598|157575090|FG004|Overall Study|Lost to Follow-up|0|||
48929806|NCT02847598|157575091|FG005|Overall Study|Lost to Follow-up|1|||
48929807|NCT02847598|157575092|FG006|Overall Study|Lost to Follow-up|1|||
48929808|NCT02847598|157575093|FG007|Overall Study|Lost to Follow-up|0|||
48951844|NCT04760314|157654917|FG003|Induction Period|Withdrawal by Subject|0|||
48951845|NCT04760314|157654918|FG004|Induction Period|Withdrawal by Subject|0|||
48951846|NCT04760314|157654919|FG005|Induction Period|Withdrawal by Subject|0|||
48951847|NCT04760314|157654920|FG006|Induction Period|Withdrawal by Subject|0|||
48951848|NCT04760314|157654921|FG007|Induction Period|Withdrawal by Subject|0|||
48951849|NCT04760314|157654922|FG008|Induction Period|Withdrawal by Subject|0|||
48951850|NCT04760314|157654923|FG009|Induction Period|Withdrawal by Subject|0|||
48951851|NCT04760314|157654924|FG010|Induction Period|Withdrawal by Subject|0|||
48951852|NCT04760314|157654914|FG000|Induction Period|Adverse Event|0|||
48951853|NCT04760314|157654915|FG001|Induction Period|Adverse Event|0|||
48951854|NCT04760314|157654916|FG002|Induction Period|Adverse Event|2|||
48951855|NCT04760314|157654917|FG003|Induction Period|Adverse Event|0|||
48951856|NCT04760314|157654918|FG004|Induction Period|Adverse Event|0|||
48951857|NCT04760314|157654919|FG005|Induction Period|Adverse Event|0|||
48951858|NCT04760314|157654920|FG006|Induction Period|Adverse Event|0|||
48951859|NCT04760314|157654921|FG007|Induction Period|Adverse Event|0|||
48951860|NCT04760314|157654922|FG008|Induction Period|Adverse Event|0|||
48951861|NCT04760314|157654923|FG009|Induction Period|Adverse Event|0|||
48951862|NCT04760314|157654924|FG010|Induction Period|Adverse Event|0|||
48951863|NCT04760314|157654914|FG000|Maintenance Blinded Period|Withdrawal by Subject|0|||
48951864|NCT04760314|157654915|FG001|Maintenance Blinded Period|Withdrawal by Subject|0|||
48951865|NCT04760314|157654916|FG002|Maintenance Blinded Period|Withdrawal by Subject|0|||
48929809|NCT05048719|157576575|FG000|Overall Study|Withdrawal by Subject|2|||
48929810|NCT05048719|157576576|FG001|Overall Study|Withdrawal by Subject|1|||
48929811|NCT05048719|157576577|FG002|Overall Study|Withdrawal by Subject|3|||
48929812|NCT05048719|157576578|FG003|Overall Study|Withdrawal by Subject|1|||
48929813|NCT05048719|157576579|FG004|Overall Study|Withdrawal by Subject|0|||
48929814|NCT05048719|157576580|FG005|Overall Study|Withdrawal by Subject|2|||
48929815|NCT05048719|157576581|FG006|Overall Study|Withdrawal by Subject|1|||
48929816|NCT05048719|157576582|FG007|Overall Study|Withdrawal by Subject|1|||
48929817|NCT05048719|157576583|FG008|Overall Study|Withdrawal by Subject|0|||
48929818|NCT05048719|157576575|FG000|Overall Study|Death|1|||
48929819|NCT05048719|157576576|FG001|Overall Study|Death|0|||
48929820|NCT05048719|157576577|FG002|Overall Study|Death|0|||
48929821|NCT05048719|157576578|FG003|Overall Study|Death|0|||
48929822|NCT05048719|157576579|FG004|Overall Study|Death|0|||
48929823|NCT05048719|157576580|FG005|Overall Study|Death|0|||
48929824|NCT05048719|157576581|FG006|Overall Study|Death|0|||
48929825|NCT05048719|157576582|FG007|Overall Study|Death|0|||
48929826|NCT05048719|157576583|FG008|Overall Study|Death|0|||
48929827|NCT05048719|157576575|FG000|Overall Study|Adverse Event|0|||
48929828|NCT05048719|157576576|FG001|Overall Study|Adverse Event|1|||
48929829|NCT05048719|157576577|FG002|Overall Study|Adverse Event|2|||
48929830|NCT05048719|157576578|FG003|Overall Study|Adverse Event|0|||
48929831|NCT05048719|157576579|FG004|Overall Study|Adverse Event|1|||
48929832|NCT05048719|157576580|FG005|Overall Study|Adverse Event|0|||
48929833|NCT05048719|157576581|FG006|Overall Study|Adverse Event|0|||
48929834|NCT05048719|157576582|FG007|Overall Study|Adverse Event|0|||
48929835|NCT05048719|157576583|FG008|Overall Study|Adverse Event|0|||
48929836|NCT05048719|157576575|FG000|Overall Study|Lost to Follow-up|0|||
48929837|NCT05048719|157576576|FG001|Overall Study|Lost to Follow-up|0|||
48929838|NCT05048719|157576577|FG002|Overall Study|Lost to Follow-up|1|||
48929839|NCT05048719|157576578|FG003|Overall Study|Lost to Follow-up|3|||
48929840|NCT05048719|157576579|FG004|Overall Study|Lost to Follow-up|1|||
48929841|NCT05048719|157576580|FG005|Overall Study|Lost to Follow-up|1|||
48929842|NCT05048719|157576581|FG006|Overall Study|Lost to Follow-up|1|||
48929843|NCT05048719|157576582|FG007|Overall Study|Lost to Follow-up|1|||
48929844|NCT05048719|157576583|FG008|Overall Study|Lost to Follow-up|0|||
48929845|NCT05048719|157576575|FG000|Overall Study|Physician Decision|0|||
48929846|NCT05048719|157576576|FG001|Overall Study|Physician Decision|0|||
48929847|NCT05048719|157576577|FG002|Overall Study|Physician Decision|0|||
48929848|NCT05048719|157576578|FG003|Overall Study|Physician Decision|0|||
48929849|NCT05048719|157576579|FG004|Overall Study|Physician Decision|0|||
48929850|NCT05048719|157576580|FG005|Overall Study|Physician Decision|0|||
48929851|NCT05048719|157576581|FG006|Overall Study|Physician Decision|0|||
48929852|NCT05048719|157576582|FG007|Overall Study|Physician Decision|1|||
48929853|NCT05048719|157576583|FG008|Overall Study|Physician Decision|1|||
48929854|NCT05048719|157576575|FG000|Overall Study|Patient Decision due To Changes in Personal Life|1|||
48929855|NCT05048719|157576576|FG001|Overall Study|Patient Decision due To Changes in Personal Life|0|||
48929856|NCT05048719|157576577|FG002|Overall Study|Patient Decision due To Changes in Personal Life|0|||
48929857|NCT05048719|157576578|FG003|Overall Study|Patient Decision due To Changes in Personal Life|0|||
48929858|NCT05048719|157576579|FG004|Overall Study|Patient Decision due To Changes in Personal Life|0|||
48929859|NCT05048719|157576580|FG005|Overall Study|Patient Decision due To Changes in Personal Life|0|||
48929860|NCT05048719|157576581|FG006|Overall Study|Patient Decision due To Changes in Personal Life|0|||
48929861|NCT05048719|157576582|FG007|Overall Study|Patient Decision due To Changes in Personal Life|0|||
48929862|NCT05048719|157576583|FG008|Overall Study|Patient Decision due To Changes in Personal Life|0|||
48844475|NCT02601820|157272756|FG000|12 Weeks Post-Treatment (T4)|Missing T4 record|3|||
48844476|NCT02601820|157272756|FG000|1-Yr Post-Treatment (T5)|Missing T5 Record|88|||
48844477|NCT01599793|157272757|FG000|Overall Study|Adverse Event|2|||
48844478|NCT02919449|157272759|FG000|Overall Study|Withdrawal by Subject|1|||
48844479|NCT02919449|157272759|FG000|Overall Study|Investigator decision|1|||
48844480|NCT04588298|157272760|FG000|Overall Study|Adverse Event|0|||
48844481|NCT04588298|157272761|FG001|Overall Study|Adverse Event|0|||
48844482|NCT04588298|157272762|FG002|Overall Study|Adverse Event|1|||
48844483|NCT04588298|157272763|FG003|Overall Study|Adverse Event|0|||
48844484|NCT04588298|157272764|FG004|Overall Study|Adverse Event|2|||
48844485|NCT04588298|157272760|FG000|Overall Study|Withdrawal by Subject|1|||
48929863|NCT05048719|157576575|FG000|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
48929864|NCT05048719|157576576|FG001|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|1|||
48929865|NCT05048719|157576577|FG002|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
48929866|NCT05048719|157576578|FG003|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
48929867|NCT05048719|157576579|FG004|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
48929868|NCT05048719|157576580|FG005|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
48929869|NCT05048719|157576581|FG006|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
48929870|NCT05048719|157576582|FG007|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
48929871|NCT05048719|157576583|FG008|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
48929872|NCT05048719|157576575|FG000|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
48929873|NCT05048719|157576576|FG001|Overall Study|Sponsor decision due To inadvertent Enrollment|1|||
48929874|NCT05048719|157576577|FG002|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
48929875|NCT05048719|157576578|FG003|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
48929876|NCT05048719|157576579|FG004|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
48929877|NCT05048719|157576580|FG005|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
48929878|NCT05048719|157576581|FG006|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
48929879|NCT05048719|157576582|FG007|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
48929880|NCT05048719|157576583|FG008|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
48929881|NCT05048719|157576575|FG000|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
48929882|NCT05048719|157576576|FG001|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
48929883|NCT05048719|157576577|FG002|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
48929884|NCT05048719|157576578|FG003|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|1|||
48929885|NCT05048719|157576579|FG004|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
48929886|NCT05048719|157576580|FG005|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
48929887|NCT05048719|157576581|FG006|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
48929888|NCT05048719|157576582|FG007|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
48929889|NCT05048719|157576583|FG008|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
48929890|NCT05048719|157576575|FG000|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
48929891|NCT05048719|157576576|FG001|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
48929892|NCT05048719|157576577|FG002|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
48929893|NCT05048719|157576578|FG003|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
48929894|NCT05048719|157576579|FG004|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
48929895|NCT05048719|157576580|FG005|Overall Study|Site Terminated Participant due to Sponsor Directions|1|||
48929896|NCT05048719|157576581|FG006|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
48929897|NCT05048719|157576582|FG007|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
48929898|NCT05048719|157576583|FG008|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
48929899|NCT02324270|157576584|FG000|Overall Study|Withdrawal by Subject|0|||
48929900|NCT02324270|157576585|FG001|Overall Study|Withdrawal by Subject|1|||
48929901|NCT02324270|157576586|FG002|Overall Study|Withdrawal by Subject|0|||
48929902|NCT02324270|157576584|FG000|Overall Study|Lost to Follow-up|4|||
48929903|NCT02324270|157576585|FG001|Overall Study|Lost to Follow-up|3|||
48929904|NCT02324270|157576586|FG002|Overall Study|Lost to Follow-up|4|||
48929905|NCT02324270|157576584|FG000|Overall Study|Protocol Violation|0|||
48929906|NCT02324270|157576585|FG001|Overall Study|Protocol Violation|1|||
48929907|NCT02324270|157576586|FG002|Overall Study|Protocol Violation|1|||
48929908|NCT02324270|157576584|FG000|Overall Study|Non Compliance with Study Drug|1|||
48929909|NCT02324270|157576585|FG001|Overall Study|Non Compliance with Study Drug|2|||
48929910|NCT02324270|157576586|FG002|Overall Study|Non Compliance with Study Drug|0|||
48929911|NCT00605085|157576588|FG000|Overall Study|Withdrawal by Subject|8|||
48929912|NCT00605085|157576589|FG001|Overall Study|Withdrawal by Subject|5|||
48929913|NCT00605085|157576588|FG000|Overall Study|Adverse Event|9|||
48929914|NCT00605085|157576589|FG001|Overall Study|Adverse Event|5|||
48929915|NCT00605085|157576588|FG000|Overall Study|Pregnancy|2|||
48929916|NCT00605085|157576589|FG001|Overall Study|Pregnancy|0|||
48929917|NCT00605085|157576588|FG000|Overall Study|Protocol Violation|3|||
48929918|NCT00605085|157576589|FG001|Overall Study|Protocol Violation|2|||
48929919|NCT00605085|157576588|FG000|Overall Study|Lost to Follow-up|10|||
48929920|NCT00605085|157576589|FG001|Overall Study|Lost to Follow-up|5|||
48929921|NCT00605085|157576588|FG000|Overall Study|administrative reasons|18|||
48929922|NCT00605085|157576589|FG001|Overall Study|administrative reasons|8|||
48929923|NCT02546986|157576590|FG000|Treatment Period|Progressive Disease|20|||
48929924|NCT02546986|157576591|FG001|Treatment Period|Progressive Disease|22|||
48929925|NCT02546986|157576590|FG000|Treatment Period|Adverse Event|14|||
48929926|NCT02546986|157576591|FG001|Treatment Period|Adverse Event|6|||
48929927|NCT02546986|157576590|FG000|Treatment Period|Symptomatic Deterioration|4|||
48929928|NCT02546986|157576591|FG001|Treatment Period|Symptomatic Deterioration|3|||
48929929|NCT02546986|157576590|FG000|Treatment Period|Death|3|||
48929930|NCT02546986|157576591|FG001|Treatment Period|Death|4|||
48929931|NCT02546986|157576590|FG000|Treatment Period|Physician Decision|1|||
48929932|NCT02546986|157576591|FG001|Treatment Period|Physician Decision|2|||
48929933|NCT02546986|157576590|FG000|Treatment Period|Protocol Violation|1|||
48929934|NCT02546986|157576591|FG001|Treatment Period|Protocol Violation|0|||
48929935|NCT02546986|157576590|FG000|Treatment Period|Withdrawal by Subject|1|||
48929936|NCT02546986|157576591|FG001|Treatment Period|Withdrawal by Subject|1|||
48929937|NCT02546986|157576590|FG000|Treatment Period|Non-compliance with Study Drug|0|||
48929938|NCT02546986|157576591|FG001|Treatment Period|Non-compliance with Study Drug|1|||
48929939|NCT02546986|157576590|FG000|Treatment Period|Study Terminated by Sponsor|0|||
48929940|NCT02546986|157576591|FG001|Treatment Period|Study Terminated by Sponsor|1|||
48929941|NCT02546986|157576590|FG000|Treatment Period|Miscellaneous|7|||
48929942|NCT02546986|157576591|FG001|Treatment Period|Miscellaneous|9|||
48929943|NCT02546986|157576590|FG000|Survival Follow-Up Phase|Missing Status|3|||
48929944|NCT02546986|157576591|FG001|Survival Follow-Up Phase|Missing Status|5|||
48929945|NCT02546986|157576590|FG000|Survival Follow-Up Phase|Death|18|||
48929946|NCT02546986|157576591|FG001|Survival Follow-Up Phase|Death|12|||
48929947|NCT02546986|157576590|FG000|Survival Follow-Up Phase|Alive|13|||
48929948|NCT02546986|157576591|FG001|Survival Follow-Up Phase|Alive|16|||
48929949|NCT02546986|157576590|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
48929950|NCT02546986|157576591|FG001|Survival Follow-Up Phase|Lost to Follow-up|2|||
48929951|NCT02002975|157576594|FG000|Overall Study|Case Report Forms Uncollected|135|||
48929952|NCT02002975|157576594|FG000|Overall Study|Protocol Deviation|437|||
48929953|NCT04660643|157576595|FG000|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|50|||
48929954|NCT04660643|157576596|FG001|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
48929955|NCT04660643|157576597|FG002|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
48929956|NCT04660643|157576595|FG000|Open-label Lead-in Period (Week 0 - 36)|Death|1|||
48929957|NCT04660643|157576596|FG001|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
48929958|NCT04660643|157576597|FG002|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
48929959|NCT04660643|157576595|FG000|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|14|||
48929960|NCT04660643|157576596|FG001|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
48929961|NCT04660643|157576597|FG002|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
48929962|NCT04660643|157576595|FG000|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|1|||
48929963|NCT04660643|157576596|FG001|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
48929964|NCT04660643|157576597|FG002|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
48929965|NCT04660643|157576595|FG000|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|1|||
48929966|NCT04660643|157576596|FG001|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
48929967|NCT04660643|157576597|FG002|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
48929968|NCT04660643|157576595|FG000|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|10|||
48929969|NCT04660643|157576596|FG001|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
48929970|NCT04660643|157576597|FG002|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
48929971|NCT04660643|157576595|FG000|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|32|||
48929972|NCT04660643|157576596|FG001|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
48929973|NCT04660643|157576597|FG002|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
48929974|NCT04660643|157576595|FG000|Open-label Lead-in Period (Week 0 - 36)|Covid-19|1|||
48929975|NCT04660643|157576596|FG001|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
48929976|NCT04660643|157576597|FG002|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
48929977|NCT04660643|157576595|FG000|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|2|||
48929978|NCT04660643|157576596|FG001|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
48929979|NCT04660643|157576597|FG002|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
48929980|NCT04660643|157576595|FG000|Double-blind Study Period (Week 36 - 92)|Death|0|||
48929981|NCT04660643|157576596|FG001|Double-blind Study Period (Week 36 - 92)|Death|1|||
48929982|NCT04660643|157576597|FG002|Double-blind Study Period (Week 36 - 92)|Death|1|||
48929983|NCT04660643|157576595|FG000|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|0|||
48929984|NCT04660643|157576596|FG001|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|10|||
48929985|NCT04660643|157576597|FG002|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|8|||
48929986|NCT04660643|157576595|FG000|Double-blind Study Period (Week 36 - 92)|Pregnancy|0|||
48929987|NCT04660643|157576596|FG001|Double-blind Study Period (Week 36 - 92)|Pregnancy|2|||
48929988|NCT04660643|157576597|FG002|Double-blind Study Period (Week 36 - 92)|Pregnancy|1|||
48929989|NCT04660643|157576595|FG000|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|0|||
48929990|NCT04660643|157576596|FG001|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|22|||
48929991|NCT04660643|157576597|FG002|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|13|||
48929992|NCT04660643|157576595|FG000|Double-blind Study Period (Week 36 - 92)|Protocol deviation|0|||
48929993|NCT04660643|157576596|FG001|Double-blind Study Period (Week 36 - 92)|Protocol deviation|1|||
48929994|NCT04660643|157576597|FG002|Double-blind Study Period (Week 36 - 92)|Protocol deviation|2|||
48929995|NCT04660643|157576595|FG000|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
48929996|NCT04660643|157576596|FG001|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|8|||
48929997|NCT04660643|157576597|FG002|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
48929998|NCT04660643|157576595|FG000|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
48929999|NCT04660643|157576596|FG001|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|1|||
48930000|NCT04660643|157576597|FG002|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
48930001|NCT03988907|157576598|FG000|Overall Study|Unable to complete visit|0|||
48930002|NCT03988907|157576599|FG001|Overall Study|Unable to complete visit|1|||
48930003|NCT02810964|157576600|FG000|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1|||
48930004|NCT02810964|157576601|FG001|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2|||
48930005|NCT02810964|157576600|FG000|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1|||
48930006|NCT02810964|157576601|FG001|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0|||
48930007|NCT02810964|157576600|FG000|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0|||
48930008|NCT02810964|157576601|FG001|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1|||
48930009|NCT02810964|157576600|FG000|Double-Blind Treatment Phase (16 Weeks)|Relocation|1|||
48930010|NCT02810964|157576601|FG001|Double-Blind Treatment Phase (16 Weeks)|Relocation|0|||
48930011|NCT01641939|157576603|FG000|Overall Study|Death|90|||
48930012|NCT01641939|157576604|FG001|Overall Study|Death|187|||
48930013|NCT01641939|157576605|FG002|Overall Study|Death|61|||
48930014|NCT01641939|157576603|FG000|Overall Study|Lost to Follow-up|3|||
48930015|NCT01641939|157576604|FG001|Overall Study|Lost to Follow-up|2|||
48930016|NCT01641939|157576605|FG002|Overall Study|Lost to Follow-up|1|||
48930017|NCT01641939|157576603|FG000|Overall Study|Withdrawal by Subject|14|||
48930018|NCT01641939|157576604|FG001|Overall Study|Withdrawal by Subject|11|||
48930019|NCT01641939|157576605|FG002|Overall Study|Withdrawal by Subject|5|||
48930020|NCT01641939|157576603|FG000|Overall Study|Study Terminated by Sponsor|10|||
48930021|NCT01641939|157576604|FG001|Overall Study|Study Terminated by Sponsor|28|||
48930022|NCT01641939|157576605|FG002|Overall Study|Study Terminated by Sponsor|3|||
48930023|NCT04356183|157576606|FG000|Overall Study|Lost to Follow-up|1|||
48930024|NCT04356183|157576607|FG001|Overall Study|Lost to Follow-up|0|||
48930025|NCT04356183|157576606|FG000|Overall Study|Withdrawal by Subject|1|||
48930026|NCT04356183|157576607|FG001|Overall Study|Withdrawal by Subject|1|||
48930027|NCT00772629|157576608|FG000|Overall Study|Subject was not vaccinated|1|||
48930028|NCT00772629|157576609|FG001|Overall Study|Subject was not vaccinated|0|||
48930029|NCT00469612|157576610|FG000|Overall Study|Study terminated before data collected|2|||
48930030|NCT00469612|157576611|FG001|Overall Study|Study terminated before data collected|0|||
48930031|NCT01885000|157576612|FG000|Overall Study|Adverse Event|1|||
48930032|NCT01885000|157576613|FG001|Overall Study|Adverse Event|0|||
48930033|NCT01885000|157576612|FG000|Overall Study|Withdrawal by Subject|1|||
48930034|NCT01885000|157576613|FG001|Overall Study|Withdrawal by Subject|1|||
48930035|NCT01885000|157576612|FG000|Overall Study|Protocol Violation|0|||
48930036|NCT01885000|157576613|FG001|Overall Study|Protocol Violation|1|||
48930037|NCT03446885|157576615|FG000|Overall Study|Lost to Follow-up|1|||
48930038|NCT03446885|157576616|FG001|Overall Study|Lost to Follow-up|0|||
48930039|NCT03446885|157576615|FG000|Overall Study|Did not complete entire visit|1|||
48930040|NCT03446885|157576616|FG001|Overall Study|Did not complete entire visit|0|||
48930041|NCT00584233|157576618|FG000|Overall Study|Withdrawal by Subject|5|||
48930042|NCT00584233|157576618|FG000|Overall Study|Subjects did not complete both CT and MRI to be evaluated in results|13|||
48930043|NCT00159432|157576619|FG000|Overall Study|Adverse Event|1|||
48930044|NCT00159432|157576619|FG000|Overall Study|Death|1|||
48930045|NCT00159432|157576619|FG000|Overall Study|Lack of Efficacy|8|||
48930046|NCT01764633|157576620|FG000|Overall Study|Withdrawal by Subject|105|||
48930047|NCT01764633|157576621|FG001|Overall Study|Withdrawal by Subject|88|||
48930048|NCT01764633|157576620|FG000|Overall Study|Lost to Follow-up|13|||
48930049|NCT01764633|157576621|FG001|Overall Study|Lost to Follow-up|5|||
48930050|NCT00493038|157576622|FG000|Treatment|Adverse Event|8|||
48930051|NCT00493038|157576623|FG001|Treatment|Adverse Event|4|||
48930052|NCT00493038|157576622|FG000|Treatment|Lost to Follow-up|5|||
48930053|NCT00493038|157576623|FG001|Treatment|Lost to Follow-up|3|||
48930054|NCT00493038|157576622|FG000|Treatment|Withdrawal by Subject|11|||
48930055|NCT00493038|157576623|FG001|Treatment|Withdrawal by Subject|12|||
48930056|NCT00493038|157576622|FG000|Treatment|Other|0|||
48930057|NCT00493038|157576623|FG001|Treatment|Other|1|||
48930058|NCT00493038|157576622|FG000|Follow-up|Lost to Follow-up|1|||
48930059|NCT00493038|157576623|FG001|Follow-up|Lost to Follow-up|0|||
48930060|NCT00704964|157576624|FG000|Overall Study|Not completed on time|328|||
48930061|NCT00763321|157576629|FG000|Open-label Period|Adverse Event|24|||
48930062|NCT00763321|157576630|FG001|Open-label Period|Adverse Event|0|||
48930063|NCT00763321|157576631|FG002|Open-label Period|Adverse Event|0|||
48930064|NCT00763321|157576629|FG000|Open-label Period|Lost to Follow-up|14|||
48930065|NCT00763321|157576630|FG001|Open-label Period|Lost to Follow-up|0|||
48930066|NCT00763321|157576631|FG002|Open-label Period|Lost to Follow-up|0|||
48930067|NCT00763321|157576629|FG000|Open-label Period|Withdrawal by Subject|7|||
48930068|NCT00763321|157576630|FG001|Open-label Period|Withdrawal by Subject|0|||
48930069|NCT00763321|157576631|FG002|Open-label Period|Withdrawal by Subject|0|||
48930070|NCT00763321|157576629|FG000|Open-label Period|Subject noncompliant|7|||
48930071|NCT00763321|157576630|FG001|Open-label Period|Subject noncompliant|0|||
48930072|NCT00763321|157576631|FG002|Open-label Period|Subject noncompliant|0|||
48930073|NCT00763321|157576629|FG000|Open-label Period|Did not meet DB randomization criteria|5|||
48930074|NCT00763321|157576630|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
48930075|NCT00763321|157576631|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
48930076|NCT00763321|157576629|FG000|Open-label Period|Lack of Efficacy|2|||
48930077|NCT00763321|157576630|FG001|Open-label Period|Lack of Efficacy|0|||
48930078|NCT00763321|157576631|FG002|Open-label Period|Lack of Efficacy|0|||
48930079|NCT00763321|157576629|FG000|Open-label Period|Other|4|||
48930080|NCT00763321|157576630|FG001|Open-label Period|Other|0|||
48930081|NCT00763321|157576631|FG002|Open-label Period|Other|0|||
48930082|NCT00763321|157576629|FG000|Double-blind Period|Lack of Efficacy|0|||
48930083|NCT00763321|157576630|FG001|Double-blind Period|Lack of Efficacy|9|||
48930084|NCT00763321|157576631|FG002|Double-blind Period|Lack of Efficacy|17|||
48930085|NCT00763321|157576629|FG000|Double-blind Period|Adverse Event|0|||
48930086|NCT00763321|157576630|FG001|Double-blind Period|Adverse Event|4|||
48930087|NCT00763321|157576631|FG002|Double-blind Period|Adverse Event|4|||
48930088|NCT00763321|157576629|FG000|Double-blind Period|Lost to Follow-up|0|||
48930089|NCT00763321|157576630|FG001|Double-blind Period|Lost to Follow-up|4|||
48930090|NCT00763321|157576631|FG002|Double-blind Period|Lost to Follow-up|2|||
48930091|NCT00763321|157576629|FG000|Double-blind Period|Withdrawal by Subject|0|||
48930092|NCT00763321|157576630|FG001|Double-blind Period|Withdrawal by Subject|2|||
48930093|NCT00763321|157576631|FG002|Double-blind Period|Withdrawal by Subject|3|||
48930094|NCT00763321|157576629|FG000|Double-blind Period|Other|0|||
48930095|NCT00763321|157576630|FG001|Double-blind Period|Other|2|||
48930096|NCT00763321|157576631|FG002|Double-blind Period|Other|3|||
48930097|NCT01017952|157576632|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356|||
48930098|NCT01017952|157576633|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
48735647|NCT02215096|156883706|FG001|Run-In Period (Up to Week 2)|Adverse Event|0|||
48930099|NCT01017952|157576634|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
48930100|NCT01017952|157576635|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
48930101|NCT01017952|157576636|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
48930102|NCT01017952|157576632|FG000|4-week, Open-label Run-In Period|Adverse Event|23|||
48930103|NCT01017952|157576633|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
48930104|NCT01017952|157576634|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
48930105|NCT01017952|157576635|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
48930106|NCT01017952|157576636|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
48930107|NCT01017952|157576632|FG000|4-week, Open-label Run-In Period|Study Closed/Tterminated|1|||
48930108|NCT01017952|157576633|FG001|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
48930109|NCT01017952|157576634|FG002|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
48930110|NCT01017952|157576635|FG003|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
48930111|NCT01017952|157576636|FG004|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
48930112|NCT01017952|157576632|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
48930113|NCT01017952|157576633|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
48930114|NCT01017952|157576634|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
48930115|NCT01017952|157576635|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
48930116|NCT01017952|157576636|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
48930117|NCT01017952|157576632|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
48930118|NCT01017952|157576633|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
48930119|NCT01017952|157576634|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
48930120|NCT01017952|157576635|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
48930121|NCT01017952|157576636|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
48930122|NCT01017952|157576632|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|63|||
48930123|NCT01017952|157576633|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
48930124|NCT01017952|157576634|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
48930125|NCT01017952|157576635|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
48930126|NCT01017952|157576636|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
48930127|NCT01017952|157576632|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
48930128|NCT01017952|157576633|FG001|52-week, Double-blind Treatment Period|Adverse Event|25|||
48930129|NCT01017952|157576634|FG002|52-week, Double-blind Treatment Period|Adverse Event|32|||
48930130|NCT01017952|157576635|FG003|52-week, Double-blind Treatment Period|Adverse Event|35|||
48930131|NCT01017952|157576636|FG004|52-week, Double-blind Treatment Period|Adverse Event|30|||
48930132|NCT01017952|157576632|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
48930133|NCT01017952|157576633|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|30|||
48930134|NCT01017952|157576634|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
48930135|NCT01017952|157576635|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
48930136|NCT01017952|157576636|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
48930137|NCT01017952|157576632|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
48930138|NCT01017952|157576633|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|35|||
48930139|NCT01017952|157576634|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
48930140|NCT01017952|157576635|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
48930141|NCT01017952|157576636|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
48930142|NCT01017952|157576632|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
48930143|NCT01017952|157576633|FG001|52-week, Double-blind Treatment Period|Protocol Violation|7|||
48930144|NCT01017952|157576634|FG002|52-week, Double-blind Treatment Period|Protocol Violation|11|||
48930145|NCT01017952|157576635|FG003|52-week, Double-blind Treatment Period|Protocol Violation|9|||
48930146|NCT01017952|157576636|FG004|52-week, Double-blind Treatment Period|Protocol Violation|8|||
48930147|NCT01017952|157576632|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
48930148|NCT01017952|157576633|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
48930149|NCT01017952|157576634|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
48930150|NCT01017952|157576635|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12|||
48930151|NCT01017952|157576636|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
48930152|NCT01017952|157576632|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
48930153|NCT01017952|157576633|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
48930154|NCT01017952|157576634|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
48930155|NCT01017952|157576635|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
48930156|NCT01017952|157576636|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
48930157|NCT01017952|157576632|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
48930158|NCT01017952|157576633|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
48930159|NCT01017952|157576634|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|8|||
48930160|NCT01017952|157576635|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
48930161|NCT01017952|157576636|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|10|||
48930162|NCT01017952|157576632|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
48930163|NCT01017952|157576633|FG001|52-week, Double-blind Treatment Period|Physician Decision|10|||
48930164|NCT01017952|157576634|FG002|52-week, Double-blind Treatment Period|Physician Decision|8|||
48930165|NCT01017952|157576635|FG003|52-week, Double-blind Treatment Period|Physician Decision|9|||
48930166|NCT01017952|157576636|FG004|52-week, Double-blind Treatment Period|Physician Decision|7|||
48930167|NCT01064167|157576637|FG000|Overall Study|Protocol Violation|14|||
48930168|NCT01064167|157576638|FG001|Overall Study|Protocol Violation|15|||
48930169|NCT03804684|157576639|FG000|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|3|||
48930170|NCT03804684|157576640|FG001|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|18|||
48930171|NCT02532855|157576643|FG000|Overall Study|Lost to Follow-up|4|||
48930172|NCT02532855|157576644|FG001|Overall Study|Lost to Follow-up|3|||
48930173|NCT02532855|157576643|FG000|Overall Study|Withdrawal by Subject|4|||
48930174|NCT02532855|157576644|FG001|Overall Study|Withdrawal by Subject|8|||
48930175|NCT02471716|157576653|FG000|Overall Study|Withdrawal by Subject|0|||
48930176|NCT02471716|157576654|FG001|Overall Study|Withdrawal by Subject|1|||
48930177|NCT02471716|157576655|FG002|Overall Study|Withdrawal by Subject|0|||
48930178|NCT02471716|157576656|FG003|Overall Study|Withdrawal by Subject|2|||
48930179|NCT02471716|157576657|FG004|Overall Study|Withdrawal by Subject|5|||
48930180|NCT02471716|157576653|FG000|Overall Study|Study Terminiated by sponsor|0|||
48930181|NCT02471716|157576654|FG001|Overall Study|Study Terminiated by sponsor|0|||
48930182|NCT02471716|157576655|FG002|Overall Study|Study Terminiated by sponsor|0|||
48930183|NCT02471716|157576656|FG003|Overall Study|Study Terminiated by sponsor|1|||
48930184|NCT02471716|157576657|FG004|Overall Study|Study Terminiated by sponsor|0|||
48930185|NCT02471716|157576653|FG000|Overall Study|Lost to Follow-up|0|||
48930186|NCT02471716|157576654|FG001|Overall Study|Lost to Follow-up|0|||
48930187|NCT02471716|157576655|FG002|Overall Study|Lost to Follow-up|0|||
48930188|NCT02471716|157576656|FG003|Overall Study|Lost to Follow-up|3|||
48930189|NCT02471716|157576657|FG004|Overall Study|Lost to Follow-up|2|||
48930190|NCT02471716|157576653|FG000|Overall Study|Death|0|||
48930191|NCT02471716|157576654|FG001|Overall Study|Death|0|||
48930192|NCT02471716|157576655|FG002|Overall Study|Death|0|||
48930193|NCT02471716|157576656|FG003|Overall Study|Death|1|||
48930194|NCT02471716|157576657|FG004|Overall Study|Death|0|||
48930195|NCT02471716|157576653|FG000|Overall Study|Other|0|||
48930196|NCT02471716|157576654|FG001|Overall Study|Other|0|||
48930197|NCT02471716|157576655|FG002|Overall Study|Other|0|||
48930198|NCT02471716|157576656|FG003|Overall Study|Other|8|||
48930199|NCT02471716|157576657|FG004|Overall Study|Other|9|||
48930200|NCT00130286|157576660|FG000|Overall Study|Withdrawal by Subject|0|||
48930201|NCT00130286|157576661|FG001|Overall Study|Withdrawal by Subject|1|||
48930202|NCT00130286|157576662|FG002|Overall Study|Withdrawal by Subject|2|||
48930203|NCT00130286|157576663|FG003|Overall Study|Withdrawal by Subject|2|||
48930204|NCT00130286|157576660|FG000|Overall Study|Adverse Event|0|||
48930205|NCT00130286|157576661|FG001|Overall Study|Adverse Event|0|||
48930206|NCT00130286|157576662|FG002|Overall Study|Adverse Event|2|||
48930207|NCT00130286|157576663|FG003|Overall Study|Adverse Event|0|||
48930208|NCT00130286|157576660|FG000|Overall Study|Missing lab specimens|0|||
48930209|NCT00130286|157576661|FG001|Overall Study|Missing lab specimens|2|||
48930210|NCT00130286|157576662|FG002|Overall Study|Missing lab specimens|0|||
48930211|NCT00130286|157576663|FG003|Overall Study|Missing lab specimens|0|||
48930212|NCT00713219|157576673|FG000|Overall Study|Death|1|||
48930213|NCT00713219|157576673|FG000|Overall Study|Protocol Violation|1|||
48930214|NCT00508391|157576674|FG000|First Treatment|Withdrawal by Subject|6|||
48930215|NCT00508391|157576675|FG001|First Treatment|Withdrawal by Subject|3|||
48930216|NCT00508391|157576674|FG000|Second Treatment|Withdrawal by Subject|2|||
48844486|NCT04588298|157272761|FG001|Overall Study|Withdrawal by Subject|0|||
48844487|NCT04588298|157272762|FG002|Overall Study|Withdrawal by Subject|0|||
48844488|NCT04588298|157272763|FG003|Overall Study|Withdrawal by Subject|1|||
48930217|NCT00508391|157576675|FG001|Second Treatment|Withdrawal by Subject|0|||
48930218|NCT02665286|157576680|FG000|Overall Study|Lost to Follow-up|3|||
48930219|NCT02665286|157576681|FG001|Overall Study|Lost to Follow-up|2|||
48930220|NCT02665286|157576682|FG002|Overall Study|Lost to Follow-up|1|||
48930221|NCT01557166|157576693|FG000|Overall Study|Adverse Event|20|||
48930222|NCT01557166|157576694|FG001|Overall Study|Adverse Event|6|||
48930223|NCT01557166|157576693|FG000|Overall Study|Lack of Efficacy|2|||
48930224|NCT01557166|157576694|FG001|Overall Study|Lack of Efficacy|1|||
48930225|NCT01557166|157576693|FG000|Overall Study|Protocol Violation|8|||
48930226|NCT01557166|157576694|FG001|Overall Study|Protocol Violation|5|||
48930227|NCT01557166|157576693|FG000|Overall Study|Withdrawn consent|12|||
48930228|NCT01557166|157576694|FG001|Overall Study|Withdrawn consent|20|||
48930229|NCT01557166|157576693|FG000|Overall Study|Target dose not tolerated|1|||
48930230|NCT01557166|157576694|FG001|Overall Study|Target dose not tolerated|0|||
48930231|NCT01557166|157576693|FG000|Overall Study|Psychiatric disorder|1|||
48930232|NCT01557166|157576694|FG001|Overall Study|Psychiatric disorder|0|||
48930233|NCT01557166|157576693|FG000|Overall Study|Unclassified|2|||
48930234|NCT01557166|157576694|FG001|Overall Study|Unclassified|5|||
48930235|NCT01818297|157576695|FG000|Blinded Phase (Randomization - 3 Months)|Adverse Event|0|||
48930236|NCT01818297|157576696|FG001|Blinded Phase (Randomization - 3 Months)|Adverse Event|1|||
48930237|NCT01818297|157576695|FG000|Open Label Phase (3-12 Months)|Physician Decision|1|||
48930238|NCT01818297|157576696|FG001|Open Label Phase (3-12 Months)|Physician Decision|0|||
48930239|NCT01818297|157576695|FG000|Open Label Phase (3-12 Months)|Early study closure|17|||
48930240|NCT01818297|157576696|FG001|Open Label Phase (3-12 Months)|Early study closure|10|||
48930241|NCT00573794|157576697|FG000|Overall Study|Adverse Event|81|||
48930242|NCT00573794|157576697|FG000|Overall Study|Withdrew Consent|90|||
48930243|NCT00573794|157576697|FG000|Overall Study|Lost to Follow-up|13|||
48930244|NCT00573794|157576697|FG000|Overall Study|Protocol Violation|6|||
48930245|NCT00573794|157576697|FG000|Overall Study|Lack of Efficacy|94|||
48930246|NCT00573794|157576697|FG000|Overall Study|Other|46|||
48930247|NCT01988090|157576698|FG000|Start Treament After Randomization|Withdrawal by Subject|2|||
48930248|NCT01988090|157576699|FG001|Start Treament After Randomization|Withdrawal by Subject|3|||
48930249|NCT01988090|157576698|FG000|Start Treament After Randomization|Protocol Violation|0|||
48930250|NCT01988090|157576699|FG001|Start Treament After Randomization|Protocol Violation|1|||
48930251|NCT01988090|157576698|FG000|Complete Study After Start|Withdrawal by Subject|2|||
48930252|NCT01988090|157576699|FG001|Complete Study After Start|Withdrawal by Subject|0|||
48930253|NCT01988090|157576698|FG000|Complete Study After Start|Protocol Violation|1|||
48930254|NCT01988090|157576699|FG001|Complete Study After Start|Protocol Violation|1|||
48930255|NCT03687502|157576703|FG000|Overall Study|IV was removed prior to radiology visit for ultrasound|1|||
48930256|NCT03687502|157576703|FG000|Overall Study|Lumason not available|1|||
48930257|NCT00486278|157576707|FG000|Overall Study|Adverse Event|5|||
48930258|NCT00486278|157576707|FG000|Overall Study|Withdrawal by Subject|2|||
48930259|NCT00486278|157576707|FG000|Overall Study|Physician Decision|2|||
48930260|NCT01725750|157576708|FG000|Overall Study|Adverse Event|1|||
48930261|NCT01725750|157576709|FG001|Overall Study|Adverse Event|0|||
48930262|NCT01725750|157576708|FG000|Overall Study|Lost to Follow-up|1|||
48930263|NCT01725750|157576709|FG001|Overall Study|Lost to Follow-up|1|||
48930264|NCT01725750|157576708|FG000|Overall Study|Withdrawal by Subject|0|||
48930265|NCT01725750|157576709|FG001|Overall Study|Withdrawal by Subject|9|||
48930266|NCT02542072|157576710|FG000|First Intervention (1 Month)|Adverse Event|1|||
48930267|NCT02542072|157576711|FG001|First Intervention (1 Month)|Adverse Event|1|||
48930268|NCT02542072|157576710|FG000|First Intervention (1 Month)|Lost to Follow-up|2|||
48930269|NCT02542072|157576711|FG001|First Intervention (1 Month)|Lost to Follow-up|0|||
48930270|NCT02542072|157576710|FG000|First Intervention (1 Month)|Lens discomfort|1|||
48930271|NCT02542072|157576711|FG001|First Intervention (1 Month)|Lens discomfort|2|||
48930272|NCT02542072|157576710|FG000|First Intervention (1 Month)|Protocol Violation|1|||
48930273|NCT02542072|157576711|FG001|First Intervention (1 Month)|Protocol Violation|0|||
48930274|NCT02542072|157576710|FG000|Second Intervention (1 Month)|Lost to Follow-up|1|||
48930275|NCT02542072|157576711|FG001|Second Intervention (1 Month)|Lost to Follow-up|0|||
48930276|NCT02542072|157576710|FG000|Second Intervention (1 Month)|Lens discomfort|1|||
48930277|NCT02542072|157576711|FG001|Second Intervention (1 Month)|Lens discomfort|0|||
48930278|NCT03828487|157576716|FG000|Overall Study|Physician Decision|1|||
48930279|NCT00630331|157576719|FG000|Overall Study|Death|2|||
48930280|NCT00630331|157576720|FG001|Overall Study|Death|1|||
48930281|NCT00630331|157576721|FG002|Overall Study|Death|1|||
48930282|NCT00630331|157576719|FG000|Overall Study|Adverse Event|1|||
48930283|NCT00630331|157576720|FG001|Overall Study|Adverse Event|0|||
48930284|NCT00630331|157576721|FG002|Overall Study|Adverse Event|0|||
48930285|NCT00630331|157576719|FG000|Overall Study|Withdrawal by Subject|12|||
48930286|NCT00630331|157576720|FG001|Overall Study|Withdrawal by Subject|7|||
48930287|NCT00630331|157576721|FG002|Overall Study|Withdrawal by Subject|5|||
48930288|NCT00630331|157576719|FG000|Overall Study|Lost to Follow-up|175|||
48844489|NCT04588298|157272764|FG004|Overall Study|Withdrawal by Subject|0|||
48844490|NCT01376700|157272765|FG000|Overall Study|Sponsor terminated study early|8|||
48844491|NCT01376700|157272765|FG000|Overall Study|Low or high titer inhibitor|8|||
48844492|NCT02564744|157272766|FG000|Overall Study|Investigator decision|0|||
48844493|NCT02564744|157272767|FG001|Overall Study|Investigator decision|0|||
48844494|NCT02564744|157272768|FG002|Overall Study|Investigator decision|0|||
48844495|NCT02564744|157272769|FG003|Overall Study|Investigator decision|0|||
48844496|NCT02564744|157272770|FG004|Overall Study|Investigator decision|1|||
48844497|NCT02564744|157272766|FG000|Overall Study|Death|10|||
48844498|NCT02564744|157272767|FG001|Overall Study|Death|5|||
48844499|NCT02564744|157272768|FG002|Overall Study|Death|4|||
48844500|NCT02564744|157272769|FG003|Overall Study|Death|16|||
48844501|NCT02564744|157272770|FG004|Overall Study|Death|16|||
48844502|NCT02564744|157272766|FG000|Overall Study|End of study Page Missing|0|||
48844503|NCT02564744|157272767|FG001|Overall Study|End of study Page Missing|0|||
48844504|NCT02564744|157272768|FG002|Overall Study|End of study Page Missing|3|||
48844505|NCT02564744|157272769|FG003|Overall Study|End of study Page Missing|3|||
48844506|NCT02564744|157272770|FG004|Overall Study|End of study Page Missing|0|||
48930289|NCT00630331|157576720|FG001|Overall Study|Lost to Follow-up|143|||
48930290|NCT00630331|157576721|FG002|Overall Study|Lost to Follow-up|170|||
48930291|NCT00630331|157576719|FG000|Overall Study|Inappropriate enrollment|3|||
48930292|NCT00630331|157576720|FG001|Overall Study|Inappropriate enrollment|6|||
48930293|NCT00630331|157576721|FG002|Overall Study|Inappropriate enrollment|3|||
48930294|NCT00630331|157576719|FG000|Overall Study|Unable to classify|9|||
48930295|NCT00630331|157576720|FG001|Overall Study|Unable to classify|4|||
48930296|NCT00630331|157576721|FG002|Overall Study|Unable to classify|3|||
48930297|NCT00630331|157576719|FG000|Overall Study|Protocol Violation|4|||
48930298|NCT00630331|157576720|FG001|Overall Study|Protocol Violation|5|||
48930299|NCT00630331|157576721|FG002|Overall Study|Protocol Violation|6|||
48930300|NCT01827384|157576722|FG000|Overall Study|Switched to alternative treatment|0|||
48930301|NCT01827384|157576723|FG001|Overall Study|Switched to alternative treatment|0|||
48930302|NCT01827384|157576724|FG002|Overall Study|Switched to alternative treatment|0|||
48930303|NCT01827384|157576725|FG003|Overall Study|Switched to alternative treatment|0|||
48930304|NCT01827384|157576726|FG004|Overall Study|Switched to alternative treatment|0|||
48930305|NCT01827384|157576727|FG005|Overall Study|Switched to alternative treatment|0|||
48930306|NCT01827384|157576728|FG006|Overall Study|Switched to alternative treatment|0|||
48930307|NCT01827384|157576729|FG007|Overall Study|Switched to alternative treatment|0|||
48930308|NCT01827384|157576730|FG008|Overall Study|Switched to alternative treatment|0|||
48930309|NCT01827384|157576731|FG009|Overall Study|Switched to alternative treatment|0|||
48930310|NCT01827384|157576732|FG010|Overall Study|Switched to alternative treatment|0|||
48930311|NCT01827384|157576733|FG011|Overall Study|Switched to alternative treatment|0|||
48930312|NCT01827384|157576734|FG012|Overall Study|Switched to alternative treatment|0|||
48930313|NCT01827384|157576735|FG013|Overall Study|Switched to alternative treatment|2|||
48930314|NCT01827384|157576722|FG000|Overall Study|Disease progression before treatment|0|||
48930315|NCT01827384|157576723|FG001|Overall Study|Disease progression before treatment|0|||
48930316|NCT01827384|157576724|FG002|Overall Study|Disease progression before treatment|0|||
48930317|NCT01827384|157576725|FG003|Overall Study|Disease progression before treatment|0|||
48930318|NCT01827384|157576726|FG004|Overall Study|Disease progression before treatment|0|||
48930319|NCT01827384|157576727|FG005|Overall Study|Disease progression before treatment|0|||
48930320|NCT01827384|157576728|FG006|Overall Study|Disease progression before treatment|0|||
48930321|NCT01827384|157576729|FG007|Overall Study|Disease progression before treatment|0|||
48930322|NCT01827384|157576730|FG008|Overall Study|Disease progression before treatment|0|||
48930323|NCT01827384|157576731|FG009|Overall Study|Disease progression before treatment|0|||
48930324|NCT01827384|157576732|FG010|Overall Study|Disease progression before treatment|0|||
48930325|NCT01827384|157576733|FG011|Overall Study|Disease progression before treatment|0|||
48930326|NCT01827384|157576734|FG012|Overall Study|Disease progression before treatment|0|||
48930327|NCT01827384|157576735|FG013|Overall Study|Disease progression before treatment|4|||
48930328|NCT01827384|157576722|FG000|Overall Study|Ineligible|0|||
48930329|NCT01827384|157576723|FG001|Overall Study|Ineligible|0|||
48930330|NCT01827384|157576724|FG002|Overall Study|Ineligible|0|||
48930331|NCT01827384|157576725|FG003|Overall Study|Ineligible|0|||
48930332|NCT01827384|157576726|FG004|Overall Study|Ineligible|0|||
48930333|NCT01827384|157576727|FG005|Overall Study|Ineligible|0|||
48930334|NCT01827384|157576728|FG006|Overall Study|Ineligible|0|||
48930335|NCT01827384|157576729|FG007|Overall Study|Ineligible|0|||
48930336|NCT01827384|157576730|FG008|Overall Study|Ineligible|0|||
48930337|NCT01827384|157576731|FG009|Overall Study|Ineligible|0|||
48930338|NCT01827384|157576732|FG010|Overall Study|Ineligible|0|||
48930339|NCT01827384|157576733|FG011|Overall Study|Ineligible|0|||
48930340|NCT01827384|157576734|FG012|Overall Study|Ineligible|0|||
48930341|NCT01827384|157576735|FG013|Overall Study|Ineligible|19|||
48930342|NCT01827384|157576722|FG000|Overall Study|Participant died before treatment|0|||
48930343|NCT01827384|157576723|FG001|Overall Study|Participant died before treatment|0|||
48930344|NCT01827384|157576724|FG002|Overall Study|Participant died before treatment|0|||
48930345|NCT01827384|157576725|FG003|Overall Study|Participant died before treatment|0|||
48930346|NCT01827384|157576726|FG004|Overall Study|Participant died before treatment|0|||
48930347|NCT01827384|157576727|FG005|Overall Study|Participant died before treatment|0|||
48930348|NCT01827384|157576728|FG006|Overall Study|Participant died before treatment|0|||
48930349|NCT01827384|157576729|FG007|Overall Study|Participant died before treatment|0|||
48930350|NCT01827384|157576730|FG008|Overall Study|Participant died before treatment|0|||
48930351|NCT01827384|157576731|FG009|Overall Study|Participant died before treatment|0|||
48930352|NCT01827384|157576732|FG010|Overall Study|Participant died before treatment|0|||
48930353|NCT01827384|157576733|FG011|Overall Study|Participant died before treatment|0|||
48930354|NCT01827384|157576734|FG012|Overall Study|Participant died before treatment|0|||
48930355|NCT01827384|157576735|FG013|Overall Study|Participant died before treatment|5|||
48930356|NCT01827384|157576722|FG000|Overall Study|Insufficient tumor cells|0|||
48930357|NCT01827384|157576723|FG001|Overall Study|Insufficient tumor cells|0|||
48930358|NCT01827384|157576724|FG002|Overall Study|Insufficient tumor cells|0|||
48930359|NCT01827384|157576725|FG003|Overall Study|Insufficient tumor cells|0|||
48930360|NCT01827384|157576726|FG004|Overall Study|Insufficient tumor cells|0|||
48930361|NCT01827384|157576727|FG005|Overall Study|Insufficient tumor cells|0|||
48930362|NCT01827384|157576728|FG006|Overall Study|Insufficient tumor cells|0|||
48930363|NCT01827384|157576729|FG007|Overall Study|Insufficient tumor cells|0|||
48930364|NCT01827384|157576730|FG008|Overall Study|Insufficient tumor cells|0|||
48930365|NCT01827384|157576731|FG009|Overall Study|Insufficient tumor cells|0|||
48930366|NCT01827384|157576732|FG010|Overall Study|Insufficient tumor cells|0|||
48930367|NCT01827384|157576733|FG011|Overall Study|Insufficient tumor cells|0|||
48930368|NCT01827384|157576734|FG012|Overall Study|Insufficient tumor cells|0|||
48930369|NCT01827384|157576735|FG013|Overall Study|Insufficient tumor cells|13|||
48930370|NCT01827384|157576722|FG000|Overall Study|No actionable mutation|0|||
48930371|NCT01827384|157576723|FG001|Overall Study|No actionable mutation|0|||
48930372|NCT01827384|157576724|FG002|Overall Study|No actionable mutation|0|||
48930373|NCT01827384|157576725|FG003|Overall Study|No actionable mutation|0|||
48930374|NCT01827384|157576726|FG004|Overall Study|No actionable mutation|0|||
48930375|NCT01827384|157576727|FG005|Overall Study|No actionable mutation|0|||
48930376|NCT01827384|157576728|FG006|Overall Study|No actionable mutation|0|||
48930377|NCT01827384|157576729|FG007|Overall Study|No actionable mutation|0|||
48930378|NCT01827384|157576730|FG008|Overall Study|No actionable mutation|0|||
48930379|NCT01827384|157576731|FG009|Overall Study|No actionable mutation|0|||
48930380|NCT01827384|157576732|FG010|Overall Study|No actionable mutation|0|||
48930381|NCT01827384|157576733|FG011|Overall Study|No actionable mutation|0|||
48930382|NCT01827384|157576734|FG012|Overall Study|No actionable mutation|0|||
48930383|NCT01827384|157576735|FG013|Overall Study|No actionable mutation|73|||
48930384|NCT01827384|157576722|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
48930385|NCT01827384|157576723|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
48930386|NCT01827384|157576724|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
48930387|NCT01827384|157576725|FG003|Overall Study|Participant declined to participate (before treatment started)|0|||
48930388|NCT01827384|157576726|FG004|Overall Study|Participant declined to participate (before treatment started)|0|||
48930389|NCT01827384|157576727|FG005|Overall Study|Participant declined to participate (before treatment started)|0|||
48930390|NCT01827384|157576728|FG006|Overall Study|Participant declined to participate (before treatment started)|0|||
48930391|NCT01827384|157576729|FG007|Overall Study|Participant declined to participate (before treatment started)|0|||
48930392|NCT01827384|157576730|FG008|Overall Study|Participant declined to participate (before treatment started)|0|||
48930393|NCT01827384|157576731|FG009|Overall Study|Participant declined to participate (before treatment started)|0|||
48930394|NCT01827384|157576732|FG010|Overall Study|Participant declined to participate (before treatment started)|0|||
48930395|NCT01827384|157576733|FG011|Overall Study|Participant declined to participate (before treatment started)|0|||
48930396|NCT01827384|157576734|FG012|Overall Study|Participant declined to participate (before treatment started)|0|||
48930397|NCT01827384|157576735|FG013|Overall Study|Participant declined to participate (before treatment started)|15|||
48930398|NCT03136107|157576742|FG000|Overall Study|Other (Not specified)|1|||
48930399|NCT00930059|157578133|FG000|Overall Study|Death|1|||
48930400|NCT00930059|157578134|FG001|Overall Study|Death|0|||
48930401|NCT00930059|157578133|FG000|Overall Study|Did not meet entrance criteria|1|||
48930402|NCT00930059|157578134|FG001|Overall Study|Did not meet entrance criteria|1|||
48930403|NCT00930059|157578133|FG000|Overall Study|Withdrawal by Subject|3|||
48930404|NCT00930059|157578134|FG001|Overall Study|Withdrawal by Subject|4|||
48930405|NCT00930059|157578133|FG000|Overall Study|Other|1|||
48930406|NCT00930059|157578134|FG001|Overall Study|Other|0|||
48930407|NCT00930059|157578133|FG000|Overall Study|1 site terminated by sponsor|1|||
48930408|NCT00930059|157578134|FG001|Overall Study|1 site terminated by sponsor|1|||
48930409|NCT00930059|157578133|FG000|Overall Study|Adverse Event|1|||
48930410|NCT00930059|157578134|FG001|Overall Study|Adverse Event|6|||
48930411|NCT02554929|157578138|FG000|Overall Study|Lost to Follow-up|4|||
48930412|NCT02554929|157578139|FG001|Overall Study|Lost to Follow-up|4|||
48930413|NCT02554929|157578138|FG000|Overall Study|Withdrawal by Subject|2|||
48930414|NCT02554929|157578139|FG001|Overall Study|Withdrawal by Subject|8|||
48930415|NCT01916980|157578140|FG000|Overall Study|Adverse Event|4|||
48930416|NCT01916980|157578141|FG001|Overall Study|Adverse Event|2|||
48930417|NCT01916980|157578140|FG000|Overall Study|Lack of Efficacy|2|||
48930418|NCT01916980|157578141|FG001|Overall Study|Lack of Efficacy|2|||
48930419|NCT01916980|157578140|FG000|Overall Study|Withdrawal by Subject|1|||
48930420|NCT01916980|157578141|FG001|Overall Study|Withdrawal by Subject|0|||
48930421|NCT01178138|157578142|FG000|Overall Study|Lost to Follow-up|8|||
48930422|NCT01178138|157578142|FG000|Overall Study|Withdrawal by Subject|7|||
48930423|NCT01178138|157578142|FG000|Overall Study|Physician Decision|8|||
48930424|NCT03786432|157578143|FG000|Overall Study|Screen Failure after consent|1|||
48930425|NCT03786432|157578143|FG000|Overall Study|Lost to Follow-up|4|||
48930426|NCT03786432|157578143|FG000|Overall Study|did not complete 12 month CT scan|1|||
48930427|NCT03705793|157578148|FG000|Overall Study|Lost to Follow-up|3|||
48930428|NCT03705793|157578149|FG001|Overall Study|Lost to Follow-up|4|||
48930429|NCT03705793|157578148|FG000|Overall Study|Withdrawal by Subject|2|||
48930430|NCT03705793|157578149|FG001|Overall Study|Withdrawal by Subject|1|||
48930431|NCT00568555|157578154|FG000|Overall Study|Withdrawal by Subject|1|||
48930432|NCT00568555|157578155|FG001|Overall Study|Withdrawal by Subject|1|||
48930433|NCT00618748|157578161|FG000|Overall Study|Adverse Event|4|||
48930434|NCT00618748|157578162|FG001|Overall Study|Adverse Event|3|||
48930435|NCT00618748|157578163|FG002|Overall Study|Adverse Event|8|||
48930436|NCT00618748|157578161|FG000|Overall Study|Physician Decision|3|||
48930437|NCT00618748|157578162|FG001|Overall Study|Physician Decision|1|||
48930438|NCT00618748|157578163|FG002|Overall Study|Physician Decision|1|||
48930439|NCT00618748|157578161|FG000|Overall Study|Withdrawal by Subject|4|||
48930440|NCT00618748|157578162|FG001|Overall Study|Withdrawal by Subject|1|||
48930441|NCT00618748|157578163|FG002|Overall Study|Withdrawal by Subject|5|||
48930442|NCT00860158|157578164|FG000|Overall Study|Study Terminated|1|||
48930443|NCT00200850|157578165|FG000|Overall Study|relocation|1|||
48930444|NCT00200850|157578166|FG001|Overall Study|relocation|0|||
48930445|NCT00200850|157578167|FG002|Overall Study|relocation|1|||
48930446|NCT00200850|157578165|FG000|Overall Study|too busy|1|||
48930447|NCT00200850|157578166|FG001|Overall Study|too busy|0|||
48930448|NCT00200850|157578167|FG002|Overall Study|too busy|0|||
48930449|NCT00200850|157578165|FG000|Overall Study|Pregnancy|0|||
48930450|NCT00200850|157578166|FG001|Overall Study|Pregnancy|0|||
48930451|NCT00200850|157578167|FG002|Overall Study|Pregnancy|1|||
48930452|NCT00200850|157578165|FG000|Overall Study|Poor adherence|0|||
48930453|NCT00200850|157578166|FG001|Overall Study|Poor adherence|0|||
48930454|NCT00200850|157578167|FG002|Overall Study|Poor adherence|1|||
48930455|NCT00200850|157578165|FG000|Overall Study|optic neuritis|0|||
48930456|NCT00200850|157578166|FG001|Overall Study|optic neuritis|0|||
48930457|NCT00200850|157578167|FG002|Overall Study|optic neuritis|1|||
48930458|NCT00200850|157578165|FG000|Overall Study|Adverse Event|1|||
48930459|NCT00200850|157578166|FG001|Overall Study|Adverse Event|1|||
48930460|NCT00200850|157578167|FG002|Overall Study|Adverse Event|2|||
48930461|NCT01449708|157578168|FG000|Overall Study|Protocol Violation|0|||
48930462|NCT01449708|157578169|FG001|Overall Study|Protocol Violation|1|||
48930463|NCT01449708|157578168|FG000|Overall Study|surgical complication|1|||
48930464|NCT01449708|157578169|FG001|Overall Study|surgical complication|2|||
48930465|NCT01449708|157578168|FG000|Overall Study|respiratory failure|1|||
48930466|NCT01449708|157578169|FG001|Overall Study|respiratory failure|0|||
48930467|NCT04162210|157578170|FG000|Overall Study|Lost to Follow-up|4|||
48930468|NCT04162210|157578171|FG001|Overall Study|Lost to Follow-up|1|||
48930469|NCT04162210|157578170|FG000|Overall Study|Withdrawal by Subject|17|||
48930470|NCT04162210|157578171|FG001|Overall Study|Withdrawal by Subject|9|||
48930471|NCT04162210|157578170|FG000|Overall Study|Ongoing|113|||
48930472|NCT04162210|157578171|FG001|Overall Study|Ongoing|59|||
48930473|NCT03980938|157578172|FG000|Treatment Period 1|Study Terminated|1|||
48930474|NCT03980938|157578173|FG001|Treatment Period 1|Study Terminated|1|||
48930475|NCT03980938|157578172|FG000|Treatment Period 2|Study Terminated|2|||
48930476|NCT03980938|157578173|FG001|Treatment Period 2|Study Terminated|2|||
48930477|NCT02118792|157578174|FG000|Overall Study|Withdrawal by Subject|6|||
48930478|NCT02118792|157578175|FG001|Overall Study|Withdrawal by Subject|3|||
48930479|NCT02118792|157578174|FG000|Overall Study|Lost to Follow-up|4|||
48930480|NCT02118792|157578175|FG001|Overall Study|Lost to Follow-up|4|||
48930481|NCT02118792|157578174|FG000|Overall Study|Adverse Event|5|||
48930482|NCT02118792|157578175|FG001|Overall Study|Adverse Event|4|||
48930483|NCT02118792|157578174|FG000|Overall Study|Withdrawal by parent/guardian|14|||
48930484|NCT02118792|157578175|FG001|Overall Study|Withdrawal by parent/guardian|20|||
48930485|NCT02118792|157578174|FG000|Overall Study|Other|1|||
48930486|NCT02118792|157578175|FG001|Overall Study|Other|6|||
48930487|NCT02118792|157578174|FG000|Overall Study|Randomised but not treated|1|||
48930488|NCT02118792|157578175|FG001|Overall Study|Randomised but not treated|0|||
48930489|NCT02908880|157578176|FG000|Overall Study|Lost to Follow-up|4|||
48930490|NCT02908880|157578176|FG000|Overall Study|Explantation of the device|1|||
48930491|NCT02908880|157578176|FG000|Overall Study|Withdrawal by Subject|17|||
48930492|NCT02908880|157578176|FG000|Overall Study|Death|5|||
48930493|NCT01337973|157578177|FG000|Overall Study|Lost to Follow-up|2|||
48930494|NCT01337973|157578178|FG001|Overall Study|Lost to Follow-up|4|||
48930495|NCT01337973|157578179|FG002|Overall Study|Lost to Follow-up|3|||
48930496|NCT01337973|157578177|FG000|Overall Study|Death|1|||
48930497|NCT01337973|157578178|FG001|Overall Study|Death|2|||
48930498|NCT01337973|157578179|FG002|Overall Study|Death|1|||
48930499|NCT01337973|157578177|FG000|Overall Study|Withdrawal by Subject|10|||
48930500|NCT01337973|157578178|FG001|Overall Study|Withdrawal by Subject|8|||
48930501|NCT01337973|157578179|FG002|Overall Study|Withdrawal by Subject|4|||
48930502|NCT01337973|157578177|FG000|Overall Study|missing data on primary outcome|3|||
48930503|NCT01337973|157578178|FG001|Overall Study|missing data on primary outcome|1|||
48930504|NCT01337973|157578179|FG002|Overall Study|missing data on primary outcome|3|||
48930505|NCT04269395|157578180|FG000|Overall Study|Lost to Follow-up|1|||
48930506|NCT04269395|157578181|FG001|Overall Study|Lost to Follow-up|0|||
48930507|NCT04269395|157578180|FG000|Overall Study|Study terminated by Sponsor|13|||
48930508|NCT04269395|157578181|FG001|Overall Study|Study terminated by Sponsor|10|||
48930509|NCT00841763|157578184|FG000|Overall Study|Withdrawal by Subject|60|||
48930510|NCT00841763|157578185|FG001|Overall Study|Withdrawal by Subject|17|||
48930511|NCT00841763|157578186|FG002|Overall Study|Withdrawal by Subject|4|||
48930512|NCT00841763|157578187|FG003|Overall Study|Withdrawal by Subject|1|||
48930513|NCT00841763|157578184|FG000|Overall Study|Adverse Event|9|||
48930514|NCT00841763|157578185|FG001|Overall Study|Adverse Event|10|||
48930515|NCT00841763|157578186|FG002|Overall Study|Adverse Event|3|||
48844507|NCT02564744|157272766|FG000|Overall Study|Subject Withdrew Consent|1|||
48844508|NCT02564744|157272767|FG001|Overall Study|Subject Withdrew Consent|1|||
48844509|NCT02564744|157272768|FG002|Overall Study|Subject Withdrew Consent|1|||
48844510|NCT02564744|157272769|FG003|Overall Study|Subject Withdrew Consent|0|||
48844511|NCT02564744|157272770|FG004|Overall Study|Subject Withdrew Consent|2|||
48844512|NCT02564744|157272766|FG000|Overall Study|Lost to Follow-up|0|||
48844513|NCT02564744|157272767|FG001|Overall Study|Lost to Follow-up|1|||
48844514|NCT02564744|157272768|FG002|Overall Study|Lost to Follow-up|0|||
48844515|NCT02564744|157272769|FG003|Overall Study|Lost to Follow-up|0|||
48844516|NCT02564744|157272770|FG004|Overall Study|Lost to Follow-up|1|||
48844517|NCT02564744|157272766|FG000|Overall Study|Reason not specified|1|||
48844518|NCT02564744|157272767|FG001|Overall Study|Reason not specified|0|||
48844519|NCT02564744|157272768|FG002|Overall Study|Reason not specified|0|||
48844520|NCT02564744|157272769|FG003|Overall Study|Reason not specified|0|||
48930516|NCT00841763|157578187|FG003|Overall Study|Adverse Event|2|||
48930517|NCT00841763|157578184|FG000|Overall Study|Lost to Follow-up|63|||
48930518|NCT00841763|157578185|FG001|Overall Study|Lost to Follow-up|25|||
48930519|NCT00841763|157578186|FG002|Overall Study|Lost to Follow-up|0|||
48930520|NCT00841763|157578187|FG003|Overall Study|Lost to Follow-up|0|||
48930521|NCT00841763|157578184|FG000|Overall Study|Protocol Violation|20|||
48930522|NCT00841763|157578185|FG001|Overall Study|Protocol Violation|3|||
48930523|NCT00841763|157578186|FG002|Overall Study|Protocol Violation|1|||
48930524|NCT00841763|157578187|FG003|Overall Study|Protocol Violation|0|||
48930525|NCT00841763|157578184|FG000|Overall Study|Administrative Reasons|3|||
48930526|NCT00841763|157578185|FG001|Overall Study|Administrative Reasons|1|||
48930527|NCT00841763|157578186|FG002|Overall Study|Administrative Reasons|0|||
48930528|NCT00841763|157578187|FG003|Overall Study|Administrative Reasons|0|||
48930529|NCT00841763|157578184|FG000|Overall Study|Unable to Classify|7|||
48930530|NCT00841763|157578185|FG001|Overall Study|Unable to Classify|1|||
48930531|NCT00841763|157578186|FG002|Overall Study|Unable to Classify|0|||
48930532|NCT00841763|157578187|FG003|Overall Study|Unable to Classify|0|||
48930533|NCT01441063|157578188|FG000|Tocilizumab Alone|Required AZT/VGC addition|3|||
48930534|NCT01441063|157578188|FG000|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1|||
48930535|NCT02161562|157578189|FG000|Overall Study|Withdrawal by Subject|5|||
48930536|NCT02161562|157578190|FG001|Overall Study|Withdrawal by Subject|8|||
48930537|NCT02161562|157578189|FG000|Overall Study|Protocol Violation|9|||
48930538|NCT02161562|157578190|FG001|Overall Study|Protocol Violation|4|||
48930539|NCT02161562|157578189|FG000|Overall Study|Pregnancy|1|||
48930540|NCT02161562|157578190|FG001|Overall Study|Pregnancy|2|||
48930541|NCT02161562|157578189|FG000|Overall Study|Lost to Follow-up|3|||
48930542|NCT02161562|157578190|FG001|Overall Study|Lost to Follow-up|1|||
48930543|NCT02161562|157578189|FG000|Overall Study|Lack of Efficacy|4|||
48930544|NCT02161562|157578190|FG001|Overall Study|Lack of Efficacy|1|||
48930545|NCT02161562|157578189|FG000|Overall Study|Adverse Event|1|||
48930546|NCT02161562|157578190|FG001|Overall Study|Adverse Event|1|||
48930547|NCT02161562|157578189|FG000|Overall Study|Participant moved back to home country|1|||
48930548|NCT02161562|157578190|FG001|Overall Study|Participant moved back to home country|0|||
48930549|NCT02161562|157578189|FG000|Overall Study|Withdrew due to being out of the country|1|||
48930550|NCT02161562|157578190|FG001|Overall Study|Withdrew due to being out of the country|0|||
48930551|NCT02161562|157578189|FG000|Overall Study|Participant moved out of province|1|||
48930552|NCT02161562|157578190|FG001|Overall Study|Participant moved out of province|0|||
48930553|NCT04607733|157578195|FG000|Overall Study|Lost to Follow-up|1|||
48930554|NCT04607733|157578196|FG001|Overall Study|Lost to Follow-up|0|||
48930555|NCT04607733|157578197|FG002|Overall Study|Lost to Follow-up|0|||
48930556|NCT04607733|157578198|FG003|Overall Study|Lost to Follow-up|1|||
48930557|NCT04607733|157578199|FG004|Overall Study|Lost to Follow-up|1|||
48930558|NCT04607733|157578200|FG005|Overall Study|Lost to Follow-up|0|||
48930559|NCT04607733|157578195|FG000|Overall Study|Withdrawal by Subject|0|||
48930560|NCT04607733|157578196|FG001|Overall Study|Withdrawal by Subject|0|||
48930561|NCT04607733|157578197|FG002|Overall Study|Withdrawal by Subject|0|||
48930562|NCT04607733|157578198|FG003|Overall Study|Withdrawal by Subject|0|||
48930563|NCT04607733|157578199|FG004|Overall Study|Withdrawal by Subject|1|||
48930564|NCT04607733|157578200|FG005|Overall Study|Withdrawal by Subject|0|||
48930565|NCT00577993|157578201|FG000|Overall Study|Adverse Event|1|||
48930566|NCT00577993|157578202|FG001|Overall Study|Adverse Event|0|||
48930567|NCT00577993|157578203|FG002|Overall Study|Adverse Event|0|||
48930568|NCT00577993|157578201|FG000|Overall Study|Death|0|||
48930569|NCT00577993|157578202|FG001|Overall Study|Death|1|||
48930570|NCT00577993|157578203|FG002|Overall Study|Death|1|||
48930571|NCT00577993|157578201|FG000|Overall Study|Lack of Efficacy|0|||
48930572|NCT00577993|157578202|FG001|Overall Study|Lack of Efficacy|1|||
48930573|NCT00577993|157578203|FG002|Overall Study|Lack of Efficacy|0|||
48930574|NCT00577993|157578201|FG000|Overall Study|Protocol Violation|2|||
48930575|NCT00577993|157578202|FG001|Overall Study|Protocol Violation|3|||
48930576|NCT00577993|157578203|FG002|Overall Study|Protocol Violation|0|||
48930577|NCT00577993|157578201|FG000|Overall Study|Withdrawal by Subject|1|||
48930578|NCT00577993|157578202|FG001|Overall Study|Withdrawal by Subject|0|||
48930579|NCT00577993|157578203|FG002|Overall Study|Withdrawal by Subject|2|||
48930580|NCT00577993|157578201|FG000|Overall Study|Conversion|2|||
48930581|NCT00577993|157578202|FG001|Overall Study|Conversion|5|||
48930582|NCT00577993|157578203|FG002|Overall Study|Conversion|0|||
48930583|NCT00577993|157578201|FG000|Overall Study|Uninsured|1|||
48930584|NCT00577993|157578202|FG001|Overall Study|Uninsured|0|||
48930585|NCT00577993|157578203|FG002|Overall Study|Uninsured|0|||
48930586|NCT00070941|157578211|FG000|Overall Study|Adverse Event|10|||
48930587|NCT00070941|157578212|FG001|Overall Study|Adverse Event|8|||
48930588|NCT00070941|157578213|FG002|Overall Study|Adverse Event|4|||
48930589|NCT00756938|157578214|FG000|12-week Base Study|Protocol-specific Criteria Met|1|||
48930590|NCT00756938|157578215|FG001|12-week Base Study|Protocol-specific Criteria Met|0|||
48930591|NCT00756938|157578216|FG002|12-week Base Study|Protocol-specific Criteria Met|1|||
48930592|NCT00756938|157578217|FG003|12-week Base Study|Protocol-specific Criteria Met|0|||
48930593|NCT00756938|157578214|FG000|12-week Base Study|Protocol Violation|0|||
48930594|NCT00756938|157578215|FG001|12-week Base Study|Protocol Violation|0|||
48930595|NCT00756938|157578216|FG002|12-week Base Study|Protocol Violation|1|||
48930596|NCT00756938|157578217|FG003|12-week Base Study|Protocol Violation|0|||
48930597|NCT00756938|157578214|FG000|12-week Base Study|Lost to Follow-up|1|||
48930598|NCT00756938|157578215|FG001|12-week Base Study|Lost to Follow-up|0|||
48930599|NCT00756938|157578216|FG002|12-week Base Study|Lost to Follow-up|0|||
48930600|NCT00756938|157578217|FG003|12-week Base Study|Lost to Follow-up|0|||
48930601|NCT00756938|157578214|FG000|Optional Extension|Lack of Efficacy|0|||
48930602|NCT00756938|157578215|FG001|Optional Extension|Lack of Efficacy|0|||
48930603|NCT00756938|157578216|FG002|Optional Extension|Lack of Efficacy|0|||
48930604|NCT00756938|157578217|FG003|Optional Extension|Lack of Efficacy|1|||
48930605|NCT00756938|157578214|FG000|Optional Extension|End of Study|0|||
48930606|NCT00756938|157578215|FG001|Optional Extension|End of Study|0|||
48930607|NCT00756938|157578216|FG002|Optional Extension|End of Study|0|||
48930608|NCT00756938|157578217|FG003|Optional Extension|End of Study|11|||
48930609|NCT00756938|157578214|FG000|Optional Extension|Protocol-specific criteria met|0|||
48930610|NCT00756938|157578215|FG001|Optional Extension|Protocol-specific criteria met|0|||
48930611|NCT00756938|157578216|FG002|Optional Extension|Protocol-specific criteria met|0|||
48930612|NCT00756938|157578217|FG003|Optional Extension|Protocol-specific criteria met|9|||
48930613|NCT00756938|157578214|FG000|Optional Extension|Physician Decision|0|||
48930614|NCT00756938|157578215|FG001|Optional Extension|Physician Decision|0|||
48930615|NCT00756938|157578216|FG002|Optional Extension|Physician Decision|0|||
48930616|NCT00756938|157578217|FG003|Optional Extension|Physician Decision|3|||
48930617|NCT00756938|157578214|FG000|Optional Extension|Lost to Follow-up|0|||
48930618|NCT00756938|157578215|FG001|Optional Extension|Lost to Follow-up|0|||
48930619|NCT00756938|157578216|FG002|Optional Extension|Lost to Follow-up|0|||
48930620|NCT00756938|157578217|FG003|Optional Extension|Lost to Follow-up|1|||
48930621|NCT00756938|157578214|FG000|Optional Extension|Protocol Violation|0|||
48930622|NCT00756938|157578215|FG001|Optional Extension|Protocol Violation|0|||
48930623|NCT00756938|157578216|FG002|Optional Extension|Protocol Violation|0|||
48930624|NCT00756938|157578217|FG003|Optional Extension|Protocol Violation|1|||
48930625|NCT00756938|157578214|FG000|Optional Extension|Withdrawal by Subject|0|||
48930626|NCT00756938|157578215|FG001|Optional Extension|Withdrawal by Subject|0|||
48930627|NCT00756938|157578216|FG002|Optional Extension|Withdrawal by Subject|0|||
48930628|NCT00756938|157578217|FG003|Optional Extension|Withdrawal by Subject|10|||
48930629|NCT00756938|157578214|FG000|Optional Extension|Adverse Event|0|||
48930630|NCT00756938|157578215|FG001|Optional Extension|Adverse Event|0|||
48930631|NCT00756938|157578216|FG002|Optional Extension|Adverse Event|0|||
48930632|NCT00756938|157578217|FG003|Optional Extension|Adverse Event|1|||
48930633|NCT03683394|157578218|FG000|Overall Study|Withdrawal by Subject|4|||
48930634|NCT03683394|157578219|FG001|Overall Study|Withdrawal by Subject|8|||
48930635|NCT03683394|157578218|FG000|Overall Study|Lost to Follow-up|7|||
48930636|NCT03683394|157578219|FG001|Overall Study|Lost to Follow-up|0|||
48930637|NCT03683394|157578218|FG000|Overall Study|Death|3|||
48930638|NCT03683394|157578219|FG001|Overall Study|Death|1|||
48930639|NCT00110019|157578220|FG000|Overall Study|Lack of Efficacy|253|||
48930640|NCT00110019|157578221|FG001|Overall Study|Lack of Efficacy|285|||
48930641|NCT00110019|157578220|FG000|Overall Study|Adverse Event|61|||
48930642|NCT00110019|157578221|FG001|Overall Study|Adverse Event|40|||
48930643|NCT00110019|157578220|FG000|Overall Study|Death|13|||
48930644|NCT00110019|157578221|FG001|Overall Study|Death|15|||
48930645|NCT00110019|157578220|FG000|Overall Study|Withdrawal by Subject|21|||
48930646|NCT00110019|157578221|FG001|Overall Study|Withdrawal by Subject|9|||
48930647|NCT00110019|157578220|FG000|Overall Study|alternative therapy|5|||
48930648|NCT00110019|157578221|FG001|Overall Study|alternative therapy|1|||
48930649|NCT00110019|157578220|FG000|Overall Study|complicating disease|1|||
48930650|NCT00110019|157578221|FG001|Overall Study|complicating disease|1|||
48930651|NCT00110019|157578220|FG000|Overall Study|symptom deterioration|13|||
48930652|NCT00110019|157578221|FG001|Overall Study|symptom deterioration|16|||
48930653|NCT00110019|157578220|FG000|Overall Study|Not start protocol therapy|17|||
48930654|NCT00110019|157578221|FG001|Overall Study|Not start protocol therapy|16|||
48930655|NCT00110019|157578220|FG000|Overall Study|other reasons|22|||
48930656|NCT00110019|157578221|FG001|Overall Study|other reasons|30|||
48930657|NCT00441545|157578222|FG000|First Intervention|Adverse Event|6|||
48930658|NCT00441545|157578223|FG001|First Intervention|Adverse Event|5|||
48930659|NCT00441545|157578222|FG000|First Intervention|Protocol Violation|2|||
48930660|NCT00441545|157578223|FG001|First Intervention|Protocol Violation|2|||
48930661|NCT00441545|157578222|FG000|First Intervention|Withdrawal by Subject|3|||
48930662|NCT00441545|157578223|FG001|First Intervention|Withdrawal by Subject|3|||
48930663|NCT00441545|157578222|FG000|First Intervention|Kidney transplant|1|||
48930664|NCT00441545|157578223|FG001|First Intervention|Kidney transplant|1|||
48930665|NCT00441545|157578222|FG000|First Intervention|Lack of Efficacy|2|||
48930666|NCT00441545|157578223|FG001|First Intervention|Lack of Efficacy|0|||
48930667|NCT00441545|157578222|FG000|First Intervention|Subject exceeded safety criteria|0|||
48930668|NCT00441545|157578223|FG001|First Intervention|Subject exceeded safety criteria|1|||
48930669|NCT00441545|157578222|FG000|First Intervention|Subject met an exclusionary criteria|1|||
48930670|NCT00441545|157578223|FG001|First Intervention|Subject met an exclusionary criteria|0|||
48930671|NCT00441545|157578222|FG000|First Intervention|Extended hospitalization|1|||
48930672|NCT00441545|157578223|FG001|First Intervention|Extended hospitalization|0|||
48930673|NCT00441545|157578222|FG000|First Intervention|Site error|1|||
48930674|NCT00441545|157578223|FG001|First Intervention|Site error|0|||
48930675|NCT00441545|157578222|FG000|First Intervention|Sponsor's request|1|||
48930676|NCT00441545|157578223|FG001|First Intervention|Sponsor's request|0|||
48930677|NCT00441545|157578222|FG000|Second Intervention|Adverse Event|5|||
48930678|NCT00441545|157578223|FG001|Second Intervention|Adverse Event|2|||
48930679|NCT00441545|157578222|FG000|Second Intervention|Protocol Violation|4|||
48930680|NCT00441545|157578223|FG001|Second Intervention|Protocol Violation|1|||
48930681|NCT00441545|157578222|FG000|Second Intervention|Withdrawal by Subject|1|||
48930682|NCT00441545|157578223|FG001|Second Intervention|Withdrawal by Subject|1|||
48930683|NCT00441545|157578222|FG000|Second Intervention|Kidney Transplant|1|||
48930684|NCT00441545|157578223|FG001|Second Intervention|Kidney Transplant|1|||
48930685|NCT00441545|157578222|FG000|Second Intervention|Lack of Efficacy|0|||
48930686|NCT00441545|157578223|FG001|Second Intervention|Lack of Efficacy|1|||
48930687|NCT00441545|157578222|FG000|Second Intervention|Subject exceeded safety criteria|1|||
48930688|NCT00441545|157578223|FG001|Second Intervention|Subject exceeded safety criteria|0|||
48930689|NCT00441545|157578222|FG000|Second Intervention|Subject moved|0|||
48930690|NCT00441545|157578223|FG001|Second Intervention|Subject moved|1|||
48930691|NCT01500057|157578224|FG000|Overall Study|Lost to Follow-up|6|||
48930692|NCT01500057|157578225|FG001|Overall Study|Lost to Follow-up|4|||
48930693|NCT00354601|157578233|FG000|Overall Study|Protocol Violation|1|||
48930694|NCT00354601|157578233|FG000|Overall Study|progression|1|||
48930695|NCT00706030|157578234|FG000|Overall Study|Disease Progression|4|||
48930696|NCT00706030|157578235|FG001|Overall Study|Disease Progression|6|||
48930697|NCT00706030|157578236|FG002|Overall Study|Disease Progression|46|||
48930698|NCT00706030|157578237|FG003|Overall Study|Disease Progression|12|||
48930699|NCT00706030|157578234|FG000|Overall Study|Adverse Event|1|||
48930700|NCT00706030|157578235|FG001|Overall Study|Adverse Event|0|||
48930701|NCT00706030|157578236|FG002|Overall Study|Adverse Event|4|||
48930702|NCT00706030|157578237|FG003|Overall Study|Adverse Event|2|||
48930703|NCT00706030|157578234|FG000|Overall Study|Withdrawal by Subject|1|||
48930704|NCT00706030|157578235|FG001|Overall Study|Withdrawal by Subject|0|||
48930705|NCT00706030|157578236|FG002|Overall Study|Withdrawal by Subject|2|||
48930706|NCT00706030|157578237|FG003|Overall Study|Withdrawal by Subject|0|||
48930707|NCT00706030|157578234|FG000|Overall Study|Physician Decision|0|||
48930708|NCT00706030|157578235|FG001|Overall Study|Physician Decision|0|||
48930709|NCT00706030|157578236|FG002|Overall Study|Physician Decision|2|||
48930710|NCT00706030|157578237|FG003|Overall Study|Physician Decision|0|||
48930711|NCT00706030|157578234|FG000|Overall Study|Not recorded|0|||
48930712|NCT00706030|157578235|FG001|Overall Study|Not recorded|0|||
48930713|NCT00706030|157578236|FG002|Overall Study|Not recorded|2|||
48930714|NCT00706030|157578237|FG003|Overall Study|Not recorded|0|||
48930715|NCT00706030|157578234|FG000|Overall Study|Protocol Violation|0|||
48930716|NCT00706030|157578235|FG001|Overall Study|Protocol Violation|0|||
48930717|NCT00706030|157578236|FG002|Overall Study|Protocol Violation|1|||
48930718|NCT00706030|157578237|FG003|Overall Study|Protocol Violation|1|||
48930719|NCT00706030|157578234|FG000|Overall Study|Failed to return|0|||
48930720|NCT00706030|157578235|FG001|Overall Study|Failed to return|0|||
48930721|NCT00706030|157578236|FG002|Overall Study|Failed to return|1|||
48930722|NCT00706030|157578237|FG003|Overall Study|Failed to return|0|||
48930723|NCT00706030|157578234|FG000|Overall Study|Symptomatic Deterioration|0|||
48930724|NCT00706030|157578235|FG001|Overall Study|Symptomatic Deterioration|0|||
48930725|NCT00706030|157578236|FG002|Overall Study|Symptomatic Deterioration|1|||
48930726|NCT00706030|157578237|FG003|Overall Study|Symptomatic Deterioration|0|||
48930727|NCT00706030|157578234|FG000|Overall Study|No treatment received|0|||
48930728|NCT00706030|157578235|FG001|Overall Study|No treatment received|0|||
48930729|NCT00706030|157578236|FG002|Overall Study|No treatment received|0|||
48930730|NCT00706030|157578237|FG003|Overall Study|No treatment received|1|||
48930731|NCT00706030|157578234|FG000|Overall Study|Death|0|||
48930732|NCT00706030|157578235|FG001|Overall Study|Death|0|||
48930733|NCT00706030|157578236|FG002|Overall Study|Death|1|||
48930734|NCT00706030|157578237|FG003|Overall Study|Death|0|||
48930735|NCT02058147|157578241|FG000|Overall Study|Randomized but not treated|0|||
48930736|NCT02058147|157578242|FG001|Overall Study|Randomized but not treated|0|||
48930737|NCT02058147|157578243|FG002|Overall Study|Randomized but not treated|1|||
48930738|NCT02058147|157578241|FG000|Overall Study|Adverse Event|12|||
48930739|NCT02058147|157578242|FG001|Overall Study|Adverse Event|9|||
48930740|NCT02058147|157578243|FG002|Overall Study|Adverse Event|21|||
48930741|NCT02058147|157578241|FG000|Overall Study|Lack of Efficacy|1|||
48930742|NCT02058147|157578242|FG001|Overall Study|Lack of Efficacy|0|||
48930743|NCT02058147|157578243|FG002|Overall Study|Lack of Efficacy|3|||
48930744|NCT02058147|157578241|FG000|Overall Study|Poor compliance to protocol|8|||
48930745|NCT02058147|157578242|FG001|Overall Study|Poor compliance to protocol|9|||
48930746|NCT02058147|157578243|FG002|Overall Study|Poor compliance to protocol|4|||
48930747|NCT02058147|157578241|FG000|Overall Study|Other than specified|8|||
48930748|NCT02058147|157578242|FG001|Overall Study|Other than specified|9|||
48930749|NCT02058147|157578243|FG002|Overall Study|Other than specified|0|||
48930750|NCT00291551|157578248|FG000|Overall Study|Death|7|||
48930751|NCT00291551|157578248|FG000|Overall Study|Withdrawal by Subject|6|||
48930752|NCT00854828|157578251|FG000|Overall Study|Death|1|||
48930753|NCT00854828|157578252|FG001|Overall Study|Death|0|||
48930754|NCT00854828|157578253|FG002|Overall Study|Death|0|||
48930755|NCT00854828|157578254|FG003|Overall Study|Death|0|||
48930756|NCT00854828|157578251|FG000|Overall Study|Withdrawal by Subject|1|||
48930757|NCT00854828|157578252|FG001|Overall Study|Withdrawal by Subject|1|||
48930758|NCT00854828|157578253|FG002|Overall Study|Withdrawal by Subject|0|||
48930759|NCT00854828|157578254|FG003|Overall Study|Withdrawal by Subject|9|||
48930760|NCT00854828|157578251|FG000|Overall Study|Missed 24mo visit|1|||
48930761|NCT00854828|157578252|FG001|Overall Study|Missed 24mo visit|1|||
48930762|NCT00854828|157578253|FG002|Overall Study|Missed 24mo visit|8|||
48930763|NCT00854828|157578254|FG003|Overall Study|Missed 24mo visit|8|||
48930764|NCT01931059|157578255|FG000|Day 1|Pregnancy|0|||
48930765|NCT01931059|157578256|FG001|Day 1|Pregnancy|1|||
48930766|NCT01931059|157578255|FG000|Day3|Lost to Follow-up|1|||
48930767|NCT01931059|157578256|FG001|Day3|Lost to Follow-up|0|||
48930768|NCT01015833|157578259|FG000|Overall Study|Death|1|||
48930769|NCT01015833|157578260|FG001|Overall Study|Death|0|||
48930770|NCT01015833|157578259|FG000|Overall Study|Withdrawal by Subject|3|||
48930771|NCT01015833|157578260|FG001|Overall Study|Withdrawal by Subject|2|||
48930772|NCT01015833|157578259|FG000|Overall Study|Adverse Event|0|||
48930773|NCT01015833|157578260|FG001|Overall Study|Adverse Event|1|||
48930774|NCT01015833|157578259|FG000|Overall Study|Physician Decision|2|||
48930775|NCT01015833|157578260|FG001|Overall Study|Physician Decision|0|||
48930776|NCT01015833|157578259|FG000|Overall Study|Symptomatic deterioration|0|||
48930777|NCT01015833|157578260|FG001|Overall Study|Symptomatic deterioration|1|||
48930778|NCT01015833|157578259|FG000|Overall Study|Other|5|||
48930779|NCT01015833|157578260|FG001|Overall Study|Other|1|||
48930780|NCT01015833|157578259|FG000|Overall Study|Motor Vehicle Accidents|1|||
48930781|NCT01015833|157578260|FG001|Overall Study|Motor Vehicle Accidents|0|||
48930782|NCT01015833|157578259|FG000|Overall Study|Did not start treatment|1|||
48930783|NCT01015833|157578260|FG001|Overall Study|Did not start treatment|0|||
48930784|NCT03308188|157578264|FG000|Overall Study|Withdrawal by Subject|0|||
48930785|NCT03308188|157578265|FG001|Overall Study|Withdrawal by Subject|3|||
48930786|NCT03308188|157578264|FG000|Overall Study|Death|0|||
48930787|NCT03308188|157578265|FG001|Overall Study|Death|1|||
48930788|NCT01791855|157578266|FG000|Overall Study|Adverse Event|0|||
48930789|NCT01791855|157578267|FG001|Overall Study|Adverse Event|0|||
48930790|NCT01791855|157578268|FG002|Overall Study|Adverse Event|0|||
48930791|NCT01791855|157578269|FG003|Overall Study|Adverse Event|1|||
48930792|NCT01791855|157578266|FG000|Overall Study|Randomized, not treated|0|||
48930793|NCT01791855|157578267|FG001|Overall Study|Randomized, not treated|1|||
48930794|NCT01791855|157578268|FG002|Overall Study|Randomized, not treated|0|||
48930795|NCT01791855|157578269|FG003|Overall Study|Randomized, not treated|0|||
48930796|NCT00481065|157578270|FG000|Overall Study|Adverse event or death|1|||
48930797|NCT00481065|157578271|FG001|Overall Study|Adverse event or death|1|||
48930798|NCT00481065|157578272|FG002|Overall Study|Adverse event or death|3|||
48930799|NCT00481065|157578273|FG003|Overall Study|Adverse event or death|0|||
48930800|NCT00481065|157578274|FG004|Overall Study|Adverse event or death|2|||
48930801|NCT00481065|157578275|FG005|Overall Study|Adverse event or death|0|||
48930802|NCT00481065|157578276|FG006|Overall Study|Adverse event or death|1|||
48930803|NCT00481065|157578277|FG007|Overall Study|Adverse event or death|1|||
48930804|NCT00481065|157578270|FG000|Overall Study|Withdrawal by Subject|11|||
48844521|NCT02564744|157272770|FG004|Overall Study|Reason not specified|0|||
48844522|NCT02765100|157272777|FG000|Overall Study|subject found ineligible after baseline|1|||
48844523|NCT02765100|157272778|FG001|Overall Study|subject found ineligible after baseline|1|||
48844524|NCT02765100|157272777|FG000|Overall Study|Lost to Follow-up|0|||
48844525|NCT02765100|157272778|FG001|Overall Study|Lost to Follow-up|1|||
48844526|NCT02675244|157272786|FG000|Overall Study|Death|9|||
48844527|NCT02675244|157272787|FG001|Overall Study|Death|6|||
48844528|NCT02675244|157272786|FG000|Overall Study|Withdrawal by Subject|3|||
48844529|NCT02675244|157272787|FG001|Overall Study|Withdrawal by Subject|6|||
48844530|NCT02675244|157272786|FG000|Overall Study|Lost to Follow-up|1|||
48844531|NCT02675244|157272787|FG001|Overall Study|Lost to Follow-up|1|||
48844532|NCT02675244|157272786|FG000|Overall Study|Ongoing at 2 Years|190|||
48844533|NCT02675244|157272787|FG001|Overall Study|Ongoing at 2 Years|185|||
48844534|NCT00071799|157272788|FG000|Overall Study|Adverse Event|19|||
48844535|NCT00071799|157272789|FG001|Overall Study|Adverse Event|10|||
48844536|NCT00071799|157272788|FG000|Overall Study|Protocol Violation|1|||
48844537|NCT00071799|157272789|FG001|Overall Study|Protocol Violation|7|||
48844538|NCT00071799|157272788|FG000|Overall Study|Lost to Follow-up|1|||
48844539|NCT00071799|157272789|FG001|Overall Study|Lost to Follow-up|1|||
48844540|NCT00071799|157272788|FG000|Overall Study|Withdrawal by Subject|15|||
48844541|NCT00071799|157272789|FG001|Overall Study|Withdrawal by Subject|37|||
48844542|NCT00071799|157272788|FG000|Overall Study|Physician Decision|0|||
48844543|NCT00071799|157272789|FG001|Overall Study|Physician Decision|2|||
48844544|NCT00071799|157272788|FG000|Overall Study|Lack of Efficacy|11|||
48844545|NCT00071799|157272789|FG001|Overall Study|Lack of Efficacy|18|||
48844546|NCT00071799|157272788|FG000|Overall Study|Disease Progression|23|||
48844547|NCT00071799|157272789|FG001|Overall Study|Disease Progression|20|||
48844548|NCT00071799|157272788|FG000|Overall Study|Different Central+Local Pathology Review|0|||
48844549|NCT00071799|157272789|FG001|Overall Study|Different Central+Local Pathology Review|1|||
48844550|NCT00071799|157272788|FG000|Overall Study|Not Documented|0|||
48844551|NCT00071799|157272789|FG001|Overall Study|Not Documented|2|||
48844552|NCT00391898|157272790|FG000|Overall Study|Adverse Event|3|||
48844553|NCT00391898|157272791|FG001|Overall Study|Adverse Event|0|||
48844554|NCT00391898|157272790|FG000|Overall Study|Other|8|||
48844555|NCT00391898|157272791|FG001|Overall Study|Other|10|||
48844556|NCT02594735|157272793|FG000|Overall Study|Adverse Event|1|||
48930805|NCT00481065|157578271|FG001|Overall Study|Withdrawal by Subject|12|||
48930806|NCT00481065|157578272|FG002|Overall Study|Withdrawal by Subject|7|||
48930807|NCT00481065|157578273|FG003|Overall Study|Withdrawal by Subject|11|||
48930808|NCT00481065|157578274|FG004|Overall Study|Withdrawal by Subject|13|||
48930809|NCT00481065|157578275|FG005|Overall Study|Withdrawal by Subject|12|||
48930810|NCT00481065|157578276|FG006|Overall Study|Withdrawal by Subject|9|||
48930811|NCT00481065|157578277|FG007|Overall Study|Withdrawal by Subject|10|||
48930812|NCT00481065|157578270|FG000|Overall Study|Lost to Follow-up|4|||
48930813|NCT00481065|157578271|FG001|Overall Study|Lost to Follow-up|2|||
48930814|NCT00481065|157578272|FG002|Overall Study|Lost to Follow-up|4|||
48930815|NCT00481065|157578273|FG003|Overall Study|Lost to Follow-up|3|||
48930816|NCT00481065|157578274|FG004|Overall Study|Lost to Follow-up|3|||
48930817|NCT00481065|157578275|FG005|Overall Study|Lost to Follow-up|3|||
48930818|NCT00481065|157578276|FG006|Overall Study|Lost to Follow-up|2|||
48930819|NCT00481065|157578277|FG007|Overall Study|Lost to Follow-up|5|||
48930820|NCT00481065|157578270|FG000|Overall Study|Inappropriate enrollment|4|||
48930821|NCT00481065|157578271|FG001|Overall Study|Inappropriate enrollment|0|||
48930822|NCT00481065|157578272|FG002|Overall Study|Inappropriate enrollment|2|||
48930823|NCT00481065|157578273|FG003|Overall Study|Inappropriate enrollment|0|||
48930824|NCT00481065|157578274|FG004|Overall Study|Inappropriate enrollment|2|||
48930825|NCT00481065|157578275|FG005|Overall Study|Inappropriate enrollment|1|||
48930826|NCT00481065|157578276|FG006|Overall Study|Inappropriate enrollment|0|||
48930827|NCT00481065|157578277|FG007|Overall Study|Inappropriate enrollment|1|||
48930828|NCT00481065|157578270|FG000|Overall Study|Administrative reason|0|||
48930829|NCT00481065|157578271|FG001|Overall Study|Administrative reason|0|||
48930830|NCT00481065|157578272|FG002|Overall Study|Administrative reason|0|||
48930831|NCT00481065|157578273|FG003|Overall Study|Administrative reason|0|||
48930832|NCT00481065|157578274|FG004|Overall Study|Administrative reason|0|||
48930833|NCT00481065|157578275|FG005|Overall Study|Administrative reason|2|||
48930834|NCT00481065|157578276|FG006|Overall Study|Administrative reason|1|||
48930835|NCT00481065|157578277|FG007|Overall Study|Administrative reason|0|||
48930836|NCT00481065|157578270|FG000|Overall Study|Protocol Violation|2|||
48930837|NCT00481065|157578271|FG001|Overall Study|Protocol Violation|1|||
48930838|NCT00481065|157578272|FG002|Overall Study|Protocol Violation|1|||
48930839|NCT00481065|157578273|FG003|Overall Study|Protocol Violation|1|||
48930840|NCT00481065|157578274|FG004|Overall Study|Protocol Violation|2|||
48930841|NCT00481065|157578275|FG005|Overall Study|Protocol Violation|6|||
48930842|NCT00481065|157578276|FG006|Overall Study|Protocol Violation|3|||
48930843|NCT00481065|157578277|FG007|Overall Study|Protocol Violation|2|||
48930844|NCT00481065|157578270|FG000|Overall Study|Unable to classify|0|||
48930845|NCT00481065|157578271|FG001|Overall Study|Unable to classify|1|||
48930846|NCT00481065|157578272|FG002|Overall Study|Unable to classify|2|||
48930847|NCT00481065|157578273|FG003|Overall Study|Unable to classify|0|||
48930848|NCT00481065|157578274|FG004|Overall Study|Unable to classify|1|||
48930849|NCT00481065|157578275|FG005|Overall Study|Unable to classify|0|||
48930850|NCT00481065|157578276|FG006|Overall Study|Unable to classify|0|||
48930851|NCT00481065|157578277|FG007|Overall Study|Unable to classify|0|||
48930852|NCT03887130|157578284|FG000|Overall Study|Progressive disease|23|||
48930853|NCT03887130|157578285|FG001|Overall Study|Progressive disease|14|||
48930854|NCT03887130|157578286|FG002|Overall Study|Progressive disease|7|||
48930855|NCT03887130|157578284|FG000|Overall Study|Protocol Violation|3|||
48930856|NCT03887130|157578285|FG001|Overall Study|Protocol Violation|1|||
48930857|NCT03887130|157578286|FG002|Overall Study|Protocol Violation|2|||
48930858|NCT03887130|157578284|FG000|Overall Study|Drug related toxicity|7|||
48930859|NCT03887130|157578285|FG001|Overall Study|Drug related toxicity|7|||
48930860|NCT03887130|157578286|FG002|Overall Study|Drug related toxicity|13|||
48930861|NCT03887130|157578284|FG000|Overall Study|Non drug related toxicity|3|||
48693070|NCT01400698|156724662|FG004|Overall Study|Other|1|||
48930862|NCT03887130|157578285|FG001|Overall Study|Non drug related toxicity|0|||
48930863|NCT03887130|157578286|FG002|Overall Study|Non drug related toxicity|0|||
48930864|NCT03887130|157578284|FG000|Overall Study|Death|2|||
48930865|NCT03887130|157578285|FG001|Overall Study|Death|2|||
48930866|NCT03887130|157578286|FG002|Overall Study|Death|1|||
48930867|NCT03887130|157578284|FG000|Overall Study|Withdrawal by Subject|7|||
48930868|NCT03887130|157578285|FG001|Overall Study|Withdrawal by Subject|6|||
48930869|NCT03887130|157578286|FG002|Overall Study|Withdrawal by Subject|11|||
48930870|NCT03887130|157578284|FG000|Overall Study|other reason|6|||
48930871|NCT03887130|157578285|FG001|Overall Study|other reason|20|||
48930872|NCT03887130|157578286|FG002|Overall Study|other reason|17|||
48930873|NCT02049944|157580327|FG000|Overall Study|Protocol Violation|2|||
48930874|NCT01761266|157580328|FG000|Overall Study|Death|415|||
48930875|NCT01761266|157580329|FG001|Overall Study|Death|402|||
48930876|NCT01761266|157580328|FG000|Overall Study|Lost to Follow-up|8|||
48930877|NCT01761266|157580329|FG001|Overall Study|Lost to Follow-up|12|||
48930878|NCT01761266|157580328|FG000|Overall Study|Withdrawal by Subject|14|||
48930879|NCT01761266|157580329|FG001|Overall Study|Withdrawal by Subject|10|||
48930880|NCT01761266|157580328|FG000|Overall Study|Sponsor Decision|41|||
48930881|NCT01761266|157580329|FG001|Overall Study|Sponsor Decision|52|||
48930882|NCT01284114|157580330|FG000|Overall Study|viral infection|1|||
48930883|NCT01284114|157580330|FG000|Overall Study|From the results of ALLTITUDE study|1|||
48930884|NCT01284114|157580330|FG000|Overall Study|Symptomatic hypotension|1|||
48930885|NCT01284114|157580330|FG000|Overall Study|dizziness|1|||
48930886|NCT00598975|157580331|FG000|Overall Study|Adverse Event|1|||
48930887|NCT00598975|157580332|FG001|Overall Study|Adverse Event|1|||
48930888|NCT00598975|157580331|FG000|Overall Study|Brain metastases|1|||
48930889|NCT00598975|157580332|FG001|Overall Study|Brain metastases|0|||
48930890|NCT00598975|157580331|FG000|Overall Study|Withdrawal by Subject|1|||
48844557|NCT02755116|157272797|FG000|Overall Study|surgery converted to open, pt admitted|3|||
48844558|NCT02755116|157272798|FG001|Overall Study|surgery converted to open, pt admitted|1|||
48844559|NCT01266122|157272800|FG000|Overall Study|Lost to Follow-up|6|||
48930891|NCT00598975|157580332|FG001|Overall Study|Withdrawal by Subject|1|||
48930892|NCT00598975|157580331|FG000|Overall Study|Withdrawal of consent|0|||
48930893|NCT00598975|157580332|FG001|Overall Study|Withdrawal of consent|1|||
48930894|NCT00598975|157580331|FG000|Overall Study|Disease progression|8|||
48930895|NCT00598975|157580332|FG001|Overall Study|Disease progression|3|||
48930896|NCT00598975|157580331|FG000|Overall Study|Tx delayed >2 wks, hospitalized for AE|1|||
48930897|NCT00598975|157580332|FG001|Overall Study|Tx delayed >2 wks, hospitalized for AE|0|||
48930898|NCT01354028|157580335|FG000|Overall Study|Physician Decision|0|||
48930899|NCT01354028|157580336|FG001|Overall Study|Physician Decision|2|||
48930900|NCT01354028|157580335|FG000|Overall Study|Discharged before study start|2|||
48930901|NCT01354028|157580336|FG001|Overall Study|Discharged before study start|2|||
48930902|NCT01354028|157580335|FG000|Overall Study|No quiet alert state|0|||
48930903|NCT01354028|157580336|FG001|Overall Study|No quiet alert state|1|||
48930904|NCT00264004|157580338|FG000|Overall Study|Adverse Event|2|||
48930905|NCT00264004|157580339|FG001|Overall Study|Adverse Event|3|||
48930906|NCT00264004|157580340|FG002|Overall Study|Adverse Event|6|||
48930907|NCT00264004|157580341|FG003|Overall Study|Adverse Event|4|||
48930908|NCT00264004|157580338|FG000|Overall Study|Withdrawal by Subject|0|||
48930909|NCT00264004|157580339|FG001|Overall Study|Withdrawal by Subject|1|||
48930910|NCT00264004|157580340|FG002|Overall Study|Withdrawal by Subject|2|||
48930911|NCT00264004|157580341|FG003|Overall Study|Withdrawal by Subject|2|||
48930912|NCT00264004|157580338|FG000|Overall Study|Other|2|||
48930913|NCT00264004|157580339|FG001|Overall Study|Other|2|||
48930914|NCT00264004|157580340|FG002|Overall Study|Other|0|||
48930915|NCT00264004|157580341|FG003|Overall Study|Other|3|||
48930916|NCT00264004|157580338|FG000|Overall Study|Development study specific disc. crit.|1|||
48930917|NCT00264004|157580339|FG001|Overall Study|Development study specific disc. crit.|0|||
48930918|NCT00264004|157580340|FG002|Overall Study|Development study specific disc. crit.|1|||
48930919|NCT00264004|157580341|FG003|Overall Study|Development study specific disc. crit.|0|||
48930920|NCT00264004|157580338|FG000|Overall Study|Cond. under inv. worsened|9|||
48930921|NCT00264004|157580339|FG001|Overall Study|Cond. under inv. worsened|5|||
48930922|NCT00264004|157580340|FG002|Overall Study|Cond. under inv. worsened|3|||
48930923|NCT00264004|157580341|FG003|Overall Study|Cond. under inv. worsened|4|||
48930924|NCT00264004|157580338|FG000|Overall Study|Not treated|3|||
48930925|NCT00264004|157580339|FG001|Overall Study|Not treated|0|||
48930926|NCT00264004|157580340|FG002|Overall Study|Not treated|2|||
48930927|NCT00264004|157580341|FG003|Overall Study|Not treated|2|||
48930928|NCT01637142|157580347|FG000|Washout Period (at Least 3 Days)|Physician Decision|1|||
48930929|NCT01707030|157580352|FG000|Overall Study|Death|1|||
48930930|NCT01707030|157580353|FG001|Overall Study|Death|1|||
48930931|NCT01707030|157580352|FG000|Overall Study|Withdrawal by Subject|2|||
48930932|NCT01707030|157580353|FG001|Overall Study|Withdrawal by Subject|3|||
48930933|NCT01707030|157580352|FG000|Overall Study|Lost to Follow-up|8|||
48930934|NCT01707030|157580353|FG001|Overall Study|Lost to Follow-up|13|||
48930935|NCT02222714|157580354|FG000|Overall Study|Death|0|||
48930936|NCT02222714|157580355|FG001|Overall Study|Death|2|||
48930937|NCT02222714|157580356|FG002|Overall Study|Death|3|||
48930938|NCT02222714|157580357|FG003|Overall Study|Death|4|||
48930939|NCT02222714|157580358|FG004|Overall Study|Death|6|||
48930940|NCT02222714|157580354|FG000|Overall Study|Withdrawal by Subject|0|||
48930941|NCT02222714|157580355|FG001|Overall Study|Withdrawal by Subject|0|||
48930942|NCT02222714|157580356|FG002|Overall Study|Withdrawal by Subject|1|||
48930943|NCT02222714|157580357|FG003|Overall Study|Withdrawal by Subject|0|||
48930944|NCT02222714|157580358|FG004|Overall Study|Withdrawal by Subject|1|||
48930945|NCT03634800|157580359|FG000|Overall Study|Adverse Event|1|||
48930946|NCT03634800|157580359|FG000|Overall Study|Disease Progression|4|||
48930947|NCT03634800|157580359|FG000|Overall Study|Withdrawal by Subject|1|||
48930948|NCT00648167|157580360|FG000|Overall Study|Adverse Event|6|||
48930949|NCT00648167|157580360|FG000|Overall Study|unable to swallow tablets|1|||
48930950|NCT02296242|157580361|FG000|Overall Study|Death|1|||
48930951|NCT02296242|157580362|FG001|Overall Study|Death|1|||
48930952|NCT02296242|157580363|FG002|Overall Study|Death|1|||
48930953|NCT02296242|157580364|FG003|Overall Study|Death|1|||
48930954|NCT02296242|157580365|FG004|Overall Study|Death|1|||
48930955|NCT02296242|157580361|FG000|Overall Study|Withdrawal by Subject|0|||
48930956|NCT02296242|157580362|FG001|Overall Study|Withdrawal by Subject|0|||
48930957|NCT02296242|157580363|FG002|Overall Study|Withdrawal by Subject|1|||
48930958|NCT02296242|157580364|FG003|Overall Study|Withdrawal by Subject|1|||
48930959|NCT02296242|157580365|FG004|Overall Study|Withdrawal by Subject|3|||
48930960|NCT02296242|157580361|FG000|Overall Study|Disease Progression|1|||
48930961|NCT02296242|157580362|FG001|Overall Study|Disease Progression|3|||
48930962|NCT02296242|157580363|FG002|Overall Study|Disease Progression|2|||
48930963|NCT02296242|157580364|FG003|Overall Study|Disease Progression|8|||
48930964|NCT02296242|157580365|FG004|Overall Study|Disease Progression|11|||
48930965|NCT02296242|157580361|FG000|Overall Study|Unacceptable Toxicity|0|||
48930966|NCT02296242|157580362|FG001|Overall Study|Unacceptable Toxicity|0|||
48930967|NCT02296242|157580363|FG002|Overall Study|Unacceptable Toxicity|0|||
48930968|NCT02296242|157580364|FG003|Overall Study|Unacceptable Toxicity|0|||
48930969|NCT02296242|157580365|FG004|Overall Study|Unacceptable Toxicity|1|||
48930970|NCT02296242|157580361|FG000|Overall Study|Patient Condition Changed|0|||
48930971|NCT02296242|157580362|FG001|Overall Study|Patient Condition Changed|0|||
48930972|NCT02296242|157580363|FG002|Overall Study|Patient Condition Changed|2|||
48930973|NCT02296242|157580364|FG003|Overall Study|Patient Condition Changed|0|||
48930974|NCT02296242|157580365|FG004|Overall Study|Patient Condition Changed|1|||
48930975|NCT02296242|157580361|FG000|Overall Study|At Least 3 Drug Interruptions|0|||
48930976|NCT02296242|157580362|FG001|Overall Study|At Least 3 Drug Interruptions|0|||
48930977|NCT02296242|157580363|FG002|Overall Study|At Least 3 Drug Interruptions|1|||
48930978|NCT02296242|157580364|FG003|Overall Study|At Least 3 Drug Interruptions|1|||
48930979|NCT02296242|157580365|FG004|Overall Study|At Least 3 Drug Interruptions|1|||
48930980|NCT02296242|157580361|FG000|Overall Study|Lost to Follow-up|1|||
48930981|NCT02296242|157580362|FG001|Overall Study|Lost to Follow-up|0|||
48930982|NCT02296242|157580363|FG002|Overall Study|Lost to Follow-up|0|||
48930983|NCT02296242|157580364|FG003|Overall Study|Lost to Follow-up|0|||
48930984|NCT02296242|157580365|FG004|Overall Study|Lost to Follow-up|0|||
48930985|NCT02296242|157580361|FG000|Overall Study|Need for Hydroxyurea|2|||
48930986|NCT02296242|157580362|FG001|Overall Study|Need for Hydroxyurea|0|||
48930987|NCT02296242|157580363|FG002|Overall Study|Need for Hydroxyurea|0|||
48930988|NCT02296242|157580364|FG003|Overall Study|Need for Hydroxyurea|0|||
48930989|NCT02296242|157580365|FG004|Overall Study|Need for Hydroxyurea|0|||
48930990|NCT02296242|157580361|FG000|Overall Study|Screened for Other Protocol|0|||
48930991|NCT02296242|157580362|FG001|Overall Study|Screened for Other Protocol|1|||
48930992|NCT02296242|157580363|FG002|Overall Study|Screened for Other Protocol|0|||
48930993|NCT02296242|157580364|FG003|Overall Study|Screened for Other Protocol|0|||
48930994|NCT02296242|157580365|FG004|Overall Study|Screened for Other Protocol|0|||
48930995|NCT02296242|157580361|FG000|Overall Study|Physician Decision|0|||
48930996|NCT02296242|157580362|FG001|Overall Study|Physician Decision|1|||
48930997|NCT02296242|157580363|FG002|Overall Study|Physician Decision|0|||
48930998|NCT02296242|157580364|FG003|Overall Study|Physician Decision|1|||
48930999|NCT02296242|157580365|FG004|Overall Study|Physician Decision|0|||
48931000|NCT02296242|157580361|FG000|Overall Study|Alternative Treatment|0|||
48931001|NCT02296242|157580362|FG001|Overall Study|Alternative Treatment|0|||
48931002|NCT02296242|157580363|FG002|Overall Study|Alternative Treatment|0|||
48931003|NCT02296242|157580364|FG003|Overall Study|Alternative Treatment|1|||
48931004|NCT02296242|157580365|FG004|Overall Study|Alternative Treatment|0|||
48931005|NCT02296242|157580361|FG000|Overall Study|Adverse Event|0|||
48931006|NCT02296242|157580362|FG001|Overall Study|Adverse Event|0|||
48931007|NCT02296242|157580363|FG002|Overall Study|Adverse Event|0|||
48931008|NCT02296242|157580364|FG003|Overall Study|Adverse Event|1|||
48931009|NCT02296242|157580365|FG004|Overall Study|Adverse Event|0|||
48931010|NCT02296242|157580361|FG000|Overall Study|Lack of Efficacy|0|||
48931011|NCT02296242|157580362|FG001|Overall Study|Lack of Efficacy|0|||
48931012|NCT02296242|157580363|FG002|Overall Study|Lack of Efficacy|0|||
48931013|NCT02296242|157580364|FG003|Overall Study|Lack of Efficacy|0|||
48931014|NCT02296242|157580365|FG004|Overall Study|Lack of Efficacy|3|||
48931015|NCT00634569|157580372|FG000|Overall Study|Withdrawal by Subject|0|||
48931016|NCT00634569|157580373|FG001|Overall Study|Withdrawal by Subject|4|||
48931017|NCT00634569|157580372|FG000|Overall Study|Physician Decision|0|||
48931018|NCT00634569|157580373|FG001|Overall Study|Physician Decision|1|||
48693071|NCT01400698|156724663|FG005|Overall Study|Other|0|||
48931019|NCT02167945|157580375|FG000|Overall Study|Adverse Event|16|||
48931020|NCT02167945|157580375|FG000|Overall Study|Withdrew Consent|42|||
48931021|NCT02167945|157580375|FG000|Overall Study|Lost to Follow-up|122|||
48931022|NCT02167945|157580375|FG000|Overall Study|COVID-19 logistical restrictions|6|||
48931023|NCT02167945|157580375|FG000|Overall Study|Other, not specified|63|||
48931024|NCT00939692|157580376|FG000|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1|||
48931025|NCT00939692|157580377|FG001|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0|||
48931026|NCT00939692|157580376|FG000|Period 2 - Second Intervent - 5 Days|Protocol Violation|0|||
48931027|NCT00939692|157580377|FG001|Period 2 - Second Intervent - 5 Days|Protocol Violation|1|||
48931028|NCT01262976|157580378|FG000|Up to Month 2|Serious Adverse Event|0|||
48931029|NCT01262976|157580379|FG001|Up to Month 2|Serious Adverse Event|0|||
48931030|NCT01262976|157580380|FG002|Up to Month 2|Serious Adverse Event|1|||
48931031|NCT01262976|157580381|FG003|Up to Month 2|Serious Adverse Event|0|||
48931032|NCT01262976|157580382|FG004|Up to Month 2|Serious Adverse Event|0|||
48931033|NCT01262976|157580383|FG005|Up to Month 2|Serious Adverse Event|0|||
48931034|NCT01262976|157580378|FG000|Up to Month 2|Withdrawal by Subject|1|||
48931035|NCT01262976|157580379|FG001|Up to Month 2|Withdrawal by Subject|0|||
48931036|NCT01262976|157580380|FG002|Up to Month 2|Withdrawal by Subject|0|||
48931037|NCT01262976|157580381|FG003|Up to Month 2|Withdrawal by Subject|0|||
48931038|NCT01262976|157580382|FG004|Up to Month 2|Withdrawal by Subject|0|||
48931039|NCT01262976|157580383|FG005|Up to Month 2|Withdrawal by Subject|0|||
48931040|NCT01262976|157580378|FG000|Up to Month 2|Migrated/moved from study area|0|||
48931041|NCT01262976|157580379|FG001|Up to Month 2|Migrated/moved from study area|1|||
48931042|NCT01262976|157580380|FG002|Up to Month 2|Migrated/moved from study area|0|||
48931043|NCT01262976|157580381|FG003|Up to Month 2|Migrated/moved from study area|0|||
48931044|NCT01262976|157580382|FG004|Up to Month 2|Migrated/moved from study area|1|||
48931045|NCT01262976|157580383|FG005|Up to Month 2|Migrated/moved from study area|1|||
48931046|NCT01262976|157580378|FG000|Up to Month 2|Lost to Follow-up|1|||
48931047|NCT01262976|157580379|FG001|Up to Month 2|Lost to Follow-up|0|||
48931048|NCT01262976|157580380|FG002|Up to Month 2|Lost to Follow-up|0|||
48931049|NCT01262976|157580381|FG003|Up to Month 2|Lost to Follow-up|1|||
48931050|NCT01262976|157580382|FG004|Up to Month 2|Lost to Follow-up|1|||
48931051|NCT01262976|157580383|FG005|Up to Month 2|Lost to Follow-up|1|||
48931052|NCT01262976|157580378|FG000|Up to Month 2|Other|1|||
48931053|NCT01262976|157580379|FG001|Up to Month 2|Other|0|||
48931054|NCT01262976|157580380|FG002|Up to Month 2|Other|0|||
48931055|NCT01262976|157580381|FG003|Up to Month 2|Other|1|||
48931056|NCT01262976|157580382|FG004|Up to Month 2|Other|0|||
48931057|NCT01262976|157580383|FG005|Up to Month 2|Other|2|||
48931058|NCT01262976|157580378|FG000|Up to Month 7|Serious Adverse Event|0|||
48931059|NCT01262976|157580379|FG001|Up to Month 7|Serious Adverse Event|0|||
48931060|NCT01262976|157580380|FG002|Up to Month 7|Serious Adverse Event|2|||
48931061|NCT01262976|157580381|FG003|Up to Month 7|Serious Adverse Event|0|||
48931062|NCT01262976|157580382|FG004|Up to Month 7|Serious Adverse Event|0|||
48931063|NCT01262976|157580383|FG005|Up to Month 7|Serious Adverse Event|0|||
48931064|NCT01262976|157580378|FG000|Up to Month 7|Withdrawal by Subject|1|||
48931065|NCT01262976|157580379|FG001|Up to Month 7|Withdrawal by Subject|0|||
48931066|NCT01262976|157580380|FG002|Up to Month 7|Withdrawal by Subject|0|||
48931067|NCT01262976|157580381|FG003|Up to Month 7|Withdrawal by Subject|0|||
48931068|NCT01262976|157580382|FG004|Up to Month 7|Withdrawal by Subject|0|||
48931069|NCT01262976|157580383|FG005|Up to Month 7|Withdrawal by Subject|0|||
48931070|NCT01262976|157580378|FG000|Up to Month 7|Migrated/moved from study area|0|||
48931071|NCT01262976|157580379|FG001|Up to Month 7|Migrated/moved from study area|0|||
48931072|NCT01262976|157580380|FG002|Up to Month 7|Migrated/moved from study area|1|||
48931073|NCT01262976|157580381|FG003|Up to Month 7|Migrated/moved from study area|3|||
48931074|NCT01262976|157580382|FG004|Up to Month 7|Migrated/moved from study area|1|||
48931075|NCT01262976|157580383|FG005|Up to Month 7|Migrated/moved from study area|1|||
48931076|NCT01262976|157580378|FG000|Up to Month 7|Lost to Follow-up|1|||
48931077|NCT01262976|157580379|FG001|Up to Month 7|Lost to Follow-up|0|||
48931078|NCT01262976|157580380|FG002|Up to Month 7|Lost to Follow-up|1|||
48931079|NCT01262976|157580381|FG003|Up to Month 7|Lost to Follow-up|3|||
48931080|NCT01262976|157580382|FG004|Up to Month 7|Lost to Follow-up|1|||
48931081|NCT01262976|157580383|FG005|Up to Month 7|Lost to Follow-up|3|||
48931082|NCT01262976|157580378|FG000|Up to Month 7|Other|3|||
48931083|NCT01262976|157580379|FG001|Up to Month 7|Other|0|||
48931084|NCT01262976|157580380|FG002|Up to Month 7|Other|2|||
48931085|NCT01262976|157580381|FG003|Up to Month 7|Other|0|||
48931086|NCT01262976|157580382|FG004|Up to Month 7|Other|0|||
48931087|NCT01262976|157580383|FG005|Up to Month 7|Other|0|||
48931088|NCT01262976|157580378|FG000|Up to Year 1|Serious Adverse Event|0|||
48931089|NCT01262976|157580379|FG001|Up to Year 1|Serious Adverse Event|0|||
48931090|NCT01262976|157580380|FG002|Up to Year 1|Serious Adverse Event|2|||
48931091|NCT01262976|157580381|FG003|Up to Year 1|Serious Adverse Event|0|||
48931092|NCT01262976|157580382|FG004|Up to Year 1|Serious Adverse Event|0|||
48931093|NCT01262976|157580383|FG005|Up to Year 1|Serious Adverse Event|0|||
48931094|NCT01262976|157580378|FG000|Up to Year 1|Withdrawal by Subject|1|||
48844560|NCT01266122|157272801|FG001|Overall Study|Lost to Follow-up|6|||
48844561|NCT03292913|157272802|FG000|Overall Study|Death|9|||
48844562|NCT03292913|157272803|FG001|Overall Study|Death|3|||
48844563|NCT03292913|157272802|FG000|Overall Study|Lost to Follow-up|49|||
48844564|NCT03292913|157272803|FG001|Overall Study|Lost to Follow-up|49|||
48844565|NCT03292913|157272802|FG000|Overall Study|Withdrawal by Subject|2|||
48844566|NCT03292913|157272803|FG001|Overall Study|Withdrawal by Subject|0|||
48844567|NCT03292913|157272802|FG000|Overall Study|Clinic closed due to COVID|22|||
48844568|NCT03292913|157272803|FG001|Overall Study|Clinic closed due to COVID|36|||
48844569|NCT03756571|157272804|FG000|Overall Study|Lost to Follow-up|1|||
48844570|NCT03756571|157272805|FG001|Overall Study|Lost to Follow-up|1|||
48844571|NCT00978042|157272806|FG000|Initial Treatment Period|Treated in Error|0|||
48844572|NCT00978042|157272807|FG001|Initial Treatment Period|Treated in Error|3|||
48844573|NCT00978042|157272806|FG000|Initial Treatment Period|Ineligibility|1|||
48844574|NCT00978042|157272807|FG001|Initial Treatment Period|Ineligibility|0|||
48844575|NCT00978042|157272806|FG000|Initial Treatment Period|Lost to Follow-up|21|||
48844576|NCT00978042|157272807|FG001|Initial Treatment Period|Lost to Follow-up|3|||
48844577|NCT00978042|157272806|FG000|Initial Treatment Period|Adverse Event|2|||
48844578|NCT00978042|157272807|FG001|Initial Treatment Period|Adverse Event|0|||
48844579|NCT00978042|157272806|FG000|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2|||
48844580|NCT00978042|157272807|FG001|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0|||
48844581|NCT00978042|157272806|FG000|Initial Treatment Period|Consent withdrawn|22|||
48844582|NCT00978042|157272807|FG001|Initial Treatment Period|Consent withdrawn|9|||
48844583|NCT00978042|157272806|FG000|Initial Treatment Period|Other Miscellaneous Reasons|13|||
48844584|NCT00978042|157272807|FG001|Initial Treatment Period|Other Miscellaneous Reasons|0|||
48844585|NCT00529516|157272808|FG000|Overall Study|Adverse Event|2|||
48844586|NCT00529516|157272809|FG001|Overall Study|Adverse Event|1|||
48844587|NCT00529516|157272810|FG002|Overall Study|Adverse Event|0|||
48931095|NCT01262976|157580379|FG001|Up to Year 1|Withdrawal by Subject|0|||
48931096|NCT01262976|157580380|FG002|Up to Year 1|Withdrawal by Subject|0|||
48931097|NCT01262976|157580381|FG003|Up to Year 1|Withdrawal by Subject|0|||
48844588|NCT00529516|157272808|FG000|Overall Study|Withdrawal by Subject|1|||
48844589|NCT00529516|157272809|FG001|Overall Study|Withdrawal by Subject|1|||
48931098|NCT01262976|157580382|FG004|Up to Year 1|Withdrawal by Subject|0|||
48931099|NCT01262976|157580383|FG005|Up to Year 1|Withdrawal by Subject|0|||
48931100|NCT01262976|157580378|FG000|Up to Year 1|Migrated/moved from study area|1|||
48931101|NCT01262976|157580379|FG001|Up to Year 1|Migrated/moved from study area|0|||
48931102|NCT01262976|157580380|FG002|Up to Year 1|Migrated/moved from study area|0|||
48931103|NCT01262976|157580381|FG003|Up to Year 1|Migrated/moved from study area|3|||
48931104|NCT01262976|157580382|FG004|Up to Year 1|Migrated/moved from study area|3|||
48931105|NCT01262976|157580383|FG005|Up to Year 1|Migrated/moved from study area|2|||
48931106|NCT01262976|157580378|FG000|Up to Year 1|Lost to Follow-up|4|||
48931107|NCT01262976|157580379|FG001|Up to Year 1|Lost to Follow-up|0|||
48931108|NCT01262976|157580380|FG002|Up to Year 1|Lost to Follow-up|0|||
48931109|NCT01262976|157580381|FG003|Up to Year 1|Lost to Follow-up|1|||
48931110|NCT01262976|157580382|FG004|Up to Year 1|Lost to Follow-up|6|||
48931111|NCT01262976|157580383|FG005|Up to Year 1|Lost to Follow-up|5|||
48931112|NCT01262976|157580378|FG000|Up to Year 1|Other|3|||
48931113|NCT01262976|157580379|FG001|Up to Year 1|Other|1|||
48931114|NCT01262976|157580380|FG002|Up to Year 1|Other|0|||
48931115|NCT01262976|157580381|FG003|Up to Year 1|Other|0|||
48931116|NCT01262976|157580382|FG004|Up to Year 1|Other|2|||
48931117|NCT01262976|157580383|FG005|Up to Year 1|Other|1|||
48931118|NCT01262976|157580378|FG000|Up to Year 1|Subjects with unknown completion status|0|||
48931119|NCT01262976|157580379|FG001|Up to Year 1|Subjects with unknown completion status|0|||
48931120|NCT01262976|157580380|FG002|Up to Year 1|Subjects with unknown completion status|1|||
48931121|NCT01262976|157580381|FG003|Up to Year 1|Subjects with unknown completion status|0|||
48931122|NCT01262976|157580382|FG004|Up to Year 1|Subjects with unknown completion status|0|||
48931123|NCT01262976|157580383|FG005|Up to Year 1|Subjects with unknown completion status|1|||
48931124|NCT01262976|157580378|FG000|Up to Year 2|Serious Adverse Event|0|||
48931125|NCT01262976|157580379|FG001|Up to Year 2|Serious Adverse Event|0|||
48931126|NCT01262976|157580380|FG002|Up to Year 2|Serious Adverse Event|2|||
48931127|NCT01262976|157580381|FG003|Up to Year 2|Serious Adverse Event|0|||
48931128|NCT01262976|157580382|FG004|Up to Year 2|Serious Adverse Event|0|||
48931129|NCT01262976|157580383|FG005|Up to Year 2|Serious Adverse Event|0|||
48931130|NCT01262976|157580378|FG000|Up to Year 2|Withdrawal by Subject|1|||
48931131|NCT01262976|157580379|FG001|Up to Year 2|Withdrawal by Subject|0|||
48931132|NCT01262976|157580380|FG002|Up to Year 2|Withdrawal by Subject|0|||
48931133|NCT01262976|157580381|FG003|Up to Year 2|Withdrawal by Subject|0|||
48931134|NCT01262976|157580382|FG004|Up to Year 2|Withdrawal by Subject|0|||
48931135|NCT01262976|157580383|FG005|Up to Year 2|Withdrawal by Subject|0|||
48931136|NCT01262976|157580378|FG000|Up to Year 2|Migrated/moved from study area|0|||
48931137|NCT01262976|157580379|FG001|Up to Year 2|Migrated/moved from study area|0|||
48931138|NCT01262976|157580380|FG002|Up to Year 2|Migrated/moved from study area|0|||
48931139|NCT01262976|157580381|FG003|Up to Year 2|Migrated/moved from study area|2|||
48931140|NCT01262976|157580382|FG004|Up to Year 2|Migrated/moved from study area|1|||
48931141|NCT01262976|157580383|FG005|Up to Year 2|Migrated/moved from study area|2|||
48931142|NCT01262976|157580378|FG000|Up to Year 2|Lost to Follow-up|1|||
48931143|NCT01262976|157580379|FG001|Up to Year 2|Lost to Follow-up|1|||
48931144|NCT01262976|157580380|FG002|Up to Year 2|Lost to Follow-up|2|||
48693072|NCT01350999|156724664|FG000|Overall Study|Adverse Event|4|||
48931145|NCT01262976|157580381|FG003|Up to Year 2|Lost to Follow-up|2|||
48931146|NCT01262976|157580382|FG004|Up to Year 2|Lost to Follow-up|3|||
48931147|NCT01262976|157580383|FG005|Up to Year 2|Lost to Follow-up|3|||
48931148|NCT01262976|157580378|FG000|Up to Year 2|Subjects with unknown completion status|0|||
48844590|NCT00529516|157272810|FG002|Overall Study|Withdrawal by Subject|0|||
48844591|NCT00529516|157272808|FG000|Overall Study|Lost to Follow-up|0|||
48844592|NCT00529516|157272809|FG001|Overall Study|Lost to Follow-up|0|||
48844593|NCT00529516|157272810|FG002|Overall Study|Lost to Follow-up|1|||
48844594|NCT00111813|157272811|FG000|Overall Study|Adverse Event|1|||
48844595|NCT00111813|157272812|FG001|Overall Study|Adverse Event|2|||
48844596|NCT00111813|157272813|FG002|Overall Study|Adverse Event|4|||
48844597|NCT00111813|157272814|FG003|Overall Study|Adverse Event|2|||
48844598|NCT00111813|157272815|FG004|Overall Study|Adverse Event|2|||
48844599|NCT00111813|157272816|FG005|Overall Study|Adverse Event|2|||
48844600|NCT00111813|157272811|FG000|Overall Study|Progressive disease|2|||
48844601|NCT00111813|157272812|FG001|Overall Study|Progressive disease|1|||
48844602|NCT00111813|157272813|FG002|Overall Study|Progressive disease|5|||
48931149|NCT01262976|157580379|FG001|Up to Year 2|Subjects with unknown completion status|0|||
48931150|NCT01262976|157580380|FG002|Up to Year 2|Subjects with unknown completion status|1|||
48931151|NCT01262976|157580381|FG003|Up to Year 2|Subjects with unknown completion status|0|||
48931152|NCT01262976|157580382|FG004|Up to Year 2|Subjects with unknown completion status|0|||
48931153|NCT01262976|157580383|FG005|Up to Year 2|Subjects with unknown completion status|0|||
48931154|NCT01262976|157580378|FG000|Up to Year 2|Other|3|||
48931155|NCT01262976|157580379|FG001|Up to Year 2|Other|0|||
48931156|NCT01262976|157580380|FG002|Up to Year 2|Other|0|||
48931157|NCT01262976|157580381|FG003|Up to Year 2|Other|0|||
48931158|NCT01262976|157580382|FG004|Up to Year 2|Other|0|||
48931159|NCT01262976|157580383|FG005|Up to Year 2|Other|0|||
48931160|NCT01262976|157580378|FG000|Up to Year 3|Serious Adverse Event|0|||
48931161|NCT01262976|157580379|FG001|Up to Year 3|Serious Adverse Event|0|||
48931162|NCT01262976|157580380|FG002|Up to Year 3|Serious Adverse Event|2|||
48931163|NCT01262976|157580381|FG003|Up to Year 3|Serious Adverse Event|0|||
48931164|NCT01262976|157580382|FG004|Up to Year 3|Serious Adverse Event|0|||
48693073|NCT01350999|156724665|FG001|Overall Study|Adverse Event|9|||
48931165|NCT01262976|157580383|FG005|Up to Year 3|Serious Adverse Event|0|||
48931166|NCT01262976|157580378|FG000|Up to Year 3|Withdrawal by Subject|1|||
48931167|NCT01262976|157580379|FG001|Up to Year 3|Withdrawal by Subject|0|||
48931168|NCT01262976|157580380|FG002|Up to Year 3|Withdrawal by Subject|0|||
48931169|NCT01262976|157580381|FG003|Up to Year 3|Withdrawal by Subject|0|||
48931170|NCT01262976|157580382|FG004|Up to Year 3|Withdrawal by Subject|0|||
48931171|NCT01262976|157580383|FG005|Up to Year 3|Withdrawal by Subject|0|||
48931172|NCT01262976|157580378|FG000|Up to Year 3|Migrated/moved from study area|0|||
48931173|NCT01262976|157580379|FG001|Up to Year 3|Migrated/moved from study area|0|||
48931174|NCT01262976|157580380|FG002|Up to Year 3|Migrated/moved from study area|0|||
48931175|NCT01262976|157580381|FG003|Up to Year 3|Migrated/moved from study area|2|||
48931176|NCT01262976|157580382|FG004|Up to Year 3|Migrated/moved from study area|1|||
48931177|NCT01262976|157580383|FG005|Up to Year 3|Migrated/moved from study area|1|||
48931178|NCT01262976|157580378|FG000|Up to Year 3|Lost to Follow-up|2|||
48931179|NCT01262976|157580379|FG001|Up to Year 3|Lost to Follow-up|2|||
48931180|NCT01262976|157580380|FG002|Up to Year 3|Lost to Follow-up|4|||
48931181|NCT01262976|157580381|FG003|Up to Year 3|Lost to Follow-up|3|||
48931182|NCT01262976|157580382|FG004|Up to Year 3|Lost to Follow-up|1|||
48931183|NCT01262976|157580383|FG005|Up to Year 3|Lost to Follow-up|3|||
48931184|NCT01262976|157580378|FG000|Up to Year 3|Subjects with unknown completion status|0|||
48931185|NCT01262976|157580379|FG001|Up to Year 3|Subjects with unknown completion status|0|||
48931186|NCT01262976|157580380|FG002|Up to Year 3|Subjects with unknown completion status|1|||
48931187|NCT01262976|157580381|FG003|Up to Year 3|Subjects with unknown completion status|0|||
48931188|NCT01262976|157580382|FG004|Up to Year 3|Subjects with unknown completion status|0|||
48931189|NCT01262976|157580383|FG005|Up to Year 3|Subjects with unknown completion status|0|||
48931190|NCT01262976|157580378|FG000|Up to Year 3|Other|3|||
48931191|NCT01262976|157580379|FG001|Up to Year 3|Other|0|||
48931192|NCT01262976|157580380|FG002|Up to Year 3|Other|0|||
48931193|NCT01262976|157580381|FG003|Up to Year 3|Other|0|||
48931194|NCT01262976|157580382|FG004|Up to Year 3|Other|0|||
48931195|NCT01262976|157580383|FG005|Up to Year 3|Other|0|||
48931196|NCT00624520|157580385|FG000|Overall Study|Withdrawal by Subject|12|||
48931197|NCT00624520|157580386|FG001|Overall Study|Withdrawal by Subject|7|||
48931198|NCT00624520|157580385|FG000|Overall Study|Death|0|||
48931199|NCT00624520|157580386|FG001|Overall Study|Death|1|||
48931200|NCT00448708|157580387|FG000|Overall Study|Death|21|||
48931201|NCT00448708|157580388|FG001|Overall Study|Death|17|||
48931202|NCT00448708|157580387|FG000|Overall Study|Withdrawal by Subject|8|||
48931203|NCT00448708|157580388|FG001|Overall Study|Withdrawal by Subject|4|||
48931204|NCT00448708|157580387|FG000|Overall Study|Lost to Follow-up|6|||
48931205|NCT00448708|157580388|FG001|Overall Study|Lost to Follow-up|8|||
48931206|NCT00448708|157580387|FG000|Overall Study|not listed|0|||
48931207|NCT00448708|157580388|FG001|Overall Study|not listed|2|||
48931208|NCT01925209|157580389|FG000|Treatment Epoch|Physician Decision|1|||
48931209|NCT01925209|157580390|FG001|Treatment Epoch|Physician Decision|0|||
48931210|NCT01925209|157580391|FG002|Treatment Epoch|Physician Decision|0|||
48931211|NCT01925209|157580392|FG003|Treatment Epoch|Physician Decision|0|||
48931212|NCT01925209|157580389|FG000|Treatment Epoch|Non-compliance with study treatment|0|||
48931213|NCT01925209|157580390|FG001|Treatment Epoch|Non-compliance with study treatment|0|||
48931214|NCT01925209|157580391|FG002|Treatment Epoch|Non-compliance with study treatment|0|||
48931215|NCT01925209|157580392|FG003|Treatment Epoch|Non-compliance with study treatment|1|||
48931216|NCT01925209|157580389|FG000|Treatment Epoch|Death|1|||
48931217|NCT01925209|157580390|FG001|Treatment Epoch|Death|0|||
48931218|NCT01925209|157580391|FG002|Treatment Epoch|Death|0|||
48931219|NCT01925209|157580392|FG003|Treatment Epoch|Death|0|||
48931220|NCT01925209|157580389|FG000|Treatment Epoch|Protocol deviation|0|||
48931221|NCT01925209|157580390|FG001|Treatment Epoch|Protocol deviation|0|||
48931222|NCT01925209|157580391|FG002|Treatment Epoch|Protocol deviation|1|||
48931223|NCT01925209|157580392|FG003|Treatment Epoch|Protocol deviation|1|||
48931224|NCT01925209|157580389|FG000|Treatment Epoch|Withdrawal by Subject|4|||
48931225|NCT01925209|157580390|FG001|Treatment Epoch|Withdrawal by Subject|3|||
48931226|NCT01925209|157580391|FG002|Treatment Epoch|Withdrawal by Subject|3|||
48931227|NCT01925209|157580392|FG003|Treatment Epoch|Withdrawal by Subject|2|||
48931228|NCT01925209|157580389|FG000|Treatment Epoch|Adverse Event|3|||
48931229|NCT01925209|157580390|FG001|Treatment Epoch|Adverse Event|5|||
48931230|NCT01925209|157580391|FG002|Treatment Epoch|Adverse Event|3|||
48931231|NCT01925209|157580392|FG003|Treatment Epoch|Adverse Event|1|||
48931232|NCT01925209|157580389|FG000|Maintenance Treatment Epoch|Withdrawal by Subject|0|||
48931233|NCT01925209|157580390|FG001|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
48931234|NCT01925209|157580391|FG002|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
48931235|NCT01925209|157580392|FG003|Maintenance Treatment Epoch|Withdrawal by Subject|2|||
48931236|NCT01925209|157580389|FG000|Maintenance Treatment Epoch|Adverse Event|0|||
48931237|NCT01925209|157580390|FG001|Maintenance Treatment Epoch|Adverse Event|0|||
48931238|NCT01925209|157580391|FG002|Maintenance Treatment Epoch|Adverse Event|1|||
48931239|NCT01925209|157580392|FG003|Maintenance Treatment Epoch|Adverse Event|0|||
48931240|NCT01925209|157580389|FG000|Follow-up|Adverse Event|1|||
48931241|NCT01925209|157580390|FG001|Follow-up|Adverse Event|4|||
48931242|NCT01925209|157580391|FG002|Follow-up|Adverse Event|0|||
48931243|NCT01925209|157580392|FG003|Follow-up|Adverse Event|1|||
48931244|NCT01925209|157580389|FG000|Follow-up|Physician Decision|0|||
48931245|NCT01925209|157580390|FG001|Follow-up|Physician Decision|0|||
48931246|NCT01925209|157580391|FG002|Follow-up|Physician Decision|1|||
48931247|NCT01925209|157580392|FG003|Follow-up|Physician Decision|0|||
48931248|NCT01925209|157580389|FG000|Follow-up|Non-compliance with study treatment|0|||
48931249|NCT01925209|157580390|FG001|Follow-up|Non-compliance with study treatment|0|||
48931250|NCT01925209|157580391|FG002|Follow-up|Non-compliance with study treatment|0|||
48931251|NCT01925209|157580392|FG003|Follow-up|Non-compliance with study treatment|1|||
48931252|NCT01925209|157580389|FG000|Follow-up|Withdrawal by Subject|0|||
48931253|NCT01925209|157580390|FG001|Follow-up|Withdrawal by Subject|2|||
48931254|NCT01925209|157580391|FG002|Follow-up|Withdrawal by Subject|0|||
48931255|NCT01925209|157580392|FG003|Follow-up|Withdrawal by Subject|2|||
48931256|NCT01700192|157580400|FG000|Overall Study|Adverse Event|73|||
48931257|NCT01700192|157580401|FG001|Overall Study|Adverse Event|18|||
48931258|NCT01700192|157580400|FG000|Overall Study|Lack of Efficacy|1|||
48931259|NCT01700192|157580401|FG001|Overall Study|Lack of Efficacy|0|||
48931260|NCT01700192|157580400|FG000|Overall Study|Lost to Follow-up|42|||
48931261|NCT01700192|157580401|FG001|Overall Study|Lost to Follow-up|29|||
48931262|NCT01700192|157580400|FG000|Overall Study|Noncompliance with study drug|0|||
48931263|NCT01700192|157580401|FG001|Overall Study|Noncompliance with study drug|5|||
48931264|NCT01700192|157580400|FG000|Overall Study|Physician Decision|2|||
48931265|NCT01700192|157580401|FG001|Overall Study|Physician Decision|3|||
48931266|NCT01700192|157580400|FG000|Overall Study|Pregnancy|1|||
48931267|NCT01700192|157580401|FG001|Overall Study|Pregnancy|4|||
48931268|NCT01700192|157580400|FG000|Overall Study|Progressive disease|1|||
48931269|NCT01700192|157580401|FG001|Overall Study|Progressive disease|0|||
48931270|NCT01700192|157580400|FG000|Overall Study|Protocol Violation|3|||
48931271|NCT01700192|157580401|FG001|Overall Study|Protocol Violation|4|||
48931272|NCT01700192|157580400|FG000|Overall Study|Technical problems|0|||
48931273|NCT01700192|157580401|FG001|Overall Study|Technical problems|1|||
48931274|NCT01700192|157580400|FG000|Overall Study|Withdrawal by Subject|56|||
48931275|NCT01700192|157580401|FG001|Overall Study|Withdrawal by Subject|64|||
48931276|NCT01700192|157580400|FG000|Overall Study|Never received study drug|1|||
48931277|NCT01700192|157580401|FG001|Overall Study|Never received study drug|0|||
48931278|NCT01703858|157580402|FG000|Overall Study|Withdrawal by Subject|0|||
48931279|NCT01703858|157580403|FG001|Overall Study|Withdrawal by Subject|1|||
48931280|NCT01703858|157580404|FG002|Overall Study|Withdrawal by Subject|0|||
48931281|NCT00792298|157580405|FG000|Treatment Period 1|Adverse Event|0|||
48931282|NCT00792298|157580406|FG001|Treatment Period 1|Adverse Event|1|||
48931283|NCT00792298|157580407|FG002|Treatment Period 1|Adverse Event|0|||
48931284|NCT00792298|157580408|FG003|Treatment Period 1|Adverse Event|1|||
48931285|NCT00792298|157580409|FG004|Treatment Period 1|Adverse Event|0|||
48931286|NCT00792298|157580410|FG005|Treatment Period 1|Adverse Event|1|||
48931287|NCT00792298|157580411|FG006|Treatment Period 1|Adverse Event|1|||
48844603|NCT00111813|157272814|FG003|Overall Study|Progressive disease|3|||
48844604|NCT00111813|157272815|FG004|Overall Study|Progressive disease|4|||
48931288|NCT00792298|157580412|FG007|Treatment Period 1|Adverse Event|0|||
48931289|NCT00792298|157580405|FG000|Treatment Period 1|Lack of Efficacy|0|||
48931290|NCT00792298|157580406|FG001|Treatment Period 1|Lack of Efficacy|0|||
48931291|NCT00792298|157580407|FG002|Treatment Period 1|Lack of Efficacy|1|||
48931292|NCT00792298|157580408|FG003|Treatment Period 1|Lack of Efficacy|0|||
48931293|NCT00792298|157580409|FG004|Treatment Period 1|Lack of Efficacy|0|||
48931294|NCT00792298|157580410|FG005|Treatment Period 1|Lack of Efficacy|0|||
48931295|NCT00792298|157580411|FG006|Treatment Period 1|Lack of Efficacy|0|||
48931296|NCT00792298|157580412|FG007|Treatment Period 1|Lack of Efficacy|0|||
48931297|NCT00792298|157580405|FG000|Treatment Period 1|Withdrawal by Subject|1|||
48931298|NCT00792298|157580406|FG001|Treatment Period 1|Withdrawal by Subject|0|||
48931299|NCT00792298|157580407|FG002|Treatment Period 1|Withdrawal by Subject|1|||
48931300|NCT00792298|157580408|FG003|Treatment Period 1|Withdrawal by Subject|2|||
48931301|NCT00792298|157580409|FG004|Treatment Period 1|Withdrawal by Subject|0|||
48931302|NCT00792298|157580410|FG005|Treatment Period 1|Withdrawal by Subject|2|||
48931303|NCT00792298|157580411|FG006|Treatment Period 1|Withdrawal by Subject|1|||
48931304|NCT00792298|157580412|FG007|Treatment Period 1|Withdrawal by Subject|0|||
48931305|NCT00792298|157580405|FG000|Treatment Period 1|Lost to Follow-up|0|||
48931306|NCT00792298|157580406|FG001|Treatment Period 1|Lost to Follow-up|0|||
48931307|NCT00792298|157580407|FG002|Treatment Period 1|Lost to Follow-up|0|||
48931308|NCT00792298|157580408|FG003|Treatment Period 1|Lost to Follow-up|0|||
48931309|NCT00792298|157580409|FG004|Treatment Period 1|Lost to Follow-up|0|||
48931310|NCT00792298|157580410|FG005|Treatment Period 1|Lost to Follow-up|0|||
48931311|NCT00792298|157580411|FG006|Treatment Period 1|Lost to Follow-up|1|||
48931312|NCT00792298|157580412|FG007|Treatment Period 1|Lost to Follow-up|0|||
48931313|NCT00792298|157580405|FG000|Treatment Period 1|Physician Decision|0|||
48931314|NCT00792298|157580406|FG001|Treatment Period 1|Physician Decision|0|||
48931315|NCT00792298|157580407|FG002|Treatment Period 1|Physician Decision|0|||
48931316|NCT00792298|157580408|FG003|Treatment Period 1|Physician Decision|1|||
48931317|NCT00792298|157580409|FG004|Treatment Period 1|Physician Decision|0|||
48931318|NCT00792298|157580410|FG005|Treatment Period 1|Physician Decision|0|||
48931319|NCT00792298|157580411|FG006|Treatment Period 1|Physician Decision|1|||
48931320|NCT00792298|157580412|FG007|Treatment Period 1|Physician Decision|0|||
48931321|NCT00792298|157580405|FG000|Treatment Period 1|Protocol Violation|0|||
48931322|NCT00792298|157580406|FG001|Treatment Period 1|Protocol Violation|0|||
48931323|NCT00792298|157580407|FG002|Treatment Period 1|Protocol Violation|0|||
48931324|NCT00792298|157580408|FG003|Treatment Period 1|Protocol Violation|0|||
48931325|NCT00792298|157580409|FG004|Treatment Period 1|Protocol Violation|0|||
48931326|NCT00792298|157580410|FG005|Treatment Period 1|Protocol Violation|0|||
48931327|NCT00792298|157580411|FG006|Treatment Period 1|Protocol Violation|0|||
48931328|NCT00792298|157580412|FG007|Treatment Period 1|Protocol Violation|1|||
48931329|NCT00792298|157580405|FG000|Washout|Adverse Event|0|||
48931330|NCT00792298|157580406|FG001|Washout|Adverse Event|0|||
48931331|NCT00792298|157580407|FG002|Washout|Adverse Event|0|||
48931332|NCT00792298|157580408|FG003|Washout|Adverse Event|0|||
48931333|NCT00792298|157580409|FG004|Washout|Adverse Event|0|||
48931334|NCT00792298|157580410|FG005|Washout|Adverse Event|1|||
48931335|NCT00792298|157580411|FG006|Washout|Adverse Event|0|||
48931336|NCT00792298|157580412|FG007|Washout|Adverse Event|0|||
48931337|NCT00792298|157580405|FG000|Washout|Withdrawal by Subject|0|||
48931338|NCT00792298|157580406|FG001|Washout|Withdrawal by Subject|0|||
48931339|NCT00792298|157580407|FG002|Washout|Withdrawal by Subject|1|||
48931340|NCT00792298|157580408|FG003|Washout|Withdrawal by Subject|0|||
48931341|NCT00792298|157580409|FG004|Washout|Withdrawal by Subject|0|||
48931342|NCT00792298|157580410|FG005|Washout|Withdrawal by Subject|1|||
48931343|NCT00792298|157580411|FG006|Washout|Withdrawal by Subject|0|||
48931344|NCT00792298|157580412|FG007|Washout|Withdrawal by Subject|0|||
48931345|NCT00792298|157580405|FG000|Treatment Period 2|Lack of Efficacy|0|||
48931346|NCT00792298|157580406|FG001|Treatment Period 2|Lack of Efficacy|0|||
48931347|NCT00792298|157580407|FG002|Treatment Period 2|Lack of Efficacy|0|||
48931348|NCT00792298|157580408|FG003|Treatment Period 2|Lack of Efficacy|0|||
48931349|NCT00792298|157580409|FG004|Treatment Period 2|Lack of Efficacy|1|||
48931350|NCT00792298|157580410|FG005|Treatment Period 2|Lack of Efficacy|0|||
48931351|NCT00792298|157580411|FG006|Treatment Period 2|Lack of Efficacy|0|||
48931352|NCT00792298|157580412|FG007|Treatment Period 2|Lack of Efficacy|0|||
48931353|NCT00792298|157580405|FG000|Treatment Period 2|Physician Decision|0|||
48931354|NCT00792298|157580406|FG001|Treatment Period 2|Physician Decision|0|||
48931355|NCT00792298|157580407|FG002|Treatment Period 2|Physician Decision|0|||
48931356|NCT00792298|157580408|FG003|Treatment Period 2|Physician Decision|0|||
48931357|NCT00792298|157580409|FG004|Treatment Period 2|Physician Decision|0|||
48931358|NCT00792298|157580410|FG005|Treatment Period 2|Physician Decision|0|||
48931359|NCT00792298|157580411|FG006|Treatment Period 2|Physician Decision|1|||
48931360|NCT00792298|157580412|FG007|Treatment Period 2|Physician Decision|0|||
48931361|NCT00792298|157580405|FG000|Treatment Period 2|Pregnancy|0|||
48931362|NCT00792298|157580406|FG001|Treatment Period 2|Pregnancy|0|||
48931363|NCT00792298|157580407|FG002|Treatment Period 2|Pregnancy|1|||
48931364|NCT00792298|157580408|FG003|Treatment Period 2|Pregnancy|0|||
48931365|NCT00792298|157580409|FG004|Treatment Period 2|Pregnancy|0|||
48931366|NCT00792298|157580410|FG005|Treatment Period 2|Pregnancy|0|||
48931367|NCT00792298|157580411|FG006|Treatment Period 2|Pregnancy|0|||
48931368|NCT00792298|157580412|FG007|Treatment Period 2|Pregnancy|0|||
48931369|NCT00792298|157580405|FG000|Treatment Period 2|Withdrawal by Subject|1|||
48931370|NCT00792298|157580406|FG001|Treatment Period 2|Withdrawal by Subject|1|||
48931371|NCT00792298|157580407|FG002|Treatment Period 2|Withdrawal by Subject|0|||
48931372|NCT00792298|157580408|FG003|Treatment Period 2|Withdrawal by Subject|2|||
48931373|NCT00792298|157580409|FG004|Treatment Period 2|Withdrawal by Subject|1|||
48931374|NCT00792298|157580410|FG005|Treatment Period 2|Withdrawal by Subject|0|||
48931375|NCT00792298|157580411|FG006|Treatment Period 2|Withdrawal by Subject|0|||
48931376|NCT00792298|157580412|FG007|Treatment Period 2|Withdrawal by Subject|2|||
48931377|NCT00666926|157580414|FG000|Overall Study|Adverse Event|0|||
48931378|NCT00666926|157580415|FG001|Overall Study|Adverse Event|0|||
48931379|NCT00666926|157580416|FG002|Overall Study|Adverse Event|0|||
48931380|NCT00666926|157580417|FG003|Overall Study|Adverse Event|0|||
48931381|NCT00666926|157580418|FG004|Overall Study|Adverse Event|0|||
48931382|NCT00666926|157580419|FG005|Overall Study|Adverse Event|0|||
48931383|NCT00666926|157580420|FG006|Overall Study|Adverse Event|0|||
48931384|NCT00666926|157580421|FG007|Overall Study|Adverse Event|0|||
48931385|NCT00666926|157580422|FG008|Overall Study|Adverse Event|0|||
48931386|NCT00666926|157580423|FG009|Overall Study|Adverse Event|2|||
48931387|NCT00666926|157580424|FG010|Overall Study|Adverse Event|2|||
48931388|NCT00666926|157580425|FG011|Overall Study|Adverse Event|2|||
48931389|NCT00666926|157580426|FG012|Overall Study|Adverse Event|0|||
48931390|NCT00666926|157580427|FG013|Overall Study|Adverse Event|1|||
48931391|NCT00666926|157580428|FG014|Overall Study|Adverse Event|0|||
48931392|NCT00666926|157580429|FG015|Overall Study|Adverse Event|0|||
48931393|NCT00666926|157580414|FG000|Overall Study|Laboratory abnormality|0|||
48931394|NCT00666926|157580415|FG001|Overall Study|Laboratory abnormality|0|||
48931395|NCT00666926|157580416|FG002|Overall Study|Laboratory abnormality|0|||
48931396|NCT00666926|157580417|FG003|Overall Study|Laboratory abnormality|0|||
48931397|NCT00666926|157580418|FG004|Overall Study|Laboratory abnormality|0|||
48931398|NCT00666926|157580419|FG005|Overall Study|Laboratory abnormality|0|||
48931399|NCT00666926|157580420|FG006|Overall Study|Laboratory abnormality|0|||
48931400|NCT00666926|157580421|FG007|Overall Study|Laboratory abnormality|0|||
48931401|NCT00666926|157580422|FG008|Overall Study|Laboratory abnormality|0|||
48931402|NCT00666926|157580423|FG009|Overall Study|Laboratory abnormality|0|||
48931403|NCT00666926|157580424|FG010|Overall Study|Laboratory abnormality|1|||
48931404|NCT00666926|157580425|FG011|Overall Study|Laboratory abnormality|0|||
48931405|NCT00666926|157580426|FG012|Overall Study|Laboratory abnormality|0|||
48931406|NCT00666926|157580427|FG013|Overall Study|Laboratory abnormality|0|||
48931407|NCT00666926|157580428|FG014|Overall Study|Laboratory abnormality|0|||
48931408|NCT00666926|157580429|FG015|Overall Study|Laboratory abnormality|1|||
48931409|NCT00666926|157580414|FG000|Overall Study|Lack of Efficacy|0|||
48931410|NCT00666926|157580415|FG001|Overall Study|Lack of Efficacy|0|||
48931411|NCT00666926|157580416|FG002|Overall Study|Lack of Efficacy|0|||
48931412|NCT00666926|157580417|FG003|Overall Study|Lack of Efficacy|0|||
48931413|NCT00666926|157580418|FG004|Overall Study|Lack of Efficacy|0|||
48931414|NCT00666926|157580419|FG005|Overall Study|Lack of Efficacy|1|||
48931415|NCT00666926|157580420|FG006|Overall Study|Lack of Efficacy|0|||
48931416|NCT00666926|157580421|FG007|Overall Study|Lack of Efficacy|0|||
48931417|NCT00666926|157580422|FG008|Overall Study|Lack of Efficacy|0|||
48931418|NCT00666926|157580423|FG009|Overall Study|Lack of Efficacy|0|||
48931419|NCT00666926|157580424|FG010|Overall Study|Lack of Efficacy|0|||
48931420|NCT00666926|157580425|FG011|Overall Study|Lack of Efficacy|1|||
48931421|NCT00666926|157580426|FG012|Overall Study|Lack of Efficacy|0|||
48931422|NCT00666926|157580427|FG013|Overall Study|Lack of Efficacy|0|||
48931423|NCT00666926|157580428|FG014|Overall Study|Lack of Efficacy|0|||
48931424|NCT00666926|157580429|FG015|Overall Study|Lack of Efficacy|0|||
48931425|NCT00666926|157580414|FG000|Overall Study|Lost to Follow-up|0|||
48931426|NCT00666926|157580415|FG001|Overall Study|Lost to Follow-up|0|||
48931427|NCT00666926|157580416|FG002|Overall Study|Lost to Follow-up|0|||
48931428|NCT00666926|157580417|FG003|Overall Study|Lost to Follow-up|1|||
48931429|NCT00666926|157580418|FG004|Overall Study|Lost to Follow-up|0|||
48931430|NCT00666926|157580419|FG005|Overall Study|Lost to Follow-up|0|||
48931431|NCT00666926|157580420|FG006|Overall Study|Lost to Follow-up|0|||
48931432|NCT00666926|157580421|FG007|Overall Study|Lost to Follow-up|0|||
48931433|NCT00666926|157580422|FG008|Overall Study|Lost to Follow-up|0|||
48931434|NCT00666926|157580423|FG009|Overall Study|Lost to Follow-up|0|||
48931435|NCT00666926|157580424|FG010|Overall Study|Lost to Follow-up|0|||
48931436|NCT00666926|157580425|FG011|Overall Study|Lost to Follow-up|0|||
48931437|NCT00666926|157580426|FG012|Overall Study|Lost to Follow-up|0|||
48931438|NCT00666926|157580427|FG013|Overall Study|Lost to Follow-up|0|||
48931439|NCT00666926|157580428|FG014|Overall Study|Lost to Follow-up|0|||
48931440|NCT00666926|157580429|FG015|Overall Study|Lost to Follow-up|0|||
48931441|NCT00666926|157580414|FG000|Overall Study|Other|2|||
48931442|NCT00666926|157580415|FG001|Overall Study|Other|4|||
48931443|NCT00666926|157580416|FG002|Overall Study|Other|3|||
48931444|NCT00666926|157580417|FG003|Overall Study|Other|3|||
48931445|NCT00666926|157580418|FG004|Overall Study|Other|3|||
48931446|NCT00666926|157580419|FG005|Overall Study|Other|3|||
48931447|NCT00666926|157580420|FG006|Overall Study|Other|4|||
48931448|NCT00666926|157580421|FG007|Overall Study|Other|0|||
48931449|NCT00666926|157580422|FG008|Overall Study|Other|3|||
48931450|NCT00666926|157580423|FG009|Overall Study|Other|5|||
48844605|NCT00111813|157272816|FG005|Overall Study|Progressive disease|3|||
48844606|NCT00111813|157272811|FG000|Overall Study|Lack of Efficacy|0|||
48931451|NCT00666926|157580424|FG010|Overall Study|Other|3|||
48931452|NCT00666926|157580425|FG011|Overall Study|Other|26|||
48931453|NCT00666926|157580426|FG012|Overall Study|Other|3|||
48931454|NCT00666926|157580427|FG013|Overall Study|Other|2|||
48931455|NCT00666926|157580428|FG014|Overall Study|Other|4|||
48931456|NCT00666926|157580429|FG015|Overall Study|Other|4|||
48931457|NCT00666926|157580414|FG000|Overall Study|Withdrawal by Subject|0|||
48931458|NCT00666926|157580415|FG001|Overall Study|Withdrawal by Subject|0|||
48931459|NCT00666926|157580416|FG002|Overall Study|Withdrawal by Subject|0|||
48931460|NCT00666926|157580417|FG003|Overall Study|Withdrawal by Subject|0|||
48931461|NCT00666926|157580418|FG004|Overall Study|Withdrawal by Subject|0|||
48931462|NCT00666926|157580419|FG005|Overall Study|Withdrawal by Subject|0|||
48931463|NCT00666926|157580420|FG006|Overall Study|Withdrawal by Subject|0|||
48931464|NCT00666926|157580421|FG007|Overall Study|Withdrawal by Subject|1|||
48931465|NCT00666926|157580422|FG008|Overall Study|Withdrawal by Subject|0|||
48931466|NCT00666926|157580423|FG009|Overall Study|Withdrawal by Subject|3|||
48931467|NCT00666926|157580424|FG010|Overall Study|Withdrawal by Subject|0|||
48931468|NCT00666926|157580425|FG011|Overall Study|Withdrawal by Subject|3|||
48931469|NCT00666926|157580426|FG012|Overall Study|Withdrawal by Subject|0|||
48844607|NCT00111813|157272812|FG001|Overall Study|Lack of Efficacy|0|||
48844608|NCT00111813|157272813|FG002|Overall Study|Lack of Efficacy|0|||
48844609|NCT00111813|157272814|FG003|Overall Study|Lack of Efficacy|0|||
48844610|NCT00111813|157272815|FG004|Overall Study|Lack of Efficacy|0|||
48844611|NCT00111813|157272816|FG005|Overall Study|Lack of Efficacy|1|||
48844612|NCT00111813|157272811|FG000|Overall Study|Other|0|||
48844613|NCT00111813|157272812|FG001|Overall Study|Other|0|||
48844614|NCT00111813|157272813|FG002|Overall Study|Other|1|||
48844615|NCT00111813|157272814|FG003|Overall Study|Other|0|||
48844616|NCT00111813|157272815|FG004|Overall Study|Other|0|||
48844617|NCT00111813|157272816|FG005|Overall Study|Other|0|||
48844618|NCT03752151|157272817|FG000|Overall Study|Withdrawal by Subject|1|||
48844619|NCT03752151|157272817|FG000|Overall Study|Protocol Violation|1|||
48844620|NCT04056624|157272818|FG000|Overall Study|Withdrawal by Subject|0|||
48844621|NCT04056624|157272819|FG001|Overall Study|Withdrawal by Subject|0|||
48844622|NCT04056624|157272820|FG002|Overall Study|Withdrawal by Subject|1|||
48844623|NCT04056624|157272818|FG000|Overall Study|Protocol Violation|1|||
48844624|NCT04056624|157272819|FG001|Overall Study|Protocol Violation|2|||
48844625|NCT04056624|157272820|FG002|Overall Study|Protocol Violation|0|||
48844626|NCT00703820|157272822|FG000|Overall Study|Adverse Event|12|||
48844627|NCT00703820|157272823|FG001|Overall Study|Adverse Event|17|||
48844628|NCT00703820|157272822|FG000|Overall Study|Death|5|||
48844629|NCT00703820|157272823|FG001|Overall Study|Death|0|||
48844630|NCT00703820|157272822|FG000|Overall Study|Lack of Efficacy|11|||
48844631|NCT00703820|157272823|FG001|Overall Study|Lack of Efficacy|11|||
48844632|NCT00703820|157272822|FG000|Overall Study|Received non-protocol therapy|1|||
48844633|NCT00703820|157272823|FG001|Overall Study|Received non-protocol therapy|0|||
48844634|NCT00703820|157272822|FG000|Overall Study|Physician Decision|4|||
48844635|NCT00703820|157272823|FG001|Overall Study|Physician Decision|5|||
48844636|NCT00703820|157272822|FG000|Overall Study|Withdrawal by Subject|2|||
48931470|NCT00666926|157580427|FG013|Overall Study|Withdrawal by Subject|1|||
48931471|NCT00666926|157580428|FG014|Overall Study|Withdrawal by Subject|3|||
48931472|NCT00666926|157580429|FG015|Overall Study|Withdrawal by Subject|3|||
48931473|NCT00666926|157580414|FG000|Overall Study|Death|0|||
48931474|NCT00666926|157580415|FG001|Overall Study|Death|0|||
48931475|NCT00666926|157580416|FG002|Overall Study|Death|0|||
48931476|NCT00666926|157580417|FG003|Overall Study|Death|0|||
48931477|NCT00666926|157580418|FG004|Overall Study|Death|0|||
48931478|NCT00666926|157580419|FG005|Overall Study|Death|0|||
48931479|NCT00666926|157580420|FG006|Overall Study|Death|0|||
48931480|NCT00666926|157580421|FG007|Overall Study|Death|0|||
48931481|NCT00666926|157580422|FG008|Overall Study|Death|0|||
48931482|NCT00666926|157580423|FG009|Overall Study|Death|0|||
48931483|NCT00666926|157580424|FG010|Overall Study|Death|0|||
48931484|NCT00666926|157580425|FG011|Overall Study|Death|1|||
48931485|NCT00666926|157580426|FG012|Overall Study|Death|0|||
48931486|NCT00666926|157580427|FG013|Overall Study|Death|0|||
48931487|NCT00666926|157580428|FG014|Overall Study|Death|0|||
48931488|NCT00666926|157580429|FG015|Overall Study|Death|0|||
48931489|NCT02883244|157580430|FG000|Overall Study|Lost to Follow-up|0|||
48931490|NCT02883244|157580431|FG001|Overall Study|Lost to Follow-up|1|||
48931491|NCT00330187|157580432|FG000|Overall Study|Lost to Follow-up|12|||
48931492|NCT00330187|157580433|FG001|Overall Study|Lost to Follow-up|13|||
48931493|NCT00330187|157580434|FG002|Overall Study|Lost to Follow-up|14|||
48931494|NCT00330187|157580435|FG003|Overall Study|Lost to Follow-up|10|||
48931495|NCT00330187|157580432|FG000|Overall Study|Withdrawal by Subject|8|||
48931496|NCT00330187|157580433|FG001|Overall Study|Withdrawal by Subject|5|||
48931497|NCT00330187|157580434|FG002|Overall Study|Withdrawal by Subject|4|||
48931498|NCT00330187|157580435|FG003|Overall Study|Withdrawal by Subject|4|||
48931499|NCT01225562|157580438|FG000|Overall Study|Withdrawal by Subject|52|||
48931500|NCT01225562|157580439|FG001|Overall Study|Withdrawal by Subject|50|||
48931501|NCT01225562|157580440|FG002|Overall Study|Withdrawal by Subject|52|||
48931502|NCT01225562|157580438|FG000|Overall Study|Lost to Follow-up|3|||
48931503|NCT01225562|157580439|FG001|Overall Study|Lost to Follow-up|6|||
48931504|NCT01225562|157580440|FG002|Overall Study|Lost to Follow-up|1|||
48931505|NCT00364182|157580442|FG000|First Intervention|Secondary prophylaxis|1|||
48931506|NCT00364182|157580443|FG001|First Intervention|Secondary prophylaxis|0|||
48931507|NCT00364182|157580444|FG002|First Intervention|Secondary prophylaxis|0|||
48931508|NCT00364182|157580442|FG000|First Intervention|Withdrawal by Subject|2|||
48931509|NCT00364182|157580443|FG001|First Intervention|Withdrawal by Subject|0|||
48931510|NCT00364182|157580444|FG002|First Intervention|Withdrawal by Subject|0|||
48931511|NCT00364182|157580442|FG000|Second Intervention|non-compliance|0|||
48931512|NCT00364182|157580443|FG001|Second Intervention|non-compliance|1|||
48931513|NCT00364182|157580444|FG002|Second Intervention|non-compliance|1|||
48931514|NCT00364182|157580442|FG000|Second Intervention|Protocol Violation|0|||
48931515|NCT00364182|157580443|FG001|Second Intervention|Protocol Violation|1|||
48931516|NCT00364182|157580444|FG002|Second Intervention|Protocol Violation|0|||
48931517|NCT00364182|157580442|FG000|Second Intervention|Adverse Event|0|||
48931518|NCT00364182|157580443|FG001|Second Intervention|Adverse Event|0|||
48931519|NCT00364182|157580444|FG002|Second Intervention|Adverse Event|1|||
48931520|NCT00364182|157580442|FG000|Third Intervention|non-compliance|0|||
48931521|NCT00364182|157580443|FG001|Third Intervention|non-compliance|1|||
48931522|NCT00364182|157580444|FG002|Third Intervention|non-compliance|0|||
48931523|NCT00364182|157580442|FG000|Third Intervention|Lost to Follow-up|0|||
48931524|NCT00364182|157580443|FG001|Third Intervention|Lost to Follow-up|0|||
48931525|NCT00364182|157580444|FG002|Third Intervention|Lost to Follow-up|1|||
48931526|NCT03336502|157580445|FG000|Overall Study|Physician Decision|0|||
48931527|NCT03336502|157580446|FG001|Overall Study|Physician Decision|1|||
48931528|NCT03336502|157580445|FG000|Overall Study|Prohibited Drugs|1|||
48931529|NCT03336502|157580446|FG001|Overall Study|Prohibited Drugs|1|||
48931530|NCT03336502|157580445|FG000|Overall Study|Death|1|||
48931531|NCT03336502|157580446|FG001|Overall Study|Death|2|||
48931532|NCT03336502|157580445|FG000|Overall Study|Adverse Event|2|||
48931533|NCT03336502|157580446|FG001|Overall Study|Adverse Event|5|||
48931534|NCT01133171|157580450|FG000|Overall Study|Withdrawal by Subject|1|||
48931535|NCT01133171|157580451|FG001|Overall Study|Withdrawal by Subject|2|||
48931536|NCT01133171|157580452|FG002|Overall Study|Withdrawal by Subject|0|||
48931537|NCT03969888|157580453|FG000|Overall Study|Never Received Study Drug|0|||
48931538|NCT03969888|157580454|FG001|Overall Study|Never Received Study Drug|0|||
48931539|NCT03969888|157580455|FG002|Overall Study|Never Received Study Drug|1|||
48931540|NCT03969888|157580456|FG003|Overall Study|Never Received Study Drug|0|||
48931541|NCT03969888|157580457|FG004|Overall Study|Never Received Study Drug|0|||
48931542|NCT03969888|157580458|FG005|Overall Study|Never Received Study Drug|0|||
48931543|NCT03969888|157580459|FG006|Overall Study|Never Received Study Drug|1|||
48931544|NCT03969888|157580460|FG007|Overall Study|Never Received Study Drug|0|||
48931545|NCT03969888|157580453|FG000|Overall Study|Reason Not Specified|0|||
48931546|NCT03969888|157580454|FG001|Overall Study|Reason Not Specified|0|||
48931547|NCT03969888|157580455|FG002|Overall Study|Reason Not Specified|0|||
48931548|NCT03969888|157580456|FG003|Overall Study|Reason Not Specified|0|||
48931549|NCT03969888|157580457|FG004|Overall Study|Reason Not Specified|0|||
48931550|NCT03969888|157580458|FG005|Overall Study|Reason Not Specified|0|||
48931551|NCT03969888|157580459|FG006|Overall Study|Reason Not Specified|0|||
48931552|NCT03969888|157580460|FG007|Overall Study|Reason Not Specified|1|||
48931553|NCT00946309|157580463|FG000|Overall Study|Protocol Violation|1|||
48931554|NCT00946309|157580464|FG001|Overall Study|Protocol Violation|0|||
48931555|NCT00946309|157580463|FG000|Overall Study|Lost to Follow-up|0|||
48931556|NCT00946309|157580464|FG001|Overall Study|Lost to Follow-up|1|||
48931557|NCT00946309|157580463|FG000|Overall Study|Procedure cancelled/discontinued|0|||
48931558|NCT00946309|157580464|FG001|Overall Study|Procedure cancelled/discontinued|3|||
48931559|NCT00584870|157580466|FG000|Overall Study|Adverse Event|4|||
48931560|NCT00584870|157580467|FG001|Overall Study|Adverse Event|3|||
48931561|NCT00584870|157580468|FG002|Overall Study|Adverse Event|2|||
48931562|NCT00584870|157580466|FG000|Overall Study|Lost to Follow-up|4|||
48931563|NCT00584870|157580467|FG001|Overall Study|Lost to Follow-up|1|||
48931564|NCT00584870|157580468|FG002|Overall Study|Lost to Follow-up|1|||
48931565|NCT00584870|157580466|FG000|Overall Study|Lack of Efficacy|7|||
48931566|NCT00584870|157580467|FG001|Overall Study|Lack of Efficacy|14|||
48931567|NCT00584870|157580468|FG002|Overall Study|Lack of Efficacy|8|||
48931568|NCT00584870|157580466|FG000|Overall Study|Withdrawal by Subject|10|||
48931569|NCT00584870|157580467|FG001|Overall Study|Withdrawal by Subject|5|||
48931570|NCT00584870|157580468|FG002|Overall Study|Withdrawal by Subject|3|||
48931571|NCT00584870|157580466|FG000|Overall Study|Protocol Violation|1|||
48931572|NCT00584870|157580467|FG001|Overall Study|Protocol Violation|1|||
48931573|NCT00584870|157580468|FG002|Overall Study|Protocol Violation|2|||
48931574|NCT00584870|157580466|FG000|Overall Study|Did not met entrance criteria|1|||
48931575|NCT00584870|157580467|FG001|Overall Study|Did not met entrance criteria|0|||
48931576|NCT00584870|157580468|FG002|Overall Study|Did not met entrance criteria|0|||
48931577|NCT00584870|157580466|FG000|Overall Study|Other|2|||
48931578|NCT00584870|157580467|FG001|Overall Study|Other|0|||
48931579|NCT00584870|157580468|FG002|Overall Study|Other|0|||
48931580|NCT00584870|157580466|FG000|Overall Study|Randomized but not treated|0|||
48931581|NCT00584870|157580467|FG001|Overall Study|Randomized but not treated|1|||
48931582|NCT00584870|157580468|FG002|Overall Study|Randomized but not treated|2|||
48931583|NCT04957290|157580469|FG000|Overall Study|Progressive disease|3|||
48931584|NCT04957290|157580470|FG001|Overall Study|Progressive disease|3|||
48931585|NCT04957290|157580471|FG002|Overall Study|Progressive disease|2|||
48931586|NCT04957290|157580472|FG003|Overall Study|Progressive disease|0|||
48931587|NCT04957290|157580473|FG004|Overall Study|Progressive disease|0|||
48931588|NCT04957290|157580474|FG005|Overall Study|Progressive disease|0|||
48931589|NCT04957290|157580469|FG000|Overall Study|Withdrawal by Subject|1|||
48931590|NCT04957290|157580470|FG001|Overall Study|Withdrawal by Subject|0|||
48931591|NCT04957290|157580471|FG002|Overall Study|Withdrawal by Subject|1|||
48931592|NCT04957290|157580472|FG003|Overall Study|Withdrawal by Subject|0|||
48931593|NCT04957290|157580473|FG004|Overall Study|Withdrawal by Subject|0|||
48931594|NCT04957290|157580474|FG005|Overall Study|Withdrawal by Subject|0|||
48931595|NCT04957290|157580469|FG000|Overall Study|Death|0|||
48931596|NCT04957290|157580470|FG001|Overall Study|Death|2|||
48931597|NCT04957290|157580471|FG002|Overall Study|Death|1|||
48931598|NCT04957290|157580472|FG003|Overall Study|Death|0|||
48931599|NCT04957290|157580473|FG004|Overall Study|Death|0|||
48931600|NCT04957290|157580474|FG005|Overall Study|Death|0|||
48931601|NCT04957290|157580469|FG000|Overall Study|non compliance with study drug|0|||
48931602|NCT04957290|157580470|FG001|Overall Study|non compliance with study drug|1|||
48931603|NCT04957290|157580471|FG002|Overall Study|non compliance with study drug|0|||
48931604|NCT04957290|157580472|FG003|Overall Study|non compliance with study drug|0|||
48844637|NCT00703820|157272823|FG001|Overall Study|Withdrawal by Subject|1|||
48844638|NCT00998881|157272824|FG000|Overall Study|Adverse Event|2|||
48844639|NCT00998881|157272825|FG001|Overall Study|Adverse Event|2|||
48931605|NCT04957290|157580473|FG004|Overall Study|non compliance with study drug|0|||
48931606|NCT04957290|157580474|FG005|Overall Study|non compliance with study drug|0|||
48931607|NCT04957290|157580469|FG000|Overall Study|none specified.|0|||
48931608|NCT04957290|157580470|FG001|Overall Study|none specified.|1|||
48931609|NCT04957290|157580471|FG002|Overall Study|none specified.|2|||
48931610|NCT04957290|157580472|FG003|Overall Study|none specified.|0|||
48931611|NCT04957290|157580473|FG004|Overall Study|none specified.|0|||
48931612|NCT04957290|157580474|FG005|Overall Study|none specified.|0|||
48931613|NCT04957290|157580469|FG000|Overall Study|unacceptable toxicity|0|||
48931614|NCT04957290|157580470|FG001|Overall Study|unacceptable toxicity|0|||
48931615|NCT04957290|157580471|FG002|Overall Study|unacceptable toxicity|1|||
48931616|NCT04957290|157580472|FG003|Overall Study|unacceptable toxicity|0|||
48931617|NCT04957290|157580473|FG004|Overall Study|unacceptable toxicity|0|||
48931618|NCT04957290|157580474|FG005|Overall Study|unacceptable toxicity|0|||
48931619|NCT04957290|157580469|FG000|Overall Study|Adverse Event|0|||
48931620|NCT04957290|157580470|FG001|Overall Study|Adverse Event|0|||
48931621|NCT04957290|157580471|FG002|Overall Study|Adverse Event|1|||
48931622|NCT04957290|157580472|FG003|Overall Study|Adverse Event|0|||
48931623|NCT04957290|157580473|FG004|Overall Study|Adverse Event|0|||
48931624|NCT04957290|157580474|FG005|Overall Study|Adverse Event|0|||
48931625|NCT04957290|157580469|FG000|Overall Study|study terminated by sponsor|0|||
48931626|NCT04957290|157580470|FG001|Overall Study|study terminated by sponsor|0|||
48931627|NCT04957290|157580471|FG002|Overall Study|study terminated by sponsor|2|||
48931628|NCT04957290|157580472|FG003|Overall Study|study terminated by sponsor|0|||
48931629|NCT04957290|157580473|FG004|Overall Study|study terminated by sponsor|0|||
48931630|NCT04957290|157580474|FG005|Overall Study|study terminated by sponsor|0|||
48931631|NCT03682120|157580475|FG000|Overall Study|Lost to Follow-up|11|||
48931632|NCT03682120|157580476|FG001|Overall Study|Lost to Follow-up|4|||
48931633|NCT03682120|157580477|FG002|Overall Study|Lost to Follow-up|5|||
48931634|NCT03682120|157580478|FG003|Overall Study|Lost to Follow-up|2|||
48931635|NCT03682120|157580475|FG000|Overall Study|Physician Decision|1|||
48931636|NCT03682120|157580476|FG001|Overall Study|Physician Decision|0|||
48931637|NCT03682120|157580477|FG002|Overall Study|Physician Decision|0|||
48931638|NCT03682120|157580478|FG003|Overall Study|Physician Decision|0|||
48931639|NCT03682120|157580475|FG000|Overall Study|Withdrawal by Subject|1|||
48931640|NCT03682120|157580476|FG001|Overall Study|Withdrawal by Subject|2|||
48931641|NCT03682120|157580477|FG002|Overall Study|Withdrawal by Subject|3|||
48931642|NCT03682120|157580478|FG003|Overall Study|Withdrawal by Subject|0|||
48931643|NCT03682120|157580475|FG000|Overall Study|Death|0|||
48931644|NCT03682120|157580476|FG001|Overall Study|Death|1|||
48931645|NCT03682120|157580477|FG002|Overall Study|Death|0|||
48931646|NCT03682120|157580478|FG003|Overall Study|Death|0|||
48931647|NCT03682120|157580475|FG000|Overall Study|Enrolled but Treatment Not Administered|0|||
48931648|NCT03682120|157580476|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
48931649|NCT03682120|157580477|FG002|Overall Study|Enrolled but Treatment Not Administered|0|||
48931650|NCT03682120|157580478|FG003|Overall Study|Enrolled but Treatment Not Administered|0|||
48931651|NCT01469000|157580479|FG000|Overall Study|Withdrawal by Subject|16|||
48931652|NCT01469000|157580480|FG001|Overall Study|Withdrawal by Subject|3|||
48931653|NCT01469000|157580479|FG000|Overall Study|Sponsor Decision|4|||
48931654|NCT01469000|157580480|FG001|Overall Study|Sponsor Decision|1|||
48931655|NCT00996203|157580481|FG000|Overall Study|Adverse Event|3|||
48931656|NCT00996203|157580481|FG000|Overall Study|Lost to Follow-up|1|||
48931657|NCT00996203|157580481|FG000|Overall Study|Lack of Efficacy|1|||
48931658|NCT00996203|157580481|FG000|Overall Study|Protocol Violation|2|||
48931659|NCT00578643|157580483|FG000|Overall Study|Death|1|||
48931660|NCT00578643|157580483|FG000|Overall Study|Lost to Follow-up|1|||
48931661|NCT03529409|157580484|FG000|Randomized|Lost to Follow-up|0|||
48844640|NCT00998881|157272824|FG000|Overall Study|Lack of Efficacy|1|||
48844641|NCT00998881|157272825|FG001|Overall Study|Lack of Efficacy|0|||
48844642|NCT00998881|157272824|FG000|Overall Study|Physician Decision|3|||
48844643|NCT00998881|157272825|FG001|Overall Study|Physician Decision|0|||
48844644|NCT00998881|157272824|FG000|Overall Study|Withdrawal by Subject|1|||
48844645|NCT00998881|157272825|FG001|Overall Study|Withdrawal by Subject|0|||
48844646|NCT00998881|157272824|FG000|Overall Study|Personal matter|1|||
48844647|NCT00998881|157272825|FG001|Overall Study|Personal matter|0|||
48844648|NCT03531840|157272829|FG000|Overall Study|Death on study|3|||
48844649|NCT03531840|157272830|FG001|Overall Study|Death on study|2|||
48844650|NCT03531840|157272831|FG002|Overall Study|Death on study|1|||
48844651|NCT03531840|157272832|FG003|Overall Study|Death on study|2|||
48844652|NCT03531840|157272829|FG000|Overall Study|Death during follow up|2|||
48844653|NCT03531840|157272830|FG001|Overall Study|Death during follow up|3|||
48931662|NCT03529409|157580485|FG001|Randomized|Lost to Follow-up|0|||
48931663|NCT03529409|157580486|FG002|Randomized|Lost to Follow-up|4|||
48844654|NCT03531840|157272831|FG002|Overall Study|Death during follow up|4|||
48844655|NCT03531840|157272832|FG003|Overall Study|Death during follow up|1|||
48844656|NCT01510717|157272833|FG000|Overall Study|Adverse Event|1|||
48844657|NCT01510717|157272834|FG001|Overall Study|Adverse Event|2|||
48931664|NCT03529409|157580484|FG000|Randomized|Excluded|0|||
48844658|NCT01510717|157272833|FG000|Overall Study|Death|1|||
48931665|NCT03529409|157580485|FG001|Randomized|Excluded|0|||
48931666|NCT03529409|157580486|FG002|Randomized|Excluded|1|||
48931667|NCT03529409|157580484|FG000|Post-treatment Assessment|Death|1|||
48931668|NCT03529409|157580485|FG001|Post-treatment Assessment|Death|0|||
48931669|NCT03529409|157580486|FG002|Post-treatment Assessment|Death|0|||
48931670|NCT03529409|157580484|FG000|Post-treatment Assessment|Lost to Follow-up|1|||
48931671|NCT03529409|157580485|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
48931672|NCT03529409|157580486|FG002|Post-treatment Assessment|Lost to Follow-up|0|||
48931673|NCT03529409|157580484|FG000|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2|||
48931674|NCT03529409|157580485|FG001|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4|||
48931675|NCT03529409|157580486|FG002|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0|||
48931676|NCT03529409|157580484|FG000|Follow-up Assessment|Death|1|||
48931677|NCT03529409|157580485|FG001|Follow-up Assessment|Death|0|||
48931678|NCT03529409|157580486|FG002|Follow-up Assessment|Death|0|||
48931679|NCT03529409|157580484|FG000|Follow-up Assessment|Withdrawal by Subject|0|||
48931680|NCT03529409|157580485|FG001|Follow-up Assessment|Withdrawal by Subject|1|||
48931681|NCT03529409|157580486|FG002|Follow-up Assessment|Withdrawal by Subject|0|||
48931682|NCT02497001|157580489|FG000|Overall Study|Lost to Follow-up|10|||
48931683|NCT02497001|157580490|FG001|Overall Study|Lost to Follow-up|2|||
48931684|NCT02497001|157580491|FG002|Overall Study|Lost to Follow-up|0|||
48931685|NCT02497001|157580492|FG003|Overall Study|Lost to Follow-up|2|||
48931686|NCT02497001|157580489|FG000|Overall Study|Adverse Event|28|||
48931687|NCT02497001|157580490|FG001|Overall Study|Adverse Event|30|||
48931688|NCT02497001|157580491|FG002|Overall Study|Adverse Event|11|||
48931689|NCT02497001|157580492|FG003|Overall Study|Adverse Event|11|||
48931690|NCT02497001|157580489|FG000|Overall Study|Withdrawal by Subject|14|||
48931691|NCT02497001|157580490|FG001|Overall Study|Withdrawal by Subject|37|||
48931692|NCT02497001|157580491|FG002|Overall Study|Withdrawal by Subject|19|||
48931693|NCT02497001|157580492|FG003|Overall Study|Withdrawal by Subject|15|||
48931694|NCT02497001|157580489|FG000|Overall Study|Physician Decision|5|||
48931695|NCT02497001|157580490|FG001|Overall Study|Physician Decision|11|||
48931696|NCT02497001|157580491|FG002|Overall Study|Physician Decision|5|||
48931697|NCT02497001|157580492|FG003|Overall Study|Physician Decision|1|||
48931698|NCT02497001|157580489|FG000|Overall Study|subjects that were not treated|1|||
48931699|NCT02497001|157580490|FG001|Overall Study|subjects that were not treated|2|||
48931700|NCT02497001|157580491|FG002|Overall Study|subjects that were not treated|2|||
48931701|NCT02497001|157580492|FG003|Overall Study|subjects that were not treated|1|||
48931702|NCT02497001|157580489|FG000|Overall Study|Major Protocol Deviation|3|||
48931703|NCT02497001|157580490|FG001|Overall Study|Major Protocol Deviation|4|||
48931704|NCT02497001|157580491|FG002|Overall Study|Major Protocol Deviation|4|||
48844659|NCT01510717|157272834|FG001|Overall Study|Death|0|||
48844660|NCT01510717|157272833|FG000|Overall Study|Lost to Follow-up|0|||
48844661|NCT01510717|157272834|FG001|Overall Study|Lost to Follow-up|1|||
48844662|NCT01510717|157272833|FG000|Overall Study|Withdrawal by Subject|0|||
48844663|NCT01510717|157272834|FG001|Overall Study|Withdrawal by Subject|2|||
48844664|NCT02121002|157272835|FG000|Overall Study|Physician Decision|2|||
48844665|NCT02121002|157272836|FG001|Overall Study|Physician Decision|0|||
48844666|NCT02121002|157272837|FG002|Overall Study|Physician Decision|0|||
48844667|NCT02121002|157272835|FG000|Overall Study|Withdrawal by Subject|3|||
48844668|NCT02121002|157272836|FG001|Overall Study|Withdrawal by Subject|1|||
48844669|NCT02121002|157272837|FG002|Overall Study|Withdrawal by Subject|4|||
48931705|NCT02497001|157580492|FG003|Overall Study|Major Protocol Deviation|4|||
48931706|NCT02497001|157580489|FG000|Overall Study|Lack of Efficacy|10|||
48931707|NCT02497001|157580490|FG001|Overall Study|Lack of Efficacy|16|||
48931708|NCT02497001|157580491|FG002|Overall Study|Lack of Efficacy|6|||
48931709|NCT02497001|157580492|FG003|Overall Study|Lack of Efficacy|6|||
48931710|NCT02497001|157580489|FG000|Overall Study|Protocol Violation|3|||
48931711|NCT02497001|157580490|FG001|Overall Study|Protocol Violation|1|||
48931712|NCT02497001|157580491|FG002|Overall Study|Protocol Violation|3|||
48931713|NCT02497001|157580492|FG003|Overall Study|Protocol Violation|1|||
48931714|NCT05299073|157580493|FG000|Overall Study|Withdrawal by Subject|0|||
48931715|NCT05299073|157580494|FG001|Overall Study|Withdrawal by Subject|0|||
48931716|NCT05299073|157580495|FG002|Overall Study|Withdrawal by Subject|1|||
48931717|NCT05299073|157580493|FG000|Overall Study|Adverse Event|0|||
48931718|NCT05299073|157580494|FG001|Overall Study|Adverse Event|1|||
48844670|NCT02121002|157272835|FG000|Overall Study|Protocol Violation|1|||
48844671|NCT02121002|157272836|FG001|Overall Study|Protocol Violation|2|||
48931719|NCT05299073|157580495|FG002|Overall Study|Adverse Event|0|||
48931720|NCT05299073|157580493|FG000|Overall Study|Lost to Follow-up|0|||
48844672|NCT02121002|157272837|FG002|Overall Study|Protocol Violation|4|||
48931721|NCT05299073|157580494|FG001|Overall Study|Lost to Follow-up|1|||
48844673|NCT02121002|157272835|FG000|Overall Study|Concomitant therapy|0|||
48844674|NCT02121002|157272836|FG001|Overall Study|Concomitant therapy|1|||
48931722|NCT05299073|157580495|FG002|Overall Study|Lost to Follow-up|0|||
48931723|NCT00705263|157580496|FG000|Overall Study|Withdrawal by Subject|2|||
48844675|NCT02121002|157272837|FG002|Overall Study|Concomitant therapy|1|||
48844676|NCT02121002|157272835|FG000|Overall Study|Others|1|||
48844677|NCT02121002|157272836|FG001|Overall Study|Others|0|||
48844678|NCT02121002|157272837|FG002|Overall Study|Others|1|||
48844679|NCT02477605|157272843|FG000|Overall Study|Discontinued prior to treatment|1|||
48844680|NCT02477605|157272844|FG001|Overall Study|Discontinued prior to treatment|0|||
48844681|NCT02477605|157272843|FG000|Overall Study|Lost to Follow-up|0|||
48844682|NCT02477605|157272844|FG001|Overall Study|Lost to Follow-up|2|||
48844683|NCT02477605|157272843|FG000|Overall Study|Withdrawal by Subject|0|||
48844684|NCT02477605|157272844|FG001|Overall Study|Withdrawal by Subject|1|||
48844685|NCT02477605|157272843|FG000|Overall Study|Administered gas during surgery|0|||
48844686|NCT02477605|157272844|FG001|Overall Study|Administered gas during surgery|1|||
48844687|NCT00593489|157272845|FG000|Allocation|did not attend workshop; allocation not|2|||
48844688|NCT00593489|157272846|FG001|Allocation|did not attend workshop; allocation not|1|||
48844689|NCT00976495|157272847|FG000|Overall Study|Withdrawal by Subject|0|||
48844690|NCT00976495|157272848|FG001|Overall Study|Withdrawal by Subject|1|||
48844691|NCT00976495|157272849|FG002|Overall Study|Withdrawal by Subject|0|||
48844692|NCT00088413|157272852|FG000|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
48844693|NCT00088413|157272853|FG001|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
48844694|NCT00088413|157272854|FG002|Overall Study|Limited supply of trmt drug (PANVAC-f)|1|||
48844695|NCT00088413|157272855|FG003|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
48844696|NCT00088413|157272852|FG000|Overall Study|Adverse Events/Side Effects|0|||
48844697|NCT00088413|157272853|FG001|Overall Study|Adverse Events/Side Effects|1|||
48844698|NCT00088413|157272854|FG002|Overall Study|Adverse Events/Side Effects|1|||
48844699|NCT00088413|157272855|FG003|Overall Study|Adverse Events/Side Effects|0|||
48844700|NCT00088413|157272852|FG000|Overall Study|Refused trmt Off-study per pt wishes|0|||
48844701|NCT00088413|157272853|FG001|Overall Study|Refused trmt Off-study per pt wishes|1|||
48844702|NCT00088413|157272854|FG002|Overall Study|Refused trmt Off-study per pt wishes|1|||
48844703|NCT00088413|157272855|FG003|Overall Study|Refused trmt Off-study per pt wishes|0|||
48844704|NCT00088413|157272852|FG000|Overall Study|Off study due to missing a vaccine dose|1|||
48844705|NCT00088413|157272853|FG001|Overall Study|Off study due to missing a vaccine dose|0|||
48844706|NCT00088413|157272854|FG002|Overall Study|Off study due to missing a vaccine dose|0|||
48844707|NCT00088413|157272855|FG003|Overall Study|Off study due to missing a vaccine dose|0|||
48844708|NCT00088413|157272852|FG000|Overall Study|Death|0|||
48844709|NCT00088413|157272853|FG001|Overall Study|Death|1|||
48844710|NCT00088413|157272854|FG002|Overall Study|Death|0|||
48844711|NCT00088413|157272855|FG003|Overall Study|Death|0|||
48844712|NCT00088413|157272852|FG000|Overall Study|Progressive disease|9|||
48844713|NCT00088413|157272853|FG001|Overall Study|Progressive disease|11|||
48844714|NCT00088413|157272854|FG002|Overall Study|Progressive disease|8|||
48844715|NCT00088413|157272855|FG003|Overall Study|Progressive disease|14|||
48844716|NCT00088413|157272852|FG000|Overall Study|Other|0|||
48844717|NCT00088413|157272853|FG001|Overall Study|Other|1|||
48844718|NCT00088413|157272854|FG002|Overall Study|Other|0|||
48844719|NCT00088413|157272855|FG003|Overall Study|Other|0|||
48844720|NCT00088413|157272852|FG000|Overall Study|Patient unevaluable due to adverse event|0|||
48844721|NCT00088413|157272853|FG001|Overall Study|Patient unevaluable due to adverse event|0|||
48844722|NCT00088413|157272854|FG002|Overall Study|Patient unevaluable due to adverse event|1|||
48844723|NCT00088413|157272855|FG003|Overall Study|Patient unevaluable due to adverse event|0|||
48844724|NCT03582722|157272856|FG000|Overall Study|Lost to Follow-up|1|||
48844725|NCT03582722|157272857|FG001|Overall Study|Lost to Follow-up|4|||
48844726|NCT03582722|157272856|FG000|Overall Study|Withdrawal by Subject|3|||
48844727|NCT03582722|157272857|FG001|Overall Study|Withdrawal by Subject|3|||
48844728|NCT05613205|157274187|FG000|Overall Study|Lost to Follow-up|0|||
48844729|NCT05613205|157274188|FG001|Overall Study|Lost to Follow-up|0|||
48844730|NCT05613205|157274189|FG002|Overall Study|Lost to Follow-up|1|||
48844731|NCT05613205|157274190|FG003|Overall Study|Lost to Follow-up|1|||
48844732|NCT05613205|157274191|FG004|Overall Study|Lost to Follow-up|0|||
48844733|NCT05613205|157274187|FG000|Overall Study|Withdrawal by Subject|0|||
48844734|NCT05613205|157274188|FG001|Overall Study|Withdrawal by Subject|0|||
48844735|NCT05613205|157274189|FG002|Overall Study|Withdrawal by Subject|1|||
48844736|NCT05613205|157274190|FG003|Overall Study|Withdrawal by Subject|1|||
48844737|NCT05613205|157274191|FG004|Overall Study|Withdrawal by Subject|0|||
48844738|NCT03086369|157274195|FG000|Overall Study|Lost to Follow-up|1|||
48844739|NCT03086369|157274196|FG001|Overall Study|Lost to Follow-up|0|||
48844740|NCT03086369|157274197|FG002|Overall Study|Lost to Follow-up|0|||
48844741|NCT03086369|157274198|FG003|Overall Study|Lost to Follow-up|2|||
48931724|NCT01752023|157580497|FG000|Overall Study|Physician Decision|2|||
48931725|NCT01752023|157580498|FG001|Overall Study|Physician Decision|1|||
48931726|NCT01976806|157580507|FG000|Overall Study|Lost to Follow-up|1|||
48931727|NCT01976806|157580508|FG001|Overall Study|Lost to Follow-up|4|||
48931728|NCT01976806|157580507|FG000|Overall Study|Adverse Event|1|||
48931729|NCT01976806|157580508|FG001|Overall Study|Adverse Event|1|||
48931730|NCT01976806|157580507|FG000|Overall Study|Withdrawal by Subject|1|||
48931731|NCT01976806|157580508|FG001|Overall Study|Withdrawal by Subject|1|||
48931732|NCT03665038|157580512|FG000|Overall Study|Lost to Follow-up|0|||
48931733|NCT03665038|157580513|FG001|Overall Study|Lost to Follow-up|0|||
48931734|NCT03665038|157580514|FG002|Overall Study|Lost to Follow-up|1|||
48931735|NCT02848833|157580521|FG000|Overall Study|subject who are duplicated|1|||
48844742|NCT03086369|157274199|FG004|Overall Study|Lost to Follow-up|1|||
48844743|NCT03086369|157274195|FG000|Overall Study|Physician Decision|0|||
48844744|NCT03086369|157274196|FG001|Overall Study|Physician Decision|0|||
48844745|NCT03086369|157274197|FG002|Overall Study|Physician Decision|0|||
48844746|NCT03086369|157274198|FG003|Overall Study|Physician Decision|1|||
48844747|NCT03086369|157274199|FG004|Overall Study|Physician Decision|2|||
48844748|NCT03086369|157274195|FG000|Overall Study|Withdrawal by Subject|0|||
48844749|NCT03086369|157274196|FG001|Overall Study|Withdrawal by Subject|0|||
48844750|NCT03086369|157274197|FG002|Overall Study|Withdrawal by Subject|0|||
48844751|NCT03086369|157274198|FG003|Overall Study|Withdrawal by Subject|5|||
48844752|NCT03086369|157274199|FG004|Overall Study|Withdrawal by Subject|3|||
48844753|NCT03086369|157274195|FG000|Overall Study|Progressive Disease|0|||
48844754|NCT03086369|157274196|FG001|Overall Study|Progressive Disease|0|||
48844755|NCT03086369|157274197|FG002|Overall Study|Progressive Disease|0|||
48844756|NCT03086369|157274198|FG003|Overall Study|Progressive Disease|1|||
48844757|NCT03086369|157274199|FG004|Overall Study|Progressive Disease|1|||
48844758|NCT02566902|157274200|FG000|Overall Study|Protocol Violation|2|||
48844759|NCT02566902|157274201|FG001|Overall Study|Protocol Violation|1|||
48844760|NCT01823536|157274202|FG000|Overall Study|Lost to Follow-up|1|||
48844761|NCT01823536|157274203|FG001|Overall Study|Lost to Follow-up|0|||
48844762|NCT01823536|157274204|FG002|Overall Study|Lost to Follow-up|0|||
48844763|NCT01823536|157274205|FG003|Overall Study|Lost to Follow-up|1|||
48844764|NCT01823536|157274206|FG004|Overall Study|Lost to Follow-up|1|||
48844765|NCT01823536|157274207|FG005|Overall Study|Lost to Follow-up|0|||
48844766|NCT01823536|157274202|FG000|Overall Study|Protocol Violation|0|||
48844767|NCT01823536|157274203|FG001|Overall Study|Protocol Violation|1|||
48844768|NCT01823536|157274204|FG002|Overall Study|Protocol Violation|0|||
48844769|NCT01823536|157274205|FG003|Overall Study|Protocol Violation|0|||
48844770|NCT01823536|157274206|FG004|Overall Study|Protocol Violation|0|||
48844771|NCT01823536|157274207|FG005|Overall Study|Protocol Violation|0|||
48844772|NCT01823536|157274202|FG000|Overall Study|Withdrawal by Subject|1|||
48844773|NCT01823536|157274203|FG001|Overall Study|Withdrawal by Subject|1|||
48844774|NCT01823536|157274204|FG002|Overall Study|Withdrawal by Subject|0|||
48844775|NCT01823536|157274205|FG003|Overall Study|Withdrawal by Subject|0|||
48844776|NCT01823536|157274206|FG004|Overall Study|Withdrawal by Subject|0|||
48931736|NCT02848833|157580521|FG000|Overall Study|have not taken the study drug|11|||
48931737|NCT02848833|157580521|FG000|Overall Study|follow-up failure|6|||
48931738|NCT02848833|157580521|FG000|Overall Study|Protocol Violation|119|||
48931739|NCT02322710|157581953|FG000|Overall Study|No efficacy assessment post-baseline|0|||
48931740|NCT02322710|157581954|FG001|Overall Study|No efficacy assessment post-baseline|1|||
48931741|NCT02322710|157581953|FG000|Overall Study|Protocol Violation|20|||
48931742|NCT02322710|157581954|FG001|Overall Study|Protocol Violation|25|||
48931743|NCT02894840|157581955|FG000|Overall Study|Lost to Follow-up|1|||
48931744|NCT02894840|157581956|FG001|Overall Study|Lost to Follow-up|0|||
48931745|NCT02894840|157581957|FG002|Overall Study|Lost to Follow-up|3|||
48931746|NCT02894840|157581958|FG003|Overall Study|Lost to Follow-up|0|||
48931747|NCT01652287|157581959|FG000|Overall Study|Withdrawal by Subject|2|||
48931748|NCT01652287|157581960|FG001|Overall Study|Withdrawal by Subject|0|||
48931749|NCT01871090|157581968|FG000|Overall Study|Interrogation not done in Emergency Room|1|||
48844777|NCT01823536|157274207|FG005|Overall Study|Withdrawal by Subject|0|||
48931750|NCT01871090|157581969|FG001|Overall Study|Interrogation not done in Emergency Room|22|||
48931751|NCT01871090|157581968|FG000|Overall Study|Interrogation not completed correctly|1|||
48844778|NCT01823536|157274202|FG000|Overall Study|Visit 1 delayed, unable to reschedule|0|||
48844779|NCT01823536|157274203|FG001|Overall Study|Visit 1 delayed, unable to reschedule|0|||
48844780|NCT01823536|157274204|FG002|Overall Study|Visit 1 delayed, unable to reschedule|1|||
48931752|NCT01871090|157581969|FG001|Overall Study|Interrogation not completed correctly|0|||
48931753|NCT01871090|157581968|FG000|Overall Study|Subject Non-Compliance|0|||
48931754|NCT01871090|157581969|FG001|Overall Study|Subject Non-Compliance|1|||
48931755|NCT01307033|157581970|FG000|8-week Double-blind Period|Adverse Event|2|||
48931756|NCT01307033|157581971|FG001|8-week Double-blind Period|Adverse Event|0|||
48931757|NCT01307033|157581972|FG002|8-week Double-blind Period|Adverse Event|0|||
48931758|NCT01307033|157581973|FG003|8-week Double-blind Period|Adverse Event|0|||
48931759|NCT01307033|157581970|FG000|8-week Double-blind Period|Withdrawal by Subject|4|||
48931760|NCT01307033|157581971|FG001|8-week Double-blind Period|Withdrawal by Subject|1|||
48931761|NCT01307033|157581972|FG002|8-week Double-blind Period|Withdrawal by Subject|0|||
48931762|NCT01307033|157581973|FG003|8-week Double-blind Period|Withdrawal by Subject|0|||
48931763|NCT01307033|157581970|FG000|8-week Double-blind Period|Lack of Efficacy|1|||
48931764|NCT01307033|157581971|FG001|8-week Double-blind Period|Lack of Efficacy|0|||
48931765|NCT01307033|157581972|FG002|8-week Double-blind Period|Lack of Efficacy|0|||
48931766|NCT01307033|157581973|FG003|8-week Double-blind Period|Lack of Efficacy|0|||
48931767|NCT01307033|157581970|FG000|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
48931768|NCT01307033|157581971|FG001|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3|||
48931769|NCT01307033|157581972|FG002|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
48931770|NCT01307033|157581973|FG003|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
48931771|NCT01307033|157581970|FG000|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6|||
48931772|NCT01307033|157581971|FG001|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3|||
48931773|NCT01307033|157581972|FG002|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
48931774|NCT01307033|157581973|FG003|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
48931775|NCT01307033|157581970|FG000|44-week Open-label Extension|Adverse Event|0|||
48931776|NCT01307033|157581971|FG001|44-week Open-label Extension|Adverse Event|0|||
48844781|NCT01823536|157274205|FG003|Overall Study|Visit 1 delayed, unable to reschedule|0|||
48844782|NCT01823536|157274206|FG004|Overall Study|Visit 1 delayed, unable to reschedule|0|||
48844783|NCT01823536|157274207|FG005|Overall Study|Visit 1 delayed, unable to reschedule|0|||
48844784|NCT01823536|157274202|FG000|Overall Study|Met exclusion criterion No 6|0|||
48844785|NCT01823536|157274203|FG001|Overall Study|Met exclusion criterion No 6|0|||
48844786|NCT01823536|157274204|FG002|Overall Study|Met exclusion criterion No 6|0|||
48844787|NCT01823536|157274205|FG003|Overall Study|Met exclusion criterion No 6|1|||
48844788|NCT01823536|157274206|FG004|Overall Study|Met exclusion criterion No 6|0|||
48844789|NCT01823536|157274207|FG005|Overall Study|Met exclusion criterion No 6|0|||
48844790|NCT01823536|157274202|FG000|Overall Study|Subject moved out of the state|0|||
48844791|NCT01823536|157274203|FG001|Overall Study|Subject moved out of the state|0|||
48844792|NCT01823536|157274204|FG002|Overall Study|Subject moved out of the state|0|||
48844793|NCT01823536|157274205|FG003|Overall Study|Subject moved out of the state|0|||
48844794|NCT01823536|157274206|FG004|Overall Study|Subject moved out of the state|1|||
48844795|NCT01823536|157274207|FG005|Overall Study|Subject moved out of the state|0|||
48844796|NCT03175172|157274209|FG000|Overall Study|Death|3|||
48931777|NCT01307033|157581972|FG002|44-week Open-label Extension|Adverse Event|2|||
48735648|NCT02215096|156883707|FG002|Run-In Period (Up to Week 2)|Adverse Event|0|||
48735649|NCT02215096|156883708|FG003|Run-In Period (Up to Week 2)|Adverse Event|0|||
48735650|NCT02215096|156883709|FG004|Run-In Period (Up to Week 2)|Adverse Event|0|||
48735651|NCT02215096|156883705|FG000|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
48931778|NCT01307033|157581973|FG003|44-week Open-label Extension|Adverse Event|1|||
48844797|NCT03175172|157274209|FG000|Overall Study|Withdrawal by Subject|3|||
48844798|NCT03175172|157274209|FG000|Overall Study|Lost to Follow-up|1|||
48844799|NCT03175172|157274209|FG000|Overall Study|Study Terminated by Sponsor|3|||
48844800|NCT02411084|157274210|FG000|Overall Study|Lack of Efficacy|6|||
48844801|NCT02411084|157274211|FG001|Overall Study|Lack of Efficacy|3|||
48844802|NCT02411084|157274210|FG000|Overall Study|Death|5|||
48844803|NCT02411084|157274211|FG001|Overall Study|Death|4|||
48844804|NCT02411084|157274210|FG000|Overall Study|Adverse Event|2|||
48844805|NCT02411084|157274211|FG001|Overall Study|Adverse Event|1|||
48844806|NCT02411084|157274210|FG000|Overall Study|Other reasons|0|||
48844807|NCT02411084|157274211|FG001|Overall Study|Other reasons|5|||
48844808|NCT03345901|157274217|FG000|Overall Study|The study was terminated|18|||
48844809|NCT01622868|157274223|FG000|Overall Study|Protocol Violation|7|||
48844810|NCT01622868|157274224|FG001|Overall Study|Protocol Violation|0|||
48844811|NCT00686855|157274230|FG000|Overall Study|Lost to Follow-up|1|||
48844812|NCT00686855|157274231|FG001|Overall Study|Lost to Follow-up|0|||
48844813|NCT00686855|157274230|FG000|Overall Study|Progressive GVHD|0|||
48844814|NCT00686855|157274231|FG001|Overall Study|Progressive GVHD|1|||
48844815|NCT00610649|157274237|FG000|Overall Study|Adverse Event|1|||
48844816|NCT00610649|157274238|FG001|Overall Study|Adverse Event|0|||
48844817|NCT00610649|157274239|FG002|Overall Study|Adverse Event|0|||
48844818|NCT00610649|157274240|FG003|Overall Study|Adverse Event|0|||
48844819|NCT00610649|157274241|FG004|Overall Study|Adverse Event|0|||
48844820|NCT00610649|157274242|FG005|Overall Study|Adverse Event|0|||
48844821|NCT00610649|157274243|FG006|Overall Study|Adverse Event|0|||
48931779|NCT01307033|157581970|FG000|44-week Open-label Extension|Withdrawal by Subject|0|||
48931780|NCT01307033|157581971|FG001|44-week Open-label Extension|Withdrawal by Subject|0|||
48931781|NCT01307033|157581972|FG002|44-week Open-label Extension|Withdrawal by Subject|2|||
48931782|NCT01307033|157581973|FG003|44-week Open-label Extension|Withdrawal by Subject|1|||
48931783|NCT01307033|157581970|FG000|44-week Open-label Extension|Physician Decision|0|||
48931784|NCT01307033|157581971|FG001|44-week Open-label Extension|Physician Decision|0|||
48931785|NCT01307033|157581972|FG002|44-week Open-label Extension|Physician Decision|1|||
48931786|NCT01307033|157581973|FG003|44-week Open-label Extension|Physician Decision|0|||
48931787|NCT01307033|157581970|FG000|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
48931788|NCT01307033|157581971|FG001|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
48931789|NCT01307033|157581972|FG002|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
48931790|NCT01307033|157581973|FG003|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2|||
48931791|NCT01307033|157581970|FG000|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
48931792|NCT01307033|157581971|FG001|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
48931793|NCT01307033|157581972|FG002|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6|||
48931794|NCT01307033|157581973|FG003|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7|||
48844822|NCT00610649|157274244|FG007|Overall Study|Adverse Event|0|||
48844823|NCT00610649|157274245|FG008|Overall Study|Adverse Event|0|||
48844824|NCT00610649|157274246|FG009|Overall Study|Adverse Event|0|||
48844825|NCT00610649|157274247|FG010|Overall Study|Adverse Event|1|||
48844826|NCT00610649|157274237|FG000|Overall Study|Family Emergency|0|||
48844827|NCT00610649|157274238|FG001|Overall Study|Family Emergency|1|||
48844828|NCT00610649|157274239|FG002|Overall Study|Family Emergency|0|||
48844829|NCT00610649|157274240|FG003|Overall Study|Family Emergency|0|||
48844830|NCT00610649|157274241|FG004|Overall Study|Family Emergency|0|||
48844831|NCT00610649|157274242|FG005|Overall Study|Family Emergency|0|||
48844832|NCT00610649|157274243|FG006|Overall Study|Family Emergency|0|||
48844833|NCT00610649|157274244|FG007|Overall Study|Family Emergency|0|||
48844834|NCT00610649|157274245|FG008|Overall Study|Family Emergency|0|||
48844835|NCT00610649|157274246|FG009|Overall Study|Family Emergency|0|||
48844836|NCT00610649|157274247|FG010|Overall Study|Family Emergency|0|||
48844837|NCT00610649|157274237|FG000|Overall Study|Withdrawal by Subject|0|||
48844838|NCT00610649|157274238|FG001|Overall Study|Withdrawal by Subject|0|||
48844839|NCT00610649|157274239|FG002|Overall Study|Withdrawal by Subject|0|||
48844840|NCT00610649|157274240|FG003|Overall Study|Withdrawal by Subject|0|||
48844841|NCT00610649|157274241|FG004|Overall Study|Withdrawal by Subject|0|||
48844842|NCT00610649|157274242|FG005|Overall Study|Withdrawal by Subject|0|||
48931795|NCT01307033|157581970|FG000|44-week Open-label Extension|Death|0|||
48931796|NCT01307033|157581971|FG001|44-week Open-label Extension|Death|0|||
48931797|NCT01307033|157581972|FG002|44-week Open-label Extension|Death|0|||
48931798|NCT01307033|157581973|FG003|44-week Open-label Extension|Death|1|||
48931799|NCT01231555|157581974|FG000|Overall Study|Study terminated|8|||
48844843|NCT00610649|157274243|FG006|Overall Study|Withdrawal by Subject|0|||
48844844|NCT00610649|157274244|FG007|Overall Study|Withdrawal by Subject|0|||
48844845|NCT00610649|157274245|FG008|Overall Study|Withdrawal by Subject|0|||
48931800|NCT01231555|157581975|FG001|Overall Study|Study terminated|5|||
48693074|NCT01350999|156724666|FG002|Overall Study|Adverse Event|10|||
48844846|NCT00610649|157274246|FG009|Overall Study|Withdrawal by Subject|1|||
48844847|NCT00610649|157274247|FG010|Overall Study|Withdrawal by Subject|0|||
48844848|NCT04252586|157274250|FG000|Overall Study|Withdrawal by parent/guardian|3|||
48844849|NCT04252586|157274250|FG000|Overall Study|Adverse Event|1|||
48844850|NCT04252586|157274250|FG000|Overall Study|Death|2|||
48844851|NCT04252586|157274250|FG000|Overall Study|Study terminated by sponsor|4|||
48844852|NCT04252586|157274250|FG000|Overall Study|Sponsor request|10|||
48844853|NCT04252586|157274250|FG000|Overall Study|Did not complete treatment period|1|||
48844854|NCT00232180|157274251|FG000|Double-blind (DB) Phase|Death|186|||
48844855|NCT00232180|157274252|FG001|Double-blind (DB) Phase|Death|222|||
48844856|NCT00232180|157274253|FG002|Double-blind (DB) Phase|Death|0|||
48844857|NCT00232180|157274251|FG000|Double-blind (DB) Phase|Lost to Follow-up|34|||
48844858|NCT00232180|157274252|FG001|Double-blind (DB) Phase|Lost to Follow-up|28|||
48844859|NCT00232180|157274253|FG002|Double-blind (DB) Phase|Lost to Follow-up|0|||
48844860|NCT00232180|157274251|FG000|Double-blind (DB) Phase|Withdrawal by Subject|131|||
48844861|NCT00232180|157274252|FG001|Double-blind (DB) Phase|Withdrawal by Subject|148|||
48844862|NCT00232180|157274253|FG002|Double-blind (DB) Phase|Withdrawal by Subject|0|||
48844863|NCT00232180|157274251|FG000|Double-blind (DB) Phase|Protocol Violation|28|||
48844864|NCT00232180|157274252|FG001|Double-blind (DB) Phase|Protocol Violation|21|||
48844865|NCT00232180|157274253|FG002|Double-blind (DB) Phase|Protocol Violation|0|||
48844866|NCT00232180|157274251|FG000|Double-blind (DB) Phase|Adverse Event|83|||
48844867|NCT00232180|157274252|FG001|Double-blind (DB) Phase|Adverse Event|100|||
48844868|NCT00232180|157274253|FG002|Double-blind (DB) Phase|Adverse Event|0|||
48844869|NCT00232180|157274251|FG000|Double-blind (DB) Phase|Other|70|||
48844870|NCT00232180|157274252|FG001|Double-blind (DB) Phase|Other|75|||
48844871|NCT00232180|157274253|FG002|Double-blind (DB) Phase|Other|0|||
48844872|NCT00232180|157274251|FG000|Double-blind (DB) Phase|Randomized but not treated|3|||
48844873|NCT00232180|157274252|FG001|Double-blind (DB) Phase|Randomized but not treated|4|||
48844874|NCT00232180|157274253|FG002|Double-blind (DB) Phase|Randomized but not treated|0|||
48844875|NCT00232180|157274251|FG000|Double-blind (DB) Phase|Laboratory abnormality|6|||
48844876|NCT00232180|157274252|FG001|Double-blind (DB) Phase|Laboratory abnormality|7|||
48844877|NCT00232180|157274253|FG002|Double-blind (DB) Phase|Laboratory abnormality|0|||
48844878|NCT00232180|157274251|FG000|Open Label Phase|Death|0|||
48844879|NCT00232180|157274252|FG001|Open Label Phase|Death|0|||
48931801|NCT01231555|157581976|FG002|Overall Study|Study terminated|8|||
48931802|NCT01231555|157581974|FG000|Overall Study|Withdrawal by Subject|0|||
48931803|NCT01231555|157581975|FG001|Overall Study|Withdrawal by Subject|2|||
48844880|NCT00232180|157274253|FG002|Open Label Phase|Death|48|||
48844881|NCT00232180|157274251|FG000|Open Label Phase|Lost to Follow-up|0|||
48844882|NCT00232180|157274252|FG001|Open Label Phase|Lost to Follow-up|0|||
48844883|NCT00232180|157274253|FG002|Open Label Phase|Lost to Follow-up|5|||
48844884|NCT00232180|157274251|FG000|Open Label Phase|Protocol Violation|0|||
48844885|NCT00232180|157274252|FG001|Open Label Phase|Protocol Violation|0|||
48931804|NCT01231555|157581976|FG002|Overall Study|Withdrawal by Subject|0|||
48844886|NCT00232180|157274253|FG002|Open Label Phase|Protocol Violation|3|||
48844887|NCT00232180|157274251|FG000|Open Label Phase|Study terminated by sponsor|0|||
48844888|NCT00232180|157274252|FG001|Open Label Phase|Study terminated by sponsor|0|||
48931805|NCT00699348|157581982|FG000|Overall Study|Death|6|||
48931806|NCT00699348|157581982|FG000|Overall Study|Adverse Event|15|||
48844889|NCT00232180|157274253|FG002|Open Label Phase|Study terminated by sponsor|3|||
48844890|NCT00232180|157274251|FG000|Open Label Phase|Withdrawal by Subject|0|||
48844891|NCT00232180|157274252|FG001|Open Label Phase|Withdrawal by Subject|0|||
48844892|NCT00232180|157274253|FG002|Open Label Phase|Withdrawal by Subject|37|||
48844893|NCT00232180|157274251|FG000|Open Label Phase|Other|0|||
48844894|NCT00232180|157274252|FG001|Open Label Phase|Other|0|||
48844895|NCT00232180|157274253|FG002|Open Label Phase|Other|16|||
48844896|NCT00232180|157274251|FG000|Open Label Phase|Adverse Event|0|||
48844897|NCT00232180|157274252|FG001|Open Label Phase|Adverse Event|0|||
48844898|NCT00232180|157274253|FG002|Open Label Phase|Adverse Event|25|||
48844899|NCT00232180|157274251|FG000|Open Label Phase|Laboratory abnormality|0|||
48844900|NCT00232180|157274252|FG001|Open Label Phase|Laboratory abnormality|0|||
48844901|NCT00232180|157274253|FG002|Open Label Phase|Laboratory abnormality|10|||
48844902|NCT00232180|157274251|FG000|Open Label Phase|Randomized but not treated|0|||
48844903|NCT00232180|157274252|FG001|Open Label Phase|Randomized but not treated|0|||
48844904|NCT00232180|157274253|FG002|Open Label Phase|Randomized but not treated|1|||
48844905|NCT02748317|157274254|FG000|Overall Study|Withdrawal by Subject|14|||
48844906|NCT02748317|157274254|FG000|Overall Study|Lost to Follow-up|8|||
48844907|NCT02748317|157274254|FG000|Overall Study|Death|1|||
48844908|NCT00505934|157274255|FG000|Overall Study|Adverse Event|1|||
48844909|NCT00505934|157274255|FG000|Overall Study|Other: Unable to obtain IV & PK samples|1|||
48844910|NCT00505934|157274255|FG000|Overall Study|Other: IV dose needed to be changed|1|||
48844911|NCT00799396|157274256|FG000|Clopidogrel Treatment|Adverse Event|6|||
48844912|NCT00799396|157274256|FG000|Clopidogrel Treatment|Physician Decision|5|||
48844913|NCT00799396|157274256|FG000|Clopidogrel Treatment|Withdrawal by Subject|2|||
48844914|NCT00799396|157274256|FG000|Clopidogrel Plus Aspirin|Adverse Event|2|||
48844915|NCT00799396|157274256|FG000|Clopidogrel Plus Aspirin|Physician Decision|4|||
48844916|NCT00714714|157274257|FG000|Overall Study|Adverse Event|1|||
48844917|NCT02252042|157274259|FG000|Overall Study|Adverse Event|9|||
48844918|NCT02252042|157274260|FG001|Overall Study|Adverse Event|6|||
48844919|NCT02252042|157274259|FG000|Overall Study|Death|209|||
48844920|NCT02252042|157274260|FG001|Overall Study|Death|217|||
48844921|NCT02252042|157274259|FG000|Overall Study|Physician Decision|0|||
48844922|NCT02252042|157274260|FG001|Overall Study|Physician Decision|2|||
48844923|NCT02252042|157274259|FG000|Overall Study|Transferred to Extension Study|7|||
48844924|NCT02252042|157274260|FG001|Overall Study|Transferred to Extension Study|1|||
48931807|NCT00699348|157581982|FG000|Overall Study|Withdrawal by Subject|11|||
48931808|NCT00699348|157581982|FG000|Overall Study|Protocol Violation|10|||
48931809|NCT00699348|157581982|FG000|Overall Study|Lack of Efficacy|8|||
48931810|NCT00699348|157581982|FG000|Overall Study|Failure to return|1|||
48931811|NCT00699348|157581982|FG000|Overall Study|Blood transfusion|24|||
48931812|NCT00699348|157581982|FG000|Overall Study|Renal transplantation|10|||
48931813|NCT00699348|157581982|FG000|Overall Study|Other|5|||
48931814|NCT00805740|157581985|FG000|Overall Study|Death|7|||
48931815|NCT00805740|157581986|FG001|Overall Study|Death|4|||
48931816|NCT00805740|157581985|FG000|Overall Study|Withdrawal by Subject|1|||
48931817|NCT00805740|157581986|FG001|Overall Study|Withdrawal by Subject|0|||
48931818|NCT00805740|157581985|FG000|Overall Study|Lost to Follow-up|1|||
48931819|NCT00805740|157581986|FG001|Overall Study|Lost to Follow-up|0|||
48931820|NCT00805740|157581985|FG000|Overall Study|Randomized, but not treated|2|||
48931821|NCT00805740|157581986|FG001|Overall Study|Randomized, but not treated|0|||
48931822|NCT02723201|157581989|FG000|Second Intervention Period|Protocol Violation|1|||
48931823|NCT02723201|157581990|FG001|Second Intervention Period|Protocol Violation|0|||
48931824|NCT02723201|157581991|FG002|Second Intervention Period|Protocol Violation|0|||
48931825|NCT02723201|157581989|FG000|Second Intervention Period|Adverse Event|1|||
48844925|NCT02252042|157274259|FG000|Overall Study|Did Not Continue on Extension Study|7|||
48844926|NCT02252042|157274260|FG001|Overall Study|Did Not Continue on Extension Study|2|||
48844927|NCT02252042|157274259|FG000|Overall Study|Withdrawal by Subject|15|||
48844928|NCT02252042|157274260|FG001|Overall Study|Withdrawal by Subject|20|||
48844929|NCT00411151|157274265|FG000|Overall Study|Death|38|||
48844930|NCT00411151|157274265|FG000|Overall Study|Withdrawal by Subject|2|||
48931826|NCT02723201|157581990|FG001|Second Intervention Period|Adverse Event|0|||
48931827|NCT02723201|157581991|FG002|Second Intervention Period|Adverse Event|0|||
48931828|NCT03569202|157581992|FG000|Part 3|Physician Decision|1|||
48931829|NCT03569202|157581993|FG001|Part 3|Physician Decision|0|||
48844931|NCT00411151|157274265|FG000|Overall Study|Lost to Follow-up|2|||
48844932|NCT00411151|157274265|FG000|Overall Study|Protocol Violation|1|||
48844933|NCT00411151|157274265|FG000|Overall Study|Trial prematurely closed|4|||
48931830|NCT03569202|157581992|FG000|Part 3|Other|1|||
48931831|NCT03569202|157581993|FG001|Part 3|Other|1|||
48931832|NCT01668654|157581994|FG000|Overall Study|Study Closed/Terminated|3|||
48844934|NCT00818246|157274268|FG000|Overall Study|Impossible to match pictures|5|||
48844935|NCT02267824|157274269|FG000|Overall Study|Pregnancy|1|||
48844936|NCT02267824|157274270|FG001|Overall Study|Pregnancy|1|||
48844937|NCT02267824|157274269|FG000|Overall Study|Lost to Follow-up|4|||
48844938|NCT02267824|157274270|FG001|Overall Study|Lost to Follow-up|0|||
48844939|NCT02267824|157274269|FG000|Overall Study|Protocol Violation|3|||
48844940|NCT02267824|157274270|FG001|Overall Study|Protocol Violation|0|||
48844941|NCT02267824|157274269|FG000|Overall Study|Did Not Meet Initial Dental Criteria|2|||
48844942|NCT02267824|157274270|FG001|Overall Study|Did Not Meet Initial Dental Criteria|0|||
48844943|NCT01007396|157274271|FG000|Overall Study|Lost to Follow-up|47|||
48844944|NCT03283371|157274275|FG000|Placebo-controlled|Adverse Event|1|||
48844945|NCT03283371|157274276|FG001|Placebo-controlled|Adverse Event|1|||
48844946|NCT03283371|157274277|FG002|Placebo-controlled|Adverse Event|0|||
48844947|NCT03283371|157274278|FG003|Placebo-controlled|Adverse Event|0|||
48844948|NCT03283371|157274275|FG000|Placebo-controlled|Lack of Efficacy|1|||
48844949|NCT03283371|157274276|FG001|Placebo-controlled|Lack of Efficacy|0|||
48844950|NCT03283371|157274277|FG002|Placebo-controlled|Lack of Efficacy|0|||
48844951|NCT03283371|157274278|FG003|Placebo-controlled|Lack of Efficacy|0|||
48844952|NCT03283371|157274275|FG000|Placebo-controlled|Withdrawal by Subject|1|||
48844953|NCT03283371|157274276|FG001|Placebo-controlled|Withdrawal by Subject|1|||
48844954|NCT03283371|157274277|FG002|Placebo-controlled|Withdrawal by Subject|0|||
48844955|NCT03283371|157274278|FG003|Placebo-controlled|Withdrawal by Subject|0|||
48844956|NCT03283371|157274275|FG000|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
48844957|NCT03283371|157274276|FG001|Placebo-controlled|Participants Did Not Receive Study Drug|1|||
48844958|NCT03283371|157274277|FG002|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
48844959|NCT03283371|157274278|FG003|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
48844960|NCT03283371|157274275|FG000|Open-label Phase|Adverse Event|0|||
48844961|NCT03283371|157274276|FG001|Open-label Phase|Adverse Event|0|||
48844962|NCT03283371|157274277|FG002|Open-label Phase|Adverse Event|2|||
48844963|NCT03283371|157274278|FG003|Open-label Phase|Adverse Event|0|||
48844964|NCT03283371|157274275|FG000|Open-label Phase|Withdrawal by Subject|0|||
48844965|NCT03283371|157274276|FG001|Open-label Phase|Withdrawal by Subject|0|||
48844966|NCT03283371|157274277|FG002|Open-label Phase|Withdrawal by Subject|1|||
48844967|NCT03283371|157274278|FG003|Open-label Phase|Withdrawal by Subject|0|||
48844968|NCT03283371|157274275|FG000|Open-label Phase|Other|0|||
48844969|NCT03283371|157274276|FG001|Open-label Phase|Other|0|||
48844970|NCT03283371|157274277|FG002|Open-label Phase|Other|1|||
48844971|NCT03283371|157274278|FG003|Open-label Phase|Other|1|||
48844972|NCT01985334|157274279|FG000|Overall Study|Administrative problems|1|||
48844973|NCT01985334|157274280|FG001|Overall Study|Administrative problems|1|||
48844974|NCT01985334|157274281|FG002|Overall Study|Administrative problems|0|||
48844975|NCT01985334|157274282|FG003|Overall Study|Administrative problems|2|||
48931833|NCT01668654|157581994|FG000|Overall Study|Withdrawal by Subject|1|||
48931834|NCT04557384|157581995|FG000|Overall Study|Study Terminated by Sponsor|1|||
48931835|NCT04557384|157581995|FG000|Overall Study|Death|1|||
48931836|NCT01084551|157581996|FG000|Overall Study|Adverse Event|2|||
48931837|NCT01084551|157581997|FG001|Overall Study|Adverse Event|9|||
48931838|NCT01084551|157581998|FG002|Overall Study|Adverse Event|4|||
48931839|NCT01084551|157581996|FG000|Overall Study|Lack of Efficacy|2|||
48931840|NCT01084551|157581997|FG001|Overall Study|Lack of Efficacy|0|||
48931841|NCT01084551|157581998|FG002|Overall Study|Lack of Efficacy|1|||
48931842|NCT01084551|157581996|FG000|Overall Study|Withdrawal by Subject|2|||
48931843|NCT01084551|157581997|FG001|Overall Study|Withdrawal by Subject|1|||
48931844|NCT01084551|157581998|FG002|Overall Study|Withdrawal by Subject|0|||
48931845|NCT01084551|157581996|FG000|Overall Study|Protocol Violation|2|||
48931846|NCT01084551|157581997|FG001|Overall Study|Protocol Violation|4|||
48931847|NCT01084551|157581998|FG002|Overall Study|Protocol Violation|0|||
48931848|NCT01084551|157581996|FG000|Overall Study|Lost to Follow-up|0|||
48931849|NCT01084551|157581997|FG001|Overall Study|Lost to Follow-up|0|||
48844976|NCT01985334|157274283|FG004|Overall Study|Administrative problems|0|||
48931850|NCT01084551|157581998|FG002|Overall Study|Lost to Follow-up|3|||
48844977|NCT01985334|157274284|FG005|Overall Study|Administrative problems|1|||
48931851|NCT01084551|157581996|FG000|Overall Study|Physician Decision|1|||
48931852|NCT01084551|157581997|FG001|Overall Study|Physician Decision|0|||
48931853|NCT01084551|157581998|FG002|Overall Study|Physician Decision|0|||
48931854|NCT03806127|157582001|FG000|Overall Study|Withdrawal by Subject|4|||
48931855|NCT03806127|157582002|FG001|Overall Study|Withdrawal by Subject|5|||
48931856|NCT03806127|157582001|FG000|Overall Study|Protocol Violation|3|||
48931857|NCT03806127|157582002|FG001|Overall Study|Protocol Violation|1|||
48844978|NCT01985334|157274285|FG006|Overall Study|Administrative problems|1|||
48844979|NCT01985334|157274286|FG007|Overall Study|Administrative problems|3|||
48844980|NCT01985334|157274279|FG000|Overall Study|Death|1|||
48931858|NCT03806127|157582001|FG000|Overall Study|Adverse Event|3|||
48844981|NCT01985334|157274280|FG001|Overall Study|Death|0|||
48931859|NCT03806127|157582002|FG001|Overall Study|Adverse Event|0|||
48931860|NCT03806127|157582001|FG000|Overall Study|Unable to Complete Procedures|0|||
48931861|NCT03806127|157582002|FG001|Overall Study|Unable to Complete Procedures|1|||
48931862|NCT03806127|157582001|FG000|Overall Study|Pregnancy|0|||
48931863|NCT03806127|157582002|FG001|Overall Study|Pregnancy|1|||
48931864|NCT03806127|157582001|FG000|Overall Study|Lost to Follow-up|5|||
48931865|NCT03806127|157582002|FG001|Overall Study|Lost to Follow-up|1|||
48931866|NCT03806127|157582001|FG000|Overall Study|Physician Decision|1|||
48931867|NCT03806127|157582002|FG001|Overall Study|Physician Decision|1|||
48931868|NCT03806127|157582001|FG000|Overall Study|Could Not Come Due to Covid|1|||
48931869|NCT03806127|157582002|FG001|Overall Study|Could Not Come Due to Covid|0|||
48931870|NCT03806127|157582001|FG000|Overall Study|Prescribed Exclusionary Medication (Med)|1|||
48931871|NCT03806127|157582002|FG001|Overall Study|Prescribed Exclusionary Medication (Med)|0|||
48931872|NCT03806127|157582001|FG000|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1|||
48931873|NCT03806127|157582002|FG001|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0|||
48931874|NCT03806127|157582001|FG000|Overall Study|Covid 19 Restrictions|2|||
48931875|NCT03806127|157582002|FG001|Overall Study|Covid 19 Restrictions|0|||
48931876|NCT03806127|157582001|FG000|Overall Study|Withdrawn Due to Work/School Schedule|0|||
48931877|NCT03806127|157582002|FG001|Overall Study|Withdrawn Due to Work/School Schedule|1|||
48931878|NCT03806127|157582001|FG000|Overall Study|Covid 19 Concern; Possible Site Closure|0|||
48931879|NCT03806127|157582002|FG001|Overall Study|Covid 19 Concern; Possible Site Closure|1|||
48931880|NCT02024971|157582003|FG000|Overall Study|Data Not Available|30|||
48931881|NCT02024971|157582003|FG000|Overall Study|Lost to Follow-up|6|||
48931882|NCT01467492|157582004|FG000|Overall Study|Withdrawal by Subject|6|||
48931883|NCT01467492|157582005|FG001|Overall Study|Withdrawal by Subject|4|||
48931884|NCT01467492|157582004|FG000|Overall Study|Study Terminated by Sponsor|6|||
48931885|NCT01467492|157582005|FG001|Overall Study|Study Terminated by Sponsor|4|||
48931886|NCT01467492|157582004|FG000|Overall Study|Adverse Event|4|||
48931887|NCT01467492|157582005|FG001|Overall Study|Adverse Event|3|||
48931888|NCT01467492|157582004|FG000|Overall Study|Lost to Follow-up|3|||
48931889|NCT01467492|157582005|FG001|Overall Study|Lost to Follow-up|2|||
48931890|NCT01467492|157582004|FG000|Overall Study|Undefined|2|||
48931891|NCT01467492|157582005|FG001|Overall Study|Undefined|0|||
48931892|NCT01467492|157582004|FG000|Overall Study|Enrolled But Not Treated|1|||
48931893|NCT01467492|157582005|FG001|Overall Study|Enrolled But Not Treated|0|||
48931894|NCT01622569|157582011|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4|||
48931895|NCT01622569|157582012|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
48735652|NCT02215096|156883706|FG001|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
48735653|NCT02215096|156883707|FG002|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
48735654|NCT02215096|156883708|FG003|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
48931896|NCT01622569|157582013|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3|||
48931897|NCT01622569|157582014|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
48931898|NCT01622569|157582011|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
48931899|NCT01622569|157582012|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
48931900|NCT01622569|157582013|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1|||
48844982|NCT01985334|157274281|FG002|Overall Study|Death|0|||
48844983|NCT01985334|157274282|FG003|Overall Study|Death|3|||
48844984|NCT01985334|157274283|FG004|Overall Study|Death|0|||
48844985|NCT01985334|157274284|FG005|Overall Study|Death|0|||
48844986|NCT01985334|157274285|FG006|Overall Study|Death|1|||
48844987|NCT01985334|157274286|FG007|Overall Study|Death|2|||
48844988|NCT01985334|157274279|FG000|Overall Study|Worsening of disease|0|||
48844989|NCT01985334|157274280|FG001|Overall Study|Worsening of disease|0|||
48844990|NCT01985334|157274281|FG002|Overall Study|Worsening of disease|0|||
48844991|NCT01985334|157274282|FG003|Overall Study|Worsening of disease|1|||
48844992|NCT01985334|157274283|FG004|Overall Study|Worsening of disease|0|||
48844993|NCT01985334|157274284|FG005|Overall Study|Worsening of disease|3|||
48844994|NCT01985334|157274285|FG006|Overall Study|Worsening of disease|0|||
48844995|NCT01985334|157274286|FG007|Overall Study|Worsening of disease|1|||
48844996|NCT01985334|157274279|FG000|Overall Study|Other|2|||
48844997|NCT01985334|157274280|FG001|Overall Study|Other|9|||
48844998|NCT01985334|157274281|FG002|Overall Study|Other|7|||
48844999|NCT01985334|157274282|FG003|Overall Study|Other|17|||
48845000|NCT01985334|157274283|FG004|Overall Study|Other|4|||
48931901|NCT01622569|157582014|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
48931902|NCT01622569|157582011|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6|||
48931903|NCT01622569|157582012|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
48931904|NCT01622569|157582013|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3|||
48931905|NCT01622569|157582014|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2|||
48931906|NCT01622569|157582011|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
48931907|NCT01622569|157582012|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2|||
48931908|NCT01622569|157582013|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
48931909|NCT01622569|157582014|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
48845001|NCT01985334|157274284|FG005|Overall Study|Other|8|||
48845002|NCT01985334|157274285|FG006|Overall Study|Other|4|||
48845003|NCT01985334|157274286|FG007|Overall Study|Other|7|||
48845004|NCT01985334|157274279|FG000|Overall Study|Protocol deviation|6|||
48845005|NCT01985334|157274280|FG001|Overall Study|Protocol deviation|31|||
48845006|NCT01985334|157274281|FG002|Overall Study|Protocol deviation|25|||
48845007|NCT01985334|157274282|FG003|Overall Study|Protocol deviation|84|||
48845008|NCT01985334|157274283|FG004|Overall Study|Protocol deviation|17|||
48845009|NCT01985334|157274284|FG005|Overall Study|Protocol deviation|47|||
48845010|NCT01985334|157274285|FG006|Overall Study|Protocol deviation|15|||
48845011|NCT01985334|157274286|FG007|Overall Study|Protocol deviation|42|||
48845012|NCT01985334|157274279|FG000|Overall Study|Moderate / severe COPD exacerbation|5|||
48845013|NCT01985334|157274280|FG001|Overall Study|Moderate / severe COPD exacerbation|14|||
48845014|NCT01985334|157274281|FG002|Overall Study|Moderate / severe COPD exacerbation|12|||
48845015|NCT01985334|157274282|FG003|Overall Study|Moderate / severe COPD exacerbation|40|||
48845016|NCT01985334|157274283|FG004|Overall Study|Moderate / severe COPD exacerbation|6|||
48845017|NCT01985334|157274284|FG005|Overall Study|Moderate / severe COPD exacerbation|40|||
48845018|NCT01985334|157274285|FG006|Overall Study|Moderate / severe COPD exacerbation|8|||
48845019|NCT01985334|157274286|FG007|Overall Study|Moderate / severe COPD exacerbation|19|||
48845020|NCT01985334|157274279|FG000|Overall Study|Subject withdrawal of consent|3|||
48845021|NCT01985334|157274280|FG001|Overall Study|Subject withdrawal of consent|6|||
48845022|NCT01985334|157274281|FG002|Overall Study|Subject withdrawal of consent|2|||
48845023|NCT01985334|157274282|FG003|Overall Study|Subject withdrawal of consent|28|||
48845024|NCT01985334|157274283|FG004|Overall Study|Subject withdrawal of consent|4|||
48845025|NCT01985334|157274284|FG005|Overall Study|Subject withdrawal of consent|19|||
48845026|NCT01985334|157274285|FG006|Overall Study|Subject withdrawal of consent|0|||
48845027|NCT01985334|157274286|FG007|Overall Study|Subject withdrawal of consent|20|||
48845028|NCT01985334|157274279|FG000|Overall Study|Adverse Event|0|||
48845029|NCT01985334|157274280|FG001|Overall Study|Adverse Event|8|||
48845030|NCT01985334|157274281|FG002|Overall Study|Adverse Event|2|||
48845031|NCT01985334|157274282|FG003|Overall Study|Adverse Event|26|||
48845032|NCT01985334|157274283|FG004|Overall Study|Adverse Event|3|||
48845033|NCT01985334|157274284|FG005|Overall Study|Adverse Event|18|||
48845034|NCT01985334|157274285|FG006|Overall Study|Adverse Event|3|||
48845035|NCT01985334|157274286|FG007|Overall Study|Adverse Event|15|||
48845036|NCT01985334|157274279|FG000|Overall Study|Other|4|||
48845037|NCT01985334|157274280|FG001|Overall Study|Other|2|||
48845038|NCT01985334|157274281|FG002|Overall Study|Other|3|||
48845039|NCT01985334|157274282|FG003|Overall Study|Other|10|||
48845040|NCT01985334|157274283|FG004|Overall Study|Other|1|||
48845041|NCT01985334|157274284|FG005|Overall Study|Other|6|||
48845042|NCT01985334|157274285|FG006|Overall Study|Other|2|||
48845043|NCT01985334|157274286|FG007|Overall Study|Other|2|||
48845044|NCT01985334|157274279|FG000|Overall Study|Medication non-compliance|0|||
48845045|NCT01985334|157274280|FG001|Overall Study|Medication non-compliance|4|||
48845046|NCT01985334|157274281|FG002|Overall Study|Medication non-compliance|1|||
48845047|NCT01985334|157274282|FG003|Overall Study|Medication non-compliance|6|||
48845048|NCT01985334|157274283|FG004|Overall Study|Medication non-compliance|2|||
48845049|NCT01985334|157274284|FG005|Overall Study|Medication non-compliance|3|||
48845050|NCT01985334|157274285|FG006|Overall Study|Medication non-compliance|1|||
48845051|NCT01985334|157274286|FG007|Overall Study|Medication non-compliance|3|||
48845052|NCT01985334|157274279|FG000|Overall Study|Use of prohibited treatment|1|||
48845053|NCT01985334|157274280|FG001|Overall Study|Use of prohibited treatment|4|||
48845054|NCT01985334|157274281|FG002|Overall Study|Use of prohibited treatment|1|||
48845055|NCT01985334|157274282|FG003|Overall Study|Use of prohibited treatment|2|||
48845056|NCT01985334|157274283|FG004|Overall Study|Use of prohibited treatment|1|||
48845057|NCT01985334|157274284|FG005|Overall Study|Use of prohibited treatment|6|||
48845058|NCT01985334|157274285|FG006|Overall Study|Use of prohibited treatment|2|||
48845059|NCT01985334|157274286|FG007|Overall Study|Use of prohibited treatment|0|||
48845060|NCT01985334|157274279|FG000|Overall Study|Investigator decision|0|||
48845061|NCT01985334|157274280|FG001|Overall Study|Investigator decision|3|||
48845062|NCT01985334|157274281|FG002|Overall Study|Investigator decision|0|||
48845063|NCT01985334|157274282|FG003|Overall Study|Investigator decision|7|||
48845064|NCT01985334|157274283|FG004|Overall Study|Investigator decision|1|||
48845065|NCT01985334|157274284|FG005|Overall Study|Investigator decision|1|||
48845066|NCT01985334|157274285|FG006|Overall Study|Investigator decision|0|||
48931910|NCT01622569|157582011|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
48931911|NCT01622569|157582012|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
48931912|NCT01622569|157582013|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
48931913|NCT01622569|157582014|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
48845067|NCT01985334|157274286|FG007|Overall Study|Investigator decision|4|||
48845068|NCT01985334|157274279|FG000|Overall Study|Lost to Follow-up|0|||
48845069|NCT01985334|157274280|FG001|Overall Study|Lost to Follow-up|2|||
48845070|NCT01985334|157274281|FG002|Overall Study|Lost to Follow-up|0|||
48845071|NCT01985334|157274282|FG003|Overall Study|Lost to Follow-up|3|||
48845072|NCT01985334|157274283|FG004|Overall Study|Lost to Follow-up|1|||
48845073|NCT01985334|157274284|FG005|Overall Study|Lost to Follow-up|4|||
48931914|NCT01622569|157582011|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
48845074|NCT01985334|157274285|FG006|Overall Study|Lost to Follow-up|0|||
48845075|NCT01985334|157274286|FG007|Overall Study|Lost to Follow-up|3|||
48845076|NCT00296036|157274287|FG000|Overall Study|Withdrawal by Subject|1|||
48845077|NCT00296036|157274288|FG001|Overall Study|Withdrawal by Subject|0|||
48845078|NCT00296036|157274289|FG002|Overall Study|Withdrawal by Subject|2|||
48931915|NCT01622569|157582012|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2|||
48845079|NCT00296036|157274290|FG003|Overall Study|Withdrawal by Subject|1|||
48845080|NCT00296036|157274291|FG004|Overall Study|Withdrawal by Subject|2|||
48931916|NCT01622569|157582013|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
48931917|NCT01622569|157582014|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
48931918|NCT01622569|157582011|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
48931919|NCT01622569|157582012|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
48931920|NCT01622569|157582013|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2|||
48931921|NCT01622569|157582014|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
48931922|NCT01622569|157582011|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
48931923|NCT01622569|157582012|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
48931924|NCT01622569|157582013|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
48931925|NCT01622569|157582014|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
48931926|NCT04173741|157582016|FG000|Overall Study|IVC measurement cannot be done|1|||
48931927|NCT04173741|157582017|FG001|Overall Study|IVC measurement cannot be done|1|||
48931928|NCT00559273|157582018|FG000|Correction Period (20 Weeks)|Death|3|||
48931929|NCT00559273|157582019|FG001|Correction Period (20 Weeks)|Death|4|||
48931930|NCT00559273|157582018|FG000|Correction Period (20 Weeks)|Adverse Event|2|||
48931931|NCT00559273|157582019|FG001|Correction Period (20 Weeks)|Adverse Event|1|||
48931932|NCT00559273|157582018|FG000|Correction Period (20 Weeks)|Withdrawal by Subject|2|||
48931933|NCT00559273|157582019|FG001|Correction Period (20 Weeks)|Withdrawal by Subject|6|||
48931934|NCT00559273|157582018|FG000|Correction Period (20 Weeks)|Participant treated by another center|0|||
48931935|NCT00559273|157582019|FG001|Correction Period (20 Weeks)|Participant treated by another center|1|||
48931936|NCT00559273|157582018|FG000|Correction Period (20 Weeks)|Did not received study treatment|2|||
48845081|NCT00296036|157274292|FG005|Overall Study|Withdrawal by Subject|1|||
48845082|NCT00296036|157274287|FG000|Overall Study|Protocol Violation|0|||
48845083|NCT00296036|157274288|FG001|Overall Study|Protocol Violation|0|||
48845084|NCT00296036|157274289|FG002|Overall Study|Protocol Violation|0|||
48931937|NCT00559273|157582019|FG001|Correction Period (20 Weeks)|Did not received study treatment|0|||
48931938|NCT00559273|157582018|FG000|Evaluation Period (8 Weeks)|Death|1|||
48931939|NCT00559273|157582019|FG001|Evaluation Period (8 Weeks)|Death|3|||
48931940|NCT00559273|157582018|FG000|Evaluation Period (8 Weeks)|Adverse Event|0|||
48931941|NCT00559273|157582019|FG001|Evaluation Period (8 Weeks)|Adverse Event|1|||
48931942|NCT00559273|157582018|FG000|Evaluation Period (8 Weeks)|Withdrawal by Subject|2|||
48845085|NCT00296036|157274290|FG003|Overall Study|Protocol Violation|0|||
48845086|NCT00296036|157274291|FG004|Overall Study|Protocol Violation|0|||
48845087|NCT00296036|157274292|FG005|Overall Study|Protocol Violation|3|||
48845088|NCT01236560|157274295|FG000|Overall Study|Adverse Event|0|||
48845089|NCT01236560|157274296|FG001|Overall Study|Adverse Event|2|||
48845090|NCT01236560|157274297|FG002|Overall Study|Adverse Event|1|||
48845091|NCT01236560|157274298|FG003|Overall Study|Adverse Event|3|||
48845092|NCT01236560|157274299|FG004|Overall Study|Adverse Event|0|||
48845093|NCT01236560|157274300|FG005|Overall Study|Adverse Event|0|||
48845094|NCT01236560|157274295|FG000|Overall Study|Death|0|||
48845095|NCT01236560|157274296|FG001|Overall Study|Death|1|||
48845096|NCT01236560|157274297|FG002|Overall Study|Death|0|||
48845097|NCT01236560|157274298|FG003|Overall Study|Death|1|||
48845098|NCT01236560|157274299|FG004|Overall Study|Death|0|||
48845099|NCT01236560|157274300|FG005|Overall Study|Death|0|||
48845100|NCT01236560|157274295|FG000|Overall Study|Lost to Follow-up|0|||
48931943|NCT00559273|157582019|FG001|Evaluation Period (8 Weeks)|Withdrawal by Subject|0|||
48931944|NCT00559273|157582018|FG000|Evaluation Period (8 Weeks)|Physician Decision|0|||
48931945|NCT00559273|157582019|FG001|Evaluation Period (8 Weeks)|Physician Decision|1|||
48931946|NCT04276207|157582020|FG000|Period 1|Withdrawal by Subject|0|||
48931947|NCT04276207|157582021|FG001|Period 1|Withdrawal by Subject|1|||
48931948|NCT05655377|157582022|FG000|Overall Study|Withdrawal by Subject|2|||
48931949|NCT01109940|157582024|FG000|Overall Study|Administrative problems|2|||
48931950|NCT01109940|157582025|FG001|Overall Study|Administrative problems|0|||
48845101|NCT01236560|157274296|FG001|Overall Study|Lost to Follow-up|1|||
48845102|NCT01236560|157274297|FG002|Overall Study|Lost to Follow-up|1|||
48845103|NCT01236560|157274298|FG003|Overall Study|Lost to Follow-up|0|||
48845104|NCT01236560|157274299|FG004|Overall Study|Lost to Follow-up|0|||
48845105|NCT01236560|157274300|FG005|Overall Study|Lost to Follow-up|0|||
48845106|NCT01236560|157274295|FG000|Overall Study|Physician Decision|0|||
48845107|NCT01236560|157274296|FG001|Overall Study|Physician Decision|1|||
48845108|NCT01236560|157274297|FG002|Overall Study|Physician Decision|8|||
48931951|NCT01109940|157582026|FG002|Overall Study|Administrative problems|0|||
48931952|NCT01109940|157582027|FG003|Overall Study|Administrative problems|0|||
48931953|NCT01109940|157582024|FG000|Overall Study|Serious Adverse Event|2|||
48931954|NCT01109940|157582025|FG001|Overall Study|Serious Adverse Event|1|||
48931955|NCT01109940|157582026|FG002|Overall Study|Serious Adverse Event|0|||
48931956|NCT01109940|157582027|FG003|Overall Study|Serious Adverse Event|0|||
48931957|NCT01109940|157582024|FG000|Overall Study|Lost to Follow-up|1|||
48931958|NCT01109940|157582025|FG001|Overall Study|Lost to Follow-up|0|||
48931959|NCT01109940|157582026|FG002|Overall Study|Lost to Follow-up|0|||
48931960|NCT01109940|157582027|FG003|Overall Study|Lost to Follow-up|0|||
48931961|NCT01109940|157582024|FG000|Overall Study|Patient withdrew consent|1|||
48931962|NCT01109940|157582025|FG001|Overall Study|Patient withdrew consent|1|||
48931963|NCT01109940|157582026|FG002|Overall Study|Patient withdrew consent|0|||
48931964|NCT01109940|157582027|FG003|Overall Study|Patient withdrew consent|0|||
48931965|NCT01109940|157582024|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
48931966|NCT01109940|157582025|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
48845109|NCT01236560|157274298|FG003|Overall Study|Physician Decision|0|||
48845110|NCT01236560|157274299|FG004|Overall Study|Physician Decision|0|||
48845111|NCT01236560|157274300|FG005|Overall Study|Physician Decision|0|||
48845112|NCT01236560|157274295|FG000|Overall Study|Withdrawal by Subject|0|||
48845113|NCT01236560|157274296|FG001|Overall Study|Withdrawal by Subject|0|||
48931967|NCT01109940|157582026|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
48931968|NCT01109940|157582027|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
48931969|NCT03653390|157582028|FG000|Overall Study|Lost to Follow-up|12|||
48931970|NCT03653390|157582029|FG001|Overall Study|Lost to Follow-up|8|||
48931971|NCT03653390|157582030|FG002|Overall Study|Lost to Follow-up|7|||
48931972|NCT03653390|157582028|FG000|Overall Study|Withdrawal by Subject|6|||
48931973|NCT03653390|157582029|FG001|Overall Study|Withdrawal by Subject|1|||
48931974|NCT03653390|157582030|FG002|Overall Study|Withdrawal by Subject|1|||
48845114|NCT01236560|157274297|FG002|Overall Study|Withdrawal by Subject|1|||
48845115|NCT01236560|157274298|FG003|Overall Study|Withdrawal by Subject|2|||
48845116|NCT01236560|157274299|FG004|Overall Study|Withdrawal by Subject|0|||
48845117|NCT01236560|157274300|FG005|Overall Study|Withdrawal by Subject|0|||
48845118|NCT01236560|157274295|FG000|Overall Study|Progressive disease|5|||
48845119|NCT01236560|157274296|FG001|Overall Study|Progressive disease|19|||
48845120|NCT01236560|157274297|FG002|Overall Study|Progressive disease|9|||
48845121|NCT01236560|157274298|FG003|Overall Study|Progressive disease|16|||
48845122|NCT01236560|157274299|FG004|Overall Study|Progressive disease|0|||
48845123|NCT01236560|157274300|FG005|Overall Study|Progressive disease|0|||
48845124|NCT00529100|157274301|FG000|Overall Study|Adverse Event|0|||
48845125|NCT00529100|157274302|FG001|Overall Study|Adverse Event|5|||
48845126|NCT00529100|157274301|FG000|Overall Study|Protocol Violation|0|||
48845127|NCT00529100|157274302|FG001|Overall Study|Protocol Violation|1|||
48845128|NCT00529100|157274301|FG000|Overall Study|Progressive Disease|0|||
48845129|NCT00529100|157274302|FG001|Overall Study|Progressive Disease|1|||
48845130|NCT00529100|157274301|FG000|Overall Study|Withdrawal by Subject|0|||
48845131|NCT00529100|157274302|FG001|Overall Study|Withdrawal by Subject|1|||
48845132|NCT00529100|157274301|FG000|Overall Study|Participant Ineligibility|0|||
48845133|NCT00529100|157274302|FG001|Overall Study|Participant Ineligibility|1|||
48845134|NCT00999167|157274303|FG000|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4|||
48845135|NCT00999167|157274304|FG001|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
48845136|NCT00999167|157274305|FG002|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
48845137|NCT00999167|157274303|FG000|Part A: Open Label Safety run-in|Adverse Event|3|||
48845138|NCT00999167|157274304|FG001|Part A: Open Label Safety run-in|Adverse Event|0|||
48845139|NCT00999167|157274305|FG002|Part A: Open Label Safety run-in|Adverse Event|0|||
48845140|NCT00999167|157274303|FG000|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0|||
48845141|NCT00999167|157274304|FG001|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19|||
48845142|NCT00999167|157274305|FG002|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16|||
48845143|NCT00999167|157274303|FG000|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0|||
48845144|NCT00999167|157274304|FG001|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7|||
48845145|NCT00999167|157274305|FG002|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4|||
48845146|NCT00999167|157274303|FG000|Part B: Randomized, Placebo Controlled|Adverse Event|0|||
48845147|NCT00999167|157274304|FG001|Part B: Randomized, Placebo Controlled|Adverse Event|6|||
48845148|NCT00999167|157274305|FG002|Part B: Randomized, Placebo Controlled|Adverse Event|1|||
48845149|NCT00999167|157274303|FG000|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
48845150|NCT00999167|157274304|FG001|Part B: Randomized, Placebo Controlled|Noncompliance|1|||
48845151|NCT00999167|157274305|FG002|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
48845152|NCT00999167|157274303|FG000|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
48845153|NCT00999167|157274304|FG001|Part B: Randomized, Placebo Controlled|Physician Decision|1|||
48845154|NCT00999167|157274305|FG002|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
48845155|NCT00999167|157274303|FG000|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
48845156|NCT00999167|157274304|FG001|Part B: Randomized, Placebo Controlled|Physician stopped drug|1|||
48845157|NCT00999167|157274305|FG002|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
48845158|NCT03733119|157274306|FG000|Overall Study|Physician Decision|2|||
48845159|NCT03733119|157274307|FG001|Overall Study|Physician Decision|1|||
48845160|NCT03733119|157274306|FG000|Overall Study|ineligible to treat per protocol|0|||
48845161|NCT03733119|157274307|FG001|Overall Study|ineligible to treat per protocol|1|||
48845162|NCT02789020|157274314|FG000|Overall Study|Withdrawal by Subject|6|||
48845163|NCT02789020|157274315|FG001|Overall Study|Withdrawal by Subject|5|||
48845164|NCT03338816|157274316|FG000|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
48845165|NCT03338816|157274317|FG001|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
48845166|NCT03338816|157274318|FG002|6-Month DB + Open-Label Extension Period|Adverse Event|2|||
48845167|NCT03338816|157274319|FG003|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
48845168|NCT03338816|157274316|FG000|6-Month DB + Open-Label Extension Period|Death|0|||
48845169|NCT03338816|157274317|FG001|6-Month DB + Open-Label Extension Period|Death|0|||
48845170|NCT03338816|157274318|FG002|6-Month DB + Open-Label Extension Period|Death|0|||
48845171|NCT03338816|157274319|FG003|6-Month DB + Open-Label Extension Period|Death|1|||
48845172|NCT03338816|157274316|FG000|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
48845173|NCT03338816|157274317|FG001|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
48845174|NCT03338816|157274318|FG002|6-Month DB + Open-Label Extension Period|Lost to Follow-up|1|||
48845175|NCT03338816|157274319|FG003|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
48845176|NCT03338816|157274316|FG000|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
48845177|NCT03338816|157274317|FG001|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
48845178|NCT03338816|157274318|FG002|6-Month DB + Open-Label Extension Period|Physician Decision|1|||
48845179|NCT03338816|157274319|FG003|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
48845180|NCT03338816|157274316|FG000|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
48845181|NCT03338816|157274317|FG001|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
48845182|NCT03338816|157274318|FG002|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
48845183|NCT03338816|157274319|FG003|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
48845184|NCT03338816|157274316|FG000|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
48845185|NCT03338816|157274317|FG001|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
48845186|NCT03338816|157274318|FG002|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
48845187|NCT03338816|157274319|FG003|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
48845188|NCT03338816|157274316|FG000|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
48845189|NCT03338816|157274317|FG001|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
48845190|NCT03338816|157274318|FG002|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
48845191|NCT03338816|157274319|FG003|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|1|||
48845192|NCT06103188|157274322|FG000|Overall Study|Lost to Follow-up|1|||
48845193|NCT06103188|157274323|FG001|Overall Study|Lost to Follow-up|6|||
48845194|NCT06103188|157274324|FG002|Overall Study|Lost to Follow-up|4|||
48845195|NCT05246670|157274325|FG000|Overall Study|Withdrawal by Subject|2|||
48845196|NCT05246670|157274326|FG001|Overall Study|Withdrawal by Subject|3|||
48845197|NCT05246670|157274327|FG002|Overall Study|Withdrawal by Subject|0|||
48845198|NCT05246670|157274328|FG003|Overall Study|Withdrawal by Subject|1|||
48845199|NCT05246670|157274325|FG000|Overall Study|Adverse Event|0|||
48845200|NCT05246670|157274326|FG001|Overall Study|Adverse Event|0|||
48845201|NCT05246670|157274327|FG002|Overall Study|Adverse Event|1|||
48931975|NCT03653390|157582028|FG000|Overall Study|Death|1|||
48931976|NCT03653390|157582029|FG001|Overall Study|Death|0|||
48931977|NCT03653390|157582030|FG002|Overall Study|Death|0|||
48931978|NCT03653390|157582028|FG000|Overall Study|Paper Survey Lost|1|||
48845202|NCT05246670|157274328|FG003|Overall Study|Adverse Event|0|||
48845203|NCT05246670|157274325|FG000|Overall Study|Physician Decision|1|||
48845204|NCT05246670|157274326|FG001|Overall Study|Physician Decision|0|||
48845205|NCT05246670|157274327|FG002|Overall Study|Physician Decision|0|||
48845206|NCT05246670|157274328|FG003|Overall Study|Physician Decision|0|||
48845207|NCT05246670|157274325|FG000|Overall Study|Protocol Violation|1|||
48845208|NCT05246670|157274326|FG001|Overall Study|Protocol Violation|0|||
48845209|NCT05246670|157274327|FG002|Overall Study|Protocol Violation|0|||
48845210|NCT05246670|157274328|FG003|Overall Study|Protocol Violation|0|||
48845211|NCT04093752|157274329|FG000|Overall Study|Adverse Event|7|||
48845212|NCT04093752|157274330|FG001|Overall Study|Adverse Event|19|||
48845213|NCT04093752|157274331|FG002|Overall Study|Adverse Event|18|||
48845214|NCT04093752|157274332|FG003|Overall Study|Adverse Event|4|||
48845215|NCT04093752|157274329|FG000|Overall Study|Withdrawal by Subject|6|||
48845216|NCT04093752|157274330|FG001|Overall Study|Withdrawal by Subject|6|||
48845217|NCT04093752|157274331|FG002|Overall Study|Withdrawal by Subject|8|||
48845218|NCT04093752|157274332|FG003|Overall Study|Withdrawal by Subject|20|||
48845219|NCT04093752|157274329|FG000|Overall Study|Lost to Follow-up|2|||
48845220|NCT04093752|157274330|FG001|Overall Study|Lost to Follow-up|1|||
48845221|NCT04093752|157274331|FG002|Overall Study|Lost to Follow-up|1|||
48845222|NCT04093752|157274332|FG003|Overall Study|Lost to Follow-up|1|||
48845223|NCT04093752|157274329|FG000|Overall Study|Death|0|||
48845224|NCT04093752|157274330|FG001|Overall Study|Death|0|||
48845225|NCT04093752|157274331|FG002|Overall Study|Death|1|||
48845226|NCT04093752|157274332|FG003|Overall Study|Death|2|||
48845227|NCT04093752|157274329|FG000|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
48931979|NCT03653390|157582029|FG001|Overall Study|Paper Survey Lost|0|||
48931980|NCT03653390|157582030|FG002|Overall Study|Paper Survey Lost|0|||
48931981|NCT02690194|157582031|FG000|Overall Study|Withdrawal by Subject|1|||
48931982|NCT02690194|157582032|FG001|Overall Study|Withdrawal by Subject|4|||
48931983|NCT02690194|157582033|FG002|Overall Study|Withdrawal by Subject|0|||
48931984|NCT03075163|157582036|FG000|Overall Study|not eligible for treatment limb|138|||
48931985|NCT03075163|157582037|FG001|Overall Study|not eligible for treatment limb|138|||
48931986|NCT03882424|157582038|FG000|Overall Study|Lost to Follow-up|3|||
48931987|NCT03882424|157582039|FG001|Overall Study|Lost to Follow-up|0|||
48931988|NCT03882424|157582040|FG002|Overall Study|Lost to Follow-up|0|||
48931989|NCT03882424|157582038|FG000|Overall Study|schedule conflict|1|||
48931990|NCT03882424|157582039|FG001|Overall Study|schedule conflict|0|||
48931991|NCT03882424|157582040|FG002|Overall Study|schedule conflict|0|||
48931992|NCT01451645|157582043|FG000|Overall Study|Protocol Violation|1|||
48931993|NCT01451645|157582044|FG001|Overall Study|Protocol Violation|0|||
48931994|NCT01451645|157582043|FG000|Overall Study|Adverse Event|0|||
48931995|NCT01451645|157582044|FG001|Overall Study|Adverse Event|3|||
48931996|NCT01451645|157582043|FG000|Overall Study|Withdrawal by Subject|4|||
48931997|NCT01451645|157582044|FG001|Overall Study|Withdrawal by Subject|2|||
48931998|NCT01451645|157582043|FG000|Overall Study|Lost to Follow-up|4|||
48931999|NCT01451645|157582044|FG001|Overall Study|Lost to Follow-up|3|||
48932000|NCT01795547|157582046|FG000|Overall Study|Adverse Event|16|||
48932001|NCT01795547|157582047|FG001|Overall Study|Adverse Event|27|||
48932002|NCT01795547|157582046|FG000|Overall Study|Lack of Efficacy|8|||
48845228|NCT04093752|157274330|FG001|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
48845229|NCT04093752|157274331|FG002|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
48932003|NCT01795547|157582047|FG001|Overall Study|Lack of Efficacy|3|||
48932004|NCT01795547|157582046|FG000|Overall Study|Protocol Violation|6|||
48845230|NCT04093752|157274332|FG003|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
48845231|NCT04093752|157274329|FG000|Overall Study|Covid 19|0|||
48932005|NCT01795547|157582047|FG001|Overall Study|Protocol Violation|4|||
48932006|NCT01795547|157582046|FG000|Overall Study|Lost to Follow-up|2|||
48932007|NCT01795547|157582047|FG001|Overall Study|Lost to Follow-up|5|||
48932008|NCT01795547|157582046|FG000|Overall Study|Withdrawal of consent|7|||
48932009|NCT01795547|157582047|FG001|Overall Study|Withdrawal of consent|12|||
48932010|NCT01795547|157582046|FG000|Overall Study|Not Treated|4|||
48932011|NCT01795547|157582047|FG001|Overall Study|Not Treated|10|||
48932012|NCT01795547|157582046|FG000|Overall Study|Non-compliance with IMP|1|||
48932013|NCT01795547|157582047|FG001|Overall Study|Non-compliance with IMP|1|||
48932014|NCT01795547|157582046|FG000|Overall Study|Others|4|||
48932015|NCT01795547|157582047|FG001|Overall Study|Others|1|||
48932016|NCT01795547|157582046|FG000|Overall Study|Not stated|0|||
48932017|NCT01795547|157582047|FG001|Overall Study|Not stated|1|||
48932018|NCT03430986|157582048|FG000|24-week Control Period|Adverse Event|1|||
48932019|NCT03430986|157582049|FG001|24-week Control Period|Adverse Event|0|||
48932020|NCT03430986|157582048|FG000|24-week Control Period|Lost to Follow-up|2|||
48932021|NCT03430986|157582049|FG001|24-week Control Period|Lost to Follow-up|2|||
48932022|NCT03430986|157582048|FG000|24-week Control Period|Withdrawal by Participant|5|||
48932023|NCT03430986|157582049|FG001|24-week Control Period|Withdrawal by Participant|0|||
48932024|NCT03430986|157582048|FG000|24-week Control Period|Protocol Deviation|0|||
48932025|NCT03430986|157582049|FG001|24-week Control Period|Protocol Deviation|2|||
48932026|NCT03430986|157582048|FG000|24-week Post-Control Period|Lost to Follow-up|1|||
48932027|NCT03430986|157582049|FG001|24-week Post-Control Period|Lost to Follow-up|1|||
48932028|NCT03430986|157582048|FG000|24-week Post-Control Period|Withdrawal by Participant|0|||
48932029|NCT03430986|157582049|FG001|24-week Post-Control Period|Withdrawal by Participant|1|||
48932030|NCT02116621|157582052|FG000|Baseline|Withdrawal by Subject|0|||
48932031|NCT02116621|157582053|FG001|Baseline|Withdrawal by Subject|4|||
48932032|NCT02116621|157582052|FG000|Three Month Follow-up|Death|1|||
48932033|NCT02116621|157582053|FG001|Three Month Follow-up|Death|1|||
48932034|NCT02116621|157582052|FG000|Three Month Follow-up|Withdrawal by Subject|4|||
48932035|NCT02116621|157582053|FG001|Three Month Follow-up|Withdrawal by Subject|1|||
48932036|NCT02116621|157582052|FG000|Three Month Follow-up|Lost to Follow-up|0|||
48932037|NCT02116621|157582053|FG001|Three Month Follow-up|Lost to Follow-up|1|||
48932038|NCT02116621|157582052|FG000|Three Month Follow-up|Did not complete follow-up survey|14|||
48932039|NCT02116621|157582053|FG001|Three Month Follow-up|Did not complete follow-up survey|4|||
48932040|NCT02116621|157582052|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
48932041|NCT02116621|157582053|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
48932042|NCT02116621|157582052|FG000|Six Month Follow-up|Lost to Follow-up|2|||
48932043|NCT02116621|157582053|FG001|Six Month Follow-up|Lost to Follow-up|1|||
48932044|NCT02116621|157582052|FG000|Six Month Follow-up|Did not complete follow-up survey|1|||
48932045|NCT02116621|157582053|FG001|Six Month Follow-up|Did not complete follow-up survey|1|||
48932046|NCT02116621|157582052|FG000|Twelve Month Follow-up|Withdrawal by Subject|1|||
48932047|NCT02116621|157582053|FG001|Twelve Month Follow-up|Withdrawal by Subject|0|||
48932048|NCT02116621|157582052|FG000|Twelve Month Follow-up|Lost to Follow-up|0|||
48932049|NCT02116621|157582053|FG001|Twelve Month Follow-up|Lost to Follow-up|1|||
48932050|NCT02116621|157582052|FG000|Twelve Month Follow-up|Did not complete follow-up survey|1|||
48932051|NCT02116621|157582053|FG001|Twelve Month Follow-up|Did not complete follow-up survey|3|||
48932052|NCT02116621|157582052|FG000|Twelve Month Follow-up|Enrolled within 12 months of study end|14|||
48932053|NCT02116621|157582053|FG001|Twelve Month Follow-up|Enrolled within 12 months of study end|8|||
48932054|NCT01412957|157582054|FG000|Overall Study|Withdrawal by Subject|6|||
48932055|NCT01412957|157582055|FG001|Overall Study|Withdrawal by Subject|22|||
48932056|NCT01412957|157582054|FG000|Overall Study|Lost to Follow-up|7|||
48932057|NCT01412957|157582055|FG001|Overall Study|Lost to Follow-up|2|||
48932058|NCT01412957|157582054|FG000|Overall Study|Death|136|||
48932059|NCT01412957|157582055|FG001|Overall Study|Death|133|||
48932060|NCT01275222|157582058|FG000|Phase l by Treatment|Adverse Event|1|||
48932061|NCT01275222|157582059|FG001|Phase l by Treatment|Adverse Event|4|||
48932062|NCT01275222|157582060|FG002|Phase l by Treatment|Adverse Event|2|||
48932063|NCT01275222|157582061|FG003|Phase l by Treatment|Adverse Event|3|||
48932064|NCT01275222|157582062|FG004|Phase l by Treatment|Adverse Event|0|||
48932065|NCT01275222|157582063|FG005|Phase l by Treatment|Adverse Event|0|||
48932066|NCT01275222|157582058|FG000|Phase l by Treatment|Abnormal laboratory value(s)|0|||
48932067|NCT01275222|157582059|FG001|Phase l by Treatment|Abnormal laboratory value(s)|0|||
48932068|NCT01275222|157582060|FG002|Phase l by Treatment|Abnormal laboratory value(s)|1|||
48932069|NCT01275222|157582061|FG003|Phase l by Treatment|Abnormal laboratory value(s)|0|||
48932070|NCT01275222|157582062|FG004|Phase l by Treatment|Abnormal laboratory value(s)|0|||
48932071|NCT01275222|157582063|FG005|Phase l by Treatment|Abnormal laboratory value(s)|0|||
48932072|NCT01275222|157582058|FG000|Phase l by Treatment|Abnormal test procedure result(s)|0|||
48932073|NCT01275222|157582059|FG001|Phase l by Treatment|Abnormal test procedure result(s)|0|||
48932074|NCT01275222|157582060|FG002|Phase l by Treatment|Abnormal test procedure result(s)|0|||
48932075|NCT01275222|157582061|FG003|Phase l by Treatment|Abnormal test procedure result(s)|1|||
48932076|NCT01275222|157582062|FG004|Phase l by Treatment|Abnormal test procedure result(s)|0|||
48932077|NCT01275222|157582063|FG005|Phase l by Treatment|Abnormal test procedure result(s)|0|||
48932078|NCT01275222|157582058|FG000|Phase l by Treatment|Disease progression|12|||
48932079|NCT01275222|157582059|FG001|Phase l by Treatment|Disease progression|8|||
48932080|NCT01275222|157582060|FG002|Phase l by Treatment|Disease progression|2|||
48932081|NCT01275222|157582061|FG003|Phase l by Treatment|Disease progression|5|||
48932082|NCT01275222|157582062|FG004|Phase l by Treatment|Disease progression|0|||
48932083|NCT01275222|157582063|FG005|Phase l by Treatment|Disease progression|0|||
48932084|NCT01275222|157582058|FG000|Phase l by Treatment|Withdrawal by Subject|0|||
48932085|NCT01275222|157582059|FG001|Phase l by Treatment|Withdrawal by Subject|0|||
48845232|NCT04093752|157274330|FG001|Overall Study|Covid 19|0|||
48845233|NCT04093752|157274331|FG002|Overall Study|Covid 19|0|||
48845234|NCT04093752|157274332|FG003|Overall Study|Covid 19|1|||
48845235|NCT04093752|157274329|FG000|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
48845236|NCT04093752|157274330|FG001|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
48845237|NCT04093752|157274331|FG002|Overall Study|Participant Thought there were Too Many Adverse Events|1|||
48845238|NCT04093752|157274332|FG003|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
48845239|NCT04093752|157274329|FG000|Overall Study|Participant was Reluctant to Follow-up|1|||
48845240|NCT04093752|157274330|FG001|Overall Study|Participant was Reluctant to Follow-up|0|||
48845241|NCT04093752|157274331|FG002|Overall Study|Participant was Reluctant to Follow-up|0|||
48845242|NCT04093752|157274332|FG003|Overall Study|Participant was Reluctant to Follow-up|0|||
48845243|NCT04093752|157274329|FG000|Overall Study|Participant Did Not Come for the Visit|1|||
48845244|NCT04093752|157274330|FG001|Overall Study|Participant Did Not Come for the Visit|0|||
48845245|NCT04093752|157274331|FG002|Overall Study|Participant Did Not Come for the Visit|0|||
48845246|NCT04093752|157274332|FG003|Overall Study|Participant Did Not Come for the Visit|0|||
48845247|NCT02140645|157274335|FG000|Overall Study|Not linked|5489|||
48845248|NCT02140645|157274336|FG001|Overall Study|Not linked|61654|||
48845249|NCT02140645|157274337|FG002|Overall Study|Not linked|4236|||
48845250|NCT02140645|157274338|FG003|Overall Study|Not linked|13833|||
48845251|NCT02140645|157274339|FG004|Overall Study|Not linked|3286|||
48845252|NCT02140645|157274340|FG005|Overall Study|Not linked|70896|||
48932086|NCT01275222|157582060|FG002|Phase l by Treatment|Withdrawal by Subject|0|||
48932087|NCT01275222|157582061|FG003|Phase l by Treatment|Withdrawal by Subject|1|||
48932088|NCT01275222|157582062|FG004|Phase l by Treatment|Withdrawal by Subject|0|||
48932089|NCT01275222|157582063|FG005|Phase l by Treatment|Withdrawal by Subject|0|||
48932090|NCT01275222|157582058|FG000|Phase l by Treatment|Death|0|||
48932091|NCT01275222|157582059|FG001|Phase l by Treatment|Death|1|||
48932092|NCT01275222|157582060|FG002|Phase l by Treatment|Death|0|||
48932093|NCT01275222|157582061|FG003|Phase l by Treatment|Death|1|||
48932094|NCT01275222|157582062|FG004|Phase l by Treatment|Death|0|||
48932095|NCT01275222|157582063|FG005|Phase l by Treatment|Death|0|||
48932096|NCT01275222|157582058|FG000|Phase ll by Stratum|Adverse Event|0|||
48932097|NCT01275222|157582059|FG001|Phase ll by Stratum|Adverse Event|0|||
48932098|NCT01275222|157582060|FG002|Phase ll by Stratum|Adverse Event|0|||
48932099|NCT01275222|157582061|FG003|Phase ll by Stratum|Adverse Event|0|||
48932100|NCT01275222|157582062|FG004|Phase ll by Stratum|Adverse Event|2|||
48932101|NCT01275222|157582063|FG005|Phase ll by Stratum|Adverse Event|10|||
48932102|NCT01275222|157582058|FG000|Phase ll by Stratum|Abnormal laboratory values|0|||
48932103|NCT01275222|157582059|FG001|Phase ll by Stratum|Abnormal laboratory values|0|||
48932104|NCT01275222|157582060|FG002|Phase ll by Stratum|Abnormal laboratory values|0|||
48932105|NCT01275222|157582061|FG003|Phase ll by Stratum|Abnormal laboratory values|0|||
48932106|NCT01275222|157582062|FG004|Phase ll by Stratum|Abnormal laboratory values|0|||
48932107|NCT01275222|157582063|FG005|Phase ll by Stratum|Abnormal laboratory values|1|||
48932108|NCT01275222|157582058|FG000|Phase ll by Stratum|Disease progression|0|||
48932109|NCT01275222|157582059|FG001|Phase ll by Stratum|Disease progression|0|||
48932110|NCT01275222|157582060|FG002|Phase ll by Stratum|Disease progression|0|||
48932111|NCT01275222|157582061|FG003|Phase ll by Stratum|Disease progression|0|||
48845253|NCT03014453|157274342|FG000|Overall Study|Lost to Follow-up|12|||
48845254|NCT03014453|157274342|FG000|Overall Study|Discontinued GER|3|||
48845255|NCT03014453|157274342|FG000|Overall Study|Excluded|19|||
48845256|NCT03014453|157274342|FG000|Overall Study|Refused to take part in|37|||
48845257|NCT02814838|157274343|FG000|Overall Study|3 agreed dates for the final visit missed|1|||
48845258|NCT02814838|157274344|FG001|Overall Study|3 agreed dates for the final visit missed|0|||
48845259|NCT02814838|157274343|FG000|Overall Study|Consent withdrawal|1|||
48932112|NCT01275222|157582062|FG004|Phase ll by Stratum|Disease progression|23|||
48932113|NCT01275222|157582063|FG005|Phase ll by Stratum|Disease progression|31|||
48932114|NCT01275222|157582058|FG000|Phase ll by Stratum|Withdrawal by Subject|0|||
48932115|NCT01275222|157582059|FG001|Phase ll by Stratum|Withdrawal by Subject|0|||
48932116|NCT01275222|157582060|FG002|Phase ll by Stratum|Withdrawal by Subject|0|||
48932117|NCT01275222|157582061|FG003|Phase ll by Stratum|Withdrawal by Subject|0|||
48932118|NCT01275222|157582062|FG004|Phase ll by Stratum|Withdrawal by Subject|2|||
48845260|NCT02814838|157274344|FG001|Overall Study|Consent withdrawal|1|||
48845261|NCT03432858|157274345|FG000|Overall Study|Protocol Violation|2|||
48845262|NCT03432858|157274346|FG001|Overall Study|Protocol Violation|1|||
48845263|NCT03432858|157274347|FG002|Overall Study|Protocol Violation|9|||
48845264|NCT03432858|157274345|FG000|Overall Study|Withdrawal by Subject|0|||
48932119|NCT01275222|157582063|FG005|Phase ll by Stratum|Withdrawal by Subject|3|||
48932120|NCT01275222|157582058|FG000|Phase ll by Stratum|Death|0|||
48932121|NCT01275222|157582059|FG001|Phase ll by Stratum|Death|0|||
48932122|NCT01275222|157582060|FG002|Phase ll by Stratum|Death|0|||
48932123|NCT01275222|157582061|FG003|Phase ll by Stratum|Death|0|||
48932124|NCT01275222|157582062|FG004|Phase ll by Stratum|Death|1|||
48932125|NCT01275222|157582063|FG005|Phase ll by Stratum|Death|1|||
48932126|NCT00490542|157582064|FG000|Overall Study|Lost to Follow-up|3|||
48932127|NCT00490542|157582065|FG001|Overall Study|Lost to Follow-up|0|||
48932128|NCT00490542|157582064|FG000|Overall Study|Adverse Event|3|||
48932129|NCT00490542|157582065|FG001|Overall Study|Adverse Event|3|||
48932130|NCT00490542|157582064|FG000|Overall Study|Lack of Efficacy|1|||
48932131|NCT00490542|157582065|FG001|Overall Study|Lack of Efficacy|1|||
48932132|NCT01813890|157582068|FG000|Overall Study|Adverse Event|0|||
48932133|NCT01813890|157582069|FG001|Overall Study|Adverse Event|3|||
48932134|NCT01813890|157582070|FG002|Overall Study|Adverse Event|4|||
48932135|NCT01813890|157582068|FG000|Overall Study|Lack of Efficacy|9|||
48932136|NCT01813890|157582069|FG001|Overall Study|Lack of Efficacy|1|||
48932137|NCT01813890|157582070|FG002|Overall Study|Lack of Efficacy|2|||
48932138|NCT01870739|157582073|FG000|Single Drug Treatment (12 Weeks)|Protocol deviation|0|||
48932139|NCT01870739|157582074|FG001|Single Drug Treatment (12 Weeks)|Protocol deviation|1|||
48932140|NCT01870739|157582073|FG000|Single Drug Treatment (12 Weeks)|Adverse Event|0|||
48932141|NCT01870739|157582074|FG001|Single Drug Treatment (12 Weeks)|Adverse Event|1|||
48932142|NCT01870739|157582073|FG000|Single Drug Treatment (12 Weeks)|Administrative problems|3|||
48932143|NCT01870739|157582074|FG001|Single Drug Treatment (12 Weeks)|Administrative problems|2|||
48932144|NCT01870739|157582073|FG000|Add-on Period (40 Weeks)|Adverse Event|0|||
48932145|NCT01870739|157582074|FG001|Add-on Period (40 Weeks)|Adverse Event|1|||
48932146|NCT01870739|157582073|FG000|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1|||
48932147|NCT01870739|157582074|FG001|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0|||
48932148|NCT01870739|157582073|FG000|Add-on Period (40 Weeks)|Protocol deviation|1|||
48932149|NCT01870739|157582074|FG001|Add-on Period (40 Weeks)|Protocol deviation|1|||
48932150|NCT01870739|157582073|FG000|Add-on Period (40 Weeks)|Patient withdrew consent|1|||
48932151|NCT01870739|157582074|FG001|Add-on Period (40 Weeks)|Patient withdrew consent|0|||
48845265|NCT03432858|157274346|FG001|Overall Study|Withdrawal by Subject|1|||
48845266|NCT03432858|157274347|FG002|Overall Study|Withdrawal by Subject|1|||
48845267|NCT03432858|157274345|FG000|Overall Study|Procedure canceled/rescheduled|0|||
48845268|NCT03432858|157274346|FG001|Overall Study|Procedure canceled/rescheduled|9|||
48845269|NCT03432858|157274347|FG002|Overall Study|Procedure canceled/rescheduled|6|||
48845270|NCT03432858|157274345|FG000|Overall Study|Required postop mobilization with splinting|0|||
48845271|NCT03432858|157274346|FG001|Overall Study|Required postop mobilization with splinting|0|||
48845272|NCT03432858|157274347|FG002|Overall Study|Required postop mobilization with splinting|1|||
48845273|NCT03939312|157274348|FG000|OL Treatment Period (40 Weeks)|Withdrawal Criteria at Visit 1|43|||
48845274|NCT03939312|157274348|FG000|OL Treatment Period (40 Weeks)|Adverse Event|25|||
48845275|NCT03939312|157274348|FG000|OL Treatment Period (40 Weeks)|Lack of Efficacy|4|||
48845276|NCT03939312|157274348|FG000|OL Treatment Period (40 Weeks)|Withdrawal by Subject|35|||
48845277|NCT03939312|157274348|FG000|OL Treatment Period (40 Weeks)|Lost to Follow-up|19|||
48845278|NCT03939312|157274348|FG000|OL Treatment Period (40 Weeks)|Pregnancy|3|||
48845279|NCT03939312|157274348|FG000|OL Treatment Period (40 Weeks)|Protocol Deviation|16|||
48845280|NCT03939312|157274348|FG000|OL Treatment Period (40 Weeks)|Non-compliance With Study Drug|4|||
48845281|NCT03939312|157274348|FG000|OL Treatment Period (40 Weeks)|Site Terminated by Sponsor|3|||
48845282|NCT03939312|157274348|FG000|OL Treatment Period (40 Weeks)|Reason Not Specified|22|||
48845283|NCT03939312|157274348|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Withdrawal by Subject|12|||
48845284|NCT03939312|157274348|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Lost to Follow-up|4|||
48845285|NCT01184326|157276612|FG000|Overall Study|Adverse Event|1|||
48845286|NCT01184326|157276613|FG001|Overall Study|Adverse Event|2|||
48845287|NCT01184326|157276614|FG002|Overall Study|Adverse Event|0|||
48845288|NCT01184326|157276612|FG000|Overall Study|Death|0|||
48845289|NCT01184326|157276613|FG001|Overall Study|Death|0|||
48845290|NCT01184326|157276614|FG002|Overall Study|Death|1|||
48845291|NCT01184326|157276612|FG000|Overall Study|Withdrawal by Subject|0|||
48845292|NCT01184326|157276613|FG001|Overall Study|Withdrawal by Subject|0|||
48845293|NCT01184326|157276614|FG002|Overall Study|Withdrawal by Subject|1|||
48845294|NCT01184326|157276612|FG000|Overall Study|Physician Decision|1|||
48845295|NCT01184326|157276613|FG001|Overall Study|Physician Decision|1|||
48845296|NCT01184326|157276614|FG002|Overall Study|Physician Decision|0|||
48845297|NCT01184326|157276612|FG000|Overall Study|Disease Progression|1|||
48845298|NCT01184326|157276613|FG001|Overall Study|Disease Progression|3|||
48845299|NCT01184326|157276614|FG002|Overall Study|Disease Progression|12|||
48845300|NCT01534494|157276617|FG000|Overall Study|Withdrawal by Subject|1|||
48845301|NCT00431834|157276618|FG000|Overall Study|Withdrawal by Subject|7|||
48845302|NCT00431834|157276618|FG000|Overall Study|Death|3|||
48845303|NCT00431834|157276618|FG000|Overall Study|Missed Endpoint Visit|2|||
48845304|NCT00431834|157276618|FG000|Overall Study|Lost to Follow-up|1|||
48845305|NCT01471691|157276619|FG000|Overall Study|Lack of Efficacy|0|||
48845306|NCT01471691|157276620|FG001|Overall Study|Lack of Efficacy|1|||
48845307|NCT02622568|157276628|FG000|Overall Study|Lost to Follow-up|5|||
48845308|NCT02622568|157276629|FG001|Overall Study|Lost to Follow-up|5|||
48845309|NCT01185561|157276630|FG000|Overall Study|Lost to Follow-up|0|||
48845310|NCT01185561|157276631|FG001|Overall Study|Lost to Follow-up|4|||
48932152|NCT03538743|157582075|FG000|Overall Study|Adverse Event|0|||
48845311|NCT01185561|157276630|FG000|Overall Study|Withdrawal by Subject|2|||
48845312|NCT01185561|157276631|FG001|Overall Study|Withdrawal by Subject|8|||
48845313|NCT02461628|157276632|FG000|Overall Study|Refused to complete survey|4|||
48845314|NCT02461628|157276633|FG001|Overall Study|Refused to complete survey|7|||
48845315|NCT02058108|157276635|FG000|Overall Study|Abnormal Laboratory Values|0|||
48845316|NCT02058108|157276636|FG001|Overall Study|Abnormal Laboratory Values|1|||
48845317|NCT02058108|157276635|FG000|Overall Study|Unsatisfactory therapeutic effect|37|||
48845318|NCT02058108|157276636|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
48845319|NCT02058108|157276635|FG000|Overall Study|No longer requires study drug|0|||
48845320|NCT02058108|157276636|FG001|Overall Study|No longer requires study drug|1|||
48845321|NCT02058108|157276635|FG000|Overall Study|Withdrawal by Subject|1|||
48845322|NCT02058108|157276636|FG001|Overall Study|Withdrawal by Subject|0|||
48845323|NCT02058108|157276635|FG000|Overall Study|Administrative problems|3|||
48845324|NCT02058108|157276636|FG001|Overall Study|Administrative problems|3|||
48845325|NCT02058108|157276635|FG000|Overall Study|Protocol Violation|0|||
48845326|NCT02058108|157276636|FG001|Overall Study|Protocol Violation|1|||
48845327|NCT00106080|157276642|FG000|Overall Study|Withdrew/Loss to follow-up|43|||
48845328|NCT00106080|157276643|FG001|Overall Study|Withdrew/Loss to follow-up|27|||
48845329|NCT02590432|157276645|FG000|Open-label Treatment Period|Adverse Event|97|||
48845330|NCT02590432|157276646|FG001|Open-label Treatment Period|Adverse Event|79|||
48845331|NCT02590432|157276647|FG002|Open-label Treatment Period|Adverse Event|0|||
48845332|NCT02590432|157276648|FG003|Open-label Treatment Period|Adverse Event|0|||
48845333|NCT02590432|157276649|FG004|Open-label Treatment Period|Adverse Event|0|||
48845334|NCT02590432|157276650|FG005|Open-label Treatment Period|Adverse Event|0|||
48845335|NCT02590432|157276651|FG006|Open-label Treatment Period|Adverse Event|0|||
48932153|NCT03538743|157582076|FG001|Overall Study|Adverse Event|0|||
48932154|NCT03538743|157582077|FG002|Overall Study|Adverse Event|1|||
48932155|NCT03538743|157582078|FG003|Overall Study|Adverse Event|1|||
48932156|NCT03538743|157582079|FG004|Overall Study|Adverse Event|0|||
48932157|NCT03538743|157582080|FG005|Overall Study|Adverse Event|0|||
48932158|NCT03538743|157582081|FG006|Overall Study|Adverse Event|0|||
48932159|NCT03538743|157582082|FG007|Overall Study|Adverse Event|0|||
48932160|NCT03538743|157582083|FG008|Overall Study|Adverse Event|0|||
48932161|NCT03538743|157582075|FG000|Overall Study|Non-Treatment-Related Reasons|0|||
48932162|NCT03538743|157582076|FG001|Overall Study|Non-Treatment-Related Reasons|0|||
48932163|NCT03538743|157582077|FG002|Overall Study|Non-Treatment-Related Reasons|0|||
48932164|NCT03538743|157582078|FG003|Overall Study|Non-Treatment-Related Reasons|0|||
48932165|NCT03538743|157582079|FG004|Overall Study|Non-Treatment-Related Reasons|0|||
48932166|NCT03538743|157582080|FG005|Overall Study|Non-Treatment-Related Reasons|0|||
48932167|NCT03538743|157582081|FG006|Overall Study|Non-Treatment-Related Reasons|0|||
48932168|NCT03538743|157582082|FG007|Overall Study|Non-Treatment-Related Reasons|0|||
48932169|NCT03538743|157582083|FG008|Overall Study|Non-Treatment-Related Reasons|3|||
48932170|NCT03538743|157582075|FG000|Overall Study|Withdrawal by Subject|0|||
48932171|NCT03538743|157582076|FG001|Overall Study|Withdrawal by Subject|0|||
48932172|NCT03538743|157582077|FG002|Overall Study|Withdrawal by Subject|0|||
48932173|NCT03538743|157582078|FG003|Overall Study|Withdrawal by Subject|1|||
48845336|NCT02590432|157276652|FG007|Open-label Treatment Period|Adverse Event|0|||
48845337|NCT02590432|157276653|FG008|Open-label Treatment Period|Adverse Event|0|||
48845338|NCT02590432|157276645|FG000|Open-label Treatment Period|Lack of Efficacy|14|||
48845339|NCT02590432|157276646|FG001|Open-label Treatment Period|Lack of Efficacy|5|||
48932174|NCT03538743|157582079|FG004|Overall Study|Withdrawal by Subject|0|||
48932175|NCT03538743|157582080|FG005|Overall Study|Withdrawal by Subject|0|||
48932176|NCT03538743|157582081|FG006|Overall Study|Withdrawal by Subject|0|||
48932177|NCT03538743|157582082|FG007|Overall Study|Withdrawal by Subject|0|||
48845340|NCT02590432|157276647|FG002|Open-label Treatment Period|Lack of Efficacy|0|||
48845341|NCT02590432|157276648|FG003|Open-label Treatment Period|Lack of Efficacy|0|||
48845342|NCT02590432|157276649|FG004|Open-label Treatment Period|Lack of Efficacy|0|||
48845343|NCT02590432|157276650|FG005|Open-label Treatment Period|Lack of Efficacy|0|||
48845344|NCT02590432|157276651|FG006|Open-label Treatment Period|Lack of Efficacy|0|||
48845345|NCT02590432|157276652|FG007|Open-label Treatment Period|Lack of Efficacy|0|||
48845346|NCT02590432|157276653|FG008|Open-label Treatment Period|Lack of Efficacy|0|||
48845347|NCT02590432|157276645|FG000|Open-label Treatment Period|Withdrawal of Consent|43|||
48845348|NCT02590432|157276646|FG001|Open-label Treatment Period|Withdrawal of Consent|28|||
48845349|NCT02590432|157276647|FG002|Open-label Treatment Period|Withdrawal of Consent|0|||
48845350|NCT02590432|157276648|FG003|Open-label Treatment Period|Withdrawal of Consent|0|||
48845351|NCT02590432|157276649|FG004|Open-label Treatment Period|Withdrawal of Consent|0|||
48845352|NCT02590432|157276650|FG005|Open-label Treatment Period|Withdrawal of Consent|0|||
48845353|NCT02590432|157276651|FG006|Open-label Treatment Period|Withdrawal of Consent|0|||
48845354|NCT02590432|157276652|FG007|Open-label Treatment Period|Withdrawal of Consent|0|||
48932178|NCT03538743|157582083|FG008|Overall Study|Withdrawal by Subject|0|||
48932179|NCT04640766|157582084|FG000|Overall Study|Withdrawn for inconsistency with visits and change in current medication|2|||
48932180|NCT01565980|157582086|FG000|Overall Study|Death|1|||
48932181|NCT01565980|157582087|FG001|Overall Study|Death|0|||
48932182|NCT01565980|157582086|FG000|Overall Study|Lost to Follow-up|1|||
48932183|NCT01565980|157582087|FG001|Overall Study|Lost to Follow-up|0|||
48932184|NCT01565980|157582086|FG000|Overall Study|health complications|1|||
48932185|NCT01565980|157582087|FG001|Overall Study|health complications|1|||
48932186|NCT01565980|157582086|FG000|Overall Study|stopped medical treatment|1|||
48932187|NCT01565980|157582087|FG001|Overall Study|stopped medical treatment|0|||
48932188|NCT01565980|157582086|FG000|Overall Study|Withdrawal by Subject|0|||
48932189|NCT01565980|157582087|FG001|Overall Study|Withdrawal by Subject|3|||
48932190|NCT02078219|157582089|FG000|Overall Study|Other|2|||
48932191|NCT02078219|157582090|FG001|Overall Study|Other|2|||
48932192|NCT02078219|157582091|FG002|Overall Study|Other|3|||
48932193|NCT02078219|157582092|FG003|Overall Study|Other|0|||
48932194|NCT02078219|157582093|FG004|Overall Study|Other|1|||
48932195|NCT02078219|157582089|FG000|Overall Study|Withdrawal by Subject|0|||
48932196|NCT02078219|157582090|FG001|Overall Study|Withdrawal by Subject|1|||
48932197|NCT02078219|157582091|FG002|Overall Study|Withdrawal by Subject|0|||
48932198|NCT02078219|157582092|FG003|Overall Study|Withdrawal by Subject|1|||
48932199|NCT02078219|157582093|FG004|Overall Study|Withdrawal by Subject|1|||
48932200|NCT02078219|157582089|FG000|Overall Study|Protocol Violation|0|||
48932201|NCT02078219|157582090|FG001|Overall Study|Protocol Violation|0|||
48932202|NCT02078219|157582091|FG002|Overall Study|Protocol Violation|0|||
48932203|NCT02078219|157582092|FG003|Overall Study|Protocol Violation|1|||
48932204|NCT02078219|157582093|FG004|Overall Study|Protocol Violation|0|||
48932205|NCT02078219|157582089|FG000|Overall Study|Death|0|||
48932206|NCT02078219|157582090|FG001|Overall Study|Death|0|||
48932207|NCT02078219|157582091|FG002|Overall Study|Death|0|||
48932208|NCT02078219|157582092|FG003|Overall Study|Death|1|||
48932209|NCT02078219|157582093|FG004|Overall Study|Death|0|||
48932210|NCT02078219|157582089|FG000|Overall Study|Adverse Event|1|||
48932211|NCT02078219|157582090|FG001|Overall Study|Adverse Event|1|||
48932212|NCT02078219|157582091|FG002|Overall Study|Adverse Event|3|||
48932213|NCT02078219|157582092|FG003|Overall Study|Adverse Event|1|||
48932214|NCT02078219|157582093|FG004|Overall Study|Adverse Event|0|||
48932215|NCT02382133|157582097|FG000|Overall Study|Death|22|||
48932216|NCT02382133|157582097|FG000|Overall Study|transfer out of ICU|4|||
48932217|NCT02382133|157582097|FG000|Overall Study|Physician Decision|2|||
48932218|NCT02382133|157582097|FG000|Overall Study|arterial catheter loss|4|||
48932219|NCT02382133|157582097|FG000|Overall Study|pressure injury both sites|1|||
48932220|NCT00275561|157582098|FG000|Overall Study|Withdrawal by Subject|0|||
48932221|NCT00275561|157582099|FG001|Overall Study|Withdrawal by Subject|1|||
48932222|NCT00275561|157582098|FG000|Overall Study|Travel|1|||
48932223|NCT00275561|157582099|FG001|Overall Study|Travel|1|||
48932224|NCT00275561|157582098|FG000|Overall Study|Scheduling|1|||
48932225|NCT00275561|157582099|FG001|Overall Study|Scheduling|2|||
48845355|NCT02590432|157276653|FG008|Open-label Treatment Period|Withdrawal of Consent|0|||
48845356|NCT02590432|157276645|FG000|Open-label Treatment Period|Lost to Follow-up|51|||
48845357|NCT02590432|157276646|FG001|Open-label Treatment Period|Lost to Follow-up|29|||
48932226|NCT00275561|157582098|FG000|Overall Study|Family Issues|0|||
48932227|NCT00275561|157582099|FG001|Overall Study|Family Issues|2|||
48932228|NCT02404103|157584359|FG000|Overall Study|Adverse Event|1|||
48932229|NCT02404103|157584360|FG001|Overall Study|Adverse Event|0|||
48932230|NCT02404103|157584359|FG000|Overall Study|Lost to Follow-up|3|||
48932231|NCT02404103|157584360|FG001|Overall Study|Lost to Follow-up|3|||
48932232|NCT00542997|157584363|FG000|Wash in / Wash Out Period|Withdrawal by Subject|2|||
48932233|NCT00542997|157584363|FG000|Wash in / Wash Out Period|Adverse Event|3|||
48932234|NCT00542997|157584363|FG000|Efficacy Period|Adverse Event|3|||
48932235|NCT01662440|157584364|FG000|Overall Study|Adverse Event|1|||
48932236|NCT01662440|157584365|FG001|Overall Study|Adverse Event|0|||
48932237|NCT01662440|157584366|FG002|Overall Study|Adverse Event|0|||
48845358|NCT02590432|157276647|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
48932238|NCT01662440|157584367|FG003|Overall Study|Adverse Event|1|||
48932239|NCT01662440|157584364|FG000|Overall Study|Death|0|||
48932240|NCT01662440|157584365|FG001|Overall Study|Death|1|||
48932241|NCT01662440|157584366|FG002|Overall Study|Death|0|||
48932242|NCT01662440|157584367|FG003|Overall Study|Death|0|||
48932243|NCT01662440|157584364|FG000|Overall Study|Lost to Follow-up|2|||
48845359|NCT02590432|157276648|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
48845360|NCT02590432|157276649|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
48845361|NCT02590432|157276650|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
48845362|NCT02590432|157276651|FG006|Open-label Treatment Period|Lost to Follow-up|0|||
48845363|NCT02590432|157276652|FG007|Open-label Treatment Period|Lost to Follow-up|0|||
48845364|NCT02590432|157276653|FG008|Open-label Treatment Period|Lost to Follow-up|0|||
48845365|NCT02590432|157276645|FG000|Open-label Treatment Period|Protocol Violation|10|||
48845366|NCT02590432|157276646|FG001|Open-label Treatment Period|Protocol Violation|4|||
48845367|NCT02590432|157276647|FG002|Open-label Treatment Period|Protocol Violation|0|||
48845368|NCT02590432|157276648|FG003|Open-label Treatment Period|Protocol Violation|0|||
48845369|NCT02590432|157276649|FG004|Open-label Treatment Period|Protocol Violation|0|||
48845370|NCT02590432|157276650|FG005|Open-label Treatment Period|Protocol Violation|0|||
48845371|NCT02590432|157276651|FG006|Open-label Treatment Period|Protocol Violation|0|||
48932244|NCT01662440|157584365|FG001|Overall Study|Lost to Follow-up|2|||
48932245|NCT01662440|157584366|FG002|Overall Study|Lost to Follow-up|4|||
48932246|NCT01662440|157584367|FG003|Overall Study|Lost to Follow-up|1|||
48845372|NCT02590432|157276652|FG007|Open-label Treatment Period|Protocol Violation|0|||
48932247|NCT01662440|157584364|FG000|Overall Study|Subject moved to another country.|0|||
48845373|NCT02590432|157276653|FG008|Open-label Treatment Period|Protocol Violation|0|||
48845374|NCT02590432|157276645|FG000|Open-label Treatment Period|Non-compliance with Study Drug|7|||
48845375|NCT02590432|157276646|FG001|Open-label Treatment Period|Non-compliance with Study Drug|1|||
48845376|NCT02590432|157276647|FG002|Open-label Treatment Period|Non-compliance with Study Drug|0|||
48845377|NCT02590432|157276648|FG003|Open-label Treatment Period|Non-compliance with Study Drug|0|||
48845378|NCT02590432|157276649|FG004|Open-label Treatment Period|Non-compliance with Study Drug|0|||
48845379|NCT02590432|157276650|FG005|Open-label Treatment Period|Non-compliance with Study Drug|0|||
48845380|NCT02590432|157276651|FG006|Open-label Treatment Period|Non-compliance with Study Drug|0|||
48845381|NCT02590432|157276652|FG007|Open-label Treatment Period|Non-compliance with Study Drug|0|||
48845382|NCT02590432|157276653|FG008|Open-label Treatment Period|Non-compliance with Study Drug|0|||
48845383|NCT02590432|157276645|FG000|Open-label Treatment Period|Other Miscellaneous Reasons|10|||
48845384|NCT02590432|157276646|FG001|Open-label Treatment Period|Other Miscellaneous Reasons|6|||
48845385|NCT02590432|157276647|FG002|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
48845386|NCT02590432|157276648|FG003|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
48845387|NCT02590432|157276649|FG004|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
48845388|NCT02590432|157276650|FG005|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
48845389|NCT02590432|157276651|FG006|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
48845390|NCT02590432|157276652|FG007|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
48845391|NCT02590432|157276653|FG008|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
48845392|NCT02590432|157276645|FG000|Double-blind Treatment Period|Adverse Event|0|||
48845393|NCT02590432|157276646|FG001|Double-blind Treatment Period|Adverse Event|0|||
48845394|NCT02590432|157276647|FG002|Double-blind Treatment Period|Adverse Event|14|||
48932248|NCT01662440|157584365|FG001|Overall Study|Subject moved to another country.|1|||
48932249|NCT01662440|157584366|FG002|Overall Study|Subject moved to another country.|0|||
48932250|NCT01662440|157584367|FG003|Overall Study|Subject moved to another country.|0|||
48932251|NCT01662440|157584364|FG000|Overall Study|Protocol Violation|1|||
48932252|NCT01662440|157584365|FG001|Overall Study|Protocol Violation|0|||
48932253|NCT01662440|157584366|FG002|Overall Study|Protocol Violation|0|||
48932254|NCT01662440|157584367|FG003|Overall Study|Protocol Violation|0|||
48932255|NCT01662440|157584364|FG000|Overall Study|Withdrawal by Subject|5|||
48932256|NCT01662440|157584365|FG001|Overall Study|Withdrawal by Subject|2|||
48932257|NCT01662440|157584366|FG002|Overall Study|Withdrawal by Subject|2|||
48932258|NCT01662440|157584367|FG003|Overall Study|Withdrawal by Subject|2|||
48932259|NCT01602341|157584370|FG000|Overall Study|Adverse Event|0|||
48932260|NCT01602341|157584371|FG001|Overall Study|Adverse Event|1|||
48932261|NCT02152345|157584372|FG000|Overall Study|Case Cancellations|2|||
48932262|NCT02152345|157584373|FG001|Overall Study|Case Cancellations|4|||
48932263|NCT02152345|157584372|FG000|Overall Study|Withdrawal by Subject|2|||
48932264|NCT02152345|157584373|FG001|Overall Study|Withdrawal by Subject|1|||
48932265|NCT03064763|157584376|FG000|Overall Study|Lost to Follow-up|1|||
48845395|NCT02590432|157276648|FG003|Double-blind Treatment Period|Adverse Event|12|||
48845396|NCT02590432|157276649|FG004|Double-blind Treatment Period|Adverse Event|6|||
48845397|NCT02590432|157276650|FG005|Double-blind Treatment Period|Adverse Event|22|||
48845398|NCT02590432|157276651|FG006|Double-blind Treatment Period|Adverse Event|20|||
48845399|NCT02590432|157276652|FG007|Double-blind Treatment Period|Adverse Event|0|||
48845400|NCT02590432|157276653|FG008|Double-blind Treatment Period|Adverse Event|0|||
48845401|NCT02590432|157276645|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
48845402|NCT02590432|157276646|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
48845403|NCT02590432|157276647|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
48845404|NCT02590432|157276648|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
48845405|NCT02590432|157276649|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
48845406|NCT02590432|157276650|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
48845407|NCT02590432|157276651|FG006|Double-blind Treatment Period|Lack of Efficacy|0|||
48845408|NCT02590432|157276652|FG007|Double-blind Treatment Period|Lack of Efficacy|0|||
48845409|NCT02590432|157276653|FG008|Double-blind Treatment Period|Lack of Efficacy|0|||
48845410|NCT02590432|157276645|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
48845411|NCT02590432|157276646|FG001|Double-blind Treatment Period|Withdrawal of Consent|0|||
48845412|NCT02590432|157276647|FG002|Double-blind Treatment Period|Withdrawal of Consent|1|||
48845413|NCT02590432|157276648|FG003|Double-blind Treatment Period|Withdrawal of Consent|3|||
48845414|NCT02590432|157276649|FG004|Double-blind Treatment Period|Withdrawal of Consent|3|||
48845415|NCT02590432|157276650|FG005|Double-blind Treatment Period|Withdrawal of Consent|1|||
48845416|NCT02590432|157276651|FG006|Double-blind Treatment Period|Withdrawal of Consent|1|||
48845417|NCT02590432|157276652|FG007|Double-blind Treatment Period|Withdrawal of Consent|0|||
48845418|NCT02590432|157276653|FG008|Double-blind Treatment Period|Withdrawal of Consent|0|||
48845419|NCT02590432|157276645|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
48845420|NCT02590432|157276646|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
48845421|NCT02590432|157276647|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
48845422|NCT02590432|157276648|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
48845423|NCT02590432|157276649|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
48845424|NCT02590432|157276650|FG005|Double-blind Treatment Period|Lost to Follow-up|2|||
48845425|NCT02590432|157276651|FG006|Double-blind Treatment Period|Lost to Follow-up|0|||
48932266|NCT03064763|157584376|FG000|Overall Study|Death|8|||
48932267|NCT01790503|157584378|FG000|Overall Study|Adverse Event|1|||
48932268|NCT01790503|157584379|FG001|Overall Study|Adverse Event|0|||
48932269|NCT01790503|157584380|FG002|Overall Study|Adverse Event|0|||
48932270|NCT01790503|157584381|FG003|Overall Study|Adverse Event|0|||
48932271|NCT01790503|157584382|FG004|Overall Study|Adverse Event|0|||
48932272|NCT01790503|157584383|FG005|Overall Study|Adverse Event|2|||
48932273|NCT01790503|157584384|FG006|Overall Study|Adverse Event|0|||
48932274|NCT01790503|157584385|FG007|Overall Study|Adverse Event|0|||
48932275|NCT01790503|157584386|FG008|Overall Study|Adverse Event|2|||
48932276|NCT01790503|157584387|FG009|Overall Study|Adverse Event|4|||
48932277|NCT01790503|157584388|FG010|Overall Study|Adverse Event|7|||
48932278|NCT01790503|157584378|FG000|Overall Study|Withdrawal by Subject|0|||
48932279|NCT01790503|157584379|FG001|Overall Study|Withdrawal by Subject|0|||
48932280|NCT01790503|157584380|FG002|Overall Study|Withdrawal by Subject|1|||
48932281|NCT01790503|157584381|FG003|Overall Study|Withdrawal by Subject|1|||
48932282|NCT01790503|157584382|FG004|Overall Study|Withdrawal by Subject|1|||
48932283|NCT01790503|157584383|FG005|Overall Study|Withdrawal by Subject|2|||
48932284|NCT01790503|157584384|FG006|Overall Study|Withdrawal by Subject|1|||
48932285|NCT01790503|157584385|FG007|Overall Study|Withdrawal by Subject|0|||
48932286|NCT01790503|157584386|FG008|Overall Study|Withdrawal by Subject|0|||
48932287|NCT01790503|157584387|FG009|Overall Study|Withdrawal by Subject|0|||
48932288|NCT01790503|157584388|FG010|Overall Study|Withdrawal by Subject|1|||
48932289|NCT01790503|157584378|FG000|Overall Study|Disease progression|2|||
48932290|NCT01790503|157584379|FG001|Overall Study|Disease progression|1|||
48932291|NCT01790503|157584380|FG002|Overall Study|Disease progression|0|||
48932292|NCT01790503|157584381|FG003|Overall Study|Disease progression|1|||
48932293|NCT01790503|157584382|FG004|Overall Study|Disease progression|2|||
48932294|NCT01790503|157584383|FG005|Overall Study|Disease progression|1|||
48932295|NCT01790503|157584384|FG006|Overall Study|Disease progression|0|||
48932296|NCT01790503|157584385|FG007|Overall Study|Disease progression|1|||
48932297|NCT01790503|157584386|FG008|Overall Study|Disease progression|0|||
48932298|NCT01790503|157584387|FG009|Overall Study|Disease progression|17|||
48932299|NCT01790503|157584388|FG010|Overall Study|Disease progression|7|||
48932300|NCT01790503|157584378|FG000|Overall Study|Protocol Violation|0|||
48932301|NCT01790503|157584379|FG001|Overall Study|Protocol Violation|0|||
48932302|NCT01790503|157584380|FG002|Overall Study|Protocol Violation|0|||
48932303|NCT01790503|157584381|FG003|Overall Study|Protocol Violation|0|||
48932304|NCT01790503|157584382|FG004|Overall Study|Protocol Violation|0|||
48932305|NCT01790503|157584383|FG005|Overall Study|Protocol Violation|0|||
48932306|NCT01790503|157584384|FG006|Overall Study|Protocol Violation|0|||
48932307|NCT01790503|157584385|FG007|Overall Study|Protocol Violation|0|||
48932308|NCT01790503|157584386|FG008|Overall Study|Protocol Violation|0|||
48932309|NCT01790503|157584387|FG009|Overall Study|Protocol Violation|1|||
48932310|NCT01790503|157584388|FG010|Overall Study|Protocol Violation|0|||
48932311|NCT01790503|157584378|FG000|Overall Study|Physician Decision|0|||
48932312|NCT01790503|157584379|FG001|Overall Study|Physician Decision|0|||
48932313|NCT01790503|157584380|FG002|Overall Study|Physician Decision|0|||
48932314|NCT01790503|157584381|FG003|Overall Study|Physician Decision|0|||
48932315|NCT01790503|157584382|FG004|Overall Study|Physician Decision|0|||
48932316|NCT01790503|157584383|FG005|Overall Study|Physician Decision|0|||
48932317|NCT01790503|157584384|FG006|Overall Study|Physician Decision|0|||
48932318|NCT01790503|157584385|FG007|Overall Study|Physician Decision|0|||
48932319|NCT01790503|157584386|FG008|Overall Study|Physician Decision|0|||
48932320|NCT01790503|157584387|FG009|Overall Study|Physician Decision|1|||
48932321|NCT01790503|157584388|FG010|Overall Study|Physician Decision|1|||
48932322|NCT01790503|157584378|FG000|Overall Study|Death|0|||
48932323|NCT01790503|157584379|FG001|Overall Study|Death|0|||
48932324|NCT01790503|157584380|FG002|Overall Study|Death|0|||
48932325|NCT01790503|157584381|FG003|Overall Study|Death|0|||
48932326|NCT01790503|157584382|FG004|Overall Study|Death|0|||
48932327|NCT01790503|157584383|FG005|Overall Study|Death|0|||
48932328|NCT01790503|157584384|FG006|Overall Study|Death|0|||
48932329|NCT01790503|157584385|FG007|Overall Study|Death|0|||
48932330|NCT01790503|157584386|FG008|Overall Study|Death|0|||
48932331|NCT01790503|157584387|FG009|Overall Study|Death|1|||
48932332|NCT01790503|157584388|FG010|Overall Study|Death|0|||
48932333|NCT01790503|157584378|FG000|Overall Study|Non Compliance|0|||
48932334|NCT01790503|157584379|FG001|Overall Study|Non Compliance|0|||
48932335|NCT01790503|157584380|FG002|Overall Study|Non Compliance|0|||
48932336|NCT01790503|157584381|FG003|Overall Study|Non Compliance|0|||
48932337|NCT01790503|157584382|FG004|Overall Study|Non Compliance|1|||
48932338|NCT01790503|157584383|FG005|Overall Study|Non Compliance|0|||
48932339|NCT01790503|157584384|FG006|Overall Study|Non Compliance|0|||
48932340|NCT01790503|157584385|FG007|Overall Study|Non Compliance|0|||
48932341|NCT01790503|157584386|FG008|Overall Study|Non Compliance|0|||
48932342|NCT01790503|157584387|FG009|Overall Study|Non Compliance|0|||
48932343|NCT01790503|157584388|FG010|Overall Study|Non Compliance|0|||
48932344|NCT01790503|157584378|FG000|Overall Study|Other|0|||
48932345|NCT01790503|157584379|FG001|Overall Study|Other|0|||
48932346|NCT01790503|157584380|FG002|Overall Study|Other|0|||
48932347|NCT01790503|157584381|FG003|Overall Study|Other|0|||
48932348|NCT01790503|157584382|FG004|Overall Study|Other|1|||
48932349|NCT01790503|157584383|FG005|Overall Study|Other|0|||
48932350|NCT01790503|157584384|FG006|Overall Study|Other|0|||
48932351|NCT01790503|157584385|FG007|Overall Study|Other|0|||
48932352|NCT01790503|157584386|FG008|Overall Study|Other|1|||
48932353|NCT01790503|157584387|FG009|Overall Study|Other|2|||
48932354|NCT01790503|157584388|FG010|Overall Study|Other|0|||
48932355|NCT01583179|157584389|FG000|Overall Study|Screen failure|1|||
48932356|NCT01583179|157584390|FG001|Overall Study|Screen failure|2|||
48932357|NCT01934140|157584397|FG000|Persistence Phase (Year 6-10)|Other|24|||
48932358|NCT01934140|157584398|FG001|Persistence Phase (Year 6-10)|Other|6|||
48932359|NCT01934140|157584397|FG000|Persistence Phase (Year 6-10)|Lost to Follow-up|5|||
48932360|NCT01934140|157584398|FG001|Persistence Phase (Year 6-10)|Lost to Follow-up|2|||
48932361|NCT01934140|157584397|FG000|Persistence Phase (Year 6-10)|Migrated/moved from study area|31|||
48932362|NCT01934140|157584398|FG001|Persistence Phase (Year 6-10)|Migrated/moved from study area|10|||
48932363|NCT01934140|157584397|FG000|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2|||
48932364|NCT01934140|157584398|FG001|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0|||
48932365|NCT01934140|157584397|FG000|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21|||
48932366|NCT01934140|157584398|FG001|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7|||
48932367|NCT01934140|157584397|FG000|Booster Phase (6 Months)|Lost to Follow-up|1|||
48932368|NCT01934140|157584398|FG001|Booster Phase (6 Months)|Lost to Follow-up|0|||
48932369|NCT01934140|157584397|FG000|Booster Phase (6 Months)|Missed at least 1 booster visit|2|||
48932370|NCT01934140|157584398|FG001|Booster Phase (6 Months)|Missed at least 1 booster visit|1|||
48932371|NCT01934140|157584397|FG000|Booster Phase (6 Months)|Migrated/moved from study area|2|||
48932372|NCT01934140|157584398|FG001|Booster Phase (6 Months)|Migrated/moved from study area|2|||
48932373|NCT04167345|157584399|FG000|Overall Study|Other|1|||
48932374|NCT04167345|157584400|FG001|Overall Study|Other|1|||
48932375|NCT04167345|157584401|FG002|Overall Study|Other|0|||
48932376|NCT04167345|157584402|FG003|Overall Study|Other|0|||
48932377|NCT04167345|157584403|FG004|Overall Study|Other|0|||
48932378|NCT01461044|157584404|FG000|Overall Study|Death|58|||
48932379|NCT01461044|157584405|FG001|Overall Study|Death|35|||
48932380|NCT01461044|157584404|FG000|Overall Study|Lost to Follow-up|12|||
48932381|NCT01461044|157584405|FG001|Overall Study|Lost to Follow-up|5|||
48932382|NCT00669617|157584406|FG000|Period 1|Withdrawal by Subject|0|||
48932383|NCT00669617|157584407|FG001|Period 1|Withdrawal by Subject|0|||
48932384|NCT00669617|157584408|FG002|Period 1|Withdrawal by Subject|1|||
48932385|NCT00669617|157584409|FG003|Period 1|Withdrawal by Subject|0|||
48932386|NCT00669617|157584410|FG004|Period 1|Withdrawal by Subject|0|||
48932387|NCT00669617|157584406|FG000|Period 1|Protocol Deviation|0|||
48932388|NCT00669617|157584407|FG001|Period 1|Protocol Deviation|0|||
48932389|NCT00669617|157584408|FG002|Period 1|Protocol Deviation|0|||
48932390|NCT00669617|157584409|FG003|Period 1|Protocol Deviation|0|||
48932391|NCT00669617|157584410|FG004|Period 1|Protocol Deviation|1|||
48932392|NCT00669617|157584406|FG000|Period 3|Lost to Follow-up|1|||
48932393|NCT00669617|157584407|FG001|Period 3|Lost to Follow-up|0|||
48932394|NCT00669617|157584408|FG002|Period 3|Lost to Follow-up|0|||
48932395|NCT00669617|157584409|FG003|Period 3|Lost to Follow-up|0|||
48932396|NCT00669617|157584410|FG004|Period 3|Lost to Follow-up|0|||
48932397|NCT02397473|157584412|FG000|Treatment Phase|Adverse Event|1|||
48932398|NCT02397473|157584413|FG001|Treatment Phase|Adverse Event|2|||
48932399|NCT02397473|157584412|FG000|Treatment Phase|Lack of Efficacy|8|||
48932400|NCT02397473|157584413|FG001|Treatment Phase|Lack of Efficacy|1|||
48932401|NCT02397473|157584412|FG000|Treatment Phase|Lost to Follow-up|1|||
48932402|NCT02397473|157584413|FG001|Treatment Phase|Lost to Follow-up|0|||
48932403|NCT02397473|157584412|FG000|Treatment Phase|Withdrawal by Subject|2|||
48932404|NCT02397473|157584413|FG001|Treatment Phase|Withdrawal by Subject|1|||
48932405|NCT02397473|157584412|FG000|Treatment Phase|Protocol Violation(did not receive drug)|0|||
48845426|NCT02590432|157276652|FG007|Double-blind Treatment Period|Lost to Follow-up|0|||
48845427|NCT02590432|157276653|FG008|Double-blind Treatment Period|Lost to Follow-up|0|||
48845428|NCT02590432|157276645|FG000|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
48845429|NCT02590432|157276646|FG001|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
48845430|NCT02590432|157276647|FG002|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
48845431|NCT02590432|157276648|FG003|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
48845432|NCT02590432|157276649|FG004|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
48845433|NCT02590432|157276650|FG005|Double-blind Treatment Period|Non-compliance with Study Drug|1|||
48845434|NCT02590432|157276651|FG006|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
48845435|NCT02590432|157276652|FG007|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
48932406|NCT02397473|157584413|FG001|Treatment Phase|Protocol Violation(did not receive drug)|3|||
48932407|NCT02397473|157584412|FG000|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
48932408|NCT02397473|157584413|FG001|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
48932409|NCT02397473|157584412|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
48932410|NCT02397473|157584413|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
48932411|NCT02397473|157584412|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
48932412|NCT02397473|157584413|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
48932413|NCT02397473|157584412|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
48932414|NCT02397473|157584413|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
48932415|NCT02009878|157584414|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
48932416|NCT02009878|157584415|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
48932417|NCT02009878|157584416|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
48932418|NCT00440726|157584417|FG000|Phase 1|Dose-Limiting Toxicity|0|||
48932419|NCT00440726|157584418|FG001|Phase 1|Dose-Limiting Toxicity|1|||
48932420|NCT00440726|157584419|FG002|Phase 1|Dose-Limiting Toxicity|0|||
48932421|NCT00440726|157584417|FG000|Phase 1|Physician Decision|1|||
48932422|NCT00440726|157584418|FG001|Phase 1|Physician Decision|0|||
48932423|NCT00440726|157584419|FG002|Phase 1|Physician Decision|0|||
48932424|NCT00440726|157584417|FG000|Phase 2|Death|0|||
48932425|NCT00440726|157584418|FG001|Phase 2|Death|0|||
48932426|NCT00440726|157584419|FG002|Phase 2|Death|1|||
48932427|NCT00440726|157584417|FG000|Phase 2|Adverse Event|0|||
48932428|NCT00440726|157584418|FG001|Phase 2|Adverse Event|0|||
48932429|NCT00440726|157584419|FG002|Phase 2|Adverse Event|1|||
48932430|NCT01482910|157584420|FG000|Overall Study|Adverse Event|6|||
48932431|NCT01482910|157584421|FG001|Overall Study|Adverse Event|5|||
48932432|NCT01482910|157584420|FG000|Overall Study|Lost to Follow-up|0|||
48932433|NCT01482910|157584421|FG001|Overall Study|Lost to Follow-up|1|||
48845436|NCT02590432|157276653|FG008|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
48845437|NCT02590432|157276645|FG000|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
48845438|NCT02590432|157276646|FG001|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
48845439|NCT02590432|157276647|FG002|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
48845440|NCT02590432|157276648|FG003|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
48845441|NCT02590432|157276649|FG004|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
48845442|NCT02590432|157276650|FG005|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
48845443|NCT02590432|157276651|FG006|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
48845444|NCT02590432|157276652|FG007|Dose-reduced Open Label Treatment Period|Adverse Event|12|||
48845445|NCT02590432|157276653|FG008|Dose-reduced Open Label Treatment Period|Adverse Event|15|||
48845446|NCT02590432|157276645|FG000|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
48845447|NCT02590432|157276646|FG001|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
48845448|NCT02590432|157276647|FG002|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
48845449|NCT02590432|157276648|FG003|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
48845450|NCT02590432|157276649|FG004|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
48845451|NCT02590432|157276650|FG005|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
48845452|NCT02590432|157276651|FG006|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
48845453|NCT02590432|157276652|FG007|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1|||
48845454|NCT02590432|157276653|FG008|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
48845455|NCT02590432|157276645|FG000|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
48845456|NCT02590432|157276646|FG001|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
48845457|NCT02590432|157276647|FG002|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
48845458|NCT02590432|157276648|FG003|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
48845459|NCT02590432|157276649|FG004|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
48845460|NCT02590432|157276650|FG005|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
48845461|NCT02590432|157276651|FG006|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
48845462|NCT02590432|157276652|FG007|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3|||
48845463|NCT02590432|157276653|FG008|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1|||
48845464|NCT02590432|157276645|FG000|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
48845465|NCT02590432|157276646|FG001|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
48845466|NCT02590432|157276647|FG002|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
48845467|NCT02590432|157276648|FG003|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
48845468|NCT02590432|157276649|FG004|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
48845469|NCT02590432|157276650|FG005|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
48845470|NCT02590432|157276651|FG006|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
48845471|NCT02590432|157276652|FG007|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
48845472|NCT02590432|157276653|FG008|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1|||
48845473|NCT02590432|157276645|FG000|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
48845474|NCT02590432|157276646|FG001|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
48845475|NCT02590432|157276647|FG002|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
48845476|NCT02590432|157276648|FG003|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
48845477|NCT02590432|157276649|FG004|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
48845478|NCT02590432|157276650|FG005|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
48845479|NCT02590432|157276651|FG006|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
48845480|NCT02590432|157276652|FG007|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
48845481|NCT02590432|157276653|FG008|Dose-reduced Open Label Treatment Period|Protocol Violation|1|||
48845482|NCT02590432|157276645|FG000|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
48932434|NCT01482910|157584420|FG000|Overall Study|Protocol Violation|1|||
48932435|NCT01482910|157584421|FG001|Overall Study|Protocol Violation|1|||
48932436|NCT01482910|157584420|FG000|Overall Study|Withdrawal by Subject|7|||
48932437|NCT01482910|157584421|FG001|Overall Study|Withdrawal by Subject|2|||
48932438|NCT01482910|157584420|FG000|Overall Study|Death|1|||
48932439|NCT01482910|157584421|FG001|Overall Study|Death|0|||
48845483|NCT02590432|157276646|FG001|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
48932440|NCT04428411|157584423|FG000|Overall Study|Lost to Follow-up|114|||
48932441|NCT01163786|157584424|FG000|Treatment With Bortezomib|Withdrawal by Subject|1|||
48932442|NCT01163786|157584424|FG000|Treatment With Bortezomib|Adverse Event|2|||
48932443|NCT01163786|157584424|FG000|Completed Follow up (Visit 9 and 10)|Other|1|||
48845484|NCT02590432|157276647|FG002|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
48845485|NCT02590432|157276648|FG003|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
48845486|NCT02590432|157276649|FG004|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
48845487|NCT02590432|157276650|FG005|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
48845488|NCT02590432|157276651|FG006|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
48845489|NCT02590432|157276652|FG007|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1|||
48845490|NCT02590432|157276653|FG008|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
48845491|NCT02590432|157276645|FG000|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
48845492|NCT02590432|157276646|FG001|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
48845493|NCT02590432|157276647|FG002|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
48845494|NCT02590432|157276648|FG003|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
48845495|NCT02590432|157276649|FG004|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
48845496|NCT02590432|157276650|FG005|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
48845497|NCT02590432|157276651|FG006|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
48845498|NCT02590432|157276652|FG007|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1|||
48845499|NCT02590432|157276653|FG008|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
48845500|NCT03451721|157276655|FG000|Overall Study|Death|1|||
48845501|NCT02538900|157276658|FG000|Overall Study|Death|2|||
48845502|NCT02538900|157276659|FG001|Overall Study|Death|2|||
48845503|NCT02538900|157276660|FG002|Overall Study|Death|2|||
48845504|NCT02538900|157276658|FG000|Overall Study|Withdrawal by Subject|18|||
48845505|NCT02538900|157276659|FG001|Overall Study|Withdrawal by Subject|16|||
48845506|NCT02538900|157276660|FG002|Overall Study|Withdrawal by Subject|15|||
48845507|NCT04110054|157276661|FG000|Overall Study|COVID-19 reason other than AE|0|||
48845508|NCT04110054|157276662|FG001|Overall Study|COVID-19 reason other than AE|0|||
48845509|NCT04110054|157276663|FG002|Overall Study|COVID-19 reason other than AE|2|||
48845510|NCT04110054|157276664|FG003|Overall Study|COVID-19 reason other than AE|0|||
48932444|NCT00132730|157584425|FG000|Period II - 12-week Treatment (Base)|Clinical adverse experience|11|||
48845511|NCT04110054|157276661|FG000|Overall Study|Withdrawal by Subject|0|||
48845512|NCT04110054|157276662|FG001|Overall Study|Withdrawal by Subject|3|||
48845513|NCT04110054|157276663|FG002|Overall Study|Withdrawal by Subject|2|||
48845514|NCT04110054|157276664|FG003|Overall Study|Withdrawal by Subject|0|||
48845515|NCT04110054|157276661|FG000|Overall Study|Adverse Event|1|||
48845516|NCT04110054|157276662|FG001|Overall Study|Adverse Event|1|||
48845517|NCT04110054|157276663|FG002|Overall Study|Adverse Event|4|||
48845518|NCT04110054|157276664|FG003|Overall Study|Adverse Event|3|||
48845519|NCT01998958|157276666|FG000|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48845520|NCT01998958|157276667|FG001|Period 1 (Panel A and B)|Withdrawal by Subject|1|||
48845521|NCT01998958|157276668|FG002|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48845522|NCT01998958|157276669|FG003|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48845523|NCT01998958|157276670|FG004|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48845524|NCT01998958|157276671|FG005|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48845525|NCT01998958|157276672|FG006|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48845526|NCT01998958|157276673|FG007|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48845527|NCT01998958|157276674|FG008|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48845528|NCT01998958|157276675|FG009|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48845529|NCT01998958|157276676|FG010|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48845530|NCT01998958|157276677|FG011|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48845531|NCT01998958|157276678|FG012|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48845532|NCT01998958|157276679|FG013|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48845533|NCT01998958|157276680|FG014|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48845534|NCT01998958|157276681|FG015|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48845535|NCT01998958|157276682|FG016|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48845536|NCT01998958|157276683|FG017|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48845537|NCT01998958|157276684|FG018|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48845538|NCT01998958|157276685|FG019|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48845539|NCT01998958|157276686|FG020|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48845540|NCT01998958|157276687|FG021|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48932445|NCT00132730|157584426|FG001|Period II - 12-week Treatment (Base)|Clinical adverse experience|4|||
48932446|NCT00132730|157584427|FG002|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
48932447|NCT00132730|157584428|FG003|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
48932448|NCT00132730|157584429|FG004|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
48932449|NCT00132730|157584430|FG005|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
48932450|NCT00132730|157584425|FG000|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
48932451|NCT00132730|157584426|FG001|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
48845541|NCT01998958|157276688|FG022|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48845542|NCT01998958|157276689|FG023|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48845543|NCT01998958|157276690|FG024|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48845544|NCT01998958|157276691|FG025|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48845545|NCT01998958|157276692|FG026|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48845546|NCT01998958|157276693|FG027|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48845547|NCT01998958|157276694|FG028|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48845548|NCT01998958|157276695|FG029|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48845549|NCT01998958|157276696|FG030|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48845550|NCT01998958|157276697|FG031|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48845551|NCT01998958|157276666|FG000|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48845552|NCT01998958|157276667|FG001|Period 1 (Panel A and B)|Lack of Efficacy|1|||
48845553|NCT01998958|157276668|FG002|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48845554|NCT01998958|157276669|FG003|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48845555|NCT01998958|157276670|FG004|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48845556|NCT01998958|157276671|FG005|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48845557|NCT01998958|157276672|FG006|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48845558|NCT01998958|157276673|FG007|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48845559|NCT01998958|157276674|FG008|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48845560|NCT01998958|157276675|FG009|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48845561|NCT01998958|157276676|FG010|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48845562|NCT01998958|157276677|FG011|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48845563|NCT01998958|157276678|FG012|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48845564|NCT01998958|157276679|FG013|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48845565|NCT01998958|157276680|FG014|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48845566|NCT01998958|157276681|FG015|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48845567|NCT01998958|157276682|FG016|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48845568|NCT01998958|157276683|FG017|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48845569|NCT01998958|157276684|FG018|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48845570|NCT01998958|157276685|FG019|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48845571|NCT01998958|157276686|FG020|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48845572|NCT01998958|157276687|FG021|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48845573|NCT01998958|157276688|FG022|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48845574|NCT01998958|157276689|FG023|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48845575|NCT01998958|157276690|FG024|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48845576|NCT01998958|157276691|FG025|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48845577|NCT01998958|157276692|FG026|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48845578|NCT01998958|157276693|FG027|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48845579|NCT01998958|157276694|FG028|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48845580|NCT01998958|157276695|FG029|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48845581|NCT01998958|157276696|FG030|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48845582|NCT01998958|157276697|FG031|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48845583|NCT01998958|157276666|FG000|Period 1 (Panel A and B)|Adverse Event|0|||
48845584|NCT01998958|157276667|FG001|Period 1 (Panel A and B)|Adverse Event|1|||
48845585|NCT01998958|157276668|FG002|Period 1 (Panel A and B)|Adverse Event|0|||
48845586|NCT01998958|157276669|FG003|Period 1 (Panel A and B)|Adverse Event|0|||
48845587|NCT01998958|157276670|FG004|Period 1 (Panel A and B)|Adverse Event|0|||
48845588|NCT01998958|157276671|FG005|Period 1 (Panel A and B)|Adverse Event|0|||
48845589|NCT01998958|157276672|FG006|Period 1 (Panel A and B)|Adverse Event|0|||
48845590|NCT01998958|157276673|FG007|Period 1 (Panel A and B)|Adverse Event|0|||
48845591|NCT01998958|157276674|FG008|Period 1 (Panel A and B)|Adverse Event|0|||
48845592|NCT01998958|157276675|FG009|Period 1 (Panel A and B)|Adverse Event|0|||
48845593|NCT01998958|157276676|FG010|Period 1 (Panel A and B)|Adverse Event|0|||
48845594|NCT01998958|157276677|FG011|Period 1 (Panel A and B)|Adverse Event|0|||
48845595|NCT01998958|157276678|FG012|Period 1 (Panel A and B)|Adverse Event|0|||
48845596|NCT01998958|157276679|FG013|Period 1 (Panel A and B)|Adverse Event|0|||
48845597|NCT01998958|157276680|FG014|Period 1 (Panel A and B)|Adverse Event|0|||
48845598|NCT01998958|157276681|FG015|Period 1 (Panel A and B)|Adverse Event|0|||
48845599|NCT01998958|157276682|FG016|Period 1 (Panel A and B)|Adverse Event|0|||
48845600|NCT01998958|157276683|FG017|Period 1 (Panel A and B)|Adverse Event|0|||
48845601|NCT01998958|157276684|FG018|Period 1 (Panel A and B)|Adverse Event|0|||
48845602|NCT01998958|157276685|FG019|Period 1 (Panel A and B)|Adverse Event|0|||
48845603|NCT01998958|157276686|FG020|Period 1 (Panel A and B)|Adverse Event|0|||
48845604|NCT01998958|157276687|FG021|Period 1 (Panel A and B)|Adverse Event|0|||
48845605|NCT01998958|157276688|FG022|Period 1 (Panel A and B)|Adverse Event|0|||
48845606|NCT01998958|157276689|FG023|Period 1 (Panel A and B)|Adverse Event|0|||
48845607|NCT01998958|157276690|FG024|Period 1 (Panel A and B)|Adverse Event|0|||
48845608|NCT01998958|157276691|FG025|Period 1 (Panel A and B)|Adverse Event|0|||
48845609|NCT01998958|157276692|FG026|Period 1 (Panel A and B)|Adverse Event|0|||
48845610|NCT01998958|157276693|FG027|Period 1 (Panel A and B)|Adverse Event|0|||
48845611|NCT01998958|157276694|FG028|Period 1 (Panel A and B)|Adverse Event|0|||
48845612|NCT01998958|157276695|FG029|Period 1 (Panel A and B)|Adverse Event|0|||
48845613|NCT01998958|157276696|FG030|Period 1 (Panel A and B)|Adverse Event|0|||
48845614|NCT01998958|157276697|FG031|Period 1 (Panel A and B)|Adverse Event|0|||
48845615|NCT01998958|157276666|FG000|Period 1 (Panel A and B)|Other|1|||
48845616|NCT01998958|157276667|FG001|Period 1 (Panel A and B)|Other|0|||
48845617|NCT01998958|157276668|FG002|Period 1 (Panel A and B)|Other|0|||
48845618|NCT01998958|157276669|FG003|Period 1 (Panel A and B)|Other|0|||
48845619|NCT01998958|157276670|FG004|Period 1 (Panel A and B)|Other|0|||
48845620|NCT01998958|157276671|FG005|Period 1 (Panel A and B)|Other|0|||
48845621|NCT01998958|157276672|FG006|Period 1 (Panel A and B)|Other|0|||
48845622|NCT01998958|157276673|FG007|Period 1 (Panel A and B)|Other|0|||
48845623|NCT01998958|157276674|FG008|Period 1 (Panel A and B)|Other|0|||
48845624|NCT01998958|157276675|FG009|Period 1 (Panel A and B)|Other|0|||
48845625|NCT01998958|157276676|FG010|Period 1 (Panel A and B)|Other|0|||
48845626|NCT01998958|157276677|FG011|Period 1 (Panel A and B)|Other|0|||
48845627|NCT01998958|157276678|FG012|Period 1 (Panel A and B)|Other|0|||
48845628|NCT01998958|157276679|FG013|Period 1 (Panel A and B)|Other|0|||
48845629|NCT01998958|157276680|FG014|Period 1 (Panel A and B)|Other|0|||
48845630|NCT01998958|157276681|FG015|Period 1 (Panel A and B)|Other|0|||
48845631|NCT01998958|157276682|FG016|Period 1 (Panel A and B)|Other|0|||
48845632|NCT01998958|157276683|FG017|Period 1 (Panel A and B)|Other|0|||
48845633|NCT01998958|157276684|FG018|Period 1 (Panel A and B)|Other|0|||
48845634|NCT01998958|157276685|FG019|Period 1 (Panel A and B)|Other|0|||
48845635|NCT01998958|157276686|FG020|Period 1 (Panel A and B)|Other|0|||
48845636|NCT01998958|157276687|FG021|Period 1 (Panel A and B)|Other|0|||
48845637|NCT01998958|157276688|FG022|Period 1 (Panel A and B)|Other|0|||
48845638|NCT01998958|157276689|FG023|Period 1 (Panel A and B)|Other|0|||
48845639|NCT01998958|157276690|FG024|Period 1 (Panel A and B)|Other|0|||
48845640|NCT01998958|157276691|FG025|Period 1 (Panel A and B)|Other|0|||
48845641|NCT01998958|157276692|FG026|Period 1 (Panel A and B)|Other|0|||
48845642|NCT01998958|157276693|FG027|Period 1 (Panel A and B)|Other|0|||
48845643|NCT01998958|157276694|FG028|Period 1 (Panel A and B)|Other|0|||
48845644|NCT01998958|157276695|FG029|Period 1 (Panel A and B)|Other|0|||
48845645|NCT01998958|157276696|FG030|Period 1 (Panel A and B)|Other|0|||
48845646|NCT01998958|157276697|FG031|Period 1 (Panel A and B)|Other|0|||
48845647|NCT01998958|157276666|FG000|Period 2 (Panel A and B)|Adverse Event|0|||
48845648|NCT01998958|157276667|FG001|Period 2 (Panel A and B)|Adverse Event|0|||
48845649|NCT01998958|157276668|FG002|Period 2 (Panel A and B)|Adverse Event|0|||
48845650|NCT01998958|157276669|FG003|Period 2 (Panel A and B)|Adverse Event|0|||
48845651|NCT01998958|157276670|FG004|Period 2 (Panel A and B)|Adverse Event|0|||
48845652|NCT01998958|157276671|FG005|Period 2 (Panel A and B)|Adverse Event|0|||
48845653|NCT01998958|157276672|FG006|Period 2 (Panel A and B)|Adverse Event|0|||
48845654|NCT01998958|157276673|FG007|Period 2 (Panel A and B)|Adverse Event|0|||
48845655|NCT01998958|157276674|FG008|Period 2 (Panel A and B)|Adverse Event|0|||
48845656|NCT01998958|157276675|FG009|Period 2 (Panel A and B)|Adverse Event|0|||
48845657|NCT01998958|157276676|FG010|Period 2 (Panel A and B)|Adverse Event|1|||
48845658|NCT01998958|157276677|FG011|Period 2 (Panel A and B)|Adverse Event|0|||
48932452|NCT00132730|157584427|FG002|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
48932453|NCT00132730|157584428|FG003|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
48932454|NCT00132730|157584429|FG004|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
48932455|NCT00132730|157584430|FG005|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
48932456|NCT00132730|157584425|FG000|Period II - 12-week Treatment (Base)|Other reasons|11|||
48932457|NCT00132730|157584426|FG001|Period II - 12-week Treatment (Base)|Other reasons|10|||
48932458|NCT00132730|157584427|FG002|Period II - 12-week Treatment (Base)|Other reasons|9|||
48932459|NCT00132730|157584428|FG003|Period II - 12-week Treatment (Base)|Other reasons|13|||
48932460|NCT00132730|157584429|FG004|Period II - 12-week Treatment (Base)|Other reasons|0|||
48932461|NCT00132730|157584430|FG005|Period II - 12-week Treatment (Base)|Other reasons|0|||
48932462|NCT00132730|157584425|FG000|Period III - Blinded Extension (EXT1)|Site terminated|0|||
48932463|NCT00132730|157584426|FG001|Period III - Blinded Extension (EXT1)|Site terminated|0|||
48932464|NCT00132730|157584427|FG002|Period III - Blinded Extension (EXT1)|Site terminated|57|||
48932465|NCT00132730|157584428|FG003|Period III - Blinded Extension (EXT1)|Site terminated|20|||
48932466|NCT00132730|157584429|FG004|Period III - Blinded Extension (EXT1)|Site terminated|0|||
48932467|NCT00132730|157584430|FG005|Period III - Blinded Extension (EXT1)|Site terminated|0|||
48932468|NCT00132730|157584425|FG000|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
48932469|NCT00132730|157584426|FG001|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
48932470|NCT00132730|157584427|FG002|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11|||
48932471|NCT00132730|157584428|FG003|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1|||
48932472|NCT00132730|157584429|FG004|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
48932473|NCT00132730|157584430|FG005|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
48932474|NCT00132730|157584425|FG000|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
48932475|NCT00132730|157584426|FG001|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
48932476|NCT00132730|157584427|FG002|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
48932477|NCT00132730|157584428|FG003|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1|||
48845659|NCT01998958|157276678|FG012|Period 2 (Panel A and B)|Adverse Event|0|||
48845660|NCT01998958|157276679|FG013|Period 2 (Panel A and B)|Adverse Event|0|||
48845661|NCT01998958|157276680|FG014|Period 2 (Panel A and B)|Adverse Event|1|||
48845662|NCT01998958|157276681|FG015|Period 2 (Panel A and B)|Adverse Event|0|||
48845663|NCT01998958|157276682|FG016|Period 2 (Panel A and B)|Adverse Event|0|||
48845664|NCT01998958|157276683|FG017|Period 2 (Panel A and B)|Adverse Event|0|||
48845665|NCT01998958|157276684|FG018|Period 2 (Panel A and B)|Adverse Event|0|||
48845666|NCT01998958|157276685|FG019|Period 2 (Panel A and B)|Adverse Event|0|||
48845667|NCT01998958|157276686|FG020|Period 2 (Panel A and B)|Adverse Event|0|||
48845668|NCT01998958|157276687|FG021|Period 2 (Panel A and B)|Adverse Event|0|||
48845669|NCT01998958|157276688|FG022|Period 2 (Panel A and B)|Adverse Event|0|||
48845670|NCT01998958|157276689|FG023|Period 2 (Panel A and B)|Adverse Event|0|||
48845671|NCT01998958|157276690|FG024|Period 2 (Panel A and B)|Adverse Event|0|||
48845672|NCT01998958|157276691|FG025|Period 2 (Panel A and B)|Adverse Event|0|||
48845673|NCT01998958|157276692|FG026|Period 2 (Panel A and B)|Adverse Event|0|||
48845674|NCT01998958|157276693|FG027|Period 2 (Panel A and B)|Adverse Event|0|||
48845675|NCT01998958|157276694|FG028|Period 2 (Panel A and B)|Adverse Event|0|||
48845676|NCT01998958|157276695|FG029|Period 2 (Panel A and B)|Adverse Event|0|||
48845677|NCT01998958|157276696|FG030|Period 2 (Panel A and B)|Adverse Event|0|||
48845678|NCT01998958|157276697|FG031|Period 2 (Panel A and B)|Adverse Event|0|||
48845679|NCT01998958|157276666|FG000|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
48845680|NCT01998958|157276667|FG001|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
48845681|NCT01998958|157276668|FG002|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
48845682|NCT01998958|157276669|FG003|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
48845683|NCT01998958|157276670|FG004|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
48845684|NCT01998958|157276671|FG005|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
48845685|NCT01998958|157276672|FG006|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
48845686|NCT01998958|157276673|FG007|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
48845687|NCT01998958|157276674|FG008|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
48845688|NCT01998958|157276675|FG009|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
48845689|NCT01998958|157276676|FG010|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
48845690|NCT01998958|157276677|FG011|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
48845691|NCT01998958|157276678|FG012|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
48845692|NCT01998958|157276679|FG013|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
48845693|NCT01998958|157276680|FG014|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
48845694|NCT01998958|157276681|FG015|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
48845695|NCT01998958|157276682|FG016|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
48845696|NCT01998958|157276683|FG017|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
48845697|NCT01998958|157276684|FG018|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
48845698|NCT01998958|157276685|FG019|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
48845699|NCT01998958|157276686|FG020|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
48845700|NCT01998958|157276687|FG021|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
48845701|NCT01998958|157276688|FG022|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
48845702|NCT01998958|157276689|FG023|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
48845703|NCT01998958|157276690|FG024|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
48845704|NCT01998958|157276691|FG025|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
48845705|NCT01998958|157276692|FG026|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
48845706|NCT01998958|157276693|FG027|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
48845707|NCT01998958|157276694|FG028|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
48845708|NCT01998958|157276695|FG029|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
48845709|NCT01998958|157276696|FG030|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
48845710|NCT01998958|157276697|FG031|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
48845711|NCT01998958|157276666|FG000|Open Label Phase (Optional)|Adverse Event|0|||
48845712|NCT01998958|157276667|FG001|Open Label Phase (Optional)|Adverse Event|0|||
48845713|NCT01998958|157276668|FG002|Open Label Phase (Optional)|Adverse Event|0|||
48845714|NCT01998958|157276669|FG003|Open Label Phase (Optional)|Adverse Event|0|||
48845715|NCT01998958|157276670|FG004|Open Label Phase (Optional)|Adverse Event|0|||
48845716|NCT01998958|157276671|FG005|Open Label Phase (Optional)|Adverse Event|0|||
48845717|NCT01998958|157276672|FG006|Open Label Phase (Optional)|Adverse Event|0|||
48845718|NCT01998958|157276673|FG007|Open Label Phase (Optional)|Adverse Event|0|||
48845719|NCT01998958|157276674|FG008|Open Label Phase (Optional)|Adverse Event|0|||
48845720|NCT01998958|157276675|FG009|Open Label Phase (Optional)|Adverse Event|0|||
48845721|NCT01998958|157276676|FG010|Open Label Phase (Optional)|Adverse Event|0|||
48932478|NCT00132730|157584429|FG004|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
48932479|NCT00132730|157584430|FG005|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
48845722|NCT01998958|157276677|FG011|Open Label Phase (Optional)|Adverse Event|0|||
48845723|NCT01998958|157276678|FG012|Open Label Phase (Optional)|Adverse Event|0|||
48845724|NCT01998958|157276679|FG013|Open Label Phase (Optional)|Adverse Event|0|||
48845725|NCT01998958|157276680|FG014|Open Label Phase (Optional)|Adverse Event|0|||
48845726|NCT01998958|157276681|FG015|Open Label Phase (Optional)|Adverse Event|0|||
48845727|NCT01998958|157276682|FG016|Open Label Phase (Optional)|Adverse Event|0|||
48845728|NCT01998958|157276683|FG017|Open Label Phase (Optional)|Adverse Event|0|||
48845729|NCT01998958|157276684|FG018|Open Label Phase (Optional)|Adverse Event|0|||
48845730|NCT01998958|157276685|FG019|Open Label Phase (Optional)|Adverse Event|0|||
48845731|NCT01998958|157276686|FG020|Open Label Phase (Optional)|Adverse Event|0|||
48845732|NCT01998958|157276687|FG021|Open Label Phase (Optional)|Adverse Event|0|||
48845733|NCT01998958|157276688|FG022|Open Label Phase (Optional)|Adverse Event|0|||
48845734|NCT01998958|157276689|FG023|Open Label Phase (Optional)|Adverse Event|1|||
48845735|NCT01998958|157276690|FG024|Open Label Phase (Optional)|Adverse Event|0|||
48845736|NCT01998958|157276691|FG025|Open Label Phase (Optional)|Adverse Event|0|||
48845737|NCT01998958|157276692|FG026|Open Label Phase (Optional)|Adverse Event|0|||
48845738|NCT01998958|157276693|FG027|Open Label Phase (Optional)|Adverse Event|0|||
48845739|NCT01998958|157276694|FG028|Open Label Phase (Optional)|Adverse Event|0|||
48845740|NCT01998958|157276695|FG029|Open Label Phase (Optional)|Adverse Event|0|||
48845741|NCT01998958|157276696|FG030|Open Label Phase (Optional)|Adverse Event|0|||
48845742|NCT01998958|157276697|FG031|Open Label Phase (Optional)|Adverse Event|0|||
48845743|NCT01998958|157276666|FG000|Open Label Phase (Optional)|Other|0|||
48845744|NCT01998958|157276667|FG001|Open Label Phase (Optional)|Other|0|||
48845745|NCT01998958|157276668|FG002|Open Label Phase (Optional)|Other|0|||
48845746|NCT01998958|157276669|FG003|Open Label Phase (Optional)|Other|0|||
48845747|NCT01998958|157276670|FG004|Open Label Phase (Optional)|Other|0|||
48845748|NCT01998958|157276671|FG005|Open Label Phase (Optional)|Other|0|||
48845749|NCT01998958|157276672|FG006|Open Label Phase (Optional)|Other|0|||
48845750|NCT01998958|157276673|FG007|Open Label Phase (Optional)|Other|0|||
48845751|NCT01998958|157276674|FG008|Open Label Phase (Optional)|Other|0|||
48845752|NCT01998958|157276675|FG009|Open Label Phase (Optional)|Other|0|||
48932480|NCT00132730|157584425|FG000|Period III - Blinded Extension (EXT1)|Other reasons|0|||
48932481|NCT00132730|157584426|FG001|Period III - Blinded Extension (EXT1)|Other reasons|0|||
48932482|NCT00132730|157584427|FG002|Period III - Blinded Extension (EXT1)|Other reasons|14|||
48932483|NCT00132730|157584428|FG003|Period III - Blinded Extension (EXT1)|Other reasons|3|||
48932484|NCT00132730|157584429|FG004|Period III - Blinded Extension (EXT1)|Other reasons|0|||
48932485|NCT00132730|157584430|FG005|Period III - Blinded Extension (EXT1)|Other reasons|0|||
48932486|NCT00132730|157584425|FG000|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
48932487|NCT00132730|157584426|FG001|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
48932488|NCT00132730|157584427|FG002|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
48932489|NCT00132730|157584428|FG003|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
48932490|NCT00132730|157584429|FG004|Period IV - Open-label Extension (EXT2)|Site terminated|169|||
48932491|NCT00132730|157584430|FG005|Period IV - Open-label Extension (EXT2)|Site terminated|68|||
48932492|NCT00132730|157584425|FG000|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
48932493|NCT00132730|157584426|FG001|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
48845753|NCT01998958|157276676|FG010|Open Label Phase (Optional)|Other|0|||
48845754|NCT01998958|157276677|FG011|Open Label Phase (Optional)|Other|0|||
48845755|NCT01998958|157276678|FG012|Open Label Phase (Optional)|Other|0|||
48845756|NCT01998958|157276679|FG013|Open Label Phase (Optional)|Other|0|||
48845757|NCT01998958|157276680|FG014|Open Label Phase (Optional)|Other|0|||
48845758|NCT01998958|157276681|FG015|Open Label Phase (Optional)|Other|0|||
48845759|NCT01998958|157276682|FG016|Open Label Phase (Optional)|Other|0|||
48845760|NCT01998958|157276683|FG017|Open Label Phase (Optional)|Other|0|||
48845761|NCT01998958|157276684|FG018|Open Label Phase (Optional)|Other|0|||
48845762|NCT01998958|157276685|FG019|Open Label Phase (Optional)|Other|0|||
48845763|NCT01998958|157276686|FG020|Open Label Phase (Optional)|Other|0|||
48845764|NCT01998958|157276687|FG021|Open Label Phase (Optional)|Other|0|||
48845765|NCT01998958|157276688|FG022|Open Label Phase (Optional)|Other|5|||
48845766|NCT01998958|157276689|FG023|Open Label Phase (Optional)|Other|1|||
48845767|NCT01998958|157276690|FG024|Open Label Phase (Optional)|Other|0|||
48845768|NCT01998958|157276691|FG025|Open Label Phase (Optional)|Other|0|||
48845769|NCT01998958|157276692|FG026|Open Label Phase (Optional)|Other|0|||
48932494|NCT00132730|157584427|FG002|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
48932495|NCT00132730|157584428|FG003|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
48932496|NCT00132730|157584429|FG004|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3|||
48932497|NCT00132730|157584430|FG005|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
48932498|NCT00132730|157584425|FG000|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
48932499|NCT00132730|157584426|FG001|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
48932500|NCT00132730|157584427|FG002|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
48932501|NCT00132730|157584428|FG003|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
48932502|NCT00132730|157584429|FG004|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1|||
48932503|NCT00132730|157584430|FG005|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
48932504|NCT00132730|157584425|FG000|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
48932505|NCT00132730|157584426|FG001|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
48932506|NCT00132730|157584427|FG002|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
48932507|NCT00132730|157584428|FG003|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
48932508|NCT00132730|157584429|FG004|Period IV - Open-label Extension (EXT2)|Other reasons|6|||
48932509|NCT00132730|157584430|FG005|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
48932510|NCT00132730|157584425|FG000|Period V - Open-label Extension (EXT2)|Site terminated|0|||
48845770|NCT01998958|157276693|FG027|Open Label Phase (Optional)|Other|0|||
48845771|NCT01998958|157276694|FG028|Open Label Phase (Optional)|Other|0|||
48932511|NCT00132730|157584426|FG001|Period V - Open-label Extension (EXT2)|Site terminated|0|||
48932512|NCT00132730|157584427|FG002|Period V - Open-label Extension (EXT2)|Site terminated|0|||
48845772|NCT01998958|157276695|FG029|Open Label Phase (Optional)|Other|0|||
48845773|NCT01998958|157276696|FG030|Open Label Phase (Optional)|Other|0|||
48932513|NCT00132730|157584428|FG003|Period V - Open-label Extension (EXT2)|Site terminated|0|||
48932514|NCT00132730|157584429|FG004|Period V - Open-label Extension (EXT2)|Site terminated|7|||
48932515|NCT00132730|157584430|FG005|Period V - Open-label Extension (EXT2)|Site terminated|2|||
48932516|NCT01192347|157584431|FG000|Overall Study|Death|3|||
48845774|NCT01998958|157276697|FG031|Open Label Phase (Optional)|Other|0|||
48845775|NCT01998958|157276666|FG000|Open Label Phase (Optional)|Lost to Follow-up|0|||
48845776|NCT01998958|157276667|FG001|Open Label Phase (Optional)|Lost to Follow-up|0|||
48845777|NCT01998958|157276668|FG002|Open Label Phase (Optional)|Lost to Follow-up|0|||
48845778|NCT01998958|157276669|FG003|Open Label Phase (Optional)|Lost to Follow-up|0|||
48845779|NCT01998958|157276670|FG004|Open Label Phase (Optional)|Lost to Follow-up|0|||
48845780|NCT01998958|157276671|FG005|Open Label Phase (Optional)|Lost to Follow-up|0|||
48845781|NCT01998958|157276672|FG006|Open Label Phase (Optional)|Lost to Follow-up|0|||
48845782|NCT01998958|157276673|FG007|Open Label Phase (Optional)|Lost to Follow-up|0|||
48845783|NCT01998958|157276674|FG008|Open Label Phase (Optional)|Lost to Follow-up|0|||
48845784|NCT01998958|157276675|FG009|Open Label Phase (Optional)|Lost to Follow-up|0|||
48845785|NCT01998958|157276676|FG010|Open Label Phase (Optional)|Lost to Follow-up|0|||
48845786|NCT01998958|157276677|FG011|Open Label Phase (Optional)|Lost to Follow-up|0|||
48845787|NCT01998958|157276678|FG012|Open Label Phase (Optional)|Lost to Follow-up|0|||
48845788|NCT01998958|157276679|FG013|Open Label Phase (Optional)|Lost to Follow-up|0|||
48845789|NCT01998958|157276680|FG014|Open Label Phase (Optional)|Lost to Follow-up|0|||
48845790|NCT01998958|157276681|FG015|Open Label Phase (Optional)|Lost to Follow-up|0|||
48845791|NCT01998958|157276682|FG016|Open Label Phase (Optional)|Lost to Follow-up|0|||
48845792|NCT01998958|157276683|FG017|Open Label Phase (Optional)|Lost to Follow-up|0|||
48845793|NCT01998958|157276684|FG018|Open Label Phase (Optional)|Lost to Follow-up|0|||
48845794|NCT01998958|157276685|FG019|Open Label Phase (Optional)|Lost to Follow-up|0|||
48845795|NCT01998958|157276686|FG020|Open Label Phase (Optional)|Lost to Follow-up|0|||
48845796|NCT01998958|157276687|FG021|Open Label Phase (Optional)|Lost to Follow-up|0|||
48845797|NCT01998958|157276688|FG022|Open Label Phase (Optional)|Lost to Follow-up|1|||
48845798|NCT01998958|157276689|FG023|Open Label Phase (Optional)|Lost to Follow-up|0|||
48932517|NCT01192347|157584431|FG000|Overall Study|Lost to Follow-up|3|||
48932518|NCT01192347|157584431|FG000|Overall Study|Withdrawal by Subject|1|||
48932519|NCT01192347|157584431|FG000|Overall Study|Adverse Event|1|||
48932520|NCT01192347|157584431|FG000|Overall Study|Suspected serious adverse drug reaction|1|||
48932521|NCT01192347|157584431|FG000|Overall Study|Patient seen in different hospital|1|||
48932522|NCT01192347|157584431|FG000|Overall Study|Patient not visiting hospital regularly|1|||
48932523|NCT01192347|157584431|FG000|Overall Study|Patient did not show up for visits|1|||
48932524|NCT02771522|157584432|FG000|Overall Study|Lost to Follow-up|3|||
48932525|NCT02771522|157584432|FG000|Overall Study|Withdrawal by Subject|2|||
48932526|NCT02771522|157584432|FG000|Overall Study|No white spot lesions|3|||
48932527|NCT03739528|157584433|FG000|Overall Study|Not treated|8|||
48932528|NCT03739528|157584434|FG001|Overall Study|Not treated|12|||
48932529|NCT03739528|157584433|FG000|Overall Study|Treatment and study discontinued|6|||
48932530|NCT03739528|157584434|FG001|Overall Study|Treatment and study discontinued|2|||
48932531|NCT03739528|157584433|FG000|Overall Study|Treatment discontinued + study completed|1|||
48932532|NCT03739528|157584434|FG001|Overall Study|Treatment discontinued + study completed|3|||
48932533|NCT04451330|157584435|FG000|Overall Study|Adverse Event|1|||
48932534|NCT04451330|157584436|FG001|Overall Study|Adverse Event|2|||
48932535|NCT04451330|157584435|FG000|Overall Study|Lost to Follow-up|5|||
48932536|NCT04451330|157584436|FG001|Overall Study|Lost to Follow-up|0|||
48932537|NCT04451330|157584435|FG000|Overall Study|Withdrawal by Subject|3|||
48932538|NCT04451330|157584436|FG001|Overall Study|Withdrawal by Subject|1|||
48932539|NCT04451330|157584435|FG000|Overall Study|Withdrawal by parent/guardian|1|||
48932540|NCT04451330|157584436|FG001|Overall Study|Withdrawal by parent/guardian|0|||
48932541|NCT04451330|157584435|FG000|Overall Study|Other than specified|0|||
48932542|NCT04451330|157584436|FG001|Overall Study|Other than specified|1|||
48932543|NCT03624946|157584439|FG000|Overall Study|Lost to Follow-up|0|||
48932544|NCT03624946|157584440|FG001|Overall Study|Lost to Follow-up|1|||
48932545|NCT01987908|157584441|FG000|Placebo Lead-in Period|Adverse Event|2|||
48932546|NCT01987908|157584442|FG001|Placebo Lead-in Period|Adverse Event|0|||
48932547|NCT01987908|157584443|FG002|Placebo Lead-in Period|Adverse Event|0|||
48932548|NCT01987908|157584441|FG000|Placebo Lead-in Period|Physician Decision|2|||
48932549|NCT01987908|157584442|FG001|Placebo Lead-in Period|Physician Decision|0|||
48932550|NCT01987908|157584443|FG002|Placebo Lead-in Period|Physician Decision|0|||
48932551|NCT01987908|157584441|FG000|Placebo Lead-in Period|Withdrawal by Subject|1|||
48932552|NCT01987908|157584442|FG001|Placebo Lead-in Period|Withdrawal by Subject|0|||
48932553|NCT01987908|157584443|FG002|Placebo Lead-in Period|Withdrawal by Subject|0|||
48932554|NCT01987908|157584441|FG000|Placebo Lead-in Period|Other: Study Termination by Sponsor|4|||
48932555|NCT01987908|157584442|FG001|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
48932556|NCT01987908|157584443|FG002|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
48932557|NCT01987908|157584441|FG000|Treatment Period|Adverse Event|0|||
48932558|NCT01987908|157584442|FG001|Treatment Period|Adverse Event|1|||
48932559|NCT01987908|157584443|FG002|Treatment Period|Adverse Event|1|||
48932560|NCT01987908|157584441|FG000|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
48932561|NCT01987908|157584442|FG001|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2|||
48932562|NCT01987908|157584443|FG002|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
48932563|NCT01987908|157584441|FG000|Post-Treatment Observation Period|Other: Bad Veins|0|||
48932564|NCT01987908|157584442|FG001|Post-Treatment Observation Period|Other: Bad Veins|1|||
48932565|NCT01987908|157584443|FG002|Post-Treatment Observation Period|Other: Bad Veins|0|||
48932566|NCT00556426|157584444|FG000|Overall Study|Withdrawal by Subject|3|||
48932567|NCT00556426|157584444|FG000|Overall Study|Death|6|||
48932568|NCT00236080|157584445|FG000|Overall Study|Adverse Event|0|||
48932569|NCT00236080|157584446|FG001|Overall Study|Adverse Event|0|||
48932570|NCT00236080|157584447|FG002|Overall Study|Adverse Event|3|||
48932571|NCT00236080|157584448|FG003|Overall Study|Adverse Event|1|||
48932572|NCT00236080|157584449|FG004|Overall Study|Adverse Event|0|||
48932573|NCT00236080|157584445|FG000|Overall Study|Lost to Follow-up|0|||
48932574|NCT00236080|157584446|FG001|Overall Study|Lost to Follow-up|1|||
48932575|NCT00236080|157584447|FG002|Overall Study|Lost to Follow-up|0|||
48932576|NCT00236080|157584448|FG003|Overall Study|Lost to Follow-up|0|||
48932577|NCT00236080|157584449|FG004|Overall Study|Lost to Follow-up|0|||
48932578|NCT00236080|157584445|FG000|Overall Study|Physician Decision|1|||
48932579|NCT00236080|157584446|FG001|Overall Study|Physician Decision|0|||
48932580|NCT00236080|157584447|FG002|Overall Study|Physician Decision|1|||
48932581|NCT00236080|157584448|FG003|Overall Study|Physician Decision|1|||
48932582|NCT00236080|157584449|FG004|Overall Study|Physician Decision|1|||
48932583|NCT00236080|157584445|FG000|Overall Study|Withdrawal by Subject|1|||
48932584|NCT00236080|157584446|FG001|Overall Study|Withdrawal by Subject|0|||
48932585|NCT00236080|157584447|FG002|Overall Study|Withdrawal by Subject|0|||
48932586|NCT00236080|157584448|FG003|Overall Study|Withdrawal by Subject|0|||
48932587|NCT00236080|157584449|FG004|Overall Study|Withdrawal by Subject|0|||
48932588|NCT00236080|157584445|FG000|Overall Study|Miscellaneous|0|||
48932589|NCT00236080|157584446|FG001|Overall Study|Miscellaneous|0|||
48932590|NCT00236080|157584447|FG002|Overall Study|Miscellaneous|1|||
48932591|NCT00236080|157584448|FG003|Overall Study|Miscellaneous|0|||
48932592|NCT00236080|157584449|FG004|Overall Study|Miscellaneous|0|||
48932593|NCT02400255|157584450|FG000|Overall Study|Relapse|4|||
48932594|NCT02400255|157584451|FG001|Overall Study|Relapse|1|||
48932595|NCT02400255|157584452|FG002|Overall Study|Relapse|1|||
48932596|NCT02400255|157584453|FG003|Overall Study|Relapse|2|||
48932597|NCT02400255|157584450|FG000|Overall Study|Adverse Event|6|||
48932598|NCT02400255|157584451|FG001|Overall Study|Adverse Event|3|||
48932599|NCT02400255|157584452|FG002|Overall Study|Adverse Event|0|||
48932600|NCT02400255|157584453|FG003|Overall Study|Adverse Event|0|||
48932601|NCT02400255|157584450|FG000|Overall Study|Physician Decision|6|||
48932602|NCT02400255|157584451|FG001|Overall Study|Physician Decision|0|||
48932603|NCT02400255|157584452|FG002|Overall Study|Physician Decision|0|||
48932604|NCT02400255|157584453|FG003|Overall Study|Physician Decision|0|||
48932605|NCT02400255|157584450|FG000|Overall Study|Loss of insurance|1|||
48932606|NCT02400255|157584451|FG001|Overall Study|Loss of insurance|0|||
48932607|NCT02400255|157584452|FG002|Overall Study|Loss of insurance|0|||
48932608|NCT02400255|157584453|FG003|Overall Study|Loss of insurance|0|||
48932609|NCT00944034|157584454|FG000|Overall Study|Inappropriate enrollment|0|||
48932610|NCT00944034|157584455|FG001|Overall Study|Inappropriate enrollment|1|||
48932611|NCT00944034|157584456|FG002|Overall Study|Inappropriate enrollment|0|||
48932612|NCT00944034|157584457|FG003|Overall Study|Inappropriate enrollment|1|||
48932613|NCT00944034|157584458|FG004|Overall Study|Inappropriate enrollment|2|||
48932614|NCT00944034|157584459|FG005|Overall Study|Inappropriate enrollment|1|||
48932615|NCT00944034|157584460|FG006|Overall Study|Inappropriate enrollment|0|||
48932616|NCT00944034|157584461|FG007|Overall Study|Inappropriate enrollment|0|||
48932617|NCT00944034|157584462|FG008|Overall Study|Inappropriate enrollment|1|||
48932618|NCT00944034|157584463|FG009|Overall Study|Inappropriate enrollment|1|||
48932619|NCT00944034|157584464|FG010|Overall Study|Inappropriate enrollment|0|||
48932620|NCT00944034|157584465|FG011|Overall Study|Inappropriate enrollment|0|||
48932621|NCT00944034|157584454|FG000|Overall Study|Withdrawal by Subject|3|||
48932622|NCT00944034|157584455|FG001|Overall Study|Withdrawal by Subject|2|||
48932623|NCT00944034|157584456|FG002|Overall Study|Withdrawal by Subject|6|||
48932624|NCT00944034|157584457|FG003|Overall Study|Withdrawal by Subject|2|||
48932625|NCT00944034|157584458|FG004|Overall Study|Withdrawal by Subject|5|||
48932626|NCT00944034|157584459|FG005|Overall Study|Withdrawal by Subject|8|||
48932627|NCT00944034|157584460|FG006|Overall Study|Withdrawal by Subject|2|||
48932628|NCT00944034|157584461|FG007|Overall Study|Withdrawal by Subject|2|||
48932629|NCT00944034|157584462|FG008|Overall Study|Withdrawal by Subject|3|||
48932630|NCT00944034|157584463|FG009|Overall Study|Withdrawal by Subject|4|||
48932631|NCT00944034|157584464|FG010|Overall Study|Withdrawal by Subject|0|||
48932632|NCT00944034|157584465|FG011|Overall Study|Withdrawal by Subject|4|||
48932633|NCT00944034|157584454|FG000|Overall Study|Lost to Follow-up|0|||
48932634|NCT00944034|157584455|FG001|Overall Study|Lost to Follow-up|4|||
48932635|NCT00944034|157584456|FG002|Overall Study|Lost to Follow-up|2|||
48932636|NCT00944034|157584457|FG003|Overall Study|Lost to Follow-up|0|||
48932637|NCT00944034|157584458|FG004|Overall Study|Lost to Follow-up|5|||
48932638|NCT00944034|157584459|FG005|Overall Study|Lost to Follow-up|7|||
48932639|NCT00944034|157584460|FG006|Overall Study|Lost to Follow-up|0|||
48932640|NCT00944034|157584461|FG007|Overall Study|Lost to Follow-up|1|||
48932641|NCT00944034|157584462|FG008|Overall Study|Lost to Follow-up|5|||
48932642|NCT00944034|157584463|FG009|Overall Study|Lost to Follow-up|1|||
48932643|NCT00944034|157584464|FG010|Overall Study|Lost to Follow-up|1|||
48932644|NCT00944034|157584465|FG011|Overall Study|Lost to Follow-up|0|||
48932645|NCT00944034|157584454|FG000|Overall Study|Death|0|||
48932646|NCT00944034|157584455|FG001|Overall Study|Death|0|||
48932647|NCT00944034|157584456|FG002|Overall Study|Death|1|||
48932648|NCT00944034|157584457|FG003|Overall Study|Death|0|||
48932649|NCT00944034|157584458|FG004|Overall Study|Death|0|||
48932650|NCT00944034|157584459|FG005|Overall Study|Death|0|||
48932651|NCT00944034|157584460|FG006|Overall Study|Death|0|||
48932652|NCT00944034|157584461|FG007|Overall Study|Death|0|||
48932653|NCT00944034|157584462|FG008|Overall Study|Death|0|||
48932654|NCT00944034|157584463|FG009|Overall Study|Death|0|||
48932655|NCT00944034|157584464|FG010|Overall Study|Death|0|||
48932656|NCT00944034|157584465|FG011|Overall Study|Death|0|||
48932657|NCT00944034|157584454|FG000|Overall Study|Protocol Violation|2|||
48932658|NCT00944034|157584455|FG001|Overall Study|Protocol Violation|0|||
48932659|NCT00944034|157584456|FG002|Overall Study|Protocol Violation|0|||
48932660|NCT00944034|157584457|FG003|Overall Study|Protocol Violation|1|||
48932661|NCT00944034|157584458|FG004|Overall Study|Protocol Violation|2|||
48932662|NCT00944034|157584459|FG005|Overall Study|Protocol Violation|3|||
48932663|NCT00944034|157584460|FG006|Overall Study|Protocol Violation|0|||
48932664|NCT00944034|157584461|FG007|Overall Study|Protocol Violation|1|||
48932665|NCT00944034|157584462|FG008|Overall Study|Protocol Violation|1|||
48932666|NCT00944034|157584463|FG009|Overall Study|Protocol Violation|4|||
48932667|NCT00944034|157584464|FG010|Overall Study|Protocol Violation|0|||
48932668|NCT00944034|157584465|FG011|Overall Study|Protocol Violation|0|||
48932669|NCT00944034|157584454|FG000|Overall Study|Unable to classify|0|||
48932670|NCT00944034|157584455|FG001|Overall Study|Unable to classify|0|||
48932671|NCT00944034|157584456|FG002|Overall Study|Unable to classify|0|||
48932672|NCT00944034|157584457|FG003|Overall Study|Unable to classify|0|||
48932673|NCT00944034|157584458|FG004|Overall Study|Unable to classify|0|||
48932674|NCT00944034|157584459|FG005|Overall Study|Unable to classify|1|||
48932675|NCT00944034|157584460|FG006|Overall Study|Unable to classify|1|||
48932676|NCT00944034|157584461|FG007|Overall Study|Unable to classify|1|||
48932677|NCT00944034|157584462|FG008|Overall Study|Unable to classify|0|||
48932678|NCT00944034|157584463|FG009|Overall Study|Unable to classify|0|||
48932679|NCT00944034|157584464|FG010|Overall Study|Unable to classify|0|||
48932680|NCT00944034|157584465|FG011|Overall Study|Unable to classify|0|||
48932681|NCT00944034|157584454|FG000|Overall Study|Administrative reason|0|||
48932682|NCT00944034|157584455|FG001|Overall Study|Administrative reason|0|||
48932683|NCT00944034|157584456|FG002|Overall Study|Administrative reason|0|||
48932684|NCT00944034|157584457|FG003|Overall Study|Administrative reason|0|||
48932685|NCT00944034|157584458|FG004|Overall Study|Administrative reason|0|||
48932686|NCT00944034|157584459|FG005|Overall Study|Administrative reason|0|||
48932687|NCT00944034|157584460|FG006|Overall Study|Administrative reason|1|||
48845799|NCT01998958|157276690|FG024|Open Label Phase (Optional)|Lost to Follow-up|0|||
48845800|NCT01998958|157276691|FG025|Open Label Phase (Optional)|Lost to Follow-up|0|||
48845801|NCT01998958|157276692|FG026|Open Label Phase (Optional)|Lost to Follow-up|0|||
48845802|NCT01998958|157276693|FG027|Open Label Phase (Optional)|Lost to Follow-up|0|||
48845803|NCT01998958|157276694|FG028|Open Label Phase (Optional)|Lost to Follow-up|0|||
48845804|NCT01998958|157276695|FG029|Open Label Phase (Optional)|Lost to Follow-up|0|||
48845805|NCT01998958|157276696|FG030|Open Label Phase (Optional)|Lost to Follow-up|0|||
48845806|NCT01998958|157276697|FG031|Open Label Phase (Optional)|Lost to Follow-up|0|||
48845807|NCT01998958|157276666|FG000|Open Label Phase (Optional)|Lack of Efficacy|0|||
48932688|NCT00944034|157584461|FG007|Overall Study|Administrative reason|0|||
48932689|NCT00944034|157584462|FG008|Overall Study|Administrative reason|0|||
48932690|NCT00944034|157584463|FG009|Overall Study|Administrative reason|0|||
48932691|NCT00944034|157584464|FG010|Overall Study|Administrative reason|0|||
48932692|NCT00944034|157584465|FG011|Overall Study|Administrative reason|0|||
48932693|NCT00510276|157584468|FG000|Acute Double-Blind Phase|Adverse Event|21|||
48932694|NCT00510276|157584469|FG001|Acute Double-Blind Phase|Adverse Event|6|||
48932695|NCT00510276|157584468|FG000|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
48932696|NCT00510276|157584469|FG001|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
48932697|NCT00510276|157584468|FG000|Acute Double-Blind Phase|Lack of Efficacy|3|||
48932698|NCT00510276|157584469|FG001|Acute Double-Blind Phase|Lack of Efficacy|4|||
48932699|NCT00510276|157584468|FG000|Acute Double-Blind Phase|Lost to Follow-up|48|||
48845808|NCT01998958|157276667|FG001|Open Label Phase (Optional)|Lack of Efficacy|0|||
48845809|NCT01998958|157276668|FG002|Open Label Phase (Optional)|Lack of Efficacy|0|||
48845810|NCT01998958|157276669|FG003|Open Label Phase (Optional)|Lack of Efficacy|0|||
48845811|NCT01998958|157276670|FG004|Open Label Phase (Optional)|Lack of Efficacy|0|||
48845812|NCT01998958|157276671|FG005|Open Label Phase (Optional)|Lack of Efficacy|0|||
48845813|NCT01998958|157276672|FG006|Open Label Phase (Optional)|Lack of Efficacy|0|||
48845814|NCT01998958|157276673|FG007|Open Label Phase (Optional)|Lack of Efficacy|0|||
48845815|NCT01998958|157276674|FG008|Open Label Phase (Optional)|Lack of Efficacy|0|||
48845816|NCT01998958|157276675|FG009|Open Label Phase (Optional)|Lack of Efficacy|0|||
48845817|NCT01998958|157276676|FG010|Open Label Phase (Optional)|Lack of Efficacy|0|||
48845818|NCT01998958|157276677|FG011|Open Label Phase (Optional)|Lack of Efficacy|0|||
48845819|NCT01998958|157276678|FG012|Open Label Phase (Optional)|Lack of Efficacy|0|||
48845820|NCT01998958|157276679|FG013|Open Label Phase (Optional)|Lack of Efficacy|0|||
48845821|NCT01998958|157276680|FG014|Open Label Phase (Optional)|Lack of Efficacy|0|||
48845822|NCT01998958|157276681|FG015|Open Label Phase (Optional)|Lack of Efficacy|0|||
48932700|NCT00510276|157584469|FG001|Acute Double-Blind Phase|Lost to Follow-up|49|||
48932701|NCT00510276|157584468|FG000|Acute Double-Blind Phase|Physician Decision|0|||
48932702|NCT00510276|157584469|FG001|Acute Double-Blind Phase|Physician Decision|3|||
48932703|NCT00510276|157584468|FG000|Acute Double-Blind Phase|Protocol Violation|4|||
48932704|NCT00510276|157584469|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
48932705|NCT00510276|157584468|FG000|Acute Double-Blind Phase|Sponsor Decision|2|||
48932706|NCT00510276|157584469|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
48932707|NCT00510276|157584468|FG000|Acute Double-Blind Phase|Subject Decision|26|||
48932708|NCT00510276|157584469|FG001|Acute Double-Blind Phase|Subject Decision|28|||
48932709|NCT00510276|157584468|FG000|Extension Open-Label Phase|Adverse Event|9|||
48932710|NCT00510276|157584469|FG001|Extension Open-Label Phase|Adverse Event|18|||
48932711|NCT00510276|157584468|FG000|Extension Open-Label Phase|Lack of Efficacy|2|||
48932712|NCT00510276|157584469|FG001|Extension Open-Label Phase|Lack of Efficacy|7|||
48932713|NCT00510276|157584468|FG000|Extension Open-Label Phase|Lost to Follow-up|12|||
48932714|NCT00510276|157584469|FG001|Extension Open-Label Phase|Lost to Follow-up|10|||
48932715|NCT00510276|157584468|FG000|Extension Open-Label Phase|Physician Decision|2|||
48932716|NCT00510276|157584469|FG001|Extension Open-Label Phase|Physician Decision|3|||
48932717|NCT00510276|157584468|FG000|Extension Open-Label Phase|Protocol Violation|0|||
48932718|NCT00510276|157584469|FG001|Extension Open-Label Phase|Protocol Violation|1|||
48932719|NCT00510276|157584468|FG000|Extension Open-Label Phase|Sponsor Decision|1|||
48932720|NCT00510276|157584469|FG001|Extension Open-Label Phase|Sponsor Decision|0|||
48932721|NCT00510276|157584468|FG000|Extension Open-Label Phase|Subject Decision|7|||
48932722|NCT00510276|157584469|FG001|Extension Open-Label Phase|Subject Decision|9|||
48932723|NCT01961544|157584470|FG000|Overall Study|Protocol Violation|1|||
48932724|NCT01961544|157584470|FG000|Overall Study|Withdrawal by Subject|7|||
48932725|NCT01961544|157584470|FG000|Overall Study|Adverse Event|1|||
48932726|NCT01961544|157584470|FG000|Overall Study|Physician Decision|2|||
48932727|NCT01961544|157584470|FG000|Overall Study|Poor Tolerance|1|||
48932728|NCT01961544|157584470|FG000|Overall Study|Aggravation of Steral Pain|1|||
48932729|NCT03403192|157584471|FG000|Overall Study|Lost to Follow-up|1|||
48932730|NCT03403192|157584472|FG001|Overall Study|Lost to Follow-up|2|||
48932731|NCT03403192|157584473|FG002|Overall Study|Lost to Follow-up|0|||
48932732|NCT03403192|157584474|FG003|Overall Study|Lost to Follow-up|0|||
48932733|NCT03403192|157584471|FG000|Overall Study|Unable to respond|0|||
48932734|NCT03403192|157584472|FG001|Overall Study|Unable to respond|1|||
48932735|NCT03403192|157584473|FG002|Overall Study|Unable to respond|0|||
48932736|NCT03403192|157584474|FG003|Overall Study|Unable to respond|0|||
48932737|NCT03403192|157584471|FG000|Overall Study|Incomplete|3|||
48932738|NCT03403192|157584472|FG001|Overall Study|Incomplete|1|||
48932739|NCT03403192|157584473|FG002|Overall Study|Incomplete|3|||
48932740|NCT03403192|157584474|FG003|Overall Study|Incomplete|6|||
48932741|NCT01551693|157584475|FG000|Overall Study|Disease Progression|1|||
48932742|NCT01551693|157584476|FG001|Overall Study|Disease Progression|0|||
48932743|NCT01551693|157584475|FG000|Overall Study|Adverse Event|0|||
48932744|NCT01551693|157584476|FG001|Overall Study|Adverse Event|1|||
48932745|NCT01551693|157584475|FG000|Overall Study|Withdrawal by Subject|0|||
48932746|NCT01551693|157584476|FG001|Overall Study|Withdrawal by Subject|1|||
48932747|NCT03543410|157584481|FG000|Overall Study|Adverse Event|10|||
48932748|NCT03543410|157584482|FG001|Overall Study|Adverse Event|8|||
48932749|NCT03543410|157584483|FG002|Overall Study|Adverse Event|2|||
48932750|NCT03543410|157584481|FG000|Overall Study|Lack of Efficacy|0|||
48932751|NCT03543410|157584482|FG001|Overall Study|Lack of Efficacy|1|||
48932752|NCT03543410|157584483|FG002|Overall Study|Lack of Efficacy|0|||
48932753|NCT03543410|157584481|FG000|Overall Study|Lost to Follow-up|0|||
48932754|NCT03543410|157584482|FG001|Overall Study|Lost to Follow-up|1|||
48932755|NCT03543410|157584483|FG002|Overall Study|Lost to Follow-up|0|||
48932756|NCT03543410|157584481|FG000|Overall Study|Withdrawal by Subject|5|||
48932757|NCT03543410|157584482|FG001|Overall Study|Withdrawal by Subject|2|||
48932758|NCT03543410|157584483|FG002|Overall Study|Withdrawal by Subject|8|||
48932759|NCT03543410|157584481|FG000|Overall Study|Protocol Violation|0|||
48932760|NCT03543410|157584482|FG001|Overall Study|Protocol Violation|1|||
48932761|NCT03543410|157584483|FG002|Overall Study|Protocol Violation|0|||
48932762|NCT03543410|157584481|FG000|Overall Study|Due to COVID-19|4|||
48932763|NCT03543410|157584482|FG001|Overall Study|Due to COVID-19|0|||
48932764|NCT03543410|157584483|FG002|Overall Study|Due to COVID-19|2|||
48932765|NCT03543410|157584481|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
48932766|NCT03543410|157584482|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
48932767|NCT03543410|157584483|FG002|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|2|||
48932768|NCT03543410|157584481|FG000|Overall Study|Not Due to COVID-19|2|||
48932769|NCT03543410|157584482|FG001|Overall Study|Not Due to COVID-19|0|||
48932770|NCT03543410|157584483|FG002|Overall Study|Not Due to COVID-19|1|||
48932771|NCT02435914|157584484|FG000|Overall Study|Ocular Adverse Event|1|||
48932772|NCT02435914|157584485|FG001|Overall Study|Ocular Adverse Event|0|||
48932773|NCT02435914|157584486|FG002|Overall Study|Ocular Adverse Event|0|||
48932774|NCT02435914|157584487|FG003|Overall Study|Ocular Adverse Event|0|||
48932775|NCT02435914|157584484|FG000|Overall Study|Withdrawal by Subject|0|||
48932776|NCT02435914|157584485|FG001|Overall Study|Withdrawal by Subject|1|||
48932777|NCT02435914|157584486|FG002|Overall Study|Withdrawal by Subject|0|||
48932778|NCT02435914|157584487|FG003|Overall Study|Withdrawal by Subject|0|||
48932779|NCT02435914|157584484|FG000|Overall Study|Other Miscellaneous Reason|0|||
48932780|NCT02435914|157584485|FG001|Overall Study|Other Miscellaneous Reason|0|||
48932781|NCT02435914|157584486|FG002|Overall Study|Other Miscellaneous Reason|1|||
48932782|NCT02435914|157584487|FG003|Overall Study|Other Miscellaneous Reason|0|||
48932783|NCT01318122|157584488|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
48932784|NCT01318122|157584489|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
48932785|NCT01318122|157584490|FG002|Enrolled - Long-Term Extension Study|Adverse Event|2|||
48932786|NCT01318122|157584491|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
48932787|NCT01318122|157584488|FG000|Enrolled - Long-Term Extension Study|Other|1|||
48932788|NCT01318122|157584489|FG001|Enrolled - Long-Term Extension Study|Other|0|||
48932789|NCT01318122|157584490|FG002|Enrolled - Long-Term Extension Study|Other|0|||
48932790|NCT01318122|157584491|FG003|Enrolled - Long-Term Extension Study|Other|0|||
48932791|NCT01318122|157584488|FG000|Entered - Long-Term Extension Study|Adverse Event|6|||
48932792|NCT01318122|157584489|FG001|Entered - Long-Term Extension Study|Adverse Event|6|||
48932793|NCT01318122|157584490|FG002|Entered - Long-Term Extension Study|Adverse Event|2|||
48932794|NCT01318122|157584491|FG003|Entered - Long-Term Extension Study|Adverse Event|4|||
48932795|NCT01318122|157584488|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|1|||
48932796|NCT01318122|157584489|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
48932797|NCT01318122|157584490|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
48932798|NCT01318122|157584491|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
48932799|NCT01318122|157584488|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
48932800|NCT01318122|157584489|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|3|||
48932801|NCT01318122|157584490|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
48932802|NCT01318122|157584491|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
48932803|NCT01318122|157584488|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
48932804|NCT01318122|157584489|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
48932805|NCT01318122|157584490|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
48932806|NCT01318122|157584491|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
48932807|NCT00880256|157584494|FG000|Overall Study|Lost to Follow-up|28|||
48932808|NCT02601573|157584498|FG000|Overall Study|Lost to Follow-up|0|||
48932809|NCT02601573|157584499|FG001|Overall Study|Lost to Follow-up|3|||
48932810|NCT02601573|157584500|FG002|Overall Study|Lost to Follow-up|1|||
48932811|NCT02601573|157584501|FG003|Overall Study|Lost to Follow-up|0|||
48932812|NCT02601573|157584502|FG004|Overall Study|Lost to Follow-up|2|||
48932813|NCT02601573|157584498|FG000|Overall Study|Withdrawal by Subject|0|||
48932814|NCT02601573|157584499|FG001|Overall Study|Withdrawal by Subject|1|||
48932815|NCT02601573|157584500|FG002|Overall Study|Withdrawal by Subject|0|||
48932816|NCT02601573|157584501|FG003|Overall Study|Withdrawal by Subject|1|||
48932817|NCT02601573|157584502|FG004|Overall Study|Withdrawal by Subject|0|||
48932818|NCT03168867|157584503|FG000|Overall Study|Withdrawal by Subject|1|||
48932819|NCT03168867|157584504|FG001|Overall Study|Withdrawal by Subject|5|||
48932820|NCT01384292|157584507|FG000|Part B|Severe non-compliance to protocol|1|||
48932821|NCT01384292|157584508|FG001|Part B|Severe non-compliance to protocol|0|||
48932822|NCT01384292|157584509|FG002|Part B|Severe non-compliance to protocol|0|||
48932823|NCT02266433|157584511|FG000|Overall Study|Lost to Follow-up|54|||
48932824|NCT02266433|157584512|FG001|Overall Study|Lost to Follow-up|46|||
48932825|NCT02266433|157584511|FG000|Overall Study|Withdrawal by Subject|5|||
48932826|NCT02266433|157584512|FG001|Overall Study|Withdrawal by Subject|7|||
48932827|NCT01285349|157584513|FG000|Overall Study|Lost to Follow-up|27|||
48932828|NCT01285349|157584514|FG001|Overall Study|Lost to Follow-up|20|||
48932829|NCT01285349|157584515|FG002|Overall Study|Lost to Follow-up|27|||
48932830|NCT01273064|157584516|FG000|Overall Study|Adverse Event|5|||
48932831|NCT01273064|157584517|FG001|Overall Study|Adverse Event|1|||
48932832|NCT01273064|157584518|FG002|Overall Study|Adverse Event|3|||
48932833|NCT01273064|157584519|FG003|Overall Study|Adverse Event|2|||
48932834|NCT01273064|157584520|FG004|Overall Study|Adverse Event|1|||
48932835|NCT01273064|157584516|FG000|Overall Study|Withdrawal by Subject|4|||
48932836|NCT01273064|157584517|FG001|Overall Study|Withdrawal by Subject|2|||
48932837|NCT01273064|157584518|FG002|Overall Study|Withdrawal by Subject|2|||
48932838|NCT01273064|157584519|FG003|Overall Study|Withdrawal by Subject|2|||
48932839|NCT01273064|157584520|FG004|Overall Study|Withdrawal by Subject|0|||
48932840|NCT01273064|157584516|FG000|Overall Study|Study Termination|13|||
48932841|NCT01273064|157584517|FG001|Overall Study|Study Termination|27|||
48932842|NCT01273064|157584518|FG002|Overall Study|Study Termination|26|||
48932843|NCT01273064|157584519|FG003|Overall Study|Study Termination|16|||
48932844|NCT01273064|157584520|FG004|Overall Study|Study Termination|8|||
48932845|NCT01273064|157584516|FG000|Overall Study|Lost to Follow-up|1|||
48932846|NCT01273064|157584517|FG001|Overall Study|Lost to Follow-up|0|||
48932847|NCT01273064|157584518|FG002|Overall Study|Lost to Follow-up|0|||
48932848|NCT01273064|157584519|FG003|Overall Study|Lost to Follow-up|0|||
48932849|NCT01273064|157584520|FG004|Overall Study|Lost to Follow-up|0|||
48932850|NCT01273064|157584516|FG000|Overall Study|Physician Decision|0|||
48932851|NCT01273064|157584517|FG001|Overall Study|Physician Decision|0|||
48932852|NCT01273064|157584518|FG002|Overall Study|Physician Decision|0|||
48932853|NCT01273064|157584519|FG003|Overall Study|Physician Decision|0|||
48932854|NCT01273064|157584520|FG004|Overall Study|Physician Decision|1|||
48932855|NCT02452762|157584521|FG000|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4|||
48932856|NCT02452762|157584522|FG001|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3|||
48932857|NCT02452762|157584521|FG000|Overall Study|Withdrawal by Subject|1|||
48932858|NCT02452762|157584522|FG001|Overall Study|Withdrawal by Subject|0|||
48932859|NCT03595280|157584524|FG000|Overall Study|Lost to Follow-up|6|||
48932860|NCT03595280|157584525|FG001|Overall Study|Lost to Follow-up|9|||
48932861|NCT03595280|157584526|FG002|Overall Study|Lost to Follow-up|15|||
48932862|NCT02675075|157584530|FG000|Overall Study|Lost to Follow-up|3|||
48932863|NCT02675075|157584531|FG001|Overall Study|Lost to Follow-up|0|||
48932864|NCT02292212|157584532|FG000|ViE Phase|Withdrawal by Subject|1|||
48932865|NCT02292212|157584532|FG000|ViE Phase|Protocol Violation|2|||
48932866|NCT00896532|157584533|FG000|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
48932867|NCT00896532|157584534|FG001|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
48932868|NCT00896532|157584535|FG002|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
48932869|NCT00896532|157584536|FG003|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
48932870|NCT00896532|157584537|FG004|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
48932871|NCT00896532|157584538|FG005|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
48932872|NCT00896532|157584539|FG006|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
48932873|NCT00896532|157584540|FG007|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
48932874|NCT00896532|157584541|FG008|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
48932875|NCT00896532|157584542|FG009|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
48932876|NCT00896532|157584543|FG010|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
48932877|NCT00896532|157584544|FG011|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
48932878|NCT00896532|157584545|FG012|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
48932879|NCT00896532|157584546|FG013|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
48932880|NCT00896532|157584547|FG014|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
48932881|NCT00896532|157584548|FG015|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
48932882|NCT00896532|157584549|FG016|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
48932883|NCT00896532|157584550|FG017|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
48932884|NCT00896532|157584551|FG018|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
48932885|NCT00896532|157584552|FG019|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
48932886|NCT00896532|157584553|FG020|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
48932887|NCT00896532|157584554|FG021|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
48932888|NCT00896532|157584555|FG022|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
48932889|NCT00896532|157584533|FG000|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
48932890|NCT00896532|157584534|FG001|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
48932891|NCT00896532|157584535|FG002|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
48932892|NCT00896532|157584536|FG003|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
48932893|NCT00896532|157584537|FG004|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
48932894|NCT00896532|157584538|FG005|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
48932895|NCT00896532|157584539|FG006|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
48932896|NCT00896532|157584540|FG007|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
48932897|NCT00896532|157584541|FG008|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
48932898|NCT00896532|157584542|FG009|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
48932899|NCT00896532|157584543|FG010|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
48932900|NCT00896532|157584544|FG011|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
48932901|NCT00896532|157584545|FG012|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
48932902|NCT00896532|157584546|FG013|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
48932903|NCT00896532|157584547|FG014|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
48932904|NCT00896532|157584548|FG015|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
48932905|NCT00896532|157584549|FG016|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
48932906|NCT00896532|157584550|FG017|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
48932907|NCT00896532|157584551|FG018|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
48932908|NCT00896532|157584552|FG019|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
48932909|NCT00896532|157584553|FG020|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
48932910|NCT00896532|157584554|FG021|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
48932911|NCT00896532|157584555|FG022|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
48932912|NCT00896532|157584533|FG000|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
48932913|NCT00896532|157584534|FG001|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3|||
48932914|NCT00896532|157584535|FG002|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
48932915|NCT00896532|157584536|FG003|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
48932916|NCT00896532|157584537|FG004|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5|||
48932917|NCT00896532|157584538|FG005|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
48932918|NCT00896532|157584539|FG006|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
48932919|NCT00896532|157584540|FG007|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
48932920|NCT00896532|157584541|FG008|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
48932921|NCT00896532|157584542|FG009|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
48932922|NCT00896532|157584543|FG010|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
48932923|NCT00896532|157584544|FG011|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
48932924|NCT00896532|157584545|FG012|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
48932925|NCT00896532|157584546|FG013|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
48932926|NCT00896532|157584547|FG014|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
48932927|NCT00896532|157584548|FG015|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
48932928|NCT00896532|157584549|FG016|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
48932929|NCT00896532|157584550|FG017|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
48932930|NCT00896532|157584551|FG018|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
48932931|NCT00896532|157584552|FG019|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
48932932|NCT00896532|157584553|FG020|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
48932933|NCT00896532|157584554|FG021|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
48932934|NCT00896532|157584555|FG022|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
48932935|NCT00896532|157584533|FG000|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
48932936|NCT00896532|157584534|FG001|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
48932937|NCT00896532|157584535|FG002|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2|||
48932938|NCT00896532|157584536|FG003|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
48932939|NCT00896532|157584537|FG004|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1|||
48932940|NCT00896532|157584538|FG005|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
48932941|NCT00896532|157584539|FG006|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
48932942|NCT00896532|157584540|FG007|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
48932943|NCT00896532|157584541|FG008|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
48932944|NCT00896532|157584542|FG009|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
48932945|NCT00896532|157584543|FG010|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
48932946|NCT00896532|157584544|FG011|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
48932947|NCT00896532|157584545|FG012|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
48932948|NCT00896532|157584546|FG013|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
48932949|NCT00896532|157584547|FG014|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
48932950|NCT00896532|157584548|FG015|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
48932951|NCT00896532|157584549|FG016|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
48932952|NCT00896532|157584550|FG017|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
48932953|NCT00896532|157584551|FG018|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
48932954|NCT00896532|157584552|FG019|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
48932955|NCT00896532|157584553|FG020|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
48932956|NCT00896532|157584554|FG021|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
48932957|NCT00896532|157584555|FG022|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
48932958|NCT00896532|157584533|FG000|Months 1-24: Romosozumab Treatment Phase|Death|1|||
48932959|NCT00896532|157584534|FG001|Months 1-24: Romosozumab Treatment Phase|Death|0|||
48932960|NCT00896532|157584535|FG002|Months 1-24: Romosozumab Treatment Phase|Death|0|||
48932961|NCT00896532|157584536|FG003|Months 1-24: Romosozumab Treatment Phase|Death|1|||
48932962|NCT00896532|157584537|FG004|Months 1-24: Romosozumab Treatment Phase|Death|0|||
48932963|NCT00896532|157584538|FG005|Months 1-24: Romosozumab Treatment Phase|Death|0|||
48932964|NCT00896532|157584539|FG006|Months 1-24: Romosozumab Treatment Phase|Death|0|||
48932965|NCT00896532|157584540|FG007|Months 1-24: Romosozumab Treatment Phase|Death|0|||
48932966|NCT00896532|157584541|FG008|Months 1-24: Romosozumab Treatment Phase|Death|0|||
48932967|NCT00896532|157584542|FG009|Months 1-24: Romosozumab Treatment Phase|Death|0|||
48932968|NCT00896532|157584543|FG010|Months 1-24: Romosozumab Treatment Phase|Death|0|||
48932969|NCT00896532|157584544|FG011|Months 1-24: Romosozumab Treatment Phase|Death|0|||
48932970|NCT00896532|157584545|FG012|Months 1-24: Romosozumab Treatment Phase|Death|0|||
48932971|NCT00896532|157584546|FG013|Months 1-24: Romosozumab Treatment Phase|Death|0|||
48932972|NCT00896532|157584547|FG014|Months 1-24: Romosozumab Treatment Phase|Death|0|||
48932973|NCT00896532|157584548|FG015|Months 1-24: Romosozumab Treatment Phase|Death|0|||
48932974|NCT00896532|157584549|FG016|Months 1-24: Romosozumab Treatment Phase|Death|0|||
48932975|NCT00896532|157584550|FG017|Months 1-24: Romosozumab Treatment Phase|Death|0|||
48932976|NCT00896532|157584551|FG018|Months 1-24: Romosozumab Treatment Phase|Death|0|||
48932977|NCT00896532|157584552|FG019|Months 1-24: Romosozumab Treatment Phase|Death|0|||
48932978|NCT00896532|157584553|FG020|Months 1-24: Romosozumab Treatment Phase|Death|0|||
48932979|NCT00896532|157584554|FG021|Months 1-24: Romosozumab Treatment Phase|Death|0|||
48932980|NCT00896532|157584555|FG022|Months 1-24: Romosozumab Treatment Phase|Death|0|||
48932981|NCT00896532|157584533|FG000|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
48932982|NCT00896532|157584534|FG001|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
48845823|NCT01998958|157276682|FG016|Open Label Phase (Optional)|Lack of Efficacy|0|||
48845824|NCT01998958|157276683|FG017|Open Label Phase (Optional)|Lack of Efficacy|0|||
48845825|NCT01998958|157276684|FG018|Open Label Phase (Optional)|Lack of Efficacy|0|||
48845826|NCT01998958|157276685|FG019|Open Label Phase (Optional)|Lack of Efficacy|0|||
48845827|NCT01998958|157276686|FG020|Open Label Phase (Optional)|Lack of Efficacy|0|||
48845828|NCT01998958|157276687|FG021|Open Label Phase (Optional)|Lack of Efficacy|1|||
48845829|NCT01998958|157276688|FG022|Open Label Phase (Optional)|Lack of Efficacy|2|||
48845830|NCT01998958|157276689|FG023|Open Label Phase (Optional)|Lack of Efficacy|0|||
48845831|NCT01998958|157276690|FG024|Open Label Phase (Optional)|Lack of Efficacy|0|||
48845832|NCT01998958|157276691|FG025|Open Label Phase (Optional)|Lack of Efficacy|0|||
48845833|NCT01998958|157276692|FG026|Open Label Phase (Optional)|Lack of Efficacy|0|||
48845834|NCT01998958|157276693|FG027|Open Label Phase (Optional)|Lack of Efficacy|0|||
48845835|NCT01998958|157276694|FG028|Open Label Phase (Optional)|Lack of Efficacy|0|||
48845836|NCT01998958|157276695|FG029|Open Label Phase (Optional)|Lack of Efficacy|0|||
48845837|NCT01998958|157276696|FG030|Open Label Phase (Optional)|Lack of Efficacy|0|||
48845838|NCT01998958|157276697|FG031|Open Label Phase (Optional)|Lack of Efficacy|0|||
48845839|NCT01998958|157276666|FG000|Open Label Phase (Optional)|Withdrawal by Subject|0|||
48845840|NCT01998958|157276667|FG001|Open Label Phase (Optional)|Withdrawal by Subject|0|||
48845841|NCT01998958|157276668|FG002|Open Label Phase (Optional)|Withdrawal by Subject|0|||
48845842|NCT01998958|157276669|FG003|Open Label Phase (Optional)|Withdrawal by Subject|0|||
48845843|NCT01998958|157276670|FG004|Open Label Phase (Optional)|Withdrawal by Subject|0|||
48845844|NCT01998958|157276671|FG005|Open Label Phase (Optional)|Withdrawal by Subject|0|||
48845845|NCT01998958|157276672|FG006|Open Label Phase (Optional)|Withdrawal by Subject|0|||
48845846|NCT01998958|157276673|FG007|Open Label Phase (Optional)|Withdrawal by Subject|0|||
48845847|NCT01998958|157276674|FG008|Open Label Phase (Optional)|Withdrawal by Subject|0|||
48845848|NCT01998958|157276675|FG009|Open Label Phase (Optional)|Withdrawal by Subject|0|||
48845849|NCT01998958|157276676|FG010|Open Label Phase (Optional)|Withdrawal by Subject|0|||
48845850|NCT01998958|157276677|FG011|Open Label Phase (Optional)|Withdrawal by Subject|0|||
48845851|NCT01998958|157276678|FG012|Open Label Phase (Optional)|Withdrawal by Subject|0|||
48845852|NCT01998958|157276679|FG013|Open Label Phase (Optional)|Withdrawal by Subject|0|||
48845853|NCT01998958|157276680|FG014|Open Label Phase (Optional)|Withdrawal by Subject|0|||
48845854|NCT01998958|157276681|FG015|Open Label Phase (Optional)|Withdrawal by Subject|0|||
48845855|NCT01998958|157276682|FG016|Open Label Phase (Optional)|Withdrawal by Subject|0|||
48845856|NCT01998958|157276683|FG017|Open Label Phase (Optional)|Withdrawal by Subject|0|||
48845857|NCT01998958|157276684|FG018|Open Label Phase (Optional)|Withdrawal by Subject|0|||
48845858|NCT01998958|157276685|FG019|Open Label Phase (Optional)|Withdrawal by Subject|0|||
48845859|NCT01998958|157276686|FG020|Open Label Phase (Optional)|Withdrawal by Subject|0|||
48845860|NCT01998958|157276687|FG021|Open Label Phase (Optional)|Withdrawal by Subject|2|||
48845861|NCT01998958|157276688|FG022|Open Label Phase (Optional)|Withdrawal by Subject|1|||
48845862|NCT01998958|157276689|FG023|Open Label Phase (Optional)|Withdrawal by Subject|2|||
48932983|NCT00896532|157584535|FG002|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1|||
48845863|NCT01998958|157276690|FG024|Open Label Phase (Optional)|Withdrawal by Subject|0|||
48932984|NCT00896532|157584536|FG003|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
48932985|NCT00896532|157584537|FG004|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
48932986|NCT00896532|157584538|FG005|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
48932987|NCT00896532|157584539|FG006|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
48932988|NCT00896532|157584540|FG007|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
48932989|NCT00896532|157584541|FG008|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
48932990|NCT00896532|157584542|FG009|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
48932991|NCT00896532|157584543|FG010|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
48932992|NCT00896532|157584544|FG011|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
48932993|NCT00896532|157584545|FG012|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
48932994|NCT00896532|157584546|FG013|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
48932995|NCT00896532|157584547|FG014|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
48932996|NCT00896532|157584548|FG015|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
48932997|NCT00896532|157584549|FG016|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
48932998|NCT00896532|157584550|FG017|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
48932999|NCT00896532|157584551|FG018|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
48933000|NCT00896532|157584552|FG019|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
48933001|NCT00896532|157584553|FG020|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
48933002|NCT00896532|157584554|FG021|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
48933003|NCT00896532|157584555|FG022|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
48933004|NCT00896532|157584533|FG000|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
48933005|NCT00896532|157584534|FG001|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
48933006|NCT00896532|157584535|FG002|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1|||
48933007|NCT00896532|157584536|FG003|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
48933008|NCT00896532|157584537|FG004|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
48933009|NCT00896532|157584538|FG005|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
48933010|NCT00896532|157584539|FG006|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
48933011|NCT00896532|157584540|FG007|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
48933012|NCT00896532|157584541|FG008|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
48933013|NCT00896532|157584542|FG009|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
48933014|NCT00896532|157584543|FG010|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
48933015|NCT00896532|157584544|FG011|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
48933016|NCT00896532|157584545|FG012|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
48933017|NCT00896532|157584546|FG013|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
48933018|NCT00896532|157584547|FG014|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
48845864|NCT01998958|157276691|FG025|Open Label Phase (Optional)|Withdrawal by Subject|0|||
48845865|NCT01998958|157276692|FG026|Open Label Phase (Optional)|Withdrawal by Subject|0|||
48845866|NCT01998958|157276693|FG027|Open Label Phase (Optional)|Withdrawal by Subject|0|||
48845867|NCT01998958|157276694|FG028|Open Label Phase (Optional)|Withdrawal by Subject|0|||
48845868|NCT01998958|157276695|FG029|Open Label Phase (Optional)|Withdrawal by Subject|0|||
48845869|NCT01998958|157276696|FG030|Open Label Phase (Optional)|Withdrawal by Subject|0|||
48845870|NCT01998958|157276697|FG031|Open Label Phase (Optional)|Withdrawal by Subject|0|||
48845871|NCT00480077|157276701|FG000|Overall Study|Death|19|||
48845872|NCT00480077|157276702|FG001|Overall Study|Death|15|||
48845873|NCT00480077|157276701|FG000|Overall Study|early exit|12|||
48845874|NCT00480077|157276702|FG001|Overall Study|early exit|11|||
48845875|NCT02101281|157276703|FG000|Overall Study|Adverse Event|0|||
48845876|NCT02101281|157276704|FG001|Overall Study|Adverse Event|1|||
48845877|NCT00002540|157276705|FG000|Overall Study|Cancer Before Rand. (Prostate Screening)|0|||
48845878|NCT00002540|157276706|FG001|Overall Study|Cancer Before Rand. (Prostate Screening)|25|||
48845879|NCT00002540|157276705|FG000|Overall Study|Died Before Randomization|2|||
48845880|NCT00002540|157276706|FG001|Overall Study|Died Before Randomization|6|||
48845881|NCT00002540|157276705|FG000|Overall Study|Died Before ASU (Control)|202|||
48845882|NCT00002540|157276706|FG001|Overall Study|Died Before ASU (Control)|0|||
48845883|NCT00002540|157276705|FG000|Overall Study|Refused ASU (Control)|597|||
48845884|NCT00002540|157276706|FG001|Overall Study|Refused ASU (Control)|0|||
48845885|NCT00002540|157276705|FG000|Overall Study|Refused Screen (Prostate Screening)|0|||
48845886|NCT00002540|157276706|FG001|Overall Study|Refused Screen (Prostate Screening)|2433|||
48845887|NCT01095796|157276707|FG000|Overall Study|Randomized but Not Treated|5|||
48845888|NCT01095796|157276708|FG001|Overall Study|Randomized but Not Treated|2|||
48845889|NCT01095796|157276707|FG000|Overall Study|Adverse Event|9|||
48933019|NCT00896532|157584548|FG015|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
48933020|NCT00896532|157584549|FG016|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
48933021|NCT00896532|157584550|FG017|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
48933022|NCT00896532|157584551|FG018|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
48933023|NCT00896532|157584552|FG019|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
48933024|NCT00896532|157584553|FG020|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
48933025|NCT00896532|157584554|FG021|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
48933026|NCT00896532|157584555|FG022|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
48933027|NCT00896532|157584533|FG000|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
48933028|NCT00896532|157584534|FG001|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
48933029|NCT00896532|157584535|FG002|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
48933030|NCT00896532|157584536|FG003|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1|||
48845890|NCT01095796|157276708|FG001|Overall Study|Adverse Event|19|||
48933031|NCT00896532|157584537|FG004|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
48933032|NCT00896532|157584538|FG005|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
48933033|NCT00896532|157584539|FG006|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
48933034|NCT00896532|157584540|FG007|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
48845891|NCT01095796|157276707|FG000|Overall Study|Death|3|||
48845892|NCT01095796|157276708|FG001|Overall Study|Death|2|||
48845893|NCT01095796|157276707|FG000|Overall Study|Pregnancy|2|||
48845894|NCT01095796|157276708|FG001|Overall Study|Pregnancy|0|||
48845895|NCT01095796|157276707|FG000|Overall Study|Lack of Efficacy|5|||
48933035|NCT00896532|157584541|FG008|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
48845896|NCT01095796|157276708|FG001|Overall Study|Lack of Efficacy|3|||
48845897|NCT01095796|157276707|FG000|Overall Study|Investigator's Discretion|7|||
48845898|NCT01095796|157276708|FG001|Overall Study|Investigator's Discretion|2|||
48845899|NCT01095796|157276707|FG000|Overall Study|Withdrew Consent|16|||
48845900|NCT01095796|157276708|FG001|Overall Study|Withdrew Consent|22|||
48845901|NCT01095796|157276707|FG000|Overall Study|Lost to Follow-up|27|||
48845902|NCT01095796|157276708|FG001|Overall Study|Lost to Follow-up|29|||
48845903|NCT01095796|157276707|FG000|Overall Study|Participant Noncompliance|5|||
48845904|NCT01095796|157276708|FG001|Overall Study|Participant Noncompliance|10|||
48845905|NCT01095796|157276707|FG000|Overall Study|Protocol Violation|1|||
48845906|NCT01095796|157276708|FG001|Overall Study|Protocol Violation|0|||
48845907|NCT01095796|157276707|FG000|Overall Study|Participant Transferred to Another Study|215|||
48845908|NCT01095796|157276708|FG001|Overall Study|Participant Transferred to Another Study|200|||
48845909|NCT03655262|157276715|FG000|Overall Study|Withdrawal by Subject|0|||
48845910|NCT03655262|157276716|FG001|Overall Study|Withdrawal by Subject|0|||
48845911|NCT03655262|157276717|FG002|Overall Study|Withdrawal by Subject|1|||
48845912|NCT01989455|157276718|FG000|Overall Study|Adverse Event|0|||
48845913|NCT01989455|157276719|FG001|Overall Study|Adverse Event|1|||
48845914|NCT01989455|157276720|FG002|Overall Study|Adverse Event|0|||
48845915|NCT01989455|157276721|FG003|Overall Study|Adverse Event|0|||
48845916|NCT01989455|157276722|FG004|Overall Study|Adverse Event|0|||
48845917|NCT01989455|157276718|FG000|Overall Study|Withdrawal by Subject|0|||
48845918|NCT01989455|157276719|FG001|Overall Study|Withdrawal by Subject|1|||
48845919|NCT01989455|157276720|FG002|Overall Study|Withdrawal by Subject|0|||
48845920|NCT01989455|157276721|FG003|Overall Study|Withdrawal by Subject|0|||
48845921|NCT01989455|157276722|FG004|Overall Study|Withdrawal by Subject|0|||
48845922|NCT01989455|157276718|FG000|Overall Study|Technical problems with infusion|0|||
48845923|NCT01989455|157276719|FG001|Overall Study|Technical problems with infusion|0|||
48845924|NCT01989455|157276720|FG002|Overall Study|Technical problems with infusion|1|||
48845925|NCT01989455|157276721|FG003|Overall Study|Technical problems with infusion|0|||
48845926|NCT01989455|157276722|FG004|Overall Study|Technical problems with infusion|1|||
48845927|NCT00632203|157276725|FG000|Overall Study|Did not start study treatment|1|||
48845928|NCT00632203|157276726|FG001|Overall Study|Did not start study treatment|0|||
48845929|NCT04452318|157276729|FG000|Overall Study|Physician Decision|1|||
48845930|NCT04452318|157276730|FG001|Overall Study|Physician Decision|2|||
48845931|NCT04452318|157276731|FG002|Overall Study|Physician Decision|0|||
48845932|NCT04452318|157276732|FG003|Overall Study|Physician Decision|2|||
48845933|NCT04452318|157276733|FG004|Overall Study|Physician Decision|0|||
48845934|NCT04452318|157276734|FG005|Overall Study|Physician Decision|2|||
48845935|NCT04452318|157276735|FG006|Overall Study|Physician Decision|5|||
48845936|NCT04452318|157276729|FG000|Overall Study|Death|2|||
48845937|NCT04452318|157276730|FG001|Overall Study|Death|3|||
48845938|NCT04452318|157276731|FG002|Overall Study|Death|0|||
48845939|NCT04452318|157276732|FG003|Overall Study|Death|0|||
48845940|NCT04452318|157276733|FG004|Overall Study|Death|0|||
48845941|NCT04452318|157276734|FG005|Overall Study|Death|0|||
48845942|NCT04452318|157276735|FG006|Overall Study|Death|0|||
48845943|NCT04452318|157276729|FG000|Overall Study|Lost to Follow-up|38|||
48845944|NCT04452318|157276730|FG001|Overall Study|Lost to Follow-up|28|||
48845945|NCT04452318|157276731|FG002|Overall Study|Lost to Follow-up|0|||
48845946|NCT04452318|157276732|FG003|Overall Study|Lost to Follow-up|3|||
48845947|NCT04452318|157276733|FG004|Overall Study|Lost to Follow-up|3|||
48845948|NCT04452318|157276734|FG005|Overall Study|Lost to Follow-up|2|||
48845949|NCT04452318|157276735|FG006|Overall Study|Lost to Follow-up|1|||
48845950|NCT04452318|157276729|FG000|Overall Study|Withdrawal by Subject|46|||
48845951|NCT04452318|157276730|FG001|Overall Study|Withdrawal by Subject|40|||
48845952|NCT04452318|157276731|FG002|Overall Study|Withdrawal by Subject|0|||
48845953|NCT04452318|157276732|FG003|Overall Study|Withdrawal by Subject|18|||
48845954|NCT04452318|157276733|FG004|Overall Study|Withdrawal by Subject|6|||
48845955|NCT04452318|157276734|FG005|Overall Study|Withdrawal by Subject|8|||
48845956|NCT04452318|157276735|FG006|Overall Study|Withdrawal by Subject|6|||
48845957|NCT02554786|157276736|FG000|Overall Study|Subject/guardian decision|29|||
48933036|NCT00896532|157584542|FG009|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
48845958|NCT02554786|157276737|FG001|Overall Study|Subject/guardian decision|17|||
48845959|NCT02554786|157276738|FG002|Overall Study|Subject/guardian decision|18|||
48845960|NCT02554786|157276739|FG003|Overall Study|Subject/guardian decision|30|||
48845961|NCT02554786|157276740|FG004|Overall Study|Subject/guardian decision|20|||
48845962|NCT02554786|157276736|FG000|Overall Study|Lost to Follow-up|4|||
48845963|NCT02554786|157276737|FG001|Overall Study|Lost to Follow-up|3|||
48845964|NCT02554786|157276738|FG002|Overall Study|Lost to Follow-up|4|||
48845965|NCT02554786|157276739|FG003|Overall Study|Lost to Follow-up|2|||
48845966|NCT02554786|157276740|FG004|Overall Study|Lost to Follow-up|2|||
48845967|NCT02554786|157276736|FG000|Overall Study|Protocol deviation|1|||
48845968|NCT02554786|157276737|FG001|Overall Study|Protocol deviation|3|||
48845969|NCT02554786|157276738|FG002|Overall Study|Protocol deviation|3|||
48845970|NCT02554786|157276739|FG003|Overall Study|Protocol deviation|4|||
48845971|NCT02554786|157276740|FG004|Overall Study|Protocol deviation|2|||
48845972|NCT02554786|157276736|FG000|Overall Study|Technical problems|1|||
48845973|NCT02554786|157276737|FG001|Overall Study|Technical problems|1|||
48845974|NCT02554786|157276738|FG002|Overall Study|Technical problems|0|||
48845975|NCT02554786|157276739|FG003|Overall Study|Technical problems|2|||
48845976|NCT02554786|157276740|FG004|Overall Study|Technical problems|1|||
48845977|NCT02554786|157276736|FG000|Overall Study|Adverse Event|0|||
48845978|NCT02554786|157276737|FG001|Overall Study|Adverse Event|0|||
48845979|NCT02554786|157276738|FG002|Overall Study|Adverse Event|0|||
48845980|NCT02554786|157276739|FG003|Overall Study|Adverse Event|0|||
48845981|NCT02554786|157276740|FG004|Overall Study|Adverse Event|2|||
48845982|NCT02554786|157276736|FG000|Overall Study|Death|0|||
48845983|NCT02554786|157276737|FG001|Overall Study|Death|0|||
48845984|NCT02554786|157276738|FG002|Overall Study|Death|0|||
48845985|NCT02554786|157276739|FG003|Overall Study|Death|1|||
48845986|NCT02554786|157276740|FG004|Overall Study|Death|0|||
48845987|NCT02554786|157276736|FG000|Overall Study|Non-compliance with study treatment|0|||
48845988|NCT02554786|157276737|FG001|Overall Study|Non-compliance with study treatment|1|||
48845989|NCT02554786|157276738|FG002|Overall Study|Non-compliance with study treatment|1|||
48845990|NCT02554786|157276739|FG003|Overall Study|Non-compliance with study treatment|0|||
48845991|NCT02554786|157276740|FG004|Overall Study|Non-compliance with study treatment|1|||
48845992|NCT02554786|157276736|FG000|Overall Study|Physician Decision|0|||
48845993|NCT02554786|157276737|FG001|Overall Study|Physician Decision|1|||
48845994|NCT02554786|157276738|FG002|Overall Study|Physician Decision|4|||
48845995|NCT02554786|157276739|FG003|Overall Study|Physician Decision|1|||
48845996|NCT02554786|157276740|FG004|Overall Study|Physician Decision|1|||
48845997|NCT02554786|157276736|FG000|Overall Study|Pregnancy|0|||
48845998|NCT02554786|157276737|FG001|Overall Study|Pregnancy|0|||
48845999|NCT02554786|157276738|FG002|Overall Study|Pregnancy|0|||
48846000|NCT02554786|157276739|FG003|Overall Study|Pregnancy|1|||
48846001|NCT02554786|157276740|FG004|Overall Study|Pregnancy|1|||
48846002|NCT00448669|157276743|FG000|Overall Study|Lost to Follow-up|52|||
48846003|NCT00448669|157276744|FG001|Overall Study|Lost to Follow-up|63|||
48846004|NCT00448669|157276743|FG000|Overall Study|Withdrawal by Subject|90|||
48846005|NCT00448669|157276744|FG001|Overall Study|Withdrawal by Subject|74|||
48846006|NCT00448669|157276743|FG000|Overall Study|Relocated|49|||
48846007|NCT00448669|157276744|FG001|Overall Study|Relocated|36|||
48846008|NCT00448669|157276743|FG000|Overall Study|Were withdrawn by investigator|10|||
48846009|NCT00448669|157276744|FG001|Overall Study|Were withdrawn by investigator|6|||
48846010|NCT00448669|157276743|FG000|Overall Study|Death|2|||
48933037|NCT00896532|157584543|FG010|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
48933038|NCT00896532|157584544|FG011|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
48933039|NCT00896532|157584545|FG012|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
48933040|NCT00896532|157584546|FG013|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
48933041|NCT00896532|157584547|FG014|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
48933042|NCT00896532|157584548|FG015|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
48933043|NCT00896532|157584549|FG016|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
48933044|NCT00896532|157584550|FG017|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
48933045|NCT00896532|157584551|FG018|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
48933046|NCT00896532|157584552|FG019|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
48933047|NCT00896532|157584553|FG020|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
48933048|NCT00896532|157584554|FG021|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
48846011|NCT00448669|157276744|FG001|Overall Study|Death|4|||
48846012|NCT00448669|157276743|FG000|Overall Study|Had other reasons|5|||
48846013|NCT00448669|157276744|FG001|Overall Study|Had other reasons|6|||
48846014|NCT00448669|157276743|FG000|Overall Study|HIV-infected at enrollment|1|||
48846015|NCT00448669|157276744|FG001|Overall Study|HIV-infected at enrollment|2|||
48846016|NCT00448669|157276743|FG000|Overall Study|Never started drug|9|||
48846017|NCT00448669|157276744|FG001|Overall Study|Never started drug|7|||
48846018|NCT04287985|157276745|FG000|Overall Study|Adverse Event|1|||
48846019|NCT04287985|157276746|FG001|Overall Study|Adverse Event|0|||
48846020|NCT04287985|157276747|FG002|Overall Study|Adverse Event|0|||
48846021|NCT04287985|157276748|FG003|Overall Study|Adverse Event|0|||
48933049|NCT00896532|157584555|FG022|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
48933050|NCT00896532|157584533|FG000|Months 1-24: Romosozumab Treatment Phase|Other|0|||
48933051|NCT00896532|157584534|FG001|Months 1-24: Romosozumab Treatment Phase|Other|1|||
48933052|NCT00896532|157584535|FG002|Months 1-24: Romosozumab Treatment Phase|Other|0|||
48933053|NCT00896532|157584536|FG003|Months 1-24: Romosozumab Treatment Phase|Other|1|||
48933054|NCT00896532|157584537|FG004|Months 1-24: Romosozumab Treatment Phase|Other|1|||
48933055|NCT00896532|157584538|FG005|Months 1-24: Romosozumab Treatment Phase|Other|0|||
48933056|NCT00896532|157584539|FG006|Months 1-24: Romosozumab Treatment Phase|Other|0|||
48933057|NCT00896532|157584540|FG007|Months 1-24: Romosozumab Treatment Phase|Other|0|||
48933058|NCT00896532|157584541|FG008|Months 1-24: Romosozumab Treatment Phase|Other|0|||
48933059|NCT00896532|157584542|FG009|Months 1-24: Romosozumab Treatment Phase|Other|0|||
48933060|NCT00896532|157584543|FG010|Months 1-24: Romosozumab Treatment Phase|Other|0|||
48933061|NCT00896532|157584544|FG011|Months 1-24: Romosozumab Treatment Phase|Other|0|||
48933062|NCT00896532|157584545|FG012|Months 1-24: Romosozumab Treatment Phase|Other|0|||
48933063|NCT00896532|157584546|FG013|Months 1-24: Romosozumab Treatment Phase|Other|0|||
48933064|NCT00896532|157584547|FG014|Months 1-24: Romosozumab Treatment Phase|Other|0|||
48933065|NCT00896532|157584548|FG015|Months 1-24: Romosozumab Treatment Phase|Other|0|||
48933066|NCT00896532|157584549|FG016|Months 1-24: Romosozumab Treatment Phase|Other|0|||
48933067|NCT00896532|157584550|FG017|Months 1-24: Romosozumab Treatment Phase|Other|0|||
48933068|NCT00896532|157584551|FG018|Months 1-24: Romosozumab Treatment Phase|Other|0|||
48933069|NCT00896532|157584552|FG019|Months 1-24: Romosozumab Treatment Phase|Other|0|||
48933070|NCT00896532|157584553|FG020|Months 1-24: Romosozumab Treatment Phase|Other|0|||
48933071|NCT00896532|157584554|FG021|Months 1-24: Romosozumab Treatment Phase|Other|0|||
48933072|NCT00896532|157584555|FG022|Months 1-24: Romosozumab Treatment Phase|Other|0|||
48933073|NCT00896532|157584533|FG000|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
48933074|NCT00896532|157584534|FG001|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
48933075|NCT00896532|157584535|FG002|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
48933076|NCT00896532|157584536|FG003|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
48933077|NCT00896532|157584537|FG004|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
48933078|NCT00896532|157584538|FG005|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
48933079|NCT00896532|157584539|FG006|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
48933080|NCT00896532|157584540|FG007|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
48933081|NCT00896532|157584541|FG008|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1|||
48933082|NCT00896532|157584542|FG009|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
48933083|NCT00896532|157584543|FG010|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
48933084|NCT00896532|157584544|FG011|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
48933085|NCT00896532|157584545|FG012|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
48933086|NCT00896532|157584546|FG013|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
48933087|NCT00896532|157584547|FG014|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
48933088|NCT00896532|157584548|FG015|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
48933089|NCT00896532|157584549|FG016|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
48933090|NCT00896532|157584550|FG017|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
48933091|NCT00896532|157584551|FG018|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
48933092|NCT00896532|157584552|FG019|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
48933093|NCT00896532|157584553|FG020|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
48933094|NCT00896532|157584554|FG021|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
48933095|NCT00896532|157584555|FG022|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
48933096|NCT00896532|157584533|FG000|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
48933097|NCT00896532|157584534|FG001|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
48933098|NCT00896532|157584535|FG002|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
48933099|NCT00896532|157584536|FG003|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
48933100|NCT00896532|157584537|FG004|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
48933101|NCT00896532|157584538|FG005|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
48933102|NCT00896532|157584539|FG006|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
48933103|NCT00896532|157584540|FG007|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
48933104|NCT00896532|157584541|FG008|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
48933105|NCT00896532|157584542|FG009|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
48933106|NCT00896532|157584543|FG010|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
48933107|NCT00896532|157584544|FG011|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
48933108|NCT00896532|157584545|FG012|Months 24-36: Denosumab Extension Phase|Noncompliance|1|||
48933109|NCT00896532|157584546|FG013|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
48933110|NCT00896532|157584547|FG014|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
48933111|NCT00896532|157584548|FG015|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
48933112|NCT00896532|157584549|FG016|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
48933113|NCT00896532|157584550|FG017|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
48933114|NCT00896532|157584551|FG018|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
48933115|NCT00896532|157584552|FG019|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
48933116|NCT00896532|157584553|FG020|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
48933117|NCT00896532|157584554|FG021|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
48933118|NCT00896532|157584555|FG022|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
48933119|NCT00896532|157584533|FG000|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
48933120|NCT00896532|157584534|FG001|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
48933121|NCT00896532|157584535|FG002|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
48933122|NCT00896532|157584536|FG003|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
48933123|NCT00896532|157584537|FG004|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
48933124|NCT00896532|157584538|FG005|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
48933125|NCT00896532|157584539|FG006|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
48933126|NCT00896532|157584540|FG007|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
48933127|NCT00896532|157584541|FG008|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
48933128|NCT00896532|157584542|FG009|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
48933129|NCT00896532|157584543|FG010|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
48933130|NCT00896532|157584544|FG011|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
48933131|NCT00896532|157584545|FG012|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
48933132|NCT00896532|157584546|FG013|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
48933133|NCT00896532|157584547|FG014|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
48933134|NCT00896532|157584548|FG015|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
48933135|NCT00896532|157584549|FG016|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
48933136|NCT00896532|157584550|FG017|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
48933137|NCT00896532|157584551|FG018|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
48933138|NCT00896532|157584552|FG019|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
48933139|NCT00896532|157584553|FG020|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
48933140|NCT00896532|157584554|FG021|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
48933141|NCT00896532|157584555|FG022|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
48933142|NCT00896532|157584533|FG000|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
48933143|NCT00896532|157584534|FG001|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
48933144|NCT00896532|157584535|FG002|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
48933145|NCT00896532|157584536|FG003|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
48933146|NCT00896532|157584537|FG004|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
48933147|NCT00896532|157584538|FG005|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
48933148|NCT00896532|157584539|FG006|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
48933149|NCT00896532|157584540|FG007|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
48933150|NCT00896532|157584541|FG008|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
48933151|NCT00896532|157584542|FG009|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
48933152|NCT00896532|157584543|FG010|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
48933153|NCT00896532|157584544|FG011|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
48933154|NCT00896532|157584545|FG012|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
48933155|NCT00896532|157584546|FG013|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
48933156|NCT00896532|157584547|FG014|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
48933157|NCT00896532|157584548|FG015|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
48933158|NCT00896532|157584549|FG016|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
48933159|NCT00896532|157584550|FG017|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
48933160|NCT00896532|157584551|FG018|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
48933161|NCT00896532|157584552|FG019|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
48933162|NCT00896532|157584553|FG020|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
48933163|NCT00896532|157584554|FG021|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
48933164|NCT00896532|157584555|FG022|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
48933165|NCT00896532|157584533|FG000|Months 24-36: Denosumab Extension Phase|Other|0|||
48933166|NCT00896532|157584534|FG001|Months 24-36: Denosumab Extension Phase|Other|0|||
48933167|NCT00896532|157584535|FG002|Months 24-36: Denosumab Extension Phase|Other|0|||
48933168|NCT00896532|157584536|FG003|Months 24-36: Denosumab Extension Phase|Other|0|||
48933169|NCT00896532|157584537|FG004|Months 24-36: Denosumab Extension Phase|Other|0|||
48933170|NCT00896532|157584538|FG005|Months 24-36: Denosumab Extension Phase|Other|0|||
48846022|NCT04287985|157276745|FG000|Overall Study|Protocol Violation|0|||
48846023|NCT04287985|157276746|FG001|Overall Study|Protocol Violation|1|||
48846024|NCT04287985|157276747|FG002|Overall Study|Protocol Violation|0|||
48846025|NCT04287985|157276748|FG003|Overall Study|Protocol Violation|0|||
48846026|NCT04287985|157276745|FG000|Overall Study|Physician Decision|0|||
48846027|NCT04287985|157276746|FG001|Overall Study|Physician Decision|0|||
48846028|NCT04287985|157276747|FG002|Overall Study|Physician Decision|0|||
48846029|NCT04287985|157276748|FG003|Overall Study|Physician Decision|1|||
48846030|NCT04287985|157276745|FG000|Overall Study|Withdrawal by Subject|2|||
48846031|NCT04287985|157276746|FG001|Overall Study|Withdrawal by Subject|1|||
48846032|NCT04287985|157276747|FG002|Overall Study|Withdrawal by Subject|1|||
48846033|NCT04287985|157276748|FG003|Overall Study|Withdrawal by Subject|2|||
48846034|NCT02638337|157276749|FG000|Overall Study|Adverse Event|6|||
48846035|NCT02638337|157276750|FG001|Overall Study|Adverse Event|10|||
48846036|NCT02638337|157276749|FG000|Overall Study|Protocol Violation|3|||
48846037|NCT02638337|157276750|FG001|Overall Study|Protocol Violation|0|||
48846038|NCT02638337|157276749|FG000|Overall Study|Withdrawal by Subject|13|||
48846039|NCT02638337|157276750|FG001|Overall Study|Withdrawal by Subject|16|||
48846040|NCT02638337|157276749|FG000|Overall Study|Lost to Follow-up|7|||
48846041|NCT02638337|157276750|FG001|Overall Study|Lost to Follow-up|7|||
48846042|NCT02638337|157276749|FG000|Overall Study|Other - Miscellaneous|4|||
48846043|NCT02638337|157276750|FG001|Overall Study|Other - Miscellaneous|3|||
48846044|NCT01340066|157276752|FG000|Placebo Run in Period|Screen Failures|27|||
48846045|NCT01340066|157276753|FG001|Placebo Run in Period|Screen Failures|0|||
48846046|NCT01340066|157276754|FG002|Placebo Run in Period|Screen Failures|0|||
48846047|NCT01340066|157276752|FG000|5 Week Double Blind Randomization Period|Adverse Event|0|||
48846048|NCT01340066|157276753|FG001|5 Week Double Blind Randomization Period|Adverse Event|2|||
48846049|NCT01340066|157276754|FG002|5 Week Double Blind Randomization Period|Adverse Event|2|||
48846050|NCT01340066|157276752|FG000|5 Week Double Blind Randomization Period|Physician Decision|0|||
48846051|NCT01340066|157276753|FG001|5 Week Double Blind Randomization Period|Physician Decision|1|||
48846052|NCT01340066|157276754|FG002|5 Week Double Blind Randomization Period|Physician Decision|0|||
48933171|NCT00896532|157584539|FG006|Months 24-36: Denosumab Extension Phase|Other|0|||
48933172|NCT00896532|157584540|FG007|Months 24-36: Denosumab Extension Phase|Other|0|||
48933173|NCT00896532|157584541|FG008|Months 24-36: Denosumab Extension Phase|Other|0|||
48933174|NCT00896532|157584542|FG009|Months 24-36: Denosumab Extension Phase|Other|0|||
48933175|NCT00896532|157584543|FG010|Months 24-36: Denosumab Extension Phase|Other|1|||
48933176|NCT00896532|157584544|FG011|Months 24-36: Denosumab Extension Phase|Other|2|||
48933177|NCT00896532|157584545|FG012|Months 24-36: Denosumab Extension Phase|Other|2|||
48933178|NCT00896532|157584546|FG013|Months 24-36: Denosumab Extension Phase|Other|1|||
48933179|NCT00896532|157584547|FG014|Months 24-36: Denosumab Extension Phase|Other|0|||
48933180|NCT00896532|157584548|FG015|Months 24-36: Denosumab Extension Phase|Other|0|||
48933181|NCT00896532|157584549|FG016|Months 24-36: Denosumab Extension Phase|Other|0|||
48933182|NCT00896532|157584550|FG017|Months 24-36: Denosumab Extension Phase|Other|0|||
48933183|NCT00896532|157584551|FG018|Months 24-36: Denosumab Extension Phase|Other|0|||
48933184|NCT00896532|157584552|FG019|Months 24-36: Denosumab Extension Phase|Other|0|||
48933185|NCT00896532|157584553|FG020|Months 24-36: Denosumab Extension Phase|Other|0|||
48933186|NCT00896532|157584554|FG021|Months 24-36: Denosumab Extension Phase|Other|0|||
48933187|NCT00896532|157584555|FG022|Months 24-36: Denosumab Extension Phase|Other|0|||
48933188|NCT00896532|157584533|FG000|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
48933189|NCT00896532|157584534|FG001|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
48933190|NCT00896532|157584535|FG002|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
48933191|NCT00896532|157584536|FG003|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
48933192|NCT00896532|157584537|FG004|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
48933193|NCT00896532|157584538|FG005|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
48933194|NCT00896532|157584539|FG006|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
48933195|NCT00896532|157584540|FG007|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
48933196|NCT00896532|157584541|FG008|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
48933197|NCT00896532|157584542|FG009|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
48933198|NCT00896532|157584543|FG010|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
48933199|NCT00896532|157584544|FG011|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
48933200|NCT00896532|157584545|FG012|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
48933201|NCT00896532|157584546|FG013|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
48933202|NCT00896532|157584547|FG014|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
48933203|NCT00896532|157584548|FG015|Months 36-48: Romosozumab Retreatment|Adverse Event|1|||
48933204|NCT00896532|157584549|FG016|Months 36-48: Romosozumab Retreatment|Adverse Event|3|||
48933205|NCT00896532|157584550|FG017|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
48933206|NCT00896532|157584551|FG018|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
48933207|NCT00896532|157584552|FG019|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
48933208|NCT00896532|157584553|FG020|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
48933209|NCT00896532|157584554|FG021|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
48933210|NCT00896532|157584555|FG022|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
48933211|NCT00896532|157584533|FG000|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
48933212|NCT00896532|157584534|FG001|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
48933213|NCT00896532|157584535|FG002|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
48933214|NCT00896532|157584536|FG003|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
48933215|NCT00896532|157584537|FG004|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
48933216|NCT00896532|157584538|FG005|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
48933217|NCT00896532|157584539|FG006|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
48933218|NCT00896532|157584540|FG007|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
48933219|NCT00896532|157584541|FG008|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
48933220|NCT00896532|157584542|FG009|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
48933221|NCT00896532|157584543|FG010|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
48933222|NCT00896532|157584544|FG011|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
48933223|NCT00896532|157584545|FG012|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
48933224|NCT00896532|157584546|FG013|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
48933225|NCT00896532|157584547|FG014|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
48933226|NCT00896532|157584548|FG015|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1|||
48933227|NCT00896532|157584549|FG016|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
48933228|NCT00896532|157584550|FG017|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
48933229|NCT00896532|157584551|FG018|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
48933230|NCT00896532|157584552|FG019|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
48933231|NCT00896532|157584553|FG020|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
48933232|NCT00896532|157584554|FG021|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
48933233|NCT00896532|157584555|FG022|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
48933234|NCT00896532|157584533|FG000|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
48933235|NCT00896532|157584534|FG001|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
48933236|NCT00896532|157584535|FG002|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
48933237|NCT00896532|157584536|FG003|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
48933238|NCT00896532|157584537|FG004|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
48933239|NCT00896532|157584538|FG005|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
48933240|NCT00896532|157584539|FG006|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
48933241|NCT00896532|157584540|FG007|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
48933242|NCT00896532|157584541|FG008|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
48933243|NCT00896532|157584542|FG009|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
48933244|NCT00896532|157584543|FG010|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
48933245|NCT00896532|157584544|FG011|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
48933246|NCT00896532|157584545|FG012|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
48933247|NCT00896532|157584546|FG013|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
48933248|NCT00896532|157584547|FG014|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
48933249|NCT00896532|157584548|FG015|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
48933250|NCT00896532|157584549|FG016|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1|||
48933251|NCT00896532|157584550|FG017|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
48933252|NCT00896532|157584551|FG018|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
48933253|NCT00896532|157584552|FG019|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
48933254|NCT00896532|157584553|FG020|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
48933255|NCT00896532|157584554|FG021|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
48933256|NCT00896532|157584555|FG022|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
48933257|NCT00896532|157584533|FG000|Months 36-48: Romosozumab Retreatment|Other|0|||
48933258|NCT00896532|157584534|FG001|Months 36-48: Romosozumab Retreatment|Other|0|||
48933259|NCT00896532|157584535|FG002|Months 36-48: Romosozumab Retreatment|Other|0|||
48933260|NCT00896532|157584536|FG003|Months 36-48: Romosozumab Retreatment|Other|0|||
48933261|NCT00896532|157584537|FG004|Months 36-48: Romosozumab Retreatment|Other|0|||
48933262|NCT00896532|157584538|FG005|Months 36-48: Romosozumab Retreatment|Other|0|||
48933263|NCT00896532|157584539|FG006|Months 36-48: Romosozumab Retreatment|Other|0|||
48933264|NCT00896532|157584540|FG007|Months 36-48: Romosozumab Retreatment|Other|0|||
48933265|NCT00896532|157584541|FG008|Months 36-48: Romosozumab Retreatment|Other|0|||
48933266|NCT00896532|157584542|FG009|Months 36-48: Romosozumab Retreatment|Other|0|||
48933267|NCT00896532|157584543|FG010|Months 36-48: Romosozumab Retreatment|Other|0|||
48933268|NCT00896532|157584544|FG011|Months 36-48: Romosozumab Retreatment|Other|0|||
48933269|NCT00896532|157584545|FG012|Months 36-48: Romosozumab Retreatment|Other|0|||
48933270|NCT00896532|157584546|FG013|Months 36-48: Romosozumab Retreatment|Other|0|||
48933271|NCT00896532|157584547|FG014|Months 36-48: Romosozumab Retreatment|Other|0|||
48933272|NCT00896532|157584548|FG015|Months 36-48: Romosozumab Retreatment|Other|0|||
48933273|NCT00896532|157584549|FG016|Months 36-48: Romosozumab Retreatment|Other|0|||
48933274|NCT00896532|157584550|FG017|Months 36-48: Romosozumab Retreatment|Other|1|||
48933275|NCT00896532|157584551|FG018|Months 36-48: Romosozumab Retreatment|Other|0|||
48933276|NCT00896532|157584552|FG019|Months 36-48: Romosozumab Retreatment|Other|0|||
48933277|NCT00896532|157584553|FG020|Months 36-48: Romosozumab Retreatment|Other|0|||
48933278|NCT00896532|157584554|FG021|Months 36-48: Romosozumab Retreatment|Other|0|||
48933279|NCT00896532|157584555|FG022|Months 36-48: Romosozumab Retreatment|Other|0|||
48933280|NCT00896532|157584533|FG000|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
48933281|NCT00896532|157584534|FG001|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
48933282|NCT00896532|157584535|FG002|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
48933283|NCT00896532|157584536|FG003|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
48933284|NCT00896532|157584537|FG004|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
48933285|NCT00896532|157584538|FG005|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
48933286|NCT00896532|157584539|FG006|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
48933287|NCT00896532|157584540|FG007|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
48933288|NCT00896532|157584541|FG008|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
48933289|NCT00896532|157584542|FG009|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
48933290|NCT00896532|157584543|FG010|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
48933291|NCT00896532|157584544|FG011|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
48933292|NCT00896532|157584545|FG012|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
48933293|NCT00896532|157584546|FG013|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
48933294|NCT00896532|157584547|FG014|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
48933295|NCT00896532|157584548|FG015|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
48933296|NCT00896532|157584549|FG016|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1|||
48933297|NCT00896532|157584550|FG017|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
48933298|NCT00896532|157584551|FG018|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
48933299|NCT00896532|157584552|FG019|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
48933300|NCT00896532|157584553|FG020|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
48933301|NCT00896532|157584554|FG021|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
48933302|NCT00896532|157584555|FG022|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
48933303|NCT00896532|157584533|FG000|Months 48-72: Follow-on Phase|Death|0|||
48933304|NCT00896532|157584534|FG001|Months 48-72: Follow-on Phase|Death|0|||
48933305|NCT00896532|157584535|FG002|Months 48-72: Follow-on Phase|Death|0|||
48933306|NCT00896532|157584536|FG003|Months 48-72: Follow-on Phase|Death|0|||
48933307|NCT00896532|157584537|FG004|Months 48-72: Follow-on Phase|Death|0|||
48933308|NCT00896532|157584538|FG005|Months 48-72: Follow-on Phase|Death|0|||
48933309|NCT00896532|157584539|FG006|Months 48-72: Follow-on Phase|Death|0|||
48933310|NCT00896532|157584540|FG007|Months 48-72: Follow-on Phase|Death|0|||
48933311|NCT00896532|157584541|FG008|Months 48-72: Follow-on Phase|Death|0|||
48933312|NCT00896532|157584542|FG009|Months 48-72: Follow-on Phase|Death|0|||
48933313|NCT00896532|157584543|FG010|Months 48-72: Follow-on Phase|Death|0|||
48933314|NCT00896532|157584544|FG011|Months 48-72: Follow-on Phase|Death|0|||
48933315|NCT00896532|157584545|FG012|Months 48-72: Follow-on Phase|Death|0|||
48933316|NCT00896532|157584546|FG013|Months 48-72: Follow-on Phase|Death|0|||
48933317|NCT00896532|157584547|FG014|Months 48-72: Follow-on Phase|Death|0|||
48933318|NCT00896532|157584548|FG015|Months 48-72: Follow-on Phase|Death|0|||
48933319|NCT00896532|157584549|FG016|Months 48-72: Follow-on Phase|Death|0|||
48933320|NCT00896532|157584550|FG017|Months 48-72: Follow-on Phase|Death|0|||
48933321|NCT00896532|157584551|FG018|Months 48-72: Follow-on Phase|Death|1|||
48933322|NCT00896532|157584552|FG019|Months 48-72: Follow-on Phase|Death|0|||
48933323|NCT00896532|157584553|FG020|Months 48-72: Follow-on Phase|Death|0|||
48933324|NCT00896532|157584554|FG021|Months 48-72: Follow-on Phase|Death|0|||
48933325|NCT00896532|157584555|FG022|Months 48-72: Follow-on Phase|Death|0|||
48933326|NCT00896532|157584533|FG000|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
48933327|NCT00896532|157584534|FG001|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
48933328|NCT00896532|157584535|FG002|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
48933329|NCT00896532|157584536|FG003|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
48933330|NCT00896532|157584537|FG004|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
48933331|NCT00896532|157584538|FG005|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
48933332|NCT00896532|157584539|FG006|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
48933333|NCT00896532|157584540|FG007|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
48933334|NCT00896532|157584541|FG008|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
48933335|NCT00896532|157584542|FG009|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
48933336|NCT00896532|157584543|FG010|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
48933337|NCT00896532|157584544|FG011|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
48933338|NCT00896532|157584545|FG012|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
48933339|NCT00896532|157584546|FG013|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
48933340|NCT00896532|157584547|FG014|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
48933341|NCT00896532|157584548|FG015|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
48933342|NCT00896532|157584549|FG016|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
48933343|NCT00896532|157584550|FG017|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
48933344|NCT00896532|157584551|FG018|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
48933345|NCT00896532|157584552|FG019|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
48933346|NCT00896532|157584553|FG020|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
48933347|NCT00896532|157584554|FG021|Months 48-72: Follow-on Phase|Ineligibility Determined|1|||
48933348|NCT00896532|157584555|FG022|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
48933349|NCT00896532|157584533|FG000|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
48933350|NCT00896532|157584534|FG001|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
48933351|NCT00896532|157584535|FG002|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
48933352|NCT00896532|157584536|FG003|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
48933353|NCT00896532|157584537|FG004|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
48933354|NCT00896532|157584538|FG005|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
48933355|NCT00896532|157584539|FG006|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
48933356|NCT00896532|157584540|FG007|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
48933357|NCT00896532|157584541|FG008|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
48933358|NCT00896532|157584542|FG009|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
48933359|NCT00896532|157584543|FG010|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
48933360|NCT00896532|157584544|FG011|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
48933361|NCT00896532|157584545|FG012|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
48933362|NCT00896532|157584546|FG013|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
48933363|NCT00896532|157584547|FG014|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
48933364|NCT00896532|157584548|FG015|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
48933365|NCT00896532|157584549|FG016|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
48933366|NCT00896532|157584550|FG017|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
48933367|NCT00896532|157584551|FG018|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
48933368|NCT00896532|157584552|FG019|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
48933369|NCT00896532|157584553|FG020|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
48933370|NCT00896532|157584554|FG021|Months 48-72: Follow-on Phase|Withdrawal by Subject|1|||
48933371|NCT00896532|157584555|FG022|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
48933372|NCT01176916|157584556|FG000|Overall Study|Adverse Event|61|||
48933373|NCT01176916|157584556|FG000|Overall Study|Death|1|||
48933374|NCT01176916|157584556|FG000|Overall Study|Lost to Follow-up|15|||
48933375|NCT01176916|157584556|FG000|Overall Study|Objective progression or relapse|17|||
48933376|NCT01176916|157584556|FG000|Overall Study|Protocol Violation|24|||
48933377|NCT01176916|157584556|FG000|Overall Study|Withdrawal by Subject|37|||
48933378|NCT01176916|157584556|FG000|Overall Study|Other|6|||
48933379|NCT01176916|157584556|FG000|Overall Study|Withdrawal prior to Treatment|6|||
48933380|NCT00631137|157584557|FG000|Overall Study|Withdrawal by Subject|1|||
48933381|NCT00631137|157584558|FG001|Overall Study|Withdrawal by Subject|0|||
48933382|NCT01671280|157584560|FG000|Overall Study|Withdrawal by Subject|2|||
48933383|NCT00848120|157584561|FG000|Overall Study|Adverse Event|1|||
48933384|NCT00560755|157584562|FG000|Overall Study|Protocol Violation|15|||
48933385|NCT00560755|157584562|FG000|Overall Study|Withdrawal by Subject|26|||
48933386|NCT00560755|157584562|FG000|Overall Study|Lost to Follow-up|9|||
48933387|NCT00560755|157584562|FG000|Overall Study|Adverse Event|8|||
48933388|NCT00560755|157584562|FG000|Overall Study|Physician Decision|2|||
48933389|NCT00769119|157584566|FG000|Overall Study|Voluntary discontinuation|0|||
48933390|NCT00769119|157584567|FG001|Overall Study|Voluntary discontinuation|2|||
48933391|NCT00769119|157584566|FG000|Overall Study|Adverse Event|1|||
48933392|NCT00769119|157584567|FG001|Overall Study|Adverse Event|1|||
48933393|NCT00769119|157584566|FG000|Overall Study|Disallowed medication|1|||
48933394|NCT00769119|157584567|FG001|Overall Study|Disallowed medication|0|||
48933395|NCT03094195|157584568|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12|||
48933396|NCT03094195|157584569|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10|||
48933397|NCT03094195|157584570|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11|||
48933398|NCT03094195|157584571|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
48933399|NCT03094195|157584572|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
48933400|NCT03094195|157584573|FG005|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
48933401|NCT03094195|157584574|FG006|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
48933402|NCT03094195|157584575|FG007|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
48933403|NCT03094195|157584568|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
48933404|NCT03094195|157584569|FG001|Double-Blind Treatment Period (DB)|Adverse Event|2|||
48933405|NCT03094195|157584570|FG002|Double-Blind Treatment Period (DB)|Adverse Event|1|||
48933406|NCT03094195|157584571|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
48933407|NCT03094195|157584572|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
48933408|NCT03094195|157584573|FG005|Double-Blind Treatment Period (DB)|Adverse Event|0|||
48933409|NCT03094195|157584574|FG006|Double-Blind Treatment Period (DB)|Adverse Event|0|||
48933410|NCT03094195|157584575|FG007|Double-Blind Treatment Period (DB)|Adverse Event|0|||
48933411|NCT03094195|157584568|FG000|Double-Blind Treatment Period (DB)|Physician Decision|0|||
48933412|NCT03094195|157584569|FG001|Double-Blind Treatment Period (DB)|Physician Decision|0|||
48933413|NCT03094195|157584570|FG002|Double-Blind Treatment Period (DB)|Physician Decision|1|||
48933414|NCT03094195|157584571|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
48933415|NCT03094195|157584572|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
48933416|NCT03094195|157584573|FG005|Double-Blind Treatment Period (DB)|Physician Decision|0|||
48933417|NCT03094195|157584574|FG006|Double-Blind Treatment Period (DB)|Physician Decision|0|||
48933418|NCT03094195|157584575|FG007|Double-Blind Treatment Period (DB)|Physician Decision|0|||
48933419|NCT03094195|157584568|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
48933420|NCT03094195|157584569|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
48933421|NCT03094195|157584570|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
48933422|NCT03094195|157584571|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
48933423|NCT03094195|157584572|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
48933424|NCT03094195|157584573|FG005|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
48933425|NCT03094195|157584574|FG006|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
48933426|NCT03094195|157584575|FG007|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
48933427|NCT01961115|157584576|FG000|Overall Study|Disease Progression|1|||
48933428|NCT01961115|157584577|FG001|Overall Study|Disease Progression|0|||
48846053|NCT01340066|157276752|FG000|5 Week Double Blind Randomization Period|Withdrawal by Subject|0|||
48846054|NCT01340066|157276753|FG001|5 Week Double Blind Randomization Period|Withdrawal by Subject|2|||
48846055|NCT01340066|157276754|FG002|5 Week Double Blind Randomization Period|Withdrawal by Subject|1|||
48846056|NCT04599062|157276765|FG000|Overall Study|Physician Decision|1|||
48846057|NCT04599062|157276766|FG001|Overall Study|Physician Decision|0|||
48846058|NCT03155997|157276767|FG000|Overall Study|Withdrawal by Subject|119|||
48846059|NCT03155997|157276768|FG001|Overall Study|Withdrawal by Subject|134|||
48846060|NCT03155997|157276767|FG000|Overall Study|Lost to Follow-up|12|||
48846061|NCT03155997|157276768|FG001|Overall Study|Lost to Follow-up|13|||
48846062|NCT03155997|157276767|FG000|Overall Study|Missing disposition data|0|||
48846063|NCT03155997|157276768|FG001|Overall Study|Missing disposition data|1|||
48846064|NCT03155997|157276767|FG000|Overall Study|On study treatment|2027|||
48846065|NCT03155997|157276768|FG001|Overall Study|On study treatment|2074|||
48846066|NCT04248725|157276769|FG000|Post-Treatment|Lost to Follow-up|6|||
48846067|NCT04248725|157276770|FG001|Post-Treatment|Lost to Follow-up|5|||
48846068|NCT04248725|157276769|FG000|6-Month Follow Up|Lost to Follow-up|9|||
48846069|NCT04248725|157276770|FG001|6-Month Follow Up|Lost to Follow-up|8|||
48846070|NCT01948661|157276771|FG000|Overall Study|Withdrawal by Subject|2|||
48846071|NCT01948661|157276772|FG001|Overall Study|Withdrawal by Subject|4|||
48846072|NCT04524442|157276775|FG000|Overall Study|Subject Decision|1|||
48846073|NCT04154384|157276778|FG000|Overall Study|Lost to Follow-up|24|||
48846074|NCT04154384|157276779|FG001|Overall Study|Lost to Follow-up|33|||
48846075|NCT04154384|157276780|FG002|Overall Study|Lost to Follow-up|0|||
48846076|NCT04154384|157276778|FG000|Overall Study|Withdrawal by Subject|7|||
48846077|NCT04154384|157276779|FG001|Overall Study|Withdrawal by Subject|18|||
48846078|NCT04154384|157276780|FG002|Overall Study|Withdrawal by Subject|0|||
48846079|NCT04154384|157276778|FG000|Overall Study|Missing outcome data|1|||
48846080|NCT04154384|157276779|FG001|Overall Study|Missing outcome data|0|||
48846081|NCT04154384|157276780|FG002|Overall Study|Missing outcome data|0|||
48846082|NCT01136876|157276781|FG000|Overall Study|Lost to Follow-up|0|||
48846083|NCT01136876|157276782|FG001|Overall Study|Lost to Follow-up|1|||
48846084|NCT01136876|157276781|FG000|Overall Study|Physician Decision|3|||
48846085|NCT01136876|157276782|FG001|Overall Study|Physician Decision|5|||
48846086|NCT01136876|157276781|FG000|Overall Study|Missing NGAL measurement|2|||
48846087|NCT01136876|157276782|FG001|Overall Study|Missing NGAL measurement|5|||
48846088|NCT01011946|157276784|FG000|Overall Study|Transferred to another hospital|2|||
48846089|NCT01011946|157276784|FG000|Overall Study|No pathological lab value|1|||
48846090|NCT01424670|157276786|FG000|6-Month Intensive Period (182 Days)|Adverse Event|2|||
48846091|NCT01424670|157276787|FG001|6-Month Intensive Period (182 Days)|Adverse Event|2|||
48846092|NCT01424670|157276786|FG000|6-Month Intensive Period (182 Days)|Lost to Follow-up|0|||
48846093|NCT01424670|157276787|FG001|6-Month Intensive Period (182 Days)|Lost to Follow-up|1|||
48846094|NCT01424670|157276786|FG000|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2|||
48846095|NCT01424670|157276787|FG001|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1|||
48846096|NCT01424670|157276786|FG000|6-Month Intensive Period (182 Days)|Physician Decision|2|||
48846097|NCT01424670|157276787|FG001|6-Month Intensive Period (182 Days)|Physician Decision|3|||
48846098|NCT01424670|157276786|FG000|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13|||
48846099|NCT01424670|157276787|FG001|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7|||
48846100|NCT01424670|157276786|FG000|Continuation Period|Adverse Event|13|||
48933429|NCT01961115|157584578|FG002|Overall Study|Disease Progression|3|||
48846101|NCT01424670|157276787|FG001|Continuation Period|Adverse Event|5|||
48846102|NCT01424670|157276786|FG000|Continuation Period|Lost to Follow-up|2|||
48846103|NCT01424670|157276787|FG001|Continuation Period|Lost to Follow-up|0|||
48846104|NCT01424670|157276786|FG000|Continuation Period|Met Protocol Withdrawal Criteria|1|||
48846105|NCT01424670|157276787|FG001|Continuation Period|Met Protocol Withdrawal Criteria|1|||
48846106|NCT01424670|157276786|FG000|Continuation Period|Physician Decision|5|||
48846107|NCT01424670|157276787|FG001|Continuation Period|Physician Decision|4|||
48846108|NCT01424670|157276786|FG000|Continuation Period|Withdrawal by Subject|13|||
48846109|NCT01424670|157276787|FG001|Continuation Period|Withdrawal by Subject|4|||
48846110|NCT01094184|157276790|FG000|Overall Study|Death|35|||
48846111|NCT01094184|157276791|FG001|Overall Study|Death|11|||
48933430|NCT01961115|157584576|FG000|Overall Study|Adverse Event|1|||
48933431|NCT01961115|157584577|FG001|Overall Study|Adverse Event|0|||
48933432|NCT01961115|157584578|FG002|Overall Study|Adverse Event|1|||
48933433|NCT01439945|157584591|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
48933434|NCT01439945|157584592|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
48933435|NCT01439945|157584593|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
48933436|NCT01439945|157584594|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
48933437|NCT01439945|157584591|FG000|Double-Blind Treatment Phase|Ineligible|1|||
48933438|NCT01439945|157584592|FG001|Double-Blind Treatment Phase|Ineligible|2|||
48933439|NCT01439945|157584593|FG002|Double-Blind Treatment Phase|Ineligible|0|||
48933440|NCT01439945|157584594|FG003|Double-Blind Treatment Phase|Ineligible|1|||
48933441|NCT04082663|157584595|FG000|Overall Study|Adverse Event|6|||
48846112|NCT02409667|157276792|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6|||
48933442|NCT04082663|157584595|FG000|Overall Study|Lost to Follow-up|1|||
48846113|NCT02409667|157276793|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
48846114|NCT02409667|157276794|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
48846115|NCT02409667|157276795|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
48846116|NCT02409667|157276796|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
48846117|NCT02409667|157276792|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6|||
48846118|NCT02409667|157276793|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
48846119|NCT02409667|157276794|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
48846120|NCT02409667|157276795|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
48846121|NCT02409667|157276796|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
48846122|NCT02409667|157276792|FG000|Treatment Period 1, Baseline to Week 24|Protocol deviation|20|||
48846123|NCT02409667|157276793|FG001|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
48846124|NCT02409667|157276794|FG002|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
48846125|NCT02409667|157276795|FG003|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
48846126|NCT02409667|157276796|FG004|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
48846127|NCT02409667|157276792|FG000|Treatment Period 1, Baseline to Week 24|Pregnancy|1|||
48846128|NCT02409667|157276793|FG001|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
48846129|NCT02409667|157276794|FG002|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
48846130|NCT02409667|157276795|FG003|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
48846131|NCT02409667|157276796|FG004|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
48846132|NCT02409667|157276792|FG000|Treatment Period 1, Baseline to Week 24|Physician Decision|4|||
48846133|NCT02409667|157276793|FG001|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
48846134|NCT02409667|157276794|FG002|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
48846135|NCT02409667|157276795|FG003|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
48846136|NCT02409667|157276796|FG004|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
48846137|NCT02409667|157276792|FG000|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5|||
48846138|NCT02409667|157276793|FG001|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
48846139|NCT02409667|157276794|FG002|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
48846140|NCT02409667|157276795|FG003|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
48846141|NCT02409667|157276796|FG004|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
48846142|NCT02409667|157276792|FG000|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6|||
48846143|NCT02409667|157276793|FG001|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
48846144|NCT02409667|157276794|FG002|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
48846145|NCT02409667|157276795|FG003|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
48846146|NCT02409667|157276796|FG004|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
48846147|NCT02409667|157276792|FG000|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48|||
48846148|NCT02409667|157276793|FG001|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
48846149|NCT02409667|157276794|FG002|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
48846150|NCT02409667|157276795|FG003|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
48846151|NCT02409667|157276796|FG004|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
48846152|NCT02409667|157276792|FG000|Treatment Period 1, Baseline to Week 24|Adverse Event|25|||
48846153|NCT02409667|157276793|FG001|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
48846154|NCT02409667|157276794|FG002|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
48846155|NCT02409667|157276795|FG003|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
48846156|NCT02409667|157276796|FG004|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
48846157|NCT02409667|157276792|FG000|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
48846158|NCT02409667|157276793|FG001|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7|||
48933443|NCT01497262|157584596|FG000|Overall Study|Abnormal Lab Values|4|||
48846159|NCT02409667|157276794|FG002|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4|||
48846160|NCT02409667|157276795|FG003|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3|||
48846161|NCT02409667|157276796|FG004|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
48846162|NCT02409667|157276792|FG000|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
48846163|NCT02409667|157276793|FG001|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
48846164|NCT02409667|157276794|FG002|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
48846165|NCT02409667|157276795|FG003|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2|||
48846166|NCT02409667|157276796|FG004|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
48846167|NCT02409667|157276792|FG000|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0|||
48846168|NCT02409667|157276793|FG001|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7|||
48846169|NCT02409667|157276794|FG002|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4|||
48846170|NCT02409667|157276795|FG003|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1|||
48846171|NCT02409667|157276796|FG004|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2|||
48846172|NCT02409667|157276792|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
48933444|NCT01497262|157584596|FG000|Overall Study|Abnormal Test Procedure Result|1|||
48933445|NCT01497262|157584596|FG000|Overall Study|Physician Decision|1|||
48933446|NCT01497262|157584596|FG000|Overall Study|Withdrawal by Subject|2|||
48933447|NCT01497262|157584596|FG000|Overall Study|Adverse Event|2|||
48933448|NCT01497262|157584596|FG000|Overall Study|Protocol Violation|1|||
48933449|NCT03898063|157584597|FG000|Overall Study|Withdrawal by Subject|10|||
48933450|NCT03898063|157584598|FG001|Overall Study|Withdrawal by Subject|8|||
48933451|NCT02440581|157584599|FG000|Overall Study|Death|0|||
48933452|NCT02440581|157584600|FG001|Overall Study|Death|0|||
48933453|NCT02440581|157584601|FG002|Overall Study|Death|7|||
48933454|NCT02440581|157584602|FG003|Overall Study|Death|5|||
48933455|NCT02440581|157584599|FG000|Overall Study|Transplanted|1|||
48933456|NCT02440581|157584600|FG001|Overall Study|Transplanted|0|||
48933457|NCT02440581|157584601|FG002|Overall Study|Transplanted|3|||
48933458|NCT02440581|157584602|FG003|Overall Study|Transplanted|2|||
48933459|NCT02440581|157584599|FG000|Overall Study|Withdrawal by Subject|4|||
48933460|NCT02440581|157584600|FG001|Overall Study|Withdrawal by Subject|11|||
48933461|NCT02440581|157584601|FG002|Overall Study|Withdrawal by Subject|3|||
48933462|NCT02440581|157584602|FG003|Overall Study|Withdrawal by Subject|7|||
48933463|NCT04373460|157584603|FG000|Overall Study|Did not receive tranfusion|18|||
48933464|NCT04373460|157584604|FG001|Overall Study|Did not receive tranfusion|26|||
48933465|NCT05032950|157584605|FG000|Overall Study|Adverse Event|0|||
48933466|NCT05032950|157584606|FG001|Overall Study|Adverse Event|0|||
48933467|NCT05032950|157584607|FG002|Overall Study|Adverse Event|1|||
48933468|NCT05032950|157584608|FG003|Overall Study|Adverse Event|1|||
48933469|NCT05032950|157584609|FG004|Overall Study|Adverse Event|0|||
48933470|NCT05032950|157584610|FG005|Overall Study|Adverse Event|0|||
48933471|NCT02959814|157584611|FG000|Overall Study|Excluded based on diagnostic angiography|16|||
48933472|NCT02959814|157584611|FG000|Overall Study|Excluded based on anatomical criteria|2|||
48933473|NCT02959814|157584611|FG000|Overall Study|Protocol Violation|7|||
48933474|NCT02959814|157584611|FG000|Overall Study|FFR not measured|2|||
48933475|NCT02959814|157584611|FG000|Overall Study|In-procedure QFR not computed|6|||
48933476|NCT02959814|157584611|FG000|Overall Study|Excluded by FFR core-lab|24|||
48933477|NCT02495948|157584612|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
48933478|NCT02495948|157584613|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
48933479|NCT02495948|157584612|FG000|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
48933480|NCT02495948|157584613|FG001|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
48933481|NCT01444300|157584614|FG000|Overall Study|Adverse Event|4|||
48933482|NCT01444300|157584615|FG001|Overall Study|Adverse Event|0|||
48933483|NCT04343651|157584616|FG000|Overall Study|Physician Decision|2|||
48933484|NCT04343651|157584617|FG001|Overall Study|Physician Decision|1|||
48933485|NCT04343651|157584616|FG000|Overall Study|Lost to Follow-up|2|||
48933486|NCT04343651|157584617|FG001|Overall Study|Lost to Follow-up|1|||
48933487|NCT04343651|157584616|FG000|Overall Study|Protocol Violation|4|||
48933488|NCT04343651|157584617|FG001|Overall Study|Protocol Violation|6|||
48933489|NCT04343651|157584616|FG000|Overall Study|Missing|3|||
48933490|NCT04343651|157584617|FG001|Overall Study|Missing|9|||
48933491|NCT04343651|157584616|FG000|Overall Study|Withdrawal by Subject|0|||
48933492|NCT04343651|157584617|FG001|Overall Study|Withdrawal by Subject|4|||
48933493|NCT04343651|157584616|FG000|Overall Study|Death|0|||
48933494|NCT04343651|157584617|FG001|Overall Study|Death|1|||
48933495|NCT04343651|157584616|FG000|Overall Study|Did not start treatment|1|||
48933496|NCT04343651|157584617|FG001|Overall Study|Did not start treatment|1|||
48933497|NCT04343651|157584616|FG000|Overall Study|Patient did not complete visits 3-6|0|||
48933498|NCT04343651|157584617|FG001|Overall Study|Patient did not complete visits 3-6|1|||
48933499|NCT02527707|157586120|FG000|Overall Study|Adverse Event|1|||
48933500|NCT02527707|157586120|FG000|Overall Study|Adverse Event|1|||
48933501|NCT00546364|157586121|FG000|Overall Study|Disease progression|5|||
48933502|NCT00546364|157586122|FG001|Overall Study|Disease progression|11|||
48933503|NCT00546364|157586123|FG002|Overall Study|Disease progression|8|||
48933504|NCT00546364|157586121|FG000|Overall Study|Completed and off treatment|1|||
48933505|NCT00546364|157586122|FG001|Overall Study|Completed and off treatment|0|||
48933506|NCT00546364|157586123|FG002|Overall Study|Completed and off treatment|2|||
48933507|NCT00546364|157586121|FG000|Overall Study|Administrative reason by sponsor|1|||
48933508|NCT00546364|157586122|FG001|Overall Study|Administrative reason by sponsor|0|||
48933509|NCT00546364|157586123|FG002|Overall Study|Administrative reason by sponsor|0|||
48933510|NCT00546364|157586121|FG000|Overall Study|Poor compliance/noncompliance|0|||
48933511|NCT00546364|157586122|FG001|Overall Study|Poor compliance/noncompliance|0|||
48933512|NCT00546364|157586123|FG002|Overall Study|Poor compliance/noncompliance|1|||
48933513|NCT00546364|157586121|FG000|Overall Study|No longer meets study criteria|1|||
48933514|NCT00546364|157586122|FG001|Overall Study|No longer meets study criteria|1|||
48933515|NCT00546364|157586123|FG002|Overall Study|No longer meets study criteria|0|||
48933516|NCT00546364|157586121|FG000|Overall Study|Withdrawal by Subject|5|||
48933517|NCT00546364|157586122|FG001|Overall Study|Withdrawal by Subject|6|||
48933518|NCT00546364|157586123|FG002|Overall Study|Withdrawal by Subject|3|||
48933519|NCT00546364|157586121|FG000|Overall Study|Prior taxotere|1|||
48933520|NCT00546364|157586122|FG001|Overall Study|Prior taxotere|0|||
48933521|NCT00546364|157586123|FG002|Overall Study|Prior taxotere|0|||
48933522|NCT00546364|157586121|FG000|Overall Study|Mixed response|1|||
48933523|NCT00546364|157586122|FG001|Overall Study|Mixed response|0|||
48933524|NCT00546364|157586123|FG002|Overall Study|Mixed response|0|||
48933525|NCT00546364|157586121|FG000|Overall Study|Palliative treatment|1|||
48933526|NCT00546364|157586122|FG001|Overall Study|Palliative treatment|0|||
48933527|NCT00546364|157586123|FG002|Overall Study|Palliative treatment|1|||
48933528|NCT00546364|157586121|FG000|Overall Study|Target lesions resected|1|||
48933529|NCT00546364|157586122|FG001|Overall Study|Target lesions resected|0|||
48933530|NCT00546364|157586123|FG002|Overall Study|Target lesions resected|0|||
48933531|NCT00546364|157586121|FG000|Overall Study|Physician Decision|0|||
48933532|NCT00546364|157586122|FG001|Overall Study|Physician Decision|0|||
48933533|NCT00546364|157586123|FG002|Overall Study|Physician Decision|1|||
48933534|NCT00546364|157586121|FG000|Overall Study|Sponsor decision|0|||
48933535|NCT00546364|157586122|FG001|Overall Study|Sponsor decision|0|||
48933536|NCT00546364|157586123|FG002|Overall Study|Sponsor decision|1|||
48933537|NCT00403260|157586124|FG000|Overall Study|Adverse Event|5|||
48933538|NCT00403260|157586125|FG001|Overall Study|Adverse Event|4|||
48933539|NCT00403260|157586124|FG000|Overall Study|Withdrawal by Subject|5|||
48933540|NCT00403260|157586125|FG001|Overall Study|Withdrawal by Subject|6|||
48933541|NCT00403260|157586124|FG000|Overall Study|Lost to Follow-up|49|||
48933542|NCT00403260|157586125|FG001|Overall Study|Lost to Follow-up|25|||
48933543|NCT00403260|157586124|FG000|Overall Study|Re-appearance of P. falciparum|34|||
48933544|NCT00403260|157586125|FG001|Overall Study|Re-appearance of P. falciparum|25|||
48933545|NCT00403260|157586124|FG000|Overall Study|P. vivax infection|26|||
48933546|NCT00403260|157586125|FG001|Overall Study|P. vivax infection|4|||
48933547|NCT00403260|157586124|FG000|Overall Study|Mixed infection with P. vivax|2|||
48933548|NCT00403260|157586125|FG001|Overall Study|Mixed infection with P. vivax|0|||
48933549|NCT00403260|157586124|FG000|Overall Study|Mixed infection with P. falciparum|1|||
48933550|NCT00403260|157586125|FG001|Overall Study|Mixed infection with P. falciparum|0|||
48933551|NCT00403260|157586124|FG000|Overall Study|P. vivax infection at screening|1|||
48933552|NCT00403260|157586125|FG001|Overall Study|P. vivax infection at screening|0|||
48933553|NCT00403260|157586124|FG000|Overall Study|P. ovale infection|1|||
48933554|NCT00403260|157586125|FG001|Overall Study|P. ovale infection|0|||
48933555|NCT00403260|157586124|FG000|Overall Study|Gametocyte re-appearance|1|||
48933556|NCT00403260|157586125|FG001|Overall Study|Gametocyte re-appearance|1|||
48933557|NCT00403260|157586124|FG000|Overall Study|Withdrawn from study accidentally|0|||
48933558|NCT00403260|157586125|FG001|Overall Study|Withdrawn from study accidentally|1|||
48933559|NCT00544869|157586126|FG000|Overall Study|Rsolution of congenitive symptoms|3|||
48933560|NCT00544869|157586127|FG001|Overall Study|Rsolution of congenitive symptoms|0|||
48933561|NCT00544869|157586128|FG002|Overall Study|Rsolution of congenitive symptoms|0|||
48933562|NCT00544869|157586126|FG000|Overall Study|Adverse Event|6|||
48933563|NCT00544869|157586127|FG001|Overall Study|Adverse Event|1|||
48933564|NCT00544869|157586128|FG002|Overall Study|Adverse Event|0|||
48933565|NCT00544869|157586126|FG000|Overall Study|Lack of Efficacy|1|||
48933566|NCT00544869|157586127|FG001|Overall Study|Lack of Efficacy|1|||
48933567|NCT00544869|157586128|FG002|Overall Study|Lack of Efficacy|0|||
48933568|NCT00544869|157586126|FG000|Overall Study|Physician Decision|2|||
48933569|NCT00544869|157586127|FG001|Overall Study|Physician Decision|0|||
48933570|NCT00544869|157586128|FG002|Overall Study|Physician Decision|0|||
48933571|NCT00771472|157586129|FG000|Overall Study|Physician Decision|2|||
48933572|NCT00771472|157586130|FG001|Overall Study|Physician Decision|3|||
48933573|NCT00771472|157586129|FG000|Overall Study|Progressive Disease|3|||
48933574|NCT00771472|157586130|FG001|Overall Study|Progressive Disease|1|||
48933575|NCT00771472|157586129|FG000|Overall Study|Protocol Violation|1|||
48933576|NCT00771472|157586130|FG001|Overall Study|Protocol Violation|0|||
48933577|NCT00434967|157586139|FG000|Overall Study|Adverse Event|2|||
48933578|NCT00434967|157586140|FG001|Overall Study|Adverse Event|4|||
48933579|NCT00434967|157586141|FG002|Overall Study|Adverse Event|3|||
48933580|NCT00434967|157586142|FG003|Overall Study|Adverse Event|3|||
48933581|NCT00434967|157586139|FG000|Overall Study|Lost to Follow-up|0|||
48933582|NCT00434967|157586140|FG001|Overall Study|Lost to Follow-up|0|||
48933583|NCT00434967|157586141|FG002|Overall Study|Lost to Follow-up|1|||
48933584|NCT00434967|157586142|FG003|Overall Study|Lost to Follow-up|0|||
48933585|NCT00434967|157586139|FG000|Overall Study|Withdrawal by Subject|2|||
48933586|NCT00434967|157586140|FG001|Overall Study|Withdrawal by Subject|2|||
48933587|NCT00434967|157586141|FG002|Overall Study|Withdrawal by Subject|4|||
48933588|NCT00434967|157586142|FG003|Overall Study|Withdrawal by Subject|6|||
48933589|NCT00434967|157586139|FG000|Overall Study|Randomized in error|0|||
48933590|NCT00434967|157586140|FG001|Overall Study|Randomized in error|0|||
48933591|NCT00434967|157586141|FG002|Overall Study|Randomized in error|0|||
48933592|NCT00434967|157586142|FG003|Overall Study|Randomized in error|1|||
48846173|NCT02409667|157276793|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5|||
48846174|NCT02409667|157276794|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4|||
48846175|NCT02409667|157276795|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
48846176|NCT02409667|157276796|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
48846177|NCT02409667|157276792|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
48846178|NCT02409667|157276793|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4|||
48846179|NCT02409667|157276794|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5|||
48846180|NCT02409667|157276795|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2|||
48846181|NCT02409667|157276796|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
48846182|NCT02409667|157276792|FG000|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
48846183|NCT02409667|157276793|FG001|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
48846184|NCT02409667|157276794|FG002|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
48846185|NCT02409667|157276795|FG003|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
48846186|NCT02409667|157276796|FG004|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
48846187|NCT02409667|157276792|FG000|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
48846188|NCT02409667|157276793|FG001|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
48933593|NCT00434967|157586139|FG000|Overall Study|Protocol Violation|0|||
48846189|NCT02409667|157276794|FG002|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3|||
48846190|NCT02409667|157276795|FG003|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
48933594|NCT00434967|157586140|FG001|Overall Study|Protocol Violation|1|||
48933595|NCT00434967|157586141|FG002|Overall Study|Protocol Violation|0|||
48933596|NCT00434967|157586142|FG003|Overall Study|Protocol Violation|1|||
48933597|NCT00434967|157586139|FG000|Overall Study|Physician Decision|1|||
48933598|NCT00434967|157586140|FG001|Overall Study|Physician Decision|1|||
48933599|NCT00434967|157586141|FG002|Overall Study|Physician Decision|1|||
48933600|NCT00434967|157586142|FG003|Overall Study|Physician Decision|0|||
48933601|NCT00434967|157586139|FG000|Overall Study|Patient Disposition Challenges|2|||
48933602|NCT00434967|157586140|FG001|Overall Study|Patient Disposition Challenges|0|||
48933603|NCT00434967|157586141|FG002|Overall Study|Patient Disposition Challenges|0|||
48933604|NCT00434967|157586142|FG003|Overall Study|Patient Disposition Challenges|3|||
48933605|NCT02494596|157586143|FG000|Overall Study|Insufficient Therapeutic Response|3|||
48933606|NCT02494596|157586144|FG001|Overall Study|Insufficient Therapeutic Response|3|||
48933607|NCT02494596|157586145|FG002|Overall Study|Insufficient Therapeutic Response|1|||
48933608|NCT02494596|157586143|FG000|Overall Study|Adverse Event|0|||
48933609|NCT02494596|157586144|FG001|Overall Study|Adverse Event|1|||
48933610|NCT02494596|157586145|FG002|Overall Study|Adverse Event|0|||
48933611|NCT02494596|157586143|FG000|Overall Study|Refused Treatment|0|||
48933612|NCT02494596|157586144|FG001|Overall Study|Refused Treatment|1|||
48933613|NCT02494596|157586145|FG002|Overall Study|Refused Treatment|0|||
48846191|NCT02409667|157276796|FG004|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
48846192|NCT03912831|157276797|FG000|Overall Study|Death|1|||
48933614|NCT01169779|157586146|FG000|Overall Study|Adverse Event|3|||
48933615|NCT01169779|157586147|FG001|Overall Study|Adverse Event|11|||
48933616|NCT01169779|157586146|FG000|Overall Study|Lack of Efficacy|1|||
48933617|NCT01169779|157586147|FG001|Overall Study|Lack of Efficacy|0|||
48933618|NCT01169779|157586146|FG000|Overall Study|Protocol Violation|1|||
48933619|NCT01169779|157586147|FG001|Overall Study|Protocol Violation|1|||
48933620|NCT01169779|157586146|FG000|Overall Study|Withdrawal by Subject|3|||
48933621|NCT01169779|157586147|FG001|Overall Study|Withdrawal by Subject|2|||
48933622|NCT01169779|157586146|FG000|Overall Study|Familial and personal reasons|3|||
48933623|NCT01169779|157586147|FG001|Overall Study|Familial and personal reasons|3|||
48933624|NCT02631538|157586155|FG000|Treatment Period (Up to Week 52)|Adverse Event|1|||
48933625|NCT02631538|157586156|FG001|Treatment Period (Up to Week 52)|Adverse Event|5|||
48933626|NCT02631538|157586157|FG002|Treatment Period (Up to Week 52)|Adverse Event|2|||
48933627|NCT02631538|157586158|FG003|Treatment Period (Up to Week 52)|Adverse Event|2|||
48933628|NCT02631538|157586155|FG000|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
48933629|NCT02631538|157586156|FG001|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
48933630|NCT02631538|157586157|FG002|Treatment Period (Up to Week 52)|Withdrawal by Subject|2|||
48933631|NCT02631538|157586158|FG003|Treatment Period (Up to Week 52)|Withdrawal by Subject|5|||
48933632|NCT02631538|157586155|FG000|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
48933633|NCT02631538|157586156|FG001|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
48933634|NCT02631538|157586157|FG002|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
48933635|NCT02631538|157586158|FG003|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
48933636|NCT02631538|157586155|FG000|Treatment Period (Up to Week 52)|Physician Decision|1|||
48933637|NCT02631538|157586156|FG001|Treatment Period (Up to Week 52)|Physician Decision|0|||
48933638|NCT02631538|157586157|FG002|Treatment Period (Up to Week 52)|Physician Decision|0|||
48933639|NCT02631538|157586158|FG003|Treatment Period (Up to Week 52)|Physician Decision|1|||
48933640|NCT02631538|157586155|FG000|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
48933641|NCT02631538|157586156|FG001|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
48933642|NCT02631538|157586157|FG002|Treatment Period (Up to Week 52)|Reached stopping criteria|1|||
48933643|NCT02631538|157586158|FG003|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
48933644|NCT02631538|157586155|FG000|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
48846193|NCT03912831|157276798|FG001|Overall Study|Death|1|||
48846194|NCT03912831|157276799|FG002|Overall Study|Death|1|||
48846195|NCT03912831|157276800|FG003|Overall Study|Death|1|||
48846196|NCT03912831|157276801|FG004|Overall Study|Death|1|||
48846197|NCT03912831|157276802|FG005|Overall Study|Death|1|||
48846198|NCT03912831|157276797|FG000|Overall Study|Reason not Specified|0|||
48846199|NCT03912831|157276798|FG001|Overall Study|Reason not Specified|0|||
48846200|NCT03912831|157276799|FG002|Overall Study|Reason not Specified|0|||
48846201|NCT03912831|157276800|FG003|Overall Study|Reason not Specified|0|||
48846202|NCT03912831|157276801|FG004|Overall Study|Reason not Specified|1|||
48846203|NCT03912831|157276802|FG005|Overall Study|Reason not Specified|0|||
48846204|NCT03912831|157276797|FG000|Overall Study|Withdrawal by Participant|0|||
48846205|NCT03912831|157276798|FG001|Overall Study|Withdrawal by Participant|0|||
48933645|NCT02631538|157586156|FG001|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
48933646|NCT02631538|157586157|FG002|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
48933647|NCT02631538|157586158|FG003|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
48933648|NCT00643994|157586159|FG000|Overall Study|Death|24|||
48933649|NCT00643994|157586159|FG000|Overall Study|Lost to Follow-up|72|||
48933650|NCT00400400|157586160|FG000|Overall Study|Adverse Event|9|||
48933651|NCT00400400|157586161|FG001|Overall Study|Adverse Event|8|||
48933652|NCT00400400|157586160|FG000|Overall Study|Protocol Violation|2|||
48933653|NCT00400400|157586161|FG001|Overall Study|Protocol Violation|0|||
48933654|NCT00400400|157586160|FG000|Overall Study|Withdrawal by Subject|1|||
48933655|NCT00400400|157586161|FG001|Overall Study|Withdrawal by Subject|3|||
48933656|NCT00400400|157586160|FG000|Overall Study|Administrative Problem|1|||
48933657|NCT00400400|157586161|FG001|Overall Study|Administrative Problem|0|||
48933658|NCT00400400|157586160|FG000|Overall Study|Lost to Follow-up|0|||
48933659|NCT00400400|157586161|FG001|Overall Study|Lost to Follow-up|1|||
48933660|NCT00400400|157586160|FG000|Overall Study|Did not receive study drug|1|||
48933661|NCT00400400|157586161|FG001|Overall Study|Did not receive study drug|3|||
48933662|NCT01688050|157586162|FG000|Overall Study|Death|7|||
48933663|NCT01688050|157586162|FG000|Overall Study|Conversion to open repair|1|||
48846206|NCT03912831|157276799|FG002|Overall Study|Withdrawal by Participant|0|||
48846207|NCT03912831|157276800|FG003|Overall Study|Withdrawal by Participant|0|||
48846208|NCT03912831|157276801|FG004|Overall Study|Withdrawal by Participant|1|||
48933664|NCT01688050|157586162|FG000|Overall Study|Lost to Follow-up|13|||
48933665|NCT01688050|157586162|FG000|Overall Study|Withdrawal by Subject|10|||
48933666|NCT00927368|157586164|FG000|Overall Study|enrollment in another study|1|||
48933667|NCT00927368|157586165|FG001|Overall Study|enrollment in another study|1|||
48933668|NCT00927368|157586166|FG002|Overall Study|enrollment in another study|2|||
48933669|NCT00927368|157586164|FG000|Overall Study|Lost to Follow-up|4|||
48846209|NCT03912831|157276802|FG005|Overall Study|Withdrawal by Participant|0|||
48846210|NCT03580369|157276803|FG000|Overall Study|No treatment due to mis-randomization|1|||
48846211|NCT03580369|157276804|FG001|Overall Study|No treatment due to mis-randomization|0|||
48846212|NCT03580369|157276805|FG002|Overall Study|No treatment due to mis-randomization|0|||
48846213|NCT03580369|157276806|FG003|Overall Study|No treatment due to mis-randomization|0|||
48846214|NCT03580369|157276807|FG004|Overall Study|No treatment due to mis-randomization|3|||
48846215|NCT03580369|157276808|FG005|Overall Study|No treatment due to mis-randomization|0|||
48933670|NCT00927368|157586165|FG001|Overall Study|Lost to Follow-up|0|||
48933671|NCT00927368|157586166|FG002|Overall Study|Lost to Follow-up|0|||
48933672|NCT00927368|157586164|FG000|Overall Study|equipment failure|1|||
48933673|NCT00927368|157586165|FG001|Overall Study|equipment failure|0|||
48933674|NCT00927368|157586166|FG002|Overall Study|equipment failure|0|||
48933675|NCT00927368|157586164|FG000|Overall Study|ineligible post randomization|0|||
48933676|NCT00927368|157586165|FG001|Overall Study|ineligible post randomization|3|||
48933677|NCT00927368|157586166|FG002|Overall Study|ineligible post randomization|1|||
48933678|NCT00927368|157586164|FG000|Overall Study|cancellation of surgery|0|||
48933679|NCT00927368|157586165|FG001|Overall Study|cancellation of surgery|1|||
48933680|NCT00927368|157586166|FG002|Overall Study|cancellation of surgery|2|||
48933681|NCT00257010|157586167|FG000|Overall Study|Lack of Efficacy|11|||
48933682|NCT00257010|157586167|FG000|Overall Study|Lost to Follow-up|53|||
48933683|NCT00257010|157586167|FG000|Overall Study|Withdrawal by Subject|34|||
48933684|NCT00257010|157586167|FG000|Overall Study|Adverse Event|10|||
48933685|NCT00257010|157586167|FG000|Overall Study|various|11|||
48933686|NCT00257010|157586167|FG000|Overall Study|no headache reported|9|||
48933687|NCT02624492|157586168|FG000|Overall Study|Adverse Event|2|||
48933688|NCT02624492|157586169|FG001|Overall Study|Adverse Event|2|||
48933689|NCT02624492|157586170|FG002|Overall Study|Adverse Event|2|||
48933690|NCT02624492|157586168|FG000|Overall Study|Progressive disease|0|||
48933691|NCT02624492|157586169|FG001|Overall Study|Progressive disease|2|||
48933692|NCT02624492|157586170|FG002|Overall Study|Progressive disease|3|||
48933693|NCT01554579|157586177|FG000|Overall Study|Adverse Event|6|||
48933694|NCT01554579|157586178|FG001|Overall Study|Adverse Event|25|||
48933695|NCT01554579|157586177|FG000|Overall Study|Lack of Efficacy|2|||
48933696|NCT01554579|157586178|FG001|Overall Study|Lack of Efficacy|1|||
48933697|NCT01554579|157586177|FG000|Overall Study|Withdrawal by Subject|2|||
48933698|NCT01554579|157586178|FG001|Overall Study|Withdrawal by Subject|1|||
48933699|NCT00094757|157586179|FG000|Overall Study|Adverse Event|11|||
48933700|NCT00094757|157586180|FG001|Overall Study|Adverse Event|9|||
48933701|NCT00094757|157586181|FG002|Overall Study|Adverse Event|6|||
48933702|NCT00094757|157586179|FG000|Overall Study|Lack of Efficacy|11|||
48933703|NCT00094757|157586180|FG001|Overall Study|Lack of Efficacy|15|||
48933704|NCT00094757|157586181|FG002|Overall Study|Lack of Efficacy|8|||
48933705|NCT00094757|157586179|FG000|Overall Study|Lost to Follow-up|3|||
48933706|NCT00094757|157586180|FG001|Overall Study|Lost to Follow-up|5|||
48933707|NCT00094757|157586181|FG002|Overall Study|Lost to Follow-up|6|||
48933708|NCT00094757|157586179|FG000|Overall Study|Patient Moved|2|||
48933709|NCT00094757|157586180|FG001|Overall Study|Patient Moved|1|||
48933710|NCT00094757|157586181|FG002|Overall Study|Patient Moved|1|||
48933711|NCT00094757|157586179|FG000|Overall Study|Protocol Violation|8|||
48933712|NCT00094757|157586180|FG001|Overall Study|Protocol Violation|5|||
48933713|NCT00094757|157586181|FG002|Overall Study|Protocol Violation|3|||
48933714|NCT00094757|157586179|FG000|Overall Study|Withdrawal by Subject|14|||
48933715|NCT00094757|157586180|FG001|Overall Study|Withdrawal by Subject|21|||
48933716|NCT00094757|157586181|FG002|Overall Study|Withdrawal by Subject|5|||
48933717|NCT00094757|157586179|FG000|Overall Study|Other|3|||
48933718|NCT00094757|157586180|FG001|Overall Study|Other|3|||
48933719|NCT00094757|157586181|FG002|Overall Study|Other|1|||
48933720|NCT00094757|157586179|FG000|Overall Study|Protocol specified discontinuation|1|||
48933721|NCT00094757|157586180|FG001|Overall Study|Protocol specified discontinuation|3|||
48933722|NCT00094757|157586181|FG002|Overall Study|Protocol specified discontinuation|0|||
48933723|NCT01808612|157586182|FG000|Treatment Period|Adverse Event|8|||
48933724|NCT01808612|157586183|FG001|Treatment Period|Adverse Event|4|||
48933725|NCT01808612|157586184|FG002|Treatment Period|Adverse Event|3|||
48933726|NCT01808612|157586182|FG000|Treatment Period|Lost to Follow-up|2|||
48933727|NCT01808612|157586183|FG001|Treatment Period|Lost to Follow-up|2|||
48933728|NCT01808612|157586184|FG002|Treatment Period|Lost to Follow-up|1|||
48933729|NCT01808612|157586182|FG000|Treatment Period|Protocol Violation|1|||
48933730|NCT01808612|157586183|FG001|Treatment Period|Protocol Violation|0|||
48933731|NCT01808612|157586184|FG002|Treatment Period|Protocol Violation|0|||
48933732|NCT01808612|157586182|FG000|Treatment Period|Withdrawal by Subject|1|||
48933733|NCT01808612|157586183|FG001|Treatment Period|Withdrawal by Subject|0|||
48933734|NCT01808612|157586184|FG002|Treatment Period|Withdrawal by Subject|4|||
48933735|NCT01808612|157586182|FG000|Treatment Period|Physician Decision|1|||
48933736|NCT01808612|157586183|FG001|Treatment Period|Physician Decision|0|||
48933737|NCT01808612|157586184|FG002|Treatment Period|Physician Decision|4|||
48933738|NCT01808612|157586182|FG000|Treatment Period|Sponsor Decision|1|||
48933739|NCT01808612|157586183|FG001|Treatment Period|Sponsor Decision|0|||
48933740|NCT01808612|157586184|FG002|Treatment Period|Sponsor Decision|0|||
48933741|NCT01808612|157586182|FG000|Treatment Period|Lack of Efficacy|1|||
48933742|NCT01808612|157586183|FG001|Treatment Period|Lack of Efficacy|1|||
48933743|NCT01808612|157586184|FG002|Treatment Period|Lack of Efficacy|2|||
48933744|NCT01808612|157586182|FG000|Discontinuation Period|Adverse Event|1|||
48933745|NCT01808612|157586183|FG001|Discontinuation Period|Adverse Event|0|||
48933746|NCT01808612|157586184|FG002|Discontinuation Period|Adverse Event|0|||
48933747|NCT01808612|157586182|FG000|Discontinuation Period|Physician Decision|1|||
48933748|NCT01808612|157586183|FG001|Discontinuation Period|Physician Decision|0|||
48933749|NCT01808612|157586184|FG002|Discontinuation Period|Physician Decision|0|||
48933750|NCT01808612|157586182|FG000|Discontinuation Period|Lost to Follow-up|0|||
48933751|NCT01808612|157586183|FG001|Discontinuation Period|Lost to Follow-up|1|||
48933752|NCT01808612|157586184|FG002|Discontinuation Period|Lost to Follow-up|0|||
48933753|NCT01046695|157586185|FG000|Overall Study|Subject had a pacemaker|0|||
48933754|NCT01046695|157586186|FG001|Overall Study|Subject had a pacemaker|1|||
48933755|NCT01046695|157586185|FG000|Overall Study|TENS interfered with the cardiac monitor|0|||
48933756|NCT01046695|157586186|FG001|Overall Study|TENS interfered with the cardiac monitor|1|||
48933757|NCT01528787|157586191|FG000|Overall Study|Withdrawal by Subject|0|||
48933758|NCT01528787|157586192|FG001|Overall Study|Withdrawal by Subject|0|||
48933759|NCT01528787|157586193|FG002|Overall Study|Withdrawal by Subject|0|||
48933760|NCT01528787|157586194|FG003|Overall Study|Withdrawal by Subject|1|||
48933761|NCT01528787|157586191|FG000|Overall Study|Family Emergency|0|||
48933762|NCT01528787|157586192|FG001|Overall Study|Family Emergency|0|||
48933763|NCT01528787|157586193|FG002|Overall Study|Family Emergency|1|||
48933764|NCT01528787|157586194|FG003|Overall Study|Family Emergency|0|||
48933765|NCT00189462|157586198|FG000|Overall Study|Lack of Efficacy|5|||
48933766|NCT00189462|157586199|FG001|Overall Study|Lack of Efficacy|1|||
48933767|NCT00189462|157586198|FG000|Overall Study|Lost to Follow-up|18|||
48933768|NCT00189462|157586199|FG001|Overall Study|Lost to Follow-up|20|||
48933769|NCT01262625|157586200|FG000|Overall Study|Administrative Error|1|||
48933770|NCT01262625|157586201|FG001|Overall Study|Administrative Error|1|||
48933771|NCT01262625|157586200|FG000|Overall Study|Site Closed|1|||
48933772|NCT01262625|157586201|FG001|Overall Study|Site Closed|0|||
48933773|NCT01869348|157586202|FG000|Overall Study|Withdrawal by Subject|1|||
48933774|NCT01869348|157586203|FG001|Overall Study|Withdrawal by Subject|1|||
48933775|NCT00441792|157586212|FG000|Overall Study|Lost to Follow-up|0|||
48933776|NCT00441792|157586213|FG001|Overall Study|Lost to Follow-up|2|||
48933777|NCT03093155|157586214|FG000|Overall Study|Not Eligible|1|||
48933778|NCT03093155|157586215|FG001|Overall Study|Not Eligible|0|||
48933779|NCT03093155|157586214|FG000|Overall Study|Withdrawal by Subject|0|||
48933780|NCT03093155|157586215|FG001|Overall Study|Withdrawal by Subject|1|||
48933781|NCT02902120|157586216|FG000|Overall Study|Lack of Efficacy|1|||
48933782|NCT01670994|157586219|FG000|Overall Study|Disease Progression and Switched to Alternative Treatment|0|||
48933783|NCT01670994|157586220|FG001|Overall Study|Disease Progression and Switched to Alternative Treatment|1|||
48933784|NCT01670994|157586219|FG000|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|0|||
48933785|NCT01670994|157586220|FG001|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|1|||
48846216|NCT03580369|157276809|FG006|Overall Study|No treatment due to mis-randomization|0|||
48846217|NCT03580369|157276810|FG007|Overall Study|No treatment due to mis-randomization|0|||
48846218|NCT03580369|157276803|FG000|Overall Study|Reason unknown|0|||
48846219|NCT03580369|157276804|FG001|Overall Study|Reason unknown|0|||
48846220|NCT03580369|157276805|FG002|Overall Study|Reason unknown|1|||
48846221|NCT03580369|157276806|FG003|Overall Study|Reason unknown|0|||
48846222|NCT03580369|157276807|FG004|Overall Study|Reason unknown|0|||
48846223|NCT03580369|157276808|FG005|Overall Study|Reason unknown|0|||
48846224|NCT03580369|157276809|FG006|Overall Study|Reason unknown|0|||
48846225|NCT03580369|157276810|FG007|Overall Study|Reason unknown|0|||
48846226|NCT03580369|157276803|FG000|Overall Study|Technical problems|0|||
48846227|NCT03580369|157276804|FG001|Overall Study|Technical problems|0|||
48846228|NCT03580369|157276805|FG002|Overall Study|Technical problems|0|||
48846229|NCT03580369|157276806|FG003|Overall Study|Technical problems|0|||
48846230|NCT03580369|157276807|FG004|Overall Study|Technical problems|1|||
48846231|NCT03580369|157276808|FG005|Overall Study|Technical problems|0|||
48846232|NCT03580369|157276809|FG006|Overall Study|Technical problems|2|||
48846233|NCT03580369|157276810|FG007|Overall Study|Technical problems|0|||
48846234|NCT03580369|157276803|FG000|Overall Study|Pregnancy|2|||
48846235|NCT03580369|157276804|FG001|Overall Study|Pregnancy|0|||
48846236|NCT03580369|157276805|FG002|Overall Study|Pregnancy|3|||
48846237|NCT03580369|157276806|FG003|Overall Study|Pregnancy|0|||
48846238|NCT03580369|157276807|FG004|Overall Study|Pregnancy|2|||
48846239|NCT03580369|157276808|FG005|Overall Study|Pregnancy|0|||
48846240|NCT03580369|157276809|FG006|Overall Study|Pregnancy|0|||
48846241|NCT03580369|157276810|FG007|Overall Study|Pregnancy|0|||
48933786|NCT01670994|157586219|FG000|Overall Study|Patient experienced DLT|0|||
48933787|NCT01670994|157586220|FG001|Overall Study|Patient experienced DLT|1|||
48933788|NCT03446456|157586221|FG000|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
48933789|NCT03446456|157586222|FG001|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
48933790|NCT03446456|157586221|FG000|Overall Study|Lost to Follow-up|1|||
48933791|NCT03446456|157586222|FG001|Overall Study|Lost to Follow-up|3|||
48933792|NCT03446456|157586221|FG000|Overall Study|Participant failed the toxicology test|1|||
48933793|NCT03446456|157586222|FG001|Overall Study|Participant failed the toxicology test|0|||
48933794|NCT03446456|157586221|FG000|Overall Study|Break down of the experimental equipment|1|||
48933795|NCT03446456|157586222|FG001|Overall Study|Break down of the experimental equipment|0|||
48933796|NCT01360645|157586223|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16|||
48933797|NCT01360645|157586224|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
48933798|NCT01360645|157586225|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
48933799|NCT01360645|157586226|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
48933800|NCT01360645|157586223|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19|||
48933801|NCT01360645|157586224|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
48933802|NCT01360645|157586225|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
48933803|NCT01360645|157586226|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
48933804|NCT01360645|157586223|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16|||
48933805|NCT01360645|157586224|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
48933806|NCT01360645|157586225|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
48933807|NCT01360645|157586226|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
48933808|NCT01360645|157586223|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34|||
48933809|NCT01360645|157586224|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
48933810|NCT01360645|157586225|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
48933811|NCT01360645|157586226|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
48933812|NCT01360645|157586223|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24|||
48933813|NCT01360645|157586224|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
48933814|NCT01360645|157586225|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
48933815|NCT01360645|157586226|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
48933816|NCT01360645|157586223|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5|||
48933817|NCT01360645|157586224|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
48933818|NCT01360645|157586225|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
48933819|NCT01360645|157586226|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
48933820|NCT01360645|157586223|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
48933821|NCT01360645|157586224|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
48933822|NCT01360645|157586225|FG002|Phase B (6 Weeks)|Lost to Follow-up|0|||
48933823|NCT01360645|157586226|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
48933824|NCT01360645|157586223|FG000|Phase B (6 Weeks)|Adverse Event|0|||
48933825|NCT01360645|157586224|FG001|Phase B (6 Weeks)|Adverse Event|6|||
48933826|NCT01360645|157586225|FG002|Phase B (6 Weeks)|Adverse Event|0|||
48933827|NCT01360645|157586226|FG003|Phase B (6 Weeks)|Adverse Event|0|||
48933828|NCT01360645|157586223|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
48933829|NCT01360645|157586224|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|3|||
48933830|NCT01360645|157586225|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
48933831|NCT01360645|157586226|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
48933832|NCT01360645|157586223|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
48933833|NCT01360645|157586224|FG001|Phase B (6 Weeks)|Withdrawal by Subject|3|||
48933834|NCT01360645|157586225|FG002|Phase B (6 Weeks)|Withdrawal by Subject|8|||
48933835|NCT01360645|157586226|FG003|Phase B (6 Weeks)|Withdrawal by Subject|0|||
48933836|NCT01360645|157586223|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
48933837|NCT01360645|157586224|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
48933838|NCT01360645|157586225|FG002|Phase B (6 Weeks)|Protocol Deviation|3|||
48933839|NCT01360645|157586226|FG003|Phase B (6 Weeks)|Protocol Deviation|0|||
48933840|NCT01360645|157586223|FG000|Phase A+|Lost to Follow-up|0|||
48933841|NCT01360645|157586224|FG001|Phase A+|Lost to Follow-up|0|||
48933842|NCT01360645|157586225|FG002|Phase A+|Lost to Follow-up|0|||
48933843|NCT01360645|157586226|FG003|Phase A+|Lost to Follow-up|7|||
48933844|NCT01360645|157586223|FG000|Phase A+|Adverse Event|0|||
48933845|NCT01360645|157586224|FG001|Phase A+|Adverse Event|0|||
48933846|NCT01360645|157586225|FG002|Phase A+|Adverse Event|0|||
48933847|NCT01360645|157586226|FG003|Phase A+|Adverse Event|2|||
48933848|NCT01360645|157586223|FG000|Phase A+|Met Withdrawal Criteria|0|||
48933849|NCT01360645|157586224|FG001|Phase A+|Met Withdrawal Criteria|0|||
48933850|NCT01360645|157586225|FG002|Phase A+|Met Withdrawal Criteria|0|||
48933851|NCT01360645|157586226|FG003|Phase A+|Met Withdrawal Criteria|4|||
48933852|NCT01360645|157586223|FG000|Phase A+|Physician Decision|0|||
48933853|NCT01360645|157586224|FG001|Phase A+|Physician Decision|0|||
48846242|NCT03580369|157276803|FG000|Overall Study|Lost to Follow-up|2|||
48846243|NCT03580369|157276804|FG001|Overall Study|Lost to Follow-up|0|||
48846244|NCT03580369|157276805|FG002|Overall Study|Lost to Follow-up|2|||
48846245|NCT03580369|157276806|FG003|Overall Study|Lost to Follow-up|0|||
48846246|NCT03580369|157276807|FG004|Overall Study|Lost to Follow-up|3|||
48846247|NCT03580369|157276808|FG005|Overall Study|Lost to Follow-up|0|||
48846248|NCT03580369|157276809|FG006|Overall Study|Lost to Follow-up|1|||
48846249|NCT03580369|157276810|FG007|Overall Study|Lost to Follow-up|0|||
48846250|NCT03580369|157276803|FG000|Overall Study|Physician Decision|4|||
48846251|NCT03580369|157276804|FG001|Overall Study|Physician Decision|0|||
48846252|NCT03580369|157276805|FG002|Overall Study|Physician Decision|4|||
48846253|NCT03580369|157276806|FG003|Overall Study|Physician Decision|1|||
48846254|NCT03580369|157276807|FG004|Overall Study|Physician Decision|1|||
48846255|NCT03580369|157276808|FG005|Overall Study|Physician Decision|0|||
48846256|NCT03580369|157276809|FG006|Overall Study|Physician Decision|0|||
48846257|NCT03580369|157276810|FG007|Overall Study|Physician Decision|0|||
48846258|NCT03580369|157276803|FG000|Overall Study|Lack of Efficacy|3|||
48846259|NCT03580369|157276804|FG001|Overall Study|Lack of Efficacy|0|||
48846260|NCT03580369|157276805|FG002|Overall Study|Lack of Efficacy|7|||
48846261|NCT03580369|157276806|FG003|Overall Study|Lack of Efficacy|0|||
48846262|NCT03580369|157276807|FG004|Overall Study|Lack of Efficacy|2|||
48846263|NCT03580369|157276808|FG005|Overall Study|Lack of Efficacy|0|||
48846264|NCT03580369|157276809|FG006|Overall Study|Lack of Efficacy|3|||
48846265|NCT03580369|157276810|FG007|Overall Study|Lack of Efficacy|0|||
48846266|NCT03580369|157276803|FG000|Overall Study|Protocol Violation|6|||
48846267|NCT03580369|157276804|FG001|Overall Study|Protocol Violation|0|||
48846268|NCT03580369|157276805|FG002|Overall Study|Protocol Violation|6|||
48846269|NCT03580369|157276806|FG003|Overall Study|Protocol Violation|1|||
48846270|NCT03580369|157276807|FG004|Overall Study|Protocol Violation|8|||
48846271|NCT03580369|157276808|FG005|Overall Study|Protocol Violation|2|||
48846272|NCT03580369|157276809|FG006|Overall Study|Protocol Violation|1|||
48846273|NCT03580369|157276810|FG007|Overall Study|Protocol Violation|0|||
48846274|NCT03580369|157276803|FG000|Overall Study|Adverse Event|7|||
48846275|NCT03580369|157276804|FG001|Overall Study|Adverse Event|0|||
48846276|NCT03580369|157276805|FG002|Overall Study|Adverse Event|14|||
48846277|NCT03580369|157276806|FG003|Overall Study|Adverse Event|1|||
48846278|NCT03580369|157276807|FG004|Overall Study|Adverse Event|6|||
48846279|NCT03580369|157276808|FG005|Overall Study|Adverse Event|0|||
48846280|NCT03580369|157276809|FG006|Overall Study|Adverse Event|1|||
48846281|NCT03580369|157276810|FG007|Overall Study|Adverse Event|0|||
48846282|NCT03580369|157276803|FG000|Overall Study|Withdrawal by Subject|19|||
48846283|NCT03580369|157276804|FG001|Overall Study|Withdrawal by Subject|0|||
48846284|NCT03580369|157276805|FG002|Overall Study|Withdrawal by Subject|17|||
48846285|NCT03580369|157276806|FG003|Overall Study|Withdrawal by Subject|0|||
48846286|NCT03580369|157276807|FG004|Overall Study|Withdrawal by Subject|16|||
48846287|NCT03580369|157276808|FG005|Overall Study|Withdrawal by Subject|1|||
48846288|NCT03580369|157276809|FG006|Overall Study|Withdrawal by Subject|7|||
48846289|NCT03580369|157276810|FG007|Overall Study|Withdrawal by Subject|0|||
48846290|NCT04766034|157276811|FG000|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
48846291|NCT04766034|157276812|FG001|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
48846292|NCT04766034|157276813|FG002|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
48846293|NCT04766034|157276814|FG003|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
48846294|NCT04766034|157276815|FG004|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|3752|||
48846295|NCT04766034|157276811|FG000|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
48846296|NCT04766034|157276812|FG001|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
48846297|NCT04766034|157276813|FG002|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
48846298|NCT04766034|157276814|FG003|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
48846299|NCT04766034|157276815|FG004|Aim 2 - Pre-Randomization Survey|Did not finish survey|120|||
48846300|NCT04766034|157276811|FG000|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|67|||
48846301|NCT04766034|157276812|FG001|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|86|||
48846302|NCT04766034|157276813|FG002|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|75|||
48846303|NCT04766034|157276814|FG003|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|84|||
48846304|NCT04766034|157276815|FG004|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|0|||
48846305|NCT04766034|157276811|FG000|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|206|||
48846306|NCT04766034|157276812|FG001|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|223|||
48846307|NCT04766034|157276813|FG002|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|155|||
48933854|NCT01360645|157586225|FG002|Phase A+|Physician Decision|0|||
48846308|NCT04766034|157276814|FG003|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|198|||
48846309|NCT04766034|157276815|FG004|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|0|||
48846310|NCT01227265|157276816|FG000|Overall Study|Did Not Receive Treatment|1|||
48846311|NCT01227265|157276817|FG001|Overall Study|Did Not Receive Treatment|2|||
48846312|NCT01227265|157276818|FG002|Overall Study|Did Not Receive Treatment|0|||
48846313|NCT01227265|157276816|FG000|Overall Study|Administrative|1|||
48846314|NCT01227265|157276817|FG001|Overall Study|Administrative|0|||
48846315|NCT01227265|157276818|FG002|Overall Study|Administrative|2|||
48846316|NCT01227265|157276816|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
48846317|NCT01227265|157276817|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
48846318|NCT01227265|157276818|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
48846319|NCT01227265|157276816|FG000|Overall Study|Protocol Violation|2|||
48846320|NCT01227265|157276817|FG001|Overall Study|Protocol Violation|1|||
48846321|NCT01227265|157276818|FG002|Overall Study|Protocol Violation|0|||
48846322|NCT01227265|157276816|FG000|Overall Study|Withdrawal by Subject|7|||
48846323|NCT01227265|157276817|FG001|Overall Study|Withdrawal by Subject|7|||
48846324|NCT01227265|157276818|FG002|Overall Study|Withdrawal by Subject|3|||
48846325|NCT01227265|157276816|FG000|Overall Study|Lost to Follow-up|2|||
48846326|NCT01227265|157276817|FG001|Overall Study|Lost to Follow-up|0|||
48846327|NCT01227265|157276818|FG002|Overall Study|Lost to Follow-up|3|||
48846328|NCT01227265|157276816|FG000|Overall Study|Adverse Event|6|||
48846329|NCT01227265|157276817|FG001|Overall Study|Adverse Event|10|||
48846330|NCT01227265|157276818|FG002|Overall Study|Adverse Event|5|||
48846331|NCT03481816|157276820|FG000|Starting Dose|Refused further vaccines after 1 dose|1|||
48846332|NCT03481816|157276821|FG001|Starting Dose|Refused further vaccines after 1 dose|0|||
48846333|NCT03481816|157276820|FG000|Dose Expansion|Off treatment due to progressive disease|0|||
48846334|NCT03481816|157276821|FG001|Dose Expansion|Off treatment due to progressive disease|5|||
48846335|NCT03481816|157276820|FG000|Dose Expansion|Withdrawal by Subject|0|||
48846336|NCT03481816|157276821|FG001|Dose Expansion|Withdrawal by Subject|2|||
48846337|NCT03481816|157276820|FG000|Dose Expansion|Physician Decision|0|||
48846338|NCT03481816|157276821|FG001|Dose Expansion|Physician Decision|5|||
48846339|NCT00823472|157276822|FG000|Overall Study|Physician Decision|24|||
48846340|NCT00823472|157276823|FG001|Overall Study|Physician Decision|28|||
48933855|NCT01360645|157586226|FG003|Phase A+|Physician Decision|2|||
48933856|NCT01360645|157586223|FG000|Phase A+|Withdrawal by Subject|0|||
48933857|NCT01360645|157586224|FG001|Phase A+|Withdrawal by Subject|0|||
48933858|NCT01360645|157586225|FG002|Phase A+|Withdrawal by Subject|0|||
48933859|NCT01360645|157586226|FG003|Phase A+|Withdrawal by Subject|5|||
48846341|NCT01721291|157276825|FG000|Overall Study|Withdrawal by Subject|1|||
48846342|NCT01721291|157276826|FG001|Overall Study|Withdrawal by Subject|0|||
48846343|NCT01721291|157276825|FG000|Overall Study|did not like the treatment|1|||
48846344|NCT01721291|157276826|FG001|Overall Study|did not like the treatment|0|||
48846345|NCT00812461|157276829|FG000|All Randomised Patients|Did not receive placebo/nalmefene|23|||
48846346|NCT00812461|157276830|FG001|All Randomised Patients|Did not receive placebo/nalmefene|17|||
48933860|NCT01360645|157586223|FG000|Phase A+|Protocol Deviation|0|||
48846347|NCT00812461|157276829|FG000|All Treated Patients|Adverse Event|8|||
48846348|NCT00812461|157276830|FG001|All Treated Patients|Adverse Event|15|||
48846349|NCT00812461|157276829|FG000|All Treated Patients|Lack of Efficacy|13|||
48846350|NCT00812461|157276830|FG001|All Treated Patients|Lack of Efficacy|7|||
48846351|NCT00812461|157276829|FG000|All Treated Patients|Non-compliance|6|||
48846352|NCT00812461|157276830|FG001|All Treated Patients|Non-compliance|9|||
48846353|NCT00812461|157276829|FG000|All Treated Patients|Protocol Violation|36|||
48933861|NCT01360645|157586224|FG001|Phase A+|Protocol Deviation|0|||
48933862|NCT01360645|157586225|FG002|Phase A+|Protocol Deviation|0|||
48933863|NCT01360645|157586226|FG003|Phase A+|Protocol Deviation|4|||
48933864|NCT03183128|157586227|FG000|Overall Study|Adverse Event|1|||
48933865|NCT03183128|157586228|FG001|Overall Study|Adverse Event|2|||
48933866|NCT03183128|157586227|FG000|Overall Study|Withdrawal by Subject|1|||
48933867|NCT03183128|157586228|FG001|Overall Study|Withdrawal by Subject|8|||
48933868|NCT03183128|157586227|FG000|Overall Study|Protocol Violation|2|||
48933869|NCT03183128|157586228|FG001|Overall Study|Protocol Violation|0|||
48933870|NCT03183128|157586227|FG000|Overall Study|Lack of Efficacy|4|||
48933871|NCT03183128|157586228|FG001|Overall Study|Lack of Efficacy|27|||
48933872|NCT03183128|157586227|FG000|Overall Study|Lost to Follow-up|1|||
48933873|NCT03183128|157586228|FG001|Overall Study|Lost to Follow-up|0|||
48933874|NCT03183128|157586227|FG000|Overall Study|Death|2|||
48933875|NCT03183128|157586228|FG001|Overall Study|Death|0|||
48933876|NCT03183128|157586227|FG000|Overall Study|Physician Decision|1|||
48933877|NCT03183128|157586228|FG001|Overall Study|Physician Decision|0|||
48933878|NCT01900002|157586231|FG000|Overall Study|Withdrawal by Subject|2|||
48933879|NCT01900002|157586231|FG000|Overall Study|ineligible for Y-90|4|||
48933880|NCT00888238|157586234|FG000|Washout Period After Period 2|Adverse Event|0|||
48933881|NCT00888238|157586235|FG001|Washout Period After Period 2|Adverse Event|0|||
48933882|NCT00888238|157586236|FG002|Washout Period After Period 2|Adverse Event|1|||
48933883|NCT01481896|157586237|FG000|Overall Study|Lost to Follow-up|12|||
48933884|NCT02251912|157586238|FG000|Overall Study|Withdrawal by Subject|2|||
48933885|NCT02251912|157586239|FG001|Overall Study|Withdrawal by Subject|3|||
48933886|NCT02251912|157586238|FG000|Overall Study|Adverse Event|0|||
48933887|NCT02251912|157586239|FG001|Overall Study|Adverse Event|2|||
48933888|NCT02921425|157586241|FG000|Overall Study|Protocol Violation|9|||
48933889|NCT01227967|157586242|FG000|Overall Study|Protocol Violation|3|||
48933890|NCT01227967|157586243|FG001|Overall Study|Protocol Violation|1|||
48933891|NCT01227967|157586242|FG000|Overall Study|Death|0|||
48933892|NCT01227967|157586243|FG001|Overall Study|Death|1|||
48933893|NCT01227967|157586242|FG000|Overall Study|Lost to Follow-up|8|||
48933894|NCT01227967|157586243|FG001|Overall Study|Lost to Follow-up|3|||
48933895|NCT01227967|157586242|FG000|Overall Study|Withdrawal by Subject|4|||
48933896|NCT01227967|157586243|FG001|Overall Study|Withdrawal by Subject|3|||
48933897|NCT01227967|157586242|FG000|Overall Study|Physician Decision|0|||
48933898|NCT01227967|157586243|FG001|Overall Study|Physician Decision|1|||
48933899|NCT01227967|157586242|FG000|Overall Study|Never Started Treatment|0|||
48933900|NCT01227967|157586243|FG001|Overall Study|Never Started Treatment|4|||
48933901|NCT01227967|157586242|FG000|Overall Study|Taking Additional Antiviral Drug|1|||
48933902|NCT01227967|157586243|FG001|Overall Study|Taking Additional Antiviral Drug|0|||
48933903|NCT00480857|157586244|FG000|Overall Study|Lack of Efficacy|2|||
48933904|NCT00611247|157586245|FG000|Overall Study|Death|1|||
48933905|NCT00611247|157586246|FG001|Overall Study|Death|5|||
48933906|NCT00611247|157586245|FG000|Overall Study|Lack of Efficacy|1|||
48933907|NCT00611247|157586246|FG001|Overall Study|Lack of Efficacy|16|||
48933908|NCT01107444|157586247|FG000|Overall Study|Withdrawal by Subject|8|||
48846354|NCT00812461|157276830|FG001|All Treated Patients|Protocol Violation|27|||
48846355|NCT00812461|157276829|FG000|All Treated Patients|Withdrawal by Subject|45|||
48933909|NCT01107444|157586248|FG001|Overall Study|Withdrawal by Subject|12|||
48933910|NCT01107444|157586247|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
48933911|NCT01107444|157586248|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
48933912|NCT01948830|157586249|FG000|Overall Study|Physician Decision|1|||
48933913|NCT01948830|157586250|FG001|Overall Study|Physician Decision|3|||
48933914|NCT01948830|157586249|FG000|Overall Study|Protocol deviation|1|||
48846356|NCT00812461|157276830|FG001|All Treated Patients|Withdrawal by Subject|54|||
48846357|NCT00812461|157276829|FG000|All Treated Patients|Lost to Follow-up|11|||
48846358|NCT00812461|157276830|FG001|All Treated Patients|Lost to Follow-up|14|||
48846359|NCT00812461|157276829|FG000|All Treated Patients|Other Reason|13|||
48846360|NCT00812461|157276830|FG001|All Treated Patients|Other Reason|21|||
48846361|NCT03613740|157278559|FG000|Overall Study|Lost to Follow-up|1|||
48846362|NCT03613740|157278560|FG001|Overall Study|Lost to Follow-up|1|||
48846363|NCT03544515|157278570|FG000|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|4|||
48846364|NCT03544515|157278571|FG001|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|2|||
48846365|NCT03544515|157278570|FG000|Overall Study|Lost to Follow-up|2|||
48846366|NCT03544515|157278571|FG001|Overall Study|Lost to Follow-up|0|||
48846367|NCT00722046|157278572|FG000|Overall Study|Adverse Event|0|||
48846368|NCT00722046|157278573|FG001|Overall Study|Adverse Event|1|||
48846369|NCT00722046|157278574|FG002|Overall Study|Adverse Event|2|||
48846370|NCT00722046|157278575|FG003|Overall Study|Adverse Event|1|||
48846371|NCT00722046|157278576|FG004|Overall Study|Adverse Event|2|||
48846372|NCT00722046|157278577|FG005|Overall Study|Adverse Event|1|||
48846373|NCT00722046|157278578|FG006|Overall Study|Adverse Event|0|||
48846374|NCT00722046|157278572|FG000|Overall Study|Death|0|||
48846375|NCT00722046|157278573|FG001|Overall Study|Death|1|||
48846376|NCT00722046|157278574|FG002|Overall Study|Death|0|||
48846377|NCT00722046|157278575|FG003|Overall Study|Death|0|||
48846378|NCT00722046|157278576|FG004|Overall Study|Death|0|||
48846379|NCT00722046|157278577|FG005|Overall Study|Death|0|||
48846380|NCT00722046|157278578|FG006|Overall Study|Death|2|||
48846381|NCT00722046|157278572|FG000|Overall Study|Protocol Violation|1|||
48846382|NCT00722046|157278573|FG001|Overall Study|Protocol Violation|0|||
48846383|NCT00722046|157278574|FG002|Overall Study|Protocol Violation|0|||
48846384|NCT00722046|157278575|FG003|Overall Study|Protocol Violation|0|||
48846385|NCT00722046|157278576|FG004|Overall Study|Protocol Violation|0|||
48846386|NCT00722046|157278577|FG005|Overall Study|Protocol Violation|1|||
48846387|NCT00722046|157278578|FG006|Overall Study|Protocol Violation|0|||
48846388|NCT00722046|157278572|FG000|Overall Study|Withdrawal by Subject|3|||
48846389|NCT00722046|157278573|FG001|Overall Study|Withdrawal by Subject|3|||
48846390|NCT00722046|157278574|FG002|Overall Study|Withdrawal by Subject|4|||
48846391|NCT00722046|157278575|FG003|Overall Study|Withdrawal by Subject|4|||
48846392|NCT00722046|157278576|FG004|Overall Study|Withdrawal by Subject|4|||
48846393|NCT00722046|157278577|FG005|Overall Study|Withdrawal by Subject|7|||
48846394|NCT00722046|157278578|FG006|Overall Study|Withdrawal by Subject|3|||
48846395|NCT00722046|157278572|FG000|Overall Study|Randomized, but not treated|1|||
48846396|NCT00722046|157278573|FG001|Overall Study|Randomized, but not treated|1|||
48846397|NCT00722046|157278574|FG002|Overall Study|Randomized, but not treated|0|||
48846398|NCT00722046|157278575|FG003|Overall Study|Randomized, but not treated|2|||
48846399|NCT00722046|157278576|FG004|Overall Study|Randomized, but not treated|0|||
48846400|NCT00722046|157278577|FG005|Overall Study|Randomized, but not treated|0|||
48846401|NCT00722046|157278578|FG006|Overall Study|Randomized, but not treated|0|||
48846402|NCT00722046|157278572|FG000|Overall Study|Other|0|||
48846403|NCT00722046|157278573|FG001|Overall Study|Other|0|||
48846404|NCT00722046|157278574|FG002|Overall Study|Other|1|||
48846405|NCT00722046|157278575|FG003|Overall Study|Other|1|||
48846406|NCT00722046|157278576|FG004|Overall Study|Other|3|||
48846407|NCT00722046|157278577|FG005|Overall Study|Other|2|||
48846408|NCT00722046|157278578|FG006|Overall Study|Other|1|||
48846415|NCT00150813|157278581|FG000|Overall Study|Adverse Event|1|||
48846416|NCT00150813|157278581|FG000|Overall Study|Lack of Efficacy|1|||
48846417|NCT00150813|157278581|FG000|Overall Study|Lost to Follow-up|5|||
48846418|NCT00150813|157278581|FG000|Overall Study|Withdrawal by Subject|5|||
48846419|NCT00150813|157278581|FG000|Overall Study|Remission|3|||
48846420|NCT00150813|157278581|FG000|Overall Study|Planned pregancy|1|||
48846421|NCT00150813|157278581|FG000|Overall Study|Switch to commercially available LEV|2|||
48846422|NCT01696968|157278582|FG000|Overall Study|Cancer Before Rand. (Lung Screening)|0|||
48846423|NCT01696968|157278583|FG001|Overall Study|Cancer Before Rand. (Lung Screening)|8|||
48846424|NCT01696968|157278582|FG000|Overall Study|Died Before Randomization|3|||
48846425|NCT01696968|157278583|FG001|Overall Study|Died Before Randomization|8|||
48846426|NCT01696968|157278582|FG000|Overall Study|Died Before ASU (Control)|278|||
48846427|NCT01696968|157278583|FG001|Overall Study|Died Before ASU (Control)|0|||
48846428|NCT01696968|157278582|FG000|Overall Study|Refused ASU (Control)|920|||
48846429|NCT01696968|157278583|FG001|Overall Study|Refused ASU (Control)|0|||
48846430|NCT01696968|157278582|FG000|Overall Study|Refused Screen (Lung Screening)|0|||
48933915|NCT01948830|157586250|FG001|Overall Study|Protocol deviation|2|||
48933916|NCT01948830|157586249|FG000|Overall Study|Lost to Follow-up|5|||
48933917|NCT01948830|157586250|FG001|Overall Study|Lost to Follow-up|4|||
48933918|NCT01948830|157586249|FG000|Overall Study|Withdrawal by Subject|14|||
48933919|NCT01948830|157586250|FG001|Overall Study|Withdrawal by Subject|17|||
48933920|NCT01948830|157586249|FG000|Overall Study|Adverse Event|9|||
48933921|NCT01948830|157586250|FG001|Overall Study|Adverse Event|2|||
48933922|NCT01948830|157586249|FG000|Overall Study|Death|3|||
48933923|NCT01948830|157586250|FG001|Overall Study|Death|4|||
48933924|NCT02149810|157586262|FG000|Overall Study|Physician Decision|1|||
48933925|NCT02149810|157586263|FG001|Overall Study|Physician Decision|2|||
48933926|NCT02149810|157586262|FG000|Overall Study|Lost to Follow-up|2|||
48933927|NCT02149810|157586263|FG001|Overall Study|Lost to Follow-up|1|||
48933928|NCT02149810|157586262|FG000|Overall Study|Withdrawal by Subject|5|||
48933929|NCT02149810|157586263|FG001|Overall Study|Withdrawal by Subject|1|||
48933930|NCT01959165|157586264|FG000|Overall Study|Adverse Event|0|||
48933931|NCT01959165|157586265|FG001|Overall Study|Adverse Event|0|||
48933932|NCT01959165|157586266|FG002|Overall Study|Adverse Event|0|||
48933933|NCT01959165|157586267|FG003|Overall Study|Adverse Event|1|||
48933934|NCT01959165|157586264|FG000|Overall Study|Lack of Efficacy|1|||
48933935|NCT01959165|157586265|FG001|Overall Study|Lack of Efficacy|0|||
48933936|NCT01959165|157586266|FG002|Overall Study|Lack of Efficacy|0|||
48933937|NCT01959165|157586267|FG003|Overall Study|Lack of Efficacy|0|||
48933938|NCT01959165|157586264|FG000|Overall Study|overdose|0|||
48933939|NCT01959165|157586265|FG001|Overall Study|overdose|0|||
48933940|NCT01959165|157586266|FG002|Overall Study|overdose|0|||
48933941|NCT01959165|157586267|FG003|Overall Study|overdose|1|||
48933942|NCT01959165|157586264|FG000|Overall Study|Welfare recipient|0|||
48933943|NCT01959165|157586265|FG001|Overall Study|Welfare recipient|1|||
48933944|NCT01959165|157586266|FG002|Overall Study|Welfare recipient|0|||
48933945|NCT01959165|157586267|FG003|Overall Study|Welfare recipient|0|||
48933946|NCT03686969|157586269|FG000|Overall Study|Study terminated|1|||
48933947|NCT03686969|157586270|FG001|Overall Study|Study terminated|0|||
48933948|NCT01651780|157586279|FG000|Overall Study|Physician decision: No 30-day visit|2|||
48933949|NCT01651780|157586280|FG001|Overall Study|Physician decision: No 30-day visit|1|||
48933950|NCT01651780|157586279|FG000|Overall Study|Reason Not Specified: No 30-day visit|2|||
48933951|NCT01651780|157586280|FG001|Overall Study|Reason Not Specified: No 30-day visit|2|||
48933952|NCT01651780|157586279|FG000|Overall Study|Withdrawal by Subject|2|||
48933953|NCT01651780|157586280|FG001|Overall Study|Withdrawal by Subject|0|||
48933954|NCT01651780|157586279|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
48933955|NCT01651780|157586280|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
48933956|NCT01651780|157586279|FG000|Overall Study|Lost to Follow-up|1|||
48933957|NCT01651780|157586280|FG001|Overall Study|Lost to Follow-up|2|||
48933958|NCT01651780|157586279|FG000|Overall Study|Physician decision: Day 30 visit <23 day|1|||
48933959|NCT01651780|157586280|FG001|Overall Study|Physician decision: Day 30 visit <23 day|5|||
48933960|NCT05224544|157586282|FG000|V2, Catheterization and Visualization|Adverse Event|2|||
48933961|NCT05224544|157586283|FG001|V2, Catheterization and Visualization|Adverse Event|1|||
48933962|NCT01468311|157586288|FG000|Overall Study|mobilization failure|1|||
48933963|NCT01468311|157586288|FG000|Overall Study|Withdrawal by Subject|1|||
48933964|NCT01671345|157586289|FG000|Overall Study|Lost to Follow-up|10|||
48933965|NCT01671345|157586290|FG001|Overall Study|Lost to Follow-up|6|||
48933966|NCT01671345|157586289|FG000|Overall Study|visit with non-participating physician|3|||
48933967|NCT01671345|157586290|FG001|Overall Study|visit with non-participating physician|3|||
48933968|NCT00768898|157588134|FG000|Overall Study|Unrelated injury|1|||
48933969|NCT00768898|157588134|FG000|Overall Study|Headache|1|||
48933970|NCT01299766|157588135|FG000|Overall Study|Death|5|||
48933971|NCT01299766|157588136|FG001|Overall Study|Death|4|||
48933972|NCT01299766|157588135|FG000|Overall Study|Withdrawal by Subject|29|||
48933973|NCT01299766|157588136|FG001|Overall Study|Withdrawal by Subject|19|||
48933974|NCT00388947|157588137|FG000|Overall Study|Protocol Violation|47|||
48933975|NCT03038308|157588138|FG000|Overall Study|Surgical resection|1|||
48933976|NCT03038308|157588138|FG000|Overall Study|Withdrawal by Subject|2|||
48933977|NCT03038308|157588138|FG000|Overall Study|Lost to Follow-up|1|||
48933978|NCT00619502|157588150|FG000|Overall Study|Lost to Follow-up|8|||
48933979|NCT00619502|157588151|FG001|Overall Study|Lost to Follow-up|10|||
48933980|NCT01777763|157588152|FG000|Overall Study|Adverse Event|2|||
48933981|NCT01777763|157588153|FG001|Overall Study|Adverse Event|32|||
48933982|NCT01777763|157588152|FG000|Overall Study|Protocol Violation|1|||
48933983|NCT01777763|157588153|FG001|Overall Study|Protocol Violation|7|||
48933984|NCT01777763|157588152|FG000|Overall Study|Withdrawal by Subject|0|||
48933985|NCT01777763|157588153|FG001|Overall Study|Withdrawal by Subject|2|||
48933986|NCT01777763|157588152|FG000|Overall Study|Treatment Failure|1|||
48933987|NCT01777763|157588153|FG001|Overall Study|Treatment Failure|6|||
48933988|NCT00667576|157588155|FG000|Overall Study|Withdrawal by Subject|1|||
48933989|NCT00667576|157588156|FG001|Overall Study|Withdrawal by Subject|0|||
48933990|NCT00667576|157588157|FG002|Overall Study|Withdrawal by Subject|1|||
48933991|NCT00667576|157588158|FG003|Overall Study|Withdrawal by Subject|1|||
48933992|NCT00667576|157588159|FG004|Overall Study|Withdrawal by Subject|1|||
48933993|NCT00667576|157588155|FG000|Overall Study|Adverse Event|1|||
48933994|NCT00667576|157588156|FG001|Overall Study|Adverse Event|1|||
48933995|NCT00667576|157588157|FG002|Overall Study|Adverse Event|0|||
48933996|NCT00667576|157588158|FG003|Overall Study|Adverse Event|0|||
48933997|NCT00667576|157588159|FG004|Overall Study|Adverse Event|0|||
48933998|NCT00667576|157588155|FG000|Overall Study|Lost to Follow-up|0|||
48933999|NCT00667576|157588156|FG001|Overall Study|Lost to Follow-up|0|||
48934000|NCT00667576|157588157|FG002|Overall Study|Lost to Follow-up|1|||
48934001|NCT00667576|157588158|FG003|Overall Study|Lost to Follow-up|0|||
48934002|NCT00667576|157588159|FG004|Overall Study|Lost to Follow-up|0|||
48934003|NCT00667576|157588155|FG000|Overall Study|Protocol Violation|0|||
48934004|NCT00667576|157588156|FG001|Overall Study|Protocol Violation|0|||
48934005|NCT00667576|157588157|FG002|Overall Study|Protocol Violation|0|||
48934006|NCT00667576|157588158|FG003|Overall Study|Protocol Violation|1|||
48934007|NCT00667576|157588159|FG004|Overall Study|Protocol Violation|0|||
48934008|NCT00667576|157588155|FG000|Overall Study|Physician Decision|0|||
48934009|NCT00667576|157588156|FG001|Overall Study|Physician Decision|0|||
48934010|NCT00667576|157588157|FG002|Overall Study|Physician Decision|0|||
48934011|NCT00667576|157588158|FG003|Overall Study|Physician Decision|1|||
48934012|NCT00667576|157588159|FG004|Overall Study|Physician Decision|0|||
48934013|NCT00667576|157588155|FG000|Overall Study|Missed Visit|0|||
48934014|NCT00667576|157588156|FG001|Overall Study|Missed Visit|0|||
48934015|NCT00667576|157588157|FG002|Overall Study|Missed Visit|0|||
48934016|NCT00667576|157588158|FG003|Overall Study|Missed Visit|1|||
48934017|NCT00667576|157588159|FG004|Overall Study|Missed Visit|0|||
48934018|NCT00132041|157588162|FG000|Baseline|Ineligible|6|||
48934019|NCT00132041|157588162|FG000|3 Months Post Ablation|Transplant|1|||
48934020|NCT00132041|157588162|FG000|3 Months Post Ablation|Non-Protocol Treatment|2|||
48934021|NCT00132041|157588162|FG000|6 Months Post Ablation|Withdrawal by Subject|2|||
48934022|NCT00132041|157588162|FG000|6 Months Post Ablation|Death|2|||
48934023|NCT00132041|157588162|FG000|6 Months Post Ablation|Transplant|6|||
48934024|NCT00132041|157588162|FG000|9 Months Post Ablation|Death|1|||
48934025|NCT00132041|157588162|FG000|9 Months Post Ablation|Transplant|1|||
48934026|NCT00132041|157588162|FG000|12 Months Post Ablation|Withdrawal by Subject|1|||
48934027|NCT00132041|157588162|FG000|12 Months Post Ablation|Death|1|||
48934028|NCT00132041|157588162|FG000|12 Months Post Ablation|Transplant|1|||
48934029|NCT00132041|157588162|FG000|12 Months Post Ablation|non-protocol Treatment|1|||
48934030|NCT00132041|157588162|FG000|15 Months Post Ablation|Withdrawal by Subject|1|||
48934031|NCT00132041|157588162|FG000|15 Months Post Ablation|Death|1|||
48934032|NCT00132041|157588162|FG000|15 Months Post Ablation|Transplant|5|||
48934033|NCT00132041|157588162|FG000|15 Months Post Ablation|Non-Protocol Treatment|1|||
48934034|NCT00132041|157588162|FG000|18 Months Post Ablation|Withdrawal by Subject|1|||
48934035|NCT00132041|157588162|FG000|18 Months Post Ablation|Transplant|1|||
48934036|NCT00132041|157588162|FG000|18 Months Post Ablation|Non-Protocol Treatment|3|||
48934037|NCT00132041|157588162|FG000|18 Months Post Ablation|ExtraHepatic tumor|1|||
48934038|NCT03969875|157588163|FG000|Overall Study|did not receive allocated intervention|3|||
48846431|NCT01696968|157278583|FG001|Overall Study|Refused Screen (Lung Screening)|6796|||
48934039|NCT03969875|157588164|FG001|Overall Study|did not receive allocated intervention|3|||
48934040|NCT03969875|157588165|FG002|Overall Study|did not receive allocated intervention|4|||
48934041|NCT03969875|157588163|FG000|Overall Study|Protocol Violation|4|||
48934042|NCT03969875|157588164|FG001|Overall Study|Protocol Violation|2|||
48934043|NCT03969875|157588165|FG002|Overall Study|Protocol Violation|2|||
48934044|NCT02971202|157588168|FG000|Overall Study|Pregnancy|1|||
48846432|NCT02729311|157278584|FG000|Overall Study|Withdrawal by Subject|8|||
48846433|NCT02729311|157278585|FG001|Overall Study|Withdrawal by Subject|2|||
48846434|NCT01308567|157278588|FG000|Overall Study|Lost to Follow-up|2|||
48846435|NCT01308567|157278589|FG001|Overall Study|Lost to Follow-up|4|||
48846436|NCT01308567|157278590|FG002|Overall Study|Lost to Follow-up|4|||
48846437|NCT02724956|157278591|FG000|Overall Study|Physician Decision|1|||
48846438|NCT02724956|157278592|FG001|Overall Study|Physician Decision|0|||
48846439|NCT02724956|157278591|FG000|Overall Study|Lack of Efficacy|0|||
48846440|NCT02724956|157278592|FG001|Overall Study|Lack of Efficacy|1|||
48846441|NCT02724956|157278591|FG000|Overall Study|Withdrawal by Subject|0|||
48846442|NCT02724956|157278592|FG001|Overall Study|Withdrawal by Subject|1|||
48846443|NCT05262738|157278593|FG000|Overall Study|Withdrawal by Subject|1|||
48934045|NCT02971202|157588169|FG001|Overall Study|Pregnancy|0|||
48846444|NCT05262738|157278594|FG001|Overall Study|Withdrawal by Subject|0|||
48846445|NCT01574716|157278602|FG000|Part 1|Death|3|||
48934046|NCT02971202|157588170|FG002|Overall Study|Pregnancy|0|||
48934047|NCT02971202|157588168|FG000|Overall Study|screen fail after consent|1|||
48934048|NCT02971202|157588169|FG001|Overall Study|screen fail after consent|0|||
48934049|NCT02971202|157588170|FG002|Overall Study|screen fail after consent|1|||
48934050|NCT03588741|157588171|FG000|Overall Study|Withdrawal by Subject|1|||
48934051|NCT01946178|157588172|FG000|Overall Study|Pregnancy|1|||
48934052|NCT01946178|157588172|FG000|Overall Study|Lost to Follow-up|1|||
48934053|NCT02421887|157588173|FG000|Overall Study|Lost to Follow-up|5|||
48934054|NCT02421887|157588174|FG001|Overall Study|Lost to Follow-up|0|||
48934055|NCT02421887|157588173|FG000|Overall Study|Withdrawal by Subject|8|||
48934056|NCT02421887|157588174|FG001|Overall Study|Withdrawal by Subject|5|||
48934057|NCT02421887|157588173|FG000|Overall Study|Physician Decision|2|||
48934058|NCT02421887|157588174|FG001|Overall Study|Physician Decision|4|||
48934059|NCT02421887|157588173|FG000|Overall Study|Adverse Event|2|||
48934060|NCT02421887|157588174|FG001|Overall Study|Adverse Event|0|||
48934061|NCT00454779|157588176|FG000|First-line Treatment Phase|Lack of Efficacy|0|||
48934062|NCT00454779|157588177|FG001|First-line Treatment Phase|Lack of Efficacy|2|||
48934063|NCT00454779|157588176|FG000|First-line Treatment Phase|Withdrawal by Subject|2|||
48934064|NCT00454779|157588177|FG001|First-line Treatment Phase|Withdrawal by Subject|4|||
48934065|NCT00454779|157588176|FG000|First-line Treatment Phase|Lost to Follow-up|1|||
48934066|NCT00454779|157588177|FG001|First-line Treatment Phase|Lost to Follow-up|0|||
48934067|NCT00454779|157588176|FG000|First-line Treatment Phase|Protocol Violation|0|||
48934068|NCT00454779|157588177|FG001|First-line Treatment Phase|Protocol Violation|1|||
48934069|NCT00454779|157588176|FG000|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
48934070|NCT00454779|157588177|FG001|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
48934071|NCT00454779|157588176|FG000|First-line Treatment Phase|Ongoing|1|||
48934072|NCT00454779|157588177|FG001|First-line Treatment Phase|Ongoing|0|||
48934073|NCT00454779|157588176|FG000|Second-line Treatment Phase|Withdrawal by Subject|0|||
48934074|NCT00454779|157588177|FG001|Second-line Treatment Phase|Withdrawal by Subject|1|||
48934075|NCT00454779|157588176|FG000|Second-line Treatment Phase|Ended follow-up prior to analysis|0|||
48934076|NCT00454779|157588177|FG001|Second-line Treatment Phase|Ended follow-up prior to analysis|1|||
48934077|NCT00454779|157588176|FG000|Second-line Treatment Phase|Ongoing|0|||
48934078|NCT00454779|157588177|FG001|Second-line Treatment Phase|Ongoing|1|||
48934079|NCT02908100|157588178|FG000|Overall Study|Adverse Event|7|||
48934080|NCT02908100|157588179|FG001|Overall Study|Adverse Event|6|||
48934081|NCT02908100|157588180|FG002|Overall Study|Adverse Event|9|||
48934082|NCT02908100|157588178|FG000|Overall Study|Death|2|||
48934083|NCT02908100|157588179|FG001|Overall Study|Death|0|||
48934084|NCT02908100|157588180|FG002|Overall Study|Death|0|||
48934085|NCT02908100|157588178|FG000|Overall Study|Lack of Efficacy|2|||
48934086|NCT02908100|157588179|FG001|Overall Study|Lack of Efficacy|3|||
48934087|NCT02908100|157588180|FG002|Overall Study|Lack of Efficacy|3|||
48934088|NCT02908100|157588178|FG000|Overall Study|Lost to Follow-up|0|||
48934089|NCT02908100|157588179|FG001|Overall Study|Lost to Follow-up|1|||
48934090|NCT02908100|157588180|FG002|Overall Study|Lost to Follow-up|2|||
48934091|NCT02908100|157588178|FG000|Overall Study|Non-Compliance With Study Drug|1|||
48934092|NCT02908100|157588179|FG001|Overall Study|Non-Compliance With Study Drug|1|||
48934093|NCT02908100|157588180|FG002|Overall Study|Non-Compliance With Study Drug|2|||
48934094|NCT02908100|157588178|FG000|Overall Study|Non-Compliance With Contraceptive Method|1|||
48934095|NCT02908100|157588179|FG001|Overall Study|Non-Compliance With Contraceptive Method|0|||
48934096|NCT02908100|157588180|FG002|Overall Study|Non-Compliance With Contraceptive Method|0|||
48934097|NCT02908100|157588178|FG000|Overall Study|Physician Decision|0|||
48934098|NCT02908100|157588179|FG001|Overall Study|Physician Decision|1|||
48934099|NCT02908100|157588180|FG002|Overall Study|Physician Decision|0|||
48934100|NCT02908100|157588178|FG000|Overall Study|Pregnancy|1|||
48934101|NCT02908100|157588179|FG001|Overall Study|Pregnancy|2|||
48934102|NCT02908100|157588180|FG002|Overall Study|Pregnancy|0|||
48934103|NCT02908100|157588178|FG000|Overall Study|Withdrawal by Subject|8|||
48934104|NCT02908100|157588179|FG001|Overall Study|Withdrawal by Subject|7|||
48934105|NCT02908100|157588180|FG002|Overall Study|Withdrawal by Subject|5|||
48934106|NCT02908100|157588178|FG000|Overall Study|Randomised in Error|1|||
48934107|NCT02908100|157588179|FG001|Overall Study|Randomised in Error|0|||
48934108|NCT02908100|157588180|FG002|Overall Study|Randomised in Error|0|||
48934109|NCT00491179|157588181|FG000|Overall Study|Adverse Event|5|||
48934110|NCT00491179|157588182|FG001|Overall Study|Adverse Event|1|||
48934111|NCT00491179|157588181|FG000|Overall Study|Withdrawal by Subject|2|||
48934112|NCT00491179|157588182|FG001|Overall Study|Withdrawal by Subject|1|||
48934113|NCT04684420|157588183|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48934114|NCT04684420|157588184|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48934115|NCT04684420|157588185|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|2|||
48934116|NCT04684420|157588186|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
48934117|NCT04684420|157588183|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
48934118|NCT04684420|157588184|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
48846446|NCT01574716|157278603|FG001|Part 1|Death|1|||
48846447|NCT01574716|157278604|FG002|Part 1|Death|8|||
48846448|NCT01574716|157278605|FG003|Part 1|Death|0|||
48846449|NCT01574716|157278606|FG004|Part 1|Death|0|||
48846450|NCT01574716|157278602|FG000|Part 1|Discontinuation of study by sponsor|0|||
48846451|NCT01574716|157278603|FG001|Part 1|Discontinuation of study by sponsor|0|||
48846452|NCT01574716|157278604|FG002|Part 1|Discontinuation of study by sponsor|1|||
48846453|NCT01574716|157278605|FG003|Part 1|Discontinuation of study by sponsor|0|||
48846454|NCT01574716|157278606|FG004|Part 1|Discontinuation of study by sponsor|0|||
48846455|NCT01574716|157278602|FG000|Part 1|Withdrawal by Subject|0|||
48846456|NCT01574716|157278603|FG001|Part 1|Withdrawal by Subject|2|||
48846457|NCT01574716|157278604|FG002|Part 1|Withdrawal by Subject|0|||
48846458|NCT01574716|157278605|FG003|Part 1|Withdrawal by Subject|0|||
48846459|NCT01574716|157278606|FG004|Part 1|Withdrawal by Subject|0|||
48846460|NCT01574716|157278602|FG000|Part 1|Lost to Follow-up|0|||
48846461|NCT01574716|157278603|FG001|Part 1|Lost to Follow-up|1|||
48846462|NCT01574716|157278604|FG002|Part 1|Lost to Follow-up|0|||
48934119|NCT04684420|157588185|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
48846463|NCT01574716|157278605|FG003|Part 1|Lost to Follow-up|0|||
48846464|NCT01574716|157278606|FG004|Part 1|Lost to Follow-up|0|||
48846465|NCT01574716|157278602|FG000|Part 2|Progressive disease|0|||
48846466|NCT01574716|157278603|FG001|Part 2|Progressive disease|0|||
48934120|NCT04684420|157588186|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
48934121|NCT00988247|157588187|FG000|Overall Study|Adverse Event|17|||
48934122|NCT00988247|157588188|FG001|Overall Study|Adverse Event|3|||
48934123|NCT00988247|157588187|FG000|Overall Study|Withdrawal by Subject|44|||
48934124|NCT00988247|157588188|FG001|Overall Study|Withdrawal by Subject|13|||
48934125|NCT00988247|157588187|FG000|Overall Study|Pregnancy|1|||
48934126|NCT00988247|157588188|FG001|Overall Study|Pregnancy|2|||
48934127|NCT00988247|157588187|FG000|Overall Study|Lost to Follow-up|11|||
48934128|NCT00988247|157588188|FG001|Overall Study|Lost to Follow-up|2|||
48934129|NCT00988247|157588187|FG000|Overall Study|Protocol Violation|4|||
48934130|NCT00988247|157588188|FG001|Overall Study|Protocol Violation|5|||
48934131|NCT00988247|157588187|FG000|Overall Study|Sponsor requested withdrawal|3|||
48934132|NCT00988247|157588188|FG001|Overall Study|Sponsor requested withdrawal|1|||
48934133|NCT00988247|157588187|FG000|Overall Study|Other|3|||
48934134|NCT00988247|157588188|FG001|Overall Study|Other|0|||
48934135|NCT01703000|157588189|FG000|Overall Study|Death|1|||
48934136|NCT00289913|157588191|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
48934137|NCT00289913|157588192|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
48934138|NCT00289913|157588193|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
48934139|NCT00289913|157588194|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
48934140|NCT00289913|157588195|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
48846467|NCT01574716|157278604|FG002|Part 2|Progressive disease|0|||
48934141|NCT00289913|157588191|FG000|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3|||
48934142|NCT00289913|157588192|FG001|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
48934143|NCT00289913|157588193|FG002|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
48934144|NCT00289913|157588194|FG003|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
48934145|NCT00289913|157588195|FG004|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1|||
48934146|NCT00289913|157588191|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
48934147|NCT00289913|157588192|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
48934148|NCT00289913|157588193|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
48934149|NCT00289913|157588194|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
48934150|NCT00289913|157588195|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
48934151|NCT00289913|157588191|FG000|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
48934152|NCT00289913|157588192|FG001|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
48934153|NCT00289913|157588193|FG002|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
48934154|NCT00289913|157588194|FG003|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
48934155|NCT00289913|157588195|FG004|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1|||
48934156|NCT00289913|157588191|FG000|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
48934157|NCT00289913|157588192|FG001|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
48934158|NCT00289913|157588193|FG002|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
48934159|NCT00289913|157588194|FG003|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1|||
48934160|NCT00289913|157588195|FG004|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
48934161|NCT00289913|157588191|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
48934162|NCT00289913|157588192|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2|||
48934163|NCT00289913|157588193|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
48934164|NCT00289913|157588194|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
48934165|NCT00289913|157588195|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
48934166|NCT00289913|157588191|FG000|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2|||
48934167|NCT00289913|157588192|FG001|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1|||
48934168|NCT00289913|157588193|FG002|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
48934169|NCT00289913|157588194|FG003|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
48846468|NCT01574716|157278605|FG003|Part 2|Progressive disease|1|||
48846469|NCT01574716|157278606|FG004|Part 2|Progressive disease|0|||
48846470|NCT01574716|157278602|FG000|Part 2|Death|0|||
48846471|NCT01574716|157278603|FG001|Part 2|Death|0|||
48846472|NCT01574716|157278604|FG002|Part 2|Death|0|||
48846473|NCT01574716|157278605|FG003|Part 2|Death|76|||
48846474|NCT01574716|157278606|FG004|Part 2|Death|35|||
48846475|NCT01574716|157278602|FG000|Part 2|Discontinuation of study by sponsor|0|||
48846476|NCT01574716|157278603|FG001|Part 2|Discontinuation of study by sponsor|0|||
48846477|NCT01574716|157278604|FG002|Part 2|Discontinuation of study by sponsor|0|||
48846478|NCT01574716|157278605|FG003|Part 2|Discontinuation of study by sponsor|51|||
48934170|NCT00289913|157588195|FG004|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5|||
48934171|NCT00289913|157588191|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
48934172|NCT00289913|157588192|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8|||
48934173|NCT00289913|157588193|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5|||
48934174|NCT00289913|157588194|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6|||
48934175|NCT00289913|157588195|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
48934176|NCT00289913|157588191|FG000|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1|||
48934177|NCT00289913|157588192|FG001|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
48846479|NCT01574716|157278606|FG004|Part 2|Discontinuation of study by sponsor|31|||
48846480|NCT01574716|157278602|FG000|Part 2|Withdrawal by Subject|0|||
48846481|NCT01574716|157278603|FG001|Part 2|Withdrawal by Subject|0|||
48846482|NCT01574716|157278604|FG002|Part 2|Withdrawal by Subject|0|||
48934178|NCT00289913|157588193|FG002|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2|||
48846483|NCT01574716|157278605|FG003|Part 2|Withdrawal by Subject|5|||
48846484|NCT01574716|157278606|FG004|Part 2|Withdrawal by Subject|4|||
48846485|NCT01574716|157278602|FG000|Part 2|Brain metastases|0|||
48846486|NCT01574716|157278603|FG001|Part 2|Brain metastases|0|||
48846487|NCT01574716|157278604|FG002|Part 2|Brain metastases|0|||
48846488|NCT01574716|157278605|FG003|Part 2|Brain metastases|1|||
48846489|NCT01574716|157278606|FG004|Part 2|Brain metastases|0|||
48846490|NCT01574716|157278602|FG000|Part 2|Lost to Follow-up|0|||
48846491|NCT01574716|157278603|FG001|Part 2|Lost to Follow-up|0|||
48934179|NCT00289913|157588194|FG003|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
48934180|NCT00289913|157588195|FG004|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
48934181|NCT00289913|157588191|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
48934182|NCT00289913|157588192|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
48934183|NCT00289913|157588193|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
48934184|NCT00289913|157588194|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
48934185|NCT00289913|157588195|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
48934186|NCT00289913|157588191|FG000|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8|||
48934187|NCT00289913|157588192|FG001|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11|||
48846492|NCT01574716|157278604|FG002|Part 2|Lost to Follow-up|0|||
48934188|NCT00289913|157588193|FG002|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
48934189|NCT00289913|157588194|FG003|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
48934190|NCT00289913|157588195|FG004|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0|||
48934191|NCT00289913|157588191|FG000|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
48934192|NCT00289913|157588192|FG001|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1|||
48846493|NCT01574716|157278605|FG003|Part 2|Lost to Follow-up|3|||
48846494|NCT01574716|157278606|FG004|Part 2|Lost to Follow-up|0|||
48846495|NCT04048681|157278607|FG000|Overall Study|family emergency|0|||
48846496|NCT04048681|157278608|FG001|Overall Study|family emergency|0|||
48846497|NCT04048681|157278609|FG002|Overall Study|family emergency|0|||
48846498|NCT04048681|157278610|FG003|Overall Study|family emergency|1|||
48846499|NCT04048681|157278611|FG004|Overall Study|family emergency|0|||
48846500|NCT02499159|157278614|FG000|Randomization|Protocol Violation|1|||
48846501|NCT02499159|157278615|FG001|Randomization|Protocol Violation|1|||
48846502|NCT02499159|157278614|FG000|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
48846503|NCT02499159|157278615|FG001|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
48846504|NCT02499159|157278614|FG000|30-Day Follow-Up Phone Call|Lost to Follow-up|3|||
48846505|NCT02499159|157278615|FG001|30-Day Follow-Up Phone Call|Lost to Follow-up|1|||
48846506|NCT02499159|157278614|FG000|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2|||
48846507|NCT02499159|157278615|FG001|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0|||
48846508|NCT02499159|157278614|FG000|30-Day Follow-Up Phone Call|Other|1|||
48846509|NCT02499159|157278615|FG001|30-Day Follow-Up Phone Call|Other|0|||
48846510|NCT01696994|157278616|FG000|Overall Study|Cancer Before Rand. (Ovarian Screening)|0|||
48846511|NCT01696994|157278617|FG001|Overall Study|Cancer Before Rand. (Ovarian Screening)|2|||
48846512|NCT01696994|157278616|FG000|Overall Study|Died Before Randomization|1|||
48846513|NCT01696994|157278617|FG001|Overall Study|Died Before Randomization|2|||
48846514|NCT01696994|157278616|FG000|Overall Study|Died Before ASU (Control)|73|||
48846515|NCT01696994|157278617|FG001|Overall Study|Died Before ASU (Control)|0|||
48846516|NCT01696994|157278616|FG000|Overall Study|No Ovaries at Baseline|4807|||
48846517|NCT01696994|157278617|FG001|Overall Study|No Ovaries at Baseline|4851|||
48846518|NCT01696994|157278616|FG000|Overall Study|Refused ASU (Control)|311|||
48846519|NCT01696994|157278617|FG001|Overall Study|Refused ASU (Control)|0|||
48846520|NCT01696994|157278616|FG000|Overall Study|Refused Screen (Ovarian Screening)|0|||
48846521|NCT01696994|157278617|FG001|Overall Study|Refused Screen (Ovarian Screening)|3582|||
48846522|NCT00727909|157278618|FG000|Overall Study|Withdrawal by Subject|5|||
48846523|NCT00727909|157278619|FG001|Overall Study|Withdrawal by Subject|11|||
48846524|NCT00727909|157278620|FG002|Overall Study|Withdrawal by Subject|8|||
48846525|NCT00727909|157278621|FG003|Overall Study|Withdrawal by Subject|5|||
48846526|NCT00727909|157278618|FG000|Overall Study|Death|0|||
48846527|NCT00727909|157278619|FG001|Overall Study|Death|0|||
48846528|NCT00727909|157278620|FG002|Overall Study|Death|1|||
48846529|NCT00727909|157278621|FG003|Overall Study|Death|0|||
48846530|NCT02500758|157278625|FG000|First Intervention (2 Minutes)|Withdrawal by Subject|0|||
48846531|NCT02500758|157278626|FG001|First Intervention (2 Minutes)|Withdrawal by Subject|1|||
48846532|NCT02500758|157278625|FG000|Washout (1 Week)|Lost to Follow-up|2|||
48846533|NCT02500758|157278626|FG001|Washout (1 Week)|Lost to Follow-up|2|||
48846534|NCT02500758|157278625|FG000|Second Intervention (2 Minutes)|Withdrawal by Subject|2|||
48846535|NCT02500758|157278626|FG001|Second Intervention (2 Minutes)|Withdrawal by Subject|0|||
48846536|NCT02500758|157278625|FG000|Second Intervention (2 Minutes)|Lost to Follow-up|0|||
48846537|NCT02500758|157278626|FG001|Second Intervention (2 Minutes)|Lost to Follow-up|1|||
48846538|NCT02500758|157278625|FG000|Second Intervention (2 Minutes)|Protocol Violation|1|||
48846539|NCT02500758|157278626|FG001|Second Intervention (2 Minutes)|Protocol Violation|1|||
48846540|NCT00220740|157278627|FG000|Efficacy Period|Entered rescue treatment with placebo|23|||
48846541|NCT00220740|157278628|FG001|Efficacy Period|Entered rescue treatment with placebo|0|||
48846542|NCT00220740|157278627|FG000|Efficacy Period|Adverse Event|1|||
48846543|NCT00220740|157278628|FG001|Efficacy Period|Adverse Event|1|||
48846544|NCT00220740|157278627|FG000|Efficacy Period|Withdrawal by Subject|1|||
48846545|NCT00220740|157278628|FG001|Efficacy Period|Withdrawal by Subject|0|||
48934193|NCT00289913|157588193|FG002|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
48934194|NCT00289913|157588194|FG003|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
48934195|NCT00289913|157588195|FG004|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
48934196|NCT00289913|157588191|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3|||
48934197|NCT00289913|157588192|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
48934198|NCT00289913|157588193|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
48934199|NCT00289913|157588194|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
48934200|NCT00289913|157588195|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
48934201|NCT00289913|157588191|FG000|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
48934202|NCT00289913|157588192|FG001|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
48934203|NCT00289913|157588193|FG002|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
48934204|NCT00289913|157588194|FG003|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
48934205|NCT00289913|157588195|FG004|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
48934206|NCT00289913|157588191|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
48934207|NCT00289913|157588192|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
48846546|NCT00220740|157278627|FG000|Efficacy Period|Protocol Violation|1|||
48846547|NCT00220740|157278628|FG001|Efficacy Period|Protocol Violation|0|||
48846548|NCT00220740|157278627|FG000|Efficacy Period|Entered Rescue Treatment with IGIV-C|0|||
48846549|NCT00220740|157278628|FG001|Efficacy Period|Entered Rescue Treatment with IGIV-C|45|||
48846550|NCT02006758|157278629|FG000|Overall Study|Protocol Violation|1|||
48846551|NCT02006758|157278629|FG000|Overall Study|Death|1|||
48846552|NCT02006758|157278629|FG000|Overall Study|Lost to Follow-up|4|||
48846553|NCT02006758|157278629|FG000|Overall Study|Withdrawal by Subject|4|||
48846554|NCT02006758|157278629|FG000|Overall Study|Procedurally excluded|1|||
48846555|NCT02006758|157278629|FG000|Overall Study|Other|2|||
48846556|NCT01619410|157278632|FG000|Overall Study|Lost to Follow-up|7|||
48846557|NCT01619410|157278633|FG001|Overall Study|Lost to Follow-up|4|||
48846558|NCT01250769|157278634|FG000|Overall Study|Withdrawal by Subject|0|||
48846559|NCT01250769|157278635|FG001|Overall Study|Withdrawal by Subject|1|||
48846560|NCT01250769|157278636|FG002|Overall Study|Withdrawal by Subject|1|||
48846561|NCT01250769|157278637|FG003|Overall Study|Withdrawal by Subject|0|||
48846562|NCT01250769|157278634|FG000|Overall Study|Adverse Event|0|||
48846563|NCT01250769|157278635|FG001|Overall Study|Adverse Event|0|||
48846564|NCT01250769|157278636|FG002|Overall Study|Adverse Event|1|||
48846565|NCT01250769|157278637|FG003|Overall Study|Adverse Event|0|||
48846566|NCT02462759|157278638|FG000|Part 1: Double Blind|Death|1|||
48846567|NCT02462759|157278639|FG001|Part 1: Double Blind|Death|0|||
48846568|NCT02462759|157278640|FG002|Part 1: Double Blind|Death|0|||
48846569|NCT00914589|157278641|FG000|Overall Study|Adverse Event|1|||
48846570|NCT00914589|157278642|FG001|Overall Study|Adverse Event|0|||
48846571|NCT00914589|157278643|FG002|Overall Study|Adverse Event|1|||
48846572|NCT00914589|157278641|FG000|Overall Study|Protocol Violation|8|||
48846573|NCT00914589|157278642|FG001|Overall Study|Protocol Violation|6|||
48846574|NCT00914589|157278643|FG002|Overall Study|Protocol Violation|3|||
48846575|NCT00914589|157278641|FG000|Overall Study|unclassified|16|||
48846576|NCT00914589|157278642|FG001|Overall Study|unclassified|9|||
48846577|NCT00914589|157278643|FG002|Overall Study|unclassified|7|||
48846578|NCT00914589|157278641|FG000|Overall Study|Death|0|||
48846579|NCT00914589|157278642|FG001|Overall Study|Death|1|||
48846580|NCT00914589|157278643|FG002|Overall Study|Death|1|||
48846581|NCT03951805|157278647|FG000|Overall Study|Adverse Event|1|||
48846582|NCT03951805|157278648|FG001|Overall Study|Adverse Event|0|||
48846583|NCT03951805|157278649|FG002|Overall Study|Adverse Event|0|||
48846584|NCT03951805|157278650|FG003|Overall Study|Adverse Event|0|||
48846585|NCT03771352|157278653|FG000|Overall Study|Screen failure|2|||
48846586|NCT03771352|157278653|FG000|Overall Study|Withdrawal by Subject|2|||
48846587|NCT00274469|157278654|FG000|Overall Study|Death|63|||
48846588|NCT00274469|157278655|FG001|Overall Study|Death|74|||
48846589|NCT00274469|157278654|FG000|Overall Study|Did not consent to OS follow-up|16|||
48846590|NCT00274469|157278655|FG001|Overall Study|Did not consent to OS follow-up|19|||
48846591|NCT03092726|157278656|FG000|Overall Study|Adverse Event|3|||
48846592|NCT03092726|157278657|FG001|Overall Study|Adverse Event|10|||
48846593|NCT03092726|157278656|FG000|Overall Study|Lack of Efficacy|0|||
48846594|NCT03092726|157278657|FG001|Overall Study|Lack of Efficacy|1|||
48846595|NCT03092726|157278656|FG000|Overall Study|Lost to Follow-up|1|||
48846596|NCT03092726|157278657|FG001|Overall Study|Lost to Follow-up|0|||
48846597|NCT03092726|157278656|FG000|Overall Study|Withdrawal by Subject|5|||
48846598|NCT03092726|157278657|FG001|Overall Study|Withdrawal by Subject|3|||
48846599|NCT02411448|157278658|FG000|Overall Study|Withdrawal by Subject|1|||
48846600|NCT02411448|157278659|FG001|Overall Study|Withdrawal by Subject|14|||
48846601|NCT02411448|157278660|FG002|Overall Study|Withdrawal by Subject|9|||
48846602|NCT02411448|157278658|FG000|Overall Study|Other|0|||
48934208|NCT00289913|157588193|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3|||
48934209|NCT00289913|157588194|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
48934210|NCT00289913|157588195|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
48934211|NCT00289913|157588191|FG000|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2|||
48934212|NCT00289913|157588192|FG001|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5|||
48934213|NCT00289913|157588193|FG002|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
48934214|NCT00289913|157588194|FG003|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3|||
48934215|NCT00289913|157588195|FG004|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
48934216|NCT00289913|157588191|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
48934217|NCT00289913|157588192|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1|||
48934218|NCT00289913|157588193|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2|||
48934219|NCT00289913|157588194|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
48934220|NCT00289913|157588195|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
48934221|NCT00289913|157588191|FG000|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1|||
48934222|NCT00289913|157588192|FG001|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
48934223|NCT00289913|157588193|FG002|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
48934224|NCT00289913|157588194|FG003|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
48934225|NCT00289913|157588195|FG004|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
48934226|NCT00289913|157588191|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
48934227|NCT00289913|157588192|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
48934228|NCT00289913|157588193|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
48934229|NCT00289913|157588194|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
48934230|NCT00289913|157588195|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7|||
48934231|NCT00289913|157588191|FG000|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
48934232|NCT00289913|157588192|FG001|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
48934233|NCT00289913|157588193|FG002|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
48934234|NCT00289913|157588194|FG003|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
48934235|NCT00289913|157588195|FG004|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11|||
48934236|NCT00289913|157588191|FG000|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
48934237|NCT00289913|157588192|FG001|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
48934238|NCT00289913|157588193|FG002|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
48934239|NCT00289913|157588194|FG003|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
48934240|NCT00289913|157588195|FG004|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6|||
48934241|NCT00289913|157588191|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
48934242|NCT00289913|157588192|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
48934243|NCT00289913|157588193|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
48934244|NCT00289913|157588194|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
48934245|NCT00289913|157588195|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7|||
48934246|NCT00289913|157588191|FG000|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
48934247|NCT00289913|157588192|FG001|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
48934248|NCT00289913|157588193|FG002|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
48934249|NCT00289913|157588194|FG003|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
48934250|NCT00289913|157588195|FG004|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9|||
48934251|NCT00289913|157588191|FG000|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
48934252|NCT00289913|157588192|FG001|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
48846603|NCT02411448|157278659|FG001|Overall Study|Other|2|||
48846604|NCT02411448|157278660|FG002|Overall Study|Other|0|||
48934253|NCT00289913|157588193|FG002|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
48934254|NCT00289913|157588194|FG003|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
48934255|NCT00289913|157588195|FG004|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
48934256|NCT00289913|157588191|FG000|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8|||
48934257|NCT00289913|157588192|FG001|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3|||
48934258|NCT00289913|157588193|FG002|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1|||
48934259|NCT00289913|157588194|FG003|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
48934260|NCT00289913|157588195|FG004|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
48934261|NCT00289913|157588191|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
48934262|NCT00289913|157588192|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
48934263|NCT00289913|157588193|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
48934264|NCT00289913|157588194|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
48934265|NCT00289913|157588195|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
48934266|NCT00289913|157588191|FG000|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
48934267|NCT00289913|157588192|FG001|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
48934268|NCT00289913|157588193|FG002|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
48934269|NCT00289913|157588194|FG003|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
48934270|NCT00289913|157588195|FG004|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1|||
48934271|NCT00289913|157588191|FG000|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
48934272|NCT00289913|157588192|FG001|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2|||
48934273|NCT00289913|157588193|FG002|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0|||
48934274|NCT00289913|157588194|FG003|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
48934275|NCT00289913|157588195|FG004|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4|||
48934276|NCT00289913|157588191|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
48934277|NCT00289913|157588192|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
48934278|NCT00289913|157588193|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
48934279|NCT00289913|157588194|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
48934280|NCT00289913|157588195|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
48934281|NCT00289913|157588191|FG000|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
48934282|NCT00289913|157588192|FG001|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
48934283|NCT00289913|157588193|FG002|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
48934284|NCT00289913|157588194|FG003|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
48934285|NCT00289913|157588195|FG004|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1|||
48934286|NCT00289913|157588191|FG000|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
48934287|NCT00289913|157588192|FG001|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1|||
48934288|NCT00289913|157588193|FG002|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
48934289|NCT00289913|157588194|FG003|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
48934290|NCT00289913|157588195|FG004|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
48934291|NCT02522767|157588198|FG000|Double-blind|Withdrawal by Subject|8|||
48934292|NCT02522767|157588199|FG001|Double-blind|Withdrawal by Subject|11|||
48934293|NCT02522767|157588198|FG000|Double-blind|Lost to Follow-up|1|||
48934294|NCT02522767|157588199|FG001|Double-blind|Lost to Follow-up|0|||
48934295|NCT02522767|157588198|FG000|Double-blind|Adverse Event|1|||
48934296|NCT02522767|157588199|FG001|Double-blind|Adverse Event|10|||
48934297|NCT02522767|157588198|FG000|Double-blind|Protocol Violation|0|||
48934298|NCT02522767|157588199|FG001|Double-blind|Protocol Violation|1|||
48934299|NCT02522767|157588198|FG000|Double-blind|Lack of Efficacy|0|||
48934300|NCT02522767|157588199|FG001|Double-blind|Lack of Efficacy|2|||
48934301|NCT02522767|157588198|FG000|Double-blind|Protocol Deviation|1|||
48934302|NCT02522767|157588199|FG001|Double-blind|Protocol Deviation|0|||
48934303|NCT02522767|157588198|FG000|Open-label|Withdrawal by Subject|2|||
48934304|NCT02522767|157588199|FG001|Open-label|Withdrawal by Subject|3|||
48934305|NCT02522767|157588198|FG000|Open-label|Lost to Follow-up|0|||
48934306|NCT02522767|157588199|FG001|Open-label|Lost to Follow-up|1|||
48934307|NCT02522767|157588198|FG000|Open-label|Adverse Event|2|||
48934308|NCT02522767|157588199|FG001|Open-label|Adverse Event|1|||
48934309|NCT02522767|157588198|FG000|Open-label|Lack of Efficacy|1|||
48934310|NCT02522767|157588199|FG001|Open-label|Lack of Efficacy|1|||
48934311|NCT02522767|157588198|FG000|Open-label|Protocol Violation|0|||
48934312|NCT02522767|157588199|FG001|Open-label|Protocol Violation|1|||
48934313|NCT00214461|157588201|FG000|Overall Study|Adverse Event|0|||
48934314|NCT00214461|157588202|FG001|Overall Study|Adverse Event|0|||
48934315|NCT00214461|157588203|FG002|Overall Study|Adverse Event|1|||
48934316|NCT00214461|157588204|FG003|Overall Study|Adverse Event|1|||
48934317|NCT00214461|157588201|FG000|Overall Study|Withdrawal by Subject|0|||
48934318|NCT00214461|157588202|FG001|Overall Study|Withdrawal by Subject|0|||
48934319|NCT00214461|157588203|FG002|Overall Study|Withdrawal by Subject|1|||
48934320|NCT00214461|157588204|FG003|Overall Study|Withdrawal by Subject|0|||
48934321|NCT00364689|157588205|FG000|Overall Study|Lost to Follow-up|1|||
48934322|NCT02796755|157588206|FG000|Overall Study|Adverse Event|2|||
48934323|NCT02796755|157588207|FG001|Overall Study|Adverse Event|0|||
48934324|NCT00045032|157588208|FG000|Overall Study|Adverse Event/Intercurrent Illness|2|||
48934325|NCT00045032|157588209|FG001|Overall Study|Adverse Event/Intercurrent Illness|2|||
48934326|NCT00045032|157588210|FG002|Overall Study|Adverse Event/Intercurrent Illness|7|||
48934327|NCT00045032|157588208|FG000|Overall Study|Death|22|||
48846605|NCT02411448|157278658|FG000|Overall Study|Did not receive study treatment|0|||
48846606|NCT02411448|157278659|FG001|Overall Study|Did not receive study treatment|3|||
48934328|NCT00045032|157588209|FG001|Overall Study|Death|24|||
48934329|NCT00045032|157588210|FG002|Overall Study|Death|17|||
48934330|NCT00045032|157588208|FG000|Overall Study|Insufficient Therapeutic Response|542|||
48846607|NCT02411448|157278660|FG002|Overall Study|Did not receive study treatment|0|||
48846608|NCT02411448|157278658|FG000|Overall Study|Alive on study treatment|3|||
48846609|NCT02411448|157278659|FG001|Overall Study|Alive on study treatment|64|||
48846610|NCT02411448|157278660|FG002|Overall Study|Alive on study treatment|43|||
48846611|NCT01696981|157278662|FG000|Overall Study|Cancer Before Rand. (Colo. Screening)|0|||
48846612|NCT01696981|157278663|FG001|Overall Study|Cancer Before Rand. (Colo. Screening)|20|||
48846613|NCT01696981|157278662|FG000|Overall Study|Died Before Randomization|3|||
48846614|NCT01696981|157278663|FG001|Overall Study|Died Before Randomization|8|||
48846615|NCT01696981|157278662|FG000|Overall Study|Died Before ASU (Control)|278|||
48846616|NCT01696981|157278663|FG001|Overall Study|Died Before ASU (Control)|0|||
48846617|NCT01696981|157278662|FG000|Overall Study|Refused ASU (Control)|920|||
48846618|NCT01696981|157278663|FG001|Overall Study|Refused ASU (Control)|0|||
48934331|NCT00045032|157588209|FG001|Overall Study|Insufficient Therapeutic Response|437|||
48934332|NCT00045032|157588210|FG002|Overall Study|Insufficient Therapeutic Response|445|||
48846619|NCT01696981|157278662|FG000|Overall Study|Refused Screen (Colorectal Screening)|0|||
48846620|NCT01696981|157278663|FG001|Overall Study|Refused Screen (Colorectal Screening)|10346|||
48846621|NCT03735121|157278664|FG000|Overall Study|Death|3|||
48846622|NCT03735121|157278665|FG001|Overall Study|Death|6|||
48846623|NCT03735121|157278666|FG002|Overall Study|Death|8|||
48934333|NCT00045032|157588208|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
48934334|NCT00045032|157588209|FG001|Overall Study|Violation of Selection Criteria at Entry|6|||
48934335|NCT00045032|157588210|FG002|Overall Study|Violation of Selection Criteria at Entry|6|||
48934336|NCT00045032|157588208|FG000|Overall Study|Other Protocol Violation|2|||
48934337|NCT00045032|157588209|FG001|Overall Study|Other Protocol Violation|0|||
48934338|NCT00045032|157588210|FG002|Overall Study|Other Protocol Violation|1|||
48934339|NCT00045032|157588208|FG000|Overall Study|Refused/Did Not Cooperate/Withdrew|142|||
48934340|NCT00045032|157588209|FG001|Overall Study|Refused/Did Not Cooperate/Withdrew|93|||
48934341|NCT00045032|157588210|FG002|Overall Study|Refused/Did Not Cooperate/Withdrew|84|||
48934342|NCT00045032|157588208|FG000|Overall Study|Failure to Return|57|||
48846624|NCT03735121|157278667|FG003|Overall Study|Death|37|||
48846625|NCT03735121|157278668|FG004|Overall Study|Death|86|||
48846626|NCT03735121|157278664|FG000|Overall Study|Withdrawal by Subject|1|||
48846627|NCT03735121|157278665|FG001|Overall Study|Withdrawal by Subject|1|||
48846628|NCT03735121|157278666|FG002|Overall Study|Withdrawal by Subject|3|||
48846629|NCT03735121|157278667|FG003|Overall Study|Withdrawal by Subject|4|||
48846630|NCT03735121|157278668|FG004|Overall Study|Withdrawal by Subject|2|||
48846631|NCT03735121|157278664|FG000|Overall Study|Progressive Disease|0|||
48846632|NCT03735121|157278665|FG001|Overall Study|Progressive Disease|0|||
48846633|NCT03735121|157278666|FG002|Overall Study|Progressive Disease|1|||
48846634|NCT03735121|157278667|FG003|Overall Study|Progressive Disease|0|||
48846635|NCT03735121|157278668|FG004|Overall Study|Progressive Disease|0|||
48846636|NCT03735121|157278664|FG000|Overall Study|Lost to Follow-up|0|||
48846637|NCT03735121|157278665|FG001|Overall Study|Lost to Follow-up|0|||
48846638|NCT03735121|157278666|FG002|Overall Study|Lost to Follow-up|0|||
48846639|NCT03735121|157278667|FG003|Overall Study|Lost to Follow-up|0|||
48846640|NCT03735121|157278668|FG004|Overall Study|Lost to Follow-up|1|||
48846641|NCT03735121|157278664|FG000|Overall Study|Ongoing|3|||
48846642|NCT03735121|157278665|FG001|Overall Study|Ongoing|3|||
48846643|NCT03735121|157278666|FG002|Overall Study|Ongoing|26|||
48846644|NCT03735121|157278667|FG003|Overall Study|Ongoing|83|||
48846645|NCT03735121|157278668|FG004|Overall Study|Ongoing|158|||
48846646|NCT03987022|157278669|FG000|Overall Study|Lost to Follow-up|2|||
48846647|NCT03987022|157278670|FG001|Overall Study|Lost to Follow-up|2|||
48934343|NCT00045032|157588209|FG001|Overall Study|Failure to Return|62|||
48934344|NCT00045032|157588210|FG002|Overall Study|Failure to Return|61|||
48846648|NCT03987022|157278669|FG000|Overall Study|Withdrawal by Subject|1|||
48846649|NCT03987022|157278670|FG001|Overall Study|Withdrawal by Subject|0|||
48846650|NCT02538341|157278671|FG000|Overall Study|Lost to Follow-up|51|||
48846651|NCT02538341|157278672|FG001|Overall Study|Lost to Follow-up|46|||
48846652|NCT02538341|157278671|FG000|Overall Study|Withdrawal by Subject|3|||
48846653|NCT02538341|157278672|FG001|Overall Study|Withdrawal by Subject|1|||
48846654|NCT02538341|157278671|FG000|Overall Study|Death|2|||
48846655|NCT02538341|157278672|FG001|Overall Study|Death|0|||
48846656|NCT02998528|157278673|FG000|Randomization Period|Adverse event unrelated to study drug|0|||
48846657|NCT02998528|157278674|FG001|Randomization Period|Adverse event unrelated to study drug|0|||
48846658|NCT02998528|157278675|FG002|Randomization Period|Adverse event unrelated to study drug|1|||
48846659|NCT02998528|157278673|FG000|Randomization Period|Participant withdrew consent|0|||
48846660|NCT02998528|157278674|FG001|Randomization Period|Participant withdrew consent|3|||
48846661|NCT02998528|157278675|FG002|Randomization Period|Participant withdrew consent|0|||
48846662|NCT02998528|157278673|FG000|Randomization Period|Participant no longer meets study criteria|1|||
48846663|NCT02998528|157278674|FG001|Randomization Period|Participant no longer meets study criteria|3|||
48846664|NCT02998528|157278675|FG002|Randomization Period|Participant no longer meets study criteria|2|||
48846665|NCT02998528|157278673|FG000|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
48846666|NCT02998528|157278674|FG001|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|7|||
48846667|NCT02998528|157278675|FG002|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
48846668|NCT02998528|157278673|FG000|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
48846669|NCT02998528|157278674|FG001|Neoadjuvant Treatment Period|Participant withdrew consent|4|||
48846670|NCT02998528|157278675|FG002|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
48846671|NCT02998528|157278673|FG000|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
48846672|NCT02998528|157278674|FG001|Neoadjuvant Treatment Period|Participant no longer meets study criteria|1|||
48934345|NCT00045032|157588208|FG000|Overall Study|Other|93|||
48846673|NCT02998528|157278675|FG002|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
48846674|NCT02998528|157278673|FG000|Neoadjuvant Treatment Period|Disease progression|3|||
48846675|NCT02998528|157278674|FG001|Neoadjuvant Treatment Period|Disease progression|2|||
48934346|NCT00045032|157588209|FG001|Overall Study|Other|84|||
48934347|NCT00045032|157588210|FG002|Overall Study|Other|105|||
48934348|NCT01214044|157588212|FG000|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5|||
48846676|NCT02998528|157278675|FG002|Neoadjuvant Treatment Period|Disease progression|1|||
48846677|NCT02998528|157278673|FG000|Neoadjuvant Treatment Period|Study drug toxicity|6|||
48846678|NCT02998528|157278674|FG001|Neoadjuvant Treatment Period|Study drug toxicity|14|||
48846679|NCT02998528|157278675|FG002|Neoadjuvant Treatment Period|Study drug toxicity|10|||
48846680|NCT02998528|157278673|FG000|Neoadjuvant Treatment Period|Death|1|||
48846681|NCT02998528|157278674|FG001|Neoadjuvant Treatment Period|Death|0|||
48846682|NCT02998528|157278675|FG002|Neoadjuvant Treatment Period|Death|0|||
48846683|NCT02998528|157278673|FG000|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
48846684|NCT02998528|157278674|FG001|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|3|||
48846685|NCT02998528|157278675|FG002|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
48846686|NCT02998528|157278673|FG000|Systemic Adjuvant Treatment Period|Disease progression|1|||
48846687|NCT02998528|157278674|FG001|Systemic Adjuvant Treatment Period|Disease progression|0|||
48846688|NCT02998528|157278675|FG002|Systemic Adjuvant Treatment Period|Disease progression|0|||
48846689|NCT02998528|157278673|FG000|Systemic Adjuvant Treatment Period|Study drug toxicity|4|||
48846690|NCT02998528|157278674|FG001|Systemic Adjuvant Treatment Period|Study drug toxicity|5|||
48846691|NCT02998528|157278675|FG002|Systemic Adjuvant Treatment Period|Study drug toxicity|1|||
48846692|NCT02998528|157278673|FG000|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
48846693|NCT02998528|157278674|FG001|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|0|||
48846694|NCT02998528|157278675|FG002|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
48846695|NCT02998528|157278673|FG000|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|3|||
48846696|NCT02998528|157278674|FG001|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
48846697|NCT02998528|157278675|FG002|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
48846698|NCT02998528|157278673|FG000|Systemic Adjuvant Treatment Period|Other reasons|0|||
48846699|NCT02998528|157278674|FG001|Systemic Adjuvant Treatment Period|Other reasons|0|||
48846700|NCT02998528|157278675|FG002|Systemic Adjuvant Treatment Period|Other reasons|1|||
48846701|NCT04218266|157278677|FG000|Overall Study|Death|1|||
48846702|NCT04218266|157278678|FG001|Overall Study|Death|2|||
48846703|NCT04218266|157278679|FG002|Overall Study|Death|3|||
48846704|NCT04218266|157278677|FG000|Overall Study|Adverse Event|13|||
48846705|NCT04218266|157278678|FG001|Overall Study|Adverse Event|14|||
48846706|NCT04218266|157278679|FG002|Overall Study|Adverse Event|11|||
48846707|NCT04218266|157278677|FG000|Overall Study|Other|7|||
48846708|NCT04218266|157278678|FG001|Overall Study|Other|5|||
48846709|NCT04218266|157278679|FG002|Overall Study|Other|14|||
48846710|NCT04218266|157278677|FG000|Overall Study|Physician Decision|1|||
48846711|NCT04218266|157278678|FG001|Overall Study|Physician Decision|3|||
48846712|NCT04218266|157278679|FG002|Overall Study|Physician Decision|2|||
48846713|NCT04218266|157278677|FG000|Overall Study|Non-compliance with study drug|0|||
48846714|NCT04218266|157278678|FG001|Overall Study|Non-compliance with study drug|0|||
48846715|NCT04218266|157278679|FG002|Overall Study|Non-compliance with study drug|1|||
48846716|NCT04218266|157278677|FG000|Overall Study|Withdrawal by Subject|1|||
48846717|NCT04218266|157278678|FG001|Overall Study|Withdrawal by Subject|3|||
48934349|NCT01214044|157588212|FG000|Visit 1: Screening and Consent, Washout|Ineligible|3|||
48934350|NCT01214044|157588212|FG000|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4|||
48846718|NCT04218266|157278679|FG002|Overall Study|Withdrawal by Subject|1|||
48934351|NCT01214044|157588212|FG000|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3|||
48846719|NCT04218266|157278677|FG000|Overall Study|Study drug never administered|2|||
48846720|NCT04218266|157278678|FG001|Overall Study|Study drug never administered|0|||
48934352|NCT01214044|157588212|FG000|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3|||
48846721|NCT04218266|157278679|FG002|Overall Study|Study drug never administered|0|||
48846722|NCT04820686|157278684|FG000|Overall Study|Withdrawal by Subject|5|||
48846723|NCT04820686|157278685|FG001|Overall Study|Withdrawal by Subject|2|||
48846724|NCT04820686|157278686|FG002|Overall Study|Withdrawal by Subject|3|||
48846725|NCT04820686|157278684|FG000|Overall Study|Study Termination|25|||
48846726|NCT04820686|157278685|FG001|Overall Study|Study Termination|13|||
48846727|NCT04820686|157278686|FG002|Overall Study|Study Termination|14|||
48846728|NCT04820686|157278684|FG000|Overall Study|Adverse Event|0|||
48846729|NCT04820686|157278685|FG001|Overall Study|Adverse Event|1|||
48846730|NCT04820686|157278686|FG002|Overall Study|Adverse Event|0|||
48846731|NCT01872078|157278687|FG000|Overall Study|Adverse Event|0|||
48846732|NCT01872078|157278688|FG001|Overall Study|Adverse Event|0|||
48846733|NCT01872078|157278689|FG002|Overall Study|Adverse Event|1|||
48846734|NCT01872078|157278690|FG003|Overall Study|Adverse Event|0|||
48846735|NCT01872078|157278687|FG000|Overall Study|Dose administration non-compliance|0|||
48846736|NCT01872078|157278688|FG001|Overall Study|Dose administration non-compliance|0|||
48846737|NCT01872078|157278689|FG002|Overall Study|Dose administration non-compliance|0|||
48846738|NCT01872078|157278690|FG003|Overall Study|Dose administration non-compliance|1|||
48846739|NCT01872078|157278687|FG000|Overall Study|Protocol Violation|0|||
48846740|NCT01872078|157278688|FG001|Overall Study|Protocol Violation|0|||
48846741|NCT01872078|157278689|FG002|Overall Study|Protocol Violation|1|||
48846742|NCT01872078|157278690|FG003|Overall Study|Protocol Violation|0|||
48846743|NCT01872078|157278687|FG000|Overall Study|Withdrawal by Subject|0|||
48846744|NCT01872078|157278688|FG001|Overall Study|Withdrawal by Subject|0|||
48846745|NCT01872078|157278689|FG002|Overall Study|Withdrawal by Subject|1|||
48846746|NCT01872078|157278690|FG003|Overall Study|Withdrawal by Subject|0|||
48846747|NCT01872078|157278687|FG000|Overall Study|Patient met exclusion criterion 16.|0|||
48846748|NCT01872078|157278688|FG001|Overall Study|Patient met exclusion criterion 16.|0|||
48846749|NCT01872078|157278689|FG002|Overall Study|Patient met exclusion criterion 16.|0|||
48846750|NCT01872078|157278690|FG003|Overall Study|Patient met exclusion criterion 16.|1|||
48846751|NCT04377308|157278691|FG000|Overall Study|Withdrawal by Subject|0|||
48846752|NCT04377308|157278692|FG001|Overall Study|Withdrawal by Subject|1|||
48846753|NCT03988842|157278693|FG000|Overall Study|Death|1|||
48846754|NCT02891915|157278694|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
48846755|NCT02891915|157278695|FG001|Overall Study|Enrolled but Treatment Not Administered|4|||
48846756|NCT02891915|157278694|FG000|Overall Study|Withdrawal by Subject|3|||
48846757|NCT02891915|157278695|FG001|Overall Study|Withdrawal by Subject|3|||
48846758|NCT02891915|157278694|FG000|Overall Study|Became Ineligible After Enrollment|2|||
48846759|NCT02891915|157278695|FG001|Overall Study|Became Ineligible After Enrollment|1|||
48846760|NCT02891915|157278694|FG000|Overall Study|Lost to Follow-up|1|||
48846761|NCT02891915|157278695|FG001|Overall Study|Lost to Follow-up|4|||
48846762|NCT02891915|157278694|FG000|Overall Study|Physician Decision|1|||
48846763|NCT02891915|157278695|FG001|Overall Study|Physician Decision|0|||
48846764|NCT01205048|157278696|FG000|Overall Study|Withdrawal by Subject|14|||
48846765|NCT01205048|157278696|FG000|Overall Study|Clinical Investigation Plan Violation|1|||
48846766|NCT01205048|157278696|FG000|Overall Study|Lost to Follow-up|4|||
48846767|NCT01205048|157278696|FG000|Overall Study|Other|2|||
48846768|NCT03394885|157278697|FG000|Overall Study|Adverse Event|4|||
48846769|NCT03394885|157278697|FG000|Overall Study|Lack of Efficacy|1|||
48846770|NCT03394885|157278697|FG000|Overall Study|Physician Decision|1|||
48846771|NCT03394885|157278697|FG000|Overall Study|Withdrawal by Subject|8|||
48934353|NCT01214044|157588212|FG000|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1|||
48934354|NCT00888355|157588215|FG000|Overall Study|Adverse Event|10|||
48934355|NCT00888355|157588216|FG001|Overall Study|Adverse Event|0|||
48934356|NCT00888355|157588217|FG002|Overall Study|Adverse Event|3|||
48934357|NCT00888355|157588218|FG003|Overall Study|Adverse Event|3|||
48934358|NCT00888355|157588215|FG000|Overall Study|Lack of Efficacy|9|||
48934359|NCT00888355|157588216|FG001|Overall Study|Lack of Efficacy|2|||
48934360|NCT00888355|157588217|FG002|Overall Study|Lack of Efficacy|5|||
48934361|NCT00888355|157588218|FG003|Overall Study|Lack of Efficacy|2|||
48934362|NCT00888355|157588215|FG000|Overall Study|Lost to Follow-up|0|||
48934363|NCT00888355|157588216|FG001|Overall Study|Lost to Follow-up|2|||
48934364|NCT00888355|157588217|FG002|Overall Study|Lost to Follow-up|2|||
48934365|NCT00888355|157588218|FG003|Overall Study|Lost to Follow-up|0|||
48934366|NCT00888355|157588215|FG000|Overall Study|Protocol Violation|3|||
48934367|NCT00888355|157588216|FG001|Overall Study|Protocol Violation|2|||
48934368|NCT00888355|157588217|FG002|Overall Study|Protocol Violation|1|||
48934369|NCT00888355|157588218|FG003|Overall Study|Protocol Violation|2|||
48934370|NCT00888355|157588215|FG000|Overall Study|Withdrawal by Subject|0|||
48934371|NCT00888355|157588216|FG001|Overall Study|Withdrawal by Subject|3|||
48934372|NCT00888355|157588217|FG002|Overall Study|Withdrawal by Subject|1|||
48934373|NCT00888355|157588218|FG003|Overall Study|Withdrawal by Subject|3|||
48934374|NCT02731742|157588219|FG000|Overall Study|Death|1|||
48934375|NCT02731742|157588220|FG001|Overall Study|Death|2|||
48934376|NCT02731742|157588221|FG002|Overall Study|Death|5|||
48934377|NCT02731742|157588222|FG003|Overall Study|Death|0|||
48934378|NCT02731742|157588219|FG000|Overall Study|Physician Decision|0|||
48934379|NCT02731742|157588220|FG001|Overall Study|Physician Decision|0|||
48934380|NCT02731742|157588221|FG002|Overall Study|Physician Decision|0|||
48934381|NCT02731742|157588222|FG003|Overall Study|Physician Decision|1|||
48934382|NCT02731742|157588219|FG000|Overall Study|Study Terminated by Sponsor|2|||
48934383|NCT02731742|157588220|FG001|Overall Study|Study Terminated by Sponsor|1|||
48934384|NCT02731742|157588221|FG002|Overall Study|Study Terminated by Sponsor|1|||
48934385|NCT02731742|157588222|FG003|Overall Study|Study Terminated by Sponsor|1|||
48934386|NCT00331006|157588223|FG000|Screening Phase|Withdrawal by Subject|1|||
48934387|NCT00331006|157588223|FG000|Screening Phase|enrollment halted|1|||
48934388|NCT00331006|157588223|FG000|Screening Phase|Lost to Follow-up|1|||
48934389|NCT00331006|157588223|FG000|Screening Phase|Ineligible for treatment phase|4|||
48846772|NCT03394885|157278697|FG000|Overall Study|Alternative Therapy|1|||
48846773|NCT04019444|157278698|FG000|Overall Study|Withdrawal by Subject|0|||
48934390|NCT00331006|157588223|FG000|Treatment Phase|Withdrawal by Subject|1|||
48934391|NCT00331006|157588223|FG000|Follow-Up Phase I|Lost to Follow-up|1|||
48934392|NCT00331006|157588223|FG000|Follow-Up Phase II|Lost to Follow-up|3|||
48934393|NCT03603652|157588224|FG000|Overall Study|Death|2|||
48934394|NCT04134494|157588227|FG000|Overall Study|Lost to Follow-up|2|||
48934395|NCT00773279|157588231|FG000|Period 1|Adverse Event|2|||
48934396|NCT00773279|157588232|FG001|Period 1|Adverse Event|1|||
48934397|NCT00773279|157588231|FG000|Period 1|Lack of Efficacy|0|||
48934398|NCT00773279|157588232|FG001|Period 1|Lack of Efficacy|2|||
48934399|NCT00773279|157588231|FG000|Period 1|Unclassified|5|||
48846774|NCT04019444|157278699|FG001|Overall Study|Withdrawal by Subject|1|||
48846775|NCT04019444|157278700|FG002|Overall Study|Withdrawal by Subject|0|||
48846776|NCT04019444|157278701|FG003|Overall Study|Withdrawal by Subject|1|||
48846777|NCT04019444|157278698|FG000|Overall Study|Solicited Event|0|||
48846778|NCT04019444|157278699|FG001|Overall Study|Solicited Event|0|||
48846779|NCT04019444|157278700|FG002|Overall Study|Solicited Event|2|||
48846780|NCT04019444|157278701|FG003|Overall Study|Solicited Event|0|||
48846781|NCT01091168|157278702|FG000|Overall Study|Progressive disease|250|||
48846782|NCT01091168|157278703|FG001|Overall Study|Progressive disease|234|||
48846783|NCT01091168|157278702|FG000|Overall Study|Adverse Event|21|||
48846784|NCT01091168|157278703|FG001|Overall Study|Adverse Event|24|||
48846785|NCT01091168|157278702|FG000|Overall Study|Lost to Follow-up|0|||
48846786|NCT01091168|157278703|FG001|Overall Study|Lost to Follow-up|1|||
48846787|NCT01091168|157278702|FG000|Overall Study|Physician, patient's decision, other|27|||
48846788|NCT01091168|157278703|FG001|Overall Study|Physician, patient's decision, other|37|||
48846789|NCT01609218|157278704|FG000|Period 1|Adverse Event|3|||
48846790|NCT01609218|157278705|FG001|Period 1|Adverse Event|5|||
48846791|NCT01609218|157278704|FG000|Period 1|Sponsor Decision|0|||
48934400|NCT00773279|157588232|FG001|Period 1|Unclassified|1|||
48846792|NCT01609218|157278705|FG001|Period 1|Sponsor Decision|1|||
48846793|NCT01609218|157278704|FG000|Period 2|Adverse Event|1|||
48846794|NCT01609218|157278705|FG001|Period 2|Adverse Event|0|||
48846795|NCT03080883|157278711|FG000|Overall Study|Withdrawal by Subject|11|||
48846796|NCT03080883|157278712|FG001|Overall Study|Withdrawal by Subject|15|||
48846797|NCT03080883|157278711|FG000|Overall Study|Adverse Event|22|||
48846798|NCT03080883|157278712|FG001|Overall Study|Adverse Event|22|||
48846799|NCT03080883|157278711|FG000|Overall Study|Alternative Therapy|0|||
48846800|NCT03080883|157278712|FG001|Overall Study|Alternative Therapy|3|||
48846801|NCT03080883|157278711|FG000|Overall Study|Other Complicating Disease|9|||
48846802|NCT03080883|157278712|FG001|Overall Study|Other Complicating Disease|5|||
48846803|NCT03080883|157278711|FG000|Overall Study|Death|21|||
48846804|NCT03080883|157278712|FG001|Overall Study|Death|16|||
48846805|NCT03080883|157278711|FG000|Overall Study|Physician Decision|2|||
48846806|NCT03080883|157278712|FG001|Overall Study|Physician Decision|2|||
48846807|NCT03080883|157278711|FG000|Overall Study|Disease Progression|2|||
48846808|NCT03080883|157278712|FG001|Overall Study|Disease Progression|8|||
48846809|NCT03080883|157278711|FG000|Overall Study|Lost to Follow-up|1|||
48846810|NCT03080883|157278712|FG001|Overall Study|Lost to Follow-up|1|||
48846811|NCT03351075|157279998|FG000|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|6|||
48846812|NCT03351075|157279999|FG001|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|4|||
48846813|NCT03351075|157279998|FG000|Intensive Treatment Phase (4 mo FU)|Death|0|||
48846814|NCT03351075|157279999|FG001|Intensive Treatment Phase (4 mo FU)|Death|1|||
48846815|NCT03351075|157279998|FG000|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|1|||
48846816|NCT03351075|157279999|FG001|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|0|||
48846817|NCT03351075|157279998|FG000|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
48846818|NCT03351075|157279999|FG001|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
48846819|NCT05608005|157280000|FG000|Overall Study|Adverse Event|2|||
48846820|NCT05608005|157280001|FG001|Overall Study|Adverse Event|1|||
48934401|NCT00773279|157588231|FG000|Period 2|Adverse Event|0|||
48934402|NCT00773279|157588232|FG001|Period 2|Adverse Event|1|||
48934403|NCT00773279|157588231|FG000|Period 2|Lack of Efficacy|1|||
48934404|NCT00773279|157588232|FG001|Period 2|Lack of Efficacy|0|||
48846821|NCT05608005|157280002|FG002|Overall Study|Adverse Event|3|||
48846822|NCT05608005|157280000|FG000|Overall Study|Protocol Violation|2|||
48846823|NCT05608005|157280001|FG001|Overall Study|Protocol Violation|3|||
48846824|NCT05608005|157280002|FG002|Overall Study|Protocol Violation|0|||
48846825|NCT05608005|157280000|FG000|Overall Study|Withdrawal by Subject|10|||
48846826|NCT05608005|157280001|FG001|Overall Study|Withdrawal by Subject|12|||
48846827|NCT05608005|157280002|FG002|Overall Study|Withdrawal by Subject|4|||
48846828|NCT05608005|157280000|FG000|Overall Study|Lost to Follow-up|25|||
48846829|NCT05608005|157280001|FG001|Overall Study|Lost to Follow-up|27|||
48846830|NCT05608005|157280002|FG002|Overall Study|Lost to Follow-up|15|||
48846831|NCT05608005|157280000|FG000|Overall Study|Participants were not vaccinated or withdrew for other reasons|6|||
48846832|NCT05608005|157280001|FG001|Overall Study|Participants were not vaccinated or withdrew for other reasons|7|||
48846833|NCT05608005|157280002|FG002|Overall Study|Participants were not vaccinated or withdrew for other reasons|0|||
48846834|NCT04593472|157280003|FG000|Overall Study|Death|31|||
48846835|NCT04593472|157280004|FG001|Overall Study|Death|27|||
48846836|NCT04593472|157280003|FG000|Overall Study|Withdrawal by Subject|12|||
48846837|NCT04593472|157280004|FG001|Overall Study|Withdrawal by Subject|12|||
48846838|NCT04593472|157280003|FG000|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|33|||
48846839|NCT04593472|157280004|FG001|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|22|||
48846840|NCT04593472|157280003|FG000|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|5|||
48846841|NCT04593472|157280004|FG001|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|4|||
48846842|NCT04593472|157280003|FG000|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|0|||
48846843|NCT04593472|157280004|FG001|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|2|||
48846844|NCT04593472|157280003|FG000|Overall Study|Lost to Follow-up|0|||
48934405|NCT00773279|157588231|FG000|Period 2|Protocol Violation|0|||
48934406|NCT00773279|157588232|FG001|Period 2|Protocol Violation|3|||
48934407|NCT00773279|157588231|FG000|Period 2|Unclassified|2|||
48934408|NCT00773279|157588232|FG001|Period 2|Unclassified|2|||
48934409|NCT02211261|157588239|FG000|Overall Study|Withdrawal by Subject|0|||
48934410|NCT02211261|157588240|FG001|Overall Study|Withdrawal by Subject|0|||
48934411|NCT02211261|157588241|FG002|Overall Study|Withdrawal by Subject|1|||
48934412|NCT02211261|157588242|FG003|Overall Study|Withdrawal by Subject|0|||
48934413|NCT02211261|157588243|FG004|Overall Study|Withdrawal by Subject|2|||
48934414|NCT02211261|157588244|FG005|Overall Study|Withdrawal by Subject|0|||
48846845|NCT04593472|157280004|FG001|Overall Study|Lost to Follow-up|2|||
48846846|NCT04593472|157280003|FG000|Overall Study|Still collecting 24-month assessment|17|||
48846847|NCT04593472|157280004|FG001|Overall Study|Still collecting 24-month assessment|10|||
48934415|NCT02211261|157588245|FG006|Overall Study|Withdrawal by Subject|0|||
48934416|NCT02211261|157588246|FG007|Overall Study|Withdrawal by Subject|0|||
48846848|NCT03655132|157280005|FG000|Overall Study|Lost to Follow-up|2|||
48846849|NCT03655132|157280006|FG001|Overall Study|Lost to Follow-up|1|||
48934417|NCT02211261|157588247|FG008|Overall Study|Withdrawal by Subject|0|||
48934418|NCT02211261|157588248|FG009|Overall Study|Withdrawal by Subject|0|||
48934419|NCT02211261|157588249|FG010|Overall Study|Withdrawal by Subject|0|||
48934420|NCT02211261|157588239|FG000|Overall Study|Other|0|||
48934421|NCT02211261|157588240|FG001|Overall Study|Other|0|||
48934422|NCT02211261|157588241|FG002|Overall Study|Other|0|||
48934423|NCT02211261|157588242|FG003|Overall Study|Other|0|||
48934424|NCT02211261|157588243|FG004|Overall Study|Other|0|||
48934425|NCT02211261|157588244|FG005|Overall Study|Other|1|||
48934426|NCT02211261|157588245|FG006|Overall Study|Other|0|||
48846850|NCT03655132|157280005|FG000|Overall Study|Withdrawal by Subject|0|||
48846851|NCT03655132|157280006|FG001|Overall Study|Withdrawal by Subject|1|||
48846852|NCT03655132|157280005|FG000|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|0|||
48846853|NCT03655132|157280006|FG001|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|1|||
48846854|NCT02651324|157280007|FG000|Overall Study|drug not administered, due dispensing issue|1|||
48846855|NCT02651324|157280008|FG001|Overall Study|drug not administered, due dispensing issue|0|||
48846856|NCT02407249|157280009|FG000|Overall Study|Did not complete 12-month follow-up|13|||
48846857|NCT02407249|157280009|FG000|Overall Study|Not treated|13|||
48846858|NCT00840177|157280010|FG000|Overall Study|Adverse Event|5|||
48846859|NCT00840177|157280011|FG001|Overall Study|Adverse Event|1|||
48846860|NCT00840177|157280012|FG002|Overall Study|Adverse Event|1|||
48846861|NCT00840177|157280010|FG000|Overall Study|Refusal unrelated to adverse events|1|||
48846862|NCT00840177|157280011|FG001|Overall Study|Refusal unrelated to adverse events|0|||
48846863|NCT00840177|157280012|FG002|Overall Study|Refusal unrelated to adverse events|1|||
48846864|NCT00840177|157280010|FG000|Overall Study|Progression/relapse|2|||
48846865|NCT00840177|157280011|FG001|Overall Study|Progression/relapse|0|||
48846866|NCT00840177|157280012|FG002|Overall Study|Progression/relapse|0|||
48846867|NCT00840177|157280010|FG000|Overall Study|Death|4|||
48846868|NCT00840177|157280011|FG001|Overall Study|Death|5|||
48846869|NCT00840177|157280012|FG002|Overall Study|Death|5|||
48846870|NCT00840177|157280010|FG000|Overall Study|not protocol specified|6|||
48846871|NCT00840177|157280011|FG001|Overall Study|not protocol specified|3|||
48846872|NCT00840177|157280012|FG002|Overall Study|not protocol specified|0|||
48846873|NCT00840177|157280010|FG000|Overall Study|Ineligible|0|||
48846874|NCT00840177|157280011|FG001|Overall Study|Ineligible|0|||
48846875|NCT00840177|157280012|FG002|Overall Study|Ineligible|3|||
48846876|NCT00840177|157280010|FG000|Overall Study|Did not start treatment|0|||
48846877|NCT00840177|157280011|FG001|Overall Study|Did not start treatment|0|||
48846878|NCT00840177|157280012|FG002|Overall Study|Did not start treatment|1|||
48846879|NCT03093428|157280013|FG000|Overall Study|Not eligible for treatment|2|||
48846880|NCT03093428|157280014|FG001|Overall Study|Not eligible for treatment|1|||
48846881|NCT03093428|157280013|FG000|Overall Study|Progression|14|||
48846882|NCT03093428|157280014|FG001|Overall Study|Progression|4|||
48846883|NCT03093428|157280013|FG000|Overall Study|Death|1|||
48934427|NCT02211261|157588246|FG007|Overall Study|Other|0|||
48934428|NCT02211261|157588247|FG008|Overall Study|Other|0|||
48934429|NCT02211261|157588248|FG009|Overall Study|Other|2|||
48934430|NCT02211261|157588249|FG010|Overall Study|Other|0|||
48934431|NCT02211261|157588239|FG000|Overall Study|Lost to Follow-up|0|||
48934432|NCT02211261|157588240|FG001|Overall Study|Lost to Follow-up|0|||
48846884|NCT03093428|157280014|FG001|Overall Study|Death|0|||
48846885|NCT03093428|157280013|FG000|Overall Study|Adverse Event|1|||
48846886|NCT03093428|157280014|FG001|Overall Study|Adverse Event|0|||
48846887|NCT03093428|157280013|FG000|Overall Study|Withdrawal by Subject|1|||
48846888|NCT03093428|157280014|FG001|Overall Study|Withdrawal by Subject|1|||
48846889|NCT03624972|157280015|FG000|Overall Study|Lost to Follow-up|2|||
48846890|NCT03624972|157280016|FG001|Overall Study|Lost to Follow-up|0|||
48846891|NCT03624972|157280017|FG002|Overall Study|Lost to Follow-up|0|||
48846892|NCT03624972|157280015|FG000|Overall Study|Withdrawal by Subject|0|||
48846893|NCT03624972|157280016|FG001|Overall Study|Withdrawal by Subject|2|||
48846894|NCT03624972|157280017|FG002|Overall Study|Withdrawal by Subject|0|||
48846895|NCT00920621|157280034|FG000|Overall Study|Lost to Follow-up|16|||
48846896|NCT00920621|157280035|FG001|Overall Study|Lost to Follow-up|17|||
48846897|NCT00920621|157280036|FG002|Overall Study|Lost to Follow-up|19|||
48846898|NCT00920621|157280037|FG003|Overall Study|Lost to Follow-up|21|||
48846899|NCT00920621|157280034|FG000|Overall Study|Fetal/neonatal deaths|16|||
48846900|NCT00920621|157280035|FG001|Overall Study|Fetal/neonatal deaths|14|||
48846901|NCT00920621|157280036|FG002|Overall Study|Fetal/neonatal deaths|16|||
48934433|NCT02211261|157588241|FG002|Overall Study|Lost to Follow-up|0|||
48934434|NCT02211261|157588242|FG003|Overall Study|Lost to Follow-up|0|||
48846902|NCT00920621|157280037|FG003|Overall Study|Fetal/neonatal deaths|14|||
48846903|NCT00920621|157280034|FG000|Overall Study|Blood sample not collected|22|||
48846904|NCT00920621|157280035|FG001|Overall Study|Blood sample not collected|14|||
48846905|NCT00920621|157280036|FG002|Overall Study|Blood sample not collected|0|||
48934435|NCT02211261|157588243|FG004|Overall Study|Lost to Follow-up|0|||
48934436|NCT02211261|157588244|FG005|Overall Study|Lost to Follow-up|0|||
48846906|NCT00920621|157280037|FG003|Overall Study|Blood sample not collected|0|||
48846907|NCT05247489|157280039|FG000|Overall Study|Lost to Follow-up|5|||
48846908|NCT05247489|157280040|FG001|Overall Study|Lost to Follow-up|1|||
48846909|NCT05247489|157280039|FG000|Overall Study|Withdrawal by Subject|6|||
48846910|NCT05247489|157280040|FG001|Overall Study|Withdrawal by Subject|7|||
48846911|NCT05247489|157280039|FG000|Overall Study|Withdrawn by Sponsor: Noncompliance|0|||
48846912|NCT05247489|157280040|FG001|Overall Study|Withdrawn by Sponsor: Noncompliance|1|||
48846913|NCT05247489|157280039|FG000|Overall Study|Left Country|1|||
48846914|NCT05247489|157280040|FG001|Overall Study|Left Country|0|||
48846915|NCT05247489|157280039|FG000|Overall Study|Noncompliance with Investigational Product|1|||
48846916|NCT05247489|157280040|FG001|Overall Study|Noncompliance with Investigational Product|0|||
48846917|NCT05247489|157280039|FG000|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|1|||
48846918|NCT05247489|157280040|FG001|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|0|||
48846919|NCT02647905|157280041|FG000|Overall Study|Lost to Follow-up|1|||
48846920|NCT02647905|157280041|FG000|Overall Study|Withdrawal by Subject|2|||
48846921|NCT00439270|157280042|FG000|Phase 1 (18.1 Months)|Disease progression|3|||
48846922|NCT00439270|157280043|FG001|Phase 1 (18.1 Months)|Disease progression|2|||
48846923|NCT00439270|157280044|FG002|Phase 1 (18.1 Months)|Disease progression|3|||
48846924|NCT00439270|157280045|FG003|Phase 1 (18.1 Months)|Disease progression|0|||
48846925|NCT00439270|157280046|FG004|Phase 1 (18.1 Months)|Disease progression|3|||
48846926|NCT00439270|157280042|FG000|Phase 1 (18.1 Months)|Study drug toxicity|0|||
48846927|NCT00439270|157280043|FG001|Phase 1 (18.1 Months)|Study drug toxicity|1|||
48846928|NCT00439270|157280044|FG002|Phase 1 (18.1 Months)|Study drug toxicity|0|||
48846929|NCT00439270|157280045|FG003|Phase 1 (18.1 Months)|Study drug toxicity|0|||
48846930|NCT00439270|157280046|FG004|Phase 1 (18.1 Months)|Study drug toxicity|0|||
48846931|NCT00439270|157280042|FG000|Phase 2 (51.6 Months)|Disease progression|0|||
48846932|NCT00439270|157280043|FG001|Phase 2 (51.6 Months)|Disease progression|0|||
48846933|NCT00439270|157280044|FG002|Phase 2 (51.6 Months)|Disease progression|0|||
48846934|NCT00439270|157280045|FG003|Phase 2 (51.6 Months)|Disease progression|18|||
48846935|NCT00439270|157280046|FG004|Phase 2 (51.6 Months)|Disease progression|0|||
48846936|NCT00439270|157280042|FG000|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
48846937|NCT00439270|157280043|FG001|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
48846938|NCT00439270|157280044|FG002|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
48846939|NCT00439270|157280045|FG003|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1|||
48846940|NCT00439270|157280046|FG004|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
48846941|NCT00439270|157280042|FG000|Phase 2 (51.6 Months)|Study drug toxicity|0|||
48846942|NCT00439270|157280043|FG001|Phase 2 (51.6 Months)|Study drug toxicity|0|||
48846943|NCT00439270|157280044|FG002|Phase 2 (51.6 Months)|Study drug toxicity|0|||
48846944|NCT00439270|157280045|FG003|Phase 2 (51.6 Months)|Study drug toxicity|6|||
48846945|NCT00439270|157280046|FG004|Phase 2 (51.6 Months)|Study drug toxicity|0|||
48934437|NCT02211261|157588245|FG006|Overall Study|Lost to Follow-up|0|||
48846946|NCT00439270|157280042|FG000|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
48846947|NCT00439270|157280043|FG001|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
48846948|NCT00439270|157280044|FG002|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
48846949|NCT00439270|157280045|FG003|Phase 2 (51.6 Months)|Maximum clinical benefit|3|||
48846950|NCT00439270|157280046|FG004|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
48846951|NCT00439270|157280042|FG000|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
48846952|NCT00439270|157280043|FG001|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
48846953|NCT00439270|157280044|FG002|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
48846954|NCT00439270|157280045|FG003|Phase 2 (51.6 Months)|No longer meets study criteria|1|||
48846955|NCT00439270|157280046|FG004|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
48846956|NCT00439270|157280042|FG000|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
48846957|NCT00439270|157280043|FG001|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
48846958|NCT00439270|157280044|FG002|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
48846959|NCT00439270|157280045|FG003|Phase 2 (51.6 Months)|Withdrawal by Subject|2|||
48846960|NCT00439270|157280046|FG004|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
48846961|NCT00439270|157280042|FG000|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
48846962|NCT00439270|157280043|FG001|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
48846963|NCT00439270|157280044|FG002|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
48846964|NCT00439270|157280045|FG003|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2|||
48846965|NCT00439270|157280046|FG004|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
48846966|NCT00439270|157280042|FG000|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
48846967|NCT00439270|157280043|FG001|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
48846968|NCT00439270|157280044|FG002|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
48846969|NCT00439270|157280045|FG003|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1|||
48846970|NCT00439270|157280046|FG004|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
48846971|NCT01532388|157280047|FG000|3-month Follow-up|Lost to Follow-up|68|||
48846972|NCT01532388|157280048|FG001|3-month Follow-up|Lost to Follow-up|68|||
48846973|NCT01532388|157280047|FG000|6-month Follow-up|Lost to Follow-up|74|||
48846974|NCT01532388|157280048|FG001|6-month Follow-up|Lost to Follow-up|66|||
48846975|NCT01532388|157280047|FG000|12-month Follow-up|Lost to Follow-up|69|||
48846976|NCT01532388|157280048|FG001|12-month Follow-up|Lost to Follow-up|67|||
48846977|NCT00792636|157280049|FG000|Overall Study|Protocol Violation|17|||
48846978|NCT00792636|157280050|FG001|Overall Study|Protocol Violation|23|||
48846979|NCT00792636|157280051|FG002|Overall Study|Protocol Violation|20|||
48846980|NCT00792636|157280049|FG000|Overall Study|Met Protocol-defined Stopping Criteria|19|||
48846981|NCT00792636|157280050|FG001|Overall Study|Met Protocol-defined Stopping Criteria|20|||
48846982|NCT00792636|157280051|FG002|Overall Study|Met Protocol-defined Stopping Criteria|20|||
48846983|NCT00792636|157280049|FG000|Overall Study|Lost to Follow-up|13|||
48846984|NCT00792636|157280050|FG001|Overall Study|Lost to Follow-up|19|||
48846985|NCT00792636|157280051|FG002|Overall Study|Lost to Follow-up|14|||
48846986|NCT00792636|157280049|FG000|Overall Study|Withdrew Consent|10|||
48846987|NCT00792636|157280050|FG001|Overall Study|Withdrew Consent|13|||
48846988|NCT00792636|157280051|FG002|Overall Study|Withdrew Consent|9|||
48846989|NCT00792636|157280049|FG000|Overall Study|Lack of Efficacy|3|||
48846990|NCT00792636|157280050|FG001|Overall Study|Lack of Efficacy|4|||
48846991|NCT00792636|157280051|FG002|Overall Study|Lack of Efficacy|13|||
48846992|NCT00792636|157280049|FG000|Overall Study|Adverse Event|4|||
48846993|NCT00792636|157280050|FG001|Overall Study|Adverse Event|2|||
48846994|NCT00792636|157280051|FG002|Overall Study|Adverse Event|3|||
48846995|NCT00792636|157280049|FG000|Overall Study|Investigator Discretion|2|||
48846996|NCT00792636|157280050|FG001|Overall Study|Investigator Discretion|0|||
48846997|NCT00792636|157280051|FG002|Overall Study|Investigator Discretion|2|||
48846998|NCT04425863|157280052|FG000|Overall Study|Death|0|||
48846999|NCT04425863|157280053|FG001|Overall Study|Death|0|||
48847000|NCT04425863|157280054|FG002|Overall Study|Death|1|||
48847001|NCT01046136|157280055|FG000|Overall Study|Withdrawal by Subject|0|||
48847002|NCT01046136|157280056|FG001|Overall Study|Withdrawal by Subject|4|||
48847003|NCT01046136|157280055|FG000|Overall Study|Physician Decision|1|||
48847004|NCT01046136|157280056|FG001|Overall Study|Physician Decision|1|||
48847005|NCT01046136|157280055|FG000|Overall Study|Lost to Follow-up|3|||
48847006|NCT01046136|157280056|FG001|Overall Study|Lost to Follow-up|3|||
48934438|NCT02211261|157588246|FG007|Overall Study|Lost to Follow-up|1|||
48934439|NCT02211261|157588247|FG008|Overall Study|Lost to Follow-up|0|||
48934440|NCT02211261|157588248|FG009|Overall Study|Lost to Follow-up|0|||
48934441|NCT02211261|157588249|FG010|Overall Study|Lost to Follow-up|0|||
48934442|NCT01737931|157588250|FG000|Overall Study|Withdrawal by Subject|0|||
48934443|NCT01737931|157588251|FG001|Overall Study|Withdrawal by Subject|1|||
48934444|NCT01737931|157588252|FG002|Overall Study|Withdrawal by Subject|1|||
48934445|NCT01737931|157588250|FG000|Overall Study|Physician Decision|0|||
48934446|NCT01737931|157588251|FG001|Overall Study|Physician Decision|1|||
48934447|NCT01737931|157588252|FG002|Overall Study|Physician Decision|0|||
48934448|NCT04336163|157588253|FG000|Overall Study|Lost to Follow-up|55|||
48934449|NCT04336163|157588254|FG001|Overall Study|Lost to Follow-up|0|||
48934450|NCT01756456|157588259|FG000|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
48934451|NCT01756456|157588260|FG001|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
48934452|NCT01756456|157588261|FG002|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
48934453|NCT01756456|157588262|FG003|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
48934454|NCT01756456|157588263|FG004|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
48934455|NCT01756456|157588264|FG005|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
48934456|NCT01756456|157588259|FG000|Treatment Period: Phase I/II|Lack of Efficacy|0|||
48934457|NCT01756456|157588260|FG001|Treatment Period: Phase I/II|Lack of Efficacy|0|||
48934458|NCT01756456|157588261|FG002|Treatment Period: Phase I/II|Lack of Efficacy|0|||
48934459|NCT01756456|157588262|FG003|Treatment Period: Phase I/II|Lack of Efficacy|2|||
48934460|NCT01756456|157588263|FG004|Treatment Period: Phase I/II|Lack of Efficacy|1|||
48934461|NCT01756456|157588264|FG005|Treatment Period: Phase I/II|Lack of Efficacy|0|||
48934462|NCT01756456|157588259|FG000|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
48934463|NCT01756456|157588260|FG001|Treatment Period: Phase I/II|Withdrawal by Subject|1|||
48934464|NCT01756456|157588261|FG002|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
48934465|NCT01756456|157588262|FG003|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
48934466|NCT01756456|157588263|FG004|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
48934467|NCT01756456|157588264|FG005|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
48934468|NCT01756456|157588259|FG000|Treatment Period: Phase I/II|Adverse Event|1|||
48934469|NCT01756456|157588260|FG001|Treatment Period: Phase I/II|Adverse Event|0|||
48934470|NCT01756456|157588261|FG002|Treatment Period: Phase I/II|Adverse Event|2|||
48934471|NCT01756456|157588262|FG003|Treatment Period: Phase I/II|Adverse Event|3|||
48934472|NCT01756456|157588263|FG004|Treatment Period: Phase I/II|Adverse Event|9|||
48934473|NCT01756456|157588264|FG005|Treatment Period: Phase I/II|Adverse Event|1|||
48934474|NCT01756456|157588259|FG000|Treatment Period: Phase I/II|Other causes|0|||
48934475|NCT01756456|157588260|FG001|Treatment Period: Phase I/II|Other causes|0|||
48934476|NCT01756456|157588261|FG002|Treatment Period: Phase I/II|Other causes|0|||
48934477|NCT01756456|157588262|FG003|Treatment Period: Phase I/II|Other causes|1|||
48934478|NCT01756456|157588263|FG004|Treatment Period: Phase I/II|Other causes|2|||
48934479|NCT01756456|157588264|FG005|Treatment Period: Phase I/II|Other causes|2|||
48934480|NCT01756456|157588259|FG000|Follow Up Period Phase I/II|still in study after week 20|0|||
48934481|NCT01756456|157588260|FG001|Follow Up Period Phase I/II|still in study after week 20|0|||
48934482|NCT01756456|157588261|FG002|Follow Up Period Phase I/II|still in study after week 20|0|||
48934483|NCT01756456|157588262|FG003|Follow Up Period Phase I/II|still in study after week 20|25|||
48934484|NCT01756456|157588263|FG004|Follow Up Period Phase I/II|still in study after week 20|23|||
48934485|NCT01756456|157588264|FG005|Follow Up Period Phase I/II|still in study after week 20|25|||
48934486|NCT01756456|157588259|FG000|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
48934487|NCT01756456|157588260|FG001|Follow Up Period Phase I/II|parent withdrew the consent to continue|1|||
48934488|NCT01756456|157588261|FG002|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
48934489|NCT01756456|157588262|FG003|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
48934490|NCT01756456|157588263|FG004|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
48934491|NCT01756456|157588264|FG005|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
48934492|NCT01756456|157588259|FG000|Follow Up Period Phase I/II|Lack of Efficacy|0|||
48934493|NCT01756456|157588260|FG001|Follow Up Period Phase I/II|Lack of Efficacy|0|||
48934494|NCT01756456|157588261|FG002|Follow Up Period Phase I/II|Lack of Efficacy|0|||
48934495|NCT01756456|157588262|FG003|Follow Up Period Phase I/II|Lack of Efficacy|0|||
48934496|NCT01756456|157588263|FG004|Follow Up Period Phase I/II|Lack of Efficacy|0|||
48934497|NCT01756456|157588264|FG005|Follow Up Period Phase I/II|Lack of Efficacy|1|||
48934498|NCT01756456|157588259|FG000|Follow Up Period Phase I/II|Adverse Event|1|||
48934499|NCT01756456|157588260|FG001|Follow Up Period Phase I/II|Adverse Event|0|||
48934500|NCT01756456|157588261|FG002|Follow Up Period Phase I/II|Adverse Event|0|||
48934501|NCT01756456|157588262|FG003|Follow Up Period Phase I/II|Adverse Event|5|||
48934502|NCT01756456|157588263|FG004|Follow Up Period Phase I/II|Adverse Event|0|||
48934503|NCT01756456|157588264|FG005|Follow Up Period Phase I/II|Adverse Event|1|||
48934504|NCT01756456|157588259|FG000|Follow Up Period Phase I/II|Lost to Follow-up|0|||
48934505|NCT01756456|157588260|FG001|Follow Up Period Phase I/II|Lost to Follow-up|0|||
48934506|NCT01756456|157588261|FG002|Follow Up Period Phase I/II|Lost to Follow-up|1|||
48934507|NCT01756456|157588262|FG003|Follow Up Period Phase I/II|Lost to Follow-up|2|||
48934508|NCT01756456|157588263|FG004|Follow Up Period Phase I/II|Lost to Follow-up|0|||
48934509|NCT01756456|157588264|FG005|Follow Up Period Phase I/II|Lost to Follow-up|1|||
48934510|NCT01756456|157588259|FG000|Follow Up Period Phase I/II|Other causes|0|||
48934511|NCT01756456|157588260|FG001|Follow Up Period Phase I/II|Other causes|0|||
48934512|NCT01756456|157588261|FG002|Follow Up Period Phase I/II|Other causes|0|||
48934513|NCT01756456|157588262|FG003|Follow Up Period Phase I/II|Other causes|1|||
48934514|NCT01756456|157588263|FG004|Follow Up Period Phase I/II|Other causes|3|||
48934515|NCT01756456|157588264|FG005|Follow Up Period Phase I/II|Other causes|5|||
48934516|NCT02908516|157588270|FG000|Overall Study|Study Terminated|3|||
48934517|NCT02908516|157588271|FG001|Overall Study|Study Terminated|3|||
48934518|NCT00772447|157588276|FG000|Overall Study|Withdrawal by Subject|9|||
48934519|NCT00772447|157588277|FG001|Overall Study|Withdrawal by Subject|5|||
48934520|NCT00772447|157588276|FG000|Overall Study|Physician Decision|4|||
48934521|NCT00772447|157588277|FG001|Overall Study|Physician Decision|8|||
48934522|NCT00772447|157588276|FG000|Overall Study|Lost to Follow-up|2|||
48934523|NCT00772447|157588277|FG001|Overall Study|Lost to Follow-up|4|||
48934524|NCT00772447|157588276|FG000|Overall Study|incorrect enrolment|3|||
48934525|NCT00772447|157588277|FG001|Overall Study|incorrect enrolment|4|||
48934526|NCT00772447|157588276|FG000|Overall Study|Protocol Violation|0|||
48934527|NCT00772447|157588277|FG001|Overall Study|Protocol Violation|1|||
48934528|NCT00772447|157588276|FG000|Overall Study|all others|2|||
48934529|NCT00772447|157588277|FG001|Overall Study|all others|2|||
48934530|NCT00927563|157588292|FG000|Overall Study|Lost to Follow-up|1|||
48934531|NCT00927563|157588292|FG000|Overall Study|Withdrawal by Subject|1|||
48934532|NCT01957137|157588293|FG000|Randomized Portion|Adverse Event|1|||
48934533|NCT01957137|157588293|FG000|Randomized Portion|Withdrawal by Subject|1|||
48934534|NCT02949830|157588296|FG000|Overall Study|Adverse Event|1|||
48934535|NCT02949830|157588296|FG000|Overall Study|Withdrawal by Subject|1|||
48934536|NCT01468987|157588297|FG000|Overall Study|Adverse Event|12|||
48934537|NCT01468987|157588298|FG001|Overall Study|Adverse Event|9|||
48934538|NCT01468987|157588297|FG000|Overall Study|Death|4|||
48847007|NCT03406871|157280057|FG000|Dose Escalation Cohort|DLT assesment cancellation**|1|||
48847008|NCT03406871|157280058|FG001|Dose Escalation Cohort|DLT assesment cancellation**|1|||
48847009|NCT03406871|157280059|FG002|Dose Escalation Cohort|DLT assesment cancellation**|0|||
48847010|NCT03406871|157280057|FG000|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|4|||
48847011|NCT03406871|157280058|FG001|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|2|||
48847012|NCT03406871|157280059|FG002|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|1|||
48847013|NCT03406871|157280057|FG000|Expansion Cohort(Final Analysis)|Progression of primary disease|17|||
48847014|NCT03406871|157280058|FG001|Expansion Cohort(Final Analysis)|Progression of primary disease|22|||
48847015|NCT03406871|157280059|FG002|Expansion Cohort(Final Analysis)|Progression of primary disease|1|||
48934539|NCT01468987|157588298|FG001|Overall Study|Death|1|||
48934540|NCT01468987|157588297|FG000|Overall Study|Lost to Follow-up|10|||
48934541|NCT01468987|157588298|FG001|Overall Study|Lost to Follow-up|5|||
48934542|NCT01468987|157588297|FG000|Overall Study|Protocol Violation|8|||
48934543|NCT01468987|157588298|FG001|Overall Study|Protocol Violation|2|||
48934544|NCT01468987|157588297|FG000|Overall Study|Withdrawal by Subject|28|||
48934545|NCT01468987|157588298|FG001|Overall Study|Withdrawal by Subject|28|||
48934546|NCT01468987|157588297|FG000|Overall Study|Physician Decision|8|||
48847016|NCT03406871|157280057|FG000|Expansion Cohort(Final Analysis)|Physician Decision|1|||
48847017|NCT03406871|157280058|FG001|Expansion Cohort(Final Analysis)|Physician Decision|0|||
48847018|NCT03406871|157280059|FG002|Expansion Cohort(Final Analysis)|Physician Decision|0|||
48847019|NCT03406871|157280057|FG000|Expansion Cohort(Final Analysis)|Death|0|||
48847020|NCT03406871|157280058|FG001|Expansion Cohort(Final Analysis)|Death|1|||
48847021|NCT03406871|157280059|FG002|Expansion Cohort(Final Analysis)|Death|0|||
48847022|NCT03406871|157280057|FG000|Expansion Cohort(Final Analysis)|Adverse Event|0|||
48847023|NCT03406871|157280058|FG001|Expansion Cohort(Final Analysis)|Adverse Event|0|||
48847024|NCT03406871|157280059|FG002|Expansion Cohort(Final Analysis)|Adverse Event|1|||
48847025|NCT00277355|157280060|FG000|Overall Study|Withdrawal by Subject|3|||
48847026|NCT00277355|157280061|FG001|Overall Study|Withdrawal by Subject|3|||
48847027|NCT00277355|157280060|FG000|Overall Study|Lost to Follow-up|2|||
48847028|NCT00277355|157280061|FG001|Overall Study|Lost to Follow-up|2|||
48847029|NCT00277355|157280060|FG000|Overall Study|Adverse Event|5|||
48847030|NCT00277355|157280061|FG001|Overall Study|Adverse Event|0|||
48847031|NCT00277355|157280060|FG000|Overall Study|Death|3|||
48847032|NCT00277355|157280061|FG001|Overall Study|Death|0|||
48847033|NCT00277355|157280060|FG000|Overall Study|Physician Decision|1|||
48847034|NCT00277355|157280061|FG001|Overall Study|Physician Decision|0|||
48847035|NCT00642850|157280062|FG000|Overall Study|Death|7|||
48847036|NCT00642850|157280062|FG000|Overall Study|Adverse Event|2|||
48847037|NCT00642850|157280062|FG000|Overall Study|Lack of Efficacy|1|||
48847038|NCT00642850|157280062|FG000|Overall Study|Protocol Violation|2|||
48847039|NCT00642850|157280062|FG000|Overall Study|Kidney transplantation|8|||
48847040|NCT00642850|157280062|FG000|Overall Study|Blood transfusion|6|||
48847041|NCT00642850|157280062|FG000|Overall Study|Other reasons|7|||
48847042|NCT04166773|157280063|FG000|Overall Study|Adverse Event|2|||
48847043|NCT04166773|157280064|FG001|Overall Study|Adverse Event|0|||
48847044|NCT04166773|157280065|FG002|Overall Study|Adverse Event|2|||
48847045|NCT04166773|157280066|FG003|Overall Study|Adverse Event|1|||
48847046|NCT04166773|157280063|FG000|Overall Study|Lost to Follow-up|4|||
48847047|NCT04166773|157280064|FG001|Overall Study|Lost to Follow-up|2|||
48847048|NCT04166773|157280065|FG002|Overall Study|Lost to Follow-up|1|||
48847049|NCT04166773|157280066|FG003|Overall Study|Lost to Follow-up|3|||
48847050|NCT04166773|157280063|FG000|Overall Study|Physician Decision|0|||
48847051|NCT04166773|157280064|FG001|Overall Study|Physician Decision|0|||
48847052|NCT04166773|157280065|FG002|Overall Study|Physician Decision|0|||
48847053|NCT04166773|157280066|FG003|Overall Study|Physician Decision|1|||
48847054|NCT04166773|157280063|FG000|Overall Study|Withdrawal by Subject|1|||
48847055|NCT04166773|157280064|FG001|Overall Study|Withdrawal by Subject|1|||
48847056|NCT04166773|157280065|FG002|Overall Study|Withdrawal by Subject|2|||
48847057|NCT04166773|157280066|FG003|Overall Study|Withdrawal by Subject|5|||
48847058|NCT01839331|157280069|FG000|Overall Study|Early Termination|3|||
48847059|NCT01839331|157280070|FG001|Overall Study|Early Termination|0|||
48847060|NCT01839331|157280071|FG002|Overall Study|Early Termination|1|||
48847061|NCT01839331|157280072|FG003|Overall Study|Early Termination|2|||
48847062|NCT01839331|157280069|FG000|Overall Study|Protocol Violation|1|||
48847063|NCT01839331|157280070|FG001|Overall Study|Protocol Violation|6|||
48847064|NCT01839331|157280071|FG002|Overall Study|Protocol Violation|4|||
48934547|NCT01468987|157588298|FG001|Overall Study|Physician Decision|15|||
48934548|NCT01468987|157588297|FG000|Overall Study|Sponsor Decision|1|||
48934549|NCT01468987|157588298|FG001|Overall Study|Sponsor Decision|0|||
48934550|NCT00700804|157588299|FG000|Overall Study|Withdrawal by Subject|1|||
48934551|NCT00700804|157588300|FG001|Overall Study|Withdrawal by Subject|2|||
48934552|NCT00700804|157588299|FG000|Overall Study|Protocol Violation|1|||
48934553|NCT00700804|157588300|FG001|Overall Study|Protocol Violation|1|||
48934554|NCT00700804|157588299|FG000|Overall Study|Loose Stools|1|||
48934555|NCT00700804|157588300|FG001|Overall Study|Loose Stools|1|||
48934556|NCT02764541|157588302|FG000|Overall Study|Withdrawal by Subject|0|||
48847065|NCT01839331|157280072|FG003|Overall Study|Protocol Violation|3|||
48847066|NCT01121991|157280074|FG000|Overall Study|Lack of Ovarian Response|2|||
48934557|NCT02764541|157588303|FG001|Overall Study|Withdrawal by Subject|0|||
48847067|NCT01121991|157280074|FG000|Overall Study|No Oocytes Retrieved|3|||
48847068|NCT01121991|157280074|FG000|Overall Study|No Fertilization|1|||
48847069|NCT00112359|157280078|FG000|Overall Study|Unrelated adverse event|16|||
48847070|NCT00112359|157280079|FG001|Overall Study|Unrelated adverse event|8|||
48847071|NCT00112359|157280078|FG000|Overall Study|Trial drug intolerance (adverse event)|2|||
48847072|NCT00112359|157280079|FG001|Overall Study|Trial drug intolerance (adverse event)|0|||
48847073|NCT00112359|157280078|FG000|Overall Study|Related adverse event|5|||
48847074|NCT00112359|157280079|FG001|Overall Study|Related adverse event|3|||
48847075|NCT00112359|157280078|FG000|Overall Study|Lost to Follow-up|0|||
48847076|NCT00112359|157280079|FG001|Overall Study|Lost to Follow-up|1|||
48847077|NCT00112359|157280078|FG000|Overall Study|Personal/administrative|1|||
48847078|NCT00112359|157280079|FG001|Overall Study|Personal/administrative|1|||
48847079|NCT00112359|157280078|FG000|Overall Study|Other|3|||
48847080|NCT00112359|157280079|FG001|Overall Study|Other|0|||
48847081|NCT00623194|157280080|FG000|Overall Study|Lack of Efficacy|1|||
48847082|NCT00623194|157280080|FG000|Overall Study|Protocol Violation|3|||
48847083|NCT00623194|157280080|FG000|Overall Study|Unclassified|1|||
48847084|NCT03785405|157280087|FG000|Overall Study|Adverse Event|16|||
48847085|NCT03785405|157280088|FG001|Overall Study|Adverse Event|1|||
48847086|NCT03785405|157280087|FG000|Overall Study|Death|6|||
48934558|NCT02764541|157588304|FG002|Overall Study|Withdrawal by Subject|0|||
48934559|NCT02764541|157588305|FG003|Overall Study|Withdrawal by Subject|0|||
48934560|NCT02764541|157588306|FG004|Overall Study|Withdrawal by Subject|1|||
48934561|NCT02764541|157588307|FG005|Overall Study|Withdrawal by Subject|1|||
48934562|NCT02764541|157588308|FG006|Overall Study|Withdrawal by Subject|0|||
48934563|NCT02764541|157588309|FG007|Overall Study|Withdrawal by Subject|1|||
48934564|NCT02764541|157588302|FG000|Overall Study|Adverse Event|1|||
48934565|NCT02764541|157588303|FG001|Overall Study|Adverse Event|0|||
48934566|NCT02764541|157588304|FG002|Overall Study|Adverse Event|0|||
48934567|NCT02764541|157588305|FG003|Overall Study|Adverse Event|0|||
48934568|NCT02764541|157588306|FG004|Overall Study|Adverse Event|0|||
48934569|NCT02764541|157588307|FG005|Overall Study|Adverse Event|0|||
48934570|NCT02764541|157588308|FG006|Overall Study|Adverse Event|1|||
48934571|NCT02764541|157588309|FG007|Overall Study|Adverse Event|0|||
48934572|NCT02764541|157588302|FG000|Overall Study|Metastasis|1|||
48934573|NCT02764541|157588303|FG001|Overall Study|Metastasis|0|||
48934574|NCT02764541|157588304|FG002|Overall Study|Metastasis|0|||
48934575|NCT02764541|157588305|FG003|Overall Study|Metastasis|0|||
48934576|NCT02764541|157588306|FG004|Overall Study|Metastasis|0|||
48934577|NCT02764541|157588307|FG005|Overall Study|Metastasis|0|||
48934578|NCT02764541|157588308|FG006|Overall Study|Metastasis|0|||
48934579|NCT02764541|157588309|FG007|Overall Study|Metastasis|0|||
48934580|NCT02764541|157588302|FG000|Overall Study|Disease progression|1|||
48934581|NCT02764541|157588303|FG001|Overall Study|Disease progression|1|||
48934582|NCT02764541|157588304|FG002|Overall Study|Disease progression|0|||
48934583|NCT02764541|157588305|FG003|Overall Study|Disease progression|0|||
48934584|NCT02764541|157588306|FG004|Overall Study|Disease progression|0|||
48934585|NCT02764541|157588307|FG005|Overall Study|Disease progression|0|||
48934586|NCT02764541|157588308|FG006|Overall Study|Disease progression|0|||
48934587|NCT02764541|157588309|FG007|Overall Study|Disease progression|1|||
48934588|NCT02764541|157588302|FG000|Overall Study|Protocol Violation|0|||
48934589|NCT02764541|157588303|FG001|Overall Study|Protocol Violation|0|||
48934590|NCT02764541|157588304|FG002|Overall Study|Protocol Violation|0|||
48934591|NCT02764541|157588305|FG003|Overall Study|Protocol Violation|1|||
48934592|NCT02764541|157588306|FG004|Overall Study|Protocol Violation|0|||
48934593|NCT02764541|157588307|FG005|Overall Study|Protocol Violation|1|||
48934594|NCT02764541|157588308|FG006|Overall Study|Protocol Violation|0|||
48934595|NCT02764541|157588309|FG007|Overall Study|Protocol Violation|0|||
48934596|NCT02764541|157588302|FG000|Overall Study|Physician Decision|0|||
48934597|NCT02764541|157588303|FG001|Overall Study|Physician Decision|0|||
48934598|NCT02764541|157588304|FG002|Overall Study|Physician Decision|0|||
48934599|NCT02764541|157588305|FG003|Overall Study|Physician Decision|1|||
48934600|NCT02764541|157588306|FG004|Overall Study|Physician Decision|0|||
48934601|NCT02764541|157588307|FG005|Overall Study|Physician Decision|0|||
48934602|NCT02764541|157588308|FG006|Overall Study|Physician Decision|0|||
48934603|NCT02764541|157588309|FG007|Overall Study|Physician Decision|1|||
48934604|NCT02764541|157588302|FG000|Overall Study|Three Cycles completed before surgery|0|||
48934605|NCT02764541|157588303|FG001|Overall Study|Three Cycles completed before surgery|0|||
48934606|NCT02764541|157588304|FG002|Overall Study|Three Cycles completed before surgery|0|||
48934607|NCT02764541|157588305|FG003|Overall Study|Three Cycles completed before surgery|1|||
48934608|NCT02764541|157588306|FG004|Overall Study|Three Cycles completed before surgery|0|||
48934609|NCT02764541|157588307|FG005|Overall Study|Three Cycles completed before surgery|0|||
48934610|NCT02764541|157588308|FG006|Overall Study|Three Cycles completed before surgery|0|||
48934611|NCT02764541|157588309|FG007|Overall Study|Three Cycles completed before surgery|0|||
48934612|NCT02764541|157588302|FG000|Overall Study|Patient Compliance|0|||
48934613|NCT02764541|157588303|FG001|Overall Study|Patient Compliance|0|||
48934614|NCT02764541|157588304|FG002|Overall Study|Patient Compliance|1|||
48934615|NCT02764541|157588305|FG003|Overall Study|Patient Compliance|0|||
48934616|NCT02764541|157588306|FG004|Overall Study|Patient Compliance|0|||
48934617|NCT02764541|157588307|FG005|Overall Study|Patient Compliance|0|||
48934618|NCT02764541|157588308|FG006|Overall Study|Patient Compliance|0|||
48934619|NCT02764541|157588309|FG007|Overall Study|Patient Compliance|0|||
48934620|NCT02764541|157588302|FG000|Overall Study|Death|0|||
48934621|NCT02764541|157588303|FG001|Overall Study|Death|0|||
48934622|NCT02764541|157588304|FG002|Overall Study|Death|0|||
48934623|NCT02764541|157588305|FG003|Overall Study|Death|0|||
48934624|NCT02764541|157588306|FG004|Overall Study|Death|0|||
48934625|NCT02764541|157588307|FG005|Overall Study|Death|0|||
48934626|NCT02764541|157588308|FG006|Overall Study|Death|1|||
48934627|NCT02764541|157588309|FG007|Overall Study|Death|0|||
48934628|NCT02764541|157588302|FG000|Overall Study|Insurance reasons|0|||
48934629|NCT02764541|157588303|FG001|Overall Study|Insurance reasons|0|||
48934630|NCT02764541|157588304|FG002|Overall Study|Insurance reasons|0|||
48934631|NCT02764541|157588305|FG003|Overall Study|Insurance reasons|0|||
48934632|NCT02764541|157588306|FG004|Overall Study|Insurance reasons|0|||
48934633|NCT02764541|157588307|FG005|Overall Study|Insurance reasons|0|||
48934634|NCT02764541|157588308|FG006|Overall Study|Insurance reasons|1|||
48934635|NCT02764541|157588309|FG007|Overall Study|Insurance reasons|0|||
48934636|NCT01990261|157588310|FG000|Overall Study|Death Before Treatment Start|2|||
48934637|NCT01990261|157588310|FG000|Overall Study|Death due to Disease Progression (PD)|10|||
48934638|NCT01990261|157588310|FG000|Overall Study|Death From other Causes|1|||
48934639|NCT01990261|157588310|FG000|Overall Study|Disease Progression (PD)|8|||
48934640|NCT01990261|157588310|FG000|Overall Study|PD Before Treatment Start|1|||
48934641|NCT01990261|157588310|FG000|Overall Study|Dossier not Approved|1|||
48934642|NCT01990261|157588310|FG000|Overall Study|Lost to Follow-up|2|||
48934643|NCT00355121|157588311|FG000|Overall Study|Did not receive study vaccine|1|||
48934644|NCT00355121|157588312|FG001|Overall Study|Did not receive study vaccine|0|||
48934645|NCT00355121|157588313|FG002|Overall Study|Did not receive study vaccine|1|||
48934646|NCT00355121|157588311|FG000|Overall Study|Adverse Event|0|||
48934647|NCT00355121|157588312|FG001|Overall Study|Adverse Event|1|||
48934648|NCT00355121|157588313|FG002|Overall Study|Adverse Event|0|||
48934649|NCT00355121|157588311|FG000|Overall Study|Protocol Violation|7|||
48934650|NCT00355121|157588312|FG001|Overall Study|Protocol Violation|9|||
48934651|NCT00355121|157588313|FG002|Overall Study|Protocol Violation|1|||
48934652|NCT00355121|157588311|FG000|Overall Study|Lost to Follow-up|4|||
48934653|NCT00355121|157588312|FG001|Overall Study|Lost to Follow-up|7|||
48934654|NCT00355121|157588313|FG002|Overall Study|Lost to Follow-up|1|||
48934655|NCT00355121|157588311|FG000|Overall Study|Withdrawal by Subject|9|||
48934656|NCT00355121|157588312|FG001|Overall Study|Withdrawal by Subject|10|||
48934657|NCT00355121|157588313|FG002|Overall Study|Withdrawal by Subject|2|||
48934658|NCT00355121|157588311|FG000|Overall Study|Serious adverse events|0|||
48934659|NCT00355121|157588312|FG001|Overall Study|Serious adverse events|2|||
48934660|NCT00355121|157588313|FG002|Overall Study|Serious adverse events|0|||
48934661|NCT00655928|157588315|FG000|Overall Study|Withdrawal by Subject|2|||
48934662|NCT00655928|157588316|FG001|Overall Study|Withdrawal by Subject|1|||
48934663|NCT00655928|157588315|FG000|Overall Study|Physician Decision|1|||
48934664|NCT00655928|157588316|FG001|Overall Study|Physician Decision|1|||
48934665|NCT03636906|157588317|FG000|Overall Study|Adverse Event|0|||
48934666|NCT03636906|157588318|FG001|Overall Study|Adverse Event|0|||
48934667|NCT03636906|157588319|FG002|Overall Study|Adverse Event|1|||
48934668|NCT03636906|157588317|FG000|Overall Study|Lost to Follow-up|1|||
48934669|NCT03636906|157588318|FG001|Overall Study|Lost to Follow-up|0|||
48934670|NCT03636906|157588319|FG002|Overall Study|Lost to Follow-up|0|||
48934671|NCT03636906|157588317|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|2|||
48934672|NCT03636906|157588318|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|0|||
48934673|NCT03636906|157588319|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|1|||
48934674|NCT03636906|157588317|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
48934675|NCT03636906|157588318|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
48934676|NCT03636906|157588319|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|2|||
48934677|NCT03636906|157588317|FG000|Overall Study|Other|0|||
48934678|NCT03636906|157588318|FG001|Overall Study|Other|0|||
48934679|NCT03636906|157588319|FG002|Overall Study|Other|1|||
48934680|NCT00483327|157589964|FG000|Overall Study|Adverse Event|1|||
48934681|NCT00483327|157589964|FG000|Overall Study|Withdrawal by Subject|3|||
48934682|NCT00483327|157589964|FG000|Overall Study|Lost to Follow-up|4|||
48847087|NCT03785405|157280088|FG001|Overall Study|Death|4|||
48847088|NCT03785405|157280087|FG000|Overall Study|Guardian decision|4|||
48847089|NCT03785405|157280088|FG001|Overall Study|Guardian decision|1|||
48847090|NCT03785405|157280087|FG000|Overall Study|Lost to Follow-up|1|||
48847091|NCT03785405|157280088|FG001|Overall Study|Lost to Follow-up|0|||
48934683|NCT00483327|157589964|FG000|Overall Study|Patient Non Compliance|2|||
48934684|NCT00670007|157589967|FG000|Overall Study|Drug abuse|1|||
48934685|NCT00670007|157589967|FG000|Overall Study|Lung transplant|1|||
48934686|NCT00670007|157589967|FG000|Overall Study|Travel/Vacation|1|||
48934687|NCT00670007|157589967|FG000|Overall Study|Adverse event, serious fatal|1|||
48934688|NCT00670007|157589967|FG000|Overall Study|Adverse Event|1|||
48934689|NCT00670007|157589967|FG000|Overall Study|Withdrawal by Subject|4|||
48934690|NCT01171820|157589968|FG000|Overall Study|Death|3|||
48934691|NCT01171820|157589969|FG001|Overall Study|Death|3|||
48934692|NCT01171820|157589968|FG000|Overall Study|Lost to Follow-up|0|||
48934693|NCT01171820|157589969|FG001|Overall Study|Lost to Follow-up|1|||
48847092|NCT03785405|157280087|FG000|Overall Study|Physician Decision|8|||
48847093|NCT03785405|157280088|FG001|Overall Study|Physician Decision|5|||
48847094|NCT03785405|157280087|FG000|Overall Study|Participant decision|2|||
48847095|NCT03785405|157280088|FG001|Overall Study|Participant decision|0|||
48847096|NCT03785405|157280087|FG000|Overall Study|Other|1|||
48847097|NCT03785405|157280088|FG001|Overall Study|Other|0|||
48847098|NCT03785405|157280087|FG000|Overall Study|No treatment was received|0|||
48847099|NCT03785405|157280088|FG001|Overall Study|No treatment was received|1|||
48847100|NCT01290341|157280089|FG000|Overall Study|Protocol Violation|7|||
48847101|NCT01290341|157280090|FG001|Overall Study|Protocol Violation|3|||
48847102|NCT01290341|157280089|FG000|Overall Study|Adverse Event|1|||
48847103|NCT01290341|157280090|FG001|Overall Study|Adverse Event|0|||
48847104|NCT01290341|157280089|FG000|Overall Study|Lost to Follow-up|21|||
48847105|NCT01290341|157280090|FG001|Overall Study|Lost to Follow-up|10|||
48847106|NCT01290341|157280089|FG000|Overall Study|Withdrawal by Subject|19|||
48847107|NCT01290341|157280090|FG001|Overall Study|Withdrawal by Subject|5|||
48934694|NCT01171820|157589968|FG000|Overall Study|Withdrawal by Subject|2|||
48934695|NCT01171820|157589969|FG001|Overall Study|Withdrawal by Subject|0|||
48934696|NCT01171820|157589968|FG000|Overall Study|Physician Decision|0|||
48934697|NCT01171820|157589969|FG001|Overall Study|Physician Decision|1|||
48847108|NCT01290341|157280089|FG000|Overall Study|Negative baseline culture and others|44|||
48847109|NCT01290341|157280090|FG001|Overall Study|Negative baseline culture and others|11|||
48847110|NCT00960141|157280091|FG000|Overall Study|Adverse Event|4|||
48847111|NCT00960141|157280092|FG001|Overall Study|Adverse Event|8|||
48847112|NCT00960141|157280093|FG002|Overall Study|Adverse Event|2|||
48847113|NCT00960141|157280091|FG000|Overall Study|Lack of Efficacy|3|||
48847114|NCT00960141|157280092|FG001|Overall Study|Lack of Efficacy|4|||
48847115|NCT00960141|157280093|FG002|Overall Study|Lack of Efficacy|2|||
48847116|NCT00960141|157280091|FG000|Overall Study|Lost to Follow-up|1|||
48847117|NCT00960141|157280092|FG001|Overall Study|Lost to Follow-up|0|||
48847118|NCT00960141|157280093|FG002|Overall Study|Lost to Follow-up|0|||
48934698|NCT01171820|157589968|FG000|Overall Study|1-Year Missed Visit|1|||
48934699|NCT01171820|157589969|FG001|Overall Study|1-Year Missed Visit|1|||
48934700|NCT00984204|157589970|FG000|Overall Study|Death|1|||
48934701|NCT00984204|157589970|FG000|Overall Study|Lost to Follow-up|4|||
48934702|NCT00984204|157589970|FG000|Overall Study|Lack of Efficacy|10|||
48934703|NCT00947531|157589971|FG000|Overall Study|Withdrawal by Subject|10|||
48934704|NCT00947531|157589972|FG001|Overall Study|Withdrawal by Subject|7|||
48934705|NCT00947531|157589971|FG000|Overall Study|Administrative Reason|0|||
48934706|NCT00947531|157589972|FG001|Overall Study|Administrative Reason|1|||
48934707|NCT00947531|157589971|FG000|Overall Study|Adverse Event|2|||
48934708|NCT00947531|157589972|FG001|Overall Study|Adverse Event|2|||
48934709|NCT00947531|157589971|FG000|Overall Study|Lack of Efficacy|1|||
48934710|NCT00947531|157589972|FG001|Overall Study|Lack of Efficacy|0|||
48934711|NCT00947531|157589971|FG000|Overall Study|Other|1|||
48934712|NCT00947531|157589972|FG001|Overall Study|Other|1|||
48934713|NCT02327260|157589973|FG000|Overall Study|Lost to Follow-up|2|||
48934714|NCT02327260|157589974|FG001|Overall Study|Lost to Follow-up|3|||
48934715|NCT02327260|157589975|FG002|Overall Study|Lost to Follow-up|2|||
48934716|NCT02327260|157589973|FG000|Overall Study|invalid phone number|1|||
48934717|NCT02327260|157589974|FG001|Overall Study|invalid phone number|1|||
48934718|NCT02327260|157589975|FG002|Overall Study|invalid phone number|0|||
48934719|NCT02327260|157589973|FG000|Overall Study|non-adherence to protocol|2|||
48934720|NCT02327260|157589974|FG001|Overall Study|non-adherence to protocol|0|||
48934721|NCT02327260|157589975|FG002|Overall Study|non-adherence to protocol|0|||
48934722|NCT02327260|157589973|FG000|Overall Study|cognitive concerns|1|||
48934723|NCT02327260|157589974|FG001|Overall Study|cognitive concerns|0|||
48934724|NCT02327260|157589975|FG002|Overall Study|cognitive concerns|0|||
48934725|NCT00688909|157589976|FG000|Overall Study|Adverse Event|28|||
48847119|NCT00960141|157280091|FG000|Overall Study|Protocol Violation|1|||
48934726|NCT00688909|157589976|FG000|Overall Study|Patient withdrew consent|2|||
48934727|NCT00688909|157589976|FG000|Overall Study|Administrative problems|1|||
48934728|NCT00688909|157589976|FG000|Overall Study|Protocol Violation|2|||
48934729|NCT01268293|157589977|FG000|Overall Study|Disease progression|7|||
48847120|NCT00960141|157280092|FG001|Overall Study|Protocol Violation|3|||
48934730|NCT01268293|157589977|FG000|Overall Study|Adverse Event|1|||
48934731|NCT01268293|157589977|FG000|Overall Study|Subject choice|1|||
48847121|NCT00960141|157280093|FG002|Overall Study|Protocol Violation|2|||
48847122|NCT00960141|157280091|FG000|Overall Study|Withdrawal by Subject|1|||
48934732|NCT00716976|157589978|FG000|Overall Study|Adverse Event|2|||
48934733|NCT00716976|157589979|FG001|Overall Study|Adverse Event|0|||
48934734|NCT00716976|157589978|FG000|Overall Study|Death|1|||
48934735|NCT00716976|157589979|FG001|Overall Study|Death|0|||
48934736|NCT00716976|157589978|FG000|Overall Study|Physician Decision|2|||
48847123|NCT00960141|157280092|FG001|Overall Study|Withdrawal by Subject|2|||
48847124|NCT00960141|157280093|FG002|Overall Study|Withdrawal by Subject|1|||
48847125|NCT02874534|157280094|FG000|Overall Study|Withdrawal by Subject|5|||
48847126|NCT02874534|157280095|FG001|Overall Study|Withdrawal by Subject|8|||
48847127|NCT02874534|157280094|FG000|Overall Study|Lost to Follow-up|2|||
48847128|NCT02874534|157280095|FG001|Overall Study|Lost to Follow-up|2|||
48847129|NCT02874534|157280094|FG000|Overall Study|Ongoing in study|1|||
48847130|NCT02874534|157280095|FG001|Overall Study|Ongoing in study|1|||
48847143|NCT04088409|157280100|FG000|Part A|Withdrawal by Subject|2|||
48847144|NCT04088409|157280101|FG001|Part A|Withdrawal by Subject|1|||
48847145|NCT04088409|157280100|FG000|Part A|Did Not Meet Randomization Criteria|2|||
48847146|NCT04088409|157280101|FG001|Part A|Did Not Meet Randomization Criteria|0|||
48847147|NCT04088409|157280100|FG000|Part A|Lack of Efficacy|9|||
48847148|NCT04088409|157280101|FG001|Part A|Lack of Efficacy|0|||
48847149|NCT04088409|157280100|FG000|Part A|Lost to Follow-up|1|||
48847150|NCT04088409|157280101|FG001|Part A|Lost to Follow-up|0|||
48847151|NCT04088409|157280100|FG000|Part A|Adverse Event|1|||
48847152|NCT04088409|157280101|FG001|Part A|Adverse Event|0|||
48847153|NCT04088409|157280100|FG000|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|0|||
48847154|NCT04088409|157280101|FG001|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|4|||
48847155|NCT04088409|157280100|FG000|Part B|Ongoing Treatment|10|||
48847156|NCT04088409|157280101|FG001|Part B|Ongoing Treatment|0|||
48847157|NCT02063724|157280102|FG000|Overall Study|Disease progression|1|||
48847158|NCT02797184|157280105|FG000|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
48847159|NCT02797184|157280106|FG001|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
48847160|NCT00604669|157280107|FG000|Overall Study|lack of information in chart|7|||
48847161|NCT00603954|157280109|FG000|Overall Study|Protocol Violation|1|||
48847162|NCT00603954|157280110|FG001|Overall Study|Protocol Violation|2|||
48847163|NCT02376790|157280111|FG000|Overall Study|Withdrawal by Subject|43|||
48847164|NCT02376790|157280112|FG001|Overall Study|Withdrawal by Subject|36|||
48847165|NCT02376790|157280113|FG002|Overall Study|Withdrawal by Subject|37|||
48847166|NCT02376790|157280111|FG000|Overall Study|Decision by Sponsor|2|||
48847167|NCT02376790|157280112|FG001|Overall Study|Decision by Sponsor|1|||
48847168|NCT02376790|157280113|FG002|Overall Study|Decision by Sponsor|4|||
48847169|NCT02376790|157280111|FG000|Overall Study|Lost to Follow-up|15|||
48934737|NCT00716976|157589979|FG001|Overall Study|Physician Decision|2|||
48934738|NCT00716976|157589978|FG000|Overall Study|Withdrawal by Subject|5|||
48934739|NCT00716976|157589979|FG001|Overall Study|Withdrawal by Subject|1|||
48934740|NCT00716976|157589978|FG000|Overall Study|Premature discontinuation cisplatin|5|||
48934741|NCT00716976|157589979|FG001|Overall Study|Premature discontinuation cisplatin|4|||
48934742|NCT00716976|157589978|FG000|Overall Study|Radiation during protocol|1|||
48934743|NCT00716976|157589979|FG001|Overall Study|Radiation during protocol|0|||
48934744|NCT00716976|157589978|FG000|Overall Study|Ineligibles|4|||
48934745|NCT00716976|157589979|FG001|Overall Study|Ineligibles|2|||
48934746|NCT02804763|157589980|FG000|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1|||
48934747|NCT02804763|157589981|FG001|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
48934748|NCT02804763|157589982|FG002|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
48934749|NCT02804763|157589983|FG003|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
48934750|NCT02804763|157589980|FG000|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
48934751|NCT02804763|157589981|FG001|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
48934752|NCT02804763|157589982|FG002|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1|||
48934753|NCT02804763|157589983|FG003|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2|||
48934754|NCT02804763|157589980|FG000|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
48934755|NCT02804763|157589981|FG001|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1|||
48934756|NCT02804763|157589982|FG002|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
48934757|NCT02804763|157589983|FG003|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
48934758|NCT02804763|157589980|FG000|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2|||
48934759|NCT02804763|157589981|FG001|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0|||
48934760|NCT02804763|157589982|FG002|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
48934761|NCT02804763|157589983|FG003|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
48934762|NCT02804763|157589980|FG000|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4|||
48934763|NCT02804763|157589981|FG001|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0|||
48934764|NCT02804763|157589982|FG002|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
48934765|NCT02804763|157589983|FG003|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
48934766|NCT02804763|157589980|FG000|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
48934767|NCT02804763|157589981|FG001|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1|||
48934768|NCT02804763|157589982|FG002|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
48934769|NCT02804763|157589983|FG003|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
48934770|NCT01445535|157589994|FG000|Overall Study|Enrolled/taken off study, no drug avail.|0|||
48934771|NCT01445535|157589995|FG001|Overall Study|Enrolled/taken off study, no drug avail.|0|||
48934772|NCT01445535|157589996|FG002|Overall Study|Enrolled/taken off study, no drug avail.|0|||
48934773|NCT01445535|157589997|FG003|Overall Study|Enrolled/taken off study, no drug avail.|1|||
48934774|NCT01445535|157589994|FG000|Overall Study|Disease progression|1|||
48934775|NCT01445535|157589995|FG001|Overall Study|Disease progression|0|||
48934776|NCT01445535|157589996|FG002|Overall Study|Disease progression|1|||
48934777|NCT01445535|157589997|FG003|Overall Study|Disease progression|0|||
48934778|NCT01445535|157589994|FG000|Overall Study|PI discretion|0|||
48934779|NCT01445535|157589995|FG001|Overall Study|PI discretion|0|||
48934780|NCT01445535|157589996|FG002|Overall Study|PI discretion|0|||
48934781|NCT01445535|157589997|FG003|Overall Study|PI discretion|1|||
48934782|NCT00600171|157589998|FG000|Overall Study|Adverse Event|0|||
48934783|NCT00600171|157589999|FG001|Overall Study|Adverse Event|1|||
48934784|NCT00600171|157590000|FG002|Overall Study|Adverse Event|0|||
48934785|NCT00600171|157590001|FG003|Overall Study|Adverse Event|0|||
48934786|NCT00600171|157590002|FG004|Overall Study|Adverse Event|1|||
48934787|NCT00600171|157590003|FG005|Overall Study|Adverse Event|0|||
48934788|NCT00600171|157589998|FG000|Overall Study|Lack of Efficacy|9|||
48934789|NCT00600171|157589999|FG001|Overall Study|Lack of Efficacy|12|||
48934790|NCT00600171|157590000|FG002|Overall Study|Lack of Efficacy|3|||
48934791|NCT00600171|157590001|FG003|Overall Study|Lack of Efficacy|5|||
48934792|NCT00600171|157590002|FG004|Overall Study|Lack of Efficacy|4|||
48934793|NCT00600171|157590003|FG005|Overall Study|Lack of Efficacy|0|||
48934794|NCT00600171|157589998|FG000|Overall Study|Protocol Violation|1|||
48934795|NCT00600171|157589999|FG001|Overall Study|Protocol Violation|2|||
48934796|NCT00600171|157590000|FG002|Overall Study|Protocol Violation|0|||
48934797|NCT00600171|157590001|FG003|Overall Study|Protocol Violation|1|||
48934798|NCT00600171|157590002|FG004|Overall Study|Protocol Violation|0|||
48934799|NCT00600171|157590003|FG005|Overall Study|Protocol Violation|0|||
48934800|NCT00600171|157589998|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
48934801|NCT00600171|157589999|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
48934802|NCT00600171|157590000|FG002|Overall Study|Met Protocol-defined Stopping Criteria|7|||
48934803|NCT00600171|157590001|FG003|Overall Study|Met Protocol-defined Stopping Criteria|3|||
48934804|NCT00600171|157590002|FG004|Overall Study|Met Protocol-defined Stopping Criteria|2|||
48934805|NCT00600171|157590003|FG005|Overall Study|Met Protocol-defined Stopping Criteria|2|||
48934806|NCT00600171|157589998|FG000|Overall Study|Withdrawal by Subject|3|||
48934807|NCT00600171|157589999|FG001|Overall Study|Withdrawal by Subject|0|||
48934808|NCT00600171|157590000|FG002|Overall Study|Withdrawal by Subject|0|||
48934809|NCT00600171|157590001|FG003|Overall Study|Withdrawal by Subject|1|||
48934810|NCT00600171|157590002|FG004|Overall Study|Withdrawal by Subject|1|||
48934811|NCT00600171|157590003|FG005|Overall Study|Withdrawal by Subject|1|||
48934812|NCT00600171|157589998|FG000|Overall Study|Physician Decision|0|||
48934813|NCT00600171|157589999|FG001|Overall Study|Physician Decision|1|||
48934814|NCT00600171|157590000|FG002|Overall Study|Physician Decision|0|||
48934815|NCT00600171|157590001|FG003|Overall Study|Physician Decision|1|||
48934816|NCT00600171|157590002|FG004|Overall Study|Physician Decision|0|||
48934817|NCT00600171|157590003|FG005|Overall Study|Physician Decision|2|||
48934818|NCT00600171|157589998|FG000|Overall Study|Lost to Follow-up|0|||
48934819|NCT00600171|157589999|FG001|Overall Study|Lost to Follow-up|0|||
48934820|NCT00600171|157590000|FG002|Overall Study|Lost to Follow-up|0|||
48934821|NCT00600171|157590001|FG003|Overall Study|Lost to Follow-up|1|||
48934822|NCT00600171|157590002|FG004|Overall Study|Lost to Follow-up|0|||
48934823|NCT00600171|157590003|FG005|Overall Study|Lost to Follow-up|0|||
48934824|NCT02720757|157590004|FG000|Overall Study|Other reason|5|||
48934825|NCT02720757|157590004|FG000|Overall Study|Loss of contact|4|||
48934826|NCT02720757|157590004|FG000|Overall Study|Informed consent withdrawal|1|||
48934827|NCT02720757|157590004|FG000|Overall Study|Patients wish to withdraw|2|||
48934828|NCT02720757|157590004|FG000|Overall Study|Missing|3|||
48934829|NCT02720757|157590004|FG000|Overall Study|General exclusion|3|||
48934830|NCT04303000|157590005|FG000|Opioid Use Questionnaire|Withdrawal by Subject|15|||
48934831|NCT04303000|157590006|FG001|Opioid Use Questionnaire|Withdrawal by Subject|0|||
48934832|NCT04303000|157590007|FG002|Opioid Use Questionnaire|Withdrawal by Subject|0|||
48934833|NCT03433781|157590008|FG000|Overall Study|Progression of Disease|1|||
48934834|NCT03433781|157590009|FG001|Overall Study|Progression of Disease|0|||
48934835|NCT03433781|157590010|FG002|Overall Study|Progression of Disease|0|||
48934836|NCT03433781|157590008|FG000|Overall Study|Physician Decision|0|||
48934837|NCT03433781|157590009|FG001|Overall Study|Physician Decision|1|||
48934838|NCT03433781|157590010|FG002|Overall Study|Physician Decision|0|||
48934839|NCT01570244|157590011|FG000|Microgynon+Faldaprevir|Adverse Event|1|||
48934840|NCT04258579|157590014|FG000|Overall Study|Withdrawal by Subject|7|||
48934841|NCT04258579|157590014|FG000|Overall Study|Lost to Follow-up|3|||
48934842|NCT04258579|157590014|FG000|Overall Study|Protocol Violation|2|||
48934843|NCT04258579|157590014|FG000|Overall Study|Adverse Event|1|||
48934844|NCT01879410|157590017|FG000|Overall Study|Adverse Event|9|||
48934845|NCT01879410|157590018|FG001|Overall Study|Adverse Event|14|||
48934846|NCT01879410|157590017|FG000|Overall Study|Lack of Efficacy|4|||
48934847|NCT01879410|157590018|FG001|Overall Study|Lack of Efficacy|6|||
48934848|NCT01879410|157590017|FG000|Overall Study|Protocol Violation|1|||
48934849|NCT01879410|157590018|FG001|Overall Study|Protocol Violation|7|||
48934850|NCT01879410|157590017|FG000|Overall Study|Lost to Follow-up|2|||
48934851|NCT01879410|157590018|FG001|Overall Study|Lost to Follow-up|1|||
48934852|NCT01879410|157590017|FG000|Overall Study|Withdrawal by Subject|7|||
48934853|NCT01879410|157590018|FG001|Overall Study|Withdrawal by Subject|8|||
48934854|NCT01879410|157590017|FG000|Overall Study|Randomised in Error|1|||
48934855|NCT01879410|157590018|FG001|Overall Study|Randomised in Error|2|||
48934856|NCT01824979|157590020|FG000|Overall Study|Withdrawal by Subject|5|||
48934857|NCT01824979|157590021|FG001|Overall Study|Withdrawal by Subject|0|||
48934858|NCT01824979|157590020|FG000|Overall Study|Physician Decision|2|||
48934859|NCT01824979|157590021|FG001|Overall Study|Physician Decision|0|||
48934860|NCT01824979|157590020|FG000|Overall Study|Protocol Violation|6|||
48934861|NCT01824979|157590021|FG001|Overall Study|Protocol Violation|13|||
48934862|NCT00802360|157590024|FG000|Overall Study|Stimulation failure|4|||
48934863|NCT00802360|157590025|FG001|Overall Study|Stimulation failure|0|||
48934864|NCT00802360|157590026|FG002|Overall Study|Stimulation failure|3|||
48934865|NCT00802360|157590027|FG003|Overall Study|Stimulation failure|3|||
48934866|NCT00802360|157590024|FG000|Overall Study|Inadequate number of oocytes retrieved|0|||
48934867|NCT00802360|157590025|FG001|Overall Study|Inadequate number of oocytes retrieved|0|||
48934868|NCT00802360|157590026|FG002|Overall Study|Inadequate number of oocytes retrieved|0|||
48934869|NCT00802360|157590027|FG003|Overall Study|Inadequate number of oocytes retrieved|1|||
48934870|NCT00802360|157590024|FG000|Overall Study|Cycle cancelled|0|||
48934871|NCT00802360|157590025|FG001|Overall Study|Cycle cancelled|1|||
48934872|NCT00802360|157590026|FG002|Overall Study|Cycle cancelled|1|||
48934873|NCT00802360|157590027|FG003|Overall Study|Cycle cancelled|1|||
48934874|NCT00802360|157590024|FG000|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
48934875|NCT00802360|157590025|FG001|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
48934876|NCT00802360|157590026|FG002|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
48934877|NCT00802360|157590027|FG003|Overall Study|Risk of ovarian hyperstimulation syndrom|1|||
48934878|NCT00802360|157590024|FG000|Overall Study|No positive serum pregnancy|17|||
48934879|NCT00802360|157590025|FG001|Overall Study|No positive serum pregnancy|20|||
48934880|NCT00802360|157590026|FG002|Overall Study|No positive serum pregnancy|14|||
48934881|NCT00802360|157590027|FG003|Overall Study|No positive serum pregnancy|10|||
48934882|NCT00802360|157590024|FG000|Overall Study|Pregnancy not confirmed by ultrasound|1|||
48934883|NCT00802360|157590025|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
48934884|NCT00802360|157590026|FG002|Overall Study|Pregnancy not confirmed by ultrasound|1|||
48934885|NCT00802360|157590027|FG003|Overall Study|Pregnancy not confirmed by ultrasound|0|||
48934886|NCT00802360|157590024|FG000|Overall Study|Pregnancy loss/miscarriage|0|||
48934887|NCT00802360|157590025|FG001|Overall Study|Pregnancy loss/miscarriage|2|||
48934888|NCT00802360|157590026|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
48934889|NCT00802360|157590027|FG003|Overall Study|Pregnancy loss/miscarriage|3|||
48934890|NCT00802360|157590024|FG000|Overall Study|Other|2|||
48934891|NCT00802360|157590025|FG001|Overall Study|Other|3|||
48934892|NCT00802360|157590026|FG002|Overall Study|Other|6|||
48934893|NCT00802360|157590027|FG003|Overall Study|Other|3|||
48934894|NCT01573910|157590030|FG000|Overall Study|Adverse Event|4|||
48934895|NCT01573910|157590031|FG001|Overall Study|Adverse Event|4|||
48934896|NCT01573910|157590030|FG000|Overall Study|Lost to Follow-up|2|||
48934897|NCT01573910|157590031|FG001|Overall Study|Lost to Follow-up|1|||
48934898|NCT01573910|157590030|FG000|Overall Study|Withdrawal by Subject|0|||
48934899|NCT01573910|157590031|FG001|Overall Study|Withdrawal by Subject|1|||
48934900|NCT01573910|157590030|FG000|Overall Study|Protocol Violation|3|||
48934901|NCT01573910|157590031|FG001|Overall Study|Protocol Violation|0|||
48934902|NCT01573910|157590030|FG000|Overall Study|Patient decision unrelated to Advs Event|11|||
48934903|NCT01573910|157590031|FG001|Overall Study|Patient decision unrelated to Advs Event|11|||
48934904|NCT00473876|157590032|FG000|Overall Study|Lost to Follow-up|3|||
48934905|NCT00473876|157590033|FG001|Overall Study|Lost to Follow-up|1|||
48934906|NCT00974220|157590035|FG000|Treatment Period 1|Adverse Event|2|||
48934907|NCT00974220|157590036|FG001|Treatment Period 1|Adverse Event|1|||
48934908|NCT00974220|157590035|FG000|Treatment Period 1|noncompliant subjects|0|||
48934909|NCT00974220|157590036|FG001|Treatment Period 1|noncompliant subjects|1|||
48934910|NCT00712348|157590042|FG000|Overall Study|Withdrawal by Subject|1|||
48934911|NCT02411747|157590043|FG000|Overall Study|Withdrawal by Subject|1|||
48934912|NCT02411747|157590044|FG001|Overall Study|Withdrawal by Subject|0|||
48934913|NCT02411747|157590043|FG000|Overall Study|Protocol Violation|2|||
48934914|NCT02411747|157590044|FG001|Overall Study|Protocol Violation|4|||
48934915|NCT03158220|157590045|FG000|Overall Study|Screen Failure|0|||
48934916|NCT03158220|157590046|FG001|Overall Study|Screen Failure|1|||
48934917|NCT03158220|157590045|FG000|Overall Study|Withdrawal by Subject|8|||
48934918|NCT03158220|157590046|FG001|Overall Study|Withdrawal by Subject|9|||
48934919|NCT03158220|157590045|FG000|Overall Study|Status unknown|0|||
48934920|NCT03158220|157590046|FG001|Overall Study|Status unknown|1|||
48934921|NCT03158220|157590045|FG000|Overall Study|Lost to Follow-up|8|||
48934922|NCT03158220|157590046|FG001|Overall Study|Lost to Follow-up|5|||
48934923|NCT03158220|157590045|FG000|Overall Study|Physician Decision|1|||
48934924|NCT03158220|157590046|FG001|Overall Study|Physician Decision|0|||
48934925|NCT00054132|157590052|FG000|Overall Study|Not Treated|1|||
48934926|NCT02305563|157590053|FG000|Treatment Period|Disease progression|0|||
48934927|NCT02305563|157590054|FG001|Treatment Period|Disease progression|0|||
48934928|NCT02305563|157590055|FG002|Treatment Period|Disease progression|15|||
48934929|NCT02305563|157590056|FG003|Treatment Period|Disease progression|6|||
48934930|NCT02305563|157590057|FG004|Treatment Period|Disease progression|6|||
48934931|NCT02305563|157590053|FG000|Treatment Period|Study drug toxicity|0|||
48934932|NCT02305563|157590054|FG001|Treatment Period|Study drug toxicity|0|||
48934933|NCT02305563|157590055|FG002|Treatment Period|Study drug toxicity|0|||
48934934|NCT02305563|157590056|FG003|Treatment Period|Study drug toxicity|1|||
48934935|NCT02305563|157590057|FG004|Treatment Period|Study drug toxicity|2|||
48934936|NCT02305563|157590053|FG000|Treatment Period|Death|0|||
48934937|NCT02305563|157590054|FG001|Treatment Period|Death|0|||
48934938|NCT02305563|157590055|FG002|Treatment Period|Death|1|||
48934939|NCT02305563|157590056|FG003|Treatment Period|Death|2|||
48934940|NCT02305563|157590057|FG004|Treatment Period|Death|1|||
48934941|NCT02305563|157590053|FG000|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
48934942|NCT02305563|157590054|FG001|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
48934943|NCT02305563|157590055|FG002|Treatment Period|Adverse Event (AE) unrelated to drug|7|||
48934944|NCT02305563|157590056|FG003|Treatment Period|Adverse Event (AE) unrelated to drug|1|||
48934945|NCT02305563|157590057|FG004|Treatment Period|Adverse Event (AE) unrelated to drug|2|||
48934946|NCT02305563|157590053|FG000|Treatment Period|Participant request to stop therapy|0|||
48934947|NCT02305563|157590054|FG001|Treatment Period|Participant request to stop therapy|2|||
48934948|NCT02305563|157590055|FG002|Treatment Period|Participant request to stop therapy|0|||
48934949|NCT02305563|157590056|FG003|Treatment Period|Participant request to stop therapy|1|||
48934950|NCT02305563|157590057|FG004|Treatment Period|Participant request to stop therapy|0|||
48934951|NCT02305563|157590053|FG000|Treatment Period|Participant withdrew consent|0|||
48934952|NCT02305563|157590054|FG001|Treatment Period|Participant withdrew consent|0|||
48934953|NCT02305563|157590055|FG002|Treatment Period|Participant withdrew consent|1|||
48934954|NCT02305563|157590056|FG003|Treatment Period|Participant withdrew consent|1|||
48934955|NCT02305563|157590057|FG004|Treatment Period|Participant withdrew consent|1|||
48934956|NCT02305563|157590053|FG000|Treatment Period|Maximum clinical benefit|0|||
48934957|NCT02305563|157590054|FG001|Treatment Period|Maximum clinical benefit|0|||
48934958|NCT02305563|157590055|FG002|Treatment Period|Maximum clinical benefit|0|||
48934959|NCT02305563|157590056|FG003|Treatment Period|Maximum clinical benefit|0|||
48934960|NCT02305563|157590057|FG004|Treatment Period|Maximum clinical benefit|1|||
48934961|NCT02305563|157590053|FG000|Treatment Period|Poor/non-compliance|0|||
48934962|NCT02305563|157590054|FG001|Treatment Period|Poor/non-compliance|0|||
48934963|NCT02305563|157590055|FG002|Treatment Period|Poor/non-compliance|0|||
48934964|NCT02305563|157590056|FG003|Treatment Period|Poor/non-compliance|0|||
48934965|NCT02305563|157590057|FG004|Treatment Period|Poor/non-compliance|1|||
48934966|NCT02305563|157590053|FG000|Treatment Period|Administrative reason by Sponsor|0|||
48934967|NCT02305563|157590054|FG001|Treatment Period|Administrative reason by Sponsor|0|||
48934968|NCT02305563|157590055|FG002|Treatment Period|Administrative reason by Sponsor|0|||
48934969|NCT02305563|157590056|FG003|Treatment Period|Administrative reason by Sponsor|0|||
48934970|NCT02305563|157590057|FG004|Treatment Period|Administrative reason by Sponsor|1|||
48934971|NCT02305563|157590053|FG000|Treatment Period|other reason|2|||
48934972|NCT02305563|157590054|FG001|Treatment Period|other reason|0|||
48934973|NCT02305563|157590055|FG002|Treatment Period|other reason|2|||
48934974|NCT02305563|157590056|FG003|Treatment Period|other reason|2|||
48934975|NCT02305563|157590057|FG004|Treatment Period|other reason|1|||
48934976|NCT02305563|157590053|FG000|Treatment Period|Randomized but not treated|0|||
48934977|NCT02305563|157590054|FG001|Treatment Period|Randomized but not treated|0|||
48934978|NCT02305563|157590055|FG002|Treatment Period|Randomized but not treated|0|||
48934979|NCT02305563|157590056|FG003|Treatment Period|Randomized but not treated|0|||
48934980|NCT02305563|157590057|FG004|Treatment Period|Randomized but not treated|2|||
48934981|NCT02305563|157590053|FG000|Treatment Period|added ULO, then disease progression|0|||
48934982|NCT02305563|157590054|FG001|Treatment Period|added ULO, then disease progression|0|||
48934983|NCT02305563|157590055|FG002|Treatment Period|added ULO, then disease progression|0|||
48934984|NCT02305563|157590056|FG003|Treatment Period|added ULO, then disease progression|0|||
48934985|NCT02305563|157590057|FG004|Treatment Period|added ULO, then disease progression|4|||
48934986|NCT02305563|157590053|FG000|Treatment Period|added ULO; then other reason|0|||
48934987|NCT02305563|157590054|FG001|Treatment Period|added ULO; then other reason|0|||
48847170|NCT02376790|157280112|FG001|Overall Study|Lost to Follow-up|10|||
48847171|NCT02376790|157280113|FG002|Overall Study|Lost to Follow-up|12|||
48847172|NCT05147116|157280116|FG000|Overall Study|Withdrawal by Subject|0|||
48847173|NCT05147116|157280117|FG001|Overall Study|Withdrawal by Subject|1|||
48847174|NCT02827877|157280118|FG000|Overall Study|Withdrawal by Subject|1|||
48847175|NCT03756662|157280119|FG000|Overall Study|due to an SAE that was not related to the medical device or medical procedure.|1|||
48847176|NCT02974621|157280121|FG000|Overall Study|Didn't receive study treatment|1|||
48847177|NCT02974621|157280122|FG001|Overall Study|Didn't receive study treatment|10|||
48847178|NCT02705820|157280123|FG000|Overall Study|Death|2|||
48847179|NCT02705820|157280123|FG000|Overall Study|Disease Progression|34|||
48847180|NCT02705820|157280123|FG000|Overall Study|Clinical Deterioration|3|||
48847181|NCT03496662|157280124|FG000|Overall Study|Adverse Event|1|||
48847182|NCT03496662|157280125|FG001|Overall Study|Adverse Event|0|||
48847183|NCT03496662|157280126|FG002|Overall Study|Adverse Event|1|||
48847184|NCT03496662|157280124|FG000|Overall Study|Physician Decision|1|||
48847185|NCT03496662|157280125|FG001|Overall Study|Physician Decision|0|||
48847186|NCT03496662|157280126|FG002|Overall Study|Physician Decision|3|||
48847187|NCT03496662|157280124|FG000|Overall Study|Withdrawal by Subject|0|||
48847188|NCT03496662|157280125|FG001|Overall Study|Withdrawal by Subject|0|||
48847189|NCT03496662|157280126|FG002|Overall Study|Withdrawal by Subject|2|||
48847190|NCT03496662|157280124|FG000|Overall Study|Death|0|||
48847191|NCT03496662|157280125|FG001|Overall Study|Death|0|||
48847192|NCT03496662|157280126|FG002|Overall Study|Death|2|||
48847193|NCT03496662|157280124|FG000|Overall Study|Noncompliance|0|||
48847194|NCT03496662|157280125|FG001|Overall Study|Noncompliance|0|||
48847195|NCT03496662|157280126|FG002|Overall Study|Noncompliance|1|||
48847196|NCT00073749|157280130|FG000|Overall Study|Disease Progression|2|||
48847197|NCT00073749|157280131|FG001|Overall Study|Disease Progression|0|||
48847198|NCT00073749|157280132|FG002|Overall Study|Disease Progression|3|||
48847199|NCT00073749|157280133|FG003|Overall Study|Disease Progression|2|||
48847200|NCT00073749|157280134|FG004|Overall Study|Disease Progression|3|||
48847201|NCT00073749|157280135|FG005|Overall Study|Disease Progression|1|||
48847202|NCT00073749|157280136|FG006|Overall Study|Disease Progression|3|||
48847203|NCT00073749|157280130|FG000|Overall Study|Death|0|||
48847204|NCT00073749|157280131|FG001|Overall Study|Death|1|||
48847205|NCT00073749|157280132|FG002|Overall Study|Death|1|||
48847206|NCT00073749|157280133|FG003|Overall Study|Death|0|||
48847207|NCT00073749|157280134|FG004|Overall Study|Death|0|||
48847208|NCT00073749|157280135|FG005|Overall Study|Death|0|||
48934988|NCT02305563|157590055|FG002|Treatment Period|added ULO; then other reason|0|||
48934989|NCT02305563|157590056|FG003|Treatment Period|added ULO; then other reason|0|||
48934990|NCT02305563|157590057|FG004|Treatment Period|added ULO; then other reason|1|||
48934991|NCT02305563|157590053|FG000|Treatment Period|added ULO, then request to stop|0|||
48934992|NCT02305563|157590054|FG001|Treatment Period|added ULO, then request to stop|0|||
48934993|NCT02305563|157590055|FG002|Treatment Period|added ULO, then request to stop|0|||
48934994|NCT02305563|157590056|FG003|Treatment Period|added ULO, then request to stop|0|||
48934995|NCT02305563|157590057|FG004|Treatment Period|added ULO, then request to stop|1|||
48934996|NCT02305563|157590053|FG000|Follow-up Period|Death|0|||
48934997|NCT02305563|157590054|FG001|Follow-up Period|Death|0|||
48934998|NCT02305563|157590055|FG002|Follow-up Period|Death|5|||
48934999|NCT02305563|157590056|FG003|Follow-up Period|Death|4|||
48935000|NCT02305563|157590057|FG004|Follow-up Period|Death|7|||
48935001|NCT02305563|157590053|FG000|Follow-up Period|Participant withdrew consent|0|||
48935002|NCT02305563|157590054|FG001|Follow-up Period|Participant withdrew consent|0|||
48935003|NCT02305563|157590055|FG002|Follow-up Period|Participant withdrew consent|2|||
48935004|NCT02305563|157590056|FG003|Follow-up Period|Participant withdrew consent|1|||
48935005|NCT02305563|157590057|FG004|Follow-up Period|Participant withdrew consent|0|||
48935006|NCT02305563|157590053|FG000|Follow-up Period|other reason|0|||
48935007|NCT02305563|157590054|FG001|Follow-up Period|other reason|0|||
48935008|NCT02305563|157590055|FG002|Follow-up Period|other reason|0|||
48935009|NCT02305563|157590056|FG003|Follow-up Period|other reason|0|||
48935010|NCT02305563|157590057|FG004|Follow-up Period|other reason|1|||
48935011|NCT02305563|157590053|FG000|Follow-up Period|Followup no longer required per protocol|3|||
48935012|NCT02305563|157590054|FG001|Follow-up Period|Followup no longer required per protocol|3|||
48935013|NCT02305563|157590055|FG002|Follow-up Period|Followup no longer required per protocol|4|||
48935014|NCT02305563|157590056|FG003|Follow-up Period|Followup no longer required per protocol|1|||
48935015|NCT02305563|157590057|FG004|Follow-up Period|Followup no longer required per protocol|4|||
48935016|NCT01290887|157590058|FG000|Overall Study|Adverse Event|6|||
48935017|NCT01290887|157590059|FG001|Overall Study|Adverse Event|11|||
48935018|NCT01290887|157590058|FG000|Overall Study|Lack of Efficacy|4|||
48935019|NCT01290887|157590059|FG001|Overall Study|Lack of Efficacy|5|||
48935020|NCT01290887|157590058|FG000|Overall Study|Withdrawal by Subject|26|||
48935021|NCT01290887|157590059|FG001|Overall Study|Withdrawal by Subject|32|||
48935022|NCT01290887|157590058|FG000|Overall Study|Protocol Violation|2|||
48935023|NCT01290887|157590059|FG001|Overall Study|Protocol Violation|1|||
48935024|NCT01290887|157590058|FG000|Overall Study|Lost to Follow-up|4|||
48935025|NCT01290887|157590059|FG001|Overall Study|Lost to Follow-up|4|||
48935026|NCT01290887|157590058|FG000|Overall Study|Non-compliance to study procedures|0|||
48935027|NCT01290887|157590059|FG001|Overall Study|Non-compliance to study procedures|1|||
48935028|NCT01290887|157590058|FG000|Overall Study|Non-compliance to study medications|1|||
48935029|NCT01290887|157590059|FG001|Overall Study|Non-compliance to study medications|0|||
48935030|NCT01290887|157590058|FG000|Overall Study|Sponsor closure of study|420|||
48935031|NCT01290887|157590059|FG001|Overall Study|Sponsor closure of study|476|||
48935032|NCT01290887|157590058|FG000|Overall Study|Other|3|||
48935033|NCT01290887|157590059|FG001|Overall Study|Other|6|||
48935034|NCT04223609|157590067|FG000|Overall Study|Adverse Event|0|||
48935035|NCT04223609|157590068|FG001|Overall Study|Adverse Event|1|||
48847209|NCT00073749|157280136|FG006|Overall Study|Death|29|||
48847210|NCT00073749|157280130|FG000|Overall Study|Adverse Event|0|||
48847211|NCT00073749|157280131|FG001|Overall Study|Adverse Event|3|||
48847212|NCT00073749|157280132|FG002|Overall Study|Adverse Event|6|||
48847213|NCT00073749|157280133|FG003|Overall Study|Adverse Event|4|||
48847214|NCT00073749|157280134|FG004|Overall Study|Adverse Event|2|||
48847215|NCT00073749|157280135|FG005|Overall Study|Adverse Event|1|||
48847216|NCT00073749|157280136|FG006|Overall Study|Adverse Event|0|||
48847217|NCT00073749|157280130|FG000|Overall Study|Physician Decision|0|||
48847218|NCT00073749|157280131|FG001|Overall Study|Physician Decision|0|||
48935036|NCT04223609|157590067|FG000|Overall Study|Missed last visit|0|||
48935037|NCT04223609|157590068|FG001|Overall Study|Missed last visit|1|||
48935038|NCT01661790|157590069|FG000|Overall Study|Lost to Follow-up|0|||
48935039|NCT01661790|157590070|FG001|Overall Study|Lost to Follow-up|2|||
48935040|NCT02853760|157590071|FG000|Washout (1 Week)|acute illness (not connected with the study)|0|||
48935041|NCT02853760|157590072|FG001|Washout (1 Week)|acute illness (not connected with the study)|0|||
48935042|NCT02853760|157590073|FG002|Washout (1 Week)|acute illness (not connected with the study)|1|||
48935043|NCT02853760|157590074|FG003|Washout (1 Week)|acute illness (not connected with the study)|2|||
48935044|NCT02853760|157590075|FG004|Washout (1 Week)|acute illness (not connected with the study)|0|||
48935045|NCT02853760|157590076|FG005|Washout (1 Week)|acute illness (not connected with the study)|2|||
48935046|NCT01245673|157590077|FG000|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1|||
48935047|NCT01506882|157590086|FG000|Overall Study|Lack of Efficacy|4|||
48935048|NCT01506882|157590087|FG001|Overall Study|Lack of Efficacy|3|||
48935049|NCT01506882|157590086|FG000|Overall Study|Lost to Follow-up|1|||
48935050|NCT01506882|157590087|FG001|Overall Study|Lost to Follow-up|0|||
48935051|NCT01506882|157590086|FG000|Overall Study|Withdrawal by Subject|9|||
48935052|NCT01506882|157590087|FG001|Overall Study|Withdrawal by Subject|3|||
48935053|NCT01506882|157590086|FG000|Overall Study|SAE, non-fatal|2|||
48935054|NCT01506882|157590087|FG001|Overall Study|SAE, non-fatal|0|||
48935055|NCT01506882|157590086|FG000|Overall Study|AE, non-serious non-fatal|3|||
48935056|NCT01506882|157590087|FG001|Overall Study|AE, non-serious non-fatal|1|||
48935057|NCT01506882|157590086|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
48935058|NCT01506882|157590087|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
48935059|NCT01506882|157590086|FG000|Overall Study|Other Reason|2|||
48935060|NCT01506882|157590087|FG001|Overall Study|Other Reason|0|||
48935061|NCT02597062|157590088|FG000|Overall Study|Ineligible|1|||
48935062|NCT01929135|157590089|FG000|Overall Study|Lost to Follow-up|1|||
48935063|NCT01929135|157590090|FG001|Overall Study|Lost to Follow-up|1|||
48935064|NCT04698629|157590093|FG000|Overall Study|Adverse Event|1|||
48935065|NCT01237951|157590095|FG000|Overall Study|Death|1|||
48935066|NCT02970929|157590096|FG000|Overall Study|Adverse Event|18|||
48935067|NCT02970929|157590096|FG000|Overall Study|Lack of Efficacy|8|||
48935068|NCT02970929|157590096|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|1|||
48935069|NCT02970929|157590096|FG000|Overall Study|INVESTIGATOR CONSIDERS SUBJECT CLINICALLY UNSTABLE, NOT APPROPRIATE FOR DISCHARGE TO AN OUTPATIENT|1|||
48935070|NCT02970929|157590096|FG000|Overall Study|SPONSOR REQUEST THAT SUBJECT BE WITHDRAWN DUE TO POSITIVE DRUG RESULTS AND FOR THE SUBJECT'S SAFETY|1|||
48935071|NCT02970929|157590096|FG000|Overall Study|LOST TO FOLLOWUP|6|||
48935072|NCT02970929|157590096|FG000|Overall Study|MOVED OUT OF STATE|1|||
48935073|NCT02970929|157590096|FG000|Overall Study|Withdrawal by Subject|16|||
48935074|NCT02654002|157590101|FG000|Overall Study|Adverse Event|0|||
48935075|NCT02654002|157590102|FG001|Overall Study|Adverse Event|0|||
48935076|NCT02654002|157590103|FG002|Overall Study|Adverse Event|0|||
48935077|NCT02654002|157590104|FG003|Overall Study|Adverse Event|0|||
48935078|NCT02654002|157590105|FG004|Overall Study|Adverse Event|0|||
48935079|NCT02654002|157590106|FG005|Overall Study|Adverse Event|0|||
48935080|NCT02654002|157590107|FG006|Overall Study|Adverse Event|1|||
48935081|NCT02654002|157590108|FG007|Overall Study|Adverse Event|0|||
48935082|NCT02654002|157590109|FG008|Overall Study|Adverse Event|0|||
48935083|NCT02654002|157590101|FG000|Overall Study|Withdrew Consent|0|||
48935084|NCT02654002|157590102|FG001|Overall Study|Withdrew Consent|0|||
48935085|NCT02654002|157590103|FG002|Overall Study|Withdrew Consent|0|||
48935086|NCT02654002|157590104|FG003|Overall Study|Withdrew Consent|0|||
48935087|NCT02654002|157590105|FG004|Overall Study|Withdrew Consent|0|||
48935088|NCT02654002|157590106|FG005|Overall Study|Withdrew Consent|1|||
48935089|NCT02654002|157590107|FG006|Overall Study|Withdrew Consent|0|||
48935090|NCT02654002|157590108|FG007|Overall Study|Withdrew Consent|1|||
48935091|NCT02654002|157590109|FG008|Overall Study|Withdrew Consent|0|||
48935092|NCT00891202|157590110|FG000|PAP (Up To Week 39)|Withdrawal by Subject|1|||
48935093|NCT00891202|157590111|FG001|PAP (Up To Week 39)|Withdrawal by Subject|0|||
48935094|NCT00891202|157590112|FG002|PAP (Up To Week 39)|Withdrawal by Subject|0|||
48935095|NCT00891202|157590113|FG003|PAP (Up To Week 39)|Withdrawal by Subject|0|||
48935096|NCT00891202|157590110|FG000|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
48935097|NCT00891202|157590111|FG001|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
48935098|NCT00891202|157590112|FG002|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4|||
48935099|NCT00891202|157590113|FG003|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
48935100|NCT00891202|157590110|FG000|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
48935101|NCT00891202|157590111|FG001|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
48935102|NCT00891202|157590112|FG002|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1|||
48935103|NCT00891202|157590113|FG003|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
48935104|NCT00891202|157590110|FG000|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
48951866|NCT04760314|157654917|FG003|Maintenance Blinded Period|Withdrawal by Subject|1|||
48935105|NCT00891202|157590111|FG001|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
48935106|NCT00891202|157590112|FG002|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2|||
48935107|NCT00891202|157590113|FG003|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5|||
48935108|NCT04429022|157590115|FG000|Overall Study|Protocol Violation|18|||
48935109|NCT04429022|157590116|FG001|Overall Study|Protocol Violation|1|||
48935110|NCT00684177|157590121|FG000|Overall Study|Adverse Event|4|||
48935111|NCT00684177|157590122|FG001|Overall Study|Adverse Event|3|||
48935112|NCT00684177|157590121|FG000|Overall Study|Lack of Efficacy|10|||
48935113|NCT00684177|157590122|FG001|Overall Study|Lack of Efficacy|15|||
48935114|NCT00684177|157590121|FG000|Overall Study|Protocol Violation|1|||
48935115|NCT00684177|157590122|FG001|Overall Study|Protocol Violation|0|||
48935116|NCT00684177|157590121|FG000|Overall Study|Lost to Follow-up|2|||
48935117|NCT00684177|157590122|FG001|Overall Study|Lost to Follow-up|1|||
48935118|NCT00684177|157590121|FG000|Overall Study|Physician Decision|2|||
48935119|NCT00684177|157590122|FG001|Overall Study|Physician Decision|0|||
48935120|NCT00684177|157590121|FG000|Overall Study|Withdrawal by Subject|1|||
48935121|NCT00684177|157590122|FG001|Overall Study|Withdrawal by Subject|2|||
48935122|NCT00684177|157590121|FG000|Overall Study|Other|1|||
48935123|NCT00684177|157590122|FG001|Overall Study|Other|2|||
48935124|NCT01446809|157590123|FG000|Overall Study|Adverse Event|0|||
48935125|NCT01446809|157590124|FG001|Overall Study|Adverse Event|0|||
48935126|NCT01446809|157590125|FG002|Overall Study|Adverse Event|1|||
48935127|NCT01446809|157590123|FG000|Overall Study|Failure to complete study procedures|0|||
48935128|NCT01446809|157590124|FG001|Overall Study|Failure to complete study procedures|0|||
48935129|NCT01446809|157590125|FG002|Overall Study|Failure to complete study procedures|1|||
48935130|NCT02363478|157592529|FG000|Overall Study|Lost to Follow-up|4|||
48935131|NCT02363478|157592529|FG000|Overall Study|Adverse Event|4|||
48935132|NCT03521791|157592530|FG000|Overall Study|Protocol Violation|7|||
48935133|NCT03521791|157592531|FG001|Overall Study|Protocol Violation|17|||
48935134|NCT00680836|157592532|FG000|Overall Study|Withdrawal by Subject|3|||
48935135|NCT00680836|157592533|FG001|Overall Study|Withdrawal by Subject|0|||
48935136|NCT00680836|157592532|FG000|Overall Study|Lost to Follow-up|3|||
48935137|NCT00680836|157592533|FG001|Overall Study|Lost to Follow-up|1|||
48935138|NCT00680836|157592532|FG000|Overall Study|Physician Decision|2|||
48935139|NCT00680836|157592533|FG001|Overall Study|Physician Decision|1|||
48935140|NCT03160560|157592534|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
48935141|NCT03160560|157592535|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
48935142|NCT03160560|157592536|FG002|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
48935143|NCT03160560|157592537|FG003|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
48935144|NCT03160560|157592534|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
48935145|NCT03160560|157592535|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
48935146|NCT03160560|157592536|FG002|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
48935147|NCT03160560|157592537|FG003|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
48935148|NCT04187092|157592538|FG000|Overall Study|Lost to Follow-up|1|||
48935149|NCT04187092|157592539|FG001|Overall Study|Lost to Follow-up|1|||
48935150|NCT04187092|157592538|FG000|Overall Study|Withdrawal by Subject|1|||
48935151|NCT04187092|157592539|FG001|Overall Study|Withdrawal by Subject|1|||
48935152|NCT04187092|157592538|FG000|Overall Study|Adverse Event|0|||
48935153|NCT04187092|157592539|FG001|Overall Study|Adverse Event|1|||
48935154|NCT00167245|157592544|FG000|Overall Study|Lost to Follow-up|20|||
48935155|NCT00167245|157592545|FG001|Overall Study|Lost to Follow-up|31|||
48935156|NCT00167245|157592544|FG000|Overall Study|Withdrawal by Subject|5|||
48935157|NCT00167245|157592545|FG001|Overall Study|Withdrawal by Subject|8|||
48935158|NCT00167245|157592544|FG000|Overall Study|Incarcerated|3|||
48935159|NCT00167245|157592545|FG001|Overall Study|Incarcerated|2|||
48935160|NCT00167245|157592544|FG000|Overall Study|Drowsy|1|||
48935161|NCT00167245|157592545|FG001|Overall Study|Drowsy|0|||
48935162|NCT01341457|157592553|FG000|Overall Study|Adverse Event|2|||
48935163|NCT01341457|157592554|FG001|Overall Study|Adverse Event|0|||
48935164|NCT01254669|157592557|FG000|Overall Study|Withdrawal by Subject|0|||
48935165|NCT01254669|157592558|FG001|Overall Study|Withdrawal by Subject|1|||
48935166|NCT01254669|157592557|FG000|Overall Study|time constraint|2|||
48935167|NCT01254669|157592558|FG001|Overall Study|time constraint|2|||
48935168|NCT01254669|157592557|FG000|Overall Study|called to clinic during intervention|1|||
48935169|NCT01254669|157592558|FG001|Overall Study|called to clinic during intervention|1|||
48935170|NCT02367521|157592559|FG000|Overall Study|severe headache after intervention|2|||
48935171|NCT02367521|157592560|FG001|Overall Study|severe headache after intervention|0|||
48935172|NCT02367521|157592559|FG000|Overall Study|unable to find transportation|2|||
48935173|NCT02367521|157592560|FG001|Overall Study|unable to find transportation|0|||
48935174|NCT00103012|157592561|FG000|Overall Study|Withdrawal by Subject|2|||
48935175|NCT00103012|157592562|FG001|Overall Study|Withdrawal by Subject|1|||
48847219|NCT00073749|157280132|FG002|Overall Study|Physician Decision|1|||
48847220|NCT00073749|157280133|FG003|Overall Study|Physician Decision|0|||
48847221|NCT00073749|157280134|FG004|Overall Study|Physician Decision|0|||
48847222|NCT00073749|157280135|FG005|Overall Study|Physician Decision|2|||
48847223|NCT00073749|157280136|FG006|Overall Study|Physician Decision|0|||
48847224|NCT00073749|157280130|FG000|Overall Study|Withdrawal by Subject|0|||
48847225|NCT00073749|157280131|FG001|Overall Study|Withdrawal by Subject|1|||
48847226|NCT00073749|157280132|FG002|Overall Study|Withdrawal by Subject|0|||
48847227|NCT00073749|157280133|FG003|Overall Study|Withdrawal by Subject|0|||
48847228|NCT00073749|157280134|FG004|Overall Study|Withdrawal by Subject|1|||
48847229|NCT00073749|157280135|FG005|Overall Study|Withdrawal by Subject|0|||
48847230|NCT00073749|157280136|FG006|Overall Study|Withdrawal by Subject|2|||
48847231|NCT00073749|157280130|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
48847232|NCT00073749|157280131|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
48847233|NCT00073749|157280132|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
48847234|NCT00073749|157280133|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
48847235|NCT00073749|157280134|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
48847236|NCT00073749|157280135|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
48847237|NCT00073749|157280136|FG006|Overall Study|Discontinuation of Study by Sponsor|4|||
48847238|NCT00073749|157280130|FG000|Overall Study|Lost to Follow-up|0|||
48847239|NCT00073749|157280131|FG001|Overall Study|Lost to Follow-up|0|||
48847240|NCT00073749|157280132|FG002|Overall Study|Lost to Follow-up|0|||
48847241|NCT00073749|157280133|FG003|Overall Study|Lost to Follow-up|0|||
48847242|NCT00073749|157280134|FG004|Overall Study|Lost to Follow-up|0|||
48847243|NCT00073749|157280135|FG005|Overall Study|Lost to Follow-up|0|||
48847244|NCT00073749|157280136|FG006|Overall Study|Lost to Follow-up|2|||
48847245|NCT00073749|157280130|FG000|Overall Study|Other|0|||
48847246|NCT00073749|157280131|FG001|Overall Study|Other|0|||
48847247|NCT00073749|157280132|FG002|Overall Study|Other|0|||
48847248|NCT00073749|157280133|FG003|Overall Study|Other|0|||
48847249|NCT00073749|157280134|FG004|Overall Study|Other|0|||
48847250|NCT00073749|157280135|FG005|Overall Study|Other|2|||
48847251|NCT00073749|157280136|FG006|Overall Study|Other|0|||
48847252|NCT03785782|157280925|FG000|Overall Study|their lesions' were not suitable for the study criteria|2|||
48847253|NCT03785782|157280926|FG001|Overall Study|their lesions' were not suitable for the study criteria|0|||
48847254|NCT03785782|157280925|FG000|Overall Study|Withdrawal by Subject|1|||
48847255|NCT03785782|157280926|FG001|Overall Study|Withdrawal by Subject|1|||
48847256|NCT03785782|157280925|FG000|Overall Study|insufficient image quality.|3|||
48847257|NCT03785782|157280926|FG001|Overall Study|insufficient image quality.|0|||
48847258|NCT05075408|157280929|FG000|Overall Study|Withdrawal by Subject|5|||
48847259|NCT05075408|157280930|FG001|Overall Study|Withdrawal by Subject|3|||
48847260|NCT05075408|157280931|FG002|Overall Study|Withdrawal by Subject|4|||
48847261|NCT05075408|157280929|FG000|Overall Study|Adverse Event|5|||
48847262|NCT05075408|157280930|FG001|Overall Study|Adverse Event|7|||
48847263|NCT05075408|157280931|FG002|Overall Study|Adverse Event|8|||
48847264|NCT05075408|157280929|FG000|Overall Study|Protocol Violation|0|||
48847265|NCT05075408|157280930|FG001|Overall Study|Protocol Violation|1|||
48847266|NCT05075408|157280931|FG002|Overall Study|Protocol Violation|0|||
48847267|NCT05075408|157280929|FG000|Overall Study|Lost to Follow-up|2|||
48847268|NCT05075408|157280930|FG001|Overall Study|Lost to Follow-up|1|||
48847269|NCT05075408|157280931|FG002|Overall Study|Lost to Follow-up|1|||
48847270|NCT05075408|157280929|FG000|Overall Study|Physician Decision|1|||
48847271|NCT05075408|157280930|FG001|Overall Study|Physician Decision|0|||
48847272|NCT05075408|157280931|FG002|Overall Study|Physician Decision|0|||
48847273|NCT05075408|157280929|FG000|Overall Study|Other-unspecified|3|||
48847274|NCT05075408|157280930|FG001|Overall Study|Other-unspecified|2|||
48847275|NCT05075408|157280931|FG002|Overall Study|Other-unspecified|0|||
48847276|NCT03940703|157280932|FG000|Overall Study|Still under treatment|31|||
48847277|NCT03940703|157280933|FG001|Overall Study|Still under treatment|0|||
48847278|NCT03047928|157280934|FG000|Overall Study|Adverse Event|0|||
48847279|NCT03047928|157280935|FG001|Overall Study|Adverse Event|2|||
48847280|NCT03047928|157280936|FG002|Overall Study|Adverse Event|0|||
48847281|NCT03047928|157280934|FG000|Overall Study|Protocol Violation|0|||
48847282|NCT03047928|157280935|FG001|Overall Study|Protocol Violation|1|||
48847283|NCT03047928|157280936|FG002|Overall Study|Protocol Violation|0|||
48847284|NCT03047928|157280934|FG000|Overall Study|included in another protocol|0|||
48847285|NCT03047928|157280935|FG001|Overall Study|included in another protocol|1|||
48847286|NCT03047928|157280936|FG002|Overall Study|included in another protocol|0|||
48847287|NCT00650104|157280937|FG000|Overall Study|Adverse Event|17|||
48847288|NCT00650104|157280937|FG000|Overall Study|Death|2|||
48847289|NCT00650104|157280937|FG000|Overall Study|Withdrawal by Subject|11|||
48847290|NCT00650104|157280937|FG000|Overall Study|Physician Decision|7|||
48847291|NCT00650104|157280937|FG000|Overall Study|Lost to Follow-up|1|||
48847292|NCT00650104|157280937|FG000|Overall Study|Non-compliance|2|||
48847293|NCT00650104|157280937|FG000|Overall Study|Sponsor Terminated Dosing|1|||
48847294|NCT04512482|157280938|FG000|Second Intervention (1 Day)|Protocol Violation|2|||
48847295|NCT04512482|157280939|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
48847296|NCT01939899|157280940|FG000|Lead-in Dose Finding Phase|Death|0|||
48935176|NCT00103012|157592563|FG002|Overall Study|Withdrawal by Subject|2|||
48935177|NCT00103012|157592561|FG000|Overall Study|Pregnancy|1|||
48935178|NCT00103012|157592562|FG001|Overall Study|Pregnancy|0|||
48935179|NCT00103012|157592563|FG002|Overall Study|Pregnancy|0|||
48935180|NCT00103012|157592561|FG000|Overall Study|Adverse Event|0|||
48935181|NCT00103012|157592562|FG001|Overall Study|Adverse Event|0|||
48935182|NCT00103012|157592563|FG002|Overall Study|Adverse Event|1|||
48935183|NCT00103012|157592561|FG000|Overall Study|Subject non-compliant with medications|0|||
48935184|NCT00103012|157592562|FG001|Overall Study|Subject non-compliant with medications|0|||
48935185|NCT00103012|157592563|FG002|Overall Study|Subject non-compliant with medications|1|||
48935186|NCT00420511|157592564|FG000|Overall Study|Adverse Event|1|||
48935187|NCT00420511|157592565|FG001|Overall Study|Adverse Event|1|||
48935188|NCT00420511|157592564|FG000|Overall Study|Lost to Follow-up|1|||
48935189|NCT00420511|157592565|FG001|Overall Study|Lost to Follow-up|0|||
48935190|NCT03902080|157592566|FG000|Overall Study|Adverse Event|17|||
48935191|NCT03902080|157592567|FG001|Overall Study|Adverse Event|15|||
48935192|NCT03902080|157592566|FG000|Overall Study|Withdrawal by Subject|28|||
48935193|NCT03902080|157592567|FG001|Overall Study|Withdrawal by Subject|35|||
48935194|NCT03902080|157592566|FG000|Overall Study|Lost to Follow-up|6|||
48935195|NCT03902080|157592567|FG001|Overall Study|Lost to Follow-up|7|||
48935196|NCT03902080|157592566|FG000|Overall Study|Other|3|||
48935197|NCT03902080|157592567|FG001|Overall Study|Other|5|||
48935198|NCT03902080|157592566|FG000|Overall Study|Non compliance|4|||
48935199|NCT03902080|157592567|FG001|Overall Study|Non compliance|3|||
48935200|NCT03902080|157592566|FG000|Overall Study|Physician Decision|5|||
48935201|NCT03902080|157592567|FG001|Overall Study|Physician Decision|1|||
48847297|NCT01939899|157280941|FG001|Lead-in Dose Finding Phase|Death|3|||
48847298|NCT01939899|157280942|FG002|Lead-in Dose Finding Phase|Death|1|||
48935202|NCT03902080|157592566|FG000|Overall Study|Protocol Violation|3|||
48935203|NCT03902080|157592567|FG001|Overall Study|Protocol Violation|3|||
48935204|NCT03902080|157592566|FG000|Overall Study|Lack of Efficacy|1|||
48935205|NCT03902080|157592567|FG001|Overall Study|Lack of Efficacy|3|||
48935206|NCT03902080|157592566|FG000|Overall Study|Withdrawn prior to dosing|0|||
48935207|NCT03902080|157592567|FG001|Overall Study|Withdrawn prior to dosing|1|||
48847299|NCT01939899|157280943|FG003|Lead-in Dose Finding Phase|Death|0|||
48847300|NCT01939899|157280944|FG004|Lead-in Dose Finding Phase|Death|0|||
48847301|NCT01939899|157280940|FG000|Lead-in Dose Finding Phase|Disease Progression|2|||
48847302|NCT01939899|157280941|FG001|Lead-in Dose Finding Phase|Disease Progression|4|||
48847303|NCT01939899|157280942|FG002|Lead-in Dose Finding Phase|Disease Progression|3|||
48847304|NCT01939899|157280943|FG003|Lead-in Dose Finding Phase|Disease Progression|0|||
48935208|NCT03575104|157592568|FG000|Overall Study|Adverse Event|4|||
48935209|NCT03575104|157592569|FG001|Overall Study|Adverse Event|3|||
48935210|NCT03575104|157592570|FG002|Overall Study|Adverse Event|4|||
48847305|NCT01939899|157280944|FG004|Lead-in Dose Finding Phase|Disease Progression|0|||
48847306|NCT01939899|157280940|FG000|Lead-in Dose Finding Phase|Other|0|||
48847307|NCT01939899|157280941|FG001|Lead-in Dose Finding Phase|Other|0|||
48847308|NCT01939899|157280942|FG002|Lead-in Dose Finding Phase|Other|1|||
48847309|NCT01939899|157280943|FG003|Lead-in Dose Finding Phase|Other|0|||
48935211|NCT03575104|157592568|FG000|Overall Study|Withdrawal by Subject|13|||
48935212|NCT03575104|157592569|FG001|Overall Study|Withdrawal by Subject|16|||
48935213|NCT03575104|157592570|FG002|Overall Study|Withdrawal by Subject|11|||
48935214|NCT03575104|157592568|FG000|Overall Study|Other reasons|6|||
48935215|NCT03575104|157592569|FG001|Overall Study|Other reasons|8|||
48935216|NCT03575104|157592570|FG002|Overall Study|Other reasons|6|||
48935217|NCT03575104|157592568|FG000|Overall Study|Lost to Follow-up|1|||
48935218|NCT03575104|157592569|FG001|Overall Study|Lost to Follow-up|2|||
48935219|NCT03575104|157592570|FG002|Overall Study|Lost to Follow-up|1|||
48935220|NCT00463476|157592571|FG000|Overall Study|Withdrawal by Subject|1|||
48935221|NCT00463476|157592572|FG001|Overall Study|Withdrawal by Subject|2|||
48935222|NCT00463476|157592571|FG000|Overall Study|Lost to Follow-up|1|||
48935223|NCT00463476|157592572|FG001|Overall Study|Lost to Follow-up|1|||
48935224|NCT01505894|157592574|FG000|Overall Study|Adverse Event|1|||
48935225|NCT01505894|157592575|FG001|Overall Study|Adverse Event|0|||
48935226|NCT01505894|157592576|FG002|Overall Study|Adverse Event|0|||
48935227|NCT01505894|157592577|FG003|Overall Study|Adverse Event|0|||
48935228|NCT01505894|157592578|FG004|Overall Study|Adverse Event|0|||
48935229|NCT01505894|157592579|FG005|Overall Study|Adverse Event|0|||
48935230|NCT01505894|157592580|FG006|Overall Study|Adverse Event|0|||
48935231|NCT01505894|157592581|FG007|Overall Study|Adverse Event|0|||
48935232|NCT01505894|157592582|FG008|Overall Study|Adverse Event|0|||
48935233|NCT01505894|157592574|FG000|Overall Study|Other than specified|0|||
48935234|NCT01505894|157592575|FG001|Overall Study|Other than specified|0|||
48935235|NCT01505894|157592576|FG002|Overall Study|Other than specified|0|||
48935236|NCT01505894|157592577|FG003|Overall Study|Other than specified|0|||
48935237|NCT01505894|157592578|FG004|Overall Study|Other than specified|1|||
48935238|NCT01505894|157592579|FG005|Overall Study|Other than specified|0|||
48935239|NCT01505894|157592580|FG006|Overall Study|Other than specified|0|||
48935240|NCT01505894|157592581|FG007|Overall Study|Other than specified|0|||
48935241|NCT01505894|157592582|FG008|Overall Study|Other than specified|0|||
48935242|NCT03823391|157592583|FG000|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
48935243|NCT03823391|157592584|FG001|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
48935244|NCT03823391|157592583|FG000|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1|||
48935245|NCT03823391|157592584|FG001|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0|||
48935246|NCT02661594|157592585|FG000|Overall Study|Protocol Violation|1|||
48935247|NCT02661594|157592586|FG001|Overall Study|Protocol Violation|0|||
48935248|NCT02661594|157592587|FG002|Overall Study|Protocol Violation|1|||
48935249|NCT02661594|157592588|FG003|Overall Study|Protocol Violation|0|||
48935250|NCT00059202|157592589|FG000|Overall Study|Withdrawal by Subject|5|||
48935251|NCT00059202|157592590|FG001|Overall Study|Withdrawal by Subject|9|||
48935252|NCT00059202|157592589|FG000|Overall Study|Protocol Violation|1|||
48935253|NCT00059202|157592590|FG001|Overall Study|Protocol Violation|3|||
48935254|NCT00059202|157592589|FG000|Overall Study|drug toxicity|0|||
48935255|NCT00059202|157592590|FG001|Overall Study|drug toxicity|3|||
48935256|NCT00548548|157592591|FG000|Overall Study|Death|345|||
48935257|NCT00548548|157592592|FG001|Overall Study|Death|348|||
48935258|NCT00548548|157592591|FG000|Overall Study|Lost to Follow-up|17|||
48935259|NCT00548548|157592592|FG001|Overall Study|Lost to Follow-up|18|||
48935260|NCT01279057|157592593|FG000|Overall Study|Adverse Event|1|||
48935261|NCT01279057|157592594|FG001|Overall Study|Adverse Event|0|||
48935262|NCT01279057|157592595|FG002|Overall Study|Adverse Event|1|||
48935263|NCT01279057|157592593|FG000|Overall Study|Insufficient therapeutic response|0|||
48935264|NCT01279057|157592594|FG001|Overall Study|Insufficient therapeutic response|0|||
48935265|NCT01279057|157592595|FG002|Overall Study|Insufficient therapeutic response|1|||
48935266|NCT01279057|157592593|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
48935267|NCT01279057|157592594|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
48935268|NCT01279057|157592595|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
48935269|NCT01279057|157592593|FG000|Overall Study|Withdrew consent|2|||
48935270|NCT01279057|157592594|FG001|Overall Study|Withdrew consent|0|||
48935271|NCT01279057|157592595|FG002|Overall Study|Withdrew consent|1|||
48935272|NCT01279057|157592593|FG000|Overall Study|Pregnancy|0|||
48935273|NCT01279057|157592594|FG001|Overall Study|Pregnancy|1|||
48935274|NCT01279057|157592595|FG002|Overall Study|Pregnancy|0|||
48935275|NCT01279057|157592593|FG000|Overall Study|Other|3|||
48935276|NCT01279057|157592594|FG001|Overall Study|Other|3|||
48935277|NCT01279057|157592595|FG002|Overall Study|Other|0|||
48935278|NCT01940484|157592596|FG000|Overall Study|Withdrawal by Subject|3|||
48935279|NCT01940484|157592596|FG000|Overall Study|Underwent transplantation|4|||
48935280|NCT01940484|157592596|FG000|Overall Study|Death|2|||
48935281|NCT01940484|157592596|FG000|Overall Study|Adverse Event|1|||
48935282|NCT01485614|157592597|FG000|Randomization|Not Treated|1|||
48935283|NCT01485614|157592598|FG001|Randomization|Not Treated|0|||
48935284|NCT01485614|157592599|FG002|Randomization|Not Treated|0|||
48935285|NCT01485614|157592600|FG003|Randomization|Not Treated|0|||
48935286|NCT01485614|157592597|FG000|Weeks 0-20|Lost to Follow-up|2|||
48935287|NCT01485614|157592598|FG001|Weeks 0-20|Lost to Follow-up|0|||
48935288|NCT01485614|157592599|FG002|Weeks 0-20|Lost to Follow-up|0|||
48935289|NCT01485614|157592600|FG003|Weeks 0-20|Lost to Follow-up|0|||
48935290|NCT01485614|157592597|FG000|Weeks 0-20|Withdrawal by Parent/Guardian|5|||
48935291|NCT01485614|157592598|FG001|Weeks 0-20|Withdrawal by Parent/Guardian|2|||
48935292|NCT01485614|157592599|FG002|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
48935293|NCT01485614|157592600|FG003|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
48935294|NCT01485614|157592597|FG000|Weeks 0-20|Withdrawal by Subject|3|||
48935295|NCT01485614|157592598|FG001|Weeks 0-20|Withdrawal by Subject|2|||
48935296|NCT01485614|157592599|FG002|Weeks 0-20|Withdrawal by Subject|1|||
48935297|NCT01485614|157592600|FG003|Weeks 0-20|Withdrawal by Subject|0|||
48935298|NCT01485614|157592597|FG000|Weeks 20-54|Lost to Follow-up|4|||
48935299|NCT01485614|157592598|FG001|Weeks 20-54|Lost to Follow-up|3|||
48935300|NCT01485614|157592599|FG002|Weeks 20-54|Lost to Follow-up|1|||
48935301|NCT01485614|157592600|FG003|Weeks 20-54|Lost to Follow-up|0|||
48935302|NCT01485614|157592597|FG000|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
48935303|NCT01485614|157592598|FG001|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
48935304|NCT01485614|157592599|FG002|Weeks 20-54|Withdrawal by Parent/Guardian|1|||
48935305|NCT01485614|157592600|FG003|Weeks 20-54|Withdrawal by Parent/Guardian|0|||
48935306|NCT01485614|157592597|FG000|Weeks 20-54|Withdrawal by Subject|5|||
48935307|NCT01485614|157592598|FG001|Weeks 20-54|Withdrawal by Subject|3|||
48935308|NCT01485614|157592599|FG002|Weeks 20-54|Withdrawal by Subject|0|||
48935309|NCT01485614|157592600|FG003|Weeks 20-54|Withdrawal by Subject|0|||
48935310|NCT00191854|157592601|FG000|Overall Study|Death|26|||
48935311|NCT00191854|157592602|FG001|Overall Study|Death|23|||
48935312|NCT00191854|157592603|FG002|Overall Study|Death|29|||
48935313|NCT00191854|157592601|FG000|Overall Study|Lost to Follow-up|7|||
48935314|NCT00191854|157592602|FG001|Overall Study|Lost to Follow-up|5|||
48935315|NCT00191854|157592603|FG002|Overall Study|Lost to Follow-up|5|||
48935316|NCT00191854|157592601|FG000|Overall Study|Withdrawal by Subject|4|||
48935317|NCT00191854|157592602|FG001|Overall Study|Withdrawal by Subject|2|||
48935318|NCT00191854|157592603|FG002|Overall Study|Withdrawal by Subject|3|||
48935319|NCT00191854|157592601|FG000|Overall Study|Sponsor Decision|0|||
48935320|NCT00191854|157592602|FG001|Overall Study|Sponsor Decision|0|||
48935321|NCT00191854|157592603|FG002|Overall Study|Sponsor Decision|1|||
48935322|NCT00191854|157592601|FG000|Overall Study|Screen Failure|0|||
48935323|NCT00191854|157592602|FG001|Overall Study|Screen Failure|0|||
48935324|NCT00191854|157592603|FG002|Overall Study|Screen Failure|1|||
48935325|NCT00849017|157592604|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
48935326|NCT00849017|157592605|FG001|Treatment Period (156 Weeks)|Adverse Event|6|||
48935327|NCT00849017|157592606|FG002|Treatment Period (156 Weeks)|Adverse Event|15|||
48935328|NCT00849017|157592604|FG000|Treatment Period (156 Weeks)|Noncompliance|3|||
48935329|NCT00849017|157592605|FG001|Treatment Period (156 Weeks)|Noncompliance|3|||
48935330|NCT00849017|157592606|FG002|Treatment Period (156 Weeks)|Noncompliance|4|||
48935331|NCT00849017|157592604|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|10|||
48935332|NCT00849017|157592605|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|7|||
48935333|NCT00849017|157592606|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|8|||
48935334|NCT00849017|157592604|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|18|||
48935335|NCT00849017|157592605|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|14|||
48847310|NCT01939899|157280944|FG004|Lead-in Dose Finding Phase|Other|0|||
48935336|NCT00849017|157592606|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|11|||
48935337|NCT00849017|157592604|FG000|Treatment Period (156 Weeks)|Physician Decision|0|||
48935338|NCT00849017|157592605|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
48847311|NCT01939899|157280940|FG000|Phase 2|Withdrawal by Subject|0|||
48847312|NCT01939899|157280941|FG001|Phase 2|Withdrawal by Subject|0|||
48847313|NCT01939899|157280942|FG002|Phase 2|Withdrawal by Subject|0|||
48847314|NCT01939899|157280943|FG003|Phase 2|Withdrawal by Subject|2|||
48935339|NCT00849017|157592606|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
48935340|NCT00849017|157592604|FG000|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3|||
48935341|NCT00849017|157592605|FG001|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
48935342|NCT00849017|157592606|FG002|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
48935343|NCT00849017|157592604|FG000|Treatment Period (156 Weeks)|Increased Calcitonin|1|||
48935344|NCT00849017|157592605|FG001|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
48935345|NCT00849017|157592606|FG002|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
48935346|NCT00849017|157592604|FG000|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1|||
48935347|NCT00849017|157592605|FG001|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
48935348|NCT00849017|157592606|FG002|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
48935349|NCT00849017|157592604|FG000|Treatment Period (156 Weeks)|Participant Moved to Africa|1|||
48935350|NCT00849017|157592605|FG001|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
48935351|NCT00849017|157592606|FG002|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
48935352|NCT00849017|157592604|FG000|Treatment Period (156 Weeks)|Pregnancy|1|||
48935353|NCT00849017|157592605|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
48935354|NCT00849017|157592606|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
48935355|NCT00849017|157592604|FG000|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
48935356|NCT00849017|157592605|FG001|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
48935357|NCT00849017|157592606|FG002|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1|||
48935358|NCT00849017|157592604|FG000|Follow-up Period (8 Weeks)|Adverse Event|1|||
48935359|NCT00849017|157592605|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
48935360|NCT00849017|157592606|FG002|Follow-up Period (8 Weeks)|Adverse Event|0|||
48935361|NCT00849017|157592604|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
48935362|NCT00849017|157592605|FG001|Follow-up Period (8 Weeks)|Noncompliance|1|||
48935363|NCT00849017|157592606|FG002|Follow-up Period (8 Weeks)|Noncompliance|0|||
48935364|NCT00849017|157592604|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|13|||
48935365|NCT00849017|157592605|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
48935366|NCT00849017|157592606|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|16|||
48935367|NCT00849017|157592604|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
48935368|NCT00849017|157592605|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
48935369|NCT00849017|157592606|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4|||
48935370|NCT00849017|157592604|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
48935371|NCT00849017|157592605|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
48847315|NCT01939899|157280944|FG004|Phase 2|Withdrawal by Subject|0|||
48847316|NCT01939899|157280940|FG000|Phase 2|Disease Progression|0|||
48935372|NCT00849017|157592606|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
48935373|NCT00849017|157592604|FG000|Follow-up Period (8 Weeks)|Physician Decision|0|||
48935374|NCT00849017|157592605|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
48935375|NCT00849017|157592606|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
48935376|NCT00849017|157592604|FG000|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3|||
48935377|NCT00849017|157592605|FG001|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
48847317|NCT01939899|157280941|FG001|Phase 2|Disease Progression|0|||
48847318|NCT01939899|157280942|FG002|Phase 2|Disease Progression|0|||
48847319|NCT01939899|157280943|FG003|Phase 2|Disease Progression|9|||
48847320|NCT01939899|157280944|FG004|Phase 2|Disease Progression|1|||
48847321|NCT00931710|157280947|FG000|Overall Study|Adverse Event|16|||
48847322|NCT00931710|157280948|FG001|Overall Study|Adverse Event|10|||
48847323|NCT00931710|157280947|FG000|Overall Study|Abnormal test procedure results|2|||
48935378|NCT00849017|157592606|FG002|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
48935379|NCT00849017|157592604|FG000|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1|||
48935380|NCT00849017|157592605|FG001|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
48935381|NCT00849017|157592606|FG002|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
48935382|NCT03502187|157592607|FG000|Overall Study|Withdrawal by Subject|4|||
48935383|NCT03502187|157592608|FG001|Overall Study|Withdrawal by Subject|3|||
48935384|NCT03502187|157592609|FG002|Overall Study|Withdrawal by Subject|3|||
48935385|NCT03502187|157592607|FG000|Overall Study|Lost to Follow-up|5|||
48935386|NCT03502187|157592608|FG001|Overall Study|Lost to Follow-up|4|||
48935387|NCT03502187|157592609|FG002|Overall Study|Lost to Follow-up|5|||
48935388|NCT02658448|157592610|FG000|Overall Study|Lost to Follow-up|1|||
48935389|NCT01323478|157592611|FG000|Overall Study|Adverse Event|7|||
48935390|NCT01323478|157592611|FG000|Overall Study|Lack of Efficacy|4|||
48935391|NCT01323478|157592611|FG000|Overall Study|Non-compliance With Study Product|3|||
48935392|NCT01323478|157592611|FG000|Overall Study|Protocol Violation|1|||
48935393|NCT01323478|157592611|FG000|Overall Study|Withdrawal of Consent|1|||
48935394|NCT01323478|157592611|FG000|Overall Study|Administrative or Other Reasons|8|||
48935395|NCT03370770|157592618|FG000|Overall Study|Patient was followed in another hospital center|1|||
48935396|NCT03370770|157592618|FG000|Overall Study|Progressive Disease|98|||
48935397|NCT03370770|157592618|FG000|Overall Study|Adverse Event|2|||
48935398|NCT03370770|157592618|FG000|Overall Study|Death|5|||
48935399|NCT00234039|157592622|FG000|Overall Study|Adverse Event|2|||
48935400|NCT00234039|157592622|FG000|Overall Study|Progression/relapse|34|||
48935401|NCT00234039|157592622|FG000|Overall Study|Other - Not Protocol Specified|3|||
48935402|NCT00234039|157592622|FG000|Overall Study|Ineligible|9|||
48935403|NCT00234039|157592622|FG000|Overall Study|No Protocol Treatment Received|2|||
48935404|NCT03072160|157592625|FG000|Overall Study|Adverse Event|3|||
48935405|NCT03072160|157592626|FG001|Overall Study|Adverse Event|1|||
48935406|NCT03072160|157592625|FG000|Overall Study|Refused further treatment|6|||
48935407|NCT03072160|157592626|FG001|Overall Study|Refused further treatment|1|||
48935408|NCT03072160|157592625|FG000|Overall Study|Physician Decision|1|||
48935409|NCT03072160|157592626|FG001|Overall Study|Physician Decision|0|||
48935410|NCT03072160|157592625|FG000|Overall Study|Disease progression on study|1|||
48935411|NCT03072160|157592626|FG001|Overall Study|Disease progression on study|1|||
48935412|NCT03072160|157592625|FG000|Overall Study|No contact|0|||
48935413|NCT03072160|157592626|FG001|Overall Study|No contact|1|||
48935414|NCT02688647|157592627|FG000|Initial Treatment Period (24 Weeks)|Death|0|||
48935415|NCT02688647|157592628|FG001|Initial Treatment Period (24 Weeks)|Death|1|||
48935416|NCT02688647|157592627|FG000|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|0|||
48935417|NCT02688647|157592628|FG001|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|5|||
48935418|NCT02688647|157592627|FG000|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|1|||
48935419|NCT02688647|157592628|FG001|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|0|||
48935420|NCT02688647|157592627|FG000|Post Switch Treatment Period (72 Weeks)|Death|7|||
48935421|NCT02688647|157592628|FG001|Post Switch Treatment Period (72 Weeks)|Death|2|||
48935422|NCT02688647|157592627|FG000|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|1|||
48935423|NCT02688647|157592628|FG001|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|0|||
48935424|NCT02688647|157592627|FG000|Post Switch Treatment Period (72 Weeks)|Other|10|||
48935425|NCT02688647|157592628|FG001|Post Switch Treatment Period (72 Weeks)|Other|6|||
48935426|NCT02688647|157592627|FG000|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|10|||
48935427|NCT02688647|157592628|FG001|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|6|||
48935428|NCT03118947|157592629|FG000|Overall Study|Adverse Event|7|||
48935429|NCT03118947|157592629|FG000|Overall Study|Death|3|||
48935430|NCT03118947|157592629|FG000|Overall Study|Lack of Efficacy|4|||
48935431|NCT03118947|157592629|FG000|Overall Study|Non-compliance with study drug|1|||
48935432|NCT03118947|157592629|FG000|Overall Study|Protocol Violation|2|||
48935433|NCT03118947|157592629|FG000|Overall Study|Withdrawal by Subject|3|||
48935434|NCT03118947|157592629|FG000|Overall Study|Withdrawal by caregiver|3|||
48935435|NCT03118947|157592629|FG000|Overall Study|Change in patient's living situation|4|||
48935436|NCT03118947|157592629|FG000|Overall Study|Lost to Follow-up|2|||
48935437|NCT00675025|157592632|FG000|Overall Study|Study Terminated by Sponsor|38|||
48935438|NCT00675025|157592633|FG001|Overall Study|Study Terminated by Sponsor|42|||
48935439|NCT00675025|157592632|FG000|Overall Study|Adverse Event|6|||
48935440|NCT00675025|157592633|FG001|Overall Study|Adverse Event|11|||
48935441|NCT00675025|157592632|FG000|Overall Study|Lost to Follow-up|6|||
48935442|NCT00675025|157592633|FG001|Overall Study|Lost to Follow-up|4|||
48935443|NCT00675025|157592632|FG000|Overall Study|Withdrawal by Subject|4|||
48935444|NCT00675025|157592633|FG001|Overall Study|Withdrawal by Subject|6|||
48935445|NCT02487108|157592637|FG000|Overall Study|Adverse Event|1|||
48935446|NCT02487108|157592638|FG001|Overall Study|Adverse Event|6|||
48935447|NCT02487108|157592639|FG002|Overall Study|Adverse Event|12|||
48935448|NCT02487108|157592640|FG003|Overall Study|Adverse Event|6|||
48935449|NCT02487108|157592637|FG000|Overall Study|Withdrawal by Subject|8|||
48935450|NCT02487108|157592638|FG001|Overall Study|Withdrawal by Subject|5|||
48935451|NCT02487108|157592639|FG002|Overall Study|Withdrawal by Subject|5|||
48935452|NCT02487108|157592640|FG003|Overall Study|Withdrawal by Subject|0|||
48935453|NCT02487108|157592637|FG000|Overall Study|Non-compliance to study medication|3|||
48935454|NCT02487108|157592638|FG001|Overall Study|Non-compliance to study medication|2|||
48935455|NCT02487108|157592639|FG002|Overall Study|Non-compliance to study medication|5|||
48935456|NCT02487108|157592640|FG003|Overall Study|Non-compliance to study medication|4|||
48935457|NCT02487108|157592637|FG000|Overall Study|Protocol Violation|1|||
48935458|NCT02487108|157592638|FG001|Overall Study|Protocol Violation|1|||
48935459|NCT02487108|157592639|FG002|Overall Study|Protocol Violation|2|||
48935460|NCT02487108|157592640|FG003|Overall Study|Protocol Violation|0|||
48935461|NCT02487108|157592637|FG000|Overall Study|Non-compliance to study procedures|0|||
48935462|NCT02487108|157592638|FG001|Overall Study|Non-compliance to study procedures|0|||
48935463|NCT02487108|157592639|FG002|Overall Study|Non-compliance to study procedures|0|||
48935464|NCT02487108|157592640|FG003|Overall Study|Non-compliance to study procedures|1|||
48935465|NCT02487108|157592637|FG000|Overall Study|Other than specified|3|||
48935466|NCT02487108|157592638|FG001|Overall Study|Other than specified|2|||
48847324|NCT00931710|157280948|FG001|Overall Study|Abnormal test procedure results|0|||
48847325|NCT00931710|157280947|FG000|Overall Study|Unsatisfactory therapeutic effects|5|||
48847326|NCT00931710|157280948|FG001|Overall Study|Unsatisfactory therapeutic effects|12|||
48847327|NCT00931710|157280947|FG000|Overall Study|Patient withdrew consent|4|||
48847328|NCT00931710|157280948|FG001|Overall Study|Patient withdrew consent|9|||
48935467|NCT02487108|157592639|FG002|Overall Study|Other than specified|2|||
48935468|NCT02487108|157592640|FG003|Overall Study|Other than specified|0|||
48935469|NCT01596257|157592641|FG000|Overall Study|Inadequate Collection|23|||
48935470|NCT01596257|157592642|FG001|Overall Study|Inadequate Collection|19|||
48847329|NCT00931710|157280947|FG000|Overall Study|Lost to Follow-up|6|||
48847330|NCT00931710|157280948|FG001|Overall Study|Lost to Follow-up|5|||
48847331|NCT00931710|157280947|FG000|Overall Study|Protocol deviation|1|||
48847332|NCT00931710|157280948|FG001|Overall Study|Protocol deviation|2|||
48847333|NCT05371652|157280957|FG000|Overall Study|Non-Compliance with Study Schedule|9|||
48847334|NCT05371652|157280957|FG000|Overall Study|Withdrawal by Subject|12|||
48847335|NCT05371652|157280957|FG000|Overall Study|Adverse Event|1|||
48935471|NCT02772757|157592643|FG000|Overall Study|Withdrawal by Subject|1|||
48935472|NCT02772757|157592644|FG001|Overall Study|Withdrawal by Subject|0|||
48935473|NCT02772757|157592645|FG002|Overall Study|Withdrawal by Subject|1|||
48935474|NCT02772757|157592643|FG000|Overall Study|Protocol Violation|0|||
48935475|NCT02772757|157592644|FG001|Overall Study|Protocol Violation|0|||
48935476|NCT02772757|157592645|FG002|Overall Study|Protocol Violation|1|||
48935477|NCT02772757|157592643|FG000|Overall Study|Physician Decision|0|||
48935478|NCT02772757|157592644|FG001|Overall Study|Physician Decision|3|||
48935479|NCT02772757|157592645|FG002|Overall Study|Physician Decision|3|||
48935480|NCT03157531|157592650|FG000|Overall Study|Death|2|||
48935481|NCT03157531|157592650|FG000|Overall Study|Lost to Follow-up|4|||
48935482|NCT01756274|157592651|FG000|Overall Study|Protocol Violation|2|||
48935483|NCT01756274|157592651|FG000|Overall Study|Laboratory error|1|||
48935484|NCT01147926|157592652|FG000|Overall Study|Subject Withdrew Consent|9|||
48935485|NCT01147926|157592653|FG001|Overall Study|Subject Withdrew Consent|10|||
48847336|NCT05371652|157280957|FG000|Overall Study|Other|11|||
48935486|NCT01147926|157592652|FG000|Overall Study|Adverse Event|7|||
48935487|NCT01147926|157592653|FG001|Overall Study|Adverse Event|6|||
48935488|NCT01147926|157592652|FG000|Overall Study|Subject Non-Compliant|5|||
48935489|NCT01147926|157592653|FG001|Overall Study|Subject Non-Compliant|4|||
48935490|NCT01147926|157592652|FG000|Overall Study|Principal investigator left hospital|1|||
48935491|NCT01147926|157592653|FG001|Overall Study|Principal investigator left hospital|3|||
48847337|NCT04098068|157280961|FG000|Overall Study|Disease Progression|7|||
48847338|NCT04098068|157280961|FG000|Overall Study|Withdrawal by Subject|2|||
48935492|NCT01147926|157592652|FG000|Overall Study|Selection criteria not met|3|||
48935493|NCT01147926|157592653|FG001|Overall Study|Selection criteria not met|1|||
48935494|NCT01147926|157592652|FG000|Overall Study|Lost to Follow-up|0|||
48935495|NCT01147926|157592653|FG001|Overall Study|Lost to Follow-up|2|||
48935496|NCT01147926|157592652|FG000|Overall Study|Sponsor's Decision|0|||
48935497|NCT01147926|157592653|FG001|Overall Study|Sponsor's Decision|1|||
48935498|NCT01147926|157592652|FG000|Overall Study|Lack of Efficacy|1|||
48935499|NCT01147926|157592653|FG001|Overall Study|Lack of Efficacy|0|||
48935500|NCT01147926|157592652|FG000|Overall Study|Too busy, no time for study|1|||
48935501|NCT01147926|157592653|FG001|Overall Study|Too busy, no time for study|0|||
48935502|NCT01147926|157592652|FG000|Overall Study|Went on holiday|0|||
48935503|NCT01147926|157592653|FG001|Overall Study|Went on holiday|1|||
48935504|NCT01147926|157592652|FG000|Overall Study|Colonoscopy result|0|||
48935505|NCT01147926|157592653|FG001|Overall Study|Colonoscopy result|1|||
48935506|NCT01727258|157592654|FG000|Overall Study|Adverse Event|0|||
48935507|NCT01727258|157592655|FG001|Overall Study|Adverse Event|2|||
48935508|NCT01727258|157592656|FG002|Overall Study|Adverse Event|0|||
48935509|NCT01727258|157592654|FG000|Overall Study|Noncompliance with Study Drug|0|||
48935510|NCT01727258|157592655|FG001|Overall Study|Noncompliance with Study Drug|0|||
48935511|NCT01727258|157592656|FG002|Overall Study|Noncompliance with Study Drug|1|||
48935512|NCT01727258|157592654|FG000|Overall Study|Withdrawal by Subject|1|||
48935513|NCT01727258|157592655|FG001|Overall Study|Withdrawal by Subject|1|||
48935514|NCT01727258|157592656|FG002|Overall Study|Withdrawal by Subject|0|||
48935515|NCT01727258|157592654|FG000|Overall Study|Lost to Follow-up|1|||
48935516|NCT01727258|157592655|FG001|Overall Study|Lost to Follow-up|0|||
48935517|NCT01727258|157592656|FG002|Overall Study|Lost to Follow-up|0|||
48935518|NCT01818726|157592661|FG000|Overall Study|Administrative reasons|5|||
48935519|NCT01818726|157592662|FG001|Overall Study|Administrative reasons|1|||
48935520|NCT01818726|157592661|FG000|Overall Study|Withdrawal by Subject|0|||
48935521|NCT01818726|157592662|FG001|Overall Study|Withdrawal by Subject|1|||
48935522|NCT01818726|157592661|FG000|Overall Study|Decision to perform 2nd course of trtmnt|1|||
48935523|NCT01818726|157592662|FG001|Overall Study|Decision to perform 2nd course of trtmnt|0|||
48935524|NCT01763164|157592669|FG000|Treatment Phase|Participant/Guardian decision|26|||
48847339|NCT04098068|157280961|FG000|Overall Study|New Cancer Diagnosis|1|||
48847340|NCT04770532|157280962|FG000|Overall Study|Withdrawal by Subject|0|||
48847341|NCT04770532|157280963|FG001|Overall Study|Withdrawal by Subject|3|||
48847342|NCT04770532|157280962|FG000|Overall Study|Physician Decision|1|||
48847343|NCT04770532|157280963|FG001|Overall Study|Physician Decision|0|||
48847344|NCT04770532|157280962|FG000|Overall Study|Death|2|||
48847345|NCT04770532|157280963|FG001|Overall Study|Death|2|||
48847346|NCT04623671|157280965|FG000|Overall Study|Adverse Event|0|||
48847347|NCT04623671|157280966|FG001|Overall Study|Adverse Event|1|||
48847348|NCT04623671|157280965|FG000|Overall Study|Lost to Follow-up|2|||
48847349|NCT04623671|157280966|FG001|Overall Study|Lost to Follow-up|1|||
48847350|NCT04623671|157280965|FG000|Overall Study|Death|5|||
48847351|NCT04623671|157280966|FG001|Overall Study|Death|5|||
48847352|NCT02519348|157280967|FG000|Overall Study|Death|31|||
48847353|NCT02519348|157280968|FG001|Overall Study|Death|74|||
48847354|NCT02519348|157280969|FG002|Overall Study|Death|47|||
48847355|NCT02519348|157280970|FG003|Overall Study|Death|54|||
48847356|NCT02519348|157280971|FG004|Overall Study|Death|63|||
48847357|NCT02519348|157280972|FG005|Overall Study|Death|18|||
48847358|NCT02519348|157280973|FG006|Overall Study|Death|2|||
48847359|NCT02519348|157280974|FG007|Overall Study|Death|5|||
48847360|NCT02519348|157280975|FG008|Overall Study|Death|5|||
48847361|NCT02519348|157280967|FG000|Overall Study|Withdrawal by Subject|4|||
48847362|NCT02519348|157280968|FG001|Overall Study|Withdrawal by Subject|7|||
48847363|NCT02519348|157280969|FG002|Overall Study|Withdrawal by Subject|4|||
48847364|NCT02519348|157280970|FG003|Overall Study|Withdrawal by Subject|3|||
48847365|NCT02519348|157280971|FG004|Overall Study|Withdrawal by Subject|3|||
48847366|NCT02519348|157280972|FG005|Overall Study|Withdrawal by Subject|2|||
48847367|NCT02519348|157280973|FG006|Overall Study|Withdrawal by Subject|0|||
48847368|NCT02519348|157280974|FG007|Overall Study|Withdrawal by Subject|0|||
48847369|NCT02519348|157280975|FG008|Overall Study|Withdrawal by Subject|1|||
48847370|NCT02519348|157280967|FG000|Overall Study|Lost to Follow-up|0|||
48847371|NCT02519348|157280968|FG001|Overall Study|Lost to Follow-up|0|||
48847372|NCT02519348|157280969|FG002|Overall Study|Lost to Follow-up|1|||
48847373|NCT02519348|157280970|FG003|Overall Study|Lost to Follow-up|0|||
48847374|NCT02519348|157280971|FG004|Overall Study|Lost to Follow-up|2|||
48935525|NCT01763164|157592670|FG001|Treatment Phase|Participant/Guardian decision|14|||
48935526|NCT01763164|157592669|FG000|Treatment Phase|Protocol Violation|1|||
48935527|NCT01763164|157592670|FG001|Treatment Phase|Protocol Violation|1|||
48935528|NCT01763164|157592669|FG000|Treatment Phase|Progressive Disease|142|||
48935529|NCT01763164|157592670|FG001|Treatment Phase|Progressive Disease|76|||
48935530|NCT01763164|157592669|FG000|Treatment Phase|Physician Decision|24|||
48935531|NCT01763164|157592670|FG001|Treatment Phase|Physician Decision|13|||
48935532|NCT01763164|157592669|FG000|Treatment Phase|Death|10|||
48935533|NCT01763164|157592670|FG001|Treatment Phase|Death|1|||
48935534|NCT01763164|157592669|FG000|Treatment Phase|Adverse Event|66|||
48935535|NCT01763164|157592670|FG001|Treatment Phase|Adverse Event|8|||
48935536|NCT01763164|157592669|FG000|Treatment Phase|Randomized but not Treated|0|||
48935537|NCT01763164|157592670|FG001|Treatment Phase|Randomized but not Treated|19|||
48935538|NCT01763164|157592669|FG000|Treatment Phase|Other|0|||
48847375|NCT02519348|157280972|FG005|Overall Study|Lost to Follow-up|1|||
48847376|NCT02519348|157280973|FG006|Overall Study|Lost to Follow-up|1|||
48847377|NCT02519348|157280974|FG007|Overall Study|Lost to Follow-up|0|||
48847378|NCT02519348|157280975|FG008|Overall Study|Lost to Follow-up|0|||
48847379|NCT02519348|157280967|FG000|Overall Study|Other|0|||
48847380|NCT02519348|157280968|FG001|Overall Study|Other|3|||
48847381|NCT02519348|157280969|FG002|Overall Study|Other|0|||
48935539|NCT01763164|157592670|FG001|Treatment Phase|Other|1|||
48935540|NCT01763164|157592669|FG000|Follow up Phase|New therapy for study indication|12|||
48935541|NCT01763164|157592670|FG001|Follow up Phase|New therapy for study indication|3|||
48847382|NCT02519348|157280970|FG003|Overall Study|Other|0|||
48847383|NCT02519348|157280971|FG004|Overall Study|Other|1|||
48847384|NCT02519348|157280972|FG005|Overall Study|Other|0|||
48847385|NCT02519348|157280973|FG006|Overall Study|Other|0|||
48847386|NCT02519348|157280974|FG007|Overall Study|Other|0|||
48847387|NCT02519348|157280975|FG008|Overall Study|Other|0|||
48847388|NCT02519348|157280967|FG000|Overall Study|Ongoing at the time of data cut-off date|5|||
48935542|NCT01763164|157592669|FG000|Follow up Phase|Death|21|||
48847389|NCT02519348|157280968|FG001|Overall Study|Ongoing at the time of data cut-off date|20|||
48847390|NCT02519348|157280969|FG002|Overall Study|Ongoing at the time of data cut-off date|23|||
48847391|NCT02519348|157280970|FG003|Overall Study|Ongoing at the time of data cut-off date|12|||
48847392|NCT02519348|157280971|FG004|Overall Study|Ongoing at the time of data cut-off date|15|||
48847393|NCT02519348|157280972|FG005|Overall Study|Ongoing at the time of data cut-off date|26|||
48847394|NCT02519348|157280973|FG006|Overall Study|Ongoing at the time of data cut-off date|0|||
48847395|NCT02519348|157280974|FG007|Overall Study|Ongoing at the time of data cut-off date|0|||
48847396|NCT02519348|157280975|FG008|Overall Study|Ongoing at the time of data cut-off date|0|||
48847397|NCT03569891|157280976|FG000|Lead-in|Ineligible during lead-in|8|||
48847398|NCT03569891|157280976|FG000|Lead-in|Withdrawal by Subject|3|||
48847399|NCT03569891|157280976|FG000|Lead-in|Risks related to COVID-19|2|||
48847400|NCT03569891|157280976|FG000|AMT-061|Adverse Event|1|||
48847401|NCT04882241|157280977|FG000|Overall Study|Ongoing in study|46|||
48847402|NCT04882241|157280978|FG001|Overall Study|Ongoing in study|48|||
48847403|NCT04882241|157280979|FG002|Overall Study|Ongoing in study|0|||
48847404|NCT04882241|157280980|FG003|Overall Study|Ongoing in study|0|||
48847405|NCT04882241|157280977|FG000|Overall Study|Death|13|||
48847406|NCT04882241|157280978|FG001|Overall Study|Death|13|||
48847407|NCT04882241|157280979|FG002|Overall Study|Death|0|||
48847408|NCT04882241|157280980|FG003|Overall Study|Death|0|||
48935543|NCT01763164|157592670|FG001|Follow up Phase|Death|4|||
48935544|NCT01763164|157592669|FG000|Follow up Phase|Subject/guardian decision|9|||
48935545|NCT01763164|157592670|FG001|Follow up Phase|Subject/guardian decision|2|||
48935546|NCT01763164|157592669|FG000|Follow up Phase|Progressive disease|127|||
48935547|NCT01763164|157592670|FG001|Follow up Phase|Progressive disease|62|||
48935548|NCT01763164|157592669|FG000|Follow up Phase|Physician Decision|10|||
48935549|NCT01763164|157592670|FG001|Follow up Phase|Physician Decision|3|||
48935550|NCT01763164|157592669|FG000|Follow up Phase|Lost to Follow-up|1|||
48935551|NCT01763164|157592670|FG001|Follow up Phase|Lost to Follow-up|0|||
48935552|NCT01763164|157592669|FG000|Follow up Phase|Adverse Event|17|||
48935553|NCT01763164|157592670|FG001|Follow up Phase|Adverse Event|1|||
48935554|NCT00074958|157592680|FG000|Overall Study|Adverse Event|1|||
48935555|NCT01709331|157592681|FG000|Overall Study|Adverse Event|1|||
48935556|NCT03896295|157592685|FG000|Overall Study|Adverse Event|0|||
48935557|NCT03896295|157592686|FG001|Overall Study|Adverse Event|1|||
48935558|NCT03896295|157592685|FG000|Overall Study|COVID-19|7|||
48935559|NCT03896295|157592686|FG001|Overall Study|COVID-19|29|||
48935560|NCT02604264|157592690|FG000|Intervention|Didn't use CVC for at least 21 days|200|||
48935561|NCT02604264|157592691|FG001|Intervention|Didn't use CVC for at least 21 days|242|||
48935562|NCT01412229|157592695|FG000|Overall Study|Physician Decision|1|||
48935563|NCT00787787|157592696|FG000|Overall Study|Lack of Efficacy|4|||
48935564|NCT00787787|157592696|FG000|Overall Study|Adverse Event|3|||
48847409|NCT05764525|157280981|FG000|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|1|||
48847410|NCT05764525|157280982|FG001|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|0|||
48847411|NCT05764525|157280981|FG000|Overall Study|Withdrawal by Subject|4|||
48847412|NCT05764525|157280982|FG001|Overall Study|Withdrawal by Subject|8|||
48935565|NCT00151892|157592706|FG000|Overall Study|Lack of Efficacy|50|||
48935566|NCT00151892|157592707|FG001|Overall Study|Lack of Efficacy|57|||
48935567|NCT00151892|157592706|FG000|Overall Study|Patient request|10|||
48935568|NCT00151892|157592707|FG001|Overall Study|Patient request|7|||
48935569|NCT00151892|157592706|FG000|Overall Study|Lost to Follow-up|5|||
48935570|NCT00151892|157592707|FG001|Overall Study|Lost to Follow-up|10|||
48935571|NCT00151892|157592706|FG000|Overall Study|Adverse Event|6|||
48847413|NCT05764525|157280981|FG000|Overall Study|Physician Decision|1|||
48847414|NCT05764525|157280982|FG001|Overall Study|Physician Decision|0|||
48935572|NCT00151892|157592707|FG001|Overall Study|Adverse Event|3|||
48935573|NCT00151892|157592706|FG000|Overall Study|Protocol Violation|3|||
48935574|NCT00151892|157592707|FG001|Overall Study|Protocol Violation|3|||
48935575|NCT00151892|157592706|FG000|Overall Study|Non-compliance|0|||
48935576|NCT00151892|157592707|FG001|Overall Study|Non-compliance|1|||
48935577|NCT00151892|157592706|FG000|Overall Study|Pregnancy|0|||
48935578|NCT00151892|157592707|FG001|Overall Study|Pregnancy|1|||
48935579|NCT00151892|157592706|FG000|Overall Study|Did not return for a visit|1|||
48935580|NCT00151892|157592707|FG001|Overall Study|Did not return for a visit|0|||
48935581|NCT00151892|157592706|FG000|Overall Study|Used prohibited corticosteroids|1|||
48935582|NCT00151892|157592707|FG001|Overall Study|Used prohibited corticosteroids|0|||
48935583|NCT00151892|157592706|FG000|Overall Study|Lack of study medication at center|0|||
48935584|NCT00151892|157592707|FG001|Overall Study|Lack of study medication at center|1|||
48935585|NCT02502864|157592708|FG000|Overall Study|Withdrawal by Subject|1|||
48935586|NCT02770807|157592709|FG000|Overall Study|Adverse Event|3|||
48935587|NCT02770807|157592710|FG001|Overall Study|Adverse Event|3|||
48935588|NCT02770807|157592711|FG002|Overall Study|Adverse Event|1|||
48935589|NCT02770807|157592709|FG000|Overall Study|Withdrawal by Subject|7|||
48935590|NCT02770807|157592710|FG001|Overall Study|Withdrawal by Subject|3|||
48935591|NCT02770807|157592711|FG002|Overall Study|Withdrawal by Subject|4|||
48935592|NCT02770807|157592709|FG000|Overall Study|Other|0|||
48935593|NCT02770807|157592710|FG001|Overall Study|Other|1|||
48935594|NCT02770807|157592711|FG002|Overall Study|Other|0|||
48935595|NCT02770807|157592709|FG000|Overall Study|Covid-Related Treatment/Visit Delay|15|||
48935596|NCT02770807|157592710|FG001|Overall Study|Covid-Related Treatment/Visit Delay|13|||
48935597|NCT02770807|157592711|FG002|Overall Study|Covid-Related Treatment/Visit Delay|17|||
48935598|NCT02770807|157592709|FG000|Overall Study|Physician Decision|0|||
48935599|NCT02770807|157592710|FG001|Overall Study|Physician Decision|0|||
48935600|NCT02770807|157592711|FG002|Overall Study|Physician Decision|1|||
48935601|NCT00818259|157592712|FG000|Part I|Withdrawal by Subject|1|||
48935602|NCT00818259|157592713|FG001|Part I|Withdrawal by Subject|0|||
48935603|NCT00818259|157592714|FG002|Part I|Withdrawal by Subject|0|||
48935604|NCT00818259|157592715|FG003|Part I|Withdrawal by Subject|0|||
48935605|NCT00818259|157592716|FG004|Part I|Withdrawal by Subject|0|||
48935606|NCT00818259|157592717|FG005|Part I|Withdrawal by Subject|0|||
48935607|NCT00818259|157592718|FG006|Part I|Withdrawal by Subject|0|||
48935608|NCT00818259|157592719|FG007|Part I|Withdrawal by Subject|0|||
48935609|NCT00818259|157592720|FG008|Part I|Withdrawal by Subject|0|||
48935610|NCT00818259|157592712|FG000|Part II|Physician Decision|0|||
48935611|NCT00818259|157592713|FG001|Part II|Physician Decision|0|||
48935612|NCT00818259|157592714|FG002|Part II|Physician Decision|1|||
48935613|NCT00818259|157592715|FG003|Part II|Physician Decision|0|||
48935614|NCT00818259|157592716|FG004|Part II|Physician Decision|0|||
48935615|NCT00818259|157592717|FG005|Part II|Physician Decision|0|||
48935616|NCT00818259|157592718|FG006|Part II|Physician Decision|0|||
48935617|NCT00818259|157592719|FG007|Part II|Physician Decision|0|||
48935618|NCT00818259|157592720|FG008|Part II|Physician Decision|0|||
48935619|NCT00818259|157592712|FG000|Part II|Lack of Efficacy|0|||
48935620|NCT00818259|157592713|FG001|Part II|Lack of Efficacy|0|||
48935621|NCT00818259|157592714|FG002|Part II|Lack of Efficacy|0|||
48935622|NCT00818259|157592715|FG003|Part II|Lack of Efficacy|1|||
48935623|NCT00818259|157592716|FG004|Part II|Lack of Efficacy|0|||
48935624|NCT00818259|157592717|FG005|Part II|Lack of Efficacy|0|||
48935625|NCT00818259|157592718|FG006|Part II|Lack of Efficacy|0|||
48935626|NCT00818259|157592719|FG007|Part II|Lack of Efficacy|0|||
48935627|NCT00818259|157592720|FG008|Part II|Lack of Efficacy|0|||
48935628|NCT00818259|157592712|FG000|Part II|Not Treated|0|||
48935629|NCT00818259|157592713|FG001|Part II|Not Treated|0|||
48935630|NCT00818259|157592714|FG002|Part II|Not Treated|0|||
48935631|NCT00818259|157592715|FG003|Part II|Not Treated|1|||
48935632|NCT00818259|157592716|FG004|Part II|Not Treated|0|||
48935633|NCT00818259|157592717|FG005|Part II|Not Treated|0|||
48935634|NCT00818259|157592718|FG006|Part II|Not Treated|0|||
48935635|NCT00818259|157592719|FG007|Part II|Not Treated|0|||
48935636|NCT00818259|157592720|FG008|Part II|Not Treated|0|||
48935637|NCT00818259|157592712|FG000|Part IV|Physician Decision|0|||
48935638|NCT00818259|157592713|FG001|Part IV|Physician Decision|0|||
48935639|NCT00818259|157592714|FG002|Part IV|Physician Decision|0|||
48935640|NCT00818259|157592715|FG003|Part IV|Physician Decision|0|||
48935641|NCT00818259|157592716|FG004|Part IV|Physician Decision|0|||
48935642|NCT00818259|157592717|FG005|Part IV|Physician Decision|1|||
48935643|NCT00818259|157592718|FG006|Part IV|Physician Decision|0|||
48935644|NCT00818259|157592719|FG007|Part IV|Physician Decision|0|||
48935645|NCT00818259|157592720|FG008|Part IV|Physician Decision|0|||
48935646|NCT00818259|157592712|FG000|Part V|Adverse Event|0|||
48935647|NCT00818259|157592713|FG001|Part V|Adverse Event|0|||
48935648|NCT00818259|157592714|FG002|Part V|Adverse Event|0|||
48935649|NCT00818259|157592715|FG003|Part V|Adverse Event|0|||
48935650|NCT00818259|157592716|FG004|Part V|Adverse Event|0|||
48935651|NCT00818259|157592717|FG005|Part V|Adverse Event|0|||
48935652|NCT00818259|157592718|FG006|Part V|Adverse Event|0|||
48935653|NCT00818259|157592719|FG007|Part V|Adverse Event|1|||
48935654|NCT00818259|157592720|FG008|Part V|Adverse Event|0|||
48935655|NCT03372941|157592721|FG000|Overall Study|Lost to Follow-up|2|||
48935656|NCT03372941|157592722|FG001|Overall Study|Lost to Follow-up|4|||
48935657|NCT02117687|157592723|FG000|Overall Study|Lost to Follow-up|0|||
48935658|NCT02117687|157592724|FG001|Overall Study|Lost to Follow-up|1|||
48935659|NCT02117687|157592723|FG000|Overall Study|Adverse Event|0|||
48935660|NCT02117687|157592724|FG001|Overall Study|Adverse Event|2|||
48935661|NCT02117687|157592723|FG000|Overall Study|Other Reasons|1|||
48935662|NCT02117687|157592724|FG001|Overall Study|Other Reasons|1|||
48935663|NCT01955707|157592725|FG000|Overall Study|Adverse Event|1|||
48935664|NCT01955707|157592726|FG001|Overall Study|Adverse Event|2|||
48935665|NCT01955707|157592725|FG000|Overall Study|Lost to Follow-up|2|||
48935666|NCT01955707|157592726|FG001|Overall Study|Lost to Follow-up|1|||
48935667|NCT01955707|157592725|FG000|Overall Study|Withdrawal by Subject|0|||
48935668|NCT01955707|157592726|FG001|Overall Study|Withdrawal by Subject|3|||
48935669|NCT01955707|157592725|FG000|Overall Study|Death|13|||
48935670|NCT01955707|157592726|FG001|Overall Study|Death|14|||
48935671|NCT01955707|157592725|FG000|Overall Study|Other|4|||
48935672|NCT01955707|157592726|FG001|Overall Study|Other|2|||
48935673|NCT01817790|157592727|FG000|Overall Study|Adverse Event|0|||
48935674|NCT01817790|157592728|FG001|Overall Study|Adverse Event|2|||
48935675|NCT01817790|157592727|FG000|Overall Study|Lost to Follow-up|0|||
48935676|NCT01817790|157592728|FG001|Overall Study|Lost to Follow-up|1|||
48935677|NCT01817790|157592727|FG000|Overall Study|Protocol Violation|2|||
48935678|NCT01817790|157592728|FG001|Overall Study|Protocol Violation|1|||
48935679|NCT01817790|157592727|FG000|Overall Study|Withdrawal by Subject|1|||
48935680|NCT01817790|157592728|FG001|Overall Study|Withdrawal by Subject|3|||
48935681|NCT01817790|157592727|FG000|Overall Study|Other: Could not attend appointment|1|||
48935682|NCT01817790|157592728|FG001|Overall Study|Other: Could not attend appointment|1|||
48935683|NCT01707992|157592729|FG000|Placebo-Controlled Phase (24 Months)|Adverse Event|8|||
48935684|NCT01707992|157592730|FG001|Placebo-Controlled Phase (24 Months)|Adverse Event|13|||
48935685|NCT01707992|157592731|FG002|Placebo-Controlled Phase (24 Months)|Adverse Event|9|||
48935686|NCT01707992|157592732|FG003|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
48935687|NCT01707992|157592733|FG004|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
48935688|NCT01707992|157592734|FG005|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
48935689|NCT01707992|157592729|FG000|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10|||
48935690|NCT01707992|157592730|FG001|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3|||
48935691|NCT01707992|157592731|FG002|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2|||
48935692|NCT01707992|157592732|FG003|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
48935693|NCT01707992|157592733|FG004|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
48935694|NCT01707992|157592734|FG005|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
48935695|NCT01707992|157592729|FG000|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88|||
48935696|NCT01707992|157592730|FG001|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68|||
48935697|NCT01707992|157592731|FG002|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154|||
48935698|NCT01707992|157592732|FG003|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
48935699|NCT01707992|157592733|FG004|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
48935700|NCT01707992|157592734|FG005|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
48935701|NCT01707992|157592729|FG000|Placebo-Controlled Phase (24 Months)|Protocol Violation|1|||
48935702|NCT01707992|157592730|FG001|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
48935703|NCT01707992|157592731|FG002|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
48935704|NCT01707992|157592732|FG003|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
48935705|NCT01707992|157592733|FG004|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
48935706|NCT01707992|157592734|FG005|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
48935707|NCT01707992|157592729|FG000|Placebo-Controlled Phase (24 Months)|Pregnancy|12|||
48847415|NCT04907357|157280983|FG000|Overall Study|Death|0|||
48847416|NCT04907357|157280984|FG001|Overall Study|Death|1|||
48847417|NCT04907357|157280983|FG000|Overall Study|Lost to Follow-up|9|||
48847418|NCT04907357|157280984|FG001|Overall Study|Lost to Follow-up|18|||
48935708|NCT01707992|157592730|FG001|Placebo-Controlled Phase (24 Months)|Pregnancy|5|||
48935709|NCT01707992|157592731|FG002|Placebo-Controlled Phase (24 Months)|Pregnancy|9|||
48935710|NCT01707992|157592732|FG003|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
48935711|NCT01707992|157592733|FG004|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
48847419|NCT04907357|157280983|FG000|Overall Study|Physician Decision|1|||
48935712|NCT01707992|157592734|FG005|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
48847420|NCT04907357|157280984|FG001|Overall Study|Physician Decision|0|||
48847421|NCT04907357|157280983|FG000|Overall Study|Withdrawal by Subject|0|||
48847422|NCT04907357|157280984|FG001|Overall Study|Withdrawal by Subject|1|||
48847423|NCT04907357|157280983|FG000|Overall Study|Unable to attend visits|1|||
48935713|NCT01707992|157592729|FG000|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10|||
48935714|NCT01707992|157592730|FG001|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4|||
48935715|NCT01707992|157592731|FG002|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9|||
48935716|NCT01707992|157592732|FG003|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
48935717|NCT01707992|157592733|FG004|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
48735655|NCT02215096|156883709|FG004|Combination TP (Up to Maximum 654 Days)|Physician Decision|1|||
48847424|NCT04907357|157280984|FG001|Overall Study|Unable to attend visits|0|||
48847425|NCT04907357|157280983|FG000|Overall Study|Incarcerated|1|||
48847426|NCT04907357|157280984|FG001|Overall Study|Incarcerated|1|||
48847427|NCT02056834|157280987|FG000|Overall Study|Lost to Follow-up|7|||
48847428|NCT05601102|157280988|FG000|Overall Study|Death|1|||
48847429|NCT05601102|157280989|FG001|Overall Study|Death|2|||
48847430|NCT05601102|157280988|FG000|Overall Study|Withdrawal by Subject|1|||
48847431|NCT05601102|157280989|FG001|Overall Study|Withdrawal by Subject|1|||
48847432|NCT05601102|157280988|FG000|Overall Study|Lost to Follow-up|0|||
48847433|NCT05601102|157280989|FG001|Overall Study|Lost to Follow-up|2|||
48847434|NCT03988621|157280990|FG000|Overall Study|Lost to Follow-up|16|||
48847435|NCT03988621|157280991|FG001|Overall Study|Lost to Follow-up|17|||
48847436|NCT03988621|157280990|FG000|Overall Study|Withdrawal by Subject|14|||
48847437|NCT03988621|157280991|FG001|Overall Study|Withdrawal by Subject|7|||
48847438|NCT03988621|157280990|FG000|Overall Study|Patient Lost to Follow Up|15|||
48847439|NCT03988621|157280991|FG001|Overall Study|Patient Lost to Follow Up|15|||
48847440|NCT03988621|157280990|FG000|Overall Study|Patient death|1|||
48847441|NCT03988621|157280991|FG001|Overall Study|Patient death|5|||
48847442|NCT01391832|157282166|FG000|Overall Study|Withdrawal by Subject|21|||
48847443|NCT01391832|157282167|FG001|Overall Study|Withdrawal by Subject|22|||
48847444|NCT01391832|157282166|FG000|Overall Study|Lost to Follow-up|0|||
48847445|NCT01391832|157282167|FG001|Overall Study|Lost to Follow-up|1|||
48847446|NCT02755805|157282170|FG000|Overall Study|Lost to Follow-up|1|||
48847447|NCT02755805|157282171|FG001|Overall Study|Lost to Follow-up|2|||
48847448|NCT02755805|157282170|FG000|Overall Study|Refused assessments|1|||
48847449|NCT02755805|157282171|FG001|Overall Study|Refused assessments|0|||
48847450|NCT02755805|157282170|FG000|Overall Study|Withdrawal by Subject|0|||
48847451|NCT02755805|157282171|FG001|Overall Study|Withdrawal by Subject|2|||
48847452|NCT02597920|157282172|FG000|Overall Study|Worsening of other pre-existing disease|0|||
48847453|NCT02597920|157282173|FG001|Overall Study|Worsening of other pre-existing disease|1|||
48847454|NCT02597920|157282174|FG002|Overall Study|Worsening of other pre-existing disease|0|||
48847455|NCT02597920|157282172|FG000|Overall Study|Other adverse event|20|||
48847456|NCT02597920|157282173|FG001|Overall Study|Other adverse event|30|||
48935718|NCT01707992|157592734|FG005|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
48935719|NCT01707992|157592729|FG000|Placebo-Controlled Phase (24 Months)|Death|2|||
48935720|NCT01707992|157592730|FG001|Placebo-Controlled Phase (24 Months)|Death|1|||
48935721|NCT01707992|157592731|FG002|Placebo-Controlled Phase (24 Months)|Death|1|||
48935722|NCT01707992|157592732|FG003|Placebo-Controlled Phase (24 Months)|Death|0|||
48935723|NCT01707992|157592733|FG004|Placebo-Controlled Phase (24 Months)|Death|0|||
48935724|NCT01707992|157592734|FG005|Placebo-Controlled Phase (24 Months)|Death|0|||
48935725|NCT01707992|157592729|FG000|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2|||
48935726|NCT01707992|157592730|FG001|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1|||
48935727|NCT01707992|157592731|FG002|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6|||
48935728|NCT01707992|157592732|FG003|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
48935729|NCT01707992|157592733|FG004|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
48935730|NCT01707992|157592734|FG005|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
48935731|NCT01707992|157592729|FG000|Placebo-Controlled Phase (24 Months)|Other than specified|11|||
48935732|NCT01707992|157592730|FG001|Placebo-Controlled Phase (24 Months)|Other than specified|9|||
48935733|NCT01707992|157592731|FG002|Placebo-Controlled Phase (24 Months)|Other than specified|10|||
48935734|NCT01707992|157592732|FG003|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
48935735|NCT01707992|157592733|FG004|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
48935736|NCT01707992|157592734|FG005|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
48935737|NCT01707992|157592729|FG000|Active Treatment Phase (24 Months)|Adverse Event|0|||
48935738|NCT01707992|157592730|FG001|Active Treatment Phase (24 Months)|Adverse Event|0|||
48935739|NCT01707992|157592731|FG002|Active Treatment Phase (24 Months)|Adverse Event|0|||
48935740|NCT01707992|157592732|FG003|Active Treatment Phase (24 Months)|Adverse Event|4|||
48935741|NCT01707992|157592733|FG004|Active Treatment Phase (24 Months)|Adverse Event|1|||
48935742|NCT01707992|157592734|FG005|Active Treatment Phase (24 Months)|Adverse Event|0|||
48935743|NCT01707992|157592729|FG000|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
48935744|NCT01707992|157592730|FG001|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
48935745|NCT01707992|157592731|FG002|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
48935746|NCT01707992|157592732|FG003|Active Treatment Phase (24 Months)|Lack of Efficacy|3|||
48935747|NCT01707992|157592733|FG004|Active Treatment Phase (24 Months)|Lack of Efficacy|1|||
48935748|NCT01707992|157592734|FG005|Active Treatment Phase (24 Months)|Lack of Efficacy|2|||
48935749|NCT01707992|157592729|FG000|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
48935750|NCT01707992|157592730|FG001|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
48935751|NCT01707992|157592731|FG002|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
48935752|NCT01707992|157592732|FG003|Active Treatment Phase (24 Months)|Withdrawal by Subject|58|||
48935753|NCT01707992|157592733|FG004|Active Treatment Phase (24 Months)|Withdrawal by Subject|220|||
48935754|NCT01707992|157592734|FG005|Active Treatment Phase (24 Months)|Withdrawal by Subject|32|||
48935755|NCT01707992|157592729|FG000|Active Treatment Phase (24 Months)|Pregnancy|0|||
48935756|NCT01707992|157592730|FG001|Active Treatment Phase (24 Months)|Pregnancy|0|||
48935757|NCT01707992|157592731|FG002|Active Treatment Phase (24 Months)|Pregnancy|0|||
48935758|NCT01707992|157592732|FG003|Active Treatment Phase (24 Months)|Pregnancy|2|||
48935759|NCT01707992|157592733|FG004|Active Treatment Phase (24 Months)|Pregnancy|5|||
48935760|NCT01707992|157592734|FG005|Active Treatment Phase (24 Months)|Pregnancy|2|||
48935761|NCT01707992|157592729|FG000|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
48935762|NCT01707992|157592730|FG001|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
48935763|NCT01707992|157592731|FG002|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
48935764|NCT01707992|157592732|FG003|Active Treatment Phase (24 Months)|Lost to Follow-up|5|||
48935765|NCT01707992|157592733|FG004|Active Treatment Phase (24 Months)|Lost to Follow-up|11|||
48935766|NCT01707992|157592734|FG005|Active Treatment Phase (24 Months)|Lost to Follow-up|1|||
48935767|NCT01707992|157592729|FG000|Active Treatment Phase (24 Months)|Death|0|||
48935768|NCT01707992|157592730|FG001|Active Treatment Phase (24 Months)|Death|0|||
48935769|NCT01707992|157592731|FG002|Active Treatment Phase (24 Months)|Death|0|||
48935770|NCT01707992|157592732|FG003|Active Treatment Phase (24 Months)|Death|2|||
48935771|NCT01707992|157592733|FG004|Active Treatment Phase (24 Months)|Death|0|||
48935772|NCT01707992|157592734|FG005|Active Treatment Phase (24 Months)|Death|0|||
48935773|NCT01707992|157592729|FG000|Active Treatment Phase (24 Months)|Other than specified|0|||
48935774|NCT01707992|157592730|FG001|Active Treatment Phase (24 Months)|Other than specified|0|||
48935775|NCT01707992|157592731|FG002|Active Treatment Phase (24 Months)|Other than specified|0|||
48935776|NCT01707992|157592732|FG003|Active Treatment Phase (24 Months)|Other than specified|1|||
48735656|NCT02215096|156883705|FG000|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
48935777|NCT01707992|157592733|FG004|Active Treatment Phase (24 Months)|Other than specified|5|||
48935778|NCT01707992|157592734|FG005|Active Treatment Phase (24 Months)|Other than specified|2|||
48935779|NCT01707992|157592729|FG000|Active Treatment Phase (24 Months)|Noncompliance|0|||
48935780|NCT01707992|157592730|FG001|Active Treatment Phase (24 Months)|Noncompliance|0|||
48935781|NCT01707992|157592731|FG002|Active Treatment Phase (24 Months)|Noncompliance|0|||
48935782|NCT01707992|157592732|FG003|Active Treatment Phase (24 Months)|Noncompliance|0|||
48935783|NCT01707992|157592733|FG004|Active Treatment Phase (24 Months)|Noncompliance|4|||
48935784|NCT01707992|157592734|FG005|Active Treatment Phase (24 Months)|Noncompliance|2|||
48935785|NCT01707992|157592729|FG000|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
48935786|NCT01707992|157592730|FG001|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
48935787|NCT01707992|157592731|FG002|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
48935788|NCT01707992|157592732|FG003|Active Treatment Phase (24 Months)|Study terminated by sponsor|809|||
48935789|NCT01707992|157592733|FG004|Active Treatment Phase (24 Months)|Study terminated by sponsor|243|||
48935790|NCT01707992|157592734|FG005|Active Treatment Phase (24 Months)|Study terminated by sponsor|174|||
48935791|NCT01707992|157592729|FG000|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
48935792|NCT01707992|157592730|FG001|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
48935793|NCT01707992|157592731|FG002|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
48935794|NCT01707992|157592732|FG003|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
48935795|NCT01707992|157592733|FG004|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4|||
48935796|NCT01707992|157592734|FG005|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
48935797|NCT02949128|157594006|FG000|Initial Evaluation Period (26 Weeks)|Failed to Meet Eligibility Criteria|2|||
48935798|NCT02949128|157594006|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|3|||
48935799|NCT02949128|157594006|FG000|Initial Evaluation Period (26 Weeks)|Death|2|||
48935800|NCT02949128|157594006|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
48935801|NCT02949128|157594006|FG000|Initial Evaluation Period (26 Weeks)|Protocol Violation|1|||
48935802|NCT02949128|157594006|FG000|Extension Period (Up to 4.5 Years)|Death|1|||
48935803|NCT02949128|157594006|FG000|Extension Period (Up to 4.5 Years)|Physician Decision|5|||
48935804|NCT02949128|157594006|FG000|Extension Period (Up to 4.5 Years)|Protocol Violation|1|||
48935805|NCT02949128|157594006|FG000|Extension Period (Up to 4.5 Years)|Withdrawal by Subject|9|||
48935806|NCT02949128|157594006|FG000|Extension Period (Up to 4.5 Years)|Other than specified|5|||
48935807|NCT02090855|157594007|FG000|Overall Study|no evaluable Standard of Truth results|2|||
48935808|NCT03968419|157594017|FG000|Treatment Period|Adverse Event|0|||
48935809|NCT03968419|157594018|FG001|Treatment Period|Adverse Event|0|||
48935810|NCT03968419|157594019|FG002|Treatment Period|Adverse Event|1|||
48935811|NCT03968419|157594017|FG000|Safety Follow-up Period|Death|3|||
48935812|NCT03968419|157594018|FG001|Safety Follow-up Period|Death|2|||
48935813|NCT03968419|157594019|FG002|Safety Follow-up Period|Death|1|||
48935814|NCT03968419|157594017|FG000|Safety Follow-up Period|Subject Decision|2|||
48935815|NCT03968419|157594018|FG001|Safety Follow-up Period|Subject Decision|1|||
48935816|NCT03968419|157594019|FG002|Safety Follow-up Period|Subject Decision|0|||
48935817|NCT00925600|157594020|FG000|Overall Study|Withdrawal by Subject|16|||
48935818|NCT00925600|157594021|FG001|Overall Study|Withdrawal by Subject|14|||
48935819|NCT00925600|157594020|FG000|Overall Study|Death|4|||
48935820|NCT00925600|157594021|FG001|Overall Study|Death|3|||
48935821|NCT00925600|157594020|FG000|Overall Study|Lost to Follow-up|2|||
48935822|NCT00925600|157594021|FG001|Overall Study|Lost to Follow-up|2|||
48935823|NCT00925600|157594020|FG000|Overall Study|Disease Progression|1|||
48935824|NCT00925600|157594021|FG001|Overall Study|Disease Progression|3|||
48935825|NCT00925600|157594020|FG000|Overall Study|Administrative Decision|1|||
48935826|NCT00925600|157594021|FG001|Overall Study|Administrative Decision|1|||
48935827|NCT00925600|157594020|FG000|Overall Study|Noncompliance|2|||
48935828|NCT00925600|157594021|FG001|Overall Study|Noncompliance|0|||
48935829|NCT00925600|157594020|FG000|Overall Study|Ineligibility Determined|2|||
48935830|NCT00925600|157594021|FG001|Overall Study|Ineligibility Determined|0|||
48935831|NCT00925600|157594020|FG000|Overall Study|Protocol Deviation|0|||
48935832|NCT00925600|157594021|FG001|Overall Study|Protocol Deviation|1|||
48935833|NCT00925600|157594020|FG000|Overall Study|Requirement for Alternative Therapy|0|||
48935834|NCT00925600|157594021|FG001|Overall Study|Requirement for Alternative Therapy|1|||
48935835|NCT00925600|157594020|FG000|Overall Study|Other|3|||
48935836|NCT00925600|157594021|FG001|Overall Study|Other|1|||
48935837|NCT00925600|157594020|FG000|Overall Study|Adverse Event|1|||
48935838|NCT00925600|157594021|FG001|Overall Study|Adverse Event|2|||
48935839|NCT00935883|157594022|FG000|Treatment Period|Physician Decision|1|||
48935840|NCT00935883|157594023|FG001|Treatment Period|Physician Decision|0|||
48935841|NCT00935883|157594022|FG000|Treatment Period|Withdrawal by Subject|0|||
48935842|NCT00935883|157594023|FG001|Treatment Period|Withdrawal by Subject|2|||
48935843|NCT01974817|157594024|FG000|Overall Study|Death|4|||
48935844|NCT01974817|157594024|FG000|Overall Study|Lost to Follow-up|2|||
48935845|NCT01974817|157594024|FG000|Overall Study|Protocol Violation|2|||
48935846|NCT03593915|157594025|FG000|Overall Study|Adverse Event|0|||
48935847|NCT03593915|157594026|FG001|Overall Study|Adverse Event|0|||
48935848|NCT03593915|157594027|FG002|Overall Study|Adverse Event|0|||
48935849|NCT03593915|157594028|FG003|Overall Study|Adverse Event|1|||
48935850|NCT03593915|157594029|FG004|Overall Study|Adverse Event|0|||
48935851|NCT03593915|157594030|FG005|Overall Study|Adverse Event|0|||
48935852|NCT03593915|157594025|FG000|Overall Study|Physician Decision|0|||
48935853|NCT03593915|157594026|FG001|Overall Study|Physician Decision|0|||
48935854|NCT03593915|157594027|FG002|Overall Study|Physician Decision|0|||
48935855|NCT03593915|157594028|FG003|Overall Study|Physician Decision|0|||
48935856|NCT03593915|157594029|FG004|Overall Study|Physician Decision|0|||
48935857|NCT03593915|157594030|FG005|Overall Study|Physician Decision|1|||
48935858|NCT01246206|157594032|FG000|Overall Study|Patient did not receive study regiments.|1|||
48935859|NCT01097629|157594035|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10|||
48935860|NCT01097629|157594036|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19|||
48935861|NCT01097629|157594037|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17|||
48935862|NCT01097629|157594038|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
48935863|NCT01097629|157594039|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
48935864|NCT01097629|157594040|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
48935865|NCT01097629|157594041|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
48935866|NCT01097629|157594042|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
48935867|NCT01097629|157594035|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
48935868|NCT01097629|157594036|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9|||
48935869|NCT01097629|157594037|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19|||
48935870|NCT01097629|157594038|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
48935871|NCT01097629|157594039|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
48935872|NCT01097629|157594040|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
48935873|NCT01097629|157594041|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
48935874|NCT01097629|157594042|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
48935875|NCT01097629|157594035|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
48935876|NCT01097629|157594036|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4|||
48935877|NCT01097629|157594037|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8|||
48935878|NCT01097629|157594038|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
48935879|NCT01097629|157594039|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
48935880|NCT01097629|157594040|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
48935881|NCT01097629|157594041|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
48935882|NCT01097629|157594042|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
48935883|NCT01097629|157594035|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2|||
48935884|NCT01097629|157594036|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4|||
48935885|NCT01097629|157594037|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
48847457|NCT02597920|157282174|FG002|Overall Study|Other adverse event|0|||
48847458|NCT02597920|157282172|FG000|Overall Study|Lost to Follow-up|7|||
48847459|NCT02597920|157282173|FG001|Overall Study|Lost to Follow-up|9|||
48847460|NCT02597920|157282174|FG002|Overall Study|Lost to Follow-up|0|||
48847461|NCT02597920|157282172|FG000|Overall Study|Refuse to continue in the study|3|||
48847462|NCT02597920|157282173|FG001|Overall Study|Refuse to continue in the study|13|||
48847463|NCT02597920|157282174|FG002|Overall Study|Refuse to continue in the study|1|||
48847464|NCT02597920|157282172|FG000|Overall Study|Other than specified|10|||
48847465|NCT02597920|157282173|FG001|Overall Study|Other than specified|31|||
48847466|NCT02597920|157282174|FG002|Overall Study|Other than specified|5|||
48847467|NCT02597920|157282172|FG000|Overall Study|Other|1|||
48847468|NCT02597920|157282173|FG001|Overall Study|Other|0|||
48847469|NCT02597920|157282174|FG002|Overall Study|Other|0|||
48847470|NCT02652442|157282178|FG000|Centrifugation - Distance|Lost to Follow-up|1|||
48847471|NCT05659537|157282179|FG000|Overall Study|Adverse Event|5|||
48847472|NCT05659537|157282179|FG000|Overall Study|Lost to Follow-up|4|||
48847473|NCT05659537|157282179|FG000|Overall Study|Withdrawal by Subject|13|||
48847474|NCT05659537|157282179|FG000|Overall Study|Migration from the Study Site Such That Follow Up Visits are not Possible|3|||
48847475|NCT05659537|157282179|FG000|Overall Study|Participant had low absolute neutrophil count value|1|||
48847476|NCT05659537|157282179|FG000|Overall Study|Participant was suffering from anaemia|1|||
48847477|NCT02379819|157282180|FG000|Overall Study|Withdrawal by Subject|10|||
48847478|NCT02379819|157282180|FG000|Overall Study|Death|2|||
48847479|NCT02379819|157282180|FG000|Overall Study|Lack of Efficacy|1|||
48847480|NCT02379819|157282180|FG000|Overall Study|Lost to Follow-up|1|||
48847481|NCT01952366|157282182|FG000|Overall Study|Death|22|||
48847482|NCT01952366|157282182|FG000|Overall Study|Withdrawal by Subject|9|||
48847483|NCT00312208|157282183|FG000|Overall Study|Adverse Event|97|||
48847484|NCT00312208|157282184|FG001|Overall Study|Adverse Event|61|||
48847485|NCT00312208|157282183|FG000|Overall Study|Protocol Violation|5|||
48847486|NCT00312208|157282184|FG001|Overall Study|Protocol Violation|3|||
48847487|NCT00312208|157282183|FG000|Overall Study|Death|2|||
48847488|NCT00312208|157282184|FG001|Overall Study|Death|1|||
48847489|NCT00312208|157282183|FG000|Overall Study|Lack of Efficacy|7|||
48847490|NCT00312208|157282184|FG001|Overall Study|Lack of Efficacy|4|||
48847491|NCT00312208|157282183|FG000|Overall Study|Lost to Follow-up|3|||
48847492|NCT00312208|157282184|FG001|Overall Study|Lost to Follow-up|5|||
48847493|NCT00312208|157282183|FG000|Overall Study|Withdrawal by Subject|53|||
48847494|NCT00312208|157282184|FG001|Overall Study|Withdrawal by Subject|42|||
48847495|NCT00312208|157282183|FG000|Overall Study|Other|5|||
48847496|NCT00312208|157282184|FG001|Overall Study|Other|7|||
48847497|NCT03257410|157282185|FG000|Overall Study|Adverse Event|2|||
48847498|NCT03257410|157282186|FG001|Overall Study|Adverse Event|3|||
48847499|NCT03257410|157282185|FG000|Overall Study|Protocol Violation|1|||
48847500|NCT03257410|157282186|FG001|Overall Study|Protocol Violation|2|||
48935886|NCT01097629|157594038|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
48935887|NCT01097629|157594039|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
48935888|NCT01097629|157594040|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
48935889|NCT01097629|157594041|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
48935890|NCT01097629|157594042|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
48935891|NCT01097629|157594035|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
48935892|NCT01097629|157594036|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4|||
48935893|NCT01097629|157594037|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8|||
48935894|NCT01097629|157594038|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
48935895|NCT01097629|157594039|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
48935896|NCT01097629|157594040|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
48935897|NCT01097629|157594041|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
48935898|NCT01097629|157594042|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
48935899|NCT01097629|157594035|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2|||
48935900|NCT01097629|157594036|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1|||
48935901|NCT01097629|157594037|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
48935902|NCT01097629|157594038|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
48935903|NCT01097629|157594039|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
48935904|NCT01097629|157594040|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
48935905|NCT01097629|157594041|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
48935906|NCT01097629|157594042|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
48935907|NCT01097629|157594035|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
48935908|NCT01097629|157594036|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5|||
48935909|NCT01097629|157594037|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4|||
48935910|NCT01097629|157594038|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
48935911|NCT01097629|157594039|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
48935912|NCT01097629|157594040|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
48935913|NCT01097629|157594041|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
48735657|NCT02215096|156883706|FG001|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
48847501|NCT03257410|157282185|FG000|Overall Study|Lost to Follow-up|1|||
48847502|NCT03257410|157282186|FG001|Overall Study|Lost to Follow-up|0|||
48847503|NCT03257410|157282185|FG000|Overall Study|Withdrawal by Subject|1|||
48847504|NCT03257410|157282186|FG001|Overall Study|Withdrawal by Subject|2|||
48847505|NCT03257410|157282185|FG000|Overall Study|Physician Decision|1|||
48847506|NCT03257410|157282186|FG001|Overall Study|Physician Decision|1|||
48847507|NCT03257410|157282185|FG000|Overall Study|Renal transplantation|2|||
48847508|NCT03257410|157282186|FG001|Overall Study|Renal transplantation|0|||
48847509|NCT03257410|157282185|FG000|Overall Study|Switch to peritoneal dialysis|1|||
48847510|NCT03257410|157282186|FG001|Overall Study|Switch to peritoneal dialysis|0|||
48847511|NCT03257410|157282185|FG000|Overall Study|Death|3|||
48847512|NCT03257410|157282186|FG001|Overall Study|Death|2|||
48847513|NCT03257410|157282185|FG000|Overall Study|Change to another dialysis center|2|||
48847514|NCT03257410|157282186|FG001|Overall Study|Change to another dialysis center|2|||
48847515|NCT03257410|157282185|FG000|Overall Study|Missing 3 consecutive study treatments|5|||
48847516|NCT03257410|157282186|FG001|Overall Study|Missing 3 consecutive study treatments|6|||
48847517|NCT03257410|157282185|FG000|Overall Study|Miscellaneous|2|||
48847518|NCT03257410|157282186|FG001|Overall Study|Miscellaneous|2|||
48847519|NCT03257410|157282185|FG000|Overall Study|Other|0|||
48847520|NCT03257410|157282186|FG001|Overall Study|Other|1|||
48847521|NCT03748641|157282187|FG000|Overall Study|Ongoing|155|||
48847522|NCT03748641|157282188|FG001|Overall Study|Ongoing|148|||
48847523|NCT03748641|157282189|FG002|Overall Study|Ongoing|66|||
48847524|NCT03748641|157282190|FG003|Overall Study|Ongoing|79|||
48847525|NCT03748641|157282191|FG004|Overall Study|Ongoing|84|||
48847526|NCT03748641|157282187|FG000|Overall Study|Death|54|||
48847527|NCT03748641|157282188|FG001|Overall Study|Death|59|||
48935914|NCT01097629|157594042|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
48935915|NCT01097629|157594035|FG000|DB RO Phase|Withdrawal by Subject|0|||
48935916|NCT01097629|157594036|FG001|DB RO Phase|Withdrawal by Subject|0|||
48935917|NCT01097629|157594037|FG002|DB RO Phase|Withdrawal by Subject|0|||
48935918|NCT01097629|157594038|FG003|DB RO Phase|Withdrawal by Subject|0|||
48935919|NCT01097629|157594039|FG004|DB RO Phase|Withdrawal by Subject|0|||
48935920|NCT01097629|157594040|FG005|DB RO Phase|Withdrawal by Subject|0|||
48735658|NCT02215096|156883707|FG002|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
48735659|NCT02215096|156883708|FG003|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1|||
48935921|NCT01097629|157594041|FG006|DB RO Phase|Withdrawal by Subject|0|||
48935922|NCT01097629|157594042|FG007|DB RO Phase|Withdrawal by Subject|1|||
48935923|NCT01097629|157594035|FG000|DB RO Phase|Protocol Violation|0|||
48935924|NCT01097629|157594036|FG001|DB RO Phase|Protocol Violation|0|||
48735660|NCT02215096|156883709|FG004|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
48935925|NCT01097629|157594037|FG002|DB RO Phase|Protocol Violation|0|||
48935926|NCT01097629|157594038|FG003|DB RO Phase|Protocol Violation|1|||
48935927|NCT01097629|157594039|FG004|DB RO Phase|Protocol Violation|0|||
48935928|NCT01097629|157594040|FG005|DB RO Phase|Protocol Violation|1|||
48935929|NCT01097629|157594041|FG006|DB RO Phase|Protocol Violation|1|||
48935930|NCT01097629|157594042|FG007|DB RO Phase|Protocol Violation|0|||
48935931|NCT01097629|157594035|FG000|DB RO Phase|Lost to Follow-up|0|||
48735661|NCT02215096|156883705|FG000|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
48935932|NCT01097629|157594036|FG001|DB RO Phase|Lost to Follow-up|0|||
48935933|NCT01097629|157594037|FG002|DB RO Phase|Lost to Follow-up|0|||
48935934|NCT01097629|157594038|FG003|DB RO Phase|Lost to Follow-up|0|||
48935935|NCT01097629|157594039|FG004|DB RO Phase|Lost to Follow-up|0|||
48935936|NCT01097629|157594040|FG005|DB RO Phase|Lost to Follow-up|0|||
48935937|NCT01097629|157594041|FG006|DB RO Phase|Lost to Follow-up|2|||
48935938|NCT01097629|157594042|FG007|DB RO Phase|Lost to Follow-up|0|||
48935939|NCT03609619|157594044|FG000|Overall Study|Adverse Event|1|||
48935940|NCT03609619|157594045|FG001|Overall Study|Adverse Event|0|||
48935941|NCT03609619|157594044|FG000|Overall Study|Lack of Efficacy|1|||
48935942|NCT03609619|157594045|FG001|Overall Study|Lack of Efficacy|2|||
48935943|NCT03609619|157594044|FG000|Overall Study|Protocol Violation|5|||
48935944|NCT03609619|157594045|FG001|Overall Study|Protocol Violation|0|||
48935945|NCT03609619|157594044|FG000|Overall Study|Withdrawal by Subject|2|||
48935946|NCT03609619|157594045|FG001|Overall Study|Withdrawal by Subject|3|||
48935947|NCT03609619|157594044|FG000|Overall Study|Lost to Follow-up|1|||
48935948|NCT03609619|157594045|FG001|Overall Study|Lost to Follow-up|1|||
48935949|NCT00956943|157594046|FG000|Overall Study|Lost to Follow-up|9|||
48935950|NCT00956943|157594047|FG001|Overall Study|Lost to Follow-up|10|||
48935951|NCT02613208|157594048|FG000|Overall Study|Withdrawal by Subject|1|||
48935952|NCT02613208|157594048|FG000|Overall Study|Change of address|2|||
48935953|NCT02613208|157594048|FG000|Overall Study|Physician Decision|2|||
48935954|NCT02613208|157594048|FG000|Overall Study|Lost to Follow-up|5|||
48935955|NCT02613208|157594048|FG000|Overall Study|Death|37|||
48935956|NCT02663895|157594049|FG000|Overall Study|Adverse Event|3|||
48935957|NCT02663895|157594049|FG000|Overall Study|Physician Decision|2|||
48935958|NCT02663895|157594049|FG000|Overall Study|Progressive Systemic Sclerosis (SSc)|1|||
48935959|NCT02663895|157594049|FG000|Overall Study|Withdrawal by Subject|1|||
48935960|NCT02911688|157594050|FG000|Washout|Lost to Follow-up|1|||
48935961|NCT02911688|157594051|FG001|Washout|Lost to Follow-up|1|||
48935962|NCT02911688|157594050|FG000|Washout|Withdrawal by Subject|0|||
48935963|NCT02911688|157594051|FG001|Washout|Withdrawal by Subject|1|||
48935964|NCT00809328|157594052|FG000|Overall Study|Lack of Efficacy|18|||
48935965|NCT00809328|157594052|FG000|Overall Study|Adverse Event|6|||
48935966|NCT00809328|157594052|FG000|Overall Study|Protocol Violation|3|||
48935967|NCT00809328|157594052|FG000|Overall Study|Withdrawal by Subject|2|||
48935968|NCT00804687|157594053|FG000|Period 3: Treatment Period|Positive Drug screen|0|||
48935969|NCT00804687|157594054|FG001|Period 3: Treatment Period|Positive Drug screen|0|||
48935970|NCT00804687|157594055|FG002|Period 3: Treatment Period|Positive Drug screen|0|||
48935971|NCT00804687|157594056|FG003|Period 3: Treatment Period|Positive Drug screen|1|||
48935972|NCT00804687|157594057|FG004|Period 3: Treatment Period|Positive Drug screen|0|||
48935973|NCT00804687|157594058|FG005|Period 3: Treatment Period|Positive Drug screen|0|||
48935974|NCT00804687|157594053|FG000|Period 5: Treatment Period|Withdrawal by Subject|0|||
48935975|NCT00804687|157594054|FG001|Period 5: Treatment Period|Withdrawal by Subject|0|||
48935976|NCT00804687|157594055|FG002|Period 5: Treatment Period|Withdrawal by Subject|0|||
48935977|NCT00804687|157594056|FG003|Period 5: Treatment Period|Withdrawal by Subject|0|||
48935978|NCT00804687|157594057|FG004|Period 5: Treatment Period|Withdrawal by Subject|1|||
48935979|NCT00804687|157594058|FG005|Period 5: Treatment Period|Withdrawal by Subject|0|||
48935980|NCT00804687|157594053|FG000|Period 5: Treatment Period|Positive drugs of abuse|0|||
48935981|NCT00804687|157594054|FG001|Period 5: Treatment Period|Positive drugs of abuse|0|||
48935982|NCT00804687|157594055|FG002|Period 5: Treatment Period|Positive drugs of abuse|1|||
48935983|NCT00804687|157594056|FG003|Period 5: Treatment Period|Positive drugs of abuse|0|||
48935984|NCT00804687|157594057|FG004|Period 5: Treatment Period|Positive drugs of abuse|0|||
48935985|NCT00804687|157594058|FG005|Period 5: Treatment Period|Positive drugs of abuse|0|||
48935986|NCT00804687|157594053|FG000|Period 5: Treatment Period|Positive drug test|1|||
48935987|NCT00804687|157594054|FG001|Period 5: Treatment Period|Positive drug test|0|||
48935988|NCT00804687|157594055|FG002|Period 5: Treatment Period|Positive drug test|0|||
48935989|NCT00804687|157594056|FG003|Period 5: Treatment Period|Positive drug test|0|||
48935990|NCT00804687|157594057|FG004|Period 5: Treatment Period|Positive drug test|0|||
48935991|NCT00804687|157594058|FG005|Period 5: Treatment Period|Positive drug test|0|||
48935992|NCT03502330|157594061|FG000|Overall Study|Adverse Event|2|||
48935993|NCT03502330|157594062|FG001|Overall Study|Adverse Event|1|||
48935994|NCT03502330|157594063|FG002|Overall Study|Adverse Event|0|||
48935995|NCT03502330|157594064|FG003|Overall Study|Adverse Event|0|||
48935996|NCT03502330|157594065|FG004|Overall Study|Adverse Event|1|||
48935997|NCT03502330|157594066|FG005|Overall Study|Adverse Event|0|||
48935998|NCT03502330|157594067|FG006|Overall Study|Adverse Event|1|||
48935999|NCT03502330|157594068|FG007|Overall Study|Adverse Event|1|||
48936000|NCT03502330|157594069|FG008|Overall Study|Adverse Event|0|||
48936001|NCT03502330|157594061|FG000|Overall Study|Lack of Efficacy|1|||
48936002|NCT03502330|157594062|FG001|Overall Study|Lack of Efficacy|5|||
48936003|NCT03502330|157594063|FG002|Overall Study|Lack of Efficacy|3|||
48936004|NCT03502330|157594064|FG003|Overall Study|Lack of Efficacy|5|||
48936005|NCT03502330|157594065|FG004|Overall Study|Lack of Efficacy|1|||
48936006|NCT03502330|157594066|FG005|Overall Study|Lack of Efficacy|5|||
48936007|NCT03502330|157594067|FG006|Overall Study|Lack of Efficacy|5|||
48936008|NCT03502330|157594068|FG007|Overall Study|Lack of Efficacy|6|||
48936009|NCT03502330|157594069|FG008|Overall Study|Lack of Efficacy|0|||
48936010|NCT03502330|157594061|FG000|Overall Study|Physician Decision|0|||
48936011|NCT03502330|157594062|FG001|Overall Study|Physician Decision|0|||
48936012|NCT03502330|157594063|FG002|Overall Study|Physician Decision|0|||
48936013|NCT03502330|157594064|FG003|Overall Study|Physician Decision|0|||
48936014|NCT03502330|157594065|FG004|Overall Study|Physician Decision|1|||
48936015|NCT03502330|157594066|FG005|Overall Study|Physician Decision|0|||
48936016|NCT03502330|157594067|FG006|Overall Study|Physician Decision|0|||
48936017|NCT03502330|157594068|FG007|Overall Study|Physician Decision|0|||
48936018|NCT03502330|157594069|FG008|Overall Study|Physician Decision|0|||
48936019|NCT03502330|157594061|FG000|Overall Study|Withdrawal by Subject|0|||
48936020|NCT03502330|157594062|FG001|Overall Study|Withdrawal by Subject|0|||
48936021|NCT03502330|157594063|FG002|Overall Study|Withdrawal by Subject|0|||
48936022|NCT03502330|157594064|FG003|Overall Study|Withdrawal by Subject|0|||
48936023|NCT03502330|157594065|FG004|Overall Study|Withdrawal by Subject|0|||
48936024|NCT03502330|157594066|FG005|Overall Study|Withdrawal by Subject|1|||
48936025|NCT03502330|157594067|FG006|Overall Study|Withdrawal by Subject|0|||
48936026|NCT03502330|157594068|FG007|Overall Study|Withdrawal by Subject|1|||
48936027|NCT03502330|157594069|FG008|Overall Study|Withdrawal by Subject|0|||
48936028|NCT03502330|157594061|FG000|Overall Study|Death|0|||
48936029|NCT03502330|157594062|FG001|Overall Study|Death|0|||
48936030|NCT03502330|157594063|FG002|Overall Study|Death|0|||
48936031|NCT03502330|157594064|FG003|Overall Study|Death|0|||
48936032|NCT03502330|157594065|FG004|Overall Study|Death|0|||
48936033|NCT03502330|157594066|FG005|Overall Study|Death|0|||
48936034|NCT03502330|157594067|FG006|Overall Study|Death|2|||
48936035|NCT03502330|157594068|FG007|Overall Study|Death|0|||
48936036|NCT03502330|157594069|FG008|Overall Study|Death|0|||
48936037|NCT02597855|157594074|FG000|Overall Study|Lost to Follow-up|2|||
48936038|NCT02597855|157594075|FG001|Overall Study|Lost to Follow-up|1|||
48936039|NCT02472847|157594076|FG000|Overall Study|Withdrawal by Subject|1|||
48936040|NCT02472847|157594077|FG001|Overall Study|Withdrawal by Subject|5|||
48936041|NCT00008385|157594078|FG000|Overall Study|Off treatment reasons not reported|79|||
48936042|NCT00008385|157594079|FG001|Overall Study|Off treatment reasons not reported|70|||
48936043|NCT00008385|157594078|FG000|Overall Study|Progressive disease|52|||
48936044|NCT00008385|157594079|FG001|Overall Study|Progressive disease|117|||
48936045|NCT00008385|157594078|FG000|Overall Study|Adverse Event|8|||
48936046|NCT00008385|157594079|FG001|Overall Study|Adverse Event|20|||
48936047|NCT00008385|157594078|FG000|Overall Study|Death|12|||
48936048|NCT00008385|157594079|FG001|Overall Study|Death|18|||
48936049|NCT00008385|157594078|FG000|Overall Study|Withdrawal by Subject|67|||
48936050|NCT00008385|157594079|FG001|Overall Study|Withdrawal by Subject|157|||
48936051|NCT00008385|157594078|FG000|Overall Study|Start non-protocol therapy|3|||
48936052|NCT00008385|157594079|FG001|Overall Study|Start non-protocol therapy|1|||
48936053|NCT00008385|157594078|FG000|Overall Study|Other complicating disease|17|||
48936054|NCT00008385|157594079|FG001|Overall Study|Other complicating disease|30|||
48936055|NCT00008385|157594078|FG000|Overall Study|Maximum dose reached|0|||
48936056|NCT00008385|157594079|FG001|Overall Study|Maximum dose reached|2|||
48847528|NCT03748641|157282189|FG002|Overall Study|Death|51|||
48847529|NCT03748641|157282190|FG003|Overall Study|Death|42|||
48936057|NCT00008385|157594078|FG000|Overall Study|Other|105|||
48936058|NCT00008385|157594079|FG001|Overall Study|Other|212|||
48936059|NCT00008385|157594078|FG000|Overall Study|Not start protocol therapy|44|||
48936060|NCT00008385|157594079|FG001|Overall Study|Not start protocol therapy|175|||
48936061|NCT00582556|157594080|FG000|Overall Study|Withdrawal by Subject|0|||
48936062|NCT00582556|157594081|FG001|Overall Study|Withdrawal by Subject|1|||
48936063|NCT00582556|157594082|FG002|Overall Study|Withdrawal by Subject|1|||
48936064|NCT00582556|157594080|FG000|Overall Study|Physician Decision|0|||
48936065|NCT00582556|157594081|FG001|Overall Study|Physician Decision|0|||
48936066|NCT00582556|157594082|FG002|Overall Study|Physician Decision|1|||
48936067|NCT00430755|157594091|FG000|Overall Study|Withdrawal by Subject|53|||
48936068|NCT00332709|157594092|FG000|Overall Study|Adverse Event|11|||
48936069|NCT00332709|157594093|FG001|Overall Study|Adverse Event|14|||
48936070|NCT00332709|157594092|FG000|Overall Study|Withdrawal by Subject|2|||
48936071|NCT00332709|157594093|FG001|Overall Study|Withdrawal by Subject|3|||
48936072|NCT00332709|157594092|FG000|Overall Study|Lost to Follow-up|2|||
48936073|NCT00332709|157594093|FG001|Overall Study|Lost to Follow-up|0|||
48936074|NCT00332709|157594092|FG000|Overall Study|Administrative Problems|0|||
48936075|NCT00332709|157594093|FG001|Overall Study|Administrative Problems|3|||
48936076|NCT00332709|157594092|FG000|Overall Study|Abnormal test procedure result|1|||
48936077|NCT00332709|157594093|FG001|Overall Study|Abnormal test procedure result|0|||
48936078|NCT05425563|157594094|FG000|Overall Study|Withdrawal by Subject|17|||
48936079|NCT01001702|157594095|FG000|Overall Study|Lost to Follow-up|7|||
48936080|NCT01001702|157594095|FG000|Overall Study|Adverse Event|7|||
48936081|NCT01001702|157594095|FG000|Overall Study|Sponsor Discontinued Study|4|||
48936082|NCT01001702|157594095|FG000|Overall Study|Subject met Withdrawal Criteria|22|||
48936083|NCT01001702|157594095|FG000|Overall Study|Investigator withdrew Subject|10|||
48936084|NCT01001702|157594095|FG000|Overall Study|Withdrawal by Subject|19|||
48936085|NCT01001702|157594095|FG000|Overall Study|Lack of Efficacy per Investigator|3|||
48936086|NCT03480802|157594096|FG000|Overall Study|Lost to Follow-up|5|||
48847530|NCT03748641|157282191|FG004|Overall Study|Death|9|||
48847531|NCT03748641|157282187|FG000|Overall Study|Lost to Follow-up|0|||
48936087|NCT03480802|157594097|FG001|Overall Study|Lost to Follow-up|1|||
48847532|NCT03748641|157282188|FG001|Overall Study|Lost to Follow-up|2|||
48847533|NCT03748641|157282189|FG002|Overall Study|Lost to Follow-up|1|||
48847534|NCT03748641|157282190|FG003|Overall Study|Lost to Follow-up|0|||
48847535|NCT03748641|157282191|FG004|Overall Study|Lost to Follow-up|0|||
48847536|NCT03748641|157282187|FG000|Overall Study|Withdrawal by Subject|3|||
48847537|NCT03748641|157282188|FG001|Overall Study|Withdrawal by Subject|2|||
48847538|NCT03748641|157282189|FG002|Overall Study|Withdrawal by Subject|5|||
48847539|NCT03748641|157282190|FG003|Overall Study|Withdrawal by Subject|3|||
48847540|NCT03748641|157282191|FG004|Overall Study|Withdrawal by Subject|2|||
48847541|NCT03656718|157282194|FG000|Treatment Period Parts A, B, D, and E|Disease progression|8|||
48847542|NCT03656718|157282195|FG001|Treatment Period Parts A, B, D, and E|Disease progression|11|||
48847543|NCT03656718|157282196|FG002|Treatment Period Parts A, B, D, and E|Disease progression|4|||
48847544|NCT03656718|157282197|FG003|Treatment Period Parts A, B, D, and E|Disease progression|6|||
48847545|NCT03656718|157282198|FG004|Treatment Period Parts A, B, D, and E|Disease progression|0|||
48847546|NCT03656718|157282199|FG005|Treatment Period Parts A, B, D, and E|Disease progression|20|||
48847547|NCT03656718|157282200|FG006|Treatment Period Parts A, B, D, and E|Disease progression|14|||
48847548|NCT03656718|157282194|FG000|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
48847549|NCT03656718|157282195|FG001|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
48847550|NCT03656718|157282196|FG002|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
48847551|NCT03656718|157282197|FG003|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
48847552|NCT03656718|157282198|FG004|Treatment Period Parts A, B, D, and E|Study drug toxicity|0|||
48847553|NCT03656718|157282199|FG005|Treatment Period Parts A, B, D, and E|Study drug toxicity|4|||
48847554|NCT03656718|157282200|FG006|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
48936088|NCT03480802|157594096|FG000|Overall Study|Withdrawal by Subject|2|||
48936089|NCT03480802|157594097|FG001|Overall Study|Withdrawal by Subject|1|||
48936090|NCT03480802|157594096|FG000|Overall Study|Relocated|0|||
48936091|NCT03480802|157594097|FG001|Overall Study|Relocated|1|||
48936092|NCT00254566|157594104|FG000|Overall Study|Death|1|||
48735662|NCT02215096|156883706|FG001|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2|||
48735663|NCT02215096|156883707|FG002|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
48735664|NCT02215096|156883708|FG003|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
48936093|NCT00254566|157594105|FG001|Overall Study|Death|0|||
48936094|NCT00254566|157594104|FG000|Overall Study|Adverse Event|5|||
48936095|NCT00254566|157594105|FG001|Overall Study|Adverse Event|4|||
48936096|NCT00254566|157594104|FG000|Overall Study|Lack of Efficacy|12|||
48936097|NCT00254566|157594105|FG001|Overall Study|Lack of Efficacy|9|||
48936098|NCT00254566|157594104|FG000|Overall Study|Other|1|||
48936099|NCT00254566|157594105|FG001|Overall Study|Other|5|||
48936100|NCT00254566|157594104|FG000|Overall Study|Withdrawal by Subject|5|||
48936101|NCT00254566|157594105|FG001|Overall Study|Withdrawal by Subject|6|||
48936102|NCT00254566|157594104|FG000|Overall Study|Lost to Follow-up|7|||
48936103|NCT00254566|157594105|FG001|Overall Study|Lost to Follow-up|2|||
48936104|NCT01705691|157594108|FG000|Overall Study|Death|1|||
48936105|NCT01705691|157594109|FG001|Overall Study|Death|2|||
48936106|NCT01705691|157594108|FG000|Overall Study|Withdrawal by Subject|1|||
48936107|NCT01705691|157594109|FG001|Overall Study|Withdrawal by Subject|2|||
48936108|NCT01705691|157594108|FG000|Overall Study|Lost to Follow-up|1|||
48936109|NCT01705691|157594109|FG001|Overall Study|Lost to Follow-up|1|||
48936110|NCT01705691|157594108|FG000|Overall Study|Other|0|||
48936111|NCT01705691|157594109|FG001|Overall Study|Other|1|||
48936112|NCT00603239|157594110|FG000|Overall Study|Adverse Event|4|||
48936113|NCT00603239|157594111|FG001|Overall Study|Adverse Event|1|||
48936114|NCT00603239|157594110|FG000|Overall Study|Entry criteria not met|0|||
48936115|NCT00603239|157594111|FG001|Overall Study|Entry criteria not met|1|||
48936116|NCT00603239|157594110|FG000|Overall Study|Loss of glucose control|3|||
48936117|NCT00603239|157594111|FG001|Overall Study|Loss of glucose control|0|||
48936118|NCT00603239|157594110|FG000|Overall Study|Lost to Follow-up|2|||
48936119|NCT00603239|157594111|FG001|Overall Study|Lost to Follow-up|1|||
48936120|NCT00603239|157594110|FG000|Overall Study|Physician Decision|2|||
48936121|NCT00603239|157594111|FG001|Overall Study|Physician Decision|0|||
48936122|NCT00603239|157594110|FG000|Overall Study|Protocol Violation|2|||
48936123|NCT00603239|157594111|FG001|Overall Study|Protocol Violation|0|||
48936124|NCT00603239|157594110|FG000|Overall Study|Subject decision|2|||
48936125|NCT00603239|157594111|FG001|Overall Study|Subject decision|1|||
48936126|NCT01354132|157594112|FG000|Randomization|Physician Decision|1|||
48936127|NCT01354132|157594113|FG001|Randomization|Physician Decision|0|||
48936128|NCT01354132|157594112|FG000|Randomization|Withdrawal by Subject|0|||
48936129|NCT01354132|157594113|FG001|Randomization|Withdrawal by Subject|1|||
48936130|NCT01354132|157594112|FG000|Double Blind (Visits 1-7)|Adverse Event|1|||
48936131|NCT01354132|157594113|FG001|Double Blind (Visits 1-7)|Adverse Event|0|||
48936132|NCT01354132|157594112|FG000|Double Blind (Visits 1-7)|Withdrawal by Subject|8|||
48936133|NCT01354132|157594113|FG001|Double Blind (Visits 1-7)|Withdrawal by Subject|11|||
48936134|NCT01354132|157594112|FG000|1 Month Post Study Medication|Withdrawal by Subject|1|||
48936135|NCT01354132|157594113|FG001|1 Month Post Study Medication|Withdrawal by Subject|3|||
48936136|NCT01256177|157594116|FG000|Overall Study|Withdrawal by Subject|23|||
48936137|NCT01256177|157594117|FG001|Overall Study|Withdrawal by Subject|22|||
48936138|NCT01256177|157594116|FG000|Overall Study|Lost to Follow-up|2|||
48936139|NCT01256177|157594117|FG001|Overall Study|Lost to Follow-up|2|||
48936140|NCT01256177|157594116|FG000|Overall Study|Adverse Event|8|||
48936141|NCT01256177|157594117|FG001|Overall Study|Adverse Event|9|||
48936142|NCT01256177|157594116|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
48936143|NCT01256177|157594117|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
48936144|NCT01256177|157594116|FG000|Overall Study|Condition under Investigation Worsened|1|||
48936145|NCT01256177|157594117|FG001|Overall Study|Condition under Investigation Worsened|0|||
48936146|NCT01256177|157594116|FG000|Overall Study|Lack of Efficacy|11|||
48936147|NCT01256177|157594117|FG001|Overall Study|Lack of Efficacy|2|||
48936148|NCT01256177|157594116|FG000|Overall Study|TG=593mg/dL, not fit to participate.|1|||
48936149|NCT01256177|157594117|FG001|Overall Study|TG=593mg/dL, not fit to participate.|0|||
48936150|NCT01552681|157594120|FG000|Overall Study|Withdrawal by Subject|4|||
48936151|NCT01552681|157594121|FG001|Overall Study|Withdrawal by Subject|0|||
48936152|NCT01552681|157594120|FG000|Overall Study|Physician Decision|1|||
48936153|NCT01552681|157594121|FG001|Overall Study|Physician Decision|0|||
48936154|NCT01552681|157594120|FG000|Overall Study|Subject moved away|0|||
48936155|NCT01552681|157594121|FG001|Overall Study|Subject moved away|1|||
48936156|NCT00553462|157594132|FG000|Overall Study|Adverse Event|4|||
48936157|NCT00553462|157594132|FG000|Overall Study|Progression|4|||
48936158|NCT00553462|157594132|FG000|Overall Study|Withdrawal by Subject|5|||
48936159|NCT00553462|157594132|FG000|Overall Study|Physician Decision|1|||
48936160|NCT02789657|157594133|FG000|Overall Study|Withdrawal by Subject|2|||
48936161|NCT02789657|157594134|FG001|Overall Study|Withdrawal by Subject|0|||
48936162|NCT02789657|157594135|FG002|Overall Study|Withdrawal by Subject|0|||
48936163|NCT02789657|157594136|FG003|Overall Study|Withdrawal by Subject|0|||
48936164|NCT01679002|157594137|FG000|Overall Study|Adverse Event|1|||
48936165|NCT01679002|157594138|FG001|Overall Study|Adverse Event|1|||
48936166|NCT01679002|157594139|FG002|Overall Study|Adverse Event|0|||
48936167|NCT01728779|157594140|FG000|Overall Study|Withdrawal by Subject|1|||
48936168|NCT00110994|157594141|FG000|Double-blind (DB) Treatment|Adverse Event|3|||
48936169|NCT00110994|157594142|FG001|Double-blind (DB) Treatment|Adverse Event|0|||
48936170|NCT00110994|157594141|FG000|Double-blind (DB) Treatment|Death|1|||
48936171|NCT00110994|157594142|FG001|Double-blind (DB) Treatment|Death|0|||
48936172|NCT00110994|157594141|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|0|||
48936173|NCT00110994|157594142|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|2|||
48936174|NCT00110994|157594141|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
48936175|NCT00110994|157594142|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|1|||
48936176|NCT00110994|157594141|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|34|||
48936177|NCT00110994|157594142|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|41|||
48936178|NCT00110994|157594141|FG000|Double-blind (DB) Treatment|other reasons|2|||
48936179|NCT00110994|157594142|FG001|Double-blind (DB) Treatment|other reasons|3|||
48936180|NCT00110994|157594141|FG000|Active Follow-up|Disease progression/recurrence/replace|1|||
48936181|NCT00110994|157594142|FG001|Active Follow-up|Disease progression/recurrence/replace|0|||
48936182|NCT00110994|157594141|FG000|Active Follow-up|Other reasons|0|||
48936183|NCT00110994|157594142|FG001|Active Follow-up|Other reasons|2|||
48936184|NCT00110994|157594141|FG000|Long Term Follow-up|Death|19|||
48936185|NCT00110994|157594142|FG001|Long Term Follow-up|Death|17|||
48936186|NCT00531960|157594146|FG000|Overall Study|Adverse Event|5|||
48936187|NCT00531960|157594147|FG001|Overall Study|Adverse Event|4|||
48936188|NCT00531960|157594146|FG000|Overall Study|Death|3|||
48936189|NCT00531960|157594147|FG001|Overall Study|Death|2|||
48936190|NCT00531960|157594146|FG000|Overall Study|Lack of Efficacy|42|||
48936191|NCT00531960|157594147|FG001|Overall Study|Lack of Efficacy|41|||
48936192|NCT00531960|157594146|FG000|Overall Study|Violation of Selection Criteria|2|||
48936193|NCT00531960|157594147|FG001|Overall Study|Violation of Selection Criteria|0|||
48936194|NCT00531960|157594146|FG000|Overall Study|Refused Treatment|5|||
48936195|NCT00531960|157594147|FG001|Overall Study|Refused Treatment|6|||
48936196|NCT00531960|157594146|FG000|Overall Study|Other|4|||
48936197|NCT00531960|157594147|FG001|Overall Study|Other|10|||
48936198|NCT03486392|157594149|FG000|Overall Study|Lost to Follow-up|0|||
48936199|NCT03486392|157594150|FG001|Overall Study|Lost to Follow-up|0|||
48936200|NCT03486392|157594151|FG002|Overall Study|Lost to Follow-up|8|||
48936201|NCT03486392|157594152|FG003|Overall Study|Lost to Follow-up|5|||
48936202|NCT03486392|157594153|FG004|Overall Study|Lost to Follow-up|2|||
48936203|NCT03486392|157594149|FG000|Overall Study|Withdrawal by Subject|3|||
48936204|NCT03486392|157594150|FG001|Overall Study|Withdrawal by Subject|0|||
48936205|NCT03486392|157594151|FG002|Overall Study|Withdrawal by Subject|6|||
48936206|NCT03486392|157594152|FG003|Overall Study|Withdrawal by Subject|4|||
48936207|NCT03486392|157594153|FG004|Overall Study|Withdrawal by Subject|1|||
48936208|NCT03486392|157594149|FG000|Overall Study|Death|0|||
48936209|NCT03486392|157594150|FG001|Overall Study|Death|0|||
48936210|NCT03486392|157594151|FG002|Overall Study|Death|0|||
48936211|NCT03486392|157594152|FG003|Overall Study|Death|0|||
48936212|NCT03486392|157594153|FG004|Overall Study|Death|1|||
48936213|NCT00501228|157594166|FG000|Overall Study|Withdrawal by Subject|1|||
48936214|NCT00934102|157594168|FG000|Period 1, One Night of Wear|Personal Reasons|1|||
48936215|NCT00934102|157594169|FG001|Period 1, One Night of Wear|Personal Reasons|0|||
48936216|NCT00934102|157594170|FG002|Period 1, One Night of Wear|Personal Reasons|0|||
48936217|NCT02318784|157594171|FG000|Overall Study|Adverse Event|13|||
48936218|NCT02318784|157594171|FG000|Overall Study|Death|2|||
48936219|NCT02318784|157594171|FG000|Overall Study|Progressive Disease|37|||
48936220|NCT02318784|157594171|FG000|Overall Study|Withdrawal by Subject|10|||
48936221|NCT00675597|157594173|FG000|Overall Study|Withdrawal by Subject|3|||
48936222|NCT00642642|157594175|FG000|Treatment & Follow Up|Adverse Event|2|||
48936223|NCT00642642|157594175|FG000|Treatment & Follow Up|Withdrawal by Subject|5|||
48936224|NCT00642642|157594175|FG000|Treatment & Follow Up|Lost to Follow-up|10|||
48936225|NCT01524991|157596759|FG000|Overall Study|Adverse Event|12|||
48936226|NCT01524991|157596759|FG000|Overall Study|Death|1|||
48936227|NCT01524991|157596759|FG000|Overall Study|Disease ProgressionDu|17|||
48936228|NCT01524991|157596759|FG000|Overall Study|Other complicating disease|1|||
48936229|NCT01524991|157596759|FG000|Overall Study|Withdrawal by Subject|2|||
48936230|NCT01524991|157596759|FG000|Overall Study|Symptomatic Deterioration|1|||
48936231|NCT01773421|157596760|FG000|Treatment Phase|Other|0|||
48936232|NCT01773421|157596761|FG001|Treatment Phase|Other|0|||
48936233|NCT01773421|157596762|FG002|Treatment Phase|Other|2|||
48936234|NCT01773421|157596763|FG003|Treatment Phase|Other|0|||
48936235|NCT01773421|157596764|FG004|Treatment Phase|Other|0|||
48936236|NCT01773421|157596765|FG005|Treatment Phase|Other|0|||
48936237|NCT01773421|157596766|FG006|Treatment Phase|Other|0|||
48936238|NCT01773421|157596760|FG000|Treatment Phase|Adverse Event|0|||
48936239|NCT01773421|157596761|FG001|Treatment Phase|Adverse Event|0|||
48936240|NCT01773421|157596762|FG002|Treatment Phase|Adverse Event|3|||
48936241|NCT01773421|157596763|FG003|Treatment Phase|Adverse Event|1|||
48936242|NCT01773421|157596764|FG004|Treatment Phase|Adverse Event|0|||
48936243|NCT01773421|157596765|FG005|Treatment Phase|Adverse Event|0|||
48936244|NCT01773421|157596766|FG006|Treatment Phase|Adverse Event|0|||
48936245|NCT01773421|157596760|FG000|Treatment Phase|Withdrawal by Subject|0|||
48936246|NCT01773421|157596761|FG001|Treatment Phase|Withdrawal by Subject|0|||
48936247|NCT01773421|157596762|FG002|Treatment Phase|Withdrawal by Subject|1|||
48936248|NCT01773421|157596763|FG003|Treatment Phase|Withdrawal by Subject|1|||
48936249|NCT01773421|157596764|FG004|Treatment Phase|Withdrawal by Subject|0|||
48936250|NCT01773421|157596765|FG005|Treatment Phase|Withdrawal by Subject|0|||
48936251|NCT01773421|157596766|FG006|Treatment Phase|Withdrawal by Subject|0|||
48936252|NCT01773421|157596760|FG000|Extension Phase|Other|0|||
48936253|NCT01773421|157596761|FG001|Extension Phase|Other|0|||
48936254|NCT01773421|157596762|FG002|Extension Phase|Other|0|||
48936255|NCT01773421|157596763|FG003|Extension Phase|Other|0|||
48936256|NCT01773421|157596764|FG004|Extension Phase|Other|1|||
48936257|NCT01773421|157596765|FG005|Extension Phase|Other|2|||
48936258|NCT01773421|157596766|FG006|Extension Phase|Other|0|||
48936259|NCT01773421|157596760|FG000|Extension Phase|Adverse Event|0|||
48936260|NCT01773421|157596761|FG001|Extension Phase|Adverse Event|0|||
48936261|NCT01773421|157596762|FG002|Extension Phase|Adverse Event|0|||
48936262|NCT01773421|157596763|FG003|Extension Phase|Adverse Event|0|||
48936263|NCT01773421|157596764|FG004|Extension Phase|Adverse Event|2|||
48936264|NCT01773421|157596765|FG005|Extension Phase|Adverse Event|0|||
48936265|NCT01773421|157596766|FG006|Extension Phase|Adverse Event|0|||
48936266|NCT00808444|157596767|FG000|Overall Study|Withdrawal by Subject|1|||
48936267|NCT00808444|157596768|FG001|Overall Study|Withdrawal by Subject|0|||
48936268|NCT00808444|157596767|FG000|Overall Study|Lost to Follow-up|0|||
48936269|NCT00808444|157596768|FG001|Overall Study|Lost to Follow-up|1|||
48936270|NCT01805180|157596769|FG000|Lead-in Donor Phase|screen failure|1|||
48936271|NCT01805180|157596770|FG001|Lead-in Donor Phase|screen failure|0|||
48936272|NCT01805180|157596771|FG002|Lead-in Donor Phase|screen failure|0|||
48936273|NCT01400932|157596772|FG000|Overall Study|Adverse Event|10|||
48936274|NCT01400932|157596773|FG001|Overall Study|Adverse Event|5|||
48936275|NCT01400932|157596772|FG000|Overall Study|Lack of Efficacy|0|||
48936276|NCT01400932|157596773|FG001|Overall Study|Lack of Efficacy|3|||
48936277|NCT01400932|157596772|FG000|Overall Study|Withdrawal by Subject|2|||
48936278|NCT01400932|157596773|FG001|Overall Study|Withdrawal by Subject|6|||
48936279|NCT01400932|157596772|FG000|Overall Study|Lost to Follow-up|1|||
48936280|NCT01400932|157596773|FG001|Overall Study|Lost to Follow-up|0|||
48936281|NCT01400932|157596772|FG000|Overall Study|Protocol Deviation|0|||
48936282|NCT01400932|157596773|FG001|Overall Study|Protocol Deviation|1|||
48936283|NCT01400932|157596772|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
48936284|NCT01400932|157596773|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
48936285|NCT00365989|157596775|FG000|Overall Study|Withdrawal by Subject|1|||
48936286|NCT00365989|157596775|FG000|Overall Study|Non-compliance|1|||
48936287|NCT05499520|157596776|FG000|Overall Study|Lost to Follow-up|0|||
48936288|NCT05499520|157596777|FG001|Overall Study|Lost to Follow-up|0|||
48936289|NCT05499520|157596778|FG002|Overall Study|Lost to Follow-up|38|||
48936290|NCT05499520|157596779|FG003|Overall Study|Lost to Follow-up|41|||
48936291|NCT05499520|157596780|FG004|Overall Study|Lost to Follow-up|46|||
48936292|NCT05499520|157596781|FG005|Overall Study|Lost to Follow-up|0|||
48936293|NCT05499520|157596782|FG006|Overall Study|Lost to Follow-up|31|||
48936294|NCT05499520|157596783|FG007|Overall Study|Lost to Follow-up|45|||
48936295|NCT05499520|157596784|FG008|Overall Study|Lost to Follow-up|42|||
48936296|NCT05499520|157596785|FG009|Overall Study|Lost to Follow-up|0|||
48936297|NCT05499520|157596786|FG010|Overall Study|Lost to Follow-up|0|||
48936298|NCT05499520|157596787|FG011|Overall Study|Lost to Follow-up|37|||
48936299|NCT05499520|157596788|FG012|Overall Study|Lost to Follow-up|53|||
48847555|NCT03656718|157282194|FG000|Treatment Period Parts A, B, D, and E|Death|1|||
48847556|NCT03656718|157282195|FG001|Treatment Period Parts A, B, D, and E|Death|0|||
48847557|NCT03656718|157282196|FG002|Treatment Period Parts A, B, D, and E|Death|0|||
48847558|NCT03656718|157282197|FG003|Treatment Period Parts A, B, D, and E|Death|0|||
48847559|NCT03656718|157282198|FG004|Treatment Period Parts A, B, D, and E|Death|0|||
48847560|NCT03656718|157282199|FG005|Treatment Period Parts A, B, D, and E|Death|0|||
48847561|NCT03656718|157282200|FG006|Treatment Period Parts A, B, D, and E|Death|2|||
48847562|NCT03656718|157282194|FG000|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
48847563|NCT03656718|157282195|FG001|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
48847564|NCT03656718|157282196|FG002|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
48847565|NCT03656718|157282197|FG003|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
48847566|NCT03656718|157282198|FG004|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
48847567|NCT03656718|157282199|FG005|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|4|||
48847568|NCT03656718|157282200|FG006|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
48847569|NCT03656718|157282194|FG000|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|1|||
48847570|NCT03656718|157282195|FG001|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
48847571|NCT03656718|157282196|FG002|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
48847572|NCT03656718|157282197|FG003|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
48847573|NCT03656718|157282198|FG004|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
48847574|NCT03656718|157282199|FG005|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
48847575|NCT03656718|157282200|FG006|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|1|||
48847576|NCT03656718|157282194|FG000|Treatment Period Parts A, B, D, and E|Other reasons|0|||
48847577|NCT03656718|157282195|FG001|Treatment Period Parts A, B, D, and E|Other reasons|0|||
48847578|NCT03656718|157282196|FG002|Treatment Period Parts A, B, D, and E|Other reasons|0|||
48847579|NCT03656718|157282197|FG003|Treatment Period Parts A, B, D, and E|Other reasons|0|||
48847580|NCT03656718|157282198|FG004|Treatment Period Parts A, B, D, and E|Other reasons|0|||
48847581|NCT03656718|157282199|FG005|Treatment Period Parts A, B, D, and E|Other reasons|1|||
48847582|NCT03656718|157282200|FG006|Treatment Period Parts A, B, D, and E|Other reasons|3|||
48847583|NCT03656718|157282194|FG000|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
48847584|NCT03656718|157282195|FG001|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
48847585|NCT03656718|157282196|FG002|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
48847586|NCT03656718|157282197|FG003|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
48847587|NCT03656718|157282198|FG004|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
48847588|NCT03656718|157282199|FG005|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
48847589|NCT03656718|157282200|FG006|Treatment Period Parts A, B, D, and E|Continuing study treatment|14|||
48847590|NCT03656718|157282194|FG000|Treatment Period Part C|Disease progression|0|||
48847591|NCT03656718|157282195|FG001|Treatment Period Part C|Disease progression|0|||
48847592|NCT03656718|157282196|FG002|Treatment Period Part C|Disease progression|0|||
48936300|NCT05499520|157596789|FG013|Overall Study|Lost to Follow-up|49|||
48936301|NCT05499520|157596790|FG014|Overall Study|Lost to Follow-up|0|||
48936302|NCT05499520|157596791|FG015|Overall Study|Lost to Follow-up|36|||
48936303|NCT05499520|157596792|FG016|Overall Study|Lost to Follow-up|58|||
48936304|NCT05499520|157596793|FG017|Overall Study|Lost to Follow-up|53|||
48936305|NCT00832819|157596794|FG000|Overall Study|Adverse Event|0|||
48936306|NCT00832819|157596795|FG001|Overall Study|Adverse Event|1|||
48936307|NCT00832819|157596796|FG002|Overall Study|Adverse Event|0|||
48936308|NCT00832819|157596794|FG000|Overall Study|Protocol Violation|0|||
48936309|NCT00832819|157596795|FG001|Overall Study|Protocol Violation|0|||
48936310|NCT00832819|157596796|FG002|Overall Study|Protocol Violation|1|||
48936311|NCT00605267|157596797|FG000|Overall Study|Adverse Event|0|||
48936312|NCT00605267|157596798|FG001|Overall Study|Adverse Event|1|||
48936313|NCT00605267|157596797|FG000|Overall Study|Lack of Efficacy|1|||
48936314|NCT00605267|157596798|FG001|Overall Study|Lack of Efficacy|5|||
48936315|NCT00605267|157596797|FG000|Overall Study|Withdrawal by Subject|2|||
48936316|NCT00605267|157596798|FG001|Overall Study|Withdrawal by Subject|3|||
48936317|NCT02939131|157596799|FG000|Overall Study|Unable to get to clinic|6|||
48936318|NCT02939131|157596800|FG001|Overall Study|Unable to get to clinic|4|||
48936319|NCT02939131|157596799|FG000|Overall Study|Lost to Follow-up|2|||
48936320|NCT02939131|157596800|FG001|Overall Study|Lost to Follow-up|4|||
48936321|NCT02939131|157596799|FG000|Overall Study|severe debilitation|1|||
48936322|NCT02939131|157596800|FG001|Overall Study|severe debilitation|0|||
48936323|NCT02939131|157596799|FG000|Overall Study|Other|0|||
48936324|NCT02939131|157596800|FG001|Overall Study|Other|1|||
48936325|NCT02939131|157596799|FG000|Overall Study|not willing to adhere to protocol|2|||
48936326|NCT02939131|157596800|FG001|Overall Study|not willing to adhere to protocol|0|||
48936327|NCT00793793|157596801|FG000|Overall Study|Adverse Event|0|||
48936328|NCT00793793|157596802|FG001|Overall Study|Adverse Event|0|||
48936329|NCT00793793|157596803|FG002|Overall Study|Adverse Event|1|||
48936330|NCT00793793|157596804|FG003|Overall Study|Adverse Event|1|||
48936331|NCT00793793|157596805|FG004|Overall Study|Adverse Event|0|||
48936332|NCT00793793|157596806|FG005|Overall Study|Adverse Event|1|||
48936333|NCT00793793|157596807|FG006|Overall Study|Adverse Event|2|||
48936334|NCT00793793|157596808|FG007|Overall Study|Adverse Event|0|||
48936335|NCT00793793|157596809|FG008|Overall Study|Adverse Event|0|||
48936336|NCT00793793|157596810|FG009|Overall Study|Adverse Event|0|||
48936337|NCT00793793|157596811|FG010|Overall Study|Adverse Event|0|||
48936338|NCT00793793|157596812|FG011|Overall Study|Adverse Event|2|||
48936339|NCT00793793|157596801|FG000|Overall Study|Protocol Violation|0|||
48936340|NCT00793793|157596802|FG001|Overall Study|Protocol Violation|0|||
48936341|NCT00793793|157596803|FG002|Overall Study|Protocol Violation|0|||
48936342|NCT00793793|157596804|FG003|Overall Study|Protocol Violation|1|||
48936343|NCT00793793|157596805|FG004|Overall Study|Protocol Violation|0|||
48936344|NCT00793793|157596806|FG005|Overall Study|Protocol Violation|0|||
48936345|NCT00793793|157596807|FG006|Overall Study|Protocol Violation|0|||
48936346|NCT00793793|157596808|FG007|Overall Study|Protocol Violation|0|||
48936347|NCT00793793|157596809|FG008|Overall Study|Protocol Violation|0|||
48936348|NCT00793793|157596810|FG009|Overall Study|Protocol Violation|0|||
48936349|NCT00793793|157596811|FG010|Overall Study|Protocol Violation|0|||
48936350|NCT00793793|157596812|FG011|Overall Study|Protocol Violation|0|||
48936351|NCT00793793|157596801|FG000|Overall Study|Lost to Follow-up|0|||
48936352|NCT00793793|157596802|FG001|Overall Study|Lost to Follow-up|0|||
48936353|NCT00793793|157596803|FG002|Overall Study|Lost to Follow-up|1|||
48936354|NCT00793793|157596804|FG003|Overall Study|Lost to Follow-up|0|||
48936355|NCT00793793|157596805|FG004|Overall Study|Lost to Follow-up|0|||
48936356|NCT00793793|157596806|FG005|Overall Study|Lost to Follow-up|0|||
48936357|NCT00793793|157596807|FG006|Overall Study|Lost to Follow-up|0|||
48936358|NCT00793793|157596808|FG007|Overall Study|Lost to Follow-up|0|||
48936359|NCT00793793|157596809|FG008|Overall Study|Lost to Follow-up|1|||
48936360|NCT00793793|157596810|FG009|Overall Study|Lost to Follow-up|3|||
48936361|NCT00793793|157596811|FG010|Overall Study|Lost to Follow-up|1|||
48936362|NCT00793793|157596812|FG011|Overall Study|Lost to Follow-up|0|||
48936363|NCT00793793|157596801|FG000|Overall Study|Withdrawal by Subject|0|||
48936364|NCT00793793|157596802|FG001|Overall Study|Withdrawal by Subject|0|||
48936365|NCT00793793|157596803|FG002|Overall Study|Withdrawal by Subject|0|||
48936366|NCT00793793|157596804|FG003|Overall Study|Withdrawal by Subject|0|||
48936367|NCT00793793|157596805|FG004|Overall Study|Withdrawal by Subject|1|||
48936368|NCT00793793|157596806|FG005|Overall Study|Withdrawal by Subject|0|||
48936369|NCT00793793|157596807|FG006|Overall Study|Withdrawal by Subject|0|||
48936370|NCT00793793|157596808|FG007|Overall Study|Withdrawal by Subject|0|||
48735665|NCT02215096|156883709|FG004|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
48936371|NCT00793793|157596809|FG008|Overall Study|Withdrawal by Subject|1|||
48936372|NCT00793793|157596810|FG009|Overall Study|Withdrawal by Subject|0|||
48936373|NCT00793793|157596811|FG010|Overall Study|Withdrawal by Subject|0|||
48936374|NCT00793793|157596812|FG011|Overall Study|Withdrawal by Subject|0|||
48936375|NCT00793793|157596801|FG000|Overall Study|reason not specified|0|||
48936376|NCT00793793|157596802|FG001|Overall Study|reason not specified|1|||
48936377|NCT00793793|157596803|FG002|Overall Study|reason not specified|0|||
48936378|NCT00793793|157596804|FG003|Overall Study|reason not specified|1|||
48936379|NCT00793793|157596805|FG004|Overall Study|reason not specified|1|||
48936380|NCT00793793|157596806|FG005|Overall Study|reason not specified|1|||
48936381|NCT00793793|157596807|FG006|Overall Study|reason not specified|2|||
48936382|NCT00793793|157596808|FG007|Overall Study|reason not specified|0|||
48936383|NCT00793793|157596809|FG008|Overall Study|reason not specified|7|||
48936384|NCT00793793|157596810|FG009|Overall Study|reason not specified|6|||
48936385|NCT00793793|157596811|FG010|Overall Study|reason not specified|2|||
48936386|NCT00793793|157596812|FG011|Overall Study|reason not specified|4|||
48936387|NCT00840827|157596814|FG000|Overall Study|Adverse Event|1|||
48936388|NCT00840827|157596814|FG000|Overall Study|Lack of Efficacy|4|||
48936389|NCT00840827|157596814|FG000|Overall Study|Physician Decision|1|||
48936390|NCT02159807|157596815|FG000|Overall Study|Adverse Event|0|||
48936391|NCT02159807|157596816|FG001|Overall Study|Adverse Event|0|||
48936392|NCT02159807|157596817|FG002|Overall Study|Adverse Event|1|||
48936393|NCT02159807|157596815|FG000|Overall Study|No CSF|1|||
48936394|NCT02159807|157596816|FG001|Overall Study|No CSF|1|||
48936395|NCT02159807|157596817|FG002|Overall Study|No CSF|1|||
48936396|NCT02159807|157596815|FG000|Overall Study|elevated blood pressure|0|||
48936397|NCT02159807|157596816|FG001|Overall Study|elevated blood pressure|0|||
48936398|NCT02159807|157596817|FG002|Overall Study|elevated blood pressure|1|||
48936399|NCT01552902|157596818|FG000|Overall Study|Adverse Event|1|||
48936400|NCT01552902|157596819|FG001|Overall Study|Adverse Event|15|||
48936401|NCT01552902|157596820|FG002|Overall Study|Adverse Event|14|||
48936402|NCT01552902|157596818|FG000|Overall Study|Protocol Violation|3|||
48936403|NCT01552902|157596819|FG001|Overall Study|Protocol Violation|3|||
48936404|NCT01552902|157596820|FG002|Overall Study|Protocol Violation|3|||
48936405|NCT01552902|157596818|FG000|Overall Study|Lack of Efficacy|4|||
48936406|NCT01552902|157596819|FG001|Overall Study|Lack of Efficacy|3|||
48936407|NCT01552902|157596820|FG002|Overall Study|Lack of Efficacy|1|||
48936408|NCT01552902|157596818|FG000|Overall Study|Withdrawal by Subject|1|||
48936409|NCT01552902|157596819|FG001|Overall Study|Withdrawal by Subject|9|||
48936410|NCT01552902|157596820|FG002|Overall Study|Withdrawal by Subject|6|||
48936411|NCT01552902|157596818|FG000|Overall Study|Lost to Follow-up|1|||
48936412|NCT01552902|157596819|FG001|Overall Study|Lost to Follow-up|3|||
48936413|NCT01552902|157596820|FG002|Overall Study|Lost to Follow-up|6|||
48936414|NCT01552902|157596818|FG000|Overall Study|Other|3|||
48936415|NCT01552902|157596819|FG001|Overall Study|Other|4|||
48936416|NCT01552902|157596820|FG002|Overall Study|Other|3|||
48936417|NCT00950170|157596821|FG000|Overall Study|Parent/Legal Guardian Request|1|||
48936418|NCT00950170|157596821|FG000|Overall Study|Adverse Event|2|||
48936419|NCT00950170|157596821|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
48936420|NCT01848145|157596825|FG000|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1|||
48936421|NCT01848145|157596825|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1|||
48936422|NCT01848145|157596825|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1|||
48936423|NCT01848145|157596825|FG000|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1|||
48936424|NCT01848145|157596825|FG000|Subsequent Infusions: Weeks 3-8|Disease Progression|6|||
48936425|NCT01848145|157596825|FG000|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3|||
48936426|NCT01848145|157596825|FG000|Subsequent Infusions: Weeks 3-8|Death|1|||
48936427|NCT04067518|157596826|FG000|Overall Study|Adverse Event|1|||
48936428|NCT04067518|157596827|FG001|Overall Study|Adverse Event|3|||
48936429|NCT04067518|157596826|FG000|Overall Study|Screen failures|0|||
48936430|NCT04067518|157596827|FG001|Overall Study|Screen failures|1|||
48936431|NCT04067518|157596826|FG000|Overall Study|Enrolled but not treated|0|||
48936432|NCT04067518|157596827|FG001|Overall Study|Enrolled but not treated|1|||
48936433|NCT04426695|157596828|FG000|Overall Study|Death|2|||
48936434|NCT04426695|157596829|FG001|Overall Study|Death|0|||
48936435|NCT04426695|157596830|FG002|Overall Study|Death|1|||
48936436|NCT04426695|157596831|FG003|Overall Study|Death|27|||
48936437|NCT04426695|157596832|FG004|Overall Study|Death|25|||
48936438|NCT04426695|157596833|FG005|Overall Study|Death|21|||
48936439|NCT04426695|157596834|FG006|Overall Study|Death|42|||
48936440|NCT04426695|157596835|FG007|Overall Study|Death|23|||
48936441|NCT04426695|157596836|FG008|Overall Study|Death|37|||
48936442|NCT04426695|157596837|FG009|Overall Study|Death|14|||
48936443|NCT04426695|157596838|FG010|Overall Study|Death|8|||
48936444|NCT04426695|157596839|FG011|Overall Study|Death|7|||
48936445|NCT04426695|157596840|FG012|Overall Study|Death|13|||
48936446|NCT04426695|157596841|FG013|Overall Study|Death|25|||
48936447|NCT04426695|157596842|FG014|Overall Study|Death|19|||
48936448|NCT04426695|157596843|FG015|Overall Study|Death|7|||
48936449|NCT04426695|157596844|FG016|Overall Study|Death|8|||
48936450|NCT04426695|157596845|FG017|Overall Study|Death|4|||
48936451|NCT04426695|157596828|FG000|Overall Study|Lost to Follow-up|2|||
48936452|NCT04426695|157596829|FG001|Overall Study|Lost to Follow-up|4|||
48936453|NCT04426695|157596830|FG002|Overall Study|Lost to Follow-up|1|||
48936454|NCT04426695|157596831|FG003|Overall Study|Lost to Follow-up|19|||
48936455|NCT04426695|157596832|FG004|Overall Study|Lost to Follow-up|10|||
48936456|NCT04426695|157596833|FG005|Overall Study|Lost to Follow-up|14|||
48936457|NCT04426695|157596834|FG006|Overall Study|Lost to Follow-up|5|||
48936458|NCT04426695|157596835|FG007|Overall Study|Lost to Follow-up|14|||
48936459|NCT04426695|157596836|FG008|Overall Study|Lost to Follow-up|10|||
48936460|NCT04426695|157596837|FG009|Overall Study|Lost to Follow-up|11|||
48847593|NCT03656718|157282197|FG003|Treatment Period Part C|Disease progression|0|||
48847594|NCT03656718|157282198|FG004|Treatment Period Part C|Disease progression|12|||
48847595|NCT03656718|157282199|FG005|Treatment Period Part C|Disease progression|0|||
48847596|NCT03656718|157282200|FG006|Treatment Period Part C|Disease progression|0|||
48847597|NCT03656718|157282194|FG000|Treatment Period Part C|Death|0|||
48847598|NCT03656718|157282195|FG001|Treatment Period Part C|Death|0|||
48847599|NCT03656718|157282196|FG002|Treatment Period Part C|Death|0|||
48847600|NCT03656718|157282197|FG003|Treatment Period Part C|Death|0|||
48847601|NCT03656718|157282198|FG004|Treatment Period Part C|Death|1|||
48847602|NCT03656718|157282199|FG005|Treatment Period Part C|Death|0|||
48847603|NCT03656718|157282200|FG006|Treatment Period Part C|Death|0|||
48847604|NCT03656718|157282194|FG000|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
48847605|NCT03656718|157282195|FG001|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
48847606|NCT03656718|157282196|FG002|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
48936461|NCT04426695|157596838|FG010|Overall Study|Lost to Follow-up|12|||
48936462|NCT04426695|157596839|FG011|Overall Study|Lost to Follow-up|6|||
48936463|NCT04426695|157596840|FG012|Overall Study|Lost to Follow-up|2|||
48936464|NCT04426695|157596841|FG013|Overall Study|Lost to Follow-up|2|||
48936465|NCT04426695|157596842|FG014|Overall Study|Lost to Follow-up|2|||
48936466|NCT04426695|157596843|FG015|Overall Study|Lost to Follow-up|0|||
48936467|NCT04426695|157596844|FG016|Overall Study|Lost to Follow-up|0|||
48936468|NCT04426695|157596845|FG017|Overall Study|Lost to Follow-up|0|||
48936469|NCT04426695|157596828|FG000|Overall Study|Participant Decision|1|||
48936470|NCT04426695|157596829|FG001|Overall Study|Participant Decision|2|||
48936471|NCT04426695|157596830|FG002|Overall Study|Participant Decision|2|||
48936472|NCT04426695|157596831|FG003|Overall Study|Participant Decision|12|||
48936473|NCT04426695|157596832|FG004|Overall Study|Participant Decision|18|||
48936474|NCT04426695|157596833|FG005|Overall Study|Participant Decision|22|||
48936475|NCT04426695|157596834|FG006|Overall Study|Participant Decision|13|||
48936476|NCT04426695|157596835|FG007|Overall Study|Participant Decision|13|||
48936477|NCT04426695|157596836|FG008|Overall Study|Participant Decision|10|||
48936478|NCT04426695|157596837|FG009|Overall Study|Participant Decision|15|||
48936479|NCT04426695|157596838|FG010|Overall Study|Participant Decision|16|||
48936480|NCT04426695|157596839|FG011|Overall Study|Participant Decision|17|||
48936481|NCT04426695|157596840|FG012|Overall Study|Participant Decision|2|||
48936482|NCT04426695|157596841|FG013|Overall Study|Participant Decision|1|||
48936483|NCT04426695|157596842|FG014|Overall Study|Participant Decision|2|||
48936484|NCT04426695|157596843|FG015|Overall Study|Participant Decision|0|||
48936485|NCT04426695|157596844|FG016|Overall Study|Participant Decision|0|||
48936486|NCT04426695|157596845|FG017|Overall Study|Participant Decision|0|||
48936487|NCT04426695|157596828|FG000|Overall Study|Adverse Event|0|||
48936488|NCT04426695|157596829|FG001|Overall Study|Adverse Event|0|||
48936489|NCT04426695|157596830|FG002|Overall Study|Adverse Event|0|||
48936490|NCT04426695|157596831|FG003|Overall Study|Adverse Event|0|||
48936491|NCT04426695|157596832|FG004|Overall Study|Adverse Event|0|||
48936492|NCT04426695|157596833|FG005|Overall Study|Adverse Event|0|||
48936493|NCT04426695|157596834|FG006|Overall Study|Adverse Event|0|||
48936494|NCT04426695|157596835|FG007|Overall Study|Adverse Event|1|||
48936495|NCT04426695|157596836|FG008|Overall Study|Adverse Event|0|||
48936496|NCT04426695|157596837|FG009|Overall Study|Adverse Event|0|||
48936497|NCT04426695|157596838|FG010|Overall Study|Adverse Event|1|||
48936498|NCT04426695|157596839|FG011|Overall Study|Adverse Event|1|||
48936499|NCT04426695|157596840|FG012|Overall Study|Adverse Event|0|||
48936500|NCT04426695|157596841|FG013|Overall Study|Adverse Event|0|||
48936501|NCT04426695|157596842|FG014|Overall Study|Adverse Event|0|||
48936502|NCT04426695|157596843|FG015|Overall Study|Adverse Event|0|||
48936503|NCT04426695|157596844|FG016|Overall Study|Adverse Event|0|||
48936504|NCT04426695|157596845|FG017|Overall Study|Adverse Event|0|||
48936505|NCT04426695|157596828|FG000|Overall Study|Sponsor Request|0|||
48936506|NCT04426695|157596829|FG001|Overall Study|Sponsor Request|0|||
48936507|NCT04426695|157596830|FG002|Overall Study|Sponsor Request|0|||
48936508|NCT04426695|157596831|FG003|Overall Study|Sponsor Request|0|||
48936509|NCT04426695|157596832|FG004|Overall Study|Sponsor Request|0|||
48936510|NCT04426695|157596833|FG005|Overall Study|Sponsor Request|0|||
48735666|NCT02840721|156883710|FG000|Treatment Period|Adverse Event|1|||
48847607|NCT03656718|157282197|FG003|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
48936511|NCT04426695|157596834|FG006|Overall Study|Sponsor Request|1|||
48936512|NCT04426695|157596835|FG007|Overall Study|Sponsor Request|0|||
48936513|NCT04426695|157596836|FG008|Overall Study|Sponsor Request|0|||
48936514|NCT04426695|157596837|FG009|Overall Study|Sponsor Request|0|||
48936515|NCT04426695|157596838|FG010|Overall Study|Sponsor Request|0|||
48936516|NCT04426695|157596839|FG011|Overall Study|Sponsor Request|0|||
48936517|NCT04426695|157596840|FG012|Overall Study|Sponsor Request|0|||
48936518|NCT04426695|157596841|FG013|Overall Study|Sponsor Request|0|||
48936519|NCT04426695|157596842|FG014|Overall Study|Sponsor Request|0|||
48936520|NCT04426695|157596843|FG015|Overall Study|Sponsor Request|0|||
48936521|NCT04426695|157596844|FG016|Overall Study|Sponsor Request|0|||
48936522|NCT04426695|157596845|FG017|Overall Study|Sponsor Request|0|||
48936523|NCT04426695|157596828|FG000|Overall Study|Physician Decision|0|||
48936524|NCT04426695|157596829|FG001|Overall Study|Physician Decision|0|||
48936525|NCT04426695|157596830|FG002|Overall Study|Physician Decision|0|||
48936526|NCT04426695|157596831|FG003|Overall Study|Physician Decision|0|||
48936527|NCT04426695|157596832|FG004|Overall Study|Physician Decision|0|||
48936528|NCT04426695|157596833|FG005|Overall Study|Physician Decision|0|||
48936529|NCT04426695|157596834|FG006|Overall Study|Physician Decision|0|||
48936530|NCT04426695|157596835|FG007|Overall Study|Physician Decision|0|||
48936531|NCT04426695|157596836|FG008|Overall Study|Physician Decision|0|||
48936532|NCT04426695|157596837|FG009|Overall Study|Physician Decision|1|||
48936533|NCT04426695|157596838|FG010|Overall Study|Physician Decision|0|||
48936534|NCT04426695|157596839|FG011|Overall Study|Physician Decision|0|||
48936535|NCT04426695|157596840|FG012|Overall Study|Physician Decision|1|||
48936536|NCT04426695|157596841|FG013|Overall Study|Physician Decision|0|||
48936537|NCT04426695|157596842|FG014|Overall Study|Physician Decision|0|||
48936538|NCT04426695|157596843|FG015|Overall Study|Physician Decision|0|||
48936539|NCT04426695|157596844|FG016|Overall Study|Physician Decision|0|||
48936540|NCT04426695|157596845|FG017|Overall Study|Physician Decision|0|||
48936541|NCT04426695|157596828|FG000|Overall Study|Randomized but Never Treated|3|||
48936542|NCT04426695|157596829|FG001|Overall Study|Randomized but Never Treated|1|||
48936543|NCT04426695|157596830|FG002|Overall Study|Randomized but Never Treated|0|||
48936544|NCT04426695|157596831|FG003|Overall Study|Randomized but Never Treated|4|||
48936545|NCT04426695|157596832|FG004|Overall Study|Randomized but Never Treated|5|||
48936546|NCT04426695|157596833|FG005|Overall Study|Randomized but Never Treated|5|||
48936547|NCT04426695|157596834|FG006|Overall Study|Randomized but Never Treated|4|||
48936548|NCT04426695|157596835|FG007|Overall Study|Randomized but Never Treated|6|||
48936549|NCT04426695|157596836|FG008|Overall Study|Randomized but Never Treated|6|||
48936550|NCT04426695|157596837|FG009|Overall Study|Randomized but Never Treated|3|||
48936551|NCT04426695|157596838|FG010|Overall Study|Randomized but Never Treated|3|||
48936552|NCT04426695|157596839|FG011|Overall Study|Randomized but Never Treated|6|||
48936553|NCT04426695|157596840|FG012|Overall Study|Randomized but Never Treated|1|||
48936554|NCT04426695|157596841|FG013|Overall Study|Randomized but Never Treated|2|||
48936555|NCT04426695|157596842|FG014|Overall Study|Randomized but Never Treated|0|||
48936556|NCT04426695|157596843|FG015|Overall Study|Randomized but Never Treated|0|||
48936557|NCT04426695|157596844|FG016|Overall Study|Randomized but Never Treated|0|||
48936558|NCT04426695|157596845|FG017|Overall Study|Randomized but Never Treated|0|||
48936559|NCT00179959|157596848|FG000|Overall Study|Lost to Follow-up|3|||
48936560|NCT00179959|157596849|FG001|Overall Study|Lost to Follow-up|1|||
48936561|NCT00179959|157596848|FG000|Overall Study|Withdrawal by Subject|3|||
48936562|NCT00179959|157596849|FG001|Overall Study|Withdrawal by Subject|2|||
48936563|NCT00849667|157596850|FG000|Overall Study|Withdrawal by Subject|16|||
48936564|NCT00849667|157596851|FG001|Overall Study|Withdrawal by Subject|33|||
48936565|NCT00849667|157596852|FG002|Overall Study|Withdrawal by Subject|35|||
48936566|NCT00849667|157596850|FG000|Overall Study|Lost to Follow-up|8|||
48936567|NCT00849667|157596851|FG001|Overall Study|Lost to Follow-up|8|||
48936568|NCT00849667|157596852|FG002|Overall Study|Lost to Follow-up|8|||
48936569|NCT00849667|157596850|FG000|Overall Study|Adverse Event|1|||
48936570|NCT00849667|157596851|FG001|Overall Study|Adverse Event|2|||
48936571|NCT00849667|157596852|FG002|Overall Study|Adverse Event|0|||
48936572|NCT00849667|157596850|FG000|Overall Study|Other|18|||
48936573|NCT00849667|157596851|FG001|Overall Study|Other|19|||
48936574|NCT00849667|157596852|FG002|Overall Study|Other|18|||
48936575|NCT00849667|157596850|FG000|Overall Study|Progressive disease|119|||
48936576|NCT00849667|157596851|FG001|Overall Study|Progressive disease|100|||
48936577|NCT00849667|157596852|FG002|Overall Study|Progressive disease|112|||
48936578|NCT00849667|157596850|FG000|Overall Study|Sponsor decision|208|||
48936579|NCT00849667|157596851|FG001|Overall Study|Sponsor decision|204|||
48936580|NCT00849667|157596852|FG002|Overall Study|Sponsor decision|190|||
48936581|NCT00849667|157596850|FG000|Overall Study|Investigator discretion|0|||
48936582|NCT00849667|157596851|FG001|Overall Study|Investigator discretion|0|||
48936583|NCT00849667|157596852|FG002|Overall Study|Investigator discretion|1|||
48936584|NCT00781365|157596863|FG000|Overall Study|Withdrawal by Subject|13|||
48936585|NCT00781365|157596864|FG001|Overall Study|Withdrawal by Subject|8|||
48936586|NCT00781365|157596863|FG000|Overall Study|Did Not Attend Visit|20|||
48936587|NCT00781365|157596864|FG001|Overall Study|Did Not Attend Visit|28|||
48936588|NCT00781365|157596863|FG000|Overall Study|Language barrier|1|||
48936589|NCT00781365|157596864|FG001|Overall Study|Language barrier|0|||
48936590|NCT01960855|157596866|FG000|Overall Study|Subject noncompliant|1|||
48936591|NCT01960855|157596867|FG001|Overall Study|Subject noncompliant|0|||
48936592|NCT01960855|157596868|FG002|Overall Study|Subject noncompliant|0|||
48936593|NCT01960855|157596869|FG003|Overall Study|Subject noncompliant|0|||
48936594|NCT01960855|157596870|FG004|Overall Study|Subject noncompliant|0|||
48936595|NCT01960855|157596866|FG000|Overall Study|Adverse Event|2|||
48936596|NCT01960855|157596867|FG001|Overall Study|Adverse Event|0|||
48936597|NCT01960855|157596868|FG002|Overall Study|Adverse Event|6|||
48936598|NCT01960855|157596869|FG003|Overall Study|Adverse Event|2|||
48936599|NCT01960855|157596870|FG004|Overall Study|Adverse Event|2|||
48936600|NCT01960855|157596866|FG000|Overall Study|Lack of Efficacy|1|||
48936601|NCT01960855|157596867|FG001|Overall Study|Lack of Efficacy|1|||
48936602|NCT01960855|157596868|FG002|Overall Study|Lack of Efficacy|0|||
48936603|NCT01960855|157596869|FG003|Overall Study|Lack of Efficacy|0|||
48936604|NCT01960855|157596870|FG004|Overall Study|Lack of Efficacy|0|||
48936605|NCT01960855|157596866|FG000|Overall Study|Other|2|||
48936606|NCT01960855|157596867|FG001|Overall Study|Other|1|||
48936607|NCT01960855|157596868|FG002|Overall Study|Other|1|||
48936608|NCT01960855|157596869|FG003|Overall Study|Other|1|||
48936609|NCT01960855|157596870|FG004|Overall Study|Other|0|||
48936610|NCT01960855|157596866|FG000|Overall Study|Consent withdrawn by subject|3|||
48936611|NCT01960855|157596867|FG001|Overall Study|Consent withdrawn by subject|1|||
48936612|NCT01960855|157596868|FG002|Overall Study|Consent withdrawn by subject|2|||
48936613|NCT01960855|157596869|FG003|Overall Study|Consent withdrawn by subject|1|||
48936614|NCT01960855|157596870|FG004|Overall Study|Consent withdrawn by subject|1|||
48936615|NCT01960855|157596866|FG000|Overall Study|Lost to Follow-up|2|||
48936616|NCT01960855|157596867|FG001|Overall Study|Lost to Follow-up|1|||
48936617|NCT01960855|157596868|FG002|Overall Study|Lost to Follow-up|0|||
48936618|NCT01960855|157596869|FG003|Overall Study|Lost to Follow-up|0|||
48936619|NCT01960855|157596870|FG004|Overall Study|Lost to Follow-up|2|||
48936620|NCT02649634|157596871|FG000|Overall Study|Withdrawal by Subject|3|||
48936621|NCT02649634|157596872|FG001|Overall Study|Withdrawal by Subject|5|||
48936622|NCT02649634|157596871|FG000|Overall Study|Lost to Follow-up|0|||
48936623|NCT02649634|157596872|FG001|Overall Study|Lost to Follow-up|1|||
48936624|NCT03367871|157596873|FG000|Overall Study|Lost to Follow-up|1|||
48936625|NCT00763009|157596875|FG000|Overall Study|Coronary Anatomy unsuitable|1|||
48936626|NCT00607048|157596876|FG000|Overall Study|Adverse Event|0|||
48936627|NCT00607048|157596877|FG001|Overall Study|Adverse Event|1|||
48936628|NCT00607048|157596878|FG002|Overall Study|Adverse Event|0|||
48936629|NCT00607048|157596879|FG003|Overall Study|Adverse Event|0|||
48936630|NCT00607048|157596880|FG004|Overall Study|Adverse Event|4|||
48936631|NCT00607048|157596881|FG005|Overall Study|Adverse Event|0|||
48936632|NCT00607048|157596876|FG000|Overall Study|Global deterioration of health|1|||
48936633|NCT00607048|157596877|FG001|Overall Study|Global deterioration of health|0|||
48936634|NCT00607048|157596878|FG002|Overall Study|Global deterioration of health|0|||
48936635|NCT00607048|157596879|FG003|Overall Study|Global deterioration of health|0|||
48936636|NCT00607048|157596880|FG004|Overall Study|Global deterioration of health|0|||
48936637|NCT00607048|157596881|FG005|Overall Study|Global deterioration of health|0|||
48936638|NCT00607048|157596876|FG000|Overall Study|Objective disease progression - relapse|1|||
48936639|NCT00607048|157596877|FG001|Overall Study|Objective disease progression - relapse|2|||
48936640|NCT00607048|157596878|FG002|Overall Study|Objective disease progression - relapse|4|||
48936641|NCT00607048|157596879|FG003|Overall Study|Objective disease progression - relapse|2|||
48936642|NCT00607048|157596880|FG004|Overall Study|Objective disease progression - relapse|2|||
48936643|NCT00607048|157596881|FG005|Overall Study|Objective disease progression - relapse|2|||
48936644|NCT00607048|157596876|FG000|Overall Study|Withdrawal by Subject|0|||
48936645|NCT00607048|157596877|FG001|Overall Study|Withdrawal by Subject|0|||
48936646|NCT00607048|157596878|FG002|Overall Study|Withdrawal by Subject|0|||
48936647|NCT00607048|157596879|FG003|Overall Study|Withdrawal by Subject|1|||
48936648|NCT00607048|157596880|FG004|Overall Study|Withdrawal by Subject|0|||
48936649|NCT00607048|157596881|FG005|Overall Study|Withdrawal by Subject|2|||
48936650|NCT00607048|157596876|FG000|Overall Study|Other|1|||
48936651|NCT00607048|157596877|FG001|Overall Study|Other|1|||
48936652|NCT00607048|157596878|FG002|Overall Study|Other|0|||
48936653|NCT00607048|157596879|FG003|Overall Study|Other|0|||
48936654|NCT00607048|157596880|FG004|Overall Study|Other|0|||
48936655|NCT00607048|157596881|FG005|Overall Study|Other|1|||
48936656|NCT02013544|157596882|FG000|Overall Study|Adverse Event|5|||
48936657|NCT02013544|157596883|FG001|Overall Study|Adverse Event|5|||
48936658|NCT02013544|157596882|FG000|Overall Study|Lost to Follow-up|2|||
48936659|NCT02013544|157596883|FG001|Overall Study|Lost to Follow-up|3|||
48936660|NCT02013544|157596882|FG000|Overall Study|Withdrawal by Subject|2|||
48936661|NCT02013544|157596883|FG001|Overall Study|Withdrawal by Subject|8|||
48936662|NCT02013544|157596882|FG000|Overall Study|Physician Decision|0|||
48936663|NCT02013544|157596883|FG001|Overall Study|Physician Decision|1|||
48936664|NCT02013544|157596882|FG000|Overall Study|Entry criteria not met/non-compliance|2|||
48936665|NCT02013544|157596883|FG001|Overall Study|Entry criteria not met/non-compliance|3|||
48936666|NCT00885365|157596889|FG000|4 Weeks ON Treatment|Adverse Event|2|||
48936667|NCT00885365|157596890|FG001|4 Weeks ON Treatment|Adverse Event|4|||
48936668|NCT00885365|157596889|FG000|4 Weeks ON Treatment|Protocol Violation|1|||
48936669|NCT00885365|157596890|FG001|4 Weeks ON Treatment|Protocol Violation|2|||
48936670|NCT00885365|157596889|FG000|4 Weeks ON Treatment|Withdrawal by Subject|1|||
48936671|NCT00885365|157596890|FG001|4 Weeks ON Treatment|Withdrawal by Subject|0|||
48936672|NCT04897867|157596893|FG000|Overall Study|Withdrawal of Consent|1|||
48936673|NCT04897867|157596893|FG000|Overall Study|Pregnancy|1|||
48936674|NCT04897867|157596893|FG000|Overall Study|Lost to Follow-up|7|||
48936675|NCT04897867|157596893|FG000|Overall Study|Reason not Specified|2|||
48936676|NCT03663166|157596894|FG000|Overall Study|Withdrawal by Subject|1|||
48936677|NCT01413958|157596895|FG000|Overall Study|Lost to Follow-up|0|||
48936678|NCT01413958|157596896|FG001|Overall Study|Lost to Follow-up|1|||
48936679|NCT01614964|157596897|FG000|Overall Study|Withdrawal by Subject|2|||
48936680|NCT01614964|157596898|FG001|Overall Study|Withdrawal by Subject|0|||
48936681|NCT01614964|157596897|FG000|Overall Study|Lost to Follow-up|3|||
48936682|NCT01614964|157596898|FG001|Overall Study|Lost to Follow-up|0|||
48936683|NCT02700984|157596899|FG000|Overall Study|Death|2|||
48936684|NCT02700984|157596900|FG001|Overall Study|Death|1|||
48936685|NCT02700984|157596899|FG000|Overall Study|Lost to Follow-up|2|||
48936686|NCT02700984|157596900|FG001|Overall Study|Lost to Follow-up|1|||
48936687|NCT02700984|157596899|FG000|Overall Study|Physician Decision|0|||
48936688|NCT02700984|157596900|FG001|Overall Study|Physician Decision|1|||
48936689|NCT02700984|157596899|FG000|Overall Study|Withdrawal by Subject|8|||
48936690|NCT02700984|157596900|FG001|Overall Study|Withdrawal by Subject|9|||
48936691|NCT02700984|157596899|FG000|Overall Study|Reason not specified|3|||
48936692|NCT02700984|157596900|FG001|Overall Study|Reason not specified|2|||
48936693|NCT02393209|157596901|FG000|Overall Study|Study Terminated by Sponsor|1|||
48936694|NCT02393209|157596902|FG001|Overall Study|Study Terminated by Sponsor|1|||
48936695|NCT02393209|157596903|FG002|Overall Study|Study Terminated by Sponsor|0|||
48936696|NCT02393209|157596904|FG003|Overall Study|Study Terminated by Sponsor|0|||
48936697|NCT02393209|157596901|FG000|Overall Study|Withdrawal by Patient|1|||
48936698|NCT02393209|157596902|FG001|Overall Study|Withdrawal by Patient|0|||
48936699|NCT02393209|157596903|FG002|Overall Study|Withdrawal by Patient|0|||
48936700|NCT02393209|157596904|FG003|Overall Study|Withdrawal by Patient|0|||
48936701|NCT02393209|157596901|FG000|Overall Study|Death|2|||
48936702|NCT02393209|157596902|FG001|Overall Study|Death|2|||
48936703|NCT02393209|157596903|FG002|Overall Study|Death|0|||
48936704|NCT02393209|157596904|FG003|Overall Study|Death|0|||
48936705|NCT02393209|157596901|FG000|Overall Study|Death due to Disease Progression|2|||
48936706|NCT02393209|157596902|FG001|Overall Study|Death due to Disease Progression|2|||
48936707|NCT02393209|157596903|FG002|Overall Study|Death due to Disease Progression|0|||
48936708|NCT02393209|157596904|FG003|Overall Study|Death due to Disease Progression|0|||
48936709|NCT02393209|157596901|FG000|Overall Study|Death from Legionella Infection|0|||
48936710|NCT02393209|157596902|FG001|Overall Study|Death from Legionella Infection|1|||
48936711|NCT02393209|157596903|FG002|Overall Study|Death from Legionella Infection|0|||
48936712|NCT02393209|157596904|FG003|Overall Study|Death from Legionella Infection|0|||
48936713|NCT02393209|157596901|FG000|Overall Study|Patient Seen by Another Oncologist|0|||
48936714|NCT02393209|157596902|FG001|Overall Study|Patient Seen by Another Oncologist|1|||
48936715|NCT02393209|157596903|FG002|Overall Study|Patient Seen by Another Oncologist|0|||
48936716|NCT02393209|157596904|FG003|Overall Study|Patient Seen by Another Oncologist|0|||
48936717|NCT02393209|157596901|FG000|Overall Study|Lost to Follow-up|0|||
48936718|NCT02393209|157596902|FG001|Overall Study|Lost to Follow-up|1|||
48936719|NCT02393209|157596903|FG002|Overall Study|Lost to Follow-up|0|||
48936720|NCT02393209|157596904|FG003|Overall Study|Lost to Follow-up|0|||
48936721|NCT04433117|157596905|FG000|Overall Study|Withdrawal by Subject|1|||
48936722|NCT04433117|157596906|FG001|Overall Study|Withdrawal by Subject|0|||
48936723|NCT01628926|157596912|FG000|Overall Study|Adverse Event|13|||
48936724|NCT01628926|157596913|FG001|Overall Study|Adverse Event|11|||
48936725|NCT01628926|157596914|FG002|Overall Study|Adverse Event|9|||
48936726|NCT01628926|157596912|FG000|Overall Study|Lack of Efficacy|2|||
48936727|NCT01628926|157596913|FG001|Overall Study|Lack of Efficacy|1|||
48936728|NCT01628926|157596914|FG002|Overall Study|Lack of Efficacy|5|||
48936729|NCT01628926|157596912|FG000|Overall Study|Withdrawal by Subject|6|||
48936730|NCT01628926|157596913|FG001|Overall Study|Withdrawal by Subject|4|||
48936731|NCT01628926|157596914|FG002|Overall Study|Withdrawal by Subject|2|||
48936732|NCT01628926|157596912|FG000|Overall Study|Protocol Violation|0|||
48936733|NCT01628926|157596913|FG001|Overall Study|Protocol Violation|1|||
48936734|NCT01628926|157596914|FG002|Overall Study|Protocol Violation|0|||
48936735|NCT01628926|157596912|FG000|Overall Study|Discontinuation criteria|3|||
48936736|NCT01628926|157596913|FG001|Overall Study|Discontinuation criteria|4|||
48936737|NCT01628926|157596914|FG002|Overall Study|Discontinuation criteria|0|||
48936738|NCT01628926|157596912|FG000|Overall Study|Physician Decision|2|||
48936739|NCT01628926|157596913|FG001|Overall Study|Physician Decision|2|||
48936740|NCT01628926|157596914|FG002|Overall Study|Physician Decision|1|||
48936741|NCT02700451|157596915|FG000|Overall Study|Protocol Violation|2|||
48936742|NCT02700451|157596916|FG001|Overall Study|Protocol Violation|2|||
48936743|NCT02700451|157596917|FG002|Overall Study|Protocol Violation|3|||
48936744|NCT02700451|157596915|FG000|Overall Study|Discontinued intervention|14|||
48936745|NCT02700451|157596916|FG001|Overall Study|Discontinued intervention|15|||
48936746|NCT02700451|157596917|FG002|Overall Study|Discontinued intervention|14|||
48936747|NCT00454207|157596918|FG000|Overall Study|Adverse Event|3|||
48936748|NCT00454207|157596919|FG001|Overall Study|Adverse Event|1|||
48936749|NCT00454207|157596918|FG000|Overall Study|Lack of Efficacy|1|||
48936750|NCT00454207|157596919|FG001|Overall Study|Lack of Efficacy|0|||
48936751|NCT00454207|157596918|FG000|Overall Study|Protocol Violation|0|||
48936752|NCT00454207|157596919|FG001|Overall Study|Protocol Violation|1|||
48936753|NCT01672957|157596920|FG000|Overall Study|Protocol Violation|48|||
48936754|NCT01672957|157596920|FG000|Overall Study|Death|2|||
48936755|NCT01672957|157596920|FG000|Overall Study|ICF Signed After Transplantation|5|||
48936756|NCT02115308|157596922|FG000|Overall Study|Safety Screening|2|||
48936757|NCT02115308|157596923|FG001|Overall Study|Safety Screening|2|||
48936758|NCT01889602|157596924|FG000|First Intervention|Adverse Event|1|||
48936759|NCT01889602|157596925|FG001|First Intervention|Adverse Event|1|||
48936760|NCT01889602|157596926|FG002|First Intervention|Adverse Event|1|||
48936761|NCT01889602|157596924|FG000|First Intervention|Protocol Violation|0|||
48936762|NCT01889602|157596925|FG001|First Intervention|Protocol Violation|1|||
48936763|NCT01889602|157596926|FG002|First Intervention|Protocol Violation|1|||
48936764|NCT01889602|157596924|FG000|First Intervention|Study ending|0|||
48936765|NCT01889602|157596925|FG001|First Intervention|Study ending|1|||
48936766|NCT01889602|157596926|FG002|First Intervention|Study ending|0|||
48936767|NCT01889602|157596924|FG000|Second Intervention|Adverse Event|0|||
48936768|NCT01889602|157596925|FG001|Second Intervention|Adverse Event|0|||
48936769|NCT01889602|157596926|FG002|Second Intervention|Adverse Event|1|||
48936770|NCT01889602|157596924|FG000|Second Intervention|Study ending|1|||
48936771|NCT01889602|157596925|FG001|Second Intervention|Study ending|0|||
48936772|NCT01889602|157596926|FG002|Second Intervention|Study ending|0|||
48936773|NCT01889602|157596924|FG000|Second Intervention|Withdrawal by Subject|0|||
48936774|NCT01889602|157596925|FG001|Second Intervention|Withdrawal by Subject|0|||
48936775|NCT01889602|157596926|FG002|Second Intervention|Withdrawal by Subject|1|||
48936776|NCT01889602|157596924|FG000|Third Intervention|Protocol Violation|1|||
48936777|NCT01889602|157596925|FG001|Third Intervention|Protocol Violation|0|||
48936778|NCT01889602|157596926|FG002|Third Intervention|Protocol Violation|0|||
48936779|NCT01889602|157596924|FG000|Third Intervention|Withdrawal by Subject|2|||
48936780|NCT01889602|157596925|FG001|Third Intervention|Withdrawal by Subject|2|||
48936781|NCT01889602|157596926|FG002|Third Intervention|Withdrawal by Subject|0|||
48936782|NCT00961961|157596927|FG000|Phase I|Withdrawal by Subject|7|||
48936783|NCT00961961|157596928|FG001|Phase I|Withdrawal by Subject|0|||
48936784|NCT00961961|157596929|FG002|Phase I|Withdrawal by Subject|0|||
48936785|NCT00961961|157596930|FG003|Phase I|Withdrawal by Subject|0|||
48936786|NCT00961961|157596927|FG000|Phase I|Lost to Follow-up|10|||
48936787|NCT00961961|157596928|FG001|Phase I|Lost to Follow-up|0|||
48936788|NCT00961961|157596929|FG002|Phase I|Lost to Follow-up|0|||
48936789|NCT00961961|157596930|FG003|Phase I|Lost to Follow-up|0|||
48936790|NCT00961961|157596927|FG000|Phase I|Lack of Efficacy|94|||
48936791|NCT00961961|157596928|FG001|Phase I|Lack of Efficacy|0|||
48936792|NCT00961961|157596929|FG002|Phase I|Lack of Efficacy|0|||
48936793|NCT00961961|157596930|FG003|Phase I|Lack of Efficacy|0|||
48936794|NCT00961961|157596927|FG000|Phase I|Adverse Event|7|||
48936795|NCT00961961|157596928|FG001|Phase I|Adverse Event|0|||
48936796|NCT00961961|157596929|FG002|Phase I|Adverse Event|0|||
48936797|NCT00961961|157596930|FG003|Phase I|Adverse Event|0|||
48936798|NCT00961961|157596927|FG000|Phase I|Physician Decision|8|||
48936799|NCT00961961|157596928|FG001|Phase I|Physician Decision|0|||
48936800|NCT00961961|157596929|FG002|Phase I|Physician Decision|0|||
48936801|NCT00961961|157596930|FG003|Phase I|Physician Decision|0|||
48936802|NCT00961961|157596927|FG000|Phase II|Lost to Follow-up|0|||
48936803|NCT00961961|157596928|FG001|Phase II|Lost to Follow-up|0|||
48936804|NCT00961961|157596929|FG002|Phase II|Lost to Follow-up|10|||
48936805|NCT00961961|157596930|FG003|Phase II|Lost to Follow-up|7|||
48936806|NCT00961961|157596927|FG000|Phase II|Adverse Event|0|||
48936807|NCT00961961|157596928|FG001|Phase II|Adverse Event|0|||
48936808|NCT00961961|157596929|FG002|Phase II|Adverse Event|0|||
48936809|NCT00961961|157596930|FG003|Phase II|Adverse Event|1|||
48936810|NCT00961961|157596927|FG000|Phase II|Physician Decision|0|||
48936811|NCT00961961|157596928|FG001|Phase II|Physician Decision|0|||
48936812|NCT00961961|157596929|FG002|Phase II|Physician Decision|1|||
48847608|NCT03656718|157282198|FG004|Treatment Period Part C|Participant requested to discontinue study treatment|1|||
48847609|NCT03656718|157282199|FG005|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
48847610|NCT03656718|157282200|FG006|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
48847611|NCT03656718|157282194|FG000|Treatment Period Part C|Other reasons|0|||
48847612|NCT03656718|157282195|FG001|Treatment Period Part C|Other reasons|0|||
48936813|NCT00961961|157596930|FG003|Phase II|Physician Decision|0|||
48936814|NCT00961961|157596927|FG000|Phase II|Withdrawal by Subject|0|||
48936815|NCT00961961|157596928|FG001|Phase II|Withdrawal by Subject|0|||
48847613|NCT03656718|157282196|FG002|Treatment Period Part C|Other reasons|0|||
48847614|NCT03656718|157282197|FG003|Treatment Period Part C|Other reasons|0|||
48847615|NCT03656718|157282198|FG004|Treatment Period Part C|Other reasons|1|||
48847616|NCT03656718|157282199|FG005|Treatment Period Part C|Other reasons|0|||
48847617|NCT03656718|157282200|FG006|Treatment Period Part C|Other reasons|0|||
48936816|NCT00961961|157596929|FG002|Phase II|Withdrawal by Subject|1|||
48936817|NCT00961961|157596930|FG003|Phase II|Withdrawal by Subject|0|||
48936818|NCT00404092|157596931|FG000|Overall Study|Death|1|||
48936819|NCT00404092|157596932|FG001|Overall Study|Death|0|||
48936820|NCT00404092|157596933|FG002|Overall Study|Death|0|||
48936821|NCT00404092|157596934|FG003|Overall Study|Death|0|||
48936822|NCT00404092|157596931|FG000|Overall Study|Adverse Event|0|||
48936823|NCT00404092|157596932|FG001|Overall Study|Adverse Event|0|||
48936824|NCT00404092|157596933|FG002|Overall Study|Adverse Event|1|||
48936825|NCT00404092|157596934|FG003|Overall Study|Adverse Event|0|||
48936826|NCT01442181|157596935|FG000|Overall Study|patient refused surgery|1|||
48936827|NCT01442181|157596936|FG001|Overall Study|patient refused surgery|0|||
48936828|NCT01442181|157596935|FG000|Overall Study|no insurance for surgery|1|||
48936829|NCT01442181|157596936|FG001|Overall Study|no insurance for surgery|0|||
48936830|NCT01442181|157596935|FG000|Overall Study|low ejection factor|0|||
48936831|NCT01442181|157596936|FG001|Overall Study|low ejection factor|1|||
48936832|NCT01442181|157596935|FG000|Overall Study|Lost to Follow-up|1|||
48936833|NCT01442181|157596936|FG001|Overall Study|Lost to Follow-up|1|||
48936834|NCT01442181|157596935|FG000|Overall Study|patient in an additional study|1|||
48936835|NCT01442181|157596936|FG001|Overall Study|patient in an additional study|0|||
48936836|NCT01442181|157596935|FG000|Overall Study|atrial fibrillation not noted|0|||
48936837|NCT01442181|157596936|FG001|Overall Study|atrial fibrillation not noted|1|||
48936838|NCT01243268|157596937|FG000|Overall Study|Lost to Follow-up|4|||
48936839|NCT01243268|157596937|FG000|Overall Study|Protocol Violation|51|||
48936840|NCT01243268|157596937|FG000|Overall Study|Deviation with contract date|7|||
48936841|NCT01243268|157596937|FG000|Overall Study|Duplicate subject|2|||
48936842|NCT01926626|157596938|FG000|Overall Study|Withdrawal by Subject|15|||
48936843|NCT01926626|157596938|FG000|Overall Study|Lost to Follow-up|7|||
48936844|NCT00741819|157596939|FG000|Overall Study|Adverse Event|3|||
48936845|NCT00741819|157596939|FG000|Overall Study|Withdrawal by Subject|3|||
48936846|NCT00741819|157596939|FG000|Overall Study|Death|1|||
48936847|NCT00741819|157596939|FG000|Overall Study|Disease progression|1|||
48936848|NCT01126580|157596940|FG000|Overall Study|Adverse Event|14|||
48936849|NCT01126580|157596941|FG001|Overall Study|Adverse Event|8|||
48936850|NCT01126580|157596942|FG002|Overall Study|Adverse Event|12|||
48936851|NCT01126580|157596940|FG000|Overall Study|Withdrawal by Subject|11|||
48936852|NCT01126580|157596941|FG001|Overall Study|Withdrawal by Subject|19|||
48936853|NCT01126580|157596942|FG002|Overall Study|Withdrawal by Subject|14|||
48936854|NCT01126580|157596940|FG000|Overall Study|Sponsor Decision|5|||
48936855|NCT01126580|157596941|FG001|Overall Study|Sponsor Decision|4|||
48936856|NCT01126580|157596942|FG002|Overall Study|Sponsor Decision|7|||
48936857|NCT01126580|157596940|FG000|Overall Study|Physician Decision|1|||
48936858|NCT01126580|157596941|FG001|Overall Study|Physician Decision|1|||
48936859|NCT01126580|157596942|FG002|Overall Study|Physician Decision|2|||
48936860|NCT01126580|157596940|FG000|Overall Study|Entry Criteria Not Met|1|||
48936861|NCT01126580|157596941|FG001|Overall Study|Entry Criteria Not Met|1|||
48936862|NCT01126580|157596942|FG002|Overall Study|Entry Criteria Not Met|2|||
48936863|NCT01126580|157596940|FG000|Overall Study|Lack of Efficacy|2|||
48936864|NCT01126580|157596941|FG001|Overall Study|Lack of Efficacy|3|||
48936865|NCT01126580|157596942|FG002|Overall Study|Lack of Efficacy|4|||
48936866|NCT01126580|157596940|FG000|Overall Study|Protocol Violation|0|||
48936867|NCT01126580|157596941|FG001|Overall Study|Protocol Violation|1|||
48936868|NCT01126580|157596942|FG002|Overall Study|Protocol Violation|2|||
48936869|NCT01126580|157596940|FG000|Overall Study|Lost to Follow-up|15|||
48936870|NCT01126580|157596941|FG001|Overall Study|Lost to Follow-up|13|||
48936871|NCT01126580|157596942|FG002|Overall Study|Lost to Follow-up|9|||
48936872|NCT01126580|157596940|FG000|Overall Study|Treatment Non-compliance|0|||
48936873|NCT01126580|157596941|FG001|Overall Study|Treatment Non-compliance|2|||
48936874|NCT01126580|157596942|FG002|Overall Study|Treatment Non-compliance|3|||
48936875|NCT01731002|157596943|FG000|Overall Study|Adverse Event|0|||
48936876|NCT01731002|157596944|FG001|Overall Study|Adverse Event|2|||
48936877|NCT01731002|157596945|FG002|Overall Study|Adverse Event|2|||
48936878|NCT01731002|157596943|FG000|Overall Study|Non-Compliant|0|||
48936879|NCT01731002|157596944|FG001|Overall Study|Non-Compliant|1|||
48936880|NCT01731002|157596945|FG002|Overall Study|Non-Compliant|0|||
48936881|NCT01731002|157596943|FG000|Overall Study|Lost to Follow-up|1|||
48936882|NCT01731002|157596944|FG001|Overall Study|Lost to Follow-up|0|||
48936883|NCT01731002|157596945|FG002|Overall Study|Lost to Follow-up|0|||
48936884|NCT01731002|157596943|FG000|Overall Study|Test Agent Discontinuation|0|||
48936885|NCT01731002|157596944|FG001|Overall Study|Test Agent Discontinuation|1|||
48936886|NCT01731002|157596945|FG002|Overall Study|Test Agent Discontinuation|0|||
48936887|NCT01731002|157596943|FG000|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2|||
48936888|NCT01731002|157596944|FG001|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
48936889|NCT01731002|157596945|FG002|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
48936890|NCT01731002|157596943|FG000|Overall Study|Elevated IOP|1|||
48936891|NCT01731002|157596944|FG001|Overall Study|Elevated IOP|0|||
48936892|NCT01731002|157596945|FG002|Overall Study|Elevated IOP|0|||
48936893|NCT01731002|157596943|FG000|Overall Study|Inappropriate use of study medications|0|||
48936894|NCT01731002|157596944|FG001|Overall Study|Inappropriate use of study medications|0|||
48936895|NCT01731002|157596945|FG002|Overall Study|Inappropriate use of study medications|1|||
48936896|NCT01053429|157596946|FG000|Overall Study|Adverse Event|64|||
48936897|NCT01053429|157596946|FG000|Overall Study|Other|309|||
48936898|NCT00924703|157596947|FG000|Overall Study|Withdrawal by Subject|11|||
48936899|NCT00924703|157596947|FG000|Overall Study|Physician Decision|5|||
48936900|NCT00924703|157596947|FG000|Overall Study|Lost to Follow-up|3|||
48936901|NCT00924703|157596947|FG000|Overall Study|Adverse Event|2|||
48936902|NCT00924703|157596947|FG000|Overall Study|Withdrawal by Sponsor|1|||
48936903|NCT02582658|157596955|FG000|Overall Study|Failure to Return|10|||
48936904|NCT02582658|157596955|FG000|Overall Study|Insufficient Virological Response|2|||
48936905|NCT02582658|157596955|FG000|Overall Study|Withdrawn Consent|1|||
48936906|NCT02582658|157596955|FG000|Overall Study|Death|1|||
48847618|NCT03656718|157282194|FG000|Treatment Period Part C|Maximum clinical benefit|0|||
48847619|NCT03656718|157282195|FG001|Treatment Period Part C|Maximum clinical benefit|0|||
48847620|NCT03656718|157282196|FG002|Treatment Period Part C|Maximum clinical benefit|0|||
48847621|NCT03656718|157282197|FG003|Treatment Period Part C|Maximum clinical benefit|0|||
48847622|NCT03656718|157282198|FG004|Treatment Period Part C|Maximum clinical benefit|1|||
48847623|NCT03656718|157282199|FG005|Treatment Period Part C|Maximum clinical benefit|0|||
48847624|NCT03656718|157282200|FG006|Treatment Period Part C|Maximum clinical benefit|0|||
48847625|NCT00943917|157282201|FG000|Stage I|Adverse Event|1|||
48847626|NCT00943917|157282202|FG001|Stage I|Adverse Event|2|||
48847627|NCT00943917|157282203|FG002|Stage I|Adverse Event|2|||
48847628|NCT00943917|157282204|FG003|Stage I|Adverse Event|0|||
48847629|NCT00943917|157282205|FG004|Stage I|Adverse Event|0|||
48847630|NCT00943917|157282206|FG005|Stage I|Adverse Event|0|||
48847631|NCT00943917|157282207|FG006|Stage I|Adverse Event|0|||
48847632|NCT00943917|157282208|FG007|Stage I|Adverse Event|0|||
48847633|NCT00943917|157282209|FG008|Stage I|Adverse Event|0|||
48847634|NCT00943917|157282210|FG009|Stage I|Adverse Event|0|||
48847635|NCT00943917|157282211|FG010|Stage I|Adverse Event|0|||
48847636|NCT00943917|157282212|FG011|Stage I|Adverse Event|0|||
48847637|NCT00943917|157282213|FG012|Stage I|Adverse Event|0|||
48847638|NCT00943917|157282214|FG013|Stage I|Adverse Event|0|||
48847639|NCT00943917|157282215|FG014|Stage I|Adverse Event|0|||
48847640|NCT00943917|157282201|FG000|Stage I|Lost to Follow-up|0|||
48847641|NCT00943917|157282202|FG001|Stage I|Lost to Follow-up|0|||
48847642|NCT00943917|157282203|FG002|Stage I|Lost to Follow-up|1|||
48847643|NCT00943917|157282204|FG003|Stage I|Lost to Follow-up|0|||
48847644|NCT00943917|157282205|FG004|Stage I|Lost to Follow-up|0|||
48847645|NCT00943917|157282206|FG005|Stage I|Lost to Follow-up|0|||
48847646|NCT00943917|157282207|FG006|Stage I|Lost to Follow-up|0|||
48847647|NCT00943917|157282208|FG007|Stage I|Lost to Follow-up|0|||
48847648|NCT00943917|157282209|FG008|Stage I|Lost to Follow-up|0|||
48847649|NCT00943917|157282210|FG009|Stage I|Lost to Follow-up|0|||
48847650|NCT00943917|157282211|FG010|Stage I|Lost to Follow-up|0|||
48847651|NCT00943917|157282212|FG011|Stage I|Lost to Follow-up|0|||
48847652|NCT00943917|157282213|FG012|Stage I|Lost to Follow-up|0|||
48847653|NCT00943917|157282214|FG013|Stage I|Lost to Follow-up|0|||
48847654|NCT00943917|157282215|FG014|Stage I|Lost to Follow-up|0|||
48847655|NCT00943917|157282201|FG000|Stage I|hyperglycemia|0|||
48847656|NCT00943917|157282202|FG001|Stage I|hyperglycemia|0|||
48847657|NCT00943917|157282203|FG002|Stage I|hyperglycemia|1|||
48847658|NCT00943917|157282204|FG003|Stage I|hyperglycemia|0|||
48847659|NCT00943917|157282205|FG004|Stage I|hyperglycemia|0|||
48847660|NCT00943917|157282206|FG005|Stage I|hyperglycemia|0|||
48847661|NCT00943917|157282207|FG006|Stage I|hyperglycemia|0|||
48847662|NCT00943917|157282208|FG007|Stage I|hyperglycemia|0|||
48847663|NCT00943917|157282209|FG008|Stage I|hyperglycemia|0|||
48847664|NCT00943917|157282210|FG009|Stage I|hyperglycemia|0|||
48847665|NCT00943917|157282211|FG010|Stage I|hyperglycemia|0|||
48847666|NCT00943917|157282212|FG011|Stage I|hyperglycemia|0|||
48847667|NCT00943917|157282213|FG012|Stage I|hyperglycemia|0|||
48847668|NCT00943917|157282214|FG013|Stage I|hyperglycemia|0|||
48847669|NCT00943917|157282215|FG014|Stage I|hyperglycemia|0|||
48847670|NCT00943917|157282201|FG000|Stage I|A1C elevation|1|||
48847671|NCT00943917|157282202|FG001|Stage I|A1C elevation|0|||
48847672|NCT00943917|157282203|FG002|Stage I|A1C elevation|0|||
48847673|NCT00943917|157282204|FG003|Stage I|A1C elevation|0|||
48847674|NCT00943917|157282205|FG004|Stage I|A1C elevation|0|||
48847675|NCT00943917|157282206|FG005|Stage I|A1C elevation|0|||
48847676|NCT00943917|157282207|FG006|Stage I|A1C elevation|0|||
48847677|NCT00943917|157282208|FG007|Stage I|A1C elevation|0|||
48847678|NCT00943917|157282209|FG008|Stage I|A1C elevation|0|||
48847679|NCT00943917|157282210|FG009|Stage I|A1C elevation|0|||
48847680|NCT00943917|157282211|FG010|Stage I|A1C elevation|0|||
48847681|NCT00943917|157282212|FG011|Stage I|A1C elevation|0|||
48847682|NCT00943917|157282213|FG012|Stage I|A1C elevation|0|||
48847683|NCT00943917|157282214|FG013|Stage I|A1C elevation|0|||
48847684|NCT00943917|157282215|FG014|Stage I|A1C elevation|0|||
48847685|NCT00943917|157282201|FG000|Stage I|Withdrawal by Subject|2|||
48847686|NCT00943917|157282202|FG001|Stage I|Withdrawal by Subject|1|||
48936907|NCT02582658|157596955|FG000|Overall Study|Not further specified|11|||
48936908|NCT00398112|157598708|FG000|Overall Study|Adverse Event|4|||
48936909|NCT00398112|157598708|FG000|Overall Study|Disease progression|9|||
48936910|NCT00398112|157598708|FG000|Overall Study|Alternative treatment|1|||
48936911|NCT00398112|157598708|FG000|Overall Study|Withdrawal by Subject|3|||
48936912|NCT00398112|157598708|FG000|Overall Study|Death|1|||
48936913|NCT05148884|157598709|FG000|Overall Study|Withdrawal by Subject|3|||
48936914|NCT05148884|157598710|FG001|Overall Study|Withdrawal by Subject|0|||
48936915|NCT05148884|157598709|FG000|Overall Study|Deep brain stimulation operation|0|||
48936916|NCT05148884|157598710|FG001|Overall Study|Deep brain stimulation operation|1|||
48936917|NCT03244059|157598711|FG000|Specific Aim 1|Physician Decision|1|||
48936918|NCT03244059|157598712|FG001|Specific Aim 1|Physician Decision|0|||
48936919|NCT03244059|157598711|FG000|Specific Aim 2|Physician Decision|1|||
48936920|NCT03244059|157598712|FG001|Specific Aim 2|Physician Decision|0|||
48936921|NCT01993888|157598715|FG000|Overall Study|Death|1|||
48936922|NCT01993888|157598716|FG001|Overall Study|Death|1|||
48936923|NCT01993888|157598715|FG000|Overall Study|Lost to Follow-up|1|||
48936924|NCT01993888|157598716|FG001|Overall Study|Lost to Follow-up|1|||
48936925|NCT01993888|157598715|FG000|Overall Study|Withdrawal by Subject|0|||
48936926|NCT01993888|157598716|FG001|Overall Study|Withdrawal by Subject|1|||
48936927|NCT01276821|157598722|FG000|Overall Study|Protocol Violation|0|||
48936928|NCT01276821|157598723|FG001|Overall Study|Protocol Violation|1|||
48936929|NCT02162862|157598724|FG000|Overall Study|Lost to Follow-up|0|||
48936930|NCT02162862|157598725|FG001|Overall Study|Lost to Follow-up|11|||
48936931|NCT02162862|157598726|FG002|Overall Study|Lost to Follow-up|0|||
48936932|NCT02162862|157598724|FG000|Overall Study|Subject did not feel the med was needed|0|||
48936933|NCT02162862|157598725|FG001|Overall Study|Subject did not feel the med was needed|0|||
48936934|NCT02162862|157598726|FG002|Overall Study|Subject did not feel the med was needed|4|||
48936935|NCT00542191|157598727|FG000|Overall Study|Death|3|||
48936936|NCT02581995|157598735|FG000|Overall Study|Unspecified other|3|||
48936937|NCT02581995|157598735|FG000|Overall Study|Adverse Event|6|||
48936938|NCT02581995|157598735|FG000|Overall Study|Lost to Follow-up|5|||
48936939|NCT02581995|157598735|FG000|Overall Study|Withdrawal by participant|12|||
48936940|NCT02581995|157598735|FG000|Overall Study|Physician Decision|1|||
48936941|NCT02581995|157598735|FG000|Overall Study|Death|4|||
48936942|NCT00733902|157598736|FG000|Overall Study|Death|0|||
48936943|NCT00733902|157598737|FG001|Overall Study|Death|0|||
48936944|NCT00733902|157598738|FG002|Overall Study|Death|0|||
48936945|NCT00733902|157598739|FG003|Overall Study|Death|1|||
48936946|NCT00733902|157598736|FG000|Overall Study|Adverse Event|3|||
48936947|NCT00733902|157598737|FG001|Overall Study|Adverse Event|4|||
48936948|NCT00733902|157598738|FG002|Overall Study|Adverse Event|7|||
48936949|NCT00733902|157598739|FG003|Overall Study|Adverse Event|11|||
48936950|NCT00733902|157598736|FG000|Overall Study|Lack of Efficacy|56|||
48936951|NCT00733902|157598737|FG001|Overall Study|Lack of Efficacy|21|||
48936952|NCT00733902|157598738|FG002|Overall Study|Lack of Efficacy|34|||
48936953|NCT00733902|157598739|FG003|Overall Study|Lack of Efficacy|23|||
48936954|NCT00733902|157598736|FG000|Overall Study|Protocol Violation|4|||
48936955|NCT00733902|157598737|FG001|Overall Study|Protocol Violation|6|||
48936956|NCT00733902|157598738|FG002|Overall Study|Protocol Violation|3|||
48936957|NCT00733902|157598739|FG003|Overall Study|Protocol Violation|3|||
48936958|NCT00733902|157598736|FG000|Overall Study|Withdrawal by Subject|10|||
48936959|NCT00733902|157598737|FG001|Overall Study|Withdrawal by Subject|5|||
48936960|NCT00733902|157598738|FG002|Overall Study|Withdrawal by Subject|4|||
48936961|NCT00733902|157598739|FG003|Overall Study|Withdrawal by Subject|16|||
48936962|NCT00733902|157598736|FG000|Overall Study|Entered extension study|89|||
48936963|NCT00733902|157598737|FG001|Overall Study|Entered extension study|124|||
48936964|NCT00733902|157598738|FG002|Overall Study|Entered extension study|111|||
48936965|NCT00733902|157598739|FG003|Overall Study|Entered extension study|109|||
48936966|NCT00733902|157598736|FG000|Overall Study|Randomized but not treated|2|||
48936967|NCT00733902|157598737|FG001|Overall Study|Randomized but not treated|2|||
48936968|NCT00733902|157598738|FG002|Overall Study|Randomized but not treated|2|||
48936969|NCT00733902|157598739|FG003|Overall Study|Randomized but not treated|1|||
48936970|NCT01491178|157598740|FG000|Overall Study|Adverse Event|1016|||
48936971|NCT01491178|157598740|FG000|Overall Study|Improvement of NVAF|210|||
48936972|NCT01491178|157598740|FG000|Overall Study|To conduct invasive treatment|59|||
48936973|NCT01491178|157598740|FG000|Overall Study|Lost to follow-up (unknown reason)|287|||
48936974|NCT01491178|157598740|FG000|Overall Study|Lost to follow-up (changing hospital)|545|||
48936975|NCT01491178|157598740|FG000|Overall Study|To take a contraindication|20|||
48936976|NCT01491178|157598740|FG000|Overall Study|Other than specified above|657|||
48936977|NCT00395967|157598741|FG000|Treatment Period|Failed Mobilization|1|||
48936978|NCT00395967|157598741|FG000|Follow-up Period|Death|1|||
48936979|NCT00395967|157598741|FG000|Follow-up Period|Lost to Follow-up|1|||
48936980|NCT04698525|157598743|FG000|Overall Study|Lost to Follow-up|1|||
48936981|NCT04698525|157598744|FG001|Overall Study|Lost to Follow-up|2|||
48936982|NCT04698525|157598743|FG000|Overall Study|Three suffered of Covid-19|2|||
48936983|NCT04698525|157598744|FG001|Overall Study|Three suffered of Covid-19|1|||
48936984|NCT00474240|157598748|FG000|Overall Study|Withdrawal by Subject|1|||
48936985|NCT00474240|157598749|FG001|Overall Study|Withdrawal by Subject|1|||
48936986|NCT00474240|157598750|FG002|Overall Study|Withdrawal by Subject|0|||
48936987|NCT00474240|157598751|FG003|Overall Study|Withdrawal by Subject|2|||
48936988|NCT00474240|157598752|FG004|Overall Study|Withdrawal by Subject|3|||
48936989|NCT00474240|157598753|FG005|Overall Study|Withdrawal by Subject|1|||
48936990|NCT00474240|157598748|FG000|Overall Study|Adverse Event|0|||
48936991|NCT00474240|157598749|FG001|Overall Study|Adverse Event|0|||
48936992|NCT00474240|157598750|FG002|Overall Study|Adverse Event|9|||
48936993|NCT00474240|157598751|FG003|Overall Study|Adverse Event|14|||
48936994|NCT00474240|157598752|FG004|Overall Study|Adverse Event|5|||
48936995|NCT00474240|157598753|FG005|Overall Study|Adverse Event|16|||
48936996|NCT00474240|157598748|FG000|Overall Study|Removed due to lab value|0|||
48936997|NCT00474240|157598749|FG001|Overall Study|Removed due to lab value|0|||
48936998|NCT00474240|157598750|FG002|Overall Study|Removed due to lab value|0|||
48936999|NCT00474240|157598751|FG003|Overall Study|Removed due to lab value|0|||
48937000|NCT00474240|157598752|FG004|Overall Study|Removed due to lab value|0|||
48937001|NCT00474240|157598753|FG005|Overall Study|Removed due to lab value|1|||
48937002|NCT02347631|157598754|FG000|First Intervention (2 Months)|Adverse Event|1|||
48937003|NCT02347631|157598755|FG001|First Intervention (2 Months)|Adverse Event|1|||
48937004|NCT02347631|157598754|FG000|First Intervention (2 Months)|Pregnancy|1|||
48937005|NCT02347631|157598755|FG001|First Intervention (2 Months)|Pregnancy|0|||
48937006|NCT02347631|157598754|FG000|First Intervention (2 Months)|Moved out of area|0|||
48937007|NCT02347631|157598755|FG001|First Intervention (2 Months)|Moved out of area|2|||
48937008|NCT02347631|157598754|FG000|First Intervention (2 Months)|Lost to Follow-up|5|||
48937009|NCT02347631|157598755|FG001|First Intervention (2 Months)|Lost to Follow-up|3|||
48937010|NCT02347631|157598754|FG000|Washout 2 (1 Month)|Withdrawal by Subject|2|||
48937011|NCT02347631|157598755|FG001|Washout 2 (1 Month)|Withdrawal by Subject|2|||
48937012|NCT02347631|157598754|FG000|Washout 2 (1 Month)|Lost to Follow-up|0|||
48937013|NCT02347631|157598755|FG001|Washout 2 (1 Month)|Lost to Follow-up|1|||
48937014|NCT02347631|157598754|FG000|Second Intervention (2 Months)|Lost to Follow-up|7|||
48937015|NCT02347631|157598755|FG001|Second Intervention (2 Months)|Lost to Follow-up|4|||
48937016|NCT02347631|157598754|FG000|Second Intervention (2 Months)|Withdrawal by Subject|6|||
48937017|NCT02347631|157598755|FG001|Second Intervention (2 Months)|Withdrawal by Subject|0|||
48937018|NCT02304926|157598756|FG000|Overall Study|Lost to Follow-up|2|||
48937019|NCT02304926|157598757|FG001|Overall Study|Lost to Follow-up|1|||
48937020|NCT02076165|157598759|FG000|Overall Study|Lost to Follow-up|7|||
48937021|NCT02076165|157598760|FG001|Overall Study|Lost to Follow-up|5|||
48937022|NCT02076165|157598759|FG000|Overall Study|Refused follow-up assessment|1|||
48937023|NCT02076165|157598760|FG001|Overall Study|Refused follow-up assessment|1|||
48937024|NCT02429856|157598761|FG000|Overall Study|Death|12|||
48937025|NCT02429856|157598762|FG001|Overall Study|Death|13|||
48937026|NCT02429856|157598761|FG000|Overall Study|Lost to Follow-up|6|||
48937027|NCT02429856|157598762|FG001|Overall Study|Lost to Follow-up|5|||
48937028|NCT02429856|157598761|FG000|Overall Study|Withdrawal by Subject|1|||
48937029|NCT02429856|157598762|FG001|Overall Study|Withdrawal by Subject|1|||
48937030|NCT01111604|157598763|FG000|Overall Study|Lost to Follow-up|0|||
48937031|NCT01111604|157598764|FG001|Overall Study|Lost to Follow-up|0|||
48937032|NCT01111604|157598765|FG002|Overall Study|Lost to Follow-up|1|||
48937033|NCT01111604|157598763|FG000|Overall Study|Withdrew Consent|3|||
48937034|NCT01111604|157598764|FG001|Overall Study|Withdrew Consent|0|||
48937035|NCT01111604|157598765|FG002|Overall Study|Withdrew Consent|2|||
48937036|NCT01111604|157598763|FG000|Overall Study|Withdrawal by Subject|2|||
48937037|NCT01111604|157598764|FG001|Overall Study|Withdrawal by Subject|0|||
48937038|NCT01111604|157598765|FG002|Overall Study|Withdrawal by Subject|0|||
48937039|NCT01111604|157598763|FG000|Overall Study|Death|1|||
48937040|NCT01111604|157598764|FG001|Overall Study|Death|0|||
48937041|NCT01111604|157598765|FG002|Overall Study|Death|0|||
48937042|NCT01111604|157598763|FG000|Overall Study|Met Exclusion Criteria|2|||
48937043|NCT01111604|157598764|FG001|Overall Study|Met Exclusion Criteria|0|||
48937044|NCT01111604|157598765|FG002|Overall Study|Met Exclusion Criteria|0|||
48937045|NCT00355264|157598766|FG000|Extension (Variable Duration)|Adverse Event|1|||
48937046|NCT00355264|157598766|FG000|Extension (Variable Duration)|Withdrew Consent|1|||
48937047|NCT00238264|157598767|FG000|Overall Study|Death|7|||
48937048|NCT00238264|157598767|FG000|Overall Study|Lost to Follow-up|18|||
48937049|NCT00238264|157598767|FG000|Overall Study|Withdrawal by Subject|4|||
48937050|NCT00238264|157598767|FG000|Overall Study|Ineligible|7|||
48937051|NCT01157117|157598768|FG000|Overall Study|Dosing Symptoms|0|||
48937052|NCT01157117|157598769|FG001|Overall Study|Dosing Symptoms|4|||
48937053|NCT01157117|157598770|FG002|Overall Study|Dosing Symptoms|0|||
48937054|NCT01157117|157598768|FG000|Overall Study|Withdrawal by Subject|4|||
48937055|NCT01157117|157598769|FG001|Overall Study|Withdrawal by Subject|1|||
48937056|NCT01157117|157598770|FG002|Overall Study|Withdrawal by Subject|1|||
48937057|NCT01157117|157598768|FG000|Overall Study|Lack of Efficacy|1|||
48937058|NCT01157117|157598769|FG001|Overall Study|Lack of Efficacy|1|||
48937059|NCT01157117|157598770|FG002|Overall Study|Lack of Efficacy|0|||
48937060|NCT01157117|157598768|FG000|Overall Study|Lost to Follow-up|0|||
48937061|NCT01157117|157598769|FG001|Overall Study|Lost to Follow-up|0|||
48937062|NCT01157117|157598770|FG002|Overall Study|Lost to Follow-up|1|||
48937063|NCT01157117|157598768|FG000|Overall Study|Unknown (Pending Final Form Submission)|4|||
48937064|NCT01157117|157598769|FG001|Overall Study|Unknown (Pending Final Form Submission)|5|||
48937065|NCT01157117|157598770|FG002|Overall Study|Unknown (Pending Final Form Submission)|13|||
48937066|NCT01686568|157598775|FG000|Main Study|Withdrawal by Subject|1|||
48937067|NCT01686568|157598776|FG001|Main Study|Withdrawal by Subject|3|||
48937068|NCT01686568|157598775|FG000|Main Study|Noncompliance with protocol|0|||
48937069|NCT01686568|157598776|FG001|Main Study|Noncompliance with protocol|1|||
48937070|NCT01686568|157598775|FG000|Main Study|Liver enzymes above range of exclusion|1|||
48937071|NCT01686568|157598776|FG001|Main Study|Liver enzymes above range of exclusion|0|||
48937072|NCT01686568|157598775|FG000|Sub-Study|Not consented for sub-study|2|||
48937073|NCT01686568|157598776|FG001|Sub-Study|Not consented for sub-study|2|||
48937074|NCT03838484|157598777|FG000|Overall Study|Lost to Follow-up|0|||
48937075|NCT03838484|157598778|FG001|Overall Study|Lost to Follow-up|1|||
48937076|NCT03838484|157598779|FG002|Overall Study|Lost to Follow-up|0|||
48937077|NCT03838484|157598780|FG003|Overall Study|Lost to Follow-up|0|||
48937078|NCT05172544|157598794|FG000|Overall Study|Withdrawal by Subject|1|||
48937079|NCT05172544|157598795|FG001|Overall Study|Withdrawal by Subject|0|||
48937080|NCT05172544|157598796|FG002|Overall Study|Withdrawal by Subject|0|||
48937081|NCT05172544|157598794|FG000|Overall Study|Physician Decision|0|||
48937082|NCT05172544|157598795|FG001|Overall Study|Physician Decision|0|||
48937083|NCT05172544|157598796|FG002|Overall Study|Physician Decision|1|||
48937084|NCT03371355|157598797|FG000|Overall Study|Investigator judgment|0|||
48937085|NCT03371355|157598798|FG001|Overall Study|Investigator judgment|0|||
48937086|NCT03371355|157598799|FG002|Overall Study|Investigator judgment|1|||
48937087|NCT03371355|157598800|FG003|Overall Study|Investigator judgment|1|||
48937088|NCT03371355|157598797|FG000|Overall Study|Voluntary withdrawal|1|||
48937089|NCT03371355|157598798|FG001|Overall Study|Voluntary withdrawal|0|||
48937090|NCT03371355|157598799|FG002|Overall Study|Voluntary withdrawal|1|||
48937091|NCT03371355|157598800|FG003|Overall Study|Voluntary withdrawal|2|||
48937092|NCT03371355|157598797|FG000|Overall Study|Adverse Event|0|||
48937093|NCT03371355|157598798|FG001|Overall Study|Adverse Event|1|||
48937094|NCT03371355|157598799|FG002|Overall Study|Adverse Event|2|||
48937095|NCT03371355|157598800|FG003|Overall Study|Adverse Event|3|||
48937096|NCT03371355|157598797|FG000|Overall Study|Reason not Specified|0|||
48937097|NCT03371355|157598798|FG001|Overall Study|Reason not Specified|1|||
48937098|NCT03371355|157598799|FG002|Overall Study|Reason not Specified|0|||
48937099|NCT03371355|157598800|FG003|Overall Study|Reason not Specified|1|||
48937100|NCT00727402|157598801|FG000|Overall Study|Physician Decision|116|||
48937101|NCT00755079|157598802|FG000|Overall Study|Lost to Follow-up|1|||
48937102|NCT00755079|157598803|FG001|Overall Study|Lost to Follow-up|3|||
48937103|NCT00755079|157598802|FG000|Overall Study|Adverse Event|0|||
48937104|NCT00755079|157598803|FG001|Overall Study|Adverse Event|1|||
48937105|NCT00755079|157598802|FG000|Overall Study|Withdrawal by Subject|0|||
48937106|NCT00755079|157598803|FG001|Overall Study|Withdrawal by Subject|2|||
48937107|NCT00723957|157598804|FG000|Overall Study|Adverse event unrelated to study drug|1|||
48937108|NCT00723957|157598805|FG001|Overall Study|Adverse event unrelated to study drug|4|||
48937109|NCT00723957|157598804|FG000|Overall Study|Death|3|||
48937110|NCT00723957|157598805|FG001|Overall Study|Death|4|||
48937111|NCT00723957|157598804|FG000|Overall Study|Disease progression|27|||
48937112|NCT00723957|157598805|FG001|Overall Study|Disease progression|25|||
48937113|NCT00723957|157598804|FG000|Overall Study|Maximum clinical benefit|4|||
48937114|NCT00723957|157598805|FG001|Overall Study|Maximum clinical benefit|5|||
48937115|NCT00723957|157598804|FG000|Overall Study|Investigator decision|1|||
48937116|NCT00723957|157598805|FG001|Overall Study|Investigator decision|1|||
48937117|NCT00723957|157598804|FG000|Overall Study|Study drug toxicity|4|||
48937118|NCT00723957|157598805|FG001|Overall Study|Study drug toxicity|6|||
48937119|NCT00723957|157598804|FG000|Overall Study|Withdrawal by Subject|7|||
48937120|NCT00723957|157598805|FG001|Overall Study|Withdrawal by Subject|5|||
48937121|NCT00723957|157598804|FG000|Overall Study|Reason not analyzed|1|||
48937122|NCT00723957|157598805|FG001|Overall Study|Reason not analyzed|0|||
48937123|NCT00723957|157598804|FG000|Overall Study|Never received treatment|3|||
48847687|NCT00943917|157282203|FG002|Stage I|Withdrawal by Subject|2|||
48847688|NCT00943917|157282204|FG003|Stage I|Withdrawal by Subject|0|||
48847689|NCT00943917|157282205|FG004|Stage I|Withdrawal by Subject|0|||
48847690|NCT00943917|157282206|FG005|Stage I|Withdrawal by Subject|0|||
48847691|NCT00943917|157282207|FG006|Stage I|Withdrawal by Subject|0|||
48847692|NCT00943917|157282208|FG007|Stage I|Withdrawal by Subject|0|||
48847693|NCT00943917|157282209|FG008|Stage I|Withdrawal by Subject|0|||
48847694|NCT00943917|157282210|FG009|Stage I|Withdrawal by Subject|0|||
48847695|NCT00943917|157282211|FG010|Stage I|Withdrawal by Subject|0|||
48847696|NCT00943917|157282212|FG011|Stage I|Withdrawal by Subject|0|||
48847697|NCT00943917|157282213|FG012|Stage I|Withdrawal by Subject|0|||
48847698|NCT00943917|157282214|FG013|Stage I|Withdrawal by Subject|0|||
48847699|NCT00943917|157282215|FG014|Stage I|Withdrawal by Subject|0|||
48847700|NCT00943917|157282201|FG000|Stage II|Adverse Event|0|||
48847701|NCT00943917|157282202|FG001|Stage II|Adverse Event|0|||
48847702|NCT00943917|157282203|FG002|Stage II|Adverse Event|0|||
48847703|NCT00943917|157282204|FG003|Stage II|Adverse Event|0|||
48847704|NCT00943917|157282205|FG004|Stage II|Adverse Event|0|||
48847705|NCT00943917|157282206|FG005|Stage II|Adverse Event|1|||
48847706|NCT00943917|157282207|FG006|Stage II|Adverse Event|3|||
48847707|NCT00943917|157282208|FG007|Stage II|Adverse Event|0|||
48847708|NCT00943917|157282209|FG008|Stage II|Adverse Event|1|||
48847709|NCT00943917|157282210|FG009|Stage II|Adverse Event|0|||
48847710|NCT00943917|157282211|FG010|Stage II|Adverse Event|0|||
48847711|NCT00943917|157282212|FG011|Stage II|Adverse Event|0|||
48847712|NCT00943917|157282213|FG012|Stage II|Adverse Event|0|||
48847713|NCT00943917|157282214|FG013|Stage II|Adverse Event|0|||
48847714|NCT00943917|157282215|FG014|Stage II|Adverse Event|0|||
48847715|NCT00943917|157282201|FG000|Stage II|Withdrawal by Subject|0|||
48847716|NCT00943917|157282202|FG001|Stage II|Withdrawal by Subject|0|||
48847717|NCT00943917|157282203|FG002|Stage II|Withdrawal by Subject|0|||
48847718|NCT00943917|157282204|FG003|Stage II|Withdrawal by Subject|0|||
48847719|NCT00943917|157282205|FG004|Stage II|Withdrawal by Subject|0|||
48847720|NCT00943917|157282206|FG005|Stage II|Withdrawal by Subject|1|||
48847721|NCT00943917|157282207|FG006|Stage II|Withdrawal by Subject|0|||
48847722|NCT00943917|157282208|FG007|Stage II|Withdrawal by Subject|0|||
48847723|NCT00943917|157282209|FG008|Stage II|Withdrawal by Subject|0|||
48847724|NCT00943917|157282210|FG009|Stage II|Withdrawal by Subject|0|||
48847725|NCT00943917|157282211|FG010|Stage II|Withdrawal by Subject|0|||
48847726|NCT00943917|157282212|FG011|Stage II|Withdrawal by Subject|0|||
48937124|NCT00723957|157598805|FG001|Overall Study|Never received treatment|3|||
48937125|NCT00868790|157598806|FG000|Period 1|Adverse Event|1|||
48937126|NCT00868790|157598807|FG001|Period 1|Adverse Event|0|||
48937127|NCT00868790|157598808|FG002|Period 1|Adverse Event|0|||
48937128|NCT00868790|157598809|FG003|Period 1|Adverse Event|0|||
48937129|NCT00868790|157598810|FG004|Period 1|Adverse Event|0|||
48937130|NCT00868790|157598811|FG005|Period 1|Adverse Event|0|||
48937131|NCT00868790|157598812|FG006|Period 1|Adverse Event|0|||
48937132|NCT00868790|157598813|FG007|Period 1|Adverse Event|3|||
48937133|NCT00868790|157598814|FG008|Period 1|Adverse Event|1|||
48937134|NCT00868790|157598815|FG009|Period 1|Adverse Event|0|||
48937135|NCT00868790|157598816|FG010|Period 1|Adverse Event|0|||
48937136|NCT00868790|157598817|FG011|Period 1|Adverse Event|0|||
48937137|NCT00868790|157598818|FG012|Period 1|Adverse Event|0|||
48937138|NCT00868790|157598819|FG013|Period 1|Adverse Event|1|||
48937139|NCT00868790|157598806|FG000|Period 1|Protocol Violation|1|||
48937140|NCT00868790|157598807|FG001|Period 1|Protocol Violation|0|||
48937141|NCT00868790|157598808|FG002|Period 1|Protocol Violation|0|||
48937142|NCT00868790|157598809|FG003|Period 1|Protocol Violation|0|||
48937143|NCT00868790|157598810|FG004|Period 1|Protocol Violation|0|||
48937144|NCT00868790|157598811|FG005|Period 1|Protocol Violation|0|||
48937145|NCT00868790|157598812|FG006|Period 1|Protocol Violation|0|||
48937146|NCT00868790|157598813|FG007|Period 1|Protocol Violation|0|||
48937147|NCT00868790|157598814|FG008|Period 1|Protocol Violation|0|||
48937148|NCT00868790|157598815|FG009|Period 1|Protocol Violation|0|||
48937149|NCT00868790|157598816|FG010|Period 1|Protocol Violation|0|||
48937150|NCT00868790|157598817|FG011|Period 1|Protocol Violation|0|||
48937151|NCT00868790|157598818|FG012|Period 1|Protocol Violation|0|||
48937152|NCT00868790|157598819|FG013|Period 1|Protocol Violation|0|||
48937153|NCT00868790|157598806|FG000|Period 1|Withdrawal by Subject|0|||
48937154|NCT00868790|157598807|FG001|Period 1|Withdrawal by Subject|1|||
48937155|NCT00868790|157598808|FG002|Period 1|Withdrawal by Subject|0|||
48937156|NCT00868790|157598809|FG003|Period 1|Withdrawal by Subject|0|||
48847727|NCT00943917|157282213|FG012|Stage II|Withdrawal by Subject|0|||
48847728|NCT00943917|157282214|FG013|Stage II|Withdrawal by Subject|0|||
48847729|NCT00943917|157282215|FG014|Stage II|Withdrawal by Subject|0|||
48847730|NCT00943917|157282201|FG000|Stage II|Pregnancy|0|||
48847731|NCT00943917|157282202|FG001|Stage II|Pregnancy|0|||
48937157|NCT00868790|157598810|FG004|Period 1|Withdrawal by Subject|0|||
48937158|NCT00868790|157598811|FG005|Period 1|Withdrawal by Subject|0|||
48937159|NCT00868790|157598812|FG006|Period 1|Withdrawal by Subject|0|||
48937160|NCT00868790|157598813|FG007|Period 1|Withdrawal by Subject|0|||
48937161|NCT00868790|157598814|FG008|Period 1|Withdrawal by Subject|0|||
48937162|NCT00868790|157598815|FG009|Period 1|Withdrawal by Subject|0|||
48937163|NCT00868790|157598816|FG010|Period 1|Withdrawal by Subject|0|||
48937164|NCT00868790|157598817|FG011|Period 1|Withdrawal by Subject|0|||
48937165|NCT00868790|157598818|FG012|Period 1|Withdrawal by Subject|0|||
48937166|NCT00868790|157598819|FG013|Period 1|Withdrawal by Subject|1|||
48937167|NCT00868790|157598806|FG000|Period 1|Abnormal Triglycerides|0|||
48937168|NCT00868790|157598807|FG001|Period 1|Abnormal Triglycerides|0|||
48937169|NCT00868790|157598808|FG002|Period 1|Abnormal Triglycerides|0|||
48937170|NCT00868790|157598809|FG003|Period 1|Abnormal Triglycerides|0|||
48937171|NCT00868790|157598810|FG004|Period 1|Abnormal Triglycerides|1|||
48937172|NCT00868790|157598811|FG005|Period 1|Abnormal Triglycerides|0|||
48937173|NCT00868790|157598812|FG006|Period 1|Abnormal Triglycerides|0|||
48937174|NCT00868790|157598813|FG007|Period 1|Abnormal Triglycerides|0|||
48937175|NCT00868790|157598814|FG008|Period 1|Abnormal Triglycerides|0|||
48937176|NCT00868790|157598815|FG009|Period 1|Abnormal Triglycerides|0|||
48937177|NCT00868790|157598816|FG010|Period 1|Abnormal Triglycerides|0|||
48937178|NCT00868790|157598817|FG011|Period 1|Abnormal Triglycerides|0|||
48937179|NCT00868790|157598818|FG012|Period 1|Abnormal Triglycerides|0|||
48937180|NCT00868790|157598819|FG013|Period 1|Abnormal Triglycerides|0|||
48937181|NCT00868790|157598806|FG000|Period 1|Lost to Follow-up|0|||
48937182|NCT00868790|157598807|FG001|Period 1|Lost to Follow-up|0|||
48937183|NCT00868790|157598808|FG002|Period 1|Lost to Follow-up|0|||
48937184|NCT00868790|157598809|FG003|Period 1|Lost to Follow-up|0|||
48937185|NCT00868790|157598810|FG004|Period 1|Lost to Follow-up|0|||
48937186|NCT00868790|157598811|FG005|Period 1|Lost to Follow-up|1|||
48937187|NCT00868790|157598812|FG006|Period 1|Lost to Follow-up|0|||
48937188|NCT00868790|157598813|FG007|Period 1|Lost to Follow-up|0|||
48937189|NCT00868790|157598814|FG008|Period 1|Lost to Follow-up|0|||
48937190|NCT00868790|157598815|FG009|Period 1|Lost to Follow-up|0|||
48937191|NCT00868790|157598816|FG010|Period 1|Lost to Follow-up|0|||
48937192|NCT00868790|157598817|FG011|Period 1|Lost to Follow-up|0|||
48937193|NCT00868790|157598818|FG012|Period 1|Lost to Follow-up|0|||
48937194|NCT00868790|157598819|FG013|Period 1|Lost to Follow-up|0|||
48937195|NCT00868790|157598806|FG000|Period 2|Adverse Event|0|||
48937196|NCT00868790|157598807|FG001|Period 2|Adverse Event|0|||
48847732|NCT00943917|157282203|FG002|Stage II|Pregnancy|0|||
48847733|NCT00943917|157282204|FG003|Stage II|Pregnancy|0|||
48847734|NCT00943917|157282205|FG004|Stage II|Pregnancy|0|||
48847735|NCT00943917|157282206|FG005|Stage II|Pregnancy|1|||
48847736|NCT00943917|157282207|FG006|Stage II|Pregnancy|0|||
48847737|NCT00943917|157282208|FG007|Stage II|Pregnancy|0|||
48847738|NCT00943917|157282209|FG008|Stage II|Pregnancy|0|||
48847739|NCT00943917|157282210|FG009|Stage II|Pregnancy|0|||
48847740|NCT00943917|157282211|FG010|Stage II|Pregnancy|0|||
48847741|NCT00943917|157282212|FG011|Stage II|Pregnancy|0|||
48847742|NCT00943917|157282213|FG012|Stage II|Pregnancy|0|||
48847743|NCT00943917|157282214|FG013|Stage II|Pregnancy|0|||
48847744|NCT00943917|157282215|FG014|Stage II|Pregnancy|0|||
48847745|NCT00943917|157282201|FG000|Stage II Continuation|Adverse Event|0|||
48937197|NCT00868790|157598808|FG002|Period 2|Adverse Event|0|||
48937198|NCT00868790|157598809|FG003|Period 2|Adverse Event|0|||
48937199|NCT00868790|157598810|FG004|Period 2|Adverse Event|0|||
48937200|NCT00868790|157598811|FG005|Period 2|Adverse Event|0|||
48937201|NCT00868790|157598812|FG006|Period 2|Adverse Event|0|||
48937202|NCT00868790|157598813|FG007|Period 2|Adverse Event|0|||
48937203|NCT00868790|157598814|FG008|Period 2|Adverse Event|1|||
48937204|NCT00868790|157598815|FG009|Period 2|Adverse Event|0|||
48847746|NCT00943917|157282202|FG001|Stage II Continuation|Adverse Event|0|||
48847747|NCT00943917|157282203|FG002|Stage II Continuation|Adverse Event|0|||
48847748|NCT00943917|157282204|FG003|Stage II Continuation|Adverse Event|0|||
48847749|NCT00943917|157282205|FG004|Stage II Continuation|Adverse Event|0|||
48937205|NCT00868790|157598816|FG010|Period 2|Adverse Event|0|||
48937206|NCT00868790|157598817|FG011|Period 2|Adverse Event|0|||
48937207|NCT00868790|157598818|FG012|Period 2|Adverse Event|0|||
48937208|NCT00868790|157598819|FG013|Period 2|Adverse Event|0|||
48937209|NCT00868790|157598806|FG000|Period 2|Lost to Follow-up|0|||
48937210|NCT00868790|157598807|FG001|Period 2|Lost to Follow-up|1|||
48937211|NCT00868790|157598808|FG002|Period 2|Lost to Follow-up|0|||
48937212|NCT00868790|157598809|FG003|Period 2|Lost to Follow-up|0|||
48937213|NCT00868790|157598810|FG004|Period 2|Lost to Follow-up|0|||
48937214|NCT00868790|157598811|FG005|Period 2|Lost to Follow-up|1|||
48937215|NCT00868790|157598812|FG006|Period 2|Lost to Follow-up|0|||
48937216|NCT00868790|157598813|FG007|Period 2|Lost to Follow-up|0|||
48937217|NCT00868790|157598814|FG008|Period 2|Lost to Follow-up|0|||
48937218|NCT00868790|157598815|FG009|Period 2|Lost to Follow-up|0|||
48937219|NCT00868790|157598816|FG010|Period 2|Lost to Follow-up|0|||
48937220|NCT00868790|157598817|FG011|Period 2|Lost to Follow-up|0|||
48937221|NCT00868790|157598818|FG012|Period 2|Lost to Follow-up|0|||
48937222|NCT00868790|157598819|FG013|Period 2|Lost to Follow-up|0|||
48937223|NCT00868790|157598806|FG000|Period 2|Withdrawal by Subject|0|||
48937224|NCT00868790|157598807|FG001|Period 2|Withdrawal by Subject|0|||
48937225|NCT00868790|157598808|FG002|Period 2|Withdrawal by Subject|0|||
48937226|NCT00868790|157598809|FG003|Period 2|Withdrawal by Subject|0|||
48937227|NCT00868790|157598810|FG004|Period 2|Withdrawal by Subject|0|||
48937228|NCT00868790|157598811|FG005|Period 2|Withdrawal by Subject|0|||
48937229|NCT00868790|157598812|FG006|Period 2|Withdrawal by Subject|0|||
48937230|NCT00868790|157598813|FG007|Period 2|Withdrawal by Subject|0|||
48937231|NCT00868790|157598814|FG008|Period 2|Withdrawal by Subject|1|||
48937232|NCT00868790|157598815|FG009|Period 2|Withdrawal by Subject|0|||
48937233|NCT00868790|157598816|FG010|Period 2|Withdrawal by Subject|0|||
48937234|NCT00868790|157598817|FG011|Period 2|Withdrawal by Subject|0|||
48937235|NCT00868790|157598818|FG012|Period 2|Withdrawal by Subject|0|||
48847750|NCT00943917|157282206|FG005|Stage II Continuation|Adverse Event|0|||
48847751|NCT00943917|157282207|FG006|Stage II Continuation|Adverse Event|0|||
48847752|NCT00943917|157282208|FG007|Stage II Continuation|Adverse Event|0|||
48937236|NCT00868790|157598819|FG013|Period 2|Withdrawal by Subject|1|||
48937237|NCT00868790|157598806|FG000|Period 3|Adverse Event|0|||
48937238|NCT00868790|157598807|FG001|Period 3|Adverse Event|0|||
48937239|NCT00868790|157598808|FG002|Period 3|Adverse Event|0|||
48937240|NCT00868790|157598809|FG003|Period 3|Adverse Event|0|||
48937241|NCT00868790|157598810|FG004|Period 3|Adverse Event|0|||
48937242|NCT00868790|157598811|FG005|Period 3|Adverse Event|0|||
48937243|NCT00868790|157598812|FG006|Period 3|Adverse Event|0|||
48937244|NCT00868790|157598813|FG007|Period 3|Adverse Event|0|||
48937245|NCT00868790|157598814|FG008|Period 3|Adverse Event|0|||
48937246|NCT00868790|157598815|FG009|Period 3|Adverse Event|1|||
48937247|NCT00868790|157598816|FG010|Period 3|Adverse Event|0|||
48847753|NCT00943917|157282209|FG008|Stage II Continuation|Adverse Event|0|||
48847754|NCT00943917|157282210|FG009|Stage II Continuation|Adverse Event|0|||
48847755|NCT00943917|157282211|FG010|Stage II Continuation|Adverse Event|0|||
48847756|NCT00943917|157282212|FG011|Stage II Continuation|Adverse Event|1|||
48847757|NCT00943917|157282213|FG012|Stage II Continuation|Adverse Event|2|||
48847758|NCT00943917|157282214|FG013|Stage II Continuation|Adverse Event|1|||
48847759|NCT00943917|157282215|FG014|Stage II Continuation|Adverse Event|1|||
48847760|NCT00943917|157282201|FG000|Stage II Continuation|Withdrawal by Subject|0|||
48847761|NCT00943917|157282202|FG001|Stage II Continuation|Withdrawal by Subject|0|||
48847762|NCT00943917|157282203|FG002|Stage II Continuation|Withdrawal by Subject|0|||
48847763|NCT00943917|157282204|FG003|Stage II Continuation|Withdrawal by Subject|0|||
48847764|NCT00943917|157282205|FG004|Stage II Continuation|Withdrawal by Subject|0|||
48847765|NCT00943917|157282206|FG005|Stage II Continuation|Withdrawal by Subject|0|||
48847766|NCT00943917|157282207|FG006|Stage II Continuation|Withdrawal by Subject|0|||
48847767|NCT00943917|157282208|FG007|Stage II Continuation|Withdrawal by Subject|0|||
48847768|NCT00943917|157282209|FG008|Stage II Continuation|Withdrawal by Subject|0|||
48847769|NCT00943917|157282210|FG009|Stage II Continuation|Withdrawal by Subject|0|||
48847770|NCT00943917|157282211|FG010|Stage II Continuation|Withdrawal by Subject|0|||
48847771|NCT00943917|157282212|FG011|Stage II Continuation|Withdrawal by Subject|0|||
48847772|NCT00943917|157282213|FG012|Stage II Continuation|Withdrawal by Subject|0|||
48847773|NCT00943917|157282214|FG013|Stage II Continuation|Withdrawal by Subject|1|||
48847774|NCT00943917|157282215|FG014|Stage II Continuation|Withdrawal by Subject|3|||
48847775|NCT00943917|157282201|FG000|Stage II Continuation|Protocol Violation|0|||
48847776|NCT00943917|157282202|FG001|Stage II Continuation|Protocol Violation|0|||
48847777|NCT00943917|157282203|FG002|Stage II Continuation|Protocol Violation|0|||
48847778|NCT00943917|157282204|FG003|Stage II Continuation|Protocol Violation|0|||
48847779|NCT00943917|157282205|FG004|Stage II Continuation|Protocol Violation|0|||
48847780|NCT00943917|157282206|FG005|Stage II Continuation|Protocol Violation|0|||
48847781|NCT00943917|157282207|FG006|Stage II Continuation|Protocol Violation|0|||
48847782|NCT00943917|157282208|FG007|Stage II Continuation|Protocol Violation|0|||
48937248|NCT00868790|157598817|FG011|Period 3|Adverse Event|0|||
48937249|NCT00868790|157598818|FG012|Period 3|Adverse Event|0|||
48937250|NCT00868790|157598819|FG013|Period 3|Adverse Event|0|||
48937251|NCT00868790|157598806|FG000|Period 3|Protocol Violation|0|||
48937252|NCT00868790|157598807|FG001|Period 3|Protocol Violation|0|||
48937253|NCT00868790|157598808|FG002|Period 3|Protocol Violation|0|||
48937254|NCT00868790|157598809|FG003|Period 3|Protocol Violation|0|||
48937255|NCT00868790|157598810|FG004|Period 3|Protocol Violation|0|||
48937256|NCT00868790|157598811|FG005|Period 3|Protocol Violation|0|||
48937257|NCT00868790|157598812|FG006|Period 3|Protocol Violation|0|||
48937258|NCT00868790|157598813|FG007|Period 3|Protocol Violation|0|||
48937259|NCT00868790|157598814|FG008|Period 3|Protocol Violation|0|||
48937260|NCT00868790|157598815|FG009|Period 3|Protocol Violation|0|||
48937261|NCT00868790|157598816|FG010|Period 3|Protocol Violation|1|||
48937262|NCT00868790|157598817|FG011|Period 3|Protocol Violation|0|||
48937263|NCT00868790|157598818|FG012|Period 3|Protocol Violation|0|||
48937264|NCT00868790|157598819|FG013|Period 3|Protocol Violation|0|||
48937265|NCT00868790|157598806|FG000|Period 3|Study Terminated by Sponsor|0|||
48937266|NCT00868790|157598807|FG001|Period 3|Study Terminated by Sponsor|0|||
48937267|NCT00868790|157598808|FG002|Period 3|Study Terminated by Sponsor|0|||
48937268|NCT00868790|157598809|FG003|Period 3|Study Terminated by Sponsor|1|||
48937269|NCT00868790|157598810|FG004|Period 3|Study Terminated by Sponsor|0|||
48937270|NCT00868790|157598811|FG005|Period 3|Study Terminated by Sponsor|0|||
48937271|NCT00868790|157598812|FG006|Period 3|Study Terminated by Sponsor|0|||
48937272|NCT00868790|157598813|FG007|Period 3|Study Terminated by Sponsor|0|||
48937273|NCT00868790|157598814|FG008|Period 3|Study Terminated by Sponsor|0|||
48937274|NCT00868790|157598815|FG009|Period 3|Study Terminated by Sponsor|0|||
48937275|NCT00868790|157598816|FG010|Period 3|Study Terminated by Sponsor|0|||
48937276|NCT00868790|157598817|FG011|Period 3|Study Terminated by Sponsor|0|||
48937277|NCT00868790|157598818|FG012|Period 3|Study Terminated by Sponsor|0|||
48937278|NCT00868790|157598819|FG013|Period 3|Study Terminated by Sponsor|0|||
48937279|NCT00868790|157598806|FG000|Period 4|Adverse Event|0|||
48937280|NCT00868790|157598807|FG001|Period 4|Adverse Event|0|||
48937281|NCT00868790|157598808|FG002|Period 4|Adverse Event|0|||
48937282|NCT00868790|157598809|FG003|Period 4|Adverse Event|0|||
48937283|NCT00868790|157598810|FG004|Period 4|Adverse Event|0|||
48937284|NCT00868790|157598811|FG005|Period 4|Adverse Event|0|||
48937285|NCT00868790|157598812|FG006|Period 4|Adverse Event|0|||
48937286|NCT00868790|157598813|FG007|Period 4|Adverse Event|1|||
48937287|NCT00868790|157598814|FG008|Period 4|Adverse Event|0|||
48937288|NCT00868790|157598815|FG009|Period 4|Adverse Event|0|||
48937289|NCT00868790|157598816|FG010|Period 4|Adverse Event|1|||
48937290|NCT00868790|157598817|FG011|Period 4|Adverse Event|0|||
48937291|NCT00868790|157598818|FG012|Period 4|Adverse Event|1|||
48937292|NCT00868790|157598819|FG013|Period 4|Adverse Event|0|||
48937293|NCT00868790|157598806|FG000|Period 4|Lost to Follow-up|0|||
48937294|NCT00868790|157598807|FG001|Period 4|Lost to Follow-up|0|||
48937295|NCT00868790|157598808|FG002|Period 4|Lost to Follow-up|0|||
48937296|NCT00868790|157598809|FG003|Period 4|Lost to Follow-up|0|||
48937297|NCT00868790|157598810|FG004|Period 4|Lost to Follow-up|0|||
48937298|NCT00868790|157598811|FG005|Period 4|Lost to Follow-up|0|||
48937299|NCT00868790|157598812|FG006|Period 4|Lost to Follow-up|0|||
48937300|NCT00868790|157598813|FG007|Period 4|Lost to Follow-up|1|||
48937301|NCT00868790|157598814|FG008|Period 4|Lost to Follow-up|0|||
48937302|NCT00868790|157598815|FG009|Period 4|Lost to Follow-up|0|||
48937303|NCT00868790|157598816|FG010|Period 4|Lost to Follow-up|0|||
48937304|NCT00868790|157598817|FG011|Period 4|Lost to Follow-up|0|||
48937305|NCT00868790|157598818|FG012|Period 4|Lost to Follow-up|0|||
48937306|NCT00868790|157598819|FG013|Period 4|Lost to Follow-up|0|||
48937307|NCT00868790|157598806|FG000|Period 4|Study Terminated by Sponsor|2|||
48937308|NCT00868790|157598807|FG001|Period 4|Study Terminated by Sponsor|0|||
48937309|NCT00868790|157598808|FG002|Period 4|Study Terminated by Sponsor|0|||
48937310|NCT00868790|157598809|FG003|Period 4|Study Terminated by Sponsor|0|||
48937311|NCT00868790|157598810|FG004|Period 4|Study Terminated by Sponsor|0|||
48937312|NCT00868790|157598811|FG005|Period 4|Study Terminated by Sponsor|0|||
48937313|NCT00868790|157598812|FG006|Period 4|Study Terminated by Sponsor|0|||
48937314|NCT00868790|157598813|FG007|Period 4|Study Terminated by Sponsor|1|||
48937315|NCT00868790|157598814|FG008|Period 4|Study Terminated by Sponsor|2|||
48937316|NCT00868790|157598815|FG009|Period 4|Study Terminated by Sponsor|0|||
48937317|NCT00868790|157598816|FG010|Period 4|Study Terminated by Sponsor|2|||
48937318|NCT00868790|157598817|FG011|Period 4|Study Terminated by Sponsor|1|||
48937319|NCT00868790|157598818|FG012|Period 4|Study Terminated by Sponsor|0|||
48937320|NCT00868790|157598819|FG013|Period 4|Study Terminated by Sponsor|1|||
48937321|NCT00868790|157598806|FG000|Period 4|Abnormal ALT/AST|0|||
48937322|NCT00868790|157598807|FG001|Period 4|Abnormal ALT/AST|0|||
48937323|NCT00868790|157598808|FG002|Period 4|Abnormal ALT/AST|1|||
48937324|NCT00868790|157598809|FG003|Period 4|Abnormal ALT/AST|0|||
48937325|NCT00868790|157598810|FG004|Period 4|Abnormal ALT/AST|0|||
48937326|NCT00868790|157598811|FG005|Period 4|Abnormal ALT/AST|0|||
48937327|NCT00868790|157598812|FG006|Period 4|Abnormal ALT/AST|0|||
48937328|NCT00868790|157598813|FG007|Period 4|Abnormal ALT/AST|0|||
48937329|NCT00868790|157598814|FG008|Period 4|Abnormal ALT/AST|0|||
48937330|NCT00868790|157598815|FG009|Period 4|Abnormal ALT/AST|0|||
48937331|NCT00868790|157598816|FG010|Period 4|Abnormal ALT/AST|0|||
48937332|NCT00868790|157598817|FG011|Period 4|Abnormal ALT/AST|0|||
48937333|NCT00868790|157598818|FG012|Period 4|Abnormal ALT/AST|0|||
48937334|NCT00868790|157598819|FG013|Period 4|Abnormal ALT/AST|0|||
48847783|NCT00943917|157282209|FG008|Stage II Continuation|Protocol Violation|0|||
48847784|NCT00943917|157282210|FG009|Stage II Continuation|Protocol Violation|1|||
48847785|NCT00943917|157282211|FG010|Stage II Continuation|Protocol Violation|0|||
48847786|NCT00943917|157282212|FG011|Stage II Continuation|Protocol Violation|1|||
48847787|NCT00943917|157282213|FG012|Stage II Continuation|Protocol Violation|0|||
48847788|NCT00943917|157282214|FG013|Stage II Continuation|Protocol Violation|0|||
48847789|NCT00943917|157282215|FG014|Stage II Continuation|Protocol Violation|0|||
48847790|NCT00943917|157282201|FG000|Stage II Continuation|hypoglycemia|0|||
48847791|NCT00943917|157282202|FG001|Stage II Continuation|hypoglycemia|0|||
48847792|NCT00943917|157282203|FG002|Stage II Continuation|hypoglycemia|0|||
48847793|NCT00943917|157282204|FG003|Stage II Continuation|hypoglycemia|0|||
48847794|NCT00943917|157282205|FG004|Stage II Continuation|hypoglycemia|0|||
48847795|NCT00943917|157282206|FG005|Stage II Continuation|hypoglycemia|0|||
48847796|NCT00943917|157282207|FG006|Stage II Continuation|hypoglycemia|0|||
48847797|NCT00943917|157282208|FG007|Stage II Continuation|hypoglycemia|0|||
48847798|NCT00943917|157282209|FG008|Stage II Continuation|hypoglycemia|0|||
48847799|NCT00943917|157282210|FG009|Stage II Continuation|hypoglycemia|0|||
48847800|NCT00943917|157282211|FG010|Stage II Continuation|hypoglycemia|0|||
48847801|NCT00943917|157282212|FG011|Stage II Continuation|hypoglycemia|0|||
48847802|NCT00943917|157282213|FG012|Stage II Continuation|hypoglycemia|1|||
48847803|NCT00943917|157282214|FG013|Stage II Continuation|hypoglycemia|0|||
48847804|NCT00943917|157282215|FG014|Stage II Continuation|hypoglycemia|0|||
48847805|NCT00943917|157282201|FG000|Stage II Continuation|A1C elevation|0|||
48847806|NCT00943917|157282202|FG001|Stage II Continuation|A1C elevation|0|||
48847807|NCT00943917|157282203|FG002|Stage II Continuation|A1C elevation|0|||
48847808|NCT00943917|157282204|FG003|Stage II Continuation|A1C elevation|0|||
48847809|NCT00943917|157282205|FG004|Stage II Continuation|A1C elevation|0|||
48847810|NCT00943917|157282206|FG005|Stage II Continuation|A1C elevation|0|||
48847811|NCT00943917|157282207|FG006|Stage II Continuation|A1C elevation|0|||
48847812|NCT00943917|157282208|FG007|Stage II Continuation|A1C elevation|0|||
48847813|NCT00943917|157282209|FG008|Stage II Continuation|A1C elevation|0|||
48847814|NCT00943917|157282210|FG009|Stage II Continuation|A1C elevation|0|||
48847815|NCT00943917|157282211|FG010|Stage II Continuation|A1C elevation|0|||
48847816|NCT00943917|157282212|FG011|Stage II Continuation|A1C elevation|0|||
48847817|NCT00943917|157282213|FG012|Stage II Continuation|A1C elevation|0|||
48847818|NCT00943917|157282214|FG013|Stage II Continuation|A1C elevation|1|||
48847819|NCT00943917|157282215|FG014|Stage II Continuation|A1C elevation|0|||
48847820|NCT03631407|157282216|FG000|Overall Study|Withdrawal by Subject|3|||
48847821|NCT03631407|157282217|FG001|Overall Study|Withdrawal by Subject|2|||
48847822|NCT03631407|157282216|FG000|Overall Study|Sponsor Decision|0|||
48847823|NCT03631407|157282217|FG001|Overall Study|Sponsor Decision|2|||
48847824|NCT03631407|157282216|FG000|Overall Study|Death|16|||
48847825|NCT03631407|157282217|FG001|Overall Study|Death|16|||
48847826|NCT03631407|157282216|FG000|Overall Study|Randomized by mistake without study treatment|1|||
48847827|NCT03631407|157282217|FG001|Overall Study|Randomized by mistake without study treatment|0|||
48847828|NCT01695954|157282218|FG000|Overall Study|Withdrawal by Subject|4|||
48847829|NCT01695954|157282219|FG001|Overall Study|Withdrawal by Subject|0|||
48847830|NCT01695954|157282218|FG000|Overall Study|Adverse Event|0|||
48847831|NCT01695954|157282219|FG001|Overall Study|Adverse Event|2|||
48847832|NCT00588770|157282222|FG000|Overall Study|Disease progression|85|||
48847833|NCT00588770|157282223|FG001|Overall Study|Disease progression|68|||
48847834|NCT00588770|157282222|FG000|Overall Study|Adverse Event|29|||
48847835|NCT00588770|157282223|FG001|Overall Study|Adverse Event|58|||
48847836|NCT00588770|157282222|FG000|Overall Study|Death|13|||
48847837|NCT00588770|157282223|FG001|Overall Study|Death|22|||
48847838|NCT00588770|157282222|FG000|Overall Study|Withdrawal by Subject|15|||
48847839|NCT00588770|157282223|FG001|Overall Study|Withdrawal by Subject|25|||
48847840|NCT00588770|157282222|FG000|Overall Study|Alternative therapy|2|||
48847841|NCT00588770|157282223|FG001|Overall Study|Alternative therapy|4|||
48847842|NCT00588770|157282222|FG000|Overall Study|Other complicating disease|3|||
48847843|NCT00588770|157282223|FG001|Overall Study|Other complicating disease|2|||
48847844|NCT00588770|157282222|FG000|Overall Study|Not start protocol therapy|0|||
48847845|NCT00588770|157282223|FG001|Overall Study|Not start protocol therapy|9|||
48847846|NCT00588770|157282222|FG000|Overall Study|Lack of Efficacy|8|||
48847847|NCT00588770|157282223|FG001|Overall Study|Lack of Efficacy|10|||
48847848|NCT00588770|157282222|FG000|Overall Study|Physician discretion|2|||
48847849|NCT00588770|157282223|FG001|Overall Study|Physician discretion|0|||
48847850|NCT00588770|157282222|FG000|Overall Study|Patient non-compliance|2|||
48847851|NCT00588770|157282223|FG001|Overall Study|Patient non-compliance|2|||
48847852|NCT05975840|157282224|FG000|Overall Study|Other|1|||
48847853|NCT05975840|157282225|FG001|Overall Study|Other|0|||
48847854|NCT05975840|157282226|FG002|Overall Study|Other|0|||
48847855|NCT05975840|157282227|FG003|Overall Study|Other|0|||
48847856|NCT05975840|157282228|FG004|Overall Study|Other|1|||
48847857|NCT05975840|157282229|FG005|Overall Study|Other|0|||
48847858|NCT05975840|157282230|FG006|Overall Study|Other|0|||
48847859|NCT05975840|157282231|FG007|Overall Study|Other|0|||
48937335|NCT00868790|157598806|FG000|Post-study|Withdrawal by Subject|0|||
48937336|NCT00868790|157598807|FG001|Post-study|Withdrawal by Subject|0|||
48937337|NCT00868790|157598808|FG002|Post-study|Withdrawal by Subject|0|||
48937338|NCT00868790|157598809|FG003|Post-study|Withdrawal by Subject|0|||
48937339|NCT00868790|157598810|FG004|Post-study|Withdrawal by Subject|1|||
48937340|NCT00868790|157598811|FG005|Post-study|Withdrawal by Subject|0|||
48937341|NCT00868790|157598812|FG006|Post-study|Withdrawal by Subject|0|||
48937342|NCT00868790|157598813|FG007|Post-study|Withdrawal by Subject|0|||
48937343|NCT00868790|157598814|FG008|Post-study|Withdrawal by Subject|0|||
48937344|NCT00868790|157598815|FG009|Post-study|Withdrawal by Subject|0|||
48937345|NCT00868790|157598816|FG010|Post-study|Withdrawal by Subject|0|||
48937346|NCT00868790|157598817|FG011|Post-study|Withdrawal by Subject|0|||
48937347|NCT00868790|157598818|FG012|Post-study|Withdrawal by Subject|0|||
48937348|NCT00868790|157598819|FG013|Post-study|Withdrawal by Subject|0|||
48937349|NCT00868790|157598806|FG000|Post-study|Excluded Medication|0|||
48937350|NCT00868790|157598807|FG001|Post-study|Excluded Medication|0|||
48937351|NCT00868790|157598808|FG002|Post-study|Excluded Medication|0|||
48937352|NCT00868790|157598809|FG003|Post-study|Excluded Medication|0|||
48937353|NCT00868790|157598810|FG004|Post-study|Excluded Medication|0|||
48937354|NCT00868790|157598811|FG005|Post-study|Excluded Medication|0|||
48937355|NCT00868790|157598812|FG006|Post-study|Excluded Medication|0|||
48937356|NCT00868790|157598813|FG007|Post-study|Excluded Medication|2|||
48937357|NCT00868790|157598814|FG008|Post-study|Excluded Medication|0|||
48937358|NCT00868790|157598815|FG009|Post-study|Excluded Medication|1|||
48937359|NCT00868790|157598816|FG010|Post-study|Excluded Medication|0|||
48937360|NCT00868790|157598817|FG011|Post-study|Excluded Medication|0|||
48937361|NCT00868790|157598818|FG012|Post-study|Excluded Medication|0|||
48937362|NCT00868790|157598819|FG013|Post-study|Excluded Medication|0|||
48937363|NCT03068715|157598820|FG000|Overall Study|No longer met inclusion criteria|1|||
48937364|NCT03068715|157598821|FG001|Overall Study|No longer met inclusion criteria|0|||
48937365|NCT03403400|157598822|FG000|Overall Study|Lost to Follow-up|1|||
48937366|NCT03403400|157598823|FG001|Overall Study|Lost to Follow-up|0|||
48937367|NCT03403400|157598824|FG002|Overall Study|Lost to Follow-up|1|||
48937368|NCT03403400|157598822|FG000|Overall Study|Hospitalization|1|||
48937369|NCT03403400|157598823|FG001|Overall Study|Hospitalization|0|||
48937370|NCT03403400|157598824|FG002|Overall Study|Hospitalization|0|||
48937371|NCT03403400|157598822|FG000|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
48937372|NCT03403400|157598823|FG001|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
48937373|NCT03403400|157598824|FG002|Overall Study|Benign Paroxysmal Positional Vertigo|1|||
48937374|NCT00737529|157598831|FG000|Overall Study|Disease Progression|95|||
48937375|NCT00737529|157598831|FG000|Overall Study|Adverse Event|24|||
48937376|NCT00737529|157598831|FG000|Overall Study|Withdrawal by Subject|5|||
48937377|NCT00737529|157598831|FG000|Overall Study|Death|4|||
48937378|NCT00737529|157598831|FG000|Overall Study|Protocol Violation|1|||
48937379|NCT00737529|157598831|FG000|Overall Study|Other|4|||
48937380|NCT00552110|157598832|FG000|Overall Study|Serious or Life-Threatening AE|0|||
48937381|NCT00552110|157598833|FG001|Overall Study|Serious or Life-Threatening AE|0|||
48937382|NCT00552110|157598834|FG002|Overall Study|Serious or Life-Threatening AE|1|||
48937383|NCT00552110|157598835|FG003|Overall Study|Serious or Life-Threatening AE|0|||
48937384|NCT00552110|157598836|FG004|Overall Study|Serious or Life-Threatening AE|0|||
48937385|NCT00552110|157598832|FG000|Overall Study|Lack of Efficacy|1|||
48937386|NCT00552110|157598833|FG001|Overall Study|Lack of Efficacy|0|||
48937387|NCT00552110|157598834|FG002|Overall Study|Lack of Efficacy|0|||
48937388|NCT00552110|157598835|FG003|Overall Study|Lack of Efficacy|1|||
48937389|NCT00552110|157598836|FG004|Overall Study|Lack of Efficacy|4|||
48937390|NCT00552110|157598832|FG000|Overall Study|Withdrawal by Subject|0|||
48937391|NCT00552110|157598833|FG001|Overall Study|Withdrawal by Subject|2|||
48937392|NCT00552110|157598834|FG002|Overall Study|Withdrawal by Subject|0|||
48937393|NCT00552110|157598835|FG003|Overall Study|Withdrawal by Subject|3|||
48937394|NCT00552110|157598836|FG004|Overall Study|Withdrawal by Subject|2|||
48937395|NCT00552110|157598832|FG000|Overall Study|Lost to Follow-up|0|||
48937396|NCT00552110|157598833|FG001|Overall Study|Lost to Follow-up|0|||
48937397|NCT00552110|157598834|FG002|Overall Study|Lost to Follow-up|0|||
48937398|NCT00552110|157598835|FG003|Overall Study|Lost to Follow-up|1|||
48937399|NCT00552110|157598836|FG004|Overall Study|Lost to Follow-up|1|||
48937400|NCT00552110|157598832|FG000|Overall Study|Failed to Comply With Study Requirements|1|||
48937401|NCT00552110|157598833|FG001|Overall Study|Failed to Comply With Study Requirements|1|||
48937402|NCT00552110|157598834|FG002|Overall Study|Failed to Comply With Study Requirements|1|||
48937403|NCT00552110|157598835|FG003|Overall Study|Failed to Comply With Study Requirements|0|||
48937404|NCT00552110|157598836|FG004|Overall Study|Failed to Comply With Study Requirements|1|||
48937405|NCT00552110|157598832|FG000|Overall Study|Withdrawn per Sponsor|0|||
48937406|NCT00552110|157598833|FG001|Overall Study|Withdrawn per Sponsor|1|||
48937407|NCT00552110|157598834|FG002|Overall Study|Withdrawn per Sponsor|0|||
48937408|NCT00552110|157598835|FG003|Overall Study|Withdrawn per Sponsor|0|||
48937409|NCT00552110|157598836|FG004|Overall Study|Withdrawn per Sponsor|1|||
48937410|NCT00552110|157598832|FG000|Overall Study|Use of Prohibited Medication|1|||
48937411|NCT00552110|157598833|FG001|Overall Study|Use of Prohibited Medication|1|||
48937412|NCT00552110|157598834|FG002|Overall Study|Use of Prohibited Medication|0|||
48937413|NCT00552110|157598835|FG003|Overall Study|Use of Prohibited Medication|0|||
48937414|NCT00552110|157598836|FG004|Overall Study|Use of Prohibited Medication|0|||
48937415|NCT00552110|157598832|FG000|Overall Study|Delay of Study due to Relabeling|0|||
48937416|NCT00552110|157598833|FG001|Overall Study|Delay of Study due to Relabeling|0|||
48937417|NCT00552110|157598834|FG002|Overall Study|Delay of Study due to Relabeling|0|||
48937418|NCT00552110|157598835|FG003|Overall Study|Delay of Study due to Relabeling|1|||
48937419|NCT00552110|157598836|FG004|Overall Study|Delay of Study due to Relabeling|0|||
48937420|NCT00552110|157598832|FG000|Overall Study|Increased Blood Pressure at Visit 2|0|||
48937421|NCT00552110|157598833|FG001|Overall Study|Increased Blood Pressure at Visit 2|0|||
48937422|NCT00552110|157598834|FG002|Overall Study|Increased Blood Pressure at Visit 2|0|||
48937423|NCT00552110|157598835|FG003|Overall Study|Increased Blood Pressure at Visit 2|1|||
48937424|NCT00552110|157598836|FG004|Overall Study|Increased Blood Pressure at Visit 2|0|||
48937425|NCT00552110|157598832|FG000|Overall Study|Nonserious Adverse Event (AE)|1|||
48937426|NCT00552110|157598833|FG001|Overall Study|Nonserious Adverse Event (AE)|0|||
48937427|NCT00552110|157598834|FG002|Overall Study|Nonserious Adverse Event (AE)|0|||
48937428|NCT00552110|157598835|FG003|Overall Study|Nonserious Adverse Event (AE)|1|||
48937429|NCT00552110|157598836|FG004|Overall Study|Nonserious Adverse Event (AE)|0|||
48937430|NCT03772327|157598838|FG000|Overall Study|Lost to Follow-up|3|||
48937431|NCT03772327|157598839|FG001|Overall Study|Lost to Follow-up|4|||
48937432|NCT03772327|157598838|FG000|Overall Study|Withdrawal by Subject|2|||
48937433|NCT03772327|157598839|FG001|Overall Study|Withdrawal by Subject|3|||
48937434|NCT01658514|157598840|FG000|Overall Study|Protocol Violation|1|||
48937435|NCT01658514|157598841|FG001|Overall Study|Protocol Violation|0|||
48937436|NCT01658514|157598842|FG002|Overall Study|Protocol Violation|2|||
48937437|NCT03437447|157598843|FG000|Treatment Period 1|Withdrawal by Subject|0|||
48937438|NCT03437447|157598844|FG001|Treatment Period 1|Withdrawal by Subject|0|||
48937439|NCT03437447|157598845|FG002|Treatment Period 1|Withdrawal by Subject|1|||
48937440|NCT01511445|157598846|FG000|Overall Study|Lost to Follow-up|3|||
48937441|NCT01511445|157598847|FG001|Overall Study|Lost to Follow-up|1|||
48937442|NCT01511445|157598846|FG000|Overall Study|Protocol Violation|1|||
48937443|NCT01511445|157598847|FG001|Overall Study|Protocol Violation|3|||
48937444|NCT01511445|157598846|FG000|Overall Study|Protocol Violation|1|||
48937445|NCT01511445|157598847|FG001|Overall Study|Protocol Violation|0|||
48937446|NCT00484315|157598848|FG000|12-Month Clinical Follow-up|Death|6|||
48937447|NCT00484315|157598849|FG001|12-Month Clinical Follow-up|Death|2|||
48937448|NCT00484315|157598848|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|4|||
48937449|NCT00484315|157598849|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|0|||
48937450|NCT00484315|157598848|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
48937451|NCT00484315|157598849|FG001|12-Month Clinical Follow-up|Lost to Follow-up|1|||
48937452|NCT00484315|157598848|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|13|||
48937453|NCT00484315|157598849|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|4|||
48937454|NCT00484315|157598848|FG000|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3|||
48937455|NCT00484315|157598849|FG001|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2|||
48937456|NCT00484315|157598848|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25|||
48937457|NCT00484315|157598849|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11|||
48937458|NCT00484315|157598848|FG000|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3|||
48937459|NCT00484315|157598849|FG001|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2|||
48937460|NCT00709202|157598850|FG000|Overall Study|Withdrawal by Subject|6|||
48937461|NCT00709202|157598851|FG001|Overall Study|Withdrawal by Subject|6|||
48937462|NCT01551745|157598852|FG000|Overall Study|Withdrawal by Subject|1|||
48937463|NCT01551745|157598852|FG000|Overall Study|Disease Progression|2|||
48937464|NCT02337387|157598869|FG000|Overall Study|Adverse Event|0|||
48937465|NCT02337387|157598870|FG001|Overall Study|Adverse Event|1|||
48937466|NCT02337387|157598871|FG002|Overall Study|Adverse Event|0|||
48937467|NCT02337387|157598872|FG003|Overall Study|Adverse Event|0|||
48937468|NCT02337387|157598869|FG000|Overall Study|Sponsor Decision to Terminate Study|14|||
48937469|NCT02337387|157598870|FG001|Overall Study|Sponsor Decision to Terminate Study|7|||
48937470|NCT02337387|157598871|FG002|Overall Study|Sponsor Decision to Terminate Study|3|||
48937471|NCT02337387|157598872|FG003|Overall Study|Sponsor Decision to Terminate Study|3|||
48937472|NCT01856114|157598874|FG000|Overall Study|Withdrawal by Subject|1|||
48937473|NCT01856114|157598875|FG001|Overall Study|Withdrawal by Subject|0|||
48937474|NCT01856114|157598874|FG000|Overall Study|Adverse Event|1|||
48937475|NCT01856114|157598875|FG001|Overall Study|Adverse Event|0|||
48937476|NCT01642212|157598876|FG000|Single-blind Baseline|Did Not Meet Eligibility Criteria|26|||
48937477|NCT01642212|157598877|FG001|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
48937478|NCT01642212|157598878|FG002|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
48937479|NCT01642212|157598879|FG003|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
48937480|NCT01642212|157598880|FG004|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
48937481|NCT01642212|157598876|FG000|Double-blind Treatment|Other|0|||
48937482|NCT01642212|157598877|FG001|Double-blind Treatment|Other|2|||
48937483|NCT01642212|157598878|FG002|Double-blind Treatment|Other|1|||
48937484|NCT01642212|157598879|FG003|Double-blind Treatment|Other|0|||
48937485|NCT01642212|157598880|FG004|Double-blind Treatment|Other|0|||
48937486|NCT01642212|157598876|FG000|Double-blind Treatment|Non-compliance|0|||
48937487|NCT01642212|157598877|FG001|Double-blind Treatment|Non-compliance|1|||
48937488|NCT01642212|157598878|FG002|Double-blind Treatment|Non-compliance|0|||
48937489|NCT01642212|157598879|FG003|Double-blind Treatment|Non-compliance|0|||
48937490|NCT01642212|157598880|FG004|Double-blind Treatment|Non-compliance|0|||
48937491|NCT01642212|157598876|FG000|Double-blind Treatment|Adverse Event|0|||
48937492|NCT01642212|157598877|FG001|Double-blind Treatment|Adverse Event|0|||
48937493|NCT01642212|157598878|FG002|Double-blind Treatment|Adverse Event|1|||
48937494|NCT01642212|157598879|FG003|Double-blind Treatment|Adverse Event|0|||
48937495|NCT01642212|157598880|FG004|Double-blind Treatment|Adverse Event|0|||
48937496|NCT01642212|157598876|FG000|Open-label Extension|Adverse Event|0|||
48937497|NCT01642212|157598877|FG001|Open-label Extension|Adverse Event|0|||
48937498|NCT01642212|157598878|FG002|Open-label Extension|Adverse Event|0|||
48937499|NCT01642212|157598879|FG003|Open-label Extension|Adverse Event|3|||
48937500|NCT01642212|157598880|FG004|Open-label Extension|Adverse Event|0|||
48937501|NCT01642212|157598876|FG000|Open-label Extension|Sponsor Decision|0|||
48937502|NCT01642212|157598877|FG001|Open-label Extension|Sponsor Decision|0|||
48937503|NCT01642212|157598878|FG002|Open-label Extension|Sponsor Decision|0|||
48937504|NCT01642212|157598879|FG003|Open-label Extension|Sponsor Decision|7|||
48937505|NCT01642212|157598880|FG004|Open-label Extension|Sponsor Decision|4|||
48937506|NCT01642212|157598876|FG000|Open-label Extension|Consent Withdrawn|0|||
48937507|NCT01642212|157598877|FG001|Open-label Extension|Consent Withdrawn|0|||
48937508|NCT01642212|157598878|FG002|Open-label Extension|Consent Withdrawn|0|||
48937509|NCT01642212|157598879|FG003|Open-label Extension|Consent Withdrawn|0|||
48937510|NCT01642212|157598880|FG004|Open-label Extension|Consent Withdrawn|2|||
48937511|NCT01642212|157598876|FG000|Open-label Extension|Lost to Follow-up|0|||
48937512|NCT01642212|157598877|FG001|Open-label Extension|Lost to Follow-up|0|||
48937513|NCT01642212|157598878|FG002|Open-label Extension|Lost to Follow-up|0|||
48937514|NCT01642212|157598879|FG003|Open-label Extension|Lost to Follow-up|0|||
48937515|NCT01642212|157598880|FG004|Open-label Extension|Lost to Follow-up|1|||
48937516|NCT01642212|157598876|FG000|Open-label Extension|Other|0|||
48937517|NCT01642212|157598877|FG001|Open-label Extension|Other|0|||
48937518|NCT01642212|157598878|FG002|Open-label Extension|Other|0|||
48937519|NCT01642212|157598879|FG003|Open-label Extension|Other|0|||
48937520|NCT01642212|157598880|FG004|Open-label Extension|Other|1|||
48937521|NCT00100048|157598883|FG000|Cohort I & II-Combination Therapy Phase|Never Treated|2|||
48937522|NCT00100048|157598884|FG001|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
48937523|NCT00100048|157598885|FG002|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
48937524|NCT00100048|157598886|FG003|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
48937525|NCT00100048|157598887|FG004|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
48937526|NCT00100048|157598888|FG005|Cohort I & II-Combination Therapy Phase|Never Treated|1|||
48937527|NCT00100048|157598883|FG000|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
48937528|NCT00100048|157598884|FG001|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
48937529|NCT00100048|157598885|FG002|Cohort I & II-Combination Therapy Phase|Adverse Event|2|||
48937530|NCT00100048|157598886|FG003|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
48937531|NCT00100048|157598887|FG004|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
48937532|NCT00100048|157598888|FG005|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
48937533|NCT00100048|157598883|FG000|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1|||
48937534|NCT00100048|157598884|FG001|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3|||
48937535|NCT00100048|157598885|FG002|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
48937536|NCT00100048|157598886|FG003|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
48937537|NCT00100048|157598887|FG004|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
48937538|NCT00100048|157598888|FG005|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2|||
48937539|NCT00100048|157598883|FG000|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
48937540|NCT00100048|157598884|FG001|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1|||
48937541|NCT00100048|157598885|FG002|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
48937542|NCT00100048|157598886|FG003|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
48937543|NCT00100048|157598887|FG004|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0|||
48937544|NCT00100048|157598888|FG005|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
48937545|NCT00100048|157598883|FG000|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1|||
48937546|NCT00100048|157598884|FG001|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
48937547|NCT00100048|157598885|FG002|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
48937548|NCT00100048|157598886|FG003|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5|||
48937549|NCT00100048|157598887|FG004|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0|||
48937550|NCT00100048|157598888|FG005|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4|||
48937551|NCT00100048|157598883|FG000|Cohort I & II-Combination Therapy Phase|Other Reason|7|||
48937552|NCT00100048|157598884|FG001|Cohort I & II-Combination Therapy Phase|Other Reason|1|||
48937553|NCT00100048|157598885|FG002|Cohort I & II-Combination Therapy Phase|Other Reason|4|||
48937554|NCT00100048|157598886|FG003|Cohort I & II-Combination Therapy Phase|Other Reason|2|||
48937555|NCT00100048|157598887|FG004|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
48937556|NCT00100048|157598888|FG005|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
48937557|NCT00100048|157598883|FG000|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
48937558|NCT00100048|157598884|FG001|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
48937559|NCT00100048|157598885|FG002|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
48937560|NCT00100048|157598886|FG003|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
48937561|NCT00100048|157598887|FG004|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
48937562|NCT00100048|157598888|FG005|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
48937563|NCT00100048|157598883|FG000|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
48937564|NCT00100048|157598884|FG001|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
48937565|NCT00100048|157598885|FG002|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
48937566|NCT00100048|157598886|FG003|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1|||
48937567|NCT00100048|157598887|FG004|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
48937568|NCT00100048|157598888|FG005|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
48937569|NCT00256295|157598891|FG000|Overall Study|Withdrawal by Subject|3|||
48937570|NCT00256295|157598891|FG000|Overall Study|Death|1|||
48937571|NCT01769105|157598892|FG000|First Intervention|Protocol Violation|2|||
48937572|NCT01769105|157598893|FG001|First Intervention|Protocol Violation|2|||
48937573|NCT01769105|157598892|FG000|Cross-over|Lost to Follow-up|5|||
48937574|NCT01769105|157598893|FG001|Cross-over|Lost to Follow-up|0|||
48937575|NCT01392183|157598894|FG000|First Drug Administration|Adverse Event|3|||
48937576|NCT01392183|157598895|FG001|First Drug Administration|Adverse Event|2|||
48937577|NCT01392183|157598894|FG000|First Drug Administration|Death|1|||
48937578|NCT01392183|157598895|FG001|First Drug Administration|Death|0|||
48937579|NCT01392183|157598894|FG000|First Drug Administration|Withdrawal by Subject|10|||
48937580|NCT01392183|157598895|FG001|First Drug Administration|Withdrawal by Subject|17|||
48937581|NCT01475734|157600817|FG000|Overall Study|Withdrawal by Subject|1|||
48937582|NCT01475734|157600818|FG001|Overall Study|Withdrawal by Subject|0|||
48937583|NCT01475734|157600817|FG000|Overall Study|Protocol Violation|1|||
48937584|NCT01475734|157600818|FG001|Overall Study|Protocol Violation|0|||
48937585|NCT01475734|157600817|FG000|Overall Study|Physician Decision|0|||
48937586|NCT01475734|157600818|FG001|Overall Study|Physician Decision|1|||
48937587|NCT00127127|157600819|FG000|Overall Study|Adverse Event|0|||
48937588|NCT00127127|157600820|FG001|Overall Study|Adverse Event|2|||
48937589|NCT00127127|157600821|FG002|Overall Study|Adverse Event|0|||
48937590|NCT00127127|157600822|FG003|Overall Study|Adverse Event|1|||
48937591|NCT00127127|157600819|FG000|Overall Study|Lack of Efficacy|1|||
48937592|NCT00127127|157600820|FG001|Overall Study|Lack of Efficacy|3|||
48937593|NCT00127127|157600821|FG002|Overall Study|Lack of Efficacy|0|||
48937594|NCT00127127|157600822|FG003|Overall Study|Lack of Efficacy|2|||
48937595|NCT00317044|157600823|FG000|Overall Study|Protocol Violation|28|||
48937596|NCT00317044|157600824|FG001|Overall Study|Protocol Violation|22|||
48937597|NCT00317044|157600825|FG002|Overall Study|Protocol Violation|20|||
48937598|NCT00317044|157600823|FG000|Overall Study|Adverse Event|4|||
48937599|NCT00317044|157600824|FG001|Overall Study|Adverse Event|7|||
48937600|NCT00317044|157600825|FG002|Overall Study|Adverse Event|4|||
48937601|NCT00317044|157600823|FG000|Overall Study|Withdrawal by Subject|10|||
48937602|NCT00317044|157600824|FG001|Overall Study|Withdrawal by Subject|7|||
48937603|NCT00317044|157600825|FG002|Overall Study|Withdrawal by Subject|12|||
48937604|NCT00317044|157600823|FG000|Overall Study|Lost to Follow-up|0|||
48937605|NCT00317044|157600824|FG001|Overall Study|Lost to Follow-up|2|||
48937606|NCT00317044|157600825|FG002|Overall Study|Lost to Follow-up|3|||
48937607|NCT00317044|157600823|FG000|Overall Study|Multiple Reasons|6|||
48937608|NCT00317044|157600824|FG001|Overall Study|Multiple Reasons|2|||
48937609|NCT00317044|157600825|FG002|Overall Study|Multiple Reasons|6|||
48937610|NCT01070329|157600826|FG000|Overall Study|Adverse Event|13|||
48937611|NCT01070329|157600827|FG001|Overall Study|Adverse Event|10|||
48937612|NCT01070329|157600826|FG000|Overall Study|Lost to Follow-up|22|||
48937613|NCT01070329|157600827|FG001|Overall Study|Lost to Follow-up|12|||
48937614|NCT01070329|157600826|FG000|Overall Study|Withdrawal by Subject|9|||
48937615|NCT01070329|157600827|FG001|Overall Study|Withdrawal by Subject|11|||
48937616|NCT01070329|157600826|FG000|Overall Study|Protocol Violation|3|||
48937617|NCT01070329|157600827|FG001|Overall Study|Protocol Violation|8|||
48937618|NCT01070329|157600826|FG000|Overall Study|Lack of Efficacy|2|||
48937619|NCT01070329|157600827|FG001|Overall Study|Lack of Efficacy|6|||
48937620|NCT01070329|157600826|FG000|Overall Study|Physician Decision|2|||
48937621|NCT01070329|157600827|FG001|Overall Study|Physician Decision|1|||
48937622|NCT01070329|157600826|FG000|Overall Study|Entry Criteria Not Met|1|||
48937623|NCT01070329|157600827|FG001|Overall Study|Entry Criteria Not Met|0|||
48937624|NCT01070329|157600826|FG000|Overall Study|Sponsor Decision|0|||
48937625|NCT01070329|157600827|FG001|Overall Study|Sponsor Decision|1|||
48937626|NCT00260208|157600828|FG000|Overall Study|Subject withdrew consent|11|||
48937627|NCT00260208|157600829|FG001|Overall Study|Subject withdrew consent|7|||
48937628|NCT00260208|157600828|FG000|Overall Study|Lost to Follow-up|6|||
48937629|NCT00260208|157600829|FG001|Overall Study|Lost to Follow-up|1|||
48937630|NCT00260208|157600828|FG000|Overall Study|Death|12|||
48937631|NCT00260208|157600829|FG001|Overall Study|Death|10|||
48937632|NCT00260208|157600828|FG000|Overall Study|Missing|18|||
48937633|NCT00260208|157600829|FG001|Overall Study|Missing|16|||
48937634|NCT01748071|157600830|FG000|Overall Study|Adverse Event|2|||
48937635|NCT01748071|157600831|FG001|Overall Study|Adverse Event|2|||
48937636|NCT01748071|157600832|FG002|Overall Study|Adverse Event|0|||
48937637|NCT02612909|157600833|FG000|Phase 2|Withdrawal by Subject|2|||
48937638|NCT02612909|157600834|FG001|Phase 2|Withdrawal by Subject|5|||
48937639|NCT02612909|157600835|FG002|Phase 2|Withdrawal by Subject|0|||
48937640|NCT02612909|157600836|FG003|Phase 2|Withdrawal by Subject|0|||
48937641|NCT02612909|157600837|FG004|Phase 2|Withdrawal by Subject|0|||
48937642|NCT02612909|157600833|FG000|Phase 2|Pregnancy|0|||
48937643|NCT02612909|157600834|FG001|Phase 2|Pregnancy|0|||
48937644|NCT02612909|157600835|FG002|Phase 2|Pregnancy|1|||
48937645|NCT02612909|157600836|FG003|Phase 2|Pregnancy|0|||
48937646|NCT02612909|157600837|FG004|Phase 2|Pregnancy|0|||
48937647|NCT02612909|157600833|FG000|Phase 3|Withdrawal by Subject|0|||
48937648|NCT02612909|157600834|FG001|Phase 3|Withdrawal by Subject|0|||
48937649|NCT02612909|157600835|FG002|Phase 3|Withdrawal by Subject|0|||
48937650|NCT02612909|157600836|FG003|Phase 3|Withdrawal by Subject|1|||
48937651|NCT02612909|157600837|FG004|Phase 3|Withdrawal by Subject|0|||
48937652|NCT05195528|157600838|FG000|Placebo-controlled Treatment Period|Protocol Violation|1|||
48937653|NCT05195528|157600839|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
48937654|NCT05195528|157600840|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
48937655|NCT05195528|157600841|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
48937656|NCT05195528|157600842|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
48937657|NCT05195528|157600838|FG000|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|2|||
48937658|NCT05195528|157600839|FG001|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|1|||
48937659|NCT05195528|157600840|FG002|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|6|||
48937660|NCT05195528|157600841|FG003|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
48937661|NCT05195528|157600842|FG004|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
48937662|NCT05195528|157600838|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
48937663|NCT05195528|157600839|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|3|||
48937664|NCT05195528|157600840|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|4|||
48937665|NCT05195528|157600841|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
48937666|NCT05195528|157600842|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
48937667|NCT05195528|157600838|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|6|||
48937668|NCT05195528|157600839|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
48937669|NCT05195528|157600840|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|4|||
48937670|NCT05195528|157600841|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
48937671|NCT05195528|157600842|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
48937672|NCT05195528|157600838|FG000|Placebo-controlled Treatment Period|Lack of Efficacy|2|||
48937673|NCT05195528|157600839|FG001|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
48937674|NCT05195528|157600840|FG002|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
48937675|NCT05195528|157600841|FG003|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
48937676|NCT05195528|157600842|FG004|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
48937677|NCT05195528|157600838|FG000|Placebo-controlled Treatment Period|Not Treated|1|||
48937678|NCT05195528|157600839|FG001|Placebo-controlled Treatment Period|Not Treated|1|||
48937679|NCT05195528|157600840|FG002|Placebo-controlled Treatment Period|Not Treated|2|||
48937680|NCT05195528|157600841|FG003|Placebo-controlled Treatment Period|Not Treated|0|||
48937681|NCT05195528|157600842|FG004|Placebo-controlled Treatment Period|Not Treated|0|||
48937682|NCT05195528|157600838|FG000|Placebo-controlled Treatment Period|Other|0|||
48937683|NCT05195528|157600839|FG001|Placebo-controlled Treatment Period|Other|0|||
48937684|NCT05195528|157600840|FG002|Placebo-controlled Treatment Period|Other|1|||
48937685|NCT05195528|157600841|FG003|Placebo-controlled Treatment Period|Other|0|||
48937686|NCT05195528|157600842|FG004|Placebo-controlled Treatment Period|Other|0|||
48937687|NCT05195528|157600838|FG000|Extension Period|PTE or AE or SAE|0|||
48937688|NCT05195528|157600839|FG001|Extension Period|PTE or AE or SAE|4|||
48937689|NCT05195528|157600840|FG002|Extension Period|PTE or AE or SAE|5|||
48937690|NCT05195528|157600841|FG003|Extension Period|PTE or AE or SAE|4|||
48937691|NCT05195528|157600842|FG004|Extension Period|PTE or AE or SAE|4|||
48937692|NCT05195528|157600838|FG000|Extension Period|Protocol Violation|0|||
48937693|NCT05195528|157600839|FG001|Extension Period|Protocol Violation|2|||
48937694|NCT05195528|157600840|FG002|Extension Period|Protocol Violation|1|||
48937695|NCT05195528|157600841|FG003|Extension Period|Protocol Violation|0|||
48937696|NCT05195528|157600842|FG004|Extension Period|Protocol Violation|1|||
48937697|NCT05195528|157600838|FG000|Extension Period|Lost to Follow-up|0|||
48937698|NCT05195528|157600839|FG001|Extension Period|Lost to Follow-up|6|||
48937699|NCT05195528|157600840|FG002|Extension Period|Lost to Follow-up|13|||
48937700|NCT05195528|157600841|FG003|Extension Period|Lost to Follow-up|3|||
48937701|NCT05195528|157600842|FG004|Extension Period|Lost to Follow-up|7|||
48937702|NCT05195528|157600838|FG000|Extension Period|Withdrawal by Subject|0|||
48937703|NCT05195528|157600839|FG001|Extension Period|Withdrawal by Subject|12|||
48937704|NCT05195528|157600840|FG002|Extension Period|Withdrawal by Subject|9|||
48937705|NCT05195528|157600841|FG003|Extension Period|Withdrawal by Subject|6|||
48937706|NCT05195528|157600842|FG004|Extension Period|Withdrawal by Subject|5|||
48937707|NCT05195528|157600838|FG000|Extension Period|Lack of Efficacy|0|||
48937708|NCT05195528|157600839|FG001|Extension Period|Lack of Efficacy|3|||
48937709|NCT05195528|157600840|FG002|Extension Period|Lack of Efficacy|0|||
48937710|NCT05195528|157600841|FG003|Extension Period|Lack of Efficacy|0|||
48937711|NCT05195528|157600842|FG004|Extension Period|Lack of Efficacy|2|||
48937712|NCT05195528|157600838|FG000|Extension Period|Not Treated|0|||
48937713|NCT05195528|157600839|FG001|Extension Period|Not Treated|0|||
48937714|NCT05195528|157600840|FG002|Extension Period|Not Treated|2|||
48937715|NCT05195528|157600841|FG003|Extension Period|Not Treated|3|||
48937716|NCT05195528|157600842|FG004|Extension Period|Not Treated|0|||
48937717|NCT05195528|157600838|FG000|Extension Period|Other|0|||
48937718|NCT05195528|157600839|FG001|Extension Period|Other|1|||
48937719|NCT05195528|157600840|FG002|Extension Period|Other|1|||
48937720|NCT05195528|157600841|FG003|Extension Period|Other|0|||
48937721|NCT05195528|157600842|FG004|Extension Period|Other|0|||
48937722|NCT01552057|157600850|FG000|Overall Study|Adverse Event|14|||
48937723|NCT01552057|157600851|FG001|Overall Study|Adverse Event|15|||
48937724|NCT01552057|157600850|FG000|Overall Study|Lack of Efficacy|8|||
48937725|NCT01552057|157600851|FG001|Overall Study|Lack of Efficacy|23|||
48937726|NCT01552057|157600850|FG000|Overall Study|Withdrawal by Subject|5|||
48937727|NCT01552057|157600851|FG001|Overall Study|Withdrawal by Subject|8|||
48937728|NCT01552057|157600850|FG000|Overall Study|Entry Criteria Not Met|2|||
48937729|NCT01552057|157600851|FG001|Overall Study|Entry Criteria Not Met|2|||
48937730|NCT01552057|157600850|FG000|Overall Study|Physician Decision|1|||
48937731|NCT01552057|157600851|FG001|Overall Study|Physician Decision|0|||
48937732|NCT00393718|157600856|FG000|Overall Study|Adverse Event|20|||
48937733|NCT00393718|157600857|FG001|Overall Study|Adverse Event|8|||
48937734|NCT00393718|157600856|FG000|Overall Study|Protocol Violation|1|||
48937735|NCT00393718|157600857|FG001|Overall Study|Protocol Violation|2|||
48937736|NCT00393718|157600856|FG000|Overall Study|Lack of Efficacy|10|||
48937737|NCT00393718|157600857|FG001|Overall Study|Lack of Efficacy|9|||
48937738|NCT00393718|157600856|FG000|Overall Study|Hypoglycaemia|3|||
48937739|NCT00393718|157600857|FG001|Overall Study|Hypoglycaemia|2|||
48937740|NCT00393718|157600856|FG000|Overall Study|Subject decision|5|||
48937741|NCT00393718|157600857|FG001|Overall Study|Subject decision|0|||
48937742|NCT00393718|157600856|FG000|Overall Study|Withdrawal of consent|2|||
48937743|NCT00393718|157600857|FG001|Overall Study|Withdrawal of consent|1|||
48937744|NCT00393718|157600856|FG000|Overall Study|Missed measurement|1|||
48937745|NCT00393718|157600857|FG001|Overall Study|Missed measurement|0|||
48937746|NCT00393718|157600856|FG000|Overall Study|Move|1|||
48937747|NCT00393718|157600857|FG001|Overall Study|Move|0|||
48937748|NCT00883493|157600858|FG000|Overall Study|Adverse Event|11|||
48937749|NCT00883493|157600859|FG001|Overall Study|Adverse Event|12|||
48937750|NCT00883493|157600858|FG000|Overall Study|Lack of Efficacy|4|||
48937751|NCT00883493|157600859|FG001|Overall Study|Lack of Efficacy|3|||
48937752|NCT00883493|157600858|FG000|Overall Study|Lost to Follow-up|7|||
48937753|NCT00883493|157600859|FG001|Overall Study|Lost to Follow-up|6|||
48937754|NCT00883493|157600858|FG000|Overall Study|Withdrawal by Subject|11|||
48937755|NCT00883493|157600859|FG001|Overall Study|Withdrawal by Subject|20|||
48937756|NCT00883493|157600858|FG000|Overall Study|Eligibility Criteria not fullfilled|6|||
48937757|NCT00883493|157600859|FG001|Overall Study|Eligibility Criteria not fullfilled|6|||
48937758|NCT00883493|157600858|FG000|Overall Study|Study specific disc. criteria|2|||
48937759|NCT00883493|157600859|FG001|Overall Study|Study specific disc. criteria|0|||
48937760|NCT00883493|157600858|FG000|Overall Study|Other|5|||
48937761|NCT00883493|157600859|FG001|Overall Study|Other|3|||
48937762|NCT01427309|157600862|FG000|Overall Study|Lost to Follow-up|130|||
48937763|NCT01427309|157600863|FG001|Overall Study|Lost to Follow-up|145|||
48937764|NCT01427309|157600864|FG002|Overall Study|Lost to Follow-up|122|||
48937765|NCT01427309|157600865|FG003|Overall Study|Lost to Follow-up|135|||
48937766|NCT01427309|157600862|FG000|Overall Study|Protocol Violation|42|||
48937767|NCT01427309|157600863|FG001|Overall Study|Protocol Violation|69|||
48937768|NCT01427309|157600864|FG002|Overall Study|Protocol Violation|125|||
48937769|NCT01427309|157600865|FG003|Overall Study|Protocol Violation|124|||
48937770|NCT01427309|157600862|FG000|Overall Study|Adverse Event|0|||
48937771|NCT01427309|157600863|FG001|Overall Study|Adverse Event|0|||
48937772|NCT01427309|157600864|FG002|Overall Study|Adverse Event|3|||
48937773|NCT01427309|157600865|FG003|Overall Study|Adverse Event|1|||
48937774|NCT01427309|157600862|FG000|Overall Study|Serious adverse event|52|||
48937775|NCT01427309|157600863|FG001|Overall Study|Serious adverse event|45|||
48937776|NCT01427309|157600864|FG002|Overall Study|Serious adverse event|50|||
48937777|NCT01427309|157600865|FG003|Overall Study|Serious adverse event|61|||
48937778|NCT01427309|157600862|FG000|Overall Study|Withdrawal by Subject|148|||
48937779|NCT01427309|157600863|FG001|Overall Study|Withdrawal by Subject|148|||
48937780|NCT01427309|157600864|FG002|Overall Study|Withdrawal by Subject|61|||
48937781|NCT01427309|157600865|FG003|Overall Study|Withdrawal by Subject|55|||
48937782|NCT03617705|157600866|FG000|Overall Study|Withdrawal by Subject|2|||
48937783|NCT03617705|157600866|FG000|Overall Study|lost contact after screening due to covid pandemic|6|||
48937784|NCT03617705|157600866|FG000|Overall Study|withdrawal by study team due to non-compliance|1|||
48937785|NCT03293654|157600867|FG000|Overall Study|Lost to Follow-up|0|||
48937786|NCT03293654|157600868|FG001|Overall Study|Lost to Follow-up|1|||
48937787|NCT03293654|157600869|FG002|Overall Study|Lost to Follow-up|0|||
48937788|NCT01061008|157600870|FG000|Overall Study|Badiocephalic fistula failed|3|||
48937789|NCT01061008|157600871|FG001|Overall Study|Badiocephalic fistula failed|2|||
48937790|NCT01061008|157600870|FG000|Overall Study|Death|1|||
48937791|NCT01061008|157600871|FG001|Overall Study|Death|0|||
48937792|NCT01061008|157600870|FG000|Overall Study|Withdrawal by Subject|1|||
48937793|NCT01061008|157600871|FG001|Overall Study|Withdrawal by Subject|3|||
48937794|NCT01061008|157600870|FG000|Overall Study|Unable to exercise following surgery|1|||
48937795|NCT01061008|157600871|FG001|Overall Study|Unable to exercise following surgery|0|||
48937796|NCT01061008|157600870|FG000|Overall Study|Adverse Event|0|||
48937797|NCT01061008|157600871|FG001|Overall Study|Adverse Event|1|||
48937798|NCT02542267|157600873|FG000|Overall Study|Withdrawal by Subject|10|||
48937799|NCT02542267|157600873|FG000|Overall Study|Physician Decision|6|||
48937800|NCT02542267|157600873|FG000|Overall Study|Lost to Follow-up|4|||
48937801|NCT02542267|157600873|FG000|Overall Study|Death|13|||
48937802|NCT02542267|157600873|FG000|Overall Study|Surgical Bypass of All Study Devices|13|||
48937803|NCT02542267|157600873|FG000|Overall Study|Other|9|||
48937804|NCT03049449|157600876|FG000|Overall Study|Did not receive treatment.|0|||
48937805|NCT03049449|157600877|FG001|Overall Study|Did not receive treatment.|0|||
48937806|NCT03049449|157600878|FG002|Overall Study|Did not receive treatment.|0|||
48937807|NCT03049449|157600879|FG003|Overall Study|Did not receive treatment.|0|||
48937808|NCT03049449|157600880|FG004|Overall Study|Did not receive treatment.|0|||
48937809|NCT03049449|157600881|FG005|Overall Study|Did not receive treatment.|0|||
48937810|NCT03049449|157600882|FG006|Overall Study|Did not receive treatment.|0|||
48937811|NCT03049449|157600883|FG007|Overall Study|Did not receive treatment.|0|||
48937812|NCT03049449|157600884|FG008|Overall Study|Did not receive treatment.|1|||
48937813|NCT03049449|157600885|FG009|Overall Study|Did not receive treatment.|0|||
48937814|NCT03049449|157600876|FG000|Overall Study|Enrolled and removed from study with no treatment|0|||
48937815|NCT03049449|157600877|FG001|Overall Study|Enrolled and removed from study with no treatment|0|||
48847860|NCT05975840|157282224|FG000|Overall Study|Lost to Follow-up|3|||
48847861|NCT05975840|157282225|FG001|Overall Study|Lost to Follow-up|6|||
48847862|NCT05975840|157282226|FG002|Overall Study|Lost to Follow-up|3|||
48847863|NCT05975840|157282227|FG003|Overall Study|Lost to Follow-up|1|||
48847864|NCT05975840|157282228|FG004|Overall Study|Lost to Follow-up|4|||
48847865|NCT05975840|157282229|FG005|Overall Study|Lost to Follow-up|1|||
48847866|NCT05975840|157282230|FG006|Overall Study|Lost to Follow-up|2|||
48847867|NCT05975840|157282231|FG007|Overall Study|Lost to Follow-up|4|||
48847868|NCT05975840|157282224|FG000|Overall Study|Migrated/moved from the study area|1|||
48847869|NCT05975840|157282225|FG001|Overall Study|Migrated/moved from the study area|0|||
48847870|NCT05975840|157282226|FG002|Overall Study|Migrated/moved from the study area|0|||
48847871|NCT05975840|157282227|FG003|Overall Study|Migrated/moved from the study area|0|||
48847872|NCT05975840|157282228|FG004|Overall Study|Migrated/moved from the study area|0|||
48847873|NCT05975840|157282229|FG005|Overall Study|Migrated/moved from the study area|0|||
48847874|NCT05975840|157282230|FG006|Overall Study|Migrated/moved from the study area|0|||
48847875|NCT05975840|157282231|FG007|Overall Study|Migrated/moved from the study area|0|||
48847876|NCT05975840|157282224|FG000|Overall Study|Withdrawal by Subject|0|||
48847877|NCT05975840|157282225|FG001|Overall Study|Withdrawal by Subject|5|||
48847878|NCT05975840|157282226|FG002|Overall Study|Withdrawal by Subject|2|||
48847879|NCT05975840|157282227|FG003|Overall Study|Withdrawal by Subject|2|||
48847880|NCT05975840|157282228|FG004|Overall Study|Withdrawal by Subject|0|||
48847881|NCT05975840|157282229|FG005|Overall Study|Withdrawal by Subject|2|||
48847882|NCT05975840|157282230|FG006|Overall Study|Withdrawal by Subject|2|||
48847883|NCT05975840|157282231|FG007|Overall Study|Withdrawal by Subject|1|||
48847884|NCT05975840|157282224|FG000|Overall Study|Protocol Violation|0|||
48847885|NCT05975840|157282225|FG001|Overall Study|Protocol Violation|1|||
48847886|NCT05975840|157282226|FG002|Overall Study|Protocol Violation|0|||
48847887|NCT05975840|157282227|FG003|Overall Study|Protocol Violation|0|||
48847888|NCT05975840|157282228|FG004|Overall Study|Protocol Violation|0|||
48847889|NCT05975840|157282229|FG005|Overall Study|Protocol Violation|0|||
48847890|NCT05975840|157282230|FG006|Overall Study|Protocol Violation|0|||
48847891|NCT05975840|157282231|FG007|Overall Study|Protocol Violation|0|||
48847892|NCT05975840|157282224|FG000|Overall Study|Adverse Event|0|||
48847893|NCT05975840|157282225|FG001|Overall Study|Adverse Event|0|||
48937816|NCT03049449|157600878|FG002|Overall Study|Enrolled and removed from study with no treatment|1|||
48937817|NCT03049449|157600879|FG003|Overall Study|Enrolled and removed from study with no treatment|1|||
48937818|NCT03049449|157600880|FG004|Overall Study|Enrolled and removed from study with no treatment|0|||
48937819|NCT03049449|157600881|FG005|Overall Study|Enrolled and removed from study with no treatment|0|||
48937820|NCT03049449|157600882|FG006|Overall Study|Enrolled and removed from study with no treatment|0|||
48937821|NCT03049449|157600883|FG007|Overall Study|Enrolled and removed from study with no treatment|0|||
48847894|NCT05975840|157282226|FG002|Overall Study|Adverse Event|0|||
48937822|NCT03049449|157600884|FG008|Overall Study|Enrolled and removed from study with no treatment|0|||
48847895|NCT05975840|157282227|FG003|Overall Study|Adverse Event|1|||
48847896|NCT05975840|157282228|FG004|Overall Study|Adverse Event|0|||
48847897|NCT05975840|157282229|FG005|Overall Study|Adverse Event|0|||
48847898|NCT05975840|157282230|FG006|Overall Study|Adverse Event|0|||
48847899|NCT05975840|157282231|FG007|Overall Study|Adverse Event|0|||
48847900|NCT05975840|157282224|FG000|Overall Study|Death|0|||
48847901|NCT05975840|157282225|FG001|Overall Study|Death|1|||
48847902|NCT05975840|157282226|FG002|Overall Study|Death|0|||
48847903|NCT05975840|157282227|FG003|Overall Study|Death|0|||
48847904|NCT05975840|157282228|FG004|Overall Study|Death|0|||
48847905|NCT05975840|157282229|FG005|Overall Study|Death|0|||
48847906|NCT05975840|157282230|FG006|Overall Study|Death|0|||
48847907|NCT05975840|157282231|FG007|Overall Study|Death|1|||
48847908|NCT01917084|157282241|FG000|Overall Study|Withdrawal by Subject|1|||
48847909|NCT04605159|157282242|FG000|Overall Study|Adverse Event|6|||
48847910|NCT04605159|157282243|FG001|Overall Study|Adverse Event|3|||
48847911|NCT04605159|157282244|FG002|Overall Study|Adverse Event|21|||
48847912|NCT04605159|157282245|FG003|Overall Study|Adverse Event|4|||
48847913|NCT04605159|157282242|FG000|Overall Study|Lost to Follow-up|74|||
48847914|NCT04605159|157282243|FG001|Overall Study|Lost to Follow-up|45|||
48847915|NCT04605159|157282244|FG002|Overall Study|Lost to Follow-up|119|||
48847916|NCT04605159|157282245|FG003|Overall Study|Lost to Follow-up|80|||
48847917|NCT04605159|157282242|FG000|Overall Study|Protocol Violation|4|||
48847918|NCT04605159|157282243|FG001|Overall Study|Protocol Violation|5|||
48847919|NCT04605159|157282244|FG002|Overall Study|Protocol Violation|2|||
48847920|NCT04605159|157282245|FG003|Overall Study|Protocol Violation|0|||
48847921|NCT04605159|157282242|FG000|Overall Study|Withdrawal by Subject|66|||
48847922|NCT04605159|157282243|FG001|Overall Study|Withdrawal by Subject|37|||
48847923|NCT04605159|157282244|FG002|Overall Study|Withdrawal by Subject|68|||
48847924|NCT04605159|157282245|FG003|Overall Study|Withdrawal by Subject|50|||
48847925|NCT04605159|157282242|FG000|Overall Study|Migrated / moved from the study area|32|||
48847926|NCT04605159|157282243|FG001|Overall Study|Migrated / moved from the study area|22|||
48847927|NCT04605159|157282244|FG002|Overall Study|Migrated / moved from the study area|41|||
48847928|NCT04605159|157282245|FG003|Overall Study|Migrated / moved from the study area|21|||
48847929|NCT04605159|157282242|FG000|Overall Study|Other|1|||
48847930|NCT04605159|157282243|FG001|Overall Study|Other|2|||
48847931|NCT04605159|157282244|FG002|Overall Study|Other|7|||
48847932|NCT04605159|157282245|FG003|Overall Study|Other|3|||
48847933|NCT03884101|157282247|FG000|Overall Study|Participant Ongoing in Study|202|||
48847934|NCT03884101|157282248|FG001|Overall Study|Participant Ongoing in Study|186|||
48847935|NCT03884101|157282247|FG000|Overall Study|Death|212|||
48847936|NCT03884101|157282248|FG001|Overall Study|Death|224|||
48847937|NCT03884101|157282247|FG000|Overall Study|Lost to Follow-up|0|||
48847938|NCT03884101|157282248|FG001|Overall Study|Lost to Follow-up|1|||
48847939|NCT03884101|157282247|FG000|Overall Study|Withdrawal by Subject|6|||
48937823|NCT03049449|157600885|FG009|Overall Study|Enrolled and removed from study with no treatment|0|||
48937824|NCT03049449|157600876|FG000|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
48937825|NCT03049449|157600877|FG001|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
48847940|NCT03884101|157282248|FG001|Overall Study|Withdrawal by Subject|11|||
48847941|NCT05741294|157282249|FG000|Overall Study|Lost to Follow-up|3|||
48847942|NCT05741294|157282249|FG000|Overall Study|Protocol deviation|3|||
48937826|NCT03049449|157600878|FG002|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
48937827|NCT03049449|157600879|FG003|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
48937828|NCT03049449|157600880|FG004|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
48937829|NCT03049449|157600881|FG005|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
48937830|NCT03049449|157600882|FG006|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
48937831|NCT03049449|157600883|FG007|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
48937832|NCT03049449|157600884|FG008|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
48937833|NCT03049449|157600885|FG009|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
48937834|NCT02388295|157600888|FG000|Dose Escalation Week 1|Adverse Event|1|||
48937835|NCT02388295|157600889|FG001|Dose Escalation Week 1|Adverse Event|2|||
48937836|NCT02388295|157600890|FG002|Dose Escalation Week 1|Adverse Event|1|||
48937837|NCT02388295|157600888|FG000|Dose Escalation Week 1|Determined not eligible|1|||
48937838|NCT02388295|157600889|FG001|Dose Escalation Week 1|Determined not eligible|1|||
48937839|NCT02388295|157600890|FG002|Dose Escalation Week 1|Determined not eligible|1|||
48937840|NCT02388295|157600888|FG000|Dose Escalation Week 2|Protocol Violation|0|||
48937841|NCT02388295|157600889|FG001|Dose Escalation Week 2|Protocol Violation|1|||
48937842|NCT02388295|157600890|FG002|Dose Escalation Week 2|Protocol Violation|0|||
48937843|NCT02388295|157600888|FG000|Dose Escalation Week 2|Determined not eligible|1|||
48937844|NCT02388295|157600889|FG001|Dose Escalation Week 2|Determined not eligible|1|||
48937845|NCT02388295|157600890|FG002|Dose Escalation Week 2|Determined not eligible|1|||
48937846|NCT02388295|157600888|FG000|Treatment Weeks 3 to 12|Adverse Event|1|||
48937847|NCT02388295|157600889|FG001|Treatment Weeks 3 to 12|Adverse Event|1|||
48937848|NCT02388295|157600890|FG002|Treatment Weeks 3 to 12|Adverse Event|0|||
48937849|NCT04007159|157600891|FG000|Induction Phase|(missed study visits)|16|||
48937850|NCT04007159|157600891|FG000|Induction Phase|Withdrawal by Subject|4|||
48937851|NCT04007159|157600891|FG000|Induction Phase|Adverse Event|2|||
48937852|NCT04007159|157600891|FG000|Challenge Phase|missed study visits|3|||
48937853|NCT00331760|157600892|FG000|Overall Study|Ineligible / no protocol treatment|15|||
48937854|NCT00331760|157600893|FG001|Overall Study|Ineligible / no protocol treatment|8|||
48937855|NCT01950819|157600895|FG000|Overall Study|Graft Loss|35|||
48937856|NCT01950819|157600896|FG001|Overall Study|Graft Loss|30|||
48937857|NCT01950819|157600895|FG000|Overall Study|Death|29|||
48937858|NCT01950819|157600896|FG001|Overall Study|Death|34|||
48937859|NCT01950819|157600895|FG000|Overall Study|Subject / Gardian decision|54|||
48937860|NCT01950819|157600896|FG001|Overall Study|Subject / Gardian decision|51|||
48937861|NCT01950819|157600895|FG000|Overall Study|technical problems|2|||
48937862|NCT01950819|157600896|FG001|Overall Study|technical problems|0|||
48937863|NCT01950819|157600895|FG000|Overall Study|Pregnancy|0|||
48937864|NCT01950819|157600896|FG001|Overall Study|Pregnancy|2|||
48937865|NCT01950819|157600895|FG000|Overall Study|Lost to Follow-up|9|||
48937866|NCT01950819|157600896|FG001|Overall Study|Lost to Follow-up|17|||
48937867|NCT00486603|157600901|FG000|Overall Study|Withdrawal by Subject|1|||
48937868|NCT00486603|157600902|FG001|Overall Study|Withdrawal by Subject|0|||
48937869|NCT00486603|157600903|FG002|Overall Study|Withdrawal by Subject|0|||
48937870|NCT00486603|157600904|FG003|Overall Study|Withdrawal by Subject|0|||
48937871|NCT00486603|157600905|FG004|Overall Study|Withdrawal by Subject|0|||
48937872|NCT00486603|157600901|FG000|Overall Study|Physician Decision|0|||
48937873|NCT00486603|157600902|FG001|Overall Study|Physician Decision|1|||
48937874|NCT00486603|157600903|FG002|Overall Study|Physician Decision|0|||
48937875|NCT00486603|157600904|FG003|Overall Study|Physician Decision|0|||
48937876|NCT00486603|157600905|FG004|Overall Study|Physician Decision|0|||
48937877|NCT01075178|157600906|FG000|Subject Matching|eligible but not matched|130|||
48937878|NCT01075178|157600907|FG001|Subject Matching|eligible but not matched|403|||
48937879|NCT01075178|157600906|FG000|Subject Chart Review|died before chart review period|0|||
48937880|NCT01075178|157600907|FG001|Subject Chart Review|died before chart review period|2|||
48937881|NCT01075178|157600906|FG000|Subject Chart Review|no data collected due to site closure|3|||
48937882|NCT01075178|157600907|FG001|Subject Chart Review|no data collected due to site closure|4|||
48937883|NCT01075178|157600906|FG000|Subject Chart Review|matched partner excluded (reasons above)|6|||
48937884|NCT01075178|157600907|FG001|Subject Chart Review|matched partner excluded (reasons above)|3|||
48937885|NCT01032629|157600909|FG000|Overall Study|Closed Site|21|||
48937886|NCT01032629|157600910|FG001|Overall Study|Closed Site|18|||
48937887|NCT01032629|157600911|FG002|Overall Study|Closed Site|16|||
48937888|NCT01032629|157600909|FG000|Overall Study|Withdrawal by Subject|50|||
48937889|NCT01032629|157600910|FG001|Overall Study|Withdrawal by Subject|36|||
48937890|NCT01032629|157600911|FG002|Overall Study|Withdrawal by Subject|35|||
48937891|NCT01032629|157600909|FG000|Overall Study|Lost to Follow-up|74|||
48937892|NCT01032629|157600910|FG001|Overall Study|Lost to Follow-up|47|||
48937893|NCT01032629|157600911|FG002|Overall Study|Lost to Follow-up|37|||
48937894|NCT00348140|157600912|FG000|Overall Study|Adverse Event|46|||
48937895|NCT00348140|157600913|FG001|Overall Study|Adverse Event|49|||
48937896|NCT00348140|157600914|FG002|Overall Study|Adverse Event|78|||
48937897|NCT00348140|157600912|FG000|Overall Study|Lost to Follow-up|4|||
48937898|NCT00348140|157600913|FG001|Overall Study|Lost to Follow-up|4|||
48937899|NCT00348140|157600914|FG002|Overall Study|Lost to Follow-up|4|||
48937900|NCT00348140|157600912|FG000|Overall Study|Protocol Violation|12|||
48937901|NCT00348140|157600913|FG001|Overall Study|Protocol Violation|13|||
48937902|NCT00348140|157600914|FG002|Overall Study|Protocol Violation|14|||
48937903|NCT00348140|157600912|FG000|Overall Study|Withdrawal by Subject|32|||
48937904|NCT00348140|157600913|FG001|Overall Study|Withdrawal by Subject|40|||
48937905|NCT00348140|157600914|FG002|Overall Study|Withdrawal by Subject|40|||
48937906|NCT00348140|157600912|FG000|Overall Study|Non-compliance|8|||
48937907|NCT00348140|157600913|FG001|Overall Study|Non-compliance|13|||
48937908|NCT00348140|157600914|FG002|Overall Study|Non-compliance|5|||
48937909|NCT00348140|157600912|FG000|Overall Study|Participant at risk due to study drug|2|||
48937910|NCT00348140|157600913|FG001|Overall Study|Participant at risk due to study drug|0|||
48937911|NCT00348140|157600914|FG002|Overall Study|Participant at risk due to study drug|0|||
48937912|NCT00348140|157600912|FG000|Overall Study|Conditional medication increased dose|1|||
48937913|NCT00348140|157600913|FG001|Overall Study|Conditional medication increased dose|0|||
48937914|NCT00348140|157600914|FG002|Overall Study|Conditional medication increased dose|0|||
48937915|NCT00348140|157600912|FG000|Overall Study|Caregiver related|4|||
48937916|NCT00348140|157600913|FG001|Overall Study|Caregiver related|7|||
48937917|NCT00348140|157600914|FG002|Overall Study|Caregiver related|3|||
48937918|NCT00348140|157600912|FG000|Overall Study|Participant hospitalised|3|||
48937919|NCT00348140|157600913|FG001|Overall Study|Participant hospitalised|0|||
48937920|NCT00348140|157600914|FG002|Overall Study|Participant hospitalised|0|||
48937921|NCT00348140|157600912|FG000|Overall Study|Efficacy related|1|||
48937922|NCT00348140|157600913|FG001|Overall Study|Efficacy related|1|||
48937923|NCT00348140|157600914|FG002|Overall Study|Efficacy related|0|||
48937924|NCT00348140|157600912|FG000|Overall Study|Administration related|3|||
48937925|NCT00348140|157600913|FG001|Overall Study|Administration related|1|||
48937926|NCT00348140|157600914|FG002|Overall Study|Administration related|1|||
48937927|NCT00348140|157600912|FG000|Overall Study|Unmet inclusion-exclusion criteria|1|||
48937928|NCT00348140|157600913|FG001|Overall Study|Unmet inclusion-exclusion criteria|0|||
48937929|NCT00348140|157600914|FG002|Overall Study|Unmet inclusion-exclusion criteria|1|||
48937930|NCT00348140|157600912|FG000|Overall Study|Participant unwell|1|||
48937931|NCT00348140|157600913|FG001|Overall Study|Participant unwell|0|||
48937932|NCT00348140|157600914|FG002|Overall Study|Participant unwell|0|||
48937933|NCT00348140|157600912|FG000|Overall Study|Screen failure|1|||
48937934|NCT00348140|157600913|FG001|Overall Study|Screen failure|0|||
48937935|NCT00348140|157600914|FG002|Overall Study|Screen failure|0|||
48937936|NCT00348140|157600912|FG000|Overall Study|Investigator decided to discontinue|4|||
48937937|NCT00348140|157600913|FG001|Overall Study|Investigator decided to discontinue|1|||
48937938|NCT00348140|157600914|FG002|Overall Study|Investigator decided to discontinue|4|||
48937939|NCT00348140|157600912|FG000|Overall Study|Decided to discontinue on their own|1|||
48937940|NCT00348140|157600913|FG001|Overall Study|Decided to discontinue on their own|4|||
48937941|NCT00348140|157600914|FG002|Overall Study|Decided to discontinue on their own|1|||
48937942|NCT00348140|157600912|FG000|Overall Study|Use of prohibited drug|1|||
48937943|NCT00348140|157600913|FG001|Overall Study|Use of prohibited drug|0|||
48937944|NCT00348140|157600914|FG002|Overall Study|Use of prohibited drug|2|||
48937945|NCT00348140|157600912|FG000|Overall Study|Disease progression|1|||
48937946|NCT00348140|157600913|FG001|Overall Study|Disease progression|2|||
48937947|NCT00348140|157600914|FG002|Overall Study|Disease progression|5|||
48937948|NCT00348140|157600912|FG000|Overall Study|Increased risk of cardiac infarction|0|||
48937949|NCT00348140|157600913|FG001|Overall Study|Increased risk of cardiac infarction|1|||
48937950|NCT00348140|157600914|FG002|Overall Study|Increased risk of cardiac infarction|0|||
48937951|NCT00348140|157600912|FG000|Overall Study|Serious adverse event|0|||
48937952|NCT00348140|157600913|FG001|Overall Study|Serious adverse event|1|||
48937953|NCT00348140|157600914|FG002|Overall Study|Serious adverse event|0|||
48937954|NCT00348140|157600912|FG000|Overall Study|Abnormal ECG|0|||
48937955|NCT00348140|157600913|FG001|Overall Study|Abnormal ECG|1|||
48937956|NCT00348140|157600914|FG002|Overall Study|Abnormal ECG|3|||
48937957|NCT00348140|157600912|FG000|Overall Study|Participant died|0|||
48937958|NCT00348140|157600913|FG001|Overall Study|Participant died|1|||
48937959|NCT00348140|157600914|FG002|Overall Study|Participant died|0|||
48937960|NCT00348140|157600912|FG000|Overall Study|Exclusion criteria met|0|||
48937961|NCT00348140|157600913|FG001|Overall Study|Exclusion criteria met|0|||
48937962|NCT00348140|157600914|FG002|Overall Study|Exclusion criteria met|1|||
48937963|NCT00348140|157600912|FG000|Overall Study|Memory declined|0|||
48937964|NCT00348140|157600913|FG001|Overall Study|Memory declined|0|||
48937965|NCT00348140|157600914|FG002|Overall Study|Memory declined|1|||
48937966|NCT01662648|157600917|FG000|Overall Study|Death|1|||
48937967|NCT01662648|157600918|FG001|Overall Study|Death|3|||
48937968|NCT01662648|157600917|FG000|Overall Study|Adverse Event|40|||
48937969|NCT01662648|157600918|FG001|Overall Study|Adverse Event|37|||
48937970|NCT01662648|157600917|FG000|Overall Study|Lack of Efficacy|17|||
48937971|NCT01662648|157600918|FG001|Overall Study|Lack of Efficacy|16|||
48937972|NCT01662648|157600917|FG000|Overall Study|Participant ineligible to continue trial|1|||
48937973|NCT01662648|157600918|FG001|Overall Study|Participant ineligible to continue trial|1|||
48937974|NCT01662648|157600917|FG000|Overall Study|Lost to Follow-up|24|||
48937975|NCT01662648|157600918|FG001|Overall Study|Lost to Follow-up|36|||
48937976|NCT01662648|157600917|FG000|Overall Study|Withdrawal by Subject|36|||
48937977|NCT01662648|157600918|FG001|Overall Study|Withdrawal by Subject|53|||
48937978|NCT01662648|157600917|FG000|Overall Study|Participant non-compliant|16|||
48937979|NCT01662648|157600918|FG001|Overall Study|Participant non-compliant|20|||
48937980|NCT01662648|157600917|FG000|Overall Study|Other|8|||
48937981|NCT01662648|157600918|FG001|Overall Study|Other|11|||
48937982|NCT01662648|157600917|FG000|Overall Study|Adverse event and lack of efficacy (LOE)|3|||
48937983|NCT01662648|157600918|FG001|Overall Study|Adverse event and lack of efficacy (LOE)|0|||
48937984|NCT01662648|157600917|FG000|Overall Study|LOE and other reason unspecified|1|||
48937985|NCT01662648|157600918|FG001|Overall Study|LOE and other reason unspecified|0|||
48937986|NCT01662648|157600917|FG000|Overall Study|LOE and Participant non-compliant|0|||
48937987|NCT01662648|157600918|FG001|Overall Study|LOE and Participant non-compliant|1|||
48937988|NCT00619957|157600922|FG000|Month 24 Double-Blind|Adverse Event|9|||
48937989|NCT00619957|157600923|FG001|Month 24 Double-Blind|Adverse Event|7|||
48937990|NCT00619957|157600922|FG000|Month 24 Double-Blind|Protocol Violation|1|||
48937991|NCT00619957|157600923|FG001|Month 24 Double-Blind|Protocol Violation|0|||
48937992|NCT00619957|157600922|FG000|Month 24 Double-Blind|Withdrawal by Subject|7|||
48937993|NCT00619957|157600923|FG001|Month 24 Double-Blind|Withdrawal by Subject|9|||
48937994|NCT00619957|157600922|FG000|Month 24 Double-Blind|Lost to Follow-up|1|||
48937995|NCT00619957|157600923|FG001|Month 24 Double-Blind|Lost to Follow-up|0|||
48937996|NCT00619957|157600922|FG000|Month 24 Double-Blind|Did not take any study medication|0|||
48937997|NCT00619957|157600923|FG001|Month 24 Double-Blind|Did not take any study medication|1|||
48937998|NCT00619957|157600922|FG000|Month 48 Open-Label|Adverse Event|4|||
48937999|NCT00619957|157600923|FG001|Month 48 Open-Label|Adverse Event|4|||
48938000|NCT00619957|157600922|FG000|Month 48 Open-Label|Lost to Follow-up|2|||
48938001|NCT00619957|157600923|FG001|Month 48 Open-Label|Lost to Follow-up|4|||
48938002|NCT00619957|157600922|FG000|Month 48 Open-Label|Withdrawal by Subject|6|||
48938003|NCT00619957|157600923|FG001|Month 48 Open-Label|Withdrawal by Subject|9|||
48938004|NCT04348851|157600924|FG000|Post-Test 1|Withdrawal by Subject|0|||
48938005|NCT04348851|157600925|FG001|Post-Test 1|Withdrawal by Subject|1|||
48938006|NCT04348851|157600926|FG002|Post-Test 1|Withdrawal by Subject|0|||
48938007|NCT04348851|157600927|FG003|Post-Test 1|Withdrawal by Subject|0|||
48938008|NCT04348851|157600924|FG000|Post-Test 1|Lost to Follow-up|0|||
48938009|NCT04348851|157600925|FG001|Post-Test 1|Lost to Follow-up|1|||
48938010|NCT04348851|157600926|FG002|Post-Test 1|Lost to Follow-up|0|||
48938011|NCT04348851|157600927|FG003|Post-Test 1|Lost to Follow-up|0|||
48938012|NCT04348851|157600924|FG000|Post-Test 2|Stroke survivor death|0|||
48938013|NCT04348851|157600925|FG001|Post-Test 2|Stroke survivor death|1|||
48938014|NCT04348851|157600926|FG002|Post-Test 2|Stroke survivor death|0|||
48938015|NCT04348851|157600927|FG003|Post-Test 2|Stroke survivor death|1|||
48938016|NCT01171612|157600932|FG000|Overall Study|Lost to Follow-up|51|||
48938017|NCT05292755|157600936|FG000|Overall Study|Lost to Follow-up|5|||
48938018|NCT05292755|157600937|FG001|Overall Study|Lost to Follow-up|9|||
48938019|NCT01147809|157600938|FG000|Phase I (168 Days)|Adverse Event|0|||
48938020|NCT01147809|157600939|FG001|Phase I (168 Days)|Adverse Event|0|||
48938021|NCT01147809|157600940|FG002|Phase I (168 Days)|Adverse Event|0|||
48938022|NCT01147809|157600941|FG003|Phase I (168 Days)|Adverse Event|1|||
48938023|NCT01147809|157600942|FG004|Phase I (168 Days)|Adverse Event|0|||
48938024|NCT01147809|157600943|FG005|Phase I (168 Days)|Adverse Event|0|||
48938025|NCT01147809|157600938|FG000|Phase I (168 Days)|Lost to Follow-up|1|||
48938026|NCT01147809|157600939|FG001|Phase I (168 Days)|Lost to Follow-up|0|||
48938027|NCT01147809|157600940|FG002|Phase I (168 Days)|Lost to Follow-up|0|||
48938028|NCT01147809|157600941|FG003|Phase I (168 Days)|Lost to Follow-up|1|||
48938029|NCT01147809|157600942|FG004|Phase I (168 Days)|Lost to Follow-up|0|||
48938030|NCT01147809|157600943|FG005|Phase I (168 Days)|Lost to Follow-up|0|||
48938031|NCT01147809|157600938|FG000|Phase I (168 Days)|Physician Decision|0|||
48938032|NCT01147809|157600939|FG001|Phase I (168 Days)|Physician Decision|1|||
48938033|NCT01147809|157600940|FG002|Phase I (168 Days)|Physician Decision|2|||
48938034|NCT01147809|157600941|FG003|Phase I (168 Days)|Physician Decision|0|||
48938035|NCT01147809|157600942|FG004|Phase I (168 Days)|Physician Decision|0|||
48938036|NCT01147809|157600943|FG005|Phase I (168 Days)|Physician Decision|0|||
48938037|NCT01147809|157600938|FG000|Phase I (168 Days)|Withdrawal by Subject|0|||
48938038|NCT01147809|157600939|FG001|Phase I (168 Days)|Withdrawal by Subject|0|||
48938039|NCT01147809|157600940|FG002|Phase I (168 Days)|Withdrawal by Subject|0|||
48938040|NCT01147809|157600941|FG003|Phase I (168 Days)|Withdrawal by Subject|3|||
48938041|NCT01147809|157600942|FG004|Phase I (168 Days)|Withdrawal by Subject|0|||
48938042|NCT01147809|157600943|FG005|Phase I (168 Days)|Withdrawal by Subject|0|||
48938043|NCT01147809|157600938|FG000|Phase II (168 Days)|Adverse Event|0|||
48938044|NCT01147809|157600939|FG001|Phase II (168 Days)|Adverse Event|0|||
48938045|NCT01147809|157600940|FG002|Phase II (168 Days)|Adverse Event|0|||
48938046|NCT01147809|157600941|FG003|Phase II (168 Days)|Adverse Event|0|||
48938047|NCT01147809|157600942|FG004|Phase II (168 Days)|Adverse Event|3|||
48938048|NCT01147809|157600943|FG005|Phase II (168 Days)|Adverse Event|6|||
48938049|NCT01147809|157600938|FG000|Phase II (168 Days)|Protocol Violation|0|||
48938050|NCT01147809|157600939|FG001|Phase II (168 Days)|Protocol Violation|0|||
48938051|NCT01147809|157600940|FG002|Phase II (168 Days)|Protocol Violation|0|||
48938052|NCT01147809|157600941|FG003|Phase II (168 Days)|Protocol Violation|0|||
48938053|NCT01147809|157600942|FG004|Phase II (168 Days)|Protocol Violation|0|||
48938054|NCT01147809|157600943|FG005|Phase II (168 Days)|Protocol Violation|1|||
48938055|NCT01147809|157600938|FG000|Phase II (168 Days)|Physician Decision|0|||
48938056|NCT01147809|157600939|FG001|Phase II (168 Days)|Physician Decision|0|||
48938057|NCT01147809|157600940|FG002|Phase II (168 Days)|Physician Decision|0|||
48938058|NCT01147809|157600941|FG003|Phase II (168 Days)|Physician Decision|0|||
48938059|NCT01147809|157600942|FG004|Phase II (168 Days)|Physician Decision|5|||
48938060|NCT01147809|157600943|FG005|Phase II (168 Days)|Physician Decision|11|||
48938061|NCT01147809|157600938|FG000|Phase II (168 Days)|Withdrawal by Subject|0|||
48938062|NCT01147809|157600939|FG001|Phase II (168 Days)|Withdrawal by Subject|0|||
48938063|NCT01147809|157600940|FG002|Phase II (168 Days)|Withdrawal by Subject|0|||
48938064|NCT01147809|157600941|FG003|Phase II (168 Days)|Withdrawal by Subject|0|||
48938065|NCT01147809|157600942|FG004|Phase II (168 Days)|Withdrawal by Subject|7|||
48938066|NCT01147809|157600943|FG005|Phase II (168 Days)|Withdrawal by Subject|15|||
48938067|NCT01147809|157600938|FG000|Phase II (168 Days)|Ongoing|0|||
48938068|NCT01147809|157600939|FG001|Phase II (168 Days)|Ongoing|0|||
48938069|NCT01147809|157600940|FG002|Phase II (168 Days)|Ongoing|0|||
48938070|NCT01147809|157600941|FG003|Phase II (168 Days)|Ongoing|0|||
48938071|NCT01147809|157600942|FG004|Phase II (168 Days)|Ongoing|1|||
48938072|NCT01147809|157600943|FG005|Phase II (168 Days)|Ongoing|0|||
48938073|NCT02209766|157600946|FG000|Overall Study|Withdrawal by Subject|0|||
48938074|NCT02209766|157600947|FG001|Overall Study|Withdrawal by Subject|0|||
48938075|NCT02209766|157600948|FG002|Overall Study|Withdrawal by Subject|0|||
48938076|NCT02209766|157600949|FG003|Overall Study|Withdrawal by Subject|1|||
48938077|NCT02209766|157600950|FG004|Overall Study|Withdrawal by Subject|0|||
48938078|NCT02344576|157600953|FG000|Enrollment|Agreed to Medical Record Review Only|7|||
48938079|NCT02344576|157600954|FG001|Enrollment|Agreed to Medical Record Review Only|8|||
48938080|NCT02344576|157600955|FG002|Enrollment|Agreed to Medical Record Review Only|0|||
48938081|NCT02344576|157600956|FG003|Enrollment|Agreed to Medical Record Review Only|0|||
48938082|NCT02344576|157600953|FG000|1-Month Follow-Up|Death|13|||
48938083|NCT02344576|157600954|FG001|1-Month Follow-Up|Death|8|||
48938084|NCT02344576|157600955|FG002|1-Month Follow-Up|Death|0|||
48938085|NCT02344576|157600956|FG003|1-Month Follow-Up|Death|0|||
48938086|NCT02344576|157600953|FG000|1-Month Follow-Up|Withdrawal by Subject|3|||
48938087|NCT02344576|157600954|FG001|1-Month Follow-Up|Withdrawal by Subject|14|||
48938088|NCT02344576|157600955|FG002|1-Month Follow-Up|Withdrawal by Subject|8|||
48938089|NCT02344576|157600956|FG003|1-Month Follow-Up|Withdrawal by Subject|10|||
48938090|NCT02344576|157600953|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
48938091|NCT02344576|157600954|FG001|1-Month Follow-Up|Lost to Follow-up|5|||
48938092|NCT02344576|157600955|FG002|1-Month Follow-Up|Lost to Follow-up|11|||
48938093|NCT02344576|157600956|FG003|1-Month Follow-Up|Lost to Follow-up|3|||
48938094|NCT02344576|157600953|FG000|6-Month Follow-Up|Death|14|||
48938095|NCT02344576|157600954|FG001|6-Month Follow-Up|Death|14|||
48938096|NCT02344576|157600955|FG002|6-Month Follow-Up|Death|0|||
48938097|NCT02344576|157600956|FG003|6-Month Follow-Up|Death|0|||
48938098|NCT02344576|157600953|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
48938099|NCT02344576|157600954|FG001|6-Month Follow-Up|Withdrawal by Subject|0|||
48938100|NCT02344576|157600955|FG002|6-Month Follow-Up|Withdrawal by Subject|1|||
48938101|NCT02344576|157600956|FG003|6-Month Follow-Up|Withdrawal by Subject|2|||
48938102|NCT02344576|157600953|FG000|6-Month Follow-Up|Lost to Follow-up|4|||
48938103|NCT02344576|157600954|FG001|6-Month Follow-Up|Lost to Follow-up|5|||
48938104|NCT02344576|157600955|FG002|6-Month Follow-Up|Lost to Follow-up|13|||
48938105|NCT02344576|157600956|FG003|6-Month Follow-Up|Lost to Follow-up|6|||
48938106|NCT02500537|157600957|FG000|Overall Study|Death|2|||
48938107|NCT02500537|157600958|FG001|Overall Study|Death|0|||
48938108|NCT02500537|157600957|FG000|Overall Study|Lost to Follow-up|0|||
48938109|NCT02500537|157600958|FG001|Overall Study|Lost to Follow-up|1|||
48938110|NCT02500537|157600957|FG000|Overall Study|Withdrawal by Subject|1|||
48938111|NCT02500537|157600958|FG001|Overall Study|Withdrawal by Subject|0|||
48938112|NCT02272790|157600961|FG000|Overall Study|Physician Decision|0|||
48938113|NCT02272790|157600962|FG001|Overall Study|Physician Decision|1|||
48938114|NCT02272790|157600963|FG002|Overall Study|Physician Decision|0|||
48938115|NCT02272790|157600964|FG003|Overall Study|Physician Decision|0|||
48938116|NCT02272790|157600965|FG004|Overall Study|Physician Decision|0|||
48938117|NCT02272790|157600966|FG005|Overall Study|Physician Decision|0|||
48938118|NCT02040142|157600967|FG000|Overall Study|Lost to Follow-up|5|||
48938119|NCT02040142|157600967|FG000|Overall Study|Death|17|||
48938120|NCT02040142|157600967|FG000|Overall Study|Not Evaluable (Surgery and/or Treatment aborted but still enrolled)|14|||
48938121|NCT03871491|157600968|FG000|Overall Study|Withdrawal by Subject|14|||
48938122|NCT03871491|157600969|FG001|Overall Study|Withdrawal by Subject|14|||
48938123|NCT03871491|157600970|FG002|Overall Study|Withdrawal by Subject|14|||
48938124|NCT03871491|157600971|FG003|Overall Study|Withdrawal by Subject|14|||
48938125|NCT03871491|157600968|FG000|Overall Study|Physician Decision|0|||
48938126|NCT03871491|157600969|FG001|Overall Study|Physician Decision|0|||
48938127|NCT03871491|157600970|FG002|Overall Study|Physician Decision|1|||
48938128|NCT03871491|157600971|FG003|Overall Study|Physician Decision|1|||
48938129|NCT03871491|157600968|FG000|Overall Study|Lost to Follow-up|50|||
48938130|NCT03871491|157600969|FG001|Overall Study|Lost to Follow-up|15|||
48938131|NCT03871491|157600970|FG002|Overall Study|Lost to Follow-up|36|||
48938132|NCT03871491|157600971|FG003|Overall Study|Lost to Follow-up|11|||
48938133|NCT05300087|157600972|FG000|Overall Study|Withdrawal by Subject|0|||
48938134|NCT05300087|157600973|FG001|Overall Study|Withdrawal by Subject|1|||
48938135|NCT01822561|157600974|FG000|Overall Study|Withdrawal by Subject|2|||
48938136|NCT04826900|157600975|FG000|Overall Study|Family factor|1|||
48938137|NCT04826900|157600976|FG001|Overall Study|Family factor|1|||
48938138|NCT03283085|157600977|FG000|Overall Study|Adverse Event|18|||
48938139|NCT03283085|157600978|FG001|Overall Study|Adverse Event|3|||
48938140|NCT03283085|157600979|FG002|Overall Study|Adverse Event|13|||
48938141|NCT03283085|157600980|FG003|Overall Study|Adverse Event|0|||
48938142|NCT03283085|157600981|FG004|Overall Study|Adverse Event|0|||
48938143|NCT03283085|157600982|FG005|Overall Study|Adverse Event|5|||
48938144|NCT03283085|157600977|FG000|Overall Study|Death|0|||
48938145|NCT03283085|157600978|FG001|Overall Study|Death|0|||
48938146|NCT03283085|157600979|FG002|Overall Study|Death|3|||
48938147|NCT03283085|157600980|FG003|Overall Study|Death|1|||
48938148|NCT03283085|157600981|FG004|Overall Study|Death|0|||
48938149|NCT03283085|157600982|FG005|Overall Study|Death|0|||
48938150|NCT03283085|157600977|FG000|Overall Study|Withdrawal by Subject|42|||
48938151|NCT03283085|157600978|FG001|Overall Study|Withdrawal by Subject|21|||
48938152|NCT03283085|157600979|FG002|Overall Study|Withdrawal by Subject|66|||
48938153|NCT03283085|157600980|FG003|Overall Study|Withdrawal by Subject|3|||
48938154|NCT03283085|157600981|FG004|Overall Study|Withdrawal by Subject|3|||
48938155|NCT03283085|157600982|FG005|Overall Study|Withdrawal by Subject|5|||
48938156|NCT03283085|157600977|FG000|Overall Study|Physician Decision|14|||
48938157|NCT03283085|157600978|FG001|Overall Study|Physician Decision|8|||
48938158|NCT03283085|157600979|FG002|Overall Study|Physician Decision|19|||
48938159|NCT03283085|157600980|FG003|Overall Study|Physician Decision|0|||
48938160|NCT03283085|157600981|FG004|Overall Study|Physician Decision|0|||
48938161|NCT03283085|157600982|FG005|Overall Study|Physician Decision|2|||
48938162|NCT03283085|157600977|FG000|Overall Study|Site Terminated by Sponsor|1|||
48938163|NCT03283085|157600978|FG001|Overall Study|Site Terminated by Sponsor|0|||
48938164|NCT03283085|157600979|FG002|Overall Study|Site Terminated by Sponsor|3|||
48938165|NCT03283085|157600980|FG003|Overall Study|Site Terminated by Sponsor|0|||
48938166|NCT03283085|157600981|FG004|Overall Study|Site Terminated by Sponsor|0|||
48938167|NCT03283085|157600982|FG005|Overall Study|Site Terminated by Sponsor|0|||
48938168|NCT03283085|157600977|FG000|Overall Study|Lost to Follow-up|2|||
48938169|NCT03283085|157600978|FG001|Overall Study|Lost to Follow-up|0|||
48938170|NCT03283085|157600979|FG002|Overall Study|Lost to Follow-up|2|||
48938171|NCT03283085|157600980|FG003|Overall Study|Lost to Follow-up|0|||
48938172|NCT03283085|157600981|FG004|Overall Study|Lost to Follow-up|0|||
48938173|NCT03283085|157600982|FG005|Overall Study|Lost to Follow-up|1|||
48938174|NCT03283085|157600977|FG000|Overall Study|Pregnancy|0|||
48938175|NCT03283085|157600978|FG001|Overall Study|Pregnancy|0|||
48938176|NCT03283085|157600979|FG002|Overall Study|Pregnancy|1|||
48938177|NCT03283085|157600980|FG003|Overall Study|Pregnancy|0|||
48938178|NCT03283085|157600981|FG004|Overall Study|Pregnancy|0|||
48938179|NCT03283085|157600982|FG005|Overall Study|Pregnancy|0|||
48938180|NCT03283085|157600977|FG000|Overall Study|Lack of Efficacy|12|||
48938181|NCT03283085|157600978|FG001|Overall Study|Lack of Efficacy|6|||
48938182|NCT03283085|157600979|FG002|Overall Study|Lack of Efficacy|24|||
48938183|NCT03283085|157600980|FG003|Overall Study|Lack of Efficacy|1|||
48938184|NCT03283085|157600981|FG004|Overall Study|Lack of Efficacy|1|||
48938185|NCT03283085|157600982|FG005|Overall Study|Lack of Efficacy|0|||
48938186|NCT03283085|157600977|FG000|Overall Study|Reason not Specified|0|||
48938187|NCT03283085|157600978|FG001|Overall Study|Reason not Specified|4|||
48938188|NCT03283085|157600979|FG002|Overall Study|Reason not Specified|8|||
48938189|NCT03283085|157600980|FG003|Overall Study|Reason not Specified|0|||
48938190|NCT03283085|157600981|FG004|Overall Study|Reason not Specified|0|||
48938191|NCT03283085|157600982|FG005|Overall Study|Reason not Specified|1|||
48938192|NCT00686543|157600983|FG000|Overall Study|Adverse Event|9|||
48938193|NCT00686543|157600984|FG001|Overall Study|Adverse Event|1|||
48938194|NCT00686543|157600985|FG002|Overall Study|Adverse Event|3|||
48938195|NCT00686543|157600986|FG003|Overall Study|Adverse Event|2|||
48938196|NCT00686543|157600983|FG000|Overall Study|Withdrawal by Subject|2|||
48938197|NCT00686543|157600984|FG001|Overall Study|Withdrawal by Subject|0|||
48938198|NCT00686543|157600985|FG002|Overall Study|Withdrawal by Subject|0|||
48938199|NCT00686543|157600986|FG003|Overall Study|Withdrawal by Subject|0|||
48938200|NCT00686543|157600983|FG000|Overall Study|Protocol Violation|3|||
48938201|NCT00686543|157600984|FG001|Overall Study|Protocol Violation|0|||
48938202|NCT00686543|157600985|FG002|Overall Study|Protocol Violation|2|||
48938203|NCT00686543|157600986|FG003|Overall Study|Protocol Violation|1|||
48938204|NCT05369806|157600989|FG000|Overall Study|Lost to Follow-up|1|||
48938205|NCT00140855|157600990|FG000|Overall Study|Progressive disease|2|||
48938206|NCT02932267|157600992|FG000|Overall Study|Withdrawal by Subject|3|||
48938207|NCT02932267|157600992|FG000|Overall Study|Lost to Follow-up|4|||
48938208|NCT02932267|157600992|FG000|Overall Study|Pregnancy|1|||
48938209|NCT03430310|157600994|FG000|Overall Study|Protocol Violation|2|||
48938210|NCT03430310|157600995|FG001|Overall Study|Protocol Violation|0|||
48938211|NCT03430310|157600994|FG000|Overall Study|Withdrawal by Subject|3|||
48938212|NCT03430310|157600995|FG001|Overall Study|Withdrawal by Subject|2|||
48938213|NCT03430310|157600994|FG000|Overall Study|COVID shutdown March 2020|0|||
48938214|NCT03430310|157600995|FG001|Overall Study|COVID shutdown March 2020|1|||
48938215|NCT03219164|157602752|FG000|Overall Study|Study Terminated by Sponsor|16|||
48938216|NCT03219164|157602753|FG001|Overall Study|Study Terminated by Sponsor|12|||
48938217|NCT03219164|157602752|FG000|Overall Study|Withdrew Consent by Parent/Guardian|5|||
48938218|NCT03219164|157602753|FG001|Overall Study|Withdrew Consent by Parent/Guardian|4|||
48938219|NCT03219164|157602752|FG000|Overall Study|Lost to Follow-up|1|||
48938220|NCT03219164|157602753|FG001|Overall Study|Lost to Follow-up|1|||
48938221|NCT03219164|157602752|FG000|Overall Study|Adverse Event|1|||
48938222|NCT03219164|157602753|FG001|Overall Study|Adverse Event|0|||
48938223|NCT03219164|157602752|FG000|Overall Study|Non-Compliance with Study Drug|1|||
48938224|NCT03219164|157602753|FG001|Overall Study|Non-Compliance with Study Drug|0|||
48938225|NCT03219164|157602752|FG000|Overall Study|Protocol Violation|0|||
48938226|NCT03219164|157602753|FG001|Overall Study|Protocol Violation|1|||
48938227|NCT03219164|157602752|FG000|Overall Study|Withdrew Assent|1|||
48938228|NCT03219164|157602753|FG001|Overall Study|Withdrew Assent|0|||
48847943|NCT05741294|157282249|FG000|Overall Study|Withdrawal by Subject|1|||
48847944|NCT04721977|157282250|FG000|Overall Study|Death|15|||
48847945|NCT04721977|157282250|FG000|Overall Study|Ongoing|51|||
48847946|NCT01778686|157282251|FG000|Overall Study|Adverse Event|0|||
48847947|NCT01778686|157282252|FG001|Overall Study|Adverse Event|0|||
48847948|NCT01778686|157282253|FG002|Overall Study|Adverse Event|1|||
48847949|NCT05432986|157282260|FG000|Overall Study|Withdrawal by Subject|2|||
48847950|NCT05432986|157282260|FG000|Overall Study|incomplete measurement|7|||
48847951|NCT00670046|157283471|FG000|Overall Study|Lost to Follow-up|1|||
48847952|NCT00670046|157283472|FG001|Overall Study|Lost to Follow-up|1|||
48847953|NCT00670046|157283471|FG000|Overall Study|Withdrawal by Subject|0|||
48847954|NCT00670046|157283472|FG001|Overall Study|Withdrawal by Subject|1|||
48847955|NCT02962284|157283475|FG000|Overall Study|Death|2|||
48847956|NCT02962284|157283476|FG001|Overall Study|Death|0|||
48847957|NCT02962284|157283475|FG000|Overall Study|Progressive disease|2|||
48847958|NCT02962284|157283476|FG001|Overall Study|Progressive disease|3|||
48847959|NCT02962284|157283475|FG000|Overall Study|Withdrawal by Subject|1|||
48847960|NCT02962284|157283476|FG001|Overall Study|Withdrawal by Subject|0|||
48847961|NCT02422615|157283479|FG000|Treatment Period|Progressive disease|314|||
48847962|NCT02422615|157283480|FG001|Treatment Period|Progressive disease|200|||
48847963|NCT02422615|157283479|FG000|Treatment Period|Adverse Event|51|||
48847964|NCT02422615|157283480|FG001|Treatment Period|Adverse Event|9|||
48847965|NCT02422615|157283479|FG000|Treatment Period|Physician Decision|32|||
48847966|NCT02422615|157283480|FG001|Treatment Period|Physician Decision|8|||
48847967|NCT02422615|157283479|FG000|Treatment Period|Subject/guardian decision|38|||
48847968|NCT02422615|157283480|FG001|Treatment Period|Subject/guardian decision|8|||
48847969|NCT02422615|157283479|FG000|Treatment Period|Death|2|||
48847970|NCT02422615|157283480|FG001|Treatment Period|Death|1|||
48847971|NCT02422615|157283479|FG000|Treatment Period|Technical problems|0|||
48847972|NCT02422615|157283480|FG001|Treatment Period|Technical problems|1|||
48847973|NCT02422615|157283479|FG000|Treatment Period|Protocol deviation|1|||
48847974|NCT02422615|157283480|FG001|Treatment Period|Protocol deviation|1|||
48847975|NCT02422615|157283479|FG000|Treatment Period|Study terminated as per protocol|46|||
48847976|NCT02422615|157283480|FG001|Treatment Period|Study terminated as per protocol|14|||
48847977|NCT02422615|157283479|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
48847978|NCT02422615|157283480|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
48847979|NCT02422615|157283479|FG000|Post-treatment Efficacy Follow-up|Death|2|||
48847980|NCT02422615|157283480|FG001|Post-treatment Efficacy Follow-up|Death|1|||
48847981|NCT02422615|157283479|FG000|Post-treatment Efficacy Follow-up|Physician Decision|0|||
48847982|NCT02422615|157283480|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
48847983|NCT02422615|157283479|FG000|Post-treatment Efficacy Follow-up|Progressive disease|23|||
48847984|NCT02422615|157283480|FG001|Post-treatment Efficacy Follow-up|Progressive disease|6|||
48938229|NCT00928070|157602757|FG000|Overall Study|Lost to Follow-up|1|||
48938230|NCT00928070|157602758|FG001|Overall Study|Lost to Follow-up|2|||
48938231|NCT00928070|157602757|FG000|Overall Study|Withdrawal by Subject|10|||
48938232|NCT00928070|157602758|FG001|Overall Study|Withdrawal by Subject|3|||
48938233|NCT00928070|157602757|FG000|Overall Study|Adverse Event|14|||
48938234|NCT00928070|157602758|FG001|Overall Study|Adverse Event|26|||
48938235|NCT00928070|157602757|FG000|Overall Study|Lack of Efficacy|9|||
48938236|NCT00928070|157602758|FG001|Overall Study|Lack of Efficacy|5|||
48938237|NCT00928070|157602757|FG000|Overall Study|Did not meet entrance criteria|16|||
48938238|NCT00928070|157602758|FG001|Overall Study|Did not meet entrance criteria|9|||
48938239|NCT00928070|157602757|FG000|Overall Study|Protocol Violation|6|||
48938240|NCT00928070|157602758|FG001|Overall Study|Protocol Violation|5|||
48938241|NCT00928070|157602757|FG000|Overall Study|Randomized but not treated|2|||
48938242|NCT00928070|157602758|FG001|Overall Study|Randomized but not treated|2|||
48938243|NCT00928070|157602757|FG000|Overall Study|Other|5|||
48938244|NCT00928070|157602758|FG001|Overall Study|Other|5|||
48938245|NCT03041311|157602761|FG000|Overall Study|Death|39|||
48938246|NCT03041311|157602762|FG001|Overall Study|Death|42|||
48938247|NCT03041311|157602761|FG000|Overall Study|Lost to Follow-up|0|||
48938248|NCT03041311|157602762|FG001|Overall Study|Lost to Follow-up|1|||
48938249|NCT03041311|157602761|FG000|Overall Study|Withdrawal by Subject|8|||
48938250|NCT03041311|157602762|FG001|Overall Study|Withdrawal by Subject|5|||
48938251|NCT03041311|157602761|FG000|Overall Study|Sponsor Terminated Study|2|||
48938252|NCT03041311|157602762|FG001|Overall Study|Sponsor Terminated Study|4|||
48938253|NCT03041311|157602761|FG000|Overall Study|Disease Progression|3|||
48938254|NCT03041311|157602762|FG001|Overall Study|Disease Progression|1|||
48938255|NCT03041311|157602761|FG000|Overall Study|Randomized in error, did not receive drug|2|||
48938256|NCT03041311|157602762|FG001|Overall Study|Randomized in error, did not receive drug|0|||
48938257|NCT04398732|157602763|FG000|Overall Study|Participants Who Did Not Meet Entrance Criteria|50|||
48938258|NCT01299727|157602764|FG000|Overall Study|Withdrawal by Subject|1|||
48938259|NCT01299727|157602765|FG001|Overall Study|Withdrawal by Subject|0|||
48938260|NCT01299727|157602766|FG002|Overall Study|Withdrawal by Subject|0|||
48938261|NCT01299727|157602764|FG000|Overall Study|Adverse Event|0|||
48938262|NCT01299727|157602765|FG001|Overall Study|Adverse Event|0|||
48938263|NCT01299727|157602766|FG002|Overall Study|Adverse Event|1|||
48938264|NCT01299727|157602764|FG000|Overall Study|Completed the Treatment Period|3|||
48938265|NCT01299727|157602765|FG001|Overall Study|Completed the Treatment Period|4|||
48938266|NCT01299727|157602766|FG002|Overall Study|Completed the Treatment Period|3|||
48938267|NCT03093402|157602767|FG000|Overall Study|Lost to Follow-up|1|||
48938268|NCT03093402|157602768|FG001|Overall Study|Lost to Follow-up|0|||
48938269|NCT03093402|157602769|FG002|Overall Study|Lost to Follow-up|0|||
48938270|NCT03093402|157602770|FG003|Overall Study|Lost to Follow-up|0|||
48938271|NCT03093402|157602767|FG000|Overall Study|Withdrawal by Subject|3|||
48938272|NCT03093402|157602768|FG001|Overall Study|Withdrawal by Subject|3|||
48938273|NCT03093402|157602769|FG002|Overall Study|Withdrawal by Subject|0|||
48938274|NCT03093402|157602770|FG003|Overall Study|Withdrawal by Subject|1|||
48938275|NCT03093402|157602767|FG000|Overall Study|Withdrew prior to dosing|2|||
48938276|NCT03093402|157602768|FG001|Overall Study|Withdrew prior to dosing|1|||
48938277|NCT03093402|157602769|FG002|Overall Study|Withdrew prior to dosing|2|||
48938278|NCT03093402|157602770|FG003|Overall Study|Withdrew prior to dosing|3|||
48938279|NCT03093402|157602767|FG000|Overall Study|Ineligible for study|1|||
48938280|NCT03093402|157602768|FG001|Overall Study|Ineligible for study|0|||
48938281|NCT03093402|157602769|FG002|Overall Study|Ineligible for study|0|||
48938282|NCT03093402|157602770|FG003|Overall Study|Ineligible for study|0|||
48938283|NCT03093402|157602767|FG000|Overall Study|Prescribed a prohibited concomitant medication|0|||
48938284|NCT03093402|157602768|FG001|Overall Study|Prescribed a prohibited concomitant medication|1|||
48938285|NCT03093402|157602769|FG002|Overall Study|Prescribed a prohibited concomitant medication|0|||
48938286|NCT03093402|157602770|FG003|Overall Study|Prescribed a prohibited concomitant medication|0|||
48938287|NCT02886702|157602771|FG000|Overall Study|Other|4|||
48938288|NCT02886702|157602772|FG001|Overall Study|Other|3|||
48938289|NCT02886702|157602773|FG002|Overall Study|Other|9|||
48938290|NCT02886702|157602771|FG000|Overall Study|Withdrawal by Subject|24|||
48938291|NCT02886702|157602772|FG001|Overall Study|Withdrawal by Subject|18|||
48938292|NCT02886702|157602773|FG002|Overall Study|Withdrawal by Subject|22|||
48938293|NCT02886702|157602771|FG000|Overall Study|Significant Worsening of Condition|0|||
48938294|NCT02886702|157602772|FG001|Overall Study|Significant Worsening of Condition|1|||
48938295|NCT02886702|157602773|FG002|Overall Study|Significant Worsening of Condition|0|||
48938296|NCT02886702|157602771|FG000|Overall Study|Protocol Violation|2|||
48938297|NCT02886702|157602772|FG001|Overall Study|Protocol Violation|2|||
48938298|NCT02886702|157602773|FG002|Overall Study|Protocol Violation|1|||
48938299|NCT02886702|157602771|FG000|Overall Study|Non-Compliance With Study Drug|0|||
48938300|NCT02886702|157602772|FG001|Overall Study|Non-Compliance With Study Drug|1|||
48938301|NCT02886702|157602773|FG002|Overall Study|Non-Compliance With Study Drug|4|||
48938302|NCT02886702|157602771|FG000|Overall Study|Lost to Follow-up|11|||
48938303|NCT02886702|157602772|FG001|Overall Study|Lost to Follow-up|13|||
48938304|NCT02886702|157602773|FG002|Overall Study|Lost to Follow-up|8|||
48938305|NCT02886702|157602771|FG000|Overall Study|Lack of Efficacy|3|||
48938306|NCT02886702|157602772|FG001|Overall Study|Lack of Efficacy|4|||
48938307|NCT02886702|157602773|FG002|Overall Study|Lack of Efficacy|5|||
48938308|NCT02886702|157602771|FG000|Overall Study|Adverse Event|4|||
48938309|NCT02886702|157602772|FG001|Overall Study|Adverse Event|9|||
48938310|NCT02886702|157602773|FG002|Overall Study|Adverse Event|3|||
48938311|NCT02886702|157602771|FG000|Overall Study|Administrative Reasons|0|||
48938312|NCT02886702|157602772|FG001|Overall Study|Administrative Reasons|0|||
48938313|NCT02886702|157602773|FG002|Overall Study|Administrative Reasons|1|||
48938314|NCT01147497|157602778|FG000|Overall Study|failed insertion|2|||
48938315|NCT01147497|157602779|FG001|Overall Study|failed insertion|0|||
48938316|NCT01700829|157602782|FG000|Overall Study|Withdrawal by Subject|1|||
48938317|NCT01700829|157602783|FG001|Overall Study|Withdrawal by Subject|1|||
48938318|NCT02786901|157602786|FG000|Overall Study|Adverse Event|1|||
48938319|NCT02786901|157602787|FG001|Overall Study|Adverse Event|1|||
48938320|NCT02786901|157602788|FG002|Overall Study|Adverse Event|2|||
48847985|NCT02422615|157283479|FG000|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|2|||
48847986|NCT02422615|157283480|FG001|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|0|||
48847987|NCT02422615|157283479|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|6|||
48847988|NCT02422615|157283480|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|1|||
48847989|NCT01036724|157283481|FG000|Overall Study|Adverse Event|1|||
48847990|NCT01036724|157283482|FG001|Overall Study|Adverse Event|2|||
48847991|NCT01036724|157283481|FG000|Overall Study|Lack of Efficacy|1|||
48847992|NCT01036724|157283482|FG001|Overall Study|Lack of Efficacy|1|||
48847993|NCT01036724|157283481|FG000|Overall Study|Protocol Violation|4|||
48847994|NCT01036724|157283482|FG001|Overall Study|Protocol Violation|5|||
48938321|NCT02786901|157602786|FG000|Overall Study|Physician Decision|1|||
48938322|NCT02786901|157602787|FG001|Overall Study|Physician Decision|0|||
48938323|NCT02786901|157602788|FG002|Overall Study|Physician Decision|0|||
48938324|NCT02786901|157602786|FG000|Overall Study|Rescue Therapy Use|71|||
48938325|NCT02786901|157602787|FG001|Overall Study|Rescue Therapy Use|49|||
48938326|NCT02786901|157602788|FG002|Overall Study|Rescue Therapy Use|33|||
48938327|NCT02786901|157602786|FG000|Overall Study|Subject Request/Lost to Follow up|1|||
48938328|NCT02786901|157602787|FG001|Overall Study|Subject Request/Lost to Follow up|5|||
48938329|NCT02786901|157602788|FG002|Overall Study|Subject Request/Lost to Follow up|5|||
48938330|NCT02786901|157602786|FG000|Overall Study|Disallowed medication|1|||
48938331|NCT02786901|157602787|FG001|Overall Study|Disallowed medication|1|||
48938332|NCT02786901|157602788|FG002|Overall Study|Disallowed medication|0|||
48938333|NCT02786901|157602786|FG000|Overall Study|Randomized in error|2|||
48938334|NCT02786901|157602787|FG001|Overall Study|Randomized in error|0|||
48938335|NCT02786901|157602788|FG002|Overall Study|Randomized in error|1|||
48938336|NCT03514914|157602789|FG000|Overall Study|Death|3|||
48938337|NCT03514914|157602790|FG001|Overall Study|Death|3|||
48938338|NCT03514914|157602789|FG000|Overall Study|Lost to Follow-up|117|||
48938339|NCT03514914|157602790|FG001|Overall Study|Lost to Follow-up|89|||
48938340|NCT02706938|157602791|FG000|First Period, 6 Weeks|Adverse Event|8|||
48938341|NCT02706938|157602792|FG001|First Period, 6 Weeks|Adverse Event|0|||
48938342|NCT02706938|157602791|FG000|First Period, 6 Weeks|Lost to Follow-up|2|||
48938343|NCT02706938|157602792|FG001|First Period, 6 Weeks|Lost to Follow-up|2|||
48938344|NCT02706938|157602791|FG000|First Period, 6 Weeks|Withdrawal by Subject|1|||
48938345|NCT02706938|157602792|FG001|First Period, 6 Weeks|Withdrawal by Subject|0|||
48938346|NCT02706938|157602791|FG000|Second Period, 6 Weeks|Adverse Event|0|||
48938347|NCT02706938|157602792|FG001|Second Period, 6 Weeks|Adverse Event|7|||
48938348|NCT02706938|157602791|FG000|Second Period, 6 Weeks|Withdrawal by Subject|0|||
48938349|NCT02706938|157602792|FG001|Second Period, 6 Weeks|Withdrawal by Subject|3|||
48938350|NCT01838044|157602793|FG000|Overall Study|Adverse Event|4|||
48938351|NCT01838044|157602794|FG001|Overall Study|Adverse Event|6|||
48938352|NCT01838044|157602793|FG000|Overall Study|Protocol Violation|3|||
48847995|NCT00402246|157283483|FG000|Overall Study|Death|62|||
48938353|NCT01838044|157602794|FG001|Overall Study|Protocol Violation|3|||
48938354|NCT01838044|157602793|FG000|Overall Study|Withdrawal by Subject|0|||
48938355|NCT01838044|157602794|FG001|Overall Study|Withdrawal by Subject|2|||
48938356|NCT01838044|157602793|FG000|Overall Study|Insufficient clinical response|1|||
48938357|NCT01838044|157602794|FG001|Overall Study|Insufficient clinical response|2|||
48938358|NCT01838044|157602793|FG000|Overall Study|Medication error without associated AE|0|||
48938359|NCT01838044|157602794|FG001|Overall Study|Medication error without associated AE|1|||
48938360|NCT01838044|157602793|FG000|Overall Study|Lost to Follow-up|0|||
48938361|NCT01838044|157602794|FG001|Overall Study|Lost to Follow-up|2|||
48938362|NCT02507349|157602797|FG000|Overall Study|Death|12|||
48938363|NCT02507349|157602798|FG001|Overall Study|Death|16|||
48938364|NCT02507349|157602797|FG000|Overall Study|Withdrawal by Subject|1|||
48938365|NCT02507349|157602798|FG001|Overall Study|Withdrawal by Subject|1|||
48938366|NCT02507349|157602797|FG000|Overall Study|Lost to Follow-up|174|||
48938367|NCT02507349|157602798|FG001|Overall Study|Lost to Follow-up|144|||
48938368|NCT03545282|157602804|FG000|Overall Study|Lost to Follow-up|15|||
48938369|NCT03545282|157602805|FG001|Overall Study|Lost to Follow-up|10|||
48847996|NCT00402246|157283484|FG001|Overall Study|Death|58|||
48847997|NCT00402246|157283483|FG000|Overall Study|Lost to Follow-up|20|||
48847998|NCT00402246|157283484|FG001|Overall Study|Lost to Follow-up|28|||
48847999|NCT00402246|157283483|FG000|Overall Study|Withdrawal by Subject|72|||
48848000|NCT00402246|157283484|FG001|Overall Study|Withdrawal by Subject|87|||
48848001|NCT00402246|157283483|FG000|Overall Study|Physician Decision|24|||
48848002|NCT00402246|157283484|FG001|Overall Study|Physician Decision|26|||
48848003|NCT00402246|157283483|FG000|Overall Study|Protocol Violation|25|||
48848004|NCT00402246|157283484|FG001|Overall Study|Protocol Violation|24|||
48848005|NCT00402246|157283483|FG000|Overall Study|Missed Final Visit|1|||
48848006|NCT00402246|157283484|FG001|Overall Study|Missed Final Visit|2|||
48848007|NCT00402246|157283483|FG000|Overall Study|Insurance Issues|2|||
48848008|NCT00402246|157283484|FG001|Overall Study|Insurance Issues|1|||
48848009|NCT00402246|157283483|FG000|Overall Study|Heart Transplant|0|||
48848010|NCT00402246|157283484|FG001|Overall Study|Heart Transplant|1|||
48848011|NCT00402246|157283483|FG000|Overall Study|Patient's device explanted|6|||
48848012|NCT00402246|157283484|FG001|Overall Study|Patient's device explanted|2|||
48848013|NCT00402246|157283483|FG000|Overall Study|Center Closure|5|||
48848014|NCT00402246|157283484|FG001|Overall Study|Center Closure|3|||
48848015|NCT00402246|157283483|FG000|Overall Study|Deterioriating Condition|3|||
48848016|NCT00402246|157283484|FG001|Overall Study|Deterioriating Condition|2|||
48848017|NCT01288443|157283485|FG000|Overall Study|Adverse Event|0|||
48848018|NCT01288443|157283486|FG001|Overall Study|Adverse Event|0|||
48848019|NCT01288443|157283487|FG002|Overall Study|Adverse Event|1|||
48848020|NCT01288443|157283488|FG003|Overall Study|Adverse Event|1|||
48848021|NCT01288443|157283489|FG004|Overall Study|Adverse Event|3|||
48848022|NCT01288443|157283490|FG005|Overall Study|Adverse Event|1|||
48848023|NCT01288443|157283485|FG000|Overall Study|Poor compliance to protocol|0|||
48848024|NCT01288443|157283486|FG001|Overall Study|Poor compliance to protocol|0|||
48848025|NCT01288443|157283487|FG002|Overall Study|Poor compliance to protocol|0|||
48848026|NCT01288443|157283488|FG003|Overall Study|Poor compliance to protocol|0|||
48848027|NCT01288443|157283489|FG004|Overall Study|Poor compliance to protocol|0|||
48848028|NCT01288443|157283490|FG005|Overall Study|Poor compliance to protocol|1|||
48848029|NCT01288443|157283485|FG000|Overall Study|Participant Moved|0|||
48848030|NCT01288443|157283486|FG001|Overall Study|Participant Moved|0|||
48848031|NCT01288443|157283487|FG002|Overall Study|Participant Moved|0|||
48848032|NCT01288443|157283488|FG003|Overall Study|Participant Moved|1|||
48848033|NCT01288443|157283489|FG004|Overall Study|Participant Moved|2|||
48848034|NCT01288443|157283490|FG005|Overall Study|Participant Moved|1|||
48848035|NCT01288443|157283485|FG000|Overall Study|Consent withdrawn by Participant|0|||
48848036|NCT01288443|157283486|FG001|Overall Study|Consent withdrawn by Participant|0|||
48848037|NCT01288443|157283487|FG002|Overall Study|Consent withdrawn by Participant|0|||
48848038|NCT01288443|157283488|FG003|Overall Study|Consent withdrawn by Participant|0|||
48848039|NCT01288443|157283489|FG004|Overall Study|Consent withdrawn by Participant|0|||
48848040|NCT01288443|157283490|FG005|Overall Study|Consent withdrawn by Participant|1|||
48848041|NCT01288443|157283485|FG000|Overall Study|Lost to Follow-up|0|||
48848042|NCT01288443|157283486|FG001|Overall Study|Lost to Follow-up|1|||
48848043|NCT01288443|157283487|FG002|Overall Study|Lost to Follow-up|0|||
48848044|NCT01288443|157283488|FG003|Overall Study|Lost to Follow-up|0|||
48848045|NCT01288443|157283489|FG004|Overall Study|Lost to Follow-up|0|||
48848046|NCT01288443|157283490|FG005|Overall Study|Lost to Follow-up|0|||
48848047|NCT01288443|157283485|FG000|Overall Study|Study drug auto-injector administration|0|||
48848048|NCT01288443|157283486|FG001|Overall Study|Study drug auto-injector administration|0|||
48938370|NCT03545282|157602804|FG000|Overall Study|Withdrawal by Subject|2|||
48938371|NCT03545282|157602805|FG001|Overall Study|Withdrawal by Subject|2|||
48938372|NCT03182738|157602807|FG000|Overall Study|Lost to Follow-up|9|||
48938373|NCT03182738|157602808|FG001|Overall Study|Lost to Follow-up|3|||
48938374|NCT03182738|157602807|FG000|Overall Study|Pregnancy|0|||
48848049|NCT01288443|157283487|FG002|Overall Study|Study drug auto-injector administration|0|||
48848050|NCT01288443|157283488|FG003|Overall Study|Study drug auto-injector administration|0|||
48848051|NCT01288443|157283489|FG004|Overall Study|Study drug auto-injector administration|1|||
48848052|NCT01288443|157283490|FG005|Overall Study|Study drug auto-injector administration|1|||
48848053|NCT01288443|157283485|FG000|Overall Study|Other than above|0|||
48848054|NCT01288443|157283486|FG001|Overall Study|Other than above|0|||
48848055|NCT01288443|157283487|FG002|Overall Study|Other than above|0|||
48848056|NCT01288443|157283488|FG003|Overall Study|Other than above|2|||
48848057|NCT01288443|157283489|FG004|Overall Study|Other than above|1|||
48848058|NCT01288443|157283490|FG005|Overall Study|Other than above|0|||
48848059|NCT00739908|157283491|FG000|Overall Study|Adverse Event|5|||
48848060|NCT00739908|157283492|FG001|Overall Study|Adverse Event|6|||
48848061|NCT00739908|157283491|FG000|Overall Study|Withdrawal by Subject|4|||
48848062|NCT00739908|157283492|FG001|Overall Study|Withdrawal by Subject|2|||
48848063|NCT00739908|157283491|FG000|Overall Study|Lost to Follow-up|14|||
48848064|NCT00739908|157283492|FG001|Overall Study|Lost to Follow-up|9|||
48938375|NCT03182738|157602808|FG001|Overall Study|Pregnancy|1|||
48938376|NCT03182738|157602807|FG000|Overall Study|Withdrawal by Subject|0|||
48938377|NCT03182738|157602808|FG001|Overall Study|Withdrawal by Subject|1|||
48938378|NCT02582671|157602809|FG000|Overall Study|Failure to return|1|||
48938379|NCT02582671|157602809|FG000|Overall Study|Other, not specified|1|||
48938380|NCT02537678|157602810|FG000|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|4|||
48938381|NCT02537678|157602811|FG001|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|3|||
48938382|NCT02537678|157602810|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
48938383|NCT02537678|157602811|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
48938384|NCT02537678|157602810|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|6|||
48938385|NCT02537678|157602811|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|5|||
48938386|NCT02537678|157602810|FG000|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|2|||
48938387|NCT02537678|157602811|FG001|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|3|||
48938388|NCT02537678|157602810|FG000|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|14|||
48938389|NCT02537678|157602811|FG001|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|6|||
48938390|NCT02537678|157602810|FG000|Post-treatment to 6 Month Assessment|Lost to Follow-up|8|||
48938391|NCT02537678|157602811|FG001|Post-treatment to 6 Month Assessment|Lost to Follow-up|7|||
48938392|NCT02537678|157602810|FG000|6 Month to 12 Month Assessment|Lost to Follow-up|0|||
48938393|NCT02537678|157602811|FG001|6 Month to 12 Month Assessment|Lost to Follow-up|1|||
48938394|NCT01360996|157602812|FG000|Overall Study|Withdrawal by Subject|4|||
48938395|NCT01360996|157602813|FG001|Overall Study|Withdrawal by Subject|3|||
48938396|NCT01360996|157602814|FG002|Overall Study|Withdrawal by Subject|2|||
48938397|NCT01360996|157602812|FG000|Overall Study|Noncompliant|2|||
48938398|NCT01360996|157602813|FG001|Overall Study|Noncompliant|0|||
48938399|NCT01360996|157602814|FG002|Overall Study|Noncompliant|0|||
48938400|NCT01264939|157602816|FG000|Overall Study|Adverse Event|1|||
48938401|NCT01264939|157602817|FG001|Overall Study|Adverse Event|3|||
48938402|NCT01264939|157602816|FG000|Overall Study|Lost to Follow-up|0|||
48938403|NCT01264939|157602817|FG001|Overall Study|Lost to Follow-up|3|||
48938404|NCT01264939|157602816|FG000|Overall Study|Physician Decision|1|||
48938405|NCT01264939|157602817|FG001|Overall Study|Physician Decision|1|||
48938406|NCT01264939|157602816|FG000|Overall Study|Patient/Guardian Decision|8|||
48938407|NCT01264939|157602817|FG001|Overall Study|Patient/Guardian Decision|10|||
48938408|NCT01264939|157602816|FG000|Overall Study|Disease Progression|8|||
48938409|NCT01264939|157602817|FG001|Overall Study|Disease Progression|11|||
48938410|NCT01454076|157602818|FG000|Overall Study|Other|2|||
48938411|NCT01454076|157602819|FG001|Overall Study|Other|0|||
48938412|NCT01454076|157602820|FG002|Overall Study|Other|0|||
48938413|NCT01454076|157602821|FG003|Overall Study|Other|1|||
48938414|NCT01454076|157602822|FG004|Overall Study|Other|2|||
48938415|NCT01454076|157602818|FG000|Overall Study|Withdrawal by Subject|3|||
48938416|NCT01454076|157602819|FG001|Overall Study|Withdrawal by Subject|4|||
48938417|NCT01454076|157602820|FG002|Overall Study|Withdrawal by Subject|2|||
48938418|NCT01454076|157602821|FG003|Overall Study|Withdrawal by Subject|1|||
48938419|NCT01454076|157602822|FG004|Overall Study|Withdrawal by Subject|2|||
48938420|NCT01454076|157602818|FG000|Overall Study|Adverse Event|8|||
48938421|NCT01454076|157602819|FG001|Overall Study|Adverse Event|2|||
48938422|NCT01454076|157602820|FG002|Overall Study|Adverse Event|7|||
48938423|NCT01454076|157602821|FG003|Overall Study|Adverse Event|0|||
48938424|NCT01454076|157602822|FG004|Overall Study|Adverse Event|2|||
48938425|NCT02965378|157602823|FG000|Overall Study|Progression|16|||
48938426|NCT02965378|157602824|FG001|Overall Study|Progression|4|||
48938427|NCT02965378|157602823|FG000|Overall Study|Adverse Event|5|||
48938428|NCT02965378|157602824|FG001|Overall Study|Adverse Event|2|||
48938429|NCT02965378|157602823|FG000|Overall Study|Death|2|||
48938430|NCT02965378|157602824|FG001|Overall Study|Death|0|||
48938431|NCT02965378|157602823|FG000|Overall Study|Refusal|2|||
48938432|NCT02965378|157602824|FG001|Overall Study|Refusal|1|||
48938433|NCT02965378|157602823|FG000|Overall Study|Not protocol specified|0|||
48938434|NCT02965378|157602824|FG001|Overall Study|Not protocol specified|2|||
48938435|NCT00195650|157602825|FG000|Overall Study|Adverse Event|194|||
48938436|NCT00195650|157602825|FG000|Overall Study|Lack of Efficacy|99|||
48938437|NCT00195650|157602825|FG000|Overall Study|Withdrawal by Subject|67|||
48938438|NCT00195650|157602825|FG000|Overall Study|Lost to Follow-up|44|||
48938439|NCT00195650|157602825|FG000|Overall Study|Death|23|||
48938440|NCT00195650|157602825|FG000|Overall Study|Protocol Violation|15|||
48938441|NCT00195650|157602825|FG000|Overall Study|Administrative reasons|83|||
48938442|NCT01535235|157602826|FG000|Overall Study|Adverse Event|1|||
48938443|NCT01535235|157602827|FG001|Overall Study|Adverse Event|0|||
48938444|NCT01193686|157602828|FG000|Overall Study|Withdrawal by Subject|4|||
48938445|NCT01193686|157602829|FG001|Overall Study|Withdrawal by Subject|1|||
48938446|NCT01193686|157602828|FG000|Overall Study|Removed by Investigators; unable to matc|3|||
48938447|NCT01193686|157602829|FG001|Overall Study|Removed by Investigators; unable to matc|0|||
48938448|NCT00432809|157602832|FG000|1 Year Follow-up|Misses 9 and 12 month visit|2|||
48938449|NCT00432809|157602833|FG001|1 Year Follow-up|Misses 9 and 12 month visit|0|||
48938450|NCT00432809|157602834|FG002|1 Year Follow-up|Misses 9 and 12 month visit|0|||
48938451|NCT00432809|157602832|FG000|1 Year Follow-up|Withdrawal by Subject|7|||
48938452|NCT00432809|157602833|FG001|1 Year Follow-up|Withdrawal by Subject|0|||
48938453|NCT00432809|157602834|FG002|1 Year Follow-up|Withdrawal by Subject|1|||
48938454|NCT03029832|157602836|FG000|Overall Study|Safety Follow-Up Completed|2|||
48938455|NCT03029832|157602837|FG001|Overall Study|Safety Follow-Up Completed|0|||
48938456|NCT03029832|157602836|FG000|Overall Study|Death due to Disease Progression|1|||
48938457|NCT03029832|157602837|FG001|Overall Study|Death due to Disease Progression|0|||
48938458|NCT03029832|157602836|FG000|Overall Study|Study Terminated By Sponsor|1|||
48938459|NCT03029832|157602837|FG001|Overall Study|Study Terminated By Sponsor|1|||
48938460|NCT01023789|157602838|FG000|3 - Year Visit|Death|29|||
48938461|NCT01023789|157602838|FG000|3 - Year Visit|Withdrawal of consent|1|||
48938462|NCT01023789|157602838|FG000|3 - Year Visit|Lost to Follow-up|13|||
48938463|NCT00749203|157602844|FG000|no Infusion at Week 1|Lost to Follow-up|0|||
48938464|NCT00749203|157602845|FG001|no Infusion at Week 1|Lost to Follow-up|1|||
48938465|NCT00749203|157602844|FG000|no Infusion at Week 1|Withdrawal by Subject|0|||
48938466|NCT00749203|157602845|FG001|no Infusion at Week 1|Withdrawal by Subject|1|||
48938467|NCT00749203|157602844|FG000|no Infusion at Week 1|delayed-onset sedation|0|||
48938468|NCT00749203|157602845|FG001|no Infusion at Week 1|delayed-onset sedation|1|||
48938469|NCT00749203|157602844|FG000|no Infusion at Week 1|low baseline PTSD symptoms level|0|||
48938470|NCT00749203|157602845|FG001|no Infusion at Week 1|low baseline PTSD symptoms level|1|||
48938471|NCT00749203|157602844|FG000|Second Infusion at 2 Weeks|Protocol Violation|0|||
48938472|NCT00749203|157602845|FG001|Second Infusion at 2 Weeks|Protocol Violation|1|||
48938473|NCT00749203|157602844|FG000|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0|||
48938474|NCT00749203|157602845|FG001|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1|||
48938475|NCT03440944|157602846|FG000|Overall Study|Physician Decision|1|||
48938476|NCT03440944|157602847|FG001|Overall Study|Physician Decision|0|||
48938477|NCT03440944|157602846|FG000|Overall Study|No Acceptable Vasculature|0|||
48938478|NCT03440944|157602847|FG001|Overall Study|No Acceptable Vasculature|1|||
48938479|NCT00591734|157602848|FG000|Overall Study|Lack of Efficacy|35|||
48938480|NCT00591734|157602848|FG000|Overall Study|Adverse Event|5|||
48938481|NCT00591734|157602848|FG000|Overall Study|Physician Decision|5|||
48938482|NCT00591734|157602848|FG000|Overall Study|Intercurrent Illness|8|||
48938483|NCT00943683|157602849|FG000|Overall Study|Adverse Event|3|||
48938484|NCT00943683|157602850|FG001|Overall Study|Adverse Event|3|||
48938485|NCT00943683|157602849|FG000|Overall Study|Lost to Follow-up|1|||
48938486|NCT00943683|157602850|FG001|Overall Study|Lost to Follow-up|1|||
48938487|NCT00943683|157602849|FG000|Overall Study|Protocol Violation|1|||
48938488|NCT00943683|157602850|FG001|Overall Study|Protocol Violation|2|||
48938489|NCT00943683|157602849|FG000|Overall Study|Withdrawal by Subject|1|||
48938490|NCT00943683|157602850|FG001|Overall Study|Withdrawal by Subject|0|||
48938491|NCT00943683|157602849|FG000|Overall Study|Patient Moved|1|||
48938492|NCT00943683|157602850|FG001|Overall Study|Patient Moved|0|||
48938493|NCT02698189|157602851|FG000|Overall Study|Physician Decision|3|||
48938494|NCT02698189|157602852|FG001|Overall Study|Physician Decision|0|||
48938495|NCT02698189|157602851|FG000|Overall Study|Progressive disease|0|||
48938496|NCT02698189|157602852|FG001|Overall Study|Progressive disease|5|||
48938497|NCT02698189|157602851|FG000|Overall Study|Study terminated by sponsor|0|||
48938498|NCT02698189|157602852|FG001|Overall Study|Study terminated by sponsor|1|||
48938499|NCT00702143|157602859|FG000|Overall Study|Lost to Follow-up|0|||
48938500|NCT00702143|157602860|FG001|Overall Study|Lost to Follow-up|0|||
48938501|NCT00702143|157602861|FG002|Overall Study|Lost to Follow-up|1|||
48938502|NCT01624142|157602864|FG000|Overall Study|Withdrawal by Subject|14|||
48938503|NCT01624142|157602865|FG001|Overall Study|Withdrawal by Subject|4|||
48938504|NCT01624142|157602864|FG000|Overall Study|Death|3|||
48938505|NCT01624142|157602865|FG001|Overall Study|Death|6|||
48938506|NCT01624142|157602864|FG000|Overall Study|Study Closure|12|||
48938507|NCT01624142|157602865|FG001|Overall Study|Study Closure|6|||
48938508|NCT01624142|157602864|FG000|Overall Study|Lost to Follow-up|2|||
48938509|NCT01624142|157602865|FG001|Overall Study|Lost to Follow-up|0|||
48938510|NCT01624142|157602864|FG000|Overall Study|Other|1|||
48938511|NCT01624142|157602865|FG001|Overall Study|Other|0|||
48938512|NCT01228747|157602866|FG000|Overall Study|Adverse Event|8|||
48938513|NCT01228747|157602867|FG001|Overall Study|Adverse Event|4|||
48938514|NCT01228747|157602866|FG000|Overall Study|Lack of Efficacy|40|||
48938515|NCT01228747|157602867|FG001|Overall Study|Lack of Efficacy|27|||
48938516|NCT01228747|157602866|FG000|Overall Study|Protocol Violation|6|||
48938517|NCT01228747|157602867|FG001|Overall Study|Protocol Violation|5|||
48938518|NCT01228747|157602866|FG000|Overall Study|Lost to Follow-up|4|||
48938519|NCT01228747|157602867|FG001|Overall Study|Lost to Follow-up|3|||
48938520|NCT01228747|157602866|FG000|Overall Study|Withdrawal by Subject|5|||
48938521|NCT01228747|157602867|FG001|Overall Study|Withdrawal by Subject|1|||
48938522|NCT01228747|157602866|FG000|Overall Study|Other Reason|2|||
48938523|NCT01228747|157602867|FG001|Overall Study|Other Reason|5|||
48938524|NCT05087030|157602868|FG000|Main Period (Week 0 to Week 52)|Withdrawal by Subject|8|||
48938525|NCT05087030|157602869|FG001|Main Period (Week 0 to Week 52)|Withdrawal by Subject|13|||
48938526|NCT05087030|157602870|FG002|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
48938527|NCT05087030|157602871|FG003|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
48938528|NCT05087030|157602872|FG004|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
48938529|NCT05087030|157602868|FG000|Main Period (Week 0 to Week 52)|Adverse Event|2|||
48938530|NCT05087030|157602869|FG001|Main Period (Week 0 to Week 52)|Adverse Event|2|||
48938531|NCT05087030|157602870|FG002|Main Period (Week 0 to Week 52)|Adverse Event|0|||
48938532|NCT05087030|157602871|FG003|Main Period (Week 0 to Week 52)|Adverse Event|0|||
48938533|NCT05087030|157602872|FG004|Main Period (Week 0 to Week 52)|Adverse Event|0|||
48938534|NCT05087030|157602868|FG000|Main Period (Week 0 to Week 52)|Lost to Follow-up|3|||
48938535|NCT05087030|157602869|FG001|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
48938536|NCT05087030|157602870|FG002|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
48938537|NCT05087030|157602871|FG003|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
48938538|NCT05087030|157602872|FG004|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
48938539|NCT05087030|157602868|FG000|Main Period (Week 0 to Week 52)|Protocol Deviation|1|||
48938540|NCT05087030|157602869|FG001|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
48938541|NCT05087030|157602870|FG002|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
48938542|NCT05087030|157602871|FG003|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
48938543|NCT05087030|157602872|FG004|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
48938544|NCT05087030|157602868|FG000|Main Period (Week 0 to Week 52)|Death|0|||
48938545|NCT05087030|157602869|FG001|Main Period (Week 0 to Week 52)|Death|1|||
48938546|NCT05087030|157602870|FG002|Main Period (Week 0 to Week 52)|Death|0|||
48938547|NCT05087030|157602871|FG003|Main Period (Week 0 to Week 52)|Death|0|||
48938548|NCT05087030|157602872|FG004|Main Period (Week 0 to Week 52)|Death|0|||
48938549|NCT05087030|157602868|FG000|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
48938550|NCT05087030|157602869|FG001|Main Period (Week 0 to Week 52)|Subject's Personal Reason|2|||
48938551|NCT05087030|157602870|FG002|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
48938552|NCT05087030|157602871|FG003|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
48938553|NCT05087030|157602872|FG004|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
48938554|NCT05087030|157602868|FG000|Main Period (Week 0 to Week 52)|Exclusion criteria met|1|||
48938555|NCT05087030|157602869|FG001|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
48938556|NCT05087030|157602870|FG002|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
48938557|NCT05087030|157602871|FG003|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
48938558|NCT05087030|157602872|FG004|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
48938559|NCT05087030|157602868|FG000|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|1|||
48938560|NCT05087030|157602869|FG001|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
48938561|NCT05087030|157602870|FG002|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
48938562|NCT05087030|157602871|FG003|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
48938563|NCT05087030|157602872|FG004|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
48938564|NCT05087030|157602868|FG000|Main Period (Week 0 to Week 52)|Other|1|||
48938565|NCT05087030|157602869|FG001|Main Period (Week 0 to Week 52)|Other|2|||
48938566|NCT05087030|157602870|FG002|Main Period (Week 0 to Week 52)|Other|0|||
48938567|NCT05087030|157602871|FG003|Main Period (Week 0 to Week 52)|Other|0|||
48938568|NCT05087030|157602872|FG004|Main Period (Week 0 to Week 52)|Other|0|||
48938569|NCT05087030|157602868|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
48938570|NCT05087030|157602869|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
48938571|NCT05087030|157602870|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
48938572|NCT05087030|157602871|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
48938573|NCT05087030|157602872|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
48938574|NCT01914679|157602874|FG000|Overall Study|Lack of Efficacy|1|||
48938575|NCT01914679|157602874|FG000|Overall Study|Sponsor terminated study|4|||
48938576|NCT01708057|157602882|FG000|Overall Study|Withdrawal due to study termination.|1|||
48938577|NCT01708057|157602883|FG001|Overall Study|Withdrawal due to study termination.|1|||
48938578|NCT01708057|157602884|FG002|Overall Study|Withdrawal due to study termination.|1|||
48938579|NCT00628355|157602890|FG000|Overall Study|Withdrawal by Subject|1|||
48938580|NCT00628355|157602891|FG001|Overall Study|Withdrawal by Subject|1|||
48938581|NCT02370121|157602894|FG000|Overall Study|Lost to Follow-up|1|||
48938582|NCT02370121|157602895|FG001|Overall Study|Lost to Follow-up|1|||
48938583|NCT01523873|157602896|FG000|Overall Study|Protocol Violation|422|||
48938584|NCT02006576|157602905|FG000|Overall Study|Withdrawal by Subject|4|||
48938585|NCT02006576|157602906|FG001|Overall Study|Withdrawal by Subject|6|||
48938586|NCT02006576|157602907|FG002|Overall Study|Withdrawal by Subject|2|||
48938587|NCT02006576|157602905|FG000|Overall Study|Death|0|||
48938588|NCT02006576|157602906|FG001|Overall Study|Death|0|||
48938589|NCT02006576|157602907|FG002|Overall Study|Death|1|||
48938590|NCT02006576|157602905|FG000|Overall Study|Lost to Follow-up|1|||
48938591|NCT02006576|157602906|FG001|Overall Study|Lost to Follow-up|0|||
48938592|NCT02006576|157602907|FG002|Overall Study|Lost to Follow-up|1|||
48938593|NCT02006576|157602905|FG000|Overall Study|Screen Failure, too sick, other|13|||
48938594|NCT02006576|157602906|FG001|Overall Study|Screen Failure, too sick, other|1|||
48938595|NCT02006576|157602907|FG002|Overall Study|Screen Failure, too sick, other|13|||
48938596|NCT00880750|157605092|FG000|First Intervention|Adverse Event|1|||
48938597|NCT00880750|157605093|FG001|First Intervention|Adverse Event|0|||
48938598|NCT00880750|157605092|FG000|First Intervention|Unable to collect urine|4|||
48938599|NCT00880750|157605093|FG001|First Intervention|Unable to collect urine|0|||
48938600|NCT00880750|157605092|FG000|First Intervention|Non-compliance with meals|0|||
48938601|NCT00880750|157605093|FG001|First Intervention|Non-compliance with meals|1|||
48938602|NCT00880750|157605092|FG000|First Intervention|Withdrawal by Subject|2|||
48938603|NCT00880750|157605093|FG001|First Intervention|Withdrawal by Subject|0|||
48938604|NCT00880750|157605092|FG000|First Intervention|Lost to Follow-up|2|||
48938605|NCT00880750|157605093|FG001|First Intervention|Lost to Follow-up|0|||
48938606|NCT00880750|157605092|FG000|Second Intervention|Withdrawal by Subject|2|||
48938607|NCT00880750|157605093|FG001|Second Intervention|Withdrawal by Subject|2|||
48938608|NCT00880750|157605092|FG000|Second Intervention|Protocol Violation|1|||
48938609|NCT00880750|157605093|FG001|Second Intervention|Protocol Violation|0|||
48938610|NCT00880750|157605092|FG000|Second Intervention|Unable to collect urine|1|||
48938611|NCT00880750|157605093|FG001|Second Intervention|Unable to collect urine|0|||
48938612|NCT00618722|157605094|FG000|Overall Study|Refusal of Treatment|0|||
48938613|NCT00618722|157605095|FG001|Overall Study|Refusal of Treatment|0|||
48938614|NCT00618722|157605096|FG002|Overall Study|Refusal of Treatment|1|||
48938615|NCT00618722|157605097|FG003|Overall Study|Refusal of Treatment|0|||
48938616|NCT00618722|157605094|FG000|Overall Study|Patient Request|1|||
48938617|NCT00618722|157605095|FG001|Overall Study|Patient Request|1|||
48938618|NCT00618722|157605096|FG002|Overall Study|Patient Request|1|||
48938619|NCT00618722|157605097|FG003|Overall Study|Patient Request|1|||
48938620|NCT00618722|157605094|FG000|Overall Study|Inability to Complete Study Procedure|0|||
48938621|NCT00618722|157605095|FG001|Overall Study|Inability to Complete Study Procedure|1|||
48938622|NCT00618722|157605096|FG002|Overall Study|Inability to Complete Study Procedure|0|||
48848065|NCT00739908|157283491|FG000|Overall Study|Non-Compliance With Study Procedures|2|||
48848066|NCT00739908|157283492|FG001|Overall Study|Non-Compliance With Study Procedures|3|||
48848067|NCT00739908|157283491|FG000|Overall Study|Non-Compliance With Study Medication|0|||
48848068|NCT00739908|157283492|FG001|Overall Study|Non-Compliance With Study Medication|3|||
48848069|NCT00739908|157283491|FG000|Overall Study|Lack of Efficacy|0|||
48848070|NCT00739908|157283492|FG001|Overall Study|Lack of Efficacy|1|||
48848071|NCT00739908|157283491|FG000|Overall Study|Relocation|0|||
48848072|NCT00739908|157283492|FG001|Overall Study|Relocation|1|||
48848073|NCT01964300|157283493|FG000|Overall Study|Ineligible after enrollment|0|||
48848074|NCT01964300|157283494|FG001|Overall Study|Ineligible after enrollment|1|||
48848075|NCT01964300|157283493|FG000|Overall Study|Adverse Event|1|||
48848076|NCT01964300|157283494|FG001|Overall Study|Adverse Event|1|||
48848077|NCT01964300|157283493|FG000|Overall Study|Lack of Efficacy|3|||
48848078|NCT01964300|157283494|FG001|Overall Study|Lack of Efficacy|5|||
48848079|NCT01964300|157283493|FG000|Overall Study|Withdrawal by Subject|0|||
48848080|NCT01964300|157283494|FG001|Overall Study|Withdrawal by Subject|1|||
48848081|NCT01964300|157283493|FG000|Overall Study|To receive alternative therapy|1|||
48848082|NCT01964300|157283494|FG001|Overall Study|To receive alternative therapy|2|||
48848083|NCT01964300|157283493|FG000|Overall Study|Enlargement of cyst requiring drainage|1|||
48848084|NCT01964300|157283494|FG001|Overall Study|Enlargement of cyst requiring drainage|0|||
48848085|NCT01964300|157283493|FG000|Overall Study|Weight criteria not met|0|||
48848086|NCT01964300|157283494|FG001|Overall Study|Weight criteria not met|1|||
48848087|NCT01951170|157283495|FG000|Overall Study|Investigator decision|1|||
48848088|NCT00557492|157283496|FG000|Overall Study|Change in health insurance|1|||
48848089|NCT02438137|157283500|FG000|Overall Study|Lost to Follow-up|3|||
48848090|NCT02438137|157283501|FG001|Overall Study|Lost to Follow-up|2|||
48848091|NCT02438137|157283500|FG000|Overall Study|Adverse Event|1|||
48848092|NCT02438137|157283501|FG001|Overall Study|Adverse Event|0|||
48848093|NCT02438137|157283500|FG000|Overall Study|Withdrawal by Subject|4|||
48848094|NCT02438137|157283501|FG001|Overall Study|Withdrawal by Subject|3|||
48848095|NCT02438137|157283500|FG000|Overall Study|Physician Decision|0|||
48848096|NCT02438137|157283501|FG001|Overall Study|Physician Decision|1|||
48848097|NCT03621735|157283502|FG000|Overall Study|Withdrawal by Subject|13|||
48848098|NCT03621735|157283503|FG001|Overall Study|Withdrawal by Subject|13|||
48848099|NCT01854385|157283504|FG000|Pre-Treatment|Withdrawal by Subject|4|||
48848100|NCT01854385|157283504|FG000|Pre-Treatment|Did not meet criteria based on headache number|15|||
48848101|NCT01854385|157283504|FG000|Pre-Treatment|Disqualified based on blood pressure requirement|3|||
48848102|NCT01854385|157283504|FG000|Pre-Treatment|Unable to come for study visits|1|||
48848103|NCT01854385|157283504|FG000|Treatment|Lost to Follow-up|1|||
48848104|NCT04579250|157283507|FG000|Overall Study|Withdrawal by Subject|1|||
48848105|NCT04579250|157283508|FG001|Overall Study|Withdrawal by Subject|1|||
48848106|NCT04579250|157283509|FG002|Overall Study|Withdrawal by Subject|0|||
48938623|NCT00618722|157605097|FG003|Overall Study|Inability to Complete Study Procedure|0|||
48938624|NCT00618722|157605094|FG000|Overall Study|Lost to Follow-up|2|||
48938625|NCT00618722|157605095|FG001|Overall Study|Lost to Follow-up|0|||
48938626|NCT00618722|157605096|FG002|Overall Study|Lost to Follow-up|0|||
48938627|NCT00618722|157605097|FG003|Overall Study|Lost to Follow-up|2|||
48938628|NCT00618722|157605094|FG000|Overall Study|Miscellaneous Reasons|0|||
48938629|NCT00618722|157605095|FG001|Overall Study|Miscellaneous Reasons|0|||
48938630|NCT00618722|157605096|FG002|Overall Study|Miscellaneous Reasons|1|||
48938631|NCT00618722|157605097|FG003|Overall Study|Miscellaneous Reasons|1|||
48938632|NCT02031679|157605098|FG000|Overall Study|Protocol Violation|0|||
48938633|NCT02031679|157605099|FG001|Overall Study|Protocol Violation|1|||
48938634|NCT02031679|157605098|FG000|Overall Study|Lack of Efficacy|0|||
48938635|NCT02031679|157605099|FG001|Overall Study|Lack of Efficacy|1|||
48938636|NCT01059448|157605102|FG000|Overall Study|Adverse Event|1|||
48938637|NCT01059448|157605103|FG001|Overall Study|Adverse Event|3|||
48938638|NCT01059448|157605104|FG002|Overall Study|Adverse Event|0|||
48938639|NCT01059448|157605105|FG003|Overall Study|Adverse Event|1|||
48938640|NCT01059448|157605102|FG000|Overall Study|Withdrawal by Subject|2|||
48938641|NCT01059448|157605103|FG001|Overall Study|Withdrawal by Subject|0|||
48938642|NCT01059448|157605104|FG002|Overall Study|Withdrawal by Subject|2|||
48938643|NCT01059448|157605105|FG003|Overall Study|Withdrawal by Subject|4|||
48938644|NCT01059448|157605102|FG000|Overall Study|Disease Progression|2|||
48938645|NCT01059448|157605103|FG001|Overall Study|Disease Progression|1|||
48938646|NCT01059448|157605104|FG002|Overall Study|Disease Progression|4|||
48938647|NCT01059448|157605105|FG003|Overall Study|Disease Progression|2|||
48938648|NCT01059448|157605102|FG000|Overall Study|Administrative Decision|43|||
48938649|NCT01059448|157605103|FG001|Overall Study|Administrative Decision|49|||
48938650|NCT01059448|157605104|FG002|Overall Study|Administrative Decision|45|||
48938651|NCT01059448|157605105|FG003|Overall Study|Administrative Decision|46|||
48938652|NCT01059448|157605102|FG000|Overall Study|Lost to Follow-up|0|||
48938653|NCT01059448|157605103|FG001|Overall Study|Lost to Follow-up|0|||
48938654|NCT01059448|157605104|FG002|Overall Study|Lost to Follow-up|2|||
48938655|NCT01059448|157605105|FG003|Overall Study|Lost to Follow-up|0|||
48938656|NCT01059448|157605102|FG000|Overall Study|Death|0|||
48938657|NCT01059448|157605103|FG001|Overall Study|Death|1|||
48938658|NCT01059448|157605104|FG002|Overall Study|Death|0|||
48938659|NCT01059448|157605105|FG003|Overall Study|Death|0|||
48938660|NCT01059448|157605102|FG000|Overall Study|Other|1|||
48938661|NCT01059448|157605103|FG001|Overall Study|Other|1|||
48938662|NCT01059448|157605104|FG002|Overall Study|Other|0|||
48938663|NCT01059448|157605105|FG003|Overall Study|Other|1|||
48938664|NCT01390389|157605106|FG000|Overall Study|Withdrawal by Subject|2|||
48938665|NCT01390389|157605107|FG001|Overall Study|Withdrawal by Subject|0|||
48938666|NCT01390389|157605106|FG000|Overall Study|Screen Fail|2|||
48938667|NCT01390389|157605107|FG001|Overall Study|Screen Fail|1|||
48938668|NCT00778830|157605108|FG000|Overall Study|Ongoing at data cut-off|0|||
48938669|NCT00778830|157605109|FG001|Overall Study|Ongoing at data cut-off|1|||
48938670|NCT03195894|157605111|FG000|Overall Study|"An example is Started other treatment."|4|||
48938671|NCT03195894|157605112|FG001|Overall Study|"An example is Started other treatment."|5|||
48938672|NCT03195894|157605111|FG000|Overall Study|Withdrawal by Subject|15|||
48938673|NCT03195894|157605112|FG001|Overall Study|Withdrawal by Subject|4|||
48938674|NCT03195894|157605111|FG000|Overall Study|Lost to Follow-up|14|||
48938675|NCT03195894|157605112|FG001|Overall Study|Lost to Follow-up|19|||
48938676|NCT02338843|157605113|FG000|Overall Study|Adverse Event|2|||
48938677|NCT02338843|157605114|FG001|Overall Study|Adverse Event|1|||
48938678|NCT02338843|157605113|FG000|Overall Study|Death|40|||
48938679|NCT02338843|157605114|FG001|Overall Study|Death|53|||
48938680|NCT02338843|157605113|FG000|Overall Study|Physician Decision|1|||
48938681|NCT02338843|157605114|FG001|Overall Study|Physician Decision|0|||
48938682|NCT02338843|157605113|FG000|Overall Study|Withdrawal by Subject|0|||
48938683|NCT02338843|157605114|FG001|Overall Study|Withdrawal by Subject|2|||
48938684|NCT02338843|157605113|FG000|Overall Study|Subject Recovered|0|||
48938685|NCT02338843|157605114|FG001|Overall Study|Subject Recovered|2|||
48938686|NCT02338843|157605113|FG000|Overall Study|Discontinued prior to randomizat|1|||
48938687|NCT02338843|157605114|FG001|Overall Study|Discontinued prior to randomizat|0|||
48938688|NCT01891643|157605115|FG000|Overall Study|Adverse event unrelated to study drug|2|||
48938689|NCT01891643|157605116|FG001|Overall Study|Adverse event unrelated to study drug|5|||
48938690|NCT01891643|157605115|FG000|Overall Study|Disease Progression|4|||
48938691|NCT01891643|157605116|FG001|Overall Study|Disease Progression|3|||
48938692|NCT01891643|157605115|FG000|Overall Study|Study Drug Toxicity|3|||
48938693|NCT01891643|157605116|FG001|Overall Study|Study Drug Toxicity|0|||
48938694|NCT01891643|157605115|FG000|Overall Study|Maximum Clinical Benefit|0|||
48938695|NCT01891643|157605116|FG001|Overall Study|Maximum Clinical Benefit|1|||
48938696|NCT01891643|157605115|FG000|Overall Study|Poor/Non-compliance|0|||
48938697|NCT01891643|157605116|FG001|Overall Study|Poor/Non-compliance|1|||
48938698|NCT01891643|157605115|FG000|Overall Study|Participant request to discontinue|1|||
48938699|NCT01891643|157605116|FG001|Overall Study|Participant request to discontinue|0|||
48938700|NCT05047523|157605117|FG000|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
48938701|NCT05047523|157605118|FG001|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
48938702|NCT05047523|157605119|FG002|Primary Evaluation Period (48 Weeks)|Physician Decision|1|||
48938703|NCT05047523|157605120|FG003|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
48938704|NCT05047523|157605121|FG004|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
48938705|NCT05047523|157605122|FG005|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
48938706|NCT05047523|157605117|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
48938707|NCT05047523|157605118|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
48938708|NCT05047523|157605119|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
48938709|NCT05047523|157605120|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
48938710|NCT05047523|157605121|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
48938711|NCT05047523|157605122|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
48938712|NCT05047523|157605117|FG000|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|2|||
48938713|NCT05047523|157605118|FG001|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
48938714|NCT05047523|157605119|FG002|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|3|||
48938715|NCT05047523|157605120|FG003|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
48938716|NCT05047523|157605121|FG004|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
48938717|NCT05047523|157605122|FG005|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
48938718|NCT05047523|157605117|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
48938719|NCT05047523|157605118|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
48938720|NCT05047523|157605119|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
48938721|NCT05047523|157605120|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
48938722|NCT05047523|157605121|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
48938723|NCT05047523|157605122|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
48938724|NCT05047523|157605117|FG000|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
48938725|NCT05047523|157605118|FG001|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
48938726|NCT05047523|157605119|FG002|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
48938727|NCT05047523|157605120|FG003|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
48938728|NCT05047523|157605121|FG004|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
48938729|NCT05047523|157605122|FG005|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
48938730|NCT05047523|157605117|FG000|Extension Period (24 Weeks)|Adverse Event|0|||
48938731|NCT05047523|157605118|FG001|Extension Period (24 Weeks)|Adverse Event|0|||
48938732|NCT05047523|157605119|FG002|Extension Period (24 Weeks)|Adverse Event|0|||
48938733|NCT05047523|157605120|FG003|Extension Period (24 Weeks)|Adverse Event|0|||
48938734|NCT05047523|157605121|FG004|Extension Period (24 Weeks)|Adverse Event|1|||
48938735|NCT05047523|157605122|FG005|Extension Period (24 Weeks)|Adverse Event|1|||
48938736|NCT00623831|157605126|FG000|Overall Study|Withdrawal by Subject|1|||
48938737|NCT00623831|157605127|FG001|Overall Study|Withdrawal by Subject|0|||
48938738|NCT00623831|157605126|FG000|Overall Study|Progressive Disease|0|||
48938739|NCT00623831|157605127|FG001|Overall Study|Progressive Disease|1|||
48938740|NCT03124459|157605128|FG000|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
48938741|NCT03124459|157605129|FG001|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
48938742|NCT03124459|157605130|FG002|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
48938743|NCT03124459|157605131|FG003|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
48938744|NCT03124459|157605132|FG004|Phase 2- Randomized Doubled-blind|Adverse Event|2|||
48938745|NCT03124459|157605133|FG005|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
48938746|NCT03124459|157605128|FG000|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
48938747|NCT03124459|157605129|FG001|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
48938748|NCT03124459|157605130|FG002|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
48938749|NCT03124459|157605131|FG003|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
48938750|NCT03124459|157605132|FG004|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1|||
48938751|NCT03124459|157605133|FG005|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
48938752|NCT03124459|157605128|FG000|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
48938753|NCT03124459|157605129|FG001|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
48938754|NCT03124459|157605130|FG002|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
48938755|NCT03124459|157605131|FG003|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11|||
48938756|NCT03124459|157605132|FG004|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12|||
48938757|NCT03124459|157605133|FG005|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
48848107|NCT04579250|157283507|FG000|Overall Study|Lost to Follow-up|1|||
48848108|NCT04579250|157283508|FG001|Overall Study|Lost to Follow-up|1|||
48848109|NCT04579250|157283509|FG002|Overall Study|Lost to Follow-up|0|||
48848110|NCT04579250|157283507|FG000|Overall Study|Moved from area|0|||
48848111|NCT04579250|157283508|FG001|Overall Study|Moved from area|1|||
48848112|NCT04579250|157283509|FG002|Overall Study|Moved from area|2|||
48848113|NCT04759833|157283512|FG000|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|1|||
48848114|NCT04759833|157283513|FG001|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|4|||
48848115|NCT04759833|157283514|FG002|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|2|||
48848116|NCT04759833|157283515|FG003|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
48848117|NCT04759833|157283516|FG004|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
48848118|NCT04759833|157283512|FG000|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
48848119|NCT04759833|157283513|FG001|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
48848120|NCT04759833|157283514|FG002|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|1|||
48848121|NCT04759833|157283515|FG003|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
48848122|NCT04759833|157283516|FG004|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
48848123|NCT04759833|157283512|FG000|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
48848124|NCT04759833|157283513|FG001|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|1|||
48848125|NCT04759833|157283514|FG002|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
48848126|NCT04759833|157283515|FG003|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
48848127|NCT04759833|157283516|FG004|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
48848128|NCT04759833|157283512|FG000|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
48848129|NCT04759833|157283513|FG001|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|2|||
48848130|NCT04759833|157283514|FG002|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|3|||
48848131|NCT04759833|157283515|FG003|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
48938758|NCT03124459|157605128|FG000|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
48938759|NCT03124459|157605129|FG001|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
48938760|NCT03124459|157605130|FG002|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
48938761|NCT03124459|157605131|FG003|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1|||
48938762|NCT03124459|157605132|FG004|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4|||
48938763|NCT03124459|157605133|FG005|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
48938764|NCT03124459|157605128|FG000|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
48938765|NCT03124459|157605129|FG001|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
48938766|NCT03124459|157605130|FG002|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
48938767|NCT03124459|157605131|FG003|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
48938768|NCT03124459|157605132|FG004|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
48938769|NCT03124459|157605133|FG005|Part 2- Open Label ACE-083|Study terminated by Sponsor|22|||
48938770|NCT03124459|157605128|FG000|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
48938771|NCT03124459|157605129|FG001|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
48938772|NCT03124459|157605130|FG002|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
48938773|NCT03124459|157605131|FG003|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
48938774|NCT03124459|157605132|FG004|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
48938775|NCT03124459|157605133|FG005|Part 2- Open Label ACE-083|Withdrawal by Subject|1|||
48938776|NCT00282243|157605134|FG000|Pharmacokinetic Treatment Period|Adverse Event|3|||
48938777|NCT00282243|157605134|FG000|Pharmacokinetic Treatment Period|Withdrawal by Subject|2|||
48938778|NCT00282243|157605134|FG000|Extension Treatment Period|Adverse Event|15|||
48938779|NCT00282243|157605134|FG000|Extension Treatment Period|Withdrawal by Subject|4|||
48938780|NCT00282243|157605134|FG000|Extension Treatment Period|Non-compliance|2|||
48938781|NCT00282243|157605134|FG000|Extension Treatment Period|Physician Decision|1|||
48938782|NCT00851903|157605135|FG000|Overall Study|Withdrawal by Subject|2|||
48938783|NCT00270894|157605136|FG000|Overall Study|Adverse Event|1|||
48938784|NCT00270894|157605136|FG000|Overall Study|Withdrawal by Subject|1|||
48938785|NCT00686127|157605141|FG000|Overall Study|Withdrawal by Subject|14|||
48938786|NCT00686127|157605142|FG001|Overall Study|Withdrawal by Subject|6|||
48938787|NCT00450580|157605148|FG000|Overall Study|Adverse Event|5|||
48938788|NCT00450580|157605149|FG001|Overall Study|Adverse Event|7|||
48938789|NCT00450580|157605148|FG000|Overall Study|Lost to Follow-up|4|||
48938790|NCT00450580|157605149|FG001|Overall Study|Lost to Follow-up|5|||
48938791|NCT00450580|157605148|FG000|Overall Study|Withdrawal by Subject|2|||
48938792|NCT00450580|157605149|FG001|Overall Study|Withdrawal by Subject|2|||
48938793|NCT00450580|157605148|FG000|Overall Study|Protocol Violation|1|||
48938794|NCT00450580|157605149|FG001|Overall Study|Protocol Violation|1|||
48938795|NCT00450580|157605148|FG000|Overall Study|Protocol-defined virologic failure|1|||
48938796|NCT00450580|157605149|FG001|Overall Study|Protocol-defined virologic failure|0|||
48938797|NCT00450580|157605148|FG000|Overall Study|Could not comply with scheduled visits|1|||
48938798|NCT00450580|157605149|FG001|Overall Study|Could not comply with scheduled visits|0|||
48938799|NCT00450580|157605148|FG000|Overall Study|Patient went to Brazil|1|||
48938800|NCT00450580|157605149|FG001|Overall Study|Patient went to Brazil|0|||
48938801|NCT00450580|157605148|FG000|Overall Study|Patient could not swallow Norvir|1|||
48938802|NCT00450580|157605149|FG001|Overall Study|Patient could not swallow Norvir|0|||
48848132|NCT04759833|157283516|FG004|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
48848133|NCT04759833|157283512|FG000|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|5|||
48938803|NCT00450580|157605148|FG000|Overall Study|Withdrawal due to pregnancy|0|||
48938804|NCT00450580|157605149|FG001|Overall Study|Withdrawal due to pregnancy|1|||
48938805|NCT02357420|157605150|FG000|Overall Study|Adverse Event|3|||
48938806|NCT02357420|157605151|FG001|Overall Study|Adverse Event|3|||
48938807|NCT02357420|157605152|FG002|Overall Study|Adverse Event|8|||
48938808|NCT02357420|157605153|FG003|Overall Study|Adverse Event|9|||
48938809|NCT02357420|157605150|FG000|Overall Study|Investigator Decision|1|||
48938810|NCT02357420|157605151|FG001|Overall Study|Investigator Decision|0|||
48938811|NCT02357420|157605152|FG002|Overall Study|Investigator Decision|0|||
48938812|NCT02357420|157605153|FG003|Overall Study|Investigator Decision|0|||
48938813|NCT02357420|157605150|FG000|Overall Study|Prohibited Medication|1|||
48938814|NCT02357420|157605151|FG001|Overall Study|Prohibited Medication|1|||
48938815|NCT02357420|157605152|FG002|Overall Study|Prohibited Medication|0|||
48938816|NCT02357420|157605153|FG003|Overall Study|Prohibited Medication|0|||
48938817|NCT02357420|157605150|FG000|Overall Study|Protocol Non-compliance|0|||
48938818|NCT02357420|157605151|FG001|Overall Study|Protocol Non-compliance|0|||
48938819|NCT02357420|157605152|FG002|Overall Study|Protocol Non-compliance|0|||
48938820|NCT02357420|157605153|FG003|Overall Study|Protocol Non-compliance|1|||
48848134|NCT04759833|157283513|FG001|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|3|||
48848135|NCT04759833|157283514|FG002|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|9|||
48848136|NCT04759833|157283515|FG003|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
48848137|NCT04759833|157283516|FG004|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
48848138|NCT04759833|157283512|FG000|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
48848139|NCT04759833|157283513|FG001|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
48848140|NCT04759833|157283514|FG002|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|1|||
48848141|NCT04759833|157283515|FG003|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
48848142|NCT04759833|157283516|FG004|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
48848143|NCT04759833|157283512|FG000|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
48848144|NCT04759833|157283513|FG001|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|1|||
48848145|NCT04759833|157283514|FG002|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
48848146|NCT04759833|157283515|FG003|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
48848147|NCT04759833|157283516|FG004|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
48848148|NCT04759833|157283512|FG000|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
48848149|NCT04759833|157283513|FG001|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
48848150|NCT04759833|157283514|FG002|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
48848151|NCT04759833|157283515|FG003|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
48848152|NCT04759833|157283516|FG004|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
48848153|NCT04759833|157283512|FG000|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
48848154|NCT04759833|157283513|FG001|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
48848155|NCT04759833|157283514|FG002|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
48848156|NCT04759833|157283515|FG003|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
48848157|NCT04759833|157283516|FG004|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|1|||
48848158|NCT04759833|157283512|FG000|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
48848159|NCT04759833|157283513|FG001|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
48848160|NCT04759833|157283514|FG002|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
48848161|NCT04759833|157283515|FG003|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|1|||
48848162|NCT04759833|157283516|FG004|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|3|||
48848163|NCT04759833|157283512|FG000|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
48848164|NCT04759833|157283513|FG001|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
48848165|NCT04759833|157283514|FG002|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
48848166|NCT04759833|157283515|FG003|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|21|||
48848167|NCT04759833|157283516|FG004|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|16|||
48848168|NCT04759833|157283512|FG000|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
48848169|NCT04759833|157283513|FG001|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
48848170|NCT04759833|157283514|FG002|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
48848171|NCT04759833|157283515|FG003|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|4|||
48848172|NCT04759833|157283516|FG004|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|8|||
48848173|NCT04759833|157283512|FG000|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
48848174|NCT04759833|157283513|FG001|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
48848175|NCT04759833|157283514|FG002|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
48938821|NCT02357420|157605150|FG000|Overall Study|Withdrawn Consent|4|||
48938822|NCT02357420|157605151|FG001|Overall Study|Withdrawn Consent|8|||
48938823|NCT02357420|157605152|FG002|Overall Study|Withdrawn Consent|6|||
48938824|NCT02357420|157605153|FG003|Overall Study|Withdrawn Consent|6|||
48938825|NCT02357420|157605150|FG000|Overall Study|Lost to Follow-up|3|||
48938826|NCT02357420|157605151|FG001|Overall Study|Lost to Follow-up|0|||
48938827|NCT02357420|157605152|FG002|Overall Study|Lost to Follow-up|2|||
48938828|NCT02357420|157605153|FG003|Overall Study|Lost to Follow-up|3|||
48938829|NCT02292849|157605154|FG000|Overall Study|Lost to Follow-up|0|||
48938830|NCT02292849|157605155|FG001|Overall Study|Lost to Follow-up|2|||
48938831|NCT02292849|157605156|FG002|Overall Study|Lost to Follow-up|2|||
48938832|NCT02292849|157605154|FG000|Overall Study|Physician Decision|4|||
48938833|NCT02292849|157605155|FG001|Overall Study|Physician Decision|0|||
48938834|NCT02292849|157605156|FG002|Overall Study|Physician Decision|0|||
48938835|NCT04125680|157605157|FG000|Overall Study|Lost to Follow-up|15|||
48938836|NCT01562028|157605158|FG000|Overall Study|Withdrawal by Subject|1|||
48938837|NCT01562028|157605159|FG001|Overall Study|Withdrawal by Subject|1|||
48938838|NCT01562028|157605158|FG000|Overall Study|Lost to Follow-up|2|||
48938839|NCT01562028|157605159|FG001|Overall Study|Lost to Follow-up|1|||
48938840|NCT00828464|157605166|FG000|Overall Study|Withdrawal by Subject|1|||
48938841|NCT04026568|157605171|FG000|Overall Study|study terminated|0|||
48938842|NCT04026568|157605172|FG001|Overall Study|study terminated|1|||
48938843|NCT02197377|157605175|FG000|Overall Study|Insertion Failure|0|||
48938844|NCT02197377|157605176|FG001|Overall Study|Insertion Failure|3|||
48938845|NCT00809133|157605177|FG000|Overall Study|Progressive disease|2|||
48938846|NCT00809133|157605178|FG001|Overall Study|Progressive disease|5|||
48938847|NCT00809133|157605179|FG002|Overall Study|Progressive disease|5|||
48938848|NCT00809133|157605180|FG003|Overall Study|Progressive disease|3|||
48938849|NCT00809133|157605181|FG004|Overall Study|Progressive disease|4|||
48938850|NCT00809133|157605182|FG005|Overall Study|Progressive disease|1|||
48938851|NCT00809133|157605183|FG006|Overall Study|Progressive disease|3|||
48938852|NCT00809133|157605184|FG007|Overall Study|Progressive disease|3|||
48938853|NCT00809133|157605185|FG008|Overall Study|Progressive disease|3|||
48938854|NCT00809133|157605186|FG009|Overall Study|Progressive disease|9|||
48938855|NCT00809133|157605187|FG010|Overall Study|Progressive disease|5|||
48938856|NCT00809133|157605188|FG011|Overall Study|Progressive disease|7|||
48938857|NCT00809133|157605189|FG012|Overall Study|Progressive disease|5|||
48938858|NCT00809133|157605190|FG013|Overall Study|Progressive disease|4|||
48938859|NCT00809133|157605177|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
48938860|NCT00809133|157605178|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
48938861|NCT00809133|157605179|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
48938862|NCT00809133|157605180|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
48938863|NCT00809133|157605181|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
48938864|NCT00809133|157605182|FG005|Overall Study|Dose Limiting Toxicity (DLT)|1|||
48938865|NCT00809133|157605183|FG006|Overall Study|Dose Limiting Toxicity (DLT)|1|||
48938866|NCT00809133|157605184|FG007|Overall Study|Dose Limiting Toxicity (DLT)|1|||
48938867|NCT00809133|157605185|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
48938868|NCT00809133|157605186|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
48938869|NCT00809133|157605187|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
48938870|NCT00809133|157605188|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
48938871|NCT00809133|157605189|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
48938872|NCT00809133|157605190|FG013|Overall Study|Dose Limiting Toxicity (DLT)|2|||
48938873|NCT00809133|157605177|FG000|Overall Study|Other adverse event|1|||
48938874|NCT00809133|157605178|FG001|Overall Study|Other adverse event|1|||
48938875|NCT00809133|157605179|FG002|Overall Study|Other adverse event|1|||
48938876|NCT00809133|157605180|FG003|Overall Study|Other adverse event|0|||
48938877|NCT00809133|157605181|FG004|Overall Study|Other adverse event|0|||
48938878|NCT00809133|157605182|FG005|Overall Study|Other adverse event|3|||
48938879|NCT00809133|157605183|FG006|Overall Study|Other adverse event|2|||
48938880|NCT00809133|157605184|FG007|Overall Study|Other adverse event|4|||
48938881|NCT00809133|157605185|FG008|Overall Study|Other adverse event|0|||
48938882|NCT00809133|157605186|FG009|Overall Study|Other adverse event|0|||
48938883|NCT00809133|157605187|FG010|Overall Study|Other adverse event|1|||
48938884|NCT00809133|157605188|FG011|Overall Study|Other adverse event|1|||
48938885|NCT00809133|157605189|FG012|Overall Study|Other adverse event|0|||
48938886|NCT00809133|157605190|FG013|Overall Study|Other adverse event|1|||
48938887|NCT00809133|157605177|FG000|Overall Study|Lost to Follow-up|0|||
48938888|NCT00809133|157605178|FG001|Overall Study|Lost to Follow-up|0|||
48938889|NCT00809133|157605179|FG002|Overall Study|Lost to Follow-up|0|||
48938890|NCT00809133|157605180|FG003|Overall Study|Lost to Follow-up|0|||
48938891|NCT00809133|157605181|FG004|Overall Study|Lost to Follow-up|0|||
48938892|NCT00809133|157605182|FG005|Overall Study|Lost to Follow-up|1|||
48848176|NCT04759833|157283515|FG003|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|8|||
48848177|NCT04759833|157283516|FG004|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|5|||
48848178|NCT02075554|157283517|FG000|Overall Study|Lost to Follow-up|7|||
48848179|NCT02075554|157283517|FG000|Overall Study|Withdrawal by Subject|5|||
48848180|NCT02075554|157283517|FG000|Overall Study|Physician Decision|3|||
48848181|NCT00409838|157283518|FG000|Short-term Period|Adverse Event|0|||
48848182|NCT00409838|157283519|FG001|Short-term Period|Adverse Event|1|||
48848183|NCT00409838|157283518|FG000|Short-term Period|Lost to Follow-up|0|||
48848184|NCT00409838|157283519|FG001|Short-term Period|Lost to Follow-up|1|||
48848185|NCT00409838|157283518|FG000|Short-term Period|Withdrawal by Subject|2|||
48848186|NCT00409838|157283519|FG001|Short-term Period|Withdrawal by Subject|3|||
48848187|NCT00409838|157283518|FG000|Short-term Period|Never Treated|1|||
48848188|NCT00409838|157283519|FG001|Short-term Period|Never Treated|0|||
48848189|NCT00409838|157283518|FG000|Long-term Extension Period|Adverse Event|10|||
48848190|NCT00409838|157283519|FG001|Long-term Extension Period|Adverse Event|0|||
48848191|NCT00409838|157283518|FG000|Long-term Extension Period|Death|1|||
48848192|NCT00409838|157283519|FG001|Long-term Extension Period|Death|0|||
48848193|NCT00409838|157283518|FG000|Long-term Extension Period|Lack of Efficacy|2|||
48848194|NCT00409838|157283519|FG001|Long-term Extension Period|Lack of Efficacy|0|||
48848195|NCT00409838|157283518|FG000|Long-term Extension Period|Withdrawal by Subject|3|||
48848196|NCT00409838|157283519|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
48848197|NCT00409838|157283518|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
48848198|NCT00409838|157283519|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
48848199|NCT00409838|157283518|FG000|Long-term Extension Period|Pregnancy|1|||
48848200|NCT00409838|157283519|FG001|Long-term Extension Period|Pregnancy|0|||
48848201|NCT01057433|157283520|FG000|Overall Study|Adverse Event|1|||
48848202|NCT01074294|157283521|FG000|Phase A (Day 1 to Week 5)|Lost to Follow-up|16|||
48848203|NCT01074294|157283522|FG001|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
48848204|NCT01074294|157283523|FG002|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
48848205|NCT01074294|157283524|FG003|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
48848206|NCT01074294|157283521|FG000|Phase A (Day 1 to Week 5)|Adverse Event|51|||
48848207|NCT01074294|157283522|FG001|Phase A (Day 1 to Week 5)|Adverse Event|0|||
48848208|NCT01074294|157283523|FG002|Phase A (Day 1 to Week 5)|Adverse Event|0|||
48848209|NCT01074294|157283524|FG003|Phase A (Day 1 to Week 5)|Adverse Event|0|||
48848210|NCT01074294|157283521|FG000|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|47|||
48848211|NCT01074294|157283522|FG001|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
48848212|NCT01074294|157283523|FG002|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
48848213|NCT01074294|157283524|FG003|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
48848214|NCT01074294|157283521|FG000|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|3|||
48848215|NCT01074294|157283522|FG001|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
48848216|NCT01074294|157283523|FG002|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
48848217|NCT01074294|157283524|FG003|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
48848218|NCT01074294|157283521|FG000|Phase A (Day 1 to Week 5)|Withdrawal by Subject|32|||
48848219|NCT01074294|157283522|FG001|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
48848220|NCT01074294|157283523|FG002|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
48848221|NCT01074294|157283524|FG003|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
48848222|NCT01074294|157283521|FG000|Phase A (Day 1 to Week 5)|Protocol deviation|10|||
48848223|NCT01074294|157283522|FG001|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
48848224|NCT01074294|157283523|FG002|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
48848225|NCT01074294|157283524|FG003|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
48848226|NCT01074294|157283521|FG000|Phase A (Day 1 to Week 5)|Participants not Dosed|7|||
48848227|NCT01074294|157283522|FG001|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
48848228|NCT01074294|157283523|FG002|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
48848229|NCT01074294|157283524|FG003|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
48848230|NCT01074294|157283521|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|0|||
48938893|NCT00809133|157605183|FG006|Overall Study|Lost to Follow-up|0|||
48938894|NCT00809133|157605184|FG007|Overall Study|Lost to Follow-up|0|||
48938895|NCT00809133|157605185|FG008|Overall Study|Lost to Follow-up|0|||
48938896|NCT00809133|157605186|FG009|Overall Study|Lost to Follow-up|0|||
48938897|NCT00809133|157605187|FG010|Overall Study|Lost to Follow-up|0|||
48938898|NCT00809133|157605188|FG011|Overall Study|Lost to Follow-up|0|||
48938899|NCT00809133|157605189|FG012|Overall Study|Lost to Follow-up|0|||
48938900|NCT00809133|157605190|FG013|Overall Study|Lost to Follow-up|0|||
48938901|NCT00809133|157605177|FG000|Overall Study|Consent withdrawn|0|||
48938902|NCT00809133|157605178|FG001|Overall Study|Consent withdrawn|0|||
48938903|NCT00809133|157605179|FG002|Overall Study|Consent withdrawn|0|||
48938904|NCT00809133|157605180|FG003|Overall Study|Consent withdrawn|0|||
48938905|NCT00809133|157605181|FG004|Overall Study|Consent withdrawn|1|||
48938906|NCT00809133|157605182|FG005|Overall Study|Consent withdrawn|0|||
48938907|NCT00809133|157605183|FG006|Overall Study|Consent withdrawn|0|||
48938908|NCT00809133|157605184|FG007|Overall Study|Consent withdrawn|0|||
48938909|NCT00809133|157605185|FG008|Overall Study|Consent withdrawn|0|||
48938910|NCT00809133|157605186|FG009|Overall Study|Consent withdrawn|0|||
48938911|NCT00809133|157605187|FG010|Overall Study|Consent withdrawn|0|||
48938912|NCT00809133|157605188|FG011|Overall Study|Consent withdrawn|0|||
48938913|NCT00809133|157605189|FG012|Overall Study|Consent withdrawn|0|||
48938914|NCT00809133|157605190|FG013|Overall Study|Consent withdrawn|0|||
48938915|NCT00809133|157605177|FG000|Overall Study|Other not mentioned above|0|||
48938916|NCT00809133|157605178|FG001|Overall Study|Other not mentioned above|1|||
48938917|NCT00809133|157605179|FG002|Overall Study|Other not mentioned above|0|||
48938918|NCT00809133|157605180|FG003|Overall Study|Other not mentioned above|0|||
48938919|NCT00809133|157605181|FG004|Overall Study|Other not mentioned above|0|||
48938920|NCT00809133|157605182|FG005|Overall Study|Other not mentioned above|1|||
48938921|NCT00809133|157605183|FG006|Overall Study|Other not mentioned above|0|||
48938922|NCT00809133|157605184|FG007|Overall Study|Other not mentioned above|0|||
48938923|NCT00809133|157605185|FG008|Overall Study|Other not mentioned above|0|||
48938924|NCT00809133|157605186|FG009|Overall Study|Other not mentioned above|0|||
48938925|NCT00809133|157605187|FG010|Overall Study|Other not mentioned above|0|||
48938926|NCT00809133|157605188|FG011|Overall Study|Other not mentioned above|0|||
48938927|NCT00809133|157605189|FG012|Overall Study|Other not mentioned above|0|||
48938928|NCT00809133|157605190|FG013|Overall Study|Other not mentioned above|0|||
48938929|NCT00087438|157605191|FG000|Overall Study|Ineligible / No protocol treatment|4|||
48938930|NCT01085682|157605192|FG000|Overall Study|Withdrawal by Subject|25|||
48938931|NCT01085682|157605193|FG001|Overall Study|Withdrawal by Subject|25|||
48938932|NCT03258814|157605198|FG000|Overall Study|Early Termination|4|||
48938933|NCT03258814|157605199|FG001|Overall Study|Early Termination|3|||
48938934|NCT03258814|157605200|FG002|Overall Study|Early Termination|10|||
48938935|NCT00813995|157605201|FG000|Overall Study|Clinical adverse event|9|||
48938936|NCT00813995|157605202|FG001|Overall Study|Clinical adverse event|3|||
48938937|NCT00813995|157605201|FG000|Overall Study|Laboratory adverse event|0|||
48938938|NCT00813995|157605202|FG001|Overall Study|Laboratory adverse event|2|||
48938939|NCT00813995|157605201|FG000|Overall Study|Lack of Efficacy|1|||
48938940|NCT00813995|157605202|FG001|Overall Study|Lack of Efficacy|0|||
48938941|NCT00813995|157605201|FG000|Overall Study|Lost to Follow-up|4|||
48938942|NCT00813995|157605202|FG001|Overall Study|Lost to Follow-up|2|||
48938943|NCT00813995|157605201|FG000|Overall Study|Other reason|2|||
48938944|NCT00813995|157605202|FG001|Overall Study|Other reason|2|||
48938945|NCT00813995|157605201|FG000|Overall Study|Protocol Violation|3|||
48938946|NCT00813995|157605202|FG001|Overall Study|Protocol Violation|2|||
48938947|NCT00813995|157605201|FG000|Overall Study|Subject moved|4|||
48938948|NCT00813995|157605202|FG001|Overall Study|Subject moved|0|||
48938949|NCT00813995|157605201|FG000|Overall Study|Withdrawal by Subject|0|||
48938950|NCT00813995|157605202|FG001|Overall Study|Withdrawal by Subject|5|||
48938951|NCT02207907|157605208|FG000|Overall Study|Lost to Follow-up|3|||
48938952|NCT02207907|157605209|FG001|Overall Study|Lost to Follow-up|1|||
48938953|NCT02207907|157605208|FG000|Overall Study|Withdrawal by Subject|5|||
48938954|NCT02207907|157605209|FG001|Overall Study|Withdrawal by Subject|6|||
48938955|NCT02207907|157605208|FG000|Overall Study|Did not meet study criteria|3|||
48938956|NCT02207907|157605209|FG001|Overall Study|Did not meet study criteria|0|||
48938957|NCT02207907|157605208|FG000|Overall Study|Pregnancy|0|||
48938958|NCT02207907|157605209|FG001|Overall Study|Pregnancy|1|||
48938959|NCT00158184|157605210|FG000|Overall Study|personal issues|3|||
48938960|NCT00158184|157605211|FG001|Overall Study|personal issues|1|||
48938961|NCT00158184|157605210|FG000|Overall Study|failed for follow unit/study rules|2|||
48938962|NCT00158184|157605211|FG001|Overall Study|failed for follow unit/study rules|0|||
48938963|NCT00158184|157605210|FG000|Overall Study|Adverse Event|1|||
48938964|NCT00158184|157605211|FG001|Overall Study|Adverse Event|1|||
48938965|NCT05340504|157605212|FG000|Overall Study|Withdrawal by Subject|1|||
48938966|NCT05340504|157605213|FG001|Overall Study|Withdrawal by Subject|0|||
48938967|NCT02928952|157605215|FG000|Overall Study|Lost to Follow-up|5|||
48938968|NCT02928952|157605216|FG001|Overall Study|Lost to Follow-up|5|||
48938969|NCT02928952|157605215|FG000|Overall Study|Withdrawal by Subject|5|||
48938970|NCT02928952|157605216|FG001|Overall Study|Withdrawal by Subject|1|||
48938971|NCT02928952|157605215|FG000|Overall Study|Physician Decision|0|||
48938972|NCT02928952|157605216|FG001|Overall Study|Physician Decision|1|||
48938973|NCT00706628|157605217|FG000|Overall Study|Other Adverse Event|16|||
48938974|NCT00706628|157605218|FG001|Overall Study|Other Adverse Event|5|||
48938975|NCT00706628|157605219|FG002|Overall Study|Other Adverse Event|5|||
48938976|NCT00706628|157605220|FG003|Overall Study|Other Adverse Event|2|||
48938977|NCT00706628|157605217|FG000|Overall Study|Non compliant with protocol|0|||
48938978|NCT00706628|157605218|FG001|Overall Study|Non compliant with protocol|1|||
48938979|NCT00706628|157605219|FG002|Overall Study|Non compliant with protocol|0|||
48938980|NCT00706628|157605220|FG003|Overall Study|Non compliant with protocol|0|||
48938981|NCT00706628|157605217|FG000|Overall Study|Consent withdrawn|6|||
48938982|NCT00706628|157605218|FG001|Overall Study|Consent withdrawn|1|||
48938983|NCT00706628|157605219|FG002|Overall Study|Consent withdrawn|3|||
48938984|NCT00706628|157605220|FG003|Overall Study|Consent withdrawn|0|||
48938985|NCT00706628|157605217|FG000|Overall Study|Progressive disease|20|||
48938986|NCT00706628|157605218|FG001|Overall Study|Progressive disease|13|||
48938987|NCT00706628|157605219|FG002|Overall Study|Progressive disease|8|||
48938988|NCT00706628|157605220|FG003|Overall Study|Progressive disease|1|||
48938989|NCT00706628|157605217|FG000|Overall Study|Other than those stated above|4|||
48938990|NCT00706628|157605218|FG001|Overall Study|Other than those stated above|0|||
48938991|NCT00706628|157605219|FG002|Overall Study|Other than those stated above|0|||
48938992|NCT00706628|157605220|FG003|Overall Study|Other than those stated above|0|||
48938993|NCT00706628|157605217|FG000|Overall Study|Not treated|1|||
48938994|NCT00706628|157605218|FG001|Overall Study|Not treated|1|||
48938995|NCT00706628|157605219|FG002|Overall Study|Not treated|0|||
48938996|NCT00706628|157605220|FG003|Overall Study|Not treated|0|||
48938997|NCT03377634|157605221|FG000|Study Period|Adverse Event|1|||
48938998|NCT03377634|157605222|FG001|Study Period|Adverse Event|0|||
48938999|NCT03377634|157605221|FG000|Study Period|Withdrawal by Subject|1|||
48939000|NCT03377634|157605222|FG001|Study Period|Withdrawal by Subject|0|||
48939001|NCT00977470|157605225|FG000|Overall Study|Lack of Efficacy|32|||
48939002|NCT00977470|157605226|FG001|Overall Study|Lack of Efficacy|30|||
48939003|NCT00977470|157605225|FG000|Overall Study|Physician Decision|2|||
48939004|NCT00977470|157605226|FG001|Overall Study|Physician Decision|0|||
48939005|NCT00977470|157605225|FG000|Overall Study|Adverse Event|1|||
48939006|NCT00977470|157605226|FG001|Overall Study|Adverse Event|2|||
48939007|NCT00977470|157605225|FG000|Overall Study|Protocol Violation|1|||
48939008|NCT00977470|157605226|FG001|Overall Study|Protocol Violation|0|||
48939009|NCT00977470|157605225|FG000|Overall Study|Withdrawal by Subject|0|||
48939010|NCT00977470|157605226|FG001|Overall Study|Withdrawal by Subject|2|||
48939011|NCT00977470|157605225|FG000|Overall Study|Death|0|||
48939012|NCT00977470|157605226|FG001|Overall Study|Death|2|||
48939013|NCT00977470|157605225|FG000|Overall Study|clinical decline|0|||
48939014|NCT00977470|157605226|FG001|Overall Study|clinical decline|1|||
48939015|NCT00977470|157605225|FG000|Overall Study|prolonged recovery post-surgery|0|||
48939016|NCT00977470|157605226|FG001|Overall Study|prolonged recovery post-surgery|1|||
48939017|NCT00977470|157605225|FG000|Overall Study|Still on-study|2|||
48939018|NCT00977470|157605226|FG001|Overall Study|Still on-study|0|||
48939019|NCT02635204|157605227|FG000|Overall Study|Adverse Event|1|||
48939020|NCT02635204|157605228|FG001|Overall Study|Adverse Event|0|||
48939021|NCT02635204|157605227|FG000|Overall Study|Lost to Follow-up|1|||
48939022|NCT02635204|157605228|FG001|Overall Study|Lost to Follow-up|1|||
48939023|NCT01145560|157605230|FG000|Overall Study|Withdrawal by Subject|2|||
48939024|NCT01145560|157605231|FG001|Overall Study|Withdrawal by Subject|1|||
48939025|NCT01145560|157605232|FG002|Overall Study|Withdrawal by Subject|0|||
48939026|NCT01145560|157605230|FG000|Overall Study|Lost to Follow-up|1|||
48939027|NCT01145560|157605231|FG001|Overall Study|Lost to Follow-up|1|||
48939028|NCT01145560|157605232|FG002|Overall Study|Lost to Follow-up|1|||
48939029|NCT01145560|157605230|FG000|Overall Study|No study drug by 24h after organ failure|1|||
48939030|NCT01145560|157605231|FG001|Overall Study|No study drug by 24h after organ failure|0|||
48939031|NCT01145560|157605232|FG002|Overall Study|No study drug by 24h after organ failure|0|||
48939032|NCT01145560|157605230|FG000|Overall Study|Accidental unblinding of study treatment|0|||
48939033|NCT01145560|157605231|FG001|Overall Study|Accidental unblinding of study treatment|1|||
48939034|NCT01145560|157605232|FG002|Overall Study|Accidental unblinding of study treatment|0|||
48939035|NCT01145560|157605230|FG000|Overall Study|False insurance information|0|||
48939036|NCT01145560|157605231|FG001|Overall Study|False insurance information|1|||
48939037|NCT01145560|157605232|FG002|Overall Study|False insurance information|0|||
48939038|NCT01145560|157605230|FG000|Overall Study|Withdrawal of therapy|0|||
48939039|NCT01145560|157605231|FG001|Overall Study|Withdrawal of therapy|0|||
48848231|NCT01074294|157283522|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
48848232|NCT01074294|157283523|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
48848233|NCT01074294|157283524|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|11|||
48848234|NCT01074294|157283521|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|0|||
48848235|NCT01074294|157283522|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|2|||
48848236|NCT01074294|157283523|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|3|||
48848237|NCT01074294|157283524|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|8|||
48848238|NCT01074294|157283521|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
48848239|NCT01074294|157283522|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|2|||
48848240|NCT01074294|157283523|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
48848241|NCT01074294|157283524|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
48848242|NCT01074294|157283521|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|0|||
48848243|NCT01074294|157283522|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
48848244|NCT01074294|157283523|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
48939040|NCT01145560|157605232|FG002|Overall Study|Withdrawal of therapy|1|||
48848245|NCT01074294|157283524|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|4|||
48848246|NCT01074294|157283521|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
48848247|NCT01074294|157283522|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
48848248|NCT01074294|157283523|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|3|||
48848249|NCT01074294|157283524|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|2|||
48848250|NCT01074294|157283521|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
48848251|NCT01074294|157283522|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|1|||
48848252|NCT01074294|157283523|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
48848253|NCT01074294|157283524|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
48848254|NCT01426412|157283540|FG000|Overall Study|Withdrawal by Subject|1|||
48848255|NCT01426412|157283541|FG001|Overall Study|Withdrawal by Subject|0|||
48848256|NCT01426412|157283542|FG002|Overall Study|Withdrawal by Subject|0|||
48848257|NCT01426412|157283543|FG003|Overall Study|Withdrawal by Subject|0|||
48848258|NCT01426412|157283544|FG004|Overall Study|Withdrawal by Subject|1|||
48848259|NCT01426412|157283545|FG005|Overall Study|Withdrawal by Subject|0|||
48848260|NCT01426412|157283546|FG006|Overall Study|Withdrawal by Subject|0|||
48848261|NCT01426412|157283547|FG007|Overall Study|Withdrawal by Subject|3|||
48848262|NCT01426412|157283548|FG008|Overall Study|Withdrawal by Subject|1|||
48848263|NCT00687219|157283550|FG000|Overall Study|Adverse Event|8|||
48848264|NCT00687219|157283550|FG000|Overall Study|Discontinuance criteria met|7|||
48848265|NCT00687219|157283550|FG000|Overall Study|HCV-RNA positive conversion|34|||
48848266|NCT00687219|157283550|FG000|Overall Study|Withdrawal by Subject|1|||
48848267|NCT00687219|157283550|FG000|Overall Study|Lack of Efficacy|1|||
48848268|NCT02008916|157283551|FG000|Primary Assessment (up to Week 16)|Withdrawal by Subject|0|||
48848269|NCT02008916|157283552|FG001|Primary Assessment (up to Week 16)|Withdrawal by Subject|1|||
48848270|NCT02008916|157283553|FG002|Primary Assessment (up to Week 16)|Withdrawal by Subject|3|||
48848271|NCT02008916|157283551|FG000|Week 16 - 156|Adverse Event|4|||
48848272|NCT02008916|157283552|FG001|Week 16 - 156|Adverse Event|2|||
48848273|NCT02008916|157283553|FG002|Week 16 - 156|Adverse Event|3|||
48848274|NCT02008916|157283551|FG000|Week 16 - 156|Withdrawal by Subject|7|||
48848275|NCT02008916|157283552|FG001|Week 16 - 156|Withdrawal by Subject|3|||
48848276|NCT02008916|157283553|FG002|Week 16 - 156|Withdrawal by Subject|5|||
48848277|NCT02008916|157283551|FG000|Week 16 - 156|No longer requires treatment|0|||
48848278|NCT02008916|157283552|FG001|Week 16 - 156|No longer requires treatment|1|||
48848279|NCT02008916|157283553|FG002|Week 16 - 156|No longer requires treatment|0|||
48848280|NCT02008916|157283551|FG000|Week 16 - 156|Lost to Follow-up|5|||
48848281|NCT02008916|157283552|FG001|Week 16 - 156|Lost to Follow-up|0|||
48848282|NCT02008916|157283553|FG002|Week 16 - 156|Lost to Follow-up|0|||
48848283|NCT02008916|157283551|FG000|Week 16 - 156|Lack of Efficacy|3|||
48848284|NCT02008916|157283552|FG001|Week 16 - 156|Lack of Efficacy|5|||
48848285|NCT02008916|157283553|FG002|Week 16 - 156|Lack of Efficacy|2|||
48848286|NCT02008916|157283551|FG000|Week 16 - 156|Pregnancy|0|||
48848287|NCT02008916|157283552|FG001|Week 16 - 156|Pregnancy|1|||
48848288|NCT02008916|157283553|FG002|Week 16 - 156|Pregnancy|0|||
48848289|NCT02008916|157283551|FG000|Week 16 - 156|Physician Decision|0|||
48848290|NCT02008916|157283552|FG001|Week 16 - 156|Physician Decision|1|||
48848291|NCT02008916|157283553|FG002|Week 16 - 156|Physician Decision|0|||
48848292|NCT01367236|157283554|FG000|Overall Study|Withdrawal by Subject|3|||
48848293|NCT01367236|157283555|FG001|Overall Study|Withdrawal by Subject|1|||
48848294|NCT05171777|157283556|FG000|Treatment Crossover Period|Adverse Event|9|||
48848295|NCT05171777|157283557|FG001|Treatment Crossover Period|Adverse Event|6|||
48848296|NCT05171777|157283558|FG002|Treatment Crossover Period|Adverse Event|0|||
48848297|NCT05171777|157283559|FG003|Treatment Crossover Period|Adverse Event|0|||
48848298|NCT05171777|157283556|FG000|Treatment Crossover Period|Death|5|||
48848299|NCT05171777|157283557|FG001|Treatment Crossover Period|Death|5|||
48848300|NCT05171777|157283558|FG002|Treatment Crossover Period|Death|0|||
48848301|NCT05171777|157283559|FG003|Treatment Crossover Period|Death|0|||
48848302|NCT05171777|157283556|FG000|Treatment Crossover Period|Disease Relapse|0|||
48848303|NCT05171777|157283557|FG001|Treatment Crossover Period|Disease Relapse|1|||
48848304|NCT05171777|157283558|FG002|Treatment Crossover Period|Disease Relapse|0|||
48848305|NCT05171777|157283559|FG003|Treatment Crossover Period|Disease Relapse|0|||
48848306|NCT05171777|157283556|FG000|Treatment Crossover Period|Reason not Specified|2|||
48848307|NCT05171777|157283557|FG001|Treatment Crossover Period|Reason not Specified|1|||
48848308|NCT05171777|157283558|FG002|Treatment Crossover Period|Reason not Specified|0|||
48848309|NCT05171777|157283559|FG003|Treatment Crossover Period|Reason not Specified|0|||
48848310|NCT05171777|157283556|FG000|Treatment Crossover Period|Physician Decision|0|||
48848311|NCT05171777|157283557|FG001|Treatment Crossover Period|Physician Decision|1|||
48848312|NCT05171777|157283558|FG002|Treatment Crossover Period|Physician Decision|0|||
48848313|NCT05171777|157283559|FG003|Treatment Crossover Period|Physician Decision|0|||
48848314|NCT05171777|157283556|FG000|Treatment Crossover Period|Progressive Disease|13|||
48848315|NCT05171777|157283557|FG001|Treatment Crossover Period|Progressive Disease|9|||
48848316|NCT05171777|157283558|FG002|Treatment Crossover Period|Progressive Disease|0|||
48848317|NCT05171777|157283559|FG003|Treatment Crossover Period|Progressive Disease|0|||
48848318|NCT05171777|157283556|FG000|Treatment Crossover Period|Protocol Violation|0|||
48848319|NCT05171777|157283557|FG001|Treatment Crossover Period|Protocol Violation|2|||
48848320|NCT05171777|157283558|FG002|Treatment Crossover Period|Protocol Violation|0|||
48848321|NCT05171777|157283559|FG003|Treatment Crossover Period|Protocol Violation|0|||
48848322|NCT05171777|157283556|FG000|Treatment Crossover Period|Symptomatic Deterioration|0|||
48848323|NCT05171777|157283557|FG001|Treatment Crossover Period|Symptomatic Deterioration|1|||
48939041|NCT00424398|157605241|FG000|Overall Study|Withdrawal by Subject|2|||
48939042|NCT00424398|157605242|FG001|Overall Study|Withdrawal by Subject|1|||
48939043|NCT00424398|157605243|FG002|Overall Study|Withdrawal by Subject|0|||
48939044|NCT00424398|157605241|FG000|Overall Study|Subject met exclusion criteria|1|||
48939045|NCT00424398|157605242|FG001|Overall Study|Subject met exclusion criteria|0|||
48939046|NCT00424398|157605243|FG002|Overall Study|Subject met exclusion criteria|0|||
48939047|NCT04672083|157605244|FG000|Overall Study|Lost to Follow-up|1|||
48939048|NCT04672083|157605245|FG001|Overall Study|Lost to Follow-up|0|||
48939049|NCT04672083|157605246|FG002|Overall Study|Lost to Follow-up|0|||
48939050|NCT04672083|157605247|FG003|Overall Study|Lost to Follow-up|0|||
48939051|NCT04672083|157605248|FG004|Overall Study|Lost to Follow-up|0|||
48939052|NCT00855439|157605251|FG000|Overall Study|Withdrawal by Subject|2|||
48939053|NCT00855439|157605252|FG001|Overall Study|Withdrawal by Subject|0|||
48939054|NCT00855439|157605251|FG000|Overall Study|Pregnancy|1|||
48939055|NCT00855439|157605252|FG001|Overall Study|Pregnancy|0|||
48939056|NCT00144170|157605255|FG000|Overall Study|Adverse Event|84|||
48939057|NCT00144170|157605256|FG001|Overall Study|Adverse Event|41|||
48939058|NCT00144170|157605255|FG000|Overall Study|Protocol Violation|23|||
48939059|NCT00144170|157605256|FG001|Overall Study|Protocol Violation|16|||
48939060|NCT00144170|157605255|FG000|Overall Study|Lost to Follow-up|5|||
48939061|NCT00144170|157605256|FG001|Overall Study|Lost to Follow-up|10|||
48939062|NCT00144170|157605255|FG000|Overall Study|Withdrawal by Subject|29|||
48939063|NCT00144170|157605256|FG001|Overall Study|Withdrawal by Subject|13|||
48939064|NCT00144170|157605255|FG000|Overall Study|Other reason not defined above|211|||
48939065|NCT00144170|157605256|FG001|Overall Study|Other reason not defined above|316|||
48939066|NCT00332202|157605257|FG000|Overall Study|Adverse Event|72|||
48939067|NCT00332202|157605258|FG001|Overall Study|Adverse Event|28|||
48939068|NCT00332202|157605257|FG000|Overall Study|Lost to Follow-up|2|||
48939069|NCT00332202|157605258|FG001|Overall Study|Lost to Follow-up|1|||
48939070|NCT00332202|157605257|FG000|Overall Study|Physician Decision|6|||
48939071|NCT00332202|157605258|FG001|Overall Study|Physician Decision|8|||
48939072|NCT00332202|157605257|FG000|Overall Study|Protocol Entry Criteria Not Met|6|||
48939073|NCT00332202|157605258|FG001|Overall Study|Protocol Entry Criteria Not Met|5|||
48939074|NCT00332202|157605257|FG000|Overall Study|Protocol Violation|7|||
48939075|NCT00332202|157605258|FG001|Overall Study|Protocol Violation|2|||
48848324|NCT05171777|157283558|FG002|Treatment Crossover Period|Symptomatic Deterioration|0|||
48848325|NCT05171777|157283559|FG003|Treatment Crossover Period|Symptomatic Deterioration|0|||
48848326|NCT05171777|157283556|FG000|Treatment Crossover Period|Withdrawal by Subject|4|||
48848327|NCT05171777|157283557|FG001|Treatment Crossover Period|Withdrawal by Subject|4|||
48848328|NCT05171777|157283558|FG002|Treatment Crossover Period|Withdrawal by Subject|0|||
48848329|NCT05171777|157283559|FG003|Treatment Crossover Period|Withdrawal by Subject|0|||
48848330|NCT05171777|157283556|FG000|Treatment Crossover Period|Ongoing in the Crossover Period|3|||
48848331|NCT05171777|157283557|FG001|Treatment Crossover Period|Ongoing in the Crossover Period|6|||
48848332|NCT05171777|157283558|FG002|Treatment Crossover Period|Ongoing in the Crossover Period|0|||
48848333|NCT05171777|157283559|FG003|Treatment Crossover Period|Ongoing in the Crossover Period|0|||
48848334|NCT05171777|157283556|FG000|Treatment Continuation Period|Death|0|||
48848335|NCT05171777|157283557|FG001|Treatment Continuation Period|Death|0|||
48848336|NCT05171777|157283558|FG002|Treatment Continuation Period|Death|1|||
48848337|NCT05171777|157283559|FG003|Treatment Continuation Period|Death|6|||
48939076|NCT00332202|157605257|FG000|Overall Study|Sponsor Decision|1|||
48939077|NCT00332202|157605258|FG001|Overall Study|Sponsor Decision|2|||
48939078|NCT00332202|157605257|FG000|Overall Study|Withdrawal by Subject|36|||
48939079|NCT00332202|157605258|FG001|Overall Study|Withdrawal by Subject|17|||
48939080|NCT00332202|157605257|FG000|Overall Study|Progressive Disease|106|||
48939081|NCT00332202|157605258|FG001|Overall Study|Progressive Disease|60|||
48939082|NCT00332202|157605257|FG000|Overall Study|Death|5|||
48939083|NCT00332202|157605258|FG001|Overall Study|Death|2|||
48939084|NCT02722044|157605259|FG000|Overall Study|Adverse Event|2|||
48939085|NCT02722044|157605259|FG000|Overall Study|Physician Decision|1|||
48939086|NCT02722044|157605259|FG000|Overall Study|Withdrawal by Subject|1|||
48939087|NCT02722044|157605259|FG000|Overall Study|Did Not Meet Criteria at Week 14|1|||
48939088|NCT05900115|157607493|FG000|Overall Study|Lost to Follow-up|129|||
48939089|NCT05900115|157607494|FG001|Overall Study|Lost to Follow-up|98|||
48939090|NCT02689492|157607495|FG000|Overall Study|Lost to Follow-up|61|||
48939091|NCT02689492|157607495|FG000|Overall Study|Withdrawal by Subject|11|||
48939092|NCT02689492|157607495|FG000|Overall Study|Death|9|||
48939093|NCT02689492|157607495|FG000|Overall Study|Physician Decision|2|||
48939094|NCT02689492|157607495|FG000|Overall Study|Withdrawal/Loss To Follow-Up|1|||
48939095|NCT02689492|157607495|FG000|Overall Study|Withdrawal/ Physician's Decision|1|||
48939096|NCT02689492|157607495|FG000|Overall Study|Other than listed|1|||
48939097|NCT01431287|157607496|FG000|Overall Study|not treated|0|||
48939098|NCT01431287|157607497|FG001|Overall Study|not treated|0|||
48939099|NCT01431287|157607498|FG002|Overall Study|not treated|1|||
48939100|NCT01431287|157607499|FG003|Overall Study|not treated|0|||
48939101|NCT01431287|157607500|FG004|Overall Study|not treated|0|||
48939102|NCT01431287|157607496|FG000|Overall Study|Adverse Event|59|||
48939103|NCT01431287|157607497|FG001|Overall Study|Adverse Event|57|||
48939104|NCT01431287|157607498|FG002|Overall Study|Adverse Event|53|||
48939105|NCT01431287|157607499|FG003|Overall Study|Adverse Event|33|||
48939106|NCT01431287|157607500|FG004|Overall Study|Adverse Event|41|||
48939107|NCT01431287|157607496|FG000|Overall Study|Non compliant with protocol|6|||
48939108|NCT01431287|157607497|FG001|Overall Study|Non compliant with protocol|6|||
48939109|NCT01431287|157607498|FG002|Overall Study|Non compliant with protocol|5|||
48939110|NCT01431287|157607499|FG003|Overall Study|Non compliant with protocol|6|||
48939111|NCT01431287|157607500|FG004|Overall Study|Non compliant with protocol|5|||
48939112|NCT01431287|157607496|FG000|Overall Study|Lost to Follow-up|0|||
48939113|NCT01431287|157607497|FG001|Overall Study|Lost to Follow-up|3|||
48939114|NCT01431287|157607498|FG002|Overall Study|Lost to Follow-up|2|||
48939115|NCT01431287|157607499|FG003|Overall Study|Lost to Follow-up|3|||
48939116|NCT01431287|157607500|FG004|Overall Study|Lost to Follow-up|1|||
48939117|NCT01431287|157607496|FG000|Overall Study|Consent withdrawn not due to AE|29|||
48939118|NCT01431287|157607497|FG001|Overall Study|Consent withdrawn not due to AE|30|||
48939119|NCT01431287|157607498|FG002|Overall Study|Consent withdrawn not due to AE|34|||
48939120|NCT01431287|157607499|FG003|Overall Study|Consent withdrawn not due to AE|19|||
48939121|NCT01431287|157607500|FG004|Overall Study|Consent withdrawn not due to AE|29|||
48939122|NCT01431287|157607496|FG000|Overall Study|not stated above|4|||
48939123|NCT01431287|157607497|FG001|Overall Study|not stated above|2|||
48939124|NCT01431287|157607498|FG002|Overall Study|not stated above|2|||
48939125|NCT01431287|157607499|FG003|Overall Study|not stated above|2|||
48939126|NCT01431287|157607500|FG004|Overall Study|not stated above|1|||
48939127|NCT02029976|157607501|FG000|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12|||
48939128|NCT02029976|157607502|FG001|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8|||
48939129|NCT02029976|157607501|FG000|YR-2 Follow Up vs Baseline|Lost to Follow-up|8|||
48939130|NCT02029976|157607502|FG001|YR-2 Follow Up vs Baseline|Lost to Follow-up|4|||
48939131|NCT02029976|157607501|FG000|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
48939132|NCT02029976|157607502|FG001|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
48939133|NCT02029976|157607501|FG000|YR-2 Follow Up vs Baseline|Moved from area|0|||
48939134|NCT02029976|157607502|FG001|YR-2 Follow Up vs Baseline|Moved from area|2|||
48939135|NCT01220414|157607508|FG000|Overall Study|Withdrawal by Subject|1|||
48939136|NCT01220414|157607509|FG001|Overall Study|Withdrawal by Subject|0|||
48939137|NCT01220414|157607510|FG002|Overall Study|Withdrawal by Subject|0|||
48939138|NCT01220414|157607511|FG003|Overall Study|Withdrawal by Subject|1|||
48939139|NCT00496366|157607514|FG000|Overall Study|Death|1|||
48939140|NCT02863848|157607515|FG000|Overall Study|Lost to Follow-up|1|||
48939141|NCT02863848|157607516|FG001|Overall Study|Lost to Follow-up|1|||
48939142|NCT02863848|157607515|FG000|Overall Study|Protocol Violation|1|||
48939143|NCT02863848|157607516|FG001|Overall Study|Protocol Violation|2|||
48939144|NCT02318095|157607523|FG000|Overall Study|Adverse Event|1|||
48939145|NCT03323749|157607524|FG000|Double-blind Period|Lost to Follow-up|4|||
48939146|NCT03323749|157607525|FG001|Double-blind Period|Lost to Follow-up|5|||
48939147|NCT03323749|157607524|FG000|Double-blind Period|Adverse Event|3|||
48939148|NCT03323749|157607525|FG001|Double-blind Period|Adverse Event|1|||
48939149|NCT03323749|157607524|FG000|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83|||
48939150|NCT03323749|157607525|FG001|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88|||
48939151|NCT03323749|157607524|FG000|Open-Label Period|Adverse Event|3|||
48735667|NCT02840721|156883710|FG000|Follow-Up|Lack of Efficacy|1|||
48939152|NCT03323749|157607525|FG001|Open-Label Period|Adverse Event|10|||
48939153|NCT03323749|157607524|FG000|Open-Label Period|Withdrawal by Subject|7|||
48939154|NCT03323749|157607525|FG001|Open-Label Period|Withdrawal by Subject|5|||
48939155|NCT02468193|157607526|FG000|Overall Study|Adverse Event|4|||
48939156|NCT02468193|157607526|FG000|Overall Study|Subject/ Guardian decision|2|||
48939157|NCT00742781|157607527|FG000|Overall Study|Withdrawal by Subject|3|||
48939158|NCT03539432|157607528|FG000|Overall Study|Lost to Follow-up|0|||
48939159|NCT03539432|157607529|FG001|Overall Study|Lost to Follow-up|1|||
48939160|NCT01381094|157607530|FG000|Overall Study|Adverse Event|1|||
48939161|NCT01381094|157607531|FG001|Overall Study|Adverse Event|2|||
48939162|NCT01381094|157607532|FG002|Overall Study|Adverse Event|0|||
48939163|NCT01381094|157607533|FG003|Overall Study|Adverse Event|1|||
48939164|NCT01381094|157607534|FG004|Overall Study|Adverse Event|0|||
48939165|NCT01381094|157607530|FG000|Overall Study|Lost to Follow-up|0|||
48939166|NCT01381094|157607531|FG001|Overall Study|Lost to Follow-up|0|||
48939167|NCT01381094|157607532|FG002|Overall Study|Lost to Follow-up|0|||
48939168|NCT01381094|157607533|FG003|Overall Study|Lost to Follow-up|0|||
48939169|NCT01381094|157607534|FG004|Overall Study|Lost to Follow-up|1|||
48939170|NCT01381094|157607530|FG000|Overall Study|Withdrawal of informed consent|0|||
48939171|NCT01381094|157607531|FG001|Overall Study|Withdrawal of informed consent|1|||
48939172|NCT01381094|157607532|FG002|Overall Study|Withdrawal of informed consent|0|||
48939173|NCT01381094|157607533|FG003|Overall Study|Withdrawal of informed consent|0|||
48939174|NCT01381094|157607534|FG004|Overall Study|Withdrawal of informed consent|0|||
48939175|NCT01381094|157607530|FG000|Overall Study|Participant given Aranesp injection|1|||
48939176|NCT01381094|157607531|FG001|Overall Study|Participant given Aranesp injection|0|||
48939177|NCT01381094|157607532|FG002|Overall Study|Participant given Aranesp injection|0|||
48939178|NCT01381094|157607533|FG003|Overall Study|Participant given Aranesp injection|0|||
48939179|NCT01381094|157607534|FG004|Overall Study|Participant given Aranesp injection|0|||
48939180|NCT01934504|157607538|FG000|Overall Study|Protocol Deviation|0|||
48939181|NCT01934504|157607539|FG001|Overall Study|Protocol Deviation|0|||
48939182|NCT01934504|157607540|FG002|Overall Study|Protocol Deviation|0|||
48939183|NCT01934504|157607541|FG003|Overall Study|Protocol Deviation|2|||
48939184|NCT01934504|157607538|FG000|Overall Study|Study Terminated by Sponsor|1|||
48939185|NCT01934504|157607539|FG001|Overall Study|Study Terminated by Sponsor|0|||
48939186|NCT01934504|157607540|FG002|Overall Study|Study Terminated by Sponsor|5|||
48939187|NCT01934504|157607541|FG003|Overall Study|Study Terminated by Sponsor|5|||
48939188|NCT00522392|157607542|FG000|Overall Study|Disease progression|0|||
48939189|NCT00522392|157607543|FG001|Overall Study|Disease progression|3|||
48939190|NCT00522392|157607542|FG000|Overall Study|Adverse Event|7|||
48939191|NCT00522392|157607543|FG001|Overall Study|Adverse Event|7|||
48939192|NCT00522392|157607542|FG000|Overall Study|Withdrawal by Subject|1|||
48848338|NCT05171777|157283556|FG000|Treatment Continuation Period|Ongoing in Continuation Period|0|||
48848339|NCT05171777|157283557|FG001|Treatment Continuation Period|Ongoing in Continuation Period|0|||
48939193|NCT00522392|157607543|FG001|Overall Study|Withdrawal by Subject|1|||
48939194|NCT00522392|157607542|FG000|Overall Study|Physician Decision|0|||
48939195|NCT00522392|157607543|FG001|Overall Study|Physician Decision|1|||
48939196|NCT00522392|157607542|FG000|Overall Study|Non-compliance|0|||
48939197|NCT00522392|157607543|FG001|Overall Study|Non-compliance|1|||
48939198|NCT00486902|157607545|FG000|Overall Study|Withdrawal by Subject|1|||
48848340|NCT05171777|157283558|FG002|Treatment Continuation Period|Ongoing in Continuation Period|21|||
48848341|NCT05171777|157283559|FG003|Treatment Continuation Period|Ongoing in Continuation Period|79|||
48848342|NCT00879333|157283560|FG000|Overall Study|Adverse Event|94|||
48848343|NCT00879333|157283561|FG001|Overall Study|Adverse Event|34|||
48848344|NCT00879333|157283560|FG000|Overall Study|Abnormal Laboratory Value|1|||
48848345|NCT00879333|157283561|FG001|Overall Study|Abnormal Laboratory Value|0|||
48848346|NCT00879333|157283560|FG000|Overall Study|Withdrawal by Subject|20|||
48848347|NCT00879333|157283561|FG001|Overall Study|Withdrawal by Subject|7|||
48848348|NCT00879333|157283560|FG000|Overall Study|Lost to Follow-up|2|||
48848349|NCT00879333|157283561|FG001|Overall Study|Lost to Follow-up|1|||
48848350|NCT00879333|157283560|FG000|Overall Study|Administrative Problems|2|||
48848351|NCT00879333|157283561|FG001|Overall Study|Administrative Problems|0|||
48848352|NCT00879333|157283560|FG000|Overall Study|Death|16|||
48848353|NCT00879333|157283561|FG001|Overall Study|Death|5|||
48848354|NCT00879333|157283560|FG000|Overall Study|Disease Progression|292|||
48848355|NCT00879333|157283561|FG001|Overall Study|Disease Progression|169|||
48848356|NCT00879333|157283560|FG000|Overall Study|Protocol Violation|1|||
48848357|NCT00879333|157283561|FG001|Overall Study|Protocol Violation|1|||
48848358|NCT00308997|157283564|FG000|Overall Study|Subject feigned clinical data|0|||
48848359|NCT00308997|157283565|FG001|Overall Study|Subject feigned clinical data|1|||
48848360|NCT00308997|157283564|FG000|Overall Study|Unable to tolerate intervention|1|||
48848361|NCT00308997|157283565|FG001|Overall Study|Unable to tolerate intervention|0|||
48848362|NCT02107261|157283568|FG000|Washout: Weakness Back to Baseline|Lost to Follow-up|1|||
48939199|NCT00486902|157607546|FG001|Overall Study|Withdrawal by Subject|2|||
48939200|NCT00486902|157607545|FG000|Overall Study|decision for postpartum tubal ligation|3|||
48939201|NCT00486902|157607546|FG001|Overall Study|decision for postpartum tubal ligation|1|||
48939202|NCT00486902|157607545|FG000|Overall Study|spinal anesthetic protocal violation|1|||
48939203|NCT00486902|157607546|FG001|Overall Study|spinal anesthetic protocal violation|1|||
48939204|NCT00486902|157607545|FG000|Overall Study|Did not meet inclusion criteria|1|||
48939205|NCT00486902|157607546|FG001|Overall Study|Did not meet inclusion criteria|0|||
48939206|NCT00486902|157607545|FG000|Overall Study|No toradol due to hemmorhage or allergy|3|||
48939207|NCT00486902|157607546|FG001|Overall Study|No toradol due to hemmorhage or allergy|1|||
48939208|NCT00541307|157607547|FG000|Overall Study|Death|5|||
48939209|NCT00541307|157607547|FG000|Overall Study|Physician Decision|3|||
48939210|NCT00541307|157607547|FG000|Overall Study|Withdrawal by Subject|6|||
48939211|NCT00541307|157607547|FG000|Overall Study|Lost to Follow-up|4|||
48939212|NCT00541307|157607547|FG000|Overall Study|Subject returned early (outside window)|1|||
48939213|NCT00541307|157607547|FG000|Overall Study|Surgical Bypass|5|||
48939214|NCT01409928|157607548|FG000|Overall Study|Physician Decision|12|||
48939215|NCT00432237|157607549|FG000|Overall Study|Adverse Event|0|||
48939216|NCT00432237|157607550|FG001|Overall Study|Adverse Event|0|||
48939217|NCT00432237|157607551|FG002|Overall Study|Adverse Event|0|||
48939218|NCT00432237|157607552|FG003|Overall Study|Adverse Event|1|||
48939219|NCT00432237|157607549|FG000|Overall Study|Lack of Efficacy|0|||
48939220|NCT00432237|157607550|FG001|Overall Study|Lack of Efficacy|0|||
48939221|NCT00432237|157607551|FG002|Overall Study|Lack of Efficacy|0|||
48939222|NCT00432237|157607552|FG003|Overall Study|Lack of Efficacy|1|||
48939223|NCT00432237|157607549|FG000|Overall Study|Lost to Follow-up|10|||
48939224|NCT00432237|157607550|FG001|Overall Study|Lost to Follow-up|10|||
48939225|NCT00432237|157607551|FG002|Overall Study|Lost to Follow-up|18|||
48939226|NCT00432237|157607552|FG003|Overall Study|Lost to Follow-up|18|||
48939227|NCT00432237|157607549|FG000|Overall Study|Physician Decision|1|||
48939228|NCT00432237|157607550|FG001|Overall Study|Physician Decision|3|||
48939229|NCT00432237|157607551|FG002|Overall Study|Physician Decision|2|||
48939230|NCT00432237|157607552|FG003|Overall Study|Physician Decision|1|||
48939231|NCT00432237|157607549|FG000|Overall Study|Pregnancy|0|||
48848363|NCT02107261|157283569|FG001|Washout: Weakness Back to Baseline|Lost to Follow-up|0|||
48848364|NCT02107261|157283568|FG000|Cycle 2: Week 12-15|Withdrawal by Subject|0|||
48848365|NCT02107261|157283569|FG001|Cycle 2: Week 12-15|Withdrawal by Subject|1|||
48848366|NCT00709098|157283570|FG000|Double-blind Period|Withdrawal of consent|3|||
48848367|NCT00709098|157283571|FG001|Double-blind Period|Withdrawal of consent|3|||
48848368|NCT00709098|157283572|FG002|Double-blind Period|Withdrawal of consent|0|||
48848369|NCT00709098|157283570|FG000|Double-blind Period|Administrative reason|1|||
48848370|NCT00709098|157283571|FG001|Double-blind Period|Administrative reason|3|||
48939232|NCT00432237|157607550|FG001|Overall Study|Pregnancy|1|||
48939233|NCT00432237|157607551|FG002|Overall Study|Pregnancy|0|||
48939234|NCT00432237|157607552|FG003|Overall Study|Pregnancy|0|||
48939235|NCT00432237|157607549|FG000|Overall Study|Protocol Violation|13|||
48939236|NCT00432237|157607550|FG001|Overall Study|Protocol Violation|10|||
48939237|NCT00432237|157607551|FG002|Overall Study|Protocol Violation|11|||
48939238|NCT00432237|157607552|FG003|Overall Study|Protocol Violation|8|||
48939239|NCT00432237|157607549|FG000|Overall Study|Withdrawal by Subject|5|||
48939240|NCT00432237|157607550|FG001|Overall Study|Withdrawal by Subject|6|||
48939241|NCT00432237|157607551|FG002|Overall Study|Withdrawal by Subject|9|||
48939242|NCT00432237|157607552|FG003|Overall Study|Withdrawal by Subject|11|||
48939243|NCT00432237|157607549|FG000|Overall Study|Lack of Qualifying Event|38|||
48939244|NCT00432237|157607550|FG001|Overall Study|Lack of Qualifying Event|71|||
48939245|NCT00432237|157607551|FG002|Overall Study|Lack of Qualifying Event|69|||
48939246|NCT00432237|157607552|FG003|Overall Study|Lack of Qualifying Event|84|||
48939247|NCT00502840|157607556|FG000|Overall Study|Adverse Event|5|||
48939248|NCT00502840|157607556|FG000|Overall Study|Additional or changed therapy|48|||
48848371|NCT00709098|157283572|FG002|Double-blind Period|Administrative reason|0|||
48848372|NCT00709098|157283570|FG000|Double-blind Period|Death|1|||
48848373|NCT00709098|157283571|FG001|Double-blind Period|Death|1|||
48939249|NCT00502840|157607556|FG000|Overall Study|Lack of Efficacy|11|||
48939250|NCT00502840|157607556|FG000|Overall Study|Protocol Violation|4|||
48939251|NCT00502840|157607556|FG000|Overall Study|Withdrawal by Subject|5|||
48939252|NCT00502840|157607556|FG000|Overall Study|Lost to Follow-up|6|||
48939253|NCT00502840|157607556|FG000|Overall Study|Administrative problems|1|||
48939254|NCT00502840|157607556|FG000|Overall Study|Other|20|||
48939255|NCT00461175|157607557|FG000|Overall Study|Protocol Violation|522|||
48939256|NCT00461175|157607558|FG001|Overall Study|Protocol Violation|365|||
48848374|NCT00709098|157283572|FG002|Double-blind Period|Death|0|||
48848375|NCT00709098|157283570|FG000|Double-blind Period|Lost to Follow-up|1|||
48939257|NCT02586805|157607562|FG000|Overall Study|Withdrawal by Subject|3|||
48939258|NCT02586805|157607563|FG001|Overall Study|Withdrawal by Subject|1|||
48939259|NCT02586805|157607564|FG002|Overall Study|Withdrawal by Subject|1|||
48939260|NCT02586805|157607565|FG003|Overall Study|Withdrawal by Subject|2|||
48939261|NCT02586805|157607562|FG000|Overall Study|Adverse Event|2|||
48939262|NCT02586805|157607563|FG001|Overall Study|Adverse Event|0|||
48939263|NCT02586805|157607564|FG002|Overall Study|Adverse Event|1|||
48939264|NCT02586805|157607565|FG003|Overall Study|Adverse Event|0|||
48939265|NCT02586805|157607562|FG000|Overall Study|Lost to Follow-up|0|||
48939266|NCT02586805|157607563|FG001|Overall Study|Lost to Follow-up|0|||
48939267|NCT02586805|157607564|FG002|Overall Study|Lost to Follow-up|1|||
48939268|NCT02586805|157607565|FG003|Overall Study|Lost to Follow-up|0|||
48939269|NCT02586805|157607562|FG000|Overall Study|Physician Decision|1|||
48939270|NCT02586805|157607563|FG001|Overall Study|Physician Decision|0|||
48939271|NCT02586805|157607564|FG002|Overall Study|Physician Decision|0|||
48939272|NCT02586805|157607565|FG003|Overall Study|Physician Decision|0|||
48939273|NCT00699192|157607567|FG000|Overall Study|Missing|1|||
48939274|NCT00699192|157607568|FG001|Overall Study|Missing|1|||
48939275|NCT00699192|157607569|FG002|Overall Study|Missing|1|||
48939276|NCT00699192|157607567|FG000|Overall Study|Adverse Event|9|||
48939277|NCT00699192|157607568|FG001|Overall Study|Adverse Event|4|||
48939278|NCT00699192|157607569|FG002|Overall Study|Adverse Event|3|||
48939279|NCT00699192|157607567|FG000|Overall Study|Abnormal test procedure result(s)|0|||
48939280|NCT00699192|157607568|FG001|Overall Study|Abnormal test procedure result(s)|0|||
48939281|NCT00699192|157607569|FG002|Overall Study|Abnormal test procedure result(s)|1|||
48939282|NCT00699192|157607567|FG000|Overall Study|Lack of Efficacy|0|||
48939283|NCT00699192|157607568|FG001|Overall Study|Lack of Efficacy|0|||
48939284|NCT00699192|157607569|FG002|Overall Study|Lack of Efficacy|1|||
48939285|NCT00699192|157607567|FG000|Overall Study|Withdrawal by Subject|3|||
48939286|NCT00699192|157607568|FG001|Overall Study|Withdrawal by Subject|2|||
48939287|NCT00699192|157607569|FG002|Overall Study|Withdrawal by Subject|4|||
48939288|NCT00699192|157607567|FG000|Overall Study|Administrative problems|1|||
48939289|NCT00699192|157607568|FG001|Overall Study|Administrative problems|3|||
48939290|NCT00699192|157607569|FG002|Overall Study|Administrative problems|1|||
48939291|NCT00699192|157607567|FG000|Overall Study|Protocol Violation|2|||
48939292|NCT00699192|157607568|FG001|Overall Study|Protocol Violation|2|||
48939293|NCT00699192|157607569|FG002|Overall Study|Protocol Violation|0|||
48939294|NCT00891735|157607572|FG000|Overall Study|Adverse Event|2|||
48939295|NCT00891735|157607573|FG001|Overall Study|Adverse Event|0|||
48939296|NCT00891735|157607574|FG002|Overall Study|Adverse Event|2|||
48939297|NCT00891735|157607575|FG003|Overall Study|Adverse Event|0|||
48939298|NCT00891735|157607572|FG000|Overall Study|Death|8|||
48939299|NCT00891735|157607573|FG001|Overall Study|Death|5|||
48939300|NCT00891735|157607574|FG002|Overall Study|Death|4|||
48939301|NCT00891735|157607575|FG003|Overall Study|Death|5|||
48939302|NCT00891735|157607572|FG000|Overall Study|Lost to Follow-up|2|||
48939303|NCT00891735|157607573|FG001|Overall Study|Lost to Follow-up|2|||
48939304|NCT00891735|157607574|FG002|Overall Study|Lost to Follow-up|2|||
48939305|NCT00891735|157607575|FG003|Overall Study|Lost to Follow-up|2|||
48939306|NCT00891735|157607572|FG000|Overall Study|Physician's decision to withdraw patient|1|||
48939307|NCT00891735|157607573|FG001|Overall Study|Physician's decision to withdraw patient|0|||
48939308|NCT00891735|157607574|FG002|Overall Study|Physician's decision to withdraw patient|0|||
48939309|NCT00891735|157607575|FG003|Overall Study|Physician's decision to withdraw patient|0|||
48939310|NCT00891735|157607572|FG000|Overall Study|Patient's decision to withdraw|4|||
48939311|NCT00891735|157607573|FG001|Overall Study|Patient's decision to withdraw|9|||
48939312|NCT00891735|157607574|FG002|Overall Study|Patient's decision to withdraw|4|||
48939313|NCT00891735|157607575|FG003|Overall Study|Patient's decision to withdraw|8|||
48939314|NCT03926143|157607576|FG000|Overall Study|Physician Decision|3|||
48939315|NCT03926143|157607576|FG000|Overall Study|Subject decision: Covid-19 Pandemic related|1|||
48939316|NCT03926143|157607576|FG000|Overall Study|Adverse Event|2|||
48939317|NCT03926143|157607576|FG000|Overall Study|Progressive disease|3|||
48939318|NCT02978222|157607577|FG000|Overall Study|Withdrawal by Subject|2|||
48939319|NCT02978222|157607578|FG001|Overall Study|Withdrawal by Subject|2|||
48939320|NCT02978222|157607577|FG000|Overall Study|Physician Decision|2|||
48939321|NCT02978222|157607578|FG001|Overall Study|Physician Decision|0|||
48939322|NCT02978222|157607577|FG000|Overall Study|Adverse Event|0|||
48939323|NCT02978222|157607578|FG001|Overall Study|Adverse Event|1|||
48939324|NCT02978222|157607577|FG000|Overall Study|Death|1|||
48939325|NCT02978222|157607578|FG001|Overall Study|Death|0|||
48939326|NCT02978222|157607577|FG000|Overall Study|Disease Progression|32|||
48939327|NCT02978222|157607578|FG001|Overall Study|Disease Progression|32|||
48939328|NCT02978222|157607577|FG000|Overall Study|Early Study Termination|24|||
48939329|NCT02978222|157607578|FG001|Overall Study|Early Study Termination|21|||
48939330|NCT01966731|157607579|FG000|Overall Study|Death|2|||
48939331|NCT01966731|157607579|FG000|Overall Study|Lost to Follow-up|1|||
48939332|NCT01966731|157607579|FG000|Overall Study|Physician Decision|2|||
48939333|NCT01966731|157607579|FG000|Overall Study|Follow up is not complete|600|||
48939334|NCT01966731|157607579|FG000|Overall Study|Screening Failure|29|||
48939335|NCT01966731|157607579|FG000|Overall Study|Found to be ineligible|1|||
48939336|NCT02620020|157607582|FG000|Overall Study|Adverse Event|8|||
48939337|NCT02620020|157607583|FG001|Overall Study|Adverse Event|4|||
48939338|NCT02620020|157607584|FG002|Overall Study|Adverse Event|3|||
48939339|NCT02620020|157607585|FG003|Overall Study|Adverse Event|5|||
48939340|NCT02620020|157607582|FG000|Overall Study|Lost to Follow-up|4|||
48939341|NCT02620020|157607583|FG001|Overall Study|Lost to Follow-up|8|||
48939342|NCT02620020|157607584|FG002|Overall Study|Lost to Follow-up|1|||
48939343|NCT02620020|157607585|FG003|Overall Study|Lost to Follow-up|4|||
48939344|NCT02620020|157607582|FG000|Overall Study|Physician Decision|7|||
48939345|NCT02620020|157607583|FG001|Overall Study|Physician Decision|4|||
48939346|NCT02620020|157607584|FG002|Overall Study|Physician Decision|3|||
48939347|NCT02620020|157607585|FG003|Overall Study|Physician Decision|4|||
48939348|NCT02620020|157607582|FG000|Overall Study|Protocol Violation|5|||
48939349|NCT02620020|157607583|FG001|Overall Study|Protocol Violation|2|||
48939350|NCT02620020|157607584|FG002|Overall Study|Protocol Violation|1|||
48939351|NCT02620020|157607585|FG003|Overall Study|Protocol Violation|1|||
48939352|NCT02620020|157607582|FG000|Overall Study|Withdrawal by Subject|20|||
48939353|NCT02620020|157607583|FG001|Overall Study|Withdrawal by Subject|16|||
48939354|NCT02620020|157607584|FG002|Overall Study|Withdrawal by Subject|17|||
48939355|NCT02620020|157607585|FG003|Overall Study|Withdrawal by Subject|12|||
48939356|NCT02620020|157607582|FG000|Overall Study|Death|0|||
48939357|NCT02620020|157607583|FG001|Overall Study|Death|1|||
48939358|NCT02620020|157607584|FG002|Overall Study|Death|0|||
48939359|NCT02620020|157607585|FG003|Overall Study|Death|0|||
48939360|NCT01025635|157607586|FG000|Overall Study|Withdrawal by Subject|6|||
48939361|NCT01025635|157607587|FG001|Overall Study|Withdrawal by Subject|7|||
48939362|NCT01025635|157607586|FG000|Overall Study|Protocol Violation|4|||
48939363|NCT01025635|157607587|FG001|Overall Study|Protocol Violation|2|||
48939364|NCT01025635|157607586|FG000|Overall Study|Lack of Efficacy|0|||
48939365|NCT01025635|157607587|FG001|Overall Study|Lack of Efficacy|1|||
48939366|NCT01025635|157607586|FG000|Overall Study|Lost to Follow-up|9|||
48939367|NCT01025635|157607587|FG001|Overall Study|Lost to Follow-up|13|||
48939368|NCT01025635|157607586|FG000|Overall Study|Reason not known|4|||
48939369|NCT01025635|157607587|FG001|Overall Study|Reason not known|2|||
48939370|NCT01128387|157607588|FG000|Overall Study|Physician Decision|0|||
48939371|NCT01128387|157607589|FG001|Overall Study|Physician Decision|1|||
48939372|NCT04525703|157607590|FG000|Overall Study|Lost to Follow-up|6|||
48939373|NCT04525703|157607591|FG001|Overall Study|Lost to Follow-up|15|||
48939374|NCT04525703|157607592|FG002|Overall Study|Lost to Follow-up|8|||
48939375|NCT02909153|157607593|FG000|Overall Study|Withdrawal by Subject|0|||
48939376|NCT02909153|157607594|FG001|Overall Study|Withdrawal by Subject|1|||
48939377|NCT02909153|157607595|FG002|Overall Study|Withdrawal by Subject|0|||
48939378|NCT02909153|157607596|FG003|Overall Study|Withdrawal by Subject|0|||
48939379|NCT02909153|157607597|FG004|Overall Study|Withdrawal by Subject|0|||
48939380|NCT01499290|157607598|FG000|Overall Study|Withdrawal by Subject|22|||
48939381|NCT01499290|157607599|FG001|Overall Study|Withdrawal by Subject|15|||
48939382|NCT01499290|157607598|FG000|Overall Study|Not specified in study report|11|||
48939383|NCT01499290|157607599|FG001|Overall Study|Not specified in study report|5|||
48939384|NCT01499290|157607598|FG000|Overall Study|Condition improved/subject recovered|1|||
48939385|NCT01499290|157607599|FG001|Overall Study|Condition improved/subject recovered|0|||
48939386|NCT01499290|157607598|FG000|Overall Study|Lack of Efficacy|7|||
48939387|NCT01499290|157607599|FG001|Overall Study|Lack of Efficacy|8|||
48939388|NCT01499290|157607598|FG000|Overall Study|Adverse Event|14|||
48939389|NCT01499290|157607599|FG001|Overall Study|Adverse Event|7|||
48939390|NCT04052139|157607600|FG000|Overall Study|Lost to Follow-up|2|||
48939391|NCT04052139|157607601|FG001|Overall Study|Lost to Follow-up|0|||
48939392|NCT04052139|157607602|FG002|Overall Study|Lost to Follow-up|0|||
48939393|NCT04052139|157607600|FG000|Overall Study|Withdrawal by Subject|1|||
48939394|NCT04052139|157607601|FG001|Overall Study|Withdrawal by Subject|0|||
48939395|NCT04052139|157607602|FG002|Overall Study|Withdrawal by Subject|0|||
48939396|NCT00190775|157607604|FG000|Overall Study|Adverse Event|57|||
48939397|NCT00190775|157607605|FG001|Overall Study|Adverse Event|22|||
48939398|NCT00190775|157607604|FG000|Overall Study|Satisfactory Response|1|||
48939399|NCT00190775|157607605|FG001|Overall Study|Satisfactory Response|0|||
48939400|NCT00190775|157607604|FG000|Overall Study|Lack of Efficacy|28|||
48939401|NCT00190775|157607605|FG001|Overall Study|Lack of Efficacy|32|||
48939402|NCT00190775|157607604|FG000|Overall Study|Lost to Follow-up|31|||
48939403|NCT00190775|157607605|FG001|Overall Study|Lost to Follow-up|23|||
48939404|NCT00190775|157607604|FG000|Overall Study|Participant Moved|0|||
48939405|NCT00190775|157607605|FG001|Overall Study|Participant Moved|1|||
48939406|NCT00190775|157607604|FG000|Overall Study|Withdrawal by Subject|24|||
48939407|NCT00190775|157607605|FG001|Overall Study|Withdrawal by Subject|13|||
48939408|NCT00190775|157607604|FG000|Overall Study|Sponsor Decision|1|||
48939409|NCT00190775|157607605|FG001|Overall Study|Sponsor Decision|0|||
48848376|NCT00709098|157283571|FG001|Double-blind Period|Lost to Follow-up|1|||
48848377|NCT00709098|157283572|FG002|Double-blind Period|Lost to Follow-up|0|||
48848378|NCT00709098|157283570|FG000|Open-label Period|Withdrawal of consent|0|||
48848379|NCT00709098|157283571|FG001|Open-label Period|Withdrawal of consent|0|||
48848380|NCT00709098|157283572|FG002|Open-label Period|Withdrawal of consent|7|||
48848381|NCT00709098|157283570|FG000|Open-label Period|Administrative reason|0|||
48848382|NCT00709098|157283571|FG001|Open-label Period|Administrative reason|0|||
48848383|NCT00709098|157283572|FG002|Open-label Period|Administrative reason|5|||
48848384|NCT00709098|157283570|FG000|Open-label Period|Death|0|||
48848385|NCT00709098|157283571|FG001|Open-label Period|Death|0|||
48848386|NCT00709098|157283572|FG002|Open-label Period|Death|1|||
48848387|NCT00709098|157283570|FG000|Open-label Period|Lost to Follow-up|0|||
48848388|NCT00709098|157283571|FG001|Open-label Period|Lost to Follow-up|0|||
48848389|NCT00709098|157283572|FG002|Open-label Period|Lost to Follow-up|1|||
48848390|NCT02269475|157283574|FG000|Overall Study|Meet Exclusion Criteria No. 17|3|||
48848391|NCT02269475|157283575|FG001|Overall Study|Meet Exclusion Criteria No. 17|0|||
48848392|NCT02269475|157283574|FG000|Overall Study|Withdrawal by Subject|0|||
48848393|NCT02269475|157283575|FG001|Overall Study|Withdrawal by Subject|1|||
48848394|NCT02910713|157283576|FG000|Overall Study|Protocol Violation|2|||
48848395|NCT02910713|157283576|FG000|Overall Study|Subject Choice|4|||
48848396|NCT02910713|157283576|FG000|Overall Study|Received One Application|10|||
48848397|NCT02910713|157283576|FG000|Overall Study|Received Neither Application|18|||
48848398|NCT02910713|157283576|FG000|Overall Study|Enrollment cap|7|||
48848399|NCT02910713|157283576|FG000|Overall Study|Investigator Discretion|1|||
48848400|NCT01701401|157283577|FG000|Overall Study|Randomized But Not Treated|3|||
48848401|NCT01701401|157283578|FG001|Overall Study|Randomized But Not Treated|1|||
48848402|NCT01701401|157283579|FG002|Overall Study|Randomized But Not Treated|0|||
48848403|NCT01701401|157283580|FG003|Overall Study|Randomized But Not Treated|1|||
48848404|NCT01701401|157283577|FG000|Overall Study|Lost to Follow-up|5|||
48848405|NCT01701401|157283578|FG001|Overall Study|Lost to Follow-up|5|||
48848406|NCT01701401|157283579|FG002|Overall Study|Lost to Follow-up|1|||
48848407|NCT01701401|157283580|FG003|Overall Study|Lost to Follow-up|3|||
48848408|NCT01701401|157283577|FG000|Overall Study|Withdrew Consent|0|||
48848409|NCT01701401|157283578|FG001|Overall Study|Withdrew Consent|3|||
48848410|NCT01701401|157283579|FG002|Overall Study|Withdrew Consent|1|||
48848411|NCT01701401|157283580|FG003|Overall Study|Withdrew Consent|2|||
48848412|NCT01701401|157283577|FG000|Overall Study|Lack of Efficacy|1|||
48848413|NCT01701401|157283578|FG001|Overall Study|Lack of Efficacy|0|||
48848414|NCT01701401|157283579|FG002|Overall Study|Lack of Efficacy|2|||
48848415|NCT01701401|157283580|FG003|Overall Study|Lack of Efficacy|0|||
48848416|NCT01701401|157283577|FG000|Overall Study|Adverse Event|1|||
48939410|NCT00190775|157607604|FG000|Overall Study|Physician Decision|3|||
48848417|NCT01701401|157283578|FG001|Overall Study|Adverse Event|0|||
48848418|NCT01701401|157283579|FG002|Overall Study|Adverse Event|0|||
48848419|NCT01701401|157283580|FG003|Overall Study|Adverse Event|0|||
48939411|NCT00190775|157607605|FG001|Overall Study|Physician Decision|0|||
48939412|NCT00190775|157607604|FG000|Overall Study|Noncompliance|3|||
48939413|NCT00190775|157607605|FG001|Overall Study|Noncompliance|5|||
48939414|NCT00190775|157607604|FG000|Overall Study|Protocol Violation|0|||
48939415|NCT00190775|157607605|FG001|Overall Study|Protocol Violation|1|||
48939416|NCT00190775|157607604|FG000|Overall Study|Exclusion Criteria Met|1|||
48939417|NCT00190775|157607605|FG001|Overall Study|Exclusion Criteria Met|3|||
48939418|NCT01526148|157607606|FG000|Overall Study|Adverse Event|6|||
48939419|NCT01526148|157607607|FG001|Overall Study|Adverse Event|5|||
48939420|NCT01526148|157607606|FG000|Overall Study|Lost to Follow-up|3|||
48939421|NCT01526148|157607607|FG001|Overall Study|Lost to Follow-up|6|||
48939422|NCT01526148|157607606|FG000|Overall Study|Withdrawal by Subject|2|||
48939423|NCT01526148|157607607|FG001|Overall Study|Withdrawal by Subject|0|||
48939424|NCT01526148|157607606|FG000|Overall Study|Unstable Medical Condition|1|||
48939425|NCT01526148|157607607|FG001|Overall Study|Unstable Medical Condition|0|||
48939426|NCT01526148|157607606|FG000|Overall Study|Unable to discontinue concomitant med|1|||
48939427|NCT01526148|157607607|FG001|Overall Study|Unable to discontinue concomitant med|0|||
48939428|NCT01526148|157607606|FG000|Overall Study|Moved out of state|1|||
48939429|NCT01526148|157607607|FG001|Overall Study|Moved out of state|0|||
48939430|NCT01526148|157607606|FG000|Overall Study|Incarcerated|0|||
48939431|NCT01526148|157607607|FG001|Overall Study|Incarcerated|2|||
48939432|NCT00927485|157607608|FG000|Overall Study|Adverse Event|4|||
48939433|NCT00927485|157607609|FG001|Overall Study|Adverse Event|2|||
48939434|NCT00927485|157607608|FG000|Overall Study|noncompliance, prophylactic surgery, inc|2|||
48939435|NCT00927485|157607609|FG001|Overall Study|noncompliance, prophylactic surgery, inc|2|||
48939436|NCT04003610|157607610|FG000|Overall Study|Lost to Follow-up|0|||
48939437|NCT04003610|157607611|FG001|Overall Study|Lost to Follow-up|1|||
48939438|NCT04003610|157607612|FG002|Overall Study|Lost to Follow-up|0|||
48939439|NCT04003610|157607610|FG000|Overall Study|Death|0|||
48939440|NCT04003610|157607611|FG001|Overall Study|Death|0|||
48939441|NCT04003610|157607612|FG002|Overall Study|Death|3|||
48939442|NCT04003610|157607610|FG000|Overall Study|Study Terminated by Sponsor|0|||
48939443|NCT04003610|157607611|FG001|Overall Study|Study Terminated by Sponsor|0|||
48939444|NCT04003610|157607612|FG002|Overall Study|Study Terminated by Sponsor|3|||
48939445|NCT01309737|157607613|FG000|Week 0 to 16|Death|1|||
48939446|NCT01309737|157607614|FG001|Week 0 to 16|Death|0|||
48939447|NCT01309737|157607615|FG002|Week 0 to 16|Death|1|||
48939448|NCT01309737|157607616|FG003|Week 0 to 16|Death|0|||
48939449|NCT01309737|157607617|FG004|Week 0 to 16|Death|0|||
48939450|NCT01309737|157607613|FG000|Week 0 to 16|Adverse Event|11|||
48939451|NCT01309737|157607614|FG001|Week 0 to 16|Adverse Event|10|||
48939452|NCT01309737|157607615|FG002|Week 0 to 16|Adverse Event|5|||
48939453|NCT01309737|157607616|FG003|Week 0 to 16|Adverse Event|0|||
48939454|NCT01309737|157607617|FG004|Week 0 to 16|Adverse Event|0|||
48939455|NCT01309737|157607613|FG000|Week 0 to 16|Lack of Efficacy|15|||
48939456|NCT01309737|157607614|FG001|Week 0 to 16|Lack of Efficacy|2|||
48939457|NCT01309737|157607615|FG002|Week 0 to 16|Lack of Efficacy|24|||
48939458|NCT01309737|157607616|FG003|Week 0 to 16|Lack of Efficacy|0|||
48939459|NCT01309737|157607617|FG004|Week 0 to 16|Lack of Efficacy|0|||
48939460|NCT01309737|157607613|FG000|Week 0 to 16|Lost to Follow-up|7|||
48939461|NCT01309737|157607614|FG001|Week 0 to 16|Lost to Follow-up|8|||
48939462|NCT01309737|157607615|FG002|Week 0 to 16|Lost to Follow-up|3|||
48939463|NCT01309737|157607616|FG003|Week 0 to 16|Lost to Follow-up|0|||
48939464|NCT01309737|157607617|FG004|Week 0 to 16|Lost to Follow-up|0|||
48939465|NCT01309737|157607613|FG000|Week 0 to 16|Withdrawal by Subject|7|||
48939466|NCT01309737|157607614|FG001|Week 0 to 16|Withdrawal by Subject|6|||
48939467|NCT01309737|157607615|FG002|Week 0 to 16|Withdrawal by Subject|7|||
48939468|NCT01309737|157607616|FG003|Week 0 to 16|Withdrawal by Subject|0|||
48939469|NCT01309737|157607617|FG004|Week 0 to 16|Withdrawal by Subject|0|||
48939470|NCT01309737|157607613|FG000|Week 0 to 16|Other|10|||
48939471|NCT01309737|157607614|FG001|Week 0 to 16|Other|14|||
48939472|NCT01309737|157607615|FG002|Week 0 to 16|Other|4|||
48939473|NCT01309737|157607616|FG003|Week 0 to 16|Other|0|||
48939474|NCT01309737|157607617|FG004|Week 0 to 16|Other|0|||
48939475|NCT01309737|157607613|FG000|Week 0 to 16|Randomized, but not treated|1|||
48939476|NCT01309737|157607614|FG001|Week 0 to 16|Randomized, but not treated|0|||
48939477|NCT01309737|157607615|FG002|Week 0 to 16|Randomized, but not treated|0|||
48939478|NCT01309737|157607616|FG003|Week 0 to 16|Randomized, but not treated|0|||
48939479|NCT01309737|157607617|FG004|Week 0 to 16|Randomized, but not treated|0|||
48939480|NCT01309737|157607613|FG000|Week 16 to 52|Death|0|||
48939481|NCT01309737|157607614|FG001|Week 16 to 52|Death|0|||
48939482|NCT01309737|157607615|FG002|Week 16 to 52|Death|0|||
48939483|NCT01309737|157607616|FG003|Week 16 to 52|Death|0|||
48939484|NCT01309737|157607617|FG004|Week 16 to 52|Death|1|||
48939485|NCT01309737|157607613|FG000|Week 16 to 52|Adverse Event|7|||
48939486|NCT01309737|157607614|FG001|Week 16 to 52|Adverse Event|7|||
48939487|NCT01309737|157607615|FG002|Week 16 to 52|Adverse Event|0|||
48939488|NCT01309737|157607616|FG003|Week 16 to 52|Adverse Event|6|||
48939489|NCT01309737|157607617|FG004|Week 16 to 52|Adverse Event|5|||
48939490|NCT01309737|157607613|FG000|Week 16 to 52|Lack of Efficacy|107|||
48939491|NCT01309737|157607614|FG001|Week 16 to 52|Lack of Efficacy|76|||
48939492|NCT01309737|157607615|FG002|Week 16 to 52|Lack of Efficacy|0|||
48939493|NCT01309737|157607616|FG003|Week 16 to 52|Lack of Efficacy|25|||
48939494|NCT01309737|157607617|FG004|Week 16 to 52|Lack of Efficacy|21|||
48939495|NCT01309737|157607613|FG000|Week 16 to 52|Lost to Follow-up|4|||
48939496|NCT01309737|157607614|FG001|Week 16 to 52|Lost to Follow-up|2|||
48939497|NCT01309737|157607615|FG002|Week 16 to 52|Lost to Follow-up|0|||
48939498|NCT01309737|157607616|FG003|Week 16 to 52|Lost to Follow-up|1|||
48939499|NCT01309737|157607617|FG004|Week 16 to 52|Lost to Follow-up|4|||
48939500|NCT01309737|157607613|FG000|Week 16 to 52|Withdrawal by Subject|5|||
48939501|NCT01309737|157607614|FG001|Week 16 to 52|Withdrawal by Subject|6|||
48939502|NCT01309737|157607615|FG002|Week 16 to 52|Withdrawal by Subject|0|||
48939503|NCT01309737|157607616|FG003|Week 16 to 52|Withdrawal by Subject|0|||
48939504|NCT01309737|157607617|FG004|Week 16 to 52|Withdrawal by Subject|2|||
48939505|NCT01309737|157607613|FG000|Week 16 to 52|Other|10|||
48939506|NCT01309737|157607614|FG001|Week 16 to 52|Other|12|||
48939507|NCT01309737|157607615|FG002|Week 16 to 52|Other|0|||
48939508|NCT01309737|157607616|FG003|Week 16 to 52|Other|2|||
48939509|NCT01309737|157607617|FG004|Week 16 to 52|Other|0|||
48939510|NCT00666562|157607632|FG000|Overall Study|Withdrawal by Subject|0|||
48939511|NCT00666562|157607633|FG001|Overall Study|Withdrawal by Subject|1|||
48939512|NCT00666562|157607634|FG002|Overall Study|Withdrawal by Subject|0|||
48939513|NCT00666562|157607632|FG000|Overall Study|Concomitant Medication|0|||
48939514|NCT00666562|157607633|FG001|Overall Study|Concomitant Medication|1|||
48939515|NCT00666562|157607634|FG002|Overall Study|Concomitant Medication|0|||
48939516|NCT01662999|157607636|FG000|Period 3|Withdrawal by Subject|0|||
48939517|NCT01662999|157607637|FG001|Period 3|Withdrawal by Subject|1|||
48939518|NCT01662999|157607638|FG002|Period 3|Withdrawal by Subject|0|||
48939519|NCT01662999|157607639|FG003|Period 3|Withdrawal by Subject|0|||
48939520|NCT01662999|157607640|FG004|Period 3|Withdrawal by Subject|0|||
48939521|NCT01662999|157607641|FG005|Period 3|Withdrawal by Subject|0|||
48939522|NCT01587989|157607644|FG000|12-Week Open-Label Run-In Period|Physician Decision|7|||
48939523|NCT01587989|157607645|FG001|12-Week Open-Label Run-In Period|Physician Decision|0|||
48939524|NCT01587989|157607646|FG002|12-Week Open-Label Run-In Period|Physician Decision|0|||
48939525|NCT01587989|157607644|FG000|12-Week Open-Label Run-In Period|Withdrawal by Subject|1|||
48939526|NCT01587989|157607645|FG001|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
48939527|NCT01587989|157607646|FG002|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
48939528|NCT01587989|157607644|FG000|12-Week Open-Label Run-In Period|No EULAR Response|4|||
48939529|NCT01587989|157607645|FG001|12-Week Open-Label Run-In Period|No EULAR Response|0|||
48939530|NCT01587989|157607646|FG002|12-Week Open-Label Run-In Period|No EULAR Response|0|||
48939531|NCT01587989|157607644|FG000|Randomized Study Treatment|Withdrawal by Subject|0|||
48939532|NCT01587989|157607645|FG001|Randomized Study Treatment|Withdrawal by Subject|1|||
48939533|NCT01587989|157607646|FG002|Randomized Study Treatment|Withdrawal by Subject|0|||
48939534|NCT01587989|157607644|FG000|Randomized Study Treatment|Screening failure|0|||
48939535|NCT01587989|157607645|FG001|Randomized Study Treatment|Screening failure|1|||
48939536|NCT01587989|157607646|FG002|Randomized Study Treatment|Screening failure|0|||
48939537|NCT01587989|157607644|FG000|Randomized Study Treatment|Physician Decision|0|||
48848420|NCT01701401|157283577|FG000|Overall Study|Protocol Violation|0|||
48939538|NCT01587989|157607645|FG001|Randomized Study Treatment|Physician Decision|0|||
48939539|NCT01587989|157607646|FG002|Randomized Study Treatment|Physician Decision|1|||
48939540|NCT03542682|157607649|FG000|Overall Study|COVID-19 Protocol|0|||
48939541|NCT03542682|157607650|FG001|Overall Study|COVID-19 Protocol|1|||
48939542|NCT04321343|157607651|FG000|Overall Study|Adverse Event|0|||
48939543|NCT04321343|157607652|FG001|Overall Study|Adverse Event|0|||
48939544|NCT04321343|157607653|FG002|Overall Study|Adverse Event|1|||
48939545|NCT04321343|157607654|FG003|Overall Study|Adverse Event|0|||
48939546|NCT04321343|157607651|FG000|Overall Study|Death|0|||
48939547|NCT04321343|157607652|FG001|Overall Study|Death|0|||
48939548|NCT04321343|157607653|FG002|Overall Study|Death|0|||
48939549|NCT04321343|157607654|FG003|Overall Study|Death|1|||
48939550|NCT04321343|157607651|FG000|Overall Study|Pregnancy|1|||
48939551|NCT04321343|157607652|FG001|Overall Study|Pregnancy|0|||
48939552|NCT04321343|157607653|FG002|Overall Study|Pregnancy|0|||
48939553|NCT04321343|157607654|FG003|Overall Study|Pregnancy|0|||
48939554|NCT04321343|157607651|FG000|Overall Study|Protocol Violation|1|||
48939555|NCT04321343|157607652|FG001|Overall Study|Protocol Violation|1|||
48939556|NCT04321343|157607653|FG002|Overall Study|Protocol Violation|1|||
48939557|NCT04321343|157607654|FG003|Overall Study|Protocol Violation|1|||
48939558|NCT04321343|157607651|FG000|Overall Study|Withdrawal by Subject|0|||
48939559|NCT04321343|157607652|FG001|Overall Study|Withdrawal by Subject|6|||
48848421|NCT01701401|157283578|FG001|Overall Study|Protocol Violation|0|||
48848422|NCT01701401|157283579|FG002|Overall Study|Protocol Violation|1|||
48848423|NCT01701401|157283580|FG003|Overall Study|Protocol Violation|0|||
48939560|NCT04321343|157607653|FG002|Overall Study|Withdrawal by Subject|0|||
48848424|NCT00309166|157283583|FG000|Overall Study|Adverse event, non-fatal|1|||
48848425|NCT00309166|157283584|FG001|Overall Study|Adverse event, non-fatal|0|||
48848426|NCT00309166|157283583|FG000|Overall Study|Withdrawal by Subject|4|||
48848427|NCT00309166|157283584|FG001|Overall Study|Withdrawal by Subject|3|||
48848428|NCT00701701|157283587|FG000|Overall Study|Withdrawal by Subject|0|||
48848429|NCT00701701|157283588|FG001|Overall Study|Withdrawal by Subject|1|||
48848430|NCT00701701|157283587|FG000|Overall Study|Adverse Event|0|||
48848431|NCT00701701|157283588|FG001|Overall Study|Adverse Event|1|||
48848432|NCT01079949|157283589|FG000|Overall Study|Withdrawal before r-hCG administration|2|||
48848433|NCT01079949|157283590|FG001|Overall Study|Withdrawal before r-hCG administration|3|||
48848434|NCT01079949|157283589|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4|||
48848435|NCT01079949|157283590|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8|||
48848436|NCT01079949|157283589|FG000|Overall Study|Withdrawal between OPU - embryo transfer|8|||
48939561|NCT04321343|157607654|FG003|Overall Study|Withdrawal by Subject|2|||
48939562|NCT04321343|157607651|FG000|Overall Study|Lost to Follow-up|2|||
48939563|NCT04321343|157607652|FG001|Overall Study|Lost to Follow-up|2|||
48939564|NCT04321343|157607653|FG002|Overall Study|Lost to Follow-up|1|||
48939565|NCT04321343|157607654|FG003|Overall Study|Lost to Follow-up|3|||
48939566|NCT04725682|157607657|FG000|Overall Study|Withdrawal by Subject|7|||
48939567|NCT04725682|157607658|FG001|Overall Study|Withdrawal by Subject|5|||
48939568|NCT04725682|157607657|FG000|Overall Study|Failed to comply with the requirements|2|||
48939569|NCT04725682|157607658|FG001|Overall Study|Failed to comply with the requirements|1|||
48848437|NCT01079949|157283590|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
48848438|NCT01079949|157283589|FG000|Overall Study|Randomized but not treated|1|||
48848439|NCT01079949|157283590|FG001|Overall Study|Randomized but not treated|0|||
48848440|NCT03221426|157283596|FG000|Overall Study|Ongoing in study|212|||
48848441|NCT03221426|157283597|FG001|Overall Study|Ongoing in study|193|||
48848442|NCT03221426|157283598|FG002|Overall Study|Ongoing in study|61|||
48848443|NCT03221426|157283599|FG003|Overall Study|Ongoing in study|55|||
48848444|NCT03221426|157283596|FG000|Overall Study|Withdrawal by Subject|12|||
48848445|NCT03221426|157283597|FG001|Overall Study|Withdrawal by Subject|4|||
48848446|NCT03221426|157283598|FG002|Overall Study|Withdrawal by Subject|2|||
48848447|NCT03221426|157283599|FG003|Overall Study|Withdrawal by Subject|3|||
48848448|NCT03221426|157283596|FG000|Overall Study|Lost to Follow-up|4|||
48848449|NCT03221426|157283597|FG001|Overall Study|Lost to Follow-up|1|||
48848450|NCT03221426|157283598|FG002|Overall Study|Lost to Follow-up|1|||
48848451|NCT03221426|157283599|FG003|Overall Study|Lost to Follow-up|0|||
48848452|NCT03221426|157283596|FG000|Overall Study|Death|174|||
48848453|NCT03221426|157283597|FG001|Overall Study|Death|204|||
48848454|NCT03221426|157283598|FG002|Overall Study|Death|36|||
48848455|NCT03221426|157283599|FG003|Overall Study|Death|45|||
48848456|NCT06571695|157284857|FG000|Overall Study|Lost to Follow-up|1|||
48848457|NCT06571695|157284858|FG001|Overall Study|Lost to Follow-up|6|||
48848458|NCT01639131|157284869|FG000|Overall Study|Disease Progression|6|||
48848459|NCT00495677|157284870|FG000|Stage 1 (25 Days)|Adverse Event|0|||
48848460|NCT00495677|157284871|FG001|Stage 1 (25 Days)|Adverse Event|0|||
48848461|NCT00495677|157284872|FG002|Stage 1 (25 Days)|Adverse Event|1|||
48848462|NCT00495677|157284873|FG003|Stage 1 (25 Days)|Adverse Event|0|||
48848463|NCT00495677|157284874|FG004|Stage 1 (25 Days)|Adverse Event|0|||
48848464|NCT00495677|157284875|FG005|Stage 1 (25 Days)|Adverse Event|0|||
48848465|NCT00495677|157284876|FG006|Stage 1 (25 Days)|Adverse Event|0|||
48848466|NCT00372775|157284882|FG000|Overall Study|Adverse Event|8|||
48848467|NCT00372775|157284882|FG000|Overall Study|Death|15|||
48848468|NCT00372775|157284882|FG000|Overall Study|Objective progression or relapse|30|||
48848469|NCT00372775|157284882|FG000|Overall Study|Global deterioration of health status|6|||
48848470|NCT00372775|157284882|FG000|Overall Study|Withdrawal by Subject|1|||
48848471|NCT00372775|157284882|FG000|Overall Study|Other|1|||
48848472|NCT00372775|157284882|FG000|Overall Study|Not Treated|2|||
48848473|NCT00246805|157284884|FG000|Phase 1|Lost to Follow-up|1|||
48848474|NCT00246805|157284885|FG001|Phase 1|Lost to Follow-up|0|||
48848475|NCT02463448|157284888|FG000|Enrollment Through 6 Months|Withdrawal by Subject|3|||
48848476|NCT02463448|157284888|FG000|6 Months Through 12 Months|Lost to Follow-up|1|||
48848477|NCT02463448|157284888|FG000|6 Months Through 12 Months|Withdrawal by Subject|1|||
48848478|NCT02463448|157284888|FG000|12 Months Through End of Study|Lost to Follow-up|1|||
48848479|NCT00571649|157284889|FG000|Treatment Period|Adverse Event|438|||
48939570|NCT04725682|157607657|FG000|Overall Study|Adverse Event|1|||
48939571|NCT04725682|157607658|FG001|Overall Study|Adverse Event|1|||
48939572|NCT04725682|157607657|FG000|Overall Study|Death|0|||
48939573|NCT04725682|157607658|FG001|Overall Study|Death|1|||
48939574|NCT00998738|157607661|FG000|Overall Study|Uknown|1|||
48939575|NCT03851510|157607663|FG000|Overall Study|Screen Fail|1|||
48939576|NCT03851510|157607663|FG000|Overall Study|Adverse Event|1|||
48939577|NCT03851510|157607663|FG000|Overall Study|Withdrawal by Subject|1|||
48939578|NCT01331161|157607664|FG000|Overall Study|Physician Decision|1|||
48939579|NCT01331161|157607665|FG001|Overall Study|Physician Decision|0|||
48939580|NCT01331161|157607664|FG000|Overall Study|Lost to Follow-up|0|||
48939581|NCT01331161|157607665|FG001|Overall Study|Lost to Follow-up|1|||
48939582|NCT01331161|157607664|FG000|Overall Study|Pregnancy|0|||
48939583|NCT01331161|157607665|FG001|Overall Study|Pregnancy|1|||
48939584|NCT00785577|157607666|FG000|Study Period 2: Therapy Phase|Adverse Event|5|||
48939585|NCT00785577|157607667|FG001|Study Period 2: Therapy Phase|Adverse Event|7|||
48939586|NCT00785577|157607668|FG002|Study Period 2: Therapy Phase|Adverse Event|14|||
48939587|NCT00785577|157607669|FG003|Study Period 2: Therapy Phase|Adverse Event|10|||
48939588|NCT00785577|157607670|FG004|Study Period 2: Therapy Phase|Adverse Event|17|||
48939589|NCT00785577|157607666|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
48939590|NCT00785577|157607667|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
48939591|NCT00785577|157607668|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
48939592|NCT00785577|157607669|FG003|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
48939593|NCT00785577|157607670|FG004|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
48939594|NCT00785577|157607666|FG000|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
48939595|NCT00785577|157607667|FG001|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
48939596|NCT00785577|157607668|FG002|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
48939597|NCT00785577|157607669|FG003|Study Period 2: Therapy Phase|Lost to Follow-up|1|||
48939598|NCT00785577|157607670|FG004|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
48939599|NCT00785577|157607666|FG000|Study Period 2: Therapy Phase|Physician Decision|1|||
48939600|NCT00785577|157607667|FG001|Study Period 2: Therapy Phase|Physician Decision|0|||
48939601|NCT00785577|157607668|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
48939602|NCT00785577|157607669|FG003|Study Period 2: Therapy Phase|Physician Decision|0|||
48939603|NCT00785577|157607670|FG004|Study Period 2: Therapy Phase|Physician Decision|0|||
48939604|NCT00785577|157607666|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
48939605|NCT00785577|157607667|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
48939606|NCT00785577|157607668|FG002|Study Period 2: Therapy Phase|Protocol Violation|1|||
48939607|NCT00785577|157607669|FG003|Study Period 2: Therapy Phase|Protocol Violation|0|||
48939608|NCT00785577|157607670|FG004|Study Period 2: Therapy Phase|Protocol Violation|1|||
48939609|NCT00785577|157607666|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
48939610|NCT00785577|157607667|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
48939611|NCT00785577|157607668|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
48939612|NCT00785577|157607669|FG003|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
48939613|NCT00785577|157607670|FG004|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
48939614|NCT00785577|157607666|FG000|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
48939615|NCT00785577|157607667|FG001|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
48939616|NCT00785577|157607668|FG002|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
48939617|NCT00785577|157607669|FG003|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
48939618|NCT00785577|157607670|FG004|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
48939619|NCT00785577|157607666|FG000|Study Period 2: Therapy Phase|Sponsor Decision|1|||
48939620|NCT00785577|157607667|FG001|Study Period 2: Therapy Phase|Sponsor Decision|0|||
48939621|NCT00785577|157607668|FG002|Study Period 2: Therapy Phase|Sponsor Decision|1|||
48939622|NCT00785577|157607669|FG003|Study Period 2: Therapy Phase|Sponsor Decision|1|||
48939623|NCT00785577|157607670|FG004|Study Period 2: Therapy Phase|Sponsor Decision|0|||
48939624|NCT00785577|157607666|FG000|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
48939625|NCT00785577|157607667|FG001|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
48939626|NCT00785577|157607668|FG002|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
48939627|NCT00785577|157607669|FG003|Study Period 3: 1-Week Washout Phase|Adverse Event|1|||
48939628|NCT00785577|157607670|FG004|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
48939629|NCT00785577|157607666|FG000|Study Period 3: 1-Week Washout Phase|Death|0|||
48939630|NCT00785577|157607667|FG001|Study Period 3: 1-Week Washout Phase|Death|0|||
48939631|NCT00785577|157607668|FG002|Study Period 3: 1-Week Washout Phase|Death|0|||
48939632|NCT00785577|157607669|FG003|Study Period 3: 1-Week Washout Phase|Death|0|||
48939633|NCT00785577|157607670|FG004|Study Period 3: 1-Week Washout Phase|Death|1|||
48939634|NCT01682044|157607674|FG000|Overall Study|Death|1|||
48939635|NCT01682044|157607674|FG000|Overall Study|Progression|3|||
48939636|NCT03277196|157607675|FG000|Overall Study|Commercial Drug is Available for Participants|20|||
48939637|NCT03277196|157607675|FG000|Overall Study|Lost to Follow-up|3|||
48939638|NCT03277196|157607675|FG000|Overall Study|Withdrawal of Consent (not due to AE)|3|||
48939639|NCT03277196|157607675|FG000|Overall Study|Other|2|||
48939640|NCT00960076|157609460|FG000|Overall Study|Adverse Event|1|||
48939641|NCT00960076|157609461|FG001|Overall Study|Adverse Event|7|||
48939642|NCT00960076|157609460|FG000|Overall Study|No longer met study criteria|1|||
48939643|NCT00960076|157609461|FG001|Overall Study|No longer met study criteria|5|||
48939644|NCT00960076|157609460|FG000|Overall Study|Withdrawal by Subject|1|||
48939645|NCT00960076|157609461|FG001|Overall Study|Withdrawal by Subject|2|||
48939646|NCT00960076|157609460|FG000|Overall Study|Lost to Follow-up|3|||
48939647|NCT00960076|157609461|FG001|Overall Study|Lost to Follow-up|3|||
48939648|NCT00960076|157609460|FG000|Overall Study|Severe non-compliance to protocol|1|||
48939649|NCT00960076|157609461|FG001|Overall Study|Severe non-compliance to protocol|2|||
48939650|NCT00960076|157609460|FG000|Overall Study|Hyperglycemia|1|||
48939651|NCT00960076|157609461|FG001|Overall Study|Hyperglycemia|5|||
48939652|NCT00960076|157609460|FG000|Overall Study|Did not attend the termination visit|0|||
48939653|NCT00960076|157609461|FG001|Overall Study|Did not attend the termination visit|1|||
48939654|NCT00500266|157609462|FG000|Overall Study|Death|3|||
48939655|NCT00500266|157609462|FG000|Overall Study|Lost to Follow-up|3|||
48939656|NCT00500266|157609462|FG000|Overall Study|Withdrawal by Subject|3|||
48939657|NCT00500266|157609462|FG000|Overall Study|Assigned, not treated|4|||
48939658|NCT04025632|157609463|FG000|Overall Study|Adverse Event|1|||
48939659|NCT04025632|157609464|FG001|Overall Study|Adverse Event|1|||
48939660|NCT04025632|157609463|FG000|Overall Study|Withdrawal by Subject|1|||
48939661|NCT04025632|157609464|FG001|Overall Study|Withdrawal by Subject|1|||
48939662|NCT04025632|157609463|FG000|Overall Study|Study Terminated by Sponsor|10|||
48939663|NCT04025632|157609464|FG001|Overall Study|Study Terminated by Sponsor|9|||
48939664|NCT04025632|157609463|FG000|Overall Study|Physician Decision|3|||
48939665|NCT04025632|157609464|FG001|Overall Study|Physician Decision|1|||
48939666|NCT00376961|157609465|FG000|Initial Registration|Adverse Event|1|||
48939667|NCT00376961|157609466|FG001|Initial Registration|Adverse Event|0|||
48939668|NCT00376961|157609465|FG000|Initial Registration|Refusal Unrelated to Adverse Event|2|||
48939669|NCT00376961|157609466|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
48939670|NCT00376961|157609465|FG000|Initial Registration|Progression/relapse|1|||
48939671|NCT00376961|157609466|FG001|Initial Registration|Progression/relapse|0|||
48939672|NCT00376961|157609465|FG000|Initial Registration|Ineligible|3|||
48939673|NCT00376961|157609466|FG001|Initial Registration|Ineligible|0|||
48939674|NCT00376961|157609465|FG000|Maintenance|Adverse Event|0|||
48939675|NCT00376961|157609466|FG001|Maintenance|Adverse Event|1|||
48939676|NCT00376961|157609465|FG000|Maintenance|Refusal Unrelated to Adverse Event|0|||
48939677|NCT00376961|157609466|FG001|Maintenance|Refusal Unrelated to Adverse Event|1|||
48939678|NCT00376961|157609465|FG000|Maintenance|Progression/relapse|0|||
48939679|NCT00376961|157609466|FG001|Maintenance|Progression/relapse|18|||
48939680|NCT00376961|157609465|FG000|Maintenance|Ineligible|0|||
48939681|NCT00376961|157609466|FG001|Maintenance|Ineligible|3|||
48939682|NCT00200057|157609467|FG000|Overall Study|Lack of Efficacy|3|||
48939683|NCT00200057|157609467|FG000|Overall Study|Exited due to terminal illness of PI|2|||
48939684|NCT00200057|157609467|FG000|Overall Study|Withdrawal by Subject|1|||
48939685|NCT00200057|157609467|FG000|Overall Study|Change in medical condition|1|||
48939686|NCT00200057|157609467|FG000|Overall Study|Infection|1|||
48939687|NCT00200057|157609467|FG000|Overall Study|Death|1|||
48939688|NCT00162773|157609469|FG000|Overall Study|P.I, Left institution. Study terminated|22|||
48939689|NCT00023322|157609470|FG000|Overall Study|Lost to Follow-up|1|||
48939690|NCT00110305|157609471|FG000|Overall Study|Adverse Event|46|||
48939691|NCT00110305|157609472|FG001|Overall Study|Adverse Event|13|||
48939692|NCT00110305|157609471|FG000|Overall Study|Sponsors Decision|1|||
48939693|NCT00110305|157609472|FG001|Overall Study|Sponsors Decision|0|||
48939694|NCT00110305|157609471|FG000|Overall Study|Subject Non-Compliant|9|||
48939695|NCT00110305|157609472|FG001|Overall Study|Subject Non-Compliant|2|||
48939696|NCT00110305|157609471|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
48939697|NCT00110305|157609472|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
48939698|NCT00110305|157609471|FG000|Overall Study|Subject Reached A Virologic Endpoint|21|||
48939699|NCT00110305|157609472|FG001|Overall Study|Subject Reached A Virologic Endpoint|3|||
48939700|NCT00110305|157609471|FG000|Overall Study|Protocol Violation|0|||
48939701|NCT00110305|157609472|FG001|Overall Study|Protocol Violation|1|||
48939702|NCT00110305|157609471|FG000|Overall Study|Withdrawal by Subject|7|||
48939703|NCT00110305|157609472|FG001|Overall Study|Withdrawal by Subject|7|||
48939704|NCT00110305|157609471|FG000|Overall Study|Lost to Follow-up|20|||
48939705|NCT00110305|157609472|FG001|Overall Study|Lost to Follow-up|3|||
48939706|NCT00110305|157609471|FG000|Overall Study|Other|8|||
48939707|NCT00110305|157609472|FG001|Overall Study|Other|2|||
48939708|NCT00206726|157609482|FG000|Overall Study|Delayed recovery of blood counts|1|||
48939709|NCT00206726|157609482|FG000|Overall Study|Progressive disease or relapsed disease|18|||
48848480|NCT00571649|157284890|FG001|Treatment Period|Adverse Event|385|||
48848481|NCT00571649|157284889|FG000|Treatment Period|Clinical endpoint reached|50|||
48848482|NCT00571649|157284890|FG001|Treatment Period|Clinical endpoint reached|56|||
48848483|NCT00571649|157284889|FG000|Treatment Period|Withdrawal by Subject|285|||
48848484|NCT00571649|157284890|FG001|Treatment Period|Withdrawal by Subject|255|||
48848485|NCT00571649|157284889|FG000|Treatment Period|Death|76|||
48848486|NCT00571649|157284890|FG001|Treatment Period|Death|59|||
48848487|NCT00571649|157284889|FG000|Treatment Period|Physician Decision|8|||
48848488|NCT00571649|157284890|FG001|Treatment Period|Physician Decision|9|||
48848489|NCT00571649|157284889|FG000|Treatment Period|Lost to Follow-up|43|||
48848490|NCT00571649|157284890|FG001|Treatment Period|Lost to Follow-up|41|||
48848491|NCT00571649|157284889|FG000|Treatment Period|Non-compliant with study medication|88|||
48848492|NCT00571649|157284890|FG001|Treatment Period|Non-compliant with study medication|89|||
48848493|NCT00571649|157284889|FG000|Treatment Period|Patient convenience|11|||
48848494|NCT00571649|157284890|FG001|Treatment Period|Patient convenience|13|||
48848495|NCT00571649|157284889|FG000|Treatment Period|Protocol Violation|90|||
48848496|NCT00571649|157284890|FG001|Treatment Period|Protocol Violation|92|||
48848497|NCT00571649|157284889|FG000|Treatment Period|Technical problems|3|||
48848498|NCT00571649|157284890|FG001|Treatment Period|Technical problems|5|||
48848499|NCT00571649|157284889|FG000|Follow-up Period|Adverse Event|46|||
48848500|NCT00571649|157284890|FG001|Follow-up Period|Adverse Event|40|||
48848501|NCT00571649|157284889|FG000|Follow-up Period|Clinical endpoint reached|5|||
48848502|NCT00571649|157284890|FG001|Follow-up Period|Clinical endpoint reached|2|||
48848503|NCT00571649|157284889|FG000|Follow-up Period|Withdrawal by Subject|119|||
48848504|NCT00571649|157284890|FG001|Follow-up Period|Withdrawal by Subject|115|||
48848505|NCT00571649|157284889|FG000|Follow-up Period|Death|132|||
48848506|NCT00571649|157284890|FG001|Follow-up Period|Death|133|||
48848507|NCT00571649|157284889|FG000|Follow-up Period|Physician Decision|7|||
48848508|NCT00571649|157284890|FG001|Follow-up Period|Physician Decision|13|||
48848509|NCT00571649|157284889|FG000|Follow-up Period|Lost to Follow-up|95|||
48848510|NCT00571649|157284890|FG001|Follow-up Period|Lost to Follow-up|92|||
48848511|NCT00571649|157284889|FG000|Follow-up Period|Patient convenience|136|||
48848512|NCT00571649|157284890|FG001|Follow-up Period|Patient convenience|121|||
48848513|NCT00571649|157284889|FG000|Follow-up Period|Protocol Violation|5|||
48848514|NCT00571649|157284890|FG001|Follow-up Period|Protocol Violation|12|||
48848515|NCT01421667|157284892|FG000|Overall Study|Withdrawal by Subject|0|||
48848516|NCT01421667|157284893|FG001|Overall Study|Withdrawal by Subject|1|||
48848517|NCT01421667|157284894|FG002|Overall Study|Withdrawal by Subject|2|||
48848518|NCT01421667|157284895|FG003|Overall Study|Withdrawal by Subject|1|||
48848519|NCT01421667|157284892|FG000|Overall Study|Lost to Follow-up|0|||
48848520|NCT01421667|157284893|FG001|Overall Study|Lost to Follow-up|1|||
48848521|NCT01421667|157284894|FG002|Overall Study|Lost to Follow-up|0|||
48848522|NCT01421667|157284895|FG003|Overall Study|Lost to Follow-up|0|||
48848523|NCT01160354|157284897|FG000|Overall Study|Death|0|||
48848524|NCT01160354|157284898|FG001|Overall Study|Death|1|||
48848525|NCT01160354|157284899|FG002|Overall Study|Death|1|||
48848526|NCT00580866|157284904|FG000|Overall Study|Lost to Follow-up|2|||
48848527|NCT00580866|157284905|FG001|Overall Study|Lost to Follow-up|2|||
48848528|NCT01083316|157284909|FG000|Overall Study|Adverse Event|2|||
48939710|NCT00206726|157609482|FG000|Overall Study|Placed on new protocol|1|||
48848529|NCT01083316|157284909|FG000|Overall Study|Withdrawal by Subject|1|||
48848530|NCT00611559|157284912|FG000|Overall Study|Lost to Follow-up|0|||
48848531|NCT00611559|157284913|FG001|Overall Study|Lost to Follow-up|1|||
48848532|NCT00611559|157284914|FG002|Overall Study|Lost to Follow-up|0|||
48848533|NCT00611559|157284912|FG000|Overall Study|Protocol Violation|1|||
48848534|NCT00611559|157284913|FG001|Overall Study|Protocol Violation|0|||
48848535|NCT00611559|157284914|FG002|Overall Study|Protocol Violation|1|||
48848536|NCT03500549|157284915|FG000|RCP (Day 1 - Week 16)|Adverse Event|3|||
48848537|NCT03500549|157284916|FG001|RCP (Day 1 - Week 16)|Adverse Event|0|||
48848538|NCT03500549|157284915|FG000|Open-label Period (Week 17 to Week 48)|Adverse Event|3|||
48848539|NCT03500549|157284916|FG001|Open-label Period (Week 17 to Week 48)|Adverse Event|7|||
48848546|NCT05048186|157284919|FG000|Overall Study|inconsistent answers for main decision for adhd treatment|9|||
48848547|NCT05048186|157284920|FG001|Overall Study|inconsistent answers for main decision for adhd treatment|0|||
48848548|NCT05048186|157284919|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|1|||
48848549|NCT05048186|157284920|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|4|||
48848550|NCT03750968|157284921|FG000|Overall Study|Adverse Event|2|||
48848551|NCT03750968|157284922|FG001|Overall Study|Adverse Event|0|||
48848552|NCT03750968|157284921|FG000|Overall Study|Lost to Follow-up|1|||
48848553|NCT03750968|157284922|FG001|Overall Study|Lost to Follow-up|3|||
48848554|NCT02754596|157284925|FG000|Overall Study|Withdrawal by Subject|3|||
48848555|NCT02754596|157284926|FG001|Overall Study|Withdrawal by Subject|4|||
48848556|NCT02754596|157284927|FG002|Overall Study|Withdrawal by Subject|0|||
48848557|NCT02754596|157284925|FG000|Overall Study|Physician Decision|1|||
48848558|NCT02754596|157284926|FG001|Overall Study|Physician Decision|1|||
48848559|NCT02754596|157284927|FG002|Overall Study|Physician Decision|1|||
48848560|NCT02754596|157284925|FG000|Overall Study|Lost to Follow-up|1|||
48848561|NCT02754596|157284926|FG001|Overall Study|Lost to Follow-up|1|||
48848562|NCT02754596|157284927|FG002|Overall Study|Lost to Follow-up|2|||
48848563|NCT02754596|157284925|FG000|Overall Study|Death|0|||
48848564|NCT02754596|157284926|FG001|Overall Study|Death|2|||
48848565|NCT02754596|157284927|FG002|Overall Study|Death|0|||
48848566|NCT02754596|157284925|FG000|Overall Study|Adverse Event|1|||
48848567|NCT02754596|157284926|FG001|Overall Study|Adverse Event|0|||
48848568|NCT02754596|157284927|FG002|Overall Study|Adverse Event|1|||
48848569|NCT02754596|157284925|FG000|Overall Study|Other|1|||
48848570|NCT02754596|157284926|FG001|Overall Study|Other|0|||
48848571|NCT02754596|157284927|FG002|Overall Study|Other|0|||
48848572|NCT02119650|157284931|FG000|Overall Study|Adverse Event|3|||
48848573|NCT02119650|157284932|FG001|Overall Study|Adverse Event|4|||
48848574|NCT02119650|157284931|FG000|Overall Study|Subject decision|2|||
48848575|NCT02119650|157284932|FG001|Overall Study|Subject decision|3|||
48848576|NCT02119650|157284931|FG000|Overall Study|Disease progression|11|||
48848577|NCT02119650|157284932|FG001|Overall Study|Disease progression|14|||
48848578|NCT02119650|157284931|FG000|Overall Study|Death|5|||
48848579|NCT02119650|157284932|FG001|Overall Study|Death|1|||
48848580|NCT02119650|157284931|FG000|Overall Study|Noncompliance with study treatment|1|||
48848581|NCT02119650|157284932|FG001|Overall Study|Noncompliance with study treatment|1|||
48848582|NCT02119650|157284931|FG000|Overall Study|Study terminated by the sponsor|1|||
48848583|NCT02119650|157284932|FG001|Overall Study|Study terminated by the sponsor|0|||
48848584|NCT02119650|157284931|FG000|Overall Study|Physician Decision|0|||
48848585|NCT02119650|157284932|FG001|Overall Study|Physician Decision|2|||
48848586|NCT02119650|157284931|FG000|Overall Study|Multiple reasons for termination|2|||
48848587|NCT02119650|157284932|FG001|Overall Study|Multiple reasons for termination|1|||
48848588|NCT01400958|157284934|FG000|Overall Study|Physician Decision|0|||
48848589|NCT01400958|157284935|FG001|Overall Study|Physician Decision|1|||
48848590|NCT01400958|157284934|FG000|Overall Study|Withdrawal by Subject|0|||
48848591|NCT01400958|157284935|FG001|Overall Study|Withdrawal by Subject|1|||
48848592|NCT01400958|157284934|FG000|Overall Study|Adverse Event|1|||
48848593|NCT01400958|157284935|FG001|Overall Study|Adverse Event|0|||
48848594|NCT04337931|157284936|FG000|Overall Study|Death|4|||
48848595|NCT04337931|157284937|FG001|Overall Study|Death|1|||
48848596|NCT04337931|157284938|FG002|Overall Study|Death|7|||
48848597|NCT04337931|157284936|FG000|Overall Study|Withdrawal by Subject|0|||
48848598|NCT04337931|157284937|FG001|Overall Study|Withdrawal by Subject|1|||
48848599|NCT04337931|157284938|FG002|Overall Study|Withdrawal by Subject|0|||
48848600|NCT04337931|157284936|FG000|Overall Study|Initiation of subsequent anti-cancer treatment|1|||
48939711|NCT00206726|157609482|FG000|Overall Study|Bone marrow transplant|1|||
48939712|NCT00206726|157609482|FG000|Overall Study|Adverse Event|17|||
48939713|NCT00206726|157609482|FG000|Overall Study|Death|4|||
48939714|NCT00206726|157609482|FG000|Overall Study|Protocol Violation|1|||
48939715|NCT00206726|157609482|FG000|Overall Study|Withdrawal by Subject|8|||
48939716|NCT04317690|157609483|FG000|Overall Study|did not have complete information for primary outcome|0|||
48939717|NCT04317690|157609484|FG001|Overall Study|did not have complete information for primary outcome|4|||
48939718|NCT04317690|157609485|FG002|Overall Study|did not have complete information for primary outcome|0|||
48939719|NCT04317690|157609486|FG003|Overall Study|did not have complete information for primary outcome|2|||
48939720|NCT04317690|157609487|FG004|Overall Study|did not have complete information for primary outcome|0|||
48939721|NCT00826748|157609488|FG000|Overall Study|Withdrawal by Subject|0|||
48939722|NCT00826748|157609489|FG001|Overall Study|Withdrawal by Subject|0|||
48939723|NCT00826748|157609490|FG002|Overall Study|Withdrawal by Subject|2|||
48939724|NCT00826748|157609488|FG000|Overall Study|Physician Decision|0|||
48939725|NCT00826748|157609489|FG001|Overall Study|Physician Decision|0|||
48939726|NCT00826748|157609490|FG002|Overall Study|Physician Decision|1|||
48939727|NCT00826748|157609488|FG000|Overall Study|Samples Did Not pass QC|0|||
48939728|NCT00826748|157609489|FG001|Overall Study|Samples Did Not pass QC|0|||
48939729|NCT00826748|157609490|FG002|Overall Study|Samples Did Not pass QC|1|||
48939730|NCT03312218|157609493|FG000|Overall Study|Never signed in to access the app|54|||
48939731|NCT03312218|157609494|FG001|Overall Study|Never signed in to access the app|58|||
48939732|NCT00824564|157609499|FG000|Overall Study|Lost to Follow-up|5|||
48939733|NCT00824564|157609500|FG001|Overall Study|Lost to Follow-up|7|||
48939734|NCT00824564|157609499|FG000|Overall Study|Withdrawal by Subject|1|||
48939735|NCT00824564|157609500|FG001|Overall Study|Withdrawal by Subject|1|||
48939736|NCT00824564|157609499|FG000|Overall Study|Other|1|||
48939737|NCT00824564|157609500|FG001|Overall Study|Other|2|||
48939738|NCT00824564|157609499|FG000|Overall Study|Randomized, but not treated|1|||
48939739|NCT00824564|157609500|FG001|Overall Study|Randomized, but not treated|0|||
48848601|NCT04337931|157284937|FG001|Overall Study|Initiation of subsequent anti-cancer treatment|0|||
48848602|NCT04337931|157284938|FG002|Overall Study|Initiation of subsequent anti-cancer treatment|9|||
48848603|NCT04337931|157284936|FG000|Overall Study|Study terminated by sponsor|3|||
48848604|NCT04337931|157284937|FG001|Overall Study|Study terminated by sponsor|6|||
48848605|NCT04337931|157284938|FG002|Overall Study|Study terminated by sponsor|2|||
48848606|NCT04337931|157284936|FG000|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|3|||
48848607|NCT04337931|157284937|FG001|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|5|||
48848608|NCT04337931|157284938|FG002|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|1|||
48848609|NCT04337931|157284936|FG000|Overall Study|Colorectal cancer treatment|1|||
48848610|NCT04337931|157284937|FG001|Overall Study|Colorectal cancer treatment|0|||
48939740|NCT01389245|157609505|FG000|Overall Study|Protocol Violation|10|||
48939741|NCT01389245|157609505|FG000|Overall Study|Lost to Follow-up|3|||
48939742|NCT01389245|157609505|FG000|Overall Study|Withdrawal by Subject|2|||
48939743|NCT03822884|157609506|FG000|Overall Study|Withdrawal by Subject|0|||
48939744|NCT03822884|157609507|FG001|Overall Study|Withdrawal by Subject|0|||
48939745|NCT03822884|157609508|FG002|Overall Study|Withdrawal by Subject|0|||
48939746|NCT03822884|157609509|FG003|Overall Study|Withdrawal by Subject|0|||
48939747|NCT03822884|157609510|FG004|Overall Study|Withdrawal by Subject|1|||
48939748|NCT03822884|157609511|FG005|Overall Study|Withdrawal by Subject|0|||
48939749|NCT01324830|157609512|FG000|Overall Study|Progressive Disease|3|||
48939750|NCT01324830|157609513|FG001|Overall Study|Progressive Disease|2|||
48939751|NCT01324830|157609514|FG002|Overall Study|Progressive Disease|3|||
48939752|NCT01324830|157609515|FG003|Overall Study|Progressive Disease|3|||
48939753|NCT01324830|157609516|FG004|Overall Study|Progressive Disease|6|||
48939754|NCT01324830|157609517|FG005|Overall Study|Progressive Disease|6|||
48939755|NCT01324830|157609518|FG006|Overall Study|Progressive Disease|3|||
48939756|NCT01324830|157609519|FG007|Overall Study|Progressive Disease|3|||
48939757|NCT01324830|157609520|FG008|Overall Study|Progressive Disease|3|||
48939758|NCT01324830|157609521|FG009|Overall Study|Progressive Disease|6|||
48939759|NCT01324830|157609522|FG010|Overall Study|Progressive Disease|2|||
48939760|NCT01324830|157609523|FG011|Overall Study|Progressive Disease|1|||
48939761|NCT01324830|157609524|FG012|Overall Study|Progressive Disease|1|||
48939762|NCT01324830|157609525|FG013|Overall Study|Progressive Disease|1|||
48939763|NCT01324830|157609526|FG014|Overall Study|Progressive Disease|1|||
48939764|NCT01324830|157609527|FG015|Overall Study|Progressive Disease|3|||
48939765|NCT01324830|157609528|FG016|Overall Study|Progressive Disease|2|||
48939766|NCT01324830|157609529|FG017|Overall Study|Progressive Disease|3|||
48939767|NCT01324830|157609530|FG018|Overall Study|Progressive Disease|4|||
48939768|NCT01324830|157609512|FG000|Overall Study|Dose limiting toxicity|0|||
48939769|NCT01324830|157609513|FG001|Overall Study|Dose limiting toxicity|0|||
48939770|NCT01324830|157609514|FG002|Overall Study|Dose limiting toxicity|0|||
48939771|NCT01324830|157609515|FG003|Overall Study|Dose limiting toxicity|0|||
48939772|NCT01324830|157609516|FG004|Overall Study|Dose limiting toxicity|1|||
48939773|NCT01324830|157609517|FG005|Overall Study|Dose limiting toxicity|0|||
48939774|NCT01324830|157609518|FG006|Overall Study|Dose limiting toxicity|0|||
48848611|NCT04337931|157284938|FG002|Overall Study|Colorectal cancer treatment|0|||
48939775|NCT01324830|157609519|FG007|Overall Study|Dose limiting toxicity|0|||
48939776|NCT01324830|157609520|FG008|Overall Study|Dose limiting toxicity|0|||
48939777|NCT01324830|157609521|FG009|Overall Study|Dose limiting toxicity|0|||
48939778|NCT01324830|157609522|FG010|Overall Study|Dose limiting toxicity|0|||
48939779|NCT01324830|157609523|FG011|Overall Study|Dose limiting toxicity|0|||
48939780|NCT01324830|157609524|FG012|Overall Study|Dose limiting toxicity|0|||
48939781|NCT01324830|157609525|FG013|Overall Study|Dose limiting toxicity|0|||
48939782|NCT01324830|157609526|FG014|Overall Study|Dose limiting toxicity|0|||
48939783|NCT01324830|157609527|FG015|Overall Study|Dose limiting toxicity|0|||
48939784|NCT01324830|157609528|FG016|Overall Study|Dose limiting toxicity|1|||
48939785|NCT01324830|157609529|FG017|Overall Study|Dose limiting toxicity|1|||
48939786|NCT01324830|157609530|FG018|Overall Study|Dose limiting toxicity|1|||
48939787|NCT01324830|157609512|FG000|Overall Study|Reason not mentioned above|0|||
48939788|NCT01324830|157609513|FG001|Overall Study|Reason not mentioned above|0|||
48939789|NCT01324830|157609514|FG002|Overall Study|Reason not mentioned above|0|||
48939790|NCT01324830|157609515|FG003|Overall Study|Reason not mentioned above|0|||
48939791|NCT01324830|157609516|FG004|Overall Study|Reason not mentioned above|0|||
48939792|NCT01324830|157609517|FG005|Overall Study|Reason not mentioned above|0|||
48939793|NCT01324830|157609518|FG006|Overall Study|Reason not mentioned above|0|||
48939794|NCT01324830|157609519|FG007|Overall Study|Reason not mentioned above|0|||
48939795|NCT01324830|157609520|FG008|Overall Study|Reason not mentioned above|0|||
48939796|NCT01324830|157609521|FG009|Overall Study|Reason not mentioned above|0|||
48939797|NCT01324830|157609522|FG010|Overall Study|Reason not mentioned above|0|||
48939798|NCT01324830|157609523|FG011|Overall Study|Reason not mentioned above|0|||
48939799|NCT01324830|157609524|FG012|Overall Study|Reason not mentioned above|0|||
48939800|NCT01324830|157609525|FG013|Overall Study|Reason not mentioned above|0|||
48939801|NCT01324830|157609526|FG014|Overall Study|Reason not mentioned above|0|||
48939802|NCT01324830|157609527|FG015|Overall Study|Reason not mentioned above|0|||
48939803|NCT01324830|157609528|FG016|Overall Study|Reason not mentioned above|0|||
48939804|NCT01324830|157609529|FG017|Overall Study|Reason not mentioned above|1|||
48939805|NCT01324830|157609530|FG018|Overall Study|Reason not mentioned above|0|||
48939806|NCT01324830|157609512|FG000|Overall Study|Adverse Event, serious fatal|0|||
48939807|NCT01324830|157609513|FG001|Overall Study|Adverse Event, serious fatal|1|||
48939808|NCT01324830|157609514|FG002|Overall Study|Adverse Event, serious fatal|0|||
48939809|NCT01324830|157609515|FG003|Overall Study|Adverse Event, serious fatal|0|||
48939810|NCT01324830|157609516|FG004|Overall Study|Adverse Event, serious fatal|0|||
48939811|NCT01324830|157609517|FG005|Overall Study|Adverse Event, serious fatal|0|||
48939812|NCT01324830|157609518|FG006|Overall Study|Adverse Event, serious fatal|0|||
48939813|NCT01324830|157609519|FG007|Overall Study|Adverse Event, serious fatal|0|||
48939814|NCT01324830|157609520|FG008|Overall Study|Adverse Event, serious fatal|0|||
48939815|NCT01324830|157609521|FG009|Overall Study|Adverse Event, serious fatal|0|||
48939816|NCT01324830|157609522|FG010|Overall Study|Adverse Event, serious fatal|0|||
48939817|NCT01324830|157609523|FG011|Overall Study|Adverse Event, serious fatal|0|||
48939818|NCT01324830|157609524|FG012|Overall Study|Adverse Event, serious fatal|0|||
48939819|NCT01324830|157609525|FG013|Overall Study|Adverse Event, serious fatal|0|||
48939820|NCT01324830|157609526|FG014|Overall Study|Adverse Event, serious fatal|0|||
48939821|NCT01324830|157609527|FG015|Overall Study|Adverse Event, serious fatal|0|||
48939822|NCT01324830|157609528|FG016|Overall Study|Adverse Event, serious fatal|0|||
48939823|NCT01324830|157609529|FG017|Overall Study|Adverse Event, serious fatal|0|||
48939824|NCT01324830|157609530|FG018|Overall Study|Adverse Event, serious fatal|0|||
48939825|NCT01324830|157609512|FG000|Overall Study|Adverse Event, non-fatal|0|||
48939826|NCT01324830|157609513|FG001|Overall Study|Adverse Event, non-fatal|0|||
48939827|NCT01324830|157609514|FG002|Overall Study|Adverse Event, non-fatal|0|||
48939828|NCT01324830|157609515|FG003|Overall Study|Adverse Event, non-fatal|0|||
48939829|NCT01324830|157609516|FG004|Overall Study|Adverse Event, non-fatal|0|||
48939830|NCT01324830|157609517|FG005|Overall Study|Adverse Event, non-fatal|0|||
48939831|NCT01324830|157609518|FG006|Overall Study|Adverse Event, non-fatal|0|||
48939832|NCT01324830|157609519|FG007|Overall Study|Adverse Event, non-fatal|0|||
48939833|NCT01324830|157609520|FG008|Overall Study|Adverse Event, non-fatal|2|||
48939834|NCT01324830|157609521|FG009|Overall Study|Adverse Event, non-fatal|0|||
48939835|NCT01324830|157609522|FG010|Overall Study|Adverse Event, non-fatal|1|||
48939836|NCT01324830|157609523|FG011|Overall Study|Adverse Event, non-fatal|0|||
48939837|NCT01324830|157609524|FG012|Overall Study|Adverse Event, non-fatal|0|||
48939838|NCT01324830|157609525|FG013|Overall Study|Adverse Event, non-fatal|0|||
48939839|NCT01324830|157609526|FG014|Overall Study|Adverse Event, non-fatal|0|||
48939840|NCT01324830|157609527|FG015|Overall Study|Adverse Event, non-fatal|0|||
48939841|NCT01324830|157609528|FG016|Overall Study|Adverse Event, non-fatal|0|||
48939842|NCT01324830|157609529|FG017|Overall Study|Adverse Event, non-fatal|1|||
48939843|NCT01324830|157609530|FG018|Overall Study|Adverse Event, non-fatal|0|||
48939844|NCT01324830|157609512|FG000|Overall Study|Withdrawal by Subject|0|||
48939845|NCT01324830|157609513|FG001|Overall Study|Withdrawal by Subject|0|||
48939846|NCT01324830|157609514|FG002|Overall Study|Withdrawal by Subject|0|||
48939847|NCT01324830|157609515|FG003|Overall Study|Withdrawal by Subject|0|||
48939848|NCT01324830|157609516|FG004|Overall Study|Withdrawal by Subject|0|||
48939849|NCT01324830|157609517|FG005|Overall Study|Withdrawal by Subject|1|||
48939850|NCT01324830|157609518|FG006|Overall Study|Withdrawal by Subject|0|||
48939851|NCT01324830|157609519|FG007|Overall Study|Withdrawal by Subject|0|||
48939852|NCT01324830|157609520|FG008|Overall Study|Withdrawal by Subject|0|||
48939853|NCT01324830|157609521|FG009|Overall Study|Withdrawal by Subject|0|||
48939854|NCT01324830|157609522|FG010|Overall Study|Withdrawal by Subject|1|||
48939855|NCT01324830|157609523|FG011|Overall Study|Withdrawal by Subject|0|||
48939856|NCT01324830|157609524|FG012|Overall Study|Withdrawal by Subject|0|||
48939857|NCT01324830|157609525|FG013|Overall Study|Withdrawal by Subject|0|||
48939858|NCT01324830|157609526|FG014|Overall Study|Withdrawal by Subject|0|||
48939859|NCT01324830|157609527|FG015|Overall Study|Withdrawal by Subject|0|||
48939860|NCT01324830|157609528|FG016|Overall Study|Withdrawal by Subject|0|||
48939861|NCT01324830|157609529|FG017|Overall Study|Withdrawal by Subject|0|||
48939862|NCT01324830|157609530|FG018|Overall Study|Withdrawal by Subject|1|||
48939863|NCT00049127|157609531|FG000|Overall Study|Withdrawal by Subject|0|||
48939864|NCT00049127|157609532|FG001|Overall Study|Withdrawal by Subject|0|||
48939865|NCT00049127|157609533|FG002|Overall Study|Withdrawal by Subject|1|||
48939866|NCT00049127|157609534|FG003|Overall Study|Withdrawal by Subject|0|||
48939867|NCT00049127|157609535|FG004|Overall Study|Withdrawal by Subject|0|||
48939868|NCT01929083|157609536|FG000|Intervention 1|Lost to Follow-up|2|||
48939869|NCT01929083|157609537|FG001|Intervention 1|Lost to Follow-up|0|||
48939870|NCT01929083|157609536|FG000|Intervention 1|Nonadherent to study medications|1|||
48939871|NCT01929083|157609537|FG001|Intervention 1|Nonadherent to study medications|0|||
48939872|NCT01929083|157609536|FG000|Intervention 2|Adverse Event|0|||
48939873|NCT01929083|157609537|FG001|Intervention 2|Adverse Event|1|||
48939874|NCT03417440|157609544|FG000|Overall Study|Lost to Follow-up|0|||
48939875|NCT03417440|157609545|FG001|Overall Study|Lost to Follow-up|1|||
48939876|NCT03417440|157609546|FG002|Overall Study|Lost to Follow-up|0|||
48939877|NCT03417440|157609547|FG003|Overall Study|Lost to Follow-up|0|||
48939878|NCT03417440|157609548|FG004|Overall Study|Lost to Follow-up|1|||
48939879|NCT03417440|157609549|FG005|Overall Study|Lost to Follow-up|0|||
48939880|NCT03417440|157609550|FG006|Overall Study|Lost to Follow-up|0|||
48939881|NCT03417440|157609551|FG007|Overall Study|Lost to Follow-up|0|||
48939882|NCT03417440|157609544|FG000|Overall Study|Withdrawal by Subject|2|||
48939883|NCT03417440|157609545|FG001|Overall Study|Withdrawal by Subject|0|||
48939884|NCT03417440|157609546|FG002|Overall Study|Withdrawal by Subject|2|||
48939885|NCT03417440|157609547|FG003|Overall Study|Withdrawal by Subject|1|||
48939886|NCT03417440|157609548|FG004|Overall Study|Withdrawal by Subject|1|||
48939887|NCT03417440|157609549|FG005|Overall Study|Withdrawal by Subject|0|||
48939888|NCT03417440|157609550|FG006|Overall Study|Withdrawal by Subject|0|||
48939889|NCT03417440|157609551|FG007|Overall Study|Withdrawal by Subject|1|||
48939890|NCT00860470|157609554|FG000|Overall Study|Death|6|||
48939891|NCT00860470|157609555|FG001|Overall Study|Death|10|||
48939892|NCT00860470|157609554|FG000|Overall Study|Moved away|8|||
48939893|NCT00860470|157609555|FG001|Overall Study|Moved away|10|||
48939894|NCT00860470|157609554|FG000|Overall Study|Lost to Follow-up|34|||
48939895|NCT00860470|157609555|FG001|Overall Study|Lost to Follow-up|39|||
48939896|NCT02868892|157609556|FG000|Overall Study|Investigator left site and no follow-up|6|||
48939897|NCT01850615|157609557|FG000|Overall Study|Protocol Violation|4|||
48939898|NCT01850615|157609558|FG001|Overall Study|Protocol Violation|1|||
48939899|NCT01850615|157609557|FG000|Overall Study|Adverse Event|2|||
48939900|NCT01850615|157609558|FG001|Overall Study|Adverse Event|1|||
48939901|NCT01850615|157609557|FG000|Overall Study|Withdrawal by Subject|3|||
48939902|NCT01850615|157609558|FG001|Overall Study|Withdrawal by Subject|1|||
48939903|NCT01850615|157609557|FG000|Overall Study|Lost to Follow-up|0|||
48939904|NCT01850615|157609558|FG001|Overall Study|Lost to Follow-up|1|||
48939905|NCT01850615|157609557|FG000|Overall Study|Unclassified|0|||
48939906|NCT01850615|157609558|FG001|Overall Study|Unclassified|1|||
48939907|NCT00222105|157609559|FG000|Overall Study|Removed due to wrong diagnosis|1|||
48939908|NCT00222105|157609559|FG000|Overall Study|Withdrawal by Subject|1|||
48939909|NCT00222105|157609559|FG000|Overall Study|Adverse Event|8|||
48939910|NCT00222105|157609559|FG000|Overall Study|Treatment delays|2|||
48939911|NCT00222105|157609559|FG000|Overall Study|Death|2|||
48939912|NCT03812510|157609560|FG000|Overall Study|Lost to Follow-up|39|||
48939913|NCT03812510|157609560|FG000|Overall Study|Withdrawal by Subject|42|||
48939914|NCT03812510|157609560|FG000|Overall Study|Physician Decision|2|||
48939915|NCT03812510|157609560|FG000|Overall Study|Study Terminated by Sponsor|9|||
48939916|NCT03812510|157609560|FG000|Overall Study|Did Not Start Study Medication|55|||
48939917|NCT03812510|157609560|FG000|Overall Study|Adverse Event|5|||
48939918|NCT03770403|157609562|FG000|Overall Study|Adverse Event|8|||
48939919|NCT03770403|157609562|FG000|Overall Study|Death|5|||
48939920|NCT03770403|157609562|FG000|Overall Study|Physician Decision|1|||
48939921|NCT03770403|157609562|FG000|Overall Study|Sponsor decision|1|||
48939922|NCT03770403|157609562|FG000|Overall Study|Study terminated by Sponsor|1|||
48939923|NCT03770403|157609562|FG000|Overall Study|Withdrawal by Subject|13|||
48939924|NCT03770403|157609562|FG000|Overall Study|Other|88|||
48939925|NCT03192904|157609563|FG000|Overall Study|Physician Decision|3|||
48939926|NCT03192904|157609564|FG001|Overall Study|Physician Decision|1|||
48939927|NCT03192904|157609563|FG000|Overall Study|Lost to Follow-up|0|||
48939928|NCT03192904|157609564|FG001|Overall Study|Lost to Follow-up|1|||
48939929|NCT02690701|157609567|FG000|Treatment Period 1|Adverse Event|2|||
48939930|NCT02690701|157609568|FG001|Treatment Period 1|Adverse Event|2|||
48939931|NCT02690701|157609567|FG000|Treatment Period 1|Withdrawal by Subject|0|||
48939932|NCT02690701|157609568|FG001|Treatment Period 1|Withdrawal by Subject|1|||
48939933|NCT02690701|157609567|FG000|Treatment Period 2|Adverse Event|2|||
48939934|NCT02690701|157609568|FG001|Treatment Period 2|Adverse Event|0|||
48939935|NCT02690701|157609567|FG000|Treatment Period 2|Lack of Efficacy|1|||
48939936|NCT02690701|157609568|FG001|Treatment Period 2|Lack of Efficacy|0|||
48939937|NCT02690701|157609567|FG000|Treatment Period 2|Lost to Follow-up|0|||
48939938|NCT02690701|157609568|FG001|Treatment Period 2|Lost to Follow-up|2|||
48939939|NCT02690701|157609567|FG000|Treatment Period 2|Withdrawal by Subject|0|||
48939940|NCT02690701|157609568|FG001|Treatment Period 2|Withdrawal by Subject|2|||
48939941|NCT02690701|157609567|FG000|Treatment Period 2|Protocol Violation|0|||
48939942|NCT02690701|157609568|FG001|Treatment Period 2|Protocol Violation|1|||
48939943|NCT02034123|157609569|FG000|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
48939944|NCT02034123|157609570|FG001|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
48939945|NCT02034123|157609571|FG002|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
48939946|NCT02034123|157609572|FG003|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
48939947|NCT02034123|157609573|FG004|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
48939948|NCT02034123|157609574|FG005|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
48939949|NCT02034123|157609575|FG006|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
48939950|NCT02034123|157609576|FG007|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
48939951|NCT02034123|157609577|FG008|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
48939952|NCT02034123|157609578|FG009|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
48939953|NCT02034123|157609579|FG010|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
48939954|NCT02034123|157609580|FG011|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
48939955|NCT02034123|157609581|FG012|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
48939956|NCT02034123|157609582|FG013|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
48939957|NCT02034123|157609583|FG014|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
48939958|NCT02034123|157609584|FG015|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
48939959|NCT02034123|157609585|FG016|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
48939960|NCT02034123|157609586|FG017|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
48939961|NCT02034123|157609569|FG000|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
48939962|NCT02034123|157609570|FG001|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
48939963|NCT02034123|157609571|FG002|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
48939964|NCT02034123|157609572|FG003|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1|||
48939965|NCT02034123|157609573|FG004|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
48939966|NCT02034123|157609574|FG005|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
48939967|NCT02034123|157609575|FG006|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
48939968|NCT02034123|157609576|FG007|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
48939969|NCT02034123|157609577|FG008|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
48939970|NCT02034123|157609578|FG009|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
48939971|NCT02034123|157609579|FG010|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
48939972|NCT02034123|157609580|FG011|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
48939973|NCT02034123|157609581|FG012|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
48939974|NCT02034123|157609582|FG013|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
48939975|NCT02034123|157609583|FG014|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
48939976|NCT02034123|157609584|FG015|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
48939977|NCT02034123|157609585|FG016|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
48939978|NCT02034123|157609586|FG017|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
48939979|NCT02034123|157609569|FG000|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
48939980|NCT02034123|157609570|FG001|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
48939981|NCT02034123|157609571|FG002|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
48939982|NCT02034123|157609572|FG003|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
48939983|NCT02034123|157609573|FG004|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
48939984|NCT02034123|157609574|FG005|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
48939985|NCT02034123|157609575|FG006|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
48939986|NCT02034123|157609576|FG007|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
48939987|NCT02034123|157609577|FG008|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1|||
48939988|NCT02034123|157609578|FG009|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
48939989|NCT02034123|157609579|FG010|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
48939990|NCT02034123|157609580|FG011|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
48939991|NCT02034123|157609581|FG012|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
48939992|NCT02034123|157609582|FG013|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
48939993|NCT02034123|157609583|FG014|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
48939994|NCT02034123|157609584|FG015|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
48939995|NCT02034123|157609585|FG016|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
48939996|NCT02034123|157609586|FG017|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
48939997|NCT02034123|157609569|FG000|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
48939998|NCT02034123|157609570|FG001|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
48939999|NCT02034123|157609571|FG002|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
48940000|NCT02034123|157609572|FG003|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
48940001|NCT02034123|157609573|FG004|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
48940002|NCT02034123|157609574|FG005|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
48940003|NCT02034123|157609575|FG006|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
48940004|NCT02034123|157609576|FG007|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
48940005|NCT02034123|157609577|FG008|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
48940006|NCT02034123|157609578|FG009|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
48940007|NCT02034123|157609579|FG010|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
48940008|NCT02034123|157609580|FG011|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
48940009|NCT02034123|157609581|FG012|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
48940010|NCT02034123|157609582|FG013|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
48940011|NCT02034123|157609583|FG014|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
48940012|NCT02034123|157609584|FG015|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
48940013|NCT02034123|157609585|FG016|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
48940014|NCT02034123|157609586|FG017|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
48940015|NCT04325503|157609589|FG000|Overall Study|Withdrawal by Subject|1|||
48940016|NCT04325503|157609589|FG000|Overall Study|PI decided to remove them from trial as they lacked motor symptoms being studied.|2|||
48940017|NCT00104871|157609592|FG000|Overall Study|Not evaluable|1|||
48940018|NCT02333227|157609594|FG000|Overall Study|Lost to Follow-up|137|||
48940019|NCT02333227|157609595|FG001|Overall Study|Lost to Follow-up|106|||
48940020|NCT02333227|157609594|FG000|Overall Study|Pregnancy Interrupted|42|||
48940021|NCT02333227|157609595|FG001|Overall Study|Pregnancy Interrupted|89|||
48940022|NCT02333227|157609594|FG000|Overall Study|Enrolled prepregnant without neonatal outcome data available|20|||
48940023|NCT02333227|157609595|FG001|Overall Study|Enrolled prepregnant without neonatal outcome data available|5|||
48940024|NCT00981526|157609596|FG000|Overall Study|Withdrawal by Subject|0|||
48940025|NCT00981526|157609597|FG001|Overall Study|Withdrawal by Subject|2|||
48940026|NCT00981526|157609596|FG000|Overall Study|Physician Decision|4|||
48940027|NCT00981526|157609597|FG001|Overall Study|Physician Decision|4|||
48940028|NCT04091217|157609598|FG000|Overall Study|Lost to Follow-up|2|||
48940029|NCT00947349|157609608|FG000|Triple Treatment Combination Period|Adverse Event|0|||
48940030|NCT00947349|157609609|FG001|Triple Treatment Combination Period|Adverse Event|1|||
48940031|NCT00947349|157609610|FG002|Triple Treatment Combination Period|Adverse Event|0|||
48940032|NCT00947349|157609611|FG003|Triple Treatment Combination Period|Adverse Event|0|||
48940033|NCT00947349|157609608|FG000|Overall Study Standard of Care|Lack of Efficacy|0|||
48940034|NCT00947349|157609609|FG001|Overall Study Standard of Care|Lack of Efficacy|0|||
48940035|NCT00947349|157609610|FG002|Overall Study Standard of Care|Lack of Efficacy|1|||
48940036|NCT00947349|157609611|FG003|Overall Study Standard of Care|Lack of Efficacy|1|||
48940037|NCT00947349|157609608|FG000|Overall Study Standard of Care|Withdrawal by Subject|0|||
48940038|NCT00947349|157609609|FG001|Overall Study Standard of Care|Withdrawal by Subject|0|||
48940039|NCT00947349|157609610|FG002|Overall Study Standard of Care|Withdrawal by Subject|1|||
48940040|NCT00947349|157609611|FG003|Overall Study Standard of Care|Withdrawal by Subject|0|||
48940041|NCT00947349|157609608|FG000|Overall Study Standard of Care|Other|0|||
48940042|NCT00947349|157609609|FG001|Overall Study Standard of Care|Other|0|||
48940043|NCT00947349|157609610|FG002|Overall Study Standard of Care|Other|0|||
48940044|NCT00947349|157609611|FG003|Overall Study Standard of Care|Other|1|||
48940045|NCT00538681|157609612|FG000|Overall Study|Progressive Disease|7|||
48940046|NCT00538681|157609613|FG001|Overall Study|Progressive Disease|0|||
48940047|NCT00538681|157609614|FG002|Overall Study|Progressive Disease|1|||
48940048|NCT00538681|157609615|FG003|Overall Study|Progressive Disease|0|||
48940049|NCT00538681|157609612|FG000|Overall Study|Sponsor Decision|1|||
48940050|NCT00538681|157609613|FG001|Overall Study|Sponsor Decision|3|||
48940051|NCT00538681|157609614|FG002|Overall Study|Sponsor Decision|8|||
48940052|NCT00538681|157609615|FG003|Overall Study|Sponsor Decision|9|||
48940053|NCT00538681|157609612|FG000|Overall Study|Adverse Event|1|||
48940054|NCT00538681|157609613|FG001|Overall Study|Adverse Event|1|||
48940055|NCT00538681|157609614|FG002|Overall Study|Adverse Event|1|||
48940056|NCT00538681|157609615|FG003|Overall Study|Adverse Event|0|||
48940057|NCT00538681|157609612|FG000|Overall Study|Death|0|||
48940058|NCT00538681|157609613|FG001|Overall Study|Death|0|||
48940059|NCT00538681|157609614|FG002|Overall Study|Death|1|||
48940060|NCT00538681|157609615|FG003|Overall Study|Death|1|||
48940061|NCT00538681|157609612|FG000|Overall Study|Investigator Decision|0|||
48940062|NCT00538681|157609613|FG001|Overall Study|Investigator Decision|0|||
48940063|NCT00538681|157609614|FG002|Overall Study|Investigator Decision|0|||
48940064|NCT00538681|157609615|FG003|Overall Study|Investigator Decision|1|||
48940065|NCT00963807|157609627|FG000|Overall Study|Physician Decision|2|||
48940066|NCT00963807|157609627|FG000|Overall Study|Reaction to study chemotherapy regimen|1|||
48940067|NCT00963807|157609627|FG000|Overall Study|Disease progression|15|||
48940068|NCT01151137|157609628|FG000|Overall Study|Death|15|||
48940069|NCT01151137|157609629|FG001|Overall Study|Death|27|||
48940070|NCT01151137|157609628|FG000|Overall Study|Lost to Follow-up|1|||
48940071|NCT01151137|157609629|FG001|Overall Study|Lost to Follow-up|1|||
48940072|NCT01097044|157609630|FG000|Overall Study|Withdrawal by Subject|4|||
48940073|NCT01097044|157609631|FG001|Overall Study|Withdrawal by Subject|4|||
48940074|NCT01097044|157609630|FG000|Overall Study|Lost to Follow-up|1|||
48940075|NCT01097044|157609631|FG001|Overall Study|Lost to Follow-up|0|||
48940076|NCT01097044|157609630|FG000|Overall Study|Withdrawal by Sponsor|0|||
48940077|NCT01097044|157609631|FG001|Overall Study|Withdrawal by Sponsor|1|||
48940078|NCT02591615|157611234|FG000|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
48940079|NCT02591615|157611235|FG001|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
48940080|NCT02591615|157611236|FG002|Arm B Pembro Lead in Phase|Withdrawal by Subject|1|||
48940081|NCT02591615|157611237|FG003|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
48940082|NCT02591615|157611234|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
48940083|NCT02591615|157611235|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|1|||
48940084|NCT02591615|157611236|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
48940085|NCT02591615|157611237|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
48940086|NCT02591615|157611234|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|1|||
48940087|NCT02591615|157611235|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
48940088|NCT02591615|157611236|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|0|||
48940089|NCT02591615|157611237|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
48940090|NCT02591615|157611234|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|1|||
48940091|NCT02591615|157611235|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|3|||
48940092|NCT02591615|157611236|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|4|||
48940093|NCT02591615|157611237|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|12|||
48940094|NCT02591615|157611234|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Death|1|||
48940095|NCT02591615|157611235|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
48940096|NCT02591615|157611236|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Death|0|||
48940097|NCT02591615|157611237|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
48940098|NCT02591615|157611234|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
48940099|NCT02591615|157611235|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|1|||
48940100|NCT02591615|157611236|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
48940101|NCT02591615|157611237|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
48940102|NCT02591615|157611234|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
48940103|NCT02591615|157611235|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
48940104|NCT02591615|157611236|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
48940105|NCT02591615|157611237|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
48940106|NCT02591615|157611234|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|1|||
48940107|NCT02591615|157611235|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
48940108|NCT02591615|157611236|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
48940109|NCT02591615|157611237|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
48940110|NCT02591615|157611234|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
48940111|NCT02591615|157611235|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|2|||
48940112|NCT02591615|157611236|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
48940113|NCT02591615|157611237|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|1|||
48940114|NCT02591615|157611234|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|2|||
48940115|NCT02591615|157611235|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|6|||
48940116|NCT02591615|157611236|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
48940117|NCT02591615|157611237|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
48940118|NCT02591615|157611234|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
48940119|NCT02591615|157611235|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
48940120|NCT02591615|157611236|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
48940121|NCT02591615|157611237|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
48940122|NCT02591615|157611234|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
48940123|NCT02591615|157611235|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
48940124|NCT02591615|157611236|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|1|||
48940125|NCT02591615|157611237|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
48940126|NCT02591615|157611234|FG000|Maintenance MK-3475|Adverse Event|0|||
48940127|NCT02591615|157611235|FG001|Maintenance MK-3475|Adverse Event|3|||
48940128|NCT02591615|157611236|FG002|Maintenance MK-3475|Adverse Event|1|||
48940129|NCT02591615|157611237|FG003|Maintenance MK-3475|Adverse Event|2|||
48940130|NCT02591615|157611234|FG000|Maintenance MK-3475|Lack of Efficacy|0|||
48940131|NCT02591615|157611235|FG001|Maintenance MK-3475|Lack of Efficacy|9|||
48940132|NCT02591615|157611236|FG002|Maintenance MK-3475|Lack of Efficacy|0|||
48940133|NCT02591615|157611237|FG003|Maintenance MK-3475|Lack of Efficacy|8|||
48940134|NCT02591615|157611234|FG000|Maintenance MK-3475|Death|0|||
48940135|NCT02591615|157611235|FG001|Maintenance MK-3475|Death|1|||
48940136|NCT02591615|157611236|FG002|Maintenance MK-3475|Death|1|||
48940137|NCT02591615|157611237|FG003|Maintenance MK-3475|Death|0|||
48940138|NCT02591615|157611234|FG000|Maintenance MK-3475|Physician discretion|0|||
48940139|NCT02591615|157611235|FG001|Maintenance MK-3475|Physician discretion|0|||
48940140|NCT02591615|157611236|FG002|Maintenance MK-3475|Physician discretion|1|||
48940141|NCT02591615|157611237|FG003|Maintenance MK-3475|Physician discretion|0|||
48940142|NCT02591615|157611234|FG000|Maintenance MK-3475|Withdrew to hospice|0|||
48940143|NCT02591615|157611235|FG001|Maintenance MK-3475|Withdrew to hospice|1|||
48940144|NCT02591615|157611236|FG002|Maintenance MK-3475|Withdrew to hospice|0|||
48940145|NCT02591615|157611237|FG003|Maintenance MK-3475|Withdrew to hospice|0|||
48940146|NCT02591615|157611234|FG000|Maintenance MK-3475|In active treatment|2|||
48940147|NCT02591615|157611235|FG001|Maintenance MK-3475|In active treatment|0|||
48940148|NCT02591615|157611236|FG002|Maintenance MK-3475|In active treatment|0|||
48940149|NCT02591615|157611237|FG003|Maintenance MK-3475|In active treatment|1|||
48940150|NCT02091440|157611239|FG000|Overall Study|Death|2|||
48940151|NCT01717638|157611242|FG000|Overall Study|Lost to Follow-up|0|||
48940152|NCT01717638|157611243|FG001|Overall Study|Lost to Follow-up|0|||
48940153|NCT01717638|157611244|FG002|Overall Study|Lost to Follow-up|0|||
48940154|NCT01717638|157611245|FG003|Overall Study|Lost to Follow-up|0|||
48940155|NCT01717638|157611246|FG004|Overall Study|Lost to Follow-up|0|||
48940156|NCT01717638|157611247|FG005|Overall Study|Lost to Follow-up|1|||
48940157|NCT01717638|157611248|FG006|Overall Study|Lost to Follow-up|0|||
48940158|NCT01717638|157611249|FG007|Overall Study|Lost to Follow-up|0|||
48940159|NCT01717638|157611250|FG008|Overall Study|Lost to Follow-up|0|||
48940160|NCT01717638|157611251|FG009|Overall Study|Lost to Follow-up|0|||
48940161|NCT01717638|157611252|FG010|Overall Study|Lost to Follow-up|0|||
48940162|NCT01717638|157611253|FG011|Overall Study|Lost to Follow-up|0|||
48940163|NCT01717638|157611254|FG012|Overall Study|Lost to Follow-up|0|||
48940164|NCT01717638|157611242|FG000|Overall Study|Father in hospital|0|||
48940165|NCT01717638|157611243|FG001|Overall Study|Father in hospital|0|||
48940166|NCT01717638|157611244|FG002|Overall Study|Father in hospital|0|||
48940167|NCT01717638|157611245|FG003|Overall Study|Father in hospital|0|||
48940168|NCT01717638|157611246|FG004|Overall Study|Father in hospital|0|||
48940169|NCT01717638|157611247|FG005|Overall Study|Father in hospital|0|||
48940170|NCT01717638|157611248|FG006|Overall Study|Father in hospital|0|||
48940171|NCT01717638|157611249|FG007|Overall Study|Father in hospital|0|||
48940172|NCT01717638|157611250|FG008|Overall Study|Father in hospital|0|||
48940173|NCT01717638|157611251|FG009|Overall Study|Father in hospital|0|||
48940174|NCT01717638|157611252|FG010|Overall Study|Father in hospital|0|||
48940175|NCT01717638|157611253|FG011|Overall Study|Father in hospital|0|||
48940176|NCT01717638|157611254|FG012|Overall Study|Father in hospital|1|||
48940177|NCT01717638|157611242|FG000|Overall Study|Withdrawal by Subject|0|||
48940178|NCT01717638|157611243|FG001|Overall Study|Withdrawal by Subject|1|||
48940179|NCT01717638|157611244|FG002|Overall Study|Withdrawal by Subject|1|||
48940180|NCT01717638|157611245|FG003|Overall Study|Withdrawal by Subject|0|||
48940181|NCT01717638|157611246|FG004|Overall Study|Withdrawal by Subject|1|||
48940182|NCT01717638|157611247|FG005|Overall Study|Withdrawal by Subject|0|||
48940183|NCT01717638|157611248|FG006|Overall Study|Withdrawal by Subject|2|||
48940184|NCT01717638|157611249|FG007|Overall Study|Withdrawal by Subject|1|||
48940185|NCT01717638|157611250|FG008|Overall Study|Withdrawal by Subject|2|||
48940186|NCT01717638|157611251|FG009|Overall Study|Withdrawal by Subject|1|||
48940187|NCT01717638|157611252|FG010|Overall Study|Withdrawal by Subject|0|||
48940188|NCT01717638|157611253|FG011|Overall Study|Withdrawal by Subject|0|||
48940189|NCT01717638|157611254|FG012|Overall Study|Withdrawal by Subject|18|||
48940190|NCT03368859|157611255|FG000|Overall Study|Withdrew Consent|5|||
48940191|NCT03368859|157611256|FG001|Overall Study|Withdrew Consent|4|||
48940192|NCT03368859|157611255|FG000|Overall Study|Death|12|||
48940193|NCT03368859|157611256|FG001|Overall Study|Death|6|||
48940194|NCT03368859|157611255|FG000|Overall Study|Study terminated by Sponsor|18|||
48940195|NCT03368859|157611256|FG001|Overall Study|Study terminated by Sponsor|23|||
48940196|NCT03368859|157611255|FG000|Overall Study|Other|1|||
48940197|NCT03368859|157611256|FG001|Overall Study|Other|1|||
48940198|NCT01901224|157611258|FG000|Overall Study|study was not funded and terminated|2|||
48940199|NCT02300129|157611259|FG000|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
48940200|NCT02300129|157611260|FG001|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1|||
48940201|NCT02300129|157611261|FG002|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
48940202|NCT02300129|157611262|FG003|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
48940203|NCT02300129|157611259|FG000|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
48940204|NCT02300129|157611260|FG001|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
48940205|NCT02300129|157611261|FG002|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
48940206|NCT02300129|157611262|FG003|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1|||
48940207|NCT02300129|157611259|FG000|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1|||
48940208|NCT02300129|157611260|FG001|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
48940209|NCT02300129|157611261|FG002|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
48940210|NCT02300129|157611262|FG003|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
48940211|NCT01887912|157611263|FG000|Overall Study|Serious adverse event|400|||
48940212|NCT01887912|157611264|FG001|Overall Study|Serious adverse event|198|||
48940213|NCT01887912|157611263|FG000|Overall Study|Other Adverse Event|34|||
48940214|NCT01887912|157611264|FG001|Overall Study|Other Adverse Event|15|||
48940215|NCT01887912|157611263|FG000|Overall Study|Protocol Violation|67|||
48940216|NCT01887912|157611264|FG001|Overall Study|Protocol Violation|37|||
48940217|NCT01887912|157611263|FG000|Overall Study|Lost to Follow-up|163|||
48940218|NCT01887912|157611264|FG001|Overall Study|Lost to Follow-up|74|||
48940219|NCT01887912|157611263|FG000|Overall Study|Withdrawal by Subject|606|||
48940220|NCT01887912|157611264|FG001|Overall Study|Withdrawal by Subject|349|||
48940221|NCT01887912|157611263|FG000|Overall Study|Other|122|||
48940222|NCT01887912|157611264|FG001|Overall Study|Other|58|||
48940223|NCT05408858|157611265|FG000|Overall Study|no longer met eligibility criteria|1|||
48940224|NCT03304522|157611272|FG000|Overall Study|Adverse Event|0|||
48940225|NCT03304522|157611273|FG001|Overall Study|Adverse Event|4|||
48940226|NCT03304522|157611272|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
48940227|NCT03304522|157611273|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
48940228|NCT03304522|157611272|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
48940229|NCT03304522|157611273|FG001|Overall Study|Withdrawal of consent (for other reason)|2|||
48940230|NCT03304522|157611272|FG000|Overall Study|Other|0|||
48940231|NCT03304522|157611273|FG001|Overall Study|Other|1|||
48940232|NCT02983604|157611274|FG000|Overall Study|Enrolled but not Treated|0|||
48940233|NCT02983604|157611275|FG001|Overall Study|Enrolled but not Treated|0|||
48848612|NCT04337931|157284936|FG000|Overall Study|Participant decision|0|||
48848613|NCT04337931|157284937|FG001|Overall Study|Participant decision|1|||
48848614|NCT04337931|157284938|FG002|Overall Study|Participant decision|0|||
48848615|NCT01738438|157284939|FG000|Overall Study|Disease Progression|32|||
48848616|NCT01738438|157284939|FG000|Overall Study|Adverse Event|3|||
48848617|NCT03102034|157284940|FG000|Overall Study|Withdrawal by Subject|1|||
48848618|NCT03102034|157284941|FG001|Overall Study|Withdrawal by Subject|0|||
48848619|NCT00145470|157284942|FG000|Overall Study|Adverse Event|19|||
48848620|NCT00145470|157284943|FG001|Overall Study|Adverse Event|25|||
48848621|NCT00145470|157284942|FG000|Overall Study|Lack of Efficacy|27|||
48848622|NCT00145470|157284943|FG001|Overall Study|Lack of Efficacy|13|||
48848623|NCT00145470|157284942|FG000|Overall Study|Withdrawal by Subject|36|||
48848624|NCT00145470|157284943|FG001|Overall Study|Withdrawal by Subject|34|||
48848625|NCT00145470|157284942|FG000|Overall Study|Lost to Follow-up|21|||
48940234|NCT02983604|157611276|FG002|Overall Study|Enrolled but not Treated|1|||
48940235|NCT02983604|157611277|FG003|Overall Study|Enrolled but not Treated|0|||
48940236|NCT00316264|157611281|FG000|Overall Study|Lost to Follow-up|0|||
48940237|NCT00316264|157611282|FG001|Overall Study|Lost to Follow-up|1|||
48940238|NCT00316264|157611283|FG002|Overall Study|Lost to Follow-up|0|||
48940239|NCT00316264|157611281|FG000|Overall Study|Withdrawal of Consent|3|||
48940240|NCT00316264|157611282|FG001|Overall Study|Withdrawal of Consent|5|||
48940241|NCT00316264|157611283|FG002|Overall Study|Withdrawal of Consent|6|||
48940242|NCT00316264|157611281|FG000|Overall Study|Death|2|||
48940243|NCT00316264|157611282|FG001|Overall Study|Death|0|||
48940244|NCT00316264|157611283|FG002|Overall Study|Death|0|||
48940245|NCT00316264|157611281|FG000|Overall Study|Other|1|||
48940246|NCT00316264|157611282|FG001|Overall Study|Other|1|||
48940247|NCT00316264|157611283|FG002|Overall Study|Other|0|||
48940248|NCT01355289|157611284|FG000|Core Study|Adverse Event, Non-Fatal|1|||
48940249|NCT01355289|157611285|FG001|Core Study|Adverse Event, Non-Fatal|0|||
48940250|NCT01355289|157611286|FG002|Core Study|Adverse Event, Non-Fatal|0|||
48940251|NCT01355289|157611287|FG003|Core Study|Adverse Event, Non-Fatal|0|||
48940252|NCT01355289|157611288|FG004|Core Study|Adverse Event, Non-Fatal|0|||
48940253|NCT01355289|157611284|FG000|Core Study|Inadequate Therapeutic Effect|0|||
48940254|NCT01355289|157611285|FG001|Core Study|Inadequate Therapeutic Effect|0|||
48940255|NCT01355289|157611286|FG002|Core Study|Inadequate Therapeutic Effect|0|||
48940256|NCT01355289|157611287|FG003|Core Study|Inadequate Therapeutic Effect|1|||
48940257|NCT01355289|157611288|FG004|Core Study|Inadequate Therapeutic Effect|0|||
48940258|NCT01355289|157611284|FG000|Core Study|Other|0|||
48940259|NCT01355289|157611285|FG001|Core Study|Other|0|||
48940260|NCT01355289|157611286|FG002|Core Study|Other|0|||
48940261|NCT01355289|157611287|FG003|Core Study|Other|1|||
48940262|NCT01355289|157611288|FG004|Core Study|Other|0|||
48940263|NCT01355289|157611284|FG000|Open Label Extension|Adverse Event, Non-Fatal|0|||
48940264|NCT01355289|157611285|FG001|Open Label Extension|Adverse Event, Non-Fatal|0|||
48940265|NCT01355289|157611286|FG002|Open Label Extension|Adverse Event, Non-Fatal|0|||
48940266|NCT01355289|157611287|FG003|Open Label Extension|Adverse Event, Non-Fatal|0|||
48940267|NCT01355289|157611288|FG004|Open Label Extension|Adverse Event, Non-Fatal|1|||
48940268|NCT01355289|157611284|FG000|Open Label Extension|Lost to Follow-up|0|||
48940269|NCT01355289|157611285|FG001|Open Label Extension|Lost to Follow-up|0|||
48940270|NCT01355289|157611286|FG002|Open Label Extension|Lost to Follow-up|0|||
48940271|NCT01355289|157611287|FG003|Open Label Extension|Lost to Follow-up|0|||
48940272|NCT01355289|157611288|FG004|Open Label Extension|Lost to Follow-up|1|||
48940273|NCT01355289|157611284|FG000|Open Label Extension|Inadequate Therapeutic Effect|0|||
48940274|NCT01355289|157611285|FG001|Open Label Extension|Inadequate Therapeutic Effect|0|||
48940275|NCT01355289|157611286|FG002|Open Label Extension|Inadequate Therapeutic Effect|0|||
48940276|NCT01355289|157611287|FG003|Open Label Extension|Inadequate Therapeutic Effect|0|||
48940277|NCT01355289|157611288|FG004|Open Label Extension|Inadequate Therapeutic Effect|29|||
48940278|NCT01355289|157611284|FG000|Open Label Extension|Other|0|||
48940279|NCT01355289|157611285|FG001|Open Label Extension|Other|0|||
48940280|NCT01355289|157611286|FG002|Open Label Extension|Other|0|||
48940281|NCT01355289|157611287|FG003|Open Label Extension|Other|0|||
48940282|NCT01355289|157611288|FG004|Open Label Extension|Other|3|||
48940283|NCT02041962|157611291|FG000|Overall Study|Lost Aetna Coverage|43|||
48940284|NCT02041962|157611292|FG001|Overall Study|Lost Aetna Coverage|40|||
48940285|NCT02041962|157611291|FG000|Overall Study|Death|1|||
48940286|NCT02041962|157611292|FG001|Overall Study|Death|1|||
48940287|NCT02041962|157611291|FG000|Overall Study|Lost to Follow-up|37|||
48940288|NCT02041962|157611292|FG001|Overall Study|Lost to Follow-up|32|||
48940289|NCT02041962|157611291|FG000|Overall Study|Withdrawal by Subject|0|||
48940290|NCT02041962|157611292|FG001|Overall Study|Withdrawal by Subject|11|||
48940291|NCT02317510|157611303|FG000|Overall Study|Adverse Event|0|||
48940292|NCT02317510|157611304|FG001|Overall Study|Adverse Event|1|||
48848626|NCT00145470|157284943|FG001|Overall Study|Lost to Follow-up|17|||
48848627|NCT00145470|157284942|FG000|Overall Study|Reason Not Reported|9|||
48848628|NCT00145470|157284943|FG001|Overall Study|Reason Not Reported|9|||
48848629|NCT02972359|157284949|FG000|Overall Study|Incl. criteria not met/Exclusion met|2|||
48848630|NCT02972359|157284949|FG000|Overall Study|Lack of Efficacy|1|||
48848631|NCT02972359|157284949|FG000|Overall Study|Adverse Event|4|||
48940293|NCT01238120|157611305|FG000|Overall Study|Withdrawal by Subject|4|||
48940294|NCT01238120|157611306|FG001|Overall Study|Withdrawal by Subject|1|||
48848632|NCT02972359|157284949|FG000|Overall Study|Death|1|||
48848633|NCT02972359|157284949|FG000|Overall Study|Withdrawal by Subject|30|||
48848634|NCT02972359|157284949|FG000|Overall Study|Protocol Violation|1|||
48848635|NCT02972359|157284949|FG000|Overall Study|Lost to Follow-up|26|||
48848636|NCT02972359|157284949|FG000|Overall Study|Other reasons|5|||
48848637|NCT02972359|157284949|FG000|Overall Study|Missing|1|||
48848638|NCT02928172|157284950|FG000|Overall Study|Device did not record data|1|||
48848639|NCT03333109|157284952|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
48848640|NCT03333109|157284953|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
48848641|NCT03333109|157284954|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
48848642|NCT03333109|157284952|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
48848643|NCT03333109|157284953|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
48848644|NCT03333109|157284954|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
48940295|NCT01238120|157611307|FG002|Overall Study|Withdrawal by Subject|2|||
48940296|NCT01238120|157611308|FG003|Overall Study|Withdrawal by Subject|5|||
48940297|NCT01238120|157611305|FG000|Overall Study|Lost to Follow-up|2|||
48940298|NCT01238120|157611306|FG001|Overall Study|Lost to Follow-up|0|||
48940299|NCT01238120|157611307|FG002|Overall Study|Lost to Follow-up|1|||
48940300|NCT01238120|157611308|FG003|Overall Study|Lost to Follow-up|1|||
48940301|NCT01238120|157611305|FG000|Overall Study|Withdrawn due to Medical Problem|2|||
48940302|NCT01238120|157611306|FG001|Overall Study|Withdrawn due to Medical Problem|0|||
48940303|NCT01238120|157611307|FG002|Overall Study|Withdrawn due to Medical Problem|1|||
48940304|NCT01238120|157611308|FG003|Overall Study|Withdrawn due to Medical Problem|0|||
48940305|NCT02209506|157611309|FG000|Overall Study|Withdrawal by Subject|0|||
48940306|NCT02209506|157611310|FG001|Overall Study|Withdrawal by Subject|0|||
48940307|NCT02209506|157611311|FG002|Overall Study|Withdrawal by Subject|0|||
48940308|NCT02209506|157611312|FG003|Overall Study|Withdrawal by Subject|0|||
48940309|NCT02209506|157611313|FG004|Overall Study|Withdrawal by Subject|1|||
48940310|NCT00098787|157611318|FG000|Overall Study|Never started treatment|3|||
48940311|NCT00098787|157611319|FG001|Overall Study|Never started treatment|2|||
48940312|NCT00098787|157611320|FG002|Overall Study|Never started treatment|1|||
48940313|NCT00098787|157611318|FG000|Overall Study|Ineligible|9|||
48940314|NCT00098787|157611319|FG001|Overall Study|Ineligible|7|||
48940315|NCT00098787|157611320|FG002|Overall Study|Ineligible|3|||
48940316|NCT00098787|157611318|FG000|Overall Study|Disease progression|28|||
48940317|NCT00098787|157611319|FG001|Overall Study|Disease progression|17|||
48940318|NCT00098787|157611320|FG002|Overall Study|Disease progression|23|||
48940319|NCT00098787|157611318|FG000|Overall Study|Adverse Event|8|||
48940320|NCT00098787|157611319|FG001|Overall Study|Adverse Event|17|||
48940321|NCT00098787|157611320|FG002|Overall Study|Adverse Event|8|||
48940322|NCT00098787|157611318|FG000|Overall Study|Death|6|||
48940323|NCT00098787|157611319|FG001|Overall Study|Death|1|||
48940324|NCT00098787|157611320|FG002|Overall Study|Death|0|||
48940325|NCT00098787|157611318|FG000|Overall Study|Withdrawal by Subject|4|||
48940326|NCT00098787|157611319|FG001|Overall Study|Withdrawal by Subject|12|||
48940327|NCT00098787|157611320|FG002|Overall Study|Withdrawal by Subject|6|||
48940328|NCT00098787|157611318|FG000|Overall Study|Alternative therapy|8|||
48940329|NCT00098787|157611319|FG001|Overall Study|Alternative therapy|13|||
48940330|NCT00098787|157611320|FG002|Overall Study|Alternative therapy|13|||
48940331|NCT00098787|157611318|FG000|Overall Study|Other|7|||
48940332|NCT00098787|157611319|FG001|Overall Study|Other|6|||
48940333|NCT00098787|157611320|FG002|Overall Study|Other|9|||
48940334|NCT01276288|157611321|FG000|Overall Study|Adverse Event|1|||
48940335|NCT01276288|157611322|FG001|Overall Study|Adverse Event|1|||
48940336|NCT01276288|157611323|FG002|Overall Study|Adverse Event|0|||
48940337|NCT01276288|157611324|FG003|Overall Study|Adverse Event|0|||
48940338|NCT01276288|157611321|FG000|Overall Study|not treated|1|||
48940339|NCT01276288|157611322|FG001|Overall Study|not treated|0|||
48940340|NCT01276288|157611323|FG002|Overall Study|not treated|0|||
48940341|NCT01276288|157611324|FG003|Overall Study|not treated|0|||
48940342|NCT02203149|157611325|FG000|Part 1|Adverse Event|0|||
48940343|NCT02203149|157611326|FG001|Part 1|Adverse Event|1|||
48940344|NCT02203149|157611327|FG002|Part 1|Adverse Event|0|||
48940345|NCT02203149|157611328|FG003|Part 1|Adverse Event|0|||
48848645|NCT03333109|157284952|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|4|||
48848646|NCT03333109|157284953|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
48848647|NCT03333109|157284954|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|1|||
48848648|NCT03333109|157284952|FG000|Double-blind Treatment Period (DBTP)|Pregnancy|1|||
48848649|NCT03333109|157284953|FG001|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
48848650|NCT03333109|157284954|FG002|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
48848651|NCT03333109|157284952|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9|||
48848652|NCT03333109|157284953|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
48848653|NCT03333109|157284954|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5|||
48848654|NCT03333109|157284952|FG000|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
48848655|NCT03333109|157284953|FG001|Double-blind Treatment Period (DBTP)|Randomized but not treated|0|||
48848656|NCT03333109|157284954|FG002|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
48848657|NCT03333109|157284952|FG000|Safety Follow-up Period|Lost to Follow-up|6|||
48848658|NCT03333109|157284953|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
48848659|NCT03333109|157284954|FG002|Safety Follow-up Period|Lost to Follow-up|1|||
48848660|NCT03333109|157284952|FG000|Safety Follow-up Period|Withdrawal by Subject|7|||
48848661|NCT03333109|157284953|FG001|Safety Follow-up Period|Withdrawal by Subject|2|||
48848662|NCT03333109|157284954|FG002|Safety Follow-up Period|Withdrawal by Subject|12|||
48848663|NCT00918203|157284955|FG000|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
48848664|NCT00918203|157284956|FG001|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
48848665|NCT00918203|157284957|FG002|Treatment With or Without Olaratumab|Lost to Follow-up|0|||
48848666|NCT00918203|157284955|FG000|Treatment With or Without Olaratumab|Withdrawal by Subject|2|||
48848667|NCT00918203|157284956|FG001|Treatment With or Without Olaratumab|Withdrawal by Subject|8|||
48848668|NCT00918203|157284957|FG002|Treatment With or Without Olaratumab|Withdrawal by Subject|0|||
48848669|NCT00918203|157284955|FG000|Treatment With or Without Olaratumab|Other Therapy Started|2|||
48940346|NCT02203149|157611329|FG004|Part 1|Adverse Event|0|||
48940347|NCT02203149|157611325|FG000|Part 2|Death|0|||
48940348|NCT02203149|157611326|FG001|Part 2|Death|0|||
48940349|NCT02203149|157611327|FG002|Part 2|Death|1|||
48940350|NCT02203149|157611328|FG003|Part 2|Death|1|||
48940351|NCT02203149|157611329|FG004|Part 2|Death|0|||
48940352|NCT02203149|157611325|FG000|Part 2|Withdrawal by Subject|0|||
48940353|NCT02203149|157611326|FG001|Part 2|Withdrawal by Subject|0|||
48940354|NCT02203149|157611327|FG002|Part 2|Withdrawal by Subject|0|||
48940355|NCT02203149|157611328|FG003|Part 2|Withdrawal by Subject|1|||
48940356|NCT02203149|157611329|FG004|Part 2|Withdrawal by Subject|0|||
48940357|NCT02203149|157611325|FG000|Part 2|Adverse Event|0|||
48940358|NCT02203149|157611326|FG001|Part 2|Adverse Event|0|||
48940359|NCT02203149|157611327|FG002|Part 2|Adverse Event|0|||
48940360|NCT02203149|157611328|FG003|Part 2|Adverse Event|1|||
48940361|NCT02203149|157611329|FG004|Part 2|Adverse Event|1|||
48940362|NCT01478958|157611335|FG000|Overall Study|Withdrawal by Subject|1|||
48940363|NCT01478958|157611336|FG001|Overall Study|Withdrawal by Subject|1|||
48940364|NCT01478958|157611337|FG002|Overall Study|Withdrawal by Subject|1|||
48940365|NCT01478958|157611335|FG000|Overall Study|Weight loss|1|||
48940366|NCT01478958|157611336|FG001|Overall Study|Weight loss|0|||
48940367|NCT01478958|157611337|FG002|Overall Study|Weight loss|0|||
48940368|NCT01478958|157611335|FG000|Overall Study|Re-located|0|||
48940369|NCT01478958|157611336|FG001|Overall Study|Re-located|1|||
48940370|NCT01478958|157611337|FG002|Overall Study|Re-located|0|||
48940371|NCT01478958|157611335|FG000|Overall Study|Unable to comply|0|||
48940372|NCT01478958|157611336|FG001|Overall Study|Unable to comply|0|||
48940373|NCT01478958|157611337|FG002|Overall Study|Unable to comply|2|||
48940374|NCT00519077|157611342|FG000|Overall Study|Death|6|||
48940375|NCT00519077|157611342|FG000|Overall Study|Other|2|||
48940376|NCT01193335|157611343|FG000|After Infant Series|Lost to Follow-up|1|||
48940377|NCT01193335|157611344|FG001|After Infant Series|Lost to Follow-up|2|||
48940378|NCT01193335|157611343|FG000|After Infant Series|No Longer Met Eligibility Criteria|0|||
48940379|NCT01193335|157611344|FG001|After Infant Series|No Longer Met Eligibility Criteria|1|||
48940380|NCT01193335|157611343|FG000|1-Year Follow-up|No Longer Willing to Participate|7|||
48940381|NCT01193335|157611344|FG001|1-Year Follow-up|No Longer Willing to Participate|9|||
48940382|NCT01193335|157611343|FG000|1-Year Follow-up|Lost to Follow-up|4|||
48940383|NCT01193335|157611344|FG001|1-Year Follow-up|Lost to Follow-up|0|||
48940384|NCT01193335|157611343|FG000|2-Year Follow-up|No Longer Willing to Participate|5|||
48940385|NCT01193335|157611344|FG001|2-Year Follow-up|No Longer Willing to Participate|6|||
48940386|NCT01193335|157611343|FG000|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
48940387|NCT01193335|157611344|FG001|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
48940388|NCT02201940|157611345|FG000|Overall Study|Randomized/Enrolled but Never Treated|1|||
48940389|NCT02201940|157611346|FG001|Overall Study|Randomized/Enrolled but Never Treated|0|||
48940390|NCT02201940|157611345|FG000|Overall Study|Lack of Efficacy|2|||
48940391|NCT02201940|157611346|FG001|Overall Study|Lack of Efficacy|113|||
48940392|NCT02201940|157611345|FG000|Overall Study|Lost to Follow-up|5|||
48940393|NCT02201940|157611346|FG001|Overall Study|Lost to Follow-up|0|||
48940394|NCT02201940|157611345|FG000|Overall Study|Withdrew Consent|2|||
48940395|NCT02201940|157611346|FG001|Overall Study|Withdrew Consent|1|||
48940396|NCT02201940|157611345|FG000|Overall Study|Investigator's Discretion|1|||
48940397|NCT02201940|157611346|FG001|Overall Study|Investigator's Discretion|1|||
48940398|NCT02201940|157611345|FG000|Overall Study|Death|1|||
48940399|NCT02201940|157611346|FG001|Overall Study|Death|0|||
48940400|NCT02201940|157611345|FG000|Overall Study|Adverse Event|0|||
48940401|NCT02201940|157611346|FG001|Overall Study|Adverse Event|1|||
48940402|NCT02469246|157611347|FG000|Double-Blind Phase|Randomized and Never Treated|5|||
48940403|NCT02469246|157611348|FG001|Double-Blind Phase|Randomized and Never Treated|6|||
48940404|NCT02469246|157611347|FG000|Double-Blind Phase|Adverse Event|12|||
48940405|NCT02469246|157611348|FG001|Double-Blind Phase|Adverse Event|9|||
48940406|NCT02469246|157611347|FG000|Double-Blind Phase|Death|2|||
48940407|NCT02469246|157611348|FG001|Double-Blind Phase|Death|0|||
48940408|NCT02469246|157611347|FG000|Double-Blind Phase|Lack of Efficacy|2|||
48940409|NCT02469246|157611348|FG001|Double-Blind Phase|Lack of Efficacy|1|||
48940410|NCT02469246|157611347|FG000|Double-Blind Phase|Investigator's Discretion|8|||
48940411|NCT02469246|157611348|FG001|Double-Blind Phase|Investigator's Discretion|8|||
48940412|NCT02469246|157611347|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
48940413|NCT02469246|157611348|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
48940414|NCT02469246|157611347|FG000|Double-Blind Phase|Protocol Violation|1|||
48940415|NCT02469246|157611348|FG001|Double-Blind Phase|Protocol Violation|1|||
48940416|NCT02469246|157611347|FG000|Double-Blind Phase|Withdrew Consent|25|||
48940417|NCT02469246|157611348|FG001|Double-Blind Phase|Withdrew Consent|25|||
48940418|NCT02469246|157611347|FG000|Double-Blind Phase|Lost to Follow-up|9|||
48940419|NCT02469246|157611348|FG001|Double-Blind Phase|Lost to Follow-up|5|||
48940420|NCT02048904|157611358|FG000|Overall Study|Withdrawal by Subject|7|||
48940421|NCT02048904|157611358|FG000|Overall Study|Physician Decision|70|||
48940422|NCT00749190|157611359|FG000|Overall Study|Adverse Event|0|||
48940423|NCT00749190|157611360|FG001|Overall Study|Adverse Event|2|||
48940424|NCT00749190|157611361|FG002|Overall Study|Adverse Event|0|||
48940425|NCT00749190|157611362|FG003|Overall Study|Adverse Event|4|||
48940426|NCT00749190|157611363|FG004|Overall Study|Adverse Event|0|||
48940427|NCT00749190|157611364|FG005|Overall Study|Adverse Event|3|||
48940428|NCT00749190|157611365|FG006|Overall Study|Adverse Event|0|||
48940429|NCT00749190|157611359|FG000|Overall Study|Lack of Efficacy|3|||
48940430|NCT00749190|157611360|FG001|Overall Study|Lack of Efficacy|1|||
48940431|NCT00749190|157611361|FG002|Overall Study|Lack of Efficacy|1|||
48940432|NCT00749190|157611362|FG003|Overall Study|Lack of Efficacy|0|||
48940433|NCT00749190|157611363|FG004|Overall Study|Lack of Efficacy|0|||
48940434|NCT00749190|157611364|FG005|Overall Study|Lack of Efficacy|1|||
48940435|NCT00749190|157611365|FG006|Overall Study|Lack of Efficacy|0|||
48940436|NCT00749190|157611359|FG000|Overall Study|Withdrawal by Subject|2|||
48940437|NCT00749190|157611360|FG001|Overall Study|Withdrawal by Subject|1|||
48940438|NCT00749190|157611361|FG002|Overall Study|Withdrawal by Subject|0|||
48940439|NCT00749190|157611362|FG003|Overall Study|Withdrawal by Subject|0|||
48940440|NCT00749190|157611363|FG004|Overall Study|Withdrawal by Subject|0|||
48940441|NCT00749190|157611364|FG005|Overall Study|Withdrawal by Subject|1|||
48940442|NCT00749190|157611365|FG006|Overall Study|Withdrawal by Subject|0|||
48940443|NCT00749190|157611359|FG000|Overall Study|Protocol Violation|0|||
48940444|NCT00749190|157611360|FG001|Overall Study|Protocol Violation|1|||
48940445|NCT00749190|157611361|FG002|Overall Study|Protocol Violation|0|||
48940446|NCT00749190|157611362|FG003|Overall Study|Protocol Violation|0|||
48940447|NCT00749190|157611363|FG004|Overall Study|Protocol Violation|0|||
48940448|NCT00749190|157611364|FG005|Overall Study|Protocol Violation|0|||
48940449|NCT00749190|157611365|FG006|Overall Study|Protocol Violation|1|||
48940450|NCT00749190|157611359|FG000|Overall Study|Other reason not defined above|0|||
48940451|NCT00749190|157611360|FG001|Overall Study|Other reason not defined above|0|||
48940452|NCT00749190|157611361|FG002|Overall Study|Other reason not defined above|0|||
48940453|NCT00749190|157611362|FG003|Overall Study|Other reason not defined above|1|||
48940454|NCT00749190|157611363|FG004|Overall Study|Other reason not defined above|0|||
48940455|NCT00749190|157611364|FG005|Overall Study|Other reason not defined above|0|||
48940456|NCT00749190|157611365|FG006|Overall Study|Other reason not defined above|0|||
48940457|NCT01299025|157611366|FG000|Overall Study|Withdrawal by Subject|2|||
48940458|NCT01299025|157611367|FG001|Overall Study|Withdrawal by Subject|1|||
48940459|NCT01299025|157611366|FG000|Overall Study|Lost to Follow-up|1|||
48940460|NCT01299025|157611367|FG001|Overall Study|Lost to Follow-up|0|||
48940461|NCT00004980|157611368|FG000|Overall Study|Withdrawal by Subject|1|||
48940462|NCT00004980|157611369|FG001|Overall Study|Withdrawal by Subject|0|||
48940463|NCT00004980|157611368|FG000|Overall Study|memory difficulties|1|||
48940464|NCT00004980|157611369|FG001|Overall Study|memory difficulties|1|||
48940465|NCT00004980|157611368|FG000|Overall Study|Physician Decision|0|||
48940466|NCT00004980|157611369|FG001|Overall Study|Physician Decision|1|||
48940467|NCT01076179|157611370|FG000|Overall Study|Withdrawal by Subject|1|||
48940468|NCT00609622|157611372|FG000|Overall Study|Adverse Event|14|||
48940469|NCT00609622|157611373|FG001|Overall Study|Adverse Event|10|||
48940470|NCT00609622|157611372|FG000|Overall Study|Withdrawal by Subject|4|||
48940471|NCT00609622|157611373|FG001|Overall Study|Withdrawal by Subject|20|||
48940472|NCT00609622|157611372|FG000|Overall Study|Death|1|||
48940473|NCT00609622|157611373|FG001|Overall Study|Death|4|||
48940474|NCT00609622|157611372|FG000|Overall Study|Protocol Violation|1|||
48940475|NCT00609622|157611373|FG001|Overall Study|Protocol Violation|1|||
48940476|NCT00609622|157611372|FG000|Overall Study|Objective progression or relapse|47|||
48940477|NCT00609622|157611373|FG001|Overall Study|Objective progression or relapse|41|||
48940478|NCT00609622|157611372|FG000|Overall Study|Study terminated by sponsor|16|||
48848670|NCT00918203|157284956|FG001|Treatment With or Without Olaratumab|Other Therapy Started|1|||
48848671|NCT00918203|157284957|FG002|Treatment With or Without Olaratumab|Other Therapy Started|0|||
48848672|NCT00918203|157284955|FG000|Treatment With or Without Olaratumab|Never Treated/Death|1|||
48848673|NCT00918203|157284956|FG001|Treatment With or Without Olaratumab|Never Treated/Death|0|||
48848674|NCT00918203|157284957|FG002|Treatment With or Without Olaratumab|Never Treated/Death|0|||
48848675|NCT01075152|157284958|FG000|Overall Study|Withdrawal by Subject|1|||
48848676|NCT01075152|157284959|FG001|Overall Study|Withdrawal by Subject|0|||
48848677|NCT00589875|157284960|FG000|Enrollment to Treatment Initiation|Patients ineligable for study.|9|||
48848678|NCT00589875|157284960|FG000|Treatment Initiation to Completion|Treatment discontinuation|7|||
48848679|NCT03488719|157284961|FG000|Overall Study|Adverse Event|0|||
48848680|NCT03488719|157284962|FG001|Overall Study|Adverse Event|4|||
48848681|NCT03488719|157284963|FG002|Overall Study|Adverse Event|2|||
48848682|NCT03488719|157284961|FG000|Overall Study|Other|0|||
48848683|NCT03488719|157284962|FG001|Overall Study|Other|0|||
48848684|NCT03488719|157284963|FG002|Overall Study|Other|5|||
48940479|NCT00609622|157611373|FG001|Overall Study|Study terminated by sponsor|3|||
48940480|NCT00609622|157611372|FG000|Overall Study|Other|7|||
48940481|NCT00609622|157611373|FG001|Overall Study|Other|14|||
48940482|NCT00609622|157611372|FG000|Overall Study|Global deterioration of health status|6|||
48940483|NCT00609622|157611373|FG001|Overall Study|Global deterioration of health status|2|||
48940484|NCT01650805|157611374|FG000|Overall Study|Withdrawal by Subject|1|||
48940485|NCT01650805|157611375|FG001|Overall Study|Withdrawal by Subject|0|||
48848685|NCT03476798|157284964|FG000|Overall Study|Death|1|||
48940486|NCT04574999|157612959|FG000|Overall Study|Adverse Event|1|||
48848686|NCT03476798|157284964|FG000|Overall Study|Withdrawal by Subject|2|||
48848687|NCT03476798|157284964|FG000|Overall Study|Protocol Violation|2|||
48848688|NCT05070741|157284965|FG000|Overall Study|Failed initial laboratory testing and was unable to progress to heat therapy treatment.|1|||
48848689|NCT05824559|157284966|FG000|Overall Study|Adverse Event|2|||
48848690|NCT05824559|157284966|FG000|Overall Study|Physician Decision|2|||
48848691|NCT05824559|157284966|FG000|Overall Study|Progressive Disease|16|||
48848692|NCT05824559|157284966|FG000|Overall Study|Study Terminated by Sponsor|1|||
48848693|NCT05824559|157284966|FG000|Overall Study|Withdrawal by Subject|2|||
48848694|NCT02409680|157284969|FG000|Overall Study|Lost to Follow-up|15|||
48848695|NCT02409680|157284970|FG001|Overall Study|Lost to Follow-up|30|||
48848696|NCT01371994|157284971|FG000|Overall Study|Adverse Event|3|||
48848697|NCT01371994|157284972|FG001|Overall Study|Adverse Event|6|||
48848698|NCT01371994|157284971|FG000|Overall Study|Lack of Efficacy|3|||
48848699|NCT01371994|157284972|FG001|Overall Study|Lack of Efficacy|0|||
48848700|NCT01371994|157284971|FG000|Overall Study|Withdrawal by Subject|13|||
48848701|NCT01371994|157284972|FG001|Overall Study|Withdrawal by Subject|7|||
48848702|NCT01371994|157284971|FG000|Overall Study|Lost to Follow-up|1|||
48848703|NCT01371994|157284972|FG001|Overall Study|Lost to Follow-up|1|||
48848704|NCT01371994|157284971|FG000|Overall Study|Protocol Violation|24|||
48848705|NCT01371994|157284972|FG001|Overall Study|Protocol Violation|17|||
48848706|NCT01371994|157284971|FG000|Overall Study|Randomized but Never Received Study Drug|6|||
48848707|NCT01371994|157284972|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
48848708|NCT01371994|157284971|FG000|Overall Study|Physician Decision|1|||
48848709|NCT01371994|157284972|FG001|Overall Study|Physician Decision|1|||
48848710|NCT01371994|157284971|FG000|Overall Study|Miscellaneous Reasons|6|||
48848711|NCT01371994|157284972|FG001|Overall Study|Miscellaneous Reasons|4|||
48848722|NCT01084863|157284975|FG000|Main Study Treatment Period|Disease progression|11|||
48848723|NCT01084863|157284976|FG001|Main Study Treatment Period|Disease progression|7|||
48848724|NCT01084863|157284975|FG000|Main Study Treatment Period|Adverse Event|5|||
48848725|NCT01084863|157284976|FG001|Main Study Treatment Period|Adverse Event|3|||
48848726|NCT01084863|157284975|FG000|Main Study Treatment Period|Other Reason|0|||
48848727|NCT01084863|157284976|FG001|Main Study Treatment Period|Other Reason|1|||
48848728|NCT01084863|157284975|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
48848729|NCT01084863|157284976|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
48848730|NCT01084863|157284975|FG000|Treatment Period Beyond Cycle 8|Physician Decision|2|||
48848731|NCT01084863|157284976|FG001|Treatment Period Beyond Cycle 8|Physician Decision|4|||
48848732|NCT01084863|157284975|FG000|Treatment Period Beyond Cycle 8|Disease progression|51|||
48848733|NCT01084863|157284976|FG001|Treatment Period Beyond Cycle 8|Disease progression|45|||
48848734|NCT01084863|157284975|FG000|Treatment Period Beyond Cycle 8|Adverse Event|1|||
48848735|NCT01084863|157284976|FG001|Treatment Period Beyond Cycle 8|Adverse Event|0|||
48848736|NCT01084863|157284975|FG000|Treatment Period Beyond Cycle 8|Other|0|||
48848737|NCT01084863|157284976|FG001|Treatment Period Beyond Cycle 8|Other|1|||
48848738|NCT01084863|157284975|FG000|Treatment Period Beyond Cycle 8|Other reason|2|||
48848739|NCT01084863|157284976|FG001|Treatment Period Beyond Cycle 8|Other reason|2|||
48848740|NCT03936660|157286857|FG000|Overall Study|Missing medication data at 6 and 12 months.|2|||
48848741|NCT03936660|157286858|FG001|Overall Study|Missing medication data at 6 and 12 months.|2|||
48848742|NCT00968149|157286859|FG000|Overall Study|Adverse Event|5|||
48848743|NCT00968149|157286860|FG001|Overall Study|Adverse Event|1|||
48848744|NCT00968149|157286859|FG000|Overall Study|Lack of Efficacy|0|||
48848745|NCT00968149|157286860|FG001|Overall Study|Lack of Efficacy|4|||
48848746|NCT00968149|157286859|FG000|Overall Study|Lost to Follow-up|0|||
48848747|NCT00968149|157286860|FG001|Overall Study|Lost to Follow-up|1|||
48848748|NCT00968149|157286859|FG000|Overall Study|Protocol Violation|4|||
48940487|NCT04574999|157612960|FG001|Overall Study|Adverse Event|0|||
48940488|NCT04574999|157612959|FG000|Overall Study|Lack of Efficacy|2|||
48940489|NCT04574999|157612960|FG001|Overall Study|Lack of Efficacy|3|||
48940490|NCT04574999|157612959|FG000|Overall Study|Protocol Violation|1|||
48940491|NCT04574999|157612960|FG001|Overall Study|Protocol Violation|0|||
48940492|NCT04574999|157612959|FG000|Overall Study|Withdrawal by Subject|2|||
48940493|NCT04574999|157612960|FG001|Overall Study|Withdrawal by Subject|2|||
48940494|NCT04574999|157612959|FG000|Overall Study|Lost to Follow-up|1|||
48940495|NCT04574999|157612960|FG001|Overall Study|Lost to Follow-up|0|||
48940496|NCT04574999|157612959|FG000|Overall Study|Personal problems|1|||
48940497|NCT04574999|157612960|FG001|Overall Study|Personal problems|0|||
48940498|NCT04574999|157612959|FG000|Overall Study|Previous planned surgery|1|||
48940499|NCT04574999|157612960|FG001|Overall Study|Previous planned surgery|0|||
48940500|NCT02185521|157612961|FG000|Overall Study|Withdrawal by Subject|1|||
48940501|NCT02185521|157612961|FG000|Overall Study|Protocol Violation|1|||
48940502|NCT00768222|157612964|FG000|Overall Study|Lost to Follow-up|1|||
48940503|NCT00768222|157612965|FG001|Overall Study|Lost to Follow-up|1|||
48940504|NCT00768222|157612964|FG000|Overall Study|Withdrawal by Subject|3|||
48940505|NCT00768222|157612965|FG001|Overall Study|Withdrawal by Subject|1|||
48940506|NCT00768222|157612964|FG000|Overall Study|Protocol Violation|0|||
48940507|NCT00768222|157612965|FG001|Overall Study|Protocol Violation|2|||
48940508|NCT03263091|157612966|FG000|OL Component|Withdrawal by Subject|1|||
48940509|NCT03263091|157612967|FG001|OL Component|Withdrawal by Subject|1|||
48940510|NCT03263091|157612968|FG002|OL Component|Withdrawal by Subject|0|||
48940511|NCT03263091|157612969|FG003|OL Component|Withdrawal by Subject|0|||
48940512|NCT03263091|157612970|FG004|OL Component|Withdrawal by Subject|0|||
48940513|NCT03263091|157612971|FG005|OL Component|Withdrawal by Subject|0|||
48940514|NCT03263091|157612966|FG000|OL Component|Physician Decision|0|||
48940515|NCT03263091|157612967|FG001|OL Component|Physician Decision|1|||
48940516|NCT03263091|157612968|FG002|OL Component|Physician Decision|2|||
48940517|NCT03263091|157612969|FG003|OL Component|Physician Decision|0|||
48940518|NCT03263091|157612970|FG004|OL Component|Physician Decision|0|||
48940519|NCT03263091|157612971|FG005|OL Component|Physician Decision|0|||
48940520|NCT03263091|157612966|FG000|OL Component|Death|1|||
48940521|NCT03263091|157612967|FG001|OL Component|Death|0|||
48940522|NCT03263091|157612968|FG002|OL Component|Death|0|||
48940523|NCT03263091|157612969|FG003|OL Component|Death|0|||
48940524|NCT03263091|157612970|FG004|OL Component|Death|0|||
48940525|NCT03263091|157612971|FG005|OL Component|Death|0|||
48940526|NCT03263091|157612966|FG000|OL High-EPO Component|Withdrawal by Subject|0|||
48940527|NCT03263091|157612967|FG001|OL High-EPO Component|Withdrawal by Subject|0|||
48940528|NCT03263091|157612968|FG002|OL High-EPO Component|Withdrawal by Subject|0|||
48940529|NCT03263091|157612969|FG003|OL High-EPO Component|Withdrawal by Subject|6|||
48940530|NCT03263091|157612970|FG004|OL High-EPO Component|Withdrawal by Subject|0|||
48940531|NCT03263091|157612971|FG005|OL High-EPO Component|Withdrawal by Subject|0|||
48940532|NCT03263091|157612966|FG000|OL High-EPO Component|Physician Decision|0|||
48940533|NCT03263091|157612967|FG001|OL High-EPO Component|Physician Decision|0|||
48940534|NCT03263091|157612968|FG002|OL High-EPO Component|Physician Decision|0|||
48940535|NCT03263091|157612969|FG003|OL High-EPO Component|Physician Decision|1|||
48940536|NCT03263091|157612970|FG004|OL High-EPO Component|Physician Decision|0|||
48940537|NCT03263091|157612971|FG005|OL High-EPO Component|Physician Decision|0|||
48940538|NCT03263091|157612966|FG000|OL High-EPO Component|Death|0|||
48940539|NCT03263091|157612967|FG001|OL High-EPO Component|Death|0|||
48940540|NCT03263091|157612968|FG002|OL High-EPO Component|Death|0|||
48940541|NCT03263091|157612969|FG003|OL High-EPO Component|Death|3|||
48940542|NCT03263091|157612970|FG004|OL High-EPO Component|Death|0|||
48940543|NCT03263091|157612971|FG005|OL High-EPO Component|Death|0|||
48940544|NCT03263091|157612966|FG000|DB Component|Withdrawal by Subject|0|||
48940545|NCT03263091|157612967|FG001|DB Component|Withdrawal by Subject|0|||
48940546|NCT03263091|157612968|FG002|DB Component|Withdrawal by Subject|0|||
48940547|NCT03263091|157612969|FG003|DB Component|Withdrawal by Subject|0|||
48940548|NCT03263091|157612970|FG004|DB Component|Withdrawal by Subject|22|||
48940549|NCT03263091|157612971|FG005|DB Component|Withdrawal by Subject|8|||
48940550|NCT03263091|157612966|FG000|DB Component|Physician Decision|0|||
48940551|NCT03263091|157612967|FG001|DB Component|Physician Decision|0|||
48940552|NCT03263091|157612968|FG002|DB Component|Physician Decision|0|||
48940553|NCT03263091|157612969|FG003|DB Component|Physician Decision|0|||
48940554|NCT03263091|157612970|FG004|DB Component|Physician Decision|3|||
48940555|NCT03263091|157612971|FG005|DB Component|Physician Decision|1|||
48940556|NCT03263091|157612966|FG000|DB Component|Adverse Event|0|||
48940557|NCT03263091|157612967|FG001|DB Component|Adverse Event|0|||
48940558|NCT03263091|157612968|FG002|DB Component|Adverse Event|0|||
48940559|NCT03263091|157612969|FG003|DB Component|Adverse Event|0|||
48940560|NCT03263091|157612970|FG004|DB Component|Adverse Event|2|||
48940561|NCT03263091|157612971|FG005|DB Component|Adverse Event|1|||
48940562|NCT03263091|157612966|FG000|DB Component|Lost to Follow-up|0|||
48940563|NCT03263091|157612967|FG001|DB Component|Lost to Follow-up|0|||
48940564|NCT03263091|157612968|FG002|DB Component|Lost to Follow-up|0|||
48940565|NCT03263091|157612969|FG003|DB Component|Lost to Follow-up|0|||
48940566|NCT03263091|157612970|FG004|DB Component|Lost to Follow-up|2|||
48940567|NCT03263091|157612971|FG005|DB Component|Lost to Follow-up|1|||
48940568|NCT03263091|157612966|FG000|DB Component|Death|0|||
48940569|NCT03263091|157612967|FG001|DB Component|Death|0|||
48940570|NCT03263091|157612968|FG002|DB Component|Death|0|||
48940571|NCT03263091|157612969|FG003|DB Component|Death|0|||
48940572|NCT03263091|157612970|FG004|DB Component|Death|7|||
48940573|NCT03263091|157612971|FG005|DB Component|Death|4|||
48940574|NCT03263091|157612966|FG000|DB Component|Other than specified|0|||
48940575|NCT03263091|157612967|FG001|DB Component|Other than specified|0|||
48940576|NCT03263091|157612968|FG002|DB Component|Other than specified|0|||
48940577|NCT03263091|157612969|FG003|DB Component|Other than specified|0|||
48940578|NCT03263091|157612970|FG004|DB Component|Other than specified|8|||
48940579|NCT03263091|157612971|FG005|DB Component|Other than specified|6|||
48940580|NCT02443402|157612973|FG000|Overall Study|Withdrawal by Subject|3|||
48940581|NCT02443402|157612974|FG001|Overall Study|Withdrawal by Subject|1|||
48940582|NCT02443402|157612973|FG000|Overall Study|Screen Failure|1|||
48940583|NCT02443402|157612974|FG001|Overall Study|Screen Failure|2|||
48940584|NCT02432807|157612977|FG000|Overall Study|Adverse Event|0|||
48940585|NCT02432807|157612978|FG001|Overall Study|Adverse Event|2|||
48940586|NCT02432807|157612977|FG000|Overall Study|Lost to Follow-up|1|||
48940587|NCT02432807|157612978|FG001|Overall Study|Lost to Follow-up|0|||
48940588|NCT02432807|157612977|FG000|Overall Study|Withdrawal by Subject|1|||
48940589|NCT02432807|157612978|FG001|Overall Study|Withdrawal by Subject|1|||
48940590|NCT02432807|157612977|FG000|Overall Study|Other|1|||
48940591|NCT02432807|157612978|FG001|Overall Study|Other|1|||
48940592|NCT00345605|157612983|FG000|Arm 1|Adverse Event|0|||
48940593|NCT00345605|157612984|FG001|Arm 1|Adverse Event|1|||
48940594|NCT00345605|157612983|FG000|Arm 2, Opposite Treatment|Adverse Event|1|||
48940595|NCT00345605|157612984|FG001|Arm 2, Opposite Treatment|Adverse Event|0|||
48940596|NCT01335971|157612985|FG000|Overall Study|Withdrawal by Subject|1|||
48940597|NCT01335971|157612986|FG001|Overall Study|Withdrawal by Subject|0|||
48940598|NCT01335971|157612987|FG002|Overall Study|Withdrawal by Subject|0|||
48940599|NCT01335971|157612985|FG000|Overall Study|Did not complete bronchoscopy|1|||
48940600|NCT01335971|157612986|FG001|Overall Study|Did not complete bronchoscopy|1|||
48940601|NCT01335971|157612987|FG002|Overall Study|Did not complete bronchoscopy|1|||
48940602|NCT02210780|157612988|FG000|Overall Study|Adverse Event|0|||
48940603|NCT02210780|157612989|FG001|Overall Study|Adverse Event|5|||
48940604|NCT02210780|157612988|FG000|Overall Study|Lost to Follow-up|2|||
48940605|NCT02210780|157612989|FG001|Overall Study|Lost to Follow-up|1|||
48940606|NCT02210780|157612988|FG000|Overall Study|Withdrawal by Subject|1|||
48940607|NCT02210780|157612989|FG001|Overall Study|Withdrawal by Subject|1|||
48940608|NCT02210780|157612988|FG000|Overall Study|Physician Decision|1|||
48940609|NCT02210780|157612989|FG001|Overall Study|Physician Decision|0|||
48940610|NCT02210780|157612988|FG000|Overall Study|Protocol Violation|1|||
48940611|NCT02210780|157612989|FG001|Overall Study|Protocol Violation|0|||
48940612|NCT02210780|157612988|FG000|Overall Study|Other than specified above|0|||
48940613|NCT02210780|157612989|FG001|Overall Study|Other than specified above|1|||
48940614|NCT02054702|157612993|FG000|Overall Study|Lost to Follow-up|3|||
48940615|NCT02054702|157612994|FG001|Overall Study|Lost to Follow-up|5|||
48940616|NCT02054702|157612993|FG000|Overall Study|Adverse Event|3|||
48940617|NCT02054702|157612994|FG001|Overall Study|Adverse Event|1|||
48940618|NCT02054702|157612993|FG000|Overall Study|Met Withdrawal Criteria|4|||
48940619|NCT02054702|157612994|FG001|Overall Study|Met Withdrawal Criteria|1|||
48940620|NCT02054702|157612993|FG000|Overall Study|Physician Decision|0|||
48940621|NCT02054702|157612994|FG001|Overall Study|Physician Decision|1|||
48940622|NCT02054702|157612993|FG000|Overall Study|Withdrawal by Subject|14|||
48940623|NCT02054702|157612994|FG001|Overall Study|Withdrawal by Subject|4|||
48940624|NCT01262898|157612995|FG000|Overall Study|Protocol Violation|1|||
48940625|NCT01262898|157612996|FG001|Overall Study|Protocol Violation|1|||
48940626|NCT01262898|157612997|FG002|Overall Study|Protocol Violation|0|||
48940627|NCT01262898|157612998|FG003|Overall Study|Protocol Violation|0|||
48940628|NCT01262898|157612995|FG000|Overall Study|Lost to Follow-up|1|||
48940629|NCT01262898|157612996|FG001|Overall Study|Lost to Follow-up|0|||
48940630|NCT01262898|157612997|FG002|Overall Study|Lost to Follow-up|0|||
48940631|NCT01262898|157612998|FG003|Overall Study|Lost to Follow-up|0|||
48940632|NCT01262898|157612995|FG000|Overall Study|Withdrawal by Subject|1|||
48940633|NCT01262898|157612996|FG001|Overall Study|Withdrawal by Subject|1|||
48940634|NCT01262898|157612997|FG002|Overall Study|Withdrawal by Subject|0|||
48940635|NCT01262898|157612998|FG003|Overall Study|Withdrawal by Subject|0|||
48940636|NCT02599402|157612999|FG000|Overall Study|Disease progression|153|||
48940637|NCT02599402|157612999|FG000|Overall Study|Study drug toxicity|201|||
48940638|NCT02599402|157612999|FG000|Overall Study|Death|26|||
48940639|NCT02599402|157612999|FG000|Overall Study|Adverse Event unrelated to study drug|23|||
48940640|NCT02599402|157612999|FG000|Overall Study|Participant request to discontinue study treatment|13|||
48940641|NCT02599402|157612999|FG000|Overall Study|Participant withdrew consent|5|||
48940642|NCT02599402|157612999|FG000|Overall Study|Lost to Follow-up|1|||
48940643|NCT02599402|157612999|FG000|Overall Study|Maximum Clinical Benefit|7|||
48940644|NCT02599402|157612999|FG000|Overall Study|Poor/non-compliance|1|||
48940645|NCT02599402|157612999|FG000|Overall Study|Pregnancy|1|||
48940646|NCT02599402|157612999|FG000|Overall Study|Participant no longer met study criteria|7|||
48940647|NCT02599402|157612999|FG000|Overall Study|Other Reasons|95|||
48940648|NCT02945657|157613000|FG000|Overall Study|Adverse Event|1|||
48940649|NCT02945657|157613000|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
48940650|NCT01295125|157613002|FG000|Overall Study|Study stopped prematurely|9|||
48940651|NCT00283387|157613005|FG000|First Intervention|Subject non-compliant|1|||
48940652|NCT00283387|157613006|FG001|First Intervention|Subject non-compliant|1|||
48940653|NCT00283387|157613005|FG000|First Intervention|Withdrawal by Subject|0|||
48940654|NCT00283387|157613006|FG001|First Intervention|Withdrawal by Subject|1|||
48940655|NCT01829048|157613007|FG000|Overall Study|Withdrawal by Subject|0|||
48940656|NCT01829048|157613008|FG001|Overall Study|Withdrawal by Subject|0|||
48940657|NCT01829048|157613009|FG002|Overall Study|Withdrawal by Subject|0|||
48940658|NCT01829048|157613010|FG003|Overall Study|Withdrawal by Subject|2|||
48940659|NCT01829048|157613011|FG004|Overall Study|Withdrawal by Subject|0|||
48940660|NCT00892437|157613014|FG000|Randomized Phase|Randomized but not treated|6|||
48940661|NCT00892437|157613015|FG001|Randomized Phase|Randomized but not treated|0|||
48940662|NCT00892437|157613014|FG000|Randomized Phase|Adverse Event|2|||
48940663|NCT00892437|157613015|FG001|Randomized Phase|Adverse Event|2|||
48940664|NCT00892437|157613014|FG000|Randomized Phase|Lost to Follow-up|1|||
48940665|NCT00892437|157613015|FG001|Randomized Phase|Lost to Follow-up|3|||
48940666|NCT00892437|157613014|FG000|Randomized Phase|Investigator's Discretion|1|||
48940667|NCT00892437|157613015|FG001|Randomized Phase|Investigator's Discretion|0|||
48940668|NCT00892437|157613014|FG000|Randomized Phase|Withdrew Consent|1|||
48940669|NCT00892437|157613015|FG001|Randomized Phase|Withdrew Consent|0|||
48940670|NCT00892437|157613014|FG000|Open-Label Extension Phase|Adverse Event|4|||
48940671|NCT00892437|157613015|FG001|Open-Label Extension Phase|Adverse Event|2|||
48940672|NCT00892437|157613014|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
48940673|NCT00892437|157613015|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
48940674|NCT00892437|157613014|FG000|Open-Label Extension Phase|Lost to Follow-up|3|||
48940675|NCT00892437|157613015|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
48940676|NCT00892437|157613014|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
48940677|NCT00892437|157613015|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
48940678|NCT00892437|157613014|FG000|Open-Label Extension Phase|Withdrew Consent|3|||
48940679|NCT00892437|157613015|FG001|Open-Label Extension Phase|Withdrew Consent|1|||
48940680|NCT04927312|157613016|FG000|Overall Study|Adverse Event|1|||
48940681|NCT04927312|157613016|FG000|Overall Study|Death|1|||
48940682|NCT04927312|157613016|FG000|Overall Study|Withdrawal by Subject|1|||
48940683|NCT04927312|157613016|FG000|Overall Study|Other|1|||
48940684|NCT00929240|157613034|FG000|Initial Treatment Phase|Adverse Event|31|||
48940685|NCT00929240|157613035|FG001|Initial Treatment Phase|Adverse Event|0|||
48940686|NCT00929240|157613036|FG002|Initial Treatment Phase|Adverse Event|0|||
48940687|NCT00929240|157613034|FG000|Initial Treatment Phase|Disease progression|41|||
48940688|NCT00929240|157613035|FG001|Initial Treatment Phase|Disease progression|0|||
48940689|NCT00929240|157613036|FG002|Initial Treatment Phase|Disease progression|0|||
48940690|NCT00929240|157613034|FG000|Initial Treatment Phase|Withdrawal by Subject|13|||
48940691|NCT00929240|157613035|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
48940692|NCT00929240|157613036|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
48940693|NCT00929240|157613034|FG000|Initial Treatment Phase|Protocol Violation|5|||
48940694|NCT00929240|157613035|FG001|Initial Treatment Phase|Protocol Violation|0|||
48940695|NCT00929240|157613036|FG002|Initial Treatment Phase|Protocol Violation|0|||
48940696|NCT00929240|157613034|FG000|Initial Treatment Phase|Death|2|||
48940697|NCT00929240|157613035|FG001|Initial Treatment Phase|Death|0|||
48940698|NCT00929240|157613036|FG002|Initial Treatment Phase|Death|0|||
48940699|NCT00929240|157613034|FG000|Initial Treatment Phase|Health authority/Study termination|3|||
48940700|NCT00929240|157613035|FG001|Initial Treatment Phase|Health authority/Study termination|0|||
48940701|NCT00929240|157613036|FG002|Initial Treatment Phase|Health authority/Study termination|0|||
48940702|NCT00929240|157613034|FG000|Initial Treatment Phase|Physician Decision|4|||
48940703|NCT00929240|157613035|FG001|Initial Treatment Phase|Physician Decision|0|||
48940704|NCT00929240|157613036|FG002|Initial Treatment Phase|Physician Decision|0|||
48940705|NCT00929240|157613034|FG000|Maintenance Phase|Disease progression|0|||
48940706|NCT00929240|157613035|FG001|Maintenance Phase|Disease progression|73|||
48940707|NCT00929240|157613036|FG002|Maintenance Phase|Disease progression|60|||
48940708|NCT00929240|157613034|FG000|Maintenance Phase|Adverse Event|0|||
48940709|NCT00929240|157613035|FG001|Maintenance Phase|Adverse Event|9|||
48940710|NCT00929240|157613036|FG002|Maintenance Phase|Adverse Event|12|||
48940711|NCT00929240|157613034|FG000|Maintenance Phase|Withdrawal by Subject|0|||
48940712|NCT00929240|157613035|FG001|Maintenance Phase|Withdrawal by Subject|2|||
48940713|NCT00929240|157613036|FG002|Maintenance Phase|Withdrawal by Subject|6|||
48940714|NCT00929240|157613034|FG000|Maintenance Phase|Protocol Violation|0|||
48940715|NCT00929240|157613035|FG001|Maintenance Phase|Protocol Violation|1|||
48940716|NCT00929240|157613036|FG002|Maintenance Phase|Protocol Violation|0|||
48940717|NCT00929240|157613034|FG000|Maintenance Phase|Health authority/Study termination|0|||
48940718|NCT00929240|157613035|FG001|Maintenance Phase|Health authority/Study termination|1|||
48940719|NCT00929240|157613036|FG002|Maintenance Phase|Health authority/Study termination|2|||
48940720|NCT00929240|157613034|FG000|Maintenance Phase|Physician Decision|0|||
48940721|NCT00929240|157613035|FG001|Maintenance Phase|Physician Decision|2|||
48940722|NCT00929240|157613036|FG002|Maintenance Phase|Physician Decision|1|||
48940723|NCT00929240|157613034|FG000|Maintenance Phase|Change of treatment|0|||
48940724|NCT00929240|157613035|FG001|Maintenance Phase|Change of treatment|4|||
48940725|NCT00929240|157613036|FG002|Maintenance Phase|Change of treatment|0|||
48940726|NCT00929240|157613034|FG000|Maintenance Phase|Treatment ongoing at study closure|0|||
48940727|NCT00929240|157613035|FG001|Maintenance Phase|Treatment ongoing at study closure|0|||
48940728|NCT00929240|157613036|FG002|Maintenance Phase|Treatment ongoing at study closure|10|||
48940729|NCT00929240|157613034|FG000|Maintenance Phase|Participant not treated|0|||
48940730|NCT00929240|157613035|FG001|Maintenance Phase|Participant not treated|2|||
48940731|NCT00929240|157613036|FG002|Maintenance Phase|Participant not treated|0|||
48940732|NCT03584009|157613037|FG000|Overall Study|Death|25|||
48940733|NCT03584009|157613038|FG001|Overall Study|Death|18|||
48940734|NCT03584009|157613037|FG000|Overall Study|Lost to Follow-up|0|||
48940735|NCT03584009|157613038|FG001|Overall Study|Lost to Follow-up|1|||
48940736|NCT03584009|157613037|FG000|Overall Study|Physician Decision|1|||
48940737|NCT03584009|157613038|FG001|Overall Study|Physician Decision|1|||
48940738|NCT03584009|157613037|FG000|Overall Study|Study Terminated by Sponsor|22|||
48940739|NCT03584009|157613038|FG001|Overall Study|Study Terminated by Sponsor|30|||
48940740|NCT03584009|157613037|FG000|Overall Study|Withdrawal by Subject|3|||
48940741|NCT03584009|157613038|FG001|Overall Study|Withdrawal by Subject|2|||
48940742|NCT04964258|157613039|FG000|Overall Study|Lost to Follow-up|1|||
48940743|NCT04964258|157613040|FG001|Overall Study|Lost to Follow-up|0|||
48940744|NCT04964258|157613041|FG002|Overall Study|Lost to Follow-up|0|||
48940745|NCT04964258|157613042|FG003|Overall Study|Lost to Follow-up|0|||
48940746|NCT04964258|157613043|FG004|Overall Study|Lost to Follow-up|0|||
48940747|NCT04964258|157613044|FG005|Overall Study|Lost to Follow-up|1|||
48940748|NCT04964258|157613045|FG006|Overall Study|Lost to Follow-up|0|||
48940749|NCT04964258|157613046|FG007|Overall Study|Lost to Follow-up|0|||
48940750|NCT04964258|157613047|FG008|Overall Study|Lost to Follow-up|0|||
48940751|NCT04964258|157613048|FG009|Overall Study|Lost to Follow-up|0|||
48940752|NCT04964258|157613049|FG010|Overall Study|Lost to Follow-up|0|||
48940753|NCT00693706|157613051|FG000|Overall Study|Protocol Violation|0|||
48940754|NCT00693706|157613052|FG001|Overall Study|Protocol Violation|1|||
48940755|NCT01794780|157613059|FG000|Overall Study|Adverse Event|0|||
48940756|NCT01794780|157613060|FG001|Overall Study|Adverse Event|1|||
48940757|NCT01794780|157613061|FG002|Overall Study|Adverse Event|2|||
48940758|NCT01794780|157613062|FG003|Overall Study|Adverse Event|0|||
48940759|NCT01794780|157613063|FG004|Overall Study|Adverse Event|0|||
48940760|NCT01794780|157613064|FG005|Overall Study|Adverse Event|0|||
48940761|NCT01794780|157613065|FG006|Overall Study|Adverse Event|0|||
48940762|NCT01794780|157613066|FG007|Overall Study|Adverse Event|0|||
48940763|NCT01794780|157613059|FG000|Overall Study|Death|0|||
48940764|NCT01794780|157613060|FG001|Overall Study|Death|2|||
48940765|NCT01794780|157613061|FG002|Overall Study|Death|14|||
48940766|NCT01794780|157613062|FG003|Overall Study|Death|1|||
48940767|NCT01794780|157613063|FG004|Overall Study|Death|0|||
48940768|NCT01794780|157613064|FG005|Overall Study|Death|9|||
48940769|NCT01794780|157613065|FG006|Overall Study|Death|4|||
48940770|NCT01794780|157613066|FG007|Overall Study|Death|0|||
48940771|NCT01794780|157613059|FG000|Overall Study|Lost to Follow-up|10|||
48940772|NCT01794780|157613060|FG001|Overall Study|Lost to Follow-up|64|||
48940773|NCT01794780|157613061|FG002|Overall Study|Lost to Follow-up|165|||
48940774|NCT01794780|157613062|FG003|Overall Study|Lost to Follow-up|53|||
48940775|NCT01794780|157613063|FG004|Overall Study|Lost to Follow-up|2|||
48940776|NCT01794780|157613064|FG005|Overall Study|Lost to Follow-up|99|||
48940777|NCT01794780|157613065|FG006|Overall Study|Lost to Follow-up|30|||
48940778|NCT01794780|157613066|FG007|Overall Study|Lost to Follow-up|5|||
48940779|NCT01794780|157613059|FG000|Overall Study|Withdrew informed consent|7|||
48940780|NCT01794780|157613060|FG001|Overall Study|Withdrew informed consent|17|||
48940781|NCT01794780|157613061|FG002|Overall Study|Withdrew informed consent|36|||
48940782|NCT01794780|157613062|FG003|Overall Study|Withdrew informed consent|9|||
48940783|NCT01794780|157613063|FG004|Overall Study|Withdrew informed consent|0|||
48940784|NCT01794780|157613064|FG005|Overall Study|Withdrew informed consent|48|||
48940785|NCT01794780|157613065|FG006|Overall Study|Withdrew informed consent|4|||
48940786|NCT01794780|157613066|FG007|Overall Study|Withdrew informed consent|3|||
48940787|NCT01794780|157613059|FG000|Overall Study|Other|0|||
48940788|NCT01794780|157613060|FG001|Overall Study|Other|12|||
48940789|NCT01794780|157613061|FG002|Overall Study|Other|25|||
48940790|NCT01794780|157613062|FG003|Overall Study|Other|20|||
48940791|NCT01794780|157613063|FG004|Overall Study|Other|1|||
48940792|NCT01794780|157613064|FG005|Overall Study|Other|24|||
48940793|NCT01794780|157613065|FG006|Overall Study|Other|4|||
48940794|NCT01794780|157613066|FG007|Overall Study|Other|1|||
48940795|NCT00805207|157613072|FG000|Overall Study|Protocol Violation|0|||
48940796|NCT00805207|157613073|FG001|Overall Study|Protocol Violation|0|||
48940797|NCT00805207|157613074|FG002|Overall Study|Protocol Violation|1|||
48940798|NCT00805207|157613075|FG003|Overall Study|Protocol Violation|0|||
48940799|NCT00805207|157613076|FG004|Overall Study|Protocol Violation|0|||
48940800|NCT00805207|157613077|FG005|Overall Study|Protocol Violation|0|||
48940801|NCT00805207|157613078|FG006|Overall Study|Protocol Violation|0|||
48940802|NCT00805207|157613079|FG007|Overall Study|Protocol Violation|0|||
48940803|NCT00805207|157613080|FG008|Overall Study|Protocol Violation|0|||
48940804|NCT00805207|157613072|FG000|Overall Study|Physician Decision|0|||
48940805|NCT00805207|157613073|FG001|Overall Study|Physician Decision|1|||
48940806|NCT00805207|157613074|FG002|Overall Study|Physician Decision|0|||
48940807|NCT00805207|157613075|FG003|Overall Study|Physician Decision|0|||
48940808|NCT00805207|157613076|FG004|Overall Study|Physician Decision|0|||
48940809|NCT00805207|157613077|FG005|Overall Study|Physician Decision|1|||
48940810|NCT00805207|157613078|FG006|Overall Study|Physician Decision|0|||
48940811|NCT00805207|157613079|FG007|Overall Study|Physician Decision|0|||
48940812|NCT00805207|157613080|FG008|Overall Study|Physician Decision|0|||
48940813|NCT00805207|157613072|FG000|Overall Study|Withdrawal by Subject|0|||
48940814|NCT00805207|157613073|FG001|Overall Study|Withdrawal by Subject|1|||
48940815|NCT00805207|157613074|FG002|Overall Study|Withdrawal by Subject|0|||
48940816|NCT00805207|157613075|FG003|Overall Study|Withdrawal by Subject|0|||
48940817|NCT00805207|157613076|FG004|Overall Study|Withdrawal by Subject|1|||
48940818|NCT00805207|157613077|FG005|Overall Study|Withdrawal by Subject|2|||
48940819|NCT00805207|157613078|FG006|Overall Study|Withdrawal by Subject|0|||
48940820|NCT00805207|157613079|FG007|Overall Study|Withdrawal by Subject|0|||
48940821|NCT00805207|157613080|FG008|Overall Study|Withdrawal by Subject|0|||
48940822|NCT00064701|157613081|FG000|One Year Post-transplant|Did not receive study drug|7|||
48940823|NCT00064701|157613082|FG001|One Year Post-transplant|Did not receive study drug|12|||
48940824|NCT00064701|157613083|FG002|One Year Post-transplant|Did not receive study drug|11|||
48940825|NCT00064701|157613081|FG000|One Year Post-transplant|Adverse Event|23|||
48940826|NCT00064701|157613082|FG001|One Year Post-transplant|Adverse Event|19|||
48940827|NCT00064701|157613083|FG002|One Year Post-transplant|Adverse Event|37|||
48940828|NCT00064701|157613081|FG000|One Year Post-transplant|Rejection|0|||
48940829|NCT00064701|157613082|FG001|One Year Post-transplant|Rejection|1|||
48940830|NCT00064701|157613083|FG002|One Year Post-transplant|Rejection|16|||
48940831|NCT00064701|157613081|FG000|One Year Post-transplant|Non-compliance|4|||
48940832|NCT00064701|157613082|FG001|One Year Post-transplant|Non-compliance|2|||
48940833|NCT00064701|157613083|FG002|One Year Post-transplant|Non-compliance|5|||
48940834|NCT00064701|157613081|FG000|One Year Post-transplant|Graft Failure|3|||
48940835|NCT00064701|157613082|FG001|One Year Post-transplant|Graft Failure|2|||
48940836|NCT00064701|157613083|FG002|One Year Post-transplant|Graft Failure|1|||
48940837|NCT00064701|157613081|FG000|One Year Post-transplant|Withdrawal by Subject|0|||
48940838|NCT00064701|157613082|FG001|One Year Post-transplant|Withdrawal by Subject|4|||
48940839|NCT00064701|157613083|FG002|One Year Post-transplant|Withdrawal by Subject|1|||
48940840|NCT00064701|157613081|FG000|One Year Post-transplant|Lost to Follow-up|1|||
48940841|NCT00064701|157613082|FG001|One Year Post-transplant|Lost to Follow-up|0|||
48940842|NCT00064701|157613083|FG002|One Year Post-transplant|Lost to Follow-up|0|||
48940843|NCT00064701|157613081|FG000|One Year Post-transplant|Converted to rapamycin|1|||
48940844|NCT00064701|157613082|FG001|One Year Post-transplant|Converted to rapamycin|0|||
48940845|NCT00064701|157613083|FG002|One Year Post-transplant|Converted to rapamycin|0|||
48940846|NCT00064701|157613081|FG000|One Year Post-transplant|Acute tubular necrosis|1|||
48940847|NCT00064701|157613082|FG001|One Year Post-transplant|Acute tubular necrosis|0|||
48940848|NCT00064701|157613083|FG002|One Year Post-transplant|Acute tubular necrosis|0|||
48940849|NCT00064701|157613081|FG000|One Year Post-transplant|Incorrect study drug dispensed|0|||
48940850|NCT00064701|157613082|FG001|One Year Post-transplant|Incorrect study drug dispensed|1|||
48940851|NCT00064701|157613083|FG002|One Year Post-transplant|Incorrect study drug dispensed|0|||
48940852|NCT00064701|157613081|FG000|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
48940853|NCT00064701|157613082|FG001|One Year Post-transplant|Crossover secondary to possible toxicity|1|||
48940854|NCT00064701|157613083|FG002|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
48940855|NCT00064701|157613081|FG000|One Year Post-transplant|Poor absorption|0|||
48940856|NCT00064701|157613082|FG001|One Year Post-transplant|Poor absorption|1|||
48940857|NCT00064701|157613083|FG002|One Year Post-transplant|Poor absorption|0|||
48940858|NCT00064701|157613081|FG000|One Year Post-transplant|Pancreas transplant|0|||
48940859|NCT00064701|157613082|FG001|One Year Post-transplant|Pancreas transplant|0|||
48940860|NCT00064701|157613083|FG002|One Year Post-transplant|Pancreas transplant|1|||
48940861|NCT00064701|157613081|FG000|Clinical Continuation Phase|Adverse Event|12|||
48940862|NCT00064701|157613082|FG001|Clinical Continuation Phase|Adverse Event|21|||
48940863|NCT00064701|157613083|FG002|Clinical Continuation Phase|Adverse Event|14|||
48940864|NCT00064701|157613081|FG000|Clinical Continuation Phase|Non-compliance|8|||
48940865|NCT00064701|157613082|FG001|Clinical Continuation Phase|Non-compliance|6|||
48940866|NCT00064701|157613083|FG002|Clinical Continuation Phase|Non-compliance|7|||
48940867|NCT00064701|157613081|FG000|Clinical Continuation Phase|Withdrawal by Subject|22|||
48940868|NCT00064701|157613082|FG001|Clinical Continuation Phase|Withdrawal by Subject|3|||
48940869|NCT00064701|157613083|FG002|Clinical Continuation Phase|Withdrawal by Subject|22|||
48940870|NCT00064701|157613081|FG000|Clinical Continuation Phase|Lost to Follow-up|6|||
48940871|NCT00064701|157613082|FG001|Clinical Continuation Phase|Lost to Follow-up|3|||
48940872|NCT00064701|157613083|FG002|Clinical Continuation Phase|Lost to Follow-up|6|||
48940873|NCT00064701|157613081|FG000|Clinical Continuation Phase|Graft Failure|5|||
48940874|NCT00064701|157613082|FG001|Clinical Continuation Phase|Graft Failure|5|||
48940875|NCT00064701|157613083|FG002|Clinical Continuation Phase|Graft Failure|2|||
48940876|NCT00064701|157613081|FG000|Clinical Continuation Phase|Rejection|1|||
48940877|NCT00064701|157613082|FG001|Clinical Continuation Phase|Rejection|2|||
48940878|NCT00064701|157613083|FG002|Clinical Continuation Phase|Rejection|2|||
48940879|NCT00064701|157613081|FG000|Clinical Continuation Phase|Sponsor discontinued study|113|||
48940880|NCT00064701|157613082|FG001|Clinical Continuation Phase|Sponsor discontinued study|129|||
48940881|NCT00064701|157613083|FG002|Clinical Continuation Phase|Sponsor discontinued study|79|||
48940882|NCT00064701|157613081|FG000|Clinical Continuation Phase|Immunosuppressive treatment crossover|0|||
48940883|NCT00064701|157613082|FG001|Clinical Continuation Phase|Immunosuppressive treatment crossover|3|||
48940884|NCT00064701|157613083|FG002|Clinical Continuation Phase|Immunosuppressive treatment crossover|6|||
48940885|NCT00064701|157613081|FG000|Clinical Continuation Phase|Physician Decision|1|||
48940886|NCT00064701|157613082|FG001|Clinical Continuation Phase|Physician Decision|3|||
48940887|NCT00064701|157613083|FG002|Clinical Continuation Phase|Physician Decision|0|||
48940888|NCT00064701|157613081|FG000|Clinical Continuation Phase|Unable to return to site for study visit|1|||
48940889|NCT00064701|157613082|FG001|Clinical Continuation Phase|Unable to return to site for study visit|0|||
48940890|NCT00064701|157613083|FG002|Clinical Continuation Phase|Unable to return to site for study visit|1|||
48940891|NCT00064701|157613081|FG000|Clinical Continuation Phase|Pancreas transplant|1|||
48940892|NCT00064701|157613082|FG001|Clinical Continuation Phase|Pancreas transplant|0|||
48940893|NCT00064701|157613083|FG002|Clinical Continuation Phase|Pancreas transplant|0|||
48940894|NCT00064701|157613081|FG000|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
48940895|NCT00064701|157613082|FG001|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1|||
48940896|NCT00064701|157613083|FG002|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
48940897|NCT00064701|157613081|FG000|Clinical Continuation Phase|Discharged to nursing home|0|||
48940898|NCT00064701|157613082|FG001|Clinical Continuation Phase|Discharged to nursing home|1|||
48940899|NCT00064701|157613083|FG002|Clinical Continuation Phase|Discharged to nursing home|0|||
48940900|NCT00064701|157613081|FG000|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
48940901|NCT00064701|157613082|FG001|Clinical Continuation Phase|Incorrect study drug dispensed|1|||
48940902|NCT00064701|157613083|FG002|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
48940903|NCT00064701|157613081|FG000|Clinical Continuation Phase|Patient opted out|0|||
48940904|NCT00064701|157613082|FG001|Clinical Continuation Phase|Patient opted out|0|||
48940905|NCT00064701|157613083|FG002|Clinical Continuation Phase|Patient opted out|1|||
48940906|NCT01985321|157613084|FG000|Overall Study|Protocol Violation|4|||
48940907|NCT01985321|157613085|FG001|Overall Study|Protocol Violation|3|||
48940908|NCT01985321|157613084|FG000|Overall Study|Withdrawal by Subject|1|||
48940909|NCT01985321|157613085|FG001|Overall Study|Withdrawal by Subject|0|||
48940910|NCT01985321|157613084|FG000|Overall Study|Lost to Follow-up|5|||
48940911|NCT01985321|157613085|FG001|Overall Study|Lost to Follow-up|2|||
48940912|NCT01985321|157613084|FG000|Overall Study|Subject treated wrong type of sore|1|||
48940913|NCT01985321|157613085|FG001|Overall Study|Subject treated wrong type of sore|0|||
48940914|NCT03293680|157613090|FG000|Overall Study|Death|1|||
48940915|NCT03293680|157613090|FG000|Overall Study|Did not meet inclusion criteria|8|||
48940916|NCT01802281|157613091|FG000|Overall Study|Death|1|||
48940917|NCT01802281|157613092|FG001|Overall Study|Death|2|||
48940918|NCT01802281|157613091|FG000|Overall Study|Withdrawal by Subject|2|||
48940919|NCT01802281|157613092|FG001|Overall Study|Withdrawal by Subject|1|||
48940920|NCT01802281|157613091|FG000|Overall Study|Ineligible|5|||
48940921|NCT01802281|157613092|FG001|Overall Study|Ineligible|3|||
48940922|NCT03832387|157613096|FG000|Overall Study|Protocol Violation|2|||
48940923|NCT03832387|157613097|FG001|Overall Study|Protocol Violation|6|||
48940924|NCT03832387|157613096|FG000|Overall Study|EXCLUSION CRITERIA|3|||
48940925|NCT03832387|157613097|FG001|Overall Study|EXCLUSION CRITERIA|1|||
48940926|NCT00613626|157613098|FG000|Overall Study|Ineligible|0|||
48940927|NCT00613626|157613099|FG001|Overall Study|Ineligible|1|||
48940928|NCT00613626|157613100|FG002|Overall Study|Ineligible|0|||
48940929|NCT01564784|157613103|FG000|Overall Study|Other|1|||
48940930|NCT01564784|157613104|FG001|Overall Study|Other|0|||
48940931|NCT01564784|157613103|FG000|Overall Study|Subject refused further follow-up|1|||
48940932|NCT01564784|157613104|FG001|Overall Study|Subject refused further follow-up|6|||
48940933|NCT01564784|157613103|FG000|Overall Study|Lost to Follow-up|1|||
48940934|NCT01564784|157613104|FG001|Overall Study|Lost to Follow-up|1|||
48940935|NCT01564784|157613103|FG000|Overall Study|Death|131|||
48940936|NCT01564784|157613104|FG001|Overall Study|Death|126|||
48940937|NCT00784758|157613105|FG000|Overall Study|Withdrawal by Subject|3|||
48940938|NCT00784758|157613106|FG001|Overall Study|Withdrawal by Subject|0|||
48940939|NCT00784758|157613105|FG000|Overall Study|Adverse Event|1|||
48940940|NCT00784758|157613106|FG001|Overall Study|Adverse Event|0|||
48940941|NCT00754390|157613109|FG000|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3|||
48940942|NCT00754390|157613109|FG000|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2|||
48940943|NCT00754390|157613109|FG000|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1|||
48940944|NCT00754390|157613109|FG000|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1|||
48940945|NCT03212261|157613112|FG000|Overall Study|Became ineligible d/t tech|2|||
48940946|NCT03212261|157613112|FG000|Overall Study|Tech Trouble- No first study visit|1|||
48940947|NCT03212261|157613112|FG000|Overall Study|Lost to Follow-up|7|||
48940948|NCT03212261|157613112|FG000|Overall Study|Family Emergency|1|||
48940949|NCT03212261|157613112|FG000|Overall Study|Too busy/ No time|5|||
48940950|NCT02498821|157613113|FG000|Overall Study|Screen failure|3|||
48940951|NCT02498821|157613114|FG001|Overall Study|Screen failure|5|||
48940952|NCT05480514|157613115|FG000|Period 1|Pd-Incorrect Lens Power Assigned|2|||
48940953|NCT05480514|157613116|FG001|Period 1|Pd-Incorrect Lens Power Assigned|3|||
48940954|NCT05480514|157613115|FG000|Period 1|Unsatisfactory Lens Fitting Due to Test Article|3|||
48940955|NCT05480514|157613116|FG001|Period 1|Unsatisfactory Lens Fitting Due to Test Article|5|||
48940956|NCT05480514|157613115|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
48940957|NCT05480514|157613116|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
48940958|NCT05480514|157613115|FG000|Period 1|Covid-19 Related|1|||
48940959|NCT05480514|157613116|FG001|Period 1|Covid-19 Related|0|||
48940960|NCT05480514|157613115|FG000|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
48940961|NCT05480514|157613116|FG001|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
48940962|NCT00883753|157613119|FG000|Overall Study|Adverse Event|37|||
48940963|NCT00883753|157613119|FG000|Overall Study|Death|2|||
48940964|NCT00883753|157613119|FG000|Overall Study|Insufficient therapeutic response|16|||
48940965|NCT00883753|157613119|FG000|Overall Study|Lost to Follow-up|4|||
48940966|NCT00883753|157613119|FG000|Overall Study|Violation of selection criteria at entry|7|||
48940967|NCT00883753|157613119|FG000|Overall Study|Protocol Violation|2|||
48940968|NCT00883753|157613119|FG000|Overall Study|Refused treatment|4|||
48940969|NCT00883753|157613119|FG000|Overall Study|Withdrew consent|10|||
48940970|NCT00883753|157613119|FG000|Overall Study|Investigator's decision|17|||
48940971|NCT00883753|157613119|FG000|Overall Study|Administrative/Other|8|||
48940972|NCT03367156|157615106|FG000|Overall Study|Lack of interest|3|||
48940973|NCT03367156|157615107|FG001|Overall Study|Lack of interest|1|||
48940974|NCT03367156|157615106|FG000|Overall Study|Death|2|||
48940975|NCT03367156|157615107|FG001|Overall Study|Death|0|||
48940976|NCT03367156|157615106|FG000|Overall Study|Lost to Follow-up|2|||
48848749|NCT00968149|157286860|FG001|Overall Study|Protocol Violation|0|||
48848750|NCT00968149|157286859|FG000|Overall Study|Withdrawal by Subject|2|||
48848751|NCT00968149|157286860|FG001|Overall Study|Withdrawal by Subject|0|||
48848752|NCT04989816|157286861|FG000|Overall Study|Death|77|||
48848753|NCT04989816|157286861|FG000|Overall Study|Lost to Follow-up|3|||
48848754|NCT03875313|157286862|FG000|Overall Study|Withdrawal by Subject|1|||
48848755|NCT03875313|157286863|FG001|Overall Study|Withdrawal by Subject|3|||
48848756|NCT03875313|157286864|FG002|Overall Study|Withdrawal by Subject|0|||
48848757|NCT03875313|157286865|FG003|Overall Study|Withdrawal by Subject|0|||
48848758|NCT03875313|157286866|FG004|Overall Study|Withdrawal by Subject|0|||
48848759|NCT03875313|157286862|FG000|Overall Study|Death|0|||
48848760|NCT03875313|157286863|FG001|Overall Study|Death|0|||
48848761|NCT03875313|157286864|FG002|Overall Study|Death|0|||
48848762|NCT03875313|157286865|FG003|Overall Study|Death|0|||
48848763|NCT03875313|157286866|FG004|Overall Study|Death|1|||
48848764|NCT03875313|157286862|FG000|Overall Study|Lost to Follow-up|0|||
48848765|NCT03875313|157286863|FG001|Overall Study|Lost to Follow-up|0|||
48848766|NCT03875313|157286864|FG002|Overall Study|Lost to Follow-up|0|||
48848767|NCT03875313|157286865|FG003|Overall Study|Lost to Follow-up|0|||
48848768|NCT03875313|157286866|FG004|Overall Study|Lost to Follow-up|1|||
48848769|NCT03875313|157286862|FG000|Overall Study|Study Termination by Sponsor|0|||
48848770|NCT03875313|157286863|FG001|Overall Study|Study Termination by Sponsor|1|||
48848771|NCT03875313|157286864|FG002|Overall Study|Study Termination by Sponsor|1|||
48848772|NCT03875313|157286865|FG003|Overall Study|Study Termination by Sponsor|0|||
48848773|NCT03875313|157286866|FG004|Overall Study|Study Termination by Sponsor|1|||
48848774|NCT03875313|157286862|FG000|Overall Study|New Anticancer Treatment|0|||
48848775|NCT03875313|157286863|FG001|Overall Study|New Anticancer Treatment|1|||
48848776|NCT03875313|157286864|FG002|Overall Study|New Anticancer Treatment|2|||
48848777|NCT03875313|157286865|FG003|Overall Study|New Anticancer Treatment|1|||
48848778|NCT03875313|157286866|FG004|Overall Study|New Anticancer Treatment|0|||
48848779|NCT03875313|157286862|FG000|Overall Study|Other, Not Specified|2|||
48848780|NCT03875313|157286863|FG001|Overall Study|Other, Not Specified|11|||
48848781|NCT03875313|157286864|FG002|Overall Study|Other, Not Specified|3|||
48848782|NCT03875313|157286865|FG003|Overall Study|Other, Not Specified|3|||
48848783|NCT03875313|157286866|FG004|Overall Study|Other, Not Specified|1|||
48848784|NCT04121546|157286867|FG000|Overall Study|Lost to Follow-up|1|||
48848785|NCT04121546|157286868|FG001|Overall Study|Lost to Follow-up|3|||
48848786|NCT01737021|157286869|FG000|Overall Study|Lost to Follow-up|5|||
48848787|NCT01737021|157286870|FG001|Overall Study|Lost to Follow-up|3|||
48848788|NCT00366249|157286871|FG000|Overall Study|Adverse Event|53|||
48848789|NCT00366249|157286872|FG001|Overall Study|Adverse Event|28|||
48848790|NCT00366249|157286871|FG000|Overall Study|Death|0|||
48848791|NCT00366249|157286872|FG001|Overall Study|Death|1|||
48848792|NCT00366249|157286871|FG000|Overall Study|Physician Decision|5|||
48848793|NCT00366249|157286872|FG001|Overall Study|Physician Decision|2|||
48848794|NCT00366249|157286871|FG000|Overall Study|Lost to Follow-up|2|||
48848795|NCT00366249|157286872|FG001|Overall Study|Lost to Follow-up|0|||
48848796|NCT00366249|157286871|FG000|Overall Study|Protocol Violation|1|||
48848797|NCT00366249|157286872|FG001|Overall Study|Protocol Violation|2|||
48848798|NCT00366249|157286871|FG000|Overall Study|Withdrawal by Subject|18|||
48848799|NCT00366249|157286872|FG001|Overall Study|Withdrawal by Subject|4|||
48848800|NCT00366249|157286871|FG000|Overall Study|Lack of Efficacy|21|||
48848801|NCT00366249|157286872|FG001|Overall Study|Lack of Efficacy|21|||
48848802|NCT00366249|157286871|FG000|Overall Study|Most due to osteomylitis status|31|||
48848803|NCT00366249|157286872|FG001|Overall Study|Most due to osteomylitis status|20|||
48848804|NCT02593149|157286875|FG000|Run-In|Didn't use CVC for at least 21 days|36|||
48848805|NCT02593149|157286876|FG001|Run-In|Didn't use CVC for at least 21 days|38|||
48848806|NCT02593149|157286875|FG000|Intervention|Didn't use CVC for at least 21 day|116|||
48848807|NCT02593149|157286876|FG001|Intervention|Didn't use CVC for at least 21 day|115|||
48848808|NCT01177670|157286877|FG000|Overall Study|Study Terminated|115|||
48848809|NCT01177670|157286877|FG000|Overall Study|Physician Decision|50|||
48848810|NCT01177670|157286877|FG000|Overall Study|Withdrawal by Subject|4|||
48848811|NCT01970007|157286879|FG000|Overall Study|Death|5|||
48940977|NCT03367156|157615107|FG001|Overall Study|Lost to Follow-up|1|||
48940978|NCT03367156|157615106|FG000|Overall Study|Became ineligible|1|||
48940979|NCT03367156|157615107|FG001|Overall Study|Became ineligible|2|||
48940980|NCT03367156|157615106|FG000|Overall Study|Hospitalization|1|||
48940981|NCT03367156|157615107|FG001|Overall Study|Hospitalization|0|||
48940982|NCT03367156|157615106|FG000|Overall Study|Concerned about Treatment|11|||
48940983|NCT03367156|157615107|FG001|Overall Study|Concerned about Treatment|3|||
48940984|NCT03367156|157615106|FG000|Overall Study|Started new treatment|4|||
48940985|NCT03367156|157615107|FG001|Overall Study|Started new treatment|1|||
48940986|NCT01903876|157615110|FG000|Baseline to Post-Intervention Period|Lost to Follow-up|184|||
48940987|NCT01903876|157615111|FG001|Baseline to Post-Intervention Period|Lost to Follow-up|108|||
48940988|NCT01903876|157615110|FG000|Six-Month Follow-up Period|Lost to Follow-up|91|||
48940989|NCT01903876|157615111|FG001|Six-Month Follow-up Period|Lost to Follow-up|145|||
48940990|NCT00469079|157615114|FG000|Overall Study|Lack of Efficacy|3|||
48940991|NCT00469079|157615115|FG001|Overall Study|Lack of Efficacy|8|||
48940992|NCT00469079|157615116|FG002|Overall Study|Lack of Efficacy|5|||
48940993|NCT00469079|157615114|FG000|Overall Study|Adverse Event|1|||
48940994|NCT00469079|157615115|FG001|Overall Study|Adverse Event|3|||
48940995|NCT00469079|157615116|FG002|Overall Study|Adverse Event|2|||
48940996|NCT00469079|157615114|FG000|Overall Study|Lost to Follow-up|4|||
48940997|NCT00469079|157615115|FG001|Overall Study|Lost to Follow-up|8|||
48940998|NCT00469079|157615116|FG002|Overall Study|Lost to Follow-up|10|||
48940999|NCT00469079|157615114|FG000|Overall Study|Withdrawal by Subject|1|||
48941000|NCT00469079|157615115|FG001|Overall Study|Withdrawal by Subject|2|||
48941001|NCT00469079|157615116|FG002|Overall Study|Withdrawal by Subject|2|||
48941002|NCT00469079|157615114|FG000|Overall Study|Ineligible|0|||
48941003|NCT00469079|157615115|FG001|Overall Study|Ineligible|1|||
48941004|NCT00469079|157615116|FG002|Overall Study|Ineligible|0|||
48941005|NCT00278629|157615117|FG000|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14|||
48941006|NCT01719757|157615121|FG000|Overall Study|Adverse Event|38|||
48941007|NCT01719757|157615121|FG000|Overall Study|Withdrawal by Subject|15|||
48941008|NCT01719757|157615121|FG000|Overall Study|Lost to Follow-up|20|||
48941009|NCT01719757|157615121|FG000|Overall Study|Protocol Violation|1|||
48941010|NCT01719757|157615121|FG000|Overall Study|well controlled pain|27|||
48941011|NCT02698410|157615125|FG000|Overall Study|Adverse Event|2|||
48941012|NCT02698410|157615125|FG000|Overall Study|Withdrawal by Subject|1|||
48941013|NCT02698410|157615125|FG000|Overall Study|Other|1|||
48941014|NCT01123889|157615126|FG000|Overall Study|Lost to Follow-up|3|||
48941015|NCT01123889|157615127|FG001|Overall Study|Lost to Follow-up|1|||
48941016|NCT01896232|157615128|FG000|Overall Study|Death|6|||
48941017|NCT01896232|157615129|FG001|Overall Study|Death|10|||
48941018|NCT01896232|157615128|FG000|Overall Study|Withdrawal by Subject|32|||
48941019|NCT01896232|157615129|FG001|Overall Study|Withdrawal by Subject|31|||
48941020|NCT01896232|157615128|FG000|Overall Study|Sponsor Decision|2|||
48941021|NCT01896232|157615129|FG001|Overall Study|Sponsor Decision|0|||
48941022|NCT01896232|157615128|FG000|Overall Study|Lost to Follow-up|9|||
48941023|NCT01896232|157615129|FG001|Overall Study|Lost to Follow-up|12|||
48941024|NCT03116113|157615130|FG000|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
48941025|NCT03116113|157615131|FG001|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
48941026|NCT03116113|157615132|FG002|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
48941027|NCT03116113|157615133|FG003|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
48941028|NCT03116113|157615134|FG004|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
48941029|NCT03116113|157615135|FG005|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
48941030|NCT03116113|157615136|FG006|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
48941031|NCT03116113|157615137|FG007|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|1|||
48941032|NCT03116113|157615138|FG008|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|2|||
48941033|NCT03715465|157615141|FG000|Overall Study|Withdrawal by Subject|1|||
48941034|NCT03715465|157615142|FG001|Overall Study|Withdrawal by Subject|2|||
48941035|NCT02665689|157615143|FG000|Overall Study|Adverse Event|1|||
48941036|NCT02665689|157615144|FG001|Overall Study|Adverse Event|0|||
48941037|NCT02665689|157615143|FG000|Overall Study|Trial termination|1|||
48941038|NCT02665689|157615144|FG001|Overall Study|Trial termination|1|||
48941039|NCT02665689|157615143|FG000|Overall Study|Lost to Follow-up|0|||
48941040|NCT02665689|157615144|FG001|Overall Study|Lost to Follow-up|1|||
48941041|NCT00384956|157615145|FG000|Overall Study|Ineligible (acute myeloid leukemia)|3|||
48941042|NCT05127486|157615148|FG000|Overall Study|Adverse Event|2|||
48941043|NCT05127486|157615149|FG001|Overall Study|Adverse Event|4|||
48941044|NCT05127486|157615148|FG000|Overall Study|Lack of Efficacy|1|||
48941045|NCT05127486|157615149|FG001|Overall Study|Lack of Efficacy|0|||
48941046|NCT05127486|157615148|FG000|Overall Study|Pregnancy|0|||
48941047|NCT05127486|157615149|FG001|Overall Study|Pregnancy|1|||
48941048|NCT05127486|157615148|FG000|Overall Study|Physician Decision|4|||
48941049|NCT05127486|157615149|FG001|Overall Study|Physician Decision|1|||
48941050|NCT05127486|157615148|FG000|Overall Study|Withdrawal by Subject|14|||
48941051|NCT05127486|157615149|FG001|Overall Study|Withdrawal by Subject|13|||
48941052|NCT05127486|157615148|FG000|Overall Study|Lost to Follow-up|5|||
48941053|NCT05127486|157615149|FG001|Overall Study|Lost to Follow-up|8|||
48941054|NCT02582515|157615152|FG000|Overall Study|Withdrawal by Subject|0|||
48941055|NCT02582515|157615153|FG001|Overall Study|Withdrawal by Subject|1|||
48941056|NCT00363415|157615154|FG000|Overall Study|Progressive Disease|196|||
48941057|NCT00363415|157615155|FG001|Overall Study|Progressive Disease|107|||
48941058|NCT00363415|157615154|FG000|Overall Study|Sponsor Decision|67|||
48941059|NCT00363415|157615155|FG001|Overall Study|Sponsor Decision|31|||
48941060|NCT00363415|157615154|FG000|Overall Study|Death|32|||
48848812|NCT01970007|157286879|FG000|Overall Study|Withdrawal by Subject|23|||
48848813|NCT01970007|157286879|FG000|Overall Study|Lost to Follow-up|24|||
48848814|NCT01970007|157286879|FG000|Overall Study|"Other endpoint"|3|||
48848815|NCT00754065|157286880|FG000|Overall Study|Never received treatment|12|||
48848816|NCT00754065|157286881|FG001|Overall Study|Never received treatment|2|||
48848817|NCT00754065|157286880|FG000|Overall Study|Adverse Event|19|||
48848818|NCT00754065|157286881|FG001|Overall Study|Adverse Event|25|||
48848819|NCT00754065|157286880|FG000|Overall Study|Lost to Follow-up|7|||
48848820|NCT00754065|157286881|FG001|Overall Study|Lost to Follow-up|11|||
48848821|NCT00754065|157286880|FG000|Overall Study|Protocol Violation|12|||
48848822|NCT00754065|157286881|FG001|Overall Study|Protocol Violation|10|||
48848823|NCT00754065|157286880|FG000|Overall Study|Withdrawal by Subject|4|||
48848824|NCT00754065|157286881|FG001|Overall Study|Withdrawal by Subject|5|||
48848825|NCT00754065|157286880|FG000|Overall Study|Pregnancy|6|||
48848826|NCT00754065|157286881|FG001|Overall Study|Pregnancy|0|||
48848827|NCT00754065|157286880|FG000|Overall Study|Reason not specified or unknown, etc.|21|||
48848828|NCT00754065|157286881|FG001|Overall Study|Reason not specified or unknown, etc.|27|||
48848829|NCT00975585|157286888|FG000|Overall Study|Adverse Event|0|||
48848830|NCT00975585|157286889|FG001|Overall Study|Adverse Event|4|||
48848831|NCT00975585|157286888|FG000|Overall Study|Lost to Follow-up|3|||
48848832|NCT00975585|157286889|FG001|Overall Study|Lost to Follow-up|5|||
48848833|NCT00975585|157286888|FG000|Overall Study|Withdrawal by Subject|2|||
48848834|NCT00975585|157286889|FG001|Overall Study|Withdrawal by Subject|1|||
48848835|NCT00975585|157286888|FG000|Overall Study|Lens issue|2|||
48848836|NCT00975585|157286889|FG001|Overall Study|Lens issue|2|||
48848837|NCT00795184|157286890|FG000|Overall Study|Tissue sampling incomplete/conclusive|8|||
48941061|NCT00363415|157615155|FG001|Overall Study|Death|29|||
48941062|NCT00363415|157615154|FG000|Overall Study|Adverse Event|24|||
48941063|NCT00363415|157615155|FG001|Overall Study|Adverse Event|15|||
48848838|NCT00795184|157286891|FG001|Overall Study|Tissue sampling incomplete/conclusive|13|||
48848839|NCT00205179|157286897|FG000|Overall Study|Death|0|||
48848840|NCT00205179|157286898|FG001|Overall Study|Death|2|||
48848841|NCT00205179|157286897|FG000|Overall Study|Physician Decision|1|||
48848842|NCT00205179|157286898|FG001|Overall Study|Physician Decision|1|||
48941064|NCT00363415|157615154|FG000|Overall Study|Physician Decision|18|||
48941065|NCT00363415|157615155|FG001|Overall Study|Physician Decision|35|||
48941066|NCT00363415|157615154|FG000|Overall Study|Entry Criteria Not Met|11|||
48941067|NCT00363415|157615155|FG001|Overall Study|Entry Criteria Not Met|10|||
48941068|NCT00363415|157615154|FG000|Overall Study|Withdrawal by Subject|9|||
48941069|NCT00363415|157615155|FG001|Overall Study|Withdrawal by Subject|15|||
48941070|NCT00363415|157615154|FG000|Overall Study|Lost to Follow-up|3|||
48941071|NCT00363415|157615155|FG001|Overall Study|Lost to Follow-up|3|||
48941072|NCT00363415|157615154|FG000|Overall Study|Protocol Violation|1|||
48941073|NCT00363415|157615155|FG001|Overall Study|Protocol Violation|4|||
48941074|NCT01021007|157615156|FG000|Overall Study|Lost to Follow-up|1|||
48941075|NCT01021007|157615157|FG001|Overall Study|Lost to Follow-up|1|||
48941076|NCT01021007|157615156|FG000|Overall Study|Adverse Event|1|||
48941077|NCT01021007|157615157|FG001|Overall Study|Adverse Event|3|||
48941078|NCT05817045|157615158|FG000|Overall Study|Protocol Violation|0|||
48941079|NCT05817045|157615159|FG001|Overall Study|Protocol Violation|3|||
48941080|NCT05817045|157615158|FG000|Overall Study|Withdrawal by Subject|10|||
48941081|NCT05817045|157615159|FG001|Overall Study|Withdrawal by Subject|7|||
48941082|NCT05817045|157615158|FG000|Overall Study|Physician Decision|3|||
48941083|NCT05817045|157615159|FG001|Overall Study|Physician Decision|0|||
48941084|NCT05817045|157615158|FG000|Overall Study|Lost to Follow-up|0|||
48941085|NCT05817045|157615159|FG001|Overall Study|Lost to Follow-up|1|||
48941086|NCT05817045|157615158|FG000|Overall Study|Device Deficiency|1|||
48941087|NCT05817045|157615159|FG001|Overall Study|Device Deficiency|0|||
48941088|NCT05817045|157615158|FG000|Overall Study|System Error|1|||
48941089|NCT05817045|157615159|FG001|Overall Study|System Error|0|||
48941090|NCT01725165|157615160|FG000|Overall Study|Death|11|||
48941091|NCT01725165|157615161|FG001|Overall Study|Death|18|||
48941092|NCT03619213|157615164|FG000|Overall Study|Lost to Follow-up|2|||
48941093|NCT03619213|157615165|FG001|Overall Study|Lost to Follow-up|1|||
48941094|NCT03619213|157615164|FG000|Overall Study|Withdrawal by Subject|8|||
48941095|NCT03619213|157615165|FG001|Overall Study|Withdrawal by Subject|10|||
48941096|NCT00382967|157615166|FG000|Overall Study|Protocol Violation|1|||
48941097|NCT00382967|157615167|FG001|Overall Study|Protocol Violation|1|||
48941098|NCT00862251|157615168|FG000|Overall Study|Adverse Event|8|||
48941099|NCT00862251|157615169|FG001|Overall Study|Adverse Event|3|||
48941100|NCT00862251|157615170|FG002|Overall Study|Adverse Event|1|||
48941101|NCT00862251|157615168|FG000|Overall Study|Lost to Follow-up|0|||
48941102|NCT00862251|157615169|FG001|Overall Study|Lost to Follow-up|0|||
48941103|NCT00862251|157615170|FG002|Overall Study|Lost to Follow-up|1|||
48941104|NCT00862251|157615168|FG000|Overall Study|Protocol Violation|2|||
48941105|NCT00862251|157615169|FG001|Overall Study|Protocol Violation|0|||
48941106|NCT00862251|157615170|FG002|Overall Study|Protocol Violation|1|||
48941107|NCT00862251|157615168|FG000|Overall Study|Withdrawal by Subject|9|||
48941108|NCT00862251|157615169|FG001|Overall Study|Withdrawal by Subject|2|||
48941109|NCT00862251|157615170|FG002|Overall Study|Withdrawal by Subject|6|||
48941110|NCT00833092|157615173|FG000|Overall Study|Withdrawal by Subject|2|||
48941111|NCT00833092|157615174|FG001|Overall Study|Withdrawal by Subject|3|||
48941112|NCT00833092|157615173|FG000|Overall Study|Protocol Violation|2|||
48941113|NCT00833092|157615174|FG001|Overall Study|Protocol Violation|1|||
48941114|NCT00833092|157615173|FG000|Overall Study|Diarrhea|0|||
48941115|NCT00833092|157615174|FG001|Overall Study|Diarrhea|2|||
48941116|NCT00833092|157615173|FG000|Overall Study|constipation|0|||
48941117|NCT00833092|157615174|FG001|Overall Study|constipation|1|||
48941118|NCT00619229|157615175|FG000|Overall Study|Withdrawal by Subject|1|||
48941119|NCT00619229|157615176|FG001|Overall Study|Withdrawal by Subject|1|||
48941120|NCT00619229|157615175|FG000|Overall Study|Lost to Follow-up|1|||
48941121|NCT00619229|157615176|FG001|Overall Study|Lost to Follow-up|0|||
48941122|NCT00619229|157615175|FG000|Overall Study|Termination of the Study by the Sponsor|1|||
48941123|NCT00619229|157615176|FG001|Overall Study|Termination of the Study by the Sponsor|1|||
48941124|NCT00619229|157615175|FG000|Overall Study|Investigator planned Cataract Operation|1|||
48941125|NCT00619229|157615176|FG001|Overall Study|Investigator planned Cataract Operation|0|||
48941126|NCT01859403|157615179|FG000|Primary Endpoint Measure|Lost to Follow-up|0|||
48941127|NCT01859403|157615180|FG001|Primary Endpoint Measure|Lost to Follow-up|2|||
48941128|NCT01859403|157615179|FG000|Primary Endpoint Measure|Withdrawal by Subject|1|||
48941129|NCT01859403|157615180|FG001|Primary Endpoint Measure|Withdrawal by Subject|1|||
48941130|NCT01859403|157615179|FG000|Primary Endpoint Measure|Physician Decision|0|||
48941131|NCT01859403|157615180|FG001|Primary Endpoint Measure|Physician Decision|1|||
48941132|NCT01859403|157615179|FG000|Secondary Endpoint Measure|Withdrawal by Subject|6|||
48941133|NCT01859403|157615180|FG001|Secondary Endpoint Measure|Withdrawal by Subject|8|||
48941134|NCT03185130|157615181|FG000|Overall Study|Withdrawal by Subject|0|||
48941135|NCT03185130|157615182|FG001|Overall Study|Withdrawal by Subject|2|||
48941136|NCT01122927|157615186|FG000|Period 1 - Conversion Phase|Adverse Event|3|||
48941137|NCT01122927|157615187|FG001|Period 1 - Conversion Phase|Adverse Event|0|||
48941138|NCT01122927|157615186|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
48941139|NCT01122927|157615187|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
48941140|NCT01122927|157615186|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
48941141|NCT01122927|157615187|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
48941142|NCT01122927|157615186|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
48941143|NCT01122927|157615187|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
48941144|NCT01122927|157615186|FG000|Period 1 - Conversion Phase|Protocol Deviation|1|||
48941145|NCT01122927|157615187|FG001|Period 1 - Conversion Phase|Protocol Deviation|0|||
48941146|NCT01122927|157615186|FG000|Period 2- Open-label Treatment Phase|Lost to Follow-up|0|||
48941147|NCT01122927|157615187|FG001|Period 2- Open-label Treatment Phase|Lost to Follow-up|21|||
48941148|NCT01122927|157615186|FG000|Period 2- Open-label Treatment Phase|Adverse Event|0|||
48941149|NCT01122927|157615187|FG001|Period 2- Open-label Treatment Phase|Adverse Event|33|||
48941150|NCT01122927|157615186|FG000|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0|||
48941151|NCT01122927|157615187|FG001|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165|||
48941152|NCT01122927|157615186|FG000|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0|||
48941153|NCT01122927|157615187|FG001|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9|||
48941154|NCT01122927|157615186|FG000|Period 2- Open-label Treatment Phase|Physician Decision|0|||
48941155|NCT01122927|157615187|FG001|Period 2- Open-label Treatment Phase|Physician Decision|12|||
48941156|NCT01122927|157615186|FG000|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0|||
48941157|NCT01122927|157615187|FG001|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65|||
48941158|NCT01122927|157615186|FG000|Period 2- Open-label Treatment Phase|Lack of Efficacy|0|||
48941159|NCT01122927|157615187|FG001|Period 2- Open-label Treatment Phase|Lack of Efficacy|7|||
48941160|NCT01287104|157615188|FG000|Overall Study|Patient developed progressive disease|1|||
48941161|NCT01287104|157615189|FG001|Overall Study|Patient developed progressive disease|1|||
48941162|NCT01287104|157615190|FG002|Overall Study|Patient developed progressive disease|3|||
48941163|NCT01287104|157615191|FG003|Overall Study|Patient developed progressive disease|2|||
48941164|NCT01287104|157615188|FG000|Overall Study|Donor anaphylaxis|0|||
48941165|NCT01287104|157615189|FG001|Overall Study|Donor anaphylaxis|1|||
48941166|NCT01287104|157615190|FG002|Overall Study|Donor anaphylaxis|0|||
48941167|NCT01287104|157615191|FG003|Overall Study|Donor anaphylaxis|1|||
48941168|NCT01287104|157615188|FG000|Overall Study|Developed GVHD or complications of BMT|0|||
48941169|NCT01287104|157615189|FG001|Overall Study|Developed GVHD or complications of BMT|1|||
48941170|NCT01287104|157615190|FG002|Overall Study|Developed GVHD or complications of BMT|4|||
48941171|NCT01287104|157615191|FG003|Overall Study|Developed GVHD or complications of BMT|0|||
48941172|NCT01287104|157615188|FG000|Overall Study|Low donor chimerism|0|||
48941173|NCT01287104|157615189|FG001|Overall Study|Low donor chimerism|1|||
48941174|NCT01287104|157615190|FG002|Overall Study|Low donor chimerism|0|||
48941175|NCT01287104|157615191|FG003|Overall Study|Low donor chimerism|0|||
48941176|NCT01287104|157615188|FG000|Overall Study|NK cells did not meet release criteria|0|||
48941177|NCT01287104|157615189|FG001|Overall Study|NK cells did not meet release criteria|1|||
48941178|NCT01287104|157615190|FG002|Overall Study|NK cells did not meet release criteria|0|||
48941179|NCT01287104|157615191|FG003|Overall Study|NK cells did not meet release criteria|0|||
48941180|NCT00503399|157615192|FG000|Overall Study|Death|2|||
48941181|NCT00503399|157615193|FG001|Overall Study|Death|1|||
48941182|NCT00503399|157615192|FG000|Overall Study|Protocol Violation|1|||
48941183|NCT00503399|157615193|FG001|Overall Study|Protocol Violation|0|||
48941184|NCT00503399|157615192|FG000|Overall Study|Withdrawal by Subject|4|||
48941185|NCT00503399|157615193|FG001|Overall Study|Withdrawal by Subject|2|||
48941186|NCT00503399|157615192|FG000|Overall Study|Adverse Event|0|||
48941187|NCT00503399|157615193|FG001|Overall Study|Adverse Event|3|||
48941188|NCT00503399|157615192|FG000|Overall Study|Lost to Follow-up|0|||
48941189|NCT00503399|157615193|FG001|Overall Study|Lost to Follow-up|2|||
48941190|NCT00768560|157615194|FG000|Intervention Set 1|Adverse Event|0|||
48941191|NCT00768560|157615195|FG001|Intervention Set 1|Adverse Event|1|||
48941192|NCT00768560|157615196|FG002|Intervention Set 1|Adverse Event|0|||
48941193|NCT00768560|157615197|FG003|Intervention Set 1|Adverse Event|0|||
48941194|NCT00768560|157615198|FG004|Intervention Set 1|Adverse Event|0|||
48941195|NCT00768560|157615199|FG005|Intervention Set 1|Adverse Event|0|||
48941196|NCT03427073|157615201|FG000|Overall Study|Disease Progression|1|||
48941197|NCT03427073|157615202|FG001|Overall Study|Disease Progression|1|||
48941198|NCT03427073|157615203|FG002|Overall Study|Disease Progression|1|||
48941199|NCT03427073|157615204|FG003|Overall Study|Disease Progression|3|||
48941200|NCT03427073|157615205|FG004|Overall Study|Disease Progression|3|||
48941201|NCT03427073|157615206|FG005|Overall Study|Disease Progression|4|||
48941202|NCT03427073|157615207|FG006|Overall Study|Disease Progression|2|||
48941203|NCT03427073|157615208|FG007|Overall Study|Disease Progression|3|||
48941204|NCT03427073|157615201|FG000|Overall Study|Physician Decision|0|||
48941205|NCT03427073|157615202|FG001|Overall Study|Physician Decision|0|||
48941206|NCT03427073|157615203|FG002|Overall Study|Physician Decision|0|||
48941207|NCT03427073|157615204|FG003|Overall Study|Physician Decision|0|||
48941208|NCT03427073|157615205|FG004|Overall Study|Physician Decision|0|||
48941209|NCT03427073|157615206|FG005|Overall Study|Physician Decision|0|||
48941210|NCT03427073|157615207|FG006|Overall Study|Physician Decision|1|||
48941211|NCT03427073|157615208|FG007|Overall Study|Physician Decision|1|||
48941212|NCT01244737|157615209|FG000|Overall Study|Physician Decision|2|||
48941213|NCT01244737|157615210|FG001|Overall Study|Physician Decision|18|||
48941214|NCT01244737|157615211|FG002|Overall Study|Physician Decision|5|||
48941215|NCT01244737|157615209|FG000|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
48941216|NCT01244737|157615210|FG001|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
48941217|NCT01244737|157615211|FG002|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|0|||
48941218|NCT01244737|157615209|FG000|Overall Study|Surgical pathology did not confirm evaluable brain tumor|2|||
48941219|NCT01244737|157615210|FG001|Overall Study|Surgical pathology did not confirm evaluable brain tumor|1|||
48941220|NCT01244737|157615211|FG002|Overall Study|Surgical pathology did not confirm evaluable brain tumor|0|||
48941221|NCT01244737|157615209|FG000|Overall Study|MIB immunopathology results not available|3|||
48941222|NCT01244737|157615210|FG001|Overall Study|MIB immunopathology results not available|2|||
48941223|NCT01244737|157615211|FG002|Overall Study|MIB immunopathology results not available|0|||
48941224|NCT01244737|157615209|FG000|Overall Study|PET data failure|0|||
48941225|NCT01244737|157615210|FG001|Overall Study|PET data failure|1|||
48941226|NCT01244737|157615211|FG002|Overall Study|PET data failure|0|||
48941227|NCT01244737|157615209|FG000|Overall Study|Withdrawal by Subject|0|||
48941228|NCT01244737|157615210|FG001|Overall Study|Withdrawal by Subject|0|||
48941229|NCT01244737|157615211|FG002|Overall Study|Withdrawal by Subject|1|||
48941230|NCT00389207|157615215|FG000|Overall Study|Adverse Event|26|||
48941231|NCT00389207|157615216|FG001|Overall Study|Adverse Event|32|||
48941232|NCT00389207|157615217|FG002|Overall Study|Adverse Event|10|||
48848843|NCT00205179|157286897|FG000|Overall Study|Adverse Event|1|||
48848844|NCT00205179|157286898|FG001|Overall Study|Adverse Event|1|||
48848845|NCT00586313|157286899|FG000|Overall Study|Lack of Efficacy|2|||
48848846|NCT01932970|157286919|FG000|Overall Study|Withdrawal by Subject|5|||
48848847|NCT01932970|157286919|FG000|Overall Study|Death|1|||
48848848|NCT01932970|157286919|FG000|Overall Study|Lost to Follow-up|2|||
48848849|NCT01932970|157286919|FG000|Overall Study|Protocol Specified Criteria|10|||
48848850|NCT01500200|157286920|FG000|Stage 1|Adverse Event|1|||
48848851|NCT01500200|157286921|FG001|Stage 1|Adverse Event|4|||
48848852|NCT01500200|157286922|FG002|Stage 1|Adverse Event|5|||
48848853|NCT01500200|157286923|FG003|Stage 1|Adverse Event|0|||
48848854|NCT01500200|157286924|FG004|Stage 1|Adverse Event|0|||
48848855|NCT01500200|157286925|FG005|Stage 1|Adverse Event|0|||
48848856|NCT01500200|157286920|FG000|Stage 1|Lost to Follow-up|2|||
48848857|NCT01500200|157286921|FG001|Stage 1|Lost to Follow-up|2|||
48848858|NCT01500200|157286922|FG002|Stage 1|Lost to Follow-up|1|||
48848859|NCT01500200|157286923|FG003|Stage 1|Lost to Follow-up|0|||
48848860|NCT01500200|157286924|FG004|Stage 1|Lost to Follow-up|0|||
48848861|NCT01500200|157286925|FG005|Stage 1|Lost to Follow-up|0|||
48848862|NCT01500200|157286920|FG000|Stage 1|Withdrawal by Subject|3|||
48848863|NCT01500200|157286921|FG001|Stage 1|Withdrawal by Subject|0|||
48848864|NCT01500200|157286922|FG002|Stage 1|Withdrawal by Subject|0|||
48848865|NCT01500200|157286923|FG003|Stage 1|Withdrawal by Subject|0|||
48848866|NCT01500200|157286924|FG004|Stage 1|Withdrawal by Subject|0|||
48848867|NCT01500200|157286925|FG005|Stage 1|Withdrawal by Subject|0|||
48848868|NCT01500200|157286920|FG000|Stage 1|Noncompliance with Study Drug|1|||
48848869|NCT01500200|157286921|FG001|Stage 1|Noncompliance with Study Drug|0|||
48848870|NCT01500200|157286922|FG002|Stage 1|Noncompliance with Study Drug|0|||
48848871|NCT01500200|157286923|FG003|Stage 1|Noncompliance with Study Drug|0|||
48941233|NCT00389207|157615215|FG000|Overall Study|Protocol Violation|3|||
48941234|NCT00389207|157615216|FG001|Overall Study|Protocol Violation|1|||
48941235|NCT00389207|157615217|FG002|Overall Study|Protocol Violation|4|||
48941236|NCT00389207|157615215|FG000|Overall Study|Lost to Follow-up|12|||
48941237|NCT00389207|157615216|FG001|Overall Study|Lost to Follow-up|9|||
48941238|NCT00389207|157615217|FG002|Overall Study|Lost to Follow-up|7|||
48941239|NCT00389207|157615215|FG000|Overall Study|Withdrawal by Subject|5|||
48941240|NCT00389207|157615216|FG001|Overall Study|Withdrawal by Subject|7|||
48941241|NCT00389207|157615217|FG002|Overall Study|Withdrawal by Subject|11|||
48941242|NCT00389207|157615215|FG000|Overall Study|Other|17|||
48941243|NCT00389207|157615216|FG001|Overall Study|Other|23|||
48941244|NCT00389207|157615217|FG002|Overall Study|Other|9|||
48941245|NCT02485717|157615221|FG000|Overall Study|Lost to Follow-up|6|||
48941246|NCT02485717|157615222|FG001|Overall Study|Lost to Follow-up|0|||
48941247|NCT02485717|157615223|FG002|Overall Study|Lost to Follow-up|0|||
48941248|NCT02485717|157615221|FG000|Overall Study|Withdrawal by Subject|0|||
48941249|NCT02485717|157615222|FG001|Overall Study|Withdrawal by Subject|0|||
48941250|NCT02485717|157615223|FG002|Overall Study|Withdrawal by Subject|1|||
48941251|NCT02485717|157615221|FG000|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
48941252|NCT02485717|157615222|FG001|Overall Study|Did Not Meet Exclusion Criteria #2|1|||
48941253|NCT02485717|157615223|FG002|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
48941254|NCT02485717|157615221|FG000|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
48941255|NCT02485717|157615222|FG001|Overall Study|Did Not Meet Exclusion Criteria #12|1|||
48941256|NCT02485717|157615223|FG002|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
48941257|NCT00467649|157615226|FG000|Phase 1 (Randomized Population)|Adverse Event|2|||
48941258|NCT00467649|157615227|FG001|Phase 1 (Randomized Population)|Adverse Event|0|||
48941259|NCT00467649|157615228|FG002|Phase 1 (Randomized Population)|Adverse Event|0|||
48941260|NCT00467649|157615229|FG003|Phase 1 (Randomized Population)|Adverse Event|0|||
48941261|NCT00467649|157615230|FG004|Phase 1 (Randomized Population)|Adverse Event|0|||
48941262|NCT00467649|157615231|FG005|Phase 1 (Randomized Population)|Adverse Event|0|||
48941263|NCT00467649|157615226|FG000|Phase 1 (Randomized Population)|Investigator Decision|1|||
48941264|NCT00467649|157615227|FG001|Phase 1 (Randomized Population)|Investigator Decision|0|||
48941265|NCT00467649|157615228|FG002|Phase 1 (Randomized Population)|Investigator Decision|0|||
48941266|NCT00467649|157615229|FG003|Phase 1 (Randomized Population)|Investigator Decision|0|||
48941267|NCT00467649|157615230|FG004|Phase 1 (Randomized Population)|Investigator Decision|0|||
48941268|NCT00467649|157615231|FG005|Phase 1 (Randomized Population)|Investigator Decision|0|||
48941269|NCT00467649|157615226|FG000|Phase 1 (Randomized Population)|Lost to Follow-up|2|||
48941270|NCT00467649|157615227|FG001|Phase 1 (Randomized Population)|Lost to Follow-up|4|||
48941271|NCT00467649|157615228|FG002|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
48941272|NCT00467649|157615229|FG003|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
48941273|NCT00467649|157615230|FG004|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
48941274|NCT00467649|157615231|FG005|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
48941275|NCT00467649|157615226|FG000|Phase 1 (Randomized Population)|Withdrawal of Consent|4|||
48941276|NCT00467649|157615227|FG001|Phase 1 (Randomized Population)|Withdrawal of Consent|2|||
48941277|NCT00467649|157615228|FG002|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
48941278|NCT00467649|157615229|FG003|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
48941279|NCT00467649|157615230|FG004|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
48941280|NCT00467649|157615231|FG005|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
48941281|NCT00467649|157615226|FG000|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
48941282|NCT00467649|157615227|FG001|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
48941283|NCT00467649|157615228|FG002|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
48941284|NCT00467649|157615229|FG003|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1|||
48941285|NCT00467649|157615230|FG004|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
48941286|NCT00467649|157615231|FG005|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
48941287|NCT00467649|157615226|FG000|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
48941288|NCT00467649|157615227|FG001|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
48941289|NCT00467649|157615228|FG002|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
48941290|NCT00467649|157615229|FG003|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1|||
48941291|NCT00467649|157615230|FG004|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
48941292|NCT00467649|157615231|FG005|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
48941293|NCT00467649|157615226|FG000|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
48941294|NCT00467649|157615227|FG001|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
48941295|NCT00467649|157615228|FG002|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
48941296|NCT00467649|157615229|FG003|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
48941297|NCT00467649|157615230|FG004|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
48941298|NCT00467649|157615231|FG005|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1|||
48941299|NCT01982630|157615232|FG000|Overall Study|Adverse Event|2|||
48941300|NCT01982630|157615233|FG001|Overall Study|Adverse Event|0|||
48941301|NCT01982630|157615234|FG002|Overall Study|Adverse Event|1|||
48941302|NCT01982630|157615235|FG003|Overall Study|Adverse Event|0|||
48941303|NCT01982630|157615236|FG004|Overall Study|Adverse Event|1|||
48941304|NCT01982630|157615237|FG005|Overall Study|Adverse Event|2|||
48941305|NCT01982630|157615238|FG006|Overall Study|Adverse Event|1|||
48941306|NCT01982630|157615239|FG007|Overall Study|Adverse Event|0|||
48941307|NCT01982630|157615232|FG000|Overall Study|Physician Decision|1|||
48941308|NCT01982630|157615233|FG001|Overall Study|Physician Decision|0|||
48941309|NCT01982630|157615234|FG002|Overall Study|Physician Decision|2|||
48941310|NCT01982630|157615235|FG003|Overall Study|Physician Decision|1|||
48941311|NCT01982630|157615236|FG004|Overall Study|Physician Decision|2|||
48941312|NCT01982630|157615237|FG005|Overall Study|Physician Decision|0|||
48941313|NCT01982630|157615238|FG006|Overall Study|Physician Decision|0|||
48941314|NCT01982630|157615239|FG007|Overall Study|Physician Decision|0|||
48941315|NCT01982630|157615232|FG000|Overall Study|Did Not Receive Drug-Technical Issues|0|||
48941316|NCT01982630|157615233|FG001|Overall Study|Did Not Receive Drug-Technical Issues|0|||
48941317|NCT01982630|157615234|FG002|Overall Study|Did Not Receive Drug-Technical Issues|2|||
48941318|NCT01982630|157615235|FG003|Overall Study|Did Not Receive Drug-Technical Issues|0|||
48941319|NCT01982630|157615236|FG004|Overall Study|Did Not Receive Drug-Technical Issues|0|||
48941320|NCT01982630|157615237|FG005|Overall Study|Did Not Receive Drug-Technical Issues|0|||
48941321|NCT01982630|157615238|FG006|Overall Study|Did Not Receive Drug-Technical Issues|0|||
48941322|NCT01982630|157615239|FG007|Overall Study|Did Not Receive Drug-Technical Issues|0|||
48941323|NCT01982630|157615232|FG000|Overall Study|Withdrawal by Subject|0|||
48941324|NCT01982630|157615233|FG001|Overall Study|Withdrawal by Subject|0|||
48941325|NCT01982630|157615234|FG002|Overall Study|Withdrawal by Subject|0|||
48941326|NCT01982630|157615235|FG003|Overall Study|Withdrawal by Subject|0|||
48941327|NCT01982630|157615236|FG004|Overall Study|Withdrawal by Subject|0|||
48941328|NCT01982630|157615237|FG005|Overall Study|Withdrawal by Subject|1|||
48941329|NCT01982630|157615238|FG006|Overall Study|Withdrawal by Subject|0|||
48941330|NCT01982630|157615239|FG007|Overall Study|Withdrawal by Subject|0|||
48941331|NCT00957853|157615240|FG000|Overall Study|Withdrawal by Subject|1|||
48941332|NCT00957853|157615241|FG001|Overall Study|Withdrawal by Subject|0|||
48941333|NCT00957853|157615242|FG002|Overall Study|Withdrawal by Subject|0|||
48941334|NCT01624194|157615243|FG000|Overall Study|Lost to Follow-up|1|||
48941335|NCT01624194|157615244|FG001|Overall Study|Lost to Follow-up|0|||
48941336|NCT01624194|157615243|FG000|Overall Study|Withdrawal by Subject|1|||
48941337|NCT01624194|157615244|FG001|Overall Study|Withdrawal by Subject|0|||
48941338|NCT03459040|157615248|FG000|Overall Study|Death|8|||
48941339|NCT03459040|157615248|FG000|Overall Study|Withdrawal by Subject|1|||
48941340|NCT00986349|157615249|FG000|Overall Study|Unsuccessful implant procedure|3|||
48941341|NCT00986349|157615249|FG000|Overall Study|Adverse Event|2|||
48941342|NCT00986349|157615249|FG000|Overall Study|Physician Decision|1|||
48941343|NCT00986349|157615249|FG000|Overall Study|device migration|1|||
48941344|NCT03815175|157615250|FG000|Overall Study|Subject Lost to Follow-up|6|||
48941345|NCT03815175|157615250|FG000|Overall Study|Subject Withdrew Consent|48|||
48941346|NCT03815175|157615250|FG000|Overall Study|Subject Withdrawn by Physician/Site|10|||
48941347|NCT03815175|157615250|FG000|Overall Study|Death|86|||
48941348|NCT03815175|157615250|FG000|Overall Study|Improper/Duplicate SubjectEnrollment|1|||
48941349|NCT03815175|157615250|FG000|Overall Study|Subject Discontinued by Sponsor|2|||
48941350|NCT03815175|157615250|FG000|Overall Study|Other Status Change Reason|1|||
48941351|NCT03815175|157615250|FG000|Overall Study|Missed Visit|12|||
48941352|NCT03577990|157615251|FG000|Overall Study|Lost to Follow-up|4|||
48941353|NCT03577990|157615252|FG001|Overall Study|Lost to Follow-up|6|||
48941354|NCT03577990|157615251|FG000|Overall Study|Withdrawal by Subject|4|||
48941355|NCT03577990|157615252|FG001|Overall Study|Withdrawal by Subject|7|||
48941356|NCT04925570|157615255|FG000|Overall Study|Protocol Violation|24|||
48941357|NCT04925570|157615256|FG001|Overall Study|Protocol Violation|30|||
48941358|NCT04925570|157615255|FG000|Overall Study|Withdrawal by Subject|0|||
48941359|NCT04925570|157615256|FG001|Overall Study|Withdrawal by Subject|2|||
48941360|NCT04488822|157615257|FG000|Overall Study|Adverse Event|8|||
48941361|NCT04488822|157615257|FG000|Overall Study|Withdrawal by Subject|1|||
48941362|NCT01361711|157615258|FG000|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1|||
48941363|NCT01361711|157615258|FG000|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1|||
48941364|NCT01361711|157615258|FG000|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7|||
48941365|NCT01361711|157615258|FG000|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2|||
48941366|NCT01361711|157615258|FG000|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1|||
48941367|NCT01361711|157615258|FG000|Completed Week 18 of Treatment|Complete Remission|2|||
48941368|NCT01361711|157615258|FG000|Completed Week 18 of Treatment|Other|9|||
48848872|NCT01500200|157286924|FG004|Stage 1|Noncompliance with Study Drug|0|||
48848873|NCT01500200|157286925|FG005|Stage 1|Noncompliance with Study Drug|0|||
48848874|NCT01500200|157286920|FG000|Stage 1|Physician Decision|1|||
48941369|NCT01361711|157615258|FG000|10 Year Follow-up|Still in follow-up|22|||
48941370|NCT01361711|157615258|FG000|10 Year Follow-up|Death|7|||
48941371|NCT01361711|157615258|FG000|10 Year Follow-up|Developed new cancer|1|||
48941372|NCT01361711|157615258|FG000|10 Year Follow-up|Lost to Follow-up|2|||
48848875|NCT01500200|157286921|FG001|Stage 1|Physician Decision|0|||
48848876|NCT01500200|157286922|FG002|Stage 1|Physician Decision|0|||
48848877|NCT01500200|157286923|FG003|Stage 1|Physician Decision|0|||
48941373|NCT01361711|157615258|FG000|10 Year Follow-up|New treatment started|6|||
48941374|NCT01361711|157615258|FG000|10 Year Follow-up|Progressive Disease and New treatment started|11|||
48941375|NCT01361711|157615258|FG000|10 Year Follow-up|Progressive Disease|1|||
48941376|NCT02986373|157615261|FG000|Overall Study|Adverse Event|4|||
48941377|NCT02986373|157615261|FG000|Overall Study|Lost to Follow-up|1|||
48941378|NCT02986373|157615261|FG000|Overall Study|Withdrawal by Subject|10|||
48941379|NCT02986373|157615261|FG000|Overall Study|Other|24|||
48941380|NCT04800315|157615262|FG000|Randomization|Did not receive study treatment|1|||
48941381|NCT04800315|157615263|FG001|Randomization|Did not receive study treatment|0|||
48941382|NCT04800315|157615264|FG002|Randomization|Did not receive study treatment|0|||
48941383|NCT04800315|157615265|FG003|Randomization|Did not receive study treatment|0|||
48941384|NCT04800315|157615262|FG000|Treatment Period|Adverse Event|4|||
48941385|NCT04800315|157615263|FG001|Treatment Period|Adverse Event|2|||
48941386|NCT04800315|157615264|FG002|Treatment Period|Adverse Event|1|||
48941387|NCT04800315|157615265|FG003|Treatment Period|Adverse Event|2|||
48941388|NCT04800315|157615262|FG000|Treatment Period|Lack of Efficacy|1|||
48941389|NCT04800315|157615263|FG001|Treatment Period|Lack of Efficacy|0|||
48941390|NCT04800315|157615264|FG002|Treatment Period|Lack of Efficacy|0|||
48941391|NCT04800315|157615265|FG003|Treatment Period|Lack of Efficacy|3|||
48941392|NCT04800315|157615262|FG000|Treatment Period|Lost to Follow-up|0|||
48941393|NCT04800315|157615263|FG001|Treatment Period|Lost to Follow-up|1|||
48941394|NCT04800315|157615264|FG002|Treatment Period|Lost to Follow-up|2|||
48941395|NCT04800315|157615265|FG003|Treatment Period|Lost to Follow-up|2|||
48941396|NCT04800315|157615262|FG000|Treatment Period|Withdrawal by participant|0|||
48941397|NCT04800315|157615263|FG001|Treatment Period|Withdrawal by participant|0|||
48941398|NCT04800315|157615264|FG002|Treatment Period|Withdrawal by participant|0|||
48941399|NCT04800315|157615265|FG003|Treatment Period|Withdrawal by participant|4|||
48941400|NCT04800315|157615262|FG000|Treatment Period|Other Reasons|0|||
48941401|NCT04800315|157615263|FG001|Treatment Period|Other Reasons|2|||
48941402|NCT04800315|157615264|FG002|Treatment Period|Other Reasons|0|||
48941403|NCT04800315|157615265|FG003|Treatment Period|Other Reasons|1|||
48941404|NCT01607892|157615270|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
48941405|NCT01607892|157615271|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
48941406|NCT01607892|157615272|FG002|Overall Study|Need of treatment not allowed per protocol|0|||
48941407|NCT01607892|157615273|FG003|Overall Study|Need of treatment not allowed per protocol|1|||
48941408|NCT01607892|157615274|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
48941409|NCT01607892|157615270|FG000|Overall Study|Death|4|||
48941410|NCT01607892|157615271|FG001|Overall Study|Death|2|||
48941411|NCT01607892|157615272|FG002|Overall Study|Death|8|||
48848878|NCT01500200|157286924|FG004|Stage 1|Physician Decision|0|||
48848879|NCT01500200|157286925|FG005|Stage 1|Physician Decision|0|||
48848880|NCT01500200|157286920|FG000|Stage 2|Adverse Event|0|||
48848881|NCT01500200|157286921|FG001|Stage 2|Adverse Event|0|||
48941412|NCT01607892|157615273|FG003|Overall Study|Death|10|||
48941413|NCT01607892|157615274|FG004|Overall Study|Death|3|||
48941414|NCT01607892|157615270|FG000|Overall Study|Investigator discretion|2|||
48941415|NCT01607892|157615271|FG001|Overall Study|Investigator discretion|4|||
48941416|NCT01607892|157615272|FG002|Overall Study|Investigator discretion|4|||
48941417|NCT01607892|157615273|FG003|Overall Study|Investigator discretion|8|||
48941418|NCT01607892|157615274|FG004|Overall Study|Investigator discretion|0|||
48941419|NCT01607892|157615270|FG000|Overall Study|Other treatments became available|1|||
48941420|NCT01607892|157615271|FG001|Overall Study|Other treatments became available|1|||
48941421|NCT01607892|157615272|FG002|Overall Study|Other treatments became available|0|||
48941422|NCT01607892|157615273|FG003|Overall Study|Other treatments became available|0|||
48941423|NCT01607892|157615274|FG004|Overall Study|Other treatments became available|2|||
48941424|NCT01607892|157615270|FG000|Overall Study|Intercurrent illness|1|||
48848882|NCT01500200|157286922|FG002|Stage 2|Adverse Event|0|||
48848883|NCT01500200|157286923|FG003|Stage 2|Adverse Event|0|||
48848884|NCT01500200|157286924|FG004|Stage 2|Adverse Event|5|||
48848885|NCT01500200|157286925|FG005|Stage 2|Adverse Event|4|||
48848886|NCT01700205|157286926|FG000|Overall Study|Withdrawal by Subject|13|||
48848887|NCT01700205|157286927|FG001|Overall Study|Withdrawal by Subject|13|||
48848888|NCT01700205|157286926|FG000|Overall Study|Protocol Violation|2|||
48848889|NCT01700205|157286927|FG001|Overall Study|Protocol Violation|2|||
48848890|NCT00491894|157286928|FG000|Overall Study|Adverse Event|14|||
48848891|NCT00491894|157286928|FG000|Overall Study|Withdrawal by Subject|5|||
48848892|NCT00491894|157286928|FG000|Overall Study|Death|3|||
48941425|NCT01607892|157615271|FG001|Overall Study|Intercurrent illness|0|||
48941426|NCT01607892|157615272|FG002|Overall Study|Intercurrent illness|0|||
48941427|NCT01607892|157615273|FG003|Overall Study|Intercurrent illness|3|||
48941428|NCT01607892|157615274|FG004|Overall Study|Intercurrent illness|0|||
48941429|NCT01607892|157615270|FG000|Overall Study|Non-Compliance with study procedures|0|||
48941430|NCT01607892|157615271|FG001|Overall Study|Non-Compliance with study procedures|0|||
48941431|NCT01607892|157615272|FG002|Overall Study|Non-Compliance with study procedures|1|||
48941432|NCT01607892|157615273|FG003|Overall Study|Non-Compliance with study procedures|0|||
48941433|NCT01607892|157615274|FG004|Overall Study|Non-Compliance with study procedures|0|||
48941434|NCT01607892|157615270|FG000|Overall Study|Consent withdrawn by participant|9|||
48941435|NCT01607892|157615271|FG001|Overall Study|Consent withdrawn by participant|4|||
48941436|NCT01607892|157615272|FG002|Overall Study|Consent withdrawn by participant|24|||
48941437|NCT01607892|157615273|FG003|Overall Study|Consent withdrawn by participant|14|||
48941438|NCT01607892|157615274|FG004|Overall Study|Consent withdrawn by participant|4|||
48941439|NCT01607892|157615270|FG000|Overall Study|Disease progression|38|||
48941440|NCT01607892|157615271|FG001|Overall Study|Disease progression|13|||
48941441|NCT01607892|157615272|FG002|Overall Study|Disease progression|37|||
48941442|NCT01607892|157615273|FG003|Overall Study|Disease progression|57|||
48941443|NCT01607892|157615274|FG004|Overall Study|Disease progression|9|||
48941444|NCT01607892|157615270|FG000|Overall Study|Incidence or severity of Adverse events|3|||
48941445|NCT01607892|157615271|FG001|Overall Study|Incidence or severity of Adverse events|3|||
48941446|NCT01607892|157615272|FG002|Overall Study|Incidence or severity of Adverse events|7|||
48941447|NCT01607892|157615273|FG003|Overall Study|Incidence or severity of Adverse events|2|||
48941448|NCT01607892|157615274|FG004|Overall Study|Incidence or severity of Adverse events|6|||
48941449|NCT01877655|157615275|FG000|Overall Study|Death|57|||
48941450|NCT01877655|157615276|FG001|Overall Study|Death|52|||
48941451|NCT01877655|157615275|FG000|Overall Study|Withdrawal by Subject|18|||
48941452|NCT01877655|157615276|FG001|Overall Study|Withdrawal by Subject|26|||
48941453|NCT01877655|157615275|FG000|Overall Study|Physician Decision|11|||
48941454|NCT01877655|157615276|FG001|Overall Study|Physician Decision|10|||
48941455|NCT01877655|157615275|FG000|Overall Study|Miscellaneous|4|||
48941456|NCT01877655|157615276|FG001|Overall Study|Miscellaneous|4|||
48941457|NCT01877655|157615275|FG000|Overall Study|Randomized but Never Received Drug|8|||
48941458|NCT01877655|157615276|FG001|Overall Study|Randomized but Never Received Drug|5|||
48941459|NCT02224664|157617175|FG000|Lead-in Period (3 Days)|Does not meet entrance criteria|5|||
48941460|NCT02224664|157617176|FG001|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
48941461|NCT02224664|157617177|FG002|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
48941462|NCT02224664|157617178|FG003|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
48941463|NCT02224664|157617179|FG004|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
48941464|NCT02224664|157617175|FG000|Dose Escalation Period (21 Days)|Adverse Event|0|||
48941465|NCT02224664|157617176|FG001|Dose Escalation Period (21 Days)|Adverse Event|0|||
48941466|NCT02224664|157617177|FG002|Dose Escalation Period (21 Days)|Adverse Event|2|||
48941467|NCT02224664|157617178|FG003|Dose Escalation Period (21 Days)|Adverse Event|2|||
48941468|NCT02224664|157617179|FG004|Dose Escalation Period (21 Days)|Adverse Event|7|||
48941469|NCT02224664|157617175|FG000|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
48941470|NCT02224664|157617176|FG001|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
48941471|NCT02224664|157617177|FG002|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
48941472|NCT02224664|157617178|FG003|Dose Escalation Period (21 Days)|Withdrawal by Subject|1|||
48848893|NCT00491894|157286928|FG000|Overall Study|Lost to Follow-up|3|||
48848894|NCT00491894|157286928|FG000|Overall Study|Lack of Efficacy|2|||
48941473|NCT02224664|157617179|FG004|Dose Escalation Period (21 Days)|Withdrawal by Subject|4|||
48941474|NCT01028352|157617186|FG000|Overall Study|Ineligible due to baseline average pain|5|||
48941475|NCT01028352|157617186|FG000|Overall Study|Withdrawal by Subject|1|||
48941476|NCT03487445|157617189|FG000|Randomization|Not treated for administrative reasons|1|||
48941477|NCT03487445|157617190|FG001|Randomization|Not treated for administrative reasons|0|||
48941478|NCT00097539|157617191|FG000|Overall Study|Status Unknown (Or no final evaluation)|11959|||
48941479|NCT00097539|157617192|FG001|Overall Study|Status Unknown (Or no final evaluation)|3948|||
48941480|NCT00097539|157617193|FG002|Overall Study|Status Unknown (Or no final evaluation)|5646|||
48848895|NCT00491894|157286928|FG000|Overall Study|Other-Failed to meet any criteria|2|||
48848896|NCT00491894|157286928|FG000|Overall Study|Physician Decision|2|||
48848897|NCT00491894|157286928|FG000|Overall Study|Protocol Violation|2|||
48941481|NCT00097539|157617194|FG003|Overall Study|Status Unknown (Or no final evaluation)|2170|||
48941482|NCT00097539|157617195|FG004|Overall Study|Status Unknown (Or no final evaluation)|1106|||
48941483|NCT00097539|157617196|FG005|Overall Study|Status Unknown (Or no final evaluation)|3546|||
48941484|NCT00097539|157617197|FG006|Overall Study|Status Unknown (Or no final evaluation)|108|||
48941485|NCT00097539|157617191|FG000|Overall Study|Withdrawal by Subject|925|||
48941486|NCT00097539|157617192|FG001|Overall Study|Withdrawal by Subject|323|||
48941487|NCT00097539|157617193|FG002|Overall Study|Withdrawal by Subject|346|||
48941488|NCT00097539|157617194|FG003|Overall Study|Withdrawal by Subject|217|||
48941489|NCT00097539|157617195|FG004|Overall Study|Withdrawal by Subject|68|||
48941490|NCT00097539|157617196|FG005|Overall Study|Withdrawal by Subject|229|||
48941491|NCT00097539|157617197|FG006|Overall Study|Withdrawal by Subject|3|||
48941492|NCT00097539|157617191|FG000|Overall Study|Participant Non-compliant|2140|||
48941493|NCT00097539|157617192|FG001|Overall Study|Participant Non-compliant|567|||
48941494|NCT00097539|157617193|FG002|Overall Study|Participant Non-compliant|1067|||
48941495|NCT00097539|157617194|FG003|Overall Study|Participant Non-compliant|353|||
48941496|NCT00097539|157617195|FG004|Overall Study|Participant Non-compliant|136|||
48941497|NCT00097539|157617196|FG005|Overall Study|Participant Non-compliant|543|||
48941498|NCT00097539|157617197|FG006|Overall Study|Participant Non-compliant|18|||
48941499|NCT00097539|157617191|FG000|Overall Study|Lack of Efficacy|249|||
48941500|NCT00097539|157617192|FG001|Overall Study|Lack of Efficacy|122|||
48941501|NCT00097539|157617193|FG002|Overall Study|Lack of Efficacy|202|||
48941502|NCT00097539|157617194|FG003|Overall Study|Lack of Efficacy|105|||
48941503|NCT00097539|157617195|FG004|Overall Study|Lack of Efficacy|45|||
48941504|NCT00097539|157617196|FG005|Overall Study|Lack of Efficacy|228|||
48941505|NCT00097539|157617197|FG006|Overall Study|Lack of Efficacy|5|||
48941506|NCT00097539|157617191|FG000|Overall Study|Adverse Event|78|||
48941507|NCT00097539|157617192|FG001|Overall Study|Adverse Event|133|||
48941508|NCT00097539|157617193|FG002|Overall Study|Adverse Event|37|||
48941509|NCT00097539|157617194|FG003|Overall Study|Adverse Event|27|||
48941510|NCT00097539|157617195|FG004|Overall Study|Adverse Event|30|||
48941511|NCT00097539|157617196|FG005|Overall Study|Adverse Event|59|||
48941512|NCT00097539|157617197|FG006|Overall Study|Adverse Event|1|||
48941513|NCT00097539|157617191|FG000|Overall Study|Death|2|||
48941514|NCT00097539|157617192|FG001|Overall Study|Death|7|||
48941515|NCT00097539|157617193|FG002|Overall Study|Death|0|||
48941516|NCT00097539|157617194|FG003|Overall Study|Death|0|||
48941517|NCT00097539|157617195|FG004|Overall Study|Death|1|||
48941518|NCT00097539|157617196|FG005|Overall Study|Death|3|||
48941519|NCT00097539|157617197|FG006|Overall Study|Death|0|||
48941520|NCT00097539|157617191|FG000|Overall Study|Reasons Other Than Above|3602|||
48941521|NCT00097539|157617192|FG001|Overall Study|Reasons Other Than Above|1382|||
48941522|NCT00097539|157617193|FG002|Overall Study|Reasons Other Than Above|1757|||
48941523|NCT00097539|157617194|FG003|Overall Study|Reasons Other Than Above|692|||
48941524|NCT00097539|157617195|FG004|Overall Study|Reasons Other Than Above|361|||
48941525|NCT00097539|157617196|FG005|Overall Study|Reasons Other Than Above|1244|||
48941526|NCT00097539|157617197|FG006|Overall Study|Reasons Other Than Above|34|||
48941527|NCT00097539|157617191|FG000|Overall Study|Reason not Specified|111|||
48941528|NCT00097539|157617192|FG001|Overall Study|Reason not Specified|49|||
48941529|NCT00097539|157617193|FG002|Overall Study|Reason not Specified|53|||
48941530|NCT00097539|157617194|FG003|Overall Study|Reason not Specified|21|||
48941531|NCT00097539|157617195|FG004|Overall Study|Reason not Specified|11|||
48941532|NCT00097539|157617196|FG005|Overall Study|Reason not Specified|40|||
48941533|NCT00097539|157617197|FG006|Overall Study|Reason not Specified|2|||
48941534|NCT00364793|157617198|FG000|Overall Study|Adverse Event|2|||
48941535|NCT00364793|157617199|FG001|Overall Study|Adverse Event|0|||
48941536|NCT00364793|157617200|FG002|Overall Study|Adverse Event|0|||
48941537|NCT00364793|157617201|FG003|Overall Study|Adverse Event|0|||
48941538|NCT00364793|157617198|FG000|Overall Study|Death|1|||
48941539|NCT00364793|157617199|FG001|Overall Study|Death|0|||
48941540|NCT00364793|157617200|FG002|Overall Study|Death|1|||
48941541|NCT00364793|157617201|FG003|Overall Study|Death|0|||
48941542|NCT00364793|157617198|FG000|Overall Study|Lack of Efficacy|3|||
48941543|NCT00364793|157617199|FG001|Overall Study|Lack of Efficacy|3|||
48941544|NCT00364793|157617200|FG002|Overall Study|Lack of Efficacy|1|||
48941545|NCT00364793|157617201|FG003|Overall Study|Lack of Efficacy|1|||
48941546|NCT00364793|157617198|FG000|Overall Study|Lost to Follow-up|1|||
48941547|NCT00364793|157617199|FG001|Overall Study|Lost to Follow-up|0|||
48941548|NCT00364793|157617200|FG002|Overall Study|Lost to Follow-up|2|||
48941549|NCT00364793|157617201|FG003|Overall Study|Lost to Follow-up|0|||
48941550|NCT00364793|157617198|FG000|Overall Study|Poor or non-compliance|1|||
48941551|NCT00364793|157617199|FG001|Overall Study|Poor or non-compliance|1|||
48941552|NCT00364793|157617200|FG002|Overall Study|Poor or non-compliance|0|||
48941553|NCT00364793|157617201|FG003|Overall Study|Poor or non-compliance|1|||
48941554|NCT00364793|157617198|FG000|Overall Study|No longer meets criteria|0|||
48941555|NCT00364793|157617199|FG001|Overall Study|No longer meets criteria|0|||
48848898|NCT00491894|157286928|FG000|Overall Study|Other-Intake of prohibited medication|1|||
48848899|NCT03066609|157286930|FG000|INDUCTION|Pregnancy|0|||
48848900|NCT03066609|157286931|FG001|INDUCTION|Pregnancy|0|||
48848901|NCT03066609|157286932|FG002|INDUCTION|Pregnancy|1|||
48848902|NCT03066609|157286933|FG003|INDUCTION|Pregnancy|0|||
48848903|NCT03066609|157286930|FG000|INDUCTION|Lack of Efficacy|0|||
48848904|NCT03066609|157286931|FG001|INDUCTION|Lack of Efficacy|0|||
48848905|NCT03066609|157286932|FG002|INDUCTION|Lack of Efficacy|1|||
48848906|NCT03066609|157286933|FG003|INDUCTION|Lack of Efficacy|0|||
48848907|NCT03066609|157286930|FG000|INDUCTION|Adverse Event|2|||
48848908|NCT03066609|157286931|FG001|INDUCTION|Adverse Event|2|||
48848909|NCT03066609|157286932|FG002|INDUCTION|Adverse Event|0|||
48848910|NCT03066609|157286933|FG003|INDUCTION|Adverse Event|0|||
48848911|NCT03066609|157286930|FG000|MAINTENANCE|Adverse Event|0|||
48848912|NCT03066609|157286931|FG001|MAINTENANCE|Adverse Event|0|||
48848913|NCT03066609|157286932|FG002|MAINTENANCE|Adverse Event|0|||
48848914|NCT03066609|157286933|FG003|MAINTENANCE|Adverse Event|1|||
48848915|NCT03066609|157286930|FG000|MAINTENANCE|Withdrawal by Subject|4|||
48848916|NCT03066609|157286931|FG001|MAINTENANCE|Withdrawal by Subject|2|||
48848917|NCT03066609|157286932|FG002|MAINTENANCE|Withdrawal by Subject|1|||
48848918|NCT03066609|157286933|FG003|MAINTENANCE|Withdrawal by Subject|1|||
48848919|NCT03066609|157286930|FG000|MAINTENANCE|Lost to Follow-up|0|||
48848920|NCT03066609|157286931|FG001|MAINTENANCE|Lost to Follow-up|1|||
48848921|NCT03066609|157286932|FG002|MAINTENANCE|Lost to Follow-up|1|||
48848922|NCT03066609|157286933|FG003|MAINTENANCE|Lost to Follow-up|0|||
48848923|NCT03066609|157286930|FG000|MAINTENANCE|Pregnancy|1|||
48848924|NCT03066609|157286931|FG001|MAINTENANCE|Pregnancy|0|||
48848925|NCT03066609|157286932|FG002|MAINTENANCE|Pregnancy|0|||
48848926|NCT03066609|157286933|FG003|MAINTENANCE|Pregnancy|0|||
48848927|NCT03066609|157286930|FG000|MAINTENANCE|Lack of Efficacy|2|||
48848928|NCT03066609|157286931|FG001|MAINTENANCE|Lack of Efficacy|1|||
48848929|NCT03066609|157286932|FG002|MAINTENANCE|Lack of Efficacy|0|||
48848930|NCT03066609|157286933|FG003|MAINTENANCE|Lack of Efficacy|1|||
48848931|NCT03066609|157286930|FG000|OVERALL STUDY|Adverse Event|2|||
48848932|NCT03066609|157286931|FG001|OVERALL STUDY|Adverse Event|2|||
48848933|NCT03066609|157286932|FG002|OVERALL STUDY|Adverse Event|0|||
48848934|NCT03066609|157286933|FG003|OVERALL STUDY|Adverse Event|1|||
48848935|NCT03066609|157286930|FG000|OVERALL STUDY|Withdrawal by Subject|4|||
48848936|NCT03066609|157286931|FG001|OVERALL STUDY|Withdrawal by Subject|2|||
48848937|NCT03066609|157286932|FG002|OVERALL STUDY|Withdrawal by Subject|1|||
48848938|NCT03066609|157286933|FG003|OVERALL STUDY|Withdrawal by Subject|2|||
48848939|NCT03066609|157286930|FG000|OVERALL STUDY|Lost to Follow-up|1|||
48848940|NCT03066609|157286931|FG001|OVERALL STUDY|Lost to Follow-up|1|||
48848941|NCT03066609|157286932|FG002|OVERALL STUDY|Lost to Follow-up|1|||
48848942|NCT03066609|157286933|FG003|OVERALL STUDY|Lost to Follow-up|1|||
48848943|NCT03066609|157286930|FG000|OVERALL STUDY|Pregnancy|1|||
48848944|NCT03066609|157286931|FG001|OVERALL STUDY|Pregnancy|0|||
48848945|NCT03066609|157286932|FG002|OVERALL STUDY|Pregnancy|1|||
48848946|NCT03066609|157286933|FG003|OVERALL STUDY|Pregnancy|0|||
48848947|NCT03066609|157286930|FG000|OVERALL STUDY|Lack of Efficacy|2|||
48848948|NCT03066609|157286931|FG001|OVERALL STUDY|Lack of Efficacy|1|||
48848949|NCT03066609|157286932|FG002|OVERALL STUDY|Lack of Efficacy|1|||
48848950|NCT03066609|157286933|FG003|OVERALL STUDY|Lack of Efficacy|1|||
48848951|NCT03066609|157286930|FG000|OVERALL STUDY|discontinued follow up|0|||
48848952|NCT03066609|157286931|FG001|OVERALL STUDY|discontinued follow up|2|||
48848953|NCT03066609|157286932|FG002|OVERALL STUDY|discontinued follow up|0|||
48848954|NCT03066609|157286933|FG003|OVERALL STUDY|discontinued follow up|0|||
48848955|NCT00003222|157286935|FG000|Overall Study|Physician Decision|0|||
48848956|NCT00003222|157286936|FG001|Overall Study|Physician Decision|1|||
48848957|NCT00756574|157286954|FG000|Overall Study|Withdrawal by Subject|9|||
48848958|NCT00756574|157286955|FG001|Overall Study|Withdrawal by Subject|7|||
48848959|NCT00756574|157286954|FG000|Overall Study|Lost to Follow-up|4|||
48848960|NCT00756574|157286955|FG001|Overall Study|Lost to Follow-up|4|||
48848961|NCT02787005|157286959|FG000|Overall Study|Adverse Event|24|||
48848962|NCT02787005|157286960|FG001|Overall Study|Adverse Event|9|||
48848963|NCT02787005|157286961|FG002|Overall Study|Adverse Event|9|||
48848964|NCT02787005|157286962|FG003|Overall Study|Adverse Event|7|||
48848965|NCT02787005|157286963|FG004|Overall Study|Adverse Event|2|||
48848966|NCT02787005|157286959|FG000|Overall Study|Death|100|||
48848967|NCT02787005|157286960|FG001|Overall Study|Death|53|||
48848968|NCT02787005|157286961|FG002|Overall Study|Death|48|||
48848969|NCT02787005|157286962|FG003|Overall Study|Death|69|||
48848970|NCT02787005|157286963|FG004|Overall Study|Death|38|||
48848971|NCT02787005|157286959|FG000|Overall Study|Sponsor Decision|7|||
48848972|NCT02787005|157286960|FG001|Overall Study|Sponsor Decision|4|||
48848973|NCT02787005|157286961|FG002|Overall Study|Sponsor Decision|0|||
48848974|NCT02787005|157286962|FG003|Overall Study|Sponsor Decision|4|||
48848975|NCT02787005|157286963|FG004|Overall Study|Sponsor Decision|5|||
48848976|NCT02787005|157286959|FG000|Overall Study|Withdrawal by Subject|2|||
48848977|NCT02787005|157286960|FG001|Overall Study|Withdrawal by Subject|1|||
48848978|NCT02787005|157286961|FG002|Overall Study|Withdrawal by Subject|1|||
48941556|NCT00364793|157617200|FG002|Overall Study|No longer meets criteria|0|||
48941557|NCT00364793|157617201|FG003|Overall Study|No longer meets criteria|1|||
48941558|NCT00364793|157617198|FG000|Overall Study|Withdrawal by Subject|0|||
48941559|NCT00364793|157617199|FG001|Overall Study|Withdrawal by Subject|1|||
48941560|NCT00364793|157617200|FG002|Overall Study|Withdrawal by Subject|0|||
48941561|NCT00364793|157617201|FG003|Overall Study|Withdrawal by Subject|0|||
48941562|NCT02966314|157617202|FG000|Overall Study|Lost to Follow-up|1|||
48941563|NCT02966314|157617203|FG001|Overall Study|Lost to Follow-up|0|||
48941564|NCT00391976|157617204|FG000|Overall Study|Adverse Event|0|||
48941565|NCT00391976|157617205|FG001|Overall Study|Adverse Event|0|||
48941566|NCT00391976|157617206|FG002|Overall Study|Adverse Event|1|||
48941567|NCT00391976|157617204|FG000|Overall Study|Withdrawal of consent|0|||
48941568|NCT00391976|157617205|FG001|Overall Study|Withdrawal of consent|1|||
48941569|NCT00391976|157617206|FG002|Overall Study|Withdrawal of consent|1|||
48941570|NCT00391976|157617204|FG000|Overall Study|Lost to Follow-up|1|||
48941571|NCT00391976|157617205|FG001|Overall Study|Lost to Follow-up|2|||
48941572|NCT00391976|157617206|FG002|Overall Study|Lost to Follow-up|0|||
48941573|NCT00391976|157617204|FG000|Overall Study|Inappropriate enrollment|1|||
48941574|NCT00391976|157617205|FG001|Overall Study|Inappropriate enrollment|1|||
48941575|NCT00391976|157617206|FG002|Overall Study|Inappropriate enrollment|0|||
48941576|NCT00391976|157617204|FG000|Overall Study|Protocol deviation/violation|4|||
48941577|NCT00391976|157617205|FG001|Overall Study|Protocol deviation/violation|2|||
48941578|NCT00391976|157617206|FG002|Overall Study|Protocol deviation/violation|1|||
48941579|NCT00391976|157617204|FG000|Overall Study|Recurrence/no eradication of infection|21|||
48941580|NCT00391976|157617205|FG001|Overall Study|Recurrence/no eradication of infection|19|||
48941581|NCT00391976|157617206|FG002|Overall Study|Recurrence/no eradication of infection|0|||
48941582|NCT00391976|157617204|FG000|Overall Study|Unable to classify|0|||
48941583|NCT00391976|157617205|FG001|Overall Study|Unable to classify|0|||
48941584|NCT00391976|157617206|FG002|Overall Study|Unable to classify|1|||
48941585|NCT00391976|157617204|FG000|Overall Study|Positive P. aeruginosa antibody test|0|||
48941586|NCT00391976|157617205|FG001|Overall Study|Positive P. aeruginosa antibody test|0|||
48941587|NCT00391976|157617206|FG002|Overall Study|Positive P. aeruginosa antibody test|31|||
48941588|NCT03180736|157617207|FG000|Overall Study|Adverse Event|3|||
48941589|NCT03180736|157617208|FG001|Overall Study|Adverse Event|4|||
48941590|NCT03180736|157617207|FG000|Overall Study|Death|10|||
48941591|NCT03180736|157617208|FG001|Overall Study|Death|7|||
48941592|NCT03180736|157617207|FG000|Overall Study|Withdrawal by Subject|5|||
48941593|NCT03180736|157617208|FG001|Overall Study|Withdrawal by Subject|12|||
48941594|NCT03180736|157617207|FG000|Overall Study|Lost to Follow-up|1|||
48941595|NCT03180736|157617208|FG001|Overall Study|Lost to Follow-up|0|||
48941596|NCT03180736|157617207|FG000|Overall Study|Lack of Efficacy|66|||
48941597|NCT03180736|157617208|FG001|Overall Study|Lack of Efficacy|87|||
48941598|NCT03180736|157617207|FG000|Overall Study|Physician Decision|4|||
48941599|NCT03180736|157617208|FG001|Overall Study|Physician Decision|7|||
48941600|NCT03180736|157617207|FG000|Overall Study|randomized but not treated|2|||
48941601|NCT03180736|157617208|FG001|Overall Study|randomized but not treated|3|||
48941602|NCT00775021|157617210|FG000|First Intervention|Lost to Follow-up|1|||
48941603|NCT00775021|157617211|FG001|First Intervention|Lost to Follow-up|0|||
48941604|NCT00775021|157617210|FG000|Second Intervention|Adverse Event|0|||
48941605|NCT00775021|157617211|FG001|Second Intervention|Adverse Event|1|||
48941606|NCT00870688|157617215|FG000|Overall Study|Lost to Follow-up|2|||
48941607|NCT00870688|157617215|FG000|Overall Study|Death, Unrelated|1|||
48941608|NCT00870688|157617215|FG000|Overall Study|Granules in the Stools|1|||
48941609|NCT01287754|157617216|FG000|Overall Study|Death|2|||
48941610|NCT01287754|157617217|FG001|Overall Study|Death|12|||
48941611|NCT01287754|157617216|FG000|Overall Study|Lost to Follow-up|1|||
48941612|NCT01287754|157617217|FG001|Overall Study|Lost to Follow-up|6|||
48941613|NCT01287754|157617216|FG000|Overall Study|Protocol Violation|0|||
48941614|NCT01287754|157617217|FG001|Overall Study|Protocol Violation|3|||
48941615|NCT05113940|157617218|FG000|Part A (18 Days)|Adverse Event|0|||
48941616|NCT05113940|157617219|FG001|Part A (18 Days)|Adverse Event|0|||
48941617|NCT05113940|157617220|FG002|Part A (18 Days)|Adverse Event|1|||
48941618|NCT05113940|157617221|FG003|Part A (18 Days)|Adverse Event|1|||
48941619|NCT05113940|157617222|FG004|Part A (18 Days)|Adverse Event|1|||
48941620|NCT05113940|157617223|FG005|Part A (18 Days)|Adverse Event|0|||
48941621|NCT05113940|157617224|FG006|Part A (18 Days)|Adverse Event|0|||
48941622|NCT05113940|157617225|FG007|Part A (18 Days)|Adverse Event|0|||
48941623|NCT05113940|157617226|FG008|Part A (18 Days)|Adverse Event|0|||
48941624|NCT05113940|157617227|FG009|Part A (18 Days)|Adverse Event|0|||
48941625|NCT05113940|157617228|FG010|Part A (18 Days)|Adverse Event|0|||
48941626|NCT05113940|157617229|FG011|Part A (18 Days)|Adverse Event|2|||
48941627|NCT05113940|157617230|FG012|Part A (18 Days)|Adverse Event|0|||
48941628|NCT05113940|157617231|FG013|Part A (18 Days)|Adverse Event|0|||
48941629|NCT05113940|157617232|FG014|Part A (18 Days)|Adverse Event|0|||
48941630|NCT05113940|157617218|FG000|Part B- Period 2 (8 Days)|Adverse Event|0|||
48941631|NCT05113940|157617219|FG001|Part B- Period 2 (8 Days)|Adverse Event|0|||
48941632|NCT05113940|157617220|FG002|Part B- Period 2 (8 Days)|Adverse Event|0|||
48848979|NCT02787005|157286962|FG003|Overall Study|Withdrawal by Subject|0|||
48848980|NCT02787005|157286963|FG004|Overall Study|Withdrawal by Subject|1|||
48848981|NCT02787005|157286959|FG000|Overall Study|Screen Failure|0|||
48848982|NCT02787005|157286960|FG001|Overall Study|Screen Failure|2|||
48848983|NCT02787005|157286961|FG002|Overall Study|Screen Failure|0|||
48848984|NCT02787005|157286962|FG003|Overall Study|Screen Failure|0|||
48848985|NCT02787005|157286963|FG004|Overall Study|Screen Failure|1|||
48848986|NCT02787005|157286959|FG000|Overall Study|Lost to Follow-up|0|||
48848987|NCT02787005|157286960|FG001|Overall Study|Lost to Follow-up|0|||
48848988|NCT02787005|157286961|FG002|Overall Study|Lost to Follow-up|0|||
48848989|NCT02787005|157286962|FG003|Overall Study|Lost to Follow-up|1|||
48848990|NCT02787005|157286963|FG004|Overall Study|Lost to Follow-up|0|||
48848991|NCT02029235|157286966|FG000|Overall Study|Non-compliance with study meds or diary|4|||
48848992|NCT02029235|157286967|FG001|Overall Study|Non-compliance with study meds or diary|1|||
48848993|NCT02052440|157286968|FG000|Overall Study|Withdrawal by Subject|0|||
48848994|NCT02052440|157286969|FG001|Overall Study|Withdrawal by Subject|1|||
48848995|NCT03246724|157286971|FG000|Overall Study|Withdrawal by Subject|5|||
48848996|NCT03246724|157286972|FG001|Overall Study|Withdrawal by Subject|2|||
48848997|NCT03246724|157286973|FG002|Overall Study|Withdrawal by Subject|4|||
48848998|NCT03246724|157286974|FG003|Overall Study|Withdrawal by Subject|2|||
48848999|NCT03246724|157286971|FG000|Overall Study|Ineligible on day of surgery|7|||
48849000|NCT03246724|157286972|FG001|Overall Study|Ineligible on day of surgery|2|||
48849001|NCT03246724|157286973|FG002|Overall Study|Ineligible on day of surgery|0|||
48849002|NCT03246724|157286974|FG003|Overall Study|Ineligible on day of surgery|3|||
48849003|NCT03246724|157286971|FG000|Overall Study|Study completed before surgical date|2|||
48849004|NCT03246724|157286972|FG001|Overall Study|Study completed before surgical date|1|||
48849005|NCT03246724|157286973|FG002|Overall Study|Study completed before surgical date|8|||
48849006|NCT03246724|157286974|FG003|Overall Study|Study completed before surgical date|1|||
48849007|NCT03246724|157286971|FG000|Overall Study|Transferred to other arm|0|||
48849008|NCT03246724|157286972|FG001|Overall Study|Transferred to other arm|0|||
48849009|NCT03246724|157286973|FG002|Overall Study|Transferred to other arm|1|||
48849010|NCT03246724|157286974|FG003|Overall Study|Transferred to other arm|0|||
48849011|NCT03246724|157286971|FG000|Overall Study|Unable to obtain medication timely|0|||
48849012|NCT03246724|157286972|FG001|Overall Study|Unable to obtain medication timely|2|||
48849013|NCT03246724|157286973|FG002|Overall Study|Unable to obtain medication timely|2|||
48849014|NCT03246724|157286974|FG003|Overall Study|Unable to obtain medication timely|1|||
48849015|NCT03246724|157286971|FG000|Overall Study|Re-consented to participate|0|||
48849016|NCT03246724|157286972|FG001|Overall Study|Re-consented to participate|0|||
48849017|NCT03246724|157286973|FG002|Overall Study|Re-consented to participate|0|||
48849018|NCT03246724|157286974|FG003|Overall Study|Re-consented to participate|1|||
48849019|NCT04436289|157286976|FG000|Overall Study|Death prior to hospital discharge|8|||
48849020|NCT04436289|157286977|FG001|Overall Study|Death prior to hospital discharge|5|||
48849021|NCT04436289|157286978|FG002|Overall Study|Death prior to hospital discharge|0|||
48849022|NCT04436289|157286979|FG003|Overall Study|Death prior to hospital discharge|1|||
48849023|NCT04436289|157286976|FG000|Overall Study|Withdrawal by Subject|0|||
48849024|NCT04436289|157286977|FG001|Overall Study|Withdrawal by Subject|1|||
48849025|NCT04436289|157286978|FG002|Overall Study|Withdrawal by Subject|4|||
48849026|NCT04436289|157286979|FG003|Overall Study|Withdrawal by Subject|0|||
48849027|NCT04436289|157286976|FG000|Overall Study|Extended hospital stay|0|||
48849028|NCT04436289|157286977|FG001|Overall Study|Extended hospital stay|1|||
48849029|NCT04436289|157286978|FG002|Overall Study|Extended hospital stay|0|||
48849030|NCT04436289|157286979|FG003|Overall Study|Extended hospital stay|0|||
48849031|NCT04436289|157286976|FG000|Overall Study|Lost to Follow-up|0|||
48849032|NCT04436289|157286977|FG001|Overall Study|Lost to Follow-up|4|||
48849033|NCT04436289|157286978|FG002|Overall Study|Lost to Follow-up|1|||
48849034|NCT04436289|157286979|FG003|Overall Study|Lost to Follow-up|3|||
48849035|NCT02222493|157286981|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
48849036|NCT02222493|157286982|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
48849037|NCT02222493|157286981|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0|||
48849038|NCT02222493|157286982|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1|||
48849039|NCT02222493|157286981|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11|||
48849040|NCT02222493|157286982|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9|||
48849041|NCT02222493|157286981|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5|||
48849042|NCT02222493|157286982|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1|||
48849043|NCT02222493|157286981|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0|||
48849044|NCT02222493|157286982|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7|||
48849045|NCT02222493|157286981|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1|||
48849046|NCT02222493|157286982|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0|||
48849047|NCT02222493|157286981|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2|||
48849048|NCT02222493|157286982|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0|||
48941633|NCT05113940|157617221|FG003|Part B- Period 2 (8 Days)|Adverse Event|0|||
48941634|NCT05113940|157617222|FG004|Part B- Period 2 (8 Days)|Adverse Event|0|||
48849049|NCT02222493|157286981|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18|||
48849050|NCT02222493|157286982|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20|||
48849051|NCT02222493|157286981|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Other|4|||
48849052|NCT02222493|157286982|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Other|0|||
48849053|NCT02222493|157286981|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1|||
48849054|NCT02222493|157286982|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0|||
48849055|NCT02222493|157286981|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1|||
48849056|NCT02222493|157286982|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0|||
48849057|NCT02222493|157286981|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22|||
48849058|NCT02222493|157286982|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9|||
48849059|NCT02222493|157286981|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3|||
48849060|NCT02222493|157286982|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0|||
48941635|NCT05113940|157617223|FG005|Part B- Period 2 (8 Days)|Adverse Event|0|||
48849061|NCT02222493|157286981|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1|||
48849062|NCT02222493|157286982|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0|||
48849063|NCT02222493|157286981|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6|||
48849064|NCT02222493|157286982|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4|||
48849065|NCT02222493|157286981|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
48849066|NCT02222493|157286982|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
48849067|NCT02222493|157286981|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9|||
48849068|NCT02222493|157286982|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3|||
48849069|NCT02222493|157286981|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3|||
48849070|NCT02222493|157286982|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0|||
48849071|NCT02222493|157286981|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14|||
48849072|NCT02222493|157286982|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0|||
48849073|NCT02222493|157286981|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Other|4|||
48849074|NCT02222493|157286982|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Other|0|||
48849075|NCT02222493|157286981|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1|||
48849076|NCT02222493|157286982|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0|||
48849077|NCT02222493|157286981|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9|||
48849078|NCT02222493|157286982|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0|||
48849079|NCT03611075|157286987|FG000|Overall Study|Physician Decision|0|||
48849080|NCT03611075|157286988|FG001|Overall Study|Physician Decision|1|||
48849081|NCT03611075|157286989|FG002|Overall Study|Physician Decision|1|||
48849082|NCT03611075|157286990|FG003|Overall Study|Physician Decision|0|||
48849083|NCT03611075|157286991|FG004|Overall Study|Physician Decision|0|||
48849084|NCT03611075|157286992|FG005|Overall Study|Physician Decision|0|||
48941636|NCT05113940|157617224|FG006|Part B- Period 2 (8 Days)|Adverse Event|0|||
48941637|NCT05113940|157617225|FG007|Part B- Period 2 (8 Days)|Adverse Event|0|||
48941638|NCT05113940|157617226|FG008|Part B- Period 2 (8 Days)|Adverse Event|0|||
48941639|NCT05113940|157617227|FG009|Part B- Period 2 (8 Days)|Adverse Event|0|||
48941640|NCT05113940|157617228|FG010|Part B- Period 2 (8 Days)|Adverse Event|0|||
48941641|NCT05113940|157617229|FG011|Part B- Period 2 (8 Days)|Adverse Event|0|||
48941642|NCT05113940|157617230|FG012|Part B- Period 2 (8 Days)|Adverse Event|0|||
48941643|NCT05113940|157617231|FG013|Part B- Period 2 (8 Days)|Adverse Event|0|||
48941644|NCT05113940|157617232|FG014|Part B- Period 2 (8 Days)|Adverse Event|2|||
48941645|NCT00900796|157617233|FG000|Phase 1|Lacked sufficient information|4|||
48941646|NCT00900796|157617233|FG000|Phase 1|Missing information at Week 16|7|||
48941647|NCT00900796|157617233|FG000|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110|||
48941648|NCT00900796|157617233|FG000|Phase 2|Lost to Follow-up|5|||
48941649|NCT01974323|157617234|FG000|Overall Study|Other Reasons|25|||
48941650|NCT01974323|157617235|FG001|Overall Study|Other Reasons|28|||
48941651|NCT01974323|157617234|FG000|Overall Study|Protocol Violation|2|||
48941652|NCT01974323|157617235|FG001|Overall Study|Protocol Violation|2|||
48941653|NCT01974323|157617234|FG000|Overall Study|Personal Reasons|15|||
48941654|NCT01974323|157617235|FG001|Overall Study|Personal Reasons|19|||
48941655|NCT01974323|157617234|FG000|Overall Study|Lost to Follow-up|45|||
48941656|NCT01974323|157617235|FG001|Overall Study|Lost to Follow-up|40|||
48941657|NCT01974323|157617234|FG000|Overall Study|Pregnancy|2|||
48941658|NCT01974323|157617235|FG001|Overall Study|Pregnancy|1|||
48941659|NCT01974323|157617234|FG000|Overall Study|Lack of Efficacy|1|||
48941660|NCT01974323|157617235|FG001|Overall Study|Lack of Efficacy|1|||
48941661|NCT01974323|157617234|FG000|Overall Study|Adverse Event|2|||
48941662|NCT01974323|157617235|FG001|Overall Study|Adverse Event|2|||
48941663|NCT00826514|157617236|FG000|Overall Study|Adverse Event|1|||
48941664|NCT00826514|157617237|FG001|Overall Study|Adverse Event|1|||
48941665|NCT00826514|157617236|FG000|Overall Study|Lack of Efficacy|0|||
48941666|NCT00826514|157617237|FG001|Overall Study|Lack of Efficacy|1|||
48941667|NCT00826514|157617236|FG000|Overall Study|Withdrawal by Subject|2|||
48941668|NCT00826514|157617237|FG001|Overall Study|Withdrawal by Subject|3|||
48941669|NCT01071070|157617239|FG000|Overall Study|Adverse Event|0|||
48941670|NCT01071070|157617240|FG001|Overall Study|Adverse Event|3|||
48941671|NCT01071070|157617239|FG000|Overall Study|Withdrawal by Subject|1|||
48941672|NCT01071070|157617240|FG001|Overall Study|Withdrawal by Subject|0|||
48941673|NCT01071070|157617239|FG000|Overall Study|Missed 3 consecutive doses of study drug|2|||
48941674|NCT01071070|157617240|FG001|Overall Study|Missed 3 consecutive doses of study drug|0|||
48941675|NCT01071070|157617239|FG000|Overall Study|Hypercalcemia|1|||
48941676|NCT01071070|157617240|FG001|Overall Study|Hypercalcemia|0|||
48941677|NCT00592683|157617241|FG000|Overall Study|Found ineligible|0|||
48941678|NCT00592683|157617242|FG001|Overall Study|Found ineligible|1|||
48941679|NCT00592683|157617241|FG000|Overall Study|Withdrawal by Subject|1|||
48941680|NCT00592683|157617242|FG001|Overall Study|Withdrawal by Subject|0|||
48941681|NCT00592683|157617241|FG000|Overall Study|Adverse Event|0|||
48941682|NCT00592683|157617242|FG001|Overall Study|Adverse Event|2|||
48941683|NCT00592683|157617241|FG000|Overall Study|Protocol Violation|1|||
48941684|NCT00592683|157617242|FG001|Overall Study|Protocol Violation|0|||
48941685|NCT00592683|157617241|FG000|Overall Study|Study drug expired|1|||
48941686|NCT00592683|157617242|FG001|Overall Study|Study drug expired|0|||
48941687|NCT00592683|157617241|FG000|Overall Study|Other|1|||
48941688|NCT00592683|157617242|FG001|Overall Study|Other|0|||
48941689|NCT00592683|157617241|FG000|Overall Study|Lost to Follow-up|0|||
48941690|NCT00592683|157617242|FG001|Overall Study|Lost to Follow-up|1|||
48941691|NCT00472303|157617243|FG000|Titration Phase|Adverse Event|22|||
48941692|NCT00472303|157617244|FG001|Titration Phase|Adverse Event|12|||
48941693|NCT00472303|157617245|FG002|Titration Phase|Adverse Event|0|||
48941694|NCT00472303|157617243|FG000|Titration Phase|Death|4|||
48941695|NCT00472303|157617244|FG001|Titration Phase|Death|2|||
48941696|NCT00472303|157617245|FG002|Titration Phase|Death|0|||
48941697|NCT00472303|157617243|FG000|Titration Phase|Lack of Efficacy|10|||
48941698|NCT00472303|157617244|FG001|Titration Phase|Lack of Efficacy|0|||
48941699|NCT00472303|157617245|FG002|Titration Phase|Lack of Efficacy|0|||
48941700|NCT00472303|157617243|FG000|Titration Phase|Withdrawal by Subject|16|||
48941701|NCT00472303|157617244|FG001|Titration Phase|Withdrawal by Subject|13|||
48941702|NCT00472303|157617245|FG002|Titration Phase|Withdrawal by Subject|0|||
48941703|NCT00472303|157617243|FG000|Titration Phase|Trial Medication non-compliant|4|||
48941704|NCT00472303|157617244|FG001|Titration Phase|Trial Medication non-compliant|1|||
48941705|NCT00472303|157617245|FG002|Titration Phase|Trial Medication non-compliant|0|||
48941706|NCT00472303|157617243|FG000|Titration Phase|Other|3|||
48941707|NCT00472303|157617244|FG001|Titration Phase|Other|1|||
48941708|NCT00472303|157617245|FG002|Titration Phase|Other|0|||
48941709|NCT00472303|157617243|FG000|Discontinuations After Titration Phase|Adverse Event|6|||
48941710|NCT00472303|157617244|FG001|Discontinuations After Titration Phase|Adverse Event|0|||
48941711|NCT00472303|157617245|FG002|Discontinuations After Titration Phase|Adverse Event|0|||
48941712|NCT00472303|157617243|FG000|Discontinuations After Titration Phase|Lack of Efficacy|48|||
48941713|NCT00472303|157617244|FG001|Discontinuations After Titration Phase|Lack of Efficacy|17|||
48941714|NCT00472303|157617245|FG002|Discontinuations After Titration Phase|Lack of Efficacy|0|||
48941715|NCT00472303|157617243|FG000|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
48941716|NCT00472303|157617244|FG001|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
48941717|NCT00472303|157617245|FG002|Discontinuations After Titration Phase|Withdrawal by Subject|0|||
48941718|NCT00472303|157617243|FG000|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
48941719|NCT00472303|157617244|FG001|Discontinuations After Titration Phase|Trial Medication non-compliant|1|||
48941720|NCT00472303|157617245|FG002|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
48941721|NCT00472303|157617243|FG000|Discontinuations After Titration Phase|Other|5|||
48941722|NCT00472303|157617244|FG001|Discontinuations After Titration Phase|Other|0|||
48941723|NCT00472303|157617245|FG002|Discontinuations After Titration Phase|Other|0|||
48941724|NCT00472303|157617243|FG000|Maintenance Phase|Adverse Event|5|||
48941725|NCT00472303|157617244|FG001|Maintenance Phase|Adverse Event|6|||
48941726|NCT00472303|157617245|FG002|Maintenance Phase|Adverse Event|6|||
48941727|NCT00472303|157617243|FG000|Maintenance Phase|Death|3|||
48941728|NCT00472303|157617244|FG001|Maintenance Phase|Death|0|||
48941729|NCT00472303|157617245|FG002|Maintenance Phase|Death|2|||
48941730|NCT00472303|157617243|FG000|Maintenance Phase|Lack of Efficacy|2|||
48941731|NCT00472303|157617244|FG001|Maintenance Phase|Lack of Efficacy|2|||
48941732|NCT00472303|157617245|FG002|Maintenance Phase|Lack of Efficacy|4|||
48941733|NCT00472303|157617243|FG000|Maintenance Phase|Withdrawal by Subject|6|||
48941734|NCT00472303|157617244|FG001|Maintenance Phase|Withdrawal by Subject|7|||
48941735|NCT00472303|157617245|FG002|Maintenance Phase|Withdrawal by Subject|3|||
48941736|NCT00472303|157617243|FG000|Maintenance Phase|Trial medication non-compliant|0|||
48941737|NCT00472303|157617244|FG001|Maintenance Phase|Trial medication non-compliant|0|||
48941738|NCT00472303|157617245|FG002|Maintenance Phase|Trial medication non-compliant|1|||
48941739|NCT00472303|157617243|FG000|Maintenance Phase|Resolution of pain|0|||
48941740|NCT00472303|157617244|FG001|Maintenance Phase|Resolution of pain|0|||
48941741|NCT00472303|157617245|FG002|Maintenance Phase|Resolution of pain|1|||
48941742|NCT00472303|157617243|FG000|Maintenance Phase|Other|1|||
48941743|NCT00472303|157617244|FG001|Maintenance Phase|Other|1|||
48941744|NCT00472303|157617245|FG002|Maintenance Phase|Other|0|||
48941745|NCT01676961|157617246|FG000|Overall Study|Death|3|||
48941746|NCT01676961|157617246|FG000|Overall Study|Lost to Follow-up|1|||
48941747|NCT01676961|157617246|FG000|Overall Study|Withdrawal by Subject|1|||
48941748|NCT00629083|157617247|FG000|Overall Study|Adverse Event|0|||
48941749|NCT00629083|157617248|FG001|Overall Study|Adverse Event|2|||
48941750|NCT00629083|157617247|FG000|Overall Study|Lack of Efficacy|3|||
48941751|NCT00629083|157617248|FG001|Overall Study|Lack of Efficacy|1|||
48941752|NCT00629083|157617247|FG000|Overall Study|Withdrawal by Subject|10|||
48941753|NCT00629083|157617248|FG001|Overall Study|Withdrawal by Subject|2|||
48941754|NCT00629083|157617247|FG000|Overall Study|Lost to Follow-up|12|||
48941755|NCT00629083|157617248|FG001|Overall Study|Lost to Follow-up|8|||
48941756|NCT00629083|157617247|FG000|Overall Study|Moved out of country/state|2|||
48941757|NCT00629083|157617248|FG001|Overall Study|Moved out of country/state|1|||
48941758|NCT00629083|157617247|FG000|Overall Study|Refused to return for 12 month visit|1|||
48941759|NCT00629083|157617248|FG001|Overall Study|Refused to return for 12 month visit|0|||
48941760|NCT03040024|157617249|FG000|Overall Study|Adverse Event|0|||
48941761|NCT03040024|157617250|FG001|Overall Study|Adverse Event|1|||
48941762|NCT03040024|157617251|FG002|Overall Study|Adverse Event|0|||
48941763|NCT03040024|157617249|FG000|Overall Study|Death|0|||
48941764|NCT03040024|157617250|FG001|Overall Study|Death|1|||
48941765|NCT03040024|157617251|FG002|Overall Study|Death|0|||
48941766|NCT03040024|157617249|FG000|Overall Study|Physician Decision|0|||
48941767|NCT03040024|157617250|FG001|Overall Study|Physician Decision|0|||
48941768|NCT03040024|157617251|FG002|Overall Study|Physician Decision|1|||
48941769|NCT03075839|157617254|FG000|Overall Study|Lost to Follow-up|4|||
48941770|NCT00488631|157617256|FG000|Double Blind Period (Week 0-54)|Adverse Event|17|||
48941771|NCT00488631|157617257|FG001|Double Blind Period (Week 0-54)|Adverse Event|12|||
48941772|NCT00488631|157617258|FG002|Double Blind Period (Week 0-54)|Adverse Event|12|||
48941773|NCT00488631|157617259|FG003|Double Blind Period (Week 0-54)|Adverse Event|12|||
48941774|NCT00488631|157617260|FG004|Double Blind Period (Week 0-54)|Adverse Event|30|||
48941775|NCT00488631|157617261|FG005|Double Blind Period (Week 0-54)|Adverse Event|50|||
48941776|NCT00488631|157617262|FG006|Double Blind Period (Week 0-54)|Adverse Event|0|||
48941777|NCT00488631|157617263|FG007|Double Blind Period (Week 0-54)|Adverse Event|0|||
48941778|NCT00488631|157617264|FG008|Double Blind Period (Week 0-54)|Adverse Event|0|||
48941779|NCT00488631|157617265|FG009|Double Blind Period (Week 0-54)|Adverse Event|0|||
48941780|NCT00488631|157617256|FG000|Double Blind Period (Week 0-54)|Death|0|||
48941781|NCT00488631|157617257|FG001|Double Blind Period (Week 0-54)|Death|0|||
48941782|NCT00488631|157617258|FG002|Double Blind Period (Week 0-54)|Death|0|||
48941783|NCT00488631|157617259|FG003|Double Blind Period (Week 0-54)|Death|0|||
48941784|NCT00488631|157617260|FG004|Double Blind Period (Week 0-54)|Death|0|||
48941785|NCT00488631|157617261|FG005|Double Blind Period (Week 0-54)|Death|1|||
48941786|NCT00488631|157617262|FG006|Double Blind Period (Week 0-54)|Death|0|||
48941787|NCT00488631|157617263|FG007|Double Blind Period (Week 0-54)|Death|0|||
48941788|NCT00488631|157617264|FG008|Double Blind Period (Week 0-54)|Death|0|||
48941789|NCT00488631|157617265|FG009|Double Blind Period (Week 0-54)|Death|0|||
48941790|NCT00488631|157617256|FG000|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19|||
48941791|NCT00488631|157617257|FG001|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17|||
48941792|NCT00488631|157617258|FG002|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22|||
48941793|NCT00488631|157617259|FG003|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18|||
48941794|NCT00488631|157617260|FG004|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56|||
48941795|NCT00488631|157617261|FG005|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124|||
48941796|NCT00488631|157617262|FG006|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
48941797|NCT00488631|157617263|FG007|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
48941798|NCT00488631|157617264|FG008|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
48941799|NCT00488631|157617265|FG009|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
48941800|NCT00488631|157617256|FG000|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
48941801|NCT00488631|157617257|FG001|Double Blind Period (Week 0-54)|Lost to Follow-up|2|||
48941802|NCT00488631|157617258|FG002|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
48941803|NCT00488631|157617259|FG003|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
48941804|NCT00488631|157617260|FG004|Double Blind Period (Week 0-54)|Lost to Follow-up|3|||
48941805|NCT00488631|157617261|FG005|Double Blind Period (Week 0-54)|Lost to Follow-up|7|||
48941806|NCT00488631|157617262|FG006|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
48941807|NCT00488631|157617263|FG007|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
48941808|NCT00488631|157617264|FG008|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
48941809|NCT00488631|157617265|FG009|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
48941810|NCT00488631|157617256|FG000|Double Blind Period (Week 0-54)|Other|6|||
48941811|NCT00488631|157617257|FG001|Double Blind Period (Week 0-54)|Other|12|||
48941812|NCT00488631|157617258|FG002|Double Blind Period (Week 0-54)|Other|10|||
48941813|NCT00488631|157617259|FG003|Double Blind Period (Week 0-54)|Other|11|||
48941814|NCT00488631|157617260|FG004|Double Blind Period (Week 0-54)|Other|14|||
48941815|NCT00488631|157617261|FG005|Double Blind Period (Week 0-54)|Other|34|||
48941816|NCT00488631|157617262|FG006|Double Blind Period (Week 0-54)|Other|0|||
48941817|NCT00488631|157617263|FG007|Double Blind Period (Week 0-54)|Other|0|||
48941818|NCT00488631|157617264|FG008|Double Blind Period (Week 0-54)|Other|0|||
48941819|NCT00488631|157617265|FG009|Double Blind Period (Week 0-54)|Other|0|||
48941820|NCT00488631|157617256|FG000|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
48941821|NCT00488631|157617257|FG001|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
48941822|NCT00488631|157617258|FG002|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
48941823|NCT00488631|157617259|FG003|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
48941824|NCT00488631|157617260|FG004|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
48941825|NCT00488631|157617261|FG005|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
48941826|NCT00488631|157617262|FG006|Open Label Study Extension (Week 54-228)|Adverse Event|10|||
48941827|NCT00488631|157617263|FG007|Open Label Study Extension (Week 54-228)|Adverse Event|8|||
48941828|NCT00488631|157617264|FG008|Open Label Study Extension (Week 54-228)|Adverse Event|54|||
48941829|NCT00488631|157617265|FG009|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
48941830|NCT00488631|157617256|FG000|Open Label Study Extension (Week 54-228)|Death|0|||
48941831|NCT00488631|157617257|FG001|Open Label Study Extension (Week 54-228)|Death|0|||
48941832|NCT00488631|157617258|FG002|Open Label Study Extension (Week 54-228)|Death|0|||
48941833|NCT00488631|157617259|FG003|Open Label Study Extension (Week 54-228)|Death|0|||
48941834|NCT00488631|157617260|FG004|Open Label Study Extension (Week 54-228)|Death|0|||
48941835|NCT00488631|157617261|FG005|Open Label Study Extension (Week 54-228)|Death|0|||
48941836|NCT00488631|157617262|FG006|Open Label Study Extension (Week 54-228)|Death|0|||
48941837|NCT00488631|157617263|FG007|Open Label Study Extension (Week 54-228)|Death|0|||
48941838|NCT00488631|157617264|FG008|Open Label Study Extension (Week 54-228)|Death|1|||
48941839|NCT00488631|157617265|FG009|Open Label Study Extension (Week 54-228)|Death|0|||
48941840|NCT00488631|157617256|FG000|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
48941841|NCT00488631|157617257|FG001|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
48941842|NCT00488631|157617258|FG002|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
48941843|NCT00488631|157617259|FG003|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
48941844|NCT00488631|157617260|FG004|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
48941845|NCT00488631|157617261|FG005|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
48941846|NCT00488631|157617262|FG006|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
48941847|NCT00488631|157617263|FG007|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
48941848|NCT00488631|157617264|FG008|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34|||
48941849|NCT00488631|157617265|FG009|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3|||
48941850|NCT00488631|157617256|FG000|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
48941851|NCT00488631|157617257|FG001|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
48941852|NCT00488631|157617258|FG002|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
48941853|NCT00488631|157617259|FG003|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
48941854|NCT00488631|157617260|FG004|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
48941855|NCT00488631|157617261|FG005|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
48941856|NCT00488631|157617262|FG006|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2|||
48941857|NCT00488631|157617263|FG007|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
48941858|NCT00488631|157617264|FG008|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6|||
48941859|NCT00488631|157617265|FG009|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
48941860|NCT00488631|157617256|FG000|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
48941861|NCT00488631|157617257|FG001|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
48941862|NCT00488631|157617258|FG002|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
48941863|NCT00488631|157617259|FG003|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
48941864|NCT00488631|157617260|FG004|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
48941865|NCT00488631|157617261|FG005|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
48941866|NCT00488631|157617262|FG006|Open Label Study Extension (Week 54-228)|Unspecified reasons|63|||
48941867|NCT00488631|157617263|FG007|Open Label Study Extension (Week 54-228)|Unspecified reasons|14|||
48941868|NCT00488631|157617264|FG008|Open Label Study Extension (Week 54-228)|Unspecified reasons|87|||
48941869|NCT00488631|157617265|FG009|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
48941870|NCT01073943|157617266|FG000|Overall Study|Withdrawal by Subject|8|||
48941871|NCT01073943|157617267|FG001|Overall Study|Withdrawal by Subject|2|||
48941872|NCT01073943|157617266|FG000|Overall Study|Protocol Violation|2|||
48941873|NCT01073943|157617267|FG001|Overall Study|Protocol Violation|1|||
48941874|NCT01073943|157617266|FG000|Overall Study|Adverse Event|1|||
48941875|NCT01073943|157617267|FG001|Overall Study|Adverse Event|1|||
48941876|NCT01073943|157617266|FG000|Overall Study|Lost to Follow-up|0|||
48941877|NCT01073943|157617267|FG001|Overall Study|Lost to Follow-up|2|||
48941878|NCT01073943|157617266|FG000|Overall Study|Power outage; colonoscopy not done|1|||
48941879|NCT01073943|157617267|FG001|Overall Study|Power outage; colonoscopy not done|0|||
48941880|NCT01073943|157617266|FG000|Overall Study|Subject forgot|0|||
48941881|NCT01073943|157617267|FG001|Overall Study|Subject forgot|1|||
48941882|NCT01073943|157617266|FG000|Overall Study|Unable to return for follow-up|0|||
48941883|NCT01073943|157617267|FG001|Overall Study|Unable to return for follow-up|1|||
48941884|NCT01073943|157617266|FG000|Overall Study|Could not tolerate prep|1|||
48941885|NCT01073943|157617267|FG001|Overall Study|Could not tolerate prep|0|||
48941886|NCT01967225|157617269|FG000|Overall Study|Adverse Event|3|||
48941887|NCT01967225|157617270|FG001|Overall Study|Adverse Event|1|||
48941888|NCT01967225|157617269|FG000|Overall Study|Withdrawal by Subject|2|||
48941889|NCT01967225|157617270|FG001|Overall Study|Withdrawal by Subject|1|||
48941890|NCT01967225|157617269|FG000|Overall Study|Lack of Efficacy|1|||
48941891|NCT01967225|157617270|FG001|Overall Study|Lack of Efficacy|1|||
48941892|NCT01967225|157617269|FG000|Overall Study|Switching to other therapy|2|||
48941893|NCT01967225|157617270|FG001|Overall Study|Switching to other therapy|0|||
48941894|NCT01967225|157617269|FG000|Overall Study|Protocol driven decision point|1|||
48941895|NCT01967225|157617270|FG001|Overall Study|Protocol driven decision point|0|||
48941896|NCT01967225|157617269|FG000|Overall Study|Logistical difficulties|1|||
48941897|NCT01967225|157617270|FG001|Overall Study|Logistical difficulties|0|||
48941898|NCT01967225|157617269|FG000|Overall Study|Protocol Violation|2|||
48941899|NCT01967225|157617270|FG001|Overall Study|Protocol Violation|0|||
48941900|NCT03486314|157617278|FG000|Part A|Adverse Event|1|||
48941901|NCT03486314|157617279|FG001|Part A|Adverse Event|0|||
48941902|NCT03486314|157617280|FG002|Part A|Adverse Event|0|||
48941903|NCT03486314|157617278|FG000|Part A|Symptomatic Deterioration|2|||
48941904|NCT03486314|157617279|FG001|Part A|Symptomatic Deterioration|0|||
48941905|NCT03486314|157617280|FG002|Part A|Symptomatic Deterioration|0|||
48941906|NCT02388776|157617281|FG000|Overall Study|Death|1|||
48941907|NCT02388776|157617281|FG000|Overall Study|Lost to Follow-up|1|||
48941908|NCT05139030|157617282|FG000|Overall Study|Withdrawal by Subject|1|||
48941909|NCT05139030|157617283|FG001|Overall Study|Withdrawal by Subject|3|||
48941910|NCT05139030|157617282|FG000|Overall Study|Adverse Event|0|||
48941911|NCT05139030|157617283|FG001|Overall Study|Adverse Event|1|||
48941912|NCT05139030|157617282|FG000|Overall Study|Failure to meet continuation criteria|0|||
48941913|NCT05139030|157617283|FG001|Overall Study|Failure to meet continuation criteria|1|||
48941914|NCT03133767|157617284|FG000|Overall Study|Lost to Follow-up|38|||
48941915|NCT03133767|157617285|FG001|Overall Study|Lost to Follow-up|24|||
48941916|NCT03133767|157617284|FG000|Overall Study|Protocol Violation|0|||
48941917|NCT03133767|157617285|FG001|Overall Study|Protocol Violation|1|||
48941918|NCT02240706|157617288|FG000|Overall Study|Lack of Efficacy|2|||
48941919|NCT02240706|157617289|FG001|Overall Study|Lack of Efficacy|2|||
48941920|NCT02240706|157617290|FG002|Overall Study|Lack of Efficacy|2|||
48941921|NCT02240706|157617291|FG003|Overall Study|Lack of Efficacy|2|||
48941922|NCT02240706|157617292|FG004|Overall Study|Lack of Efficacy|5|||
48941923|NCT02240706|157617293|FG005|Overall Study|Lack of Efficacy|0|||
48941924|NCT02240706|157617294|FG006|Overall Study|Lack of Efficacy|0|||
48941925|NCT02240706|157617288|FG000|Overall Study|Adverse Event|1|||
48941926|NCT02240706|157617289|FG001|Overall Study|Adverse Event|0|||
48941927|NCT02240706|157617290|FG002|Overall Study|Adverse Event|1|||
48941928|NCT02240706|157617291|FG003|Overall Study|Adverse Event|0|||
48941929|NCT02240706|157617292|FG004|Overall Study|Adverse Event|2|||
48941930|NCT02240706|157617293|FG005|Overall Study|Adverse Event|0|||
48941931|NCT02240706|157617294|FG006|Overall Study|Adverse Event|0|||
48735668|NCT02840721|156883710|FG000|Follow-Up|Withdrawal by Subject|4|||
48941932|NCT02240706|157617288|FG000|Overall Study|Progressive disease|0|||
48941933|NCT02240706|157617289|FG001|Overall Study|Progressive disease|0|||
48941934|NCT02240706|157617290|FG002|Overall Study|Progressive disease|0|||
48941935|NCT02240706|157617291|FG003|Overall Study|Progressive disease|0|||
48941936|NCT02240706|157617292|FG004|Overall Study|Progressive disease|1|||
48941937|NCT02240706|157617293|FG005|Overall Study|Progressive disease|0|||
48941938|NCT02240706|157617294|FG006|Overall Study|Progressive disease|0|||
48941939|NCT02240706|157617288|FG000|Overall Study|Dose limiting toxicity|0|||
48941940|NCT02240706|157617289|FG001|Overall Study|Dose limiting toxicity|0|||
48941941|NCT02240706|157617290|FG002|Overall Study|Dose limiting toxicity|0|||
48941942|NCT02240706|157617291|FG003|Overall Study|Dose limiting toxicity|0|||
48941943|NCT02240706|157617292|FG004|Overall Study|Dose limiting toxicity|1|||
48941944|NCT02240706|157617293|FG005|Overall Study|Dose limiting toxicity|0|||
48941945|NCT02240706|157617294|FG006|Overall Study|Dose limiting toxicity|0|||
48941946|NCT02240706|157617288|FG000|Overall Study|Refused to continue taking medication|0|||
48941947|NCT02240706|157617289|FG001|Overall Study|Refused to continue taking medication|1|||
48941948|NCT02240706|157617290|FG002|Overall Study|Refused to continue taking medication|3|||
48941949|NCT02240706|157617291|FG003|Overall Study|Refused to continue taking medication|1|||
48941950|NCT02240706|157617292|FG004|Overall Study|Refused to continue taking medication|2|||
48941951|NCT02240706|157617293|FG005|Overall Study|Refused to continue taking medication|0|||
48941952|NCT02240706|157617294|FG006|Overall Study|Refused to continue taking medication|0|||
48941953|NCT02240706|157617288|FG000|Overall Study|Insurance billing concerns|0|||
48941954|NCT02240706|157617289|FG001|Overall Study|Insurance billing concerns|0|||
48941955|NCT02240706|157617290|FG002|Overall Study|Insurance billing concerns|0|||
48941956|NCT02240706|157617291|FG003|Overall Study|Insurance billing concerns|1|||
48941957|NCT02240706|157617292|FG004|Overall Study|Insurance billing concerns|0|||
48941958|NCT02240706|157617293|FG005|Overall Study|Insurance billing concerns|0|||
48941959|NCT02240706|157617294|FG006|Overall Study|Insurance billing concerns|0|||
48941960|NCT05502289|157617299|FG000|Period 1|Out Of Window|1|||
48941961|NCT05502289|157617300|FG001|Period 1|Out Of Window|0|||
48941962|NCT01254344|157617301|FG000|Overall Study|Adverse Event|2|||
48941963|NCT01254344|157617302|FG001|Overall Study|Adverse Event|5|||
48941964|NCT01254344|157617301|FG000|Overall Study|Physician Decision|7|||
48941965|NCT01254344|157617302|FG001|Overall Study|Physician Decision|4|||
48941966|NCT01254344|157617301|FG000|Overall Study|Protocol Violation|1|||
48941967|NCT01254344|157617302|FG001|Overall Study|Protocol Violation|4|||
48941968|NCT01254344|157617301|FG000|Overall Study|Withdrawal by Subject|3|||
48941969|NCT01254344|157617302|FG001|Overall Study|Withdrawal by Subject|6|||
48941970|NCT00816036|157617303|FG000|Overall Study|Death|47|||
48941971|NCT00816036|157617304|FG001|Overall Study|Death|28|||
48941972|NCT00816036|157617303|FG000|Overall Study|Lost to Follow-up|75|||
48941973|NCT00816036|157617304|FG001|Overall Study|Lost to Follow-up|57|||
48941974|NCT00816036|157617303|FG000|Overall Study|Withdrawal by Subject|54|||
48941975|NCT00816036|157617304|FG001|Overall Study|Withdrawal by Subject|23|||
48941976|NCT03633331|157617305|FG000|Overall Study|Withdrawal by Subject|1|||
48941977|NCT02493751|157617306|FG000|Overall Study|Withdrawal by Subject|2|||
48941978|NCT02493751|157617307|FG001|Overall Study|Withdrawal by Subject|8|||
48941979|NCT02493751|157617306|FG000|Overall Study|Death|6|||
48941980|NCT02493751|157617307|FG001|Overall Study|Death|13|||
48941981|NCT02493751|157617306|FG000|Overall Study|Lost to Follow-up|2|||
48941982|NCT02493751|157617307|FG001|Overall Study|Lost to Follow-up|3|||
48941983|NCT02493751|157617306|FG000|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|6|||
48941984|NCT02493751|157617307|FG001|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|15|||
48941985|NCT01259466|157617308|FG000|Overall Study|Withdrawal by Subject|1|||
48941986|NCT01259466|157617309|FG001|Overall Study|Withdrawal by Subject|9|||
48941987|NCT00761215|157617310|FG000|Overall Study|Randomized but didn't receive drug|1|||
48941988|NCT00761215|157617311|FG001|Overall Study|Randomized but didn't receive drug|1|||
48941989|NCT00761215|157617312|FG002|Overall Study|Randomized but didn't receive drug|2|||
48941990|NCT00761215|157617310|FG000|Overall Study|Lost to Follow-up|6|||
48941991|NCT00761215|157617311|FG001|Overall Study|Lost to Follow-up|3|||
48941992|NCT00761215|157617312|FG002|Overall Study|Lost to Follow-up|6|||
48941993|NCT00761215|157617310|FG000|Overall Study|Withdrawal by Subject|1|||
48941994|NCT00761215|157617311|FG001|Overall Study|Withdrawal by Subject|0|||
48941995|NCT00761215|157617312|FG002|Overall Study|Withdrawal by Subject|0|||
48941996|NCT00761215|157617310|FG000|Overall Study|Bacteremia|1|||
48941997|NCT00761215|157617311|FG001|Overall Study|Bacteremia|0|||
48941998|NCT00761215|157617312|FG002|Overall Study|Bacteremia|0|||
48941999|NCT00828451|157617313|FG000|Overall Study|Death|2|||
48942000|NCT00828451|157617313|FG000|Overall Study|Lack of intravenous line|7|||
48942001|NCT00828451|157617313|FG000|Overall Study|Withdrawal by Subject|1|||
48942002|NCT00828451|157617313|FG000|Overall Study|Deterioration in clinical status|1|||
48942003|NCT05593432|157617318|FG000|16-Week DBVC Period|Withdrawal by Subject|2|||
48942004|NCT05593432|157617319|FG001|16-Week DBVC Period|Withdrawal by Subject|3|||
48942005|NCT05593432|157617320|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
48942006|NCT05593432|157617321|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
48942007|NCT05593432|157617318|FG000|16-Week OLE Period|Lack of Efficacy|0|||
48942008|NCT05593432|157617319|FG001|16-Week OLE Period|Lack of Efficacy|0|||
48942009|NCT05593432|157617320|FG002|16-Week OLE Period|Lack of Efficacy|0|||
48942010|NCT05593432|157617321|FG003|16-Week OLE Period|Lack of Efficacy|1|||
48942011|NCT05593432|157617318|FG000|16-Week OLE Period|Lost to Follow-up|0|||
48942012|NCT05593432|157617319|FG001|16-Week OLE Period|Lost to Follow-up|0|||
48942013|NCT05593432|157617320|FG002|16-Week OLE Period|Lost to Follow-up|1|||
48942014|NCT05593432|157617321|FG003|16-Week OLE Period|Lost to Follow-up|2|||
48942015|NCT05593432|157617318|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
48942016|NCT05593432|157617319|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
48942017|NCT05593432|157617320|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
48942018|NCT05593432|157617321|FG003|16-Week OLE Period|Withdrawal by Subject|3|||
48942019|NCT00995371|157617325|FG000|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
48942020|NCT00995371|157617326|FG001|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
48942021|NCT01901328|157617330|FG000|Overall Study|Lost to Follow-up|1|||
48942022|NCT01901328|157617331|FG001|Overall Study|Lost to Follow-up|0|||
48942023|NCT01901328|157617330|FG000|Overall Study|Physician Decision|0|||
48942024|NCT01901328|157617331|FG001|Overall Study|Physician Decision|1|||
48942025|NCT01901328|157617330|FG000|Overall Study|Protocol Violation|1|||
48942026|NCT01901328|157617331|FG001|Overall Study|Protocol Violation|1|||
48942027|NCT01901328|157617330|FG000|Overall Study|Study Terminated by Sponsor|19|||
48942028|NCT01901328|157617331|FG001|Overall Study|Study Terminated by Sponsor|16|||
48942029|NCT01901328|157617330|FG000|Overall Study|Withdrawal by Subject|1|||
48942030|NCT01901328|157617331|FG001|Overall Study|Withdrawal by Subject|2|||
48942031|NCT01901328|157617330|FG000|Overall Study|Lack of Efficacy|0|||
48942032|NCT01901328|157617331|FG001|Overall Study|Lack of Efficacy|1|||
48942033|NCT04358458|157617335|FG000|Overall Study|Death|1|||
48942034|NCT04358458|157617336|FG001|Overall Study|Death|1|||
48849085|NCT03611075|157286993|FG006|Overall Study|Physician Decision|0|||
48849086|NCT03611075|157286994|FG007|Overall Study|Physician Decision|0|||
48849087|NCT03611075|157286995|FG008|Overall Study|Physician Decision|0|||
48849088|NCT03611075|157286987|FG000|Overall Study|Lost to Follow-up|1|||
48849089|NCT03611075|157286988|FG001|Overall Study|Lost to Follow-up|0|||
48849090|NCT03611075|157286989|FG002|Overall Study|Lost to Follow-up|0|||
48849091|NCT03611075|157286990|FG003|Overall Study|Lost to Follow-up|2|||
48849092|NCT03611075|157286991|FG004|Overall Study|Lost to Follow-up|0|||
48849093|NCT03611075|157286992|FG005|Overall Study|Lost to Follow-up|0|||
48849094|NCT03611075|157286993|FG006|Overall Study|Lost to Follow-up|0|||
48849095|NCT03611075|157286994|FG007|Overall Study|Lost to Follow-up|0|||
48849096|NCT03611075|157286995|FG008|Overall Study|Lost to Follow-up|0|||
48849097|NCT03611075|157286987|FG000|Overall Study|Withdrawal by Subject|0|||
48849098|NCT03611075|157286988|FG001|Overall Study|Withdrawal by Subject|1|||
48849099|NCT03611075|157286989|FG002|Overall Study|Withdrawal by Subject|1|||
48849100|NCT03611075|157286990|FG003|Overall Study|Withdrawal by Subject|1|||
48849101|NCT03611075|157286991|FG004|Overall Study|Withdrawal by Subject|0|||
48849102|NCT03611075|157286992|FG005|Overall Study|Withdrawal by Subject|0|||
48849103|NCT03611075|157286993|FG006|Overall Study|Withdrawal by Subject|1|||
48849104|NCT03611075|157286994|FG007|Overall Study|Withdrawal by Subject|0|||
48849105|NCT03611075|157286995|FG008|Overall Study|Withdrawal by Subject|0|||
48849106|NCT03611075|157286987|FG000|Overall Study|Reason unknown|0|||
48849107|NCT03611075|157286988|FG001|Overall Study|Reason unknown|0|||
48849108|NCT03611075|157286989|FG002|Overall Study|Reason unknown|0|||
48849109|NCT03611075|157286990|FG003|Overall Study|Reason unknown|1|||
48849110|NCT03611075|157286991|FG004|Overall Study|Reason unknown|0|||
48849111|NCT03611075|157286992|FG005|Overall Study|Reason unknown|0|||
48849112|NCT03611075|157286993|FG006|Overall Study|Reason unknown|1|||
48849113|NCT03611075|157286994|FG007|Overall Study|Reason unknown|0|||
48849114|NCT03611075|157286995|FG008|Overall Study|Reason unknown|0|||
48849115|NCT00676091|157286996|FG000|Infant Series|Parent or legal guardian request|10|||
48849116|NCT00676091|157286997|FG001|Infant Series|Parent or legal guardian request|8|||
48849117|NCT00676091|157286996|FG000|Infant Series|Protocol Violation|6|||
48849118|NCT00676091|157286997|FG001|Infant Series|Protocol Violation|3|||
48849119|NCT00676091|157286996|FG000|Infant Series|Adverse Event|2|||
48849120|NCT00676091|157286997|FG001|Infant Series|Adverse Event|3|||
48849121|NCT00676091|157286996|FG000|Infant Series|Failed to return|1|||
48849122|NCT00676091|157286997|FG001|Infant Series|Failed to return|3|||
48849123|NCT00676091|157286996|FG000|Infant Series|Lost to Follow-up|1|||
48849124|NCT00676091|157286997|FG001|Infant Series|Lost to Follow-up|0|||
48849125|NCT00676091|157286996|FG000|Infant Series|Died prior to receiving 7vPnC|0|||
48849126|NCT00676091|157286997|FG001|Infant Series|Died prior to receiving 7vPnC|1|||
48849127|NCT00676091|157286996|FG000|After Infant Series|Adverse Event|0|||
48849128|NCT00676091|157286997|FG001|After Infant Series|Adverse Event|1|||
48849129|NCT00676091|157286996|FG000|After Infant Series|Protocol Violation|0|||
48849130|NCT00676091|157286997|FG001|After Infant Series|Protocol Violation|1|||
48849131|NCT00676091|157286996|FG000|After Infant Series|Failed to return|1|||
48849132|NCT00676091|157286997|FG001|After Infant Series|Failed to return|1|||
48849133|NCT00676091|157286996|FG000|Toddler Dose|Failed to return|2|||
48849134|NCT00676091|157286997|FG001|Toddler Dose|Failed to return|0|||
48849135|NCT00676091|157286996|FG000|Toddler Dose|Parent or legal guardian request|1|||
48849136|NCT00676091|157286997|FG001|Toddler Dose|Parent or legal guardian request|0|||
48849137|NCT02130557|157286999|FG000|Overall Study|Withdrawal by Subject|12|||
48849138|NCT02130557|157287000|FG001|Overall Study|Withdrawal by Subject|12|||
48849139|NCT02130557|157286999|FG000|Overall Study|Investigator Request|0|||
48849140|NCT02130557|157287000|FG001|Overall Study|Investigator Request|2|||
48849141|NCT02130557|157286999|FG000|Overall Study|Deceased|14|||
48849142|NCT02130557|157287000|FG001|Overall Study|Deceased|14|||
48849143|NCT02130557|157286999|FG000|Overall Study|Lost to Follow-up|6|||
48849144|NCT02130557|157287000|FG001|Overall Study|Lost to Follow-up|7|||
48942035|NCT04358458|157617337|FG002|Overall Study|Death|3|||
48942036|NCT04358458|157617338|FG003|Overall Study|Death|8|||
48942037|NCT04358458|157617339|FG004|Overall Study|Death|1|||
48942038|NCT04358458|157617340|FG005|Overall Study|Death|6|||
48942039|NCT04358458|157617341|FG006|Overall Study|Death|2|||
48942040|NCT04358458|157617342|FG007|Overall Study|Death|3|||
48942041|NCT04358458|157617335|FG000|Overall Study|Lost to Follow-up|0|||
48942042|NCT04358458|157617336|FG001|Overall Study|Lost to Follow-up|0|||
48942043|NCT04358458|157617337|FG002|Overall Study|Lost to Follow-up|0|||
48942044|NCT04358458|157617338|FG003|Overall Study|Lost to Follow-up|0|||
48942045|NCT04358458|157617339|FG004|Overall Study|Lost to Follow-up|0|||
48942046|NCT04358458|157617340|FG005|Overall Study|Lost to Follow-up|0|||
48942047|NCT04358458|157617341|FG006|Overall Study|Lost to Follow-up|0|||
48942048|NCT04358458|157617342|FG007|Overall Study|Lost to Follow-up|1|||
48942049|NCT04358458|157617335|FG000|Overall Study|Site is closing study participation|0|||
48942050|NCT04358458|157617336|FG001|Overall Study|Site is closing study participation|0|||
48942051|NCT04358458|157617337|FG002|Overall Study|Site is closing study participation|0|||
48942052|NCT04358458|157617338|FG003|Overall Study|Site is closing study participation|1|||
48942053|NCT04358458|157617339|FG004|Overall Study|Site is closing study participation|0|||
48942054|NCT04358458|157617340|FG005|Overall Study|Site is closing study participation|0|||
48942055|NCT04358458|157617341|FG006|Overall Study|Site is closing study participation|0|||
48942056|NCT04358458|157617342|FG007|Overall Study|Site is closing study participation|0|||
48942057|NCT04358458|157617335|FG000|Overall Study|Sponsor request|2|||
48942058|NCT04358458|157617336|FG001|Overall Study|Sponsor request|3|||
48942059|NCT04358458|157617337|FG002|Overall Study|Sponsor request|3|||
48942060|NCT04358458|157617338|FG003|Overall Study|Sponsor request|0|||
48942061|NCT04358458|157617339|FG004|Overall Study|Sponsor request|2|||
48942062|NCT04358458|157617340|FG005|Overall Study|Sponsor request|3|||
48942063|NCT04358458|157617341|FG006|Overall Study|Sponsor request|1|||
48942064|NCT04358458|157617342|FG007|Overall Study|Sponsor request|1|||
48942065|NCT04358458|157617335|FG000|Overall Study|Withdrawal by Subject|0|||
48942066|NCT04358458|157617336|FG001|Overall Study|Withdrawal by Subject|0|||
48942067|NCT04358458|157617337|FG002|Overall Study|Withdrawal by Subject|1|||
48942068|NCT04358458|157617338|FG003|Overall Study|Withdrawal by Subject|1|||
48942069|NCT04358458|157617339|FG004|Overall Study|Withdrawal by Subject|0|||
48942070|NCT04358458|157617340|FG005|Overall Study|Withdrawal by Subject|1|||
48942071|NCT04358458|157617341|FG006|Overall Study|Withdrawal by Subject|0|||
48942072|NCT04358458|157617342|FG007|Overall Study|Withdrawal by Subject|1|||
48942073|NCT04513158|157617343|FG000|Overall Study|Screen Failure|1|||
48942074|NCT01445171|157618604|FG000|Overall Study|Lost to Follow-up|11|||
48942075|NCT01445171|157618604|FG000|Overall Study|Withdrawal by Subject|16|||
48942076|NCT01445171|157618604|FG000|Overall Study|Death|51|||
48942077|NCT01445171|157618604|FG000|Overall Study|Subjects declined to return for followup|9|||
48942078|NCT01445171|157618604|FG000|Overall Study|Consented but did not receive device|8|||
48942079|NCT00473694|157618605|FG000|Overall Study|Adverse Event|0|||
48942080|NCT00473694|157618606|FG001|Overall Study|Adverse Event|1|||
48942081|NCT00473694|157618607|FG002|Overall Study|Adverse Event|0|||
48942082|NCT00473694|157618608|FG003|Overall Study|Adverse Event|0|||
48942083|NCT00473694|157618605|FG000|Overall Study|Participants did not receive treatment|11|||
48942084|NCT00473694|157618606|FG001|Overall Study|Participants did not receive treatment|3|||
48942085|NCT00473694|157618607|FG002|Overall Study|Participants did not receive treatment|5|||
48942086|NCT00473694|157618608|FG003|Overall Study|Participants did not receive treatment|6|||
48942087|NCT00473694|157618605|FG000|Overall Study|Lost to Follow-up|0|||
48942088|NCT00473694|157618606|FG001|Overall Study|Lost to Follow-up|0|||
48942089|NCT00473694|157618607|FG002|Overall Study|Lost to Follow-up|0|||
48942090|NCT00473694|157618608|FG003|Overall Study|Lost to Follow-up|1|||
48942091|NCT02579603|157618609|FG000|Overall Study|Not treated|1|||
48942092|NCT02579603|157618610|FG001|Overall Study|Not treated|0|||
48942093|NCT02579603|157618609|FG000|Overall Study|Adverse Event|2|||
48942094|NCT02579603|157618610|FG001|Overall Study|Adverse Event|2|||
48942095|NCT02579603|157618609|FG000|Overall Study|Other than stated|1|||
48942096|NCT02579603|157618610|FG001|Overall Study|Other than stated|0|||
48942097|NCT02626338|157618611|FG000|Overall Study|Lack of Efficacy|3|||
48942098|NCT02626338|157618612|FG001|Overall Study|Lack of Efficacy|2|||
48942099|NCT02626338|157618613|FG002|Overall Study|Lack of Efficacy|0|||
48942100|NCT01217606|157618616|FG000|Initial Treatment Phase|Other Reasons|0|||
48942101|NCT01217606|157618617|FG001|Initial Treatment Phase|Other Reasons|2|||
48942102|NCT01217606|157618616|FG000|Initial Treatment Phase|Protocol Violation|3|||
48942103|NCT01217606|157618617|FG001|Initial Treatment Phase|Protocol Violation|2|||
48942104|NCT01217606|157618616|FG000|Initial Treatment Phase|Personal Reasons|0|||
48942105|NCT01217606|157618617|FG001|Initial Treatment Phase|Personal Reasons|2|||
48942106|NCT01217606|157618616|FG000|Initial Treatment Phase|Lack of Efficacy|1|||
48942107|NCT01217606|157618617|FG001|Initial Treatment Phase|Lack of Efficacy|0|||
48942108|NCT01217606|157618616|FG000|Initial Treatment Phase|Adverse Event|10|||
48942109|NCT01217606|157618617|FG001|Initial Treatment Phase|Adverse Event|6|||
48942110|NCT01217606|157618616|FG000|9-Month Masked Extension|Adverse Event|3|||
48849145|NCT02130557|157286999|FG000|Overall Study|Other|2|||
48849146|NCT02130557|157287000|FG001|Overall Study|Other|1|||
48849147|NCT02130557|157286999|FG000|Overall Study|Missing|2|||
48849148|NCT02130557|157287000|FG001|Overall Study|Missing|1|||
48849149|NCT01736475|157287001|FG000|Overall Study|Adverse Event|4|||
48849150|NCT01736475|157287002|FG001|Overall Study|Adverse Event|0|||
48849151|NCT01736475|157287001|FG000|Overall Study|Withdrawal by Subject|2|||
48849152|NCT01736475|157287002|FG001|Overall Study|Withdrawal by Subject|0|||
48849153|NCT01736475|157287001|FG000|Overall Study|Protocol Violation|4|||
48849154|NCT01736475|157287002|FG001|Overall Study|Protocol Violation|0|||
48849155|NCT01736475|157287001|FG000|Overall Study|Other - Screen failure|1|||
48849156|NCT01736475|157287002|FG001|Overall Study|Other - Screen failure|0|||
48849157|NCT01736475|157287001|FG000|Overall Study|Other - Surgical procedure|1|||
48849158|NCT01736475|157287002|FG001|Overall Study|Other - Surgical procedure|0|||
48849159|NCT02408887|157287003|FG000|Overall Study|Participant was inevaluable due to advanced cancer|1|||
48849160|NCT02408887|157287004|FG001|Overall Study|Participant was inevaluable due to advanced cancer|0|||
48849161|NCT02408887|157287003|FG000|Overall Study|Participant was inevaluable due to benign pathology.|0|||
48849162|NCT02408887|157287004|FG001|Overall Study|Participant was inevaluable due to benign pathology.|1|||
48849163|NCT00914966|157287005|FG000|Step 1: 1500 Units|Withdrawal by Subject|1|||
48849164|NCT00914966|157287005|FG000|Step 1: 1500 Units|Physician Decision|1|||
48849165|NCT00914966|157287005|FG000|Step 2: 2000 Units|Withdrawal by Subject|1|||
48849166|NCT03539952|157287006|FG000|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|24|||
48849167|NCT03539952|157287007|FG001|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|0|||
48849168|NCT03539952|157287006|FG000|Post-randomization Period (Week 12-36)|Withdrawal by Subject|1|||
48849169|NCT03539952|157287007|FG001|Post-randomization Period (Week 12-36)|Withdrawal by Subject|0|||
48849170|NCT03539952|157287006|FG000|Extension Post Random. (Week 36-60)|Adverse Event|1|||
48849171|NCT03539952|157287007|FG001|Extension Post Random. (Week 36-60)|Adverse Event|1|||
48849172|NCT03539952|157287006|FG000|Extension Post Random. (Week 36-60)|Withdrawal by Subject|3|||
48849173|NCT03539952|157287007|FG001|Extension Post Random. (Week 36-60)|Withdrawal by Subject|1|||
48849174|NCT03539952|157287006|FG000|Extension Post Random. (Week 36-60)|Not further documented|3|||
48849175|NCT03539952|157287007|FG001|Extension Post Random. (Week 36-60)|Not further documented|1|||
48849176|NCT03539952|157287006|FG000|All on TETA 4HCl, From wk 60 Till 108max|Death|0|||
48849177|NCT03539952|157287007|FG001|All on TETA 4HCl, From wk 60 Till 108max|Death|1|||
48849178|NCT03539952|157287006|FG000|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|0|||
48849179|NCT03539952|157287007|FG001|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|1|||
48849180|NCT02909686|157287008|FG000|Overall Study|Physician Decision|3|||
48849181|NCT02909686|157287008|FG000|Overall Study|Withdrawal by Subject|2|||
48849182|NCT00989196|157287009|FG000|Treatment Period|Lost to Follow-up|1|||
48849183|NCT00989196|157287010|FG001|Treatment Period|Lost to Follow-up|0|||
48849184|NCT03699163|157288753|FG000|Overall Study|Physician Decision|12|||
48849185|NCT03699163|157288754|FG001|Overall Study|Physician Decision|0|||
48849186|NCT03699163|157288753|FG000|Overall Study|failed QC measures|205|||
48849187|NCT03699163|157288754|FG001|Overall Study|failed QC measures|206|||
48849188|NCT02128113|157288758|FG000|Overall Study|Withdrawal by Subject|3|||
48849189|NCT02128113|157288759|FG001|Overall Study|Withdrawal by Subject|1|||
48849190|NCT02128113|157288760|FG002|Overall Study|Withdrawal by Subject|0|||
48849191|NCT02128113|157288758|FG000|Overall Study|Protocol Violation|0|||
48849192|NCT02128113|157288759|FG001|Overall Study|Protocol Violation|1|||
48849193|NCT02128113|157288760|FG002|Overall Study|Protocol Violation|0|||
48849194|NCT02128113|157288758|FG000|Overall Study|Surgery cancelled|0|||
48849195|NCT02128113|157288759|FG001|Overall Study|Surgery cancelled|1|||
48849196|NCT02128113|157288760|FG002|Overall Study|Surgery cancelled|0|||
48849197|NCT02128113|157288758|FG000|Overall Study|Adverse Event|0|||
48849198|NCT02128113|157288759|FG001|Overall Study|Adverse Event|0|||
48849199|NCT02128113|157288760|FG002|Overall Study|Adverse Event|1|||
48849200|NCT00945321|157288761|FG000|Period 1|Adverse Event|0|||
48849201|NCT00945321|157288762|FG001|Period 1|Adverse Event|0|||
48849202|NCT00945321|157288763|FG002|Period 1|Adverse Event|0|||
48849203|NCT00945321|157288764|FG003|Period 1|Adverse Event|0|||
48849204|NCT00945321|157288765|FG004|Period 1|Adverse Event|1|||
48849205|NCT00945321|157288766|FG005|Period 1|Adverse Event|0|||
48849206|NCT00945321|157288761|FG000|Period 4|Lost to Follow-up|0|||
48849207|NCT00945321|157288762|FG001|Period 4|Lost to Follow-up|0|||
48849208|NCT00945321|157288763|FG002|Period 4|Lost to Follow-up|0|||
48849209|NCT00945321|157288764|FG003|Period 4|Lost to Follow-up|0|||
48849210|NCT00945321|157288765|FG004|Period 4|Lost to Follow-up|0|||
48849211|NCT00945321|157288766|FG005|Period 4|Lost to Follow-up|1|||
48849212|NCT04876417|157288767|FG000|Overall Study|Lost to Follow-up|5|||
48849213|NCT04876417|157288768|FG001|Overall Study|Lost to Follow-up|8|||
48849214|NCT04876417|157288769|FG002|Overall Study|Lost to Follow-up|0|||
48849215|NCT04876417|157288770|FG003|Overall Study|Lost to Follow-up|0|||
48849216|NCT00774397|157288771|FG000|Overall Study|Adverse Event|1|||
48849217|NCT00774397|157288772|FG001|Overall Study|Adverse Event|3|||
48942111|NCT01217606|157618617|FG001|9-Month Masked Extension|Adverse Event|6|||
48942112|NCT01217606|157618616|FG000|9-Month Masked Extension|Other Reasons|4|||
48942113|NCT01217606|157618617|FG001|9-Month Masked Extension|Other Reasons|4|||
48942114|NCT01217606|157618616|FG000|9-Month Masked Extension|Personal Reasons|2|||
48942115|NCT01217606|157618617|FG001|9-Month Masked Extension|Personal Reasons|1|||
48942116|NCT01217606|157618616|FG000|9-Month Masked Extension|Lost to Follow-up|1|||
48942117|NCT01217606|157618617|FG001|9-Month Masked Extension|Lost to Follow-up|0|||
48942118|NCT01217606|157618616|FG000|9-Month Masked Extension|Pregnancy|1|||
48942119|NCT01217606|157618617|FG001|9-Month Masked Extension|Pregnancy|0|||
48942120|NCT01217606|157618616|FG000|9-Month Masked Extension|Lack of Efficacy|2|||
48942121|NCT01217606|157618617|FG001|9-Month Masked Extension|Lack of Efficacy|0|||
48942122|NCT04331899|157618618|FG000|Trial Period (28 Days)|Withdrawal by Subject|2|||
48942123|NCT04331899|157618619|FG001|Trial Period (28 Days)|Withdrawal by Subject|2|||
48942124|NCT01973283|157618620|FG000|Overall Study|Lost to Follow-up|4|||
48942125|NCT00886938|157618621|FG000|Overall Study|Adverse Event|1|||
48942126|NCT00886938|157618621|FG000|Overall Study|Withdrawal by Subject|1|||
48942127|NCT02725788|157618627|FG000|Overall Study|Lost to Follow-up|1|||
48942128|NCT02725788|157618628|FG001|Overall Study|Lost to Follow-up|1|||
48942129|NCT02725788|157618627|FG000|Overall Study|Protocol Violation|0|||
48942130|NCT02725788|157618628|FG001|Overall Study|Protocol Violation|1|||
48942131|NCT00442598|157618629|FG000|Overall Study|Adverse Event|1|||
48942132|NCT00442598|157618630|FG001|Overall Study|Adverse Event|0|||
48942133|NCT00442598|157618631|FG002|Overall Study|Adverse Event|0|||
48942134|NCT00442598|157618629|FG000|Overall Study|Tumor progression|3|||
48942135|NCT00442598|157618630|FG001|Overall Study|Tumor progression|4|||
48942136|NCT00442598|157618631|FG002|Overall Study|Tumor progression|0|||
48942137|NCT00442598|157618629|FG000|Overall Study|Clinical deterioration|1|||
48942138|NCT00442598|157618630|FG001|Overall Study|Clinical deterioration|2|||
48942139|NCT00442598|157618631|FG002|Overall Study|Clinical deterioration|0|||
48942140|NCT00442598|157618629|FG000|Overall Study|CA125 progression|0|||
48942141|NCT00442598|157618630|FG001|Overall Study|CA125 progression|1|||
48942142|NCT00442598|157618631|FG002|Overall Study|CA125 progression|0|||
48942143|NCT00442598|157618629|FG000|Overall Study|Reduced creatinine clearance|1|||
48942144|NCT00442598|157618630|FG001|Overall Study|Reduced creatinine clearance|0|||
48942145|NCT00442598|157618631|FG002|Overall Study|Reduced creatinine clearance|0|||
48942146|NCT00442598|157618629|FG000|Overall Study|Death|0|||
48942147|NCT00442598|157618630|FG001|Overall Study|Death|1|||
48942148|NCT00442598|157618631|FG002|Overall Study|Death|0|||
48942149|NCT00813748|157618638|FG000|Skin Test Substudy|Physician Decision|0|||
48942150|NCT00813748|157618639|FG001|Skin Test Substudy|Physician Decision|1|||
48942151|NCT03794986|157618641|FG000|Overall Study|0 Sessions Attended|34|||
48942152|NCT03794986|157618642|FG001|Overall Study|0 Sessions Attended|37|||
48942153|NCT03794986|157618641|FG000|Overall Study|Withdrawal by Subject|4|||
48942154|NCT03794986|157618642|FG001|Overall Study|Withdrawal by Subject|6|||
48942155|NCT03794986|157618641|FG000|Overall Study|Protocol Violation|1|||
48942156|NCT03794986|157618642|FG001|Overall Study|Protocol Violation|0|||
48942157|NCT03401749|157618648|FG000|Overall Study|Lost to Follow-up|20|||
48942158|NCT03401749|157618649|FG001|Overall Study|Lost to Follow-up|16|||
48942159|NCT03401749|157618650|FG002|Overall Study|Lost to Follow-up|26|||
48942160|NCT00356915|157618651|FG000|Overall Study|Non compliance|1|||
48942161|NCT00356915|157618652|FG001|Overall Study|Non compliance|2|||
48942162|NCT00356915|157618653|FG002|Overall Study|Non compliance|1|||
48942163|NCT00356915|157618651|FG000|Overall Study|Protocol Violation|2|||
48942164|NCT00356915|157618652|FG001|Overall Study|Protocol Violation|3|||
48942165|NCT00356915|157618653|FG002|Overall Study|Protocol Violation|2|||
48942166|NCT00356915|157618651|FG000|Overall Study|Withdrawal by Subject|14|||
48942167|NCT00356915|157618652|FG001|Overall Study|Withdrawal by Subject|14|||
48942168|NCT00356915|157618653|FG002|Overall Study|Withdrawal by Subject|10|||
48942169|NCT00356915|157618651|FG000|Overall Study|Lack of Efficacy|0|||
48942170|NCT00356915|157618652|FG001|Overall Study|Lack of Efficacy|0|||
48942171|NCT00356915|157618653|FG002|Overall Study|Lack of Efficacy|3|||
48942172|NCT00356915|157618651|FG000|Overall Study|Lost to Follow-up|27|||
48942173|NCT00356915|157618652|FG001|Overall Study|Lost to Follow-up|34|||
48942174|NCT00356915|157618653|FG002|Overall Study|Lost to Follow-up|14|||
48942175|NCT00356915|157618651|FG000|Overall Study|Administrative Decision|0|||
48942176|NCT00356915|157618652|FG001|Overall Study|Administrative Decision|0|||
48942177|NCT00356915|157618653|FG002|Overall Study|Administrative Decision|1|||
48942178|NCT00356915|157618651|FG000|Overall Study|Physician Decision|0|||
48942179|NCT00356915|157618652|FG001|Overall Study|Physician Decision|2|||
48942180|NCT00356915|157618653|FG002|Overall Study|Physician Decision|0|||
48942181|NCT00356915|157618651|FG000|Overall Study|Adverse Event|21|||
48942182|NCT00356915|157618652|FG001|Overall Study|Adverse Event|31|||
48942183|NCT00356915|157618653|FG002|Overall Study|Adverse Event|8|||
48942184|NCT00356915|157618651|FG000|Overall Study|Miscellaneous reasons|11|||
48942185|NCT00356915|157618652|FG001|Overall Study|Miscellaneous reasons|8|||
48942186|NCT00356915|157618653|FG002|Overall Study|Miscellaneous reasons|3|||
48942187|NCT01307423|157618654|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
48942188|NCT01307423|157618655|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
48942189|NCT01307423|157618656|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6|||
48942190|NCT01307423|157618657|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
48942191|NCT01307423|157618658|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
48942192|NCT01307423|157618659|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
48942193|NCT01307423|157618660|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
48942194|NCT01307423|157618661|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
48942195|NCT01307423|157618662|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
48942196|NCT01307423|157618654|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1|||
48942197|NCT01307423|157618655|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
48942198|NCT01307423|157618656|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
48942199|NCT01307423|157618657|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
48942200|NCT01307423|157618658|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
48942201|NCT01307423|157618659|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
48942202|NCT01307423|157618660|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
48942203|NCT01307423|157618661|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
48942204|NCT01307423|157618662|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
48942205|NCT01307423|157618654|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8|||
48942206|NCT01307423|157618655|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
48942207|NCT01307423|157618656|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10|||
48942208|NCT01307423|157618657|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
48942209|NCT01307423|157618658|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
48942210|NCT01307423|157618659|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
48942211|NCT01307423|157618660|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
48942212|NCT01307423|157618661|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
48942213|NCT01307423|157618662|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
48942214|NCT01307423|157618654|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
48942215|NCT01307423|157618655|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
48942216|NCT01307423|157618656|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
48942217|NCT01307423|157618657|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
48942218|NCT01307423|157618658|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
48942219|NCT01307423|157618659|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
48942220|NCT01307423|157618660|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
48942221|NCT01307423|157618661|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
48942222|NCT01307423|157618662|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
48942223|NCT01307423|157618654|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5|||
48942224|NCT01307423|157618655|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
48942225|NCT01307423|157618656|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
48942226|NCT01307423|157618657|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
48942227|NCT01307423|157618658|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
48942228|NCT01307423|157618659|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
48942229|NCT01307423|157618660|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
48942230|NCT01307423|157618661|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
48942231|NCT01307423|157618662|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
48942232|NCT01307423|157618654|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
48942233|NCT01307423|157618655|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
48942234|NCT01307423|157618656|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
48942235|NCT01307423|157618657|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
48942236|NCT01307423|157618658|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
48942237|NCT01307423|157618659|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
48942238|NCT01307423|157618660|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
48942239|NCT01307423|157618661|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
48942240|NCT01307423|157618662|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
48942241|NCT01307423|157618654|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
48942242|NCT01307423|157618655|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
48942243|NCT01307423|157618656|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
48942244|NCT01307423|157618657|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
48942245|NCT01307423|157618658|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
48942246|NCT01307423|157618659|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
48942247|NCT01307423|157618660|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
48942248|NCT01307423|157618661|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
48942249|NCT01307423|157618662|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
48942250|NCT01307423|157618654|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
48942251|NCT01307423|157618655|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
48942252|NCT01307423|157618656|FG002|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
48942253|NCT01307423|157618657|FG003|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
48942254|NCT01307423|157618658|FG004|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
48942255|NCT01307423|157618659|FG005|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
48942256|NCT01307423|157618660|FG006|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
48942257|NCT01307423|157618661|FG007|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
48942258|NCT01307423|157618662|FG008|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
48942259|NCT01307423|157618654|FG000|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
48942260|NCT01307423|157618655|FG001|Active Treatment Phase (Week 25-52)|Adverse Event|3|||
48942261|NCT01307423|157618656|FG002|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
48942262|NCT01307423|157618657|FG003|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
48942263|NCT01307423|157618658|FG004|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
48942264|NCT01307423|157618659|FG005|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
48942265|NCT01307423|157618660|FG006|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
48942266|NCT01307423|157618661|FG007|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
48942267|NCT01307423|157618662|FG008|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
48942268|NCT01307423|157618654|FG000|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
48942269|NCT01307423|157618655|FG001|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
48942270|NCT01307423|157618656|FG002|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
48942271|NCT01307423|157618657|FG003|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3|||
48942272|NCT01307423|157618658|FG004|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1|||
48942273|NCT01307423|157618659|FG005|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
48942274|NCT01307423|157618660|FG006|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
48942275|NCT01307423|157618661|FG007|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
48942276|NCT01307423|157618662|FG008|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
48942277|NCT01307423|157618654|FG000|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
48942278|NCT01307423|157618655|FG001|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
48942279|NCT01307423|157618656|FG002|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
48942280|NCT01307423|157618657|FG003|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
48942281|NCT01307423|157618658|FG004|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
48942282|NCT01307423|157618659|FG005|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1|||
48942283|NCT01307423|157618660|FG006|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
48942284|NCT01307423|157618661|FG007|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
48942285|NCT01307423|157618662|FG008|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
48942286|NCT01307423|157618654|FG000|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
48942287|NCT01307423|157618655|FG001|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11|||
48942288|NCT01307423|157618656|FG002|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2|||
48942289|NCT01307423|157618657|FG003|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
48942290|NCT01307423|157618658|FG004|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
48942291|NCT01307423|157618659|FG005|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
48942292|NCT01307423|157618660|FG006|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
48942293|NCT01307423|157618661|FG007|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
48942294|NCT01307423|157618662|FG008|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
48942295|NCT01307423|157618654|FG000|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
48942296|NCT01307423|157618655|FG001|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
48942297|NCT01307423|157618656|FG002|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
48942298|NCT01307423|157618657|FG003|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2|||
48942299|NCT01307423|157618658|FG004|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
48942300|NCT01307423|157618659|FG005|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
48942301|NCT01307423|157618660|FG006|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
48942302|NCT01307423|157618661|FG007|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
48942303|NCT01307423|157618662|FG008|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
48942304|NCT01307423|157618654|FG000|Active Treatment Phase (Week 25-52)|Other|0|||
48942305|NCT01307423|157618655|FG001|Active Treatment Phase (Week 25-52)|Other|0|||
48942306|NCT01307423|157618656|FG002|Active Treatment Phase (Week 25-52)|Other|0|||
48942307|NCT01307423|157618657|FG003|Active Treatment Phase (Week 25-52)|Other|1|||
48942308|NCT01307423|157618658|FG004|Active Treatment Phase (Week 25-52)|Other|0|||
48942309|NCT01307423|157618659|FG005|Active Treatment Phase (Week 25-52)|Other|0|||
48942310|NCT01307423|157618660|FG006|Active Treatment Phase (Week 25-52)|Other|0|||
48942311|NCT01307423|157618661|FG007|Active Treatment Phase (Week 25-52)|Other|0|||
48942312|NCT01307423|157618662|FG008|Active Treatment Phase (Week 25-52)|Other|0|||
48942313|NCT01307423|157618654|FG000|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
48942314|NCT01307423|157618655|FG001|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
48942315|NCT01307423|157618656|FG002|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
48942316|NCT01307423|157618657|FG003|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
48942317|NCT01307423|157618658|FG004|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
48942318|NCT01307423|157618659|FG005|Active Treatment Phase (Week 25-52)|Protocol Violation|1|||
48942319|NCT01307423|157618660|FG006|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
48942320|NCT01307423|157618661|FG007|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
48942321|NCT01307423|157618662|FG008|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
48942322|NCT01307423|157618654|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
48942323|NCT01307423|157618655|FG001|Long-term Safety Phase (Year 2)|Adverse Event|2|||
48942324|NCT01307423|157618656|FG002|Long-term Safety Phase (Year 2)|Adverse Event|7|||
48942325|NCT01307423|157618657|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
48942326|NCT01307423|157618658|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
48942327|NCT01307423|157618659|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
48942328|NCT01307423|157618660|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
48942329|NCT01307423|157618661|FG007|Long-term Safety Phase (Year 2)|Adverse Event|1|||
48942330|NCT01307423|157618662|FG008|Long-term Safety Phase (Year 2)|Adverse Event|1|||
48942331|NCT01307423|157618654|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
48942332|NCT01307423|157618655|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
48942333|NCT01307423|157618656|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|5|||
48942334|NCT01307423|157618657|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
48942335|NCT01307423|157618658|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
48942336|NCT01307423|157618659|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
48942337|NCT01307423|157618660|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
48942338|NCT01307423|157618661|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
48942339|NCT01307423|157618662|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|3|||
48942340|NCT01307423|157618654|FG000|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
48942341|NCT01307423|157618655|FG001|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
48942342|NCT01307423|157618656|FG002|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1|||
48942343|NCT01307423|157618657|FG003|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
48942344|NCT01307423|157618658|FG004|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
48942345|NCT01307423|157618659|FG005|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
48942346|NCT01307423|157618660|FG006|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
48942347|NCT01307423|157618661|FG007|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
48942348|NCT01307423|157618662|FG008|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
48942349|NCT01307423|157618654|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
48942350|NCT01307423|157618655|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13|||
48942351|NCT01307423|157618656|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12|||
48942352|NCT01307423|157618657|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
48942353|NCT01307423|157618658|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
48942354|NCT01307423|157618659|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
48942355|NCT01307423|157618660|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
48942356|NCT01307423|157618661|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
48942357|NCT01307423|157618662|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2|||
48942358|NCT01307423|157618654|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
48942359|NCT01307423|157618655|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
48942360|NCT01307423|157618656|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
48942361|NCT01307423|157618657|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
48942362|NCT01307423|157618658|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
48942363|NCT01307423|157618659|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
48942364|NCT01307423|157618660|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
48942365|NCT01307423|157618661|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
48942366|NCT01307423|157618662|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
48942367|NCT01307423|157618654|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
48942368|NCT01307423|157618655|FG001|Long-term Safety Phase (Year 3)|Adverse Event|1|||
48942369|NCT01307423|157618656|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
48942370|NCT01307423|157618657|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
48942371|NCT01307423|157618658|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
48942372|NCT01307423|157618659|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
48942373|NCT01307423|157618660|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
48942374|NCT01307423|157618661|FG007|Long-term Safety Phase (Year 3)|Adverse Event|3|||
48942375|NCT01307423|157618662|FG008|Long-term Safety Phase (Year 3)|Adverse Event|4|||
48942376|NCT01307423|157618654|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
48942377|NCT01307423|157618655|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
48942378|NCT01307423|157618656|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
48942379|NCT01307423|157618657|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
48942380|NCT01307423|157618658|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
48942381|NCT01307423|157618659|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
48942382|NCT01307423|157618660|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
48942383|NCT01307423|157618661|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|1|||
48942384|NCT01307423|157618662|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
48942385|NCT01307423|157618654|FG000|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
48942386|NCT01307423|157618655|FG001|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
48942387|NCT01307423|157618656|FG002|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
48942388|NCT01307423|157618657|FG003|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
48942389|NCT01307423|157618658|FG004|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
48942390|NCT01307423|157618659|FG005|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
48942391|NCT01307423|157618660|FG006|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
48849218|NCT00774397|157288773|FG002|Overall Study|Adverse Event|16|||
48849219|NCT00774397|157288774|FG003|Overall Study|Adverse Event|8|||
48849220|NCT00774397|157288775|FG004|Overall Study|Adverse Event|8|||
48849221|NCT00774397|157288776|FG005|Overall Study|Adverse Event|3|||
48849222|NCT00774397|157288777|FG006|Overall Study|Adverse Event|16|||
48849223|NCT00774397|157288771|FG000|Overall Study|Lack of Efficacy|11|||
48849224|NCT00774397|157288772|FG001|Overall Study|Lack of Efficacy|4|||
48849225|NCT00774397|157288773|FG002|Overall Study|Lack of Efficacy|5|||
48849226|NCT00774397|157288774|FG003|Overall Study|Lack of Efficacy|3|||
48849227|NCT00774397|157288775|FG004|Overall Study|Lack of Efficacy|27|||
48849228|NCT00774397|157288776|FG005|Overall Study|Lack of Efficacy|15|||
48849229|NCT00774397|157288777|FG006|Overall Study|Lack of Efficacy|9|||
48849230|NCT00774397|157288771|FG000|Overall Study|Protocol Violation|0|||
48849231|NCT00774397|157288772|FG001|Overall Study|Protocol Violation|1|||
48849232|NCT00774397|157288773|FG002|Overall Study|Protocol Violation|3|||
48849233|NCT00774397|157288774|FG003|Overall Study|Protocol Violation|1|||
48849234|NCT00774397|157288775|FG004|Overall Study|Protocol Violation|2|||
48849235|NCT00774397|157288776|FG005|Overall Study|Protocol Violation|1|||
48849236|NCT00774397|157288777|FG006|Overall Study|Protocol Violation|0|||
48849237|NCT00774397|157288771|FG000|Overall Study|Lost to Follow-up|0|||
48849238|NCT00774397|157288772|FG001|Overall Study|Lost to Follow-up|1|||
48849239|NCT00774397|157288773|FG002|Overall Study|Lost to Follow-up|1|||
48849240|NCT00774397|157288774|FG003|Overall Study|Lost to Follow-up|1|||
48849241|NCT00774397|157288775|FG004|Overall Study|Lost to Follow-up|0|||
48849242|NCT00774397|157288776|FG005|Overall Study|Lost to Follow-up|1|||
48849243|NCT00774397|157288777|FG006|Overall Study|Lost to Follow-up|0|||
48849244|NCT00774397|157288771|FG000|Overall Study|Refused to continue trial medication|1|||
48849245|NCT00774397|157288772|FG001|Overall Study|Refused to continue trial medication|3|||
48849246|NCT00774397|157288773|FG002|Overall Study|Refused to continue trial medication|2|||
48849247|NCT00774397|157288774|FG003|Overall Study|Refused to continue trial medication|2|||
48849248|NCT00774397|157288775|FG004|Overall Study|Refused to continue trial medication|6|||
48849249|NCT00774397|157288776|FG005|Overall Study|Refused to continue trial medication|2|||
48849250|NCT00774397|157288777|FG006|Overall Study|Refused to continue trial medication|3|||
48849251|NCT00774397|157288771|FG000|Overall Study|Not treated|0|||
48849252|NCT00774397|157288772|FG001|Overall Study|Not treated|0|||
48849253|NCT00774397|157288773|FG002|Overall Study|Not treated|0|||
48849254|NCT00774397|157288774|FG003|Overall Study|Not treated|0|||
48849255|NCT00774397|157288775|FG004|Overall Study|Not treated|1|||
48849256|NCT00774397|157288776|FG005|Overall Study|Not treated|0|||
48849257|NCT00774397|157288777|FG006|Overall Study|Not treated|1|||
48942392|NCT01307423|157618661|FG007|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
48942393|NCT01307423|157618662|FG008|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
48942394|NCT01307423|157618654|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
48942395|NCT01307423|157618655|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
48942396|NCT01307423|157618656|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8|||
48942397|NCT01307423|157618657|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
48942398|NCT01307423|157618658|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
48942399|NCT01307423|157618659|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
48942400|NCT01307423|157618660|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
48942401|NCT01307423|157618661|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
48942402|NCT01307423|157618662|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
48942403|NCT01307423|157618654|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
48942404|NCT01307423|157618655|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|2|||
48942405|NCT01307423|157618656|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|3|||
48942406|NCT01307423|157618657|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
48942407|NCT01307423|157618658|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
48942408|NCT01307423|157618659|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
48942409|NCT01307423|157618660|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
48942410|NCT01307423|157618661|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
48942411|NCT01307423|157618662|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
48942412|NCT01307423|157618654|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
48942413|NCT01307423|157618655|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
48942414|NCT01307423|157618656|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
48942415|NCT01307423|157618657|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
48942416|NCT01307423|157618658|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
48942417|NCT01307423|157618659|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
48942418|NCT01307423|157618660|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
48942419|NCT01307423|157618661|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
48942420|NCT01307423|157618662|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
48942421|NCT01307423|157618654|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
48942422|NCT01307423|157618655|FG001|Long-term Safety Phase (Year 4)|Adverse Event|2|||
48942423|NCT01307423|157618656|FG002|Long-term Safety Phase (Year 4)|Adverse Event|0|||
48942424|NCT01307423|157618657|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
48942425|NCT01307423|157618658|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
48942426|NCT01307423|157618659|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
48942427|NCT01307423|157618660|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
48942428|NCT01307423|157618661|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
48942429|NCT01307423|157618662|FG008|Long-term Safety Phase (Year 4)|Adverse Event|0|||
48942430|NCT01307423|157618654|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
48942431|NCT01307423|157618655|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
48942432|NCT01307423|157618656|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
48942433|NCT01307423|157618657|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
48942434|NCT01307423|157618658|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
48942435|NCT01307423|157618659|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
48942436|NCT01307423|157618660|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
48942437|NCT01307423|157618661|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
48942438|NCT01307423|157618662|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
48942439|NCT01307423|157618654|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
48942440|NCT01307423|157618655|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5|||
48942441|NCT01307423|157618656|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
48942442|NCT01307423|157618657|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
48942443|NCT01307423|157618658|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
48942444|NCT01307423|157618659|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
48849258|NCT00774397|157288771|FG000|Overall Study|Other than those stated above|1|||
48849259|NCT00774397|157288772|FG001|Overall Study|Other than those stated above|1|||
48849260|NCT00774397|157288773|FG002|Overall Study|Other than those stated above|3|||
48849261|NCT00774397|157288774|FG003|Overall Study|Other than those stated above|2|||
48849262|NCT00774397|157288775|FG004|Overall Study|Other than those stated above|2|||
48849263|NCT00774397|157288776|FG005|Overall Study|Other than those stated above|0|||
48849264|NCT00774397|157288777|FG006|Overall Study|Other than those stated above|1|||
48849265|NCT02285270|157288778|FG000|Overall Study|Lost to Follow-up|1|||
48849266|NCT02285270|157288778|FG000|Overall Study|Physician Decision|3|||
48849267|NCT02285270|157288778|FG000|Overall Study|Determined to be ineligible|1|||
48849268|NCT02866942|157288779|FG000|Overall Study|Invalid consent|1|||
48849269|NCT03801148|157288782|FG000|Period 1 (2 Days)|Adverse Event|1|||
48849270|NCT03801148|157288783|FG001|Period 1 (2 Days)|Adverse Event|1|||
48849271|NCT03801148|157288784|FG002|Period 1 (2 Days)|Adverse Event|0|||
48849272|NCT03801148|157288785|FG003|Period 1 (2 Days)|Adverse Event|0|||
48942445|NCT01307423|157618660|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
48942446|NCT01307423|157618661|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1|||
48942447|NCT01307423|157618662|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
48942448|NCT01307423|157618654|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
48942449|NCT01307423|157618655|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
48942450|NCT01307423|157618656|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
48942451|NCT01307423|157618657|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
48942452|NCT01307423|157618658|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
48942453|NCT01307423|157618659|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
48942454|NCT01307423|157618660|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
48942455|NCT01307423|157618661|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
48942456|NCT01307423|157618662|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
48942457|NCT01307423|157618654|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
48849273|NCT03801148|157288782|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
48849274|NCT03801148|157288783|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
48849275|NCT03801148|157288784|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
48849276|NCT03801148|157288785|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|1|||
48849277|NCT03801148|157288782|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
48849278|NCT03801148|157288783|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
48849279|NCT03801148|157288784|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
48849280|NCT03801148|157288785|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
48849281|NCT03801148|157288782|FG000|Follow-Up (12 Days)|Lost to Follow-up|0|||
48849282|NCT03801148|157288783|FG001|Follow-Up (12 Days)|Lost to Follow-up|1|||
48849283|NCT03801148|157288784|FG002|Follow-Up (12 Days)|Lost to Follow-up|1|||
48849284|NCT03801148|157288785|FG003|Follow-Up (12 Days)|Lost to Follow-up|0|||
48942458|NCT01307423|157618655|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
48942459|NCT01307423|157618656|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
48942460|NCT01307423|157618657|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
48942461|NCT01307423|157618658|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
48942462|NCT01307423|157618659|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
48942463|NCT01307423|157618660|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
48942464|NCT01307423|157618661|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
48942465|NCT01307423|157618662|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
48942466|NCT01307423|157618654|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
48942467|NCT01307423|157618655|FG001|Long-term Safety Phase (Year 5)|Adverse Event|1|||
48942468|NCT01307423|157618656|FG002|Long-term Safety Phase (Year 5)|Adverse Event|1|||
48942469|NCT01307423|157618657|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
48942470|NCT01307423|157618658|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
48942471|NCT01307423|157618659|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
48942472|NCT01307423|157618660|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
48942473|NCT01307423|157618661|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
48942474|NCT01307423|157618662|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
48942475|NCT01307423|157618654|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
48942476|NCT01307423|157618655|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|2|||
48942477|NCT01307423|157618656|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|1|||
48942478|NCT01307423|157618657|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
48942479|NCT01307423|157618658|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
48942480|NCT01307423|157618659|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
48942481|NCT01307423|157618660|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
48942482|NCT01307423|157618661|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
48942483|NCT01307423|157618662|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
48942484|NCT01307423|157618654|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
48942485|NCT01307423|157618655|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6|||
48942486|NCT01307423|157618656|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
48942487|NCT01307423|157618657|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
48942488|NCT01307423|157618658|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
48942489|NCT01307423|157618659|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
48942490|NCT01307423|157618660|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
48942491|NCT01307423|157618661|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
48942492|NCT01307423|157618662|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
48942493|NCT01307423|157618654|FG000|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
48942494|NCT01307423|157618655|FG001|Long-term Safety Phase (Year 5)|Lost to Follow-up|1|||
48942495|NCT01307423|157618656|FG002|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
48942496|NCT01307423|157618657|FG003|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
48942497|NCT01307423|157618658|FG004|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
48942498|NCT01307423|157618659|FG005|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
48942499|NCT01307423|157618660|FG006|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
48942500|NCT01307423|157618661|FG007|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
48942501|NCT01307423|157618662|FG008|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
48942502|NCT01307423|157618654|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
48942503|NCT01307423|157618655|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
48942504|NCT01307423|157618656|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|2|||
48942505|NCT01307423|157618657|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
48942506|NCT01307423|157618658|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
48942507|NCT01307423|157618659|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
48942508|NCT01307423|157618660|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
48942509|NCT01307423|157618661|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
48942510|NCT01307423|157618662|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
48942511|NCT02318602|157618663|FG000|Overall Study|Adverse Event|0|||
48942512|NCT02318602|157618664|FG001|Overall Study|Adverse Event|1|||
48942513|NCT02318602|157618665|FG002|Overall Study|Adverse Event|1|||
48942514|NCT02318602|157618663|FG000|Overall Study|Withdrawal by Subject|0|||
48942515|NCT02318602|157618664|FG001|Overall Study|Withdrawal by Subject|3|||
48942516|NCT02318602|157618665|FG002|Overall Study|Withdrawal by Subject|0|||
48942517|NCT02318602|157618663|FG000|Overall Study|Death|1|||
48942518|NCT02318602|157618664|FG001|Overall Study|Death|0|||
48942519|NCT02318602|157618665|FG002|Overall Study|Death|0|||
48849285|NCT01268306|157288788|FG000|Overall Study|Lost to Follow-up|1|||
48849286|NCT02964741|157288795|FG000|Overall Study|Protocol Violation|1|||
48849287|NCT02964741|157288796|FG001|Overall Study|Protocol Violation|0|||
48849288|NCT02964741|157288797|FG002|Overall Study|Protocol Violation|0|||
48849289|NCT02964741|157288795|FG000|Overall Study|Withdrawal by Subject|0|||
48849290|NCT02964741|157288796|FG001|Overall Study|Withdrawal by Subject|1|||
48849291|NCT02964741|157288797|FG002|Overall Study|Withdrawal by Subject|0|||
48849292|NCT02964741|157288795|FG000|Overall Study|claustrophobia|1|||
48849293|NCT02964741|157288796|FG001|Overall Study|claustrophobia|0|||
48849294|NCT02964741|157288797|FG002|Overall Study|claustrophobia|0|||
48849295|NCT00683800|157288801|FG000|Overall Study|Adverse Event|195|||
48849296|NCT00683800|157288802|FG001|Overall Study|Adverse Event|102|||
48849297|NCT00683800|157288801|FG000|Overall Study|Death|0|||
48849298|NCT00683800|157288802|FG001|Overall Study|Death|1|||
48849299|NCT00683800|157288801|FG000|Overall Study|Lost to Follow-up|57|||
48849300|NCT00683800|157288802|FG001|Overall Study|Lost to Follow-up|44|||
48849301|NCT00683800|157288801|FG000|Overall Study|Other|5|||
48849302|NCT00683800|157288802|FG001|Overall Study|Other|2|||
48849303|NCT00683800|157288801|FG000|Overall Study|Protocol Violation|13|||
48849304|NCT00683800|157288802|FG001|Overall Study|Protocol Violation|16|||
48849305|NCT00683800|157288801|FG000|Overall Study|Withdrawal by Subject|66|||
48849306|NCT00683800|157288802|FG001|Overall Study|Withdrawal by Subject|64|||
48849307|NCT00683800|157288801|FG000|Overall Study|Lack of Efficacy|61|||
48849308|NCT00683800|157288802|FG001|Overall Study|Lack of Efficacy|104|||
48849309|NCT00683800|157288801|FG000|Overall Study|Randomized, not treated|35|||
48849310|NCT00683800|157288802|FG001|Overall Study|Randomized, not treated|33|||
48849311|NCT04679675|157288804|FG000|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|356|||
48849312|NCT04679675|157288805|FG001|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|261|||
48849313|NCT04679675|157288806|FG002|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|50|||
48849314|NCT04679675|157288807|FG003|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|210|||
48849315|NCT04679675|157288804|FG000|Overall Study|Excluded from analysis, recent disenrollment from KPWA|211|||
48849316|NCT04679675|157288805|FG001|Overall Study|Excluded from analysis, recent disenrollment from KPWA|164|||
48849317|NCT04679675|157288806|FG002|Overall Study|Excluded from analysis, recent disenrollment from KPWA|27|||
48849318|NCT04679675|157288807|FG003|Overall Study|Excluded from analysis, recent disenrollment from KPWA|137|||
48849319|NCT01359150|157288808|FG000|Overall Study|Lack of Efficacy|1|||
48849320|NCT01359150|157288809|FG001|Overall Study|Lack of Efficacy|1|||
48849321|NCT01359150|157288808|FG000|Overall Study|Withdrawal by Subject|1|||
48849322|NCT01359150|157288809|FG001|Overall Study|Withdrawal by Subject|1|||
48849323|NCT01359150|157288808|FG000|Overall Study|Adverse Event|4|||
48849324|NCT01359150|157288809|FG001|Overall Study|Adverse Event|3|||
48849325|NCT01359150|157288808|FG000|Overall Study|Other|1|||
48849326|NCT01359150|157288809|FG001|Overall Study|Other|0|||
48849327|NCT01260896|157288810|FG000|First Intervention|Withdrawn Due to Emesis|2|||
48849328|NCT01260896|157288811|FG001|First Intervention|Withdrawn Due to Emesis|0|||
48849329|NCT01212744|157288812|FG000|Overall Study|Withdrawal by Subject|1|||
48849330|NCT01773993|157288813|FG000|Overall Study|No Visit After Treatment|35|||
48849331|NCT01968967|157288814|FG000|Treatment Period|Other|22|||
48849332|NCT01968967|157288815|FG001|Treatment Period|Other|22|||
48849333|NCT01968967|157288816|FG002|Treatment Period|Other|0|||
48849334|NCT01968967|157288817|FG003|Treatment Period|Other|0|||
48849335|NCT01968967|157288818|FG004|Treatment Period|Other|0|||
48849336|NCT01968967|157288814|FG000|Treatment Period|Withdrawal by Subject|71|||
48849337|NCT01968967|157288815|FG001|Treatment Period|Withdrawal by Subject|61|||
48849338|NCT01968967|157288816|FG002|Treatment Period|Withdrawal by Subject|0|||
48849339|NCT01968967|157288817|FG003|Treatment Period|Withdrawal by Subject|0|||
48849340|NCT01968967|157288818|FG004|Treatment Period|Withdrawal by Subject|0|||
48849341|NCT01968967|157288814|FG000|Treatment Period|Did Not Meet Entrance Criteria|2|||
48849342|NCT01968967|157288815|FG001|Treatment Period|Did Not Meet Entrance Criteria|3|||
48849343|NCT01968967|157288816|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
48849344|NCT01968967|157288817|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
48849345|NCT01968967|157288818|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
48849346|NCT01968967|157288814|FG000|Treatment Period|Lost to Follow-up|26|||
48849347|NCT01968967|157288815|FG001|Treatment Period|Lost to Follow-up|31|||
48849348|NCT01968967|157288816|FG002|Treatment Period|Lost to Follow-up|0|||
48849349|NCT01968967|157288817|FG003|Treatment Period|Lost to Follow-up|0|||
48849350|NCT01968967|157288818|FG004|Treatment Period|Lost to Follow-up|0|||
48849351|NCT01968967|157288814|FG000|Treatment Period|Protocol Violation|1|||
48849352|NCT01968967|157288815|FG001|Treatment Period|Protocol Violation|2|||
48849353|NCT01968967|157288816|FG002|Treatment Period|Protocol Violation|0|||
48849354|NCT01968967|157288817|FG003|Treatment Period|Protocol Violation|0|||
48849355|NCT01968967|157288818|FG004|Treatment Period|Protocol Violation|0|||
48849356|NCT01968967|157288814|FG000|Treatment Period|Adverse Event|9|||
48849357|NCT01968967|157288815|FG001|Treatment Period|Adverse Event|8|||
48849358|NCT01968967|157288816|FG002|Treatment Period|Adverse Event|0|||
48849359|NCT01968967|157288817|FG003|Treatment Period|Adverse Event|0|||
48942520|NCT02318602|157618663|FG000|Overall Study|Guardian decision to withdraw|0|||
48942521|NCT02318602|157618664|FG001|Overall Study|Guardian decision to withdraw|0|||
48942522|NCT02318602|157618665|FG002|Overall Study|Guardian decision to withdraw|1|||
48942523|NCT02371629|157618668|FG000|Overall Study|Patient decision|14|||
48942524|NCT02371629|157618669|FG001|Overall Study|Patient decision|10|||
48942525|NCT02371629|157618668|FG000|Overall Study|Adverse Event|8|||
48942526|NCT02371629|157618669|FG001|Overall Study|Adverse Event|8|||
48942527|NCT02371629|157618668|FG000|Overall Study|Physician Decision|2|||
48942528|NCT02371629|157618669|FG001|Overall Study|Physician Decision|3|||
48942529|NCT02371629|157618668|FG000|Overall Study|Death|1|||
48942530|NCT02371629|157618669|FG001|Overall Study|Death|1|||
48942531|NCT02371629|157618668|FG000|Overall Study|Noncompliance with study treatment|1|||
48942532|NCT02371629|157618669|FG001|Overall Study|Noncompliance with study treatment|0|||
48942533|NCT02371629|157618668|FG000|Overall Study|Lack of Efficacy|0|||
48942534|NCT02371629|157618669|FG001|Overall Study|Lack of Efficacy|2|||
48942535|NCT02371629|157618668|FG000|Overall Study|Protocol deviation|0|||
48942536|NCT02371629|157618669|FG001|Overall Study|Protocol deviation|1|||
48942537|NCT01051739|157618672|FG000|Overall Study|Death|3|||
48942538|NCT01051739|157618673|FG001|Overall Study|Death|3|||
48942539|NCT01051739|157618672|FG000|Overall Study|Withdrawal by Subject|25|||
48942540|NCT01051739|157618673|FG001|Overall Study|Withdrawal by Subject|10|||
48942541|NCT03853694|157618674|FG000|Overall Study|Protocol Violation|3|||
48942542|NCT03853694|157618675|FG001|Overall Study|Protocol Violation|5|||
48942543|NCT03853694|157618676|FG002|Overall Study|Protocol Violation|3|||
48942544|NCT03853694|157618674|FG000|Overall Study|Delivered early|0|||
48942545|NCT03853694|157618675|FG001|Overall Study|Delivered early|1|||
48942546|NCT03853694|157618676|FG002|Overall Study|Delivered early|0|||
48942547|NCT03853694|157618674|FG000|Overall Study|not suitable to proceed|0|||
48942548|NCT03853694|157618675|FG001|Overall Study|not suitable to proceed|1|||
48942549|NCT03853694|157618676|FG002|Overall Study|not suitable to proceed|0|||
48942550|NCT03853694|157618674|FG000|Overall Study|difficult surgery|0|||
48942551|NCT03853694|157618675|FG001|Overall Study|difficult surgery|0|||
48942552|NCT03853694|157618676|FG002|Overall Study|difficult surgery|1|||
48942553|NCT03853694|157618674|FG000|Overall Study|Lost to Follow-up|0|||
48942554|NCT03853694|157618675|FG001|Overall Study|Lost to Follow-up|1|||
48942555|NCT03853694|157618676|FG002|Overall Study|Lost to Follow-up|0|||
48942556|NCT03853694|157618674|FG000|Overall Study|Withdrawal by Subject|0|||
48942557|NCT03853694|157618675|FG001|Overall Study|Withdrawal by Subject|1|||
48942558|NCT03853694|157618676|FG002|Overall Study|Withdrawal by Subject|0|||
48942559|NCT00824421|157618678|FG000|Overall Study|Adverse Event|6|||
48942560|NCT00824421|157618679|FG001|Overall Study|Adverse Event|6|||
48942561|NCT00824421|157618680|FG002|Overall Study|Adverse Event|6|||
48942562|NCT00824421|157618678|FG000|Overall Study|Death|0|||
48942563|NCT00824421|157618679|FG001|Overall Study|Death|1|||
48942564|NCT00824421|157618680|FG002|Overall Study|Death|0|||
48942565|NCT00824421|157618678|FG000|Overall Study|Lack of Efficacy|5|||
48942566|NCT00824421|157618679|FG001|Overall Study|Lack of Efficacy|7|||
48942567|NCT00824421|157618680|FG002|Overall Study|Lack of Efficacy|4|||
48942568|NCT00824421|157618678|FG000|Overall Study|Lost to Follow-up|2|||
48942569|NCT00824421|157618679|FG001|Overall Study|Lost to Follow-up|3|||
48942570|NCT00824421|157618680|FG002|Overall Study|Lost to Follow-up|0|||
48942571|NCT00824421|157618678|FG000|Overall Study|Pregnancy|1|||
48942572|NCT00824421|157618679|FG001|Overall Study|Pregnancy|0|||
48942573|NCT00824421|157618680|FG002|Overall Study|Pregnancy|1|||
48942574|NCT00824421|157618678|FG000|Overall Study|Withdrawal by Subject|2|||
48942575|NCT00824421|157618679|FG001|Overall Study|Withdrawal by Subject|3|||
48942576|NCT00824421|157618680|FG002|Overall Study|Withdrawal by Subject|3|||
48942577|NCT00824421|157618678|FG000|Overall Study|Randomized but not Treated|1|||
48942578|NCT00824421|157618679|FG001|Overall Study|Randomized but not Treated|1|||
48942579|NCT00824421|157618680|FG002|Overall Study|Randomized but not Treated|0|||
48942580|NCT00824421|157618678|FG000|Overall Study|Other|0|||
48942581|NCT00824421|157618679|FG001|Overall Study|Other|1|||
48942582|NCT00824421|157618680|FG002|Overall Study|Other|0|||
48942583|NCT05089708|157618681|FG000|Overall Study|Lost to Follow-up|9|||
48942584|NCT05089708|157618682|FG001|Overall Study|Lost to Follow-up|7|||
48942585|NCT05089708|157618681|FG000|Overall Study|Withdrawal by Subject|3|||
48942586|NCT05089708|157618682|FG001|Overall Study|Withdrawal by Subject|1|||
48942587|NCT05089708|157618681|FG000|Overall Study|Non-Compliance with Investigational Product|1|||
48942588|NCT05089708|157618682|FG001|Overall Study|Non-Compliance with Investigational Product|1|||
48942589|NCT05089708|157618681|FG000|Overall Study|Withdrawal by Parent or Guardian|2|||
48942590|NCT05089708|157618682|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
48942591|NCT01173653|157618683|FG000|Overall Study|Pts unwilling to provide follow-up|53|||
48942592|NCT01173653|157618684|FG001|Overall Study|Pts unwilling to provide follow-up|41|||
48942593|NCT02120417|157618687|FG000|Overall Study|Death|5|||
48942594|NCT02120417|157618688|FG001|Overall Study|Death|1|||
48942595|NCT02120417|157618687|FG000|Overall Study|Adverse Event|3|||
48942596|NCT02120417|157618688|FG001|Overall Study|Adverse Event|9|||
48942597|NCT02120417|157618687|FG000|Overall Study|Participant decision|4|||
48942598|NCT02120417|157618688|FG001|Overall Study|Participant decision|4|||
48942599|NCT02120417|157618687|FG000|Overall Study|Disease progression|41|||
48942600|NCT02120417|157618688|FG001|Overall Study|Disease progression|45|||
48942601|NCT02120417|157618687|FG000|Overall Study|Noncompliance with study treatment|0|||
48942602|NCT02120417|157618688|FG001|Overall Study|Noncompliance with study treatment|2|||
48942603|NCT02120417|157618687|FG000|Overall Study|Physician Decision|2|||
48942604|NCT02120417|157618688|FG001|Overall Study|Physician Decision|3|||
48942605|NCT02120417|157618687|FG000|Overall Study|Other unspecified|5|||
48942606|NCT02120417|157618688|FG001|Overall Study|Other unspecified|4|||
48942607|NCT02286102|157618689|FG000|Overall Study|Screen Failure|1|||
48942608|NCT02286102|157618690|FG001|Overall Study|Screen Failure|1|||
48942609|NCT00730236|157618692|FG000|Overall Study|Adverse Event|4|||
48942610|NCT00730236|157618692|FG000|Overall Study|Withdrawal by Subject|1|||
48942611|NCT00730236|157618692|FG000|Overall Study|Non-compliance|1|||
48942612|NCT00479466|157618693|FG000|Overall Study|Adverse Event|5|||
48942613|NCT00479466|157618694|FG001|Overall Study|Adverse Event|1|||
48942614|NCT00479466|157618695|FG002|Overall Study|Adverse Event|0|||
48942615|NCT00479466|157618696|FG003|Overall Study|Adverse Event|1|||
48942616|NCT00479466|157618697|FG004|Overall Study|Adverse Event|2|||
48942617|NCT00479466|157618698|FG005|Overall Study|Adverse Event|0|||
48942618|NCT00479466|157618693|FG000|Overall Study|Hyperglycemia|0|||
48942619|NCT00479466|157618694|FG001|Overall Study|Hyperglycemia|0|||
48942620|NCT00479466|157618695|FG002|Overall Study|Hyperglycemia|0|||
48942621|NCT00479466|157618696|FG003|Overall Study|Hyperglycemia|0|||
48942622|NCT00479466|157618697|FG004|Overall Study|Hyperglycemia|0|||
48942623|NCT00479466|157618698|FG005|Overall Study|Hyperglycemia|1|||
48942624|NCT00479466|157618693|FG000|Overall Study|Lack of Efficacy|2|||
48942625|NCT00479466|157618694|FG001|Overall Study|Lack of Efficacy|0|||
48942626|NCT00479466|157618695|FG002|Overall Study|Lack of Efficacy|1|||
48942627|NCT00479466|157618696|FG003|Overall Study|Lack of Efficacy|0|||
48942628|NCT00479466|157618697|FG004|Overall Study|Lack of Efficacy|0|||
48942629|NCT00479466|157618698|FG005|Overall Study|Lack of Efficacy|0|||
48942630|NCT00479466|157618693|FG000|Overall Study|Lost to Follow-up|0|||
48942631|NCT00479466|157618694|FG001|Overall Study|Lost to Follow-up|1|||
48942632|NCT00479466|157618695|FG002|Overall Study|Lost to Follow-up|1|||
48942633|NCT00479466|157618696|FG003|Overall Study|Lost to Follow-up|0|||
48942634|NCT00479466|157618697|FG004|Overall Study|Lost to Follow-up|2|||
48942635|NCT00479466|157618698|FG005|Overall Study|Lost to Follow-up|2|||
48849360|NCT01968967|157288818|FG004|Treatment Period|Adverse Event|0|||
48849361|NCT01968967|157288814|FG000|Treatment Period|Death|9|||
48849362|NCT01968967|157288815|FG001|Treatment Period|Death|2|||
48849363|NCT01968967|157288816|FG002|Treatment Period|Death|0|||
48849364|NCT01968967|157288817|FG003|Treatment Period|Death|0|||
48849365|NCT01968967|157288818|FG004|Treatment Period|Death|0|||
48849366|NCT01968967|157288814|FG000|Treatment Period|Randomized Not Treated|6|||
48849367|NCT01968967|157288815|FG001|Treatment Period|Randomized Not Treated|5|||
48849368|NCT01968967|157288816|FG002|Treatment Period|Randomized Not Treated|0|||
48849369|NCT01968967|157288817|FG003|Treatment Period|Randomized Not Treated|0|||
48849370|NCT01968967|157288818|FG004|Treatment Period|Randomized Not Treated|0|||
48849371|NCT01968967|157288814|FG000|Extension Period|Withdrew Consent|0|||
48849372|NCT01968967|157288815|FG001|Extension Period|Withdrew Consent|0|||
48849373|NCT01968967|157288816|FG002|Extension Period|Withdrew Consent|2|||
48849374|NCT01968967|157288817|FG003|Extension Period|Withdrew Consent|0|||
48849375|NCT01968967|157288818|FG004|Extension Period|Withdrew Consent|5|||
48849376|NCT02284113|157288825|FG000|Overall Study|Adverse Event|1|||
48849377|NCT02284113|157288826|FG001|Overall Study|Adverse Event|0|||
48849378|NCT02284113|157288825|FG000|Overall Study|non-compliance|0|||
48849379|NCT02284113|157288826|FG001|Overall Study|non-compliance|1|||
48849380|NCT02284113|157288825|FG000|Overall Study|Withdrawal by Subject|0|||
48849381|NCT02284113|157288826|FG001|Overall Study|Withdrawal by Subject|1|||
48849382|NCT02284113|157288825|FG000|Overall Study|not provided|0|||
48849383|NCT02284113|157288826|FG001|Overall Study|not provided|1|||
48849384|NCT02284113|157288825|FG000|Overall Study|surgery cancelled|2|||
48849385|NCT02284113|157288826|FG001|Overall Study|surgery cancelled|0|||
48849386|NCT01953692|157288827|FG000|Overall Study|Adverse Event|5|||
48849387|NCT01953692|157288828|FG001|Overall Study|Adverse Event|2|||
48849388|NCT01953692|157288829|FG002|Overall Study|Adverse Event|4|||
48849389|NCT01953692|157288830|FG003|Overall Study|Adverse Event|2|||
48849390|NCT01953692|157288831|FG004|Overall Study|Adverse Event|1|||
48849391|NCT01953692|157288832|FG005|Overall Study|Adverse Event|2|||
48849392|NCT01953692|157288833|FG006|Overall Study|Adverse Event|0|||
48849393|NCT01953692|157288834|FG007|Overall Study|Adverse Event|0|||
48849394|NCT01953692|157288835|FG008|Overall Study|Adverse Event|0|||
48849395|NCT01953692|157288827|FG000|Overall Study|Clinical Progression|0|||
48942636|NCT00479466|157618693|FG000|Overall Study|Physician Decision|2|||
48849396|NCT01953692|157288828|FG001|Overall Study|Clinical Progression|15|||
48942637|NCT00479466|157618694|FG001|Overall Study|Physician Decision|1|||
48942638|NCT00479466|157618695|FG002|Overall Study|Physician Decision|1|||
48942639|NCT00479466|157618696|FG003|Overall Study|Physician Decision|0|||
48942640|NCT00479466|157618697|FG004|Overall Study|Physician Decision|0|||
48942641|NCT00479466|157618698|FG005|Overall Study|Physician Decision|0|||
48942642|NCT00479466|157618693|FG000|Overall Study|Pregnancy|0|||
48942643|NCT00479466|157618694|FG001|Overall Study|Pregnancy|0|||
48942644|NCT00479466|157618695|FG002|Overall Study|Pregnancy|0|||
48942645|NCT00479466|157618696|FG003|Overall Study|Pregnancy|0|||
48942646|NCT00479466|157618697|FG004|Overall Study|Pregnancy|1|||
48942647|NCT00479466|157618698|FG005|Overall Study|Pregnancy|0|||
48942648|NCT00479466|157618693|FG000|Overall Study|Protocol Violation|1|||
48942649|NCT00479466|157618694|FG001|Overall Study|Protocol Violation|0|||
48942650|NCT00479466|157618695|FG002|Overall Study|Protocol Violation|0|||
48942651|NCT00479466|157618696|FG003|Overall Study|Protocol Violation|0|||
48942652|NCT00479466|157618697|FG004|Overall Study|Protocol Violation|0|||
48942653|NCT00479466|157618698|FG005|Overall Study|Protocol Violation|0|||
48942654|NCT00479466|157618693|FG000|Overall Study|Withdrawal by Subject|3|||
48942655|NCT00479466|157618694|FG001|Overall Study|Withdrawal by Subject|5|||
48942656|NCT00479466|157618695|FG002|Overall Study|Withdrawal by Subject|0|||
48942657|NCT00479466|157618696|FG003|Overall Study|Withdrawal by Subject|2|||
48942658|NCT00479466|157618697|FG004|Overall Study|Withdrawal by Subject|3|||
48942659|NCT00479466|157618698|FG005|Overall Study|Withdrawal by Subject|1|||
48942660|NCT01772134|157618699|FG000|Overall Study|Adverse Event|6|||
48942661|NCT01772134|157618700|FG001|Overall Study|Adverse Event|5|||
48942662|NCT01772134|157618701|FG002|Overall Study|Adverse Event|10|||
48942663|NCT01772134|157618699|FG000|Overall Study|Withdrew Consent|3|||
48942664|NCT01772134|157618700|FG001|Overall Study|Withdrew Consent|1|||
48942665|NCT01772134|157618701|FG002|Overall Study|Withdrew Consent|5|||
48942666|NCT01772134|157618699|FG000|Overall Study|Lost to Follow-up|2|||
48942667|NCT01772134|157618700|FG001|Overall Study|Lost to Follow-up|0|||
48942668|NCT01772134|157618701|FG002|Overall Study|Lost to Follow-up|0|||
48942669|NCT01772134|157618699|FG000|Overall Study|Protocol Deviation|4|||
48942670|NCT01772134|157618700|FG001|Overall Study|Protocol Deviation|3|||
48942671|NCT01772134|157618701|FG002|Overall Study|Protocol Deviation|3|||
48942672|NCT01772134|157618699|FG000|Overall Study|Lack of Efficacy|11|||
48942673|NCT01772134|157618700|FG001|Overall Study|Lack of Efficacy|5|||
48942674|NCT01772134|157618701|FG002|Overall Study|Lack of Efficacy|3|||
48942675|NCT01772134|157618699|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
48942676|NCT01772134|157618700|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
48942677|NCT01772134|157618701|FG002|Overall Study|Protocol-defined Stopping Criteria|0|||
48942678|NCT01772134|157618699|FG000|Overall Study|Randomized Study Medication Not Received|2|||
48942679|NCT01772134|157618700|FG001|Overall Study|Randomized Study Medication Not Received|0|||
48942680|NCT01772134|157618701|FG002|Overall Study|Randomized Study Medication Not Received|1|||
48942681|NCT02500550|157618702|FG000|Overall Study|Death|7|||
48942682|NCT03830281|157618703|FG000|Lead-in Period (2 Weeks)|Adverse Event|2|||
48942683|NCT03830281|157618704|FG001|Lead-in Period (2 Weeks)|Adverse Event|0|||
48942684|NCT03830281|157618703|FG000|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6|||
48942685|NCT03830281|157618704|FG001|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0|||
48942686|NCT03830281|157618703|FG000|Lead-in Period (2 Weeks)|Physician Decision|2|||
48942687|NCT03830281|157618704|FG001|Lead-in Period (2 Weeks)|Physician Decision|0|||
48942688|NCT03830281|157618703|FG000|Lead-in Period (2 Weeks)|Withdrawal by Subject|29|||
48942689|NCT03830281|157618704|FG001|Lead-in Period (2 Weeks)|Withdrawal by Subject|0|||
48942690|NCT03830281|157618703|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
48942691|NCT03830281|157618704|FG001|Treatment Period (16 Weeks)|Adverse Event|7|||
48942692|NCT03830281|157618703|FG000|Treatment Period (16 Weeks)|Lost to Follow-up|4|||
48942693|NCT03830281|157618704|FG001|Treatment Period (16 Weeks)|Lost to Follow-up|3|||
48942694|NCT03830281|157618703|FG000|Treatment Period (16 Weeks)|Sponsor Decision|1|||
48942695|NCT03830281|157618704|FG001|Treatment Period (16 Weeks)|Sponsor Decision|1|||
48942696|NCT03830281|157618703|FG000|Treatment Period (16 Weeks)|Physician Decision|1|||
48942697|NCT03830281|157618704|FG001|Treatment Period (16 Weeks)|Physician Decision|0|||
48942698|NCT03830281|157618703|FG000|Treatment Period (16 Weeks)|Withdrawal by Subject|5|||
48942699|NCT03830281|157618704|FG001|Treatment Period (16 Weeks)|Withdrawal by Subject|6|||
48942700|NCT00594399|157618705|FG000|Initial 3 Month Counseling|Not ready to exercise|1|||
48942701|NCT00594399|157618706|FG001|Initial 3 Month Counseling|Not ready to exercise|0|||
48942702|NCT00594399|157618707|FG002|Initial 3 Month Counseling|Not ready to exercise|0|||
48942703|NCT00594399|157618705|FG000|Initial 3 Month Counseling|Lack of Interest|3|||
48942704|NCT00594399|157618706|FG001|Initial 3 Month Counseling|Lack of Interest|3|||
48942705|NCT00594399|157618707|FG002|Initial 3 Month Counseling|Lack of Interest|0|||
48942706|NCT00594399|157618705|FG000|Initial 3 Month Counseling|Personal issues|2|||
48942707|NCT00594399|157618706|FG001|Initial 3 Month Counseling|Personal issues|0|||
48942708|NCT00594399|157618707|FG002|Initial 3 Month Counseling|Personal issues|0|||
48942709|NCT00594399|157618705|FG000|Initial 3 Month Counseling|Too busy|7|||
48942710|NCT00594399|157618706|FG001|Initial 3 Month Counseling|Too busy|1|||
48942711|NCT00594399|157618707|FG002|Initial 3 Month Counseling|Too busy|0|||
48942712|NCT00594399|157618705|FG000|Initial 3 Month Counseling|Pain|2|||
48942713|NCT00594399|157618706|FG001|Initial 3 Month Counseling|Pain|0|||
48942714|NCT00594399|157618707|FG002|Initial 3 Month Counseling|Pain|0|||
48942715|NCT00594399|157618705|FG000|Initial 3 Month Counseling|Moved|1|||
48942716|NCT00594399|157618706|FG001|Initial 3 Month Counseling|Moved|0|||
48942717|NCT00594399|157618707|FG002|Initial 3 Month Counseling|Moved|0|||
48942718|NCT00594399|157618705|FG000|Initial 3 Month Counseling|Family illness|1|||
48942719|NCT00594399|157618706|FG001|Initial 3 Month Counseling|Family illness|0|||
48942720|NCT00594399|157618707|FG002|Initial 3 Month Counseling|Family illness|0|||
48942721|NCT00594399|157618705|FG000|Rerandomization Arm 1 Only|Death|2|||
48942722|NCT00594399|157618706|FG001|Rerandomization Arm 1 Only|Death|1|||
48942723|NCT00594399|157618707|FG002|Rerandomization Arm 1 Only|Death|0|||
48942724|NCT00594399|157618705|FG000|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
48942725|NCT00594399|157618706|FG001|Rerandomization Arm 1 Only|Withdrawal by Subject|3|||
48942726|NCT00594399|157618707|FG002|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
48942727|NCT01440101|157618708|FG000|Overall Study|Adverse Event|2|||
48942728|NCT01440101|157618709|FG001|Overall Study|Adverse Event|0|||
48942729|NCT01440101|157618710|FG002|Overall Study|Adverse Event|0|||
48942730|NCT01440101|157618708|FG000|Overall Study|Withdrawal by Subject|0|||
48942731|NCT01440101|157618709|FG001|Overall Study|Withdrawal by Subject|3|||
48942732|NCT01440101|157618710|FG002|Overall Study|Withdrawal by Subject|1|||
48942733|NCT01440101|157618708|FG000|Overall Study|Other|0|||
48942734|NCT01440101|157618709|FG001|Overall Study|Other|1|||
48942735|NCT01440101|157618710|FG002|Overall Study|Other|0|||
48942736|NCT00201851|157618712|FG000|Overall Study|Lost to Follow-up|2|||
48942737|NCT00201851|157618713|FG001|Overall Study|Lost to Follow-up|1|||
48942738|NCT00201851|157618714|FG002|Overall Study|Lost to Follow-up|0|||
48942739|NCT00201851|157618712|FG000|Overall Study|Ineligible post enrollment|6|||
48942740|NCT00201851|157618713|FG001|Overall Study|Ineligible post enrollment|1|||
48942741|NCT00201851|157618714|FG002|Overall Study|Ineligible post enrollment|1|||
48942742|NCT00636818|157618715|FG000|Overall Study|Adverse Event|1|||
48942743|NCT00636818|157618715|FG000|Overall Study|Lost to Follow-up|2|||
48942744|NCT00636818|157618715|FG000|Overall Study|Entry Criteria Exclusion|3|||
48942745|NCT00636818|157618715|FG000|Overall Study|Protocol Violation|1|||
48942746|NCT00636818|157618715|FG000|Overall Study|Withdrawal by Subject|4|||
48942747|NCT01491945|157618716|FG000|Overall Study|Death|30|||
48942748|NCT01491945|157618716|FG000|Overall Study|Withdrwan/LTF|16|||
48942749|NCT01491945|157618716|FG000|Overall Study|Conversion|4|||
48942750|NCT01491945|157618716|FG000|Overall Study|Missed Visit|1|||
48942751|NCT01499576|157618717|FG000|Overall Study|Physician Decision|12|||
48942752|NCT01499576|157618717|FG000|Overall Study|Withdrawal by Subject|9|||
48942753|NCT04246047|157618718|FG000|Overall Study|Death|50|||
48942754|NCT04246047|157618719|FG001|Overall Study|Death|77|||
48942755|NCT04246047|157618718|FG000|Overall Study|Lost to Follow-up|1|||
48942756|NCT04246047|157618719|FG001|Overall Study|Lost to Follow-up|3|||
48942757|NCT04246047|157618718|FG000|Overall Study|Physician Decision|4|||
48942758|NCT04246047|157618719|FG001|Overall Study|Physician Decision|10|||
48942759|NCT04246047|157618718|FG000|Overall Study|Withdrawal by Subject|19|||
48942760|NCT04246047|157618719|FG001|Overall Study|Withdrawal by Subject|26|||
48942761|NCT04246047|157618718|FG000|Overall Study|Ongoing|169|||
48942762|NCT04246047|157618719|FG001|Overall Study|Ongoing|135|||
48942763|NCT00246259|157618728|FG000|Overall Study|Other|3|||
48942764|NCT00246259|157618729|FG001|Overall Study|Other|3|||
48942765|NCT00246259|157618728|FG000|Overall Study|Not stable by Week 18|2|||
48942766|NCT00246259|157618729|FG001|Overall Study|Not stable by Week 18|1|||
48942767|NCT00246259|157618728|FG000|Overall Study|Participant non-compliant|4|||
48942768|NCT00246259|157618729|FG001|Overall Study|Participant non-compliant|9|||
48942769|NCT00246259|157618728|FG000|Overall Study|Lack of Efficacy|2|||
48942770|NCT00246259|157618729|FG001|Overall Study|Lack of Efficacy|2|||
48942771|NCT00246259|157618728|FG000|Overall Study|Investigator withdrew participant|2|||
48942772|NCT00246259|157618729|FG001|Overall Study|Investigator withdrew participant|0|||
48942773|NCT00246259|157618728|FG000|Overall Study|Adverse Event|5|||
48942774|NCT00246259|157618729|FG001|Overall Study|Adverse Event|0|||
48942775|NCT00246259|157618728|FG000|Overall Study|Lost to Follow-up|3|||
48942776|NCT00246259|157618729|FG001|Overall Study|Lost to Follow-up|4|||
48942777|NCT00246259|157618728|FG000|Overall Study|Withdrawal by Subject|5|||
48942778|NCT00246259|157618729|FG001|Overall Study|Withdrawal by Subject|1|||
48942779|NCT00246259|157618728|FG000|Overall Study|randomly assigned, not eligible for ITT|2|||
48942780|NCT00246259|157618729|FG001|Overall Study|randomly assigned, not eligible for ITT|6|||
48942781|NCT03517436|157618732|FG000|Overall Study|Death|3|||
48942782|NCT03517436|157618732|FG000|Overall Study|Withdrawal by Subject|4|||
48942783|NCT03517436|157618732|FG000|Overall Study|Did not receive study valve.|1|||
48942784|NCT03567187|157618733|FG000|Overall Study|Lost to Follow-up|18|||
48942785|NCT00752986|157618734|FG000|Overall Study|Withdrawal by Subject|2|||
48942786|NCT00752986|157618735|FG001|Overall Study|Withdrawal by Subject|1|||
48942787|NCT00752986|157618736|FG002|Overall Study|Withdrawal by Subject|2|||
48942788|NCT00752986|157618734|FG000|Overall Study|Protocol Violation|3|||
48942789|NCT00752986|157618735|FG001|Overall Study|Protocol Violation|0|||
48942790|NCT00752986|157618736|FG002|Overall Study|Protocol Violation|0|||
48942791|NCT01687673|157618738|FG000|Overall Study|Physician Decision|1|||
48942792|NCT02732951|157620827|FG000|Overall Study|Other than listed|1|||
48735669|NCT02840721|156883710|FG000|Follow-Up|Withdrawal of Consent|2|||
48735670|NCT00722800|156883718|FG000|Overall Study|Withdrawal by Subject|1|||
48735671|NCT00722800|156883719|FG001|Overall Study|Withdrawal by Subject|0|||
48735672|NCT00722800|156883718|FG000|Overall Study|Physician Decision|1|||
48735673|NCT00722800|156883719|FG001|Overall Study|Physician Decision|0|||
48735674|NCT00347360|156883720|FG000|Overall Study|Adverse Event|1|||
48735675|NCT00347360|156883721|FG001|Overall Study|Adverse Event|2|||
48735676|NCT00347360|156883722|FG002|Overall Study|Adverse Event|0|||
48735677|NCT00347360|156883723|FG003|Overall Study|Adverse Event|4|||
48735678|NCT00347360|156883724|FG004|Overall Study|Adverse Event|1|||
48735679|NCT00347360|156883725|FG005|Overall Study|Adverse Event|2|||
48735680|NCT00347360|156883726|FG006|Overall Study|Adverse Event|2|||
48735681|NCT00347360|156883727|FG007|Overall Study|Adverse Event|0|||
48735682|NCT00347360|156883728|FG008|Overall Study|Adverse Event|2|||
48735683|NCT00347360|156883729|FG009|Overall Study|Adverse Event|3|||
48735684|NCT00347360|156883730|FG010|Overall Study|Adverse Event|3|||
48735685|NCT00347360|156883731|FG011|Overall Study|Adverse Event|1|||
48735686|NCT00347360|156883732|FG012|Overall Study|Adverse Event|3|||
48735687|NCT00347360|156883733|FG013|Overall Study|Adverse Event|2|||
48735688|NCT00347360|156883734|FG014|Overall Study|Adverse Event|2|||
48735689|NCT00347360|156883720|FG000|Overall Study|Lost to Follow-up|0|||
48735690|NCT00347360|156883721|FG001|Overall Study|Lost to Follow-up|0|||
48735691|NCT00347360|156883722|FG002|Overall Study|Lost to Follow-up|0|||
48735692|NCT00347360|156883723|FG003|Overall Study|Lost to Follow-up|2|||
48735693|NCT00347360|156883724|FG004|Overall Study|Lost to Follow-up|1|||
48735694|NCT00347360|156883725|FG005|Overall Study|Lost to Follow-up|1|||
48735695|NCT00347360|156883726|FG006|Overall Study|Lost to Follow-up|0|||
48735696|NCT00347360|156883727|FG007|Overall Study|Lost to Follow-up|1|||
48735697|NCT00347360|156883728|FG008|Overall Study|Lost to Follow-up|1|||
48735698|NCT00347360|156883729|FG009|Overall Study|Lost to Follow-up|2|||
48735699|NCT00347360|156883730|FG010|Overall Study|Lost to Follow-up|0|||
48735700|NCT00347360|156883731|FG011|Overall Study|Lost to Follow-up|0|||
48735701|NCT00347360|156883732|FG012|Overall Study|Lost to Follow-up|1|||
48735702|NCT00347360|156883733|FG013|Overall Study|Lost to Follow-up|0|||
48735703|NCT00347360|156883734|FG014|Overall Study|Lost to Follow-up|0|||
48735704|NCT00347360|156883720|FG000|Overall Study|Protocol Violation|2|||
48735705|NCT00347360|156883721|FG001|Overall Study|Protocol Violation|3|||
48735706|NCT00347360|156883722|FG002|Overall Study|Protocol Violation|1|||
48735707|NCT00347360|156883723|FG003|Overall Study|Protocol Violation|2|||
48735708|NCT00347360|156883724|FG004|Overall Study|Protocol Violation|1|||
48735709|NCT00347360|156883725|FG005|Overall Study|Protocol Violation|2|||
48735710|NCT00347360|156883726|FG006|Overall Study|Protocol Violation|0|||
48735711|NCT00347360|156883727|FG007|Overall Study|Protocol Violation|0|||
48735712|NCT00347360|156883728|FG008|Overall Study|Protocol Violation|1|||
48735713|NCT00347360|156883729|FG009|Overall Study|Protocol Violation|2|||
48735714|NCT00347360|156883730|FG010|Overall Study|Protocol Violation|0|||
48735715|NCT00347360|156883731|FG011|Overall Study|Protocol Violation|0|||
48735716|NCT00347360|156883732|FG012|Overall Study|Protocol Violation|0|||
48735717|NCT00347360|156883733|FG013|Overall Study|Protocol Violation|1|||
48735718|NCT00347360|156883734|FG014|Overall Study|Protocol Violation|0|||
48735719|NCT00347360|156883720|FG000|Overall Study|Withdrawal by Subject|0|||
48735720|NCT00347360|156883721|FG001|Overall Study|Withdrawal by Subject|1|||
48735721|NCT00347360|156883722|FG002|Overall Study|Withdrawal by Subject|2|||
48735722|NCT00347360|156883723|FG003|Overall Study|Withdrawal by Subject|4|||
48735723|NCT00347360|156883724|FG004|Overall Study|Withdrawal by Subject|1|||
48735724|NCT00347360|156883725|FG005|Overall Study|Withdrawal by Subject|2|||
48735725|NCT00347360|156883726|FG006|Overall Study|Withdrawal by Subject|1|||
48735726|NCT00347360|156883727|FG007|Overall Study|Withdrawal by Subject|1|||
48735727|NCT00347360|156883728|FG008|Overall Study|Withdrawal by Subject|1|||
48735728|NCT00347360|156883729|FG009|Overall Study|Withdrawal by Subject|1|||
48735729|NCT00347360|156883730|FG010|Overall Study|Withdrawal by Subject|0|||
48735730|NCT00347360|156883731|FG011|Overall Study|Withdrawal by Subject|3|||
48735731|NCT00347360|156883732|FG012|Overall Study|Withdrawal by Subject|4|||
48735732|NCT00347360|156883733|FG013|Overall Study|Withdrawal by Subject|2|||
48735733|NCT00347360|156883734|FG014|Overall Study|Withdrawal by Subject|1|||
48942793|NCT02732951|157620828|FG001|Overall Study|Other than listed|0|||
48942794|NCT02732951|157620827|FG000|Overall Study|Lost to Follow-up|0|||
48735734|NCT00347360|156883720|FG000|Overall Study|Lack of Efficacy|1|||
48735735|NCT00347360|156883721|FG001|Overall Study|Lack of Efficacy|1|||
48735736|NCT00347360|156883722|FG002|Overall Study|Lack of Efficacy|3|||
48735737|NCT00347360|156883723|FG003|Overall Study|Lack of Efficacy|1|||
48735738|NCT00347360|156883724|FG004|Overall Study|Lack of Efficacy|0|||
48735739|NCT00347360|156883725|FG005|Overall Study|Lack of Efficacy|1|||
48735740|NCT00347360|156883726|FG006|Overall Study|Lack of Efficacy|0|||
48735741|NCT00347360|156883727|FG007|Overall Study|Lack of Efficacy|1|||
48735742|NCT00347360|156883728|FG008|Overall Study|Lack of Efficacy|1|||
48735743|NCT00347360|156883729|FG009|Overall Study|Lack of Efficacy|0|||
48735744|NCT00347360|156883730|FG010|Overall Study|Lack of Efficacy|0|||
48735745|NCT00347360|156883731|FG011|Overall Study|Lack of Efficacy|0|||
48735746|NCT00347360|156883732|FG012|Overall Study|Lack of Efficacy|0|||
48735747|NCT00347360|156883733|FG013|Overall Study|Lack of Efficacy|0|||
48735748|NCT00347360|156883734|FG014|Overall Study|Lack of Efficacy|0|||
48735749|NCT00347360|156883720|FG000|Overall Study|Reason not listed/blank|1|||
48735750|NCT00347360|156883721|FG001|Overall Study|Reason not listed/blank|0|||
48735751|NCT00347360|156883722|FG002|Overall Study|Reason not listed/blank|0|||
48735752|NCT00347360|156883723|FG003|Overall Study|Reason not listed/blank|0|||
48735753|NCT00347360|156883724|FG004|Overall Study|Reason not listed/blank|0|||
48735754|NCT00347360|156883725|FG005|Overall Study|Reason not listed/blank|0|||
48735755|NCT00347360|156883726|FG006|Overall Study|Reason not listed/blank|1|||
48735756|NCT00347360|156883727|FG007|Overall Study|Reason not listed/blank|0|||
48735757|NCT00347360|156883728|FG008|Overall Study|Reason not listed/blank|0|||
48735758|NCT00347360|156883729|FG009|Overall Study|Reason not listed/blank|0|||
48735759|NCT00347360|156883730|FG010|Overall Study|Reason not listed/blank|0|||
48735760|NCT00347360|156883731|FG011|Overall Study|Reason not listed/blank|0|||
48735761|NCT00347360|156883732|FG012|Overall Study|Reason not listed/blank|0|||
48735762|NCT00347360|156883733|FG013|Overall Study|Reason not listed/blank|1|||
48735763|NCT00347360|156883734|FG014|Overall Study|Reason not listed/blank|0|||
48735764|NCT00347360|156883720|FG000|Overall Study|Per sponsors instruction|0|||
48735765|NCT00347360|156883721|FG001|Overall Study|Per sponsors instruction|1|||
48735766|NCT00347360|156883722|FG002|Overall Study|Per sponsors instruction|0|||
48735767|NCT00347360|156883723|FG003|Overall Study|Per sponsors instruction|0|||
48735768|NCT00347360|156883724|FG004|Overall Study|Per sponsors instruction|0|||
48735769|NCT00347360|156883725|FG005|Overall Study|Per sponsors instruction|0|||
48735770|NCT00347360|156883726|FG006|Overall Study|Per sponsors instruction|0|||
48735771|NCT00347360|156883727|FG007|Overall Study|Per sponsors instruction|0|||
48735772|NCT00347360|156883728|FG008|Overall Study|Per sponsors instruction|0|||
48735773|NCT00347360|156883729|FG009|Overall Study|Per sponsors instruction|0|||
48735774|NCT00347360|156883730|FG010|Overall Study|Per sponsors instruction|0|||
48735775|NCT00347360|156883731|FG011|Overall Study|Per sponsors instruction|0|||
48735776|NCT00347360|156883732|FG012|Overall Study|Per sponsors instruction|0|||
48735777|NCT00347360|156883733|FG013|Overall Study|Per sponsors instruction|0|||
48735778|NCT00347360|156883734|FG014|Overall Study|Per sponsors instruction|0|||
48735779|NCT00347360|156883720|FG000|Overall Study|P.I. recommended due to blood pressure|0|||
48735780|NCT00347360|156883721|FG001|Overall Study|P.I. recommended due to blood pressure|0|||
48735781|NCT00347360|156883722|FG002|Overall Study|P.I. recommended due to blood pressure|0|||
48735782|NCT00347360|156883723|FG003|Overall Study|P.I. recommended due to blood pressure|0|||
48735783|NCT00347360|156883724|FG004|Overall Study|P.I. recommended due to blood pressure|1|||
48735784|NCT00347360|156883725|FG005|Overall Study|P.I. recommended due to blood pressure|0|||
48735785|NCT00347360|156883726|FG006|Overall Study|P.I. recommended due to blood pressure|0|||
48735786|NCT00347360|156883727|FG007|Overall Study|P.I. recommended due to blood pressure|0|||
48735787|NCT00347360|156883728|FG008|Overall Study|P.I. recommended due to blood pressure|0|||
48735788|NCT00347360|156883729|FG009|Overall Study|P.I. recommended due to blood pressure|0|||
48735789|NCT00347360|156883730|FG010|Overall Study|P.I. recommended due to blood pressure|0|||
48735790|NCT00347360|156883731|FG011|Overall Study|P.I. recommended due to blood pressure|0|||
48735791|NCT00347360|156883732|FG012|Overall Study|P.I. recommended due to blood pressure|0|||
48735792|NCT00347360|156883733|FG013|Overall Study|P.I. recommended due to blood pressure|0|||
48735793|NCT00347360|156883734|FG014|Overall Study|P.I. recommended due to blood pressure|0|||
48735794|NCT00347360|156883720|FG000|Overall Study|Subject did not meet end of study ABPM|0|||
48735795|NCT00347360|156883721|FG001|Overall Study|Subject did not meet end of study ABPM|0|||
48735796|NCT00347360|156883722|FG002|Overall Study|Subject did not meet end of study ABPM|0|||
48735797|NCT00347360|156883723|FG003|Overall Study|Subject did not meet end of study ABPM|0|||
48735798|NCT00347360|156883724|FG004|Overall Study|Subject did not meet end of study ABPM|0|||
48735799|NCT00347360|156883725|FG005|Overall Study|Subject did not meet end of study ABPM|0|||
48735800|NCT00347360|156883726|FG006|Overall Study|Subject did not meet end of study ABPM|1|||
48735801|NCT00347360|156883727|FG007|Overall Study|Subject did not meet end of study ABPM|0|||
48735802|NCT00347360|156883728|FG008|Overall Study|Subject did not meet end of study ABPM|0|||
48735803|NCT00347360|156883729|FG009|Overall Study|Subject did not meet end of study ABPM|0|||
48735804|NCT00347360|156883730|FG010|Overall Study|Subject did not meet end of study ABPM|1|||
48735805|NCT00347360|156883731|FG011|Overall Study|Subject did not meet end of study ABPM|0|||
48735806|NCT00347360|156883732|FG012|Overall Study|Subject did not meet end of study ABPM|1|||
48735807|NCT00347360|156883733|FG013|Overall Study|Subject did not meet end of study ABPM|1|||
48735808|NCT00347360|156883734|FG014|Overall Study|Subject did not meet end of study ABPM|0|||
48735809|NCT00347360|156883720|FG000|Overall Study|Abnormal lab values|0|||
48735810|NCT00347360|156883721|FG001|Overall Study|Abnormal lab values|0|||
48735811|NCT00347360|156883722|FG002|Overall Study|Abnormal lab values|0|||
48735812|NCT00347360|156883723|FG003|Overall Study|Abnormal lab values|0|||
48735813|NCT00347360|156883724|FG004|Overall Study|Abnormal lab values|0|||
48735814|NCT00347360|156883725|FG005|Overall Study|Abnormal lab values|0|||
48735815|NCT00347360|156883726|FG006|Overall Study|Abnormal lab values|1|||
48735816|NCT00347360|156883727|FG007|Overall Study|Abnormal lab values|0|||
48735817|NCT00347360|156883728|FG008|Overall Study|Abnormal lab values|0|||
48735818|NCT00347360|156883729|FG009|Overall Study|Abnormal lab values|0|||
48735819|NCT00347360|156883730|FG010|Overall Study|Abnormal lab values|0|||
48735820|NCT00347360|156883731|FG011|Overall Study|Abnormal lab values|0|||
48735821|NCT00347360|156883732|FG012|Overall Study|Abnormal lab values|0|||
48735822|NCT00347360|156883733|FG013|Overall Study|Abnormal lab values|0|||
48735823|NCT00347360|156883734|FG014|Overall Study|Abnormal lab values|0|||
48735824|NCT00347360|156883720|FG000|Overall Study|PI recommended early withdrawal|0|||
48735825|NCT00347360|156883721|FG001|Overall Study|PI recommended early withdrawal|0|||
48735826|NCT00347360|156883722|FG002|Overall Study|PI recommended early withdrawal|0|||
48735827|NCT00347360|156883723|FG003|Overall Study|PI recommended early withdrawal|0|||
48735828|NCT00347360|156883724|FG004|Overall Study|PI recommended early withdrawal|0|||
48735829|NCT00347360|156883725|FG005|Overall Study|PI recommended early withdrawal|0|||
48735830|NCT00347360|156883726|FG006|Overall Study|PI recommended early withdrawal|0|||
48735831|NCT00347360|156883727|FG007|Overall Study|PI recommended early withdrawal|0|||
48735832|NCT00347360|156883728|FG008|Overall Study|PI recommended early withdrawal|0|||
48735833|NCT00347360|156883729|FG009|Overall Study|PI recommended early withdrawal|1|||
48735834|NCT00347360|156883730|FG010|Overall Study|PI recommended early withdrawal|0|||
48735835|NCT00347360|156883731|FG011|Overall Study|PI recommended early withdrawal|0|||
48735836|NCT00347360|156883732|FG012|Overall Study|PI recommended early withdrawal|0|||
48735837|NCT00347360|156883733|FG013|Overall Study|PI recommended early withdrawal|0|||
48735838|NCT00347360|156883734|FG014|Overall Study|PI recommended early withdrawal|0|||
48735839|NCT00347360|156883720|FG000|Overall Study|Did not meet criteria before ABPM|0|||
48735840|NCT00347360|156883721|FG001|Overall Study|Did not meet criteria before ABPM|0|||
48735841|NCT00347360|156883722|FG002|Overall Study|Did not meet criteria before ABPM|0|||
48735842|NCT00347360|156883723|FG003|Overall Study|Did not meet criteria before ABPM|0|||
48735843|NCT00347360|156883724|FG004|Overall Study|Did not meet criteria before ABPM|0|||
48735844|NCT00347360|156883725|FG005|Overall Study|Did not meet criteria before ABPM|0|||
48735845|NCT00347360|156883726|FG006|Overall Study|Did not meet criteria before ABPM|0|||
48735846|NCT00347360|156883727|FG007|Overall Study|Did not meet criteria before ABPM|0|||
48735847|NCT00347360|156883728|FG008|Overall Study|Did not meet criteria before ABPM|0|||
48735848|NCT00347360|156883729|FG009|Overall Study|Did not meet criteria before ABPM|0|||
48735849|NCT00347360|156883730|FG010|Overall Study|Did not meet criteria before ABPM|1|||
48735850|NCT00347360|156883731|FG011|Overall Study|Did not meet criteria before ABPM|0|||
48735851|NCT00347360|156883732|FG012|Overall Study|Did not meet criteria before ABPM|0|||
48735852|NCT00347360|156883733|FG013|Overall Study|Did not meet criteria before ABPM|0|||
48735853|NCT00347360|156883734|FG014|Overall Study|Did not meet criteria before ABPM|0|||
48735854|NCT00347360|156883720|FG000|Overall Study|Randomized in error|0|||
48735855|NCT00347360|156883721|FG001|Overall Study|Randomized in error|0|||
48735856|NCT00347360|156883722|FG002|Overall Study|Randomized in error|0|||
48735857|NCT00347360|156883723|FG003|Overall Study|Randomized in error|0|||
48735858|NCT00347360|156883724|FG004|Overall Study|Randomized in error|0|||
48735859|NCT00347360|156883725|FG005|Overall Study|Randomized in error|0|||
48735860|NCT00347360|156883726|FG006|Overall Study|Randomized in error|0|||
48735861|NCT00347360|156883727|FG007|Overall Study|Randomized in error|0|||
48735862|NCT00347360|156883728|FG008|Overall Study|Randomized in error|0|||
48735863|NCT00347360|156883729|FG009|Overall Study|Randomized in error|0|||
48735864|NCT00347360|156883730|FG010|Overall Study|Randomized in error|0|||
48849397|NCT01953692|157288829|FG002|Overall Study|Clinical Progression|7|||
48849398|NCT01953692|157288830|FG003|Overall Study|Clinical Progression|5|||
48849399|NCT01953692|157288831|FG004|Overall Study|Clinical Progression|0|||
48849400|NCT01953692|157288832|FG005|Overall Study|Clinical Progression|7|||
48849401|NCT01953692|157288833|FG006|Overall Study|Clinical Progression|20|||
48849402|NCT01953692|157288834|FG007|Overall Study|Clinical Progression|3|||
48849403|NCT01953692|157288835|FG008|Overall Study|Clinical Progression|3|||
48849404|NCT01953692|157288827|FG000|Overall Study|Death|5|||
48849405|NCT01953692|157288828|FG001|Overall Study|Death|0|||
48849406|NCT01953692|157288829|FG002|Overall Study|Death|2|||
48849407|NCT01953692|157288830|FG003|Overall Study|Death|2|||
48849408|NCT01953692|157288831|FG004|Overall Study|Death|1|||
48849409|NCT01953692|157288832|FG005|Overall Study|Death|3|||
48849410|NCT01953692|157288833|FG006|Overall Study|Death|6|||
48849411|NCT01953692|157288834|FG007|Overall Study|Death|2|||
48849412|NCT01953692|157288835|FG008|Overall Study|Death|1|||
48849413|NCT01953692|157288827|FG000|Overall Study|Excluded Medication|1|||
48849414|NCT01953692|157288828|FG001|Overall Study|Excluded Medication|0|||
48849415|NCT01953692|157288829|FG002|Overall Study|Excluded Medication|0|||
48849416|NCT01953692|157288830|FG003|Overall Study|Excluded Medication|0|||
48849417|NCT01953692|157288831|FG004|Overall Study|Excluded Medication|0|||
48849418|NCT01953692|157288832|FG005|Overall Study|Excluded Medication|0|||
48849419|NCT01953692|157288833|FG006|Overall Study|Excluded Medication|0|||
48849420|NCT01953692|157288834|FG007|Overall Study|Excluded Medication|0|||
48849421|NCT01953692|157288835|FG008|Overall Study|Excluded Medication|0|||
48849422|NCT01953692|157288827|FG000|Overall Study|Lost to Follow-up|1|||
48849423|NCT01953692|157288828|FG001|Overall Study|Lost to Follow-up|0|||
48849424|NCT01953692|157288829|FG002|Overall Study|Lost to Follow-up|3|||
48849425|NCT01953692|157288830|FG003|Overall Study|Lost to Follow-up|1|||
48849426|NCT01953692|157288831|FG004|Overall Study|Lost to Follow-up|0|||
48849427|NCT01953692|157288832|FG005|Overall Study|Lost to Follow-up|1|||
48849428|NCT01953692|157288833|FG006|Overall Study|Lost to Follow-up|0|||
48735865|NCT00347360|156883731|FG011|Overall Study|Randomized in error|1|||
48849429|NCT01953692|157288834|FG007|Overall Study|Lost to Follow-up|0|||
48849430|NCT01953692|157288835|FG008|Overall Study|Lost to Follow-up|0|||
48849431|NCT01953692|157288827|FG000|Overall Study|Physician Decision|11|||
48849432|NCT01953692|157288828|FG001|Overall Study|Physician Decision|4|||
48849433|NCT01953692|157288829|FG002|Overall Study|Physician Decision|2|||
48849434|NCT01953692|157288830|FG003|Overall Study|Physician Decision|2|||
48849435|NCT01953692|157288831|FG004|Overall Study|Physician Decision|1|||
48849436|NCT01953692|157288832|FG005|Overall Study|Physician Decision|2|||
48849437|NCT01953692|157288833|FG006|Overall Study|Physician Decision|4|||
48849438|NCT01953692|157288834|FG007|Overall Study|Physician Decision|1|||
48849439|NCT01953692|157288835|FG008|Overall Study|Physician Decision|0|||
48849440|NCT01953692|157288827|FG000|Overall Study|Protocol Violation|0|||
48849441|NCT01953692|157288828|FG001|Overall Study|Protocol Violation|2|||
48849442|NCT01953692|157288829|FG002|Overall Study|Protocol Violation|1|||
48849443|NCT01953692|157288830|FG003|Overall Study|Protocol Violation|0|||
48849444|NCT01953692|157288831|FG004|Overall Study|Protocol Violation|0|||
48849445|NCT01953692|157288832|FG005|Overall Study|Protocol Violation|0|||
48735866|NCT00347360|156883732|FG012|Overall Study|Randomized in error|0|||
48735867|NCT00347360|156883733|FG013|Overall Study|Randomized in error|0|||
48735868|NCT00347360|156883734|FG014|Overall Study|Randomized in error|0|||
48735869|NCT00347360|156883720|FG000|Overall Study|Failed inclusion criteria #4|0|||
48735870|NCT00347360|156883721|FG001|Overall Study|Failed inclusion criteria #4|0|||
48735871|NCT00347360|156883722|FG002|Overall Study|Failed inclusion criteria #4|0|||
48735872|NCT00347360|156883723|FG003|Overall Study|Failed inclusion criteria #4|0|||
48735873|NCT00347360|156883724|FG004|Overall Study|Failed inclusion criteria #4|0|||
48735874|NCT00347360|156883725|FG005|Overall Study|Failed inclusion criteria #4|0|||
48735875|NCT00347360|156883726|FG006|Overall Study|Failed inclusion criteria #4|0|||
48735876|NCT00347360|156883727|FG007|Overall Study|Failed inclusion criteria #4|0|||
48735877|NCT00347360|156883728|FG008|Overall Study|Failed inclusion criteria #4|0|||
48735878|NCT00347360|156883729|FG009|Overall Study|Failed inclusion criteria #4|0|||
48735879|NCT00347360|156883730|FG010|Overall Study|Failed inclusion criteria #4|0|||
48735880|NCT00347360|156883731|FG011|Overall Study|Failed inclusion criteria #4|1|||
48735881|NCT00347360|156883732|FG012|Overall Study|Failed inclusion criteria #4|0|||
48735882|NCT00347360|156883733|FG013|Overall Study|Failed inclusion criteria #4|0|||
48735883|NCT00347360|156883734|FG014|Overall Study|Failed inclusion criteria #4|0|||
48735884|NCT00347360|156883720|FG000|Overall Study|Prolonged duration between visits|0|||
48735885|NCT00347360|156883721|FG001|Overall Study|Prolonged duration between visits|0|||
48735886|NCT00347360|156883722|FG002|Overall Study|Prolonged duration between visits|0|||
48735887|NCT00347360|156883723|FG003|Overall Study|Prolonged duration between visits|0|||
48735888|NCT00347360|156883724|FG004|Overall Study|Prolonged duration between visits|0|||
48735889|NCT00347360|156883725|FG005|Overall Study|Prolonged duration between visits|0|||
48735890|NCT00347360|156883726|FG006|Overall Study|Prolonged duration between visits|0|||
48735891|NCT00347360|156883727|FG007|Overall Study|Prolonged duration between visits|0|||
48735892|NCT00347360|156883728|FG008|Overall Study|Prolonged duration between visits|0|||
48735893|NCT00347360|156883729|FG009|Overall Study|Prolonged duration between visits|0|||
48735894|NCT00347360|156883730|FG010|Overall Study|Prolonged duration between visits|0|||
48735895|NCT00347360|156883731|FG011|Overall Study|Prolonged duration between visits|0|||
48735896|NCT00347360|156883732|FG012|Overall Study|Prolonged duration between visits|1|||
48735897|NCT00347360|156883733|FG013|Overall Study|Prolonged duration between visits|0|||
48735898|NCT00347360|156883734|FG014|Overall Study|Prolonged duration between visits|0|||
48735899|NCT00347360|156883720|FG000|Overall Study|Subject left town, ran out of study drug|0|||
48735900|NCT00347360|156883721|FG001|Overall Study|Subject left town, ran out of study drug|0|||
48735901|NCT00347360|156883722|FG002|Overall Study|Subject left town, ran out of study drug|0|||
48735902|NCT00347360|156883723|FG003|Overall Study|Subject left town, ran out of study drug|0|||
48735903|NCT00347360|156883724|FG004|Overall Study|Subject left town, ran out of study drug|0|||
48735904|NCT00347360|156883725|FG005|Overall Study|Subject left town, ran out of study drug|0|||
48735905|NCT00347360|156883726|FG006|Overall Study|Subject left town, ran out of study drug|0|||
48735906|NCT00347360|156883727|FG007|Overall Study|Subject left town, ran out of study drug|0|||
48735907|NCT00347360|156883728|FG008|Overall Study|Subject left town, ran out of study drug|0|||
48735908|NCT00347360|156883729|FG009|Overall Study|Subject left town, ran out of study drug|0|||
48735909|NCT00347360|156883730|FG010|Overall Study|Subject left town, ran out of study drug|0|||
48735910|NCT00347360|156883731|FG011|Overall Study|Subject left town, ran out of study drug|0|||
48735911|NCT00347360|156883732|FG012|Overall Study|Subject left town, ran out of study drug|0|||
48735912|NCT00347360|156883733|FG013|Overall Study|Subject left town, ran out of study drug|1|||
48735913|NCT00347360|156883734|FG014|Overall Study|Subject left town, ran out of study drug|0|||
48735914|NCT00347360|156883720|FG000|Overall Study|Subject refuse to sign updated consent|0|||
48735915|NCT00347360|156883721|FG001|Overall Study|Subject refuse to sign updated consent|0|||
48735916|NCT00347360|156883722|FG002|Overall Study|Subject refuse to sign updated consent|0|||
48735917|NCT00347360|156883723|FG003|Overall Study|Subject refuse to sign updated consent|0|||
48735918|NCT00347360|156883724|FG004|Overall Study|Subject refuse to sign updated consent|0|||
48735919|NCT00347360|156883725|FG005|Overall Study|Subject refuse to sign updated consent|0|||
48735920|NCT00347360|156883726|FG006|Overall Study|Subject refuse to sign updated consent|0|||
48735921|NCT00347360|156883727|FG007|Overall Study|Subject refuse to sign updated consent|0|||
48735922|NCT00347360|156883728|FG008|Overall Study|Subject refuse to sign updated consent|0|||
48735923|NCT00347360|156883729|FG009|Overall Study|Subject refuse to sign updated consent|0|||
48735924|NCT00347360|156883730|FG010|Overall Study|Subject refuse to sign updated consent|0|||
48735925|NCT00347360|156883731|FG011|Overall Study|Subject refuse to sign updated consent|0|||
48735926|NCT00347360|156883732|FG012|Overall Study|Subject refuse to sign updated consent|0|||
48735927|NCT00347360|156883733|FG013|Overall Study|Subject refuse to sign updated consent|0|||
48735928|NCT00347360|156883734|FG014|Overall Study|Subject refuse to sign updated consent|1|||
48735929|NCT00347360|156883720|FG000|Overall Study|Visits conflicted with new job|0|||
48735930|NCT00347360|156883721|FG001|Overall Study|Visits conflicted with new job|0|||
48735931|NCT00347360|156883722|FG002|Overall Study|Visits conflicted with new job|0|||
48735932|NCT00347360|156883723|FG003|Overall Study|Visits conflicted with new job|0|||
48735933|NCT00347360|156883724|FG004|Overall Study|Visits conflicted with new job|0|||
48735934|NCT00347360|156883725|FG005|Overall Study|Visits conflicted with new job|0|||
48735935|NCT00347360|156883726|FG006|Overall Study|Visits conflicted with new job|1|||
48735936|NCT00347360|156883727|FG007|Overall Study|Visits conflicted with new job|0|||
48735937|NCT00347360|156883728|FG008|Overall Study|Visits conflicted with new job|0|||
48735938|NCT00347360|156883729|FG009|Overall Study|Visits conflicted with new job|0|||
48735939|NCT00347360|156883730|FG010|Overall Study|Visits conflicted with new job|0|||
48735940|NCT00347360|156883731|FG011|Overall Study|Visits conflicted with new job|0|||
48735941|NCT00347360|156883732|FG012|Overall Study|Visits conflicted with new job|0|||
48735942|NCT00347360|156883733|FG013|Overall Study|Visits conflicted with new job|0|||
48735943|NCT00347360|156883734|FG014|Overall Study|Visits conflicted with new job|0|||
48735944|NCT00508755|156883735|FG000|Overall Study|Withdrawal by Subject|1|||
48735945|NCT04478266|156883736|FG000|Overall Study|Adverse Event|20|||
48735946|NCT04478266|156883737|FG001|Overall Study|Adverse Event|21|||
48735947|NCT04478266|156883736|FG000|Overall Study|Progressive disease|146|||
48735948|NCT04478266|156883737|FG001|Overall Study|Progressive disease|168|||
48735949|NCT04478266|156883736|FG000|Overall Study|Poor compliance to protocol|1|||
48735950|NCT04478266|156883737|FG001|Overall Study|Poor compliance to protocol|0|||
48735951|NCT04478266|156883736|FG000|Overall Study|Withdrawal by Subject|19|||
48849446|NCT01953692|157288833|FG006|Overall Study|Protocol Violation|0|||
48849447|NCT01953692|157288834|FG007|Overall Study|Protocol Violation|1|||
48849448|NCT01953692|157288835|FG008|Overall Study|Protocol Violation|0|||
48849449|NCT01953692|157288827|FG000|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
48849450|NCT01953692|157288828|FG001|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
48849451|NCT01953692|157288829|FG002|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
48849452|NCT01953692|157288830|FG003|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
48849453|NCT01953692|157288831|FG004|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
48849454|NCT01953692|157288832|FG005|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
48849455|NCT01953692|157288833|FG006|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
48849456|NCT01953692|157288834|FG007|Overall Study|Study for Cohort 5 Terminated by Sponsor|2|||
48849457|NCT01953692|157288835|FG008|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
48849458|NCT01953692|157288827|FG000|Overall Study|Withdrawal by Subject|4|||
48849459|NCT01953692|157288828|FG001|Overall Study|Withdrawal by Subject|2|||
48849460|NCT01953692|157288829|FG002|Overall Study|Withdrawal by Subject|1|||
48849461|NCT01953692|157288830|FG003|Overall Study|Withdrawal by Subject|2|||
48849462|NCT01953692|157288831|FG004|Overall Study|Withdrawal by Subject|0|||
48849463|NCT01953692|157288832|FG005|Overall Study|Withdrawal by Subject|3|||
48849464|NCT01953692|157288833|FG006|Overall Study|Withdrawal by Subject|2|||
48849465|NCT01953692|157288834|FG007|Overall Study|Withdrawal by Subject|1|||
48849466|NCT01953692|157288835|FG008|Overall Study|Withdrawal by Subject|1|||
48849467|NCT02251652|157288836|FG000|Overall Study|Withdrawal by Subject|1|||
48849468|NCT02275611|157288837|FG000|Inpatient Withdrawal|Withdrawal by Subject|1|||
48849469|NCT02275611|157288838|FG001|Inpatient Withdrawal|Withdrawal by Subject|0|||
48849470|NCT02275611|157288839|FG002|Inpatient Withdrawal|Withdrawal by Subject|0|||
48849471|NCT02275611|157288840|FG003|Inpatient Withdrawal|Withdrawal by Subject|0|||
48849472|NCT00822120|157288841|FG000|Initial Registration|Adverse Event|1|||
48849473|NCT00822120|157288842|FG001|Initial Registration|Adverse Event|0|||
48849474|NCT00822120|157288843|FG002|Initial Registration|Adverse Event|0|||
48849475|NCT00822120|157288844|FG003|Initial Registration|Adverse Event|0|||
48849476|NCT00822120|157288845|FG004|Initial Registration|Adverse Event|0|||
48849477|NCT00822120|157288846|FG005|Initial Registration|Adverse Event|0|||
48849478|NCT00822120|157288841|FG000|Initial Registration|Refusal Unrelated to Adverse Event|1|||
48849479|NCT00822120|157288842|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
48849480|NCT00822120|157288843|FG002|Initial Registration|Refusal Unrelated to Adverse Event|0|||
48849481|NCT00822120|157288844|FG003|Initial Registration|Refusal Unrelated to Adverse Event|0|||
48849482|NCT00822120|157288845|FG004|Initial Registration|Refusal Unrelated to Adverse Event|0|||
48849483|NCT00822120|157288846|FG005|Initial Registration|Refusal Unrelated to Adverse Event|0|||
48849484|NCT00822120|157288841|FG000|Initial Registration|Reasons not Protocol Specified|2|||
48849485|NCT00822120|157288842|FG001|Initial Registration|Reasons not Protocol Specified|0|||
48849486|NCT00822120|157288843|FG002|Initial Registration|Reasons not Protocol Specified|0|||
48849487|NCT00822120|157288844|FG003|Initial Registration|Reasons not Protocol Specified|0|||
48849488|NCT00822120|157288845|FG004|Initial Registration|Reasons not Protocol Specified|0|||
48849489|NCT00822120|157288846|FG005|Initial Registration|Reasons not Protocol Specified|0|||
48849490|NCT00822120|157288841|FG000|Initial Registration|Ineligible|22|||
48849491|NCT00822120|157288842|FG001|Initial Registration|Ineligible|1|||
48849492|NCT00822120|157288843|FG002|Initial Registration|Ineligible|0|||
48849493|NCT00822120|157288844|FG003|Initial Registration|Ineligible|0|||
48849494|NCT00822120|157288845|FG004|Initial Registration|Ineligible|0|||
48849495|NCT00822120|157288846|FG005|Initial Registration|Ineligible|0|||
48849496|NCT00822120|157288841|FG000|PET-directed Therapy|Adverse Event|0|||
48849497|NCT00822120|157288842|FG001|PET-directed Therapy|Adverse Event|0|||
48849498|NCT00822120|157288843|FG002|PET-directed Therapy|Adverse Event|0|||
48735952|NCT04478266|156883737|FG001|Overall Study|Withdrawal by Subject|16|||
48849499|NCT00822120|157288844|FG003|PET-directed Therapy|Adverse Event|1|||
48849500|NCT00822120|157288845|FG004|PET-directed Therapy|Adverse Event|0|||
48849501|NCT00822120|157288846|FG005|PET-directed Therapy|Adverse Event|0|||
48849502|NCT00822120|157288841|FG000|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
48849503|NCT00822120|157288842|FG001|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
48849504|NCT00822120|157288843|FG002|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
48849505|NCT00822120|157288844|FG003|PET-directed Therapy|Refusal Unrelated to Adverse Event|1|||
48849506|NCT00822120|157288845|FG004|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
48849507|NCT00822120|157288846|FG005|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
48849508|NCT00822120|157288841|FG000|PET-directed Therapy|Death|0|||
48849509|NCT00822120|157288842|FG001|PET-directed Therapy|Death|0|||
48849510|NCT00822120|157288843|FG002|PET-directed Therapy|Death|0|||
48849511|NCT00822120|157288844|FG003|PET-directed Therapy|Death|2|||
48849512|NCT00822120|157288845|FG004|PET-directed Therapy|Death|0|||
48849513|NCT00822120|157288846|FG005|PET-directed Therapy|Death|0|||
48849514|NCT00822120|157288841|FG000|PET-directed Therapy|Protocol Violation|0|||
48849515|NCT00822120|157288842|FG001|PET-directed Therapy|Protocol Violation|0|||
48849516|NCT00822120|157288843|FG002|PET-directed Therapy|Protocol Violation|0|||
48849517|NCT00822120|157288844|FG003|PET-directed Therapy|Protocol Violation|6|||
48849518|NCT00822120|157288845|FG004|PET-directed Therapy|Protocol Violation|0|||
48849519|NCT00822120|157288846|FG005|PET-directed Therapy|Protocol Violation|0|||
48849520|NCT00503906|157288847|FG000|Overall Study|Withdrawal by Subject|1|||
48849521|NCT01324310|157288848|FG000|Overall Study|Adverse Event|1|||
48849522|NCT01324310|157288848|FG000|Overall Study|Disease Progression|1|||
48849523|NCT01437319|157288851|FG000|Phase I|Lost to Follow-up|2|||
48849524|NCT01437319|157288852|FG001|Phase I|Lost to Follow-up|0|||
48849525|NCT01437319|157288853|FG002|Phase I|Lost to Follow-up|0|||
48849526|NCT01437319|157288851|FG000|Phase I|Protocol Violation|1|||
48849527|NCT01437319|157288852|FG001|Phase I|Protocol Violation|0|||
48849528|NCT01437319|157288853|FG002|Phase I|Protocol Violation|0|||
48849529|NCT01437319|157288851|FG000|Phase I|Study related symptoms/complaints|27|||
48849530|NCT01437319|157288852|FG001|Phase I|Study related symptoms/complaints|0|||
48849531|NCT01437319|157288853|FG002|Phase I|Study related symptoms/complaints|0|||
48849532|NCT01437319|157288851|FG000|Phase I|Withdrawal by Subject|25|||
48849533|NCT01437319|157288852|FG001|Phase I|Withdrawal by Subject|0|||
48849534|NCT01437319|157288853|FG002|Phase I|Withdrawal by Subject|0|||
48849535|NCT01437319|157288851|FG000|Phase II|Withdrawal by Subject|0|||
48849536|NCT01437319|157288852|FG001|Phase II|Withdrawal by Subject|8|||
48849537|NCT01437319|157288853|FG002|Phase II|Withdrawal by Subject|16|||
48849538|NCT01437319|157288851|FG000|Phase II|Lost to Follow-up|0|||
48849539|NCT01437319|157288852|FG001|Phase II|Lost to Follow-up|7|||
48849540|NCT01437319|157288853|FG002|Phase II|Lost to Follow-up|2|||
48849541|NCT01437319|157288851|FG000|Phase II|Study related symptoms/complaints|0|||
48849542|NCT01437319|157288852|FG001|Phase II|Study related symptoms/complaints|28|||
48849543|NCT01437319|157288853|FG002|Phase II|Study related symptoms/complaints|19|||
48849544|NCT01437319|157288851|FG000|Phase II|Protocol Violation|0|||
48849545|NCT01437319|157288852|FG001|Phase II|Protocol Violation|1|||
48849546|NCT01437319|157288853|FG002|Phase II|Protocol Violation|0|||
48849547|NCT01171976|157288854|FG000|Overall Study|Protocol Violation|0|||
48849548|NCT01171976|157288855|FG001|Overall Study|Protocol Violation|0|||
48849549|NCT01171976|157288856|FG002|Overall Study|Protocol Violation|1|||
48849550|NCT01171976|157288854|FG000|Overall Study|Death|2|||
48849551|NCT01171976|157288855|FG001|Overall Study|Death|4|||
48849552|NCT01171976|157288856|FG002|Overall Study|Death|1|||
48849553|NCT01171976|157288854|FG000|Overall Study|Lost to Follow-up|4|||
48849554|NCT01171976|157288855|FG001|Overall Study|Lost to Follow-up|0|||
48849555|NCT01171976|157288856|FG002|Overall Study|Lost to Follow-up|2|||
48849556|NCT01171976|157288854|FG000|Overall Study|Withdrawal by Subject|1|||
48849557|NCT01171976|157288855|FG001|Overall Study|Withdrawal by Subject|5|||
48849558|NCT01171976|157288856|FG002|Overall Study|Withdrawal by Subject|6|||
48849559|NCT01171976|157288854|FG000|Overall Study|Abnormal test result|1|||
48849560|NCT01171976|157288855|FG001|Overall Study|Abnormal test result|0|||
48849561|NCT01171976|157288856|FG002|Overall Study|Abnormal test result|0|||
48849562|NCT01171976|157288854|FG000|Overall Study|Adverse Event|6|||
48849563|NCT01171976|157288855|FG001|Overall Study|Adverse Event|2|||
48849564|NCT01171976|157288856|FG002|Overall Study|Adverse Event|5|||
48849565|NCT03170882|157288857|FG000|Overall Study|Death|17|||
48849566|NCT03170882|157288858|FG001|Overall Study|Death|29|||
48849567|NCT03170882|157288857|FG000|Overall Study|Lost to Follow-up|0|||
48849568|NCT03170882|157288858|FG001|Overall Study|Lost to Follow-up|1|||
48849569|NCT03170882|157288857|FG000|Overall Study|Withdrawal by Subject|4|||
48942795|NCT02732951|157620828|FG001|Overall Study|Lost to Follow-up|1|||
48942796|NCT02732951|157620827|FG000|Overall Study|Adverse Event|4|||
48942797|NCT02732951|157620828|FG001|Overall Study|Adverse Event|4|||
48942798|NCT02732951|157620827|FG000|Overall Study|Protocol Violation|0|||
48942799|NCT02732951|157620828|FG001|Overall Study|Protocol Violation|1|||
48942800|NCT01826214|157620830|FG000|Overall Study|Adverse Event|7|||
48942801|NCT01826214|157620831|FG001|Overall Study|Adverse Event|6|||
48942802|NCT01826214|157620830|FG000|Overall Study|Death|3|||
48942803|NCT01826214|157620831|FG001|Overall Study|Death|1|||
48942804|NCT01826214|157620830|FG000|Overall Study|Lost to Follow-up|1|||
48942805|NCT01826214|157620831|FG001|Overall Study|Lost to Follow-up|0|||
48942806|NCT01826214|157620830|FG000|Overall Study|Physician Decision|0|||
48942807|NCT01826214|157620831|FG001|Overall Study|Physician Decision|2|||
48942808|NCT01826214|157620830|FG000|Overall Study|Progressive disease|22|||
48942809|NCT01826214|157620831|FG001|Overall Study|Progressive disease|21|||
48942810|NCT01826214|157620830|FG000|Overall Study|Study terminated by Sponsor|0|||
48942811|NCT01826214|157620831|FG001|Overall Study|Study terminated by Sponsor|1|||
48942812|NCT01826214|157620830|FG000|Overall Study|Subject/guardian decision|2|||
48942813|NCT01826214|157620831|FG001|Overall Study|Subject/guardian decision|3|||
48942814|NCT03658889|157620839|FG000|Overall Study|Protocol Violation|2|||
48942815|NCT03658889|157620840|FG001|Overall Study|Protocol Violation|0|||
48942816|NCT02128490|157620843|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
48942817|NCT02128490|157620844|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
48942818|NCT02128490|157620845|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
48942819|NCT02128490|157620846|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
48942820|NCT02128490|157620847|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
48942821|NCT02128490|157620843|FG000|Overall Study|Major Protocol Deviation|1|||
48942822|NCT02128490|157620844|FG001|Overall Study|Major Protocol Deviation|2|||
48942823|NCT02128490|157620845|FG002|Overall Study|Major Protocol Deviation|0|||
48942824|NCT02128490|157620846|FG003|Overall Study|Major Protocol Deviation|2|||
48942825|NCT02128490|157620847|FG004|Overall Study|Major Protocol Deviation|2|||
48942826|NCT02128490|157620843|FG000|Overall Study|Lost to Follow-up|0|||
48942827|NCT02128490|157620844|FG001|Overall Study|Lost to Follow-up|0|||
48942828|NCT02128490|157620845|FG002|Overall Study|Lost to Follow-up|1|||
48942829|NCT02128490|157620846|FG003|Overall Study|Lost to Follow-up|1|||
48942830|NCT02128490|157620847|FG004|Overall Study|Lost to Follow-up|1|||
48942831|NCT02128490|157620843|FG000|Overall Study|Voluntary Withdrawal|3|||
48942832|NCT02128490|157620844|FG001|Overall Study|Voluntary Withdrawal|3|||
48942833|NCT02128490|157620845|FG002|Overall Study|Voluntary Withdrawal|1|||
48942834|NCT02128490|157620846|FG003|Overall Study|Voluntary Withdrawal|1|||
48942835|NCT02128490|157620847|FG004|Overall Study|Voluntary Withdrawal|2|||
48942836|NCT02128490|157620843|FG000|Overall Study|Lack of Efficacy|0|||
48942837|NCT02128490|157620844|FG001|Overall Study|Lack of Efficacy|1|||
48942838|NCT02128490|157620845|FG002|Overall Study|Lack of Efficacy|0|||
48942839|NCT02128490|157620846|FG003|Overall Study|Lack of Efficacy|0|||
48942840|NCT02128490|157620847|FG004|Overall Study|Lack of Efficacy|0|||
48942841|NCT02128490|157620843|FG000|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
48942842|NCT02128490|157620844|FG001|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
48942843|NCT02128490|157620845|FG002|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
48942844|NCT02128490|157620846|FG003|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
48942845|NCT02128490|157620847|FG004|Overall Study|Withdraw from Study Drug, Gout Flare|1|||
48942846|NCT02128490|157620843|FG000|Overall Study|Other Miscellaneous Reasons|0|||
48942847|NCT02128490|157620844|FG001|Overall Study|Other Miscellaneous Reasons|0|||
48942848|NCT02128490|157620845|FG002|Overall Study|Other Miscellaneous Reasons|2|||
48942849|NCT02128490|157620846|FG003|Overall Study|Other Miscellaneous Reasons|1|||
48942850|NCT02128490|157620847|FG004|Overall Study|Other Miscellaneous Reasons|1|||
48942851|NCT00224016|157620849|FG000|Titration Period|Withdrawal by Subject|0|||
48942852|NCT00224016|157620850|FG001|Titration Period|Withdrawal by Subject|1|||
48942853|NCT00224016|157620849|FG000|Titration Period|Lost to Follow-up|1|||
48942854|NCT00224016|157620850|FG001|Titration Period|Lost to Follow-up|0|||
48942855|NCT00224016|157620849|FG000|Maintenance Period|Withdrawal by Subject|2|||
48942856|NCT00224016|157620850|FG001|Maintenance Period|Withdrawal by Subject|0|||
48942857|NCT00224016|157620849|FG000|Maintenance Period|Lost to Follow-up|0|||
48942858|NCT00224016|157620850|FG001|Maintenance Period|Lost to Follow-up|1|||
48942859|NCT03311126|157620852|FG000|Induction|Death|1|||
48942860|NCT03311126|157620852|FG000|Restaging Imaging|Radiographic Complete Response moved to Observation rather than Maintenance|10|||
48942861|NCT02251743|157620853|FG000|Overall Study|Withdrawal by Subject|1|||
48942862|NCT02251743|157620854|FG001|Overall Study|Withdrawal by Subject|1|||
48942863|NCT00613314|157620859|FG000|Overall Study|Adverse Event|5|||
48942864|NCT00613314|157620859|FG000|Overall Study|Protocol Violation|14|||
48942865|NCT00613314|157620859|FG000|Overall Study|Lost to Follow-up|46|||
48942866|NCT00613314|157620859|FG000|Overall Study|Other reason not defined above|90|||
48942867|NCT01154101|157620863|FG000|Overall Study|Adverse Event|0|||
48942868|NCT01154101|157620864|FG001|Overall Study|Adverse Event|2|||
48942869|NCT01154101|157620865|FG002|Overall Study|Adverse Event|1|||
48942870|NCT01154101|157620866|FG003|Overall Study|Adverse Event|1|||
48942871|NCT01154101|157620867|FG004|Overall Study|Adverse Event|0|||
48942872|NCT01154101|157620863|FG000|Overall Study|Lost to Follow-up|0|||
48942873|NCT01154101|157620864|FG001|Overall Study|Lost to Follow-up|1|||
48942874|NCT01154101|157620865|FG002|Overall Study|Lost to Follow-up|0|||
48942875|NCT01154101|157620866|FG003|Overall Study|Lost to Follow-up|1|||
48942876|NCT01154101|157620867|FG004|Overall Study|Lost to Follow-up|0|||
48942877|NCT01154101|157620863|FG000|Overall Study|Withdrawal by Subject|0|||
48942878|NCT01154101|157620864|FG001|Overall Study|Withdrawal by Subject|1|||
48942879|NCT01154101|157620865|FG002|Overall Study|Withdrawal by Subject|2|||
48942880|NCT01154101|157620866|FG003|Overall Study|Withdrawal by Subject|0|||
48942881|NCT01154101|157620867|FG004|Overall Study|Withdrawal by Subject|1|||
48942882|NCT04178590|157620868|FG000|Overall Study|Pregnancy|1|||
48942883|NCT04178590|157620868|FG000|Overall Study|Lost to Follow-up|1|||
48942884|NCT00996840|157620869|FG000|Overall Study|Adverse Event|0|||
48942885|NCT00996840|157620870|FG001|Overall Study|Adverse Event|1|||
48942886|NCT00996840|157620871|FG002|Overall Study|Adverse Event|0|||
48942887|NCT00996840|157620872|FG003|Overall Study|Adverse Event|0|||
48942888|NCT00996840|157620873|FG004|Overall Study|Adverse Event|0|||
48942889|NCT00996840|157620869|FG000|Overall Study|Physician Decision|0|||
48942890|NCT00996840|157620870|FG001|Overall Study|Physician Decision|0|||
48942891|NCT00996840|157620871|FG002|Overall Study|Physician Decision|1|||
48942892|NCT00996840|157620872|FG003|Overall Study|Physician Decision|1|||
48942893|NCT00996840|157620873|FG004|Overall Study|Physician Decision|2|||
48942894|NCT00996840|157620869|FG000|Overall Study|Withdrawal by Subject|1|||
48942895|NCT00996840|157620870|FG001|Overall Study|Withdrawal by Subject|1|||
48942896|NCT00996840|157620871|FG002|Overall Study|Withdrawal by Subject|0|||
48942897|NCT00996840|157620872|FG003|Overall Study|Withdrawal by Subject|0|||
48942898|NCT00996840|157620873|FG004|Overall Study|Withdrawal by Subject|0|||
48942899|NCT00817414|157620881|FG000|Overall Study|Adverse Event|1|||
48942900|NCT00817414|157620882|FG001|Overall Study|Adverse Event|1|||
48942901|NCT00817414|157620883|FG002|Overall Study|Adverse Event|1|||
48942902|NCT00817414|157620884|FG003|Overall Study|Adverse Event|0|||
48942903|NCT00817414|157620885|FG004|Overall Study|Adverse Event|0|||
48942904|NCT00817414|157620881|FG000|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
48942905|NCT00817414|157620882|FG001|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1|||
48942906|NCT00817414|157620883|FG002|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2|||
48942907|NCT00817414|157620884|FG003|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4|||
48942908|NCT00817414|157620885|FG004|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
48942909|NCT00817414|157620881|FG000|Overall Study|Withdrawal by Subject|1|||
48942910|NCT00817414|157620882|FG001|Overall Study|Withdrawal by Subject|1|||
48942911|NCT00817414|157620883|FG002|Overall Study|Withdrawal by Subject|0|||
48942912|NCT00817414|157620884|FG003|Overall Study|Withdrawal by Subject|0|||
48942913|NCT00817414|157620885|FG004|Overall Study|Withdrawal by Subject|0|||
48942914|NCT00817414|157620881|FG000|Overall Study|Lost to Follow-up|0|||
48942915|NCT00817414|157620882|FG001|Overall Study|Lost to Follow-up|0|||
48942916|NCT00817414|157620883|FG002|Overall Study|Lost to Follow-up|1|||
48942917|NCT00817414|157620884|FG003|Overall Study|Lost to Follow-up|1|||
48942918|NCT00817414|157620885|FG004|Overall Study|Lost to Follow-up|1|||
48942919|NCT00817414|157620881|FG000|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
48942920|NCT00817414|157620882|FG001|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
48942921|NCT00817414|157620883|FG002|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
48942922|NCT00817414|157620884|FG003|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7|||
48942923|NCT00817414|157620885|FG004|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
48942924|NCT00817414|157620881|FG000|Overall Study|Protocol Violation|0|||
48942925|NCT00817414|157620882|FG001|Overall Study|Protocol Violation|0|||
48942926|NCT00817414|157620883|FG002|Overall Study|Protocol Violation|0|||
48942927|NCT00817414|157620884|FG003|Overall Study|Protocol Violation|0|||
48942928|NCT00817414|157620885|FG004|Overall Study|Protocol Violation|1|||
48942929|NCT01503021|157620886|FG000|Overall Study|Adverse Event|7|||
48942930|NCT01503021|157620887|FG001|Overall Study|Adverse Event|6|||
48942931|NCT01503021|157620886|FG000|Overall Study|Death|0|||
48942932|NCT01503021|157620887|FG001|Overall Study|Death|2|||
48942933|NCT01503021|157620886|FG000|Overall Study|Lost to Follow-up|2|||
48942934|NCT01503021|157620887|FG001|Overall Study|Lost to Follow-up|0|||
48942935|NCT01503021|157620886|FG000|Overall Study|Physician Decision|3|||
48942936|NCT01503021|157620887|FG001|Overall Study|Physician Decision|0|||
48942937|NCT01503021|157620886|FG000|Overall Study|Protocol Violation|1|||
48942938|NCT01503021|157620887|FG001|Overall Study|Protocol Violation|3|||
48942939|NCT01503021|157620886|FG000|Overall Study|Withdrawal by Subject|9|||
48942940|NCT01503021|157620887|FG001|Overall Study|Withdrawal by Subject|8|||
48942941|NCT01503021|157620886|FG000|Overall Study|Moved, received transplant, etc.|5|||
48942942|NCT01503021|157620887|FG001|Overall Study|Moved, received transplant, etc.|7|||
48942943|NCT04938648|157620888|FG000|Overall Study|Patient admitted to SNF hospice/LTC|2|||
48942944|NCT04938648|157620889|FG001|Overall Study|Patient admitted to SNF hospice/LTC|1|||
48942945|NCT04938648|157620888|FG000|Overall Study|Patient too ill|0|||
48942946|NCT04938648|157620889|FG001|Overall Study|Patient too ill|1|||
48942947|NCT04938648|157620888|FG000|Overall Study|Patient in rehab at the time of intervention|1|||
48942948|NCT04938648|157620889|FG001|Overall Study|Patient in rehab at the time of intervention|0|||
48942949|NCT04938648|157620888|FG000|Overall Study|Patient did not have memory problems|1|||
48942950|NCT04938648|157620889|FG001|Overall Study|Patient did not have memory problems|1|||
48942951|NCT04938648|157620888|FG000|Overall Study|Intervention could not be scheduled within protocol window|1|||
48942952|NCT04938648|157620889|FG001|Overall Study|Intervention could not be scheduled within protocol window|0|||
48942953|NCT04938648|157620888|FG000|Overall Study|Care partner could not be reached|0|||
48942954|NCT04938648|157620889|FG001|Overall Study|Care partner could not be reached|1|||
48942955|NCT04938648|157620888|FG000|Overall Study|Patient no longer receiving care at an eligible clinic|0|||
48942956|NCT04938648|157620889|FG001|Overall Study|Patient no longer receiving care at an eligible clinic|2|||
48942957|NCT04938648|157620888|FG000|Overall Study|Withdrawal by Subject|2|||
48942958|NCT04938648|157620889|FG001|Overall Study|Withdrawal by Subject|1|||
48942959|NCT03941548|157620890|FG000|Overall Study|Adverse Event|0|||
48942960|NCT03941548|157620891|FG001|Overall Study|Adverse Event|1|||
48942961|NCT03941548|157620890|FG000|Overall Study|Lost to Follow-up|0|||
48942962|NCT03941548|157620891|FG001|Overall Study|Lost to Follow-up|1|||
48942963|NCT03941548|157620890|FG000|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|1|||
48942964|NCT03941548|157620891|FG001|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|0|||
48942965|NCT01059812|157620894|FG000|Overall Study|Adverse Event|9|||
48942966|NCT01059812|157620895|FG001|Overall Study|Adverse Event|5|||
48942967|NCT01059812|157620894|FG000|Overall Study|Lack of Efficacy|2|||
48942968|NCT01059812|157620895|FG001|Overall Study|Lack of Efficacy|2|||
48942969|NCT01059812|157620894|FG000|Overall Study|Protocol Violation|3|||
48942970|NCT01059812|157620895|FG001|Overall Study|Protocol Violation|1|||
48942971|NCT01059812|157620894|FG000|Overall Study|Withdrawal Criteria|9|||
48942972|NCT01059812|157620895|FG001|Overall Study|Withdrawal Criteria|4|||
48942973|NCT01059812|157620894|FG000|Overall Study|Unclassified|14|||
48942974|NCT01059812|157620895|FG001|Overall Study|Unclassified|4|||
48942975|NCT01919307|157620899|FG000|Overall Study|Withdrawal by Subject|9|||
48942976|NCT01451515|157620900|FG000|Overall Study|Death|0|||
48942977|NCT01451515|157620901|FG001|Overall Study|Death|1|||
48942978|NCT01451515|157620902|FG002|Overall Study|Death|0|||
48942979|NCT01451515|157620900|FG000|Overall Study|Withdrawal by Subject|0|||
48942980|NCT01451515|157620901|FG001|Overall Study|Withdrawal by Subject|1|||
48942981|NCT01451515|157620902|FG002|Overall Study|Withdrawal by Subject|0|||
48942982|NCT01451515|157620900|FG000|Overall Study|Development of unacceptable toxicity during treatment|0|||
48942983|NCT01451515|157620901|FG001|Overall Study|Development of unacceptable toxicity during treatment|0|||
48942984|NCT01451515|157620902|FG002|Overall Study|Development of unacceptable toxicity during treatment|1|||
48942985|NCT01451515|157620900|FG000|Overall Study|Relapse (except CNS)|1|||
48942986|NCT01451515|157620901|FG001|Overall Study|Relapse (except CNS)|1|||
48942987|NCT01451515|157620902|FG002|Overall Study|Relapse (except CNS)|0|||
48942988|NCT00466505|157620905|FG000|Overall Study|disease progression|13|||
48942989|NCT00466505|157620905|FG000|Overall Study|Adverse Event|4|||
48942990|NCT00811252|157620906|FG000|Overall Study|Adverse Event|6|||
48942991|NCT00811252|157620907|FG001|Overall Study|Adverse Event|10|||
48942992|NCT00811252|157620908|FG002|Overall Study|Adverse Event|15|||
48942993|NCT00811252|157620906|FG000|Overall Study|Lack of Efficacy|7|||
48942994|NCT00811252|157620907|FG001|Overall Study|Lack of Efficacy|2|||
48942995|NCT00811252|157620908|FG002|Overall Study|Lack of Efficacy|0|||
48942996|NCT00811252|157620906|FG000|Overall Study|Protocol Violation|3|||
48942997|NCT00811252|157620907|FG001|Overall Study|Protocol Violation|3|||
48942998|NCT00811252|157620908|FG002|Overall Study|Protocol Violation|2|||
48942999|NCT00811252|157620906|FG000|Overall Study|Withdrawal of Consent|1|||
48943000|NCT00811252|157620907|FG001|Overall Study|Withdrawal of Consent|2|||
48943001|NCT00811252|157620908|FG002|Overall Study|Withdrawal of Consent|2|||
48943002|NCT00811252|157620906|FG000|Overall Study|Lost to Follow-up|0|||
48943003|NCT00811252|157620907|FG001|Overall Study|Lost to Follow-up|0|||
48943004|NCT00811252|157620908|FG002|Overall Study|Lost to Follow-up|2|||
48943005|NCT00811252|157620906|FG000|Overall Study|Administrative or Other Reasons|0|||
48943006|NCT00811252|157620907|FG001|Overall Study|Administrative or Other Reasons|3|||
48943007|NCT00811252|157620908|FG002|Overall Study|Administrative or Other Reasons|2|||
48943008|NCT01931865|157620911|FG000|Overall Study|Lost to Follow-up|2|||
48943009|NCT01931865|157620911|FG000|Overall Study|Withdrawal by Subject|2|||
48943010|NCT00504257|157620912|FG000|Overall Study|Withdrawal by Subject|2|||
48943011|NCT00504257|157620912|FG000|Overall Study|ineligible histology|2|||
48943012|NCT02561156|157620913|FG000|Part 2|Adverse Event|0|||
48943013|NCT02561156|157620914|FG001|Part 2|Adverse Event|0|||
48943014|NCT02561156|157620915|FG002|Part 2|Adverse Event|0|||
48943015|NCT02561156|157620916|FG003|Part 2|Adverse Event|0|||
48943016|NCT02561156|157620917|FG004|Part 2|Adverse Event|0|||
48943017|NCT02561156|157620918|FG005|Part 2|Adverse Event|0|||
48943018|NCT02561156|157620919|FG006|Part 2|Adverse Event|0|||
48943019|NCT02561156|157620920|FG007|Part 2|Adverse Event|0|||
48943020|NCT02561156|157620921|FG008|Part 2|Adverse Event|0|||
48943021|NCT02561156|157620922|FG009|Part 2|Adverse Event|0|||
48943022|NCT02561156|157620923|FG010|Part 2|Adverse Event|0|||
48943023|NCT02561156|157620924|FG011|Part 2|Adverse Event|1|||
48943024|NCT02561156|157620925|FG012|Part 2|Adverse Event|0|||
48943025|NCT04919564|157620927|FG000|Overall Study|Lost to Follow-up|1|||
48943026|NCT04919564|157620928|FG001|Overall Study|Lost to Follow-up|0|||
48943027|NCT04919564|157620927|FG000|Overall Study|Physician Decision|1|||
48943028|NCT04919564|157620928|FG001|Overall Study|Physician Decision|1|||
48943029|NCT02504541|157620934|FG000|Overall Study|Adverse Event|4|||
48943030|NCT02504541|157620934|FG000|Overall Study|Withdrawal by Subject|4|||
48943031|NCT02504541|157620934|FG000|Overall Study|Lost to Follow-up|1|||
48943032|NCT02504541|157620934|FG000|Overall Study|Met Stopping Criteria|1|||
48943033|NCT02504541|157620934|FG000|Overall Study|Protocol Violation|2|||
48943034|NCT02504541|157620934|FG000|Overall Study|Termination by Sponsor|1|||
48943035|NCT02504541|157620934|FG000|Overall Study|Other|2|||
48943036|NCT02504541|157620934|FG000|Overall Study|Multiple|5|||
48943037|NCT01937312|157620936|FG000|Overall Study|Adverse Event|10|||
48943038|NCT01937312|157620937|FG001|Overall Study|Adverse Event|1|||
48943039|NCT01937312|157620936|FG000|Overall Study|Lack of Efficacy|0|||
48943040|NCT01937312|157620937|FG001|Overall Study|Lack of Efficacy|1|||
48943041|NCT01937312|157620936|FG000|Overall Study|Withdrawal of subject prior to treatment|1|||
48943042|NCT01937312|157620937|FG001|Overall Study|Withdrawal of subject prior to treatment|1|||
48943043|NCT00858832|157620953|FG000|Overall Study|became ineligible: delivered vaginally|1|||
48943044|NCT00858832|157620954|FG001|Overall Study|became ineligible: delivered vaginally|0|||
48943045|NCT00858832|157620953|FG000|Overall Study|Adverse Event|0|||
48943046|NCT00858832|157620954|FG001|Overall Study|Adverse Event|1|||
48943047|NCT00509106|157620957|FG000|Overall Study|Adverse Event|3|||
48943048|NCT00509106|157620958|FG001|Overall Study|Adverse Event|2|||
48943049|NCT00509106|157620957|FG000|Overall Study|Noncompliance|0|||
48943050|NCT00509106|157620958|FG001|Overall Study|Noncompliance|1|||
48943051|NCT00509106|157620957|FG000|Overall Study|At the request of sponsor/investigator|1|||
48943052|NCT00509106|157620958|FG001|Overall Study|At the request of sponsor/investigator|2|||
48943053|NCT00509106|157620957|FG000|Overall Study|Withdrew consent|4|||
48943054|NCT00509106|157620958|FG001|Overall Study|Withdrew consent|8|||
48943055|NCT00509106|157620957|FG000|Overall Study|Lost to Follow-up|16|||
48943056|NCT00509106|157620958|FG001|Overall Study|Lost to Follow-up|10|||
48943057|NCT00509106|157620957|FG000|Overall Study|Other|1|||
48943058|NCT00509106|157620958|FG001|Overall Study|Other|0|||
48943059|NCT00509106|157620957|FG000|Overall Study|Death|6|||
48943060|NCT00509106|157620958|FG001|Overall Study|Death|6|||
48943061|NCT03826914|157620962|FG000|Overall Study|Withdrawal by Subject|1|||
48943062|NCT03826914|157620963|FG001|Overall Study|Withdrawal by Subject|1|||
48943063|NCT02259231|157620964|FG000|Overall Study|Adverse Event|1|||
48943064|NCT02259231|157620965|FG001|Overall Study|Adverse Event|1|||
48943065|NCT02259231|157620966|FG002|Overall Study|Adverse Event|2|||
48943066|NCT02259231|157620967|FG003|Overall Study|Adverse Event|0|||
48943067|NCT02259231|157620968|FG004|Overall Study|Adverse Event|0|||
48943068|NCT02259231|157620969|FG005|Overall Study|Adverse Event|0|||
48943069|NCT02259231|157620970|FG006|Overall Study|Adverse Event|0|||
48943070|NCT02259231|157620964|FG000|Overall Study|Progressive Disease|4|||
48943071|NCT02259231|157620965|FG001|Overall Study|Progressive Disease|5|||
48943072|NCT02259231|157620966|FG002|Overall Study|Progressive Disease|4|||
48943073|NCT02259231|157620967|FG003|Overall Study|Progressive Disease|5|||
48943074|NCT02259231|157620968|FG004|Overall Study|Progressive Disease|4|||
48943075|NCT02259231|157620969|FG005|Overall Study|Progressive Disease|5|||
48943076|NCT02259231|157620970|FG006|Overall Study|Progressive Disease|4|||
48943077|NCT02259231|157620964|FG000|Overall Study|Sponsor termination of study|1|||
48943078|NCT02259231|157620965|FG001|Overall Study|Sponsor termination of study|0|||
48943079|NCT02259231|157620966|FG002|Overall Study|Sponsor termination of study|0|||
48943080|NCT02259231|157620967|FG003|Overall Study|Sponsor termination of study|1|||
48943081|NCT02259231|157620968|FG004|Overall Study|Sponsor termination of study|2|||
48943082|NCT02259231|157620969|FG005|Overall Study|Sponsor termination of study|1|||
48943083|NCT02259231|157620970|FG006|Overall Study|Sponsor termination of study|1|||
48943084|NCT00849212|157620973|FG000|Overall Study|Lack of Efficacy|1|||
48943085|NCT00849212|157620973|FG000|Overall Study|Withdrawal by Subject|3|||
48943086|NCT00849212|157620973|FG000|Overall Study|Adverse Event|2|||
48943087|NCT00849212|157620973|FG000|Overall Study|Miscellaneous|1|||
48943088|NCT00542828|157620974|FG000|Overall Study|Physician Decision|1|||
48943089|NCT00542828|157620974|FG000|Overall Study|Need for Prohibited Treatment|3|||
48943090|NCT00542828|157620974|FG000|Overall Study|Study Prematurely Discontinued|7|||
48943091|NCT00542828|157620974|FG000|Overall Study|Did Not Receive Thymoglobulin Treatment|2|||
48943092|NCT01009294|157620975|FG000|Overall Study|Study discontinued by Sponsor|6|||
48943093|NCT04332419|157620976|FG000|Overall Study|Withdrawal by Subject|1|||
48943094|NCT01824602|157620979|FG000|Overall Study|Withdrawal by Subject|0|||
48943095|NCT01824602|157620980|FG001|Overall Study|Withdrawal by Subject|0|||
48943096|NCT01824602|157620981|FG002|Overall Study|Withdrawal by Subject|1|||
48943097|NCT01824602|157620982|FG003|Overall Study|Withdrawal by Subject|2|||
48943098|NCT01824602|157620979|FG000|Overall Study|Patient non-compliance|0|||
48943099|NCT01824602|157620980|FG001|Overall Study|Patient non-compliance|0|||
48943100|NCT01824602|157620981|FG002|Overall Study|Patient non-compliance|1|||
48943101|NCT01824602|157620982|FG003|Overall Study|Patient non-compliance|0|||
48943102|NCT01824602|157620979|FG000|Overall Study|Adverse Event|1|||
48943103|NCT01824602|157620980|FG001|Overall Study|Adverse Event|0|||
48943104|NCT01824602|157620981|FG002|Overall Study|Adverse Event|2|||
48943105|NCT01824602|157620982|FG003|Overall Study|Adverse Event|2|||
48943106|NCT01824602|157620979|FG000|Overall Study|Treatment failure|0|||
48943107|NCT01824602|157620980|FG001|Overall Study|Treatment failure|0|||
48943108|NCT01824602|157620981|FG002|Overall Study|Treatment failure|0|||
48943109|NCT01824602|157620982|FG003|Overall Study|Treatment failure|1|||
48943110|NCT03138564|157620989|FG000|Overall Study|Death of patient prior to the Week 2 assessment|14|||
48943111|NCT03138564|157620990|FG001|Overall Study|Death of patient prior to the Week 2 assessment|2|||
48943112|NCT03138564|157620989|FG000|Overall Study|Lost to Follow-up|16|||
48943113|NCT03138564|157620990|FG001|Overall Study|Lost to Follow-up|2|||
48943114|NCT03138564|157620989|FG000|Overall Study|Withdrawal by Subject|48|||
48943115|NCT03138564|157620990|FG001|Overall Study|Withdrawal by Subject|4|||
48943116|NCT03138564|157620989|FG000|Overall Study|No longer met eligibility criteria|2|||
48943117|NCT03138564|157620990|FG001|Overall Study|No longer met eligibility criteria|0|||
48943118|NCT03138564|157620989|FG000|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|4|||
48943119|NCT03138564|157620990|FG001|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|0|||
48943120|NCT03138564|157620989|FG000|Overall Study|Patient died before surrogate completed Week 2 assessment|12|||
48943121|NCT03138564|157620990|FG001|Overall Study|Patient died before surrogate completed Week 2 assessment|0|||
48943122|NCT03138564|157620989|FG000|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|0|||
48943123|NCT03138564|157620990|FG001|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|1|||
48943124|NCT03138564|157620989|FG000|Overall Study|Death of surrogate prior to Week 2 assessment|1|||
48943125|NCT03138564|157620990|FG001|Overall Study|Death of surrogate prior to Week 2 assessment|0|||
48943126|NCT00814710|157620991|FG000|Overall Study|Adverse Event|1|||
48943127|NCT00814710|157620992|FG001|Overall Study|Adverse Event|0|||
48943128|NCT00814710|157620991|FG000|Overall Study|Lost to Follow-up|7|||
48943129|NCT00814710|157620992|FG001|Overall Study|Lost to Follow-up|3|||
48943130|NCT02609399|157620993|FG000|Influenza Season 2015-2016|Lost to Follow-up|3|||
48943131|NCT02609399|157620994|FG001|Influenza Season 2015-2016|Lost to Follow-up|2|||
48943132|NCT02609399|157620993|FG000|Influenza Season 2016-2017|Lost to Follow-up|8|||
48943133|NCT02609399|157620994|FG001|Influenza Season 2016-2017|Lost to Follow-up|5|||
48943134|NCT02609399|157620993|FG000|Influenza Season 2016-2017|Found ineligible after randomization|1|||
48943135|NCT02609399|157620994|FG001|Influenza Season 2016-2017|Found ineligible after randomization|0|||
48943136|NCT03476239|157620995|FG000|Overall Study|Withdrawal by Subject|10|||
48943137|NCT03476239|157620995|FG000|Overall Study|Death|80|||
48943138|NCT03476239|157620995|FG000|Overall Study|Lost to Follow-up|8|||
48943139|NCT03191786|157620996|FG000|Overall Study|Death|236|||
48943140|NCT03191786|157620997|FG001|Overall Study|Death|127|||
48943141|NCT03191786|157620996|FG000|Overall Study|Lost to Follow-up|9|||
48943142|NCT03191786|157620997|FG001|Overall Study|Lost to Follow-up|3|||
48943143|NCT03191786|157620996|FG000|Overall Study|Physician Decision|1|||
48943144|NCT03191786|157620997|FG001|Overall Study|Physician Decision|0|||
48943145|NCT03191786|157620996|FG000|Overall Study|Moved to Post Trial Access Program|30|||
48943146|NCT03191786|157620997|FG001|Overall Study|Moved to Post Trial Access Program|5|||
48943147|NCT03191786|157620996|FG000|Overall Study|Withdrawal by Subject|26|||
48943148|NCT03191786|157620997|FG001|Overall Study|Withdrawal by Subject|16|||
48943149|NCT00075881|157622570|FG000|Overall Study|Lack of Efficacy|18|||
48943150|NCT00075881|157622570|FG000|Overall Study|Adverse Event|7|||
48943151|NCT00075881|157622570|FG000|Overall Study|Death|1|||
48943152|NCT00075881|157622570|FG000|Overall Study|Withdrawal by Subject|2|||
48943153|NCT00075881|157622570|FG000|Overall Study|Protocol Violation|4|||
48943154|NCT00075881|157622570|FG000|Overall Study|other complicating disease|3|||
48943155|NCT00075881|157622570|FG000|Overall Study|other|4|||
48943156|NCT00075881|157622570|FG000|Overall Study|missing data|2|||
48943157|NCT00075881|157622570|FG000|Overall Study|Ineligible|1|||
48943158|NCT00075881|157622570|FG000|Overall Study|never start protocol therapy|1|||
48943159|NCT03019549|157622571|FG000|Washout|DId not meet genotype criteria|11|||
48943160|NCT03019549|157622571|FG000|Period 2|Adverse Event|2|||
48943161|NCT03019549|157622571|FG000|Period 2|Physician Decision|2|||
48943162|NCT03019549|157622571|FG000|Period 2|Withdrawal by Subject|1|||
48943163|NCT03263806|157622572|FG000|Overall Study|Elevated Troponin (failed screen)|1|||
48943164|NCT03263806|157622573|FG001|Overall Study|Elevated Troponin (failed screen)|0|||
48943165|NCT03263806|157622572|FG000|Overall Study|Withdrawal by Subject|0|||
48943166|NCT03263806|157622573|FG001|Overall Study|Withdrawal by Subject|1|||
48943167|NCT03263806|157622572|FG000|Overall Study|Study Termination|5|||
48943168|NCT03263806|157622573|FG001|Overall Study|Study Termination|6|||
48943169|NCT01412879|157622574|FG000|Initial Registration (Induction Therapy)|Adverse Event|5|||
48943170|NCT01412879|157622575|FG001|Initial Registration (Induction Therapy)|Adverse Event|3|||
48943171|NCT01412879|157622576|FG002|Initial Registration (Induction Therapy)|Adverse Event|0|||
48943172|NCT01412879|157622574|FG000|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1|||
48943173|NCT01412879|157622575|FG001|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3|||
48943174|NCT01412879|157622576|FG002|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0|||
48943175|NCT01412879|157622574|FG000|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
48943176|NCT01412879|157622575|FG001|Initial Registration (Induction Therapy)|Progression/Relapse|1|||
48943177|NCT01412879|157622576|FG002|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
48943178|NCT01412879|157622574|FG000|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6|||
48943179|NCT01412879|157622575|FG001|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1|||
48943180|NCT01412879|157622576|FG002|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0|||
48943181|NCT01412879|157622574|FG000|Initial Registration (Induction Therapy)|Treatment not Given|1|||
48943182|NCT01412879|157622575|FG001|Initial Registration (Induction Therapy)|Treatment not Given|0|||
48943183|NCT01412879|157622576|FG002|Initial Registration (Induction Therapy)|Treatment not Given|0|||
48943184|NCT04030195|157622577|FG000|Overall Study|Withdrawal by Subject|2|||
48943185|NCT04030195|157622578|FG001|Overall Study|Withdrawal by Subject|0|||
48943186|NCT04030195|157622579|FG002|Overall Study|Withdrawal by Subject|0|||
48943187|NCT02109029|157622580|FG000|Part B|Adverse Event|0|||
48943188|NCT02109029|157622581|FG001|Part B|Adverse Event|0|||
48943189|NCT02109029|157622582|FG002|Part B|Adverse Event|0|||
48943190|NCT02109029|157622583|FG003|Part B|Adverse Event|0|||
48943191|NCT02109029|157622584|FG004|Part B|Adverse Event|1|||
48943192|NCT02109029|157622585|FG005|Part B|Adverse Event|1|||
48943193|NCT04840667|157622586|FG000|Overall Study|Screen failures/ Failure to meet inclusion criteria|17|||
48943194|NCT01672892|157622587|FG000|Overall Study|Protocol Violation|7|||
48943195|NCT01672892|157622588|FG001|Overall Study|Protocol Violation|3|||
48943196|NCT02243176|157622603|FG000|Overall Study|Other reason|1|||
48943197|NCT02243176|157622604|FG001|Overall Study|Other reason|2|||
48943198|NCT02243176|157622603|FG000|Overall Study|protocol specified withdrawal critera|1|||
48943199|NCT02243176|157622604|FG001|Overall Study|protocol specified withdrawal critera|3|||
48943200|NCT02243176|157622603|FG000|Overall Study|Protocol Violation|2|||
48943201|NCT02243176|157622604|FG001|Overall Study|Protocol Violation|1|||
48943202|NCT02243176|157622603|FG000|Overall Study|Withdrawal by Subject|8|||
48943203|NCT02243176|157622604|FG001|Overall Study|Withdrawal by Subject|7|||
48943204|NCT02243176|157622603|FG000|Overall Study|Adverse Event|2|||
48943205|NCT02243176|157622604|FG001|Overall Study|Adverse Event|2|||
48943206|NCT01024244|157622605|FG000|Overall Study|Adverse Event|1|||
48943207|NCT01024244|157622606|FG001|Overall Study|Adverse Event|2|||
48943208|NCT01024244|157622607|FG002|Overall Study|Adverse Event|0|||
48943209|NCT01024244|157622608|FG003|Overall Study|Adverse Event|1|||
48943210|NCT01024244|157622609|FG004|Overall Study|Adverse Event|2|||
48943211|NCT01024244|157622605|FG000|Overall Study|Entry Criteria Not Met|0|||
48943212|NCT01024244|157622606|FG001|Overall Study|Entry Criteria Not Met|1|||
48943213|NCT01024244|157622607|FG002|Overall Study|Entry Criteria Not Met|0|||
48943214|NCT01024244|157622608|FG003|Overall Study|Entry Criteria Not Met|0|||
48943215|NCT01024244|157622609|FG004|Overall Study|Entry Criteria Not Met|0|||
48943216|NCT01024244|157622605|FG000|Overall Study|Lack of Efficacy|1|||
48943217|NCT01024244|157622606|FG001|Overall Study|Lack of Efficacy|0|||
48943218|NCT01024244|157622607|FG002|Overall Study|Lack of Efficacy|0|||
48943219|NCT01024244|157622608|FG003|Overall Study|Lack of Efficacy|0|||
48943220|NCT01024244|157622609|FG004|Overall Study|Lack of Efficacy|0|||
48849570|NCT03170882|157288858|FG001|Overall Study|Withdrawal by Subject|7|||
48849571|NCT03170882|157288857|FG000|Overall Study|Reason not Specified|28|||
48943221|NCT01024244|157622605|FG000|Overall Study|Protocol Violation|1|||
48943222|NCT01024244|157622606|FG001|Overall Study|Protocol Violation|0|||
48943223|NCT01024244|157622607|FG002|Overall Study|Protocol Violation|0|||
48943224|NCT01024244|157622608|FG003|Overall Study|Protocol Violation|0|||
48943225|NCT01024244|157622609|FG004|Overall Study|Protocol Violation|2|||
48943226|NCT01024244|157622605|FG000|Overall Study|Sponsor Decision|14|||
48943227|NCT01024244|157622606|FG001|Overall Study|Sponsor Decision|7|||
48943228|NCT01024244|157622607|FG002|Overall Study|Sponsor Decision|14|||
48943229|NCT01024244|157622608|FG003|Overall Study|Sponsor Decision|12|||
48943230|NCT01024244|157622609|FG004|Overall Study|Sponsor Decision|10|||
48943231|NCT01024244|157622605|FG000|Overall Study|Withdrawal by Subject|0|||
48943232|NCT01024244|157622606|FG001|Overall Study|Withdrawal by Subject|1|||
48943233|NCT01024244|157622607|FG002|Overall Study|Withdrawal by Subject|0|||
48849572|NCT03170882|157288858|FG001|Overall Study|Reason not Specified|36|||
48943234|NCT01024244|157622608|FG003|Overall Study|Withdrawal by Subject|0|||
48943235|NCT01024244|157622609|FG004|Overall Study|Withdrawal by Subject|0|||
48943236|NCT01609933|157622611|FG000|Overall Study|Adverse Event|1|||
48943237|NCT01609933|157622611|FG000|Overall Study|Withdrawal by Subject|3|||
48943238|NCT01252966|157622612|FG000|Overall Study|Lost to Follow-up|16|||
48943239|NCT01252966|157622613|FG001|Overall Study|Lost to Follow-up|10|||
48943240|NCT01252966|157622612|FG000|Overall Study|Withdrawal by Subject|7|||
48943241|NCT01252966|157622613|FG001|Overall Study|Withdrawal by Subject|3|||
48943242|NCT03716726|157622614|FG000|Completed Baseline Assessment|Did not complete baseline assessment|10|||
48943243|NCT03716726|157622615|FG001|Completed Baseline Assessment|Did not complete baseline assessment|12|||
48943244|NCT03716726|157622614|FG000|12 Months Followup|Lost to Follow-up|10|||
48943245|NCT03716726|157622615|FG001|12 Months Followup|Lost to Follow-up|17|||
48943246|NCT00783289|157622618|FG000|Overall Study|Protocol Violation|0|||
48943247|NCT00783289|157622619|FG001|Overall Study|Protocol Violation|1|||
48943248|NCT00783289|157622620|FG002|Overall Study|Protocol Violation|0|||
48943249|NCT00783289|157622621|FG003|Overall Study|Protocol Violation|0|||
48943250|NCT00506389|157622622|FG000|In-treatment Period|Other|3|||
48943251|NCT00506389|157622623|FG001|In-treatment Period|Other|3|||
48943252|NCT00506389|157622624|FG002|In-treatment Period|Other|4|||
48943253|NCT00506389|157622622|FG000|In-treatment Period|Lost to Follow-up|0|||
48943254|NCT00506389|157622623|FG001|In-treatment Period|Lost to Follow-up|0|||
48943255|NCT00506389|157622624|FG002|In-treatment Period|Lost to Follow-up|1|||
48943256|NCT00506389|157622622|FG000|In-treatment Period|Lack of compliance|1|||
48943257|NCT00506389|157622623|FG001|In-treatment Period|Lack of compliance|0|||
48943258|NCT00506389|157622624|FG002|In-treatment Period|Lack of compliance|0|||
48943259|NCT00506389|157622622|FG000|In-treatment Period|Reasons not related to trial|4|||
48943260|NCT00506389|157622623|FG001|In-treatment Period|Reasons not related to trial|1|||
48943261|NCT00506389|157622624|FG002|In-treatment Period|Reasons not related to trial|0|||
48849573|NCT02844439|157288861|FG000|Overall Study|Withdrawal by Subject|1|||
48849574|NCT02844439|157288861|FG000|Overall Study|Lost to Follow-up|2|||
48849575|NCT02844439|157288861|FG000|Overall Study|Termination by Sponsor|4|||
48849576|NCT02844439|157288861|FG000|Overall Study|Death|28|||
48849577|NCT02844439|157288861|FG000|Overall Study|Other|5|||
48849578|NCT01638000|157288864|FG000|Overall Study|Randomized but Never Received Drug|7|||
48849579|NCT01638000|157288865|FG001|Overall Study|Randomized but Never Received Drug|10|||
48849580|NCT01638000|157288864|FG000|Overall Study|Adverse Event|14|||
48849581|NCT01638000|157288865|FG001|Overall Study|Adverse Event|16|||
48849582|NCT01638000|157288864|FG000|Overall Study|Lack of Efficacy|5|||
48849583|NCT01638000|157288865|FG001|Overall Study|Lack of Efficacy|6|||
48849584|NCT01638000|157288864|FG000|Overall Study|Protocol Violation|11|||
48943262|NCT00506389|157622622|FG000|In-treatment Period|Withdrawal by Subject|3|||
48943263|NCT00506389|157622623|FG001|In-treatment Period|Withdrawal by Subject|3|||
48943264|NCT00506389|157622624|FG002|In-treatment Period|Withdrawal by Subject|4|||
48943265|NCT00506389|157622622|FG000|In-treatment Period|Lack of Efficacy|0|||
48943266|NCT00506389|157622623|FG001|In-treatment Period|Lack of Efficacy|2|||
48943267|NCT00506389|157622624|FG002|In-treatment Period|Lack of Efficacy|0|||
48943268|NCT00506389|157622622|FG000|In-treatment Period|Adverse Event|11|||
48943269|NCT00506389|157622623|FG001|In-treatment Period|Adverse Event|5|||
48943270|NCT00506389|157622624|FG002|In-treatment Period|Adverse Event|2|||
48943271|NCT00506389|157622622|FG000|In-treatment Period|Randomized but not treated|4|||
48943272|NCT00506389|157622623|FG001|In-treatment Period|Randomized but not treated|1|||
48943273|NCT00506389|157622624|FG002|In-treatment Period|Randomized but not treated|1|||
48943274|NCT01584024|157622625|FG000|Overall Study|Lost to Follow-up|10|||
48943275|NCT01584024|157622625|FG000|Overall Study|Withdrawal by Subject|3|||
48943276|NCT00942409|157622629|FG000|Overall Study|Lack of Efficacy|1|||
48943277|NCT00942409|157622629|FG000|Overall Study|study drug unavailable|2|||
48943278|NCT01486264|157622630|FG000|Overall Study|Death|1|||
48943279|NCT01486264|157622631|FG001|Overall Study|Death|1|||
48943280|NCT01486264|157622630|FG000|Overall Study|Adverse Event|3|||
48943281|NCT01486264|157622631|FG001|Overall Study|Adverse Event|3|||
48943282|NCT01486264|157622630|FG000|Overall Study|Lack of Efficacy|6|||
48943283|NCT01486264|157622631|FG001|Overall Study|Lack of Efficacy|10|||
48943284|NCT01486264|157622630|FG000|Overall Study|Withdrawal by Subject|7|||
48943285|NCT01486264|157622631|FG001|Overall Study|Withdrawal by Subject|18|||
48943286|NCT01486264|157622630|FG000|Overall Study|Physician Decision|1|||
48943287|NCT01486264|157622631|FG001|Overall Study|Physician Decision|1|||
48943288|NCT01486264|157622630|FG000|Overall Study|Protocol Violation|3|||
48943289|NCT01486264|157622631|FG001|Overall Study|Protocol Violation|0|||
48943290|NCT01486264|157622630|FG000|Overall Study|Lost to Follow-up|3|||
48943291|NCT01486264|157622631|FG001|Overall Study|Lost to Follow-up|2|||
48943292|NCT01486264|157622630|FG000|Overall Study|Other|5|||
48943293|NCT01486264|157622631|FG001|Overall Study|Other|11|||
48943294|NCT01486264|157622630|FG000|Overall Study|Not treated|0|||
48943295|NCT01486264|157622631|FG001|Overall Study|Not treated|1|||
48943296|NCT01531725|157622632|FG000|Overall Study|Protocol Violation|5|||
48943297|NCT04734873|157622634|FG000|Overall Study|Lost to Follow-up|1|||
48943298|NCT04734873|157622635|FG001|Overall Study|Lost to Follow-up|3|||
48943299|NCT04734873|157622636|FG002|Overall Study|Lost to Follow-up|2|||
48943300|NCT04734873|157622634|FG000|Overall Study|Randomized but not dosed|1|||
48943301|NCT04734873|157622635|FG001|Overall Study|Randomized but not dosed|0|||
48943302|NCT04734873|157622636|FG002|Overall Study|Randomized but not dosed|1|||
48943303|NCT03215277|157622637|FG000|Overall Study|Adverse Event|2|||
48943304|NCT03215277|157622638|FG001|Overall Study|Adverse Event|3|||
48943305|NCT03215277|157622637|FG000|Overall Study|Death|1|||
48943306|NCT03215277|157622638|FG001|Overall Study|Death|0|||
48943307|NCT03215277|157622637|FG000|Overall Study|Lost to Follow-up|0|||
48943308|NCT03215277|157622638|FG001|Overall Study|Lost to Follow-up|1|||
48943309|NCT03215277|157622637|FG000|Overall Study|Participant was unable to attend clinic visit|0|||
48943310|NCT03215277|157622638|FG001|Overall Study|Participant was unable to attend clinic visit|1|||
48943311|NCT05309083|157622639|FG000|Overall Study|Withdrawal by Subject|2|||
48943312|NCT00684814|157622641|FG000|Washout Period of 7 Days|Adverse Event|1|||
48943313|NCT00684814|157622642|FG001|Washout Period of 7 Days|Adverse Event|2|||
48943314|NCT00684814|157622641|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
48943315|NCT00684814|157622642|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
48943316|NCT00684814|157622641|FG000|Second Intervention|Adverse Event|1|||
48943317|NCT00684814|157622642|FG001|Second Intervention|Adverse Event|0|||
48943318|NCT03596164|157622643|FG000|Overall Study|Adverse Event|0|||
48943319|NCT03596164|157622644|FG001|Overall Study|Adverse Event|1|||
48943320|NCT03596164|157622643|FG000|Overall Study|Death|1|||
48943321|NCT03596164|157622644|FG001|Overall Study|Death|0|||
48943322|NCT00446030|157622645|FG000|TREATMENT (up to 52 Weeks)|Adverse Event|29|||
48943323|NCT00446030|157622646|FG001|TREATMENT (up to 52 Weeks)|Adverse Event|8|||
48943324|NCT00446030|157622645|FG000|TREATMENT (up to 52 Weeks)|Subject Request|9|||
48943325|NCT00446030|157622646|FG001|TREATMENT (up to 52 Weeks)|Subject Request|1|||
48943326|NCT00446030|157622645|FG000|TREATMENT (up to 52 Weeks)|Poor compliance|1|||
48943327|NCT00446030|157622646|FG001|TREATMENT (up to 52 Weeks)|Poor compliance|0|||
48943328|NCT00446030|157622645|FG000|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1|||
48943329|NCT00446030|157622646|FG001|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0|||
48943330|NCT00446030|157622645|FG000|TREATMENT (up to 52 Weeks)|Protocol Violation|1|||
48943331|NCT00446030|157622646|FG001|TREATMENT (up to 52 Weeks)|Protocol Violation|0|||
48943332|NCT00446030|157622645|FG000|TREATMENT (up to 52 Weeks)|Physician Decision|1|||
48943333|NCT00446030|157622646|FG001|TREATMENT (up to 52 Weeks)|Physician Decision|0|||
48943334|NCT00446030|157622645|FG000|TREATMENT (up to 52 Weeks)|Patient concern|1|||
48943335|NCT00446030|157622646|FG001|TREATMENT (up to 52 Weeks)|Patient concern|0|||
48943336|NCT00446030|157622645|FG000|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1|||
48943337|NCT00446030|157622646|FG001|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0|||
48943338|NCT00446030|157622645|FG000|FOLLOW-UP (up to 2-years)|Subject's request|9|||
48943339|NCT00446030|157622646|FG001|FOLLOW-UP (up to 2-years)|Subject's request|4|||
48943340|NCT00446030|157622645|FG000|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5|||
48943341|NCT00446030|157622646|FG001|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0|||
48943342|NCT00446030|157622645|FG000|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4|||
48943343|NCT00446030|157622646|FG001|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0|||
48943344|NCT00446030|157622645|FG000|FOLLOW-UP (up to 2-years)|Death|2|||
48943345|NCT00446030|157622646|FG001|FOLLOW-UP (up to 2-years)|Death|2|||
48943346|NCT00446030|157622645|FG000|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3|||
48943347|NCT00446030|157622646|FG001|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2|||
48943348|NCT00446030|157622645|FG000|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2|||
48943349|NCT00446030|157622646|FG001|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0|||
48943350|NCT00446030|157622645|FG000|FOLLOW-UP (up to 2-years)|Per physician discretion|2|||
48943351|NCT00446030|157622646|FG001|FOLLOW-UP (up to 2-years)|Per physician discretion|0|||
48943352|NCT00446030|157622645|FG000|FOLLOW-UP (up to 2-years)|Protocol Violation|1|||
48943353|NCT00446030|157622646|FG001|FOLLOW-UP (up to 2-years)|Protocol Violation|0|||
48943354|NCT00446030|157622645|FG000|FOLLOW-UP (up to 2-years)|Patient concern|1|||
48943355|NCT00446030|157622646|FG001|FOLLOW-UP (up to 2-years)|Patient concern|0|||
48943356|NCT00446030|157622645|FG000|FOLLOW-UP (up to 2-years)|Right axilla wound|1|||
48943357|NCT00446030|157622646|FG001|FOLLOW-UP (up to 2-years)|Right axilla wound|0|||
48943358|NCT00446030|157622645|FG000|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0|||
48943359|NCT00446030|157622646|FG001|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1|||
48943360|NCT02886715|157622647|FG000|Overall Study|Non-Compliance With Study Drug|0|||
48943361|NCT02886715|157622648|FG001|Overall Study|Non-Compliance With Study Drug|2|||
48943362|NCT02886715|157622649|FG002|Overall Study|Non-Compliance With Study Drug|0|||
48943363|NCT02886715|157622647|FG000|Overall Study|Adverse Event|4|||
48943364|NCT02886715|157622648|FG001|Overall Study|Adverse Event|2|||
48943365|NCT02886715|157622649|FG002|Overall Study|Adverse Event|0|||
48943366|NCT02886715|157622647|FG000|Overall Study|Lack of Efficacy|0|||
48943367|NCT02886715|157622648|FG001|Overall Study|Lack of Efficacy|2|||
48943368|NCT02886715|157622649|FG002|Overall Study|Lack of Efficacy|1|||
48943369|NCT02886715|157622647|FG000|Overall Study|Lost to Follow-up|29|||
48943370|NCT02886715|157622648|FG001|Overall Study|Lost to Follow-up|26|||
48943371|NCT02886715|157622649|FG002|Overall Study|Lost to Follow-up|10|||
48943372|NCT02886715|157622647|FG000|Overall Study|Pregnancy|1|||
48943373|NCT02886715|157622648|FG001|Overall Study|Pregnancy|1|||
48943374|NCT02886715|157622649|FG002|Overall Study|Pregnancy|1|||
48943375|NCT02886715|157622647|FG000|Overall Study|Protocol Violation|3|||
48943376|NCT02886715|157622648|FG001|Overall Study|Protocol Violation|2|||
48943377|NCT02886715|157622649|FG002|Overall Study|Protocol Violation|1|||
48943378|NCT02886715|157622647|FG000|Overall Study|Withdrawal by Subject|20|||
48943379|NCT02886715|157622648|FG001|Overall Study|Withdrawal by Subject|18|||
48943380|NCT02886715|157622649|FG002|Overall Study|Withdrawal by Subject|5|||
48943381|NCT02886715|157622647|FG000|Overall Study|missing|7|||
48943382|NCT02886715|157622648|FG001|Overall Study|missing|2|||
48943383|NCT02886715|157622649|FG002|Overall Study|missing|2|||
48943384|NCT00117312|157622650|FG000|Overall Study|Testosterone >1.0 ng/mL|9|||
48943385|NCT00117312|157622651|FG001|Overall Study|Testosterone >1.0 ng/mL|9|||
48943386|NCT00117312|157622652|FG002|Overall Study|Testosterone >1.0 ng/mL|5|||
48943387|NCT00117312|157622653|FG003|Overall Study|Testosterone >1.0 ng/mL|9|||
48943388|NCT00117312|157622650|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
48943389|NCT00117312|157622651|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
48943390|NCT00117312|157622652|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
48943391|NCT00117312|157622653|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
48943392|NCT00117312|157622650|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
48943393|NCT00117312|157622651|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
48943394|NCT00117312|157622652|FG002|Overall Study|Prostate-specific antigen increase >=25%|5|||
48943395|NCT00117312|157622653|FG003|Overall Study|Prostate-specific antigen increase >=25%|3|||
48943396|NCT00117312|157622650|FG000|Overall Study|Other|0|||
48943397|NCT00117312|157622651|FG001|Overall Study|Other|1|||
48943398|NCT00117312|157622652|FG002|Overall Study|Other|3|||
48943399|NCT00117312|157622653|FG003|Overall Study|Other|1|||
48943400|NCT00117312|157622650|FG000|Overall Study|Patient choice|0|||
48943401|NCT00117312|157622651|FG001|Overall Study|Patient choice|0|||
48943402|NCT00117312|157622652|FG002|Overall Study|Patient choice|2|||
48943403|NCT00117312|157622653|FG003|Overall Study|Patient choice|1|||
48943404|NCT00117312|157622650|FG000|Overall Study|Adverse Event|0|||
48943405|NCT00117312|157622651|FG001|Overall Study|Adverse Event|2|||
48943406|NCT00117312|157622652|FG002|Overall Study|Adverse Event|0|||
48943407|NCT00117312|157622653|FG003|Overall Study|Adverse Event|0|||
48943408|NCT00117312|157622650|FG000|Overall Study|Protocol Violation|0|||
48943409|NCT00117312|157622651|FG001|Overall Study|Protocol Violation|1|||
48943410|NCT00117312|157622652|FG002|Overall Study|Protocol Violation|3|||
48943411|NCT00117312|157622653|FG003|Overall Study|Protocol Violation|0|||
48943412|NCT00117312|157622650|FG000|Overall Study|PSA decrease <=50%|0|||
48943413|NCT00117312|157622651|FG001|Overall Study|PSA decrease <=50%|2|||
48943414|NCT00117312|157622652|FG002|Overall Study|PSA decrease <=50%|2|||
48943415|NCT00117312|157622653|FG003|Overall Study|PSA decrease <=50%|4|||
48943416|NCT00117312|157622650|FG000|Overall Study|PSA increase >= 10ng/mL|0|||
48943417|NCT00117312|157622651|FG001|Overall Study|PSA increase >= 10ng/mL|1|||
48943418|NCT00117312|157622652|FG002|Overall Study|PSA increase >= 10ng/mL|1|||
48943419|NCT00117312|157622653|FG003|Overall Study|PSA increase >= 10ng/mL|0|||
48943420|NCT00117312|157622650|FG000|Overall Study|Hepatic abnormality|0|||
48943421|NCT00117312|157622651|FG001|Overall Study|Hepatic abnormality|1|||
48849585|NCT01638000|157288865|FG001|Overall Study|Protocol Violation|13|||
48943422|NCT00117312|157622652|FG002|Overall Study|Hepatic abnormality|0|||
48943423|NCT00117312|157622653|FG003|Overall Study|Hepatic abnormality|1|||
48943424|NCT00117312|157622650|FG000|Overall Study|Withdrawal by Subject|0|||
48943425|NCT00117312|157622651|FG001|Overall Study|Withdrawal by Subject|2|||
48943426|NCT00117312|157622652|FG002|Overall Study|Withdrawal by Subject|0|||
48943427|NCT00117312|157622653|FG003|Overall Study|Withdrawal by Subject|0|||
48943428|NCT01120626|157622654|FG000|Overall Study|Withdrawal by Subject|1|||
48943429|NCT01120626|157622655|FG001|Overall Study|Withdrawal by Subject|0|||
48943430|NCT00327444|157622657|FG000|Double Blind Treatment (DB) Period|Disease progression|10|||
48943431|NCT00327444|157622658|FG001|Double Blind Treatment (DB) Period|Disease progression|13|||
48943432|NCT00327444|157622657|FG000|Double Blind Treatment (DB) Period|Adverse Event|5|||
48943433|NCT00327444|157622658|FG001|Double Blind Treatment (DB) Period|Adverse Event|5|||
48943434|NCT00327444|157622657|FG000|Double Blind Treatment (DB) Period|Subject request|0|||
48943435|NCT00327444|157622658|FG001|Double Blind Treatment (DB) Period|Subject request|1|||
48943436|NCT00327444|157622657|FG000|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11|||
48943437|NCT00327444|157622658|FG001|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10|||
48943438|NCT00327444|157622657|FG000|Open Label Treatment (OL) Period|Disease progression|8|||
48943439|NCT00327444|157622658|FG001|Open Label Treatment (OL) Period|Disease progression|7|||
48943440|NCT00327444|157622657|FG000|Open Label Treatment (OL) Period|Adverse Event|2|||
48943441|NCT00327444|157622658|FG001|Open Label Treatment (OL) Period|Adverse Event|2|||
48943442|NCT00327444|157622657|FG000|Open Label Treatment (OL) Period|Worsening dyspnea|0|||
48943443|NCT00327444|157622658|FG001|Open Label Treatment (OL) Period|Worsening dyspnea|1|||
48943444|NCT00327444|157622657|FG000|Open Label Treatment (OL) Period|Ongoing Treatment|1|||
48943445|NCT00327444|157622658|FG001|Open Label Treatment (OL) Period|Ongoing Treatment|0|||
48943446|NCT04814823|157622659|FG000|Overall Study|Could not obtain valid arterial line for subject|2|||
48943447|NCT03301857|157622660|FG000|Overall Study|Death|0|||
48943448|NCT03301857|157622661|FG001|Overall Study|Death|2|||
48943449|NCT03301857|157622660|FG000|Overall Study|Lost to Follow-up|4|||
48943450|NCT03301857|157622661|FG001|Overall Study|Lost to Follow-up|2|||
48943451|NCT03301857|157622660|FG000|Overall Study|Decision by Sponsor|6|||
48943452|NCT03301857|157622661|FG001|Overall Study|Decision by Sponsor|0|||
48943453|NCT03301857|157622660|FG000|Overall Study|Withdrawal by Subject|12|||
48943454|NCT03301857|157622661|FG001|Overall Study|Withdrawal by Subject|4|||
48943455|NCT00847613|157622666|FG000|Overall Study|Ongoing at cut-off date|250|||
48943456|NCT00847613|157622667|FG001|Overall Study|Ongoing at cut-off date|265|||
48943457|NCT00847613|157622668|FG002|Overall Study|Ongoing at cut-off date|64|||
48943458|NCT00847613|157622669|FG003|Overall Study|Ongoing at cut-off date|64|||
48943459|NCT00847613|157622666|FG000|Overall Study|Death|1|||
48943460|NCT00847613|157622667|FG001|Overall Study|Death|1|||
48943461|NCT00847613|157622668|FG002|Overall Study|Death|0|||
48943462|NCT00847613|157622669|FG003|Overall Study|Death|0|||
48943463|NCT00847613|157622666|FG000|Overall Study|Adverse Event|36|||
48943464|NCT00847613|157622667|FG001|Overall Study|Adverse Event|26|||
48943465|NCT00847613|157622668|FG002|Overall Study|Adverse Event|5|||
48849586|NCT01638000|157288864|FG000|Overall Study|Withdrawal by Subject|21|||
48849587|NCT01638000|157288865|FG001|Overall Study|Withdrawal by Subject|24|||
48849588|NCT01638000|157288864|FG000|Overall Study|Miscellaneous|2|||
48849589|NCT01638000|157288865|FG001|Overall Study|Miscellaneous|2|||
48849590|NCT05580003|157288866|FG000|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48849591|NCT05580003|157288867|FG001|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48849592|NCT05580003|157288868|FG002|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48849593|NCT05580003|157288869|FG003|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48849594|NCT05580003|157288870|FG004|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48849595|NCT05580003|157288871|FG005|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48849596|NCT05580003|157288872|FG006|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
48849597|NCT05580003|157288873|FG007|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48849598|NCT05580003|157288874|FG008|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48849599|NCT05580003|157288875|FG009|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48849600|NCT05580003|157288876|FG010|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48849601|NCT05580003|157288877|FG011|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48849602|NCT05580003|157288878|FG012|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48849603|NCT05580003|157288879|FG013|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48849604|NCT05580003|157288880|FG014|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48849605|NCT05580003|157288881|FG015|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48849606|NCT05580003|157288882|FG016|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48943466|NCT00847613|157622669|FG003|Overall Study|Adverse Event|6|||
48943467|NCT00847613|157622666|FG000|Overall Study|Lack of Efficacy|7|||
48943468|NCT00847613|157622667|FG001|Overall Study|Lack of Efficacy|3|||
48943469|NCT00847613|157622668|FG002|Overall Study|Lack of Efficacy|3|||
48943470|NCT00847613|157622669|FG003|Overall Study|Lack of Efficacy|1|||
48943471|NCT00847613|157622666|FG000|Overall Study|Study terminated by Sponsor|1|||
48943472|NCT00847613|157622667|FG001|Overall Study|Study terminated by Sponsor|0|||
48943473|NCT00847613|157622668|FG002|Overall Study|Study terminated by Sponsor|2|||
48943474|NCT00847613|157622669|FG003|Overall Study|Study terminated by Sponsor|1|||
48943475|NCT00847613|157622666|FG000|Overall Study|Lost to Follow-up|5|||
48943476|NCT00847613|157622667|FG001|Overall Study|Lost to Follow-up|0|||
48943477|NCT00847613|157622668|FG002|Overall Study|Lost to Follow-up|0|||
48943478|NCT00847613|157622669|FG003|Overall Study|Lost to Follow-up|3|||
48943479|NCT00847613|157622666|FG000|Overall Study|Protocol Violation|6|||
48943480|NCT00847613|157622667|FG001|Overall Study|Protocol Violation|6|||
48943481|NCT00847613|157622668|FG002|Overall Study|Protocol Violation|3|||
48943482|NCT00847613|157622669|FG003|Overall Study|Protocol Violation|1|||
48943483|NCT00847613|157622666|FG000|Overall Study|Pregnancy|1|||
48849607|NCT05580003|157288883|FG017|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48943484|NCT00847613|157622667|FG001|Overall Study|Pregnancy|1|||
48943485|NCT00847613|157622668|FG002|Overall Study|Pregnancy|0|||
48943486|NCT00847613|157622669|FG003|Overall Study|Pregnancy|0|||
48943487|NCT00847613|157622666|FG000|Overall Study|Site closure|1|||
48943488|NCT00847613|157622667|FG001|Overall Study|Site closure|0|||
48943489|NCT00847613|157622668|FG002|Overall Study|Site closure|0|||
48943490|NCT00847613|157622669|FG003|Overall Study|Site closure|1|||
48943491|NCT00847613|157622666|FG000|Overall Study|Withdrawal by Subject|8|||
48943492|NCT00847613|157622667|FG001|Overall Study|Withdrawal by Subject|11|||
48943493|NCT00847613|157622668|FG002|Overall Study|Withdrawal by Subject|2|||
48943494|NCT00847613|157622669|FG003|Overall Study|Withdrawal by Subject|2|||
48943495|NCT00847613|157622666|FG000|Overall Study|Participant moved|4|||
48943496|NCT00847613|157622667|FG001|Overall Study|Participant moved|1|||
48943497|NCT00847613|157622668|FG002|Overall Study|Participant moved|0|||
48943498|NCT00847613|157622669|FG003|Overall Study|Participant moved|0|||
48943499|NCT00847613|157622666|FG000|Overall Study|Sponsor request|0|||
48943500|NCT00847613|157622667|FG001|Overall Study|Sponsor request|1|||
48943501|NCT00847613|157622668|FG002|Overall Study|Sponsor request|0|||
48943502|NCT00847613|157622669|FG003|Overall Study|Sponsor request|0|||
48943503|NCT00847613|157622666|FG000|Overall Study|Randomized, but not treated|0|||
48943504|NCT00847613|157622667|FG001|Overall Study|Randomized, but not treated|3|||
48943505|NCT00847613|157622668|FG002|Overall Study|Randomized, but not treated|0|||
48943506|NCT00847613|157622669|FG003|Overall Study|Randomized, but not treated|0|||
48943507|NCT00847613|157622666|FG000|Overall Study|Other|1|||
48849608|NCT05580003|157288884|FG018|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48849609|NCT05580003|157288885|FG019|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48849610|NCT05580003|157288886|FG020|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48849611|NCT05580003|157288887|FG021|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48849612|NCT05580003|157288888|FG022|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48849613|NCT05580003|157288889|FG023|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48849614|NCT05580003|157288890|FG024|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48849615|NCT05580003|157288891|FG025|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48849616|NCT05580003|157288892|FG026|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48849617|NCT05580003|157288893|FG027|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48849618|NCT05580003|157288866|FG000|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
48849619|NCT05580003|157288867|FG001|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
48849620|NCT05580003|157288868|FG002|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
48849621|NCT05580003|157288869|FG003|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
48849622|NCT05580003|157288870|FG004|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
48849623|NCT05580003|157288871|FG005|Part 1 Treatment Period 2 (Day 1)|Physician Decision|1|||
48849624|NCT05580003|157288872|FG006|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
48849625|NCT05580003|157288873|FG007|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
48849626|NCT05580003|157288874|FG008|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
48849627|NCT05580003|157288875|FG009|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
48849628|NCT05580003|157288876|FG010|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
48849629|NCT05580003|157288877|FG011|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
48849630|NCT05580003|157288878|FG012|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
48849631|NCT05580003|157288879|FG013|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
48849632|NCT05580003|157288880|FG014|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
48849633|NCT05580003|157288881|FG015|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
48849634|NCT05580003|157288882|FG016|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
48849635|NCT05580003|157288883|FG017|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
48943508|NCT00847613|157622667|FG001|Overall Study|Other|1|||
48943509|NCT00847613|157622668|FG002|Overall Study|Other|2|||
48943510|NCT00847613|157622669|FG003|Overall Study|Other|0|||
48943511|NCT03022461|157622670|FG000|Overall Study|Death|3|||
48943512|NCT00587223|157622671|FG000|Overall Study|Adverse Event|1|||
48943513|NCT00561353|157622672|FG000|Overall Study|Subject reached a virologic endpoint|2|||
48943514|NCT00561353|157622673|FG001|Overall Study|Subject reached a virologic endpoint|1|||
48943515|NCT00561353|157622674|FG002|Overall Study|Subject reached a virologic endpoint|1|||
48943516|NCT00561353|157622675|FG003|Overall Study|Subject reached a virologic endpoint|4|||
48943517|NCT00561353|157622676|FG004|Overall Study|Subject reached a virologic endpoint|1|||
48943518|NCT00561353|157622677|FG005|Overall Study|Subject reached a virologic endpoint|3|||
48943519|NCT00561353|157622678|FG006|Overall Study|Subject reached a virologic endpoint|4|||
48943520|NCT00561353|157622679|FG007|Overall Study|Subject reached a virologic endpoint|4|||
48943521|NCT00561353|157622680|FG008|Overall Study|Subject reached a virologic endpoint|5|||
48943522|NCT00561353|157622681|FG009|Overall Study|Subject reached a virologic endpoint|0|||
48943523|NCT00561353|157622672|FG000|Overall Study|Subject ineligible to continue the trial|0|||
48943524|NCT00561353|157622673|FG001|Overall Study|Subject ineligible to continue the trial|0|||
48943525|NCT00561353|157622674|FG002|Overall Study|Subject ineligible to continue the trial|0|||
48943526|NCT00561353|157622675|FG003|Overall Study|Subject ineligible to continue the trial|0|||
48943527|NCT00561353|157622676|FG004|Overall Study|Subject ineligible to continue the trial|0|||
48943528|NCT00561353|157622677|FG005|Overall Study|Subject ineligible to continue the trial|1|||
48943529|NCT00561353|157622678|FG006|Overall Study|Subject ineligible to continue the trial|1|||
48943530|NCT00561353|157622679|FG007|Overall Study|Subject ineligible to continue the trial|0|||
48943531|NCT00561353|157622680|FG008|Overall Study|Subject ineligible to continue the trial|2|||
48943532|NCT00561353|157622681|FG009|Overall Study|Subject ineligible to continue the trial|1|||
48943533|NCT00561353|157622672|FG000|Overall Study|Other|1|||
48943534|NCT00561353|157622673|FG001|Overall Study|Other|0|||
48943535|NCT00561353|157622674|FG002|Overall Study|Other|1|||
48943536|NCT00561353|157622675|FG003|Overall Study|Other|0|||
48943537|NCT00561353|157622676|FG004|Overall Study|Other|0|||
48943538|NCT00561353|157622677|FG005|Overall Study|Other|2|||
48943539|NCT00561353|157622678|FG006|Overall Study|Other|0|||
48943540|NCT00561353|157622679|FG007|Overall Study|Other|0|||
48943541|NCT00561353|157622680|FG008|Overall Study|Other|0|||
48943542|NCT00561353|157622681|FG009|Overall Study|Other|0|||
48943543|NCT00561353|157622672|FG000|Overall Study|Adverse Event|0|||
48943544|NCT00561353|157622673|FG001|Overall Study|Adverse Event|0|||
48943545|NCT00561353|157622674|FG002|Overall Study|Adverse Event|0|||
48943546|NCT00561353|157622675|FG003|Overall Study|Adverse Event|2|||
48943547|NCT00561353|157622676|FG004|Overall Study|Adverse Event|0|||
48943548|NCT00561353|157622677|FG005|Overall Study|Adverse Event|0|||
48943549|NCT00561353|157622678|FG006|Overall Study|Adverse Event|1|||
48943550|NCT00561353|157622679|FG007|Overall Study|Adverse Event|0|||
48943551|NCT00561353|157622680|FG008|Overall Study|Adverse Event|0|||
48943552|NCT00561353|157622681|FG009|Overall Study|Adverse Event|1|||
48943553|NCT00561353|157622672|FG000|Overall Study|Lost to Follow-up|2|||
48943554|NCT00561353|157622673|FG001|Overall Study|Lost to Follow-up|0|||
48943555|NCT00561353|157622674|FG002|Overall Study|Lost to Follow-up|1|||
48943556|NCT00561353|157622675|FG003|Overall Study|Lost to Follow-up|0|||
48943557|NCT00561353|157622676|FG004|Overall Study|Lost to Follow-up|0|||
48943558|NCT00561353|157622677|FG005|Overall Study|Lost to Follow-up|0|||
48943559|NCT00561353|157622678|FG006|Overall Study|Lost to Follow-up|0|||
48849636|NCT05580003|157288884|FG018|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
48849637|NCT05580003|157288885|FG019|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
48849638|NCT05580003|157288886|FG020|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
48849639|NCT05580003|157288887|FG021|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
48849640|NCT05580003|157288888|FG022|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
48849641|NCT05580003|157288889|FG023|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
48849642|NCT05580003|157288890|FG024|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
48849643|NCT05580003|157288891|FG025|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
48849644|NCT05580003|157288892|FG026|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
48849645|NCT05580003|157288893|FG027|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
48849646|NCT05580003|157288866|FG000|Part 1 Treatment Period 2 (Day 1)|Other|0|||
48849647|NCT05580003|157288867|FG001|Part 1 Treatment Period 2 (Day 1)|Other|0|||
48849648|NCT05580003|157288868|FG002|Part 1 Treatment Period 2 (Day 1)|Other|0|||
48849649|NCT05580003|157288869|FG003|Part 1 Treatment Period 2 (Day 1)|Other|1|||
48849650|NCT05580003|157288870|FG004|Part 1 Treatment Period 2 (Day 1)|Other|0|||
48849651|NCT05580003|157288871|FG005|Part 1 Treatment Period 2 (Day 1)|Other|0|||
48849652|NCT05580003|157288872|FG006|Part 1 Treatment Period 2 (Day 1)|Other|0|||
48849653|NCT05580003|157288873|FG007|Part 1 Treatment Period 2 (Day 1)|Other|0|||
48849654|NCT05580003|157288874|FG008|Part 1 Treatment Period 2 (Day 1)|Other|0|||
48849655|NCT05580003|157288875|FG009|Part 1 Treatment Period 2 (Day 1)|Other|0|||
48943560|NCT00561353|157622679|FG007|Overall Study|Lost to Follow-up|0|||
48943561|NCT00561353|157622680|FG008|Overall Study|Lost to Follow-up|0|||
48943562|NCT00561353|157622681|FG009|Overall Study|Lost to Follow-up|0|||
48943563|NCT00561353|157622672|FG000|Overall Study|Withdrawal by Subject|0|||
48943564|NCT00561353|157622673|FG001|Overall Study|Withdrawal by Subject|2|||
48943565|NCT00561353|157622674|FG002|Overall Study|Withdrawal by Subject|0|||
48943566|NCT00561353|157622675|FG003|Overall Study|Withdrawal by Subject|0|||
48943567|NCT00561353|157622676|FG004|Overall Study|Withdrawal by Subject|0|||
48943568|NCT00561353|157622677|FG005|Overall Study|Withdrawal by Subject|0|||
48943569|NCT00561353|157622678|FG006|Overall Study|Withdrawal by Subject|0|||
48943570|NCT00561353|157622679|FG007|Overall Study|Withdrawal by Subject|0|||
48943571|NCT00561353|157622680|FG008|Overall Study|Withdrawal by Subject|0|||
48943572|NCT00561353|157622681|FG009|Overall Study|Withdrawal by Subject|0|||
48943573|NCT02111369|157622682|FG000|Overall Study|Lost to Follow-up|2|||
48943574|NCT02111369|157622682|FG000|Overall Study|Withdrawal by Subject|1|||
48943575|NCT00519623|157622689|FG000|Overall Study|Adverse Event|1|||
48943576|NCT03885284|157622696|FG000|Overall Study|Disease Progression|1|||
48943577|NCT03885284|157622697|FG001|Overall Study|Disease Progression|3|||
48943578|NCT03885284|157622696|FG000|Overall Study|Physician Decision|0|||
48943579|NCT03885284|157622697|FG001|Overall Study|Physician Decision|1|||
48943580|NCT01591330|157622698|FG000|Period 1|Adverse Event|1|||
48943581|NCT01591330|157622699|FG001|Period 1|Adverse Event|0|||
48943582|NCT01591330|157622700|FG002|Period 1|Adverse Event|0|||
48943583|NCT01591330|157622701|FG003|Period 1|Adverse Event|0|||
48943584|NCT01591330|157622698|FG000|Washout of at Least 3 Days|Withdrawal by Subject|1|||
48943585|NCT01591330|157622699|FG001|Washout of at Least 3 Days|Withdrawal by Subject|0|||
48943586|NCT01591330|157622700|FG002|Washout of at Least 3 Days|Withdrawal by Subject|0|||
48943587|NCT01591330|157622701|FG003|Washout of at Least 3 Days|Withdrawal by Subject|0|||
48943588|NCT01591330|157622698|FG000|Period 2|Adverse Event|1|||
48943589|NCT01591330|157622699|FG001|Period 2|Adverse Event|0|||
48943590|NCT01591330|157622700|FG002|Period 2|Adverse Event|0|||
48943591|NCT01591330|157622701|FG003|Period 2|Adverse Event|0|||
48943592|NCT01450540|157622702|FG000|Overall Study|Withdrawal by Subject|19|||
48943593|NCT01450540|157622703|FG001|Overall Study|Withdrawal by Subject|13|||
48943594|NCT01450540|157622702|FG000|Overall Study|protocol deviation|3|||
48943595|NCT01450540|157622703|FG001|Overall Study|protocol deviation|23|||
48943596|NCT02234622|157622707|FG000|Overall Study|Withdrawal by Subject|16|||
48943597|NCT02234622|157622708|FG001|Overall Study|Withdrawal by Subject|22|||
48943598|NCT02234622|157622707|FG000|Overall Study|Lost to Follow-up|27|||
48943599|NCT02234622|157622708|FG001|Overall Study|Lost to Follow-up|14|||
48943600|NCT00586690|157622709|FG000|Overall Study|Death|2|||
48943601|NCT00586690|157622710|FG001|Overall Study|Death|0|||
48943602|NCT00586690|157622709|FG000|Overall Study|Disease Progression|10|||
48943603|NCT00586690|157622710|FG001|Overall Study|Disease Progression|0|||
48943604|NCT00586690|157622709|FG000|Overall Study|Adverse Event|1|||
48943605|NCT00586690|157622710|FG001|Overall Study|Adverse Event|0|||
48943606|NCT00586690|157622709|FG000|Overall Study|Lack of Efficacy|2|||
48943607|NCT00586690|157622710|FG001|Overall Study|Lack of Efficacy|0|||
48943608|NCT00586690|157622709|FG000|Overall Study|Lab can't accommodate|1|||
48943609|NCT00586690|157622710|FG001|Overall Study|Lab can't accommodate|0|||
48943610|NCT00618956|157622711|FG000|Overall Study|Adverse Event|10|||
48943611|NCT00618956|157622712|FG001|Overall Study|Adverse Event|34|||
48943612|NCT00618956|157622711|FG000|Overall Study|Lack of Efficacy|2|||
48943613|NCT00618956|157622712|FG001|Overall Study|Lack of Efficacy|1|||
48943614|NCT00618956|157622711|FG000|Overall Study|Withdrawal by Subject|5|||
48943615|NCT00618956|157622712|FG001|Overall Study|Withdrawal by Subject|7|||
48943616|NCT00618956|157622711|FG000|Overall Study|Lost to Follow-up|4|||
48943617|NCT00618956|157622712|FG001|Overall Study|Lost to Follow-up|5|||
48943618|NCT00618956|157622711|FG000|Overall Study|Protocol Violation|2|||
48943619|NCT00618956|157622712|FG001|Overall Study|Protocol Violation|2|||
48943620|NCT00618956|157622711|FG000|Overall Study|did not meet criteria, non-compliance|2|||
48943621|NCT00618956|157622712|FG001|Overall Study|did not meet criteria, non-compliance|1|||
48943622|NCT00524303|157622715|FG000|Overall Study|Lost to Follow-up|6|||
48943623|NCT00524303|157622716|FG001|Overall Study|Lost to Follow-up|0|||
48943624|NCT00524303|157622717|FG002|Overall Study|Lost to Follow-up|3|||
48943625|NCT00524303|157622715|FG000|Overall Study|Protocol Violation|0|||
48943626|NCT00524303|157622716|FG001|Overall Study|Protocol Violation|1|||
48943627|NCT00524303|157622717|FG002|Overall Study|Protocol Violation|1|||
48943628|NCT00524303|157622715|FG000|Overall Study|Withdrawal by Subject|3|||
48943629|NCT00524303|157622716|FG001|Overall Study|Withdrawal by Subject|0|||
48943630|NCT00524303|157622717|FG002|Overall Study|Withdrawal by Subject|4|||
48943631|NCT00524303|157622715|FG000|Overall Study|Death|0|||
48943632|NCT00524303|157622716|FG001|Overall Study|Death|2|||
48943633|NCT00524303|157622717|FG002|Overall Study|Death|3|||
48943634|NCT00524303|157622715|FG000|Overall Study|Adverse Event|1|||
48943635|NCT00524303|157622716|FG001|Overall Study|Adverse Event|2|||
48943636|NCT00524303|157622717|FG002|Overall Study|Adverse Event|3|||
48943637|NCT00524303|157622715|FG000|Overall Study|Did not Complete Study Dosing|1|||
48943638|NCT00524303|157622716|FG001|Overall Study|Did not Complete Study Dosing|0|||
48943639|NCT00524303|157622717|FG002|Overall Study|Did not Complete Study Dosing|0|||
48943640|NCT00524303|157622715|FG000|Overall Study|Worsening Peripheral Neuropathy|1|||
48943641|NCT00524303|157622716|FG001|Overall Study|Worsening Peripheral Neuropathy|0|||
48943642|NCT00524303|157622717|FG002|Overall Study|Worsening Peripheral Neuropathy|0|||
48943643|NCT00524303|157622715|FG000|Overall Study|Disease Progression|0|||
48943644|NCT00524303|157622716|FG001|Overall Study|Disease Progression|4|||
48943645|NCT00524303|157622717|FG002|Overall Study|Disease Progression|1|||
48943646|NCT00524303|157622715|FG000|Overall Study|Disease Recurrence|0|||
48943647|NCT00524303|157622716|FG001|Overall Study|Disease Recurrence|1|||
48943648|NCT00524303|157622717|FG002|Overall Study|Disease Recurrence|0|||
48943649|NCT00524303|157622715|FG000|Overall Study|Sponsor Request|0|||
48943650|NCT00524303|157622716|FG001|Overall Study|Sponsor Request|0|||
48849656|NCT05580003|157288876|FG010|Part 1 Treatment Period 2 (Day 1)|Other|0|||
48943651|NCT00524303|157622717|FG002|Overall Study|Sponsor Request|1|||
48943652|NCT00524303|157622715|FG000|Overall Study|Physician Decision|0|||
48943653|NCT00524303|157622716|FG001|Overall Study|Physician Decision|0|||
48943654|NCT00524303|157622717|FG002|Overall Study|Physician Decision|1|||
48943655|NCT00524303|157622715|FG000|Overall Study|Completed 5 years|0|||
48943656|NCT00524303|157622716|FG001|Overall Study|Completed 5 years|0|||
48943657|NCT00524303|157622717|FG002|Overall Study|Completed 5 years|1|||
48943658|NCT00840463|157622721|FG000|Overall Study|Adverse Event|1|||
48943659|NCT00840463|157622722|FG001|Overall Study|Adverse Event|0|||
48943660|NCT02452359|157622723|FG000|Overall Study|Adverse Event|1|||
48943661|NCT02452359|157622723|FG000|Overall Study|Lost to Follow-up|15|||
48943662|NCT02452359|157622723|FG000|Overall Study|Pregnancy|1|||
48943663|NCT02452359|157622723|FG000|Overall Study|Withdrawal by Subject|4|||
48943664|NCT02017444|157624128|FG000|Overall Study|Physician Decision|1|||
48849657|NCT05580003|157288877|FG011|Part 1 Treatment Period 2 (Day 1)|Other|0|||
48849658|NCT05580003|157288878|FG012|Part 1 Treatment Period 2 (Day 1)|Other|0|||
48849659|NCT05580003|157288879|FG013|Part 1 Treatment Period 2 (Day 1)|Other|0|||
48849660|NCT05580003|157288880|FG014|Part 1 Treatment Period 2 (Day 1)|Other|0|||
48849661|NCT05580003|157288881|FG015|Part 1 Treatment Period 2 (Day 1)|Other|0|||
48849662|NCT05580003|157288882|FG016|Part 1 Treatment Period 2 (Day 1)|Other|0|||
48849663|NCT05580003|157288883|FG017|Part 1 Treatment Period 2 (Day 1)|Other|0|||
48849664|NCT05580003|157288884|FG018|Part 1 Treatment Period 2 (Day 1)|Other|0|||
48849665|NCT05580003|157288885|FG019|Part 1 Treatment Period 2 (Day 1)|Other|0|||
48849666|NCT05580003|157288886|FG020|Part 1 Treatment Period 2 (Day 1)|Other|0|||
48849667|NCT05580003|157288887|FG021|Part 1 Treatment Period 2 (Day 1)|Other|0|||
48849668|NCT05580003|157288888|FG022|Part 1 Treatment Period 2 (Day 1)|Other|0|||
48849669|NCT05580003|157288889|FG023|Part 1 Treatment Period 2 (Day 1)|Other|0|||
48849670|NCT05580003|157288890|FG024|Part 1 Treatment Period 2 (Day 1)|Other|0|||
48849671|NCT05580003|157288891|FG025|Part 1 Treatment Period 2 (Day 1)|Other|0|||
48849672|NCT05580003|157288892|FG026|Part 1 Treatment Period 2 (Day 1)|Other|0|||
48849673|NCT05580003|157288893|FG027|Part 1 Treatment Period 2 (Day 1)|Other|0|||
48849674|NCT05580003|157288866|FG000|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
48849675|NCT05580003|157288867|FG001|Part 1: Treatment Period 3 (Day 1)|Physician Decision|1|||
48849676|NCT05580003|157288868|FG002|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
48849677|NCT05580003|157288869|FG003|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
48849678|NCT05580003|157288870|FG004|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
48849679|NCT05580003|157288871|FG005|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
48849680|NCT05580003|157288872|FG006|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
48849681|NCT05580003|157288873|FG007|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
48849682|NCT05580003|157288874|FG008|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
48849683|NCT05580003|157288875|FG009|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
48849684|NCT05580003|157288876|FG010|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
48849685|NCT05580003|157288877|FG011|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
48849686|NCT05580003|157288878|FG012|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
48849687|NCT05580003|157288879|FG013|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
48849688|NCT05580003|157288880|FG014|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
48849689|NCT05580003|157288881|FG015|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
48943665|NCT02017444|157624129|FG001|Overall Study|Physician Decision|0|||
48951867|NCT04760314|157654918|FG004|Maintenance Blinded Period|Withdrawal by Subject|2|||
48943666|NCT02017444|157624128|FG000|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1|||
48943667|NCT02017444|157624129|FG001|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0|||
48943668|NCT00377962|157624130|FG000|Core Study: 0-12 Months|Adverse Event|18|||
48943669|NCT00377962|157624131|FG001|Core Study: 0-12 Months|Adverse Event|2|||
48943670|NCT00377962|157624130|FG000|Core Study: 0-12 Months|Death|3|||
48943671|NCT00377962|157624131|FG001|Core Study: 0-12 Months|Death|0|||
48943672|NCT00377962|157624130|FG000|Core Study: 0-12 Months|Withdrew Consent|5|||
48943673|NCT00377962|157624131|FG001|Core Study: 0-12 Months|Withdrew Consent|2|||
48943674|NCT00377962|157624130|FG000|Core Study: 0-12 Months|Administrative Reason|1|||
48943675|NCT00377962|157624131|FG001|Core Study: 0-12 Months|Administrative Reason|1|||
48943676|NCT00377962|157624130|FG000|Core Study: 0-12 Months|Unspecified reasons|1|||
48943677|NCT00377962|157624131|FG001|Core Study: 0-12 Months|Unspecified reasons|4|||
48943678|NCT00377962|157624130|FG000|Extension Study: 12-24 Months|Death|1|||
48943679|NCT00377962|157624131|FG001|Extension Study: 12-24 Months|Death|1|||
48943680|NCT00377962|157624130|FG000|Extension Study: 12-24 Months|Adverse Event|8|||
48943681|NCT00377962|157624131|FG001|Extension Study: 12-24 Months|Adverse Event|0|||
48943682|NCT00377962|157624130|FG000|Extension Study: 12-24 Months|Abnormal laboratory value|1|||
48943683|NCT00377962|157624131|FG001|Extension Study: 12-24 Months|Abnormal laboratory value|0|||
48943684|NCT00377962|157624130|FG000|Extension Study: 12-24 Months|Unspecified reason|0|||
48943685|NCT00377962|157624131|FG001|Extension Study: 12-24 Months|Unspecified reason|3|||
48943686|NCT00215150|157624132|FG000|Open Label Phase|Lost to Follow-up|7|||
48943687|NCT00215150|157624132|FG000|Open Label Phase|Withdrawal by Subject|1|||
48943688|NCT00215150|157624132|FG000|Open Label Phase|Did not complete a post base visit|13|||
48943689|NCT00215150|157624132|FG000|Open Label Phase|Did not meet randomization criteria|9|||
48943690|NCT00215150|157624132|FG000|Randomization Phase Ziprasidone|Lost to Follow-up|2|||
48943691|NCT00215150|157624132|FG000|Randomization Phase Ziprasidone|Withdrawal by Subject|1|||
48943692|NCT00215150|157624132|FG000|Randomization Phase Placebo|Withdrawal by Subject|1|||
48943693|NCT00374556|157624135|FG000|Overall Study|Lost to Follow-up|1|||
48943694|NCT00374556|157624136|FG001|Overall Study|Lost to Follow-up|0|||
48943695|NCT00374556|157624135|FG000|Overall Study|Removed at baseline due to medical cond|0|||
48943696|NCT00374556|157624136|FG001|Overall Study|Removed at baseline due to medical cond|1|||
48943697|NCT04426630|157624137|FG000|Overall Study|Death|4|||
48943698|NCT04426630|157624137|FG000|Overall Study|Lost to Follow-up|2|||
48943699|NCT00942162|157624140|FG000|Overall Study|Death|45|||
48943700|NCT00942162|157624141|FG001|Overall Study|Death|35|||
48943701|NCT00942162|157624142|FG002|Overall Study|Death|0|||
48943702|NCT00942162|157624140|FG000|Overall Study|Withdrawal by Subject|7|||
48943703|NCT00942162|157624141|FG001|Overall Study|Withdrawal by Subject|2|||
48943704|NCT00942162|157624142|FG002|Overall Study|Withdrawal by Subject|0|||
48943705|NCT00942162|157624140|FG000|Overall Study|Lost to Follow-up|4|||
48943706|NCT00942162|157624141|FG001|Overall Study|Lost to Follow-up|0|||
48943707|NCT00942162|157624142|FG002|Overall Study|Lost to Follow-up|0|||
48943708|NCT00942162|157624140|FG000|Overall Study|Other|14|||
48943709|NCT00942162|157624141|FG001|Overall Study|Other|13|||
48943710|NCT00942162|157624142|FG002|Overall Study|Other|2|||
48943711|NCT03874234|157624148|FG000|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
48943712|NCT03874234|157624149|FG001|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
48943713|NCT03874234|157624150|FG002|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
48943714|NCT03874234|157624151|FG003|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|1|||
48943715|NCT03874234|157624152|FG004|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
48943716|NCT03874234|157624153|FG005|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
48943717|NCT03874234|157624154|FG006|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
48943718|NCT03874234|157624155|FG007|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
48943719|NCT03874234|157624156|FG008|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
48943720|NCT03874234|157624157|FG009|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
48943721|NCT03874234|157624158|FG010|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
48943722|NCT03874234|157624159|FG011|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
48943723|NCT03874234|157624160|FG012|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
48943724|NCT03874234|157624148|FG000|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|1|||
48943725|NCT03874234|157624149|FG001|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
48943726|NCT03874234|157624150|FG002|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
48943727|NCT03874234|157624151|FG003|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
48943728|NCT03874234|157624152|FG004|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
48943729|NCT03874234|157624153|FG005|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
48943730|NCT03874234|157624154|FG006|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
48943731|NCT03874234|157624155|FG007|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
48943732|NCT03874234|157624156|FG008|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
48943733|NCT03874234|157624157|FG009|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
48943734|NCT03874234|157624158|FG010|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
48943735|NCT03874234|157624159|FG011|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
48943736|NCT03874234|157624160|FG012|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
48943737|NCT03874234|157624148|FG000|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
48943738|NCT03874234|157624149|FG001|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
48943739|NCT03874234|157624150|FG002|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
48943740|NCT03874234|157624151|FG003|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|1|||
48943741|NCT03874234|157624152|FG004|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
48943742|NCT03874234|157624153|FG005|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
48943743|NCT03874234|157624154|FG006|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
48943744|NCT03874234|157624155|FG007|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
48943745|NCT03874234|157624156|FG008|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
48943746|NCT03874234|157624157|FG009|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
48943747|NCT03874234|157624158|FG010|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
48943748|NCT03874234|157624159|FG011|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
48943749|NCT03874234|157624160|FG012|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
48943750|NCT03874234|157624148|FG000|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
48943751|NCT03874234|157624149|FG001|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
48943752|NCT03874234|157624150|FG002|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
48943753|NCT03874234|157624151|FG003|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
48943754|NCT03874234|157624152|FG004|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|1|||
48943755|NCT03874234|157624153|FG005|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
48943756|NCT03874234|157624154|FG006|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
48943757|NCT03874234|157624155|FG007|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
48943758|NCT03874234|157624156|FG008|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
48943759|NCT03874234|157624157|FG009|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
48943760|NCT03874234|157624158|FG010|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
48943761|NCT03874234|157624159|FG011|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
48943762|NCT03874234|157624160|FG012|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
48943763|NCT03874234|157624148|FG000|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
48943764|NCT03874234|157624149|FG001|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
48943765|NCT03874234|157624150|FG002|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
48943766|NCT03874234|157624151|FG003|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
48943767|NCT03874234|157624152|FG004|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
48943768|NCT03874234|157624153|FG005|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
48943769|NCT03874234|157624154|FG006|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
48943770|NCT03874234|157624155|FG007|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|1|||
48849690|NCT05580003|157288882|FG016|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
48849691|NCT05580003|157288883|FG017|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
48849692|NCT05580003|157288884|FG018|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
48849693|NCT05580003|157288885|FG019|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
48849694|NCT05580003|157288886|FG020|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
48849695|NCT05580003|157288887|FG021|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
48849696|NCT05580003|157288888|FG022|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
48849697|NCT05580003|157288889|FG023|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
48943771|NCT03874234|157624156|FG008|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
48943772|NCT03874234|157624157|FG009|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
48943773|NCT03874234|157624158|FG010|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
48943774|NCT03874234|157624159|FG011|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
48943775|NCT03874234|157624160|FG012|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
48943776|NCT03874234|157624148|FG000|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
48943777|NCT03874234|157624149|FG001|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
48943778|NCT03874234|157624150|FG002|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
48943779|NCT03874234|157624151|FG003|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
48943780|NCT03874234|157624152|FG004|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
48943781|NCT03874234|157624153|FG005|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
48943782|NCT03874234|157624154|FG006|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
48943783|NCT03874234|157624155|FG007|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
48943784|NCT03874234|157624156|FG008|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
48943785|NCT03874234|157624157|FG009|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
48943786|NCT03874234|157624158|FG010|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
48943787|NCT03874234|157624159|FG011|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
48943788|NCT03874234|157624160|FG012|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
48943789|NCT03874234|157624148|FG000|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
48943790|NCT03874234|157624149|FG001|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
48943791|NCT03874234|157624150|FG002|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
48943792|NCT03874234|157624151|FG003|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
48943793|NCT03874234|157624152|FG004|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
48943794|NCT03874234|157624153|FG005|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
48943795|NCT03874234|157624154|FG006|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|1|||
48943796|NCT03874234|157624155|FG007|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
48943797|NCT03874234|157624156|FG008|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
48943798|NCT03874234|157624157|FG009|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
48943799|NCT03874234|157624158|FG010|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
48943800|NCT03874234|157624159|FG011|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
48943801|NCT03874234|157624160|FG012|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
48943802|NCT03874234|157624148|FG000|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
48943803|NCT03874234|157624149|FG001|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
48943804|NCT03874234|157624150|FG002|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
48943805|NCT03874234|157624151|FG003|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
48943806|NCT03874234|157624152|FG004|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|1|||
48943807|NCT03874234|157624153|FG005|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
48943808|NCT03874234|157624154|FG006|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
48943809|NCT03874234|157624155|FG007|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
48943810|NCT03874234|157624156|FG008|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
48943811|NCT03874234|157624157|FG009|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
48943812|NCT03874234|157624158|FG010|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
48943813|NCT03874234|157624159|FG011|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
48943814|NCT03874234|157624160|FG012|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
48943815|NCT01157169|157624165|FG000|First Intervention|Emesis Within 4 hrs of Administration|4|||
48943816|NCT01157169|157624166|FG001|First Intervention|Emesis Within 4 hrs of Administration|2|||
48943817|NCT01157169|157624165|FG000|Second Intervention|Emesis Within 4 hrs of Administration|0|||
48943818|NCT01157169|157624166|FG001|Second Intervention|Emesis Within 4 hrs of Administration|1|||
48943819|NCT01756157|157624167|FG000|First Intervention Period|Withdrawal by Subject|1|||
48943820|NCT01756157|157624168|FG001|First Intervention Period|Withdrawal by Subject|0|||
48943821|NCT01756157|157624167|FG000|First Intervention Period|Lost to Follow-up|0|||
48943822|NCT01756157|157624168|FG001|First Intervention Period|Lost to Follow-up|2|||
48943823|NCT02799381|157624169|FG000|Overall Study|Withdrew consent|3|||
48943824|NCT02799381|157624170|FG001|Overall Study|Withdrew consent|2|||
48943825|NCT02799381|157624169|FG000|Overall Study|Adverse Event|0|||
48943826|NCT02799381|157624170|FG001|Overall Study|Adverse Event|1|||
48943827|NCT02799381|157624169|FG000|Overall Study|Participant did not take any study drug|1|||
48943828|NCT02799381|157624170|FG001|Overall Study|Participant did not take any study drug|0|||
48943829|NCT01981187|157624173|FG000|Overall Study|Participant/guardian decision|2|||
48849698|NCT05580003|157288890|FG024|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
48849699|NCT05580003|157288891|FG025|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
48849700|NCT05580003|157288892|FG026|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
48849701|NCT05580003|157288893|FG027|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
48849702|NCT05580003|157288866|FG000|Part 2 (up to 10 Days)|Other|0|||
48849703|NCT05580003|157288867|FG001|Part 2 (up to 10 Days)|Other|0|||
48849704|NCT05580003|157288868|FG002|Part 2 (up to 10 Days)|Other|0|||
48849705|NCT05580003|157288869|FG003|Part 2 (up to 10 Days)|Other|0|||
48849706|NCT05580003|157288870|FG004|Part 2 (up to 10 Days)|Other|0|||
48849707|NCT05580003|157288871|FG005|Part 2 (up to 10 Days)|Other|0|||
48849708|NCT05580003|157288872|FG006|Part 2 (up to 10 Days)|Other|0|||
48943830|NCT01981187|157624173|FG000|Overall Study|Physician Decision|1|||
48943831|NCT01981187|157624173|FG000|Overall Study|Disease progression|2|||
48943832|NCT01981187|157624173|FG000|Overall Study|Adverse Event|7|||
48943833|NCT03846947|157624174|FG000|Overall Study|technical issues with imaging sequence|2|||
48943834|NCT02586207|157624178|FG000|Overall Study|Physician Decision|1|||
48943835|NCT02586207|157624178|FG000|Overall Study|Withdrawal by Subject|1|||
48943836|NCT00756002|157624179|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
48943837|NCT00756002|157624180|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
48943838|NCT00756002|157624179|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
48943839|NCT00756002|157624180|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
48943840|NCT00756002|157624179|FG000|Double-Blind Treatment Period|Withdrawal by Subject|6|||
48943841|NCT00756002|157624180|FG001|Double-Blind Treatment Period|Withdrawal by Subject|6|||
48943842|NCT00756002|157624179|FG000|Double-Blind Treatment Period|Protocol Violation|6|||
48943843|NCT00756002|157624180|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
48943844|NCT00756002|157624179|FG000|Double-Blind Treatment Period|Other|2|||
48943845|NCT00756002|157624180|FG001|Double-Blind Treatment Period|Other|2|||
48943846|NCT01844076|157624188|FG000|Overall Study|Adverse Event|1|||
48943847|NCT01844076|157624189|FG001|Overall Study|Adverse Event|0|||
48943848|NCT01844076|157624190|FG002|Overall Study|Adverse Event|0|||
48943849|NCT01844076|157624191|FG003|Overall Study|Adverse Event|0|||
48943850|NCT01844076|157624188|FG000|Overall Study|Withdrawal by Subject|1|||
48943851|NCT01844076|157624189|FG001|Overall Study|Withdrawal by Subject|0|||
48943852|NCT01844076|157624190|FG002|Overall Study|Withdrawal by Subject|0|||
48943853|NCT01844076|157624191|FG003|Overall Study|Withdrawal by Subject|0|||
48943854|NCT01773473|157624192|FG000|Overall Study|Adverse Event|3|||
48943855|NCT01773473|157624193|FG001|Overall Study|Adverse Event|2|||
48943856|NCT01773473|157624192|FG000|Overall Study|Protocol Violation|0|||
48943857|NCT01773473|157624193|FG001|Overall Study|Protocol Violation|4|||
48943858|NCT01773473|157624192|FG000|Overall Study|Physician Decision|3|||
48943859|NCT01773473|157624193|FG001|Overall Study|Physician Decision|5|||
48943860|NCT01773473|157624192|FG000|Overall Study|Sponsor Decision|2|||
48943861|NCT01773473|157624193|FG001|Overall Study|Sponsor Decision|0|||
48943862|NCT01773473|157624192|FG000|Overall Study|Lack of Efficacy|0|||
48943863|NCT01773473|157624193|FG001|Overall Study|Lack of Efficacy|1|||
48943864|NCT01773473|157624192|FG000|Overall Study|Non-Compliance with study drug|1|||
48943865|NCT01773473|157624193|FG001|Overall Study|Non-Compliance with study drug|4|||
48943866|NCT01773473|157624192|FG000|Overall Study|Withdrawal by Subject|5|||
48943867|NCT01773473|157624193|FG001|Overall Study|Withdrawal by Subject|3|||
48943868|NCT01773473|157624192|FG000|Overall Study|Lost to Follow-up|2|||
48943869|NCT01773473|157624193|FG001|Overall Study|Lost to Follow-up|0|||
48943870|NCT01925703|157624194|FG000|Overall Study|Physician Decision|1|||
48943871|NCT01925703|157624194|FG000|Overall Study|Lost to Follow-up|2|||
48943872|NCT01925703|157624194|FG000|Overall Study|Discharge prior to full iron repletion|1|||
48943873|NCT02424149|157624196|FG000|Overall Study|surgery cancelled|2|||
48943874|NCT02424149|157624197|FG001|Overall Study|surgery cancelled|0|||
48943875|NCT02424149|157624196|FG000|Overall Study|Withdrawal by Subject|0|||
48943876|NCT02424149|157624197|FG001|Overall Study|Withdrawal by Subject|1|||
48943877|NCT01873950|157624200|FG000|Period 5|Withdrawal by Subject|0|||
48943878|NCT01873950|157624201|FG001|Period 5|Withdrawal by Subject|0|||
48943879|NCT01873950|157624202|FG002|Period 5|Withdrawal by Subject|0|||
48943880|NCT01873950|157624203|FG003|Period 5|Withdrawal by Subject|1|||
48943881|NCT01873950|157624204|FG004|Period 5|Withdrawal by Subject|0|||
48943882|NCT03406962|157624205|FG000|Overall Study|Death|2|||
48943883|NCT03406962|157624205|FG000|Overall Study|Adverse Event|1|||
48943884|NCT02499952|157624206|FG000|Overall Study|Lost to Follow-up|1|||
48943885|NCT02499952|157624206|FG000|Overall Study|Death|9|||
48943886|NCT01733329|157624207|FG000|Overall Study|Protocol Violation|1|||
48943887|NCT01733329|157624208|FG001|Overall Study|Protocol Violation|1|||
48943888|NCT01733329|157624207|FG000|Overall Study|Uterine artery injury|1|||
48943889|NCT01733329|157624208|FG001|Overall Study|Uterine artery injury|0|||
48943890|NCT00852930|157624209|FG000|Overall Study|Withdrawal by Subject|1|||
48943891|NCT00852930|157624210|FG001|Overall Study|Withdrawal by Subject|1|||
48943892|NCT00852930|157624211|FG002|Overall Study|Withdrawal by Subject|1|||
48943893|NCT00852930|157624209|FG000|Overall Study|Physician Decision|0|||
48943894|NCT00852930|157624210|FG001|Overall Study|Physician Decision|0|||
48943895|NCT00852930|157624211|FG002|Overall Study|Physician Decision|1|||
48943896|NCT04786210|157624214|FG000|Overall Study|Lost to Follow-up|2|||
48943897|NCT04786210|157624214|FG000|Overall Study|Withdrawal by Subject|4|||
48943898|NCT00845429|157624217|FG000|Overall Study|Protocol Violation|5|||
48943899|NCT00845429|157624218|FG001|Overall Study|Protocol Violation|4|||
48943900|NCT00845429|157624219|FG002|Overall Study|Protocol Violation|7|||
48943901|NCT00845429|157624217|FG000|Overall Study|Lost to Follow-up|7|||
48943902|NCT00845429|157624218|FG001|Overall Study|Lost to Follow-up|9|||
48943903|NCT00845429|157624219|FG002|Overall Study|Lost to Follow-up|10|||
48943904|NCT00845429|157624217|FG000|Overall Study|Withdrawal by Subject|2|||
48943905|NCT00845429|157624218|FG001|Overall Study|Withdrawal by Subject|2|||
48943906|NCT00845429|157624219|FG002|Overall Study|Withdrawal by Subject|2|||
48943907|NCT00845429|157624217|FG000|Overall Study|Serious adverse event|0|||
48943908|NCT00845429|157624218|FG001|Overall Study|Serious adverse event|0|||
48943909|NCT00845429|157624219|FG002|Overall Study|Serious adverse event|1|||
48943910|NCT01273818|157624220|FG000|Overall Study|Physician Decision|13|||
48943911|NCT01273818|157624221|FG001|Overall Study|Physician Decision|2|||
48943912|NCT01273818|157624222|FG002|Overall Study|Physician Decision|9|||
48943913|NCT01716169|157624226|FG000|Overall Study|Adverse Event|1|||
48943914|NCT01716169|157624226|FG000|Overall Study|Lost to Follow-up|1|||
48943915|NCT01716169|157624226|FG000|Overall Study|Withdrawal by Subject|1|||
48943916|NCT01716169|157624226|FG000|Overall Study|inconsistent dressing application|1|||
48943917|NCT02111811|157624227|FG000|Treatment Phase|Lost to Follow-up|22|||
48943918|NCT02111811|157624228|FG001|Treatment Phase|Lost to Follow-up|18|||
48943919|NCT02111811|157624227|FG000|Treatment Phase|Death|2|||
48943920|NCT02111811|157624228|FG001|Treatment Phase|Death|0|||
48943921|NCT02111811|157624227|FG000|Follow up Period (Aim 2)|Lost to Follow-up|26|||
48943922|NCT02111811|157624228|FG001|Follow up Period (Aim 2)|Lost to Follow-up|17|||
48943923|NCT02111811|157624227|FG000|Follow up Period (Aim 2)|Death|2|||
48943924|NCT02111811|157624228|FG001|Follow up Period (Aim 2)|Death|0|||
48943925|NCT03443024|157624231|FG000|Overall Study|Adverse Event|2|||
48943926|NCT03443024|157624232|FG001|Overall Study|Adverse Event|4|||
48943927|NCT03443024|157624233|FG002|Overall Study|Adverse Event|3|||
48943928|NCT03443024|157624234|FG003|Overall Study|Adverse Event|1|||
48943929|NCT03443024|157624231|FG000|Overall Study|Lost to Follow-up|9|||
48943930|NCT03443024|157624232|FG001|Overall Study|Lost to Follow-up|9|||
48943931|NCT03443024|157624233|FG002|Overall Study|Lost to Follow-up|7|||
48849709|NCT05580003|157288873|FG007|Part 2 (up to 10 Days)|Other|0|||
48849710|NCT05580003|157288874|FG008|Part 2 (up to 10 Days)|Other|0|||
48849711|NCT05580003|157288875|FG009|Part 2 (up to 10 Days)|Other|1|||
48849712|NCT05580003|157288876|FG010|Part 2 (up to 10 Days)|Other|0|||
48849713|NCT05580003|157288877|FG011|Part 2 (up to 10 Days)|Other|0|||
48849714|NCT05580003|157288878|FG012|Part 2 (up to 10 Days)|Other|0|||
48849715|NCT05580003|157288879|FG013|Part 2 (up to 10 Days)|Other|0|||
48849716|NCT05580003|157288880|FG014|Part 2 (up to 10 Days)|Other|0|||
48849717|NCT05580003|157288881|FG015|Part 2 (up to 10 Days)|Other|0|||
48849718|NCT05580003|157288882|FG016|Part 2 (up to 10 Days)|Other|0|||
48849719|NCT05580003|157288883|FG017|Part 2 (up to 10 Days)|Other|0|||
48849720|NCT05580003|157288884|FG018|Part 2 (up to 10 Days)|Other|0|||
48849721|NCT05580003|157288885|FG019|Part 2 (up to 10 Days)|Other|0|||
48849722|NCT05580003|157288886|FG020|Part 2 (up to 10 Days)|Other|0|||
48849723|NCT05580003|157288887|FG021|Part 2 (up to 10 Days)|Other|0|||
48849724|NCT05580003|157288888|FG022|Part 2 (up to 10 Days)|Other|0|||
48849725|NCT05580003|157288889|FG023|Part 2 (up to 10 Days)|Other|0|||
48849726|NCT05580003|157288890|FG024|Part 2 (up to 10 Days)|Other|0|||
48849727|NCT05580003|157288891|FG025|Part 2 (up to 10 Days)|Other|0|||
48849728|NCT05580003|157288892|FG026|Part 2 (up to 10 Days)|Other|0|||
48849729|NCT05580003|157288893|FG027|Part 2 (up to 10 Days)|Other|0|||
48849730|NCT05580003|157288866|FG000|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
48849731|NCT05580003|157288867|FG001|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
48849732|NCT05580003|157288868|FG002|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
48849733|NCT05580003|157288869|FG003|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
48849734|NCT05580003|157288870|FG004|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
48849735|NCT05580003|157288871|FG005|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
48849736|NCT05580003|157288872|FG006|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
48849737|NCT05580003|157288873|FG007|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
48849738|NCT05580003|157288874|FG008|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
48849739|NCT05580003|157288875|FG009|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
48849740|NCT05580003|157288876|FG010|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
48849741|NCT05580003|157288877|FG011|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
48849742|NCT05580003|157288878|FG012|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
48943932|NCT03443024|157624234|FG003|Overall Study|Lost to Follow-up|5|||
48943933|NCT03443024|157624231|FG000|Overall Study|Withdrawal by Subject|8|||
48943934|NCT03443024|157624232|FG001|Overall Study|Withdrawal by Subject|15|||
48849743|NCT05580003|157288879|FG013|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
48849744|NCT05580003|157288880|FG014|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
48849745|NCT05580003|157288881|FG015|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
48849746|NCT05580003|157288882|FG016|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
48849747|NCT05580003|157288883|FG017|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
48849748|NCT05580003|157288884|FG018|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
48849749|NCT05580003|157288885|FG019|Part 4 (Day 1 to Day 11)|Adverse Event|1|||
48849750|NCT05580003|157288886|FG020|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
48849751|NCT05580003|157288887|FG021|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
48849752|NCT05580003|157288888|FG022|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
48849753|NCT05580003|157288889|FG023|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
48849754|NCT05580003|157288890|FG024|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
48943935|NCT03443024|157624233|FG002|Overall Study|Withdrawal by Subject|9|||
48943936|NCT03443024|157624234|FG003|Overall Study|Withdrawal by Subject|23|||
48849755|NCT05580003|157288891|FG025|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
48943937|NCT03443024|157624231|FG000|Overall Study|Physician Decision|1|||
48943938|NCT03443024|157624232|FG001|Overall Study|Physician Decision|2|||
48943939|NCT03443024|157624233|FG002|Overall Study|Physician Decision|0|||
48943940|NCT03443024|157624234|FG003|Overall Study|Physician Decision|1|||
48943941|NCT03443024|157624231|FG000|Overall Study|Sponsor Decision|1|||
48943942|NCT03443024|157624232|FG001|Overall Study|Sponsor Decision|1|||
48943943|NCT03443024|157624233|FG002|Overall Study|Sponsor Decision|0|||
48943944|NCT03443024|157624234|FG003|Overall Study|Sponsor Decision|0|||
48943945|NCT03443024|157624231|FG000|Overall Study|Protocol Deviation|0|||
48943946|NCT03443024|157624232|FG001|Overall Study|Protocol Deviation|0|||
48943947|NCT03443024|157624233|FG002|Overall Study|Protocol Deviation|0|||
48943948|NCT03443024|157624234|FG003|Overall Study|Protocol Deviation|2|||
48943949|NCT00624338|157624236|FG000|Overall Study|Adverse Event|14|||
48943950|NCT00624338|157624237|FG001|Overall Study|Adverse Event|14|||
48943951|NCT00624338|157624238|FG002|Overall Study|Adverse Event|18|||
48943952|NCT00624338|157624236|FG000|Overall Study|Lost to Follow-up|1|||
48943953|NCT00624338|157624237|FG001|Overall Study|Lost to Follow-up|0|||
48943954|NCT00624338|157624238|FG002|Overall Study|Lost to Follow-up|0|||
48943955|NCT00624338|157624236|FG000|Overall Study|Lack of Efficacy|11|||
48943956|NCT00624338|157624237|FG001|Overall Study|Lack of Efficacy|3|||
48943957|NCT00624338|157624238|FG002|Overall Study|Lack of Efficacy|14|||
48943958|NCT00624338|157624236|FG000|Overall Study|Protocol Violation|3|||
48943959|NCT00624338|157624237|FG001|Overall Study|Protocol Violation|3|||
48943960|NCT00624338|157624238|FG002|Overall Study|Protocol Violation|2|||
48943961|NCT00624338|157624236|FG000|Overall Study|Death|0|||
48943962|NCT00624338|157624237|FG001|Overall Study|Death|2|||
48943963|NCT00624338|157624238|FG002|Overall Study|Death|0|||
48943964|NCT00624338|157624236|FG000|Overall Study|Immunoglobulin less than 3gram per liter|1|||
48943965|NCT00624338|157624237|FG001|Overall Study|Immunoglobulin less than 3gram per liter|0|||
48943966|NCT00624338|157624238|FG002|Overall Study|Immunoglobulin less than 3gram per liter|0|||
48943967|NCT00624338|157624236|FG000|Overall Study|Termination of 150 mg group by Sponsor|0|||
48943968|NCT00624338|157624237|FG001|Overall Study|Termination of 150 mg group by Sponsor|55|||
48943969|NCT00624338|157624238|FG002|Overall Study|Termination of 150 mg group by Sponsor|0|||
48943970|NCT00624338|157624236|FG000|Overall Study|Other|15|||
48943971|NCT00624338|157624237|FG001|Overall Study|Other|5|||
48943972|NCT00624338|157624238|FG002|Overall Study|Other|9|||
48943973|NCT00624338|157624236|FG000|Overall Study|Randomized but not treated|2|||
48943974|NCT00624338|157624237|FG001|Overall Study|Randomized but not treated|1|||
48943975|NCT00624338|157624238|FG002|Overall Study|Randomized but not treated|3|||
48943976|NCT01548638|157624239|FG000|Overall Study|Protocol Violation|3|||
48943977|NCT01548638|157624239|FG000|Overall Study|Withdrawal by Subject|1|||
48943978|NCT00002850|157624242|FG000|Overall Study|Death|4|||
48943979|NCT00002850|157624243|FG001|Overall Study|Death|1|||
48943980|NCT00002850|157624244|FG002|Overall Study|Death|3|||
48943981|NCT00002850|157624242|FG000|Overall Study|Protocol Violation|1|||
48943982|NCT00002850|157624243|FG001|Overall Study|Protocol Violation|0|||
48943983|NCT00002850|157624244|FG002|Overall Study|Protocol Violation|1|||
48943984|NCT00002850|157624242|FG000|Overall Study|Withdrawal by Subject|0|||
48943985|NCT00002850|157624243|FG001|Overall Study|Withdrawal by Subject|1|||
48943986|NCT00002850|157624244|FG002|Overall Study|Withdrawal by Subject|0|||
48943987|NCT03015532|157624245|FG000|Overall Study|Adverse Event|0|||
48943988|NCT03015532|157624246|FG001|Overall Study|Adverse Event|0|||
48943989|NCT03015532|157624247|FG002|Overall Study|Adverse Event|0|||
48943990|NCT03015532|157624248|FG003|Overall Study|Adverse Event|0|||
48943991|NCT03015532|157624249|FG004|Overall Study|Adverse Event|0|||
48943992|NCT03015532|157624250|FG005|Overall Study|Adverse Event|2|||
48943993|NCT03015532|157624251|FG006|Overall Study|Adverse Event|1|||
48943994|NCT03015532|157624252|FG007|Overall Study|Adverse Event|0|||
48943995|NCT03015532|157624245|FG000|Overall Study|Withdrawal by Subject|0|||
48943996|NCT03015532|157624246|FG001|Overall Study|Withdrawal by Subject|0|||
48943997|NCT03015532|157624247|FG002|Overall Study|Withdrawal by Subject|0|||
48943998|NCT03015532|157624248|FG003|Overall Study|Withdrawal by Subject|0|||
48943999|NCT03015532|157624249|FG004|Overall Study|Withdrawal by Subject|0|||
48944000|NCT03015532|157624250|FG005|Overall Study|Withdrawal by Subject|0|||
48944001|NCT03015532|157624251|FG006|Overall Study|Withdrawal by Subject|1|||
48944002|NCT03015532|157624252|FG007|Overall Study|Withdrawal by Subject|0|||
48944003|NCT01697345|157624253|FG000|Overall Study|Withdrawal by Subject|1|||
48944004|NCT01926886|157624254|FG000|Overall Study|Administrative/other|1|||
48944005|NCT01926886|157624255|FG001|Overall Study|Administrative/other|0|||
48944006|NCT01926886|157624254|FG000|Overall Study|Adverse event/intercurrent illness|4|||
48944007|NCT01926886|157624255|FG001|Overall Study|Adverse event/intercurrent illness|0|||
48944008|NCT01926886|157624254|FG000|Overall Study|Disease progression/recurrence|4|||
48944009|NCT01926886|157624255|FG001|Overall Study|Disease progression/recurrence|0|||
48944010|NCT01926886|157624254|FG000|Overall Study|Withdrawal by Subject|15|||
48944011|NCT01926886|157624255|FG001|Overall Study|Withdrawal by Subject|0|||
48944012|NCT01926886|157624254|FG000|Overall Study|Failure to return|3|||
48944013|NCT01926886|157624255|FG001|Overall Study|Failure to return|0|||
48944014|NCT01926886|157624254|FG000|Overall Study|Recurrence of disease|1|||
48944015|NCT01926886|157624255|FG001|Overall Study|Recurrence of disease|0|||
48944016|NCT01926886|157624254|FG000|Overall Study|Progression of disease|2|||
48944017|NCT01926886|157624255|FG001|Overall Study|Progression of disease|0|||
48944018|NCT01926886|157624254|FG000|Overall Study|Death|1|||
48944019|NCT01926886|157624255|FG001|Overall Study|Death|0|||
48944020|NCT01926886|157624254|FG000|Overall Study|Did not cooperate|1|||
48944021|NCT01926886|157624255|FG001|Overall Study|Did not cooperate|0|||
48944022|NCT00196937|157624264|FG000|Overall Study|Serious Adverse Event|1|||
48944023|NCT00196937|157624265|FG001|Overall Study|Serious Adverse Event|0|||
48944024|NCT00196937|157624266|FG002|Overall Study|Serious Adverse Event|0|||
48944025|NCT00196937|157624264|FG000|Overall Study|Non-serious adverse event|1|||
48944026|NCT00196937|157624265|FG001|Overall Study|Non-serious adverse event|1|||
48944027|NCT00196937|157624266|FG002|Overall Study|Non-serious adverse event|1|||
48944028|NCT00196937|157624264|FG000|Overall Study|Withdrawal by Subject|0|||
48944029|NCT00196937|157624265|FG001|Overall Study|Withdrawal by Subject|0|||
48944030|NCT00196937|157624266|FG002|Overall Study|Withdrawal by Subject|2|||
48944031|NCT00196937|157624264|FG000|Overall Study|Lost to Follow-up|4|||
48944032|NCT00196937|157624265|FG001|Overall Study|Lost to Follow-up|3|||
48944033|NCT00196937|157624266|FG002|Overall Study|Lost to Follow-up|3|||
48944034|NCT00196937|157624264|FG000|Overall Study|Other|3|||
48944035|NCT00196937|157624265|FG001|Overall Study|Other|1|||
48944036|NCT00196937|157624266|FG002|Overall Study|Other|1|||
48944037|NCT00964795|157624270|FG000|Overall Study|Withdrawal by Subject|79|||
48944038|NCT00964795|157624270|FG000|Overall Study|Adverse Event|12|||
48944039|NCT00964795|157624270|FG000|Overall Study|Death|14|||
48944040|NCT00964795|157624270|FG000|Overall Study|Lost to Follow-up|7|||
48944041|NCT00964795|157624270|FG000|Overall Study|Termination of Study by Sponsor|169|||
48944042|NCT00964795|157624270|FG000|Overall Study|Unwilling to sign ICF for amendment 4|3|||
48944043|NCT00964795|157624270|FG000|Overall Study|Other|23|||
48944044|NCT03245814|157624271|FG000|Overall Study|Lost to Follow-up|5|||
48944045|NCT03245814|157624272|FG001|Overall Study|Lost to Follow-up|8|||
48944046|NCT03245814|157624271|FG000|Overall Study|Excluded (did not receive allocated condition)|10|||
48944047|NCT03245814|157624272|FG001|Overall Study|Excluded (did not receive allocated condition)|4|||
48944048|NCT02522377|157624274|FG000|Overall Study|Withdrawal by Subject|1|||
48944049|NCT02522377|157624275|FG001|Overall Study|Withdrawal by Subject|0|||
48944050|NCT02522377|157624274|FG000|Overall Study|Remission Achieved|3|||
48944051|NCT02522377|157624275|FG001|Overall Study|Remission Achieved|0|||
48944052|NCT01750918|157625764|FG000|Overall Study|Last patient transitioned to a rollover protocol|0|||
48944053|NCT01750918|157625765|FG001|Overall Study|Last patient transitioned to a rollover protocol|0|||
48944054|NCT01750918|157625766|FG002|Overall Study|Last patient transitioned to a rollover protocol|5|||
48944055|NCT01750918|157625767|FG003|Overall Study|Last patient transitioned to a rollover protocol|2|||
48944056|NCT01750918|157625768|FG004|Overall Study|Last patient transitioned to a rollover protocol|0|||
48944057|NCT01750918|157625769|FG005|Overall Study|Last patient transitioned to a rollover protocol|2|||
48944058|NCT01750918|157625770|FG006|Overall Study|Last patient transitioned to a rollover protocol|1|||
48944059|NCT01750918|157625771|FG007|Overall Study|Last patient transitioned to a rollover protocol|1|||
48944060|NCT01750918|157625764|FG000|Overall Study|Lost to Follow-up|0|||
48944061|NCT01750918|157625765|FG001|Overall Study|Lost to Follow-up|0|||
48944062|NCT01750918|157625766|FG002|Overall Study|Lost to Follow-up|2|||
48944063|NCT01750918|157625767|FG003|Overall Study|Lost to Follow-up|2|||
48944064|NCT01750918|157625768|FG004|Overall Study|Lost to Follow-up|0|||
48944065|NCT01750918|157625769|FG005|Overall Study|Lost to Follow-up|0|||
48944066|NCT01750918|157625770|FG006|Overall Study|Lost to Follow-up|0|||
48944067|NCT01750918|157625771|FG007|Overall Study|Lost to Follow-up|1|||
48944068|NCT01750918|157625764|FG000|Overall Study|Withdrawal by Subject|0|||
48944069|NCT01750918|157625765|FG001|Overall Study|Withdrawal by Subject|0|||
48944070|NCT01750918|157625766|FG002|Overall Study|Withdrawal by Subject|1|||
48944071|NCT01750918|157625767|FG003|Overall Study|Withdrawal by Subject|2|||
48944072|NCT01750918|157625768|FG004|Overall Study|Withdrawal by Subject|1|||
48944073|NCT01750918|157625769|FG005|Overall Study|Withdrawal by Subject|1|||
48944074|NCT01750918|157625770|FG006|Overall Study|Withdrawal by Subject|2|||
48944075|NCT01750918|157625771|FG007|Overall Study|Withdrawal by Subject|2|||
48944076|NCT01006356|157625778|FG000|Overall Study|Adverse Event|6|||
48944077|NCT01006356|157625778|FG000|Overall Study|Physician Decision|1|||
48944078|NCT01006356|157625778|FG000|Overall Study|Paticipants did not cooperate|6|||
48944079|NCT01006356|157625778|FG000|Overall Study|Withdrawal by Subject|1|||
48944080|NCT01006356|157625778|FG000|Overall Study|Choice by participants|2|||
48944081|NCT01006356|157625778|FG000|Overall Study|Protocol Violation|3|||
48944082|NCT01006356|157625778|FG000|Overall Study|Other|23|||
48944083|NCT02638012|157625779|FG000|Overall Study|Lost to Follow-up|1|||
48944084|NCT04430348|157625784|FG000|Overall Study|Death|3|||
48944085|NCT04430348|157625785|FG001|Overall Study|Death|2|||
48944086|NCT04430348|157625786|FG002|Overall Study|Death|2|||
48944087|NCT04430348|157625787|FG003|Overall Study|Death|2|||
48944088|NCT04430348|157625788|FG004|Overall Study|Death|2|||
48944089|NCT04430348|157625789|FG005|Overall Study|Death|3|||
48944090|NCT04430348|157625784|FG000|Overall Study|Lost to Follow-up|0|||
48944091|NCT04430348|157625785|FG001|Overall Study|Lost to Follow-up|0|||
48944092|NCT04430348|157625786|FG002|Overall Study|Lost to Follow-up|0|||
48849756|NCT05580003|157288892|FG026|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
48849757|NCT05580003|157288893|FG027|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
48849758|NCT05580003|157288866|FG000|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
48849759|NCT05580003|157288867|FG001|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
48849760|NCT05580003|157288868|FG002|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
48849761|NCT05580003|157288869|FG003|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
48849762|NCT05580003|157288870|FG004|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
48849763|NCT05580003|157288871|FG005|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
48849764|NCT05580003|157288872|FG006|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
48849765|NCT05580003|157288873|FG007|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
48849766|NCT05580003|157288874|FG008|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
48849767|NCT05580003|157288875|FG009|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
48849768|NCT05580003|157288876|FG010|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
48849769|NCT05580003|157288877|FG011|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
48849770|NCT05580003|157288878|FG012|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
48849771|NCT05580003|157288879|FG013|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
48849772|NCT05580003|157288880|FG014|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
48849773|NCT05580003|157288881|FG015|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
48849774|NCT05580003|157288882|FG016|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
48849775|NCT05580003|157288883|FG017|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
48849776|NCT05580003|157288884|FG018|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
48849777|NCT05580003|157288885|FG019|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
48849778|NCT05580003|157288886|FG020|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|1|||
48849779|NCT05580003|157288887|FG021|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
48849780|NCT05580003|157288888|FG022|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
48849781|NCT05580003|157288889|FG023|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
48849782|NCT05580003|157288890|FG024|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
48849783|NCT05580003|157288891|FG025|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
48849784|NCT05580003|157288892|FG026|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
48849785|NCT05580003|157288893|FG027|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
48849786|NCT05580003|157288866|FG000|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
48849787|NCT05580003|157288867|FG001|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
48849788|NCT05580003|157288868|FG002|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
48849789|NCT05580003|157288869|FG003|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
48849790|NCT05580003|157288870|FG004|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
48849791|NCT05580003|157288871|FG005|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
48849792|NCT05580003|157288872|FG006|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
48849793|NCT05580003|157288873|FG007|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
48849794|NCT05580003|157288874|FG008|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
48849795|NCT05580003|157288875|FG009|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
48849796|NCT05580003|157288876|FG010|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
48849797|NCT05580003|157288877|FG011|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
48849798|NCT05580003|157288878|FG012|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
48849799|NCT05580003|157288879|FG013|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
48849800|NCT05580003|157288880|FG014|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
48849801|NCT05580003|157288881|FG015|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
48849802|NCT05580003|157288882|FG016|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
48849803|NCT05580003|157288883|FG017|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
48849804|NCT05580003|157288884|FG018|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
48849805|NCT05580003|157288885|FG019|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
48849806|NCT05580003|157288886|FG020|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
48849807|NCT05580003|157288887|FG021|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|1|||
48849808|NCT05580003|157288888|FG022|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
48849809|NCT05580003|157288889|FG023|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
48849810|NCT05580003|157288890|FG024|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
48849811|NCT05580003|157288891|FG025|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
48849812|NCT05580003|157288892|FG026|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
48849813|NCT05580003|157288893|FG027|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
48849814|NCT05580003|157288866|FG000|Part 6 Period 2 (Day 1)|Adverse Event|0|||
48849815|NCT05580003|157288867|FG001|Part 6 Period 2 (Day 1)|Adverse Event|0|||
48849816|NCT05580003|157288868|FG002|Part 6 Period 2 (Day 1)|Adverse Event|0|||
48849817|NCT05580003|157288869|FG003|Part 6 Period 2 (Day 1)|Adverse Event|0|||
48849818|NCT05580003|157288870|FG004|Part 6 Period 2 (Day 1)|Adverse Event|0|||
48849819|NCT05580003|157288871|FG005|Part 6 Period 2 (Day 1)|Adverse Event|0|||
48849820|NCT05580003|157288872|FG006|Part 6 Period 2 (Day 1)|Adverse Event|0|||
48849821|NCT05580003|157288873|FG007|Part 6 Period 2 (Day 1)|Adverse Event|0|||
48849822|NCT05580003|157288874|FG008|Part 6 Period 2 (Day 1)|Adverse Event|0|||
48944093|NCT04430348|157625787|FG003|Overall Study|Lost to Follow-up|1|||
48944094|NCT04430348|157625788|FG004|Overall Study|Lost to Follow-up|0|||
48944095|NCT04430348|157625789|FG005|Overall Study|Lost to Follow-up|0|||
48944096|NCT04430348|157625784|FG000|Overall Study|Adverse Event|0|||
48944097|NCT04430348|157625785|FG001|Overall Study|Adverse Event|0|||
48944098|NCT04430348|157625786|FG002|Overall Study|Adverse Event|0|||
48944099|NCT04430348|157625787|FG003|Overall Study|Adverse Event|0|||
48944100|NCT04430348|157625788|FG004|Overall Study|Adverse Event|0|||
48944101|NCT04430348|157625789|FG005|Overall Study|Adverse Event|1|||
48944102|NCT04430348|157625784|FG000|Overall Study|Withdrawal by Subject|0|||
48944103|NCT04430348|157625785|FG001|Overall Study|Withdrawal by Subject|1|||
48944104|NCT04430348|157625786|FG002|Overall Study|Withdrawal by Subject|0|||
48944105|NCT04430348|157625787|FG003|Overall Study|Withdrawal by Subject|0|||
48944106|NCT04430348|157625788|FG004|Overall Study|Withdrawal by Subject|0|||
48944107|NCT04430348|157625789|FG005|Overall Study|Withdrawal by Subject|1|||
48944108|NCT04430348|157625784|FG000|Overall Study|Study Terminated by Sponsor|0|||
48944109|NCT04430348|157625785|FG001|Overall Study|Study Terminated by Sponsor|0|||
48944110|NCT04430348|157625786|FG002|Overall Study|Study Terminated by Sponsor|2|||
48944111|NCT04430348|157625787|FG003|Overall Study|Study Terminated by Sponsor|0|||
48944112|NCT04430348|157625788|FG004|Overall Study|Study Terminated by Sponsor|1|||
48944113|NCT04430348|157625789|FG005|Overall Study|Study Terminated by Sponsor|1|||
48944114|NCT02559505|157625790|FG000|Overall Study|Lost to Follow-up|23|||
48944115|NCT02559505|157625791|FG001|Overall Study|Lost to Follow-up|20|||
48944116|NCT02559505|157625790|FG000|Overall Study|Withdrawal by Subject|4|||
48944117|NCT02559505|157625791|FG001|Overall Study|Withdrawal by Subject|2|||
48944118|NCT02024464|157625804|FG000|Overall Study|Discontinued|5|||
48944119|NCT02024464|157625805|FG001|Overall Study|Discontinued|4|||
48944120|NCT02024464|157625804|FG000|Overall Study|Missed Visits|1|||
48944121|NCT02024464|157625805|FG001|Overall Study|Missed Visits|0|||
48944122|NCT02024464|157625804|FG000|Overall Study|Lost to Follow-up|4|||
48944123|NCT02024464|157625805|FG001|Overall Study|Lost to Follow-up|7|||
48944124|NCT03615222|157625808|FG000|Overall Study|Ineligible|26|||
48944125|NCT03615222|157625808|FG000|Overall Study|Withdrawal by Subject|7|||
48944126|NCT03615222|157625808|FG000|Overall Study|Death|1|||
48944127|NCT02900092|157625811|FG000|Overall Study|Adverse Event|1|||
48944128|NCT02360098|157625812|FG000|Overall Study|Physician Decision|7|||
48944129|NCT00917384|157625813|FG000|Overall Study|Lost to Follow-up|4|||
48944130|NCT00917384|157625814|FG001|Overall Study|Lost to Follow-up|2|||
48944131|NCT00917384|157625813|FG000|Overall Study|Withdrawal by Subject|10|||
48944132|NCT00917384|157625814|FG001|Overall Study|Withdrawal by Subject|2|||
48944133|NCT05299892|157625815|FG000|Overall Study|Withdrawal by Subject|2|||
48944134|NCT01389128|157625816|FG000|Overall Study|Fetal distress|1|||
48944135|NCT01389128|157625817|FG001|Overall Study|Fetal distress|0|||
48944136|NCT01389128|157625816|FG000|Overall Study|Cervix dilation stop|1|||
48944137|NCT01389128|157625817|FG001|Overall Study|Cervix dilation stop|2|||
48944138|NCT01389128|157625816|FG000|Overall Study|Rapid labor evolution|3|||
48944139|NCT01389128|157625817|FG001|Overall Study|Rapid labor evolution|2|||
48944140|NCT01389128|157625816|FG000|Overall Study|Intolerance to procedure|0|||
48944141|NCT01389128|157625817|FG001|Overall Study|Intolerance to procedure|2|||
48944142|NCT03717922|157625820|FG000|Overall Study|Lost to Follow-up|2|||
48944143|NCT03717922|157625821|FG001|Overall Study|Lost to Follow-up|2|||
48944144|NCT02397655|157625822|FG000|Overall Study|data not completed|1301|||
48944145|NCT01242111|157625823|FG000|Overall Study|Adverse Event|1|||
48944146|NCT01242111|157625823|FG000|Overall Study|Withdrawal by Subject|1|||
48944147|NCT01242111|157625823|FG000|Overall Study|Did not consent to MOR-100 follow-up|1|||
48944148|NCT02750410|157625826|FG000|Double-Blind Treatment Period|Adverse Event|2|||
48944149|NCT02750410|157625827|FG001|Double-Blind Treatment Period|Adverse Event|2|||
48944150|NCT02750410|157625826|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
48944151|NCT02750410|157625827|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
48944152|NCT02750410|157625826|FG000|Open-Label Extension Period|Adverse Event|5|||
48944153|NCT02750410|157625827|FG001|Open-Label Extension Period|Adverse Event|3|||
48944154|NCT02750410|157625826|FG000|Open-Label Extension Period|Protocol Violation|0|||
48944155|NCT02750410|157625827|FG001|Open-Label Extension Period|Protocol Violation|1|||
48944156|NCT02750410|157625826|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
48944157|NCT02750410|157625827|FG001|Open-Label Extension Period|Withdrawal by Subject|2|||
48944158|NCT00482001|157625836|FG000|Overall Study|Protocol Violation|1|||
48944159|NCT00482001|157625837|FG001|Overall Study|Protocol Violation|1|||
48944160|NCT04375878|157625838|FG000|Crossover First and Second Interventions|Withdrawal by Subject|1|||
48944161|NCT04375878|157625839|FG001|Crossover First and Second Interventions|Withdrawal by Subject|1|||
48944162|NCT04375878|157625840|FG002|Crossover First and Second Interventions|Withdrawal by Subject|0|||
48944163|NCT04375878|157625841|FG003|Crossover First and Second Interventions|Withdrawal by Subject|0|||
48944164|NCT04375878|157625842|FG004|Crossover First and Second Interventions|Withdrawal by Subject|0|||
48944165|NCT04375878|157625843|FG005|Crossover First and Second Interventions|Withdrawal by Subject|0|||
48944166|NCT04375878|157625838|FG000|Crossover First and Second Interventions|Adverse Event|0|||
48944167|NCT04375878|157625839|FG001|Crossover First and Second Interventions|Adverse Event|0|||
48944168|NCT04375878|157625840|FG002|Crossover First and Second Interventions|Adverse Event|1|||
48944169|NCT04375878|157625841|FG003|Crossover First and Second Interventions|Adverse Event|0|||
48944170|NCT04375878|157625842|FG004|Crossover First and Second Interventions|Adverse Event|0|||
48944171|NCT04375878|157625843|FG005|Crossover First and Second Interventions|Adverse Event|0|||
48944172|NCT04375878|157625838|FG000|Extension Phase|Withdrawal by Subject|0|||
48944173|NCT04375878|157625839|FG001|Extension Phase|Withdrawal by Subject|0|||
48944174|NCT04375878|157625840|FG002|Extension Phase|Withdrawal by Subject|0|||
48944175|NCT04375878|157625841|FG003|Extension Phase|Withdrawal by Subject|0|||
48944176|NCT04375878|157625842|FG004|Extension Phase|Withdrawal by Subject|1|||
48944177|NCT04375878|157625843|FG005|Extension Phase|Withdrawal by Subject|0|||
48944178|NCT02299934|157625847|FG000|Overall Study|Termination of study|13|||
48944179|NCT03240081|157625848|FG000|Overall Study|Withdrawal by Subject|0|||
48944180|NCT03240081|157625849|FG001|Overall Study|Withdrawal by Subject|2|||
48944181|NCT03240081|157625848|FG000|Overall Study|Lost to Follow-up|0|||
48944182|NCT03240081|157625849|FG001|Overall Study|Lost to Follow-up|1|||
48944183|NCT00820040|157625850|FG000|Overall Study|Death|1|||
48944184|NCT00820040|157625850|FG000|Overall Study|Sponsor terminated study|1|||
48944185|NCT00820040|157625850|FG000|Overall Study|Screen failure|1|||
48944186|NCT01480180|157625851|FG000|Main Phase|Withdrawal criteria|12|||
48944187|NCT01480180|157625852|FG001|Main Phase|Withdrawal criteria|1|||
48944188|NCT01480180|157625853|FG002|Main Phase|Withdrawal criteria|0|||
48944189|NCT01480180|157625854|FG003|Main Phase|Withdrawal criteria|0|||
48944190|NCT01480180|157625855|FG004|Main Phase|Withdrawal criteria|0|||
48944191|NCT01480180|157625856|FG005|Main Phase|Withdrawal criteria|0|||
48849823|NCT05580003|157288875|FG009|Part 6 Period 2 (Day 1)|Adverse Event|0|||
48849824|NCT05580003|157288876|FG010|Part 6 Period 2 (Day 1)|Adverse Event|0|||
48849825|NCT05580003|157288877|FG011|Part 6 Period 2 (Day 1)|Adverse Event|0|||
48849826|NCT05580003|157288878|FG012|Part 6 Period 2 (Day 1)|Adverse Event|0|||
48849827|NCT05580003|157288879|FG013|Part 6 Period 2 (Day 1)|Adverse Event|0|||
48849828|NCT05580003|157288880|FG014|Part 6 Period 2 (Day 1)|Adverse Event|0|||
48849829|NCT05580003|157288881|FG015|Part 6 Period 2 (Day 1)|Adverse Event|0|||
48849830|NCT05580003|157288882|FG016|Part 6 Period 2 (Day 1)|Adverse Event|0|||
48849831|NCT05580003|157288883|FG017|Part 6 Period 2 (Day 1)|Adverse Event|0|||
48849832|NCT05580003|157288884|FG018|Part 6 Period 2 (Day 1)|Adverse Event|0|||
48849833|NCT05580003|157288885|FG019|Part 6 Period 2 (Day 1)|Adverse Event|0|||
48849834|NCT05580003|157288886|FG020|Part 6 Period 2 (Day 1)|Adverse Event|0|||
48849835|NCT05580003|157288887|FG021|Part 6 Period 2 (Day 1)|Adverse Event|0|||
48849836|NCT05580003|157288888|FG022|Part 6 Period 2 (Day 1)|Adverse Event|0|||
48849837|NCT05580003|157288889|FG023|Part 6 Period 2 (Day 1)|Adverse Event|0|||
48849838|NCT05580003|157288890|FG024|Part 6 Period 2 (Day 1)|Adverse Event|0|||
48849839|NCT05580003|157288891|FG025|Part 6 Period 2 (Day 1)|Adverse Event|0|||
48849840|NCT05580003|157288892|FG026|Part 6 Period 2 (Day 1)|Adverse Event|0|||
48849841|NCT05580003|157288893|FG027|Part 6 Period 2 (Day 1)|Adverse Event|1|||
48849842|NCT05580003|157288866|FG000|Part 6 Period 2 (Day 1)|Other|0|||
48849843|NCT05580003|157288867|FG001|Part 6 Period 2 (Day 1)|Other|0|||
48849844|NCT05580003|157288868|FG002|Part 6 Period 2 (Day 1)|Other|0|||
48849845|NCT05580003|157288869|FG003|Part 6 Period 2 (Day 1)|Other|0|||
48849846|NCT05580003|157288870|FG004|Part 6 Period 2 (Day 1)|Other|0|||
48849847|NCT05580003|157288871|FG005|Part 6 Period 2 (Day 1)|Other|0|||
48849848|NCT05580003|157288872|FG006|Part 6 Period 2 (Day 1)|Other|0|||
48849849|NCT05580003|157288873|FG007|Part 6 Period 2 (Day 1)|Other|0|||
48849850|NCT05580003|157288874|FG008|Part 6 Period 2 (Day 1)|Other|0|||
48849851|NCT05580003|157288875|FG009|Part 6 Period 2 (Day 1)|Other|0|||
48944192|NCT01480180|157625851|FG000|Main Phase|Lack of Efficacy|1|||
48944193|NCT01480180|157625852|FG001|Main Phase|Lack of Efficacy|0|||
48944194|NCT01480180|157625853|FG002|Main Phase|Lack of Efficacy|0|||
48944195|NCT01480180|157625854|FG003|Main Phase|Lack of Efficacy|0|||
48944196|NCT01480180|157625855|FG004|Main Phase|Lack of Efficacy|0|||
48849852|NCT05580003|157288876|FG010|Part 6 Period 2 (Day 1)|Other|0|||
48849853|NCT05580003|157288877|FG011|Part 6 Period 2 (Day 1)|Other|0|||
48849854|NCT05580003|157288878|FG012|Part 6 Period 2 (Day 1)|Other|0|||
48849855|NCT05580003|157288879|FG013|Part 6 Period 2 (Day 1)|Other|0|||
48849856|NCT05580003|157288880|FG014|Part 6 Period 2 (Day 1)|Other|0|||
48849857|NCT05580003|157288881|FG015|Part 6 Period 2 (Day 1)|Other|0|||
48849858|NCT05580003|157288882|FG016|Part 6 Period 2 (Day 1)|Other|0|||
48849859|NCT05580003|157288883|FG017|Part 6 Period 2 (Day 1)|Other|0|||
48849860|NCT05580003|157288884|FG018|Part 6 Period 2 (Day 1)|Other|0|||
48849861|NCT05580003|157288885|FG019|Part 6 Period 2 (Day 1)|Other|0|||
48849862|NCT05580003|157288886|FG020|Part 6 Period 2 (Day 1)|Other|0|||
48849863|NCT05580003|157288887|FG021|Part 6 Period 2 (Day 1)|Other|0|||
48849864|NCT05580003|157288888|FG022|Part 6 Period 2 (Day 1)|Other|0|||
48849865|NCT05580003|157288889|FG023|Part 6 Period 2 (Day 1)|Other|0|||
48849866|NCT05580003|157288890|FG024|Part 6 Period 2 (Day 1)|Other|1|||
48849867|NCT05580003|157288891|FG025|Part 6 Period 2 (Day 1)|Other|0|||
48849868|NCT05580003|157288892|FG026|Part 6 Period 2 (Day 1)|Other|0|||
48849869|NCT05580003|157288893|FG027|Part 6 Period 2 (Day 1)|Other|0|||
48849870|NCT03840902|157288894|FG000|Overall Study|Randomized but not treated|1|||
48944197|NCT01480180|157625856|FG005|Main Phase|Lack of Efficacy|0|||
48944198|NCT01480180|157625851|FG000|Main Phase|Non-compliance|3|||
48944199|NCT01480180|157625852|FG001|Main Phase|Non-compliance|0|||
48849871|NCT03840902|157288895|FG001|Overall Study|Randomized but not treated|1|||
48849872|NCT02426138|157288896|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
48849873|NCT02426138|157288897|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
48849874|NCT02392234|157288902|FG000|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
48849875|NCT02392234|157288903|FG001|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
48849876|NCT02392234|157288904|FG002|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
48849877|NCT02392234|157288905|FG003|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
48849878|NCT02392234|157288906|FG004|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
48944200|NCT01480180|157625853|FG002|Main Phase|Non-compliance|0|||
48944201|NCT01480180|157625854|FG003|Main Phase|Non-compliance|0|||
48944202|NCT01480180|157625855|FG004|Main Phase|Non-compliance|0|||
48944203|NCT01480180|157625856|FG005|Main Phase|Non-compliance|0|||
48944204|NCT01480180|157625851|FG000|Main Phase|Unclassified|3|||
48944205|NCT01480180|157625852|FG001|Main Phase|Unclassified|0|||
48944206|NCT01480180|157625853|FG002|Main Phase|Unclassified|0|||
48944207|NCT01480180|157625854|FG003|Main Phase|Unclassified|0|||
48944208|NCT01480180|157625855|FG004|Main Phase|Unclassified|0|||
48944209|NCT01480180|157625856|FG005|Main Phase|Unclassified|0|||
48944210|NCT01480180|157625851|FG000|Extension Phase, Part 1|Withdrawal criteria|0|||
48944211|NCT01480180|157625852|FG001|Extension Phase, Part 1|Withdrawal criteria|0|||
48944212|NCT01480180|157625853|FG002|Extension Phase, Part 1|Withdrawal criteria|5|||
48944213|NCT01480180|157625854|FG003|Extension Phase, Part 1|Withdrawal criteria|0|||
48944214|NCT01480180|157625855|FG004|Extension Phase, Part 1|Withdrawal criteria|0|||
48944215|NCT01480180|157625856|FG005|Extension Phase, Part 1|Withdrawal criteria|0|||
48944216|NCT01480180|157625851|FG000|Extension Phase, Part 1|Unclassified|0|||
48944217|NCT01480180|157625852|FG001|Extension Phase, Part 1|Unclassified|0|||
48849879|NCT02392234|157288907|FG005|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
48849880|NCT02392234|157288902|FG000|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
48849881|NCT02392234|157288903|FG001|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
48944218|NCT01480180|157625853|FG002|Extension Phase, Part 1|Unclassified|1|||
48944219|NCT01480180|157625854|FG003|Extension Phase, Part 1|Unclassified|0|||
48944220|NCT01480180|157625855|FG004|Extension Phase, Part 1|Unclassified|0|||
48849882|NCT02392234|157288904|FG002|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
48944221|NCT01480180|157625856|FG005|Extension Phase, Part 1|Unclassified|0|||
48944222|NCT01480180|157625851|FG000|Extension Phase, Part 1|Adverse Event|0|||
48944223|NCT01480180|157625852|FG001|Extension Phase, Part 1|Adverse Event|0|||
48944224|NCT01480180|157625853|FG002|Extension Phase, Part 1|Adverse Event|4|||
48944225|NCT01480180|157625854|FG003|Extension Phase, Part 1|Adverse Event|1|||
48944226|NCT01480180|157625855|FG004|Extension Phase, Part 1|Adverse Event|0|||
48944227|NCT01480180|157625856|FG005|Extension Phase, Part 1|Adverse Event|0|||
48944228|NCT01480180|157625851|FG000|Extension Phase, Part 1|Change of treatment|0|||
48944229|NCT01480180|157625852|FG001|Extension Phase, Part 1|Change of treatment|0|||
48944230|NCT01480180|157625853|FG002|Extension Phase, Part 1|Change of treatment|0|||
48944231|NCT01480180|157625854|FG003|Extension Phase, Part 1|Change of treatment|9|||
48944232|NCT01480180|157625855|FG004|Extension Phase, Part 1|Change of treatment|0|||
48944233|NCT01480180|157625856|FG005|Extension Phase, Part 1|Change of treatment|0|||
48944234|NCT01480180|157625851|FG000|Extension Phase, Part 2|Withdrawal criteria|0|||
48944235|NCT01480180|157625852|FG001|Extension Phase, Part 2|Withdrawal criteria|0|||
48944236|NCT01480180|157625853|FG002|Extension Phase, Part 2|Withdrawal criteria|10|||
48944237|NCT01480180|157625854|FG003|Extension Phase, Part 2|Withdrawal criteria|6|||
48944238|NCT01480180|157625855|FG004|Extension Phase, Part 2|Withdrawal criteria|1|||
48944239|NCT01480180|157625856|FG005|Extension Phase, Part 2|Withdrawal criteria|0|||
48944240|NCT01480180|157625851|FG000|Extension Phase, Part 2|Lack of Efficacy|0|||
48944241|NCT01480180|157625852|FG001|Extension Phase, Part 2|Lack of Efficacy|0|||
48944242|NCT01480180|157625853|FG002|Extension Phase, Part 2|Lack of Efficacy|4|||
48944243|NCT01480180|157625854|FG003|Extension Phase, Part 2|Lack of Efficacy|0|||
48944244|NCT01480180|157625855|FG004|Extension Phase, Part 2|Lack of Efficacy|0|||
48944245|NCT01480180|157625856|FG005|Extension Phase, Part 2|Lack of Efficacy|0|||
48944246|NCT01480180|157625851|FG000|Extension Phase, Part 2|Unclassified|0|||
48944247|NCT01480180|157625852|FG001|Extension Phase, Part 2|Unclassified|0|||
48944248|NCT01480180|157625853|FG002|Extension Phase, Part 2|Unclassified|3|||
48944249|NCT01480180|157625854|FG003|Extension Phase, Part 2|Unclassified|1|||
48944250|NCT01480180|157625855|FG004|Extension Phase, Part 2|Unclassified|1|||
48944251|NCT01480180|157625856|FG005|Extension Phase, Part 2|Unclassified|0|||
48944252|NCT00971321|157625857|FG000|Up to Month 7|Withdrawal by Subject|1|||
48944253|NCT00971321|157625858|FG001|Up to Month 7|Withdrawal by Subject|0|||
48944254|NCT00971321|157625857|FG000|Up to Month 7|Migrated/moved from study area|3|||
48944255|NCT00971321|157625858|FG001|Up to Month 7|Migrated/moved from study area|2|||
48944256|NCT00971321|157625857|FG000|Up to Month 11-12|Withdrawal by Subject|2|||
48944257|NCT00971321|157625858|FG001|Up to Month 11-12|Withdrawal by Subject|1|||
48944258|NCT00971321|157625857|FG000|Up to Month 11-12|Migrated/moved from study area|2|||
48944259|NCT00971321|157625858|FG001|Up to Month 11-12|Migrated/moved from study area|2|||
48944260|NCT00971321|157625857|FG000|Up to Month 11-12|Lost to Follow-up|1|||
48944261|NCT00971321|157625858|FG001|Up to Month 11-12|Lost to Follow-up|0|||
48944262|NCT00553787|157625869|FG000|Overall Study|Adverse Event|34|||
48944263|NCT00553787|157625870|FG001|Overall Study|Adverse Event|21|||
48944264|NCT00553787|157625871|FG002|Overall Study|Adverse Event|67|||
48849883|NCT02392234|157288905|FG003|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
48849884|NCT02392234|157288906|FG004|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2|||
48849885|NCT02392234|157288907|FG005|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
48849886|NCT02392234|157288902|FG000|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
48849887|NCT02392234|157288903|FG001|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
48849888|NCT02392234|157288904|FG002|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
48849889|NCT02392234|157288905|FG003|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
48849890|NCT02392234|157288906|FG004|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
48944265|NCT00553787|157625869|FG000|Overall Study|Lost to Follow-up|132|||
48944266|NCT00553787|157625870|FG001|Overall Study|Lost to Follow-up|44|||
48944267|NCT00553787|157625871|FG002|Overall Study|Lost to Follow-up|78|||
48944268|NCT00553787|157625869|FG000|Overall Study|Withdrawal by Subject|151|||
48944269|NCT00553787|157625870|FG001|Overall Study|Withdrawal by Subject|40|||
48944270|NCT00553787|157625871|FG002|Overall Study|Withdrawal by Subject|83|||
48944271|NCT00553787|157625869|FG000|Overall Study|Lack of Efficacy|31|||
48944272|NCT00553787|157625870|FG001|Overall Study|Lack of Efficacy|1|||
48944273|NCT00553787|157625871|FG002|Overall Study|Lack of Efficacy|3|||
48944274|NCT00553787|157625869|FG000|Overall Study|Pregnancy|0|||
48944275|NCT00553787|157625870|FG001|Overall Study|Pregnancy|1|||
48944276|NCT00553787|157625871|FG002|Overall Study|Pregnancy|2|||
48944277|NCT00553787|157625869|FG000|Overall Study|non compliance|4|||
48944278|NCT00553787|157625870|FG001|Overall Study|non compliance|0|||
48944279|NCT00553787|157625871|FG002|Overall Study|non compliance|11|||
48944280|NCT00553787|157625869|FG000|Overall Study|Requirement for restricted medication|8|||
48944281|NCT00553787|157625870|FG001|Overall Study|Requirement for restricted medication|7|||
48944282|NCT00553787|157625871|FG002|Overall Study|Requirement for restricted medication|5|||
48944283|NCT00553787|157625869|FG000|Overall Study|Other|18|||
48944284|NCT00553787|157625870|FG001|Overall Study|Other|10|||
48944285|NCT00553787|157625871|FG002|Overall Study|Other|13|||
48944286|NCT00667277|157625872|FG000|Overall Study|Withdrawal by Subject|2|||
48944287|NCT01748760|157625878|FG000|Overall Study|Withdrawal by Subject|1|||
48944288|NCT01748760|157625879|FG001|Overall Study|Withdrawal by Subject|1|||
48944289|NCT01748760|157625878|FG000|Overall Study|Lost to Follow-up|5|||
48944290|NCT01748760|157625879|FG001|Overall Study|Lost to Follow-up|1|||
48944291|NCT04538950|157625886|FG000|Overall Study|Pulmonary Issues|2|||
48944292|NCT04538950|157625886|FG000|Overall Study|illness|2|||
48944293|NCT01887210|157625890|FG000|Overall Study|Withdrawal by Subject|1|||
48944294|NCT01887210|157625891|FG001|Overall Study|Withdrawal by Subject|3|||
48944295|NCT01887210|157625890|FG000|Overall Study|Lost to Follow-up|0|||
48944296|NCT01887210|157625891|FG001|Overall Study|Lost to Follow-up|1|||
48944297|NCT03414359|157625894|FG000|Overall Study|Lack of Efficacy|1|||
48944298|NCT03414359|157625895|FG001|Overall Study|Lack of Efficacy|1|||
48944299|NCT03414359|157625894|FG000|Overall Study|Protocol Violation|0|||
48944300|NCT03414359|157625895|FG001|Overall Study|Protocol Violation|1|||
48944301|NCT02273973|157625896|FG000|Overall Study|Adverse Event|4|||
48944302|NCT02273973|157625897|FG001|Overall Study|Adverse Event|0|||
48944303|NCT02273973|157625896|FG000|Overall Study|Withdrawal by Subject|2|||
48944304|NCT02273973|157625897|FG001|Overall Study|Withdrawal by Subject|3|||
48944305|NCT02273973|157625896|FG000|Overall Study|Death|1|||
48944306|NCT02273973|157625897|FG001|Overall Study|Death|0|||
48944307|NCT02273973|157625896|FG000|Overall Study|Non-compliance|1|||
48944308|NCT02273973|157625897|FG001|Overall Study|Non-compliance|0|||
48944309|NCT02273973|157625896|FG000|Overall Study|Protocol Violation|1|||
48944310|NCT02273973|157625897|FG001|Overall Study|Protocol Violation|0|||
48944311|NCT02273973|157625896|FG000|Overall Study|Progression of disease|0|||
48944312|NCT02273973|157625897|FG001|Overall Study|Progression of disease|2|||
48944313|NCT02273973|157625896|FG000|Overall Study|Lost to Follow-up|0|||
48944314|NCT02273973|157625897|FG001|Overall Study|Lost to Follow-up|1|||
48944315|NCT02273973|157625896|FG000|Overall Study|Physician Decision|0|||
48944316|NCT02273973|157625897|FG001|Overall Study|Physician Decision|1|||
48944317|NCT02273973|157625896|FG000|Overall Study|Reason not specified|0|||
48944318|NCT02273973|157625897|FG001|Overall Study|Reason not specified|1|||
48944319|NCT01333189|157625898|FG000|Overall Study|Time constraints|1|||
48944320|NCT01333189|157625899|FG001|Overall Study|Time constraints|0|||
48944321|NCT01333189|157625898|FG000|Overall Study|Adverse Event|1|||
48944322|NCT01333189|157625899|FG001|Overall Study|Adverse Event|0|||
48944323|NCT01333189|157625898|FG000|Overall Study|Transportation difficulties|0|||
48944324|NCT01333189|157625899|FG001|Overall Study|Transportation difficulties|1|||
48944325|NCT01333189|157625898|FG000|Overall Study|Moved from region|0|||
48944326|NCT01333189|157625899|FG001|Overall Study|Moved from region|1|||
48944327|NCT02179398|157625902|FG000|Overall Study|Lack of obligatory data|3|||
48944328|NCT02179398|157625903|FG001|Overall Study|Lack of obligatory data|3|||
48944329|NCT02179398|157625902|FG000|Overall Study|Lost to Follow-up|0|||
48944330|NCT02179398|157625903|FG001|Overall Study|Lost to Follow-up|1|||
48944331|NCT03022422|157625904|FG000|Overall Study|3 subjects consented but not vaccinated|0|||
48944332|NCT03022422|157625905|FG001|Overall Study|3 subjects consented but not vaccinated|0|||
48944333|NCT03022422|157625906|FG002|Overall Study|3 subjects consented but not vaccinated|3|||
48944334|NCT03022422|157625907|FG003|Overall Study|3 subjects consented but not vaccinated|0|||
48944335|NCT03022422|157625908|FG004|Overall Study|3 subjects consented but not vaccinated|0|||
48944336|NCT03022422|157625909|FG005|Overall Study|3 subjects consented but not vaccinated|0|||
48944337|NCT03497689|157625914|FG000|Overall Study|Adverse Event|2|||
48944338|NCT03497689|157625914|FG000|Overall Study|Death|1|||
48944339|NCT03497689|157625914|FG000|Overall Study|Physician Decision|1|||
48944340|NCT03497689|157625914|FG000|Overall Study|Withdrawal by Subject|1|||
48944341|NCT03497689|157625914|FG000|Overall Study|Protocol Violation|2|||
48944342|NCT02032524|157625915|FG000|Period 1: TDR12857 Study|Adverse Event|1|||
48944343|NCT02032524|157625916|FG001|Period 1: TDR12857 Study|Adverse Event|0|||
48944344|NCT02032524|157625917|FG002|Period 1: TDR12857 Study|Adverse Event|0|||
48944345|NCT02032524|157625918|FG003|Period 1: TDR12857 Study|Adverse Event|0|||
48944346|NCT02032524|157625919|FG004|Period 1: TDR12857 Study|Adverse Event|0|||
48944347|NCT02032524|157625920|FG005|Period 1: TDR12857 Study|Adverse Event|0|||
48944348|NCT02032524|157625915|FG000|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
48944349|NCT02032524|157625916|FG001|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
48944350|NCT02032524|157625917|FG002|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
48944351|NCT02032524|157625918|FG003|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
48944352|NCT02032524|157625919|FG004|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
48944353|NCT02032524|157625920|FG005|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
48944354|NCT02032524|157625915|FG000|Period 2: LTS13769 Study|Adverse Event|0|||
48944355|NCT02032524|157625916|FG001|Period 2: LTS13769 Study|Adverse Event|0|||
48944356|NCT02032524|157625917|FG002|Period 2: LTS13769 Study|Adverse Event|1|||
48944357|NCT02032524|157625918|FG003|Period 2: LTS13769 Study|Adverse Event|0|||
48944358|NCT02032524|157625919|FG004|Period 2: LTS13769 Study|Adverse Event|0|||
48944359|NCT02032524|157625920|FG005|Period 2: LTS13769 Study|Adverse Event|0|||
48944360|NCT02032524|157625915|FG000|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
48944361|NCT02032524|157625916|FG001|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
48944362|NCT02032524|157625917|FG002|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
48944363|NCT02032524|157625918|FG003|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
48944364|NCT02032524|157625919|FG004|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
48944365|NCT02032524|157625920|FG005|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
48944366|NCT02032524|157625915|FG000|Period 2: LTS13769 Study|Other|0|||
48944367|NCT02032524|157625916|FG001|Period 2: LTS13769 Study|Other|0|||
48944368|NCT02032524|157625917|FG002|Period 2: LTS13769 Study|Other|0|||
48944369|NCT02032524|157625918|FG003|Period 2: LTS13769 Study|Other|0|||
48944370|NCT02032524|157625919|FG004|Period 2: LTS13769 Study|Other|0|||
48944371|NCT02032524|157625920|FG005|Period 2: LTS13769 Study|Other|1|||
48944372|NCT05847881|157625921|FG000|Overall Study|Principal Investigator Decision|8|||
48944373|NCT05847881|157625921|FG000|Overall Study|Withdrawal by Subject|2|||
48944374|NCT00476086|157627293|FG000|Overall Study|Alternative therapy|1|||
48944375|NCT00476086|157627293|FG000|Overall Study|Progressive Disease|4|||
48944376|NCT02015819|157627296|FG000|Overall Study|Rickham catheter was misaligned|0|||
48944377|NCT02015819|157627297|FG001|Overall Study|Rickham catheter was misaligned|0|||
48944378|NCT02015819|157627298|FG002|Overall Study|Rickham catheter was misaligned|0|||
48944379|NCT02015819|157627299|FG003|Overall Study|Rickham catheter was misaligned|1|||
48944380|NCT02286960|157627306|FG000|Overall Study|Lost to Follow-up|3|||
48944381|NCT02286960|157627307|FG001|Overall Study|Lost to Follow-up|3|||
48944382|NCT01241786|157627308|FG000|Overall Study|Lack of Efficacy|5|||
48944383|NCT01165229|157627314|FG000|Overall Study|Serious Adverse Event|456|||
48944384|NCT01165229|157627315|FG001|Overall Study|Serious Adverse Event|487|||
48944385|NCT01165229|157627314|FG000|Overall Study|Non-Serious Adverse Event|47|||
48944386|NCT01165229|157627315|FG001|Overall Study|Non-Serious Adverse Event|15|||
48944387|NCT01165229|157627314|FG000|Overall Study|Protocol Violation|6|||
48944388|NCT01165229|157627315|FG001|Overall Study|Protocol Violation|8|||
48944389|NCT01165229|157627314|FG000|Overall Study|Withdrawal by Subject|387|||
48944390|NCT01165229|157627315|FG001|Overall Study|Withdrawal by Subject|396|||
48944391|NCT01165229|157627314|FG000|Overall Study|Migrated/moved from study area|51|||
48944392|NCT01165229|157627315|FG001|Overall Study|Migrated/moved from study area|46|||
48944393|NCT01165229|157627314|FG000|Overall Study|Lost to Follow-up|123|||
48944394|NCT01165229|157627315|FG001|Overall Study|Lost to Follow-up|133|||
48944395|NCT01165229|157627314|FG000|Overall Study|Suspected HZ Episode|2|||
48944396|NCT01165229|157627315|FG001|Overall Study|Suspected HZ Episode|2|||
48944397|NCT01165229|157627314|FG000|Overall Study|No reason from the subject|108|||
48944398|NCT01165229|157627315|FG001|Overall Study|No reason from the subject|102|||
48944399|NCT01165229|157627314|FG000|Overall Study|Unknown completion status|0|||
48944400|NCT01165229|157627315|FG001|Overall Study|Unknown completion status|1|||
48944401|NCT02835495|157627329|FG000|Overall Study|Cancer diagnosis prior intervention|1|||
48944402|NCT02835495|157627330|FG001|Overall Study|Cancer diagnosis prior intervention|0|||
48944403|NCT02835495|157627329|FG000|Overall Study|Declined in-person follow-up visit|4|||
48944404|NCT02835495|157627330|FG001|Overall Study|Declined in-person follow-up visit|2|||
48944405|NCT00609609|157627331|FG000|Overall Study|Withdrawal by Subject|2|||
48944406|NCT00609609|157627332|FG001|Overall Study|Withdrawal by Subject|0|||
48944407|NCT00609609|157627331|FG000|Overall Study|Progression|4|||
48944408|NCT00609609|157627332|FG001|Overall Study|Progression|2|||
48944409|NCT00637728|157627333|FG000|Double-blind Phase|Adverse Event|1|||
48944410|NCT00637728|157627334|FG001|Double-blind Phase|Adverse Event|0|||
48944411|NCT00637728|157627335|FG002|Double-blind Phase|Adverse Event|0|||
48944412|NCT00637728|157627333|FG000|Double-blind Phase|Non-compliance|2|||
48944413|NCT00637728|157627334|FG001|Double-blind Phase|Non-compliance|0|||
48944414|NCT00637728|157627335|FG002|Double-blind Phase|Non-compliance|0|||
48944415|NCT00637728|157627333|FG000|Double-blind Phase|Study Discontinued|1|||
48944416|NCT00637728|157627334|FG001|Double-blind Phase|Study Discontinued|1|||
48944417|NCT00637728|157627335|FG002|Double-blind Phase|Study Discontinued|0|||
48944418|NCT00670111|157627336|FG000|Enrollment to One Month|Testing Failure|0|||
48944419|NCT00670111|157627337|FG001|Enrollment to One Month|Testing Failure|0|||
48944420|NCT00670111|157627338|FG002|Enrollment to One Month|Testing Failure|13|||
48944421|NCT00670111|157627336|FG000|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
48944422|NCT00670111|157627337|FG001|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
48944423|NCT00670111|157627338|FG002|Enrollment to One Month|Ebrolled Patients but not Implanted|6|||
48944424|NCT00670111|157627336|FG000|Enrollment to One Month|Physician Decision|1|||
48944425|NCT00670111|157627337|FG001|Enrollment to One Month|Physician Decision|0|||
48944426|NCT00670111|157627338|FG002|Enrollment to One Month|Physician Decision|0|||
48944427|NCT05421754|157627348|FG000|Overall Study|Technical issue with sensor|1|||
48944428|NCT02580058|157627351|FG000|Overall Study|Adverse Event|16|||
48735953|NCT04478266|156883736|FG000|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|309|||
48735954|NCT04478266|156883737|FG001|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|286|||
48735955|NCT04478266|156883736|FG000|Overall Study|Study terminated by sponsor|33|||
48735956|NCT04478266|156883737|FG001|Overall Study|Study terminated by sponsor|35|||
48735957|NCT04478266|156883736|FG000|Overall Study|Other: unspecified|5|||
48735958|NCT04478266|156883737|FG001|Overall Study|Other: unspecified|7|||
48735959|NCT04478266|156883736|FG000|Overall Study|Randomized but not treated|1|||
48735960|NCT04478266|156883737|FG001|Overall Study|Randomized but not treated|1|||
48735961|NCT02699593|156883745|FG000|Period 1|Unsatisfactory Visual Response|0|||
48735962|NCT02699593|156883746|FG001|Period 1|Unsatisfactory Visual Response|1|||
48735963|NCT02699593|156883745|FG000|Period 1|Torn Contact Len|4|||
48735964|NCT02699593|156883746|FG001|Period 1|Torn Contact Len|3|||
48735965|NCT02699593|156883745|FG000|Period 1|Protocol Violation|0|||
48735966|NCT02699593|156883746|FG001|Period 1|Protocol Violation|1|||
48735967|NCT02699593|156883745|FG000|Period 1|Withdrawal by Subject|0|||
48735968|NCT02699593|156883746|FG001|Period 1|Withdrawal by Subject|1|||
48735969|NCT02699593|156883745|FG000|Period 1|Adverse Event|1|||
48735970|NCT02699593|156883746|FG001|Period 1|Adverse Event|1|||
48735971|NCT02699593|156883745|FG000|Period 2|Adverse Event|1|||
48735972|NCT02699593|156883746|FG001|Period 2|Adverse Event|1|||
48735973|NCT02699593|156883745|FG000|Period 2|Lost Contact Lens|0|||
48735974|NCT02699593|156883746|FG001|Period 2|Lost Contact Lens|1|||
48735975|NCT02699593|156883745|FG000|Period 2|Torn Contact Lens|1|||
48735976|NCT02699593|156883746|FG001|Period 2|Torn Contact Lens|0|||
48735977|NCT02935842|156883747|FG000|Testing and Therapy Period 2|Withdrawal by Subject|2|||
48735978|NCT02935842|156883748|FG001|Testing and Therapy Period 2|Withdrawal by Subject|0|||
48735979|NCT02935842|156883749|FG002|Testing and Therapy Period 2|Withdrawal by Subject|0|||
48735980|NCT02935842|156883750|FG003|Testing and Therapy Period 2|Withdrawal by Subject|0|||
48735981|NCT02935842|156883747|FG000|Testing and Therapy Period 3|Required other therapy (dysphagia)|1|||
48735982|NCT02935842|156883748|FG001|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
48735983|NCT02935842|156883749|FG002|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
48735984|NCT02935842|156883750|FG003|Testing and Therapy Period 3|Required other therapy (dysphagia)|0|||
48735985|NCT02935842|156883747|FG000|Testing and Therapy Period 3|Accident prior to treatment|2|||
48735986|NCT02935842|156883748|FG001|Testing and Therapy Period 3|Accident prior to treatment|2|||
48944429|NCT02580058|157627352|FG001|Overall Study|Adverse Event|30|||
48944430|NCT02580058|157627353|FG002|Overall Study|Adverse Event|20|||
48944431|NCT02580058|157627351|FG000|Overall Study|Death|4|||
48944432|NCT02580058|157627352|FG001|Overall Study|Death|4|||
48944433|NCT02580058|157627353|FG002|Overall Study|Death|5|||
48944434|NCT02580058|157627351|FG000|Overall Study|Physician Decision|1|||
48944435|NCT02580058|157627352|FG001|Overall Study|Physician Decision|3|||
48944436|NCT02580058|157627353|FG002|Overall Study|Physician Decision|11|||
48944437|NCT02580058|157627351|FG000|Overall Study|Other|5|||
48944438|NCT02580058|157627352|FG001|Overall Study|Other|1|||
48944439|NCT02580058|157627353|FG002|Overall Study|Other|3|||
48944440|NCT02580058|157627351|FG000|Overall Study|Withdrawal by Subject|4|||
48944441|NCT02580058|157627352|FG001|Overall Study|Withdrawal by Subject|7|||
48944442|NCT02580058|157627353|FG002|Overall Study|Withdrawal by Subject|31|||
48944443|NCT02580058|157627351|FG000|Overall Study|Global Deterioration of Health Status|19|||
48944444|NCT02580058|157627352|FG001|Overall Study|Global Deterioration of Health Status|18|||
48944445|NCT02580058|157627353|FG002|Overall Study|Global Deterioration of Health Status|24|||
48944446|NCT02580058|157627351|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
48944447|NCT02580058|157627352|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
48944448|NCT02580058|157627353|FG002|Overall Study|No Longer Meets Eligibility Criteria|2|||
48944449|NCT02580058|157627351|FG000|Overall Study|Progressive Disease|137|||
48944450|NCT02580058|157627352|FG001|Overall Study|Progressive Disease|125|||
48944451|NCT02580058|157627353|FG002|Overall Study|Progressive Disease|94|||
48944452|NCT02580058|157627351|FG000|Overall Study|Non-Compliance With Study Drug|1|||
48944453|NCT02580058|157627352|FG001|Overall Study|Non-Compliance With Study Drug|0|||
48944454|NCT02580058|157627353|FG002|Overall Study|Non-Compliance With Study Drug|0|||
48944455|NCT00707577|157627354|FG000|Overall Study|Withdrawal by Subject|3|||
48944456|NCT00707577|157627355|FG001|Overall Study|Withdrawal by Subject|2|||
48944457|NCT00707577|157627354|FG000|Overall Study|Lost to Follow-up|34|||
48944458|NCT00707577|157627355|FG001|Overall Study|Lost to Follow-up|25|||
48944459|NCT00707577|157627354|FG000|Overall Study|Left employment|13|||
48944460|NCT00707577|157627355|FG001|Overall Study|Left employment|10|||
48944461|NCT00707577|157627354|FG000|Overall Study|Pregnancy|4|||
48944462|NCT00707577|157627355|FG001|Overall Study|Pregnancy|1|||
48944463|NCT01570491|157627361|FG000|Overall Study|Lost to Follow-up|3|||
48944464|NCT01570491|157627362|FG001|Overall Study|Lost to Follow-up|1|||
48944465|NCT01570491|157627361|FG000|Overall Study|treatment: not given or discontinued|2|||
48944466|NCT01570491|157627362|FG001|Overall Study|treatment: not given or discontinued|0|||
48944467|NCT00659438|157627363|FG000|Overall Study|Withdrawal by Subject|2|||
48944468|NCT00659438|157627364|FG001|Overall Study|Withdrawal by Subject|2|||
48944469|NCT00659438|157627363|FG000|Overall Study|Death|11|||
48944470|NCT00659438|157627364|FG001|Overall Study|Death|6|||
48944471|NCT00659438|157627363|FG000|Overall Study|Lost to Follow-up|1|||
48944472|NCT00659438|157627364|FG001|Overall Study|Lost to Follow-up|0|||
48944473|NCT02614794|157627366|FG000|Overall Study|Death|258|||
48944474|NCT02614794|157627367|FG001|Overall Study|Death|151|||
48944475|NCT02614794|157627366|FG000|Overall Study|Study closure by Sponsor|119|||
48944476|NCT02614794|157627367|FG001|Overall Study|Study closure by Sponsor|45|||
48944477|NCT02614794|157627366|FG000|Overall Study|Withdrawal by Subject|24|||
48944478|NCT02614794|157627367|FG001|Overall Study|Withdrawal by Subject|5|||
48944479|NCT02614794|157627366|FG000|Overall Study|Lost to Follow-up|7|||
48944480|NCT02614794|157627367|FG001|Overall Study|Lost to Follow-up|0|||
48735987|NCT02935842|156883749|FG002|Testing and Therapy Period 3|Accident prior to treatment|0|||
48849891|NCT02392234|157288907|FG005|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
48849892|NCT02392234|157288902|FG000|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
48849893|NCT02392234|157288903|FG001|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
48849894|NCT02392234|157288904|FG002|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
48849895|NCT02392234|157288905|FG003|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
48849896|NCT02392234|157288906|FG004|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
48849897|NCT02392234|157288907|FG005|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
48849898|NCT02392234|157288902|FG000|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
48849899|NCT02392234|157288903|FG001|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
48849900|NCT02392234|157288904|FG002|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
48849901|NCT02392234|157288905|FG003|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
48849902|NCT02392234|157288906|FG004|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
48849903|NCT02392234|157288907|FG005|Treatment Period 1 (8 Weeks)|Noncompliance|1|||
48849904|NCT02392234|157288902|FG000|Treatment Period 1 (8 Weeks)|Other|1|||
48849905|NCT02392234|157288903|FG001|Treatment Period 1 (8 Weeks)|Other|0|||
48849906|NCT02392234|157288904|FG002|Treatment Period 1 (8 Weeks)|Other|0|||
48849907|NCT02392234|157288905|FG003|Treatment Period 1 (8 Weeks)|Other|0|||
48849908|NCT02392234|157288906|FG004|Treatment Period 1 (8 Weeks)|Other|0|||
48849909|NCT02392234|157288907|FG005|Treatment Period 1 (8 Weeks)|Other|0|||
48849910|NCT02392234|157288902|FG000|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
48849911|NCT02392234|157288903|FG001|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
48849912|NCT02392234|157288904|FG002|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
48944481|NCT02614794|157627366|FG000|Overall Study|Physician Decision|1|||
48944482|NCT02614794|157627367|FG001|Overall Study|Physician Decision|1|||
48944483|NCT02614794|157627366|FG000|Overall Study|Hospital closure|1|||
48944484|NCT02614794|157627367|FG001|Overall Study|Hospital closure|0|||
48944485|NCT03233048|157627378|FG000|Overall Study|Withdrawal by Subject|1|||
48944486|NCT01856673|157627379|FG000|Overall Study|Withdrawal by Subject|44|||
48944487|NCT01856673|157627380|FG001|Overall Study|Withdrawal by Subject|50|||
48944488|NCT01856673|157627381|FG002|Overall Study|Withdrawal by Subject|33|||
48944489|NCT01856673|157627379|FG000|Overall Study|Lost to Follow-up|31|||
48849913|NCT02392234|157288905|FG003|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
48849914|NCT02392234|157288906|FG004|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
48849915|NCT02392234|157288907|FG005|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
48849916|NCT02392234|157288902|FG000|Treatment Period 2 (8 Weeks)|Adverse Event|1|||
48849917|NCT02392234|157288903|FG001|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
48849918|NCT02392234|157288904|FG002|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
48849919|NCT02392234|157288905|FG003|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
48849920|NCT02392234|157288906|FG004|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
48849921|NCT02392234|157288907|FG005|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
48849922|NCT01588951|157288915|FG000|Overall Study|Ineligible in retrospect|0|||
48849923|NCT01588951|157288916|FG001|Overall Study|Ineligible in retrospect|0|||
48849924|NCT01588951|157288917|FG002|Overall Study|Ineligible in retrospect|1|||
48849925|NCT00467272|157288921|FG000|Overall Study|Pneumonia|2|||
48849926|NCT00467272|157288921|FG000|Overall Study|Thrombophlebitis|1|||
48849927|NCT00146172|157290484|FG000|Overall Study|Adverse Event|0|||
48849928|NCT00146172|157290485|FG001|Overall Study|Adverse Event|0|||
48849929|NCT00146172|157290486|FG002|Overall Study|Adverse Event|1|||
48849930|NCT00146172|157290487|FG003|Overall Study|Adverse Event|1|||
48849931|NCT00146172|157290488|FG004|Overall Study|Adverse Event|0|||
48849932|NCT00146172|157290489|FG005|Overall Study|Adverse Event|2|||
48849933|NCT00146172|157290490|FG006|Overall Study|Adverse Event|3|||
48849934|NCT00146172|157290491|FG007|Overall Study|Adverse Event|10|||
48849935|NCT00146172|157290484|FG000|Overall Study|Lost to Follow-up|0|||
48849936|NCT00146172|157290485|FG001|Overall Study|Lost to Follow-up|0|||
48849937|NCT00146172|157290486|FG002|Overall Study|Lost to Follow-up|0|||
48849938|NCT00146172|157290487|FG003|Overall Study|Lost to Follow-up|0|||
48849939|NCT00146172|157290488|FG004|Overall Study|Lost to Follow-up|0|||
48849940|NCT00146172|157290489|FG005|Overall Study|Lost to Follow-up|0|||
48849941|NCT00146172|157290490|FG006|Overall Study|Lost to Follow-up|0|||
48944490|NCT01856673|157627380|FG001|Overall Study|Lost to Follow-up|34|||
48849942|NCT00146172|157290491|FG007|Overall Study|Lost to Follow-up|1|||
48849943|NCT00146172|157290484|FG000|Overall Study|Disease Progression|2|||
48849944|NCT00146172|157290485|FG001|Overall Study|Disease Progression|4|||
48849945|NCT00146172|157290486|FG002|Overall Study|Disease Progression|2|||
48849946|NCT00146172|157290487|FG003|Overall Study|Disease Progression|5|||
48849947|NCT00146172|157290488|FG004|Overall Study|Disease Progression|2|||
48849948|NCT00146172|157290489|FG005|Overall Study|Disease Progression|2|||
48944491|NCT01856673|157627381|FG002|Overall Study|Lost to Follow-up|0|||
48944492|NCT01856673|157627379|FG000|Overall Study|Unknown reasons|9|||
48944493|NCT01856673|157627380|FG001|Overall Study|Unknown reasons|0|||
48944494|NCT01856673|157627381|FG002|Overall Study|Unknown reasons|0|||
48944495|NCT01856673|157627379|FG000|Overall Study|Psychologist decision|1|||
48944496|NCT01856673|157627380|FG001|Overall Study|Psychologist decision|0|||
48944497|NCT01856673|157627381|FG002|Overall Study|Psychologist decision|0|||
48944498|NCT01856673|157627379|FG000|Overall Study|Paperwork errors|8|||
48944499|NCT01856673|157627380|FG001|Overall Study|Paperwork errors|0|||
48944500|NCT01856673|157627381|FG002|Overall Study|Paperwork errors|0|||
48944501|NCT01856673|157627379|FG000|Overall Study|Death|1|||
48944502|NCT01856673|157627380|FG001|Overall Study|Death|1|||
48944503|NCT01856673|157627381|FG002|Overall Study|Death|0|||
48944504|NCT01856673|157627379|FG000|Overall Study|Protocol Violation|1|||
48944505|NCT01856673|157627380|FG001|Overall Study|Protocol Violation|0|||
48944506|NCT01856673|157627381|FG002|Overall Study|Protocol Violation|1|||
48944507|NCT00195351|157627382|FG000|Overall Study|Lost to Follow-up|9|||
48944508|NCT00195351|157627383|FG001|Overall Study|Lost to Follow-up|9|||
48944509|NCT00195351|157627382|FG000|Overall Study|Withdrawal by Subject|6|||
48944510|NCT00195351|157627383|FG001|Overall Study|Withdrawal by Subject|3|||
48944511|NCT00195351|157627382|FG000|Overall Study|Protocol Deviation|3|||
48944512|NCT00195351|157627383|FG001|Overall Study|Protocol Deviation|2|||
48944513|NCT00195351|157627382|FG000|Overall Study|Death|3|||
48944514|NCT00195351|157627383|FG001|Overall Study|Death|1|||
48944515|NCT00195351|157627382|FG000|Overall Study|Lack of Efficacy|0|||
48944516|NCT00195351|157627383|FG001|Overall Study|Lack of Efficacy|1|||
48944517|NCT00519532|157627387|FG000|Overall Study|Adverse Event|11|||
48944518|NCT00519532|157627387|FG000|Overall Study|Withdrawal by Subject|5|||
48944519|NCT00519532|157627387|FG000|Overall Study|Lost to Follow-up|2|||
48944520|NCT01088412|157627388|FG000|Overall Study|Adverse Event|38|||
48944521|NCT01088412|157627389|FG001|Overall Study|Adverse Event|0|||
48944522|NCT01088412|157627390|FG002|Overall Study|Adverse Event|0|||
48944523|NCT01088412|157627388|FG000|Overall Study|Death|42|||
48944524|NCT01088412|157627389|FG001|Overall Study|Death|6|||
48944525|NCT01088412|157627390|FG002|Overall Study|Death|0|||
48944526|NCT01088412|157627388|FG000|Overall Study|Other Reason per Case Report Form|2089|||
48944527|NCT01088412|157627389|FG001|Overall Study|Other Reason per Case Report Form|103|||
48944528|NCT01088412|157627390|FG002|Overall Study|Other Reason per Case Report Form|9|||
48944529|NCT01088412|157627388|FG000|Overall Study|Withdrawal by Subject|1761|||
48944530|NCT01088412|157627389|FG001|Overall Study|Withdrawal by Subject|25|||
48944531|NCT01088412|157627390|FG002|Overall Study|Withdrawal by Subject|1|||
48944532|NCT01088412|157627388|FG000|Overall Study|Received Another GH Product|79|||
48944533|NCT01088412|157627389|FG001|Overall Study|Received Another GH Product|0|||
48944534|NCT01088412|157627390|FG002|Overall Study|Received Another GH Product|0|||
48944535|NCT01088412|157627388|FG000|Overall Study|Participant Moved|601|||
48944536|NCT01088412|157627389|FG001|Overall Study|Participant Moved|21|||
48944537|NCT01088412|157627390|FG002|Overall Study|Participant Moved|2|||
48944538|NCT01088412|157627388|FG000|Overall Study|Physician Decision|1041|||
48944539|NCT01088412|157627389|FG001|Overall Study|Physician Decision|8|||
48944540|NCT01088412|157627390|FG002|Overall Study|Physician Decision|4|||
48944541|NCT01088412|157627388|FG000|Overall Study|Sponsor Decision|4467|||
48944542|NCT01088412|157627389|FG001|Overall Study|Sponsor Decision|79|||
48944543|NCT01088412|157627390|FG002|Overall Study|Sponsor Decision|23|||
48944544|NCT01088412|157627388|FG000|Overall Study|Third Party Required to Change Brand|487|||
48944545|NCT01088412|157627389|FG001|Overall Study|Third Party Required to Change Brand|0|||
48944546|NCT01088412|157627390|FG002|Overall Study|Third Party Required to Change Brand|0|||
48944547|NCT01088412|157627388|FG000|Overall Study|Lost to Follow-up|3052|||
48944548|NCT01088412|157627389|FG001|Overall Study|Lost to Follow-up|130|||
48944549|NCT01088412|157627390|FG002|Overall Study|Lost to Follow-up|11|||
48944550|NCT01088412|157627388|FG000|Overall Study|Study Summary Not Completed|4360|||
48944551|NCT01088412|157627389|FG001|Overall Study|Study Summary Not Completed|64|||
48944552|NCT01088412|157627390|FG002|Overall Study|Study Summary Not Completed|22|||
48944553|NCT02285010|157627391|FG000|Overall Study|not abdominal hysterectomy|2|||
48944554|NCT02285010|157627392|FG001|Overall Study|not abdominal hysterectomy|0|||
48944555|NCT02285010|157627391|FG000|Overall Study|Not spinal anesthesia|3|||
48944556|NCT02285010|157627392|FG001|Overall Study|Not spinal anesthesia|1|||
48944557|NCT00847561|157627393|FG000|Overall Study|Withdrawal by Subject|4|||
48944558|NCT00847561|157627394|FG001|Overall Study|Withdrawal by Subject|3|||
48944559|NCT00847561|157627393|FG000|Overall Study|Unable to schedule|9|||
48944560|NCT00847561|157627394|FG001|Overall Study|Unable to schedule|1|||
48944561|NCT01507246|157627398|FG000|Overall Study|Required different surgical procedures|2|||
48944562|NCT01507246|157627399|FG001|Overall Study|Required different surgical procedures|1|||
48944563|NCT01739595|157627400|FG000|Overall Study|Adverse Event|3|||
48849949|NCT00146172|157290490|FG006|Overall Study|Disease Progression|1|||
48849950|NCT00146172|157290491|FG007|Overall Study|Disease Progression|22|||
48849951|NCT00146172|157290484|FG000|Overall Study|Death|0|||
48849952|NCT00146172|157290485|FG001|Overall Study|Death|0|||
48849953|NCT00146172|157290486|FG002|Overall Study|Death|0|||
48849954|NCT00146172|157290487|FG003|Overall Study|Death|0|||
48849955|NCT00146172|157290488|FG004|Overall Study|Death|0|||
48849956|NCT00146172|157290489|FG005|Overall Study|Death|0|||
48849957|NCT00146172|157290490|FG006|Overall Study|Death|1|||
48849958|NCT00146172|157290491|FG007|Overall Study|Death|0|||
48849959|NCT00146172|157290484|FG000|Overall Study|Physician Decision|0|||
48849960|NCT00146172|157290485|FG001|Overall Study|Physician Decision|0|||
48849961|NCT00146172|157290486|FG002|Overall Study|Physician Decision|0|||
48849962|NCT00146172|157290487|FG003|Overall Study|Physician Decision|0|||
48849963|NCT00146172|157290488|FG004|Overall Study|Physician Decision|0|||
48849964|NCT00146172|157290489|FG005|Overall Study|Physician Decision|0|||
48849965|NCT00146172|157290490|FG006|Overall Study|Physician Decision|0|||
48849966|NCT00146172|157290491|FG007|Overall Study|Physician Decision|1|||
48849967|NCT00146172|157290484|FG000|Overall Study|Withdrawal by Subject|0|||
48849968|NCT00146172|157290485|FG001|Overall Study|Withdrawal by Subject|0|||
48849969|NCT00146172|157290486|FG002|Overall Study|Withdrawal by Subject|0|||
48849970|NCT00146172|157290487|FG003|Overall Study|Withdrawal by Subject|0|||
48849971|NCT00146172|157290488|FG004|Overall Study|Withdrawal by Subject|0|||
48849972|NCT00146172|157290489|FG005|Overall Study|Withdrawal by Subject|1|||
48849973|NCT00146172|157290490|FG006|Overall Study|Withdrawal by Subject|1|||
48849974|NCT00146172|157290491|FG007|Overall Study|Withdrawal by Subject|4|||
48849975|NCT00146172|157290484|FG000|Overall Study|Symptomatic Deterioration|1|||
48849976|NCT00146172|157290485|FG001|Overall Study|Symptomatic Deterioration|0|||
48944564|NCT01739595|157627401|FG001|Overall Study|Adverse Event|0|||
48944565|NCT01739595|157627402|FG002|Overall Study|Adverse Event|0|||
48944566|NCT01739595|157627400|FG000|Overall Study|Lost to Follow-up|2|||
48944567|NCT01739595|157627401|FG001|Overall Study|Lost to Follow-up|0|||
48944568|NCT01739595|157627402|FG002|Overall Study|Lost to Follow-up|0|||
48944569|NCT01739595|157627400|FG000|Overall Study|Withdrawal by Subject|2|||
48944570|NCT01739595|157627401|FG001|Overall Study|Withdrawal by Subject|1|||
48944571|NCT01739595|157627402|FG002|Overall Study|Withdrawal by Subject|2|||
48944572|NCT01739595|157627400|FG000|Overall Study|Eligibility issue|3|||
48944573|NCT01739595|157627401|FG001|Overall Study|Eligibility issue|0|||
48944574|NCT01739595|157627402|FG002|Overall Study|Eligibility issue|0|||
48944575|NCT01739595|157627400|FG000|Overall Study|Protocol Violation|1|||
48944576|NCT01739595|157627401|FG001|Overall Study|Protocol Violation|0|||
48944577|NCT01739595|157627402|FG002|Overall Study|Protocol Violation|0|||
48944578|NCT01739595|157627400|FG000|Overall Study|Lab assessment|1|||
48944579|NCT01739595|157627401|FG001|Overall Study|Lab assessment|0|||
48944580|NCT01739595|157627402|FG002|Overall Study|Lab assessment|0|||
48944581|NCT01739595|157627400|FG000|Overall Study|Drug discrepancy|1|||
48944582|NCT01739595|157627401|FG001|Overall Study|Drug discrepancy|0|||
48944583|NCT01739595|157627402|FG002|Overall Study|Drug discrepancy|0|||
48944584|NCT00393458|157627403|FG000|Overall Study|Adverse Event|35|||
48944585|NCT00393458|157627404|FG001|Overall Study|Adverse Event|24|||
48944586|NCT00393458|157627405|FG002|Overall Study|Adverse Event|40|||
48944587|NCT00393458|157627406|FG003|Overall Study|Adverse Event|35|||
48944588|NCT00393458|157627403|FG000|Overall Study|Subject withdrew consent|27|||
48944589|NCT00393458|157627404|FG001|Overall Study|Subject withdrew consent|40|||
48944590|NCT00393458|157627405|FG002|Overall Study|Subject withdrew consent|33|||
48944591|NCT00393458|157627406|FG003|Overall Study|Subject withdrew consent|50|||
48944592|NCT00393458|157627403|FG000|Overall Study|Unsatisfactory therapeutic effect|12|||
48944593|NCT00393458|157627404|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
48944594|NCT00393458|157627405|FG002|Overall Study|Unsatisfactory therapeutic effect|12|||
48944595|NCT00393458|157627406|FG003|Overall Study|Unsatisfactory therapeutic effect|30|||
48944596|NCT00393458|157627403|FG000|Overall Study|Protocol deviation|11|||
48944597|NCT00393458|157627404|FG001|Overall Study|Protocol deviation|11|||
48944598|NCT00393458|157627405|FG002|Overall Study|Protocol deviation|11|||
48944599|NCT00393458|157627406|FG003|Overall Study|Protocol deviation|10|||
48944600|NCT00393458|157627403|FG000|Overall Study|Administrative problems|7|||
48944601|NCT00393458|157627404|FG001|Overall Study|Administrative problems|8|||
48944602|NCT00393458|157627405|FG002|Overall Study|Administrative problems|5|||
48944603|NCT00393458|157627406|FG003|Overall Study|Administrative problems|2|||
48944604|NCT00393458|157627403|FG000|Overall Study|Lost to Follow-up|5|||
48944605|NCT00393458|157627404|FG001|Overall Study|Lost to Follow-up|6|||
48944606|NCT00393458|157627405|FG002|Overall Study|Lost to Follow-up|5|||
48944607|NCT00393458|157627406|FG003|Overall Study|Lost to Follow-up|3|||
48944608|NCT00393458|157627403|FG000|Overall Study|Abnormal laboratory value(s)|1|||
48944609|NCT00393458|157627404|FG001|Overall Study|Abnormal laboratory value(s)|1|||
48944610|NCT00393458|157627405|FG002|Overall Study|Abnormal laboratory value(s)|0|||
48944611|NCT00393458|157627406|FG003|Overall Study|Abnormal laboratory value(s)|0|||
48944612|NCT00393458|157627403|FG000|Overall Study|Death|1|||
48944613|NCT00393458|157627404|FG001|Overall Study|Death|1|||
48944614|NCT00393458|157627405|FG002|Overall Study|Death|5|||
48944615|NCT00393458|157627406|FG003|Overall Study|Death|5|||
48944616|NCT00393458|157627403|FG000|Overall Study|Abnormal test procedure result(s)|0|||
48944617|NCT00393458|157627404|FG001|Overall Study|Abnormal test procedure result(s)|1|||
48944618|NCT00393458|157627405|FG002|Overall Study|Abnormal test procedure result(s)|1|||
48944619|NCT00393458|157627406|FG003|Overall Study|Abnormal test procedure result(s)|2|||
48944620|NCT00393458|157627403|FG000|Overall Study|Subject no longer requires study drug|0|||
48944621|NCT00393458|157627404|FG001|Overall Study|Subject no longer requires study drug|1|||
48944622|NCT00393458|157627405|FG002|Overall Study|Subject no longer requires study drug|0|||
48849977|NCT00146172|157290486|FG002|Overall Study|Symptomatic Deterioration|1|||
48849978|NCT00146172|157290487|FG003|Overall Study|Symptomatic Deterioration|0|||
48849979|NCT00146172|157290488|FG004|Overall Study|Symptomatic Deterioration|1|||
48849980|NCT00146172|157290489|FG005|Overall Study|Symptomatic Deterioration|2|||
48849981|NCT00146172|157290490|FG006|Overall Study|Symptomatic Deterioration|0|||
48849982|NCT00146172|157290491|FG007|Overall Study|Symptomatic Deterioration|2|||
48849983|NCT02633215|157290496|FG000|Overall Study|Lost to Follow-up|2|||
48849984|NCT02633215|157290497|FG001|Overall Study|Lost to Follow-up|3|||
48849985|NCT02291913|157290498|FG000|Overall Study|Progressive Disease|32|||
48849986|NCT02291913|157290498|FG000|Overall Study|Adverse Event|11|||
48849987|NCT02291913|157290498|FG000|Overall Study|Death|2|||
48849988|NCT02291913|157290498|FG000|Overall Study|Physician Decision|1|||
48849989|NCT02291913|157290498|FG000|Overall Study|Withdrawal by Subject|1|||
48849990|NCT02291913|157290498|FG000|Overall Study|Protocol Violation|1|||
48944623|NCT00393458|157627406|FG003|Overall Study|Subject no longer requires study drug|0|||
48944624|NCT02515669|157627409|FG000|228 Week Open-Label Phase|Other|0|||
48944625|NCT02515669|157627410|FG001|228 Week Open-Label Phase|Other|0|||
48944626|NCT02515669|157627411|FG002|228 Week Open-Label Phase|Other|1|||
48944627|NCT02515669|157627412|FG003|228 Week Open-Label Phase|Other|4|||
48944628|NCT02515669|157627409|FG000|228 Week Open-Label Phase|Lack of Efficacy|0|||
48944629|NCT02515669|157627410|FG001|228 Week Open-Label Phase|Lack of Efficacy|0|||
48944630|NCT02515669|157627411|FG002|228 Week Open-Label Phase|Lack of Efficacy|1|||
48944631|NCT02515669|157627412|FG003|228 Week Open-Label Phase|Lack of Efficacy|0|||
48944632|NCT02515669|157627409|FG000|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
48944633|NCT02515669|157627410|FG001|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
48944634|NCT02515669|157627411|FG002|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2|||
48944635|NCT02515669|157627412|FG003|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3|||
48944636|NCT02515669|157627409|FG000|228 Week Open-Label Phase|Administrative Reason by Sponsor|0|||
48944637|NCT02515669|157627410|FG001|228 Week Open-Label Phase|Administrative Reason by Sponsor|7|||
48944638|NCT02515669|157627411|FG002|228 Week Open-Label Phase|Administrative Reason by Sponsor|2|||
48944639|NCT02515669|157627412|FG003|228 Week Open-Label Phase|Administrative Reason by Sponsor|17|||
48944640|NCT02515669|157627409|FG000|228 Week Open-Label Phase|Missing|0|||
48944641|NCT02515669|157627410|FG001|228 Week Open-Label Phase|Missing|2|||
48944642|NCT02515669|157627411|FG002|228 Week Open-Label Phase|Missing|2|||
48944643|NCT02515669|157627412|FG003|228 Week Open-Label Phase|Missing|2|||
48944644|NCT00957372|157627413|FG000|PART I|Lost to Follow-up|0|||
48944645|NCT00957372|157627414|FG001|PART I|Lost to Follow-up|0|||
48944646|NCT00957372|157627415|FG002|PART I|Lost to Follow-up|1|||
48735988|NCT02935842|156883750|FG003|Testing and Therapy Period 3|Accident prior to treatment|0|||
48944647|NCT00957372|157627416|FG003|PART I|Lost to Follow-up|0|||
48944648|NCT00957372|157627413|FG000|PART II|Withdrawal by Subject|0|||
48944649|NCT00957372|157627414|FG001|PART II|Withdrawal by Subject|0|||
48735989|NCT02935842|156883747|FG000|Testing and Therapy Period 3|Lost to Follow-up|0|||
48849991|NCT01637402|157290499|FG000|Standard Dose Regimen|Lack of Efficacy|2|||
48849992|NCT01637402|157290500|FG001|Standard Dose Regimen|Lack of Efficacy|0|||
48849993|NCT01637402|157290499|FG000|Standard Dose Regimen|Adverse Event|1|||
48849994|NCT01637402|157290500|FG001|Standard Dose Regimen|Adverse Event|0|||
48849995|NCT01637402|157290499|FG000|Week 12 Evaluation|Lack of Efficacy|6|||
48849996|NCT01637402|157290500|FG001|Week 12 Evaluation|Lack of Efficacy|0|||
48849997|NCT01637402|157290499|FG000|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0|||
48849998|NCT01637402|157290500|FG001|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4|||
48849999|NCT01637402|157290499|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|4|||
48850000|NCT01637402|157290500|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
48850001|NCT01637402|157290499|FG000|Treatment Regiments Post Week 12|Progression after escalation arm closed|5|||
48850002|NCT01637402|157290500|FG001|Treatment Regiments Post Week 12|Progression after escalation arm closed|0|||
48850003|NCT02132949|157290501|FG000|Overall Study|Death|7|||
48850004|NCT02132949|157290502|FG001|Overall Study|Death|13|||
48850005|NCT02132949|157290501|FG000|Overall Study|Lost to Follow-up|14|||
48850006|NCT02132949|157290502|FG001|Overall Study|Lost to Follow-up|4|||
48850007|NCT02132949|157290501|FG000|Overall Study|Withdrawal by Subject|6|||
48850008|NCT02132949|157290502|FG001|Overall Study|Withdrawal by Subject|5|||
48850009|NCT02132949|157290501|FG000|Overall Study|Noncompliance|5|||
48850010|NCT02132949|157290502|FG001|Overall Study|Noncompliance|1|||
48850011|NCT02132949|157290501|FG000|Overall Study|Physician Decision|3|||
48850012|NCT02132949|157290502|FG001|Overall Study|Physician Decision|1|||
48850013|NCT02132949|157290501|FG000|Overall Study|Disease Progression|3|||
49015282|NCT01446913|157892136|FG001|Overall Study|Withdrawal by Subject|3|||
48850014|NCT02132949|157290502|FG001|Overall Study|Disease Progression|0|||
48850015|NCT02132949|157290501|FG000|Overall Study|Adverse Event|2|||
48850016|NCT02132949|157290502|FG001|Overall Study|Adverse Event|1|||
48850017|NCT02132949|157290501|FG000|Overall Study|Withdrew Prior to Treatment|1|||
48850018|NCT02132949|157290502|FG001|Overall Study|Withdrew Prior to Treatment|2|||
48850019|NCT02132949|157290501|FG000|Overall Study|Reason Unspecified|0|||
48850020|NCT02132949|157290502|FG001|Overall Study|Reason Unspecified|1|||
48850021|NCT04334317|157290508|FG000|Overall Study|Adverse Event|1|||
48850022|NCT04334317|157290509|FG001|Overall Study|Adverse Event|2|||
48850023|NCT04334317|157290510|FG002|Overall Study|Adverse Event|0|||
48850024|NCT04334317|157290511|FG003|Overall Study|Adverse Event|0|||
48850025|NCT04334317|157290508|FG000|Overall Study|Protocol Deviation|0|||
48944650|NCT00957372|157627415|FG002|PART II|Withdrawal by Subject|0|||
48944651|NCT00957372|157627416|FG003|PART II|Withdrawal by Subject|8|||
49015283|NCT01446913|157892137|FG002|Overall Study|Withdrawal by Subject|5|||
48850026|NCT04334317|157290509|FG001|Overall Study|Protocol Deviation|1|||
48850027|NCT04334317|157290510|FG002|Overall Study|Protocol Deviation|0|||
48944652|NCT00957372|157627413|FG000|PART II|Physician Decision|0|||
48944653|NCT00957372|157627414|FG001|PART II|Physician Decision|0|||
48944654|NCT00957372|157627415|FG002|PART II|Physician Decision|0|||
48944655|NCT00957372|157627416|FG003|PART II|Physician Decision|1|||
48944656|NCT00957372|157627413|FG000|PART II|Pregnancy|0|||
48944657|NCT00957372|157627414|FG001|PART II|Pregnancy|0|||
48944658|NCT00957372|157627415|FG002|PART II|Pregnancy|0|||
48944659|NCT00957372|157627416|FG003|PART II|Pregnancy|1|||
48944660|NCT00957372|157627413|FG000|PART II|Not Know|0|||
48944661|NCT00957372|157627414|FG001|PART II|Not Know|0|||
48944662|NCT00957372|157627415|FG002|PART II|Not Know|0|||
48944663|NCT00957372|157627416|FG003|PART II|Not Know|20|||
48944664|NCT00957372|157627413|FG000|PART II|Adverse Event|0|||
48944665|NCT00957372|157627414|FG001|PART II|Adverse Event|0|||
48944666|NCT00957372|157627415|FG002|PART II|Adverse Event|0|||
48944667|NCT00957372|157627416|FG003|PART II|Adverse Event|10|||
48944668|NCT00957372|157627413|FG000|PART II|Patient non-compliance|0|||
48944669|NCT00957372|157627414|FG001|PART II|Patient non-compliance|0|||
48944670|NCT00957372|157627415|FG002|PART II|Patient non-compliance|0|||
48944671|NCT00957372|157627416|FG003|PART II|Patient non-compliance|4|||
48944672|NCT01282814|157627423|FG000|First Intervention|Emesis During Dosing Interval|0|||
48944673|NCT01282814|157627424|FG001|First Intervention|Emesis During Dosing Interval|3|||
48944674|NCT01282814|157627423|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
48944675|NCT01282814|157627424|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
48944676|NCT02403206|157627425|FG000|Overall Study|Lost to Follow-up|4|||
48944677|NCT02403206|157627426|FG001|Overall Study|Lost to Follow-up|3|||
48944678|NCT02403206|157627425|FG000|Overall Study|Physician Decision|2|||
48944679|NCT02403206|157627426|FG001|Overall Study|Physician Decision|0|||
48944680|NCT02403206|157627425|FG000|Overall Study|Withdrawal by Subject|3|||
48944681|NCT02403206|157627426|FG001|Overall Study|Withdrawal by Subject|3|||
48944682|NCT02403206|157627425|FG000|Overall Study|Reason not given|2|||
48944683|NCT02403206|157627426|FG001|Overall Study|Reason not given|4|||
48944684|NCT01524289|157627427|FG000|Overall Study|Lost to Follow-up|0|||
48944685|NCT01524289|157627428|FG001|Overall Study|Lost to Follow-up|1|||
48944686|NCT01524289|157627427|FG000|Overall Study|Physician Decision|1|||
48944687|NCT01524289|157627428|FG001|Overall Study|Physician Decision|0|||
48944688|NCT01524289|157627427|FG000|Overall Study|Protocol Violation|5|||
48944689|NCT01524289|157627428|FG001|Overall Study|Protocol Violation|1|||
48944690|NCT01524289|157627427|FG000|Overall Study|Withdrawal by Subject|11|||
48944691|NCT01524289|157627428|FG001|Overall Study|Withdrawal by Subject|7|||
48944692|NCT01524289|157627427|FG000|Overall Study|Adverse Event|12|||
48944693|NCT01524289|157627428|FG001|Overall Study|Adverse Event|5|||
48944694|NCT01524289|157627427|FG000|Overall Study|Did not take study medication|1|||
48944695|NCT01524289|157627428|FG001|Overall Study|Did not take study medication|0|||
48944696|NCT02104180|157627429|FG000|Overall Study|Protocol Violation|1|||
48944697|NCT02104180|157627430|FG001|Overall Study|Protocol Violation|0|||
48944698|NCT01444391|157627433|FG000|Overall Study|Death|1|||
48944699|NCT03750838|157627434|FG000|Overall Study|Lost to Follow-up|10|||
48944700|NCT03750838|157627435|FG001|Overall Study|Lost to Follow-up|6|||
48944701|NCT03067311|157627438|FG000|Overall Study|Lost to Follow-up|1|||
48944702|NCT03067311|157627439|FG001|Overall Study|Lost to Follow-up|1|||
48944703|NCT03067311|157627438|FG000|Overall Study|Moved away|1|||
48944704|NCT03067311|157627439|FG001|Overall Study|Moved away|1|||
48944705|NCT01614457|157629062|FG000|Overall Study|Non-Compliance|1|||
48944706|NCT01614457|157629063|FG001|Overall Study|Non-Compliance|0|||
48944707|NCT01614457|157629062|FG000|Overall Study|Pregnancy (Self or Partner)|1|||
48944708|NCT01614457|157629063|FG001|Overall Study|Pregnancy (Self or Partner)|0|||
48944709|NCT02981472|157629076|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
49015284|NCT01446913|157892135|FG000|Overall Study|Physician Decision|0|||
48850028|NCT04334317|157290511|FG003|Overall Study|Protocol Deviation|0|||
48850029|NCT04334317|157290508|FG000|Overall Study|Withdrawal by Subject|2|||
48850030|NCT04334317|157290509|FG001|Overall Study|Withdrawal by Subject|2|||
48850031|NCT04334317|157290510|FG002|Overall Study|Withdrawal by Subject|0|||
48850032|NCT04334317|157290511|FG003|Overall Study|Withdrawal by Subject|0|||
48850033|NCT02148705|157290516|FG000|Overall Study|Death|2|||
48850034|NCT02148705|157290517|FG001|Overall Study|Death|0|||
48850035|NCT02148705|157290518|FG002|Overall Study|Death|0|||
48850036|NCT02148705|157290516|FG000|Overall Study|Lost to Follow-up|13|||
48850037|NCT02148705|157290517|FG001|Overall Study|Lost to Follow-up|4|||
48850038|NCT02148705|157290518|FG002|Overall Study|Lost to Follow-up|10|||
48944710|NCT02981472|157629077|FG001|Pre-Treatment Period|Participant withdrew consent|1|||
49015285|NCT01446913|157892136|FG001|Overall Study|Physician Decision|0|||
48850039|NCT02148705|157290516|FG000|Overall Study|Withdrawal by Subject|3|||
48850040|NCT02148705|157290517|FG001|Overall Study|Withdrawal by Subject|0|||
48850041|NCT02148705|157290518|FG002|Overall Study|Withdrawal by Subject|2|||
48850042|NCT02148705|157290516|FG000|Overall Study|Not Treated|0|||
48850043|NCT02148705|157290517|FG001|Overall Study|Not Treated|1|||
48850044|NCT02148705|157290518|FG002|Overall Study|Not Treated|5|||
48850045|NCT03709706|157290521|FG000|Overall Study|Adverse Event|0|||
48850046|NCT03709706|157290522|FG001|Overall Study|Adverse Event|1|||
48850047|NCT03709706|157290521|FG000|Overall Study|Physician Decision|14|||
48850048|NCT03709706|157290522|FG001|Overall Study|Physician Decision|8|||
48850049|NCT03709706|157290521|FG000|Overall Study|Withdrawal by Subject|2|||
48850050|NCT03709706|157290522|FG001|Overall Study|Withdrawal by Subject|1|||
48850051|NCT03709706|157290521|FG000|Overall Study|Death Prior to Lete-cel Infusion|1|||
48850052|NCT03709706|157290522|FG001|Overall Study|Death Prior to Lete-cel Infusion|1|||
48850053|NCT01105975|157290525|FG000|Overall Study|Adverse Event|2|||
48850054|NCT01105975|157290526|FG001|Overall Study|Adverse Event|1|||
48850055|NCT01105975|157290527|FG002|Overall Study|Adverse Event|5|||
48850056|NCT01105975|157290528|FG003|Overall Study|Adverse Event|1|||
48850057|NCT01105975|157290529|FG004|Overall Study|Adverse Event|0|||
48850058|NCT01105975|157290530|FG005|Overall Study|Adverse Event|1|||
48850059|NCT01105975|157290531|FG006|Overall Study|Adverse Event|2|||
48850060|NCT01105975|157290532|FG007|Overall Study|Adverse Event|4|||
48944711|NCT02981472|157629076|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
48944712|NCT02981472|157629077|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
48944713|NCT02981472|157629076|FG000|Treatment Period|Adverse Event|6|||
48944714|NCT02981472|157629077|FG001|Treatment Period|Adverse Event|1|||
48944715|NCT02981472|157629076|FG000|Treatment Period|Participant withdrew consent|1|||
48944716|NCT02981472|157629077|FG001|Treatment Period|Participant withdrew consent|0|||
48944717|NCT02981472|157629076|FG000|Treatment Period|Lost to Follow-up|0|||
48944718|NCT02981472|157629077|FG001|Treatment Period|Lost to Follow-up|1|||
48850061|NCT01105975|157290533|FG008|Overall Study|Adverse Event|1|||
48944719|NCT01713348|157629078|FG000|Overall Study|Withdrawal by Subject|3|||
48944720|NCT01713348|157629079|FG001|Overall Study|Withdrawal by Subject|2|||
48944721|NCT01713348|157629080|FG002|Overall Study|Withdrawal by Subject|2|||
48850062|NCT01105975|157290534|FG009|Overall Study|Adverse Event|4|||
48850063|NCT01105975|157290525|FG000|Overall Study|Withdrawal by Subject|2|||
48850064|NCT01105975|157290526|FG001|Overall Study|Withdrawal by Subject|2|||
49015286|NCT01446913|157892137|FG002|Overall Study|Physician Decision|2|||
48944722|NCT01713348|157629081|FG003|Overall Study|Withdrawal by Subject|0|||
48944723|NCT01713348|157629078|FG000|Overall Study|Lost to Follow-up|1|||
48944724|NCT01713348|157629079|FG001|Overall Study|Lost to Follow-up|0|||
48944725|NCT01713348|157629080|FG002|Overall Study|Lost to Follow-up|0|||
48944726|NCT01713348|157629081|FG003|Overall Study|Lost to Follow-up|0|||
48944727|NCT00621023|157629082|FG000|Overall Study|Death|5|||
48944728|NCT00621023|157629082|FG000|Overall Study|Follow up discontinued|1|||
48944729|NCT03095703|157629083|FG000|Overall Study|Withdrawal by Subject|1|||
48944730|NCT04723537|157629087|FG000|Overall Study|Withdrawal by Subject|3|||
48944731|NCT04723537|157629088|FG001|Overall Study|Withdrawal by Subject|0|||
48944732|NCT04723537|157629089|FG002|Overall Study|Withdrawal by Subject|0|||
48944733|NCT04723537|157629087|FG000|Overall Study|Physician Decision|0|||
48944734|NCT04723537|157629088|FG001|Overall Study|Physician Decision|0|||
48944735|NCT04723537|157629089|FG002|Overall Study|Physician Decision|1|||
48944736|NCT04723537|157629087|FG000|Overall Study|Medical monitor decision, sponsor decision and other|1|||
48944737|NCT04723537|157629088|FG001|Overall Study|Medical monitor decision, sponsor decision and other|1|||
48944738|NCT04723537|157629089|FG002|Overall Study|Medical monitor decision, sponsor decision and other|1|||
48944739|NCT02158533|157629090|FG000|Stage 1|Adverse Event|6|||
48944740|NCT02158533|157629091|FG001|Stage 1|Adverse Event|4|||
48944741|NCT02158533|157629092|FG002|Stage 1|Adverse Event|7|||
48944742|NCT02158533|157629093|FG003|Stage 1|Adverse Event|0|||
48944743|NCT02158533|157629094|FG004|Stage 1|Adverse Event|0|||
48944744|NCT02158533|157629095|FG005|Stage 1|Adverse Event|0|||
48944745|NCT02158533|157629090|FG000|Stage 1|Withdrawal by Subject|3|||
48944746|NCT02158533|157629091|FG001|Stage 1|Withdrawal by Subject|2|||
48944747|NCT02158533|157629092|FG002|Stage 1|Withdrawal by Subject|1|||
48944748|NCT02158533|157629093|FG003|Stage 1|Withdrawal by Subject|0|||
48944749|NCT02158533|157629094|FG004|Stage 1|Withdrawal by Subject|0|||
48944750|NCT02158533|157629095|FG005|Stage 1|Withdrawal by Subject|0|||
48944751|NCT02158533|157629090|FG000|Stage 1|Lack of Efficacy|1|||
48944752|NCT02158533|157629091|FG001|Stage 1|Lack of Efficacy|0|||
48944753|NCT02158533|157629092|FG002|Stage 1|Lack of Efficacy|0|||
48944754|NCT02158533|157629093|FG003|Stage 1|Lack of Efficacy|0|||
48944755|NCT02158533|157629094|FG004|Stage 1|Lack of Efficacy|0|||
48944756|NCT02158533|157629095|FG005|Stage 1|Lack of Efficacy|0|||
48944757|NCT02158533|157629090|FG000|Stage 1|Lost to Follow-up|3|||
48944758|NCT02158533|157629091|FG001|Stage 1|Lost to Follow-up|1|||
48944759|NCT02158533|157629092|FG002|Stage 1|Lost to Follow-up|0|||
48944760|NCT02158533|157629093|FG003|Stage 1|Lost to Follow-up|0|||
48944761|NCT02158533|157629094|FG004|Stage 1|Lost to Follow-up|0|||
48944762|NCT02158533|157629095|FG005|Stage 1|Lost to Follow-up|0|||
48944763|NCT02158533|157629090|FG000|Stage 1|Failure to Meet Eligibility Criteria|0|||
48944764|NCT02158533|157629091|FG001|Stage 1|Failure to Meet Eligibility Criteria|1|||
48944765|NCT02158533|157629092|FG002|Stage 1|Failure to Meet Eligibility Criteria|0|||
48944766|NCT02158533|157629093|FG003|Stage 1|Failure to Meet Eligibility Criteria|0|||
48944767|NCT02158533|157629094|FG004|Stage 1|Failure to Meet Eligibility Criteria|0|||
48944768|NCT02158533|157629095|FG005|Stage 1|Failure to Meet Eligibility Criteria|0|||
48944769|NCT02158533|157629090|FG000|Stage 1|Non-compliance with study visits|1|||
48850065|NCT01105975|157290527|FG002|Overall Study|Withdrawal by Subject|2|||
48850066|NCT01105975|157290528|FG003|Overall Study|Withdrawal by Subject|0|||
48850067|NCT01105975|157290529|FG004|Overall Study|Withdrawal by Subject|4|||
48850068|NCT01105975|157290530|FG005|Overall Study|Withdrawal by Subject|1|||
48850069|NCT01105975|157290531|FG006|Overall Study|Withdrawal by Subject|2|||
48944770|NCT02158533|157629091|FG001|Stage 1|Non-compliance with study visits|0|||
48944771|NCT02158533|157629092|FG002|Stage 1|Non-compliance with study visits|0|||
48944772|NCT02158533|157629093|FG003|Stage 1|Non-compliance with study visits|0|||
48944773|NCT02158533|157629094|FG004|Stage 1|Non-compliance with study visits|0|||
48944774|NCT02158533|157629095|FG005|Stage 1|Non-compliance with study visits|0|||
48944775|NCT02158533|157629090|FG000|Stage 2|Adverse Event|0|||
48944776|NCT02158533|157629091|FG001|Stage 2|Adverse Event|0|||
48944777|NCT02158533|157629092|FG002|Stage 2|Adverse Event|0|||
48944778|NCT02158533|157629093|FG003|Stage 2|Adverse Event|0|||
48944779|NCT02158533|157629094|FG004|Stage 2|Adverse Event|0|||
48944780|NCT02158533|157629095|FG005|Stage 2|Adverse Event|1|||
48944781|NCT02158533|157629090|FG000|Stage 2|Lack of Efficacy|0|||
48944782|NCT02158533|157629091|FG001|Stage 2|Lack of Efficacy|0|||
48944783|NCT02158533|157629092|FG002|Stage 2|Lack of Efficacy|0|||
48944784|NCT02158533|157629093|FG003|Stage 2|Lack of Efficacy|0|||
48944785|NCT02158533|157629094|FG004|Stage 2|Lack of Efficacy|1|||
48944786|NCT02158533|157629095|FG005|Stage 2|Lack of Efficacy|0|||
48944787|NCT02158533|157629090|FG000|Stage 2|Lost to Follow-up|0|||
48944788|NCT02158533|157629091|FG001|Stage 2|Lost to Follow-up|0|||
48944789|NCT02158533|157629092|FG002|Stage 2|Lost to Follow-up|0|||
48944790|NCT02158533|157629093|FG003|Stage 2|Lost to Follow-up|1|||
48850070|NCT01105975|157290532|FG007|Overall Study|Withdrawal by Subject|1|||
48850071|NCT01105975|157290533|FG008|Overall Study|Withdrawal by Subject|0|||
48850072|NCT01105975|157290534|FG009|Overall Study|Withdrawal by Subject|3|||
48850073|NCT01105975|157290525|FG000|Overall Study|Lost to Follow-up|1|||
48850074|NCT01105975|157290526|FG001|Overall Study|Lost to Follow-up|0|||
48850075|NCT01105975|157290527|FG002|Overall Study|Lost to Follow-up|0|||
48850076|NCT01105975|157290528|FG003|Overall Study|Lost to Follow-up|1|||
48850077|NCT01105975|157290529|FG004|Overall Study|Lost to Follow-up|1|||
48944791|NCT02158533|157629094|FG004|Stage 2|Lost to Follow-up|1|||
48944792|NCT02158533|157629095|FG005|Stage 2|Lost to Follow-up|2|||
48944793|NCT02158533|157629090|FG000|Stage 2|Withdrawal by Subject|0|||
48944794|NCT02158533|157629091|FG001|Stage 2|Withdrawal by Subject|0|||
48850078|NCT01105975|157290530|FG005|Overall Study|Lost to Follow-up|0|||
48944795|NCT02158533|157629092|FG002|Stage 2|Withdrawal by Subject|0|||
48944796|NCT02158533|157629093|FG003|Stage 2|Withdrawal by Subject|0|||
48944797|NCT02158533|157629094|FG004|Stage 2|Withdrawal by Subject|1|||
48944798|NCT02158533|157629095|FG005|Stage 2|Withdrawal by Subject|2|||
48944799|NCT02158533|157629090|FG000|Stage 2|Physician Decision|0|||
48944800|NCT02158533|157629091|FG001|Stage 2|Physician Decision|0|||
48944801|NCT02158533|157629092|FG002|Stage 2|Physician Decision|0|||
48944802|NCT02158533|157629093|FG003|Stage 2|Physician Decision|0|||
48944803|NCT02158533|157629094|FG004|Stage 2|Physician Decision|1|||
48944804|NCT02158533|157629095|FG005|Stage 2|Physician Decision|0|||
48944805|NCT02158533|157629090|FG000|Stage 2|Pregnancy|0|||
48944806|NCT02158533|157629091|FG001|Stage 2|Pregnancy|0|||
48944807|NCT02158533|157629092|FG002|Stage 2|Pregnancy|0|||
48944808|NCT02158533|157629093|FG003|Stage 2|Pregnancy|1|||
48944809|NCT02158533|157629094|FG004|Stage 2|Pregnancy|0|||
48944810|NCT02158533|157629095|FG005|Stage 2|Pregnancy|0|||
48944811|NCT02158533|157629090|FG000|Stage 2|Psychiatrist decision to try new tx|0|||
48944812|NCT02158533|157629091|FG001|Stage 2|Psychiatrist decision to try new tx|0|||
48944813|NCT02158533|157629092|FG002|Stage 2|Psychiatrist decision to try new tx|0|||
48944814|NCT02158533|157629093|FG003|Stage 2|Psychiatrist decision to try new tx|1|||
48944815|NCT02158533|157629094|FG004|Stage 2|Psychiatrist decision to try new tx|0|||
48944816|NCT02158533|157629095|FG005|Stage 2|Psychiatrist decision to try new tx|0|||
48944817|NCT02158533|157629090|FG000|Stage 2|Non-adherence with study visits|0|||
48944818|NCT02158533|157629091|FG001|Stage 2|Non-adherence with study visits|0|||
48944819|NCT02158533|157629092|FG002|Stage 2|Non-adherence with study visits|0|||
48944820|NCT02158533|157629093|FG003|Stage 2|Non-adherence with study visits|0|||
48944821|NCT02158533|157629094|FG004|Stage 2|Non-adherence with study visits|0|||
48944822|NCT02158533|157629095|FG005|Stage 2|Non-adherence with study visits|1|||
48944823|NCT03842709|157629103|FG000|Overall Study|Withdrawal by Subject|3|||
48944824|NCT03842709|157629104|FG001|Overall Study|Withdrawal by Subject|3|||
48944825|NCT03842709|157629103|FG000|Overall Study|Lost to Follow-up|1|||
48944826|NCT03842709|157629104|FG001|Overall Study|Lost to Follow-up|0|||
48944827|NCT00635102|157629109|FG000|Overall Study|Withdrawal by Subject|7|||
48944828|NCT00635102|157629110|FG001|Overall Study|Withdrawal by Subject|8|||
48944829|NCT00440401|157629111|FG000|Overall Study|Adverse Event|2|||
48944830|NCT00440401|157629112|FG001|Overall Study|Adverse Event|1|||
48944831|NCT00440401|157629111|FG000|Overall Study|Other|2|||
48944832|NCT00440401|157629112|FG001|Overall Study|Other|5|||
48944833|NCT00546351|157629115|FG000|Overall Study|Adverse Event|76|||
48944834|NCT00546351|157629115|FG000|Overall Study|Lack of Efficacy|15|||
48944835|NCT00546351|157629115|FG000|Overall Study|Withdrawal by Subject|109|||
48944836|NCT00546351|157629115|FG000|Overall Study|Lost to Follow-up|9|||
48944837|NCT00546351|157629115|FG000|Overall Study|Protocol Deviation|1|||
48944838|NCT00546351|157629115|FG000|Overall Study|Unsatisfactory compliance|9|||
48944839|NCT00546351|157629115|FG000|Overall Study|Other reasons for premature termination|17|||
48944840|NCT00500071|157629116|FG000|Screening and Washout Phase|Protocol Violation|1|||
48944841|NCT00500071|157629116|FG000|Dose-optimization and Maintenance Phase|Adverse Event|13|||
48944842|NCT00500071|157629116|FG000|Dose-optimization and Maintenance Phase|Protocol Violation|2|||
48944843|NCT00500071|157629116|FG000|Dose-optimization and Maintenance Phase|Lack of Efficacy|2|||
48944844|NCT00500071|157629116|FG000|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1|||
48944845|NCT00500071|157629116|FG000|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4|||
48944846|NCT00500071|157629116|FG000|30-day Safety Follow-up|Lost to Follow-up|17|||
48944847|NCT04112914|157629117|FG000|Overall Study|Lost to Follow-up|13|||
48944848|NCT04112914|157629118|FG001|Overall Study|Lost to Follow-up|9|||
48944849|NCT04112914|157629117|FG000|Overall Study|Withdrawal by Subject|1|||
48944850|NCT04112914|157629118|FG001|Overall Study|Withdrawal by Subject|0|||
48944851|NCT01486238|157629129|FG000|Overall Study|Death|0|||
48944852|NCT01486238|157629130|FG001|Overall Study|Death|2|||
48944853|NCT01486238|157629129|FG000|Overall Study|Withdrawal by Subject|2|||
48944854|NCT01486238|157629130|FG001|Overall Study|Withdrawal by Subject|1|||
48944855|NCT01486238|157629129|FG000|Overall Study|Lost to Follow-up|0|||
48944856|NCT01486238|157629130|FG001|Overall Study|Lost to Follow-up|3|||
48944857|NCT04334148|157629135|FG000|Overall Study|positive nasal swab at baseline|0|||
48944858|NCT04334148|157629136|FG001|Overall Study|positive nasal swab at baseline|1|||
48944859|NCT04101422|157629137|FG000|Overall Study|Ineligible|1|||
48944860|NCT04101422|157629138|FG001|Overall Study|Ineligible|0|||
48944861|NCT04101422|157629139|FG002|Overall Study|Ineligible|9|||
48944862|NCT04101422|157629140|FG003|Overall Study|Ineligible|0|||
48944863|NCT04101422|157629137|FG000|Overall Study|Withdrawal by Subject|0|||
48944864|NCT04101422|157629138|FG001|Overall Study|Withdrawal by Subject|0|||
48944865|NCT04101422|157629139|FG002|Overall Study|Withdrawal by Subject|1|||
48944866|NCT04101422|157629140|FG003|Overall Study|Withdrawal by Subject|0|||
48944867|NCT04101422|157629137|FG000|Overall Study|Not attending to the stimuli|0|||
48944868|NCT04101422|157629138|FG001|Overall Study|Not attending to the stimuli|0|||
48944869|NCT04101422|157629139|FG002|Overall Study|Not attending to the stimuli|4|||
48944870|NCT04101422|157629140|FG003|Overall Study|Not attending to the stimuli|0|||
48944871|NCT04101422|157629137|FG000|Overall Study|Did not download app|0|||
48944872|NCT04101422|157629138|FG001|Overall Study|Did not download app|0|||
48944873|NCT04101422|157629139|FG002|Overall Study|Did not download app|0|||
48944874|NCT04101422|157629140|FG003|Overall Study|Did not download app|17|||
48944875|NCT04101422|157629137|FG000|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
48944876|NCT04101422|157629138|FG001|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
48944877|NCT04101422|157629139|FG002|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
48944878|NCT04101422|157629140|FG003|Overall Study|Did not use app on 4 or more occasions per protocol|3|||
48944879|NCT01720667|157629141|FG000|Overall Study|Adverse Event|1|||
48944880|NCT01720667|157629142|FG001|Overall Study|Adverse Event|1|||
48944881|NCT01720667|157629141|FG000|Overall Study|Withdrawal by Subject|3|||
48944882|NCT01720667|157629142|FG001|Overall Study|Withdrawal by Subject|0|||
48944883|NCT00850499|157629143|FG000|Overall Study|Adverse Event|3|||
48944884|NCT00850499|157629144|FG001|Overall Study|Adverse Event|1|||
48944885|NCT00850499|157629143|FG000|Overall Study|Lack of Efficacy|0|||
48944886|NCT00850499|157629144|FG001|Overall Study|Lack of Efficacy|1|||
48944887|NCT00095303|157629145|FG000|Main Study|Lost to Follow-up|91|||
48944888|NCT00095303|157629146|FG001|Main Study|Lost to Follow-up|87|||
48944889|NCT00095303|157629145|FG000|Follow Up Study|Lost to Follow-up|59|||
48944890|NCT00095303|157629146|FG001|Follow Up Study|Lost to Follow-up|58|||
48944891|NCT01364467|157629147|FG000|Overall Study|Lost to Follow-up|1|||
48944892|NCT01364467|157629148|FG001|Overall Study|Lost to Follow-up|2|||
48944893|NCT03228186|157629149|FG000|Overall Study|Patient never started treatment|1|||
48944894|NCT01634243|157629152|FG000|Overall Study|Adverse Event|5|||
48944895|NCT01634243|157629153|FG001|Overall Study|Adverse Event|5|||
48944896|NCT01634243|157629152|FG000|Overall Study|Lack of Efficacy|1|||
48944897|NCT01634243|157629153|FG001|Overall Study|Lack of Efficacy|0|||
48944898|NCT01670500|157629154|FG000|Overall Study|Withdrawal by Subject|1|||
48944899|NCT01670500|157629155|FG001|Overall Study|Withdrawal by Subject|0|||
48944900|NCT00491530|157629156|FG000|Overall Study|Adverse Event|6|||
48944901|NCT00491530|157629157|FG001|Overall Study|Adverse Event|1|||
48944902|NCT00491530|157629158|FG002|Overall Study|Adverse Event|2|||
48944903|NCT00491530|157629156|FG000|Overall Study|Withdrawal by Subject|3|||
48944904|NCT00491530|157629157|FG001|Overall Study|Withdrawal by Subject|0|||
48944905|NCT00491530|157629158|FG002|Overall Study|Withdrawal by Subject|0|||
48944906|NCT00491530|157629156|FG000|Overall Study|Lost to Follow-up|3|||
48944907|NCT00491530|157629157|FG001|Overall Study|Lost to Follow-up|2|||
48944908|NCT00491530|157629158|FG002|Overall Study|Lost to Follow-up|2|||
48944909|NCT00491530|157629156|FG000|Overall Study|Lack of Efficacy|0|||
48944910|NCT00491530|157629157|FG001|Overall Study|Lack of Efficacy|1|||
48944911|NCT00491530|157629158|FG002|Overall Study|Lack of Efficacy|0|||
48944912|NCT00491530|157629156|FG000|Overall Study|Investigator Discretion|0|||
48944913|NCT00491530|157629157|FG001|Overall Study|Investigator Discretion|1|||
48944914|NCT00491530|157629158|FG002|Overall Study|Investigator Discretion|0|||
48944915|NCT00491530|157629156|FG000|Overall Study|Patient Request|0|||
48944916|NCT00491530|157629157|FG001|Overall Study|Patient Request|1|||
48944917|NCT00491530|157629158|FG002|Overall Study|Patient Request|0|||
48850079|NCT01105975|157290531|FG006|Overall Study|Lost to Follow-up|0|||
48850080|NCT01105975|157290532|FG007|Overall Study|Lost to Follow-up|0|||
48850081|NCT01105975|157290533|FG008|Overall Study|Lost to Follow-up|1|||
48850082|NCT01105975|157290534|FG009|Overall Study|Lost to Follow-up|0|||
48850083|NCT01105975|157290525|FG000|Overall Study|Physician Decision|0|||
48850084|NCT01105975|157290526|FG001|Overall Study|Physician Decision|0|||
48850085|NCT01105975|157290527|FG002|Overall Study|Physician Decision|0|||
48850086|NCT01105975|157290528|FG003|Overall Study|Physician Decision|0|||
48850087|NCT01105975|157290529|FG004|Overall Study|Physician Decision|0|||
48850088|NCT01105975|157290530|FG005|Overall Study|Physician Decision|0|||
48850089|NCT01105975|157290531|FG006|Overall Study|Physician Decision|2|||
48850090|NCT01105975|157290532|FG007|Overall Study|Physician Decision|0|||
48850091|NCT01105975|157290533|FG008|Overall Study|Physician Decision|0|||
48850092|NCT01105975|157290534|FG009|Overall Study|Physician Decision|0|||
48850093|NCT01105975|157290525|FG000|Overall Study|Protocol Violation|0|||
48850094|NCT01105975|157290526|FG001|Overall Study|Protocol Violation|2|||
48850095|NCT01105975|157290527|FG002|Overall Study|Protocol Violation|2|||
48850096|NCT01105975|157290528|FG003|Overall Study|Protocol Violation|0|||
48850097|NCT01105975|157290529|FG004|Overall Study|Protocol Violation|1|||
48850098|NCT01105975|157290530|FG005|Overall Study|Protocol Violation|1|||
48850099|NCT01105975|157290531|FG006|Overall Study|Protocol Violation|1|||
48850100|NCT01105975|157290532|FG007|Overall Study|Protocol Violation|1|||
48850101|NCT01105975|157290533|FG008|Overall Study|Protocol Violation|2|||
48850102|NCT01105975|157290534|FG009|Overall Study|Protocol Violation|2|||
48850103|NCT01105975|157290525|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
48850104|NCT01105975|157290526|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
48850105|NCT01105975|157290527|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
48850106|NCT01105975|157290528|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
48850107|NCT01105975|157290529|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
48850108|NCT01105975|157290530|FG005|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
48944918|NCT00491530|157629156|FG000|Overall Study|Use of Prohibited Medication|0|||
48944919|NCT00491530|157629157|FG001|Overall Study|Use of Prohibited Medication|0|||
48944920|NCT00491530|157629158|FG002|Overall Study|Use of Prohibited Medication|1|||
48944921|NCT03114969|157629161|FG000|Overall Study|Lost to Follow-up|0|||
48944922|NCT03114969|157629162|FG001|Overall Study|Lost to Follow-up|0|||
48944923|NCT03114969|157629163|FG002|Overall Study|Lost to Follow-up|3|||
48944924|NCT03114969|157629164|FG003|Overall Study|Lost to Follow-up|2|||
48944925|NCT03114969|157629165|FG004|Overall Study|Lost to Follow-up|0|||
48850109|NCT01105975|157290531|FG006|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
48850110|NCT01105975|157290532|FG007|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
48850111|NCT01105975|157290533|FG008|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
48850112|NCT01105975|157290534|FG009|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
48850113|NCT01372085|157290535|FG000|Washout Period 2|Physician Decision|0|||
48850114|NCT01372085|157290536|FG001|Washout Period 2|Physician Decision|0|||
48850115|NCT01372085|157290537|FG002|Washout Period 2|Physician Decision|0|||
48944926|NCT03114969|157629166|FG005|Overall Study|Lost to Follow-up|0|||
48944927|NCT03114969|157629167|FG006|Overall Study|Lost to Follow-up|0|||
48944928|NCT03114969|157629168|FG007|Overall Study|Lost to Follow-up|0|||
48944929|NCT03114969|157629169|FG008|Overall Study|Lost to Follow-up|0|||
48944930|NCT03114969|157629161|FG000|Overall Study|Adverse Event|0|||
48944931|NCT03114969|157629162|FG001|Overall Study|Adverse Event|0|||
48944932|NCT03114969|157629163|FG002|Overall Study|Adverse Event|1|||
48944933|NCT03114969|157629164|FG003|Overall Study|Adverse Event|0|||
48944934|NCT03114969|157629165|FG004|Overall Study|Adverse Event|0|||
48944935|NCT03114969|157629166|FG005|Overall Study|Adverse Event|1|||
48944936|NCT03114969|157629167|FG006|Overall Study|Adverse Event|1|||
48944937|NCT03114969|157629168|FG007|Overall Study|Adverse Event|0|||
48944938|NCT03114969|157629169|FG008|Overall Study|Adverse Event|2|||
48944939|NCT02436239|157629170|FG000|Open-Lable Treatment Period|Adverse Event|12|||
48944940|NCT02436239|157629171|FG001|Open-Lable Treatment Period|Adverse Event|3|||
48944941|NCT02436239|157629172|FG002|Open-Lable Treatment Period|Adverse Event|4|||
48944942|NCT02436239|157629173|FG003|Open-Lable Treatment Period|Adverse Event|2|||
48944943|NCT02436239|157629170|FG000|Open-Lable Treatment Period|Lack of Efficacy|1|||
48944944|NCT02436239|157629171|FG001|Open-Lable Treatment Period|Lack of Efficacy|6|||
48944945|NCT02436239|157629172|FG002|Open-Lable Treatment Period|Lack of Efficacy|6|||
48944946|NCT02436239|157629173|FG003|Open-Lable Treatment Period|Lack of Efficacy|1|||
49015287|NCT01446913|157892135|FG000|Overall Study|Lost to Follow-up|3|||
49015288|NCT01446913|157892136|FG001|Overall Study|Lost to Follow-up|5|||
48944947|NCT02436239|157629170|FG000|Open-Lable Treatment Period|Withdrawal by Subject|10|||
48944948|NCT02436239|157629171|FG001|Open-Lable Treatment Period|Withdrawal by Subject|15|||
48944949|NCT02436239|157629172|FG002|Open-Lable Treatment Period|Withdrawal by Subject|9|||
49015289|NCT01446913|157892137|FG002|Overall Study|Lost to Follow-up|3|||
48944950|NCT02436239|157629173|FG003|Open-Lable Treatment Period|Withdrawal by Subject|0|||
48944951|NCT02436239|157629170|FG000|Open-Lable Treatment Period|Lost to Follow-up|4|||
48944952|NCT02436239|157629171|FG001|Open-Lable Treatment Period|Lost to Follow-up|2|||
48944953|NCT02436239|157629172|FG002|Open-Lable Treatment Period|Lost to Follow-up|4|||
48944954|NCT02436239|157629173|FG003|Open-Lable Treatment Period|Lost to Follow-up|1|||
48944955|NCT02436239|157629170|FG000|Open-Lable Treatment Period|Protocol Violation|0|||
48944956|NCT02436239|157629171|FG001|Open-Lable Treatment Period|Protocol Violation|1|||
48944957|NCT02436239|157629172|FG002|Open-Lable Treatment Period|Protocol Violation|1|||
48944958|NCT02436239|157629173|FG003|Open-Lable Treatment Period|Protocol Violation|0|||
49015290|NCT03443869|157892138|FG000|Overall Study|Death|3|||
48944959|NCT02436239|157629170|FG000|Open-Lable Treatment Period|Noncompliance with Study Drug|5|||
48944960|NCT02436239|157629171|FG001|Open-Lable Treatment Period|Noncompliance with Study Drug|6|||
48944961|NCT02436239|157629172|FG002|Open-Lable Treatment Period|Noncompliance with Study Drug|3|||
48944962|NCT02436239|157629173|FG003|Open-Lable Treatment Period|Noncompliance with Study Drug|1|||
48944963|NCT02436239|157629170|FG000|Open-Lable Treatment Period|Other Reason|1|||
48944964|NCT02436239|157629171|FG001|Open-Lable Treatment Period|Other Reason|1|||
48944965|NCT02436239|157629172|FG002|Open-Lable Treatment Period|Other Reason|0|||
48944966|NCT02436239|157629173|FG003|Open-Lable Treatment Period|Other Reason|0|||
49015291|NCT03443869|157892139|FG001|Overall Study|Death|3|||
48850116|NCT01372085|157290538|FG003|Washout Period 2|Physician Decision|0|||
48850117|NCT01372085|157290539|FG004|Washout Period 2|Physician Decision|1|||
48850118|NCT01372085|157290540|FG005|Washout Period 2|Physician Decision|0|||
48850119|NCT01372085|157290541|FG006|Washout Period 2|Physician Decision|0|||
48850120|NCT01372085|157290542|FG007|Washout Period 2|Physician Decision|0|||
48850121|NCT01372085|157290543|FG008|Washout Period 2|Physician Decision|0|||
48850122|NCT01372085|157290544|FG009|Washout Period 2|Physician Decision|0|||
48850123|NCT01372085|157290535|FG000|Washout Period 3|Withdrawal by Subject|0|||
48850124|NCT01372085|157290536|FG001|Washout Period 3|Withdrawal by Subject|0|||
48850125|NCT01372085|157290537|FG002|Washout Period 3|Withdrawal by Subject|0|||
48850126|NCT01372085|157290538|FG003|Washout Period 3|Withdrawal by Subject|0|||
48850127|NCT01372085|157290539|FG004|Washout Period 3|Withdrawal by Subject|0|||
48850128|NCT01372085|157290540|FG005|Washout Period 3|Withdrawal by Subject|2|||
48850129|NCT01372085|157290541|FG006|Washout Period 3|Withdrawal by Subject|0|||
48850130|NCT01372085|157290542|FG007|Washout Period 3|Withdrawal by Subject|0|||
48850131|NCT01372085|157290543|FG008|Washout Period 3|Withdrawal by Subject|0|||
48850132|NCT01372085|157290544|FG009|Washout Period 3|Withdrawal by Subject|0|||
48850133|NCT01561300|157290545|FG000|Run in on Placebo|Adverse Event|1|||
48850134|NCT01561300|157290546|FG001|Run in on Placebo|Adverse Event|0|||
48850135|NCT03689946|157290547|FG000|Overall Study|Withdrawal by Subject|3|||
48850136|NCT03689946|157290547|FG000|Overall Study|Lost to Follow-up|3|||
48850137|NCT03689946|157290547|FG000|Overall Study|Data corruption|2|||
48850138|NCT01627561|157290548|FG000|Overall Study|Lost to Follow-up|1|||
48850139|NCT01627561|157290549|FG001|Overall Study|Lost to Follow-up|0|||
48850140|NCT01627561|157290548|FG000|Overall Study|Withdrawal by Subject|0|||
48850141|NCT01627561|157290549|FG001|Overall Study|Withdrawal by Subject|1|||
48850142|NCT01627561|157290548|FG000|Overall Study|Migrated/moved from study area|0|||
48850143|NCT01627561|157290549|FG001|Overall Study|Migrated/moved from study area|2|||
48850144|NCT03220724|157290555|FG000|Overall Study|Lost to Follow-up|2|||
48850145|NCT03220724|157290556|FG001|Overall Study|Lost to Follow-up|2|||
48850146|NCT03220724|157290557|FG002|Overall Study|Lost to Follow-up|0|||
48850147|NCT03220724|157290558|FG003|Overall Study|Lost to Follow-up|3|||
48850148|NCT03220724|157290559|FG004|Overall Study|Lost to Follow-up|1|||
48850149|NCT03220724|157290560|FG005|Overall Study|Lost to Follow-up|0|||
48850150|NCT03220724|157290561|FG006|Overall Study|Lost to Follow-up|2|||
48850151|NCT03220724|157290562|FG007|Overall Study|Lost to Follow-up|1|||
48850152|NCT03220724|157290563|FG008|Overall Study|Lost to Follow-up|0|||
48850153|NCT03220724|157290555|FG000|Overall Study|Withdrawal by Subject|1|||
48850154|NCT03220724|157290556|FG001|Overall Study|Withdrawal by Subject|0|||
48850155|NCT03220724|157290557|FG002|Overall Study|Withdrawal by Subject|1|||
48850156|NCT03220724|157290558|FG003|Overall Study|Withdrawal by Subject|0|||
48850157|NCT03220724|157290559|FG004|Overall Study|Withdrawal by Subject|0|||
48850158|NCT03220724|157290560|FG005|Overall Study|Withdrawal by Subject|0|||
48850159|NCT03220724|157290561|FG006|Overall Study|Withdrawal by Subject|0|||
48850160|NCT03220724|157290562|FG007|Overall Study|Withdrawal by Subject|0|||
48850161|NCT03220724|157290563|FG008|Overall Study|Withdrawal by Subject|0|||
48850162|NCT01185600|157290566|FG000|Overall Study|Adverse Event|1|||
48850163|NCT01185600|157290567|FG001|Overall Study|Adverse Event|1|||
48850164|NCT01185600|157290566|FG000|Overall Study|Death|0|||
48850165|NCT01185600|157290567|FG001|Overall Study|Death|1|||
48850166|NCT01185600|157290566|FG000|Overall Study|Lost to Follow-up|0|||
48850167|NCT01185600|157290567|FG001|Overall Study|Lost to Follow-up|5|||
48850168|NCT01185600|157290566|FG000|Overall Study|Physician Decision|29|||
48850169|NCT01185600|157290567|FG001|Overall Study|Physician Decision|35|||
48850170|NCT01185600|157290566|FG000|Overall Study|Withdrawal by Subject|1|||
48850171|NCT01185600|157290567|FG001|Overall Study|Withdrawal by Subject|1|||
48850172|NCT01185600|157290566|FG000|Overall Study|Hold by DSMB|1|||
48850173|NCT01185600|157290567|FG001|Overall Study|Hold by DSMB|2|||
48850174|NCT00890591|157290568|FG000|Overall Study|Lack of Efficacy|20|||
48850175|NCT00371345|157290569|FG000|Overall Study|Disease Progression|21|||
48850176|NCT00371345|157290570|FG001|Overall Study|Disease Progression|35|||
48850177|NCT00371345|157290569|FG000|Overall Study|Study Drug Toxicity|1|||
48850178|NCT00371345|157290570|FG001|Overall Study|Study Drug Toxicity|7|||
48850179|NCT00371345|157290569|FG000|Overall Study|Adverse event(AE Unrelated to Study Drug|1|||
48850180|NCT00371345|157290570|FG001|Overall Study|Adverse event(AE Unrelated to Study Drug|2|||
48850181|NCT00371345|157290569|FG000|Overall Study|Participant Request|1|||
48850182|NCT00371345|157290570|FG001|Overall Study|Participant Request|1|||
48850183|NCT00371345|157290569|FG000|Overall Study|Participant Withdrew Consent|0|||
48850184|NCT00371345|157290570|FG001|Overall Study|Participant Withdrew Consent|1|||
48850185|NCT02357966|157290576|FG000|Overall Study|Death|0|||
48944967|NCT02436239|157629170|FG000|Down-Taper Period|Withdrawal by Subject|4|||
48944968|NCT02436239|157629171|FG001|Down-Taper Period|Withdrawal by Subject|4|||
48944969|NCT02436239|157629172|FG002|Down-Taper Period|Withdrawal by Subject|1|||
48944970|NCT02436239|157629173|FG003|Down-Taper Period|Withdrawal by Subject|2|||
48944971|NCT00414440|157629176|FG000|Core Period|Withdrawal by Subject|70|||
48944972|NCT00414440|157629177|FG001|Core Period|Withdrawal by Subject|32|||
48944973|NCT00414440|157629176|FG000|Extension Period|Lost to Follow-up|44|||
48944974|NCT00414440|157629177|FG001|Extension Period|Lost to Follow-up|52|||
48944975|NCT00414440|157629176|FG000|Extension Period|Did not consent to continue follow up|61|||
48944976|NCT00414440|157629177|FG001|Extension Period|Did not consent to continue follow up|54|||
48944977|NCT00414440|157629176|FG000|Extension Period|Other|1|||
48944978|NCT00414440|157629177|FG001|Extension Period|Other|1|||
48944979|NCT00414440|157629176|FG000|Extension Period|Administrative|16|||
48944980|NCT00414440|157629177|FG001|Extension Period|Administrative|16|||
48944981|NCT00414440|157629176|FG000|Extension Period|Death|1|||
48944982|NCT00414440|157629177|FG001|Extension Period|Death|2|||
48944983|NCT00414440|157629176|FG000|Extension Period|Withdrawal by Subject|9|||
48944984|NCT00414440|157629177|FG001|Extension Period|Withdrawal by Subject|7|||
48944985|NCT00414440|157629176|FG000|Extension Period|Not included in follow up period|18|||
48944986|NCT00414440|157629177|FG001|Extension Period|Not included in follow up period|8|||
48944987|NCT02426086|157629178|FG000|Overall Study|Death|33|||
48944988|NCT02426086|157629179|FG001|Overall Study|Death|36|||
48944989|NCT02426086|157629178|FG000|Overall Study|Lost to Follow-up|2|||
48944990|NCT02426086|157629179|FG001|Overall Study|Lost to Follow-up|0|||
48944991|NCT02426086|157629178|FG000|Overall Study|Study Terminated by Sponsor|5|||
48944992|NCT02426086|157629179|FG001|Overall Study|Study Terminated by Sponsor|14|||
48944993|NCT02426086|157629178|FG000|Overall Study|Withdrawal by Subject|8|||
48944994|NCT02426086|157629179|FG001|Overall Study|Withdrawal by Subject|9|||
48944995|NCT00231478|157629180|FG000|Overall Study|Protocol Violation|3|||
48944996|NCT00231478|157629181|FG001|Overall Study|Protocol Violation|2|||
48944997|NCT00231478|157629180|FG000|Overall Study|Refused Treatment|1|||
48944998|NCT00231478|157629181|FG001|Overall Study|Refused Treatment|1|||
48944999|NCT00231478|157629180|FG000|Overall Study|Withdrawal by Subject|1|||
48945000|NCT00231478|157629181|FG001|Overall Study|Withdrawal by Subject|0|||
48945001|NCT00231478|157629180|FG000|Overall Study|Adverse Event|0|||
48945002|NCT00231478|157629181|FG001|Overall Study|Adverse Event|1|||
48945003|NCT00231478|157629180|FG000|Overall Study|Administrative|3|||
48945004|NCT00231478|157629181|FG001|Overall Study|Administrative|2|||
48945005|NCT00408681|157629189|FG000|Overall Study|Lack of Efficacy|2|||
48945006|NCT00408681|157629189|FG000|Overall Study|Adverse Event|7|||
48945007|NCT05253807|157629200|FG000|Overall Study|Death|1|||
48945008|NCT05253807|157629201|FG001|Overall Study|Death|4|||
48945009|NCT05253807|157629200|FG000|Overall Study|Withdrawal by Subject|1|||
48945010|NCT05253807|157629201|FG001|Overall Study|Withdrawal by Subject|0|||
48945011|NCT05253807|157629200|FG000|Overall Study|Study Terminated by Sponsor|1|||
48945012|NCT05253807|157629201|FG001|Overall Study|Study Terminated by Sponsor|1|||
48945013|NCT02704429|157629206|FG000|Part A: 24 Weeks|Adverse Event|3|||
48945014|NCT02704429|157629207|FG001|Part A: 24 Weeks|Adverse Event|0|||
48945015|NCT02704429|157629206|FG000|Part B: 28 Weeks|Worsening of pemphigus|0|||
48945016|NCT02704429|157629207|FG001|Part B: 28 Weeks|Worsening of pemphigus|1|||
48945017|NCT00104104|157629209|FG000|Overall Study|Adverse Event|8|||
48945018|NCT00104104|157629210|FG001|Overall Study|Adverse Event|8|||
48945019|NCT00104104|157629209|FG000|Overall Study|Abnormal laboratory value(s)|20|||
48945020|NCT00104104|157629210|FG001|Overall Study|Abnormal laboratory value(s)|14|||
48945021|NCT00104104|157629209|FG000|Overall Study|Lack of Efficacy|0|||
48945022|NCT00104104|157629210|FG001|Overall Study|Lack of Efficacy|3|||
48945023|NCT00104104|157629209|FG000|Overall Study|Condition no longer requires study drug|7|||
48945024|NCT00104104|157629210|FG001|Overall Study|Condition no longer requires study drug|4|||
48945025|NCT00104104|157629209|FG000|Overall Study|Protocol Violation|5|||
48945026|NCT00104104|157629210|FG001|Overall Study|Protocol Violation|2|||
48945027|NCT00104104|157629209|FG000|Overall Study|Withdrawal by Subject|11|||
48945028|NCT00104104|157629210|FG001|Overall Study|Withdrawal by Subject|15|||
48945029|NCT00104104|157629209|FG000|Overall Study|Lost to Follow-up|3|||
48945030|NCT00104104|157629210|FG001|Overall Study|Lost to Follow-up|7|||
48945031|NCT00104104|157629209|FG000|Overall Study|Administrative problems|12|||
48945032|NCT00104104|157629210|FG001|Overall Study|Administrative problems|13|||
48945033|NCT00104104|157629209|FG000|Overall Study|Death|9|||
48945034|NCT00104104|157629210|FG001|Overall Study|Death|6|||
48945035|NCT01287117|157629211|FG000|Overall Study|Adverse Event|2|||
48945036|NCT01287117|157629212|FG001|Overall Study|Adverse Event|1|||
48945037|NCT01287117|157629213|FG002|Overall Study|Adverse Event|1|||
48945038|NCT01287117|157629214|FG003|Overall Study|Adverse Event|1|||
48945039|NCT01287117|157629211|FG000|Overall Study|Lost to Follow-up|1|||
48945040|NCT01287117|157629212|FG001|Overall Study|Lost to Follow-up|1|||
48945041|NCT01287117|157629213|FG002|Overall Study|Lost to Follow-up|0|||
48945042|NCT01287117|157629214|FG003|Overall Study|Lost to Follow-up|0|||
48945043|NCT01287117|157629211|FG000|Overall Study|Physician Decision|0|||
48945044|NCT01287117|157629212|FG001|Overall Study|Physician Decision|1|||
48945045|NCT01287117|157629213|FG002|Overall Study|Physician Decision|1|||
48945046|NCT01287117|157629214|FG003|Overall Study|Physician Decision|1|||
48945047|NCT01287117|157629211|FG000|Overall Study|Patient/Legal Guardian's Decision|2|||
48945048|NCT01287117|157629212|FG001|Overall Study|Patient/Legal Guardian's Decision|6|||
48945049|NCT01287117|157629213|FG002|Overall Study|Patient/Legal Guardian's Decision|8|||
48945050|NCT01287117|157629214|FG003|Overall Study|Patient/Legal Guardian's Decision|5|||
48945051|NCT01287117|157629211|FG000|Overall Study|Disease Progression|10|||
48945052|NCT01287117|157629212|FG001|Overall Study|Disease Progression|5|||
48945053|NCT01287117|157629213|FG002|Overall Study|Disease Progression|6|||
48945054|NCT01287117|157629214|FG003|Overall Study|Disease Progression|5|||
48945055|NCT00630032|157629215|FG000|Overall Study|Death|55|||
48945056|NCT00630032|157629216|FG001|Overall Study|Death|49|||
48945057|NCT00630032|157629215|FG000|Overall Study|Withdrawal by Subject|3|||
48945058|NCT00630032|157629216|FG001|Overall Study|Withdrawal by Subject|2|||
48945059|NCT00630032|157629215|FG000|Overall Study|Lost to Follow-up|18|||
48945060|NCT00630032|157629216|FG001|Overall Study|Lost to Follow-up|31|||
48945061|NCT00630032|157629215|FG000|Overall Study|Protocol Violation|1|||
48945062|NCT00630032|157629216|FG001|Overall Study|Protocol Violation|0|||
48945063|NCT00630032|157629215|FG000|Overall Study|Patient has moved|1|||
48945064|NCT00630032|157629216|FG001|Overall Study|Patient has moved|1|||
48945065|NCT00630032|157629215|FG000|Overall Study|Disease progression|1|||
48945066|NCT00630032|157629216|FG001|Overall Study|Disease progression|1|||
48945067|NCT00630032|157629215|FG000|Overall Study|End of monitoring in US centers|11|||
48850186|NCT02357966|157290577|FG001|Overall Study|Death|0|||
48850187|NCT02357966|157290578|FG002|Overall Study|Death|1|||
48945068|NCT00630032|157629216|FG001|Overall Study|End of monitoring in US centers|11|||
48945069|NCT04285723|157629218|FG000|Overall Study|Subject decision|1|||
48945070|NCT04285723|157629219|FG001|Overall Study|Subject decision|2|||
48945071|NCT04285723|157629218|FG000|Overall Study|Physician Decision|1|||
48945072|NCT04285723|157629219|FG001|Overall Study|Physician Decision|0|||
48945073|NCT04285723|157629218|FG000|Overall Study|No efficiency|1|||
48945074|NCT04285723|157629219|FG001|Overall Study|No efficiency|0|||
48945075|NCT00465738|157629220|FG000|Overall Study|Lost to Follow-up|2|||
48945076|NCT00465738|157629221|FG001|Overall Study|Lost to Follow-up|0|||
48945077|NCT00465738|157629220|FG000|Overall Study|Adverse Event|0|||
48945078|NCT00465738|157629221|FG001|Overall Study|Adverse Event|1|||
48945079|NCT00465738|157629220|FG000|Overall Study|Withdrawal by Subject|2|||
48945080|NCT00465738|157629221|FG001|Overall Study|Withdrawal by Subject|0|||
48945081|NCT00465738|157629220|FG000|Overall Study|Other|2|||
48850188|NCT02357966|157290579|FG003|Overall Study|Death|0|||
48850189|NCT02357966|157290580|FG004|Overall Study|Death|2|||
48850190|NCT02357966|157290581|FG005|Overall Study|Death|0|||
48850191|NCT02357966|157290576|FG000|Overall Study|Physician Decision|1|||
48850192|NCT02357966|157290577|FG001|Overall Study|Physician Decision|0|||
48850193|NCT02357966|157290578|FG002|Overall Study|Physician Decision|0|||
48850194|NCT02357966|157290579|FG003|Overall Study|Physician Decision|0|||
48850195|NCT02357966|157290580|FG004|Overall Study|Physician Decision|1|||
48850196|NCT02357966|157290581|FG005|Overall Study|Physician Decision|0|||
48850197|NCT03577106|157290582|FG000|Overall Study|Withdrawal by Subject|3|||
48850198|NCT01579318|157290586|FG000|Overall Study|Disease Progression|1|||
48850199|NCT02797132|157290587|FG000|Part A (15 Days)|Adverse Event|1|||
48850200|NCT02797132|157290587|FG000|Part B (24 Weeks)|Adverse Event|3|||
48850201|NCT00442104|157290588|FG000|Overall Study|Adverse Event|5|||
48850202|NCT00442104|157290588|FG000|Overall Study|Death|2|||
48850203|NCT00442104|157290588|FG000|Overall Study|Lost to Follow-up|3|||
48850204|NCT00442104|157290588|FG000|Overall Study|Withdrawal by Subject|5|||
48850205|NCT00442104|157290588|FG000|Overall Study|Insufficient Clinical Response|10|||
48850206|NCT00442104|157290588|FG000|Overall Study|Other|21|||
48850207|NCT00442104|157290588|FG000|Overall Study|Discretion of the Investigator/Sponsor|1|||
48850208|NCT03601715|157290589|FG000|Second Intervention|Lost to Follow-up|1|||
48850209|NCT03601715|157290590|FG001|Second Intervention|Lost to Follow-up|1|||
48850210|NCT03601715|157290591|FG002|Second Intervention|Lost to Follow-up|0|||
48850211|NCT02347332|157290592|FG000|Overall Study|Not treated|5|||
48850212|NCT02347332|157290593|FG001|Overall Study|Not treated|2|||
48850213|NCT02347332|157290592|FG000|Overall Study|Progressive disease|141|||
48850214|NCT02347332|157290593|FG001|Overall Study|Progressive disease|159|||
48850215|NCT02347332|157290592|FG000|Overall Study|Adverse Event|50|||
48850216|NCT02347332|157290593|FG001|Overall Study|Adverse Event|41|||
48850217|NCT02347332|157290592|FG000|Overall Study|Death (Unknown, Various reasons)|6|||
48850218|NCT02347332|157290593|FG001|Overall Study|Death (Unknown, Various reasons)|6|||
48850219|NCT02347332|157290592|FG000|Overall Study|Protocol Violation|1|||
48850220|NCT02347332|157290593|FG001|Overall Study|Protocol Violation|1|||
48850221|NCT02347332|157290592|FG000|Overall Study|Lost to Follow-up|2|||
48850222|NCT02347332|157290593|FG001|Overall Study|Lost to Follow-up|1|||
48850223|NCT02347332|157290592|FG000|Overall Study|Physician Decision|4|||
48850224|NCT02347332|157290593|FG001|Overall Study|Physician Decision|3|||
48850225|NCT02347332|157290592|FG000|Overall Study|Withdrawal by Subject|20|||
48850226|NCT02347332|157290593|FG001|Overall Study|Withdrawal by Subject|14|||
48850227|NCT02347332|157290592|FG000|Overall Study|Protocol requirement|1|||
48850228|NCT02347332|157290593|FG001|Overall Study|Protocol requirement|1|||
48850229|NCT02347332|157290592|FG000|Overall Study|Switch Post-Trial program|0|||
48850230|NCT02347332|157290593|FG001|Overall Study|Switch Post-Trial program|1|||
48850231|NCT02502526|157290596|FG000|Overall Study|Lost to Follow-up|2|||
48850232|NCT02502526|157290597|FG001|Overall Study|Lost to Follow-up|2|||
48850233|NCT02502526|157290598|FG002|Overall Study|Lost to Follow-up|3|||
48850234|NCT02502526|157290596|FG000|Overall Study|Withdrawal by Subject|0|||
48850235|NCT02502526|157290597|FG001|Overall Study|Withdrawal by Subject|1|||
48850236|NCT02502526|157290598|FG002|Overall Study|Withdrawal by Subject|1|||
48850237|NCT02502526|157290596|FG000|Overall Study|Disqualified due to cataract grading|0|||
48850238|NCT02502526|157290597|FG001|Overall Study|Disqualified due to cataract grading|0|||
48850239|NCT02502526|157290598|FG002|Overall Study|Disqualified due to cataract grading|1|||
48850240|NCT02502526|157290596|FG000|Overall Study|Enrollment suspension|4|||
48850241|NCT02502526|157290597|FG001|Overall Study|Enrollment suspension|1|||
48945082|NCT00465738|157629221|FG001|Overall Study|Other|5|||
48945083|NCT00969618|157629222|FG000|Overall Study|Adverse Event|29|||
48945084|NCT00969618|157629222|FG000|Overall Study|Entry Criteria Not Met|3|||
48945085|NCT00969618|157629222|FG000|Overall Study|Lack of Efficacy|2|||
48945086|NCT00969618|157629222|FG000|Overall Study|Lost to Follow-up|7|||
48945087|NCT00969618|157629222|FG000|Overall Study|Physician Decision|1|||
48945088|NCT00969618|157629222|FG000|Overall Study|Protocol Violation|9|||
48945089|NCT00969618|157629222|FG000|Overall Study|Withdrawal by Subject|27|||
48945090|NCT01326962|157629223|FG000|Overall Study|Adverse Event|1|||
48945091|NCT01326962|157629223|FG000|Overall Study|Withdrawal by Subject|1|||
48945092|NCT01326962|157629223|FG000|Overall Study|Lost to Follow-up|3|||
48945093|NCT01326962|157629223|FG000|Overall Study|Other|2|||
48945094|NCT01938625|157630831|FG000|Overall Study|Withdrawal by Subject|0|||
48945095|NCT01938625|157630832|FG001|Overall Study|Withdrawal by Subject|1|||
48945096|NCT01938625|157630831|FG000|Overall Study|Adverse Event|0|||
48945097|NCT01938625|157630832|FG001|Overall Study|Adverse Event|1|||
48945098|NCT00728416|157630836|FG000|Overall Study|Adverse Event|1|||
48945099|NCT00728416|157630837|FG001|Overall Study|Adverse Event|1|||
48945100|NCT00728416|157630836|FG000|Overall Study|Treatment Failure|0|||
48945101|NCT00728416|157630837|FG001|Overall Study|Treatment Failure|1|||
48945102|NCT00728416|157630836|FG000|Overall Study|Withdrawal by Subject|1|||
48945103|NCT00728416|157630837|FG001|Overall Study|Withdrawal by Subject|0|||
48945104|NCT00881205|157630838|FG000|Overall Study|Adverse Event|8|||
48945105|NCT00881205|157630839|FG001|Overall Study|Adverse Event|3|||
48945106|NCT00881205|157630838|FG000|Overall Study|Withdrawal by Subject|1|||
48945107|NCT00881205|157630839|FG001|Overall Study|Withdrawal by Subject|2|||
48945108|NCT00881205|157630838|FG000|Overall Study|Lost to Follow-up|0|||
48945109|NCT00881205|157630839|FG001|Overall Study|Lost to Follow-up|1|||
48945110|NCT00881205|157630838|FG000|Overall Study|Administrative problems|1|||
48945111|NCT00881205|157630839|FG001|Overall Study|Administrative problems|1|||
48945112|NCT00881205|157630838|FG000|Overall Study|Condition no longer requires drug|1|||
48945113|NCT00881205|157630839|FG001|Overall Study|Condition no longer requires drug|0|||
48945114|NCT00545818|157630846|FG000|Overall Study|Protocol Violation|1|||
48945115|NCT00545818|157630847|FG001|Overall Study|Protocol Violation|0|||
48945116|NCT00545818|157630846|FG000|Overall Study|Adverse Event|1|||
48945117|NCT00545818|157630847|FG001|Overall Study|Adverse Event|1|||
48945118|NCT00545818|157630846|FG000|Overall Study|Lost to Follow-up|1|||
48945119|NCT00545818|157630847|FG001|Overall Study|Lost to Follow-up|6|||
48945120|NCT00844883|157630848|FG000|Overall Study|Bridged to liver transplant|3|||
48945121|NCT00844883|157630848|FG000|Overall Study|Bridged to resection|1|||
48945122|NCT02498652|157630851|FG000|Overall Study|Protocol Violation|0|||
48945123|NCT02498652|157630852|FG001|Overall Study|Protocol Violation|1|||
48945124|NCT03455543|157630853|FG000|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2|||
48945125|NCT03455543|157630854|FG001|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5|||
48945126|NCT03455543|157630855|FG002|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0|||
48945127|NCT03455543|157630853|FG000|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7|||
48945128|NCT03455543|157630854|FG001|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2|||
48945129|NCT03455543|157630855|FG002|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0|||
48945130|NCT03455543|157630853|FG000|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2|||
48945131|NCT03455543|157630854|FG001|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
48945132|NCT03455543|157630855|FG002|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
48945133|NCT03455543|157630853|FG000|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
48945134|NCT03455543|157630854|FG001|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
48945135|NCT03455543|157630855|FG002|Part B: Open-label Extension (24 Weeks)|Adverse Event|3|||
48945136|NCT03455543|157630853|FG000|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
48945137|NCT03455543|157630854|FG001|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
48945138|NCT03455543|157630855|FG002|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20|||
48945139|NCT03455543|157630853|FG000|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
48850242|NCT02502526|157290598|FG002|Overall Study|Enrollment suspension|1|||
48850243|NCT00229658|157290610|FG000|Overall Study|Administrative|2|||
48850244|NCT00229658|157290611|FG001|Overall Study|Administrative|1|||
48850245|NCT00229658|157290610|FG000|Overall Study|Investigator decision|13|||
48850246|NCT00229658|157290611|FG001|Overall Study|Investigator decision|10|||
48850247|NCT00229658|157290610|FG000|Overall Study|Other|80|||
48850248|NCT00229658|157290611|FG001|Overall Study|Other|60|||
48850249|NCT00229658|157290610|FG000|Overall Study|Lost to Follow-up|82|||
48850250|NCT00229658|157290611|FG001|Overall Study|Lost to Follow-up|55|||
48850251|NCT00229658|157290610|FG000|Overall Study|Serious Adverse Event|2|||
48850252|NCT00229658|157290611|FG001|Overall Study|Serious Adverse Event|2|||
48850253|NCT00229658|157290610|FG000|Overall Study|Withdrawal of consent|46|||
48850254|NCT00229658|157290611|FG001|Overall Study|Withdrawal of consent|39|||
48850255|NCT00249769|157290612|FG000|Overall Study|Withdrawal by Subject|1|||
48850256|NCT00249769|157290613|FG001|Overall Study|Withdrawal by Subject|10|||
48850257|NCT00249769|157290614|FG002|Overall Study|Withdrawal by Subject|6|||
48850258|NCT00249769|157290612|FG000|Overall Study|Migration from Study Area|1|||
48850259|NCT00249769|157290613|FG001|Overall Study|Migration from Study Area|3|||
48850260|NCT00249769|157290614|FG002|Overall Study|Migration from Study Area|14|||
48850261|NCT00249769|157290612|FG000|Overall Study|Miscellaneous|0|||
48850262|NCT00249769|157290613|FG001|Overall Study|Miscellaneous|2|||
48850263|NCT00249769|157290614|FG002|Overall Study|Miscellaneous|2|||
48850264|NCT00249769|157290612|FG000|Overall Study|Adverse Event|0|||
48850265|NCT00249769|157290613|FG001|Overall Study|Adverse Event|0|||
48850266|NCT00249769|157290614|FG002|Overall Study|Adverse Event|1|||
48850267|NCT00249769|157290612|FG000|Overall Study|Physician Decision|0|||
48850268|NCT00249769|157290613|FG001|Overall Study|Physician Decision|0|||
48850269|NCT00249769|157290614|FG002|Overall Study|Physician Decision|2|||
48850270|NCT00249769|157290612|FG000|Overall Study|Lost to Follow-up|0|||
48850271|NCT00249769|157290613|FG001|Overall Study|Lost to Follow-up|0|||
48850272|NCT00249769|157290614|FG002|Overall Study|Lost to Follow-up|3|||
48850273|NCT03489369|157290619|FG000|Overall Study|Documented Progressive Disease|3|||
48850274|NCT03489369|157290620|FG001|Overall Study|Documented Progressive Disease|2|||
48850275|NCT03489369|157290621|FG002|Overall Study|Documented Progressive Disease|3|||
48850276|NCT03489369|157290622|FG003|Overall Study|Documented Progressive Disease|6|||
48850277|NCT03489369|157290619|FG000|Overall Study|Clinical Progression (Worsening of Clini|0|||
48850278|NCT03489369|157290620|FG001|Overall Study|Clinical Progression (Worsening of Clini|1|||
48850279|NCT03489369|157290621|FG002|Overall Study|Clinical Progression (Worsening of Clini|0|||
48850280|NCT03489369|157290622|FG003|Overall Study|Clinical Progression (Worsening of Clini|0|||
48850281|NCT01170208|157290625|FG000|Overall Study|Withdrawal by Subject|5|||
48850282|NCT01170208|157290626|FG001|Overall Study|Withdrawal by Subject|0|||
48850283|NCT01170208|157290627|FG002|Overall Study|Withdrawal by Subject|1|||
48850284|NCT01170208|157290625|FG000|Overall Study|Protocol Violation|1|||
48850285|NCT01170208|157290626|FG001|Overall Study|Protocol Violation|0|||
48850286|NCT01170208|157290627|FG002|Overall Study|Protocol Violation|1|||
48945140|NCT03455543|157630854|FG001|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
48945141|NCT03455543|157630855|FG002|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7|||
48945142|NCT03455543|157630853|FG000|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
48945143|NCT03455543|157630854|FG001|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
48945144|NCT03455543|157630855|FG002|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4|||
48945145|NCT03455543|157630853|FG000|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
48945146|NCT03455543|157630854|FG001|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
48945147|NCT03455543|157630855|FG002|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2|||
48945148|NCT03455543|157630853|FG000|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
48945149|NCT03455543|157630854|FG001|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
48945150|NCT03455543|157630855|FG002|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1|||
48945151|NCT01325493|157630856|FG000|Overall Study|Protocol Violation|0|||
48945152|NCT01325493|157630857|FG001|Overall Study|Protocol Violation|1|||
48945153|NCT01325493|157630856|FG000|Overall Study|loss of neuromonitoring signals|0|||
48945154|NCT01325493|157630857|FG001|Overall Study|loss of neuromonitoring signals|2|||
48735990|NCT02935842|156883748|FG001|Testing and Therapy Period 3|Lost to Follow-up|0|||
48945155|NCT01325493|157630856|FG000|Overall Study|Allergy|1|||
48945156|NCT01325493|157630857|FG001|Overall Study|Allergy|0|||
48945157|NCT00465569|157630859|FG000|Overall Study|persistent eczema during dose escalation|1|||
48945158|NCT00465569|157630860|FG001|Overall Study|persistent eczema during dose escalation|0|||
48945159|NCT05370157|157630864|FG000|Participants Entering at Baseline|Lost to Follow-up|11|||
48945160|NCT05370157|157630865|FG001|Participants Entering at Baseline|Lost to Follow-up|11|||
48945161|NCT05370157|157630864|FG000|Participants Entering at Baseline|Not eligible for followup - no longer member of team|17|||
48945162|NCT05370157|157630865|FG001|Participants Entering at Baseline|Not eligible for followup - no longer member of team|4|||
48945163|NCT01508676|157630866|FG000|Phase I (2 Weeks)|Medication Exclusion|1|||
48945164|NCT01508676|157630867|FG001|Phase I (2 Weeks)|Medication Exclusion|1|||
48945165|NCT01508676|157630866|FG000|Phase I (2 Weeks)|Wrong Pain Type|1|||
48945166|NCT01508676|157630867|FG001|Phase I (2 Weeks)|Wrong Pain Type|0|||
48945167|NCT01508676|157630866|FG000|Phase I (2 Weeks)|Positive Drug Screen|0|||
48945168|NCT01508676|157630867|FG001|Phase I (2 Weeks)|Positive Drug Screen|2|||
48945169|NCT01508676|157630866|FG000|Phase II (2 Weeks)|Skin Sensitivity|0|||
48945170|NCT01508676|157630867|FG001|Phase II (2 Weeks)|Skin Sensitivity|1|||
48945171|NCT01508676|157630866|FG000|Phase II (2 Weeks)|Medication Exclusion|1|||
48945172|NCT01508676|157630867|FG001|Phase II (2 Weeks)|Medication Exclusion|0|||
48945173|NCT00552305|157630875|FG000|Overall Study|Adverse Event|43|||
48945174|NCT00552305|157630875|FG000|Overall Study|Lack of Efficacy|120|||
48945175|NCT00552305|157630875|FG000|Overall Study|Lost to Follow-up|4|||
48945176|NCT00552305|157630875|FG000|Overall Study|Protocol Violation|3|||
48945177|NCT00552305|157630875|FG000|Overall Study|Withdrawal by Subject|44|||
48945178|NCT00552305|157630875|FG000|Overall Study|Lack of efficacy/withdrew consent|1|||
48945179|NCT00552305|157630875|FG000|Overall Study|Lack of efficacy (LoE)/adverse event|3|||
48945180|NCT00552305|157630875|FG000|Overall Study|Adverse event (AE)/withdrew (WD) consent|2|||
48945181|NCT00552305|157630875|FG000|Overall Study|Unsatisfactory compliance|11|||
48945182|NCT00552305|157630875|FG000|Overall Study|Poor compliance/lost to follow-up|1|||
48945183|NCT00552305|157630875|FG000|Overall Study|AE/Other: prohibited drug required|1|||
48945184|NCT00552305|157630875|FG000|Overall Study|LoE/WD consent/Other: cannot make visits|1|||
48945185|NCT00552305|157630875|FG000|Overall Study|Other: Site closed|4|||
48945186|NCT00552305|157630875|FG000|Overall Study|Other: Personal problems|1|||
48945187|NCT00552305|157630875|FG000|Overall Study|Other: Unable to attend visits|1|||
48945188|NCT00552305|157630875|FG000|Overall Study|Other: Subject underwent surgery|4|||
48945189|NCT00552305|157630875|FG000|Overall Study|Other: Subject became pregnant|1|||
48945190|NCT00552305|157630875|FG000|Overall Study|Other: Health problems, not drug related|1|||
48945191|NCT00552305|157630875|FG000|Overall Study|Other: Subject moved from area|2|||
48945192|NCT00552305|157630875|FG000|Overall Study|Other: Subject incarcerated|1|||
48945193|NCT00552305|157630875|FG000|Overall Study|Other: Subject went to rehab|1|||
48945194|NCT04498910|157630876|FG000|Overall Study|Lost to Follow-up|0|||
48945195|NCT04498910|157630877|FG001|Overall Study|Lost to Follow-up|1|||
48945196|NCT04498910|157630876|FG000|Overall Study|Withdrawal by Subject|2|||
48945197|NCT04498910|157630877|FG001|Overall Study|Withdrawal by Subject|1|||
48945198|NCT04498910|157630876|FG000|Overall Study|Adverse Event|1|||
48945199|NCT04498910|157630877|FG001|Overall Study|Adverse Event|0|||
48945200|NCT02732912|157630882|FG000|Overall Study|Discharged before night|2|||
48945201|NCT02732912|157630883|FG001|Overall Study|Discharged before night|6|||
48945202|NCT02732912|157630882|FG000|Overall Study|Incomplete completion of questionnaire|2|||
48945203|NCT02732912|157630883|FG001|Overall Study|Incomplete completion of questionnaire|3|||
48945204|NCT02732912|157630882|FG000|Overall Study|No outcome; discharged or refused|6|||
48945205|NCT02732912|157630883|FG001|Overall Study|No outcome; discharged or refused|9|||
48945206|NCT02902809|157630886|FG000|Overall Study|Discontinuation of asthma program|28|||
48945207|NCT02782715|157630887|FG000|Overall Study|Withdrawal by Subject|1|||
48945208|NCT00069121|157630891|FG000|Overall Study|Death|286|||
48945209|NCT00069121|157630892|FG001|Overall Study|Death|242|||
48945210|NCT00069121|157630891|FG000|Overall Study|Withdrawal by Subject|18|||
48945211|NCT00069121|157630892|FG001|Overall Study|Withdrawal by Subject|20|||
48945212|NCT00069121|157630891|FG000|Overall Study|Lost to Follow-up|63|||
48945213|NCT00069121|157630892|FG001|Overall Study|Lost to Follow-up|63|||
48850287|NCT03113409|157290628|FG000|Overall Study|Withdrawal by Subject|5|||
48850288|NCT03113409|157290629|FG001|Overall Study|Withdrawal by Subject|0|||
48850289|NCT03113409|157290630|FG002|Overall Study|Withdrawal by Subject|0|||
48850290|NCT00582972|157290631|FG000|Overall Study|Protocol Violation|2|||
48850291|NCT03355573|157290632|FG000|Overall Study|Withdrew consent due to refused treatment to AE latent tuberculosis|1|||
48850292|NCT03355573|157290632|FG000|Overall Study|Sponsor's decision|1|||
48850293|NCT03355573|157290632|FG000|Overall Study|Participant withdrew consent due to AEs|1|||
48850294|NCT03355573|157290632|FG000|Overall Study|PI's decision|2|||
48850295|NCT03355573|157290632|FG000|Overall Study|Withdrawal by Subject|23|||
48850296|NCT03355573|157290632|FG000|Overall Study|Lost to Follow-up|4|||
48850297|NCT03355573|157290632|FG000|Overall Study|Lack of Efficacy|2|||
48850298|NCT03355573|157290632|FG000|Overall Study|Adverse Event, non-fatal|17|||
48945214|NCT01208181|157630893|FG000|Part 1|Withdrawal by Subject|11|||
48945215|NCT01208181|157630894|FG001|Part 1|Withdrawal by Subject|10|||
48945216|NCT01208181|157630895|FG002|Part 1|Withdrawal by Subject|0|||
48945217|NCT01208181|157630896|FG003|Part 1|Withdrawal by Subject|0|||
48945218|NCT01208181|157630897|FG004|Part 1|Withdrawal by Subject|0|||
48945219|NCT01208181|157630893|FG000|Part 1|Technical problem|5|||
48945220|NCT01208181|157630894|FG001|Part 1|Technical problem|0|||
48945221|NCT01208181|157630895|FG002|Part 1|Technical problem|0|||
48945222|NCT01208181|157630896|FG003|Part 1|Technical problem|0|||
48945223|NCT01208181|157630897|FG004|Part 1|Technical problem|0|||
48945224|NCT01208181|157630893|FG000|Part 1|Protocol Violation|10|||
48945225|NCT01208181|157630894|FG001|Part 1|Protocol Violation|5|||
48945226|NCT01208181|157630895|FG002|Part 1|Protocol Violation|0|||
48945227|NCT01208181|157630896|FG003|Part 1|Protocol Violation|0|||
48945228|NCT01208181|157630897|FG004|Part 1|Protocol Violation|0|||
48945229|NCT01208181|157630893|FG000|Part 1|Physician Decision|4|||
48945230|NCT01208181|157630894|FG001|Part 1|Physician Decision|0|||
48945231|NCT01208181|157630895|FG002|Part 1|Physician Decision|0|||
48945232|NCT01208181|157630896|FG003|Part 1|Physician Decision|0|||
48945233|NCT01208181|157630897|FG004|Part 1|Physician Decision|0|||
48945234|NCT01208181|157630893|FG000|Part 1|Non-compliance with study drug|1|||
48945235|NCT01208181|157630894|FG001|Part 1|Non-compliance with study drug|1|||
48850299|NCT03355573|157290632|FG000|Overall Study|Adverse Event, serious fatal|2|||
48850300|NCT01566890|157290634|FG000|Overall Study|Adverse Event|1|||
48850301|NCT01566890|157290635|FG001|Overall Study|Adverse Event|0|||
48850302|NCT01566890|157290636|FG002|Overall Study|Adverse Event|0|||
48850303|NCT01566890|157290637|FG003|Overall Study|Adverse Event|0|||
48850304|NCT01566890|157290638|FG004|Overall Study|Adverse Event|0|||
48850305|NCT01566890|157290634|FG000|Overall Study|Withdrawal by Subject|3|||
48850306|NCT01566890|157290635|FG001|Overall Study|Withdrawal by Subject|1|||
48850307|NCT01566890|157290636|FG002|Overall Study|Withdrawal by Subject|1|||
48850308|NCT01566890|157290637|FG003|Overall Study|Withdrawal by Subject|1|||
48850309|NCT01566890|157290638|FG004|Overall Study|Withdrawal by Subject|0|||
48850310|NCT01566890|157290634|FG000|Overall Study|Screen failure|6|||
48850311|NCT01566890|157290635|FG001|Overall Study|Screen failure|0|||
48850312|NCT01566890|157290636|FG002|Overall Study|Screen failure|1|||
48850313|NCT01566890|157290637|FG003|Overall Study|Screen failure|1|||
48850314|NCT01566890|157290638|FG004|Overall Study|Screen failure|0|||
48850315|NCT01566890|157290634|FG000|Overall Study|Incomplete CEU data|1|||
48850316|NCT01566890|157290635|FG001|Overall Study|Incomplete CEU data|3|||
48945236|NCT01208181|157630895|FG002|Part 1|Non-compliance with study drug|0|||
48945237|NCT01208181|157630896|FG003|Part 1|Non-compliance with study drug|0|||
48945238|NCT01208181|157630897|FG004|Part 1|Non-compliance with study drug|0|||
48850317|NCT01566890|157290636|FG002|Overall Study|Incomplete CEU data|5|||
48945239|NCT01208181|157630893|FG000|Part 1|Lost to Follow-up|5|||
48850318|NCT01566890|157290637|FG003|Overall Study|Incomplete CEU data|8|||
48850319|NCT01566890|157290638|FG004|Overall Study|Incomplete CEU data|0|||
48850320|NCT01566890|157290634|FG000|Overall Study|Lost to Follow-up|0|||
48850321|NCT01566890|157290635|FG001|Overall Study|Lost to Follow-up|0|||
48850322|NCT01566890|157290636|FG002|Overall Study|Lost to Follow-up|4|||
48850323|NCT01566890|157290637|FG003|Overall Study|Lost to Follow-up|4|||
48945240|NCT01208181|157630894|FG001|Part 1|Lost to Follow-up|3|||
48945241|NCT01208181|157630895|FG002|Part 1|Lost to Follow-up|0|||
49015292|NCT03443869|157892138|FG000|Overall Study|Withdrawal by Subject|34|||
48850324|NCT01566890|157290638|FG004|Overall Study|Lost to Follow-up|0|||
48850325|NCT01566890|157290634|FG000|Overall Study|Other|0|||
48850326|NCT01566890|157290635|FG001|Overall Study|Other|0|||
48850327|NCT01566890|157290636|FG002|Overall Study|Other|0|||
48850328|NCT01566890|157290637|FG003|Overall Study|Other|0|||
48850329|NCT01566890|157290638|FG004|Overall Study|Other|7|||
48850330|NCT04638816|157290639|FG000|Overall Study|Withdrawal by Subject|0|||
48850331|NCT04638816|157290640|FG001|Overall Study|Withdrawal by Subject|1|||
48850332|NCT04638816|157290639|FG000|Overall Study|Lost to Follow-up|0|||
48850333|NCT04638816|157290640|FG001|Overall Study|Lost to Follow-up|1|||
48850334|NCT00879710|157290643|FG000|Phase 1 - 6 Weeks|Lost to Follow-up|2|||
48850335|NCT00879710|157290644|FG001|Phase 1 - 6 Weeks|Lost to Follow-up|3|||
48850336|NCT00879710|157290645|FG002|Phase 1 - 6 Weeks|Lost to Follow-up|1|||
48850337|NCT00879710|157290646|FG003|Phase 1 - 6 Weeks|Lost to Follow-up|4|||
48850338|NCT00879710|157290643|FG000|Phase 1 - 6 Weeks|Adverse Event|0|||
48850339|NCT00879710|157290644|FG001|Phase 1 - 6 Weeks|Adverse Event|0|||
48850340|NCT00879710|157290645|FG002|Phase 1 - 6 Weeks|Adverse Event|1|||
48850341|NCT00879710|157290646|FG003|Phase 1 - 6 Weeks|Adverse Event|0|||
48850342|NCT00293397|157290651|FG000|Overall Study|Death|2|||
48850343|NCT01211184|157290654|FG000|Overall Study|Withdrawal by Subject|0|||
48850344|NCT01211184|157290655|FG001|Overall Study|Withdrawal by Subject|2|||
48850345|NCT01211184|157290656|FG002|Overall Study|Withdrawal by Subject|1|||
48850346|NCT02397096|157290659|FG000|Day 1 to Week 24|Adverse Event|7|||
48850347|NCT02397096|157290660|FG001|Day 1 to Week 24|Adverse Event|1|||
48850348|NCT02397096|157290659|FG000|Day 1 to Week 24|Death|1|||
48850349|NCT02397096|157290660|FG001|Day 1 to Week 24|Death|0|||
48850350|NCT02397096|157290659|FG000|Day 1 to Week 24|Lack of Efficacy|0|||
48850351|NCT02397096|157290660|FG001|Day 1 to Week 24|Lack of Efficacy|1|||
48850352|NCT02397096|157290659|FG000|Day 1 to Week 24|Lost to Follow-up|3|||
48850353|NCT02397096|157290660|FG001|Day 1 to Week 24|Lost to Follow-up|4|||
48850354|NCT02397096|157290659|FG000|Day 1 to Week 24|Physician Decision|2|||
48850355|NCT02397096|157290660|FG001|Day 1 to Week 24|Physician Decision|3|||
48850356|NCT02397096|157290659|FG000|Day 1 to Week 24|Protocol Violation|1|||
48850357|NCT02397096|157290660|FG001|Day 1 to Week 24|Protocol Violation|4|||
48850358|NCT02397096|157290659|FG000|Day 1 to Week 24|Withdrawal by Subject|6|||
48850359|NCT02397096|157290660|FG001|Day 1 to Week 24|Withdrawal by Subject|1|||
48850360|NCT02397096|157290659|FG000|Day 1 to Week 24|Randomized, not treated|3|||
48850361|NCT02397096|157290660|FG001|Day 1 to Week 24|Randomized, not treated|0|||
48850362|NCT02397096|157290659|FG000|Week 24 to Week 48|Adverse Event|6|||
48850363|NCT02397096|157290660|FG001|Week 24 to Week 48|Adverse Event|2|||
48850364|NCT02397096|157290659|FG000|Week 24 to Week 48|Lack of Efficacy|5|||
48850365|NCT02397096|157290660|FG001|Week 24 to Week 48|Lack of Efficacy|1|||
48850366|NCT02397096|157290659|FG000|Week 24 to Week 48|Non-Compliance With Study Drug|0|||
48850367|NCT02397096|157290660|FG001|Week 24 to Week 48|Non-Compliance With Study Drug|1|||
48850368|NCT02397096|157290659|FG000|Week 24 to Week 48|Physician Decision|2|||
48850369|NCT02397096|157290660|FG001|Week 24 to Week 48|Physician Decision|1|||
48850370|NCT02397096|157290659|FG000|Week 24 to Week 48|Withdrawal by Subject|5|||
48945242|NCT01208181|157630896|FG003|Part 1|Lost to Follow-up|0|||
48945243|NCT01208181|157630897|FG004|Part 1|Lost to Follow-up|1|||
48945244|NCT01208181|157630893|FG000|Part 1|Lack of Efficacy|37|||
48945245|NCT01208181|157630894|FG001|Part 1|Lack of Efficacy|12|||
48945246|NCT01208181|157630895|FG002|Part 1|Lack of Efficacy|0|||
48850371|NCT02397096|157290660|FG001|Week 24 to Week 48|Withdrawal by Subject|2|||
48850372|NCT02397096|157290659|FG000|Week 24 to Week 48|Lost to Follow-up|2|||
48850373|NCT02397096|157290660|FG001|Week 24 to Week 48|Lost to Follow-up|0|||
48850374|NCT02397096|157290659|FG000|Study Extension 1|Adverse Event|7|||
48850375|NCT02397096|157290660|FG001|Study Extension 1|Adverse Event|5|||
48850376|NCT02397096|157290659|FG000|Study Extension 1|Death|1|||
48850377|NCT02397096|157290660|FG001|Study Extension 1|Death|0|||
48850378|NCT02397096|157290659|FG000|Study Extension 1|Lack of Efficacy|2|||
48850379|NCT02397096|157290660|FG001|Study Extension 1|Lack of Efficacy|5|||
48850380|NCT02397096|157290659|FG000|Study Extension 1|Lost to Follow-up|2|||
48850381|NCT02397096|157290660|FG001|Study Extension 1|Lost to Follow-up|3|||
48850382|NCT02397096|157290659|FG000|Study Extension 1|Non-compliance with study drug|3|||
48850383|NCT02397096|157290660|FG001|Study Extension 1|Non-compliance with study drug|0|||
48850384|NCT02397096|157290659|FG000|Study Extension 1|Physician Decision|4|||
48850385|NCT02397096|157290660|FG001|Study Extension 1|Physician Decision|2|||
48850386|NCT02397096|157290659|FG000|Study Extension 1|Pregnancy|1|||
48850387|NCT02397096|157290660|FG001|Study Extension 1|Pregnancy|0|||
48850388|NCT02397096|157290659|FG000|Study Extension 1|Protocol Violation|0|||
48850389|NCT02397096|157290660|FG001|Study Extension 1|Protocol Violation|1|||
48945247|NCT01208181|157630896|FG003|Part 1|Lack of Efficacy|0|||
49015293|NCT03443869|157892139|FG001|Overall Study|Withdrawal by Subject|22|||
48945248|NCT01208181|157630897|FG004|Part 1|Lack of Efficacy|17|||
48945249|NCT01208181|157630893|FG000|Part 1|Adverse Event|26|||
48945250|NCT01208181|157630894|FG001|Part 1|Adverse Event|24|||
48945251|NCT01208181|157630895|FG002|Part 1|Adverse Event|0|||
48945252|NCT01208181|157630896|FG003|Part 1|Adverse Event|0|||
48945253|NCT01208181|157630897|FG004|Part 1|Adverse Event|4|||
48945254|NCT01208181|157630893|FG000|Part 2|Adverse Event|0|||
48945255|NCT01208181|157630894|FG001|Part 2|Adverse Event|0|||
48945256|NCT01208181|157630895|FG002|Part 2|Adverse Event|6|||
48945257|NCT01208181|157630896|FG003|Part 2|Adverse Event|7|||
48945258|NCT01208181|157630897|FG004|Part 2|Adverse Event|0|||
48945259|NCT01208181|157630893|FG000|Part 2|Withdrawal by Subject|0|||
48945260|NCT01208181|157630894|FG001|Part 2|Withdrawal by Subject|0|||
48945261|NCT01208181|157630895|FG002|Part 2|Withdrawal by Subject|1|||
48945262|NCT01208181|157630896|FG003|Part 2|Withdrawal by Subject|1|||
48945263|NCT01208181|157630897|FG004|Part 2|Withdrawal by Subject|0|||
48945264|NCT01208181|157630893|FG000|Part 2|Protocol Violation|0|||
48945265|NCT01208181|157630894|FG001|Part 2|Protocol Violation|0|||
48945266|NCT01208181|157630895|FG002|Part 2|Protocol Violation|1|||
48945267|NCT01208181|157630896|FG003|Part 2|Protocol Violation|0|||
48945268|NCT01208181|157630897|FG004|Part 2|Protocol Violation|0|||
48945269|NCT01208181|157630893|FG000|Part 2|Physician Decision|0|||
48945270|NCT01208181|157630894|FG001|Part 2|Physician Decision|0|||
48945271|NCT01208181|157630895|FG002|Part 2|Physician Decision|1|||
48945272|NCT01208181|157630896|FG003|Part 2|Physician Decision|2|||
48945273|NCT01208181|157630897|FG004|Part 2|Physician Decision|0|||
48945274|NCT01208181|157630893|FG000|Part 2|Non-compliance with study drug|0|||
48945275|NCT01208181|157630894|FG001|Part 2|Non-compliance with study drug|0|||
48945276|NCT01208181|157630895|FG002|Part 2|Non-compliance with study drug|1|||
48945277|NCT01208181|157630896|FG003|Part 2|Non-compliance with study drug|1|||
48945278|NCT01208181|157630897|FG004|Part 2|Non-compliance with study drug|0|||
48945279|NCT01208181|157630893|FG000|Part 2|Lost to Follow-up|0|||
48945280|NCT01208181|157630894|FG001|Part 2|Lost to Follow-up|0|||
48945281|NCT01208181|157630895|FG002|Part 2|Lost to Follow-up|1|||
48945282|NCT01208181|157630896|FG003|Part 2|Lost to Follow-up|2|||
48945283|NCT01208181|157630897|FG004|Part 2|Lost to Follow-up|0|||
48945284|NCT01208181|157630893|FG000|Part 2|Lack of Efficacy|0|||
48945285|NCT01208181|157630894|FG001|Part 2|Lack of Efficacy|0|||
48945286|NCT01208181|157630895|FG002|Part 2|Lack of Efficacy|5|||
48945287|NCT01208181|157630896|FG003|Part 2|Lack of Efficacy|7|||
48945288|NCT01208181|157630897|FG004|Part 2|Lack of Efficacy|0|||
48945289|NCT00942708|157630900|FG000|Overall Study|Withdrawal by Subject|1|||
48945290|NCT01426386|157630901|FG000|Overall Study|Adverse Event|0|||
48945291|NCT01426386|157630902|FG001|Overall Study|Adverse Event|1|||
48945292|NCT01426386|157630903|FG002|Overall Study|Adverse Event|0|||
48945293|NCT01426386|157630904|FG003|Overall Study|Adverse Event|0|||
48945294|NCT01426386|157630905|FG004|Overall Study|Adverse Event|0|||
48945295|NCT01426386|157630906|FG005|Overall Study|Adverse Event|0|||
48945296|NCT01426386|157630901|FG000|Overall Study|Did not attend scheduled visit|1|||
48945297|NCT01426386|157630902|FG001|Overall Study|Did not attend scheduled visit|4|||
48945298|NCT01426386|157630903|FG002|Overall Study|Did not attend scheduled visit|0|||
48945299|NCT01426386|157630904|FG003|Overall Study|Did not attend scheduled visit|0|||
48945300|NCT01426386|157630905|FG004|Overall Study|Did not attend scheduled visit|2|||
48945301|NCT01426386|157630906|FG005|Overall Study|Did not attend scheduled visit|1|||
48945302|NCT01426386|157630901|FG000|Overall Study|Poor response|2|||
48945303|NCT01426386|157630902|FG001|Overall Study|Poor response|1|||
48945304|NCT01426386|157630903|FG002|Overall Study|Poor response|2|||
48945305|NCT01426386|157630904|FG003|Overall Study|Poor response|0|||
48945306|NCT01426386|157630905|FG004|Overall Study|Poor response|1|||
48945307|NCT01426386|157630906|FG005|Overall Study|Poor response|0|||
48945308|NCT01426386|157630901|FG000|Overall Study|Personal reasons|0|||
48945309|NCT01426386|157630902|FG001|Overall Study|Personal reasons|0|||
48945310|NCT01426386|157630903|FG002|Overall Study|Personal reasons|0|||
48945311|NCT01426386|157630904|FG003|Overall Study|Personal reasons|0|||
48945312|NCT01426386|157630905|FG004|Overall Study|Personal reasons|1|||
48945313|NCT01426386|157630906|FG005|Overall Study|Personal reasons|0|||
48945314|NCT01457339|157630907|FG000|Period 3 (100 mg)|Adverse Event|0|||
48945315|NCT01457339|157630908|FG001|Period 3 (100 mg)|Adverse Event|1|||
48945316|NCT01457339|157630907|FG000|Period 5 (200 mg)|Met stopping criteria for PANSS score|0|||
48945317|NCT01457339|157630908|FG001|Period 5 (200 mg)|Met stopping criteria for PANSS score|1|||
48945318|NCT01457339|157630907|FG000|Period 6 (250 mg)|Family Emergency|1|||
48945319|NCT01457339|157630908|FG001|Period 6 (250 mg)|Family Emergency|0|||
48945320|NCT01457339|157630907|FG000|Period 6 (250 mg)|Personal appointment|0|||
48945321|NCT01457339|157630908|FG001|Period 6 (250 mg)|Personal appointment|1|||
48945322|NCT01478347|157630912|FG000|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1|||
48945323|NCT01478347|157630912|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4|||
48945324|NCT01478347|157630912|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4|||
48945325|NCT03694522|157630913|FG000|Overall Study|Withdrawal by Subject|8|||
48945326|NCT03694522|157630914|FG001|Overall Study|Withdrawal by Subject|10|||
48945327|NCT03694522|157630913|FG000|Overall Study|Physician Decision|53|||
48945328|NCT03694522|157630914|FG001|Overall Study|Physician Decision|54|||
48945329|NCT03694522|157630913|FG000|Overall Study|Other|1|||
48945330|NCT03694522|157630914|FG001|Overall Study|Other|1|||
48945331|NCT03694522|157630913|FG000|Overall Study|Lost to Follow-up|0|||
48945332|NCT03694522|157630914|FG001|Overall Study|Lost to Follow-up|1|||
48945333|NCT00753922|157630915|FG000|Overall Study|Lost to Follow-up|155|||
48945334|NCT00753922|157630916|FG001|Overall Study|Lost to Follow-up|24|||
48945335|NCT00753922|157630917|FG002|Overall Study|Lost to Follow-up|28|||
48945336|NCT00753922|157630918|FG003|Overall Study|Lost to Follow-up|5|||
48945337|NCT00753922|157630915|FG000|Overall Study|Withdrawal by Subject|9|||
48945338|NCT00753922|157630916|FG001|Overall Study|Withdrawal by Subject|11|||
48945339|NCT00753922|157630917|FG002|Overall Study|Withdrawal by Subject|4|||
48945340|NCT00753922|157630918|FG003|Overall Study|Withdrawal by Subject|2|||
48945341|NCT00753922|157630915|FG000|Overall Study|Patient Non-compliance|55|||
48945342|NCT00753922|157630916|FG001|Overall Study|Patient Non-compliance|22|||
48945343|NCT00753922|157630917|FG002|Overall Study|Patient Non-compliance|14|||
48945344|NCT00753922|157630918|FG003|Overall Study|Patient Non-compliance|11|||
48945345|NCT00753922|157630915|FG000|Overall Study|Patients Not Completing Visit|11|||
48945346|NCT00753922|157630916|FG001|Overall Study|Patients Not Completing Visit|0|||
48945347|NCT00753922|157630917|FG002|Overall Study|Patients Not Completing Visit|1|||
48945348|NCT00753922|157630918|FG003|Overall Study|Patients Not Completing Visit|0|||
48945349|NCT00753922|157630915|FG000|Overall Study|Death|2|||
48945350|NCT00753922|157630916|FG001|Overall Study|Death|23|||
48945351|NCT00753922|157630917|FG002|Overall Study|Death|2|||
48945352|NCT00753922|157630918|FG003|Overall Study|Death|1|||
48945353|NCT00753922|157630915|FG000|Overall Study|Discontinuation Due to Explantation|14|||
48945354|NCT00753922|157630916|FG001|Overall Study|Discontinuation Due to Explantation|14|||
48945355|NCT00753922|157630917|FG002|Overall Study|Discontinuation Due to Explantation|14|||
48945356|NCT00753922|157630918|FG003|Overall Study|Discontinuation Due to Explantation|4|||
48945357|NCT01318902|157630919|FG000|Overall Study|Symptomatic Deterioration|0|||
49015294|NCT03443869|157892138|FG000|Overall Study|Lost to Follow-up|1|||
48945358|NCT01318902|157630920|FG001|Overall Study|Symptomatic Deterioration|1|||
48945359|NCT01318902|157630921|FG002|Overall Study|Symptomatic Deterioration|1|||
48945360|NCT01318902|157630922|FG003|Overall Study|Symptomatic Deterioration|2|||
48945361|NCT01318902|157630919|FG000|Overall Study|Withdrawal by Patient|0|||
48945362|NCT01318902|157630920|FG001|Overall Study|Withdrawal by Patient|1|||
48945363|NCT01318902|157630921|FG002|Overall Study|Withdrawal by Patient|0|||
48945364|NCT01318902|157630922|FG003|Overall Study|Withdrawal by Patient|3|||
48945365|NCT01318902|157630919|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
48945366|NCT01318902|157630920|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
48945367|NCT01318902|157630921|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
48945368|NCT01318902|157630922|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
48945369|NCT01318902|157630919|FG000|Overall Study|Adverse Event|0|||
48945370|NCT01318902|157630920|FG001|Overall Study|Adverse Event|1|||
48945371|NCT01318902|157630921|FG002|Overall Study|Adverse Event|0|||
48945372|NCT01318902|157630922|FG003|Overall Study|Adverse Event|0|||
48945373|NCT01318902|157630919|FG000|Overall Study|Terminated by Sponsor|0|||
48945374|NCT01318902|157630920|FG001|Overall Study|Terminated by Sponsor|0|||
48945375|NCT01318902|157630921|FG002|Overall Study|Terminated by Sponsor|1|||
48945376|NCT01318902|157630922|FG003|Overall Study|Terminated by Sponsor|0|||
48945377|NCT01164501|157630923|FG000|Overall Study|Not treated|2|||
48945378|NCT01164501|157630924|FG001|Overall Study|Not treated|0|||
48735991|NCT02935842|156883749|FG002|Testing and Therapy Period 3|Lost to Follow-up|0|||
48945379|NCT01164501|157630925|FG002|Overall Study|Not treated|1|||
48945380|NCT01164501|157630923|FG000|Overall Study|Adverse Event|18|||
48945381|NCT01164501|157630924|FG001|Overall Study|Adverse Event|4|||
48735992|NCT02935842|156883750|FG003|Testing and Therapy Period 3|Lost to Follow-up|1|||
48945382|NCT01164501|157630925|FG002|Overall Study|Adverse Event|21|||
48945383|NCT01164501|157630923|FG000|Overall Study|Lack of Efficacy|0|||
48945384|NCT01164501|157630924|FG001|Overall Study|Lack of Efficacy|0|||
48945385|NCT01164501|157630925|FG002|Overall Study|Lack of Efficacy|1|||
48945386|NCT01164501|157630923|FG000|Overall Study|Non compliant with protocol|1|||
48945387|NCT01164501|157630924|FG001|Overall Study|Non compliant with protocol|1|||
48945388|NCT01164501|157630925|FG002|Overall Study|Non compliant with protocol|4|||
48945389|NCT01164501|157630923|FG000|Overall Study|Lost to Follow-up|3|||
48945390|NCT01164501|157630924|FG001|Overall Study|Lost to Follow-up|0|||
48945391|NCT01164501|157630925|FG002|Overall Study|Lost to Follow-up|3|||
48945392|NCT01164501|157630923|FG000|Overall Study|Patient refusal to continue,not due toAE|10|||
48945393|NCT01164501|157630924|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
48945394|NCT01164501|157630925|FG002|Overall Study|Patient refusal to continue,not due toAE|8|||
48945395|NCT01164501|157630923|FG000|Overall Study|Other reason not defined above|9|||
48945396|NCT01164501|157630924|FG001|Overall Study|Other reason not defined above|1|||
48945397|NCT01164501|157630925|FG002|Overall Study|Other reason not defined above|4|||
48945398|NCT01096667|157630926|FG000|Overall Study|Lost to Follow-up|1|||
48945399|NCT01096667|157630927|FG001|Overall Study|Lost to Follow-up|1|||
48945400|NCT01096667|157630928|FG002|Overall Study|Lost to Follow-up|1|||
48945401|NCT01096667|157630929|FG003|Overall Study|Lost to Follow-up|0|||
48945402|NCT01096667|157630930|FG004|Overall Study|Lost to Follow-up|0|||
48945403|NCT01096667|157630926|FG000|Overall Study|Withdrawal by Subject|1|||
48945404|NCT01096667|157630927|FG001|Overall Study|Withdrawal by Subject|0|||
48945405|NCT01096667|157630928|FG002|Overall Study|Withdrawal by Subject|0|||
48945406|NCT01096667|157630929|FG003|Overall Study|Withdrawal by Subject|1|||
48945407|NCT01096667|157630930|FG004|Overall Study|Withdrawal by Subject|0|||
48945408|NCT01096667|157630926|FG000|Overall Study|Reason not available|0|||
48945409|NCT01096667|157630927|FG001|Overall Study|Reason not available|1|||
48945410|NCT01096667|157630928|FG002|Overall Study|Reason not available|1|||
48945411|NCT01096667|157630929|FG003|Overall Study|Reason not available|1|||
48945412|NCT01096667|157630930|FG004|Overall Study|Reason not available|0|||
48945413|NCT01096667|157630926|FG000|Overall Study|Protocol Violation|0|||
48945414|NCT01096667|157630927|FG001|Overall Study|Protocol Violation|0|||
48945415|NCT01096667|157630928|FG002|Overall Study|Protocol Violation|0|||
48945416|NCT01096667|157630929|FG003|Overall Study|Protocol Violation|1|||
48945417|NCT01096667|157630930|FG004|Overall Study|Protocol Violation|0|||
48945418|NCT01096667|157630926|FG000|Overall Study|Not treated|1|||
48945419|NCT01096667|157630927|FG001|Overall Study|Not treated|0|||
48945420|NCT01096667|157630928|FG002|Overall Study|Not treated|0|||
48945421|NCT01096667|157630929|FG003|Overall Study|Not treated|0|||
48945422|NCT01096667|157630930|FG004|Overall Study|Not treated|0|||
48945423|NCT02453841|157630934|FG000|Overall Study|Protocol Violation|1|||
48945424|NCT02453841|157630934|FG000|Overall Study|Unable to obtain blood samples|2|||
48945425|NCT00857246|157630935|FG000|Induction Regimen|Adverse Event|1|||
48945426|NCT00857246|157630935|FG000|Induction Regimen|disease-related complications|1|||
48945427|NCT00857246|157630935|FG000|Induction Regimen|Withdrawal by Subject|1|||
48945428|NCT00857246|157630935|FG000|Surgery (Curative)|disease progression|6|||
48945429|NCT00857246|157630935|FG000|ChemoRT|Withdrawal by Subject|1|||
48945430|NCT00857246|157630935|FG000|ChemoRT|Adverse Event|2|||
48945431|NCT01919411|157630936|FG000|Overall Study|Lost to Follow-up|2|||
48945432|NCT01919411|157630937|FG001|Overall Study|Lost to Follow-up|4|||
48945433|NCT01919411|157630936|FG000|Overall Study|Physician Decision|1|||
48945434|NCT01919411|157630937|FG001|Overall Study|Physician Decision|0|||
48945435|NCT01919411|157630936|FG000|Overall Study|Protocol Violation|2|||
48945436|NCT01919411|157630937|FG001|Overall Study|Protocol Violation|1|||
48945437|NCT00144300|157630938|FG000|Overall Study|Adverse Event|18|||
48945438|NCT00144300|157630939|FG001|Overall Study|Adverse Event|16|||
48945439|NCT00144300|157630938|FG000|Overall Study|Protocol Violation|1|||
48945440|NCT00144300|157630939|FG001|Overall Study|Protocol Violation|3|||
48945441|NCT00144300|157630938|FG000|Overall Study|Lost to Follow-up|3|||
48945442|NCT00144300|157630939|FG001|Overall Study|Lost to Follow-up|0|||
48945443|NCT00144300|157630938|FG000|Overall Study|Withdrawal by Subject|6|||
48945444|NCT00144300|157630939|FG001|Overall Study|Withdrawal by Subject|6|||
48945445|NCT00144300|157630938|FG000|Overall Study|Other reason (not specified)|1|||
48945446|NCT00144300|157630939|FG001|Overall Study|Other reason (not specified)|3|||
48945447|NCT03478683|157630943|FG000|Overall Study|Adverse Event|5|||
48945448|NCT03478683|157630944|FG001|Overall Study|Adverse Event|3|||
48945449|NCT03478683|157630943|FG000|Overall Study|Lost to Follow-up|0|||
48945450|NCT03478683|157630944|FG001|Overall Study|Lost to Follow-up|5|||
48945451|NCT03478683|157630943|FG000|Overall Study|Physician Decision|1|||
48945452|NCT03478683|157630944|FG001|Overall Study|Physician Decision|3|||
48945453|NCT03478683|157630943|FG000|Overall Study|Withdrawal by Subject|7|||
48945454|NCT03478683|157630944|FG001|Overall Study|Withdrawal by Subject|7|||
48945455|NCT00853905|157630945|FG000|Overall Study|Lost to Follow-up|1|||
48945456|NCT00853905|157630946|FG001|Overall Study|Lost to Follow-up|3|||
48945457|NCT00853905|157630945|FG000|Overall Study|Withdrawal by Subject|0|||
48945458|NCT00853905|157630946|FG001|Overall Study|Withdrawal by Subject|1|||
48945459|NCT00853905|157630945|FG000|Overall Study|never had surgery|1|||
48945460|NCT00853905|157630946|FG001|Overall Study|never had surgery|0|||
48945461|NCT04090164|157630949|FG000|Overall Study|incomplete data on file|245|||
48945462|NCT04090164|157630950|FG001|Overall Study|incomplete data on file|0|||
48945463|NCT02519231|157630951|FG000|Overall Study|Lost to Follow-up|2|||
48850390|NCT02397096|157290659|FG000|Study Extension 1|Withdrawal by Subject|21|||
48850391|NCT02397096|157290660|FG001|Study Extension 1|Withdrawal by Subject|7|||
48850392|NCT02397096|157290659|FG000|Study Extension 2|Adverse Event|3|||
48850393|NCT02397096|157290660|FG001|Study Extension 2|Adverse Event|3|||
48850394|NCT02397096|157290659|FG000|Study Extension 2|Availability of study medication locally|152|||
48850395|NCT02397096|157290660|FG001|Study Extension 2|Availability of study medication locally|64|||
48945464|NCT02519231|157630952|FG001|Overall Study|Lost to Follow-up|5|||
48945465|NCT02519231|157630951|FG000|Overall Study|Withdrawal by Subject|0|||
48945466|NCT02519231|157630952|FG001|Overall Study|Withdrawal by Subject|1|||
48850396|NCT02397096|157290659|FG000|Study Extension 2|Death|2|||
48850397|NCT02397096|157290660|FG001|Study Extension 2|Death|0|||
48850398|NCT02397096|157290659|FG000|Study Extension 2|Lack of Efficacy|1|||
48850399|NCT02397096|157290660|FG001|Study Extension 2|Lack of Efficacy|0|||
48945467|NCT00447421|157630953|FG000|Overall Study|Lack of Efficacy|1|||
48850400|NCT02397096|157290659|FG000|Study Extension 2|Lost to Follow-up|2|||
48850401|NCT02397096|157290660|FG001|Study Extension 2|Lost to Follow-up|1|||
48850402|NCT02397096|157290659|FG000|Study Extension 2|Non-compliance with study drug|1|||
48850403|NCT02397096|157290660|FG001|Study Extension 2|Non-compliance with study drug|0|||
48850404|NCT02397096|157290659|FG000|Study Extension 2|Physician Decision|2|||
48945468|NCT00447421|157630953|FG000|Overall Study|Adverse Event|3|||
48945469|NCT00447421|157630953|FG000|Overall Study|Sponsor Decision|2|||
48945470|NCT02489630|157630958|FG000|Overall Study|Oversedation|1|||
48945471|NCT02489630|157630959|FG001|Overall Study|Oversedation|1|||
48850405|NCT02397096|157290660|FG001|Study Extension 2|Physician Decision|5|||
48850406|NCT02397096|157290659|FG000|Study Extension 2|Pregnancy|1|||
48850407|NCT02397096|157290660|FG001|Study Extension 2|Pregnancy|0|||
48850408|NCT02397096|157290659|FG000|Study Extension 2|Withdrawal by Subject|10|||
48850409|NCT02397096|157290660|FG001|Study Extension 2|Withdrawal by Subject|3|||
48850410|NCT02397096|157290659|FG000|Study Extension 3|Adverse Event|1|||
48850411|NCT02397096|157290660|FG001|Study Extension 3|Adverse Event|0|||
48850412|NCT02397096|157290659|FG000|Study Extension 3|Availability of study medication locally|11|||
48850413|NCT02397096|157290660|FG001|Study Extension 3|Availability of study medication locally|3|||
49015295|NCT03443869|157892139|FG001|Overall Study|Lost to Follow-up|2|||
48945472|NCT02489630|157630958|FG000|Overall Study|Time to med. admin. > protocol limit|1|||
48945473|NCT02489630|157630959|FG001|Overall Study|Time to med. admin. > protocol limit|1|||
48945474|NCT02725177|157630963|FG000|Overall Study|Physician Decision|4|||
48945475|NCT02725177|157630963|FG000|Overall Study|Adverse Event|1|||
48945476|NCT00772967|157630964|FG000|Crossover Treatment 1|Adverse Event (Pain)|0|||
48945477|NCT00772967|157630965|FG001|Crossover Treatment 1|Adverse Event (Pain)|0|||
48945478|NCT00772967|157630966|FG002|Crossover Treatment 1|Adverse Event (Pain)|0|||
48945479|NCT00772967|157630967|FG003|Crossover Treatment 1|Adverse Event (Pain)|1|||
48945480|NCT00772967|157630968|FG004|Crossover Treatment 1|Adverse Event (Pain)|0|||
48945481|NCT00772967|157630969|FG005|Crossover Treatment 1|Adverse Event (Pain)|0|||
48945482|NCT00772967|157630964|FG000|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
48945483|NCT00772967|157630965|FG001|Break 1 (4-7 Days)|Withdrawal by Subject|1|||
48945484|NCT00772967|157630966|FG002|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
48945485|NCT00772967|157630967|FG003|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
48945486|NCT00772967|157630968|FG004|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
48945487|NCT00772967|157630969|FG005|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
48945488|NCT00772967|157630964|FG000|Crossover Treatment 3|Adverse Event|0|||
48945489|NCT00772967|157630965|FG001|Crossover Treatment 3|Adverse Event|0|||
48945490|NCT00772967|157630966|FG002|Crossover Treatment 3|Adverse Event|0|||
48945491|NCT00772967|157630967|FG003|Crossover Treatment 3|Adverse Event|0|||
48945492|NCT00772967|157630968|FG004|Crossover Treatment 3|Adverse Event|1|||
48945493|NCT00772967|157630969|FG005|Crossover Treatment 3|Adverse Event|0|||
48945494|NCT02053246|157630973|FG000|Overall Study|Withdrawal by Subject|3|||
48945495|NCT02053246|157630973|FG000|Overall Study|Physician Decision|1|||
48945496|NCT02795156|157630974|FG000|Overall Study|Progressive Disease|22|||
48945497|NCT02795156|157630975|FG001|Overall Study|Progressive Disease|7|||
48945498|NCT02795156|157630976|FG002|Overall Study|Progressive Disease|34|||
48945499|NCT02795156|157630977|FG003|Overall Study|Progressive Disease|7|||
48945500|NCT02795156|157630974|FG000|Overall Study|Adverse Event|13|||
48945501|NCT02795156|157630975|FG001|Overall Study|Adverse Event|2|||
48945502|NCT02795156|157630976|FG002|Overall Study|Adverse Event|3|||
48945503|NCT02795156|157630977|FG003|Overall Study|Adverse Event|2|||
48945504|NCT02795156|157630974|FG000|Overall Study|Death|1|||
48945505|NCT02795156|157630975|FG001|Overall Study|Death|1|||
48945506|NCT02795156|157630976|FG002|Overall Study|Death|1|||
48945507|NCT02795156|157630977|FG003|Overall Study|Death|0|||
48945508|NCT02795156|157630974|FG000|Overall Study|Physician Decision|1|||
48945509|NCT02795156|157630975|FG001|Overall Study|Physician Decision|0|||
48945510|NCT02795156|157630976|FG002|Overall Study|Physician Decision|1|||
48945511|NCT02795156|157630977|FG003|Overall Study|Physician Decision|0|||
48945512|NCT02795156|157630974|FG000|Overall Study|Withdrawal by Subject|2|||
48945513|NCT02795156|157630975|FG001|Overall Study|Withdrawal by Subject|0|||
48945514|NCT02795156|157630976|FG002|Overall Study|Withdrawal by Subject|3|||
48945515|NCT02795156|157630977|FG003|Overall Study|Withdrawal by Subject|0|||
48945516|NCT01200511|157630978|FG000|Overall Study|Lost to Follow-up|3|||
48945517|NCT01200511|157630978|FG000|Overall Study|Withdrawal by Subject|1|||
48945518|NCT01200511|157630978|FG000|Overall Study|Adverse Event|1|||
48945519|NCT01056107|157632904|FG000|Overall Study|Withdrawal by Subject|0|||
48945520|NCT01056107|157632905|FG001|Overall Study|Withdrawal by Subject|1|||
48945521|NCT01056107|157632906|FG002|Overall Study|Withdrawal by Subject|3|||
48945522|NCT01056107|157632907|FG003|Overall Study|Withdrawal by Subject|0|||
48945523|NCT02031146|157632908|FG000|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
48945524|NCT02031146|157632909|FG001|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
48945525|NCT02031146|157632910|FG002|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
48945526|NCT02031146|157632911|FG003|Overall Study|Did not meet criteria for inclusion in data analysis|100|||
48945527|NCT02031146|157632912|FG004|Overall Study|Did not meet criteria for inclusion in data analysis|26|||
48945528|NCT02031146|157632913|FG005|Overall Study|Did not meet criteria for inclusion in data analysis|4|||
48945529|NCT02031146|157632914|FG006|Overall Study|Did not meet criteria for inclusion in data analysis|5|||
48945530|NCT02629393|157632915|FG000|Overall Study|MOCD Type A not genetically confirmed|2|||
48945531|NCT02629393|157632915|FG000|Overall Study|Physician Decision|1|||
48945532|NCT03270085|157632916|FG000|Overall Study|Withdrawal by Subject|1|||
48945533|NCT03270085|157632917|FG001|Overall Study|Withdrawal by Subject|0|||
48945534|NCT03952130|157632924|FG000|Overall Study|Adverse Event|0|||
48945535|NCT03952130|157632925|FG001|Overall Study|Adverse Event|1|||
48945536|NCT03952130|157632924|FG000|Overall Study|Lost to Follow-up|1|||
48945537|NCT03952130|157632925|FG001|Overall Study|Lost to Follow-up|0|||
48945538|NCT03952130|157632924|FG000|Overall Study|Withdrawal by Subject|1|||
49015296|NCT03443869|157892138|FG000|Overall Study|Physician Decision|3|||
48850414|NCT02397096|157290659|FG000|Study Extension 3|Lost to Follow-up|1|||
48850415|NCT02397096|157290660|FG001|Study Extension 3|Lost to Follow-up|0|||
48850416|NCT02397096|157290659|FG000|Study Extension 3|Withdrawal by Subject|2|||
48850417|NCT02397096|157290660|FG001|Study Extension 3|Withdrawal by Subject|1|||
48850418|NCT03890289|157290661|FG000|Overall Study|Adverse Event|1|||
48850419|NCT03890289|157290661|FG000|Overall Study|Physician Decision|1|||
48850420|NCT03890289|157290661|FG000|Overall Study|Lack of Efficacy|2|||
48850421|NCT02972034|157292188|FG000|Overall Study|Death|11|||
48850422|NCT02972034|157292189|FG001|Overall Study|Death|1|||
48945539|NCT03952130|157632925|FG001|Overall Study|Withdrawal by Subject|5|||
48945540|NCT02786537|157632926|FG000|As Randomized|Adverse Event|0|||
48945541|NCT02786537|157632927|FG001|As Randomized|Adverse Event|11|||
48945542|NCT02786537|157632928|FG002|As Randomized|Adverse Event|0|||
48945543|NCT02786537|157632929|FG003|As Randomized|Adverse Event|4|||
48945544|NCT02786537|157632930|FG004|As Randomized|Adverse Event|6|||
48945545|NCT02786537|157632931|FG005|As Randomized|Adverse Event|2|||
48945546|NCT02786537|157632926|FG000|As Randomized|Lack of Efficacy|0|||
48945547|NCT02786537|157632927|FG001|As Randomized|Lack of Efficacy|0|||
48945548|NCT02786537|157632928|FG002|As Randomized|Lack of Efficacy|0|||
48945549|NCT02786537|157632929|FG003|As Randomized|Lack of Efficacy|1|||
48945550|NCT02786537|157632930|FG004|As Randomized|Lack of Efficacy|0|||
48945551|NCT02786537|157632931|FG005|As Randomized|Lack of Efficacy|0|||
48945552|NCT02786537|157632926|FG000|As Randomized|Withdrawal by Subject|1|||
48945553|NCT02786537|157632927|FG001|As Randomized|Withdrawal by Subject|2|||
48945554|NCT02786537|157632928|FG002|As Randomized|Withdrawal by Subject|0|||
48945555|NCT02786537|157632929|FG003|As Randomized|Withdrawal by Subject|1|||
48945556|NCT02786537|157632930|FG004|As Randomized|Withdrawal by Subject|1|||
48945557|NCT02786537|157632931|FG005|As Randomized|Withdrawal by Subject|0|||
48945558|NCT02786537|157632926|FG000|As Randomized|Death|0|||
48945559|NCT02786537|157632927|FG001|As Randomized|Death|2|||
48945560|NCT02786537|157632928|FG002|As Randomized|Death|0|||
48945561|NCT02786537|157632929|FG003|As Randomized|Death|3|||
48945562|NCT02786537|157632930|FG004|As Randomized|Death|1|||
48945563|NCT02786537|157632931|FG005|As Randomized|Death|0|||
48945564|NCT02786537|157632926|FG000|As Randomized|Non-compliance with study drug|1|||
48945565|NCT02786537|157632927|FG001|As Randomized|Non-compliance with study drug|11|||
48945566|NCT02786537|157632928|FG002|As Randomized|Non-compliance with study drug|0|||
48945567|NCT02786537|157632929|FG003|As Randomized|Non-compliance with study drug|1|||
48945568|NCT02786537|157632930|FG004|As Randomized|Non-compliance with study drug|0|||
48945569|NCT02786537|157632931|FG005|As Randomized|Non-compliance with study drug|1|||
48945570|NCT02786537|157632926|FG000|As Randomized|Lost to treatment follow-up|4|||
48945571|NCT02786537|157632927|FG001|As Randomized|Lost to treatment follow-up|32|||
48945572|NCT02786537|157632928|FG002|As Randomized|Lost to treatment follow-up|0|||
48945573|NCT02786537|157632929|FG003|As Randomized|Lost to treatment follow-up|24|||
48945574|NCT02786537|157632930|FG004|As Randomized|Lost to treatment follow-up|4|||
48945575|NCT02786537|157632931|FG005|As Randomized|Lost to treatment follow-up|4|||
48945576|NCT02786537|157632926|FG000|As Randomized|Incarceration|0|||
48945577|NCT02786537|157632927|FG001|As Randomized|Incarceration|1|||
48945578|NCT02786537|157632928|FG002|As Randomized|Incarceration|0|||
48945579|NCT02786537|157632929|FG003|As Randomized|Incarceration|0|||
48945580|NCT02786537|157632930|FG004|As Randomized|Incarceration|0|||
48945581|NCT02786537|157632931|FG005|As Randomized|Incarceration|0|||
48945582|NCT02786537|157632926|FG000|As Randomized|Opiate Dependency Relapse|0|||
48945583|NCT02786537|157632927|FG001|As Randomized|Opiate Dependency Relapse|1|||
48945584|NCT02786537|157632928|FG002|As Randomized|Opiate Dependency Relapse|0|||
48945585|NCT02786537|157632929|FG003|As Randomized|Opiate Dependency Relapse|0|||
48945586|NCT02786537|157632930|FG004|As Randomized|Opiate Dependency Relapse|0|||
48945587|NCT02786537|157632931|FG005|As Randomized|Opiate Dependency Relapse|0|||
48945588|NCT02786537|157632926|FG000|As Randomized|HCV drugs stolen from pt|0|||
48945589|NCT02786537|157632927|FG001|As Randomized|HCV drugs stolen from pt|1|||
48945590|NCT02786537|157632928|FG002|As Randomized|HCV drugs stolen from pt|0|||
48945591|NCT02786537|157632929|FG003|As Randomized|HCV drugs stolen from pt|0|||
48945592|NCT02786537|157632930|FG004|As Randomized|HCV drugs stolen from pt|0|||
48945593|NCT02786537|157632931|FG005|As Randomized|HCV drugs stolen from pt|0|||
48735993|NCT02935842|156883747|FG000|Testing and Therapy Period 3|Withdrawal by Subject|0|||
48945594|NCT02786537|157632926|FG000|As Randomized|Advised to stop after lapse in dosing|0|||
48945595|NCT02786537|157632927|FG001|As Randomized|Advised to stop after lapse in dosing|1|||
48945596|NCT02786537|157632928|FG002|As Randomized|Advised to stop after lapse in dosing|0|||
48945597|NCT02786537|157632929|FG003|As Randomized|Advised to stop after lapse in dosing|0|||
49015297|NCT03443869|157892139|FG001|Overall Study|Physician Decision|3|||
48945598|NCT02786537|157632930|FG004|As Randomized|Advised to stop after lapse in dosing|0|||
48945599|NCT02786537|157632931|FG005|As Randomized|Advised to stop after lapse in dosing|0|||
48945600|NCT02786537|157632926|FG000|As Randomized|Subject lost insurance|0|||
48945601|NCT02786537|157632927|FG001|As Randomized|Subject lost insurance|0|||
48945602|NCT02786537|157632928|FG002|As Randomized|Subject lost insurance|0|||
48945603|NCT02786537|157632929|FG003|As Randomized|Subject lost insurance|1|||
48945604|NCT02786537|157632930|FG004|As Randomized|Subject lost insurance|0|||
48945605|NCT02786537|157632931|FG005|As Randomized|Subject lost insurance|0|||
48945606|NCT02786537|157632926|FG000|As Treated|Adverse Event|0|||
48945607|NCT02786537|157632927|FG001|As Treated|Adverse Event|11|||
48945608|NCT02786537|157632928|FG002|As Treated|Adverse Event|0|||
48945609|NCT02786537|157632929|FG003|As Treated|Adverse Event|4|||
48945610|NCT02786537|157632930|FG004|As Treated|Adverse Event|6|||
48945611|NCT02786537|157632931|FG005|As Treated|Adverse Event|2|||
48945612|NCT02786537|157632926|FG000|As Treated|Death|0|||
48945613|NCT02786537|157632927|FG001|As Treated|Death|2|||
48945614|NCT02786537|157632928|FG002|As Treated|Death|0|||
48945615|NCT02786537|157632929|FG003|As Treated|Death|3|||
48945616|NCT02786537|157632930|FG004|As Treated|Death|1|||
48945617|NCT02786537|157632931|FG005|As Treated|Death|0|||
48945618|NCT02786537|157632926|FG000|As Treated|Lack of Efficacy|0|||
48945619|NCT02786537|157632927|FG001|As Treated|Lack of Efficacy|0|||
48945620|NCT02786537|157632928|FG002|As Treated|Lack of Efficacy|0|||
48945621|NCT02786537|157632929|FG003|As Treated|Lack of Efficacy|1|||
48945622|NCT02786537|157632930|FG004|As Treated|Lack of Efficacy|0|||
48945623|NCT02786537|157632931|FG005|As Treated|Lack of Efficacy|0|||
48945624|NCT02786537|157632926|FG000|As Treated|Lost to Follow-up|4|||
48945625|NCT02786537|157632927|FG001|As Treated|Lost to Follow-up|32|||
48850423|NCT02972034|157292190|FG002|Overall Study|Death|3|||
48850424|NCT02972034|157292191|FG003|Overall Study|Death|3|||
48850425|NCT02972034|157292192|FG004|Overall Study|Death|2|||
48850426|NCT02972034|157292193|FG005|Overall Study|Death|2|||
48850427|NCT02972034|157292194|FG006|Overall Study|Death|3|||
48850428|NCT02972034|157292195|FG007|Overall Study|Death|4|||
48850429|NCT02972034|157292196|FG008|Overall Study|Death|8|||
48850430|NCT02972034|157292197|FG009|Overall Study|Death|11|||
48850431|NCT02972034|157292198|FG010|Overall Study|Death|3|||
48850432|NCT02972034|157292199|FG011|Overall Study|Death|2|||
48850433|NCT02972034|157292200|FG012|Overall Study|Death|11|||
48850434|NCT02972034|157292201|FG013|Overall Study|Death|10|||
48850435|NCT02972034|157292202|FG014|Overall Study|Death|9|||
48850436|NCT02972034|157292188|FG000|Overall Study|Lost to Follow-up|0|||
48850437|NCT02972034|157292189|FG001|Overall Study|Lost to Follow-up|0|||
48850438|NCT02972034|157292190|FG002|Overall Study|Lost to Follow-up|0|||
48850439|NCT02972034|157292191|FG003|Overall Study|Lost to Follow-up|0|||
48850440|NCT02972034|157292192|FG004|Overall Study|Lost to Follow-up|1|||
48850441|NCT02972034|157292193|FG005|Overall Study|Lost to Follow-up|0|||
48850442|NCT02972034|157292194|FG006|Overall Study|Lost to Follow-up|0|||
48945626|NCT02786537|157632928|FG002|As Treated|Lost to Follow-up|0|||
48945627|NCT02786537|157632929|FG003|As Treated|Lost to Follow-up|25|||
48945628|NCT02786537|157632930|FG004|As Treated|Lost to Follow-up|4|||
48945629|NCT02786537|157632931|FG005|As Treated|Lost to Follow-up|4|||
48945630|NCT02786537|157632926|FG000|As Treated|Non-compliance with study drug|1|||
48735994|NCT02935842|156883748|FG001|Testing and Therapy Period 3|Withdrawal by Subject|0|||
48850443|NCT02972034|157292195|FG007|Overall Study|Lost to Follow-up|1|||
48850444|NCT02972034|157292196|FG008|Overall Study|Lost to Follow-up|0|||
48850445|NCT02972034|157292197|FG009|Overall Study|Lost to Follow-up|0|||
48850446|NCT02972034|157292198|FG010|Overall Study|Lost to Follow-up|0|||
48850447|NCT02972034|157292199|FG011|Overall Study|Lost to Follow-up|0|||
48850448|NCT02972034|157292200|FG012|Overall Study|Lost to Follow-up|0|||
48850449|NCT02972034|157292201|FG013|Overall Study|Lost to Follow-up|0|||
48850450|NCT02972034|157292202|FG014|Overall Study|Lost to Follow-up|1|||
48850451|NCT02972034|157292188|FG000|Overall Study|Physician Decision|0|||
48850452|NCT02972034|157292189|FG001|Overall Study|Physician Decision|0|||
48850453|NCT02972034|157292190|FG002|Overall Study|Physician Decision|0|||
48850454|NCT02972034|157292191|FG003|Overall Study|Physician Decision|0|||
48850455|NCT02972034|157292192|FG004|Overall Study|Physician Decision|0|||
48850456|NCT02972034|157292193|FG005|Overall Study|Physician Decision|0|||
48850457|NCT02972034|157292194|FG006|Overall Study|Physician Decision|0|||
48850458|NCT02972034|157292195|FG007|Overall Study|Physician Decision|1|||
48850459|NCT02972034|157292196|FG008|Overall Study|Physician Decision|0|||
48850460|NCT02972034|157292197|FG009|Overall Study|Physician Decision|0|||
48850461|NCT02972034|157292198|FG010|Overall Study|Physician Decision|1|||
48945631|NCT02786537|157632927|FG001|As Treated|Non-compliance with study drug|11|||
48850462|NCT02972034|157292199|FG011|Overall Study|Physician Decision|0|||
48945632|NCT02786537|157632928|FG002|As Treated|Non-compliance with study drug|0|||
48945633|NCT02786537|157632929|FG003|As Treated|Non-compliance with study drug|1|||
48945634|NCT02786537|157632930|FG004|As Treated|Non-compliance with study drug|0|||
48945635|NCT02786537|157632931|FG005|As Treated|Non-compliance with study drug|1|||
48945636|NCT02786537|157632926|FG000|As Treated|Lost insurance|0|||
48945637|NCT02786537|157632927|FG001|As Treated|Lost insurance|0|||
48945638|NCT02786537|157632928|FG002|As Treated|Lost insurance|0|||
48945639|NCT02786537|157632929|FG003|As Treated|Lost insurance|1|||
48945640|NCT02786537|157632930|FG004|As Treated|Lost insurance|0|||
48945641|NCT02786537|157632931|FG005|As Treated|Lost insurance|0|||
48945642|NCT02786537|157632926|FG000|As Treated|Withdrawal by Subject|1|||
48945643|NCT02786537|157632927|FG001|As Treated|Withdrawal by Subject|2|||
48945644|NCT02786537|157632928|FG002|As Treated|Withdrawal by Subject|0|||
48945645|NCT02786537|157632929|FG003|As Treated|Withdrawal by Subject|0|||
48945646|NCT02786537|157632930|FG004|As Treated|Withdrawal by Subject|1|||
48945647|NCT02786537|157632931|FG005|As Treated|Withdrawal by Subject|0|||
48945648|NCT02786537|157632926|FG000|As Treated|Incarceration|0|||
48945649|NCT02786537|157632927|FG001|As Treated|Incarceration|1|||
48945650|NCT02786537|157632928|FG002|As Treated|Incarceration|0|||
48945651|NCT02786537|157632929|FG003|As Treated|Incarceration|0|||
48945652|NCT02786537|157632930|FG004|As Treated|Incarceration|0|||
48945653|NCT02786537|157632931|FG005|As Treated|Incarceration|0|||
48945654|NCT02786537|157632926|FG000|As Treated|Opiate dependency relapse|0|||
48945655|NCT02786537|157632927|FG001|As Treated|Opiate dependency relapse|1|||
48945656|NCT02786537|157632928|FG002|As Treated|Opiate dependency relapse|0|||
48945657|NCT02786537|157632929|FG003|As Treated|Opiate dependency relapse|0|||
48945658|NCT02786537|157632930|FG004|As Treated|Opiate dependency relapse|0|||
48945659|NCT02786537|157632931|FG005|As Treated|Opiate dependency relapse|0|||
48945660|NCT02786537|157632926|FG000|As Treated|Drugs stolen from patient|0|||
48945661|NCT02786537|157632927|FG001|As Treated|Drugs stolen from patient|1|||
48945662|NCT02786537|157632928|FG002|As Treated|Drugs stolen from patient|0|||
48945663|NCT02786537|157632929|FG003|As Treated|Drugs stolen from patient|0|||
48945664|NCT02786537|157632930|FG004|As Treated|Drugs stolen from patient|0|||
48945665|NCT02786537|157632931|FG005|As Treated|Drugs stolen from patient|0|||
48945666|NCT02786537|157632926|FG000|As Treated|Advised to stop tx after loss of meds|0|||
48945667|NCT02786537|157632927|FG001|As Treated|Advised to stop tx after loss of meds|1|||
48945668|NCT02786537|157632928|FG002|As Treated|Advised to stop tx after loss of meds|0|||
48945669|NCT02786537|157632929|FG003|As Treated|Advised to stop tx after loss of meds|0|||
48945670|NCT02786537|157632930|FG004|As Treated|Advised to stop tx after loss of meds|0|||
48945671|NCT02786537|157632931|FG005|As Treated|Advised to stop tx after loss of meds|0|||
48945672|NCT02082184|157632935|FG000|Overall Study|Adverse Event|1|||
48850463|NCT02972034|157292200|FG012|Overall Study|Physician Decision|0|||
48735995|NCT02935842|156883749|FG002|Testing and Therapy Period 3|Withdrawal by Subject|3|||
48850464|NCT02972034|157292201|FG013|Overall Study|Physician Decision|0|||
48850465|NCT02972034|157292202|FG014|Overall Study|Physician Decision|0|||
48850466|NCT02972034|157292188|FG000|Overall Study|Sponsor Decision|0|||
48850467|NCT02972034|157292189|FG001|Overall Study|Sponsor Decision|0|||
48850468|NCT02972034|157292190|FG002|Overall Study|Sponsor Decision|0|||
48850469|NCT02972034|157292191|FG003|Overall Study|Sponsor Decision|1|||
48945673|NCT02082184|157632936|FG001|Overall Study|Adverse Event|0|||
48850470|NCT02972034|157292192|FG004|Overall Study|Sponsor Decision|0|||
48850471|NCT02972034|157292193|FG005|Overall Study|Sponsor Decision|0|||
48850472|NCT02972034|157292194|FG006|Overall Study|Sponsor Decision|1|||
48850473|NCT02972034|157292195|FG007|Overall Study|Sponsor Decision|1|||
48850474|NCT02972034|157292196|FG008|Overall Study|Sponsor Decision|1|||
48850475|NCT02972034|157292197|FG009|Overall Study|Sponsor Decision|2|||
48850476|NCT02972034|157292198|FG010|Overall Study|Sponsor Decision|2|||
48850477|NCT02972034|157292199|FG011|Overall Study|Sponsor Decision|0|||
48850478|NCT02972034|157292200|FG012|Overall Study|Sponsor Decision|1|||
48850479|NCT02972034|157292201|FG013|Overall Study|Sponsor Decision|0|||
48850480|NCT02972034|157292202|FG014|Overall Study|Sponsor Decision|1|||
48850481|NCT02972034|157292188|FG000|Overall Study|Withdrawal by Subject|3|||
48850482|NCT02972034|157292189|FG001|Overall Study|Withdrawal by Subject|0|||
48850483|NCT02972034|157292190|FG002|Overall Study|Withdrawal by Subject|0|||
48850484|NCT02972034|157292191|FG003|Overall Study|Withdrawal by Subject|0|||
48850485|NCT02972034|157292192|FG004|Overall Study|Withdrawal by Subject|1|||
48850486|NCT02972034|157292193|FG005|Overall Study|Withdrawal by Subject|1|||
48850487|NCT02972034|157292194|FG006|Overall Study|Withdrawal by Subject|0|||
48850488|NCT02972034|157292195|FG007|Overall Study|Withdrawal by Subject|0|||
48850489|NCT02972034|157292196|FG008|Overall Study|Withdrawal by Subject|1|||
48850490|NCT02972034|157292197|FG009|Overall Study|Withdrawal by Subject|1|||
48850491|NCT02972034|157292198|FG010|Overall Study|Withdrawal by Subject|2|||
48850492|NCT02972034|157292199|FG011|Overall Study|Withdrawal by Subject|1|||
48850493|NCT02972034|157292200|FG012|Overall Study|Withdrawal by Subject|1|||
48735996|NCT02935842|156883750|FG003|Testing and Therapy Period 3|Withdrawal by Subject|0|||
48850494|NCT02972034|157292201|FG013|Overall Study|Withdrawal by Subject|1|||
48850495|NCT02972034|157292202|FG014|Overall Study|Withdrawal by Subject|0|||
48850496|NCT02972034|157292188|FG000|Overall Study|Screen Failure|0|||
48850497|NCT02972034|157292189|FG001|Overall Study|Screen Failure|0|||
48850498|NCT02972034|157292190|FG002|Overall Study|Screen Failure|0|||
48850499|NCT02972034|157292191|FG003|Overall Study|Screen Failure|0|||
48850500|NCT02972034|157292192|FG004|Overall Study|Screen Failure|0|||
48850501|NCT02972034|157292193|FG005|Overall Study|Screen Failure|0|||
48850502|NCT02972034|157292194|FG006|Overall Study|Screen Failure|0|||
48850503|NCT02972034|157292195|FG007|Overall Study|Screen Failure|0|||
48850504|NCT02972034|157292196|FG008|Overall Study|Screen Failure|0|||
48850505|NCT02972034|157292197|FG009|Overall Study|Screen Failure|0|||
48850506|NCT02972034|157292198|FG010|Overall Study|Screen Failure|0|||
48850507|NCT02972034|157292199|FG011|Overall Study|Screen Failure|0|||
48850508|NCT02972034|157292200|FG012|Overall Study|Screen Failure|1|||
48850509|NCT02972034|157292201|FG013|Overall Study|Screen Failure|0|||
48945674|NCT02082184|157632935|FG000|Overall Study|Medical diagnosis|1|||
48945675|NCT02082184|157632936|FG001|Overall Study|Medical diagnosis|2|||
48945676|NCT02082184|157632935|FG000|Overall Study|Device associated symptoms|5|||
48945677|NCT02082184|157632936|FG001|Overall Study|Device associated symptoms|0|||
48945678|NCT02082184|157632935|FG000|Overall Study|Withdrawal by Subject|3|||
48945679|NCT02082184|157632936|FG001|Overall Study|Withdrawal by Subject|2|||
48945680|NCT02082184|157632935|FG000|Overall Study|Protocol Violation|0|||
48945681|NCT02082184|157632936|FG001|Overall Study|Protocol Violation|6|||
48945682|NCT02082184|157632935|FG000|Overall Study|Lost to Follow-up|0|||
48945683|NCT02082184|157632936|FG001|Overall Study|Lost to Follow-up|2|||
48945684|NCT02082184|157632935|FG000|Overall Study|Subject non-compliance|0|||
48945685|NCT02082184|157632936|FG001|Overall Study|Subject non-compliance|1|||
48945686|NCT01362322|157632937|FG000|Overall Study|Withdrawal by Subject|3|||
48945687|NCT01362322|157632938|FG001|Overall Study|Withdrawal by Subject|1|||
48945688|NCT01362322|157632937|FG000|Overall Study|Lost to Follow-up|2|||
48945689|NCT01362322|157632938|FG001|Overall Study|Lost to Follow-up|6|||
48945690|NCT00265941|157632949|FG000|Overall Study|Protocol Violation|22|||
48945691|NCT00265941|157632950|FG001|Overall Study|Protocol Violation|25|||
48945692|NCT00265941|157632949|FG000|Overall Study|Lost to Follow-up|1|||
48945693|NCT00265941|157632950|FG001|Overall Study|Lost to Follow-up|1|||
48945694|NCT00149214|157632953|FG000|Overall Study|Adverse Event|12|||
48945695|NCT00149214|157632954|FG001|Overall Study|Adverse Event|9|||
48945696|NCT00149214|157632953|FG000|Overall Study|Withdrawal by Subject|4|||
48945697|NCT00149214|157632954|FG001|Overall Study|Withdrawal by Subject|1|||
48945698|NCT00149214|157632953|FG000|Overall Study|Physician Decision|3|||
48945699|NCT00149214|157632954|FG001|Overall Study|Physician Decision|3|||
48945700|NCT00149214|157632953|FG000|Overall Study|Sponsor Decision|0|||
48945701|NCT00149214|157632954|FG001|Overall Study|Sponsor Decision|1|||
48945702|NCT00149214|157632953|FG000|Overall Study|Progressive Disease|7|||
48945703|NCT00149214|157632954|FG001|Overall Study|Progressive Disease|3|||
48945704|NCT00174941|157632955|FG000|Overall Study|Adverse Event|1|||
48945705|NCT00174941|157632956|FG001|Overall Study|Adverse Event|10|||
48945706|NCT00174941|157632957|FG002|Overall Study|Adverse Event|2|||
48945707|NCT00174941|157632958|FG003|Overall Study|Adverse Event|13|||
48945708|NCT00174941|157632955|FG000|Overall Study|Protocol Violation|0|||
48945709|NCT00174941|157632956|FG001|Overall Study|Protocol Violation|1|||
48945710|NCT00174941|157632957|FG002|Overall Study|Protocol Violation|0|||
48945711|NCT00174941|157632958|FG003|Overall Study|Protocol Violation|1|||
48945712|NCT00174941|157632955|FG000|Overall Study|Lost to Follow-up|0|||
48945713|NCT00174941|157632956|FG001|Overall Study|Lost to Follow-up|3|||
48945714|NCT00174941|157632957|FG002|Overall Study|Lost to Follow-up|2|||
48945715|NCT00174941|157632958|FG003|Overall Study|Lost to Follow-up|5|||
48945716|NCT00174941|157632955|FG000|Overall Study|Personal Reason(s)|0|||
48945717|NCT00174941|157632956|FG001|Overall Study|Personal Reason(s)|14|||
48945718|NCT00174941|157632957|FG002|Overall Study|Personal Reason(s)|8|||
48945719|NCT00174941|157632958|FG003|Overall Study|Personal Reason(s)|22|||
48945720|NCT00174941|157632955|FG000|Overall Study|Gout Flare|0|||
48945721|NCT00174941|157632956|FG001|Overall Study|Gout Flare|4|||
48945722|NCT00174941|157632957|FG002|Overall Study|Gout Flare|4|||
48945723|NCT00174941|157632958|FG003|Overall Study|Gout Flare|8|||
48850510|NCT02972034|157292202|FG014|Overall Study|Screen Failure|0|||
48850511|NCT00210106|157292214|FG000|Overall Study|Death|1|||
48850512|NCT00210106|157292214|FG000|Overall Study|Protocol Violation|13|||
48850513|NCT03876457|157292215|FG000|Overall Study|Lost to Follow-up|1|||
48850514|NCT03876457|157292216|FG001|Overall Study|Lost to Follow-up|3|||
48850515|NCT01596972|157292217|FG000|Overall Study|Physician Decision|1|||
48850516|NCT01596972|157292218|FG001|Overall Study|Physician Decision|9|||
48850517|NCT01596972|157292217|FG000|Overall Study|Lost to Follow-up|0|||
48850518|NCT01596972|157292218|FG001|Overall Study|Lost to Follow-up|4|||
48850519|NCT01596972|157292217|FG000|Overall Study|Withdrawal by Subject|0|||
48850520|NCT01596972|157292218|FG001|Overall Study|Withdrawal by Subject|1|||
48850521|NCT01084694|157292219|FG000|Overall Study|Withdrawal by Subject|2|||
48850522|NCT01084694|157292220|FG001|Overall Study|Withdrawal by Subject|1|||
48850523|NCT01084694|157292219|FG000|Overall Study|Death|2|||
48850524|NCT01084694|157292220|FG001|Overall Study|Death|12|||
48850525|NCT01084694|157292219|FG000|Overall Study|eligibility not maintained|2|||
48850526|NCT01084694|157292220|FG001|Overall Study|eligibility not maintained|7|||
48850527|NCT01532648|157292225|FG000|Overall Study|Lost to Follow-up|3|||
48850528|NCT01532648|157292226|FG001|Overall Study|Lost to Follow-up|4|||
48850529|NCT01532648|157292225|FG000|Overall Study|Lack of Efficacy|4|||
48850530|NCT01532648|157292226|FG001|Overall Study|Lack of Efficacy|1|||
48850531|NCT01532648|157292225|FG000|Overall Study|Protocol Violation|1|||
48850532|NCT01532648|157292226|FG001|Overall Study|Protocol Violation|1|||
48850533|NCT01532648|157292225|FG000|Overall Study|Adverse Event|12|||
48850534|NCT01532648|157292226|FG001|Overall Study|Adverse Event|9|||
48850535|NCT01532648|157292225|FG000|Overall Study|Withdrawal by Subject|16|||
48850536|NCT01532648|157292226|FG001|Overall Study|Withdrawal by Subject|2|||
48850537|NCT01750684|157292227|FG000|Overall Study|Death|1|||
48850538|NCT01750684|157292228|FG001|Overall Study|Death|0|||
48850539|NCT01750684|157292227|FG000|Overall Study|Non-compliance with Study Drug|0|||
48850540|NCT01750684|157292228|FG001|Overall Study|Non-compliance with Study Drug|1|||
48850541|NCT01750684|157292227|FG000|Overall Study|Withdrawn by Sponsor|0|||
48850542|NCT01750684|157292228|FG001|Overall Study|Withdrawn by Sponsor|1|||
48850543|NCT01750684|157292227|FG000|Overall Study|Protocol Violation|1|||
48850544|NCT01750684|157292228|FG001|Overall Study|Protocol Violation|0|||
48850545|NCT02568215|157292234|FG000|Overall Study|Death|1|||
48850546|NCT02568215|157292235|FG001|Overall Study|Death|2|||
48850547|NCT02568215|157292236|FG002|Overall Study|Death|0|||
48850548|NCT02568215|157292234|FG000|Overall Study|Physician Decision|2|||
48850549|NCT02568215|157292235|FG001|Overall Study|Physician Decision|2|||
48850550|NCT02568215|157292236|FG002|Overall Study|Physician Decision|2|||
48850551|NCT02568215|157292234|FG000|Overall Study|Lost to Follow-up|29|||
48850552|NCT02568215|157292235|FG001|Overall Study|Lost to Follow-up|32|||
48850553|NCT02568215|157292236|FG002|Overall Study|Lost to Follow-up|41|||
48850554|NCT02568215|157292234|FG000|Overall Study|Withdrawal by Subject|21|||
48850555|NCT02568215|157292235|FG001|Overall Study|Withdrawal by Subject|19|||
48850556|NCT02568215|157292236|FG002|Overall Study|Withdrawal by Subject|22|||
48850557|NCT02568215|157292234|FG000|Overall Study|Protocol Violation|1|||
48850558|NCT02568215|157292235|FG001|Overall Study|Protocol Violation|1|||
48850559|NCT02568215|157292236|FG002|Overall Study|Protocol Violation|0|||
48850560|NCT02568215|157292234|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|25|||
48850561|NCT02568215|157292235|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|23|||
48850562|NCT02568215|157292236|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
48850563|NCT02568215|157292234|FG000|Overall Study|Other|0|||
48850564|NCT02568215|157292235|FG001|Overall Study|Other|1|||
48850565|NCT02568215|157292236|FG002|Overall Study|Other|4|||
48850566|NCT02022657|157292237|FG000|Overall Study|Withdrawal by Subject|2|||
48850567|NCT02022657|157292238|FG001|Overall Study|Withdrawal by Subject|0|||
48850568|NCT02022657|157292239|FG002|Overall Study|Withdrawal by Subject|1|||
48850569|NCT02022657|157292240|FG003|Overall Study|Withdrawal by Subject|0|||
48850570|NCT02022657|157292241|FG004|Overall Study|Withdrawal by Subject|0|||
48850571|NCT02022657|157292242|FG005|Overall Study|Withdrawal by Subject|0|||
48850572|NCT02022657|157292237|FG000|Overall Study|Physician Decision|0|||
48850573|NCT02022657|157292238|FG001|Overall Study|Physician Decision|0|||
48850574|NCT02022657|157292239|FG002|Overall Study|Physician Decision|0|||
48850575|NCT02022657|157292240|FG003|Overall Study|Physician Decision|0|||
48850576|NCT02022657|157292241|FG004|Overall Study|Physician Decision|0|||
48850577|NCT02022657|157292242|FG005|Overall Study|Physician Decision|1|||
48850578|NCT01629589|157292243|FG000|Overall Study|Protocol Violation|4|||
48850579|NCT01629589|157292244|FG001|Overall Study|Protocol Violation|2|||
48850580|NCT01629589|157292243|FG000|Overall Study|Lost to Follow-up|2|||
48850581|NCT01629589|157292244|FG001|Overall Study|Lost to Follow-up|1|||
48850582|NCT01629589|157292243|FG000|Overall Study|Withdrawal by Subject|2|||
48850583|NCT01629589|157292244|FG001|Overall Study|Withdrawal by Subject|3|||
48850584|NCT01629589|157292243|FG000|Overall Study|Did not receive study vaccine|0|||
48850585|NCT01629589|157292244|FG001|Overall Study|Did not receive study vaccine|1|||
48735997|NCT01686828|156883752|FG000|Overall Study|Physician Decision|1|||
48850586|NCT02079649|157292245|FG000|Overall Study|Lost to Follow-up|0|||
48850587|NCT02079649|157292246|FG001|Overall Study|Lost to Follow-up|0|||
48850588|NCT02079649|157292247|FG002|Overall Study|Lost to Follow-up|0|||
48850589|NCT02079649|157292248|FG003|Overall Study|Lost to Follow-up|1|||
48850590|NCT02079649|157292245|FG000|Overall Study|Withdrawal by Subject|0|||
48850591|NCT02079649|157292246|FG001|Overall Study|Withdrawal by Subject|0|||
48850592|NCT02079649|157292247|FG002|Overall Study|Withdrawal by Subject|0|||
48850593|NCT02079649|157292248|FG003|Overall Study|Withdrawal by Subject|1|||
48850594|NCT02079649|157292245|FG000|Overall Study|Randomization error (prior to treatment)|1|||
48850595|NCT02079649|157292246|FG001|Overall Study|Randomization error (prior to treatment)|0|||
48850596|NCT02079649|157292247|FG002|Overall Study|Randomization error (prior to treatment)|1|||
48850597|NCT02079649|157292248|FG003|Overall Study|Randomization error (prior to treatment)|0|||
48850598|NCT00640159|157292249|FG000|Overall Study|Lost to Follow-up|2|||
48850599|NCT00463229|157292250|FG000|Overall Study|Lost to Follow-up|5|||
48850600|NCT00463229|157292251|FG001|Overall Study|Lost to Follow-up|7|||
48850601|NCT00463229|157292250|FG000|Overall Study|Death|4|||
48850602|NCT00463229|157292251|FG001|Overall Study|Death|3|||
48850603|NCT02404441|157292252|FG000|Phase 1 Part|Adverse Event|1|||
48850604|NCT02404441|157292253|FG001|Phase 1 Part|Adverse Event|0|||
48850605|NCT02404441|157292254|FG002|Phase 1 Part|Adverse Event|0|||
48850606|NCT02404441|157292255|FG003|Phase 1 Part|Adverse Event|0|||
48850607|NCT02404441|157292256|FG004|Phase 1 Part|Adverse Event|0|||
48850608|NCT02404441|157292257|FG005|Phase 1 Part|Adverse Event|0|||
48850609|NCT02404441|157292258|FG006|Phase 1 Part|Adverse Event|0|||
48850610|NCT02404441|157292259|FG007|Phase 1 Part|Adverse Event|0|||
48850611|NCT02404441|157292260|FG008|Phase 1 Part|Adverse Event|0|||
48850612|NCT02404441|157292261|FG009|Phase 1 Part|Adverse Event|0|||
48850613|NCT02404441|157292252|FG000|Phase 1 Part|Physician Decision|0|||
48850614|NCT02404441|157292253|FG001|Phase 1 Part|Physician Decision|1|||
48850615|NCT02404441|157292254|FG002|Phase 1 Part|Physician Decision|0|||
48850616|NCT02404441|157292255|FG003|Phase 1 Part|Physician Decision|0|||
48850617|NCT02404441|157292256|FG004|Phase 1 Part|Physician Decision|0|||
48850618|NCT02404441|157292257|FG005|Phase 1 Part|Physician Decision|0|||
48850619|NCT02404441|157292258|FG006|Phase 1 Part|Physician Decision|0|||
48850620|NCT02404441|157292259|FG007|Phase 1 Part|Physician Decision|0|||
48850621|NCT02404441|157292260|FG008|Phase 1 Part|Physician Decision|0|||
48850622|NCT02404441|157292261|FG009|Phase 1 Part|Physician Decision|0|||
48850623|NCT02404441|157292252|FG000|Phase 1 Part|Progressive Disease|14|||
48850624|NCT02404441|157292253|FG001|Phase 1 Part|Progressive Disease|11|||
48850625|NCT02404441|157292254|FG002|Phase 1 Part|Progressive Disease|7|||
48850626|NCT02404441|157292255|FG003|Phase 1 Part|Progressive Disease|6|||
48850627|NCT02404441|157292256|FG004|Phase 1 Part|Progressive Disease|9|||
48850628|NCT02404441|157292257|FG005|Phase 1 Part|Progressive Disease|0|||
48850629|NCT02404441|157292258|FG006|Phase 1 Part|Progressive Disease|0|||
48945724|NCT00174941|157632955|FG000|Overall Study|Reason Not Specified|1|||
48945725|NCT00174941|157632956|FG001|Overall Study|Reason Not Specified|6|||
48945726|NCT00174941|157632957|FG002|Overall Study|Reason Not Specified|2|||
48945727|NCT00174941|157632958|FG003|Overall Study|Reason Not Specified|9|||
48945728|NCT00283712|157632959|FG000|Overall Study|Death|0|||
48735998|NCT01686828|156883753|FG001|Overall Study|Physician Decision|0|||
48945729|NCT00283712|157632960|FG001|Overall Study|Death|1|||
48945730|NCT05590403|157632963|FG000|Overall Study|Lost to Follow-up|3|||
48945731|NCT05590403|157632964|FG001|Overall Study|Lost to Follow-up|0|||
48945732|NCT05590403|157632965|FG002|Overall Study|Lost to Follow-up|2|||
48945733|NCT05590403|157632966|FG003|Overall Study|Lost to Follow-up|0|||
48945734|NCT05590403|157632967|FG004|Overall Study|Lost to Follow-up|0|||
48945735|NCT05590403|157632963|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|0|||
48945736|NCT05590403|157632964|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|1|||
48945737|NCT05590403|157632965|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|0|||
48945738|NCT05590403|157632966|FG003|Overall Study|Consent withdrawal, not due to a (S)AE|1|||
48945739|NCT05590403|157632967|FG004|Overall Study|Consent withdrawal, not due to a (S)AE|0|||
48945740|NCT03126227|157632968|FG000|Overall Study|Adverse Event|43|||
48945741|NCT03126227|157632969|FG001|Overall Study|Adverse Event|4|||
48945742|NCT03126227|157632968|FG000|Overall Study|Death|0|||
48945743|NCT03126227|157632969|FG001|Overall Study|Death|1|||
48945744|NCT03126227|157632968|FG000|Overall Study|Lost to Follow-up|0|||
48945745|NCT03126227|157632969|FG001|Overall Study|Lost to Follow-up|1|||
48945746|NCT03126227|157632968|FG000|Overall Study|Physician Decision|2|||
48945747|NCT03126227|157632969|FG001|Overall Study|Physician Decision|0|||
48945748|NCT03126227|157632968|FG000|Overall Study|Protocol Violation|1|||
48945749|NCT03126227|157632969|FG001|Overall Study|Protocol Violation|0|||
48945750|NCT03126227|157632968|FG000|Overall Study|Withdrawal by Subject|19|||
48945751|NCT03126227|157632969|FG001|Overall Study|Withdrawal by Subject|3|||
48945752|NCT03126227|157632968|FG000|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|8|||
48945753|NCT03126227|157632969|FG001|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|1|||
48945754|NCT03126227|157632968|FG000|Overall Study|Lack of dosing compliance|2|||
48945755|NCT03126227|157632969|FG001|Overall Study|Lack of dosing compliance|0|||
48945756|NCT03126227|157632968|FG000|Overall Study|Did not meet eligibility criteria subsequent to enrollment|2|||
48945757|NCT03126227|157632969|FG001|Overall Study|Did not meet eligibility criteria subsequent to enrollment|0|||
48945758|NCT03126227|157632968|FG000|Overall Study|Scheduling conflict|1|||
48945759|NCT03126227|157632969|FG001|Overall Study|Scheduling conflict|0|||
48945760|NCT00947154|157632972|FG000|Overall Study|Lost to Follow-up|1|||
48945761|NCT01121406|157632974|FG000|Overall Study|Progressive disease RECIST|44|||
48945762|NCT01121406|157632975|FG001|Overall Study|Progressive disease RECIST|28|||
48945763|NCT01121406|157632974|FG000|Overall Study|Wors. or AE of underlying cancer disease|4|||
48945764|NCT01121406|157632975|FG001|Overall Study|Wors. or AE of underlying cancer disease|6|||
48945765|NCT01121406|157632974|FG000|Overall Study|Other AE|3|||
48945766|NCT01121406|157632975|FG001|Overall Study|Other AE|10|||
48945767|NCT01121406|157632974|FG000|Overall Study|Non-compliant with protocol|0|||
48945768|NCT01121406|157632975|FG001|Overall Study|Non-compliant with protocol|2|||
48945769|NCT01121406|157632974|FG000|Overall Study|Lost to Follow-up|0|||
48945770|NCT01121406|157632975|FG001|Overall Study|Lost to Follow-up|1|||
48945771|NCT01121406|157632974|FG000|Overall Study|Refused continuation of study med.|1|||
48945772|NCT01121406|157632975|FG001|Overall Study|Refused continuation of study med.|2|||
48945773|NCT01121406|157632974|FG000|Overall Study|Reason other than specified above|2|||
48945774|NCT01121406|157632975|FG001|Overall Study|Reason other than specified above|6|||
48945775|NCT01121406|157632974|FG000|Overall Study|Not treated|1|||
48945776|NCT01121406|157632975|FG001|Overall Study|Not treated|0|||
48945777|NCT02088034|157632979|FG000|Overall Study|Lost to Follow-up|1|||
48945778|NCT02088034|157632980|FG001|Overall Study|Lost to Follow-up|1|||
48945779|NCT02088034|157632981|FG002|Overall Study|Lost to Follow-up|0|||
48945780|NCT02088034|157632979|FG000|Overall Study|Pregnancy|2|||
48945781|NCT02088034|157632980|FG001|Overall Study|Pregnancy|1|||
48945782|NCT02088034|157632981|FG002|Overall Study|Pregnancy|2|||
48945783|NCT01380093|157632982|FG000|Naloxone Challenge Phase|Screen failures|21|||
48945784|NCT01380093|157632983|FG001|Naloxone Challenge Phase|Screen failures|0|||
48945785|NCT01380093|157632984|FG002|Naloxone Challenge Phase|Screen failures|0|||
48945786|NCT01380093|157632985|FG003|Naloxone Challenge Phase|Screen failures|0|||
48945787|NCT01380093|157632986|FG004|Naloxone Challenge Phase|Screen failures|0|||
48945788|NCT01380093|157632987|FG005|Naloxone Challenge Phase|Screen failures|0|||
48945789|NCT01380093|157632988|FG006|Naloxone Challenge Phase|Screen failures|0|||
48945790|NCT01380093|157632989|FG007|Naloxone Challenge Phase|Screen failures|0|||
48945791|NCT01380093|157632990|FG008|Naloxone Challenge Phase|Screen failures|0|||
48945792|NCT01380093|157632982|FG000|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
48945793|NCT01380093|157632983|FG001|Drug Discrimination Phase: Day 1|Discrimination failure|1|||
48945794|NCT01380093|157632984|FG002|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
48945795|NCT01380093|157632985|FG003|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
48945796|NCT01380093|157632986|FG004|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
48945797|NCT01380093|157632987|FG005|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
48945798|NCT01380093|157632988|FG006|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
48735999|NCT01686828|156883754|FG002|Overall Study|Physician Decision|0|||
48945799|NCT01380093|157632989|FG007|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
48945800|NCT01380093|157632990|FG008|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
48945801|NCT01380093|157632982|FG000|Drug Discrimination Phase: Day 2|Physician Decision|0|||
48945802|NCT01380093|157632983|FG001|Drug Discrimination Phase: Day 2|Physician Decision|3|||
48945803|NCT01380093|157632984|FG002|Drug Discrimination Phase: Day 2|Physician Decision|1|||
48945804|NCT01380093|157632985|FG003|Drug Discrimination Phase: Day 2|Physician Decision|0|||
49015298|NCT03443869|157892138|FG000|Overall Study|Other|4|||
48850630|NCT02404441|157292259|FG007|Phase 1 Part|Progressive Disease|0|||
48850631|NCT02404441|157292260|FG008|Phase 1 Part|Progressive Disease|0|||
48945805|NCT01380093|157632986|FG004|Drug Discrimination Phase: Day 2|Physician Decision|0|||
48945806|NCT01380093|157632987|FG005|Drug Discrimination Phase: Day 2|Physician Decision|0|||
48945807|NCT01380093|157632988|FG006|Drug Discrimination Phase: Day 2|Physician Decision|0|||
48945808|NCT01380093|157632989|FG007|Drug Discrimination Phase: Day 2|Physician Decision|0|||
48945809|NCT01380093|157632990|FG008|Drug Discrimination Phase: Day 2|Physician Decision|0|||
48945810|NCT01380093|157632982|FG000|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
48945811|NCT01380093|157632983|FG001|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1|||
48945812|NCT01380093|157632984|FG002|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
48945813|NCT01380093|157632985|FG003|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
48945814|NCT01380093|157632986|FG004|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
48945815|NCT01380093|157632987|FG005|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
48945816|NCT01380093|157632988|FG006|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
48945817|NCT01380093|157632989|FG007|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
48945818|NCT01380093|157632990|FG008|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
48945819|NCT01380093|157632982|FG000|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
48945820|NCT01380093|157632983|FG001|Drug Discrimination Phase: Day 2|Discrimination failure|4|||
48945821|NCT01380093|157632984|FG002|Drug Discrimination Phase: Day 2|Discrimination failure|9|||
48945822|NCT01380093|157632985|FG003|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
48945823|NCT01380093|157632986|FG004|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
48945824|NCT01380093|157632987|FG005|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
48945825|NCT01380093|157632988|FG006|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
48850632|NCT02404441|157292261|FG009|Phase 1 Part|Progressive Disease|0|||
48850633|NCT02404441|157292252|FG000|Phase 1 Part|Subject/Guardian Decision|0|||
48850634|NCT02404441|157292253|FG001|Phase 1 Part|Subject/Guardian Decision|2|||
48850635|NCT02404441|157292254|FG002|Phase 1 Part|Subject/Guardian Decision|3|||
48850636|NCT02404441|157292255|FG003|Phase 1 Part|Subject/Guardian Decision|0|||
48850637|NCT02404441|157292256|FG004|Phase 1 Part|Subject/Guardian Decision|0|||
48850638|NCT02404441|157292257|FG005|Phase 1 Part|Subject/Guardian Decision|0|||
48850639|NCT02404441|157292258|FG006|Phase 1 Part|Subject/Guardian Decision|0|||
48850640|NCT02404441|157292259|FG007|Phase 1 Part|Subject/Guardian Decision|0|||
48850641|NCT02404441|157292260|FG008|Phase 1 Part|Subject/Guardian Decision|0|||
48850642|NCT02404441|157292261|FG009|Phase 1 Part|Subject/Guardian Decision|0|||
48850643|NCT02404441|157292252|FG000|Phase 1 Part|Death|1|||
48945826|NCT01380093|157632989|FG007|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
48945827|NCT01380093|157632990|FG008|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
48850644|NCT02404441|157292253|FG001|Phase 1 Part|Death|1|||
48850645|NCT02404441|157292254|FG002|Phase 1 Part|Death|1|||
48850646|NCT02404441|157292255|FG003|Phase 1 Part|Death|0|||
48945828|NCT01380093|157632982|FG000|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
48850647|NCT02404441|157292256|FG004|Phase 1 Part|Death|1|||
48850648|NCT02404441|157292257|FG005|Phase 1 Part|Death|0|||
48850649|NCT02404441|157292258|FG006|Phase 1 Part|Death|0|||
48850650|NCT02404441|157292259|FG007|Phase 1 Part|Death|0|||
48850651|NCT02404441|157292260|FG008|Phase 1 Part|Death|0|||
48850652|NCT02404441|157292261|FG009|Phase 1 Part|Death|0|||
48850653|NCT02404441|157292252|FG000|Phase 2 Part|Adverse Event|0|||
48850654|NCT02404441|157292253|FG001|Phase 2 Part|Adverse Event|0|||
48850655|NCT02404441|157292254|FG002|Phase 2 Part|Adverse Event|0|||
48850656|NCT02404441|157292255|FG003|Phase 2 Part|Adverse Event|0|||
48850657|NCT02404441|157292256|FG004|Phase 2 Part|Adverse Event|0|||
48850658|NCT02404441|157292257|FG005|Phase 2 Part|Adverse Event|2|||
48850659|NCT02404441|157292258|FG006|Phase 2 Part|Adverse Event|3|||
48850660|NCT02404441|157292259|FG007|Phase 2 Part|Adverse Event|3|||
48736000|NCT01686828|156883755|FG003|Overall Study|Physician Decision|0|||
48736001|NCT01686828|156883752|FG000|Overall Study|New Job|0|||
48736002|NCT01686828|156883753|FG001|Overall Study|New Job|1|||
48736003|NCT01686828|156883754|FG002|Overall Study|New Job|0|||
48736004|NCT01686828|156883755|FG003|Overall Study|New Job|0|||
48736005|NCT01686828|156883752|FG000|Overall Study|Weight Loss|0|||
48736006|NCT01686828|156883753|FG001|Overall Study|Weight Loss|0|||
48736007|NCT01686828|156883754|FG002|Overall Study|Weight Loss|1|||
48736008|NCT01686828|156883755|FG003|Overall Study|Weight Loss|0|||
48736009|NCT01790932|156883757|FG000|Overall Study|Disease Progression|41|||
48850661|NCT02404441|157292260|FG008|Phase 2 Part|Adverse Event|6|||
48850662|NCT02404441|157292261|FG009|Phase 2 Part|Adverse Event|1|||
48736010|NCT01790932|156883757|FG000|Overall Study|Adverse Event|7|||
48736011|NCT01790932|156883757|FG000|Overall Study|Physician Decision|1|||
48736012|NCT01790932|156883757|FG000|Overall Study|Withdrawal by Subject|1|||
48736013|NCT00257608|156885621|FG000|Chemotherapy Phase|Adverse Event|138|||
48736014|NCT00257608|156885622|FG001|Chemotherapy Phase|Adverse Event|0|||
48736015|NCT00257608|156885623|FG002|Chemotherapy Phase|Adverse Event|0|||
48736016|NCT00257608|156885621|FG000|Chemotherapy Phase|Disease progression|139|||
48736017|NCT00257608|156885622|FG001|Chemotherapy Phase|Disease progression|0|||
48736018|NCT00257608|156885623|FG002|Chemotherapy Phase|Disease progression|0|||
48850663|NCT02404441|157292252|FG000|Phase 2 Part|Physician Decision|0|||
48736019|NCT00257608|156885621|FG000|Chemotherapy Phase|Unwillingness or inability to comply|6|||
48736020|NCT00257608|156885622|FG001|Chemotherapy Phase|Unwillingness or inability to comply|0|||
48736021|NCT00257608|156885623|FG002|Chemotherapy Phase|Unwillingness or inability to comply|0|||
48736022|NCT00257608|156885621|FG000|Chemotherapy Phase|Need for concomitant/ancillary therapy|27|||
48736023|NCT00257608|156885622|FG001|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
48850664|NCT02404441|157292253|FG001|Phase 2 Part|Physician Decision|0|||
48850665|NCT02404441|157292254|FG002|Phase 2 Part|Physician Decision|0|||
48850666|NCT02404441|157292255|FG003|Phase 2 Part|Physician Decision|0|||
48850667|NCT02404441|157292256|FG004|Phase 2 Part|Physician Decision|0|||
48850668|NCT02404441|157292257|FG005|Phase 2 Part|Physician Decision|7|||
48850669|NCT02404441|157292258|FG006|Phase 2 Part|Physician Decision|9|||
48850670|NCT02404441|157292259|FG007|Phase 2 Part|Physician Decision|2|||
48850671|NCT02404441|157292260|FG008|Phase 2 Part|Physician Decision|1|||
48850672|NCT02404441|157292261|FG009|Phase 2 Part|Physician Decision|3|||
48945829|NCT01380093|157632983|FG001|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
48945830|NCT01380093|157632984|FG002|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
48945831|NCT01380093|157632985|FG003|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
48945832|NCT01380093|157632986|FG004|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
48945833|NCT01380093|157632987|FG005|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
48945834|NCT01380093|157632988|FG006|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
48850673|NCT02404441|157292252|FG000|Phase 2 Part|Progressive disease|0|||
48850674|NCT02404441|157292253|FG001|Phase 2 Part|Progressive disease|0|||
48945835|NCT01380093|157632989|FG007|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
48736024|NCT00257608|156885623|FG002|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
48736025|NCT00257608|156885621|FG000|Chemotherapy Phase|Patient's decision to discontinue|35|||
48736026|NCT00257608|156885622|FG001|Chemotherapy Phase|Patient's decision to discontinue|0|||
48736027|NCT00257608|156885623|FG002|Chemotherapy Phase|Patient's decision to discontinue|0|||
48736028|NCT00257608|156885621|FG000|Chemotherapy Phase|Unrelated intercurrent illness|3|||
48736029|NCT00257608|156885622|FG001|Chemotherapy Phase|Unrelated intercurrent illness|0|||
48736030|NCT00257608|156885623|FG002|Chemotherapy Phase|Unrelated intercurrent illness|0|||
48736031|NCT00257608|156885621|FG000|Chemotherapy Phase|Physician Decision|28|||
48736032|NCT00257608|156885622|FG001|Chemotherapy Phase|Physician Decision|0|||
48736033|NCT00257608|156885623|FG002|Chemotherapy Phase|Physician Decision|0|||
48736034|NCT00257608|156885621|FG000|Post Chemotherapy Phase|Adverse Event|0|||
48736035|NCT00257608|156885622|FG001|Post Chemotherapy Phase|Adverse Event|34|||
48736036|NCT00257608|156885623|FG002|Post Chemotherapy Phase|Adverse Event|38|||
48736037|NCT00257608|156885621|FG000|Post Chemotherapy Phase|Disease progression|0|||
49015299|NCT03443869|157892139|FG001|Overall Study|Other|4|||
48736038|NCT00257608|156885622|FG001|Post Chemotherapy Phase|Disease progression|204|||
48736039|NCT00257608|156885623|FG002|Post Chemotherapy Phase|Disease progression|168|||
48850675|NCT02404441|157292254|FG002|Phase 2 Part|Progressive disease|0|||
48850676|NCT02404441|157292255|FG003|Phase 2 Part|Progressive disease|0|||
48850677|NCT02404441|157292256|FG004|Phase 2 Part|Progressive disease|0|||
48850678|NCT02404441|157292257|FG005|Phase 2 Part|Progressive disease|43|||
48850679|NCT02404441|157292258|FG006|Phase 2 Part|Progressive disease|32|||
48850680|NCT02404441|157292259|FG007|Phase 2 Part|Progressive disease|31|||
48850681|NCT02404441|157292260|FG008|Phase 2 Part|Progressive disease|39|||
48850682|NCT02404441|157292261|FG009|Phase 2 Part|Progressive disease|27|||
48850683|NCT02404441|157292252|FG000|Phase 2 Part|Subject/guardian decision|0|||
48850684|NCT02404441|157292253|FG001|Phase 2 Part|Subject/guardian decision|0|||
48850685|NCT02404441|157292254|FG002|Phase 2 Part|Subject/guardian decision|0|||
48850686|NCT02404441|157292255|FG003|Phase 2 Part|Subject/guardian decision|0|||
48850687|NCT02404441|157292256|FG004|Phase 2 Part|Subject/guardian decision|0|||
48850688|NCT02404441|157292257|FG005|Phase 2 Part|Subject/guardian decision|3|||
48850689|NCT02404441|157292258|FG006|Phase 2 Part|Subject/guardian decision|9|||
48945836|NCT01380093|157632990|FG008|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
48945837|NCT01380093|157632982|FG000|Drug Discrimination Phase: Day 2|Backup participant|0|||
48945838|NCT01380093|157632983|FG001|Drug Discrimination Phase: Day 2|Backup participant|0|||
48945839|NCT01380093|157632984|FG002|Drug Discrimination Phase: Day 2|Backup participant|1|||
48945840|NCT01380093|157632985|FG003|Drug Discrimination Phase: Day 2|Backup participant|0|||
48945841|NCT01380093|157632986|FG004|Drug Discrimination Phase: Day 2|Backup participant|0|||
48945842|NCT01380093|157632987|FG005|Drug Discrimination Phase: Day 2|Backup participant|0|||
48945843|NCT01380093|157632988|FG006|Drug Discrimination Phase: Day 2|Backup participant|0|||
48945844|NCT01380093|157632989|FG007|Drug Discrimination Phase: Day 2|Backup participant|0|||
48945845|NCT01380093|157632990|FG008|Drug Discrimination Phase: Day 2|Backup participant|0|||
48945846|NCT01380093|157632982|FG000|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
48945847|NCT01380093|157632983|FG001|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
48945848|NCT01380093|157632984|FG002|Drug Discrimination Phase: Day 2|Sponsor decision|1|||
48945849|NCT01380093|157632985|FG003|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
48945850|NCT01380093|157632986|FG004|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
48945851|NCT01380093|157632987|FG005|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
48945852|NCT01380093|157632988|FG006|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
48945853|NCT01380093|157632989|FG007|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
48850690|NCT02404441|157292259|FG007|Phase 2 Part|Subject/guardian decision|0|||
48850691|NCT02404441|157292260|FG008|Phase 2 Part|Subject/guardian decision|3|||
48850692|NCT02404441|157292261|FG009|Phase 2 Part|Subject/guardian decision|2|||
48850693|NCT02404441|157292252|FG000|Phase 2 Part|Death|0|||
48850694|NCT02404441|157292253|FG001|Phase 2 Part|Death|0|||
48850695|NCT02404441|157292254|FG002|Phase 2 Part|Death|0|||
48850696|NCT02404441|157292255|FG003|Phase 2 Part|Death|0|||
48945854|NCT01380093|157632990|FG008|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
48945855|NCT01380093|157632982|FG000|Treatment Phase: Second Intervention|Other|0|||
48945856|NCT01380093|157632983|FG001|Treatment Phase: Second Intervention|Other|0|||
48945857|NCT01380093|157632984|FG002|Treatment Phase: Second Intervention|Other|0|||
48945858|NCT01380093|157632985|FG003|Treatment Phase: Second Intervention|Other|1|||
48945859|NCT01380093|157632986|FG004|Treatment Phase: Second Intervention|Other|0|||
48945860|NCT01380093|157632987|FG005|Treatment Phase: Second Intervention|Other|0|||
48945861|NCT01380093|157632988|FG006|Treatment Phase: Second Intervention|Other|0|||
48945862|NCT01380093|157632989|FG007|Treatment Phase: Second Intervention|Other|0|||
48945863|NCT01380093|157632990|FG008|Treatment Phase: Second Intervention|Other|0|||
48945864|NCT01380093|157632982|FG000|Treatment Phase: Third Intervention|Non-compliance|0|||
48945865|NCT01380093|157632983|FG001|Treatment Phase: Third Intervention|Non-compliance|0|||
48945866|NCT01380093|157632984|FG002|Treatment Phase: Third Intervention|Non-compliance|0|||
48945867|NCT01380093|157632985|FG003|Treatment Phase: Third Intervention|Non-compliance|0|||
48945868|NCT01380093|157632986|FG004|Treatment Phase: Third Intervention|Non-compliance|0|||
48945869|NCT01380093|157632987|FG005|Treatment Phase: Third Intervention|Non-compliance|0|||
48945870|NCT01380093|157632988|FG006|Treatment Phase: Third Intervention|Non-compliance|0|||
48945871|NCT01380093|157632989|FG007|Treatment Phase: Third Intervention|Non-compliance|0|||
48945872|NCT01380093|157632990|FG008|Treatment Phase: Third Intervention|Non-compliance|1|||
48945873|NCT01380093|157632982|FG000|Treatment Phase: Third Intervention|Other|0|||
49015300|NCT00423800|157892140|FG000|Overall Study|Protocol Violation|0|||
48850697|NCT02404441|157292256|FG004|Phase 2 Part|Death|0|||
48850698|NCT02404441|157292257|FG005|Phase 2 Part|Death|4|||
48850699|NCT02404441|157292258|FG006|Phase 2 Part|Death|8|||
48850700|NCT02404441|157292259|FG007|Phase 2 Part|Death|4|||
48850701|NCT02404441|157292260|FG008|Phase 2 Part|Death|10|||
48850702|NCT02404441|157292261|FG009|Phase 2 Part|Death|9|||
48850703|NCT03205566|157292262|FG000|Phase 1|Protocol Violation|1|||
49015301|NCT00423800|157892141|FG001|Overall Study|Protocol Violation|1|||
48850704|NCT03205566|157292263|FG001|Phase 1|Protocol Violation|1|||
49015302|NCT01754259|157892142|FG000|Overall Study|Withdrawal by Subject|2|||
48850705|NCT03739866|157292264|FG000|Overall Study|Lost to Follow-up|0|||
48850706|NCT03739866|157292265|FG001|Overall Study|Lost to Follow-up|0|||
48850707|NCT03739866|157292266|FG002|Overall Study|Lost to Follow-up|0|||
48850708|NCT03739866|157292267|FG003|Overall Study|Lost to Follow-up|1|||
48850709|NCT03739866|157292268|FG004|Overall Study|Lost to Follow-up|0|||
48850710|NCT03739866|157292269|FG005|Overall Study|Lost to Follow-up|0|||
48850711|NCT03739866|157292270|FG006|Overall Study|Lost to Follow-up|0|||
48850712|NCT03739866|157292271|FG007|Overall Study|Lost to Follow-up|0|||
48850713|NCT03739866|157292264|FG000|Overall Study|Enrolled but not treated|0|||
48850714|NCT03739866|157292265|FG001|Overall Study|Enrolled but not treated|0|||
48850715|NCT03739866|157292266|FG002|Overall Study|Enrolled but not treated|1|||
48850716|NCT03739866|157292267|FG003|Overall Study|Enrolled but not treated|0|||
48850717|NCT03739866|157292268|FG004|Overall Study|Enrolled but not treated|1|||
48850718|NCT03739866|157292269|FG005|Overall Study|Enrolled but not treated|0|||
48850719|NCT03739866|157292270|FG006|Overall Study|Enrolled but not treated|0|||
48850720|NCT03739866|157292271|FG007|Overall Study|Enrolled but not treated|0|||
48850721|NCT00853580|157292272|FG000|Overall Study|Lost to Follow-up|3|||
48850722|NCT00853580|157292273|FG001|Overall Study|Lost to Follow-up|5|||
48850723|NCT00853580|157292272|FG000|Overall Study|Protocol Violation|2|||
48850724|NCT00853580|157292273|FG001|Overall Study|Protocol Violation|1|||
48850725|NCT00853580|157292272|FG000|Overall Study|Withdrawal by Subject|2|||
48850726|NCT00853580|157292273|FG001|Overall Study|Withdrawal by Subject|8|||
48850727|NCT00853580|157292272|FG000|Overall Study|Commenced contraindicated therapy|0|||
48850728|NCT00853580|157292273|FG001|Overall Study|Commenced contraindicated therapy|2|||
48850729|NCT01767467|157292274|FG000|Vaccination Phase (up to Month 2)|Adverse Event|8|||
48850730|NCT01767467|157292275|FG001|Vaccination Phase (up to Month 2)|Adverse Event|8|||
48850731|NCT01767467|157292274|FG000|Vaccination Phase (up to Month 2)|Protocol Violation|1|||
48850732|NCT01767467|157292275|FG001|Vaccination Phase (up to Month 2)|Protocol Violation|0|||
48850733|NCT01767467|157292274|FG000|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7|||
48850734|NCT01767467|157292275|FG001|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10|||
48850735|NCT01767467|157292274|FG000|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0|||
48850736|NCT01767467|157292275|FG001|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1|||
48850737|NCT01767467|157292274|FG000|Vaccination Phase (up to Month 2)|Physician Decision|1|||
48850738|NCT01767467|157292275|FG001|Vaccination Phase (up to Month 2)|Physician Decision|0|||
48850739|NCT01767467|157292274|FG000|Vaccination Phase (up to Month 2)|Subject unavailable|0|||
48850740|NCT01767467|157292275|FG001|Vaccination Phase (up to Month 2)|Subject unavailable|1|||
48850741|NCT01767467|157292274|FG000|End of Study Phase (up to Month 13)|Adverse Event|29|||
48850742|NCT01767467|157292275|FG001|End of Study Phase (up to Month 13)|Adverse Event|39|||
48850743|NCT01767467|157292274|FG000|End of Study Phase (up to Month 13)|Protocol Violation|2|||
48850744|NCT01767467|157292275|FG001|End of Study Phase (up to Month 13)|Protocol Violation|0|||
48850745|NCT01767467|157292274|FG000|End of Study Phase (up to Month 13)|Withdrawal by Subject|9|||
48945874|NCT01380093|157632983|FG001|Treatment Phase: Third Intervention|Other|0|||
48945875|NCT01380093|157632984|FG002|Treatment Phase: Third Intervention|Other|0|||
48945876|NCT01380093|157632985|FG003|Treatment Phase: Third Intervention|Other|0|||
48945877|NCT01380093|157632986|FG004|Treatment Phase: Third Intervention|Other|0|||
48945878|NCT01380093|157632987|FG005|Treatment Phase: Third Intervention|Other|0|||
48945879|NCT01380093|157632988|FG006|Treatment Phase: Third Intervention|Other|0|||
48945880|NCT01380093|157632989|FG007|Treatment Phase: Third Intervention|Other|0|||
48945881|NCT01380093|157632990|FG008|Treatment Phase: Third Intervention|Other|1|||
48945882|NCT00091793|157632991|FG000|Overall Study|Adverse Event|1|||
48945883|NCT00091793|157632992|FG001|Overall Study|Adverse Event|2|||
48945884|NCT00091793|157632991|FG000|Overall Study|Withdrawal by Subject|10|||
48945885|NCT00091793|157632992|FG001|Overall Study|Withdrawal by Subject|15|||
48945886|NCT00091793|157632991|FG000|Overall Study|Ineligibility determined|2|||
48736040|NCT00257608|156885621|FG000|Post Chemotherapy Phase|Unwillingness or inability to comply|0|||
48945887|NCT00091793|157632992|FG001|Overall Study|Ineligibility determined|0|||
48945888|NCT00091793|157632991|FG000|Overall Study|Lost to Follow-up|7|||
48945889|NCT00091793|157632992|FG001|Overall Study|Lost to Follow-up|5|||
48945890|NCT00091793|157632991|FG000|Overall Study|Noncompliance|2|||
48945891|NCT00091793|157632992|FG001|Overall Study|Noncompliance|0|||
48945892|NCT00091793|157632991|FG000|Overall Study|Other|2|||
48945893|NCT00091793|157632992|FG001|Overall Study|Other|0|||
48945894|NCT01025336|157632996|FG000|Overall Study|Protocol Violation|0|||
48945895|NCT01025336|157632997|FG001|Overall Study|Protocol Violation|0|||
48945896|NCT01025336|157632998|FG002|Overall Study|Protocol Violation|0|||
48945897|NCT01025336|157632999|FG003|Overall Study|Protocol Violation|2|||
48945898|NCT01025336|157633000|FG004|Overall Study|Protocol Violation|0|||
48945899|NCT00474253|157633008|FG000|Overall Study|Withdrew consent|2|||
48945900|NCT00474253|157633009|FG001|Overall Study|Withdrew consent|0|||
48945901|NCT00474253|157633008|FG000|Overall Study|Withdrew due to surgery-related issues|0|||
48945902|NCT00474253|157633009|FG001|Overall Study|Withdrew due to surgery-related issues|3|||
48945903|NCT00474253|157633008|FG000|Overall Study|Lost to Follow-up|1|||
48945904|NCT00474253|157633009|FG001|Overall Study|Lost to Follow-up|0|||
48945905|NCT00474253|157633008|FG000|Overall Study|Discharged prior to study completion|0|||
48945906|NCT00474253|157633009|FG001|Overall Study|Discharged prior to study completion|1|||
48945907|NCT01359982|157633010|FG000|Overall Study|Adverse Event|2|||
48945908|NCT01359982|157633011|FG001|Overall Study|Adverse Event|0|||
48945909|NCT01359982|157633012|FG002|Overall Study|Adverse Event|0|||
48945910|NCT01359982|157633013|FG003|Overall Study|Adverse Event|1|||
48945911|NCT01359982|157633014|FG004|Overall Study|Adverse Event|0|||
48945912|NCT01359982|157633015|FG005|Overall Study|Adverse Event|0|||
48945913|NCT01359982|157633010|FG000|Overall Study|Death|1|||
48945914|NCT01359982|157633011|FG001|Overall Study|Death|0|||
48945915|NCT01359982|157633012|FG002|Overall Study|Death|0|||
48945916|NCT01359982|157633013|FG003|Overall Study|Death|0|||
48945917|NCT01359982|157633014|FG004|Overall Study|Death|0|||
48945918|NCT01359982|157633015|FG005|Overall Study|Death|0|||
48945919|NCT01450137|157633017|FG000|Up to Week 12|Adverse Event|2|||
48945920|NCT01450137|157633018|FG001|Up to Week 12|Adverse Event|1|||
48945921|NCT01450137|157633017|FG000|Up to Week 12|Withdrawal by Subject|0|||
48850746|NCT01767467|157292275|FG001|End of Study Phase (up to Month 13)|Withdrawal by Subject|14|||
48850747|NCT01767467|157292274|FG000|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0|||
48850748|NCT01767467|157292275|FG001|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3|||
48850749|NCT01767467|157292274|FG000|End of Study Phase (up to Month 13)|Lost to Follow-up|6|||
48850750|NCT01767467|157292275|FG001|End of Study Phase (up to Month 13)|Lost to Follow-up|4|||
48850751|NCT01767467|157292274|FG000|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0|||
48850752|NCT01767467|157292275|FG001|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1|||
48850753|NCT01767467|157292274|FG000|End of Study Phase (up to Month 13)|Physician Decision|1|||
48850754|NCT01767467|157292275|FG001|End of Study Phase (up to Month 13)|Physician Decision|0|||
48850755|NCT01767467|157292274|FG000|End of Study Phase (up to Month 13)|Subject Unavailable|0|||
48850756|NCT01767467|157292275|FG001|End of Study Phase (up to Month 13)|Subject Unavailable|2|||
48850757|NCT02022670|157292276|FG000|Overall Study|Adverse Event|1|||
48850758|NCT02022670|157292277|FG001|Overall Study|Adverse Event|0|||
48850759|NCT02022670|157292278|FG002|Overall Study|Adverse Event|1|||
48850760|NCT01536093|157292279|FG000|Overall Study|Death|1|||
48850761|NCT01536093|157292280|FG001|Overall Study|Death|2|||
48850762|NCT01536093|157292279|FG000|Overall Study|absence of maternal colostrum|2|||
48850763|NCT01536093|157292280|FG001|Overall Study|absence of maternal colostrum|0|||
48850764|NCT01536093|157292279|FG000|Overall Study|Withdrawal by Subject|0|||
48850765|NCT01536093|157292280|FG001|Overall Study|Withdrawal by Subject|1|||
48850766|NCT03861234|157292281|FG000|Overall Study|Not treated|0|||
48850767|NCT03861234|157292282|FG001|Overall Study|Not treated|0|||
48850768|NCT03861234|157292283|FG002|Overall Study|Not treated|0|||
48945922|NCT01450137|157633018|FG001|Up to Week 12|Withdrawal by Subject|2|||
48945923|NCT01450137|157633017|FG000|Week 12 to Study End|Death|0|||
48945924|NCT01450137|157633018|FG001|Week 12 to Study End|Death|1|||
48945925|NCT01450137|157633017|FG000|Week 12 to Study End|Withdrawal by Subject|0|||
48945926|NCT01450137|157633018|FG001|Week 12 to Study End|Withdrawal by Subject|1|||
48945927|NCT01158950|157633023|FG000|1st Intervention (1 Day)|Physician Decision|1|||
48945928|NCT01158950|157633024|FG001|1st Intervention (1 Day)|Physician Decision|2|||
48945929|NCT02263365|157633025|FG000|Overall Study|Physician Decision|22|||
48945930|NCT02263365|157633026|FG001|Overall Study|Physician Decision|18|||
48945931|NCT02190591|157633029|FG000|Overall Study|Withdrawal by Subject|1|||
48945932|NCT02190591|157633030|FG001|Overall Study|Withdrawal by Subject|8|||
48945933|NCT02190591|157633029|FG000|Overall Study|Protocol Violation|1|||
48945934|NCT02190591|157633030|FG001|Overall Study|Protocol Violation|0|||
48945935|NCT02190591|157633029|FG000|Overall Study|did not use peanut ball as instructed|0|||
48945936|NCT02190591|157633030|FG001|Overall Study|did not use peanut ball as instructed|2|||
48945937|NCT02190591|157633029|FG000|Overall Study|face presentation so she was ineligible|0|||
48945938|NCT02190591|157633030|FG001|Overall Study|face presentation so she was ineligible|1|||
48945939|NCT00206518|157633031|FG000|Overall Study|Lack of Efficacy|6|||
48945940|NCT00206518|157633032|FG001|Overall Study|Lack of Efficacy|4|||
48945941|NCT00206518|157633031|FG000|Overall Study|Adverse Event|2|||
48945942|NCT00206518|157633032|FG001|Overall Study|Adverse Event|1|||
48945943|NCT00206518|157633031|FG000|Overall Study|Physician Decision|1|||
48945944|NCT00206518|157633032|FG001|Overall Study|Physician Decision|0|||
48945945|NCT00206518|157633031|FG000|Overall Study|Protocol Violation|1|||
48945946|NCT00206518|157633032|FG001|Overall Study|Protocol Violation|1|||
49015303|NCT01754259|157892143|FG001|Overall Study|Withdrawal by Subject|4|||
48850769|NCT03861234|157292284|FG003|Overall Study|Not treated|0|||
48850770|NCT03861234|157292285|FG004|Overall Study|Not treated|0|||
48850771|NCT03861234|157292286|FG005|Overall Study|Not treated|1|||
48850772|NCT03861234|157292287|FG006|Overall Study|Not treated|0|||
48850773|NCT03861234|157292288|FG007|Overall Study|Not treated|0|||
48850774|NCT03861234|157292281|FG000|Overall Study|Adverse Event|0|||
48850775|NCT03861234|157292282|FG001|Overall Study|Adverse Event|0|||
48850776|NCT03861234|157292283|FG002|Overall Study|Adverse Event|0|||
48850777|NCT03861234|157292284|FG003|Overall Study|Adverse Event|0|||
48850778|NCT03861234|157292285|FG004|Overall Study|Adverse Event|0|||
48945947|NCT03598777|157633033|FG000|Overall Study|Study Terminated by Sponsor|3|||
48945948|NCT03598777|157633034|FG001|Overall Study|Study Terminated by Sponsor|0|||
48945949|NCT03598777|157633035|FG002|Overall Study|Study Terminated by Sponsor|0|||
48945950|NCT03598777|157633036|FG003|Overall Study|Study Terminated by Sponsor|0|||
48945951|NCT03598777|157633037|FG004|Overall Study|Study Terminated by Sponsor|15|||
48945952|NCT03598777|157633033|FG000|Overall Study|Withdrawal by Subject|1|||
48945953|NCT03598777|157633034|FG001|Overall Study|Withdrawal by Subject|1|||
48945954|NCT03598777|157633035|FG002|Overall Study|Withdrawal by Subject|0|||
48945955|NCT03598777|157633036|FG003|Overall Study|Withdrawal by Subject|0|||
48945956|NCT03598777|157633037|FG004|Overall Study|Withdrawal by Subject|0|||
48945957|NCT03598777|157633033|FG000|Overall Study|Adverse Event|1|||
48945958|NCT03598777|157633034|FG001|Overall Study|Adverse Event|0|||
48850779|NCT03861234|157292286|FG005|Overall Study|Adverse Event|1|||
48850780|NCT03861234|157292287|FG006|Overall Study|Adverse Event|0|||
48850781|NCT03861234|157292288|FG007|Overall Study|Adverse Event|0|||
48850782|NCT03861234|157292281|FG000|Overall Study|Study medication discontinued due to safety notification|0|||
48850783|NCT03861234|157292282|FG001|Overall Study|Study medication discontinued due to safety notification|0|||
48850784|NCT03861234|157292283|FG002|Overall Study|Study medication discontinued due to safety notification|0|||
48850785|NCT03861234|157292284|FG003|Overall Study|Study medication discontinued due to safety notification|0|||
48850786|NCT03861234|157292285|FG004|Overall Study|Study medication discontinued due to safety notification|0|||
48850787|NCT03861234|157292286|FG005|Overall Study|Study medication discontinued due to safety notification|1|||
48850788|NCT03861234|157292287|FG006|Overall Study|Study medication discontinued due to safety notification|0|||
48850789|NCT03861234|157292288|FG007|Overall Study|Study medication discontinued due to safety notification|0|||
48850790|NCT03861234|157292281|FG000|Overall Study|As per sponsor decision|0|||
48850791|NCT03861234|157292282|FG001|Overall Study|As per sponsor decision|0|||
48945959|NCT03598777|157633035|FG002|Overall Study|Adverse Event|0|||
48945960|NCT03598777|157633036|FG003|Overall Study|Adverse Event|0|||
48945961|NCT03598777|157633037|FG004|Overall Study|Adverse Event|0|||
48945962|NCT03598777|157633033|FG000|Overall Study|Lost to Follow-up|1|||
48736041|NCT00257608|156885622|FG001|Post Chemotherapy Phase|Unwillingness or inability to comply|4|||
48945963|NCT03598777|157633034|FG001|Overall Study|Lost to Follow-up|0|||
48945964|NCT03598777|157633035|FG002|Overall Study|Lost to Follow-up|0|||
48945965|NCT03598777|157633036|FG003|Overall Study|Lost to Follow-up|0|||
48945966|NCT03598777|157633037|FG004|Overall Study|Lost to Follow-up|0|||
48945967|NCT00072189|157633038|FG000|Overall Study|Withdrawal by Subject|1|||
48945968|NCT01933672|157633039|FG000|Metformin Run-in Period|Adverse Event|1|||
48945969|NCT01933672|157633040|FG001|Metformin Run-in Period|Adverse Event|0|||
48945970|NCT01933672|157633041|FG002|Metformin Run-in Period|Adverse Event|0|||
48945971|NCT01933672|157633042|FG003|Metformin Run-in Period|Adverse Event|0|||
48945972|NCT01933672|157633043|FG004|Metformin Run-in Period|Adverse Event|0|||
48945973|NCT01933672|157633044|FG005|Metformin Run-in Period|Adverse Event|0|||
48945974|NCT01933672|157633045|FG006|Metformin Run-in Period|Adverse Event|0|||
48945975|NCT01933672|157633039|FG000|Metformin Run-in Period|No longer meets eligibility criteria|4|||
48945976|NCT01933672|157633040|FG001|Metformin Run-in Period|No longer meets eligibility criteria|0|||
48736042|NCT00257608|156885623|FG002|Post Chemotherapy Phase|Unwillingness or inability to comply|5|||
48945977|NCT01933672|157633041|FG002|Metformin Run-in Period|No longer meets eligibility criteria|0|||
48945978|NCT01933672|157633042|FG003|Metformin Run-in Period|No longer meets eligibility criteria|0|||
49015304|NCT01754259|157892142|FG000|Overall Study|Adverse Event|3|||
48945979|NCT01933672|157633043|FG004|Metformin Run-in Period|No longer meets eligibility criteria|0|||
48945980|NCT01933672|157633044|FG005|Metformin Run-in Period|No longer meets eligibility criteria|0|||
48945981|NCT01933672|157633045|FG006|Metformin Run-in Period|No longer meets eligibility criteria|0|||
48945982|NCT01933672|157633039|FG000|Metformin Run-in Period|Other|5|||
48945983|NCT01933672|157633040|FG001|Metformin Run-in Period|Other|0|||
48945984|NCT01933672|157633041|FG002|Metformin Run-in Period|Other|0|||
48945985|NCT01933672|157633042|FG003|Metformin Run-in Period|Other|0|||
48945986|NCT01933672|157633043|FG004|Metformin Run-in Period|Other|0|||
48945987|NCT01933672|157633044|FG005|Metformin Run-in Period|Other|0|||
48945988|NCT01933672|157633045|FG006|Metformin Run-in Period|Other|0|||
48945989|NCT01933672|157633039|FG000|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
48945990|NCT01933672|157633040|FG001|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
48945991|NCT01933672|157633041|FG002|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
48945992|NCT01933672|157633042|FG003|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
48945993|NCT01933672|157633043|FG004|First Intervention Period (12-16 Days)|Lost to Follow-up|1|||
48945994|NCT01933672|157633044|FG005|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
48945995|NCT01933672|157633045|FG006|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
48945996|NCT01933672|157633039|FG000|First Intervention Period (12-16 Days)|Other|0|||
48945997|NCT01933672|157633040|FG001|First Intervention Period (12-16 Days)|Other|0|||
48945998|NCT01933672|157633041|FG002|First Intervention Period (12-16 Days)|Other|1|||
48945999|NCT01933672|157633042|FG003|First Intervention Period (12-16 Days)|Other|0|||
48946000|NCT01933672|157633043|FG004|First Intervention Period (12-16 Days)|Other|0|||
48946001|NCT01933672|157633044|FG005|First Intervention Period (12-16 Days)|Other|1|||
48946002|NCT01933672|157633045|FG006|First Intervention Period (12-16 Days)|Other|0|||
48946003|NCT01933672|157633039|FG000|Second Intervention Period (12-16 Days)|Other|0|||
48946004|NCT01933672|157633040|FG001|Second Intervention Period (12-16 Days)|Other|1|||
48946005|NCT01933672|157633041|FG002|Second Intervention Period (12-16 Days)|Other|1|||
48946006|NCT01933672|157633042|FG003|Second Intervention Period (12-16 Days)|Other|0|||
48946007|NCT01933672|157633043|FG004|Second Intervention Period (12-16 Days)|Other|0|||
48946008|NCT01933672|157633044|FG005|Second Intervention Period (12-16 Days)|Other|0|||
48946009|NCT01933672|157633045|FG006|Second Intervention Period (12-16 Days)|Other|0|||
48946010|NCT01933672|157633039|FG000|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
48946011|NCT01933672|157633040|FG001|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
48946012|NCT01933672|157633041|FG002|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
48946013|NCT01933672|157633042|FG003|Third Intervention Period (12-16 Days)|Lost to Follow-up|1|||
48946014|NCT01933672|157633043|FG004|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
48946015|NCT01933672|157633044|FG005|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
48946016|NCT01933672|157633045|FG006|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
48946017|NCT01933672|157633039|FG000|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
48946018|NCT01933672|157633040|FG001|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1|||
48946019|NCT01933672|157633041|FG002|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
48946020|NCT01933672|157633042|FG003|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
48946021|NCT01933672|157633043|FG004|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
48946022|NCT01933672|157633044|FG005|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
48946023|NCT01933672|157633045|FG006|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
48946024|NCT01089725|157633048|FG000|Overall Study|Adverse Event|1|||
48946025|NCT01089725|157633049|FG001|Overall Study|Adverse Event|1|||
48946026|NCT01089725|157633050|FG002|Overall Study|Adverse Event|0|||
48946027|NCT01089725|157633051|FG003|Overall Study|Adverse Event|0|||
48946028|NCT01089725|157633052|FG004|Overall Study|Adverse Event|2|||
48946029|NCT01089725|157633048|FG000|Overall Study|Lack of Efficacy|4|||
48946030|NCT01089725|157633049|FG001|Overall Study|Lack of Efficacy|3|||
48946031|NCT01089725|157633050|FG002|Overall Study|Lack of Efficacy|1|||
48946032|NCT01089725|157633051|FG003|Overall Study|Lack of Efficacy|0|||
48946033|NCT01089725|157633052|FG004|Overall Study|Lack of Efficacy|4|||
48946034|NCT01089725|157633048|FG000|Overall Study|Lost to Follow-up|2|||
48946035|NCT01089725|157633049|FG001|Overall Study|Lost to Follow-up|2|||
48946036|NCT01089725|157633050|FG002|Overall Study|Lost to Follow-up|0|||
48946037|NCT01089725|157633051|FG003|Overall Study|Lost to Follow-up|3|||
48946038|NCT01089725|157633052|FG004|Overall Study|Lost to Follow-up|0|||
48946039|NCT01089725|157633048|FG000|Overall Study|Protocol Violation|0|||
48946040|NCT01089725|157633049|FG001|Overall Study|Protocol Violation|0|||
48946041|NCT01089725|157633050|FG002|Overall Study|Protocol Violation|1|||
48946042|NCT01089725|157633051|FG003|Overall Study|Protocol Violation|1|||
48946043|NCT01089725|157633052|FG004|Overall Study|Protocol Violation|0|||
48946044|NCT01089725|157633048|FG000|Overall Study|Withdrawal by Subject|5|||
48946045|NCT01089725|157633049|FG001|Overall Study|Withdrawal by Subject|5|||
48946046|NCT01089725|157633050|FG002|Overall Study|Withdrawal by Subject|4|||
48946047|NCT01089725|157633051|FG003|Overall Study|Withdrawal by Subject|5|||
48946048|NCT01089725|157633052|FG004|Overall Study|Withdrawal by Subject|4|||
48946049|NCT01089725|157633048|FG000|Overall Study|Study Terminated by Sponsor|51|||
48946050|NCT01089725|157633049|FG001|Overall Study|Study Terminated by Sponsor|56|||
48946051|NCT01089725|157633050|FG002|Overall Study|Study Terminated by Sponsor|53|||
48946052|NCT01089725|157633051|FG003|Overall Study|Study Terminated by Sponsor|68|||
48946053|NCT01089725|157633052|FG004|Overall Study|Study Terminated by Sponsor|68|||
48946054|NCT01089725|157633048|FG000|Overall Study|Randomized, but not treated|0|||
48946055|NCT01089725|157633049|FG001|Overall Study|Randomized, but not treated|1|||
48946056|NCT01089725|157633050|FG002|Overall Study|Randomized, but not treated|2|||
48946057|NCT01089725|157633051|FG003|Overall Study|Randomized, but not treated|1|||
48946058|NCT01089725|157633052|FG004|Overall Study|Randomized, but not treated|2|||
48946059|NCT01089725|157633048|FG000|Overall Study|Other|3|||
48946060|NCT01089725|157633049|FG001|Overall Study|Other|0|||
48946061|NCT01089725|157633050|FG002|Overall Study|Other|0|||
48946062|NCT01089725|157633051|FG003|Overall Study|Other|1|||
48946063|NCT01089725|157633052|FG004|Overall Study|Other|0|||
48946064|NCT01676116|157633053|FG000|Overall Study|Withdrawal criteria|2|||
48946065|NCT01676116|157633054|FG001|Overall Study|Withdrawal criteria|14|||
48946066|NCT01676116|157633053|FG000|Overall Study|Adverse Event|1|||
48946067|NCT01676116|157633054|FG001|Overall Study|Adverse Event|2|||
48946068|NCT01676116|157633053|FG000|Overall Study|Unclassified|4|||
48946069|NCT01676116|157633054|FG001|Overall Study|Unclassified|10|||
48946070|NCT01676116|157633053|FG000|Overall Study|Protocol Violation|9|||
48946071|NCT01676116|157633054|FG001|Overall Study|Protocol Violation|3|||
48946072|NCT01787591|157633059|FG000|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
48946073|NCT01787591|157633060|FG001|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
48946074|NCT01787591|157633061|FG002|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
48946075|NCT01787591|157633062|FG003|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1|||
48946076|NCT02124798|157633064|FG000|Overall Study|Adverse Event|3|||
48946077|NCT02124798|157633064|FG000|Overall Study|Lost to Follow-up|1|||
48946078|NCT00907738|157633069|FG000|Overall Study|Adverse Event|2|||
48946079|NCT00907738|157633070|FG001|Overall Study|Adverse Event|0|||
48946080|NCT00907738|157633071|FG002|Overall Study|Adverse Event|1|||
48946081|NCT00907738|157633072|FG003|Overall Study|Adverse Event|0|||
48946082|NCT00907738|157633073|FG004|Overall Study|Adverse Event|0|||
48946083|NCT00907738|157633069|FG000|Overall Study|not specified or withdrew consent|3|||
48946084|NCT00907738|157633070|FG001|Overall Study|not specified or withdrew consent|0|||
48946085|NCT00907738|157633071|FG002|Overall Study|not specified or withdrew consent|0|||
48946086|NCT00907738|157633072|FG003|Overall Study|not specified or withdrew consent|0|||
48946087|NCT00907738|157633073|FG004|Overall Study|not specified or withdrew consent|0|||
48946088|NCT00907738|157633069|FG000|Overall Study|Disease progression|8|||
48946089|NCT00907738|157633070|FG001|Overall Study|Disease progression|1|||
48946090|NCT00907738|157633071|FG002|Overall Study|Disease progression|6|||
48946091|NCT00907738|157633072|FG003|Overall Study|Disease progression|4|||
48946092|NCT00907738|157633073|FG004|Overall Study|Disease progression|2|||
48946093|NCT02032875|157633078|FG000|Treatment Period|Adverse Event|1|||
48946094|NCT02032875|157633079|FG001|Treatment Period|Adverse Event|0|||
48946095|NCT02032875|157633078|FG000|Treatment Period|Liver transplant, No extension needed|0|||
48946096|NCT02032875|157633079|FG001|Treatment Period|Liver transplant, No extension needed|1|||
48946097|NCT02032875|157633078|FG000|Treatment Period|Liver transplant, Treatment extension|0|||
48946098|NCT02032875|157633079|FG001|Treatment Period|Liver transplant, Treatment extension|3|||
48946099|NCT02032875|157633078|FG000|Follow-up Period|Death|0|||
48946100|NCT02032875|157633079|FG001|Follow-up Period|Death|1|||
48946101|NCT02032875|157633078|FG000|Follow-up Period|Virologic Relapse|3|||
48946102|NCT02032875|157633079|FG001|Follow-up Period|Virologic Relapse|10|||
48946103|NCT01707147|157633080|FG000|Overall Study|Administered Trajenta prior to contract|5|||
48946104|NCT01707147|157633080|FG000|Overall Study|Patients who have not taken Trajenta|1|||
48946105|NCT01707147|157633080|FG000|Overall Study|Follow-up failure|17|||
48946106|NCT01707147|157633080|FG000|Overall Study|Violated inclusion/exclusion criteria|77|||
48946107|NCT00793585|157633081|FG000|Overall Study|Adverse Event|1|||
48946108|NCT00793585|157633082|FG001|Overall Study|Adverse Event|1|||
48946109|NCT00793585|157633081|FG000|Overall Study|Protocol Violation|1|||
48946110|NCT00793585|157633082|FG001|Overall Study|Protocol Violation|2|||
48946111|NCT02903511|157633083|FG000|Overall Study|Withdrawal by Subject|1|||
48946112|NCT02903511|157633084|FG001|Overall Study|Withdrawal by Subject|0|||
48946113|NCT02903511|157633083|FG000|Overall Study|Lost to Follow-up|3|||
48946114|NCT02903511|157633084|FG001|Overall Study|Lost to Follow-up|2|||
48946115|NCT02707757|157633085|FG000|Overall Study|Protocol Violation|3|||
48946116|NCT02707757|157633086|FG001|Overall Study|Protocol Violation|2|||
48946117|NCT02707757|157633085|FG000|Overall Study|Withdrawal by Subject|2|||
48946118|NCT02707757|157633086|FG001|Overall Study|Withdrawal by Subject|0|||
48946119|NCT02707757|157633085|FG000|Overall Study|Death|0|||
48946120|NCT02707757|157633086|FG001|Overall Study|Death|1|||
48946121|NCT02707757|157633085|FG000|Overall Study|Adverse Event|6|||
48946122|NCT02707757|157633086|FG001|Overall Study|Adverse Event|4|||
48946123|NCT02707757|157633085|FG000|Overall Study|Renal transplant/elective operation|1|||
48946124|NCT02707757|157633086|FG001|Overall Study|Renal transplant/elective operation|5|||
48946125|NCT01056523|157633087|FG000|Overall Study|Death|1|||
48946126|NCT01056523|157633088|FG001|Overall Study|Death|0|||
48946127|NCT01056523|157633089|FG002|Overall Study|Death|2|||
48946128|NCT01056523|157633090|FG003|Overall Study|Death|3|||
48946129|NCT01056523|157633091|FG004|Overall Study|Death|0|||
48946130|NCT01056523|157633092|FG005|Overall Study|Death|0|||
48946131|NCT01056523|157633093|FG006|Overall Study|Death|1|||
48946132|NCT00815308|157633094|FG000|Overall Study|Adverse Event|4|||
48946133|NCT00815308|157633094|FG000|Overall Study|Withdrawal by Subject|0|||
48946134|NCT00815308|157633094|FG000|Overall Study|Protocol Violation|6|||
48946135|NCT04024228|157634638|FG000|Overall Study|Adverse Event|1|||
48946136|NCT04024228|157634639|FG001|Overall Study|Adverse Event|0|||
48946137|NCT04024228|157634638|FG000|Overall Study|Protocol Deviation|0|||
48946138|NCT04024228|157634639|FG001|Overall Study|Protocol Deviation|2|||
49015305|NCT01754259|157892143|FG001|Overall Study|Adverse Event|1|||
48946139|NCT04024228|157634638|FG000|Overall Study|Withdrawal by Subject|3|||
48946140|NCT04024228|157634639|FG001|Overall Study|Withdrawal by Subject|4|||
48946141|NCT03937986|157634640|FG000|Overall Study|COVID-19 Pandemic|1|||
48946142|NCT03199911|157634641|FG000|Overall Study|Lost to Follow-up|5|||
48946143|NCT03199911|157634642|FG001|Overall Study|Lost to Follow-up|5|||
48946144|NCT03199911|157634641|FG000|Overall Study|Did not proceed with surgery|2|||
48946145|NCT03199911|157634642|FG001|Overall Study|Did not proceed with surgery|1|||
48946146|NCT03060577|157634643|FG000|Overall Study|Withdrawal by Subject|25|||
48946147|NCT03060577|157634644|FG001|Overall Study|Withdrawal by Subject|5|||
48946148|NCT03060577|157634643|FG000|Overall Study|Physician Decision|4|||
48946149|NCT03060577|157634644|FG001|Overall Study|Physician Decision|3|||
48946150|NCT03060577|157634643|FG000|Overall Study|Lost to Follow-up|3|||
48946151|NCT03060577|157634644|FG001|Overall Study|Lost to Follow-up|0|||
48946152|NCT03060577|157634643|FG000|Overall Study|Death|7|||
48946153|NCT03060577|157634644|FG001|Overall Study|Death|1|||
48946154|NCT03060577|157634643|FG000|Overall Study|Adverse Event|9|||
48946155|NCT03060577|157634644|FG001|Overall Study|Adverse Event|1|||
48946156|NCT03060577|157634643|FG000|Overall Study|Inclusion/Exclusion|1|||
48946157|NCT03060577|157634644|FG001|Overall Study|Inclusion/Exclusion|0|||
48946158|NCT03060577|157634643|FG000|Overall Study|Other|8|||
48946159|NCT03060577|157634644|FG001|Overall Study|Other|2|||
48946160|NCT02333331|157634645|FG000|Overall Study|Adverse Event|1|||
48946161|NCT02333331|157634646|FG001|Overall Study|Adverse Event|0|||
48946162|NCT02333331|157634647|FG002|Overall Study|Adverse Event|4|||
48946163|NCT02333331|157634648|FG003|Overall Study|Adverse Event|1|||
48946164|NCT02333331|157634645|FG000|Overall Study|Death|0|||
48946165|NCT02333331|157634646|FG001|Overall Study|Death|0|||
48946166|NCT02333331|157634647|FG002|Overall Study|Death|2|||
48946167|NCT02333331|157634648|FG003|Overall Study|Death|0|||
48946168|NCT02333331|157634645|FG000|Overall Study|Lost to Follow-up|0|||
48946169|NCT02333331|157634646|FG001|Overall Study|Lost to Follow-up|0|||
48946170|NCT02333331|157634647|FG002|Overall Study|Lost to Follow-up|1|||
48946171|NCT02333331|157634648|FG003|Overall Study|Lost to Follow-up|0|||
48946172|NCT02333331|157634645|FG000|Overall Study|Physician Decision|0|||
48946173|NCT02333331|157634646|FG001|Overall Study|Physician Decision|1|||
48850792|NCT03861234|157292283|FG002|Overall Study|As per sponsor decision|0|||
48850793|NCT03861234|157292284|FG003|Overall Study|As per sponsor decision|0|||
48850794|NCT03861234|157292285|FG004|Overall Study|As per sponsor decision|0|||
48850795|NCT03861234|157292286|FG005|Overall Study|As per sponsor decision|0|||
48946174|NCT02333331|157634647|FG002|Overall Study|Physician Decision|0|||
48736043|NCT00257608|156885621|FG000|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
48736044|NCT00257608|156885622|FG001|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
48736045|NCT00257608|156885623|FG002|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
48736046|NCT00257608|156885621|FG000|Post Chemotherapy Phase|Patient's decision to discontinue|0|||
48850796|NCT03861234|157292287|FG006|Overall Study|As per sponsor decision|1|||
48850797|NCT03861234|157292288|FG007|Overall Study|As per sponsor decision|0|||
48850798|NCT03861234|157292281|FG000|Overall Study|IMP on hold as per sponsor instructions|0|||
48850799|NCT03861234|157292282|FG001|Overall Study|IMP on hold as per sponsor instructions|0|||
48850800|NCT03861234|157292283|FG002|Overall Study|IMP on hold as per sponsor instructions|0|||
48850801|NCT03861234|157292284|FG003|Overall Study|IMP on hold as per sponsor instructions|0|||
48850802|NCT03861234|157292285|FG004|Overall Study|IMP on hold as per sponsor instructions|0|||
48946175|NCT02333331|157634648|FG003|Overall Study|Physician Decision|0|||
48946176|NCT02333331|157634645|FG000|Overall Study|Protocol Deviation|0|||
48946177|NCT02333331|157634646|FG001|Overall Study|Protocol Deviation|3|||
48946178|NCT02333331|157634647|FG002|Overall Study|Protocol Deviation|2|||
48946179|NCT02333331|157634648|FG003|Overall Study|Protocol Deviation|1|||
48946180|NCT02333331|157634645|FG000|Overall Study|Patient/Guardian Decision|1|||
48946181|NCT02333331|157634646|FG001|Overall Study|Patient/Guardian Decision|2|||
48946182|NCT02333331|157634647|FG002|Overall Study|Patient/Guardian Decision|9|||
48946183|NCT02333331|157634648|FG003|Overall Study|Patient/Guardian Decision|1|||
48946184|NCT02424539|157634651|FG000|Overall Study|Adverse Event|0|||
48946185|NCT02424539|157634652|FG001|Overall Study|Adverse Event|0|||
48946186|NCT02424539|157634653|FG002|Overall Study|Adverse Event|1|||
48946187|NCT02424539|157634651|FG000|Overall Study|Physician Decision|0|||
48946188|NCT02424539|157634652|FG001|Overall Study|Physician Decision|0|||
48946189|NCT02424539|157634653|FG002|Overall Study|Physician Decision|1|||
48946190|NCT02424539|157634651|FG000|Overall Study|Withdrawal by Subject|3|||
48946191|NCT02424539|157634652|FG001|Overall Study|Withdrawal by Subject|1|||
48946192|NCT02424539|157634653|FG002|Overall Study|Withdrawal by Subject|0|||
48946193|NCT02424539|157634651|FG000|Overall Study|Other: Reached stopping criteria|11|||
48946194|NCT02424539|157634652|FG001|Overall Study|Other: Reached stopping criteria|7|||
48946195|NCT02424539|157634653|FG002|Overall Study|Other: Reached stopping criteria|6|||
48946196|NCT00719810|157634654|FG000|Overall Study|Adverse Event|0|||
48946197|NCT00719810|157634655|FG001|Overall Study|Adverse Event|2|||
48946198|NCT00719810|157634656|FG002|Overall Study|Adverse Event|3|||
48946199|NCT00719810|157634654|FG000|Overall Study|Lost to Follow-up|2|||
48946200|NCT00719810|157634655|FG001|Overall Study|Lost to Follow-up|0|||
48946201|NCT00719810|157634656|FG002|Overall Study|Lost to Follow-up|3|||
48850803|NCT03861234|157292286|FG005|Overall Study|IMP on hold as per sponsor instructions|0|||
48946202|NCT00719810|157634654|FG000|Overall Study|Physician Decision|0|||
48850804|NCT03861234|157292287|FG006|Overall Study|IMP on hold as per sponsor instructions|2|||
48946203|NCT00719810|157634655|FG001|Overall Study|Physician Decision|1|||
48946204|NCT00719810|157634656|FG002|Overall Study|Physician Decision|0|||
49015306|NCT01754259|157892142|FG000|Overall Study|Lost to Follow-up|0|||
49015307|NCT01754259|157892143|FG001|Overall Study|Lost to Follow-up|1|||
48850805|NCT03861234|157292288|FG007|Overall Study|IMP on hold as per sponsor instructions|0|||
48946205|NCT00719810|157634654|FG000|Overall Study|Withdrawal by Subject|1|||
48946206|NCT00719810|157634655|FG001|Overall Study|Withdrawal by Subject|1|||
48850806|NCT00982644|157292291|FG000|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20|||
48946207|NCT00719810|157634656|FG002|Overall Study|Withdrawal by Subject|2|||
48850807|NCT00982644|157292292|FG001|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5|||
48850808|NCT00982644|157292291|FG000|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7|||
48850809|NCT00982644|157292292|FG001|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2|||
48850810|NCT00982644|157292291|FG000|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46|||
48850811|NCT00982644|157292292|FG001|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18|||
48850812|NCT00982644|157292291|FG000|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9|||
48850813|NCT00982644|157292292|FG001|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5|||
48850814|NCT00982644|157292291|FG000|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84|||
48850815|NCT00982644|157292292|FG001|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30|||
48850816|NCT00982644|157292291|FG000|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12|||
48946208|NCT00573131|157634657|FG000|Overall Study|Withdrawal by Subject|10|||
48946209|NCT00573131|157634658|FG001|Overall Study|Withdrawal by Subject|8|||
48946210|NCT04419506|157634666|FG000|Overall Study|Adverse Event|0|||
48946211|NCT04419506|157634667|FG001|Overall Study|Adverse Event|10|||
48946212|NCT04419506|157634668|FG002|Overall Study|Adverse Event|0|||
48850817|NCT00982644|157292292|FG001|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5|||
48946213|NCT04419506|157634669|FG003|Overall Study|Adverse Event|3|||
48946214|NCT04419506|157634666|FG000|Overall Study|Withdrawal by Subject|0|||
48946215|NCT04419506|157634667|FG001|Overall Study|Withdrawal by Subject|0|||
48946216|NCT04419506|157634668|FG002|Overall Study|Withdrawal by Subject|0|||
48850818|NCT00982644|157292291|FG000|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3|||
48850819|NCT00982644|157292292|FG001|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1|||
48850820|NCT00982644|157292291|FG000|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2|||
48850821|NCT00982644|157292292|FG001|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4|||
48850822|NCT00982644|157292291|FG000|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6|||
48850823|NCT00982644|157292292|FG001|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3|||
48850824|NCT00982644|157292291|FG000|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23|||
48850825|NCT00982644|157292292|FG001|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7|||
48850826|NCT01759862|157292293|FG000|Overall Study|Physician Decision|3|||
48850827|NCT01759862|157292294|FG001|Overall Study|Physician Decision|1|||
48850828|NCT01759862|157292293|FG000|Overall Study|Adverse Event|0|||
48850829|NCT01759862|157292294|FG001|Overall Study|Adverse Event|1|||
48850830|NCT04060212|157292295|FG000|Overall Study|Withdrawal by Subject|7|||
48850831|NCT00174252|157292302|FG000|Overall Study|Protocol Violation|2|||
48850832|NCT00811941|157292303|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
48850833|NCT00811941|157292304|FG001|All Randomised Patients|Did not receive placebo/nalmefene|8|||
48850834|NCT00811941|157292303|FG000|All Treated Patients|Adverse Event|2|||
48850835|NCT00811941|157292304|FG001|All Treated Patients|Adverse Event|43|||
48850836|NCT00811941|157292303|FG000|All Treated Patients|Lack of Efficacy|2|||
48850837|NCT00811941|157292304|FG001|All Treated Patients|Lack of Efficacy|3|||
48850838|NCT00811941|157292303|FG000|All Treated Patients|Non-compliance|1|||
48850839|NCT00811941|157292304|FG001|All Treated Patients|Non-compliance|8|||
48850840|NCT00811941|157292303|FG000|All Treated Patients|Protocol Violation|5|||
48850841|NCT00811941|157292304|FG001|All Treated Patients|Protocol Violation|17|||
48850842|NCT00811941|157292303|FG000|All Treated Patients|Withdrawal by Subject|35|||
48850843|NCT00811941|157292304|FG001|All Treated Patients|Withdrawal by Subject|94|||
48850844|NCT00811941|157292303|FG000|All Treated Patients|Lost to Follow-up|3|||
48850845|NCT00811941|157292304|FG001|All Treated Patients|Lost to Follow-up|12|||
48850846|NCT00811941|157292303|FG000|All Treated Patients|Other Reason|4|||
48850847|NCT00811941|157292304|FG001|All Treated Patients|Other Reason|14|||
48850848|NCT03802994|157292309|FG000|Overall Study|Lost to Follow-up|0|||
48850849|NCT03802994|157292310|FG001|Overall Study|Lost to Follow-up|2|||
48850850|NCT03802994|157292311|FG002|Overall Study|Lost to Follow-up|3|||
48946217|NCT04419506|157634669|FG003|Overall Study|Withdrawal by Subject|1|||
48946218|NCT04419506|157634666|FG000|Overall Study|poor-compliance|0|||
48946219|NCT04419506|157634667|FG001|Overall Study|poor-compliance|0|||
48946220|NCT04419506|157634668|FG002|Overall Study|poor-compliance|0|||
48946221|NCT04419506|157634669|FG003|Overall Study|poor-compliance|1|||
48946222|NCT03952650|157634671|FG000|Overall Study|TRAVEL|0|||
48946223|NCT03952650|157634672|FG001|Overall Study|TRAVEL|4|||
48946224|NCT03952650|157634673|FG002|Overall Study|TRAVEL|0|||
48946225|NCT03952650|157634674|FG003|Overall Study|TRAVEL|4|||
48850851|NCT03802994|157292312|FG003|Overall Study|Lost to Follow-up|2|||
48850852|NCT03802994|157292313|FG004|Overall Study|Lost to Follow-up|2|||
48946226|NCT03952650|157634675|FG004|Overall Study|TRAVEL|0|||
48946227|NCT03952650|157634676|FG005|Overall Study|TRAVEL|3|||
48850853|NCT01394276|157292314|FG000|Overall Study|Related Adverse event (AEs)|15|||
48946228|NCT03952650|157634677|FG006|Overall Study|TRAVEL|2|||
48946229|NCT03952650|157634671|FG000|Overall Study|Withdrawal by Subject|0|||
48946230|NCT03952650|157634672|FG001|Overall Study|Withdrawal by Subject|2|||
48850854|NCT01394276|157292314|FG000|Overall Study|Not related AEs|9|||
48850855|NCT01394276|157292314|FG000|Overall Study|Remission of disease|2|||
48850856|NCT01394276|157292314|FG000|Overall Study|Insufficient therapeutic effect|17|||
48850857|NCT01394276|157292314|FG000|Overall Study|Insufficient compliance|9|||
48850858|NCT01394276|157292314|FG000|Overall Study|Lost to Follow-up|5|||
48850859|NCT01394276|157292314|FG000|Overall Study|Participant moved to another site|1|||
48850860|NCT01394276|157292314|FG000|Overall Study|Pregnancy|1|||
48850861|NCT01394276|157292314|FG000|Overall Study|unavailability of drug at the Hospital|2|||
48850862|NCT01394276|157292314|FG000|Overall Study|Symptoms of concurrent diseases|1|||
48850863|NCT00600353|157292321|FG000|Overall Study|history of malignancy within 5 years|1|||
48850864|NCT00600353|157292322|FG001|Overall Study|history of malignancy within 5 years|0|||
48850865|NCT00600353|157292321|FG000|Overall Study|History of prepartive regimen|0|||
48850866|NCT00600353|157292322|FG001|Overall Study|History of prepartive regimen|1|||
48850867|NCT00090519|157292326|FG000|Overall Study|Adverse Event|5|||
48850868|NCT00090519|157292327|FG001|Overall Study|Adverse Event|4|||
48850869|NCT00090519|157292326|FG000|Overall Study|Death|9|||
48850870|NCT00090519|157292327|FG001|Overall Study|Death|9|||
48850871|NCT00090519|157292326|FG000|Overall Study|Lost to Follow-up|26|||
48850872|NCT00090519|157292327|FG001|Overall Study|Lost to Follow-up|29|||
48850873|NCT00090519|157292326|FG000|Overall Study|Withdrawal by Subject|28|||
48850874|NCT00090519|157292327|FG001|Overall Study|Withdrawal by Subject|29|||
48850875|NCT00090519|157292326|FG000|Overall Study|Physician Decision|2|||
48850876|NCT00090519|157292327|FG001|Overall Study|Physician Decision|3|||
48850877|NCT00090519|157292326|FG000|Overall Study|Sponsor Decision|3|||
48850878|NCT00090519|157292327|FG001|Overall Study|Sponsor Decision|1|||
48850879|NCT02180724|157293708|FG000|Overall Study|Death|26|||
48850880|NCT02180724|157293709|FG001|Overall Study|Death|1|||
48850881|NCT02180724|157293708|FG000|Overall Study|Lost to Follow-up|3|||
48850882|NCT02180724|157293709|FG001|Overall Study|Lost to Follow-up|1|||
48850883|NCT02180724|157293708|FG000|Overall Study|Withdrawal by Subject|4|||
48850884|NCT02180724|157293709|FG001|Overall Study|Withdrawal by Subject|2|||
48850885|NCT02180724|157293708|FG000|Overall Study|PI Decision|5|||
48850886|NCT02180724|157293709|FG001|Overall Study|PI Decision|2|||
48850887|NCT02180724|157293708|FG000|Overall Study|Study terminated by sponsor|54|||
48850888|NCT02180724|157293709|FG001|Overall Study|Study terminated by sponsor|8|||
48850889|NCT04503681|157293713|FG000|Overall Study|Subjects did not complete outcome questionnaire|5|||
48850890|NCT04503681|157293714|FG001|Overall Study|Subjects did not complete outcome questionnaire|7|||
48850891|NCT01808534|157293718|FG000|Overall Study|Disease progression|3|||
48850892|NCT01808534|157293718|FG000|Overall Study|Physician Decision|1|||
48850893|NCT02111096|157293719|FG000|Overall Study|Adverse Event|4|||
48850894|NCT02111096|157293720|FG001|Overall Study|Adverse Event|1|||
48850895|NCT02111096|157293721|FG002|Overall Study|Adverse Event|2|||
48850896|NCT02111096|157293719|FG000|Overall Study|Non-Compliance with Study Drug|1|||
48850897|NCT02111096|157293720|FG001|Overall Study|Non-Compliance with Study Drug|1|||
48850898|NCT02111096|157293721|FG002|Overall Study|Non-Compliance with Study Drug|0|||
48850899|NCT02111096|157293719|FG000|Overall Study|Lost to Follow Up|1|||
48850900|NCT02111096|157293720|FG001|Overall Study|Lost to Follow Up|1|||
48850901|NCT02111096|157293721|FG002|Overall Study|Lost to Follow Up|1|||
48850902|NCT02111096|157293719|FG000|Overall Study|Physician Decision|0|||
48850903|NCT02111096|157293720|FG001|Overall Study|Physician Decision|1|||
48850904|NCT02111096|157293721|FG002|Overall Study|Physician Decision|0|||
48850905|NCT02111096|157293719|FG000|Overall Study|Protocol Violation|1|||
48850906|NCT02111096|157293720|FG001|Overall Study|Protocol Violation|0|||
48850907|NCT02111096|157293721|FG002|Overall Study|Protocol Violation|1|||
48946231|NCT03952650|157634673|FG002|Overall Study|Withdrawal by Subject|0|||
48946232|NCT03952650|157634674|FG003|Overall Study|Withdrawal by Subject|3|||
48946233|NCT03952650|157634675|FG004|Overall Study|Withdrawal by Subject|0|||
48946234|NCT03952650|157634676|FG005|Overall Study|Withdrawal by Subject|1|||
48946235|NCT03952650|157634677|FG006|Overall Study|Withdrawal by Subject|1|||
48946236|NCT03952650|157634671|FG000|Overall Study|Lost to Follow-up|0|||
48946237|NCT03952650|157634672|FG001|Overall Study|Lost to Follow-up|1|||
48946238|NCT03952650|157634673|FG002|Overall Study|Lost to Follow-up|0|||
48946239|NCT03952650|157634674|FG003|Overall Study|Lost to Follow-up|0|||
48946240|NCT03952650|157634675|FG004|Overall Study|Lost to Follow-up|0|||
48850908|NCT02111096|157293719|FG000|Overall Study|Terminated by Sponsor|53|||
48946241|NCT03952650|157634676|FG005|Overall Study|Lost to Follow-up|1|||
48850909|NCT02111096|157293720|FG001|Overall Study|Terminated by Sponsor|35|||
48850910|NCT02111096|157293721|FG002|Overall Study|Terminated by Sponsor|54|||
48850911|NCT02111096|157293719|FG000|Overall Study|Withdrawal by Subject|4|||
48946242|NCT03952650|157634677|FG006|Overall Study|Lost to Follow-up|1|||
48946243|NCT03952650|157634671|FG000|Overall Study|Received wrong vaccine and travelled|0|||
48946244|NCT03952650|157634672|FG001|Overall Study|Received wrong vaccine and travelled|0|||
48850912|NCT02111096|157293720|FG001|Overall Study|Withdrawal by Subject|2|||
48850913|NCT02111096|157293721|FG002|Overall Study|Withdrawal by Subject|8|||
48850914|NCT00345046|157293722|FG000|Overall Study|Protocol Violation|1|||
48850915|NCT00345046|157293723|FG001|Overall Study|Protocol Violation|1|||
48850916|NCT00345046|157293724|FG002|Overall Study|Protocol Violation|2|||
48850917|NCT02824198|157293727|FG000|Overall Study|Non-compliance with the protocol|5|||
48850918|NCT02824198|157293728|FG001|Overall Study|Non-compliance with the protocol|1|||
48850919|NCT02824198|157293727|FG000|Overall Study|Lost to Follow-up|5|||
48850920|NCT02824198|157293728|FG001|Overall Study|Lost to Follow-up|2|||
48850921|NCT02824198|157293727|FG000|Overall Study|Withdrawal by Subject|5|||
48850922|NCT02824198|157293728|FG001|Overall Study|Withdrawal by Subject|0|||
48850923|NCT04250636|157293729|FG000|Overall Study|Lost to Follow-up|2|||
48850924|NCT00609869|157293730|FG000|Overall Study|Withdrawn, ischemic stroke|1|||
48946245|NCT03952650|157634673|FG002|Overall Study|Received wrong vaccine and travelled|0|||
48946246|NCT03952650|157634674|FG003|Overall Study|Received wrong vaccine and travelled|0|||
48946247|NCT03952650|157634675|FG004|Overall Study|Received wrong vaccine and travelled|0|||
48946248|NCT03952650|157634676|FG005|Overall Study|Received wrong vaccine and travelled|1|||
48946249|NCT03952650|157634677|FG006|Overall Study|Received wrong vaccine and travelled|0|||
48946250|NCT03952650|157634671|FG000|Overall Study|Unable to make study visit|0|||
48946251|NCT03952650|157634672|FG001|Overall Study|Unable to make study visit|0|||
48946252|NCT03952650|157634673|FG002|Overall Study|Unable to make study visit|0|||
48946253|NCT03952650|157634674|FG003|Overall Study|Unable to make study visit|0|||
48946254|NCT03952650|157634675|FG004|Overall Study|Unable to make study visit|0|||
48946255|NCT03952650|157634676|FG005|Overall Study|Unable to make study visit|1|||
48946256|NCT03952650|157634677|FG006|Overall Study|Unable to make study visit|0|||
48946257|NCT00201201|157634678|FG000|Overall Study|Death|0|||
48946258|NCT00201201|157634679|FG001|Overall Study|Death|2|||
48946259|NCT00201201|157634678|FG000|Overall Study|Withdrawal by Subject|5|||
48946260|NCT00201201|157634679|FG001|Overall Study|Withdrawal by Subject|5|||
48946261|NCT01357239|157634680|FG000|Stratum: All Patients|Adverse Event|0|||
48946262|NCT01357239|157634681|FG001|Stratum: All Patients|Adverse Event|0|||
48946263|NCT01357239|157634682|FG002|Stratum: All Patients|Adverse Event|1|||
48736047|NCT00257608|156885622|FG001|Post Chemotherapy Phase|Patient's decision to discontinue|4|||
48736048|NCT00257608|156885623|FG002|Post Chemotherapy Phase|Patient's decision to discontinue|8|||
48736049|NCT00257608|156885621|FG000|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
48736050|NCT00257608|156885622|FG001|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
48736051|NCT00257608|156885623|FG002|Post Chemotherapy Phase|Unrelated intercurrent illness|1|||
48736052|NCT00257608|156885621|FG000|Post Chemotherapy Phase|Lost to Follow-up|0|||
48736053|NCT00257608|156885622|FG001|Post Chemotherapy Phase|Lost to Follow-up|0|||
48736054|NCT00257608|156885623|FG002|Post Chemotherapy Phase|Lost to Follow-up|1|||
48736055|NCT00257608|156885621|FG000|Post Chemotherapy Phase|Physician Decision|0|||
48736056|NCT00257608|156885622|FG001|Post Chemotherapy Phase|Physician Decision|8|||
48736057|NCT00257608|156885623|FG002|Post Chemotherapy Phase|Physician Decision|11|||
48736058|NCT00257608|156885621|FG000|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
48736059|NCT00257608|156885622|FG001|Post Chemotherapy Phase|Sponsor's decision to terminate study|1|||
48736060|NCT00257608|156885623|FG002|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
48736061|NCT00257608|156885621|FG000|Post Chemotherapy Phase|Not treated|0|||
48736062|NCT00257608|156885622|FG001|Post Chemotherapy Phase|Not treated|4|||
48736063|NCT00257608|156885623|FG002|Post Chemotherapy Phase|Not treated|7|||
48736064|NCT00866788|156885625|FG000|Overall Study|Adverse Event|0|||
48736065|NCT00866788|156885626|FG001|Overall Study|Adverse Event|2|||
48736066|NCT00866788|156885627|FG002|Overall Study|Adverse Event|0|||
48736067|NCT00866788|156885628|FG003|Overall Study|Adverse Event|1|||
48736068|NCT00866788|156885625|FG000|Overall Study|Lost to Follow-up|1|||
48736069|NCT00866788|156885626|FG001|Overall Study|Lost to Follow-up|1|||
48736070|NCT00866788|156885627|FG002|Overall Study|Lost to Follow-up|0|||
48736071|NCT00866788|156885628|FG003|Overall Study|Lost to Follow-up|2|||
48736072|NCT00866788|156885625|FG000|Overall Study|Withdrawal by Subject|2|||
48736073|NCT00866788|156885626|FG001|Overall Study|Withdrawal by Subject|1|||
48736074|NCT00866788|156885627|FG002|Overall Study|Withdrawal by Subject|0|||
48736075|NCT00866788|156885628|FG003|Overall Study|Withdrawal by Subject|1|||
48736076|NCT00866788|156885625|FG000|Overall Study|Pregnancy|0|||
48946264|NCT01357239|157634683|FG003|Stratum: All Patients|Adverse Event|1|||
48946265|NCT01357239|157634680|FG000|Stratum: All Patients|Subject withdrew consent|0|||
48946266|NCT01357239|157634681|FG001|Stratum: All Patients|Subject withdrew consent|0|||
48946267|NCT01357239|157634682|FG002|Stratum: All Patients|Subject withdrew consent|1|||
48946268|NCT01357239|157634683|FG003|Stratum: All Patients|Subject withdrew consent|1|||
48946269|NCT01357239|157634680|FG000|Stratum I: Fully-Methylated|Adverse Event|0|||
48946270|NCT01357239|157634681|FG001|Stratum I: Fully-Methylated|Adverse Event|0|||
48946271|NCT01357239|157634682|FG002|Stratum I: Fully-Methylated|Adverse Event|1|||
48946272|NCT01357239|157634683|FG003|Stratum I: Fully-Methylated|Adverse Event|0|||
48946273|NCT01357239|157634680|FG000|Stratum II: Partially-Methylated|Adverse Event|0|||
48850925|NCT00609869|157293730|FG000|Overall Study|Severe hematologic toxicity|1|||
48850926|NCT00609869|157293730|FG000|Overall Study|Withdrawal by Subject|1|||
48850927|NCT00609869|157293730|FG000|Overall Study|Seizures|1|||
48850928|NCT00609869|157293730|FG000|Overall Study|Severe tumor flare reaction|1|||
48850929|NCT00609869|157293730|FG000|Overall Study|Hepatitis B infection|1|||
48850930|NCT00609869|157293730|FG000|Overall Study|Rituximab reaction prior to lenalidomide|1|||
48850931|NCT00609869|157293730|FG000|Overall Study|Mantle cell: not evaluable|4|||
48850932|NCT00918333|157293733|FG000|Overall Study|Drug not taken per protocol|1|||
48850933|NCT00918333|157293734|FG001|Overall Study|Drug not taken per protocol|0|||
48850934|NCT00918333|157293733|FG000|Overall Study|Inadequate amount of drugs provided|1|||
48850935|NCT00918333|157293734|FG001|Overall Study|Inadequate amount of drugs provided|4|||
48850936|NCT00918333|157293733|FG000|Overall Study|Ineligible|1|||
48850937|NCT00918333|157293734|FG001|Overall Study|Ineligible|0|||
48850938|NCT00918333|157293733|FG000|Overall Study|Withdrawal by Subject|0|||
48850939|NCT00918333|157293734|FG001|Overall Study|Withdrawal by Subject|1|||
48850940|NCT00713596|157293739|FG000|Overall Study|Study was terminated|2|||
48850941|NCT00713596|157293740|FG001|Overall Study|Study was terminated|3|||
48946274|NCT01357239|157634681|FG001|Stratum II: Partially-Methylated|Adverse Event|0|||
48946275|NCT01357239|157634682|FG002|Stratum II: Partially-Methylated|Adverse Event|0|||
48946276|NCT01357239|157634683|FG003|Stratum II: Partially-Methylated|Adverse Event|1|||
48850942|NCT00713596|157293741|FG002|Overall Study|Study was terminated|2|||
48850943|NCT02157116|157293742|FG000|Overall Study|Withdrawal by Subject|4|||
48850944|NCT02157116|157293742|FG000|Overall Study|Physician Decision|3|||
48850945|NCT02157116|157293742|FG000|Overall Study|Failed Screening|2|||
48850946|NCT00093496|157293743|FG000|Overall Study|Protocol Violation|1|||
48850947|NCT00093496|157293744|FG001|Overall Study|Protocol Violation|3|||
48850948|NCT01953224|157293745|FG000|Overall Study|Lost to Follow-up|1|||
48850949|NCT01953224|157293746|FG001|Overall Study|Lost to Follow-up|1|||
48850950|NCT01953224|157293745|FG000|Overall Study|Withdrawal by Subject|1|||
48850951|NCT01953224|157293746|FG001|Overall Study|Withdrawal by Subject|2|||
48850952|NCT03781375|157293755|FG000|Double-blind Phase|Adverse Event|0|||
48850953|NCT03781375|157293756|FG001|Double-blind Phase|Adverse Event|1|||
48850954|NCT03781375|157293755|FG000|Double-blind Phase|Lack of Response|6|||
48850955|NCT03781375|157293756|FG001|Double-blind Phase|Lack of Response|2|||
48850956|NCT03781375|157293755|FG000|Double-blind Phase|Other|1|||
48850957|NCT03781375|157293756|FG001|Double-blind Phase|Other|3|||
48850958|NCT03781375|157293755|FG000|Open-label Phase|Protocol Issues|0|||
48850959|NCT03781375|157293756|FG001|Open-label Phase|Protocol Issues|1|||
48850960|NCT03781375|157293755|FG000|Open-label Phase|Suboptimal Clinical Response|1|||
48850961|NCT03781375|157293756|FG001|Open-label Phase|Suboptimal Clinical Response|0|||
48850962|NCT03781375|157293755|FG000|Open-label Phase|Other|2|||
48850963|NCT03781375|157293756|FG001|Open-label Phase|Other|2|||
48850964|NCT01303510|157293758|FG000|Overall Study|Lost to Follow-up|1|||
48850965|NCT01303510|157293759|FG001|Overall Study|Lost to Follow-up|0|||
48850966|NCT01485887|157293760|FG000|Overall Study|Withdrawal by Subject|2|||
48850967|NCT01485887|157293760|FG000|Overall Study|Adverse Event|8|||
48850968|NCT01485887|157293760|FG000|Overall Study|Deterioration of primary disease|1|||
48850969|NCT01485887|157293760|FG000|Overall Study|Primary disease markedly improved|1|||
48850970|NCT04860505|157293761|FG000|Overall Study|Lost to Follow-up|2|||
48850971|NCT01034306|157293762|FG000|Overall Study|Adverse Event|1|||
48850972|NCT01034306|157293763|FG001|Overall Study|Adverse Event|0|||
48850973|NCT01034306|157293762|FG000|Overall Study|Lost to Follow-up|0|||
48850974|NCT01034306|157293763|FG001|Overall Study|Lost to Follow-up|1|||
48850975|NCT01034306|157293762|FG000|Overall Study|Withdrawal by Subject|2|||
48850976|NCT01034306|157293763|FG001|Overall Study|Withdrawal by Subject|2|||
48850977|NCT01034306|157293762|FG000|Overall Study|hospitalized and decided to stop|1|||
48850978|NCT01034306|157293763|FG001|Overall Study|hospitalized and decided to stop|0|||
48850979|NCT01034306|157293762|FG000|Overall Study|Noncomplience|1|||
48850980|NCT01034306|157293763|FG001|Overall Study|Noncomplience|0|||
48850981|NCT00836498|157293764|FG000|Overall Study|Adverse Event|1|||
48850982|NCT00836498|157293765|FG001|Overall Study|Adverse Event|0|||
48850983|NCT00836498|157293764|FG000|Overall Study|Lost to Follow-up|1|||
48850984|NCT00836498|157293765|FG001|Overall Study|Lost to Follow-up|0|||
48850985|NCT00836498|157293764|FG000|Overall Study|Withdrawal by Subject|2|||
48850986|NCT00836498|157293765|FG001|Overall Study|Withdrawal by Subject|1|||
48850987|NCT00857766|157293766|FG000|Overall Study|Adverse Event|13|||
48850988|NCT00857766|157293767|FG001|Overall Study|Adverse Event|12|||
48850989|NCT00857766|157293766|FG000|Overall Study|Protocol Violation|11|||
48850990|NCT00857766|157293767|FG001|Overall Study|Protocol Violation|11|||
48850991|NCT00857766|157293766|FG000|Overall Study|Lost to Follow-up|1|||
48850992|NCT00857766|157293767|FG001|Overall Study|Lost to Follow-up|0|||
48850993|NCT00857766|157293766|FG000|Overall Study|Investigator Discretion|2|||
48850994|NCT00857766|157293767|FG001|Overall Study|Investigator Discretion|3|||
48850995|NCT00857766|157293766|FG000|Overall Study|Participant Withdrew Consent|4|||
48850996|NCT00857766|157293767|FG001|Overall Study|Participant Withdrew Consent|4|||
48850997|NCT01988402|157293768|FG000|Overall Study|Adverse Event|1|||
48850998|NCT01988402|157293769|FG001|Overall Study|Adverse Event|2|||
48850999|NCT01988402|157293768|FG000|Overall Study|Withdrawal by Subject|1|||
48851000|NCT01988402|157293769|FG001|Overall Study|Withdrawal by Subject|0|||
48851001|NCT01961609|157293770|FG000|Initiation|Missing|3|||
48851002|NCT01961609|157293771|FG001|Initiation|Missing|2|||
48851003|NCT01961609|157293772|FG002|Initiation|Missing|0|||
48851004|NCT01961609|157293773|FG003|Initiation|Missing|0|||
48851005|NCT01961609|157293770|FG000|Initiation|Protocol deviation|1|||
48851006|NCT01961609|157293771|FG001|Initiation|Protocol deviation|0|||
48851007|NCT01961609|157293772|FG002|Initiation|Protocol deviation|0|||
48851008|NCT01961609|157293773|FG003|Initiation|Protocol deviation|0|||
48946277|NCT01357239|157634680|FG000|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
48946278|NCT01357239|157634681|FG001|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
48946279|NCT01357239|157634682|FG002|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
48851009|NCT01961609|157293770|FG000|Initiation|Death|0|||
48851010|NCT01961609|157293771|FG001|Initiation|Death|1|||
48851011|NCT01961609|157293772|FG002|Initiation|Death|0|||
48851012|NCT01961609|157293773|FG003|Initiation|Death|0|||
48851013|NCT01961609|157293770|FG000|Initiation|Administrative problems|1|||
48851014|NCT01961609|157293771|FG001|Initiation|Administrative problems|0|||
48851015|NCT01961609|157293772|FG002|Initiation|Administrative problems|0|||
48851016|NCT01961609|157293773|FG003|Initiation|Administrative problems|0|||
48851017|NCT01961609|157293770|FG000|Initiation|Withdrawal by Subject|1|||
48851018|NCT01961609|157293771|FG001|Initiation|Withdrawal by Subject|2|||
48851019|NCT01961609|157293772|FG002|Initiation|Withdrawal by Subject|0|||
48851020|NCT01961609|157293773|FG003|Initiation|Withdrawal by Subject|0|||
48851021|NCT01961609|157293770|FG000|Initiation|Lack of Efficacy|2|||
48851022|NCT01961609|157293771|FG001|Initiation|Lack of Efficacy|1|||
48851023|NCT01961609|157293772|FG002|Initiation|Lack of Efficacy|0|||
48851024|NCT01961609|157293773|FG003|Initiation|Lack of Efficacy|0|||
48851025|NCT01961609|157293770|FG000|Initiation|Abnormal lab values|0|||
48851026|NCT01961609|157293771|FG001|Initiation|Abnormal lab values|1|||
48946280|NCT01357239|157634683|FG003|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
48946281|NCT03894540|157634692|FG000|Overall Study|Adverse Event|0|||
48946282|NCT03894540|157634693|FG001|Overall Study|Adverse Event|0|||
48946283|NCT03894540|157634694|FG002|Overall Study|Adverse Event|0|||
48946284|NCT03894540|157634695|FG003|Overall Study|Adverse Event|0|||
48946285|NCT03894540|157634696|FG004|Overall Study|Adverse Event|1|||
48946286|NCT03894540|157634697|FG005|Overall Study|Adverse Event|0|||
48946287|NCT03894540|157634692|FG000|Overall Study|Withdrawal by Subject|0|||
48946288|NCT03894540|157634693|FG001|Overall Study|Withdrawal by Subject|0|||
48946289|NCT03894540|157634694|FG002|Overall Study|Withdrawal by Subject|0|||
48946290|NCT03894540|157634695|FG003|Overall Study|Withdrawal by Subject|0|||
48946291|NCT03894540|157634696|FG004|Overall Study|Withdrawal by Subject|1|||
48946292|NCT03894540|157634697|FG005|Overall Study|Withdrawal by Subject|0|||
48851027|NCT01961609|157293772|FG002|Initiation|Abnormal lab values|0|||
48851028|NCT01961609|157293773|FG003|Initiation|Abnormal lab values|0|||
48851029|NCT01961609|157293770|FG000|Initiation|Adverse Event|3|||
48851030|NCT01961609|157293771|FG001|Initiation|Adverse Event|5|||
48851031|NCT01961609|157293772|FG002|Initiation|Adverse Event|0|||
48851032|NCT01961609|157293773|FG003|Initiation|Adverse Event|0|||
48946293|NCT03894540|157634692|FG000|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
48851033|NCT01961609|157293770|FG000|Initiation|Randomized but not treated|1|||
48851034|NCT01961609|157293771|FG001|Initiation|Randomized but not treated|1|||
48946294|NCT03894540|157634693|FG001|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
48946295|NCT03894540|157634694|FG002|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|1|||
48851035|NCT01961609|157293772|FG002|Initiation|Randomized but not treated|0|||
48851036|NCT01961609|157293773|FG003|Initiation|Randomized but not treated|0|||
48851037|NCT01961609|157293770|FG000|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1|||
48851038|NCT01961609|157293771|FG001|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
48851039|NCT01961609|157293772|FG002|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3|||
48851040|NCT01961609|157293773|FG003|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
48851041|NCT01961609|157293770|FG000|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3|||
48851042|NCT01961609|157293771|FG001|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
48851043|NCT01961609|157293772|FG002|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1|||
48851044|NCT01961609|157293773|FG003|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
48851045|NCT01961609|157293770|FG000|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
48851046|NCT01961609|157293771|FG001|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
48851047|NCT01961609|157293772|FG002|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
48851048|NCT01961609|157293773|FG003|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
48851049|NCT01961609|157293770|FG000|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13|||
48851050|NCT01961609|157293771|FG001|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4|||
48946296|NCT03894540|157634695|FG003|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
48946297|NCT03894540|157634696|FG004|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|2|||
48851051|NCT01961609|157293772|FG002|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10|||
48851052|NCT01961609|157293773|FG003|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0|||
48851053|NCT01961609|157293770|FG000|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
48851054|NCT01961609|157293771|FG001|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
48851055|NCT01961609|157293772|FG002|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3|||
48851056|NCT01961609|157293773|FG003|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0|||
48851057|NCT01961609|157293770|FG000|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
48851058|NCT01961609|157293771|FG001|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
48851059|NCT01961609|157293772|FG002|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1|||
48851060|NCT01961609|157293773|FG003|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
48851061|NCT01961609|157293770|FG000|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7|||
48851062|NCT01961609|157293771|FG001|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5|||
48851063|NCT01961609|157293772|FG002|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0|||
48851064|NCT01961609|157293773|FG003|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4|||
48851065|NCT01961609|157293770|FG000|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
48851066|NCT01961609|157293771|FG001|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
48851067|NCT01961609|157293772|FG002|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1|||
48851068|NCT01961609|157293773|FG003|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
48851069|NCT01961609|157293770|FG000|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1|||
48851070|NCT01961609|157293771|FG001|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
48851071|NCT01961609|157293772|FG002|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
48851072|NCT01961609|157293773|FG003|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
48851073|NCT01961609|157293770|FG000|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
48851074|NCT01961609|157293771|FG001|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1|||
48851075|NCT01961609|157293772|FG002|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
48851076|NCT01961609|157293773|FG003|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
48851077|NCT01961609|157293770|FG000|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
48851078|NCT01961609|157293771|FG001|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0|||
48851079|NCT01961609|157293772|FG002|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
48851080|NCT01961609|157293773|FG003|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1|||
48851081|NCT01961609|157293770|FG000|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1|||
48851082|NCT01961609|157293771|FG001|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
48851083|NCT01961609|157293772|FG002|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
48851084|NCT01961609|157293773|FG003|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2|||
48851085|NCT03418545|157293780|FG000|Overall Study|Withdrawal by Participant|2|||
48851086|NCT03418545|157293781|FG001|Overall Study|Withdrawal by Participant|4|||
48851087|NCT03418545|157293780|FG000|Overall Study|Lost to Follow-up|3|||
48851088|NCT03418545|157293781|FG001|Overall Study|Lost to Follow-up|5|||
48851089|NCT03418545|157293780|FG000|Overall Study|Reason Not Specified|0|||
48851090|NCT03418545|157293781|FG001|Overall Study|Reason Not Specified|1|||
48851091|NCT03418545|157293780|FG000|Overall Study|Missing Completion Status|0|||
48851092|NCT03418545|157293781|FG001|Overall Study|Missing Completion Status|1|||
48851093|NCT00776009|157293782|FG000|Period 1: First Intervention|Withdrawal by Subject|0|||
48851094|NCT00776009|157293783|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
48851095|NCT00776009|157293784|FG002|Period 1: First Intervention|Withdrawal by Subject|1|||
48851096|NCT00776009|157293785|FG003|Period 1: First Intervention|Withdrawal by Subject|0|||
48851097|NCT00776009|157293786|FG004|Period 1: First Intervention|Withdrawal by Subject|1|||
48851098|NCT00776009|157293787|FG005|Period 1: First Intervention|Withdrawal by Subject|0|||
48851099|NCT00776009|157293782|FG000|Period 1: First Intervention|Protocol Violation|0|||
48851100|NCT00776009|157293783|FG001|Period 1: First Intervention|Protocol Violation|1|||
48851101|NCT00776009|157293784|FG002|Period 1: First Intervention|Protocol Violation|0|||
48851102|NCT00776009|157293785|FG003|Period 1: First Intervention|Protocol Violation|0|||
48851103|NCT00776009|157293786|FG004|Period 1: First Intervention|Protocol Violation|1|||
48946298|NCT03894540|157634697|FG005|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
48946299|NCT03894540|157634692|FG000|Overall Study|Progressive Disease Clinical|1|||
48946300|NCT03894540|157634693|FG001|Overall Study|Progressive Disease Clinical|1|||
48946301|NCT03894540|157634694|FG002|Overall Study|Progressive Disease Clinical|0|||
48946302|NCT03894540|157634695|FG003|Overall Study|Progressive Disease Clinical|1|||
48946303|NCT03894540|157634696|FG004|Overall Study|Progressive Disease Clinical|5|||
48851104|NCT00776009|157293787|FG005|Period 1: First Intervention|Protocol Violation|0|||
48851105|NCT00776009|157293782|FG000|Period 2: Second Intervention|Withdrawal by Subject|0|||
48851106|NCT00776009|157293783|FG001|Period 2: Second Intervention|Withdrawal by Subject|0|||
48851107|NCT00776009|157293784|FG002|Period 2: Second Intervention|Withdrawal by Subject|0|||
48851108|NCT00776009|157293785|FG003|Period 2: Second Intervention|Withdrawal by Subject|0|||
48851109|NCT00776009|157293786|FG004|Period 2: Second Intervention|Withdrawal by Subject|0|||
48851110|NCT00776009|157293787|FG005|Period 2: Second Intervention|Withdrawal by Subject|1|||
48851111|NCT00776009|157293782|FG000|Period 2: Second Intervention|Protocol Violation|1|||
48851112|NCT00776009|157293783|FG001|Period 2: Second Intervention|Protocol Violation|0|||
48851113|NCT00776009|157293784|FG002|Period 2: Second Intervention|Protocol Violation|1|||
48851114|NCT00776009|157293785|FG003|Period 2: Second Intervention|Protocol Violation|0|||
48946304|NCT03894540|157634697|FG005|Overall Study|Progressive Disease Clinical|1|||
48946305|NCT03894540|157634692|FG000|Overall Study|Study termination by sponsor|0|||
48851115|NCT00776009|157293786|FG004|Period 2: Second Intervention|Protocol Violation|0|||
48851116|NCT00776009|157293787|FG005|Period 2: Second Intervention|Protocol Violation|0|||
48851117|NCT00776009|157293782|FG000|Period 3: Third Intervention|Withdrawal by Subject|1|||
48851118|NCT00776009|157293783|FG001|Period 3: Third Intervention|Withdrawal by Subject|0|||
48851119|NCT00776009|157293784|FG002|Period 3: Third Intervention|Withdrawal by Subject|0|||
48851120|NCT00776009|157293785|FG003|Period 3: Third Intervention|Withdrawal by Subject|0|||
48851121|NCT00776009|157293786|FG004|Period 3: Third Intervention|Withdrawal by Subject|0|||
48851122|NCT00776009|157293787|FG005|Period 3: Third Intervention|Withdrawal by Subject|0|||
48851123|NCT01640951|157293794|FG000|Overall Study|Adverse Event|8|||
48851124|NCT01640951|157293795|FG001|Overall Study|Adverse Event|3|||
48851125|NCT01640951|157293796|FG002|Overall Study|Adverse Event|10|||
48851126|NCT01640951|157293797|FG003|Overall Study|Adverse Event|6|||
48851127|NCT01640951|157293798|FG004|Overall Study|Adverse Event|1|||
48851128|NCT01640951|157293799|FG005|Overall Study|Adverse Event|11|||
48851129|NCT01640951|157293800|FG006|Overall Study|Adverse Event|1|||
48851130|NCT01640951|157293801|FG007|Overall Study|Adverse Event|3|||
48851131|NCT01640951|157293794|FG000|Overall Study|Lack of Efficacy|20|||
48851132|NCT01640951|157293795|FG001|Overall Study|Lack of Efficacy|1|||
48851133|NCT01640951|157293796|FG002|Overall Study|Lack of Efficacy|7|||
48851134|NCT01640951|157293797|FG003|Overall Study|Lack of Efficacy|14|||
48851135|NCT01640951|157293798|FG004|Overall Study|Lack of Efficacy|0|||
48851136|NCT01640951|157293799|FG005|Overall Study|Lack of Efficacy|6|||
48851137|NCT01640951|157293800|FG006|Overall Study|Lack of Efficacy|5|||
48851138|NCT01640951|157293801|FG007|Overall Study|Lack of Efficacy|6|||
48851139|NCT01640951|157293794|FG000|Overall Study|Lost to Follow-up|1|||
48851140|NCT01640951|157293795|FG001|Overall Study|Lost to Follow-up|0|||
48851141|NCT01640951|157293796|FG002|Overall Study|Lost to Follow-up|6|||
48851142|NCT01640951|157293797|FG003|Overall Study|Lost to Follow-up|2|||
48851143|NCT01640951|157293798|FG004|Overall Study|Lost to Follow-up|2|||
48851144|NCT01640951|157293799|FG005|Overall Study|Lost to Follow-up|3|||
48851145|NCT01640951|157293800|FG006|Overall Study|Lost to Follow-up|1|||
48851146|NCT01640951|157293801|FG007|Overall Study|Lost to Follow-up|1|||
48851147|NCT01640951|157293794|FG000|Overall Study|Non-compliance with study treatment|0|||
48851148|NCT01640951|157293795|FG001|Overall Study|Non-compliance with study treatment|0|||
48851149|NCT01640951|157293796|FG002|Overall Study|Non-compliance with study treatment|1|||
48851150|NCT01640951|157293797|FG003|Overall Study|Non-compliance with study treatment|1|||
48851151|NCT01640951|157293798|FG004|Overall Study|Non-compliance with study treatment|1|||
48851152|NCT01640951|157293799|FG005|Overall Study|Non-compliance with study treatment|4|||
48851153|NCT01640951|157293800|FG006|Overall Study|Non-compliance with study treatment|1|||
48851154|NCT01640951|157293801|FG007|Overall Study|Non-compliance with study treatment|0|||
48851155|NCT01640951|157293794|FG000|Overall Study|Physician Decision|2|||
48851156|NCT01640951|157293795|FG001|Overall Study|Physician Decision|5|||
48851157|NCT01640951|157293796|FG002|Overall Study|Physician Decision|2|||
48851158|NCT01640951|157293797|FG003|Overall Study|Physician Decision|2|||
48851159|NCT01640951|157293798|FG004|Overall Study|Physician Decision|2|||
48851160|NCT01640951|157293799|FG005|Overall Study|Physician Decision|3|||
48851161|NCT01640951|157293800|FG006|Overall Study|Physician Decision|3|||
48851162|NCT01640951|157293801|FG007|Overall Study|Physician Decision|0|||
48851163|NCT01640951|157293794|FG000|Overall Study|Pregnancy|3|||
48851164|NCT01640951|157293795|FG001|Overall Study|Pregnancy|0|||
48851165|NCT01640951|157293796|FG002|Overall Study|Pregnancy|0|||
48851166|NCT01640951|157293797|FG003|Overall Study|Pregnancy|4|||
48851167|NCT01640951|157293798|FG004|Overall Study|Pregnancy|0|||
48851168|NCT01640951|157293799|FG005|Overall Study|Pregnancy|0|||
48851169|NCT01640951|157293800|FG006|Overall Study|Pregnancy|2|||
48851170|NCT01640951|157293801|FG007|Overall Study|Pregnancy|0|||
48851171|NCT01640951|157293794|FG000|Overall Study|Protocol Deviation|0|||
48851172|NCT01640951|157293795|FG001|Overall Study|Protocol Deviation|1|||
48851173|NCT01640951|157293796|FG002|Overall Study|Protocol Deviation|2|||
48851174|NCT01640951|157293797|FG003|Overall Study|Protocol Deviation|1|||
48851175|NCT01640951|157293798|FG004|Overall Study|Protocol Deviation|0|||
48851176|NCT01640951|157293799|FG005|Overall Study|Protocol Deviation|1|||
48851177|NCT01640951|157293800|FG006|Overall Study|Protocol Deviation|0|||
48851178|NCT01640951|157293801|FG007|Overall Study|Protocol Deviation|0|||
48851179|NCT01640951|157293794|FG000|Overall Study|Subject/Guardian decision|12|||
48851180|NCT01640951|157293795|FG001|Overall Study|Subject/Guardian decision|4|||
48851181|NCT01640951|157293796|FG002|Overall Study|Subject/Guardian decision|13|||
48851182|NCT01640951|157293797|FG003|Overall Study|Subject/Guardian decision|15|||
48851183|NCT01640951|157293798|FG004|Overall Study|Subject/Guardian decision|7|||
48851184|NCT01640951|157293799|FG005|Overall Study|Subject/Guardian decision|19|||
48851185|NCT01640951|157293800|FG006|Overall Study|Subject/Guardian decision|5|||
48851186|NCT01640951|157293801|FG007|Overall Study|Subject/Guardian decision|4|||
48851187|NCT01640951|157293794|FG000|Overall Study|Death|0|||
48851188|NCT01640951|157293795|FG001|Overall Study|Death|1|||
48851189|NCT01640951|157293796|FG002|Overall Study|Death|1|||
48851190|NCT01640951|157293797|FG003|Overall Study|Death|0|||
48851191|NCT01640951|157293798|FG004|Overall Study|Death|0|||
48851192|NCT01640951|157293799|FG005|Overall Study|Death|0|||
48851193|NCT01640951|157293800|FG006|Overall Study|Death|0|||
48851194|NCT01640951|157293801|FG007|Overall Study|Death|2|||
48851195|NCT04492475|157293810|FG000|Overall Study|Enrolled but not treated|8|||
48851196|NCT04492475|157293811|FG001|Overall Study|Enrolled but not treated|8|||
48851197|NCT04492475|157293810|FG000|Overall Study|Withdrawal by Subject|4|||
48851198|NCT04492475|157293811|FG001|Overall Study|Withdrawal by Subject|0|||
48851199|NCT04492475|157293810|FG000|Overall Study|Became ineligible after enrollment|2|||
48851200|NCT04492475|157293811|FG001|Overall Study|Became ineligible after enrollment|0|||
48851201|NCT00705159|157293812|FG000|Overall Study|Withdrawal by Subject|0|||
48851202|NCT00705159|157293813|FG001|Overall Study|Withdrawal by Subject|1|||
48851203|NCT00705159|157293814|FG002|Overall Study|Withdrawal by Subject|1|||
48851204|NCT00705159|157293815|FG003|Overall Study|Withdrawal by Subject|1|||
48851205|NCT00705159|157293812|FG000|Overall Study|Protocol Violation|0|||
48851206|NCT00705159|157293813|FG001|Overall Study|Protocol Violation|1|||
48851207|NCT00705159|157293814|FG002|Overall Study|Protocol Violation|0|||
48851208|NCT00705159|157293815|FG003|Overall Study|Protocol Violation|0|||
48851209|NCT00705159|157293812|FG000|Overall Study|Adverse Event|0|||
48851210|NCT00705159|157293813|FG001|Overall Study|Adverse Event|0|||
48851211|NCT00705159|157293814|FG002|Overall Study|Adverse Event|1|||
48851212|NCT00705159|157293815|FG003|Overall Study|Adverse Event|0|||
48851213|NCT00705159|157293812|FG000|Overall Study|Lost to Follow-up|0|||
48851214|NCT00705159|157293813|FG001|Overall Study|Lost to Follow-up|0|||
48851215|NCT00705159|157293814|FG002|Overall Study|Lost to Follow-up|3|||
48851216|NCT00705159|157293815|FG003|Overall Study|Lost to Follow-up|2|||
48851217|NCT00705159|157293812|FG000|Overall Study|Screen Failure|0|||
48851218|NCT00705159|157293813|FG001|Overall Study|Screen Failure|0|||
48851219|NCT00705159|157293814|FG002|Overall Study|Screen Failure|0|||
48851220|NCT00705159|157293815|FG003|Overall Study|Screen Failure|1|||
48851221|NCT01499849|157293816|FG000|Overall Study|Adverse Event|28|||
48851222|NCT01499849|157293817|FG001|Overall Study|Adverse Event|32|||
48851223|NCT01499849|157293816|FG000|Overall Study|Chemo completed or Change in Therapy|70|||
48851224|NCT01499849|157293817|FG001|Overall Study|Chemo completed or Change in Therapy|67|||
48851225|NCT01499849|157293816|FG000|Overall Study|Withdrawal by Subject|43|||
48851226|NCT01499849|157293817|FG001|Overall Study|Withdrawal by Subject|43|||
48851227|NCT01499849|157293816|FG000|Overall Study|Death|5|||
48851228|NCT01499849|157293817|FG001|Overall Study|Death|7|||
48851229|NCT01499849|157293816|FG000|Overall Study|Disease Progression|11|||
48851230|NCT01499849|157293817|FG001|Overall Study|Disease Progression|10|||
48851231|NCT01499849|157293816|FG000|Overall Study|Protocol Violation|11|||
48851232|NCT01499849|157293817|FG001|Overall Study|Protocol Violation|11|||
48851233|NCT01499849|157293816|FG000|Overall Study|Physician Decision|20|||
48851234|NCT01499849|157293817|FG001|Overall Study|Physician Decision|19|||
48851235|NCT01499849|157293816|FG000|Overall Study|Lack of Efficacy|3|||
48851236|NCT01499849|157293817|FG001|Overall Study|Lack of Efficacy|4|||
48851237|NCT01499849|157293816|FG000|Overall Study|Lost to Follow-up|6|||
48851238|NCT01499849|157293817|FG001|Overall Study|Lost to Follow-up|3|||
48851239|NCT01499849|157293816|FG000|Overall Study|Other Reasons|27|||
48851240|NCT01499849|157293817|FG001|Overall Study|Other Reasons|30|||
48851241|NCT02644122|157293826|FG000|Overall Study|Withdrawal by Subject|1|||
48851242|NCT02816398|157293837|FG000|Overall Study|Death|5|||
48851243|NCT02816398|157293837|FG000|Overall Study|Lack of Efficacy|8|||
48851244|NCT02816398|157293837|FG000|Overall Study|Lost to Follow-up|1|||
48851245|NCT03803475|157293838|FG000|Overall Study|Physician Decision|1|||
48851246|NCT02235298|157293839|FG000|Overall Study|Lost to Follow-up|6|||
48851247|NCT02235298|157293840|FG001|Overall Study|Lost to Follow-up|5|||
48851248|NCT02235298|157293839|FG000|Overall Study|Adverse Event|2|||
48851249|NCT02235298|157293840|FG001|Overall Study|Adverse Event|2|||
48851250|NCT02235298|157293839|FG000|Overall Study|Withdrawal by Subject|0|||
48851251|NCT02235298|157293840|FG001|Overall Study|Withdrawal by Subject|1|||
48851252|NCT00912964|157293843|FG000|Overall Study|Eligibility criterion not met|1|||
48851253|NCT00912964|157293844|FG001|Overall Study|Eligibility criterion not met|1|||
48851254|NCT00912964|157293845|FG002|Overall Study|Eligibility criterion not met|0|||
48851255|NCT00912964|157293843|FG000|Overall Study|Adverse Event|15|||
48851256|NCT00912964|157293844|FG001|Overall Study|Adverse Event|18|||
48851257|NCT00912964|157293845|FG002|Overall Study|Adverse Event|12|||
48851258|NCT00912964|157293843|FG000|Overall Study|Lack of Efficacy|11|||
48851259|NCT00912964|157293844|FG001|Overall Study|Lack of Efficacy|4|||
48851260|NCT00912964|157293845|FG002|Overall Study|Lack of Efficacy|3|||
48851261|NCT00912964|157293843|FG000|Overall Study|Withdrawal by Subject|20|||
48851262|NCT00912964|157293844|FG001|Overall Study|Withdrawal by Subject|12|||
48851263|NCT00912964|157293845|FG002|Overall Study|Withdrawal by Subject|18|||
48851264|NCT00912964|157293843|FG000|Overall Study|Lost to Follow-up|4|||
48851265|NCT00912964|157293844|FG001|Overall Study|Lost to Follow-up|3|||
48851266|NCT00912964|157293845|FG002|Overall Study|Lost to Follow-up|3|||
48851267|NCT00912964|157293843|FG000|Overall Study|Protocol Violation|5|||
48851268|NCT00912964|157293844|FG001|Overall Study|Protocol Violation|3|||
48851269|NCT00912964|157293845|FG002|Overall Study|Protocol Violation|8|||
48851270|NCT00912964|157293843|FG000|Overall Study|Taking exclusionary medications|7|||
48736077|NCT00866788|156885626|FG001|Overall Study|Pregnancy|1|||
48851271|NCT00912964|157293844|FG001|Overall Study|Taking exclusionary medications|4|||
48851272|NCT00912964|157293845|FG002|Overall Study|Taking exclusionary medications|8|||
48851273|NCT00912964|157293843|FG000|Overall Study|Medical History|1|||
48851274|NCT00912964|157293844|FG001|Overall Study|Medical History|0|||
48851275|NCT00912964|157293845|FG002|Overall Study|Medical History|0|||
49015308|NCT00814320|157892146|FG000|Epoch 1 (IV Treatment)|Withdrawal by Subject|1|||
48851276|NCT00912964|157293843|FG000|Overall Study|Non-compliance with study procedures|2|||
48851277|NCT00912964|157293844|FG001|Overall Study|Non-compliance with study procedures|0|||
48851278|NCT00912964|157293845|FG002|Overall Study|Non-compliance with study procedures|0|||
48851279|NCT00912964|157293843|FG000|Overall Study|Violation of exclusion criterion|0|||
48851280|NCT00912964|157293844|FG001|Overall Study|Violation of exclusion criterion|0|||
48851281|NCT00912964|157293845|FG002|Overall Study|Violation of exclusion criterion|2|||
48851282|NCT00912964|157293843|FG000|Overall Study|Randomized but never received study drug|0|||
48851283|NCT00912964|157293844|FG001|Overall Study|Randomized but never received study drug|1|||
48851284|NCT00912964|157293845|FG002|Overall Study|Randomized but never received study drug|0|||
48851285|NCT04447287|157293846|FG000|Period 1: Run-in Period|Adverse Event|3|||
48851286|NCT04447287|157293847|FG001|Period 1: Run-in Period|Adverse Event|0|||
48851287|NCT04447287|157293848|FG002|Period 1: Run-in Period|Adverse Event|0|||
48851288|NCT04447287|157293846|FG000|Period 1: Run-in Period|Withdrawal by Subject|1|||
48851289|NCT04447287|157293847|FG001|Period 1: Run-in Period|Withdrawal by Subject|0|||
48851290|NCT04447287|157293848|FG002|Period 1: Run-in Period|Withdrawal by Subject|0|||
48851291|NCT04447287|157293846|FG000|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|1|||
48851292|NCT04447287|157293847|FG001|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
48851293|NCT04447287|157293848|FG002|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
48851294|NCT01000805|157293851|FG000|Overall Study|Adverse Event|21|||
48851295|NCT01000805|157293852|FG001|Overall Study|Adverse Event|9|||
48851296|NCT01000805|157293851|FG000|Overall Study|Lack of Efficacy|5|||
48851297|NCT01000805|157293852|FG001|Overall Study|Lack of Efficacy|16|||
48851298|NCT01000805|157293851|FG000|Overall Study|Lost to Follow-up|16|||
48851299|NCT01000805|157293852|FG001|Overall Study|Lost to Follow-up|21|||
48851300|NCT01000805|157293851|FG000|Overall Study|Physician Decision|0|||
48851301|NCT01000805|157293852|FG001|Overall Study|Physician Decision|1|||
48851302|NCT01000805|157293851|FG000|Overall Study|Protocol Violation|12|||
48851303|NCT01000805|157293852|FG001|Overall Study|Protocol Violation|8|||
48851304|NCT01000805|157293851|FG000|Overall Study|Withdrawal by Subject|16|||
48851305|NCT01000805|157293852|FG001|Overall Study|Withdrawal by Subject|6|||
48851306|NCT01000805|157293851|FG000|Overall Study|Sponsor Decision|0|||
48851307|NCT01000805|157293852|FG001|Overall Study|Sponsor Decision|1|||
48851308|NCT03345095|157293855|FG000|Overall Study|Lack of Efficacy|184|||
48851309|NCT03345095|157293856|FG001|Overall Study|Lack of Efficacy|156|||
48851310|NCT03345095|157293855|FG000|Overall Study|Adverse Event|36|||
48851311|NCT03345095|157293856|FG001|Overall Study|Adverse Event|118|||
48851312|NCT03345095|157293855|FG000|Overall Study|Withdrawal by Subject|22|||
48851313|NCT03345095|157293856|FG001|Overall Study|Withdrawal by Subject|59|||
48851314|NCT03345095|157293855|FG000|Overall Study|Physician Decision|3|||
48851315|NCT03345095|157293856|FG001|Overall Study|Physician Decision|18|||
48851316|NCT03345095|157293855|FG000|Overall Study|Death|2|||
48851317|NCT03345095|157293856|FG001|Overall Study|Death|4|||
48851318|NCT03345095|157293855|FG000|Overall Study|Other reasons|2|||
48851319|NCT03345095|157293856|FG001|Overall Study|Other reasons|11|||
48851320|NCT03345095|157293855|FG000|Overall Study|Protocol Violation|0|||
48851321|NCT03345095|157293856|FG001|Overall Study|Protocol Violation|1|||
48851322|NCT02542943|157293857|FG000|Overall Study|Lost to Follow-up|1|||
48851323|NCT02542943|157293858|FG001|Overall Study|Lost to Follow-up|0|||
48851324|NCT02542943|157293859|FG002|Overall Study|Lost to Follow-up|0|||
48851325|NCT02542943|157293857|FG000|Overall Study|Withdrawal by Subject|0|||
48851326|NCT02542943|157293858|FG001|Overall Study|Withdrawal by Subject|1|||
48851327|NCT02542943|157293859|FG002|Overall Study|Withdrawal by Subject|0|||
48856565|NCT00446095|157312874|FG002|Phase I (28 Days)|Lack of Efficacy|0|||
48856566|NCT00446095|157312875|FG003|Phase I (28 Days)|Lack of Efficacy|0|||
48856567|NCT00446095|157312876|FG004|Phase I (28 Days)|Lack of Efficacy|3|||
48856568|NCT03692871|157312877|FG000|Overall Study|Death|1|||
48856569|NCT03692871|157312878|FG001|Overall Study|Death|1|||
48856570|NCT03692871|157312877|FG000|Overall Study|Lost to Follow-up|24|||
48856571|NCT03692871|157312878|FG001|Overall Study|Lost to Follow-up|9|||
48856572|NCT03692871|157312877|FG000|Overall Study|Physician Decision|22|||
48856573|NCT03692871|157312878|FG001|Overall Study|Physician Decision|7|||
48856574|NCT03692871|157312877|FG000|Overall Study|Protocol Deviation|1|||
48856575|NCT03692871|157312878|FG001|Overall Study|Protocol Deviation|0|||
48856576|NCT03692871|157312877|FG000|Overall Study|Withdrawal by Parent/Guardian|77|||
48856577|NCT03692871|157312878|FG001|Overall Study|Withdrawal by Parent/Guardian|20|||
48856578|NCT02833948|157312879|FG000|Overall Study|Death|2|||
48856579|NCT02833948|157312880|FG001|Overall Study|Death|3|||
48856580|NCT02833948|157312879|FG000|Overall Study|were not scanned|8|||
48856581|NCT02833948|157312880|FG001|Overall Study|were not scanned|13|||
48856582|NCT02833948|157312879|FG000|Overall Study|scans could not be evaluated|5|||
48856583|NCT02833948|157312880|FG001|Overall Study|scans could not be evaluated|2|||
48856584|NCT01930188|157312881|FG000|Overall Study|unclassified|4|||
48856585|NCT01930188|157312882|FG001|Overall Study|unclassified|5|||
48856586|NCT01930188|157312883|FG002|Overall Study|unclassified|3|||
48856587|NCT01930188|157312881|FG000|Overall Study|Missing follow-up information|2|||
48851328|NCT00655499|157295256|FG000|Overall Study|not eligible|4|||
48851329|NCT03140670|157295257|FG000|Overall Study|Withdrawal by Subject|2|||
48851330|NCT03140670|157295257|FG000|Overall Study|Lost to Follow-up|1|||
48851331|NCT03140670|157295257|FG000|Overall Study|Physician Decision|1|||
48851332|NCT02325466|157295258|FG000|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
48851333|NCT02325466|157295259|FG001|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
48851334|NCT02325466|157295260|FG002|Period 1 Timeframe - Baseline to Week 4|Adverse Event|1|||
48851335|NCT02325466|157295258|FG000|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
48851336|NCT02325466|157295259|FG001|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|2|||
48851337|NCT02325466|157295260|FG002|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
48851338|NCT02325466|157295258|FG000|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|1|||
48851339|NCT02325466|157295259|FG001|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|0|||
48851340|NCT02325466|157295260|FG002|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|2|||
48851341|NCT02325466|157295258|FG000|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|1|||
48851342|NCT02325466|157295259|FG001|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
48851343|NCT02325466|157295260|FG002|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
48851344|NCT02325466|157295258|FG000|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
48851345|NCT02325466|157295259|FG001|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
48851346|NCT02325466|157295260|FG002|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|0|||
48851347|NCT02325466|157295258|FG000|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|1|||
48851348|NCT02325466|157295259|FG001|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
48851349|NCT02325466|157295260|FG002|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
48851350|NCT02325466|157295258|FG000|3rd Crossover - Week 10 to Week 16|Adverse Event|1|||
48851351|NCT02325466|157295259|FG001|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
48851352|NCT02325466|157295260|FG002|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
48851353|NCT02325466|157295258|FG000|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
48851354|NCT02325466|157295259|FG001|3rd Crossover - Week 10 to Week 16|Protocol Violation|1|||
48851355|NCT02325466|157295260|FG002|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
48851356|NCT02325466|157295258|FG000|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
48851357|NCT02325466|157295259|FG001|3rd Crossover - Week 10 to Week 16|urgent vascularization|1|||
48851358|NCT02325466|157295260|FG002|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
48851359|NCT03352713|157295262|FG000|Overall Study|Lost to Follow-up|8|||
48851360|NCT03352713|157295262|FG000|Overall Study|Withdrawn by investigator|5|||
48851361|NCT03352713|157295262|FG000|Overall Study|Completed 0 EMAs|8|||
48851362|NCT03352713|157295262|FG000|Overall Study|Device incompatible/stolen|5|||
48851363|NCT01812759|157295263|FG000|Overall Study|Physician Decision|0|||
48851364|NCT01812759|157295264|FG001|Overall Study|Physician Decision|0|||
48851365|NCT01812759|157295265|FG002|Overall Study|Physician Decision|1|||
48851366|NCT00536120|157295266|FG000|Overall Study|Lost to Follow-up|1|||
48851367|NCT00536120|157295267|FG001|Overall Study|Lost to Follow-up|0|||
48851368|NCT00536120|157295266|FG000|Overall Study|Positive for Anti-natalizumab Antibodies|3|||
48851369|NCT00536120|157295267|FG001|Overall Study|Positive for Anti-natalizumab Antibodies|0|||
48851370|NCT00536120|157295266|FG000|Overall Study|Non-compliance|1|||
48851371|NCT00536120|157295267|FG001|Overall Study|Non-compliance|0|||
48851372|NCT00536120|157295266|FG000|Overall Study|Sponsor Decision Due to Lab Values|1|||
48851373|NCT00536120|157295267|FG001|Overall Study|Sponsor Decision Due to Lab Values|0|||
48851374|NCT00536120|157295266|FG000|Overall Study|Steroid Use|0|||
48851375|NCT00536120|157295267|FG001|Overall Study|Steroid Use|2|||
48851376|NCT00536120|157295266|FG000|Overall Study|Missed Study Visit|0|||
48851377|NCT00536120|157295267|FG001|Overall Study|Missed Study Visit|1|||
48851378|NCT02722434|157295268|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
48851379|NCT02722434|157295269|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
48851380|NCT02722434|157295268|FG000|Overall Study|Withdrawal After Beginning Treatment|0|||
48851381|NCT02722434|157295269|FG001|Overall Study|Withdrawal After Beginning Treatment|3|||
48851382|NCT00949117|157295270|FG000|Overall Study|Lack of Efficacy|2|||
48851383|NCT00949117|157295271|FG001|Overall Study|Lack of Efficacy|3|||
48851384|NCT00949117|157295270|FG000|Overall Study|Protocol Violation|1|||
48851385|NCT00949117|157295271|FG001|Overall Study|Protocol Violation|1|||
48851386|NCT00949117|157295270|FG000|Overall Study|Adverse Event|0|||
48851387|NCT00949117|157295271|FG001|Overall Study|Adverse Event|1|||
48851388|NCT00360269|157295272|FG000|Overall Study|Lost to Follow-up|7|||
48851389|NCT00360269|157295273|FG001|Overall Study|Lost to Follow-up|9|||
48851390|NCT00360269|157295272|FG000|Overall Study|Physician Decision|1|||
48851391|NCT00360269|157295273|FG001|Overall Study|Physician Decision|2|||
48851392|NCT00360269|157295272|FG000|Overall Study|Adverse Event|1|||
48851393|NCT00360269|157295273|FG001|Overall Study|Adverse Event|0|||
48851394|NCT00360269|157295272|FG000|Overall Study|Withdrawal by Subject|1|||
48851395|NCT00360269|157295273|FG001|Overall Study|Withdrawal by Subject|1|||
48851396|NCT03002194|157295274|FG000|Overall Study|Lost to Follow-up|6|||
48851397|NCT03002194|157295274|FG000|Overall Study|Adverse Event|1|||
48851398|NCT03002194|157295274|FG000|Overall Study|Lack of Efficacy|1|||
48851399|NCT03002194|157295274|FG000|Overall Study|Withdrawal by Subject|2|||
48851400|NCT04559698|157295278|FG000|Overall Study|Lost to Follow-up|14|||
48851401|NCT04559698|157295279|FG001|Overall Study|Lost to Follow-up|15|||
48851402|NCT04559698|157295278|FG000|Overall Study|Withdrawal by Subject|0|||
48851403|NCT04559698|157295279|FG001|Overall Study|Withdrawal by Subject|1|||
48851404|NCT01278030|157295280|FG000|Overall Study|Withdrawal by Subject|8|||
48851405|NCT01278030|157295281|FG001|Overall Study|Withdrawal by Subject|4|||
48851406|NCT02760654|157295282|FG000|Overall Study|Lost to Follow-up|3|||
48851407|NCT02760654|157295283|FG001|Overall Study|Lost to Follow-up|3|||
48851408|NCT02760654|157295282|FG000|Overall Study|Withdrawal by Subject|4|||
48851409|NCT02760654|157295283|FG001|Overall Study|Withdrawal by Subject|3|||
48851410|NCT00786864|157295284|FG000|Overall Study|Lost to Follow-up|0|||
48851411|NCT00786864|157295285|FG001|Overall Study|Lost to Follow-up|1|||
48946306|NCT03894540|157634693|FG001|Overall Study|Study termination by sponsor|0|||
48851412|NCT00786864|157295284|FG000|Overall Study|Sustained serious back injury|1|||
48851413|NCT00786864|157295285|FG001|Overall Study|Sustained serious back injury|0|||
48851414|NCT00065182|157295290|FG000|Overall Study|Adverse Event|24|||
48851415|NCT00065182|157295291|FG001|Overall Study|Adverse Event|17|||
48851416|NCT00065182|157295290|FG000|Overall Study|Lost to Follow-up|0|||
48851417|NCT00065182|157295291|FG001|Overall Study|Lost to Follow-up|4|||
48851418|NCT00065182|157295290|FG000|Overall Study|Protocol Violation|3|||
48851419|NCT00065182|157295291|FG001|Overall Study|Protocol Violation|4|||
48851420|NCT00065182|157295290|FG000|Overall Study|Serious adverse events (SAE)|1|||
48851421|NCT00065182|157295291|FG001|Overall Study|Serious adverse events (SAE)|0|||
48851422|NCT00065182|157295290|FG000|Overall Study|Sponsor Decision|11|||
48851423|NCT00065182|157295291|FG001|Overall Study|Sponsor Decision|7|||
48851424|NCT00065182|157295290|FG000|Overall Study|Withdrawal by Subject|8|||
48851425|NCT00065182|157295291|FG001|Overall Study|Withdrawal by Subject|3|||
48851426|NCT00065182|157295290|FG000|Overall Study|No clinical benefit|1|||
48851427|NCT00065182|157295291|FG001|Overall Study|No clinical benefit|0|||
48851428|NCT00065182|157295290|FG000|Overall Study|Death|0|||
48851429|NCT00065182|157295291|FG001|Overall Study|Death|1|||
48851430|NCT00065182|157295290|FG000|Overall Study|Decline in Status|0|||
48851431|NCT00065182|157295291|FG001|Overall Study|Decline in Status|1|||
48851432|NCT03244800|157295292|FG000|Overall Study|Adverse Event|0|||
48851433|NCT03244800|157295293|FG001|Overall Study|Adverse Event|1|||
48851434|NCT03244800|157295294|FG002|Overall Study|Adverse Event|0|||
48851435|NCT03244800|157295295|FG003|Overall Study|Adverse Event|1|||
48851436|NCT03244800|157295292|FG000|Overall Study|Withdrew treatment|0|||
48851437|NCT03244800|157295293|FG001|Overall Study|Withdrew treatment|0|||
48851438|NCT03244800|157295294|FG002|Overall Study|Withdrew treatment|0|||
48851439|NCT03244800|157295295|FG003|Overall Study|Withdrew treatment|1|||
48851440|NCT03478969|157295296|FG000|Overall Study|Withdrawal by Subject|4|||
48851441|NCT03478969|157295297|FG001|Overall Study|Withdrawal by Subject|7|||
48946307|NCT03894540|157634694|FG002|Overall Study|Study termination by sponsor|0|||
48946308|NCT03894540|157634695|FG003|Overall Study|Study termination by sponsor|0|||
48946309|NCT03894540|157634696|FG004|Overall Study|Study termination by sponsor|2|||
48851442|NCT03478969|157295298|FG002|Overall Study|Withdrawal by Subject|6|||
48851443|NCT03478969|157295296|FG000|Overall Study|Adverse Event|2|||
48851444|NCT03478969|157295297|FG001|Overall Study|Adverse Event|0|||
48851445|NCT03478969|157295298|FG002|Overall Study|Adverse Event|1|||
48851446|NCT03478969|157295296|FG000|Overall Study|Pregnancy|1|||
48851447|NCT03478969|157295297|FG001|Overall Study|Pregnancy|0|||
48851448|NCT03478969|157295298|FG002|Overall Study|Pregnancy|0|||
48851449|NCT03478969|157295296|FG000|Overall Study|Personal Reasons|1|||
48851450|NCT03478969|157295297|FG001|Overall Study|Personal Reasons|0|||
48851451|NCT03478969|157295298|FG002|Overall Study|Personal Reasons|1|||
48851452|NCT03478969|157295296|FG000|Overall Study|Covid-19|1|||
48851453|NCT03478969|157295297|FG001|Overall Study|Covid-19|4|||
48851454|NCT03478969|157295298|FG002|Overall Study|Covid-19|3|||
48851455|NCT03478969|157295296|FG000|Overall Study|Multiple Reasons|0|||
48851456|NCT03478969|157295297|FG001|Overall Study|Multiple Reasons|1|||
48851457|NCT03478969|157295298|FG002|Overall Study|Multiple Reasons|1|||
48851458|NCT03478969|157295296|FG000|Overall Study|Eligibility Criteria|0|||
48851459|NCT03478969|157295297|FG001|Overall Study|Eligibility Criteria|0|||
48851460|NCT03478969|157295298|FG002|Overall Study|Eligibility Criteria|5|||
48851461|NCT03478969|157295296|FG000|Overall Study|Lost to Follow-up|0|||
48851462|NCT03478969|157295297|FG001|Overall Study|Lost to Follow-up|0|||
48851463|NCT03478969|157295298|FG002|Overall Study|Lost to Follow-up|1|||
48851464|NCT03653364|157295304|FG000|Overall Study|Withdrawal by Subject|1|||
48851465|NCT03653364|157295304|FG000|Overall Study|Enrolled in Error|1|||
48851466|NCT03653364|157295304|FG000|Overall Study|Death|1|||
48851467|NCT02941549|157295305|FG000|Overall Study|Adverse Event|1|||
48851468|NCT02941549|157295306|FG001|Overall Study|Adverse Event|0|||
48851469|NCT02941549|157295307|FG002|Overall Study|Adverse Event|0|||
48851470|NCT02941549|157295305|FG000|Overall Study|Withdrawal by Subject|2|||
48851471|NCT02941549|157295306|FG001|Overall Study|Withdrawal by Subject|1|||
48851472|NCT02941549|157295307|FG002|Overall Study|Withdrawal by Subject|2|||
48851473|NCT00512252|157295309|FG000|Overall Study|Lost to Follow-up|0|||
48851474|NCT00512252|157295310|FG001|Overall Study|Lost to Follow-up|0|||
48851475|NCT00512252|157295311|FG002|Overall Study|Lost to Follow-up|1|||
48851476|NCT00512252|157295309|FG000|Overall Study|Protocol Violation|0|||
48851477|NCT00512252|157295310|FG001|Overall Study|Protocol Violation|0|||
48851478|NCT00512252|157295311|FG002|Overall Study|Protocol Violation|1|||
48851479|NCT00512252|157295309|FG000|Overall Study|Death|0|||
48851480|NCT00512252|157295310|FG001|Overall Study|Death|0|||
48851481|NCT00512252|157295311|FG002|Overall Study|Death|1|||
48851482|NCT00705406|157295314|FG000|Overall Study|Lost to Follow-up|3|||
48851483|NCT00705406|157295315|FG001|Overall Study|Lost to Follow-up|3|||
48851484|NCT00705406|157295314|FG000|Overall Study|Did not receive study drug|1|||
48851485|NCT00705406|157295315|FG001|Overall Study|Did not receive study drug|2|||
48851486|NCT01079806|157295316|FG000|Day 1 to Week 96|Adverse Event|0|||
48851487|NCT01079806|157295317|FG001|Day 1 to Week 96|Adverse Event|3|||
48851488|NCT01079806|157295316|FG000|Day 1 to Week 96|Withdrawal by Subject|3|||
48851489|NCT01079806|157295317|FG001|Day 1 to Week 96|Withdrawal by Subject|2|||
48851490|NCT01079806|157295316|FG000|Day 1 to Week 96|Pregnancy|0|||
48851491|NCT01079806|157295317|FG001|Day 1 to Week 96|Pregnancy|1|||
48851492|NCT01079806|157295316|FG000|Day 1 to Week 96|Poor compliance or noncompliance|2|||
48851493|NCT01079806|157295317|FG001|Day 1 to Week 96|Poor compliance or noncompliance|0|||
48851494|NCT01079806|157295316|FG000|Day 1 to Week 96|Lost to Follow-up|1|||
48851495|NCT01079806|157295317|FG001|Day 1 to Week 96|Lost to Follow-up|0|||
48851496|NCT01079806|157295316|FG000|Day 1 to Week 96|Subject request to stop study treatment|1|||
48851497|NCT01079806|157295317|FG001|Day 1 to Week 96|Subject request to stop study treatment|0|||
48851498|NCT01079806|157295316|FG000|Day 1 to Week 96|Removal by Medical Monitor|0|||
48851499|NCT01079806|157295317|FG001|Day 1 to Week 96|Removal by Medical Monitor|1|||
48851500|NCT01079806|157295316|FG000|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13|||
48851501|NCT01079806|157295317|FG001|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8|||
48851502|NCT01079806|157295316|FG000|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0|||
48851503|NCT01079806|157295317|FG001|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1|||
48851504|NCT01079806|157295316|FG000|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
48851505|NCT01079806|157295317|FG001|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
48851506|NCT01779700|157295318|FG000|Overall Study|Adverse Event|4|||
48851507|NCT01779700|157295319|FG001|Overall Study|Adverse Event|3|||
48851508|NCT01779700|157295318|FG000|Overall Study|Withdrawal by Subject|0|||
48851509|NCT01779700|157295319|FG001|Overall Study|Withdrawal by Subject|2|||
48851510|NCT00739934|157295322|FG000|Voriconazole IV|Adverse Event|6|||
48851511|NCT00739934|157295322|FG000|Voriconazole Oral|Other|3|||
48851512|NCT02455557|157295323|FG000|Overall Study|Withdrawal by Subject|2|||
48851513|NCT03418922|157295324|FG000|Overall Study|Withdrawal by Subject|0|||
48851514|NCT03418922|157295325|FG001|Overall Study|Withdrawal by Subject|2|||
48851515|NCT03418922|157295324|FG000|Overall Study|Adverse Event|2|||
48851516|NCT03418922|157295325|FG001|Overall Study|Adverse Event|2|||
48851517|NCT03418922|157295324|FG000|Overall Study|Death|0|||
48851518|NCT03418922|157295325|FG001|Overall Study|Death|1|||
48851519|NCT03418922|157295324|FG000|Overall Study|Physician Decision|0|||
48851520|NCT03418922|157295325|FG001|Overall Study|Physician Decision|1|||
48851521|NCT03451422|157295327|FG000|Overall Study|Lost to Follow-up|0|||
48851522|NCT03451422|157295328|FG001|Overall Study|Lost to Follow-up|0|||
48851523|NCT03451422|157295329|FG002|Overall Study|Lost to Follow-up|0|||
48851524|NCT03451422|157295330|FG003|Overall Study|Lost to Follow-up|0|||
48851525|NCT03451422|157295331|FG004|Overall Study|Lost to Follow-up|0|||
48851526|NCT03451422|157295332|FG005|Overall Study|Lost to Follow-up|1|||
48851527|NCT03451422|157295327|FG000|Overall Study|Decision by sponsor|1|||
48851528|NCT03451422|157295328|FG001|Overall Study|Decision by sponsor|0|||
48851529|NCT03451422|157295329|FG002|Overall Study|Decision by sponsor|1|||
48851530|NCT03451422|157295330|FG003|Overall Study|Decision by sponsor|0|||
48851531|NCT03451422|157295331|FG004|Overall Study|Decision by sponsor|0|||
48851532|NCT03451422|157295332|FG005|Overall Study|Decision by sponsor|0|||
48851533|NCT03451422|157295327|FG000|Overall Study|Withdrawal by Subject|0|||
48851534|NCT03451422|157295328|FG001|Overall Study|Withdrawal by Subject|0|||
48851535|NCT03451422|157295329|FG002|Overall Study|Withdrawal by Subject|2|||
48851536|NCT03451422|157295330|FG003|Overall Study|Withdrawal by Subject|3|||
48851537|NCT03451422|157295331|FG004|Overall Study|Withdrawal by Subject|2|||
48851538|NCT03451422|157295332|FG005|Overall Study|Withdrawal by Subject|1|||
48851539|NCT00403494|157295333|FG000|Overall Study|Adverse Event|10|||
48851540|NCT00403494|157295334|FG001|Overall Study|Adverse Event|8|||
48851541|NCT00403494|157295333|FG000|Overall Study|Withdrew Consent|3|||
48851542|NCT00403494|157295334|FG001|Overall Study|Withdrew Consent|2|||
48851543|NCT00403494|157295333|FG000|Overall Study|Inappropriately enrolled|0|||
48851544|NCT00403494|157295334|FG001|Overall Study|Inappropriately enrolled|1|||
48851545|NCT00403494|157295333|FG000|Overall Study|Lost to Follow-up|0|||
48851546|NCT00403494|157295334|FG001|Overall Study|Lost to Follow-up|2|||
48851547|NCT00403494|157295333|FG000|Overall Study|Protocol noncompliance|0|||
48851548|NCT00403494|157295334|FG001|Overall Study|Protocol noncompliance|1|||
48851549|NCT00403494|157295333|FG000|Overall Study|Death|1|||
48851550|NCT00403494|157295334|FG001|Overall Study|Death|0|||
48851551|NCT00403494|157295333|FG000|Overall Study|Sponsor Request|1|||
48851552|NCT00403494|157295334|FG001|Overall Study|Sponsor Request|0|||
48851553|NCT03274076|157295339|FG000|24 Weeks Double Blind|Withdrawal by Subject|0|||
48851554|NCT03274076|157295340|FG001|24 Weeks Double Blind|Withdrawal by Subject|1|||
48851555|NCT03274076|157295341|FG002|24 Weeks Double Blind|Withdrawal by Subject|0|||
48851556|NCT03274076|157295342|FG003|24 Weeks Double Blind|Withdrawal by Subject|0|||
48851557|NCT03274076|157295339|FG000|24 Weeks Open Label|Adverse Event|0|||
48851558|NCT03274076|157295340|FG001|24 Weeks Open Label|Adverse Event|0|||
48851559|NCT03274076|157295341|FG002|24 Weeks Open Label|Adverse Event|2|||
48851560|NCT03274076|157295342|FG003|24 Weeks Open Label|Adverse Event|0|||
48946310|NCT03894540|157634697|FG005|Overall Study|Study termination by sponsor|0|||
48946311|NCT02723630|157634699|FG000|Intervention Period 1|Adverse Event|1|||
48946312|NCT02723630|157634700|FG001|Intervention Period 1|Adverse Event|0|||
48946313|NCT02723630|157634701|FG002|Intervention Period 1|Adverse Event|0|||
48946314|NCT02723630|157634702|FG003|Intervention Period 1|Adverse Event|0|||
48946315|NCT02723630|157634703|FG004|Intervention Period 1|Adverse Event|0|||
48946316|NCT02723630|157634704|FG005|Intervention Period 1|Adverse Event|0|||
48946317|NCT02723630|157634699|FG000|Intervention Period 3|consumption of restricted item|0|||
48946318|NCT02723630|157634700|FG001|Intervention Period 3|consumption of restricted item|1|||
48946319|NCT02723630|157634701|FG002|Intervention Period 3|consumption of restricted item|0|||
48946320|NCT02723630|157634702|FG003|Intervention Period 3|consumption of restricted item|0|||
48946321|NCT02723630|157634703|FG004|Intervention Period 3|consumption of restricted item|0|||
48946322|NCT02723630|157634704|FG005|Intervention Period 3|consumption of restricted item|0|||
48946323|NCT00537745|157634705|FG000|Overall Study|Did not meet eligibility criteria|2|||
48946324|NCT00537745|157634705|FG000|Overall Study|Withdrawal by Subject|2|||
48946325|NCT00537745|157634705|FG000|Overall Study|Subject unable to provide Interlock info|1|||
48946326|NCT05372315|157634706|FG000|Overall Study|Withdrawal by Subject|1|||
48946327|NCT05372315|157634707|FG001|Overall Study|Withdrawal by Subject|0|||
48946328|NCT02240628|157634708|FG000|Overall Study|Physician Decision|6|||
48946329|NCT02240628|157634709|FG001|Overall Study|Physician Decision|5|||
48946330|NCT00922935|157634710|FG000|Overall Study|Protocol Violation|0|||
48851561|NCT03274076|157295339|FG000|24 Weeks Open Label|Withdrawal by Subject|0|||
48851562|NCT03274076|157295340|FG001|24 Weeks Open Label|Withdrawal by Subject|0|||
48851563|NCT03274076|157295341|FG002|24 Weeks Open Label|Withdrawal by Subject|0|||
48851564|NCT03274076|157295342|FG003|24 Weeks Open Label|Withdrawal by Subject|1|||
48851565|NCT01619059|157295346|FG000|Short-Term (ST) Treatment Period|Adverse Event|1|||
48946331|NCT00922935|157634711|FG001|Overall Study|Protocol Violation|3|||
48946332|NCT00922935|157634712|FG002|Overall Study|Protocol Violation|0|||
48946333|NCT00922935|157634710|FG000|Overall Study|Physician Decision|1|||
48946334|NCT00922935|157634711|FG001|Overall Study|Physician Decision|1|||
48946335|NCT00922935|157634712|FG002|Overall Study|Physician Decision|0|||
48946336|NCT00922935|157634710|FG000|Overall Study|Lost to Follow-up|0|||
48851566|NCT01619059|157295347|FG001|Short-Term (ST) Treatment Period|Adverse Event|0|||
48851567|NCT01619059|157295346|FG000|Short-Term (ST) Treatment Period|Withdrawal by Subject|2|||
48851568|NCT01619059|157295347|FG001|Short-Term (ST) Treatment Period|Withdrawal by Subject|5|||
48851569|NCT01619059|157295346|FG000|Short-Term (ST) Treatment Period|Lost to Follow-up|2|||
48851570|NCT01619059|157295347|FG001|Short-Term (ST) Treatment Period|Lost to Follow-up|4|||
48851571|NCT01619059|157295346|FG000|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1|||
48851572|NCT01619059|157295347|FG001|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2|||
48851573|NCT01619059|157295346|FG000|Long-Term (LT) Treatment Period|Lack of Efficacy|0|||
48851574|NCT01619059|157295347|FG001|Long-Term (LT) Treatment Period|Lack of Efficacy|1|||
48946337|NCT00922935|157634711|FG001|Overall Study|Lost to Follow-up|1|||
48946338|NCT00922935|157634712|FG002|Overall Study|Lost to Follow-up|0|||
48946339|NCT02532543|157634713|FG000|Overall Study|Lost to Follow-up|0|||
48946340|NCT02532543|157634714|FG001|Overall Study|Lost to Follow-up|0|||
48946341|NCT02532543|157634715|FG002|Overall Study|Lost to Follow-up|1|||
48851575|NCT01619059|157295346|FG000|Long-Term (LT) Treatment Period|Adverse Event|2|||
48946342|NCT02532543|157634716|FG003|Overall Study|Lost to Follow-up|0|||
48946343|NCT00650585|157634717|FG000|Overall Study|Lost to Follow-up|505|||
48851576|NCT01619059|157295347|FG001|Long-Term (LT) Treatment Period|Adverse Event|3|||
48851577|NCT01619059|157295346|FG000|Long-Term (LT) Treatment Period|Withdrawal by Subject|3|||
48851578|NCT01619059|157295347|FG001|Long-Term (LT) Treatment Period|Withdrawal by Subject|2|||
48851579|NCT01619059|157295346|FG000|Long-Term (LT) Treatment Period|Death|1|||
48946344|NCT00650585|157634718|FG001|Overall Study|Lost to Follow-up|482|||
48851580|NCT01619059|157295347|FG001|Long-Term (LT) Treatment Period|Death|0|||
48851581|NCT01619059|157295346|FG000|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
48851582|NCT01619059|157295347|FG001|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
48851583|NCT01619059|157295346|FG000|Long-Term (LT) Treatment Period|Not Met Study Criteria|0|||
48946345|NCT00650585|157634717|FG000|Overall Study|No parental consent|935|||
48946346|NCT00650585|157634718|FG001|Overall Study|No parental consent|866|||
48946347|NCT00650585|157634717|FG000|Overall Study|Excluded/ruled ineligible|357|||
48851584|NCT01619059|157295347|FG001|Long-Term (LT) Treatment Period|Not Met Study Criteria|1|||
48946348|NCT00650585|157634718|FG001|Overall Study|Excluded/ruled ineligible|129|||
48946349|NCT02385123|157634719|FG000|Overall Study|15 participants were unable to complete study. Research was halted due to Coronavirus Disease 2019.|15|||
48946350|NCT00923091|157634727|FG000|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11|||
48946351|NCT00923091|157634728|FG001|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3|||
48946352|NCT00923091|157634729|FG002|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7|||
48946353|NCT00923091|157634730|FG003|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13|||
48946354|NCT00923091|157634731|FG004|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10|||
48946355|NCT00923091|157634732|FG005|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5|||
48946356|NCT00923091|157634733|FG006|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9|||
48946357|NCT00923091|157634734|FG007|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17|||
48946358|NCT00923091|157634735|FG008|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
48946359|NCT00923091|157634736|FG009|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
48946360|NCT00923091|157634737|FG010|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
48946361|NCT00923091|157634738|FG011|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
48946362|NCT00923091|157634739|FG012|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
48946363|NCT00923091|157634727|FG000|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4|||
48946364|NCT00923091|157634728|FG001|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
48946365|NCT00923091|157634729|FG002|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
48946366|NCT00923091|157634730|FG003|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8|||
48946367|NCT00923091|157634731|FG004|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7|||
48946368|NCT00923091|157634732|FG005|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
48946369|NCT00923091|157634733|FG006|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
48946370|NCT00923091|157634734|FG007|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
48946371|NCT00923091|157634735|FG008|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
48946372|NCT00923091|157634736|FG009|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
48946373|NCT00923091|157634737|FG010|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
48946374|NCT00923091|157634738|FG011|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
48736078|NCT00866788|156885627|FG002|Overall Study|Pregnancy|0|||
48946375|NCT00923091|157634739|FG012|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
48946376|NCT00923091|157634727|FG000|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
48946377|NCT00923091|157634728|FG001|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
48946378|NCT00923091|157634729|FG002|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
49015309|NCT00814320|157892147|FG001|Epoch 1 (IV Treatment)|Withdrawal by Subject|0|||
48851585|NCT00148122|157295348|FG000|Overall Study|Withdrawal by Subject|2|||
48851586|NCT00523419|157295349|FG000|Overall Study|Adverse Event|1|||
48851587|NCT00523419|157295349|FG000|Overall Study|Withdrawal by Subject|1|||
48851588|NCT00523419|157295349|FG000|Overall Study|Physician Decision|2|||
48851589|NCT00523419|157295349|FG000|Overall Study|Progressive Disease|22|||
48851590|NCT00523419|157295349|FG000|Overall Study|Death due to Study Disease|4|||
48851591|NCT00523419|157295349|FG000|Overall Study|Death due to Adverse Event|2|||
48851592|NCT01957163|157295350|FG000|Overall Study|Adverse Event|5|||
48851593|NCT01957163|157295351|FG001|Overall Study|Adverse Event|2|||
48851594|NCT01957163|157295352|FG002|Overall Study|Adverse Event|4|||
48851595|NCT01957163|157295350|FG000|Overall Study|Lack of Efficacy|5|||
48946379|NCT00923091|157634730|FG003|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5|||
48946380|NCT00923091|157634731|FG004|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
48946381|NCT00923091|157634732|FG005|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2|||
48946382|NCT00923091|157634733|FG006|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
48946383|NCT00923091|157634734|FG007|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3|||
48736079|NCT00866788|156885628|FG003|Overall Study|Pregnancy|0|||
48736080|NCT00866788|156885625|FG000|Overall Study|Disease progression|3|||
48736081|NCT00866788|156885626|FG001|Overall Study|Disease progression|1|||
48736082|NCT00866788|156885627|FG002|Overall Study|Disease progression|1|||
48736083|NCT00866788|156885628|FG003|Overall Study|Disease progression|0|||
48736084|NCT00866788|156885625|FG000|Overall Study|Physician Decision|0|||
48851596|NCT01957163|157295351|FG001|Overall Study|Lack of Efficacy|4|||
48851597|NCT01957163|157295352|FG002|Overall Study|Lack of Efficacy|9|||
48851598|NCT01957163|157295350|FG000|Overall Study|Protocol Violation|1|||
48851599|NCT01957163|157295351|FG001|Overall Study|Protocol Violation|2|||
48851600|NCT01957163|157295352|FG002|Overall Study|Protocol Violation|0|||
48851601|NCT01957163|157295350|FG000|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
48851602|NCT01957163|157295351|FG001|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
48851603|NCT01957163|157295352|FG002|Overall Study|Met Protocol-Defined Stopping Criteria|1|||
48851604|NCT01957163|157295350|FG000|Overall Study|Lost to Follow-up|0|||
48851605|NCT01957163|157295351|FG001|Overall Study|Lost to Follow-up|1|||
48851606|NCT01957163|157295352|FG002|Overall Study|Lost to Follow-up|0|||
48851607|NCT01957163|157295350|FG000|Overall Study|Withdrawal by Subject|4|||
48851608|NCT01957163|157295351|FG001|Overall Study|Withdrawal by Subject|2|||
48851609|NCT01957163|157295352|FG002|Overall Study|Withdrawal by Subject|4|||
48851610|NCT02091752|157295353|FG000|Overall Study|Study terminated by Sponsor|2|||
48851611|NCT02091752|157295353|FG000|Overall Study|Adverse Event|1|||
48851612|NCT04029090|157295354|FG000|Overall Study|Protocol Violation|1|||
48851613|NCT04029090|157295355|FG001|Overall Study|Protocol Violation|0|||
48851614|NCT04029090|157295356|FG002|Overall Study|Protocol Violation|0|||
48736085|NCT00866788|156885626|FG001|Overall Study|Physician Decision|0|||
48851615|NCT04029090|157295354|FG000|Overall Study|Withdrawal by Subject|0|||
48851616|NCT04029090|157295355|FG001|Overall Study|Withdrawal by Subject|1|||
48946384|NCT00923091|157634735|FG008|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
48851617|NCT04029090|157295356|FG002|Overall Study|Withdrawal by Subject|0|||
48851618|NCT02157948|157295360|FG000|Overall Study|Withdrawal by Subject|4|||
48851619|NCT02157948|157295361|FG001|Overall Study|Withdrawal by Subject|5|||
48851620|NCT02157948|157295360|FG000|Overall Study|Lost to Follow-up|3|||
48851621|NCT02157948|157295361|FG001|Overall Study|Lost to Follow-up|2|||
48851622|NCT02157948|157295360|FG000|Overall Study|Protocol Specified Criteria|2|||
48851623|NCT02157948|157295361|FG001|Overall Study|Protocol Specified Criteria|1|||
48851624|NCT02157948|157295360|FG000|Overall Study|Decision by Sponsor|0|||
48851625|NCT02157948|157295361|FG001|Overall Study|Decision by Sponsor|1|||
48851626|NCT02852824|157295364|FG000|Overall Study|Withdrawal by Subject|1|||
48851627|NCT02852824|157295365|FG001|Overall Study|Withdrawal by Subject|0|||
48851628|NCT02852824|157295366|FG002|Overall Study|Withdrawal by Subject|0|||
48851629|NCT02852824|157295367|FG003|Overall Study|Withdrawal by Subject|0|||
48851630|NCT02852824|157295368|FG004|Overall Study|Withdrawal by Subject|0|||
48851631|NCT02852824|157295369|FG005|Overall Study|Withdrawal by Subject|0|||
48851632|NCT02852824|157295370|FG006|Overall Study|Withdrawal by Subject|0|||
48851633|NCT02852824|157295364|FG000|Overall Study|Adverse Event|0|||
48851634|NCT02852824|157295365|FG001|Overall Study|Adverse Event|0|||
48851635|NCT02852824|157295366|FG002|Overall Study|Adverse Event|0|||
48851636|NCT02852824|157295367|FG003|Overall Study|Adverse Event|0|||
48851637|NCT02852824|157295368|FG004|Overall Study|Adverse Event|2|||
48851638|NCT02852824|157295369|FG005|Overall Study|Adverse Event|0|||
48851639|NCT02852824|157295370|FG006|Overall Study|Adverse Event|0|||
48851640|NCT02646618|157295375|FG000|Overall Study|Lost to Follow-up|10|||
48851641|NCT02646618|157295376|FG001|Overall Study|Lost to Follow-up|14|||
48851642|NCT00680771|157295377|FG000|Overall Study|Withdrawal by Subject|1|||
48851643|NCT00680771|157295378|FG001|Overall Study|Withdrawal by Subject|0|||
48851644|NCT00680771|157295377|FG000|Overall Study|Sleep Apnea suspected after PSG|1|||
48851645|NCT00680771|157295378|FG001|Overall Study|Sleep Apnea suspected after PSG|0|||
48946385|NCT00923091|157634736|FG009|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
48946386|NCT00923091|157634737|FG010|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
48851646|NCT00680771|157295377|FG000|Overall Study|Prior Exposure to Hepatitus B Vaccine|4|||
48851647|NCT00680771|157295378|FG001|Overall Study|Prior Exposure to Hepatitus B Vaccine|2|||
48851648|NCT02630966|157295379|FG000|Overall Study|Adverse Event|1|||
48851649|NCT02630966|157295380|FG001|Overall Study|Adverse Event|3|||
49015310|NCT00814320|157892146|FG000|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0|||
48851650|NCT02630966|157295379|FG000|Overall Study|Significant Protocol Deviation|0|||
48851651|NCT02630966|157295380|FG001|Overall Study|Significant Protocol Deviation|2|||
48851652|NCT02630966|157295379|FG000|Overall Study|Voluntary Withdrawal|1|||
48851653|NCT02630966|157295380|FG001|Overall Study|Voluntary Withdrawal|1|||
48851654|NCT02630966|157295379|FG000|Overall Study|Lack of Efficacy|0|||
48851655|NCT02630966|157295380|FG001|Overall Study|Lack of Efficacy|2|||
48851656|NCT00390884|157295381|FG000|Overall Study|Withdrawal by Subject|2|||
48851657|NCT00390884|157295382|FG001|Overall Study|Withdrawal by Subject|2|||
48851658|NCT05484661|157295384|FG000|Overall Study|Withdrawal by Subject|1|||
48851659|NCT05484661|157295385|FG001|Overall Study|Withdrawal by Subject|0|||
48851660|NCT01683409|157295388|FG000|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
48851661|NCT01683409|157295389|FG001|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
48851662|NCT01683409|157295390|FG002|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1|||
48851663|NCT01683409|157295391|FG003|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
48851664|NCT01683409|157295392|FG004|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
48851665|NCT01683409|157295388|FG000|Treatment Period (Weeks 1-24)|Adverse Event|0|||
48851666|NCT01683409|157295389|FG001|Treatment Period (Weeks 1-24)|Adverse Event|3|||
48851667|NCT01683409|157295390|FG002|Treatment Period (Weeks 1-24)|Adverse Event|0|||
48851668|NCT01683409|157295391|FG003|Treatment Period (Weeks 1-24)|Adverse Event|1|||
48851669|NCT01683409|157295392|FG004|Treatment Period (Weeks 1-24)|Adverse Event|1|||
48851670|NCT01683409|157295388|FG000|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
48851671|NCT01683409|157295389|FG001|Treatment Period (Weeks 1-24)|Lost to Follow-up|1|||
48851672|NCT01683409|157295390|FG002|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
48851673|NCT01683409|157295391|FG003|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
48851674|NCT01683409|157295392|FG004|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
48851675|NCT01683409|157295388|FG000|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
48851676|NCT01683409|157295389|FG001|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
48851677|NCT01683409|157295390|FG002|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
48851678|NCT01683409|157295391|FG003|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
48851679|NCT01683409|157295392|FG004|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
48851680|NCT01683409|157295388|FG000|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
48851681|NCT01683409|157295389|FG001|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
48851682|NCT01683409|157295390|FG002|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1|||
48851683|NCT01683409|157295391|FG003|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
48851684|NCT01683409|157295392|FG004|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
48851685|NCT01683409|157295388|FG000|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
48851686|NCT01683409|157295389|FG001|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
48851687|NCT01683409|157295390|FG002|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
48851688|NCT01683409|157295391|FG003|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
48851689|NCT01683409|157295392|FG004|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
48851690|NCT01683409|157295388|FG000|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
48851691|NCT01683409|157295389|FG001|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
48851692|NCT01683409|157295390|FG002|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
48851693|NCT01683409|157295391|FG003|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
48851694|NCT01683409|157295392|FG004|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
48851695|NCT01683409|157295388|FG000|Washout Period 1 (Weeks 25-28)|Physician Decision|1|||
48851696|NCT01683409|157295389|FG001|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
48851697|NCT01683409|157295390|FG002|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
48851698|NCT01683409|157295391|FG003|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
48851699|NCT01683409|157295392|FG004|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
48851700|NCT01683409|157295388|FG000|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
48851701|NCT01683409|157295389|FG001|Washout Period 1 (Weeks 25-28)|Adverse Event|4|||
48851702|NCT01683409|157295390|FG002|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
48851703|NCT01683409|157295391|FG003|Washout Period 1 (Weeks 25-28)|Adverse Event|1|||
48851704|NCT01683409|157295392|FG004|Washout Period 1 (Weeks 25-28)|Adverse Event|2|||
48851705|NCT01683409|157295388|FG000|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
48851706|NCT01683409|157295389|FG001|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
48851707|NCT01683409|157295390|FG002|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
48851708|NCT01683409|157295391|FG003|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
48851709|NCT01683409|157295392|FG004|Washout Period 2 (Weeks 29-32)|Adverse Event|3|||
48851710|NCT01683409|157295388|FG000|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
48851711|NCT01683409|157295389|FG001|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
48851712|NCT01683409|157295390|FG002|Washout Period 2 (Weeks 29-32)|Physician Decision|1|||
48851713|NCT01683409|157295391|FG003|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
48851714|NCT01683409|157295392|FG004|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
48851715|NCT03509909|157295396|FG000|Overall Study|Withdrawal by Subject|16|||
48851716|NCT03509909|157295397|FG001|Overall Study|Withdrawal by Subject|9|||
48851717|NCT03509909|157295396|FG000|Overall Study|Lost to Follow-up|3|||
48851718|NCT03509909|157295397|FG001|Overall Study|Lost to Follow-up|4|||
48851719|NCT03509909|157295396|FG000|Overall Study|Adverse Event|2|||
48851720|NCT03509909|157295397|FG001|Overall Study|Adverse Event|0|||
48851721|NCT02513667|157295398|FG000|Overall Study|Withdrawal by Subject|0|||
48851722|NCT02513667|157295399|FG001|Overall Study|Withdrawal by Subject|1|||
48851723|NCT03520036|157295400|FG000|Overall Study|Adverse Event|1|||
48851724|NCT03520036|157295401|FG001|Overall Study|Adverse Event|2|||
48851725|NCT03520036|157295402|FG002|Overall Study|Adverse Event|0|||
48851726|NCT03520036|157295400|FG000|Overall Study|Protocol Violation|1|||
48851727|NCT03520036|157295401|FG001|Overall Study|Protocol Violation|0|||
48851728|NCT03520036|157295402|FG002|Overall Study|Protocol Violation|0|||
48851729|NCT03520036|157295400|FG000|Overall Study|Withdrawal by Subject|0|||
48851730|NCT03520036|157295401|FG001|Overall Study|Withdrawal by Subject|1|||
48851731|NCT03520036|157295402|FG002|Overall Study|Withdrawal by Subject|4|||
48851732|NCT03520036|157295400|FG000|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
48851733|NCT03520036|157295401|FG001|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|1|||
48851734|NCT03520036|157295402|FG002|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
48851735|NCT02189759|157295406|FG000|Overall Study|Lost to Follow-up|0|||
48851736|NCT02189759|157295407|FG001|Overall Study|Lost to Follow-up|0|||
48851737|NCT02189759|157295408|FG002|Overall Study|Lost to Follow-up|2|||
48851738|NCT02189759|157295409|FG003|Overall Study|Lost to Follow-up|5|||
48851739|NCT01662505|157295410|FG000|Overall Study|Progressive disease|6|||
48946387|NCT00923091|157634738|FG011|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
48851740|NCT01662505|157295411|FG001|Overall Study|Progressive disease|1|||
48851741|NCT01662505|157295412|FG002|Overall Study|Progressive disease|5|||
48946388|NCT00923091|157634739|FG012|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
48851742|NCT01662505|157295410|FG000|Overall Study|Refused cont. medication|0|||
48851743|NCT01662505|157295411|FG001|Overall Study|Refused cont. medication|0|||
48851744|NCT01662505|157295412|FG002|Overall Study|Refused cont. medication|1|||
48851745|NCT01662505|157295410|FG000|Overall Study|Not specified above|1|||
48736086|NCT00866788|156885627|FG002|Overall Study|Physician Decision|1|||
48736087|NCT00866788|156885628|FG003|Overall Study|Physician Decision|1|||
48736088|NCT00108433|156885629|FG000|Overall Study|Lack of Efficacy|1|||
48736089|NCT00108433|156885630|FG001|Overall Study|Lack of Efficacy|2|||
48736090|NCT00108433|156885629|FG000|Overall Study|Death|3|||
48736091|NCT00108433|156885630|FG001|Overall Study|Death|0|||
48736092|NCT00108433|156885629|FG000|Overall Study|Adverse Event|3|||
48736093|NCT00108433|156885630|FG001|Overall Study|Adverse Event|1|||
48736094|NCT00108433|156885629|FG000|Overall Study|Other|14|||
48736095|NCT00108433|156885630|FG001|Overall Study|Other|14|||
48736096|NCT02202837|156885631|FG000|Overall Study|Enbrel treatment discontinued|36|||
48736097|NCT02202837|156885632|FG001|Overall Study|Enbrel treatment discontinued|4|||
48736098|NCT02202837|156885631|FG000|Overall Study|Other|10|||
48736099|NCT02202837|156885632|FG001|Overall Study|Other|0|||
48851746|NCT01662505|157295411|FG001|Overall Study|Not specified above|3|||
48851747|NCT01662505|157295412|FG002|Overall Study|Not specified above|2|||
48851748|NCT00357994|157297405|FG000|Overall Study|Adverse Event|1|||
48736100|NCT02202837|156885631|FG000|Overall Study|Lost to Follow-up|7|||
48851749|NCT00357994|157297406|FG001|Overall Study|Adverse Event|2|||
48851750|NCT00357994|157297405|FG000|Overall Study|Lack of Efficacy|0|||
48851751|NCT00357994|157297406|FG001|Overall Study|Lack of Efficacy|1|||
48851752|NCT00357994|157297405|FG000|Overall Study|Protocol Violation|1|||
48851753|NCT00357994|157297406|FG001|Overall Study|Protocol Violation|0|||
48851754|NCT04213807|157297407|FG000|Overall Study|Physician Decision|0|||
48851755|NCT04213807|157297408|FG001|Overall Study|Physician Decision|0|||
48851756|NCT04213807|157297409|FG002|Overall Study|Physician Decision|1|||
48851757|NCT02698475|157297410|FG000|Main Study Period|Lack of Efficacy|1|||
48851758|NCT02698475|157297410|FG000|Main Study Period|Protocol Violation|2|||
48851759|NCT02698475|157297410|FG000|Long-Term Extension Period|Lost to Follow-up|1|||
48851760|NCT02698475|157297410|FG000|Long-Term Extension Period|Trial Site Terminated by Sponsor|1|||
48851761|NCT02698475|157297410|FG000|Long-Term Extension Period|Withdrawal by Subject|3|||
48851762|NCT02698475|157297410|FG000|Long-Term Extension Period|Due to Long Term Extension Protocol-Specified Criteria|22|||
48851763|NCT02698475|157297410|FG000|Long-Term Extension Period|Other|1|||
48851764|NCT00692913|157297416|FG000|Overall Study|Adverse Event|8|||
48851765|NCT00692913|157297417|FG001|Overall Study|Adverse Event|4|||
48736101|NCT02202837|156885632|FG001|Overall Study|Lost to Follow-up|1|||
48736102|NCT00231842|156885639|FG000|Overall Study|Withdrawal by Subject|3|||
48851766|NCT00692913|157297416|FG000|Overall Study|Lost to Follow-up|3|||
48851767|NCT00692913|157297417|FG001|Overall Study|Lost to Follow-up|5|||
48851768|NCT00692913|157297416|FG000|Overall Study|Physician Decision|2|||
48851769|NCT00692913|157297417|FG001|Overall Study|Physician Decision|0|||
48851770|NCT00692913|157297416|FG000|Overall Study|Protocol Violation|1|||
48851771|NCT00692913|157297417|FG001|Overall Study|Protocol Violation|1|||
48851772|NCT00692913|157297416|FG000|Overall Study|Withdrawal by Subject|15|||
48851773|NCT00692913|157297417|FG001|Overall Study|Withdrawal by Subject|20|||
48736103|NCT00231842|156885639|FG000|Overall Study|Did not complete the last 3 cycle|8|||
48736104|NCT00313300|156885640|FG000|Randomized in Phase A (26 Weeks)|Adverse Event|19|||
48736105|NCT00313300|156885641|FG001|Randomized in Phase A (26 Weeks)|Adverse Event|14|||
48736106|NCT00313300|156885642|FG002|Randomized in Phase A (26 Weeks)|Adverse Event|17|||
48736107|NCT00313300|156885643|FG003|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
48736108|NCT00313300|156885644|FG004|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
48736109|NCT00313300|156885640|FG000|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20|||
48736110|NCT00313300|156885641|FG001|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12|||
48736111|NCT00313300|156885642|FG002|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13|||
48736112|NCT00313300|156885643|FG003|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
48736113|NCT00313300|156885644|FG004|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
48736114|NCT00313300|156885640|FG000|Randomized in Phase A (26 Weeks)|Death|3|||
48736115|NCT00313300|156885641|FG001|Randomized in Phase A (26 Weeks)|Death|4|||
48736116|NCT00313300|156885642|FG002|Randomized in Phase A (26 Weeks)|Death|0|||
48736117|NCT00313300|156885643|FG003|Randomized in Phase A (26 Weeks)|Death|0|||
48736118|NCT00313300|156885644|FG004|Randomized in Phase A (26 Weeks)|Death|0|||
48736119|NCT00313300|156885640|FG000|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
48736120|NCT00313300|156885641|FG001|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
48736121|NCT00313300|156885642|FG002|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2|||
48736122|NCT00313300|156885643|FG003|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
48736123|NCT00313300|156885644|FG004|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
48736124|NCT00313300|156885640|FG000|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3|||
48736125|NCT00313300|156885641|FG001|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2|||
48736126|NCT00313300|156885642|FG002|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1|||
48736127|NCT00313300|156885643|FG003|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
48736128|NCT00313300|156885644|FG004|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
48736129|NCT00313300|156885640|FG000|Randomized in Phase A (26 Weeks)|no longer meets criteria|4|||
48736130|NCT00313300|156885641|FG001|Randomized in Phase A (26 Weeks)|no longer meets criteria|3|||
48736131|NCT00313300|156885642|FG002|Randomized in Phase A (26 Weeks)|no longer meets criteria|2|||
48736132|NCT00313300|156885643|FG003|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
48851774|NCT04017611|157297418|FG000|Overall Study|Withdrawn prior to completion|1|||
48851775|NCT03442777|157297427|FG000|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8|||
48851776|NCT03442777|157297428|FG001|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13|||
48851777|NCT03442777|157297429|FG002|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7|||
48851778|NCT01823224|157297430|FG000|Overall Study|Lost to Follow-up|5|||
48851779|NCT01823224|157297431|FG001|Overall Study|Lost to Follow-up|6|||
48851780|NCT01823224|157297430|FG000|Overall Study|didn't qualify|1|||
48851781|NCT01823224|157297431|FG001|Overall Study|didn't qualify|2|||
48851782|NCT01823224|157297430|FG000|Overall Study|pharmacy error|0|||
48851783|NCT01823224|157297431|FG001|Overall Study|pharmacy error|1|||
48851784|NCT01823224|157297430|FG000|Overall Study|missed med dose|0|||
48851785|NCT01823224|157297431|FG001|Overall Study|missed med dose|1|||
48851786|NCT01823224|157297430|FG000|Overall Study|Withdrawal by Subject|0|||
48851787|NCT01823224|157297431|FG001|Overall Study|Withdrawal by Subject|1|||
48851788|NCT02605174|157297433|FG000|Overall Study|Adverse Event|0|||
48851789|NCT02605174|157297434|FG001|Overall Study|Adverse Event|0|||
48851790|NCT02605174|157297435|FG002|Overall Study|Adverse Event|1|||
48851791|NCT02605174|157297436|FG003|Overall Study|Adverse Event|0|||
48851792|NCT02605174|157297437|FG004|Overall Study|Adverse Event|4|||
48851793|NCT02605174|157297438|FG005|Overall Study|Adverse Event|0|||
48736133|NCT00313300|156885644|FG004|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
48736134|NCT00313300|156885640|FG000|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1|||
48736135|NCT00313300|156885641|FG001|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
48736136|NCT00313300|156885642|FG002|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
48736137|NCT00313300|156885643|FG003|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
48736138|NCT00313300|156885644|FG004|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
48736139|NCT00313300|156885640|FG000|Randomized in Phase B (26 Weeks)|Adverse Event|34|||
48736140|NCT00313300|156885641|FG001|Randomized in Phase B (26 Weeks)|Adverse Event|9|||
48736141|NCT00313300|156885642|FG002|Randomized in Phase B (26 Weeks)|Adverse Event|12|||
48736142|NCT00313300|156885643|FG003|Randomized in Phase B (26 Weeks)|Adverse Event|23|||
48736143|NCT00313300|156885644|FG004|Randomized in Phase B (26 Weeks)|Adverse Event|19|||
48736144|NCT00313300|156885640|FG000|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35|||
48736145|NCT00313300|156885641|FG001|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14|||
48736146|NCT00313300|156885642|FG002|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
48736147|NCT00313300|156885643|FG003|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15|||
48736148|NCT00313300|156885644|FG004|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
48736149|NCT00313300|156885640|FG000|Randomized in Phase B (26 Weeks)|Death|5|||
48736150|NCT00313300|156885641|FG001|Randomized in Phase B (26 Weeks)|Death|3|||
48736151|NCT00313300|156885642|FG002|Randomized in Phase B (26 Weeks)|Death|1|||
48736152|NCT00313300|156885643|FG003|Randomized in Phase B (26 Weeks)|Death|0|||
48736153|NCT00313300|156885644|FG004|Randomized in Phase B (26 Weeks)|Death|1|||
48736154|NCT00313300|156885640|FG000|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5|||
48736155|NCT00313300|156885641|FG001|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
48736156|NCT00313300|156885642|FG002|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
48736157|NCT00313300|156885643|FG003|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
48736158|NCT00313300|156885644|FG004|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
48736159|NCT00313300|156885640|FG000|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
48736160|NCT00313300|156885641|FG001|Randomized in Phase B (26 Weeks)|poor/non-compliance|1|||
48736161|NCT00313300|156885642|FG002|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
48736162|NCT00313300|156885643|FG003|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
48736163|NCT00313300|156885644|FG004|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
48736164|NCT00313300|156885640|FG000|Randomized in Phase B (26 Weeks)|no longer meets criteria|9|||
48736165|NCT00313300|156885641|FG001|Randomized in Phase B (26 Weeks)|no longer meets criteria|3|||
48736166|NCT00313300|156885642|FG002|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
48736167|NCT00313300|156885643|FG003|Randomized in Phase B (26 Weeks)|no longer meets criteria|0|||
48851794|NCT02605174|157297439|FG006|Overall Study|Adverse Event|0|||
48851795|NCT02605174|157297433|FG000|Overall Study|Lost to Follow-up|20|||
48851796|NCT02605174|157297434|FG001|Overall Study|Lost to Follow-up|7|||
48851797|NCT02605174|157297435|FG002|Overall Study|Lost to Follow-up|27|||
48736168|NCT00313300|156885644|FG004|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
48851798|NCT02605174|157297436|FG003|Overall Study|Lost to Follow-up|10|||
48851799|NCT02605174|157297437|FG004|Overall Study|Lost to Follow-up|20|||
48851800|NCT02605174|157297438|FG005|Overall Study|Lost to Follow-up|10|||
48851801|NCT02605174|157297439|FG006|Overall Study|Lost to Follow-up|29|||
48851802|NCT02605174|157297433|FG000|Overall Study|Protocol Violation|10|||
48851803|NCT02605174|157297434|FG001|Overall Study|Protocol Violation|4|||
48851804|NCT02605174|157297435|FG002|Overall Study|Protocol Violation|14|||
48851805|NCT02605174|157297436|FG003|Overall Study|Protocol Violation|6|||
48851806|NCT02605174|157297437|FG004|Overall Study|Protocol Violation|7|||
48851807|NCT02605174|157297438|FG005|Overall Study|Protocol Violation|7|||
48851808|NCT02605174|157297439|FG006|Overall Study|Protocol Violation|12|||
48851809|NCT02605174|157297433|FG000|Overall Study|Pregnancy|1|||
48736169|NCT00313300|156885640|FG000|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2|||
48736170|NCT00313300|156885641|FG001|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1|||
48736171|NCT00313300|156885642|FG002|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0|||
48736172|NCT00313300|156885643|FG003|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193|||
48736173|NCT00313300|156885644|FG004|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164|||
48736174|NCT00313300|156885640|FG000|Randomized in Phase B (26 Weeks)|non-specified|1|||
48736175|NCT00313300|156885641|FG001|Randomized in Phase B (26 Weeks)|non-specified|0|||
48736176|NCT00313300|156885642|FG002|Randomized in Phase B (26 Weeks)|non-specified|0|||
48736177|NCT00313300|156885643|FG003|Randomized in Phase B (26 Weeks)|non-specified|0|||
48736178|NCT00313300|156885644|FG004|Randomized in Phase B (26 Weeks)|non-specified|0|||
48736179|NCT00313300|156885640|FG000|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
48736180|NCT00313300|156885641|FG001|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
48736181|NCT00313300|156885642|FG002|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2|||
48736182|NCT00313300|156885643|FG003|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
48736183|NCT00313300|156885644|FG004|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
48736184|NCT00313300|156885640|FG000|Follow-Up(30days)-Randomized Phase A|Death|0|||
48736185|NCT00313300|156885641|FG001|Follow-Up(30days)-Randomized Phase A|Death|1|||
48736186|NCT00313300|156885642|FG002|Follow-Up(30days)-Randomized Phase A|Death|0|||
48736187|NCT00313300|156885643|FG003|Follow-Up(30days)-Randomized Phase A|Death|0|||
48736188|NCT00313300|156885644|FG004|Follow-Up(30days)-Randomized Phase A|Death|0|||
48736189|NCT00313300|156885640|FG000|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
48851810|NCT02605174|157297434|FG001|Overall Study|Pregnancy|0|||
48851811|NCT02605174|157297435|FG002|Overall Study|Pregnancy|0|||
48851812|NCT02605174|157297436|FG003|Overall Study|Pregnancy|2|||
48851813|NCT02605174|157297437|FG004|Overall Study|Pregnancy|0|||
48736190|NCT00313300|156885641|FG001|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0|||
48736191|NCT00313300|156885642|FG002|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2|||
48736192|NCT00313300|156885643|FG003|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
48736193|NCT00313300|156885644|FG004|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
48736194|NCT00313300|156885640|FG000|Follow-Up(30days)-Randomized Phase B|Death|1|||
48736195|NCT00313300|156885641|FG001|Follow-Up(30days)-Randomized Phase B|Death|0|||
48736196|NCT00313300|156885642|FG002|Follow-Up(30days)-Randomized Phase B|Death|0|||
48736197|NCT00313300|156885643|FG003|Follow-Up(30days)-Randomized Phase B|Death|0|||
48736198|NCT00313300|156885644|FG004|Follow-Up(30days)-Randomized Phase B|Death|0|||
48736199|NCT00313300|156885640|FG000|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
48736200|NCT00313300|156885641|FG001|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
48736201|NCT00313300|156885642|FG002|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
48736202|NCT00313300|156885643|FG003|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2|||
48736203|NCT00313300|156885644|FG004|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1|||
48736204|NCT00313300|156885640|FG000|Follow-Up(30days)-Randomized Phase B|missing end of study status|1|||
48736205|NCT00313300|156885641|FG001|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
48736206|NCT00313300|156885642|FG002|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
48851814|NCT02605174|157297438|FG005|Overall Study|Pregnancy|0|||
48851815|NCT02605174|157297439|FG006|Overall Study|Pregnancy|0|||
48851816|NCT02605174|157297433|FG000|Overall Study|Withdrawal by Subject|9|||
48851817|NCT02605174|157297434|FG001|Overall Study|Withdrawal by Subject|6|||
48851818|NCT02605174|157297435|FG002|Overall Study|Withdrawal by Subject|14|||
48851819|NCT02605174|157297436|FG003|Overall Study|Withdrawal by Subject|11|||
48851820|NCT02605174|157297437|FG004|Overall Study|Withdrawal by Subject|6|||
48851821|NCT02605174|157297438|FG005|Overall Study|Withdrawal by Subject|4|||
48851822|NCT02605174|157297439|FG006|Overall Study|Withdrawal by Subject|15|||
48851823|NCT02605174|157297433|FG000|Overall Study|Physician Decision|2|||
48851824|NCT02605174|157297434|FG001|Overall Study|Physician Decision|0|||
48851825|NCT02605174|157297435|FG002|Overall Study|Physician Decision|0|||
48851826|NCT02605174|157297436|FG003|Overall Study|Physician Decision|0|||
48851827|NCT02605174|157297437|FG004|Overall Study|Physician Decision|0|||
48851828|NCT02605174|157297438|FG005|Overall Study|Physician Decision|0|||
48851829|NCT02605174|157297439|FG006|Overall Study|Physician Decision|3|||
48851830|NCT02605174|157297433|FG000|Overall Study|Randomization Failure|22|||
48851831|NCT02605174|157297434|FG001|Overall Study|Randomization Failure|6|||
48851832|NCT02605174|157297435|FG002|Overall Study|Randomization Failure|20|||
48736207|NCT00313300|156885643|FG003|Follow-Up(30days)-Randomized Phase B|missing end of study status|2|||
48736208|NCT00313300|156885644|FG004|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
48736209|NCT02436304|156885645|FG000|Overall Study|Lost to Follow-up|0|||
48736210|NCT02436304|156885646|FG001|Overall Study|Lost to Follow-up|1|||
48736211|NCT02436304|156885647|FG002|Overall Study|Lost to Follow-up|0|||
48736212|NCT02436304|156885645|FG000|Overall Study|Withdrawal by Subject|0|||
48736213|NCT02436304|156885646|FG001|Overall Study|Withdrawal by Subject|1|||
48736214|NCT02436304|156885647|FG002|Overall Study|Withdrawal by Subject|0|||
48736215|NCT02436304|156885645|FG000|Overall Study|Randomized in error didn't meet I/E crit|0|||
48851833|NCT02605174|157297436|FG003|Overall Study|Randomization Failure|7|||
48736216|NCT02436304|156885646|FG001|Overall Study|Randomized in error didn't meet I/E crit|0|||
48736217|NCT02436304|156885647|FG002|Overall Study|Randomized in error didn't meet I/E crit|1|||
48736218|NCT02764333|156885648|FG000|Overall Study|Ineligible|1|||
48736219|NCT00864721|156885651|FG000|Overall Study|Patient request|11|||
48736220|NCT00864721|156885651|FG000|Overall Study|Hospitalized|1|||
48736221|NCT00864721|156885651|FG000|Overall Study|Drug hold/delay more than 4 weeks|1|||
48736222|NCT00864721|156885651|FG000|Overall Study|Adverse Event|21|||
48736223|NCT00615108|156885652|FG000|Overall Study|Adverse Event|122|||
48736224|NCT00615108|156885652|FG000|Overall Study|Other|370|||
48851834|NCT02605174|157297437|FG004|Overall Study|Randomization Failure|16|||
48851835|NCT02605174|157297438|FG005|Overall Study|Randomization Failure|11|||
48851836|NCT02605174|157297439|FG006|Overall Study|Randomization Failure|30|||
48851837|NCT00562094|157297440|FG000|Overall Study|Lost to Follow-up|62|||
48851838|NCT00887224|157297441|FG000|Open-label Response (OLR) Phase|Adverse Event|46|||
48851839|NCT00887224|157297442|FG001|Open-label Response (OLR) Phase|Adverse Event|0|||
48851840|NCT00887224|157297443|FG002|Open-label Response (OLR) Phase|Adverse Event|0|||
48736225|NCT00615108|156885652|FG000|Overall Study|Lost to Follow-up|15|||
48851841|NCT00887224|157297441|FG000|Open-label Response (OLR) Phase|Failed to return|6|||
48736226|NCT01868503|156885653|FG000|Overall Study|Withdrawal by Subject|1|||
48736227|NCT01868503|156885653|FG000|Overall Study|Protocol Violation|1|||
48736228|NCT02651467|156885654|FG000|Overall Study|Withdrawal by Subject|0|||
48736229|NCT02651467|156885655|FG001|Overall Study|Withdrawal by Subject|0|||
48736230|NCT02651467|156885656|FG002|Overall Study|Withdrawal by Subject|2|||
48736231|NCT02651467|156885654|FG000|Overall Study|Other (Not specified)|1|||
48736232|NCT02651467|156885655|FG001|Overall Study|Other (Not specified)|0|||
48736233|NCT02651467|156885656|FG002|Overall Study|Other (Not specified)|2|||
48736234|NCT02607930|156885661|FG000|Double-Blinded Treatment Phase|Lost to Follow-up|25|||
48736235|NCT02607930|156885662|FG001|Double-Blinded Treatment Phase|Lost to Follow-up|19|||
48736236|NCT02607930|156885663|FG002|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
48736237|NCT02607930|156885664|FG003|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
48736238|NCT02607930|156885661|FG000|Double-Blinded Treatment Phase|Withdrew consent|14|||
48736239|NCT02607930|156885662|FG001|Double-Blinded Treatment Phase|Withdrew consent|18|||
48736240|NCT02607930|156885663|FG002|Double-Blinded Treatment Phase|Withdrew consent|0|||
48736241|NCT02607930|156885664|FG003|Double-Blinded Treatment Phase|Withdrew consent|0|||
48736242|NCT02607930|156885661|FG000|Double-Blinded Treatment Phase|Investigator's discretion|6|||
48736243|NCT02607930|156885662|FG001|Double-Blinded Treatment Phase|Investigator's discretion|3|||
48736244|NCT02607930|156885663|FG002|Double-Blinded Treatment Phase|Investigator's discretion|0|||
48736245|NCT02607930|156885664|FG003|Double-Blinded Treatment Phase|Investigator's discretion|0|||
48736246|NCT02607930|156885661|FG000|Double-Blinded Treatment Phase|Non-compliance with study drug|3|||
48736247|NCT02607930|156885662|FG001|Double-Blinded Treatment Phase|Non-compliance with study drug|5|||
48736248|NCT02607930|156885663|FG002|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
48736249|NCT02607930|156885664|FG003|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
48736250|NCT02607930|156885661|FG000|Double-Blinded Treatment Phase|Protocol Violation|2|||
48736251|NCT02607930|156885662|FG001|Double-Blinded Treatment Phase|Protocol Violation|3|||
48736252|NCT02607930|156885663|FG002|Double-Blinded Treatment Phase|Protocol Violation|0|||
48736253|NCT02607930|156885664|FG003|Double-Blinded Treatment Phase|Protocol Violation|0|||
48736254|NCT02607930|156885661|FG000|Double-Blinded Treatment Phase|Adverse Event|0|||
48736255|NCT02607930|156885662|FG001|Double-Blinded Treatment Phase|Adverse Event|4|||
48736256|NCT02607930|156885663|FG002|Double-Blinded Treatment Phase|Adverse Event|0|||
48736257|NCT02607930|156885664|FG003|Double-Blinded Treatment Phase|Adverse Event|0|||
48736258|NCT02607930|156885661|FG000|Double-Blinded Treatment Phase|Death|2|||
48736259|NCT02607930|156885662|FG001|Double-Blinded Treatment Phase|Death|1|||
48736260|NCT02607930|156885663|FG002|Double-Blinded Treatment Phase|Death|0|||
48736261|NCT02607930|156885664|FG003|Double-Blinded Treatment Phase|Death|0|||
48736262|NCT02607930|156885661|FG000|Double-Blinded Treatment Phase|Randomized but never treated|2|||
48736263|NCT02607930|156885662|FG001|Double-Blinded Treatment Phase|Randomized but never treated|0|||
48736264|NCT02607930|156885663|FG002|Double-Blinded Treatment Phase|Randomized but never treated|0|||
48946389|NCT00923091|157634727|FG000|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
48946390|NCT00923091|157634728|FG001|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
48946391|NCT00923091|157634729|FG002|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
48736265|NCT02607930|156885664|FG003|Double-Blinded Treatment Phase|Randomized but never treated|0|||
48736266|NCT02607930|156885661|FG000|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
48736267|NCT02607930|156885662|FG001|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
48736268|NCT02607930|156885663|FG002|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|15|||
48736269|NCT02607930|156885664|FG003|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|10|||
48736270|NCT02607930|156885661|FG000|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
48736271|NCT02607930|156885662|FG001|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
48736272|NCT02607930|156885663|FG002|Open-Label B/F/TAF Extension Phase|Withdrew consent|10|||
48736273|NCT02607930|156885664|FG003|Open-Label B/F/TAF Extension Phase|Withdrew consent|13|||
48736274|NCT02607930|156885661|FG000|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
48736275|NCT02607930|156885662|FG001|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
48736276|NCT02607930|156885663|FG002|Open-Label B/F/TAF Extension Phase|Investigator's discretion|2|||
48736277|NCT02607930|156885664|FG003|Open-Label B/F/TAF Extension Phase|Investigator's discretion|5|||
48736278|NCT02607930|156885661|FG000|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
48736279|NCT02607930|156885662|FG001|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
48736280|NCT02607930|156885663|FG002|Open-Label B/F/TAF Extension Phase|Adverse Event|4|||
48736281|NCT02607930|156885664|FG003|Open-Label B/F/TAF Extension Phase|Adverse Event|2|||
48736282|NCT02607930|156885661|FG000|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
48736283|NCT02607930|156885662|FG001|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
48736284|NCT02607930|156885663|FG002|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
48736285|NCT02607930|156885664|FG003|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
48736286|NCT02607930|156885661|FG000|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
48736287|NCT02607930|156885662|FG001|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
48736288|NCT02607930|156885663|FG002|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
48736289|NCT02607930|156885664|FG003|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
48736290|NCT02607930|156885661|FG000|Open-Label B/F/TAF Extension Phase|Death|0|||
48736291|NCT02607930|156885662|FG001|Open-Label B/F/TAF Extension Phase|Death|0|||
48736292|NCT02607930|156885663|FG002|Open-Label B/F/TAF Extension Phase|Death|0|||
48736293|NCT02607930|156885664|FG003|Open-Label B/F/TAF Extension Phase|Death|1|||
48736294|NCT02607930|156885661|FG000|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
48736295|NCT02607930|156885662|FG001|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
48736296|NCT02607930|156885663|FG002|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|1|||
48736297|NCT02607930|156885664|FG003|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
48736298|NCT02833350|156885669|FG000|Overall Study|Adverse Event|0|||
48736299|NCT02833350|156885670|FG001|Overall Study|Adverse Event|3|||
48736300|NCT02833350|156885671|FG002|Overall Study|Adverse Event|4|||
48736301|NCT02833350|156885672|FG003|Overall Study|Adverse Event|4|||
48736302|NCT02833350|156885673|FG004|Overall Study|Adverse Event|1|||
48736303|NCT02833350|156885674|FG005|Overall Study|Adverse Event|0|||
48736304|NCT02833350|156885675|FG006|Overall Study|Adverse Event|1|||
48946392|NCT00923091|157634730|FG003|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
48946393|NCT00923091|157634731|FG004|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
48736305|NCT02833350|156885669|FG000|Overall Study|Death|0|||
48736306|NCT02833350|156885670|FG001|Overall Study|Death|0|||
48736307|NCT02833350|156885671|FG002|Overall Study|Death|1|||
48736308|NCT02833350|156885672|FG003|Overall Study|Death|0|||
48736309|NCT02833350|156885673|FG004|Overall Study|Death|0|||
48736310|NCT02833350|156885674|FG005|Overall Study|Death|0|||
48736311|NCT02833350|156885675|FG006|Overall Study|Death|0|||
48736312|NCT02833350|156885669|FG000|Overall Study|Lack of Efficacy|0|||
48736313|NCT02833350|156885670|FG001|Overall Study|Lack of Efficacy|2|||
48736314|NCT02833350|156885671|FG002|Overall Study|Lack of Efficacy|1|||
48736315|NCT02833350|156885672|FG003|Overall Study|Lack of Efficacy|4|||
48736316|NCT02833350|156885673|FG004|Overall Study|Lack of Efficacy|0|||
48736317|NCT02833350|156885674|FG005|Overall Study|Lack of Efficacy|1|||
48736318|NCT02833350|156885675|FG006|Overall Study|Lack of Efficacy|1|||
48736319|NCT02833350|156885669|FG000|Overall Study|Lost to Follow-up|0|||
48736320|NCT02833350|156885670|FG001|Overall Study|Lost to Follow-up|1|||
48736321|NCT02833350|156885671|FG002|Overall Study|Lost to Follow-up|0|||
48736322|NCT02833350|156885672|FG003|Overall Study|Lost to Follow-up|0|||
48736323|NCT02833350|156885673|FG004|Overall Study|Lost to Follow-up|0|||
48736324|NCT02833350|156885674|FG005|Overall Study|Lost to Follow-up|0|||
48736325|NCT02833350|156885675|FG006|Overall Study|Lost to Follow-up|1|||
48736326|NCT02833350|156885669|FG000|Overall Study|Withdrawal by Subject|3|||
48736327|NCT02833350|156885670|FG001|Overall Study|Withdrawal by Subject|3|||
48736328|NCT02833350|156885671|FG002|Overall Study|Withdrawal by Subject|2|||
48736329|NCT02833350|156885672|FG003|Overall Study|Withdrawal by Subject|0|||
48736330|NCT02833350|156885673|FG004|Overall Study|Withdrawal by Subject|2|||
48736331|NCT02833350|156885674|FG005|Overall Study|Withdrawal by Subject|0|||
48736332|NCT02833350|156885675|FG006|Overall Study|Withdrawal by Subject|2|||
48736333|NCT00570765|156885676|FG000|DB Phase|Withdrawal by Subject|1|||
48736334|NCT00570765|156885677|FG001|DB Phase|Withdrawal by Subject|0|||
48736335|NCT00570765|156885678|FG002|DB Phase|Withdrawal by Subject|0|||
48736336|NCT00570765|156885679|FG003|DB Phase|Withdrawal by Subject|0|||
48736337|NCT00570765|156885676|FG000|DB Phase|Protocol Violation|0|||
48736338|NCT00570765|156885677|FG001|DB Phase|Protocol Violation|1|||
48736339|NCT00570765|156885678|FG002|DB Phase|Protocol Violation|0|||
48736340|NCT00570765|156885679|FG003|DB Phase|Protocol Violation|0|||
48736341|NCT00570765|156885676|FG000|DB Phase|Adverse Event|3|||
48736342|NCT00570765|156885677|FG001|DB Phase|Adverse Event|6|||
48736343|NCT00570765|156885678|FG002|DB Phase|Adverse Event|0|||
48736344|NCT00570765|156885679|FG003|DB Phase|Adverse Event|0|||
48736345|NCT00570765|156885676|FG000|DB Phase|Did Not Receive Study Drug|0|||
48736346|NCT00570765|156885677|FG001|DB Phase|Did Not Receive Study Drug|0|||
48736347|NCT00570765|156885678|FG002|DB Phase|Did Not Receive Study Drug|1|||
48736348|NCT00570765|156885679|FG003|DB Phase|Did Not Receive Study Drug|0|||
48736349|NCT00570765|156885676|FG000|LTSE Phase|Withdrawal by Subject|0|||
48736350|NCT00570765|156885677|FG001|LTSE Phase|Withdrawal by Subject|0|||
48736351|NCT00570765|156885678|FG002|LTSE Phase|Withdrawal by Subject|0|||
48736352|NCT00570765|156885679|FG003|LTSE Phase|Withdrawal by Subject|1|||
48736353|NCT00570765|156885676|FG000|LTSE Phase|Adverse Event|0|||
48851842|NCT00887224|157297442|FG001|Open-label Response (OLR) Phase|Failed to return|0|||
48851843|NCT00887224|157297443|FG002|Open-label Response (OLR) Phase|Failed to return|0|||
48851844|NCT00887224|157297441|FG000|Open-label Response (OLR) Phase|Lack of Efficacy|26|||
48851845|NCT00887224|157297442|FG001|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
48736354|NCT00570765|156885677|FG001|LTSE Phase|Adverse Event|0|||
48736355|NCT00570765|156885678|FG002|LTSE Phase|Adverse Event|0|||
48736356|NCT00570765|156885679|FG003|LTSE Phase|Adverse Event|7|||
48736357|NCT00570765|156885676|FG000|LTSE Phase|Physician Decision|0|||
48736358|NCT00570765|156885677|FG001|LTSE Phase|Physician Decision|0|||
48736359|NCT00570765|156885678|FG002|LTSE Phase|Physician Decision|0|||
48736360|NCT00570765|156885679|FG003|LTSE Phase|Physician Decision|4|||
48736361|NCT01500031|156885680|FG000|Overall Study|Death|1|||
48736362|NCT01500031|156885680|FG000|Overall Study|Withdrawal by Subject|4|||
48736363|NCT01739309|156885682|FG000|Overall Study|Adverse Event|1|||
48736364|NCT01739309|156885682|FG000|Overall Study|Withdrawal by Subject|1|||
48736365|NCT00875979|156885686|FG000|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1|||
48736366|NCT00875979|156885687|FG001|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0|||
48736367|NCT00875979|156885686|FG000|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1|||
48736368|NCT00875979|156885687|FG001|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0|||
48736369|NCT00875979|156885686|FG000|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1|||
48736370|NCT00875979|156885687|FG001|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0|||
48736371|NCT00875979|156885686|FG000|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0|||
48736372|NCT00875979|156885687|FG001|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6|||
48736373|NCT00875979|156885686|FG000|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0|||
48736374|NCT00875979|156885687|FG001|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37|||
48736375|NCT00875979|156885686|FG000|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0|||
48736376|NCT00875979|156885687|FG001|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3|||
48736377|NCT00875979|156885686|FG000|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0|||
48736378|NCT00875979|156885687|FG001|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3|||
48736379|NCT00875979|156885686|FG000|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0|||
48736380|NCT00875979|156885687|FG001|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3|||
48736381|NCT00875979|156885686|FG000|Dose Expansion Phase - 3.6 mg/kg|Death|0|||
48736382|NCT00875979|156885687|FG001|Dose Expansion Phase - 3.6 mg/kg|Death|1|||
48736383|NCT01254292|156885688|FG000|Comparative Phase|Adverse Event|25|||
48736384|NCT01254292|156885689|FG001|Comparative Phase|Adverse Event|25|||
48736385|NCT01254292|156885688|FG000|Comparative Phase|Lost to Follow-up|3|||
48736386|NCT01254292|156885689|FG001|Comparative Phase|Lost to Follow-up|21|||
48736387|NCT01254292|156885688|FG000|Comparative Phase|Pregnancy|2|||
48736388|NCT01254292|156885689|FG001|Comparative Phase|Pregnancy|6|||
48736389|NCT01254292|156885688|FG000|Comparative Phase|Withdrawal by Subject|20|||
48736390|NCT01254292|156885689|FG001|Comparative Phase|Withdrawal by Subject|21|||
48736391|NCT01254292|156885688|FG000|Comparative Phase|Protocol Violation|1|||
48736392|NCT01254292|156885689|FG001|Comparative Phase|Protocol Violation|2|||
48736393|NCT01254292|156885688|FG000|Comparative Phase|Wish for pregnancy|4|||
48736394|NCT01254292|156885689|FG001|Comparative Phase|Wish for pregnancy|6|||
48736395|NCT01254292|156885688|FG000|LCS12 Extension Phase|Wish for pregnancy|14|||
48736396|NCT01254292|156885689|FG001|LCS12 Extension Phase|Wish for pregnancy|0|||
48736397|NCT01254292|156885688|FG000|LCS12 Extension Phase|Adverse Event|9|||
48736398|NCT01254292|156885689|FG001|LCS12 Extension Phase|Adverse Event|0|||
48736399|NCT01254292|156885688|FG000|LCS12 Extension Phase|Withdrawal by Subject|7|||
48736400|NCT01254292|156885689|FG001|LCS12 Extension Phase|Withdrawal by Subject|0|||
48736401|NCT01254292|156885688|FG000|LCS12 Extension Phase|Other unknown|4|||
48736402|NCT01254292|156885689|FG001|LCS12 Extension Phase|Other unknown|0|||
48736403|NCT01254292|156885688|FG000|LCS12 Extension Phase|Pregnancy|2|||
48736404|NCT01254292|156885689|FG001|LCS12 Extension Phase|Pregnancy|0|||
48851846|NCT00887224|157297443|FG002|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
48851847|NCT00887224|157297441|FG000|Open-label Response (OLR) Phase|Lost to Follow-up|16|||
48851848|NCT00887224|157297442|FG001|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
48851849|NCT00887224|157297443|FG002|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
48851850|NCT00887224|157297441|FG000|Open-label Response (OLR) Phase|Other|1|||
48851851|NCT00887224|157297442|FG001|Open-label Response (OLR) Phase|Other|0|||
48851852|NCT00887224|157297443|FG002|Open-label Response (OLR) Phase|Other|0|||
48851853|NCT00887224|157297441|FG000|Open-label Response (OLR) Phase|Protocol Violation|12|||
48851854|NCT00887224|157297442|FG001|Open-label Response (OLR) Phase|Protocol Violation|0|||
48851855|NCT00887224|157297443|FG002|Open-label Response (OLR) Phase|Protocol Violation|0|||
48851856|NCT00887224|157297441|FG000|Open-label Response (OLR) Phase|Withdrawal by Subject|15|||
48851857|NCT00887224|157297442|FG001|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
48851858|NCT00887224|157297443|FG002|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
48736405|NCT01254292|156885688|FG000|LCS12 Extension Phase|Lost to Follow-up|1|||
48736406|NCT01254292|156885689|FG001|LCS12 Extension Phase|Lost to Follow-up|0|||
48736407|NCT01328431|156885690|FG000|Baseline|Protocol Violation|0|||
48736408|NCT01328431|156885691|FG001|Baseline|Protocol Violation|2|||
48736409|NCT01328431|156885690|FG000|1 Month (1M)|Lost to Follow-up|55|||
48736410|NCT01328431|156885691|FG001|1 Month (1M)|Lost to Follow-up|58|||
48736411|NCT01328431|156885690|FG000|3 Month (3M)|Death|2|||
48946394|NCT00923091|157634732|FG005|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1|||
48946395|NCT00923091|157634733|FG006|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
48736412|NCT01328431|156885691|FG001|3 Month (3M)|Death|2|||
48736413|NCT01328431|156885690|FG000|3 Month (3M)|Lost to Follow-up|75|||
48736414|NCT01328431|156885691|FG001|3 Month (3M)|Lost to Follow-up|70|||
48736415|NCT01328431|156885690|FG000|12 Month (12M)|Death|2|||
48736416|NCT01328431|156885691|FG001|12 Month (12M)|Death|6|||
48736417|NCT01328431|156885690|FG000|12 Month (12M)|Lost to Follow-up|82|||
48736418|NCT01328431|156885691|FG001|12 Month (12M)|Lost to Follow-up|91|||
48736419|NCT00199875|156885693|FG000|Overall Study|Withdrawal by Subject|0|||
48736420|NCT00199875|156885694|FG001|Overall Study|Withdrawal by Subject|0|||
48736421|NCT00199875|156885695|FG002|Overall Study|Withdrawal by Subject|0|||
48736422|NCT00199875|156885696|FG003|Overall Study|Withdrawal by Subject|0|||
48736423|NCT00199875|156885697|FG004|Overall Study|Withdrawal by Subject|1|||
48736424|NCT02589405|156885698|FG000|Overall Study|Adverse Event|3|||
48736425|NCT02589405|156885698|FG000|Overall Study|Withdrawal by Subject|1|||
48736426|NCT02905149|156885699|FG000|Overall Study|Lost to Follow-up|2|||
48736427|NCT02905149|156885700|FG001|Overall Study|Lost to Follow-up|0|||
48736428|NCT03330288|156885702|FG000|Overall Study|Other reason|1|||
48736429|NCT03330288|156885703|FG001|Overall Study|Other reason|1|||
48736430|NCT03330288|156885702|FG000|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1|||
48736431|NCT03330288|156885703|FG001|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0|||
48736432|NCT03330288|156885702|FG000|Overall Study|Adverse Event|1|||
48736433|NCT03330288|156885703|FG001|Overall Study|Adverse Event|0|||
48736434|NCT03330288|156885702|FG000|Overall Study|Withdrawal by Subject|1|||
48736435|NCT03330288|156885703|FG001|Overall Study|Withdrawal by Subject|0|||
48736436|NCT03330288|156885702|FG000|Overall Study|Lost to Follow-up|26|||
48736437|NCT03330288|156885703|FG001|Overall Study|Lost to Follow-up|7|||
48736438|NCT01042678|156885704|FG000|Overall Study|Physician Decision|1|||
48736439|NCT01042678|156885705|FG001|Overall Study|Physician Decision|0|||
48736440|NCT01042678|156885706|FG002|Overall Study|Physician Decision|0|||
48736441|NCT01042678|156885707|FG003|Overall Study|Physician Decision|0|||
48736442|NCT01042678|156885708|FG004|Overall Study|Physician Decision|0|||
48736443|NCT01042678|156885709|FG005|Overall Study|Physician Decision|0|||
48736444|NCT04889222|156885714|FG000|Overall Study|Did not meet eligibility criteria|8|||
48736445|NCT04889222|156885714|FG000|Overall Study|Failure to place intravenous or arterial line|3|||
48736446|NCT04889222|156885714|FG000|Overall Study|Did not proceed due to time constraints|5|||
48946396|NCT00923091|157634734|FG007|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
48946397|NCT00923091|157634735|FG008|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
48946398|NCT00923091|157634736|FG009|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
48946399|NCT00923091|157634737|FG010|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
48946400|NCT00923091|157634738|FG011|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
48946401|NCT00923091|157634739|FG012|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
48736447|NCT01609231|156885715|FG000|Overall Study|Adverse Event|1|||
48736448|NCT01609231|156885716|FG001|Overall Study|Adverse Event|3|||
48736449|NCT01609231|156885715|FG000|Overall Study|Physician Decision|1|||
48736450|NCT01609231|156885716|FG001|Overall Study|Physician Decision|0|||
48736451|NCT01609231|156885715|FG000|Overall Study|Withdrawal by Subject|1|||
48736452|NCT01609231|156885716|FG001|Overall Study|Withdrawal by Subject|0|||
48736453|NCT01180647|156885717|FG000|Overall Study|Lost to Follow-up|5|||
48736454|NCT01180647|156885718|FG001|Overall Study|Lost to Follow-up|6|||
48736455|NCT02761733|156885721|FG000|Overall Study|Death|3|||
48736456|NCT02761733|156885722|FG001|Overall Study|Death|5|||
48736457|NCT02761733|156885723|FG002|Overall Study|Death|1|||
48736458|NCT02761733|156885724|FG003|Overall Study|Death|1|||
48736459|NCT02761733|156885721|FG000|Overall Study|Lost to Follow-up|6|||
48736460|NCT02761733|156885722|FG001|Overall Study|Lost to Follow-up|7|||
48736461|NCT02761733|156885723|FG002|Overall Study|Lost to Follow-up|0|||
48736462|NCT02761733|156885724|FG003|Overall Study|Lost to Follow-up|3|||
48736463|NCT02761733|156885721|FG000|Overall Study|Physician Decision|4|||
48736464|NCT02761733|156885722|FG001|Overall Study|Physician Decision|0|||
48851859|NCT00887224|157297441|FG000|Open-label Stability (OLS) Phase|Adverse Event|22|||
48851860|NCT00887224|157297442|FG001|Open-label Stability (OLS) Phase|Adverse Event|0|||
48851861|NCT00887224|157297443|FG002|Open-label Stability (OLS) Phase|Adverse Event|0|||
48851862|NCT00887224|157297441|FG000|Open-label Stability (OLS) Phase|Failed to return|3|||
48736465|NCT02761733|156885723|FG002|Overall Study|Physician Decision|0|||
48736466|NCT02761733|156885724|FG003|Overall Study|Physician Decision|0|||
48736467|NCT02761733|156885721|FG000|Overall Study|Withdrawal by Subject|2|||
48736468|NCT02761733|156885722|FG001|Overall Study|Withdrawal by Subject|0|||
48736469|NCT02761733|156885723|FG002|Overall Study|Withdrawal by Subject|0|||
48736470|NCT02761733|156885724|FG003|Overall Study|Withdrawal by Subject|0|||
48736471|NCT02761733|156885721|FG000|Overall Study|Discharged from Study Site|10|||
48736472|NCT02761733|156885722|FG001|Overall Study|Discharged from Study Site|9|||
48736473|NCT02761733|156885723|FG002|Overall Study|Discharged from Study Site|25|||
48736474|NCT02761733|156885724|FG003|Overall Study|Discharged from Study Site|11|||
48736475|NCT02761733|156885721|FG000|Overall Study|Cognitive Impairment|5|||
48851863|NCT00887224|157297442|FG001|Open-label Stability (OLS) Phase|Failed to return|0|||
48736476|NCT02761733|156885722|FG001|Overall Study|Cognitive Impairment|0|||
48736477|NCT02761733|156885723|FG002|Overall Study|Cognitive Impairment|1|||
48736478|NCT02761733|156885724|FG003|Overall Study|Cognitive Impairment|0|||
48736479|NCT00936611|156885726|FG000|Overall Study|Progressive Disease|3|||
48736480|NCT00936611|156885726|FG000|Overall Study|New Systemic Therapy|22|||
48736481|NCT00936611|156885726|FG000|Overall Study|Lost to Follow-up|1|||
48736482|NCT00936611|156885726|FG000|Overall Study|Withdrawal by Subject|2|||
48736483|NCT00936611|156885726|FG000|Overall Study|Still on Follow-up|1|||
48736484|NCT00936611|156885726|FG000|Overall Study|Still on Active Therapy|7|||
48736485|NCT00936611|156885726|FG000|Overall Study|Ineligible for Study Drug|3|||
48736486|NCT02979197|156885727|FG000|Overall Study|Adverse Event|4|||
48736487|NCT02979197|156885728|FG001|Overall Study|Adverse Event|2|||
48736488|NCT02979197|156885729|FG002|Overall Study|Adverse Event|0|||
48736489|NCT02979197|156885727|FG000|Overall Study|Protocol Violation|0|||
48736490|NCT02979197|156885728|FG001|Overall Study|Protocol Violation|1|||
48736491|NCT02979197|156885729|FG002|Overall Study|Protocol Violation|0|||
48736492|NCT02979197|156885727|FG000|Overall Study|Subject unable to commit to study dates|0|||
48736493|NCT02979197|156885728|FG001|Overall Study|Subject unable to commit to study dates|1|||
48736494|NCT02979197|156885729|FG002|Overall Study|Subject unable to commit to study dates|0|||
48736495|NCT00066729|156885735|FG000|Overall Study|Lost to Follow-up|1|||
48736496|NCT00066729|156885735|FG000|Overall Study|Disease progression|1|||
48851864|NCT00887224|157297443|FG002|Open-label Stability (OLS) Phase|Failed to return|0|||
48851865|NCT00887224|157297441|FG000|Open-label Stability (OLS) Phase|Lack of Efficacy|16|||
48851866|NCT00887224|157297442|FG001|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
48851867|NCT00887224|157297443|FG002|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
48851868|NCT00887224|157297441|FG000|Open-label Stability (OLS) Phase|Lost to Follow-up|9|||
48851869|NCT00887224|157297442|FG001|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
48851870|NCT00887224|157297443|FG002|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
48851871|NCT00887224|157297441|FG000|Open-label Stability (OLS) Phase|Other|1|||
48851872|NCT00887224|157297442|FG001|Open-label Stability (OLS) Phase|Other|0|||
48851873|NCT00887224|157297443|FG002|Open-label Stability (OLS) Phase|Other|0|||
48851874|NCT00887224|157297441|FG000|Open-label Stability (OLS) Phase|Protocol Violation|13|||
48851875|NCT00887224|157297442|FG001|Open-label Stability (OLS) Phase|Protocol Violation|0|||
48736497|NCT03841448|156885736|FG000|Double-blind Treatment (DBT) Period|Death|1|||
48736498|NCT03841448|156885737|FG001|Double-blind Treatment (DBT) Period|Death|1|||
48736499|NCT03841448|156885738|FG002|Double-blind Treatment (DBT) Period|Death|0|||
48736500|NCT03841448|156885739|FG003|Double-blind Treatment (DBT) Period|Death|0|||
48736501|NCT03841448|156885736|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
48736502|NCT03841448|156885737|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
48736503|NCT03841448|156885738|FG002|Open-Label Extension (OLE) Period|Adverse Event|1|||
48736504|NCT03841448|156885739|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
48736505|NCT03841448|156885736|FG000|Open-Label Extension (OLE) Period|Death|0|||
48736506|NCT03841448|156885737|FG001|Open-Label Extension (OLE) Period|Death|0|||
48736507|NCT03841448|156885738|FG002|Open-Label Extension (OLE) Period|Death|0|||
48736508|NCT03841448|156885739|FG003|Open-Label Extension (OLE) Period|Death|1|||
48736509|NCT03841448|156885736|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
48736510|NCT03841448|156885737|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
48736511|NCT03841448|156885738|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
48736512|NCT03841448|156885739|FG003|Open-Label Extension (OLE) Period|Physician Decision|3|||
48736513|NCT03841448|156885736|FG000|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
48736514|NCT03841448|156885737|FG001|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
48736515|NCT03841448|156885738|FG002|Open-Label Extension (OLE) Period|Study termination by Sponsor|4|||
48736516|NCT03841448|156885739|FG003|Open-Label Extension (OLE) Period|Study termination by Sponsor|9|||
48946402|NCT00923091|157634727|FG000|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
48946403|NCT00923091|157634728|FG001|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
48946404|NCT00923091|157634729|FG002|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
48946405|NCT00923091|157634730|FG003|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
48946406|NCT00923091|157634731|FG004|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
48736517|NCT03841448|156885736|FG000|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
48736518|NCT03841448|156885737|FG001|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
48736519|NCT03841448|156885738|FG002|Open-Label Extension (OLE) Period|Other Reason Not Specified|2|||
48736520|NCT03841448|156885739|FG003|Open-Label Extension (OLE) Period|Other Reason Not Specified|5|||
48736521|NCT01811225|156885740|FG000|Treatment Period 1|Adverse Event|2|||
48736522|NCT01811225|156885741|FG001|Treatment Period 1|Adverse Event|3|||
48736523|NCT01811225|156885740|FG000|Treatment Period 1|Lost to Follow-up|12|||
48736524|NCT01811225|156885741|FG001|Treatment Period 1|Lost to Follow-up|8|||
48736525|NCT01811225|156885740|FG000|Treatment Period 1|transporation|1|||
48736526|NCT01811225|156885741|FG001|Treatment Period 1|transporation|0|||
48736527|NCT01811225|156885740|FG000|Treatment Period 1|unable to remain smoke free overnight|10|||
48736528|NCT01811225|156885741|FG001|Treatment Period 1|unable to remain smoke free overnight|6|||
48736529|NCT01811225|156885740|FG000|Treatment Period 2|Lost to Follow-up|1|||
48946407|NCT00923091|157634732|FG005|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
48946408|NCT00923091|157634733|FG006|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
48736530|NCT01811225|156885741|FG001|Treatment Period 2|Lost to Follow-up|2|||
48736531|NCT01811225|156885740|FG000|Treatment Period 2|unable to remain smoke free overnight|3|||
48736532|NCT01811225|156885741|FG001|Treatment Period 2|unable to remain smoke free overnight|4|||
48736533|NCT00492531|156885743|FG000|Overall Study|Withdrawn(More than one reason selected)|22|||
48946409|NCT00923091|157634734|FG007|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
48946410|NCT00923091|157634735|FG008|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
48946411|NCT00923091|157634736|FG009|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
48946412|NCT00923091|157634737|FG010|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
48946413|NCT00923091|157634738|FG011|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
48946414|NCT00923091|157634739|FG012|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
48946415|NCT00923091|157634727|FG000|Period III (Single-Blind)|Adverse Event|5|||
48946416|NCT00923091|157634728|FG001|Period III (Single-Blind)|Adverse Event|0|||
48946417|NCT00923091|157634729|FG002|Period III (Single-Blind)|Adverse Event|0|||
48851876|NCT00887224|157297443|FG002|Open-label Stability (OLS) Phase|Protocol Violation|0|||
48851877|NCT00887224|157297441|FG000|Open-label Stability (OLS) Phase|Withdrawal by Subject|19|||
48851878|NCT00887224|157297442|FG001|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
48851879|NCT00887224|157297443|FG002|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
48851880|NCT00887224|157297441|FG000|OL Taper Phase / OL Follow Up|Adverse Event|28|||
48851881|NCT00887224|157297442|FG001|OL Taper Phase / OL Follow Up|Adverse Event|0|||
48851882|NCT00887224|157297443|FG002|OL Taper Phase / OL Follow Up|Adverse Event|0|||
48851883|NCT00887224|157297441|FG000|OL Taper Phase / OL Follow Up|Failed to return|17|||
48736534|NCT00492531|156885744|FG001|Overall Study|Withdrawn(More than one reason selected)|23|||
48736535|NCT00810355|156885745|FG000|Overall Study|Lost to Follow-up|13|||
48736536|NCT00810355|156885746|FG001|Overall Study|Lost to Follow-up|17|||
48736537|NCT00810355|156885747|FG002|Overall Study|Lost to Follow-up|11|||
48736538|NCT00810355|156885745|FG000|Overall Study|Withdrawal by Subject|1|||
48736539|NCT00810355|156885746|FG001|Overall Study|Withdrawal by Subject|0|||
48736540|NCT00810355|156885747|FG002|Overall Study|Withdrawal by Subject|0|||
48736541|NCT00397215|156885748|FG000|Month 0 (Day 0)|Adverse Event|0|||
48736542|NCT00397215|156885749|FG001|Month 0 (Day 0)|Adverse Event|1|||
48736543|NCT00397215|156885750|FG002|Month 0 (Day 0)|Adverse Event|0|||
48736544|NCT00397215|156885751|FG003|Month 0 (Day 0)|Adverse Event|0|||
48736545|NCT00397215|156885748|FG000|Month 0 (Day 0)|Withdrawal by Subject|3|||
48736546|NCT00397215|156885749|FG001|Month 0 (Day 0)|Withdrawal by Subject|3|||
48736547|NCT00397215|156885750|FG002|Month 0 (Day 0)|Withdrawal by Subject|3|||
48736548|NCT00397215|156885751|FG003|Month 0 (Day 0)|Withdrawal by Subject|1|||
48736549|NCT00397215|156885748|FG000|Month 0 (Day 0)|Other|4|||
48736550|NCT00397215|156885749|FG001|Month 0 (Day 0)|Other|1|||
48736551|NCT00397215|156885750|FG002|Month 0 (Day 0)|Other|3|||
48736552|NCT00397215|156885751|FG003|Month 0 (Day 0)|Other|3|||
48736553|NCT00397215|156885748|FG000|Month 6 (Day 180)|Adverse Event|0|||
48736554|NCT00397215|156885749|FG001|Month 6 (Day 180)|Adverse Event|3|||
48946418|NCT00923091|157634730|FG003|Period III (Single-Blind)|Adverse Event|0|||
48736555|NCT00397215|156885750|FG002|Month 6 (Day 180)|Adverse Event|2|||
48736556|NCT00397215|156885751|FG003|Month 6 (Day 180)|Adverse Event|0|||
48946419|NCT00923091|157634731|FG004|Period III (Single-Blind)|Adverse Event|0|||
48736557|NCT00397215|156885748|FG000|Month 6 (Day 180)|Other|2|||
48736558|NCT00397215|156885749|FG001|Month 6 (Day 180)|Other|0|||
48736559|NCT00397215|156885750|FG002|Month 6 (Day 180)|Other|3|||
48736560|NCT00397215|156885751|FG003|Month 6 (Day 180)|Other|0|||
48736561|NCT01893203|156885753|FG000|Overall Study|Withdrawal by Subject|1|||
48736562|NCT00306189|156885756|FG000|Overall Study|Physician Decision|0|||
48736563|NCT00306189|156885757|FG001|Overall Study|Physician Decision|0|||
48736564|NCT00306189|156885758|FG002|Overall Study|Physician Decision|0|||
48736565|NCT00306189|156885759|FG003|Overall Study|Physician Decision|1|||
48736566|NCT00306189|156885756|FG000|Overall Study|Adverse Event|3|||
48736567|NCT00306189|156885757|FG001|Overall Study|Adverse Event|3|||
48851884|NCT00887224|157297442|FG001|OL Taper Phase / OL Follow Up|Failed to return|0|||
48851885|NCT00887224|157297443|FG002|OL Taper Phase / OL Follow Up|Failed to return|0|||
48851886|NCT00887224|157297441|FG000|OL Taper Phase / OL Follow Up|Physician Decision|10|||
48851887|NCT00887224|157297442|FG001|OL Taper Phase / OL Follow Up|Physician Decision|0|||
48851888|NCT00887224|157297443|FG002|OL Taper Phase / OL Follow Up|Physician Decision|0|||
48851889|NCT00887224|157297441|FG000|OL Taper Phase / OL Follow Up|Lost to Follow-up|8|||
48851890|NCT00887224|157297442|FG001|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
48851891|NCT00887224|157297443|FG002|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
48851892|NCT00887224|157297441|FG000|OL Taper Phase / OL Follow Up|Other|30|||
48851893|NCT00887224|157297442|FG001|OL Taper Phase / OL Follow Up|Other|0|||
48851894|NCT00887224|157297443|FG002|OL Taper Phase / OL Follow Up|Other|0|||
48736568|NCT00306189|156885758|FG002|Overall Study|Adverse Event|2|||
48736569|NCT00306189|156885759|FG003|Overall Study|Adverse Event|2|||
48736570|NCT00306189|156885756|FG000|Overall Study|Withdrawal by Subject|4|||
48736571|NCT00306189|156885757|FG001|Overall Study|Withdrawal by Subject|2|||
48736572|NCT00306189|156885758|FG002|Overall Study|Withdrawal by Subject|8|||
48851895|NCT00887224|157297441|FG000|OL Taper Phase / OL Follow Up|Protocol Violation|3|||
48736573|NCT00306189|156885759|FG003|Overall Study|Withdrawal by Subject|1|||
48736574|NCT00306189|156885756|FG000|Overall Study|Ineligibility determined|1|||
48736575|NCT00306189|156885757|FG001|Overall Study|Ineligibility determined|1|||
48736576|NCT00306189|156885758|FG002|Overall Study|Ineligibility determined|1|||
48946420|NCT00923091|157634732|FG005|Period III (Single-Blind)|Adverse Event|0|||
48946421|NCT00923091|157634733|FG006|Period III (Single-Blind)|Adverse Event|0|||
48946422|NCT00923091|157634734|FG007|Period III (Single-Blind)|Adverse Event|0|||
48946423|NCT00923091|157634735|FG008|Period III (Single-Blind)|Adverse Event|0|||
48946424|NCT00923091|157634736|FG009|Period III (Single-Blind)|Adverse Event|0|||
48946425|NCT00923091|157634737|FG010|Period III (Single-Blind)|Adverse Event|0|||
48946426|NCT00923091|157634738|FG011|Period III (Single-Blind)|Adverse Event|0|||
48946427|NCT00923091|157634739|FG012|Period III (Single-Blind)|Adverse Event|0|||
48946428|NCT00923091|157634727|FG000|Period III (Single-Blind)|Withdrawal by Subject|10|||
48946429|NCT00923091|157634728|FG001|Period III (Single-Blind)|Withdrawal by Subject|0|||
48946430|NCT00923091|157634729|FG002|Period III (Single-Blind)|Withdrawal by Subject|0|||
48946431|NCT00923091|157634730|FG003|Period III (Single-Blind)|Withdrawal by Subject|0|||
48946432|NCT00923091|157634731|FG004|Period III (Single-Blind)|Withdrawal by Subject|0|||
48946433|NCT00923091|157634732|FG005|Period III (Single-Blind)|Withdrawal by Subject|0|||
48946434|NCT00923091|157634733|FG006|Period III (Single-Blind)|Withdrawal by Subject|0|||
48946435|NCT00923091|157634734|FG007|Period III (Single-Blind)|Withdrawal by Subject|0|||
48946436|NCT00923091|157634735|FG008|Period III (Single-Blind)|Withdrawal by Subject|0|||
48946437|NCT00923091|157634736|FG009|Period III (Single-Blind)|Withdrawal by Subject|0|||
48946438|NCT00923091|157634737|FG010|Period III (Single-Blind)|Withdrawal by Subject|0|||
48946439|NCT00923091|157634738|FG011|Period III (Single-Blind)|Withdrawal by Subject|0|||
48946440|NCT00923091|157634739|FG012|Period III (Single-Blind)|Withdrawal by Subject|0|||
48946441|NCT00923091|157634727|FG000|Period III (Single-Blind)|Protocol Violation|3|||
48946442|NCT00923091|157634728|FG001|Period III (Single-Blind)|Protocol Violation|0|||
48946443|NCT00923091|157634729|FG002|Period III (Single-Blind)|Protocol Violation|0|||
48946444|NCT00923091|157634730|FG003|Period III (Single-Blind)|Protocol Violation|0|||
48946445|NCT00923091|157634731|FG004|Period III (Single-Blind)|Protocol Violation|0|||
48946446|NCT00923091|157634732|FG005|Period III (Single-Blind)|Protocol Violation|0|||
48946447|NCT00923091|157634733|FG006|Period III (Single-Blind)|Protocol Violation|0|||
48946448|NCT00923091|157634734|FG007|Period III (Single-Blind)|Protocol Violation|0|||
48946449|NCT00923091|157634735|FG008|Period III (Single-Blind)|Protocol Violation|0|||
48946450|NCT00923091|157634736|FG009|Period III (Single-Blind)|Protocol Violation|0|||
48946451|NCT00923091|157634737|FG010|Period III (Single-Blind)|Protocol Violation|0|||
48946452|NCT00923091|157634738|FG011|Period III (Single-Blind)|Protocol Violation|0|||
48946453|NCT00923091|157634739|FG012|Period III (Single-Blind)|Protocol Violation|0|||
48946454|NCT00923091|157634727|FG000|Period III (Single-Blind)|Lost to Follow-up|2|||
48946455|NCT00923091|157634728|FG001|Period III (Single-Blind)|Lost to Follow-up|0|||
48946456|NCT00923091|157634729|FG002|Period III (Single-Blind)|Lost to Follow-up|0|||
48851896|NCT00887224|157297442|FG001|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
48851897|NCT00887224|157297443|FG002|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
48851898|NCT00887224|157297441|FG000|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48|||
48851899|NCT00887224|157297442|FG001|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
48851900|NCT00887224|157297443|FG002|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
48851901|NCT00887224|157297441|FG000|Double-blind (DB) Phase|Adverse Event|0|||
48851902|NCT00887224|157297442|FG001|Double-blind (DB) Phase|Adverse Event|7|||
48851903|NCT00887224|157297443|FG002|Double-blind (DB) Phase|Adverse Event|2|||
48851904|NCT00887224|157297441|FG000|Double-blind (DB) Phase|Failed to return|0|||
48851905|NCT00887224|157297442|FG001|Double-blind (DB) Phase|Failed to return|2|||
48851906|NCT00887224|157297443|FG002|Double-blind (DB) Phase|Failed to return|2|||
48851907|NCT00887224|157297441|FG000|Double-blind (DB) Phase|Lack of Efficacy|0|||
48851908|NCT00887224|157297442|FG001|Double-blind (DB) Phase|Lack of Efficacy|67|||
48736577|NCT00306189|156885759|FG003|Overall Study|Ineligibility determined|1|||
48736578|NCT00306189|156885756|FG000|Overall Study|Other|1|||
48736579|NCT00306189|156885757|FG001|Overall Study|Other|0|||
48736580|NCT00306189|156885758|FG002|Overall Study|Other|0|||
48736581|NCT00306189|156885759|FG003|Overall Study|Other|0|||
48736582|NCT00191269|156885762|FG000|Overall Study|Protocol Violation|0|||
48736583|NCT00191269|156885763|FG001|Overall Study|Protocol Violation|2|||
48736584|NCT00191269|156885762|FG000|Overall Study|Adverse Event|1|||
48851909|NCT00887224|157297443|FG002|Double-blind (DB) Phase|Lack of Efficacy|33|||
48736585|NCT00191269|156885763|FG001|Overall Study|Adverse Event|4|||
48736586|NCT00191269|156885762|FG000|Overall Study|Progression of Disease|4|||
48736587|NCT00191269|156885763|FG001|Overall Study|Progression of Disease|42|||
48736588|NCT00191269|156885762|FG000|Overall Study|Lack of Efficacy|1|||
48736589|NCT00191269|156885763|FG001|Overall Study|Lack of Efficacy|5|||
48736590|NCT00191269|156885762|FG000|Overall Study|Withdrawal by Subject|0|||
48736591|NCT00191269|156885763|FG001|Overall Study|Withdrawal by Subject|1|||
48736592|NCT00191269|156885762|FG000|Overall Study|Pathologic Aggrevation|0|||
48736593|NCT00191269|156885763|FG001|Overall Study|Pathologic Aggrevation|1|||
48736594|NCT00191269|156885762|FG000|Overall Study|Physician Decision|0|||
48736595|NCT00191269|156885763|FG001|Overall Study|Physician Decision|3|||
48736596|NCT01201785|156885764|FG000|Overall Study|Lost to Follow-up|16|||
48736597|NCT01696071|156885772|FG000|Treatment Period 2: 4 Weeks|Adverse Event|1|||
48736598|NCT01696071|156885773|FG001|Treatment Period 2: 4 Weeks|Adverse Event|0|||
48736599|NCT04223973|156885775|FG000|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|5|||
48736600|NCT04223973|156885776|FG001|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|0|||
48736601|NCT04223973|156885775|FG000|Overall Study|Adverse Event|4|||
48736602|NCT04223973|156885776|FG001|Overall Study|Adverse Event|0|||
48736603|NCT04223973|156885775|FG000|Overall Study|patients reported product dysfunctions and decided to stop the study|3|||
48736604|NCT04223973|156885776|FG001|Overall Study|patients reported product dysfunctions and decided to stop the study|0|||
48736605|NCT04223973|156885775|FG000|Overall Study|Physician Decision|1|||
48736606|NCT04223973|156885776|FG001|Overall Study|Physician Decision|1|||
48736607|NCT04223973|156885775|FG000|Overall Study|Withdrawal by Subject|0|||
48736608|NCT04223973|156885776|FG001|Overall Study|Withdrawal by Subject|1|||
48736609|NCT00293033|156885777|FG000|Open-label Titration Period|Adverse Event|10|||
48736610|NCT00293033|156885777|FG000|Open-label Titration Period|Death|3|||
48736611|NCT00293033|156885777|FG000|Open-label Titration Period|Lack of Efficacy|5|||
48851910|NCT00887224|157297441|FG000|Double-blind (DB) Phase|Lost to Follow-up|0|||
48851911|NCT00887224|157297442|FG001|Double-blind (DB) Phase|Lost to Follow-up|8|||
48851912|NCT00887224|157297443|FG002|Double-blind (DB) Phase|Lost to Follow-up|8|||
48851913|NCT00887224|157297441|FG000|Double-blind (DB) Phase|Other|0|||
48851914|NCT00887224|157297442|FG001|Double-blind (DB) Phase|Other|2|||
48851915|NCT00887224|157297443|FG002|Double-blind (DB) Phase|Other|0|||
48851916|NCT00887224|157297441|FG000|Double-blind (DB) Phase|Protocol Violation|0|||
48851917|NCT00887224|157297442|FG001|Double-blind (DB) Phase|Protocol Violation|8|||
48851918|NCT00887224|157297443|FG002|Double-blind (DB) Phase|Protocol Violation|5|||
48851919|NCT00887224|157297441|FG000|Double-blind (DB) Phase|Withdrawal by Subject|0|||
48851920|NCT00887224|157297442|FG001|Double-blind (DB) Phase|Withdrawal by Subject|6|||
48851921|NCT00887224|157297443|FG002|Double-blind (DB) Phase|Withdrawal by Subject|12|||
48851922|NCT00887224|157297441|FG000|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
48736612|NCT00293033|156885777|FG000|Open-label Titration Period|Protocol Violation|2|||
48736613|NCT00293033|156885777|FG000|Open-label Titration Period|Withdrawal by Subject|22|||
48736614|NCT00293033|156885777|FG000|Open-label Titration Period|Noncompliance and other|27|||
48736615|NCT00293033|156885777|FG000|Double-blind Treatment Period|Adverse Event|3|||
48736616|NCT00293033|156885777|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
48946457|NCT00923091|157634730|FG003|Period III (Single-Blind)|Lost to Follow-up|0|||
48946458|NCT00923091|157634731|FG004|Period III (Single-Blind)|Lost to Follow-up|0|||
48946459|NCT00923091|157634732|FG005|Period III (Single-Blind)|Lost to Follow-up|0|||
48946460|NCT00923091|157634733|FG006|Period III (Single-Blind)|Lost to Follow-up|0|||
48946461|NCT00923091|157634734|FG007|Period III (Single-Blind)|Lost to Follow-up|0|||
48946462|NCT00923091|157634735|FG008|Period III (Single-Blind)|Lost to Follow-up|0|||
48946463|NCT00923091|157634736|FG009|Period III (Single-Blind)|Lost to Follow-up|0|||
48946464|NCT00923091|157634737|FG010|Period III (Single-Blind)|Lost to Follow-up|0|||
48736617|NCT00293033|156885777|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
48946465|NCT00923091|157634738|FG011|Period III (Single-Blind)|Lost to Follow-up|0|||
48946466|NCT00923091|157634739|FG012|Period III (Single-Blind)|Lost to Follow-up|0|||
48946467|NCT00923091|157634727|FG000|Period IV (Double-Blind)|Adverse Event|2|||
48946468|NCT00923091|157634728|FG001|Period IV (Double-Blind)|Adverse Event|0|||
48946469|NCT00923091|157634729|FG002|Period IV (Double-Blind)|Adverse Event|0|||
48946470|NCT00923091|157634730|FG003|Period IV (Double-Blind)|Adverse Event|0|||
48946471|NCT00923091|157634731|FG004|Period IV (Double-Blind)|Adverse Event|0|||
48946472|NCT00923091|157634732|FG005|Period IV (Double-Blind)|Adverse Event|0|||
48736618|NCT00293033|156885777|FG000|Double-blind Treatment Period|Noncompliance|4|||
48946473|NCT00923091|157634733|FG006|Period IV (Double-Blind)|Adverse Event|0|||
48851923|NCT00887224|157297442|FG001|DB Taper Phase / Post Study Follow Up|Adverse Event|5|||
48851924|NCT00887224|157297443|FG002|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
48851925|NCT00887224|157297441|FG000|DB Taper Phase / Post Study Follow Up|Failed to return|0|||
48851926|NCT00887224|157297442|FG001|DB Taper Phase / Post Study Follow Up|Failed to return|5|||
48946474|NCT00923091|157634734|FG007|Period IV (Double-Blind)|Adverse Event|0|||
48946475|NCT00923091|157634735|FG008|Period IV (Double-Blind)|Adverse Event|0|||
48946476|NCT00923091|157634736|FG009|Period IV (Double-Blind)|Adverse Event|0|||
48946477|NCT00923091|157634737|FG010|Period IV (Double-Blind)|Adverse Event|0|||
48946478|NCT00923091|157634738|FG011|Period IV (Double-Blind)|Adverse Event|0|||
48851927|NCT00887224|157297443|FG002|DB Taper Phase / Post Study Follow Up|Failed to return|4|||
48851928|NCT00887224|157297441|FG000|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
48851929|NCT00887224|157297442|FG001|DB Taper Phase / Post Study Follow Up|Physician Decision|6|||
48851930|NCT00887224|157297443|FG002|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
48851931|NCT00887224|157297441|FG000|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0|||
48851932|NCT00887224|157297442|FG001|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
48851933|NCT00887224|157297443|FG002|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
48946479|NCT00923091|157634739|FG012|Period IV (Double-Blind)|Adverse Event|0|||
48946480|NCT00923091|157634727|FG000|Period IV (Double-Blind)|Withdrawal by Subject|0|||
48946481|NCT00923091|157634728|FG001|Period IV (Double-Blind)|Withdrawal by Subject|1|||
48736619|NCT03583697|156885778|FG000|Overall Study|Withdrawal by Subject|0|||
48736620|NCT03583697|156885779|FG001|Overall Study|Withdrawal by Subject|0|||
48736621|NCT03583697|156885780|FG002|Overall Study|Withdrawal by Subject|1|||
48736622|NCT03583697|156885778|FG000|Overall Study|AE of sudden infant death syndrome, not related|0|||
48736623|NCT03583697|156885779|FG001|Overall Study|AE of sudden infant death syndrome, not related|1|||
48736624|NCT03583697|156885780|FG002|Overall Study|AE of sudden infant death syndrome, not related|0|||
48736625|NCT04444895|156887918|FG000|Overall Study|Adverse Event|2|||
48736626|NCT04444895|156887918|FG000|Overall Study|Lost to Follow-up|2|||
48736627|NCT04444895|156887918|FG000|Overall Study|Withdrawal by Subject|5|||
48736628|NCT01313858|156887921|FG000|Overall Study|Premature Treatment Termination|251|||
48736629|NCT01313858|156887922|FG001|Overall Study|Premature Treatment Termination|219|||
48736630|NCT01313858|156887923|FG002|Overall Study|Premature Treatment Termination|191|||
48736631|NCT01313858|156887921|FG000|Overall Study|Lost to Follow-up|35|||
48736632|NCT01313858|156887922|FG001|Overall Study|Lost to Follow-up|51|||
48736633|NCT01313858|156887923|FG002|Overall Study|Lost to Follow-up|47|||
48736634|NCT01890746|156887924|FG000|Overall Study|Death|39|||
48736635|NCT01890746|156887925|FG001|Overall Study|Death|30|||
48736636|NCT01890746|156887924|FG000|Overall Study|Adverse Event|1|||
48736637|NCT01890746|156887925|FG001|Overall Study|Adverse Event|0|||
48736638|NCT01890746|156887924|FG000|Overall Study|Lost to Follow-up|4|||
48736639|NCT01890746|156887925|FG001|Overall Study|Lost to Follow-up|1|||
48736640|NCT01890746|156887924|FG000|Overall Study|Physician Decision|3|||
48736641|NCT01890746|156887925|FG001|Overall Study|Physician Decision|2|||
48736642|NCT01890746|156887924|FG000|Overall Study|Withdrawal by Subject|5|||
48736643|NCT01890746|156887925|FG001|Overall Study|Withdrawal by Subject|8|||
48736644|NCT03917459|156887926|FG000|Overall Study|Adverse Event|1|||
48946482|NCT00923091|157634729|FG002|Period IV (Double-Blind)|Withdrawal by Subject|0|||
48946483|NCT00923091|157634730|FG003|Period IV (Double-Blind)|Withdrawal by Subject|0|||
48946484|NCT00923091|157634731|FG004|Period IV (Double-Blind)|Withdrawal by Subject|0|||
48736645|NCT03917459|156887927|FG001|Overall Study|Adverse Event|0|||
48736646|NCT03917459|156887926|FG000|Overall Study|Withdrawal by Subject|0|||
48736647|NCT03917459|156887927|FG001|Overall Study|Withdrawal by Subject|1|||
48736648|NCT00491764|156887929|FG000|Overall Study|Adverse Event|1|||
48736649|NCT00491764|156887930|FG001|Overall Study|Adverse Event|2|||
48736650|NCT00491764|156887931|FG002|Overall Study|Adverse Event|4|||
48736651|NCT00491764|156887932|FG003|Overall Study|Adverse Event|4|||
48851934|NCT00887224|157297441|FG000|DB Taper Phase / Post Study Follow Up|Other|0|||
48851935|NCT00887224|157297442|FG001|DB Taper Phase / Post Study Follow Up|Other|11|||
48851936|NCT00887224|157297443|FG002|DB Taper Phase / Post Study Follow Up|Other|12|||
48851937|NCT00887224|157297441|FG000|DB Taper Phase / Post Study Follow Up|Protocol Violation|0|||
48851938|NCT00887224|157297442|FG001|DB Taper Phase / Post Study Follow Up|Protocol Violation|4|||
48851939|NCT00887224|157297443|FG002|DB Taper Phase / Post Study Follow Up|Protocol Violation|1|||
48851940|NCT00887224|157297441|FG000|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0|||
48851941|NCT00887224|157297442|FG001|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8|||
48851942|NCT00887224|157297443|FG002|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11|||
48851943|NCT00790569|157297446|FG000|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
48851944|NCT00790569|157297447|FG001|End of Treatment (6 Month Interview)|Lost to Follow-up|8|||
48851945|NCT00790569|157297448|FG002|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
48851946|NCT00790569|157297446|FG000|End of Treatment (6 Month Interview)|Death|0|||
48851947|NCT00790569|157297447|FG001|End of Treatment (6 Month Interview)|Death|2|||
48851948|NCT00790569|157297448|FG002|End of Treatment (6 Month Interview)|Death|1|||
48851949|NCT00790569|157297446|FG000|End of Treatment (6 Month Interview)|Hospitalized|2|||
48851950|NCT00790569|157297447|FG001|End of Treatment (6 Month Interview)|Hospitalized|0|||
48851951|NCT00790569|157297448|FG002|End of Treatment (6 Month Interview)|Hospitalized|0|||
48851952|NCT00790569|157297446|FG000|End of Treatment (6 Month Interview)|Residential Treatment|0|||
48851953|NCT00790569|157297447|FG001|End of Treatment (6 Month Interview)|Residential Treatment|0|||
48851954|NCT00790569|157297448|FG002|End of Treatment (6 Month Interview)|Residential Treatment|2|||
48851955|NCT00790569|157297446|FG000|End of Treatment (6 Month Interview)|Incarcerated|0|||
48851956|NCT00790569|157297447|FG001|End of Treatment (6 Month Interview)|Incarcerated|0|||
48851957|NCT00790569|157297448|FG002|End of Treatment (6 Month Interview)|Incarcerated|3|||
48851958|NCT00790569|157297446|FG000|End of Study (12 Month Interview)|Lost to Follow-up|66|||
48851959|NCT00790569|157297447|FG001|End of Study (12 Month Interview)|Lost to Follow-up|19|||
48851960|NCT00790569|157297448|FG002|End of Study (12 Month Interview)|Lost to Follow-up|50|||
48851961|NCT01313884|157297449|FG000|Overall Study|Per insurance pvdr, pt can't be on cl tr|1|||
48851962|NCT00999596|157297450|FG000|Overall Study|Statistical population not required|101|||
48851963|NCT02085941|157297452|FG000|Overall Study|Lack of Efficacy|1|||
48851964|NCT02085941|157297453|FG001|Overall Study|Lack of Efficacy|0|||
48851965|NCT02085941|157297452|FG000|Overall Study|Death|6|||
48851966|NCT02085941|157297453|FG001|Overall Study|Death|1|||
48851967|NCT02085941|157297452|FG000|Overall Study|Lost to Follow-up|1|||
48851968|NCT02085941|157297453|FG001|Overall Study|Lost to Follow-up|0|||
48851969|NCT02085941|157297452|FG000|Overall Study|Physician Decision|0|||
48851970|NCT02085941|157297453|FG001|Overall Study|Physician Decision|2|||
48851971|NCT01530334|157297454|FG000|Overall Study|Adverse Event|3|||
48851972|NCT01530334|157297454|FG000|Overall Study|unknown reason|1|||
48851973|NCT01530334|157297454|FG000|Overall Study|Progressive disease|47|||
48851974|NCT02234141|157297462|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
48851975|NCT02234141|157297463|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
48736652|NCT00491764|156887933|FG004|Overall Study|Adverse Event|0|||
48851976|NCT02234141|157297464|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
48851977|NCT02234141|157297465|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
48851978|NCT02234141|157297466|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
48851979|NCT02234141|157297467|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
48851980|NCT02234141|157297468|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
48851981|NCT02234141|157297462|FG000|Treatment Period (24 Weeks)|Investigator's discretion|0|||
48851982|NCT02234141|157297463|FG001|Treatment Period (24 Weeks)|Investigator's discretion|2|||
48851983|NCT02234141|157297464|FG002|Treatment Period (24 Weeks)|Investigator's discretion|0|||
48851984|NCT02234141|157297465|FG003|Treatment Period (24 Weeks)|Investigator's discretion|0|||
48946485|NCT00923091|157634732|FG005|Period IV (Double-Blind)|Withdrawal by Subject|0|||
48736653|NCT00491764|156887934|FG005|Overall Study|Adverse Event|1|||
48736654|NCT00491764|156887929|FG000|Overall Study|Lost to Follow-up|0|||
48736655|NCT00491764|156887930|FG001|Overall Study|Lost to Follow-up|1|||
48736656|NCT00491764|156887931|FG002|Overall Study|Lost to Follow-up|0|||
48736657|NCT00491764|156887932|FG003|Overall Study|Lost to Follow-up|1|||
48736658|NCT00491764|156887933|FG004|Overall Study|Lost to Follow-up|0|||
48736659|NCT00491764|156887934|FG005|Overall Study|Lost to Follow-up|3|||
48736660|NCT00491764|156887929|FG000|Overall Study|Withdrawal by Subject|2|||
48851985|NCT02234141|157297466|FG004|Treatment Period (24 Weeks)|Investigator's discretion|0|||
48851986|NCT02234141|157297467|FG005|Treatment Period (24 Weeks)|Investigator's discretion|0|||
48851987|NCT02234141|157297468|FG006|Treatment Period (24 Weeks)|Investigator's discretion|0|||
48851988|NCT02234141|157297462|FG000|Treatment Period (24 Weeks)|Death|1|||
48851989|NCT02234141|157297463|FG001|Treatment Period (24 Weeks)|Death|2|||
48736661|NCT00491764|156887930|FG001|Overall Study|Withdrawal by Subject|3|||
48736662|NCT00491764|156887931|FG002|Overall Study|Withdrawal by Subject|1|||
48851990|NCT02234141|157297464|FG002|Treatment Period (24 Weeks)|Death|0|||
48851991|NCT02234141|157297465|FG003|Treatment Period (24 Weeks)|Death|1|||
48851992|NCT02234141|157297466|FG004|Treatment Period (24 Weeks)|Death|0|||
48851993|NCT02234141|157297467|FG005|Treatment Period (24 Weeks)|Death|0|||
48851994|NCT02234141|157297468|FG006|Treatment Period (24 Weeks)|Death|0|||
48851995|NCT02234141|157297462|FG000|Treatment Period (24 Weeks)|Adverse Event|3|||
48851996|NCT02234141|157297463|FG001|Treatment Period (24 Weeks)|Adverse Event|1|||
48851997|NCT02234141|157297464|FG002|Treatment Period (24 Weeks)|Adverse Event|2|||
48851998|NCT02234141|157297465|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
48851999|NCT02234141|157297466|FG004|Treatment Period (24 Weeks)|Adverse Event|0|||
48852000|NCT02234141|157297467|FG005|Treatment Period (24 Weeks)|Adverse Event|0|||
48852001|NCT02234141|157297468|FG006|Treatment Period (24 Weeks)|Adverse Event|0|||
48852002|NCT02234141|157297462|FG000|Treatment Period (24 Weeks)|Randomized but not treated|0|||
48852003|NCT02234141|157297463|FG001|Treatment Period (24 Weeks)|Randomized but not treated|1|||
48852004|NCT02234141|157297464|FG002|Treatment Period (24 Weeks)|Randomized but not treated|0|||
48852005|NCT02234141|157297465|FG003|Treatment Period (24 Weeks)|Randomized but not treated|0|||
48852006|NCT02234141|157297466|FG004|Treatment Period (24 Weeks)|Randomized but not treated|0|||
48852007|NCT02234141|157297467|FG005|Treatment Period (24 Weeks)|Randomized but not treated|0|||
48852008|NCT02234141|157297468|FG006|Treatment Period (24 Weeks)|Randomized but not treated|0|||
48852009|NCT02234141|157297462|FG000|Long-Term Treatment Period|Death|0|||
48852010|NCT02234141|157297463|FG001|Long-Term Treatment Period|Death|0|||
48852011|NCT02234141|157297464|FG002|Long-Term Treatment Period|Death|0|||
48852012|NCT02234141|157297465|FG003|Long-Term Treatment Period|Death|0|||
48852013|NCT02234141|157297466|FG004|Long-Term Treatment Period|Death|0|||
48852014|NCT02234141|157297467|FG005|Long-Term Treatment Period|Death|1|||
48852015|NCT02234141|157297468|FG006|Long-Term Treatment Period|Death|0|||
48852016|NCT02234141|157297462|FG000|Long-Term Treatment Period|Investigator's discretion|1|||
48852017|NCT02234141|157297463|FG001|Long-Term Treatment Period|Investigator's discretion|3|||
48852018|NCT02234141|157297464|FG002|Long-Term Treatment Period|Investigator's discretion|2|||
48852019|NCT02234141|157297465|FG003|Long-Term Treatment Period|Investigator's discretion|0|||
48852020|NCT02234141|157297466|FG004|Long-Term Treatment Period|Investigator's discretion|0|||
48852021|NCT02234141|157297467|FG005|Long-Term Treatment Period|Investigator's discretion|0|||
48852022|NCT02234141|157297468|FG006|Long-Term Treatment Period|Investigator's discretion|1|||
48852023|NCT02234141|157297462|FG000|Long-Term Treatment Period|Adverse Event|4|||
48736663|NCT00491764|156887932|FG003|Overall Study|Withdrawal by Subject|2|||
48736664|NCT00491764|156887933|FG004|Overall Study|Withdrawal by Subject|2|||
48736665|NCT00491764|156887934|FG005|Overall Study|Withdrawal by Subject|4|||
48736666|NCT00491764|156887929|FG000|Overall Study|Non Compliance with the Protocol|1|||
48736667|NCT00491764|156887930|FG001|Overall Study|Non Compliance with the Protocol|0|||
48736668|NCT00491764|156887931|FG002|Overall Study|Non Compliance with the Protocol|0|||
48736669|NCT00491764|156887932|FG003|Overall Study|Non Compliance with the Protocol|0|||
48736670|NCT00491764|156887933|FG004|Overall Study|Non Compliance with the Protocol|0|||
48736671|NCT00491764|156887934|FG005|Overall Study|Non Compliance with the Protocol|0|||
48736672|NCT00491764|156887929|FG000|Overall Study|Did not Meet Protocol Eligibility|0|||
48736673|NCT00491764|156887930|FG001|Overall Study|Did not Meet Protocol Eligibility|1|||
48736674|NCT00491764|156887931|FG002|Overall Study|Did not Meet Protocol Eligibility|1|||
48736675|NCT00491764|156887932|FG003|Overall Study|Did not Meet Protocol Eligibility|0|||
48736676|NCT00491764|156887933|FG004|Overall Study|Did not Meet Protocol Eligibility|1|||
48736677|NCT00491764|156887934|FG005|Overall Study|Did not Meet Protocol Eligibility|1|||
48736678|NCT00491764|156887929|FG000|Overall Study|Administrative|1|||
48736679|NCT00491764|156887930|FG001|Overall Study|Administrative|0|||
48736680|NCT00491764|156887931|FG002|Overall Study|Administrative|2|||
48736681|NCT00491764|156887932|FG003|Overall Study|Administrative|1|||
48736682|NCT00491764|156887933|FG004|Overall Study|Administrative|0|||
48736683|NCT00491764|156887934|FG005|Overall Study|Administrative|0|||
48852024|NCT02234141|157297463|FG001|Long-Term Treatment Period|Adverse Event|0|||
48852025|NCT02234141|157297464|FG002|Long-Term Treatment Period|Adverse Event|5|||
48852026|NCT02234141|157297465|FG003|Long-Term Treatment Period|Adverse Event|0|||
48852027|NCT02234141|157297466|FG004|Long-Term Treatment Period|Adverse Event|1|||
48736684|NCT01426438|156887935|FG000|Overall Study|Lost to Follow-up|1|||
48736685|NCT01426438|156887936|FG001|Overall Study|Lost to Follow-up|3|||
48736686|NCT01426438|156887935|FG000|Overall Study|Off study Treatment|9|||
48736687|NCT01426438|156887936|FG001|Overall Study|Off study Treatment|3|||
48736688|NCT01426438|156887935|FG000|Overall Study|Poor scan quality|3|||
48736689|NCT01426438|156887936|FG001|Overall Study|Poor scan quality|2|||
48736690|NCT01426438|156887935|FG000|Overall Study|Missed Scan|2|||
48852028|NCT02234141|157297467|FG005|Long-Term Treatment Period|Adverse Event|1|||
48852029|NCT02234141|157297468|FG006|Long-Term Treatment Period|Adverse Event|1|||
48852030|NCT02234141|157297462|FG000|Long-Term Treatment Period|Withdrew Consent|0|||
48852031|NCT02234141|157297463|FG001|Long-Term Treatment Period|Withdrew Consent|1|||
48852032|NCT02234141|157297464|FG002|Long-Term Treatment Period|Withdrew Consent|1|||
48852033|NCT02234141|157297465|FG003|Long-Term Treatment Period|Withdrew Consent|0|||
48852034|NCT02234141|157297466|FG004|Long-Term Treatment Period|Withdrew Consent|0|||
48852035|NCT02234141|157297467|FG005|Long-Term Treatment Period|Withdrew Consent|0|||
48852036|NCT02234141|157297468|FG006|Long-Term Treatment Period|Withdrew Consent|0|||
48852037|NCT02234141|157297462|FG000|Long-Term Treatment Period|Study Discontinued by Sponsor|28|||
48852038|NCT02234141|157297463|FG001|Long-Term Treatment Period|Study Discontinued by Sponsor|27|||
48852039|NCT02234141|157297464|FG002|Long-Term Treatment Period|Study Discontinued by Sponsor|25|||
48852040|NCT02234141|157297465|FG003|Long-Term Treatment Period|Study Discontinued by Sponsor|0|||
48852041|NCT02234141|157297466|FG004|Long-Term Treatment Period|Study Discontinued by Sponsor|9|||
48852042|NCT02234141|157297467|FG005|Long-Term Treatment Period|Study Discontinued by Sponsor|10|||
48852043|NCT02234141|157297468|FG006|Long-Term Treatment Period|Study Discontinued by Sponsor|8|||
48852044|NCT03589768|157297469|FG000|Overall Study|Death|1|||
48852045|NCT03589768|157297470|FG001|Overall Study|Death|0|||
48852046|NCT03589768|157297471|FG002|Overall Study|Death|8|||
48852047|NCT03589768|157297472|FG003|Overall Study|Death|3|||
48852048|NCT03589768|157297469|FG000|Overall Study|Withdrawal by Subject|2|||
48852049|NCT03589768|157297470|FG001|Overall Study|Withdrawal by Subject|0|||
48852050|NCT03589768|157297471|FG002|Overall Study|Withdrawal by Subject|0|||
48852051|NCT03589768|157297472|FG003|Overall Study|Withdrawal by Subject|0|||
48852052|NCT03589768|157297469|FG000|Overall Study|Protocol Violation|1|||
48852053|NCT03589768|157297470|FG001|Overall Study|Protocol Violation|0|||
48852054|NCT03589768|157297471|FG002|Overall Study|Protocol Violation|0|||
48852055|NCT03589768|157297472|FG003|Overall Study|Protocol Violation|0|||
48852056|NCT01972776|157297475|FG000|Part 1|Withdrawal by Subject|0|||
48852057|NCT01972776|157297476|FG001|Part 1|Withdrawal by Subject|0|||
48852058|NCT01972776|157297477|FG002|Part 1|Withdrawal by Subject|1|||
48852059|NCT01972776|157297478|FG003|Part 1|Withdrawal by Subject|0|||
48852060|NCT01972776|157297479|FG004|Part 1|Withdrawal by Subject|0|||
48852061|NCT01972776|157297480|FG005|Part 1|Withdrawal by Subject|0|||
48852062|NCT01972776|157297475|FG000|Part 1|Adverse Event|0|||
48852063|NCT01972776|157297476|FG001|Part 1|Adverse Event|0|||
48852064|NCT01972776|157297477|FG002|Part 1|Adverse Event|1|||
48852065|NCT01972776|157297478|FG003|Part 1|Adverse Event|1|||
48852066|NCT01972776|157297479|FG004|Part 1|Adverse Event|0|||
48852067|NCT01972776|157297480|FG005|Part 1|Adverse Event|0|||
48852068|NCT01972776|157297475|FG000|Part 2|Adverse Event|0|||
48852069|NCT01972776|157297476|FG001|Part 2|Adverse Event|0|||
48852070|NCT01972776|157297477|FG002|Part 2|Adverse Event|0|||
48852071|NCT01972776|157297478|FG003|Part 2|Adverse Event|0|||
48852072|NCT01972776|157297479|FG004|Part 2|Adverse Event|3|||
48852073|NCT01972776|157297480|FG005|Part 2|Adverse Event|0|||
48852074|NCT01972776|157297475|FG000|Part 2|Administrative problems|0|||
48852075|NCT01972776|157297476|FG001|Part 2|Administrative problems|0|||
48852076|NCT01972776|157297477|FG002|Part 2|Administrative problems|0|||
48852077|NCT01972776|157297478|FG003|Part 2|Administrative problems|0|||
48852078|NCT01972776|157297479|FG004|Part 2|Administrative problems|10|||
48852079|NCT01972776|157297480|FG005|Part 2|Administrative problems|7|||
48852080|NCT02410278|157297486|FG000|Run-in Period|Adverse Event|5|||
48852081|NCT02410278|157297487|FG001|Run-in Period|Adverse Event|0|||
48852082|NCT02410278|157297488|FG002|Run-in Period|Adverse Event|0|||
48852083|NCT02410278|157297486|FG000|Run-in Period|GSRS Threshold Not Met|30|||
48852084|NCT02410278|157297487|FG001|Run-in Period|GSRS Threshold Not Met|0|||
48852085|NCT02410278|157297488|FG002|Run-in Period|GSRS Threshold Not Met|0|||
48852086|NCT02410278|157297486|FG000|Run-in Period|Lost to Follow-up|1|||
48852087|NCT02410278|157297487|FG001|Run-in Period|Lost to Follow-up|0|||
48852088|NCT02410278|157297488|FG002|Run-in Period|Lost to Follow-up|0|||
48852089|NCT02410278|157297486|FG000|Run-in Period|Withdrawal by Subject|1|||
48852090|NCT02410278|157297487|FG001|Run-in Period|Withdrawal by Subject|0|||
48852091|NCT02410278|157297488|FG002|Run-in Period|Withdrawal by Subject|0|||
48852092|NCT02410278|157297486|FG000|Run-in Period|Pregnancy|1|||
48852093|NCT02410278|157297487|FG001|Run-in Period|Pregnancy|0|||
48852094|NCT02410278|157297488|FG002|Run-in Period|Pregnancy|0|||
48852095|NCT02410278|157297486|FG000|Study Treatment Period|Adverse Event|0|||
48852096|NCT02410278|157297487|FG001|Study Treatment Period|Adverse Event|6|||
48852097|NCT02410278|157297488|FG002|Study Treatment Period|Adverse Event|3|||
48852098|NCT02410278|157297486|FG000|Study Treatment Period|Physician Decision|0|||
48852099|NCT02410278|157297487|FG001|Study Treatment Period|Physician Decision|0|||
48852100|NCT02410278|157297488|FG002|Study Treatment Period|Physician Decision|1|||
48852101|NCT02410278|157297486|FG000|Study Treatment Period|Withdrawal by Subject|0|||
48852102|NCT02410278|157297487|FG001|Study Treatment Period|Withdrawal by Subject|1|||
48852103|NCT02410278|157297488|FG002|Study Treatment Period|Withdrawal by Subject|0|||
48852104|NCT02410278|157297486|FG000|Study Treatment Period|Other|0|||
48852105|NCT02410278|157297487|FG001|Study Treatment Period|Other|3|||
48852106|NCT02410278|157297488|FG002|Study Treatment Period|Other|0|||
48852107|NCT02410278|157297486|FG000|Study Treatment Period|GSRS Threshold Not Met|0|||
48852108|NCT02410278|157297487|FG001|Study Treatment Period|GSRS Threshold Not Met|1|||
48852109|NCT02410278|157297488|FG002|Study Treatment Period|GSRS Threshold Not Met|0|||
48852110|NCT03567616|157297493|FG000|Overall Study|Disease progression|4|||
48852111|NCT03567616|157297493|FG000|Overall Study|Withdrawal by Subject|1|||
48852112|NCT03567616|157297493|FG000|Overall Study|Physician Decision|1|||
48852113|NCT03567616|157297493|FG000|Overall Study|Death|1|||
48852114|NCT03567616|157297493|FG000|Overall Study|Adverse Event|1|||
48852115|NCT01074242|157297494|FG000|Overall Study|Case report before date of contract|40|||
48852116|NCT01074242|157297494|FG000|Overall Study|Lost to Follow-up|1|||
48852117|NCT01074242|157297494|FG000|Overall Study|Case report unclear|6|||
48852118|NCT01074242|157297494|FG000|Overall Study|Violation of vaccine dose or dosage|351|||
48852119|NCT01074242|157297494|FG000|Overall Study|Duplicate Case Report Form|5|||
48852120|NCT01822756|157297495|FG000|Overall Study|Adverse Event|0|||
48852121|NCT01822756|157297496|FG001|Overall Study|Adverse Event|0|||
48852122|NCT01822756|157297497|FG002|Overall Study|Adverse Event|0|||
48852123|NCT01822756|157297498|FG003|Overall Study|Adverse Event|2|||
48852124|NCT01822756|157297499|FG004|Overall Study|Adverse Event|0|||
48852125|NCT01822756|157297495|FG000|Overall Study|Disease progression|11|||
48852126|NCT01822756|157297496|FG001|Overall Study|Disease progression|1|||
48852127|NCT01822756|157297497|FG002|Overall Study|Disease progression|7|||
48852128|NCT01822756|157297498|FG003|Overall Study|Disease progression|2|||
48852129|NCT01822756|157297499|FG004|Overall Study|Disease progression|6|||
48852130|NCT01822756|157297495|FG000|Overall Study|Death|2|||
48852131|NCT01822756|157297496|FG001|Overall Study|Death|2|||
48852132|NCT01822756|157297497|FG002|Overall Study|Death|1|||
48852133|NCT01822756|157297498|FG003|Overall Study|Death|0|||
48852134|NCT01822756|157297499|FG004|Overall Study|Death|0|||
48852135|NCT01822756|157297495|FG000|Overall Study|Lost to Follow-up|1|||
48852136|NCT01822756|157297496|FG001|Overall Study|Lost to Follow-up|0|||
48852137|NCT01822756|157297497|FG002|Overall Study|Lost to Follow-up|1|||
48852138|NCT01822756|157297498|FG003|Overall Study|Lost to Follow-up|0|||
48852139|NCT01822756|157297499|FG004|Overall Study|Lost to Follow-up|1|||
48852140|NCT01822756|157297495|FG000|Overall Study|Physician Decision|0|||
48852141|NCT01822756|157297496|FG001|Overall Study|Physician Decision|1|||
48852142|NCT01822756|157297497|FG002|Overall Study|Physician Decision|0|||
48852143|NCT01822756|157297498|FG003|Overall Study|Physician Decision|0|||
48852144|NCT01822756|157297499|FG004|Overall Study|Physician Decision|0|||
48852145|NCT01822756|157297495|FG000|Overall Study|disease progression & patient preference|2|||
48852146|NCT01822756|157297496|FG001|Overall Study|disease progression & patient preference|0|||
48852147|NCT01822756|157297497|FG002|Overall Study|disease progression & patient preference|1|||
48852148|NCT01822756|157297498|FG003|Overall Study|disease progression & patient preference|0|||
48852149|NCT01822756|157297499|FG004|Overall Study|disease progression & patient preference|0|||
48852150|NCT03041233|157297500|FG000|Overall Study|Death|5|||
48852151|NCT03041233|157297500|FG000|Overall Study|Physician Decision|1|||
48852152|NCT03041233|157297500|FG000|Overall Study|Lost to Follow-up|16|||
48852153|NCT03041233|157297500|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|7|||
48852154|NCT03041233|157297500|FG000|Overall Study|Sponsor Request|1|||
48852155|NCT03041233|157297500|FG000|Overall Study|Duplicate subject|1|||
48852156|NCT03041233|157297500|FG000|Overall Study|Re-ablation|1|||
48852157|NCT01856569|157297505|FG000|Overall Study|Other|1|||
48852158|NCT01856569|157297505|FG000|Overall Study|Changed Site/Structure|1|||
48852159|NCT01856569|157297505|FG000|Overall Study|Lost to Follow-up|3|||
48852160|NCT01856569|157297505|FG000|Overall Study|Did not met inclusion criteria|8|||
48852161|NCT01860079|157297507|FG000|Overall Study|Physician Decision|14|||
48852162|NCT01860079|157297508|FG001|Overall Study|Physician Decision|22|||
48852163|NCT00326183|157297509|FG000|Overall Study|Lost to Follow-up|104|||
48852164|NCT00326183|157297510|FG001|Overall Study|Lost to Follow-up|56|||
48852165|NCT00326183|157297509|FG000|Overall Study|Protocol Violation|6|||
48852166|NCT00326183|157297510|FG001|Overall Study|Protocol Violation|3|||
48852167|NCT00326183|157297509|FG000|Overall Study|Withdrawal by Subject|35|||
48852168|NCT00326183|157297510|FG001|Overall Study|Withdrawal by Subject|7|||
48852169|NCT00326183|157297509|FG000|Overall Study|Subject Moved|7|||
48852170|NCT00326183|157297510|FG001|Overall Study|Subject Moved|4|||
48852171|NCT00326183|157297509|FG000|Overall Study|Other|47|||
48852172|NCT00326183|157297510|FG001|Overall Study|Other|13|||
48852173|NCT00326183|157297509|FG000|Overall Study|Adverse Event|1|||
48852174|NCT00326183|157297510|FG001|Overall Study|Adverse Event|0|||
48852175|NCT03683576|157297519|FG000|Overall Study|Withdrawal by Subject|2|||
48852176|NCT03683576|157297520|FG001|Overall Study|Withdrawal by Subject|0|||
48852177|NCT03683576|157297521|FG002|Overall Study|Withdrawal by Subject|8|||
48852178|NCT03683576|157297522|FG003|Overall Study|Withdrawal by Subject|3|||
48852179|NCT03683576|157297519|FG000|Overall Study|Adverse Event|3|||
48852180|NCT03683576|157297520|FG001|Overall Study|Adverse Event|0|||
48852181|NCT03683576|157297521|FG002|Overall Study|Adverse Event|0|||
48852182|NCT03683576|157297522|FG003|Overall Study|Adverse Event|4|||
48852183|NCT03683576|157297519|FG000|Overall Study|Lack of Efficacy|1|||
48852184|NCT03683576|157297520|FG001|Overall Study|Lack of Efficacy|0|||
48852185|NCT03683576|157297521|FG002|Overall Study|Lack of Efficacy|1|||
48852186|NCT03683576|157297522|FG003|Overall Study|Lack of Efficacy|1|||
48852187|NCT03683576|157297519|FG000|Overall Study|Lost to Follow-up|0|||
48852188|NCT03683576|157297520|FG001|Overall Study|Lost to Follow-up|1|||
48852189|NCT03683576|157297521|FG002|Overall Study|Lost to Follow-up|2|||
48852190|NCT03683576|157297522|FG003|Overall Study|Lost to Follow-up|0|||
48852191|NCT03683576|157297519|FG000|Overall Study|Other, Not Specified|0|||
48852192|NCT03683576|157297520|FG001|Overall Study|Other, Not Specified|2|||
48852193|NCT03683576|157297521|FG002|Overall Study|Other, Not Specified|0|||
48852194|NCT03683576|157297522|FG003|Overall Study|Other, Not Specified|0|||
48852195|NCT03683576|157297519|FG000|Overall Study|Protocol Violation|0|||
48852196|NCT03683576|157297520|FG001|Overall Study|Protocol Violation|1|||
48852197|NCT03683576|157297521|FG002|Overall Study|Protocol Violation|1|||
48852198|NCT03683576|157297522|FG003|Overall Study|Protocol Violation|0|||
48852199|NCT01593020|157297525|FG000|Overall Study|Adverse Event|1|||
48852200|NCT01593020|157297526|FG001|Overall Study|Adverse Event|1|||
48946486|NCT00923091|157634733|FG006|Period IV (Double-Blind)|Withdrawal by Subject|0|||
48946487|NCT00923091|157634734|FG007|Period IV (Double-Blind)|Withdrawal by Subject|0|||
48946488|NCT00923091|157634735|FG008|Period IV (Double-Blind)|Withdrawal by Subject|0|||
48946489|NCT00923091|157634736|FG009|Period IV (Double-Blind)|Withdrawal by Subject|0|||
48946490|NCT00923091|157634737|FG010|Period IV (Double-Blind)|Withdrawal by Subject|0|||
48946491|NCT00923091|157634738|FG011|Period IV (Double-Blind)|Withdrawal by Subject|0|||
48946492|NCT00923091|157634739|FG012|Period IV (Double-Blind)|Withdrawal by Subject|0|||
48852201|NCT01593020|157297525|FG000|Overall Study|Death|0|||
48946493|NCT00923091|157634727|FG000|Period IV (Double-Blind)|Protocol Violation|0|||
48946494|NCT00923091|157634728|FG001|Period IV (Double-Blind)|Protocol Violation|1|||
48852202|NCT01593020|157297526|FG001|Overall Study|Death|1|||
48852203|NCT01593020|157297525|FG000|Overall Study|Ineligible|1|||
48852204|NCT01593020|157297526|FG001|Overall Study|Ineligible|0|||
48852205|NCT02203032|157297527|FG000|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2|||
48852206|NCT02203032|157297528|FG001|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
48852207|NCT02203032|157297529|FG002|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
48852208|NCT02203032|157297530|FG003|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
48852209|NCT02203032|157297527|FG000|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1|||
48946495|NCT00923091|157634729|FG002|Period IV (Double-Blind)|Protocol Violation|0|||
48946496|NCT00923091|157634730|FG003|Period IV (Double-Blind)|Protocol Violation|0|||
48946497|NCT00923091|157634731|FG004|Period IV (Double-Blind)|Protocol Violation|0|||
48946498|NCT00923091|157634732|FG005|Period IV (Double-Blind)|Protocol Violation|0|||
48946499|NCT00923091|157634733|FG006|Period IV (Double-Blind)|Protocol Violation|0|||
48946500|NCT00923091|157634734|FG007|Period IV (Double-Blind)|Protocol Violation|0|||
48736691|NCT01426438|156887936|FG001|Overall Study|Missed Scan|2|||
48736692|NCT00412542|156887937|FG000|Overall Study|Withdrawal by Subject|0|||
48736693|NCT00412542|156887938|FG001|Overall Study|Withdrawal by Subject|2|||
48736694|NCT00412542|156887937|FG000|Overall Study|Not Eligible|0|||
48736695|NCT00412542|156887938|FG001|Overall Study|Not Eligible|1|||
48736696|NCT01393301|156887941|FG000|Overall Study|Lost to Follow-up|5|||
48736697|NCT01393301|156887942|FG001|Overall Study|Lost to Follow-up|3|||
48736698|NCT01393301|156887941|FG000|Overall Study|Withdrawal by Subject|2|||
48736699|NCT01393301|156887942|FG001|Overall Study|Withdrawal by Subject|0|||
48736700|NCT01393301|156887941|FG000|Overall Study|Completed <7 sessions (intervention)|2|||
48736701|NCT01393301|156887942|FG001|Overall Study|Completed <7 sessions (intervention)|0|||
48736702|NCT00464269|156887947|FG000|Overall Study|Lack of Efficacy|1|||
48736703|NCT00464269|156887948|FG001|Overall Study|Lack of Efficacy|0|||
48736704|NCT00464269|156887949|FG002|Overall Study|Lack of Efficacy|0|||
48736705|NCT00464269|156887950|FG003|Overall Study|Lack of Efficacy|0|||
48736706|NCT00464269|156887947|FG000|Overall Study|Lost to Follow-up|0|||
48736707|NCT00464269|156887948|FG001|Overall Study|Lost to Follow-up|4|||
48736708|NCT00464269|156887949|FG002|Overall Study|Lost to Follow-up|0|||
48736709|NCT00464269|156887950|FG003|Overall Study|Lost to Follow-up|1|||
48736710|NCT00464269|156887947|FG000|Overall Study|Withdrawal by Subject|0|||
48736711|NCT00464269|156887948|FG001|Overall Study|Withdrawal by Subject|2|||
48736712|NCT00464269|156887949|FG002|Overall Study|Withdrawal by Subject|1|||
48736713|NCT00464269|156887950|FG003|Overall Study|Withdrawal by Subject|1|||
48736714|NCT00464269|156887947|FG000|Overall Study|Other reason|3|||
48736715|NCT00464269|156887948|FG001|Overall Study|Other reason|3|||
48736716|NCT00464269|156887949|FG002|Overall Study|Other reason|1|||
48736717|NCT00464269|156887950|FG003|Overall Study|Other reason|1|||
48736718|NCT00464269|156887947|FG000|Overall Study|AE, serious fatal|0|||
48736719|NCT00464269|156887948|FG001|Overall Study|AE, serious fatal|0|||
48736720|NCT00464269|156887949|FG002|Overall Study|AE, serious fatal|1|||
48736721|NCT00464269|156887950|FG003|Overall Study|AE, serious fatal|1|||
48736722|NCT00464269|156887947|FG000|Overall Study|SAE, non-fatal|0|||
48736723|NCT00464269|156887948|FG001|Overall Study|SAE, non-fatal|0|||
48736724|NCT00464269|156887949|FG002|Overall Study|SAE, non-fatal|0|||
48736725|NCT00464269|156887950|FG003|Overall Study|SAE, non-fatal|1|||
48736726|NCT00464269|156887947|FG000|Overall Study|AE, non-serious non-fatal|2|||
48736727|NCT00464269|156887948|FG001|Overall Study|AE, non-serious non-fatal|8|||
48736728|NCT00464269|156887949|FG002|Overall Study|AE, non-serious non-fatal|3|||
48736729|NCT00464269|156887950|FG003|Overall Study|AE, non-serious non-fatal|4|||
48736730|NCT00464269|156887947|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
48736731|NCT00464269|156887948|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
48736732|NCT00464269|156887949|FG002|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
48736733|NCT00464269|156887950|FG003|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
48852210|NCT02203032|157297528|FG001|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
48736734|NCT02913612|156887953|FG000|Overall Study|Lost to Follow-up|6|||
48736735|NCT02913612|156887954|FG001|Overall Study|Lost to Follow-up|5|||
48736736|NCT02913612|156887955|FG002|Overall Study|Lost to Follow-up|2|||
48736737|NCT02913612|156887956|FG003|Overall Study|Lost to Follow-up|0|||
48736738|NCT02913612|156887953|FG000|Overall Study|Physician Decision|1|||
48736739|NCT02913612|156887954|FG001|Overall Study|Physician Decision|4|||
48736740|NCT02913612|156887955|FG002|Overall Study|Physician Decision|1|||
48736741|NCT02913612|156887956|FG003|Overall Study|Physician Decision|0|||
48736742|NCT02913612|156887953|FG000|Overall Study|Withdrawal by Subject|2|||
48736743|NCT02913612|156887954|FG001|Overall Study|Withdrawal by Subject|4|||
48852211|NCT02203032|157297529|FG002|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
48852212|NCT02203032|157297530|FG003|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
48852213|NCT02203032|157297527|FG000|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3|||
48852214|NCT02203032|157297528|FG001|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
48852215|NCT02203032|157297529|FG002|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
48852216|NCT02203032|157297530|FG003|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
48852217|NCT02203032|157297527|FG000|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6|||
48852218|NCT02203032|157297528|FG001|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
48852219|NCT02203032|157297529|FG002|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
48736744|NCT02913612|156887955|FG002|Overall Study|Withdrawal by Subject|0|||
48736745|NCT02913612|156887956|FG003|Overall Study|Withdrawal by Subject|0|||
48736746|NCT02913612|156887953|FG000|Overall Study|Hemangioma resolved|1|||
48736747|NCT02913612|156887954|FG001|Overall Study|Hemangioma resolved|0|||
48736748|NCT02913612|156887955|FG002|Overall Study|Hemangioma resolved|0|||
48736749|NCT02913612|156887956|FG003|Overall Study|Hemangioma resolved|0|||
48736750|NCT02913612|156887953|FG000|Overall Study|Local IRB decision|1|||
48736751|NCT02913612|156887954|FG001|Overall Study|Local IRB decision|0|||
48736752|NCT02913612|156887955|FG002|Overall Study|Local IRB decision|0|||
48736753|NCT02913612|156887956|FG003|Overall Study|Local IRB decision|0|||
48736754|NCT02913612|156887953|FG000|Overall Study|Study drug non-compliance|1|||
48736755|NCT02913612|156887954|FG001|Overall Study|Study drug non-compliance|1|||
48736756|NCT02913612|156887955|FG002|Overall Study|Study drug non-compliance|0|||
48852220|NCT02203032|157297530|FG003|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
48852221|NCT02203032|157297527|FG000|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4|||
48852222|NCT02203032|157297528|FG001|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
48852223|NCT02203032|157297529|FG002|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
48852224|NCT02203032|157297530|FG003|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
48852225|NCT02203032|157297527|FG000|Open Label Run-in (Week 0 to Week 16)|Other|2|||
48852226|NCT02203032|157297528|FG001|Open Label Run-in (Week 0 to Week 16)|Other|0|||
48852227|NCT02203032|157297529|FG002|Open Label Run-in (Week 0 to Week 16)|Other|0|||
48852228|NCT02203032|157297530|FG003|Open Label Run-in (Week 0 to Week 16)|Other|0|||
48852229|NCT02203032|157297527|FG000|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1|||
48852230|NCT02203032|157297528|FG001|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
48852231|NCT02203032|157297529|FG002|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
48852232|NCT02203032|157297530|FG003|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
48852233|NCT02203032|157297527|FG000|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0|||
48852234|NCT02203032|157297528|FG001|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2|||
48852235|NCT02203032|157297529|FG002|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3|||
48852236|NCT02203032|157297530|FG003|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8|||
48852237|NCT02203032|157297527|FG000|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0|||
48852238|NCT02203032|157297528|FG001|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8|||
48852239|NCT02203032|157297529|FG002|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19|||
48852240|NCT02203032|157297530|FG003|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20|||
48852241|NCT02203032|157297527|FG000|Blinded Phase (Week 16 to Week 44)|Other|0|||
48852242|NCT02203032|157297528|FG001|Blinded Phase (Week 16 to Week 44)|Other|4|||
48852243|NCT02203032|157297529|FG002|Blinded Phase (Week 16 to Week 44)|Other|1|||
48852244|NCT02203032|157297530|FG003|Blinded Phase (Week 16 to Week 44)|Other|15|||
48852245|NCT02203032|157297527|FG000|Blinded Phase (Week 16 to Week 44)|Death|0|||
48852246|NCT02203032|157297528|FG001|Blinded Phase (Week 16 to Week 44)|Death|0|||
48852247|NCT02203032|157297529|FG002|Blinded Phase (Week 16 to Week 44)|Death|0|||
48852248|NCT02203032|157297530|FG003|Blinded Phase (Week 16 to Week 44)|Death|1|||
48852249|NCT02203032|157297527|FG000|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0|||
48852250|NCT02203032|157297528|FG001|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1|||
48852251|NCT02203032|157297529|FG002|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3|||
48852252|NCT02203032|157297530|FG003|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2|||
48852253|NCT04748341|157297531|FG000|Overall Study|Lost to Follow-up|1|||
48852254|NCT04748341|157297532|FG001|Overall Study|Lost to Follow-up|1|||
48852255|NCT00392197|157297533|FG000|Overall Study|Adverse Event|4|||
48852256|NCT00392197|157297534|FG001|Overall Study|Adverse Event|12|||
48852257|NCT00392197|157297533|FG000|Overall Study|Lack of Efficacy|3|||
48852258|NCT00392197|157297534|FG001|Overall Study|Lack of Efficacy|4|||
48852259|NCT00392197|157297533|FG000|Overall Study|Lost to Follow-up|0|||
48852260|NCT00392197|157297534|FG001|Overall Study|Lost to Follow-up|1|||
48852261|NCT00392197|157297533|FG000|Overall Study|Physician Decision|3|||
48852262|NCT00392197|157297534|FG001|Overall Study|Physician Decision|2|||
48852263|NCT00392197|157297533|FG000|Overall Study|Protocol Violation|7|||
48852264|NCT00392197|157297534|FG001|Overall Study|Protocol Violation|5|||
48852265|NCT00392197|157297533|FG000|Overall Study|Withdrawal by Subject|4|||
48852266|NCT00392197|157297534|FG001|Overall Study|Withdrawal by Subject|6|||
48852267|NCT02432274|157297536|FG000|Overall Study|Death|2|||
48852268|NCT02432274|157297537|FG001|Overall Study|Death|6|||
48852269|NCT02432274|157297538|FG002|Overall Study|Death|7|||
48852270|NCT02432274|157297539|FG003|Overall Study|Death|0|||
48852271|NCT02432274|157297540|FG004|Overall Study|Death|27|||
49015311|NCT00814320|157892147|FG001|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2|||
48736757|NCT02913612|156887956|FG003|Overall Study|Study drug non-compliance|0|||
48946501|NCT00923091|157634735|FG008|Period IV (Double-Blind)|Protocol Violation|0|||
48946502|NCT00923091|157634736|FG009|Period IV (Double-Blind)|Protocol Violation|0|||
48736758|NCT02913612|156887953|FG000|Overall Study|Insurance issues|0|||
48736759|NCT02913612|156887954|FG001|Overall Study|Insurance issues|1|||
48736760|NCT02913612|156887955|FG002|Overall Study|Insurance issues|0|||
48736761|NCT02913612|156887956|FG003|Overall Study|Insurance issues|0|||
48736762|NCT02913612|156887953|FG000|Overall Study|Needed to treat second hemangioma|0|||
48946503|NCT00923091|157634737|FG010|Period IV (Double-Blind)|Protocol Violation|0|||
48736763|NCT02913612|156887954|FG001|Overall Study|Needed to treat second hemangioma|1|||
48736764|NCT02913612|156887955|FG002|Overall Study|Needed to treat second hemangioma|0|||
48736765|NCT02913612|156887956|FG003|Overall Study|Needed to treat second hemangioma|0|||
48946504|NCT00923091|157634738|FG011|Period IV (Double-Blind)|Protocol Violation|0|||
48946505|NCT00923091|157634739|FG012|Period IV (Double-Blind)|Protocol Violation|0|||
48946506|NCT00923091|157634727|FG000|Period V (Double -Blind)|Withdrawal by Subject|0|||
48736766|NCT02913612|156887953|FG000|Overall Study|Study completion criteria not met|0|||
48736767|NCT02913612|156887954|FG001|Overall Study|Study completion criteria not met|1|||
48736768|NCT02913612|156887955|FG002|Overall Study|Study completion criteria not met|0|||
48852272|NCT02432274|157297541|FG005|Overall Study|Death|7|||
48852273|NCT02432274|157297542|FG006|Overall Study|Death|9|||
48852274|NCT02432274|157297543|FG007|Overall Study|Death|14|||
48852275|NCT02432274|157297536|FG000|Overall Study|Withdrawal of Consent|0|||
48736769|NCT02913612|156887956|FG003|Overall Study|Study completion criteria not met|0|||
48736770|NCT02913612|156887953|FG000|Overall Study|Ineligible|0|||
48852276|NCT02432274|157297537|FG001|Overall Study|Withdrawal of Consent|0|||
48852277|NCT02432274|157297538|FG002|Overall Study|Withdrawal of Consent|0|||
48852278|NCT02432274|157297539|FG003|Overall Study|Withdrawal of Consent|0|||
48852279|NCT02432274|157297540|FG004|Overall Study|Withdrawal of Consent|2|||
48852280|NCT02432274|157297541|FG005|Overall Study|Withdrawal of Consent|0|||
48852281|NCT02432274|157297542|FG006|Overall Study|Withdrawal of Consent|1|||
48852282|NCT02432274|157297543|FG007|Overall Study|Withdrawal of Consent|2|||
48852283|NCT02978716|157297546|FG000|Overall Study|Death|25|||
48852284|NCT02978716|157297547|FG001|Overall Study|Death|13|||
48852285|NCT02978716|157297548|FG002|Overall Study|Death|20|||
48852286|NCT02978716|157297546|FG000|Overall Study|Lost to Follow-up|0|||
48852287|NCT02978716|157297547|FG001|Overall Study|Lost to Follow-up|0|||
48852288|NCT02978716|157297548|FG002|Overall Study|Lost to Follow-up|1|||
48852289|NCT02978716|157297546|FG000|Overall Study|Withdrawal by Subject|6|||
48852290|NCT02978716|157297547|FG001|Overall Study|Withdrawal by Subject|4|||
48852291|NCT02978716|157297548|FG002|Overall Study|Withdrawal by Subject|5|||
48852292|NCT02978716|157297546|FG000|Overall Study|Sponsor terminated|2|||
48852293|NCT02978716|157297547|FG001|Overall Study|Sponsor terminated|13|||
48736771|NCT02913612|156887954|FG001|Overall Study|Ineligible|1|||
48736772|NCT02913612|156887955|FG002|Overall Study|Ineligible|0|||
48736773|NCT02913612|156887956|FG003|Overall Study|Ineligible|0|||
48736774|NCT03082261|156887959|FG000|Overall Study|Death|4|||
48736775|NCT03082261|156887959|FG000|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1|||
48736776|NCT03082261|156887959|FG000|Overall Study|Insurance denial|1|||
48736777|NCT03082261|156887959|FG000|Overall Study|Peripheral lead added|1|||
48736778|NCT03082261|156887959|FG000|Overall Study|Withdrawal by Subject|40|||
48736779|NCT03082261|156887959|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2|||
48736780|NCT03082261|156887959|FG000|Overall Study|Subject implanted with device other than study device|1|||
48736781|NCT03082261|156887959|FG000|Overall Study|Lost to Follow-up|14|||
48736782|NCT03082261|156887959|FG000|Overall Study|Subject moved to a different state|1|||
48736783|NCT03082261|156887959|FG000|Overall Study|Subject non-compliance|2|||
48736784|NCT03082261|156887959|FG000|Overall Study|Subject participation terminated by investigator|9|||
48736785|NCT03082261|156887959|FG000|Overall Study|Subject participation terminated by sponsor|4|||
48736786|NCT03082261|156887959|FG000|Overall Study|System explant|19|||
48852294|NCT02978716|157297548|FG002|Overall Study|Sponsor terminated|9|||
48736787|NCT03082261|156887959|FG000|Overall Study|Unable to place lead(s)|2|||
48852295|NCT02978716|157297546|FG000|Overall Study|Other|1|||
48852296|NCT02978716|157297547|FG001|Overall Study|Other|3|||
48852297|NCT02978716|157297548|FG002|Overall Study|Other|0|||
48852298|NCT00960206|157297549|FG000|Overall Study|Death|7|||
48852299|NCT00960206|157297550|FG001|Overall Study|Death|4|||
48852300|NCT00960206|157297551|FG002|Overall Study|Death|1|||
48852301|NCT00960206|157297549|FG000|Overall Study|Unwilling/Unable to return|1|||
48852302|NCT00960206|157297550|FG001|Overall Study|Unwilling/Unable to return|2|||
48852303|NCT00960206|157297551|FG002|Overall Study|Unwilling/Unable to return|0|||
48852304|NCT00960206|157297549|FG000|Overall Study|Lost to Follow-up|8|||
48852305|NCT00960206|157297550|FG001|Overall Study|Lost to Follow-up|14|||
48852306|NCT00960206|157297551|FG002|Overall Study|Lost to Follow-up|8|||
48852307|NCT00960206|157297549|FG000|Overall Study|Withdrawal by Subject|2|||
48852308|NCT00960206|157297550|FG001|Overall Study|Withdrawal by Subject|4|||
48852309|NCT00960206|157297551|FG002|Overall Study|Withdrawal by Subject|0|||
48852310|NCT00960206|157297549|FG000|Overall Study|Revision of study component|2|||
48852311|NCT00960206|157297550|FG001|Overall Study|Revision of study component|2|||
48852312|NCT00960206|157297551|FG002|Overall Study|Revision of study component|2|||
48852313|NCT00960206|157297549|FG000|Overall Study|Missing 10 year data|20|||
48852314|NCT00960206|157297550|FG001|Overall Study|Missing 10 year data|1|||
48852315|NCT00960206|157297551|FG002|Overall Study|Missing 10 year data|1|||
48852316|NCT00116649|157297552|FG000|Overall Study|Adverse Event|20|||
48852317|NCT00116649|157297552|FG000|Overall Study|Lack of Efficacy|1|||
48852318|NCT00116649|157297552|FG000|Overall Study|Lost to Follow-up|32|||
48852319|NCT00116649|157297552|FG000|Overall Study|Withdrawal by Subject|68|||
48852320|NCT00116649|157297552|FG000|Overall Study|Local Skin Reaction|9|||
48852321|NCT00116649|157297552|FG000|Overall Study|Various Reasons|18|||
48852322|NCT00116649|157297552|FG000|Overall Study|Protocol Specified|7|||
48736788|NCT03082261|156887959|FG000|Overall Study|Unsuccessful trial evaluation period|19|||
48736789|NCT01032174|156887960|FG000|Overall Study|Adverse Event|0|||
48736790|NCT01032174|156887961|FG001|Overall Study|Adverse Event|1|||
48736791|NCT00113087|156887962|FG000|Overall Study|Death or Transplant|14|||
48736792|NCT00113087|156887963|FG001|Overall Study|Death or Transplant|16|||
48736793|NCT00113087|156887962|FG000|Overall Study|Family or MD withdrew subject|10|||
48736794|NCT00113087|156887963|FG001|Overall Study|Family or MD withdrew subject|5|||
48736795|NCT04402060|156887964|FG000|Overall Study|Death|1|||
48736796|NCT04402060|156887965|FG001|Overall Study|Death|12|||
48736797|NCT04402060|156887966|FG002|Overall Study|Death|7|||
48736798|NCT04402060|156887964|FG000|Overall Study|Adverse Event|0|||
48736799|NCT04402060|156887965|FG001|Overall Study|Adverse Event|0|||
48736800|NCT04402060|156887966|FG002|Overall Study|Adverse Event|1|||
48736801|NCT04402060|156887964|FG000|Overall Study|Withdrawal by Subject|0|||
48736802|NCT04402060|156887965|FG001|Overall Study|Withdrawal by Subject|1|||
48736803|NCT04402060|156887966|FG002|Overall Study|Withdrawal by Subject|2|||
48736804|NCT04402060|156887964|FG000|Overall Study|Sponsor Request|0|||
48736805|NCT04402060|156887965|FG001|Overall Study|Sponsor Request|2|||
48736806|NCT04402060|156887966|FG002|Overall Study|Sponsor Request|0|||
48736807|NCT04402060|156887964|FG000|Overall Study|Physician Decision|0|||
48946507|NCT00923091|157634728|FG001|Period V (Double -Blind)|Withdrawal by Subject|0|||
48946508|NCT00923091|157634729|FG002|Period V (Double -Blind)|Withdrawal by Subject|0|||
48946509|NCT00923091|157634730|FG003|Period V (Double -Blind)|Withdrawal by Subject|0|||
48946510|NCT00923091|157634731|FG004|Period V (Double -Blind)|Withdrawal by Subject|0|||
48946511|NCT00923091|157634732|FG005|Period V (Double -Blind)|Withdrawal by Subject|0|||
48946512|NCT00923091|157634733|FG006|Period V (Double -Blind)|Withdrawal by Subject|0|||
48946513|NCT00923091|157634734|FG007|Period V (Double -Blind)|Withdrawal by Subject|0|||
48736808|NCT04402060|156887965|FG001|Overall Study|Physician Decision|0|||
48736809|NCT04402060|156887966|FG002|Overall Study|Physician Decision|1|||
48736810|NCT04402060|156887964|FG000|Overall Study|Other|0|||
48946514|NCT00923091|157634735|FG008|Period V (Double -Blind)|Withdrawal by Subject|1|||
48736811|NCT04402060|156887965|FG001|Overall Study|Other|1|||
48736812|NCT04402060|156887966|FG002|Overall Study|Other|0|||
48736813|NCT02158975|156887969|FG000|Overall Study|Did not complete 1 cycle nor > 1dose|1|||
48736814|NCT01967173|156887972|FG000|Overall Study|Lost to Follow-up|5|||
48736815|NCT01967173|156887973|FG001|Overall Study|Lost to Follow-up|3|||
48852323|NCT02161146|157297553|FG000|Overall Study|Adverse Event|1|||
48852324|NCT02161146|157297554|FG001|Overall Study|Adverse Event|1|||
48852325|NCT02161146|157297555|FG002|Overall Study|Adverse Event|0|||
48852326|NCT02161146|157297556|FG003|Overall Study|Adverse Event|1|||
48852327|NCT02161146|157297557|FG004|Overall Study|Adverse Event|0|||
48852328|NCT02161146|157297553|FG000|Overall Study|Lost to Follow-up|0|||
48852329|NCT02161146|157297554|FG001|Overall Study|Lost to Follow-up|1|||
48852330|NCT02161146|157297555|FG002|Overall Study|Lost to Follow-up|0|||
48852331|NCT02161146|157297556|FG003|Overall Study|Lost to Follow-up|0|||
48852332|NCT02161146|157297557|FG004|Overall Study|Lost to Follow-up|0|||
48852333|NCT02161146|157297553|FG000|Overall Study|Personal Reasons|0|||
48852334|NCT02161146|157297554|FG001|Overall Study|Personal Reasons|1|||
48852335|NCT02161146|157297555|FG002|Overall Study|Personal Reasons|0|||
48852336|NCT02161146|157297556|FG003|Overall Study|Personal Reasons|2|||
48852337|NCT02161146|157297557|FG004|Overall Study|Personal Reasons|1|||
48736816|NCT01967173|156887974|FG002|Overall Study|Lost to Follow-up|2|||
48736817|NCT01967173|156887975|FG003|Overall Study|Lost to Follow-up|4|||
48736818|NCT01967173|156887976|FG004|Overall Study|Lost to Follow-up|8|||
48736819|NCT01967173|156887977|FG005|Overall Study|Lost to Follow-up|12|||
48736820|NCT01967173|156887978|FG006|Overall Study|Lost to Follow-up|6|||
48736821|NCT01967173|156887979|FG007|Overall Study|Lost to Follow-up|8|||
48736822|NCT01967173|156887972|FG000|Overall Study|Physician Decision|2|||
48736823|NCT01967173|156887973|FG001|Overall Study|Physician Decision|0|||
48736824|NCT01967173|156887974|FG002|Overall Study|Physician Decision|2|||
48852338|NCT02161146|157297553|FG000|Overall Study|Other Miscellaneous Reasons|0|||
48852339|NCT02161146|157297554|FG001|Overall Study|Other Miscellaneous Reasons|1|||
48852340|NCT02161146|157297555|FG002|Overall Study|Other Miscellaneous Reasons|0|||
48852341|NCT02161146|157297556|FG003|Overall Study|Other Miscellaneous Reasons|0|||
48852342|NCT02161146|157297557|FG004|Overall Study|Other Miscellaneous Reasons|0|||
48852343|NCT02063659|157297558|FG000|Double-Blind Treatment Period|Adverse Event|1|||
48852344|NCT02063659|157297559|FG001|Double-Blind Treatment Period|Adverse Event|2|||
48852345|NCT02063659|157297560|FG002|Double-Blind Treatment Period|Adverse Event|0|||
48946515|NCT00923091|157634736|FG009|Period V (Double -Blind)|Withdrawal by Subject|0|||
48946516|NCT00923091|157634737|FG010|Period V (Double -Blind)|Withdrawal by Subject|0|||
48736825|NCT01967173|156887975|FG003|Overall Study|Physician Decision|1|||
48736826|NCT01967173|156887976|FG004|Overall Study|Physician Decision|1|||
48736827|NCT01967173|156887977|FG005|Overall Study|Physician Decision|1|||
48736828|NCT01967173|156887978|FG006|Overall Study|Physician Decision|1|||
48852346|NCT02063659|157297561|FG003|Double-Blind Treatment Period|Adverse Event|0|||
48852347|NCT02063659|157297558|FG000|Double-Blind Treatment Period|Physician Decision|1|||
48852348|NCT02063659|157297559|FG001|Double-Blind Treatment Period|Physician Decision|0|||
48852349|NCT02063659|157297560|FG002|Double-Blind Treatment Period|Physician Decision|0|||
48852350|NCT02063659|157297561|FG003|Double-Blind Treatment Period|Physician Decision|0|||
48852351|NCT02063659|157297558|FG000|Double-Blind Treatment Period|Withdrawal of consent|0|||
48852352|NCT02063659|157297559|FG001|Double-Blind Treatment Period|Withdrawal of consent|1|||
48852353|NCT02063659|157297560|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
48852354|NCT02063659|157297561|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
48852355|NCT02063659|157297558|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
48852356|NCT02063659|157297559|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
48852357|NCT02063659|157297560|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
48852358|NCT02063659|157297561|FG003|Open-Label Extension Period (OLE)|Physician Decision|1|||
48852359|NCT02063659|157297558|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
48852360|NCT02063659|157297559|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
48852361|NCT02063659|157297560|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
48852362|NCT02063659|157297561|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
48852363|NCT02063659|157297558|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
48852364|NCT02063659|157297559|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
48852365|NCT02063659|157297560|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
48852366|NCT02063659|157297561|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|1|||
48852367|NCT02063659|157297558|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
48852368|NCT02063659|157297559|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
48852369|NCT02063659|157297560|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
48852370|NCT02063659|157297561|FG003|Open-Label Extension Period (OLE)|Adverse Event|7|||
48852371|NCT02063659|157297558|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
48852372|NCT02063659|157297559|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
48852373|NCT02063659|157297560|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
48852374|NCT02063659|157297561|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
48852375|NCT01532999|157297562|FG000|Overall Study|Lost to Follow-up|14|||
48852376|NCT01532999|157297563|FG001|Overall Study|Lost to Follow-up|8|||
48852377|NCT01532999|157297562|FG000|Overall Study|Physician Decision|1|||
48852378|NCT01532999|157297563|FG001|Overall Study|Physician Decision|2|||
48852379|NCT01532999|157297562|FG000|Overall Study|Withdrawal by Subject|5|||
48852380|NCT01532999|157297563|FG001|Overall Study|Withdrawal by Subject|0|||
48852381|NCT01532999|157297562|FG000|Overall Study|Relocated|2|||
48852382|NCT01532999|157297563|FG001|Overall Study|Relocated|0|||
48852383|NCT01532999|157297562|FG000|Overall Study|should not have been randomized|1|||
48852384|NCT01532999|157297563|FG001|Overall Study|should not have been randomized|0|||
48852385|NCT01532999|157297562|FG000|Overall Study|substantial noncompliance|2|||
48852386|NCT01532999|157297563|FG001|Overall Study|substantial noncompliance|0|||
48852387|NCT01532999|157297562|FG000|Overall Study|no show for week 9 assessments|6|||
48852388|NCT01532999|157297563|FG001|Overall Study|no show for week 9 assessments|4|||
48852389|NCT01532999|157297562|FG000|Overall Study|Adverse Event|0|||
48852390|NCT01532999|157297563|FG001|Overall Study|Adverse Event|1|||
48852391|NCT01532999|157297562|FG000|Overall Study|incarcerated|0|||
48852392|NCT01532999|157297563|FG001|Overall Study|incarcerated|1|||
48852393|NCT01532999|157297562|FG000|Overall Study|New job|0|||
48852394|NCT01532999|157297563|FG001|Overall Study|New job|2|||
48852395|NCT00933270|157297564|FG000|Overall Study|Withdrawal by Subject|26|||
48852396|NCT00933270|157297564|FG000|Overall Study|Insufficient Follow-up|10|||
48852397|NCT00933270|157297564|FG000|Overall Study|Lost to Follow-up|14|||
48852398|NCT00933270|157297564|FG000|Overall Study|Adverse Event|1|||
48852399|NCT00933270|157297564|FG000|Overall Study|Missed Visit|2|||
48852400|NCT00933270|157297564|FG000|Overall Study|Death|24|||
48852401|NCT00933270|157297564|FG000|Overall Study|Moved or would not return|10|||
48852402|NCT02470806|157297565|FG000|Overall Study|Lost to Follow-up|1|||
48852403|NCT02470806|157297566|FG001|Overall Study|Lost to Follow-up|1|||
48852404|NCT02470806|157297565|FG000|Overall Study|Adverse Event|5|||
48852405|NCT02470806|157297566|FG001|Overall Study|Adverse Event|2|||
48852406|NCT02470806|157297565|FG000|Overall Study|Protocol Violation|4|||
48852407|NCT02470806|157297566|FG001|Overall Study|Protocol Violation|11|||
48852408|NCT02470806|157297565|FG000|Overall Study|Physician Decision|0|||
48946517|NCT00923091|157634738|FG011|Period V (Double -Blind)|Withdrawal by Subject|0|||
48946518|NCT00923091|157634739|FG012|Period V (Double -Blind)|Withdrawal by Subject|1|||
48852409|NCT02470806|157297566|FG001|Overall Study|Physician Decision|3|||
48852410|NCT02470806|157297565|FG000|Overall Study|Withdrawal by Subject|3|||
48852411|NCT02470806|157297566|FG001|Overall Study|Withdrawal by Subject|10|||
48852412|NCT02470806|157297565|FG000|Overall Study|Lack of Efficacy|5|||
48852413|NCT02470806|157297566|FG001|Overall Study|Lack of Efficacy|15|||
48852414|NCT02659540|157297569|FG000|Overall Study|Adverse Event|3|||
48852415|NCT02659540|157297570|FG001|Overall Study|Adverse Event|2|||
48852416|NCT02659540|157297569|FG000|Overall Study|Death|1|||
48946519|NCT00923091|157634727|FG000|Period V (Double -Blind)|Protocol Violation|0|||
48852417|NCT02659540|157297570|FG001|Overall Study|Death|0|||
48852418|NCT02659540|157297569|FG000|Overall Study|Progressive disease|2|||
48852419|NCT02659540|157297570|FG001|Overall Study|Progressive disease|6|||
48852420|NCT01529632|157297574|FG000|Overall Study|Administrative problem|2|||
48852421|NCT01529632|157297575|FG001|Overall Study|Administrative problem|1|||
48852422|NCT01529632|157297574|FG000|Overall Study|Protocol Violation|0|||
48852423|NCT01529632|157297575|FG001|Overall Study|Protocol Violation|1|||
48852424|NCT01529632|157297574|FG000|Overall Study|Adverse Event|1|||
48852425|NCT01529632|157297575|FG001|Overall Study|Adverse Event|1|||
48852426|NCT02386098|157299583|FG000|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30|||
48852427|NCT02386098|157299584|FG001|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29|||
48852428|NCT02386098|157299585|FG002|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
48852429|NCT02386098|157299586|FG003|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
48852430|NCT02386098|157299587|FG004|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
48852431|NCT02386098|157299583|FG000|Stage 1 (96 Weeks)|Adverse Event|2|||
48852432|NCT02386098|157299584|FG001|Stage 1 (96 Weeks)|Adverse Event|1|||
48852433|NCT02386098|157299585|FG002|Stage 1 (96 Weeks)|Adverse Event|0|||
48852434|NCT02386098|157299586|FG003|Stage 1 (96 Weeks)|Adverse Event|0|||
48852435|NCT02386098|157299587|FG004|Stage 1 (96 Weeks)|Adverse Event|0|||
48852436|NCT02386098|157299583|FG000|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
48852437|NCT02386098|157299584|FG001|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
48946520|NCT00923091|157634728|FG001|Period V (Double -Blind)|Protocol Violation|0|||
48946521|NCT00923091|157634729|FG002|Period V (Double -Blind)|Protocol Violation|0|||
48736829|NCT01967173|156887979|FG007|Overall Study|Physician Decision|0|||
48736830|NCT01967173|156887972|FG000|Overall Study|Lack of Efficacy|2|||
48736831|NCT01967173|156887973|FG001|Overall Study|Lack of Efficacy|0|||
48736832|NCT01967173|156887974|FG002|Overall Study|Lack of Efficacy|2|||
48736833|NCT01967173|156887975|FG003|Overall Study|Lack of Efficacy|2|||
48736834|NCT01967173|156887976|FG004|Overall Study|Lack of Efficacy|0|||
48736835|NCT01967173|156887977|FG005|Overall Study|Lack of Efficacy|1|||
48736836|NCT01967173|156887978|FG006|Overall Study|Lack of Efficacy|0|||
48736837|NCT01967173|156887979|FG007|Overall Study|Lack of Efficacy|2|||
48736838|NCT01967173|156887972|FG000|Overall Study|Pregnancy|0|||
48736839|NCT01967173|156887973|FG001|Overall Study|Pregnancy|0|||
48736840|NCT01967173|156887974|FG002|Overall Study|Pregnancy|0|||
48736841|NCT01967173|156887975|FG003|Overall Study|Pregnancy|0|||
48736842|NCT01967173|156887976|FG004|Overall Study|Pregnancy|0|||
48736843|NCT01967173|156887977|FG005|Overall Study|Pregnancy|0|||
48736844|NCT01967173|156887978|FG006|Overall Study|Pregnancy|1|||
48736845|NCT01967173|156887979|FG007|Overall Study|Pregnancy|1|||
48736846|NCT01967173|156887972|FG000|Overall Study|Adverse Event|0|||
48736847|NCT01967173|156887973|FG001|Overall Study|Adverse Event|0|||
48736848|NCT01967173|156887974|FG002|Overall Study|Adverse Event|0|||
48736849|NCT01967173|156887975|FG003|Overall Study|Adverse Event|0|||
48736850|NCT01967173|156887976|FG004|Overall Study|Adverse Event|0|||
48736851|NCT01967173|156887977|FG005|Overall Study|Adverse Event|0|||
48736852|NCT01967173|156887978|FG006|Overall Study|Adverse Event|0|||
48736853|NCT01967173|156887979|FG007|Overall Study|Adverse Event|1|||
48736854|NCT01967173|156887972|FG000|Overall Study|Withdrawal by Subject|15|||
48736855|NCT01967173|156887973|FG001|Overall Study|Withdrawal by Subject|14|||
48852438|NCT02386098|157299585|FG002|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
48852439|NCT02386098|157299586|FG003|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
48852440|NCT02386098|157299587|FG004|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
48852441|NCT02386098|157299583|FG000|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
48852442|NCT02386098|157299584|FG001|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2|||
48852443|NCT02386098|157299585|FG002|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
48852444|NCT02386098|157299586|FG003|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
48852445|NCT02386098|157299587|FG004|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
48852446|NCT02386098|157299583|FG000|Stage 1 (96 Weeks)|Withdrawal by Subject|3|||
48852447|NCT02386098|157299584|FG001|Stage 1 (96 Weeks)|Withdrawal by Subject|1|||
48852448|NCT02386098|157299585|FG002|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
48946522|NCT00923091|157634730|FG003|Period V (Double -Blind)|Protocol Violation|0|||
48736856|NCT01967173|156887974|FG002|Overall Study|Withdrawal by Subject|10|||
48736857|NCT01967173|156887975|FG003|Overall Study|Withdrawal by Subject|7|||
48736858|NCT01967173|156887976|FG004|Overall Study|Withdrawal by Subject|8|||
48736859|NCT01967173|156887977|FG005|Overall Study|Withdrawal by Subject|9|||
48852449|NCT02386098|157299586|FG003|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
48852450|NCT02386098|157299587|FG004|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
48852451|NCT02386098|157299583|FG000|Stage 1 (96 Weeks)|Other|1|||
48946523|NCT00923091|157634731|FG004|Period V (Double -Blind)|Protocol Violation|0|||
48946524|NCT00923091|157634732|FG005|Period V (Double -Blind)|Protocol Violation|0|||
48736860|NCT01967173|156887978|FG006|Overall Study|Withdrawal by Subject|10|||
48736861|NCT01967173|156887979|FG007|Overall Study|Withdrawal by Subject|12|||
48736862|NCT03307785|156887980|FG000|Part A: Up to 28.5 Months|Disease progression|2|||
48736863|NCT03307785|156887981|FG001|Part A: Up to 28.5 Months|Disease progression|0|||
48736864|NCT03307785|156887982|FG002|Part A: Up to 28.5 Months|Disease progression|0|||
48736865|NCT03307785|156887983|FG003|Part A: Up to 28.5 Months|Disease progression|0|||
48736866|NCT03307785|156887984|FG004|Part A: Up to 28.5 Months|Disease progression|0|||
48736867|NCT03307785|156887985|FG005|Part A: Up to 28.5 Months|Disease progression|0|||
48736868|NCT03307785|156887986|FG006|Part A: Up to 28.5 Months|Disease progression|0|||
48736869|NCT03307785|156887987|FG007|Part A: Up to 28.5 Months|Disease progression|0|||
48736870|NCT03307785|156887988|FG008|Part A: Up to 28.5 Months|Disease progression|0|||
48736871|NCT03307785|156887989|FG009|Part A: Up to 28.5 Months|Disease progression|0|||
48736872|NCT03307785|156887990|FG010|Part A: Up to 28.5 Months|Disease progression|0|||
48736873|NCT03307785|156887980|FG000|Part A: Up to 28.5 Months|Withdrawal by Subject|7|||
48736874|NCT03307785|156887981|FG001|Part A: Up to 28.5 Months|Withdrawal by Subject|1|||
48736875|NCT03307785|156887982|FG002|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
48736876|NCT03307785|156887983|FG003|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
48736877|NCT03307785|156887984|FG004|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
48736878|NCT03307785|156887985|FG005|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
48736879|NCT03307785|156887986|FG006|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
48736880|NCT03307785|156887987|FG007|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
48852452|NCT02386098|157299584|FG001|Stage 1 (96 Weeks)|Other|0|||
48852453|NCT02386098|157299585|FG002|Stage 1 (96 Weeks)|Other|0|||
48852454|NCT02386098|157299586|FG003|Stage 1 (96 Weeks)|Other|0|||
48852455|NCT02386098|157299587|FG004|Stage 1 (96 Weeks)|Other|0|||
48852456|NCT02386098|157299583|FG000|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5|||
48852457|NCT02386098|157299584|FG001|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8|||
48852458|NCT02386098|157299585|FG002|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
48736881|NCT03307785|156887988|FG008|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
48736882|NCT03307785|156887989|FG009|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
48736883|NCT03307785|156887990|FG010|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
48736884|NCT03307785|156887980|FG000|Part A: Up to 28.5 Months|Death|4|||
48852459|NCT02386098|157299586|FG003|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
48852460|NCT02386098|157299587|FG004|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
48852461|NCT03861052|157299588|FG000|Overall Study|Adverse Event|1|||
48852462|NCT03861052|157299589|FG001|Overall Study|Adverse Event|1|||
48852463|NCT03861052|157299590|FG002|Overall Study|Adverse Event|2|||
48852464|NCT03861052|157299591|FG003|Overall Study|Adverse Event|4|||
48852465|NCT03861052|157299588|FG000|Overall Study|Lost to Follow-up|0|||
48852466|NCT03861052|157299589|FG001|Overall Study|Lost to Follow-up|0|||
48736885|NCT03307785|156887981|FG001|Part A: Up to 28.5 Months|Death|4|||
48736886|NCT03307785|156887982|FG002|Part A: Up to 28.5 Months|Death|0|||
48736887|NCT03307785|156887983|FG003|Part A: Up to 28.5 Months|Death|0|||
48736888|NCT03307785|156887984|FG004|Part A: Up to 28.5 Months|Death|0|||
48736889|NCT03307785|156887985|FG005|Part A: Up to 28.5 Months|Death|0|||
48736890|NCT03307785|156887986|FG006|Part A: Up to 28.5 Months|Death|0|||
48736891|NCT03307785|156887987|FG007|Part A: Up to 28.5 Months|Death|0|||
48736892|NCT03307785|156887988|FG008|Part A: Up to 28.5 Months|Death|0|||
48736893|NCT03307785|156887989|FG009|Part A: Up to 28.5 Months|Death|0|||
48736894|NCT03307785|156887990|FG010|Part A: Up to 28.5 Months|Death|0|||
48736895|NCT03307785|156887980|FG000|Part A: Up to 28.5 Months|Physician Decision|3|||
48736896|NCT03307785|156887981|FG001|Part A: Up to 28.5 Months|Physician Decision|1|||
48736897|NCT03307785|156887982|FG002|Part A: Up to 28.5 Months|Physician Decision|0|||
48736898|NCT03307785|156887983|FG003|Part A: Up to 28.5 Months|Physician Decision|0|||
48736899|NCT03307785|156887984|FG004|Part A: Up to 28.5 Months|Physician Decision|0|||
48736900|NCT03307785|156887985|FG005|Part A: Up to 28.5 Months|Physician Decision|0|||
48736901|NCT03307785|156887986|FG006|Part A: Up to 28.5 Months|Physician Decision|0|||
48736902|NCT03307785|156887987|FG007|Part A: Up to 28.5 Months|Physician Decision|0|||
48736903|NCT03307785|156887988|FG008|Part A: Up to 28.5 Months|Physician Decision|0|||
48736904|NCT03307785|156887989|FG009|Part A: Up to 28.5 Months|Physician Decision|0|||
48736905|NCT03307785|156887990|FG010|Part A: Up to 28.5 Months|Physician Decision|0|||
48736906|NCT03307785|156887980|FG000|Part B: Up to Approx. 66 Months|Disease progression|0|||
48852467|NCT03861052|157299590|FG002|Overall Study|Lost to Follow-up|0|||
48852468|NCT03861052|157299591|FG003|Overall Study|Lost to Follow-up|1|||
48852469|NCT03861052|157299588|FG000|Overall Study|Physician Decision|0|||
48852470|NCT03861052|157299589|FG001|Overall Study|Physician Decision|1|||
48852471|NCT03861052|157299590|FG002|Overall Study|Physician Decision|0|||
48946525|NCT00923091|157634733|FG006|Period V (Double -Blind)|Protocol Violation|0|||
48852472|NCT03861052|157299591|FG003|Overall Study|Physician Decision|0|||
48736907|NCT03307785|156887981|FG001|Part B: Up to Approx. 66 Months|Disease progression|0|||
48736908|NCT03307785|156887982|FG002|Part B: Up to Approx. 66 Months|Disease progression|2|||
48736909|NCT03307785|156887983|FG003|Part B: Up to Approx. 66 Months|Disease progression|0|||
48736910|NCT03307785|156887984|FG004|Part B: Up to Approx. 66 Months|Disease progression|0|||
48736911|NCT03307785|156887985|FG005|Part B: Up to Approx. 66 Months|Disease progression|0|||
48852473|NCT03861052|157299588|FG000|Overall Study|Withdrawal by Subject|2|||
48736912|NCT03307785|156887986|FG006|Part B: Up to Approx. 66 Months|Disease progression|0|||
48736913|NCT03307785|156887987|FG007|Part B: Up to Approx. 66 Months|Disease progression|0|||
48736914|NCT03307785|156887988|FG008|Part B: Up to Approx. 66 Months|Disease progression|0|||
48736915|NCT03307785|156887989|FG009|Part B: Up to Approx. 66 Months|Disease progression|0|||
48736916|NCT03307785|156887990|FG010|Part B: Up to Approx. 66 Months|Disease progression|0|||
48736917|NCT03307785|156887980|FG000|Part B: Up to Approx. 66 Months|Death|0|||
48736918|NCT03307785|156887981|FG001|Part B: Up to Approx. 66 Months|Death|0|||
48736919|NCT03307785|156887982|FG002|Part B: Up to Approx. 66 Months|Death|7|||
48736920|NCT03307785|156887983|FG003|Part B: Up to Approx. 66 Months|Death|0|||
48736921|NCT03307785|156887984|FG004|Part B: Up to Approx. 66 Months|Death|0|||
48736922|NCT03307785|156887985|FG005|Part B: Up to Approx. 66 Months|Death|0|||
48736923|NCT03307785|156887986|FG006|Part B: Up to Approx. 66 Months|Death|0|||
48736924|NCT03307785|156887987|FG007|Part B: Up to Approx. 66 Months|Death|0|||
48736925|NCT03307785|156887988|FG008|Part B: Up to Approx. 66 Months|Death|0|||
48736926|NCT03307785|156887989|FG009|Part B: Up to Approx. 66 Months|Death|0|||
48736927|NCT03307785|156887990|FG010|Part B: Up to Approx. 66 Months|Death|0|||
48736928|NCT03307785|156887980|FG000|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
48736929|NCT03307785|156887981|FG001|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
48736930|NCT03307785|156887982|FG002|Part B: Up to Approx. 66 Months|Withdrawal by Subject|2|||
48736931|NCT03307785|156887983|FG003|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
48736932|NCT03307785|156887984|FG004|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
48736933|NCT03307785|156887985|FG005|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
48736934|NCT03307785|156887986|FG006|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
48736935|NCT03307785|156887987|FG007|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
48736936|NCT03307785|156887988|FG008|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
48736937|NCT03307785|156887989|FG009|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
48736938|NCT03307785|156887990|FG010|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
48736939|NCT03307785|156887980|FG000|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
48736940|NCT03307785|156887981|FG001|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
48736941|NCT03307785|156887982|FG002|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|2|||
48736942|NCT03307785|156887983|FG003|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
48852474|NCT03861052|157299589|FG001|Overall Study|Withdrawal by Subject|5|||
48852475|NCT03861052|157299590|FG002|Overall Study|Withdrawal by Subject|3|||
48852476|NCT03861052|157299591|FG003|Overall Study|Withdrawal by Subject|0|||
48736943|NCT03307785|156887984|FG004|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
48852477|NCT03861052|157299588|FG000|Overall Study|Relocation to other city|1|||
48852478|NCT03861052|157299589|FG001|Overall Study|Relocation to other city|0|||
48852479|NCT03861052|157299590|FG002|Overall Study|Relocation to other city|0|||
48852480|NCT03861052|157299591|FG003|Overall Study|Relocation to other city|0|||
48852481|NCT00220805|157299592|FG000|Overall Study|Adverse Event|1|||
48852482|NCT00220805|157299593|FG001|Overall Study|Adverse Event|3|||
48852483|NCT00220805|157299592|FG000|Overall Study|Withdrawal by Subject|3|||
48852484|NCT00220805|157299593|FG001|Overall Study|Withdrawal by Subject|0|||
48852485|NCT00220805|157299592|FG000|Overall Study|Lack of Efficacy|1|||
48852486|NCT00220805|157299593|FG001|Overall Study|Lack of Efficacy|0|||
48736944|NCT03307785|156887985|FG005|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
48736945|NCT03307785|156887986|FG006|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
48736946|NCT03307785|156887987|FG007|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
48736947|NCT03307785|156887988|FG008|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
48946526|NCT00923091|157634734|FG007|Period V (Double -Blind)|Protocol Violation|0|||
48946527|NCT00923091|157634735|FG008|Period V (Double -Blind)|Protocol Violation|0|||
48946528|NCT00923091|157634736|FG009|Period V (Double -Blind)|Protocol Violation|0|||
48946529|NCT00923091|157634737|FG010|Period V (Double -Blind)|Protocol Violation|0|||
48946530|NCT00923091|157634738|FG011|Period V (Double -Blind)|Protocol Violation|0|||
48946531|NCT00923091|157634739|FG012|Period V (Double -Blind)|Protocol Violation|1|||
48946532|NCT00923091|157634727|FG000|Period V (Double -Blind)|Lost to Follow-up|0|||
48946533|NCT00923091|157634728|FG001|Period V (Double -Blind)|Lost to Follow-up|0|||
48946534|NCT00923091|157634729|FG002|Period V (Double -Blind)|Lost to Follow-up|0|||
48946535|NCT00923091|157634730|FG003|Period V (Double -Blind)|Lost to Follow-up|0|||
48946536|NCT00923091|157634731|FG004|Period V (Double -Blind)|Lost to Follow-up|0|||
48946537|NCT00923091|157634732|FG005|Period V (Double -Blind)|Lost to Follow-up|0|||
48946538|NCT00923091|157634733|FG006|Period V (Double -Blind)|Lost to Follow-up|0|||
48946539|NCT00923091|157634734|FG007|Period V (Double -Blind)|Lost to Follow-up|0|||
48946540|NCT00923091|157634735|FG008|Period V (Double -Blind)|Lost to Follow-up|0|||
48946541|NCT00923091|157634736|FG009|Period V (Double -Blind)|Lost to Follow-up|0|||
48946542|NCT00923091|157634737|FG010|Period V (Double -Blind)|Lost to Follow-up|1|||
48946543|NCT00923091|157634738|FG011|Period V (Double -Blind)|Lost to Follow-up|0|||
48946544|NCT00923091|157634739|FG012|Period V (Double -Blind)|Lost to Follow-up|0|||
48946545|NCT00923091|157634727|FG000|Period VI (Open-Label)|Adverse Event|17|||
48946546|NCT00923091|157634728|FG001|Period VI (Open-Label)|Adverse Event|0|||
48946547|NCT00923091|157634729|FG002|Period VI (Open-Label)|Adverse Event|4|||
48736948|NCT03307785|156887989|FG009|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
48736949|NCT03307785|156887990|FG010|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
48852487|NCT00220805|157299592|FG000|Overall Study|Develop. of choroidal neovascularization|3|||
48852488|NCT00220805|157299593|FG001|Overall Study|Develop. of choroidal neovascularization|8|||
48852489|NCT00747006|157299597|FG000|Overall Study|Adverse Event|1|||
48852490|NCT00747006|157299598|FG001|Overall Study|Adverse Event|0|||
48852491|NCT00747006|157299599|FG002|Overall Study|Adverse Event|0|||
48852492|NCT00747006|157299597|FG000|Overall Study|Lost to Follow-up|0|||
48852493|NCT00747006|157299598|FG001|Overall Study|Lost to Follow-up|1|||
48852494|NCT00747006|157299599|FG002|Overall Study|Lost to Follow-up|0|||
48852495|NCT00747006|157299597|FG000|Overall Study|Physician Decision|2|||
48852496|NCT00747006|157299598|FG001|Overall Study|Physician Decision|0|||
48852497|NCT00747006|157299599|FG002|Overall Study|Physician Decision|1|||
48852498|NCT00745875|157299604|FG000|Overall Study|Continuing study treatment|4|||
48852499|NCT00745875|157299605|FG001|Overall Study|Continuing study treatment|4|||
48852500|NCT01128595|157299608|FG000|Treatment Period 3|Withdrawal by Subject|0|||
48852501|NCT01128595|157299609|FG001|Treatment Period 3|Withdrawal by Subject|1|||
48852502|NCT01128595|157299610|FG002|Treatment Period 3|Withdrawal by Subject|0|||
48852503|NCT01128595|157299611|FG003|Treatment Period 3|Withdrawal by Subject|0|||
48852504|NCT00605306|157299612|FG000|Overall Study|Adverse Event|0|||
48852505|NCT00605306|157299613|FG001|Overall Study|Adverse Event|1|||
48946548|NCT00923091|157634730|FG003|Period VI (Open-Label)|Adverse Event|1|||
48946549|NCT00923091|157634731|FG004|Period VI (Open-Label)|Adverse Event|1|||
48946550|NCT00923091|157634732|FG005|Period VI (Open-Label)|Adverse Event|0|||
48852506|NCT02310581|157299616|FG000|Overall Study|Adverse Event|1|||
48946551|NCT00923091|157634733|FG006|Period VI (Open-Label)|Adverse Event|0|||
48946552|NCT00923091|157634734|FG007|Period VI (Open-Label)|Adverse Event|0|||
48946553|NCT00923091|157634735|FG008|Period VI (Open-Label)|Adverse Event|0|||
48946554|NCT00923091|157634736|FG009|Period VI (Open-Label)|Adverse Event|0|||
48946555|NCT00923091|157634737|FG010|Period VI (Open-Label)|Adverse Event|0|||
48946556|NCT00923091|157634738|FG011|Period VI (Open-Label)|Adverse Event|0|||
48946557|NCT00923091|157634739|FG012|Period VI (Open-Label)|Adverse Event|0|||
48946558|NCT00923091|157634727|FG000|Period VI (Open-Label)|Withdrawal by Subject|15|||
48946559|NCT00923091|157634728|FG001|Period VI (Open-Label)|Withdrawal by Subject|7|||
48946560|NCT00923091|157634729|FG002|Period VI (Open-Label)|Withdrawal by Subject|5|||
48946561|NCT00923091|157634730|FG003|Period VI (Open-Label)|Withdrawal by Subject|0|||
48946562|NCT00923091|157634731|FG004|Period VI (Open-Label)|Withdrawal by Subject|1|||
48946563|NCT00923091|157634732|FG005|Period VI (Open-Label)|Withdrawal by Subject|0|||
48946564|NCT00923091|157634733|FG006|Period VI (Open-Label)|Withdrawal by Subject|0|||
48946565|NCT00923091|157634734|FG007|Period VI (Open-Label)|Withdrawal by Subject|0|||
48946566|NCT00923091|157634735|FG008|Period VI (Open-Label)|Withdrawal by Subject|0|||
48946567|NCT00923091|157634736|FG009|Period VI (Open-Label)|Withdrawal by Subject|0|||
48946568|NCT00923091|157634737|FG010|Period VI (Open-Label)|Withdrawal by Subject|0|||
48946569|NCT00923091|157634738|FG011|Period VI (Open-Label)|Withdrawal by Subject|0|||
48946570|NCT00923091|157634739|FG012|Period VI (Open-Label)|Withdrawal by Subject|0|||
48946571|NCT00923091|157634727|FG000|Period VI (Open-Label)|Protocol Violation|6|||
48946572|NCT00923091|157634728|FG001|Period VI (Open-Label)|Protocol Violation|1|||
48946573|NCT00923091|157634729|FG002|Period VI (Open-Label)|Protocol Violation|3|||
48946574|NCT00923091|157634730|FG003|Period VI (Open-Label)|Protocol Violation|1|||
48946575|NCT00923091|157634731|FG004|Period VI (Open-Label)|Protocol Violation|4|||
48946576|NCT00923091|157634732|FG005|Period VI (Open-Label)|Protocol Violation|0|||
48946577|NCT00923091|157634733|FG006|Period VI (Open-Label)|Protocol Violation|0|||
48946578|NCT00923091|157634734|FG007|Period VI (Open-Label)|Protocol Violation|0|||
48946579|NCT00923091|157634735|FG008|Period VI (Open-Label)|Protocol Violation|0|||
48946580|NCT00923091|157634736|FG009|Period VI (Open-Label)|Protocol Violation|0|||
48946581|NCT00923091|157634737|FG010|Period VI (Open-Label)|Protocol Violation|0|||
48946582|NCT00923091|157634738|FG011|Period VI (Open-Label)|Protocol Violation|0|||
48946583|NCT00923091|157634739|FG012|Period VI (Open-Label)|Protocol Violation|0|||
48946584|NCT00923091|157634727|FG000|Period VI (Open-Label)|Lost to Follow-up|1|||
48946585|NCT00923091|157634728|FG001|Period VI (Open-Label)|Lost to Follow-up|0|||
48946586|NCT00923091|157634729|FG002|Period VI (Open-Label)|Lost to Follow-up|1|||
48946587|NCT00923091|157634730|FG003|Period VI (Open-Label)|Lost to Follow-up|0|||
48946588|NCT00923091|157634731|FG004|Period VI (Open-Label)|Lost to Follow-up|0|||
48946589|NCT00923091|157634732|FG005|Period VI (Open-Label)|Lost to Follow-up|0|||
48946590|NCT00923091|157634733|FG006|Period VI (Open-Label)|Lost to Follow-up|0|||
48946591|NCT00923091|157634734|FG007|Period VI (Open-Label)|Lost to Follow-up|0|||
48946592|NCT00923091|157634735|FG008|Period VI (Open-Label)|Lost to Follow-up|0|||
48946593|NCT00923091|157634736|FG009|Period VI (Open-Label)|Lost to Follow-up|0|||
48946594|NCT00923091|157634737|FG010|Period VI (Open-Label)|Lost to Follow-up|0|||
48946595|NCT00923091|157634738|FG011|Period VI (Open-Label)|Lost to Follow-up|0|||
48736950|NCT03307785|156887980|FG000|Part B: Up to Approx. 66 Months|Physician Decision|0|||
48736951|NCT03307785|156887981|FG001|Part B: Up to Approx. 66 Months|Physician Decision|0|||
48736952|NCT03307785|156887982|FG002|Part B: Up to Approx. 66 Months|Physician Decision|1|||
48736953|NCT03307785|156887983|FG003|Part B: Up to Approx. 66 Months|Physician Decision|0|||
48736954|NCT03307785|156887984|FG004|Part B: Up to Approx. 66 Months|Physician Decision|0|||
48852507|NCT02310581|157299617|FG001|Overall Study|Adverse Event|1|||
48852508|NCT02310581|157299618|FG002|Overall Study|Adverse Event|1|||
48852509|NCT02310581|157299619|FG003|Overall Study|Adverse Event|0|||
48852510|NCT02310581|157299616|FG000|Overall Study|Withdrawal by Subject|2|||
48852511|NCT02310581|157299617|FG001|Overall Study|Withdrawal by Subject|1|||
48852512|NCT02310581|157299618|FG002|Overall Study|Withdrawal by Subject|0|||
48852513|NCT02310581|157299619|FG003|Overall Study|Withdrawal by Subject|1|||
48852514|NCT00336505|157299620|FG000|Overall Study|Adverse Event|10|||
48852515|NCT00336505|157299621|FG001|Overall Study|Adverse Event|9|||
48852516|NCT00336505|157299620|FG000|Overall Study|Lack of Efficacy|8|||
48852517|NCT00336505|157299621|FG001|Overall Study|Lack of Efficacy|4|||
48852518|NCT00336505|157299620|FG000|Overall Study|Lost to Follow-up|7|||
48852519|NCT00336505|157299621|FG001|Overall Study|Lost to Follow-up|4|||
48852520|NCT00336505|157299620|FG000|Overall Study|Withdrawal by Subject|5|||
48852521|NCT00336505|157299621|FG001|Overall Study|Withdrawal by Subject|3|||
48852522|NCT00336505|157299620|FG000|Overall Study|Other|7|||
48852523|NCT00336505|157299621|FG001|Overall Study|Other|7|||
48852524|NCT01555138|157299622|FG000|Overall Study|Death|0|||
48852525|NCT01555138|157299623|FG001|Overall Study|Death|1|||
48852526|NCT01555138|157299622|FG000|Overall Study|Lost to Follow-up|1|||
48852527|NCT01555138|157299623|FG001|Overall Study|Lost to Follow-up|0|||
48852528|NCT01555138|157299622|FG000|Overall Study|Abnormal Lab reults|1|||
48852529|NCT01555138|157299623|FG001|Overall Study|Abnormal Lab reults|3|||
48852530|NCT01555138|157299622|FG000|Overall Study|Lack of Efficacy|2|||
48736955|NCT03307785|156887985|FG005|Part B: Up to Approx. 66 Months|Physician Decision|0|||
48736956|NCT03307785|156887986|FG006|Part B: Up to Approx. 66 Months|Physician Decision|0|||
48736957|NCT03307785|156887987|FG007|Part B: Up to Approx. 66 Months|Physician Decision|0|||
48736958|NCT03307785|156887988|FG008|Part B: Up to Approx. 66 Months|Physician Decision|0|||
48736959|NCT03307785|156887989|FG009|Part B: Up to Approx. 66 Months|Physician Decision|0|||
48736960|NCT03307785|156887990|FG010|Part B: Up to Approx. 66 Months|Physician Decision|0|||
48736961|NCT03307785|156887980|FG000|Part C: Up to Approx. 60 Months|Physician Decision|0|||
48736962|NCT03307785|156887981|FG001|Part C: Up to Approx. 60 Months|Physician Decision|0|||
48736963|NCT03307785|156887982|FG002|Part C: Up to Approx. 60 Months|Physician Decision|0|||
48736964|NCT03307785|156887983|FG003|Part C: Up to Approx. 60 Months|Physician Decision|3|||
48736965|NCT03307785|156887984|FG004|Part C: Up to Approx. 60 Months|Physician Decision|1|||
48736966|NCT03307785|156887985|FG005|Part C: Up to Approx. 60 Months|Physician Decision|0|||
48736967|NCT03307785|156887986|FG006|Part C: Up to Approx. 60 Months|Physician Decision|0|||
48736968|NCT03307785|156887987|FG007|Part C: Up to Approx. 60 Months|Physician Decision|0|||
48736969|NCT03307785|156887988|FG008|Part C: Up to Approx. 60 Months|Physician Decision|0|||
48736970|NCT03307785|156887989|FG009|Part C: Up to Approx. 60 Months|Physician Decision|0|||
48736971|NCT03307785|156887990|FG010|Part C: Up to Approx. 60 Months|Physician Decision|0|||
48736972|NCT03307785|156887980|FG000|Part C: Up to Approx. 60 Months|Death|0|||
48736973|NCT03307785|156887981|FG001|Part C: Up to Approx. 60 Months|Death|0|||
48736974|NCT03307785|156887982|FG002|Part C: Up to Approx. 60 Months|Death|0|||
48736975|NCT03307785|156887983|FG003|Part C: Up to Approx. 60 Months|Death|2|||
48736976|NCT03307785|156887984|FG004|Part C: Up to Approx. 60 Months|Death|5|||
48736977|NCT03307785|156887985|FG005|Part C: Up to Approx. 60 Months|Death|0|||
48736978|NCT03307785|156887986|FG006|Part C: Up to Approx. 60 Months|Death|0|||
48736979|NCT03307785|156887987|FG007|Part C: Up to Approx. 60 Months|Death|0|||
48736980|NCT03307785|156887988|FG008|Part C: Up to Approx. 60 Months|Death|0|||
48852531|NCT01555138|157299623|FG001|Overall Study|Lack of Efficacy|2|||
48852532|NCT01555138|157299622|FG000|Overall Study|Protocol Violation|5|||
48946596|NCT00923091|157634739|FG012|Period VI (Open-Label)|Lost to Follow-up|0|||
48736981|NCT03307785|156887989|FG009|Part C: Up to Approx. 60 Months|Death|0|||
48736982|NCT03307785|156887990|FG010|Part C: Up to Approx. 60 Months|Death|0|||
48736983|NCT03307785|156887980|FG000|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
48736984|NCT03307785|156887981|FG001|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
48736985|NCT03307785|156887982|FG002|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
48852533|NCT01555138|157299623|FG001|Overall Study|Protocol Violation|3|||
48852534|NCT01555138|157299622|FG000|Overall Study|Administrative problems|8|||
48852535|NCT01555138|157299623|FG001|Overall Study|Administrative problems|0|||
48852536|NCT01555138|157299622|FG000|Overall Study|Withdrawal by Subject|16|||
48852537|NCT01555138|157299623|FG001|Overall Study|Withdrawal by Subject|15|||
48852538|NCT01555138|157299622|FG000|Overall Study|Adverse Event|14|||
48852539|NCT01555138|157299623|FG001|Overall Study|Adverse Event|14|||
48852540|NCT02202317|157299625|FG000|Overall Study|Lost to Follow-up|1|||
48852541|NCT01128959|157299626|FG000|Lead in Period|Adverse Event|3|||
48852542|NCT01128959|157299626|FG000|Treatment Period|Adverse Event|3|||
48852543|NCT01128959|157299626|FG000|Treatment Period|Withdrawal by Subject|1|||
48852544|NCT02701296|157299627|FG000|Overall Study|Incomplete Data|0|||
48852545|NCT02701296|157299628|FG001|Overall Study|Incomplete Data|2|||
48852546|NCT01409837|157299629|FG000|Overall Study|Withdrawal by Subject|2|||
48852547|NCT01409837|157299630|FG001|Overall Study|Withdrawal by Subject|1|||
48852548|NCT01409837|157299629|FG000|Overall Study|Lost to Follow-up|1|||
48852549|NCT01409837|157299630|FG001|Overall Study|Lost to Follow-up|0|||
48852550|NCT01409837|157299629|FG000|Overall Study|Physician Decision|0|||
48852551|NCT01409837|157299630|FG001|Overall Study|Physician Decision|1|||
48946597|NCT00923091|157634727|FG000|Period VI (Open-Label)|Other Reason|0|||
48946598|NCT00923091|157634728|FG001|Period VI (Open-Label)|Other Reason|0|||
48946599|NCT00923091|157634729|FG002|Period VI (Open-Label)|Other Reason|0|||
48946600|NCT00923091|157634730|FG003|Period VI (Open-Label)|Other Reason|1|||
48946601|NCT00923091|157634731|FG004|Period VI (Open-Label)|Other Reason|1|||
48946602|NCT00923091|157634732|FG005|Period VI (Open-Label)|Other Reason|0|||
48946603|NCT00923091|157634733|FG006|Period VI (Open-Label)|Other Reason|0|||
48946604|NCT00923091|157634734|FG007|Period VI (Open-Label)|Other Reason|0|||
48946605|NCT00923091|157634735|FG008|Period VI (Open-Label)|Other Reason|0|||
48946606|NCT00923091|157634736|FG009|Period VI (Open-Label)|Other Reason|0|||
48946607|NCT00923091|157634737|FG010|Period VI (Open-Label)|Other Reason|0|||
48946608|NCT00923091|157634738|FG011|Period VI (Open-Label)|Other Reason|0|||
48946609|NCT00923091|157634739|FG012|Period VI (Open-Label)|Other Reason|0|||
48946610|NCT00258154|157634741|FG000|Overall Study|Adverse Event|1|||
48946611|NCT00258154|157634742|FG001|Overall Study|Adverse Event|0|||
48946612|NCT00258154|157634741|FG000|Overall Study|Lost to Follow-up|0|||
48946613|NCT00258154|157634742|FG001|Overall Study|Lost to Follow-up|1|||
48946614|NCT00258154|157634741|FG000|Overall Study|Protocol Violation|2|||
48946615|NCT00258154|157634742|FG001|Overall Study|Protocol Violation|1|||
48946616|NCT00258154|157634741|FG000|Overall Study|Withdrawal by Subject|3|||
48946617|NCT00258154|157634742|FG001|Overall Study|Withdrawal by Subject|4|||
48946618|NCT00258154|157634741|FG000|Overall Study|Patient Moved|3|||
48946619|NCT00258154|157634742|FG001|Overall Study|Patient Moved|1|||
48946620|NCT04983901|157634743|FG000|Overall Study|Death|1|||
48736986|NCT03307785|156887983|FG003|Part C: Up to Approx. 60 Months|Withdrawal by Subject|1|||
48736987|NCT03307785|156887984|FG004|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
48736988|NCT03307785|156887985|FG005|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
48736989|NCT03307785|156887986|FG006|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
48736990|NCT03307785|156887987|FG007|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
48736991|NCT03307785|156887988|FG008|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
48736992|NCT03307785|156887989|FG009|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
48736993|NCT03307785|156887990|FG010|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
48736994|NCT03307785|156887980|FG000|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
48736995|NCT03307785|156887981|FG001|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
48736996|NCT03307785|156887982|FG002|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
48736997|NCT03307785|156887983|FG003|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
48736998|NCT03307785|156887984|FG004|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|1|||
48736999|NCT03307785|156887985|FG005|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
48737000|NCT03307785|156887986|FG006|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
48737001|NCT03307785|156887987|FG007|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
48737002|NCT03307785|156887988|FG008|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
48737003|NCT03307785|156887989|FG009|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
48737004|NCT03307785|156887990|FG010|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
48737005|NCT03307785|156887980|FG000|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
48737006|NCT03307785|156887981|FG001|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
48946621|NCT04983901|157634744|FG001|Overall Study|Death|4|||
48737007|NCT03307785|156887982|FG002|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
48737008|NCT03307785|156887983|FG003|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
48946622|NCT04983901|157634743|FG000|Overall Study|Lost to Follow-up|3|||
48946623|NCT04983901|157634744|FG001|Overall Study|Lost to Follow-up|0|||
48946624|NCT04983901|157634743|FG000|Overall Study|Protocol Violation|1|||
48946625|NCT04983901|157634744|FG001|Overall Study|Protocol Violation|0|||
48946626|NCT04983901|157634743|FG000|Overall Study|Withdrawal by Subject|1|||
48946627|NCT04983901|157634744|FG001|Overall Study|Withdrawal by Subject|2|||
49015312|NCT00814320|157892146|FG000|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0|||
48946628|NCT01633060|157634745|FG000|Randomization Phase|Protocol deviation|1|||
48946629|NCT01633060|157634746|FG001|Randomization Phase|Protocol deviation|2|||
48946630|NCT01633060|157634745|FG000|Randomization Phase|Technical problem|0|||
48946631|NCT01633060|157634746|FG001|Randomization Phase|Technical problem|1|||
48946632|NCT01633060|157634745|FG000|Treatment Phase|Adverse Event|24|||
48946633|NCT01633060|157634746|FG001|Treatment Phase|Adverse Event|3|||
48946634|NCT01633060|157634745|FG000|Treatment Phase|Lost to Follow-up|1|||
48946635|NCT01633060|157634746|FG001|Treatment Phase|Lost to Follow-up|0|||
48946636|NCT01633060|157634745|FG000|Treatment Phase|Physician Decision|16|||
48737009|NCT03307785|156887984|FG004|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
48737010|NCT03307785|156887985|FG005|Part D: Up to Approx. 62.5 Months|Physician Decision|2|||
48737011|NCT03307785|156887986|FG006|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
48737012|NCT03307785|156887987|FG007|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
48737013|NCT03307785|156887988|FG008|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
48737014|NCT03307785|156887989|FG009|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
48737015|NCT03307785|156887990|FG010|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
48737016|NCT03307785|156887980|FG000|Part D: Up to Approx. 62.5 Months|Death|0|||
48737017|NCT03307785|156887981|FG001|Part D: Up to Approx. 62.5 Months|Death|0|||
48737018|NCT03307785|156887982|FG002|Part D: Up to Approx. 62.5 Months|Death|0|||
48737019|NCT03307785|156887983|FG003|Part D: Up to Approx. 62.5 Months|Death|0|||
48737020|NCT03307785|156887984|FG004|Part D: Up to Approx. 62.5 Months|Death|0|||
48737021|NCT03307785|156887985|FG005|Part D: Up to Approx. 62.5 Months|Death|1|||
48737022|NCT03307785|156887986|FG006|Part D: Up to Approx. 62.5 Months|Death|0|||
48737023|NCT03307785|156887987|FG007|Part D: Up to Approx. 62.5 Months|Death|0|||
48737024|NCT03307785|156887988|FG008|Part D: Up to Approx. 62.5 Months|Death|0|||
48946637|NCT01633060|157634746|FG001|Treatment Phase|Physician Decision|7|||
48946638|NCT01633060|157634745|FG000|Treatment Phase|Progressive Disease|210|||
48946639|NCT01633060|157634746|FG001|Treatment Phase|Progressive Disease|120|||
48946640|NCT01633060|157634745|FG000|Treatment Phase|Protocol Deviation|1|||
48946641|NCT01633060|157634746|FG001|Treatment Phase|Protocol Deviation|0|||
48737025|NCT03307785|156887989|FG009|Part D: Up to Approx. 62.5 Months|Death|0|||
48737026|NCT03307785|156887990|FG010|Part D: Up to Approx. 62.5 Months|Death|0|||
48737027|NCT03307785|156887980|FG000|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
48737028|NCT03307785|156887981|FG001|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
48737029|NCT03307785|156887982|FG002|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
48737030|NCT03307785|156887983|FG003|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
48737031|NCT03307785|156887984|FG004|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
48737032|NCT03307785|156887985|FG005|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|1|||
48946642|NCT01633060|157634745|FG000|Treatment Phase|Study Terminated by sponsor|7|||
48946643|NCT01633060|157634746|FG001|Treatment Phase|Study Terminated by sponsor|3|||
48946644|NCT01633060|157634745|FG000|Treatment Phase|Subject/guardian decision|25|||
48946645|NCT01633060|157634746|FG001|Treatment Phase|Subject/guardian decision|4|||
48946646|NCT01633060|157634745|FG000|Treatment Phase|Death|4|||
48946647|NCT01633060|157634746|FG001|Treatment Phase|Death|3|||
48946648|NCT01633060|157634745|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
48946649|NCT01633060|157634746|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
48946650|NCT01633060|157634745|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1|||
48946651|NCT01633060|157634746|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0|||
48946652|NCT01633060|157634745|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10|||
48946653|NCT01633060|157634746|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1|||
48946654|NCT01633060|157634745|FG000|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1|||
48946655|NCT01633060|157634746|FG001|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0|||
48946656|NCT01633060|157634745|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
48946657|NCT01633060|157634746|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
48946658|NCT01633060|157634745|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|1|||
48946659|NCT01633060|157634746|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|0|||
48946660|NCT02859415|157634749|FG000|Overall Study|Physician Decision|1|||
48946661|NCT02859415|157634750|FG001|Overall Study|Physician Decision|0|||
48946662|NCT02859415|157634749|FG000|Overall Study|Off treatment due to cardiac event|0|||
48946663|NCT02859415|157634750|FG001|Overall Study|Off treatment due to cardiac event|1|||
48946664|NCT01396525|157634751|FG000|Overall Study|Withdrawal by Subject|8|||
48946665|NCT01396525|157634751|FG000|Overall Study|Death|14|||
48946666|NCT01396525|157634751|FG000|Overall Study|Lost to Follow-up|4|||
48946667|NCT04601272|157634753|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
48946668|NCT04601272|157634754|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|3|||
48946669|NCT04601272|157634755|FG002|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
48946670|NCT01743027|157634758|FG000|Overall Study|Adverse Event|2|||
48946671|NCT01743027|157634759|FG001|Overall Study|Adverse Event|0|||
48946672|NCT01743027|157634760|FG002|Overall Study|Adverse Event|0|||
48737033|NCT03307785|156887986|FG006|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
48737034|NCT03307785|156887987|FG007|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
48737035|NCT03307785|156887988|FG008|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
48737036|NCT03307785|156887989|FG009|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
48737037|NCT03307785|156887990|FG010|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
48737038|NCT03307785|156887980|FG000|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
48737039|NCT03307785|156887981|FG001|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
48737040|NCT03307785|156887982|FG002|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
48737041|NCT03307785|156887983|FG003|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
48737042|NCT03307785|156887984|FG004|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
48737043|NCT03307785|156887985|FG005|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|1|||
48737044|NCT03307785|156887986|FG006|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
48737045|NCT03307785|156887987|FG007|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
48737046|NCT03307785|156887988|FG008|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
48737047|NCT03307785|156887989|FG009|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
48737048|NCT03307785|156887990|FG010|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
48737049|NCT03307785|156887980|FG000|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
48737050|NCT03307785|156887981|FG001|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
48737051|NCT03307785|156887982|FG002|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
48737052|NCT03307785|156887983|FG003|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
48737053|NCT03307785|156887984|FG004|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
48737054|NCT03307785|156887985|FG005|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|1|||
48737055|NCT03307785|156887986|FG006|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
48737056|NCT03307785|156887987|FG007|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
48737057|NCT03307785|156887988|FG008|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
48737058|NCT03307785|156887989|FG009|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
48946673|NCT01743027|157634761|FG003|Overall Study|Adverse Event|0|||
48737059|NCT03307785|156887990|FG010|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
48737060|NCT03307785|156887980|FG000|Part E: Up to 4.4 Months|Death|0|||
48737061|NCT03307785|156887981|FG001|Part E: Up to 4.4 Months|Death|0|||
48737062|NCT03307785|156887982|FG002|Part E: Up to 4.4 Months|Death|0|||
48737063|NCT03307785|156887983|FG003|Part E: Up to 4.4 Months|Death|0|||
48737064|NCT03307785|156887984|FG004|Part E: Up to 4.4 Months|Death|0|||
48946674|NCT01743027|157634758|FG000|Overall Study|Lost to Follow-up|0|||
48946675|NCT01743027|157634759|FG001|Overall Study|Lost to Follow-up|0|||
48946676|NCT01743027|157634760|FG002|Overall Study|Lost to Follow-up|2|||
48946677|NCT01743027|157634761|FG003|Overall Study|Lost to Follow-up|0|||
48737065|NCT03307785|156887985|FG005|Part E: Up to 4.4 Months|Death|0|||
48852552|NCT01436175|157299631|FG000|Overall Study|Adverse Event|111|||
48852553|NCT01436175|157299631|FG000|Overall Study|Protocol Violation|49|||
48852554|NCT01436175|157299631|FG000|Overall Study|Withdrawal by Subject|108|||
48852555|NCT01436175|157299631|FG000|Overall Study|Lost to Follow-up|89|||
48852556|NCT01436175|157299631|FG000|Overall Study|Lack of Efficacy|24|||
48852557|NCT01436175|157299631|FG000|Overall Study|Met blood pressure or pulse withdrawal|63|||
48852558|NCT01436175|157299631|FG000|Overall Study|Other|826|||
48852559|NCT00724126|157299632|FG000|Overall Study|Adverse Event|2|||
48852560|NCT00724126|157299633|FG001|Overall Study|Adverse Event|0|||
48852561|NCT00724126|157299632|FG000|Overall Study|Withdrawal by Subject|8|||
48852562|NCT00724126|157299633|FG001|Overall Study|Withdrawal by Subject|6|||
48852563|NCT00724126|157299632|FG000|Overall Study|Lost to Follow-up|6|||
48852564|NCT00724126|157299633|FG001|Overall Study|Lost to Follow-up|6|||
48852565|NCT00724126|157299632|FG000|Overall Study|Noncompliance|2|||
48852566|NCT00724126|157299633|FG001|Overall Study|Noncompliance|1|||
48852567|NCT00724126|157299632|FG000|Overall Study|Subject randomized although ineligible|1|||
48852568|NCT00724126|157299633|FG001|Overall Study|Subject randomized although ineligible|1|||
48852569|NCT00724126|157299632|FG000|Overall Study|Subject had to leave vicinity of site|0|||
48852570|NCT00724126|157299633|FG001|Overall Study|Subject had to leave vicinity of site|1|||
48852571|NCT03732807|157299637|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
48852572|NCT03732807|157299638|FG001|Treatment Period (up to Week 24)|Adverse Event|0|||
48852573|NCT03732807|157299639|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
48852574|NCT03732807|157299640|FG003|Treatment Period (up to Week 24)|Adverse Event|4|||
48852575|NCT03732807|157299641|FG004|Treatment Period (up to Week 24)|Adverse Event|2|||
48852576|NCT03732807|157299642|FG005|Treatment Period (up to Week 24)|Adverse Event|0|||
48852577|NCT03732807|157299643|FG006|Treatment Period (up to Week 24)|Adverse Event|1|||
48852578|NCT03732807|157299637|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
48852579|NCT03732807|157299638|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
48852580|NCT03732807|157299639|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
48946678|NCT01743027|157634758|FG000|Overall Study|Progressive Disease|1|||
48946679|NCT01743027|157634759|FG001|Overall Study|Progressive Disease|4|||
48946680|NCT01743027|157634760|FG002|Overall Study|Progressive Disease|3|||
48946681|NCT01743027|157634761|FG003|Overall Study|Progressive Disease|0|||
48946682|NCT01743027|157634758|FG000|Overall Study|Protocol Violation|1|||
48946683|NCT01743027|157634759|FG001|Overall Study|Protocol Violation|1|||
48946684|NCT01743027|157634760|FG002|Overall Study|Protocol Violation|1|||
48946685|NCT01743027|157634761|FG003|Overall Study|Protocol Violation|0|||
48946686|NCT01743027|157634758|FG000|Overall Study|Withdrawal by Subject|1|||
48946687|NCT01743027|157634759|FG001|Overall Study|Withdrawal by Subject|0|||
48946688|NCT01743027|157634760|FG002|Overall Study|Withdrawal by Subject|3|||
48946689|NCT01743027|157634761|FG003|Overall Study|Withdrawal by Subject|1|||
48946690|NCT01753518|157634762|FG000|Intention-to-Treat Analysis|Missing consent form|5|||
48946691|NCT01753518|157634763|FG001|Intention-to-Treat Analysis|Missing consent form|3|||
48946692|NCT01753518|157634762|FG000|Intention-to-Treat Analysis|Multifetal gestation|2|||
48946693|NCT01753518|157634763|FG001|Intention-to-Treat Analysis|Multifetal gestation|3|||
48737066|NCT03307785|156887986|FG006|Part E: Up to 4.4 Months|Death|1|||
48852581|NCT03732807|157299640|FG003|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
48737067|NCT03307785|156887987|FG007|Part E: Up to 4.4 Months|Death|0|||
48737068|NCT03307785|156887988|FG008|Part E: Up to 4.4 Months|Death|0|||
48852582|NCT03732807|157299641|FG004|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
48852583|NCT03732807|157299642|FG005|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
48852584|NCT03732807|157299643|FG006|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
48946694|NCT01753518|157634762|FG000|Intention-to-Treat Analysis|Body Mass Index>50|0|||
48946695|NCT01753518|157634763|FG001|Intention-to-Treat Analysis|Body Mass Index>50|1|||
48852585|NCT03732807|157299637|FG000|Treatment Period (up to Week 24)|Physician Decision|0|||
48852586|NCT03732807|157299638|FG001|Treatment Period (up to Week 24)|Physician Decision|1|||
48852587|NCT03732807|157299639|FG002|Treatment Period (up to Week 24)|Physician Decision|2|||
48852588|NCT03732807|157299640|FG003|Treatment Period (up to Week 24)|Physician Decision|5|||
48852589|NCT03732807|157299641|FG004|Treatment Period (up to Week 24)|Physician Decision|0|||
48852590|NCT03732807|157299642|FG005|Treatment Period (up to Week 24)|Physician Decision|0|||
48852591|NCT03732807|157299643|FG006|Treatment Period (up to Week 24)|Physician Decision|1|||
48852592|NCT03732807|157299637|FG000|Treatment Period (up to Week 24)|Pregnancy|1|||
48852593|NCT03732807|157299638|FG001|Treatment Period (up to Week 24)|Pregnancy|0|||
48852594|NCT03732807|157299639|FG002|Treatment Period (up to Week 24)|Pregnancy|0|||
48852595|NCT03732807|157299640|FG003|Treatment Period (up to Week 24)|Pregnancy|0|||
48852596|NCT03732807|157299641|FG004|Treatment Period (up to Week 24)|Pregnancy|1|||
48852597|NCT03732807|157299642|FG005|Treatment Period (up to Week 24)|Pregnancy|0|||
48852598|NCT03732807|157299643|FG006|Treatment Period (up to Week 24)|Pregnancy|1|||
48852599|NCT03732807|157299637|FG000|Treatment Period (up to Week 24)|Protocol Violation|1|||
48852600|NCT03732807|157299638|FG001|Treatment Period (up to Week 24)|Protocol Violation|1|||
48852601|NCT03732807|157299639|FG002|Treatment Period (up to Week 24)|Protocol Violation|0|||
48737069|NCT03307785|156887989|FG009|Part E: Up to 4.4 Months|Death|0|||
48737070|NCT03307785|156887990|FG010|Part E: Up to 4.4 Months|Death|0|||
48737071|NCT03307785|156887980|FG000|Part E: Up to 4.4 Months|Physician Decision|0|||
48737072|NCT03307785|156887981|FG001|Part E: Up to 4.4 Months|Physician Decision|0|||
48737073|NCT03307785|156887982|FG002|Part E: Up to 4.4 Months|Physician Decision|0|||
48737074|NCT03307785|156887983|FG003|Part E: Up to 4.4 Months|Physician Decision|0|||
48737075|NCT03307785|156887984|FG004|Part E: Up to 4.4 Months|Physician Decision|0|||
48737076|NCT03307785|156887985|FG005|Part E: Up to 4.4 Months|Physician Decision|0|||
48737077|NCT03307785|156887986|FG006|Part E: Up to 4.4 Months|Physician Decision|1|||
48737078|NCT03307785|156887987|FG007|Part E: Up to 4.4 Months|Physician Decision|0|||
48737079|NCT03307785|156887988|FG008|Part E: Up to 4.4 Months|Physician Decision|0|||
48737080|NCT03307785|156887989|FG009|Part E: Up to 4.4 Months|Physician Decision|0|||
48737081|NCT03307785|156887990|FG010|Part E: Up to 4.4 Months|Physician Decision|0|||
48737082|NCT03307785|156887980|FG000|Part F: Up to 3.5 Months|Physician Decision|0|||
48737083|NCT03307785|156887981|FG001|Part F: Up to 3.5 Months|Physician Decision|0|||
48737084|NCT03307785|156887982|FG002|Part F: Up to 3.5 Months|Physician Decision|0|||
48737085|NCT03307785|156887983|FG003|Part F: Up to 3.5 Months|Physician Decision|0|||
48737086|NCT03307785|156887984|FG004|Part F: Up to 3.5 Months|Physician Decision|0|||
48737087|NCT03307785|156887985|FG005|Part F: Up to 3.5 Months|Physician Decision|0|||
48737088|NCT03307785|156887986|FG006|Part F: Up to 3.5 Months|Physician Decision|0|||
48737089|NCT03307785|156887987|FG007|Part F: Up to 3.5 Months|Physician Decision|1|||
48737090|NCT03307785|156887988|FG008|Part F: Up to 3.5 Months|Physician Decision|0|||
48737091|NCT03307785|156887989|FG009|Part F: Up to 3.5 Months|Physician Decision|0|||
48737092|NCT03307785|156887990|FG010|Part F: Up to 3.5 Months|Physician Decision|0|||
48737093|NCT00566111|156887991|FG000|Overall Study|Adverse Event|0|||
48737094|NCT00566111|156887992|FG001|Overall Study|Adverse Event|2|||
48737095|NCT03666624|156887993|FG000|Overall Study|participant grieving over recent death of parent|1|||
48852602|NCT03732807|157299640|FG003|Treatment Period (up to Week 24)|Protocol Violation|0|||
48737096|NCT03666624|156887994|FG001|Overall Study|participant grieving over recent death of parent|0|||
48737097|NCT01612858|156887999|FG000|Overall Study|Withdrawal by Subject|5|||
48737098|NCT01612858|156888000|FG001|Overall Study|Withdrawal by Subject|1|||
48737099|NCT02128932|156888001|FG000|Overall Study|Withdrawal by Subject|11|||
48737100|NCT02128932|156888002|FG001|Overall Study|Withdrawal by Subject|7|||
48737101|NCT02128932|156888003|FG002|Overall Study|Withdrawal by Subject|8|||
48737102|NCT02128932|156888001|FG000|Overall Study|Death|2|||
48737103|NCT02128932|156888002|FG001|Overall Study|Death|0|||
48852603|NCT03732807|157299641|FG004|Treatment Period (up to Week 24)|Protocol Violation|0|||
48852604|NCT03732807|157299642|FG005|Treatment Period (up to Week 24)|Protocol Violation|0|||
48852605|NCT03732807|157299643|FG006|Treatment Period (up to Week 24)|Protocol Violation|0|||
48852606|NCT03732807|157299637|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
48737104|NCT02128932|156888003|FG002|Overall Study|Death|2|||
48946696|NCT01753518|157634762|FG000|Postpartum Follow-up|Lost to Follow-up|22|||
48946697|NCT01753518|157634763|FG001|Postpartum Follow-up|Lost to Follow-up|15|||
48946698|NCT00532259|157634764|FG000|Overall Study|Withdrawal by Subject|2|||
48946699|NCT00532259|157634764|FG000|Overall Study|Adverse Event|1|||
48946700|NCT00532259|157634764|FG000|Overall Study|Death|1|||
48946701|NCT00532259|157634764|FG000|Overall Study|Lack of Efficacy|21|||
48946702|NCT00532259|157634764|FG000|Overall Study|Lost to Follow-up|3|||
48946703|NCT00532259|157634764|FG000|Overall Study|Physician Decision|3|||
48946704|NCT00532259|157634764|FG000|Overall Study|Protocol Violation|1|||
48946705|NCT00871858|157634767|FG000|Overall Study|Protocol Violation|3|||
48946706|NCT00871858|157634768|FG001|Overall Study|Protocol Violation|4|||
48946707|NCT00871858|157634767|FG000|Overall Study|Adverse Event|1|||
48946708|NCT00871858|157634768|FG001|Overall Study|Adverse Event|1|||
48946709|NCT00871858|157634767|FG000|Overall Study|Withdrawal by Subject|1|||
48946710|NCT00871858|157634768|FG001|Overall Study|Withdrawal by Subject|1|||
48946711|NCT00871858|157634767|FG000|Overall Study|Lost to Follow-up|0|||
48946712|NCT00871858|157634768|FG001|Overall Study|Lost to Follow-up|1|||
48946713|NCT03429556|157634779|FG000|Overall Study|Lost to Follow-up|0|||
48946714|NCT03429556|157634780|FG001|Overall Study|Lost to Follow-up|1|||
48946715|NCT03429556|157634781|FG002|Overall Study|Lost to Follow-up|0|||
48946716|NCT03429556|157634782|FG003|Overall Study|Lost to Follow-up|0|||
48946717|NCT02332915|157634785|FG000|Overall Study|Moved out of region|3|||
48946718|NCT02332915|157634786|FG001|Overall Study|Moved out of region|0|||
48946719|NCT02332915|157634785|FG000|Overall Study|Unrelated illness|1|||
48946720|NCT02332915|157634786|FG001|Overall Study|Unrelated illness|1|||
48946721|NCT02332915|157634785|FG000|Overall Study|Travel distance prohibitive|0|||
48946722|NCT02332915|157634786|FG001|Overall Study|Travel distance prohibitive|1|||
48946723|NCT02332915|157634785|FG000|Overall Study|did not meet inclusion criteria|2|||
48946724|NCT02332915|157634786|FG001|Overall Study|did not meet inclusion criteria|4|||
48946725|NCT01769404|157634787|FG000|Treatment Period 1|Did not meet eligibility criteria|1|||
48737105|NCT02128932|156888001|FG000|Overall Study|Lost to Follow-up|2|||
48946726|NCT01769404|157634788|FG001|Treatment Period 1|Did not meet eligibility criteria|0|||
48946727|NCT01769404|157634787|FG000|Treatment Period 1|Withdrawal by Subject|3|||
48946728|NCT01769404|157634788|FG001|Treatment Period 1|Withdrawal by Subject|0|||
48946729|NCT01769404|157634787|FG000|Treatment Period 1|Sponsor decision|1|||
48946730|NCT01769404|157634788|FG001|Treatment Period 1|Sponsor decision|0|||
48946731|NCT01769404|157634787|FG000|Treatment Period 2|Sponsor decision|7|||
48946732|NCT01769404|157634788|FG001|Treatment Period 2|Sponsor decision|0|||
48946733|NCT00377299|157634789|FG000|Overall Study|Lost to Follow-up|14|||
48946734|NCT00377299|157634790|FG001|Overall Study|Lost to Follow-up|19|||
48946735|NCT00377299|157634789|FG000|Overall Study|Adverse Event|0|||
48946736|NCT00377299|157634790|FG001|Overall Study|Adverse Event|1|||
48946737|NCT00377299|157634789|FG000|Overall Study|Withdrawal by Subject|5|||
48946738|NCT00377299|157634790|FG001|Overall Study|Withdrawal by Subject|4|||
48946739|NCT02522481|157634795|FG000|Overall Study|discontinued|1|||
48946740|NCT02522481|157634795|FG000|Overall Study|Not dosed|2|||
48946741|NCT00538733|157634796|FG000|Overall Study|Adverse Event|8|||
48946742|NCT00538733|157634796|FG000|Overall Study|Death|1|||
48946743|NCT00538733|157634796|FG000|Overall Study|declined to participate|2|||
48946744|NCT00538733|157634796|FG000|Overall Study|still on therapy|1|||
48946745|NCT01137435|157634798|FG000|Overall Study|Lost to Follow-up|24|||
48946746|NCT01137435|157634798|FG000|Overall Study|Off label usage|4|||
48946747|NCT03607682|157634799|FG000|Overall Study|Withdrawal by Subject|1|||
48946748|NCT03607682|157634799|FG000|Overall Study|Disease progression|1|||
48737106|NCT02128932|156888002|FG001|Overall Study|Lost to Follow-up|1|||
48737107|NCT02128932|156888003|FG002|Overall Study|Lost to Follow-up|1|||
48737108|NCT02128932|156888001|FG000|Overall Study|No reason for withdrawal|12|||
48737109|NCT02128932|156888002|FG001|Overall Study|No reason for withdrawal|11|||
48737110|NCT02128932|156888003|FG002|Overall Study|No reason for withdrawal|7|||
48737111|NCT01361568|156888004|FG000|Overall Study|Adverse Event|0|||
48737112|NCT01361568|156888005|FG001|Overall Study|Adverse Event|0|||
48737113|NCT01361568|156888006|FG002|Overall Study|Adverse Event|0|||
48737114|NCT01361568|156888007|FG003|Overall Study|Adverse Event|0|||
48737115|NCT01361568|156888008|FG004|Overall Study|Adverse Event|1|||
48737116|NCT01361568|156888009|FG005|Overall Study|Adverse Event|0|||
48946749|NCT00336492|157634800|FG000|Overall Study|Adverse Event|4|||
48946750|NCT00336492|157634801|FG001|Overall Study|Adverse Event|3|||
48946751|NCT00336492|157634802|FG002|Overall Study|Adverse Event|6|||
48946752|NCT00336492|157634800|FG000|Overall Study|Lack of Efficacy|6|||
48737117|NCT01361568|156888004|FG000|Overall Study|Physician Decision|0|||
48946753|NCT00336492|157634801|FG001|Overall Study|Lack of Efficacy|1|||
48946754|NCT00336492|157634802|FG002|Overall Study|Lack of Efficacy|4|||
48946755|NCT00336492|157634800|FG000|Overall Study|Other|5|||
48946756|NCT00336492|157634801|FG001|Overall Study|Other|0|||
48946757|NCT00336492|157634802|FG002|Overall Study|Other|1|||
48946758|NCT03518840|157636356|FG000|Overall Study|Lost to Follow-up|6|||
48946759|NCT05165394|157636357|FG000|Overall Study|Withdrawal by Subject|5|||
48946760|NCT05165394|157636358|FG001|Overall Study|Withdrawal by Subject|1|||
48946761|NCT05165394|157636357|FG000|Overall Study|Lost to Follow-up|1|||
48737118|NCT01361568|156888005|FG001|Overall Study|Physician Decision|0|||
48737119|NCT01361568|156888006|FG002|Overall Study|Physician Decision|0|||
48737120|NCT01361568|156888007|FG003|Overall Study|Physician Decision|0|||
48737121|NCT01361568|156888008|FG004|Overall Study|Physician Decision|0|||
48737122|NCT01361568|156888009|FG005|Overall Study|Physician Decision|1|||
48737123|NCT01361568|156888004|FG000|Overall Study|Withdrawal by Subject|2|||
48737124|NCT01361568|156888005|FG001|Overall Study|Withdrawal by Subject|1|||
48737125|NCT01361568|156888006|FG002|Overall Study|Withdrawal by Subject|0|||
48737126|NCT01361568|156888007|FG003|Overall Study|Withdrawal by Subject|0|||
48737127|NCT01361568|156888008|FG004|Overall Study|Withdrawal by Subject|0|||
48737128|NCT01361568|156888009|FG005|Overall Study|Withdrawal by Subject|1|||
48737129|NCT04154930|156888012|FG000|Overall Study|Withdrawal by Subject|15|||
48737130|NCT04154930|156888013|FG001|Overall Study|Withdrawal by Subject|6|||
48737131|NCT04154930|156888012|FG000|Overall Study|Withdrew consent- Covid-19 related|2|||
48737132|NCT04154930|156888013|FG001|Overall Study|Withdrew consent- Covid-19 related|1|||
48737133|NCT04154930|156888012|FG000|Overall Study|Lost to Follow-up|14|||
48737134|NCT04154930|156888013|FG001|Overall Study|Lost to Follow-up|6|||
48737135|NCT04154930|156888012|FG000|Overall Study|Other|6|||
48737136|NCT04154930|156888013|FG001|Overall Study|Other|0|||
48737137|NCT02106975|156888014|FG000|Overall Study|Death|25|||
48737138|NCT02106975|156888015|FG001|Overall Study|Death|39|||
48737139|NCT01254630|156888016|FG000|Overall Study|Adverse Event|36|||
48737140|NCT01254630|156888017|FG001|Overall Study|Adverse Event|15|||
48737141|NCT01254630|156888018|FG002|Overall Study|Adverse Event|40|||
48737142|NCT01254630|156888019|FG003|Overall Study|Adverse Event|8|||
48737143|NCT01254630|156888016|FG000|Overall Study|Death|461|||
48737144|NCT01254630|156888017|FG001|Overall Study|Death|151|||
48737145|NCT01254630|156888018|FG002|Overall Study|Death|478|||
48737146|NCT01254630|156888019|FG003|Overall Study|Death|139|||
48737147|NCT01254630|156888016|FG000|Overall Study|Lost to Follow-up|80|||
48737148|NCT01254630|156888017|FG001|Overall Study|Lost to Follow-up|26|||
48737149|NCT01254630|156888018|FG002|Overall Study|Lost to Follow-up|89|||
48737150|NCT01254630|156888019|FG003|Overall Study|Lost to Follow-up|32|||
48737151|NCT01254630|156888016|FG000|Overall Study|Physician Decision|24|||
48737152|NCT01254630|156888017|FG001|Overall Study|Physician Decision|8|||
48737153|NCT01254630|156888018|FG002|Overall Study|Physician Decision|16|||
48737154|NCT01254630|156888019|FG003|Overall Study|Physician Decision|7|||
48737155|NCT01254630|156888016|FG000|Overall Study|Withdrawal by Subject|201|||
48737156|NCT01254630|156888017|FG001|Overall Study|Withdrawal by Subject|94|||
48737157|NCT01254630|156888018|FG002|Overall Study|Withdrawal by Subject|188|||
48737158|NCT01254630|156888019|FG003|Overall Study|Withdrawal by Subject|89|||
48737159|NCT01254630|156888016|FG000|Overall Study|Study terminated by sponsor|0|||
48737160|NCT01254630|156888017|FG001|Overall Study|Study terminated by sponsor|994|||
48737161|NCT01254630|156888018|FG002|Overall Study|Study terminated by sponsor|0|||
48737162|NCT01254630|156888019|FG003|Overall Study|Study terminated by sponsor|1010|||
48737163|NCT01254630|156888016|FG000|Overall Study|Status not recorded|0|||
48737164|NCT01254630|156888017|FG001|Overall Study|Status not recorded|0|||
48737165|NCT01254630|156888018|FG002|Overall Study|Status not recorded|1|||
48737166|NCT01254630|156888019|FG003|Overall Study|Status not recorded|0|||
48737167|NCT00241358|156888022|FG000|Overall Study|Determined to be not ineligible|0|||
48737168|NCT00241358|156888023|FG001|Overall Study|Determined to be not ineligible|1|||
48737169|NCT00241358|156888024|FG002|Overall Study|Determined to be not ineligible|1|||
48737170|NCT01758523|156888029|FG000|Overall Study|Adverse Event|2|||
48737171|NCT01758523|156888030|FG001|Overall Study|Adverse Event|1|||
48737172|NCT01758523|156888029|FG000|Overall Study|Lack of Efficacy|4|||
48737173|NCT01758523|156888030|FG001|Overall Study|Lack of Efficacy|2|||
48737174|NCT01758523|156888029|FG000|Overall Study|Lost to Follow-up|3|||
48737175|NCT01758523|156888030|FG001|Overall Study|Lost to Follow-up|4|||
48737176|NCT01758523|156888029|FG000|Overall Study|Withdrawal by Subject|12|||
48737177|NCT01758523|156888030|FG001|Overall Study|Withdrawal by Subject|7|||
48737178|NCT04729621|156888031|FG000|Main Treatment Period (Week1 to Week 52)|Adverse Event|3|||
48737179|NCT04729621|156888032|FG001|Main Treatment Period (Week1 to Week 52)|Adverse Event|7|||
48737180|NCT04729621|156888033|FG002|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
48737181|NCT04729621|156888034|FG003|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
48737182|NCT04729621|156888035|FG004|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
48737183|NCT04729621|156888031|FG000|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|13|||
48737184|NCT04729621|156888032|FG001|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|12|||
48737185|NCT04729621|156888033|FG002|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
48946762|NCT05165394|157636358|FG001|Overall Study|Lost to Follow-up|2|||
48737186|NCT04729621|156888034|FG003|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
48737187|NCT04729621|156888035|FG004|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
48737188|NCT04729621|156888031|FG000|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|2|||
48737189|NCT04729621|156888032|FG001|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|4|||
48737190|NCT04729621|156888033|FG002|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
48946763|NCT05165394|157636357|FG000|Overall Study|Other Than Specified|0|||
48737191|NCT04729621|156888034|FG003|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
48737192|NCT04729621|156888035|FG004|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
48737193|NCT04729621|156888031|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
48737194|NCT04729621|156888032|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
48737195|NCT04729621|156888033|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|7|||
48737196|NCT04729621|156888034|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|2|||
48737197|NCT04729621|156888035|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
48737198|NCT04729621|156888031|FG000|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
48737199|NCT04729621|156888032|FG001|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
48737200|NCT04729621|156888033|FG002|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
48737201|NCT04729621|156888034|FG003|Transition Period (Week 52 to Week 78)|Lost to Follow-up|1|||
48737202|NCT04729621|156888035|FG004|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
48737203|NCT04729621|156888031|FG000|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
48737204|NCT04729621|156888032|FG001|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
48737205|NCT04729621|156888033|FG002|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
48737206|NCT04729621|156888034|FG003|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|2|||
48737207|NCT04729621|156888035|FG004|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
48737208|NCT02925117|156888036|FG000|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
48737209|NCT02925117|156888037|FG001|Period 1 (Weeks 0 - 16)|Adverse Event|3|||
48737210|NCT02925117|156888038|FG002|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
48737211|NCT02925117|156888039|FG003|Period 1 (Weeks 0 - 16)|Adverse Event|2|||
48737212|NCT02925117|156888040|FG004|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
48737213|NCT02925117|156888041|FG005|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
48737214|NCT02925117|156888042|FG006|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
48737215|NCT02925117|156888043|FG007|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
48737216|NCT02925117|156888044|FG008|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
48737217|NCT02925117|156888045|FG009|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
48737218|NCT02925117|156888046|FG010|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
48737219|NCT02925117|156888047|FG011|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
48737220|NCT02925117|156888036|FG000|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10|||
48737221|NCT02925117|156888037|FG001|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
48737222|NCT02925117|156888038|FG002|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
48737223|NCT02925117|156888039|FG003|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
48737224|NCT02925117|156888040|FG004|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
48737225|NCT02925117|156888041|FG005|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
48737226|NCT02925117|156888042|FG006|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
48737227|NCT02925117|156888043|FG007|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
48737228|NCT02925117|156888044|FG008|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
48737229|NCT02925117|156888045|FG009|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
48737230|NCT02925117|156888046|FG010|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
48737231|NCT02925117|156888047|FG011|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
48737232|NCT02925117|156888036|FG000|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2|||
48737233|NCT02925117|156888037|FG001|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1|||
48737234|NCT02925117|156888038|FG002|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
48737235|NCT02925117|156888039|FG003|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
48737236|NCT02925117|156888040|FG004|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
48737237|NCT02925117|156888041|FG005|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
48737238|NCT02925117|156888042|FG006|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
48737239|NCT02925117|156888043|FG007|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
48737240|NCT02925117|156888044|FG008|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
48737241|NCT02925117|156888045|FG009|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
48737242|NCT02925117|156888046|FG010|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
48737243|NCT02925117|156888047|FG011|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
48737244|NCT02925117|156888036|FG000|Period 1 (Weeks 0 - 16)|Other|5|||
48737245|NCT02925117|156888037|FG001|Period 1 (Weeks 0 - 16)|Other|4|||
48737246|NCT02925117|156888038|FG002|Period 1 (Weeks 0 - 16)|Other|1|||
48737247|NCT02925117|156888039|FG003|Period 1 (Weeks 0 - 16)|Other|1|||
48737248|NCT02925117|156888040|FG004|Period 1 (Weeks 0 - 16)|Other|0|||
48737249|NCT02925117|156888041|FG005|Period 1 (Weeks 0 - 16)|Other|0|||
48737250|NCT02925117|156888042|FG006|Period 1 (Weeks 0 - 16)|Other|0|||
48737251|NCT02925117|156888043|FG007|Period 1 (Weeks 0 - 16)|Other|0|||
48737252|NCT02925117|156888044|FG008|Period 1 (Weeks 0 - 16)|Other|0|||
48946764|NCT05165394|157636358|FG001|Overall Study|Other Than Specified|1|||
48946765|NCT00001259|157636359|FG000|Study 2|Adverse Event|0|||
48946766|NCT00001259|157636360|FG001|Study 2|Adverse Event|0|||
48946767|NCT00001259|157636361|FG002|Study 2|Adverse Event|0|||
48946768|NCT00001259|157636362|FG003|Study 2|Adverse Event|0|||
48946769|NCT00001259|157636363|FG004|Study 2|Adverse Event|2|||
48946770|NCT00001259|157636364|FG005|Study 2|Adverse Event|0|||
48946771|NCT00001259|157636365|FG006|Study 2|Adverse Event|0|||
48946772|NCT03366844|157636370|FG000|Overall Study|Physician Decision|1|||
48946773|NCT03366844|157636370|FG000|Overall Study|Unevaluable for co-primary endpoint (did not complete all required biopsies)|5|||
48946774|NCT00886821|157636371|FG000|Stage 2|Adverse Event|0|||
48946775|NCT00886821|157636372|FG001|Stage 2|Adverse Event|0|||
48946776|NCT00886821|157636373|FG002|Stage 2|Adverse Event|0|||
48946777|NCT00886821|157636374|FG003|Stage 2|Adverse Event|0|||
48946778|NCT00886821|157636375|FG004|Stage 2|Adverse Event|0|||
48946779|NCT00886821|157636376|FG005|Stage 2|Adverse Event|0|||
48946780|NCT00886821|157636377|FG006|Stage 2|Adverse Event|0|||
48946781|NCT00886821|157636378|FG007|Stage 2|Adverse Event|0|||
48946782|NCT00886821|157636379|FG008|Stage 2|Adverse Event|0|||
48737253|NCT02925117|156888045|FG009|Period 1 (Weeks 0 - 16)|Other|0|||
48737254|NCT02925117|156888046|FG010|Period 1 (Weeks 0 - 16)|Other|0|||
48946783|NCT00886821|157636380|FG009|Stage 2|Adverse Event|0|||
48946784|NCT00886821|157636381|FG010|Stage 2|Adverse Event|0|||
48946785|NCT00886821|157636382|FG011|Stage 2|Adverse Event|1|||
48946786|NCT00886821|157636383|FG012|Stage 2|Adverse Event|3|||
48946787|NCT00886821|157636384|FG013|Stage 2|Adverse Event|0|||
48946788|NCT00886821|157636371|FG000|Stage 2|Lost to Follow-up|0|||
48946789|NCT00886821|157636372|FG001|Stage 2|Lost to Follow-up|0|||
48737255|NCT02925117|156888047|FG011|Period 1 (Weeks 0 - 16)|Other|0|||
48737256|NCT02925117|156888036|FG000|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
48737257|NCT02925117|156888037|FG001|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
48737258|NCT02925117|156888038|FG002|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
48737259|NCT02925117|156888039|FG003|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
48737260|NCT02925117|156888040|FG004|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
48737261|NCT02925117|156888041|FG005|Period 2 (Weeks 16 - 88)|Adverse Event|1|||
48737262|NCT02925117|156888042|FG006|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
48737263|NCT02925117|156888043|FG007|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
48737264|NCT02925117|156888044|FG008|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
48852607|NCT03732807|157299638|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
48852608|NCT03732807|157299639|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
48852609|NCT03732807|157299640|FG003|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
48852610|NCT03732807|157299641|FG004|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
48852611|NCT03732807|157299642|FG005|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
48852612|NCT03732807|157299643|FG006|Treatment Period (up to Week 24)|Withdrawal by Subject|2|||
48852613|NCT03732807|157299637|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
48852614|NCT03732807|157299638|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
48852615|NCT03732807|157299639|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
48852616|NCT03732807|157299640|FG003|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
48852617|NCT03732807|157299641|FG004|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
48852618|NCT03732807|157299642|FG005|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
48852619|NCT03732807|157299643|FG006|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
48852620|NCT03732807|157299637|FG000|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
48852621|NCT03732807|157299638|FG001|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
48852622|NCT03732807|157299639|FG002|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
48852623|NCT03732807|157299640|FG003|Treatment Extension (Week 25 up to 48)|Adverse Event|1|||
48852624|NCT03732807|157299641|FG004|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
48852625|NCT03732807|157299642|FG005|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
48737265|NCT02925117|156888045|FG009|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
48737266|NCT02925117|156888046|FG010|Period 2 (Weeks 16 - 88)|Adverse Event|3|||
48737267|NCT02925117|156888047|FG011|Period 2 (Weeks 16 - 88)|Adverse Event|2|||
48737268|NCT02925117|156888036|FG000|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
48737269|NCT02925117|156888037|FG001|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
48737270|NCT02925117|156888038|FG002|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
48737271|NCT02925117|156888039|FG003|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
48737272|NCT02925117|156888040|FG004|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
48737273|NCT02925117|156888041|FG005|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1|||
48737274|NCT02925117|156888042|FG006|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4|||
48852626|NCT03732807|157299643|FG006|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
48737275|NCT02925117|156888043|FG007|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3|||
48737276|NCT02925117|156888044|FG008|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
48737277|NCT02925117|156888045|FG009|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
48852627|NCT03732807|157299637|FG000|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|2|||
48852628|NCT03732807|157299638|FG001|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
48852629|NCT03732807|157299639|FG002|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
48852630|NCT03732807|157299640|FG003|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
48852631|NCT03732807|157299641|FG004|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
48852632|NCT03732807|157299642|FG005|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
48852633|NCT03732807|157299643|FG006|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
48852634|NCT03732807|157299637|FG000|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
48852635|NCT03732807|157299638|FG001|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
48852636|NCT03732807|157299639|FG002|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
48852637|NCT03732807|157299640|FG003|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
48852638|NCT03732807|157299641|FG004|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
48852639|NCT03732807|157299642|FG005|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
48852640|NCT03732807|157299643|FG006|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
48852641|NCT03732807|157299637|FG000|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
48852642|NCT03732807|157299638|FG001|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|1|||
48852643|NCT03732807|157299639|FG002|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
48852644|NCT03732807|157299640|FG003|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
48852645|NCT03732807|157299641|FG004|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
48852646|NCT03732807|157299642|FG005|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
48852647|NCT03732807|157299643|FG006|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
48852648|NCT03732807|157299637|FG000|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
48852649|NCT03732807|157299638|FG001|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
48737278|NCT02925117|156888046|FG010|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
48737279|NCT02925117|156888047|FG011|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
48737280|NCT02925117|156888036|FG000|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
48737281|NCT02925117|156888037|FG001|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
48737282|NCT02925117|156888038|FG002|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
48737283|NCT02925117|156888039|FG003|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
48737284|NCT02925117|156888040|FG004|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
48737285|NCT02925117|156888041|FG005|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2|||
48737286|NCT02925117|156888042|FG006|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
48737287|NCT02925117|156888043|FG007|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
48737288|NCT02925117|156888044|FG008|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
48737289|NCT02925117|156888045|FG009|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
48737290|NCT02925117|156888046|FG010|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
48737291|NCT02925117|156888047|FG011|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
48737292|NCT02925117|156888036|FG000|Period 2 (Weeks 16 - 88)|Other|0|||
48737293|NCT02925117|156888037|FG001|Period 2 (Weeks 16 - 88)|Other|0|||
48737294|NCT02925117|156888038|FG002|Period 2 (Weeks 16 - 88)|Other|0|||
48737295|NCT02925117|156888039|FG003|Period 2 (Weeks 16 - 88)|Other|0|||
48737296|NCT02925117|156888040|FG004|Period 2 (Weeks 16 - 88)|Other|1|||
48737297|NCT02925117|156888041|FG005|Period 2 (Weeks 16 - 88)|Other|1|||
48737298|NCT02925117|156888042|FG006|Period 2 (Weeks 16 - 88)|Other|1|||
48737299|NCT02925117|156888043|FG007|Period 2 (Weeks 16 - 88)|Other|1|||
48737300|NCT02925117|156888044|FG008|Period 2 (Weeks 16 - 88)|Other|3|||
48737301|NCT02925117|156888045|FG009|Period 2 (Weeks 16 - 88)|Other|4|||
48737302|NCT02925117|156888046|FG010|Period 2 (Weeks 16 - 88)|Other|3|||
48737303|NCT02925117|156888047|FG011|Period 2 (Weeks 16 - 88)|Other|0|||
48737304|NCT04032652|156888048|FG000|Overall Study|The study was terminated and the PI has|1|||
48737305|NCT04032652|156888049|FG001|Overall Study|The study was terminated and the PI has|1|||
48737306|NCT02663908|156888050|FG000|Overall Study|Withdrawal by Subject|8|||
48737307|NCT02663908|156888051|FG001|Overall Study|Withdrawal by Subject|5|||
48737308|NCT02663908|156888050|FG000|Overall Study|Lost to Follow-up|1|||
48737309|NCT02663908|156888051|FG001|Overall Study|Lost to Follow-up|5|||
48737310|NCT02663908|156888050|FG000|Overall Study|Adverse Event|13|||
48737311|NCT02663908|156888051|FG001|Overall Study|Adverse Event|11|||
48737312|NCT02663908|156888050|FG000|Overall Study|Protocol Violation|1|||
48737313|NCT02663908|156888051|FG001|Overall Study|Protocol Violation|2|||
48737314|NCT02663908|156888050|FG000|Overall Study|Lack of therapeutic response|2|||
48737315|NCT02663908|156888051|FG001|Overall Study|Lack of therapeutic response|0|||
48737316|NCT02663908|156888050|FG000|Overall Study|COVID-19|1|||
48737317|NCT02663908|156888051|FG001|Overall Study|COVID-19|0|||
48737318|NCT02663908|156888050|FG000|Overall Study|Site closed|1|||
48737319|NCT02663908|156888051|FG001|Overall Study|Site closed|0|||
48737320|NCT02663908|156888050|FG000|Overall Study|Subject to begin treatment with an exclusionary medication|1|||
48737321|NCT02663908|156888051|FG001|Overall Study|Subject to begin treatment with an exclusionary medication|0|||
48737322|NCT02663908|156888050|FG000|Overall Study|Subject ended trial due to being prescribed prohibited medication|1|||
48852650|NCT03732807|157299639|FG002|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
48852651|NCT03732807|157299640|FG003|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
48852652|NCT03732807|157299641|FG004|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
48852653|NCT03732807|157299642|FG005|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
48852654|NCT03732807|157299643|FG006|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
48852655|NCT03732807|157299637|FG000|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|3|||
48852656|NCT03732807|157299638|FG001|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|2|||
48737323|NCT02663908|156888051|FG001|Overall Study|Subject ended trial due to being prescribed prohibited medication|0|||
48737324|NCT02663908|156888050|FG000|Overall Study|Intolerance to FIRMAGON therapy|1|||
48737325|NCT02663908|156888051|FG001|Overall Study|Intolerance to FIRMAGON therapy|0|||
48737326|NCT02663908|156888050|FG000|Overall Study|Death|1|||
48737327|NCT02663908|156888051|FG001|Overall Study|Death|0|||
48737328|NCT02663908|156888050|FG000|Overall Study|Subject randomized in error and did not receive the IMP|1|||
48737329|NCT02663908|156888051|FG001|Overall Study|Subject randomized in error and did not receive the IMP|0|||
48737330|NCT02663908|156888050|FG000|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|0|||
48737331|NCT02663908|156888051|FG001|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|1|||
48737332|NCT02906332|156888053|FG000|Overall Study|Withdrawal by Subject|1|||
48737333|NCT00913380|156888054|FG000|Clinical Outcomes|Lost to Follow-up|6|||
48737334|NCT00913380|156888055|FG001|Clinical Outcomes|Lost to Follow-up|6|||
48737335|NCT00181155|156888056|FG000|Overall Study|Physician Decision|1|||
48737336|NCT00181155|156888057|FG001|Overall Study|Physician Decision|0|||
48737337|NCT00181155|156888056|FG000|Overall Study|Withdrawal by Subject|1|||
48737338|NCT00181155|156888057|FG001|Overall Study|Withdrawal by Subject|0|||
48737339|NCT01788228|156888058|FG000|Overall Study|Migrated/moved from study area|1|||
48737340|NCT01788228|156888059|FG001|Overall Study|Migrated/moved from study area|0|||
48737341|NCT00370071|156888060|FG000|Overall Study|Withdrawal by Subject|2|||
48737342|NCT01548287|156888061|FG000|Screening|No reason provided|0|||
48737343|NCT01548287|156888062|FG001|Screening|No reason provided|0|||
48737344|NCT01548287|156888063|FG002|Screening|No reason provided|0|||
48737345|NCT01548287|156888064|FG003|Screening|No reason provided|0|||
48737346|NCT01548287|156888065|FG004|Screening|No reason provided|9|||
48737347|NCT01548287|156888061|FG000|Screening|Did not meet eligibility criteria|0|||
48737348|NCT01548287|156888062|FG001|Screening|Did not meet eligibility criteria|0|||
48737349|NCT01548287|156888063|FG002|Screening|Did not meet eligibility criteria|0|||
48737350|NCT01548287|156888064|FG003|Screening|Did not meet eligibility criteria|0|||
48737351|NCT01548287|156888065|FG004|Screening|Did not meet eligibility criteria|74|||
48737352|NCT01548287|156888061|FG000|Randomized Period|Did not meet inclusion criteria|0|||
48737353|NCT01548287|156888062|FG001|Randomized Period|Did not meet inclusion criteria|0|||
48737354|NCT01548287|156888063|FG002|Randomized Period|Did not meet inclusion criteria|2|||
48737355|NCT01548287|156888064|FG003|Randomized Period|Did not meet inclusion criteria|0|||
48737356|NCT01548287|156888065|FG004|Randomized Period|Did not meet inclusion criteria|0|||
48737357|NCT01548287|156888061|FG000|Randomized Period|Adverse Event|0|||
48737358|NCT01548287|156888062|FG001|Randomized Period|Adverse Event|2|||
48737359|NCT01548287|156888063|FG002|Randomized Period|Adverse Event|5|||
48737360|NCT01548287|156888064|FG003|Randomized Period|Adverse Event|0|||
48737361|NCT01548287|156888065|FG004|Randomized Period|Adverse Event|0|||
48737362|NCT02762578|156888066|FG000|Overall Study|Adverse Event|1|||
48737363|NCT02762578|156888067|FG001|Overall Study|Adverse Event|6|||
48737364|NCT02762578|156888066|FG000|Overall Study|Protocol Violation|4|||
48737365|NCT02762578|156888067|FG001|Overall Study|Protocol Violation|2|||
48737366|NCT02762578|156888066|FG000|Overall Study|Withdrawal by Subject|4|||
48737367|NCT02762578|156888067|FG001|Overall Study|Withdrawal by Subject|2|||
48737368|NCT02762578|156888066|FG000|Overall Study|Unclassified|6|||
48737369|NCT02762578|156888067|FG001|Overall Study|Unclassified|0|||
48737370|NCT02083965|156888068|FG000|Treatment Period|Other|1|||
48737371|NCT02083965|156888069|FG001|Treatment Period|Other|0|||
48737372|NCT01128842|156888072|FG000|Overall Study|Adverse Event|1|||
48737373|NCT01128842|156888072|FG000|Overall Study|Disease Progression|6|||
48737374|NCT02405780|156888073|FG000|Period I|Adverse Event|8|||
48737375|NCT02405780|156888074|FG001|Period I|Adverse Event|0|||
48737376|NCT02405780|156888075|FG002|Period I|Adverse Event|3|||
48737377|NCT02405780|156888076|FG003|Period I|Adverse Event|7|||
48737378|NCT02405780|156888073|FG000|Period I|Medical reasons|1|||
48737379|NCT02405780|156888074|FG001|Period I|Medical reasons|1|||
48737380|NCT02405780|156888075|FG002|Period I|Medical reasons|0|||
48946790|NCT00886821|157636373|FG002|Stage 2|Lost to Follow-up|0|||
48737381|NCT02405780|156888076|FG003|Period I|Medical reasons|1|||
48737382|NCT02405780|156888073|FG000|Period I|Screening Failure|1|||
48737383|NCT02405780|156888074|FG001|Period I|Screening Failure|0|||
48737384|NCT02405780|156888075|FG002|Period I|Screening Failure|1|||
48737385|NCT02405780|156888076|FG003|Period I|Screening Failure|0|||
48737386|NCT02405780|156888073|FG000|Period I|Withdrawal by Subject|9|||
48737387|NCT02405780|156888074|FG001|Period I|Withdrawal by Subject|1|||
48737388|NCT02405780|156888075|FG002|Period I|Withdrawal by Subject|3|||
48737389|NCT02405780|156888076|FG003|Period I|Withdrawal by Subject|4|||
48737390|NCT02405780|156888073|FG000|Period I|Non-compliance with study procedures|8|||
48737391|NCT02405780|156888074|FG001|Period I|Non-compliance with study procedures|6|||
48737392|NCT02405780|156888075|FG002|Period I|Non-compliance with study procedures|8|||
48737393|NCT02405780|156888076|FG003|Period I|Non-compliance with study procedures|11|||
48737394|NCT02405780|156888073|FG000|Period II|Adverse Event|3|||
48737395|NCT02405780|156888074|FG001|Period II|Adverse Event|5|||
48737396|NCT02405780|156888075|FG002|Period II|Adverse Event|4|||
48737397|NCT02405780|156888076|FG003|Period II|Adverse Event|11|||
48737398|NCT02405780|156888073|FG000|Period II|Medical reason|0|||
48946791|NCT00886821|157636374|FG003|Stage 2|Lost to Follow-up|0|||
48946792|NCT00886821|157636375|FG004|Stage 2|Lost to Follow-up|0|||
48946793|NCT00886821|157636376|FG005|Stage 2|Lost to Follow-up|0|||
48946794|NCT00886821|157636377|FG006|Stage 2|Lost to Follow-up|0|||
48946795|NCT00886821|157636378|FG007|Stage 2|Lost to Follow-up|0|||
48946796|NCT00886821|157636379|FG008|Stage 2|Lost to Follow-up|0|||
48946797|NCT00886821|157636380|FG009|Stage 2|Lost to Follow-up|0|||
48946798|NCT00886821|157636381|FG010|Stage 2|Lost to Follow-up|0|||
48946799|NCT00886821|157636382|FG011|Stage 2|Lost to Follow-up|0|||
48946800|NCT00886821|157636383|FG012|Stage 2|Lost to Follow-up|2|||
48946801|NCT00886821|157636384|FG013|Stage 2|Lost to Follow-up|1|||
48946802|NCT02660580|157636385|FG000|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
48946803|NCT02660580|157636386|FG001|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
48946804|NCT02660580|157636387|FG002|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
48946805|NCT02660580|157636388|FG003|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
48946806|NCT02660580|157636389|FG004|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
48946807|NCT02660580|157636385|FG000|Core Treatment Period (Week 1 to 16)|Protocol Violation|3|||
48946808|NCT02660580|157636386|FG001|Core Treatment Period (Week 1 to 16)|Protocol Violation|1|||
48946809|NCT02660580|157636387|FG002|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
48946810|NCT02660580|157636388|FG003|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
48946811|NCT02660580|157636389|FG004|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
48946812|NCT02660580|157636385|FG000|Core Treatment Period (Week 1 to 16)|Other un-specified|1|||
48946813|NCT02660580|157636386|FG001|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
48946814|NCT02660580|157636387|FG002|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
48946815|NCT02660580|157636388|FG003|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
48946816|NCT02660580|157636389|FG004|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
48946817|NCT02660580|157636385|FG000|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
48946818|NCT02660580|157636386|FG001|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2|||
48946819|NCT02660580|157636387|FG002|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
48946820|NCT02660580|157636388|FG003|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
48946821|NCT02660580|157636389|FG004|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
48946822|NCT02660580|157636385|FG000|Core Treatment Period (Week 1 to 16)|Adverse Event|2|||
48946823|NCT02660580|157636386|FG001|Core Treatment Period (Week 1 to 16)|Adverse Event|9|||
48946824|NCT02660580|157636387|FG002|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
48946825|NCT02660580|157636388|FG003|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
48946826|NCT02660580|157636389|FG004|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
48946827|NCT02660580|157636385|FG000|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1|||
48946828|NCT02660580|157636386|FG001|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4|||
48946829|NCT02660580|157636387|FG002|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
48946830|NCT02660580|157636388|FG003|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
48946831|NCT02660580|157636389|FG004|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
48946832|NCT02660580|157636385|FG000|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1|||
48946833|NCT02660580|157636386|FG001|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2|||
48946834|NCT02660580|157636387|FG002|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
48946835|NCT02660580|157636388|FG003|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
48946836|NCT02660580|157636389|FG004|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
48946837|NCT02660580|157636385|FG000|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
48946838|NCT02660580|157636386|FG001|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
48946839|NCT02660580|157636387|FG002|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2|||
48946840|NCT02660580|157636388|FG003|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
48946841|NCT02660580|157636389|FG004|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1|||
48946842|NCT02660580|157636385|FG000|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
48946843|NCT02660580|157636386|FG001|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
48737399|NCT02405780|156888074|FG001|Period II|Medical reason|1|||
48737400|NCT02405780|156888075|FG002|Period II|Medical reason|0|||
48737401|NCT02405780|156888076|FG003|Period II|Medical reason|0|||
48737402|NCT02405780|156888073|FG000|Period II|Pregnancy|0|||
48737403|NCT02405780|156888074|FG001|Period II|Pregnancy|0|||
48946844|NCT02660580|157636387|FG002|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
48737404|NCT02405780|156888075|FG002|Period II|Pregnancy|1|||
48737405|NCT02405780|156888076|FG003|Period II|Pregnancy|0|||
48737406|NCT02405780|156888073|FG000|Period II|Withdrawal by Subject|7|||
48946845|NCT02660580|157636388|FG003|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
48946846|NCT02660580|157636389|FG004|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
48946847|NCT02660580|157636385|FG000|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
48946848|NCT02660580|157636386|FG001|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
48946849|NCT02660580|157636387|FG002|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4|||
48946850|NCT02660580|157636388|FG003|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
48946851|NCT02660580|157636389|FG004|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
48946852|NCT02660580|157636385|FG000|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
48946853|NCT02660580|157636386|FG001|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
48946854|NCT02660580|157636387|FG002|Extended Treatment Period(Week 16 to 52)|Adverse Event|8|||
48946855|NCT02660580|157636388|FG003|Extended Treatment Period(Week 16 to 52)|Adverse Event|6|||
48946856|NCT02660580|157636389|FG004|Extended Treatment Period(Week 16 to 52)|Adverse Event|4|||
48946857|NCT02660580|157636385|FG000|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
48946858|NCT02660580|157636386|FG001|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
48946859|NCT02660580|157636387|FG002|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3|||
48946860|NCT02660580|157636388|FG003|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
48946861|NCT02660580|157636389|FG004|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
48946862|NCT02660580|157636385|FG000|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
48946863|NCT02660580|157636386|FG001|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
48946864|NCT02660580|157636387|FG002|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
48946865|NCT02660580|157636388|FG003|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
48946866|NCT02660580|157636389|FG004|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
48946867|NCT00128206|157636390|FG000|Overall Study|Lost to Follow-up|137|||
48946868|NCT00128206|157636391|FG001|Overall Study|Lost to Follow-up|118|||
48946869|NCT00128206|157636390|FG000|Overall Study|Adverse Event|0|||
48946870|NCT00128206|157636391|FG001|Overall Study|Adverse Event|2|||
48946871|NCT01853228|157636397|FG000|Phase 1|Lack of Efficacy|8|||
48946872|NCT01853228|157636398|FG001|Phase 1|Lack of Efficacy|0|||
48946873|NCT01853228|157636397|FG000|Phase 1|Other|1|||
48946874|NCT01853228|157636398|FG001|Phase 1|Other|0|||
48946875|NCT01853228|157636397|FG000|Phase 2|Physician Decision|0|||
48946876|NCT01853228|157636398|FG001|Phase 2|Physician Decision|1|||
48946877|NCT01853228|157636397|FG000|Phase 2|Proceed To Transplant|0|||
48946878|NCT01853228|157636398|FG001|Phase 2|Proceed To Transplant|3|||
48946879|NCT01853228|157636397|FG000|Phase 2|Lack of Efficacy|0|||
48946880|NCT01853228|157636398|FG001|Phase 2|Lack of Efficacy|4|||
48946881|NCT03167619|157636407|FG000|Overall Study|Death|11|||
48946882|NCT03167619|157636408|FG001|Overall Study|Death|8|||
48946883|NCT03167619|157636407|FG000|Overall Study|Withdrawal by Subject|1|||
48946884|NCT03167619|157636408|FG001|Overall Study|Withdrawal by Subject|2|||
48946885|NCT03167619|157636407|FG000|Overall Study|Physician Decision|0|||
48946886|NCT03167619|157636408|FG001|Overall Study|Physician Decision|1|||
48946887|NCT01416181|157636413|FG000|Part 1|Other|10|||
48946888|NCT01416181|157636414|FG001|Part 1|Other|24|||
48946889|NCT01416181|157636413|FG000|Part 1|Death|0|||
48946890|NCT01416181|157636414|FG001|Part 1|Death|1|||
48946891|NCT01416181|157636413|FG000|Part 1|Investigator Decision|7|||
48946892|NCT01416181|157636414|FG001|Part 1|Investigator Decision|6|||
48946893|NCT01416181|157636413|FG000|Part 1|Withdrawal by Subject|74|||
48946894|NCT01416181|157636414|FG001|Part 1|Withdrawal by Subject|48|||
48946895|NCT01416181|157636413|FG000|Part 1|Lack of Efficacy|16|||
48946896|NCT01416181|157636414|FG001|Part 1|Lack of Efficacy|8|||
48946897|NCT01416181|157636413|FG000|Part 1|Lost to Follow-up|1|||
48946898|NCT01416181|157636414|FG001|Part 1|Lost to Follow-up|1|||
48946899|NCT01416181|157636413|FG000|Part 1|Adverse Event|15|||
48946900|NCT01416181|157636414|FG001|Part 1|Adverse Event|18|||
48946901|NCT01416181|157636413|FG000|Part 1|Ongoing in Follow-Up|14|||
48946902|NCT01416181|157636414|FG001|Part 1|Ongoing in Follow-Up|8|||
48946903|NCT01416181|157636413|FG000|Part 2|Adverse Event|11|||
48946904|NCT01416181|157636414|FG001|Part 2|Adverse Event|4|||
48946905|NCT01416181|157636413|FG000|Part 2|Other|234|||
48946906|NCT01416181|157636414|FG001|Part 2|Other|267|||
48946907|NCT01416181|157636413|FG000|Part 2|Investigator Decision|6|||
48946908|NCT01416181|157636414|FG001|Part 2|Investigator Decision|7|||
48946909|NCT01416181|157636413|FG000|Part 2|Withdrawal by Subject|14|||
48946910|NCT01416181|157636414|FG001|Part 2|Withdrawal by Subject|5|||
48946911|NCT01416181|157636413|FG000|Part 2|Lack of Efficacy|4|||
48946912|NCT01416181|157636414|FG001|Part 2|Lack of Efficacy|1|||
48946913|NCT01416181|157636413|FG000|Part 2|Lost to Follow-up|2|||
48946914|NCT01416181|157636414|FG001|Part 2|Lost to Follow-up|2|||
48737407|NCT02405780|156888074|FG001|Period II|Withdrawal by Subject|4|||
48737408|NCT02405780|156888075|FG002|Period II|Withdrawal by Subject|0|||
48737409|NCT02405780|156888076|FG003|Period II|Withdrawal by Subject|3|||
48946915|NCT01821963|157636415|FG000|Overall Study|Adverse Event|1|||
48946916|NCT00663858|157636416|FG000|Overall Study|Adverse Event|9|||
48946917|NCT00663858|157636417|FG001|Overall Study|Adverse Event|1|||
48946918|NCT00663858|157636418|FG002|Overall Study|Adverse Event|6|||
48946919|NCT00663858|157636416|FG000|Overall Study|Lack of Efficacy|5|||
48946920|NCT00663858|157636417|FG001|Overall Study|Lack of Efficacy|1|||
48946921|NCT00663858|157636418|FG002|Overall Study|Lack of Efficacy|3|||
48946922|NCT00663858|157636416|FG000|Overall Study|Withdrawal by Subject|7|||
48946923|NCT00663858|157636417|FG001|Overall Study|Withdrawal by Subject|3|||
48946924|NCT00663858|157636418|FG002|Overall Study|Withdrawal by Subject|3|||
48946925|NCT00663858|157636416|FG000|Overall Study|Protocol Violation|5|||
48946926|NCT00663858|157636417|FG001|Overall Study|Protocol Violation|3|||
48946927|NCT00663858|157636418|FG002|Overall Study|Protocol Violation|4|||
48946928|NCT00663858|157636416|FG000|Overall Study|Other|8|||
48946929|NCT00663858|157636417|FG001|Overall Study|Other|2|||
48946930|NCT00663858|157636418|FG002|Overall Study|Other|4|||
48946931|NCT00443560|157636422|FG000|Overall Study|No intrathecal dose|58|||
48946932|NCT00443560|157636423|FG001|Overall Study|No intrathecal dose|26|||
48946933|NCT00443560|157636422|FG000|Overall Study|Multiple pregnancies or fetal demise|2|||
48946934|NCT00443560|157636423|FG001|Overall Study|Multiple pregnancies or fetal demise|4|||
48946935|NCT00686205|157636424|FG000|Overall Study|Protocol Violation|127|||
48946936|NCT00686205|157636425|FG001|Overall Study|Protocol Violation|0|||
48946937|NCT00686205|157636424|FG000|Overall Study|Withdrawal by Subject|2|||
48946938|NCT00686205|157636425|FG001|Overall Study|Withdrawal by Subject|0|||
48946939|NCT00686205|157636424|FG000|Overall Study|Specimen handling procedure altered|5878|||
48946940|NCT00686205|157636425|FG001|Overall Study|Specimen handling procedure altered|0|||
48946941|NCT00686205|157636424|FG000|Overall Study|Specimens not confirmed HIV positive|0|||
48946942|NCT00686205|157636425|FG001|Overall Study|Specimens not confirmed HIV positive|981|||
48946943|NCT03090191|157636430|FG000|Overall Study|Adverse Event|90|||
48946944|NCT03090191|157636431|FG001|Overall Study|Adverse Event|72|||
48946945|NCT03090191|157636430|FG000|Overall Study|Death|365|||
48946946|NCT03090191|157636431|FG001|Overall Study|Death|358|||
48946947|NCT03090191|157636430|FG000|Overall Study|Lost to Follow-up|382|||
48946948|NCT03090191|157636431|FG001|Overall Study|Lost to Follow-up|394|||
48946949|NCT03090191|157636430|FG000|Overall Study|Physician Decision|77|||
48946950|NCT03090191|157636431|FG001|Overall Study|Physician Decision|66|||
48946951|NCT03090191|157636430|FG000|Overall Study|Protocol Violation|43|||
48946952|NCT03090191|157636431|FG001|Overall Study|Protocol Violation|52|||
48737410|NCT02405780|156888073|FG000|Period II|Non-compliance with study procedures|5|||
48737411|NCT02405780|156888074|FG001|Period II|Non-compliance with study procedures|2|||
48737412|NCT02405780|156888075|FG002|Period II|Non-compliance with study procedures|7|||
48737413|NCT02405780|156888076|FG003|Period II|Non-compliance with study procedures|4|||
48946953|NCT03090191|157636430|FG000|Overall Study|Withdrawal by Subject|2160|||
48946954|NCT03090191|157636431|FG001|Overall Study|Withdrawal by Subject|2133|||
48946955|NCT03090191|157636430|FG000|Overall Study|Site terminated|7|||
48946956|NCT03090191|157636431|FG001|Overall Study|Site terminated|8|||
48946957|NCT03090191|157636430|FG000|Overall Study|Other|66|||
48946958|NCT03090191|157636431|FG001|Overall Study|Other|60|||
48946959|NCT03090191|157636430|FG000|Overall Study|Withdrawn before any study vaccination|43|||
48946960|NCT03090191|157636431|FG001|Overall Study|Withdrawn before any study vaccination|52|||
48946961|NCT04329949|157636435|FG000|Overall Study|Death|36|||
48946962|NCT04329949|157636435|FG000|Overall Study|Withdrawal by Subject|4|||
48946963|NCT04329949|157636435|FG000|Overall Study|Termination of study by sponsor|3|||
48946964|NCT03976401|157636436|FG000|Overall Study|Adverse Event|2|||
48946965|NCT03976401|157636437|FG001|Overall Study|Adverse Event|0|||
48946966|NCT03976401|157636438|FG002|Overall Study|Adverse Event|4|||
48946967|NCT03976401|157636439|FG003|Overall Study|Adverse Event|1|||
48946968|NCT03976401|157636440|FG004|Overall Study|Adverse Event|1|||
48946969|NCT03976401|157636441|FG005|Overall Study|Adverse Event|0|||
48946970|NCT03976401|157636436|FG000|Overall Study|Withdrawal by Subject|0|||
48946971|NCT03976401|157636437|FG001|Overall Study|Withdrawal by Subject|1|||
48946972|NCT03976401|157636438|FG002|Overall Study|Withdrawal by Subject|0|||
48946973|NCT03976401|157636439|FG003|Overall Study|Withdrawal by Subject|0|||
48946974|NCT03976401|157636440|FG004|Overall Study|Withdrawal by Subject|0|||
48946975|NCT03976401|157636441|FG005|Overall Study|Withdrawal by Subject|1|||
48946976|NCT03976401|157636436|FG000|Overall Study|Physician Decision|0|||
48946977|NCT03976401|157636437|FG001|Overall Study|Physician Decision|0|||
48946978|NCT03976401|157636438|FG002|Overall Study|Physician Decision|1|||
48946979|NCT03976401|157636439|FG003|Overall Study|Physician Decision|0|||
48946980|NCT03976401|157636440|FG004|Overall Study|Physician Decision|0|||
48946981|NCT03976401|157636441|FG005|Overall Study|Physician Decision|0|||
48946982|NCT03976401|157636436|FG000|Overall Study|Lost to Follow-up|1|||
48946983|NCT03976401|157636437|FG001|Overall Study|Lost to Follow-up|2|||
48946984|NCT03976401|157636438|FG002|Overall Study|Lost to Follow-up|0|||
48946985|NCT03976401|157636439|FG003|Overall Study|Lost to Follow-up|0|||
48946986|NCT03976401|157636440|FG004|Overall Study|Lost to Follow-up|0|||
48946987|NCT03976401|157636441|FG005|Overall Study|Lost to Follow-up|0|||
48946988|NCT03976401|157636436|FG000|Overall Study|Protocol Violation|0|||
48946989|NCT03976401|157636437|FG001|Overall Study|Protocol Violation|1|||
48946990|NCT03976401|157636438|FG002|Overall Study|Protocol Violation|0|||
48946991|NCT03976401|157636439|FG003|Overall Study|Protocol Violation|0|||
48946992|NCT03976401|157636440|FG004|Overall Study|Protocol Violation|0|||
48946993|NCT03976401|157636441|FG005|Overall Study|Protocol Violation|0|||
48946994|NCT03976401|157636436|FG000|Overall Study|Withdrew Consent|0|||
48946995|NCT03976401|157636437|FG001|Overall Study|Withdrew Consent|0|||
48946996|NCT03976401|157636438|FG002|Overall Study|Withdrew Consent|0|||
48946997|NCT03976401|157636439|FG003|Overall Study|Withdrew Consent|1|||
48737414|NCT00302107|156888079|FG000|Overall Study|Lost to Follow-up|6|||
48946998|NCT03976401|157636440|FG004|Overall Study|Withdrew Consent|0|||
48946999|NCT03976401|157636441|FG005|Overall Study|Withdrew Consent|0|||
48947000|NCT00791128|157636446|FG000|Overall Study|Adverse Event|4|||
48947001|NCT00791128|157636446|FG000|Overall Study|Device migration|2|||
48947002|NCT00791128|157636446|FG000|Overall Study|non-compliance by subject|2|||
48947003|NCT00791128|157636446|FG000|Overall Study|abdominal tumor, unrelated to device|1|||
48947004|NCT00641147|157636447|FG000|Completed 4 Months.|Physician Decision|1|||
48947005|NCT00641147|157636448|FG001|Completed 4 Months.|Physician Decision|0|||
48947006|NCT00641147|157636447|FG000|Completed 4 Months.|Adverse Event|1|||
48947007|NCT00641147|157636448|FG001|Completed 4 Months.|Adverse Event|0|||
48947008|NCT00641147|157636447|FG000|Completed 8 Months.|Physician Decision|2|||
48947009|NCT00641147|157636448|FG001|Completed 8 Months.|Physician Decision|1|||
48947010|NCT00641147|157636447|FG000|Completed 8 Months.|non compliance|1|||
48947011|NCT00641147|157636448|FG001|Completed 8 Months.|non compliance|0|||
48947012|NCT00641147|157636447|FG000|Completed 8 Months.|Withdrawal by Subject|0|||
48947013|NCT00641147|157636448|FG001|Completed 8 Months.|Withdrawal by Subject|1|||
48947014|NCT00641147|157636447|FG000|Completed 12 Months.|Physician Decision|1|||
48947015|NCT00641147|157636448|FG001|Completed 12 Months.|Physician Decision|1|||
48947016|NCT00641147|157636447|FG000|Completed 12 Months.|Withdrawal by Subject|0|||
48947017|NCT00641147|157636448|FG001|Completed 12 Months.|Withdrawal by Subject|1|||
48947018|NCT00641147|157636447|FG000|Completed 16 Months.|Physician Decision|1|||
48947019|NCT00641147|157636448|FG001|Completed 16 Months.|Physician Decision|0|||
48947020|NCT00641147|157636447|FG000|Completed 16 Months.|Lost to Follow-up|1|||
48947021|NCT00641147|157636448|FG001|Completed 16 Months.|Lost to Follow-up|0|||
48947022|NCT00308620|157636449|FG000|Overall Study|Death|1|||
48947023|NCT00308620|157636450|FG001|Overall Study|Death|1|||
48947024|NCT00308620|157636451|FG002|Overall Study|Death|0|||
48947025|NCT00308620|157636449|FG000|Overall Study|Lost to Follow-up|0|||
48947026|NCT00308620|157636450|FG001|Overall Study|Lost to Follow-up|0|||
48947027|NCT00308620|157636451|FG002|Overall Study|Lost to Follow-up|1|||
48947028|NCT00550238|157636452|FG000|Overall Study|Adverse Event|88|||
48947029|NCT00550238|157636452|FG000|Overall Study|Death|34|||
48947030|NCT00550238|157636452|FG000|Overall Study|Disease progression|46|||
48852657|NCT03732807|157299639|FG002|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
48852658|NCT03732807|157299640|FG003|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
48852659|NCT03732807|157299641|FG004|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|0|||
48852660|NCT03732807|157299642|FG005|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
48852661|NCT03732807|157299643|FG006|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
48852662|NCT03732807|157299637|FG000|Treatment Extension (Week 25 up to 48)|Other|1|||
48852663|NCT03732807|157299638|FG001|Treatment Extension (Week 25 up to 48)|Other|4|||
48852664|NCT03732807|157299639|FG002|Treatment Extension (Week 25 up to 48)|Other|0|||
48852665|NCT03732807|157299640|FG003|Treatment Extension (Week 25 up to 48)|Other|2|||
48852666|NCT03732807|157299641|FG004|Treatment Extension (Week 25 up to 48)|Other|0|||
48852667|NCT03732807|157299642|FG005|Treatment Extension (Week 25 up to 48)|Other|0|||
48852668|NCT03732807|157299643|FG006|Treatment Extension (Week 25 up to 48)|Other|0|||
48852669|NCT00686595|157299646|FG000|Overall Study|Adverse Event|3|||
48852670|NCT00686595|157299646|FG000|Overall Study|Protocol Violation|1|||
48852671|NCT00686595|157299646|FG000|Overall Study|Lost to Follow-up|1|||
48852672|NCT00686595|157299646|FG000|Overall Study|Lack of Efficacy|1|||
48852673|NCT00686595|157299646|FG000|Overall Study|Poor Compliance|1|||
48852674|NCT03851094|157299650|FG000|Overall Study|Withdrawal by Subject|0|||
48852675|NCT03851094|157299651|FG001|Overall Study|Withdrawal by Subject|1|||
48852676|NCT03851094|157299650|FG000|Overall Study|Participant lost device|0|||
48852677|NCT03851094|157299651|FG001|Overall Study|Participant lost device|1|||
48852678|NCT03851094|157299650|FG000|Overall Study|Participant returned device|0|||
48852679|NCT03851094|157299651|FG001|Overall Study|Participant returned device|2|||
48852680|NCT03490032|157299655|FG000|Overall Study|family issue (child custody)|1|||
48852681|NCT03490032|157299656|FG001|Overall Study|family issue (child custody)|0|||
48852682|NCT03490032|157299657|FG002|Overall Study|family issue (child custody)|0|||
48852683|NCT01478594|157299658|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
48852684|NCT01478594|157299659|FG001|Overall Study|Randomized but Never Received Study Drug|1|||
48852685|NCT01478594|157299658|FG000|Overall Study|Death|45|||
48852686|NCT01478594|157299659|FG001|Overall Study|Death|18|||
48852687|NCT01478594|157299658|FG000|Overall Study|Lost to Follow-up|3|||
48852688|NCT01478594|157299659|FG001|Overall Study|Lost to Follow-up|1|||
48852689|NCT01478594|157299658|FG000|Overall Study|Withdrawal by Subject|9|||
48852690|NCT01478594|157299659|FG001|Overall Study|Withdrawal by Subject|3|||
48852691|NCT01478594|157299658|FG000|Overall Study|Study Closed by Sponsor|8|||
48852692|NCT01478594|157299659|FG001|Overall Study|Study Closed by Sponsor|5|||
48852693|NCT00273052|157299674|FG000|Overall Study|Withdrawal by Subject|16|||
48852694|NCT00273052|157299675|FG001|Overall Study|Withdrawal by Subject|19|||
48852695|NCT00273052|157299674|FG000|Overall Study|Adverse Event|21|||
48947031|NCT00550238|157636452|FG000|Overall Study|Withdrawal by Subject|167|||
48947032|NCT00550238|157636452|FG000|Overall Study|Physician Decision|31|||
48947033|NCT00550238|157636452|FG000|Overall Study|Patient noncompliance|25|||
48947034|NCT00550238|157636452|FG000|Overall Study|Lost to Follow-up|13|||
48947035|NCT00550238|157636452|FG000|Overall Study|Sponsor decision|55|||
48947036|NCT01050062|157636453|FG000|Overall Study|Adverse Event|75|||
48947037|NCT01050062|157636454|FG001|Overall Study|Adverse Event|22|||
48852696|NCT00273052|157299675|FG001|Overall Study|Adverse Event|19|||
48852697|NCT00273052|157299674|FG000|Overall Study|Protocol Violation|14|||
48852698|NCT00273052|157299675|FG001|Overall Study|Protocol Violation|18|||
48852699|NCT00273052|157299674|FG000|Overall Study|Lost to Follow-up|7|||
48947038|NCT01050062|157636453|FG000|Overall Study|Lost to Follow-up|83|||
48947039|NCT01050062|157636454|FG001|Overall Study|Lost to Follow-up|35|||
48947040|NCT01050062|157636453|FG000|Overall Study|Lack of Efficacy|22|||
48852700|NCT00273052|157299675|FG001|Overall Study|Lost to Follow-up|25|||
48852701|NCT00273052|157299674|FG000|Overall Study|Lack of Efficacy|6|||
48947041|NCT01050062|157636454|FG001|Overall Study|Lack of Efficacy|35|||
48947042|NCT01050062|157636453|FG000|Overall Study|Physician Decision|74|||
48852702|NCT00273052|157299675|FG001|Overall Study|Lack of Efficacy|4|||
48852703|NCT00273052|157299674|FG000|Overall Study|Non-Compliance|3|||
48852704|NCT00273052|157299675|FG001|Overall Study|Non-Compliance|1|||
48852705|NCT00273052|157299674|FG000|Overall Study|Other|2|||
48947043|NCT01050062|157636454|FG001|Overall Study|Physician Decision|9|||
48947044|NCT01050062|157636453|FG000|Overall Study|Others|17|||
48852706|NCT00273052|157299675|FG001|Overall Study|Other|0|||
48852707|NCT00273052|157299674|FG000|Overall Study|Worsening serum lipid levels|0|||
48947045|NCT01050062|157636454|FG001|Overall Study|Others|11|||
48947046|NCT02623361|157636455|FG000|Overall Study|Protocol Violation|0|||
48947047|NCT02623361|157636456|FG001|Overall Study|Protocol Violation|1|||
48947048|NCT02623361|157636455|FG000|Overall Study|Withdrawal by Subject|0|||
48947049|NCT02623361|157636456|FG001|Overall Study|Withdrawal by Subject|1|||
48947050|NCT03000452|157636457|FG000|Treatment Period|Death|1|||
48947051|NCT03000452|157636457|FG000|Treatment Period|Progressive Disease (PD)|14|||
48947052|NCT03000452|157636457|FG000|Treatment Period|Physician Decision|1|||
48947053|NCT03000452|157636457|FG000|Treatment Period|Miscellaneous|2|||
48947054|NCT03000452|157636457|FG000|Follow-Up Period|Study Terminated by Sponsor|1|||
48947055|NCT03000452|157636457|FG000|Follow-Up Period|Death|3|||
48947056|NCT03000452|157636457|FG000|Follow-Up Period|Withdrawal by Subject|3|||
48947057|NCT03065530|157636458|FG000|Overall Study|Lack of Efficacy|1|||
48947058|NCT03065530|157636459|FG001|Overall Study|Lack of Efficacy|1|||
48947059|NCT03065530|157636460|FG002|Overall Study|Lack of Efficacy|0|||
48947060|NCT03065530|157636461|FG003|Overall Study|Lack of Efficacy|1|||
48947061|NCT03065530|157636458|FG000|Overall Study|Protocol Violation|1|||
48947062|NCT03065530|157636459|FG001|Overall Study|Protocol Violation|0|||
48947063|NCT03065530|157636460|FG002|Overall Study|Protocol Violation|1|||
48947064|NCT03065530|157636461|FG003|Overall Study|Protocol Violation|1|||
48947065|NCT02717546|157636462|FG000|Overall Study|Lost to Follow-up|12|||
48947066|NCT04407507|157636463|FG000|Overall Study|Withdrawal by Subject|0|||
48947067|NCT04407507|157636464|FG001|Overall Study|Withdrawal by Subject|1|||
48947068|NCT00793104|157636468|FG000|Overall Study|Lost to Follow-up|1|||
48947069|NCT00003641|157636469|FG000|Overall Study|Withdrawal by Subject|0|||
48947070|NCT00003641|157636470|FG001|Overall Study|Withdrawal by Subject|100|||
48947071|NCT00003641|157636469|FG000|Overall Study|Adverse Event|0|||
48947072|NCT00003641|157636470|FG001|Overall Study|Adverse Event|38|||
48947073|NCT00003641|157636469|FG000|Overall Study|Disease progression|0|||
48947074|NCT00003641|157636470|FG001|Overall Study|Disease progression|2|||
48947075|NCT00003641|157636469|FG000|Overall Study|Unknown/missing|0|||
48947076|NCT00003641|157636470|FG001|Overall Study|Unknown/missing|22|||
48947077|NCT00003641|157636469|FG000|Overall Study|Should not receive interferon therapy|2|||
48947078|NCT00003641|157636470|FG001|Overall Study|Should not receive interferon therapy|0|||
48947079|NCT00003641|157636469|FG000|Overall Study|Never started interferon|567|||
48947080|NCT00003641|157636470|FG001|Overall Study|Never started interferon|12|||
48947081|NCT00376688|157636471|FG000|Overall Study|Adverse Event|3|||
48947082|NCT00376688|157636471|FG000|Overall Study|Death|1|||
48947083|NCT02792777|157636473|FG000|Overall Study|Withdrawal by Subject|2|||
48947084|NCT02792777|157636474|FG001|Overall Study|Withdrawal by Subject|0|||
48947085|NCT02792777|157636473|FG000|Overall Study|Recording malfunction|2|||
48947086|NCT02792777|157636474|FG001|Overall Study|Recording malfunction|0|||
48947087|NCT02792777|157636473|FG000|Overall Study|Later determined to be ineligible|2|||
48947088|NCT02792777|157636474|FG001|Overall Study|Later determined to be ineligible|0|||
48947089|NCT02792777|157636473|FG000|Overall Study|Participant interviewed twice|1|||
48947090|NCT02792777|157636474|FG001|Overall Study|Participant interviewed twice|0|||
48947091|NCT01821677|157636475|FG000|Overall Study|Adverse Event|4|||
48947092|NCT01821677|157636476|FG001|Overall Study|Adverse Event|6|||
48947093|NCT01821677|157636477|FG002|Overall Study|Adverse Event|5|||
48947094|NCT01821677|157636475|FG000|Overall Study|Physician Decision|1|||
48947095|NCT01821677|157636476|FG001|Overall Study|Physician Decision|4|||
48947096|NCT01821677|157636477|FG002|Overall Study|Physician Decision|1|||
48947097|NCT01821677|157636475|FG000|Overall Study|Non-compliance|0|||
48737415|NCT00302107|156888080|FG001|Overall Study|Lost to Follow-up|5|||
48947098|NCT01821677|157636476|FG001|Overall Study|Non-compliance|1|||
48947099|NCT01821677|157636477|FG002|Overall Study|Non-compliance|2|||
48947100|NCT01821677|157636475|FG000|Overall Study|Lost to Follow-up|2|||
48947101|NCT01821677|157636476|FG001|Overall Study|Lost to Follow-up|1|||
48947102|NCT01821677|157636477|FG002|Overall Study|Lost to Follow-up|3|||
48947103|NCT01821677|157636475|FG000|Overall Study|Protocol Violation|0|||
48947104|NCT01821677|157636476|FG001|Overall Study|Protocol Violation|0|||
48947105|NCT01821677|157636477|FG002|Overall Study|Protocol Violation|2|||
48947106|NCT01821677|157636475|FG000|Overall Study|Withdrawal by Subject|7|||
48947107|NCT01821677|157636476|FG001|Overall Study|Withdrawal by Subject|3|||
48947108|NCT01821677|157636477|FG002|Overall Study|Withdrawal by Subject|2|||
48947109|NCT01821677|157636475|FG000|Overall Study|Other|9|||
48947110|NCT01821677|157636476|FG001|Overall Study|Other|0|||
48947111|NCT01821677|157636477|FG002|Overall Study|Other|0|||
48737416|NCT00302107|156888079|FG000|Overall Study|Protocol Violation|1|||
48947112|NCT00658333|157636478|FG000|Overall Study|Adverse Event|2|||
48947113|NCT00658333|157636479|FG001|Overall Study|Adverse Event|1|||
48947114|NCT00638846|157636482|FG000|Overall Study|Adverse Event|0|||
48947115|NCT00638846|157636483|FG001|Overall Study|Adverse Event|1|||
48947116|NCT00638846|157636482|FG000|Overall Study|Lost to Follow-up|3|||
48947117|NCT00638846|157636483|FG001|Overall Study|Lost to Follow-up|2|||
48947118|NCT00638846|157636482|FG000|Overall Study|lens issue|1|||
48947119|NCT00638846|157636483|FG001|Overall Study|lens issue|3|||
48947120|NCT02675517|157636486|FG000|Overall Study|No evaluable PF-10 questionnaire at all|8|||
48947121|NCT02675517|157636486|FG000|Overall Study|Evaluable PF-10 questionnaire at visit1|151|||
48947122|NCT01632878|157636487|FG000|Screening|Physician Decision|268|||
48947123|NCT01632878|157636487|FG000|Treatment|Lost to Follow-up|41|||
48947124|NCT01632878|157636487|FG000|Treatment|Withdrawal by Subject|36|||
48947125|NCT01632878|157636487|FG000|Treatment|Physician Decision|34|||
48737417|NCT00302107|156888080|FG001|Overall Study|Protocol Violation|0|||
48737418|NCT00302107|156888079|FG000|Overall Study|Relocation|0|||
48737419|NCT00302107|156888080|FG001|Overall Study|Relocation|1|||
48947126|NCT01632878|157636487|FG000|Treatment|missing information|4|||
48947127|NCT01632878|157636487|FG000|Treatment|no information on study completion|43|||
48947128|NCT01415440|157636492|FG000|Overall Study|Lost to Follow-up|0|||
48947129|NCT01415440|157636493|FG001|Overall Study|Lost to Follow-up|1|||
48947130|NCT01415440|157636494|FG002|Overall Study|Lost to Follow-up|2|||
48947131|NCT01415440|157636492|FG000|Overall Study|Physician Decision|3|||
48947132|NCT01415440|157636493|FG001|Overall Study|Physician Decision|0|||
48947133|NCT01415440|157636494|FG002|Overall Study|Physician Decision|0|||
48947134|NCT01415440|157636492|FG000|Overall Study|Withdrawal by Subject|1|||
48947135|NCT01415440|157636493|FG001|Overall Study|Withdrawal by Subject|0|||
48947136|NCT01415440|157636494|FG002|Overall Study|Withdrawal by Subject|0|||
48947137|NCT02504892|157636495|FG000|Overall Study|Adverse event-pneumonitis|2|||
48852708|NCT00273052|157299675|FG001|Overall Study|Worsening serum lipid levels|2|||
48852709|NCT00454194|157299676|FG000|Overall Study|Adverse Event|7|||
48852710|NCT00454194|157299677|FG001|Overall Study|Adverse Event|2|||
48852711|NCT00454194|157299676|FG000|Overall Study|Withdrawal by Subject|12|||
48852712|NCT00454194|157299677|FG001|Overall Study|Withdrawal by Subject|8|||
48852713|NCT00454194|157299676|FG000|Overall Study|Other Medical Problems|1|||
48852714|NCT00454194|157299677|FG001|Overall Study|Other Medical Problems|2|||
48852715|NCT00454194|157299676|FG000|Overall Study|Other Unspecified Reason|2|||
48852716|NCT00454194|157299677|FG001|Overall Study|Other Unspecified Reason|2|||
48852717|NCT00734578|157299678|FG000|Overall Study|Adverse Event|4|||
48852718|NCT00734578|157299679|FG001|Overall Study|Adverse Event|6|||
48852719|NCT00734578|157299680|FG002|Overall Study|Adverse Event|1|||
48852720|NCT00734578|157299678|FG000|Overall Study|Protocol Violation|8|||
48852721|NCT00734578|157299679|FG001|Overall Study|Protocol Violation|6|||
48852722|NCT00734578|157299680|FG002|Overall Study|Protocol Violation|3|||
48947138|NCT00095121|157636501|FG000|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1|||
48947139|NCT00095121|157636502|FG001|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0|||
48947140|NCT00095121|157636501|FG000|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2|||
48947141|NCT00095121|157636502|FG001|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0|||
48947142|NCT01118143|157636503|FG000|Overall Study|Withdrawal by Subject|2|||
48947143|NCT01118143|157636504|FG001|Overall Study|Withdrawal by Subject|5|||
48947144|NCT00487279|157636505|FG000|Overall Study|Death|1|||
48852723|NCT00734578|157299678|FG000|Overall Study|Withdrawal by Subject|7|||
48852724|NCT00734578|157299679|FG001|Overall Study|Withdrawal by Subject|8|||
48852725|NCT00734578|157299680|FG002|Overall Study|Withdrawal by Subject|11|||
48852726|NCT00734578|157299678|FG000|Overall Study|Lost to Follow-up|9|||
48852727|NCT00734578|157299679|FG001|Overall Study|Lost to Follow-up|3|||
48852728|NCT00734578|157299680|FG002|Overall Study|Lost to Follow-up|5|||
48852729|NCT00734578|157299678|FG000|Overall Study|Lack of Efficacy|3|||
48852730|NCT00734578|157299679|FG001|Overall Study|Lack of Efficacy|2|||
48852731|NCT00734578|157299680|FG002|Overall Study|Lack of Efficacy|5|||
48852732|NCT00734578|157299678|FG000|Overall Study|Randomized in error|1|||
48852733|NCT00734578|157299679|FG001|Overall Study|Randomized in error|0|||
48947145|NCT00487279|157636506|FG001|Overall Study|Death|0|||
48947146|NCT00487279|157636505|FG000|Overall Study|Withdrawal by Subject|0|||
48947147|NCT00487279|157636506|FG001|Overall Study|Withdrawal by Subject|2|||
48947148|NCT02746679|157636507|FG000|Overall Study|Lost to Follow-up|4|||
48947149|NCT02746679|157636508|FG001|Overall Study|Lost to Follow-up|6|||
48947150|NCT01084252|157638159|FG000|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
48947151|NCT01084252|157638160|FG001|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
48947152|NCT01084252|157638161|FG002|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
48947153|NCT01084252|157638162|FG003|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
48947154|NCT01084252|157638163|FG004|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
48947155|NCT01084252|157638164|FG005|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
48852734|NCT00734578|157299680|FG002|Overall Study|Randomized in error|0|||
48852735|NCT00734578|157299678|FG000|Overall Study|Exclusion criteria|1|||
48852736|NCT00734578|157299679|FG001|Overall Study|Exclusion criteria|0|||
48852737|NCT00734578|157299680|FG002|Overall Study|Exclusion criteria|0|||
48852738|NCT02169414|157299681|FG000|Overall Study|Withdrawal by Subject|1|||
48852739|NCT02169414|157299682|FG001|Overall Study|Withdrawal by Subject|0|||
48852740|NCT02169414|157299683|FG002|Overall Study|Withdrawal by Subject|0|||
48947156|NCT01084252|157638165|FG006|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
48947157|NCT01084252|157638166|FG007|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
48947158|NCT01084252|157638167|FG008|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
48947159|NCT01084252|157638168|FG009|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
48947160|NCT01084252|157638169|FG010|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
48947161|NCT01084252|157638170|FG011|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
48947162|NCT01084252|157638171|FG012|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|1|||
48947163|NCT01084252|157638172|FG013|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
48947164|NCT05111249|157638173|FG000|Overall Study|Lost to Follow-up|0|||
48947165|NCT05111249|157638174|FG001|Overall Study|Lost to Follow-up|2|||
48947166|NCT05111249|157638173|FG000|Overall Study|Physician Decision|0|||
48947167|NCT05111249|157638174|FG001|Overall Study|Physician Decision|1|||
48947168|NCT05111249|157638173|FG000|Overall Study|Participant decision|1|||
48947169|NCT05111249|157638174|FG001|Overall Study|Participant decision|5|||
48947170|NCT05635838|157638175|FG000|16-Week DBVC Period|Adverse Event|2|||
48947171|NCT05635838|157638176|FG001|16-Week DBVC Period|Adverse Event|0|||
48947172|NCT05635838|157638177|FG002|16-Week DBVC Period|Adverse Event|0|||
48737420|NCT00302107|156888079|FG000|Overall Study|Withdrawal by Subject|0|||
48737421|NCT00302107|156888080|FG001|Overall Study|Withdrawal by Subject|3|||
48947173|NCT05635838|157638178|FG003|16-Week DBVC Period|Adverse Event|0|||
48947174|NCT05635838|157638175|FG000|16-Week DBVC Period|Lost to Follow-up|5|||
48947175|NCT05635838|157638176|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
48947176|NCT05635838|157638177|FG002|16-Week DBVC Period|Lost to Follow-up|0|||
48737422|NCT00302107|156888079|FG000|Overall Study|Adverse Event|1|||
48737423|NCT00302107|156888080|FG001|Overall Study|Adverse Event|0|||
48947177|NCT05635838|157638178|FG003|16-Week DBVC Period|Lost to Follow-up|0|||
48947178|NCT05635838|157638175|FG000|16-Week DBVC Period|Physician Decision|0|||
48947179|NCT05635838|157638176|FG001|16-Week DBVC Period|Physician Decision|1|||
48947180|NCT05635838|157638177|FG002|16-Week DBVC Period|Physician Decision|0|||
48947181|NCT05635838|157638178|FG003|16-Week DBVC Period|Physician Decision|0|||
48737424|NCT02777333|156888081|FG000|Overall Study|Withdrawal by Subject|0|||
48737425|NCT02777333|156888082|FG001|Overall Study|Withdrawal by Subject|1|||
48737426|NCT02777333|156888081|FG000|Overall Study|Lost to Follow-up|0|||
48947182|NCT05635838|157638175|FG000|16-Week DBVC Period|Protocol Violation|1|||
48947183|NCT05635838|157638176|FG001|16-Week DBVC Period|Protocol Violation|0|||
48947184|NCT05635838|157638177|FG002|16-Week DBVC Period|Protocol Violation|0|||
48947185|NCT05635838|157638178|FG003|16-Week DBVC Period|Protocol Violation|0|||
48947186|NCT05635838|157638175|FG000|16-Week DBVC Period|Withdrawal by Subject|1|||
48947187|NCT05635838|157638176|FG001|16-Week DBVC Period|Withdrawal by Subject|0|||
48947188|NCT05635838|157638177|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
48737427|NCT02777333|156888082|FG001|Overall Study|Lost to Follow-up|1|||
48737428|NCT00518687|156890084|FG000|Overall Study|Adverse Event|201|||
48737429|NCT00518687|156890085|FG001|Overall Study|Adverse Event|177|||
48737430|NCT00518687|156890084|FG000|Overall Study|Lost to Follow-up|144|||
48737431|NCT00518687|156890085|FG001|Overall Study|Lost to Follow-up|155|||
48737432|NCT00518687|156890084|FG000|Overall Study|Physician Decision|42|||
48737433|NCT00518687|156890085|FG001|Overall Study|Physician Decision|48|||
48737434|NCT00518687|156890084|FG000|Overall Study|Progressive disease|2|||
48737435|NCT00518687|156890085|FG001|Overall Study|Progressive disease|2|||
48737436|NCT00518687|156890084|FG000|Overall Study|Protocol Violation|8|||
48737437|NCT00518687|156890085|FG001|Overall Study|Protocol Violation|10|||
48737438|NCT00518687|156890084|FG000|Overall Study|Study terminated by sponsor|930|||
48737439|NCT00518687|156890085|FG001|Overall Study|Study terminated by sponsor|918|||
48737440|NCT00518687|156890084|FG000|Overall Study|Withdrawal by Subject|110|||
48737441|NCT00518687|156890085|FG001|Overall Study|Withdrawal by Subject|110|||
48737442|NCT02360995|156890088|FG000|Overall Study|Lost to Follow-up|2|||
48737443|NCT02360995|156890089|FG001|Overall Study|Lost to Follow-up|0|||
48737444|NCT02360995|156890090|FG002|Overall Study|Lost to Follow-up|2|||
48737445|NCT02360995|156890088|FG000|Overall Study|Withdrawal by Subject|0|||
48737446|NCT02360995|156890089|FG001|Overall Study|Withdrawal by Subject|1|||
48737447|NCT02360995|156890090|FG002|Overall Study|Withdrawal by Subject|0|||
48737448|NCT00428792|156890093|FG000|Overall Study|Lack of Efficacy|1|||
48737449|NCT00428792|156890094|FG001|Overall Study|Lack of Efficacy|3|||
48737450|NCT00428792|156890093|FG000|Overall Study|Lost to Follow-up|0|||
48737451|NCT00428792|156890094|FG001|Overall Study|Lost to Follow-up|1|||
48737452|NCT00809354|156890096|FG000|Overall Study|Adverse Event|32|||
48737453|NCT00809354|156890097|FG001|Overall Study|Adverse Event|45|||
48737454|NCT00809354|156890098|FG002|Overall Study|Adverse Event|37|||
48737455|NCT00809354|156890099|FG003|Overall Study|Adverse Event|53|||
48737456|NCT00809354|156890100|FG004|Overall Study|Adverse Event|26|||
48737457|NCT00809354|156890101|FG005|Overall Study|Adverse Event|33|||
48737458|NCT00809354|156890102|FG006|Overall Study|Adverse Event|44|||
48737459|NCT00809354|156890103|FG007|Overall Study|Adverse Event|40|||
48947189|NCT05635838|157638178|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
48947190|NCT05635838|157638175|FG000|16-Week DBVC Period|Presence of Disease Tunnel|1|||
48947191|NCT05635838|157638176|FG001|16-Week DBVC Period|Presence of Disease Tunnel|0|||
48947192|NCT05635838|157638177|FG002|16-Week DBVC Period|Presence of Disease Tunnel|0|||
48947193|NCT05635838|157638178|FG003|16-Week DBVC Period|Presence of Disease Tunnel|0|||
48947194|NCT05635838|157638175|FG000|16-Week DBVC Period|Developed Draining Fistula|0|||
48947195|NCT05635838|157638176|FG001|16-Week DBVC Period|Developed Draining Fistula|1|||
48947196|NCT05635838|157638177|FG002|16-Week DBVC Period|Developed Draining Fistula|0|||
48737460|NCT00809354|156890104|FG008|Overall Study|Adverse Event|46|||
48737461|NCT00809354|156890105|FG009|Overall Study|Adverse Event|26|||
48737462|NCT00809354|156890096|FG000|Overall Study|Lack of Efficacy|23|||
48947197|NCT05635838|157638178|FG003|16-Week DBVC Period|Developed Draining Fistula|0|||
48947198|NCT05635838|157638175|FG000|16-Week OLE Period|Adverse Event|0|||
48737463|NCT00809354|156890097|FG001|Overall Study|Lack of Efficacy|23|||
48737464|NCT00809354|156890098|FG002|Overall Study|Lack of Efficacy|22|||
48947199|NCT05635838|157638176|FG001|16-Week OLE Period|Adverse Event|0|||
48947200|NCT05635838|157638177|FG002|16-Week OLE Period|Adverse Event|0|||
48737465|NCT00809354|156890099|FG003|Overall Study|Lack of Efficacy|15|||
48737466|NCT00809354|156890100|FG004|Overall Study|Lack of Efficacy|40|||
48737467|NCT00809354|156890101|FG005|Overall Study|Lack of Efficacy|19|||
48737468|NCT00809354|156890102|FG006|Overall Study|Lack of Efficacy|21|||
48737469|NCT00809354|156890103|FG007|Overall Study|Lack of Efficacy|15|||
48737470|NCT00809354|156890104|FG008|Overall Study|Lack of Efficacy|18|||
48737471|NCT00809354|156890105|FG009|Overall Study|Lack of Efficacy|38|||
48737472|NCT00809354|156890096|FG000|Overall Study|Lost to Follow-up|10|||
48737473|NCT00809354|156890097|FG001|Overall Study|Lost to Follow-up|11|||
48737474|NCT00809354|156890098|FG002|Overall Study|Lost to Follow-up|8|||
48737475|NCT00809354|156890099|FG003|Overall Study|Lost to Follow-up|13|||
48737476|NCT00809354|156890100|FG004|Overall Study|Lost to Follow-up|6|||
48737477|NCT00809354|156890101|FG005|Overall Study|Lost to Follow-up|2|||
48737478|NCT00809354|156890102|FG006|Overall Study|Lost to Follow-up|0|||
48737479|NCT00809354|156890103|FG007|Overall Study|Lost to Follow-up|5|||
48737480|NCT00809354|156890104|FG008|Overall Study|Lost to Follow-up|4|||
48737481|NCT00809354|156890105|FG009|Overall Study|Lost to Follow-up|0|||
48737482|NCT00809354|156890096|FG000|Overall Study|Protocol Violation|7|||
48737483|NCT00809354|156890097|FG001|Overall Study|Protocol Violation|14|||
48737484|NCT00809354|156890098|FG002|Overall Study|Protocol Violation|14|||
48947201|NCT05635838|157638178|FG003|16-Week OLE Period|Adverse Event|2|||
48947202|NCT05635838|157638175|FG000|16-Week OLE Period|Lost to Follow-up|0|||
48947203|NCT05635838|157638176|FG001|16-Week OLE Period|Lost to Follow-up|0|||
48947204|NCT05635838|157638177|FG002|16-Week OLE Period|Lost to Follow-up|1|||
48947205|NCT05635838|157638178|FG003|16-Week OLE Period|Lost to Follow-up|3|||
48947206|NCT05635838|157638175|FG000|16-Week OLE Period|Physician Decision|0|||
48947207|NCT05635838|157638176|FG001|16-Week OLE Period|Physician Decision|0|||
48947208|NCT05635838|157638177|FG002|16-Week OLE Period|Physician Decision|0|||
48947209|NCT05635838|157638178|FG003|16-Week OLE Period|Physician Decision|1|||
48947210|NCT05635838|157638175|FG000|16-Week OLE Period|Protocol Violation|0|||
48947211|NCT05635838|157638176|FG001|16-Week OLE Period|Protocol Violation|0|||
48947212|NCT05635838|157638177|FG002|16-Week OLE Period|Protocol Violation|1|||
48947213|NCT05635838|157638178|FG003|16-Week OLE Period|Protocol Violation|1|||
48947214|NCT05635838|157638175|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
48947215|NCT05635838|157638176|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
48947216|NCT05635838|157638177|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
48947217|NCT05635838|157638178|FG003|16-Week OLE Period|Withdrawal by Subject|1|||
48947218|NCT05635838|157638175|FG000|16-Week OLE Period|Pregnancy|0|||
48947219|NCT05635838|157638176|FG001|16-Week OLE Period|Pregnancy|0|||
48947220|NCT05635838|157638177|FG002|16-Week OLE Period|Pregnancy|1|||
48947221|NCT05635838|157638178|FG003|16-Week OLE Period|Pregnancy|0|||
48947222|NCT00955110|157638185|FG000|Qualification Phase|Did not meet eligibility criteria|24|||
48947223|NCT00955110|157638185|FG000|Treatment Phase|Adverse Event|2|||
48947224|NCT00955110|157638185|FG000|Treatment Phase|Administrative reasons|2|||
48947225|NCT00955110|157638185|FG000|Treatment Phase|Non-compliance with study restrictions|1|||
48947226|NCT00955110|157638185|FG000|Treatment Phase|Withdrawn by physician pre-treatment|1|||
48947227|NCT01736683|157638199|FG000|Overall Study|Disease Relapse|0|||
48947228|NCT01736683|157638200|FG001|Overall Study|Disease Relapse|0|||
48947229|NCT01736683|157638201|FG002|Overall Study|Disease Relapse|2|||
48947230|NCT01736683|157638202|FG003|Overall Study|Disease Relapse|1|||
48737485|NCT00809354|156890099|FG003|Overall Study|Protocol Violation|12|||
48947231|NCT01736683|157638203|FG004|Overall Study|Disease Relapse|0|||
48947232|NCT01736683|157638199|FG000|Overall Study|Adverse Event|0|||
48737486|NCT00809354|156890100|FG004|Overall Study|Protocol Violation|14|||
48737487|NCT00809354|156890101|FG005|Overall Study|Protocol Violation|6|||
48737488|NCT00809354|156890102|FG006|Overall Study|Protocol Violation|4|||
48737489|NCT00809354|156890103|FG007|Overall Study|Protocol Violation|6|||
48947233|NCT01736683|157638200|FG001|Overall Study|Adverse Event|2|||
48947234|NCT01736683|157638201|FG002|Overall Study|Adverse Event|2|||
48947235|NCT01736683|157638202|FG003|Overall Study|Adverse Event|3|||
48947236|NCT01736683|157638203|FG004|Overall Study|Adverse Event|2|||
48947237|NCT01736683|157638199|FG000|Overall Study|Withdrawal by Subject|0|||
48947238|NCT01736683|157638200|FG001|Overall Study|Withdrawal by Subject|0|||
48737490|NCT00809354|156890104|FG008|Overall Study|Protocol Violation|9|||
48947239|NCT01736683|157638201|FG002|Overall Study|Withdrawal by Subject|3|||
48947240|NCT01736683|157638202|FG003|Overall Study|Withdrawal by Subject|1|||
48947241|NCT01736683|157638203|FG004|Overall Study|Withdrawal by Subject|1|||
48947242|NCT01736683|157638199|FG000|Overall Study|Lack of Therapeutic Effect|7|||
48947243|NCT01736683|157638200|FG001|Overall Study|Lack of Therapeutic Effect|4|||
48947244|NCT01736683|157638201|FG002|Overall Study|Lack of Therapeutic Effect|13|||
48947245|NCT01736683|157638202|FG003|Overall Study|Lack of Therapeutic Effect|20|||
48947246|NCT01736683|157638203|FG004|Overall Study|Lack of Therapeutic Effect|1|||
48947247|NCT01736683|157638199|FG000|Overall Study|Progressive Disease|0|||
48947248|NCT01736683|157638200|FG001|Overall Study|Progressive Disease|0|||
48947249|NCT01736683|157638201|FG002|Overall Study|Progressive Disease|0|||
48737491|NCT00809354|156890105|FG009|Overall Study|Protocol Violation|3|||
48737492|NCT00809354|156890096|FG000|Overall Study|Withdrawal by Subject|32|||
48737493|NCT00809354|156890097|FG001|Overall Study|Withdrawal by Subject|27|||
48737494|NCT00809354|156890098|FG002|Overall Study|Withdrawal by Subject|31|||
48737495|NCT00809354|156890099|FG003|Overall Study|Withdrawal by Subject|33|||
48737496|NCT00809354|156890100|FG004|Overall Study|Withdrawal by Subject|34|||
48737497|NCT00809354|156890101|FG005|Overall Study|Withdrawal by Subject|29|||
48737498|NCT00809354|156890102|FG006|Overall Study|Withdrawal by Subject|27|||
48737499|NCT00809354|156890103|FG007|Overall Study|Withdrawal by Subject|19|||
48737500|NCT00809354|156890104|FG008|Overall Study|Withdrawal by Subject|18|||
48737501|NCT00809354|156890105|FG009|Overall Study|Withdrawal by Subject|20|||
48737502|NCT00809354|156890096|FG000|Overall Study|Other|10|||
48737503|NCT00809354|156890097|FG001|Overall Study|Other|2|||
48737504|NCT00809354|156890098|FG002|Overall Study|Other|7|||
48737505|NCT00809354|156890099|FG003|Overall Study|Other|10|||
48737506|NCT00809354|156890100|FG004|Overall Study|Other|5|||
48737507|NCT00809354|156890101|FG005|Overall Study|Other|3|||
48737508|NCT00809354|156890102|FG006|Overall Study|Other|2|||
48737509|NCT00809354|156890103|FG007|Overall Study|Other|3|||
48737510|NCT00809354|156890104|FG008|Overall Study|Other|4|||
48852741|NCT02169414|157299684|FG003|Overall Study|Withdrawal by Subject|0|||
48852742|NCT02169414|157299681|FG000|Overall Study|Adverse Event|0|||
48852743|NCT02169414|157299682|FG001|Overall Study|Adverse Event|1|||
48852744|NCT02169414|157299683|FG002|Overall Study|Adverse Event|0|||
48852745|NCT02169414|157299684|FG003|Overall Study|Adverse Event|0|||
48852746|NCT03547154|157299685|FG000|Overall Study|Disease Progression/Recurrence|6|||
48852747|NCT03547154|157299686|FG001|Overall Study|Disease Progression/Recurrence|14|||
48852748|NCT03547154|157299685|FG000|Overall Study|Adverse Event|26|||
48852749|NCT03547154|157299686|FG001|Overall Study|Adverse Event|31|||
48852750|NCT03547154|157299685|FG000|Overall Study|Protocol Violation|6|||
48852751|NCT03547154|157299686|FG001|Overall Study|Protocol Violation|1|||
48852752|NCT03547154|157299685|FG000|Overall Study|Physician Decision|4|||
48947250|NCT01736683|157638202|FG003|Overall Study|Progressive Disease|1|||
48947251|NCT01736683|157638203|FG004|Overall Study|Progressive Disease|0|||
48947252|NCT01736683|157638199|FG000|Overall Study|Other|0|||
48737511|NCT00809354|156890105|FG009|Overall Study|Other|3|||
48947253|NCT01736683|157638200|FG001|Overall Study|Other|0|||
48947254|NCT01736683|157638201|FG002|Overall Study|Other|1|||
48947255|NCT01736683|157638202|FG003|Overall Study|Other|9|||
48947256|NCT01736683|157638203|FG004|Overall Study|Other|1|||
48947257|NCT01183858|157638204|FG000|Overall Study|Death not related to Progressive Disease|5|||
48947258|NCT01183858|157638205|FG001|Overall Study|Death not related to Progressive Disease|6|||
48947259|NCT01183858|157638204|FG000|Overall Study|Adverse Event|14|||
48947260|NCT01183858|157638205|FG001|Overall Study|Adverse Event|11|||
48947261|NCT01183858|157638204|FG000|Overall Study|Investigator's Decision|0|||
48947262|NCT01183858|157638205|FG001|Overall Study|Investigator's Decision|3|||
48947263|NCT01183858|157638204|FG000|Overall Study|Insufficient Therapeutic Response|2|||
48947264|NCT01183858|157638205|FG001|Overall Study|Insufficient Therapeutic Response|0|||
48947265|NCT01183858|157638204|FG000|Overall Study|Refused Treatment|1|||
48947266|NCT01183858|157638205|FG001|Overall Study|Refused Treatment|4|||
48947267|NCT01183858|157638204|FG000|Overall Study|Withdrew Consent|4|||
48947268|NCT01183858|157638205|FG001|Overall Study|Withdrew Consent|4|||
48947269|NCT01183858|157638204|FG000|Overall Study|Discontinued Smoking|3|||
48947270|NCT01183858|157638205|FG001|Overall Study|Discontinued Smoking|1|||
48737512|NCT00809354|156890096|FG000|Overall Study|Study terminated by sponsor|138|||
48737513|NCT00809354|156890097|FG001|Overall Study|Study terminated by sponsor|134|||
48947271|NCT01183858|157638204|FG000|Overall Study|Protocol Violation|1|||
48737514|NCT00809354|156890098|FG002|Overall Study|Study terminated by sponsor|129|||
48737515|NCT00809354|156890099|FG003|Overall Study|Study terminated by sponsor|120|||
48947272|NCT01183858|157638205|FG001|Overall Study|Protocol Violation|0|||
48737516|NCT00809354|156890100|FG004|Overall Study|Study terminated by sponsor|126|||
48852753|NCT03547154|157299686|FG001|Overall Study|Physician Decision|3|||
48947273|NCT01183858|157638204|FG000|Overall Study|Administrative/Other|6|||
48947274|NCT01183858|157638205|FG001|Overall Study|Administrative/Other|6|||
48947275|NCT01183858|157638204|FG000|Overall Study|Progressive Disease|112|||
48947276|NCT01183858|157638205|FG001|Overall Study|Progressive Disease|115|||
48737517|NCT00809354|156890101|FG005|Overall Study|Study terminated by sponsor|133|||
48737518|NCT00809354|156890102|FG006|Overall Study|Study terminated by sponsor|124|||
48737519|NCT00809354|156890103|FG007|Overall Study|Study terminated by sponsor|148|||
48737520|NCT00809354|156890104|FG008|Overall Study|Study terminated by sponsor|127|||
48737521|NCT00809354|156890105|FG009|Overall Study|Study terminated by sponsor|135|||
48737522|NCT00809354|156890096|FG000|Overall Study|Withdrawn due to pregnancy|0|||
48737523|NCT00809354|156890097|FG001|Overall Study|Withdrawn due to pregnancy|1|||
48737524|NCT00809354|156890098|FG002|Overall Study|Withdrawn due to pregnancy|0|||
48947277|NCT01183858|157638204|FG000|Overall Study|Death related to Progressive Disease|4|||
48947278|NCT01183858|157638205|FG001|Overall Study|Death related to Progressive Disease|5|||
48947279|NCT01183858|157638204|FG000|Overall Study|Lost to Follow-up|1|||
48947280|NCT01183858|157638205|FG001|Overall Study|Lost to Follow-up|1|||
48947281|NCT00537823|157638209|FG000|Overall Study|Adverse Event|2|||
48947282|NCT00537823|157638210|FG001|Overall Study|Adverse Event|0|||
48947283|NCT03043365|157638211|FG000|Weeks 0 to Week 8|Adverse Event|1|||
48947284|NCT03043365|157638212|FG001|Weeks 0 to Week 8|Adverse Event|3|||
48947285|NCT03043365|157638211|FG000|Weeks 0 to Week 8|Lost to Follow-up|2|||
48947286|NCT03043365|157638212|FG001|Weeks 0 to Week 8|Lost to Follow-up|0|||
48947287|NCT03043365|157638211|FG000|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1|||
48947288|NCT03043365|157638212|FG001|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0|||
48947289|NCT02873221|157638213|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
48947290|NCT02873221|157638214|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
48947291|NCT02873221|157638215|FG002|Treatment Period|Other Miscellaneous Reasons|1|||
48947292|NCT02873221|157638213|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
48737525|NCT00809354|156890099|FG003|Overall Study|Withdrawn due to pregnancy|0|||
48737526|NCT00809354|156890100|FG004|Overall Study|Withdrawn due to pregnancy|0|||
48737527|NCT00809354|156890101|FG005|Overall Study|Withdrawn due to pregnancy|0|||
48737528|NCT00809354|156890102|FG006|Overall Study|Withdrawn due to pregnancy|0|||
48737529|NCT00809354|156890103|FG007|Overall Study|Withdrawn due to pregnancy|0|||
48737530|NCT00809354|156890104|FG008|Overall Study|Withdrawn due to pregnancy|0|||
48737531|NCT00809354|156890105|FG009|Overall Study|Withdrawn due to pregnancy|0|||
48737532|NCT00809354|156890096|FG000|Overall Study|Randomized but not Treated|3|||
48737533|NCT00809354|156890097|FG001|Overall Study|Randomized but not Treated|1|||
48737534|NCT00809354|156890098|FG002|Overall Study|Randomized but not Treated|6|||
48737535|NCT00809354|156890099|FG003|Overall Study|Randomized but not Treated|0|||
48737536|NCT00809354|156890100|FG004|Overall Study|Randomized but not Treated|5|||
48737537|NCT00809354|156890101|FG005|Overall Study|Randomized but not Treated|0|||
48737538|NCT00809354|156890102|FG006|Overall Study|Randomized but not Treated|1|||
48947293|NCT02873221|157638214|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
48737539|NCT00809354|156890103|FG007|Overall Study|Randomized but not Treated|1|||
48737540|NCT00809354|156890104|FG008|Overall Study|Randomized but not Treated|2|||
48947294|NCT02873221|157638215|FG002|Treatment Period|Non-Compliance with Study Drug|2|||
48947295|NCT02873221|157638213|FG000|Treatment Period|Protocol Violation|2|||
48947296|NCT02873221|157638214|FG001|Treatment Period|Protocol Violation|5|||
48947297|NCT02873221|157638215|FG002|Treatment Period|Protocol Violation|8|||
48947298|NCT02873221|157638213|FG000|Treatment Period|Pregnancy|4|||
48737541|NCT00809354|156890105|FG009|Overall Study|Randomized but not Treated|1|||
48737542|NCT00809354|156890096|FG000|Overall Study|Death|0|||
48947299|NCT02873221|157638214|FG001|Treatment Period|Pregnancy|6|||
48947300|NCT02873221|157638215|FG002|Treatment Period|Pregnancy|3|||
48947301|NCT02873221|157638213|FG000|Treatment Period|Lack of Qualifying Event|0|||
48947302|NCT02873221|157638214|FG001|Treatment Period|Lack of Qualifying Event|3|||
48947303|NCT02873221|157638215|FG002|Treatment Period|Lack of Qualifying Event|1|||
48947304|NCT02873221|157638213|FG000|Treatment Period|Withdrawal of Consent|52|||
48947305|NCT02873221|157638214|FG001|Treatment Period|Withdrawal of Consent|51|||
48947306|NCT02873221|157638215|FG002|Treatment Period|Withdrawal of Consent|41|||
48947307|NCT02873221|157638213|FG000|Treatment Period|Lack of Efficacy|0|||
48947308|NCT02873221|157638214|FG001|Treatment Period|Lack of Efficacy|17|||
48947309|NCT02873221|157638215|FG002|Treatment Period|Lack of Efficacy|12|||
48947310|NCT02873221|157638213|FG000|Treatment Period|Adverse Event|4|||
48947311|NCT02873221|157638214|FG001|Treatment Period|Adverse Event|9|||
48947312|NCT02873221|157638215|FG002|Treatment Period|Adverse Event|11|||
48947313|NCT02873221|157638213|FG000|Treatment Period|Lost to Follow-up|26|||
48947314|NCT02873221|157638214|FG001|Treatment Period|Lost to Follow-up|30|||
48947315|NCT02873221|157638215|FG002|Treatment Period|Lost to Follow-up|26|||
48737543|NCT00809354|156890097|FG001|Overall Study|Death|0|||
48947316|NCT02873221|157638213|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
48947317|NCT02873221|157638214|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|2|||
48947318|NCT02873221|157638215|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
48947319|NCT02873221|157638213|FG000|Safety Follow-up Period|Protocol Violation|0|||
48947320|NCT02873221|157638214|FG001|Safety Follow-up Period|Protocol Violation|0|||
48737544|NCT00809354|156890098|FG002|Overall Study|Death|0|||
48737545|NCT00809354|156890099|FG003|Overall Study|Death|0|||
48737546|NCT00809354|156890100|FG004|Overall Study|Death|0|||
48737547|NCT00809354|156890101|FG005|Overall Study|Death|0|||
48737548|NCT00809354|156890102|FG006|Overall Study|Death|0|||
48737549|NCT00809354|156890103|FG007|Overall Study|Death|1|||
48737550|NCT00809354|156890104|FG008|Overall Study|Death|0|||
48737551|NCT00809354|156890105|FG009|Overall Study|Death|0|||
48737552|NCT01823146|156890106|FG000|Overall Study|Withdrawal by Subject|0|||
48737553|NCT01823146|156890107|FG001|Overall Study|Withdrawal by Subject|1|||
48737554|NCT01823146|156890106|FG000|Overall Study|Lost to Follow-up|2|||
48737555|NCT01823146|156890107|FG001|Overall Study|Lost to Follow-up|1|||
48737556|NCT02122458|156890111|FG000|Overall Study|Withdrawal by Subject|0|||
48737557|NCT02122458|156890112|FG001|Overall Study|Withdrawal by Subject|0|||
48737558|NCT02122458|156890113|FG002|Overall Study|Withdrawal by Subject|0|||
48737559|NCT02122458|156890114|FG003|Overall Study|Withdrawal by Subject|4|||
48737560|NCT02122458|156890115|FG004|Overall Study|Withdrawal by Subject|4|||
48737561|NCT02122458|156890116|FG005|Overall Study|Withdrawal by Subject|4|||
48737562|NCT02122458|156890117|FG006|Overall Study|Withdrawal by Subject|0|||
48737563|NCT02122458|156890111|FG000|Overall Study|Lost to Follow-up|1|||
48737564|NCT02122458|156890112|FG001|Overall Study|Lost to Follow-up|3|||
48737565|NCT02122458|156890113|FG002|Overall Study|Lost to Follow-up|0|||
48737566|NCT02122458|156890114|FG003|Overall Study|Lost to Follow-up|7|||
48737567|NCT02122458|156890115|FG004|Overall Study|Lost to Follow-up|5|||
48737568|NCT02122458|156890116|FG005|Overall Study|Lost to Follow-up|15|||
48737569|NCT02122458|156890117|FG006|Overall Study|Lost to Follow-up|1|||
48737570|NCT02122458|156890111|FG000|Overall Study|Did not qualify at initial testing or after chart review|1|||
48737571|NCT02122458|156890112|FG001|Overall Study|Did not qualify at initial testing or after chart review|0|||
48737572|NCT02122458|156890113|FG002|Overall Study|Did not qualify at initial testing or after chart review|0|||
48737573|NCT02122458|156890114|FG003|Overall Study|Did not qualify at initial testing or after chart review|0|||
48737574|NCT02122458|156890115|FG004|Overall Study|Did not qualify at initial testing or after chart review|0|||
48737575|NCT02122458|156890116|FG005|Overall Study|Did not qualify at initial testing or after chart review|0|||
48737576|NCT02122458|156890117|FG006|Overall Study|Did not qualify at initial testing or after chart review|0|||
48737577|NCT02122458|156890111|FG000|Overall Study|Adverse Event|1|||
48737578|NCT02122458|156890112|FG001|Overall Study|Adverse Event|0|||
48852754|NCT03547154|157299685|FG000|Overall Study|Insufficient Therapeutic Response|13|||
48852755|NCT03547154|157299686|FG001|Overall Study|Insufficient Therapeutic Response|10|||
48852756|NCT03547154|157299685|FG000|Overall Study|Withdrawal by Subject|10|||
48852757|NCT03547154|157299686|FG001|Overall Study|Withdrawal by Subject|6|||
48852758|NCT03547154|157299685|FG000|Overall Study|Not Selected|0|||
48852759|NCT03547154|157299686|FG001|Overall Study|Not Selected|1|||
48852760|NCT03547154|157299685|FG000|Overall Study|Continued treatment beyond 12 mo.|58|||
48852761|NCT03547154|157299686|FG001|Overall Study|Continued treatment beyond 12 mo.|50|||
48852762|NCT03057600|157299690|FG000|Overall Study|Adverse Event|0|||
48852763|NCT03057600|157299691|FG001|Overall Study|Adverse Event|0|||
48852764|NCT03057600|157299692|FG002|Overall Study|Adverse Event|4|||
48852765|NCT03057600|157299693|FG003|Overall Study|Adverse Event|0|||
48852766|NCT03057600|157299690|FG000|Overall Study|Radiologic Disease Progression|8|||
48852767|NCT03057600|157299691|FG001|Overall Study|Radiologic Disease Progression|7|||
48852768|NCT03057600|157299692|FG002|Overall Study|Radiologic Disease Progression|13|||
48852769|NCT03057600|157299693|FG003|Overall Study|Radiologic Disease Progression|10|||
48852770|NCT03057600|157299690|FG000|Overall Study|Symptomatic Deterioration|0|||
48852771|NCT03057600|157299691|FG001|Overall Study|Symptomatic Deterioration|1|||
48852772|NCT03057600|157299692|FG002|Overall Study|Symptomatic Deterioration|1|||
48852773|NCT03057600|157299693|FG003|Overall Study|Symptomatic Deterioration|0|||
48852774|NCT03057600|157299690|FG000|Overall Study|Investigator Decision|0|||
48852775|NCT03057600|157299691|FG001|Overall Study|Investigator Decision|0|||
48852776|NCT03057600|157299692|FG002|Overall Study|Investigator Decision|1|||
48852777|NCT03057600|157299693|FG003|Overall Study|Investigator Decision|0|||
48852778|NCT03057600|157299690|FG000|Overall Study|Study Termination by Sponsor|0|||
48852779|NCT03057600|157299691|FG001|Overall Study|Study Termination by Sponsor|0|||
48852780|NCT03057600|157299692|FG002|Overall Study|Study Termination by Sponsor|0|||
48852781|NCT03057600|157299693|FG003|Overall Study|Study Termination by Sponsor|2|||
48852782|NCT03057600|157299690|FG000|Overall Study|Withdrawal by Subject|0|||
48852783|NCT03057600|157299691|FG001|Overall Study|Withdrawal by Subject|1|||
48852784|NCT03057600|157299692|FG002|Overall Study|Withdrawal by Subject|0|||
48737579|NCT02122458|156890113|FG002|Overall Study|Adverse Event|0|||
48737580|NCT02122458|156890114|FG003|Overall Study|Adverse Event|0|||
48737581|NCT02122458|156890115|FG004|Overall Study|Adverse Event|0|||
48737582|NCT02122458|156890116|FG005|Overall Study|Adverse Event|0|||
48737583|NCT02122458|156890117|FG006|Overall Study|Adverse Event|0|||
48737584|NCT02122458|156890111|FG000|Overall Study|Experimental Error|0|||
48737585|NCT02122458|156890112|FG001|Overall Study|Experimental Error|0|||
48737586|NCT02122458|156890113|FG002|Overall Study|Experimental Error|0|||
48737587|NCT02122458|156890114|FG003|Overall Study|Experimental Error|0|||
48737588|NCT02122458|156890115|FG004|Overall Study|Experimental Error|3|||
48737589|NCT02122458|156890116|FG005|Overall Study|Experimental Error|0|||
48737590|NCT02122458|156890117|FG006|Overall Study|Experimental Error|0|||
48737591|NCT02122458|156890111|FG000|Overall Study|Deployed or Moved|0|||
48737592|NCT02122458|156890112|FG001|Overall Study|Deployed or Moved|0|||
48737593|NCT02122458|156890113|FG002|Overall Study|Deployed or Moved|0|||
48737594|NCT02122458|156890114|FG003|Overall Study|Deployed or Moved|0|||
48737595|NCT02122458|156890115|FG004|Overall Study|Deployed or Moved|1|||
48737596|NCT02122458|156890116|FG005|Overall Study|Deployed or Moved|0|||
48737597|NCT02122458|156890117|FG006|Overall Study|Deployed or Moved|0|||
48737598|NCT02122458|156890111|FG000|Overall Study|Scheduling Delays - Unable to Complete|0|||
48737599|NCT02122458|156890112|FG001|Overall Study|Scheduling Delays - Unable to Complete|1|||
48737600|NCT02122458|156890113|FG002|Overall Study|Scheduling Delays - Unable to Complete|0|||
48947321|NCT02873221|157638215|FG002|Safety Follow-up Period|Protocol Violation|1|||
48947322|NCT02873221|157638213|FG000|Safety Follow-up Period|Lost to Follow-up|3|||
48947323|NCT02873221|157638214|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
48737601|NCT02122458|156890114|FG003|Overall Study|Scheduling Delays - Unable to Complete|4|||
48737602|NCT02122458|156890115|FG004|Overall Study|Scheduling Delays - Unable to Complete|1|||
48737603|NCT02122458|156890116|FG005|Overall Study|Scheduling Delays - Unable to Complete|1|||
48737604|NCT02122458|156890117|FG006|Overall Study|Scheduling Delays - Unable to Complete|0|||
48737605|NCT02122458|156890111|FG000|Overall Study|Noncompliance|0|||
48737606|NCT02122458|156890112|FG001|Overall Study|Noncompliance|1|||
48737607|NCT02122458|156890113|FG002|Overall Study|Noncompliance|0|||
48737608|NCT02122458|156890114|FG003|Overall Study|Noncompliance|0|||
48737609|NCT02122458|156890115|FG004|Overall Study|Noncompliance|0|||
48737610|NCT02122458|156890116|FG005|Overall Study|Noncompliance|0|||
48737611|NCT02122458|156890117|FG006|Overall Study|Noncompliance|0|||
48737612|NCT00075218|156890118|FG000|Double-Blind Treatment|Adverse Event|23|||
48737613|NCT00075218|156890119|FG001|Double-Blind Treatment|Adverse Event|4|||
48737614|NCT00075218|156890120|FG002|Double-Blind Treatment|Adverse Event|0|||
48737615|NCT00075218|156890118|FG000|Double-Blind Treatment|Withdrawal by Subject|7|||
48737616|NCT00075218|156890119|FG001|Double-Blind Treatment|Withdrawal by Subject|4|||
48737617|NCT00075218|156890120|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
48737618|NCT00075218|156890118|FG000|Double-Blind Treatment|Lost to Follow-up|1|||
48737619|NCT00075218|156890119|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
48947324|NCT02873221|157638215|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
48947325|NCT02873221|157638213|FG000|Safety Follow-up Period|Withdrawal of Consent|4|||
48947326|NCT02873221|157638214|FG001|Safety Follow-up Period|Withdrawal of Consent|10|||
48947327|NCT02873221|157638215|FG002|Safety Follow-up Period|Withdrawal of Consent|8|||
48947328|NCT04530825|157638216|FG000|Overall Study|No longer eligible on the day of baseline visit|0|||
48947329|NCT04530825|157638217|FG001|Overall Study|No longer eligible on the day of baseline visit|1|||
48947330|NCT04530825|157638218|FG002|Overall Study|No longer eligible on the day of baseline visit|0|||
48947331|NCT04530825|157638219|FG003|Overall Study|No longer eligible on the day of baseline visit|1|||
48947332|NCT04530825|157638216|FG000|Overall Study|Did not complete follow-up|3|||
48947333|NCT04530825|157638217|FG001|Overall Study|Did not complete follow-up|0|||
48737620|NCT00075218|156890120|FG002|Double-Blind Treatment|Lost to Follow-up|0|||
48737621|NCT00075218|156890118|FG000|Double-Blind Treatment|Lack of Efficacy|58|||
48737622|NCT00075218|156890119|FG001|Double-Blind Treatment|Lack of Efficacy|6|||
48737623|NCT00075218|156890120|FG002|Double-Blind Treatment|Lack of Efficacy|0|||
48737624|NCT00075218|156890118|FG000|Double-Blind Treatment|Decision of Sponsor|0|||
48737625|NCT00075218|156890119|FG001|Double-Blind Treatment|Decision of Sponsor|1|||
48737626|NCT00075218|156890120|FG002|Double-Blind Treatment|Decision of Sponsor|0|||
48737627|NCT00075218|156890118|FG000|Double-Blind Treatment|No study medication taken|2|||
48737628|NCT00075218|156890119|FG001|Double-Blind Treatment|No study medication taken|0|||
48737629|NCT00075218|156890120|FG002|Double-Blind Treatment|No study medication taken|0|||
48947334|NCT04530825|157638218|FG002|Overall Study|Did not complete follow-up|0|||
48947335|NCT04530825|157638219|FG003|Overall Study|Did not complete follow-up|0|||
48737630|NCT00075218|156890118|FG000|Open-Label Treatment|Lack of Efficacy|0|||
48737631|NCT00075218|156890119|FG001|Open-Label Treatment|Lack of Efficacy|0|||
48737632|NCT00075218|156890120|FG002|Open-Label Treatment|Lack of Efficacy|174|||
48737633|NCT00075218|156890118|FG000|Open-Label Treatment|Adverse Event|0|||
48737634|NCT00075218|156890119|FG001|Open-Label Treatment|Adverse Event|0|||
48737635|NCT00075218|156890120|FG002|Open-Label Treatment|Adverse Event|51|||
48737636|NCT00075218|156890118|FG000|Open-Label Treatment|Withdrawal by Subject|0|||
48737637|NCT00075218|156890119|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
48737638|NCT00075218|156890120|FG002|Open-Label Treatment|Withdrawal by Subject|12|||
48737639|NCT00075218|156890118|FG000|Open-Label Treatment|Decision of Sponsor|0|||
48737640|NCT00075218|156890119|FG001|Open-Label Treatment|Decision of Sponsor|0|||
48737641|NCT00075218|156890120|FG002|Open-Label Treatment|Decision of Sponsor|8|||
48737642|NCT00075218|156890118|FG000|Open-Label Treatment|Protocol Violation|0|||
48737643|NCT00075218|156890119|FG001|Open-Label Treatment|Protocol Violation|0|||
48737644|NCT00075218|156890120|FG002|Open-Label Treatment|Protocol Violation|1|||
48737645|NCT00075218|156890118|FG000|Open-Label Treatment|enrolled in a separate continuation|0|||
48737646|NCT00075218|156890119|FG001|Open-Label Treatment|enrolled in a separate continuation|0|||
48737647|NCT00075218|156890120|FG002|Open-Label Treatment|enrolled in a separate continuation|9|||
48737648|NCT05095454|156890121|FG000|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|0|||
48737649|NCT05095454|156890122|FG001|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|1|||
48737650|NCT03840174|156890123|FG000|Overall Study|Withdrawal by Subject|1|||
48737651|NCT03840174|156890124|FG001|Overall Study|Withdrawal by Subject|0|||
48737652|NCT03840174|156890125|FG002|Overall Study|Withdrawal by Subject|0|||
48737653|NCT03840174|156890126|FG003|Overall Study|Withdrawal by Subject|0|||
48737654|NCT00722423|156890129|FG000|Overall Study|Protocol Violation|0|||
48737655|NCT00722423|156890130|FG001|Overall Study|Protocol Violation|1|||
48737656|NCT00131508|156890131|FG000|Overall Study|Disease progression|0|||
48737657|NCT00131508|156890132|FG001|Overall Study|Disease progression|2|||
48737658|NCT00131508|156890131|FG000|Overall Study|Non-Compliance|2|||
48737659|NCT00131508|156890132|FG001|Overall Study|Non-Compliance|4|||
48737660|NCT00131508|156890131|FG000|Overall Study|Withdrawal by Subject|1|||
48737661|NCT00131508|156890132|FG001|Overall Study|Withdrawal by Subject|2|||
48737662|NCT03643575|156890133|FG000|Washout: 7 Days|Withdrew consent due to illness|0|||
48737663|NCT03643575|156890134|FG001|Washout: 7 Days|Withdrew consent due to illness|0|||
48737664|NCT03643575|156890135|FG002|Washout: 7 Days|Withdrew consent due to illness|0|||
48737665|NCT03643575|156890136|FG003|Washout: 7 Days|Withdrew consent due to illness|1|||
48737666|NCT03643575|156890137|FG004|Washout: 7 Days|Withdrew consent due to illness|0|||
48737667|NCT03643575|156890138|FG005|Washout: 7 Days|Withdrew consent due to illness|0|||
48737668|NCT03643575|156890133|FG000|Washout: 7 Days|Adverse Event|1|||
48737669|NCT03643575|156890134|FG001|Washout: 7 Days|Adverse Event|0|||
48737670|NCT03643575|156890135|FG002|Washout: 7 Days|Adverse Event|0|||
48737671|NCT03643575|156890136|FG003|Washout: 7 Days|Adverse Event|0|||
48737672|NCT03643575|156890137|FG004|Washout: 7 Days|Adverse Event|0|||
48737673|NCT03643575|156890138|FG005|Washout: 7 Days|Adverse Event|0|||
48737674|NCT03643575|156890133|FG000|Washout: 7 Days|Non compliance check in|0|||
48947336|NCT02640612|157638220|FG000|Overall Study|Adverse Event|6|||
48947337|NCT02640612|157638221|FG001|Overall Study|Adverse Event|7|||
48947338|NCT02640612|157638222|FG002|Overall Study|Adverse Event|2|||
48947339|NCT02640612|157638220|FG000|Overall Study|Death|1|||
48947340|NCT02640612|157638221|FG001|Overall Study|Death|0|||
48947341|NCT02640612|157638222|FG002|Overall Study|Death|0|||
48737675|NCT03643575|156890134|FG001|Washout: 7 Days|Non compliance check in|1|||
48737676|NCT03643575|156890135|FG002|Washout: 7 Days|Non compliance check in|0|||
48737677|NCT03643575|156890136|FG003|Washout: 7 Days|Non compliance check in|0|||
48947342|NCT02640612|157638220|FG000|Overall Study|Withdrawal by Subject|10|||
48737678|NCT03643575|156890137|FG004|Washout: 7 Days|Non compliance check in|0|||
48737679|NCT03643575|156890138|FG005|Washout: 7 Days|Non compliance check in|0|||
48947343|NCT02640612|157638221|FG001|Overall Study|Withdrawal by Subject|3|||
48737680|NCT01950169|156890139|FG000|Overall Study|Withdrawal by Subject|2|||
48737681|NCT01950169|156890140|FG001|Overall Study|Withdrawal by Subject|8|||
48737682|NCT01950169|156890141|FG002|Overall Study|Withdrawal by Subject|1|||
48737683|NCT01950169|156890139|FG000|Overall Study|Death|1|||
48947344|NCT02640612|157638222|FG002|Overall Study|Withdrawal by Subject|3|||
48947345|NCT02640612|157638220|FG000|Overall Study|Lost to Follow-up|4|||
48947346|NCT02640612|157638221|FG001|Overall Study|Lost to Follow-up|1|||
48947347|NCT02640612|157638222|FG002|Overall Study|Lost to Follow-up|1|||
48947348|NCT02640612|157638220|FG000|Overall Study|Protocol Violation|0|||
48947349|NCT02640612|157638221|FG001|Overall Study|Protocol Violation|2|||
48947350|NCT02640612|157638222|FG002|Overall Study|Protocol Violation|0|||
48947351|NCT02640612|157638220|FG000|Overall Study|Lack of Efficacy|1|||
48737684|NCT01950169|156890140|FG001|Overall Study|Death|0|||
48737685|NCT01950169|156890141|FG002|Overall Study|Death|0|||
48947352|NCT02640612|157638221|FG001|Overall Study|Lack of Efficacy|1|||
48947353|NCT02640612|157638222|FG002|Overall Study|Lack of Efficacy|0|||
48947354|NCT03396471|157638227|FG000|Study Treatment - Up to 22 Months|Disease Progression|6|||
48947355|NCT03396471|157638227|FG000|Study Treatment - Up to 22 Months|Alternative Cancer Therapy|2|||
48947356|NCT03396471|157638227|FG000|Study Treatment - Up to 22 Months|AE / Side Effects / Complications|3|||
48947357|NCT03396471|157638227|FG000|Study Treatment - Up to 22 Months|Death|2|||
48947358|NCT03396471|157638227|FG000|Study Treatment - Up to 22 Months|Symptomatic Deterioration|1|||
48947359|NCT03396471|157638227|FG000|Follow up - Up to 2 Years|Death|9|||
48947360|NCT03396471|157638227|FG000|Follow up - Up to 2 Years|Patient lost to follow up|1|||
48947361|NCT03396471|157638227|FG000|Follow up - Up to 2 Years|Patient Refused to follow up|1|||
48947362|NCT03396471|157638227|FG000|Follow up - Up to 2 Years|study terminated|1|||
48947363|NCT03396471|157638227|FG000|Follow up - Up to 2 Years|Patient would like to seek treatments locally.|1|||
48947364|NCT03396471|157638227|FG000|Follow up - Up to 2 Years|Patient stopped protocol treatment due to lack of response to treatment regimen.|1|||
48947365|NCT04283461|157638233|FG000|Overall Study|Enrolled in separate trial|0|||
48947366|NCT04283461|157638234|FG001|Overall Study|Enrolled in separate trial|0|||
48947367|NCT04283461|157638235|FG002|Overall Study|Enrolled in separate trial|8|||
48947368|NCT04283461|157638236|FG003|Overall Study|Enrolled in separate trial|13|||
48947369|NCT04283461|157638237|FG004|Overall Study|Enrolled in separate trial|12|||
48947370|NCT04283461|157638238|FG005|Overall Study|Enrolled in separate trial|0|||
48947371|NCT04283461|157638239|FG006|Overall Study|Enrolled in separate trial|0|||
48947372|NCT04283461|157638240|FG007|Overall Study|Enrolled in separate trial|8|||
48947373|NCT04283461|157638241|FG008|Overall Study|Enrolled in separate trial|0|||
48947374|NCT04283461|157638242|FG009|Overall Study|Enrolled in separate trial|0|||
48947375|NCT04283461|157638243|FG010|Overall Study|Enrolled in separate trial|0|||
48737686|NCT01146912|156890144|FG000|Overall Study|Already received influenza vaccination|817|||
48947376|NCT04283461|157638244|FG011|Overall Study|Enrolled in separate trial|7|||
48947377|NCT04283461|157638245|FG012|Overall Study|Enrolled in separate trial|0|||
48947378|NCT03237845|157638246|FG000|Overall Study|Adverse Event|0|||
48947379|NCT03237845|157638247|FG001|Overall Study|Adverse Event|1|||
48947380|NCT03237845|157638246|FG000|Overall Study|Lost to Follow-up|13|||
48947381|NCT03237845|157638247|FG001|Overall Study|Lost to Follow-up|10|||
48947382|NCT03237845|157638246|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|26|||
48947383|NCT03237845|157638247|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|31|||
48947384|NCT03237845|157638246|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
48947385|NCT03237845|157638247|FG001|Overall Study|Non-Compliance With Study Treatment|1|||
48947386|NCT03237845|157638246|FG000|Overall Study|Physician Decision|1|||
48947387|NCT03237845|157638247|FG001|Overall Study|Physician Decision|2|||
48947388|NCT03237845|157638246|FG000|Overall Study|Pregnancy|1|||
48947389|NCT03237845|157638247|FG001|Overall Study|Pregnancy|0|||
48947390|NCT03237845|157638246|FG000|Overall Study|Protocol Deviation|0|||
48947391|NCT03237845|157638247|FG001|Overall Study|Protocol Deviation|1|||
48737687|NCT01146912|156890145|FG001|Overall Study|Already received influenza vaccination|822|||
48737688|NCT01146912|156890146|FG002|Overall Study|Already received influenza vaccination|13|||
48947392|NCT03237845|157638246|FG000|Overall Study|Technical Problems|8|||
48947393|NCT03237845|157638247|FG001|Overall Study|Technical Problems|1|||
49015313|NCT00814320|157892147|FG001|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1|||
48947394|NCT03237845|157638246|FG000|Overall Study|Withdrawal by Subject|3|||
48852785|NCT03057600|157299693|FG003|Overall Study|Withdrawal by Subject|0|||
48852786|NCT03057600|157299690|FG000|Overall Study|Other, Not Specified|1|||
48852787|NCT03057600|157299691|FG001|Overall Study|Other, Not Specified|1|||
48852788|NCT03057600|157299692|FG002|Overall Study|Other, Not Specified|1|||
48947395|NCT03237845|157638247|FG001|Overall Study|Withdrawal by Subject|3|||
48947396|NCT03237845|157638246|FG000|Overall Study|Other Reasons|4|||
48947397|NCT03237845|157638247|FG001|Overall Study|Other Reasons|0|||
48947398|NCT01749735|157638248|FG000|Overall Study|Withdrawal by Subject|1|||
48947399|NCT01749735|157638249|FG001|Overall Study|Withdrawal by Subject|0|||
48947400|NCT01221233|157638250|FG000|Overall Study|Withdrawal by Subject|3|||
48947401|NCT01221233|157638251|FG001|Overall Study|Withdrawal by Subject|1|||
48947402|NCT02117050|157638252|FG000|Overall Study|Subject Enrolled but not Dosed|1|||
48947403|NCT04382651|157638253|FG000|Overall Study|Death|26|||
48947404|NCT04382651|157638254|FG001|Overall Study|Death|23|||
48947405|NCT04382651|157638253|FG000|Overall Study|Lost to Follow-up|3|||
48947406|NCT04382651|157638254|FG001|Overall Study|Lost to Follow-up|4|||
48947407|NCT04382651|157638253|FG000|Overall Study|Withdrawal by Subject|2|||
48947408|NCT04382651|157638254|FG001|Overall Study|Withdrawal by Subject|0|||
48947409|NCT04382651|157638253|FG000|Overall Study|Physician Decision|0|||
48947410|NCT04382651|157638254|FG001|Overall Study|Physician Decision|1|||
48947411|NCT02168946|157638255|FG000|Overall Study|Adverse Event|8|||
48947412|NCT02168946|157638256|FG001|Overall Study|Adverse Event|5|||
48947413|NCT02168946|157638255|FG000|Overall Study|Lost to Follow-up|3|||
48737689|NCT01146912|156890147|FG003|Overall Study|Already received influenza vaccination|15|||
48737690|NCT01146912|156890148|FG004|Overall Study|Already received influenza vaccination|41|||
48737691|NCT01146912|156890149|FG005|Overall Study|Already received influenza vaccination|61|||
48737692|NCT01146912|156890150|FG006|Overall Study|Already received influenza vaccination|56|||
48947414|NCT02168946|157638256|FG001|Overall Study|Lost to Follow-up|0|||
48947415|NCT02168946|157638255|FG000|Overall Study|Subject unable to come back for visits|1|||
48947416|NCT02168946|157638256|FG001|Overall Study|Subject unable to come back for visits|0|||
48947417|NCT01770353|157638259|FG000|Overall Study|Progressive disease|2|||
48947418|NCT01770353|157638260|FG001|Overall Study|Progressive disease|1|||
48947419|NCT01770353|157638259|FG000|Overall Study|Adverse Event|0|||
48947420|NCT01770353|157638260|FG001|Overall Study|Adverse Event|1|||
48947421|NCT01770353|157638259|FG000|Overall Study|Protocol Violation|1|||
48947422|NCT01770353|157638260|FG001|Overall Study|Protocol Violation|0|||
48947423|NCT01770353|157638259|FG000|Overall Study|Physician Decision|0|||
48947424|NCT01770353|157638260|FG001|Overall Study|Physician Decision|3|||
48947425|NCT01770353|157638259|FG000|Overall Study|Clinical deterioration|3|||
48947426|NCT01770353|157638260|FG001|Overall Study|Clinical deterioration|6|||
48947427|NCT01770353|157638259|FG000|Overall Study|Toxicity related diarrhoea + progression|0|||
48947428|NCT01770353|157638260|FG001|Overall Study|Toxicity related diarrhoea + progression|1|||
48947429|NCT01188798|157638263|FG000|Overall Study|Death|0|||
48947430|NCT01188798|157638264|FG001|Overall Study|Death|1|||
48947431|NCT01188798|157638263|FG000|Overall Study|Required additional transplant|1|||
48947432|NCT01188798|157638264|FG001|Overall Study|Required additional transplant|1|||
48947433|NCT01188798|157638263|FG000|Overall Study|Protocol closure|1|||
48947434|NCT01188798|157638264|FG001|Overall Study|Protocol closure|1|||
48947435|NCT00306891|157638267|FG000|Part A|Withdrawal by Subject|1|||
48947436|NCT00306891|157638268|FG001|Part A|Withdrawal by Subject|1|||
48947437|NCT00306891|157638269|FG002|Part A|Withdrawal by Subject|0|||
48947438|NCT00306891|157638270|FG003|Part A|Withdrawal by Subject|0|||
48947439|NCT00306891|157638267|FG000|Part A|Condition under investigation worsened|2|||
48947440|NCT00306891|157638268|FG001|Part A|Condition under investigation worsened|2|||
48947441|NCT00306891|157638269|FG002|Part A|Condition under investigation worsened|0|||
48947442|NCT00306891|157638270|FG003|Part A|Condition under investigation worsened|0|||
48947443|NCT00306891|157638267|FG000|Part A|Incorrect enrol/entry crit not fulfilled|0|||
48852789|NCT03057600|157299693|FG003|Overall Study|Other, Not Specified|1|||
48852790|NCT02167451|157299694|FG000|Overall Study|Withdrawal by Subject|1|||
48852791|NCT01218659|157299695|FG000|18-Month Randomized Period|Withdrawal by Subject|2|||
48852792|NCT01218659|157299696|FG001|18-Month Randomized Period|Withdrawal by Subject|3|||
48852793|NCT01218659|157299697|FG002|18-Month Randomized Period|Withdrawal by Subject|0|||
48852794|NCT01218659|157299695|FG000|18-Month Randomized Period|Did not receive study drug|0|||
48852795|NCT01218659|157299696|FG001|18-Month Randomized Period|Did not receive study drug|3|||
48947444|NCT00306891|157638268|FG001|Part A|Incorrect enrol/entry crit not fulfilled|1|||
48947445|NCT00306891|157638269|FG002|Part A|Incorrect enrol/entry crit not fulfilled|0|||
48947446|NCT00306891|157638270|FG003|Part A|Incorrect enrol/entry crit not fulfilled|0|||
48947447|NCT00306891|157638267|FG000|Part A|Partial bowel obstruction|1|||
48947448|NCT00306891|157638268|FG001|Part A|Partial bowel obstruction|0|||
48947449|NCT00306891|157638269|FG002|Part A|Partial bowel obstruction|0|||
48947450|NCT00306891|157638270|FG003|Part A|Partial bowel obstruction|0|||
48947451|NCT00306891|157638267|FG000|Part A|Reaccumul. of ascites following drainage|0|||
48737693|NCT01146912|156890151|FG007|Overall Study|Already received influenza vaccination|0|||
48737694|NCT01146912|156890144|FG000|Overall Study|< 14 weeks gestational age|0|||
48737695|NCT01146912|156890145|FG001|Overall Study|< 14 weeks gestational age|0|||
48737696|NCT01146912|156890146|FG002|Overall Study|< 14 weeks gestational age|3|||
48737697|NCT01146912|156890147|FG003|Overall Study|< 14 weeks gestational age|2|||
48737698|NCT01146912|156890148|FG004|Overall Study|< 14 weeks gestational age|0|||
48737699|NCT01146912|156890149|FG005|Overall Study|< 14 weeks gestational age|0|||
48737700|NCT01146912|156890150|FG006|Overall Study|< 14 weeks gestational age|0|||
48737701|NCT01146912|156890151|FG007|Overall Study|< 14 weeks gestational age|0|||
48737702|NCT01146912|156890144|FG000|Overall Study|Duplicate patient|0|||
48737703|NCT01146912|156890145|FG001|Overall Study|Duplicate patient|0|||
48737704|NCT01146912|156890146|FG002|Overall Study|Duplicate patient|1|||
48737705|NCT01146912|156890147|FG003|Overall Study|Duplicate patient|0|||
48737706|NCT01146912|156890148|FG004|Overall Study|Duplicate patient|0|||
48737707|NCT01146912|156890149|FG005|Overall Study|Duplicate patient|0|||
48737708|NCT01146912|156890150|FG006|Overall Study|Duplicate patient|0|||
48737709|NCT01146912|156890151|FG007|Overall Study|Duplicate patient|0|||
48737710|NCT00333840|156890152|FG000|First-line Treatment Period|Adverse Event|38|||
48737711|NCT00333840|156890153|FG001|First-line Treatment Period|Adverse Event|37|||
48737712|NCT00333840|156890154|FG002|First-line Treatment Period|Adverse Event|0|||
48737713|NCT00333840|156890155|FG003|First-line Treatment Period|Adverse Event|0|||
48737714|NCT00333840|156890152|FG000|First-line Treatment Period|Abnormal laboratory values|3|||
48737715|NCT00333840|156890153|FG001|First-line Treatment Period|Abnormal laboratory values|1|||
48947452|NCT00306891|157638268|FG001|Part A|Reaccumul. of ascites following drainage|1|||
48947453|NCT00306891|157638269|FG002|Part A|Reaccumul. of ascites following drainage|0|||
48737716|NCT00333840|156890154|FG002|First-line Treatment Period|Abnormal laboratory values|0|||
48852796|NCT01218659|157299697|FG002|18-Month Randomized Period|Did not receive study drug|0|||
48737717|NCT00333840|156890155|FG003|First-line Treatment Period|Abnormal laboratory values|0|||
48737718|NCT00333840|156890152|FG000|First-line Treatment Period|Abnormal procedure|2|||
48737719|NCT00333840|156890153|FG001|First-line Treatment Period|Abnormal procedure|0|||
48852797|NCT01218659|157299695|FG000|12-Month OLE|Withdrawal by Subject|0|||
48852798|NCT01218659|157299696|FG001|12-Month OLE|Withdrawal by Subject|0|||
48947454|NCT00306891|157638270|FG003|Part A|Reaccumul. of ascites following drainage|0|||
48947455|NCT00306891|157638267|FG000|Part A|Suspicion of second malignancy|0|||
48737720|NCT00333840|156890154|FG002|First-line Treatment Period|Abnormal procedure|0|||
48737721|NCT00333840|156890155|FG003|First-line Treatment Period|Abnormal procedure|0|||
48737722|NCT00333840|156890152|FG000|First-line Treatment Period|Unsatisfactory therapeutic effect|88|||
48737723|NCT00333840|156890153|FG001|First-line Treatment Period|Unsatisfactory therapeutic effect|29|||
48737724|NCT00333840|156890154|FG002|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
48737725|NCT00333840|156890155|FG003|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
48737726|NCT00333840|156890152|FG000|First-line Treatment Period|No longer required study drug|21|||
48737727|NCT00333840|156890153|FG001|First-line Treatment Period|No longer required study drug|8|||
48737728|NCT00333840|156890154|FG002|First-line Treatment Period|No longer required study drug|0|||
48737729|NCT00333840|156890155|FG003|First-line Treatment Period|No longer required study drug|0|||
48737730|NCT00333840|156890152|FG000|First-line Treatment Period|Protocol Violation|17|||
48737731|NCT00333840|156890153|FG001|First-line Treatment Period|Protocol Violation|17|||
48737732|NCT00333840|156890154|FG002|First-line Treatment Period|Protocol Violation|0|||
48737733|NCT00333840|156890155|FG003|First-line Treatment Period|Protocol Violation|0|||
48737734|NCT00333840|156890152|FG000|First-line Treatment Period|Subject withdrew consent|57|||
48737735|NCT00333840|156890153|FG001|First-line Treatment Period|Subject withdrew consent|77|||
48737736|NCT00333840|156890154|FG002|First-line Treatment Period|Subject withdrew consent|0|||
48737737|NCT00333840|156890155|FG003|First-line Treatment Period|Subject withdrew consent|0|||
48737738|NCT00333840|156890152|FG000|First-line Treatment Period|Lost to Follow-up|15|||
48737739|NCT00333840|156890153|FG001|First-line Treatment Period|Lost to Follow-up|6|||
48737740|NCT00333840|156890154|FG002|First-line Treatment Period|Lost to Follow-up|0|||
48737741|NCT00333840|156890155|FG003|First-line Treatment Period|Lost to Follow-up|0|||
48737742|NCT00333840|156890152|FG000|First-line Treatment Period|Administrative problems|12|||
48737743|NCT00333840|156890153|FG001|First-line Treatment Period|Administrative problems|6|||
48737744|NCT00333840|156890154|FG002|First-line Treatment Period|Administrative problems|0|||
48737745|NCT00333840|156890155|FG003|First-line Treatment Period|Administrative problems|0|||
48737746|NCT00333840|156890152|FG000|First-line Treatment Period|Death|19|||
48737747|NCT00333840|156890153|FG001|First-line Treatment Period|Death|2|||
48947456|NCT00306891|157638268|FG001|Part A|Suspicion of second malignancy|1|||
48947457|NCT00306891|157638269|FG002|Part A|Suspicion of second malignancy|0|||
48947458|NCT00306891|157638270|FG003|Part A|Suspicion of second malignancy|0|||
48947459|NCT00306891|157638267|FG000|Part A|QTC interval outwith elig. criteria|1|||
48947460|NCT00306891|157638268|FG001|Part A|QTC interval outwith elig. criteria|0|||
48737748|NCT00333840|156890154|FG002|First-line Treatment Period|Death|0|||
48737749|NCT00333840|156890155|FG003|First-line Treatment Period|Death|0|||
48737750|NCT00333840|156890152|FG000|First-line Treatment Period|Crossed over to other treatment arm|14|||
48737751|NCT00333840|156890153|FG001|First-line Treatment Period|Crossed over to other treatment arm|363|||
48947461|NCT00306891|157638269|FG002|Part A|QTC interval outwith elig. criteria|0|||
48947462|NCT00306891|157638270|FG003|Part A|QTC interval outwith elig. criteria|0|||
48947463|NCT00306891|157638267|FG000|Part B|Death|0|||
48947464|NCT00306891|157638268|FG001|Part B|Death|0|||
48947465|NCT00306891|157638269|FG002|Part B|Death|1|||
48947466|NCT00306891|157638270|FG003|Part B|Death|2|||
48947467|NCT00306891|157638267|FG000|Part B|Adverse Event|0|||
48737752|NCT00333840|156890154|FG002|First-line Treatment Period|Crossed over to other treatment arm|0|||
48737753|NCT00333840|156890155|FG003|First-line Treatment Period|Crossed over to other treatment arm|0|||
48737754|NCT00333840|156890152|FG000|Second-line Treatment Period|Adverse Event|0|||
48737755|NCT00333840|156890153|FG001|Second-line Treatment Period|Adverse Event|0|||
48737756|NCT00333840|156890154|FG002|Second-line Treatment Period|Adverse Event|3|||
48737757|NCT00333840|156890155|FG003|Second-line Treatment Period|Adverse Event|34|||
48737758|NCT00333840|156890152|FG000|Second-line Treatment Period|Abnormal Laboratory Values|0|||
48947468|NCT00306891|157638268|FG001|Part B|Adverse Event|0|||
48947469|NCT00306891|157638269|FG002|Part B|Adverse Event|5|||
48947470|NCT00306891|157638270|FG003|Part B|Adverse Event|5|||
48947471|NCT00306891|157638267|FG000|Part B|Withdrawal by Subject|0|||
48737759|NCT00333840|156890153|FG001|Second-line Treatment Period|Abnormal Laboratory Values|0|||
48737760|NCT00333840|156890154|FG002|Second-line Treatment Period|Abnormal Laboratory Values|0|||
48737761|NCT00333840|156890155|FG003|Second-line Treatment Period|Abnormal Laboratory Values|3|||
48737762|NCT00333840|156890152|FG000|Second-line Treatment Period|Abnormal procedure|0|||
48737763|NCT00333840|156890153|FG001|Second-line Treatment Period|Abnormal procedure|0|||
48737764|NCT00333840|156890154|FG002|Second-line Treatment Period|Abnormal procedure|0|||
48737765|NCT00333840|156890155|FG003|Second-line Treatment Period|Abnormal procedure|1|||
48737766|NCT00333840|156890152|FG000|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
48737767|NCT00333840|156890153|FG001|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
48737768|NCT00333840|156890154|FG002|Second-line Treatment Period|Unsatisfactory therapeutic effect|9|||
48737769|NCT00333840|156890155|FG003|Second-line Treatment Period|Unsatisfactory therapeutic effect|70|||
48737770|NCT00333840|156890152|FG000|Second-line Treatment Period|No longer required study drug|0|||
48737771|NCT00333840|156890153|FG001|Second-line Treatment Period|No longer required study drug|0|||
48737772|NCT00333840|156890154|FG002|Second-line Treatment Period|No longer required study drug|1|||
48737773|NCT00333840|156890155|FG003|Second-line Treatment Period|No longer required study drug|14|||
48737774|NCT00333840|156890152|FG000|Second-line Treatment Period|Protocol Violation|0|||
48737775|NCT00333840|156890153|FG001|Second-line Treatment Period|Protocol Violation|0|||
48737776|NCT00333840|156890154|FG002|Second-line Treatment Period|Protocol Violation|1|||
48737777|NCT00333840|156890155|FG003|Second-line Treatment Period|Protocol Violation|10|||
48737778|NCT00333840|156890152|FG000|Second-line Treatment Period|Subject withdrew consent|0|||
48737779|NCT00333840|156890153|FG001|Second-line Treatment Period|Subject withdrew consent|0|||
48737780|NCT00333840|156890154|FG002|Second-line Treatment Period|Subject withdrew consent|0|||
48737781|NCT00333840|156890155|FG003|Second-line Treatment Period|Subject withdrew consent|34|||
48737782|NCT00333840|156890152|FG000|Second-line Treatment Period|Lost to Follow-up|0|||
48737783|NCT00333840|156890153|FG001|Second-line Treatment Period|Lost to Follow-up|0|||
48737784|NCT00333840|156890154|FG002|Second-line Treatment Period|Lost to Follow-up|0|||
48737785|NCT00333840|156890155|FG003|Second-line Treatment Period|Lost to Follow-up|6|||
48737786|NCT00333840|156890152|FG000|Second-line Treatment Period|Administrative problems|0|||
48737787|NCT00333840|156890153|FG001|Second-line Treatment Period|Administrative problems|0|||
48737788|NCT00333840|156890154|FG002|Second-line Treatment Period|Administrative problems|0|||
48737789|NCT00333840|156890155|FG003|Second-line Treatment Period|Administrative problems|7|||
48737790|NCT00333840|156890152|FG000|Second-line Treatment Period|Death|0|||
48737791|NCT00333840|156890153|FG001|Second-line Treatment Period|Death|0|||
48737792|NCT00333840|156890154|FG002|Second-line Treatment Period|Death|0|||
48737793|NCT00333840|156890155|FG003|Second-line Treatment Period|Death|9|||
48737794|NCT01453725|156890156|FG000|Overall Study|Adverse Event|3|||
48737795|NCT01453725|156890157|FG001|Overall Study|Adverse Event|3|||
48737796|NCT01453725|156890156|FG000|Overall Study|Lost to Follow-up|4|||
48737797|NCT01453725|156890157|FG001|Overall Study|Lost to Follow-up|0|||
48737798|NCT01453725|156890156|FG000|Overall Study|Non-compliance With Protocol|1|||
48737799|NCT01453725|156890157|FG001|Overall Study|Non-compliance With Protocol|2|||
48737800|NCT01453725|156890156|FG000|Overall Study|Protocol Violation|1|||
48947472|NCT00306891|157638268|FG001|Part B|Withdrawal by Subject|0|||
48947473|NCT00306891|157638269|FG002|Part B|Withdrawal by Subject|3|||
48947474|NCT00306891|157638270|FG003|Part B|Withdrawal by Subject|1|||
48947475|NCT00306891|157638267|FG000|Part B|Condition under investigation worsened|0|||
48947476|NCT00306891|157638268|FG001|Part B|Condition under investigation worsened|0|||
48737801|NCT01453725|156890157|FG001|Overall Study|Protocol Violation|0|||
48737802|NCT01453725|156890156|FG000|Overall Study|Withdrawal by Subject|2|||
48737803|NCT01453725|156890157|FG001|Overall Study|Withdrawal by Subject|3|||
48737804|NCT01453725|156890156|FG000|Overall Study|Pregnancy Wish|0|||
48947477|NCT00306891|157638269|FG002|Part B|Condition under investigation worsened|2|||
48947478|NCT00306891|157638270|FG003|Part B|Condition under investigation worsened|8|||
48947479|NCT00306891|157638267|FG000|Part B|Development of study specific disc crit.|0|||
48737805|NCT01453725|156890157|FG001|Overall Study|Pregnancy Wish|2|||
48737806|NCT01453725|156890156|FG000|Overall Study|Pregnancy|1|||
48737807|NCT01453725|156890157|FG001|Overall Study|Pregnancy|0|||
48737808|NCT01453725|156890156|FG000|Overall Study|Physician Decision|1|||
48737809|NCT01453725|156890157|FG001|Overall Study|Physician Decision|1|||
48737810|NCT00074984|156890158|FG000|Overall Study|Death|1|||
48737811|NCT00074984|156890159|FG001|Overall Study|Death|2|||
48947480|NCT00306891|157638268|FG001|Part B|Development of study specific disc crit.|0|||
48947481|NCT00306891|157638269|FG002|Part B|Development of study specific disc crit.|0|||
48737812|NCT00074984|156890158|FG000|Overall Study|Withdrawal by Subject|2|||
48737813|NCT00074984|156890159|FG001|Overall Study|Withdrawal by Subject|3|||
48737814|NCT00074984|156890158|FG000|Overall Study|Patient Withdrawn Per Protocol|0|||
48737815|NCT00074984|156890159|FG001|Overall Study|Patient Withdrawn Per Protocol|3|||
48737816|NCT01436396|156890168|FG000|Overall Study|Protocol Violation|7|||
48737817|NCT01436396|156890169|FG001|Overall Study|Protocol Violation|5|||
48737818|NCT01436396|156890168|FG000|Overall Study|Adverse Event|1|||
48737819|NCT01436396|156890169|FG001|Overall Study|Adverse Event|2|||
48737820|NCT01436396|156890168|FG000|Overall Study|Withdrawal by Subject|19|||
48737821|NCT01436396|156890169|FG001|Overall Study|Withdrawal by Subject|29|||
48737822|NCT01436396|156890168|FG000|Overall Study|Serious adverse event|2|||
48737823|NCT01436396|156890169|FG001|Overall Study|Serious adverse event|3|||
48947482|NCT00306891|157638270|FG003|Part B|Development of study specific disc crit.|1|||
48947483|NCT01751646|157638271|FG000|Overall Study|Lost to Follow-up|5|||
48947484|NCT01751646|157638272|FG001|Overall Study|Lost to Follow-up|1|||
48947485|NCT01751646|157638271|FG000|Overall Study|Withdrawal by Subject|0|||
48947486|NCT01751646|157638272|FG001|Overall Study|Withdrawal by Subject|4|||
48947487|NCT01751646|157638271|FG000|Overall Study|Starting hormone therapy|1|||
48947488|NCT01751646|157638272|FG001|Overall Study|Starting hormone therapy|0|||
48947489|NCT01751646|157638271|FG000|Overall Study|Missed 4 or more consecutive DOT visits|2|||
48737824|NCT01436396|156890168|FG000|Overall Study|Lost to Follow-up|3|||
48737825|NCT01436396|156890169|FG001|Overall Study|Lost to Follow-up|3|||
48737826|NCT00216476|156890170|FG000|Overall Study|Withdrawal by Subject|59|||
48737827|NCT00216476|156890171|FG001|Overall Study|Withdrawal by Subject|72|||
48737828|NCT00216476|156890172|FG002|Overall Study|Withdrawal by Subject|9|||
48737829|NCT00216476|156890170|FG000|Overall Study|Lost to Follow-up|10|||
48737830|NCT00216476|156890171|FG001|Overall Study|Lost to Follow-up|9|||
48947490|NCT01751646|157638272|FG001|Overall Study|Missed 4 or more consecutive DOT visits|3|||
48947491|NCT01751646|157638271|FG000|Overall Study|Inadvertent enrollment|1|||
48947492|NCT01751646|157638272|FG001|Overall Study|Inadvertent enrollment|1|||
48947493|NCT01751646|157638271|FG000|Overall Study|Moved out of the area|1|||
48947494|NCT01751646|157638272|FG001|Overall Study|Moved out of the area|5|||
48947495|NCT01751646|157638271|FG000|Overall Study|Inability to attend required visits|0|||
48737831|NCT00216476|156890172|FG002|Overall Study|Lost to Follow-up|1|||
48737832|NCT00216476|156890170|FG000|Overall Study|Adverse Event|6|||
48947496|NCT01751646|157638272|FG001|Overall Study|Inability to attend required visits|1|||
48737833|NCT00216476|156890171|FG001|Overall Study|Adverse Event|10|||
48737834|NCT00216476|156890172|FG002|Overall Study|Adverse Event|1|||
48737835|NCT00216476|156890170|FG000|Overall Study|Lack of Efficacy|4|||
48947497|NCT01751646|157638271|FG000|Overall Study|Off study due to multiple obligations|0|||
48947498|NCT01751646|157638272|FG001|Overall Study|Off study due to multiple obligations|1|||
48737836|NCT00216476|156890171|FG001|Overall Study|Lack of Efficacy|3|||
48737837|NCT00216476|156890172|FG002|Overall Study|Lack of Efficacy|0|||
48737838|NCT00216476|156890170|FG000|Overall Study|Death|2|||
48737839|NCT00216476|156890171|FG001|Overall Study|Death|0|||
48737840|NCT00216476|156890172|FG002|Overall Study|Death|0|||
48737841|NCT00216476|156890170|FG000|Overall Study|Pregnancy|0|||
48737842|NCT00216476|156890171|FG001|Overall Study|Pregnancy|1|||
48947499|NCT01751646|157638271|FG000|Overall Study|Fails to comply with study requirements|0|||
48947500|NCT01751646|157638272|FG001|Overall Study|Fails to comply with study requirements|1|||
48947501|NCT01751646|157638271|FG000|Overall Study|Childcare issues|1|||
48947502|NCT01751646|157638272|FG001|Overall Study|Childcare issues|1|||
48947503|NCT00510692|157638273|FG000|Overall Study|Adverse Event|1|||
48947504|NCT00510692|157638274|FG001|Overall Study|Adverse Event|3|||
48947505|NCT00510692|157638273|FG000|Overall Study|Withdrawal by Subject|1|||
48947506|NCT00510692|157638274|FG001|Overall Study|Withdrawal by Subject|0|||
48947507|NCT01845077|157638275|FG000|Washout Period|Lost to Follow-up|0|||
48947508|NCT01845077|157638276|FG001|Washout Period|Lost to Follow-up|1|||
48947509|NCT01845077|157638277|FG002|Washout Period|Lost to Follow-up|0|||
48947510|NCT01845077|157638278|FG003|Washout Period|Lost to Follow-up|1|||
48947511|NCT01845077|157638279|FG004|Washout Period|Lost to Follow-up|0|||
48947512|NCT01845077|157638280|FG005|Washout Period|Lost to Follow-up|1|||
48947513|NCT01845077|157638275|FG000|Washout Period|Adverse Event|1|||
48947514|NCT01845077|157638276|FG001|Washout Period|Adverse Event|0|||
48947515|NCT01845077|157638277|FG002|Washout Period|Adverse Event|0|||
48947516|NCT01845077|157638278|FG003|Washout Period|Adverse Event|0|||
48947517|NCT01845077|157638279|FG004|Washout Period|Adverse Event|0|||
48947518|NCT01845077|157638280|FG005|Washout Period|Adverse Event|0|||
48947519|NCT01845077|157638275|FG000|Washout Period|elevated lab values (not clinic. sign.)|0|||
48737843|NCT00216476|156890172|FG002|Overall Study|Pregnancy|1|||
48737844|NCT00216476|156890170|FG000|Overall Study|Other|0|||
48737845|NCT00216476|156890171|FG001|Overall Study|Other|0|||
48737846|NCT00216476|156890172|FG002|Overall Study|Other|1|||
48737847|NCT00216476|156890170|FG000|Overall Study|Refuses Injection|11|||
48737848|NCT00216476|156890171|FG001|Overall Study|Refuses Injection|0|||
48947520|NCT01845077|157638276|FG001|Washout Period|elevated lab values (not clinic. sign.)|0|||
48947521|NCT01845077|157638277|FG002|Washout Period|elevated lab values (not clinic. sign.)|1|||
48947522|NCT01845077|157638278|FG003|Washout Period|elevated lab values (not clinic. sign.)|0|||
48947523|NCT01845077|157638279|FG004|Washout Period|elevated lab values (not clinic. sign.)|0|||
48737849|NCT00216476|156890172|FG002|Overall Study|Refuses Injection|0|||
48737850|NCT00216476|156890170|FG000|Overall Study|No Further Need for Treatment|3|||
48737851|NCT00216476|156890171|FG001|Overall Study|No Further Need for Treatment|4|||
48737852|NCT00216476|156890172|FG002|Overall Study|No Further Need for Treatment|1|||
48737853|NCT00216476|156890170|FG000|Overall Study|Non-compliance|0|||
48737854|NCT00216476|156890171|FG001|Overall Study|Non-compliance|4|||
48947524|NCT01845077|157638280|FG005|Washout Period|elevated lab values (not clinic. sign.)|0|||
48947525|NCT01845077|157638275|FG000|Washout Period|Protocol Violation|0|||
48947526|NCT01845077|157638276|FG001|Washout Period|Protocol Violation|0|||
48947527|NCT01845077|157638277|FG002|Washout Period|Protocol Violation|0|||
48737855|NCT00216476|156890172|FG002|Overall Study|Non-compliance|1|||
48737856|NCT00216476|156890170|FG000|Overall Study|Higher dose/Extra Medication Required|2|||
48737857|NCT00216476|156890171|FG001|Overall Study|Higher dose/Extra Medication Required|0|||
48737858|NCT00216476|156890172|FG002|Overall Study|Higher dose/Extra Medication Required|2|||
48737859|NCT00216476|156890170|FG000|Overall Study|Administrative Reasons|1|||
48737860|NCT00216476|156890171|FG001|Overall Study|Administrative Reasons|1|||
48737861|NCT00216476|156890172|FG002|Overall Study|Administrative Reasons|0|||
48737862|NCT00216476|156890170|FG000|Overall Study|Protocol Deviation|5|||
48737863|NCT00216476|156890171|FG001|Overall Study|Protocol Deviation|1|||
48737864|NCT00216476|156890172|FG002|Overall Study|Protocol Deviation|0|||
48737865|NCT00216476|156890170|FG000|Overall Study|Patient Moved|2|||
48737866|NCT00216476|156890171|FG001|Overall Study|Patient Moved|2|||
48737867|NCT00216476|156890172|FG002|Overall Study|Patient Moved|0|||
48737868|NCT01952145|156890175|FG000|Overall Study|Protocol Violation|2|||
48737869|NCT01952145|156890176|FG001|Overall Study|Protocol Violation|1|||
48737870|NCT01952145|156890175|FG000|Overall Study|Death|0|||
48737871|NCT01952145|156890176|FG001|Overall Study|Death|1|||
48737872|NCT01952145|156890175|FG000|Overall Study|Adverse Event|9|||
48737873|NCT01952145|156890176|FG001|Overall Study|Adverse Event|0|||
48947528|NCT01845077|157638278|FG003|Washout Period|Protocol Violation|1|||
48737874|NCT01952145|156890175|FG000|Overall Study|Withdrawal Criteria|16|||
48737875|NCT01952145|156890176|FG001|Overall Study|Withdrawal Criteria|11|||
48737876|NCT01952145|156890175|FG000|Overall Study|Unclassified|1|||
48737877|NCT01952145|156890176|FG001|Overall Study|Unclassified|1|||
48737878|NCT00178633|156890177|FG000|Overall Study|Lost to Follow-up|6|||
48737879|NCT03570697|156890178|FG000|Overall Study|Lost to Follow-up|0|||
48737880|NCT03570697|156890179|FG001|Overall Study|Lost to Follow-up|1|||
48737881|NCT03570697|156890178|FG000|Overall Study|Death|2|||
48737882|NCT03570697|156890179|FG001|Overall Study|Death|0|||
48737883|NCT03570697|156890178|FG000|Overall Study|Withdrawal by Subject|4|||
48737884|NCT03570697|156890179|FG001|Overall Study|Withdrawal by Subject|2|||
48737885|NCT03469934|156890180|FG000|Overall Study|Withdrawal by Subject|0|||
48737886|NCT03469934|156890181|FG001|Overall Study|Withdrawal by Subject|1|||
48737887|NCT02693119|156890182|FG000|Open-Label Period|Withdrawal by Subject|0|||
48737888|NCT02693119|156890183|FG001|Open-Label Period|Withdrawal by Subject|1|||
48737889|NCT01719783|156890186|FG000|Dose 2|Physician Decision|1|||
48947529|NCT01845077|157638279|FG004|Washout Period|Protocol Violation|1|||
48947530|NCT01845077|157638280|FG005|Washout Period|Protocol Violation|0|||
48737890|NCT01719783|156890187|FG001|Dose 2|Physician Decision|0|||
48737891|NCT00494299|156890188|FG000|Overall Study|Adverse Event|93|||
48737892|NCT00494299|156890189|FG001|Overall Study|Adverse Event|13|||
48737893|NCT00494299|156890188|FG000|Overall Study|Lost to Follow-up|1|||
48737894|NCT00494299|156890189|FG001|Overall Study|Lost to Follow-up|0|||
48852799|NCT01218659|157299697|FG002|12-Month OLE|Withdrawal by Subject|2|||
48852800|NCT01218659|157299695|FG000|12-Month OLE|Physician Decision|0|||
48852801|NCT01218659|157299696|FG001|12-Month OLE|Physician Decision|0|||
48852802|NCT01218659|157299697|FG002|12-Month OLE|Physician Decision|1|||
48852803|NCT01218659|157299695|FG000|12-Month OLE|Lost to Follow-up|0|||
48852804|NCT01218659|157299696|FG001|12-Month OLE|Lost to Follow-up|0|||
48852805|NCT01218659|157299697|FG002|12-Month OLE|Lost to Follow-up|1|||
48852806|NCT01218659|157299695|FG000|12-Month OLE|Pregnancy|0|||
48737895|NCT00494299|156890188|FG000|Overall Study|Physician Decision|0|||
48737896|NCT00494299|156890189|FG001|Overall Study|Physician Decision|2|||
48737897|NCT00494299|156890188|FG000|Overall Study|Protocol Violation|1|||
48737898|NCT00494299|156890189|FG001|Overall Study|Protocol Violation|2|||
48737899|NCT00494299|156890188|FG000|Overall Study|Withdrawal by Subject|8|||
48737900|NCT00494299|156890189|FG001|Overall Study|Withdrawal by Subject|3|||
48737901|NCT00494299|156890188|FG000|Overall Study|Disease Progression, Recurrence/Relapse|109|||
48737902|NCT00494299|156890189|FG001|Overall Study|Disease Progression, Recurrence/Relapse|185|||
48737903|NCT00494299|156890188|FG000|Overall Study|Participant Did Not Take Study Drug|0|||
48737904|NCT00494299|156890189|FG001|Overall Study|Participant Did Not Take Study Drug|2|||
48737905|NCT00494299|156890188|FG000|Overall Study|Site Closed by Sponsor|6|||
48737906|NCT00494299|156890189|FG001|Overall Study|Site Closed by Sponsor|0|||
48737907|NCT00494299|156890188|FG000|Overall Study|Protocol Driven Decision Point|11|||
48737908|NCT00494299|156890189|FG001|Overall Study|Protocol Driven Decision Point|22|||
48737909|NCT03780543|156890194|FG000|Overall Study|Adverse Event|1|||
48737910|NCT03780543|156890195|FG001|Overall Study|Adverse Event|0|||
48737911|NCT03780543|156890196|FG002|Overall Study|Adverse Event|2|||
48737912|NCT03780543|156890194|FG000|Overall Study|Lost to Follow-up|2|||
48737913|NCT03780543|156890195|FG001|Overall Study|Lost to Follow-up|0|||
48737914|NCT03780543|156890196|FG002|Overall Study|Lost to Follow-up|1|||
48737915|NCT03780543|156890194|FG000|Overall Study|Study terminated by Sponsor|8|||
48737916|NCT03780543|156890195|FG001|Overall Study|Study terminated by Sponsor|7|||
48737917|NCT03780543|156890196|FG002|Overall Study|Study terminated by Sponsor|13|||
48737918|NCT03780543|156890194|FG000|Overall Study|Withdrawal by Subject|1|||
48947531|NCT02973815|157638281|FG000|Post Intervention|Death|1|||
48737919|NCT03780543|156890195|FG001|Overall Study|Withdrawal by Subject|8|||
48852807|NCT01218659|157299696|FG001|12-Month OLE|Pregnancy|0|||
48947532|NCT02973815|157638282|FG001|Post Intervention|Death|0|||
48737920|NCT03780543|156890196|FG002|Overall Study|Withdrawal by Subject|1|||
48737921|NCT03780543|156890194|FG000|Overall Study|Noncompliance with study drug|1|||
48737922|NCT03780543|156890195|FG001|Overall Study|Noncompliance with study drug|0|||
48737923|NCT03780543|156890196|FG002|Overall Study|Noncompliance with study drug|0|||
48737924|NCT01254331|156890203|FG000|Initial Phase|Adverse Event|3|||
48737925|NCT01254331|156890203|FG000|Initial Phase|Withdrawal by Subject|1|||
48852808|NCT01218659|157299697|FG002|12-Month OLE|Pregnancy|1|||
48852809|NCT01218659|157299695|FG000|12-Month OLE|Lack of Efficacy|0|||
48852810|NCT01218659|157299696|FG001|12-Month OLE|Lack of Efficacy|0|||
49015314|NCT00814320|157892146|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1|||
49015315|NCT00814320|157892147|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0|||
48737926|NCT01254331|156890203|FG000|Initial Phase|Pregnancy|1|||
48737927|NCT01254331|156890203|FG000|Extension Phase|Lack of Efficacy|1|||
48737928|NCT01254331|156890203|FG000|Extension Phase|Lost to Follow-up|3|||
48737929|NCT00516074|156890206|FG000|Overall Study|Adverse Event|0|||
48947533|NCT02973815|157638281|FG000|Post Intervention|Lost to Follow-up|7|||
48947534|NCT02973815|157638282|FG001|Post Intervention|Lost to Follow-up|24|||
48947535|NCT02973815|157638281|FG000|Follow-up|Lost to Follow-up|2|||
48947536|NCT02973815|157638282|FG001|Follow-up|Lost to Follow-up|0|||
48947537|NCT02492711|157638285|FG000|Overall Study|Adverse Event|9|||
48947538|NCT02492711|157638286|FG001|Overall Study|Adverse Event|9|||
48947539|NCT02492711|157638287|FG002|Overall Study|Adverse Event|2|||
48947540|NCT02492711|157638285|FG000|Overall Study|Death|3|||
48947541|NCT02492711|157638286|FG001|Overall Study|Death|3|||
48947542|NCT02492711|157638287|FG002|Overall Study|Death|0|||
48852811|NCT01218659|157299697|FG002|12-Month OLE|Lack of Efficacy|1|||
48852812|NCT01218659|157299695|FG000|12-Month OLE|Declined to participate in the OLE|0|||
48852813|NCT01218659|157299696|FG001|12-Month OLE|Declined to participate in the OLE|0|||
48737930|NCT00516074|156890207|FG001|Overall Study|Adverse Event|1|||
48737931|NCT00516074|156890206|FG000|Overall Study|Subject Decision|4|||
48737932|NCT00516074|156890207|FG001|Overall Study|Subject Decision|2|||
48737933|NCT00516074|156890206|FG000|Overall Study|Loss of Glucose Control|2|||
48737934|NCT00516074|156890207|FG001|Overall Study|Loss of Glucose Control|0|||
48737935|NCT01903031|156890209|FG000|Overall Study|Not Able to Attend Clinic|1|||
48737936|NCT01903031|156890210|FG001|Overall Study|Not Able to Attend Clinic|1|||
48737937|NCT01903031|156890211|FG002|Overall Study|Not Able to Attend Clinic|0|||
48737938|NCT01903031|156890209|FG000|Overall Study|Missed Day 21 Primary Endpoint Visit|1|||
48737939|NCT01903031|156890210|FG001|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
48737940|NCT01903031|156890211|FG002|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
48947543|NCT02492711|157638285|FG000|Overall Study|Withdrawal by Subject|10|||
48947544|NCT02492711|157638286|FG001|Overall Study|Withdrawal by Subject|16|||
48947545|NCT02492711|157638287|FG002|Overall Study|Withdrawal by Subject|5|||
48947546|NCT02492711|157638285|FG000|Overall Study|Physician Decision|10|||
48947547|NCT02492711|157638286|FG001|Overall Study|Physician Decision|6|||
48947548|NCT02492711|157638287|FG002|Overall Study|Physician Decision|4|||
48947549|NCT02492711|157638285|FG000|Overall Study|Lost to Follow-up|0|||
48947550|NCT02492711|157638286|FG001|Overall Study|Lost to Follow-up|0|||
48947551|NCT02492711|157638287|FG002|Overall Study|Lost to Follow-up|1|||
48947552|NCT02492711|157638285|FG000|Overall Study|study treatment delay|2|||
48947553|NCT02492711|157638286|FG001|Overall Study|study treatment delay|1|||
48947554|NCT02492711|157638287|FG002|Overall Study|study treatment delay|0|||
48947555|NCT02492711|157638285|FG000|Overall Study|change in chemotherapy|0|||
48737941|NCT01903031|156890209|FG000|Overall Study|Adverse Event|0|||
48737942|NCT01903031|156890210|FG001|Overall Study|Adverse Event|1|||
48947556|NCT02492711|157638286|FG001|Overall Study|change in chemotherapy|1|||
48947557|NCT02492711|157638287|FG002|Overall Study|change in chemotherapy|0|||
48947558|NCT02492711|157638285|FG000|Overall Study|never treated|2|||
48947559|NCT02492711|157638286|FG001|Overall Study|never treated|4|||
48947560|NCT02492711|157638287|FG002|Overall Study|never treated|0|||
48947561|NCT02492711|157638285|FG000|Overall Study|Other|0|||
48947562|NCT02492711|157638286|FG001|Overall Study|Other|0|||
48947563|NCT02492711|157638287|FG002|Overall Study|Other|1|||
48947564|NCT01589094|157638288|FG000|Overall Study|Did not receive treatment|2|||
48947565|NCT00035815|157638295|FG000|Overall Study|Withdrawal by Subject|17|||
48947566|NCT00035815|157638296|FG001|Overall Study|Withdrawal by Subject|11|||
48947567|NCT01416610|157638303|FG000|Overall Study|Adverse Event|4|||
48947568|NCT01416610|157638303|FG000|Overall Study|Adverse Event -Patient decision|3|||
48947569|NCT01416610|157638303|FG000|Overall Study|Lack of Efficacy|4|||
48737943|NCT01903031|156890211|FG002|Overall Study|Adverse Event|0|||
48737944|NCT01903031|156890209|FG000|Overall Study|Withdrawal by Subject|0|||
48737945|NCT01903031|156890210|FG001|Overall Study|Withdrawal by Subject|1|||
48737946|NCT01903031|156890211|FG002|Overall Study|Withdrawal by Subject|1|||
48737947|NCT01903031|156890209|FG000|Overall Study|Protocol Violation|0|||
48737948|NCT01903031|156890210|FG001|Overall Study|Protocol Violation|0|||
48737949|NCT01903031|156890211|FG002|Overall Study|Protocol Violation|2|||
48737950|NCT01903031|156890209|FG000|Overall Study|Lost to Follow-up|0|||
48737951|NCT01903031|156890210|FG001|Overall Study|Lost to Follow-up|0|||
48737952|NCT01903031|156890211|FG002|Overall Study|Lost to Follow-up|1|||
48737953|NCT01903031|156890209|FG000|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
48737954|NCT01903031|156890210|FG001|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
48737955|NCT01903031|156890211|FG002|Overall Study|NuvaRing removed prior to Day 21 visit|1|||
48737956|NCT03896165|156890212|FG000|Overall Study|Withdrawal by Subject|2|||
48737957|NCT00415168|156890216|FG000|Overall Study|Death|26|||
48737958|NCT00415168|156890216|FG000|Overall Study|Lost to Follow-up|3|||
48737959|NCT00415168|156890216|FG000|Overall Study|Physician Decision|13|||
48947570|NCT01416610|157638303|FG000|Overall Study|No reason given|5|||
48947571|NCT01416610|157638303|FG000|Overall Study|Withdrawal by Subject|13|||
48947572|NCT01416610|157638303|FG000|Overall Study|Lost to Follow-up|7|||
48947573|NCT01416610|157638303|FG000|Overall Study|Sufficient treatment duration (PCR neg.)|7|||
48737960|NCT00415168|156890216|FG000|Overall Study|Sponsor Decision|4|||
48737961|NCT00415168|156890216|FG000|Overall Study|Withdrawal by Subject|6|||
48737962|NCT00400764|156890220|FG000|Phase Ib|Adverse Event|1|||
48737963|NCT00400764|156890221|FG001|Phase Ib|Adverse Event|0|||
48947574|NCT01171521|157638304|FG000|Overall Study|Lost to Follow-up|5|||
48947575|NCT01171521|157638304|FG000|Overall Study|screen failure|1|||
48947576|NCT01161524|157638305|FG000|Core Study (23 Weeks)|Adverse Event|3|||
48737964|NCT00400764|156890222|FG002|Phase Ib|Adverse Event|0|||
48737965|NCT00400764|156890223|FG003|Phase Ib|Adverse Event|0|||
48947577|NCT01161524|157638306|FG001|Core Study (23 Weeks)|Adverse Event|0|||
48737966|NCT00400764|156890224|FG004|Phase Ib|Adverse Event|0|||
48737967|NCT00400764|156890220|FG000|Phase Ib|Death|1|||
48737968|NCT00400764|156890221|FG001|Phase Ib|Death|0|||
48947578|NCT01161524|157638307|FG002|Core Study (23 Weeks)|Adverse Event|0|||
48737969|NCT00400764|156890222|FG002|Phase Ib|Death|0|||
48737970|NCT00400764|156890223|FG003|Phase Ib|Death|0|||
48737971|NCT00400764|156890224|FG004|Phase Ib|Death|0|||
48947579|NCT01161524|157638305|FG000|Core Study (23 Weeks)|Other|1|||
48947580|NCT01161524|157638306|FG001|Core Study (23 Weeks)|Other|0|||
48737972|NCT00400764|156890220|FG000|Phase Ib|Disease Progression|4|||
48737973|NCT00400764|156890221|FG001|Phase Ib|Disease Progression|4|||
48737974|NCT00400764|156890222|FG002|Phase Ib|Disease Progression|0|||
48737975|NCT00400764|156890223|FG003|Phase Ib|Disease Progression|0|||
48737976|NCT00400764|156890224|FG004|Phase Ib|Disease Progression|0|||
48737977|NCT00400764|156890220|FG000|Phase II|Death|0|||
48737978|NCT00400764|156890221|FG001|Phase II|Death|0|||
48737979|NCT00400764|156890222|FG002|Phase II|Death|1|||
48737980|NCT00400764|156890223|FG003|Phase II|Death|2|||
48737981|NCT00400764|156890224|FG004|Phase II|Death|0|||
48737982|NCT00400764|156890220|FG000|Phase II|Lost to Follow-up|0|||
48737983|NCT00400764|156890221|FG001|Phase II|Lost to Follow-up|0|||
48737984|NCT00400764|156890222|FG002|Phase II|Lost to Follow-up|1|||
48737985|NCT00400764|156890223|FG003|Phase II|Lost to Follow-up|0|||
48737986|NCT00400764|156890224|FG004|Phase II|Lost to Follow-up|0|||
48737987|NCT00400764|156890220|FG000|Phase II|Physician Decision|0|||
48737988|NCT00400764|156890221|FG001|Phase II|Physician Decision|0|||
48737989|NCT00400764|156890222|FG002|Phase II|Physician Decision|1|||
48737990|NCT00400764|156890223|FG003|Phase II|Physician Decision|1|||
48947581|NCT01161524|157638307|FG002|Core Study (23 Weeks)|Other|0|||
48737991|NCT00400764|156890224|FG004|Phase II|Physician Decision|0|||
48737992|NCT00400764|156890220|FG000|Phase II|Sponsor's decision to terminate|0|||
48737993|NCT00400764|156890221|FG001|Phase II|Sponsor's decision to terminate|0|||
48737994|NCT00400764|156890222|FG002|Phase II|Sponsor's decision to terminate|18|||
48737995|NCT00400764|156890223|FG003|Phase II|Sponsor's decision to terminate|22|||
48737996|NCT00400764|156890224|FG004|Phase II|Sponsor's decision to terminate|11|||
48737997|NCT00400764|156890220|FG000|Phase II|Patient began new, non-protocol, therapy|0|||
48737998|NCT00400764|156890221|FG001|Phase II|Patient began new, non-protocol, therapy|0|||
48737999|NCT00400764|156890222|FG002|Phase II|Patient began new, non-protocol, therapy|1|||
48738000|NCT00400764|156890223|FG003|Phase II|Patient began new, non-protocol, therapy|0|||
48738001|NCT00400764|156890224|FG004|Phase II|Patient began new, non-protocol, therapy|0|||
48738002|NCT00400764|156890220|FG000|Phase II|Withdrawal by Subject|0|||
48738003|NCT00400764|156890221|FG001|Phase II|Withdrawal by Subject|0|||
48738004|NCT00400764|156890222|FG002|Phase II|Withdrawal by Subject|1|||
48738005|NCT00400764|156890223|FG003|Phase II|Withdrawal by Subject|1|||
48738006|NCT00400764|156890224|FG004|Phase II|Withdrawal by Subject|0|||
48738007|NCT02058693|156890225|FG000|Phase 1|Withdrawal by Subject|3|||
48738008|NCT02058693|156890226|FG001|Phase 1|Withdrawal by Subject|2|||
48738009|NCT02058693|156890225|FG000|Phase 1|Adverse Event|0|||
48738010|NCT02058693|156890226|FG001|Phase 1|Adverse Event|1|||
48738011|NCT02058693|156890225|FG000|Phase 1|Lack of Efficacy|1|||
48947582|NCT01161524|157638305|FG000|Core Study (23 Weeks)|Withdrawal of Consent|1|||
48947583|NCT01161524|157638306|FG001|Core Study (23 Weeks)|Withdrawal of Consent|1|||
48738012|NCT02058693|156890226|FG001|Phase 1|Lack of Efficacy|0|||
48738013|NCT02058693|156890225|FG000|Phase 1|Physician Decision|1|||
48738014|NCT02058693|156890226|FG001|Phase 1|Physician Decision|1|||
48738015|NCT02058693|156890225|FG000|Phase 2|Withdrawal by Subject|0|||
48738016|NCT02058693|156890226|FG001|Phase 2|Withdrawal by Subject|2|||
48738017|NCT00450255|156890230|FG000|Overall Study|Prior RFA ablation of liver|1|||
48738018|NCT02465515|156890232|FG000|Overall Study|Investigator site closed|4|||
48738019|NCT02465515|156890233|FG001|Overall Study|Investigator site closed|5|||
48852814|NCT01218659|157299697|FG002|12-Month OLE|Declined to participate in the OLE|4|||
48852815|NCT01787032|157299700|FG000|Overall Study|Protocol Violation|0|||
48852816|NCT01787032|157299701|FG001|Overall Study|Protocol Violation|0|||
48738020|NCT02465515|156890232|FG000|Overall Study|Withdrawal by Subject|74|||
48738021|NCT02465515|156890233|FG001|Overall Study|Withdrawal by Subject|43|||
48738022|NCT02465515|156890232|FG000|Overall Study|Physician Decision|8|||
48738023|NCT02465515|156890233|FG001|Overall Study|Physician Decision|12|||
48738024|NCT02465515|156890232|FG000|Overall Study|Lost to Follow-up|68|||
48738025|NCT02465515|156890233|FG001|Overall Study|Lost to Follow-up|51|||
48738026|NCT01897714|156892448|FG000|Phase I (Dose Escalation)|Disease progression|3|||
48738027|NCT01897714|156892449|FG001|Phase I (Dose Escalation)|Disease progression|5|||
48738028|NCT01897714|156892450|FG002|Phase I (Dose Escalation)|Disease progression|1|||
48738029|NCT01897714|156892451|FG003|Phase I (Dose Escalation)|Disease progression|3|||
48738030|NCT01897714|156892452|FG004|Phase I (Dose Escalation)|Disease progression|0|||
48738031|NCT01897714|156892453|FG005|Phase I (Dose Escalation)|Disease progression|0|||
48738032|NCT01897714|156892448|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
48738033|NCT01897714|156892449|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
48738034|NCT01897714|156892450|FG002|Phase I (Dose Escalation)|Adverse Event|4|||
48738035|NCT01897714|156892451|FG003|Phase I (Dose Escalation)|Adverse Event|3|||
48738036|NCT01897714|156892452|FG004|Phase I (Dose Escalation)|Adverse Event|0|||
48738037|NCT01897714|156892453|FG005|Phase I (Dose Escalation)|Adverse Event|0|||
48738038|NCT01897714|156892448|FG000|Phase I (Dose Escalation)|Other|0|||
48738039|NCT01897714|156892449|FG001|Phase I (Dose Escalation)|Other|1|||
48738040|NCT01897714|156892450|FG002|Phase I (Dose Escalation)|Other|0|||
48738041|NCT01897714|156892451|FG003|Phase I (Dose Escalation)|Other|0|||
48738042|NCT01897714|156892452|FG004|Phase I (Dose Escalation)|Other|0|||
48738043|NCT01897714|156892453|FG005|Phase I (Dose Escalation)|Other|0|||
48738044|NCT01897714|156892448|FG000|Phase II (MTD)|Withdrawal by Subject|0|||
48738045|NCT01897714|156892449|FG001|Phase II (MTD)|Withdrawal by Subject|0|||
48738046|NCT01897714|156892450|FG002|Phase II (MTD)|Withdrawal by Subject|0|||
48738047|NCT01897714|156892451|FG003|Phase II (MTD)|Withdrawal by Subject|0|||
48738048|NCT01897714|156892452|FG004|Phase II (MTD)|Withdrawal by Subject|0|||
48738049|NCT01897714|156892453|FG005|Phase II (MTD)|Withdrawal by Subject|1|||
48738050|NCT01897714|156892448|FG000|Phase II (MTD)|Lost to Follow-up|0|||
48738051|NCT01897714|156892449|FG001|Phase II (MTD)|Lost to Follow-up|0|||
48738052|NCT01897714|156892450|FG002|Phase II (MTD)|Lost to Follow-up|0|||
48738053|NCT01897714|156892451|FG003|Phase II (MTD)|Lost to Follow-up|0|||
48738054|NCT01897714|156892452|FG004|Phase II (MTD)|Lost to Follow-up|1|||
48738055|NCT01897714|156892453|FG005|Phase II (MTD)|Lost to Follow-up|0|||
48738056|NCT01897714|156892448|FG000|Phase II (MTD)|Death|0|||
48738057|NCT01897714|156892449|FG001|Phase II (MTD)|Death|0|||
48738058|NCT01897714|156892450|FG002|Phase II (MTD)|Death|0|||
48738059|NCT01897714|156892451|FG003|Phase II (MTD)|Death|0|||
48738060|NCT01897714|156892452|FG004|Phase II (MTD)|Death|25|||
48738061|NCT01897714|156892453|FG005|Phase II (MTD)|Death|10|||
48738062|NCT01897714|156892448|FG000|Phase II (MTD)|Study terminated with patient alive|0|||
48738063|NCT01897714|156892449|FG001|Phase II (MTD)|Study terminated with patient alive|0|||
48852817|NCT01787032|157299702|FG002|Overall Study|Protocol Violation|0|||
48852818|NCT01787032|157299703|FG003|Overall Study|Protocol Violation|0|||
48852819|NCT01787032|157299704|FG004|Overall Study|Protocol Violation|1|||
48852820|NCT01787032|157299705|FG005|Overall Study|Protocol Violation|1|||
48738064|NCT01897714|156892450|FG002|Phase II (MTD)|Study terminated with patient alive|0|||
48738065|NCT01897714|156892451|FG003|Phase II (MTD)|Study terminated with patient alive|0|||
48738066|NCT01897714|156892452|FG004|Phase II (MTD)|Study terminated with patient alive|1|||
48738067|NCT01897714|156892453|FG005|Phase II (MTD)|Study terminated with patient alive|0|||
48738068|NCT01897714|156892448|FG000|Phase II (MTD)|Other|0|||
48738069|NCT01897714|156892449|FG001|Phase II (MTD)|Other|0|||
48738070|NCT01897714|156892450|FG002|Phase II (MTD)|Other|0|||
48738071|NCT01897714|156892451|FG003|Phase II (MTD)|Other|0|||
48738072|NCT01897714|156892452|FG004|Phase II (MTD)|Other|3|||
48738073|NCT01897714|156892453|FG005|Phase II (MTD)|Other|0|||
48852821|NCT05270460|157299706|FG000|Overall Study|Adverse Event|0|||
48852822|NCT05270460|157299707|FG001|Overall Study|Adverse Event|1|||
48738074|NCT00423722|156892454|FG000|Overall Study|Death|4|||
48738075|NCT00423722|156892455|FG001|Overall Study|Death|4|||
48738076|NCT00423722|156892454|FG000|Overall Study|Declined to participate|2|||
48852823|NCT05270460|157299708|FG002|Overall Study|Adverse Event|0|||
48852824|NCT05270460|157299706|FG000|Overall Study|Early Termination|0|||
48852825|NCT05270460|157299707|FG001|Overall Study|Early Termination|1|||
48852826|NCT05270460|157299708|FG002|Overall Study|Early Termination|0|||
48852827|NCT00274261|157299709|FG000|Overall Study|Adverse Event|19|||
48852828|NCT00274261|157299710|FG001|Overall Study|Adverse Event|11|||
48852829|NCT00274261|157299709|FG000|Overall Study|Pregnancy|114|||
48852830|NCT00274261|157299710|FG001|Overall Study|Pregnancy|83|||
48852831|NCT00274261|157299709|FG000|Overall Study|Withdrawal by Subject|179|||
48852832|NCT00274261|157299710|FG001|Overall Study|Withdrawal by Subject|126|||
48852833|NCT00274261|157299709|FG000|Overall Study|Protocol Violation|71|||
48852834|NCT00274261|157299710|FG001|Overall Study|Protocol Violation|42|||
48852835|NCT00274261|157299709|FG000|Overall Study|Lost to Follow-up|106|||
48852836|NCT00274261|157299710|FG001|Overall Study|Lost to Follow-up|75|||
48852837|NCT05445557|157299716|FG000|Double Blind Part|Lost to Follow-up|1|||
48738077|NCT00423722|156892455|FG001|Overall Study|Declined to participate|3|||
48738078|NCT00423722|156892454|FG000|Overall Study|Unable to complete questionnaires|4|||
48738079|NCT00423722|156892455|FG001|Overall Study|Unable to complete questionnaires|4|||
48738080|NCT00423722|156892454|FG000|Overall Study|Withdrawal by Subject|4|||
48738081|NCT00423722|156892455|FG001|Overall Study|Withdrawal by Subject|2|||
48852838|NCT01880736|157299717|FG000|Overall Study|Adverse Event|0|||
48852839|NCT01880736|157299718|FG001|Overall Study|Adverse Event|0|||
48852840|NCT01880736|157299719|FG002|Overall Study|Adverse Event|0|||
48852841|NCT01880736|157299720|FG003|Overall Study|Adverse Event|1|||
48738082|NCT02171065|156892458|FG000|Overall Study|Withdrawal by Subject|1|||
48738083|NCT02171065|156892459|FG001|Overall Study|Withdrawal by Subject|0|||
48738084|NCT02171065|156892460|FG002|Overall Study|Withdrawal by Subject|0|||
48738085|NCT02171065|156892458|FG000|Overall Study|Lost to Follow-up|0|||
48738086|NCT02171065|156892459|FG001|Overall Study|Lost to Follow-up|0|||
48738087|NCT02171065|156892460|FG002|Overall Study|Lost to Follow-up|1|||
48738088|NCT01896050|156892462|FG000|Overall Study|Adverse Event|37|||
48738089|NCT01896050|156892463|FG001|Overall Study|Adverse Event|2|||
48738090|NCT01896050|156892462|FG000|Overall Study|Death|1|||
48738091|NCT01896050|156892463|FG001|Overall Study|Death|0|||
48738092|NCT02598960|156892464|FG000|Treatment Period|Disease Progression|4|||
48738093|NCT02598960|156892465|FG001|Treatment Period|Disease Progression|4|||
48738094|NCT02598960|156892466|FG002|Treatment Period|Disease Progression|4|||
48738095|NCT02598960|156892467|FG003|Treatment Period|Disease Progression|6|||
48738096|NCT02598960|156892468|FG004|Treatment Period|Disease Progression|8|||
48738097|NCT02598960|156892469|FG005|Treatment Period|Disease Progression|2|||
48738098|NCT02598960|156892470|FG006|Treatment Period|Disease Progression|2|||
48738099|NCT02598960|156892471|FG007|Treatment Period|Disease Progression|3|||
48738100|NCT02598960|156892472|FG008|Treatment Period|Disease Progression|7|||
48738101|NCT02598960|156892473|FG009|Treatment Period|Disease Progression|9|||
48738102|NCT02598960|156892474|FG010|Treatment Period|Disease Progression|7|||
48738103|NCT02598960|156892475|FG011|Treatment Period|Disease Progression|143|||
48738104|NCT02598960|156892476|FG012|Treatment Period|Disease Progression|23|||
48738105|NCT02598960|156892464|FG000|Treatment Period|Study drug toxicity|0|||
48738106|NCT02598960|156892465|FG001|Treatment Period|Study drug toxicity|0|||
48852842|NCT01880736|157299717|FG000|Overall Study|Withdrawal Criteria|1|||
48852843|NCT01880736|157299718|FG001|Overall Study|Withdrawal Criteria|2|||
48852844|NCT01880736|157299719|FG002|Overall Study|Withdrawal Criteria|1|||
48738107|NCT02598960|156892466|FG002|Treatment Period|Study drug toxicity|0|||
48738108|NCT02598960|156892467|FG003|Treatment Period|Study drug toxicity|0|||
48738109|NCT02598960|156892468|FG004|Treatment Period|Study drug toxicity|0|||
48738110|NCT02598960|156892469|FG005|Treatment Period|Study drug toxicity|0|||
48738111|NCT02598960|156892470|FG006|Treatment Period|Study drug toxicity|0|||
48738112|NCT02598960|156892471|FG007|Treatment Period|Study drug toxicity|0|||
48852845|NCT01880736|157299720|FG003|Overall Study|Withdrawal Criteria|5|||
48852846|NCT01227421|157299721|FG000|Overall Study|Lost to Follow-up|6|||
48852847|NCT01227421|157299722|FG001|Overall Study|Lost to Follow-up|7|||
48852848|NCT01227421|157299723|FG002|Overall Study|Lost to Follow-up|5|||
49015316|NCT00814320|157892146|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1|||
48738113|NCT02598960|156892472|FG008|Treatment Period|Study drug toxicity|0|||
48738114|NCT02598960|156892473|FG009|Treatment Period|Study drug toxicity|1|||
48738115|NCT02598960|156892474|FG010|Treatment Period|Study drug toxicity|0|||
48738116|NCT02598960|156892475|FG011|Treatment Period|Study drug toxicity|3|||
48738117|NCT02598960|156892476|FG012|Treatment Period|Study drug toxicity|0|||
48852849|NCT01227421|157299721|FG000|Overall Study|Adverse Event|2|||
48852850|NCT01227421|157299722|FG001|Overall Study|Adverse Event|7|||
48852851|NCT01227421|157299723|FG002|Overall Study|Adverse Event|2|||
48852852|NCT01227421|157299721|FG000|Overall Study|Withdrawal by Subject|1|||
48852853|NCT01227421|157299722|FG001|Overall Study|Withdrawal by Subject|2|||
48852854|NCT01227421|157299723|FG002|Overall Study|Withdrawal by Subject|1|||
48852855|NCT01227421|157299721|FG000|Overall Study|Protocol Violation|1|||
48852856|NCT01227421|157299722|FG001|Overall Study|Protocol Violation|1|||
48852857|NCT01227421|157299723|FG002|Overall Study|Protocol Violation|2|||
48852858|NCT01227421|157299721|FG000|Overall Study|Randomized in error|1|||
48852859|NCT01227421|157299722|FG001|Overall Study|Randomized in error|1|||
48852860|NCT01227421|157299723|FG002|Overall Study|Randomized in error|0|||
48852861|NCT01827839|157299724|FG000|Overall Study|Adverse Event|1|||
48852862|NCT01827839|157299724|FG000|Overall Study|Consent Withdrawal|2|||
48852863|NCT02628626|157299728|FG000|Overall Study|Withdrawal by Subject|2|||
48852864|NCT02628626|157299729|FG001|Overall Study|Withdrawal by Subject|2|||
48852865|NCT00266656|157299730|FG000|Overall Study|Death|1|||
48852866|NCT00266656|157299731|FG001|Overall Study|Death|0|||
48852867|NCT00266656|157299730|FG000|Overall Study|Lost to Follow-up|4|||
48852868|NCT00266656|157299731|FG001|Overall Study|Lost to Follow-up|1|||
48852869|NCT00266656|157299730|FG000|Overall Study|Withdrawal by Subject|4|||
48852870|NCT00266656|157299731|FG001|Overall Study|Withdrawal by Subject|2|||
48852871|NCT00266656|157299730|FG000|Overall Study|Did Not Reach Final Height|4|||
48852872|NCT00266656|157299731|FG001|Overall Study|Did Not Reach Final Height|8|||
48852873|NCT00266656|157299730|FG000|Overall Study|Parent/Caregiver Decision|1|||
48852874|NCT00266656|157299731|FG001|Overall Study|Parent/Caregiver Decision|2|||
48852875|NCT00070317|157299732|FG000|Overall Study|Inevaluable (Never Treated)|1|||
48852876|NCT00070317|157299732|FG000|Overall Study|Ineligible Wrong Cell type/primary/stage|3|||
48852877|NCT00070317|157299732|FG000|Overall Study|Ineligible required test not done|1|||
48852878|NCT00070317|157299732|FG000|Overall Study|Ineligible-Improper prior treatment|2|||
48852879|NCT00070317|157299732|FG000|Overall Study|Ineligible-Inadequate pathology|6|||
48852880|NCT00866619|157299733|FG000|Overall Study|Adverse Event|112|||
48852881|NCT00866619|157299734|FG001|Overall Study|Adverse Event|106|||
48852882|NCT00866619|157299735|FG002|Overall Study|Adverse Event|47|||
48947584|NCT01161524|157638307|FG002|Core Study (23 Weeks)|Withdrawal of Consent|0|||
48947585|NCT01161524|157638305|FG000|Core Study (23 Weeks)|Lost to Follow-up|1|||
48947586|NCT01161524|157638306|FG001|Core Study (23 Weeks)|Lost to Follow-up|2|||
48738118|NCT02598960|156892464|FG000|Treatment Period|Adverse Event unrelated to study drug|0|||
48738119|NCT02598960|156892465|FG001|Treatment Period|Adverse Event unrelated to study drug|1|||
48738120|NCT02598960|156892466|FG002|Treatment Period|Adverse Event unrelated to study drug|0|||
48738121|NCT02598960|156892467|FG003|Treatment Period|Adverse Event unrelated to study drug|0|||
48738122|NCT02598960|156892468|FG004|Treatment Period|Adverse Event unrelated to study drug|0|||
48738123|NCT02598960|156892469|FG005|Treatment Period|Adverse Event unrelated to study drug|0|||
48738124|NCT02598960|156892470|FG006|Treatment Period|Adverse Event unrelated to study drug|0|||
48738125|NCT02598960|156892471|FG007|Treatment Period|Adverse Event unrelated to study drug|0|||
48738126|NCT02598960|156892472|FG008|Treatment Period|Adverse Event unrelated to study drug|0|||
48852883|NCT00866619|157299736|FG003|Overall Study|Adverse Event|44|||
48852884|NCT00866619|157299733|FG000|Overall Study|Protocol Violation|2|||
48852885|NCT00866619|157299734|FG001|Overall Study|Protocol Violation|39|||
48738127|NCT02598960|156892473|FG009|Treatment Period|Adverse Event unrelated to study drug|1|||
48852886|NCT00866619|157299735|FG002|Overall Study|Protocol Violation|2|||
48852887|NCT00866619|157299736|FG003|Overall Study|Protocol Violation|17|||
48852888|NCT00866619|157299733|FG000|Overall Study|Withdrawal by Subject|587|||
48852889|NCT00866619|157299734|FG001|Overall Study|Withdrawal by Subject|295|||
48852890|NCT00866619|157299735|FG002|Overall Study|Withdrawal by Subject|272|||
48852891|NCT00866619|157299736|FG003|Overall Study|Withdrawal by Subject|144|||
48852892|NCT00866619|157299733|FG000|Overall Study|Lost to Follow-up|1145|||
48738128|NCT02598960|156892474|FG010|Treatment Period|Adverse Event unrelated to study drug|0|||
48738129|NCT02598960|156892475|FG011|Treatment Period|Adverse Event unrelated to study drug|11|||
48738130|NCT02598960|156892476|FG012|Treatment Period|Adverse Event unrelated to study drug|2|||
48738131|NCT02598960|156892464|FG000|Treatment Period|participant request to discontinue|0|||
48738132|NCT02598960|156892465|FG001|Treatment Period|participant request to discontinue|1|||
48947587|NCT01161524|157638307|FG002|Core Study (23 Weeks)|Lost to Follow-up|0|||
48852893|NCT00866619|157299734|FG001|Overall Study|Lost to Follow-up|830|||
48852894|NCT00866619|157299735|FG002|Overall Study|Lost to Follow-up|568|||
48852895|NCT00866619|157299736|FG003|Overall Study|Lost to Follow-up|425|||
48852896|NCT03136159|157301478|FG000|Overall Study|chorioamnionitis|2|||
48852897|NCT03136159|157301479|FG001|Overall Study|chorioamnionitis|0|||
48852898|NCT03136159|157301478|FG000|Overall Study|vertical skin incision|1|||
48852899|NCT03136159|157301479|FG001|Overall Study|vertical skin incision|0|||
48852900|NCT03136159|157301478|FG000|Overall Study|additional dressing|1|||
48852901|NCT03136159|157301479|FG001|Overall Study|additional dressing|0|||
48852902|NCT03136159|157301478|FG000|Overall Study|never got dressing placed|1|||
48852903|NCT03136159|157301479|FG001|Overall Study|never got dressing placed|0|||
48852904|NCT00799409|157301480|FG000|Overall Study|Withdrawal by Subject|1|||
48852905|NCT00799409|157301481|FG001|Overall Study|Withdrawal by Subject|0|||
48852906|NCT00799409|157301482|FG002|Overall Study|Withdrawal by Subject|0|||
48852907|NCT00799409|157301480|FG000|Overall Study|Lost to Follow-up|1|||
48852908|NCT00799409|157301481|FG001|Overall Study|Lost to Follow-up|0|||
48852909|NCT00799409|157301482|FG002|Overall Study|Lost to Follow-up|0|||
48852910|NCT00799409|157301480|FG000|Overall Study|Optimal Dose Not Achieved|2|||
48852911|NCT00799409|157301481|FG001|Overall Study|Optimal Dose Not Achieved|0|||
48852912|NCT00799409|157301482|FG002|Overall Study|Optimal Dose Not Achieved|0|||
48852913|NCT00799409|157301480|FG000|Overall Study|Failure to follow study protocol)|1|||
48852914|NCT00799409|157301481|FG001|Overall Study|Failure to follow study protocol)|0|||
48852915|NCT00799409|157301482|FG002|Overall Study|Failure to follow study protocol)|0|||
48852916|NCT00799409|157301480|FG000|Overall Study|Did not attend lab school day 1|1|||
48852917|NCT00799409|157301481|FG001|Overall Study|Did not attend lab school day 1|0|||
48852918|NCT00799409|157301482|FG002|Overall Study|Did not attend lab school day 1|0|||
48852919|NCT00799409|157301480|FG000|Overall Study|medication compliance|1|||
48852920|NCT00799409|157301481|FG001|Overall Study|medication compliance|0|||
48852921|NCT00799409|157301482|FG002|Overall Study|medication compliance|0|||
48852922|NCT03964974|157301483|FG000|Overall Study|Lost to Follow-up|3|||
48852923|NCT03964974|157301484|FG001|Overall Study|Lost to Follow-up|2|||
48852924|NCT03964974|157301483|FG000|Overall Study|Withdrawal by Subject|0|||
48852925|NCT03964974|157301484|FG001|Overall Study|Withdrawal by Subject|3|||
48852926|NCT01214200|157301487|FG000|Overall Study|Did not meet inclusion/exclusion|9|||
48852927|NCT01214200|157301487|FG000|Overall Study|Withdrawal by Subject|2|||
48852928|NCT00667017|157301488|FG000|Overall Study|Withdrawal by Subject|1|||
48852929|NCT01641900|157301491|FG000|Overall Study|Withdrawal by Subject|2|||
48852930|NCT01641900|157301492|FG001|Overall Study|Withdrawal by Subject|2|||
48852931|NCT04652869|157301493|FG000|Overall Study|Withdrawal by Subject|0|||
48852932|NCT04652869|157301494|FG001|Overall Study|Withdrawal by Subject|2|||
48852933|NCT04652869|157301495|FG002|Overall Study|Withdrawal by Subject|0|||
48852934|NCT01833455|157301498|FG000|Overall Study|Withdrawal by Subject|1|||
48852935|NCT01833455|157301499|FG001|Overall Study|Withdrawal by Subject|0|||
48852936|NCT01779050|157301500|FG000|Overall Study|Withdrawal by Subject|1|||
48852937|NCT01779050|157301501|FG001|Overall Study|Withdrawal by Subject|0|||
48852938|NCT01613417|157301503|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|13|||
48852939|NCT01613417|157301504|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|7|||
48852940|NCT01332266|157301505|FG000|Phase 1b|Death|3|||
48852941|NCT01332266|157301506|FG001|Phase 1b|Death|3|||
48852942|NCT01332266|157301507|FG002|Phase 1b|Death|2|||
48852943|NCT01332266|157301508|FG003|Phase 1b|Death|0|||
48852944|NCT01332266|157301509|FG004|Phase 1b|Death|0|||
48852945|NCT01332266|157301505|FG000|Phase 1b|Lost to Follow-up|0|||
48852946|NCT01332266|157301506|FG001|Phase 1b|Lost to Follow-up|1|||
48852947|NCT01332266|157301507|FG002|Phase 1b|Lost to Follow-up|0|||
48852948|NCT01332266|157301508|FG003|Phase 1b|Lost to Follow-up|0|||
48852949|NCT01332266|157301509|FG004|Phase 1b|Lost to Follow-up|0|||
48852950|NCT01332266|157301505|FG000|Phase 1b|Withdrawal by Subject|1|||
48852951|NCT01332266|157301506|FG001|Phase 1b|Withdrawal by Subject|1|||
48852952|NCT01332266|157301507|FG002|Phase 1b|Withdrawal by Subject|1|||
48852953|NCT01332266|157301508|FG003|Phase 1b|Withdrawal by Subject|0|||
49015317|NCT00814320|157892147|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0|||
48852954|NCT01332266|157301509|FG004|Phase 1b|Withdrawal by Subject|0|||
48852955|NCT01332266|157301505|FG000|Phase 2|Death|0|||
48852956|NCT01332266|157301506|FG001|Phase 2|Death|0|||
48852957|NCT01332266|157301507|FG002|Phase 2|Death|0|||
48852958|NCT01332266|157301508|FG003|Phase 2|Death|33|||
48852959|NCT01332266|157301509|FG004|Phase 2|Death|36|||
48852960|NCT01332266|157301505|FG000|Phase 2|Lost to Follow-up|0|||
48852961|NCT01332266|157301506|FG001|Phase 2|Lost to Follow-up|0|||
48852962|NCT01332266|157301507|FG002|Phase 2|Lost to Follow-up|0|||
48852963|NCT01332266|157301508|FG003|Phase 2|Lost to Follow-up|2|||
48852964|NCT01332266|157301509|FG004|Phase 2|Lost to Follow-up|0|||
48852965|NCT01332266|157301505|FG000|Phase 2|Physician Decision|0|||
48852966|NCT01332266|157301506|FG001|Phase 2|Physician Decision|0|||
48852967|NCT01332266|157301507|FG002|Phase 2|Physician Decision|0|||
48852968|NCT01332266|157301508|FG003|Phase 2|Physician Decision|3|||
48852969|NCT01332266|157301509|FG004|Phase 2|Physician Decision|1|||
48852970|NCT01332266|157301505|FG000|Phase 2|Symptomatic deterioration|0|||
48852971|NCT01332266|157301506|FG001|Phase 2|Symptomatic deterioration|0|||
48852972|NCT01332266|157301507|FG002|Phase 2|Symptomatic deterioration|0|||
48852973|NCT01332266|157301508|FG003|Phase 2|Symptomatic deterioration|0|||
48852974|NCT01332266|157301509|FG004|Phase 2|Symptomatic deterioration|1|||
48852975|NCT01332266|157301505|FG000|Phase 2|Progression Disease|0|||
48852976|NCT01332266|157301506|FG001|Phase 2|Progression Disease|0|||
48852977|NCT01332266|157301507|FG002|Phase 2|Progression Disease|0|||
48852978|NCT01332266|157301508|FG003|Phase 2|Progression Disease|2|||
48852979|NCT01332266|157301509|FG004|Phase 2|Progression Disease|1|||
48852980|NCT01332266|157301505|FG000|Phase 2|Withdrawal by Subject|0|||
48738133|NCT02598960|156892466|FG002|Treatment Period|participant request to discontinue|0|||
48738134|NCT02598960|156892467|FG003|Treatment Period|participant request to discontinue|0|||
48738135|NCT02598960|156892468|FG004|Treatment Period|participant request to discontinue|1|||
48738136|NCT02598960|156892469|FG005|Treatment Period|participant request to discontinue|0|||
48738137|NCT02598960|156892470|FG006|Treatment Period|participant request to discontinue|0|||
48738138|NCT02598960|156892471|FG007|Treatment Period|participant request to discontinue|0|||
48738139|NCT02598960|156892472|FG008|Treatment Period|participant request to discontinue|0|||
48738140|NCT02598960|156892473|FG009|Treatment Period|participant request to discontinue|0|||
48738141|NCT02598960|156892474|FG010|Treatment Period|participant request to discontinue|1|||
48738142|NCT02598960|156892475|FG011|Treatment Period|participant request to discontinue|4|||
48738143|NCT02598960|156892476|FG012|Treatment Period|participant request to discontinue|0|||
48738144|NCT02598960|156892464|FG000|Treatment Period|participant withdrew consent|0|||
48738145|NCT02598960|156892465|FG001|Treatment Period|participant withdrew consent|0|||
48738146|NCT02598960|156892466|FG002|Treatment Period|participant withdrew consent|0|||
48738147|NCT02598960|156892467|FG003|Treatment Period|participant withdrew consent|0|||
48738148|NCT02598960|156892468|FG004|Treatment Period|participant withdrew consent|0|||
48738149|NCT02598960|156892469|FG005|Treatment Period|participant withdrew consent|0|||
48738150|NCT02598960|156892470|FG006|Treatment Period|participant withdrew consent|0|||
48738151|NCT02598960|156892471|FG007|Treatment Period|participant withdrew consent|0|||
48738152|NCT02598960|156892472|FG008|Treatment Period|participant withdrew consent|0|||
48738153|NCT02598960|156892473|FG009|Treatment Period|participant withdrew consent|0|||
48738154|NCT02598960|156892474|FG010|Treatment Period|participant withdrew consent|0|||
48738155|NCT02598960|156892475|FG011|Treatment Period|participant withdrew consent|3|||
48738156|NCT02598960|156892476|FG012|Treatment Period|participant withdrew consent|0|||
48738157|NCT02598960|156892464|FG000|Treatment Period|No longer meets study criteria|0|||
48738158|NCT02598960|156892465|FG001|Treatment Period|No longer meets study criteria|0|||
48738159|NCT02598960|156892466|FG002|Treatment Period|No longer meets study criteria|0|||
48738160|NCT02598960|156892467|FG003|Treatment Period|No longer meets study criteria|0|||
48738161|NCT02598960|156892468|FG004|Treatment Period|No longer meets study criteria|0|||
48738162|NCT02598960|156892469|FG005|Treatment Period|No longer meets study criteria|0|||
48738163|NCT02598960|156892470|FG006|Treatment Period|No longer meets study criteria|0|||
48738164|NCT02598960|156892471|FG007|Treatment Period|No longer meets study criteria|0|||
48738165|NCT02598960|156892472|FG008|Treatment Period|No longer meets study criteria|0|||
48738166|NCT02598960|156892473|FG009|Treatment Period|No longer meets study criteria|0|||
48738167|NCT02598960|156892474|FG010|Treatment Period|No longer meets study criteria|0|||
48738168|NCT02598960|156892475|FG011|Treatment Period|No longer meets study criteria|1|||
48738169|NCT02598960|156892476|FG012|Treatment Period|No longer meets study criteria|0|||
48738170|NCT02598960|156892464|FG000|Treatment Period|Other Reasons|0|||
48738171|NCT02598960|156892465|FG001|Treatment Period|Other Reasons|0|||
48738172|NCT02598960|156892466|FG002|Treatment Period|Other Reasons|0|||
48738173|NCT02598960|156892467|FG003|Treatment Period|Other Reasons|0|||
48738174|NCT02598960|156892468|FG004|Treatment Period|Other Reasons|0|||
48738175|NCT02598960|156892469|FG005|Treatment Period|Other Reasons|0|||
48738176|NCT02598960|156892470|FG006|Treatment Period|Other Reasons|0|||
48738177|NCT02598960|156892471|FG007|Treatment Period|Other Reasons|0|||
48738178|NCT02598960|156892472|FG008|Treatment Period|Other Reasons|0|||
48738179|NCT02598960|156892473|FG009|Treatment Period|Other Reasons|0|||
48738180|NCT02598960|156892474|FG010|Treatment Period|Other Reasons|0|||
48738181|NCT02598960|156892475|FG011|Treatment Period|Other Reasons|0|||
48738182|NCT02598960|156892476|FG012|Treatment Period|Other Reasons|1|||
48738183|NCT02598960|156892464|FG000|Participants Entering Follow Up Period|Death|1|||
48738184|NCT02598960|156892465|FG001|Participants Entering Follow Up Period|Death|0|||
48738185|NCT02598960|156892466|FG002|Participants Entering Follow Up Period|Death|0|||
48738186|NCT02598960|156892467|FG003|Participants Entering Follow Up Period|Death|0|||
48738187|NCT02598960|156892468|FG004|Participants Entering Follow Up Period|Death|0|||
48947588|NCT01161524|157638305|FG000|Core Study (23 Weeks)|Subject Choice|3|||
48947589|NCT01161524|157638306|FG001|Core Study (23 Weeks)|Subject Choice|2|||
48947590|NCT01161524|157638307|FG002|Core Study (23 Weeks)|Subject Choice|0|||
48947591|NCT01161524|157638305|FG000|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
48947592|NCT01161524|157638306|FG001|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
48947593|NCT01161524|157638307|FG002|Extension Phase (Approximately 83 Weeks)|Adverse Event|8|||
48947594|NCT01161524|157638305|FG000|Extension Phase (Approximately 83 Weeks)|Other|0|||
48947595|NCT01161524|157638306|FG001|Extension Phase (Approximately 83 Weeks)|Other|0|||
48947596|NCT01161524|157638307|FG002|Extension Phase (Approximately 83 Weeks)|Other|6|||
48947597|NCT01161524|157638305|FG000|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
48947598|NCT01161524|157638306|FG001|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
48738188|NCT02598960|156892469|FG005|Participants Entering Follow Up Period|Death|0|||
48738189|NCT02598960|156892470|FG006|Participants Entering Follow Up Period|Death|0|||
48738190|NCT02598960|156892471|FG007|Participants Entering Follow Up Period|Death|0|||
48947599|NCT01161524|157638307|FG002|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1|||
48947600|NCT01161524|157638305|FG000|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
48947601|NCT01161524|157638306|FG001|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
48947602|NCT01161524|157638307|FG002|Extension Phase (Approximately 83 Weeks)|Subject Choice|5|||
48947603|NCT01161524|157638305|FG000|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
48947604|NCT01161524|157638306|FG001|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
48947605|NCT01161524|157638307|FG002|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4|||
48947606|NCT00642616|157638308|FG000|Overall Study|Adverse Event|2|||
48947607|NCT00642616|157638309|FG001|Overall Study|Adverse Event|0|||
48947608|NCT00642616|157638310|FG002|Overall Study|Adverse Event|1|||
48947609|NCT00642616|157638311|FG003|Overall Study|Adverse Event|0|||
48947610|NCT00642616|157638308|FG000|Overall Study|Study Terminated by Sponsor|7|||
48947611|NCT00642616|157638309|FG001|Overall Study|Study Terminated by Sponsor|6|||
48947612|NCT00642616|157638310|FG002|Overall Study|Study Terminated by Sponsor|4|||
48947613|NCT00642616|157638311|FG003|Overall Study|Study Terminated by Sponsor|5|||
48947614|NCT00642616|157638308|FG000|Overall Study|Withdrawal by Subject|0|||
49015318|NCT00814320|157892146|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1|||
48738191|NCT02598960|156892472|FG008|Participants Entering Follow Up Period|Death|0|||
48738192|NCT02598960|156892473|FG009|Participants Entering Follow Up Period|Death|1|||
48738193|NCT02598960|156892474|FG010|Participants Entering Follow Up Period|Death|0|||
48738194|NCT02598960|156892475|FG011|Participants Entering Follow Up Period|Death|11|||
48738195|NCT02598960|156892476|FG012|Participants Entering Follow Up Period|Death|2|||
48738196|NCT02598960|156892464|FG000|Participants Entering Follow Up Period|participant withdrew consent|0|||
48738197|NCT02598960|156892465|FG001|Participants Entering Follow Up Period|participant withdrew consent|0|||
48738198|NCT02598960|156892466|FG002|Participants Entering Follow Up Period|participant withdrew consent|0|||
48738199|NCT02598960|156892467|FG003|Participants Entering Follow Up Period|participant withdrew consent|0|||
48738200|NCT02598960|156892468|FG004|Participants Entering Follow Up Period|participant withdrew consent|0|||
48738201|NCT02598960|156892469|FG005|Participants Entering Follow Up Period|participant withdrew consent|0|||
48738202|NCT02598960|156892470|FG006|Participants Entering Follow Up Period|participant withdrew consent|0|||
48738203|NCT02598960|156892471|FG007|Participants Entering Follow Up Period|participant withdrew consent|0|||
48947615|NCT00642616|157638309|FG001|Overall Study|Withdrawal by Subject|1|||
48738204|NCT02598960|156892472|FG008|Participants Entering Follow Up Period|participant withdrew consent|0|||
48947616|NCT00642616|157638310|FG002|Overall Study|Withdrawal by Subject|1|||
48947617|NCT00642616|157638311|FG003|Overall Study|Withdrawal by Subject|1|||
48852981|NCT01332266|157301506|FG001|Phase 2|Withdrawal by Subject|0|||
48947618|NCT00642616|157638308|FG000|Overall Study|Protocol Violation|0|||
48738205|NCT02598960|156892473|FG009|Participants Entering Follow Up Period|participant withdrew consent|0|||
48852982|NCT01332266|157301507|FG002|Phase 2|Withdrawal by Subject|0|||
48852983|NCT01332266|157301508|FG003|Phase 2|Withdrawal by Subject|2|||
48852984|NCT01332266|157301509|FG004|Phase 2|Withdrawal by Subject|2|||
48852985|NCT02575365|157301511|FG000|Overall Study|Lost to Follow-up|4|||
48852986|NCT00666705|157301513|FG000|Overall Study|Withdrawal by Subject|1|||
48852987|NCT03259568|157301514|FG000|Overall Study|Participant performance was low|3|||
48852988|NCT01328496|157301517|FG000|Overall Study|Significant Change in Health Status|1|||
48852989|NCT01328496|157301518|FG001|Overall Study|Significant Change in Health Status|0|||
48852990|NCT00526994|157301522|FG000|Overall Study|Lost to Follow-up|98|||
48852991|NCT00526994|157301523|FG001|Overall Study|Lost to Follow-up|108|||
48852992|NCT00526994|157301524|FG002|Overall Study|Lost to Follow-up|96|||
48852993|NCT00526994|157301522|FG000|Overall Study|Death|4|||
48852994|NCT00526994|157301523|FG001|Overall Study|Death|3|||
48852995|NCT00526994|157301524|FG002|Overall Study|Death|3|||
48852996|NCT00526994|157301522|FG000|Overall Study|Withdrawal by Subject|2|||
48852997|NCT00526994|157301523|FG001|Overall Study|Withdrawal by Subject|7|||
48852998|NCT00526994|157301524|FG002|Overall Study|Withdrawal by Subject|5|||
48852999|NCT00526994|157301522|FG000|Overall Study|incarcerated, impaired, incomplete|4|||
48853000|NCT00526994|157301523|FG001|Overall Study|incarcerated, impaired, incomplete|3|||
48853001|NCT00526994|157301524|FG002|Overall Study|incarcerated, impaired, incomplete|3|||
48738206|NCT02598960|156892474|FG010|Participants Entering Follow Up Period|participant withdrew consent|0|||
48738207|NCT02598960|156892475|FG011|Participants Entering Follow Up Period|participant withdrew consent|7|||
48738208|NCT02598960|156892476|FG012|Participants Entering Follow Up Period|participant withdrew consent|0|||
48738209|NCT02598960|156892464|FG000|Participants Entering Follow Up Period|lost to follow up|0|||
48738210|NCT02598960|156892465|FG001|Participants Entering Follow Up Period|lost to follow up|0|||
48738211|NCT02598960|156892466|FG002|Participants Entering Follow Up Period|lost to follow up|0|||
48738212|NCT02598960|156892467|FG003|Participants Entering Follow Up Period|lost to follow up|0|||
48738213|NCT02598960|156892468|FG004|Participants Entering Follow Up Period|lost to follow up|0|||
48738214|NCT02598960|156892469|FG005|Participants Entering Follow Up Period|lost to follow up|0|||
48738215|NCT02598960|156892470|FG006|Participants Entering Follow Up Period|lost to follow up|0|||
48738216|NCT02598960|156892471|FG007|Participants Entering Follow Up Period|lost to follow up|0|||
48738217|NCT02598960|156892472|FG008|Participants Entering Follow Up Period|lost to follow up|0|||
48738218|NCT02598960|156892473|FG009|Participants Entering Follow Up Period|lost to follow up|0|||
48738219|NCT02598960|156892474|FG010|Participants Entering Follow Up Period|lost to follow up|0|||
48738220|NCT02598960|156892475|FG011|Participants Entering Follow Up Period|lost to follow up|3|||
48738221|NCT02598960|156892476|FG012|Participants Entering Follow Up Period|lost to follow up|0|||
48853002|NCT04009291|157301530|FG000|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
48853003|NCT04009291|157301531|FG001|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
48853004|NCT04009291|157301532|FG002|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
48853005|NCT04009291|157301533|FG003|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
48853006|NCT04009291|157301534|FG004|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|1|||
48853007|NCT04009291|157301530|FG000|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
48853008|NCT04009291|157301531|FG001|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
48853009|NCT04009291|157301532|FG002|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
48853010|NCT04009291|157301533|FG003|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
48853011|NCT04009291|157301534|FG004|Open-Label Period (Weeks 4 to 266)|Study Ongoing|58|||
48853012|NCT03288506|157301535|FG000|Overall Study|Withdrawal by Subject|52|||
48853013|NCT00853593|157301536|FG000|Overall Study|Subjects did not receive a 4396 lead|12|||
48853014|NCT00853593|157301536|FG000|Overall Study|Model 4396 lead not attempted|29|||
48853015|NCT00853593|157301536|FG000|Overall Study|Implant not attempted|4|||
48853016|NCT00622700|157301537|FG000|Core Treatment Period|Randomized but Not Treated|0|||
48853017|NCT00622700|157301538|FG001|Core Treatment Period|Randomized but Not Treated|2|||
48853018|NCT00622700|157301539|FG002|Core Treatment Period|Randomized but Not Treated|2|||
48853019|NCT00622700|157301540|FG003|Core Treatment Period|Randomized but Not Treated|0|||
48853020|NCT00622700|157301541|FG004|Core Treatment Period|Randomized but Not Treated|0|||
48853021|NCT00622700|157301542|FG005|Core Treatment Period|Randomized but Not Treated|0|||
48853022|NCT00622700|157301543|FG006|Core Treatment Period|Randomized but Not Treated|0|||
48853023|NCT00622700|157301537|FG000|Core Treatment Period|Adverse Event|18|||
48853024|NCT00622700|157301538|FG001|Core Treatment Period|Adverse Event|25|||
48853025|NCT00622700|157301539|FG002|Core Treatment Period|Adverse Event|18|||
48853026|NCT00622700|157301540|FG003|Core Treatment Period|Adverse Event|0|||
48853027|NCT00622700|157301541|FG004|Core Treatment Period|Adverse Event|0|||
48853028|NCT00622700|157301542|FG005|Core Treatment Period|Adverse Event|0|||
48853029|NCT00622700|157301543|FG006|Core Treatment Period|Adverse Event|0|||
48853030|NCT00622700|157301537|FG000|Core Treatment Period|Lack of Efficacy|19|||
48853031|NCT00622700|157301538|FG001|Core Treatment Period|Lack of Efficacy|6|||
48853032|NCT00622700|157301539|FG002|Core Treatment Period|Lack of Efficacy|12|||
48853033|NCT00622700|157301540|FG003|Core Treatment Period|Lack of Efficacy|0|||
48853034|NCT00622700|157301541|FG004|Core Treatment Period|Lack of Efficacy|0|||
48853035|NCT00622700|157301542|FG005|Core Treatment Period|Lack of Efficacy|0|||
48853036|NCT00622700|157301543|FG006|Core Treatment Period|Lack of Efficacy|0|||
48853037|NCT00622700|157301537|FG000|Core Treatment Period|Lost to Follow-up|1|||
48853038|NCT00622700|157301538|FG001|Core Treatment Period|Lost to Follow-up|1|||
48853039|NCT00622700|157301539|FG002|Core Treatment Period|Lost to Follow-up|1|||
48853040|NCT00622700|157301540|FG003|Core Treatment Period|Lost to Follow-up|0|||
48853041|NCT00622700|157301541|FG004|Core Treatment Period|Lost to Follow-up|0|||
48853042|NCT00622700|157301542|FG005|Core Treatment Period|Lost to Follow-up|0|||
48853043|NCT00622700|157301543|FG006|Core Treatment Period|Lost to Follow-up|0|||
48853044|NCT00622700|157301537|FG000|Core Treatment Period|Death|1|||
48853045|NCT00622700|157301538|FG001|Core Treatment Period|Death|0|||
48853046|NCT00622700|157301539|FG002|Core Treatment Period|Death|0|||
48853047|NCT00622700|157301540|FG003|Core Treatment Period|Death|0|||
48853048|NCT00622700|157301541|FG004|Core Treatment Period|Death|0|||
48853049|NCT00622700|157301542|FG005|Core Treatment Period|Death|0|||
48853050|NCT00622700|157301543|FG006|Core Treatment Period|Death|0|||
48853051|NCT00622700|157301537|FG000|Core Treatment Period|Progressive Disease|3|||
48853052|NCT00622700|157301538|FG001|Core Treatment Period|Progressive Disease|1|||
48853053|NCT00622700|157301539|FG002|Core Treatment Period|Progressive Disease|0|||
48853054|NCT00622700|157301540|FG003|Core Treatment Period|Progressive Disease|0|||
48853055|NCT00622700|157301541|FG004|Core Treatment Period|Progressive Disease|0|||
48853056|NCT00622700|157301542|FG005|Core Treatment Period|Progressive Disease|0|||
48853057|NCT00622700|157301543|FG006|Core Treatment Period|Progressive Disease|0|||
48853058|NCT00622700|157301537|FG000|Core Treatment Period|Withdrawal by Subject|12|||
48853059|NCT00622700|157301538|FG001|Core Treatment Period|Withdrawal by Subject|18|||
48853060|NCT00622700|157301539|FG002|Core Treatment Period|Withdrawal by Subject|15|||
48853061|NCT00622700|157301540|FG003|Core Treatment Period|Withdrawal by Subject|0|||
48853062|NCT00622700|157301541|FG004|Core Treatment Period|Withdrawal by Subject|0|||
48853063|NCT00622700|157301542|FG005|Core Treatment Period|Withdrawal by Subject|0|||
48853064|NCT00622700|157301543|FG006|Core Treatment Period|Withdrawal by Subject|0|||
48853065|NCT00622700|157301537|FG000|Core Treatment Period|Other than specified above|2|||
48853066|NCT00622700|157301538|FG001|Core Treatment Period|Other than specified above|2|||
48947619|NCT00642616|157638309|FG001|Overall Study|Protocol Violation|0|||
48947620|NCT00642616|157638310|FG002|Overall Study|Protocol Violation|2|||
48947621|NCT00642616|157638311|FG003|Overall Study|Protocol Violation|0|||
48947622|NCT00642616|157638308|FG000|Overall Study|Physician Decision|0|||
48947623|NCT00642616|157638309|FG001|Overall Study|Physician Decision|0|||
48947624|NCT00642616|157638310|FG002|Overall Study|Physician Decision|1|||
48947625|NCT00642616|157638311|FG003|Overall Study|Physician Decision|1|||
48947626|NCT00734929|157638312|FG000|Overall Study|Lost to Follow-up|1|||
48947627|NCT00734929|157638313|FG001|Overall Study|Lost to Follow-up|2|||
48947628|NCT00734929|157638312|FG000|Overall Study|No intervention/ screen fail|5|||
48947629|NCT00734929|157638313|FG001|Overall Study|No intervention/ screen fail|3|||
48947630|NCT02112448|157638315|FG000|Overall Study|lab values precluding use of ketorolac|2|||
48947631|NCT02112448|157638316|FG001|Overall Study|lab values precluding use of ketorolac|2|||
48947632|NCT02112448|157638315|FG000|Overall Study|Protocol Violation|1|||
48947633|NCT02112448|157638316|FG001|Overall Study|Protocol Violation|2|||
48947634|NCT02112448|157638315|FG000|Overall Study|Physician Decision|4|||
48947635|NCT02112448|157638316|FG001|Overall Study|Physician Decision|6|||
48947636|NCT02112448|157638315|FG000|Overall Study|required heparin so could not use ketoro|1|||
48947637|NCT02112448|157638316|FG001|Overall Study|required heparin so could not use ketoro|0|||
48947638|NCT00875420|157639881|FG000|Overall Study|Adverse Event|0|||
48947639|NCT00875420|157639882|FG001|Overall Study|Adverse Event|1|||
48947640|NCT00875420|157639883|FG002|Overall Study|Adverse Event|1|||
48947641|NCT00875420|157639884|FG003|Overall Study|Adverse Event|0|||
48947642|NCT00875420|157639885|FG004|Overall Study|Adverse Event|0|||
48947643|NCT00875420|157639881|FG000|Overall Study|Inability to complete study procedures|1|||
48947644|NCT00875420|157639882|FG001|Overall Study|Inability to complete study procedures|0|||
48947645|NCT00875420|157639883|FG002|Overall Study|Inability to complete study procedures|1|||
48947646|NCT00875420|157639884|FG003|Overall Study|Inability to complete study procedures|1|||
48947647|NCT00875420|157639885|FG004|Overall Study|Inability to complete study procedures|1|||
48947648|NCT00875420|157639881|FG000|Overall Study|Lost to Follow-up|1|||
48947649|NCT00875420|157639882|FG001|Overall Study|Lost to Follow-up|0|||
48947650|NCT00875420|157639883|FG002|Overall Study|Lost to Follow-up|0|||
48947651|NCT00875420|157639884|FG003|Overall Study|Lost to Follow-up|0|||
48947652|NCT00875420|157639885|FG004|Overall Study|Lost to Follow-up|0|||
48947653|NCT00875420|157639881|FG000|Overall Study|Personal reason|0|||
48947654|NCT00875420|157639882|FG001|Overall Study|Personal reason|0|||
48947655|NCT00875420|157639883|FG002|Overall Study|Personal reason|0|||
48947656|NCT00875420|157639884|FG003|Overall Study|Personal reason|0|||
48947657|NCT00875420|157639885|FG004|Overall Study|Personal reason|1|||
48947658|NCT00875420|157639881|FG000|Overall Study|Prohibited medication|0|||
48947659|NCT00875420|157639882|FG001|Overall Study|Prohibited medication|0|||
48947660|NCT00875420|157639883|FG002|Overall Study|Prohibited medication|0|||
48947661|NCT00875420|157639884|FG003|Overall Study|Prohibited medication|1|||
48947662|NCT00875420|157639885|FG004|Overall Study|Prohibited medication|0|||
48947663|NCT00875420|157639881|FG000|Overall Study|Sponsor decision|0|||
48947664|NCT00875420|157639882|FG001|Overall Study|Sponsor decision|1|||
48947665|NCT00875420|157639883|FG002|Overall Study|Sponsor decision|0|||
48947666|NCT00875420|157639884|FG003|Overall Study|Sponsor decision|0|||
48947667|NCT00875420|157639885|FG004|Overall Study|Sponsor decision|0|||
48947668|NCT00875420|157639881|FG000|Overall Study|Withdrawal by Subject|0|||
48947669|NCT00875420|157639882|FG001|Overall Study|Withdrawal by Subject|0|||
48947670|NCT00875420|157639883|FG002|Overall Study|Withdrawal by Subject|1|||
48947671|NCT00875420|157639884|FG003|Overall Study|Withdrawal by Subject|0|||
48738222|NCT02598960|156892464|FG000|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
48947672|NCT00875420|157639885|FG004|Overall Study|Withdrawal by Subject|0|||
48947673|NCT03705494|157639890|FG000|Overall Study|Lost to Follow-up|2|||
48947674|NCT03705494|157639891|FG001|Overall Study|Lost to Follow-up|1|||
48947675|NCT03705494|157639890|FG000|Overall Study|Withdrawal by Subject|5|||
48947676|NCT03705494|157639891|FG001|Overall Study|Withdrawal by Subject|2|||
48947677|NCT03704051|157639892|FG000|Overall Study|Withdrawal by Subject|4|||
48947678|NCT03704051|157639893|FG001|Overall Study|Withdrawal by Subject|0|||
48947679|NCT00914628|157639896|FG000|Overall Study|Death|35|||
48947680|NCT00914628|157639897|FG001|Overall Study|Death|17|||
48947681|NCT00914628|157639896|FG000|Overall Study|Medical decision|4|||
48947682|NCT00914628|157639897|FG001|Overall Study|Medical decision|0|||
48947683|NCT00914628|157639896|FG000|Overall Study|Protocol Violation|1|||
48947684|NCT00914628|157639897|FG001|Overall Study|Protocol Violation|0|||
48947685|NCT00914628|157639896|FG000|Overall Study|Lack of Efficacy|1|||
48947686|NCT00914628|157639897|FG001|Overall Study|Lack of Efficacy|0|||
48947687|NCT00914628|157639896|FG000|Overall Study|non-randomized|1|||
48947688|NCT00914628|157639897|FG001|Overall Study|non-randomized|0|||
48947689|NCT00914628|157639896|FG000|Overall Study|Relapse|1|||
48947690|NCT00914628|157639897|FG001|Overall Study|Relapse|2|||
48947691|NCT00914628|157639896|FG000|Overall Study|Study terminated by Sponsor|14|||
48947692|NCT00914628|157639897|FG001|Overall Study|Study terminated by Sponsor|8|||
48947693|NCT00914628|157639896|FG000|Overall Study|Patients who did not receive a single dose|7|||
48947694|NCT00914628|157639897|FG001|Overall Study|Patients who did not receive a single dose|1|||
48947695|NCT02400346|157639898|FG000|Overall Study|Adverse Event|24|||
48947696|NCT02400346|157639898|FG000|Overall Study|Lack of Efficacy|9|||
48947697|NCT02400346|157639898|FG000|Overall Study|Non-compliance with IMP|1|||
48947698|NCT02400346|157639898|FG000|Overall Study|Withdrawal by Subject|7|||
48947699|NCT02400346|157639898|FG000|Overall Study|Administrative or other reason(s)|2|||
48947700|NCT02400346|157639898|FG000|Overall Study|Lost to Follow-up|1|||
48738223|NCT02598960|156892465|FG001|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
48738224|NCT02598960|156892466|FG002|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
48738225|NCT02598960|156892467|FG003|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
48738226|NCT02598960|156892468|FG004|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
48738227|NCT02598960|156892469|FG005|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
48738228|NCT02598960|156892470|FG006|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
48947701|NCT00092547|157639903|FG000|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5|||
48947702|NCT00092547|157639904|FG001|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1|||
48947703|NCT00092547|157639905|FG002|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0|||
48947704|NCT00092547|157639903|FG000|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4|||
48947705|NCT00092547|157639904|FG001|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1|||
48947706|NCT00092547|157639905|FG002|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0|||
48947707|NCT00092547|157639903|FG000|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18|||
48947708|NCT00092547|157639904|FG001|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7|||
48947709|NCT00092547|157639905|FG002|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0|||
48947710|NCT00092547|157639903|FG000|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28|||
48947711|NCT00092547|157639904|FG001|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21|||
48947712|NCT00092547|157639905|FG002|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0|||
48947713|NCT00092547|157639903|FG000|Base Vaccine Phase (Day 1 to Month 7)|Moved|3|||
48947714|NCT00092547|157639904|FG001|Base Vaccine Phase (Day 1 to Month 7)|Moved|1|||
48947715|NCT00092547|157639905|FG002|Base Vaccine Phase (Day 1 to Month 7)|Moved|0|||
48947716|NCT00092547|157639903|FG000|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
48947717|NCT00092547|157639904|FG001|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1|||
48947718|NCT00092547|157639905|FG002|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
48947719|NCT00092547|157639903|FG000|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
48947720|NCT00092547|157639904|FG001|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1|||
48947721|NCT00092547|157639905|FG002|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
48947722|NCT00092547|157639903|FG000|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5|||
48947723|NCT00092547|157639904|FG001|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3|||
48947724|NCT00092547|157639905|FG002|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0|||
48947725|NCT00092547|157639903|FG000|Base Follow-up Phase (Month 7 to 18)|Subject moved|1|||
48947726|NCT00092547|157639904|FG001|Base Follow-up Phase (Month 7 to 18)|Subject moved|5|||
48947727|NCT00092547|157639905|FG002|Base Follow-up Phase (Month 7 to 18)|Subject moved|0|||
48947728|NCT00092547|157639903|FG000|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4|||
48738229|NCT02598960|156892471|FG007|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
48947729|NCT00092547|157639904|FG001|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2|||
48947730|NCT00092547|157639905|FG002|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0|||
48947731|NCT00092547|157639903|FG000|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13|||
48947732|NCT00092547|157639904|FG001|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7|||
48738230|NCT02598960|156892472|FG008|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
48738231|NCT02598960|156892473|FG009|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
48738232|NCT02598960|156892474|FG010|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
48738233|NCT02598960|156892475|FG011|Participants Entering Follow Up Period|follow up no longer required per protocol|2|||
48738234|NCT02598960|156892476|FG012|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
48738235|NCT02598960|156892464|FG000|Participants Entering Follow Up Period|Other Reasons|0|||
48738236|NCT02598960|156892465|FG001|Participants Entering Follow Up Period|Other Reasons|0|||
48738237|NCT02598960|156892466|FG002|Participants Entering Follow Up Period|Other Reasons|0|||
48738238|NCT02598960|156892467|FG003|Participants Entering Follow Up Period|Other Reasons|0|||
48738239|NCT02598960|156892468|FG004|Participants Entering Follow Up Period|Other Reasons|0|||
48738240|NCT02598960|156892469|FG005|Participants Entering Follow Up Period|Other Reasons|0|||
48738241|NCT02598960|156892470|FG006|Participants Entering Follow Up Period|Other Reasons|0|||
48738242|NCT02598960|156892471|FG007|Participants Entering Follow Up Period|Other Reasons|0|||
48738243|NCT02598960|156892472|FG008|Participants Entering Follow Up Period|Other Reasons|0|||
48738244|NCT02598960|156892473|FG009|Participants Entering Follow Up Period|Other Reasons|0|||
48738245|NCT02598960|156892474|FG010|Participants Entering Follow Up Period|Other Reasons|1|||
48738246|NCT02598960|156892475|FG011|Participants Entering Follow Up Period|Other Reasons|6|||
48738247|NCT02598960|156892476|FG012|Participants Entering Follow Up Period|Other Reasons|3|||
48738248|NCT00531934|156892477|FG000|Overall Study|Adverse Event|4|||
48738249|NCT00531934|156892478|FG001|Overall Study|Adverse Event|8|||
48738250|NCT00531934|156892477|FG000|Overall Study|Progression|52|||
48738251|NCT00531934|156892478|FG001|Overall Study|Progression|42|||
48738252|NCT00531934|156892477|FG000|Overall Study|Death|7|||
48947733|NCT00092547|157639905|FG002|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0|||
48947734|NCT00092547|157639903|FG000|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1|||
48947735|NCT00092547|157639904|FG001|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
48738253|NCT00531934|156892478|FG001|Overall Study|Death|10|||
48738254|NCT00531934|156892477|FG000|Overall Study|Withdrawal by Subject|1|||
48738255|NCT00531934|156892478|FG001|Overall Study|Withdrawal by Subject|1|||
48738256|NCT00531934|156892477|FG000|Overall Study|Other|2|||
48853067|NCT00622700|157301539|FG002|Core Treatment Period|Other than specified above|5|||
48853068|NCT00622700|157301540|FG003|Core Treatment Period|Other than specified above|0|||
48853069|NCT00622700|157301541|FG004|Core Treatment Period|Other than specified above|0|||
48853070|NCT00622700|157301542|FG005|Core Treatment Period|Other than specified above|0|||
48853071|NCT00622700|157301543|FG006|Core Treatment Period|Other than specified above|0|||
48853072|NCT00622700|157301537|FG000|Extension Treatment Period|Adverse Event|0|||
48853073|NCT00622700|157301538|FG001|Extension Treatment Period|Adverse Event|0|||
48853074|NCT00622700|157301539|FG002|Extension Treatment Period|Adverse Event|0|||
48853075|NCT00622700|157301540|FG003|Extension Treatment Period|Adverse Event|5|||
48947736|NCT00092547|157639905|FG002|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
48947737|NCT00092547|157639903|FG000|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1|||
48947738|NCT00092547|157639904|FG001|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
48947739|NCT00092547|157639905|FG002|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
48947740|NCT00092547|157639903|FG000|Base Follow-up Phase (Month 18 to 30)|Subject moved|4|||
48947741|NCT00092547|157639904|FG001|Base Follow-up Phase (Month 18 to 30)|Subject moved|2|||
48947742|NCT00092547|157639905|FG002|Base Follow-up Phase (Month 18 to 30)|Subject moved|0|||
48947743|NCT00092547|157639903|FG000|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1|||
48947744|NCT00092547|157639904|FG001|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3|||
48947745|NCT00092547|157639905|FG002|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0|||
48947746|NCT00092547|157639903|FG000|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2|||
48947747|NCT00092547|157639904|FG001|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
48947748|NCT00092547|157639905|FG002|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
48738257|NCT00531934|156892478|FG001|Overall Study|Other|2|||
48738258|NCT00851630|156892479|FG000|Overall Study|Death|2|||
48738259|NCT00851630|156892480|FG001|Overall Study|Death|1|||
48738260|NCT00851630|156892479|FG000|Overall Study|Clinical failure|0|||
48738261|NCT00851630|156892480|FG001|Overall Study|Clinical failure|1|||
48738262|NCT02339285|156892483|FG000|Overall Study|Withdrawal by Subject|0|||
48738263|NCT02339285|156892484|FG001|Overall Study|Withdrawal by Subject|1|||
48738264|NCT02339285|156892485|FG002|Overall Study|Withdrawal by Subject|1|||
48738265|NCT02339285|156892483|FG000|Overall Study|Lost to Follow-up|1|||
48738266|NCT02339285|156892484|FG001|Overall Study|Lost to Follow-up|1|||
48738267|NCT02339285|156892485|FG002|Overall Study|Lost to Follow-up|1|||
48738268|NCT02339285|156892483|FG000|Overall Study|Protocol Deviation|0|||
48738269|NCT02339285|156892484|FG001|Overall Study|Protocol Deviation|1|||
48738270|NCT02339285|156892485|FG002|Overall Study|Protocol Deviation|0|||
48738271|NCT01854658|156892488|FG000|Overall Study|Protocol Violation|6|||
48738272|NCT01854658|156892489|FG001|Overall Study|Protocol Violation|2|||
48738273|NCT01854658|156892490|FG002|Overall Study|Protocol Violation|2|||
48738274|NCT01854658|156892491|FG003|Overall Study|Protocol Violation|1|||
48738275|NCT01854658|156892488|FG000|Overall Study|Physician Decision|7|||
48738276|NCT01854658|156892489|FG001|Overall Study|Physician Decision|5|||
48738277|NCT01854658|156892490|FG002|Overall Study|Physician Decision|2|||
48738278|NCT01854658|156892491|FG003|Overall Study|Physician Decision|4|||
48738279|NCT01854658|156892488|FG000|Overall Study|Lost to Follow-up|8|||
48738280|NCT01854658|156892489|FG001|Overall Study|Lost to Follow-up|9|||
48738281|NCT01854658|156892490|FG002|Overall Study|Lost to Follow-up|8|||
48738282|NCT01854658|156892491|FG003|Overall Study|Lost to Follow-up|4|||
48738283|NCT01854658|156892488|FG000|Overall Study|Withdrawal by Subject|28|||
48738284|NCT01854658|156892489|FG001|Overall Study|Withdrawal by Subject|21|||
48738285|NCT01854658|156892490|FG002|Overall Study|Withdrawal by Subject|29|||
48853076|NCT00622700|157301541|FG004|Extension Treatment Period|Adverse Event|9|||
48853077|NCT00622700|157301542|FG005|Extension Treatment Period|Adverse Event|6|||
48853078|NCT00622700|157301543|FG006|Extension Treatment Period|Adverse Event|8|||
48853079|NCT00622700|157301537|FG000|Extension Treatment Period|Lack of Efficacy|0|||
48853080|NCT00622700|157301538|FG001|Extension Treatment Period|Lack of Efficacy|0|||
48853081|NCT00622700|157301539|FG002|Extension Treatment Period|Lack of Efficacy|0|||
48853082|NCT00622700|157301540|FG003|Extension Treatment Period|Lack of Efficacy|2|||
48853083|NCT00622700|157301541|FG004|Extension Treatment Period|Lack of Efficacy|8|||
48853084|NCT00622700|157301542|FG005|Extension Treatment Period|Lack of Efficacy|1|||
48853085|NCT00622700|157301543|FG006|Extension Treatment Period|Lack of Efficacy|9|||
48853086|NCT00622700|157301537|FG000|Extension Treatment Period|Protocol Violation|0|||
48853087|NCT00622700|157301538|FG001|Extension Treatment Period|Protocol Violation|0|||
48853088|NCT00622700|157301539|FG002|Extension Treatment Period|Protocol Violation|0|||
48853089|NCT00622700|157301540|FG003|Extension Treatment Period|Protocol Violation|0|||
48853090|NCT00622700|157301541|FG004|Extension Treatment Period|Protocol Violation|0|||
48853091|NCT00622700|157301542|FG005|Extension Treatment Period|Protocol Violation|2|||
48853092|NCT00622700|157301543|FG006|Extension Treatment Period|Protocol Violation|0|||
48853093|NCT00622700|157301537|FG000|Extension Treatment Period|Lost to Follow-up|0|||
48853094|NCT00622700|157301538|FG001|Extension Treatment Period|Lost to Follow-up|0|||
48853095|NCT00622700|157301539|FG002|Extension Treatment Period|Lost to Follow-up|0|||
48853096|NCT00622700|157301540|FG003|Extension Treatment Period|Lost to Follow-up|0|||
48853097|NCT00622700|157301541|FG004|Extension Treatment Period|Lost to Follow-up|1|||
48853098|NCT00622700|157301542|FG005|Extension Treatment Period|Lost to Follow-up|0|||
48853099|NCT00622700|157301543|FG006|Extension Treatment Period|Lost to Follow-up|0|||
48853100|NCT00622700|157301537|FG000|Extension Treatment Period|Progressive Disease|0|||
48853101|NCT00622700|157301538|FG001|Extension Treatment Period|Progressive Disease|0|||
48853102|NCT00622700|157301539|FG002|Extension Treatment Period|Progressive Disease|0|||
48853103|NCT00622700|157301540|FG003|Extension Treatment Period|Progressive Disease|1|||
48853104|NCT00622700|157301541|FG004|Extension Treatment Period|Progressive Disease|2|||
48853105|NCT00622700|157301542|FG005|Extension Treatment Period|Progressive Disease|0|||
48853106|NCT00622700|157301543|FG006|Extension Treatment Period|Progressive Disease|2|||
48853107|NCT00622700|157301537|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
48853108|NCT00622700|157301538|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
48853109|NCT00622700|157301539|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
48853110|NCT00622700|157301540|FG003|Extension Treatment Period|Withdrawal by Subject|11|||
48738286|NCT01854658|156892491|FG003|Overall Study|Withdrawal by Subject|15|||
48738287|NCT01854658|156892488|FG000|Overall Study|Protocol-specified criteria|15|||
48738288|NCT01854658|156892489|FG001|Overall Study|Protocol-specified criteria|15|||
48738289|NCT01854658|156892490|FG002|Overall Study|Protocol-specified criteria|10|||
48738290|NCT01854658|156892491|FG003|Overall Study|Protocol-specified criteria|7|||
48738291|NCT01854658|156892488|FG000|Overall Study|Lack of Efficacy|3|||
48738292|NCT01854658|156892489|FG001|Overall Study|Lack of Efficacy|8|||
48853111|NCT00622700|157301541|FG004|Extension Treatment Period|Withdrawal by Subject|16|||
48947749|NCT00092547|157639903|FG000|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1|||
48947750|NCT00092547|157639904|FG001|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
48947751|NCT00092547|157639905|FG002|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
48947752|NCT00092547|157639903|FG000|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3|||
48947753|NCT00092547|157639904|FG001|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
48947754|NCT00092547|157639905|FG002|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
48947755|NCT00092547|157639903|FG000|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6|||
48947756|NCT00092547|157639904|FG001|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0|||
48947757|NCT00092547|157639905|FG002|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9|||
48947758|NCT00092547|157639903|FG000|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14|||
48947759|NCT00092547|157639904|FG001|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0|||
48738293|NCT01854658|156892490|FG002|Overall Study|Lack of Efficacy|4|||
48738294|NCT01854658|156892491|FG003|Overall Study|Lack of Efficacy|7|||
48738295|NCT01854658|156892488|FG000|Overall Study|Adverse Event|21|||
48738296|NCT01854658|156892489|FG001|Overall Study|Adverse Event|14|||
48738297|NCT01854658|156892490|FG002|Overall Study|Adverse Event|23|||
48947760|NCT00092547|157639905|FG002|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7|||
48738298|NCT01854658|156892491|FG003|Overall Study|Adverse Event|19|||
48738299|NCT01854658|156892488|FG000|Overall Study|Administrative reasons|5|||
48738300|NCT01854658|156892489|FG001|Overall Study|Administrative reasons|1|||
48738301|NCT01854658|156892490|FG002|Overall Study|Administrative reasons|2|||
48738302|NCT01854658|156892491|FG003|Overall Study|Administrative reasons|2|||
48738303|NCT04195906|156892494|FG000|Part 1|Adverse Event|3|||
48738304|NCT04195906|156892495|FG001|Part 1|Adverse Event|7|||
48738305|NCT04195906|156892494|FG000|Part 1|Withdrawal by Subject|0|||
48738306|NCT04195906|156892495|FG001|Part 1|Withdrawal by Subject|1|||
48738307|NCT04195906|156892494|FG000|Part 2|Adverse Event|1|||
48738308|NCT04195906|156892495|FG001|Part 2|Adverse Event|1|||
48738309|NCT04195906|156892494|FG000|Part 2|Withdrawal by Subject|0|||
48947761|NCT00092547|157639903|FG000|Long-term Follow-up (Month 42 Visit)|Adverse Event|1|||
48738310|NCT04195906|156892495|FG001|Part 2|Withdrawal by Subject|3|||
48738311|NCT04195906|156892494|FG000|Part 2|Other|1|||
48738312|NCT04195906|156892495|FG001|Part 2|Other|3|||
48738313|NCT02281773|156892499|FG000|Overall Study|Adverse Event|6|||
48738314|NCT02281773|156892500|FG001|Overall Study|Adverse Event|1|||
48738315|NCT02281773|156892501|FG002|Overall Study|Adverse Event|4|||
48947762|NCT00092547|157639904|FG001|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
48947763|NCT00092547|157639905|FG002|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
48947764|NCT01371838|157639907|FG000|Overall Study|Withdrawal by Subject|27|||
48947765|NCT01371838|157639908|FG001|Overall Study|Withdrawal by Subject|33|||
48947766|NCT01371838|157639907|FG000|Overall Study|Lost to Follow-up|10|||
48947767|NCT01371838|157639908|FG001|Overall Study|Lost to Follow-up|20|||
48947768|NCT01371838|157639907|FG000|Overall Study|Death|3|||
48947769|NCT01371838|157639908|FG001|Overall Study|Death|4|||
48947770|NCT01371838|157639907|FG000|Overall Study|Protocol Violation|3|||
48947771|NCT01371838|157639908|FG001|Overall Study|Protocol Violation|0|||
48947772|NCT01371838|157639907|FG000|Overall Study|Investigator Decision|3|||
48947773|NCT01371838|157639908|FG001|Overall Study|Investigator Decision|8|||
48947774|NCT01371838|157639907|FG000|Overall Study|Last follow-up visit not conducted|2|||
48947775|NCT01371838|157639908|FG001|Overall Study|Last follow-up visit not conducted|0|||
48947776|NCT01371838|157639907|FG000|Overall Study|Lack of therapeutic response|0|||
48947777|NCT01371838|157639908|FG001|Overall Study|Lack of therapeutic response|1|||
48947778|NCT01371838|157639907|FG000|Overall Study|Surgery|1|||
48947779|NCT01371838|157639908|FG001|Overall Study|Surgery|0|||
48947780|NCT02465034|157639909|FG000|Overall Study|Withdrawal by Subject|1|||
48947781|NCT02465034|157639910|FG001|Overall Study|Withdrawal by Subject|1|||
48947782|NCT02465034|157639909|FG000|Overall Study|Screen fail|2|||
48947783|NCT02465034|157639910|FG001|Overall Study|Screen fail|0|||
48947784|NCT02465034|157639909|FG000|Overall Study|Could not be scheduled for study visit|0|||
48947785|NCT02465034|157639910|FG001|Overall Study|Could not be scheduled for study visit|5|||
48947786|NCT02421120|157639913|FG000|Overall Study|Adverse Event|1|||
48947787|NCT00893789|157639914|FG000|Overall Study|Withdrawal by Subject|3|||
48947788|NCT00893789|157639915|FG001|Overall Study|Withdrawal by Subject|1|||
48947789|NCT00893789|157639916|FG002|Overall Study|Withdrawal by Subject|3|||
48947790|NCT00893789|157639917|FG003|Overall Study|Withdrawal by Subject|1|||
48947791|NCT00893789|157639914|FG000|Overall Study|Noncompliance With Study Drug|1|||
48738316|NCT02281773|156892502|FG003|Overall Study|Adverse Event|8|||
48738317|NCT02281773|156892503|FG004|Overall Study|Adverse Event|9|||
48738318|NCT02281773|156892499|FG000|Overall Study|Protocol Violation|1|||
48738319|NCT02281773|156892500|FG001|Overall Study|Protocol Violation|0|||
48738320|NCT02281773|156892501|FG002|Overall Study|Protocol Violation|0|||
48738321|NCT02281773|156892502|FG003|Overall Study|Protocol Violation|2|||
48738322|NCT02281773|156892503|FG004|Overall Study|Protocol Violation|2|||
48738323|NCT02281773|156892499|FG000|Overall Study|Lost to Follow-up|2|||
48738324|NCT02281773|156892500|FG001|Overall Study|Lost to Follow-up|2|||
48738325|NCT02281773|156892501|FG002|Overall Study|Lost to Follow-up|6|||
48947792|NCT00893789|157639915|FG001|Overall Study|Noncompliance With Study Drug|0|||
48947793|NCT00893789|157639916|FG002|Overall Study|Noncompliance With Study Drug|1|||
48947794|NCT00893789|157639917|FG003|Overall Study|Noncompliance With Study Drug|2|||
48947795|NCT00893789|157639914|FG000|Overall Study|Noncompliance With Study Procedures|1|||
48738326|NCT02281773|156892502|FG003|Overall Study|Lost to Follow-up|2|||
48738327|NCT02281773|156892503|FG004|Overall Study|Lost to Follow-up|10|||
48853112|NCT00622700|157301542|FG005|Extension Treatment Period|Withdrawal by Subject|6|||
48853113|NCT00622700|157301543|FG006|Extension Treatment Period|Withdrawal by Subject|10|||
48853114|NCT00622700|157301537|FG000|Extension Treatment Period|Missing|0|||
48853115|NCT00622700|157301538|FG001|Extension Treatment Period|Missing|0|||
48853116|NCT00622700|157301539|FG002|Extension Treatment Period|Missing|0|||
48853117|NCT00622700|157301540|FG003|Extension Treatment Period|Missing|2|||
48853118|NCT00622700|157301541|FG004|Extension Treatment Period|Missing|3|||
48853119|NCT00622700|157301542|FG005|Extension Treatment Period|Missing|1|||
48853120|NCT00622700|157301543|FG006|Extension Treatment Period|Missing|0|||
48853121|NCT00622700|157301537|FG000|Extension Treatment Period|Other than specified above|0|||
48853122|NCT00622700|157301538|FG001|Extension Treatment Period|Other than specified above|0|||
48853123|NCT00622700|157301539|FG002|Extension Treatment Period|Other than specified above|0|||
48853124|NCT00622700|157301540|FG003|Extension Treatment Period|Other than specified above|0|||
48853125|NCT00622700|157301541|FG004|Extension Treatment Period|Other than specified above|0|||
48853126|NCT00622700|157301542|FG005|Extension Treatment Period|Other than specified above|1|||
48853127|NCT00622700|157301543|FG006|Extension Treatment Period|Other than specified above|1|||
48853128|NCT00942266|157301547|FG000|Overall Study|Withdrawal by Subject|1|||
48853129|NCT00942266|157301548|FG001|Overall Study|Withdrawal by Subject|0|||
48853130|NCT00942266|157301547|FG000|Overall Study|Adverse Event|2|||
48947796|NCT00893789|157639915|FG001|Overall Study|Noncompliance With Study Procedures|0|||
48947797|NCT00893789|157639916|FG002|Overall Study|Noncompliance With Study Procedures|0|||
48738328|NCT02281773|156892499|FG000|Overall Study|Withdrawal by Subject|2|||
48738329|NCT02281773|156892500|FG001|Overall Study|Withdrawal by Subject|8|||
48738330|NCT02281773|156892501|FG002|Overall Study|Withdrawal by Subject|6|||
48738331|NCT02281773|156892502|FG003|Overall Study|Withdrawal by Subject|6|||
48738332|NCT02281773|156892503|FG004|Overall Study|Withdrawal by Subject|8|||
48738333|NCT02281773|156892499|FG000|Overall Study|Other Reason|0|||
48738334|NCT02281773|156892500|FG001|Overall Study|Other Reason|4|||
48738335|NCT02281773|156892501|FG002|Overall Study|Other Reason|2|||
48738336|NCT02281773|156892502|FG003|Overall Study|Other Reason|3|||
48738337|NCT02281773|156892503|FG004|Overall Study|Other Reason|1|||
48738338|NCT00085709|156892505|FG000|Overall Study|Adverse Event|8|||
48738339|NCT00085709|156892506|FG001|Overall Study|Adverse Event|0|||
48738340|NCT00085709|156892505|FG000|Overall Study|Death|8|||
48738341|NCT00085709|156892506|FG001|Overall Study|Death|2|||
48738342|NCT00085709|156892505|FG000|Overall Study|Refusal unrelated to adverse events|1|||
48738343|NCT00085709|156892506|FG001|Overall Study|Refusal unrelated to adverse events|2|||
48738344|NCT00085709|156892505|FG000|Overall Study|Progression|3|||
48738345|NCT00085709|156892506|FG001|Overall Study|Progression|4|||
48738346|NCT00085709|156892505|FG000|Overall Study|Not protocol specified|12|||
48738347|NCT00085709|156892506|FG001|Overall Study|Not protocol specified|22|||
48738348|NCT00085709|156892505|FG000|Overall Study|Not eligible|19|||
48738349|NCT00085709|156892506|FG001|Overall Study|Not eligible|19|||
48738350|NCT00085709|156892505|FG000|Overall Study|Withdrawal by Subject|2|||
48738351|NCT00085709|156892506|FG001|Overall Study|Withdrawal by Subject|1|||
48738352|NCT00734474|156892507|FG000|Overall Study|Entry Criteria Not Met|0|||
48738353|NCT00734474|156892508|FG001|Overall Study|Entry Criteria Not Met|0|||
48738354|NCT00734474|156892509|FG002|Overall Study|Entry Criteria Not Met|5|||
48738355|NCT00734474|156892510|FG003|Overall Study|Entry Criteria Not Met|0|||
48738356|NCT00734474|156892511|FG004|Overall Study|Entry Criteria Not Met|3|||
48738357|NCT00734474|156892512|FG005|Overall Study|Entry Criteria Not Met|1|||
48853131|NCT00942266|157301548|FG001|Overall Study|Adverse Event|1|||
48853132|NCT00942266|157301547|FG000|Overall Study|Disease Progression|38|||
49015319|NCT00814320|157892147|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4|||
49015320|NCT00814320|157892146|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2|||
49015321|NCT00814320|157892147|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1|||
49015322|NCT00814320|157892146|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0|||
49015323|NCT00814320|157892147|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1|||
49015324|NCT00814320|157892146|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0|||
49015325|NCT00814320|157892147|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1|||
49015326|NCT00814320|157892146|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0|||
49015327|NCT00814320|157892147|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3|||
49015328|NCT00673790|157892152|FG000|Overall Study|Adverse Event|23|||
49015329|NCT00673790|157892153|FG001|Overall Study|Adverse Event|14|||
49015330|NCT00673790|157892154|FG002|Overall Study|Adverse Event|2|||
49015331|NCT00673790|157892152|FG000|Overall Study|Lack of Efficacy|2|||
49015332|NCT00673790|157892153|FG001|Overall Study|Lack of Efficacy|2|||
49015333|NCT00673790|157892154|FG002|Overall Study|Lack of Efficacy|2|||
49015334|NCT00673790|157892152|FG000|Overall Study|Protocol Violation|6|||
49015335|NCT00673790|157892153|FG001|Overall Study|Protocol Violation|9|||
49015336|NCT00673790|157892154|FG002|Overall Study|Protocol Violation|1|||
49015337|NCT00673790|157892152|FG000|Overall Study|Withdrawal by Subject|7|||
49015338|NCT00673790|157892153|FG001|Overall Study|Withdrawal by Subject|4|||
49015339|NCT00673790|157892154|FG002|Overall Study|Withdrawal by Subject|1|||
48947798|NCT00893789|157639917|FG003|Overall Study|Noncompliance With Study Procedures|0|||
48947799|NCT00893789|157639914|FG000|Overall Study|Taking Excluded Concomitant Medication|1|||
48947800|NCT00893789|157639915|FG001|Overall Study|Taking Excluded Concomitant Medication|0|||
48947801|NCT00893789|157639916|FG002|Overall Study|Taking Excluded Concomitant Medication|1|||
48947802|NCT00893789|157639917|FG003|Overall Study|Taking Excluded Concomitant Medication|0|||
48947803|NCT00893789|157639914|FG000|Overall Study|Adverse Event|0|||
48947804|NCT00893789|157639915|FG001|Overall Study|Adverse Event|2|||
48947805|NCT00893789|157639916|FG002|Overall Study|Adverse Event|1|||
48947806|NCT00893789|157639917|FG003|Overall Study|Adverse Event|5|||
48947807|NCT00893789|157639914|FG000|Overall Study|Protocol Violation|0|||
48947808|NCT00893789|157639915|FG001|Overall Study|Protocol Violation|1|||
48947809|NCT00893789|157639916|FG002|Overall Study|Protocol Violation|1|||
48947810|NCT00893789|157639917|FG003|Overall Study|Protocol Violation|4|||
48947811|NCT00893789|157639914|FG000|Overall Study|Lost to Follow-up|0|||
48738358|NCT00734474|156892513|FG006|Overall Study|Entry Criteria Not Met|0|||
48738359|NCT00734474|156892514|FG007|Overall Study|Entry Criteria Not Met|1|||
48738360|NCT00734474|156892515|FG008|Overall Study|Entry Criteria Not Met|1|||
48738361|NCT00734474|156892507|FG000|Overall Study|Lost to Follow-up|1|||
48738362|NCT00734474|156892508|FG001|Overall Study|Lost to Follow-up|0|||
48738363|NCT00734474|156892509|FG002|Overall Study|Lost to Follow-up|13|||
48738364|NCT00734474|156892510|FG003|Overall Study|Lost to Follow-up|0|||
48738365|NCT00734474|156892511|FG004|Overall Study|Lost to Follow-up|11|||
48738366|NCT00734474|156892512|FG005|Overall Study|Lost to Follow-up|1|||
48738367|NCT00734474|156892513|FG006|Overall Study|Lost to Follow-up|0|||
48738368|NCT00734474|156892514|FG007|Overall Study|Lost to Follow-up|9|||
48738369|NCT00734474|156892515|FG008|Overall Study|Lost to Follow-up|4|||
48738370|NCT00734474|156892507|FG000|Overall Study|Withdrawal by Subject|2|||
48738371|NCT00734474|156892508|FG001|Overall Study|Withdrawal by Subject|1|||
48738372|NCT00734474|156892509|FG002|Overall Study|Withdrawal by Subject|18|||
48738373|NCT00734474|156892510|FG003|Overall Study|Withdrawal by Subject|0|||
48738374|NCT00734474|156892511|FG004|Overall Study|Withdrawal by Subject|24|||
48738375|NCT00734474|156892512|FG005|Overall Study|Withdrawal by Subject|2|||
48738376|NCT00734474|156892513|FG006|Overall Study|Withdrawal by Subject|0|||
48738377|NCT00734474|156892514|FG007|Overall Study|Withdrawal by Subject|36|||
48738378|NCT00734474|156892515|FG008|Overall Study|Withdrawal by Subject|21|||
48738379|NCT00734474|156892507|FG000|Overall Study|Physician Decision|0|||
48738380|NCT00734474|156892508|FG001|Overall Study|Physician Decision|0|||
48738381|NCT00734474|156892509|FG002|Overall Study|Physician Decision|4|||
48738382|NCT00734474|156892510|FG003|Overall Study|Physician Decision|1|||
48738383|NCT00734474|156892511|FG004|Overall Study|Physician Decision|11|||
48738384|NCT00734474|156892512|FG005|Overall Study|Physician Decision|0|||
48738385|NCT00734474|156892513|FG006|Overall Study|Physician Decision|0|||
48738386|NCT00734474|156892514|FG007|Overall Study|Physician Decision|9|||
48738387|NCT00734474|156892515|FG008|Overall Study|Physician Decision|9|||
48738388|NCT00734474|156892507|FG000|Overall Study|Adverse Event|4|||
48738389|NCT00734474|156892508|FG001|Overall Study|Adverse Event|4|||
48738390|NCT00734474|156892509|FG002|Overall Study|Adverse Event|63|||
48738391|NCT00734474|156892510|FG003|Overall Study|Adverse Event|1|||
48738392|NCT00734474|156892511|FG004|Overall Study|Adverse Event|64|||
48738393|NCT00734474|156892512|FG005|Overall Study|Adverse Event|0|||
48738394|NCT00734474|156892513|FG006|Overall Study|Adverse Event|1|||
48738395|NCT00734474|156892514|FG007|Overall Study|Adverse Event|65|||
48738396|NCT00734474|156892515|FG008|Overall Study|Adverse Event|39|||
48738397|NCT00734474|156892507|FG000|Overall Study|Protocol Violation|0|||
48738398|NCT00734474|156892508|FG001|Overall Study|Protocol Violation|0|||
48738399|NCT00734474|156892509|FG002|Overall Study|Protocol Violation|4|||
48738400|NCT00734474|156892510|FG003|Overall Study|Protocol Violation|0|||
48738401|NCT00734474|156892511|FG004|Overall Study|Protocol Violation|3|||
48738402|NCT00734474|156892512|FG005|Overall Study|Protocol Violation|0|||
48738403|NCT00734474|156892513|FG006|Overall Study|Protocol Violation|0|||
48738404|NCT00734474|156892514|FG007|Overall Study|Protocol Violation|3|||
48738405|NCT00734474|156892515|FG008|Overall Study|Protocol Violation|1|||
48738406|NCT00734474|156892507|FG000|Overall Study|Sponsor Decision, Arm Discontinued|8|||
48738407|NCT00734474|156892508|FG001|Overall Study|Sponsor Decision, Arm Discontinued|25|||
48738408|NCT00734474|156892509|FG002|Overall Study|Sponsor Decision, Arm Discontinued|0|||
48738409|NCT00734474|156892510|FG003|Overall Study|Sponsor Decision, Arm Discontinued|8|||
48947812|NCT00893789|157639915|FG001|Overall Study|Lost to Follow-up|0|||
48738410|NCT00734474|156892511|FG004|Overall Study|Sponsor Decision, Arm Discontinued|0|||
48738411|NCT00734474|156892512|FG005|Overall Study|Sponsor Decision, Arm Discontinued|21|||
48738412|NCT00734474|156892513|FG006|Overall Study|Sponsor Decision, Arm Discontinued|23|||
48738413|NCT00734474|156892514|FG007|Overall Study|Sponsor Decision, Arm Discontinued|0|||
48738414|NCT00734474|156892515|FG008|Overall Study|Sponsor Decision, Arm Discontinued|0|||
48738415|NCT00734474|156892507|FG000|Overall Study|Sponsor Decision|0|||
48738416|NCT00734474|156892508|FG001|Overall Study|Sponsor Decision|0|||
48738417|NCT00734474|156892509|FG002|Overall Study|Sponsor Decision|0|||
48738418|NCT00734474|156892510|FG003|Overall Study|Sponsor Decision|0|||
48738419|NCT00734474|156892511|FG004|Overall Study|Sponsor Decision|2|||
48947813|NCT00893789|157639916|FG002|Overall Study|Lost to Follow-up|0|||
48738420|NCT00734474|156892512|FG005|Overall Study|Sponsor Decision|0|||
48738421|NCT00734474|156892513|FG006|Overall Study|Sponsor Decision|0|||
48947814|NCT00893789|157639917|FG003|Overall Study|Lost to Follow-up|1|||
48947815|NCT01408537|157639920|FG000|Overall Study|Withdrawal by Subject|2|||
48738422|NCT00734474|156892514|FG007|Overall Study|Sponsor Decision|0|||
48738423|NCT00734474|156892515|FG008|Overall Study|Sponsor Decision|0|||
48947816|NCT01408537|157639920|FG000|Overall Study|Protocol Violation|3|||
48947817|NCT01408537|157639920|FG000|Overall Study|Lost to Follow-up|3|||
48947818|NCT04075604|157639923|FG000|Overall Study|Adverse Event|0|||
48947819|NCT04075604|157639924|FG001|Overall Study|Adverse Event|0|||
48947820|NCT04075604|157639925|FG002|Overall Study|Adverse Event|3|||
48947821|NCT04075604|157639923|FG000|Overall Study|Participant request to discontinue study treatment|0|||
48947822|NCT04075604|157639924|FG001|Overall Study|Participant request to discontinue study treatment|0|||
48947823|NCT04075604|157639925|FG002|Overall Study|Participant request to discontinue study treatment|1|||
48947824|NCT04075604|157639923|FG000|Overall Study|Participant withdrew consent|0|||
48947825|NCT04075604|157639924|FG001|Overall Study|Participant withdrew consent|0|||
48947826|NCT04075604|157639925|FG002|Overall Study|Participant withdrew consent|1|||
48947827|NCT04075604|157639923|FG000|Overall Study|Other reasons|1|||
48947828|NCT04075604|157639924|FG001|Overall Study|Other reasons|0|||
48947829|NCT04075604|157639925|FG002|Overall Study|Other reasons|0|||
48947830|NCT04075604|157639923|FG000|Overall Study|Disease progression|0|||
48947831|NCT04075604|157639924|FG001|Overall Study|Disease progression|1|||
48947832|NCT04075604|157639925|FG002|Overall Study|Disease progression|0|||
48947833|NCT04075604|157639923|FG000|Overall Study|Study drug toxicity|0|||
48947834|NCT04075604|157639924|FG001|Overall Study|Study drug toxicity|5|||
48738424|NCT00734474|156892507|FG000|Overall Study|Death|0|||
48947835|NCT04075604|157639925|FG002|Overall Study|Study drug toxicity|1|||
48738425|NCT00734474|156892508|FG001|Overall Study|Death|0|||
48738426|NCT00734474|156892509|FG002|Overall Study|Death|1|||
48947836|NCT01845025|157639932|FG000|Overall Study|Adverse Event|6|||
48947837|NCT01845025|157639933|FG001|Overall Study|Adverse Event|3|||
48947838|NCT01845025|157639932|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
49015340|NCT00673790|157892152|FG000|Overall Study|Lost to Follow-up|6|||
48738427|NCT00734474|156892510|FG003|Overall Study|Death|0|||
48738428|NCT00734474|156892511|FG004|Overall Study|Death|0|||
48738429|NCT00734474|156892512|FG005|Overall Study|Death|0|||
48738430|NCT00734474|156892513|FG006|Overall Study|Death|0|||
48738431|NCT00734474|156892514|FG007|Overall Study|Death|2|||
48738432|NCT00734474|156892515|FG008|Overall Study|Death|1|||
48738433|NCT00734474|156892507|FG000|Overall Study|Lack of Efficacy|0|||
48738434|NCT00734474|156892508|FG001|Overall Study|Lack of Efficacy|0|||
48738435|NCT00734474|156892509|FG002|Overall Study|Lack of Efficacy|4|||
48738436|NCT00734474|156892510|FG003|Overall Study|Lack of Efficacy|0|||
48738437|NCT00734474|156892511|FG004|Overall Study|Lack of Efficacy|0|||
48738438|NCT00734474|156892512|FG005|Overall Study|Lack of Efficacy|0|||
48738439|NCT00734474|156892513|FG006|Overall Study|Lack of Efficacy|0|||
48738440|NCT00734474|156892514|FG007|Overall Study|Lack of Efficacy|4|||
48738441|NCT00734474|156892515|FG008|Overall Study|Lack of Efficacy|6|||
48738442|NCT00785928|156892516|FG000|Treatment Phase|Adverse Event|1|||
48738443|NCT00785928|156892517|FG001|Treatment Phase|Adverse Event|1|||
48738444|NCT00785928|156892518|FG002|Treatment Phase|Adverse Event|2|||
48738445|NCT00785928|156892519|FG003|Treatment Phase|Adverse Event|0|||
48947839|NCT01845025|157639933|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
48947840|NCT01845025|157639932|FG000|Overall Study|Withdrawal by Subject|48|||
48947841|NCT01845025|157639933|FG001|Overall Study|Withdrawal by Subject|44|||
48947842|NCT01845025|157639932|FG000|Overall Study|Lost to Follow-up|13|||
48947843|NCT01845025|157639933|FG001|Overall Study|Lost to Follow-up|13|||
48947844|NCT01845025|157639932|FG000|Overall Study|Administrative problems|8|||
48947845|NCT01845025|157639933|FG001|Overall Study|Administrative problems|8|||
48947846|NCT01845025|157639932|FG000|Overall Study|Death|2|||
48947847|NCT01845025|157639933|FG001|Overall Study|Death|0|||
48947848|NCT01845025|157639932|FG000|Overall Study|Protocol deviation|3|||
48947849|NCT01845025|157639933|FG001|Overall Study|Protocol deviation|6|||
48947850|NCT01845025|157639932|FG000|Overall Study|Missing|1|||
48947851|NCT01845025|157639933|FG001|Overall Study|Missing|1|||
48947852|NCT01272180|157639936|FG000|Overall Study|Adverse Event|0|||
48947853|NCT01272180|157639937|FG001|Overall Study|Adverse Event|0|||
48947854|NCT01272180|157639938|FG002|Overall Study|Adverse Event|1|||
48947855|NCT01272180|157639939|FG003|Overall Study|Adverse Event|0|||
48947856|NCT01272180|157639936|FG000|Overall Study|Withdrawal by Subject|2|||
48947857|NCT01272180|157639937|FG001|Overall Study|Withdrawal by Subject|6|||
48947858|NCT01272180|157639938|FG002|Overall Study|Withdrawal by Subject|3|||
48947859|NCT01272180|157639939|FG003|Overall Study|Withdrawal by Subject|2|||
48947860|NCT01272180|157639936|FG000|Overall Study|Lost to Follow-up|15|||
48947861|NCT01272180|157639937|FG001|Overall Study|Lost to Follow-up|14|||
48947862|NCT01272180|157639938|FG002|Overall Study|Lost to Follow-up|8|||
48947863|NCT01272180|157639939|FG003|Overall Study|Lost to Follow-up|10|||
48947864|NCT01272180|157639936|FG000|Overall Study|Inappropriate enrollment|0|||
48738446|NCT00785928|156892520|FG004|Treatment Phase|Adverse Event|0|||
48738447|NCT00785928|156892521|FG005|Treatment Phase|Adverse Event|0|||
48738448|NCT00785928|156892522|FG006|Treatment Phase|Adverse Event|2|||
48738449|NCT00785928|156892516|FG000|Treatment Phase|Inadequate Response|0|||
48738450|NCT00785928|156892517|FG001|Treatment Phase|Inadequate Response|1|||
48738451|NCT00785928|156892518|FG002|Treatment Phase|Inadequate Response|0|||
48947865|NCT01272180|157639937|FG001|Overall Study|Inappropriate enrollment|0|||
48947866|NCT01272180|157639938|FG002|Overall Study|Inappropriate enrollment|1|||
48947867|NCT01272180|157639939|FG003|Overall Study|Inappropriate enrollment|1|||
48947868|NCT01272180|157639936|FG000|Overall Study|Protocol Violation|0|||
48947869|NCT01272180|157639937|FG001|Overall Study|Protocol Violation|1|||
48947870|NCT01272180|157639938|FG002|Overall Study|Protocol Violation|0|||
48947871|NCT01272180|157639939|FG003|Overall Study|Protocol Violation|1|||
48738452|NCT00785928|156892519|FG003|Treatment Phase|Inadequate Response|0|||
48738453|NCT00785928|156892520|FG004|Treatment Phase|Inadequate Response|0|||
48738454|NCT00785928|156892521|FG005|Treatment Phase|Inadequate Response|0|||
48738455|NCT00785928|156892522|FG006|Treatment Phase|Inadequate Response|0|||
48738456|NCT00785928|156892516|FG000|Treatment Phase|Lack of Efficacy|0|||
48738457|NCT00785928|156892517|FG001|Treatment Phase|Lack of Efficacy|1|||
48738458|NCT00785928|156892518|FG002|Treatment Phase|Lack of Efficacy|1|||
48738459|NCT00785928|156892519|FG003|Treatment Phase|Lack of Efficacy|0|||
48738460|NCT00785928|156892520|FG004|Treatment Phase|Lack of Efficacy|0|||
48738461|NCT00785928|156892521|FG005|Treatment Phase|Lack of Efficacy|0|||
48738462|NCT00785928|156892522|FG006|Treatment Phase|Lack of Efficacy|0|||
48738463|NCT00785928|156892516|FG000|Treatment Phase|Physician Decision|0|||
48738464|NCT00785928|156892517|FG001|Treatment Phase|Physician Decision|0|||
48853133|NCT00942266|157301548|FG001|Overall Study|Disease Progression|11|||
48853134|NCT00942266|157301547|FG000|Overall Study|Failure to thrive and pt withdrawal|0|||
48853135|NCT00942266|157301548|FG001|Overall Study|Failure to thrive and pt withdrawal|1|||
48853136|NCT00942266|157301547|FG000|Overall Study|Intercurrent illness|0|||
48738465|NCT00785928|156892518|FG002|Treatment Phase|Physician Decision|0|||
48738466|NCT00785928|156892519|FG003|Treatment Phase|Physician Decision|0|||
48738467|NCT00785928|156892520|FG004|Treatment Phase|Physician Decision|1|||
48738468|NCT00785928|156892521|FG005|Treatment Phase|Physician Decision|0|||
48738469|NCT00785928|156892522|FG006|Treatment Phase|Physician Decision|0|||
48738470|NCT00785928|156892516|FG000|Treatment Phase|Sponsor Decision|1|||
48738471|NCT00785928|156892517|FG001|Treatment Phase|Sponsor Decision|0|||
48738472|NCT00785928|156892518|FG002|Treatment Phase|Sponsor Decision|0|||
48738473|NCT00785928|156892519|FG003|Treatment Phase|Sponsor Decision|0|||
48738474|NCT00785928|156892520|FG004|Treatment Phase|Sponsor Decision|0|||
48738475|NCT00785928|156892521|FG005|Treatment Phase|Sponsor Decision|0|||
48738476|NCT00785928|156892522|FG006|Treatment Phase|Sponsor Decision|1|||
48738477|NCT00785928|156892516|FG000|Treatment Phase|Withdrawal by Subject|1|||
48738478|NCT00785928|156892517|FG001|Treatment Phase|Withdrawal by Subject|2|||
48738479|NCT00785928|156892518|FG002|Treatment Phase|Withdrawal by Subject|0|||
48738480|NCT00785928|156892519|FG003|Treatment Phase|Withdrawal by Subject|0|||
48738481|NCT00785928|156892520|FG004|Treatment Phase|Withdrawal by Subject|1|||
48738482|NCT00785928|156892521|FG005|Treatment Phase|Withdrawal by Subject|0|||
48738483|NCT00785928|156892522|FG006|Treatment Phase|Withdrawal by Subject|0|||
48738484|NCT02104752|156892525|FG000|Overall Study|Withdrawal by Subject|1|||
48738485|NCT02104752|156892526|FG001|Overall Study|Withdrawal by Subject|0|||
48738486|NCT02104752|156892525|FG000|Overall Study|Weight gain; unrelated anxiety|0|||
48738487|NCT02104752|156892526|FG001|Overall Study|Weight gain; unrelated anxiety|2|||
48738488|NCT00573183|156892527|FG000|Overall Study|Lost to Follow-up|52|||
48738489|NCT00573183|156892528|FG001|Overall Study|Lost to Follow-up|50|||
48738490|NCT00573183|156892527|FG000|Overall Study|Withdrawal by Subject|8|||
48738491|NCT00573183|156892528|FG001|Overall Study|Withdrawal by Subject|2|||
48738492|NCT00573183|156892527|FG000|Overall Study|Death|0|||
48738493|NCT00573183|156892528|FG001|Overall Study|Death|1|||
48738494|NCT00573183|156892527|FG000|Overall Study|Adverse Event|2|||
48853137|NCT00942266|157301548|FG001|Overall Study|Intercurrent illness|1|||
48853138|NCT00942266|157301547|FG000|Overall Study|Physician Decision|2|||
48738495|NCT00573183|156892528|FG001|Overall Study|Adverse Event|0|||
48738496|NCT00573183|156892527|FG000|Overall Study|Incarceration|5|||
48738497|NCT00573183|156892528|FG001|Overall Study|Incarceration|8|||
48738498|NCT00573183|156892527|FG000|Overall Study|Other|5|||
48738499|NCT00573183|156892528|FG001|Overall Study|Other|2|||
48853139|NCT00942266|157301548|FG001|Overall Study|Physician Decision|0|||
48853140|NCT00942266|157301547|FG000|Overall Study|medical deterioration (pneumonia)|0|||
48853141|NCT00942266|157301548|FG001|Overall Study|medical deterioration (pneumonia)|1|||
48853142|NCT01604824|157301557|FG000|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
48853143|NCT01604824|157301558|FG001|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
48853144|NCT01604824|157301559|FG002|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
48853145|NCT01604824|157301560|FG003|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
48853146|NCT01604824|157301561|FG004|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2|||
48853147|NCT01604824|157301562|FG005|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
48853148|NCT01604824|157301557|FG000|Open-label Extension (OLE) Period|Refused to come into office|0|||
48738500|NCT02422303|156892529|FG000|Overall Study|Lost to Follow-up|1|||
48738501|NCT02422303|156892530|FG001|Overall Study|Lost to Follow-up|1|||
48738502|NCT01816074|156892531|FG000|Phase 1|Time commitment issues|0|||
48738503|NCT01816074|156892532|FG001|Phase 1|Time commitment issues|0|||
48738504|NCT01816074|156892533|FG002|Phase 1|Time commitment issues|1|||
48738505|NCT01816074|156892534|FG003|Phase 1|Time commitment issues|0|||
48738506|NCT01816074|156892531|FG000|Phase 2|Time commitment Issues|0|||
48738507|NCT01816074|156892532|FG001|Phase 2|Time commitment Issues|2|||
48738508|NCT01816074|156892533|FG002|Phase 2|Time commitment Issues|0|||
48738509|NCT01816074|156892534|FG003|Phase 2|Time commitment Issues|0|||
48947872|NCT03334214|157639940|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
48947873|NCT03334214|157639941|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
48947874|NCT03334214|157639940|FG000|Overall Study|Withdrawal by Subject|0|||
48947875|NCT03334214|157639941|FG001|Overall Study|Withdrawal by Subject|1|||
49015341|NCT00673790|157892153|FG001|Overall Study|Lost to Follow-up|6|||
48738510|NCT01816074|156892531|FG000|Phase 2|Unsatisfied with Randomization assignmen|1|||
48738511|NCT01816074|156892532|FG001|Phase 2|Unsatisfied with Randomization assignmen|0|||
48738512|NCT01816074|156892533|FG002|Phase 2|Unsatisfied with Randomization assignmen|0|||
48738513|NCT01816074|156892534|FG003|Phase 2|Unsatisfied with Randomization assignmen|0|||
48738514|NCT01816074|156892531|FG000|Phase 2|Physician Decision|0|||
48738515|NCT01816074|156892532|FG001|Phase 2|Physician Decision|0|||
48738516|NCT01816074|156892533|FG002|Phase 2|Physician Decision|0|||
48738517|NCT01816074|156892534|FG003|Phase 2|Physician Decision|1|||
48738518|NCT01816074|156892531|FG000|Phase 2|Withdrawal by Subject|1|||
48853149|NCT01604824|157301558|FG001|Open-label Extension (OLE) Period|Refused to come into office|0|||
48853150|NCT01604824|157301559|FG002|Open-label Extension (OLE) Period|Refused to come into office|0|||
48853151|NCT01604824|157301560|FG003|Open-label Extension (OLE) Period|Refused to come into office|0|||
48853152|NCT01604824|157301561|FG004|Open-label Extension (OLE) Period|Refused to come into office|1|||
48853153|NCT01604824|157301562|FG005|Open-label Extension (OLE) Period|Refused to come into office|0|||
48853154|NCT01316913|157301563|FG000|Overall Study|Adverse Event|17|||
48853155|NCT01316913|157301564|FG001|Overall Study|Adverse Event|20|||
48853156|NCT01316913|157301565|FG002|Overall Study|Adverse Event|15|||
48853157|NCT01316913|157301566|FG003|Overall Study|Adverse Event|11|||
48853158|NCT01316913|157301563|FG000|Overall Study|Lack of Efficacy|22|||
48853159|NCT01316913|157301564|FG001|Overall Study|Lack of Efficacy|12|||
48853160|NCT01316913|157301565|FG002|Overall Study|Lack of Efficacy|9|||
48853161|NCT01316913|157301566|FG003|Overall Study|Lack of Efficacy|13|||
48853162|NCT01316913|157301563|FG000|Overall Study|Protocol Violation|1|||
48853163|NCT01316913|157301564|FG001|Overall Study|Protocol Violation|4|||
48853164|NCT01316913|157301565|FG002|Overall Study|Protocol Violation|4|||
48853165|NCT01316913|157301566|FG003|Overall Study|Protocol Violation|1|||
48853166|NCT01316913|157301563|FG000|Overall Study|Protocol-defined Stopping Criteria|7|||
48853167|NCT01316913|157301564|FG001|Overall Study|Protocol-defined Stopping Criteria|8|||
48853168|NCT01316913|157301565|FG002|Overall Study|Protocol-defined Stopping Criteria|11|||
48853169|NCT01316913|157301566|FG003|Overall Study|Protocol-defined Stopping Criteria|6|||
48853170|NCT01316913|157301563|FG000|Overall Study|Lost to Follow-up|0|||
48853171|NCT01316913|157301564|FG001|Overall Study|Lost to Follow-up|1|||
48853172|NCT01316913|157301565|FG002|Overall Study|Lost to Follow-up|0|||
48853173|NCT01316913|157301566|FG003|Overall Study|Lost to Follow-up|2|||
48853174|NCT01316913|157301563|FG000|Overall Study|Withdrawal by Subject|10|||
48853175|NCT01316913|157301564|FG001|Overall Study|Withdrawal by Subject|9|||
48853176|NCT01316913|157301565|FG002|Overall Study|Withdrawal by Subject|10|||
48853177|NCT01316913|157301566|FG003|Overall Study|Withdrawal by Subject|6|||
48853178|NCT03697603|157301567|FG000|Overall Study|Adverse Event|3|||
48853179|NCT03697603|157301568|FG001|Overall Study|Adverse Event|18|||
48853180|NCT03697603|157301569|FG002|Overall Study|Adverse Event|3|||
48853181|NCT03697603|157301567|FG000|Overall Study|Physician Decision|1|||
48853182|NCT03697603|157301568|FG001|Overall Study|Physician Decision|0|||
48853183|NCT03697603|157301569|FG002|Overall Study|Physician Decision|2|||
48853184|NCT03697603|157301567|FG000|Overall Study|Protocol Violation|3|||
48853185|NCT03697603|157301568|FG001|Overall Study|Protocol Violation|8|||
48853186|NCT03697603|157301569|FG002|Overall Study|Protocol Violation|5|||
48853187|NCT03697603|157301567|FG000|Overall Study|Withdrawal by Subject|5|||
48853188|NCT03697603|157301568|FG001|Overall Study|Withdrawal by Subject|1|||
48853189|NCT03697603|157301569|FG002|Overall Study|Withdrawal by Subject|1|||
48738519|NCT01816074|156892532|FG001|Phase 2|Withdrawal by Subject|0|||
48738520|NCT01816074|156892533|FG002|Phase 2|Withdrawal by Subject|0|||
48738521|NCT01816074|156892534|FG003|Phase 2|Withdrawal by Subject|0|||
48738522|NCT00408629|156892537|FG000|Overall Study|Adverse Event|13|||
48738523|NCT00408629|156892538|FG001|Overall Study|Adverse Event|27|||
48738524|NCT00408629|156892537|FG000|Overall Study|Withdrawal by Subject|8|||
48947876|NCT03334214|157639940|FG000|Overall Study|Other|1|||
48947877|NCT03334214|157639941|FG001|Overall Study|Other|0|||
48947878|NCT01126619|157639945|FG000|Overall Study|Not eligible for the study|2|||
48947879|NCT01126619|157639945|FG000|Overall Study|Investigator decision|4|||
48947880|NCT01126619|157639945|FG000|Overall Study|Serious adverse event|1|||
48947881|NCT01126619|157639945|FG000|Overall Study|Withdrawal by Subject|9|||
48947882|NCT01126619|157639945|FG000|Overall Study|Non-compliance|1|||
48947883|NCT03988751|157639946|FG000|Overall Study|Withdrawal by Subject|1|||
48947884|NCT03988751|157639947|FG001|Overall Study|Withdrawal by Subject|0|||
48947885|NCT03988751|157639946|FG000|Overall Study|Protocol Violation|0|||
48947886|NCT03988751|157639947|FG001|Overall Study|Protocol Violation|1|||
48947887|NCT02441803|157639948|FG000|Overall Study|Physician Decision|0|||
48947888|NCT02441803|157639949|FG001|Overall Study|Physician Decision|2|||
48947889|NCT02441803|157639950|FG002|Overall Study|Physician Decision|2|||
48738525|NCT00408629|156892538|FG001|Overall Study|Withdrawal by Subject|4|||
48853190|NCT03697603|157301567|FG000|Overall Study|Protocol Violation|0|||
48853191|NCT03697603|157301568|FG001|Overall Study|Protocol Violation|0|||
48853192|NCT03697603|157301569|FG002|Overall Study|Protocol Violation|1|||
48853193|NCT03775213|157301572|FG000|Overall Study|Withdrawal by Subject|51|||
48853194|NCT03775213|157301573|FG001|Overall Study|Withdrawal by Subject|53|||
48853195|NCT03775213|157301572|FG000|Overall Study|Incomplete Survey|7|||
48853196|NCT03775213|157301573|FG001|Overall Study|Incomplete Survey|7|||
48853197|NCT00553332|157301576|FG000|Overall Study|ineligible, incorrect diagnosis|1|||
48853198|NCT03072862|157301580|FG000|Overall Study|Withdrawal by Subject|4|||
48853199|NCT03072862|157301580|FG000|Overall Study|Lost to Follow-up|6|||
48853200|NCT03072862|157301580|FG000|Overall Study|Protocol Violation|4|||
48853201|NCT03072862|157301580|FG000|Overall Study|Physician Decision|2|||
48853202|NCT03072862|157301580|FG000|Overall Study|Death|1|||
48853203|NCT03072862|157301580|FG000|Overall Study|Adverse Event|1|||
48853204|NCT03347396|157301581|FG000|Part A (26 Weeks)|Adverse Event|1|||
48853205|NCT03347396|157301582|FG001|Part A (26 Weeks)|Adverse Event|0|||
48853206|NCT03347396|157301581|FG000|Part A (26 Weeks)|Death|0|||
48853207|NCT03347396|157301582|FG001|Part A (26 Weeks)|Death|1|||
48853208|NCT03347396|157301581|FG000|Part B (149 Weeks)|Adverse Event|1|||
48853209|NCT03347396|157301582|FG001|Part B (149 Weeks)|Adverse Event|1|||
48853210|NCT03347396|157301581|FG000|Part B (149 Weeks)|Death|1|||
48853211|NCT03347396|157301582|FG001|Part B (149 Weeks)|Death|0|||
48853212|NCT02309294|157301583|FG000|Overall Study|Withdrawal by Subject|2|||
48853213|NCT01263496|157301584|FG000|Enrolled - Long-Term Extension Study|Protocol Violation|1|||
48853214|NCT01263496|157301585|FG001|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
48853215|NCT01263496|157301586|FG002|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
48853216|NCT01263496|157301587|FG003|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
48853217|NCT01263496|157301588|FG004|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
48853218|NCT01263496|157301589|FG005|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
48853219|NCT01263496|157301590|FG006|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
48853220|NCT01263496|157301591|FG007|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
48853221|NCT01263496|157301592|FG008|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
48853222|NCT01263496|157301584|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
48853223|NCT01263496|157301585|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
48853224|NCT01263496|157301586|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
48853225|NCT01263496|157301587|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
48853226|NCT01263496|157301588|FG004|Enrolled - Long-Term Extension Study|Adverse Event|2|||
48853227|NCT01263496|157301589|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
48947890|NCT01849848|157639952|FG000|Overall Study|Physician Decision|1|||
48947891|NCT01849848|157639952|FG000|Overall Study|Progression of the primary disease|3|||
48947892|NCT01070303|157639953|FG000|Overall Study|Adverse Event|39|||
48947893|NCT01070303|157639953|FG000|Overall Study|Withdrawal by Subject|20|||
48947894|NCT01070303|157639953|FG000|Overall Study|Lost to Follow-up|9|||
48947895|NCT01070303|157639953|FG000|Overall Study|Protocol Violation|0|||
48947896|NCT01070303|157639953|FG000|Overall Study|Lack of Efficacy|2|||
48947897|NCT01070303|157639953|FG000|Overall Study|Administrative Reason|1|||
48947898|NCT01070303|157639953|FG000|Overall Study|Other|18|||
48947899|NCT01645280|157639954|FG000|Overall Study|Death|0|||
48947900|NCT01645280|157639955|FG001|Overall Study|Death|1|||
48947901|NCT01645280|157639956|FG002|Overall Study|Death|0|||
48947902|NCT01645280|157639957|FG003|Overall Study|Death|0|||
48947903|NCT01645280|157639958|FG004|Overall Study|Death|0|||
48947904|NCT01645280|157639954|FG000|Overall Study|Withdrawal by Subject|4|||
48947905|NCT01645280|157639955|FG001|Overall Study|Withdrawal by Subject|0|||
48947906|NCT01645280|157639956|FG002|Overall Study|Withdrawal by Subject|2|||
48947907|NCT01645280|157639957|FG003|Overall Study|Withdrawal by Subject|4|||
48947908|NCT01645280|157639958|FG004|Overall Study|Withdrawal by Subject|5|||
48738526|NCT00408629|156892537|FG000|Overall Study|Lost to Follow-up|1|||
48738527|NCT00408629|156892538|FG001|Overall Study|Lost to Follow-up|1|||
48947909|NCT01645280|157639954|FG000|Overall Study|Lost to Follow-up|0|||
49015342|NCT00673790|157892154|FG002|Overall Study|Lost to Follow-up|5|||
48947910|NCT01645280|157639955|FG001|Overall Study|Lost to Follow-up|0|||
48947911|NCT01645280|157639956|FG002|Overall Study|Lost to Follow-up|0|||
48947912|NCT01645280|157639957|FG003|Overall Study|Lost to Follow-up|2|||
48947913|NCT01645280|157639958|FG004|Overall Study|Lost to Follow-up|1|||
48947914|NCT01645280|157639954|FG000|Overall Study|Other|1|||
48853228|NCT01263496|157301590|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
48853229|NCT01263496|157301591|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
48853230|NCT01263496|157301592|FG008|Enrolled - Long-Term Extension Study|Adverse Event|0|||
48853231|NCT01263496|157301584|FG000|Entered - Long-Term Extension Study|Adverse Event|0|||
48853232|NCT01263496|157301585|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
48853233|NCT01263496|157301586|FG002|Entered - Long-Term Extension Study|Adverse Event|6|||
48853234|NCT01263496|157301587|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
48853235|NCT01263496|157301588|FG004|Entered - Long-Term Extension Study|Adverse Event|1|||
48853236|NCT01263496|157301589|FG005|Entered - Long-Term Extension Study|Adverse Event|0|||
48853237|NCT01263496|157301590|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
48853238|NCT01263496|157301591|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
48853239|NCT01263496|157301592|FG008|Entered - Long-Term Extension Study|Adverse Event|1|||
48853240|NCT01263496|157301584|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
48853241|NCT01263496|157301585|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|2|||
48853242|NCT01263496|157301586|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
48853243|NCT01263496|157301587|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
48853244|NCT01263496|157301588|FG004|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
48853245|NCT01263496|157301589|FG005|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
48853246|NCT01263496|157301590|FG006|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
48853247|NCT01263496|157301591|FG007|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
48853248|NCT01263496|157301592|FG008|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
48853249|NCT01263496|157301584|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
48853250|NCT01263496|157301585|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
48853251|NCT01263496|157301586|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
48853252|NCT01263496|157301587|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
48853253|NCT01263496|157301588|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|4|||
48853254|NCT01263496|157301589|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
48853255|NCT01263496|157301590|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
48947915|NCT01645280|157639955|FG001|Overall Study|Other|1|||
48947916|NCT01645280|157639956|FG002|Overall Study|Other|2|||
48947917|NCT01645280|157639957|FG003|Overall Study|Other|0|||
48947918|NCT01645280|157639958|FG004|Overall Study|Other|0|||
49015343|NCT00673790|157892152|FG000|Overall Study|Sponsor Terminated due to PI oversight|0|||
48947919|NCT01645280|157639954|FG000|Overall Study|Treatment not completed/Completed f/u|1|||
48738528|NCT00408629|156892537|FG000|Overall Study|Lack of Efficacy|63|||
48738529|NCT00408629|156892538|FG001|Overall Study|Lack of Efficacy|73|||
48738530|NCT00408629|156892537|FG000|Overall Study|Protocol Violation|1|||
48738531|NCT00408629|156892538|FG001|Overall Study|Protocol Violation|5|||
48738532|NCT00408629|156892537|FG000|Overall Study|Miscellaneous|11|||
48738533|NCT00408629|156892538|FG001|Overall Study|Miscellaneous|15|||
48738534|NCT04638660|156892539|FG000|Overall Study|Withdrawal by Subject|2|||
48738535|NCT04638660|156892540|FG001|Overall Study|Withdrawal by Subject|0|||
48738536|NCT04638660|156892539|FG000|Overall Study|Lost to Follow-up|1|||
48738537|NCT04638660|156892540|FG001|Overall Study|Lost to Follow-up|0|||
48738538|NCT02110238|156892541|FG000|12 Week Pivotal Phase|Adverse Event|3|||
48738539|NCT02110238|156892542|FG001|12 Week Pivotal Phase|Adverse Event|0|||
48738540|NCT02110238|156892541|FG000|12 Week Pivotal Phase|Lack of Efficacy|2|||
48738541|NCT02110238|156892542|FG001|12 Week Pivotal Phase|Lack of Efficacy|3|||
48738542|NCT02110238|156892541|FG000|12 Week Pivotal Phase|Lost to Follow-up|2|||
48738543|NCT02110238|156892542|FG001|12 Week Pivotal Phase|Lost to Follow-up|0|||
48738544|NCT02110238|156892541|FG000|12 Week Pivotal Phase|Physician Decision|0|||
48738545|NCT02110238|156892542|FG001|12 Week Pivotal Phase|Physician Decision|2|||
48738546|NCT02110238|156892541|FG000|12 Week Pivotal Phase|Protocol Violation|0|||
48738547|NCT02110238|156892542|FG001|12 Week Pivotal Phase|Protocol Violation|1|||
48947920|NCT01645280|157639955|FG001|Overall Study|Treatment not completed/Completed f/u|1|||
48947921|NCT01645280|157639956|FG002|Overall Study|Treatment not completed/Completed f/u|2|||
48947922|NCT01645280|157639957|FG003|Overall Study|Treatment not completed/Completed f/u|0|||
48947923|NCT01645280|157639958|FG004|Overall Study|Treatment not completed/Completed f/u|2|||
48947924|NCT00546819|157639959|FG000|Overall Study|Adverse Event|2|||
48947925|NCT00546819|157639960|FG001|Overall Study|Adverse Event|3|||
48738548|NCT02110238|156892541|FG000|12 Week Pivotal Phase|Withdrawal by Subject|3|||
48738549|NCT02110238|156892542|FG001|12 Week Pivotal Phase|Withdrawal by Subject|3|||
48738550|NCT02110238|156892541|FG000|14 Week Blinded Extension Phase|Adverse Event|1|||
48738551|NCT02110238|156892542|FG001|14 Week Blinded Extension Phase|Adverse Event|1|||
48738552|NCT02110238|156892541|FG000|14 Week Blinded Extension Phase|Lack of Efficacy|2|||
48738553|NCT02110238|156892542|FG001|14 Week Blinded Extension Phase|Lack of Efficacy|4|||
48738554|NCT02110238|156892541|FG000|14 Week Blinded Extension Phase|Lost to Follow-up|3|||
48738555|NCT02110238|156892542|FG001|14 Week Blinded Extension Phase|Lost to Follow-up|1|||
48738556|NCT02110238|156892541|FG000|14 Week Blinded Extension Phase|Protocol Violation|2|||
48738557|NCT02110238|156892542|FG001|14 Week Blinded Extension Phase|Protocol Violation|3|||
48738558|NCT02110238|156892541|FG000|14 Week Blinded Extension Phase|Withdrawal by Subject|4|||
48738559|NCT02110238|156892542|FG001|14 Week Blinded Extension Phase|Withdrawal by Subject|3|||
48738560|NCT01604408|156892543|FG000|Treatment Period 1|Protocol Violation|0|||
48738561|NCT01604408|156892544|FG001|Treatment Period 1|Protocol Violation|1|||
48738562|NCT01604408|156892543|FG000|Treatment Period 2|Withdrawal by Subject|1|||
48738563|NCT01604408|156892544|FG001|Treatment Period 2|Withdrawal by Subject|1|||
48738564|NCT01604408|156892543|FG000|Treatment Period 2|Protocol Violation|1|||
48738565|NCT01604408|156892544|FG001|Treatment Period 2|Protocol Violation|0|||
48738566|NCT01604408|156892543|FG000|Treatment Period 2|Adverse Event|0|||
48738567|NCT01604408|156892544|FG001|Treatment Period 2|Adverse Event|1|||
48738568|NCT01604408|156892543|FG000|Treatment Period 3|Protocol Violation|1|||
48738569|NCT01604408|156892544|FG001|Treatment Period 3|Protocol Violation|1|||
48738570|NCT01604408|156892543|FG000|Treatment Period 3|Adverse Event|0|||
48738571|NCT01604408|156892544|FG001|Treatment Period 3|Adverse Event|3|||
48738572|NCT01604408|156892543|FG000|Treatment Period 3|Withdrawal by Subject|3|||
48738573|NCT01604408|156892544|FG001|Treatment Period 3|Withdrawal by Subject|1|||
48853256|NCT01263496|157301591|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
48853257|NCT01263496|157301592|FG008|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
48853258|NCT01263496|157301584|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|8|||
48853259|NCT01263496|157301585|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
48853260|NCT01263496|157301586|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
48853261|NCT01263496|157301587|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
48947926|NCT00546819|157639959|FG000|Overall Study|Lost to Follow-up|2|||
48738574|NCT01604408|156892543|FG000|Treatment Period 3|Sponsor Decision|1|||
48738575|NCT01604408|156892544|FG001|Treatment Period 3|Sponsor Decision|0|||
48738576|NCT01604408|156892543|FG000|Treatment Period 4|Death|1|||
48947927|NCT00546819|157639960|FG001|Overall Study|Lost to Follow-up|1|||
48738577|NCT01604408|156892544|FG001|Treatment Period 4|Death|0|||
48738578|NCT01604408|156892543|FG000|Treatment Period 4|Withdrawal by Subject|2|||
48738579|NCT01604408|156892544|FG001|Treatment Period 4|Withdrawal by Subject|1|||
48738580|NCT01604408|156892543|FG000|Treatment Period 4|Adverse Event|0|||
48738581|NCT01604408|156892544|FG001|Treatment Period 4|Adverse Event|1|||
48738582|NCT01604408|156892543|FG000|Treatment Period 5|Adverse Event|4|||
48738583|NCT01604408|156892544|FG001|Treatment Period 5|Adverse Event|0|||
48738584|NCT01604408|156892543|FG000|Treatment Period 6|Lost to Follow-up|0|||
48738585|NCT01604408|156892544|FG001|Treatment Period 6|Lost to Follow-up|1|||
48738586|NCT01604408|156892543|FG000|Treatment Period 6|Adverse Event|2|||
48738587|NCT01604408|156892544|FG001|Treatment Period 6|Adverse Event|0|||
48738588|NCT01604408|156892543|FG000|Treatment Period 6|Sponsor decision|0|||
48738589|NCT01604408|156892544|FG001|Treatment Period 6|Sponsor decision|1|||
48738590|NCT01604408|156892543|FG000|Observation Period|Adverse Event|1|||
48738591|NCT01604408|156892544|FG001|Observation Period|Adverse Event|1|||
48738592|NCT01604408|156892543|FG000|Observation Period|Withdrawal by Subject|0|||
48738593|NCT01604408|156892544|FG001|Observation Period|Withdrawal by Subject|2|||
48738594|NCT00917501|156892545|FG000|Overall Study|Lost to Follow-up|4|||
48738595|NCT00917501|156892546|FG001|Overall Study|Lost to Follow-up|1|||
48738596|NCT00917501|156892545|FG000|Overall Study|Withdrawal by Subject|3|||
48738597|NCT00917501|156892546|FG001|Overall Study|Withdrawal by Subject|1|||
48738598|NCT00917501|156892545|FG000|Overall Study|Lack of Efficacy|1|||
48738599|NCT00917501|156892546|FG001|Overall Study|Lack of Efficacy|2|||
48738600|NCT00917501|156892545|FG000|Overall Study|trouble swollowing capsules|0|||
48738601|NCT00917501|156892546|FG001|Overall Study|trouble swollowing capsules|1|||
48738602|NCT02410551|156892552|FG000|Overall Study|Adverse Event|1|||
48738603|NCT02410551|156892552|FG000|Overall Study|Withdrawal by Subject|1|||
48738604|NCT02410551|156892552|FG000|Overall Study|FDA Clinical hold-patients taken off|2|||
48738605|NCT01419626|156892553|FG000|Overall Study|Protocol Violation|3|||
48738606|NCT01419626|156892554|FG001|Overall Study|Protocol Violation|2|||
48738607|NCT01419626|156892555|FG002|Overall Study|Protocol Violation|2|||
48738608|NCT01419626|156892553|FG000|Overall Study|Withdrawal by Subject|1|||
48738609|NCT01419626|156892554|FG001|Overall Study|Withdrawal by Subject|0|||
48738610|NCT01419626|156892555|FG002|Overall Study|Withdrawal by Subject|0|||
48738611|NCT01419626|156892553|FG000|Overall Study|Lost to Follow-up|0|||
48738612|NCT01419626|156892554|FG001|Overall Study|Lost to Follow-up|1|||
48738613|NCT01419626|156892555|FG002|Overall Study|Lost to Follow-up|1|||
48738614|NCT02609828|156892556|FG000|Overall Study|Adverse Event|8|||
48738615|NCT02609828|156892557|FG001|Overall Study|Adverse Event|1|||
48738616|NCT02609828|156892558|FG002|Overall Study|Adverse Event|0|||
48738617|NCT02609828|156892559|FG003|Overall Study|Adverse Event|6|||
48738618|NCT02609828|156892556|FG000|Overall Study|Death|15|||
48738619|NCT02609828|156892557|FG001|Overall Study|Death|1|||
48738620|NCT02609828|156892558|FG002|Overall Study|Death|1|||
48738621|NCT02609828|156892559|FG003|Overall Study|Death|19|||
48738622|NCT02609828|156892556|FG000|Overall Study|Insufficient clinical response|2|||
48738623|NCT02609828|156892557|FG001|Overall Study|Insufficient clinical response|1|||
48738624|NCT02609828|156892558|FG002|Overall Study|Insufficient clinical response|0|||
48738625|NCT02609828|156892559|FG003|Overall Study|Insufficient clinical response|0|||
48738626|NCT02609828|156892556|FG000|Overall Study|Lost to Follow-up|0|||
48738627|NCT02609828|156892557|FG001|Overall Study|Lost to Follow-up|0|||
48738628|NCT02609828|156892558|FG002|Overall Study|Lost to Follow-up|0|||
48738629|NCT02609828|156892559|FG003|Overall Study|Lost to Follow-up|1|||
48738630|NCT02609828|156892556|FG000|Overall Study|Protocol Violation|2|||
48738631|NCT02609828|156892557|FG001|Overall Study|Protocol Violation|0|||
48738632|NCT02609828|156892558|FG002|Overall Study|Protocol Violation|0|||
48738633|NCT02609828|156892559|FG003|Overall Study|Protocol Violation|1|||
48738634|NCT02609828|156892556|FG000|Overall Study|Withdrawal by Subject|12|||
48738635|NCT02609828|156892557|FG001|Overall Study|Withdrawal by Subject|1|||
48738636|NCT02609828|156892558|FG002|Overall Study|Withdrawal by Subject|0|||
48738637|NCT02609828|156892559|FG003|Overall Study|Withdrawal by Subject|10|||
48738638|NCT02609828|156892556|FG000|Overall Study|Other|3|||
48738639|NCT02609828|156892557|FG001|Overall Study|Other|0|||
48738640|NCT02609828|156892558|FG002|Overall Study|Other|0|||
48738641|NCT02609828|156892559|FG003|Overall Study|Other|6|||
48738642|NCT02609828|156892556|FG000|Overall Study|Randomized but not treated|1|||
48738643|NCT02609828|156892557|FG001|Overall Study|Randomized but not treated|0|||
48738644|NCT02609828|156892558|FG002|Overall Study|Randomized but not treated|0|||
48738645|NCT02609828|156892559|FG003|Overall Study|Randomized but not treated|0|||
48738646|NCT00747812|156892570|FG000|Overall Study|Research Site Staff Relocation|5|||
48738647|NCT00747812|156892571|FG001|Overall Study|Research Site Staff Relocation|3|||
48738648|NCT03208127|156892573|FG000|Overall Study|Death|1|||
48738649|NCT00660673|156892574|FG000|Overall Study|Adverse Event|84|||
48738650|NCT00660673|156892574|FG000|Overall Study|Lack of Efficacy|7|||
48738651|NCT00660673|156892574|FG000|Overall Study|Withdrawal by Subject|22|||
48738652|NCT00660673|156892574|FG000|Overall Study|Administrative|2|||
48738653|NCT00660673|156892574|FG000|Overall Study|Protocol Violation|2|||
48738654|NCT01786148|156892575|FG000|Overall Study|Lost to Follow-up|21|||
48738655|NCT01786148|156892576|FG001|Overall Study|Lost to Follow-up|13|||
48738656|NCT01786148|156892575|FG000|Overall Study|Death|0|||
48738657|NCT01786148|156892576|FG001|Overall Study|Death|1|||
48738658|NCT01786148|156892575|FG000|Overall Study|Withdrawal by Subject|0|||
48738659|NCT01786148|156892576|FG001|Overall Study|Withdrawal by Subject|7|||
48738660|NCT01786148|156892575|FG000|Overall Study|Incarceration|1|||
48738661|NCT01786148|156892576|FG001|Overall Study|Incarceration|1|||
48738662|NCT00239590|156892577|FG000|Randomized|Lost to Follow-up|0|||
48738663|NCT00239590|156892578|FG001|Randomized|Lost to Follow-up|1|||
48738664|NCT00239590|156892577|FG000|Randomized|Withdrawal by Subject|0|||
48738665|NCT00239590|156892578|FG001|Randomized|Withdrawal by Subject|1|||
48738666|NCT00239590|156892577|FG000|Completed Study Protocol|Adverse Event|1|||
48738667|NCT00239590|156892578|FG001|Completed Study Protocol|Adverse Event|1|||
48738668|NCT00239590|156892577|FG000|Completed Study Protocol|Withdrawal by Subject|0|||
48738669|NCT00239590|156892578|FG001|Completed Study Protocol|Withdrawal by Subject|1|||
48738670|NCT03000569|156892579|FG000|Overall Study|Withdrawal by Subject|1|||
48738671|NCT03000569|156892580|FG001|Overall Study|Withdrawal by Subject|0|||
48738672|NCT00968864|156892581|FG000|Overall Study|Protocol exception/ not evaluable|1|||
48738673|NCT00657358|156892584|FG000|Overall Study|Lack of Efficacy|6|||
48738674|NCT01752985|156892587|FG000|Treatment Period|Subject request to discontinue treatment|1|||
48738675|NCT01752985|156892588|FG001|Treatment Period|Subject request to discontinue treatment|0|||
48738676|NCT01752985|156892589|FG002|Treatment Period|Subject request to discontinue treatment|1|||
48738677|NCT01752985|156892587|FG000|Treatment Period|Subject no longer meets study criteria|0|||
48738678|NCT01752985|156892588|FG001|Treatment Period|Subject no longer meets study criteria|1|||
48738679|NCT01752985|156892589|FG002|Treatment Period|Subject no longer meets study criteria|1|||
48738680|NCT01752985|156892587|FG000|Treatment Period|Adverse Event|2|||
48738681|NCT01752985|156892588|FG001|Treatment Period|Adverse Event|1|||
48738682|NCT01752985|156892589|FG002|Treatment Period|Adverse Event|2|||
48738683|NCT01752985|156892587|FG000|Treatment Period|Withdrawal by Subject|1|||
48738684|NCT01752985|156892588|FG001|Treatment Period|Withdrawal by Subject|1|||
48738685|NCT01752985|156892589|FG002|Treatment Period|Withdrawal by Subject|0|||
48738686|NCT01752985|156892587|FG000|Treatment Period|Lost to Follow-up|0|||
48738687|NCT01752985|156892588|FG001|Treatment Period|Lost to Follow-up|0|||
48738688|NCT01752985|156892589|FG002|Treatment Period|Lost to Follow-up|1|||
48738689|NCT03546062|156892596|FG000|Overall Study|Adverse Event|6|||
48738690|NCT03546062|156892597|FG001|Overall Study|Adverse Event|5|||
48738691|NCT03546062|156892598|FG002|Overall Study|Adverse Event|8|||
48738692|NCT02130297|156892599|FG000|Overall Study|Lost to Follow-up|4|||
48738693|NCT03308786|156892600|FG000|Overall Study|study terminated after discussion with Safety Monitoring Committee|9|||
48738694|NCT02949700|156892603|FG000|Phase I|Withdrawal by Subject|1|||
48738695|NCT02949700|156892604|FG001|Phase I|Withdrawal by Subject|1|||
48738696|NCT02949700|156892605|FG002|Phase I|Withdrawal by Subject|0|||
48738697|NCT02949700|156892606|FG003|Phase I|Withdrawal by Subject|0|||
48738698|NCT02949700|156892603|FG000|Phase I|Protocol Violation|1|||
48738699|NCT02949700|156892604|FG001|Phase I|Protocol Violation|0|||
48738700|NCT02949700|156892605|FG002|Phase I|Protocol Violation|0|||
48738701|NCT02949700|156892606|FG003|Phase I|Protocol Violation|0|||
48738702|NCT02949700|156892603|FG000|Phase II|Withdrawal by Subject|0|||
48738703|NCT02949700|156892604|FG001|Phase II|Withdrawal by Subject|0|||
48738704|NCT02949700|156892605|FG002|Phase II|Withdrawal by Subject|0|||
48738705|NCT02949700|156892606|FG003|Phase II|Withdrawal by Subject|2|||
48738706|NCT02949700|156892603|FG000|Phase II|Protocol Violation|0|||
48738707|NCT02949700|156892604|FG001|Phase II|Protocol Violation|0|||
48738708|NCT02949700|156892605|FG002|Phase II|Protocol Violation|1|||
48738709|NCT02949700|156892606|FG003|Phase II|Protocol Violation|3|||
48738710|NCT00806351|156892609|FG000|Overall Study|Death|5|||
48738711|NCT00806351|156892610|FG001|Overall Study|Death|4|||
48738712|NCT02187744|156892611|FG000|Study|Participant refused further follow-up|1|||
48738713|NCT02187744|156892612|FG001|Study|Participant refused further follow-up|0|||
48738714|NCT02187744|156892611|FG000|Study|Other|2|||
48738715|NCT02187744|156892612|FG001|Study|Other|1|||
48738716|NCT02187744|156892611|FG000|Study|Lost to Follow-up|0|||
48738717|NCT02187744|156892612|FG001|Study|Lost to Follow-up|2|||
48738718|NCT02187744|156892611|FG000|Study|Related adverse event, not serious|0|||
48738719|NCT02187744|156892612|FG001|Study|Related adverse event, not serious|2|||
48853262|NCT01263496|157301588|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
48853263|NCT01263496|157301589|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
48853264|NCT01263496|157301590|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
48853265|NCT01263496|157301591|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
48853266|NCT01263496|157301592|FG008|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
48853267|NCT01263496|157301584|FG000|Entered - Long-Term Extension Study|Participant Unavailability|0|||
48853268|NCT01263496|157301585|FG001|Entered - Long-Term Extension Study|Participant Unavailability|0|||
48853269|NCT01263496|157301586|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
48853270|NCT01263496|157301587|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
48853271|NCT01263496|157301588|FG004|Entered - Long-Term Extension Study|Participant Unavailability|0|||
48853272|NCT01263496|157301589|FG005|Entered - Long-Term Extension Study|Participant Unavailability|0|||
48853273|NCT01263496|157301590|FG006|Entered - Long-Term Extension Study|Participant Unavailability|0|||
48853274|NCT01263496|157301591|FG007|Entered - Long-Term Extension Study|Participant Unavailability|1|||
48853275|NCT01263496|157301592|FG008|Entered - Long-Term Extension Study|Participant Unavailability|0|||
48853276|NCT02744066|157301595|FG000|Overall Study|Withdrawal by parent|0|||
48853277|NCT02744066|157301596|FG001|Overall Study|Withdrawal by parent|1|||
48853278|NCT02744066|157301595|FG000|Overall Study|Discharged from NICU prior to completion|0|||
48947928|NCT00546819|157639959|FG000|Overall Study|Withdrawal by Subject|4|||
48947929|NCT00546819|157639960|FG001|Overall Study|Withdrawal by Subject|2|||
48947930|NCT00949650|157639963|FG000|Overall Study|Progressive disease|188|||
48947931|NCT00949650|157639964|FG001|Overall Study|Progressive disease|19|||
48947932|NCT00949650|157639963|FG000|Overall Study|Completed 6 courses of chemotherapy|0|||
48947933|NCT00949650|157639964|FG001|Overall Study|Completed 6 courses of chemotherapy|60|||
48947934|NCT00949650|157639963|FG000|Overall Study|Other Adverse Event (AE)|28|||
48738720|NCT02187744|156892611|FG000|Study|Death|1|||
48738721|NCT02187744|156892612|FG001|Study|Death|0|||
48738722|NCT02187744|156892611|FG000|Study|Related adverse event, serious non-fatal|0|||
48738723|NCT02187744|156892612|FG001|Study|Related adverse event, serious non-fatal|1|||
48738724|NCT02187744|156892611|FG000|Treatment|Death|1|||
48738725|NCT02187744|156892612|FG001|Treatment|Death|0|||
48738726|NCT02187744|156892611|FG000|Treatment|Related adverse event, serious non-fatal|0|||
48738727|NCT02187744|156892612|FG001|Treatment|Related adverse event, serious non-fatal|1|||
48738728|NCT02187744|156892611|FG000|Treatment|Related adverse event, not serious|0|||
48947935|NCT00949650|157639964|FG001|Overall Study|Other Adverse Event (AE)|17|||
48738729|NCT02187744|156892612|FG001|Treatment|Related adverse event, not serious|2|||
48853279|NCT02744066|157301596|FG001|Overall Study|Discharged from NICU prior to completion|4|||
48853280|NCT02241785|157301597|FG000|Overall Study|Sponsor Termination|43|||
48853281|NCT02241785|157301597|FG000|Overall Study|Withdrawal by Subject|1|||
48853282|NCT02241785|157301597|FG000|Overall Study|Lost to Follow-up|2|||
48853283|NCT02241785|157301597|FG000|Overall Study|Adverse Event|1|||
48853284|NCT01915914|157301598|FG000|Acute Phase|Withdrawal by Subject|4|||
48853285|NCT01915914|157301599|FG001|Acute Phase|Withdrawal by Subject|0|||
48853286|NCT01915914|157301600|FG002|Acute Phase|Withdrawal by Subject|0|||
48853287|NCT01915914|157301601|FG003|Acute Phase|Withdrawal by Subject|0|||
48853288|NCT01915914|157301598|FG000|Acute Phase|Lost to Follow-up|4|||
48738730|NCT02187744|156892611|FG000|Treatment|Lost to Follow-up|0|||
48738731|NCT02187744|156892612|FG001|Treatment|Lost to Follow-up|1|||
48738732|NCT02187744|156892611|FG000|Treatment|Other|2|||
48738733|NCT02187744|156892612|FG001|Treatment|Other|0|||
48738734|NCT02187744|156892611|FG000|Treatment|Participant refused continued treatment|1|||
48738735|NCT02187744|156892612|FG001|Treatment|Participant refused continued treatment|1|||
48738736|NCT01972568|156892617|FG000|Overall Study|Other events|3|||
48738737|NCT01972568|156892618|FG001|Overall Study|Other events|0|||
48738738|NCT01972568|156892619|FG002|Overall Study|Other events|0|||
48738739|NCT01972568|156892617|FG000|Overall Study|Lack of Efficacy|0|||
48738740|NCT01972568|156892618|FG001|Overall Study|Lack of Efficacy|1|||
48738741|NCT01972568|156892619|FG002|Overall Study|Lack of Efficacy|2|||
48738742|NCT01972568|156892617|FG000|Overall Study|Protocol Violation|1|||
48738743|NCT01972568|156892618|FG001|Overall Study|Protocol Violation|2|||
48738744|NCT01972568|156892619|FG002|Overall Study|Protocol Violation|2|||
48738745|NCT01972568|156892617|FG000|Overall Study|Withdrawal by Subject|6|||
48738746|NCT01972568|156892618|FG001|Overall Study|Withdrawal by Subject|3|||
48738747|NCT01972568|156892619|FG002|Overall Study|Withdrawal by Subject|7|||
48738748|NCT01972568|156892617|FG000|Overall Study|Lost to Follow-up|1|||
48738749|NCT01972568|156892618|FG001|Overall Study|Lost to Follow-up|0|||
48738750|NCT01972568|156892619|FG002|Overall Study|Lost to Follow-up|0|||
48738751|NCT01972568|156892617|FG000|Overall Study|Adverse Event|5|||
48738752|NCT01972568|156892618|FG001|Overall Study|Adverse Event|6|||
48738753|NCT01972568|156892619|FG002|Overall Study|Adverse Event|5|||
48738754|NCT03113071|156892620|FG000|Overall Study|Withdrawal by Subject|1|||
48738755|NCT03113071|156892621|FG001|Overall Study|Withdrawal by Subject|0|||
48738756|NCT01602120|156892622|FG000|Overall Study|Adverse Event|3|||
48738757|NCT01602120|156892623|FG001|Overall Study|Adverse Event|6|||
48738758|NCT01602120|156892624|FG002|Overall Study|Adverse Event|0|||
48738759|NCT01602120|156892625|FG003|Overall Study|Adverse Event|2|||
48738760|NCT01602120|156892622|FG000|Overall Study|Death|0|||
48738761|NCT01602120|156892623|FG001|Overall Study|Death|4|||
48738762|NCT01602120|156892624|FG002|Overall Study|Death|0|||
48738763|NCT01602120|156892625|FG003|Overall Study|Death|0|||
48738764|NCT01602120|156892622|FG000|Overall Study|Lost to Follow-up|0|||
48738765|NCT01602120|156892623|FG001|Overall Study|Lost to Follow-up|1|||
48738766|NCT01602120|156892624|FG002|Overall Study|Lost to Follow-up|0|||
48738767|NCT01602120|156892625|FG003|Overall Study|Lost to Follow-up|1|||
48738768|NCT01602120|156892622|FG000|Overall Study|Protocol Violation|1|||
48738769|NCT01602120|156892623|FG001|Overall Study|Protocol Violation|1|||
48738770|NCT01602120|156892624|FG002|Overall Study|Protocol Violation|0|||
48738771|NCT01602120|156892625|FG003|Overall Study|Protocol Violation|0|||
48738772|NCT01602120|156892622|FG000|Overall Study|Non-compliance|0|||
48738773|NCT01602120|156892623|FG001|Overall Study|Non-compliance|3|||
48738774|NCT01602120|156892624|FG002|Overall Study|Non-compliance|0|||
48738775|NCT01602120|156892625|FG003|Overall Study|Non-compliance|1|||
48738776|NCT01602120|156892622|FG000|Overall Study|Withdrawal by Subject|8|||
48738777|NCT01602120|156892623|FG001|Overall Study|Withdrawal by Subject|17|||
48738778|NCT01602120|156892624|FG002|Overall Study|Withdrawal by Subject|0|||
48738779|NCT01602120|156892625|FG003|Overall Study|Withdrawal by Subject|3|||
48947936|NCT00949650|157639963|FG000|Overall Study|Protocol Violation|1|||
48947937|NCT00949650|157639964|FG001|Overall Study|Protocol Violation|4|||
48947938|NCT00949650|157639963|FG000|Overall Study|Refusal to continue medication|7|||
48947939|NCT00949650|157639964|FG001|Overall Study|Refusal to continue medication|11|||
48947940|NCT00949650|157639963|FG000|Overall Study|Not treated|1|||
48947941|NCT00949650|157639964|FG001|Overall Study|Not treated|4|||
48947942|NCT00949650|157639963|FG000|Overall Study|Other not specified above|5|||
48947943|NCT00949650|157639964|FG001|Overall Study|Other not specified above|0|||
48947944|NCT03671369|157639965|FG000|Overall Study|Other|1|||
48947945|NCT03671369|157639965|FG000|Overall Study|Withdrawal by Subject|289|||
48947946|NCT03671369|157639965|FG000|Overall Study|Not willing to be vaccinated|1|||
48947947|NCT04222725|157639969|FG000|Overall Study|Adverse Event|0|||
48947948|NCT04222725|157639970|FG001|Overall Study|Adverse Event|1|||
48947949|NCT04222725|157639971|FG002|Overall Study|Adverse Event|0|||
48947950|NCT04222725|157639972|FG003|Overall Study|Adverse Event|0|||
48947951|NCT00611130|157639975|FG000|Overall Study|Lost to Follow-up|25|||
48947952|NCT00611130|157639976|FG001|Overall Study|Lost to Follow-up|29|||
48947953|NCT00611130|157639975|FG000|Overall Study|Protocol noncompliance|7|||
48947954|NCT00611130|157639976|FG001|Overall Study|Protocol noncompliance|6|||
48947955|NCT00611130|157639975|FG000|Overall Study|Withdrawal by Subject|6|||
48947956|NCT00611130|157639976|FG001|Overall Study|Withdrawal by Subject|5|||
48947957|NCT00611130|157639975|FG000|Overall Study|Other|5|||
48947958|NCT00611130|157639976|FG001|Overall Study|Other|4|||
48947959|NCT00611130|157639975|FG000|Overall Study|Incarceration|3|||
48947960|NCT00611130|157639976|FG001|Overall Study|Incarceration|2|||
48947961|NCT00611130|157639975|FG000|Overall Study|Administrative|1|||
48947962|NCT00611130|157639976|FG001|Overall Study|Administrative|1|||
48947963|NCT00611130|157639975|FG000|Overall Study|Adverse Event|1|||
48947964|NCT00611130|157639976|FG001|Overall Study|Adverse Event|0|||
48947965|NCT00611130|157639975|FG000|Overall Study|Death|1|||
48947966|NCT00611130|157639976|FG001|Overall Study|Death|0|||
48947967|NCT03303339|157639988|FG000|Overall Study|Death|2|||
48947968|NCT03303339|157639989|FG001|Overall Study|Death|2|||
48947969|NCT03303339|157639990|FG002|Overall Study|Death|2|||
48947970|NCT03303339|157639991|FG003|Overall Study|Death|1|||
48947971|NCT03303339|157639992|FG004|Overall Study|Death|4|||
48947972|NCT03303339|157639993|FG005|Overall Study|Death|2|||
48947973|NCT03303339|157639994|FG006|Overall Study|Death|2|||
48947974|NCT03303339|157639995|FG007|Overall Study|Death|2|||
48947975|NCT03303339|157639996|FG008|Overall Study|Death|3|||
48947976|NCT03303339|157639997|FG009|Overall Study|Death|3|||
48947977|NCT03303339|157639998|FG010|Overall Study|Death|4|||
48947978|NCT03303339|157639999|FG011|Overall Study|Death|24|||
48947979|NCT03303339|157639988|FG000|Overall Study|Study Terminated by Sponsor|0|||
48947980|NCT03303339|157639989|FG001|Overall Study|Study Terminated by Sponsor|0|||
48947981|NCT03303339|157639990|FG002|Overall Study|Study Terminated by Sponsor|0|||
48947982|NCT03303339|157639991|FG003|Overall Study|Study Terminated by Sponsor|0|||
48947983|NCT03303339|157639992|FG004|Overall Study|Study Terminated by Sponsor|0|||
48738780|NCT01602120|156892622|FG000|Overall Study|Study Terminated by Sponsor|12|||
48738781|NCT01602120|156892623|FG001|Overall Study|Study Terminated by Sponsor|24|||
48738782|NCT01602120|156892624|FG002|Overall Study|Study Terminated by Sponsor|17|||
48738783|NCT01602120|156892625|FG003|Overall Study|Study Terminated by Sponsor|44|||
48738784|NCT01602120|156892622|FG000|Overall Study|Physician Decision|2|||
48738785|NCT01602120|156892623|FG001|Overall Study|Physician Decision|3|||
48738786|NCT01602120|156892624|FG002|Overall Study|Physician Decision|0|||
48738787|NCT01602120|156892625|FG003|Overall Study|Physician Decision|0|||
48738788|NCT01602120|156892622|FG000|Overall Study|Unspecified Reason|3|||
48738789|NCT01602120|156892623|FG001|Overall Study|Unspecified Reason|1|||
48738790|NCT01602120|156892624|FG002|Overall Study|Unspecified Reason|0|||
48738791|NCT01602120|156892625|FG003|Overall Study|Unspecified Reason|2|||
48738792|NCT01787331|156892626|FG000|Overall Study|Physician Decision|1|||
48738793|NCT01787331|156892626|FG000|Overall Study|Withdrawal by Subject|1|||
48738794|NCT00911547|156892627|FG000|Overall Study|Adverse Event|8|||
48738795|NCT00911547|156892628|FG001|Overall Study|Adverse Event|27|||
48853289|NCT01915914|157301599|FG001|Acute Phase|Lost to Follow-up|0|||
48853290|NCT01915914|157301600|FG002|Acute Phase|Lost to Follow-up|0|||
48853291|NCT01915914|157301601|FG003|Acute Phase|Lost to Follow-up|0|||
48853292|NCT01915914|157301598|FG000|Acute Phase|Physician Decision|1|||
48853293|NCT01915914|157301599|FG001|Acute Phase|Physician Decision|0|||
48738796|NCT00911547|156892629|FG002|Overall Study|Adverse Event|11|||
48738797|NCT00911547|156892630|FG003|Overall Study|Adverse Event|6|||
48738798|NCT00911547|156892627|FG000|Overall Study|Lost to Follow-up|0|||
48738799|NCT00911547|156892628|FG001|Overall Study|Lost to Follow-up|0|||
48738800|NCT00911547|156892629|FG002|Overall Study|Lost to Follow-up|2|||
48738801|NCT00911547|156892630|FG003|Overall Study|Lost to Follow-up|1|||
48738802|NCT00911547|156892627|FG000|Overall Study|Protocol Violation|0|||
48738803|NCT00911547|156892628|FG001|Overall Study|Protocol Violation|5|||
48738804|NCT00911547|156892629|FG002|Overall Study|Protocol Violation|5|||
48738805|NCT00911547|156892630|FG003|Overall Study|Protocol Violation|1|||
48738806|NCT00911547|156892627|FG000|Overall Study|Withdrawal by Subject|3|||
48738807|NCT00911547|156892628|FG001|Overall Study|Withdrawal by Subject|10|||
48738808|NCT00911547|156892629|FG002|Overall Study|Withdrawal by Subject|4|||
48738809|NCT00911547|156892630|FG003|Overall Study|Withdrawal by Subject|8|||
48738810|NCT00319501|156892635|FG000|Double-blind Period|Withdrawal by Subject|0|||
48853294|NCT01915914|157301600|FG002|Acute Phase|Physician Decision|0|||
48853295|NCT01915914|157301601|FG003|Acute Phase|Physician Decision|0|||
48853296|NCT01915914|157301598|FG000|Acute Phase|Accepted Other Topic Therapies|1|||
48853297|NCT01915914|157301599|FG001|Acute Phase|Accepted Other Topic Therapies|0|||
48853298|NCT01915914|157301600|FG002|Acute Phase|Accepted Other Topic Therapies|0|||
48947984|NCT03303339|157639993|FG005|Overall Study|Study Terminated by Sponsor|0|||
48738811|NCT00319501|156892636|FG001|Double-blind Period|Withdrawal by Subject|3|||
48853299|NCT01915914|157301601|FG003|Acute Phase|Accepted Other Topic Therapies|0|||
48947985|NCT03303339|157639994|FG006|Overall Study|Study Terminated by Sponsor|0|||
48947986|NCT03303339|157639995|FG007|Overall Study|Study Terminated by Sponsor|0|||
48947987|NCT03303339|157639996|FG008|Overall Study|Study Terminated by Sponsor|1|||
48947988|NCT03303339|157639997|FG009|Overall Study|Study Terminated by Sponsor|0|||
48947989|NCT03303339|157639998|FG010|Overall Study|Study Terminated by Sponsor|1|||
48947990|NCT03303339|157639999|FG011|Overall Study|Study Terminated by Sponsor|1|||
48947991|NCT03303339|157639988|FG000|Overall Study|Withdrawal by Subject|1|||
48947992|NCT03303339|157639989|FG001|Overall Study|Withdrawal by Subject|0|||
48947993|NCT03303339|157639990|FG002|Overall Study|Withdrawal by Subject|0|||
48947994|NCT03303339|157639991|FG003|Overall Study|Withdrawal by Subject|0|||
48947995|NCT03303339|157639992|FG004|Overall Study|Withdrawal by Subject|0|||
48947996|NCT03303339|157639993|FG005|Overall Study|Withdrawal by Subject|1|||
48947997|NCT03303339|157639994|FG006|Overall Study|Withdrawal by Subject|1|||
48947998|NCT03303339|157639995|FG007|Overall Study|Withdrawal by Subject|0|||
48947999|NCT03303339|157639996|FG008|Overall Study|Withdrawal by Subject|0|||
48948000|NCT03303339|157639997|FG009|Overall Study|Withdrawal by Subject|0|||
48948001|NCT03303339|157639998|FG010|Overall Study|Withdrawal by Subject|0|||
48948002|NCT03303339|157639999|FG011|Overall Study|Withdrawal by Subject|2|||
48948003|NCT03303339|157639988|FG000|Overall Study|Physician Decision|0|||
48948004|NCT03303339|157639989|FG001|Overall Study|Physician Decision|0|||
48948005|NCT03303339|157639990|FG002|Overall Study|Physician Decision|0|||
48948006|NCT03303339|157639991|FG003|Overall Study|Physician Decision|0|||
48948007|NCT03303339|157639992|FG004|Overall Study|Physician Decision|1|||
48948008|NCT03303339|157639993|FG005|Overall Study|Physician Decision|0|||
48948009|NCT03303339|157639994|FG006|Overall Study|Physician Decision|0|||
48948010|NCT03303339|157639995|FG007|Overall Study|Physician Decision|0|||
48948011|NCT03303339|157639996|FG008|Overall Study|Physician Decision|0|||
48948012|NCT03303339|157639997|FG009|Overall Study|Physician Decision|0|||
48948013|NCT03303339|157639998|FG010|Overall Study|Physician Decision|0|||
48948014|NCT03303339|157639999|FG011|Overall Study|Physician Decision|0|||
48948015|NCT03303339|157639988|FG000|Overall Study|Safety/Non-compliance|0|||
48948016|NCT03303339|157639989|FG001|Overall Study|Safety/Non-compliance|0|||
48948017|NCT03303339|157639990|FG002|Overall Study|Safety/Non-compliance|0|||
48948018|NCT03303339|157639991|FG003|Overall Study|Safety/Non-compliance|0|||
48948019|NCT03303339|157639992|FG004|Overall Study|Safety/Non-compliance|0|||
48948020|NCT03303339|157639993|FG005|Overall Study|Safety/Non-compliance|0|||
48948021|NCT03303339|157639994|FG006|Overall Study|Safety/Non-compliance|0|||
48948022|NCT03303339|157639995|FG007|Overall Study|Safety/Non-compliance|0|||
48948023|NCT03303339|157639996|FG008|Overall Study|Safety/Non-compliance|0|||
48948024|NCT03303339|157639997|FG009|Overall Study|Safety/Non-compliance|0|||
48948025|NCT03303339|157639998|FG010|Overall Study|Safety/Non-compliance|0|||
48948026|NCT03303339|157639999|FG011|Overall Study|Safety/Non-compliance|1|||
48948027|NCT02760407|157640001|FG000|Overall Study|Death|2|||
48948028|NCT02760407|157640002|FG001|Overall Study|Death|3|||
48948029|NCT02760407|157640003|FG002|Overall Study|Death|1|||
48948030|NCT02760407|157640004|FG003|Overall Study|Death|1|||
48948031|NCT02760407|157640001|FG000|Overall Study|Lost to Follow-up|1|||
48948032|NCT02760407|157640002|FG001|Overall Study|Lost to Follow-up|7|||
48948033|NCT02760407|157640003|FG002|Overall Study|Lost to Follow-up|4|||
48948034|NCT02760407|157640004|FG003|Overall Study|Lost to Follow-up|6|||
48948035|NCT02760407|157640001|FG000|Overall Study|Withdrawal by Subject|25|||
48948036|NCT02760407|157640002|FG001|Overall Study|Withdrawal by Subject|31|||
48948037|NCT02760407|157640003|FG002|Overall Study|Withdrawal by Subject|37|||
48948038|NCT02760407|157640004|FG003|Overall Study|Withdrawal by Subject|25|||
48738812|NCT00319501|156892635|FG000|Double-blind Period|Sponsor Request|1|||
48738813|NCT00319501|156892636|FG001|Double-blind Period|Sponsor Request|0|||
48738814|NCT00319501|156892635|FG000|Double-blind Period|Did not receive treatment|42|||
48738815|NCT00319501|156892636|FG001|Double-blind Period|Did not receive treatment|29|||
48738816|NCT00319501|156892635|FG000|Open-label Period|Adverse Event|5|||
48738817|NCT00319501|156892636|FG001|Open-label Period|Adverse Event|0|||
48738818|NCT00319501|156892635|FG000|Open-label Period|Protocol Violation|6|||
48738819|NCT00319501|156892636|FG001|Open-label Period|Protocol Violation|0|||
48738820|NCT00319501|156892635|FG000|Open-label Period|Withdrawal by Subject|38|||
48738821|NCT00319501|156892636|FG001|Open-label Period|Withdrawal by Subject|0|||
48738822|NCT00319501|156892635|FG000|Open-label Period|Principal Investigator decision|6|||
48738823|NCT00319501|156892636|FG001|Open-label Period|Principal Investigator decision|0|||
48738824|NCT00319501|156892635|FG000|Open-label Period|Sponsor request|12|||
48948039|NCT02760407|157640001|FG000|Overall Study|Violation of Eligibility criteria|0|||
48948040|NCT02760407|157640002|FG001|Overall Study|Violation of Eligibility criteria|0|||
48948041|NCT02760407|157640003|FG002|Overall Study|Violation of Eligibility criteria|1|||
48948042|NCT02760407|157640004|FG003|Overall Study|Violation of Eligibility criteria|1|||
48948043|NCT02760407|157640001|FG000|Overall Study|Personal reasons|0|||
48948044|NCT02760407|157640002|FG001|Overall Study|Personal reasons|0|||
48948045|NCT02760407|157640003|FG002|Overall Study|Personal reasons|0|||
48948046|NCT02760407|157640004|FG003|Overall Study|Personal reasons|1|||
48948047|NCT02760407|157640001|FG000|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1|||
48738825|NCT00319501|156892636|FG001|Open-label Period|Sponsor request|0|||
48948048|NCT02760407|157640002|FG001|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
48948049|NCT02760407|157640003|FG002|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
48948050|NCT02760407|157640004|FG003|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
48948051|NCT02760407|157640001|FG000|Overall Study|Use of prohibited Medication|0|||
48948052|NCT02760407|157640002|FG001|Overall Study|Use of prohibited Medication|0|||
48948053|NCT02760407|157640003|FG002|Overall Study|Use of prohibited Medication|1|||
48948054|NCT02760407|157640004|FG003|Overall Study|Use of prohibited Medication|0|||
48948055|NCT02760407|157640001|FG000|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
48948056|NCT02760407|157640002|FG001|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
48948057|NCT02760407|157640003|FG002|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1|||
48948058|NCT02760407|157640004|FG003|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
48948059|NCT02760407|157640001|FG000|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1|||
48948060|NCT02760407|157640002|FG001|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
48948061|NCT02760407|157640003|FG002|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
48948062|NCT02760407|157640004|FG003|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
48948063|NCT02760407|157640001|FG000|Overall Study|Investigator's Decision (Adverse Event)|0|||
48948064|NCT02760407|157640002|FG001|Overall Study|Investigator's Decision (Adverse Event)|1|||
48948065|NCT02760407|157640003|FG002|Overall Study|Investigator's Decision (Adverse Event)|0|||
48738826|NCT00319501|156892635|FG000|Open-label Period|Lost to Follow-up|5|||
48738827|NCT00319501|156892636|FG001|Open-label Period|Lost to Follow-up|0|||
48738828|NCT00319501|156892635|FG000|Open-label Period|Did not receive treatment|33|||
48738829|NCT00319501|156892636|FG001|Open-label Period|Did not receive treatment|0|||
48738830|NCT00319501|156892635|FG000|Open-label Period|Other|11|||
48948066|NCT02760407|157640004|FG003|Overall Study|Investigator's Decision (Adverse Event)|0|||
48948067|NCT02760407|157640001|FG000|Overall Study|Inadequately Enrolled|0|||
48948068|NCT02760407|157640002|FG001|Overall Study|Inadequately Enrolled|0|||
48948069|NCT02760407|157640003|FG002|Overall Study|Inadequately Enrolled|0|||
48738831|NCT00319501|156892636|FG001|Open-label Period|Other|0|||
48738832|NCT00319501|156892635|FG000|Open-label Extension Period|Adverse Event|2|||
48738833|NCT00319501|156892636|FG001|Open-label Extension Period|Adverse Event|0|||
48738834|NCT00319501|156892635|FG000|Open-label Extension Period|Did not receive treatment|18|||
48738835|NCT00319501|156892636|FG001|Open-label Extension Period|Did not receive treatment|0|||
48738836|NCT00319501|156892635|FG000|Open-label Extension Period|Other|1|||
48738837|NCT00319501|156892636|FG001|Open-label Extension Period|Other|0|||
48948070|NCT02760407|157640004|FG003|Overall Study|Inadequately Enrolled|1|||
48948071|NCT02760407|157640001|FG000|Overall Study|Withdrawal By PI's Decision|0|||
48948072|NCT02760407|157640002|FG001|Overall Study|Withdrawal By PI's Decision|1|||
48948073|NCT02760407|157640003|FG002|Overall Study|Withdrawal By PI's Decision|0|||
48948074|NCT02760407|157640004|FG003|Overall Study|Withdrawal By PI's Decision|0|||
48948075|NCT02760407|157640001|FG000|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
48948076|NCT02760407|157640002|FG001|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
48948077|NCT02760407|157640003|FG002|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
48948078|NCT02760407|157640004|FG003|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
48948079|NCT02760407|157640001|FG000|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
48948080|NCT02760407|157640002|FG001|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
48948081|NCT02760407|157640003|FG002|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1|||
48948082|NCT02760407|157640004|FG003|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
48948083|NCT02760407|157640001|FG000|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1|||
48948084|NCT02760407|157640002|FG001|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
48948085|NCT02760407|157640003|FG002|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
48948086|NCT02760407|157640004|FG003|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
48948087|NCT02760407|157640001|FG000|Overall Study|Study Treatment Was Terminated At The Site|0|||
48948088|NCT02760407|157640002|FG001|Overall Study|Study Treatment Was Terminated At The Site|0|||
48948089|NCT02760407|157640003|FG002|Overall Study|Study Treatment Was Terminated At The Site|1|||
48948090|NCT02760407|157640004|FG003|Overall Study|Study Treatment Was Terminated At The Site|0|||
48948091|NCT02760407|157640001|FG000|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1|||
48948092|NCT02760407|157640002|FG001|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
48738838|NCT00319501|156892635|FG000|Open-label Extension Period|Principal investigator decision|2|||
48738839|NCT00319501|156892636|FG001|Open-label Extension Period|Principal investigator decision|0|||
48738840|NCT00319501|156892635|FG000|Open-label Extension Period|Sponsor request|26|||
48738841|NCT00319501|156892636|FG001|Open-label Extension Period|Sponsor request|0|||
48738842|NCT00319501|156892635|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
48738843|NCT00319501|156892636|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
48738844|NCT02564796|156892640|FG000|Overall Study|Physician Decision|2|||
48738845|NCT02564796|156892641|FG001|Overall Study|Physician Decision|2|||
48738846|NCT01817530|156892642|FG000|Overall Study|Exclusionary Medication Received|0|||
48738847|NCT01817530|156892643|FG001|Overall Study|Exclusionary Medication Received|0|||
48738848|NCT01817530|156892644|FG002|Overall Study|Exclusionary Medication Received|0|||
48948093|NCT02760407|157640003|FG002|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
48948094|NCT02760407|157640004|FG003|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
48948095|NCT02760407|157640001|FG000|Overall Study|Inadequately enrolled patient refused to Follow-Up|1|||
48948096|NCT02760407|157640002|FG001|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
48738849|NCT01817530|156892645|FG003|Overall Study|Exclusionary Medication Received|0|||
48738850|NCT01817530|156892646|FG004|Overall Study|Exclusionary Medication Received|1|||
48738851|NCT01817530|156892647|FG005|Overall Study|Exclusionary Medication Received|0|||
48738852|NCT01817530|156892648|FG006|Overall Study|Exclusionary Medication Received|0|||
48738853|NCT01817530|156892649|FG007|Overall Study|Exclusionary Medication Received|0|||
48738854|NCT01817530|156892642|FG000|Overall Study|Adverse Event|6|||
48738855|NCT01817530|156892643|FG001|Overall Study|Adverse Event|3|||
48948097|NCT02760407|157640003|FG002|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
48948098|NCT02760407|157640004|FG003|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
48948099|NCT02760407|157640001|FG000|Overall Study|Lack Of Efficacy Per PI|0|||
48948100|NCT02760407|157640002|FG001|Overall Study|Lack Of Efficacy Per PI|0|||
48948101|NCT02760407|157640003|FG002|Overall Study|Lack Of Efficacy Per PI|0|||
48948102|NCT02760407|157640004|FG003|Overall Study|Lack Of Efficacy Per PI|1|||
48948103|NCT02760407|157640001|FG000|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1|||
48948104|NCT02760407|157640002|FG001|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
48738856|NCT01817530|156892644|FG002|Overall Study|Adverse Event|2|||
48738857|NCT01817530|156892645|FG003|Overall Study|Adverse Event|5|||
48738858|NCT01817530|156892646|FG004|Overall Study|Adverse Event|0|||
48738859|NCT01817530|156892647|FG005|Overall Study|Adverse Event|10|||
48948105|NCT02760407|157640003|FG002|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
48948106|NCT02760407|157640004|FG003|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
48948107|NCT02760407|157640001|FG000|Overall Study|Investigator recorded as Adverse Event|1|||
48948108|NCT02760407|157640002|FG001|Overall Study|Investigator recorded as Adverse Event|0|||
48948109|NCT02760407|157640003|FG002|Overall Study|Investigator recorded as Adverse Event|2|||
48948110|NCT02760407|157640004|FG003|Overall Study|Investigator recorded as Adverse Event|0|||
48948111|NCT00945191|157640013|FG000|Overall Study|Did not achieve a complete response|18|||
48948112|NCT00945191|157640013|FG000|Overall Study|Participant relocated to another state|1|||
48948113|NCT00945191|157640013|FG000|Overall Study|Disease progression|3|||
48738860|NCT01817530|156892648|FG006|Overall Study|Adverse Event|5|||
48738861|NCT01817530|156892649|FG007|Overall Study|Adverse Event|8|||
48738862|NCT01817530|156892642|FG000|Overall Study|Subject Noncompliant|3|||
48853300|NCT01915914|157301598|FG000|Acute Phase|"Not Achieved treatment success"|1|||
48853301|NCT01915914|157301599|FG001|Acute Phase|"Not Achieved treatment success"|0|||
48853302|NCT01915914|157301600|FG002|Acute Phase|"Not Achieved treatment success"|0|||
48853303|NCT01915914|157301601|FG003|Acute Phase|"Not Achieved treatment success"|0|||
48853304|NCT01915914|157301598|FG000|Acute Phase|Missing|1|||
48853305|NCT01915914|157301599|FG001|Acute Phase|Missing|0|||
48853306|NCT01915914|157301600|FG002|Acute Phase|Missing|0|||
48853307|NCT01915914|157301601|FG003|Acute Phase|Missing|0|||
48853308|NCT01915914|157301598|FG000|Maintenance Phase|Withdrawal by Subject|0|||
48853309|NCT01915914|157301599|FG001|Maintenance Phase|Withdrawal by Subject|1|||
48948114|NCT00945191|157640013|FG000|Overall Study|Serious adverse event or adverse event|1|||
48948115|NCT00945191|157640013|FG000|Overall Study|Investigator's discretion|1|||
48738863|NCT01817530|156892643|FG001|Overall Study|Subject Noncompliant|1|||
48738864|NCT01817530|156892644|FG002|Overall Study|Subject Noncompliant|0|||
48738865|NCT01817530|156892645|FG003|Overall Study|Subject Noncompliant|4|||
48738866|NCT01817530|156892646|FG004|Overall Study|Subject Noncompliant|0|||
48738867|NCT01817530|156892647|FG005|Overall Study|Subject Noncompliant|1|||
48738868|NCT01817530|156892648|FG006|Overall Study|Subject Noncompliant|1|||
48738869|NCT01817530|156892649|FG007|Overall Study|Subject Noncompliant|1|||
48738870|NCT01817530|156892642|FG000|Overall Study|Lack of Efficacy|1|||
48738871|NCT01817530|156892643|FG001|Overall Study|Lack of Efficacy|0|||
48738872|NCT01817530|156892644|FG002|Overall Study|Lack of Efficacy|0|||
48738873|NCT01817530|156892645|FG003|Overall Study|Lack of Efficacy|0|||
48738874|NCT01817530|156892646|FG004|Overall Study|Lack of Efficacy|0|||
48738875|NCT01817530|156892647|FG005|Overall Study|Lack of Efficacy|1|||
48738876|NCT01817530|156892648|FG006|Overall Study|Lack of Efficacy|0|||
48738877|NCT01817530|156892649|FG007|Overall Study|Lack of Efficacy|1|||
48738878|NCT01817530|156892642|FG000|Overall Study|Pregnancy|0|||
48738879|NCT01817530|156892643|FG001|Overall Study|Pregnancy|0|||
48738880|NCT01817530|156892644|FG002|Overall Study|Pregnancy|0|||
48738881|NCT01817530|156892645|FG003|Overall Study|Pregnancy|0|||
48738882|NCT01817530|156892646|FG004|Overall Study|Pregnancy|0|||
48738883|NCT01817530|156892647|FG005|Overall Study|Pregnancy|1|||
48853310|NCT01915914|157301600|FG002|Maintenance Phase|Withdrawal by Subject|1|||
48948116|NCT04579393|157640016|FG000|Overall Study|Withdrawal by Subject|2|||
48948117|NCT04579393|157640017|FG001|Overall Study|Withdrawal by Subject|2|||
48853311|NCT01915914|157301601|FG003|Maintenance Phase|Withdrawal by Subject|0|||
48738884|NCT01817530|156892648|FG006|Overall Study|Pregnancy|0|||
48738885|NCT01817530|156892649|FG007|Overall Study|Pregnancy|0|||
48738886|NCT01817530|156892642|FG000|Overall Study|Other|0|||
48853312|NCT01915914|157301598|FG000|Maintenance Phase|Lost to Follow-up|0|||
48853313|NCT01915914|157301599|FG001|Maintenance Phase|Lost to Follow-up|4|||
48948118|NCT04579393|157640016|FG000|Overall Study|Death|1|||
48738887|NCT01817530|156892643|FG001|Overall Study|Other|1|||
48948119|NCT04579393|157640017|FG001|Overall Study|Death|3|||
48948120|NCT02209597|157640019|FG000|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2|||
48948121|NCT02209597|157640019|FG000|Phase 1 Current Tx (Non-randomized)|Adverse Event|1|||
48738888|NCT01817530|156892644|FG002|Overall Study|Other|0|||
48738889|NCT01817530|156892645|FG003|Overall Study|Other|0|||
48738890|NCT01817530|156892646|FG004|Overall Study|Other|1|||
48738891|NCT01817530|156892647|FG005|Overall Study|Other|0|||
48738892|NCT01817530|156892648|FG006|Overall Study|Other|5|||
48738893|NCT01817530|156892649|FG007|Overall Study|Other|0|||
48948122|NCT02209597|157640019|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3|||
48948123|NCT02209597|157640019|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1|||
48948124|NCT01595646|157640021|FG000|Overall Study|Withdrawal by Subject|1|||
48738894|NCT01817530|156892642|FG000|Overall Study|Surgery or Invasive Intervention|1|||
48738895|NCT01817530|156892643|FG001|Overall Study|Surgery or Invasive Intervention|0|||
48948125|NCT01595646|157640022|FG001|Overall Study|Withdrawal by Subject|0|||
48948126|NCT01595646|157640023|FG002|Overall Study|Withdrawal by Subject|0|||
48948127|NCT03103750|157640024|FG000|Overall Study|Adverse Event|1|||
48948128|NCT03103750|157640025|FG001|Overall Study|Adverse Event|0|||
48948129|NCT03103750|157640024|FG000|Overall Study|Lost to Follow-up|1|||
48948130|NCT03103750|157640025|FG001|Overall Study|Lost to Follow-up|0|||
48948131|NCT03103750|157640024|FG000|Overall Study|PET Equipment Related|2|||
48948132|NCT03103750|157640025|FG001|Overall Study|PET Equipment Related|2|||
48948133|NCT00501852|157640028|FG000|Overall Study|Adverse Event|3|||
48948134|NCT00501852|157640028|FG000|Overall Study|Withdrawal by Subject|2|||
48948135|NCT00778999|157640036|FG000|Overall Study|Discontinuation: no embryo transfer|14|||
48948136|NCT00778999|157640037|FG001|Overall Study|Discontinuation: no embryo transfer|14|||
48948137|NCT00778999|157640036|FG000|Overall Study|Did not receive recFSH|14|||
48948138|NCT00778999|157640037|FG001|Overall Study|Did not receive recFSH|20|||
48948139|NCT00399802|157640038|FG000|Overall Study|Adverse Event|0|||
48948140|NCT00399802|157640039|FG001|Overall Study|Adverse Event|2|||
48948141|NCT00399802|157640038|FG000|Overall Study|Participant discontinued by mistake|0|||
48948142|NCT00399802|157640039|FG001|Overall Study|Participant discontinued by mistake|1|||
48948143|NCT01276847|157640044|FG000|Overall Study|Withdrawal by Subject|1|||
48948144|NCT01276847|157640045|FG001|Overall Study|Withdrawal by Subject|0|||
48948145|NCT01276847|157640046|FG002|Overall Study|Withdrawal by Subject|0|||
48948146|NCT00231062|157640047|FG000|Overall Study|Physician Decision|6|||
48948147|NCT01855789|157640048|FG000|1) Baseline up to Week 24|Adverse Event|37|||
48948148|NCT01855789|157640049|FG001|1) Baseline up to Week 24|Adverse Event|0|||
48948149|NCT01855789|157640050|FG002|1) Baseline up to Week 24|Adverse Event|0|||
48948150|NCT01855789|157640051|FG003|1) Baseline up to Week 24|Adverse Event|0|||
48948151|NCT01855789|157640048|FG000|1) Baseline up to Week 24|Death|2|||
48948152|NCT01855789|157640049|FG001|1) Baseline up to Week 24|Death|0|||
48948153|NCT01855789|157640050|FG002|1) Baseline up to Week 24|Death|0|||
48948154|NCT01855789|157640051|FG003|1) Baseline up to Week 24|Death|0|||
48948155|NCT01855789|157640048|FG000|1) Baseline up to Week 24|Lack of Efficacy|16|||
48948156|NCT01855789|157640049|FG001|1) Baseline up to Week 24|Lack of Efficacy|0|||
48948157|NCT01855789|157640050|FG002|1) Baseline up to Week 24|Lack of Efficacy|0|||
48948158|NCT01855789|157640051|FG003|1) Baseline up to Week 24|Lack of Efficacy|0|||
48948159|NCT01855789|157640048|FG000|1) Baseline up to Week 24|Lost to Follow-up|11|||
48948160|NCT01855789|157640049|FG001|1) Baseline up to Week 24|Lost to Follow-up|0|||
48948161|NCT01855789|157640050|FG002|1) Baseline up to Week 24|Lost to Follow-up|0|||
48948162|NCT01855789|157640051|FG003|1) Baseline up to Week 24|Lost to Follow-up|0|||
48948163|NCT01855789|157640048|FG000|1) Baseline up to Week 24|Protocol Violation|4|||
48948164|NCT01855789|157640049|FG001|1) Baseline up to Week 24|Protocol Violation|0|||
48948165|NCT01855789|157640050|FG002|1) Baseline up to Week 24|Protocol Violation|0|||
48948166|NCT01855789|157640051|FG003|1) Baseline up to Week 24|Protocol Violation|0|||
48948167|NCT01855789|157640048|FG000|1) Baseline up to Week 24|Withdrawal by Subject|31|||
48948168|NCT01855789|157640049|FG001|1) Baseline up to Week 24|Withdrawal by Subject|0|||
48948169|NCT01855789|157640050|FG002|1) Baseline up to Week 24|Withdrawal by Subject|0|||
48948170|NCT01855789|157640051|FG003|1) Baseline up to Week 24|Withdrawal by Subject|0|||
48948171|NCT01855789|157640048|FG000|1) Baseline up to Week 24|Physician Decision|4|||
48948172|NCT01855789|157640049|FG001|1) Baseline up to Week 24|Physician Decision|0|||
48948173|NCT01855789|157640050|FG002|1) Baseline up to Week 24|Physician Decision|0|||
48948174|NCT01855789|157640051|FG003|1) Baseline up to Week 24|Physician Decision|0|||
48853314|NCT01915914|157301600|FG002|Maintenance Phase|Lost to Follow-up|1|||
48738896|NCT01817530|156892644|FG002|Overall Study|Surgery or Invasive Intervention|0|||
48738897|NCT01817530|156892645|FG003|Overall Study|Surgery or Invasive Intervention|0|||
48738898|NCT01817530|156892646|FG004|Overall Study|Surgery or Invasive Intervention|1|||
48738899|NCT01817530|156892647|FG005|Overall Study|Surgery or Invasive Intervention|1|||
48738900|NCT01817530|156892648|FG006|Overall Study|Surgery or Invasive Intervention|1|||
48738901|NCT01817530|156892649|FG007|Overall Study|Surgery or Invasive Intervention|0|||
48738902|NCT01817530|156892642|FG000|Overall Study|Consent Withdrawn by Subject|3|||
48738903|NCT01817530|156892643|FG001|Overall Study|Consent Withdrawn by Subject|4|||
48738904|NCT01817530|156892644|FG002|Overall Study|Consent Withdrawn by Subject|7|||
48738905|NCT01817530|156892645|FG003|Overall Study|Consent Withdrawn by Subject|3|||
48738906|NCT01817530|156892646|FG004|Overall Study|Consent Withdrawn by Subject|5|||
48738907|NCT01817530|156892647|FG005|Overall Study|Consent Withdrawn by Subject|3|||
48738908|NCT01817530|156892648|FG006|Overall Study|Consent Withdrawn by Subject|3|||
48738909|NCT01817530|156892649|FG007|Overall Study|Consent Withdrawn by Subject|10|||
48738910|NCT01817530|156892642|FG000|Overall Study|Lost to Follow-up|1|||
48738911|NCT01817530|156892643|FG001|Overall Study|Lost to Follow-up|4|||
48738912|NCT01817530|156892644|FG002|Overall Study|Lost to Follow-up|2|||
48738913|NCT01817530|156892645|FG003|Overall Study|Lost to Follow-up|1|||
48738914|NCT01817530|156892646|FG004|Overall Study|Lost to Follow-up|3|||
48738915|NCT01817530|156892647|FG005|Overall Study|Lost to Follow-up|2|||
48738916|NCT01817530|156892648|FG006|Overall Study|Lost to Follow-up|8|||
48738917|NCT01817530|156892649|FG007|Overall Study|Lost to Follow-up|4|||
48738918|NCT02008318|156894048|FG000|Overall Study|Adverse Event|4|||
48738919|NCT02008318|156894049|FG001|Overall Study|Adverse Event|0|||
48738920|NCT02008318|156894048|FG000|Overall Study|Physician Decision|2|||
48738921|NCT02008318|156894049|FG001|Overall Study|Physician Decision|0|||
48738922|NCT02008318|156894048|FG000|Overall Study|Progressive Disease|2|||
48738923|NCT02008318|156894049|FG001|Overall Study|Progressive Disease|0|||
48853315|NCT01915914|157301601|FG003|Maintenance Phase|Lost to Follow-up|0|||
48853316|NCT01915914|157301598|FG000|Maintenance Phase|Missing|0|||
48853317|NCT01915914|157301599|FG001|Maintenance Phase|Missing|1|||
48853318|NCT01915914|157301600|FG002|Maintenance Phase|Missing|0|||
48853319|NCT01915914|157301601|FG003|Maintenance Phase|Missing|0|||
48853320|NCT01915914|157301598|FG000|Follow-up Phase|Withdrawal by Subject|0|||
48853321|NCT01915914|157301599|FG001|Follow-up Phase|Withdrawal by Subject|0|||
48853322|NCT01915914|157301600|FG002|Follow-up Phase|Withdrawal by Subject|0|||
48853323|NCT01915914|157301601|FG003|Follow-up Phase|Withdrawal by Subject|1|||
48853324|NCT01915914|157301598|FG000|Follow-up Phase|Physician Decision|0|||
48853325|NCT01915914|157301599|FG001|Follow-up Phase|Physician Decision|0|||
48853326|NCT01915914|157301600|FG002|Follow-up Phase|Physician Decision|0|||
48853327|NCT01915914|157301601|FG003|Follow-up Phase|Physician Decision|1|||
48853328|NCT02147093|157301604|FG000|Period 1|Lost to Follow-up|0|||
48853329|NCT02147093|157301605|FG001|Period 1|Lost to Follow-up|1|||
48853330|NCT02147093|157301604|FG000|Period 2|Protocol Violation|2|||
48853331|NCT02147093|157301605|FG001|Period 2|Protocol Violation|0|||
48853332|NCT00845520|157301612|FG000|Overall Study|Death|1|||
48853333|NCT00845520|157301613|FG001|Overall Study|Death|2|||
48853334|NCT00845520|157301614|FG002|Overall Study|Death|0|||
48738924|NCT02008318|156894048|FG000|Overall Study|Protocol Violation|1|||
48853335|NCT00845520|157301612|FG000|Overall Study|Lost to Follow-up|1|||
48853336|NCT00845520|157301613|FG001|Overall Study|Lost to Follow-up|0|||
48853337|NCT00845520|157301614|FG002|Overall Study|Lost to Follow-up|0|||
48853338|NCT00845520|157301612|FG000|Overall Study|Adverse Event|0|||
48853339|NCT00845520|157301613|FG001|Overall Study|Adverse Event|0|||
48853340|NCT00845520|157301614|FG002|Overall Study|Adverse Event|1|||
48738925|NCT02008318|156894049|FG001|Overall Study|Protocol Violation|1|||
48738926|NCT02008318|156894048|FG000|Overall Study|Withdrawal by Subject|3|||
48738927|NCT02008318|156894049|FG001|Overall Study|Withdrawal by Subject|0|||
48738928|NCT00293215|156894055|FG000|Overall Study|Progressive disease|3|||
48738929|NCT00293215|156894056|FG001|Overall Study|Progressive disease|1|||
48738930|NCT00293215|156894055|FG000|Overall Study|Adverse Event|2|||
48738931|NCT00293215|156894056|FG001|Overall Study|Adverse Event|2|||
48738932|NCT00371826|156894057|FG000|Core Phase (12 Months)|Adverse Event|15|||
48738933|NCT00371826|156894058|FG001|Core Phase (12 Months)|Adverse Event|4|||
48738934|NCT00371826|156894059|FG002|Core Phase (12 Months)|Adverse Event|9|||
48738935|NCT00371826|156894057|FG000|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
48738936|NCT00371826|156894058|FG001|Core Phase (12 Months)|Abnormal test procedure result(s)|0|||
48738937|NCT00371826|156894059|FG002|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
48853341|NCT02807857|157301616|FG000|Enrolled Set|Patients not suitable for follow-up.|551|||
48853342|NCT02807857|157301616|FG000|Follow-Up Set|Study Terminated By Sponsor|131|||
48853343|NCT02807857|157301616|FG000|Follow-Up Set|Withdrawal by Subject|8|||
48738938|NCT00371826|156894057|FG000|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6|||
48738939|NCT00371826|156894058|FG001|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3|||
48738940|NCT00371826|156894059|FG002|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2|||
48738941|NCT00371826|156894057|FG000|Core Phase (12 Months)|Protocol Violation|1|||
48738942|NCT00371826|156894058|FG001|Core Phase (12 Months)|Protocol Violation|0|||
48738943|NCT00371826|156894059|FG002|Core Phase (12 Months)|Protocol Violation|1|||
48738944|NCT00371826|156894057|FG000|Core Phase (12 Months)|Subject withdrew consent|0|||
48738945|NCT00371826|156894058|FG001|Core Phase (12 Months)|Subject withdrew consent|0|||
48738946|NCT00371826|156894059|FG002|Core Phase (12 Months)|Subject withdrew consent|3|||
48738947|NCT00371826|156894057|FG000|Core Phase (12 Months)|Administrative problems|1|||
48738948|NCT00371826|156894058|FG001|Core Phase (12 Months)|Administrative problems|0|||
48738949|NCT00371826|156894059|FG002|Core Phase (12 Months)|Administrative problems|8|||
48738950|NCT00371826|156894057|FG000|Core Phase (12 Months)|Graft Loss|0|||
48738951|NCT00371826|156894058|FG001|Core Phase (12 Months)|Graft Loss|1|||
48738952|NCT00371826|156894059|FG002|Core Phase (12 Months)|Graft Loss|0|||
48738953|NCT00371826|156894057|FG000|Extension Phase (24 Months)|Adverse Event|4|||
48738954|NCT00371826|156894058|FG001|Extension Phase (24 Months)|Adverse Event|5|||
48738955|NCT00371826|156894059|FG002|Extension Phase (24 Months)|Adverse Event|0|||
48738956|NCT00371826|156894057|FG000|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
48738957|NCT00371826|156894058|FG001|Extension Phase (24 Months)|Abnormal test procedure result(s)|1|||
48738958|NCT00371826|156894059|FG002|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
48738959|NCT00371826|156894057|FG000|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
48738960|NCT00371826|156894058|FG001|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2|||
48738961|NCT00371826|156894059|FG002|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
48738962|NCT00371826|156894057|FG000|Extension Phase (24 Months)|Subject withdrew consent|1|||
48738963|NCT00371826|156894058|FG001|Extension Phase (24 Months)|Subject withdrew consent|2|||
48738964|NCT00371826|156894059|FG002|Extension Phase (24 Months)|Subject withdrew consent|0|||
48738965|NCT00371826|156894057|FG000|Extension Phase (24 Months)|Administrative problems|0|||
48853344|NCT02807857|157301616|FG000|Follow-Up Set|Lost to Follow-up|7|||
48738966|NCT00371826|156894058|FG001|Extension Phase (24 Months)|Administrative problems|0|||
48853345|NCT02807857|157301616|FG000|Follow-Up Set|Physician Decision|6|||
48853346|NCT02807857|157301616|FG000|Follow-Up Set|Adverse Event|3|||
48853347|NCT02807857|157301616|FG000|Follow-Up Set|Death|27|||
48853348|NCT02807857|157301616|FG000|Follow-Up Set|Relocation|2|||
48738967|NCT00371826|156894059|FG002|Extension Phase (24 Months)|Administrative problems|2|||
48738968|NCT00533897|156894062|FG000|Lead-in (LI) Period 1|Adverse Event|1|||
48738969|NCT00533897|156894063|FG001|Lead-in (LI) Period 1|Adverse Event|0|||
48738970|NCT00533897|156894064|FG002|Lead-in (LI) Period 1|Adverse Event|0|||
48738971|NCT00533897|156894065|FG003|Lead-in (LI) Period 1|Adverse Event|0|||
48738972|NCT00533897|156894066|FG004|Lead-in (LI) Period 1|Adverse Event|0|||
48738973|NCT00533897|156894067|FG005|Lead-in (LI) Period 1|Adverse Event|0|||
48738974|NCT00533897|156894068|FG006|Lead-in (LI) Period 1|Adverse Event|0|||
48738975|NCT00533897|156894069|FG007|Lead-in (LI) Period 1|Adverse Event|0|||
48738976|NCT00533897|156894062|FG000|Lead-in (LI) Period 1|Participant Withdrew Consent|2|||
48738977|NCT00533897|156894063|FG001|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
48738978|NCT00533897|156894064|FG002|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
48738979|NCT00533897|156894065|FG003|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
48738980|NCT00533897|156894066|FG004|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
48738981|NCT00533897|156894067|FG005|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
48738982|NCT00533897|156894068|FG006|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
48853349|NCT00738400|157301622|FG000|Overall Study|Adverse Event|3|||
48853350|NCT00738400|157301623|FG001|Overall Study|Adverse Event|1|||
48853351|NCT00738400|157301622|FG000|Overall Study|Withdrawal by Subject|0|||
48853352|NCT00738400|157301623|FG001|Overall Study|Withdrawal by Subject|1|||
48853353|NCT00738400|157301622|FG000|Overall Study|Lack of Efficacy|0|||
48853354|NCT00738400|157301623|FG001|Overall Study|Lack of Efficacy|1|||
48853355|NCT00738400|157301622|FG000|Overall Study|Lost to Follow-up|0|||
48853356|NCT00738400|157301623|FG001|Overall Study|Lost to Follow-up|3|||
48853357|NCT00738400|157301622|FG000|Overall Study|Protocol Violation|1|||
48853358|NCT00738400|157301623|FG001|Overall Study|Protocol Violation|0|||
48853359|NCT00738400|157301622|FG000|Overall Study|Non-compliant with study medication|0|||
48853360|NCT00738400|157301623|FG001|Overall Study|Non-compliant with study medication|1|||
48853361|NCT01307800|157301624|FG000|Overall Study|Adverse Event|9|||
48853362|NCT01307800|157301625|FG001|Overall Study|Adverse Event|8|||
48853363|NCT01307800|157301626|FG002|Overall Study|Adverse Event|10|||
48853364|NCT01307800|157301627|FG003|Overall Study|Adverse Event|14|||
48853365|NCT01307800|157301624|FG000|Overall Study|Entry Criteria Not Met|0|||
48853366|NCT01307800|157301625|FG001|Overall Study|Entry Criteria Not Met|0|||
48853367|NCT01307800|157301626|FG002|Overall Study|Entry Criteria Not Met|0|||
48853368|NCT01307800|157301627|FG003|Overall Study|Entry Criteria Not Met|2|||
48738983|NCT00533897|156894069|FG007|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
48948175|NCT01855789|157640048|FG000|1) Baseline up to Week 24|Pregnancy|1|||
48948176|NCT01855789|157640049|FG001|1) Baseline up to Week 24|Pregnancy|0|||
48948177|NCT01855789|157640050|FG002|1) Baseline up to Week 24|Pregnancy|0|||
48948178|NCT01855789|157640051|FG003|1) Baseline up to Week 24|Pregnancy|0|||
48948179|NCT01855789|157640048|FG000|1) Baseline up to Week 24|Participant Non-compliance|3|||
48948180|NCT01855789|157640049|FG001|1) Baseline up to Week 24|Participant Non-compliance|0|||
48948181|NCT01855789|157640050|FG002|1) Baseline up to Week 24|Participant Non-compliance|0|||
48948182|NCT01855789|157640051|FG003|1) Baseline up to Week 24|Participant Non-compliance|0|||
48948183|NCT01855789|157640048|FG000|1) Baseline up to Week 24|Sponsor Decision|3|||
48948184|NCT01855789|157640049|FG001|1) Baseline up to Week 24|Sponsor Decision|0|||
48948185|NCT01855789|157640050|FG002|1) Baseline up to Week 24|Sponsor Decision|0|||
48948186|NCT01855789|157640051|FG003|1) Baseline up to Week 24|Sponsor Decision|0|||
48948187|NCT01855789|157640048|FG000|1) Baseline up to Week 24|Other|4|||
48948188|NCT01855789|157640049|FG001|1) Baseline up to Week 24|Other|0|||
48948189|NCT01855789|157640050|FG002|1) Baseline up to Week 24|Other|0|||
48948190|NCT01855789|157640051|FG003|1) Baseline up to Week 24|Other|0|||
48948191|NCT01855789|157640048|FG000|2) Week 24 up to End of Study|Adverse Event|0|||
48948192|NCT01855789|157640049|FG001|2) Week 24 up to End of Study|Adverse Event|4|||
48948193|NCT01855789|157640050|FG002|2) Week 24 up to End of Study|Adverse Event|5|||
48948194|NCT01855789|157640051|FG003|2) Week 24 up to End of Study|Adverse Event|21|||
48948195|NCT01855789|157640048|FG000|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
48948196|NCT01855789|157640049|FG001|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
48948197|NCT01855789|157640050|FG002|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
48948198|NCT01855789|157640051|FG003|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1|||
48948199|NCT01855789|157640048|FG000|2) Week 24 up to End of Study|Lack of Efficacy|0|||
48948200|NCT01855789|157640049|FG001|2) Week 24 up to End of Study|Lack of Efficacy|2|||
48948201|NCT01855789|157640050|FG002|2) Week 24 up to End of Study|Lack of Efficacy|5|||
48948202|NCT01855789|157640051|FG003|2) Week 24 up to End of Study|Lack of Efficacy|16|||
48948203|NCT01855789|157640048|FG000|2) Week 24 up to End of Study|Lost to Follow-up|0|||
48948204|NCT01855789|157640049|FG001|2) Week 24 up to End of Study|Lost to Follow-up|1|||
48948205|NCT01855789|157640050|FG002|2) Week 24 up to End of Study|Lost to Follow-up|1|||
48948206|NCT01855789|157640051|FG003|2) Week 24 up to End of Study|Lost to Follow-up|4|||
48948207|NCT01855789|157640048|FG000|2) Week 24 up to End of Study|Protocol Violation|0|||
48948208|NCT01855789|157640049|FG001|2) Week 24 up to End of Study|Protocol Violation|0|||
48948209|NCT01855789|157640050|FG002|2) Week 24 up to End of Study|Protocol Violation|0|||
48948210|NCT01855789|157640051|FG003|2) Week 24 up to End of Study|Protocol Violation|1|||
48948211|NCT01855789|157640048|FG000|2) Week 24 up to End of Study|Withdrawal by Subject|0|||
48948212|NCT01855789|157640049|FG001|2) Week 24 up to End of Study|Withdrawal by Subject|7|||
48948213|NCT01855789|157640050|FG002|2) Week 24 up to End of Study|Withdrawal by Subject|5|||
48948214|NCT01855789|157640051|FG003|2) Week 24 up to End of Study|Withdrawal by Subject|8|||
48948215|NCT01855789|157640048|FG000|2) Week 24 up to End of Study|Physician Decision|0|||
48948216|NCT01855789|157640049|FG001|2) Week 24 up to End of Study|Physician Decision|0|||
48948217|NCT01855789|157640050|FG002|2) Week 24 up to End of Study|Physician Decision|2|||
48948218|NCT01855789|157640051|FG003|2) Week 24 up to End of Study|Physician Decision|4|||
48948219|NCT01855789|157640048|FG000|2) Week 24 up to End of Study|Participant Non-compliance|0|||
48948220|NCT01855789|157640049|FG001|2) Week 24 up to End of Study|Participant Non-compliance|1|||
48948221|NCT01855789|157640050|FG002|2) Week 24 up to End of Study|Participant Non-compliance|0|||
48948222|NCT01855789|157640051|FG003|2) Week 24 up to End of Study|Participant Non-compliance|1|||
48948223|NCT01855789|157640048|FG000|2) Week 24 up to End of Study|Sponsor Decision|0|||
48948224|NCT01855789|157640049|FG001|2) Week 24 up to End of Study|Sponsor Decision|0|||
48948225|NCT01855789|157640050|FG002|2) Week 24 up to End of Study|Sponsor Decision|0|||
48948226|NCT01855789|157640051|FG003|2) Week 24 up to End of Study|Sponsor Decision|1|||
48948227|NCT01855789|157640048|FG000|2) Week 24 up to End of Study|Other|0|||
48948228|NCT01855789|157640049|FG001|2) Week 24 up to End of Study|Other|0|||
48948229|NCT01855789|157640050|FG002|2) Week 24 up to End of Study|Other|0|||
48948230|NCT01855789|157640051|FG003|2) Week 24 up to End of Study|Other|1|||
48948231|NCT02269319|157640052|FG000|Overall Study|Lost to Follow-up|4|||
48948232|NCT02269319|157640053|FG001|Overall Study|Lost to Follow-up|3|||
48948233|NCT02269319|157640052|FG000|Overall Study|Adverse Event|0|||
48948234|NCT02269319|157640053|FG001|Overall Study|Adverse Event|1|||
48948235|NCT02269319|157640052|FG000|Overall Study|Instructions not followed|1|||
48948236|NCT02269319|157640053|FG001|Overall Study|Instructions not followed|0|||
48948237|NCT04430582|157640054|FG000|Overall Study|Found to meet exclusionary criteria|1|||
48948238|NCT04430582|157640055|FG001|Overall Study|Found to meet exclusionary criteria|0|||
48738984|NCT00533897|156894062|FG000|Lead-in (LI) Period 1|Lost to Follow-up|1|||
48738985|NCT00533897|156894063|FG001|Lead-in (LI) Period 1|Lost to Follow-up|0|||
48738986|NCT00533897|156894064|FG002|Lead-in (LI) Period 1|Lost to Follow-up|0|||
48738987|NCT00533897|156894065|FG003|Lead-in (LI) Period 1|Lost to Follow-up|0|||
48738988|NCT00533897|156894066|FG004|Lead-in (LI) Period 1|Lost to Follow-up|0|||
48738989|NCT00533897|156894067|FG005|Lead-in (LI) Period 1|Lost to Follow-up|0|||
48738990|NCT00533897|156894068|FG006|Lead-in (LI) Period 1|Lost to Follow-up|0|||
48738991|NCT00533897|156894069|FG007|Lead-in (LI) Period 1|Lost to Follow-up|0|||
48738992|NCT00533897|156894062|FG000|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2|||
48738993|NCT00533897|156894063|FG001|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
48738994|NCT00533897|156894064|FG002|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
48738995|NCT00533897|156894065|FG003|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
48738996|NCT00533897|156894066|FG004|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
48738997|NCT00533897|156894067|FG005|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
48738998|NCT00533897|156894068|FG006|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
48738999|NCT00533897|156894069|FG007|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
48739000|NCT00533897|156894062|FG000|Lead-in (LI) Period 1|Lack of Efficacy|3|||
48739001|NCT00533897|156894063|FG001|Lead-in (LI) Period 1|Lack of Efficacy|0|||
48739002|NCT00533897|156894064|FG002|Lead-in (LI) Period 1|Lack of Efficacy|0|||
48739003|NCT00533897|156894065|FG003|Lead-in (LI) Period 1|Lack of Efficacy|0|||
48739004|NCT00533897|156894066|FG004|Lead-in (LI) Period 1|Lack of Efficacy|0|||
48739005|NCT00533897|156894067|FG005|Lead-in (LI) Period 1|Lack of Efficacy|0|||
48739006|NCT00533897|156894068|FG006|Lead-in (LI) Period 1|Lack of Efficacy|0|||
48739007|NCT00533897|156894069|FG007|Lead-in (LI) Period 1|Lack of Efficacy|0|||
48739008|NCT00533897|156894062|FG000|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1|||
48739009|NCT00533897|156894063|FG001|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
48739010|NCT00533897|156894064|FG002|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
48739011|NCT00533897|156894065|FG003|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
48739012|NCT00533897|156894066|FG004|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
48739013|NCT00533897|156894067|FG005|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
48739014|NCT00533897|156894068|FG006|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
48739015|NCT00533897|156894069|FG007|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
48739016|NCT00533897|156894062|FG000|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
48739017|NCT00533897|156894063|FG001|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1|||
48739018|NCT00533897|156894064|FG002|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2|||
48739019|NCT00533897|156894065|FG003|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
48739020|NCT00533897|156894066|FG004|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
48948239|NCT04430582|157640054|FG000|Overall Study|Withdrawal by Subject|0|||
48948240|NCT04430582|157640055|FG001|Overall Study|Withdrawal by Subject|1|||
48948241|NCT02658656|157640056|FG000|Screening|Failed eligibility criteria|0|||
48948242|NCT02658656|157640057|FG001|Screening|Failed eligibility criteria|0|||
48948243|NCT02658656|157640058|FG002|Screening|Failed eligibility criteria|263|||
48948244|NCT02658656|157640056|FG000|Randomization|Withdrawal by Subject|8|||
48948245|NCT02658656|157640057|FG001|Randomization|Withdrawal by Subject|7|||
48948246|NCT02658656|157640058|FG002|Randomization|Withdrawal by Subject|0|||
48948247|NCT02658656|157640056|FG000|Randomization|Lost to Follow-up|1|||
48948248|NCT02658656|157640057|FG001|Randomization|Lost to Follow-up|3|||
48948249|NCT02658656|157640058|FG002|Randomization|Lost to Follow-up|0|||
48948250|NCT02658656|157640056|FG000|Randomization|Adverse Event|4|||
48948251|NCT02658656|157640057|FG001|Randomization|Adverse Event|0|||
48948252|NCT02658656|157640058|FG002|Randomization|Adverse Event|0|||
48948253|NCT02658656|157640056|FG000|Randomization|Administrative Termination|3|||
48948254|NCT02658656|157640057|FG001|Randomization|Administrative Termination|1|||
48948255|NCT02658656|157640058|FG002|Randomization|Administrative Termination|0|||
48948256|NCT02658656|157640056|FG000|Randomization|Administrative Termination due to COVID-19 Restrictions|13|||
48948257|NCT02658656|157640057|FG001|Randomization|Administrative Termination due to COVID-19 Restrictions|15|||
48948258|NCT02658656|157640058|FG002|Randomization|Administrative Termination due to COVID-19 Restrictions|0|||
48948259|NCT02658656|157640056|FG000|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|2|||
48948260|NCT02658656|157640057|FG001|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
48948261|NCT02658656|157640058|FG002|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
48948262|NCT02658656|157640056|FG000|Randomization|Not eligible for Randomization|1|||
48948263|NCT02658656|157640057|FG001|Randomization|Not eligible for Randomization|0|||
48948264|NCT02658656|157640058|FG002|Randomization|Not eligible for Randomization|0|||
48948265|NCT02658656|157640056|FG000|Randomization|Protocol Violation|1|||
48948266|NCT02658656|157640057|FG001|Randomization|Protocol Violation|0|||
48948267|NCT02658656|157640058|FG002|Randomization|Protocol Violation|0|||
48948268|NCT01269125|157641917|FG000|Overall Study|Adverse Event|3|||
48948269|NCT01269125|157641918|FG001|Overall Study|Adverse Event|5|||
48948270|NCT01269125|157641919|FG002|Overall Study|Adverse Event|0|||
48739021|NCT00533897|156894067|FG005|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
48739022|NCT00533897|156894068|FG006|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
48739023|NCT00533897|156894069|FG007|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
48739024|NCT00533897|156894062|FG000|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
48739025|NCT00533897|156894063|FG001|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
48739026|NCT00533897|156894064|FG002|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1|||
48739027|NCT00533897|156894065|FG003|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
48739028|NCT00533897|156894066|FG004|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
48739029|NCT00533897|156894067|FG005|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
48739030|NCT00533897|156894068|FG006|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
48739031|NCT00533897|156894069|FG007|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
48739032|NCT00533897|156894062|FG000|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
48739033|NCT00533897|156894063|FG001|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
48948271|NCT01269125|157641917|FG000|Overall Study|Lost to Follow-up|4|||
48948272|NCT01269125|157641918|FG001|Overall Study|Lost to Follow-up|0|||
48948273|NCT01269125|157641919|FG002|Overall Study|Lost to Follow-up|0|||
48948274|NCT01348919|157641920|FG000|Overall Study|Adverse Event|3|||
48948275|NCT01348919|157641921|FG001|Overall Study|Adverse Event|1|||
48948276|NCT01348919|157641922|FG002|Overall Study|Adverse Event|0|||
48948277|NCT01348919|157641920|FG000|Overall Study|Withdrawal by Subject|0|||
48948278|NCT01348919|157641921|FG001|Overall Study|Withdrawal by Subject|1|||
48948279|NCT01348919|157641922|FG002|Overall Study|Withdrawal by Subject|0|||
48948280|NCT01348919|157641920|FG000|Overall Study|Disease progression|0|||
48948281|NCT01348919|157641921|FG001|Overall Study|Disease progression|1|||
48948282|NCT01348919|157641922|FG002|Overall Study|Disease progression|1|||
48948283|NCT03825042|157641923|FG000|Overall Study|Adverse Event|1|||
48948284|NCT03825042|157641924|FG001|Overall Study|Adverse Event|0|||
48948285|NCT03825042|157641923|FG000|Overall Study|Withdrawal by Subject|1|||
48948286|NCT03825042|157641924|FG001|Overall Study|Withdrawal by Subject|0|||
48739034|NCT00533897|156894064|FG002|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
48739035|NCT00533897|156894065|FG003|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
48739036|NCT00533897|156894066|FG004|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
48739037|NCT00533897|156894067|FG005|Re-introduction (RI) Period 3|Participant Withdrew Consent|1|||
48739038|NCT00533897|156894068|FG006|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
48739039|NCT00533897|156894069|FG007|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
48739040|NCT00533897|156894062|FG000|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
48739041|NCT00533897|156894063|FG001|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
48739042|NCT00533897|156894064|FG002|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
48948287|NCT02114203|157641925|FG000|Overall Study|Adverse Event|0|||
48948288|NCT02114203|157641926|FG001|Overall Study|Adverse Event|1|||
48948289|NCT02114203|157641927|FG002|Overall Study|Adverse Event|0|||
48948290|NCT02114203|157641925|FG000|Overall Study|Withdrawal by Subject|0|||
48739043|NCT00533897|156894065|FG003|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
48739044|NCT00533897|156894066|FG004|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
48739045|NCT00533897|156894067|FG005|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1|||
48739046|NCT00533897|156894068|FG006|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
48739047|NCT00533897|156894069|FG007|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
48739048|NCT00533897|156894062|FG000|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
48739049|NCT00533897|156894063|FG001|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
48739050|NCT00533897|156894064|FG002|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
48853369|NCT01307800|157301624|FG000|Overall Study|Lost to Follow-up|5|||
48853370|NCT01307800|157301625|FG001|Overall Study|Lost to Follow-up|6|||
48739051|NCT00533897|156894065|FG003|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
48739052|NCT00533897|156894066|FG004|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
48739053|NCT00533897|156894067|FG005|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
48853371|NCT01307800|157301626|FG002|Overall Study|Lost to Follow-up|2|||
48853372|NCT01307800|157301627|FG003|Overall Study|Lost to Follow-up|8|||
48853373|NCT01307800|157301624|FG000|Overall Study|Perceived Lack of Efficacy|24|||
48853374|NCT01307800|157301625|FG001|Overall Study|Perceived Lack of Efficacy|23|||
48853375|NCT01307800|157301626|FG002|Overall Study|Perceived Lack of Efficacy|20|||
48853376|NCT01307800|157301627|FG003|Overall Study|Perceived Lack of Efficacy|33|||
48853377|NCT01307800|157301624|FG000|Overall Study|Protocol Violation|0|||
48739054|NCT00533897|156894068|FG006|Long Term Extension (LTE)|Participant Withdrew Consent|2|||
48739055|NCT00533897|156894069|FG007|Long Term Extension (LTE)|Participant Withdrew Consent|5|||
48739056|NCT00533897|156894062|FG000|Long Term Extension (LTE)|Death|0|||
48739057|NCT00533897|156894063|FG001|Long Term Extension (LTE)|Death|0|||
48739058|NCT00533897|156894064|FG002|Long Term Extension (LTE)|Death|0|||
48739059|NCT00533897|156894065|FG003|Long Term Extension (LTE)|Death|0|||
48739060|NCT00533897|156894066|FG004|Long Term Extension (LTE)|Death|0|||
48739061|NCT00533897|156894067|FG005|Long Term Extension (LTE)|Death|0|||
48739062|NCT00533897|156894068|FG006|Long Term Extension (LTE)|Death|1|||
48739063|NCT00533897|156894069|FG007|Long Term Extension (LTE)|Death|3|||
48739064|NCT00533897|156894062|FG000|Long Term Extension (LTE)|Lack of Efficacy|0|||
48739065|NCT00533897|156894063|FG001|Long Term Extension (LTE)|Lack of Efficacy|0|||
48739066|NCT00533897|156894064|FG002|Long Term Extension (LTE)|Lack of Efficacy|0|||
48853378|NCT01307800|157301625|FG001|Overall Study|Protocol Violation|3|||
48853379|NCT01307800|157301626|FG002|Overall Study|Protocol Violation|4|||
48853380|NCT01307800|157301627|FG003|Overall Study|Protocol Violation|5|||
48853381|NCT01307800|157301624|FG000|Overall Study|Schedule Conflict Prevented Continuation|0|||
48853382|NCT01307800|157301625|FG001|Overall Study|Schedule Conflict Prevented Continuation|3|||
48853383|NCT01307800|157301626|FG002|Overall Study|Schedule Conflict Prevented Continuation|1|||
48853384|NCT01307800|157301627|FG003|Overall Study|Schedule Conflict Prevented Continuation|2|||
48853385|NCT01307800|157301624|FG000|Overall Study|Sponsor Decision|6|||
48853386|NCT01307800|157301625|FG001|Overall Study|Sponsor Decision|9|||
48853387|NCT01307800|157301626|FG002|Overall Study|Sponsor Decision|12|||
48853388|NCT01307800|157301627|FG003|Overall Study|Sponsor Decision|28|||
48853389|NCT01307800|157301624|FG000|Overall Study|Withdrawal by Subject|10|||
48853390|NCT01307800|157301625|FG001|Overall Study|Withdrawal by Subject|11|||
48853391|NCT01307800|157301626|FG002|Overall Study|Withdrawal by Subject|8|||
48853392|NCT01307800|157301627|FG003|Overall Study|Withdrawal by Subject|15|||
48853393|NCT01307800|157301624|FG000|Overall Study|Participant Moved|0|||
48853394|NCT01307800|157301625|FG001|Overall Study|Participant Moved|2|||
48853395|NCT01307800|157301626|FG002|Overall Study|Participant Moved|1|||
48853396|NCT01307800|157301627|FG003|Overall Study|Participant Moved|3|||
48853397|NCT00667732|157301635|FG000|Run -In (8 Weeks)|Adverse Event|4|||
48853398|NCT00667732|157301636|FG001|Run -In (8 Weeks)|Adverse Event|0|||
48853399|NCT00667732|157301637|FG002|Run -In (8 Weeks)|Adverse Event|0|||
48853400|NCT00667732|157301635|FG000|Run -In (8 Weeks)|Withdrawal by Subject|3|||
48853401|NCT00667732|157301636|FG001|Run -In (8 Weeks)|Withdrawal by Subject|0|||
48853402|NCT00667732|157301637|FG002|Run -In (8 Weeks)|Withdrawal by Subject|0|||
48853403|NCT00667732|157301635|FG000|Randomization (24 Weeks)|Withdrawal by Subject|0|||
48853404|NCT00667732|157301636|FG001|Randomization (24 Weeks)|Withdrawal by Subject|1|||
48853405|NCT00667732|157301637|FG002|Randomization (24 Weeks)|Withdrawal by Subject|0|||
48739067|NCT00533897|156894065|FG003|Long Term Extension (LTE)|Lack of Efficacy|0|||
48739068|NCT00533897|156894066|FG004|Long Term Extension (LTE)|Lack of Efficacy|0|||
48739069|NCT00533897|156894067|FG005|Long Term Extension (LTE)|Lack of Efficacy|0|||
48739070|NCT00533897|156894068|FG006|Long Term Extension (LTE)|Lack of Efficacy|5|||
48739071|NCT00533897|156894069|FG007|Long Term Extension (LTE)|Lack of Efficacy|3|||
48739072|NCT00533897|156894062|FG000|Long Term Extension (LTE)|Poor/Non-compliance|0|||
48739073|NCT00533897|156894063|FG001|Long Term Extension (LTE)|Poor/Non-compliance|0|||
48739074|NCT00533897|156894064|FG002|Long Term Extension (LTE)|Poor/Non-compliance|0|||
48739075|NCT00533897|156894065|FG003|Long Term Extension (LTE)|Poor/Non-compliance|0|||
48739076|NCT00533897|156894066|FG004|Long Term Extension (LTE)|Poor/Non-compliance|0|||
48739077|NCT00533897|156894067|FG005|Long Term Extension (LTE)|Poor/Non-compliance|0|||
48739078|NCT00533897|156894068|FG006|Long Term Extension (LTE)|Poor/Non-compliance|1|||
48853406|NCT03890484|157301638|FG000|Overall Study|Lost to Follow-up|1|||
48853407|NCT03890484|157301639|FG001|Overall Study|Lost to Follow-up|1|||
48853408|NCT02993926|157301640|FG000|Enantone Treatment Phase|Adverse Event|1|||
48853409|NCT02993926|157301641|FG001|Enantone Treatment Phase|Adverse Event|0|||
48853410|NCT02993926|157301642|FG002|Enantone Treatment Phase|Adverse Event|0|||
48853411|NCT02993926|157301640|FG000|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26|||
48853412|NCT02993926|157301641|FG001|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
48853413|NCT02993926|157301642|FG002|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
48853414|NCT02993926|157301640|FG000|Enantone Treatment Phase|Investigator Judgment|1|||
48739079|NCT00533897|156894069|FG007|Long Term Extension (LTE)|Poor/Non-compliance|0|||
48739080|NCT00533897|156894062|FG000|Long Term Extension (LTE)|Adverse Event|0|||
48739081|NCT00533897|156894063|FG001|Long Term Extension (LTE)|Adverse Event|0|||
48739082|NCT00533897|156894064|FG002|Long Term Extension (LTE)|Adverse Event|0|||
48739083|NCT00533897|156894065|FG003|Long Term Extension (LTE)|Adverse Event|0|||
48739084|NCT00533897|156894066|FG004|Long Term Extension (LTE)|Adverse Event|0|||
48739085|NCT00533897|156894067|FG005|Long Term Extension (LTE)|Adverse Event|0|||
48739086|NCT00533897|156894068|FG006|Long Term Extension (LTE)|Adverse Event|2|||
48739087|NCT00533897|156894069|FG007|Long Term Extension (LTE)|Adverse Event|5|||
48739088|NCT00533897|156894062|FG000|Long Term Extension (LTE)|Pregnancy|0|||
48739089|NCT00533897|156894063|FG001|Long Term Extension (LTE)|Pregnancy|0|||
48739090|NCT00533897|156894064|FG002|Long Term Extension (LTE)|Pregnancy|0|||
48739091|NCT00533897|156894065|FG003|Long Term Extension (LTE)|Pregnancy|0|||
48739092|NCT00533897|156894066|FG004|Long Term Extension (LTE)|Pregnancy|0|||
48853415|NCT02993926|157301641|FG001|Enantone Treatment Phase|Investigator Judgment|0|||
48853416|NCT02993926|157301642|FG002|Enantone Treatment Phase|Investigator Judgment|0|||
48853417|NCT02993926|157301640|FG000|Enantone Treatment Phase|Reason Not Specified|4|||
48853418|NCT02993926|157301641|FG001|Enantone Treatment Phase|Reason Not Specified|0|||
48853419|NCT02993926|157301642|FG002|Enantone Treatment Phase|Reason Not Specified|0|||
48853420|NCT00452114|157301643|FG000|Overall Study|Physician Decision|3|||
48853421|NCT00452114|157301644|FG001|Overall Study|Physician Decision|3|||
48853422|NCT00518206|157301645|FG000|Overall Study|Disease Progression Requiring Therapy|6|||
48853423|NCT00518206|157301646|FG001|Overall Study|Disease Progression Requiring Therapy|6|||
48853424|NCT00518206|157301645|FG000|Overall Study|Withdrawal by Subject|2|||
48739093|NCT00533897|156894067|FG005|Long Term Extension (LTE)|Pregnancy|0|||
48739094|NCT00533897|156894068|FG006|Long Term Extension (LTE)|Pregnancy|0|||
48739095|NCT00533897|156894069|FG007|Long Term Extension (LTE)|Pregnancy|2|||
48739096|NCT00533897|156894062|FG000|Long Term Extension (LTE)|Lost to Follow-up|0|||
48739097|NCT00533897|156894063|FG001|Long Term Extension (LTE)|Lost to Follow-up|0|||
48739098|NCT00533897|156894064|FG002|Long Term Extension (LTE)|Lost to Follow-up|0|||
48739099|NCT00533897|156894065|FG003|Long Term Extension (LTE)|Lost to Follow-up|0|||
48739100|NCT00533897|156894066|FG004|Long Term Extension (LTE)|Lost to Follow-up|0|||
48739101|NCT00533897|156894067|FG005|Long Term Extension (LTE)|Lost to Follow-up|0|||
48739102|NCT00533897|156894068|FG006|Long Term Extension (LTE)|Lost to Follow-up|1|||
48739103|NCT00533897|156894069|FG007|Long Term Extension (LTE)|Lost to Follow-up|1|||
48739104|NCT00533897|156894062|FG000|Long Term Extension (LTE)|Other|0|||
48739105|NCT00533897|156894063|FG001|Long Term Extension (LTE)|Other|0|||
48739106|NCT00533897|156894064|FG002|Long Term Extension (LTE)|Other|0|||
48739107|NCT00533897|156894065|FG003|Long Term Extension (LTE)|Other|0|||
48739108|NCT00533897|156894066|FG004|Long Term Extension (LTE)|Other|0|||
48739109|NCT00533897|156894067|FG005|Long Term Extension (LTE)|Other|0|||
48739110|NCT00533897|156894068|FG006|Long Term Extension (LTE)|Other|1|||
48739111|NCT00533897|156894069|FG007|Long Term Extension (LTE)|Other|6|||
48739112|NCT00246753|156894071|FG000|Overall Study|Withdrawal by Subject|2|||
48739113|NCT00246753|156894071|FG000|Overall Study|Physician Decision|2|||
48739114|NCT00246753|156894071|FG000|Overall Study|Adverse Event|2|||
48739115|NCT00246753|156894071|FG000|Overall Study|Unacceptable toxicity|2|||
48739116|NCT00434954|156894076|FG000|Overall Study|Adverse Event|17|||
48739117|NCT00434954|156894077|FG001|Overall Study|Adverse Event|2|||
48739118|NCT00434954|156894076|FG000|Overall Study|Entry criteria not met|14|||
48739119|NCT00434954|156894077|FG001|Overall Study|Entry criteria not met|16|||
48739120|NCT00434954|156894076|FG000|Overall Study|Lost to Follow-up|0|||
48948291|NCT02114203|157641926|FG001|Overall Study|Withdrawal by Subject|1|||
48948292|NCT02114203|157641927|FG002|Overall Study|Withdrawal by Subject|0|||
48948293|NCT01518699|157641928|FG000|Period 2|Protocol Violation|1|||
48948294|NCT01518699|157641929|FG001|Period 2|Protocol Violation|1|||
48948295|NCT01518699|157641930|FG002|Period 2|Protocol Violation|0|||
48739121|NCT00434954|156894077|FG001|Overall Study|Lost to Follow-up|1|||
48853425|NCT00518206|157301646|FG001|Overall Study|Withdrawal by Subject|0|||
48948296|NCT01518699|157641931|FG003|Period 2|Protocol Violation|0|||
48948297|NCT01518699|157641932|FG004|Period 2|Protocol Violation|0|||
48739122|NCT00434954|156894076|FG000|Overall Study|Physician Decision|6|||
48739123|NCT00434954|156894077|FG001|Overall Study|Physician Decision|3|||
48739124|NCT00434954|156894076|FG000|Overall Study|Protocol Violation|36|||
48739125|NCT00434954|156894077|FG001|Overall Study|Protocol Violation|27|||
48853426|NCT00518206|157301645|FG000|Overall Study|Drug Supply Issue|1|||
48853427|NCT00518206|157301646|FG001|Overall Study|Drug Supply Issue|0|||
48853428|NCT00518206|157301645|FG000|Overall Study|Reason Unknown|1|||
48853429|NCT00518206|157301646|FG001|Overall Study|Reason Unknown|0|||
48853430|NCT00518206|157301645|FG000|Overall Study|Completion Status Unknown|1|||
48853431|NCT00518206|157301646|FG001|Overall Study|Completion Status Unknown|0|||
48853432|NCT03075878|157301647|FG000|Overall Study|Physician Decision|1|||
48853433|NCT01719172|157302766|FG000|Overall Study|Lost to Follow-up|1|||
48853434|NCT01719172|157302766|FG000|Overall Study|Death|1|||
48853435|NCT01673594|157302767|FG000|Overall Study|Adverse Event|3|||
48853436|NCT01673594|157302768|FG001|Overall Study|Adverse Event|1|||
48853437|NCT01673594|157302767|FG000|Overall Study|Lost to Follow-up|1|||
48853438|NCT01673594|157302768|FG001|Overall Study|Lost to Follow-up|0|||
48853439|NCT01673594|157302767|FG000|Overall Study|Physician Decision|2|||
48853440|NCT01673594|157302768|FG001|Overall Study|Physician Decision|4|||
48853441|NCT01673594|157302767|FG000|Overall Study|Withdrawal by Subject|0|||
48853442|NCT01673594|157302768|FG001|Overall Study|Withdrawal by Subject|1|||
48853443|NCT01450007|157302772|FG000|Overall Study|Late exclusion before treatment|2|||
48853444|NCT01450007|157302773|FG001|Overall Study|Late exclusion before treatment|3|||
48853445|NCT01450007|157302774|FG002|Overall Study|Late exclusion before treatment|2|||
48948298|NCT01518699|157641933|FG005|Period 2|Protocol Violation|0|||
48948299|NCT01518699|157641928|FG000|Period 2|Lost to Follow-up|0|||
48739126|NCT00434954|156894076|FG000|Overall Study|Sponsor decision|1|||
48739127|NCT00434954|156894077|FG001|Overall Study|Sponsor decision|0|||
48739128|NCT00434954|156894076|FG000|Overall Study|Subject decision|8|||
48739129|NCT00434954|156894077|FG001|Overall Study|Subject decision|22|||
48739130|NCT00002651|156894078|FG000|Induction|Adverse Event|44|||
48739131|NCT00002651|156894079|FG001|Induction|Adverse Event|0|||
48739132|NCT00002651|156894080|FG002|Induction|Adverse Event|0|||
48739133|NCT00002651|156894078|FG000|Induction|Refusal unrelated to adverse event|50|||
48739134|NCT00002651|156894079|FG001|Induction|Refusal unrelated to adverse event|0|||
48739135|NCT00002651|156894080|FG002|Induction|Refusal unrelated to adverse event|0|||
48739136|NCT00002651|156894078|FG000|Induction|Progression/relapse|274|||
48739137|NCT00002651|156894079|FG001|Induction|Progression/relapse|0|||
48739138|NCT00002651|156894080|FG002|Induction|Progression/relapse|0|||
48739139|NCT00002651|156894078|FG000|Induction|Death|62|||
48739140|NCT00002651|156894079|FG001|Induction|Death|0|||
48739141|NCT00002651|156894080|FG002|Induction|Death|0|||
48739142|NCT00002651|156894078|FG000|Induction|Other|823|||
48739143|NCT00002651|156894079|FG001|Induction|Other|0|||
48739144|NCT00002651|156894080|FG002|Induction|Other|0|||
48739145|NCT00002651|156894078|FG000|Induction|not eligible|90|||
48948300|NCT01518699|157641929|FG001|Period 2|Lost to Follow-up|1|||
48948301|NCT01518699|157641930|FG002|Period 2|Lost to Follow-up|0|||
48948302|NCT01518699|157641931|FG003|Period 2|Lost to Follow-up|0|||
48948303|NCT01518699|157641932|FG004|Period 2|Lost to Follow-up|0|||
48739146|NCT00002651|156894079|FG001|Induction|not eligible|0|||
48948304|NCT01518699|157641933|FG005|Period 2|Lost to Follow-up|0|||
48948305|NCT01518699|157641928|FG000|Period 2|Adverse Event|1|||
48948306|NCT01518699|157641929|FG001|Period 2|Adverse Event|0|||
48948307|NCT01518699|157641930|FG002|Period 2|Adverse Event|0|||
48739147|NCT00002651|156894080|FG002|Induction|not eligible|0|||
48948308|NCT01518699|157641931|FG003|Period 2|Adverse Event|0|||
48948309|NCT01518699|157641932|FG004|Period 2|Adverse Event|0|||
48948310|NCT01518699|157641933|FG005|Period 2|Adverse Event|0|||
48948311|NCT01009463|157641938|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373|||
48948312|NCT01009463|157641939|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
48948313|NCT01009463|157641940|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
48948314|NCT01009463|157641941|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
48948315|NCT01009463|157641942|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
48948316|NCT01009463|157641938|FG000|4-week, Open-label Run-In Period|Adverse Event|10|||
48948317|NCT01009463|157641939|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
48948318|NCT01009463|157641940|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
48948319|NCT01009463|157641941|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
48948320|NCT01009463|157641942|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
48948321|NCT01009463|157641938|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
48948322|NCT01009463|157641939|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
48948323|NCT01009463|157641940|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
48948324|NCT01009463|157641941|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
48948325|NCT01009463|157641942|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
48739148|NCT00002651|156894078|FG000|Consolidation and Randomization|Adverse Event|0|||
48739149|NCT00002651|156894079|FG001|Consolidation and Randomization|Adverse Event|36|||
48948326|NCT01009463|157641938|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
48739150|NCT00002651|156894080|FG002|Consolidation and Randomization|Adverse Event|14|||
48948327|NCT01009463|157641939|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
48948328|NCT01009463|157641940|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
48948329|NCT01009463|157641941|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
48948330|NCT01009463|157641942|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
48948331|NCT01009463|157641938|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|50|||
48948332|NCT01009463|157641939|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
48948333|NCT01009463|157641940|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
48948334|NCT01009463|157641941|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
48948335|NCT01009463|157641942|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
48948336|NCT01009463|157641938|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
48948337|NCT01009463|157641939|FG001|52-week, Double-blind Treatment Period|Adverse Event|22|||
48948338|NCT01009463|157641940|FG002|52-week, Double-blind Treatment Period|Adverse Event|25|||
48948339|NCT01009463|157641941|FG003|52-week, Double-blind Treatment Period|Adverse Event|29|||
48948340|NCT01009463|157641942|FG004|52-week, Double-blind Treatment Period|Adverse Event|31|||
48948341|NCT01009463|157641938|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
48948342|NCT01009463|157641939|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|34|||
48948343|NCT01009463|157641940|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|18|||
48948344|NCT01009463|157641941|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|17|||
48948345|NCT01009463|157641942|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
48948346|NCT01009463|157641938|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
48948347|NCT01009463|157641939|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|24|||
48948348|NCT01009463|157641940|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
48948349|NCT01009463|157641941|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|11|||
48948350|NCT01009463|157641942|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|18|||
48948351|NCT01009463|157641938|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
48948352|NCT01009463|157641939|FG001|52-week, Double-blind Treatment Period|Protocol Violation|8|||
48948353|NCT01009463|157641940|FG002|52-week, Double-blind Treatment Period|Protocol Violation|7|||
48948354|NCT01009463|157641941|FG003|52-week, Double-blind Treatment Period|Protocol Violation|8|||
48948355|NCT01009463|157641942|FG004|52-week, Double-blind Treatment Period|Protocol Violation|7|||
48948356|NCT01009463|157641938|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
48948357|NCT01009463|157641939|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
48948358|NCT01009463|157641940|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14|||
48948359|NCT01009463|157641941|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
48948360|NCT01009463|157641942|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
48948361|NCT01009463|157641938|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
48948362|NCT01009463|157641939|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|2|||
48948363|NCT01009463|157641940|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
48948364|NCT01009463|157641941|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
48948365|NCT01009463|157641942|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
48948366|NCT01009463|157641938|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
48948367|NCT01009463|157641939|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|11|||
48948368|NCT01009463|157641940|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|7|||
48948369|NCT01009463|157641941|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
48948370|NCT01009463|157641942|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|5|||
48948371|NCT01009463|157641938|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
48948372|NCT01009463|157641939|FG001|52-week, Double-blind Treatment Period|Physician Decision|4|||
48948373|NCT01009463|157641940|FG002|52-week, Double-blind Treatment Period|Physician Decision|6|||
48948374|NCT01009463|157641941|FG003|52-week, Double-blind Treatment Period|Physician Decision|6|||
48948375|NCT01009463|157641942|FG004|52-week, Double-blind Treatment Period|Physician Decision|8|||
48948376|NCT01494038|157641946|FG000|Overall Study|Protocol Violation|1|||
48948377|NCT01494038|157641947|FG001|Overall Study|Protocol Violation|1|||
48948378|NCT01494038|157641946|FG000|Overall Study|Lost to Follow-up|18|||
48948379|NCT01494038|157641947|FG001|Overall Study|Lost to Follow-up|20|||
48948380|NCT01494038|157641946|FG000|Overall Study|Withdrawal by Subject|44|||
48948381|NCT01494038|157641947|FG001|Overall Study|Withdrawal by Subject|34|||
48948382|NCT01494038|157641946|FG000|Overall Study|Not able to get to clinic|21|||
48948383|NCT01494038|157641947|FG001|Overall Study|Not able to get to clinic|15|||
48948384|NCT01494038|157641946|FG000|Overall Study|Not willing to adhere to reqs|2|||
48948385|NCT01494038|157641947|FG001|Overall Study|Not willing to adhere to reqs|9|||
48948386|NCT01494038|157641946|FG000|Overall Study|Death|2|||
48948387|NCT01494038|157641947|FG001|Overall Study|Death|4|||
48948388|NCT01334125|157641951|FG000|Overall Study|Lost to Follow-up|3|||
48948389|NCT01334125|157641952|FG001|Overall Study|Lost to Follow-up|3|||
48948390|NCT02138110|157641954|FG000|Enrolled for Scaffold Implantation|Physician Decision|1|||
48948391|NCT02138110|157641954|FG000|Overall Scaffold Implantation|Death|3|||
48948392|NCT00430781|157641955|FG000|Interim Analysis; 11 February 2008|Adverse Event|10|||
48948393|NCT00430781|157641956|FG001|Interim Analysis; 11 February 2008|Adverse Event|3|||
48948394|NCT00430781|157641957|FG002|Interim Analysis; 11 February 2008|Adverse Event|7|||
48948395|NCT00430781|157641955|FG000|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
48739151|NCT00002651|156894078|FG000|Consolidation and Randomization|Refusal unrelated to adverse event|0|||
48948396|NCT00430781|157641956|FG001|Interim Analysis; 11 February 2008|Lost to Follow-up|0|||
48948397|NCT00430781|157641957|FG002|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
48948398|NCT00430781|157641955|FG000|Interim Analysis; 11 February 2008|Protocol Violation|0|||
48948399|NCT00430781|157641956|FG001|Interim Analysis; 11 February 2008|Protocol Violation|1|||
48948400|NCT00430781|157641957|FG002|Interim Analysis; 11 February 2008|Protocol Violation|0|||
48948401|NCT00430781|157641955|FG000|Interim Analysis; 11 February 2008|Withdrawal by Subject|4|||
48948402|NCT00430781|157641956|FG001|Interim Analysis; 11 February 2008|Withdrawal by Subject|0|||
48948403|NCT00430781|157641957|FG002|Interim Analysis; 11 February 2008|Withdrawal by Subject|2|||
48948404|NCT00430781|157641955|FG000|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1|||
48948405|NCT00430781|157641956|FG001|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
48739152|NCT00002651|156894079|FG001|Consolidation and Randomization|Refusal unrelated to adverse event|53|||
48743074|NCT00968201|156910495|FG001|Extension Study - (Period III)|Adverse Event|5|||
48948406|NCT00430781|157641957|FG002|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
48948407|NCT00430781|157641955|FG000|Interim Analysis; 11 February 2008|Disease Progression|16|||
48948408|NCT00430781|157641956|FG001|Interim Analysis; 11 February 2008|Disease Progression|30|||
48948409|NCT00430781|157641957|FG002|Interim Analysis; 11 February 2008|Disease Progression|22|||
48948410|NCT00430781|157641955|FG000|Interim Analysis; 11 February 2008|Death|0|||
48948411|NCT00430781|157641956|FG001|Interim Analysis; 11 February 2008|Death|1|||
48948412|NCT00430781|157641957|FG002|Interim Analysis; 11 February 2008|Death|0|||
48948413|NCT00430781|157641955|FG000|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2|||
48948414|NCT00430781|157641956|FG001|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
48948415|NCT00430781|157641957|FG002|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
48948416|NCT00430781|157641955|FG000|Interim Analysis; 11 February 2008|Physician Decision|2|||
48948417|NCT00430781|157641956|FG001|Interim Analysis; 11 February 2008|Physician Decision|3|||
48948418|NCT00430781|157641957|FG002|Interim Analysis; 11 February 2008|Physician Decision|3|||
48948419|NCT00430781|157641955|FG000|Interim Analysis; 11 February 2008|Ongoing|23|||
48948420|NCT00430781|157641956|FG001|Interim Analysis; 11 February 2008|Ongoing|20|||
48853446|NCT01450007|157302772|FG000|Overall Study|Protocol Violation|0|||
48853447|NCT01450007|157302773|FG001|Overall Study|Protocol Violation|1|||
48853448|NCT01450007|157302774|FG002|Overall Study|Protocol Violation|1|||
48853449|NCT01450007|157302772|FG000|Overall Study|Adverse Event|0|||
48853450|NCT01450007|157302773|FG001|Overall Study|Adverse Event|1|||
48853451|NCT01450007|157302774|FG002|Overall Study|Adverse Event|0|||
48853452|NCT00599196|157302776|FG000|Overall Study|Lack of Efficacy|22|||
48853453|NCT00599196|157302776|FG000|Overall Study|Adverse Event|93|||
48853454|NCT00599196|157302776|FG000|Overall Study|Unsatisfactory compliance of subject|3|||
48853455|NCT00599196|157302776|FG000|Overall Study|Subject withdrew consent|43|||
48853456|NCT00599196|157302776|FG000|Overall Study|Study ended per sponsor|197|||
48853457|NCT00599196|157302776|FG000|Overall Study|Lost to Follow-up|17|||
48853458|NCT00599196|157302776|FG000|Overall Study|Other: Patient Leaving For Israel|1|||
48853459|NCT00599196|157302776|FG000|Overall Study|Other: Spouse Withdrew Consent|1|||
48853460|NCT00599196|157302776|FG000|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1|||
48853461|NCT00599196|157302776|FG000|Overall Study|Other: Pt Moved To Australia|1|||
48853462|NCT00599196|157302776|FG000|Overall Study|Other: Patient Stopped Due To Moving|1|||
48853463|NCT00599196|157302776|FG000|Overall Study|Other: Inv Switched Dopamine Agonist|1|||
48853464|NCT04497415|157302777|FG000|Overall Study|Lost to Follow-up|43|||
48853465|NCT04497415|157302778|FG001|Overall Study|Lost to Follow-up|27|||
48853466|NCT00263757|157302779|FG000|Overall Study|Withdrawal by Subject|5|||
48853467|NCT00263757|157302780|FG001|Overall Study|Withdrawal by Subject|4|||
48853468|NCT00263757|157302779|FG000|Overall Study|Screen failure|0|||
48739153|NCT00002651|156894080|FG002|Consolidation and Randomization|Refusal unrelated to adverse event|75|||
48739154|NCT00002651|156894078|FG000|Consolidation and Randomization|Progression/relapse|0|||
48739155|NCT00002651|156894079|FG001|Consolidation and Randomization|Progression/relapse|295|||
48739156|NCT00002651|156894080|FG002|Consolidation and Randomization|Progression/relapse|298|||
48948421|NCT00430781|157641957|FG002|Interim Analysis; 11 February 2008|Ongoing|25|||
49015344|NCT00673790|157892153|FG001|Overall Study|Sponsor Terminated due to PI oversight|1|||
48739157|NCT00002651|156894078|FG000|Consolidation and Randomization|Death|0|||
48739158|NCT00002651|156894079|FG001|Consolidation and Randomization|Death|38|||
48739159|NCT00002651|156894080|FG002|Consolidation and Randomization|Death|48|||
48739160|NCT00002651|156894078|FG000|Consolidation and Randomization|Other|0|||
48739161|NCT00002651|156894079|FG001|Consolidation and Randomization|Other|314|||
48739162|NCT00002651|156894080|FG002|Consolidation and Randomization|Other|313|||
48739163|NCT00002651|156894078|FG000|Consolidation and Randomization|not eligible|0|||
48739164|NCT00002651|156894079|FG001|Consolidation and Randomization|not eligible|102|||
48739165|NCT00002651|156894080|FG002|Consolidation and Randomization|not eligible|112|||
48739166|NCT00004635|156894081|FG000|Period One|refused|2|||
48739167|NCT00004635|156894082|FG001|Period One|refused|1|||
48739168|NCT00004635|156894081|FG000|Period One|Withdrawal by Subject|1|||
48739169|NCT00004635|156894082|FG001|Period One|Withdrawal by Subject|1|||
48739170|NCT00004635|156894081|FG000|Period One|Protocol Violation|1|||
48948422|NCT00430781|157641955|FG000|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
48948423|NCT00430781|157641956|FG001|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
48739171|NCT00004635|156894082|FG001|Period One|Protocol Violation|0|||
48739172|NCT00004635|156894081|FG000|Period One|PSA did not go <5 ng/mL|1|||
48739173|NCT00004635|156894082|FG001|Period One|PSA did not go <5 ng/mL|0|||
48739174|NCT00004635|156894081|FG000|Period One|second malignancy|1|||
48739175|NCT00004635|156894082|FG001|Period One|second malignancy|0|||
48739176|NCT00004635|156894081|FG000|Period One|progressed|0|||
48739177|NCT00004635|156894082|FG001|Period One|progressed|2|||
48739178|NCT00004635|156894081|FG000|Period One|health problem|0|||
48739179|NCT00004635|156894082|FG001|Period One|health problem|1|||
48739180|NCT00004635|156894081|FG000|Period One|discrepancy in data entry|0|||
48739181|NCT00004635|156894082|FG001|Period One|discrepancy in data entry|1|||
48739182|NCT00004635|156894081|FG000|Period Two|progression|2|||
48739183|NCT00004635|156894082|FG001|Period Two|progression|3|||
48739184|NCT00004635|156894081|FG000|Period Two|Adverse Event|1|||
48739185|NCT00004635|156894082|FG001|Period Two|Adverse Event|0|||
48739186|NCT00004635|156894081|FG000|Period Two|refused|0|||
48739187|NCT00004635|156894082|FG001|Period Two|refused|2|||
48739188|NCT00004635|156894081|FG000|Period Two|health problem|1|||
48739189|NCT00004635|156894082|FG001|Period Two|health problem|1|||
48739190|NCT00004635|156894081|FG000|Period Two|travel issues|0|||
48739191|NCT00004635|156894082|FG001|Period Two|travel issues|1|||
48739192|NCT00004635|156894081|FG000|Period Two|secondary malignancy|1|||
48739193|NCT00004635|156894082|FG001|Period Two|secondary malignancy|1|||
48739194|NCT00004635|156894081|FG000|Period Two|Lost to Follow-up|1|||
48739195|NCT00004635|156894082|FG001|Period Two|Lost to Follow-up|0|||
48739196|NCT00004635|156894081|FG000|Period Two|discrepancy in data entry|0|||
48739197|NCT00004635|156894082|FG001|Period Two|discrepancy in data entry|1|||
48739198|NCT00573937|156894083|FG000|Overall Study|Study Terminated|0|||
48739199|NCT00573937|156894084|FG001|Overall Study|Study Terminated|1|||
48739200|NCT00691301|156894085|FG000|Overall Study|Adverse Event|10|||
48739201|NCT00691301|156894085|FG000|Overall Study|Death|2|||
48739202|NCT00691301|156894085|FG000|Overall Study|Lack of Efficacy|32|||
48739203|NCT00691301|156894085|FG000|Overall Study|Withdrawal by Subject|4|||
48739204|NCT00691301|156894085|FG000|Overall Study|Concurrent illness|2|||
48739205|NCT00691301|156894085|FG000|Overall Study|other reason|3|||
48739206|NCT00691301|156894085|FG000|Overall Study|Did not initiate study treatment|1|||
48853469|NCT00263757|157302780|FG001|Overall Study|Screen failure|1|||
48853470|NCT00263757|157302779|FG000|Overall Study|Adverse Event|3|||
48853471|NCT00263757|157302780|FG001|Overall Study|Adverse Event|3|||
48853472|NCT00822900|157302781|FG000|Overall Study|Withdrawal by Subject|14|||
48853473|NCT00822900|157302782|FG001|Overall Study|Withdrawal by Subject|14|||
48853474|NCT00822900|157302781|FG000|Overall Study|Lost to Follow-up|9|||
48853475|NCT00822900|157302782|FG001|Overall Study|Lost to Follow-up|9|||
48853476|NCT00822900|157302781|FG000|Overall Study|Death|83|||
48853477|NCT00822900|157302782|FG001|Overall Study|Death|69|||
48853478|NCT00822900|157302781|FG000|Overall Study|Became a ward of the state|2|||
48853479|NCT00822900|157302782|FG001|Overall Study|Became a ward of the state|1|||
48853480|NCT04248868|157302783|FG000|Overall Study|Death|1|||
48853481|NCT04248868|157302783|FG000|Overall Study|Lost to Follow-up|3|||
48853482|NCT04248868|157302783|FG000|Overall Study|Protocol Violation|2|||
48853483|NCT04660799|157302784|FG000|Overall Study|Progressive Disease|1|||
48853484|NCT04660799|157302785|FG001|Overall Study|Progressive Disease|1|||
48853485|NCT04660799|157302784|FG000|Overall Study|Death|2|||
48853486|NCT04660799|157302785|FG001|Overall Study|Death|1|||
48853487|NCT04660799|157302784|FG000|Overall Study|Adverse Event|2|||
48853488|NCT04660799|157302785|FG001|Overall Study|Adverse Event|1|||
48853489|NCT04660799|157302784|FG000|Overall Study|Withdrawal by Subject|2|||
48853490|NCT04660799|157302785|FG001|Overall Study|Withdrawal by Subject|5|||
48853491|NCT02106884|157302790|FG000|Overall Study|Change of diagnosis/exclusion|0|||
48853492|NCT02106884|157302791|FG001|Overall Study|Change of diagnosis/exclusion|1|||
48853493|NCT00089791|157302792|FG000|Overall Study|Physician Decision|6|||
48853494|NCT00089791|157302793|FG001|Overall Study|Physician Decision|3|||
48853495|NCT00089791|157302792|FG000|Overall Study|Adverse Event|81|||
48853496|NCT00089791|157302793|FG001|Overall Study|Adverse Event|93|||
48853497|NCT00089791|157302792|FG000|Overall Study|Withdrawal by Subject|403|||
48853498|NCT00089791|157302793|FG001|Overall Study|Withdrawal by Subject|344|||
48853499|NCT00089791|157302792|FG000|Overall Study|Death|78|||
48853500|NCT00089791|157302793|FG001|Overall Study|Death|62|||
48853501|NCT00089791|157302792|FG000|Overall Study|Disease progression|7|||
48853502|NCT00089791|157302793|FG001|Overall Study|Disease progression|3|||
48853503|NCT00089791|157302792|FG000|Overall Study|Ineligibility determined|12|||
48853504|NCT00089791|157302793|FG001|Overall Study|Ineligibility determined|9|||
48853505|NCT00089791|157302792|FG000|Overall Study|Lost to Follow-up|57|||
48853506|NCT00089791|157302793|FG001|Overall Study|Lost to Follow-up|57|||
48739207|NCT03342963|156894093|FG000|Overall Study|Adverse Event|1|||
48739208|NCT03342963|156894094|FG001|Overall Study|Adverse Event|2|||
48853507|NCT00089791|157302792|FG000|Overall Study|Noncompliance|17|||
48739209|NCT03342963|156894095|FG002|Overall Study|Adverse Event|0|||
48739210|NCT03342963|156894096|FG003|Overall Study|Adverse Event|0|||
48739211|NCT03342963|156894093|FG000|Overall Study|Withdrawal by Subject|1|||
48739212|NCT03342963|156894094|FG001|Overall Study|Withdrawal by Subject|0|||
48739213|NCT03342963|156894095|FG002|Overall Study|Withdrawal by Subject|0|||
48739214|NCT03342963|156894096|FG003|Overall Study|Withdrawal by Subject|0|||
48739215|NCT02527161|156894097|FG000|Overall Study|Failed MRI|52|||
48739216|NCT02527161|156894097|FG000|Overall Study|Withdrawal by Subject|19|||
48739217|NCT02527161|156894097|FG000|Overall Study|Delay in or unfit for surgery|16|||
48739218|NCT02527161|156894097|FG000|Overall Study|MRI contraindication|6|||
48739219|NCT02527161|156894097|FG000|Overall Study|Consent violation|4|||
48739220|NCT02527161|156894097|FG000|Overall Study|Only Recruited to Part A|27|||
48739221|NCT02527161|156894097|FG000|Overall Study|Physician Decision|1|||
48739222|NCT02527161|156894097|FG000|Overall Study|Adverse Event|1|||
48739223|NCT02527161|156894097|FG000|Overall Study|Lost to Follow-up|6|||
48739224|NCT01330030|156894098|FG000|Overall Study|Lost to Follow-up|16|||
48739225|NCT01330030|156894099|FG001|Overall Study|Lost to Follow-up|17|||
48739226|NCT02248701|156894100|FG000|Overall Study|Withdrawal by Subject|2|||
48739227|NCT02248701|156894101|FG001|Overall Study|Withdrawal by Subject|1|||
48739228|NCT02248701|156894100|FG000|Overall Study|Physician Decision|0|||
48739229|NCT02248701|156894101|FG001|Overall Study|Physician Decision|1|||
48739230|NCT02248701|156894100|FG000|Overall Study|Adverse Event|1|||
48739231|NCT02248701|156894101|FG001|Overall Study|Adverse Event|0|||
48739232|NCT02248701|156894100|FG000|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|1|||
48739233|NCT02248701|156894101|FG001|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|0|||
48739234|NCT00986830|156894102|FG000|Overall Study|Death|1|||
48739235|NCT00986830|156894102|FG000|Overall Study|Lost to Follow-up|1|||
48739236|NCT00986830|156894102|FG000|Overall Study|Lack of Efficacy|1|||
48739237|NCT00986830|156894102|FG000|Overall Study|Unable to access sinus with device|5|||
48739238|NCT05085730|156894103|FG000|Overall Study|Withdrawal by Subject|4|||
48739239|NCT05085730|156894103|FG000|Overall Study|Physician Decision|1|||
48739240|NCT04553679|156894104|FG000|Overall Study|Withdrawal by Subject|2|||
48853508|NCT00089791|157302793|FG001|Overall Study|Noncompliance|13|||
48853509|NCT00089791|157302792|FG000|Overall Study|Other|20|||
48853510|NCT00089791|157302793|FG001|Overall Study|Other|32|||
48739241|NCT04553679|156894105|FG001|Overall Study|Withdrawal by Subject|0|||
48739242|NCT04553679|156894104|FG000|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|0|||
48739243|NCT04553679|156894105|FG001|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|1|||
48739244|NCT01145625|156894106|FG000|Overall Study|Lost to Follow-up|8|||
48739245|NCT01145625|156894107|FG001|Overall Study|Lost to Follow-up|9|||
48739246|NCT01145625|156894106|FG000|Overall Study|Adverse Event|6|||
48739247|NCT01145625|156894107|FG001|Overall Study|Adverse Event|4|||
48739248|NCT01145625|156894106|FG000|Overall Study|Protocol Violation|3|||
48739249|NCT01145625|156894107|FG001|Overall Study|Protocol Violation|1|||
48853511|NCT00089791|157302792|FG000|Overall Study|Protocol deviation|12|||
48853512|NCT00089791|157302793|FG001|Overall Study|Protocol deviation|10|||
48853513|NCT00089791|157302792|FG000|Overall Study|Requirement for alternative therapy|7|||
48739250|NCT01145625|156894106|FG000|Overall Study|Withdrawal by Subject|7|||
48739251|NCT01145625|156894107|FG001|Overall Study|Withdrawal by Subject|16|||
48739252|NCT01145625|156894106|FG000|Overall Study|Pregnancy|0|||
48739253|NCT01145625|156894107|FG001|Overall Study|Pregnancy|1|||
48739254|NCT03945214|156894108|FG000|Overall Study|Lost to Follow-up|3|||
48739255|NCT03945214|156894109|FG001|Overall Study|Lost to Follow-up|4|||
48853514|NCT00089791|157302793|FG001|Overall Study|Requirement for alternative therapy|4|||
48853515|NCT02161458|157302797|FG000|Overall Study|Withdrawal by Subject|0|||
48739256|NCT03945214|156894110|FG002|Overall Study|Lost to Follow-up|7|||
48739257|NCT03945214|156894111|FG003|Overall Study|Lost to Follow-up|4|||
48853516|NCT02161458|157302798|FG001|Overall Study|Withdrawal by Subject|4|||
48853517|NCT02161458|157302799|FG002|Overall Study|Withdrawal by Subject|4|||
48853518|NCT02161458|157302800|FG003|Overall Study|Withdrawal by Subject|0|||
48853519|NCT02161458|157302797|FG000|Overall Study|Lost to Follow-up|0|||
49015345|NCT00673790|157892154|FG002|Overall Study|Sponsor Terminated due to PI oversight|0|||
48853520|NCT02161458|157302798|FG001|Overall Study|Lost to Follow-up|2|||
48853521|NCT02161458|157302799|FG002|Overall Study|Lost to Follow-up|1|||
48853522|NCT02161458|157302800|FG003|Overall Study|Lost to Follow-up|0|||
48853523|NCT02384382|157302803|FG000|Overall Study|Transitioned to study-NCT02960022|5|||
48853524|NCT02384382|157302803|FG000|Overall Study|Death|1|||
48853525|NCT02384382|157302803|FG000|Overall Study|Adverse Event|1|||
48853526|NCT02384382|157302803|FG000|Overall Study|Disease progression|16|||
48853527|NCT02542696|157302804|FG000|Overall Study|Adverse Event|167|||
48853528|NCT02542696|157302804|FG000|Overall Study|Lack of Efficacy|26|||
48853529|NCT02542696|157302804|FG000|Overall Study|Lost to Follow-up|6|||
48853530|NCT02542696|157302804|FG000|Overall Study|Withdrawal by Subject|104|||
48853531|NCT02542696|157302804|FG000|Overall Study|Protocol Violation|5|||
48853532|NCT02542696|157302804|FG000|Overall Study|Death|8|||
48853533|NCT02542696|157302804|FG000|Overall Study|DECREASED OFF TIME|1|||
48853534|NCT02542696|157302804|FG000|Overall Study|DID NOT MEET CRITERIA FOR CONTINUATION|1|||
48853535|NCT02542696|157302804|FG000|Overall Study|ELIGIBILITY CRITERIA NOT MET|8|||
48853536|NCT02542696|157302804|FG000|Overall Study|MEDICAL HISTORY|1|||
48853537|NCT02542696|157302804|FG000|Overall Study|"PATIENT WITHDRAWN DURING TITRATION AS COULD NOT TITRATE DRUG TO GET RESPONSE OF ON FROM PATIENT"|1|||
48853538|NCT02542696|157302804|FG000|Overall Study|PROGRESSION OF PARKINSON'S DISEASE|5|||
48853539|NCT02542696|157302804|FG000|Overall Study|SITE UNABLE TO COMPLY WITH PROTOCOL|2|||
48853540|NCT02542696|157302804|FG000|Overall Study|SPONSOR DECISION|3|||
48853541|NCT02542696|157302804|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|36|||
48853542|NCT02542696|157302804|FG000|Overall Study|SUBJECT DECISION|2|||
48853543|NCT02113449|157302810|FG000|Overall Study|Adverse Event|4|||
48853544|NCT05376397|157302813|FG000|Overall Study|Lost to Follow-up|1|||
48853545|NCT02406092|157302819|FG000|Overall Study|Screen failure|10|||
48853546|NCT02406092|157302820|FG001|Overall Study|Screen failure|7|||
48853547|NCT02406092|157302819|FG000|Overall Study|Death|22|||
48853548|NCT02406092|157302820|FG001|Overall Study|Death|5|||
48853549|NCT02406092|157302819|FG000|Overall Study|Lost to Follow-up|4|||
48853550|NCT02406092|157302820|FG001|Overall Study|Lost to Follow-up|1|||
48853551|NCT02406092|157302819|FG000|Overall Study|Adverse Event|1|||
48853552|NCT02406092|157302820|FG001|Overall Study|Adverse Event|0|||
48853553|NCT02406092|157302819|FG000|Overall Study|Withdrawal by Subject|1|||
48853554|NCT02406092|157302820|FG001|Overall Study|Withdrawal by Subject|0|||
48948424|NCT00430781|157641957|FG002|Final Analysis; 31 July 2008|Lost to Follow-up|3|||
48948425|NCT00430781|157641955|FG000|Final Analysis; 31 July 2008|Protocol Violation|0|||
48948426|NCT00430781|157641956|FG001|Final Analysis; 31 July 2008|Protocol Violation|1|||
48948427|NCT00430781|157641957|FG002|Final Analysis; 31 July 2008|Protocol Violation|0|||
48948428|NCT00430781|157641955|FG000|Final Analysis; 31 July 2008|Withdrawal by Subject|0|||
48948429|NCT00430781|157641956|FG001|Final Analysis; 31 July 2008|Withdrawal by Subject|2|||
48948430|NCT00430781|157641957|FG002|Final Analysis; 31 July 2008|Withdrawal by Subject|7|||
48948431|NCT00430781|157641955|FG000|Final Analysis; 31 July 2008|Physician Decision|0|||
48948432|NCT00430781|157641956|FG001|Final Analysis; 31 July 2008|Physician Decision|6|||
48948433|NCT00430781|157641957|FG002|Final Analysis; 31 July 2008|Physician Decision|6|||
48948434|NCT00430781|157641955|FG000|Final Analysis; 31 July 2008|Other|0|||
48948435|NCT00430781|157641956|FG001|Final Analysis; 31 July 2008|Other|1|||
48948436|NCT00430781|157641957|FG002|Final Analysis; 31 July 2008|Other|0|||
48948437|NCT00430781|157641955|FG000|Final Analysis; 31 July 2008|Ongoing|0|||
48948438|NCT00430781|157641956|FG001|Final Analysis; 31 July 2008|Ongoing|29|||
48853555|NCT01218009|157302821|FG000|Overall Study|Protocol Violation|2|||
48853556|NCT01218009|157302822|FG001|Overall Study|Protocol Violation|1|||
48948439|NCT00430781|157641957|FG002|Final Analysis; 31 July 2008|Ongoing|32|||
48948440|NCT00430781|157641955|FG000|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5|||
48948441|NCT00430781|157641956|FG001|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
48948442|NCT00430781|157641957|FG002|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
48948443|NCT00430781|157641955|FG000|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
48948444|NCT00430781|157641956|FG001|End-of-Study Analysis; 28 July 2011|Protocol Violation|1|||
48948445|NCT00430781|157641957|FG002|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
48948446|NCT00430781|157641955|FG000|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
48853557|NCT01218009|157302821|FG000|Overall Study|Withdrawal by Subject|3|||
48853558|NCT01218009|157302822|FG001|Overall Study|Withdrawal by Subject|1|||
48853559|NCT01218009|157302821|FG000|Overall Study|Sponsor terminated study|161|||
48853560|NCT01218009|157302822|FG001|Overall Study|Sponsor terminated study|163|||
48853561|NCT00109031|157302823|FG000|Overall Study|Adverse Event|0|||
48853562|NCT00109031|157302824|FG001|Overall Study|Adverse Event|0|||
48948447|NCT00430781|157641956|FG001|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2|||
48948448|NCT00430781|157641957|FG002|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
48853563|NCT00109031|157302825|FG002|Overall Study|Adverse Event|1|||
48948449|NCT00430781|157641955|FG000|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
48948450|NCT00430781|157641956|FG001|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5|||
48948451|NCT00430781|157641957|FG002|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
48948452|NCT00430781|157641955|FG000|End-of-Study Analysis; 28 July 2011|Physician Decision|4|||
48948453|NCT00430781|157641956|FG001|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
48948454|NCT00430781|157641957|FG002|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
48948455|NCT00430781|157641955|FG000|End-of-Study Analysis; 28 July 2011|Other|4|||
48948456|NCT00430781|157641956|FG001|End-of-Study Analysis; 28 July 2011|Other|1|||
48948457|NCT00430781|157641957|FG002|End-of-Study Analysis; 28 July 2011|Other|0|||
48948458|NCT00882713|157641958|FG000|Overall Study|Adverse Event|2|||
48948459|NCT00882713|157641958|FG000|Overall Study|Death|3|||
48948460|NCT00882713|157641958|FG000|Overall Study|Administrative reasons|4|||
48948461|NCT00882713|157641958|FG000|Overall Study|refused treatment/withdrew consent|4|||
48948462|NCT00882713|157641958|FG000|Overall Study|Blood transfusion|2|||
48948463|NCT00882713|157641958|FG000|Overall Study|Insufficient therapeutic response|3|||
48948464|NCT00882713|157641958|FG000|Overall Study|Failure to return|2|||
48739258|NCT02980783|156894112|FG000|Overall Study|Lost to Follow-up|1|||
48739259|NCT00880542|156894113|FG000|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1|||
48739260|NCT00880542|156894113|FG000|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2|||
48739261|NCT00880542|156894113|FG000|REP: Surgical Resection|progressive disease|1|||
48739262|NCT01522248|156894116|FG000|Overall Study|Lost to Follow-up|1|||
48739263|NCT01522248|156894117|FG001|Overall Study|Lost to Follow-up|0|||
48739264|NCT03719586|156894118|FG000|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8|||
48739265|NCT03719586|156894119|FG001|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7|||
48948465|NCT00882713|157641958|FG000|Overall Study|Other - Reasons|2|||
48948466|NCT02760602|157641959|FG000|Overall Study|Withdrawal by Subject|1|||
48948467|NCT02760602|157641960|FG001|Overall Study|Withdrawal by Subject|0|||
48948468|NCT02760602|157641959|FG000|Overall Study|Terminated by sponsor|12|||
48948469|NCT02760602|157641960|FG001|Overall Study|Terminated by sponsor|13|||
48948470|NCT04275310|157641966|FG000|Overall Study|Non-randomized due to running out of funding|4|||
48948471|NCT04275310|157641967|FG001|Overall Study|Non-randomized due to running out of funding|0|||
48948472|NCT03088605|157641972|FG000|Overall Study|Withdrawal by Subject|1|||
48948473|NCT03088605|157641973|FG001|Overall Study|Withdrawal by Subject|0|||
48948474|NCT02345161|157641974|FG000|Overall Study|Withdrawal by Subject|25|||
48948475|NCT02345161|157641975|FG001|Overall Study|Withdrawal by Subject|33|||
48948476|NCT02345161|157641974|FG000|Overall Study|Adverse Event|16|||
48948477|NCT02345161|157641975|FG001|Overall Study|Adverse Event|19|||
48948478|NCT02345161|157641974|FG000|Overall Study|Physician Decision|4|||
48948479|NCT02345161|157641975|FG001|Overall Study|Physician Decision|4|||
48948480|NCT02345161|157641974|FG000|Overall Study|Lost to Follow-up|0|||
48948481|NCT02345161|157641975|FG001|Overall Study|Lost to Follow-up|1|||
48948482|NCT02037919|157641976|FG000|Overall Study|Lost to Follow-up|30|||
48948483|NCT02037919|157641977|FG001|Overall Study|Lost to Follow-up|45|||
48948484|NCT00090285|157641987|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|7|||
48948485|NCT00090285|157641988|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|3|||
48948486|NCT00090285|157641989|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
48948487|NCT00090285|157641990|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
48948488|NCT00090285|157641991|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
48948489|NCT00090285|157641992|FG005|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
48948490|NCT00090285|157641987|FG000|Base Study Vaccination Period|Adverse Event|2|||
48948491|NCT00090285|157641988|FG001|Base Study Vaccination Period|Adverse Event|4|||
48948492|NCT00090285|157641989|FG002|Base Study Vaccination Period|Adverse Event|0|||
48948493|NCT00090285|157641990|FG003|Base Study Vaccination Period|Adverse Event|0|||
48948494|NCT00090285|157641991|FG004|Base Study Vaccination Period|Adverse Event|0|||
48948495|NCT00090285|157641992|FG005|Base Study Vaccination Period|Adverse Event|0|||
48948496|NCT00090285|157641987|FG000|Base Study Vaccination Period|Lost to Follow-up|111|||
48948497|NCT00090285|157641988|FG001|Base Study Vaccination Period|Lost to Follow-up|112|||
48948498|NCT00090285|157641989|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
48948499|NCT00090285|157641990|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
48948500|NCT00090285|157641991|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
48948501|NCT00090285|157641992|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
48948502|NCT00090285|157641987|FG000|Base Study Vaccination Period|Protocol Violation|2|||
48948503|NCT00090285|157641988|FG001|Base Study Vaccination Period|Protocol Violation|3|||
48853564|NCT00109031|157302826|FG003|Overall Study|Adverse Event|0|||
48853565|NCT00109031|157302823|FG000|Overall Study|Withdrawal by Subject|0|||
48948504|NCT00090285|157641989|FG002|Base Study Vaccination Period|Protocol Violation|0|||
48853566|NCT00109031|157302824|FG001|Overall Study|Withdrawal by Subject|1|||
48853567|NCT00109031|157302825|FG002|Overall Study|Withdrawal by Subject|0|||
48853568|NCT00109031|157302826|FG003|Overall Study|Withdrawal by Subject|0|||
48853569|NCT00109031|157302823|FG000|Overall Study|Physician Decision|0|||
48853570|NCT00109031|157302824|FG001|Overall Study|Physician Decision|1|||
48853571|NCT00109031|157302825|FG002|Overall Study|Physician Decision|0|||
48853572|NCT00109031|157302826|FG003|Overall Study|Physician Decision|0|||
48853573|NCT00109031|157302823|FG000|Overall Study|Protocol Violation|0|||
48853574|NCT00109031|157302824|FG001|Overall Study|Protocol Violation|0|||
48853575|NCT00109031|157302825|FG002|Overall Study|Protocol Violation|1|||
48853576|NCT00109031|157302826|FG003|Overall Study|Protocol Violation|0|||
48853577|NCT01801007|157302833|FG000|Overall Study|Adverse Event|2|||
48948505|NCT00090285|157641990|FG003|Base Study Vaccination Period|Protocol Violation|0|||
48948506|NCT00090285|157641991|FG004|Base Study Vaccination Period|Protocol Violation|0|||
48948507|NCT00090285|157641992|FG005|Base Study Vaccination Period|Protocol Violation|0|||
48948508|NCT00090285|157641987|FG000|Base Study Vaccination Period|Withdrawal by Subject|64|||
48948509|NCT00090285|157641988|FG001|Base Study Vaccination Period|Withdrawal by Subject|69|||
48948510|NCT00090285|157641989|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
48948511|NCT00090285|157641990|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
48948512|NCT00090285|157641991|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
48948513|NCT00090285|157641992|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
48948514|NCT00090285|157641987|FG000|Base Study Vaccination Period|Uncooperative|2|||
48948515|NCT00090285|157641988|FG001|Base Study Vaccination Period|Uncooperative|2|||
48948516|NCT00090285|157641989|FG002|Base Study Vaccination Period|Uncooperative|0|||
48948517|NCT00090285|157641990|FG003|Base Study Vaccination Period|Uncooperative|0|||
48948518|NCT00090285|157641991|FG004|Base Study Vaccination Period|Uncooperative|0|||
48948519|NCT00090285|157641992|FG005|Base Study Vaccination Period|Uncooperative|0|||
48948520|NCT00090285|157641987|FG000|Base Study Vaccination Period|Moved|20|||
48948521|NCT00090285|157641988|FG001|Base Study Vaccination Period|Moved|21|||
48948522|NCT00090285|157641989|FG002|Base Study Vaccination Period|Moved|0|||
48948523|NCT00090285|157641990|FG003|Base Study Vaccination Period|Moved|0|||
48948524|NCT00090285|157641991|FG004|Base Study Vaccination Period|Moved|0|||
48948525|NCT00090285|157641992|FG005|Base Study Vaccination Period|Moved|0|||
48948526|NCT00090285|157641987|FG000|Base Study Vaccination Period|Site Terminated|1|||
48948527|NCT00090285|157641988|FG001|Base Study Vaccination Period|Site Terminated|0|||
48948528|NCT00090285|157641989|FG002|Base Study Vaccination Period|Site Terminated|0|||
48948529|NCT00090285|157641990|FG003|Base Study Vaccination Period|Site Terminated|0|||
48948530|NCT00090285|157641991|FG004|Base Study Vaccination Period|Site Terminated|0|||
48948531|NCT00090285|157641992|FG005|Base Study Vaccination Period|Site Terminated|0|||
48948532|NCT00090285|157641987|FG000|Base Study Vaccination Period|Other|2|||
48948533|NCT00090285|157641988|FG001|Base Study Vaccination Period|Other|2|||
48948534|NCT00090285|157641989|FG002|Base Study Vaccination Period|Other|0|||
48948535|NCT00090285|157641990|FG003|Base Study Vaccination Period|Other|0|||
48948536|NCT00090285|157641991|FG004|Base Study Vaccination Period|Other|0|||
48948537|NCT00090285|157641992|FG005|Base Study Vaccination Period|Other|0|||
48948538|NCT00090285|157641987|FG000|Base Study Vaccination Period|Subject Incarcerated|2|||
48948539|NCT00090285|157641988|FG001|Base Study Vaccination Period|Subject Incarcerated|2|||
48948540|NCT00090285|157641989|FG002|Base Study Vaccination Period|Subject Incarcerated|0|||
48948541|NCT00090285|157641990|FG003|Base Study Vaccination Period|Subject Incarcerated|0|||
48948542|NCT00090285|157641991|FG004|Base Study Vaccination Period|Subject Incarcerated|0|||
48948543|NCT00090285|157641992|FG005|Base Study Vaccination Period|Subject Incarcerated|0|||
48948544|NCT00090285|157641987|FG000|Base Study Vaccination Period|HIV positive|1|||
48948545|NCT00090285|157641988|FG001|Base Study Vaccination Period|HIV positive|1|||
48948546|NCT00090285|157641989|FG002|Base Study Vaccination Period|HIV positive|0|||
48948547|NCT00090285|157641990|FG003|Base Study Vaccination Period|HIV positive|0|||
48948548|NCT00090285|157641991|FG004|Base Study Vaccination Period|HIV positive|0|||
48948549|NCT00090285|157641992|FG005|Base Study Vaccination Period|HIV positive|0|||
48948550|NCT00090285|157641987|FG000|Base Study Follow-up Period|Adverse Event|3|||
48948551|NCT00090285|157641988|FG001|Base Study Follow-up Period|Adverse Event|10|||
48948552|NCT00090285|157641989|FG002|Base Study Follow-up Period|Adverse Event|0|||
48948553|NCT00090285|157641990|FG003|Base Study Follow-up Period|Adverse Event|0|||
48948554|NCT00090285|157641991|FG004|Base Study Follow-up Period|Adverse Event|0|||
48948555|NCT00090285|157641992|FG005|Base Study Follow-up Period|Adverse Event|0|||
48948556|NCT00090285|157641987|FG000|Base Study Follow-up Period|Lost to Follow-up|232|||
48948557|NCT00090285|157641988|FG001|Base Study Follow-up Period|Lost to Follow-up|226|||
48948558|NCT00090285|157641989|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
48948559|NCT00090285|157641990|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
48948560|NCT00090285|157641991|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
48948561|NCT00090285|157641992|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
48948562|NCT00090285|157641987|FG000|Base Study Follow-up Period|Withdrawal by Subject|53|||
48948563|NCT00090285|157641988|FG001|Base Study Follow-up Period|Withdrawal by Subject|64|||
48948564|NCT00090285|157641989|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
48948565|NCT00090285|157641990|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
48948566|NCT00090285|157641991|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
48948567|NCT00090285|157641992|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
48948568|NCT00090285|157641987|FG000|Base Study Follow-up Period|Moved|41|||
48948569|NCT00090285|157641988|FG001|Base Study Follow-up Period|Moved|36|||
48948570|NCT00090285|157641989|FG002|Base Study Follow-up Period|Moved|0|||
48948571|NCT00090285|157641990|FG003|Base Study Follow-up Period|Moved|0|||
48948572|NCT00090285|157641991|FG004|Base Study Follow-up Period|Moved|0|||
48948573|NCT00090285|157641992|FG005|Base Study Follow-up Period|Moved|0|||
48948574|NCT00090285|157641987|FG000|Base Study Follow-up Period|Other|2|||
48948575|NCT00090285|157641988|FG001|Base Study Follow-up Period|Other|0|||
48948576|NCT00090285|157641989|FG002|Base Study Follow-up Period|Other|0|||
48948577|NCT00090285|157641990|FG003|Base Study Follow-up Period|Other|0|||
48948578|NCT00090285|157641991|FG004|Base Study Follow-up Period|Other|0|||
48948579|NCT00090285|157641992|FG005|Base Study Follow-up Period|Other|0|||
48948580|NCT00090285|157641987|FG000|Base Study Follow-up Period|Protocol Violation|1|||
48948581|NCT00090285|157641988|FG001|Base Study Follow-up Period|Protocol Violation|0|||
48948582|NCT00090285|157641989|FG002|Base Study Follow-up Period|Protocol Violation|0|||
48948583|NCT00090285|157641990|FG003|Base Study Follow-up Period|Protocol Violation|0|||
48948584|NCT00090285|157641991|FG004|Base Study Follow-up Period|Protocol Violation|0|||
48948585|NCT00090285|157641992|FG005|Base Study Follow-up Period|Protocol Violation|0|||
48948586|NCT00090285|157641987|FG000|Base Study Follow-up Period|Uncooperative|3|||
48948587|NCT00090285|157641988|FG001|Base Study Follow-up Period|Uncooperative|4|||
48948588|NCT00090285|157641989|FG002|Base Study Follow-up Period|Uncooperative|0|||
48948589|NCT00090285|157641990|FG003|Base Study Follow-up Period|Uncooperative|0|||
48948590|NCT00090285|157641991|FG004|Base Study Follow-up Period|Uncooperative|0|||
48948591|NCT00090285|157641992|FG005|Base Study Follow-up Period|Uncooperative|0|||
48948592|NCT00090285|157641987|FG000|Base Study Follow-up Period|Subject Incarcerated|0|||
48948593|NCT00090285|157641988|FG001|Base Study Follow-up Period|Subject Incarcerated|2|||
48948594|NCT00090285|157641989|FG002|Base Study Follow-up Period|Subject Incarcerated|0|||
48948595|NCT00090285|157641990|FG003|Base Study Follow-up Period|Subject Incarcerated|0|||
48948596|NCT00090285|157641991|FG004|Base Study Follow-up Period|Subject Incarcerated|0|||
48948597|NCT00090285|157641992|FG005|Base Study Follow-up Period|Subject Incarcerated|0|||
48948598|NCT00090285|157641987|FG000|Extension 1|Adverse Event|0|||
48948599|NCT00090285|157641988|FG001|Extension 1|Adverse Event|0|||
48948600|NCT00090285|157641989|FG002|Extension 1|Adverse Event|2|||
48948601|NCT00090285|157641990|FG003|Extension 1|Adverse Event|0|||
48948602|NCT00090285|157641991|FG004|Extension 1|Adverse Event|0|||
48948603|NCT00090285|157641992|FG005|Extension 1|Adverse Event|0|||
48948604|NCT00090285|157641987|FG000|Extension 1|Lost to Follow-up|0|||
48948605|NCT00090285|157641988|FG001|Extension 1|Lost to Follow-up|0|||
48948606|NCT00090285|157641989|FG002|Extension 1|Lost to Follow-up|35|||
48948607|NCT00090285|157641990|FG003|Extension 1|Lost to Follow-up|0|||
48948608|NCT00090285|157641991|FG004|Extension 1|Lost to Follow-up|0|||
48948609|NCT00090285|157641992|FG005|Extension 1|Lost to Follow-up|0|||
48948610|NCT00090285|157641987|FG000|Extension 1|Withdrawal by Subject|0|||
48948611|NCT00090285|157641988|FG001|Extension 1|Withdrawal by Subject|0|||
48948612|NCT00090285|157641989|FG002|Extension 1|Withdrawal by Subject|13|||
48948613|NCT00090285|157641990|FG003|Extension 1|Withdrawal by Subject|1|||
48948614|NCT00090285|157641991|FG004|Extension 1|Withdrawal by Subject|0|||
48948615|NCT00090285|157641992|FG005|Extension 1|Withdrawal by Subject|0|||
48948616|NCT00090285|157641987|FG000|Extension 1|Other|0|||
48948617|NCT00090285|157641988|FG001|Extension 1|Other|0|||
48948618|NCT00090285|157641989|FG002|Extension 1|Other|4|||
48948619|NCT00090285|157641990|FG003|Extension 1|Other|0|||
48948620|NCT00090285|157641991|FG004|Extension 1|Other|0|||
48948621|NCT00090285|157641992|FG005|Extension 1|Other|0|||
48948622|NCT00090285|157641987|FG000|Extension 1|Moved|0|||
48948623|NCT00090285|157641988|FG001|Extension 1|Moved|0|||
48948624|NCT00090285|157641989|FG002|Extension 1|Moved|3|||
48948625|NCT00090285|157641990|FG003|Extension 1|Moved|0|||
48948626|NCT00090285|157641991|FG004|Extension 1|Moved|0|||
48948627|NCT00090285|157641992|FG005|Extension 1|Moved|0|||
48948628|NCT00090285|157641987|FG000|Long-term Follow-up (EXT2)|Adverse Event|0|||
48948629|NCT00090285|157641988|FG001|Long-term Follow-up (EXT2)|Adverse Event|0|||
48948630|NCT00090285|157641989|FG002|Long-term Follow-up (EXT2)|Adverse Event|0|||
48948631|NCT00090285|157641990|FG003|Long-term Follow-up (EXT2)|Adverse Event|0|||
48948632|NCT00090285|157641991|FG004|Long-term Follow-up (EXT2)|Adverse Event|5|||
48948633|NCT00090285|157641992|FG005|Long-term Follow-up (EXT2)|Adverse Event|2|||
48948634|NCT00090285|157641987|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
48948635|NCT00090285|157641988|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
48948636|NCT00090285|157641989|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
48948637|NCT00090285|157641990|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
48948638|NCT00090285|157641991|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|156|||
48948639|NCT00090285|157641992|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|143|||
48948640|NCT00090285|157641987|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
48948641|NCT00090285|157641988|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
48948642|NCT00090285|157641989|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
48948643|NCT00090285|157641990|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
48948644|NCT00090285|157641991|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|60|||
48948645|NCT00090285|157641992|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|53|||
48948646|NCT00090285|157641987|FG000|Long-term Follow-up (EXT2)|Physician Decision|0|||
48948647|NCT00090285|157641988|FG001|Long-term Follow-up (EXT2)|Physician Decision|0|||
48948648|NCT00090285|157641989|FG002|Long-term Follow-up (EXT2)|Physician Decision|0|||
48948649|NCT00090285|157641990|FG003|Long-term Follow-up (EXT2)|Physician Decision|0|||
48948650|NCT00090285|157641991|FG004|Long-term Follow-up (EXT2)|Physician Decision|6|||
48948651|NCT00090285|157641992|FG005|Long-term Follow-up (EXT2)|Physician Decision|5|||
48948652|NCT01458340|157641993|FG000|Overall Study|Adverse Event|5|||
48948653|NCT01458340|157641994|FG001|Overall Study|Adverse Event|4|||
48948654|NCT01458340|157641995|FG002|Overall Study|Adverse Event|2|||
48948655|NCT01458340|157641993|FG000|Overall Study|Lost to Follow-up|3|||
48948656|NCT01458340|157641994|FG001|Overall Study|Lost to Follow-up|3|||
48948657|NCT01458340|157641995|FG002|Overall Study|Lost to Follow-up|10|||
48948658|NCT01458340|157641993|FG000|Overall Study|Miscellaneous|0|||
48948659|NCT01458340|157641994|FG001|Overall Study|Miscellaneous|1|||
48948660|NCT01458340|157641995|FG002|Overall Study|Miscellaneous|0|||
48948661|NCT01458340|157641993|FG000|Overall Study|Physician Decision|1|||
48948662|NCT01458340|157641994|FG001|Overall Study|Physician Decision|1|||
48948663|NCT01458340|157641995|FG002|Overall Study|Physician Decision|2|||
48948664|NCT01458340|157641993|FG000|Overall Study|Protocol Violation|6|||
48948665|NCT01458340|157641994|FG001|Overall Study|Protocol Violation|6|||
48948666|NCT01458340|157641995|FG002|Overall Study|Protocol Violation|5|||
48948667|NCT01458340|157641993|FG000|Overall Study|Withdrawal by Subject|12|||
48948668|NCT01458340|157641994|FG001|Overall Study|Withdrawal by Subject|6|||
48948669|NCT01458340|157641995|FG002|Overall Study|Withdrawal by Subject|4|||
48948670|NCT02046564|157641996|FG000|Overall Study|Adverse Event|6|||
48948671|NCT02046564|157641997|FG001|Overall Study|Adverse Event|3|||
48948672|NCT02046564|157641996|FG000|Overall Study|Physician Decision|0|||
48948673|NCT02046564|157641997|FG001|Overall Study|Physician Decision|1|||
48948674|NCT02046564|157641996|FG000|Overall Study|Protocol Violation|3|||
48948675|NCT02046564|157641997|FG001|Overall Study|Protocol Violation|1|||
48948676|NCT02046564|157641996|FG000|Overall Study|Withdrawal by Subject|4|||
48948677|NCT02046564|157641997|FG001|Overall Study|Withdrawal by Subject|10|||
48948678|NCT02046564|157641996|FG000|Overall Study|Subject met withdrawal criteria|2|||
48948679|NCT02046564|157641997|FG001|Overall Study|Subject met withdrawal criteria|5|||
48948680|NCT03700892|157642007|FG000|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
48948681|NCT03700892|157642008|FG001|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1|||
48948682|NCT03700892|157642009|FG002|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
48948683|NCT03849560|157642013|FG000|Overall Study|Withdrawal by Subject|1|||
48948684|NCT03849560|157642014|FG001|Overall Study|Withdrawal by Subject|0|||
48948685|NCT03849560|157642015|FG002|Overall Study|Withdrawal by Subject|0|||
48948686|NCT04651777|157642016|FG000|Overall Study|Adverse Event|1|||
48948687|NCT04651777|157642016|FG000|Overall Study|Withdrawal by Subject|2|||
48948688|NCT00184054|157642019|FG000|Overall Study|Adverse Event|1|||
48948689|NCT00450866|157642027|FG000|Overall Study|Adverse Event|0|||
48948690|NCT00450866|157642028|FG001|Overall Study|Adverse Event|1|||
48948691|NCT00450866|157642027|FG000|Overall Study|Withdrawal by Subject|5|||
48948692|NCT00450866|157642028|FG001|Overall Study|Withdrawal by Subject|2|||
48948693|NCT00450866|157642027|FG000|Overall Study|Death|1|||
48948694|NCT00450866|157642028|FG001|Overall Study|Death|0|||
48948695|NCT00450866|157642027|FG000|Overall Study|Physician Decision|1|||
48948696|NCT00450866|157642028|FG001|Overall Study|Physician Decision|0|||
48948697|NCT02795767|157642032|FG000|Overall Study|Received Commercial Emicizumab|1|||
48948698|NCT02795767|157642033|FG001|Overall Study|Received Commercial Emicizumab|0|||
48948699|NCT02795767|157642034|FG002|Overall Study|Received Commercial Emicizumab|0|||
48948700|NCT00872898|157642042|FG000|Part Two - Double Blind|Adverse Event|4|||
48948701|NCT00872898|157642043|FG001|Part Two - Double Blind|Adverse Event|3|||
48948702|NCT00872898|157642042|FG000|Part Two - Double Blind|Lack of Efficacy|1|||
48948703|NCT00872898|157642043|FG001|Part Two - Double Blind|Lack of Efficacy|0|||
48948704|NCT00872898|157642042|FG000|Part Two - Double Blind|Protocol Violation|1|||
48948705|NCT00872898|157642043|FG001|Part Two - Double Blind|Protocol Violation|0|||
48948706|NCT00872898|157642042|FG000|Part Two - Double Blind|Withdrawal by Subject|3|||
48948707|NCT00872898|157642043|FG001|Part Two - Double Blind|Withdrawal by Subject|1|||
48948708|NCT00872898|157642042|FG000|Part Two - Double Blind|Lost to Follow-up|0|||
48948709|NCT00872898|157642043|FG001|Part Two - Double Blind|Lost to Follow-up|2|||
48948710|NCT00872898|157642042|FG000|Part Two - Double Blind|Other reasons|2|||
48948711|NCT00872898|157642043|FG001|Part Two - Double Blind|Other reasons|0|||
48948712|NCT01927562|157642044|FG000|Overall Study|Lost to Follow-up|30|||
48948713|NCT01927562|157642044|FG000|Overall Study|Withdrawal by Subject|3|||
48948714|NCT01927562|157642044|FG000|Overall Study|Physician Decision|5|||
48948715|NCT00492921|157642045|FG000|Overall Study|Death|1|||
48948716|NCT00492921|157642046|FG001|Overall Study|Death|0|||
48948717|NCT00492921|157642047|FG002|Overall Study|Death|1|||
48948718|NCT00542815|157642048|FG000|Overall Study|Adverse Event|19|||
48948719|NCT00542815|157642049|FG001|Overall Study|Adverse Event|6|||
48948720|NCT00542815|157642050|FG002|Overall Study|Adverse Event|9|||
48948721|NCT00542815|157642048|FG000|Overall Study|Death|10|||
48948722|NCT00542815|157642049|FG001|Overall Study|Death|7|||
48948723|NCT00542815|157642050|FG002|Overall Study|Death|3|||
48948724|NCT00542815|157642048|FG000|Overall Study|Lack of Efficacy|9|||
48948725|NCT00542815|157642049|FG001|Overall Study|Lack of Efficacy|2|||
48948726|NCT00542815|157642050|FG002|Overall Study|Lack of Efficacy|0|||
48948727|NCT00542815|157642048|FG000|Overall Study|Physician Decision|2|||
48739266|NCT03719586|156894120|FG002|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4|||
48739267|NCT03719586|156894121|FG003|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0|||
48739268|NCT02747875|156894122|FG000|Overall Study|Physician Decision|1|||
48739269|NCT02747875|156894123|FG001|Overall Study|Physician Decision|0|||
48948728|NCT00542815|157642049|FG001|Overall Study|Physician Decision|1|||
48739270|NCT02747875|156894122|FG000|Overall Study|Adverse Event|0|||
48948729|NCT00542815|157642050|FG002|Overall Study|Physician Decision|0|||
48948730|NCT00542815|157642048|FG000|Overall Study|Protocol Violation|1|||
48948731|NCT00542815|157642049|FG001|Overall Study|Protocol Violation|1|||
48948732|NCT00542815|157642050|FG002|Overall Study|Protocol Violation|2|||
48948733|NCT00542815|157642048|FG000|Overall Study|Withdrawal by Subject|41|||
48948734|NCT00542815|157642049|FG001|Overall Study|Withdrawal by Subject|5|||
48948735|NCT00542815|157642050|FG002|Overall Study|Withdrawal by Subject|8|||
48948736|NCT00542815|157642048|FG000|Overall Study|Other reasons|24|||
48948737|NCT00542815|157642049|FG001|Overall Study|Other reasons|10|||
48948738|NCT00542815|157642050|FG002|Overall Study|Other reasons|10|||
48948739|NCT00652093|157642051|FG000|Overall Study|Withdrawal by Subject|0|||
48948740|NCT00652093|157642052|FG001|Overall Study|Withdrawal by Subject|0|||
48948741|NCT00652093|157642053|FG002|Overall Study|Withdrawal by Subject|1|||
48948742|NCT00652093|157642054|FG003|Overall Study|Withdrawal by Subject|0|||
48948743|NCT00652093|157642055|FG004|Overall Study|Withdrawal by Subject|1|||
48948744|NCT00652093|157642056|FG005|Overall Study|Withdrawal by Subject|0|||
48948745|NCT00652093|157642051|FG000|Overall Study|Physician Decision|0|||
48948746|NCT00652093|157642052|FG001|Overall Study|Physician Decision|0|||
48948747|NCT00652093|157642053|FG002|Overall Study|Physician Decision|0|||
48948748|NCT00652093|157642054|FG003|Overall Study|Physician Decision|0|||
48948749|NCT00652093|157642055|FG004|Overall Study|Physician Decision|1|||
48948750|NCT00652093|157642056|FG005|Overall Study|Physician Decision|0|||
48948751|NCT01520922|157642057|FG000|Treatment Phase|Physician Decision|2|||
48948752|NCT01520922|157642058|FG001|Treatment Phase|Physician Decision|1|||
48948753|NCT01520922|157642057|FG000|Treatment Phase|Progression|0|||
48948754|NCT01520922|157642058|FG001|Treatment Phase|Progression|2|||
48948755|NCT01520922|157642057|FG000|Treatment Phase|Adverse Event|3|||
48948756|NCT01520922|157642058|FG001|Treatment Phase|Adverse Event|5|||
48948757|NCT01520922|157642057|FG000|Follow up|Lost to Follow-up|0|||
48948758|NCT01520922|157642058|FG001|Follow up|Lost to Follow-up|1|||
48948759|NCT01520922|157642057|FG000|Survival Follow-up|Withdrawal by Subject|1|||
48948760|NCT01520922|157642058|FG001|Survival Follow-up|Withdrawal by Subject|0|||
48948761|NCT01696877|157642060|FG000|Overall Study|Adverse Event|0|||
48948762|NCT01696877|157642061|FG001|Overall Study|Adverse Event|1|||
48948763|NCT01721369|157642062|FG000|Overall Study|Not initial etiological diagnosis|12|||
48948764|NCT01899144|157642065|FG000|Treatment Period 2|Other|1|||
48948765|NCT01899144|157642065|FG000|Treatment Period 3|Other|2|||
48948766|NCT01899144|157642065|FG000|Treatment Period 5|Other|1|||
48948767|NCT00866294|157642069|FG000|Overall Study|Adverse Event|12|||
48948768|NCT00866294|157642070|FG001|Overall Study|Adverse Event|13|||
48948769|NCT00866294|157642071|FG002|Overall Study|Adverse Event|9|||
48948770|NCT00866294|157642069|FG000|Overall Study|Lack of Efficacy|7|||
48948771|NCT00866294|157642070|FG001|Overall Study|Lack of Efficacy|1|||
48948772|NCT00866294|157642071|FG002|Overall Study|Lack of Efficacy|0|||
48948773|NCT00866294|157642069|FG000|Overall Study|Protocol Violation|2|||
48948774|NCT00866294|157642070|FG001|Overall Study|Protocol Violation|0|||
48948775|NCT00866294|157642071|FG002|Overall Study|Protocol Violation|0|||
48948776|NCT00866294|157642069|FG000|Overall Study|Met Protocol-defined Stopping Criteria|5|||
48948777|NCT00866294|157642070|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
48948778|NCT00866294|157642071|FG002|Overall Study|Met Protocol-defined Stopping Criteria|1|||
48948779|NCT00866294|157642069|FG000|Overall Study|Lost to Follow-up|1|||
48948780|NCT00866294|157642070|FG001|Overall Study|Lost to Follow-up|3|||
48948781|NCT00866294|157642071|FG002|Overall Study|Lost to Follow-up|0|||
48948782|NCT00866294|157642069|FG000|Overall Study|Physician Decision|6|||
48948783|NCT00866294|157642070|FG001|Overall Study|Physician Decision|2|||
48948784|NCT00866294|157642071|FG002|Overall Study|Physician Decision|1|||
48948785|NCT00616239|157642072|FG000|Overall Study|Withdrawal by Subject|2|||
48948786|NCT01052012|157642073|FG000|Overall Study|Not treated|2|||
48948787|NCT01052012|157642074|FG001|Overall Study|Not treated|5|||
48948788|NCT01052012|157642075|FG002|Overall Study|Not treated|0|||
48948789|NCT01052012|157642076|FG003|Overall Study|Not treated|0|||
48948790|NCT01052012|157642077|FG004|Overall Study|Not treated|11|||
48948791|NCT01052012|157642078|FG005|Overall Study|Not treated|8|||
48948792|NCT01052012|157642073|FG000|Overall Study|Adverse Event|1|||
48948793|NCT01052012|157642074|FG001|Overall Study|Adverse Event|0|||
48948794|NCT01052012|157642075|FG002|Overall Study|Adverse Event|0|||
48948795|NCT01052012|157642076|FG003|Overall Study|Adverse Event|1|||
48948796|NCT01052012|157642077|FG004|Overall Study|Adverse Event|0|||
48948797|NCT01052012|157642078|FG005|Overall Study|Adverse Event|0|||
48948798|NCT01052012|157642073|FG000|Overall Study|Lost to Follow-up|0|||
48948799|NCT01052012|157642074|FG001|Overall Study|Lost to Follow-up|0|||
48948800|NCT01052012|157642075|FG002|Overall Study|Lost to Follow-up|0|||
48948801|NCT01052012|157642076|FG003|Overall Study|Lost to Follow-up|0|||
48948802|NCT01052012|157642077|FG004|Overall Study|Lost to Follow-up|1|||
48948803|NCT01052012|157642078|FG005|Overall Study|Lost to Follow-up|0|||
48948804|NCT01052012|157642073|FG000|Overall Study|Withdrawal by Subject|1|||
48948805|NCT01052012|157642074|FG001|Overall Study|Withdrawal by Subject|1|||
48948806|NCT01052012|157642075|FG002|Overall Study|Withdrawal by Subject|0|||
48948807|NCT01052012|157642076|FG003|Overall Study|Withdrawal by Subject|0|||
48948808|NCT01052012|157642077|FG004|Overall Study|Withdrawal by Subject|3|||
48948809|NCT01052012|157642078|FG005|Overall Study|Withdrawal by Subject|1|||
48948810|NCT01052012|157642073|FG000|Overall Study|Physician Decision|0|||
48948811|NCT01052012|157642074|FG001|Overall Study|Physician Decision|0|||
48948812|NCT01052012|157642075|FG002|Overall Study|Physician Decision|0|||
48948813|NCT01052012|157642076|FG003|Overall Study|Physician Decision|0|||
48948814|NCT01052012|157642077|FG004|Overall Study|Physician Decision|0|||
48948815|NCT01052012|157642078|FG005|Overall Study|Physician Decision|1|||
48948816|NCT01052012|157642073|FG000|Overall Study|Other|0|||
48948817|NCT01052012|157642074|FG001|Overall Study|Other|0|||
48948818|NCT01052012|157642075|FG002|Overall Study|Other|0|||
48948819|NCT01052012|157642076|FG003|Overall Study|Other|0|||
48948820|NCT01052012|157642077|FG004|Overall Study|Other|1|||
48948821|NCT01052012|157642078|FG005|Overall Study|Other|0|||
48739271|NCT02747875|156894123|FG001|Overall Study|Adverse Event|1|||
48739272|NCT00696800|156894124|FG000|Overall Study|Adverse Event|16|||
48739273|NCT00696800|156894125|FG001|Overall Study|Adverse Event|3|||
48739274|NCT00696800|156894124|FG000|Overall Study|Insufficient compliance with medication|2|||
48739275|NCT00696800|156894125|FG001|Overall Study|Insufficient compliance with medication|1|||
48948822|NCT02369510|157642079|FG000|Overall Study|Spilled Medication|1|||
48948823|NCT02369510|157642080|FG001|Overall Study|Spilled Medication|2|||
48948824|NCT02369510|157642081|FG002|Overall Study|Spilled Medication|1|||
48948825|NCT02369510|157642079|FG000|Overall Study|Epidural Activation|1|||
48948826|NCT02369510|157642080|FG001|Overall Study|Epidural Activation|1|||
48948827|NCT02369510|157642081|FG002|Overall Study|Epidural Activation|5|||
48948828|NCT02873715|157642082|FG000|Overall Study|Lost to Follow-up|84|||
48948829|NCT02873715|157642083|FG001|Overall Study|Lost to Follow-up|94|||
48948830|NCT02873715|157642082|FG000|Overall Study|Withdrawal by Subject|7|||
48948831|NCT02873715|157642083|FG001|Overall Study|Withdrawal by Subject|26|||
48948832|NCT03575468|157642086|FG000|Overall Study|Withdrawal by Subject|3|||
48948833|NCT03575468|157642087|FG001|Overall Study|Withdrawal by Subject|0|||
48948834|NCT03575468|157642086|FG000|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|10|||
48948835|NCT03575468|157642087|FG001|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|4|||
48948836|NCT03575468|157642086|FG000|Overall Study|Lost to Follow-up|13|||
48948837|NCT03575468|157642087|FG001|Overall Study|Lost to Follow-up|17|||
48948838|NCT03280550|157642088|FG000|Overall Study|Withdrawal by Subject|2|||
48948839|NCT03280550|157642089|FG001|Overall Study|Withdrawal by Subject|2|||
48948840|NCT03280550|157642088|FG000|Overall Study|Physician Decision|0|||
48948841|NCT03280550|157642089|FG001|Overall Study|Physician Decision|1|||
48948842|NCT02714205|157642091|FG000|Overall Study|Cannot tolerate medication|1|||
48948843|NCT02714205|157642092|FG001|Overall Study|Cannot tolerate medication|0|||
48948844|NCT02714205|157642091|FG000|Overall Study|Adverse Event|2|||
48948845|NCT02714205|157642092|FG001|Overall Study|Adverse Event|0|||
48948846|NCT02714205|157642091|FG000|Overall Study|Too busy|1|||
48948847|NCT02714205|157642092|FG001|Overall Study|Too busy|0|||
48739276|NCT00696800|156894124|FG000|Overall Study|Insufficient ovarian response on Day 8|4|||
48739277|NCT00696800|156894125|FG001|Overall Study|Insufficient ovarian response on Day 8|1|||
48948848|NCT02714205|157642091|FG000|Overall Study|Incomplete outcome data|0|||
48853578|NCT01801007|157302833|FG000|Overall Study|Lost to Follow-up|4|||
48853579|NCT01801007|157302833|FG000|Overall Study|Withdrawal by Subject|5|||
48853580|NCT02060487|157302834|FG000|Overall Study|Other|1|||
48853581|NCT02060487|157302835|FG001|Overall Study|Other|2|||
48853582|NCT02060487|157302836|FG002|Overall Study|Other|1|||
48853583|NCT02060487|157302834|FG000|Overall Study|Lack of Efficacy|0|||
48853584|NCT02060487|157302835|FG001|Overall Study|Lack of Efficacy|1|||
48853585|NCT02060487|157302836|FG002|Overall Study|Lack of Efficacy|0|||
48853586|NCT02060487|157302834|FG000|Overall Study|Withdrawal by Subject|3|||
48853587|NCT02060487|157302835|FG001|Overall Study|Withdrawal by Subject|10|||
48853588|NCT02060487|157302836|FG002|Overall Study|Withdrawal by Subject|4|||
48853589|NCT02060487|157302834|FG000|Overall Study|Study Terminated By Sponsor|87|||
48853590|NCT02060487|157302835|FG001|Overall Study|Study Terminated By Sponsor|89|||
48853591|NCT02060487|157302836|FG002|Overall Study|Study Terminated By Sponsor|100|||
48853592|NCT02060487|157302834|FG000|Overall Study|Randomized in error|1|||
48853593|NCT02060487|157302835|FG001|Overall Study|Randomized in error|0|||
48853594|NCT02060487|157302836|FG002|Overall Study|Randomized in error|0|||
48853595|NCT02060487|157302834|FG000|Overall Study|Protocol Violation|0|||
48853596|NCT02060487|157302835|FG001|Overall Study|Protocol Violation|1|||
48853597|NCT02060487|157302836|FG002|Overall Study|Protocol Violation|1|||
48853598|NCT02060487|157302834|FG000|Overall Study|Lost to Follow-up|3|||
48853599|NCT02060487|157302835|FG001|Overall Study|Lost to Follow-up|0|||
48853600|NCT02060487|157302836|FG002|Overall Study|Lost to Follow-up|2|||
48853601|NCT02060487|157302834|FG000|Overall Study|Death|34|||
48853602|NCT02060487|157302835|FG001|Overall Study|Death|25|||
48853603|NCT02060487|157302836|FG002|Overall Study|Death|19|||
48853604|NCT02060487|157302834|FG000|Overall Study|Adverse Event|0|||
48853605|NCT02060487|157302835|FG001|Overall Study|Adverse Event|0|||
48853606|NCT02060487|157302836|FG002|Overall Study|Adverse Event|1|||
48853607|NCT00875706|157302839|FG000|Overall Study|Withdrawal by Subject|1|||
48853608|NCT00875706|157302840|FG001|Overall Study|Withdrawal by Subject|0|||
48853609|NCT00875706|157302841|FG002|Overall Study|Withdrawal by Subject|0|||
48853610|NCT01706159|157302842|FG000|Overall Study|Withdrawal Criteria|2|||
48853611|NCT01706159|157302843|FG001|Overall Study|Withdrawal Criteria|1|||
48853612|NCT01706159|157302842|FG000|Overall Study|Unclassified|6|||
48853613|NCT01706159|157302843|FG001|Overall Study|Unclassified|1|||
48853614|NCT00824408|157302844|FG000|Run-in Phase|Progressive disease|4|||
48853615|NCT00824408|157302845|FG001|Run-in Phase|Progressive disease|4|||
48853616|NCT00824408|157302846|FG002|Run-in Phase|Progressive disease|0|||
48853617|NCT00824408|157302847|FG003|Run-in Phase|Progressive disease|0|||
48853618|NCT00824408|157302848|FG004|Run-in Phase|Progressive disease|0|||
48853619|NCT00824408|157302844|FG000|Run-in Phase|Adverse Event|1|||
48853620|NCT00824408|157302845|FG001|Run-in Phase|Adverse Event|1|||
48853621|NCT00824408|157302846|FG002|Run-in Phase|Adverse Event|0|||
48853622|NCT00824408|157302847|FG003|Run-in Phase|Adverse Event|0|||
48853623|NCT00824408|157302848|FG004|Run-in Phase|Adverse Event|0|||
49015346|NCT00673790|157892152|FG000|Overall Study|Poor compliance|1|||
48739278|NCT00696800|156894124|FG000|Overall Study|Insufficient ovarian response|4|||
48853624|NCT00824408|157302844|FG000|Run-in Phase|Refused to continue medication|1|||
48853625|NCT00824408|157302845|FG001|Run-in Phase|Refused to continue medication|0|||
48853626|NCT00824408|157302846|FG002|Run-in Phase|Refused to continue medication|0|||
48853627|NCT00824408|157302847|FG003|Run-in Phase|Refused to continue medication|0|||
48853628|NCT00824408|157302848|FG004|Run-in Phase|Refused to continue medication|0|||
48853629|NCT00824408|157302844|FG000|Run-in Phase|Other reason not defined above|0|||
48853630|NCT00824408|157302845|FG001|Run-in Phase|Other reason not defined above|1|||
48853631|NCT00824408|157302846|FG002|Run-in Phase|Other reason not defined above|0|||
48853632|NCT00824408|157302847|FG003|Run-in Phase|Other reason not defined above|0|||
48853633|NCT00824408|157302848|FG004|Run-in Phase|Other reason not defined above|0|||
48853634|NCT00824408|157302844|FG000|Randomized Phase|Not treated|0|||
48948849|NCT02714205|157642092|FG001|Overall Study|Incomplete outcome data|1|||
48948850|NCT01486316|157643394|FG000|Overall Study|Device explanted with/without re-implant|3|||
48948851|NCT01486316|157643395|FG001|Overall Study|Device explanted with/without re-implant|2|||
48948852|NCT01486316|157643396|FG002|Overall Study|Device explanted with/without re-implant|0|||
48948853|NCT01486316|157643397|FG003|Overall Study|Device explanted with/without re-implant|2|||
48948854|NCT01486316|157643394|FG000|Overall Study|Not meeting eligibility criteria|0|||
48853635|NCT00824408|157302845|FG001|Randomized Phase|Not treated|0|||
48853636|NCT00824408|157302846|FG002|Randomized Phase|Not treated|1|||
48853637|NCT00824408|157302847|FG003|Randomized Phase|Not treated|1|||
48853638|NCT00824408|157302848|FG004|Randomized Phase|Not treated|1|||
48948855|NCT01486316|157643395|FG001|Overall Study|Not meeting eligibility criteria|0|||
48948856|NCT01486316|157643396|FG002|Overall Study|Not meeting eligibility criteria|1|||
48948857|NCT01486316|157643397|FG003|Overall Study|Not meeting eligibility criteria|0|||
48948858|NCT01486316|157643394|FG000|Overall Study|Withdrawal by Subject|1|||
48853639|NCT00824408|157302844|FG000|Randomized Phase|Progressive disease|0|||
48853640|NCT00824408|157302845|FG001|Randomized Phase|Progressive disease|0|||
48853641|NCT00824408|157302846|FG002|Randomized Phase|Progressive disease|25|||
48853642|NCT00824408|157302847|FG003|Randomized Phase|Progressive disease|36|||
48853643|NCT00824408|157302848|FG004|Randomized Phase|Progressive disease|34|||
48853644|NCT00824408|157302844|FG000|Randomized Phase|Adverse Event|0|||
48853645|NCT00824408|157302845|FG001|Randomized Phase|Adverse Event|0|||
48853646|NCT00824408|157302846|FG002|Randomized Phase|Adverse Event|4|||
48853647|NCT00824408|157302847|FG003|Randomized Phase|Adverse Event|5|||
48853648|NCT00824408|157302848|FG004|Randomized Phase|Adverse Event|5|||
48853649|NCT00824408|157302844|FG000|Randomized Phase|Refused to continue medication|0|||
48853650|NCT00824408|157302845|FG001|Randomized Phase|Refused to continue medication|0|||
48853651|NCT00824408|157302846|FG002|Randomized Phase|Refused to continue medication|2|||
48948859|NCT01486316|157643395|FG001|Overall Study|Withdrawal by Subject|0|||
48948860|NCT01486316|157643396|FG002|Overall Study|Withdrawal by Subject|3|||
48853652|NCT00824408|157302847|FG003|Randomized Phase|Refused to continue medication|2|||
48853653|NCT00824408|157302848|FG004|Randomized Phase|Refused to continue medication|2|||
48853654|NCT00824408|157302844|FG000|Randomized Phase|Other reason not defined above|0|||
48853655|NCT00824408|157302845|FG001|Randomized Phase|Other reason not defined above|0|||
48853656|NCT00824408|157302846|FG002|Randomized Phase|Other reason not defined above|4|||
48853657|NCT00824408|157302847|FG003|Randomized Phase|Other reason not defined above|2|||
48739279|NCT00696800|156894125|FG001|Overall Study|Insufficient ovarian response|1|||
48739280|NCT00696800|156894124|FG000|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8|||
48739281|NCT00696800|156894125|FG001|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2|||
48739282|NCT00696800|156894124|FG000|Overall Study|Too high ovarian response|6|||
48739283|NCT00696800|156894125|FG001|Overall Study|Too high ovarian response|1|||
48739284|NCT00696800|156894124|FG000|Overall Study|No/too few/bad quality oocytes|4|||
48739285|NCT00696800|156894125|FG001|Overall Study|No/too few/bad quality oocytes|3|||
48948861|NCT01486316|157643397|FG003|Overall Study|Withdrawal by Subject|0|||
48739286|NCT00696800|156894124|FG000|Overall Study|No/abnormal fertilization|11|||
48739287|NCT00696800|156894125|FG001|Overall Study|No/abnormal fertilization|13|||
48739288|NCT00696800|156894124|FG000|Overall Study|No/too few/bad quality embryos|24|||
48739289|NCT00696800|156894125|FG001|Overall Study|No/too few/bad quality embryos|18|||
48739290|NCT00696800|156894124|FG000|Overall Study|Other Reasons|5|||
48739291|NCT00696800|156894125|FG001|Overall Study|Other Reasons|3|||
48739292|NCT00696800|156894124|FG000|Overall Study|Not treated|1|||
48739293|NCT00696800|156894125|FG001|Overall Study|Not treated|2|||
48739294|NCT00762385|156894126|FG000|First Intervention|Lens Issue|1|||
48739295|NCT00762385|156894127|FG001|First Intervention|Lens Issue|1|||
48739296|NCT00762385|156894126|FG000|First Intervention|Lost to Follow-up|0|||
48739297|NCT00762385|156894127|FG001|First Intervention|Lost to Follow-up|2|||
48739298|NCT00762385|156894126|FG000|First Intervention|Ineligible|1|||
48739299|NCT00762385|156894127|FG001|First Intervention|Ineligible|0|||
48739300|NCT00762385|156894126|FG000|First Intervention|Protocol Violation|0|||
48739301|NCT00762385|156894127|FG001|First Intervention|Protocol Violation|1|||
48739302|NCT00762385|156894126|FG000|Second Intervention|Protocol Violation|3|||
48739303|NCT00762385|156894127|FG001|Second Intervention|Protocol Violation|3|||
48739304|NCT00538291|156894128|FG000|Overall Study|Adverse Event|2|||
48739305|NCT00538291|156894128|FG000|Overall Study|Withdrawal by Subject|1|||
48739306|NCT04515394|156894132|FG000|Overall Study|Participant did not receive treatment|1|||
48739307|NCT02404220|156894138|FG000|Overall Study|Adverse Event|0|||
48739308|NCT02404220|156894139|FG001|Overall Study|Adverse Event|0|||
48739309|NCT02404220|156894140|FG002|Overall Study|Adverse Event|1|||
48739310|NCT02404220|156894141|FG003|Overall Study|Adverse Event|0|||
48739311|NCT02404220|156894138|FG000|Overall Study|Death|5|||
48739312|NCT02404220|156894139|FG001|Overall Study|Death|5|||
48739313|NCT02404220|156894140|FG002|Overall Study|Death|3|||
48739314|NCT02404220|156894141|FG003|Overall Study|Death|8|||
48739315|NCT02404220|156894138|FG000|Overall Study|Progressive Disease|0|||
48853658|NCT00824408|157302848|FG004|Randomized Phase|Other reason not defined above|4|||
48853659|NCT04867382|157302849|FG000|Overall Study|Did not complete the survey|2|||
48853660|NCT04867382|157302850|FG001|Overall Study|Did not complete the survey|1|||
48853661|NCT03065400|157302853|FG000|Overall Study|Adverse Event|1|||
48853662|NCT03065400|157302853|FG000|Overall Study|Physician Decision|3|||
48853663|NCT03065400|157302853|FG000|Overall Study|Withdrawal by Subject|1|||
48853664|NCT03065400|157302853|FG000|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5|||
48853665|NCT00570505|157302857|FG000|Overall Study|Adverse Event|7|||
48853666|NCT00570505|157302857|FG000|Overall Study|Withdrawal by Subject|7|||
48853667|NCT00570505|157302857|FG000|Overall Study|Lost to Follow-up|23|||
48853668|NCT00570505|157302857|FG000|Overall Study|Other loss to follow-up|4|||
48853669|NCT02454959|157302858|FG000|Overall Study|Protocol-Specified Criteria|3|||
48853670|NCT02454959|157302858|FG000|Overall Study|Physician Decision|1|||
48853671|NCT02454959|157302858|FG000|Overall Study|Withdrawal by Subject|3|||
48853672|NCT02454959|157302858|FG000|Overall Study|Adverse Event|2|||
48853673|NCT02915783|157302859|FG000|Overall Study|Death|21|||
48853674|NCT02915783|157302859|FG000|Overall Study|Lost to Follow-up|1|||
48853675|NCT02915783|157302859|FG000|Overall Study|Withdrawal by Subject|2|||
48853676|NCT02613403|157302864|FG000|Overall Study|Lost to Follow-up|0|||
48853677|NCT02613403|157302865|FG001|Overall Study|Lost to Follow-up|1|||
48853678|NCT02613403|157302866|FG002|Overall Study|Lost to Follow-up|0|||
48853679|NCT02613403|157302867|FG003|Overall Study|Lost to Follow-up|0|||
48853680|NCT02613403|157302868|FG004|Overall Study|Lost to Follow-up|0|||
48853681|NCT02613403|157302864|FG000|Overall Study|Withdrawal by Subject|2|||
48853682|NCT02613403|157302865|FG001|Overall Study|Withdrawal by Subject|0|||
48853683|NCT02613403|157302866|FG002|Overall Study|Withdrawal by Subject|0|||
48853684|NCT02613403|157302867|FG003|Overall Study|Withdrawal by Subject|0|||
48853685|NCT02613403|157302868|FG004|Overall Study|Withdrawal by Subject|0|||
48853686|NCT03032198|157302871|FG000|Overall Study|Screen Fail|1|||
48853687|NCT02188459|157302874|FG000|Overall Study|Lost to Follow-up|3|||
48853688|NCT02188459|157302875|FG001|Overall Study|Lost to Follow-up|4|||
48739316|NCT02404220|156894139|FG001|Overall Study|Progressive Disease|0|||
48853689|NCT02188459|157302874|FG000|Overall Study|Early Termination|0|||
48853690|NCT02188459|157302875|FG001|Overall Study|Early Termination|3|||
48853691|NCT02158806|157302876|FG000|Overall Study|Death|2|||
48853692|NCT02158806|157302877|FG001|Overall Study|Death|0|||
48853693|NCT02158806|157302876|FG000|Overall Study|Withdrawal by Subject|2|||
48948862|NCT01486316|157643394|FG000|Overall Study|Physician Decision|0|||
48853694|NCT02158806|157302877|FG001|Overall Study|Withdrawal by Subject|0|||
48853695|NCT02158806|157302876|FG000|Overall Study|Lost to Follow-up|0|||
48853696|NCT02158806|157302877|FG001|Overall Study|Lost to Follow-up|3|||
48853697|NCT02158806|157302876|FG000|Overall Study|Moved out of area|0|||
48853698|NCT02158806|157302877|FG001|Overall Study|Moved out of area|1|||
48853699|NCT02158806|157302876|FG000|Overall Study|Transferred to palliative care|0|||
48853700|NCT02158806|157302877|FG001|Overall Study|Transferred to palliative care|1|||
48853701|NCT04820491|157302878|FG000|Overall Study|Withdrawal by Subject|1|||
48853702|NCT04820491|157302879|FG001|Overall Study|Withdrawal by Subject|0|||
48853703|NCT01898299|157302880|FG000|Post Treatment (One Month)|Lost to Follow-up|3|||
48853704|NCT01898299|157302881|FG001|Post Treatment (One Month)|Lost to Follow-up|4|||
48739317|NCT02404220|156894140|FG002|Overall Study|Progressive Disease|1|||
48739318|NCT02404220|156894141|FG003|Overall Study|Progressive Disease|1|||
48739319|NCT02404220|156894138|FG000|Overall Study|Study Terminated by Sponsor|0|||
48739320|NCT02404220|156894139|FG001|Overall Study|Study Terminated by Sponsor|0|||
48739321|NCT02404220|156894140|FG002|Overall Study|Study Terminated by Sponsor|2|||
48739322|NCT02404220|156894141|FG003|Overall Study|Study Terminated by Sponsor|1|||
48853705|NCT03122548|157302890|FG000|Overall Study|Death|2|||
48853706|NCT03122548|157302890|FG000|Overall Study|Progression - subject went into hospice|1|||
48853707|NCT03122548|157302890|FG000|Overall Study|Study Terminated by Sponsor|2|||
48853708|NCT00452452|157302891|FG000|Overall Study|Protocol Violation|0|||
48853709|NCT00452452|157302892|FG001|Overall Study|Protocol Violation|0|||
48853710|NCT00452452|157302893|FG002|Overall Study|Protocol Violation|1|||
48853711|NCT00452452|157302891|FG000|Overall Study|Withdrawal by Subject|1|||
48853712|NCT00452452|157302892|FG001|Overall Study|Withdrawal by Subject|0|||
48739323|NCT02404220|156894138|FG000|Overall Study|Withdrawal by Subject|0|||
48739324|NCT02404220|156894139|FG001|Overall Study|Withdrawal by Subject|1|||
48739325|NCT02404220|156894140|FG002|Overall Study|Withdrawal by Subject|0|||
48739326|NCT02404220|156894141|FG003|Overall Study|Withdrawal by Subject|0|||
48853713|NCT00452452|157302893|FG002|Overall Study|Withdrawal by Subject|0|||
48853714|NCT00452452|157302891|FG000|Overall Study|Lost to Follow-up|1|||
48853715|NCT00452452|157302892|FG001|Overall Study|Lost to Follow-up|0|||
48853716|NCT00452452|157302893|FG002|Overall Study|Lost to Follow-up|0|||
48853717|NCT04433091|157302896|FG000|Overall Study|Lost to Follow-up|1|||
48853718|NCT04433091|157302897|FG001|Overall Study|Lost to Follow-up|0|||
48853719|NCT04433091|157302896|FG000|Overall Study|Withdrawn .|2|||
48739327|NCT02404220|156894138|FG000|Overall Study|Enrolled but Never Treated|0|||
48739328|NCT02404220|156894139|FG001|Overall Study|Enrolled but Never Treated|2|||
48739329|NCT02404220|156894140|FG002|Overall Study|Enrolled but Never Treated|0|||
48739330|NCT02404220|156894141|FG003|Overall Study|Enrolled but Never Treated|0|||
48853720|NCT04433091|157302897|FG001|Overall Study|Withdrawn .|4|||
48853721|NCT04919499|157302898|FG000|Overall Study|Adverse Event|0|||
48853722|NCT04919499|157302899|FG001|Overall Study|Adverse Event|0|||
48853723|NCT04919499|157302900|FG002|Overall Study|Adverse Event|0|||
48853724|NCT04919499|157302901|FG003|Overall Study|Adverse Event|0|||
48739331|NCT02264639|156894150|FG000|Overall Study|Death (after completing single-dose phase)|1|||
48739332|NCT02264639|156894151|FG001|Overall Study|Death (after completing single-dose phase)|0|||
48739333|NCT02264639|156894152|FG002|Overall Study|Death (after completing single-dose phase)|0|||
48739334|NCT02264639|156894153|FG003|Overall Study|Death (after completing single-dose phase)|0|||
48739335|NCT02264639|156894154|FG004|Overall Study|Death (after completing single-dose phase)|0|||
48853725|NCT04919499|157302902|FG004|Overall Study|Adverse Event|2|||
48853726|NCT04919499|157302898|FG000|Overall Study|Not treated|0|||
48853727|NCT04919499|157302899|FG001|Overall Study|Not treated|0|||
48853728|NCT04919499|157302900|FG002|Overall Study|Not treated|0|||
48853729|NCT04919499|157302901|FG003|Overall Study|Not treated|1|||
48739336|NCT02264639|156894150|FG000|Overall Study|Withdrawal by subject (during multiple-dose phase)|1|||
48853730|NCT04919499|157302902|FG004|Overall Study|Not treated|0|||
48853731|NCT04705051|157304837|FG000|Overall Study|Enrolled but not treated|1|||
48853732|NCT04705051|157304837|FG000|Overall Study|Study terminated by sponsor|23|||
48853733|NCT03009344|157304838|FG000|Overall Study|Lack of Efficacy|5|||
48853734|NCT03009344|157304838|FG000|Overall Study|Withdrawal by Subject|1|||
48853735|NCT03009344|157304838|FG000|Overall Study|Adverse Event|1|||
48853736|NCT04131556|157304839|FG000|Overall Study|Adverse Event|1|||
48853737|NCT04131556|157304839|FG000|Overall Study|Withdrawal by Subject|1|||
48853738|NCT00597376|157304840|FG000|Overall Study|Withdrawal by Subject|4|||
48853739|NCT00597376|157304841|FG001|Overall Study|Withdrawal by Subject|3|||
48853740|NCT00597376|157304840|FG000|Overall Study|Adverse Event|4|||
48853741|NCT00597376|157304841|FG001|Overall Study|Adverse Event|1|||
48853742|NCT02634307|157304842|FG000|Overall Study|Adverse Event|50|||
48853743|NCT02634307|157304843|FG001|Overall Study|Adverse Event|24|||
48853744|NCT02634307|157304844|FG002|Overall Study|Adverse Event|14|||
48853745|NCT02634307|157304842|FG000|Overall Study|Lost to Follow-up|21|||
48853746|NCT02634307|157304843|FG001|Overall Study|Lost to Follow-up|5|||
48853747|NCT02634307|157304844|FG002|Overall Study|Lost to Follow-up|6|||
48853748|NCT02634307|157304842|FG000|Overall Study|Pregnancy|5|||
48853749|NCT02634307|157304843|FG001|Overall Study|Pregnancy|1|||
48853750|NCT02634307|157304844|FG002|Overall Study|Pregnancy|3|||
48853751|NCT02634307|157304842|FG000|Overall Study|Withdrawal by Subject|38|||
48853752|NCT02634307|157304843|FG001|Overall Study|Withdrawal by Subject|24|||
48853753|NCT02634307|157304844|FG002|Overall Study|Withdrawal by Subject|18|||
48853754|NCT02634307|157304842|FG000|Overall Study|Non-Compliance with Study Drug|0|||
48853755|NCT02634307|157304843|FG001|Overall Study|Non-Compliance with Study Drug|2|||
48853756|NCT02634307|157304844|FG002|Overall Study|Non-Compliance with Study Drug|2|||
48853757|NCT02634307|157304842|FG000|Overall Study|Lack of Efficacy|1|||
48853758|NCT02634307|157304843|FG001|Overall Study|Lack of Efficacy|5|||
48853759|NCT02634307|157304844|FG002|Overall Study|Lack of Efficacy|3|||
48853760|NCT02634307|157304842|FG000|Overall Study|Physician Decision|7|||
48853761|NCT02634307|157304843|FG001|Overall Study|Physician Decision|5|||
48853762|NCT02634307|157304844|FG002|Overall Study|Physician Decision|5|||
48853763|NCT02634307|157304842|FG000|Overall Study|Reason not Specified|3|||
48853764|NCT02634307|157304843|FG001|Overall Study|Reason not Specified|5|||
48853765|NCT02634307|157304844|FG002|Overall Study|Reason not Specified|10|||
48853766|NCT02185794|157304845|FG000|Overall Study|Enrolled but Never Dosed|1|||
48853767|NCT02185794|157304846|FG001|Overall Study|Enrolled but Never Dosed|6|||
48853768|NCT02185794|157304847|FG002|Overall Study|Enrolled but Never Dosed|3|||
48853769|NCT02185794|157304848|FG003|Overall Study|Enrolled but Never Dosed|1|||
48853770|NCT02185794|157304849|FG004|Overall Study|Enrolled but Never Dosed|1|||
48853771|NCT02185794|157304850|FG005|Overall Study|Enrolled but Never Dosed|0|||
48853772|NCT02185794|157304845|FG000|Overall Study|Investigator's Discretion|1|||
48853773|NCT02185794|157304846|FG001|Overall Study|Investigator's Discretion|0|||
48853774|NCT02185794|157304847|FG002|Overall Study|Investigator's Discretion|1|||
48853775|NCT02185794|157304848|FG003|Overall Study|Investigator's Discretion|2|||
48853776|NCT02185794|157304849|FG004|Overall Study|Investigator's Discretion|2|||
48853777|NCT02185794|157304850|FG005|Overall Study|Investigator's Discretion|15|||
48853778|NCT02185794|157304845|FG000|Overall Study|Withdrew Consent|2|||
48853779|NCT02185794|157304846|FG001|Overall Study|Withdrew Consent|5|||
48853780|NCT02185794|157304847|FG002|Overall Study|Withdrew Consent|10|||
48853781|NCT02185794|157304848|FG003|Overall Study|Withdrew Consent|2|||
48853782|NCT02185794|157304849|FG004|Overall Study|Withdrew Consent|0|||
48853783|NCT02185794|157304850|FG005|Overall Study|Withdrew Consent|0|||
48853784|NCT02185794|157304845|FG000|Overall Study|Lost to Follow-up|1|||
48853785|NCT02185794|157304846|FG001|Overall Study|Lost to Follow-up|2|||
48853786|NCT02185794|157304847|FG002|Overall Study|Lost to Follow-up|2|||
48853787|NCT02185794|157304848|FG003|Overall Study|Lost to Follow-up|3|||
48853788|NCT02185794|157304849|FG004|Overall Study|Lost to Follow-up|0|||
48853789|NCT02185794|157304850|FG005|Overall Study|Lost to Follow-up|1|||
48853790|NCT01092416|157304851|FG000|Enrollment|Atherectomy device not inserted|3|||
48853791|NCT01092416|157304851|FG000|30-Day Follow-up|Death|2|||
48853792|NCT01092416|157304851|FG000|30-Day Follow-up|Missed 30-day follow-up|3|||
48853793|NCT01092416|157304851|FG000|30-Day Follow-up|Data collected after close of 30D window|5|||
48853794|NCT01092416|157304851|FG000|12-Month Follow-up|Death|16|||
48853795|NCT01092416|157304851|FG000|12-Month Follow-up|Lost to Follow-up|4|||
48853796|NCT01092416|157304851|FG000|12-Month Follow-up|Withdrawal by Subject|2|||
48853797|NCT01092416|157304851|FG000|12-Month Follow-up|Missed 1-year follow-up|1|||
48853798|NCT01092416|157304851|FG000|12-Month Follow-up|Data collected after close of 1Y window|2|||
48853799|NCT03883828|157304852|FG000|Overall Study|Did not start radiotherapy|1|||
48853800|NCT03883828|157304853|FG001|Overall Study|Did not start radiotherapy|2|||
48853801|NCT03041090|157304854|FG000|Overall Study|technical error|0|||
48853802|NCT03041090|157304855|FG001|Overall Study|technical error|3|||
48853803|NCT03675321|157304856|FG000|Overall Study|Lack of Efficacy|2|||
48853804|NCT03675321|157304857|FG001|Overall Study|Lack of Efficacy|2|||
48853805|NCT03675321|157304856|FG000|Overall Study|Withdrawal by Subject|1|||
48853806|NCT03675321|157304857|FG001|Overall Study|Withdrawal by Subject|3|||
48853807|NCT03374254|157304860|FG000|Overall Study|Death|5|||
48853808|NCT03374254|157304861|FG001|Overall Study|Death|16|||
48853809|NCT03374254|157304862|FG002|Overall Study|Death|13|||
48853810|NCT03374254|157304863|FG003|Overall Study|Death|11|||
48948863|NCT01486316|157643395|FG001|Overall Study|Physician Decision|0|||
48853811|NCT03374254|157304864|FG004|Overall Study|Death|9|||
48853812|NCT03374254|157304865|FG005|Overall Study|Death|12|||
48853813|NCT03374254|157304866|FG006|Overall Study|Death|11|||
48853814|NCT03374254|157304867|FG007|Overall Study|Death|6|||
48853815|NCT03374254|157304868|FG008|Overall Study|Death|7|||
48853816|NCT03374254|157304860|FG000|Overall Study|Lost to Follow-up|0|||
48853817|NCT03374254|157304861|FG001|Overall Study|Lost to Follow-up|0|||
48853818|NCT03374254|157304862|FG002|Overall Study|Lost to Follow-up|0|||
48853819|NCT03374254|157304863|FG003|Overall Study|Lost to Follow-up|0|||
48853820|NCT03374254|157304864|FG004|Overall Study|Lost to Follow-up|0|||
48853821|NCT03374254|157304865|FG005|Overall Study|Lost to Follow-up|0|||
48853822|NCT03374254|157304866|FG006|Overall Study|Lost to Follow-up|2|||
48853823|NCT03374254|157304867|FG007|Overall Study|Lost to Follow-up|0|||
48853824|NCT03374254|157304868|FG008|Overall Study|Lost to Follow-up|0|||
48853825|NCT03374254|157304860|FG000|Overall Study|Sponsor Decision|1|||
48853826|NCT03374254|157304861|FG001|Overall Study|Sponsor Decision|0|||
48853827|NCT03374254|157304862|FG002|Overall Study|Sponsor Decision|2|||
48853828|NCT03374254|157304863|FG003|Overall Study|Sponsor Decision|3|||
48853829|NCT03374254|157304864|FG004|Overall Study|Sponsor Decision|2|||
48853830|NCT03374254|157304865|FG005|Overall Study|Sponsor Decision|3|||
48853831|NCT03374254|157304866|FG006|Overall Study|Sponsor Decision|3|||
48853832|NCT03374254|157304867|FG007|Overall Study|Sponsor Decision|3|||
48853833|NCT03374254|157304868|FG008|Overall Study|Sponsor Decision|4|||
48853834|NCT03374254|157304860|FG000|Overall Study|Withdrawal by Subject|0|||
48853835|NCT03374254|157304861|FG001|Overall Study|Withdrawal by Subject|0|||
48853836|NCT03374254|157304862|FG002|Overall Study|Withdrawal by Subject|0|||
48853837|NCT03374254|157304863|FG003|Overall Study|Withdrawal by Subject|2|||
48853838|NCT03374254|157304864|FG004|Overall Study|Withdrawal by Subject|0|||
48853839|NCT03374254|157304865|FG005|Overall Study|Withdrawal by Subject|1|||
48853840|NCT03374254|157304866|FG006|Overall Study|Withdrawal by Subject|0|||
48853841|NCT03374254|157304867|FG007|Overall Study|Withdrawal by Subject|0|||
48853842|NCT03374254|157304868|FG008|Overall Study|Withdrawal by Subject|0|||
48853843|NCT04070105|157304869|FG000|Overall Study|Lost to Follow-up|0|||
48853844|NCT04070105|157304870|FG001|Overall Study|Lost to Follow-up|0|||
48853845|NCT04070105|157304871|FG002|Overall Study|Lost to Follow-up|0|||
48853846|NCT04070105|157304872|FG003|Overall Study|Lost to Follow-up|0|||
48853847|NCT04070105|157304873|FG004|Overall Study|Lost to Follow-up|0|||
48853848|NCT04070105|157304874|FG005|Overall Study|Lost to Follow-up|1|||
48853849|NCT03184987|157304875|FG000|Overall Study|Withdrawal by Subject|0|||
48853850|NCT03184987|157304876|FG001|Overall Study|Withdrawal by Subject|1|||
48853851|NCT03184987|157304877|FG002|Overall Study|Withdrawal by Subject|2|||
48853852|NCT03184987|157304875|FG000|Overall Study|Physician Decision|0|||
48948864|NCT01486316|157643396|FG002|Overall Study|Physician Decision|1|||
48948865|NCT01486316|157643397|FG003|Overall Study|Physician Decision|0|||
48948866|NCT01486316|157643394|FG000|Overall Study|Death|0|||
48948867|NCT01486316|157643395|FG001|Overall Study|Death|1|||
48948868|NCT01486316|157643396|FG002|Overall Study|Death|0|||
48948869|NCT01486316|157643397|FG003|Overall Study|Death|0|||
48948870|NCT01040832|157643398|FG000|Overall Study|Adverse Event|4|||
48739337|NCT02264639|156894151|FG001|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
48739338|NCT02264639|156894152|FG002|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
48739339|NCT02264639|156894153|FG003|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
48739340|NCT02264639|156894154|FG004|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
48948871|NCT01040832|157643399|FG001|Overall Study|Adverse Event|5|||
48948872|NCT01040832|157643398|FG000|Overall Study|Death|4|||
48948873|NCT01040832|157643399|FG001|Overall Study|Death|6|||
48948874|NCT01040832|157643398|FG000|Overall Study|Withdrawal by Subject|2|||
48948875|NCT01040832|157643399|FG001|Overall Study|Withdrawal by Subject|3|||
48948876|NCT01040832|157643398|FG000|Overall Study|Progressive disease|32|||
48948877|NCT01040832|157643399|FG001|Overall Study|Progressive disease|17|||
48948878|NCT01040832|157643398|FG000|Overall Study|Symptomatic deterioration|2|||
48948879|NCT01040832|157643399|FG001|Overall Study|Symptomatic deterioration|5|||
48948880|NCT01040832|157643398|FG000|Overall Study|Other|2|||
48948881|NCT01040832|157643399|FG001|Overall Study|Other|1|||
48948882|NCT02839746|157643401|FG000|Overall Study|Not met selection criteria|12|||
48739341|NCT02264639|156894150|FG000|Overall Study|Pregnancy (during multiple-dose phase)|0|||
48739342|NCT02264639|156894151|FG001|Overall Study|Pregnancy (during multiple-dose phase)|0|||
48739343|NCT02264639|156894152|FG002|Overall Study|Pregnancy (during multiple-dose phase)|1|||
48948883|NCT02874794|157643402|FG000|Overall Study|Physician Decision|3|||
48948884|NCT02874794|157643403|FG001|Overall Study|Physician Decision|2|||
48948885|NCT02874794|157643402|FG000|Overall Study|Withdrawal by Subject|2|||
48853853|NCT03184987|157304876|FG001|Overall Study|Physician Decision|0|||
48853854|NCT03184987|157304877|FG002|Overall Study|Physician Decision|1|||
48853855|NCT03184987|157304875|FG000|Overall Study|Adverse Event|1|||
48853856|NCT03184987|157304876|FG001|Overall Study|Adverse Event|0|||
48853857|NCT03184987|157304877|FG002|Overall Study|Adverse Event|1|||
48853858|NCT02823574|157304882|FG000|Randomization|Disease Progression|0|||
48948886|NCT02874794|157643403|FG001|Overall Study|Withdrawal by Subject|8|||
48948887|NCT02874794|157643402|FG000|Overall Study|Death|2|||
48853859|NCT02823574|157304883|FG001|Randomization|Disease Progression|0|||
48853860|NCT02823574|157304884|FG002|Randomization|Disease Progression|1|||
48853861|NCT02823574|157304885|FG003|Randomization|Disease Progression|0|||
48853862|NCT02823574|157304882|FG000|Randomization|AE unrelated to Study Drug|1|||
48853863|NCT02823574|157304883|FG001|Randomization|AE unrelated to Study Drug|0|||
48853864|NCT02823574|157304884|FG002|Randomization|AE unrelated to Study Drug|0|||
48853865|NCT02823574|157304885|FG003|Randomization|AE unrelated to Study Drug|0|||
48948888|NCT02874794|157643403|FG001|Overall Study|Death|1|||
48948889|NCT00698516|157643404|FG000|Overall Study|Study Termination|2|||
48948890|NCT00698516|157643404|FG000|Overall Study|Withdrawal by Subject|3|||
48948891|NCT00098345|157643407|FG000|Overall Study|Adverse Event|7|||
48948892|NCT00098345|157643407|FG000|Overall Study|Withdrawal by Subject|2|||
48948893|NCT00098345|157643407|FG000|Overall Study|progression|4|||
48948894|NCT03133481|157643408|FG000|Overall Study|FC Catheter fell out post operative day1|0|||
48739344|NCT02264639|156894153|FG003|Overall Study|Pregnancy (during multiple-dose phase)|0|||
48739345|NCT02264639|156894154|FG004|Overall Study|Pregnancy (during multiple-dose phase)|0|||
48739346|NCT02264639|156894150|FG000|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
48739347|NCT02264639|156894151|FG001|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
48739348|NCT02264639|156894152|FG002|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
48739349|NCT02264639|156894153|FG003|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
48739350|NCT02264639|156894154|FG004|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1|||
48739351|NCT00406354|156894159|FG000|All Randomized Patients|Protocol Violation|0|||
48739352|NCT00406354|156894160|FG001|All Randomized Patients|Protocol Violation|0|||
48739353|NCT00406354|156894161|FG002|All Randomized Patients|Protocol Violation|1|||
48739354|NCT00406354|156894159|FG000|All Randomized and Treated Patients|Lack of Efficacy|7|||
48739355|NCT00406354|156894160|FG001|All Randomized and Treated Patients|Lack of Efficacy|4|||
48739356|NCT00406354|156894161|FG002|All Randomized and Treated Patients|Lack of Efficacy|17|||
48739357|NCT00406354|156894159|FG000|All Randomized and Treated Patients|Adverse Event|6|||
48739358|NCT00406354|156894160|FG001|All Randomized and Treated Patients|Adverse Event|2|||
48739359|NCT00406354|156894161|FG002|All Randomized and Treated Patients|Adverse Event|1|||
48739360|NCT00406354|156894159|FG000|All Randomized and Treated Patients|Parent/Caregiver Decision|2|||
48739361|NCT00406354|156894160|FG001|All Randomized and Treated Patients|Parent/Caregiver Decision|6|||
48739362|NCT00406354|156894161|FG002|All Randomized and Treated Patients|Parent/Caregiver Decision|1|||
48739363|NCT00406354|156894159|FG000|All Randomized and Treated Patients|Withdrawal by Subject|1|||
48739364|NCT00406354|156894160|FG001|All Randomized and Treated Patients|Withdrawal by Subject|1|||
48739365|NCT00406354|156894161|FG002|All Randomized and Treated Patients|Withdrawal by Subject|2|||
48739366|NCT00406354|156894159|FG000|All Randomized and Treated Patients|Physician Decision|0|||
48739367|NCT00406354|156894160|FG001|All Randomized and Treated Patients|Physician Decision|0|||
48739368|NCT00406354|156894161|FG002|All Randomized and Treated Patients|Physician Decision|1|||
48739369|NCT02639546|156894162|FG000|Overall Study|Death|2|||
48739370|NCT02639546|156894163|FG001|Overall Study|Death|2|||
48739371|NCT02639546|156894164|FG002|Overall Study|Death|1|||
48739372|NCT02639546|156894165|FG003|Overall Study|Death|2|||
48739373|NCT02639546|156894166|FG004|Overall Study|Death|2|||
48739374|NCT02639546|156894167|FG005|Overall Study|Death|2|||
48739375|NCT02639546|156894168|FG006|Overall Study|Death|0|||
48739376|NCT02639546|156894169|FG007|Overall Study|Death|0|||
48739377|NCT02639546|156894162|FG000|Overall Study|Lost to Follow-up|0|||
48739378|NCT02639546|156894163|FG001|Overall Study|Lost to Follow-up|0|||
48739379|NCT02639546|156894164|FG002|Overall Study|Lost to Follow-up|1|||
48739380|NCT02639546|156894165|FG003|Overall Study|Lost to Follow-up|0|||
48739381|NCT02639546|156894166|FG004|Overall Study|Lost to Follow-up|1|||
48739382|NCT02639546|156894167|FG005|Overall Study|Lost to Follow-up|1|||
48739383|NCT02639546|156894168|FG006|Overall Study|Lost to Follow-up|0|||
48739384|NCT02639546|156894169|FG007|Overall Study|Lost to Follow-up|1|||
48739385|NCT02639546|156894162|FG000|Overall Study|PI, physician decision; no response to trt.|2|||
48739386|NCT02639546|156894163|FG001|Overall Study|PI, physician decision; no response to trt.|0|||
48739387|NCT02639546|156894164|FG002|Overall Study|PI, physician decision; no response to trt.|0|||
48739388|NCT02639546|156894165|FG003|Overall Study|PI, physician decision; no response to trt.|0|||
48739389|NCT02639546|156894166|FG004|Overall Study|PI, physician decision; no response to trt.|0|||
48739390|NCT02639546|156894167|FG005|Overall Study|PI, physician decision; no response to trt.|1|||
48739391|NCT02639546|156894168|FG006|Overall Study|PI, physician decision; no response to trt.|0|||
48739392|NCT02639546|156894169|FG007|Overall Study|PI, physician decision; no response to trt.|1|||
48739393|NCT02639546|156894162|FG000|Overall Study|Study Terminated By Sponsor|0|||
48739394|NCT02639546|156894163|FG001|Overall Study|Study Terminated By Sponsor|2|||
48739395|NCT02639546|156894164|FG002|Overall Study|Study Terminated By Sponsor|3|||
48739396|NCT02639546|156894165|FG003|Overall Study|Study Terminated By Sponsor|4|||
48739397|NCT02639546|156894166|FG004|Overall Study|Study Terminated By Sponsor|4|||
48739398|NCT02639546|156894167|FG005|Overall Study|Study Terminated By Sponsor|3|||
48739399|NCT02639546|156894168|FG006|Overall Study|Study Terminated By Sponsor|3|||
48739400|NCT02639546|156894169|FG007|Overall Study|Study Terminated By Sponsor|9|||
48739401|NCT02639546|156894162|FG000|Overall Study|Withdrawal by Subject|2|||
48739402|NCT02639546|156894163|FG001|Overall Study|Withdrawal by Subject|2|||
48739403|NCT02639546|156894164|FG002|Overall Study|Withdrawal by Subject|1|||
48739404|NCT02639546|156894165|FG003|Overall Study|Withdrawal by Subject|0|||
48739405|NCT02639546|156894166|FG004|Overall Study|Withdrawal by Subject|0|||
48948895|NCT03133481|157643409|FG001|Overall Study|FC Catheter fell out post operative day1|4|||
48948896|NCT00593112|157643410|FG000|Overall Study|Scan Anxiety|3|||
48948897|NCT00593112|157643411|FG001|Overall Study|Scan Anxiety|0|||
48948898|NCT00593112|157643410|FG000|Overall Study|Abnormal Scan|1|||
48948899|NCT00593112|157643411|FG001|Overall Study|Abnormal Scan|0|||
48948900|NCT00593112|157643410|FG000|Overall Study|Unreadable Scan|1|||
48948901|NCT00593112|157643411|FG001|Overall Study|Unreadable Scan|0|||
48948902|NCT00593112|157643410|FG000|Overall Study|Withdrawal by Subject|5|||
48948903|NCT00593112|157643411|FG001|Overall Study|Withdrawal by Subject|0|||
48948904|NCT00779038|157643412|FG000|Overall Study|Study Prematurely Terminated|13|||
48948905|NCT01184989|157643413|FG000|Overall Study|Adverse Event|11|||
48948906|NCT01184989|157643413|FG000|Overall Study|Withdrawal by Subject|1|||
48948907|NCT02927171|157643415|FG000|Overall Study|Lost to Follow-up|0|||
48948908|NCT02927171|157643416|FG001|Overall Study|Lost to Follow-up|1|||
48948909|NCT01319929|157643419|FG000|First Treatment Period (4 Weeks)|Adverse Event|2|||
48948910|NCT01319929|157643420|FG001|First Treatment Period (4 Weeks)|Adverse Event|0|||
48948911|NCT01319929|157643419|FG000|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
48948912|NCT01319929|157643420|FG001|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
48948913|NCT01319929|157643419|FG000|First Treatment Period (4 Weeks)|Protocol Violation|0|||
48948914|NCT01319929|157643420|FG001|First Treatment Period (4 Weeks)|Protocol Violation|1|||
48948915|NCT01319929|157643419|FG000|Second Treatment Period (4 Weeks)|Adverse Event|1|||
48948916|NCT01319929|157643420|FG001|Second Treatment Period (4 Weeks)|Adverse Event|0|||
48948917|NCT01319929|157643419|FG000|Second Treatment Period (4 Weeks)|Sponsor Decision|0|||
48948918|NCT01319929|157643420|FG001|Second Treatment Period (4 Weeks)|Sponsor Decision|1|||
48948919|NCT00234104|157643426|FG000|Overall Study|Adverse Event|4|||
48948920|NCT00234104|157643427|FG001|Overall Study|Adverse Event|0|||
48948921|NCT00234104|157643428|FG002|Overall Study|Adverse Event|3|||
48948922|NCT00234104|157643429|FG003|Overall Study|Adverse Event|5|||
48948923|NCT00234104|157643426|FG000|Overall Study|Protocol Violation|0|||
48948924|NCT00234104|157643427|FG001|Overall Study|Protocol Violation|0|||
48739406|NCT02639546|156894167|FG005|Overall Study|Withdrawal by Subject|1|||
48739407|NCT02639546|156894168|FG006|Overall Study|Withdrawal by Subject|2|||
48739408|NCT02639546|156894169|FG007|Overall Study|Withdrawal by Subject|1|||
48739409|NCT02716805|156894172|FG000|Overall Study|Progressive disease|2|||
48948925|NCT00234104|157643428|FG002|Overall Study|Protocol Violation|0|||
48948926|NCT00234104|157643429|FG003|Overall Study|Protocol Violation|1|||
48948927|NCT00234104|157643426|FG000|Overall Study|Physician Decision|0|||
48948928|NCT00234104|157643427|FG001|Overall Study|Physician Decision|1|||
48739410|NCT02716805|156894173|FG001|Overall Study|Progressive disease|0|||
48739411|NCT02716805|156894174|FG002|Overall Study|Progressive disease|0|||
48948929|NCT00234104|157643428|FG002|Overall Study|Physician Decision|2|||
48739412|NCT02716805|156894175|FG003|Overall Study|Progressive disease|0|||
48739413|NCT00939640|156894179|FG000|Overall Study|Physician Decision|1|||
48739414|NCT03817879|156895610|FG000|Overall Study|Drop out|5|||
48739415|NCT03817879|156895611|FG001|Overall Study|Drop out|12|||
48739416|NCT03817879|156895610|FG000|Overall Study|Withdrawal by Subject|0|||
48739417|NCT03817879|156895611|FG001|Overall Study|Withdrawal by Subject|1|||
48739418|NCT02925923|156895612|FG000|Overall Study|blood samples hemolyzed|0|||
48739419|NCT02925923|156895613|FG001|Overall Study|blood samples hemolyzed|2|||
48739420|NCT01846104|156895614|FG000|Overall Study|Withdrawal by Subject|1|||
48739421|NCT00282412|156895615|FG000|Overall Study|Death|2|||
48739422|NCT03055858|156895616|FG000|Overall Study|Death|9|||
48948930|NCT00234104|157643429|FG003|Overall Study|Physician Decision|2|||
48948931|NCT01873742|157643430|FG000|Overall Study|Lost to Follow-up|68|||
48948932|NCT01873742|157643431|FG001|Overall Study|Lost to Follow-up|76|||
48948933|NCT01507545|157643432|FG000|Overall Study|Withdrawal by Subject|6|||
48948934|NCT01507545|157643433|FG001|Overall Study|Withdrawal by Subject|2|||
48948935|NCT01507545|157643432|FG000|Overall Study|Lost to Follow-up|1|||
48948936|NCT01507545|157643433|FG001|Overall Study|Lost to Follow-up|0|||
48948937|NCT01507545|157643432|FG000|Overall Study|Discontinuation of the study by sponsor|11|||
48948938|NCT01507545|157643433|FG001|Overall Study|Discontinuation of the study by sponsor|9|||
48948939|NCT01507545|157643432|FG000|Overall Study|Progressive disease|60|||
48948940|NCT01507545|157643433|FG001|Overall Study|Progressive disease|27|||
48948941|NCT01507545|157643432|FG000|Overall Study|Other|6|||
48948942|NCT01507545|157643433|FG001|Overall Study|Other|4|||
48948943|NCT00790296|157643435|FG000|Overall Study|Did not meet study eligibility criteria|1|||
48948944|NCT00790296|157643436|FG001|Overall Study|Did not meet study eligibility criteria|1|||
48948945|NCT00790296|157643435|FG000|Overall Study|Adverse Event|0|||
48948946|NCT00790296|157643436|FG001|Overall Study|Adverse Event|1|||
48948947|NCT01541254|157643439|FG000|Overall Study|Withdrawal by Subject|1|||
48948948|NCT01541254|157643439|FG000|Overall Study|excluded - metal allergy|1|||
48948949|NCT01541254|157643439|FG000|Overall Study|enrolled after study closed|1|||
48948950|NCT01541254|157643439|FG000|Overall Study|GI bleed prior to procedure|1|||
48948951|NCT01541254|157643439|FG000|Overall Study|stent not required|1|||
48948952|NCT01541254|157643439|FG000|Overall Study|alternate stent used|1|||
48948953|NCT01022853|157643440|FG000|Overall Study|Progressive disease|2|||
48739423|NCT03055858|156895616|FG000|Overall Study|Withdrawal by Subject|11|||
48739424|NCT03055858|156895616|FG000|Overall Study|Lost to Follow-up|6|||
48739425|NCT03055858|156895616|FG000|Overall Study|Missed Follow-Up Visits|18|||
48739426|NCT04218695|156895620|FG000|Overall Study|Adverse Event|1|||
48739427|NCT04218695|156895621|FG001|Overall Study|Adverse Event|0|||
48739428|NCT02899299|156895622|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
48739429|NCT02899299|156895623|FG001|Pre-treatment|Participant request to discontinue study treatment|3|||
48739430|NCT02899299|156895622|FG000|Pre-treatment|Participant withdrew consent|1|||
48739431|NCT02899299|156895623|FG001|Pre-treatment|Participant withdrew consent|11|||
48739432|NCT02899299|156895622|FG000|Pre-treatment|Participant no longer meets study criteria|2|||
48739433|NCT02899299|156895623|FG001|Pre-treatment|Participant no longer meets study criteria|3|||
48739434|NCT02899299|156895622|FG000|Pre-treatment|Not reported|0|||
48739435|NCT02899299|156895623|FG001|Pre-treatment|Not reported|1|||
48739436|NCT02899299|156895622|FG000|Treatment|Disease Progression|182|||
48739437|NCT02899299|156895623|FG001|Treatment|Disease Progression|43|||
48739438|NCT02899299|156895622|FG000|Treatment|Study Drug Toxicity|60|||
48739439|NCT02899299|156895623|FG001|Treatment|Study Drug Toxicity|24|||
48739440|NCT02899299|156895622|FG000|Treatment|Adverse Event unrelated to Study Drug|11|||
48739441|NCT02899299|156895623|FG001|Treatment|Adverse Event unrelated to Study Drug|9|||
48739442|NCT02899299|156895622|FG000|Treatment|Participant request to discontinue Study treatment|4|||
48948954|NCT01022853|157643441|FG001|Overall Study|Progressive disease|3|||
48948955|NCT01022853|157643442|FG002|Overall Study|Progressive disease|11|||
48948956|NCT01022853|157643443|FG003|Overall Study|Progressive disease|7|||
48948957|NCT01022853|157643444|FG004|Overall Study|Progressive disease|1|||
48948958|NCT01022853|157643440|FG000|Overall Study|Dose-limiting toxicity|0|||
48948959|NCT01022853|157643441|FG001|Overall Study|Dose-limiting toxicity|0|||
48948960|NCT01022853|157643442|FG002|Overall Study|Dose-limiting toxicity|0|||
48948961|NCT01022853|157643443|FG003|Overall Study|Dose-limiting toxicity|0|||
48948962|NCT01022853|157643444|FG004|Overall Study|Dose-limiting toxicity|1|||
48739443|NCT02899299|156895623|FG001|Treatment|Participant request to discontinue Study treatment|10|||
48739444|NCT02899299|156895622|FG000|Treatment|Participant withdrew consent|6|||
48739445|NCT02899299|156895623|FG001|Treatment|Participant withdrew consent|3|||
48739446|NCT02899299|156895622|FG000|Treatment|Lost to Follow-up|0|||
48739447|NCT02899299|156895623|FG001|Treatment|Lost to Follow-up|2|||
48739448|NCT02899299|156895622|FG000|Treatment|Maximum Clinical Benefit|11|||
48739449|NCT02899299|156895623|FG001|Treatment|Maximum Clinical Benefit|2|||
48739450|NCT02899299|156895622|FG000|Treatment|Poor/Non-compliance|1|||
48739451|NCT02899299|156895623|FG001|Treatment|Poor/Non-compliance|0|||
48739452|NCT02899299|156895622|FG000|Treatment|Participant no longer meets Study criteria|4|||
48739453|NCT02899299|156895623|FG001|Treatment|Participant no longer meets Study criteria|0|||
48739454|NCT02899299|156895622|FG000|Treatment|Administrative reason by Sponsor|2|||
48739455|NCT02899299|156895623|FG001|Treatment|Administrative reason by Sponsor|0|||
48739456|NCT02899299|156895622|FG000|Treatment|Other reasons|12|||
48739457|NCT02899299|156895623|FG001|Treatment|Other reasons|2|||
48739458|NCT02899299|156895622|FG000|Treatment|Not reported|7|||
48739459|NCT02899299|156895623|FG001|Treatment|Not reported|0|||
48739460|NCT01392443|156895626|FG000|Overall Study|Disease progression|30|||
48739461|NCT01392443|156895626|FG000|Overall Study|Adverse Event|24|||
48739462|NCT01392443|156895626|FG000|Overall Study|Death|7|||
48739463|NCT01392443|156895626|FG000|Overall Study|Withdrawal by Subject|5|||
48739464|NCT01392443|156895626|FG000|Overall Study|Lost to Follow-up|1|||
48739465|NCT01392443|156895626|FG000|Overall Study|Protocol Violation|1|||
48739466|NCT00289133|156895629|FG000|Overall Study|Non-study device implanted|12|||
48739467|NCT00289133|156895630|FG001|Overall Study|Non-study device implanted|0|||
48739468|NCT00289133|156895629|FG000|Overall Study|Protocol Violation|32|||
48739469|NCT00289133|156895630|FG001|Overall Study|Protocol Violation|38|||
48739470|NCT00289133|156895629|FG000|Overall Study|Withdrawal by Subject|9|||
48739471|NCT00289133|156895630|FG001|Overall Study|Withdrawal by Subject|10|||
48739472|NCT00289133|156895629|FG000|Overall Study|Death|5|||
48739473|NCT00289133|156895630|FG001|Overall Study|Death|10|||
48739474|NCT00289133|156895629|FG000|Overall Study|Lost to Follow-up - Hurricane Katri|73|||
48739475|NCT00289133|156895630|FG001|Overall Study|Lost to Follow-up - Hurricane Katri|74|||
48739476|NCT00289133|156895629|FG000|Overall Study|Physician Decision|41|||
48739477|NCT00289133|156895630|FG001|Overall Study|Physician Decision|45|||
48739478|NCT00289133|156895629|FG000|Overall Study|Revision|8|||
48739479|NCT00289133|156895630|FG001|Overall Study|Revision|6|||
48739480|NCT00289133|156895629|FG000|Overall Study|Lost to Follow-up|92|||
48739481|NCT00289133|156895630|FG001|Overall Study|Lost to Follow-up|115|||
48739482|NCT01364649|156895631|FG000|Overall Study|Pretreatment Event or Adverse Event|20|||
48739483|NCT01364649|156895632|FG001|Overall Study|Pretreatment Event or Adverse Event|14|||
48739484|NCT01364649|156895631|FG000|Overall Study|Lack of Efficacy|6|||
48739485|NCT01364649|156895632|FG001|Overall Study|Lack of Efficacy|0|||
48739486|NCT01364649|156895631|FG000|Overall Study|Non-compliance with Investigational Drug|1|||
48739487|NCT01364649|156895632|FG001|Overall Study|Non-compliance with Investigational Drug|0|||
48739488|NCT01364649|156895631|FG000|Overall Study|Protocol Deviations|4|||
48739489|NCT01364649|156895632|FG001|Overall Study|Protocol Deviations|8|||
48739490|NCT01364649|156895631|FG000|Overall Study|Withdrawal of Consent|9|||
48739491|NCT01364649|156895632|FG001|Overall Study|Withdrawal of Consent|7|||
48739492|NCT01364649|156895631|FG000|Overall Study|Lost to Follow-up|12|||
48739493|NCT01364649|156895632|FG001|Overall Study|Lost to Follow-up|13|||
48739494|NCT01364649|156895631|FG000|Overall Study|Other|4|||
48739495|NCT01364649|156895632|FG001|Overall Study|Other|1|||
48739496|NCT02097420|156895635|FG000|Overall Study|Death|6|||
48739497|NCT02097420|156895635|FG000|Overall Study|Valve explanted|13|||
48739498|NCT02097420|156895635|FG000|Overall Study|Other Reason|1|||
48739499|NCT04938492|156895639|FG000|Overall Study|Lost to Follow-up|17|||
48739500|NCT04938492|156895640|FG001|Overall Study|Lost to Follow-up|18|||
48739501|NCT01065597|156895647|FG000|Overall Study|Adverse Event|1|||
48739502|NCT01453361|156895648|FG000|Overall Study|Disease Progression|6|||
48739503|NCT01453361|156895648|FG000|Overall Study|Screen-Failures|10|||
48739504|NCT01708161|156895649|FG000|Overall Study|Adverse Event|1|||
48739505|NCT01708161|156895650|FG001|Overall Study|Adverse Event|3|||
48739506|NCT01708161|156895651|FG002|Overall Study|Adverse Event|4|||
48739507|NCT01708161|156895652|FG003|Overall Study|Adverse Event|2|||
48739508|NCT01708161|156895653|FG004|Overall Study|Adverse Event|3|||
48739509|NCT01708161|156895654|FG005|Overall Study|Adverse Event|0|||
48739510|NCT01708161|156895649|FG000|Overall Study|Death|0|||
48739511|NCT01708161|156895650|FG001|Overall Study|Death|0|||
48739512|NCT01708161|156895651|FG002|Overall Study|Death|0|||
48739513|NCT01708161|156895652|FG003|Overall Study|Death|1|||
48739514|NCT01708161|156895653|FG004|Overall Study|Death|0|||
48739515|NCT01708161|156895654|FG005|Overall Study|Death|1|||
48739516|NCT01708161|156895649|FG000|Overall Study|Withdrawal by Subject|0|||
48739517|NCT01708161|156895650|FG001|Overall Study|Withdrawal by Subject|1|||
48739518|NCT01708161|156895651|FG002|Overall Study|Withdrawal by Subject|1|||
48948963|NCT01022853|157643440|FG000|Overall Study|Withdrawal by Subject|0|||
48948964|NCT01022853|157643441|FG001|Overall Study|Withdrawal by Subject|1|||
48948965|NCT01022853|157643442|FG002|Overall Study|Withdrawal by Subject|1|||
48948966|NCT01022853|157643443|FG003|Overall Study|Withdrawal by Subject|1|||
48739519|NCT01708161|156895652|FG003|Overall Study|Withdrawal by Subject|0|||
48739520|NCT01708161|156895653|FG004|Overall Study|Withdrawal by Subject|0|||
48739521|NCT01708161|156895654|FG005|Overall Study|Withdrawal by Subject|0|||
48739522|NCT01708161|156895649|FG000|Overall Study|Administrative problems|0|||
48948967|NCT01022853|157643444|FG004|Overall Study|Withdrawal by Subject|0|||
48948968|NCT01022853|157643440|FG000|Overall Study|Other not stated above|1|||
48739523|NCT01708161|156895650|FG001|Overall Study|Administrative problems|1|||
48739524|NCT01708161|156895651|FG002|Overall Study|Administrative problems|0|||
48739525|NCT01708161|156895652|FG003|Overall Study|Administrative problems|0|||
48739526|NCT01708161|156895653|FG004|Overall Study|Administrative problems|0|||
48739527|NCT01708161|156895654|FG005|Overall Study|Administrative problems|0|||
48739528|NCT01708161|156895649|FG000|Overall Study|Disease progression|3|||
48739529|NCT01708161|156895650|FG001|Overall Study|Disease progression|5|||
49015347|NCT00673790|157892153|FG001|Overall Study|Poor compliance|0|||
48739530|NCT01708161|156895651|FG002|Overall Study|Disease progression|5|||
48739531|NCT01708161|156895652|FG003|Overall Study|Disease progression|13|||
48739532|NCT01708161|156895653|FG004|Overall Study|Disease progression|3|||
48948969|NCT01022853|157643441|FG001|Overall Study|Other not stated above|0|||
48739533|NCT01708161|156895654|FG005|Overall Study|Disease progression|0|||
48739534|NCT01058655|156895655|FG000|Overall Study|Withdrawal by Subject|1|||
48739535|NCT01058655|156895656|FG001|Overall Study|Withdrawal by Subject|0|||
48739536|NCT01058655|156895657|FG002|Overall Study|Withdrawal by Subject|3|||
48853866|NCT02823574|157304882|FG000|Treatment Period|Poor/Non Compliance|1|||
48853867|NCT02823574|157304883|FG001|Treatment Period|Poor/Non Compliance|0|||
48853868|NCT02823574|157304884|FG002|Treatment Period|Poor/Non Compliance|0|||
48853869|NCT02823574|157304885|FG003|Treatment Period|Poor/Non Compliance|1|||
48853870|NCT02823574|157304882|FG000|Treatment Period|Maximum Clinical Benefit|8|||
48853871|NCT02823574|157304883|FG001|Treatment Period|Maximum Clinical Benefit|4|||
48853872|NCT02823574|157304884|FG002|Treatment Period|Maximum Clinical Benefit|7|||
48853873|NCT02823574|157304885|FG003|Treatment Period|Maximum Clinical Benefit|1|||
48853874|NCT02823574|157304882|FG000|Treatment Period|Lost to Follow-up|1|||
48853875|NCT02823574|157304883|FG001|Treatment Period|Lost to Follow-up|1|||
48853876|NCT02823574|157304884|FG002|Treatment Period|Lost to Follow-up|0|||
48853877|NCT02823574|157304885|FG003|Treatment Period|Lost to Follow-up|0|||
48853878|NCT02823574|157304882|FG000|Treatment Period|Participant withdrew consent|4|||
48853879|NCT02823574|157304883|FG001|Treatment Period|Participant withdrew consent|0|||
48853880|NCT02823574|157304884|FG002|Treatment Period|Participant withdrew consent|0|||
48853881|NCT02823574|157304885|FG003|Treatment Period|Participant withdrew consent|1|||
48853882|NCT02823574|157304882|FG000|Treatment Period|Participant request to discontinue|5|||
48853883|NCT02823574|157304883|FG001|Treatment Period|Participant request to discontinue|0|||
48853884|NCT02823574|157304884|FG002|Treatment Period|Participant request to discontinue|3|||
48853885|NCT02823574|157304885|FG003|Treatment Period|Participant request to discontinue|2|||
48853886|NCT02823574|157304882|FG000|Treatment Period|Adverse Event unrelated to to study Drug|10|||
48853887|NCT02823574|157304883|FG001|Treatment Period|Adverse Event unrelated to to study Drug|2|||
48853888|NCT02823574|157304884|FG002|Treatment Period|Adverse Event unrelated to to study Drug|9|||
48853889|NCT02823574|157304885|FG003|Treatment Period|Adverse Event unrelated to to study Drug|2|||
48853890|NCT02823574|157304882|FG000|Treatment Period|Study Drug Toxicity|11|||
48853891|NCT02823574|157304883|FG001|Treatment Period|Study Drug Toxicity|2|||
48853892|NCT02823574|157304884|FG002|Treatment Period|Study Drug Toxicity|14|||
48853893|NCT02823574|157304885|FG003|Treatment Period|Study Drug Toxicity|4|||
48853894|NCT02823574|157304882|FG000|Treatment Period|Disease Progression|113|||
48853895|NCT02823574|157304883|FG001|Treatment Period|Disease Progression|64|||
48853896|NCT02823574|157304884|FG002|Treatment Period|Disease Progression|82|||
48853897|NCT02823574|157304885|FG003|Treatment Period|Disease Progression|43|||
48853898|NCT02823574|157304882|FG000|Treatment Period|Other reasons|5|||
48853899|NCT02823574|157304883|FG001|Treatment Period|Other reasons|9|||
48853900|NCT02823574|157304884|FG002|Treatment Period|Other reasons|3|||
48853901|NCT02823574|157304885|FG003|Treatment Period|Other reasons|6|||
48853902|NCT02823574|157304882|FG000|Treatment Period|Participant no longer meets study criteria|0|||
48853903|NCT02823574|157304883|FG001|Treatment Period|Participant no longer meets study criteria|0|||
48853904|NCT02823574|157304884|FG002|Treatment Period|Participant no longer meets study criteria|1|||
48853905|NCT02823574|157304885|FG003|Treatment Period|Participant no longer meets study criteria|0|||
48853906|NCT02823574|157304882|FG000|Treatment Period|Death|0|||
48853907|NCT02823574|157304883|FG001|Treatment Period|Death|0|||
48853908|NCT02823574|157304884|FG002|Treatment Period|Death|3|||
48853909|NCT02823574|157304885|FG003|Treatment Period|Death|1|||
48853910|NCT01728324|157304886|FG000|Termination of DBV|Adverse Event|14|||
48853911|NCT01728324|157304887|FG001|Termination of DBV|Adverse Event|13|||
48853912|NCT01728324|157304888|FG002|Termination of DBV|Adverse Event|4|||
48853913|NCT01728324|157304886|FG000|Termination of DBV|Lack of Efficacy|14|||
48853914|NCT01728324|157304887|FG001|Termination of DBV|Lack of Efficacy|12|||
48853915|NCT01728324|157304888|FG002|Termination of DBV|Lack of Efficacy|8|||
48853916|NCT01728324|157304886|FG000|Termination of DBV|Withdrawal by Subject|9|||
48739537|NCT01058655|156895658|FG003|Overall Study|Withdrawal by Subject|4|||
48739538|NCT01058655|156895655|FG000|Overall Study|Prolonged Treatment Delay|0|||
48739539|NCT01058655|156895656|FG001|Overall Study|Prolonged Treatment Delay|0|||
48739540|NCT01058655|156895657|FG002|Overall Study|Prolonged Treatment Delay|0|||
48739541|NCT01058655|156895658|FG003|Overall Study|Prolonged Treatment Delay|2|||
48739542|NCT01058655|156895655|FG000|Overall Study|Symptomatic Deterioration|0|||
48739543|NCT01058655|156895656|FG001|Overall Study|Symptomatic Deterioration|0|||
48739544|NCT01058655|156895657|FG002|Overall Study|Symptomatic Deterioration|0|||
48739545|NCT01058655|156895658|FG003|Overall Study|Symptomatic Deterioration|1|||
48739546|NCT01058655|156895655|FG000|Overall Study|Clinical Progression (non-RECIST)|1|||
48739547|NCT01058655|156895656|FG001|Overall Study|Clinical Progression (non-RECIST)|0|||
48739548|NCT01058655|156895657|FG002|Overall Study|Clinical Progression (non-RECIST)|0|||
48739549|NCT01058655|156895658|FG003|Overall Study|Clinical Progression (non-RECIST)|7|||
48739550|NCT01058655|156895655|FG000|Overall Study|Death|0|||
48739551|NCT01058655|156895656|FG001|Overall Study|Death|1|||
48739552|NCT01058655|156895657|FG002|Overall Study|Death|1|||
48853917|NCT01728324|157304887|FG001|Termination of DBV|Withdrawal by Subject|6|||
48853918|NCT01728324|157304888|FG002|Termination of DBV|Withdrawal by Subject|2|||
48853919|NCT01728324|157304886|FG000|Termination of DBV|Other than stated|1|||
48739553|NCT01058655|156895658|FG003|Overall Study|Death|0|||
48739554|NCT01058655|156895655|FG000|Overall Study|Disease Progression|1|||
48853920|NCT01728324|157304887|FG001|Termination of DBV|Other than stated|3|||
48739555|NCT01058655|156895656|FG001|Overall Study|Disease Progression|2|||
48739556|NCT01058655|156895657|FG002|Overall Study|Disease Progression|4|||
48739557|NCT01058655|156895658|FG003|Overall Study|Disease Progression|24|||
48739558|NCT01058655|156895655|FG000|Overall Study|Other|0|||
48739559|NCT01058655|156895656|FG001|Overall Study|Other|0|||
48948970|NCT01022853|157643442|FG002|Overall Study|Other not stated above|1|||
48948971|NCT01022853|157643443|FG003|Overall Study|Other not stated above|0|||
48948972|NCT01022853|157643444|FG004|Overall Study|Other not stated above|0|||
48739560|NCT01058655|156895657|FG002|Overall Study|Other|0|||
48739561|NCT01058655|156895658|FG003|Overall Study|Other|4|||
48739562|NCT03212690|156895659|FG000|Overall Study|Protocol Violation|1|||
48948973|NCT00700752|157643445|FG000|First Intervention|Withdrawal by Subject|0|||
48948974|NCT00700752|157643446|FG001|First Intervention|Withdrawal by Subject|2|||
49015348|NCT00673790|157892154|FG002|Overall Study|Poor compliance|0|||
48739563|NCT01313312|156895660|FG000|Overall Study|Adverse Event|5|||
48739564|NCT01313312|156895660|FG000|Overall Study|Withdrawal by Subject|18|||
48739565|NCT01313312|156895660|FG000|Overall Study|Lack of Efficacy|3|||
48739566|NCT01313312|156895660|FG000|Overall Study|Investigator Decision|1|||
48739567|NCT01313312|156895660|FG000|Overall Study|Observational Phase|1|||
48739568|NCT01313312|156895660|FG000|Overall Study|Subject Withdrawn Early in Error|4|||
48739569|NCT01313312|156895660|FG000|Overall Study|Did Not Receive Treatment with Dysport®|4|||
48739570|NCT00932126|156895666|FG000|Overall Study|Adverse Event|0|||
48739571|NCT00932126|156895667|FG001|Overall Study|Adverse Event|0|||
48739572|NCT00932126|156895668|FG002|Overall Study|Adverse Event|0|||
48739573|NCT00932126|156895669|FG003|Overall Study|Adverse Event|0|||
48739574|NCT00932126|156895670|FG004|Overall Study|Adverse Event|0|||
48739575|NCT00932126|156895671|FG005|Overall Study|Adverse Event|0|||
48739576|NCT00932126|156895672|FG006|Overall Study|Adverse Event|1|||
48853921|NCT01728324|157304888|FG002|Termination of DBV|Other than stated|0|||
48853922|NCT01728324|157304886|FG000|Termination of DBV|Adverse Event (Placebo Period)|0|||
48853923|NCT01728324|157304887|FG001|Termination of DBV|Adverse Event (Placebo Period)|1|||
48853924|NCT01728324|157304888|FG002|Termination of DBV|Adverse Event (Placebo Period)|0|||
48853925|NCT01728324|157304886|FG000|Termination of DBV|Protocol Violation (Placebo Period)|0|||
48853926|NCT01728324|157304887|FG001|Termination of DBV|Protocol Violation (Placebo Period)|1|||
48853927|NCT01728324|157304888|FG002|Termination of DBV|Protocol Violation (Placebo Period)|0|||
48853928|NCT01728324|157304886|FG000|Termination of FDV|Adverse Event|14|||
48853929|NCT01728324|157304887|FG001|Termination of FDV|Adverse Event|13|||
48853930|NCT01728324|157304888|FG002|Termination of FDV|Adverse Event|4|||
48739577|NCT00932126|156895673|FG007|Overall Study|Adverse Event|2|||
48739578|NCT00932126|156895666|FG000|Overall Study|Protocol Violation|0|||
48739579|NCT00932126|156895667|FG001|Overall Study|Protocol Violation|0|||
48739580|NCT00932126|156895668|FG002|Overall Study|Protocol Violation|0|||
48739581|NCT00932126|156895669|FG003|Overall Study|Protocol Violation|0|||
48739582|NCT00932126|156895670|FG004|Overall Study|Protocol Violation|1|||
48739583|NCT00932126|156895671|FG005|Overall Study|Protocol Violation|0|||
48853931|NCT01728324|157304886|FG000|Termination of FDV|Lack of Efficacy|14|||
48853932|NCT01728324|157304887|FG001|Termination of FDV|Lack of Efficacy|12|||
48853933|NCT01728324|157304888|FG002|Termination of FDV|Lack of Efficacy|8|||
48853934|NCT01728324|157304886|FG000|Termination of FDV|Withdrawal by Subject|9|||
48853935|NCT01728324|157304887|FG001|Termination of FDV|Withdrawal by Subject|6|||
48853936|NCT01728324|157304888|FG002|Termination of FDV|Withdrawal by Subject|2|||
48853937|NCT01728324|157304886|FG000|Termination of FDV|Other than stated|1|||
48853938|NCT01728324|157304887|FG001|Termination of FDV|Other than stated|3|||
48853939|NCT01728324|157304888|FG002|Termination of FDV|Other than stated|0|||
48853940|NCT01728324|157304886|FG000|Termination of FDV|Adverse Event (Placebo Period)|0|||
48853941|NCT01728324|157304887|FG001|Termination of FDV|Adverse Event (Placebo Period)|1|||
48853942|NCT01728324|157304888|FG002|Termination of FDV|Adverse Event (Placebo Period)|0|||
48853943|NCT01728324|157304886|FG000|Termination of FDV|Protocol Violation (Placebo Period)|0|||
48853944|NCT01728324|157304887|FG001|Termination of FDV|Protocol Violation (Placebo Period)|1|||
48853945|NCT01728324|157304888|FG002|Termination of FDV|Protocol Violation (Placebo Period)|0|||
48948975|NCT00673673|157643451|FG000|Overall Study|Progressive disease|27|||
48853946|NCT01728324|157304886|FG000|Termination of RBV|Adverse Event|15|||
48853947|NCT01728324|157304887|FG001|Termination of RBV|Adverse Event|16|||
48853948|NCT01728324|157304888|FG002|Termination of RBV|Adverse Event|5|||
48853949|NCT01728324|157304886|FG000|Termination of RBV|Lack of Efficacy|14|||
48853950|NCT01728324|157304887|FG001|Termination of RBV|Lack of Efficacy|11|||
48853951|NCT01728324|157304888|FG002|Termination of RBV|Lack of Efficacy|7|||
48853952|NCT01728324|157304886|FG000|Termination of RBV|Withdrawal by Subject|9|||
48853953|NCT01728324|157304887|FG001|Termination of RBV|Withdrawal by Subject|5|||
48853954|NCT01728324|157304888|FG002|Termination of RBV|Withdrawal by Subject|2|||
48853955|NCT01728324|157304886|FG000|Termination of RBV|Other than stated|1|||
48853956|NCT01728324|157304887|FG001|Termination of RBV|Other than stated|3|||
48853957|NCT01728324|157304888|FG002|Termination of RBV|Other than stated|1|||
48853958|NCT01728324|157304886|FG000|Termination of RBV|Adverse Event (Placebo Period)|0|||
48853959|NCT01728324|157304887|FG001|Termination of RBV|Adverse Event (Placebo Period)|1|||
48853960|NCT01728324|157304888|FG002|Termination of RBV|Adverse Event (Placebo Period)|0|||
48853961|NCT01728324|157304886|FG000|Termination of RBV|Protocol Violation (Placebo Period)|0|||
48853962|NCT01728324|157304887|FG001|Termination of RBV|Protocol Violation (Placebo Period)|1|||
48853963|NCT01728324|157304888|FG002|Termination of RBV|Protocol Violation (Placebo Period)|0|||
48853964|NCT02040870|157304889|FG000|Overall Study|Completed treatment phase|6|||
48853965|NCT02040870|157304889|FG000|Overall Study|Adverse Event|7|||
48853966|NCT02040870|157304889|FG000|Overall Study|Progressive disease|58|||
48853967|NCT02040870|157304889|FG000|Overall Study|Physician Decision|6|||
48853968|NCT02040870|157304889|FG000|Overall Study|Subject/guardian decision|10|||
48853969|NCT02040870|157304889|FG000|Overall Study|Lost to Follow-up|3|||
48853970|NCT02040870|157304889|FG000|Overall Study|Death|13|||
48853971|NCT03131713|157304892|FG000|Overall Study|Lost to Follow-up|5|||
48948976|NCT00673673|157643451|FG000|Overall Study|Adverse Event|4|||
48853972|NCT03131713|157304893|FG001|Overall Study|Lost to Follow-up|0|||
48853973|NCT00701415|157304894|FG000|Overall Study|Adverse Event|0|||
48948977|NCT00673673|157643451|FG000|Overall Study|Withdrawal by Subject|3|||
48948978|NCT00673673|157643451|FG000|Overall Study|Investigators' discretion|2|||
48948979|NCT00312377|157643452|FG000|Overall Study|Death|403|||
48948980|NCT00312377|157643453|FG001|Overall Study|Death|418|||
48948981|NCT00312377|157643452|FG000|Overall Study|Withdrawal by Subject|23|||
48948982|NCT00312377|157643453|FG001|Overall Study|Withdrawal by Subject|30|||
48948983|NCT00312377|157643452|FG000|Overall Study|Lost to Follow-up|9|||
48948984|NCT00312377|157643453|FG001|Overall Study|Lost to Follow-up|12|||
48948985|NCT00312377|157643452|FG000|Overall Study|Non-compliance|0|||
48948986|NCT00312377|157643453|FG001|Overall Study|Non-compliance|2|||
48948987|NCT00312377|157643452|FG000|Overall Study|Randomised but never received treatment|6|||
48948988|NCT00312377|157643453|FG001|Overall Study|Randomised but never received treatment|6|||
48948989|NCT00312377|157643452|FG000|Overall Study|Discontinue treatment survival follow up|202|||
48948990|NCT00312377|157643453|FG001|Overall Study|Discontinue treatment survival follow up|200|||
48948991|NCT00312377|157643452|FG000|Overall Study|Site ended participation in study|1|||
48948992|NCT00312377|157643453|FG001|Overall Study|Site ended participation in study|0|||
48948993|NCT04083222|157643454|FG000|Overall Study|Voluntary Withdrawal|0|||
48948994|NCT04083222|157643455|FG001|Overall Study|Voluntary Withdrawal|1|||
48948995|NCT04083222|157643454|FG000|Overall Study|Reason not Specified|0|||
48948996|NCT04083222|157643455|FG001|Overall Study|Reason not Specified|1|||
48948997|NCT00970294|157643458|FG000|Overall Study|Physician Decision|4|||
48853974|NCT00701415|157304895|FG001|Overall Study|Adverse Event|1|||
48853975|NCT00701415|157304894|FG000|Overall Study|Social/family issues and needle phobia|1|||
48853976|NCT00701415|157304895|FG001|Overall Study|Social/family issues and needle phobia|0|||
48853977|NCT02208843|157304896|FG000|Overall Study|Clinical symptoms of progression|2|||
48948998|NCT00970294|157643458|FG000|Overall Study|Withdrawal by Subject|1|||
48948999|NCT04172831|157643463|FG000|Overall Study|Adverse Event|21|||
48949000|NCT04172831|157643464|FG001|Overall Study|Adverse Event|9|||
48949001|NCT04172831|157643463|FG000|Overall Study|Lack of Efficacy|2|||
48949002|NCT04172831|157643464|FG001|Overall Study|Lack of Efficacy|8|||
48949003|NCT04172831|157643463|FG000|Overall Study|Physician Decision|0|||
48949004|NCT04172831|157643464|FG001|Overall Study|Physician Decision|1|||
48949005|NCT04172831|157643463|FG000|Overall Study|Withdrawal by Subject|12|||
48949006|NCT04172831|157643464|FG001|Overall Study|Withdrawal by Subject|11|||
48949007|NCT04172831|157643463|FG000|Overall Study|Lost to Follow-up|4|||
48949008|NCT04172831|157643464|FG001|Overall Study|Lost to Follow-up|9|||
48949009|NCT04172831|157643463|FG000|Overall Study|COVID-19 related crisis|3|||
48853978|NCT02208843|157304896|FG000|Overall Study|Progression disease according to RECIST|24|||
48853979|NCT02208843|157304896|FG000|Overall Study|Adverse Event|12|||
48853980|NCT02208843|157304896|FG000|Overall Study|Protocol Violation|1|||
48853981|NCT02208843|157304896|FG000|Overall Study|Withdrawal by Subject|1|||
48949010|NCT04172831|157643464|FG001|Overall Study|COVID-19 related crisis|3|||
48949011|NCT04172831|157643463|FG000|Overall Study|Subject non-compliance|1|||
48949012|NCT04172831|157643464|FG001|Overall Study|Subject non-compliance|1|||
48949013|NCT04172831|157643463|FG000|Overall Study|Family emergency|1|||
48949014|NCT04172831|157643464|FG001|Overall Study|Family emergency|0|||
48949015|NCT01041573|157643465|FG000|Overall Study|Withdrawal by Subject|2|||
48853982|NCT02208843|157304896|FG000|Overall Study|Switched to commercial afatinib|20|||
48853983|NCT01794299|157304901|FG000|Overall Study|ATIR manufacturing not possible|1|||
48853984|NCT01794299|157304901|FG000|Overall Study|Death|14|||
48853985|NCT01794299|157304901|FG000|Overall Study|Graft failure|1|||
48853986|NCT01794299|157304901|FG000|Overall Study|ATIR batch rejected|2|||
48853987|NCT01794299|157304901|FG000|Overall Study|Relapse|2|||
48949016|NCT01041573|157643466|FG001|Overall Study|Withdrawal by Subject|5|||
48949017|NCT01041573|157643467|FG002|Overall Study|Withdrawal by Subject|2|||
48949018|NCT01041573|157643468|FG003|Overall Study|Withdrawal by Subject|0|||
48949019|NCT01041573|157643465|FG000|Overall Study|Death|1|||
48949020|NCT01041573|157643466|FG001|Overall Study|Death|0|||
48949021|NCT01041573|157643467|FG002|Overall Study|Death|0|||
48949022|NCT01041573|157643468|FG003|Overall Study|Death|0|||
48949023|NCT01041573|157643465|FG000|Overall Study|Lost to Follow-up|0|||
48949024|NCT01041573|157643466|FG001|Overall Study|Lost to Follow-up|1|||
48949025|NCT01041573|157643467|FG002|Overall Study|Lost to Follow-up|2|||
48949026|NCT01041573|157643468|FG003|Overall Study|Lost to Follow-up|1|||
48853988|NCT01794299|157304901|FG000|Overall Study|Discontinued from active follow-up|1|||
48853989|NCT01794299|157304901|FG000|Overall Study|Relapse and rejection of ATIR batch|1|||
48853990|NCT01228734|157304904|FG000|Overall Study|Randomized, but not treated|0|||
48853991|NCT01228734|157304905|FG001|Overall Study|Randomized, but not treated|4|||
48853992|NCT03128099|157304906|FG000|Overall Study|High dose task was too long|0|||
48949027|NCT01041573|157643465|FG000|Overall Study|Adverse Event|0|||
48949028|NCT01041573|157643466|FG001|Overall Study|Adverse Event|2|||
48853993|NCT03128099|157304907|FG001|Overall Study|High dose task was too long|4|||
48853994|NCT03128099|157304908|FG002|Overall Study|High dose task was too long|0|||
48853995|NCT03128099|157304906|FG000|Overall Study|Participant got a full time job.|1|||
48853996|NCT03128099|157304907|FG001|Overall Study|Participant got a full time job.|0|||
48853997|NCT03128099|157304908|FG002|Overall Study|Participant got a full time job.|0|||
48853998|NCT03128099|157304906|FG000|Overall Study|Became homeless and lost contact|1|||
48853999|NCT03128099|157304907|FG001|Overall Study|Became homeless and lost contact|0|||
48854000|NCT03128099|157304908|FG002|Overall Study|Became homeless and lost contact|0|||
48854001|NCT03128099|157304906|FG000|Overall Study|Did not complete all the assessments|0|||
48854002|NCT03128099|157304907|FG001|Overall Study|Did not complete all the assessments|0|||
48854003|NCT03128099|157304908|FG002|Overall Study|Did not complete all the assessments|1|||
48854004|NCT03335488|157304909|FG000|Maintenance Period|Withdrawal by Parent/Guardian|1|||
48854005|NCT03335488|157304910|FG001|Maintenance Period|Withdrawal by Parent/Guardian|0|||
48854006|NCT03335488|157304909|FG000|Safety Extension Period|Adverse Event|1|||
48854007|NCT03335488|157304910|FG001|Safety Extension Period|Adverse Event|0|||
48854008|NCT03335488|157304909|FG000|Safety Extension Period|Did Not Return to Study Visit|1|||
48854009|NCT03335488|157304910|FG001|Safety Extension Period|Did Not Return to Study Visit|0|||
48854010|NCT03456856|157304913|FG000|Overall Study|Lost to Follow-up|2|||
48854011|NCT03456856|157304913|FG000|Overall Study|Withdrawal by Subject|1|||
48854012|NCT00388726|157304914|FG000|Overall Study|Adverse Event|50|||
48854013|NCT00388726|157304915|FG001|Overall Study|Adverse Event|24|||
48854014|NCT00388726|157304914|FG000|Overall Study|Progressive Disease|336|||
48854015|NCT00388726|157304915|FG001|Overall Study|Progressive Disease|153|||
48854016|NCT00388726|157304914|FG000|Overall Study|Clinical Progression|61|||
48854017|NCT00388726|157304915|FG001|Overall Study|Clinical Progression|36|||
48854018|NCT00388726|157304914|FG000|Overall Study|Withdrawal by Subject|10|||
48854019|NCT00388726|157304915|FG001|Overall Study|Withdrawal by Subject|7|||
48854020|NCT00388726|157304914|FG000|Overall Study|Administrative|6|||
48854021|NCT00388726|157304915|FG001|Overall Study|Administrative|9|||
48854022|NCT00388726|157304914|FG000|Overall Study|Physician Decision|18|||
48854023|NCT00388726|157304915|FG001|Overall Study|Physician Decision|13|||
48854024|NCT00388726|157304914|FG000|Overall Study|Death|3|||
48854025|NCT00388726|157304915|FG001|Overall Study|Death|2|||
48854026|NCT01584648|157304916|FG000|Overall Study|Death|136|||
48854027|NCT01584648|157304917|FG001|Overall Study|Death|146|||
48854028|NCT01584648|157304916|FG000|Overall Study|Lost to Follow-up|9|||
48949029|NCT01041573|157643467|FG002|Overall Study|Adverse Event|0|||
48949030|NCT01041573|157643468|FG003|Overall Study|Adverse Event|0|||
48949031|NCT01041573|157643465|FG000|Overall Study|relocation|1|||
48949032|NCT01041573|157643466|FG001|Overall Study|relocation|4|||
48949033|NCT01041573|157643467|FG002|Overall Study|relocation|3|||
48949034|NCT01041573|157643468|FG003|Overall Study|relocation|1|||
48949035|NCT01041573|157643465|FG000|Overall Study|further blood extraction|0|||
48949036|NCT01041573|157643466|FG001|Overall Study|further blood extraction|1|||
48949037|NCT01041573|157643467|FG002|Overall Study|further blood extraction|0|||
48949038|NCT01041573|157643468|FG003|Overall Study|further blood extraction|0|||
48949039|NCT01041573|157643465|FG000|Overall Study|positive to anti-HCV|1|||
48949040|NCT01041573|157643466|FG001|Overall Study|positive to anti-HCV|0|||
48949041|NCT01041573|157643467|FG002|Overall Study|positive to anti-HCV|0|||
48949042|NCT01041573|157643468|FG003|Overall Study|positive to anti-HCV|0|||
48949043|NCT03176966|157643469|FG000|Baseline to 3 Months (1st Intervention)|Death|2|||
48949044|NCT03176966|157643470|FG001|Baseline to 3 Months (1st Intervention)|Death|1|||
48949045|NCT03176966|157643469|FG000|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|1|||
48949046|NCT03176966|157643470|FG001|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|4|||
48949047|NCT03176966|157643469|FG000|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|1|||
48949048|NCT03176966|157643470|FG001|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|2|||
48949049|NCT03176966|157643469|FG000|3 Month to 6 Months (2nd Intervention)|Death|0|||
48949050|NCT03176966|157643470|FG001|3 Month to 6 Months (2nd Intervention)|Death|1|||
48949051|NCT03176966|157643469|FG000|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|3|||
48949052|NCT03176966|157643470|FG001|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|4|||
48949053|NCT03176966|157643469|FG000|3 Month to 6 Months (2nd Intervention)|Physician Decision|1|||
48949054|NCT03176966|157643470|FG001|3 Month to 6 Months (2nd Intervention)|Physician Decision|0|||
48949055|NCT03176966|157643469|FG000|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|2|||
48949056|NCT03176966|157643470|FG001|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|0|||
48949057|NCT02955186|157643474|FG000|Overall Study|Withdrawal by Subject|6|||
48949058|NCT02955186|157643475|FG001|Overall Study|Withdrawal by Subject|2|||
48949059|NCT02955186|157643474|FG000|Overall Study|Protocol Violation|1|||
48949060|NCT02955186|157643475|FG001|Overall Study|Protocol Violation|0|||
48949061|NCT01618656|157643480|FG000|Overall Study|Withdrawal by Subject|7|||
48949062|NCT01618656|157643481|FG001|Overall Study|Withdrawal by Subject|3|||
48949063|NCT01618656|157643480|FG000|Overall Study|Physician Decision|1|||
48949064|NCT01618656|157643481|FG001|Overall Study|Physician Decision|1|||
48949065|NCT01422304|157643482|FG000|Overall Study|Adverse Event|0|||
48949066|NCT01422304|157643483|FG001|Overall Study|Adverse Event|1|||
48949067|NCT01422304|157643482|FG000|Overall Study|Lost to Follow-up|14|||
48949068|NCT01422304|157643483|FG001|Overall Study|Lost to Follow-up|20|||
48949069|NCT01422304|157643482|FG000|Overall Study|Never Entered Follow-up|2|||
48949070|NCT01422304|157643483|FG001|Overall Study|Never Entered Follow-up|1|||
48949071|NCT01422304|157643482|FG000|Overall Study|Protocol Violation|1|||
48949072|NCT01422304|157643483|FG001|Overall Study|Protocol Violation|0|||
48949073|NCT01422304|157643482|FG000|Overall Study|Withdrawal by Subject|4|||
48949074|NCT01422304|157643483|FG001|Overall Study|Withdrawal by Subject|2|||
48949075|NCT01422304|157643482|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
48949076|NCT01422304|157643483|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
48949077|NCT01422304|157643482|FG000|Overall Study|Not Treated|3|||
48854029|NCT01584648|157304917|FG001|Overall Study|Lost to Follow-up|9|||
48854030|NCT01584648|157304916|FG000|Overall Study|Investigator discretion|3|||
48739584|NCT00932126|156895672|FG006|Overall Study|Protocol Violation|0|||
48739585|NCT00932126|156895673|FG007|Overall Study|Protocol Violation|0|||
48739586|NCT00932126|156895666|FG000|Overall Study|Withdrawal by Subject|0|||
48739587|NCT00932126|156895667|FG001|Overall Study|Withdrawal by Subject|0|||
48739588|NCT00932126|156895668|FG002|Overall Study|Withdrawal by Subject|1|||
48739589|NCT00932126|156895669|FG003|Overall Study|Withdrawal by Subject|0|||
48739590|NCT00932126|156895670|FG004|Overall Study|Withdrawal by Subject|0|||
48739591|NCT00932126|156895671|FG005|Overall Study|Withdrawal by Subject|0|||
48739592|NCT00932126|156895672|FG006|Overall Study|Withdrawal by Subject|0|||
48739593|NCT00932126|156895673|FG007|Overall Study|Withdrawal by Subject|1|||
48739594|NCT00932126|156895666|FG000|Overall Study|Objective progression or relapse|3|||
48739595|NCT00932126|156895667|FG001|Overall Study|Objective progression or relapse|3|||
48739596|NCT00932126|156895668|FG002|Overall Study|Objective progression or relapse|2|||
48739597|NCT00932126|156895669|FG003|Overall Study|Objective progression or relapse|3|||
48739598|NCT00932126|156895670|FG004|Overall Study|Objective progression or relapse|3|||
48739599|NCT00932126|156895671|FG005|Overall Study|Objective progression or relapse|3|||
48739600|NCT00932126|156895672|FG006|Overall Study|Objective progression or relapse|3|||
48739601|NCT00932126|156895673|FG007|Overall Study|Objective progression or relapse|5|||
48739602|NCT00932126|156895666|FG000|Overall Study|Other|0|||
48739603|NCT00932126|156895667|FG001|Overall Study|Other|0|||
48854031|NCT01584648|157304917|FG001|Overall Study|Investigator discretion|2|||
48854032|NCT01584648|157304916|FG000|Overall Study|Withdrew consent|13|||
48854033|NCT01584648|157304917|FG001|Overall Study|Withdrew consent|4|||
48854034|NCT01584648|157304916|FG000|Overall Study|Study closed/terminated|50|||
48854035|NCT01584648|157304917|FG001|Overall Study|Study closed/terminated|23|||
48854036|NCT01584648|157304916|FG000|Overall Study|Crossover to Dabrafenib + Trametinib|0|||
48854037|NCT01584648|157304917|FG001|Overall Study|Crossover to Dabrafenib + Trametinib|28|||
48854038|NCT03162614|157304918|FG000|Overall Study|Lost to Follow-up|2|||
48854039|NCT03162614|157304919|FG001|Overall Study|Lost to Follow-up|1|||
48854040|NCT03162614|157304920|FG002|Overall Study|Lost to Follow-up|1|||
48854041|NCT03162614|157304921|FG003|Overall Study|Lost to Follow-up|1|||
48854042|NCT03162614|157304922|FG004|Overall Study|Lost to Follow-up|2|||
48854043|NCT03162614|157304923|FG005|Overall Study|Lost to Follow-up|0|||
48854044|NCT03162614|157304918|FG000|Overall Study|Protocol Violation|0|||
48854045|NCT03162614|157304919|FG001|Overall Study|Protocol Violation|1|||
48854046|NCT03162614|157304920|FG002|Overall Study|Protocol Violation|0|||
48854047|NCT03162614|157304921|FG003|Overall Study|Protocol Violation|1|||
48854048|NCT03162614|157304922|FG004|Overall Study|Protocol Violation|0|||
48854049|NCT03162614|157304923|FG005|Overall Study|Protocol Violation|0|||
48854050|NCT03162614|157304918|FG000|Overall Study|Withdrawal by Subject|2|||
48949078|NCT01422304|157643483|FG001|Overall Study|Not Treated|11|||
48739604|NCT00932126|156895668|FG002|Overall Study|Other|0|||
48949079|NCT01260181|157643484|FG000|Overall Study|Decision of Investigator|1|||
48949080|NCT04655586|157643485|FG000|Overall Study|Physician Decision|1|||
48949081|NCT04655586|157643486|FG001|Overall Study|Physician Decision|3|||
48949082|NCT04655586|157643487|FG002|Overall Study|Physician Decision|4|||
48739605|NCT00932126|156895669|FG003|Overall Study|Other|0|||
48854051|NCT03162614|157304919|FG001|Overall Study|Withdrawal by Subject|1|||
48854052|NCT03162614|157304920|FG002|Overall Study|Withdrawal by Subject|1|||
48949083|NCT04655586|157643485|FG000|Overall Study|Withdrawal by Subject|1|||
48949084|NCT04655586|157643486|FG001|Overall Study|Withdrawal by Subject|3|||
48949085|NCT04655586|157643487|FG002|Overall Study|Withdrawal by Subject|1|||
48949086|NCT02961764|157643488|FG000|Overall Study|Protocol Violation|0|||
48949087|NCT02961764|157643489|FG001|Overall Study|Protocol Violation|1|||
48949088|NCT02961764|157643488|FG000|Overall Study|Death|2|||
48949089|NCT02961764|157643489|FG001|Overall Study|Death|0|||
48949090|NCT02961764|157643488|FG000|Overall Study|Lost to Follow-up|35|||
48949091|NCT02961764|157643489|FG001|Overall Study|Lost to Follow-up|24|||
48949092|NCT02961764|157643488|FG000|Overall Study|Withdrawal by Subject|2|||
48949093|NCT02961764|157643489|FG001|Overall Study|Withdrawal by Subject|0|||
48949094|NCT00469014|157643492|FG000|Initial Phase Randomization|Disease Progression|0|||
48949095|NCT00469014|157643493|FG001|Initial Phase Randomization|Disease Progression|1|||
48739606|NCT00932126|156895670|FG004|Overall Study|Other|1|||
48739607|NCT00932126|156895671|FG005|Overall Study|Other|0|||
48739608|NCT00932126|156895672|FG006|Overall Study|Other|1|||
48739609|NCT00932126|156895673|FG007|Overall Study|Other|2|||
48739610|NCT00066365|156895674|FG000|Overall Study|Adverse Event|1|||
48739611|NCT00066365|156895675|FG001|Overall Study|Adverse Event|0|||
48739612|NCT00066365|156895674|FG000|Overall Study|Lack of Efficacy|15|||
48739613|NCT00066365|156895675|FG001|Overall Study|Lack of Efficacy|12|||
48739614|NCT00066365|156895674|FG000|Overall Study|Physician Decision|1|||
48739615|NCT00066365|156895675|FG001|Overall Study|Physician Decision|0|||
48739616|NCT00066365|156895674|FG000|Overall Study|No viable tumor after 1 cycle of therapy|2|||
48739617|NCT00066365|156895675|FG001|Overall Study|No viable tumor after 1 cycle of therapy|0|||
48739618|NCT00066365|156895674|FG000|Overall Study|Ineligible|4|||
48739619|NCT00066365|156895675|FG001|Overall Study|Ineligible|2|||
48739620|NCT04203498|156895676|FG000|Overall Study|Decision by the investigator, GW, or authority|0|||
48739621|NCT04203498|156895677|FG001|Overall Study|Decision by the investigator, GW, or authority|1|||
48739622|NCT04203498|156895676|FG000|Overall Study|Withdrawal of patient consent|7|||
48739623|NCT04203498|156895677|FG001|Overall Study|Withdrawal of patient consent|2|||
48739624|NCT04203498|156895676|FG000|Overall Study|Adverse Event|4|||
48739625|NCT04203498|156895677|FG001|Overall Study|Adverse Event|1|||
48739626|NCT04203498|156895676|FG000|Overall Study|Drug not dispensed due to endpoint error|1|||
48739627|NCT04203498|156895677|FG001|Overall Study|Drug not dispensed due to endpoint error|0|||
48739628|NCT04203498|156895676|FG000|Overall Study|Did not receive IMP|2|||
48739629|NCT04203498|156895677|FG001|Overall Study|Did not receive IMP|0|||
48739630|NCT04203797|156895678|FG000|Overall Study|Adverse Event|1|||
48739631|NCT04203797|156895679|FG001|Overall Study|Adverse Event|0|||
48739632|NCT04203797|156895678|FG000|Overall Study|Did not complete End of Study follow-up|1|||
48854053|NCT03162614|157304921|FG003|Overall Study|Withdrawal by Subject|1|||
48854054|NCT03162614|157304922|FG004|Overall Study|Withdrawal by Subject|0|||
48854055|NCT03162614|157304923|FG005|Overall Study|Withdrawal by Subject|0|||
48854056|NCT03162614|157304918|FG000|Overall Study|Missed vaccination, exclusion criteria|2|||
48854057|NCT03162614|157304919|FG001|Overall Study|Missed vaccination, exclusion criteria|2|||
48854058|NCT03162614|157304920|FG002|Overall Study|Missed vaccination, exclusion criteria|2|||
48854059|NCT03162614|157304921|FG003|Overall Study|Missed vaccination, exclusion criteria|4|||
48854060|NCT03162614|157304922|FG004|Overall Study|Missed vaccination, exclusion criteria|3|||
48854061|NCT03162614|157304923|FG005|Overall Study|Missed vaccination, exclusion criteria|0|||
48854062|NCT03611556|157304933|FG000|Overall Study|Death|7|||
48854063|NCT03611556|157304934|FG001|Overall Study|Death|7|||
48854064|NCT03611556|157304935|FG002|Overall Study|Death|3|||
48854065|NCT03611556|157304936|FG003|Overall Study|Death|8|||
48854066|NCT03611556|157304937|FG004|Overall Study|Death|47|||
48854067|NCT03611556|157304938|FG005|Overall Study|Death|32|||
48854068|NCT03611556|157304939|FG006|Overall Study|Death|53|||
48854069|NCT03611556|157304933|FG000|Overall Study|Withdrawal by Subject|0|||
48854070|NCT03611556|157304934|FG001|Overall Study|Withdrawal by Subject|0|||
48854071|NCT03611556|157304935|FG002|Overall Study|Withdrawal by Subject|0|||
48854072|NCT03611556|157304936|FG003|Overall Study|Withdrawal by Subject|0|||
48854073|NCT03611556|157304937|FG004|Overall Study|Withdrawal by Subject|4|||
48854074|NCT03611556|157304938|FG005|Overall Study|Withdrawal by Subject|2|||
48854075|NCT03611556|157304939|FG006|Overall Study|Withdrawal by Subject|4|||
48854076|NCT03611556|157304933|FG000|Overall Study|Sponsor decision|0|||
48854077|NCT03611556|157304934|FG001|Overall Study|Sponsor decision|0|||
48854078|NCT03611556|157304935|FG002|Overall Study|Sponsor decision|0|||
48854079|NCT03611556|157304936|FG003|Overall Study|Sponsor decision|0|||
48949096|NCT00469014|157643494|FG002|Initial Phase Randomization|Disease Progression|1|||
48949097|NCT00469014|157643495|FG003|Initial Phase Randomization|Disease Progression|0|||
48739633|NCT04203797|156895679|FG001|Overall Study|Did not complete End of Study follow-up|0|||
48739634|NCT01611155|156895687|FG000|Overall Study|Adverse Event|1|||
48739635|NCT01611155|156895688|FG001|Overall Study|Adverse Event|1|||
48739636|NCT01611155|156895687|FG000|Overall Study|Refused further treatment|6|||
48739637|NCT01611155|156895688|FG001|Overall Study|Refused further treatment|4|||
48739638|NCT01611155|156895687|FG000|Overall Study|Disease progression|1|||
48739639|NCT01611155|156895688|FG001|Overall Study|Disease progression|0|||
48739640|NCT01611155|156895687|FG000|Overall Study|Withdrawal by Subject|1|||
48739641|NCT01611155|156895688|FG001|Overall Study|Withdrawal by Subject|0|||
48739642|NCT01611155|156895687|FG000|Overall Study|Alternative treatment|0|||
48739643|NCT01611155|156895688|FG001|Overall Study|Alternative treatment|1|||
48739644|NCT01611155|156895687|FG000|Overall Study|Ineligible patient|0|||
48739645|NCT01611155|156895688|FG001|Overall Study|Ineligible patient|1|||
48739646|NCT02021773|156895691|FG000|Overall Study|Adverse Event|1|||
48739647|NCT02021773|156895692|FG001|Overall Study|Adverse Event|4|||
48739648|NCT02021773|156895693|FG002|Overall Study|Adverse Event|3|||
48739649|NCT02021773|156895691|FG000|Overall Study|Lack of Efficacy|2|||
48739650|NCT02021773|156895692|FG001|Overall Study|Lack of Efficacy|2|||
48854080|NCT03611556|157304937|FG004|Overall Study|Sponsor decision|9|||
48949098|NCT00469014|157643492|FG000|Initial Phase Randomization|No Response|1|||
48949099|NCT00469014|157643493|FG001|Initial Phase Randomization|No Response|0|||
48949100|NCT00469014|157643494|FG002|Initial Phase Randomization|No Response|0|||
48949101|NCT00469014|157643495|FG003|Initial Phase Randomization|No Response|1|||
48949102|NCT00469014|157643492|FG000|Adaptive Randomization|Not Evaluable|1|||
48949103|NCT00469014|157643493|FG001|Adaptive Randomization|Not Evaluable|0|||
48949104|NCT00469014|157643494|FG002|Adaptive Randomization|Not Evaluable|0|||
48949105|NCT00469014|157643495|FG003|Adaptive Randomization|Not Evaluable|1|||
48949106|NCT00469014|157643492|FG000|Adaptive Randomization|No Response|0|||
48949107|NCT00469014|157643493|FG001|Adaptive Randomization|No Response|1|||
48949108|NCT00469014|157643494|FG002|Adaptive Randomization|No Response|0|||
48949109|NCT00469014|157643495|FG003|Adaptive Randomization|No Response|0|||
48949110|NCT00469014|157643492|FG000|Adaptive Randomization|Death|0|||
48949111|NCT00469014|157643493|FG001|Adaptive Randomization|Death|0|||
48949112|NCT00469014|157643494|FG002|Adaptive Randomization|Death|1|||
48949113|NCT00469014|157643495|FG003|Adaptive Randomization|Death|0|||
48949114|NCT04770155|157643496|FG000|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
48951868|NCT04760314|157654919|FG005|Maintenance Blinded Period|Withdrawal by Subject|1|||
48739651|NCT02021773|156895693|FG002|Overall Study|Lack of Efficacy|2|||
48739652|NCT02021773|156895691|FG000|Overall Study|Protocol Violation|2|||
48739653|NCT02021773|156895692|FG001|Overall Study|Protocol Violation|3|||
48739654|NCT02021773|156895693|FG002|Overall Study|Protocol Violation|1|||
48739655|NCT02021773|156895691|FG000|Overall Study|Withdrawal by Subject|3|||
48854081|NCT03611556|157304938|FG005|Overall Study|Sponsor decision|4|||
48854082|NCT03611556|157304939|FG006|Overall Study|Sponsor decision|12|||
48854083|NCT03611556|157304933|FG000|Overall Study|Reasons|0|||
48854084|NCT03611556|157304934|FG001|Overall Study|Reasons|0|||
48854085|NCT03611556|157304935|FG002|Overall Study|Reasons|0|||
48854086|NCT03611556|157304936|FG003|Overall Study|Reasons|0|||
48854087|NCT03611556|157304937|FG004|Overall Study|Reasons|2|||
48854088|NCT03611556|157304938|FG005|Overall Study|Reasons|0|||
48854089|NCT03611556|157304939|FG006|Overall Study|Reasons|1|||
48854090|NCT02399449|157304940|FG000|Overall Study|Withdrawal by Subject|3|||
48854091|NCT02399449|157304941|FG001|Overall Study|Withdrawal by Subject|9|||
48854092|NCT02399449|157304940|FG000|Overall Study|Physician Decision|0|||
48854093|NCT02399449|157304941|FG001|Overall Study|Physician Decision|1|||
48854094|NCT02159352|157304942|FG000|Overall Study|Adverse Event|3|||
48854095|NCT02159352|157304943|FG001|Overall Study|Adverse Event|1|||
48854096|NCT02159352|157304942|FG000|Overall Study|Withdrawal by Subject|0|||
48854097|NCT02159352|157304943|FG001|Overall Study|Withdrawal by Subject|1|||
48854098|NCT02260154|157304952|FG000|Overall Study|Screening failure|2|||
48854099|NCT02561195|157304955|FG000|Vaccination 1 to 3|Adverse Event|4|||
48854100|NCT02561195|157304956|FG001|Vaccination 1 to 3|Adverse Event|5|||
48854101|NCT02561195|157304957|FG002|Vaccination 1 to 3|Adverse Event|0|||
48854102|NCT02561195|157304958|FG003|Vaccination 1 to 3|Adverse Event|3|||
48854103|NCT02561195|157304959|FG004|Vaccination 1 to 3|Adverse Event|4|||
48854104|NCT02561195|157304960|FG005|Vaccination 1 to 3|Adverse Event|0|||
48854105|NCT02561195|157304961|FG006|Vaccination 1 to 3|Adverse Event|0|||
48854106|NCT02561195|157304962|FG007|Vaccination 1 to 3|Adverse Event|0|||
48854107|NCT02561195|157304963|FG008|Vaccination 1 to 3|Adverse Event|0|||
48854108|NCT02561195|157304964|FG009|Vaccination 1 to 3|Adverse Event|0|||
48854109|NCT02561195|157304965|FG010|Vaccination 1 to 3|Adverse Event|0|||
48854110|NCT02561195|157304966|FG011|Vaccination 1 to 3|Adverse Event|0|||
48854111|NCT02561195|157304967|FG012|Vaccination 1 to 3|Adverse Event|0|||
48854112|NCT02561195|157304968|FG013|Vaccination 1 to 3|Adverse Event|0|||
48854113|NCT02561195|157304955|FG000|Vaccination 1 to 3|Lost to Follow-up|3|||
48854114|NCT02561195|157304956|FG001|Vaccination 1 to 3|Lost to Follow-up|4|||
48854115|NCT02561195|157304957|FG002|Vaccination 1 to 3|Lost to Follow-up|0|||
48854116|NCT02561195|157304958|FG003|Vaccination 1 to 3|Lost to Follow-up|2|||
48854117|NCT02561195|157304959|FG004|Vaccination 1 to 3|Lost to Follow-up|3|||
48854118|NCT02561195|157304960|FG005|Vaccination 1 to 3|Lost to Follow-up|3|||
48854119|NCT02561195|157304961|FG006|Vaccination 1 to 3|Lost to Follow-up|0|||
48854120|NCT02561195|157304962|FG007|Vaccination 1 to 3|Lost to Follow-up|0|||
48854121|NCT02561195|157304963|FG008|Vaccination 1 to 3|Lost to Follow-up|0|||
48854122|NCT02561195|157304964|FG009|Vaccination 1 to 3|Lost to Follow-up|0|||
48854123|NCT02561195|157304965|FG010|Vaccination 1 to 3|Lost to Follow-up|0|||
48854124|NCT02561195|157304966|FG011|Vaccination 1 to 3|Lost to Follow-up|0|||
48949115|NCT04770155|157643497|FG001|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
48949116|NCT04770155|157643498|FG002|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
48949117|NCT04770155|157643499|FG003|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
48949118|NCT04770155|157643500|FG004|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
48949119|NCT04770155|157643501|FG005|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
48949120|NCT04770155|157643502|FG006|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
48949121|NCT04770155|157643503|FG007|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
48949122|NCT00864227|157643504|FG000|Overall Study|Withdrawal by Subject|1|||
48949123|NCT00864227|157643504|FG000|Overall Study|Disease Relapse/Progression|3|||
48854125|NCT02561195|157304967|FG012|Vaccination 1 to 3|Lost to Follow-up|0|||
48854126|NCT02561195|157304968|FG013|Vaccination 1 to 3|Lost to Follow-up|0|||
48854127|NCT02561195|157304955|FG000|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
48854128|NCT02561195|157304956|FG001|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
48854129|NCT02561195|157304957|FG002|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
48854130|NCT02561195|157304958|FG003|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
48854131|NCT02561195|157304959|FG004|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
48949124|NCT03321929|157643506|FG000|Overall Study|Withdrawn prior to LUM Imaging Procedure completed|4|||
48949125|NCT03461289|157643507|FG000|Overall Study|Death|1|||
48949126|NCT04799782|157643511|FG000|Washout|Physician Decision|2|||
48949127|NCT04799782|157643512|FG001|Washout|Physician Decision|0|||
48949128|NCT04799782|157643511|FG000|Washout|Withdrawal by Subject|0|||
48949129|NCT04799782|157643512|FG001|Washout|Withdrawal by Subject|2|||
48949130|NCT04799782|157643511|FG000|Washout|Lost to Follow-up|0|||
48949131|NCT04799782|157643512|FG001|Washout|Lost to Follow-up|1|||
48949132|NCT02021812|157643513|FG000|Overall Study|Death|8|||
48949133|NCT02021812|157643513|FG000|Overall Study|Withdrawal by Subject|3|||
48949134|NCT02021812|157643513|FG000|Overall Study|Lost to Follow-up|2|||
48949135|NCT02021812|157643513|FG000|Overall Study|Refuse to return, COVD 19|2|||
48949136|NCT03241173|157643514|FG000|Overall Study|Death|3|||
48949137|NCT03241173|157643515|FG001|Overall Study|Death|2|||
48949138|NCT03241173|157643516|FG002|Overall Study|Death|4|||
48949139|NCT03241173|157643517|FG003|Overall Study|Death|4|||
48949140|NCT03241173|157643518|FG004|Overall Study|Death|2|||
48949141|NCT03241173|157643519|FG005|Overall Study|Death|2|||
48949142|NCT03241173|157643520|FG006|Overall Study|Death|3|||
48949143|NCT03241173|157643521|FG007|Overall Study|Death|1|||
48949144|NCT03241173|157643522|FG008|Overall Study|Death|0|||
48949145|NCT03241173|157643523|FG009|Overall Study|Death|5|||
48949146|NCT03241173|157643524|FG010|Overall Study|Death|4|||
48949147|NCT03241173|157643525|FG011|Overall Study|Death|3|||
48949148|NCT03241173|157643526|FG012|Overall Study|Death|0|||
48949149|NCT03241173|157643527|FG013|Overall Study|Death|0|||
48949150|NCT03241173|157643528|FG014|Overall Study|Death|0|||
48949151|NCT03241173|157643514|FG000|Overall Study|Withdrawal by Subject|0|||
48949152|NCT03241173|157643515|FG001|Overall Study|Withdrawal by Subject|0|||
48949153|NCT03241173|157643516|FG002|Overall Study|Withdrawal by Subject|1|||
48949154|NCT03241173|157643517|FG003|Overall Study|Withdrawal by Subject|0|||
48949155|NCT03241173|157643518|FG004|Overall Study|Withdrawal by Subject|0|||
48949156|NCT03241173|157643519|FG005|Overall Study|Withdrawal by Subject|1|||
48949157|NCT03241173|157643520|FG006|Overall Study|Withdrawal by Subject|0|||
48949158|NCT03241173|157643521|FG007|Overall Study|Withdrawal by Subject|0|||
48949159|NCT03241173|157643522|FG008|Overall Study|Withdrawal by Subject|0|||
48949160|NCT03241173|157643523|FG009|Overall Study|Withdrawal by Subject|0|||
48949161|NCT03241173|157643524|FG010|Overall Study|Withdrawal by Subject|0|||
48949162|NCT03241173|157643525|FG011|Overall Study|Withdrawal by Subject|0|||
48949163|NCT03241173|157643526|FG012|Overall Study|Withdrawal by Subject|0|||
48949164|NCT03241173|157643527|FG013|Overall Study|Withdrawal by Subject|0|||
48949165|NCT03241173|157643528|FG014|Overall Study|Withdrawal by Subject|0|||
48949166|NCT03241173|157643514|FG000|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
48949167|NCT03241173|157643515|FG001|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
48949168|NCT03241173|157643516|FG002|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
48949169|NCT03241173|157643517|FG003|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
48949170|NCT03241173|157643518|FG004|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
48949171|NCT03241173|157643519|FG005|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
48949172|NCT03241173|157643520|FG006|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
48949173|NCT03241173|157643521|FG007|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
48949174|NCT03241173|157643522|FG008|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
48949175|NCT03241173|157643523|FG009|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
48949176|NCT03241173|157643524|FG010|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
48949177|NCT03241173|157643525|FG011|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|3|||
48949178|NCT03241173|157643526|FG012|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
48949179|NCT03241173|157643527|FG013|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
48949180|NCT03241173|157643528|FG014|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
48949181|NCT03241173|157643514|FG000|Overall Study|Lost to Follow-up|0|||
48949182|NCT03241173|157643515|FG001|Overall Study|Lost to Follow-up|0|||
48949183|NCT03241173|157643516|FG002|Overall Study|Lost to Follow-up|0|||
48949184|NCT03241173|157643517|FG003|Overall Study|Lost to Follow-up|0|||
48949185|NCT03241173|157643518|FG004|Overall Study|Lost to Follow-up|1|||
48949186|NCT03241173|157643519|FG005|Overall Study|Lost to Follow-up|0|||
48949187|NCT03241173|157643520|FG006|Overall Study|Lost to Follow-up|0|||
48949188|NCT03241173|157643521|FG007|Overall Study|Lost to Follow-up|0|||
48949189|NCT03241173|157643522|FG008|Overall Study|Lost to Follow-up|0|||
48949190|NCT03241173|157643523|FG009|Overall Study|Lost to Follow-up|1|||
48949191|NCT03241173|157643524|FG010|Overall Study|Lost to Follow-up|0|||
48949192|NCT03241173|157643525|FG011|Overall Study|Lost to Follow-up|0|||
48949193|NCT03241173|157643526|FG012|Overall Study|Lost to Follow-up|0|||
48949194|NCT03241173|157643527|FG013|Overall Study|Lost to Follow-up|0|||
48949195|NCT03241173|157643528|FG014|Overall Study|Lost to Follow-up|0|||
48949196|NCT00564629|157643529|FG000|Overall Study|Vomited within 2 hours of receiving drug|15|||
48949197|NCT00564629|157643530|FG001|Overall Study|Vomited within 2 hours of receiving drug|9|||
48949198|NCT02224846|157643531|FG000|Period 1 (Month 3)|Adverse Event|2|||
48949199|NCT02224846|157643532|FG001|Period 1 (Month 3)|Adverse Event|1|||
48949200|NCT02224846|157643531|FG000|Period 1 (Month 3)|Lost to Follow-up|3|||
48949201|NCT02224846|157643532|FG001|Period 1 (Month 3)|Lost to Follow-up|8|||
48949202|NCT02224846|157643531|FG000|Period 1 (Month 3)|Protocol Violation|4|||
48949203|NCT02224846|157643532|FG001|Period 1 (Month 3)|Protocol Violation|8|||
48949204|NCT02224846|157643531|FG000|Period 1 (Month 3)|Withdrawal by Subject|8|||
48949205|NCT02224846|157643532|FG001|Period 1 (Month 3)|Withdrawal by Subject|18|||
48949206|NCT02224846|157643531|FG000|Period 1 (Month 3)|Sponsor Decision|2|||
48949207|NCT02224846|157643532|FG001|Period 1 (Month 3)|Sponsor Decision|1|||
48949208|NCT02224846|157643531|FG000|Period 2 (Month 3 to Month 12)|Adverse Event|1|||
48949209|NCT02224846|157643532|FG001|Period 2 (Month 3 to Month 12)|Adverse Event|2|||
48949210|NCT02224846|157643531|FG000|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3|||
48949211|NCT02224846|157643532|FG001|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5|||
48949212|NCT02224846|157643531|FG000|Period 2 (Month 3 to Month 12)|Protocol Violation|0|||
48949213|NCT02224846|157643532|FG001|Period 2 (Month 3 to Month 12)|Protocol Violation|3|||
48949214|NCT02224846|157643531|FG000|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15|||
48949215|NCT02224846|157643532|FG001|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19|||
48949216|NCT02224846|157643531|FG000|Period 2 (Month 3 to Month 12)|Physician Decision|0|||
48949217|NCT02224846|157643532|FG001|Period 2 (Month 3 to Month 12)|Physician Decision|2|||
48949218|NCT02224846|157643531|FG000|Period 2 (Month 12 to Month 24)|Adverse Event|3|||
48949219|NCT02224846|157643532|FG001|Period 2 (Month 12 to Month 24)|Adverse Event|4|||
48949220|NCT02224846|157643531|FG000|Period 2 (Month 12 to Month 24)|Death|1|||
48949221|NCT02224846|157643532|FG001|Period 2 (Month 12 to Month 24)|Death|0|||
48949222|NCT02224846|157643531|FG000|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7|||
48949223|NCT02224846|157643532|FG001|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13|||
48949224|NCT02224846|157643531|FG000|Period 2 (Month 12 to Month 24)|Protocol Violation|4|||
48949225|NCT02224846|157643532|FG001|Period 2 (Month 12 to Month 24)|Protocol Violation|11|||
48949226|NCT02224846|157643531|FG000|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25|||
48949227|NCT02224846|157643532|FG001|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43|||
48949228|NCT02224846|157643531|FG000|Period 2 (Month 12 to Month 24)|Physician Decision|0|||
48949229|NCT02224846|157643532|FG001|Period 2 (Month 12 to Month 24)|Physician Decision|2|||
48949230|NCT02224846|157643531|FG000|Period 2 (Month 12 to Month 24)|Sponsor Decision|2|||
48949231|NCT02224846|157643532|FG001|Period 2 (Month 12 to Month 24)|Sponsor Decision|1|||
48949232|NCT02342171|157645108|FG000|Overall Study|Death|4|||
48949233|NCT02342171|157645109|FG001|Overall Study|Death|87|||
48949234|NCT02342171|157645108|FG000|Overall Study|Received favipiravir|10|||
48949235|NCT02342171|157645109|FG001|Overall Study|Received favipiravir|0|||
48949236|NCT02342171|157645108|FG000|Overall Study|Missing cycle treshold value|1|||
48949237|NCT02342171|157645109|FG001|Overall Study|Missing cycle treshold value|0|||
48949238|NCT02342171|157645108|FG000|Overall Study|Unknown outcome|0|||
48949239|NCT02342171|157645109|FG001|Overall Study|Unknown outcome|1|||
48949240|NCT02342171|157645108|FG000|Overall Study|Missing age data|0|||
48949241|NCT02342171|157645109|FG001|Overall Study|Missing age data|1|||
48949242|NCT02495077|157645117|FG000|Overall Study|Adverse Event|0|||
48949243|NCT02495077|157645118|FG001|Overall Study|Adverse Event|1|||
48949244|NCT02495077|157645119|FG002|Overall Study|Adverse Event|1|||
48949245|NCT02495077|157645120|FG003|Overall Study|Adverse Event|0|||
48949246|NCT02495077|157645117|FG000|Overall Study|Death|3|||
48949247|NCT02495077|157645118|FG001|Overall Study|Death|5|||
48949248|NCT02495077|157645119|FG002|Overall Study|Death|0|||
48949249|NCT02495077|157645120|FG003|Overall Study|Death|0|||
48949250|NCT02495077|157645117|FG000|Overall Study|Lost to Follow-up|6|||
48949251|NCT02495077|157645118|FG001|Overall Study|Lost to Follow-up|4|||
48949252|NCT02495077|157645119|FG002|Overall Study|Lost to Follow-up|0|||
48949253|NCT02495077|157645120|FG003|Overall Study|Lost to Follow-up|0|||
48949254|NCT02495077|157645117|FG000|Overall Study|Physician Decision|2|||
48949255|NCT02495077|157645118|FG001|Overall Study|Physician Decision|1|||
48949256|NCT02495077|157645119|FG002|Overall Study|Physician Decision|4|||
48739656|NCT02021773|156895692|FG001|Overall Study|Withdrawal by Subject|4|||
48739657|NCT02021773|156895693|FG002|Overall Study|Withdrawal by Subject|5|||
48949257|NCT02495077|157645120|FG003|Overall Study|Physician Decision|0|||
48949258|NCT02495077|157645117|FG000|Overall Study|Protocol Violation|0|||
48949259|NCT02495077|157645118|FG001|Overall Study|Protocol Violation|1|||
48949260|NCT02495077|157645119|FG002|Overall Study|Protocol Violation|0|||
48949261|NCT02495077|157645120|FG003|Overall Study|Protocol Violation|0|||
48949262|NCT02495077|157645117|FG000|Overall Study|Screen Failure|0|||
48949263|NCT02495077|157645118|FG001|Overall Study|Screen Failure|0|||
48949264|NCT02495077|157645119|FG002|Overall Study|Screen Failure|0|||
48739658|NCT02021773|156895691|FG000|Overall Study|Lost to Follow-up|1|||
48739659|NCT02021773|156895692|FG001|Overall Study|Lost to Follow-up|3|||
48739660|NCT02021773|156895693|FG002|Overall Study|Lost to Follow-up|0|||
48739661|NCT02021773|156895691|FG000|Overall Study|Reason not specified|3|||
48739662|NCT02021773|156895692|FG001|Overall Study|Reason not specified|0|||
48739663|NCT02021773|156895693|FG002|Overall Study|Reason not specified|0|||
48739664|NCT04545385|156895695|FG000|Overall Study|Withdrawal by Subject|2|||
48739665|NCT04545385|156895696|FG001|Overall Study|Withdrawal by Subject|0|||
48739666|NCT04545385|156895695|FG000|Overall Study|Loss of asthma control (LoAC)|0|||
48739667|NCT04545385|156895696|FG001|Overall Study|Loss of asthma control (LoAC)|1|||
48739668|NCT04545385|156895695|FG000|Overall Study|Study termination|10|||
48739669|NCT04545385|156895696|FG001|Overall Study|Study termination|10|||
48739670|NCT04545385|156895695|FG000|Overall Study|Sponsor decision|2|||
48739671|NCT04545385|156895696|FG001|Overall Study|Sponsor decision|2|||
48739672|NCT04545385|156895695|FG000|Overall Study|Other than specified|1|||
48739673|NCT04545385|156895696|FG001|Overall Study|Other than specified|0|||
48739674|NCT00915278|156895697|FG000|Overall Study|Death|1|||
48739675|NCT00915278|156895698|FG001|Overall Study|Death|0|||
48739676|NCT00915278|156895699|FG002|Overall Study|Death|0|||
48854132|NCT02561195|157304960|FG005|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
48949265|NCT02495077|157645120|FG003|Overall Study|Screen Failure|48|||
48739677|NCT00915278|156895700|FG003|Overall Study|Death|0|||
48854133|NCT02561195|157304961|FG006|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
48854134|NCT02561195|157304962|FG007|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
48854135|NCT02561195|157304963|FG008|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
48854136|NCT02561195|157304964|FG009|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
48854137|NCT02561195|157304965|FG010|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
48854138|NCT02561195|157304966|FG011|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
48854139|NCT02561195|157304967|FG012|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
48854140|NCT02561195|157304968|FG013|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
48854141|NCT02561195|157304955|FG000|Vaccination 1 to 3|No longer willing to participate|2|||
48854142|NCT02561195|157304956|FG001|Vaccination 1 to 3|No longer willing to participate|4|||
48854143|NCT02561195|157304957|FG002|Vaccination 1 to 3|No longer willing to participate|0|||
48854144|NCT02561195|157304958|FG003|Vaccination 1 to 3|No longer willing to participate|4|||
48854145|NCT02561195|157304959|FG004|Vaccination 1 to 3|No longer willing to participate|1|||
48854146|NCT02561195|157304960|FG005|Vaccination 1 to 3|No longer willing to participate|3|||
48854147|NCT02561195|157304961|FG006|Vaccination 1 to 3|No longer willing to participate|0|||
48854148|NCT02561195|157304962|FG007|Vaccination 1 to 3|No longer willing to participate|0|||
48854149|NCT02561195|157304963|FG008|Vaccination 1 to 3|No longer willing to participate|0|||
48854150|NCT02561195|157304964|FG009|Vaccination 1 to 3|No longer willing to participate|0|||
48854151|NCT02561195|157304965|FG010|Vaccination 1 to 3|No longer willing to participate|0|||
48854152|NCT02561195|157304966|FG011|Vaccination 1 to 3|No longer willing to participate|0|||
48854153|NCT02561195|157304967|FG012|Vaccination 1 to 3|No longer willing to participate|0|||
48854154|NCT02561195|157304968|FG013|Vaccination 1 to 3|No longer willing to participate|0|||
48739678|NCT00915278|156895701|FG004|Overall Study|Death|0|||
48739679|NCT00915278|156895702|FG005|Overall Study|Death|0|||
48739680|NCT00915278|156895697|FG000|Overall Study|Lost to Follow-up|0|||
48854155|NCT02561195|157304955|FG000|Vaccination 1 to 3|Other|7|||
48854156|NCT02561195|157304956|FG001|Vaccination 1 to 3|Other|3|||
48854157|NCT02561195|157304957|FG002|Vaccination 1 to 3|Other|1|||
48854158|NCT02561195|157304958|FG003|Vaccination 1 to 3|Other|7|||
48854159|NCT02561195|157304959|FG004|Vaccination 1 to 3|Other|5|||
48854160|NCT02561195|157304960|FG005|Vaccination 1 to 3|Other|1|||
48854161|NCT02561195|157304961|FG006|Vaccination 1 to 3|Other|0|||
48854162|NCT02561195|157304962|FG007|Vaccination 1 to 3|Other|0|||
48854163|NCT02561195|157304963|FG008|Vaccination 1 to 3|Other|0|||
48854164|NCT02561195|157304964|FG009|Vaccination 1 to 3|Other|0|||
48854165|NCT02561195|157304965|FG010|Vaccination 1 to 3|Other|0|||
48854166|NCT02561195|157304966|FG011|Vaccination 1 to 3|Other|0|||
48854167|NCT02561195|157304967|FG012|Vaccination 1 to 3|Other|0|||
48949266|NCT02495077|157645117|FG000|Overall Study|Withdrawal by Subject|7|||
48949267|NCT02495077|157645118|FG001|Overall Study|Withdrawal by Subject|7|||
48949268|NCT02495077|157645119|FG002|Overall Study|Withdrawal by Subject|7|||
48854168|NCT02561195|157304968|FG013|Vaccination 1 to 3|Other|0|||
48949269|NCT02495077|157645120|FG003|Overall Study|Withdrawal by Subject|0|||
48949270|NCT02495077|157645117|FG000|Overall Study|Covid-19 research restrictions|1|||
48949271|NCT02495077|157645118|FG001|Overall Study|Covid-19 research restrictions|0|||
48949272|NCT02495077|157645119|FG002|Overall Study|Covid-19 research restrictions|0|||
48949273|NCT02495077|157645120|FG003|Overall Study|Covid-19 research restrictions|0|||
48949274|NCT02495077|157645117|FG000|Overall Study|Visit 14 scheduling difficulties|1|||
48949275|NCT02495077|157645118|FG001|Overall Study|Visit 14 scheduling difficulties|0|||
48949276|NCT02495077|157645119|FG002|Overall Study|Visit 14 scheduling difficulties|0|||
48949277|NCT02495077|157645120|FG003|Overall Study|Visit 14 scheduling difficulties|0|||
48949278|NCT02495077|157645117|FG000|Overall Study|Incarcerated|0|||
48949279|NCT02495077|157645118|FG001|Overall Study|Incarcerated|1|||
48949280|NCT02495077|157645119|FG002|Overall Study|Incarcerated|0|||
48949281|NCT02495077|157645120|FG003|Overall Study|Incarcerated|0|||
48854169|NCT02561195|157304955|FG000|Vaccination 1 to 3|Protocol Violation|1|||
48854170|NCT02561195|157304956|FG001|Vaccination 1 to 3|Protocol Violation|0|||
48854171|NCT02561195|157304957|FG002|Vaccination 1 to 3|Protocol Violation|1|||
48949282|NCT02495077|157645117|FG000|Overall Study|Transplant nephrectomy, patient decision|0|||
48949283|NCT02495077|157645118|FG001|Overall Study|Transplant nephrectomy, patient decision|1|||
48949284|NCT02495077|157645119|FG002|Overall Study|Transplant nephrectomy, patient decision|0|||
48854172|NCT02561195|157304958|FG003|Vaccination 1 to 3|Protocol Violation|2|||
48854173|NCT02561195|157304959|FG004|Vaccination 1 to 3|Protocol Violation|5|||
48854174|NCT02561195|157304960|FG005|Vaccination 1 to 3|Protocol Violation|2|||
48854175|NCT02561195|157304961|FG006|Vaccination 1 to 3|Protocol Violation|0|||
48854176|NCT02561195|157304962|FG007|Vaccination 1 to 3|Protocol Violation|0|||
48739681|NCT00915278|156895698|FG001|Overall Study|Lost to Follow-up|1|||
48739682|NCT00915278|156895699|FG002|Overall Study|Lost to Follow-up|0|||
48739683|NCT00915278|156895700|FG003|Overall Study|Lost to Follow-up|0|||
48739684|NCT00915278|156895701|FG004|Overall Study|Lost to Follow-up|0|||
48739685|NCT00915278|156895702|FG005|Overall Study|Lost to Follow-up|0|||
48739686|NCT00915278|156895697|FG000|Overall Study|Withdrawal by Subject|0|||
48739687|NCT00915278|156895698|FG001|Overall Study|Withdrawal by Subject|1|||
48739688|NCT00915278|156895699|FG002|Overall Study|Withdrawal by Subject|0|||
48739689|NCT00915278|156895700|FG003|Overall Study|Withdrawal by Subject|0|||
48739690|NCT00915278|156895701|FG004|Overall Study|Withdrawal by Subject|1|||
48739691|NCT00915278|156895702|FG005|Overall Study|Withdrawal by Subject|4|||
48739692|NCT00915278|156895697|FG000|Overall Study|Adverse Event|4|||
48739693|NCT00915278|156895698|FG001|Overall Study|Adverse Event|1|||
48739694|NCT00915278|156895699|FG002|Overall Study|Adverse Event|0|||
48739695|NCT00915278|156895700|FG003|Overall Study|Adverse Event|0|||
48739696|NCT00915278|156895701|FG004|Overall Study|Adverse Event|0|||
48739697|NCT00915278|156895702|FG005|Overall Study|Adverse Event|0|||
48739698|NCT00915278|156895697|FG000|Overall Study|Progressive disease/clinical progression|0|||
48739699|NCT00915278|156895698|FG001|Overall Study|Progressive disease/clinical progression|0|||
48739700|NCT00915278|156895699|FG002|Overall Study|Progressive disease/clinical progression|0|||
48739701|NCT00915278|156895700|FG003|Overall Study|Progressive disease/clinical progression|3|||
48739702|NCT00915278|156895701|FG004|Overall Study|Progressive disease/clinical progression|1|||
48739703|NCT00915278|156895702|FG005|Overall Study|Progressive disease/clinical progression|2|||
48739704|NCT00915278|156895697|FG000|Overall Study|Infusion related AEs|0|||
48739705|NCT00915278|156895698|FG001|Overall Study|Infusion related AEs|0|||
48739706|NCT00915278|156895699|FG002|Overall Study|Infusion related AEs|0|||
48739707|NCT00915278|156895700|FG003|Overall Study|Infusion related AEs|0|||
48739708|NCT00915278|156895701|FG004|Overall Study|Infusion related AEs|0|||
48739709|NCT00915278|156895702|FG005|Overall Study|Infusion related AEs|2|||
48739710|NCT00915278|156895697|FG000|Overall Study|Admission to hospice|0|||
48739711|NCT00915278|156895698|FG001|Overall Study|Admission to hospice|0|||
48739712|NCT00915278|156895699|FG002|Overall Study|Admission to hospice|1|||
48739713|NCT00915278|156895700|FG003|Overall Study|Admission to hospice|0|||
48739714|NCT00915278|156895701|FG004|Overall Study|Admission to hospice|0|||
48739715|NCT00915278|156895702|FG005|Overall Study|Admission to hospice|0|||
48739716|NCT00437983|156895705|FG000|Overall Study|Adverse Event|6|||
48739717|NCT00437983|156895706|FG001|Overall Study|Adverse Event|6|||
48739718|NCT00437983|156895705|FG000|Overall Study|Protocol Violation|2|||
48739719|NCT00437983|156895706|FG001|Overall Study|Protocol Violation|1|||
48739720|NCT00437983|156895705|FG000|Overall Study|Withdrawal by Subject|5|||
48739721|NCT00437983|156895706|FG001|Overall Study|Withdrawal by Subject|6|||
48739722|NCT03137537|156895707|FG000|Overall Study|Adverse Event|0|||
48739723|NCT03137537|156895708|FG001|Overall Study|Adverse Event|1|||
48739724|NCT02192359|156895709|FG000|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
48739725|NCT02192359|156895710|FG001|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
48739726|NCT02192359|156895711|FG002|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|1|||
48739727|NCT02192359|156895712|FG003|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
48739728|NCT02192359|156895709|FG000|Overall Study|Could not receive irinotecan due to low KPS score post surgery|1|||
48739729|NCT02192359|156895710|FG001|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
48739730|NCT02192359|156895711|FG002|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
48739731|NCT02192359|156895712|FG003|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
48743075|NCT00968201|156910496|FG002|Extension Study - (Period III)|Adverse Event|22|||
48949285|NCT02495077|157645120|FG003|Overall Study|Transplant nephrectomy, patient decision|0|||
48949286|NCT02495077|157645117|FG000|Overall Study|Timing of transplant and randomization|0|||
48949287|NCT02495077|157645118|FG001|Overall Study|Timing of transplant and randomization|0|||
48949288|NCT02495077|157645119|FG002|Overall Study|Timing of transplant and randomization|5|||
48949289|NCT02495077|157645120|FG003|Overall Study|Timing of transplant and randomization|0|||
48949290|NCT02517515|157645121|FG000|Overall Study|Adverse Event|0|||
48949291|NCT02517515|157645122|FG001|Overall Study|Adverse Event|1|||
48949292|NCT02517515|157645121|FG000|Overall Study|Withdrew Consent|0|||
48949293|NCT02517515|157645122|FG001|Overall Study|Withdrew Consent|1|||
48949294|NCT02517515|157645121|FG000|Overall Study|Lost to Follow-up|1|||
48949295|NCT02517515|157645122|FG001|Overall Study|Lost to Follow-up|0|||
48949296|NCT02517515|157645121|FG000|Overall Study|Other|1|||
48949297|NCT02517515|157645122|FG001|Overall Study|Other|0|||
48949298|NCT02089737|157645123|FG000|Overall Study|Survey form not completed|5|||
48949299|NCT02089737|157645123|FG000|Overall Study|Not treated|1|||
48949300|NCT02767570|157645126|FG000|Overall Study|Lost to Follow-up|3|||
48949301|NCT02767570|157645127|FG001|Overall Study|Lost to Follow-up|0|||
48949302|NCT02767570|157645126|FG000|Overall Study|COVID shutdown|2|||
48949303|NCT02767570|157645127|FG001|Overall Study|COVID shutdown|5|||
48949304|NCT02767570|157645126|FG000|Overall Study|Increased pain|2|||
48949305|NCT02767570|157645127|FG001|Overall Study|Increased pain|0|||
48949306|NCT02767570|157645126|FG000|Overall Study|Withdrawal by Subject|1|||
48949307|NCT02767570|157645127|FG001|Overall Study|Withdrawal by Subject|3|||
48949308|NCT02767570|157645126|FG000|Overall Study|Unrelated medical issue|1|||
48949309|NCT02767570|157645127|FG001|Overall Study|Unrelated medical issue|1|||
48949310|NCT02767570|157645126|FG000|Overall Study|Received intra-articular injection|0|||
48949311|NCT02767570|157645127|FG001|Overall Study|Received intra-articular injection|1|||
48949312|NCT01943539|157645128|FG000|Overall Study|Non-compliance with at-home intervention|4|||
48949313|NCT01943539|157645129|FG001|Overall Study|Non-compliance with at-home intervention|0|||
48949314|NCT02413255|157645130|FG000|Overall Study|Voluntary Withdrawal|0|||
48949315|NCT02413255|157645131|FG001|Overall Study|Voluntary Withdrawal|0|||
48949316|NCT02413255|157645132|FG002|Overall Study|Voluntary Withdrawal|0|||
48949317|NCT02413255|157645133|FG003|Overall Study|Voluntary Withdrawal|0|||
48949318|NCT02413255|157645134|FG004|Overall Study|Voluntary Withdrawal|0|||
48949319|NCT02413255|157645135|FG005|Overall Study|Voluntary Withdrawal|0|||
48949320|NCT02413255|157645136|FG006|Overall Study|Voluntary Withdrawal|0|||
48949321|NCT02413255|157645137|FG007|Overall Study|Voluntary Withdrawal|0|||
48949322|NCT02413255|157645138|FG008|Overall Study|Voluntary Withdrawal|0|||
48949323|NCT02413255|157645139|FG009|Overall Study|Voluntary Withdrawal|0|||
48949324|NCT02413255|157645140|FG010|Overall Study|Voluntary Withdrawal|0|||
48949325|NCT02413255|157645141|FG011|Overall Study|Voluntary Withdrawal|0|||
48949326|NCT02413255|157645142|FG012|Overall Study|Voluntary Withdrawal|0|||
48949327|NCT02413255|157645143|FG013|Overall Study|Voluntary Withdrawal|0|||
48949328|NCT02413255|157645144|FG014|Overall Study|Voluntary Withdrawal|1|||
48949329|NCT02413255|157645145|FG015|Overall Study|Voluntary Withdrawal|0|||
48739732|NCT02192359|156895709|FG000|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
48949330|NCT02413255|157645146|FG016|Overall Study|Voluntary Withdrawal|0|||
48949331|NCT01277289|157645153|FG000|Overall Study|fragile vein|1|||
48949332|NCT01277289|157645154|FG001|Overall Study|fragile vein|0|||
48949333|NCT01277289|157645153|FG000|Overall Study|Physician Decision|1|||
48949334|NCT01277289|157645154|FG001|Overall Study|Physician Decision|0|||
48949335|NCT01277289|157645153|FG000|Overall Study|therapy failure and/or Crohn's surgery|13|||
48949336|NCT01277289|157645154|FG001|Overall Study|therapy failure and/or Crohn's surgery|16|||
48949337|NCT01277289|157645153|FG000|Overall Study|Protocol Violation|1|||
48949338|NCT01277289|157645154|FG001|Overall Study|Protocol Violation|1|||
48949339|NCT01277289|157645153|FG000|Overall Study|Adverse Event|2|||
48949340|NCT01277289|157645154|FG001|Overall Study|Adverse Event|1|||
48854177|NCT02561195|157304963|FG008|Vaccination 1 to 3|Protocol Violation|0|||
48854178|NCT02561195|157304964|FG009|Vaccination 1 to 3|Protocol Violation|0|||
48854179|NCT02561195|157304965|FG010|Vaccination 1 to 3|Protocol Violation|0|||
48854180|NCT02561195|157304966|FG011|Vaccination 1 to 3|Protocol Violation|0|||
48854181|NCT02561195|157304967|FG012|Vaccination 1 to 3|Protocol Violation|0|||
48854182|NCT02561195|157304968|FG013|Vaccination 1 to 3|Protocol Violation|0|||
48854183|NCT02561195|157304955|FG000|Vaccination 1 to 3|Death|2|||
48854184|NCT02561195|157304956|FG001|Vaccination 1 to 3|Death|1|||
48854185|NCT02561195|157304957|FG002|Vaccination 1 to 3|Death|0|||
48854186|NCT02561195|157304958|FG003|Vaccination 1 to 3|Death|2|||
48854187|NCT02561195|157304959|FG004|Vaccination 1 to 3|Death|0|||
48854188|NCT02561195|157304960|FG005|Vaccination 1 to 3|Death|0|||
48854189|NCT02561195|157304961|FG006|Vaccination 1 to 3|Death|0|||
48854190|NCT02561195|157304962|FG007|Vaccination 1 to 3|Death|0|||
48854191|NCT02561195|157304963|FG008|Vaccination 1 to 3|Death|0|||
48854192|NCT02561195|157304964|FG009|Vaccination 1 to 3|Death|0|||
48854193|NCT02561195|157304965|FG010|Vaccination 1 to 3|Death|0|||
48854194|NCT02561195|157304966|FG011|Vaccination 1 to 3|Death|0|||
48854195|NCT02561195|157304967|FG012|Vaccination 1 to 3|Death|0|||
48854196|NCT02561195|157304968|FG013|Vaccination 1 to 3|Death|0|||
48854197|NCT02561195|157304955|FG000|Vaccination 1 to 3|Withdrawal by Subject|3|||
48854198|NCT02561195|157304956|FG001|Vaccination 1 to 3|Withdrawal by Subject|4|||
48854199|NCT02561195|157304957|FG002|Vaccination 1 to 3|Withdrawal by Subject|4|||
48854200|NCT02561195|157304958|FG003|Vaccination 1 to 3|Withdrawal by Subject|2|||
48854201|NCT02561195|157304959|FG004|Vaccination 1 to 3|Withdrawal by Subject|6|||
48739733|NCT02192359|156895710|FG001|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
48739734|NCT02192359|156895711|FG002|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
48949341|NCT01277289|157645153|FG000|Overall Study|consent withdrawn|1|||
48949342|NCT01277289|157645154|FG001|Overall Study|consent withdrawn|1|||
48949343|NCT01277289|157645153|FG000|Overall Study|premature closure of the study|4|||
48949344|NCT01277289|157645154|FG001|Overall Study|premature closure of the study|2|||
48949345|NCT00537940|157645155|FG000|Overall Study|Adverse Event|20|||
48949346|NCT00537940|157645156|FG001|Overall Study|Adverse Event|19|||
48949347|NCT00537940|157645155|FG000|Overall Study|Lack of Efficacy|8|||
48949348|NCT00537940|157645156|FG001|Overall Study|Lack of Efficacy|16|||
48949349|NCT00537940|157645155|FG000|Overall Study|Lost to Follow-up|23|||
48949350|NCT00537940|157645156|FG001|Overall Study|Lost to Follow-up|29|||
48949351|NCT00537940|157645155|FG000|Overall Study|Withdrawal by Subject|113|||
48949352|NCT00537940|157645156|FG001|Overall Study|Withdrawal by Subject|95|||
48949353|NCT00537940|157645155|FG000|Overall Study|Protocol Violation|6|||
48949354|NCT00537940|157645156|FG001|Overall Study|Protocol Violation|4|||
48949355|NCT00537940|157645155|FG000|Overall Study|Pregnancy|1|||
48949356|NCT00537940|157645156|FG001|Overall Study|Pregnancy|1|||
48949357|NCT00537940|157645155|FG000|Overall Study|Study terminated by sponsor|2|||
48949358|NCT00537940|157645156|FG001|Overall Study|Study terminated by sponsor|3|||
48739735|NCT02192359|156895712|FG003|Overall Study|Taken off study treatment to catheter infection not related to treatment|1|||
48949359|NCT00537940|157645155|FG000|Overall Study|Other|10|||
48949360|NCT00537940|157645156|FG001|Overall Study|Other|12|||
48949361|NCT00685178|157645160|FG000|Overall Study|Adverse Event|1|||
48949362|NCT00685178|157645161|FG001|Overall Study|Adverse Event|5|||
48949363|NCT00685178|157645162|FG002|Overall Study|Adverse Event|2|||
48949364|NCT00685178|157645163|FG003|Overall Study|Adverse Event|4|||
48739736|NCT00114530|156895714|FG000|Overall Study|Death|3|||
48739737|NCT00114530|156895715|FG001|Overall Study|Death|11|||
48739738|NCT00114530|156895714|FG000|Overall Study|Lost to Follow-up|1|||
48739739|NCT00114530|156895715|FG001|Overall Study|Lost to Follow-up|1|||
48739740|NCT00114530|156895714|FG000|Overall Study|Physician Decision|1|||
48949365|NCT00685178|157645160|FG000|Overall Study|missed 3 consecutive methadone clin days|7|||
48949366|NCT00685178|157645161|FG001|Overall Study|missed 3 consecutive methadone clin days|5|||
48949367|NCT00685178|157645162|FG002|Overall Study|missed 3 consecutive methadone clin days|2|||
48949368|NCT00685178|157645163|FG003|Overall Study|missed 3 consecutive methadone clin days|6|||
48949369|NCT00685178|157645160|FG000|Overall Study|voluntary study discharge|4|||
48949370|NCT00685178|157645161|FG001|Overall Study|voluntary study discharge|5|||
48949371|NCT00685178|157645162|FG002|Overall Study|voluntary study discharge|1|||
48949372|NCT00685178|157645163|FG003|Overall Study|voluntary study discharge|1|||
48949373|NCT00685178|157645160|FG000|Overall Study|incarcerated|1|||
48949374|NCT00685178|157645161|FG001|Overall Study|incarcerated|3|||
48949375|NCT00685178|157645162|FG002|Overall Study|incarcerated|7|||
48949376|NCT00685178|157645163|FG003|Overall Study|incarcerated|0|||
48949377|NCT00685178|157645160|FG000|Overall Study|administrative (disciplinary) discharge|0|||
48949378|NCT00685178|157645161|FG001|Overall Study|administrative (disciplinary) discharge|1|||
48949379|NCT00685178|157645162|FG002|Overall Study|administrative (disciplinary) discharge|0|||
48949380|NCT00685178|157645163|FG003|Overall Study|administrative (disciplinary) discharge|2|||
48949381|NCT00685178|157645160|FG000|Overall Study|Pregnancy|0|||
48949382|NCT00685178|157645161|FG001|Overall Study|Pregnancy|0|||
48949383|NCT00685178|157645162|FG002|Overall Study|Pregnancy|0|||
48949384|NCT00685178|157645163|FG003|Overall Study|Pregnancy|1|||
48949385|NCT00401973|157645164|FG000|Overall Study|Adverse Event|2|||
48949386|NCT00401973|157645165|FG001|Overall Study|Adverse Event|8|||
48949387|NCT00401973|157645166|FG002|Overall Study|Adverse Event|4|||
48949388|NCT00401973|157645164|FG000|Overall Study|Clinical Relapse|0|||
48949389|NCT00401973|157645165|FG001|Overall Study|Clinical Relapse|1|||
48949390|NCT00401973|157645166|FG002|Overall Study|Clinical Relapse|1|||
48949391|NCT00401973|157645164|FG000|Overall Study|Lack of Efficacy|0|||
48949392|NCT00401973|157645165|FG001|Overall Study|Lack of Efficacy|0|||
48949393|NCT00401973|157645166|FG002|Overall Study|Lack of Efficacy|3|||
48949394|NCT00401973|157645164|FG000|Overall Study|Lost to Follow-up|2|||
48949395|NCT00401973|157645165|FG001|Overall Study|Lost to Follow-up|2|||
48949396|NCT00401973|157645166|FG002|Overall Study|Lost to Follow-up|2|||
48949397|NCT00401973|157645164|FG000|Overall Study|Physician Decision|2|||
48949398|NCT00401973|157645165|FG001|Overall Study|Physician Decision|0|||
48739741|NCT00114530|156895715|FG001|Overall Study|Physician Decision|1|||
48739742|NCT00114530|156895714|FG000|Overall Study|Withdrawal by Subject|2|||
48739743|NCT00114530|156895715|FG001|Overall Study|Withdrawal by Subject|6|||
48739744|NCT00114530|156895714|FG000|Overall Study|Breast Cancer|1|||
48739745|NCT00114530|156895715|FG001|Overall Study|Breast Cancer|0|||
48739746|NCT00114530|156895714|FG000|Overall Study|Subject decision after endpoint failure|0|||
48739747|NCT00114530|156895715|FG001|Overall Study|Subject decision after endpoint failure|1|||
48739748|NCT00114530|156895714|FG000|Overall Study|Ineligible|1|||
48739749|NCT00114530|156895715|FG001|Overall Study|Ineligible|0|||
48739750|NCT03846804|156895724|FG000|Overall Study|Refused blood draw|1|||
48739751|NCT03846804|156895724|FG000|Overall Study|Protocol Violation|1|||
48739752|NCT02538029|156895725|FG000|Overall Study|unable to complete cognitive assessments|1|||
48739753|NCT02538029|156895726|FG001|Overall Study|unable to complete cognitive assessments|0|||
48739754|NCT02538029|156895727|FG002|Overall Study|unable to complete cognitive assessments|1|||
48949399|NCT00401973|157645166|FG002|Overall Study|Physician Decision|1|||
48739755|NCT00566995|156895728|FG000|Overall Study|Toxicity|4|||
48949400|NCT00401973|157645164|FG000|Overall Study|Protocol Violation|1|||
48949401|NCT00401973|157645165|FG001|Overall Study|Protocol Violation|2|||
48949402|NCT00401973|157645166|FG002|Overall Study|Protocol Violation|3|||
48949403|NCT00401973|157645164|FG000|Overall Study|Sponsor Decision|0|||
48949404|NCT00401973|157645165|FG001|Overall Study|Sponsor Decision|1|||
48739756|NCT00566995|156895728|FG000|Overall Study|Withdrew consent|3|||
48739757|NCT00404235|156895729|FG000|Overall Study|Withdrawal by Subject|1|||
48739758|NCT00404235|156895730|FG001|Overall Study|Withdrawal by Subject|2|||
48739759|NCT05248867|156895731|FG000|Double-blind Period|Lost to Follow-up|0|||
48739760|NCT05248867|156895732|FG001|Double-blind Period|Lost to Follow-up|3|||
48739761|NCT05248867|156895733|FG002|Double-blind Period|Lost to Follow-up|0|||
48739762|NCT05248867|156895734|FG003|Double-blind Period|Lost to Follow-up|0|||
48739763|NCT05248867|156895735|FG004|Double-blind Period|Lost to Follow-up|0|||
48739764|NCT05248867|156895736|FG005|Double-blind Period|Lost to Follow-up|0|||
48739765|NCT05248867|156895731|FG000|Double-blind Period|Withdrawal by Subject|5|||
48739766|NCT05248867|156895732|FG001|Double-blind Period|Withdrawal by Subject|14|||
48739767|NCT05248867|156895733|FG002|Double-blind Period|Withdrawal by Subject|0|||
48739768|NCT05248867|156895734|FG003|Double-blind Period|Withdrawal by Subject|0|||
48739769|NCT05248867|156895735|FG004|Double-blind Period|Withdrawal by Subject|0|||
48739770|NCT05248867|156895736|FG005|Double-blind Period|Withdrawal by Subject|0|||
48739771|NCT05248867|156895731|FG000|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
48739772|NCT05248867|156895732|FG001|Double-blind Period|Withdrawal by Subject due to Adverse Event|3|||
48739773|NCT05248867|156895733|FG002|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
48949405|NCT00401973|157645166|FG002|Overall Study|Sponsor Decision|0|||
48739774|NCT05248867|156895734|FG003|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
48739775|NCT05248867|156895735|FG004|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
48739776|NCT05248867|156895736|FG005|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
48739777|NCT05248867|156895731|FG000|Double-blind Period|Other, not specified|3|||
48739778|NCT05248867|156895732|FG001|Double-blind Period|Other, not specified|8|||
48739779|NCT05248867|156895733|FG002|Double-blind Period|Other, not specified|0|||
48949406|NCT00401973|157645164|FG000|Overall Study|Withdrawal by Subject|4|||
48949407|NCT00401973|157645165|FG001|Overall Study|Withdrawal by Subject|12|||
48949408|NCT00401973|157645166|FG002|Overall Study|Withdrawal by Subject|9|||
48739780|NCT05248867|156895734|FG003|Double-blind Period|Other, not specified|0|||
48739781|NCT05248867|156895735|FG004|Double-blind Period|Other, not specified|0|||
48739782|NCT05248867|156895736|FG005|Double-blind Period|Other, not specified|0|||
48739783|NCT05248867|156895731|FG000|Open-label Period|Withdrawal by Subject|0|||
48739784|NCT05248867|156895732|FG001|Open-label Period|Withdrawal by Subject|0|||
48739785|NCT05248867|156895733|FG002|Open-label Period|Withdrawal by Subject|3|||
48739786|NCT05248867|156895734|FG003|Open-label Period|Withdrawal by Subject|1|||
48739787|NCT05248867|156895735|FG004|Open-label Period|Withdrawal by Subject|7|||
48739788|NCT05248867|156895736|FG005|Open-label Period|Withdrawal by Subject|9|||
48739789|NCT05248867|156895731|FG000|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
48739790|NCT05248867|156895732|FG001|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
48739791|NCT05248867|156895733|FG002|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
48739792|NCT05248867|156895734|FG003|Open-label Period|Withdrawal by Subject due to Adverse Event|1|||
48739793|NCT05248867|156895735|FG004|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
48739794|NCT05248867|156895736|FG005|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
48739795|NCT05248867|156895731|FG000|Open-label Period|Lost to Follow-up|0|||
48739796|NCT05248867|156895732|FG001|Open-label Period|Lost to Follow-up|0|||
48739797|NCT05248867|156895733|FG002|Open-label Period|Lost to Follow-up|0|||
48739798|NCT05248867|156895734|FG003|Open-label Period|Lost to Follow-up|0|||
48739799|NCT05248867|156895735|FG004|Open-label Period|Lost to Follow-up|5|||
48739800|NCT05248867|156895736|FG005|Open-label Period|Lost to Follow-up|2|||
48739801|NCT05248867|156895731|FG000|Open-label Period|COVID-19 Infection|0|||
48739802|NCT05248867|156895732|FG001|Open-label Period|COVID-19 Infection|0|||
48739803|NCT05248867|156895733|FG002|Open-label Period|COVID-19 Infection|0|||
48739804|NCT05248867|156895734|FG003|Open-label Period|COVID-19 Infection|0|||
48739805|NCT05248867|156895735|FG004|Open-label Period|COVID-19 Infection|1|||
48739806|NCT05248867|156895736|FG005|Open-label Period|COVID-19 Infection|0|||
48739807|NCT05248867|156895731|FG000|Open-label Period|Other, not specified|0|||
48739808|NCT05248867|156895732|FG001|Open-label Period|Other, not specified|0|||
48739809|NCT05248867|156895733|FG002|Open-label Period|Other, not specified|0|||
48739810|NCT05248867|156895734|FG003|Open-label Period|Other, not specified|0|||
48739811|NCT05248867|156895735|FG004|Open-label Period|Other, not specified|4|||
48949409|NCT03515538|157645167|FG000|Overall Study|Lack of Efficacy|2|||
48949410|NCT03515538|157645168|FG001|Overall Study|Lack of Efficacy|0|||
48949411|NCT03515538|157645169|FG002|Overall Study|Lack of Efficacy|2|||
48949412|NCT03515538|157645170|FG003|Overall Study|Lack of Efficacy|0|||
48949413|NCT03515538|157645167|FG000|Overall Study|Death|0|||
48949414|NCT03515538|157645168|FG001|Overall Study|Death|0|||
48949415|NCT03515538|157645169|FG002|Overall Study|Death|1|||
48949416|NCT03515538|157645170|FG003|Overall Study|Death|0|||
48949417|NCT03515538|157645167|FG000|Overall Study|Protocol Violation|0|||
48949418|NCT03515538|157645168|FG001|Overall Study|Protocol Violation|0|||
48739812|NCT05248867|156895736|FG005|Open-label Period|Other, not specified|0|||
48739813|NCT00001880|156895737|FG000|Overall Study|Death|14|||
48739814|NCT01441180|156895738|FG000|Overall Study|Lost to Follow-up|1|||
48739815|NCT01441180|156895739|FG001|Overall Study|Lost to Follow-up|1|||
48739816|NCT01441180|156895740|FG002|Overall Study|Lost to Follow-up|1|||
48739817|NCT01441180|156895738|FG000|Overall Study|Discontinued|0|||
48739818|NCT01441180|156895739|FG001|Overall Study|Discontinued|0|||
48739819|NCT01441180|156895740|FG002|Overall Study|Discontinued|2|||
48739820|NCT00824720|156895741|FG000|Overall Study|failed plug insertion|3|||
48739821|NCT00824720|156895742|FG001|Overall Study|failed plug insertion|1|||
48739822|NCT00824720|156895743|FG002|Overall Study|failed plug insertion|0|||
48949419|NCT03515538|157645169|FG002|Overall Study|Protocol Violation|0|||
48949420|NCT03515538|157645170|FG003|Overall Study|Protocol Violation|1|||
48949421|NCT03515538|157645167|FG000|Overall Study|Screen failure (baseline dropout)|0|||
48949422|NCT03515538|157645168|FG001|Overall Study|Screen failure (baseline dropout)|1|||
48949423|NCT03515538|157645169|FG002|Overall Study|Screen failure (baseline dropout)|0|||
48949424|NCT03515538|157645170|FG003|Overall Study|Screen failure (baseline dropout)|0|||
48949425|NCT03515538|157645167|FG000|Overall Study|Withdrawal by Subject|2|||
48949426|NCT03515538|157645168|FG001|Overall Study|Withdrawal by Subject|2|||
48739823|NCT00824720|156895741|FG000|Overall Study|Protocol Violation|0|||
48739824|NCT00824720|156895742|FG001|Overall Study|Protocol Violation|0|||
48739825|NCT00824720|156895743|FG002|Overall Study|Protocol Violation|1|||
48739826|NCT00142298|156895746|FG000|Overall Study|Adverse Event|10|||
48739827|NCT00142298|156895747|FG001|Overall Study|Adverse Event|10|||
48739828|NCT00142298|156895748|FG002|Overall Study|Adverse Event|1|||
48739829|NCT00142298|156895749|FG003|Overall Study|Adverse Event|5|||
48739830|NCT00142298|156895750|FG004|Overall Study|Adverse Event|2|||
48739831|NCT00142298|156895751|FG005|Overall Study|Adverse Event|2|||
48739832|NCT00142298|156895752|FG006|Overall Study|Adverse Event|0|||
48739833|NCT00142298|156895753|FG007|Overall Study|Adverse Event|0|||
48949427|NCT03515538|157645169|FG002|Overall Study|Withdrawal by Subject|1|||
48739834|NCT00142298|156895754|FG008|Overall Study|Adverse Event|0|||
48739835|NCT00142298|156895755|FG009|Overall Study|Adverse Event|0|||
48739836|NCT00142298|156895746|FG000|Overall Study|Clinical disease progression|1|||
48949428|NCT03515538|157645170|FG003|Overall Study|Withdrawal by Subject|3|||
48739837|NCT00142298|156895747|FG001|Overall Study|Clinical disease progression|0|||
48739838|NCT00142298|156895748|FG002|Overall Study|Clinical disease progression|0|||
48739839|NCT00142298|156895749|FG003|Overall Study|Clinical disease progression|0|||
48739840|NCT00142298|156895750|FG004|Overall Study|Clinical disease progression|0|||
48739841|NCT00142298|156895751|FG005|Overall Study|Clinical disease progression|0|||
48739842|NCT00142298|156895752|FG006|Overall Study|Clinical disease progression|0|||
48739843|NCT00142298|156895753|FG007|Overall Study|Clinical disease progression|0|||
48739844|NCT00142298|156895754|FG008|Overall Study|Clinical disease progression|0|||
48739845|NCT00142298|156895755|FG009|Overall Study|Clinical disease progression|0|||
48739846|NCT00142298|156895746|FG000|Overall Study|Death|1|||
48739847|NCT00142298|156895747|FG001|Overall Study|Death|1|||
48739848|NCT00142298|156895748|FG002|Overall Study|Death|1|||
48739849|NCT00142298|156895749|FG003|Overall Study|Death|0|||
48739850|NCT00142298|156895750|FG004|Overall Study|Death|0|||
48739851|NCT00142298|156895751|FG005|Overall Study|Death|6|||
48739852|NCT00142298|156895752|FG006|Overall Study|Death|0|||
48739853|NCT00142298|156895753|FG007|Overall Study|Death|0|||
48739854|NCT00142298|156895754|FG008|Overall Study|Death|0|||
48739855|NCT00142298|156895755|FG009|Overall Study|Death|0|||
48739856|NCT00142298|156895746|FG000|Overall Study|Lack of Efficacy|44|||
48739857|NCT00142298|156895747|FG001|Overall Study|Lack of Efficacy|62|||
48739858|NCT00142298|156895748|FG002|Overall Study|Lack of Efficacy|9|||
48739859|NCT00142298|156895749|FG003|Overall Study|Lack of Efficacy|12|||
48739860|NCT00142298|156895750|FG004|Overall Study|Lack of Efficacy|1|||
48739861|NCT00142298|156895751|FG005|Overall Study|Lack of Efficacy|0|||
48739862|NCT00142298|156895752|FG006|Overall Study|Lack of Efficacy|0|||
48739863|NCT00142298|156895753|FG007|Overall Study|Lack of Efficacy|1|||
48739864|NCT00142298|156895754|FG008|Overall Study|Lack of Efficacy|0|||
48739865|NCT00142298|156895755|FG009|Overall Study|Lack of Efficacy|0|||
48739866|NCT00142298|156895746|FG000|Overall Study|Non-compliance|15|||
48739867|NCT00142298|156895747|FG001|Overall Study|Non-compliance|13|||
48739868|NCT00142298|156895748|FG002|Overall Study|Non-compliance|0|||
48739869|NCT00142298|156895749|FG003|Overall Study|Non-compliance|6|||
48739870|NCT00142298|156895750|FG004|Overall Study|Non-compliance|1|||
48739871|NCT00142298|156895751|FG005|Overall Study|Non-compliance|0|||
48739872|NCT00142298|156895752|FG006|Overall Study|Non-compliance|0|||
48739873|NCT00142298|156895753|FG007|Overall Study|Non-compliance|3|||
48739874|NCT00142298|156895754|FG008|Overall Study|Non-compliance|3|||
48739875|NCT00142298|156895755|FG009|Overall Study|Non-compliance|0|||
48739876|NCT00142298|156895746|FG000|Overall Study|Patient, Investigator,or Sponsor request|66|||
48739877|NCT00142298|156895747|FG001|Overall Study|Patient, Investigator,or Sponsor request|60|||
48739878|NCT00142298|156895748|FG002|Overall Study|Patient, Investigator,or Sponsor request|11|||
48739879|NCT00142298|156895749|FG003|Overall Study|Patient, Investigator,or Sponsor request|51|||
48739880|NCT00142298|156895750|FG004|Overall Study|Patient, Investigator,or Sponsor request|4|||
48739881|NCT00142298|156895751|FG005|Overall Study|Patient, Investigator,or Sponsor request|3|||
48739882|NCT00142298|156895752|FG006|Overall Study|Patient, Investigator,or Sponsor request|1|||
48739883|NCT00142298|156895753|FG007|Overall Study|Patient, Investigator,or Sponsor request|4|||
48739884|NCT00142298|156895754|FG008|Overall Study|Patient, Investigator,or Sponsor request|1|||
48739885|NCT00142298|156895755|FG009|Overall Study|Patient, Investigator,or Sponsor request|0|||
48739886|NCT00142298|156895746|FG000|Overall Study|Pregnancy|4|||
48739887|NCT00142298|156895747|FG001|Overall Study|Pregnancy|4|||
48739888|NCT00142298|156895748|FG002|Overall Study|Pregnancy|2|||
48739889|NCT00142298|156895749|FG003|Overall Study|Pregnancy|3|||
48739890|NCT00142298|156895750|FG004|Overall Study|Pregnancy|0|||
48949429|NCT03515538|157645167|FG000|Overall Study|Physician Decision|1|||
48949430|NCT03515538|157645168|FG001|Overall Study|Physician Decision|0|||
48949431|NCT03515538|157645169|FG002|Overall Study|Physician Decision|0|||
48949432|NCT03515538|157645170|FG003|Overall Study|Physician Decision|1|||
48949433|NCT01097616|157645173|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6|||
48949434|NCT01097616|157645174|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15|||
48949435|NCT01097616|157645175|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21|||
48949436|NCT01097616|157645176|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
48949437|NCT01097616|157645177|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
48949438|NCT01097616|157645178|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
48949439|NCT01097616|157645179|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
48949440|NCT01097616|157645180|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
48949441|NCT01097616|157645173|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6|||
48949442|NCT01097616|157645174|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
48949443|NCT01097616|157645175|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12|||
48739891|NCT00142298|156895751|FG005|Overall Study|Pregnancy|0|||
48739892|NCT00142298|156895752|FG006|Overall Study|Pregnancy|0|||
48739893|NCT00142298|156895753|FG007|Overall Study|Pregnancy|0|||
48739894|NCT00142298|156895754|FG008|Overall Study|Pregnancy|1|||
48739895|NCT00142298|156895755|FG009|Overall Study|Pregnancy|0|||
48739896|NCT00142298|156895746|FG000|Overall Study|Virologic breakthrough|19|||
48739897|NCT00142298|156895747|FG001|Overall Study|Virologic breakthrough|23|||
48739898|NCT00142298|156895748|FG002|Overall Study|Virologic breakthrough|9|||
48739899|NCT00142298|156895749|FG003|Overall Study|Virologic breakthrough|7|||
48739900|NCT00142298|156895750|FG004|Overall Study|Virologic breakthrough|2|||
48739901|NCT00142298|156895751|FG005|Overall Study|Virologic breakthrough|3|||
48739902|NCT00142298|156895752|FG006|Overall Study|Virologic breakthrough|3|||
48739903|NCT00142298|156895753|FG007|Overall Study|Virologic breakthrough|0|||
48739904|NCT00142298|156895754|FG008|Overall Study|Virologic breakthrough|0|||
48739905|NCT00142298|156895755|FG009|Overall Study|Virologic breakthrough|0|||
48739906|NCT00142298|156895746|FG000|Overall Study|Other- not specified|0|||
48739907|NCT00142298|156895747|FG001|Overall Study|Other- not specified|3|||
48739908|NCT00142298|156895748|FG002|Overall Study|Other- not specified|0|||
48739909|NCT00142298|156895749|FG003|Overall Study|Other- not specified|1|||
48739910|NCT00142298|156895750|FG004|Overall Study|Other- not specified|0|||
48739911|NCT00142298|156895751|FG005|Overall Study|Other- not specified|0|||
48739912|NCT00142298|156895752|FG006|Overall Study|Other- not specified|0|||
48739913|NCT00142298|156895753|FG007|Overall Study|Other- not specified|0|||
48739914|NCT00142298|156895754|FG008|Overall Study|Other- not specified|0|||
48739915|NCT00142298|156895755|FG009|Overall Study|Other- not specified|0|||
48854202|NCT02561195|157304960|FG005|Vaccination 1 to 3|Withdrawal by Subject|0|||
48739916|NCT00142298|156895746|FG000|Overall Study|Lost to Follow-up|0|||
48854203|NCT02561195|157304961|FG006|Vaccination 1 to 3|Withdrawal by Subject|0|||
48854204|NCT02561195|157304962|FG007|Vaccination 1 to 3|Withdrawal by Subject|0|||
48739917|NCT00142298|156895747|FG001|Overall Study|Lost to Follow-up|0|||
48854205|NCT02561195|157304963|FG008|Vaccination 1 to 3|Withdrawal by Subject|0|||
48854206|NCT02561195|157304964|FG009|Vaccination 1 to 3|Withdrawal by Subject|0|||
48854207|NCT02561195|157304965|FG010|Vaccination 1 to 3|Withdrawal by Subject|0|||
48854208|NCT02561195|157304966|FG011|Vaccination 1 to 3|Withdrawal by Subject|0|||
48854209|NCT02561195|157304967|FG012|Vaccination 1 to 3|Withdrawal by Subject|0|||
48854210|NCT02561195|157304968|FG013|Vaccination 1 to 3|Withdrawal by Subject|0|||
48854211|NCT02561195|157304955|FG000|Vaccination 1 to 3|Randomized but not treated|1|||
48854212|NCT02561195|157304956|FG001|Vaccination 1 to 3|Randomized but not treated|0|||
48854213|NCT02561195|157304957|FG002|Vaccination 1 to 3|Randomized but not treated|0|||
48854214|NCT02561195|157304958|FG003|Vaccination 1 to 3|Randomized but not treated|0|||
48739918|NCT00142298|156895748|FG002|Overall Study|Lost to Follow-up|0|||
48739919|NCT00142298|156895749|FG003|Overall Study|Lost to Follow-up|0|||
48854215|NCT02561195|157304959|FG004|Vaccination 1 to 3|Randomized but not treated|0|||
48854216|NCT02561195|157304960|FG005|Vaccination 1 to 3|Randomized but not treated|0|||
48854217|NCT02561195|157304961|FG006|Vaccination 1 to 3|Randomized but not treated|0|||
48854218|NCT02561195|157304962|FG007|Vaccination 1 to 3|Randomized but not treated|0|||
48854219|NCT02561195|157304963|FG008|Vaccination 1 to 3|Randomized but not treated|0|||
48854220|NCT02561195|157304964|FG009|Vaccination 1 to 3|Randomized but not treated|0|||
48854221|NCT02561195|157304965|FG010|Vaccination 1 to 3|Randomized but not treated|0|||
48854222|NCT02561195|157304966|FG011|Vaccination 1 to 3|Randomized but not treated|0|||
48854223|NCT02561195|157304967|FG012|Vaccination 1 to 3|Randomized but not treated|0|||
48739920|NCT00142298|156895750|FG004|Overall Study|Lost to Follow-up|0|||
48739921|NCT00142298|156895751|FG005|Overall Study|Lost to Follow-up|0|||
48739922|NCT00142298|156895752|FG006|Overall Study|Lost to Follow-up|2|||
48739923|NCT00142298|156895753|FG007|Overall Study|Lost to Follow-up|0|||
48739924|NCT00142298|156895754|FG008|Overall Study|Lost to Follow-up|0|||
48739925|NCT00142298|156895755|FG009|Overall Study|Lost to Follow-up|0|||
48739926|NCT00142298|156895746|FG000|Overall Study|Treatment Failure|0|||
48739927|NCT00142298|156895747|FG001|Overall Study|Treatment Failure|0|||
48739928|NCT00142298|156895748|FG002|Overall Study|Treatment Failure|0|||
48739929|NCT00142298|156895749|FG003|Overall Study|Treatment Failure|0|||
48739930|NCT00142298|156895750|FG004|Overall Study|Treatment Failure|0|||
48739931|NCT00142298|156895751|FG005|Overall Study|Treatment Failure|2|||
48739932|NCT00142298|156895752|FG006|Overall Study|Treatment Failure|2|||
48739933|NCT00142298|156895753|FG007|Overall Study|Treatment Failure|0|||
48739934|NCT00142298|156895754|FG008|Overall Study|Treatment Failure|0|||
48739935|NCT00142298|156895755|FG009|Overall Study|Treatment Failure|0|||
48739936|NCT00242216|156895756|FG000|Overall Study|Lost to Follow-up|12|||
48739937|NCT00242216|156895757|FG001|Overall Study|Lost to Follow-up|17|||
48739938|NCT00242216|156895756|FG000|Overall Study|Death|4|||
48739939|NCT00242216|156895757|FG001|Overall Study|Death|2|||
48739940|NCT00242216|156895756|FG000|Overall Study|Lack of Efficacy|1|||
48739941|NCT00242216|156895757|FG001|Overall Study|Lack of Efficacy|2|||
48739942|NCT00242216|156895756|FG000|Overall Study|no medicaiton dispensed|1|||
48739943|NCT00242216|156895757|FG001|Overall Study|no medicaiton dispensed|1|||
48739944|NCT01980940|156895758|FG000|Overall Study|Protocol Violation|0|||
48739945|NCT01980940|156895759|FG001|Overall Study|Protocol Violation|0|||
48739946|NCT01980940|156895760|FG002|Overall Study|Protocol Violation|0|||
48854224|NCT02561195|157304968|FG013|Vaccination 1 to 3|Randomized but not treated|0|||
48854225|NCT02561195|157304955|FG000|Extension Stage (Vaccination 4)|Withdrew consent|0|||
48739947|NCT01980940|156895761|FG003|Overall Study|Protocol Violation|0|||
48739948|NCT01980940|156895762|FG004|Overall Study|Protocol Violation|0|||
48739949|NCT01980940|156895763|FG005|Overall Study|Protocol Violation|2|||
48739950|NCT01980940|156895764|FG006|Overall Study|Protocol Violation|0|||
48739951|NCT01980940|156895765|FG007|Overall Study|Protocol Violation|0|||
48739952|NCT02079740|156897368|FG000|Phase 1b: Dose Escalation|Adverse Event|0|||
48739953|NCT02079740|156897369|FG001|Phase 1b: Dose Escalation|Adverse Event|0|||
48739954|NCT02079740|156897370|FG002|Phase 1b: Dose Escalation|Adverse Event|0|||
48854226|NCT02561195|157304956|FG001|Extension Stage (Vaccination 4)|Withdrew consent|0|||
48854227|NCT02561195|157304957|FG002|Extension Stage (Vaccination 4)|Withdrew consent|0|||
48854228|NCT02561195|157304958|FG003|Extension Stage (Vaccination 4)|Withdrew consent|0|||
48854229|NCT02561195|157304959|FG004|Extension Stage (Vaccination 4)|Withdrew consent|0|||
48854230|NCT02561195|157304960|FG005|Extension Stage (Vaccination 4)|Withdrew consent|0|||
48854231|NCT02561195|157304961|FG006|Extension Stage (Vaccination 4)|Withdrew consent|0|||
48854232|NCT02561195|157304962|FG007|Extension Stage (Vaccination 4)|Withdrew consent|0|||
48854233|NCT02561195|157304963|FG008|Extension Stage (Vaccination 4)|Withdrew consent|3|||
48854234|NCT02561195|157304964|FG009|Extension Stage (Vaccination 4)|Withdrew consent|1|||
48854235|NCT02561195|157304965|FG010|Extension Stage (Vaccination 4)|Withdrew consent|2|||
48854236|NCT02561195|157304966|FG011|Extension Stage (Vaccination 4)|Withdrew consent|2|||
48854237|NCT02561195|157304967|FG012|Extension Stage (Vaccination 4)|Withdrew consent|3|||
48854238|NCT02561195|157304968|FG013|Extension Stage (Vaccination 4)|Withdrew consent|0|||
48854239|NCT02561195|157304955|FG000|Extension Stage (Vaccination 4)|Adverse Event|0|||
48854240|NCT02561195|157304956|FG001|Extension Stage (Vaccination 4)|Adverse Event|0|||
48949444|NCT01097616|157645176|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
48949445|NCT01097616|157645177|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
48949446|NCT01097616|157645178|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
48949447|NCT01097616|157645179|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
48949448|NCT01097616|157645180|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
48949449|NCT01097616|157645173|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
48949450|NCT01097616|157645174|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3|||
48949451|NCT01097616|157645175|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1|||
48949452|NCT01097616|157645176|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
48949453|NCT01097616|157645177|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
48949454|NCT01097616|157645178|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
48949455|NCT01097616|157645179|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
48949456|NCT01097616|157645180|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
48949457|NCT01097616|157645173|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
48949458|NCT01097616|157645174|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
48949459|NCT01097616|157645175|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
48949460|NCT01097616|157645176|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
48949461|NCT01097616|157645177|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
48949462|NCT01097616|157645178|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
48949463|NCT01097616|157645179|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
48949464|NCT01097616|157645180|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
48949465|NCT01097616|157645173|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1|||
48949466|NCT01097616|157645174|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
48949467|NCT01097616|157645175|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9|||
48949468|NCT01097616|157645176|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
48949469|NCT01097616|157645177|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
48739955|NCT02079740|156897371|FG003|Phase 1b: Dose Escalation|Adverse Event|0|||
48739956|NCT02079740|156897372|FG004|Phase 1b: Dose Escalation|Adverse Event|1|||
48739957|NCT02079740|156897373|FG005|Phase 1b: Dose Escalation|Adverse Event|0|||
48739958|NCT02079740|156897374|FG006|Phase 1b: Dose Escalation|Adverse Event|0|||
48739959|NCT02079740|156897375|FG007|Phase 1b: Dose Escalation|Adverse Event|0|||
48739960|NCT02079740|156897376|FG008|Phase 1b: Dose Escalation|Adverse Event|0|||
48739961|NCT02079740|156897377|FG009|Phase 1b: Dose Escalation|Adverse Event|0|||
48739962|NCT02079740|156897378|FG010|Phase 1b: Dose Escalation|Adverse Event|0|||
48739963|NCT02079740|156897379|FG011|Phase 1b: Dose Escalation|Adverse Event|0|||
48739964|NCT02079740|156897380|FG012|Phase 1b: Dose Escalation|Adverse Event|0|||
48739965|NCT02079740|156897368|FG000|Phase 1b: Dose Escalation|Physician Decision|0|||
48739966|NCT02079740|156897369|FG001|Phase 1b: Dose Escalation|Physician Decision|0|||
48739967|NCT02079740|156897370|FG002|Phase 1b: Dose Escalation|Physician Decision|0|||
48739968|NCT02079740|156897371|FG003|Phase 1b: Dose Escalation|Physician Decision|0|||
48739969|NCT02079740|156897372|FG004|Phase 1b: Dose Escalation|Physician Decision|1|||
48739970|NCT02079740|156897373|FG005|Phase 1b: Dose Escalation|Physician Decision|0|||
48739971|NCT02079740|156897374|FG006|Phase 1b: Dose Escalation|Physician Decision|0|||
48739972|NCT02079740|156897375|FG007|Phase 1b: Dose Escalation|Physician Decision|0|||
48739973|NCT02079740|156897376|FG008|Phase 1b: Dose Escalation|Physician Decision|0|||
48739974|NCT02079740|156897377|FG009|Phase 1b: Dose Escalation|Physician Decision|0|||
48739975|NCT02079740|156897378|FG010|Phase 1b: Dose Escalation|Physician Decision|0|||
48739976|NCT02079740|156897379|FG011|Phase 1b: Dose Escalation|Physician Decision|0|||
48739977|NCT02079740|156897380|FG012|Phase 1b: Dose Escalation|Physician Decision|0|||
48739978|NCT02079740|156897368|FG000|Phase 1b: Dose Escalation|Clinical Progression|0|||
48739979|NCT02079740|156897369|FG001|Phase 1b: Dose Escalation|Clinical Progression|0|||
48739980|NCT02079740|156897370|FG002|Phase 1b: Dose Escalation|Clinical Progression|0|||
48739981|NCT02079740|156897371|FG003|Phase 1b: Dose Escalation|Clinical Progression|0|||
48739982|NCT02079740|156897372|FG004|Phase 1b: Dose Escalation|Clinical Progression|0|||
48739983|NCT02079740|156897373|FG005|Phase 1b: Dose Escalation|Clinical Progression|0|||
48739984|NCT02079740|156897374|FG006|Phase 1b: Dose Escalation|Clinical Progression|0|||
48739985|NCT02079740|156897375|FG007|Phase 1b: Dose Escalation|Clinical Progression|1|||
48739986|NCT02079740|156897376|FG008|Phase 1b: Dose Escalation|Clinical Progression|0|||
48739987|NCT02079740|156897377|FG009|Phase 1b: Dose Escalation|Clinical Progression|0|||
48739988|NCT02079740|156897378|FG010|Phase 1b: Dose Escalation|Clinical Progression|0|||
48739989|NCT02079740|156897379|FG011|Phase 1b: Dose Escalation|Clinical Progression|0|||
48949470|NCT01097616|157645178|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
48949471|NCT01097616|157645179|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
48949472|NCT01097616|157645180|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
48949473|NCT01097616|157645173|FG000|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
48949474|NCT01097616|157645174|FG001|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
48949475|NCT01097616|157645175|FG002|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
48949476|NCT01097616|157645176|FG003|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
48949477|NCT01097616|157645177|FG004|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
48949478|NCT01097616|157645178|FG005|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
48949479|NCT01097616|157645179|FG006|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
48949480|NCT01097616|157645180|FG007|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
48949481|NCT01097616|157645173|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4|||
48949482|NCT01097616|157645174|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3|||
48949483|NCT01097616|157645175|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
48949484|NCT01097616|157645176|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
48949485|NCT01097616|157645177|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
48949486|NCT01097616|157645178|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
48949487|NCT01097616|157645179|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
48949488|NCT01097616|157645180|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
48949489|NCT01097616|157645173|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
48949490|NCT01097616|157645174|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
48949491|NCT01097616|157645175|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
48949492|NCT01097616|157645176|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
48949493|NCT01097616|157645177|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
48949494|NCT01097616|157645178|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
48949495|NCT01097616|157645179|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
48949496|NCT01097616|157645180|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
48949497|NCT01097616|157645173|FG000|Optional DB EXT Phase|Adverse Event|0|||
48949498|NCT01097616|157645174|FG001|Optional DB EXT Phase|Adverse Event|7|||
48949499|NCT01097616|157645175|FG002|Optional DB EXT Phase|Adverse Event|2|||
48949500|NCT01097616|157645176|FG003|Optional DB EXT Phase|Adverse Event|0|||
48949501|NCT01097616|157645177|FG004|Optional DB EXT Phase|Adverse Event|0|||
48949502|NCT01097616|157645178|FG005|Optional DB EXT Phase|Adverse Event|0|||
48949503|NCT01097616|157645179|FG006|Optional DB EXT Phase|Adverse Event|0|||
48949504|NCT01097616|157645180|FG007|Optional DB EXT Phase|Adverse Event|0|||
48949505|NCT01097616|157645173|FG000|Optional DB EXT Phase|Withdrawal by Subject|12|||
48949506|NCT01097616|157645174|FG001|Optional DB EXT Phase|Withdrawal by Subject|6|||
48949507|NCT01097616|157645175|FG002|Optional DB EXT Phase|Withdrawal by Subject|3|||
48949508|NCT01097616|157645176|FG003|Optional DB EXT Phase|Withdrawal by Subject|0|||
48949509|NCT01097616|157645177|FG004|Optional DB EXT Phase|Withdrawal by Subject|0|||
48949510|NCT01097616|157645178|FG005|Optional DB EXT Phase|Withdrawal by Subject|0|||
48949511|NCT01097616|157645179|FG006|Optional DB EXT Phase|Withdrawal by Subject|0|||
48949512|NCT01097616|157645180|FG007|Optional DB EXT Phase|Withdrawal by Subject|0|||
48949513|NCT01097616|157645173|FG000|Optional DB EXT Phase|Protocol Violation|0|||
48949514|NCT01097616|157645174|FG001|Optional DB EXT Phase|Protocol Violation|2|||
48739990|NCT02079740|156897380|FG012|Phase 1b: Dose Escalation|Clinical Progression|0|||
48949515|NCT01097616|157645175|FG002|Optional DB EXT Phase|Protocol Violation|3|||
48949516|NCT01097616|157645176|FG003|Optional DB EXT Phase|Protocol Violation|0|||
48949517|NCT01097616|157645177|FG004|Optional DB EXT Phase|Protocol Violation|0|||
48949518|NCT01097616|157645178|FG005|Optional DB EXT Phase|Protocol Violation|0|||
48949519|NCT01097616|157645179|FG006|Optional DB EXT Phase|Protocol Violation|0|||
48949520|NCT01097616|157645180|FG007|Optional DB EXT Phase|Protocol Violation|0|||
48949521|NCT01097616|157645173|FG000|Optional DB EXT Phase|Lost to Follow-up|1|||
48949522|NCT01097616|157645174|FG001|Optional DB EXT Phase|Lost to Follow-up|5|||
48949523|NCT01097616|157645175|FG002|Optional DB EXT Phase|Lost to Follow-up|1|||
48949524|NCT01097616|157645176|FG003|Optional DB EXT Phase|Lost to Follow-up|0|||
48739991|NCT02079740|156897368|FG000|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
48739992|NCT02079740|156897369|FG001|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
48739993|NCT02079740|156897370|FG002|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
48739994|NCT02079740|156897371|FG003|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
48739995|NCT02079740|156897372|FG004|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
48739996|NCT02079740|156897373|FG005|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
48739997|NCT02079740|156897374|FG006|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
48739998|NCT02079740|156897375|FG007|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|1|||
48739999|NCT02079740|156897376|FG008|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
48740000|NCT02079740|156897377|FG009|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
48740001|NCT02079740|156897378|FG010|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
48740002|NCT02079740|156897379|FG011|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
48740003|NCT02079740|156897380|FG012|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
48740004|NCT02079740|156897368|FG000|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
48949525|NCT01097616|157645177|FG004|Optional DB EXT Phase|Lost to Follow-up|0|||
48949526|NCT01097616|157645178|FG005|Optional DB EXT Phase|Lost to Follow-up|0|||
48949527|NCT01097616|157645179|FG006|Optional DB EXT Phase|Lost to Follow-up|0|||
48949528|NCT01097616|157645180|FG007|Optional DB EXT Phase|Lost to Follow-up|0|||
48949529|NCT01097616|157645173|FG000|Optional DB EXT Phase|Lack of Efficacy|1|||
48949530|NCT01097616|157645174|FG001|Optional DB EXT Phase|Lack of Efficacy|1|||
48949531|NCT01097616|157645175|FG002|Optional DB EXT Phase|Lack of Efficacy|1|||
48740005|NCT02079740|156897369|FG001|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
48949532|NCT01097616|157645176|FG003|Optional DB EXT Phase|Lack of Efficacy|0|||
48949533|NCT01097616|157645177|FG004|Optional DB EXT Phase|Lack of Efficacy|0|||
48949534|NCT01097616|157645178|FG005|Optional DB EXT Phase|Lack of Efficacy|0|||
48949535|NCT01097616|157645179|FG006|Optional DB EXT Phase|Lack of Efficacy|0|||
48949536|NCT01097616|157645180|FG007|Optional DB EXT Phase|Lack of Efficacy|0|||
48949537|NCT01097616|157645173|FG000|Optional DB EXT Phase|Physician Decision|1|||
48949538|NCT01097616|157645174|FG001|Optional DB EXT Phase|Physician Decision|0|||
48949539|NCT01097616|157645175|FG002|Optional DB EXT Phase|Physician Decision|0|||
48949540|NCT01097616|157645176|FG003|Optional DB EXT Phase|Physician Decision|0|||
48949541|NCT01097616|157645177|FG004|Optional DB EXT Phase|Physician Decision|0|||
48949542|NCT01097616|157645178|FG005|Optional DB EXT Phase|Physician Decision|0|||
48949543|NCT01097616|157645179|FG006|Optional DB EXT Phase|Physician Decision|0|||
48949544|NCT01097616|157645180|FG007|Optional DB EXT Phase|Physician Decision|0|||
48949545|NCT01097616|157645173|FG000|DB RO Phase|Adverse Event|0|||
48949546|NCT01097616|157645174|FG001|DB RO Phase|Adverse Event|0|||
48949547|NCT01097616|157645175|FG002|DB RO Phase|Adverse Event|0|||
48949548|NCT01097616|157645176|FG003|DB RO Phase|Adverse Event|0|||
48949549|NCT01097616|157645177|FG004|DB RO Phase|Adverse Event|0|||
48949550|NCT01097616|157645178|FG005|DB RO Phase|Adverse Event|0|||
48949551|NCT01097616|157645179|FG006|DB RO Phase|Adverse Event|1|||
48949552|NCT01097616|157645180|FG007|DB RO Phase|Adverse Event|0|||
48949553|NCT01097616|157645173|FG000|DB RO Phase|Withdrawal by Subject|0|||
48949554|NCT01097616|157645174|FG001|DB RO Phase|Withdrawal by Subject|0|||
48740006|NCT02079740|156897370|FG002|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
48949555|NCT01097616|157645175|FG002|DB RO Phase|Withdrawal by Subject|0|||
48949556|NCT01097616|157645176|FG003|DB RO Phase|Withdrawal by Subject|0|||
48949557|NCT01097616|157645177|FG004|DB RO Phase|Withdrawal by Subject|0|||
48949558|NCT01097616|157645178|FG005|DB RO Phase|Withdrawal by Subject|1|||
48949559|NCT01097616|157645179|FG006|DB RO Phase|Withdrawal by Subject|0|||
48949560|NCT01097616|157645180|FG007|DB RO Phase|Withdrawal by Subject|0|||
48949561|NCT01097616|157645173|FG000|DB RO Phase|Lost to Follow-up|0|||
48949562|NCT01097616|157645174|FG001|DB RO Phase|Lost to Follow-up|0|||
48949563|NCT01097616|157645175|FG002|DB RO Phase|Lost to Follow-up|0|||
48949564|NCT01097616|157645176|FG003|DB RO Phase|Lost to Follow-up|1|||
48949565|NCT01097616|157645177|FG004|DB RO Phase|Lost to Follow-up|1|||
48949566|NCT01097616|157645178|FG005|DB RO Phase|Lost to Follow-up|0|||
48949567|NCT01097616|157645179|FG006|DB RO Phase|Lost to Follow-up|0|||
48740007|NCT02079740|156897371|FG003|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
48740008|NCT02079740|156897372|FG004|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
48740009|NCT02079740|156897373|FG005|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
48949568|NCT01097616|157645180|FG007|DB RO Phase|Lost to Follow-up|1|||
48949569|NCT01097616|157645173|FG000|DB RO Phase|Not Treated in RO|0|||
48949570|NCT01097616|157645174|FG001|DB RO Phase|Not Treated in RO|0|||
48949571|NCT01097616|157645175|FG002|DB RO Phase|Not Treated in RO|0|||
48949572|NCT01097616|157645176|FG003|DB RO Phase|Not Treated in RO|0|||
48949573|NCT01097616|157645177|FG004|DB RO Phase|Not Treated in RO|0|||
48949574|NCT01097616|157645178|FG005|DB RO Phase|Not Treated in RO|1|||
48949575|NCT01097616|157645179|FG006|DB RO Phase|Not Treated in RO|0|||
48949576|NCT01097616|157645180|FG007|DB RO Phase|Not Treated in RO|0|||
48949577|NCT00891657|157645181|FG000|Overall Study|Withdrawal by Subject|1|||
48740010|NCT02079740|156897374|FG006|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
48740011|NCT02079740|156897375|FG007|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
48949578|NCT00891657|157645182|FG001|Overall Study|Withdrawal by Subject|1|||
48949579|NCT03472534|157645183|FG000|Overall Study|Withdrawal by Subject|9|||
48949580|NCT03472534|157645183|FG000|Overall Study|Adverse Event|2|||
48949581|NCT00909090|157645186|FG000|Overall Study|Lost to Follow-up|17|||
48740012|NCT02079740|156897376|FG008|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
48949582|NCT00909090|157645187|FG001|Overall Study|Lost to Follow-up|17|||
48949583|NCT01174784|157645188|FG000|Overall Study|Screen fails|4|||
48949584|NCT02296840|157645193|FG000|Overall Study|Adverse Event|1|||
48949585|NCT02296840|157645194|FG001|Overall Study|Adverse Event|1|||
48949586|NCT02296840|157645193|FG000|Overall Study|Protocol Violation|2|||
48949587|NCT02296840|157645194|FG001|Overall Study|Protocol Violation|1|||
48949588|NCT02296840|157645193|FG000|Overall Study|Lost to Follow-up|6|||
48949589|NCT02296840|157645194|FG001|Overall Study|Lost to Follow-up|17|||
48949590|NCT03662334|157645198|FG000|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1|||
48949591|NCT03662334|157645199|FG001|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0|||
48949592|NCT04542291|157645200|FG000|Overall Study|Adverse Event|1|||
48949593|NCT04542291|157645200|FG000|Overall Study|Physician Decision|2|||
48740013|NCT02079740|156897377|FG009|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
48740014|NCT02079740|156897378|FG010|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
48740015|NCT02079740|156897379|FG011|Phase 2: Expansion Cohorts|Withdrawal by Subject|1|||
48949594|NCT00394914|157645201|FG000|Treatment Period|Adverse Event|0|||
48949595|NCT00394914|157645202|FG001|Treatment Period|Adverse Event|3|||
48949596|NCT00394914|157645203|FG002|Treatment Period|Adverse Event|1|||
48949597|NCT00394914|157645201|FG000|Treatment Period|Lost to Follow-up|0|||
48949598|NCT00394914|157645202|FG001|Treatment Period|Lost to Follow-up|1|||
48949599|NCT00394914|157645203|FG002|Treatment Period|Lost to Follow-up|0|||
48949600|NCT00394914|157645201|FG000|Treatment Period|Withdrawal by Subject|0|||
48949601|NCT00394914|157645202|FG001|Treatment Period|Withdrawal by Subject|2|||
48949602|NCT00394914|157645203|FG002|Treatment Period|Withdrawal by Subject|2|||
48949603|NCT00394914|157645201|FG000|Treatment Period|Noncompliance with protocol|0|||
48949604|NCT00394914|157645202|FG001|Treatment Period|Noncompliance with protocol|3|||
48949605|NCT00394914|157645203|FG002|Treatment Period|Noncompliance with protocol|2|||
48949606|NCT00394914|157645201|FG000|Treatment Period|Did not meet protocol eligibility|0|||
48949607|NCT00394914|157645202|FG001|Treatment Period|Did not meet protocol eligibility|1|||
48949608|NCT00394914|157645203|FG002|Treatment Period|Did not meet protocol eligibility|1|||
48949609|NCT02749721|157645205|FG000|Screening|Withdrawal by Subject|1|||
48949610|NCT02749721|157645205|FG000|Screening|Lost to Follow-up|2|||
48949611|NCT02749721|157645205|FG000|Screening|Protocol Violation|3|||
48949612|NCT02749721|157645205|FG000|8-week Open-Label Treatment Phase|Lost to Follow-up|2|||
48949613|NCT02749721|157645205|FG000|8-week Open-Label Treatment Phase|Withdrawal by Subject|1|||
48949614|NCT00404768|157645206|FG000|Part A and B|Withdrawn due to labor progression|1|||
48949615|NCT00404768|157645207|FG001|Part A and B|Withdrawn due to labor progression|0|||
48949616|NCT00404768|157645208|FG002|Part A and B|Withdrawn due to labor progression|0|||
48949617|NCT00404768|157645209|FG003|Part A and B|Withdrawn due to labor progression|0|||
48949618|NCT00404768|157645206|FG000|Part A and B|Withdrawn as delivery imminemnt|0|||
48740016|NCT02079740|156897380|FG012|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
48740017|NCT05644444|156897381|FG000|Tolerance Phase|Adverse Event|0|||
48740018|NCT05644444|156897382|FG001|Tolerance Phase|Adverse Event|2|||
48740019|NCT05644444|156897381|FG000|Treatment Phase|Adverse Event|0|||
48740020|NCT05644444|156897382|FG001|Treatment Phase|Adverse Event|2|||
48740021|NCT01649271|156897390|FG000|Overall Study|Progressive disease|4|||
48740022|NCT01649271|156897391|FG001|Overall Study|Progressive disease|5|||
48740023|NCT01649271|156897390|FG000|Overall Study|Other Adverse Event|0|||
48740024|NCT01649271|156897391|FG001|Overall Study|Other Adverse Event|2|||
48740025|NCT01649271|156897390|FG000|Overall Study|Withdrawal by Subject|1|||
48740026|NCT01649271|156897391|FG001|Overall Study|Withdrawal by Subject|0|||
48740027|NCT01649271|156897390|FG000|Overall Study|Other than stated above|1|||
48740028|NCT01649271|156897391|FG001|Overall Study|Other than stated above|0|||
48740029|NCT00392015|156897392|FG000|Overall Study|Lost to Follow-up|2|||
48740030|NCT00392015|156897393|FG001|Overall Study|Lost to Follow-up|0|||
48949619|NCT00404768|157645207|FG001|Part A and B|Withdrawn as delivery imminemnt|1|||
48949620|NCT00404768|157645208|FG002|Part A and B|Withdrawn as delivery imminemnt|0|||
48949621|NCT00404768|157645209|FG003|Part A and B|Withdrawn as delivery imminemnt|0|||
48949622|NCT00404768|157645206|FG000|Part C|Adverse Event|0|||
48949623|NCT00404768|157645207|FG001|Part C|Adverse Event|0|||
48949624|NCT00404768|157645208|FG002|Part C|Adverse Event|0|||
48949625|NCT00404768|157645209|FG003|Part C|Adverse Event|3|||
48949626|NCT00404768|157645206|FG000|Part C|Lost to Follow-up|0|||
48740031|NCT00392015|156897394|FG002|Overall Study|Lost to Follow-up|2|||
48740032|NCT00392015|156897395|FG003|Overall Study|Lost to Follow-up|1|||
48740033|NCT00392015|156897396|FG004|Overall Study|Lost to Follow-up|1|||
48740034|NCT00392015|156897397|FG005|Overall Study|Lost to Follow-up|0|||
48949627|NCT00404768|157645207|FG001|Part C|Lost to Follow-up|0|||
48949628|NCT00404768|157645208|FG002|Part C|Lost to Follow-up|3|||
48949629|NCT00404768|157645209|FG003|Part C|Lost to Follow-up|1|||
48949630|NCT00404768|157645206|FG000|Part C|Withdrawal by Subject|0|||
48949631|NCT00404768|157645207|FG001|Part C|Withdrawal by Subject|0|||
48949632|NCT00404768|157645208|FG002|Part C|Withdrawal by Subject|2|||
48949633|NCT00404768|157645209|FG003|Part C|Withdrawal by Subject|1|||
48949634|NCT00404768|157645206|FG000|Part C|Early withdrawal from study medication|0|||
48949635|NCT00404768|157645207|FG001|Part C|Early withdrawal from study medication|0|||
48949636|NCT00404768|157645208|FG002|Part C|Early withdrawal from study medication|1|||
48949637|NCT00404768|157645209|FG003|Part C|Early withdrawal from study medication|0|||
48949638|NCT00404768|157645206|FG000|Part C|Participant did not respond to therapy|0|||
48949639|NCT00404768|157645207|FG001|Part C|Participant did not respond to therapy|0|||
48949640|NCT00404768|157645208|FG002|Part C|Participant did not respond to therapy|1|||
48949641|NCT00404768|157645209|FG003|Part C|Participant did not respond to therapy|1|||
48949642|NCT00404768|157645206|FG000|Part C|Physician withdrew the study medication|0|||
48949643|NCT00404768|157645207|FG001|Part C|Physician withdrew the study medication|0|||
48854241|NCT02561195|157304957|FG002|Extension Stage (Vaccination 4)|Adverse Event|0|||
48854242|NCT02561195|157304958|FG003|Extension Stage (Vaccination 4)|Adverse Event|0|||
48949644|NCT00404768|157645208|FG002|Part C|Physician withdrew the study medication|1|||
48949645|NCT00404768|157645209|FG003|Part C|Physician withdrew the study medication|0|||
48949646|NCT00404768|157645206|FG000|Part C|Participant delivered baby|0|||
48949647|NCT00404768|157645207|FG001|Part C|Participant delivered baby|0|||
48949648|NCT00404768|157645208|FG002|Part C|Participant delivered baby|0|||
48949649|NCT00404768|157645209|FG003|Part C|Participant delivered baby|1|||
48949650|NCT00404768|157645206|FG000|Part C|Unsatisfactory uterine response to IP|0|||
48949651|NCT00404768|157645207|FG001|Part C|Unsatisfactory uterine response to IP|0|||
48949652|NCT00404768|157645208|FG002|Part C|Unsatisfactory uterine response to IP|0|||
48949653|NCT00404768|157645209|FG003|Part C|Unsatisfactory uterine response to IP|1|||
48949654|NCT00404768|157645206|FG000|Part C|Active labor|0|||
48949655|NCT00404768|157645207|FG001|Part C|Active labor|0|||
48949656|NCT00404768|157645208|FG002|Part C|Active labor|0|||
48949657|NCT00404768|157645209|FG003|Part C|Active labor|1|||
48949658|NCT00404768|157645206|FG000|Part C|Lack of Efficacy|0|||
48949659|NCT00404768|157645207|FG001|Part C|Lack of Efficacy|0|||
48949660|NCT00404768|157645208|FG002|Part C|Lack of Efficacy|0|||
48949661|NCT00404768|157645209|FG003|Part C|Lack of Efficacy|2|||
48949662|NCT00404768|157645206|FG000|Part C|Treatment failure|0|||
48740035|NCT00392015|156897392|FG000|Overall Study|Withdrawal by Subject|0|||
48854243|NCT02561195|157304959|FG004|Extension Stage (Vaccination 4)|Adverse Event|0|||
48854244|NCT02561195|157304960|FG005|Extension Stage (Vaccination 4)|Adverse Event|0|||
48854245|NCT02561195|157304961|FG006|Extension Stage (Vaccination 4)|Adverse Event|0|||
48854246|NCT02561195|157304962|FG007|Extension Stage (Vaccination 4)|Adverse Event|0|||
48854247|NCT02561195|157304963|FG008|Extension Stage (Vaccination 4)|Adverse Event|0|||
48854248|NCT02561195|157304964|FG009|Extension Stage (Vaccination 4)|Adverse Event|0|||
48854249|NCT02561195|157304965|FG010|Extension Stage (Vaccination 4)|Adverse Event|0|||
48854250|NCT02561195|157304966|FG011|Extension Stage (Vaccination 4)|Adverse Event|0|||
48854251|NCT02561195|157304967|FG012|Extension Stage (Vaccination 4)|Adverse Event|0|||
48854252|NCT02561195|157304968|FG013|Extension Stage (Vaccination 4)|Adverse Event|2|||
48854253|NCT02561195|157304955|FG000|Extension Stage (Vaccination 4)|Death|0|||
48854254|NCT02561195|157304956|FG001|Extension Stage (Vaccination 4)|Death|0|||
48854255|NCT02561195|157304957|FG002|Extension Stage (Vaccination 4)|Death|0|||
48949663|NCT00404768|157645207|FG001|Part C|Treatment failure|0|||
48949664|NCT00404768|157645208|FG002|Part C|Treatment failure|0|||
48949665|NCT00404768|157645209|FG003|Part C|Treatment failure|1|||
48740036|NCT00392015|156897393|FG001|Overall Study|Withdrawal by Subject|0|||
48740037|NCT00392015|156897394|FG002|Overall Study|Withdrawal by Subject|2|||
48740038|NCT00392015|156897395|FG003|Overall Study|Withdrawal by Subject|0|||
48740039|NCT00392015|156897396|FG004|Overall Study|Withdrawal by Subject|0|||
48740040|NCT00392015|156897397|FG005|Overall Study|Withdrawal by Subject|0|||
48740041|NCT00392015|156897392|FG000|Overall Study|Adverse Event|0|||
48740042|NCT00392015|156897393|FG001|Overall Study|Adverse Event|0|||
48740043|NCT00392015|156897394|FG002|Overall Study|Adverse Event|0|||
48740044|NCT00392015|156897395|FG003|Overall Study|Adverse Event|0|||
48740045|NCT00392015|156897396|FG004|Overall Study|Adverse Event|1|||
48740046|NCT00392015|156897397|FG005|Overall Study|Adverse Event|0|||
48740047|NCT00392015|156897392|FG000|Overall Study|Previous trial recipient|0|||
48740048|NCT00392015|156897393|FG001|Overall Study|Previous trial recipient|0|||
48740049|NCT00392015|156897394|FG002|Overall Study|Previous trial recipient|0|||
48740050|NCT00392015|156897395|FG003|Overall Study|Previous trial recipient|0|||
48740051|NCT00392015|156897396|FG004|Overall Study|Previous trial recipient|1|||
48740052|NCT00392015|156897397|FG005|Overall Study|Previous trial recipient|0|||
48740053|NCT05369208|156897398|FG000|Core Phase|Prohibited Medication Required|2|||
48740054|NCT05369208|156897398|FG000|Core Phase|Adverse Event|1|||
48854256|NCT02561195|157304958|FG003|Extension Stage (Vaccination 4)|Death|0|||
48854257|NCT02561195|157304959|FG004|Extension Stage (Vaccination 4)|Death|0|||
48854258|NCT02561195|157304960|FG005|Extension Stage (Vaccination 4)|Death|0|||
48740055|NCT05369208|156897398|FG000|Core Phase|Lack of Efficacy|1|||
48740056|NCT03693300|156897399|FG000|Overall Study|Withdrawal by Subject|6|||
48740057|NCT03693300|156897400|FG001|Overall Study|Withdrawal by Subject|0|||
48740058|NCT03693300|156897399|FG000|Overall Study|Death|50|||
48740059|NCT03693300|156897400|FG001|Overall Study|Death|2|||
48740060|NCT03693300|156897399|FG000|Overall Study|Lost to Follow-up|2|||
48854259|NCT02561195|157304961|FG006|Extension Stage (Vaccination 4)|Death|0|||
48740061|NCT03693300|156897400|FG001|Overall Study|Lost to Follow-up|0|||
48740062|NCT04855760|156897404|FG000|Overall Study|Adverse Event|21|||
48740063|NCT04855760|156897404|FG000|Overall Study|Withdrawal by Subject|116|||
48740064|NCT04855760|156897404|FG000|Overall Study|Lack of Efficacy|21|||
48854260|NCT02561195|157304962|FG007|Extension Stage (Vaccination 4)|Death|0|||
48854261|NCT02561195|157304963|FG008|Extension Stage (Vaccination 4)|Death|0|||
48740065|NCT04855760|156897404|FG000|Overall Study|Lost to Follow-up|49|||
48740066|NCT04855760|156897404|FG000|Overall Study|Protocol Violation|2|||
48740067|NCT04855760|156897404|FG000|Overall Study|Physician Decision|5|||
48740068|NCT04855760|156897404|FG000|Overall Study|Pregnancy|1|||
48740069|NCT04855760|156897404|FG000|Overall Study|Non-Compliance with Study Drug|11|||
48740070|NCT04855760|156897404|FG000|Overall Study|Non-Compliance with Study Schedule|4|||
48740071|NCT04855760|156897404|FG000|Overall Study|Study Completed by Sponsor|202|||
48740072|NCT04855760|156897404|FG000|Overall Study|Other|13|||
48740073|NCT01543958|156897417|FG000|Overall Study|Loss to follow-up|3|||
48740074|NCT01543958|156897417|FG000|Overall Study|ART initiation|1|||
48740075|NCT01020981|156897418|FG000|Overall Study|Did not return mailed survey|74|||
48740076|NCT01020981|156897419|FG001|Overall Study|Did not return mailed survey|58|||
48740077|NCT01020981|156897418|FG000|Overall Study|Survey returned undeliverable|8|||
48740078|NCT01020981|156897419|FG001|Overall Study|Survey returned undeliverable|32|||
48740079|NCT01020981|156897418|FG000|Overall Study|Participant declined to complete survey|2|||
48740080|NCT01020981|156897419|FG001|Overall Study|Participant declined to complete survey|0|||
48740081|NCT05439941|156897420|FG000|Overall Study|Lack of Efficacy|8|||
48740082|NCT05439941|156897421|FG001|Overall Study|Lack of Efficacy|5|||
48740083|NCT05439941|156897422|FG002|Overall Study|Lack of Efficacy|3|||
48740084|NCT05439941|156897420|FG000|Overall Study|Treatment Failure|0|||
48740085|NCT05439941|156897421|FG001|Overall Study|Treatment Failure|1|||
48740086|NCT05439941|156897422|FG002|Overall Study|Treatment Failure|0|||
48740087|NCT05439941|156897420|FG000|Overall Study|Adverse Event|1|||
48740088|NCT05439941|156897421|FG001|Overall Study|Adverse Event|3|||
48740089|NCT05439941|156897422|FG002|Overall Study|Adverse Event|0|||
48740090|NCT05439941|156897420|FG000|Overall Study|Adverse Event - Parent Study|1|||
48740091|NCT05439941|156897421|FG001|Overall Study|Adverse Event - Parent Study|0|||
48740092|NCT05439941|156897422|FG002|Overall Study|Adverse Event - Parent Study|0|||
48740093|NCT05439941|156897420|FG000|Overall Study|Pregnancy|1|||
48740094|NCT05439941|156897421|FG001|Overall Study|Pregnancy|0|||
48740095|NCT05439941|156897422|FG002|Overall Study|Pregnancy|0|||
48740096|NCT05439941|156897420|FG000|Overall Study|Withdrawal by Subject|9|||
48740097|NCT05439941|156897421|FG001|Overall Study|Withdrawal by Subject|6|||
48740098|NCT05439941|156897422|FG002|Overall Study|Withdrawal by Subject|10|||
48740099|NCT05439941|156897420|FG000|Overall Study|Non-Compliance|1|||
48740100|NCT05439941|156897421|FG001|Overall Study|Non-Compliance|1|||
48740101|NCT05439941|156897422|FG002|Overall Study|Non-Compliance|1|||
48740102|NCT05439941|156897420|FG000|Overall Study|Lost to Follow-up|2|||
48740103|NCT05439941|156897421|FG001|Overall Study|Lost to Follow-up|2|||
48740104|NCT05439941|156897422|FG002|Overall Study|Lost to Follow-up|0|||
48740105|NCT05439941|156897420|FG000|Overall Study|Physician Decision|1|||
48740106|NCT05439941|156897421|FG001|Overall Study|Physician Decision|0|||
48740107|NCT05439941|156897422|FG002|Overall Study|Physician Decision|0|||
48740108|NCT05439941|156897420|FG000|Overall Study|Trial Termination by Sponsor|78|||
48740109|NCT05439941|156897421|FG001|Overall Study|Trial Termination by Sponsor|83|||
48740110|NCT05439941|156897422|FG002|Overall Study|Trial Termination by Sponsor|65|||
48740111|NCT05439941|156897420|FG000|Overall Study|Other than Reasons Listed|2|||
48740112|NCT05439941|156897421|FG001|Overall Study|Other than Reasons Listed|1|||
48740113|NCT05439941|156897422|FG002|Overall Study|Other than Reasons Listed|0|||
48740114|NCT03689530|156897423|FG000|Overall Study|Withdrawal by Subject|53|||
48740115|NCT03689530|156897424|FG001|Overall Study|Withdrawal by Subject|16|||
48740116|NCT01926015|156897425|FG000|Overall Study|Withdrawal by parent/guardian|0|||
48740117|NCT01926015|156897426|FG001|Overall Study|Withdrawal by parent/guardian|1|||
48740118|NCT01926015|156897425|FG000|Overall Study|Randomized not treated|2|||
48740119|NCT01926015|156897426|FG001|Overall Study|Randomized not treated|0|||
48740120|NCT03314987|156897427|FG000|Overall Study|Lost to Follow-up|13|||
48740121|NCT03314987|156897428|FG001|Overall Study|Lost to Follow-up|13|||
48740122|NCT03594110|156897430|FG000|Overall Study|Participant concerned about study treatment|23|||
48854262|NCT02561195|157304964|FG009|Extension Stage (Vaccination 4)|Death|1|||
48854263|NCT02561195|157304965|FG010|Extension Stage (Vaccination 4)|Death|0|||
48854264|NCT02561195|157304966|FG011|Extension Stage (Vaccination 4)|Death|0|||
48740123|NCT03594110|156897431|FG001|Overall Study|Participant concerned about study treatment|28|||
48740124|NCT03594110|156897430|FG000|Overall Study|Doctor advice|38|||
48949666|NCT00404768|157645206|FG000|Part C|Investigator discretion|0|||
48949667|NCT00404768|157645207|FG001|Part C|Investigator discretion|0|||
48949668|NCT00404768|157645208|FG002|Part C|Investigator discretion|0|||
48949669|NCT00404768|157645209|FG003|Part C|Investigator discretion|1|||
48949670|NCT00404768|157645206|FG000|Part C|Researcher suspended study medication|0|||
48949671|NCT00404768|157645207|FG001|Part C|Researcher suspended study medication|0|||
48854265|NCT02561195|157304967|FG012|Extension Stage (Vaccination 4)|Death|0|||
48854266|NCT02561195|157304968|FG013|Extension Stage (Vaccination 4)|Death|0|||
48854267|NCT02561195|157304955|FG000|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
48854268|NCT02561195|157304956|FG001|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
48854269|NCT02561195|157304957|FG002|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
48854270|NCT02561195|157304958|FG003|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
48854271|NCT02561195|157304959|FG004|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
48949672|NCT00404768|157645208|FG002|Part C|Researcher suspended study medication|0|||
48949673|NCT00404768|157645209|FG003|Part C|Researcher suspended study medication|1|||
48949674|NCT03290300|157645212|FG000|Overall Study|Lost to Follow-up|3|||
48949675|NCT01863758|157645213|FG000|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1|||
48854272|NCT02561195|157304960|FG005|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
48854273|NCT02561195|157304961|FG006|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
48854274|NCT02561195|157304962|FG007|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
48854275|NCT02561195|157304963|FG008|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
48854276|NCT02561195|157304964|FG009|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
48854277|NCT02561195|157304965|FG010|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
48854278|NCT02561195|157304966|FG011|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
48854279|NCT02561195|157304967|FG012|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
48854280|NCT02561195|157304968|FG013|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
48854281|NCT02561195|157304955|FG000|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
48854282|NCT02561195|157304956|FG001|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
48854283|NCT02561195|157304957|FG002|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
48854284|NCT02561195|157304958|FG003|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
48854285|NCT02561195|157304959|FG004|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
48854286|NCT02561195|157304960|FG005|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
48854287|NCT02561195|157304961|FG006|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
48854288|NCT02561195|157304962|FG007|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
48854289|NCT02561195|157304963|FG008|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
48854290|NCT02561195|157304964|FG009|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
48854291|NCT02561195|157304965|FG010|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
48854292|NCT02561195|157304966|FG011|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
48854293|NCT02561195|157304967|FG012|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
48854294|NCT02561195|157304968|FG013|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
48854295|NCT02561195|157304955|FG000|Extension Stage (Vaccination 4)|Other|0|||
48854296|NCT02561195|157304956|FG001|Extension Stage (Vaccination 4)|Other|0|||
48854297|NCT02561195|157304957|FG002|Extension Stage (Vaccination 4)|Other|0|||
48854298|NCT02561195|157304958|FG003|Extension Stage (Vaccination 4)|Other|0|||
48949676|NCT01863758|157645213|FG000|Prophylactic Treatment-Phase II|Lost to Follow-up|1|||
48949677|NCT00803244|157645216|FG000|Overall Study|Adverse Event|1|||
48949678|NCT00803244|157645217|FG001|Overall Study|Adverse Event|2|||
48949679|NCT00803244|157645216|FG000|Overall Study|Withdrawal by Subject|2|||
48740125|NCT03594110|156897431|FG001|Overall Study|Doctor advice|40|||
48949680|NCT00803244|157645217|FG001|Overall Study|Withdrawal by Subject|3|||
48740126|NCT03594110|156897430|FG000|Overall Study|Participants' wish|89|||
48740127|NCT03594110|156897431|FG001|Overall Study|Participants' wish|68|||
48740128|NCT03594110|156897430|FG000|Overall Study|Adverse event-non-fatal events|119|||
48740129|NCT03594110|156897431|FG001|Overall Study|Adverse event-non-fatal events|116|||
48740130|NCT03594110|156897430|FG000|Overall Study|Study drug stopped, reason missing|336|||
48740131|NCT03594110|156897431|FG001|Overall Study|Study drug stopped, reason missing|294|||
48854299|NCT02561195|157304959|FG004|Extension Stage (Vaccination 4)|Other|0|||
48854300|NCT02561195|157304960|FG005|Extension Stage (Vaccination 4)|Other|0|||
48949681|NCT00803244|157645216|FG000|Overall Study|Any other reason not above-mentioned|4|||
48949682|NCT00803244|157645217|FG001|Overall Study|Any other reason not above-mentioned|10|||
48949683|NCT00751881|157645220|FG000|Core Treatment Period|Not treated|1|||
48740132|NCT03594110|156897430|FG000|Overall Study|Cannot attend clinic because of personal problems|8|||
48854301|NCT02561195|157304961|FG006|Extension Stage (Vaccination 4)|Other|0|||
48854302|NCT02561195|157304962|FG007|Extension Stage (Vaccination 4)|Other|0|||
48854303|NCT02561195|157304963|FG008|Extension Stage (Vaccination 4)|Other|0|||
48854304|NCT02561195|157304964|FG009|Extension Stage (Vaccination 4)|Other|0|||
48854305|NCT02561195|157304965|FG010|Extension Stage (Vaccination 4)|Other|2|||
48949684|NCT00751881|157645221|FG001|Core Treatment Period|Not treated|1|||
48949685|NCT00751881|157645222|FG002|Core Treatment Period|Not treated|2|||
48740133|NCT03594110|156897431|FG001|Overall Study|Cannot attend clinic because of personal problems|16|||
48740134|NCT03594110|156897430|FG000|Overall Study|Cannot attend clinic because moving out of the area|15|||
48740135|NCT03594110|156897431|FG001|Overall Study|Cannot attend clinic because moving out of the area|9|||
48740136|NCT03594110|156897430|FG000|Overall Study|Contraindicated drug started|32|||
48740137|NCT03594110|156897431|FG001|Overall Study|Contraindicated drug started|18|||
48740138|NCT03594110|156897430|FG000|Overall Study|Other reasons (include any category with a frequency <20 patients in total)|58|||
48740139|NCT03594110|156897431|FG001|Overall Study|Other reasons (include any category with a frequency <20 patients in total)|45|||
48740140|NCT03594110|156897430|FG000|Overall Study|Adverse event-Serious fatal events|130|||
48740141|NCT03594110|156897431|FG001|Overall Study|Adverse event-Serious fatal events|121|||
48740142|NCT03436745|156897432|FG000|Overall Study|Ineligible|0|||
48740143|NCT03436745|156897433|FG001|Overall Study|Ineligible|0|||
48740144|NCT03436745|156897434|FG002|Overall Study|Ineligible|1|||
48740145|NCT02476201|156897435|FG000|Overall Study|Unable to program MPP|9|||
48740146|NCT02476201|156897435|FG000|Overall Study|Study echo not performed|5|||
48740147|NCT02476201|156897435|FG000|Overall Study|Adverse Event|4|||
48740148|NCT02476201|156897435|FG000|Overall Study|Death|2|||
48854306|NCT02561195|157304966|FG011|Extension Stage (Vaccination 4)|Other|2|||
48854307|NCT02561195|157304967|FG012|Extension Stage (Vaccination 4)|Other|1|||
48854308|NCT02561195|157304968|FG013|Extension Stage (Vaccination 4)|Other|0|||
48854309|NCT02561195|157304955|FG000|Extension Stage (Vaccination 4)|Protocol Violation|0|||
48854310|NCT02561195|157304956|FG001|Extension Stage (Vaccination 4)|Protocol Violation|0|||
48854311|NCT02561195|157304957|FG002|Extension Stage (Vaccination 4)|Protocol Violation|0|||
48854312|NCT02561195|157304958|FG003|Extension Stage (Vaccination 4)|Protocol Violation|0|||
48854313|NCT02561195|157304959|FG004|Extension Stage (Vaccination 4)|Protocol Violation|0|||
48854314|NCT02561195|157304960|FG005|Extension Stage (Vaccination 4)|Protocol Violation|0|||
48854315|NCT02561195|157304961|FG006|Extension Stage (Vaccination 4)|Protocol Violation|1|||
48854316|NCT02561195|157304962|FG007|Extension Stage (Vaccination 4)|Protocol Violation|0|||
48854317|NCT02561195|157304963|FG008|Extension Stage (Vaccination 4)|Protocol Violation|0|||
48854318|NCT02561195|157304964|FG009|Extension Stage (Vaccination 4)|Protocol Violation|0|||
48854319|NCT02561195|157304965|FG010|Extension Stage (Vaccination 4)|Protocol Violation|2|||
48854320|NCT02561195|157304966|FG011|Extension Stage (Vaccination 4)|Protocol Violation|1|||
48854321|NCT02561195|157304967|FG012|Extension Stage (Vaccination 4)|Protocol Violation|0|||
48854322|NCT02561195|157304968|FG013|Extension Stage (Vaccination 4)|Protocol Violation|1|||
48854323|NCT03905512|157304969|FG000|Overall Study|Withdrawal by Subject|9|||
48854324|NCT03905512|157304970|FG001|Overall Study|Withdrawal by Subject|8|||
48854325|NCT03905512|157304969|FG000|Overall Study|Adverse Event|1|||
48854326|NCT03905512|157304970|FG001|Overall Study|Adverse Event|2|||
48854327|NCT03905512|157304969|FG000|Overall Study|Lost to Follow-up|4|||
48854328|NCT03905512|157304970|FG001|Overall Study|Lost to Follow-up|3|||
48854329|NCT03905512|157304969|FG000|Overall Study|Other than Specified|7|||
48854330|NCT03905512|157304970|FG001|Overall Study|Other than Specified|4|||
48854331|NCT01147471|157304979|FG000|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0|||
48854332|NCT01147471|157304980|FG001|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1|||
48854333|NCT01147471|157304979|FG000|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0|||
48854334|NCT01147471|157304980|FG001|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1|||
48854335|NCT01147471|157304979|FG000|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0|||
48854336|NCT01147471|157304980|FG001|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1|||
48854337|NCT01147471|157304979|FG000|3 Month Follow Up|Lost to Follow-up|1|||
48854338|NCT01147471|157304980|FG001|3 Month Follow Up|Lost to Follow-up|1|||
48854339|NCT01147471|157304979|FG000|3 Month Follow Up|Physician Decision|0|||
48854340|NCT01147471|157304980|FG001|3 Month Follow Up|Physician Decision|1|||
48854341|NCT01147471|157304979|FG000|6 Month Follow Up|Lost to Follow-up|4|||
48854342|NCT01147471|157304980|FG001|6 Month Follow Up|Lost to Follow-up|2|||
48854343|NCT00800176|157304982|FG000|Overall Study|Adverse Event|2|||
48740149|NCT02476201|156897435|FG000|Overall Study|Lost to Follow-up|2|||
48740150|NCT02476201|156897435|FG000|Overall Study|MPP programmed to OFF|2|||
48740151|NCT02476201|156897435|FG000|Overall Study|Withdrawal by Subject|1|||
48740152|NCT02476201|156897435|FG000|Overall Study|Unsuccessful implant|1|||
48740153|NCT03650556|156897436|FG000|Overall Study|Death|2|||
48740154|NCT03650556|156897436|FG000|Overall Study|Withdrawal by Subject|20|||
48740155|NCT03650556|156897436|FG000|Overall Study|Physician Decision|2|||
48740156|NCT03650556|156897436|FG000|Overall Study|Lost to Follow-up|8|||
48740157|NCT03650556|156897436|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|4|||
48740158|NCT03650556|156897436|FG000|Overall Study|Enrolled, but no ablation performed-investigational catheter was not inserted|1|||
48740159|NCT01705730|156897439|FG000|Overall Study|Lack of Efficacy|1|||
48740160|NCT01705730|156897439|FG000|Overall Study|Adverse Event|3|||
48740161|NCT01705730|156897439|FG000|Overall Study|Lost to Follow-up|1|||
48740162|NCT01705730|156897439|FG000|Overall Study|Reason not Specified|4|||
48740163|NCT00142935|156897441|FG000|Overall Study|Other reason|1|||
48740164|NCT00142935|156897442|FG001|Overall Study|Other reason|1|||
48740165|NCT00142935|156897443|FG002|Overall Study|Other reason|1|||
48740166|NCT00142935|156897441|FG000|Overall Study|Lost to Follow-up|2|||
48740167|NCT00142935|156897442|FG001|Overall Study|Lost to Follow-up|5|||
48740168|NCT00142935|156897443|FG002|Overall Study|Lost to Follow-up|5|||
48740169|NCT00142935|156897441|FG000|Overall Study|Death|0|||
48740170|NCT00142935|156897442|FG001|Overall Study|Death|2|||
48740171|NCT00142935|156897443|FG002|Overall Study|Death|1|||
48740172|NCT03345914|156897448|FG000|Overall Study|Transition to another study at week 16|80|||
48740173|NCT03345914|156897449|FG001|Overall Study|Transition to another study at week 16|86|||
48740174|NCT03345914|156897450|FG002|Overall Study|Transition to another study at week 16|78|||
48740175|NCT03345914|156897448|FG000|Overall Study|Transition to OLE during follow-up|37|||
48740176|NCT03345914|156897449|FG001|Overall Study|Transition to OLE during follow-up|33|||
48740177|NCT03345914|156897450|FG002|Overall Study|Transition to OLE during follow-up|39|||
48740178|NCT03345914|156897448|FG000|Overall Study|Physician Decision|0|||
48740179|NCT03345914|156897449|FG001|Overall Study|Physician Decision|1|||
48740180|NCT03345914|156897450|FG002|Overall Study|Physician Decision|1|||
48740181|NCT03345914|156897448|FG000|Overall Study|Withdrawal by Subject|5|||
48740182|NCT03345914|156897449|FG001|Overall Study|Withdrawal by Subject|1|||
48740183|NCT03345914|156897450|FG002|Overall Study|Withdrawal by Subject|2|||
48740184|NCT03345914|156897448|FG000|Overall Study|Other|1|||
48740185|NCT03345914|156897449|FG001|Overall Study|Other|1|||
48740186|NCT03345914|156897450|FG002|Overall Study|Other|1|||
48854344|NCT00800176|157304983|FG001|Overall Study|Adverse Event|1|||
48854345|NCT00800176|157304984|FG002|Overall Study|Adverse Event|0|||
48854346|NCT00800176|157304985|FG003|Overall Study|Adverse Event|2|||
48854347|NCT00800176|157304986|FG004|Overall Study|Adverse Event|1|||
48740187|NCT03345914|156897448|FG000|Overall Study|Ongoing|0|||
48740188|NCT03345914|156897449|FG001|Overall Study|Ongoing|0|||
48740189|NCT03345914|156897450|FG002|Overall Study|Ongoing|1|||
48740190|NCT00675948|156897451|FG000|Overall Study|Adverse Event|23|||
48740191|NCT00675948|156897452|FG001|Overall Study|Adverse Event|1|||
48740192|NCT00675948|156897451|FG000|Overall Study|Lack of Efficacy|3|||
48740193|NCT00675948|156897452|FG001|Overall Study|Lack of Efficacy|0|||
48740194|NCT00675948|156897451|FG000|Overall Study|Withdrawal by Subject|7|||
48740195|NCT00675948|156897452|FG001|Overall Study|Withdrawal by Subject|0|||
48740196|NCT00675948|156897451|FG000|Overall Study|Lost to Follow-up|2|||
48740197|NCT00675948|156897452|FG001|Overall Study|Lost to Follow-up|0|||
48740198|NCT00675948|156897451|FG000|Overall Study|Protocol Violation|1|||
48740199|NCT00675948|156897452|FG001|Overall Study|Protocol Violation|0|||
48740200|NCT00675948|156897451|FG000|Overall Study|Pain under control|1|||
48740201|NCT00675948|156897452|FG001|Overall Study|Pain under control|0|||
48740202|NCT00675948|156897451|FG000|Overall Study|Sponsor decision|0|||
48740203|NCT00675948|156897452|FG001|Overall Study|Sponsor decision|1|||
48854348|NCT00800176|157304987|FG005|Overall Study|Adverse Event|1|||
48740204|NCT00675948|156897451|FG000|Overall Study|Patient died|1|||
48854349|NCT00800176|157304982|FG000|Overall Study|Refused treatment|3|||
48740205|NCT00675948|156897452|FG001|Overall Study|Patient died|0|||
48740206|NCT00675948|156897451|FG000|Overall Study|Patient unable to comply with diaries|1|||
48740207|NCT00675948|156897452|FG001|Overall Study|Patient unable to comply with diaries|0|||
48740208|NCT00675948|156897451|FG000|Overall Study|Patient feels unable to take medication|0|||
48740209|NCT00675948|156897452|FG001|Overall Study|Patient feels unable to take medication|1|||
48740210|NCT00762229|156897455|FG000|Overall Study|Lost to Follow-up|1|||
48740211|NCT00762229|156897456|FG001|Overall Study|Lost to Follow-up|1|||
48740212|NCT00762229|156897455|FG000|Overall Study|did not recveive intervention|0|||
48740213|NCT00762229|156897456|FG001|Overall Study|did not recveive intervention|1|||
48740214|NCT02191137|156897458|FG000|Treatment|Death|4|||
48740215|NCT02191137|156897458|FG000|Treatment|Withdrawal by Subject|3|||
48740216|NCT02191137|156897458|FG000|Treatment|Adverse Event|2|||
48740217|NCT02191137|156897458|FG000|Treatment|Other|1|||
48740218|NCT02191137|156897458|FG000|Follow-up|Lost to Follow-up|2|||
48740219|NCT02191137|156897458|FG000|Follow-up|Ongoing/unknown|2|||
48740220|NCT02191137|156897458|FG000|Follow-up|Adverse Event|1|||
48740221|NCT01696695|156897459|FG000|Overall Study|Disease progression|373|||
48740222|NCT01696695|156897459|FG000|Overall Study|Death|29|||
48740223|NCT01696695|156897459|FG000|Overall Study|Adverse Event|74|||
48740224|NCT01696695|156897459|FG000|Overall Study|Withdrawal by Subject|92|||
48740225|NCT01696695|156897459|FG000|Overall Study|Lost to Follow-up|48|||
48740226|NCT01696695|156897459|FG000|Overall Study|Other|74|||
48740227|NCT01696695|156897459|FG000|Overall Study|Major Protocol Violation|192|||
48740228|NCT03948581|156897460|FG000|Overall Study|Lost to Follow-up|0|||
48740229|NCT03948581|156897461|FG001|Overall Study|Lost to Follow-up|1|||
48740230|NCT01593917|156897466|FG000|Overall Study|Death|67|||
48740231|NCT01593917|156897466|FG000|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60|||
48740232|NCT01593917|156897466|FG000|Overall Study|Withdrawal by Subject|23|||
48854350|NCT00800176|157304983|FG001|Overall Study|Refused treatment|2|||
48740233|NCT01593917|156897466|FG000|Overall Study|Lost to Follow-up|12|||
48740234|NCT01593917|156897466|FG000|Overall Study|Protocol Violation|5|||
48740235|NCT01593917|156897466|FG000|Overall Study|Physician Decision|3|||
48740236|NCT05457647|156897467|FG000|Overall Study|Lost to Follow-up|3|||
48740237|NCT01802788|156897468|FG000|Overall Study|Withdrawal by Subject|102|||
48740238|NCT01802788|156897469|FG001|Overall Study|Withdrawal by Subject|5|||
48740239|NCT01802788|156897468|FG000|Overall Study|Death|382|||
48740240|NCT01802788|156897469|FG001|Overall Study|Death|18|||
48740241|NCT01802788|156897468|FG000|Overall Study|Lost to Follow-up|31|||
48740242|NCT01802788|156897469|FG001|Overall Study|Lost to Follow-up|2|||
48740243|NCT01802788|156897468|FG000|Overall Study|Physician Decision|3|||
48740244|NCT01802788|156897469|FG001|Overall Study|Physician Decision|0|||
48740245|NCT01802788|156897468|FG000|Overall Study|Patient Non-Compliance|1|||
48740246|NCT01802788|156897469|FG001|Overall Study|Patient Non-Compliance|0|||
48740247|NCT01802788|156897468|FG000|Overall Study|Study Stopped/Terminated at Site|5|||
48740248|NCT01802788|156897469|FG001|Overall Study|Study Stopped/Terminated at Site|0|||
48740249|NCT01802788|156897468|FG000|Overall Study|Other Reasons|19|||
48740250|NCT01802788|156897469|FG001|Overall Study|Other Reasons|0|||
48949686|NCT00751881|157645220|FG000|Core Treatment Period|Adverse Event|26|||
48949687|NCT00751881|157645221|FG001|Core Treatment Period|Adverse Event|54|||
48949688|NCT00751881|157645222|FG002|Core Treatment Period|Adverse Event|58|||
48949689|NCT00751881|157645220|FG000|Core Treatment Period|Lack of Efficacy|37|||
48949690|NCT00751881|157645221|FG001|Core Treatment Period|Lack of Efficacy|30|||
48949691|NCT00751881|157645222|FG002|Core Treatment Period|Lack of Efficacy|20|||
48949692|NCT00751881|157645220|FG000|Core Treatment Period|Poor compliance to protocol|15|||
48949693|NCT00751881|157645221|FG001|Core Treatment Period|Poor compliance to protocol|3|||
48949694|NCT00751881|157645222|FG002|Core Treatment Period|Poor compliance to protocol|4|||
48949695|NCT00751881|157645220|FG000|Core Treatment Period|Lost to Follow-up|6|||
48949696|NCT00751881|157645221|FG001|Core Treatment Period|Lost to Follow-up|4|||
48949697|NCT00751881|157645222|FG002|Core Treatment Period|Lost to Follow-up|3|||
48949698|NCT00751881|157645220|FG000|Core Treatment Period|Other: protocol deviation|3|||
48949699|NCT00751881|157645221|FG001|Core Treatment Period|Other: protocol deviation|3|||
48949700|NCT00751881|157645222|FG002|Core Treatment Period|Other: protocol deviation|7|||
48740251|NCT03270501|156897470|FG000|Overall Study|Screen failure|6|||
48740252|NCT03270501|156897470|FG000|Overall Study|Lost to Follow-up|2|||
48740253|NCT03270501|156897470|FG000|Overall Study|Adverse Event|1|||
48740254|NCT05661851|156897471|FG000|Overall Study|Protocol Violation|1|||
48740255|NCT05661851|156897472|FG001|Overall Study|Protocol Violation|1|||
48740256|NCT05661851|156897471|FG000|Overall Study|Covid-19 Related|3|||
48740257|NCT05661851|156897472|FG001|Overall Study|Covid-19 Related|4|||
48740258|NCT05661851|156897471|FG000|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|1|||
48740259|NCT05661851|156897472|FG001|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|0|||
48740260|NCT05661851|156897471|FG000|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|0|||
48743076|NCT00968201|156910494|FG000|Extension Study - (Period III)|Lost to Follow-up|0|||
48740261|NCT05661851|156897472|FG001|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|1|||
48740262|NCT00446251|156897475|FG000|Overall Study|On-study Transplants|2|||
48740263|NCT00446251|156897475|FG000|Overall Study|Rituximab Infusion Reaction|2|||
48740264|NCT00446251|156897475|FG000|Overall Study|Lost to Follow-up|1|||
48740265|NCT00474760|156897476|FG000|Overall Study|Death|0|||
48740266|NCT00474760|156897477|FG001|Overall Study|Death|0|||
48854351|NCT00800176|157304984|FG002|Overall Study|Refused treatment|0|||
48854352|NCT00800176|157304985|FG003|Overall Study|Refused treatment|0|||
48854353|NCT00800176|157304986|FG004|Overall Study|Refused treatment|1|||
48740267|NCT00474760|156897478|FG002|Overall Study|Death|0|||
48740268|NCT00474760|156897479|FG003|Overall Study|Death|0|||
48854354|NCT00800176|157304987|FG005|Overall Study|Refused treatment|4|||
48740269|NCT00474760|156897480|FG004|Overall Study|Death|2|||
48740270|NCT00474760|156897481|FG005|Overall Study|Death|0|||
48854355|NCT00800176|157304982|FG000|Overall Study|Failure to return|3|||
48740271|NCT00474760|156897482|FG006|Overall Study|Death|0|||
48740272|NCT00474760|156897476|FG000|Overall Study|Adverse Event|0|||
48740273|NCT00474760|156897477|FG001|Overall Study|Adverse Event|0|||
48854356|NCT00800176|157304983|FG001|Overall Study|Failure to return|3|||
48854357|NCT00800176|157304984|FG002|Overall Study|Failure to return|0|||
48740274|NCT00474760|156897478|FG002|Overall Study|Adverse Event|0|||
48740275|NCT00474760|156897479|FG003|Overall Study|Adverse Event|0|||
48740276|NCT00474760|156897480|FG004|Overall Study|Adverse Event|1|||
48740277|NCT00474760|156897481|FG005|Overall Study|Adverse Event|7|||
48949701|NCT00751881|157645220|FG000|Core Treatment Period|Other: wish to parent|5|||
48949702|NCT00751881|157645221|FG001|Core Treatment Period|Other: wish to parent|7|||
48949703|NCT00751881|157645222|FG002|Core Treatment Period|Other: wish to parent|4|||
48949704|NCT00751881|157645220|FG000|Core Treatment Period|Other: personal/family constraints|6|||
48949705|NCT00751881|157645221|FG001|Core Treatment Period|Other: personal/family constraints|7|||
48740278|NCT00474760|156897482|FG006|Overall Study|Adverse Event|0|||
48740279|NCT00474760|156897476|FG000|Overall Study|Laboratory abnormality|0|||
48740280|NCT00474760|156897477|FG001|Overall Study|Laboratory abnormality|0|||
48740281|NCT00474760|156897478|FG002|Overall Study|Laboratory abnormality|0|||
48740282|NCT00474760|156897479|FG003|Overall Study|Laboratory abnormality|0|||
48740283|NCT00474760|156897480|FG004|Overall Study|Laboratory abnormality|0|||
48740284|NCT00474760|156897481|FG005|Overall Study|Laboratory abnormality|1|||
48740285|NCT00474760|156897482|FG006|Overall Study|Laboratory abnormality|0|||
48740286|NCT00474760|156897476|FG000|Overall Study|Withdrawal by Subject|0|||
48740287|NCT00474760|156897477|FG001|Overall Study|Withdrawal by Subject|0|||
48740288|NCT00474760|156897478|FG002|Overall Study|Withdrawal by Subject|0|||
48740289|NCT00474760|156897479|FG003|Overall Study|Withdrawal by Subject|1|||
48740290|NCT00474760|156897480|FG004|Overall Study|Withdrawal by Subject|0|||
48740291|NCT00474760|156897481|FG005|Overall Study|Withdrawal by Subject|1|||
48740292|NCT00474760|156897482|FG006|Overall Study|Withdrawal by Subject|1|||
48740293|NCT00474760|156897476|FG000|Overall Study|Other|0|||
48740294|NCT00474760|156897477|FG001|Overall Study|Other|1|||
48740295|NCT00474760|156897478|FG002|Overall Study|Other|0|||
48740296|NCT00474760|156897479|FG003|Overall Study|Other|0|||
48740297|NCT00474760|156897480|FG004|Overall Study|Other|1|||
48740298|NCT00474760|156897481|FG005|Overall Study|Other|0|||
48854358|NCT00800176|157304985|FG003|Overall Study|Failure to return|2|||
48949706|NCT00751881|157645222|FG002|Core Treatment Period|Other: personal/family constraints|10|||
48949707|NCT00751881|157645220|FG000|Core Treatment Period|Other: MS treatment change|6|||
48740299|NCT00474760|156897482|FG006|Overall Study|Other|0|||
48740300|NCT00474760|156897476|FG000|Overall Study|Progressive disease|3|||
48740301|NCT00474760|156897477|FG001|Overall Study|Progressive disease|2|||
48740302|NCT00474760|156897478|FG002|Overall Study|Progressive disease|3|||
48854359|NCT00800176|157304986|FG004|Overall Study|Failure to return|0|||
48854360|NCT00800176|157304987|FG005|Overall Study|Failure to return|0|||
48854361|NCT00800176|157304982|FG000|Overall Study|Other|1|||
48740303|NCT00474760|156897479|FG003|Overall Study|Progressive disease|2|||
48740304|NCT00474760|156897480|FG004|Overall Study|Progressive disease|8|||
48740305|NCT00474760|156897481|FG005|Overall Study|Progressive disease|20|||
48740306|NCT00474760|156897482|FG006|Overall Study|Progressive disease|7|||
48740307|NCT00474760|156897476|FG000|Overall Study|Terminated by sponsor|0|||
48740308|NCT00474760|156897477|FG001|Overall Study|Terminated by sponsor|0|||
48740309|NCT00474760|156897478|FG002|Overall Study|Terminated by sponsor|0|||
48740310|NCT00474760|156897479|FG003|Overall Study|Terminated by sponsor|0|||
48740311|NCT00474760|156897480|FG004|Overall Study|Terminated by sponsor|0|||
48740312|NCT00474760|156897481|FG005|Overall Study|Terminated by sponsor|0|||
48740313|NCT00474760|156897482|FG006|Overall Study|Terminated by sponsor|2|||
48740314|NCT01206166|156897483|FG000|Overall Study|No evaluable data|2|||
48740315|NCT01206166|156897484|FG001|Overall Study|No evaluable data|3|||
48740316|NCT03338010|156897488|FG000|Overall Study|Withdrawal by Subject|14|||
48740317|NCT03338010|156897489|FG001|Overall Study|Withdrawal by Subject|8|||
48854362|NCT00800176|157304983|FG001|Overall Study|Other|0|||
48854363|NCT00800176|157304984|FG002|Overall Study|Other|0|||
48854364|NCT00800176|157304985|FG003|Overall Study|Other|0|||
48854365|NCT00800176|157304986|FG004|Overall Study|Other|2|||
48854366|NCT00800176|157304987|FG005|Overall Study|Other|0|||
48854367|NCT03987074|157304988|FG000|Overall Study|Withdrew Consent|1|||
48854368|NCT03987074|157304989|FG001|Overall Study|Withdrew Consent|1|||
48854369|NCT03987074|157304990|FG002|Overall Study|Withdrew Consent|0|||
48854370|NCT03987074|157304991|FG003|Overall Study|Withdrew Consent|2|||
48854371|NCT03987074|157304992|FG004|Overall Study|Withdrew Consent|1|||
48854372|NCT03987074|157304988|FG000|Overall Study|Adverse Event|2|||
48854373|NCT03987074|157304989|FG001|Overall Study|Adverse Event|1|||
48854374|NCT03987074|157304990|FG002|Overall Study|Adverse Event|0|||
48854375|NCT03987074|157304991|FG003|Overall Study|Adverse Event|0|||
48854376|NCT03987074|157304992|FG004|Overall Study|Adverse Event|1|||
48854377|NCT03987074|157304988|FG000|Overall Study|Lost to Follow-up|0|||
48854378|NCT03987074|157304989|FG001|Overall Study|Lost to Follow-up|0|||
48854379|NCT03987074|157304990|FG002|Overall Study|Lost to Follow-up|1|||
48854380|NCT03987074|157304991|FG003|Overall Study|Lost to Follow-up|1|||
48854381|NCT03987074|157304992|FG004|Overall Study|Lost to Follow-up|0|||
48854382|NCT03987074|157304988|FG000|Overall Study|Investigator's Discretion|0|||
48854383|NCT03987074|157304989|FG001|Overall Study|Investigator's Discretion|0|||
48854384|NCT03987074|157304990|FG002|Overall Study|Investigator's Discretion|0|||
48854385|NCT03987074|157304991|FG003|Overall Study|Investigator's Discretion|1|||
48854386|NCT03987074|157304992|FG004|Overall Study|Investigator's Discretion|0|||
48854387|NCT02326220|157304995|FG000|Double-blind Treatment Period|Adverse Event|1|||
48854388|NCT02326220|157304996|FG001|Double-blind Treatment Period|Adverse Event|2|||
48854389|NCT02326220|157304997|FG002|Double-blind Treatment Period|Adverse Event|0|||
48854390|NCT02326220|157304995|FG000|Double-blind Treatment Period|Protocol Violation|0|||
48854391|NCT02326220|157304996|FG001|Double-blind Treatment Period|Protocol Violation|1|||
48740318|NCT03338010|156897488|FG000|Overall Study|Lost to Follow-up|4|||
48740319|NCT03338010|156897489|FG001|Overall Study|Lost to Follow-up|2|||
48740320|NCT03338010|156897488|FG000|Overall Study|Adverse Event|3|||
48740321|NCT03338010|156897489|FG001|Overall Study|Adverse Event|2|||
48740322|NCT03338010|156897488|FG000|Overall Study|Physician Decision|2|||
48740323|NCT03338010|156897489|FG001|Overall Study|Physician Decision|2|||
48740324|NCT03338010|156897488|FG000|Overall Study|Non-Compliance with Study Drug|0|||
48740325|NCT03338010|156897489|FG001|Overall Study|Non-Compliance with Study Drug|3|||
48740326|NCT03338010|156897488|FG000|Overall Study|Protocol Violation|0|||
48740327|NCT03338010|156897489|FG001|Overall Study|Protocol Violation|1|||
48740328|NCT00453063|156897490|FG000|Overall Study|Adverse Event|1|||
48740329|NCT00453063|156897491|FG001|Overall Study|Adverse Event|2|||
48740330|NCT00453063|156897490|FG000|Overall Study|Withdrawal by Subject|1|||
48740331|NCT00453063|156897491|FG001|Overall Study|Withdrawal by Subject|1|||
48740332|NCT00453063|156897490|FG000|Overall Study|Protocol Violation|1|||
48740333|NCT00453063|156897491|FG001|Overall Study|Protocol Violation|0|||
48740334|NCT04797195|156897494|FG000|Overall Study|Death|8|||
48740335|NCT04797195|156897495|FG001|Overall Study|Death|15|||
48740336|NCT04797195|156897494|FG000|Overall Study|Change from PD|15|||
48740337|NCT04797195|156897495|FG001|Overall Study|Change from PD|15|||
48740338|NCT04797195|156897494|FG000|Overall Study|Withdrawal by Subject|3|||
48740339|NCT04797195|156897495|FG001|Overall Study|Withdrawal by Subject|2|||
48949708|NCT00751881|157645221|FG001|Core Treatment Period|Other: MS treatment change|4|||
48949709|NCT00751881|157645222|FG002|Core Treatment Period|Other: MS treatment change|4|||
48949710|NCT00751881|157645220|FG000|Core Treatment Period|Other: tolerability complaints|2|||
48949711|NCT00751881|157645221|FG001|Core Treatment Period|Other: tolerability complaints|0|||
48949712|NCT00751881|157645222|FG002|Core Treatment Period|Other: tolerability complaints|0|||
48949713|NCT00751881|157645220|FG000|Core Treatment Period|Other:participant's decision/unspecified|19|||
48949714|NCT00751881|157645221|FG001|Core Treatment Period|Other:participant's decision/unspecified|22|||
48949715|NCT00751881|157645222|FG002|Core Treatment Period|Other:participant's decision/unspecified|16|||
48949716|NCT00751881|157645220|FG000|Extension Study Period|Adverse Event|18|||
48949717|NCT00751881|157645221|FG001|Extension Study Period|Adverse Event|20|||
48949718|NCT00751881|157645222|FG002|Extension Study Period|Adverse Event|21|||
48949719|NCT00751881|157645220|FG000|Extension Study Period|Lack of Efficacy|14|||
48949720|NCT00751881|157645221|FG001|Extension Study Period|Lack of Efficacy|10|||
48949721|NCT00751881|157645222|FG002|Extension Study Period|Lack of Efficacy|20|||
48949722|NCT00751881|157645220|FG000|Extension Study Period|Lost to Follow-up|4|||
48949723|NCT00751881|157645221|FG001|Extension Study Period|Lost to Follow-up|9|||
48740340|NCT05307692|156897496|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
48740341|NCT05307692|156897497|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|1|||
48740342|NCT05307692|156897498|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
48740343|NCT05307692|156897499|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
48740344|NCT05307692|156897496|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
48740345|NCT05307692|156897497|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|2|||
48740346|NCT05307692|156897498|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
48949724|NCT00751881|157645222|FG002|Extension Study Period|Lost to Follow-up|6|||
48949725|NCT00751881|157645220|FG000|Extension Study Period|Poor Compliance to Protocol|3|||
48949726|NCT00751881|157645221|FG001|Extension Study Period|Poor Compliance to Protocol|2|||
48740347|NCT05307692|156897499|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
48949727|NCT00751881|157645222|FG002|Extension Study Period|Poor Compliance to Protocol|1|||
48949728|NCT00751881|157645220|FG000|Extension Study Period|Other than specified above|26|||
48949729|NCT00751881|157645221|FG001|Extension Study Period|Other than specified above|30|||
48949730|NCT00751881|157645222|FG002|Extension Study Period|Other than specified above|18|||
48949731|NCT02119104|157645225|FG000|Overall Study|Protocol Violation|16|||
48949732|NCT03634072|157645232|FG000|Overall Study|Early termination of overall study|1|||
48949733|NCT03634072|157645233|FG001|Overall Study|Early termination of overall study|0|||
48949734|NCT00515463|157645237|FG000|Overall Study|Physician Decision|4|||
48949735|NCT00515463|157645238|FG001|Overall Study|Physician Decision|2|||
48949736|NCT00515463|157645237|FG000|Overall Study|Adverse Event|1|||
48949737|NCT00515463|157645238|FG001|Overall Study|Adverse Event|2|||
48949738|NCT00515463|157645237|FG000|Overall Study|Withdrawal by Subject|3|||
48949739|NCT00515463|157645238|FG001|Overall Study|Withdrawal by Subject|4|||
48949740|NCT00515463|157645237|FG000|Overall Study|Lost to Follow-up|6|||
48949741|NCT00515463|157645238|FG001|Overall Study|Lost to Follow-up|5|||
48949742|NCT00515463|157645237|FG000|Overall Study|Other|0|||
48949743|NCT00515463|157645238|FG001|Overall Study|Other|1|||
48740348|NCT05307692|156897496|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
48740349|NCT05307692|156897497|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
48949744|NCT01651260|157645239|FG000|Overall Study|unable to apply product|3|||
48949745|NCT00081289|157645240|FG000|Overall Study|Accrued prior to chemotherapy amendment|18|||
48949746|NCT00081289|157645241|FG001|Overall Study|Accrued prior to chemotherapy amendment|17|||
48949747|NCT00081289|157645240|FG000|Overall Study|Ineligible / no protocol treatment|3|||
48949748|NCT00081289|157645241|FG001|Overall Study|Ineligible / no protocol treatment|4|||
48949749|NCT02144220|157645244|FG000|Overall Study|technology incompatibility|9|||
48949750|NCT02144220|157645244|FG000|Overall Study|Lack of Efficacy|4|||
48949751|NCT02144220|157645244|FG000|Overall Study|Physician Decision|3|||
48949752|NCT02144220|157645244|FG000|Overall Study|Withdrawal by Subject|2|||
48949753|NCT02144220|157645244|FG000|Overall Study|Protocol Violation|1|||
48949754|NCT00723840|157645245|FG000|Overall Study|Lost to Follow-up|2|||
48949755|NCT00723840|157645245|FG000|Overall Study|Failure to return|18|||
48949756|NCT00723840|157645245|FG000|Overall Study|Withdrawal by Subject|55|||
48949757|NCT00723840|157645245|FG000|Overall Study|Serious Adverse Events|3|||
48949758|NCT00723840|157645245|FG000|Overall Study|Other Medical Event|2|||
48949759|NCT00723840|157645245|FG000|Overall Study|Unspecified reason|2|||
48949760|NCT01558089|157645246|FG000|Overall Study|Adverse Event|1|||
48949761|NCT01558089|157645246|FG000|Overall Study|Lack of Efficacy|1|||
48949762|NCT01558089|157645246|FG000|Overall Study|Lost to Follow-up|5|||
48949763|NCT01558089|157645246|FG000|Overall Study|Withdrawal by Subject|6|||
48949764|NCT01781026|157645247|FG000|Overall Study|Lack of Efficacy|2|||
48949765|NCT00916721|157645248|FG000|Overall Study|Lost to Follow-up|0|||
48949766|NCT00916721|157645249|FG001|Overall Study|Lost to Follow-up|1|||
48740350|NCT05307692|156897498|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
48740351|NCT05307692|156897499|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
48740352|NCT05307692|156897496|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|2|||
48949767|NCT00916721|157645248|FG000|Overall Study|Adverse Event|6|||
48949768|NCT00916721|157645249|FG001|Overall Study|Adverse Event|3|||
48949769|NCT00916721|157645248|FG000|Overall Study|Withdrawal by Subject|2|||
48949770|NCT00916721|157645249|FG001|Overall Study|Withdrawal by Subject|2|||
48740353|NCT05307692|156897497|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|3|||
48949771|NCT00916721|157645248|FG000|Overall Study|Protocol Violation|2|||
48949772|NCT00916721|157645249|FG001|Overall Study|Protocol Violation|4|||
48949773|NCT04493619|157647026|FG000|Overall Study|Death|4|||
48949774|NCT04493619|157647027|FG001|Overall Study|Death|3|||
48949775|NCT04493619|157647028|FG002|Overall Study|Death|3|||
48949776|NCT04493619|157647029|FG003|Overall Study|Death|4|||
48949777|NCT04493619|157647026|FG000|Overall Study|Study discontinued early|10|||
48949778|NCT04493619|157647027|FG001|Overall Study|Study discontinued early|0|||
48740354|NCT05307692|156897498|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
48740355|NCT05307692|156897499|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
48740356|NCT05307692|156897496|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
48740357|NCT05307692|156897497|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Other|1|||
48740358|NCT05307692|156897498|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
48740359|NCT05307692|156897499|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
48740360|NCT05307692|156897496|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|2|||
48740361|NCT05307692|156897497|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|1|||
48740362|NCT05307692|156897498|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
48797776|NCT00483184|157097061|FG000|Overall Study|Protocol Violation|1|||
48949779|NCT04493619|157647028|FG002|Overall Study|Study discontinued early|4|||
48949780|NCT04493619|157647029|FG003|Overall Study|Study discontinued early|8|||
48949781|NCT04493619|157647026|FG000|Overall Study|Lost to Follow-up|0|||
48949782|NCT04493619|157647027|FG001|Overall Study|Lost to Follow-up|0|||
48949783|NCT04493619|157647028|FG002|Overall Study|Lost to Follow-up|0|||
48949784|NCT04493619|157647029|FG003|Overall Study|Lost to Follow-up|1|||
48949785|NCT00375934|157647032|FG000|Overall Study|Adverse Event|1|||
48949786|NCT00375934|157647033|FG001|Overall Study|Adverse Event|1|||
48949787|NCT00375934|157647032|FG000|Overall Study|Withdrawal by Subject|2|||
48949788|NCT00375934|157647033|FG001|Overall Study|Withdrawal by Subject|2|||
48949789|NCT00375934|157647032|FG000|Overall Study|Lack of Efficacy|0|||
48949790|NCT00375934|157647033|FG001|Overall Study|Lack of Efficacy|2|||
48949791|NCT00375934|157647032|FG000|Overall Study|Physician Decision|0|||
48949792|NCT00375934|157647033|FG001|Overall Study|Physician Decision|1|||
48949793|NCT03191396|157647034|FG000|Overall Study|Lost to Follow-up|0|||
48949794|NCT03191396|157647035|FG001|Overall Study|Lost to Follow-up|3|||
48949795|NCT03191396|157647034|FG000|Overall Study|Withdrawal by Subject|3|||
48949796|NCT03191396|157647035|FG001|Overall Study|Withdrawal by Subject|2|||
48949797|NCT03032068|157647036|FG000|Overall Study|Adverse Event|1|||
48949798|NCT01300286|157647037|FG000|Overall Study|did not get dosed|1|||
48949799|NCT00744055|157647038|FG000|Overall Study|Withdrawal by Subject|6|||
48949800|NCT00744055|157647039|FG001|Overall Study|Withdrawal by Subject|9|||
48949801|NCT00744055|157647038|FG000|Overall Study|Lack of Efficacy|0|||
48949802|NCT00744055|157647039|FG001|Overall Study|Lack of Efficacy|1|||
48949803|NCT00744055|157647038|FG000|Overall Study|Physician Decision|0|||
48949804|NCT00744055|157647039|FG001|Overall Study|Physician Decision|2|||
48949805|NCT00744055|157647038|FG000|Overall Study|Protocol Violation|1|||
48949806|NCT00744055|157647039|FG001|Overall Study|Protocol Violation|1|||
48949807|NCT00744055|157647038|FG000|Overall Study|Lost to Follow-up|0|||
48949808|NCT00744055|157647039|FG001|Overall Study|Lost to Follow-up|1|||
48949809|NCT03635190|157647040|FG000|Overall Study|Lost to Follow-up|4|||
48949810|NCT03635190|157647040|FG000|Overall Study|Death|3|||
48949811|NCT03635190|157647040|FG000|Overall Study|Withdrawal by Subject|1|||
48949812|NCT03635190|157647040|FG000|Overall Study|Patient moved and did not return for follow up|1|||
48949813|NCT03692910|157647044|FG000|Overall Study|Lost to Follow-up|4|||
48949814|NCT03692910|157647045|FG001|Overall Study|Lost to Follow-up|0|||
48949815|NCT03692910|157647046|FG002|Overall Study|Lost to Follow-up|0|||
48949816|NCT03692910|157647044|FG000|Overall Study|Withdrawal by Subject|2|||
48949817|NCT03692910|157647045|FG001|Overall Study|Withdrawal by Subject|0|||
48949818|NCT03692910|157647046|FG002|Overall Study|Withdrawal by Subject|0|||
48949819|NCT01330381|157647047|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
48949820|NCT01330381|157647048|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4|||
48949821|NCT01330381|157647049|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
48949822|NCT01330381|157647047|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance|2|||
48949823|NCT01330381|157647048|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance|1|||
48949824|NCT01330381|157647049|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance|0|||
48949825|NCT01330381|157647047|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
48949826|NCT01330381|157647048|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
48949827|NCT01330381|157647049|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|0|||
48949828|NCT01330381|157647047|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1|||
48949829|NCT01330381|157647048|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
48949830|NCT01330381|157647049|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
48949831|NCT01330381|157647047|FG000|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1|||
48949832|NCT01330381|157647048|FG001|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
48949833|NCT01330381|157647049|FG002|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
48949834|NCT01330381|157647047|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
48949835|NCT01330381|157647048|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
48949836|NCT01330381|157647049|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
48949837|NCT01330381|157647047|FG000|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7|||
48949838|NCT01330381|157647048|FG001|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0|||
48949839|NCT01330381|157647049|FG002|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16|||
48949840|NCT01330381|157647047|FG000|Open-label Treatment Period (16 Weeks)|Adverse Event|2|||
48949841|NCT01330381|157647048|FG001|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
48949842|NCT01330381|157647049|FG002|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
48949843|NCT01330381|157647047|FG000|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
48949844|NCT01330381|157647048|FG001|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0|||
48949845|NCT01330381|157647049|FG002|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
48949846|NCT01330381|157647047|FG000|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
48949847|NCT01330381|157647048|FG001|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
48949848|NCT01330381|157647049|FG002|Open-label Treatment Period (16 Weeks)|Non-compliance|1|||
48949849|NCT04003155|157647050|FG000|Double-Blind (DB) Period (12 Weeks)|Adverse Event|9|||
48949850|NCT04003155|157647051|FG001|Double-Blind (DB) Period (12 Weeks)|Adverse Event|8|||
48949851|NCT04003155|157647052|FG002|Double-Blind (DB) Period (12 Weeks)|Adverse Event|5|||
48949852|NCT04003155|157647053|FG003|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
48949853|NCT04003155|157647054|FG004|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
48949854|NCT04003155|157647050|FG000|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|3|||
48949855|NCT04003155|157647051|FG001|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
48949856|NCT04003155|157647052|FG002|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
48949857|NCT04003155|157647053|FG003|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
48949858|NCT04003155|157647054|FG004|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
48949859|NCT04003155|157647050|FG000|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|1|||
48949860|NCT04003155|157647051|FG001|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
48949861|NCT04003155|157647052|FG002|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
48949862|NCT04003155|157647053|FG003|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
48949863|NCT04003155|157647054|FG004|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
48949864|NCT04003155|157647050|FG000|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|9|||
48949865|NCT04003155|157647051|FG001|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|12|||
48949866|NCT04003155|157647052|FG002|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
48949867|NCT04003155|157647053|FG003|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
48949868|NCT04003155|157647054|FG004|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
48949869|NCT04003155|157647050|FG000|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|1|||
48949870|NCT04003155|157647051|FG001|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|7|||
48949871|NCT04003155|157647052|FG002|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|3|||
48949872|NCT04003155|157647053|FG003|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
48949873|NCT04003155|157647054|FG004|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
48949874|NCT04003155|157647050|FG000|Extension Period (EP) (40 Weeks)|Adverse Event|0|||
48949875|NCT04003155|157647051|FG001|Extension Period (EP) (40 Weeks)|Adverse Event|5|||
48949876|NCT04003155|157647052|FG002|Extension Period (EP) (40 Weeks)|Adverse Event|4|||
48949877|NCT04003155|157647053|FG003|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
48949878|NCT04003155|157647054|FG004|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
48949879|NCT04003155|157647050|FG000|Extension Period (EP) (40 Weeks)|Lost to Follow-up|0|||
48949880|NCT04003155|157647051|FG001|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
48949881|NCT04003155|157647052|FG002|Extension Period (EP) (40 Weeks)|Lost to Follow-up|3|||
48949882|NCT04003155|157647053|FG003|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
48949883|NCT04003155|157647054|FG004|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
48949884|NCT04003155|157647050|FG000|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|0|||
48949885|NCT04003155|157647051|FG001|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|12|||
48949886|NCT04003155|157647052|FG002|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|7|||
48949887|NCT04003155|157647053|FG003|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|9|||
48949888|NCT04003155|157647054|FG004|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|5|||
48949889|NCT04003155|157647050|FG000|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
48949890|NCT04003155|157647051|FG001|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
48949891|NCT04003155|157647052|FG002|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
48949892|NCT04003155|157647053|FG003|Extension Period (EP) (40 Weeks)|Miscellaneous|2|||
48797777|NCT00483184|157097062|FG001|Overall Study|Protocol Violation|0|||
48797778|NCT00483184|157097063|FG002|Overall Study|Protocol Violation|1|||
48797779|NCT02570126|157097064|FG000|Overall Study|Lost to Follow-up|2|||
48797780|NCT02570126|157097065|FG001|Overall Study|Lost to Follow-up|0|||
48797781|NCT02570126|157097064|FG000|Overall Study|Unable To Arrange Visit 3|1|||
48797782|NCT02570126|157097065|FG001|Overall Study|Unable To Arrange Visit 3|0|||
48949893|NCT04003155|157647054|FG004|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
48740363|NCT05307692|156897499|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
48740364|NCT05307692|156897496|FG000|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
48740365|NCT05307692|156897497|FG001|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
48740366|NCT05307692|156897498|FG002|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
48740367|NCT05307692|156897499|FG003|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|1|||
48949894|NCT02940886|157647055|FG000|Overall Study|Adverse Event|7|||
48949895|NCT02940886|157647056|FG001|Overall Study|Adverse Event|3|||
48949896|NCT02940886|157647055|FG000|Overall Study|Protocol Violation|0|||
48949897|NCT02940886|157647056|FG001|Overall Study|Protocol Violation|2|||
48949898|NCT02940886|157647055|FG000|Overall Study|Withdrawal by Subject|28|||
48949899|NCT02940886|157647056|FG001|Overall Study|Withdrawal by Subject|20|||
48949900|NCT02940886|157647055|FG000|Overall Study|Death|1|||
48949901|NCT02940886|157647056|FG001|Overall Study|Death|0|||
48949902|NCT02940886|157647055|FG000|Overall Study|Lack of Efficacy|1|||
48949903|NCT02940886|157647056|FG001|Overall Study|Lack of Efficacy|0|||
48949904|NCT02940886|157647055|FG000|Overall Study|Lost to Follow-up|49|||
48740368|NCT05307692|156897496|FG000|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
48740369|NCT05307692|156897497|FG001|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
48740370|NCT05307692|156897498|FG002|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
48740371|NCT05307692|156897499|FG003|FU Phase (Day 43 to Day 57):|Protocol Violation|3|||
48740372|NCT03673046|156898854|FG000|Overall Study|Adverse Event|1|||
48740373|NCT03673046|156898855|FG001|Overall Study|Adverse Event|1|||
48740374|NCT03673046|156898854|FG000|Overall Study|Withdrawal by Subject|8|||
48740375|NCT03673046|156898855|FG001|Overall Study|Withdrawal by Subject|2|||
48949905|NCT02940886|157647056|FG001|Overall Study|Lost to Follow-up|21|||
48949906|NCT02940886|157647055|FG000|Overall Study|Physician Decision|9|||
48949907|NCT02940886|157647056|FG001|Overall Study|Physician Decision|4|||
48949908|NCT02940886|157647055|FG000|Overall Study|Sponsor decision|0|||
48949909|NCT02940886|157647056|FG001|Overall Study|Sponsor decision|1|||
48949910|NCT02940886|157647055|FG000|Overall Study|No treatment|7|||
48949911|NCT02940886|157647056|FG001|Overall Study|No treatment|2|||
48949912|NCT02940886|157647055|FG000|Overall Study|Enrolment error|0|||
48949913|NCT02940886|157647056|FG001|Overall Study|Enrolment error|1|||
48949914|NCT03216265|157647060|FG000|Overall Study|Adverse Event|2|||
48949915|NCT03216265|157647061|FG001|Overall Study|Adverse Event|0|||
48949916|NCT03216265|157647062|FG002|Overall Study|Adverse Event|2|||
48949917|NCT03216265|157647060|FG000|Overall Study|Lost to Follow-up|0|||
48949918|NCT03216265|157647061|FG001|Overall Study|Lost to Follow-up|1|||
48949919|NCT03216265|157647062|FG002|Overall Study|Lost to Follow-up|0|||
48949920|NCT03216265|157647060|FG000|Overall Study|Withdrawal by Subject|0|||
48949921|NCT03216265|157647061|FG001|Overall Study|Withdrawal by Subject|0|||
48949922|NCT03216265|157647062|FG002|Overall Study|Withdrawal by Subject|1|||
48949923|NCT02413398|157647063|FG000|Overall Study|Lost to Follow-up|2|||
48949924|NCT02413398|157647064|FG001|Overall Study|Lost to Follow-up|4|||
48740376|NCT00150709|156898856|FG000|Overall Study|Protocol Violation|7|||
48740377|NCT00150709|156898857|FG001|Overall Study|Protocol Violation|8|||
48854392|NCT02326220|157304997|FG002|Double-blind Treatment Period|Protocol Violation|0|||
48854393|NCT02326220|157304995|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
48854394|NCT02326220|157304996|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
48854395|NCT02326220|157304997|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
48854396|NCT02326220|157304995|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
48854397|NCT02326220|157304996|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
48854398|NCT02326220|157304997|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
48854399|NCT02326220|157304995|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
48854400|NCT02326220|157304996|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
48854401|NCT02326220|157304997|FG002|Open-label Treatment Period|Lost to Follow-up|1|||
48949925|NCT02413398|157647063|FG000|Overall Study|Withdrawal by Subject|1|||
48949926|NCT02413398|157647064|FG001|Overall Study|Withdrawal by Subject|1|||
48949927|NCT02413398|157647063|FG000|Overall Study|Other Eligibility criteria|1|||
48740378|NCT00150709|156898858|FG002|Overall Study|Protocol Violation|3|||
48740379|NCT00150709|156898859|FG003|Overall Study|Protocol Violation|1|||
48740380|NCT00150709|156898856|FG000|Overall Study|Adverse Event|8|||
48740381|NCT00150709|156898857|FG001|Overall Study|Adverse Event|2|||
48740382|NCT00150709|156898858|FG002|Overall Study|Adverse Event|2|||
48740383|NCT00150709|156898859|FG003|Overall Study|Adverse Event|3|||
48740384|NCT00150709|156898856|FG000|Overall Study|Lack of Efficacy|6|||
48740385|NCT00150709|156898857|FG001|Overall Study|Lack of Efficacy|11|||
48740386|NCT00150709|156898858|FG002|Overall Study|Lack of Efficacy|9|||
48740387|NCT00150709|156898859|FG003|Overall Study|Lack of Efficacy|0|||
48740388|NCT00150709|156898856|FG000|Overall Study|Withdrawal by Subject|7|||
48740389|NCT00150709|156898857|FG001|Overall Study|Withdrawal by Subject|10|||
48740390|NCT00150709|156898858|FG002|Overall Study|Withdrawal by Subject|5|||
48740391|NCT00150709|156898859|FG003|Overall Study|Withdrawal by Subject|0|||
48740392|NCT00150709|156898856|FG000|Overall Study|Lost to Follow-up|3|||
48740393|NCT00150709|156898857|FG001|Overall Study|Lost to Follow-up|2|||
48740394|NCT00150709|156898858|FG002|Overall Study|Lost to Follow-up|0|||
48740395|NCT00150709|156898859|FG003|Overall Study|Lost to Follow-up|0|||
48740396|NCT00150709|156898856|FG000|Overall Study|Sponsor decision|0|||
48740397|NCT00150709|156898857|FG001|Overall Study|Sponsor decision|0|||
48740398|NCT00150709|156898858|FG002|Overall Study|Sponsor decision|0|||
48740399|NCT00150709|156898859|FG003|Overall Study|Sponsor decision|1|||
48740400|NCT00150709|156898856|FG000|Overall Study|Site/Investigator discontinued the study|5|||
48740401|NCT00150709|156898857|FG001|Overall Study|Site/Investigator discontinued the study|5|||
48740402|NCT00150709|156898858|FG002|Overall Study|Site/Investigator discontinued the study|2|||
48740403|NCT00150709|156898859|FG003|Overall Study|Site/Investigator discontinued the study|0|||
48740404|NCT00150709|156898856|FG000|Overall Study|Decision of parent(s)|1|||
48797938|NCT02291679|157097124|FG001|Overall Study|Withdrew Consent|10|||
48797939|NCT02291679|157097125|FG002|Overall Study|Withdrew Consent|15|||
48797940|NCT02291679|157097123|FG000|Overall Study|Lost to Follow-up|12|||
48797941|NCT02291679|157097124|FG001|Overall Study|Lost to Follow-up|10|||
48797942|NCT02291679|157097125|FG002|Overall Study|Lost to Follow-up|9|||
48797943|NCT02291679|157097123|FG000|Overall Study|Insufficient Therapeutic Response|5|||
48797944|NCT02291679|157097124|FG001|Overall Study|Insufficient Therapeutic Response|5|||
48797945|NCT02291679|157097125|FG002|Overall Study|Insufficient Therapeutic Response|7|||
48797946|NCT02291679|157097123|FG000|Overall Study|Other|2|||
48797947|NCT02291679|157097124|FG001|Overall Study|Other|4|||
48797948|NCT02291679|157097125|FG002|Overall Study|Other|2|||
48797949|NCT02048072|157097126|FG000|Overall Study|Adverse Event|3|||
48797950|NCT02048072|157097126|FG000|Overall Study|Lost to Follow-up|1|||
48797951|NCT02276222|157097127|FG000|Overall Study|Adverse Event|62|||
48797952|NCT02276222|157097128|FG001|Overall Study|Adverse Event|11|||
48797953|NCT02276222|157097127|FG000|Overall Study|Death|3|||
48797954|NCT02276222|157097128|FG001|Overall Study|Death|4|||
48797955|NCT02276222|157097127|FG000|Overall Study|Lack of Efficacy|13|||
48797956|NCT02276222|157097128|FG001|Overall Study|Lack of Efficacy|3|||
48797957|NCT02276222|157097127|FG000|Overall Study|Protocol Violation|3|||
48797958|NCT02276222|157097128|FG001|Overall Study|Protocol Violation|2|||
48797959|NCT02276222|157097127|FG000|Overall Study|Withdrawal by Subject|79|||
48797960|NCT02276222|157097128|FG001|Overall Study|Withdrawal by Subject|33|||
48797961|NCT02276222|157097127|FG000|Overall Study|non compliance with study medication|6|||
48797962|NCT02276222|157097128|FG001|Overall Study|non compliance with study medication|2|||
48797963|NCT02276222|157097127|FG000|Overall Study|sponsor decision|0|||
48797964|NCT02276222|157097128|FG001|Overall Study|sponsor decision|3|||
48797965|NCT02276222|157097127|FG000|Overall Study|Lost to Follow-up|15|||
48797966|NCT02276222|157097128|FG001|Overall Study|Lost to Follow-up|5|||
48797967|NCT02276222|157097127|FG000|Overall Study|Physician Decision|2|||
48797968|NCT02276222|157097128|FG001|Overall Study|Physician Decision|1|||
48797969|NCT02276222|157097127|FG000|Overall Study|sheduling conflict|1|||
48797970|NCT02276222|157097128|FG001|Overall Study|sheduling conflict|0|||
48797971|NCT02276222|157097127|FG000|Overall Study|subject withdrew after randomization|1|||
48797972|NCT02276222|157097128|FG001|Overall Study|subject withdrew after randomization|0|||
48740405|NCT00150709|156898857|FG001|Overall Study|Decision of parent(s)|2|||
48740406|NCT00150709|156898858|FG002|Overall Study|Decision of parent(s)|0|||
48740407|NCT00150709|156898859|FG003|Overall Study|Decision of parent(s)|0|||
48740408|NCT00150709|156898856|FG000|Overall Study|Decision of parent(s) and investigator|3|||
48740409|NCT00150709|156898857|FG001|Overall Study|Decision of parent(s) and investigator|0|||
48740410|NCT00150709|156898858|FG002|Overall Study|Decision of parent(s) and investigator|0|||
48740411|NCT00150709|156898859|FG003|Overall Study|Decision of parent(s) and investigator|0|||
48740412|NCT00150709|156898856|FG000|Overall Study|Loss/ incompleteness of efficacy|12|||
48740413|NCT00150709|156898857|FG001|Overall Study|Loss/ incompleteness of efficacy|12|||
48740414|NCT00150709|156898858|FG002|Overall Study|Loss/ incompleteness of efficacy|2|||
48740415|NCT00150709|156898859|FG003|Overall Study|Loss/ incompleteness of efficacy|2|||
48740416|NCT00150709|156898856|FG000|Overall Study|Investigator decision|1|||
48740417|NCT00150709|156898857|FG001|Overall Study|Investigator decision|0|||
48740418|NCT00150709|156898858|FG002|Overall Study|Investigator decision|0|||
48740419|NCT00150709|156898859|FG003|Overall Study|Investigator decision|1|||
48740420|NCT00150709|156898856|FG000|Overall Study|Subject relocated|2|||
48740421|NCT00150709|156898857|FG001|Overall Study|Subject relocated|2|||
48740422|NCT00150709|156898858|FG002|Overall Study|Subject relocated|1|||
48740423|NCT00150709|156898859|FG003|Overall Study|Subject relocated|0|||
48740424|NCT00150709|156898856|FG000|Overall Study|Subject continues Keppra through prescriptions|0|||
48740425|NCT00150709|156898857|FG001|Overall Study|Subject continues Keppra through prescriptions|4|||
48740426|NCT00150709|156898858|FG002|Overall Study|Subject continues Keppra through prescriptions|0|||
48740427|NCT00150709|156898859|FG003|Overall Study|Subject continues Keppra through prescriptions|0|||
48740428|NCT00150709|156898856|FG000|Overall Study|Convenience|0|||
48740429|NCT00150709|156898857|FG001|Overall Study|Convenience|1|||
48740430|NCT00150709|156898858|FG002|Overall Study|Convenience|0|||
48740431|NCT00150709|156898859|FG003|Overall Study|Convenience|0|||
48740432|NCT00150709|156898856|FG000|Overall Study|Subject entered new drug study|0|||
48740433|NCT00150709|156898857|FG001|Overall Study|Subject entered new drug study|1|||
48740434|NCT00150709|156898858|FG002|Overall Study|Subject entered new drug study|0|||
48740435|NCT00150709|156898859|FG003|Overall Study|Subject entered new drug study|0|||
48740436|NCT00150709|156898856|FG000|Overall Study|Subject to undergo surgery for seizures|0|||
48740437|NCT00150709|156898857|FG001|Overall Study|Subject to undergo surgery for seizures|1|||
48740438|NCT00150709|156898858|FG002|Overall Study|Subject to undergo surgery for seizures|0|||
48740439|NCT00150709|156898859|FG003|Overall Study|Subject to undergo surgery for seizures|0|||
48740440|NCT00150709|156898856|FG000|Overall Study|Lack of ease of swallowing|0|||
48740441|NCT00150709|156898857|FG001|Overall Study|Lack of ease of swallowing|1|||
48740442|NCT00150709|156898858|FG002|Overall Study|Lack of ease of swallowing|0|||
48740443|NCT00150709|156898859|FG003|Overall Study|Lack of ease of swallowing|0|||
48740444|NCT02349061|156898860|FG000|Main Study: PCP (Up to Week 24)|Adverse Event|4|||
48740445|NCT02349061|156898861|FG001|Main Study: PCP (Up to Week 24)|Adverse Event|3|||
48740446|NCT02349061|156898862|FG002|Main Study: PCP (Up to Week 24)|Adverse Event|0|||
48740447|NCT02349061|156898860|FG000|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1|||
48740448|NCT02349061|156898861|FG001|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
48740449|NCT02349061|156898862|FG002|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
48740450|NCT02349061|156898860|FG000|Main Study: PCP (Up to Week 24)|Physician Decision|1|||
48740451|NCT02349061|156898861|FG001|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
48740452|NCT02349061|156898862|FG002|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
48740453|NCT02349061|156898860|FG000|Main Study: PCP (Up to Week 24)|Other|1|||
48740454|NCT02349061|156898861|FG001|Main Study: PCP (Up to Week 24)|Other|1|||
48740455|NCT02349061|156898862|FG002|Main Study: PCP (Up to Week 24)|Other|0|||
48740456|NCT02349061|156898860|FG000|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2|||
48949928|NCT02413398|157647064|FG001|Overall Study|Other Eligibility criteria|2|||
48949929|NCT03074162|157647067|FG000|Period 1 Including Washout 1|Withdrawal by Subject|0|||
48949930|NCT03074162|157647068|FG001|Period 1 Including Washout 1|Withdrawal by Subject|0|||
48949931|NCT03074162|157647069|FG002|Period 1 Including Washout 1|Withdrawal by Subject|1|||
48949932|NCT03074162|157647070|FG003|Period 1 Including Washout 1|Withdrawal by Subject|0|||
48949933|NCT03074162|157647071|FG004|Period 1 Including Washout 1|Withdrawal by Subject|0|||
48949934|NCT03074162|157647072|FG005|Period 1 Including Washout 1|Withdrawal by Subject|0|||
48949935|NCT03074162|157647067|FG000|Period 2 Including Washout 2|Withdrawal by Subject|0|||
48949936|NCT03074162|157647068|FG001|Period 2 Including Washout 2|Withdrawal by Subject|0|||
48949937|NCT03074162|157647069|FG002|Period 2 Including Washout 2|Withdrawal by Subject|1|||
48949938|NCT03074162|157647070|FG003|Period 2 Including Washout 2|Withdrawal by Subject|0|||
48949939|NCT03074162|157647071|FG004|Period 2 Including Washout 2|Withdrawal by Subject|0|||
48949940|NCT03074162|157647072|FG005|Period 2 Including Washout 2|Withdrawal by Subject|1|||
48949941|NCT03074162|157647067|FG000|Period 3|Withdrawal by Subject|1|||
48740457|NCT02349061|156898861|FG001|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
48740458|NCT02349061|156898862|FG002|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
48854402|NCT02114515|157304999|FG000|Overall Study|Lost to Follow-up|52|||
48854403|NCT02114515|157305000|FG001|Overall Study|Lost to Follow-up|55|||
48854404|NCT02114515|157304999|FG000|Overall Study|Death|12|||
48854405|NCT02114515|157305000|FG001|Overall Study|Death|12|||
48740459|NCT02349061|156898860|FG000|Main Study: Week 24 to 56|Adverse Event|0|||
48740460|NCT02349061|156898861|FG001|Main Study: Week 24 to 56|Adverse Event|2|||
48740461|NCT02349061|156898862|FG002|Main Study: Week 24 to 56|Adverse Event|1|||
48740462|NCT02349061|156898860|FG000|Main Study: Week 24 to 56|Lack of Efficacy|0|||
48740463|NCT02349061|156898861|FG001|Main Study: Week 24 to 56|Lack of Efficacy|1|||
48740464|NCT02349061|156898862|FG002|Main Study: Week 24 to 56|Lack of Efficacy|0|||
48740465|NCT02349061|156898860|FG000|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
48740466|NCT02349061|156898861|FG001|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
48740467|NCT02349061|156898862|FG002|Main Study: Week 24 to 56|Withdrawal by Subject|1|||
48740468|NCT02349061|156898860|FG000|Main Study: Week 24 to 56|Physician Decision|0|||
48740469|NCT02349061|156898861|FG001|Main Study: Week 24 to 56|Physician Decision|0|||
48740470|NCT02349061|156898862|FG002|Main Study: Week 24 to 56|Physician Decision|1|||
48740471|NCT02349061|156898860|FG000|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
48740472|NCT02349061|156898861|FG001|Study Extension (Week 56 to Week 120)|Adverse Event|3|||
48740473|NCT02349061|156898862|FG002|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
48740474|NCT02349061|156898860|FG000|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
48740475|NCT02349061|156898861|FG001|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
48740476|NCT02349061|156898862|FG002|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1|||
48740477|NCT02349061|156898860|FG000|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0|||
48740478|NCT02349061|156898861|FG001|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2|||
48740479|NCT02349061|156898862|FG002|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1|||
48740480|NCT02349061|156898860|FG000|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
48740481|NCT02349061|156898861|FG001|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
48740482|NCT02349061|156898862|FG002|Study Extension (Week 56 to Week 120)|Physician Decision|1|||
48854406|NCT02114515|157304999|FG000|Overall Study|Withdrawal by Subject|4|||
48854407|NCT02114515|157305000|FG001|Overall Study|Withdrawal by Subject|22|||
48949942|NCT03074162|157647068|FG001|Period 3|Withdrawal by Subject|0|||
48949943|NCT03074162|157647069|FG002|Period 3|Withdrawal by Subject|0|||
48854408|NCT02114515|157304999|FG000|Overall Study|Other|65|||
48854409|NCT02114515|157305000|FG001|Overall Study|Other|61|||
48854410|NCT01661972|157305001|FG000|Overall Study|Adverse Event|1|||
48854411|NCT01661972|157305002|FG001|Overall Study|Adverse Event|2|||
48854412|NCT01661972|157305001|FG000|Overall Study|Death during Treatment period|1|||
48854413|NCT01661972|157305002|FG001|Overall Study|Death during Treatment period|1|||
48854414|NCT01661972|157305001|FG000|Overall Study|Withdrawal by Subject|0|||
48854415|NCT01661972|157305002|FG001|Overall Study|Withdrawal by Subject|1|||
48854416|NCT01240590|157305008|FG000|Phase I|Refused further treatment|0|||
48854417|NCT01240590|157305009|FG001|Phase I|Refused further treatment|0|||
48854418|NCT01240590|157305010|FG002|Phase I|Refused further treatment|3|||
48854419|NCT01240590|157305011|FG003|Phase I|Refused further treatment|0|||
48854420|NCT01240590|157305012|FG004|Phase I|Refused further treatment|0|||
48854421|NCT01240590|157305008|FG000|Phase II|Refused further treatment|0|||
48854422|NCT01240590|157305009|FG001|Phase II|Refused further treatment|0|||
48854423|NCT01240590|157305010|FG002|Phase II|Refused further treatment|0|||
48854424|NCT01240590|157305011|FG003|Phase II|Refused further treatment|2|||
48854425|NCT01240590|157305012|FG004|Phase II|Refused further treatment|1|||
48854426|NCT02334215|157305016|FG000|Overall Study|Death|1|||
48854427|NCT02334215|157305017|FG001|Overall Study|Death|1|||
48854428|NCT02334215|157305018|FG002|Overall Study|Death|0|||
48854429|NCT02334215|157305016|FG000|Overall Study|Lost to Follow-up|1|||
48854430|NCT02334215|157305017|FG001|Overall Study|Lost to Follow-up|0|||
48854431|NCT02334215|157305018|FG002|Overall Study|Lost to Follow-up|4|||
48854432|NCT02334215|157305016|FG000|Overall Study|Withdrawal by Subject|2|||
48854433|NCT02334215|157305017|FG001|Overall Study|Withdrawal by Subject|2|||
48854434|NCT02334215|157305018|FG002|Overall Study|Withdrawal by Subject|1|||
48854435|NCT02334215|157305016|FG000|Overall Study|Not released from incarceration on time|3|||
48854436|NCT02334215|157305017|FG001|Overall Study|Not released from incarceration on time|3|||
48949944|NCT03074162|157647070|FG003|Period 3|Withdrawal by Subject|0|||
48949945|NCT03074162|157647071|FG004|Period 3|Withdrawal by Subject|1|||
48949946|NCT03074162|157647072|FG005|Period 3|Withdrawal by Subject|0|||
48949947|NCT04328623|157647077|FG000|Overall Study|Protocol Violation|0|||
48949948|NCT04328623|157647078|FG001|Overall Study|Protocol Violation|1|||
48949949|NCT00849693|157647081|FG000|Acute Treatment Phase|Adverse Event|12|||
48949950|NCT00849693|157647082|FG001|Acute Treatment Phase|Adverse Event|7|||
48949951|NCT00849693|157647083|FG002|Acute Treatment Phase|Adverse Event|6|||
48949952|NCT00849693|157647084|FG003|Acute Treatment Phase|Adverse Event|4|||
48949953|NCT00849693|157647081|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
48740483|NCT00316719|156898863|FG000|Overall Study|Adverse Event|0|||
48740484|NCT00316719|156898864|FG001|Overall Study|Adverse Event|6|||
48740485|NCT00316719|156898863|FG000|Overall Study|Consent withdrawn|2|||
48740486|NCT00316719|156898864|FG001|Overall Study|Consent withdrawn|0|||
48740487|NCT05215847|156898868|FG000|Overall Study|Lost to Follow-up|1|||
48740488|NCT01560403|156898869|FG000|Overall Study|Lost to Follow-up|0|||
48740489|NCT01560403|156898870|FG001|Overall Study|Lost to Follow-up|1|||
48740490|NCT05228470|156898877|FG000|Overall Study|Death|6|||
48740491|NCT05228470|156898878|FG001|Overall Study|Death|11|||
48740492|NCT05228470|156898877|FG000|Overall Study|Withdrawal by Subject|1|||
48740493|NCT05228470|156898878|FG001|Overall Study|Withdrawal by Subject|8|||
48740494|NCT05228470|156898877|FG000|Overall Study|Ongoing|1|||
48740495|NCT05228470|156898878|FG001|Overall Study|Ongoing|11|||
48740496|NCT02300298|156898879|FG000|Disposition for Nintedanib|Progressive disease|10|||
48740497|NCT02300298|156898880|FG001|Disposition for Nintedanib|Progressive disease|0|||
48740498|NCT02300298|156898879|FG000|Disposition for Docetaxel|Progressive disease|0|||
48740499|NCT02300298|156898880|FG001|Disposition for Docetaxel|Progressive disease|6|||
48740500|NCT02300298|156898879|FG000|Disposition for Docetaxel|other adverse event|0|||
48740501|NCT02300298|156898880|FG001|Disposition for Docetaxel|other adverse event|4|||
48740502|NCT03016169|156898881|FG000|Overall Study|Lost to Follow-up|4|||
48740503|NCT03016169|156898881|FG000|Overall Study|Death|54|||
48740504|NCT03016169|156898881|FG000|Overall Study|Device Explant|11|||
48740505|NCT03016169|156898881|FG000|Overall Study|Withdrawal by Subject|19|||
48740506|NCT03016169|156898881|FG000|Overall Study|Other Reasons|1|||
48740507|NCT04390048|156898882|FG000|Overall Study|Withdrawal by Subject|1|||
48740508|NCT04390048|156898883|FG001|Overall Study|Withdrawal by Subject|3|||
48740509|NCT04812535|156898886|FG000|Overall Study|Withdrawal by Subject|0|||
48740510|NCT04812535|156898887|FG001|Overall Study|Withdrawal by Subject|0|||
48740511|NCT04812535|156898888|FG002|Overall Study|Withdrawal by Subject|0|||
48740512|NCT04812535|156898889|FG003|Overall Study|Withdrawal by Subject|1|||
48740513|NCT04812535|156898886|FG000|Overall Study|Death|7|||
48740514|NCT04812535|156898887|FG001|Overall Study|Death|2|||
48740515|NCT04812535|156898888|FG002|Overall Study|Death|4|||
48740516|NCT04812535|156898889|FG003|Overall Study|Death|1|||
48740517|NCT04812535|156898886|FG000|Overall Study|Due to premature study termination by sponsor|2|||
48740518|NCT04812535|156898887|FG001|Overall Study|Due to premature study termination by sponsor|0|||
48740519|NCT04812535|156898888|FG002|Overall Study|Due to premature study termination by sponsor|1|||
48740520|NCT04812535|156898889|FG003|Overall Study|Due to premature study termination by sponsor|3|||
48740521|NCT01084876|156898891|FG000|Main Study Treatment Period|Adverse Event|12|||
48740522|NCT01084876|156898892|FG001|Main Study Treatment Period|Adverse Event|7|||
48740523|NCT01084876|156898891|FG000|Main Study Treatment Period|Disease Progression|41|||
48740524|NCT01084876|156898892|FG001|Main Study Treatment Period|Disease Progression|24|||
48797973|NCT01949311|157098516|FG000|Overall Study|Lost to Follow-up|73|||
48797974|NCT01949311|157098516|FG000|Overall Study|Terminated by Sponsor|708|||
48797975|NCT01949311|157098516|FG000|Overall Study|Withdrawal by Subject|375|||
48797976|NCT01949311|157098516|FG000|Overall Study|Lack of Efficacy|50|||
48797977|NCT01949311|157098516|FG000|Overall Study|Protocol Deviation|34|||
48797978|NCT01949311|157098516|FG000|Overall Study|Pregnancy|20|||
48797979|NCT01949311|157098516|FG000|Overall Study|Physician Decision|9|||
48797980|NCT01949311|157098516|FG000|Overall Study|Other|4|||
48797981|NCT01949311|157098516|FG000|Overall Study|Adverse Event|107|||
48797982|NCT00677833|157098520|FG000|Overall Study|Withdrawal by Subject|4|||
48797983|NCT00677833|157098521|FG001|Overall Study|Withdrawal by Subject|0|||
48740525|NCT01084876|156898891|FG000|Main Study Treatment Period|Physician Decision|2|||
48949954|NCT00849693|157647082|FG001|Acute Treatment Phase|Lost to Follow-up|8|||
48949955|NCT00849693|157647083|FG002|Acute Treatment Phase|Lost to Follow-up|11|||
48949956|NCT00849693|157647084|FG003|Acute Treatment Phase|Lost to Follow-up|9|||
48949957|NCT00849693|157647081|FG000|Acute Treatment Phase|Protocol Violation|1|||
48949958|NCT00849693|157647082|FG001|Acute Treatment Phase|Protocol Violation|5|||
48949959|NCT00849693|157647083|FG002|Acute Treatment Phase|Protocol Violation|2|||
48949960|NCT00849693|157647084|FG003|Acute Treatment Phase|Protocol Violation|6|||
48949961|NCT00849693|157647081|FG000|Acute Treatment Phase|Withdrawal by Subject|5|||
48949962|NCT00849693|157647082|FG001|Acute Treatment Phase|Withdrawal by Subject|5|||
48949963|NCT00849693|157647083|FG002|Acute Treatment Phase|Withdrawal by Subject|3|||
48949964|NCT00849693|157647084|FG003|Acute Treatment Phase|Withdrawal by Subject|8|||
48949965|NCT00849693|157647081|FG000|Acute Treatment Phase|Parent or caregiver decision|7|||
48949966|NCT00849693|157647082|FG001|Acute Treatment Phase|Parent or caregiver decision|6|||
48949967|NCT00849693|157647083|FG002|Acute Treatment Phase|Parent or caregiver decision|7|||
48949968|NCT00849693|157647084|FG003|Acute Treatment Phase|Parent or caregiver decision|7|||
48949969|NCT00849693|157647081|FG000|Acute Treatment Phase|Physician Decision|2|||
48949970|NCT00849693|157647082|FG001|Acute Treatment Phase|Physician Decision|1|||
48949971|NCT00849693|157647083|FG002|Acute Treatment Phase|Physician Decision|2|||
48949972|NCT00849693|157647084|FG003|Acute Treatment Phase|Physician Decision|1|||
48949973|NCT00849693|157647081|FG000|Acute Treatment Phase|Sponsor decision|0|||
48949974|NCT00849693|157647082|FG001|Acute Treatment Phase|Sponsor decision|0|||
48949975|NCT00849693|157647083|FG002|Acute Treatment Phase|Sponsor decision|1|||
48949976|NCT00849693|157647084|FG003|Acute Treatment Phase|Sponsor decision|0|||
48949977|NCT00849693|157647081|FG000|Acute Treatment Phase|Lack of Efficacy|1|||
48949978|NCT00849693|157647082|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
48949979|NCT00849693|157647083|FG002|Acute Treatment Phase|Lack of Efficacy|1|||
48949980|NCT00849693|157647084|FG003|Acute Treatment Phase|Lack of Efficacy|2|||
48740526|NCT01084876|156898892|FG001|Main Study Treatment Period|Physician Decision|0|||
48740527|NCT01084876|156898891|FG000|Main Study Treatment Period|Withdrawal by Subject|4|||
48740528|NCT01084876|156898892|FG001|Main Study Treatment Period|Withdrawal by Subject|6|||
48740529|NCT01084876|156898891|FG000|Main Study Treatment Period|Other Reason|0|||
48740530|NCT01084876|156898892|FG001|Main Study Treatment Period|Other Reason|1|||
48740531|NCT01084876|156898891|FG000|Main Study Treatment Period|Other|0|||
48740532|NCT01084876|156898892|FG001|Main Study Treatment Period|Other|1|||
48740533|NCT01084876|156898891|FG000|Treatment Period Beyond Cycle 8|Adverse Event|8|||
48740534|NCT01084876|156898892|FG001|Treatment Period Beyond Cycle 8|Adverse Event|2|||
48740535|NCT01084876|156898891|FG000|Treatment Period Beyond Cycle 8|Disease Progression|129|||
48740536|NCT01084876|156898892|FG001|Treatment Period Beyond Cycle 8|Disease Progression|119|||
48740537|NCT01084876|156898891|FG000|Treatment Period Beyond Cycle 8|Physician Decision|6|||
48740538|NCT01084876|156898892|FG001|Treatment Period Beyond Cycle 8|Physician Decision|5|||
48740539|NCT01084876|156898891|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|12|||
48740540|NCT01084876|156898892|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|20|||
48740541|NCT01084876|156898891|FG000|Treatment Period Beyond Cycle 8|Other Reason|7|||
48740542|NCT01084876|156898892|FG001|Treatment Period Beyond Cycle 8|Other Reason|13|||
48740543|NCT01084876|156898891|FG000|Treatment Period Beyond Cycle 8|Other|6|||
48740544|NCT01084876|156898892|FG001|Treatment Period Beyond Cycle 8|Other|9|||
48740545|NCT02075840|156898893|FG000|Overall Study|Withdrawal by Subject|13|||
48740546|NCT02075840|156898894|FG001|Overall Study|Withdrawal by Subject|22|||
48740547|NCT02075840|156898893|FG000|Overall Study|Reason not specified|1|||
48740548|NCT02075840|156898894|FG001|Overall Study|Reason not specified|0|||
48740549|NCT02075840|156898893|FG000|Overall Study|Adverse Event|0|||
48740550|NCT02075840|156898894|FG001|Overall Study|Adverse Event|2|||
48740551|NCT02075840|156898893|FG000|Overall Study|Death|35|||
48740552|NCT02075840|156898894|FG001|Overall Study|Death|40|||
48740553|NCT02075840|156898893|FG000|Overall Study|Lost to Follow-up|3|||
48740554|NCT02075840|156898894|FG001|Overall Study|Lost to Follow-up|2|||
48740555|NCT02075840|156898893|FG000|Overall Study|Physician Decision|1|||
48740556|NCT02075840|156898894|FG001|Overall Study|Physician Decision|3|||
48740557|NCT02075840|156898893|FG000|Overall Study|Ongoing at CCOD|99|||
48740558|NCT02075840|156898894|FG001|Overall Study|Ongoing at CCOD|82|||
48854437|NCT02334215|157305018|FG002|Overall Study|Not released from incarceration on time|3|||
48740559|NCT05028634|156898895|FG000|Overall Study|Withdrawal by Subject|0|||
48740560|NCT05028634|156898896|FG001|Overall Study|Withdrawal by Subject|1|||
48740561|NCT02908477|156898897|FG000|Overall Study|Withdrawal by Subject|8|||
48854438|NCT02334215|157305016|FG000|Overall Study|Incarcerated|0|||
48740562|NCT02908477|156898898|FG001|Overall Study|Withdrawal by Subject|28|||
48740563|NCT01999114|156898907|FG000|Overall Study|Adverse Event|8|||
48740564|NCT01999114|156898908|FG001|Overall Study|Adverse Event|7|||
48740565|NCT01999114|156898909|FG002|Overall Study|Adverse Event|2|||
48740566|NCT01999114|156898910|FG003|Overall Study|Adverse Event|2|||
48854439|NCT02334215|157305017|FG001|Overall Study|Incarcerated|0|||
48854440|NCT02334215|157305018|FG002|Overall Study|Incarcerated|7|||
48854441|NCT04895085|157305019|FG000|Overall Study|Death|1|||
48854442|NCT04895085|157305019|FG000|Overall Study|Withdrawal by Subject|1|||
48854443|NCT04895085|157305019|FG000|Overall Study|No longer eligible: Moved from area|1|||
48854444|NCT04448561|157305020|FG000|Overall Study|Noncompliance|1|||
48854445|NCT04448561|157305021|FG001|Overall Study|Noncompliance|0|||
48854446|NCT01920932|157306795|FG000|Overall Study|Death|1|||
48854447|NCT01920932|157306795|FG000|Overall Study|Withdrawal of consent|1|||
48854448|NCT03678688|157306796|FG000|Overall Study|Reason not Specified|0|||
48854449|NCT03678688|157306797|FG001|Overall Study|Reason not Specified|0|||
48854450|NCT03678688|157306798|FG002|Overall Study|Reason not Specified|3|||
48854451|NCT03678688|157306799|FG003|Overall Study|Reason not Specified|0|||
48854452|NCT03678688|157306800|FG004|Overall Study|Reason not Specified|1|||
48854453|NCT03678688|157306801|FG005|Overall Study|Reason not Specified|0|||
48854454|NCT03678688|157306802|FG006|Overall Study|Reason not Specified|0|||
48854455|NCT03678688|157306803|FG007|Overall Study|Reason not Specified|0|||
48854456|NCT03678688|157306804|FG008|Overall Study|Reason not Specified|0|||
48854457|NCT03678688|157306796|FG000|Overall Study|Non-Covid Related Adverse Event|0|||
48854458|NCT03678688|157306797|FG001|Overall Study|Non-Covid Related Adverse Event|0|||
48854459|NCT03678688|157306798|FG002|Overall Study|Non-Covid Related Adverse Event|0|||
48854460|NCT03678688|157306799|FG003|Overall Study|Non-Covid Related Adverse Event|1|||
48854461|NCT03678688|157306800|FG004|Overall Study|Non-Covid Related Adverse Event|0|||
48854462|NCT03678688|157306801|FG005|Overall Study|Non-Covid Related Adverse Event|0|||
48854463|NCT03678688|157306802|FG006|Overall Study|Non-Covid Related Adverse Event|2|||
48854464|NCT03678688|157306803|FG007|Overall Study|Non-Covid Related Adverse Event|1|||
48854465|NCT03678688|157306804|FG008|Overall Study|Non-Covid Related Adverse Event|0|||
48854466|NCT03678688|157306796|FG000|Overall Study|Covid Related Adverse Event|0|||
48854467|NCT03678688|157306797|FG001|Overall Study|Covid Related Adverse Event|0|||
48854468|NCT03678688|157306798|FG002|Overall Study|Covid Related Adverse Event|0|||
48854469|NCT03678688|157306799|FG003|Overall Study|Covid Related Adverse Event|0|||
48854470|NCT03678688|157306800|FG004|Overall Study|Covid Related Adverse Event|0|||
48854471|NCT03678688|157306801|FG005|Overall Study|Covid Related Adverse Event|3|||
48854472|NCT03678688|157306802|FG006|Overall Study|Covid Related Adverse Event|1|||
48854473|NCT03678688|157306803|FG007|Overall Study|Covid Related Adverse Event|1|||
48854474|NCT03678688|157306804|FG008|Overall Study|Covid Related Adverse Event|0|||
48854475|NCT03678688|157306796|FG000|Overall Study|Physician Decision|0|||
48854476|NCT03678688|157306797|FG001|Overall Study|Physician Decision|0|||
48854477|NCT03678688|157306798|FG002|Overall Study|Physician Decision|0|||
48854478|NCT03678688|157306799|FG003|Overall Study|Physician Decision|0|||
48854479|NCT03678688|157306800|FG004|Overall Study|Physician Decision|0|||
48854480|NCT03678688|157306801|FG005|Overall Study|Physician Decision|1|||
48854481|NCT03678688|157306802|FG006|Overall Study|Physician Decision|0|||
48854482|NCT03678688|157306803|FG007|Overall Study|Physician Decision|0|||
48740567|NCT01999114|156898911|FG004|Overall Study|Adverse Event|1|||
48740568|NCT01999114|156898907|FG000|Overall Study|Withdrawal by Subject|0|||
48740569|NCT01999114|156898908|FG001|Overall Study|Withdrawal by Subject|0|||
48949981|NCT00849693|157647081|FG000|Extension Phase|Adverse Event|4|||
48740570|NCT01999114|156898909|FG002|Overall Study|Withdrawal by Subject|1|||
48740571|NCT01999114|156898910|FG003|Overall Study|Withdrawal by Subject|0|||
48949982|NCT00849693|157647082|FG001|Extension Phase|Adverse Event|6|||
48949983|NCT00849693|157647083|FG002|Extension Phase|Adverse Event|3|||
48949984|NCT00849693|157647084|FG003|Extension Phase|Adverse Event|7|||
48949985|NCT00849693|157647081|FG000|Extension Phase|Lost to Follow-up|7|||
48949986|NCT00849693|157647082|FG001|Extension Phase|Lost to Follow-up|5|||
48949987|NCT00849693|157647083|FG002|Extension Phase|Lost to Follow-up|6|||
48740572|NCT01999114|156898911|FG004|Overall Study|Withdrawal by Subject|1|||
48949988|NCT00849693|157647084|FG003|Extension Phase|Lost to Follow-up|6|||
48949989|NCT00849693|157647081|FG000|Extension Phase|Protocol Violation|0|||
48949990|NCT00849693|157647082|FG001|Extension Phase|Protocol Violation|3|||
48949991|NCT00849693|157647083|FG002|Extension Phase|Protocol Violation|2|||
48949992|NCT00849693|157647084|FG003|Extension Phase|Protocol Violation|3|||
48949993|NCT00849693|157647081|FG000|Extension Phase|Withdrawal by Subject|6|||
48949994|NCT00849693|157647082|FG001|Extension Phase|Withdrawal by Subject|9|||
48949995|NCT00849693|157647083|FG002|Extension Phase|Withdrawal by Subject|10|||
48949996|NCT00849693|157647084|FG003|Extension Phase|Withdrawal by Subject|15|||
48949997|NCT00849693|157647081|FG000|Extension Phase|Parent or caregiver decision|9|||
48949998|NCT00849693|157647082|FG001|Extension Phase|Parent or caregiver decision|4|||
48949999|NCT00849693|157647083|FG002|Extension Phase|Parent or caregiver decision|10|||
48950000|NCT00849693|157647084|FG003|Extension Phase|Parent or caregiver decision|5|||
48950001|NCT00849693|157647081|FG000|Extension Phase|Physician Decision|1|||
48950002|NCT00849693|157647082|FG001|Extension Phase|Physician Decision|1|||
48950003|NCT00849693|157647083|FG002|Extension Phase|Physician Decision|2|||
48950004|NCT00849693|157647084|FG003|Extension Phase|Physician Decision|0|||
48950005|NCT00849693|157647081|FG000|Extension Phase|Sponsor decision|1|||
48950006|NCT00849693|157647082|FG001|Extension Phase|Sponsor decision|0|||
48950007|NCT00849693|157647083|FG002|Extension Phase|Sponsor decision|0|||
48740573|NCT01999114|156898907|FG000|Overall Study|Lost to Follow-up|0|||
48740574|NCT01999114|156898908|FG001|Overall Study|Lost to Follow-up|0|||
48740575|NCT01999114|156898909|FG002|Overall Study|Lost to Follow-up|1|||
48740576|NCT01999114|156898910|FG003|Overall Study|Lost to Follow-up|0|||
48740577|NCT01999114|156898911|FG004|Overall Study|Lost to Follow-up|0|||
48740578|NCT01999114|156898907|FG000|Overall Study|Administrative|0|||
48740579|NCT01999114|156898908|FG001|Overall Study|Administrative|0|||
48740580|NCT01999114|156898909|FG002|Overall Study|Administrative|1|||
48740581|NCT01999114|156898910|FG003|Overall Study|Administrative|1|||
48740582|NCT01999114|156898911|FG004|Overall Study|Administrative|2|||
48740583|NCT05047770|156898915|FG000|Overall Study|Withdrawal by Subject|15|||
48740584|NCT05047770|156898916|FG001|Overall Study|Withdrawal by Subject|10|||
48740585|NCT05047770|156898917|FG002|Overall Study|Withdrawal by Subject|6|||
48740586|NCT05047770|156898918|FG003|Overall Study|Withdrawal by Subject|12|||
48740587|NCT05047770|156898915|FG000|Overall Study|Lost to Follow-up|7|||
48740588|NCT05047770|156898916|FG001|Overall Study|Lost to Follow-up|5|||
48740589|NCT05047770|156898917|FG002|Overall Study|Lost to Follow-up|12|||
48740590|NCT05047770|156898918|FG003|Overall Study|Lost to Follow-up|13|||
48740591|NCT05047770|156898915|FG000|Overall Study|Other|1|||
48950008|NCT00849693|157647084|FG003|Extension Phase|Sponsor decision|1|||
48950009|NCT00849693|157647081|FG000|Extension Phase|Lack of Efficacy|2|||
48950010|NCT00849693|157647082|FG001|Extension Phase|Lack of Efficacy|2|||
48740592|NCT05047770|156898916|FG001|Overall Study|Other|0|||
48740593|NCT05047770|156898917|FG002|Overall Study|Other|1|||
48740594|NCT05047770|156898918|FG003|Overall Study|Other|0|||
48740595|NCT04489771|156898919|FG000|Overall Study|Death|27|||
48740596|NCT04489771|156898920|FG001|Overall Study|Death|25|||
48740597|NCT04489771|156898919|FG000|Overall Study|Withdrawal by Subject|1|||
48740598|NCT04489771|156898920|FG001|Overall Study|Withdrawal by Subject|0|||
48740599|NCT04489771|156898919|FG000|Overall Study|Participants Ongoing in Study|50|||
48740600|NCT04489771|156898920|FG001|Overall Study|Participants Ongoing in Study|51|||
48740601|NCT03173313|156898921|FG000|Overall Study|Lost to Follow-up|2|||
48740602|NCT03173313|156898922|FG001|Overall Study|Lost to Follow-up|3|||
48740603|NCT03173313|156898921|FG000|Overall Study|Withdrawal by Subject|0|||
48740604|NCT03173313|156898922|FG001|Overall Study|Withdrawal by Subject|1|||
48740605|NCT03173313|156898921|FG000|Overall Study|Death|5|||
48740606|NCT03173313|156898922|FG001|Overall Study|Death|0|||
48740607|NCT03173313|156898921|FG000|Overall Study|Physician Decision|1|||
48740608|NCT03173313|156898922|FG001|Overall Study|Physician Decision|0|||
48740609|NCT03173313|156898921|FG000|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0|||
48740610|NCT03173313|156898922|FG001|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1|||
48740611|NCT03173313|156898921|FG000|Overall Study|Bone Fracture|1|||
48740612|NCT03173313|156898922|FG001|Overall Study|Bone Fracture|0|||
48740613|NCT02195479|156898923|FG000|Overall Study|Lost to Follow-up|3|||
48740614|NCT02195479|156898924|FG001|Overall Study|Lost to Follow-up|0|||
48740615|NCT02195479|156898923|FG000|Overall Study|Death|48|||
48740616|NCT02195479|156898924|FG001|Overall Study|Death|45|||
48740617|NCT02195479|156898923|FG000|Overall Study|Physician Decision|1|||
48740618|NCT02195479|156898924|FG001|Overall Study|Physician Decision|0|||
48740619|NCT02195479|156898923|FG000|Overall Study|Withdrawal by Subject|11|||
48740620|NCT02195479|156898924|FG001|Overall Study|Withdrawal by Subject|6|||
48740621|NCT02195479|156898923|FG000|Overall Study|Other|2|||
48740622|NCT02195479|156898924|FG001|Overall Study|Other|2|||
48740623|NCT02195479|156898923|FG000|Overall Study|Ongoing|291|||
48740624|NCT02195479|156898924|FG001|Overall Study|Ongoing|297|||
48740625|NCT04696055|156898928|FG000|Overall Study|Adverse Event|10|||
48740626|NCT04696055|156898929|FG001|Overall Study|Adverse Event|0|||
48740627|NCT04696055|156898928|FG000|Overall Study|Death|2|||
48740628|NCT04696055|156898929|FG001|Overall Study|Death|1|||
48740629|NCT04696055|156898928|FG000|Overall Study|Other|4|||
48740630|NCT04696055|156898929|FG001|Overall Study|Other|0|||
48740631|NCT04696055|156898928|FG000|Overall Study|Physician Decision|1|||
48740632|NCT04696055|156898929|FG001|Overall Study|Physician Decision|0|||
48740633|NCT04696055|156898928|FG000|Overall Study|Progressive Disease - Clinical Progression|1|||
48740634|NCT04696055|156898929|FG001|Overall Study|Progressive Disease - Clinical Progression|1|||
48740635|NCT04696055|156898928|FG000|Overall Study|Progressive Disease - Radiological Progression|36|||
48740636|NCT04696055|156898929|FG001|Overall Study|Progressive Disease - Radiological Progression|13|||
48740637|NCT04696055|156898928|FG000|Overall Study|Subject Decision|1|||
48740638|NCT04696055|156898929|FG001|Overall Study|Subject Decision|2|||
48740639|NCT04696055|156898928|FG000|Overall Study|Ongoing with study treatment|13|||
48740640|NCT04696055|156898929|FG001|Overall Study|Ongoing with study treatment|10|||
48950011|NCT00849693|157647083|FG002|Extension Phase|Lack of Efficacy|2|||
48950012|NCT00849693|157647084|FG003|Extension Phase|Lack of Efficacy|1|||
48950013|NCT03238248|157647085|FG000|Overall Study|Death|5|||
48950014|NCT03238248|157647085|FG000|Overall Study|Withdrawal by Subject|7|||
48740641|NCT00389597|156898934|FG000|Overall Study|Lost to Follow-up|8|||
48740642|NCT00389597|156898935|FG001|Overall Study|Lost to Follow-up|6|||
48740643|NCT00389597|156898936|FG002|Overall Study|Lost to Follow-up|4|||
48740644|NCT00389597|156898937|FG003|Overall Study|Lost to Follow-up|6|||
48740645|NCT03685123|156898938|FG000|Weight Loss Phase|Withdrawal by Subject|1|||
48950015|NCT03238248|157647085|FG000|Overall Study|Participant proceeding to transplant|10|||
48950016|NCT03238248|157647085|FG000|Overall Study|Lack of Efficacy|4|||
48740646|NCT03685123|156898939|FG001|Weight Loss Phase|Withdrawal by Subject|0|||
48740647|NCT03685123|156898940|FG002|Weight Loss Phase|Withdrawal by Subject|0|||
48740648|NCT03685123|156898938|FG000|Weight Loss Phase|Did not obtain weight loss goal|3|||
48740649|NCT03685123|156898939|FG001|Weight Loss Phase|Did not obtain weight loss goal|0|||
48740650|NCT03685123|156898940|FG002|Weight Loss Phase|Did not obtain weight loss goal|0|||
48740651|NCT03685123|156898938|FG000|Weight Loss Phase|Lost to Follow-up|1|||
48740652|NCT03685123|156898939|FG001|Weight Loss Phase|Lost to Follow-up|0|||
48740653|NCT03685123|156898940|FG002|Weight Loss Phase|Lost to Follow-up|0|||
48740654|NCT03685123|156898938|FG000|Weight Loss Phase|PI removal due to subject lack of compliance|1|||
48950017|NCT03238248|157647085|FG000|Overall Study|Physician Decision|3|||
48740655|NCT03685123|156898939|FG001|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
48740656|NCT03685123|156898940|FG002|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
48740657|NCT03685123|156898938|FG000|Weight Maintenance Phase|Covid Pandemic|0|||
48740658|NCT03685123|156898939|FG001|Weight Maintenance Phase|Covid Pandemic|4|||
48740659|NCT03685123|156898940|FG002|Weight Maintenance Phase|Covid Pandemic|5|||
48740660|NCT03685123|156898938|FG000|Weight Maintenance Phase|Withdrawal by Subject|0|||
48740661|NCT03685123|156898939|FG001|Weight Maintenance Phase|Withdrawal by Subject|0|||
48740662|NCT03685123|156898940|FG002|Weight Maintenance Phase|Withdrawal by Subject|3|||
48740663|NCT00586625|156898941|FG000|Overall Study|Adverse Event|6|||
48740664|NCT00586625|156898942|FG001|Overall Study|Adverse Event|6|||
48740665|NCT00586625|156898941|FG000|Overall Study|Protocol Violation|3|||
48740666|NCT00586625|156898942|FG001|Overall Study|Protocol Violation|0|||
48740667|NCT00586625|156898941|FG000|Overall Study|Withdrawal by Subject|32|||
48740668|NCT00586625|156898942|FG001|Overall Study|Withdrawal by Subject|10|||
48740669|NCT00586625|156898941|FG000|Overall Study|Subject non-compliance|0|||
48740670|NCT00586625|156898942|FG001|Overall Study|Subject non-compliance|1|||
48740671|NCT00586625|156898941|FG000|Overall Study|Subject unable to return for visit|2|||
48740672|NCT00586625|156898942|FG001|Overall Study|Subject unable to return for visit|0|||
48740673|NCT04528732|156898944|FG000|Overall Study|Death|1|||
48740674|NCT04528732|156898945|FG001|Overall Study|Death|0|||
48740675|NCT04528732|156898946|FG002|Overall Study|Death|1|||
48740676|NCT04528732|156898944|FG000|Overall Study|Lost to Follow-up|0|||
48740677|NCT04528732|156898945|FG001|Overall Study|Lost to Follow-up|1|||
48740678|NCT04528732|156898946|FG002|Overall Study|Lost to Follow-up|2|||
48740679|NCT02369016|156898949|FG000|Overall Study|AE associated with clinical disease progression|2|||
48740680|NCT02369016|156898950|FG001|Overall Study|AE associated with clinical disease progression|1|||
48740681|NCT02369016|156898949|FG000|Overall Study|AE not associated with clinical diseaseprogression|4|||
48740682|NCT02369016|156898950|FG001|Overall Study|AE not associated with clinical diseaseprogression|1|||
48740683|NCT02369016|156898949|FG000|Overall Study|Progressive disease - clinical progression|1|||
48740684|NCT02369016|156898950|FG001|Overall Study|Progressive disease - clinical progression|4|||
48740685|NCT02369016|156898949|FG000|Overall Study|withdrawal by patient|4|||
48740686|NCT02369016|156898950|FG001|Overall Study|withdrawal by patient|0|||
48740687|NCT02369016|156898949|FG000|Overall Study|Progressive disease - radiological progression|6|||
48740688|NCT02369016|156898950|FG001|Overall Study|Progressive disease - radiological progression|2|||
48740689|NCT00660699|156898953|FG000|Overall Study|Withdrawal by Subject|2|||
48740690|NCT01397162|156900160|FG000|Overall Study|Adverse Event|4|||
48740691|NCT01397162|156900161|FG001|Overall Study|Adverse Event|0|||
49015349|NCT00673790|157892152|FG000|Overall Study|Participated in two Nebivolol studies|0|||
48854483|NCT03678688|157306804|FG008|Overall Study|Physician Decision|0|||
48854484|NCT03678688|157306796|FG000|Overall Study|Withdrawal by Subject|0|||
48854485|NCT03678688|157306797|FG001|Overall Study|Withdrawal by Subject|0|||
48854486|NCT03678688|157306798|FG002|Overall Study|Withdrawal by Subject|0|||
48854487|NCT03678688|157306799|FG003|Overall Study|Withdrawal by Subject|0|||
48854488|NCT03678688|157306800|FG004|Overall Study|Withdrawal by Subject|0|||
48854489|NCT03678688|157306801|FG005|Overall Study|Withdrawal by Subject|0|||
48854490|NCT03678688|157306802|FG006|Overall Study|Withdrawal by Subject|2|||
48854491|NCT03678688|157306803|FG007|Overall Study|Withdrawal by Subject|1|||
48854492|NCT03678688|157306804|FG008|Overall Study|Withdrawal by Subject|0|||
48854493|NCT00378898|157306805|FG000|Overall Study|Withdrawal by Subject|10|||
48854494|NCT00378898|157306806|FG001|Overall Study|Withdrawal by Subject|5|||
48854495|NCT00378898|157306805|FG000|Overall Study|Protocol Violation|1|||
48854496|NCT00378898|157306806|FG001|Overall Study|Protocol Violation|1|||
48854497|NCT00048932|157306807|FG000|Double Blind Period (DB)|Administrative Reason By Sponsor|1|||
48854498|NCT00048932|157306808|FG001|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
48854499|NCT00048932|157306809|FG002|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
48854500|NCT00048932|157306807|FG000|Double Blind Period (DB)|Adverse Event|51|||
48854501|NCT00048932|157306808|FG001|Double Blind Period (DB)|Adverse Event|19|||
48854502|NCT00048932|157306809|FG002|Double Blind Period (DB)|Adverse Event|0|||
48854503|NCT00048932|157306807|FG000|Double Blind Period (DB)|Death|5|||
48854504|NCT00048932|157306808|FG001|Double Blind Period (DB)|Death|3|||
48854505|NCT00048932|157306809|FG002|Double Blind Period (DB)|Death|0|||
48854506|NCT00048932|157306807|FG000|Double Blind Period (DB)|Lack of Efficacy|26|||
48854507|NCT00048932|157306808|FG001|Double Blind Period (DB)|Lack of Efficacy|44|||
48854508|NCT00048932|157306809|FG002|Double Blind Period (DB)|Lack of Efficacy|0|||
48854509|NCT00048932|157306807|FG000|Double Blind Period (DB)|Lost to Follow-up|3|||
48854510|NCT00048932|157306808|FG001|Double Blind Period (DB)|Lost to Follow-up|4|||
48950018|NCT03238248|157647085|FG000|Overall Study|Transitioning to another study|1|||
48740692|NCT01397162|156900162|FG002|Overall Study|Adverse Event|0|||
48740693|NCT01397162|156900163|FG003|Overall Study|Adverse Event|0|||
48740694|NCT01397162|156900164|FG004|Overall Study|Adverse Event|0|||
48740695|NCT01397162|156900160|FG000|Overall Study|Not yet defined|3|||
48740696|NCT01397162|156900161|FG001|Overall Study|Not yet defined|4|||
48740697|NCT01397162|156900162|FG002|Overall Study|Not yet defined|3|||
48740698|NCT01397162|156900163|FG003|Overall Study|Not yet defined|5|||
48740699|NCT01397162|156900164|FG004|Overall Study|Not yet defined|3|||
48740700|NCT00560105|156900165|FG000|Overall Study|musculoskeletal chest discomfort with us|1|||
48740701|NCT00560105|156900166|FG001|Overall Study|musculoskeletal chest discomfort with us|2|||
48740702|NCT01507298|156900167|FG000|Overall Study|Protocol Violation|0|||
48740703|NCT01507298|156900168|FG001|Overall Study|Protocol Violation|6|||
48740704|NCT01945281|156900169|FG000|Overall Study|Adverse Event|1|||
48740705|NCT01945281|156900170|FG001|Overall Study|Adverse Event|0|||
48740706|NCT01945281|156900169|FG000|Overall Study|Death|3|||
48740707|NCT01945281|156900170|FG001|Overall Study|Death|3|||
48740708|NCT01945281|156900169|FG000|Overall Study|Physician Decision|1|||
48740709|NCT01945281|156900170|FG001|Overall Study|Physician Decision|1|||
48740710|NCT01945281|156900169|FG000|Overall Study|Technical Problems|1|||
48740711|NCT01945281|156900170|FG001|Overall Study|Technical Problems|0|||
48740712|NCT00385762|156900171|FG000|Overall Study|Adverse Event|1|||
48740713|NCT00385762|156900171|FG000|Overall Study|Lost to Follow-up|1|||
48854511|NCT00048932|157306809|FG002|Double Blind Period (DB)|Lost to Follow-up|0|||
48950019|NCT03238248|157647085|FG000|Overall Study|No longer benefiting|1|||
48950020|NCT03238248|157647085|FG000|Overall Study|Other complicating disease|1|||
48740714|NCT00894166|156900186|FG000|Overall Study|Withdrew or Lost to Follow-Up|61|||
48740715|NCT00894166|156900187|FG001|Overall Study|Withdrew or Lost to Follow-Up|63|||
48740716|NCT00894166|156900188|FG002|Overall Study|Withdrew or Lost to Follow-Up|62|||
48740717|NCT00894166|156900189|FG003|Overall Study|Withdrew or Lost to Follow-Up|68|||
48740718|NCT00894166|156900190|FG004|Overall Study|Withdrew or Lost to Follow-Up|24|||
48854512|NCT00048932|157306807|FG000|Double Blind Period (DB)|Relocation|1|||
48740719|NCT00894166|156900191|FG005|Overall Study|Withdrew or Lost to Follow-Up|16|||
48740720|NCT00894166|156900192|FG006|Overall Study|Withdrew or Lost to Follow-Up|16|||
48740721|NCT00894166|156900193|FG007|Overall Study|Withdrew or Lost to Follow-Up|34|||
48740722|NCT00894166|156900186|FG000|Overall Study|Death|0|||
48740723|NCT00894166|156900187|FG001|Overall Study|Death|0|||
48740724|NCT00894166|156900188|FG002|Overall Study|Death|0|||
48740725|NCT00894166|156900189|FG003|Overall Study|Death|1|||
48740726|NCT00894166|156900190|FG004|Overall Study|Death|0|||
48740727|NCT00894166|156900191|FG005|Overall Study|Death|0|||
48740728|NCT00894166|156900192|FG006|Overall Study|Death|0|||
48740729|NCT00894166|156900193|FG007|Overall Study|Death|0|||
48740730|NCT04898673|156900195|FG000|Overall Study|Screenfail|1|||
48740731|NCT04898673|156900196|FG001|Overall Study|Screenfail|0|||
48740732|NCT00369824|156900199|FG000|Overall Study|Adverse Event|0|||
48740733|NCT00369824|156900200|FG001|Overall Study|Adverse Event|2|||
48740734|NCT00369824|156900201|FG002|Overall Study|Adverse Event|0|||
48740735|NCT00369824|156900202|FG003|Overall Study|Adverse Event|0|||
48740736|NCT00369824|156900203|FG004|Overall Study|Adverse Event|1|||
48740737|NCT00369824|156900204|FG005|Overall Study|Adverse Event|0|||
48740738|NCT00369824|156900199|FG000|Overall Study|Protocol Violation|0|||
48740739|NCT00369824|156900200|FG001|Overall Study|Protocol Violation|1|||
48740740|NCT00369824|156900201|FG002|Overall Study|Protocol Violation|0|||
48740741|NCT00369824|156900202|FG003|Overall Study|Protocol Violation|1|||
48740742|NCT00369824|156900203|FG004|Overall Study|Protocol Violation|1|||
48854513|NCT00048932|157306808|FG001|Double Blind Period (DB)|Relocation|0|||
48854514|NCT00048932|157306809|FG002|Double Blind Period (DB)|Relocation|0|||
48854515|NCT00048932|157306807|FG000|Double Blind Period (DB)|Uncontrolled hypertension|0|||
48854516|NCT00048932|157306808|FG001|Double Blind Period (DB)|Uncontrolled hypertension|1|||
48854517|NCT00048932|157306809|FG002|Double Blind Period (DB)|Uncontrolled hypertension|0|||
48854518|NCT00048932|157306807|FG000|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1|||
48854519|NCT00048932|157306808|FG001|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
48854520|NCT00048932|157306809|FG002|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
48854521|NCT00048932|157306807|FG000|Double Blind Period (DB)|Pregnancy|1|||
48854522|NCT00048932|157306808|FG001|Double Blind Period (DB)|Pregnancy|0|||
48854523|NCT00048932|157306809|FG002|Double Blind Period (DB)|Pregnancy|0|||
48854524|NCT00048932|157306807|FG000|Double Blind Period (DB)|No Longer Meets Study Criteria|8|||
48854525|NCT00048932|157306808|FG001|Double Blind Period (DB)|No Longer Meets Study Criteria|2|||
48854526|NCT00048932|157306809|FG002|Double Blind Period (DB)|No Longer Meets Study Criteria|0|||
48854527|NCT00048932|157306807|FG000|Double Blind Period (DB)|Withdrawal by Subject|24|||
48854528|NCT00048932|157306808|FG001|Double Blind Period (DB)|Withdrawal by Subject|10|||
48854529|NCT00048932|157306809|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
48854530|NCT00048932|157306807|FG000|Double Blind Period (DB)|Poor/Non-Compliance|2|||
48854531|NCT00048932|157306808|FG001|Double Blind Period (DB)|Poor/Non-Compliance|4|||
48854532|NCT00048932|157306809|FG002|Double Blind Period (DB)|Poor/Non-Compliance|0|||
48854533|NCT00048932|157306807|FG000|Open Label Period (OL)|Death|0|||
48854534|NCT00048932|157306808|FG001|Open Label Period (OL)|Death|0|||
48854535|NCT00048932|157306809|FG002|Open Label Period (OL)|Death|25|||
48854536|NCT00048932|157306807|FG000|Open Label Period (OL)|Adverse Event|0|||
48854537|NCT00048932|157306808|FG001|Open Label Period (OL)|Adverse Event|0|||
48854538|NCT00048932|157306809|FG002|Open Label Period (OL)|Adverse Event|103|||
48854539|NCT00048932|157306807|FG000|Open Label Period (OL)|Lack of Efficacy|0|||
48740743|NCT00369824|156900204|FG005|Overall Study|Protocol Violation|0|||
48740744|NCT00369824|156900199|FG000|Overall Study|Withdrawal by Subject|9|||
48740745|NCT00369824|156900200|FG001|Overall Study|Withdrawal by Subject|5|||
48740746|NCT00369824|156900201|FG002|Overall Study|Withdrawal by Subject|5|||
48740747|NCT00369824|156900202|FG003|Overall Study|Withdrawal by Subject|4|||
48740748|NCT00369824|156900203|FG004|Overall Study|Withdrawal by Subject|6|||
48740749|NCT00369824|156900204|FG005|Overall Study|Withdrawal by Subject|2|||
48740750|NCT00369824|156900199|FG000|Overall Study|Lost to Follow-up|6|||
48740751|NCT00369824|156900200|FG001|Overall Study|Lost to Follow-up|11|||
48740752|NCT00369824|156900201|FG002|Overall Study|Lost to Follow-up|7|||
48740753|NCT00369824|156900202|FG003|Overall Study|Lost to Follow-up|8|||
48740754|NCT00369824|156900203|FG004|Overall Study|Lost to Follow-up|9|||
48740755|NCT00369824|156900204|FG005|Overall Study|Lost to Follow-up|6|||
48740756|NCT00369824|156900199|FG000|Overall Study|Other|0|||
48740757|NCT00369824|156900200|FG001|Overall Study|Other|0|||
48740758|NCT00369824|156900201|FG002|Overall Study|Other|0|||
48854540|NCT00048932|157306808|FG001|Open Label Period (OL)|Lack of Efficacy|0|||
48854541|NCT00048932|157306809|FG002|Open Label Period (OL)|Lack of Efficacy|81|||
48854542|NCT00048932|157306807|FG000|Open Label Period (OL)|Lost to Follow-up|0|||
48740759|NCT00369824|156900202|FG003|Overall Study|Other|2|||
48740760|NCT00369824|156900203|FG004|Overall Study|Other|1|||
48854543|NCT00048932|157306808|FG001|Open Label Period (OL)|Lost to Follow-up|0|||
48854544|NCT00048932|157306809|FG002|Open Label Period (OL)|Lost to Follow-up|27|||
48950021|NCT03238248|157647085|FG000|Overall Study|Adverse Event|5|||
48854545|NCT00048932|157306807|FG000|Open Label Period (OL)|Withdrawal by Subject|0|||
48854546|NCT00048932|157306808|FG001|Open Label Period (OL)|Withdrawal by Subject|0|||
48854547|NCT00048932|157306809|FG002|Open Label Period (OL)|Withdrawal by Subject|117|||
48854548|NCT00048932|157306807|FG000|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
48854549|NCT00048932|157306808|FG001|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
48854550|NCT00048932|157306809|FG002|Open Label Period (OL)|No Longer Meets Study Criteria|5|||
48854551|NCT00048932|157306807|FG000|Open Label Period (OL)|Poor/Non-Compliance|0|||
48854552|NCT00048932|157306808|FG001|Open Label Period (OL)|Poor/Non-Compliance|0|||
48854553|NCT00048932|157306809|FG002|Open Label Period (OL)|Poor/Non-Compliance|13|||
48854554|NCT00048932|157306807|FG000|Open Label Period (OL)|Pregnancy|0|||
48854555|NCT00048932|157306808|FG001|Open Label Period (OL)|Pregnancy|0|||
48854556|NCT00048932|157306809|FG002|Open Label Period (OL)|Pregnancy|6|||
48854557|NCT00048932|157306807|FG000|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
48854558|NCT00048932|157306808|FG001|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
48854559|NCT00048932|157306809|FG002|Open Label Period (OL)|Administrative Reason By Sponsor|20|||
48854560|NCT00048932|157306807|FG000|Open Label Period (OL)|Investigator Retiring|0|||
48854561|NCT00048932|157306808|FG001|Open Label Period (OL)|Investigator Retiring|0|||
48854562|NCT00048932|157306809|FG002|Open Label Period (OL)|Investigator Retiring|2|||
48854563|NCT00048932|157306807|FG000|Open Label Period (OL)|Participant Transportation Issues|0|||
48854564|NCT00048932|157306808|FG001|Open Label Period (OL)|Participant Transportation Issues|0|||
48854565|NCT00048932|157306809|FG002|Open Label Period (OL)|Participant Transportation Issues|1|||
48854566|NCT00048932|157306807|FG000|Open Label Period (OL)|Participant Relocated|0|||
48854567|NCT00048932|157306808|FG001|Open Label Period (OL)|Participant Relocated|0|||
48854568|NCT00048932|157306809|FG002|Open Label Period (OL)|Participant Relocated|6|||
48854569|NCT00048932|157306807|FG000|Open Label Period (OL)|Investigator Dosing the Trial|0|||
48854570|NCT00048932|157306808|FG001|Open Label Period (OL)|Investigator Dosing the Trial|0|||
48854571|NCT00048932|157306809|FG002|Open Label Period (OL)|Investigator Dosing the Trial|1|||
48854572|NCT00048932|157306807|FG000|Open Label Period (OL)|Site Closure|0|||
48854573|NCT00048932|157306808|FG001|Open Label Period (OL)|Site Closure|0|||
48854574|NCT00048932|157306809|FG002|Open Label Period (OL)|Site Closure|3|||
48854575|NCT00048932|157306807|FG000|Open Label Period (OL)|Trial Terminated|0|||
48854576|NCT00048932|157306808|FG001|Open Label Period (OL)|Trial Terminated|0|||
48854577|NCT00048932|157306809|FG002|Open Label Period (OL)|Trial Terminated|1|||
48854578|NCT00048932|157306807|FG000|Open Label Period (OL)|Difficult IV Access with Participant|0|||
48854579|NCT00048932|157306808|FG001|Open Label Period (OL)|Difficult IV Access with Participant|0|||
48854580|NCT00048932|157306809|FG002|Open Label Period (OL)|Difficult IV Access with Participant|1|||
48854581|NCT00048932|157306807|FG000|Open Label Period (OL)|Patient Decision|0|||
48854582|NCT00048932|157306808|FG001|Open Label Period (OL)|Patient Decision|0|||
48854583|NCT00048932|157306809|FG002|Open Label Period (OL)|Patient Decision|4|||
48854584|NCT00048932|157306807|FG000|Open Label Period (OL)|Participant Received Wrong Medication|0|||
48854585|NCT00048932|157306808|FG001|Open Label Period (OL)|Participant Received Wrong Medication|0|||
48854586|NCT00048932|157306809|FG002|Open Label Period (OL)|Participant Received Wrong Medication|1|||
48854587|NCT00048932|157306807|FG000|Open Label Period (OL)|Participant Desires Pregnancy|0|||
48854588|NCT00048932|157306808|FG001|Open Label Period (OL)|Participant Desires Pregnancy|0|||
48854589|NCT00048932|157306809|FG002|Open Label Period (OL)|Participant Desires Pregnancy|2|||
48854590|NCT00048932|157306807|FG000|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
48854591|NCT00048932|157306808|FG001|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
48854592|NCT00048932|157306809|FG002|Open Label Period (OL)|Participant Missed Consecutive Doses|5|||
48854593|NCT00048932|157306807|FG000|Open Label Period (OL)|Medication Lost Efficacy|0|||
48854594|NCT00048932|157306808|FG001|Open Label Period (OL)|Medication Lost Efficacy|0|||
48854595|NCT00048932|157306809|FG002|Open Label Period (OL)|Medication Lost Efficacy|1|||
48854596|NCT00048932|157306807|FG000|Open Label Period (OL)|Investigator Decision|0|||
48854597|NCT00048932|157306808|FG001|Open Label Period (OL)|Investigator Decision|0|||
48854598|NCT00048932|157306809|FG002|Open Label Period (OL)|Investigator Decision|4|||
48854599|NCT00048932|157306807|FG000|Open Label Period (OL)|Site Staff Issues|0|||
48854600|NCT00048932|157306808|FG001|Open Label Period (OL)|Site Staff Issues|0|||
48854601|NCT00048932|157306809|FG002|Open Label Period (OL)|Site Staff Issues|2|||
48854602|NCT00048932|157306807|FG000|Open Label Period (OL)|Site Not Participating in Open Label|0|||
48854603|NCT00048932|157306808|FG001|Open Label Period (OL)|Site Not Participating in Open Label|0|||
48854604|NCT00048932|157306809|FG002|Open Label Period (OL)|Site Not Participating in Open Label|9|||
48854605|NCT00048932|157306807|FG000|Open Label Period (OL)|Participant Surgery|0|||
48854606|NCT00048932|157306808|FG001|Open Label Period (OL)|Participant Surgery|0|||
48854607|NCT00048932|157306809|FG002|Open Label Period (OL)|Participant Surgery|1|||
48854608|NCT04809623|157306814|FG000|Overall Study|Study Terminated by Sponsor|1|||
48854609|NCT04809623|157306815|FG001|Overall Study|Study Terminated by Sponsor|0|||
48740761|NCT00369824|156900204|FG005|Overall Study|Other|3|||
48740762|NCT01390649|156900205|FG000|Overall Study|Physician Decision|1|||
48740763|NCT03822182|156900208|FG000|Overall Study|Protocol Violation|0|||
48740764|NCT03822182|156900209|FG001|Overall Study|Protocol Violation|1|||
48740765|NCT03822182|156900210|FG002|Overall Study|Protocol Violation|1|||
48740766|NCT01484275|156900211|FG000|Overall Study|Study terminated by sponsor|28|||
48740767|NCT01484275|156900212|FG001|Overall Study|Study terminated by sponsor|32|||
48740768|NCT01484275|156900211|FG000|Overall Study|Other|10|||
48740769|NCT01484275|156900212|FG001|Overall Study|Other|0|||
48740770|NCT01484275|156900211|FG000|Overall Study|Death|3|||
48740771|NCT01484275|156900212|FG001|Overall Study|Death|4|||
48740772|NCT01484275|156900211|FG000|Overall Study|Withdrawal by Subject|1|||
48740773|NCT01484275|156900212|FG001|Overall Study|Withdrawal by Subject|5|||
48740774|NCT01484275|156900211|FG000|Overall Study|Lost to Follow-up|1|||
48740775|NCT01484275|156900212|FG001|Overall Study|Lost to Follow-up|1|||
48854610|NCT01380145|157306816|FG000|Overall Study|Progressive disease|4|||
48854611|NCT00754325|157306817|FG000|Initial Treatment|Continuing Active Treatment|4|||
48854612|NCT00754325|157306818|FG001|Initial Treatment|Continuing Active Treatment|5|||
48854613|NCT00754325|157306817|FG000|Initial Treatment|Adverse Event|7|||
48950022|NCT03238248|157647085|FG000|Overall Study|Disease progression|26|||
48854614|NCT00754325|157306818|FG001|Initial Treatment|Adverse Event|6|||
48740776|NCT00005044|156900213|FG000|Overall Study|Protocol Violation|37|||
48740777|NCT00005044|156900214|FG001|Overall Study|Protocol Violation|46|||
48740778|NCT00005044|156900213|FG000|Overall Study|Withdrawal by Subject|1|||
48854615|NCT00754325|157306817|FG000|Initial Treatment|Withdrawal by Subject|2|||
48854616|NCT00754325|157306818|FG001|Initial Treatment|Withdrawal by Subject|2|||
48854617|NCT00754325|157306817|FG000|Initial Treatment|Physician Decision|2|||
48854618|NCT00754325|157306818|FG001|Initial Treatment|Physician Decision|0|||
48854619|NCT00754325|157306817|FG000|Initial Treatment|Sponsor Request|0|||
48854620|NCT00754325|157306818|FG001|Initial Treatment|Sponsor Request|1|||
48854621|NCT00754325|157306817|FG000|Initial Treatment|Disease Progression|35|||
48854622|NCT00754325|157306818|FG001|Initial Treatment|Disease Progression|35|||
48854623|NCT01583166|157306819|FG000|Overall Study|Withdrawal by Subject|4|||
48854624|NCT01583166|157306820|FG001|Overall Study|Withdrawal by Subject|6|||
48854625|NCT01353274|157306827|FG000|Overall Study|No case report form (CRF) collected|28|||
48854626|NCT03735849|157306828|FG000|Overall Study|Lost to Follow-up|1|||
48854627|NCT03735849|157306829|FG001|Overall Study|Lost to Follow-up|0|||
48854628|NCT03735849|157306830|FG002|Overall Study|Lost to Follow-up|0|||
48854629|NCT03735849|157306828|FG000|Overall Study|Participant unable to adhere to visit|1|||
48854630|NCT03735849|157306829|FG001|Overall Study|Participant unable to adhere to visit|0|||
48854631|NCT03735849|157306830|FG002|Overall Study|Participant unable to adhere to visit|0|||
48854632|NCT03735849|157306828|FG000|Overall Study|Not Randomized|0|||
48854633|NCT03735849|157306829|FG001|Overall Study|Not Randomized|0|||
48854634|NCT03735849|157306830|FG002|Overall Study|Not Randomized|4|||
48854635|NCT00022672|157306831|FG000|Main Phase: 24 Months|Adverse Event|6|||
48854636|NCT00022672|157306832|FG001|Main Phase: 24 Months|Adverse Event|0|||
48854637|NCT00022672|157306831|FG000|Main Phase: 24 Months|Death|0|||
48854638|NCT00022672|157306832|FG001|Main Phase: 24 Months|Death|3|||
48854639|NCT00022672|157306831|FG000|Main Phase: 24 Months|Insufficient Therapeutic Response|75|||
48854640|NCT00022672|157306832|FG001|Main Phase: 24 Months|Insufficient Therapeutic Response|91|||
48854641|NCT00022672|157306831|FG000|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0|||
48854642|NCT00022672|157306832|FG001|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1|||
48854643|NCT00022672|157306831|FG000|Main Phase: 24 Months|Other Protocol Violation|1|||
48854644|NCT00022672|157306832|FG001|Main Phase: 24 Months|Other Protocol Violation|0|||
48854645|NCT00022672|157306831|FG000|Main Phase: 24 Months|Refused Treatment|3|||
48854646|NCT00022672|157306832|FG001|Main Phase: 24 Months|Refused Treatment|4|||
48854647|NCT00022672|157306831|FG000|Main Phase: 24 Months|Failure to Return|1|||
48854648|NCT00022672|157306832|FG001|Main Phase: 24 Months|Failure to Return|1|||
48854649|NCT00022672|157306831|FG000|Main Phase: 24 Months|Other|1|||
48854650|NCT00022672|157306832|FG001|Main Phase: 24 Months|Other|0|||
48854651|NCT00022672|157306831|FG000|Extension Phase|Adverse Event|1|||
48854652|NCT00022672|157306832|FG001|Extension Phase|Adverse Event|3|||
48854653|NCT00022672|157306831|FG000|Extension Phase|Death|0|||
48854654|NCT00022672|157306832|FG001|Extension Phase|Death|1|||
48854655|NCT00022672|157306831|FG000|Extension Phase|Insufficient Therapeutic Response|1|||
48854656|NCT00022672|157306832|FG001|Extension Phase|Insufficient Therapeutic Response|44|||
48854657|NCT00022672|157306831|FG000|Extension Phase|Refused Treatment|0|||
48854658|NCT00022672|157306832|FG001|Extension Phase|Refused Treatment|2|||
48854659|NCT00022672|157306831|FG000|Extension Phase|Other|1|||
48854660|NCT00022672|157306832|FG001|Extension Phase|Other|1|||
48854661|NCT02958553|157306833|FG000|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1|||
48854662|NCT02958553|157306833|FG000|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2|||
48854663|NCT03340961|157306834|FG000|Overall Study|Adverse Event|1|||
48854664|NCT03340961|157306835|FG001|Overall Study|Adverse Event|3|||
48854665|NCT03340961|157306836|FG002|Overall Study|Adverse Event|2|||
48854666|NCT03340961|157306837|FG003|Overall Study|Adverse Event|4|||
48854667|NCT03340961|157306834|FG000|Overall Study|Lost to Follow-up|0|||
48854668|NCT03340961|157306835|FG001|Overall Study|Lost to Follow-up|1|||
48854669|NCT03340961|157306836|FG002|Overall Study|Lost to Follow-up|0|||
48854670|NCT03340961|157306837|FG003|Overall Study|Lost to Follow-up|1|||
48854671|NCT03340961|157306834|FG000|Overall Study|Withdrawal by Subject|3|||
48854672|NCT03340961|157306835|FG001|Overall Study|Withdrawal by Subject|2|||
48854673|NCT03340961|157306836|FG002|Overall Study|Withdrawal by Subject|4|||
48854674|NCT03340961|157306837|FG003|Overall Study|Withdrawal by Subject|7|||
48854675|NCT03340961|157306834|FG000|Overall Study|Use of prohibited treatment|0|||
48854676|NCT03340961|157306835|FG001|Overall Study|Use of prohibited treatment|3|||
48854677|NCT03340961|157306836|FG002|Overall Study|Use of prohibited treatment|2|||
48854678|NCT03340961|157306837|FG003|Overall Study|Use of prohibited treatment|4|||
48950023|NCT03238248|157647085|FG000|Overall Study|N/A participant is still on treatment|1|||
48740779|NCT00005044|156900214|FG001|Overall Study|Withdrawal by Subject|5|||
48740780|NCT00005044|156900213|FG000|Overall Study|No protocol treatment|0|||
48740781|NCT00005044|156900214|FG001|Overall Study|No protocol treatment|1|||
48740782|NCT00843856|156900215|FG000|Overall Study|Lost to Follow-up|1|||
48740783|NCT00843856|156900216|FG001|Overall Study|Lost to Follow-up|2|||
48740784|NCT02059408|156900235|FG000|Overall Study|Did not get tested|0|||
48950024|NCT03238248|157647085|FG000|Overall Study|Decline in condition|1|||
48740785|NCT02059408|156900236|FG001|Overall Study|Did not get tested|330|||
48740786|NCT02059408|156900237|FG002|Overall Study|Did not get tested|358|||
48740787|NCT00259610|156900238|FG000|Overall Study|Withdrawal by Subject|33|||
48740788|NCT00259610|156900239|FG001|Overall Study|Withdrawal by Subject|25|||
48740789|NCT00259610|156900240|FG002|Overall Study|Withdrawal by Subject|29|||
48854679|NCT03340961|157306834|FG000|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
48854680|NCT03340961|157306835|FG001|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
48854681|NCT03340961|157306836|FG002|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
48950025|NCT03238248|157647085|FG000|Overall Study|Alternative therapy|2|||
48950026|NCT01062399|157647087|FG000|Overall Study|Protocol Violation|0|||
48740790|NCT00259610|156900241|FG003|Overall Study|Withdrawal by Subject|19|||
48740791|NCT00259610|156900238|FG000|Overall Study|Lost to Follow-up|19|||
48740792|NCT00259610|156900239|FG001|Overall Study|Lost to Follow-up|8|||
48740793|NCT00259610|156900240|FG002|Overall Study|Lost to Follow-up|18|||
48740794|NCT00259610|156900241|FG003|Overall Study|Lost to Follow-up|15|||
48854682|NCT03340961|157306837|FG003|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
48740795|NCT00259610|156900238|FG000|Overall Study|Physician Decision|6|||
48740796|NCT00259610|156900239|FG001|Overall Study|Physician Decision|4|||
48740797|NCT00259610|156900240|FG002|Overall Study|Physician Decision|7|||
48740798|NCT00259610|156900241|FG003|Overall Study|Physician Decision|2|||
48740799|NCT00259610|156900238|FG000|Overall Study|Death|1|||
48740800|NCT00259610|156900239|FG001|Overall Study|Death|1|||
48740801|NCT00259610|156900240|FG002|Overall Study|Death|2|||
48740802|NCT00259610|156900241|FG003|Overall Study|Death|0|||
48740803|NCT00259610|156900238|FG000|Overall Study|non medical reason|6|||
48740804|NCT00259610|156900239|FG001|Overall Study|non medical reason|2|||
48740805|NCT00259610|156900240|FG002|Overall Study|non medical reason|10|||
48740806|NCT00259610|156900241|FG003|Overall Study|non medical reason|3|||
48740807|NCT00259610|156900238|FG000|Overall Study|Adverse Event|3|||
48740808|NCT00259610|156900239|FG001|Overall Study|Adverse Event|4|||
48740809|NCT00259610|156900240|FG002|Overall Study|Adverse Event|5|||
48740810|NCT00259610|156900241|FG003|Overall Study|Adverse Event|2|||
48740811|NCT00259610|156900238|FG000|Overall Study|Serious Adverse Event|8|||
48740812|NCT00259610|156900239|FG001|Overall Study|Serious Adverse Event|2|||
48740813|NCT00259610|156900240|FG002|Overall Study|Serious Adverse Event|2|||
48740814|NCT00259610|156900241|FG003|Overall Study|Serious Adverse Event|2|||
48740815|NCT01090492|156900242|FG000|First Intervention Period (4 Weeks)|Protocol Violation|1|||
48740816|NCT01090492|156900243|FG001|First Intervention Period (4 Weeks)|Protocol Violation|1|||
48740817|NCT01090492|156900244|FG002|First Intervention Period (4 Weeks)|Protocol Violation|1|||
48740818|NCT01090492|156900245|FG003|First Intervention Period (4 Weeks)|Protocol Violation|2|||
48740819|NCT01090492|156900246|FG004|First Intervention Period (4 Weeks)|Protocol Violation|0|||
48740820|NCT01090492|156900247|FG005|First Intervention Period (4 Weeks)|Protocol Violation|0|||
48854683|NCT03340961|157306834|FG000|Overall Study|Subject developed an exclusion criterion|0|||
48740821|NCT01090492|156900248|FG006|First Intervention Period (4 Weeks)|Protocol Violation|1|||
48740822|NCT01090492|156900249|FG007|First Intervention Period (4 Weeks)|Protocol Violation|0|||
48740823|NCT01090492|156900242|FG000|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
48740824|NCT01090492|156900243|FG001|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2|||
48740825|NCT01090492|156900244|FG002|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
48740826|NCT01090492|156900245|FG003|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
48740827|NCT01090492|156900246|FG004|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
48740828|NCT01090492|156900247|FG005|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
48740829|NCT01090492|156900248|FG006|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
48740830|NCT01090492|156900249|FG007|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1|||
48740831|NCT01090492|156900242|FG000|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
48740832|NCT01090492|156900243|FG001|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
48740833|NCT01090492|156900244|FG002|First Intervention Period (4 Weeks)|Lost to Follow-up|1|||
48740834|NCT01090492|156900245|FG003|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
48740835|NCT01090492|156900246|FG004|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
48740836|NCT01090492|156900247|FG005|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
48740837|NCT01090492|156900248|FG006|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
48740838|NCT01090492|156900249|FG007|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
48740839|NCT01090492|156900242|FG000|First Intervention Period (4 Weeks)|Other|0|||
48740840|NCT01090492|156900243|FG001|First Intervention Period (4 Weeks)|Other|0|||
48740841|NCT01090492|156900244|FG002|First Intervention Period (4 Weeks)|Other|1|||
48740842|NCT01090492|156900245|FG003|First Intervention Period (4 Weeks)|Other|1|||
48740843|NCT01090492|156900246|FG004|First Intervention Period (4 Weeks)|Other|2|||
48740844|NCT01090492|156900247|FG005|First Intervention Period (4 Weeks)|Other|0|||
48740845|NCT01090492|156900248|FG006|First Intervention Period (4 Weeks)|Other|0|||
48740846|NCT01090492|156900249|FG007|First Intervention Period (4 Weeks)|Other|0|||
48798063|NCT00677352|157098541|FG001|Tapering Phase|Adverse Event|5|||
48740847|NCT01090492|156900242|FG000|First Intervention Period (4 Weeks)|Pregnancy|0|||
48740848|NCT01090492|156900243|FG001|First Intervention Period (4 Weeks)|Pregnancy|0|||
48740849|NCT01090492|156900244|FG002|First Intervention Period (4 Weeks)|Pregnancy|0|||
48740850|NCT01090492|156900245|FG003|First Intervention Period (4 Weeks)|Pregnancy|0|||
48740851|NCT01090492|156900246|FG004|First Intervention Period (4 Weeks)|Pregnancy|1|||
48740852|NCT01090492|156900247|FG005|First Intervention Period (4 Weeks)|Pregnancy|0|||
48950027|NCT01062399|157647088|FG001|Overall Study|Protocol Violation|1|||
48740853|NCT01090492|156900248|FG006|First Intervention Period (4 Weeks)|Pregnancy|0|||
48950028|NCT01062399|157647089|FG002|Overall Study|Protocol Violation|0|||
48740854|NCT01090492|156900249|FG007|First Intervention Period (4 Weeks)|Pregnancy|0|||
48950029|NCT01062399|157647090|FG003|Overall Study|Protocol Violation|6|||
48950030|NCT01062399|157647091|FG004|Overall Study|Protocol Violation|4|||
48950031|NCT01978912|157647097|FG000|Overall Study|Adverse Event|0|||
48950032|NCT01978912|157647098|FG001|Overall Study|Adverse Event|1|||
48950033|NCT01978912|157647099|FG002|Overall Study|Adverse Event|0|||
48950034|NCT01978912|157647100|FG003|Overall Study|Adverse Event|0|||
48950035|NCT01978912|157647097|FG000|Overall Study|Lost to Follow-up|1|||
48950036|NCT01978912|157647098|FG001|Overall Study|Lost to Follow-up|1|||
48950037|NCT01978912|157647099|FG002|Overall Study|Lost to Follow-up|0|||
48950038|NCT01978912|157647100|FG003|Overall Study|Lost to Follow-up|1|||
48950039|NCT01978912|157647097|FG000|Overall Study|Withdrawal by Subject|1|||
48950040|NCT01978912|157647098|FG001|Overall Study|Withdrawal by Subject|0|||
48950041|NCT01978912|157647099|FG002|Overall Study|Withdrawal by Subject|2|||
48740855|NCT01090492|156900242|FG000|First Intervention Period (4 Weeks)|Adverse Event|0|||
48740856|NCT01090492|156900243|FG001|First Intervention Period (4 Weeks)|Adverse Event|2|||
48740857|NCT01090492|156900244|FG002|First Intervention Period (4 Weeks)|Adverse Event|0|||
48740858|NCT01090492|156900245|FG003|First Intervention Period (4 Weeks)|Adverse Event|3|||
48740859|NCT01090492|156900246|FG004|First Intervention Period (4 Weeks)|Adverse Event|1|||
48740860|NCT01090492|156900247|FG005|First Intervention Period (4 Weeks)|Adverse Event|2|||
48740861|NCT01090492|156900248|FG006|First Intervention Period (4 Weeks)|Adverse Event|0|||
48740862|NCT01090492|156900249|FG007|First Intervention Period (4 Weeks)|Adverse Event|5|||
48740863|NCT01090492|156900242|FG000|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
48854684|NCT03340961|157306835|FG001|Overall Study|Subject developed an exclusion criterion|1|||
48740864|NCT01090492|156900243|FG001|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
48740865|NCT01090492|156900244|FG002|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
48740866|NCT01090492|156900245|FG003|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
48740867|NCT01090492|156900246|FG004|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
48740868|NCT01090492|156900247|FG005|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
48740869|NCT01090492|156900248|FG006|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
48740870|NCT01090492|156900249|FG007|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
48740871|NCT01090492|156900242|FG000|Second Intervention Period (4 Weeks)|Non-compliance|0|||
48740872|NCT01090492|156900243|FG001|Second Intervention Period (4 Weeks)|Non-compliance|1|||
48740873|NCT01090492|156900244|FG002|Second Intervention Period (4 Weeks)|Non-compliance|0|||
48740874|NCT01090492|156900245|FG003|Second Intervention Period (4 Weeks)|Non-compliance|0|||
48740875|NCT01090492|156900246|FG004|Second Intervention Period (4 Weeks)|Non-compliance|0|||
48740876|NCT01090492|156900247|FG005|Second Intervention Period (4 Weeks)|Non-compliance|0|||
48740877|NCT01090492|156900248|FG006|Second Intervention Period (4 Weeks)|Non-compliance|0|||
48740878|NCT01090492|156900249|FG007|Second Intervention Period (4 Weeks)|Non-compliance|0|||
48740879|NCT01090492|156900242|FG000|Second Intervention Period (4 Weeks)|Other|0|||
48740880|NCT01090492|156900243|FG001|Second Intervention Period (4 Weeks)|Other|1|||
48740881|NCT01090492|156900244|FG002|Second Intervention Period (4 Weeks)|Other|1|||
48740882|NCT01090492|156900245|FG003|Second Intervention Period (4 Weeks)|Other|0|||
48740883|NCT01090492|156900246|FG004|Second Intervention Period (4 Weeks)|Other|0|||
48740884|NCT01090492|156900247|FG005|Second Intervention Period (4 Weeks)|Other|0|||
48740885|NCT01090492|156900248|FG006|Second Intervention Period (4 Weeks)|Other|0|||
48740886|NCT01090492|156900249|FG007|Second Intervention Period (4 Weeks)|Other|0|||
48740887|NCT01090492|156900242|FG000|Second Intervention Period (4 Weeks)|Adverse Event|0|||
48740888|NCT01090492|156900243|FG001|Second Intervention Period (4 Weeks)|Adverse Event|0|||
48854685|NCT03340961|157306836|FG002|Overall Study|Subject developed an exclusion criterion|0|||
48854686|NCT03340961|157306837|FG003|Overall Study|Subject developed an exclusion criterion|0|||
48740889|NCT01090492|156900244|FG002|Second Intervention Period (4 Weeks)|Adverse Event|1|||
48740890|NCT01090492|156900245|FG003|Second Intervention Period (4 Weeks)|Adverse Event|0|||
48740891|NCT01090492|156900246|FG004|Second Intervention Period (4 Weeks)|Adverse Event|1|||
48740892|NCT01090492|156900247|FG005|Second Intervention Period (4 Weeks)|Adverse Event|1|||
48854687|NCT03340961|157306834|FG000|Overall Study|Protocol Violation|1|||
48854688|NCT03340961|157306835|FG001|Overall Study|Protocol Violation|0|||
48740893|NCT01090492|156900248|FG006|Second Intervention Period (4 Weeks)|Adverse Event|7|||
48740894|NCT01090492|156900249|FG007|Second Intervention Period (4 Weeks)|Adverse Event|1|||
48854689|NCT03340961|157306836|FG002|Overall Study|Protocol Violation|1|||
48740895|NCT01090492|156900242|FG000|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
48740896|NCT01090492|156900243|FG001|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
48740897|NCT01090492|156900244|FG002|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
48740898|NCT01090492|156900245|FG003|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
48740899|NCT01090492|156900246|FG004|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
48740900|NCT01090492|156900247|FG005|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
48740901|NCT01090492|156900248|FG006|Second Intervention Period (4 Weeks)|Lost to Follow-up|1|||
48740902|NCT01090492|156900249|FG007|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
48740903|NCT00945893|156900250|FG000|Overall Study|Lost to Follow-up|2|||
48740904|NCT00945893|156900251|FG001|Overall Study|Lost to Follow-up|8|||
48740905|NCT00945893|156900250|FG000|Overall Study|Withdrawal of consent|1|||
48740906|NCT00945893|156900251|FG001|Overall Study|Withdrawal of consent|2|||
48740907|NCT01768286|156900252|FG000|Overall Study|Randomized But Not Treated|0|||
48740908|NCT01768286|156900253|FG001|Overall Study|Randomized But Not Treated|0|||
48740909|NCT01768286|156900254|FG002|Overall Study|Randomized But Not Treated|1|||
48740910|NCT01768286|156900255|FG003|Overall Study|Randomized But Not Treated|0|||
48740911|NCT01768286|156900252|FG000|Overall Study|Lack of Efficacy|7|||
48740912|NCT01768286|156900253|FG001|Overall Study|Lack of Efficacy|4|||
48740913|NCT01768286|156900254|FG002|Overall Study|Lack of Efficacy|0|||
48740914|NCT01768286|156900255|FG003|Overall Study|Lack of Efficacy|1|||
48740915|NCT01768286|156900252|FG000|Overall Study|Withdrew Consent|0|||
48740916|NCT01768286|156900253|FG001|Overall Study|Withdrew Consent|0|||
48740917|NCT01768286|156900254|FG002|Overall Study|Withdrew Consent|1|||
48740918|NCT01768286|156900255|FG003|Overall Study|Withdrew Consent|0|||
48740919|NCT02004522|156900258|FG000|Overall Study|Adverse Event|55|||
48854690|NCT03340961|157306837|FG003|Overall Study|Protocol Violation|0|||
48854691|NCT03340961|157306834|FG000|Overall Study|Adverse Event|1|||
48854692|NCT03340961|157306835|FG001|Overall Study|Adverse Event|1|||
48854693|NCT03340961|157306836|FG002|Overall Study|Adverse Event|0|||
48854694|NCT03340961|157306837|FG003|Overall Study|Adverse Event|0|||
48854695|NCT03340961|157306834|FG000|Overall Study|Lack of Efficacy|0|||
48854696|NCT03340961|157306835|FG001|Overall Study|Lack of Efficacy|0|||
48740920|NCT02004522|156900259|FG001|Overall Study|Adverse Event|6|||
48740921|NCT02004522|156900258|FG000|Overall Study|Withdrawal by Subject|13|||
48740922|NCT02004522|156900259|FG001|Overall Study|Withdrawal by Subject|7|||
48740923|NCT02004522|156900258|FG000|Overall Study|Death|12|||
48740924|NCT02004522|156900259|FG001|Overall Study|Death|3|||
48740925|NCT02004522|156900258|FG000|Overall Study|Physician Decision|3|||
48740926|NCT02004522|156900259|FG001|Overall Study|Physician Decision|4|||
48854697|NCT03340961|157306836|FG002|Overall Study|Lack of Efficacy|0|||
48854698|NCT03340961|157306837|FG003|Overall Study|Lack of Efficacy|1|||
48740927|NCT02004522|156900258|FG000|Overall Study|Protocol Violation|1|||
48740928|NCT02004522|156900259|FG001|Overall Study|Protocol Violation|0|||
48740929|NCT02004522|156900258|FG000|Overall Study|Other is reason listed by PI|4|||
48740930|NCT02004522|156900259|FG001|Overall Study|Other is reason listed by PI|1|||
48740931|NCT02004522|156900258|FG000|Overall Study|Never Dosed|2|||
48740932|NCT02004522|156900259|FG001|Overall Study|Never Dosed|4|||
48740933|NCT02004522|156900258|FG000|Overall Study|Disease Progression|35|||
48740934|NCT02004522|156900259|FG001|Overall Study|Disease Progression|31|||
48740935|NCT02004522|156900258|FG000|Overall Study|Completed Treatment Cycles Per Protocol|1|||
48740936|NCT02004522|156900259|FG001|Overall Study|Completed Treatment Cycles Per Protocol|103|||
48740937|NCT04502433|156900260|FG000|Overall Study|Death|2|||
48740938|NCT04502433|156900261|FG001|Overall Study|Death|4|||
48740939|NCT04502433|156900260|FG000|Overall Study|Lost to Follow-up|1|||
48740940|NCT04502433|156900261|FG001|Overall Study|Lost to Follow-up|0|||
48740941|NCT04502433|156900260|FG000|Overall Study|Physician Decision|0|||
48740942|NCT04502433|156900261|FG001|Overall Study|Physician Decision|1|||
48740943|NCT02252172|156900262|FG000|Overall Study|Lost to Follow-up|3|||
48740944|NCT02252172|156900263|FG001|Overall Study|Lost to Follow-up|1|||
48740945|NCT02252172|156900262|FG000|Overall Study|Ongoing|276|||
48740946|NCT02252172|156900263|FG001|Overall Study|Ongoing|298|||
48740947|NCT00674362|156900265|FG000|Double Blind|Adverse Event|6|||
48740948|NCT00674362|156900266|FG001|Double Blind|Adverse Event|6|||
48740949|NCT00674362|156900265|FG000|Double Blind|Lack of Efficacy|2|||
48740950|NCT00674362|156900266|FG001|Double Blind|Lack of Efficacy|6|||
48740951|NCT00674362|156900265|FG000|Double Blind|Loss of efficacy|0|||
48740952|NCT00674362|156900266|FG001|Double Blind|Loss of efficacy|1|||
48740953|NCT00674362|156900265|FG000|Double Blind|Withdrawal by Subject|4|||
48740954|NCT00674362|156900266|FG001|Double Blind|Withdrawal by Subject|3|||
48740955|NCT00674362|156900265|FG000|Double Blind|Other: Loss of Patient Compliance|0|||
48740956|NCT00674362|156900266|FG001|Double Blind|Other: Loss of Patient Compliance|1|||
48740957|NCT00674362|156900265|FG000|Double Blind|Other: Surgery|0|||
48740958|NCT00674362|156900266|FG001|Double Blind|Other: Surgery|1|||
48740959|NCT00674362|156900265|FG000|Open Label|Adverse Event|1|||
48740960|NCT00674362|156900266|FG001|Open Label|Adverse Event|0|||
48740961|NCT00674362|156900265|FG000|Open Label|Other: Subject moved to extension study|1|||
48740962|NCT00674362|156900266|FG001|Open Label|Other: Subject moved to extension study|0|||
48740963|NCT00594659|156900268|FG000|Overall Study|Lost to Follow-up|13|||
48740964|NCT00594659|156900269|FG001|Overall Study|Lost to Follow-up|9|||
48740965|NCT00594659|156900270|FG002|Overall Study|Lost to Follow-up|7|||
48740966|NCT04865289|156900271|FG000|Overall Study|Participant ongoing in study|47|||
48740967|NCT04865289|156900272|FG001|Overall Study|Participant ongoing in study|35|||
48740968|NCT04865289|156900271|FG000|Overall Study|Death|27|||
48740969|NCT04865289|156900272|FG001|Overall Study|Death|21|||
48740970|NCT02302807|156900273|FG000|Overall Study|Withdrawal by Subject|28|||
48740971|NCT02302807|156900274|FG001|Overall Study|Withdrawal by Subject|11|||
48740972|NCT02302807|156900273|FG000|Overall Study|Lost to Follow-up|4|||
48740973|NCT02302807|156900274|FG001|Overall Study|Lost to Follow-up|6|||
48740974|NCT02302807|156900273|FG000|Overall Study|Death|397|||
48740975|NCT02302807|156900274|FG001|Overall Study|Death|385|||
48740976|NCT02302807|156900273|FG000|Overall Study|Study Terminated By Sponsor|35|||
48740977|NCT02302807|156900274|FG001|Overall Study|Study Terminated By Sponsor|64|||
48740978|NCT02302807|156900273|FG000|Overall Study|Physician Decision|0|||
48740979|NCT02302807|156900274|FG001|Overall Study|Physician Decision|1|||
48740980|NCT03056573|156900275|FG000|Overall Study|Death|2|||
48740981|NCT03056573|156900276|FG001|Overall Study|Death|4|||
48740982|NCT03056573|156900275|FG000|Overall Study|Withdrawal by Subject|2|||
48740983|NCT03056573|156900276|FG001|Overall Study|Withdrawal by Subject|0|||
48740984|NCT03056573|156900275|FG000|Overall Study|Lost to Follow-up|1|||
48740985|NCT03056573|156900276|FG001|Overall Study|Lost to Follow-up|1|||
48740986|NCT05601544|156900277|FG000|Phase 2 Period 1|Adverse Event|0|||
48740987|NCT05601544|156900278|FG001|Phase 2 Period 1|Adverse Event|1|||
48740988|NCT05601544|156900279|FG002|Phase 2 Period 1|Adverse Event|0|||
48740989|NCT05601544|156900280|FG003|Phase 2 Period 1|Adverse Event|0|||
48740990|NCT05601544|156900281|FG004|Phase 2 Period 1|Adverse Event|0|||
48740991|NCT05601544|156900282|FG005|Phase 2 Period 1|Adverse Event|0|||
48740992|NCT01892722|156900283|FG000|Overall Study|Protocol deviation|0|||
48740993|NCT01892722|156900284|FG001|Overall Study|Protocol deviation|1|||
48740994|NCT01892722|156900283|FG000|Overall Study|Administrative problems|0|||
48950042|NCT01978912|157647100|FG003|Overall Study|Withdrawal by Subject|2|||
48950043|NCT01978912|157647097|FG000|Overall Study|Lumbar Surgery|1|||
48740995|NCT01892722|156900284|FG001|Overall Study|Administrative problems|1|||
48950044|NCT01978912|157647098|FG001|Overall Study|Lumbar Surgery|0|||
48950045|NCT01978912|157647099|FG002|Overall Study|Lumbar Surgery|1|||
48950046|NCT01978912|157647100|FG003|Overall Study|Lumbar Surgery|0|||
48950047|NCT01978912|157647097|FG000|Overall Study|Intradiscal Steroid Injection|0|||
48950048|NCT01978912|157647098|FG001|Overall Study|Intradiscal Steroid Injection|1|||
48950049|NCT01978912|157647099|FG002|Overall Study|Intradiscal Steroid Injection|0|||
48950050|NCT01978912|157647100|FG003|Overall Study|Intradiscal Steroid Injection|0|||
48950051|NCT00224107|157647107|FG000|Overall Study|Adverse Event|20|||
48950052|NCT00224107|157647108|FG001|Overall Study|Adverse Event|6|||
48950053|NCT00224107|157647107|FG000|Overall Study|Protocol Violation|2|||
48950054|NCT00224107|157647108|FG001|Overall Study|Protocol Violation|3|||
48740996|NCT01892722|156900283|FG000|Overall Study|Patient/guardian decision|0|||
48740997|NCT01892722|156900284|FG001|Overall Study|Patient/guardian decision|2|||
48740998|NCT01892722|156900283|FG000|Overall Study|Physician Decision|1|||
48950055|NCT00224107|157647107|FG000|Overall Study|Withdrawal by Subject|1|||
48950056|NCT00224107|157647108|FG001|Overall Study|Withdrawal by Subject|4|||
48740999|NCT01892722|156900284|FG001|Overall Study|Physician Decision|2|||
48741000|NCT01892722|156900283|FG000|Overall Study|Adverse Event|3|||
48741001|NCT01892722|156900284|FG001|Overall Study|Adverse Event|2|||
48741002|NCT01892722|156900283|FG000|Overall Study|Lack of Efficacy|0|||
48741003|NCT01892722|156900284|FG001|Overall Study|Lack of Efficacy|7|||
48741004|NCT01892722|156900283|FG000|Overall Study|Withdrawal by Subject|3|||
48741005|NCT01892722|156900284|FG001|Overall Study|Withdrawal by Subject|5|||
48741006|NCT01199133|156900285|FG000|Year 1|Adverse Event|16|||
48741007|NCT01199133|156900286|FG001|Year 1|Adverse Event|4|||
48741008|NCT01199133|156900285|FG000|Year 1|Withdrawal by Subject|8|||
48741009|NCT01199133|156900286|FG001|Year 1|Withdrawal by Subject|4|||
48741010|NCT01199133|156900285|FG000|Year 1|Any other reason not above-mentioned|6|||
48741011|NCT01199133|156900286|FG001|Year 1|Any other reason not above-mentioned|7|||
48741012|NCT01199133|156900285|FG000|Year 2|Adverse Event|1|||
48854699|NCT01951703|157306841|FG000|First Intervention|Withdrawal by Subject|1|||
48854700|NCT01951703|157306842|FG001|First Intervention|Withdrawal by Subject|0|||
48741013|NCT01199133|156900286|FG001|Year 2|Adverse Event|0|||
48854701|NCT01951703|157306841|FG000|First Intervention|Subject was not compliant|1|||
48854702|NCT01951703|157306842|FG001|First Intervention|Subject was not compliant|1|||
48854703|NCT01951703|157306841|FG000|First Intervention|Physician Decision|1|||
48854704|NCT01951703|157306842|FG001|First Intervention|Physician Decision|0|||
48854705|NCT01951703|157306841|FG000|Second Intervention|Protocol Violation|0|||
48854706|NCT01951703|157306842|FG001|Second Intervention|Protocol Violation|1|||
48854707|NCT01951703|157306841|FG000|Second Intervention|Unsatisfactory Lens fitting|0|||
48854708|NCT01951703|157306842|FG001|Second Intervention|Unsatisfactory Lens fitting|1|||
48854709|NCT01852045|157306843|FG000|Overall Study|Adverse Event|1|||
48854710|NCT01852045|157306844|FG001|Overall Study|Adverse Event|0|||
48854711|NCT01852045|157306845|FG002|Overall Study|Adverse Event|0|||
48854712|NCT01852045|157306843|FG000|Overall Study|Lack of Efficacy|3|||
48854713|NCT01852045|157306844|FG001|Overall Study|Lack of Efficacy|0|||
48854714|NCT01852045|157306845|FG002|Overall Study|Lack of Efficacy|0|||
48854715|NCT01852045|157306843|FG000|Overall Study|Lost to Follow-up|0|||
48854716|NCT01852045|157306844|FG001|Overall Study|Lost to Follow-up|1|||
48854717|NCT01852045|157306845|FG002|Overall Study|Lost to Follow-up|1|||
48854718|NCT01852045|157306843|FG000|Overall Study|Withdrawal by Subject|1|||
48854719|NCT01852045|157306844|FG001|Overall Study|Withdrawal by Subject|0|||
48854720|NCT01852045|157306845|FG002|Overall Study|Withdrawal by Subject|1|||
48854721|NCT01852045|157306843|FG000|Overall Study|Other Miscellaneous Reasons|1|||
48854722|NCT01852045|157306844|FG001|Overall Study|Other Miscellaneous Reasons|3|||
48854723|NCT01852045|157306845|FG002|Overall Study|Other Miscellaneous Reasons|2|||
48854724|NCT00620854|157306846|FG000|Washout 1|Withdrawal by Subject|0|||
48854725|NCT00620854|157306847|FG001|Washout 1|Withdrawal by Subject|0|||
48854726|NCT00620854|157306848|FG002|Washout 1|Withdrawal by Subject|1|||
48854727|NCT00620854|157306849|FG003|Washout 1|Withdrawal by Subject|1|||
48854728|NCT00620854|157306850|FG004|Washout 1|Withdrawal by Subject|0|||
48854729|NCT00620854|157306851|FG005|Washout 1|Withdrawal by Subject|0|||
48854730|NCT03137784|157306852|FG000|Overall Study|Adverse Event|1|||
48854731|NCT03137784|157306853|FG001|Overall Study|Adverse Event|1|||
48854732|NCT03137784|157306854|FG002|Overall Study|Adverse Event|0|||
48854733|NCT03137784|157306855|FG003|Overall Study|Adverse Event|0|||
48854734|NCT03137784|157306856|FG004|Overall Study|Adverse Event|0|||
48854735|NCT03137784|157306857|FG005|Overall Study|Adverse Event|0|||
48854736|NCT03137784|157306852|FG000|Overall Study|Subject/guardian decision|1|||
48854737|NCT03137784|157306853|FG001|Overall Study|Subject/guardian decision|0|||
48854738|NCT03137784|157306854|FG002|Overall Study|Subject/guardian decision|0|||
48854739|NCT03137784|157306855|FG003|Overall Study|Subject/guardian decision|0|||
48854740|NCT03137784|157306856|FG004|Overall Study|Subject/guardian decision|0|||
48854741|NCT03137784|157306857|FG005|Overall Study|Subject/guardian decision|0|||
48854742|NCT03137784|157306852|FG000|Overall Study|Non-compliance with study treatment|0|||
48741014|NCT01199133|156900285|FG000|Year 2|Withdrawal by Subject|1|||
48741015|NCT01199133|156900286|FG001|Year 2|Withdrawal by Subject|1|||
48741016|NCT01199133|156900285|FG000|Year 2|Any other reason not above-mentioned|1|||
48854743|NCT03137784|157306853|FG001|Overall Study|Non-compliance with study treatment|0|||
48854744|NCT03137784|157306854|FG002|Overall Study|Non-compliance with study treatment|0|||
48854745|NCT03137784|157306855|FG003|Overall Study|Non-compliance with study treatment|0|||
48854746|NCT03137784|157306856|FG004|Overall Study|Non-compliance with study treatment|1|||
48854747|NCT03137784|157306857|FG005|Overall Study|Non-compliance with study treatment|0|||
48741017|NCT01199133|156900286|FG001|Year 2|Any other reason not above-mentioned|2|||
48741018|NCT03742258|156900287|FG000|Continued Treatment After 1st Response|Adverse Event|0|||
48741019|NCT03742258|156900288|FG001|Continued Treatment After 1st Response|Adverse Event|1|||
48741020|NCT03742258|156900289|FG002|Continued Treatment After 1st Response|Adverse Event|1|||
48741021|NCT03742258|156900287|FG000|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
48741022|NCT03742258|156900288|FG001|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
48741023|NCT03742258|156900289|FG002|Continued Treatment After 1st Response|Withdrawal by Subject|1|||
48741024|NCT03742258|156900287|FG000|Survival Follow-Up|Still in Follow-up|0|||
48741025|NCT03742258|156900288|FG001|Survival Follow-Up|Still in Follow-up|0|||
48950057|NCT00224107|157647107|FG000|Overall Study|Lack of Efficacy|2|||
48950058|NCT00224107|157647108|FG001|Overall Study|Lack of Efficacy|0|||
48950059|NCT00224107|157647107|FG000|Overall Study|Lost to Follow-up|4|||
48950060|NCT00224107|157647108|FG001|Overall Study|Lost to Follow-up|0|||
48950061|NCT00224107|157647107|FG000|Overall Study|Physician Decision|1|||
48950062|NCT00224107|157647108|FG001|Overall Study|Physician Decision|0|||
48950063|NCT00224107|157647107|FG000|Overall Study|Other|1|||
48950064|NCT00224107|157647108|FG001|Overall Study|Other|1|||
48950065|NCT02225223|157647119|FG000|Overall Study|Death|10|||
48950066|NCT02225223|157647120|FG001|Overall Study|Death|1|||
48950067|NCT02225223|157647119|FG000|Overall Study|Lost to Follow-up|5|||
48950068|NCT02225223|157647120|FG001|Overall Study|Lost to Follow-up|0|||
48950069|NCT02225223|157647119|FG000|Overall Study|Other|1|||
48950070|NCT02225223|157647120|FG001|Overall Study|Other|2|||
48950071|NCT02225223|157647119|FG000|Overall Study|Physician Decision|1|||
48950072|NCT02225223|157647120|FG001|Overall Study|Physician Decision|0|||
48950073|NCT02225223|157647119|FG000|Overall Study|Withdrawal by Subject|2|||
48950074|NCT02225223|157647120|FG001|Overall Study|Withdrawal by Subject|2|||
48950075|NCT04329923|157647125|FG000|Overall Study|Withdrawal by Subject|1|||
48950076|NCT04329923|157647126|FG001|Overall Study|Withdrawal by Subject|4|||
48950077|NCT04329923|157647127|FG002|Overall Study|Withdrawal by Subject|1|||
48950078|NCT04329923|157647128|FG003|Overall Study|Withdrawal by Subject|1|||
48950079|NCT04329923|157647129|FG004|Overall Study|Withdrawal by Subject|1|||
48950080|NCT04329923|157647130|FG005|Overall Study|Withdrawal by Subject|1|||
48950081|NCT04329923|157647125|FG000|Overall Study|early termination of study|0|||
48950082|NCT04329923|157647126|FG001|Overall Study|early termination of study|0|||
48950083|NCT04329923|157647127|FG002|Overall Study|early termination of study|0|||
48950084|NCT04329923|157647128|FG003|Overall Study|early termination of study|0|||
48950085|NCT04329923|157647129|FG004|Overall Study|early termination of study|1|||
48950086|NCT04329923|157647130|FG005|Overall Study|early termination of study|2|||
48950087|NCT04329923|157647125|FG000|Overall Study|positive SARS-COV2 PCR at baseline|0|||
48950088|NCT04329923|157647126|FG001|Overall Study|positive SARS-COV2 PCR at baseline|0|||
48950089|NCT04329923|157647127|FG002|Overall Study|positive SARS-COV2 PCR at baseline|0|||
48950090|NCT04329923|157647128|FG003|Overall Study|positive SARS-COV2 PCR at baseline|0|||
48950091|NCT04329923|157647129|FG004|Overall Study|positive SARS-COV2 PCR at baseline|0|||
48950092|NCT04329923|157647130|FG005|Overall Study|positive SARS-COV2 PCR at baseline|2|||
48950093|NCT00984659|157647131|FG000|2-week Run-in Period|Adverse Event|8|||
48950094|NCT00984659|157647132|FG001|2-week Run-in Period|Adverse Event|0|||
48950095|NCT00984659|157647133|FG002|2-week Run-in Period|Adverse Event|0|||
48950096|NCT00984659|157647134|FG003|2-week Run-in Period|Adverse Event|0|||
48950097|NCT00984659|157647131|FG000|2-week Run-in Period|Protocol Violation|5|||
48950098|NCT00984659|157647132|FG001|2-week Run-in Period|Protocol Violation|0|||
48950099|NCT00984659|157647133|FG002|2-week Run-in Period|Protocol Violation|0|||
48950100|NCT00984659|157647134|FG003|2-week Run-in Period|Protocol Violation|0|||
48950101|NCT00984659|157647131|FG000|2-week Run-in Period|Study Closed/Terminated|2|||
48950102|NCT00984659|157647132|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
48741026|NCT03742258|156900289|FG002|Survival Follow-Up|Still in Follow-up|2|||
48741027|NCT04424316|156900292|FG000|Overall Study|Adverse Event|0|||
48741028|NCT04424316|156900293|FG001|Overall Study|Adverse Event|1|||
48741029|NCT04424316|156900294|FG002|Overall Study|Adverse Event|0|||
48741030|NCT04424316|156900295|FG003|Overall Study|Adverse Event|0|||
48741031|NCT04424316|156900292|FG000|Overall Study|Death|1|||
48741032|NCT04424316|156900293|FG001|Overall Study|Death|0|||
48741033|NCT04424316|156900294|FG002|Overall Study|Death|8|||
48741034|NCT04424316|156900295|FG003|Overall Study|Death|14|||
48741035|NCT04424316|156900292|FG000|Overall Study|Lost to Follow-up|93|||
48741036|NCT04424316|156900293|FG001|Overall Study|Lost to Follow-up|88|||
48741037|NCT04424316|156900294|FG002|Overall Study|Lost to Follow-up|224|||
48741038|NCT04424316|156900295|FG003|Overall Study|Lost to Follow-up|211|||
48741039|NCT04424316|156900292|FG000|Overall Study|No longer met eligibility criteria|1|||
48741040|NCT04424316|156900293|FG001|Overall Study|No longer met eligibility criteria|0|||
48741041|NCT04424316|156900294|FG002|Overall Study|No longer met eligibility criteria|0|||
48741042|NCT04424316|156900295|FG003|Overall Study|No longer met eligibility criteria|0|||
48741043|NCT04424316|156900292|FG000|Overall Study|Other|15|||
48854748|NCT01698918|157306862|FG000|First Line Treatment (Core+Extension)|Adverse Event|33|||
48854749|NCT01698918|157306862|FG000|First Line Treatment (Core+Extension)|Withdrawal by Subject|11|||
48854750|NCT01698918|157306862|FG000|First Line Treatment (Core+Extension)|Death|2|||
48854751|NCT01698918|157306862|FG000|First Line Treatment (Core+Extension)|Disease progression|120|||
48854752|NCT01698918|157306862|FG000|First Line Treatment (Core+Extension)|Physician Decision|7|||
48854753|NCT01698918|157306862|FG000|Second Line Treatment (Core+Extension)|Adverse Event|3|||
48854754|NCT01698918|157306862|FG000|Second Line Treatment (Core+Extension)|Withdrawal by Subject|1|||
48854755|NCT01698918|157306862|FG000|Second Line Treatment (Core+Extension)|Death|1|||
48741044|NCT04424316|156900293|FG001|Overall Study|Other|11|||
48854756|NCT01698918|157306862|FG000|Second Line Treatment (Core+Extension)|Disease progression|38|||
48854757|NCT01698918|157306862|FG000|Second Line Treatment (Core+Extension)|Physician Decision|3|||
48854758|NCT03176407|157306864|FG000|Overall Study|Protocol Violation|1|||
48741045|NCT04424316|156900294|FG002|Overall Study|Other|34|||
48741046|NCT04424316|156900295|FG003|Overall Study|Other|45|||
48741047|NCT04424316|156900292|FG000|Overall Study|Physician Decision|1|||
48741048|NCT04424316|156900293|FG001|Overall Study|Physician Decision|0|||
48741049|NCT04424316|156900294|FG002|Overall Study|Physician Decision|1|||
48741050|NCT04424316|156900295|FG003|Overall Study|Physician Decision|1|||
48741051|NCT04424316|156900292|FG000|Overall Study|Protocol Violation|0|||
48741052|NCT04424316|156900293|FG001|Overall Study|Protocol Violation|1|||
48741053|NCT04424316|156900294|FG002|Overall Study|Protocol Violation|0|||
48741054|NCT04424316|156900295|FG003|Overall Study|Protocol Violation|0|||
48741055|NCT04424316|156900292|FG000|Overall Study|Withdrawal by Subject|71|||
48741056|NCT04424316|156900293|FG001|Overall Study|Withdrawal by Subject|77|||
48741057|NCT04424316|156900294|FG002|Overall Study|Withdrawal by Subject|0|||
48741058|NCT04424316|156900295|FG003|Overall Study|Withdrawal by Subject|0|||
48741059|NCT04424316|156900292|FG000|Overall Study|Withdrawal by parent/guardian|0|||
48741060|NCT04424316|156900293|FG001|Overall Study|Withdrawal by parent/guardian|0|||
48741061|NCT04424316|156900294|FG002|Overall Study|Withdrawal by parent/guardian|74|||
48741062|NCT04424316|156900295|FG003|Overall Study|Withdrawal by parent/guardian|81|||
48854759|NCT03176407|157306864|FG000|Overall Study|human failure|1|||
48854760|NCT03176407|157306864|FG000|Overall Study|EGD showed esophageal varices=excl. crit|1|||
48854761|NCT00310037|157306865|FG000|Overall Study|Adverse Event|7|||
48854762|NCT00310037|157306866|FG001|Overall Study|Adverse Event|14|||
48854763|NCT00310037|157306865|FG000|Overall Study|Withdrawal by Subject|4|||
48854764|NCT00310037|157306866|FG001|Overall Study|Withdrawal by Subject|3|||
48854765|NCT00310037|157306865|FG000|Overall Study|Progression|6|||
48854766|NCT00310037|157306866|FG001|Overall Study|Progression|0|||
48854767|NCT00310037|157306865|FG000|Overall Study|Non-protocol treatment|1|||
48854768|NCT00310037|157306866|FG001|Overall Study|Non-protocol treatment|0|||
48854769|NCT03142932|157306867|FG000|Overall Study|Lost to Follow-up|2|||
48854770|NCT03142932|157306868|FG001|Overall Study|Lost to Follow-up|11|||
48854771|NCT02309515|157306869|FG000|Overall Study|Withdrawal by Subject|0|||
48854772|NCT02309515|157306870|FG001|Overall Study|Withdrawal by Subject|1|||
48854773|NCT00910962|157306871|FG000|Overall Study|Adverse Event|5|||
48854774|NCT00910962|157306872|FG001|Overall Study|Adverse Event|20|||
48854775|NCT00910962|157306873|FG002|Overall Study|Adverse Event|17|||
48854776|NCT00910962|157306871|FG000|Overall Study|Protocol Violation|1|||
48854777|NCT00910962|157306872|FG001|Overall Study|Protocol Violation|3|||
48950103|NCT00984659|157647133|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
48950104|NCT00984659|157647134|FG003|2-week Run-in Period|Study Closed/Terminated|0|||
48950105|NCT00984659|157647131|FG000|2-week Run-in Period|Lost to Follow-up|3|||
48950106|NCT00984659|157647132|FG001|2-week Run-in Period|Lost to Follow-up|0|||
48950107|NCT00984659|157647133|FG002|2-week Run-in Period|Lost to Follow-up|0|||
48950108|NCT00984659|157647134|FG003|2-week Run-in Period|Lost to Follow-up|0|||
48950109|NCT00984659|157647131|FG000|2-week Run-in Period|Physician Decision|10|||
48950110|NCT00984659|157647132|FG001|2-week Run-in Period|Physician Decision|0|||
48950111|NCT00984659|157647133|FG002|2-week Run-in Period|Physician Decision|0|||
48950112|NCT00984659|157647134|FG003|2-week Run-in Period|Physician Decision|0|||
48950113|NCT00984659|157647131|FG000|2-week Run-in Period|Withdrawal by Subject|10|||
48950114|NCT00984659|157647132|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
48950115|NCT00984659|157647133|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
48950116|NCT00984659|157647134|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
48950117|NCT00984659|157647131|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|14|||
48950118|NCT00984659|157647132|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
48950119|NCT00984659|157647133|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
48950120|NCT00984659|157647134|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
48950121|NCT00984659|157647131|FG000|6-week Double-blind Treatment Period|Adverse Event|0|||
48950122|NCT00984659|157647132|FG001|6-week Double-blind Treatment Period|Adverse Event|3|||
48741063|NCT04424316|156900292|FG000|Overall Study|Randomized but not vaccinated|13|||
48741064|NCT04424316|156900293|FG001|Overall Study|Randomized but not vaccinated|21|||
48741065|NCT04424316|156900294|FG002|Overall Study|Randomized but not vaccinated|0|||
48741066|NCT04424316|156900295|FG003|Overall Study|Randomized but not vaccinated|0|||
48741067|NCT04424316|156900292|FG000|Overall Study|Mother vaccinated but unblinded during study|1|||
48741068|NCT04424316|156900293|FG001|Overall Study|Mother vaccinated but unblinded during study|0|||
48741069|NCT04424316|156900294|FG002|Overall Study|Mother vaccinated but unblinded during study|2|||
48741070|NCT04424316|156900295|FG003|Overall Study|Mother vaccinated but unblinded during study|0|||
48741071|NCT02277444|156900296|FG000|Overall Study|Adverse Event|10|||
48741072|NCT02277444|156900296|FG000|Overall Study|Withdrawal by Subject|3|||
48741073|NCT02277444|156900296|FG000|Overall Study|Other|1|||
48741074|NCT02277444|156900296|FG000|Overall Study|Enrolled and not Treated|3|||
48741075|NCT02277444|156900296|FG000|Overall Study|Ongoing|113|||
48741076|NCT03320057|156901718|FG000|Overall Study|Lost to Follow-up|4|||
48741077|NCT03320057|156901719|FG001|Overall Study|Lost to Follow-up|17|||
48854778|NCT00910962|157306873|FG002|Overall Study|Protocol Violation|3|||
48854779|NCT00910962|157306871|FG000|Overall Study|Lost to Follow-up|0|||
48854780|NCT00910962|157306872|FG001|Overall Study|Lost to Follow-up|3|||
48854781|NCT00910962|157306873|FG002|Overall Study|Lost to Follow-up|1|||
48854782|NCT00910962|157306871|FG000|Overall Study|Physician Decision|0|||
48950123|NCT00984659|157647133|FG002|6-week Double-blind Treatment Period|Adverse Event|3|||
48950124|NCT00984659|157647134|FG003|6-week Double-blind Treatment Period|Adverse Event|7|||
48950125|NCT00984659|157647131|FG000|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
48950126|NCT00984659|157647132|FG001|6-week Double-blind Treatment Period|Lack of Efficacy|2|||
48950127|NCT00984659|157647133|FG002|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
48950128|NCT00984659|157647134|FG003|6-week Double-blind Treatment Period|Lack of Efficacy|1|||
48950129|NCT00984659|157647131|FG000|6-week Double-blind Treatment Period|Protocol Violation|0|||
48950130|NCT00984659|157647132|FG001|6-week Double-blind Treatment Period|Protocol Violation|0|||
48950131|NCT00984659|157647133|FG002|6-week Double-blind Treatment Period|Protocol Violation|0|||
48950132|NCT00984659|157647134|FG003|6-week Double-blind Treatment Period|Protocol Violation|4|||
48741078|NCT03320057|156901718|FG000|Overall Study|Did not take mifepristone or misoprostol|2|||
48854783|NCT00910962|157306872|FG001|Overall Study|Physician Decision|6|||
48741079|NCT03320057|156901719|FG001|Overall Study|Did not take mifepristone or misoprostol|0|||
48741080|NCT00717093|156901720|FG000|Overall Study|Adverse Event|19|||
48741081|NCT00717093|156901721|FG001|Overall Study|Adverse Event|9|||
48741082|NCT00717093|156901720|FG000|Overall Study|Lack of Efficacy|3|||
48741083|NCT00717093|156901721|FG001|Overall Study|Lack of Efficacy|13|||
48741084|NCT00717093|156901720|FG000|Overall Study|Lost to Follow-up|9|||
48741085|NCT00717093|156901721|FG001|Overall Study|Lost to Follow-up|6|||
48741086|NCT00717093|156901720|FG000|Overall Study|Withdrawal by Subject|12|||
48741087|NCT00717093|156901721|FG001|Overall Study|Withdrawal by Subject|19|||
48741088|NCT00717093|156901720|FG000|Overall Study|Other|0|||
48741089|NCT00717093|156901721|FG001|Overall Study|Other|1|||
48741090|NCT00717093|156901720|FG000|Overall Study|Randomized but not treated|1|||
48741091|NCT00717093|156901721|FG001|Overall Study|Randomized but not treated|0|||
48741092|NCT00825682|156901722|FG000|Overall Study|personal reasons/ inconvenience|13|||
48741093|NCT00825682|156901723|FG001|Overall Study|personal reasons/ inconvenience|5|||
48950133|NCT00984659|157647131|FG000|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
48950134|NCT00984659|157647132|FG001|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
48950135|NCT00984659|157647133|FG002|6-week Double-blind Treatment Period|Study Closed/Terminated|1|||
48950136|NCT00984659|157647134|FG003|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
48950137|NCT00984659|157647131|FG000|6-week Double-blind Treatment Period|Withdrawal by Subject|0|||
48741094|NCT00115739|156901727|FG000|Overall Study|Lost to Follow-up|3|||
48741095|NCT02742441|156901728|FG000|Overall Study|Lost to Follow-up|4|||
48741096|NCT02742441|156901729|FG001|Overall Study|Lost to Follow-up|4|||
48741097|NCT02742441|156901728|FG000|Overall Study|Withdrawal by Subject|2|||
48950138|NCT00984659|157647132|FG001|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
48950139|NCT00984659|157647133|FG002|6-week Double-blind Treatment Period|Withdrawal by Subject|7|||
48950140|NCT00984659|157647134|FG003|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
48950141|NCT00117338|157647135|FG000|Overall Study|Adverse Event|0|||
48950142|NCT00117338|157647136|FG001|Overall Study|Adverse Event|1|||
48950143|NCT00117338|157647135|FG000|Overall Study|Protocol Violation|3|||
48950144|NCT00117338|157647136|FG001|Overall Study|Protocol Violation|2|||
48950145|NCT00117338|157647135|FG000|Overall Study|Withdrawal by Subject|1|||
48950146|NCT00117338|157647136|FG001|Overall Study|Withdrawal by Subject|0|||
48950147|NCT00117338|157647135|FG000|Overall Study|Did not meet Inclusion Criteria|1|||
48950148|NCT00117338|157647136|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
48950149|NCT00117338|157647135|FG000|Overall Study|Lack of Efficacy|0|||
48741098|NCT02742441|156901729|FG001|Overall Study|Withdrawal by Subject|2|||
48741099|NCT02742441|156901728|FG000|Overall Study|Adverse Event|0|||
48741100|NCT02742441|156901729|FG001|Overall Study|Adverse Event|2|||
48741101|NCT02468674|156901730|FG000|Overall Study|Adverse Event|0|||
48741102|NCT02468674|156901731|FG001|Overall Study|Adverse Event|0|||
48741103|NCT02468674|156901732|FG002|Overall Study|Adverse Event|0|||
48741104|NCT02468674|156901733|FG003|Overall Study|Adverse Event|1|||
48741105|NCT02468674|156901734|FG004|Overall Study|Adverse Event|0|||
48741106|NCT02468674|156901735|FG005|Overall Study|Adverse Event|1|||
48741107|NCT02468674|156901736|FG006|Overall Study|Adverse Event|0|||
48741108|NCT02468674|156901737|FG007|Overall Study|Adverse Event|0|||
48741109|NCT02468674|156901738|FG008|Overall Study|Adverse Event|0|||
48741110|NCT02468674|156901730|FG000|Overall Study|Lost to Follow-up|1|||
48950150|NCT00117338|157647136|FG001|Overall Study|Lack of Efficacy|1|||
48950151|NCT01342640|157647137|FG000|Overall Study|Adverse Event|3|||
48950152|NCT01342640|157647137|FG000|Overall Study|Protocol Violation|16|||
48950153|NCT01342640|157647137|FG000|Overall Study|Lost to Follow-up|21|||
48950154|NCT01342640|157647137|FG000|Overall Study|Other|1|||
48950155|NCT02345434|157647140|FG000|Overall Study|Deceased (excluded from intervention and analysis)|5|||
48950156|NCT02345434|157647141|FG001|Overall Study|Deceased (excluded from intervention and analysis)|2|||
48950157|NCT03865407|157647142|FG000|Overall Study|Adverse Event|1|||
48950158|NCT03865407|157647143|FG001|Overall Study|Adverse Event|0|||
48950159|NCT03865407|157647142|FG000|Overall Study|Withdrawal by Subject|1|||
48950160|NCT03865407|157647143|FG001|Overall Study|Withdrawal by Subject|0|||
48950161|NCT03865407|157647142|FG000|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1|||
48950162|NCT03865407|157647143|FG001|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0|||
48950163|NCT02052960|157647144|FG000|Overall Study|Adverse Event|19|||
48950164|NCT02052960|157647145|FG001|Overall Study|Adverse Event|17|||
48950165|NCT02052960|157647144|FG000|Overall Study|Protocol Violation|4|||
48950166|NCT02052960|157647145|FG001|Overall Study|Protocol Violation|3|||
48950167|NCT02052960|157647144|FG000|Overall Study|Withdrawal by Subject|6|||
48950168|NCT02052960|157647145|FG001|Overall Study|Withdrawal by Subject|11|||
48950169|NCT02052960|157647144|FG000|Overall Study|Other|25|||
48950170|NCT02052960|157647145|FG001|Overall Study|Other|15|||
48950171|NCT02612077|157647146|FG000|Overall Study|Adverse Event|3|||
48950172|NCT02612077|157647146|FG000|Overall Study|Withdrawal by Subject|9|||
48950173|NCT02612077|157647146|FG000|Overall Study|Protocol Violation|28|||
48950174|NCT02612077|157647146|FG000|Overall Study|Lost to Follow-up|20|||
48950175|NCT02612077|157647146|FG000|Overall Study|Death|377|||
48741111|NCT02468674|156901731|FG001|Overall Study|Lost to Follow-up|0|||
48741112|NCT02468674|156901732|FG002|Overall Study|Lost to Follow-up|0|||
48741113|NCT02468674|156901733|FG003|Overall Study|Lost to Follow-up|0|||
48741114|NCT02468674|156901734|FG004|Overall Study|Lost to Follow-up|0|||
48741115|NCT02468674|156901735|FG005|Overall Study|Lost to Follow-up|0|||
48741116|NCT02468674|156901736|FG006|Overall Study|Lost to Follow-up|0|||
48741117|NCT02468674|156901737|FG007|Overall Study|Lost to Follow-up|1|||
48854784|NCT00910962|157306873|FG002|Overall Study|Physician Decision|6|||
48854785|NCT00910962|157306871|FG000|Overall Study|Withdrawal by Subject|25|||
48854786|NCT00910962|157306872|FG001|Overall Study|Withdrawal by Subject|32|||
48854787|NCT00910962|157306873|FG002|Overall Study|Withdrawal by Subject|32|||
48854788|NCT00910962|157306871|FG000|Overall Study|Reached defined stopping criteria|12|||
48854789|NCT00910962|157306872|FG001|Overall Study|Reached defined stopping criteria|14|||
48854790|NCT00910962|157306873|FG002|Overall Study|Reached defined stopping criteria|17|||
48854791|NCT00923078|157306874|FG000|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
48854792|NCT00923078|157306875|FG001|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
48854793|NCT00923078|157306876|FG002|First Intervention (Weeks 1-4)|Withdrawal by Subject|0|||
48854794|NCT00923078|157306874|FG000|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
48741118|NCT02468674|156901738|FG008|Overall Study|Lost to Follow-up|1|||
48741119|NCT02468674|156901730|FG000|Overall Study|Physician Decision|0|||
48741120|NCT02468674|156901731|FG001|Overall Study|Physician Decision|0|||
48741121|NCT02468674|156901732|FG002|Overall Study|Physician Decision|0|||
48741122|NCT02468674|156901733|FG003|Overall Study|Physician Decision|0|||
48741123|NCT02468674|156901734|FG004|Overall Study|Physician Decision|0|||
48741124|NCT02468674|156901735|FG005|Overall Study|Physician Decision|0|||
48741125|NCT02468674|156901736|FG006|Overall Study|Physician Decision|1|||
48741126|NCT02468674|156901737|FG007|Overall Study|Physician Decision|0|||
48741127|NCT02468674|156901738|FG008|Overall Study|Physician Decision|0|||
48741128|NCT02468674|156901730|FG000|Overall Study|Patient/Guardian Decision|0|||
48741129|NCT02468674|156901731|FG001|Overall Study|Patient/Guardian Decision|0|||
48741130|NCT02468674|156901732|FG002|Overall Study|Patient/Guardian Decision|0|||
48741131|NCT02468674|156901733|FG003|Overall Study|Patient/Guardian Decision|0|||
48741132|NCT02468674|156901734|FG004|Overall Study|Patient/Guardian Decision|1|||
48741133|NCT02468674|156901735|FG005|Overall Study|Patient/Guardian Decision|0|||
48741134|NCT02468674|156901736|FG006|Overall Study|Patient/Guardian Decision|0|||
48741135|NCT02468674|156901737|FG007|Overall Study|Patient/Guardian Decision|2|||
48741136|NCT02468674|156901738|FG008|Overall Study|Patient/Guardian Decision|1|||
48741137|NCT02468674|156901730|FG000|Overall Study|Protocol Deviation|0|||
48741138|NCT02468674|156901731|FG001|Overall Study|Protocol Deviation|0|||
48741139|NCT02468674|156901732|FG002|Overall Study|Protocol Deviation|0|||
48741140|NCT02468674|156901733|FG003|Overall Study|Protocol Deviation|0|||
48741141|NCT02468674|156901734|FG004|Overall Study|Protocol Deviation|0|||
48741142|NCT02468674|156901735|FG005|Overall Study|Protocol Deviation|0|||
48741143|NCT02468674|156901736|FG006|Overall Study|Protocol Deviation|0|||
48741144|NCT02468674|156901737|FG007|Overall Study|Protocol Deviation|1|||
48741145|NCT02468674|156901738|FG008|Overall Study|Protocol Deviation|1|||
48741146|NCT00401531|156901739|FG000|Overall Study|Adverse Event|2|||
48741147|NCT00401531|156901740|FG001|Overall Study|Adverse Event|0|||
48741148|NCT00401531|156901739|FG000|Overall Study|Protocol Violation|3|||
48741149|NCT00401531|156901740|FG001|Overall Study|Protocol Violation|7|||
48741150|NCT00401531|156901739|FG000|Overall Study|Lost to Follow-up|1|||
48741151|NCT00401531|156901740|FG001|Overall Study|Lost to Follow-up|1|||
48741152|NCT00401531|156901739|FG000|Overall Study|Withdrawal by Subject|3|||
48741153|NCT00401531|156901740|FG001|Overall Study|Withdrawal by Subject|2|||
48741154|NCT02975336|156901741|FG000|DBPC (52 Weeks)|Adverse Event|16|||
48741155|NCT02975336|156901742|FG001|DBPC (52 Weeks)|Adverse Event|17|||
48950176|NCT02612077|157647146|FG000|Overall Study|Moved or Changed Medical Team|23|||
48950177|NCT02612077|157647146|FG000|Overall Study|Enrollment in a Clinical Trial|1|||
48950178|NCT02612077|157647146|FG000|Overall Study|Disease Progression|3|||
48950179|NCT02612077|157647146|FG000|Overall Study|Unknown reason|2|||
48950180|NCT01645930|157647148|FG000|Overall Study|Participants Ongoing on Study Treatment|22|||
48950181|NCT01645930|157647148|FG000|Overall Study|Progressive Disease|12|||
48950182|NCT01645930|157647148|FG000|Overall Study|Adverse Event|4|||
48950183|NCT01645930|157647148|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
48950184|NCT01645930|157647148|FG000|Overall Study|Withdrawal by Participant|2|||
48950185|NCT01645930|157647148|FG000|Overall Study|Reason not Defined|1|||
48950186|NCT00570739|157647149|FG000|Overall Study|Adverse Event|8|||
48950187|NCT00570739|157647150|FG001|Overall Study|Adverse Event|6|||
48950188|NCT00570739|157647151|FG002|Overall Study|Adverse Event|2|||
48950189|NCT00570739|157647152|FG003|Overall Study|Adverse Event|2|||
48741156|NCT02975336|156901743|FG002|DBPC (52 Weeks)|Adverse Event|13|||
48741157|NCT02975336|156901744|FG003|DBPC (52 Weeks)|Adverse Event|18|||
48741158|NCT02975336|156901745|FG004|DBPC (52 Weeks)|Adverse Event|0|||
48741159|NCT02975336|156901746|FG005|DBPC (52 Weeks)|Adverse Event|0|||
48741160|NCT02975336|156901747|FG006|DBPC (52 Weeks)|Adverse Event|0|||
48741161|NCT02975336|156901748|FG007|DBPC (52 Weeks)|Adverse Event|0|||
48741162|NCT02975336|156901741|FG000|DBPC (52 Weeks)|Lost to Follow-up|2|||
48741163|NCT02975336|156901742|FG001|DBPC (52 Weeks)|Lost to Follow-up|1|||
48950190|NCT00570739|157647149|FG000|Overall Study|Lost to Follow-up|4|||
48950191|NCT00570739|157647150|FG001|Overall Study|Lost to Follow-up|5|||
48741164|NCT02975336|156901743|FG002|DBPC (52 Weeks)|Lost to Follow-up|2|||
48741165|NCT02975336|156901744|FG003|DBPC (52 Weeks)|Lost to Follow-up|4|||
48741166|NCT02975336|156901745|FG004|DBPC (52 Weeks)|Lost to Follow-up|0|||
48741167|NCT02975336|156901746|FG005|DBPC (52 Weeks)|Lost to Follow-up|0|||
48741168|NCT02975336|156901747|FG006|DBPC (52 Weeks)|Lost to Follow-up|0|||
48741169|NCT02975336|156901748|FG007|DBPC (52 Weeks)|Lost to Follow-up|0|||
48741170|NCT02975336|156901741|FG000|DBPC (52 Weeks)|Protocol Violation|4|||
48741171|NCT02975336|156901742|FG001|DBPC (52 Weeks)|Protocol Violation|1|||
48741172|NCT02975336|156901743|FG002|DBPC (52 Weeks)|Protocol Violation|3|||
48741173|NCT02975336|156901744|FG003|DBPC (52 Weeks)|Protocol Violation|1|||
48741174|NCT02975336|156901745|FG004|DBPC (52 Weeks)|Protocol Violation|0|||
48741175|NCT02975336|156901746|FG005|DBPC (52 Weeks)|Protocol Violation|0|||
48741176|NCT02975336|156901747|FG006|DBPC (52 Weeks)|Protocol Violation|0|||
48741177|NCT02975336|156901748|FG007|DBPC (52 Weeks)|Protocol Violation|0|||
48741178|NCT02975336|156901741|FG000|DBPC (52 Weeks)|Lack of Efficacy|4|||
48741179|NCT02975336|156901742|FG001|DBPC (52 Weeks)|Lack of Efficacy|4|||
48741180|NCT02975336|156901743|FG002|DBPC (52 Weeks)|Lack of Efficacy|2|||
48741181|NCT02975336|156901744|FG003|DBPC (52 Weeks)|Lack of Efficacy|3|||
48741182|NCT02975336|156901745|FG004|DBPC (52 Weeks)|Lack of Efficacy|0|||
48741183|NCT02975336|156901746|FG005|DBPC (52 Weeks)|Lack of Efficacy|0|||
48741184|NCT02975336|156901747|FG006|DBPC (52 Weeks)|Lack of Efficacy|0|||
48741185|NCT02975336|156901748|FG007|DBPC (52 Weeks)|Lack of Efficacy|0|||
48741186|NCT02975336|156901741|FG000|DBPC (52 Weeks)|Withdrawal by Subject|1|||
48741187|NCT02975336|156901742|FG001|DBPC (52 Weeks)|Withdrawal by Subject|0|||
48854795|NCT00923078|157306875|FG001|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
48854796|NCT00923078|157306876|FG002|First Intervention (Weeks 1-4)|No intervention per protocol|20|||
48854797|NCT00787176|157306877|FG000|Overall Study|Low quality fetal heart rate tracing|7|||
48854798|NCT00787176|157306878|FG001|Overall Study|Low quality fetal heart rate tracing|3|||
48854799|NCT00787176|157306879|FG002|Overall Study|Low quality fetal heart rate tracing|6|||
48854800|NCT00787176|157306880|FG003|Overall Study|Low quality fetal heart rate tracing|5|||
48854801|NCT01124045|157306881|FG000|Overall Study|Lost to Follow-up|0|||
48741188|NCT02975336|156901743|FG002|DBPC (52 Weeks)|Withdrawal by Subject|1|||
48741189|NCT02975336|156901744|FG003|DBPC (52 Weeks)|Withdrawal by Subject|3|||
48741190|NCT02975336|156901745|FG004|DBPC (52 Weeks)|Withdrawal by Subject|0|||
48854802|NCT01124045|157306882|FG001|Overall Study|Lost to Follow-up|1|||
48854803|NCT01124045|157306881|FG000|Overall Study|Physician Decision|0|||
48854804|NCT01124045|157306882|FG001|Overall Study|Physician Decision|2|||
48854805|NCT02988713|157306886|FG000|Overall Study|Withdrawal by Subject|1|||
48741191|NCT02975336|156901746|FG005|DBPC (52 Weeks)|Withdrawal by Subject|0|||
48741192|NCT02975336|156901747|FG006|DBPC (52 Weeks)|Withdrawal by Subject|0|||
48741193|NCT02975336|156901748|FG007|DBPC (52 Weeks)|Withdrawal by Subject|0|||
48741194|NCT02975336|156901741|FG000|DBPC (52 Weeks)|Premature termination of the study|5|||
48741195|NCT02975336|156901742|FG001|DBPC (52 Weeks)|Premature termination of the study|6|||
48741196|NCT02975336|156901743|FG002|DBPC (52 Weeks)|Premature termination of the study|6|||
48741197|NCT02975336|156901744|FG003|DBPC (52 Weeks)|Premature termination of the study|4|||
48741198|NCT02975336|156901745|FG004|DBPC (52 Weeks)|Premature termination of the study|0|||
48741199|NCT02975336|156901746|FG005|DBPC (52 Weeks)|Premature termination of the study|0|||
48741200|NCT02975336|156901747|FG006|DBPC (52 Weeks)|Premature termination of the study|0|||
48741201|NCT02975336|156901748|FG007|DBPC (52 Weeks)|Premature termination of the study|0|||
48741202|NCT02975336|156901741|FG000|LTE (104 Weeks)|Adverse Event|0|||
48741203|NCT02975336|156901742|FG001|LTE (104 Weeks)|Adverse Event|0|||
48741204|NCT02975336|156901743|FG002|LTE (104 Weeks)|Adverse Event|0|||
48741205|NCT02975336|156901744|FG003|LTE (104 Weeks)|Adverse Event|0|||
48854806|NCT02988713|157306886|FG000|Overall Study|Subject's failure to meet study inclusion or exclusion criteria after enrollment|2|||
48854807|NCT00895245|157306889|FG000|Overall Study|Lack of Efficacy|6|||
48741206|NCT02975336|156901745|FG004|LTE (104 Weeks)|Adverse Event|7|||
48741207|NCT02975336|156901746|FG005|LTE (104 Weeks)|Adverse Event|4|||
48741208|NCT02975336|156901747|FG006|LTE (104 Weeks)|Adverse Event|2|||
48741209|NCT02975336|156901748|FG007|LTE (104 Weeks)|Adverse Event|0|||
48741210|NCT02975336|156901741|FG000|LTE (104 Weeks)|Lost to Follow-up|0|||
48741211|NCT02975336|156901742|FG001|LTE (104 Weeks)|Lost to Follow-up|0|||
48741212|NCT02975336|156901743|FG002|LTE (104 Weeks)|Lost to Follow-up|0|||
48854808|NCT02095678|157306892|FG000|Overall Study|Withdrawal by Subject|0|||
48854809|NCT02095678|157306893|FG001|Overall Study|Withdrawal by Subject|1|||
48741213|NCT02975336|156901744|FG003|LTE (104 Weeks)|Lost to Follow-up|0|||
48741214|NCT02975336|156901745|FG004|LTE (104 Weeks)|Lost to Follow-up|0|||
48741215|NCT02975336|156901746|FG005|LTE (104 Weeks)|Lost to Follow-up|1|||
48741216|NCT02975336|156901747|FG006|LTE (104 Weeks)|Lost to Follow-up|0|||
48741217|NCT02975336|156901748|FG007|LTE (104 Weeks)|Lost to Follow-up|0|||
48741218|NCT02975336|156901741|FG000|LTE (104 Weeks)|Lack of Efficacy|0|||
48741219|NCT02975336|156901742|FG001|LTE (104 Weeks)|Lack of Efficacy|0|||
48741220|NCT02975336|156901743|FG002|LTE (104 Weeks)|Lack of Efficacy|0|||
48741221|NCT02975336|156901744|FG003|LTE (104 Weeks)|Lack of Efficacy|0|||
48741222|NCT02975336|156901745|FG004|LTE (104 Weeks)|Lack of Efficacy|0|||
48950192|NCT00570739|157647151|FG002|Overall Study|Lost to Follow-up|4|||
48950193|NCT00570739|157647152|FG003|Overall Study|Lost to Follow-up|1|||
48950194|NCT00570739|157647149|FG000|Overall Study|Physician Decision|1|||
48950195|NCT00570739|157647150|FG001|Overall Study|Physician Decision|1|||
48950196|NCT00570739|157647151|FG002|Overall Study|Physician Decision|0|||
48950197|NCT00570739|157647152|FG003|Overall Study|Physician Decision|0|||
48950198|NCT00570739|157647149|FG000|Overall Study|Withdrawal by Subject|7|||
48950199|NCT00570739|157647150|FG001|Overall Study|Withdrawal by Subject|7|||
48950200|NCT00570739|157647151|FG002|Overall Study|Withdrawal by Subject|3|||
48950201|NCT00570739|157647152|FG003|Overall Study|Withdrawal by Subject|5|||
48950202|NCT00570739|157647149|FG000|Overall Study|Required restricted medication|0|||
48741223|NCT02975336|156901746|FG005|LTE (104 Weeks)|Lack of Efficacy|1|||
48741224|NCT02975336|156901747|FG006|LTE (104 Weeks)|Lack of Efficacy|2|||
48950203|NCT00570739|157647150|FG001|Overall Study|Required restricted medication|0|||
48741225|NCT02975336|156901748|FG007|LTE (104 Weeks)|Lack of Efficacy|0|||
48854810|NCT02095678|157306892|FG000|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11|||
48854811|NCT02095678|157306893|FG001|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12|||
48741226|NCT02975336|156901741|FG000|LTE (104 Weeks)|Other|0|||
48741227|NCT02975336|156901742|FG001|LTE (104 Weeks)|Other|0|||
48741228|NCT02975336|156901743|FG002|LTE (104 Weeks)|Other|0|||
48741229|NCT02975336|156901744|FG003|LTE (104 Weeks)|Other|0|||
48741230|NCT02975336|156901745|FG004|LTE (104 Weeks)|Other|55|||
48741231|NCT02975336|156901746|FG005|LTE (104 Weeks)|Other|63|||
48741232|NCT02975336|156901747|FG006|LTE (104 Weeks)|Other|76|||
48741233|NCT02975336|156901748|FG007|LTE (104 Weeks)|Other|72|||
48741234|NCT03372096|156901753|FG000|Overall Study|Study Closed|8|||
48741235|NCT02468232|156901754|FG000|Core Part of Study|Adverse Event|0|||
48741236|NCT02468232|156901755|FG001|Core Part of Study|Adverse Event|1|||
48741237|NCT02468232|156901756|FG002|Core Part of Study|Adverse Event|0|||
48741238|NCT02468232|156901757|FG003|Core Part of Study|Adverse Event|0|||
48741239|NCT02468232|156901754|FG000|Core Part of Study|Death|20|||
48854812|NCT02095678|157306892|FG000|Overall Study|lesion impacted by previous treatment|1|||
48854813|NCT02095678|157306893|FG001|Overall Study|lesion impacted by previous treatment|1|||
48854814|NCT02095678|157306892|FG000|Overall Study|No Confirmed Diagnosis|0|||
48854815|NCT02095678|157306893|FG001|Overall Study|No Confirmed Diagnosis|3|||
48854816|NCT02095678|157306892|FG000|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
48854817|NCT02095678|157306893|FG001|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
48854818|NCT02095678|157306892|FG000|Overall Study|No Visible Lesion or Pathological Finding|4|||
48854819|NCT02095678|157306893|FG001|Overall Study|No Visible Lesion or Pathological Finding|0|||
48741240|NCT02468232|156901755|FG001|Core Part of Study|Death|17|||
48741241|NCT02468232|156901756|FG002|Core Part of Study|Death|0|||
48741242|NCT02468232|156901757|FG003|Core Part of Study|Death|0|||
48741243|NCT02468232|156901754|FG000|Core Part of Study|Technical Problems|1|||
48741244|NCT02468232|156901755|FG001|Core Part of Study|Technical Problems|1|||
48741245|NCT02468232|156901756|FG002|Core Part of Study|Technical Problems|0|||
48741246|NCT02468232|156901757|FG003|Core Part of Study|Technical Problems|0|||
48741247|NCT02468232|156901754|FG000|OLE Part of Study|Adverse Event|0|||
48741248|NCT02468232|156901755|FG001|OLE Part of Study|Adverse Event|0|||
48741249|NCT02468232|156901756|FG002|OLE Part of Study|Adverse Event|4|||
48741250|NCT02468232|156901757|FG003|OLE Part of Study|Adverse Event|5|||
48741251|NCT02468232|156901754|FG000|OLE Part of Study|Death|0|||
48741252|NCT02468232|156901755|FG001|OLE Part of Study|Death|0|||
48741253|NCT02468232|156901756|FG002|OLE Part of Study|Death|4|||
48741254|NCT02468232|156901757|FG003|OLE Part of Study|Death|2|||
48741255|NCT02468232|156901754|FG000|OLE Part of Study|Physician Decision|0|||
48741256|NCT02468232|156901755|FG001|OLE Part of Study|Physician Decision|0|||
48741257|NCT02468232|156901756|FG002|OLE Part of Study|Physician Decision|4|||
48741258|NCT02468232|156901757|FG003|OLE Part of Study|Physician Decision|0|||
48741259|NCT02468232|156901754|FG000|OLE Part of Study|Subject/Guardian decision|0|||
48741260|NCT02468232|156901755|FG001|OLE Part of Study|Subject/Guardian decision|0|||
48741261|NCT02468232|156901756|FG002|OLE Part of Study|Subject/Guardian decision|2|||
48741262|NCT02468232|156901757|FG003|OLE Part of Study|Subject/Guardian decision|5|||
48741263|NCT01773733|156901760|FG000|Overall Study|Adverse Event|3286|||
48741264|NCT01773733|156901761|FG001|Overall Study|Adverse Event|540|||
48741265|NCT01773733|156901760|FG000|Overall Study|Pregnancy|28|||
48741266|NCT01773733|156901761|FG001|Overall Study|Pregnancy|0|||
48741267|NCT01773733|156901760|FG000|Overall Study|Other different categories of not compl|55415|||
48741268|NCT01773733|156901761|FG001|Overall Study|Other different categories of not compl|7781|||
48741269|NCT02846324|156901767|FG000|Overall Study|Other|1|||
48741270|NCT02846324|156901768|FG001|Overall Study|Other|0|||
48741271|NCT02846324|156901769|FG002|Overall Study|Other|0|||
48741272|NCT02846324|156901770|FG003|Overall Study|Other|0|||
48741273|NCT02846324|156901767|FG000|Overall Study|Withdrawal by Subject|1|||
48741274|NCT02846324|156901768|FG001|Overall Study|Withdrawal by Subject|0|||
48741275|NCT02846324|156901769|FG002|Overall Study|Withdrawal by Subject|4|||
48741276|NCT02846324|156901770|FG003|Overall Study|Withdrawal by Subject|0|||
48741277|NCT00892047|156901775|FG000|Overall Study|Adverse Event|2|||
48741278|NCT00892047|156901776|FG001|Overall Study|Adverse Event|2|||
48741279|NCT00892047|156901775|FG000|Overall Study|subject burden|2|||
48741280|NCT00892047|156901776|FG001|Overall Study|subject burden|3|||
48741281|NCT00892047|156901775|FG000|Overall Study|Lack of Efficacy|0|||
48854820|NCT01989689|157306895|FG000|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0|||
48854821|NCT01989689|157306896|FG001|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2|||
48741282|NCT00892047|156901776|FG001|Overall Study|Lack of Efficacy|2|||
48741283|NCT01235689|156901778|FG000|Overall Study|Adverse Event|12|||
48741284|NCT01235689|156901779|FG001|Overall Study|Adverse Event|16|||
48741285|NCT01235689|156901778|FG000|Overall Study|Lack of Efficacy|12|||
48741286|NCT01235689|156901779|FG001|Overall Study|Lack of Efficacy|5|||
48741287|NCT01235689|156901778|FG000|Overall Study|Withdrawal by Subject|3|||
48741288|NCT01235689|156901779|FG001|Overall Study|Withdrawal by Subject|4|||
48741289|NCT01235689|156901778|FG000|Overall Study|Lost to Follow-up|1|||
48741290|NCT01235689|156901779|FG001|Overall Study|Lost to Follow-up|2|||
48741291|NCT01235689|156901778|FG000|Overall Study|Miscellaneous|1|||
48741292|NCT01235689|156901779|FG001|Overall Study|Miscellaneous|5|||
48741293|NCT02728596|156901780|FG000|Overall Study|Refusal unrelated to adverse event|3|||
48741294|NCT02728596|156901781|FG001|Overall Study|Refusal unrelated to adverse event|6|||
48741295|NCT02728596|156901782|FG002|Overall Study|Refusal unrelated to adverse event|7|||
48741296|NCT02728596|156901783|FG003|Overall Study|Refusal unrelated to adverse event|7|||
48741297|NCT02728596|156901780|FG000|Overall Study|Death|44|||
48741298|NCT02728596|156901781|FG001|Overall Study|Death|42|||
48741299|NCT02728596|156901782|FG002|Overall Study|Death|123|||
48741300|NCT02728596|156901783|FG003|Overall Study|Death|68|||
48741301|NCT01999868|156901788|FG000|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
48741302|NCT01999868|156901789|FG001|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
48741303|NCT01999868|156901790|FG002|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5|||
48741304|NCT01999868|156901788|FG000|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
48741305|NCT01999868|156901789|FG001|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
48741306|NCT01999868|156901790|FG002|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0|||
48741307|NCT01999868|156901788|FG000|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3|||
48741308|NCT01999868|156901789|FG001|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4|||
48741309|NCT01999868|156901790|FG002|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0|||
48741310|NCT01999868|156901788|FG000|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
48854822|NCT01989689|157306895|FG000|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0|||
48854823|NCT01989689|157306896|FG001|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1|||
48854824|NCT00391170|157306903|FG000|Overall Study|Withdrawal by Subject|1|||
48854825|NCT00391170|157306904|FG001|Overall Study|Withdrawal by Subject|0|||
48741311|NCT01999868|156901789|FG001|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1|||
48741312|NCT01999868|156901790|FG002|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
48741313|NCT01999868|156901788|FG000|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
48741314|NCT01999868|156901789|FG001|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2|||
48950204|NCT00570739|157647151|FG002|Overall Study|Required restricted medication|1|||
48950205|NCT00570739|157647152|FG003|Overall Study|Required restricted medication|0|||
48950206|NCT00570739|157647149|FG000|Overall Study|Met discontinuation criteria|1|||
48741315|NCT01999868|156901790|FG002|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
48741316|NCT01999868|156901788|FG000|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1|||
48741317|NCT01999868|156901789|FG001|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2|||
48741318|NCT01999868|156901790|FG002|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0|||
48950207|NCT00570739|157647150|FG001|Overall Study|Met discontinuation criteria|0|||
48950208|NCT00570739|157647151|FG002|Overall Study|Met discontinuation criteria|1|||
48950209|NCT00570739|157647152|FG003|Overall Study|Met discontinuation criteria|1|||
48950210|NCT00570739|157647149|FG000|Overall Study|Other|0|||
48950211|NCT00570739|157647150|FG001|Overall Study|Other|2|||
48950212|NCT00570739|157647151|FG002|Overall Study|Other|5|||
48950213|NCT00570739|157647152|FG003|Overall Study|Other|3|||
48950214|NCT00751101|157647153|FG000|Overall Study|Withdrawal by Subject|1|||
48950215|NCT00751101|157647154|FG001|Overall Study|Withdrawal by Subject|0|||
48950216|NCT00751101|157647153|FG000|Overall Study|No HFS / Never Started Patch/|0|||
48950217|NCT00751101|157647154|FG001|Overall Study|No HFS / Never Started Patch/|4|||
48741319|NCT01999868|156901788|FG000|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8|||
48741320|NCT01999868|156901789|FG001|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1|||
48741321|NCT01999868|156901790|FG002|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0|||
48741322|NCT01999868|156901788|FG000|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1|||
48741323|NCT01999868|156901789|FG001|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
48741324|NCT01999868|156901790|FG002|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
48741325|NCT01999868|156901788|FG000|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4|||
48741326|NCT01999868|156901789|FG001|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
48741327|NCT01999868|156901790|FG002|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
48741328|NCT01999868|156901788|FG000|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
48741329|NCT01999868|156901789|FG001|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1|||
48741330|NCT01999868|156901790|FG002|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
48741331|NCT01999868|156901788|FG000|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
48741332|NCT01999868|156901789|FG001|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1|||
48741333|NCT01999868|156901790|FG002|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
48741334|NCT01999868|156901788|FG000|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1|||
48741335|NCT01999868|156901789|FG001|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2|||
48741336|NCT01999868|156901790|FG002|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0|||
48741337|NCT01999868|156901788|FG000|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10|||
48741338|NCT01999868|156901789|FG001|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19|||
48741339|NCT01999868|156901790|FG002|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0|||
48741340|NCT01999868|156901788|FG000|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
48741341|NCT01999868|156901789|FG001|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2|||
48741342|NCT01999868|156901790|FG002|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
48741343|NCT01999868|156901788|FG000|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12|||
48741344|NCT01999868|156901789|FG001|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4|||
48741345|NCT01999868|156901790|FG002|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0|||
48741346|NCT01681472|156901791|FG000|Overall Study|Adverse Event|0|||
48741347|NCT01681472|156901792|FG001|Overall Study|Adverse Event|1|||
48741348|NCT01681472|156901793|FG002|Overall Study|Adverse Event|0|||
48741349|NCT01681472|156901794|FG003|Overall Study|Adverse Event|0|||
48741350|NCT01217801|156901795|FG000|Period 1|Protocol Violation|1|||
48950218|NCT00751101|157647153|FG000|Overall Study|Never began capecitabine|1|||
49015350|NCT00673790|157892153|FG001|Overall Study|Participated in two Nebivolol studies|0|||
48741351|NCT01217801|156901796|FG001|Period 1|Protocol Violation|1|||
48741352|NCT01217801|156901795|FG000|Period 1|Withdrawal by Subject|0|||
48854826|NCT00391170|157306903|FG000|Overall Study|Adverse Event|3|||
48854827|NCT00391170|157306904|FG001|Overall Study|Adverse Event|2|||
48854828|NCT00391170|157306903|FG000|Overall Study|Physician Decision|2|||
48854829|NCT00391170|157306904|FG001|Overall Study|Physician Decision|2|||
48854830|NCT00595959|157306905|FG000|Overall Study|Withdrawal by Subject|1|||
48741353|NCT01217801|156901796|FG001|Period 1|Withdrawal by Subject|1|||
48741354|NCT00191139|156901797|FG000|Overall Study|Adverse Event|2|||
48741355|NCT00191139|156901798|FG001|Overall Study|Adverse Event|6|||
48741356|NCT00191139|156901797|FG000|Overall Study|Death|2|||
48741357|NCT00191139|156901798|FG001|Overall Study|Death|0|||
48741358|NCT00191139|156901797|FG000|Overall Study|Withdrawal by Subject|0|||
48741359|NCT00191139|156901798|FG001|Overall Study|Withdrawal by Subject|3|||
48741360|NCT00191139|156901797|FG000|Overall Study|Disease Progression|0|||
48741361|NCT00191139|156901798|FG001|Overall Study|Disease Progression|1|||
48741362|NCT00191139|156901797|FG000|Overall Study|Other|1|||
48741363|NCT00191139|156901798|FG001|Overall Study|Other|2|||
48741364|NCT01402011|156901803|FG000|Delayed Treatment Period|Withdrawal by Subject|1|||
48741365|NCT01402011|156901804|FG001|Delayed Treatment Period|Withdrawal by Subject|0|||
48741366|NCT01402011|156901805|FG002|Delayed Treatment Period|Withdrawal by Subject|0|||
48741367|NCT01402011|156901803|FG000|Active Treatment Period|Withdrawal by Subject|1|||
48741368|NCT01402011|156901804|FG001|Active Treatment Period|Withdrawal by Subject|3|||
48741369|NCT01402011|156901805|FG002|Active Treatment Period|Withdrawal by Subject|0|||
48741370|NCT01402011|156901803|FG000|Nine Month Follow-up|Withdrawal by Subject|0|||
48741371|NCT01402011|156901804|FG001|Nine Month Follow-up|Withdrawal by Subject|1|||
48741372|NCT01402011|156901805|FG002|Nine Month Follow-up|Withdrawal by Subject|0|||
48741373|NCT03607487|156901806|FG000|Overall Study|Withdrawal by Subject|2|||
48741374|NCT03607487|156901807|FG001|Overall Study|Withdrawal by Subject|0|||
48741375|NCT03607487|156901808|FG002|Overall Study|Withdrawal by Subject|0|||
48741376|NCT03607487|156901809|FG003|Overall Study|Withdrawal by Subject|1|||
48741377|NCT01273597|156901810|FG000|Overall Study|Adverse Event|5|||
48741378|NCT01273597|156901810|FG000|Overall Study|Underwent Kidney Transplantation|2|||
48741379|NCT01273597|156901810|FG000|Overall Study|Reason Not Reported|1|||
48741380|NCT00873912|156901811|FG000|Overall Study|Withdrawal by Subject|1|||
48741381|NCT00873912|156901812|FG001|Overall Study|Withdrawal by Subject|0|||
48741382|NCT00873912|156901811|FG000|Overall Study|Lost to Follow-up|2|||
48741383|NCT00873912|156901812|FG001|Overall Study|Lost to Follow-up|0|||
48741384|NCT01466153|156901814|FG000|Overall Study|Disease Progression|2|||
48741385|NCT01466153|156901815|FG001|Overall Study|Disease Progression|2|||
48741386|NCT01466153|156901816|FG002|Overall Study|Disease Progression|0|||
48741387|NCT01466153|156901814|FG000|Overall Study|Adverse Event|14|||
48741388|NCT01466153|156901815|FG001|Overall Study|Adverse Event|13|||
48741389|NCT01466153|156901816|FG002|Overall Study|Adverse Event|17|||
48741390|NCT01466153|156901814|FG000|Overall Study|Withdrawal of Consent|2|||
48741391|NCT01466153|156901815|FG001|Overall Study|Withdrawal of Consent|0|||
48741392|NCT01466153|156901816|FG002|Overall Study|Withdrawal of Consent|0|||
48741393|NCT01466153|156901814|FG000|Overall Study|Investigator Discretion|3|||
48741394|NCT01466153|156901815|FG001|Overall Study|Investigator Discretion|2|||
48741395|NCT01466153|156901816|FG002|Overall Study|Investigator Discretion|2|||
48741396|NCT01466153|156901814|FG000|Overall Study|Randomized-Not Treated|2|||
48741397|NCT01466153|156901815|FG001|Overall Study|Randomized-Not Treated|3|||
48741398|NCT01466153|156901816|FG002|Overall Study|Randomized-Not Treated|4|||
48741399|NCT01466153|156901814|FG000|Overall Study|Other-Unspecified|6|||
48741400|NCT01466153|156901815|FG001|Overall Study|Other-Unspecified|4|||
48741401|NCT01466153|156901816|FG002|Overall Study|Other-Unspecified|2|||
48741402|NCT01785069|156901817|FG000|Overall Study|Implanted with nonstudy device|1|||
48798206|NCT00441701|157098562|FG001|Overall Study|Lack of Efficacy|0|||
48798207|NCT00441701|157098563|FG002|Overall Study|Lack of Efficacy|2|||
48798208|NCT00441701|157098564|FG003|Overall Study|Lack of Efficacy|2|||
48798209|NCT00441701|157098565|FG004|Overall Study|Lack of Efficacy|0|||
48798210|NCT00441701|157098566|FG005|Overall Study|Lack of Efficacy|1|||
48798211|NCT00441701|157098567|FG006|Overall Study|Lack of Efficacy|0|||
48741403|NCT01785069|156901818|FG001|Overall Study|Implanted with nonstudy device|2|||
48741404|NCT01785069|156901819|FG002|Overall Study|Implanted with nonstudy device|1|||
48741405|NCT01785069|156901820|FG003|Overall Study|Implanted with nonstudy device|0|||
48741406|NCT01785069|156901817|FG000|Overall Study|Death|0|||
48741407|NCT01785069|156901818|FG001|Overall Study|Death|0|||
48741408|NCT01785069|156901819|FG002|Overall Study|Death|2|||
48741409|NCT01785069|156901820|FG003|Overall Study|Death|0|||
48741410|NCT01785069|156901817|FG000|Overall Study|Subject choice|2|||
48741411|NCT01785069|156901818|FG001|Overall Study|Subject choice|2|||
48741412|NCT01785069|156901819|FG002|Overall Study|Subject choice|0|||
48741413|NCT01785069|156901820|FG003|Overall Study|Subject choice|1|||
48741414|NCT01785069|156901817|FG000|Overall Study|Lost to Follow-up|1|||
48741415|NCT01785069|156901818|FG001|Overall Study|Lost to Follow-up|2|||
48741416|NCT01785069|156901819|FG002|Overall Study|Lost to Follow-up|4|||
48741417|NCT01785069|156901820|FG003|Overall Study|Lost to Follow-up|1|||
48741418|NCT01785069|156901817|FG000|Overall Study|Reason not Specified|1|||
48741419|NCT01785069|156901818|FG001|Overall Study|Reason not Specified|2|||
48741420|NCT01785069|156901819|FG002|Overall Study|Reason not Specified|1|||
48741421|NCT01785069|156901820|FG003|Overall Study|Reason not Specified|4|||
48950219|NCT00751101|157647154|FG001|Overall Study|Never began capecitabine|0|||
48950220|NCT00751101|157647153|FG000|Overall Study|Physician Decision|0|||
48741422|NCT01785069|156901817|FG000|Overall Study|Not evaluable|7|||
48741423|NCT01785069|156901818|FG001|Overall Study|Not evaluable|4|||
48741424|NCT01785069|156901819|FG002|Overall Study|Not evaluable|5|||
48741425|NCT01785069|156901820|FG003|Overall Study|Not evaluable|8|||
48741426|NCT03280030|156901827|FG000|Part 1 - Safety Evaluation|Physician Decision|2|||
48741427|NCT03280030|156901828|FG001|Part 1 - Safety Evaluation|Physician Decision|0|||
48741428|NCT03280030|156901829|FG002|Part 1 - Safety Evaluation|Physician Decision|0|||
48950221|NCT00751101|157647154|FG001|Overall Study|Physician Decision|1|||
48950222|NCT02613572|157647157|FG000|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1|||
48950223|NCT02613572|157647158|FG001|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
48950224|NCT02613572|157647159|FG002|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
48950225|NCT02613572|157647157|FG000|Phase II: Double-Blind Rand Plac Control|Death|0|||
48950226|NCT02613572|157647158|FG001|Phase II: Double-Blind Rand Plac Control|Death|1|||
48950227|NCT02613572|157647159|FG002|Phase II: Double-Blind Rand Plac Control|Death|0|||
48950228|NCT01001494|157647163|FG000|Overall Study|Adverse Event|8|||
48950229|NCT01001494|157647164|FG001|Overall Study|Adverse Event|4|||
48950230|NCT01001494|157647165|FG002|Overall Study|Adverse Event|6|||
48950231|NCT01001494|157647163|FG000|Overall Study|Protocol Violation|0|||
48741429|NCT03280030|156901827|FG000|Part 1 - Safety Evaluation|Disease progression|1|||
48741430|NCT03280030|156901828|FG001|Part 1 - Safety Evaluation|Disease progression|0|||
48741431|NCT03280030|156901829|FG002|Part 1 - Safety Evaluation|Disease progression|0|||
48741432|NCT03280030|156901827|FG000|Part 1 - Safety Evaluation|Adverse Event|2|||
48741433|NCT03280030|156901828|FG001|Part 1 - Safety Evaluation|Adverse Event|0|||
48741434|NCT03280030|156901829|FG002|Part 1 - Safety Evaluation|Adverse Event|0|||
48741435|NCT03280030|156901827|FG000|Part 2 - Efficacy|Adverse Event|0|||
48741436|NCT03280030|156901828|FG001|Part 2 - Efficacy|Adverse Event|4|||
48741437|NCT03280030|156901829|FG002|Part 2 - Efficacy|Adverse Event|6|||
48950232|NCT01001494|157647164|FG001|Overall Study|Protocol Violation|1|||
48741438|NCT03280030|156901827|FG000|Part 2 - Efficacy|Death|0|||
48741439|NCT03280030|156901828|FG001|Part 2 - Efficacy|Death|3|||
48741440|NCT03280030|156901829|FG002|Part 2 - Efficacy|Death|0|||
48854831|NCT00595959|157306905|FG000|Overall Study|Lost to Follow-up|1|||
48854832|NCT03035942|157306906|FG000|Overall Study|Adverse Event|8|||
48854833|NCT03035942|157306907|FG001|Overall Study|Adverse Event|4|||
48741441|NCT03280030|156901827|FG000|Part 2 - Efficacy|Physician Decision|0|||
48741442|NCT03280030|156901828|FG001|Part 2 - Efficacy|Physician Decision|10|||
48741443|NCT03280030|156901829|FG002|Part 2 - Efficacy|Physician Decision|16|||
48741444|NCT03280030|156901827|FG000|Part 2 - Efficacy|Withdrawal by Subject|0|||
48741445|NCT03280030|156901828|FG001|Part 2 - Efficacy|Withdrawal by Subject|2|||
48741446|NCT03280030|156901829|FG002|Part 2 - Efficacy|Withdrawal by Subject|1|||
48741447|NCT03280030|156901827|FG000|Part 2 - Efficacy|Progressive disease|0|||
48741448|NCT03280030|156901828|FG001|Part 2 - Efficacy|Progressive disease|7|||
48741449|NCT03280030|156901829|FG002|Part 2 - Efficacy|Progressive disease|5|||
48741450|NCT00748709|156901830|FG000|Overall Study|Progressive disease|15|||
48741451|NCT00748709|156901830|FG000|Overall Study|Drug reducing Toxity|2|||
48741452|NCT00748709|156901830|FG000|Overall Study|Other Adverse Event|1|||
48741453|NCT00748709|156901830|FG000|Overall Study|Withdrawal by Subject|1|||
48741454|NCT00748709|156901830|FG000|Overall Study|Other Reasons|1|||
48854834|NCT03035942|157306908|FG002|Overall Study|Adverse Event|5|||
48854835|NCT00380250|157306909|FG000|Overall Study|Withdrawal by Subject|39|||
48854836|NCT00380250|157306910|FG001|Overall Study|Withdrawal by Subject|28|||
48854837|NCT00380250|157306909|FG000|Overall Study|Adverse Event|20|||
48854838|NCT00380250|157306910|FG001|Overall Study|Adverse Event|9|||
48854839|NCT00380250|157306909|FG000|Overall Study|Lack of Efficacy|10|||
48741455|NCT00647387|156901831|FG000|Overall Study|Lost to Follow-up|6|||
48950233|NCT01001494|157647165|FG002|Overall Study|Protocol Violation|1|||
48950234|NCT01001494|157647163|FG000|Overall Study|Lost to Follow-up|2|||
48950235|NCT01001494|157647164|FG001|Overall Study|Lost to Follow-up|0|||
48950236|NCT01001494|157647165|FG002|Overall Study|Lost to Follow-up|1|||
48950237|NCT01001494|157647163|FG000|Overall Study|Withdrawal by Subject|9|||
48950238|NCT01001494|157647164|FG001|Overall Study|Withdrawal by Subject|7|||
48950239|NCT01001494|157647165|FG002|Overall Study|Withdrawal by Subject|17|||
48950240|NCT01001494|157647163|FG000|Overall Study|COPD exacerbation|3|||
48950241|NCT01001494|157647164|FG001|Overall Study|COPD exacerbation|4|||
48950242|NCT01001494|157647165|FG002|Overall Study|COPD exacerbation|5|||
48950243|NCT01001494|157647163|FG000|Overall Study|Lack of Efficacy|2|||
48950244|NCT01001494|157647164|FG001|Overall Study|Lack of Efficacy|0|||
48950245|NCT01001494|157647165|FG002|Overall Study|Lack of Efficacy|8|||
48950246|NCT01001494|157647163|FG000|Overall Study|Other|0|||
48950247|NCT01001494|157647164|FG001|Overall Study|Other|1|||
48950248|NCT01001494|157647165|FG002|Overall Study|Other|3|||
48950249|NCT04156646|157647166|FG000|Treatment Period 3 (6 Days)|Withdrawal by Subject|0|||
48950250|NCT04156646|157647167|FG001|Treatment Period 3 (6 Days)|Withdrawal by Subject|1|||
48950251|NCT00425438|157647172|FG000|Overall Study|Termination by Sponsor|25|||
48950252|NCT00425438|157647173|FG001|Overall Study|Termination by Sponsor|27|||
48741456|NCT00647387|156901831|FG000|Overall Study|Unsuccessful implant|5|||
48950253|NCT02698423|157647174|FG000|Overall Study|Lost to Follow-up|19|||
48950254|NCT02698423|157647175|FG001|Overall Study|Lost to Follow-up|24|||
48950255|NCT02606877|157647176|FG000|Overall Study|Adverse Event|3|||
48950256|NCT02606877|157647177|FG001|Overall Study|Adverse Event|0|||
48950257|NCT02606877|157647176|FG000|Overall Study|Non-compliance with protocol|0|||
48854840|NCT00380250|157306910|FG001|Overall Study|Lack of Efficacy|8|||
48854841|NCT00380250|157306909|FG000|Overall Study|Protocol Violation|15|||
48854842|NCT00380250|157306910|FG001|Overall Study|Protocol Violation|5|||
48854843|NCT00380250|157306909|FG000|Overall Study|Lost to Follow-up|14|||
48854844|NCT00380250|157306910|FG001|Overall Study|Lost to Follow-up|5|||
48854845|NCT00380250|157306909|FG000|Overall Study|Physician Decision|1|||
48854846|NCT00380250|157306910|FG001|Overall Study|Physician Decision|0|||
48854847|NCT01262456|157306911|FG000|3-Month Double-Blind Period|Withdrawal by Subject|6|||
48854848|NCT01262456|157306912|FG001|3-Month Double-Blind Period|Withdrawal by Subject|8|||
48854849|NCT01262456|157306913|FG002|3-Month Double-Blind Period|Withdrawal by Subject|9|||
48854850|NCT01262456|157306911|FG000|3-Month Double-Blind Period|Lost to Follow-up|4|||
48854851|NCT01262456|157306912|FG001|3-Month Double-Blind Period|Lost to Follow-up|5|||
48854852|NCT01262456|157306913|FG002|3-Month Double-Blind Period|Lost to Follow-up|3|||
48854853|NCT01262456|157306911|FG000|3-Month Double-Blind Period|Adverse Event|6|||
48854854|NCT01262456|157306912|FG001|3-Month Double-Blind Period|Adverse Event|4|||
48854855|NCT01262456|157306913|FG002|3-Month Double-Blind Period|Adverse Event|8|||
48854856|NCT01262456|157306911|FG000|3-Month Double-Blind Period|Protocol Violation|3|||
48854857|NCT01262456|157306912|FG001|3-Month Double-Blind Period|Protocol Violation|6|||
48854858|NCT01262456|157306913|FG002|3-Month Double-Blind Period|Protocol Violation|6|||
48854859|NCT01262456|157306911|FG000|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
48854860|NCT01262456|157306912|FG001|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
48854861|NCT01262456|157306913|FG002|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
48854862|NCT01262456|157306911|FG000|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
48854863|NCT01262456|157306912|FG001|1-Month Open-Label Extension Period|Lost to Follow-up|1|||
48854864|NCT01262456|157306913|FG002|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
48854865|NCT01262456|157306911|FG000|1-Month Open-Label Extension Period|Adverse Event|2|||
48854866|NCT01262456|157306912|FG001|1-Month Open-Label Extension Period|Adverse Event|0|||
48854867|NCT01262456|157306913|FG002|1-Month Open-Label Extension Period|Adverse Event|2|||
48854868|NCT01262456|157306911|FG000|1-Month Open-Label Extension Period|Protocol Violation|1|||
48854869|NCT01262456|157306912|FG001|1-Month Open-Label Extension Period|Protocol Violation|0|||
48854870|NCT01262456|157306913|FG002|1-Month Open-Label Extension Period|Protocol Violation|2|||
48854871|NCT01262456|157306911|FG000|1-Month Open-Label Extension Period|Other Reason|0|||
48854872|NCT01262456|157306912|FG001|1-Month Open-Label Extension Period|Other Reason|1|||
48854873|NCT01262456|157306913|FG002|1-Month Open-Label Extension Period|Other Reason|0|||
48854874|NCT01419184|157306914|FG000|Overall Study|Site data not available|3|||
48854875|NCT01419184|157306915|FG001|Overall Study|Site data not available|2|||
48854876|NCT01419184|157306914|FG000|Overall Study|No IRLOS-No in-patient end date reported|3|||
48854877|NCT01419184|157306915|FG001|Overall Study|No IRLOS-No in-patient end date reported|6|||
48854878|NCT01419184|157306914|FG000|Overall Study|No IRLOS-randomized, not treated|2|||
48854879|NCT01419184|157306915|FG001|Overall Study|No IRLOS-randomized, not treated|4|||
48854880|NCT01419184|157306914|FG000|Overall Study|No IRLOS-non trial antibiotic used|1|||
48854881|NCT01419184|157306915|FG001|Overall Study|No IRLOS-non trial antibiotic used|2|||
48854882|NCT01419184|157306914|FG000|Overall Study|No IRLOS-No adverse event treatment date|0|||
48854883|NCT01419184|157306915|FG001|Overall Study|No IRLOS-No adverse event treatment date|1|||
48854884|NCT01419184|157306914|FG000|Overall Study|Participant randomized, not treated|1|||
48854885|NCT01419184|157306915|FG001|Overall Study|Participant randomized, not treated|0|||
48854886|NCT02514824|157306917|FG000|Overall Study|Withdrawal by Subject|1|||
48854887|NCT02514824|157306918|FG001|Overall Study|Withdrawal by Subject|0|||
48854888|NCT02514824|157306919|FG002|Overall Study|Withdrawal by Subject|0|||
48854889|NCT02514824|157306920|FG003|Overall Study|Withdrawal by Subject|0|||
48854890|NCT02514824|157306917|FG000|Overall Study|Dose-Limiting Toxicity|0|||
48854891|NCT02514824|157306918|FG001|Overall Study|Dose-Limiting Toxicity|1|||
48854892|NCT02514824|157306919|FG002|Overall Study|Dose-Limiting Toxicity|0|||
48854893|NCT02514824|157306920|FG003|Overall Study|Dose-Limiting Toxicity|0|||
48950258|NCT02606877|157647177|FG001|Overall Study|Non-compliance with protocol|1|||
48950259|NCT02606877|157647176|FG000|Overall Study|Other than listed above|1|||
48950260|NCT02606877|157647177|FG001|Overall Study|Other than listed above|0|||
48950261|NCT01765764|157647184|FG000|Treatment Period|Adverse Event|1|||
48950262|NCT01765764|157647185|FG001|Treatment Period|Adverse Event|2|||
48950263|NCT01765764|157647186|FG002|Treatment Period|Adverse Event|1|||
48950264|NCT01765764|157647184|FG000|Treatment Period|Lost to Follow-up|0|||
48950265|NCT01765764|157647185|FG001|Treatment Period|Lost to Follow-up|3|||
48950266|NCT01765764|157647186|FG002|Treatment Period|Lost to Follow-up|2|||
48854894|NCT01138657|157306921|FG000|Overall Study|Adverse Event|3|||
48854895|NCT01138657|157306922|FG001|Overall Study|Adverse Event|10|||
48950267|NCT01765764|157647184|FG000|Treatment Period|Personal Reasons|1|||
48950268|NCT01765764|157647185|FG001|Treatment Period|Personal Reasons|2|||
48854896|NCT01138657|157306921|FG000|Overall Study|Lack of Efficacy|2|||
48854897|NCT01138657|157306922|FG001|Overall Study|Lack of Efficacy|1|||
48854898|NCT01138657|157306921|FG000|Overall Study|Lost to Follow-up|0|||
48950269|NCT01765764|157647186|FG002|Treatment Period|Personal Reasons|1|||
48950270|NCT01765764|157647184|FG000|Treatment Period|Other Miscellaneous Reasons|1|||
48950271|NCT01765764|157647185|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
48854899|NCT01138657|157306922|FG001|Overall Study|Lost to Follow-up|3|||
48741457|NCT00647387|156901831|FG000|Overall Study|Device explanted|3|||
48741458|NCT00647387|156901831|FG000|Overall Study|Other Reason|3|||
48741459|NCT00647387|156901831|FG000|Overall Study|Death|2|||
48741460|NCT01644565|156903093|FG000|Overall Study|Undisclosed Medical History|1|||
48741461|NCT01644565|156903094|FG001|Overall Study|Undisclosed Medical History|0|||
48741462|NCT01644565|156903095|FG002|Overall Study|Undisclosed Medical History|0|||
48741463|NCT01644565|156903096|FG003|Overall Study|Undisclosed Medical History|0|||
48741464|NCT01644565|156903097|FG004|Overall Study|Undisclosed Medical History|0|||
48741465|NCT01644565|156903098|FG005|Overall Study|Undisclosed Medical History|0|||
48741466|NCT01644565|156903099|FG006|Overall Study|Undisclosed Medical History|0|||
48741467|NCT01644565|156903100|FG007|Overall Study|Undisclosed Medical History|0|||
48741468|NCT01644565|156903101|FG008|Overall Study|Undisclosed Medical History|0|||
48741469|NCT01644565|156903093|FG000|Overall Study|Lost to Follow-up|0|||
48741470|NCT01644565|156903094|FG001|Overall Study|Lost to Follow-up|0|||
48741471|NCT01644565|156903095|FG002|Overall Study|Lost to Follow-up|0|||
48741472|NCT01644565|156903096|FG003|Overall Study|Lost to Follow-up|1|||
48741473|NCT01644565|156903097|FG004|Overall Study|Lost to Follow-up|0|||
48741474|NCT01644565|156903098|FG005|Overall Study|Lost to Follow-up|0|||
48741475|NCT01644565|156903099|FG006|Overall Study|Lost to Follow-up|0|||
48741476|NCT01644565|156903100|FG007|Overall Study|Lost to Follow-up|2|||
48741477|NCT01644565|156903101|FG008|Overall Study|Lost to Follow-up|0|||
48741478|NCT01644565|156903093|FG000|Overall Study|Family emergency|0|||
48741479|NCT01644565|156903094|FG001|Overall Study|Family emergency|0|||
48741480|NCT01644565|156903095|FG002|Overall Study|Family emergency|0|||
48741481|NCT01644565|156903096|FG003|Overall Study|Family emergency|0|||
48741482|NCT01644565|156903097|FG004|Overall Study|Family emergency|1|||
48741483|NCT01644565|156903098|FG005|Overall Study|Family emergency|0|||
48741484|NCT01644565|156903099|FG006|Overall Study|Family emergency|0|||
48741485|NCT01644565|156903100|FG007|Overall Study|Family emergency|0|||
48741486|NCT01644565|156903101|FG008|Overall Study|Family emergency|0|||
48741487|NCT01644565|156903093|FG000|Overall Study|Relocation|0|||
48741488|NCT01644565|156903094|FG001|Overall Study|Relocation|0|||
48741489|NCT01644565|156903095|FG002|Overall Study|Relocation|0|||
48741490|NCT01644565|156903096|FG003|Overall Study|Relocation|0|||
48741491|NCT01644565|156903097|FG004|Overall Study|Relocation|0|||
48741492|NCT01644565|156903098|FG005|Overall Study|Relocation|0|||
48741493|NCT01644565|156903099|FG006|Overall Study|Relocation|0|||
48741494|NCT01644565|156903100|FG007|Overall Study|Relocation|0|||
48741495|NCT01644565|156903101|FG008|Overall Study|Relocation|1|||
48741496|NCT01034631|156903102|FG000|Phase I|Symptomatic Deterioration before Treatme|3|||
48741497|NCT01034631|156903103|FG001|Phase I|Symptomatic Deterioration before Treatme|0|||
48741498|NCT01034631|156903104|FG002|Phase I|Symptomatic Deterioration before Treatme|0|||
48741499|NCT01034631|156903102|FG000|Phase II|Not Evaluable per protocol|0|||
48741500|NCT01034631|156903103|FG001|Phase II|Not Evaluable per protocol|0|||
48741501|NCT01034631|156903104|FG002|Phase II|Not Evaluable per protocol|2|||
48741502|NCT01034631|156903102|FG000|Phase II|Determined Ineligible per protocol|0|||
48741503|NCT01034631|156903103|FG001|Phase II|Determined Ineligible per protocol|1|||
48741504|NCT01034631|156903104|FG002|Phase II|Determined Ineligible per protocol|0|||
48741505|NCT01193530|156903106|FG000|Overall Study|Withdrawal by Subject|2|||
48741506|NCT01193530|156903107|FG001|Overall Study|Withdrawal by Subject|2|||
48741507|NCT01193530|156903106|FG000|Overall Study|Began Contraindicated Therapy|1|||
48741508|NCT01193530|156903107|FG001|Overall Study|Began Contraindicated Therapy|0|||
48741509|NCT01193530|156903106|FG000|Overall Study|Lost Light Box|0|||
48741510|NCT01193530|156903107|FG001|Overall Study|Lost Light Box|1|||
48741511|NCT01193530|156903106|FG000|Overall Study|Returned home - out of state|0|||
48854900|NCT01138657|157306921|FG000|Overall Study|Miscellaneous Reasons|3|||
48854901|NCT01138657|157306922|FG001|Overall Study|Miscellaneous Reasons|4|||
48854902|NCT00337610|157306925|FG000|Overall Study|Adverse Event|2|||
48854903|NCT00337610|157306926|FG001|Overall Study|Adverse Event|2|||
48854904|NCT00337610|157306925|FG000|Overall Study|Death|0|||
48854905|NCT00337610|157306926|FG001|Overall Study|Death|1|||
48854906|NCT00337610|157306925|FG000|Overall Study|Lack of Efficacy|6|||
48854907|NCT00337610|157306926|FG001|Overall Study|Lack of Efficacy|3|||
48854908|NCT00337610|157306925|FG000|Overall Study|Lost to Follow-up|3|||
48854909|NCT00337610|157306926|FG001|Overall Study|Lost to Follow-up|3|||
48854910|NCT00337610|157306925|FG000|Overall Study|Withdrawal by Subject|6|||
48854911|NCT00337610|157306926|FG001|Overall Study|Withdrawal by Subject|5|||
48854912|NCT00641537|157306927|FG000|96-week Period|Adverse Event|0|||
48741512|NCT01193530|156903107|FG001|Overall Study|Returned home - out of state|1|||
48741513|NCT01193530|156903106|FG000|Overall Study|Non-Compliance|0|||
48741514|NCT01193530|156903107|FG001|Overall Study|Non-Compliance|1|||
48741515|NCT01890473|156903108|FG000|Overall Study|Lost to Follow-up|1|||
48741516|NCT01890473|156903109|FG001|Overall Study|Lost to Follow-up|0|||
48854913|NCT00641537|157306928|FG001|96-week Period|Adverse Event|1|||
48854914|NCT00641537|157306929|FG002|96-week Period|Adverse Event|3|||
48854915|NCT00641537|157306930|FG003|96-week Period|Adverse Event|0|||
48950272|NCT01765764|157647186|FG002|Treatment Period|Other Miscellaneous Reasons|2|||
48950273|NCT01266148|157648624|FG000|Overall Study|Adverse Event|2|||
48950274|NCT01266148|157648625|FG001|Overall Study|Adverse Event|0|||
48950275|NCT01266148|157648624|FG000|Overall Study|Ongoing rejection|1|||
48950276|NCT01266148|157648625|FG001|Overall Study|Ongoing rejection|0|||
48950277|NCT01266148|157648624|FG000|Overall Study|2 2R rejections|1|||
48950278|NCT01266148|157648625|FG001|Overall Study|2 2R rejections|0|||
48950279|NCT01266148|157648624|FG000|Overall Study|Death|2|||
48950280|NCT01266148|157648625|FG001|Overall Study|Death|3|||
48950281|NCT01266148|157648624|FG000|Overall Study|missing mGFR value + AE|1|||
48950282|NCT01266148|157648625|FG001|Overall Study|missing mGFR value + AE|0|||
48950283|NCT04220866|157648626|FG000|Overall Study|Death|4|||
48950284|NCT04220866|157648627|FG001|Overall Study|Death|5|||
48950285|NCT04220866|157648626|FG000|Overall Study|Participation at the site terminated By Sponsor|2|||
48950286|NCT04220866|157648627|FG001|Overall Study|Participation at the site terminated By Sponsor|0|||
48950287|NCT04220866|157648626|FG000|Overall Study|Participation in the study terminated By Sponsor|2|||
48950288|NCT04220866|157648627|FG001|Overall Study|Participation in the study terminated By Sponsor|4|||
48950289|NCT04220866|157648626|FG000|Overall Study|Withdrawal by Subject|0|||
48950290|NCT04220866|157648627|FG001|Overall Study|Withdrawal by Subject|1|||
48950291|NCT01650779|157648628|FG000|Overall Study|Withdrawal by Subject|1|||
48950292|NCT01996319|157648629|FG000|Overall Study|Protocol Violation|1|||
48950293|NCT01996319|157648630|FG001|Overall Study|Protocol Violation|0|||
48950294|NCT01996319|157648629|FG000|Overall Study|Severe or moderate (COPD) Exacerbation|5|||
48950295|NCT01996319|157648630|FG001|Overall Study|Severe or moderate (COPD) Exacerbation|1|||
48950296|NCT01996319|157648629|FG000|Overall Study|Adverse Event|2|||
48950297|NCT01996319|157648630|FG001|Overall Study|Adverse Event|2|||
48950298|NCT04003636|157648631|FG000|Overall Study|Death|409|||
48950299|NCT04003636|157648632|FG001|Overall Study|Death|443|||
48950300|NCT04003636|157648631|FG000|Overall Study|Lost to Follow-up|0|||
48950301|NCT04003636|157648632|FG001|Overall Study|Lost to Follow-up|1|||
48741517|NCT01890473|156903108|FG000|Overall Study|Poor/non-compliance|1|||
48741518|NCT01890473|156903109|FG001|Overall Study|Poor/non-compliance|0|||
48741519|NCT00983437|156903110|FG000|Overall Study|Adverse Event|9|||
48741520|NCT00983437|156903110|FG000|Overall Study|Lack of Efficacy|1|||
48741521|NCT00983437|156903110|FG000|Overall Study|Withdrawal by Subject|8|||
48741522|NCT00983437|156903110|FG000|Overall Study|Noncompliance to Study Procedures|1|||
48741523|NCT00983437|156903110|FG000|Overall Study|Lost to Follow-up|2|||
48741524|NCT00983437|156903110|FG000|Overall Study|Other Reason|26|||
48741525|NCT00094172|156903111|FG000|Overall Study|Adverse Event|0|||
48741526|NCT00094172|156903112|FG001|Overall Study|Adverse Event|1|||
48741527|NCT00094172|156903111|FG000|Overall Study|Lost to Follow-up|2|||
48741528|NCT00094172|156903112|FG001|Overall Study|Lost to Follow-up|0|||
48741529|NCT00094172|156903111|FG000|Overall Study|Protocol Violation|0|||
48741530|NCT00094172|156903112|FG001|Overall Study|Protocol Violation|1|||
48741531|NCT00094172|156903111|FG000|Overall Study|Withdrawal by Subject|10|||
48741532|NCT00094172|156903112|FG001|Overall Study|Withdrawal by Subject|5|||
48741533|NCT00094172|156903111|FG000|Overall Study|Primary endpoint met.|1|||
48741534|NCT00094172|156903112|FG001|Overall Study|Primary endpoint met.|0|||
48741535|NCT00094172|156903111|FG000|Overall Study|Started other MS therapy due to disease|1|||
48741536|NCT00094172|156903112|FG001|Overall Study|Started other MS therapy due to disease|0|||
48950302|NCT04003636|157648631|FG000|Overall Study|Withdrawal by Subject|5|||
48950303|NCT04003636|157648632|FG001|Overall Study|Withdrawal by Subject|2|||
48950304|NCT04003636|157648631|FG000|Overall Study|Participant On-going|119|||
48950305|NCT04003636|157648632|FG001|Overall Study|Participant On-going|90|||
48950306|NCT01302041|157648633|FG000|Overall Study|Death|5|||
48950307|NCT01302041|157648633|FG000|Overall Study|Withdrawal by Subject|4|||
48950308|NCT01302041|157648633|FG000|Overall Study|Other-Transitioned to 9785-CL-0123|29|||
48950309|NCT01302041|157648633|FG000|Overall Study|Other-Miscellaneous Reason|2|||
48950310|NCT01797783|157648635|FG000|Overall Study|Adverse Event|1|||
48950311|NCT01797783|157648636|FG001|Overall Study|Adverse Event|1|||
48950312|NCT01797783|157648635|FG000|Overall Study|Withdrawal by Subject|1|||
48950313|NCT01797783|157648636|FG001|Overall Study|Withdrawal by Subject|0|||
48950314|NCT02075255|157648637|FG000|Overall Study|Study specific withdrawal criteria|0|||
48950315|NCT02075255|157648638|FG001|Overall Study|Study specific withdrawal criteria|1|||
48950316|NCT02075255|157648639|FG002|Overall Study|Study specific withdrawal criteria|1|||
48741537|NCT00003473|156903113|FG000|Overall Study|Three patients were not evaluable.|3|||
48741538|NCT00799383|156903118|FG000|Overall Study|Protocol Violation|1|||
48741539|NCT00799383|156903119|FG001|Overall Study|Protocol Violation|1|||
48950317|NCT02075255|157648637|FG000|Overall Study|Withdrawal by Subject|4|||
48950318|NCT02075255|157648638|FG001|Overall Study|Withdrawal by Subject|1|||
48950319|NCT02075255|157648639|FG002|Overall Study|Withdrawal by Subject|0|||
48950320|NCT02075255|157648637|FG000|Overall Study|Lost to Follow-up|0|||
48950321|NCT02075255|157648638|FG001|Overall Study|Lost to Follow-up|0|||
48950322|NCT02075255|157648639|FG002|Overall Study|Lost to Follow-up|1|||
48950323|NCT02075255|157648637|FG000|Overall Study|Adverse Event|0|||
48950324|NCT02075255|157648638|FG001|Overall Study|Adverse Event|0|||
48950325|NCT02075255|157648639|FG002|Overall Study|Adverse Event|1|||
48950326|NCT02075255|157648637|FG000|Overall Study|Death|0|||
48950327|NCT02075255|157648638|FG001|Overall Study|Death|2|||
48950328|NCT02075255|157648639|FG002|Overall Study|Death|0|||
48950329|NCT03964415|157648640|FG000|Overall Study|Sponsor's decision|1563|||
48950330|NCT03964415|157648641|FG001|Overall Study|Sponsor's decision|1528|||
48950331|NCT03964415|157648640|FG000|Overall Study|Lost to Follow-up|139|||
48950332|NCT03964415|157648641|FG001|Overall Study|Lost to Follow-up|146|||
48950333|NCT03964415|157648640|FG000|Overall Study|Withdrawal by Subject|68|||
48950334|NCT03964415|157648641|FG001|Overall Study|Withdrawal by Subject|72|||
48950335|NCT03964415|157648640|FG000|Overall Study|Physician Decision|34|||
48950336|NCT03964415|157648641|FG001|Overall Study|Physician Decision|48|||
48950337|NCT03964415|157648640|FG000|Overall Study|Adverse Event|3|||
48950338|NCT03964415|157648641|FG001|Overall Study|Adverse Event|0|||
48950339|NCT03964415|157648640|FG000|Overall Study|Death|4|||
48950340|NCT03964415|157648641|FG001|Overall Study|Death|6|||
48950341|NCT03964415|157648640|FG000|Overall Study|Protocol Violation|1|||
48950342|NCT03964415|157648641|FG001|Overall Study|Protocol Violation|4|||
48950343|NCT03964415|157648640|FG000|Overall Study|Other|35|||
48950344|NCT03964415|157648641|FG001|Overall Study|Other|38|||
48950345|NCT03964415|157648640|FG000|Overall Study|Randomized but not treated|6|||
48950346|NCT03964415|157648641|FG001|Overall Study|Randomized but not treated|7|||
48950347|NCT01302769|157648643|FG000|Overall Study|Lost to Follow-up|1|||
48950348|NCT01302769|157648644|FG001|Overall Study|Lost to Follow-up|1|||
48950349|NCT00309777|157648649|FG000|Overall Study|Adverse Event|13|||
48950350|NCT00309777|157648650|FG001|Overall Study|Adverse Event|2|||
48950351|NCT00309777|157648651|FG002|Overall Study|Adverse Event|8|||
48950352|NCT00309777|157648652|FG003|Overall Study|Adverse Event|1|||
48950353|NCT00309777|157648649|FG000|Overall Study|Protocol Violation|4|||
48950354|NCT00309777|157648650|FG001|Overall Study|Protocol Violation|1|||
48950355|NCT00309777|157648651|FG002|Overall Study|Protocol Violation|3|||
48950356|NCT00309777|157648652|FG003|Overall Study|Protocol Violation|1|||
48950357|NCT00309777|157648649|FG000|Overall Study|Withdrawal by Subject|6|||
48950358|NCT00309777|157648650|FG001|Overall Study|Withdrawal by Subject|5|||
48950359|NCT00309777|157648651|FG002|Overall Study|Withdrawal by Subject|7|||
48950360|NCT00309777|157648652|FG003|Overall Study|Withdrawal by Subject|2|||
48950361|NCT00309777|157648649|FG000|Overall Study|Lost to Follow-up|0|||
48950362|NCT00309777|157648650|FG001|Overall Study|Lost to Follow-up|0|||
48950363|NCT00309777|157648651|FG002|Overall Study|Lost to Follow-up|1|||
48950364|NCT00309777|157648652|FG003|Overall Study|Lost to Follow-up|0|||
48950365|NCT00309777|157648649|FG000|Overall Study|Death|0|||
48950366|NCT00309777|157648650|FG001|Overall Study|Death|1|||
48950367|NCT00309777|157648651|FG002|Overall Study|Death|0|||
48950368|NCT00309777|157648652|FG003|Overall Study|Death|0|||
48950369|NCT03494725|157648653|FG000|Overall Study|Withdrawal by Subject|0|||
48950370|NCT03494725|157648654|FG001|Overall Study|Withdrawal by Subject|2|||
48950371|NCT03494725|157648653|FG000|Overall Study|Antibiotic use|1|||
48950372|NCT03494725|157648654|FG001|Overall Study|Antibiotic use|0|||
48950373|NCT00149825|157648655|FG000|Overall Study|Intolerance to medication side effects|1|||
48950374|NCT00149825|157648656|FG001|Overall Study|Intolerance to medication side effects|2|||
48950375|NCT00149825|157648655|FG000|Overall Study|Time commitments|2|||
48950376|NCT00149825|157648656|FG001|Overall Study|Time commitments|1|||
48950377|NCT00149825|157648655|FG000|Overall Study|Not liking insomnia therapy|1|||
48950378|NCT00149825|157648656|FG001|Overall Study|Not liking insomnia therapy|0|||
48950379|NCT00149825|157648655|FG000|Overall Study|Other|1|||
48950380|NCT00149825|157648656|FG001|Overall Study|Other|0|||
48950381|NCT02062151|157648657|FG000|Overall Study|screen failure|1|||
48950382|NCT02983292|157648658|FG000|Overall Study|Participant unwell & cannot travel|2|||
48950383|NCT02983292|157648658|FG000|Overall Study|Lost to Follow-up|3|||
48950384|NCT02983292|157648658|FG000|Overall Study|Participant withdrew consent|2|||
48950385|NCT02983292|157648658|FG000|Overall Study|Revision|7|||
48950386|NCT02983292|157648658|FG000|Overall Study|Death|1|||
48950387|NCT02983292|157648658|FG000|Overall Study|Participant did not return due to COVID-19 related lockdown|30|||
48950388|NCT02983292|157648658|FG000|Overall Study|Participant failed to return for follow-up visits|6|||
48950389|NCT02983292|157648658|FG000|Overall Study|Participant relocation|1|||
48950390|NCT02335450|157648662|FG000|Overall Study|Pregnancy|1|||
48950391|NCT01004146|157648671|FG000|Overall Study|Withdrawal by Subject|4|||
48950392|NCT01004146|157648672|FG001|Overall Study|Withdrawal by Subject|5|||
48950393|NCT00455858|157648673|FG000|Overall Study|Lost to Follow-up|2|||
48950394|NCT00455858|157648673|FG000|Overall Study|Protocol Violation|1|||
48950395|NCT00455858|157648673|FG000|Overall Study|Lack of Efficacy|1|||
48950396|NCT00455858|157648673|FG000|Overall Study|Well controlled FPG without insulin|1|||
48950397|NCT00455858|157648673|FG000|Overall Study|Withdrawal|1|||
48950398|NCT05258058|157648674|FG000|Overall Study|Withdrawal by Subject|2|||
48950399|NCT00227877|157648679|FG000|Pre-visit Assessment|Technical difficulties|7|||
48950400|NCT00227877|157648680|FG001|Pre-visit Assessment|Technical difficulties|3|||
48950401|NCT00227877|157648681|FG002|Pre-visit Assessment|Technical difficulties|0|||
48950402|NCT00227877|157648682|FG003|Pre-visit Assessment|Technical difficulties|0|||
48950403|NCT00227877|157648679|FG000|Post-visit Checklist|Lost to Follow-up|24|||
48741540|NCT00799383|156903118|FG000|Overall Study|Adverse Event|0|||
48741541|NCT00799383|156903119|FG001|Overall Study|Adverse Event|1|||
48741542|NCT00799383|156903118|FG000|Overall Study|Lost to Follow-up|1|||
48741543|NCT00799383|156903119|FG001|Overall Study|Lost to Follow-up|2|||
48741544|NCT00799383|156903118|FG000|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
48741545|NCT00799383|156903119|FG001|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
48741546|NCT00799383|156903118|FG000|Overall Study|Withdrawal by Subject|0|||
48741547|NCT00799383|156903119|FG001|Overall Study|Withdrawal by Subject|1|||
48741548|NCT00850343|156903123|FG000|Overall Study|Withdrawal by Subject|11|||
48741549|NCT00850343|156903124|FG001|Overall Study|Withdrawal by Subject|0|||
48741550|NCT00850343|156903125|FG002|Overall Study|Withdrawal by Subject|3|||
48741551|NCT00850343|156903126|FG003|Overall Study|Withdrawal by Subject|2|||
48741552|NCT00850343|156903123|FG000|Overall Study|Adverse Event|15|||
48741553|NCT00850343|156903124|FG001|Overall Study|Adverse Event|2|||
48741554|NCT00850343|156903125|FG002|Overall Study|Adverse Event|6|||
48741555|NCT00850343|156903126|FG003|Overall Study|Adverse Event|6|||
48741556|NCT00850343|156903123|FG000|Overall Study|Pregnancy|0|||
48741557|NCT00850343|156903124|FG001|Overall Study|Pregnancy|0|||
48741558|NCT00850343|156903125|FG002|Overall Study|Pregnancy|0|||
48950404|NCT00227877|157648680|FG001|Post-visit Checklist|Lost to Follow-up|13|||
48950405|NCT00227877|157648681|FG002|Post-visit Checklist|Lost to Follow-up|1|||
48950406|NCT00227877|157648682|FG003|Post-visit Checklist|Lost to Follow-up|0|||
48950407|NCT00227877|157648679|FG000|3-months Follow-up|Completed late|135|||
48950408|NCT00227877|157648680|FG001|3-months Follow-up|Completed late|128|||
48741559|NCT00850343|156903126|FG003|Overall Study|Pregnancy|1|||
48741560|NCT00850343|156903123|FG000|Overall Study|Lack of Efficacy|17|||
48741561|NCT00850343|156903124|FG001|Overall Study|Lack of Efficacy|0|||
48950409|NCT00227877|157648681|FG002|3-months Follow-up|Completed late|34|||
48950410|NCT00227877|157648682|FG003|3-months Follow-up|Completed late|8|||
48741562|NCT00850343|156903125|FG002|Overall Study|Lack of Efficacy|3|||
48741563|NCT00850343|156903126|FG003|Overall Study|Lack of Efficacy|2|||
48741564|NCT00850343|156903123|FG000|Overall Study|Non-compliance with Study Procedures|1|||
48741565|NCT00850343|156903124|FG001|Overall Study|Non-compliance with Study Procedures|0|||
48741566|NCT00850343|156903125|FG002|Overall Study|Non-compliance with Study Procedures|1|||
48741567|NCT00850343|156903126|FG003|Overall Study|Non-compliance with Study Procedures|1|||
48741568|NCT00850343|156903123|FG000|Overall Study|Physician Decision|2|||
48741569|NCT00850343|156903124|FG001|Overall Study|Physician Decision|1|||
48741570|NCT00850343|156903125|FG002|Overall Study|Physician Decision|1|||
48741571|NCT00850343|156903126|FG003|Overall Study|Physician Decision|1|||
48741572|NCT02570074|156903127|FG000|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1|||
48741573|NCT02570074|156903128|FG001|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0|||
48741574|NCT01626456|156903131|FG000|Overall Study|Withdrawal by Subject|21|||
48741575|NCT01626456|156903132|FG001|Overall Study|Withdrawal by Subject|46|||
48741576|NCT01626456|156903131|FG000|Overall Study|Adverse Event|2|||
48741577|NCT01626456|156903132|FG001|Overall Study|Adverse Event|27|||
48741578|NCT01626456|156903131|FG000|Overall Study|Lost to Follow-up|2|||
48741579|NCT01626456|156903132|FG001|Overall Study|Lost to Follow-up|27|||
48741580|NCT01626456|156903131|FG000|Overall Study|Lack of Efficacy|6|||
48741581|NCT01626456|156903132|FG001|Overall Study|Lack of Efficacy|7|||
48741582|NCT01626456|156903131|FG000|Overall Study|Physician Decision|1|||
48741583|NCT01626456|156903132|FG001|Overall Study|Physician Decision|4|||
48741584|NCT01626456|156903131|FG000|Overall Study|Protocol Violation|1|||
48741585|NCT01626456|156903132|FG001|Overall Study|Protocol Violation|1|||
48741586|NCT01626456|156903131|FG000|Overall Study|Site Closure|2|||
48741587|NCT01626456|156903132|FG001|Overall Study|Site Closure|3|||
48741588|NCT01626456|156903131|FG000|Overall Study|Incarceration|0|||
48741589|NCT01626456|156903132|FG001|Overall Study|Incarceration|2|||
48741590|NCT02587234|156903133|FG000|Overall Study|Withdrawal by Subject|1|||
48741591|NCT02587234|156903134|FG001|Overall Study|Withdrawal by Subject|1|||
48741592|NCT02587234|156903133|FG000|Overall Study|Lost to Follow-up|0|||
48741593|NCT02587234|156903134|FG001|Overall Study|Lost to Follow-up|2|||
48741594|NCT01826604|156903139|FG000|Overall Study|Lost to Follow-up|8|||
48741595|NCT01826604|156903140|FG001|Overall Study|Lost to Follow-up|9|||
48741596|NCT01397890|156903141|FG000|Overall Study|Withdrawal by Subject|7|||
48741597|NCT01397890|156903142|FG001|Overall Study|Withdrawal by Subject|11|||
48741598|NCT01397890|156903141|FG000|Overall Study|Eligibility Criteria Not Fulfilled|7|||
48741599|NCT01397890|156903142|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
48741600|NCT01397890|156903141|FG000|Overall Study|Death|2|||
48741601|NCT01397890|156903142|FG001|Overall Study|Death|3|||
48741602|NCT01397890|156903141|FG000|Overall Study|Lost to Follow-up|1|||
48741603|NCT01397890|156903142|FG001|Overall Study|Lost to Follow-up|4|||
48741604|NCT01397890|156903141|FG000|Overall Study|Condition under Investigation Worsened|1|||
48741605|NCT01397890|156903142|FG001|Overall Study|Condition under Investigation Worsened|3|||
48741606|NCT01397890|156903141|FG000|Overall Study|Adverse Event|1|||
48950411|NCT00227877|157648679|FG000|3-months Follow-up|Lost to Follow-up|178|||
48950412|NCT00227877|157648680|FG001|3-months Follow-up|Lost to Follow-up|139|||
48950413|NCT00227877|157648681|FG002|3-months Follow-up|Lost to Follow-up|18|||
48950414|NCT00227877|157648682|FG003|3-months Follow-up|Lost to Follow-up|13|||
48950415|NCT00227877|157648679|FG000|12-months Follow-up|Completed late|78|||
48741607|NCT01397890|156903142|FG001|Overall Study|Adverse Event|2|||
48741608|NCT01397890|156903141|FG000|Overall Study|Severe Non-Compliance to Protocol|2|||
48741609|NCT01397890|156903142|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
48950416|NCT00227877|157648680|FG001|12-months Follow-up|Completed late|74|||
48950417|NCT00227877|157648681|FG002|12-months Follow-up|Completed late|1|||
48950418|NCT00227877|157648682|FG003|12-months Follow-up|Completed late|0|||
48950419|NCT00227877|157648679|FG000|12-months Follow-up|Lost to Follow-up|232|||
48950420|NCT00227877|157648680|FG001|12-months Follow-up|Lost to Follow-up|189|||
48950421|NCT00227877|157648681|FG002|12-months Follow-up|Lost to Follow-up|30|||
48950422|NCT00227877|157648682|FG003|12-months Follow-up|Lost to Follow-up|26|||
48950423|NCT01413178|157648683|FG000|Overall Study|Toxicity|1|||
48950424|NCT01413178|157648684|FG001|Overall Study|Toxicity|0|||
48950425|NCT01413178|157648683|FG000|Overall Study|Ineligible|0|||
48950426|NCT01413178|157648684|FG001|Overall Study|Ineligible|2|||
48950427|NCT01952015|157648685|FG000|Induction|Protocol Violation|1|||
48950428|NCT01952015|157648685|FG000|Maintenance|Adverse Event|2|||
48950429|NCT01952015|157648685|FG000|Treatment Period 3|Physician Decision|9|||
48950430|NCT00576693|157648686|FG000|Overall Study|Lost to Follow-up|7|||
48950431|NCT00576693|157648687|FG001|Overall Study|Lost to Follow-up|11|||
48741610|NCT01397890|156903141|FG000|Overall Study|Others|2|||
48741611|NCT01397890|156903142|FG001|Overall Study|Others|1|||
48741612|NCT00736944|156903145|FG000|Induction|Death|1|||
48741613|NCT00736944|156903145|FG000|Definitive Treatment|Physician Decision|1|||
48741614|NCT03741062|156903146|FG000|Overall Study|Protocol Violation|1|||
48950432|NCT00576693|157648686|FG000|Overall Study|Withdrawal by Subject|3|||
48950433|NCT00576693|157648687|FG001|Overall Study|Withdrawal by Subject|13|||
48950434|NCT04973228|157648688|FG000|Overall Study|Adverse Event|2|||
48950435|NCT04973228|157648689|FG001|Overall Study|Adverse Event|3|||
48741615|NCT03741062|156903147|FG001|Overall Study|Protocol Violation|0|||
48741616|NCT01030536|156903148|FG000|Overall Study|Withdrawal by Subject|0|||
48854916|NCT00641537|157306931|FG004|96-week Period|Adverse Event|2|||
48854917|NCT00641537|157306932|FG005|96-week Period|Adverse Event|0|||
48854918|NCT00641537|157306933|FG006|96-week Period|Adverse Event|0|||
48854919|NCT00641537|157306934|FG007|96-week Period|Adverse Event|0|||
48854920|NCT00641537|157306927|FG000|96-week Period|Lost to Follow-up|3|||
48854921|NCT00641537|157306928|FG001|96-week Period|Lost to Follow-up|1|||
48854922|NCT00641537|157306929|FG002|96-week Period|Lost to Follow-up|2|||
48854923|NCT00641537|157306930|FG003|96-week Period|Lost to Follow-up|2|||
48854924|NCT00641537|157306931|FG004|96-week Period|Lost to Follow-up|4|||
48950436|NCT04973228|157648688|FG000|Overall Study|Lack of Efficacy|1|||
48950437|NCT04973228|157648689|FG001|Overall Study|Lack of Efficacy|3|||
48950438|NCT04973228|157648688|FG000|Overall Study|Lost to Follow-up|12|||
48950439|NCT04973228|157648689|FG001|Overall Study|Lost to Follow-up|4|||
48950440|NCT04973228|157648688|FG000|Overall Study|Withdrawal by Subject|11|||
48950441|NCT04973228|157648689|FG001|Overall Study|Withdrawal by Subject|4|||
48950442|NCT04973228|157648688|FG000|Overall Study|Did not tolerate application|1|||
48950443|NCT04973228|157648689|FG001|Overall Study|Did not tolerate application|0|||
48950444|NCT04973228|157648688|FG000|Overall Study|Wanted to early terminate and use own product|0|||
48950445|NCT04973228|157648689|FG001|Overall Study|Wanted to early terminate and use own product|1|||
48741617|NCT01030536|156903149|FG001|Overall Study|Withdrawal by Subject|0|||
48741618|NCT01030536|156903150|FG002|Overall Study|Withdrawal by Subject|1|||
48741619|NCT01030536|156903151|FG003|Overall Study|Withdrawal by Subject|0|||
48741620|NCT01030536|156903152|FG004|Overall Study|Withdrawal by Subject|0|||
48741621|NCT01030536|156903148|FG000|Overall Study|undefined|1|||
48741622|NCT01030536|156903149|FG001|Overall Study|undefined|0|||
48741623|NCT01030536|156903150|FG002|Overall Study|undefined|1|||
48741624|NCT01030536|156903151|FG003|Overall Study|undefined|1|||
48741625|NCT01030536|156903152|FG004|Overall Study|undefined|0|||
48741626|NCT01030536|156903148|FG000|Overall Study|Adverse Event|0|||
48741627|NCT01030536|156903149|FG001|Overall Study|Adverse Event|3|||
48741628|NCT01030536|156903150|FG002|Overall Study|Adverse Event|1|||
48741629|NCT01030536|156903151|FG003|Overall Study|Adverse Event|0|||
48741630|NCT01030536|156903152|FG004|Overall Study|Adverse Event|1|||
48741631|NCT01030536|156903148|FG000|Overall Study|Progressive disease|6|||
48854925|NCT00641537|157306932|FG005|96-week Period|Lost to Follow-up|0|||
48741632|NCT01030536|156903149|FG001|Overall Study|Progressive disease|2|||
48741633|NCT01030536|156903150|FG002|Overall Study|Progressive disease|3|||
48741634|NCT01030536|156903151|FG003|Overall Study|Progressive disease|2|||
48741635|NCT01030536|156903152|FG004|Overall Study|Progressive disease|0|||
48854926|NCT00641537|157306933|FG006|96-week Period|Lost to Follow-up|1|||
48854927|NCT00641537|157306934|FG007|96-week Period|Lost to Follow-up|0|||
48854928|NCT00641537|157306927|FG000|96-week Period|Protocol Violation|0|||
48741636|NCT01030536|156903148|FG000|Overall Study|Death|0|||
48741637|NCT01030536|156903149|FG001|Overall Study|Death|1|||
48741638|NCT01030536|156903150|FG002|Overall Study|Death|0|||
48741639|NCT01030536|156903151|FG003|Overall Study|Death|0|||
48741640|NCT01030536|156903152|FG004|Overall Study|Death|0|||
48854929|NCT00641537|157306928|FG001|96-week Period|Protocol Violation|1|||
48741641|NCT01189604|156903156|FG000|Overall Study|Impossible to visit|0|||
48741642|NCT01189604|156903157|FG001|Overall Study|Impossible to visit|0|||
48741643|NCT01189604|156903158|FG002|Overall Study|Impossible to visit|0|||
48854930|NCT00641537|157306929|FG002|96-week Period|Protocol Violation|0|||
48854931|NCT00641537|157306930|FG003|96-week Period|Protocol Violation|1|||
48854932|NCT00641537|157306931|FG004|96-week Period|Protocol Violation|0|||
48854933|NCT00641537|157306932|FG005|96-week Period|Protocol Violation|1|||
48854934|NCT00641537|157306933|FG006|96-week Period|Protocol Violation|0|||
48854935|NCT00641537|157306934|FG007|96-week Period|Protocol Violation|0|||
48854936|NCT00641537|157306927|FG000|96-week Period|Death|2|||
48854937|NCT00641537|157306928|FG001|96-week Period|Death|0|||
48854938|NCT00641537|157306929|FG002|96-week Period|Death|1|||
48854939|NCT00641537|157306930|FG003|96-week Period|Death|0|||
48854940|NCT00641537|157306931|FG004|96-week Period|Death|0|||
48741644|NCT01189604|156903159|FG003|Overall Study|Impossible to visit|0|||
48741645|NCT01189604|156903160|FG004|Overall Study|Impossible to visit|0|||
48741646|NCT01189604|156903161|FG005|Overall Study|Impossible to visit|1|||
48741647|NCT01189604|156903162|FG006|Overall Study|Impossible to visit|0|||
48741648|NCT01189604|156903156|FG000|Overall Study|Adverse Event|0|||
48741649|NCT01189604|156903157|FG001|Overall Study|Adverse Event|1|||
48741650|NCT01189604|156903158|FG002|Overall Study|Adverse Event|0|||
48741651|NCT01189604|156903159|FG003|Overall Study|Adverse Event|0|||
48741652|NCT01189604|156903160|FG004|Overall Study|Adverse Event|2|||
48741653|NCT01189604|156903161|FG005|Overall Study|Adverse Event|0|||
48741654|NCT01189604|156903162|FG006|Overall Study|Adverse Event|1|||
48741655|NCT01189604|156903156|FG000|Overall Study|Withdrawal by Subject|1|||
48741656|NCT01189604|156903157|FG001|Overall Study|Withdrawal by Subject|0|||
48741657|NCT01189604|156903158|FG002|Overall Study|Withdrawal by Subject|0|||
48741658|NCT01189604|156903159|FG003|Overall Study|Withdrawal by Subject|0|||
48741659|NCT01189604|156903160|FG004|Overall Study|Withdrawal by Subject|0|||
48741660|NCT01189604|156903161|FG005|Overall Study|Withdrawal by Subject|0|||
48741661|NCT01189604|156903162|FG006|Overall Study|Withdrawal by Subject|0|||
48741662|NCT02100514|156903163|FG000|Treatment Period|Adverse Event|0|||
48741663|NCT02100514|156903164|FG001|Treatment Period|Adverse Event|5|||
48741664|NCT02100514|156903165|FG002|Treatment Period|Adverse Event|0|||
48741665|NCT02100514|156903166|FG003|Treatment Period|Adverse Event|0|||
48741666|NCT02100514|156903167|FG004|Treatment Period|Adverse Event|0|||
48741667|NCT02100514|156903163|FG000|Treatment Period|Death|2|||
48950446|NCT04973228|157648688|FG000|Overall Study|Missed visits due to new work schedule|1|||
48950447|NCT04973228|157648689|FG001|Overall Study|Missed visits due to new work schedule|0|||
48950448|NCT03090737|157648690|FG000|Overall Study|Other reasons|1|||
48950449|NCT03090737|157648690|FG000|Overall Study|Completed treatment as per protocol|17|||
48950450|NCT03090737|157648690|FG000|Overall Study|Maximum clinical benefit|2|||
48741668|NCT02100514|156903164|FG001|Treatment Period|Death|2|||
48741669|NCT02100514|156903165|FG002|Treatment Period|Death|0|||
48741670|NCT02100514|156903166|FG003|Treatment Period|Death|0|||
48741671|NCT02100514|156903167|FG004|Treatment Period|Death|0|||
48950451|NCT03090737|157648690|FG000|Overall Study|Adverse event unrelated to study drug|7|||
48741672|NCT02100514|156903163|FG000|Treatment Period|Lost to Follow-up|5|||
48741673|NCT02100514|156903164|FG001|Treatment Period|Lost to Follow-up|17|||
48741674|NCT02100514|156903165|FG002|Treatment Period|Lost to Follow-up|0|||
48741675|NCT02100514|156903166|FG003|Treatment Period|Lost to Follow-up|0|||
48741676|NCT02100514|156903167|FG004|Treatment Period|Lost to Follow-up|0|||
48741677|NCT02100514|156903163|FG000|Treatment Period|Did Not Meet Entrance Criteria|0|||
48741678|NCT02100514|156903164|FG001|Treatment Period|Did Not Meet Entrance Criteria|1|||
48741679|NCT02100514|156903165|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
48741680|NCT02100514|156903166|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
48741681|NCT02100514|156903167|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
48741682|NCT02100514|156903163|FG000|Treatment Period|Protocol Violation|1|||
48741683|NCT02100514|156903164|FG001|Treatment Period|Protocol Violation|1|||
48741684|NCT02100514|156903165|FG002|Treatment Period|Protocol Violation|0|||
48741685|NCT02100514|156903166|FG003|Treatment Period|Protocol Violation|0|||
48741686|NCT02100514|156903167|FG004|Treatment Period|Protocol Violation|0|||
48741687|NCT02100514|156903163|FG000|Treatment Period|Withdrawal by Subject|12|||
48741688|NCT02100514|156903164|FG001|Treatment Period|Withdrawal by Subject|37|||
48741689|NCT02100514|156903165|FG002|Treatment Period|Withdrawal by Subject|0|||
48741690|NCT02100514|156903166|FG003|Treatment Period|Withdrawal by Subject|0|||
48741691|NCT02100514|156903167|FG004|Treatment Period|Withdrawal by Subject|0|||
48950452|NCT03090737|157648690|FG000|Overall Study|Study drug toxicity|4|||
48950453|NCT03090737|157648690|FG000|Overall Study|Disease progression|98|||
48854941|NCT00641537|157306932|FG005|96-week Period|Death|0|||
48854942|NCT00641537|157306933|FG006|96-week Period|Death|0|||
48854943|NCT00641537|157306934|FG007|96-week Period|Death|0|||
48854944|NCT00641537|157306927|FG000|96-week Period|Other|4|||
48854945|NCT00641537|157306928|FG001|96-week Period|Other|7|||
48854946|NCT00641537|157306929|FG002|96-week Period|Other|14|||
48854947|NCT00641537|157306930|FG003|96-week Period|Other|9|||
48854948|NCT00641537|157306931|FG004|96-week Period|Other|11|||
48854949|NCT00641537|157306932|FG005|96-week Period|Other|6|||
48854950|NCT00641537|157306933|FG006|96-week Period|Other|4|||
48854951|NCT00641537|157306934|FG007|96-week Period|Other|6|||
48854952|NCT00641537|157306927|FG000|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
48854953|NCT00641537|157306928|FG001|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
48854954|NCT00641537|157306929|FG002|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
48854955|NCT00641537|157306930|FG003|24-Week Supplemental Follow-up Period|Lost to Follow-up|3|||
48854956|NCT00641537|157306931|FG004|24-Week Supplemental Follow-up Period|Lost to Follow-up|2|||
48854957|NCT00641537|157306932|FG005|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
48854958|NCT00641537|157306933|FG006|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
48854959|NCT00641537|157306934|FG007|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
48854960|NCT00641537|157306927|FG000|24-Week Supplemental Follow-up Period|Other|0|||
48854961|NCT00641537|157306928|FG001|24-Week Supplemental Follow-up Period|Other|2|||
48854962|NCT00641537|157306929|FG002|24-Week Supplemental Follow-up Period|Other|2|||
48854963|NCT00641537|157306930|FG003|24-Week Supplemental Follow-up Period|Other|1|||
48854964|NCT00641537|157306931|FG004|24-Week Supplemental Follow-up Period|Other|3|||
48854965|NCT00641537|157306932|FG005|24-Week Supplemental Follow-up Period|Other|0|||
48854966|NCT00641537|157306933|FG006|24-Week Supplemental Follow-up Period|Other|1|||
48854967|NCT00641537|157306934|FG007|24-Week Supplemental Follow-up Period|Other|1|||
48854968|NCT01005914|157306937|FG000|Overall Study|Adverse Event|4|||
48854969|NCT01005914|157306937|FG000|Overall Study|Death|4|||
48854970|NCT01005914|157306937|FG000|Overall Study|Lack of Efficacy|1|||
48854971|NCT01005914|157306937|FG000|Overall Study|Withdrawal by Subject|1|||
48854972|NCT01240785|157306938|FG000|Overall Study|Lost to Follow-up|1|||
48854973|NCT01240785|157306939|FG001|Overall Study|Lost to Follow-up|0|||
48854974|NCT01240785|157306938|FG000|Overall Study|Protocol Violation|0|||
48854975|NCT01240785|157306939|FG001|Overall Study|Protocol Violation|3|||
48854976|NCT00786188|157306940|FG000|Overall Study|Adverse Event|3|||
48854977|NCT00786188|157306941|FG001|Overall Study|Adverse Event|1|||
48854978|NCT00786188|157306940|FG000|Overall Study|Withdrawal by Subject|2|||
48854979|NCT00786188|157306941|FG001|Overall Study|Withdrawal by Subject|0|||
48854980|NCT03100370|157306945|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
48854981|NCT03100370|157306946|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
48854982|NCT03100370|157306947|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
48854983|NCT03100370|157306948|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
48854984|NCT03100370|157306949|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
48854985|NCT03100370|157306950|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
48854986|NCT03138499|157306951|FG000|Overall Study|Lost to Follow-up|1|||
48854987|NCT03138499|157306952|FG001|Overall Study|Lost to Follow-up|0|||
48854988|NCT03138499|157306951|FG000|Overall Study|Participants withdrew consent|1|||
48854989|NCT03138499|157306952|FG001|Overall Study|Participants withdrew consent|0|||
48741692|NCT02100514|156903163|FG000|Treatment Period|Other|9|||
48741693|NCT02100514|156903164|FG001|Treatment Period|Other|11|||
48741694|NCT02100514|156903165|FG002|Treatment Period|Other|0|||
48741695|NCT02100514|156903166|FG003|Treatment Period|Other|0|||
48741696|NCT02100514|156903167|FG004|Treatment Period|Other|0|||
48741697|NCT02100514|156903163|FG000|Extension Period|Withdrew consent|0|||
48741698|NCT02100514|156903164|FG001|Extension Period|Withdrew consent|0|||
48741699|NCT02100514|156903165|FG002|Extension Period|Withdrew consent|2|||
48854990|NCT03138499|157306951|FG000|Overall Study|Participant discontinued study before treatment|0|||
48950454|NCT02239094|157648691|FG000|Overall Study|Withdrawal by Subject|1|||
48950455|NCT02239094|157648691|FG000|Overall Study|Remitted before started|1|||
48854991|NCT03138499|157306952|FG001|Overall Study|Participant discontinued study before treatment|1|||
48854992|NCT03138499|157306951|FG000|Overall Study|Disease Progression|2|||
48950456|NCT04952389|157648692|FG000|Overall Study|Withdrawal by Subject|8|||
48950457|NCT04952389|157648693|FG001|Overall Study|Withdrawal by Subject|4|||
48950458|NCT02050048|157648699|FG000|Overall Study|Lost to Follow-up|0|||
48741700|NCT02100514|156903166|FG003|Extension Period|Withdrew consent|0|||
48741701|NCT02100514|156903167|FG004|Extension Period|Withdrew consent|0|||
48741702|NCT01365052|156903169|FG000|Overall Study|Adverse Event|4|||
48854993|NCT03138499|157306952|FG001|Overall Study|Disease Progression|6|||
48854994|NCT03138499|157306951|FG000|Overall Study|Study drug toxicity|2|||
48854995|NCT03138499|157306952|FG001|Overall Study|Study drug toxicity|2|||
48854996|NCT03138499|157306951|FG000|Overall Study|Participant request to discontinue study treatment|1|||
48854997|NCT03138499|157306952|FG001|Overall Study|Participant request to discontinue study treatment|1|||
48741703|NCT01365052|156903170|FG001|Overall Study|Adverse Event|4|||
48741704|NCT00044083|156903173|FG000|First Intervention (One Week)- HV's|Adverse Event|1|||
48741705|NCT00044083|156903174|FG001|First Intervention (One Week)- HV's|Adverse Event|0|||
48741706|NCT00044083|156903173|FG000|First Intervention (One Week)- HV's|Not follow directions|2|||
48741707|NCT00044083|156903174|FG001|First Intervention (One Week)- HV's|Not follow directions|2|||
48741708|NCT00044083|156903173|FG000|First Intervention (One Week)- HV's|Withdrawal by Subject|5|||
48741709|NCT00044083|156903174|FG001|First Intervention (One Week)- HV's|Withdrawal by Subject|3|||
48741710|NCT00044083|156903173|FG000|First Intervention (One Week)- HV's|Pregnancy|1|||
48741711|NCT00044083|156903174|FG001|First Intervention (One Week)- HV's|Pregnancy|0|||
48741712|NCT00044083|156903173|FG000|First Intervention (One Week)- HV's|Used illegal drugs|1|||
48741713|NCT00044083|156903174|FG001|First Intervention (One Week)- HV's|Used illegal drugs|0|||
48741714|NCT00044083|156903173|FG000|First Intervention (One Week)- HV's|Abnormal MRI|0|||
48741715|NCT00044083|156903174|FG001|First Intervention (One Week)- HV's|Abnormal MRI|1|||
48741716|NCT00044083|156903173|FG000|First Intervention (One Week)- HV's|Drank while on protocol|0|||
48741717|NCT00044083|156903174|FG001|First Intervention (One Week)- HV's|Drank while on protocol|1|||
48741718|NCT00044083|156903173|FG000|First Intervention (One Week) Patients|Not follow directions|0|||
48741719|NCT00044083|156903174|FG001|First Intervention (One Week) Patients|Not follow directions|2|||
48741720|NCT00044083|156903173|FG000|First Intervention (One Week) Patients|Used illegal drug|1|||
48741721|NCT00044083|156903174|FG001|First Intervention (One Week) Patients|Used illegal drug|0|||
48741722|NCT00044083|156903173|FG000|Second Intervention (One Week) Patients|Withdrawal by Subject|0|||
48741723|NCT00044083|156903174|FG001|Second Intervention (One Week) Patients|Withdrawal by Subject|1|||
48741724|NCT04447794|156903180|FG000|Overall Study|Lost to Follow-up|2|||
48741725|NCT04447794|156903181|FG001|Overall Study|Lost to Follow-up|3|||
48741726|NCT04447794|156903182|FG002|Overall Study|Lost to Follow-up|8|||
48741727|NCT04447794|156903180|FG000|Overall Study|Withdrawal by Subject|1|||
48741728|NCT04447794|156903181|FG001|Overall Study|Withdrawal by Subject|1|||
48741729|NCT04447794|156903182|FG002|Overall Study|Withdrawal by Subject|0|||
48741730|NCT05306977|156903185|FG000|Overall Study|Withdrawal by Subject|1|||
48741731|NCT01443078|156903190|FG000|Overall Study|Responded to neoadjuvant platinum txt|27|||
48741732|NCT01443078|156903190|FG000|Overall Study|Withdrawal by Subject|1|||
48741733|NCT01443078|156903190|FG000|Overall Study|Patient had brain mets|1|||
48741734|NCT00781274|156903191|FG000|Overall Study|Withdrawal by Subject|2|||
48741735|NCT00190671|156903193|FG000|Overall Study|Satisfactory Response|4|||
48741736|NCT00190671|156903194|FG001|Overall Study|Satisfactory Response|7|||
48741737|NCT00190671|156903193|FG000|Overall Study|Lack of Efficacy|19|||
48741738|NCT00190671|156903194|FG001|Overall Study|Lack of Efficacy|24|||
48741739|NCT00190671|156903193|FG000|Overall Study|Death from Study Disease|1|||
48741740|NCT00190671|156903194|FG001|Overall Study|Death from Study Disease|1|||
48741741|NCT00190671|156903193|FG000|Overall Study|Adverse Event|3|||
48741742|NCT00190671|156903194|FG001|Overall Study|Adverse Event|2|||
48741743|NCT00190671|156903193|FG000|Overall Study|Clinical Relapse|0|||
48741744|NCT00190671|156903194|FG001|Overall Study|Clinical Relapse|1|||
48741745|NCT00190671|156903193|FG000|Overall Study|Death from Study-Drug Toxicity|0|||
48741746|NCT00190671|156903194|FG001|Overall Study|Death from Study-Drug Toxicity|2|||
48741747|NCT00190671|156903193|FG000|Overall Study|Death from Other Causes|0|||
48741748|NCT00190671|156903194|FG001|Overall Study|Death from Other Causes|2|||
48741749|NCT00190671|156903193|FG000|Overall Study|Protocol Violation|0|||
48741750|NCT00190671|156903194|FG001|Overall Study|Protocol Violation|1|||
48741751|NCT00190671|156903193|FG000|Overall Study|Withdrawal by Subject|0|||
48741752|NCT00190671|156903194|FG001|Overall Study|Withdrawal by Subject|2|||
48741753|NCT00457301|156903195|FG000|Overall Study|Withdrawal by Subject|3|||
48741754|NCT00457301|156903196|FG001|Overall Study|Withdrawal by Subject|3|||
48741755|NCT00457301|156903195|FG000|Overall Study|Censored out of the study|15|||
48741756|NCT00457301|156903196|FG001|Overall Study|Censored out of the study|14|||
48854998|NCT03138499|157306951|FG000|Overall Study|Other reasons|2|||
48854999|NCT03138499|157306952|FG001|Overall Study|Other reasons|0|||
48741757|NCT00457301|156903195|FG000|Overall Study|Death|5|||
48741758|NCT00457301|156903196|FG001|Overall Study|Death|7|||
48741759|NCT01702961|156903197|FG000|Overall Study|Additional treatment|3|||
48741760|NCT01702961|156903197|FG000|Overall Study|Progressive disease|5|||
48741761|NCT01702961|156903197|FG000|Overall Study|Relapse|20|||
48855000|NCT02892019|157306953|FG000|Overall Study|randomized but not treated|0|||
48855001|NCT02892019|157306954|FG001|Overall Study|randomized but not treated|1|||
48855002|NCT02892019|157306953|FG000|Overall Study|Withdrawal by Subject|0|||
48855003|NCT02892019|157306954|FG001|Overall Study|Withdrawal by Subject|1|||
48855004|NCT02892019|157306953|FG000|Overall Study|Adverse Event|1|||
48855005|NCT02892019|157306954|FG001|Overall Study|Adverse Event|1|||
48855006|NCT02442622|157306957|FG000|Overall Study|Withdrawal by Subject|3|||
48855007|NCT02442622|157306958|FG001|Overall Study|Withdrawal by Subject|1|||
48855008|NCT05184062|157306959|FG000|Overall Study|Lost to Follow-up|5|||
48855009|NCT05184062|157306960|FG001|Overall Study|Lost to Follow-up|1|||
48855010|NCT05184062|157306959|FG000|Overall Study|Withdrawal by Subject|1|||
48855011|NCT05184062|157306960|FG001|Overall Study|Withdrawal by Subject|0|||
48855012|NCT04984889|157306961|FG000|Extension Part|Ongoing|5|||
48855013|NCT04097535|157306962|FG000|Overall Study|[18F]FPIA/radiotracer production failure - Participant subsequently withdrew consent.|1|||
48855014|NCT03905642|157306963|FG000|Overall Study|Withdrawal by Subject|3|||
48855015|NCT03905642|157306963|FG000|Overall Study|Pregnancy|1|||
48855016|NCT03905642|157306963|FG000|Overall Study|Adverse Event|1|||
48855017|NCT03905642|157306963|FG000|Overall Study|Lack of Efficacy|1|||
48855018|NCT03905642|157306963|FG000|Overall Study|Completed study but not 24 of 28 days|2|||
48855019|NCT05405244|157308525|FG000|Washout (2 Weeks)|Lost to Follow-up|0|||
48855020|NCT05405244|157308526|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
48855021|NCT05405244|157308525|FG000|Washout (2 Weeks)|Adverse Event|2|||
48855022|NCT05405244|157308526|FG001|Washout (2 Weeks)|Adverse Event|0|||
48855023|NCT05405244|157308525|FG000|Washout (2 Weeks)|Withdrawal by Subject|2|||
48855024|NCT05405244|157308526|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
48855025|NCT00019604|157308527|FG000|Overall Study|Death|1|||
48855026|NCT00019604|157308527|FG000|Overall Study|Progressive disease|23|||
48855027|NCT00019604|157308527|FG000|Overall Study|Refused treatment|1|||
48855028|NCT00019604|157308527|FG000|Overall Study|Carcinoid tumor, not treatable|1|||
48855029|NCT00019604|157308527|FG000|Overall Study|Going to have liver transplant|1|||
48855030|NCT00019604|157308527|FG000|Overall Study|Move to a different study|1|||
48855031|NCT00019604|157308527|FG000|Overall Study|Non compliant on systemic CH|1|||
48855032|NCT00019604|157308527|FG000|Overall Study|Non compliant|1|||
48855033|NCT00019604|157308527|FG000|Overall Study|Resectable disease|1|||
48855034|NCT00019604|157308527|FG000|Overall Study|Started new chemo regimen|1|||
48741762|NCT01702961|156903197|FG000|Overall Study|Death|6|||
48741763|NCT01702961|156903197|FG000|Overall Study|Lost to Follow-up|2|||
48741764|NCT01702961|156903197|FG000|Overall Study|Ongoing|11|||
48741765|NCT02229383|156903198|FG000|Overall Study|Adverse Event|7|||
48741766|NCT02229383|156903199|FG001|Overall Study|Adverse Event|4|||
48741767|NCT02229383|156903198|FG000|Overall Study|Death|0|||
48741768|NCT02229383|156903199|FG001|Overall Study|Death|1|||
48741769|NCT02229383|156903198|FG000|Overall Study|Lost to Follow-up|5|||
48741770|NCT02229383|156903199|FG001|Overall Study|Lost to Follow-up|3|||
48741771|NCT02229383|156903198|FG000|Overall Study|Withdrawal by Subject|4|||
48741772|NCT02229383|156903199|FG001|Overall Study|Withdrawal by Subject|6|||
48741773|NCT02229383|156903198|FG000|Overall Study|Did not receive treatment|1|||
48741774|NCT02229383|156903199|FG001|Overall Study|Did not receive treatment|0|||
48741775|NCT02229383|156903198|FG000|Overall Study|Other|3|||
48741776|NCT02229383|156903199|FG001|Overall Study|Other|8|||
48741777|NCT04057365|156903200|FG000|Overall Study|Withdrawal by Subject|2|||
48741778|NCT04057365|156903201|FG001|Overall Study|Withdrawal by Subject|0|||
48741779|NCT01133522|156903204|FG000|Overall Study|Withdrawal by Subject|0|||
48741780|NCT01133522|156903205|FG001|Overall Study|Withdrawal by Subject|1|||
48741781|NCT01133522|156903206|FG002|Overall Study|Withdrawal by Subject|0|||
48950459|NCT02050048|157648700|FG001|Overall Study|Lost to Follow-up|1|||
48950460|NCT02050048|157648699|FG000|Overall Study|Death|1|||
48741782|NCT01133522|156903207|FG003|Overall Study|Withdrawal by Subject|1|||
48741783|NCT01133522|156903208|FG004|Overall Study|Withdrawal by Subject|0|||
48741784|NCT01133522|156903209|FG005|Overall Study|Withdrawal by Subject|0|||
48950461|NCT02050048|157648700|FG001|Overall Study|Death|0|||
48950462|NCT02050048|157648699|FG000|Overall Study|Ineligible after ERCP|4|||
48741785|NCT01133522|156903210|FG006|Overall Study|Withdrawal by Subject|0|||
48855035|NCT00019604|157308527|FG000|Overall Study|Pt going to immunotherapy study|1|||
48855036|NCT00019604|157308527|FG000|Overall Study|Too much disease|1|||
48855037|NCT00019604|157308527|FG000|Overall Study|Unable to evaluate|1|||
48855038|NCT00019604|157308527|FG000|Overall Study|Details for other not available|4|||
48855039|NCT00569166|157308529|FG000|Overall Study|Withdrawal by Subject|7|||
48950463|NCT02050048|157648700|FG001|Overall Study|Ineligible after ERCP|1|||
48950464|NCT01903434|157648703|FG000|Washout Period 1 (at Least 14 Days)|Adverse Event|1|||
48741786|NCT01133522|156903211|FG007|Overall Study|Withdrawal by Subject|0|||
48741787|NCT01133522|156903212|FG008|Overall Study|Withdrawal by Subject|0|||
48741788|NCT01133522|156903213|FG009|Overall Study|Withdrawal by Subject|0|||
48741789|NCT01133522|156903204|FG000|Overall Study|Physician Decision|0|||
48741790|NCT01133522|156903205|FG001|Overall Study|Physician Decision|0|||
48855040|NCT00569166|157308530|FG001|Overall Study|Withdrawal by Subject|5|||
48741791|NCT01133522|156903206|FG002|Overall Study|Physician Decision|0|||
48741792|NCT01133522|156903207|FG003|Overall Study|Physician Decision|0|||
48741793|NCT01133522|156903208|FG004|Overall Study|Physician Decision|1|||
48741794|NCT01133522|156903209|FG005|Overall Study|Physician Decision|0|||
48741795|NCT01133522|156903210|FG006|Overall Study|Physician Decision|0|||
48741796|NCT01133522|156903211|FG007|Overall Study|Physician Decision|0|||
48741797|NCT01133522|156903212|FG008|Overall Study|Physician Decision|0|||
48741798|NCT01133522|156903213|FG009|Overall Study|Physician Decision|0|||
48741799|NCT00668707|156903214|FG000|Overall Study|Cancer Recurrence|58|||
48741800|NCT00668707|156903215|FG001|Overall Study|Cancer Recurrence|58|||
48741801|NCT00668707|156903214|FG000|Overall Study|Withdrawal by Subject|117|||
48741802|NCT00668707|156903215|FG001|Overall Study|Withdrawal by Subject|100|||
48741803|NCT00668707|156903214|FG000|Overall Study|Lost to Follow-up|3|||
48741804|NCT00668707|156903215|FG001|Overall Study|Lost to Follow-up|6|||
48741805|NCT00668707|156903214|FG000|Overall Study|Protocol Violation|10|||
48950465|NCT01903434|157648704|FG001|Washout Period 1 (at Least 14 Days)|Adverse Event|0|||
48950466|NCT01903434|157648703|FG000|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0|||
48950467|NCT01903434|157648704|FG001|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2|||
48950468|NCT01469052|157648705|FG000|Overall Study|Adverse Event|2|||
48950469|NCT01469052|157648706|FG001|Overall Study|Adverse Event|3|||
48950470|NCT01469052|157648707|FG002|Overall Study|Adverse Event|0|||
48950471|NCT01469052|157648708|FG003|Overall Study|Adverse Event|2|||
48950472|NCT01469052|157648709|FG004|Overall Study|Adverse Event|0|||
48950473|NCT01469052|157648710|FG005|Overall Study|Adverse Event|1|||
48950474|NCT01469052|157648705|FG000|Overall Study|Progressive disease|3|||
48950475|NCT01469052|157648706|FG001|Overall Study|Progressive disease|0|||
48950476|NCT01469052|157648707|FG002|Overall Study|Progressive disease|5|||
48950477|NCT01469052|157648708|FG003|Overall Study|Progressive disease|3|||
48950478|NCT01469052|157648709|FG004|Overall Study|Progressive disease|7|||
48950479|NCT01469052|157648710|FG005|Overall Study|Progressive disease|2|||
48950480|NCT01469052|157648705|FG000|Overall Study|Lack of Efficacy|0|||
48950481|NCT01469052|157648706|FG001|Overall Study|Lack of Efficacy|0|||
48950482|NCT01469052|157648707|FG002|Overall Study|Lack of Efficacy|0|||
48950483|NCT01469052|157648708|FG003|Overall Study|Lack of Efficacy|0|||
48950484|NCT01469052|157648709|FG004|Overall Study|Lack of Efficacy|0|||
48950485|NCT01469052|157648710|FG005|Overall Study|Lack of Efficacy|2|||
48950486|NCT01469052|157648705|FG000|Overall Study|Moved to rollover protocol|1|||
48950487|NCT01469052|157648706|FG001|Overall Study|Moved to rollover protocol|0|||
48950488|NCT01469052|157648707|FG002|Overall Study|Moved to rollover protocol|1|||
48950489|NCT01469052|157648708|FG003|Overall Study|Moved to rollover protocol|0|||
48950490|NCT01469052|157648709|FG004|Overall Study|Moved to rollover protocol|0|||
48950491|NCT01469052|157648710|FG005|Overall Study|Moved to rollover protocol|1|||
48950492|NCT01469052|157648705|FG000|Overall Study|Other|0|||
48950493|NCT01469052|157648706|FG001|Overall Study|Other|1|||
48950494|NCT01469052|157648707|FG002|Overall Study|Other|0|||
48950495|NCT01469052|157648708|FG003|Overall Study|Other|0|||
48950496|NCT01469052|157648709|FG004|Overall Study|Other|1|||
48950497|NCT01469052|157648710|FG005|Overall Study|Other|0|||
48950498|NCT03141307|157648711|FG000|In-Hospital|Withdrawal by Subject|0|||
48950499|NCT03141307|157648712|FG001|In-Hospital|Withdrawal by Subject|2|||
48950500|NCT03141307|157648711|FG000|In-Hospital|Protocol Violation|4|||
48950501|NCT03141307|157648712|FG001|In-Hospital|Protocol Violation|0|||
48950502|NCT03141307|157648711|FG000|Follow-Up|Lost to Follow-up|97|||
48950503|NCT03141307|157648712|FG001|Follow-Up|Lost to Follow-up|54|||
48950504|NCT01597193|157648715|FG000|Stage 1: Dose Escalation (141 Days)|Disease progression|7|||
48950505|NCT01597193|157648716|FG001|Stage 1: Dose Escalation (141 Days)|Disease progression|8|||
48950506|NCT01597193|157648717|FG002|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
48950507|NCT01597193|157648718|FG003|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
48950508|NCT01597193|157648719|FG004|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
48741806|NCT00668707|156903215|FG001|Overall Study|Protocol Violation|12|||
48741807|NCT00668707|156903214|FG000|Overall Study|Death|11|||
48741808|NCT00668707|156903215|FG001|Overall Study|Death|4|||
48741809|NCT00672646|156903217|FG000|Overall Study|Lost to Follow-up|0|||
48950509|NCT01597193|157648720|FG005|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
48950510|NCT01597193|157648721|FG006|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
48741810|NCT00672646|156903218|FG001|Overall Study|Lost to Follow-up|1|||
48741811|NCT00672646|156903219|FG002|Overall Study|Lost to Follow-up|2|||
48741812|NCT00672646|156903217|FG000|Overall Study|Withdrawal by Subject|0|||
48741813|NCT00672646|156903218|FG001|Overall Study|Withdrawal by Subject|0|||
48741814|NCT00672646|156903219|FG002|Overall Study|Withdrawal by Subject|1|||
48741815|NCT03386448|156903220|FG000|Overall Study|Adverse Event|0|||
48855041|NCT00569166|157308531|FG002|Overall Study|Withdrawal by Subject|3|||
48741816|NCT03386448|156903221|FG001|Overall Study|Adverse Event|2|||
48741817|NCT02657369|156903222|FG000|Overall Study|Death|27|||
48741818|NCT02657369|156903222|FG000|Overall Study|Study terminated by sponsor|7|||
48741819|NCT04094883|156903225|FG000|Overall Study|Withdrawal by Subject|1|||
48741820|NCT03298867|156903226|FG000|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
48741821|NCT03298867|156903227|FG001|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
48741822|NCT03298867|156903226|FG000|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
48741823|NCT03298867|156903227|FG001|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
48741824|NCT03298867|156903226|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|1|||
48741825|NCT03298867|156903227|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|9|||
48741826|NCT03298867|156903226|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|0|||
48741827|NCT03298867|156903227|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|1|||
48741828|NCT03298867|156903226|FG000|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|0|||
48741829|NCT03298867|156903227|FG001|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|1|||
48741830|NCT03298867|156903226|FG000|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|0|||
48741831|NCT03298867|156903227|FG001|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|2|||
48741832|NCT03298867|156903226|FG000|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|0|||
48741833|NCT03298867|156903227|FG001|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|1|||
48741834|NCT03298867|156903226|FG000|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|0|||
48741835|NCT03298867|156903227|FG001|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|2|||
48741836|NCT03298867|156903226|FG000|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|0|||
48741837|NCT03298867|156903227|FG001|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|1|||
48741838|NCT00300274|156903229|FG000|Overall Study|Withdrawal by Subject|12|||
48741839|NCT00300274|156903230|FG001|Overall Study|Withdrawal by Subject|3|||
48741840|NCT00300274|156903231|FG002|Overall Study|Withdrawal by Subject|14|||
48855042|NCT00569166|157308529|FG000|Overall Study|Lost to Follow-up|2|||
48855043|NCT00569166|157308530|FG001|Overall Study|Lost to Follow-up|1|||
48855044|NCT00569166|157308531|FG002|Overall Study|Lost to Follow-up|1|||
48855045|NCT03292406|157308532|FG000|Overall Study|Progressive Disease|6|||
48855046|NCT03292406|157308533|FG001|Overall Study|Progressive Disease|3|||
48855047|NCT03292406|157308534|FG002|Overall Study|Progressive Disease|4|||
48855048|NCT03292406|157308532|FG000|Overall Study|Adverse Event|7|||
48855049|NCT03292406|157308533|FG001|Overall Study|Adverse Event|1|||
48855050|NCT03292406|157308534|FG002|Overall Study|Adverse Event|4|||
48855051|NCT03292406|157308532|FG000|Overall Study|Withdrawal by Subject|0|||
48855052|NCT03292406|157308533|FG001|Overall Study|Withdrawal by Subject|7|||
48855053|NCT03292406|157308534|FG002|Overall Study|Withdrawal by Subject|2|||
48855054|NCT03292406|157308532|FG000|Overall Study|Protocol Violation|0|||
48855055|NCT03292406|157308533|FG001|Overall Study|Protocol Violation|1|||
48855056|NCT03292406|157308534|FG002|Overall Study|Protocol Violation|1|||
48855057|NCT03292406|157308532|FG000|Overall Study|Other|0|||
48855058|NCT03292406|157308533|FG001|Overall Study|Other|1|||
48855059|NCT03292406|157308534|FG002|Overall Study|Other|2|||
48855060|NCT04658784|157308535|FG000|6-month Follow-up|Lost to Follow-up|2|||
48855061|NCT04658784|157308536|FG001|6-month Follow-up|Lost to Follow-up|5|||
48855062|NCT03392194|157308537|FG000|Overall Study|Withdrawal by Subject|1|||
48855063|NCT03392194|157308538|FG001|Overall Study|Withdrawal by Subject|2|||
48741841|NCT00300274|156903229|FG000|Overall Study|Lost to Follow-up|3|||
48950511|NCT01597193|157648715|FG000|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
48950512|NCT01597193|157648716|FG001|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
48950513|NCT01597193|157648717|FG002|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
48950514|NCT01597193|157648718|FG003|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1|||
48741842|NCT00300274|156903230|FG001|Overall Study|Lost to Follow-up|4|||
48741843|NCT00300274|156903231|FG002|Overall Study|Lost to Follow-up|5|||
48741844|NCT00300274|156903229|FG000|Overall Study|Death|31|||
48741845|NCT00300274|156903230|FG001|Overall Study|Death|20|||
48741846|NCT00300274|156903231|FG002|Overall Study|Death|25|||
48741847|NCT00300274|156903229|FG000|Overall Study|Re-transplant|0|||
48741848|NCT00300274|156903230|FG001|Overall Study|Re-transplant|0|||
48741849|NCT00300274|156903231|FG002|Overall Study|Re-transplant|1|||
48741850|NCT02400333|156904345|FG000|Overall Study|Withdrawal by Subject|0|||
48741851|NCT02400333|156904346|FG001|Overall Study|Withdrawal by Subject|1|||
48741852|NCT02400333|156904347|FG002|Overall Study|Withdrawal by Subject|0|||
48741853|NCT02400333|156904348|FG003|Overall Study|Withdrawal by Subject|1|||
48741854|NCT02400333|156904345|FG000|Overall Study|Protocol Violation|1|||
48741855|NCT02400333|156904346|FG001|Overall Study|Protocol Violation|0|||
48741856|NCT02400333|156904347|FG002|Overall Study|Protocol Violation|2|||
48741857|NCT02400333|156904348|FG003|Overall Study|Protocol Violation|1|||
48741858|NCT00354744|156904349|FG000|Overall Study|Adverse Event|2|||
48741859|NCT00354744|156904349|FG000|Overall Study|Death|2|||
48741860|NCT00354744|156904349|FG000|Overall Study|Lack of Efficacy|11|||
48741861|NCT00354744|156904349|FG000|Overall Study|Lost to Follow-up|2|||
48741862|NCT00354744|156904349|FG000|Overall Study|Physician Decision|11|||
48741863|NCT00354744|156904349|FG000|Overall Study|Withdrawal by Subject|14|||
48741864|NCT00934089|156904350|FG000|First Intervention Period (14 Days)|Withdrawal by Subject|1|||
48741865|NCT00934089|156904351|FG001|First Intervention Period (14 Days)|Withdrawal by Subject|0|||
48741866|NCT00934089|156904350|FG000|First Intervention Period (14 Days)|Randomized, but not treated|1|||
48741867|NCT00934089|156904351|FG001|First Intervention Period (14 Days)|Randomized, but not treated|0|||
48741868|NCT05350410|156904356|FG000|Overall Study|Withdrawal by Subject|1|||
48741869|NCT03750955|156904357|FG000|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
48741870|NCT03750955|156904358|FG001|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
48741871|NCT03750955|156904357|FG000|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
48741872|NCT03750955|156904358|FG001|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
48741873|NCT00705289|156904362|FG000|Overall Study|Subject or treating physician's choice|131|||
48741874|NCT00091442|156904365|FG000|Overall Study|Progressive Disease|220|||
48741875|NCT00091442|156904366|FG001|Overall Study|Progressive Disease|189|||
48741876|NCT00091442|156904365|FG000|Overall Study|Physician Decision|61|||
48741877|NCT00091442|156904366|FG001|Overall Study|Physician Decision|58|||
48741878|NCT00091442|156904365|FG000|Overall Study|Withdrawal by Subject|38|||
48741879|NCT00091442|156904366|FG001|Overall Study|Withdrawal by Subject|46|||
48741880|NCT00091442|156904365|FG000|Overall Study|Adverse Event|29|||
48741881|NCT00091442|156904366|FG001|Overall Study|Adverse Event|48|||
48741882|NCT00091442|156904365|FG000|Overall Study|2cycles therapy beyond Complete response|9|||
48741883|NCT00091442|156904366|FG001|Overall Study|2cycles therapy beyond Complete response|16|||
48741884|NCT00091442|156904365|FG000|Overall Study|Death|9|||
48741885|NCT00091442|156904366|FG001|Overall Study|Death|7|||
48741886|NCT00091442|156904365|FG000|Overall Study|Lost to Follow-up|1|||
48741887|NCT00091442|156904366|FG001|Overall Study|Lost to Follow-up|3|||
48741888|NCT00091442|156904365|FG000|Overall Study|Other|2|||
48741889|NCT00091442|156904366|FG001|Overall Study|Other|6|||
48741890|NCT03417219|156904367|FG000|Overall Study|Lost to Follow-up|0|||
48741891|NCT03417219|156904368|FG001|Overall Study|Lost to Follow-up|3|||
48741892|NCT02038881|156904369|FG000|Overall Study|Withdrawal by Subject|0|||
48741893|NCT02038881|156904370|FG001|Overall Study|Withdrawal by Subject|0|||
48741894|NCT02038881|156904371|FG002|Overall Study|Withdrawal by Subject|1|||
48741895|NCT02038881|156904369|FG000|Overall Study|Lost to Follow-up|2|||
48741896|NCT02038881|156904370|FG001|Overall Study|Lost to Follow-up|0|||
48741897|NCT02038881|156904371|FG002|Overall Study|Lost to Follow-up|0|||
48741898|NCT02038881|156904369|FG000|Overall Study|incarcerated|1|||
48741899|NCT02038881|156904370|FG001|Overall Study|incarcerated|0|||
48950515|NCT01597193|157648719|FG004|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2|||
48741900|NCT02038881|156904371|FG002|Overall Study|incarcerated|0|||
48741901|NCT03978832|156904372|FG000|Overall Study|Adverse Event|1|||
48741902|NCT03978832|156904372|FG000|Overall Study|Lost to Follow-up|1|||
48741903|NCT03978832|156904372|FG000|Overall Study|Withdrawal by Subject|6|||
48741904|NCT03978832|156904372|FG000|Overall Study|Physician Decision|2|||
48741905|NCT03978832|156904372|FG000|Overall Study|did not pass screening criteria|44|||
48741906|NCT00845858|156904373|FG000|Overall Study|Withdrawal by Subject|5|||
48741907|NCT00845858|156904374|FG001|Overall Study|Withdrawal by Subject|1|||
48741908|NCT00845858|156904375|FG002|Overall Study|Withdrawal by Subject|1|||
48741909|NCT00845858|156904373|FG000|Overall Study|Adverse Event|3|||
48741910|NCT00845858|156904374|FG001|Overall Study|Adverse Event|8|||
48741911|NCT00845858|156904375|FG002|Overall Study|Adverse Event|4|||
48741912|NCT00845858|156904373|FG000|Overall Study|Protocol Violation|0|||
48741913|NCT00845858|156904374|FG001|Overall Study|Protocol Violation|0|||
48741914|NCT00845858|156904375|FG002|Overall Study|Protocol Violation|1|||
48741915|NCT00845858|156904373|FG000|Overall Study|not eligible|0|||
48741916|NCT00845858|156904374|FG001|Overall Study|not eligible|3|||
48741917|NCT00845858|156904375|FG002|Overall Study|not eligible|2|||
48741918|NCT02202980|156904377|FG000|Overall Study|Lack of Efficacy|1|||
48950516|NCT01597193|157648720|FG005|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3|||
48950517|NCT01597193|157648721|FG006|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
48950518|NCT01597193|157648715|FG000|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
48950519|NCT01597193|157648716|FG001|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
48950520|NCT01597193|157648717|FG002|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
48950521|NCT01597193|157648718|FG003|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
48950522|NCT01597193|157648719|FG004|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
48950523|NCT01597193|157648720|FG005|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
48950524|NCT01597193|157648721|FG006|Stage 2: Dose Expansion (1067 Days)|Disease progression|11|||
48950525|NCT01597193|157648715|FG000|Stage 2: Dose Expansion (1067 Days)|Other|0|||
48950526|NCT01597193|157648716|FG001|Stage 2: Dose Expansion (1067 Days)|Other|0|||
48950527|NCT01597193|157648717|FG002|Stage 2: Dose Expansion (1067 Days)|Other|0|||
48950528|NCT01597193|157648718|FG003|Stage 2: Dose Expansion (1067 Days)|Other|0|||
48950529|NCT01597193|157648719|FG004|Stage 2: Dose Expansion (1067 Days)|Other|0|||
48950530|NCT01597193|157648720|FG005|Stage 2: Dose Expansion (1067 Days)|Other|1|||
48950531|NCT01597193|157648721|FG006|Stage 2: Dose Expansion (1067 Days)|Other|0|||
48950532|NCT01597193|157648715|FG000|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
48950533|NCT01597193|157648716|FG001|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
48950534|NCT01597193|157648717|FG002|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
48950535|NCT01597193|157648718|FG003|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
48950536|NCT01597193|157648719|FG004|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
48950537|NCT01597193|157648720|FG005|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
48950538|NCT01597193|157648721|FG006|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
48950539|NCT01522651|157648722|FG000|Overall Study|Adverse Event|3|||
48950540|NCT01522651|157648723|FG001|Overall Study|Adverse Event|4|||
48950541|NCT01522651|157648724|FG002|Overall Study|Adverse Event|4|||
48950542|NCT01522651|157648725|FG003|Overall Study|Adverse Event|5|||
48950543|NCT01522651|157648726|FG004|Overall Study|Adverse Event|4|||
48950544|NCT01522651|157648722|FG000|Overall Study|Cardioversion|1|||
48950545|NCT01522651|157648723|FG001|Overall Study|Cardioversion|0|||
48950546|NCT01522651|157648724|FG002|Overall Study|Cardioversion|0|||
48950547|NCT01522651|157648725|FG003|Overall Study|Cardioversion|0|||
48950548|NCT01522651|157648726|FG004|Overall Study|Cardioversion|0|||
48950549|NCT01522651|157648722|FG000|Overall Study|Device Malfunction|0|||
48950550|NCT01522651|157648723|FG001|Overall Study|Device Malfunction|1|||
48950551|NCT01522651|157648724|FG002|Overall Study|Device Malfunction|0|||
48950552|NCT01522651|157648725|FG003|Overall Study|Device Malfunction|0|||
48950553|NCT01522651|157648726|FG004|Overall Study|Device Malfunction|0|||
48950554|NCT01522651|157648722|FG000|Overall Study|Investigator's Discretion|0|||
48950555|NCT01522651|157648723|FG001|Overall Study|Investigator's Discretion|1|||
48950556|NCT01522651|157648724|FG002|Overall Study|Investigator's Discretion|0|||
48950557|NCT01522651|157648725|FG003|Overall Study|Investigator's Discretion|0|||
48950558|NCT01522651|157648726|FG004|Overall Study|Investigator's Discretion|0|||
48741919|NCT02202980|156904378|FG001|Overall Study|Lack of Efficacy|0|||
48741920|NCT02202980|156904379|FG002|Overall Study|Lack of Efficacy|7|||
48950559|NCT01522651|157648722|FG000|Overall Study|Protocol Violation|3|||
48950560|NCT01522651|157648723|FG001|Overall Study|Protocol Violation|0|||
48950561|NCT01522651|157648724|FG002|Overall Study|Protocol Violation|0|||
48950562|NCT01522651|157648725|FG003|Overall Study|Protocol Violation|0|||
48741921|NCT02202980|156904380|FG003|Overall Study|Lack of Efficacy|0|||
48741922|NCT02202980|156904381|FG004|Overall Study|Lack of Efficacy|3|||
48741923|NCT02202980|156904382|FG005|Overall Study|Lack of Efficacy|1|||
48741924|NCT02202980|156904383|FG006|Overall Study|Lack of Efficacy|11|||
48741925|NCT02202980|156904384|FG007|Overall Study|Lack of Efficacy|2|||
48741926|NCT02202980|156904385|FG008|Overall Study|Lack of Efficacy|2|||
48741927|NCT02202980|156904386|FG009|Overall Study|Lack of Efficacy|0|||
48950563|NCT01522651|157648726|FG004|Overall Study|Protocol Violation|0|||
48950564|NCT01522651|157648722|FG000|Overall Study|Reason Not Specified|0|||
48741928|NCT02202980|156904387|FG010|Overall Study|Lack of Efficacy|0|||
48741929|NCT02202980|156904388|FG011|Overall Study|Lack of Efficacy|3|||
48950565|NCT01522651|157648723|FG001|Overall Study|Reason Not Specified|0|||
48950566|NCT01522651|157648724|FG002|Overall Study|Reason Not Specified|0|||
48950567|NCT01522651|157648725|FG003|Overall Study|Reason Not Specified|1|||
48950568|NCT01522651|157648726|FG004|Overall Study|Reason Not Specified|0|||
48950569|NCT01522651|157648722|FG000|Overall Study|Participant Non-Compliance|1|||
48950570|NCT01522651|157648723|FG001|Overall Study|Participant Non-Compliance|0|||
48950571|NCT01522651|157648724|FG002|Overall Study|Participant Non-Compliance|0|||
48950572|NCT01522651|157648725|FG003|Overall Study|Participant Non-Compliance|0|||
48950573|NCT01522651|157648726|FG004|Overall Study|Participant Non-Compliance|0|||
48950574|NCT01522651|157648722|FG000|Overall Study|Withdrew Consent|1|||
48741930|NCT02202980|156904389|FG012|Overall Study|Lack of Efficacy|10|||
48741931|NCT02202980|156904390|FG013|Overall Study|Lack of Efficacy|0|||
48950575|NCT01522651|157648723|FG001|Overall Study|Withdrew Consent|1|||
48950576|NCT01522651|157648724|FG002|Overall Study|Withdrew Consent|0|||
48950577|NCT01522651|157648725|FG003|Overall Study|Withdrew Consent|1|||
48950578|NCT01522651|157648726|FG004|Overall Study|Withdrew Consent|1|||
48950579|NCT01522651|157648722|FG000|Overall Study|Randomized but Never Treated|0|||
48950580|NCT01522651|157648723|FG001|Overall Study|Randomized but Never Treated|1|||
48741932|NCT02202980|156904377|FG000|Overall Study|Protocol Violation|0|||
48741933|NCT02202980|156904378|FG001|Overall Study|Protocol Violation|0|||
48741934|NCT02202980|156904379|FG002|Overall Study|Protocol Violation|0|||
48741935|NCT02202980|156904380|FG003|Overall Study|Protocol Violation|3|||
48741936|NCT02202980|156904381|FG004|Overall Study|Protocol Violation|3|||
48741937|NCT02202980|156904382|FG005|Overall Study|Protocol Violation|0|||
48741938|NCT02202980|156904383|FG006|Overall Study|Protocol Violation|0|||
48741939|NCT02202980|156904384|FG007|Overall Study|Protocol Violation|0|||
48741940|NCT02202980|156904385|FG008|Overall Study|Protocol Violation|0|||
48741941|NCT02202980|156904386|FG009|Overall Study|Protocol Violation|0|||
48741942|NCT02202980|156904387|FG010|Overall Study|Protocol Violation|0|||
48741943|NCT02202980|156904388|FG011|Overall Study|Protocol Violation|0|||
48741944|NCT02202980|156904389|FG012|Overall Study|Protocol Violation|0|||
48741945|NCT02202980|156904390|FG013|Overall Study|Protocol Violation|0|||
48741946|NCT02202980|156904377|FG000|Overall Study|Lost to Follow-up|0|||
48741947|NCT02202980|156904378|FG001|Overall Study|Lost to Follow-up|1|||
48741948|NCT02202980|156904379|FG002|Overall Study|Lost to Follow-up|1|||
48741949|NCT02202980|156904380|FG003|Overall Study|Lost to Follow-up|1|||
48741950|NCT02202980|156904381|FG004|Overall Study|Lost to Follow-up|0|||
48741951|NCT02202980|156904382|FG005|Overall Study|Lost to Follow-up|0|||
48741952|NCT02202980|156904383|FG006|Overall Study|Lost to Follow-up|0|||
48741953|NCT02202980|156904384|FG007|Overall Study|Lost to Follow-up|1|||
48741954|NCT02202980|156904385|FG008|Overall Study|Lost to Follow-up|1|||
48855064|NCT03392194|157308537|FG000|Overall Study|Conflicts with personal schedule|1|||
48855065|NCT03392194|157308538|FG001|Overall Study|Conflicts with personal schedule|0|||
48855066|NCT00308308|157308539|FG000|Overall Study|Adverse Event|17|||
48741955|NCT02202980|156904386|FG009|Overall Study|Lost to Follow-up|0|||
48741956|NCT02202980|156904387|FG010|Overall Study|Lost to Follow-up|0|||
48741957|NCT02202980|156904388|FG011|Overall Study|Lost to Follow-up|0|||
48741958|NCT02202980|156904389|FG012|Overall Study|Lost to Follow-up|1|||
48741959|NCT02202980|156904390|FG013|Overall Study|Lost to Follow-up|0|||
48741960|NCT02202980|156904377|FG000|Overall Study|Withdrew Consent|0|||
48855067|NCT00308308|157308540|FG001|Overall Study|Adverse Event|2|||
48855068|NCT00308308|157308539|FG000|Overall Study|Lost to Follow-up|5|||
48855069|NCT00308308|157308540|FG001|Overall Study|Lost to Follow-up|5|||
48855070|NCT00308308|157308539|FG000|Overall Study|Physician Decision|15|||
48855071|NCT00308308|157308540|FG001|Overall Study|Physician Decision|7|||
48855072|NCT00308308|157308539|FG000|Overall Study|Protocol Violation|3|||
48855073|NCT00308308|157308540|FG001|Overall Study|Protocol Violation|14|||
48855074|NCT00308308|157308539|FG000|Overall Study|Withdrawal by Subject|47|||
48855075|NCT00308308|157308540|FG001|Overall Study|Withdrawal by Subject|19|||
48855076|NCT00308308|157308539|FG000|Overall Study|Various|7|||
48855077|NCT00308308|157308540|FG001|Overall Study|Various|5|||
48855078|NCT00308308|157308539|FG000|Overall Study|Randomized but not dosed|8|||
48855079|NCT00308308|157308540|FG001|Overall Study|Randomized but not dosed|16|||
48855080|NCT00308308|157308539|FG000|Overall Study|Other|1|||
48855081|NCT00308308|157308540|FG001|Overall Study|Other|0|||
48855082|NCT01009645|157308541|FG000|Overall Study|Lost to Follow-up|2|||
48855083|NCT01009645|157308542|FG001|Overall Study|Lost to Follow-up|8|||
48855084|NCT01009645|157308543|FG002|Overall Study|Lost to Follow-up|4|||
48855085|NCT01009645|157308544|FG003|Overall Study|Lost to Follow-up|5|||
48855086|NCT00240994|157308545|FG000|Overall Study|Lost to Follow-up|1|||
48855087|NCT00240994|157308545|FG000|Overall Study|Protocol Violation|1|||
48855088|NCT00240994|157308545|FG000|Overall Study|Graft failure|1|||
48855089|NCT05124210|157308546|FG000|Overall Study|Lost to Follow-up|1|||
48855090|NCT05124210|157308547|FG001|Overall Study|Lost to Follow-up|0|||
48855091|NCT05124210|157308546|FG000|Overall Study|Withdrawal by Subject|1|||
48855092|NCT05124210|157308547|FG001|Overall Study|Withdrawal by Subject|0|||
48855093|NCT00768755|157308548|FG000|Phase 1|Death|6|||
48855094|NCT00768755|157308549|FG001|Phase 1|Death|0|||
48855095|NCT00768755|157308550|FG002|Phase 1|Death|0|||
48855096|NCT00768755|157308551|FG003|Phase 1|Death|0|||
48855097|NCT00768755|157308548|FG000|Phase 1|Other|4|||
48855098|NCT00768755|157308549|FG001|Phase 1|Other|0|||
48855099|NCT00768755|157308550|FG002|Phase 1|Other|0|||
48855100|NCT00768755|157308551|FG003|Phase 1|Other|0|||
48855101|NCT00768755|157308548|FG000|Phase 2|Death|0|||
48855102|NCT00768755|157308549|FG001|Phase 2|Death|37|||
48855103|NCT00768755|157308550|FG002|Phase 2|Death|48|||
48855104|NCT00768755|157308551|FG003|Phase 2|Death|31|||
48855105|NCT00768755|157308548|FG000|Phase 2|Protocol Violation|0|||
48855106|NCT00768755|157308549|FG001|Phase 2|Protocol Violation|2|||
48855107|NCT00768755|157308550|FG002|Phase 2|Protocol Violation|0|||
48855108|NCT00768755|157308551|FG003|Phase 2|Protocol Violation|1|||
48855109|NCT00768755|157308548|FG000|Phase 2|Lost to Follow-up|0|||
48855110|NCT00768755|157308549|FG001|Phase 2|Lost to Follow-up|1|||
48855111|NCT00768755|157308550|FG002|Phase 2|Lost to Follow-up|1|||
48855112|NCT00768755|157308551|FG003|Phase 2|Lost to Follow-up|4|||
48855113|NCT00768755|157308548|FG000|Phase 2|Withdrawal by Subject|0|||
48855114|NCT00768755|157308549|FG001|Phase 2|Withdrawal by Subject|1|||
48855115|NCT00768755|157308550|FG002|Phase 2|Withdrawal by Subject|0|||
48855116|NCT00768755|157308551|FG003|Phase 2|Withdrawal by Subject|1|||
48855117|NCT00768755|157308548|FG000|Phase 2|Other|0|||
48855118|NCT00768755|157308549|FG001|Phase 2|Other|1|||
48855119|NCT00768755|157308550|FG002|Phase 2|Other|2|||
48855120|NCT00768755|157308551|FG003|Phase 2|Other|4|||
48855121|NCT00768755|157308548|FG000|Phase 2|Study Terminated by Sponsor|0|||
48855122|NCT00768755|157308549|FG001|Phase 2|Study Terminated by Sponsor|13|||
48855123|NCT00768755|157308550|FG002|Phase 2|Study Terminated by Sponsor|7|||
48855124|NCT00768755|157308551|FG003|Phase 2|Study Terminated by Sponsor|14|||
48950581|NCT01522651|157648724|FG002|Overall Study|Randomized but Never Treated|0|||
48950582|NCT01522651|157648725|FG003|Overall Study|Randomized but Never Treated|1|||
48950583|NCT01522651|157648726|FG004|Overall Study|Randomized but Never Treated|1|||
48950584|NCT02508701|157648727|FG000|Overall Study|Lost to Follow-up|9|||
48950585|NCT02508701|157648728|FG001|Overall Study|Lost to Follow-up|5|||
48855125|NCT00768755|157308548|FG000|Phase 2|Randomized but not treated|0|||
48855126|NCT00768755|157308549|FG001|Phase 2|Randomized but not treated|0|||
48855127|NCT00768755|157308550|FG002|Phase 2|Randomized but not treated|0|||
48855128|NCT00768755|157308551|FG003|Phase 2|Randomized but not treated|2|||
48855129|NCT00703092|157308553|FG000|Overall Study|Withdrawal by Subject|2|||
48855130|NCT02007070|157308554|FG000|Overall Study|Adverse Event|4|||
48855131|NCT02007070|157308554|FG000|Overall Study|Clinical Progression|4|||
48855132|NCT02007070|157308554|FG000|Overall Study|Death|1|||
48855133|NCT02007070|157308554|FG000|Overall Study|Protocol Violation|2|||
48855134|NCT02007070|157308554|FG000|Overall Study|Physician Decision|1|||
48855135|NCT02007070|157308554|FG000|Overall Study|Progressive Disease|21|||
48855136|NCT04237792|157308555|FG000|Treatment (Day 1)|Adverse Event|1|||
48855137|NCT04237792|157308556|FG001|Treatment (Day 1)|Adverse Event|0|||
48741961|NCT02202980|156904378|FG001|Overall Study|Withdrew Consent|1|||
48741962|NCT02202980|156904379|FG002|Overall Study|Withdrew Consent|2|||
48741963|NCT02202980|156904380|FG003|Overall Study|Withdrew Consent|0|||
48741964|NCT02202980|156904381|FG004|Overall Study|Withdrew Consent|0|||
48741965|NCT02202980|156904382|FG005|Overall Study|Withdrew Consent|0|||
48741966|NCT02202980|156904383|FG006|Overall Study|Withdrew Consent|0|||
48741967|NCT02202980|156904384|FG007|Overall Study|Withdrew Consent|0|||
48741968|NCT02202980|156904385|FG008|Overall Study|Withdrew Consent|1|||
48741969|NCT02202980|156904386|FG009|Overall Study|Withdrew Consent|0|||
48741970|NCT02202980|156904387|FG010|Overall Study|Withdrew Consent|0|||
48741971|NCT02202980|156904388|FG011|Overall Study|Withdrew Consent|0|||
48741972|NCT02202980|156904389|FG012|Overall Study|Withdrew Consent|0|||
48741973|NCT02202980|156904390|FG013|Overall Study|Withdrew Consent|0|||
48741974|NCT03641339|156904397|FG000|Overall Study|Physician Decision|1|||
48741975|NCT03641339|156904398|FG001|Overall Study|Physician Decision|0|||
48741976|NCT03641339|156904399|FG002|Overall Study|Physician Decision|0|||
48741977|NCT03641339|156904400|FG003|Overall Study|Physician Decision|0|||
48741978|NCT03641339|156904401|FG004|Overall Study|Physician Decision|0|||
48741979|NCT03641339|156904402|FG005|Overall Study|Physician Decision|0|||
48741980|NCT03641339|156904397|FG000|Overall Study|Withdrawal by Subject|0|||
48741981|NCT03641339|156904398|FG001|Overall Study|Withdrawal by Subject|2|||
48741982|NCT03641339|156904399|FG002|Overall Study|Withdrawal by Subject|0|||
48741983|NCT03641339|156904400|FG003|Overall Study|Withdrawal by Subject|2|||
48741984|NCT03641339|156904401|FG004|Overall Study|Withdrawal by Subject|0|||
48741985|NCT03641339|156904402|FG005|Overall Study|Withdrawal by Subject|1|||
48741986|NCT02296320|156904405|FG000|Overall Study|Withdrawal by Subject|4|||
48741987|NCT02296320|156904406|FG001|Overall Study|Withdrawal by Subject|0|||
48741988|NCT02296320|156904407|FG002|Overall Study|Withdrawal by Subject|2|||
48741989|NCT02296320|156904405|FG000|Overall Study|Death|24|||
48741990|NCT02296320|156904406|FG001|Overall Study|Death|3|||
48741991|NCT02296320|156904407|FG002|Overall Study|Death|27|||
48741992|NCT02296320|156904405|FG000|Overall Study|Lost to Follow-up|5|||
48741993|NCT02296320|156904406|FG001|Overall Study|Lost to Follow-up|2|||
48741994|NCT02296320|156904407|FG002|Overall Study|Lost to Follow-up|7|||
48741995|NCT02296320|156904405|FG000|Overall Study|Not treated|2|||
48741996|NCT02296320|156904406|FG001|Overall Study|Not treated|0|||
48741997|NCT02296320|156904407|FG002|Overall Study|Not treated|0|||
48741998|NCT02296320|156904405|FG000|Overall Study|Not - specified|0|||
48741999|NCT02296320|156904406|FG001|Overall Study|Not - specified|0|||
48950586|NCT02508701|157648729|FG002|Overall Study|Lost to Follow-up|5|||
48950587|NCT02508701|157648730|FG003|Overall Study|Lost to Follow-up|3|||
48950588|NCT03184701|157648732|FG000|Overall Study|Death|3|||
48950589|NCT03184701|157648732|FG000|Overall Study|Physician Decision|3|||
48950590|NCT03184701|157648732|FG000|Overall Study|Withdrawal by Subject|6|||
48950591|NCT03184701|157648732|FG000|Overall Study|Lost to Follow-up|5|||
48950592|NCT00590681|157648739|FG000|Overall Study|Withdrawal by Subject|7|||
48950593|NCT00590681|157648739|FG000|Overall Study|Adverse Event|8|||
48950594|NCT00590681|157648739|FG000|Overall Study|Death|3|||
48950595|NCT00590681|157648739|FG000|Overall Study|Lost to Follow-up|1|||
48950596|NCT00590681|157648739|FG000|Overall Study|disease progression|1|||
48950597|NCT00530712|157648745|FG000|30 Day Follow-up Visit|Withdrawal by Subject|2|||
48950598|NCT00530712|157648745|FG000|30 Day Follow-up Visit|Missed Visit|5|||
48950599|NCT00530712|157648745|FG000|6 Month Follow-up Visit|Withdrawal by Subject|4|||
48950600|NCT00530712|157648745|FG000|6 Month Follow-up Visit|Missed Visit|3|||
48950601|NCT00530712|157648745|FG000|6 Month Follow-up Visit|Lost to Follow-up|3|||
48950602|NCT00530712|157648745|FG000|6 Month Follow-up Visit|Death|2|||
48950603|NCT00530712|157648745|FG000|12 Month Follow-up Visit|Withdrawal by Subject|5|||
48950604|NCT00530712|157648745|FG000|12 Month Follow-up Visit|Missed Visit|3|||
48950605|NCT00530712|157648745|FG000|12 Month Follow-up Visit|Lost to Follow-up|7|||
48742000|NCT02296320|156904407|FG002|Overall Study|Not - specified|1|||
48742001|NCT01781975|156904408|FG000|Overall Study|Death|1|||
48742002|NCT01781975|156904409|FG001|Overall Study|Death|0|||
48742003|NCT01781975|156904408|FG000|Overall Study|Withdrawal by Subject|1|||
48742004|NCT01781975|156904409|FG001|Overall Study|Withdrawal by Subject|1|||
48742005|NCT01622231|156904410|FG000|Overall Study|Physician Decision|1|||
48742006|NCT01622231|156904410|FG000|Overall Study|Withdrawal by Subject|1|||
48742007|NCT01447433|156904413|FG000|Overall Study|Lost to Follow-up|0|||
48742008|NCT01447433|156904414|FG001|Overall Study|Lost to Follow-up|2|||
48742009|NCT01447433|156904413|FG000|Overall Study|Withdrawal by Subject|3|||
48855138|NCT04237792|157308557|FG002|Treatment (Day 1)|Adverse Event|0|||
48855139|NCT04237792|157308558|FG003|Treatment (Day 1)|Adverse Event|0|||
48855140|NCT04237792|157308559|FG004|Treatment (Day 1)|Adverse Event|1|||
48855141|NCT04237792|157308560|FG005|Treatment (Day 1)|Adverse Event|1|||
48855142|NCT04237792|157308555|FG000|Treatment (Day 1)|Other|0|||
48855143|NCT04237792|157308556|FG001|Treatment (Day 1)|Other|0|||
48855144|NCT04237792|157308557|FG002|Treatment (Day 1)|Other|1|||
48855145|NCT04237792|157308558|FG003|Treatment (Day 1)|Other|0|||
48855146|NCT04237792|157308559|FG004|Treatment (Day 1)|Other|0|||
48855147|NCT04237792|157308560|FG005|Treatment (Day 1)|Other|1|||
48855148|NCT04237792|157308555|FG000|Treatment (Day 1)|Not treated|1|||
48855149|NCT04237792|157308556|FG001|Treatment (Day 1)|Not treated|1|||
48855150|NCT04237792|157308557|FG002|Treatment (Day 1)|Not treated|2|||
48855151|NCT04237792|157308558|FG003|Treatment (Day 1)|Not treated|1|||
48855152|NCT04237792|157308559|FG004|Treatment (Day 1)|Not treated|0|||
48855153|NCT04237792|157308560|FG005|Treatment (Day 1)|Not treated|1|||
48855154|NCT04693637|157308561|FG000|Overall Study|Death|4|||
48855155|NCT04693637|157308561|FG000|Overall Study|Withdrawal by Subject|3|||
48855156|NCT04693637|157308561|FG000|Overall Study|Physician Decision|2|||
48855157|NCT04693637|157308561|FG000|Overall Study|Lost to Follow-up|1|||
48855158|NCT01021748|157308563|FG000|Overall Study|Adverse Event|2|||
48855159|NCT01021748|157308564|FG001|Overall Study|Adverse Event|1|||
48855160|NCT01021748|157308565|FG002|Overall Study|Adverse Event|2|||
48855161|NCT01021748|157308566|FG003|Overall Study|Adverse Event|0|||
48855162|NCT01021748|157308567|FG004|Overall Study|Adverse Event|2|||
48855163|NCT01021748|157308568|FG005|Overall Study|Adverse Event|0|||
48855164|NCT01021748|157308569|FG006|Overall Study|Adverse Event|1|||
48855165|NCT01021748|157308570|FG007|Overall Study|Adverse Event|0|||
48855166|NCT01021748|157308571|FG008|Overall Study|Adverse Event|7|||
48855167|NCT01021748|157308563|FG000|Overall Study|Physician Decision|1|||
48855168|NCT01021748|157308564|FG001|Overall Study|Physician Decision|0|||
48855169|NCT01021748|157308565|FG002|Overall Study|Physician Decision|1|||
48855170|NCT01021748|157308566|FG003|Overall Study|Physician Decision|1|||
48855171|NCT01021748|157308567|FG004|Overall Study|Physician Decision|0|||
48855172|NCT01021748|157308568|FG005|Overall Study|Physician Decision|0|||
48855173|NCT01021748|157308569|FG006|Overall Study|Physician Decision|1|||
48855174|NCT01021748|157308570|FG007|Overall Study|Physician Decision|1|||
48855175|NCT01021748|157308571|FG008|Overall Study|Physician Decision|2|||
48855176|NCT01021748|157308563|FG000|Overall Study|Progressive Disease|3|||
48855177|NCT01021748|157308564|FG001|Overall Study|Progressive Disease|3|||
48855178|NCT01021748|157308565|FG002|Overall Study|Progressive Disease|4|||
48855179|NCT01021748|157308566|FG003|Overall Study|Progressive Disease|6|||
48855180|NCT01021748|157308567|FG004|Overall Study|Progressive Disease|7|||
48855181|NCT01021748|157308568|FG005|Overall Study|Progressive Disease|3|||
48855182|NCT01021748|157308569|FG006|Overall Study|Progressive Disease|0|||
48855183|NCT01021748|157308570|FG007|Overall Study|Progressive Disease|5|||
48855184|NCT01021748|157308571|FG008|Overall Study|Progressive Disease|6|||
48855185|NCT01021748|157308563|FG000|Overall Study|Withdrawal by Subject|0|||
48950606|NCT00530712|157648745|FG000|12 Month Follow-up Visit|Death|9|||
48950607|NCT02749370|157648746|FG000|Overall Study|Withdrawal by Subject|11|||
48855186|NCT01021748|157308564|FG001|Overall Study|Withdrawal by Subject|0|||
48855187|NCT01021748|157308565|FG002|Overall Study|Withdrawal by Subject|0|||
48855188|NCT01021748|157308566|FG003|Overall Study|Withdrawal by Subject|0|||
48855189|NCT01021748|157308567|FG004|Overall Study|Withdrawal by Subject|0|||
48855190|NCT01021748|157308568|FG005|Overall Study|Withdrawal by Subject|0|||
48855191|NCT01021748|157308569|FG006|Overall Study|Withdrawal by Subject|1|||
48855192|NCT01021748|157308570|FG007|Overall Study|Withdrawal by Subject|0|||
48855193|NCT01021748|157308571|FG008|Overall Study|Withdrawal by Subject|1|||
48855194|NCT01021748|157308563|FG000|Overall Study|Not Treated|0|||
48855195|NCT01021748|157308564|FG001|Overall Study|Not Treated|1|||
48855196|NCT01021748|157308565|FG002|Overall Study|Not Treated|0|||
48855197|NCT01021748|157308566|FG003|Overall Study|Not Treated|0|||
48855198|NCT01021748|157308567|FG004|Overall Study|Not Treated|0|||
48855199|NCT01021748|157308568|FG005|Overall Study|Not Treated|0|||
48855200|NCT01021748|157308569|FG006|Overall Study|Not Treated|0|||
48855201|NCT01021748|157308570|FG007|Overall Study|Not Treated|0|||
48855202|NCT01021748|157308571|FG008|Overall Study|Not Treated|0|||
48855203|NCT00929526|157308573|FG000|Overall Study|Withdrawal by Subject|1|||
48855204|NCT00929526|157308574|FG001|Overall Study|Withdrawal by Subject|11|||
48855205|NCT00929526|157308573|FG000|Overall Study|Lost to Follow-up|8|||
48855206|NCT00929526|157308574|FG001|Overall Study|Lost to Follow-up|12|||
48855207|NCT00929526|157308573|FG000|Overall Study|Other|8|||
48855208|NCT00929526|157308574|FG001|Overall Study|Other|6|||
48855209|NCT01829711|157308575|FG000|Overall Study|Lost to Follow-up|2|||
48855210|NCT01829711|157308575|FG000|Overall Study|Withdrawal by Subject|3|||
48855211|NCT01829711|157308575|FG000|Overall Study|Death|4|||
48855212|NCT01829711|157308575|FG000|Overall Study|Started new therapies|17|||
48855213|NCT01829711|157308575|FG000|Overall Study|Adverse Event|3|||
48855214|NCT01829711|157308575|FG000|Overall Study|Due to progression of disease|13|||
48855215|NCT01829711|157308575|FG000|Overall Study|Due to lack of response|1|||
48855216|NCT02165202|157308578|FG000|Oral Phase|Refused further participation|5|||
48855217|NCT02165202|157308579|FG001|Oral Phase|Refused further participation|1|||
48855218|NCT02165202|157308578|FG000|Oral Phase|Study product Related Toxicity|1|||
48855219|NCT02165202|157308579|FG001|Oral Phase|Study product Related Toxicity|0|||
48855220|NCT02165202|157308578|FG000|Oral Phase|Unable to contact Participant|1|||
48855221|NCT02165202|157308579|FG001|Oral Phase|Unable to contact Participant|1|||
48855222|NCT02165202|157308578|FG000|Oral Phase|Clinical reasons|1|||
48855223|NCT02165202|157308579|FG001|Oral Phase|Clinical reasons|0|||
48855224|NCT02165202|157308578|FG000|Oral Phase|QTcF>500 ms or increase of>60 ms|1|||
48855225|NCT02165202|157308579|FG001|Oral Phase|QTcF>500 ms or increase of>60 ms|0|||
48855226|NCT02165202|157308578|FG000|Oral Phase|CMC advised termination|1|||
48855227|NCT02165202|157308579|FG001|Oral Phase|CMC advised termination|0|||
48855228|NCT02165202|157308578|FG000|Oral Phase|Relocated, no follow-up planned|1|||
48855229|NCT02165202|157308579|FG001|Oral Phase|Relocated, no follow-up planned|0|||
48855230|NCT02165202|157308578|FG000|Oral Phase|Abnormal EKG|0|||
48855231|NCT02165202|157308579|FG001|Oral Phase|Abnormal EKG|1|||
48742010|NCT01447433|156904414|FG001|Overall Study|Withdrawal by Subject|3|||
48742011|NCT01447433|156904413|FG000|Overall Study|Protocol Violation|1|||
48742012|NCT01447433|156904414|FG001|Overall Study|Protocol Violation|1|||
48742013|NCT00621582|156904415|FG000|Overall Study|Adverse Event|7|||
48742014|NCT00621582|156904415|FG000|Overall Study|Protocol Violation|57|||
48950608|NCT02749370|157648746|FG000|Overall Study|Lost to Follow-up|3|||
48950609|NCT01259297|157648752|FG000|Double Blind Randomized Period|Death|1|||
48950610|NCT01259297|157648753|FG001|Double Blind Randomized Period|Death|1|||
48950611|NCT01259297|157648754|FG002|Double Blind Randomized Period|Death|1|||
48950612|NCT01259297|157648755|FG003|Double Blind Randomized Period|Death|2|||
48950613|NCT01259297|157648756|FG004|Double Blind Randomized Period|Death|1|||
48742015|NCT00621582|156904415|FG000|Overall Study|Lost to Follow-up|24|||
48798212|NCT00441701|157098568|FG007|Overall Study|Lack of Efficacy|0|||
48950614|NCT01259297|157648757|FG005|Double Blind Randomized Period|Death|5|||
48950615|NCT01259297|157648758|FG006|Double Blind Randomized Period|Death|2|||
48950616|NCT01259297|157648759|FG007|Double Blind Randomized Period|Death|1|||
48950617|NCT01259297|157648752|FG000|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
48950618|NCT01259297|157648753|FG001|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
48950619|NCT01259297|157648754|FG002|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0|||
48950620|NCT01259297|157648755|FG003|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
48950621|NCT01259297|157648756|FG004|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
48950622|NCT01259297|157648757|FG005|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
48950623|NCT01259297|157648758|FG006|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
48950624|NCT01259297|157648759|FG007|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
48950625|NCT01259297|157648752|FG000|Double Blind Randomized Period|Other reasons|0|||
48950626|NCT01259297|157648753|FG001|Double Blind Randomized Period|Other reasons|1|||
48950627|NCT01259297|157648754|FG002|Double Blind Randomized Period|Other reasons|0|||
48950628|NCT01259297|157648755|FG003|Double Blind Randomized Period|Other reasons|0|||
48950629|NCT01259297|157648756|FG004|Double Blind Randomized Period|Other reasons|1|||
48950630|NCT01259297|157648757|FG005|Double Blind Randomized Period|Other reasons|2|||
48950631|NCT01259297|157648758|FG006|Double Blind Randomized Period|Other reasons|3|||
48950632|NCT01259297|157648759|FG007|Double Blind Randomized Period|Other reasons|1|||
48950633|NCT02574312|157648760|FG000|3 Months Follow-up|Withdrawal by Subject|1|||
48950634|NCT02574312|157648761|FG001|3 Months Follow-up|Withdrawal by Subject|0|||
48950635|NCT01519427|157648762|FG000|Overall Study|disease progression|2|||
48950636|NCT03242759|157648766|FG000|Overall Study|Adverse Event|5|||
48950637|NCT03242759|157648767|FG001|Overall Study|Adverse Event|1|||
48950638|NCT03242759|157648766|FG000|Overall Study|Withdrawal by Subject|4|||
48950639|NCT03242759|157648767|FG001|Overall Study|Withdrawal by Subject|3|||
48950640|NCT03242759|157648766|FG000|Overall Study|Lost to Follow-up|3|||
48950641|NCT03242759|157648767|FG001|Overall Study|Lost to Follow-up|1|||
48950642|NCT03242759|157648766|FG000|Overall Study|Administrative problems|1|||
48950643|NCT03242759|157648767|FG001|Overall Study|Administrative problems|1|||
48950644|NCT03242759|157648766|FG000|Overall Study|Death|22|||
48950645|NCT03242759|157648767|FG001|Overall Study|Death|0|||
48950646|NCT03242759|157648766|FG000|Overall Study|Change visit schedule|0|||
48950647|NCT03242759|157648767|FG001|Overall Study|Change visit schedule|1|||
48950648|NCT04773041|157648774|FG000|Overall Study|Unable to data match|1|||
48950649|NCT04773041|157648775|FG001|Overall Study|Unable to data match|0|||
48950650|NCT04773041|157648776|FG002|Overall Study|Unable to data match|0|||
48950651|NCT05094154|157649798|FG000|Overall Study|Participants experiencing incarceration or involuntary detainment.|3|||
48950652|NCT05094154|157649799|FG001|Overall Study|Participants experiencing incarceration or involuntary detainment.|1|||
48950653|NCT05094154|157649798|FG000|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|60|||
48950654|NCT05094154|157649799|FG001|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|59|||
48950655|NCT00151411|157649804|FG000|Overall Study|Lost to Follow-up|15|||
48950656|NCT00151411|157649805|FG001|Overall Study|Lost to Follow-up|19|||
48950657|NCT00151411|157649804|FG000|Overall Study|Withdrawal by Subject|12|||
48950658|NCT00151411|157649805|FG001|Overall Study|Withdrawal by Subject|20|||
48950659|NCT00151411|157649804|FG000|Overall Study|Adverse Event|6|||
48950660|NCT00151411|157649805|FG001|Overall Study|Adverse Event|0|||
48950661|NCT00151411|157649804|FG000|Overall Study|Pregnancy|0|||
48950662|NCT00151411|157649805|FG001|Overall Study|Pregnancy|4|||
48950663|NCT02601001|157649806|FG000|Dosing Period 2|Adverse Event|0|||
48950664|NCT02601001|157649807|FG001|Dosing Period 2|Adverse Event|0|||
48950665|NCT02601001|157649808|FG002|Dosing Period 2|Adverse Event|0|||
48950666|NCT02601001|157649809|FG003|Dosing Period 2|Adverse Event|0|||
48950667|NCT02601001|157649810|FG004|Dosing Period 2|Adverse Event|0|||
48950668|NCT02601001|157649811|FG005|Dosing Period 2|Adverse Event|0|||
48950669|NCT02601001|157649812|FG006|Dosing Period 2|Adverse Event|1|||
48950670|NCT00417612|157649813|FG000|Overall Study|Errant diagnosis|0|||
48950671|NCT00417612|157649814|FG001|Overall Study|Errant diagnosis|1|||
48950672|NCT00417612|157649813|FG000|Overall Study|Adverse Event|2|||
48950673|NCT00417612|157649814|FG001|Overall Study|Adverse Event|0|||
48950674|NCT00417612|157649813|FG000|Overall Study|Protocol Violation|0|||
48950675|NCT00417612|157649814|FG001|Overall Study|Protocol Violation|2|||
48950676|NCT00417612|157649813|FG000|Overall Study|Lost to Follow-up|1|||
48950677|NCT00417612|157649814|FG001|Overall Study|Lost to Follow-up|0|||
48950678|NCT01713036|157649815|FG000|Overall Study|Death|1|||
48950679|NCT00634543|157649816|FG000|Overall Study|Other|1|||
48950680|NCT00634543|157649817|FG001|Overall Study|Other|2|||
48742016|NCT00621582|156904415|FG000|Overall Study|issues not identified by investigators|18|||
48742017|NCT03725852|156904416|FG000|Overall Study|Death|1|||
48950681|NCT00634543|157649816|FG000|Overall Study|Protocol Violation|3|||
48950682|NCT00634543|157649817|FG001|Overall Study|Protocol Violation|3|||
48950683|NCT00634543|157649816|FG000|Overall Study|Adverse Event|11|||
48950684|NCT00634543|157649817|FG001|Overall Study|Adverse Event|11|||
48950685|NCT00634543|157649816|FG000|Overall Study|Withdrawal by Subject|4|||
48950686|NCT00634543|157649817|FG001|Overall Study|Withdrawal by Subject|4|||
48950687|NCT00634543|157649816|FG000|Overall Study|Lost to Follow-up|0|||
48950688|NCT00634543|157649817|FG001|Overall Study|Lost to Follow-up|1|||
48950689|NCT00077623|157649820|FG000|Overall Study|Adverse Event|1|||
48950690|NCT00077623|157649821|FG001|Overall Study|Adverse Event|0|||
48950691|NCT00077623|157649822|FG002|Overall Study|Adverse Event|1|||
48950692|NCT00077623|157649820|FG000|Overall Study|Withdrawal by Subject|2|||
48950693|NCT00077623|157649821|FG001|Overall Study|Withdrawal by Subject|10|||
48950694|NCT00077623|157649822|FG002|Overall Study|Withdrawal by Subject|1|||
48950695|NCT00077623|157649820|FG000|Overall Study|Other-Non safety reason|18|||
48950696|NCT00077623|157649821|FG001|Overall Study|Other-Non safety reason|15|||
48950697|NCT00077623|157649822|FG002|Overall Study|Other-Non safety reason|19|||
48950698|NCT00077623|157649820|FG000|Overall Study|Insufficient therapeutic response|2|||
48950699|NCT00077623|157649821|FG001|Overall Study|Insufficient therapeutic response|0|||
48950700|NCT00077623|157649822|FG002|Overall Study|Insufficient therapeutic response|0|||
48950701|NCT00077623|157649820|FG000|Overall Study|Death|12|||
48950702|NCT00077623|157649821|FG001|Overall Study|Death|18|||
48950703|NCT00077623|157649822|FG002|Overall Study|Death|11|||
48950704|NCT00077623|157649820|FG000|Overall Study|Failure to return|1|||
48950705|NCT00077623|157649821|FG001|Overall Study|Failure to return|0|||
48950706|NCT00077623|157649822|FG002|Overall Study|Failure to return|0|||
48742018|NCT03725852|156904417|FG001|Overall Study|Death|0|||
48742019|NCT03725852|156904416|FG000|Overall Study|Withdrawal by Subject|1|||
48742020|NCT03725852|156904417|FG001|Overall Study|Withdrawal by Subject|0|||
48742021|NCT03725852|156904416|FG000|Overall Study|Travel restrictions due to COVID-19|2|||
48742022|NCT03725852|156904417|FG001|Overall Study|Travel restrictions due to COVID-19|0|||
48742023|NCT02572401|156904429|FG000|Overall Study|Lost to Follow-up|5|||
48742024|NCT02572401|156904430|FG001|Overall Study|Lost to Follow-up|8|||
48950707|NCT02401256|157649823|FG000|Overall Study|Adverse Event|5|||
48950708|NCT02401256|157649823|FG000|Overall Study|Withdrawal by Subject|12|||
48950709|NCT00641043|157649826|FG000|Overall Study|Adverse Event|6|||
48950710|NCT00641043|157649827|FG001|Overall Study|Adverse Event|4|||
48950711|NCT00641043|157649826|FG000|Overall Study|Protocol Violation|2|||
48950712|NCT00641043|157649827|FG001|Overall Study|Protocol Violation|3|||
48950713|NCT00641043|157649826|FG000|Overall Study|Lost to Follow-up|3|||
48950714|NCT00641043|157649827|FG001|Overall Study|Lost to Follow-up|2|||
48742025|NCT02572401|156904431|FG002|Overall Study|Lost to Follow-up|9|||
48742026|NCT02572401|156904432|FG003|Overall Study|Lost to Follow-up|9|||
48742027|NCT02572401|156904429|FG000|Overall Study|Death|0|||
48742028|NCT02572401|156904430|FG001|Overall Study|Death|0|||
48742029|NCT02572401|156904431|FG002|Overall Study|Death|0|||
48742030|NCT02572401|156904432|FG003|Overall Study|Death|1|||
48950715|NCT00641043|157649826|FG000|Overall Study|Withdrawal by Subject|4|||
48950716|NCT00641043|157649827|FG001|Overall Study|Withdrawal by Subject|4|||
48950717|NCT00641043|157649826|FG000|Overall Study|Other incl. lack of efficacy|4|||
48950718|NCT00641043|157649827|FG001|Overall Study|Other incl. lack of efficacy|2|||
48950719|NCT00474630|157649828|FG000|Overall Study|Adverse Event|98|||
49015351|NCT00673790|157892154|FG002|Overall Study|Participated in two Nebivolol studies|1|||
48742031|NCT02993757|156904433|FG000|Overall Study|Non compliance with the protocol|155|||
48742032|NCT02993757|156904434|FG001|Overall Study|Non compliance with the protocol|170|||
48950720|NCT00474630|157649829|FG001|Overall Study|Adverse Event|26|||
48950721|NCT00474630|157649828|FG000|Overall Study|Lost to Follow-up|22|||
48950722|NCT00474630|157649829|FG001|Overall Study|Lost to Follow-up|15|||
48950723|NCT00474630|157649828|FG000|Overall Study|Withdrawal by Subject|21|||
48855232|NCT02165202|157308578|FG000|Injection Phase|Abnormal Lab Value|5|||
48855233|NCT02165202|157308579|FG001|Injection Phase|Abnormal Lab Value|1|||
48855234|NCT02165202|157308578|FG000|Injection Phase|Reactive HIV or HIV Suspected|0|||
48742033|NCT02993757|156904433|FG000|Overall Study|Lost to Follow-up|1|||
48855235|NCT02165202|157308579|FG001|Injection Phase|Reactive HIV or HIV Suspected|2|||
48855236|NCT02165202|157308578|FG000|Injection Phase|Unable to attend within Visit Window|1|||
48855237|NCT02165202|157308579|FG001|Injection Phase|Unable to attend within Visit Window|0|||
48855238|NCT02165202|157308578|FG000|Injection Phase|QTcF>500 ms or increase of>60 ms|0|||
48855239|NCT02165202|157308579|FG001|Injection Phase|QTcF>500 ms or increase of>60 ms|1|||
48855240|NCT02165202|157308578|FG000|Injection Phase|End of Study|2|||
48855241|NCT02165202|157308579|FG001|Injection Phase|End of Study|1|||
48855242|NCT02165202|157308578|FG000|Injection Phase|Study Product related Toxicity|1|||
48855243|NCT02165202|157308579|FG001|Injection Phase|Study Product related Toxicity|0|||
48855244|NCT02165202|157308578|FG000|Injection Phase|No longer interested|0|||
48855245|NCT02165202|157308579|FG001|Injection Phase|No longer interested|1|||
48855246|NCT02165202|157308578|FG000|Injection Phase|Participant unwilling to comply|1|||
48855247|NCT02165202|157308579|FG001|Injection Phase|Participant unwilling to comply|0|||
48855248|NCT03909100|157308587|FG000|Overall Study|Protocol Deviation|2|||
48855249|NCT03909100|157308587|FG000|Overall Study|Technical Problems|4|||
48855250|NCT03909100|157308587|FG000|Overall Study|Withdrawal by Subject|4|||
48855251|NCT03909100|157308587|FG000|Overall Study|Lost to Follow-up|1|||
48855252|NCT03909100|157308587|FG000|Overall Study|Reason not Specified|4|||
48742034|NCT02993757|156904434|FG001|Overall Study|Lost to Follow-up|0|||
48742035|NCT02993757|156904433|FG000|Overall Study|Voluntary withdraw not due adverse event|8|||
48742036|NCT02993757|156904434|FG001|Overall Study|Voluntary withdraw not due adverse event|8|||
48742037|NCT00622284|156904437|FG000|Overall Study|Lack of Efficacy|45|||
48855253|NCT02203799|157308588|FG000|Overall Study|Withdrawal by Subject|3|||
48855254|NCT02671266|157308589|FG000|Overall Study|Withdrawal by Subject|1|||
48855255|NCT02671266|157308590|FG001|Overall Study|Withdrawal by Subject|1|||
48855256|NCT00681109|157308593|FG000|Overall Study|Lost to Follow-up|2|||
48855257|NCT00681109|157308594|FG001|Overall Study|Lost to Follow-up|6|||
48855258|NCT00681109|157308595|FG002|Overall Study|Lost to Follow-up|0|||
48855259|NCT02706483|157308596|FG000|Overall Study|Adverse Event|97|||
48855260|NCT02706483|157308596|FG000|Overall Study|Death|1|||
48855261|NCT02706483|157308596|FG000|Overall Study|Lack of Efficacy|39|||
48855262|NCT02706483|157308596|FG000|Overall Study|Lost to Follow-up|101|||
48855263|NCT02706483|157308596|FG000|Overall Study|Non-compliance with study drug|15|||
48855264|NCT02706483|157308596|FG000|Overall Study|Physician Decision|6|||
48855265|NCT02706483|157308596|FG000|Overall Study|Pregnancy|6|||
48855266|NCT02706483|157308596|FG000|Overall Study|Protocol Violation|18|||
48855267|NCT02706483|157308596|FG000|Overall Study|Withdrawal by Subject|136|||
48855268|NCT02706483|157308596|FG000|Overall Study|Non-compliance with visits|6|||
48855269|NCT02706483|157308596|FG000|Overall Study|Site closure|4|||
48855270|NCT02706483|157308596|FG000|Overall Study|Subject moved|1|||
48855271|NCT00687297|157308606|FG000|Randomization|Withdrawal by Subject|2|||
48855272|NCT00687297|157308607|FG001|Randomization|Withdrawal by Subject|0|||
48855273|NCT00687297|157308606|FG000|Randomization|Withdrew before treatment, ineligible|1|||
48855274|NCT00687297|157308607|FG001|Randomization|Withdrew before treatment, ineligible|1|||
48855275|NCT00687297|157308606|FG000|Induction|Withdrawal by Subject|4|||
48855276|NCT00687297|157308607|FG001|Induction|Withdrawal by Subject|4|||
48855277|NCT00687297|157308606|FG000|Induction|Adverse Event|16|||
48855278|NCT00687297|157308607|FG001|Induction|Adverse Event|15|||
48855279|NCT00687297|157308606|FG000|Induction|Death|7|||
48855280|NCT00687297|157308607|FG001|Induction|Death|11|||
48855281|NCT00687297|157308606|FG000|Induction|Lack of Efficacy|17|||
48855282|NCT00687297|157308607|FG001|Induction|Lack of Efficacy|21|||
48855283|NCT00687297|157308606|FG000|Induction|Ineligible|0|||
48855284|NCT00687297|157308607|FG001|Induction|Ineligible|1|||
48855285|NCT00687297|157308606|FG000|Induction|Patient Noncompliance|1|||
48855286|NCT00687297|157308607|FG001|Induction|Patient Noncompliance|0|||
48855287|NCT00687297|157308606|FG000|Induction|Physician Decision|0|||
48855288|NCT00687297|157308607|FG001|Induction|Physician Decision|2|||
48855289|NCT00687297|157308606|FG000|Induction|Other|0|||
48855290|NCT00687297|157308607|FG001|Induction|Other|1|||
48855291|NCT02584257|157308610|FG000|Period 1|Withdrawal by Subject|0|||
48855292|NCT02584257|157308611|FG001|Period 1|Withdrawal by Subject|0|||
48855293|NCT02584257|157308612|FG002|Period 1|Withdrawal by Subject|0|||
48855294|NCT02584257|157308613|FG003|Period 1|Withdrawal by Subject|0|||
48855295|NCT02584257|157308614|FG004|Period 1|Withdrawal by Subject|0|||
48855296|NCT02584257|157308615|FG005|Period 1|Withdrawal by Subject|0|||
48855297|NCT02584257|157308616|FG006|Period 1|Withdrawal by Subject|1|||
48855298|NCT02584257|157308617|FG007|Period 1|Withdrawal by Subject|0|||
48855299|NCT02584257|157308618|FG008|Period 1|Withdrawal by Subject|0|||
48855300|NCT02584257|157308610|FG000|Period 2|Physician Decision|1|||
48855301|NCT02584257|157308611|FG001|Period 2|Physician Decision|0|||
48855302|NCT02584257|157308612|FG002|Period 2|Physician Decision|0|||
48855303|NCT02584257|157308613|FG003|Period 2|Physician Decision|0|||
48855304|NCT02584257|157308614|FG004|Period 2|Physician Decision|0|||
48855305|NCT02584257|157308615|FG005|Period 2|Physician Decision|0|||
48855306|NCT02584257|157308616|FG006|Period 2|Physician Decision|0|||
48855307|NCT02584257|157308617|FG007|Period 2|Physician Decision|0|||
48855308|NCT02584257|157308618|FG008|Period 2|Physician Decision|0|||
48855309|NCT02584257|157308610|FG000|Period 2|Adverse Event|0|||
48855310|NCT02584257|157308611|FG001|Period 2|Adverse Event|1|||
48855311|NCT02584257|157308612|FG002|Period 2|Adverse Event|0|||
48855312|NCT02584257|157308613|FG003|Period 2|Adverse Event|0|||
48855313|NCT02584257|157308614|FG004|Period 2|Adverse Event|0|||
48855314|NCT02584257|157308615|FG005|Period 2|Adverse Event|0|||
48855315|NCT02584257|157308616|FG006|Period 2|Adverse Event|0|||
48855316|NCT02584257|157308617|FG007|Period 2|Adverse Event|0|||
48950724|NCT00474630|157649829|FG001|Overall Study|Withdrawal by Subject|15|||
48950725|NCT00474630|157649828|FG000|Overall Study|Protocol Violation|3|||
48950726|NCT00474630|157649829|FG001|Overall Study|Protocol Violation|4|||
48950727|NCT00474630|157649828|FG000|Overall Study|Lack of Efficacy|5|||
48950728|NCT00474630|157649829|FG001|Overall Study|Lack of Efficacy|6|||
48950729|NCT00474630|157649828|FG000|Overall Study|Drug noncompliance, other|11|||
48950730|NCT00474630|157649829|FG001|Overall Study|Drug noncompliance, other|4|||
48950731|NCT03567291|157649831|FG000|Period I|Adverse Event|14|||
48950732|NCT03567291|157649832|FG001|Period I|Adverse Event|0|||
48950733|NCT03567291|157649833|FG002|Period I|Adverse Event|0|||
48950734|NCT03567291|157649834|FG003|Period I|Adverse Event|0|||
48950735|NCT03567291|157649831|FG000|Period I|Protocol Violation|1|||
48950736|NCT03567291|157649832|FG001|Period I|Protocol Violation|0|||
48950737|NCT03567291|157649833|FG002|Period I|Protocol Violation|0|||
48950738|NCT03567291|157649834|FG003|Period I|Protocol Violation|0|||
48950739|NCT03567291|157649831|FG000|Period I|Withdrawal by Subject|23|||
48950740|NCT03567291|157649832|FG001|Period I|Withdrawal by Subject|0|||
48742038|NCT00622284|156904438|FG001|Overall Study|Lack of Efficacy|15|||
48742039|NCT00622284|156904437|FG000|Overall Study|Adverse Event|61|||
48742040|NCT00622284|156904438|FG001|Overall Study|Adverse Event|90|||
48742041|NCT00622284|156904437|FG000|Overall Study|Protocol Violation|12|||
48742042|NCT00622284|156904438|FG001|Overall Study|Protocol Violation|5|||
48742043|NCT00622284|156904437|FG000|Overall Study|Lost to Follow-up|11|||
48742044|NCT00622284|156904438|FG001|Overall Study|Lost to Follow-up|13|||
48742045|NCT00622284|156904437|FG000|Overall Study|Withdrawal by Subject|27|||
48742046|NCT00622284|156904438|FG001|Overall Study|Withdrawal by Subject|24|||
48855317|NCT02584257|157308618|FG008|Period 2|Adverse Event|0|||
48950741|NCT03567291|157649833|FG002|Period I|Withdrawal by Subject|0|||
48950742|NCT03567291|157649834|FG003|Period I|Withdrawal by Subject|0|||
48950743|NCT03567291|157649831|FG000|Period I|Lost to Follow-up|2|||
48950744|NCT03567291|157649832|FG001|Period I|Lost to Follow-up|0|||
48950745|NCT03567291|157649833|FG002|Period I|Lost to Follow-up|0|||
48950746|NCT03567291|157649834|FG003|Period I|Lost to Follow-up|0|||
48950747|NCT03567291|157649831|FG000|Period I|Terminated by sponsor|44|||
48950748|NCT03567291|157649832|FG001|Period I|Terminated by sponsor|0|||
48950749|NCT03567291|157649833|FG002|Period I|Terminated by sponsor|0|||
48950750|NCT03567291|157649834|FG003|Period I|Terminated by sponsor|0|||
48950751|NCT03567291|157649831|FG000|Period I|Missing or unknown|7|||
48950752|NCT03567291|157649832|FG001|Period I|Missing or unknown|0|||
48950753|NCT03567291|157649833|FG002|Period I|Missing or unknown|0|||
48950754|NCT03567291|157649834|FG003|Period I|Missing or unknown|0|||
48950755|NCT03567291|157649831|FG000|Period II|Adverse Event|0|||
48742047|NCT00622284|156904437|FG000|Overall Study|Other reason (not specified)|33|||
48742048|NCT00622284|156904438|FG001|Overall Study|Other reason (not specified)|24|||
48742049|NCT01300650|156904439|FG000|Overall Study|Adverse Event|1|||
48742050|NCT02639065|156904452|FG000|Study Treatment|Disease Progression|13|||
48742051|NCT02639065|156904452|FG000|Study Treatment|Adverse Event|9|||
48855318|NCT02309892|157308619|FG000|Overall Study|Physician Decision|1|||
48855319|NCT02309892|157308620|FG001|Overall Study|Physician Decision|0|||
48855320|NCT02309892|157308621|FG002|Overall Study|Physician Decision|0|||
48855321|NCT02309892|157308622|FG003|Overall Study|Physician Decision|0|||
48855322|NCT02309892|157308623|FG004|Overall Study|Physician Decision|0|||
48855323|NCT02309892|157308624|FG005|Overall Study|Physician Decision|0|||
48855324|NCT02309892|157308625|FG006|Overall Study|Physician Decision|0|||
48855325|NCT02309892|157308619|FG000|Overall Study|Adverse Event|1|||
48855326|NCT02309892|157308620|FG001|Overall Study|Adverse Event|0|||
48855327|NCT02309892|157308621|FG002|Overall Study|Adverse Event|1|||
48855328|NCT02309892|157308622|FG003|Overall Study|Adverse Event|0|||
48855329|NCT02309892|157308623|FG004|Overall Study|Adverse Event|0|||
48855330|NCT02309892|157308624|FG005|Overall Study|Adverse Event|0|||
48855331|NCT02309892|157308625|FG006|Overall Study|Adverse Event|0|||
48855332|NCT02309892|157308619|FG000|Overall Study|Progressive Disease|0|||
48855333|NCT02309892|157308620|FG001|Overall Study|Progressive Disease|1|||
48950756|NCT03567291|157649832|FG001|Period II|Adverse Event|1|||
48950757|NCT03567291|157649833|FG002|Period II|Adverse Event|0|||
48950758|NCT03567291|157649834|FG003|Period II|Adverse Event|0|||
48950759|NCT03567291|157649831|FG000|Period II|Missing or unknown|0|||
48950760|NCT03567291|157649832|FG001|Period II|Missing or unknown|2|||
48950761|NCT03567291|157649833|FG002|Period II|Missing or unknown|1|||
48855334|NCT02309892|157308621|FG002|Overall Study|Progressive Disease|0|||
48855335|NCT02309892|157308622|FG003|Overall Study|Progressive Disease|0|||
48855336|NCT02309892|157308623|FG004|Overall Study|Progressive Disease|1|||
48855337|NCT02309892|157308624|FG005|Overall Study|Progressive Disease|0|||
48855338|NCT02309892|157308625|FG006|Overall Study|Progressive Disease|0|||
48950762|NCT03567291|157649834|FG003|Period II|Missing or unknown|0|||
48950763|NCT03567291|157649831|FG000|Period III|Adverse Event|0|||
48950764|NCT03567291|157649832|FG001|Period III|Adverse Event|0|||
48950765|NCT03567291|157649833|FG002|Period III|Adverse Event|0|||
48950766|NCT03567291|157649834|FG003|Period III|Adverse Event|4|||
48950767|NCT03567291|157649831|FG000|Period III|Withdrawal by Subject|0|||
48950768|NCT03567291|157649832|FG001|Period III|Withdrawal by Subject|0|||
48950769|NCT03567291|157649833|FG002|Period III|Withdrawal by Subject|0|||
48950770|NCT03567291|157649834|FG003|Period III|Withdrawal by Subject|4|||
48950771|NCT03567291|157649831|FG000|Period III|Lost to Follow-up|0|||
48950772|NCT03567291|157649832|FG001|Period III|Lost to Follow-up|0|||
48950773|NCT03567291|157649833|FG002|Period III|Lost to Follow-up|0|||
48950774|NCT03567291|157649834|FG003|Period III|Lost to Follow-up|1|||
48950775|NCT03567291|157649831|FG000|Period III|Terminated by sponsor|0|||
48950776|NCT03567291|157649832|FG001|Period III|Terminated by sponsor|0|||
48950777|NCT03567291|157649833|FG002|Period III|Terminated by sponsor|0|||
48950778|NCT03567291|157649834|FG003|Period III|Terminated by sponsor|68|||
48950779|NCT03567291|157649831|FG000|Period III|Missing or unknown|0|||
48950780|NCT03567291|157649832|FG001|Period III|Missing or unknown|0|||
48950781|NCT03567291|157649833|FG002|Period III|Missing or unknown|0|||
48950782|NCT03567291|157649834|FG003|Period III|Missing or unknown|8|||
48950783|NCT03666143|157649835|FG000|Overall Study|Death|158|||
48950784|NCT03666143|157649835|FG000|Overall Study|Sponsor Decision|31|||
48950785|NCT03666143|157649835|FG000|Overall Study|Withdrawal by Subject|11|||
48950786|NCT03666143|157649835|FG000|Overall Study|Lost to Follow-up|5|||
48950787|NCT03666143|157649835|FG000|Overall Study|Physician Decision|1|||
48950788|NCT03666143|157649835|FG000|Overall Study|Rolled into extension study|9|||
48950789|NCT03666143|157649835|FG000|Overall Study|Progressive Disease|1|||
48950790|NCT02834403|157649836|FG000|Overall Study|Physician Decision|2|||
48950791|NCT02834403|157649837|FG001|Overall Study|Physician Decision|1|||
48950792|NCT02834403|157649838|FG002|Overall Study|Physician Decision|2|||
48950793|NCT02834403|157649839|FG003|Overall Study|Physician Decision|1|||
48950794|NCT02834403|157649840|FG004|Overall Study|Physician Decision|1|||
48950795|NCT02834403|157649841|FG005|Overall Study|Physician Decision|2|||
48950796|NCT02834403|157649842|FG006|Overall Study|Physician Decision|12|||
48950797|NCT02834403|157649836|FG000|Overall Study|Adverse Event|0|||
48950798|NCT02834403|157649837|FG001|Overall Study|Adverse Event|0|||
48950799|NCT02834403|157649838|FG002|Overall Study|Adverse Event|0|||
48950800|NCT02834403|157649839|FG003|Overall Study|Adverse Event|0|||
48950801|NCT02834403|157649840|FG004|Overall Study|Adverse Event|1|||
48950802|NCT02834403|157649841|FG005|Overall Study|Adverse Event|1|||
48950803|NCT02834403|157649842|FG006|Overall Study|Adverse Event|3|||
48950804|NCT02834403|157649836|FG000|Overall Study|Withdrawal by Subject|0|||
48950805|NCT02834403|157649837|FG001|Overall Study|Withdrawal by Subject|1|||
48950806|NCT02834403|157649838|FG002|Overall Study|Withdrawal by Subject|0|||
48950807|NCT02834403|157649839|FG003|Overall Study|Withdrawal by Subject|0|||
48950808|NCT02834403|157649840|FG004|Overall Study|Withdrawal by Subject|1|||
48950809|NCT02834403|157649841|FG005|Overall Study|Withdrawal by Subject|0|||
48950810|NCT02834403|157649842|FG006|Overall Study|Withdrawal by Subject|0|||
48950811|NCT02834403|157649836|FG000|Overall Study|Complete response before the end of 6 cycles|0|||
48950812|NCT02834403|157649837|FG001|Overall Study|Complete response before the end of 6 cycles|0|||
48950813|NCT02834403|157649838|FG002|Overall Study|Complete response before the end of 6 cycles|0|||
48950814|NCT02834403|157649839|FG003|Overall Study|Complete response before the end of 6 cycles|0|||
48950815|NCT02834403|157649840|FG004|Overall Study|Complete response before the end of 6 cycles|0|||
48950816|NCT02834403|157649841|FG005|Overall Study|Complete response before the end of 6 cycles|0|||
48950817|NCT02834403|157649842|FG006|Overall Study|Complete response before the end of 6 cycles|3|||
48950818|NCT02747043|157649849|FG000|Overall Study|Other|1|||
48950819|NCT02747043|157649850|FG001|Overall Study|Other|1|||
48950820|NCT02747043|157649849|FG000|Overall Study|Adverse Event|3|||
48950821|NCT02747043|157649850|FG001|Overall Study|Adverse Event|1|||
48950822|NCT02747043|157649849|FG000|Overall Study|Withdrawal by Subject|1|||
48950823|NCT02747043|157649850|FG001|Overall Study|Withdrawal by Subject|1|||
48950824|NCT02747043|157649849|FG000|Overall Study|Physician Decision|1|||
48950825|NCT02747043|157649850|FG001|Overall Study|Physician Decision|1|||
48950826|NCT02747043|157649849|FG000|Overall Study|Protocol Violation|0|||
48950827|NCT02747043|157649850|FG001|Overall Study|Protocol Violation|1|||
48950828|NCT02747043|157649849|FG000|Overall Study|Disease progression|4|||
48950829|NCT02747043|157649850|FG001|Overall Study|Disease progression|0|||
48950830|NCT00907478|157649851|FG000|Overall Study|Ineligibility determined|0|||
48950831|NCT00907478|157649852|FG001|Overall Study|Ineligibility determined|0|||
48742052|NCT02639065|156904452|FG000|Study Treatment|Withdrawal by Subject|1|||
48742053|NCT02639065|156904452|FG000|Follow up|Subject refused to follow up|1|||
48742054|NCT02639065|156904452|FG000|Follow up|Symptomatic Deterioration|2|||
48742055|NCT02639065|156904452|FG000|Follow up|Death|2|||
48742056|NCT02639065|156904452|FG000|Follow up|Study Terminated|1|||
48742057|NCT02639065|156904452|FG000|Follow up|Disease Progression|3|||
48950832|NCT00907478|157649853|FG002|Overall Study|Ineligibility determined|1|||
48950833|NCT00907478|157649851|FG000|Overall Study|Noncompliance|0|||
48950834|NCT00907478|157649852|FG001|Overall Study|Noncompliance|0|||
48950835|NCT00907478|157649853|FG002|Overall Study|Noncompliance|1|||
48950836|NCT00907478|157649851|FG000|Overall Study|Adverse Event|3|||
48950837|NCT00907478|157649852|FG001|Overall Study|Adverse Event|1|||
48950838|NCT00907478|157649853|FG002|Overall Study|Adverse Event|2|||
48950839|NCT00907478|157649851|FG000|Overall Study|Withdrawal by Subject|8|||
48950840|NCT00907478|157649852|FG001|Overall Study|Withdrawal by Subject|9|||
48950841|NCT00907478|157649853|FG002|Overall Study|Withdrawal by Subject|6|||
48950842|NCT00907478|157649851|FG000|Overall Study|Requirement for alternative therapy|1|||
48950843|NCT00907478|157649852|FG001|Overall Study|Requirement for alternative therapy|2|||
48950844|NCT00907478|157649853|FG002|Overall Study|Requirement for alternative therapy|3|||
48950845|NCT00907478|157649851|FG000|Overall Study|Physician Decision|2|||
48742058|NCT03128411|156904453|FG000|Treatment Phase|Adverse Event|21|||
48742059|NCT03128411|156904453|FG000|Treatment Phase|Physician Decision|1|||
48742060|NCT03128411|156904453|FG000|Treatment Phase|Other|2|||
48742061|NCT03128411|156904453|FG000|Long Term Follow-up Phase|Death|2|||
48950846|NCT00907478|157649852|FG001|Overall Study|Physician Decision|0|||
48950847|NCT00907478|157649853|FG002|Overall Study|Physician Decision|3|||
48950848|NCT00907478|157649851|FG000|Overall Study|Death|4|||
48950849|NCT00907478|157649852|FG001|Overall Study|Death|2|||
48950850|NCT00907478|157649853|FG002|Overall Study|Death|1|||
48950851|NCT00907478|157649851|FG000|Overall Study|Protocol-specified criteria|5|||
48950852|NCT00907478|157649852|FG001|Overall Study|Protocol-specified criteria|2|||
48950853|NCT00907478|157649853|FG002|Overall Study|Protocol-specified criteria|3|||
48742062|NCT01197560|156904454|FG000|Overall Study|Adverse Event|6|||
48742063|NCT01197560|156904455|FG001|Overall Study|Adverse Event|8|||
48742064|NCT01197560|156904454|FG000|Overall Study|Death|3|||
48950854|NCT00907478|157649851|FG000|Overall Study|Pregnancy|0|||
48950855|NCT00907478|157649852|FG001|Overall Study|Pregnancy|1|||
48950856|NCT00907478|157649853|FG002|Overall Study|Pregnancy|1|||
48950857|NCT00907478|157649851|FG000|Overall Study|Lost to Follow-up|1|||
48950858|NCT00907478|157649852|FG001|Overall Study|Lost to Follow-up|0|||
48950859|NCT00907478|157649853|FG002|Overall Study|Lost to Follow-up|0|||
48950860|NCT00907478|157649851|FG000|Overall Study|Other|3|||
48950861|NCT00907478|157649852|FG001|Overall Study|Other|0|||
48950862|NCT00907478|157649853|FG002|Overall Study|Other|1|||
48950863|NCT01936649|157649854|FG000|Overall Study|Withdrawal by Subject|4|||
48950864|NCT01936649|157649854|FG000|Overall Study|Physician Decision|2|||
48950865|NCT01936649|157649854|FG000|Overall Study|Protocol Violation|2|||
48950866|NCT01936649|157649854|FG000|Overall Study|Other than specified above|5|||
48950867|NCT01512368|157649860|FG000|Overall Study|Protocol Violation|3|||
48950868|NCT00718861|157649864|FG000|Overall Study|Withdrawal by Subject|15|||
48855339|NCT02309892|157308619|FG000|Overall Study|Death|0|||
48855340|NCT02309892|157308620|FG001|Overall Study|Death|0|||
48855341|NCT02309892|157308621|FG002|Overall Study|Death|0|||
48950869|NCT00718861|157649865|FG001|Overall Study|Withdrawal by Subject|10|||
48950870|NCT00718861|157649864|FG000|Overall Study|Adverse Event|2|||
48950871|NCT00718861|157649865|FG001|Overall Study|Adverse Event|1|||
48950872|NCT00718861|157649864|FG000|Overall Study|Lost to Follow-up|2|||
48950873|NCT00718861|157649865|FG001|Overall Study|Lost to Follow-up|1|||
48950874|NCT00718861|157649864|FG000|Overall Study|Administrative Problems|1|||
48950875|NCT00718861|157649865|FG001|Overall Study|Administrative Problems|1|||
48950876|NCT00718861|157649864|FG000|Overall Study|Death|1|||
48950877|NCT00718861|157649865|FG001|Overall Study|Death|5|||
48950878|NCT00859898|157649870|FG000|Overall Study|Lack of Efficacy|0|||
48950879|NCT00859898|157649871|FG001|Overall Study|Lack of Efficacy|1|||
48950880|NCT00859898|157649872|FG002|Overall Study|Lack of Efficacy|1|||
48950881|NCT00859898|157649870|FG000|Overall Study|Adverse Event|4|||
48950882|NCT00859898|157649871|FG001|Overall Study|Adverse Event|9|||
48950883|NCT00859898|157649872|FG002|Overall Study|Adverse Event|8|||
48950884|NCT00859898|157649870|FG000|Overall Study|Withdrawal by Subject|11|||
48950885|NCT00859898|157649871|FG001|Overall Study|Withdrawal by Subject|8|||
48950886|NCT00859898|157649872|FG002|Overall Study|Withdrawal by Subject|11|||
48950887|NCT00859898|157649870|FG000|Overall Study|Death|0|||
48950888|NCT00859898|157649871|FG001|Overall Study|Death|0|||
48950889|NCT00859898|157649872|FG002|Overall Study|Death|1|||
48950890|NCT00859898|157649870|FG000|Overall Study|Lost to Follow-up|10|||
48950891|NCT00859898|157649871|FG001|Overall Study|Lost to Follow-up|11|||
48950892|NCT00859898|157649872|FG002|Overall Study|Lost to Follow-up|5|||
48950893|NCT00859898|157649870|FG000|Overall Study|poor/non-compliance|2|||
48950894|NCT00859898|157649871|FG001|Overall Study|poor/non-compliance|0|||
48950895|NCT00859898|157649872|FG002|Overall Study|poor/non-compliance|0|||
48950896|NCT00859898|157649870|FG000|Overall Study|No longer meets criteria|0|||
48855342|NCT02309892|157308622|FG003|Overall Study|Death|0|||
48855343|NCT02309892|157308623|FG004|Overall Study|Death|0|||
48855344|NCT02309892|157308624|FG005|Overall Study|Death|1|||
48855345|NCT02309892|157308625|FG006|Overall Study|Death|0|||
48855346|NCT01137682|157308627|FG000|Overall Study|Adverse Event-CORE|2|||
48855347|NCT01137682|157308628|FG001|Overall Study|Adverse Event-CORE|4|||
48855348|NCT01137682|157308629|FG002|Overall Study|Adverse Event-CORE|0|||
48855349|NCT01137682|157308627|FG000|Overall Study|Withdrawal by Subject-CORE|2|||
48950897|NCT00859898|157649871|FG001|Overall Study|No longer meets criteria|1|||
48950898|NCT00859898|157649872|FG002|Overall Study|No longer meets criteria|0|||
48950899|NCT00859898|157649870|FG000|Overall Study|non-specified|1|||
48950900|NCT00859898|157649871|FG001|Overall Study|non-specified|1|||
48950901|NCT00859898|157649872|FG002|Overall Study|non-specified|1|||
48855350|NCT01137682|157308628|FG001|Overall Study|Withdrawal by Subject-CORE|2|||
48950902|NCT02460822|157649880|FG000|Overall Study|Withdrawal by Subject|1|||
48950903|NCT00858702|157649883|FG000|Overall Study|Lack of Efficacy|1|||
48950904|NCT00858702|157649884|FG001|Overall Study|Lack of Efficacy|0|||
48742065|NCT01197560|156904455|FG001|Overall Study|Death|5|||
48742066|NCT01197560|156904454|FG000|Overall Study|Withdrawal by Subject|1|||
48742067|NCT01197560|156904455|FG001|Overall Study|Withdrawal by Subject|1|||
48742068|NCT01197560|156904454|FG000|Overall Study|Disease progression|40|||
48742069|NCT01197560|156904455|FG001|Overall Study|Disease progression|35|||
48742070|NCT01197560|156904454|FG000|Overall Study|Miscellaneous|4|||
48742071|NCT01197560|156904455|FG001|Overall Study|Miscellaneous|3|||
48742072|NCT01197560|156904454|FG000|Overall Study|Missing|0|||
48742073|NCT01197560|156904455|FG001|Overall Study|Missing|1|||
48742074|NCT04213079|156906151|FG000|Overall Study|Lost to Follow-up|0|||
48742075|NCT04213079|156906152|FG001|Overall Study|Lost to Follow-up|2|||
48742076|NCT03228433|156906153|FG000|Overall Study|Lost to Follow-up|1|||
48742077|NCT03228433|156906154|FG001|Overall Study|Lost to Follow-up|0|||
48742078|NCT03228433|156906155|FG002|Overall Study|Lost to Follow-up|0|||
48742079|NCT03228433|156906156|FG003|Overall Study|Lost to Follow-up|0|||
48742080|NCT03228433|156906157|FG004|Overall Study|Lost to Follow-up|0|||
48742081|NCT03228433|156906158|FG005|Overall Study|Lost to Follow-up|0|||
48742082|NCT03228433|156906153|FG000|Overall Study|Positive alcohol test|0|||
48742083|NCT03228433|156906154|FG001|Overall Study|Positive alcohol test|0|||
48742084|NCT03228433|156906155|FG002|Overall Study|Positive alcohol test|0|||
48742085|NCT03228433|156906156|FG003|Overall Study|Positive alcohol test|1|||
48742086|NCT03228433|156906157|FG004|Overall Study|Positive alcohol test|0|||
48742087|NCT03228433|156906158|FG005|Overall Study|Positive alcohol test|0|||
48798213|NCT00441701|157098569|FG008|Overall Study|Lack of Efficacy|0|||
48798214|NCT00441701|157098570|FG009|Overall Study|Lack of Efficacy|0|||
48798215|NCT00441701|157098561|FG000|Overall Study|Withdrawal by Subject|0|||
48798216|NCT00441701|157098562|FG001|Overall Study|Withdrawal by Subject|2|||
48798217|NCT00441701|157098563|FG002|Overall Study|Withdrawal by Subject|1|||
48798218|NCT00441701|157098564|FG003|Overall Study|Withdrawal by Subject|1|||
48798219|NCT00441701|157098565|FG004|Overall Study|Withdrawal by Subject|0|||
48798220|NCT00441701|157098566|FG005|Overall Study|Withdrawal by Subject|0|||
48798221|NCT00441701|157098567|FG006|Overall Study|Withdrawal by Subject|0|||
48798222|NCT00441701|157098568|FG007|Overall Study|Withdrawal by Subject|0|||
48798223|NCT00441701|157098569|FG008|Overall Study|Withdrawal by Subject|0|||
48798224|NCT00441701|157098570|FG009|Overall Study|Withdrawal by Subject|0|||
48798225|NCT01113502|157098573|FG000|Overall Study|Withdrawal by Subject|1|||
48798226|NCT01113502|157098574|FG001|Overall Study|Withdrawal by Subject|0|||
48798227|NCT01113502|157098575|FG002|Overall Study|Withdrawal by Subject|1|||
48798228|NCT01113502|157098576|FG003|Overall Study|Withdrawal by Subject|1|||
48798229|NCT01113502|157098577|FG004|Overall Study|Withdrawal by Subject|0|||
48798230|NCT01113502|157098573|FG000|Overall Study|Adverse Event|0|||
48798231|NCT01113502|157098574|FG001|Overall Study|Adverse Event|0|||
48798232|NCT01113502|157098575|FG002|Overall Study|Adverse Event|3|||
48798233|NCT01113502|157098576|FG003|Overall Study|Adverse Event|2|||
48798234|NCT01113502|157098577|FG004|Overall Study|Adverse Event|0|||
48798235|NCT04535947|157098578|FG000|Overall Study|Adverse Event|1|||
48798236|NCT04535947|157098579|FG001|Overall Study|Adverse Event|4|||
48798237|NCT04535947|157098578|FG000|Overall Study|Other reasons not specified|2|||
48798238|NCT04535947|157098579|FG001|Overall Study|Other reasons not specified|0|||
48798239|NCT04535947|157098578|FG000|Overall Study|Withdrawal by Subject|1|||
48798240|NCT04535947|157098579|FG001|Overall Study|Withdrawal by Subject|1|||
48798241|NCT02255357|157098581|FG000|Overall Study|Physician Decision|10|||
48798242|NCT02255357|157098582|FG001|Overall Study|Physician Decision|24|||
48798243|NCT03802123|157098583|FG000|Overall Study|Withdrawal by Subject|3|||
48798244|NCT03802123|157098583|FG000|Overall Study|Physician Decision|1|||
48798245|NCT03802123|157098583|FG000|Overall Study|Subject moved to hospice care|1|||
48798246|NCT03802123|157098583|FG000|Overall Study|technician error|1|||
48798247|NCT03802123|157098583|FG000|Overall Study|Death|3|||
48798248|NCT01274182|157098584|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
48798249|NCT01274182|157098585|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
48798250|NCT01274182|157098586|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
48798251|NCT01274182|157098584|FG000|Overall Study|Adverse Event|4|||
48798252|NCT01274182|157098585|FG001|Overall Study|Adverse Event|5|||
48798253|NCT01274182|157098586|FG002|Overall Study|Adverse Event|3|||
48798254|NCT01274182|157098584|FG000|Overall Study|Withdrawal by Subject|5|||
48742088|NCT01797731|156906161|FG000|Overall Study|Didn't have proper radiographs required|3|||
48742089|NCT01797731|156906162|FG001|Overall Study|Didn't have proper radiographs required|3|||
48742090|NCT00129272|156906163|FG000|Overall Study|Lost to Follow-up|12|||
48742091|NCT00129272|156906164|FG001|Overall Study|Lost to Follow-up|11|||
48742092|NCT00129272|156906163|FG000|Overall Study|Withdrawal by Subject|5|||
48742093|NCT00129272|156906164|FG001|Overall Study|Withdrawal by Subject|11|||
48742094|NCT00261807|156906165|FG000|Overall Study|Lost to Follow-up|2|||
48742095|NCT00261807|156906165|FG000|Overall Study|Adverse Event|2|||
48742096|NCT00261807|156906165|FG000|Overall Study|Death|1|||
48742097|NCT00261807|156906165|FG000|Overall Study|Protocol Violation|2|||
48742098|NCT02582983|156906169|FG000|Overall Study|Death|3|||
48742099|NCT02582983|156906169|FG000|Overall Study|Withdrawal by Subject|2|||
48742100|NCT02582983|156906169|FG000|Overall Study|Adverse Event|1|||
48742101|NCT04377620|156906170|FG000|Overall Study|Death|42|||
48742102|NCT04377620|156906171|FG001|Overall Study|Death|48|||
48742103|NCT04377620|156906172|FG002|Overall Study|Death|36|||
48742104|NCT04377620|156906170|FG000|Overall Study|Withdrawal by Subject|0|||
48742105|NCT04377620|156906171|FG001|Overall Study|Withdrawal by Subject|2|||
48742106|NCT04377620|156906172|FG002|Overall Study|Withdrawal by Subject|0|||
48742107|NCT00724932|156906173|FG000|Overall Study|Lost to Follow-up|1|||
48742108|NCT00724932|156906174|FG001|Overall Study|Lost to Follow-up|0|||
48742109|NCT00724932|156906173|FG000|Overall Study|Not treated|4|||
48742110|NCT00724932|156906174|FG001|Overall Study|Not treated|3|||
48742111|NCT02021331|156906175|FG000|Overall Study|Adverse Event|0|||
48742112|NCT02021331|156906176|FG001|Overall Study|Adverse Event|2|||
48742113|NCT04138810|156906182|FG000|Overall Study|Withdrawal by Subject|0|||
48742114|NCT04138810|156906183|FG001|Overall Study|Withdrawal by Subject|1|||
48742115|NCT04138810|156906182|FG000|Overall Study|Subject cancelled surgery|1|||
48742116|NCT04138810|156906183|FG001|Overall Study|Subject cancelled surgery|0|||
48742117|NCT03478657|156906186|FG000|Overall Study|Withdrawal by Subject|0|||
48742118|NCT03478657|156906187|FG001|Overall Study|Withdrawal by Subject|1|||
48742119|NCT01786668|156906188|FG000|Overall Study|Adverse Event|0|||
48742120|NCT01786668|156906189|FG001|Overall Study|Adverse Event|1|||
48742121|NCT01786668|156906190|FG002|Overall Study|Adverse Event|1|||
48742122|NCT01786668|156906191|FG003|Overall Study|Adverse Event|2|||
48742123|NCT01786668|156906188|FG000|Overall Study|Withdrawal by Subject|0|||
48742124|NCT01786668|156906189|FG001|Overall Study|Withdrawal by Subject|0|||
48742125|NCT01786668|156906190|FG002|Overall Study|Withdrawal by Subject|3|||
48742126|NCT01786668|156906191|FG003|Overall Study|Withdrawal by Subject|1|||
48742127|NCT01786668|156906188|FG000|Overall Study|Pregnancy|0|||
48742128|NCT01786668|156906189|FG001|Overall Study|Pregnancy|0|||
48742129|NCT01786668|156906190|FG002|Overall Study|Pregnancy|0|||
48742130|NCT01786668|156906191|FG003|Overall Study|Pregnancy|1|||
48742131|NCT01786668|156906188|FG000|Overall Study|Lost to Follow-up|1|||
48742132|NCT01786668|156906189|FG001|Overall Study|Lost to Follow-up|0|||
48742133|NCT01786668|156906190|FG002|Overall Study|Lost to Follow-up|1|||
48742134|NCT01786668|156906191|FG003|Overall Study|Lost to Follow-up|0|||
48742135|NCT01702805|156906193|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
48742136|NCT01702805|156906194|FG001|Overall Study|Data withdrawn prior to hospital discharge|7|||
48742137|NCT01702805|156906193|FG000|Overall Study|Incomplete Follow-up|18|||
48742138|NCT01702805|156906194|FG001|Overall Study|Incomplete Follow-up|15|||
48742139|NCT01702805|156906193|FG000|Overall Study|Vital Status Assessment Only|40|||
48742140|NCT01702805|156906194|FG001|Overall Study|Vital Status Assessment Only|39|||
48742141|NCT01702805|156906193|FG000|Overall Study|Lost to Follow-up|5|||
48742142|NCT01702805|156906194|FG001|Overall Study|Lost to Follow-up|5|||
48742143|NCT01540838|156906201|FG000|Overall Study|Open nasogastric tube|9|||
48742144|NCT01540838|156906202|FG001|Overall Study|Open nasogastric tube|7|||
48742145|NCT01540838|156906201|FG000|Overall Study|Treatment doses missing|8|||
48742146|NCT01540838|156906202|FG001|Overall Study|Treatment doses missing|12|||
48742147|NCT01540838|156906201|FG000|Overall Study|Additional antibiotic treatment|1|||
48742148|NCT01540838|156906202|FG001|Overall Study|Additional antibiotic treatment|2|||
48742149|NCT01540838|156906201|FG000|Overall Study|Died before treatment initiation|1|||
48742150|NCT01540838|156906202|FG001|Overall Study|Died before treatment initiation|1|||
48742151|NCT01540838|156906201|FG000|Overall Study|Not BM. Other treatment|3|||
48742152|NCT01540838|156906202|FG001|Overall Study|Not BM. Other treatment|1|||
48742153|NCT01849783|156906205|FG000|Overall Study|Adverse Event|5|||
48742154|NCT01849783|156906205|FG000|Overall Study|Death|2|||
48855351|NCT01137682|157308629|FG002|Overall Study|Withdrawal by Subject-CORE|2|||
48855352|NCT01137682|157308627|FG000|Overall Study|Administrative problems-CORE|2|||
48855353|NCT01137682|157308628|FG001|Overall Study|Administrative problems-CORE|1|||
48742155|NCT01849783|156906205|FG000|Overall Study|Physician Decision|1|||
48742156|NCT01849783|156906205|FG000|Overall Study|Withdrawal by Subject|1|||
48855354|NCT01137682|157308629|FG002|Overall Study|Administrative problems-CORE|0|||
48855355|NCT01137682|157308627|FG000|Overall Study|Protocol Violation-CORE|0|||
48855356|NCT01137682|157308628|FG001|Overall Study|Protocol Violation-CORE|1|||
48855357|NCT01137682|157308629|FG002|Overall Study|Protocol Violation-CORE|1|||
48855358|NCT01137682|157308627|FG000|Overall Study|Adverse Event-Extension|4|||
48855359|NCT01137682|157308628|FG001|Overall Study|Adverse Event-Extension|8|||
48855360|NCT01137682|157308629|FG002|Overall Study|Adverse Event-Extension|7|||
48855361|NCT01137682|157308627|FG000|Overall Study|Lack of Efficacy-Extension|15|||
48855362|NCT01137682|157308628|FG001|Overall Study|Lack of Efficacy-Extension|9|||
48855363|NCT01137682|157308629|FG002|Overall Study|Lack of Efficacy-Extension|13|||
48855364|NCT01137682|157308627|FG000|Overall Study|Withdrawal by Subject-Extension|6|||
48855365|NCT01137682|157308628|FG001|Overall Study|Withdrawal by Subject-Extension|8|||
48855366|NCT01137682|157308629|FG002|Overall Study|Withdrawal by Subject-Extension|8|||
48855367|NCT01137682|157308627|FG000|Overall Study|Lost to Follow Up-Extension|0|||
48855368|NCT01137682|157308628|FG001|Overall Study|Lost to Follow Up-Extension|1|||
48742157|NCT01849783|156906205|FG000|Overall Study|Unable to comply|2|||
48855369|NCT01137682|157308629|FG002|Overall Study|Lost to Follow Up-Extension|0|||
48855370|NCT01137682|157308627|FG000|Overall Study|Administrative problems-Extension|0|||
48855371|NCT01137682|157308628|FG001|Overall Study|Administrative problems-Extension|2|||
48855372|NCT01137682|157308629|FG002|Overall Study|Administrative problems-Extension|0|||
48855373|NCT01137682|157308627|FG000|Overall Study|Death-Extension|2|||
48855374|NCT01137682|157308628|FG001|Overall Study|Death-Extension|0|||
48855375|NCT01137682|157308629|FG002|Overall Study|Death-Extension|0|||
48855376|NCT01137682|157308627|FG000|Overall Study|Protocol Violation-Extension|2|||
48855377|NCT01137682|157308628|FG001|Overall Study|Protocol Violation-Extension|1|||
48855378|NCT01137682|157308629|FG002|Overall Study|Protocol Violation-Extension|0|||
48855379|NCT01137682|157308627|FG000|Overall Study|Did not enter extension|2|||
48855380|NCT01137682|157308628|FG001|Overall Study|Did not enter extension|3|||
48855381|NCT01137682|157308629|FG002|Overall Study|Did not enter extension|2|||
48855382|NCT01137682|157308627|FG000|Overall Study|Did not receive treatment in extension|0|||
48855383|NCT01137682|157308628|FG001|Overall Study|Did not receive treatment in extension|0|||
48855384|NCT01137682|157308629|FG002|Overall Study|Did not receive treatment in extension|1|||
48855385|NCT02362789|157308630|FG000|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1|||
48855386|NCT02362789|157308631|FG001|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
48855387|NCT02362789|157308632|FG002|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
48855388|NCT02362789|157308630|FG000|Run-in Phase (Week 0 to 16)|Adverse Event|1|||
48855389|NCT02362789|157308631|FG001|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
48855390|NCT02362789|157308632|FG002|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
48855391|NCT02362789|157308630|FG000|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0|||
48855392|NCT02362789|157308631|FG001|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2|||
48855393|NCT02362789|157308632|FG002|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6|||
48855394|NCT02362789|157308630|FG000|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0|||
48855395|NCT02362789|157308631|FG001|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1|||
48855396|NCT02362789|157308632|FG002|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4|||
48855397|NCT02362789|157308630|FG000|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0|||
48855398|NCT02362789|157308631|FG001|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1|||
48855399|NCT02362789|157308632|FG002|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2|||
48855400|NCT00761267|157308633|FG000|Overall Study|Death|1|||
48855401|NCT00761267|157308634|FG001|Overall Study|Death|2|||
48855402|NCT00761267|157308635|FG002|Overall Study|Death|5|||
48855403|NCT00761267|157308633|FG000|Overall Study|Lost to Follow-up|0|||
48855404|NCT00761267|157308634|FG001|Overall Study|Lost to Follow-up|0|||
48855405|NCT00761267|157308635|FG002|Overall Study|Lost to Follow-up|1|||
48855406|NCT00761267|157308633|FG000|Overall Study|Randomized but not treated|1|||
48855407|NCT00761267|157308634|FG001|Overall Study|Randomized but not treated|1|||
48950905|NCT00858702|157649883|FG000|Overall Study|Protocol Violation|1|||
48950906|NCT00858702|157649884|FG001|Overall Study|Protocol Violation|1|||
48950907|NCT00858702|157649883|FG000|Overall Study|Other|2|||
48950908|NCT00858702|157649884|FG001|Overall Study|Other|1|||
48950909|NCT00858702|157649883|FG000|Overall Study|Withdrawal by Subject|1|||
48950910|NCT00858702|157649884|FG001|Overall Study|Withdrawal by Subject|0|||
48950911|NCT04045613|157649885|FG000|Overall Study|Adverse Event|2|||
48950912|NCT04045613|157649886|FG001|Overall Study|Adverse Event|2|||
48950913|NCT04045613|157649887|FG002|Overall Study|Adverse Event|1|||
48950914|NCT04045613|157649888|FG003|Overall Study|Adverse Event|1|||
48950915|NCT04045613|157649889|FG004|Overall Study|Adverse Event|0|||
48950916|NCT04045613|157649890|FG005|Overall Study|Adverse Event|0|||
48950917|NCT04045613|157649891|FG006|Overall Study|Adverse Event|1|||
48950918|NCT04045613|157649885|FG000|Overall Study|Withdrawal by Subject|0|||
48950919|NCT04045613|157649886|FG001|Overall Study|Withdrawal by Subject|5|||
48950920|NCT04045613|157649887|FG002|Overall Study|Withdrawal by Subject|0|||
48950921|NCT04045613|157649888|FG003|Overall Study|Withdrawal by Subject|0|||
48950922|NCT04045613|157649889|FG004|Overall Study|Withdrawal by Subject|0|||
48950923|NCT04045613|157649890|FG005|Overall Study|Withdrawal by Subject|1|||
48950924|NCT04045613|157649891|FG006|Overall Study|Withdrawal by Subject|0|||
48950925|NCT04045613|157649885|FG000|Overall Study|Physician Decision|2|||
48950926|NCT04045613|157649886|FG001|Overall Study|Physician Decision|0|||
48950927|NCT04045613|157649887|FG002|Overall Study|Physician Decision|0|||
48950928|NCT04045613|157649888|FG003|Overall Study|Physician Decision|0|||
48950929|NCT04045613|157649889|FG004|Overall Study|Physician Decision|1|||
48855408|NCT00761267|157308635|FG002|Overall Study|Randomized but not treated|0|||
48855409|NCT00761267|157308633|FG000|Overall Study|Withdrawal by Subject|0|||
48855410|NCT00761267|157308634|FG001|Overall Study|Withdrawal by Subject|1|||
48855411|NCT00761267|157308635|FG002|Overall Study|Withdrawal by Subject|0|||
48855412|NCT04183491|157308643|FG000|Overall Study|Withdrawal by Subject|0|||
48855413|NCT04183491|157308644|FG001|Overall Study|Withdrawal by Subject|0|||
48855414|NCT04183491|157308645|FG002|Overall Study|Withdrawal by Subject|1|||
48855415|NCT04183491|157308646|FG003|Overall Study|Withdrawal by Subject|0|||
48855416|NCT04183491|157308647|FG004|Overall Study|Withdrawal by Subject|0|||
48855417|NCT04183491|157308648|FG005|Overall Study|Withdrawal by Subject|1|||
48855418|NCT04183491|157308649|FG006|Overall Study|Withdrawal by Subject|0|||
48855419|NCT02538094|157308650|FG000|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0|||
48855420|NCT02538094|157308651|FG001|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1|||
48855421|NCT02538094|157308650|FG000|Washout (4 Weeks)|Withdrawal by Subject|0|||
48855422|NCT02538094|157308651|FG001|Washout (4 Weeks)|Withdrawal by Subject|1|||
48950930|NCT04045613|157649890|FG005|Overall Study|Physician Decision|0|||
48742158|NCT01849783|156906205|FG000|Overall Study|Disease progression|11|||
48855423|NCT01989104|157308652|FG000|Overall Study|Withdrawal by Subject|3|||
48950931|NCT04045613|157649891|FG006|Overall Study|Physician Decision|0|||
48950932|NCT04045613|157649885|FG000|Overall Study|Death|3|||
48950933|NCT04045613|157649886|FG001|Overall Study|Death|0|||
48950934|NCT04045613|157649887|FG002|Overall Study|Death|0|||
48950935|NCT04045613|157649888|FG003|Overall Study|Death|0|||
48950936|NCT04045613|157649889|FG004|Overall Study|Death|0|||
48950937|NCT04045613|157649890|FG005|Overall Study|Death|0|||
48950938|NCT04045613|157649891|FG006|Overall Study|Death|1|||
48950939|NCT04045613|157649885|FG000|Overall Study|Other reasons|0|||
48950940|NCT04045613|157649886|FG001|Overall Study|Other reasons|1|||
48950941|NCT04045613|157649887|FG002|Overall Study|Other reasons|0|||
48950942|NCT04045613|157649888|FG003|Overall Study|Other reasons|0|||
48950943|NCT04045613|157649889|FG004|Overall Study|Other reasons|0|||
48950944|NCT04045613|157649890|FG005|Overall Study|Other reasons|0|||
48950945|NCT04045613|157649891|FG006|Overall Study|Other reasons|1|||
48950946|NCT04045613|157649885|FG000|Overall Study|Progressive disease: Clinical progression|1|||
48950947|NCT04045613|157649886|FG001|Overall Study|Progressive disease: Clinical progression|0|||
48950948|NCT04045613|157649887|FG002|Overall Study|Progressive disease: Clinical progression|3|||
48950949|NCT04045613|157649888|FG003|Overall Study|Progressive disease: Clinical progression|1|||
48950950|NCT04045613|157649889|FG004|Overall Study|Progressive disease: Clinical progression|1|||
48950951|NCT04045613|157649890|FG005|Overall Study|Progressive disease: Clinical progression|3|||
48950952|NCT04045613|157649891|FG006|Overall Study|Progressive disease: Clinical progression|3|||
48950953|NCT04045613|157649885|FG000|Overall Study|Progressive disease: Radiological progression|24|||
48950954|NCT04045613|157649886|FG001|Overall Study|Progressive disease: Radiological progression|6|||
48950955|NCT04045613|157649887|FG002|Overall Study|Progressive disease: Radiological progression|8|||
48950956|NCT04045613|157649888|FG003|Overall Study|Progressive disease: Radiological progression|0|||
48950957|NCT04045613|157649889|FG004|Overall Study|Progressive disease: Radiological progression|6|||
48950958|NCT04045613|157649890|FG005|Overall Study|Progressive disease: Radiological progression|6|||
48950959|NCT04045613|157649891|FG006|Overall Study|Progressive disease: Radiological progression|11|||
48950960|NCT02805907|157649892|FG000|Overall Study|Lost to Follow-up|3|||
48950961|NCT02805907|157649893|FG001|Overall Study|Lost to Follow-up|3|||
48950962|NCT00514449|157649894|FG000|Overall Study|Withdrawal by Subject|1|||
48950963|NCT00514449|157649895|FG001|Overall Study|Withdrawal by Subject|2|||
48950964|NCT00514449|157649894|FG000|Overall Study|Protocol Violation|1|||
48950965|NCT00514449|157649895|FG001|Overall Study|Protocol Violation|2|||
48950966|NCT00514449|157649894|FG000|Overall Study|Lost to Follow-up|1|||
48950967|NCT00514449|157649895|FG001|Overall Study|Lost to Follow-up|0|||
48950968|NCT02853331|157649896|FG000|Overall Study|Death|59|||
48950969|NCT02853331|157649897|FG001|Overall Study|Death|95|||
48950970|NCT02853331|157649896|FG000|Overall Study|Withdrawal by Subject|5|||
48950971|NCT02853331|157649897|FG001|Overall Study|Withdrawal by Subject|9|||
48950972|NCT02853331|157649896|FG000|Overall Study|Ongoing in study|368|||
48950973|NCT02853331|157649897|FG001|Overall Study|Ongoing in study|325|||
48950974|NCT00739297|157649898|FG000|First Washout Period of 4-7 Days|Adverse Event|0|||
48950975|NCT00739297|157649899|FG001|First Washout Period of 4-7 Days|Adverse Event|0|||
48950976|NCT00739297|157649900|FG002|First Washout Period of 4-7 Days|Adverse Event|0|||
48950977|NCT00739297|157649901|FG003|First Washout Period of 4-7 Days|Adverse Event|2|||
48950978|NCT00739297|157649902|FG004|First Washout Period of 4-7 Days|Adverse Event|0|||
48950979|NCT00739297|157649903|FG005|First Washout Period of 4-7 Days|Adverse Event|0|||
48950980|NCT00739297|157649904|FG006|First Washout Period of 4-7 Days|Adverse Event|2|||
48950981|NCT00739297|157649898|FG000|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
48950982|NCT00739297|157649899|FG001|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
48950983|NCT00739297|157649900|FG002|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
48950984|NCT00739297|157649901|FG003|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
48950985|NCT00739297|157649902|FG004|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
48950986|NCT00739297|157649903|FG005|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
48798333|NCT04252742|157098608|FG001|Overall Study|Decision by sponsor|2|||
48950987|NCT00739297|157649904|FG006|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
48950988|NCT00784784|157649905|FG000|Overall Study|Withdrawal by Subject|2|||
48950989|NCT00784784|157649906|FG001|Overall Study|Withdrawal by Subject|2|||
48950990|NCT01797432|157649913|FG000|Overall Study|Lost to Follow-up|1|||
48950991|NCT01797432|157649913|FG000|Overall Study|Adverse Event|1|||
48950992|NCT01797432|157649913|FG000|Overall Study|Withdrawal by Subject|1|||
48798334|NCT04252742|157098607|FG000|Overall Study|Withdrawal by Subject|15|||
48798335|NCT04252742|157098608|FG001|Overall Study|Withdrawal by Subject|9|||
48798336|NCT04252742|157098607|FG000|Overall Study|Lost to Follow-up|0|||
48798337|NCT04252742|157098608|FG001|Overall Study|Lost to Follow-up|1|||
48798338|NCT04040751|157098609|FG000|Overall Study|Withdrawal by Subject|2|||
48798339|NCT04040751|157098610|FG001|Overall Study|Withdrawal by Subject|0|||
48798340|NCT04040751|157098611|FG002|Overall Study|Withdrawal by Subject|2|||
48798341|NCT04040751|157098612|FG003|Overall Study|Withdrawal by Subject|0|||
48798342|NCT02275065|157098619|FG000|Overall Study|Randomized but not treated|1|||
48798343|NCT02275065|157098620|FG001|Overall Study|Randomized but not treated|0|||
48798344|NCT02275065|157098621|FG002|Overall Study|Randomized but not treated|1|||
48798345|NCT02275065|157098622|FG003|Overall Study|Randomized but not treated|1|||
48798346|NCT02275065|157098623|FG004|Overall Study|Randomized but not treated|0|||
48798347|NCT00377403|157098624|FG000|Overall Study|Unable to contact for telephone intervie|4|||
48742159|NCT02571777|156906206|FG000|Overall Study|Subject/guardian decision|34|||
48742160|NCT02571777|156906207|FG001|Overall Study|Subject/guardian decision|26|||
48742161|NCT02571777|156906208|FG002|Overall Study|Subject/guardian decision|26|||
48950993|NCT01797432|157649913|FG000|Overall Study|lived too far from study site|1|||
48742162|NCT02571777|156906209|FG003|Overall Study|Subject/guardian decision|25|||
48742163|NCT02571777|156906210|FG004|Overall Study|Subject/guardian decision|27|||
48742164|NCT02571777|156906206|FG000|Overall Study|Protocol Deviation|2|||
48742165|NCT02571777|156906207|FG001|Overall Study|Protocol Deviation|3|||
48742166|NCT02571777|156906208|FG002|Overall Study|Protocol Deviation|4|||
48742167|NCT02571777|156906209|FG003|Overall Study|Protocol Deviation|8|||
48855424|NCT01989104|157308653|FG001|Overall Study|Withdrawal by Subject|0|||
48855425|NCT01989104|157308654|FG002|Overall Study|Withdrawal by Subject|0|||
48855426|NCT01989104|157308655|FG003|Overall Study|Withdrawal by Subject|0|||
48855427|NCT01989104|157308656|FG004|Overall Study|Withdrawal by Subject|0|||
48855428|NCT00068107|157308657|FG000|Overall Study|end-stage renal disease|6|||
48855429|NCT00068107|157308657|FG000|Overall Study|Death|2|||
48855430|NCT00068107|157308657|FG000|Overall Study|Withdrawal by Subject|1|||
48855431|NCT00886834|157308663|FG000|Overall Study|Protocol Violation|0|||
48855432|NCT00886834|157308664|FG001|Overall Study|Protocol Violation|3|||
48855433|NCT02574286|157308665|FG000|Overall Study|Adverse Event|3|||
48855434|NCT02574286|157308665|FG000|Overall Study|Withdrawal by Subject|2|||
48855435|NCT01065779|157308666|FG000|Overall Study|Duplicate Investigation|1|||
48855436|NCT01065779|157308666|FG000|Overall Study|Investigation Before Contract Date|37|||
48855437|NCT01065779|157308666|FG000|Overall Study|Non-enrollment Period Administration|10|||
48855438|NCT01065779|157308666|FG000|Overall Study|Not Administered With Study Drug|17|||
48855439|NCT01065779|157308666|FG000|Overall Study|Failed to Follow-up|10|||
48855440|NCT01065779|157308666|FG000|Overall Study|Inclusion Criteria Violation|7|||
48855441|NCT03541369|157308667|FG000|Overall Study|Death|0|||
48855442|NCT03541369|157308668|FG001|Overall Study|Death|0|||
48855443|NCT03541369|157308669|FG002|Overall Study|Death|0|||
48855444|NCT03541369|157308670|FG003|Overall Study|Death|0|||
48855445|NCT03541369|157308671|FG004|Overall Study|Death|1|||
48855446|NCT03541369|157308672|FG005|Overall Study|Death|1|||
48855447|NCT03541369|157308673|FG006|Overall Study|Death|0|||
48855448|NCT03541369|157308674|FG007|Overall Study|Death|2|||
48855449|NCT03541369|157308675|FG008|Overall Study|Death|1|||
48855450|NCT03541369|157308676|FG009|Overall Study|Death|2|||
48855451|NCT03541369|157308677|FG010|Overall Study|Death|1|||
48855452|NCT03541369|157308678|FG011|Overall Study|Death|0|||
48855453|NCT03541369|157308679|FG012|Overall Study|Death|2|||
48855454|NCT03541369|157308680|FG013|Overall Study|Death|1|||
48855455|NCT03541369|157308681|FG014|Overall Study|Death|1|||
48855456|NCT03541369|157308682|FG015|Overall Study|Death|1|||
48855457|NCT03541369|157308683|FG016|Overall Study|Death|0|||
48855458|NCT03541369|157308684|FG017|Overall Study|Death|1|||
48855459|NCT03541369|157308667|FG000|Overall Study|Decision by sponsor|0|||
48855460|NCT03541369|157308668|FG001|Overall Study|Decision by sponsor|0|||
48855461|NCT03541369|157308669|FG002|Overall Study|Decision by sponsor|0|||
48855462|NCT03541369|157308670|FG003|Overall Study|Decision by sponsor|1|||
48855463|NCT03541369|157308671|FG004|Overall Study|Decision by sponsor|0|||
48855464|NCT03541369|157308672|FG005|Overall Study|Decision by sponsor|2|||
48855465|NCT03541369|157308673|FG006|Overall Study|Decision by sponsor|0|||
48855466|NCT03541369|157308674|FG007|Overall Study|Decision by sponsor|1|||
48855467|NCT03541369|157308675|FG008|Overall Study|Decision by sponsor|2|||
48855468|NCT03541369|157308676|FG009|Overall Study|Decision by sponsor|0|||
48855469|NCT03541369|157308677|FG010|Overall Study|Decision by sponsor|0|||
48855470|NCT03541369|157308678|FG011|Overall Study|Decision by sponsor|0|||
48742168|NCT02571777|156906210|FG004|Overall Study|Protocol Deviation|4|||
48742169|NCT02571777|156906206|FG000|Overall Study|Death|1|||
48742170|NCT02571777|156906207|FG001|Overall Study|Death|1|||
48742171|NCT02571777|156906208|FG002|Overall Study|Death|4|||
48742172|NCT02571777|156906209|FG003|Overall Study|Death|0|||
48742173|NCT02571777|156906210|FG004|Overall Study|Death|0|||
48950994|NCT03648996|157649915|FG000|Overall Study|Withdrawal by Subject|0|||
48950995|NCT03648996|157649916|FG001|Overall Study|Withdrawal by Subject|2|||
48950996|NCT03648996|157649917|FG002|Overall Study|Withdrawal by Subject|2|||
48950997|NCT03648996|157649915|FG000|Overall Study|Physician Decision|2|||
48742174|NCT02571777|156906206|FG000|Overall Study|Lost to Follow-up|1|||
48742175|NCT02571777|156906207|FG001|Overall Study|Lost to Follow-up|1|||
48950998|NCT03648996|157649916|FG001|Overall Study|Physician Decision|0|||
48950999|NCT03648996|157649917|FG002|Overall Study|Physician Decision|0|||
48951000|NCT00839098|157649924|FG000|Overall Study|Withdrawal by Subject|2|||
48951001|NCT00839098|157649925|FG001|Overall Study|Withdrawal by Subject|1|||
48951002|NCT00839098|157649926|FG002|Overall Study|Withdrawal by Subject|7|||
48951003|NCT01894516|157651286|FG000|Period 1 (Baseline up to Week 12)|Other|0|||
48951004|NCT01894516|157651287|FG001|Period 1 (Baseline up to Week 12)|Other|1|||
48951005|NCT01894516|157651288|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
48951006|NCT01894516|157651289|FG003|Period 1 (Baseline up to Week 12)|Other|0|||
48951007|NCT01894516|157651286|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2|||
48951008|NCT01894516|157651287|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
48951009|NCT01894516|157651288|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
48951010|NCT01894516|157651289|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
48951011|NCT01894516|157651286|FG000|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
48951012|NCT01894516|157651287|FG001|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
48951013|NCT01894516|157651288|FG002|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
48951014|NCT01894516|157651289|FG003|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
48951015|NCT01894516|157651286|FG000|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
48951016|NCT01894516|157651287|FG001|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
48951017|NCT01894516|157651288|FG002|Period 1 (Baseline up to Week 12)|Treatment failure|1|||
48951018|NCT01894516|157651289|FG003|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
48951019|NCT01894516|157651286|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
48951020|NCT01894516|157651287|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
48951021|NCT01894516|157651288|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
48951022|NCT01894516|157651289|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
48951023|NCT01894516|157651286|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
48951024|NCT01894516|157651287|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
48951025|NCT01894516|157651288|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1|||
48951026|NCT01894516|157651289|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
48951027|NCT01894516|157651286|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
48951028|NCT01894516|157651287|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
48951029|NCT01894516|157651288|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
48951030|NCT01894516|157651289|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
48951031|NCT01894516|157651286|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
48951032|NCT01894516|157651287|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
48951033|NCT01894516|157651288|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
48951034|NCT01894516|157651289|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
48951035|NCT02452970|157651294|FG000|Overall Study|Adverse Event|1|||
48951036|NCT02100657|157651295|FG000|Cohort 1: Dose Level 1|Progressive disease|6|||
48742176|NCT02571777|156906208|FG002|Overall Study|Lost to Follow-up|2|||
48742177|NCT02571777|156906209|FG003|Overall Study|Lost to Follow-up|0|||
48742178|NCT02571777|156906210|FG004|Overall Study|Lost to Follow-up|1|||
48742179|NCT02571777|156906206|FG000|Overall Study|Physician Decision|1|||
48951037|NCT02100657|157651296|FG001|Cohort 1: Dose Level 1|Progressive disease|0|||
48951038|NCT02100657|157651297|FG002|Cohort 1: Dose Level 1|Progressive disease|0|||
48951039|NCT02100657|157651295|FG000|Cohort 1: Dose Level 1|Treatment-related adverse event|1|||
48951040|NCT02100657|157651296|FG001|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
48951041|NCT02100657|157651297|FG002|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
48742180|NCT02571777|156906207|FG001|Overall Study|Physician Decision|7|||
48742181|NCT02571777|156906208|FG002|Overall Study|Physician Decision|5|||
48742182|NCT02571777|156906209|FG003|Overall Study|Physician Decision|2|||
48742183|NCT02571777|156906210|FG004|Overall Study|Physician Decision|4|||
48742184|NCT02571777|156906206|FG000|Overall Study|Pregnancy|0|||
48742185|NCT02571777|156906207|FG001|Overall Study|Pregnancy|0|||
48742186|NCT02571777|156906208|FG002|Overall Study|Pregnancy|0|||
48742187|NCT02571777|156906209|FG003|Overall Study|Pregnancy|2|||
48742188|NCT02571777|156906210|FG004|Overall Study|Pregnancy|0|||
48742189|NCT03706079|156906212|FG000|Predecessor Study|Death|0|||
48742190|NCT03706079|156906213|FG001|Predecessor Study|Death|2|||
48742191|NCT03706079|156906214|FG002|Predecessor Study|Death|0|||
48742192|NCT03706079|156906215|FG003|Predecessor Study|Death|1|||
48951042|NCT02100657|157651295|FG000|Cohort 1: Dose Level 1|Withdrawal by Subject|1|||
48742193|NCT03706079|156906216|FG004|Predecessor Study|Death|0|||
48742194|NCT03706079|156906217|FG005|Predecessor Study|Death|0|||
48742195|NCT03706079|156906212|FG000|Predecessor Study|Lost to Follow-up|5|||
48742196|NCT03706079|156906213|FG001|Predecessor Study|Lost to Follow-up|2|||
48742197|NCT03706079|156906214|FG002|Predecessor Study|Lost to Follow-up|0|||
48742198|NCT03706079|156906215|FG003|Predecessor Study|Lost to Follow-up|0|||
48742199|NCT03706079|156906216|FG004|Predecessor Study|Lost to Follow-up|1|||
48855471|NCT03541369|157308679|FG012|Overall Study|Decision by sponsor|2|||
48855472|NCT03541369|157308680|FG013|Overall Study|Decision by sponsor|2|||
48855473|NCT03541369|157308681|FG014|Overall Study|Decision by sponsor|0|||
48855474|NCT03541369|157308682|FG015|Overall Study|Decision by sponsor|1|||
48855475|NCT03541369|157308683|FG016|Overall Study|Decision by sponsor|1|||
48855476|NCT03541369|157308684|FG017|Overall Study|Decision by sponsor|1|||
48855477|NCT03541369|157308667|FG000|Overall Study|Withdrawal by Subject|0|||
48855478|NCT03541369|157308668|FG001|Overall Study|Withdrawal by Subject|0|||
48855479|NCT03541369|157308669|FG002|Overall Study|Withdrawal by Subject|0|||
48855480|NCT03541369|157308670|FG003|Overall Study|Withdrawal by Subject|0|||
48855481|NCT03541369|157308671|FG004|Overall Study|Withdrawal by Subject|0|||
48855482|NCT03541369|157308672|FG005|Overall Study|Withdrawal by Subject|0|||
48855483|NCT03541369|157308673|FG006|Overall Study|Withdrawal by Subject|1|||
48855484|NCT03541369|157308674|FG007|Overall Study|Withdrawal by Subject|0|||
48855485|NCT03541369|157308675|FG008|Overall Study|Withdrawal by Subject|0|||
48855486|NCT03541369|157308676|FG009|Overall Study|Withdrawal by Subject|0|||
48855487|NCT03541369|157308677|FG010|Overall Study|Withdrawal by Subject|0|||
48855488|NCT03541369|157308678|FG011|Overall Study|Withdrawal by Subject|1|||
48855489|NCT03541369|157308679|FG012|Overall Study|Withdrawal by Subject|0|||
48855490|NCT03541369|157308680|FG013|Overall Study|Withdrawal by Subject|0|||
48855491|NCT03541369|157308681|FG014|Overall Study|Withdrawal by Subject|3|||
48855492|NCT03541369|157308682|FG015|Overall Study|Withdrawal by Subject|0|||
48855493|NCT03541369|157308683|FG016|Overall Study|Withdrawal by Subject|4|||
48855494|NCT03541369|157308684|FG017|Overall Study|Withdrawal by Subject|2|||
48855495|NCT03541369|157308667|FG000|Overall Study|Lost to Follow-up|0|||
48855496|NCT03541369|157308668|FG001|Overall Study|Lost to Follow-up|0|||
48855497|NCT03541369|157308669|FG002|Overall Study|Lost to Follow-up|0|||
48855498|NCT03541369|157308670|FG003|Overall Study|Lost to Follow-up|0|||
48855499|NCT03541369|157308671|FG004|Overall Study|Lost to Follow-up|1|||
48855500|NCT03541369|157308672|FG005|Overall Study|Lost to Follow-up|0|||
48855501|NCT03541369|157308673|FG006|Overall Study|Lost to Follow-up|0|||
48855502|NCT03541369|157308674|FG007|Overall Study|Lost to Follow-up|0|||
48855503|NCT03541369|157308675|FG008|Overall Study|Lost to Follow-up|1|||
48855504|NCT03541369|157308676|FG009|Overall Study|Lost to Follow-up|0|||
48855505|NCT03541369|157308677|FG010|Overall Study|Lost to Follow-up|0|||
48855506|NCT03541369|157308678|FG011|Overall Study|Lost to Follow-up|0|||
48855507|NCT03541369|157308679|FG012|Overall Study|Lost to Follow-up|1|||
48855508|NCT03541369|157308680|FG013|Overall Study|Lost to Follow-up|0|||
48855509|NCT03541369|157308681|FG014|Overall Study|Lost to Follow-up|0|||
48855510|NCT03541369|157308682|FG015|Overall Study|Lost to Follow-up|0|||
48855511|NCT03541369|157308683|FG016|Overall Study|Lost to Follow-up|0|||
48855512|NCT03541369|157308684|FG017|Overall Study|Lost to Follow-up|0|||
48855513|NCT03205488|157308685|FG000|Overall Study|Adverse Event|1|||
48855514|NCT03205488|157308686|FG001|Overall Study|Adverse Event|2|||
48855515|NCT03205488|157308687|FG002|Overall Study|Adverse Event|4|||
48855516|NCT03205488|157308685|FG000|Overall Study|Protocol Violation|0|||
48855517|NCT03205488|157308686|FG001|Overall Study|Protocol Violation|0|||
48855518|NCT03205488|157308687|FG002|Overall Study|Protocol Violation|1|||
48855519|NCT02950961|157308690|FG000|Overall Study|Study had to stop due to COVID.|7|||
48855520|NCT00614614|157308691|FG000|Primary Vaccination Phase|Adverse Event|6|||
48855521|NCT00614614|157308692|FG001|Primary Vaccination Phase|Adverse Event|0|||
48855522|NCT00614614|157308693|FG002|Primary Vaccination Phase|Adverse Event|0|||
48855523|NCT00614614|157308694|FG003|Primary Vaccination Phase|Adverse Event|0|||
48855524|NCT00614614|157308695|FG004|Primary Vaccination Phase|Adverse Event|0|||
48855525|NCT00614614|157308691|FG000|Primary Vaccination Phase|Withdrawal by Subject|45|||
48855526|NCT00614614|157308692|FG001|Primary Vaccination Phase|Withdrawal by Subject|6|||
48855527|NCT00614614|157308693|FG002|Primary Vaccination Phase|Withdrawal by Subject|0|||
48855528|NCT00614614|157308694|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
48855529|NCT00614614|157308695|FG004|Primary Vaccination Phase|Withdrawal by Subject|0|||
48855530|NCT00614614|157308691|FG000|Primary Vaccination Phase|Lost to Follow-up|26|||
48855531|NCT00614614|157308692|FG001|Primary Vaccination Phase|Lost to Follow-up|8|||
48855532|NCT00614614|157308693|FG002|Primary Vaccination Phase|Lost to Follow-up|0|||
48855533|NCT00614614|157308694|FG003|Primary Vaccination Phase|Lost to Follow-up|0|||
48855534|NCT00614614|157308695|FG004|Primary Vaccination Phase|Lost to Follow-up|0|||
48855535|NCT00614614|157308691|FG000|Primary Vaccination Phase|Protocol Violation|9|||
48855536|NCT00614614|157308692|FG001|Primary Vaccination Phase|Protocol Violation|3|||
48855537|NCT00614614|157308693|FG002|Primary Vaccination Phase|Protocol Violation|0|||
48855538|NCT00614614|157308694|FG003|Primary Vaccination Phase|Protocol Violation|0|||
48855539|NCT00614614|157308695|FG004|Primary Vaccination Phase|Protocol Violation|0|||
48855540|NCT00614614|157308691|FG000|Primary Vaccination Phase|Other|4|||
48855541|NCT00614614|157308692|FG001|Primary Vaccination Phase|Other|0|||
48855542|NCT00614614|157308693|FG002|Primary Vaccination Phase|Other|0|||
48855543|NCT00614614|157308694|FG003|Primary Vaccination Phase|Other|0|||
48855544|NCT00614614|157308695|FG004|Primary Vaccination Phase|Other|0|||
48855545|NCT00614614|157308691|FG000|Booster Vaccination Phase|Adverse Event|0|||
48855546|NCT00614614|157308692|FG001|Booster Vaccination Phase|Adverse Event|0|||
48855547|NCT00614614|157308693|FG002|Booster Vaccination Phase|Adverse Event|1|||
48742200|NCT03706079|156906217|FG005|Predecessor Study|Lost to Follow-up|0|||
48742201|NCT03706079|156906212|FG000|Predecessor Study|Withdrawal by Subject|8|||
48742202|NCT03706079|156906213|FG001|Predecessor Study|Withdrawal by Subject|15|||
48742203|NCT03706079|156906214|FG002|Predecessor Study|Withdrawal by Subject|0|||
48742204|NCT03706079|156906215|FG003|Predecessor Study|Withdrawal by Subject|5|||
48742205|NCT03706079|156906216|FG004|Predecessor Study|Withdrawal by Subject|2|||
48742206|NCT03706079|156906217|FG005|Predecessor Study|Withdrawal by Subject|0|||
48742207|NCT03706079|156906212|FG000|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
48742208|NCT03706079|156906213|FG001|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
48742209|NCT03706079|156906214|FG002|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
48742210|NCT03706079|156906215|FG003|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
48742211|NCT03706079|156906216|FG004|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
48742212|NCT03706079|156906217|FG005|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
48742213|NCT03706079|156906212|FG000|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
48742214|NCT03706079|156906213|FG001|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
48742215|NCT03706079|156906214|FG002|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
48742216|NCT03706079|156906215|FG003|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
48742217|NCT03706079|156906216|FG004|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
48742218|NCT03706079|156906217|FG005|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|1|||
48742219|NCT03706079|156906212|FG000|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|1|||
48742220|NCT03706079|156906213|FG001|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
48742221|NCT03706079|156906214|FG002|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|2|||
48742222|NCT03706079|156906215|FG003|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
48742223|NCT03706079|156906216|FG004|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
48742224|NCT03706079|156906217|FG005|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
48742225|NCT03706079|156906212|FG000|Long Term Extension (DESTINATION)|Pregnancy|1|||
48742226|NCT03706079|156906213|FG001|Long Term Extension (DESTINATION)|Pregnancy|0|||
48742227|NCT03706079|156906214|FG002|Long Term Extension (DESTINATION)|Pregnancy|0|||
48742228|NCT03706079|156906215|FG003|Long Term Extension (DESTINATION)|Pregnancy|0|||
48742229|NCT03706079|156906216|FG004|Long Term Extension (DESTINATION)|Pregnancy|0|||
48742230|NCT03706079|156906217|FG005|Long Term Extension (DESTINATION)|Pregnancy|0|||
48742231|NCT03706079|156906212|FG000|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
48742232|NCT03706079|156906213|FG001|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
48742233|NCT03706079|156906214|FG002|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
48742234|NCT03706079|156906215|FG003|Long Term Extension (DESTINATION)|Withdrawal by Subject|1|||
48742235|NCT03706079|156906216|FG004|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
48742236|NCT03706079|156906217|FG005|Long Term Extension (DESTINATION)|Withdrawal by Subject|0|||
48742237|NCT03706079|156906212|FG000|Long Term Extension (DESTINATION)|Lost to Follow-up|2|||
48742238|NCT03706079|156906213|FG001|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
48742239|NCT03706079|156906214|FG002|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
48742240|NCT03706079|156906215|FG003|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
48742241|NCT03706079|156906216|FG004|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
48855548|NCT00614614|157308694|FG003|Booster Vaccination Phase|Adverse Event|1|||
48855549|NCT00614614|157308695|FG004|Booster Vaccination Phase|Adverse Event|0|||
48855550|NCT00614614|157308691|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
48742242|NCT03706079|156906217|FG005|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
48742243|NCT03706079|156906212|FG000|Long Term Extension (DESTINATION)|Death|8|||
48742244|NCT03706079|156906213|FG001|Long Term Extension (DESTINATION)|Death|2|||
48742245|NCT03706079|156906214|FG002|Long Term Extension (DESTINATION)|Death|2|||
48742246|NCT03706079|156906215|FG003|Long Term Extension (DESTINATION)|Death|1|||
48855551|NCT00614614|157308692|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
48742247|NCT03706079|156906216|FG004|Long Term Extension (DESTINATION)|Death|0|||
48742248|NCT03706079|156906217|FG005|Long Term Extension (DESTINATION)|Death|0|||
48742249|NCT03095612|156906218|FG000|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
48742250|NCT03095612|156906219|FG001|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|4|||
48742251|NCT03095612|156906220|FG002|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
48742252|NCT03095612|156906221|FG003|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
48742253|NCT03095612|156906222|FG004|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
48742254|NCT03095612|156906223|FG005|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
48742255|NCT03095612|156906224|FG006|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
48742256|NCT00633750|156906225|FG000|Overall Study|Adverse Event|2|||
48742257|NCT00633750|156906225|FG000|Overall Study|Withdrawal by Subject|3|||
48742258|NCT02362269|156906226|FG000|Overall Study|Moved|1|||
48742259|NCT02362269|156906227|FG001|Overall Study|Moved|0|||
48742260|NCT02362269|156906226|FG000|Overall Study|Lost to Follow-up|0|||
48742261|NCT02362269|156906227|FG001|Overall Study|Lost to Follow-up|6|||
48742262|NCT03953820|156906228|FG000|Two-Sequence, Two-Way Crossover|Adverse Event|1|||
48742263|NCT03953820|156906229|FG001|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
48742264|NCT03953820|156906230|FG002|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
48742265|NCT03953820|156906228|FG000|Two-Sequence, Two-Way Crossover|Physician Decision|1|||
48742266|NCT03953820|156906229|FG001|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
48742267|NCT03953820|156906230|FG002|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
48742268|NCT03988088|156906235|FG000|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
48742269|NCT03988088|156906236|FG001|Single-Dose Pharmacokinetic Study|Adverse Event|1|||
48742270|NCT03988088|156906237|FG002|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
48742271|NCT03988088|156906238|FG003|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
48742272|NCT03988088|156906235|FG000|Open-Label Addendum|Lost to Follow-up|0|||
48742273|NCT03988088|156906236|FG001|Open-Label Addendum|Lost to Follow-up|0|||
48742274|NCT03988088|156906237|FG002|Open-Label Addendum|Lost to Follow-up|1|||
48742275|NCT03988088|156906238|FG003|Open-Label Addendum|Lost to Follow-up|0|||
48742276|NCT01218243|156906240|FG000|Overall Study|Lack of Efficacy|1|||
48742277|NCT01218243|156906241|FG001|Overall Study|Lack of Efficacy|1|||
48742278|NCT01218243|156906240|FG000|Overall Study|Lost to Follow-up|3|||
48742279|NCT01218243|156906241|FG001|Overall Study|Lost to Follow-up|3|||
48742280|NCT01218243|156906240|FG000|Overall Study|Protocol Violation|5|||
48742281|NCT01218243|156906241|FG001|Overall Study|Protocol Violation|10|||
48742282|NCT01387789|156906243|FG000|Overall Study|Adverse Event|5|||
48742283|NCT01387789|156906243|FG000|Overall Study|Lack of Efficacy|2|||
48742284|NCT01387789|156906243|FG000|Overall Study|Lost to Follow-up|1|||
48742285|NCT01233258|156906244|FG000|First Intervention (6 Months)|Withdrawal by Subject|0|||
48742286|NCT01233258|156906245|FG001|First Intervention (6 Months)|Withdrawal by Subject|0|||
48742287|NCT01233258|156906246|FG002|First Intervention (6 Months)|Withdrawal by Subject|0|||
48742288|NCT01233258|156906247|FG003|First Intervention (6 Months)|Withdrawal by Subject|1|||
48742289|NCT01233258|156906248|FG004|First Intervention (6 Months)|Withdrawal by Subject|0|||
48742290|NCT01233258|156906249|FG005|First Intervention (6 Months)|Withdrawal by Subject|1|||
48742291|NCT01233258|156906244|FG000|First Intervention (6 Months)|Protocol Violation|0|||
48742292|NCT01233258|156906245|FG001|First Intervention (6 Months)|Protocol Violation|0|||
48742293|NCT01233258|156906246|FG002|First Intervention (6 Months)|Protocol Violation|1|||
48742294|NCT01233258|156906247|FG003|First Intervention (6 Months)|Protocol Violation|0|||
48742295|NCT01233258|156906248|FG004|First Intervention (6 Months)|Protocol Violation|0|||
48742296|NCT01233258|156906249|FG005|First Intervention (6 Months)|Protocol Violation|0|||
48855552|NCT00614614|157308693|FG002|Booster Vaccination Phase|Withdrawal by Subject|4|||
48855553|NCT00614614|157308694|FG003|Booster Vaccination Phase|Withdrawal by Subject|3|||
48855554|NCT00614614|157308695|FG004|Booster Vaccination Phase|Withdrawal by Subject|4|||
48855555|NCT00614614|157308691|FG000|Booster Vaccination Phase|Lost to Follow-up|0|||
48855556|NCT00614614|157308692|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
48855557|NCT00614614|157308693|FG002|Booster Vaccination Phase|Lost to Follow-up|17|||
48742297|NCT01233258|156906244|FG000|First Intervention (6 Months)|Non-compliance with study medication|1|||
48742298|NCT01233258|156906245|FG001|First Intervention (6 Months)|Non-compliance with study medication|0|||
48742299|NCT01233258|156906246|FG002|First Intervention (6 Months)|Non-compliance with study medication|0|||
48742300|NCT01233258|156906247|FG003|First Intervention (6 Months)|Non-compliance with study medication|0|||
48742301|NCT01233258|156906248|FG004|First Intervention (6 Months)|Non-compliance with study medication|0|||
48742302|NCT01233258|156906249|FG005|First Intervention (6 Months)|Non-compliance with study medication|0|||
48742303|NCT01546883|156906250|FG000|Overall Study|Withdrawal by Subject|3|||
48742304|NCT01546883|156906250|FG000|Overall Study|Adverse Event|4|||
48742305|NCT01546883|156906250|FG000|Overall Study|Lost to Follow-up|2|||
48742306|NCT01546883|156906250|FG000|Overall Study|early closure of study|2|||
48742307|NCT01546883|156906250|FG000|Overall Study|other unrelated illness|1|||
48742308|NCT01534962|156906253|FG000|Overall Study|Randomized but did not start treatment|2|||
48742309|NCT01534962|156906254|FG001|Overall Study|Randomized but did not start treatment|0|||
48742310|NCT01534962|156906255|FG002|Overall Study|Randomized but did not start treatment|0|||
48951043|NCT02100657|157651296|FG001|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
48951044|NCT02100657|157651297|FG002|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
48742311|NCT01534962|156906256|FG003|Overall Study|Randomized but did not start treatment|1|||
48742312|NCT01534962|156906253|FG000|Overall Study|Discontinued at AF recurrence|35|||
48742313|NCT01534962|156906254|FG001|Overall Study|Discontinued at AF recurrence|26|||
48742314|NCT01534962|156906255|FG002|Overall Study|Discontinued at AF recurrence|24|||
48742315|NCT01534962|156906256|FG003|Overall Study|Discontinued at AF recurrence|31|||
48742316|NCT02243696|156906257|FG000|Overall Study|Death|282|||
48742317|NCT02243696|156906257|FG000|Overall Study|Withdrawal by Subject|79|||
48742318|NCT02243696|156906257|FG000|Overall Study|Lost to Follow-up|57|||
48742319|NCT02243696|156906257|FG000|Overall Study|Subject No Longer has Study System|42|||
48742320|NCT02243696|156906257|FG000|Overall Study|Subject Withdrawn by Investigator|273|||
48742321|NCT02243696|156906257|FG000|Overall Study|Study Terminated for EP PASSION|961|||
48855558|NCT00614614|157308694|FG003|Booster Vaccination Phase|Lost to Follow-up|10|||
48855559|NCT00614614|157308695|FG004|Booster Vaccination Phase|Lost to Follow-up|8|||
48951045|NCT02100657|157651295|FG000|Cohort 2: Dose Level 2|Progressive disease|0|||
48951046|NCT02100657|157651296|FG001|Cohort 2: Dose Level 2|Progressive disease|2|||
48742322|NCT00282984|156906258|FG000|Overall Study|Death|2|||
48742323|NCT00282984|156906259|FG001|Overall Study|Death|5|||
48742324|NCT00282984|156906258|FG000|Overall Study|Adverse Event|8|||
48855560|NCT00614614|157308691|FG000|Booster Vaccination Phase|Protocol Violation|0|||
48855561|NCT00614614|157308692|FG001|Booster Vaccination Phase|Protocol Violation|0|||
48855562|NCT00614614|157308693|FG002|Booster Vaccination Phase|Protocol Violation|2|||
48855563|NCT00614614|157308694|FG003|Booster Vaccination Phase|Protocol Violation|3|||
48855564|NCT00614614|157308695|FG004|Booster Vaccination Phase|Protocol Violation|0|||
48855565|NCT00614614|157308691|FG000|Booster Vaccination Phase|Other|0|||
48855566|NCT00614614|157308692|FG001|Booster Vaccination Phase|Other|1|||
48855567|NCT00614614|157308693|FG002|Booster Vaccination Phase|Other|3|||
48951047|NCT02100657|157651297|FG002|Cohort 2: Dose Level 2|Progressive disease|0|||
48951048|NCT02100657|157651295|FG000|Cohort 2: Dose Level 2|Physician Decision|0|||
48951049|NCT02100657|157651296|FG001|Cohort 2: Dose Level 2|Physician Decision|1|||
48951050|NCT02100657|157651297|FG002|Cohort 2: Dose Level 2|Physician Decision|0|||
48951051|NCT02100657|157651295|FG000|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
48951052|NCT02100657|157651296|FG001|Cohort 2: Dose Level 2|Treatment-related adverse event|1|||
48951053|NCT02100657|157651297|FG002|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
48951054|NCT02100657|157651295|FG000|Cohort 3: Dose Level 3|Progressive disease|0|||
48951055|NCT02100657|157651296|FG001|Cohort 3: Dose Level 3|Progressive disease|0|||
48951056|NCT02100657|157651297|FG002|Cohort 3: Dose Level 3|Progressive disease|15|||
48951057|NCT02100657|157651295|FG000|Cohort 3: Dose Level 3|Death|0|||
48951058|NCT02100657|157651296|FG001|Cohort 3: Dose Level 3|Death|0|||
48951059|NCT02100657|157651297|FG002|Cohort 3: Dose Level 3|Death|1|||
48951060|NCT02100657|157651295|FG000|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
48951061|NCT02100657|157651296|FG001|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
48951062|NCT02100657|157651297|FG002|Cohort 3: Dose Level 3|Non-treatment related adverse event|1|||
48951063|NCT02100657|157651295|FG000|Cohort 3: Dose Level 3|Physician Decision|0|||
48951064|NCT02100657|157651296|FG001|Cohort 3: Dose Level 3|Physician Decision|0|||
48742325|NCT00282984|156906259|FG001|Overall Study|Adverse Event|5|||
48742326|NCT00282984|156906258|FG000|Overall Study|Lack of Efficacy|0|||
48742327|NCT00282984|156906259|FG001|Overall Study|Lack of Efficacy|2|||
48742328|NCT00282984|156906258|FG000|Overall Study|Lost to Follow-up|14|||
48742329|NCT00282984|156906259|FG001|Overall Study|Lost to Follow-up|10|||
48742330|NCT00282984|156906258|FG000|Overall Study|Withdrawal by Participant|22|||
48742331|NCT00282984|156906259|FG001|Overall Study|Withdrawal by Participant|34|||
48742332|NCT00282984|156906258|FG000|Overall Study|Participant stopped study medication|2|||
48742333|NCT00282984|156906259|FG001|Overall Study|Participant stopped study medication|2|||
48742334|NCT00282984|156906258|FG000|Overall Study|Participant only allowed phone follow-up|0|||
48742335|NCT00282984|156906259|FG001|Overall Study|Participant only allowed phone follow-up|1|||
48742336|NCT00282984|156906258|FG000|Overall Study|Participant used antipsychosis meds|0|||
48742337|NCT00282984|156906259|FG001|Overall Study|Participant used antipsychosis meds|1|||
48742338|NCT00282984|156906258|FG000|Overall Study|lack of motivation|1|||
48742339|NCT00282984|156906259|FG001|Overall Study|lack of motivation|0|||
48742340|NCT00282984|156906258|FG000|Overall Study|in prison|0|||
48742341|NCT00282984|156906259|FG001|Overall Study|in prison|1|||
48742342|NCT00282984|156906258|FG000|Overall Study|Protocol Violation|2|||
48742343|NCT00282984|156906259|FG001|Overall Study|Protocol Violation|0|||
48742344|NCT00087607|156906260|FG000|Overall Study|Adverse Event|14|||
48742345|NCT00087607|156906261|FG001|Overall Study|Adverse Event|24|||
48951065|NCT02100657|157651297|FG002|Cohort 3: Dose Level 3|Physician Decision|1|||
48951066|NCT02100657|157651295|FG000|Cohort 3: Dose Level 3|Never were treated|0|||
48951067|NCT02100657|157651296|FG001|Cohort 3: Dose Level 3|Never were treated|0|||
48951068|NCT02100657|157651297|FG002|Cohort 3: Dose Level 3|Never were treated|3|||
48951069|NCT02100657|157651295|FG000|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
48951070|NCT02100657|157651296|FG001|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
48951071|NCT02100657|157651297|FG002|Cohort 3: Dose Level 3|Treatment-related adverse event|3|||
48951072|NCT02100657|157651295|FG000|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
48951073|NCT02100657|157651296|FG001|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
48951074|NCT02100657|157651297|FG002|Cohort 3: Dose Level 3|Withdrawal by Subject|3|||
48951075|NCT02742649|157651299|FG000|Pre-Randomization Washout Period|Washout/Randomization Failure|5|||
48951076|NCT02742649|157651300|FG001|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
48951077|NCT02742649|157651301|FG002|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
48951078|NCT02742649|157651302|FG003|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
48951079|NCT02742649|157651303|FG004|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
48951080|NCT02742649|157651299|FG000|Double-Blind Treatment Period|Adverse Event|0|||
48742346|NCT00087607|156906260|FG000|Overall Study|Death|0|||
48742347|NCT00087607|156906261|FG001|Overall Study|Death|1|||
48742348|NCT00087607|156906260|FG000|Overall Study|Insufficient Therapeutic Response|53|||
48951081|NCT02742649|157651300|FG001|Double-Blind Treatment Period|Adverse Event|1|||
48951082|NCT02742649|157651301|FG002|Double-Blind Treatment Period|Adverse Event|0|||
48951083|NCT02742649|157651302|FG003|Double-Blind Treatment Period|Adverse Event|0|||
48951084|NCT02742649|157651303|FG004|Double-Blind Treatment Period|Adverse Event|0|||
48951085|NCT02742649|157651299|FG000|Open-Label Period|Lost to Follow-up|0|||
48951086|NCT02742649|157651300|FG001|Open-Label Period|Lost to Follow-up|0|||
48951087|NCT02742649|157651301|FG002|Open-Label Period|Lost to Follow-up|0|||
48951088|NCT02742649|157651302|FG003|Open-Label Period|Lost to Follow-up|0|||
48951089|NCT02742649|157651303|FG004|Open-Label Period|Lost to Follow-up|1|||
48951090|NCT03918642|157651306|FG000|Overall Study|Lost to Follow-up|12|||
48951091|NCT03918642|157651307|FG001|Overall Study|Lost to Follow-up|10|||
48951092|NCT01283581|157651310|FG000|Overall Study|Lost to Follow-up|8|||
48951093|NCT01283581|157651311|FG001|Overall Study|Lost to Follow-up|6|||
48951094|NCT01283581|157651312|FG002|Overall Study|Lost to Follow-up|8|||
48951095|NCT01283581|157651310|FG000|Overall Study|Withdrawal by Subject|2|||
48951096|NCT01283581|157651311|FG001|Overall Study|Withdrawal by Subject|5|||
48951097|NCT01283581|157651312|FG002|Overall Study|Withdrawal by Subject|2|||
48951098|NCT01283581|157651310|FG000|Overall Study|Adverse Event|1|||
48951099|NCT01283581|157651311|FG001|Overall Study|Adverse Event|1|||
48951100|NCT01283581|157651312|FG002|Overall Study|Adverse Event|4|||
48951101|NCT01283581|157651310|FG000|Overall Study|Physician Decision|0|||
48951102|NCT01283581|157651311|FG001|Overall Study|Physician Decision|1|||
48951103|NCT01283581|157651312|FG002|Overall Study|Physician Decision|2|||
48951104|NCT01283581|157651310|FG000|Overall Study|Protocol Violation|0|||
48951105|NCT01283581|157651311|FG001|Overall Study|Protocol Violation|1|||
48951106|NCT01283581|157651312|FG002|Overall Study|Protocol Violation|2|||
48951107|NCT01283581|157651310|FG000|Overall Study|Noncompliance|1|||
48951108|NCT01283581|157651311|FG001|Overall Study|Noncompliance|0|||
48951109|NCT01283581|157651312|FG002|Overall Study|Noncompliance|0|||
48742349|NCT00087607|156906261|FG001|Overall Study|Insufficient Therapeutic Response|42|||
48742350|NCT00087607|156906260|FG000|Overall Study|Failure to return|21|||
48742351|NCT00087607|156906261|FG001|Overall Study|Failure to return|17|||
48742352|NCT00087607|156906260|FG000|Overall Study|Withdrew Consent|12|||
48742353|NCT00087607|156906261|FG001|Overall Study|Withdrew Consent|16|||
48742354|NCT00087607|156906260|FG000|Overall Study|Administrative|12|||
48951110|NCT01283581|157651310|FG000|Overall Study|Investigator unblinded|0|||
48951111|NCT01283581|157651311|FG001|Overall Study|Investigator unblinded|0|||
48951112|NCT01283581|157651312|FG002|Overall Study|Investigator unblinded|1|||
48742355|NCT00087607|156906261|FG001|Overall Study|Administrative|12|||
48742356|NCT00087607|156906260|FG000|Overall Study|Refused Treatment|5|||
48855568|NCT00614614|157308694|FG003|Booster Vaccination Phase|Other|2|||
48855569|NCT00614614|157308695|FG004|Booster Vaccination Phase|Other|1|||
48951113|NCT01283581|157651310|FG000|Overall Study|"Early termination"|0|||
48951114|NCT01283581|157651311|FG001|Overall Study|"Early termination"|0|||
48951115|NCT01283581|157651312|FG002|Overall Study|"Early termination"|1|||
48951116|NCT01790438|157651313|FG000|Overall Study|Adverse Event|3|||
48951117|NCT01790438|157651314|FG001|Overall Study|Adverse Event|2|||
48951118|NCT01790438|157651313|FG000|Overall Study|Death|4|||
48951119|NCT01790438|157651314|FG001|Overall Study|Death|0|||
48951120|NCT01790438|157651313|FG000|Overall Study|Lost to Follow-up|5|||
48951121|NCT01790438|157651314|FG001|Overall Study|Lost to Follow-up|2|||
48742357|NCT00087607|156906261|FG001|Overall Study|Refused Treatment|7|||
48742358|NCT00087607|156906260|FG000|Overall Study|Other Protocol Violation|5|||
48742359|NCT00087607|156906261|FG001|Overall Study|Other Protocol Violation|2|||
48742360|NCT00087607|156906260|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
48742361|NCT00087607|156906261|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
48742362|NCT00868608|156906262|FG000|Overall Study|Withdrawal by Subject|3|||
48742363|NCT00868608|156906263|FG001|Overall Study|Withdrawal by Subject|1|||
48742364|NCT00868608|156906264|FG002|Overall Study|Withdrawal by Subject|0|||
48742365|NCT00868608|156906262|FG000|Overall Study|Lost to Follow-up|3|||
48742366|NCT00868608|156906263|FG001|Overall Study|Lost to Follow-up|0|||
48742367|NCT00868608|156906264|FG002|Overall Study|Lost to Follow-up|1|||
48742368|NCT00868608|156906262|FG000|Overall Study|Death|16|||
48742369|NCT00868608|156906263|FG001|Overall Study|Death|2|||
48742370|NCT00868608|156906264|FG002|Overall Study|Death|4|||
48742371|NCT00868608|156906262|FG000|Overall Study|Other - Unspecified|1|||
48742372|NCT00868608|156906263|FG001|Overall Study|Other - Unspecified|0|||
48742373|NCT00868608|156906264|FG002|Overall Study|Other - Unspecified|0|||
48742374|NCT02015754|156906265|FG000|Overall Study|Disease progression|5|||
48742375|NCT02015754|156906265|FG000|Overall Study|Change in treatment modality|5|||
48742376|NCT02015754|156906265|FG000|Overall Study|Lost to Follow-up|1|||
48742377|NCT00667875|156906273|FG000|Overall Study|Adverse Event|0|||
48742378|NCT00667875|156906274|FG001|Overall Study|Adverse Event|2|||
48742379|NCT00667875|156906275|FG002|Overall Study|Adverse Event|6|||
48742380|NCT00667875|156906273|FG000|Overall Study|Withdrawal by Subject|10|||
48742381|NCT00667875|156906274|FG001|Overall Study|Withdrawal by Subject|9|||
48951122|NCT01790438|157651313|FG000|Overall Study|Withdrawal by Subject|13|||
48951123|NCT01790438|157651314|FG001|Overall Study|Withdrawal by Subject|2|||
48951124|NCT01790438|157651313|FG000|Overall Study|Physician Decision|3|||
48951125|NCT01790438|157651314|FG001|Overall Study|Physician Decision|1|||
48951126|NCT01790438|157651313|FG000|Overall Study|Sponsor Decision|0|||
48951127|NCT01790438|157651314|FG001|Overall Study|Sponsor Decision|3|||
48951128|NCT01790438|157651313|FG000|Overall Study|Protocol Required Discontinuation|7|||
48951129|NCT01790438|157651314|FG001|Overall Study|Protocol Required Discontinuation|1|||
48951130|NCT02948777|157651320|FG000|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1|||
48951131|NCT01013883|157651321|FG000|Overall Study|Lost to Follow-up|2|||
48951132|NCT01013883|157651322|FG001|Overall Study|Lost to Follow-up|2|||
48742382|NCT00667875|156906275|FG002|Overall Study|Withdrawal by Subject|7|||
48742383|NCT00478231|156906276|FG000|Overall Study|Death|7|||
48742384|NCT00478231|156906276|FG000|Overall Study|Lack of Efficacy|47|||
48742385|NCT00478231|156906276|FG000|Overall Study|Lost to Follow-up|7|||
48742386|NCT00478231|156906276|FG000|Overall Study|Withdrawal by Subject|6|||
48742387|NCT00478231|156906276|FG000|Overall Study|Other|9|||
48742388|NCT00478231|156906276|FG000|Overall Study|Adverse Event|5|||
48855570|NCT01885559|157308696|FG000|Overall Study|Lost to Follow-up|15|||
48855571|NCT01885559|157308697|FG001|Overall Study|Lost to Follow-up|16|||
48855572|NCT01885559|157308696|FG000|Overall Study|Less than full participation|9|||
48855573|NCT01885559|157308697|FG001|Overall Study|Less than full participation|19|||
48742389|NCT00478231|156906276|FG000|Overall Study|Randomized, not treated|3|||
48742390|NCT00939770|156906282|FG000|Overall Study|Adverse Event|1|||
48742391|NCT00939770|156906283|FG001|Overall Study|Adverse Event|1|||
48742392|NCT00939770|156906284|FG002|Overall Study|Adverse Event|0|||
48742393|NCT00939770|156906285|FG003|Overall Study|Adverse Event|0|||
48742394|NCT00939770|156906286|FG004|Overall Study|Adverse Event|6|||
48742395|NCT00939770|156906287|FG005|Overall Study|Adverse Event|2|||
48742396|NCT00939770|156906288|FG006|Overall Study|Adverse Event|1|||
48742397|NCT00939770|156906289|FG007|Overall Study|Adverse Event|1|||
48742398|NCT00939770|156906282|FG000|Overall Study|Lack of Efficacy|4|||
48742399|NCT00939770|156906283|FG001|Overall Study|Lack of Efficacy|6|||
48742400|NCT00939770|156906284|FG002|Overall Study|Lack of Efficacy|13|||
48742401|NCT00939770|156906285|FG003|Overall Study|Lack of Efficacy|9|||
48742402|NCT00939770|156906286|FG004|Overall Study|Lack of Efficacy|16|||
48742403|NCT00939770|156906287|FG005|Overall Study|Lack of Efficacy|8|||
48742404|NCT00939770|156906288|FG006|Overall Study|Lack of Efficacy|11|||
48742405|NCT00939770|156906289|FG007|Overall Study|Lack of Efficacy|1|||
48742406|NCT00939770|156906282|FG000|Overall Study|Lost to Follow-up|0|||
48742407|NCT00939770|156906283|FG001|Overall Study|Lost to Follow-up|0|||
48742408|NCT00939770|156906284|FG002|Overall Study|Lost to Follow-up|0|||
48742409|NCT00939770|156906285|FG003|Overall Study|Lost to Follow-up|0|||
48742410|NCT00939770|156906286|FG004|Overall Study|Lost to Follow-up|1|||
48742411|NCT00939770|156906287|FG005|Overall Study|Lost to Follow-up|0|||
48742412|NCT00939770|156906288|FG006|Overall Study|Lost to Follow-up|0|||
48742413|NCT00939770|156906289|FG007|Overall Study|Lost to Follow-up|0|||
48742414|NCT00939770|156906282|FG000|Overall Study|Physician Decision|0|||
48742415|NCT00939770|156906283|FG001|Overall Study|Physician Decision|0|||
48742416|NCT00939770|156906284|FG002|Overall Study|Physician Decision|2|||
48742417|NCT00939770|156906285|FG003|Overall Study|Physician Decision|0|||
48742418|NCT00939770|156906286|FG004|Overall Study|Physician Decision|7|||
48742419|NCT00939770|156906287|FG005|Overall Study|Physician Decision|1|||
48742420|NCT00939770|156906288|FG006|Overall Study|Physician Decision|0|||
48742421|NCT00939770|156906289|FG007|Overall Study|Physician Decision|6|||
48742422|NCT00939770|156906282|FG000|Overall Study|Protocol Violation|0|||
48742423|NCT00939770|156906283|FG001|Overall Study|Protocol Violation|0|||
48742424|NCT00939770|156906284|FG002|Overall Study|Protocol Violation|0|||
48742425|NCT00939770|156906285|FG003|Overall Study|Protocol Violation|0|||
48742426|NCT00939770|156906286|FG004|Overall Study|Protocol Violation|1|||
48742427|NCT00939770|156906287|FG005|Overall Study|Protocol Violation|0|||
48742428|NCT00939770|156906288|FG006|Overall Study|Protocol Violation|0|||
48742429|NCT00939770|156906289|FG007|Overall Study|Protocol Violation|0|||
48742430|NCT00939770|156906282|FG000|Overall Study|Withdrawal by Subject|0|||
48742431|NCT00939770|156906283|FG001|Overall Study|Withdrawal by Subject|1|||
48742432|NCT00939770|156906284|FG002|Overall Study|Withdrawal by Subject|5|||
48742433|NCT00939770|156906285|FG003|Overall Study|Withdrawal by Subject|2|||
48742434|NCT00939770|156906286|FG004|Overall Study|Withdrawal by Subject|6|||
48742435|NCT00939770|156906287|FG005|Overall Study|Withdrawal by Subject|0|||
48742436|NCT00939770|156906288|FG006|Overall Study|Withdrawal by Subject|2|||
48742437|NCT00939770|156906289|FG007|Overall Study|Withdrawal by Subject|2|||
48742438|NCT01999179|156906290|FG000|Overall Study|Adverse Event|1|||
48742439|NCT01999179|156906290|FG000|Overall Study|Lost to Follow-up|1|||
48742440|NCT01999179|156906290|FG000|Overall Study|Change in Therapy|3|||
48742441|NCT01999179|156906290|FG000|Overall Study|New catheter|2|||
48742442|NCT00816595|156906291|FG000|Overall Study|Withdrawal by Subject|2|||
48742443|NCT00816595|156906292|FG001|Overall Study|Withdrawal by Subject|0|||
48742444|NCT03724032|156906293|FG000|Overall Study|Physician Decision|1|||
48742445|NCT03724032|156906294|FG001|Overall Study|Physician Decision|0|||
48742446|NCT03724032|156906295|FG002|Overall Study|Physician Decision|0|||
48742447|NCT03724032|156906293|FG000|Overall Study|Protocol Violation|2|||
48742448|NCT03724032|156906294|FG001|Overall Study|Protocol Violation|2|||
48742449|NCT03724032|156906295|FG002|Overall Study|Protocol Violation|1|||
48742450|NCT01064310|156906299|FG000|Period 1|Adverse Event|7|||
48742451|NCT01064310|156906300|FG001|Period 1|Adverse Event|10|||
48742452|NCT01064310|156906301|FG002|Period 1|Adverse Event|0|||
48742453|NCT01064310|156906299|FG000|Period 1|Physician Decision|1|||
48742454|NCT01064310|156906300|FG001|Period 1|Physician Decision|0|||
48742455|NCT01064310|156906301|FG002|Period 1|Physician Decision|0|||
48742456|NCT01064310|156906299|FG000|Period 1|Withdrawal by Subject|2|||
48855574|NCT01885559|157308696|FG000|Overall Study|Protocol Violation|0|||
48855575|NCT01885559|157308697|FG001|Overall Study|Protocol Violation|1|||
48855576|NCT00645411|157308698|FG000|Overall Study|Adverse Event|0|||
48855577|NCT00645411|157308699|FG001|Overall Study|Adverse Event|0|||
48855578|NCT00645411|157308700|FG002|Overall Study|Adverse Event|0|||
48855579|NCT00645411|157308701|FG003|Overall Study|Adverse Event|2|||
48855580|NCT00645411|157308698|FG000|Overall Study|Withdrawal by Subject|2|||
48855581|NCT00645411|157308699|FG001|Overall Study|Withdrawal by Subject|1|||
48855582|NCT00645411|157308700|FG002|Overall Study|Withdrawal by Subject|19|||
48855583|NCT00645411|157308701|FG003|Overall Study|Withdrawal by Subject|21|||
48855584|NCT00645411|157308698|FG000|Overall Study|Lost to Follow-up|10|||
48855585|NCT00645411|157308699|FG001|Overall Study|Lost to Follow-up|5|||
48855586|NCT00645411|157308700|FG002|Overall Study|Lost to Follow-up|124|||
48855587|NCT00645411|157308701|FG003|Overall Study|Lost to Follow-up|75|||
48855588|NCT00645411|157308698|FG000|Overall Study|Protocol Violation|1|||
48855589|NCT00645411|157308699|FG001|Overall Study|Protocol Violation|0|||
48855590|NCT00645411|157308700|FG002|Overall Study|Protocol Violation|1|||
48855591|NCT00645411|157308701|FG003|Overall Study|Protocol Violation|0|||
48855592|NCT00645411|157308698|FG000|Overall Study|Inappropriate enrollment|0|||
48855593|NCT00645411|157308699|FG001|Overall Study|Inappropriate enrollment|0|||
48855594|NCT00645411|157308700|FG002|Overall Study|Inappropriate enrollment|4|||
48855595|NCT00645411|157308701|FG003|Overall Study|Inappropriate enrollment|1|||
48855596|NCT00645411|157308698|FG000|Overall Study|Unable to classify|0|||
48855597|NCT00645411|157308699|FG001|Overall Study|Unable to classify|0|||
48855598|NCT00645411|157308700|FG002|Overall Study|Unable to classify|3|||
48855599|NCT00645411|157308701|FG003|Overall Study|Unable to classify|4|||
48855600|NCT00513071|157308703|FG000|Overall Study|Adverse Event|1|||
48855601|NCT00513071|157308703|FG000|Overall Study|Withdrawal by Subject|1|||
48855602|NCT00513071|157308703|FG000|Overall Study|Physician Decision|3|||
48855603|NCT00551421|157310441|FG000|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1|||
48855604|NCT01567852|157310442|FG000|Overall Study|Withdrawal by Subject|3|||
48855605|NCT01567852|157310443|FG001|Overall Study|Withdrawal by Subject|6|||
48855606|NCT01567852|157310442|FG000|Overall Study|ECT discontinued|1|||
48855607|NCT01567852|157310443|FG001|Overall Study|ECT discontinued|1|||
48855608|NCT00089609|157310444|FG000|Overall Study|Withdrawal by Subject|3|||
48855609|NCT00089609|157310445|FG001|Overall Study|Withdrawal by Subject|1|||
48855610|NCT02637063|157310446|FG000|Overall Study|Lost to Follow-up|3|||
48855611|NCT02637063|157310447|FG001|Overall Study|Lost to Follow-up|2|||
48855612|NCT02637063|157310448|FG002|Overall Study|Lost to Follow-up|3|||
48855613|NCT02637063|157310446|FG000|Overall Study|Withdrawal by Subject|2|||
48855614|NCT02637063|157310447|FG001|Overall Study|Withdrawal by Subject|2|||
48855615|NCT02637063|157310448|FG002|Overall Study|Withdrawal by Subject|3|||
48855616|NCT01523392|157310449|FG000|Treatment Period 1|Withdrawal by Subject|2|||
48855617|NCT01523392|157310450|FG001|Treatment Period 1|Withdrawal by Subject|0|||
48855618|NCT01523392|157310449|FG000|Treatment Period 1|Did not complete 7-9 days of treatment.|1|||
48855619|NCT01523392|157310450|FG001|Treatment Period 1|Did not complete 7-9 days of treatment.|0|||
48855620|NCT01523392|157310449|FG000|Washout Period - 10 to 14 Days|Adverse Event|1|||
48855621|NCT01523392|157310450|FG001|Washout Period - 10 to 14 Days|Adverse Event|0|||
48855622|NCT02002689|157310452|FG000|Overall Study|Disease Progression|7|||
48855623|NCT02002689|157310452|FG000|Overall Study|Adverse Event|3|||
48855624|NCT00777049|157310458|FG000|Overall Study|Withdrawal by Subject|1|||
48855625|NCT00777049|157310459|FG001|Overall Study|Withdrawal by Subject|0|||
48855626|NCT00777049|157310458|FG000|Overall Study|No treatment (elevated liver enzymes)|0|||
48855627|NCT00777049|157310459|FG001|Overall Study|No treatment (elevated liver enzymes)|1|||
48855628|NCT02236611|157310460|FG000|Overall Study|Adverse Event|10|||
48855629|NCT02236611|157310461|FG001|Overall Study|Adverse Event|16|||
48855630|NCT02236611|157310460|FG000|Overall Study|Lack of Efficacy|4|||
48855631|NCT02236611|157310461|FG001|Overall Study|Lack of Efficacy|7|||
48855632|NCT02236611|157310460|FG000|Overall Study|Lost to Follow-up|0|||
48855633|NCT02236611|157310461|FG001|Overall Study|Lost to Follow-up|2|||
48855634|NCT02236611|157310460|FG000|Overall Study|Protocol deviation|3|||
48855635|NCT02236611|157310461|FG001|Overall Study|Protocol deviation|5|||
48855636|NCT02236611|157310460|FG000|Overall Study|Withdrew consent|9|||
48855637|NCT02236611|157310461|FG001|Overall Study|Withdrew consent|4|||
48855638|NCT03403036|157310462|FG000|Overall Study|Lack of Efficacy|5|||
48855639|NCT03865732|157310464|FG000|Overall Study|Adverse Event|0|||
48855640|NCT03865732|157310465|FG001|Overall Study|Adverse Event|1|||
48855641|NCT01686152|157310472|FG000|Overall Study|Withdrawal by Subject|11|||
48855642|NCT01686152|157310473|FG001|Overall Study|Withdrawal by Subject|11|||
48855643|NCT01686152|157310474|FG002|Overall Study|Withdrawal by Subject|3|||
48855644|NCT01686152|157310472|FG000|Overall Study|Drug Code Unblinded|0|||
48855645|NCT01686152|157310473|FG001|Overall Study|Drug Code Unblinded|1|||
48855646|NCT01686152|157310474|FG002|Overall Study|Drug Code Unblinded|0|||
48855647|NCT01686152|157310472|FG000|Overall Study|Protocol Violation|6|||
48855648|NCT01686152|157310473|FG001|Overall Study|Protocol Violation|1|||
48951133|NCT02207530|157651328|FG000|Overall Study|Worsening condition under investigation|78|||
48951134|NCT02207530|157651328|FG000|Overall Study|Patient decision to stop study treatment|5|||
48951135|NCT02207530|157651328|FG000|Overall Study|Adverse Event|8|||
48951136|NCT00370149|157651329|FG000|Overall Study|Physician Decision|16|||
48951137|NCT00370149|157651330|FG001|Overall Study|Physician Decision|16|||
48951138|NCT00370149|157651329|FG000|Overall Study|Protocol Violation|1|||
48951139|NCT00370149|157651330|FG001|Overall Study|Protocol Violation|0|||
48951140|NCT00370149|157651329|FG000|Overall Study|Catheter inserted in wrong vessel-|2|||
48951141|NCT00370149|157651330|FG001|Overall Study|Catheter inserted in wrong vessel-|1|||
48951142|NCT00370149|157651329|FG000|Overall Study|Pre-existing infection|0|||
48951143|NCT00370149|157651330|FG001|Overall Study|Pre-existing infection|1|||
48951144|NCT00370149|157651329|FG000|Overall Study|Antibiotic coated dressing placed|0|||
48742457|NCT01064310|156906300|FG001|Period 1|Withdrawal by Subject|2|||
48742458|NCT01064310|156906301|FG002|Period 1|Withdrawal by Subject|0|||
48742459|NCT01064310|156906299|FG000|Period 1|Lack of Efficacy|3|||
48742460|NCT01064310|156906300|FG001|Period 1|Lack of Efficacy|5|||
48742461|NCT01064310|156906301|FG002|Period 1|Lack of Efficacy|0|||
48742462|NCT01064310|156906299|FG000|Period 1|Entered Open-label Period|1|||
48742463|NCT01064310|156906300|FG001|Period 1|Entered Open-label Period|1|||
48742464|NCT01064310|156906301|FG002|Period 1|Entered Open-label Period|0|||
48742465|NCT01064310|156906299|FG000|Period 2|Adverse Event|2|||
48742466|NCT01064310|156906300|FG001|Period 2|Adverse Event|1|||
48742467|NCT01064310|156906301|FG002|Period 2|Adverse Event|0|||
48742468|NCT01064310|156906299|FG000|Period 2|Physician Decision|0|||
48742469|NCT01064310|156906300|FG001|Period 2|Physician Decision|1|||
48742470|NCT01064310|156906301|FG002|Period 2|Physician Decision|0|||
48742471|NCT01064310|156906299|FG000|Period 2|Entered Open-label Period|1|||
48742472|NCT01064310|156906300|FG001|Period 2|Entered Open-label Period|0|||
48742473|NCT01064310|156906301|FG002|Period 2|Entered Open-label Period|0|||
48742474|NCT01064310|156906299|FG000|Period 2|Lack of Efficacy|1|||
48742475|NCT01064310|156906300|FG001|Period 2|Lack of Efficacy|4|||
48742476|NCT01064310|156906301|FG002|Period 2|Lack of Efficacy|0|||
48742477|NCT01064310|156906299|FG000|Open Label Pazopinib|Withdrawal by Subject|0|||
48742478|NCT01064310|156906300|FG001|Open Label Pazopinib|Withdrawal by Subject|0|||
48742479|NCT01064310|156906301|FG002|Open Label Pazopinib|Withdrawal by Subject|1|||
48742480|NCT01064310|156906299|FG000|Open Label Pazopinib|Adverse Event|0|||
48742481|NCT01064310|156906300|FG001|Open Label Pazopinib|Adverse Event|0|||
48742482|NCT01064310|156906301|FG002|Open Label Pazopinib|Adverse Event|12|||
48742483|NCT01064310|156906299|FG000|Open Label Pazopinib|Lack of Efficacy|0|||
48951145|NCT00370149|157651330|FG001|Overall Study|Antibiotic coated dressing placed|1|||
48951146|NCT05372575|157651331|FG000|Overall Study|Protocol Violation|7|||
48742484|NCT01064310|156906300|FG001|Open Label Pazopinib|Lack of Efficacy|0|||
48742485|NCT01064310|156906301|FG002|Open Label Pazopinib|Lack of Efficacy|51|||
48742486|NCT01064310|156906299|FG000|Open Label Pazopinib|Physician Decision|0|||
48742487|NCT01064310|156906300|FG001|Open Label Pazopinib|Physician Decision|0|||
48951147|NCT05372575|157651332|FG001|Overall Study|Protocol Violation|16|||
48951148|NCT00443430|157651335|FG000|Overall Study|Lack of Efficacy|3|||
48951149|NCT00443430|157651336|FG001|Overall Study|Lack of Efficacy|3|||
48951150|NCT00443430|157651335|FG000|Overall Study|Adverse Event|1|||
48742488|NCT01064310|156906301|FG002|Open Label Pazopinib|Physician Decision|20|||
48742489|NCT00679432|156906302|FG000|Overall Study|Adverse Event|5|||
48742490|NCT00679432|156906303|FG001|Overall Study|Adverse Event|6|||
48742491|NCT00679432|156906304|FG002|Overall Study|Adverse Event|10|||
48742492|NCT00679432|156906305|FG003|Overall Study|Adverse Event|7|||
48742493|NCT00679432|156906302|FG000|Overall Study|Protocol Violation|1|||
48742494|NCT00679432|156906303|FG001|Overall Study|Protocol Violation|1|||
48742495|NCT00679432|156906304|FG002|Overall Study|Protocol Violation|2|||
48951151|NCT00443430|157651336|FG001|Overall Study|Adverse Event|1|||
48951152|NCT00592501|157651337|FG000|Overall Study|Withdrawal by Subject|1|||
48951153|NCT00592501|157651337|FG000|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1|||
48951154|NCT01663740|157651338|FG000|Overall Study|Lost to Follow-up|1|||
48951155|NCT01663740|157651339|FG001|Overall Study|Lost to Follow-up|4|||
48951156|NCT01663740|157651338|FG000|Overall Study|Other|9|||
48951157|NCT01663740|157651339|FG001|Overall Study|Other|2|||
48951158|NCT01663740|157651338|FG000|Overall Study|Inclusion/Exclusion not met|1|||
48951159|NCT01663740|157651339|FG001|Overall Study|Inclusion/Exclusion not met|0|||
48951160|NCT01663740|157651338|FG000|Overall Study|Death|0|||
48951161|NCT01663740|157651339|FG001|Overall Study|Death|1|||
48951162|NCT01663740|157651338|FG000|Overall Study|Withdrawal by Subject|2|||
48951163|NCT01663740|157651339|FG001|Overall Study|Withdrawal by Subject|1|||
48951164|NCT01663740|157651338|FG000|Overall Study|No end of study status|3|||
48951165|NCT01663740|157651339|FG001|Overall Study|No end of study status|0|||
48951166|NCT03894904|157651345|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|2|||
48951167|NCT03894904|157651346|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|3|||
48951168|NCT03894904|157651345|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|2|||
48951169|NCT03894904|157651346|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|1|||
48951170|NCT00053846|157651347|FG000|Overall Study|Changed mind|8|||
48742496|NCT00679432|156906305|FG003|Overall Study|Protocol Violation|1|||
48742497|NCT00679432|156906302|FG000|Overall Study|Withdrawal by Subject|8|||
48742498|NCT00679432|156906303|FG001|Overall Study|Withdrawal by Subject|11|||
48742499|NCT00679432|156906304|FG002|Overall Study|Withdrawal by Subject|10|||
48742500|NCT00679432|156906305|FG003|Overall Study|Withdrawal by Subject|9|||
48742501|NCT00679432|156906302|FG000|Overall Study|Lost to Follow-up|1|||
48742502|NCT00679432|156906303|FG001|Overall Study|Lost to Follow-up|5|||
48742503|NCT00679432|156906304|FG002|Overall Study|Lost to Follow-up|4|||
48951171|NCT00053846|157651348|FG001|Overall Study|Changed mind|13|||
48951172|NCT00053846|157651347|FG000|Overall Study|Became too ill|8|||
48951173|NCT00053846|157651348|FG001|Overall Study|Became too ill|7|||
48951174|NCT00053846|157651347|FG000|Overall Study|Expired|5|||
48951175|NCT00053846|157651348|FG001|Overall Study|Expired|0|||
48951176|NCT00053846|157651347|FG000|Overall Study|Became ineligible|3|||
48951177|NCT00053846|157651348|FG001|Overall Study|Became ineligible|1|||
48742504|NCT00679432|156906305|FG003|Overall Study|Lost to Follow-up|2|||
48742505|NCT00679432|156906302|FG000|Overall Study|Physician Decision|3|||
48742506|NCT00679432|156906303|FG001|Overall Study|Physician Decision|2|||
48742507|NCT00679432|156906304|FG002|Overall Study|Physician Decision|2|||
48742508|NCT00679432|156906305|FG003|Overall Study|Physician Decision|2|||
48951178|NCT00053846|157651347|FG000|Overall Study|Did not return data|1|||
48951179|NCT00053846|157651348|FG001|Overall Study|Did not return data|2|||
48951180|NCT00053846|157651347|FG000|Overall Study|Quit due to side effects|1|||
48742509|NCT00679432|156906302|FG000|Overall Study|Sponsor decision|1|||
48742510|NCT00679432|156906303|FG001|Overall Study|Sponsor decision|0|||
48951181|NCT00053846|157651348|FG001|Overall Study|Quit due to side effects|3|||
48855649|NCT01686152|157310474|FG002|Overall Study|Protocol Violation|0|||
48855650|NCT01686152|157310472|FG000|Overall Study|Adverse Event|12|||
48855651|NCT01686152|157310473|FG001|Overall Study|Adverse Event|11|||
48855652|NCT01686152|157310474|FG002|Overall Study|Adverse Event|0|||
48855653|NCT01686152|157310472|FG000|Overall Study|Lack of Efficacy|0|||
48855654|NCT01686152|157310473|FG001|Overall Study|Lack of Efficacy|0|||
48855655|NCT01686152|157310474|FG002|Overall Study|Lack of Efficacy|1|||
48855656|NCT01686152|157310472|FG000|Overall Study|IP Non-compliance|5|||
48855657|NCT01686152|157310473|FG001|Overall Study|IP Non-compliance|5|||
48855658|NCT01686152|157310474|FG002|Overall Study|IP Non-compliance|0|||
48855659|NCT01686152|157310472|FG000|Overall Study|Lost to Follow-up|7|||
48855660|NCT01686152|157310473|FG001|Overall Study|Lost to Follow-up|6|||
48855661|NCT01686152|157310474|FG002|Overall Study|Lost to Follow-up|5|||
48855662|NCT01853384|157310475|FG000|Randomized|Adverse Event|5|||
48855663|NCT01853384|157310476|FG001|Randomized|Adverse Event|3|||
48855664|NCT01853384|157310475|FG000|Randomized|Death|1|||
48855665|NCT01853384|157310476|FG001|Randomized|Death|2|||
48855666|NCT01853384|157310475|FG000|Randomized|Lost to Follow-up|1|||
48855667|NCT01853384|157310476|FG001|Randomized|Lost to Follow-up|1|||
48855668|NCT01853384|157310475|FG000|Randomized|Withdrawal by Subject|5|||
48855669|NCT01853384|157310476|FG001|Randomized|Withdrawal by Subject|3|||
48855670|NCT01853384|157310475|FG000|Randomized|Sponsor Decision|47|||
48855671|NCT01853384|157310476|FG001|Randomized|Sponsor Decision|34|||
48855672|NCT01853384|157310475|FG000|Randomized|Other|3|||
48855673|NCT01853384|157310476|FG001|Randomized|Other|3|||
48855674|NCT01853384|157310475|FG000|Completed Follow up Visit 1|Early Termination|13|||
48855675|NCT01853384|157310476|FG001|Completed Follow up Visit 1|Early Termination|9|||
48855676|NCT01853384|157310475|FG000|Completed Follow up Visit 1|Withdrawal by Subject|1|||
48855677|NCT01853384|157310476|FG001|Completed Follow up Visit 1|Withdrawal by Subject|0|||
48855678|NCT01853384|157310475|FG000|Completed Follow up Visit 2|Adverse Event|1|||
48855679|NCT01853384|157310476|FG001|Completed Follow up Visit 2|Adverse Event|0|||
48855680|NCT01853384|157310475|FG000|Completed Follow up Visit 2|Withdrawal by Subject|1|||
48855681|NCT01853384|157310476|FG001|Completed Follow up Visit 2|Withdrawal by Subject|2|||
48855682|NCT01853384|157310475|FG000|Completed Follow up Visit 2|Death|1|||
48855683|NCT01853384|157310476|FG001|Completed Follow up Visit 2|Death|0|||
48855684|NCT01853384|157310475|FG000|Completed Follow up Visit 2|Lost to Follow-up|0|||
48855685|NCT01853384|157310476|FG001|Completed Follow up Visit 2|Lost to Follow-up|1|||
48855686|NCT01947491|157310477|FG000|Overall Study|Lost to Follow-up|5|||
48951182|NCT00053846|157651347|FG000|Overall Study|Pills too large|0|||
48951183|NCT00053846|157651348|FG001|Overall Study|Pills too large|1|||
48951184|NCT00064662|157651351|FG000|Overall Study|Death|1|||
48951185|NCT00064662|157651352|FG001|Overall Study|Death|1|||
48951186|NCT00064662|157651351|FG000|Overall Study|Lost to Follow-up|57|||
48951187|NCT00064662|157651352|FG001|Overall Study|Lost to Follow-up|44|||
48951188|NCT00064662|157651351|FG000|Overall Study|Withdrawal by Subject|14|||
48951189|NCT00064662|157651352|FG001|Overall Study|Withdrawal by Subject|14|||
48951190|NCT00064662|157651351|FG000|Overall Study|Administratively withdrawn|2|||
48742511|NCT00679432|156906304|FG002|Overall Study|Sponsor decision|0|||
48951191|NCT00064662|157651352|FG001|Overall Study|Administratively withdrawn|2|||
48951192|NCT00933335|157651357|FG000|Overall Study|Lost to Follow-up|1|||
48951193|NCT00933335|157651358|FG001|Overall Study|Lost to Follow-up|3|||
48951194|NCT00933335|157651357|FG000|Overall Study|Withdrawal by Subject|0|||
48951195|NCT00933335|157651358|FG001|Overall Study|Withdrawal by Subject|1|||
48951196|NCT00933335|157651357|FG000|Overall Study|Progressive Disease|0|||
48951197|NCT00933335|157651358|FG001|Overall Study|Progressive Disease|11|||
48951198|NCT00933335|157651357|FG000|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0|||
48951199|NCT00933335|157651358|FG001|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1|||
48951200|NCT00933335|157651357|FG000|Overall Study|Co-morbid Illness|1|||
48951201|NCT00933335|157651358|FG001|Overall Study|Co-morbid Illness|0|||
48951202|NCT02203838|157651361|FG000|Overall Study|Lack of Efficacy|7|||
48742512|NCT00679432|156906305|FG003|Overall Study|Sponsor decision|0|||
48742513|NCT00679432|156906302|FG000|Overall Study|Lack of Efficacy|13|||
48951203|NCT02203838|157651362|FG001|Overall Study|Lack of Efficacy|0|||
48951204|NCT02203838|157651363|FG002|Overall Study|Lack of Efficacy|1|||
48951205|NCT02203838|157651364|FG003|Overall Study|Lack of Efficacy|1|||
48951206|NCT02203838|157651361|FG000|Overall Study|Adverse Event|46|||
48951207|NCT02203838|157651362|FG001|Overall Study|Adverse Event|6|||
48951208|NCT02203838|157651363|FG002|Overall Study|Adverse Event|3|||
48951209|NCT02203838|157651364|FG003|Overall Study|Adverse Event|2|||
48951210|NCT02203838|157651361|FG000|Overall Study|Lost to Follow-up|39|||
48951211|NCT02203838|157651362|FG001|Overall Study|Lost to Follow-up|3|||
48951212|NCT02203838|157651363|FG002|Overall Study|Lost to Follow-up|2|||
48951213|NCT02203838|157651364|FG003|Overall Study|Lost to Follow-up|1|||
48951214|NCT02203838|157651361|FG000|Overall Study|Protocol Violation|7|||
48951215|NCT02203838|157651362|FG001|Overall Study|Protocol Violation|3|||
48951216|NCT02203838|157651363|FG002|Overall Study|Protocol Violation|0|||
48951217|NCT02203838|157651364|FG003|Overall Study|Protocol Violation|0|||
48951218|NCT02203838|157651361|FG000|Overall Study|Withdrawal by Subject|83|||
48951219|NCT02203838|157651362|FG001|Overall Study|Withdrawal by Subject|10|||
48951220|NCT02203838|157651363|FG002|Overall Study|Withdrawal by Subject|8|||
48951221|NCT02203838|157651364|FG003|Overall Study|Withdrawal by Subject|11|||
48951222|NCT02203838|157651361|FG000|Overall Study|Physician Decision|27|||
48951223|NCT02203838|157651362|FG001|Overall Study|Physician Decision|0|||
48951224|NCT02203838|157651363|FG002|Overall Study|Physician Decision|2|||
48951225|NCT02203838|157651364|FG003|Overall Study|Physician Decision|3|||
48951226|NCT02203838|157651361|FG000|Overall Study|Other|1|||
48742514|NCT00679432|156906303|FG001|Overall Study|Lack of Efficacy|9|||
48951227|NCT02203838|157651362|FG001|Overall Study|Other|0|||
48951228|NCT02203838|157651363|FG002|Overall Study|Other|0|||
48951229|NCT02203838|157651364|FG003|Overall Study|Other|0|||
48951230|NCT00436215|157651365|FG000|Overall Study|Refused further treatment|3|||
48951231|NCT00436215|157651365|FG000|Overall Study|Small bowel obstruction|1|||
48951232|NCT03880227|157651366|FG000|First Visit|Withdrawal by Subject|1|||
48951233|NCT03880227|157651367|FG001|First Visit|Withdrawal by Subject|0|||
48951234|NCT03880227|157651368|FG002|First Visit|Withdrawal by Subject|0|||
48951235|NCT03880227|157651369|FG003|First Visit|Withdrawal by Subject|0|||
48951236|NCT03880227|157651366|FG000|1 Week Washout/ Delay|Lost to Follow-up|0|||
48951237|NCT03880227|157651367|FG001|1 Week Washout/ Delay|Lost to Follow-up|1|||
48951238|NCT03880227|157651368|FG002|1 Week Washout/ Delay|Lost to Follow-up|0|||
48951239|NCT03880227|157651369|FG003|1 Week Washout/ Delay|Lost to Follow-up|0|||
48951240|NCT03880227|157651366|FG000|1 Week Washout/ Delay|Withdrawal by Subject|0|||
48951241|NCT03880227|157651367|FG001|1 Week Washout/ Delay|Withdrawal by Subject|0|||
48951242|NCT03880227|157651368|FG002|1 Week Washout/ Delay|Withdrawal by Subject|2|||
48951243|NCT03880227|157651369|FG003|1 Week Washout/ Delay|Withdrawal by Subject|0|||
48951244|NCT03880227|157651366|FG000|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
48951245|NCT03880227|157651367|FG001|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
48951246|NCT03880227|157651368|FG002|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1|||
48951247|NCT03880227|157651369|FG003|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
48951248|NCT00504166|157651370|FG000|Overall Study|Adverse Event|1|||
48951249|NCT00504166|157651371|FG001|Overall Study|Adverse Event|4|||
48951250|NCT00504166|157651370|FG000|Overall Study|Withdrawal by Subject|3|||
48742515|NCT00679432|156906304|FG002|Overall Study|Lack of Efficacy|14|||
48742516|NCT00679432|156906305|FG003|Overall Study|Lack of Efficacy|8|||
48742517|NCT00679432|156906302|FG000|Overall Study|Infectious colitis, normal histology|5|||
48951251|NCT00504166|157651371|FG001|Overall Study|Withdrawal by Subject|6|||
48951252|NCT00504166|157651370|FG000|Overall Study|Physician Decision|1|||
48951253|NCT00504166|157651371|FG001|Overall Study|Physician Decision|1|||
48951254|NCT00504166|157651370|FG000|Overall Study|Lost to Follow-up|1|||
48951255|NCT00504166|157651371|FG001|Overall Study|Lost to Follow-up|3|||
48951256|NCT01096550|157651379|FG000|Overall Study|discontinued site|10|||
48951257|NCT01096550|157651380|FG001|Overall Study|discontinued site|11|||
48951258|NCT01096550|157651379|FG000|Overall Study|non-regular treatment track at clinic|1|||
48742518|NCT00679432|156906303|FG001|Overall Study|Infectious colitis, normal histology|4|||
48951259|NCT01096550|157651380|FG001|Overall Study|non-regular treatment track at clinic|1|||
48951260|NCT01096550|157651379|FG000|Overall Study|clinic readmission|1|||
48951261|NCT01096550|157651380|FG001|Overall Study|clinic readmission|1|||
48951262|NCT01096550|157651379|FG000|Overall Study|Withdrawal by Subject|0|||
48951263|NCT01096550|157651380|FG001|Overall Study|Withdrawal by Subject|1|||
48742519|NCT00679432|156906304|FG002|Overall Study|Infectious colitis, normal histology|8|||
48742520|NCT00679432|156906305|FG003|Overall Study|Infectious colitis, normal histology|3|||
48951264|NCT01096550|157651379|FG000|Overall Study|non-African American participant|13|||
48951265|NCT01096550|157651380|FG001|Overall Study|non-African American participant|6|||
48951266|NCT01096550|157651379|FG000|Overall Study|Lost to Follow-up|12|||
48951267|NCT01096550|157651380|FG001|Overall Study|Lost to Follow-up|9|||
48951268|NCT00651118|157651381|FG000|Overall Study|Adverse Event|4|||
48951269|NCT00651118|157651382|FG001|Overall Study|Adverse Event|0|||
48951270|NCT00651118|157651383|FG002|Overall Study|Adverse Event|1|||
48951271|NCT00651118|157651384|FG003|Overall Study|Adverse Event|1|||
48951272|NCT00651118|157651381|FG000|Overall Study|Protocol Violation|2|||
48951273|NCT00651118|157651382|FG001|Overall Study|Protocol Violation|2|||
48951274|NCT00651118|157651383|FG002|Overall Study|Protocol Violation|6|||
48951275|NCT00651118|157651384|FG003|Overall Study|Protocol Violation|2|||
48951276|NCT00651118|157651381|FG000|Overall Study|Lost to Follow-up|2|||
48951277|NCT00651118|157651382|FG001|Overall Study|Lost to Follow-up|0|||
48951278|NCT00651118|157651383|FG002|Overall Study|Lost to Follow-up|1|||
48951279|NCT00651118|157651384|FG003|Overall Study|Lost to Follow-up|2|||
48951280|NCT00651118|157651381|FG000|Overall Study|administrative|1|||
48951281|NCT00651118|157651382|FG001|Overall Study|administrative|4|||
48951282|NCT00651118|157651383|FG002|Overall Study|administrative|2|||
48742521|NCT00679432|156906302|FG000|Overall Study|Randomization error, return to prior Rx|0|||
48742522|NCT00679432|156906303|FG001|Overall Study|Randomization error, return to prior Rx|0|||
48742523|NCT00679432|156906304|FG002|Overall Study|Randomization error, return to prior Rx|3|||
48742524|NCT00679432|156906305|FG003|Overall Study|Randomization error, return to prior Rx|0|||
48742525|NCT02339584|156906306|FG000|Overall Study|Adverse Event|11|||
48742526|NCT02339584|156906307|FG001|Overall Study|Adverse Event|7|||
48742527|NCT02339584|156906306|FG000|Overall Study|Lack of Efficacy|0|||
48951283|NCT00651118|157651384|FG003|Overall Study|administrative|1|||
48951284|NCT00651118|157651381|FG000|Overall Study|Withdrawal by Subject|0|||
48951285|NCT00651118|157651382|FG001|Overall Study|Withdrawal by Subject|1|||
48951286|NCT00651118|157651383|FG002|Overall Study|Withdrawal by Subject|1|||
48951287|NCT00651118|157651384|FG003|Overall Study|Withdrawal by Subject|1|||
48951288|NCT03117049|157651385|FG000|Overall Study|Continued the follow-up period|109|||
48951289|NCT03117049|157651386|FG001|Overall Study|Continued the follow-up period|129|||
48951290|NCT03117049|157651385|FG000|Overall Study|Died|82|||
48951291|NCT03117049|157651386|FG001|Overall Study|Died|93|||
48951292|NCT03117049|157651385|FG000|Overall Study|Consent withdrawal|7|||
48951293|NCT03117049|157651386|FG001|Overall Study|Consent withdrawal|6|||
48951294|NCT03117049|157651385|FG000|Overall Study|Missing contact|3|||
48951295|NCT03117049|157651386|FG001|Overall Study|Missing contact|3|||
48951296|NCT02229864|157651387|FG000|Overall Study|Death|2|||
48742528|NCT02339584|156906307|FG001|Overall Study|Lack of Efficacy|1|||
48742529|NCT02339584|156906306|FG000|Overall Study|Physician Decision|1|||
48742530|NCT02339584|156906307|FG001|Overall Study|Physician Decision|2|||
48742531|NCT02339584|156906306|FG000|Overall Study|Protocol Violation|1|||
48742532|NCT02339584|156906307|FG001|Overall Study|Protocol Violation|1|||
48951297|NCT02229864|157651387|FG000|Overall Study|Lost to Follow-up|1|||
48951298|NCT01172288|157651388|FG000|Overall Study|Adverse Event|1|||
48951299|NCT01172288|157651389|FG001|Overall Study|Adverse Event|0|||
48951300|NCT01172288|157651388|FG000|Overall Study|Protocol Violation|0|||
48951301|NCT01172288|157651389|FG001|Overall Study|Protocol Violation|1|||
48951302|NCT03196297|157651394|FG000|Main Period|Withdrawal by Subject|4|||
48855687|NCT01947491|157310478|FG001|Overall Study|Lost to Follow-up|3|||
48855688|NCT01947491|157310479|FG002|Overall Study|Lost to Follow-up|1|||
48855689|NCT01947491|157310480|FG003|Overall Study|Lost to Follow-up|2|||
48855690|NCT01947491|157310477|FG000|Overall Study|Lack of Efficacy|1|||
48855691|NCT01947491|157310478|FG001|Overall Study|Lack of Efficacy|0|||
48855692|NCT01947491|157310479|FG002|Overall Study|Lack of Efficacy|0|||
48855693|NCT01947491|157310480|FG003|Overall Study|Lack of Efficacy|1|||
48855694|NCT01947491|157310477|FG000|Overall Study|Protocol Violation|1|||
48855695|NCT01947491|157310478|FG001|Overall Study|Protocol Violation|0|||
48855696|NCT01947491|157310479|FG002|Overall Study|Protocol Violation|0|||
48855697|NCT01947491|157310480|FG003|Overall Study|Protocol Violation|0|||
48855698|NCT01947491|157310477|FG000|Overall Study|Withdrawal by Subject|1|||
48855699|NCT01947491|157310478|FG001|Overall Study|Withdrawal by Subject|1|||
48855700|NCT01947491|157310479|FG002|Overall Study|Withdrawal by Subject|1|||
48855701|NCT01947491|157310480|FG003|Overall Study|Withdrawal by Subject|0|||
48855702|NCT01947491|157310477|FG000|Overall Study|Worsening of condition|0|||
48855703|NCT01947491|157310478|FG001|Overall Study|Worsening of condition|1|||
48855704|NCT01947491|157310479|FG002|Overall Study|Worsening of condition|0|||
48855705|NCT01947491|157310480|FG003|Overall Study|Worsening of condition|0|||
48855706|NCT01947491|157310477|FG000|Overall Study|Adverse Event|0|||
48855707|NCT01947491|157310478|FG001|Overall Study|Adverse Event|1|||
48855708|NCT01947491|157310479|FG002|Overall Study|Adverse Event|0|||
48855709|NCT01947491|157310480|FG003|Overall Study|Adverse Event|2|||
48742533|NCT02339584|156906306|FG000|Overall Study|Withdrawal by Subject|2|||
48742534|NCT02339584|156906307|FG001|Overall Study|Withdrawal by Subject|4|||
48742535|NCT01348165|156906308|FG000|Overall Study|Adverse Event|0|||
48742536|NCT01348165|156906309|FG001|Overall Study|Adverse Event|0|||
48742537|NCT01348165|156906310|FG002|Overall Study|Adverse Event|0|||
48742538|NCT01348165|156906311|FG003|Overall Study|Adverse Event|0|||
48742539|NCT01348165|156906312|FG004|Overall Study|Adverse Event|0|||
48742540|NCT01348165|156906313|FG005|Overall Study|Adverse Event|0|||
48742541|NCT01348165|156906314|FG006|Overall Study|Adverse Event|1|||
48742542|NCT03547583|156906317|FG000|Overall Study|Adverse Event|16|||
48742543|NCT03547583|156906318|FG001|Overall Study|Adverse Event|11|||
48742544|NCT03547583|156906319|FG002|Overall Study|Adverse Event|10|||
48742545|NCT03547583|156906317|FG000|Overall Study|Death|11|||
48742546|NCT03547583|156906318|FG001|Overall Study|Death|7|||
48742547|NCT03547583|156906319|FG002|Overall Study|Death|4|||
48742548|NCT03547583|156906317|FG000|Overall Study|Lost to Follow-up|1|||
48742549|NCT03547583|156906318|FG001|Overall Study|Lost to Follow-up|0|||
48742550|NCT03547583|156906319|FG002|Overall Study|Lost to Follow-up|0|||
48951303|NCT03196297|157651394|FG000|Extension Period|Withdrawal by Subject|1|||
48742551|NCT03547583|156906317|FG000|Overall Study|Non-compliance with study drug|0|||
48742552|NCT03547583|156906318|FG001|Overall Study|Non-compliance with study drug|0|||
48951304|NCT03196297|157651394|FG000|Extension Period|Lack of Efficacy|2|||
48951305|NCT03510663|157651399|FG000|Overall Study|Withdrawal by Subject|0|||
48951306|NCT03510663|157651400|FG001|Overall Study|Withdrawal by Subject|1|||
48951307|NCT03510663|157651401|FG002|Overall Study|Withdrawal by Subject|0|||
48951308|NCT03510663|157651402|FG003|Overall Study|Withdrawal by Subject|0|||
48742553|NCT03547583|156906319|FG002|Overall Study|Non-compliance with study drug|1|||
48742554|NCT03547583|156906317|FG000|Overall Study|Physician Decision|1|||
48742555|NCT03547583|156906318|FG001|Overall Study|Physician Decision|0|||
48742556|NCT03547583|156906319|FG002|Overall Study|Physician Decision|3|||
48951309|NCT03510663|157651403|FG004|Overall Study|Withdrawal by Subject|0|||
48951310|NCT03510663|157651404|FG005|Overall Study|Withdrawal by Subject|0|||
48951311|NCT03510663|157651405|FG006|Overall Study|Withdrawal by Subject|0|||
48742557|NCT03547583|156906317|FG000|Overall Study|Protocol Violation|2|||
48742558|NCT03547583|156906318|FG001|Overall Study|Protocol Violation|1|||
48742559|NCT03547583|156906319|FG002|Overall Study|Protocol Violation|1|||
48742560|NCT03547583|156906317|FG000|Overall Study|Withdrawal by Subject|12|||
48742561|NCT03547583|156906318|FG001|Overall Study|Withdrawal by Subject|19|||
48742562|NCT03547583|156906319|FG002|Overall Study|Withdrawal by Subject|10|||
48742563|NCT03547583|156906317|FG000|Overall Study|Other|2|||
48742564|NCT03547583|156906318|FG001|Overall Study|Other|2|||
48742565|NCT03547583|156906319|FG002|Overall Study|Other|3|||
48742566|NCT03307967|156906327|FG000|Overall Study|Lost to Follow-up|4|||
48742567|NCT02166905|156906328|FG000|Overall Study|Withdrawal by Subject|1|||
48742568|NCT02166905|156906329|FG001|Overall Study|Withdrawal by Subject|0|||
48742569|NCT02166905|156906330|FG002|Overall Study|Withdrawal by Subject|0|||
48742570|NCT02166905|156906331|FG003|Overall Study|Withdrawal by Subject|0|||
48742571|NCT01218113|156908167|FG000|Overall Study|Withdrawal by Subject|1|||
48951312|NCT03510663|157651406|FG007|Overall Study|Withdrawal by Subject|0|||
48951313|NCT02190435|157651407|FG000|Overall Study|First 12 patients were lead-ins|12|||
48951314|NCT02190435|157651408|FG001|Overall Study|First 12 patients were lead-ins|0|||
48951315|NCT02190435|157651407|FG000|Overall Study|3 consented screen fails|3|||
48951316|NCT02190435|157651408|FG001|Overall Study|3 consented screen fails|0|||
48951317|NCT04333433|157651419|FG000|Overall Study|Withdrawal by Subject|6|||
48951318|NCT04333433|157651420|FG001|Overall Study|Withdrawal by Subject|3|||
48951319|NCT04333433|157651419|FG000|Overall Study|Death|3|||
48951320|NCT04333433|157651420|FG001|Overall Study|Death|0|||
48951321|NCT04333433|157651419|FG000|Overall Study|Lost to Follow-up|6|||
48951322|NCT04333433|157651420|FG001|Overall Study|Lost to Follow-up|1|||
48951323|NCT04333433|157651419|FG000|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|4|||
48951324|NCT04333433|157651420|FG001|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|0|||
48951325|NCT02275026|157651426|FG000|Overall Study|Ineligible after cognitive baseline testing|11|||
48951326|NCT02275026|157651426|FG000|Overall Study|Withdrawal by Subject|4|||
48951327|NCT02275026|157651426|FG000|Overall Study|Ineligible due to medical history|13|||
48951328|NCT02275026|157651426|FG000|Overall Study|MRI malfunction precluded testing|1|||
48951329|NCT02275026|157651426|FG000|Overall Study|Ineligible after MRI findings|1|||
48951330|NCT02275026|157651426|FG000|Overall Study|Lost to Follow-up|2|||
48951331|NCT02275026|157651426|FG000|Overall Study|Scanner failure|1|||
48951332|NCT00374907|157651435|FG000|12-Week Short-term Period|Subject Withdrew Consent|3|||
48951333|NCT00374907|157651436|FG001|12-Week Short-term Period|Subject Withdrew Consent|1|||
48951334|NCT00374907|157651435|FG000|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8|||
48951335|NCT00374907|157651436|FG001|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9|||
48951336|NCT00374907|157651435|FG000|116-Week Short-term + Long-term Period|Lack of Efficacy|4|||
48951337|NCT00374907|157651436|FG001|116-Week Short-term + Long-term Period|Lack of Efficacy|2|||
48951338|NCT00374907|157651435|FG000|116-Week Short-term + Long-term Period|Adverse Event|0|||
48951339|NCT00374907|157651436|FG001|116-Week Short-term + Long-term Period|Adverse Event|2|||
48742572|NCT01218113|156908168|FG001|Overall Study|Withdrawal by Subject|0|||
48742573|NCT01218113|156908169|FG002|Overall Study|Withdrawal by Subject|1|||
48951340|NCT00374907|157651435|FG000|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
48951341|NCT00374907|157651436|FG001|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
48742574|NCT01218113|156908167|FG000|Overall Study|Lost to Follow-up|4|||
48951342|NCT01108809|157651437|FG000|Overall Study|Adverse Event|3|||
48951343|NCT01108809|157651437|FG000|Overall Study|Lost to Follow-up|1|||
48951344|NCT04370028|157651438|FG000|Overall Study|Withdrawal by Subject|695|||
48951345|NCT04370028|157651438|FG000|Overall Study|Protocol Violation|9|||
48951346|NCT04370028|157651438|FG000|Overall Study|Adverse Event|3|||
49015352|NCT00673790|157892152|FG000|Overall Study|Unconfirmed pregnancy|0|||
48951347|NCT02160977|157651439|FG000|Six Weeks After Surgery|Lost to Follow-up|1|||
48951348|NCT02160977|157651440|FG001|Six Weeks After Surgery|Lost to Follow-up|0|||
48951349|NCT02160977|157651439|FG000|Three Months After Surgery|Lost to Follow-up|0|||
48951350|NCT02160977|157651440|FG001|Three Months After Surgery|Lost to Follow-up|2|||
48951351|NCT02160977|157651439|FG000|Six Months After Surgery|Lost to Follow-up|2|||
48951352|NCT02160977|157651440|FG001|Six Months After Surgery|Lost to Follow-up|1|||
48742575|NCT01218113|156908168|FG001|Overall Study|Lost to Follow-up|1|||
48742576|NCT01218113|156908169|FG002|Overall Study|Lost to Follow-up|4|||
48742577|NCT01218113|156908167|FG000|Overall Study|Protocol Deviation Eligibility Criteria|0|||
48742578|NCT01218113|156908168|FG001|Overall Study|Protocol Deviation Eligibility Criteria|0|||
48742579|NCT01218113|156908169|FG002|Overall Study|Protocol Deviation Eligibility Criteria|1|||
48742580|NCT04092582|156908181|FG000|Overall Study|Death|1|||
48742581|NCT04092582|156908182|FG001|Overall Study|Death|1|||
48742582|NCT04092582|156908181|FG000|Overall Study|Withdrawal by Subject|4|||
48742583|NCT04092582|156908182|FG001|Overall Study|Withdrawal by Subject|1|||
48742584|NCT04092582|156908181|FG000|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|0|||
48742585|NCT04092582|156908182|FG001|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|1|||
48742586|NCT00709761|156908187|FG000|Overall Study|Withdrawal by Subject|8|||
48742587|NCT00709761|156908187|FG000|Overall Study|study closed/terminated|17|||
48742588|NCT00709761|156908187|FG000|Overall Study|Lost to Follow-up|2|||
48742589|NCT00283400|156908196|FG000|Overall Study|Withdrawal by Subject|1|||
48742590|NCT00283400|156908197|FG001|Overall Study|Withdrawal by Subject|1|||
48742591|NCT00283400|156908198|FG002|Overall Study|Withdrawal by Subject|0|||
48742592|NCT00283400|156908199|FG003|Overall Study|Withdrawal by Subject|0|||
48742593|NCT00283400|156908196|FG000|Overall Study|Death|1|||
48742594|NCT00283400|156908197|FG001|Overall Study|Death|0|||
48742595|NCT00283400|156908198|FG002|Overall Study|Death|1|||
48742596|NCT00283400|156908199|FG003|Overall Study|Death|0|||
48742597|NCT01970397|156908203|FG000|Overall Study|Adverse Event|0|||
48742598|NCT01970397|156908204|FG001|Overall Study|Adverse Event|1|||
48742599|NCT01970397|156908203|FG000|Overall Study|Lost to Follow-up|0|||
48742600|NCT01970397|156908204|FG001|Overall Study|Lost to Follow-up|1|||
48742601|NCT01970397|156908203|FG000|Overall Study|Personal Reasons|1|||
48742602|NCT01970397|156908204|FG001|Overall Study|Personal Reasons|2|||
48742603|NCT01970397|156908203|FG000|Overall Study|Protocol Violation|1|||
48742604|NCT01970397|156908204|FG001|Overall Study|Protocol Violation|1|||
48742605|NCT00926328|156908205|FG000|Overall Study|Lost to Follow-up|12|||
48742606|NCT00926328|156908206|FG001|Overall Study|Lost to Follow-up|14|||
48742607|NCT00726986|156908207|FG000|Induction Phase|Adverse Event|4|||
48742608|NCT00726986|156908207|FG000|Induction Phase|Withdrawal by Subject|2|||
48742609|NCT00726986|156908207|FG000|Induction Phase|Death|2|||
48742610|NCT00726986|156908207|FG000|Induction Phase|Lack of Efficacy|5|||
48742611|NCT00726986|156908207|FG000|Induction Phase|Secondary Disease|2|||
48742612|NCT00726986|156908207|FG000|Maintenance Phase|Adverse Event|1|||
48742613|NCT00726986|156908207|FG000|Maintenance Phase|Lack of Efficacy|2|||
48951353|NCT00893113|157653173|FG000|Overall Study|Lost to Follow-up|4|||
48855710|NCT02067663|157310487|FG000|Overall Study|Lost to Follow-up|13|||
48855711|NCT02067663|157310488|FG001|Overall Study|Lost to Follow-up|14|||
48855712|NCT00704340|157310490|FG000|Overall Study|Lost to Follow-up|2|||
48855713|NCT00704340|157310491|FG001|Overall Study|Lost to Follow-up|1|||
48855714|NCT00704340|157310490|FG000|Overall Study|Death|0|||
48855715|NCT00704340|157310491|FG001|Overall Study|Death|1|||
48855716|NCT02827201|157310492|FG000|Overall Study|Death|1|||
48855717|NCT02827201|157310493|FG001|Overall Study|Death|2|||
48855718|NCT02827201|157310492|FG000|Overall Study|Patients not treated|1|||
48855719|NCT02827201|157310493|FG001|Overall Study|Patients not treated|1|||
48855720|NCT03345979|157310494|FG000|Overall Study|Withdrawal by Subject|20|||
48855721|NCT03345979|157310495|FG001|Overall Study|Withdrawal by Subject|31|||
48855722|NCT03345979|157310494|FG000|Overall Study|Adverse Event|10|||
48855723|NCT03345979|157310495|FG001|Overall Study|Adverse Event|11|||
48855724|NCT03345979|157310494|FG000|Overall Study|Lost to Follow-up|8|||
48855725|NCT03345979|157310495|FG001|Overall Study|Lost to Follow-up|9|||
48855726|NCT03345979|157310494|FG000|Overall Study|Lack of Efficacy|4|||
48855727|NCT03345979|157310495|FG001|Overall Study|Lack of Efficacy|2|||
48855728|NCT03345979|157310494|FG000|Overall Study|Protocol Violation|1|||
48855729|NCT03345979|157310495|FG001|Overall Study|Protocol Violation|3|||
48855730|NCT03345979|157310494|FG000|Overall Study|Physician Decision|0|||
48855731|NCT03345979|157310495|FG001|Overall Study|Physician Decision|2|||
48855732|NCT02736188|157310496|FG000|Overall Study|Discontinuation of Study by Sponsor|134|||
48855733|NCT02736188|157310496|FG000|Overall Study|Adverse Event|1|||
48855734|NCT02736188|157310496|FG000|Overall Study|Withdrawal by Subject|1|||
48855735|NCT02736188|157310496|FG000|Overall Study|Other|6|||
48855736|NCT02630186|157310498|FG000|Overall Study|Withdrawal by Subject|1|||
48855737|NCT00439218|157310499|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
48855738|NCT00486954|157310500|FG000|Pilot Part|Adverse Event|4|||
48855739|NCT00486954|157310501|FG001|Pilot Part|Adverse Event|0|||
48855740|NCT00486954|157310502|FG002|Pilot Part|Adverse Event|5|||
48855741|NCT00486954|157310503|FG003|Pilot Part|Adverse Event|0|||
48855742|NCT00486954|157310504|FG004|Pilot Part|Adverse Event|0|||
48855743|NCT00486954|157310500|FG000|Pilot Part|Disease Progression|2|||
48855744|NCT00486954|157310501|FG001|Pilot Part|Disease Progression|0|||
48855745|NCT00486954|157310502|FG002|Pilot Part|Disease Progression|1|||
48855746|NCT00486954|157310503|FG003|Pilot Part|Disease Progression|0|||
48855747|NCT00486954|157310504|FG004|Pilot Part|Disease Progression|0|||
48855748|NCT00486954|157310500|FG000|Randomized Part|Lost to Follow-up|0|||
48855749|NCT00486954|157310501|FG001|Randomized Part|Lost to Follow-up|0|||
48855750|NCT00486954|157310502|FG002|Randomized Part|Lost to Follow-up|0|||
48855751|NCT00486954|157310503|FG003|Randomized Part|Lost to Follow-up|0|||
48855752|NCT00486954|157310504|FG004|Randomized Part|Lost to Follow-up|1|||
48855753|NCT00486954|157310500|FG000|Randomized Part|Withdrawal by Subject|0|||
48855754|NCT00486954|157310501|FG001|Randomized Part|Withdrawal by Subject|0|||
48855755|NCT00486954|157310502|FG002|Randomized Part|Withdrawal by Subject|0|||
48855756|NCT00486954|157310503|FG003|Randomized Part|Withdrawal by Subject|1|||
48855757|NCT00486954|157310504|FG004|Randomized Part|Withdrawal by Subject|0|||
48855758|NCT00486954|157310500|FG000|Randomized Part|Sponsor Terminated Study|0|||
48855759|NCT00486954|157310501|FG001|Randomized Part|Sponsor Terminated Study|0|||
48855760|NCT00486954|157310502|FG002|Randomized Part|Sponsor Terminated Study|0|||
48855761|NCT00486954|157310503|FG003|Randomized Part|Sponsor Terminated Study|19|||
48855762|NCT00486954|157310504|FG004|Randomized Part|Sponsor Terminated Study|13|||
48855763|NCT02128269|157310510|FG000|Treatment Period|Adverse Event|1|||
48855764|NCT02128269|157310510|FG000|Treatment Period|Physician Decision|1|||
48855765|NCT00878189|157310511|FG000|Overall Study|Death|0|||
48855766|NCT00878189|157310512|FG001|Overall Study|Death|1|||
48855767|NCT00878189|157310513|FG002|Overall Study|Death|0|||
48855768|NCT00878189|157310514|FG003|Overall Study|Death|1|||
48855769|NCT00878189|157310515|FG004|Overall Study|Death|0|||
48855770|NCT00878189|157310516|FG005|Overall Study|Death|0|||
48951354|NCT00893113|157653174|FG001|Overall Study|Lost to Follow-up|8|||
48855771|NCT00878189|157310517|FG006|Overall Study|Death|0|||
48855772|NCT00878189|157310518|FG007|Overall Study|Death|0|||
48951355|NCT00893113|157653173|FG000|Overall Study|Early Termination|1|||
48951356|NCT00893113|157653174|FG001|Overall Study|Early Termination|1|||
48855773|NCT00878189|157310519|FG008|Overall Study|Death|1|||
48855774|NCT00878189|157310511|FG000|Overall Study|Participant Refused to Follow-up|0|||
48855775|NCT00878189|157310512|FG001|Overall Study|Participant Refused to Follow-up|0|||
48855776|NCT00878189|157310513|FG002|Overall Study|Participant Refused to Follow-up|0|||
48855777|NCT00878189|157310514|FG003|Overall Study|Participant Refused to Follow-up|0|||
48855778|NCT00878189|157310515|FG004|Overall Study|Participant Refused to Follow-up|0|||
48951357|NCT00893113|157653173|FG000|Overall Study|Withdrew Consent|8|||
48855779|NCT00878189|157310516|FG005|Overall Study|Participant Refused to Follow-up|4|||
48855780|NCT00878189|157310517|FG006|Overall Study|Participant Refused to Follow-up|0|||
48855781|NCT00878189|157310518|FG007|Overall Study|Participant Refused to Follow-up|0|||
48855782|NCT00878189|157310519|FG008|Overall Study|Participant Refused to Follow-up|0|||
48855783|NCT00878189|157310511|FG000|Overall Study|Other|3|||
48855784|NCT00878189|157310512|FG001|Overall Study|Other|2|||
48855785|NCT00878189|157310513|FG002|Overall Study|Other|4|||
48855786|NCT00878189|157310514|FG003|Overall Study|Other|7|||
48855787|NCT00878189|157310515|FG004|Overall Study|Other|4|||
48855788|NCT00878189|157310516|FG005|Overall Study|Other|18|||
48855789|NCT00878189|157310517|FG006|Overall Study|Other|15|||
48855790|NCT00878189|157310518|FG007|Overall Study|Other|3|||
48855791|NCT00878189|157310519|FG008|Overall Study|Other|4|||
48855792|NCT00878189|157310511|FG000|Overall Study|Lost to Follow-up|0|||
48855793|NCT00878189|157310512|FG001|Overall Study|Lost to Follow-up|0|||
48855794|NCT00878189|157310513|FG002|Overall Study|Lost to Follow-up|0|||
48855795|NCT00878189|157310514|FG003|Overall Study|Lost to Follow-up|0|||
48855796|NCT00878189|157310515|FG004|Overall Study|Lost to Follow-up|0|||
48855797|NCT00878189|157310516|FG005|Overall Study|Lost to Follow-up|1|||
48855798|NCT00878189|157310517|FG006|Overall Study|Lost to Follow-up|1|||
48855799|NCT00878189|157310518|FG007|Overall Study|Lost to Follow-up|0|||
48855800|NCT00878189|157310519|FG008|Overall Study|Lost to Follow-up|0|||
48855801|NCT00878189|157310511|FG000|Overall Study|Objection Progression or Relapse|0|||
48855802|NCT00878189|157310512|FG001|Overall Study|Objection Progression or Relapse|0|||
48855803|NCT00878189|157310513|FG002|Overall Study|Objection Progression or Relapse|0|||
48855804|NCT00878189|157310514|FG003|Overall Study|Objection Progression or Relapse|0|||
48855805|NCT00878189|157310515|FG004|Overall Study|Objection Progression or Relapse|0|||
48855806|NCT00878189|157310516|FG005|Overall Study|Objection Progression or Relapse|0|||
48855807|NCT00878189|157310517|FG006|Overall Study|Objection Progression or Relapse|0|||
48855808|NCT00878189|157310518|FG007|Overall Study|Objection Progression or Relapse|0|||
48855809|NCT00878189|157310519|FG008|Overall Study|Objection Progression or Relapse|3|||
48855810|NCT01836523|157310520|FG000|Overall Study|Adverse Event|15|||
48855811|NCT01836523|157310521|FG001|Overall Study|Adverse Event|41|||
48855812|NCT01836523|157310522|FG002|Overall Study|Adverse Event|49|||
48855813|NCT01836523|157310523|FG003|Overall Study|Adverse Event|14|||
48855814|NCT01836523|157310520|FG000|Overall Study|Protocol Violation|6|||
48855815|NCT01836523|157310521|FG001|Overall Study|Protocol Violation|3|||
48855816|NCT01836523|157310522|FG002|Overall Study|Protocol Violation|2|||
48855817|NCT01836523|157310523|FG003|Overall Study|Protocol Violation|4|||
48855818|NCT01836523|157310520|FG000|Overall Study|Met Withdrawal Criteria|13|||
48855819|NCT01836523|157310521|FG001|Overall Study|Met Withdrawal Criteria|13|||
48855820|NCT01836523|157310522|FG002|Overall Study|Met Withdrawal Criteria|21|||
48855821|NCT01836523|157310523|FG003|Overall Study|Met Withdrawal Criteria|27|||
48855822|NCT01836523|157310520|FG000|Overall Study|Unclassified|17|||
48855823|NCT01836523|157310521|FG001|Overall Study|Unclassified|28|||
48855824|NCT01836523|157310522|FG002|Overall Study|Unclassified|19|||
48855825|NCT01836523|157310523|FG003|Overall Study|Unclassified|29|||
48855826|NCT00195819|157310526|FG000|Double-Blind|Withdrawal by Subject|1|||
48855827|NCT00195819|157310527|FG001|Double-Blind|Withdrawal by Subject|0|||
48855828|NCT00195819|157310526|FG000|Double-Blind|Moved|1|||
48951358|NCT00893113|157653174|FG001|Overall Study|Withdrew Consent|7|||
48855829|NCT00195819|157310527|FG001|Double-Blind|Moved|0|||
48951359|NCT00486226|157653175|FG000|Overall Study|Death|3|||
48951360|NCT00486226|157653175|FG000|Overall Study|Adverse Event|1|||
48951361|NCT00486226|157653175|FG000|Overall Study|Withdrawal by Subject|1|||
48855830|NCT00195819|157310526|FG000|Open-label|Adverse Event|0|||
48855831|NCT00195819|157310527|FG001|Open-label|Adverse Event|9|||
48855832|NCT00195819|157310526|FG000|Open-label|Lack of Efficacy|0|||
48855833|NCT00195819|157310527|FG001|Open-label|Lack of Efficacy|2|||
48855834|NCT00195819|157310526|FG000|Open-label|Pregnancy|0|||
48855835|NCT00195819|157310527|FG001|Open-label|Pregnancy|1|||
48855836|NCT00195819|157310526|FG000|Open-label|Protocol Violation|0|||
48855837|NCT00195819|157310527|FG001|Open-label|Protocol Violation|2|||
48855838|NCT00195819|157310526|FG000|Open-label|Moved|0|||
48855839|NCT00195819|157310527|FG001|Open-label|Moved|1|||
48855840|NCT00195819|157310526|FG000|Open-label|Withdrawal by Subject|0|||
48855841|NCT00195819|157310527|FG001|Open-label|Withdrawal by Subject|5|||
48855842|NCT01858688|157310528|FG000|Overall Study|Withdrawal by Subject|8|||
48855843|NCT01858688|157310528|FG000|Overall Study|Participant began another therapy|3|||
48855844|NCT01858688|157310528|FG000|Overall Study|Physician Decision|2|||
48855845|NCT01858688|157310528|FG000|Overall Study|Progressive Disease|2|||
48855846|NCT01858688|157310528|FG000|Overall Study|Reason not reproted|5|||
48855847|NCT01999335|157310529|FG000|Overall Study|Discontinued before receiving treatment|0|||
48855848|NCT01999335|157310530|FG001|Overall Study|Discontinued before receiving treatment|0|||
48855849|NCT01999335|157310531|FG002|Overall Study|Discontinued before receiving treatment|0|||
48951362|NCT00486226|157653175|FG000|Overall Study|Lost to Follow-up|8|||
48951363|NCT01712438|157653176|FG000|Overall Study|Not treated with Human-cl rhFVIII|2|||
48742614|NCT00639678|156908208|FG000|Overall Study|Withdrawal by Subject|3|||
48742615|NCT00639678|156908209|FG001|Overall Study|Withdrawal by Subject|0|||
48742616|NCT00639678|156908210|FG002|Overall Study|Withdrawal by Subject|4|||
48742617|NCT00639678|156908211|FG003|Overall Study|Withdrawal by Subject|0|||
48742618|NCT00639678|156908208|FG000|Overall Study|Lost to Follow-up|1|||
48742619|NCT00639678|156908209|FG001|Overall Study|Lost to Follow-up|0|||
48742620|NCT00639678|156908210|FG002|Overall Study|Lost to Follow-up|6|||
48742621|NCT00639678|156908211|FG003|Overall Study|Lost to Follow-up|0|||
48742622|NCT00639678|156908208|FG000|Overall Study|Adverse Event|0|||
48742623|NCT00639678|156908209|FG001|Overall Study|Adverse Event|1|||
48742624|NCT00639678|156908210|FG002|Overall Study|Adverse Event|0|||
48742625|NCT00639678|156908211|FG003|Overall Study|Adverse Event|0|||
48742626|NCT00639678|156908208|FG000|Overall Study|Lack of Compliance|0|||
48742627|NCT00639678|156908209|FG001|Overall Study|Lack of Compliance|0|||
48742628|NCT00639678|156908210|FG002|Overall Study|Lack of Compliance|1|||
48742629|NCT00639678|156908211|FG003|Overall Study|Lack of Compliance|0|||
48742630|NCT01513343|156908220|FG000|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|8|||
48742631|NCT01513343|156908221|FG001|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|0|||
48742632|NCT01513343|156908220|FG000|Post Data Collection|Dropped/withdrew from study|7|||
48742633|NCT01513343|156908221|FG001|Post Data Collection|Dropped/withdrew from study|1|||
48742634|NCT01513343|156908220|FG000|Post Data Collection|Lost to Follow-up|10|||
48742635|NCT01513343|156908221|FG001|Post Data Collection|Lost to Follow-up|23|||
48742636|NCT01513343|156908220|FG000|6-month Follow-up|Lost to Follow-up|28|||
48742637|NCT01513343|156908221|FG001|6-month Follow-up|Lost to Follow-up|17|||
48742638|NCT01513343|156908220|FG000|12-month Follow-up|Lost to Follow-up|10|||
48742639|NCT01513343|156908221|FG001|12-month Follow-up|Lost to Follow-up|3|||
48742640|NCT00040365|156908222|FG000|Overall Study|Death|1|||
48742641|NCT00040365|156908222|FG000|Overall Study|Progressive disease|7|||
48951364|NCT01712438|157653176|FG000|Overall Study|Ongoing ITI treatment|6|||
48951365|NCT01712438|157653176|FG000|Overall Study|Violated inclusion & exclusion criteria|4|||
48951366|NCT01712438|157653176|FG000|Overall Study|Prematurely Discontinued|25|||
48951367|NCT01881620|157653184|FG000|Overall Study|Protocol Violation|4|||
48951368|NCT01912872|157653185|FG000|Overall Study|Lost to Follow-up|2|||
48951369|NCT01912872|157653186|FG001|Overall Study|Lost to Follow-up|3|||
48951370|NCT01912872|157653187|FG002|Overall Study|Lost to Follow-up|5|||
48951371|NCT01912872|157653188|FG003|Overall Study|Lost to Follow-up|5|||
48951372|NCT01912872|157653185|FG000|Overall Study|Other unspecified|3|||
48951373|NCT01912872|157653186|FG001|Overall Study|Other unspecified|1|||
48951374|NCT01912872|157653187|FG002|Overall Study|Other unspecified|3|||
48951375|NCT01912872|157653188|FG003|Overall Study|Other unspecified|0|||
48951376|NCT01912872|157653185|FG000|Overall Study|Informed consent withdrawn|0|||
48951377|NCT01912872|157653186|FG001|Overall Study|Informed consent withdrawn|0|||
48951378|NCT01912872|157653187|FG002|Overall Study|Informed consent withdrawn|1|||
48951379|NCT01912872|157653188|FG003|Overall Study|Informed consent withdrawn|1|||
48951380|NCT01912872|157653185|FG000|Overall Study|Non-compliance with lab inc/exclusion|0|||
48951381|NCT01912872|157653186|FG001|Overall Study|Non-compliance with lab inc/exclusion|0|||
48951382|NCT01912872|157653187|FG002|Overall Study|Non-compliance with lab inc/exclusion|0|||
48951383|NCT01912872|157653188|FG003|Overall Study|Non-compliance with lab inc/exclusion|1|||
48951384|NCT01912872|157653185|FG000|Overall Study|Protocol Violation|0|||
48951385|NCT01912872|157653186|FG001|Overall Study|Protocol Violation|0|||
48951386|NCT01912872|157653187|FG002|Overall Study|Protocol Violation|1|||
48951387|NCT01912872|157653188|FG003|Overall Study|Protocol Violation|0|||
48951388|NCT01912872|157653185|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
48951389|NCT01912872|157653186|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
48951390|NCT01912872|157653187|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
48951391|NCT01912872|157653188|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
48951392|NCT01912872|157653185|FG000|Overall Study|Withdrawal of study medication|0|||
48951393|NCT01912872|157653186|FG001|Overall Study|Withdrawal of study medication|0|||
48951394|NCT01912872|157653187|FG002|Overall Study|Withdrawal of study medication|0|||
48951395|NCT01912872|157653188|FG003|Overall Study|Withdrawal of study medication|2|||
48951396|NCT01912872|157653185|FG000|Overall Study|Missing|0|||
48951397|NCT01912872|157653186|FG001|Overall Study|Missing|0|||
48951398|NCT01912872|157653187|FG002|Overall Study|Missing|0|||
48742642|NCT00040365|156908222|FG000|Overall Study|Lost to Follow-up|3|||
48742643|NCT00713323|156908223|FG000|Overall Study|Adverse Event|75|||
48742644|NCT00713323|156908223|FG000|Overall Study|Withdrawal by Subject|15|||
48951399|NCT01912872|157653188|FG003|Overall Study|Missing|1|||
48951400|NCT01666444|157653194|FG000|Overall Study|Did not initiate treatment|2|||
48951401|NCT01666444|157653195|FG001|Overall Study|Did not initiate treatment|1|||
48951402|NCT00130208|157653202|FG000|Maintenance Period (26 Weeks)|Adverse Event|10|||
48951403|NCT00130208|157653203|FG001|Maintenance Period (26 Weeks)|Adverse Event|12|||
48951404|NCT00130208|157653202|FG000|Maintenance Period (26 Weeks)|Physician Decision|0|||
48951405|NCT00130208|157653203|FG001|Maintenance Period (26 Weeks)|Physician Decision|2|||
48951406|NCT00130208|157653202|FG000|Maintenance Period (26 Weeks)|Withdrawal by Subject|8|||
48951407|NCT00130208|157653203|FG001|Maintenance Period (26 Weeks)|Withdrawal by Subject|11|||
48951408|NCT00130208|157653202|FG000|Maintenance Period (26 Weeks)|Lost to Follow-up|5|||
48951409|NCT00130208|157653203|FG001|Maintenance Period (26 Weeks)|Lost to Follow-up|4|||
48951410|NCT00130208|157653202|FG000|Maintenance Period (26 Weeks)|Other|1|||
48951411|NCT00130208|157653203|FG001|Maintenance Period (26 Weeks)|Other|1|||
48951412|NCT00130208|157653202|FG000|Washout Period (8 Weeks)|Adverse Event|3|||
48951413|NCT00130208|157653203|FG001|Washout Period (8 Weeks)|Adverse Event|6|||
48951414|NCT00130208|157653202|FG000|Washout Period (8 Weeks)|Withdrawal by Subject|2|||
48951415|NCT00130208|157653203|FG001|Washout Period (8 Weeks)|Withdrawal by Subject|4|||
48951416|NCT00130208|157653202|FG000|Washout Period (8 Weeks)|Lost to Follow-up|0|||
48951417|NCT00130208|157653203|FG001|Washout Period (8 Weeks)|Lost to Follow-up|1|||
48951418|NCT00130208|157653202|FG000|Washout Period (8 Weeks)|Other|1|||
48951419|NCT00130208|157653203|FG001|Washout Period (8 Weeks)|Other|1|||
48951420|NCT01671085|157653204|FG000|Overall Study|Withdrawal by Subject|1|||
48951421|NCT01671085|157653205|FG001|Overall Study|Withdrawal by Subject|0|||
48951422|NCT01588197|157653206|FG000|Overall Study|Lack of Efficacy|0|||
48951423|NCT01588197|157653207|FG001|Overall Study|Lack of Efficacy|1|||
48742645|NCT00713323|156908223|FG000|Overall Study|Lost to Follow-up|11|||
48951424|NCT01588197|157653206|FG000|Overall Study|No MRI|1|||
48951425|NCT01588197|157653207|FG001|Overall Study|No MRI|0|||
48951426|NCT02616029|157653208|FG000|Overall Study|Adverse Event|1|||
48742646|NCT00713323|156908223|FG000|Overall Study|Lack of Efficacy|36|||
48951427|NCT02616029|157653209|FG001|Overall Study|Adverse Event|0|||
48951428|NCT02616029|157653208|FG000|Overall Study|Death|0|||
48951429|NCT02616029|157653209|FG001|Overall Study|Death|1|||
48951430|NCT02616029|157653208|FG000|Overall Study|Protocol Violation|1|||
48951431|NCT02616029|157653209|FG001|Overall Study|Protocol Violation|0|||
48951432|NCT02616029|157653208|FG000|Overall Study|Withdrew Consent|1|||
48951433|NCT02616029|157653209|FG001|Overall Study|Withdrew Consent|0|||
48951434|NCT02616029|157653208|FG000|Overall Study|Enrolled and Never Treated|1|||
48951435|NCT02616029|157653209|FG001|Overall Study|Enrolled and Never Treated|1|||
48951436|NCT01214434|157653210|FG000|Overall Study|Withdrawal by Subject|1|||
48951437|NCT01214434|157653211|FG001|Overall Study|Withdrawal by Subject|0|||
48951438|NCT01214434|157653210|FG000|Overall Study|Lost to Follow-up|2|||
48951439|NCT01214434|157653211|FG001|Overall Study|Lost to Follow-up|2|||
48951440|NCT01214434|157653210|FG000|Overall Study|Site error|1|||
48951441|NCT01214434|157653211|FG001|Overall Study|Site error|0|||
48951442|NCT02092389|157653214|FG000|Overall Study|Adverse Event|1|||
48951443|NCT02092389|157653214|FG000|Overall Study|Other|5|||
48951444|NCT04590937|157653217|FG000|Period 2 - BI 730357+Cocktail|COVID-19 related|1|||
48951445|NCT01635933|157653218|FG000|Overall Study|Adverse Event|1|||
48951446|NCT01635933|157653219|FG001|Overall Study|Adverse Event|0|||
48951447|NCT01635933|157653218|FG000|Overall Study|Lost to Follow-up|0|||
48951448|NCT01635933|157653219|FG001|Overall Study|Lost to Follow-up|5|||
48951449|NCT01635933|157653218|FG000|Overall Study|Subject decision|1|||
48951450|NCT01635933|157653219|FG001|Overall Study|Subject decision|1|||
48951451|NCT01635933|157653218|FG000|Overall Study|Noncompliance|0|||
48951452|NCT01635933|157653219|FG001|Overall Study|Noncompliance|1|||
48951453|NCT01635933|157653218|FG000|Overall Study|No longer had transportation|0|||
48951454|NCT01635933|157653219|FG001|Overall Study|No longer had transportation|1|||
48951455|NCT01544595|157653220|FG000|Status at Week 68|Adverse Event|3|||
48951456|NCT01544595|157653221|FG001|Status at Week 68|Adverse Event|2|||
48951457|NCT01544595|157653222|FG002|Status at Week 68|Adverse Event|1|||
48951458|NCT01544595|157653223|FG003|Status at Week 68|Adverse Event|0|||
48951459|NCT01544595|157653224|FG004|Status at Week 68|Adverse Event|0|||
48951460|NCT01544595|157653225|FG005|Status at Week 68|Adverse Event|0|||
48951461|NCT01544595|157653220|FG000|Status at Week 68|Lack of Efficacy|1|||
48951462|NCT01544595|157653221|FG001|Status at Week 68|Lack of Efficacy|0|||
48951463|NCT01544595|157653222|FG002|Status at Week 68|Lack of Efficacy|0|||
48742647|NCT00713323|156908223|FG000|Overall Study|Low creatine clearance at screening|1|||
48742648|NCT00713323|156908223|FG000|Overall Study|Withdrawn due to exclusion criteria 11|1|||
48742649|NCT00713323|156908223|FG000|Overall Study|Surgery cured allodynic pain|1|||
48742650|NCT00713323|156908223|FG000|Overall Study|Pain free|1|||
48742651|NCT00713323|156908223|FG000|Overall Study|Non-compliance|1|||
48742652|NCT00713323|156908223|FG000|Overall Study|Pain resolved|1|||
48742653|NCT00713323|156908223|FG000|Overall Study|Subject travelling to USA|1|||
48742654|NCT00713323|156908223|FG000|Overall Study|Subject travelling to Dominica Republic|1|||
48742655|NCT00713323|156908223|FG000|Overall Study|Treatment that may interact with Sativex|1|||
48742656|NCT01706146|156908226|FG000|Overall Study|Withdrawal by Subject|1|||
48742657|NCT01706146|156908226|FG000|Overall Study|Adverse Event|3|||
48742658|NCT01706146|156908226|FG000|Overall Study|Developed AF and need for antiplatelets|2|||
48742659|NCT01488370|156908227|FG000|Overall Study|Protocol Violation|0|||
48742660|NCT01488370|156908228|FG001|Overall Study|Protocol Violation|1|||
48742661|NCT01488370|156908229|FG002|Overall Study|Protocol Violation|1|||
48742662|NCT01471171|156908230|FG000|Treatment Period 1|Adverse Event|4|||
48742663|NCT01471171|156908231|FG001|Treatment Period 1|Adverse Event|1|||
48742664|NCT01471171|156908230|FG000|Treatment Period 2|Adverse Event|1|||
48742665|NCT01471171|156908231|FG001|Treatment Period 2|Adverse Event|0|||
48742666|NCT00705484|156908239|FG000|Overall Study|Adverse Event|28|||
48742667|NCT00705484|156908240|FG001|Overall Study|Adverse Event|27|||
48742668|NCT00705484|156908239|FG000|Overall Study|Lost to Follow-up|169|||
48951464|NCT01544595|157653223|FG003|Status at Week 68|Lack of Efficacy|0|||
48951465|NCT01544595|157653224|FG004|Status at Week 68|Lack of Efficacy|0|||
48951466|NCT01544595|157653225|FG005|Status at Week 68|Lack of Efficacy|0|||
48951467|NCT01544595|157653220|FG000|Status at Week 68|Lost to Follow-up|1|||
48951468|NCT01544595|157653221|FG001|Status at Week 68|Lost to Follow-up|1|||
48951469|NCT01544595|157653222|FG002|Status at Week 68|Lost to Follow-up|0|||
48951470|NCT01544595|157653223|FG003|Status at Week 68|Lost to Follow-up|0|||
48951471|NCT01544595|157653224|FG004|Status at Week 68|Lost to Follow-up|0|||
48855850|NCT01999335|157310532|FG003|Overall Study|Discontinued before receiving treatment|0|||
48855851|NCT01999335|157310533|FG004|Overall Study|Discontinued before receiving treatment|2|||
48855852|NCT04410445|157310534|FG000|Overall Study|Lost to Follow-up|3|||
48855853|NCT04410445|157310535|FG001|Overall Study|Lost to Follow-up|9|||
48855854|NCT04410445|157310534|FG000|Overall Study|Withdrawal by Subject|27|||
48855855|NCT04410445|157310535|FG001|Overall Study|Withdrawal by Subject|15|||
48855856|NCT04361617|157310536|FG000|Overall Study|Withdrawal by Subject|0|||
48855857|NCT04361617|157310537|FG001|Overall Study|Withdrawal by Subject|1|||
48855858|NCT01918033|157310538|FG000|Overall Study|Adverse Event|1|||
48855859|NCT01918033|157310539|FG001|Overall Study|Adverse Event|0|||
48855860|NCT01918033|157310540|FG002|Overall Study|Adverse Event|2|||
48855861|NCT01918033|157310538|FG000|Overall Study|Lost to Follow-up|0|||
48855862|NCT01918033|157310539|FG001|Overall Study|Lost to Follow-up|1|||
48855863|NCT01918033|157310540|FG002|Overall Study|Lost to Follow-up|0|||
48855864|NCT01918033|157310538|FG000|Overall Study|Protocol Violation|2|||
48855865|NCT01918033|157310539|FG001|Overall Study|Protocol Violation|0|||
48855866|NCT01918033|157310540|FG002|Overall Study|Protocol Violation|1|||
48855867|NCT01918033|157310538|FG000|Overall Study|Withdrawal by Subject|2|||
48855868|NCT01918033|157310539|FG001|Overall Study|Withdrawal by Subject|1|||
48855869|NCT01918033|157310540|FG002|Overall Study|Withdrawal by Subject|0|||
48855870|NCT03132636|157310543|FG000|Overall Study|Adverse Event|1|||
48855871|NCT03132636|157310544|FG001|Overall Study|Adverse Event|2|||
48855872|NCT03132636|157310543|FG000|Overall Study|Death|4|||
48951472|NCT01544595|157653225|FG005|Status at Week 68|Lost to Follow-up|0|||
48951473|NCT01544595|157653220|FG000|Status at Week 68|Non-compliance with study treatment|1|||
48951474|NCT01544595|157653221|FG001|Status at Week 68|Non-compliance with study treatment|0|||
48951475|NCT01544595|157653222|FG002|Status at Week 68|Non-compliance with study treatment|0|||
48951476|NCT01544595|157653223|FG003|Status at Week 68|Non-compliance with study treatment|1|||
48951477|NCT01544595|157653224|FG004|Status at Week 68|Non-compliance with study treatment|0|||
48951478|NCT01544595|157653225|FG005|Status at Week 68|Non-compliance with study treatment|0|||
48951479|NCT01544595|157653220|FG000|Status at Week 68|Protocol Violation|2|||
48951480|NCT01544595|157653221|FG001|Status at Week 68|Protocol Violation|0|||
48951481|NCT01544595|157653222|FG002|Status at Week 68|Protocol Violation|1|||
48951482|NCT01544595|157653223|FG003|Status at Week 68|Protocol Violation|1|||
48951483|NCT01544595|157653224|FG004|Status at Week 68|Protocol Violation|0|||
48951484|NCT01544595|157653225|FG005|Status at Week 68|Protocol Violation|0|||
48951485|NCT01544595|157653220|FG000|Status at Week 68|Technical problems|1|||
48951486|NCT01544595|157653221|FG001|Status at Week 68|Technical problems|0|||
48951487|NCT01544595|157653222|FG002|Status at Week 68|Technical problems|0|||
48951488|NCT01544595|157653223|FG003|Status at Week 68|Technical problems|1|||
48951489|NCT01544595|157653224|FG004|Status at Week 68|Technical problems|0|||
48951490|NCT01544595|157653225|FG005|Status at Week 68|Technical problems|0|||
48951491|NCT01544595|157653220|FG000|Status at Week 68|Withdrawal by Subject|0|||
48951492|NCT01544595|157653221|FG001|Status at Week 68|Withdrawal by Subject|1|||
48951493|NCT01544595|157653222|FG002|Status at Week 68|Withdrawal by Subject|1|||
48951494|NCT01544595|157653223|FG003|Status at Week 68|Withdrawal by Subject|2|||
48951495|NCT01544595|157653224|FG004|Status at Week 68|Withdrawal by Subject|0|||
48951496|NCT01544595|157653225|FG005|Status at Week 68|Withdrawal by Subject|0|||
48742669|NCT00705484|156908240|FG001|Overall Study|Lost to Follow-up|250|||
48742670|NCT00705484|156908239|FG000|Overall Study|Withdrawal by Subject|96|||
48742671|NCT00705484|156908240|FG001|Overall Study|Withdrawal by Subject|72|||
48742672|NCT00705484|156908239|FG000|Overall Study|Administrative|89|||
48742673|NCT00705484|156908240|FG001|Overall Study|Administrative|59|||
48742674|NCT00444912|156908241|FG000|Overall Study|Death|1|||
48742675|NCT00444912|156908242|FG001|Overall Study|Death|2|||
48742676|NCT00444912|156908241|FG000|Overall Study|Lost to Follow-up|1|||
48742677|NCT00444912|156908242|FG001|Overall Study|Lost to Follow-up|0|||
48742678|NCT00444912|156908241|FG000|Overall Study|Participant Failed Mobilization|1|||
48742679|NCT00444912|156908242|FG001|Overall Study|Participant Failed Mobilization|0|||
48742680|NCT03758066|156908243|FG000|Overall Study|Lost to Follow-up|14|||
48855873|NCT03132636|157310544|FG001|Overall Study|Death|7|||
48742681|NCT03733470|156908244|FG000|Overall Study|PI Decision|1|||
48742682|NCT03733470|156908245|FG001|Overall Study|PI Decision|1|||
48855874|NCT03132636|157310543|FG000|Overall Study|Lost to Follow-up|3|||
48951497|NCT01544595|157653220|FG000|Status at Week 68|Moved to treatment period ≤ wk 68|30|||
48951498|NCT01544595|157653221|FG001|Status at Week 68|Moved to treatment period ≤ wk 68|13|||
48951499|NCT01544595|157653222|FG002|Status at Week 68|Moved to treatment period ≤ wk 68|60|||
48951500|NCT01544595|157653223|FG003|Status at Week 68|Moved to treatment period ≤ wk 68|46|||
48742683|NCT01866293|156908247|FG000|Overall Study|Adverse Event|2|||
48742684|NCT00493025|156908248|FG000|Overall Study|Physician Decision|19|||
48855875|NCT03132636|157310544|FG001|Overall Study|Lost to Follow-up|2|||
48855876|NCT03132636|157310543|FG000|Overall Study|Non compliance with protocol by participant|1|||
48855877|NCT03132636|157310544|FG001|Overall Study|Non compliance with protocol by participant|1|||
48855878|NCT03132636|157310543|FG000|Overall Study|Subject decision|1|||
48855879|NCT03132636|157310544|FG001|Overall Study|Subject decision|9|||
48855880|NCT03132636|157310543|FG000|Overall Study|Sponsor decision|0|||
48855881|NCT03132636|157310544|FG001|Overall Study|Sponsor decision|1|||
48855882|NCT03132636|157310543|FG000|Overall Study|Physician Decision|1|||
48742685|NCT01876420|156908249|FG000|Overall Study|Missed 30 day visit|1|||
48855883|NCT03132636|157310544|FG001|Overall Study|Physician Decision|0|||
48855884|NCT03132636|157310543|FG000|Overall Study|Progressive disease|33|||
48855885|NCT03132636|157310544|FG001|Overall Study|Progressive disease|36|||
48855886|NCT03132636|157310543|FG000|Overall Study|Withdrawal of consent|2|||
48855887|NCT03132636|157310544|FG001|Overall Study|Withdrawal of consent|5|||
48855888|NCT03132636|157310543|FG000|Overall Study|Did not re-consent|1|||
48855889|NCT03132636|157310544|FG001|Overall Study|Did not re-consent|0|||
48855890|NCT03132636|157310543|FG000|Overall Study|Lost insurance coverage|1|||
48855891|NCT03132636|157310544|FG001|Overall Study|Lost insurance coverage|0|||
48855892|NCT03132636|157310543|FG000|Overall Study|Related to radiological outcomes|0|||
48855893|NCT03132636|157310544|FG001|Overall Study|Related to radiological outcomes|1|||
48855894|NCT03132636|157310543|FG000|Overall Study|Unable to come to site for continued visits|0|||
48855895|NCT03132636|157310544|FG001|Overall Study|Unable to come to site for continued visits|1|||
48855896|NCT03006393|157310545|FG000|Overall Study|Withdrawal by Subject|1|||
48855897|NCT03006393|157310546|FG001|Overall Study|Withdrawal by Subject|1|||
48855898|NCT03006393|157310545|FG000|Overall Study|Pregnancy|0|||
48855899|NCT03006393|157310546|FG001|Overall Study|Pregnancy|1|||
48855900|NCT03006393|157310545|FG000|Overall Study|Lost to Follow-up|0|||
48855901|NCT03006393|157310546|FG001|Overall Study|Lost to Follow-up|1|||
48855902|NCT00807599|157310547|FG000|Overall Study|Not treated on protocol study|0|||
48855903|NCT00807599|157310548|FG001|Overall Study|Not treated on protocol study|0|||
48855904|NCT00807599|157310549|FG002|Overall Study|Not treated on protocol study|2|||
48855905|NCT00807599|157310547|FG000|Overall Study|Adverse Event|0|||
48855906|NCT00807599|157310548|FG001|Overall Study|Adverse Event|0|||
48855907|NCT00807599|157310549|FG002|Overall Study|Adverse Event|5|||
48855908|NCT00807599|157310547|FG000|Overall Study|Inadequate response to induction|0|||
48855909|NCT00807599|157310548|FG001|Overall Study|Inadequate response to induction|0|||
48855910|NCT00807599|157310549|FG002|Overall Study|Inadequate response to induction|9|||
48855911|NCT00807599|157310547|FG000|Overall Study|Withdrawal by Subject|0|||
48855912|NCT00807599|157310548|FG001|Overall Study|Withdrawal by Subject|0|||
48855913|NCT00807599|157310549|FG002|Overall Study|Withdrawal by Subject|1|||
48855914|NCT02137785|157310551|FG000|Overall Study|Lost to Follow-up|1|||
48855915|NCT02137785|157310552|FG001|Overall Study|Lost to Follow-up|0|||
48855916|NCT02137785|157310551|FG000|Overall Study|Withdrawal by Subject|1|||
48855917|NCT02137785|157310552|FG001|Overall Study|Withdrawal by Subject|4|||
48855918|NCT02137785|157310551|FG000|Overall Study|subject moved out of state|1|||
48855919|NCT02137785|157310552|FG001|Overall Study|subject moved out of state|0|||
48855920|NCT03042767|157310553|FG000|Overall Study|Lost to Follow-up|1|||
48855921|NCT03042767|157310554|FG001|Overall Study|Lost to Follow-up|2|||
48855922|NCT03146845|157310555|FG000|Overall Study|Reference ulcer healed|1|||
48855923|NCT03146845|157310556|FG001|Overall Study|Reference ulcer healed|0|||
48855924|NCT03146845|157310555|FG000|Overall Study|Physician Decision|1|||
48742686|NCT05229406|156908253|FG000|Overall Study|Withdrawal by Subject|1|||
48742687|NCT05229406|156908254|FG001|Overall Study|Withdrawal by Subject|2|||
48855925|NCT03146845|157310556|FG001|Overall Study|Physician Decision|0|||
48855926|NCT03146845|157310555|FG000|Overall Study|Adverse Event|1|||
48855927|NCT03146845|157310556|FG001|Overall Study|Adverse Event|0|||
48855928|NCT03146845|157310555|FG000|Overall Study|Withdrawal by Subject|2|||
48855929|NCT03146845|157310556|FG001|Overall Study|Withdrawal by Subject|0|||
48855930|NCT03146845|157310555|FG000|Overall Study|Noncompliance|0|||
48855931|NCT03146845|157310556|FG001|Overall Study|Noncompliance|1|||
48855932|NCT03146845|157310555|FG000|Overall Study|Protocol Violation|0|||
48855933|NCT03146845|157310556|FG001|Overall Study|Protocol Violation|2|||
48855934|NCT03146845|157310555|FG000|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|0|||
48855935|NCT03146845|157310556|FG001|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|1|||
48855936|NCT00721734|157310557|FG000|Overall Study|Progressive Disease|3|||
48855937|NCT00721734|157310558|FG001|Overall Study|Progressive Disease|10|||
48855938|NCT00721734|157310559|FG002|Overall Study|Progressive Disease|4|||
48855939|NCT00721734|157310560|FG003|Overall Study|Progressive Disease|5|||
48855940|NCT00721734|157310561|FG004|Overall Study|Progressive Disease|2|||
48855941|NCT00721734|157310557|FG000|Overall Study|Adverse Event|3|||
48855942|NCT00721734|157310558|FG001|Overall Study|Adverse Event|1|||
48855943|NCT00721734|157310559|FG002|Overall Study|Adverse Event|4|||
48855944|NCT00721734|157310560|FG003|Overall Study|Adverse Event|0|||
48855945|NCT00721734|157310561|FG004|Overall Study|Adverse Event|3|||
48855946|NCT00721734|157310557|FG000|Overall Study|Withdrawal by Subject|2|||
48855947|NCT00721734|157310558|FG001|Overall Study|Withdrawal by Subject|1|||
48855948|NCT00721734|157310559|FG002|Overall Study|Withdrawal by Subject|0|||
48855949|NCT00721734|157310560|FG003|Overall Study|Withdrawal by Subject|0|||
48855950|NCT00721734|157310561|FG004|Overall Study|Withdrawal by Subject|1|||
48855951|NCT00721734|157310557|FG000|Overall Study|Other|0|||
48855952|NCT00721734|157310558|FG001|Overall Study|Other|0|||
48855953|NCT00721734|157310559|FG002|Overall Study|Other|0|||
48855954|NCT00721734|157310560|FG003|Overall Study|Other|1|||
48855955|NCT00721734|157310561|FG004|Overall Study|Other|0|||
48855956|NCT03200574|157310562|FG000|Overall Study|Death|4|||
48855957|NCT03200574|157310562|FG000|Overall Study|Withdrawal by Subject|8|||
48855958|NCT03200574|157310562|FG000|Overall Study|Long-Term need for anticoagulation|1|||
48855959|NCT03200574|157310562|FG000|Overall Study|Relocation|2|||
48855960|NCT03200574|157310562|FG000|Overall Study|Lost to Follow-up|2|||
48855961|NCT03026166|157310563|FG000|Overall Study|Death|22|||
48855962|NCT03026166|157310564|FG001|Overall Study|Death|7|||
48855963|NCT03026166|157310563|FG000|Overall Study|Physician Decision|2|||
48855964|NCT03026166|157310564|FG001|Overall Study|Physician Decision|0|||
48855965|NCT03026166|157310563|FG000|Overall Study|Withdrawal by Subject|1|||
48855966|NCT03026166|157310564|FG001|Overall Study|Withdrawal by Subject|2|||
48855967|NCT03026166|157310563|FG000|Overall Study|Lost to Follow-up|1|||
48855968|NCT03026166|157310564|FG001|Overall Study|Lost to Follow-up|0|||
48855969|NCT03026166|157310563|FG000|Overall Study|Study Terminated by Sponsor|3|||
48855970|NCT03026166|157310564|FG001|Overall Study|Study Terminated by Sponsor|3|||
48855971|NCT03026166|157310563|FG000|Overall Study|Other|1|||
48855972|NCT03026166|157310564|FG001|Overall Study|Other|0|||
48855973|NCT03938272|157310565|FG000|Overall Study|Withdrawal by Subject|1|||
48855974|NCT03938272|157310566|FG001|Overall Study|Withdrawal by Subject|0|||
48855975|NCT03938272|157310565|FG000|Overall Study|Physician Decision|0|||
48855976|NCT03938272|157310566|FG001|Overall Study|Physician Decision|2|||
48855977|NCT03938272|157310565|FG000|Overall Study|Study termination by sponsor|10|||
48855978|NCT03938272|157310566|FG001|Overall Study|Study termination by sponsor|8|||
48855979|NCT02991456|157310569|FG000|Overall Study|Adverse Event|2|||
48855980|NCT02991456|157310570|FG001|Overall Study|Adverse Event|0|||
48742688|NCT05466682|156908257|FG000|Overall Study|Withdrawal by Subject|0|||
48742689|NCT05466682|156908258|FG001|Overall Study|Withdrawal by Subject|2|||
48742690|NCT05466682|156908257|FG000|Overall Study|Lost to Follow-up|2|||
48742691|NCT05466682|156908258|FG001|Overall Study|Lost to Follow-up|1|||
48855981|NCT02991456|157310569|FG000|Overall Study|Lost to Follow-up|0|||
48855982|NCT02991456|157310570|FG001|Overall Study|Lost to Follow-up|2|||
48855983|NCT02991456|157310569|FG000|Overall Study|Withdrawal by Subject|1|||
48855984|NCT02991456|157310570|FG001|Overall Study|Withdrawal by Subject|0|||
48855985|NCT00321555|157310571|FG000|Overall Study|Developed antibodies|1|||
48855986|NCT00321555|157310571|FG000|Overall Study|Switched to alternative treatment|3|||
48855987|NCT00321555|157310571|FG000|Overall Study|Physician Decision|1|||
48855988|NCT00321555|157310571|FG000|Overall Study|Disease progression on study|1|||
48855989|NCT03005106|157310572|FG000|Overall Study|Lost to Follow-up|16|||
48855990|NCT03005106|157310572|FG000|Overall Study|Adverse Event|1|||
48855991|NCT03005106|157310572|FG000|Overall Study|Physician Decision|1|||
48855992|NCT03005106|157310572|FG000|Overall Study|Death|2|||
48855993|NCT01218594|157310575|FG000|Overall Study|Death|1|||
48855994|NCT01218594|157310575|FG000|Overall Study|Withdrawal by Subject|3|||
48855995|NCT01218594|157310575|FG000|Overall Study|Adverse Event|2|||
48951501|NCT01544595|157653224|FG004|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
48951502|NCT01544595|157653225|FG005|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
48951503|NCT01544595|157653220|FG000|Status at Week 156|Withdrawal by Subject|9|||
48951504|NCT01544595|157653221|FG001|Status at Week 156|Withdrawal by Subject|10|||
48951505|NCT01544595|157653222|FG002|Status at Week 156|Withdrawal by Subject|4|||
48951506|NCT01544595|157653223|FG003|Status at Week 156|Withdrawal by Subject|9|||
48951507|NCT01544595|157653224|FG004|Status at Week 156|Withdrawal by Subject|20|||
48951508|NCT01544595|157653225|FG005|Status at Week 156|Withdrawal by Subject|6|||
48742692|NCT00036270|156908259|FG000|Randomized to Study Treatment|Withdrawal by Subject|6|||
48742693|NCT00036270|156908260|FG001|Randomized to Study Treatment|Withdrawal by Subject|7|||
48742694|NCT00036270|156908259|FG000|Study Treatment to 5 Year Report|Ongoing|1081|||
48951509|NCT01544595|157653220|FG000|Status at Week 156|Adverse Event|9|||
48951510|NCT01544595|157653221|FG001|Status at Week 156|Adverse Event|11|||
48951511|NCT01544595|157653222|FG002|Status at Week 156|Adverse Event|1|||
48951512|NCT01544595|157653223|FG003|Status at Week 156|Adverse Event|3|||
48951513|NCT01544595|157653224|FG004|Status at Week 156|Adverse Event|4|||
48951514|NCT01544595|157653225|FG005|Status at Week 156|Adverse Event|2|||
48742695|NCT00036270|156908260|FG001|Study Treatment to 5 Year Report|Ongoing|736|||
48742696|NCT00036270|156908259|FG000|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507|||
48855996|NCT01218594|157310575|FG000|Overall Study|Physician Decision|6|||
48855997|NCT03055988|157310577|FG000|Period 1|Adverse Event|0|||
48951515|NCT01544595|157653220|FG000|Status at Week 156|Lost to Follow-up|4|||
48951516|NCT01544595|157653221|FG001|Status at Week 156|Lost to Follow-up|4|||
48855998|NCT03055988|157310578|FG001|Period 1|Adverse Event|1|||
48855999|NCT03055988|157310577|FG000|Period 1|Lost to Follow-up|1|||
48856000|NCT03055988|157310578|FG001|Period 1|Lost to Follow-up|0|||
48742697|NCT00036270|156908260|FG001|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447|||
48742698|NCT00036270|156908259|FG000|Study Treatment to 5 Year Report|Adverse Event|501|||
48742699|NCT00036270|156908260|FG001|Study Treatment to 5 Year Report|Adverse Event|782|||
48742700|NCT00036270|156908259|FG000|Study Treatment to 5 Year Report|Other|277|||
48742701|NCT00036270|156908260|FG001|Study Treatment to 5 Year Report|Other|288|||
48742702|NCT00036270|156908259|FG000|Study Treatment to 5 Year Report|Treatment refusal|113|||
48742703|NCT00036270|156908260|FG001|Study Treatment to 5 Year Report|Treatment refusal|208|||
48742704|NCT00036270|156908259|FG000|Study Treatment to 5 Year Report|Randomized but not treated|46|||
48742705|NCT00036270|156908260|FG001|Study Treatment to 5 Year Report|Randomized but not treated|54|||
48742706|NCT00036270|156908259|FG000|Study Treatment to 5 Year Report|Protocol Violation|23|||
48742707|NCT00036270|156908260|FG001|Study Treatment to 5 Year Report|Protocol Violation|91|||
48742708|NCT00036270|156908259|FG000|Study Treatment to 5 Year Report|Intercurrent illness|17|||
48742709|NCT00036270|156908260|FG001|Study Treatment to 5 Year Report|Intercurrent illness|29|||
48742710|NCT00036270|156908259|FG000|Study Treatment to 5 Year Report|Too early switch|0|||
48742711|NCT00036270|156908260|FG001|Study Treatment to 5 Year Report|Too early switch|103|||
48742712|NCT00036270|156908259|FG000|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0|||
48742713|NCT00036270|156908260|FG001|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750|||
48742714|NCT01387932|156908261|FG000|Randomized and Treated|Physician Decision|3|||
48742715|NCT01387932|156908262|FG001|Randomized and Treated|Physician Decision|2|||
48742716|NCT01387932|156908261|FG000|Randomized and Treated|Withdrawal by Subject|4|||
48742717|NCT01387932|156908262|FG001|Randomized and Treated|Withdrawal by Subject|2|||
48742718|NCT01387932|156908261|FG000|Survival Follow-up|Liver Transplant|24|||
48742719|NCT01387932|156908262|FG001|Survival Follow-up|Liver Transplant|28|||
48742720|NCT01387932|156908261|FG000|Survival Follow-up|Additional treatment excluding liver transplant|52|||
48742721|NCT01387932|156908262|FG001|Survival Follow-up|Additional treatment excluding liver transplant|53|||
48742722|NCT01387932|156908261|FG000|Survival Follow-up|Withdrawal by Subject|2|||
48742723|NCT01387932|156908262|FG001|Survival Follow-up|Withdrawal by Subject|4|||
48742724|NCT01387932|156908261|FG000|Survival Follow-up|Lost to Follow-up|6|||
48742725|NCT01387932|156908262|FG001|Survival Follow-up|Lost to Follow-up|5|||
48742726|NCT01416272|156908263|FG000|Overall Study|Unacceptable distance visual acuity|2|||
48742727|NCT01416272|156908263|FG000|Overall Study|Lost to Follow-up|1|||
48742728|NCT01416272|156908263|FG000|Overall Study|Study related complaints|1|||
48742729|NCT02571075|156908264|FG000|Overall Study|Lost to Follow-up|20|||
48742730|NCT02571075|156908265|FG001|Overall Study|Lost to Follow-up|24|||
48742731|NCT02002091|156908266|FG000|Screening|Lost to Follow-up|10|||
48742732|NCT02002091|156908267|FG001|Screening|Lost to Follow-up|12|||
48742733|NCT02002091|156908266|FG000|Screening|Death|3|||
48742734|NCT02002091|156908267|FG001|Screening|Death|2|||
48742735|NCT05213481|156908268|FG000|Overall Study|Adverse Event|3|||
48742736|NCT05213481|156908268|FG000|Overall Study|Lost to Follow-up|1|||
48742737|NCT02217878|156908269|FG000|Overall Study|required morphine due to chest pain|1|||
48742738|NCT02217878|156908270|FG001|Overall Study|required morphine due to chest pain|2|||
48742739|NCT02217878|156908269|FG000|Overall Study|initial diagnosis of STEMI not confirmed|1|||
48742740|NCT02217878|156908270|FG001|Overall Study|initial diagnosis of STEMI not confirmed|0|||
48742741|NCT00003487|156908271|FG000|Overall Study|Not evaluable|2|||
48742742|NCT00334958|156908272|FG000|Overall Study|Medication Noncompliance|0|||
48742743|NCT00334958|156908273|FG001|Overall Study|Medication Noncompliance|3|||
48742744|NCT00334958|156908272|FG000|Overall Study|Protocol Violation|2|||
48742745|NCT00334958|156908273|FG001|Overall Study|Protocol Violation|2|||
48742746|NCT00334958|156908272|FG000|Overall Study|Request of the investigator or sponsor|0|||
48742747|NCT00334958|156908273|FG001|Overall Study|Request of the investigator or sponsor|1|||
48742748|NCT00334958|156908272|FG000|Overall Study|Withdrawal by Subject|7|||
48742749|NCT00334958|156908273|FG001|Overall Study|Withdrawal by Subject|4|||
48742750|NCT00334958|156908272|FG000|Overall Study|Adverse Event|27|||
48742751|NCT00334958|156908273|FG001|Overall Study|Adverse Event|12|||
48856001|NCT03055988|157310577|FG000|Period 1|Withdrawal by Subject|0|||
48856002|NCT03055988|157310578|FG001|Period 1|Withdrawal by Subject|4|||
48856003|NCT03055988|157310577|FG000|Period 2|Adverse Event|0|||
48856004|NCT03055988|157310578|FG001|Period 2|Adverse Event|1|||
48856005|NCT03055988|157310577|FG000|Period 2|Other than listed|1|||
48856006|NCT03055988|157310578|FG001|Period 2|Other than listed|1|||
48856007|NCT00428714|157310579|FG000|Overall Study|Progressive Disease|28|||
48856008|NCT00428714|157310580|FG001|Overall Study|Progressive Disease|36|||
48856009|NCT00428714|157310579|FG000|Overall Study|Withdrawal by Subject|0|||
48856010|NCT00428714|157310580|FG001|Overall Study|Withdrawal by Subject|3|||
48856011|NCT00428714|157310579|FG000|Overall Study|Adverse Event|0|||
48856012|NCT00428714|157310580|FG001|Overall Study|Adverse Event|2|||
48856013|NCT00428714|157310579|FG000|Overall Study|Physician Decision|1|||
48856014|NCT00428714|157310580|FG001|Overall Study|Physician Decision|1|||
48856015|NCT00428714|157310579|FG000|Overall Study|Death due to Progressive Disease (PD)|1|||
48856016|NCT00428714|157310580|FG001|Overall Study|Death due to Progressive Disease (PD)|0|||
48856017|NCT00428714|157310579|FG000|Overall Study|Death due to other then PD|1|||
48856018|NCT00428714|157310580|FG001|Overall Study|Death due to other then PD|0|||
48856019|NCT03547167|157310581|FG000|Overall Study|Withdrawal by Subject|34|||
48856020|NCT03547167|157310582|FG001|Overall Study|Withdrawal by Subject|12|||
48856021|NCT03547167|157310581|FG000|Overall Study|Screen Failure|0|||
48856022|NCT03547167|157310582|FG001|Overall Study|Screen Failure|1|||
48856023|NCT03547167|157310581|FG000|Overall Study|Lost to Follow-up|59|||
48856024|NCT03547167|157310582|FG001|Overall Study|Lost to Follow-up|15|||
48856025|NCT03547167|157310581|FG000|Overall Study|Death|4|||
48742752|NCT00334958|156908272|FG000|Overall Study|Other|1|||
48742753|NCT00334958|156908273|FG001|Overall Study|Other|2|||
48742754|NCT04431453|156908274|FG000|Overall Study|Withdrew Consent|0|||
48742755|NCT04431453|156908275|FG001|Overall Study|Withdrew Consent|1|||
48856026|NCT03547167|157310582|FG001|Overall Study|Death|2|||
48856027|NCT00736502|157310583|FG000|Overall Study|Adverse Event|22|||
48856028|NCT00736502|157310583|FG000|Overall Study|Lack of Efficacy|16|||
48742756|NCT04431453|156908276|FG002|Overall Study|Withdrew Consent|0|||
48742757|NCT04431453|156908277|FG003|Overall Study|Withdrew Consent|2|||
48742758|NCT04431453|156908278|FG004|Overall Study|Withdrew Consent|0|||
48742759|NCT04431453|156908279|FG005|Overall Study|Withdrew Consent|0|||
48856029|NCT00736502|157310583|FG000|Overall Study|Lost to Follow-up|27|||
48856030|NCT03820024|157310587|FG000|Overall Study|Physician Decision|1|||
48951517|NCT01544595|157653222|FG002|Status at Week 156|Lost to Follow-up|0|||
48951518|NCT01544595|157653223|FG003|Status at Week 156|Lost to Follow-up|1|||
48951519|NCT01544595|157653224|FG004|Status at Week 156|Lost to Follow-up|4|||
48951520|NCT01544595|157653225|FG005|Status at Week 156|Lost to Follow-up|1|||
48951521|NCT01544595|157653220|FG000|Status at Week 156|Non-compliance with study treatement|0|||
48951522|NCT01544595|157653221|FG001|Status at Week 156|Non-compliance with study treatement|1|||
48951523|NCT01544595|157653222|FG002|Status at Week 156|Non-compliance with study treatement|0|||
48951524|NCT01544595|157653223|FG003|Status at Week 156|Non-compliance with study treatement|1|||
48951525|NCT01544595|157653224|FG004|Status at Week 156|Non-compliance with study treatement|0|||
48951526|NCT01544595|157653225|FG005|Status at Week 156|Non-compliance with study treatement|1|||
48951527|NCT01544595|157653220|FG000|Status at Week 156|Physician Decision|0|||
48951528|NCT01544595|157653221|FG001|Status at Week 156|Physician Decision|3|||
48951529|NCT01544595|157653222|FG002|Status at Week 156|Physician Decision|1|||
48742760|NCT04431453|156908280|FG006|Overall Study|Withdrew Consent|0|||
48951530|NCT01544595|157653223|FG003|Status at Week 156|Physician Decision|0|||
48951531|NCT01544595|157653224|FG004|Status at Week 156|Physician Decision|0|||
48951532|NCT01544595|157653225|FG005|Status at Week 156|Physician Decision|0|||
48951533|NCT01544595|157653220|FG000|Status at Week 156|Pregnancy|2|||
48951534|NCT01544595|157653221|FG001|Status at Week 156|Pregnancy|3|||
48951535|NCT01544595|157653222|FG002|Status at Week 156|Pregnancy|0|||
48951536|NCT01544595|157653223|FG003|Status at Week 156|Pregnancy|0|||
48951537|NCT01544595|157653224|FG004|Status at Week 156|Pregnancy|0|||
48951538|NCT01544595|157653225|FG005|Status at Week 156|Pregnancy|0|||
48951539|NCT01544595|157653220|FG000|Status at Week 156|Protocol Violation|3|||
48951540|NCT01544595|157653221|FG001|Status at Week 156|Protocol Violation|1|||
48951541|NCT01544595|157653222|FG002|Status at Week 156|Protocol Violation|2|||
48951542|NCT01544595|157653223|FG003|Status at Week 156|Protocol Violation|2|||
48951543|NCT01544595|157653224|FG004|Status at Week 156|Protocol Violation|0|||
48951544|NCT01544595|157653225|FG005|Status at Week 156|Protocol Violation|0|||
48951545|NCT01544595|157653220|FG000|Status at Week 156|Technical problems|3|||
48951546|NCT01544595|157653221|FG001|Status at Week 156|Technical problems|1|||
48951547|NCT01544595|157653222|FG002|Status at Week 156|Technical problems|0|||
48951548|NCT01544595|157653223|FG003|Status at Week 156|Technical problems|1|||
48951549|NCT01544595|157653224|FG004|Status at Week 156|Technical problems|0|||
48951550|NCT01544595|157653225|FG005|Status at Week 156|Technical problems|0|||
48951551|NCT01544595|157653220|FG000|Status at Week 156|Moved to treatment period ≤ wk 156|86|||
48951552|NCT01544595|157653221|FG001|Status at Week 156|Moved to treatment period ≤ wk 156|44|||
48951553|NCT01544595|157653222|FG002|Status at Week 156|Moved to treatment period ≤ wk 156|131|||
48951554|NCT01544595|157653223|FG003|Status at Week 156|Moved to treatment period ≤ wk 156|145|||
48951555|NCT01544595|157653224|FG004|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
48742761|NCT04431453|156908281|FG007|Overall Study|Withdrew Consent|0|||
48951556|NCT01544595|157653225|FG005|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
48742762|NCT04431453|156908274|FG000|Overall Study|Death|1|||
48742763|NCT04431453|156908275|FG001|Overall Study|Death|0|||
48951557|NCT01544595|157653220|FG000|Status at Week 156|Lack of Efficacy|1|||
48951558|NCT01544595|157653221|FG001|Status at Week 156|Lack of Efficacy|0|||
48951559|NCT01544595|157653222|FG002|Status at Week 156|Lack of Efficacy|1|||
48742764|NCT04431453|156908276|FG002|Overall Study|Death|0|||
48742765|NCT04431453|156908277|FG003|Overall Study|Death|0|||
48951560|NCT01544595|157653223|FG003|Status at Week 156|Lack of Efficacy|4|||
48951561|NCT01544595|157653224|FG004|Status at Week 156|Lack of Efficacy|10|||
48951562|NCT01544595|157653225|FG005|Status at Week 156|Lack of Efficacy|5|||
48951563|NCT00365976|157653228|FG000|Overall Study|Withdrawal by Subject|1|||
48951564|NCT00365976|157653229|FG001|Overall Study|Withdrawal by Subject|5|||
48951565|NCT01345786|157653235|FG000|Overall Study|Adverse Event|0|||
48951566|NCT01345786|157653236|FG001|Overall Study|Adverse Event|1|||
48951567|NCT01345786|157653237|FG002|Overall Study|Adverse Event|3|||
48951568|NCT01345786|157653238|FG003|Overall Study|Adverse Event|1|||
48951569|NCT01345786|157653235|FG000|Overall Study|Subject withdrew consent|2|||
48951570|NCT01345786|157653236|FG001|Overall Study|Subject withdrew consent|2|||
48951571|NCT01345786|157653237|FG002|Overall Study|Subject withdrew consent|1|||
48951572|NCT01345786|157653238|FG003|Overall Study|Subject withdrew consent|0|||
48951573|NCT01345786|157653235|FG000|Overall Study|Noncompliance with protocol|1|||
48951574|NCT01345786|157653236|FG001|Overall Study|Noncompliance with protocol|0|||
48951575|NCT01345786|157653237|FG002|Overall Study|Noncompliance with protocol|1|||
48951576|NCT01345786|157653238|FG003|Overall Study|Noncompliance with protocol|0|||
48951577|NCT01345786|157653235|FG000|Overall Study|Administrative|3|||
48951578|NCT01345786|157653236|FG001|Overall Study|Administrative|5|||
48951579|NCT01345786|157653237|FG002|Overall Study|Administrative|0|||
48951580|NCT01345786|157653238|FG003|Overall Study|Administrative|0|||
48951581|NCT01345786|157653235|FG000|Overall Study|Lost to Follow-up|0|||
48951582|NCT01345786|157653236|FG001|Overall Study|Lost to Follow-up|0|||
48951583|NCT01345786|157653237|FG002|Overall Study|Lost to Follow-up|0|||
48951584|NCT01345786|157653238|FG003|Overall Study|Lost to Follow-up|2|||
48951585|NCT01327339|157653239|FG000|Overall Study|Protocol Violation|8|||
48951586|NCT01629667|157653240|FG000|Overall Study|Lost to Follow-up|0|||
48951587|NCT01629667|157653241|FG001|Overall Study|Lost to Follow-up|1|||
48951588|NCT01629667|157653242|FG002|Overall Study|Lost to Follow-up|1|||
48951589|NCT01629667|157653240|FG000|Overall Study|Withdrawal by Subject|31|||
48951590|NCT01629667|157653241|FG001|Overall Study|Withdrawal by Subject|20|||
48951591|NCT01629667|157653242|FG002|Overall Study|Withdrawal by Subject|28|||
48951592|NCT01629667|157653240|FG000|Overall Study|Death|1|||
48951593|NCT01629667|157653241|FG001|Overall Study|Death|5|||
48951594|NCT01629667|157653242|FG002|Overall Study|Death|3|||
48951595|NCT01629667|157653240|FG000|Overall Study|Randomized, not treated|2|||
48951596|NCT01629667|157653241|FG001|Overall Study|Randomized, not treated|1|||
48951597|NCT01629667|157653242|FG002|Overall Study|Randomized, not treated|0|||
48951598|NCT01629667|157653240|FG000|Overall Study|Ongoing AE worsening right heart failure|0|||
48951599|NCT01629667|157653241|FG001|Overall Study|Ongoing AE worsening right heart failure|1|||
48742766|NCT04431453|156908278|FG004|Overall Study|Death|0|||
48951600|NCT01629667|157653242|FG002|Overall Study|Ongoing AE worsening right heart failure|0|||
48951601|NCT01629667|157653240|FG000|Overall Study|Requiring lung transplant|2|||
48951602|NCT01629667|157653241|FG001|Overall Study|Requiring lung transplant|1|||
48951603|NCT01629667|157653242|FG002|Overall Study|Requiring lung transplant|3|||
48951604|NCT01629667|157653240|FG000|Overall Study|Early tretmt termntd, cmpltd safety f-up|9|||
48951605|NCT01629667|157653241|FG001|Overall Study|Early tretmt termntd, cmpltd safety f-up|11|||
48951606|NCT01629667|157653242|FG002|Overall Study|Early tretmt termntd, cmpltd safety f-up|8|||
48951607|NCT01629667|157653240|FG000|Overall Study|Started other medicine|1|||
48951608|NCT01629667|157653241|FG001|Overall Study|Started other medicine|0|||
48951609|NCT01629667|157653242|FG002|Overall Study|Started other medicine|1|||
48951610|NCT01629667|157653240|FG000|Overall Study|Site error in safety follow-up|0|||
48951611|NCT01629667|157653241|FG001|Overall Study|Site error in safety follow-up|0|||
48951612|NCT01629667|157653242|FG002|Overall Study|Site error in safety follow-up|1|||
48951613|NCT01629667|157653240|FG000|Overall Study|Enrolled in another clinical study|0|||
48951614|NCT01629667|157653241|FG001|Overall Study|Enrolled in another clinical study|1|||
48951615|NCT01629667|157653242|FG002|Overall Study|Enrolled in another clinical study|0|||
48951616|NCT01629667|157653240|FG000|Overall Study|Code break|1|||
48951617|NCT01629667|157653241|FG001|Overall Study|Code break|0|||
48951618|NCT01629667|157653242|FG002|Overall Study|Code break|0|||
48951619|NCT01929044|157653247|FG000|Overall Study|Adverse Event|1|||
48951620|NCT01929044|157653248|FG001|Overall Study|Adverse Event|0|||
48951621|NCT01929044|157653247|FG000|Overall Study|Protocol Violation|9|||
48951622|NCT01929044|157653248|FG001|Overall Study|Protocol Violation|14|||
48951623|NCT01929044|157653247|FG000|Overall Study|Not Treated|1|||
48951624|NCT01929044|157653248|FG001|Overall Study|Not Treated|3|||
48951625|NCT00091390|157653253|FG000|Overall Study|Protocol Violation|1|||
48951626|NCT00091390|157653253|FG000|Overall Study|No protocol treatment|3|||
48951627|NCT01555463|157653256|FG000|Treatment|Adverse Event|6|||
48951628|NCT01555463|157653257|FG001|Treatment|Adverse Event|12|||
48951629|NCT01555463|157653256|FG000|Treatment|Withdrawal by Subject|24|||
48951630|NCT01555463|157653257|FG001|Treatment|Withdrawal by Subject|36|||
48951631|NCT01555463|157653256|FG000|Treatment|Lost to Follow-up|28|||
48951632|NCT01555463|157653257|FG001|Treatment|Lost to Follow-up|23|||
48951633|NCT01555463|157653256|FG000|Treatment|Protocol Violation|4|||
48951634|NCT01555463|157653257|FG001|Treatment|Protocol Violation|5|||
48951635|NCT01555463|157653256|FG000|Treatment|Other reason|2|||
48951636|NCT01555463|157653257|FG001|Treatment|Other reason|3|||
48951637|NCT01555463|157653256|FG000|Follow up|Adverse Event|2|||
48951638|NCT01555463|157653257|FG001|Follow up|Adverse Event|5|||
48951639|NCT01555463|157653256|FG000|Follow up|Death|0|||
48951640|NCT01555463|157653257|FG001|Follow up|Death|1|||
48951641|NCT01555463|157653256|FG000|Follow up|Withdrawal by Subject|22|||
48951642|NCT01555463|157653257|FG001|Follow up|Withdrawal by Subject|22|||
48951643|NCT01555463|157653256|FG000|Follow up|Lost to Follow-up|9|||
48951644|NCT01555463|157653257|FG001|Follow up|Lost to Follow-up|10|||
48951645|NCT01555463|157653256|FG000|Follow up|Protocol Violation|2|||
48951646|NCT01555463|157653257|FG001|Follow up|Protocol Violation|4|||
48951647|NCT01555463|157653256|FG000|Follow up|Other reason|3|||
48951648|NCT01555463|157653257|FG001|Follow up|Other reason|3|||
48951649|NCT02084134|157653258|FG000|Overall Study|Protocol Violation|4|||
48951650|NCT02084134|157653259|FG001|Overall Study|Protocol Violation|2|||
48951651|NCT02084134|157653258|FG000|Overall Study|Death|0|||
48951652|NCT02084134|157653259|FG001|Overall Study|Death|1|||
48951653|NCT02399475|157653262|FG000|Overall Study|Physician Decision|1|||
48951654|NCT02399475|157653263|FG001|Overall Study|Physician Decision|0|||
48951655|NCT02260193|157653264|FG000|Overall Study|Lack of Efficacy|0|||
48951656|NCT02260193|157653265|FG001|Overall Study|Lack of Efficacy|1|||
48951657|NCT02260193|157653266|FG002|Overall Study|Lack of Efficacy|6|||
48951658|NCT02260193|157653264|FG000|Overall Study|Adverse Event|3|||
48951659|NCT02260193|157653265|FG001|Overall Study|Adverse Event|4|||
48951660|NCT02260193|157653266|FG002|Overall Study|Adverse Event|1|||
48951661|NCT02260193|157653264|FG000|Overall Study|Protocol Violation|0|||
48951662|NCT02260193|157653265|FG001|Overall Study|Protocol Violation|4|||
48951663|NCT02260193|157653266|FG002|Overall Study|Protocol Violation|0|||
48951664|NCT02260193|157653264|FG000|Overall Study|Withdrawal by Subject|3|||
48951665|NCT02260193|157653265|FG001|Overall Study|Withdrawal by Subject|0|||
48951666|NCT02260193|157653266|FG002|Overall Study|Withdrawal by Subject|2|||
48951667|NCT02260193|157653264|FG000|Overall Study|Kidney Transplantation|0|||
48951668|NCT02260193|157653265|FG001|Overall Study|Kidney Transplantation|0|||
48951669|NCT02260193|157653266|FG002|Overall Study|Kidney Transplantation|1|||
48951670|NCT02807454|157653267|FG000|Overall Study|Adverse Event|1|||
48951671|NCT02807454|157653268|FG001|Overall Study|Adverse Event|0|||
48951672|NCT02807454|157653267|FG000|Overall Study|Withdrawal by Subject|0|||
48951673|NCT02807454|157653268|FG001|Overall Study|Withdrawal by Subject|1|||
48951674|NCT02807454|157653267|FG000|Overall Study|Progressive Disease|30|||
48951675|NCT02807454|157653268|FG001|Overall Study|Progressive Disease|3|||
48951676|NCT02807454|157653267|FG000|Overall Study|Other Reasons|1|||
48951677|NCT02807454|157653268|FG001|Overall Study|Other Reasons|1|||
48951678|NCT05468086|157653271|FG000|Overall Study|Withdrawal by Subject|3|||
48951679|NCT05468086|157653271|FG000|Overall Study|Subject was found ineligible after consent|1|||
48951680|NCT00320385|157653272|FG000|Overall Study|Lost to Follow-up|7|||
48951681|NCT00320385|157653273|FG001|Overall Study|Lost to Follow-up|10|||
48951682|NCT00320385|157653272|FG000|Overall Study|Withdrawal by Subject|6|||
48951683|NCT00320385|157653273|FG001|Overall Study|Withdrawal by Subject|7|||
48951684|NCT00320385|157653272|FG000|Overall Study|Sponsor Terminated Study|2|||
48951685|NCT00320385|157653273|FG001|Overall Study|Sponsor Terminated Study|1|||
48951686|NCT00320385|157653272|FG000|Overall Study|Investigator Decision|0|||
48951687|NCT00320385|157653273|FG001|Overall Study|Investigator Decision|1|||
48951688|NCT00320385|157653272|FG000|Overall Study|Death|1|||
48951689|NCT00320385|157653273|FG001|Overall Study|Death|2|||
48951690|NCT00320385|157653272|FG000|Overall Study|Serious Adverse Event|1|||
48951691|NCT00320385|157653273|FG001|Overall Study|Serious Adverse Event|0|||
48951692|NCT00320385|157653272|FG000|Overall Study|Withdrew Consent|1|||
48951693|NCT00320385|157653273|FG001|Overall Study|Withdrew Consent|0|||
48951694|NCT00320385|157653272|FG000|Overall Study|Adverse Event|0|||
48951695|NCT00320385|157653273|FG001|Overall Study|Adverse Event|1|||
48951696|NCT00589472|157653282|FG000|Overall Study|Adverse Event|1|||
48951697|NCT01454401|157653283|FG000|Overall Study|Death|1|||
48951698|NCT01454401|157653283|FG000|Overall Study|hospitalised|1|||
48951699|NCT01454401|157653283|FG000|Overall Study|osteomyelitis|2|||
48951700|NCT01454401|157653283|FG000|Overall Study|non-adherence|1|||
48951701|NCT03268746|157653284|FG000|Overall Study|Withdrawal by Subject|1|||
48951702|NCT00637273|157653285|FG000|Overall Study|Adverse Event|11|||
48951703|NCT00637273|157653286|FG001|Overall Study|Adverse Event|5|||
48951704|NCT00637273|157653287|FG002|Overall Study|Adverse Event|7|||
48951705|NCT00637273|157653285|FG000|Overall Study|Lost to Follow-up|8|||
48951706|NCT00637273|157653286|FG001|Overall Study|Lost to Follow-up|9|||
48951707|NCT00637273|157653287|FG002|Overall Study|Lost to Follow-up|13|||
48951708|NCT00637273|157653285|FG000|Overall Study|Protocol Violation|2|||
48951709|NCT00637273|157653286|FG001|Overall Study|Protocol Violation|4|||
48951710|NCT00637273|157653287|FG002|Overall Study|Protocol Violation|1|||
48951711|NCT00637273|157653285|FG000|Overall Study|Withdrawal of Consent|18|||
48951712|NCT00637273|157653286|FG001|Overall Study|Withdrawal of Consent|6|||
48951713|NCT00637273|157653287|FG002|Overall Study|Withdrawal of Consent|18|||
48951714|NCT00637273|157653285|FG000|Overall Study|Investigator Decision|1|||
48951715|NCT00637273|157653286|FG001|Overall Study|Investigator Decision|3|||
48951716|NCT00637273|157653287|FG002|Overall Study|Investigator Decision|1|||
48951717|NCT00637273|157653285|FG000|Overall Study|Administrative|2|||
48951718|NCT00637273|157653286|FG001|Overall Study|Administrative|0|||
48951719|NCT00637273|157653287|FG002|Overall Study|Administrative|0|||
48951720|NCT00637273|157653285|FG000|Overall Study|Loss of Glucose Control|1|||
48951721|NCT00637273|157653286|FG001|Overall Study|Loss of Glucose Control|1|||
48951722|NCT00637273|157653287|FG002|Overall Study|Loss of Glucose Control|1|||
48951723|NCT01915849|157653290|FG000|Treatment Period 1 (4 Days)|Protocol Violation|1|||
48951724|NCT01915849|157653291|FG001|Treatment Period 1 (4 Days)|Protocol Violation|0|||
48951725|NCT01915849|157653292|FG002|Treatment Period 1 (4 Days)|Protocol Violation|0|||
48951726|NCT01915849|157653293|FG003|Treatment Period 1 (4 Days)|Protocol Violation|0|||
48951727|NCT01915849|157653290|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
48951728|NCT01915849|157653291|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
48951729|NCT01915849|157653292|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
48951730|NCT01915849|157653293|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
48951731|NCT01000064|157653294|FG000|Overall Study|Withdrawal by Subject|1|||
48951732|NCT01000064|157653295|FG001|Overall Study|Withdrawal by Subject|1|||
48951733|NCT01678807|157653296|FG000|Overall Study|Adverse Event|4|||
48951734|NCT01678807|157653297|FG001|Overall Study|Adverse Event|4|||
48951735|NCT01678807|157653298|FG002|Overall Study|Adverse Event|0|||
48742767|NCT04431453|156908279|FG005|Overall Study|Death|0|||
48742768|NCT04431453|156908280|FG006|Overall Study|Death|0|||
48742769|NCT04431453|156908281|FG007|Overall Study|Death|1|||
48742770|NCT04431453|156908274|FG000|Overall Study|Lost to Follow-up|0|||
48742771|NCT04431453|156908275|FG001|Overall Study|Lost to Follow-up|0|||
48951736|NCT01678807|157653296|FG000|Overall Study|Withdrawn by Parent/Guardian|0|||
48951737|NCT01678807|157653297|FG001|Overall Study|Withdrawn by Parent/Guardian|1|||
48742772|NCT04431453|156908276|FG002|Overall Study|Lost to Follow-up|1|||
48742773|NCT04431453|156908277|FG003|Overall Study|Lost to Follow-up|1|||
48951738|NCT01678807|157653298|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
48951739|NCT01259492|157654894|FG000|Period 1 (9 Weeks)|Adverse Event|13|||
48951740|NCT01259492|157654895|FG001|Period 1 (9 Weeks)|Adverse Event|18|||
48951741|NCT01259492|157654896|FG002|Period 1 (9 Weeks)|Adverse Event|26|||
48856031|NCT03820024|157310588|FG001|Overall Study|Physician Decision|2|||
48856032|NCT02255474|157310589|FG000|Overall Study|Lost to Follow-up|1|||
48856033|NCT02255474|157310590|FG001|Overall Study|Lost to Follow-up|1|||
48856034|NCT02255474|157310591|FG002|Overall Study|Lost to Follow-up|3|||
48856035|NCT02255474|157310589|FG000|Overall Study|Withdrawal by Subject|1|||
48856036|NCT02255474|157310590|FG001|Overall Study|Withdrawal by Subject|1|||
48856037|NCT02255474|157310591|FG002|Overall Study|Withdrawal by Subject|0|||
48856038|NCT02372799|157312734|FG000|Treatment Period|Adverse Event|3|||
48856039|NCT02372799|157312735|FG001|Treatment Period|Adverse Event|10|||
48856040|NCT02372799|157312736|FG002|Treatment Period|Adverse Event|6|||
48856041|NCT02372799|157312734|FG000|Treatment Period|Insufficient therapeutic response|2|||
48856042|NCT02372799|157312735|FG001|Treatment Period|Insufficient therapeutic response|2|||
48856043|NCT02372799|157312736|FG002|Treatment Period|Insufficient therapeutic response|0|||
48856044|NCT02372799|157312734|FG000|Treatment Period|Withdrawal by Subject|10|||
48856045|NCT02372799|157312735|FG001|Treatment Period|Withdrawal by Subject|10|||
48856046|NCT02372799|157312736|FG002|Treatment Period|Withdrawal by Subject|2|||
48856047|NCT02372799|157312734|FG000|Treatment Period|Lost to Follow-up|11|||
48856048|NCT02372799|157312735|FG001|Treatment Period|Lost to Follow-up|5|||
48856049|NCT02372799|157312736|FG002|Treatment Period|Lost to Follow-up|3|||
48742774|NCT04431453|156908278|FG004|Overall Study|Lost to Follow-up|0|||
48856050|NCT02372799|157312734|FG000|Treatment Period|Protocol Violation|3|||
48856051|NCT02372799|157312735|FG001|Treatment Period|Protocol Violation|0|||
48856052|NCT02372799|157312736|FG002|Treatment Period|Protocol Violation|0|||
48856053|NCT02372799|157312734|FG000|Treatment Period|Non-compliance with study drug|4|||
48856054|NCT02372799|157312735|FG001|Treatment Period|Non-compliance with study drug|4|||
48856055|NCT02372799|157312736|FG002|Treatment Period|Non-compliance with study drug|4|||
48856056|NCT02372799|157312734|FG000|Treatment Period|Miscellaneous Reasons|1|||
48856057|NCT02372799|157312735|FG001|Treatment Period|Miscellaneous Reasons|1|||
48856058|NCT02372799|157312736|FG002|Treatment Period|Miscellaneous Reasons|0|||
48856059|NCT02372799|157312734|FG000|Down-taper Period|Lost to Follow-up|1|||
48856060|NCT02372799|157312735|FG001|Down-taper Period|Lost to Follow-up|2|||
48856061|NCT02372799|157312736|FG002|Down-taper Period|Lost to Follow-up|2|||
48856062|NCT01190124|157312737|FG000|Overall Study|Death|3|||
48856063|NCT01190124|157312738|FG001|Overall Study|Death|0|||
48856064|NCT01190124|157312739|FG002|Overall Study|Death|0|||
48856065|NCT01190124|157312737|FG000|Overall Study|Therapeutic Failure|12|||
48856066|NCT01190124|157312738|FG001|Overall Study|Therapeutic Failure|0|||
48856067|NCT01190124|157312739|FG002|Overall Study|Therapeutic Failure|1|||
48856068|NCT01190124|157312737|FG000|Overall Study|Lost to Follow-up|2|||
48856069|NCT01190124|157312738|FG001|Overall Study|Lost to Follow-up|0|||
48856070|NCT01190124|157312739|FG002|Overall Study|Lost to Follow-up|0|||
48856071|NCT00491400|157312740|FG000|Overall Study|Withdrawal by Subject|5|||
48856072|NCT00491400|157312741|FG001|Overall Study|Withdrawal by Subject|4|||
48856073|NCT02338999|157312746|FG000|First Intervention|Withdrawal by Subject|3|||
48856074|NCT02338999|157312747|FG001|First Intervention|Withdrawal by Subject|1|||
48856075|NCT02338999|157312746|FG000|Washout Period|Withdrawal by Subject|0|||
48856076|NCT02338999|157312747|FG001|Washout Period|Withdrawal by Subject|2|||
48856077|NCT02338999|157312746|FG000|Second Intervention|Withdrawal by Subject|0|||
48856078|NCT02338999|157312747|FG001|Second Intervention|Withdrawal by Subject|2|||
48856079|NCT01256359|157312748|FG000|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
48742775|NCT04431453|156908279|FG005|Overall Study|Lost to Follow-up|0|||
48856080|NCT01256359|157312749|FG001|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
48856588|NCT01930188|157312882|FG001|Overall Study|Missing follow-up information|2|||
48856081|NCT01256359|157312748|FG000|Overall Study|Randomised and found to be too unwell to start treatment|2|||
48856082|NCT01256359|157312749|FG001|Overall Study|Randomised and found to be too unwell to start treatment|0|||
48856083|NCT03960645|157312750|FG000|Overall Study|Protocol Violation|1|||
48856084|NCT03960645|157312751|FG001|Overall Study|Protocol Violation|0|||
48856085|NCT02000752|157312752|FG000|Overall Study|Dystocic delivery|19|||
48856086|NCT02000752|157312753|FG001|Overall Study|Dystocic delivery|8|||
48856087|NCT02000752|157312752|FG000|Overall Study|Shift Changes|12|||
48856088|NCT02000752|157312753|FG001|Overall Study|Shift Changes|5|||
48856089|NCT03737110|157312754|FG000|Run-in (RI) Period|Lack of Efficacy|3|||
48856090|NCT03737110|157312755|FG001|Run-in (RI) Period|Lack of Efficacy|0|||
48856091|NCT03737110|157312756|FG002|Run-in (RI) Period|Lack of Efficacy|0|||
48951742|NCT01259492|157654897|FG003|Period 1 (9 Weeks)|Adverse Event|3|||
48856092|NCT03737110|157312757|FG003|Run-in (RI) Period|Lack of Efficacy|0|||
48856093|NCT03737110|157312758|FG004|Run-in (RI) Period|Lack of Efficacy|0|||
48856094|NCT03737110|157312759|FG005|Run-in (RI) Period|Lack of Efficacy|0|||
48856095|NCT03737110|157312754|FG000|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3|||
48742776|NCT04431453|156908280|FG006|Overall Study|Lost to Follow-up|0|||
48742777|NCT04431453|156908281|FG007|Overall Study|Lost to Follow-up|0|||
48742778|NCT04431453|156908274|FG000|Overall Study|Enrolled but Never Treated|0|||
48742779|NCT04431453|156908275|FG001|Overall Study|Enrolled but Never Treated|0|||
48742780|NCT04431453|156908276|FG002|Overall Study|Enrolled but Never Treated|0|||
48742781|NCT04431453|156908277|FG003|Overall Study|Enrolled but Never Treated|0|||
48742782|NCT04431453|156908278|FG004|Overall Study|Enrolled but Never Treated|1|||
48742783|NCT04431453|156908279|FG005|Overall Study|Enrolled but Never Treated|0|||
48856096|NCT03737110|157312755|FG001|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
48856097|NCT03737110|157312756|FG002|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
48742784|NCT04431453|156908280|FG006|Overall Study|Enrolled but Never Treated|0|||
48856098|NCT03737110|157312757|FG003|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
48856099|NCT03737110|157312758|FG004|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
48856100|NCT03737110|157312759|FG005|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
48856101|NCT03737110|157312754|FG000|Run-in (RI) Period|Adverse Event|4|||
48856102|NCT03737110|157312755|FG001|Run-in (RI) Period|Adverse Event|0|||
48856103|NCT03737110|157312756|FG002|Run-in (RI) Period|Adverse Event|0|||
48856104|NCT03737110|157312757|FG003|Run-in (RI) Period|Adverse Event|0|||
48856105|NCT03737110|157312758|FG004|Run-in (RI) Period|Adverse Event|0|||
48856106|NCT03737110|157312759|FG005|Run-in (RI) Period|Adverse Event|0|||
48856107|NCT03737110|157312754|FG000|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
48856108|NCT03737110|157312755|FG001|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1|||
48856109|NCT03737110|157312756|FG002|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
48856110|NCT03737110|157312757|FG003|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
48856111|NCT03737110|157312758|FG004|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
48742785|NCT04431453|156908281|FG007|Overall Study|Enrolled but Never Treated|0|||
48742786|NCT00622401|156908282|FG000|Overall Study|Disease progression prior to treatment|3|||
48742787|NCT00622401|156908283|FG001|Overall Study|Disease progression prior to treatment|2|||
48742788|NCT00622401|156908284|FG002|Overall Study|Disease progression prior to treatment|0|||
48742789|NCT03087643|156908285|FG000|Overall Study|Withdrawal by Subject|2|||
48742790|NCT03087643|156908286|FG001|Overall Study|Withdrawal by Subject|4|||
48742791|NCT03087643|156908285|FG000|Overall Study|Death|2|||
48742792|NCT03087643|156908286|FG001|Overall Study|Death|2|||
48742793|NCT01449539|156908289|FG000|Overall Study|Withdrawal by Subject|3|||
48742794|NCT01449539|156908289|FG000|Overall Study|Toxicity not study related|1|||
48742795|NCT00957580|156908294|FG000|Overall Study|Ongoing at data cut-off|0|||
48742796|NCT00957580|156908295|FG001|Overall Study|Ongoing at data cut-off|1|||
48742797|NCT00957580|156908296|FG002|Overall Study|Ongoing at data cut-off|0|||
48951743|NCT01259492|157654894|FG000|Period 1 (9 Weeks)|Lack of Efficacy|2|||
48951744|NCT01259492|157654895|FG001|Period 1 (9 Weeks)|Lack of Efficacy|2|||
48951745|NCT01259492|157654896|FG002|Period 1 (9 Weeks)|Lack of Efficacy|4|||
48951746|NCT01259492|157654897|FG003|Period 1 (9 Weeks)|Lack of Efficacy|11|||
48951747|NCT01259492|157654894|FG000|Period 1 (9 Weeks)|Withdrawal by Subject|5|||
48951748|NCT01259492|157654895|FG001|Period 1 (9 Weeks)|Withdrawal by Subject|8|||
48951749|NCT01259492|157654896|FG002|Period 1 (9 Weeks)|Withdrawal by Subject|6|||
48951750|NCT01259492|157654897|FG003|Period 1 (9 Weeks)|Withdrawal by Subject|7|||
48951751|NCT01259492|157654894|FG000|Period 1 (9 Weeks)|Lost to Follow-up|4|||
48951752|NCT01259492|157654895|FG001|Period 1 (9 Weeks)|Lost to Follow-up|6|||
48951753|NCT01259492|157654896|FG002|Period 1 (9 Weeks)|Lost to Follow-up|3|||
48951754|NCT01259492|157654897|FG003|Period 1 (9 Weeks)|Lost to Follow-up|4|||
48951755|NCT01259492|157654894|FG000|Period 1 (9 Weeks)|Administrative Problems|0|||
48951756|NCT01259492|157654895|FG001|Period 1 (9 Weeks)|Administrative Problems|1|||
48951757|NCT01259492|157654896|FG002|Period 1 (9 Weeks)|Administrative Problems|1|||
48951758|NCT01259492|157654897|FG003|Period 1 (9 Weeks)|Administrative Problems|2|||
48951759|NCT01259492|157654894|FG000|Period 1 (9 Weeks)|Protocol Violation|5|||
48951760|NCT01259492|157654895|FG001|Period 1 (9 Weeks)|Protocol Violation|6|||
48951761|NCT01259492|157654896|FG002|Period 1 (9 Weeks)|Protocol Violation|3|||
48951762|NCT01259492|157654897|FG003|Period 1 (9 Weeks)|Protocol Violation|1|||
48951763|NCT01259492|157654894|FG000|Period 2 (Week 10 to Week 14)|Adverse Event|3|||
48951764|NCT01259492|157654895|FG001|Period 2 (Week 10 to Week 14)|Adverse Event|4|||
48951765|NCT01259492|157654896|FG002|Period 2 (Week 10 to Week 14)|Adverse Event|7|||
48951766|NCT01259492|157654897|FG003|Period 2 (Week 10 to Week 14)|Adverse Event|8|||
48951767|NCT01259492|157654894|FG000|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
48742798|NCT00957580|156908294|FG000|Overall Study|Enrolled but not treated|0|||
48742799|NCT00957580|156908295|FG001|Overall Study|Enrolled but not treated|1|||
48742800|NCT00957580|156908296|FG002|Overall Study|Enrolled but not treated|0|||
48742801|NCT00799422|156908297|FG000|First Week of Wear|Lost to Follow-up|0|||
48742802|NCT00799422|156908298|FG001|First Week of Wear|Lost to Follow-up|0|||
48742803|NCT00799422|156908299|FG002|First Week of Wear|Lost to Follow-up|1|||
48951768|NCT01259492|157654895|FG001|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
48951769|NCT01259492|157654896|FG002|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
48951770|NCT01259492|157654897|FG003|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
48951771|NCT01259492|157654894|FG000|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6|||
48856112|NCT03737110|157312759|FG005|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
48856113|NCT03737110|157312754|FG000|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
48856114|NCT03737110|157312755|FG001|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
48856115|NCT03737110|157312756|FG002|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
48856116|NCT03737110|157312757|FG003|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
48856117|NCT03737110|157312758|FG004|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
48856118|NCT03737110|157312759|FG005|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
48856119|NCT03737110|157312754|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
48856120|NCT03737110|157312755|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
48856121|NCT03737110|157312756|FG002|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
48856122|NCT03737110|157312757|FG003|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
48856123|NCT03737110|157312758|FG004|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
48856124|NCT03737110|157312759|FG005|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
48856125|NCT03737110|157312754|FG000|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
48856126|NCT03737110|157312755|FG001|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
48742804|NCT00799422|156908300|FG003|First Week of Wear|Lost to Follow-up|0|||
48742805|NCT00799422|156908301|FG004|First Week of Wear|Lost to Follow-up|0|||
48742806|NCT00799422|156908302|FG005|First Week of Wear|Lost to Follow-up|0|||
48742807|NCT00799422|156908297|FG000|First Week of Wear|Adverse Event|0|||
48742808|NCT00799422|156908298|FG001|First Week of Wear|Adverse Event|0|||
48742809|NCT00799422|156908299|FG002|First Week of Wear|Adverse Event|0|||
48856127|NCT03737110|157312756|FG002|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
48856128|NCT03737110|157312757|FG003|Long-Term Extension (LTE) Period|Withdrawal by Subject|1|||
48856129|NCT03737110|157312758|FG004|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
48856130|NCT03737110|157312759|FG005|Long-Term Extension (LTE) Period|Withdrawal by Subject|2|||
48856131|NCT03737110|157312754|FG000|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
48856132|NCT03737110|157312755|FG001|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
48856133|NCT03737110|157312756|FG002|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
48856134|NCT03737110|157312757|FG003|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
48856135|NCT03737110|157312758|FG004|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|1|||
48856136|NCT03737110|157312759|FG005|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
48856137|NCT01536704|157312764|FG000|Washout Period 1|Withdrawal by Subject|1|||
48856138|NCT01536704|157312765|FG001|Washout Period 1|Withdrawal by Subject|2|||
48856139|NCT01536704|157312766|FG002|Washout Period 1|Withdrawal by Subject|0|||
48856140|NCT01536704|157312767|FG003|Washout Period 1|Withdrawal by Subject|0|||
48856141|NCT01536704|157312764|FG000|Washout Period 2|Adverse Event|1|||
48856142|NCT01536704|157312765|FG001|Washout Period 2|Adverse Event|0|||
48856143|NCT01536704|157312766|FG002|Washout Period 2|Adverse Event|0|||
48856144|NCT01536704|157312767|FG003|Washout Period 2|Adverse Event|0|||
48856145|NCT01536704|157312764|FG000|Washout Period 2|Withdrawal by Subject|0|||
48856146|NCT01536704|157312765|FG001|Washout Period 2|Withdrawal by Subject|0|||
48856147|NCT01536704|157312766|FG002|Washout Period 2|Withdrawal by Subject|0|||
48856148|NCT01536704|157312767|FG003|Washout Period 2|Withdrawal by Subject|1|||
48856149|NCT01536704|157312764|FG000|Period 3|Adverse Event|0|||
48856150|NCT01536704|157312765|FG001|Period 3|Adverse Event|0|||
48856151|NCT01536704|157312766|FG002|Period 3|Adverse Event|0|||
48856152|NCT01536704|157312767|FG003|Period 3|Adverse Event|1|||
48856153|NCT01536704|157312764|FG000|Washout Period 3|Adverse Event|0|||
48856154|NCT01536704|157312765|FG001|Washout Period 3|Adverse Event|0|||
48856155|NCT01536704|157312766|FG002|Washout Period 3|Adverse Event|1|||
48856156|NCT01536704|157312767|FG003|Washout Period 3|Adverse Event|0|||
48856157|NCT00047385|157312769|FG000|Overall Study|Death before any screening|2|||
48856158|NCT00047385|157312770|FG001|Overall Study|Death before any screening|5|||
48856159|NCT00047385|157312769|FG000|Overall Study|Lung Cancer diagnosed before screening|5|||
48856160|NCT00047385|157312770|FG001|Overall Study|Lung Cancer diagnosed before screening|3|||
48856161|NCT00047385|157312769|FG000|Overall Study|Eligible for screening but had no screen|260|||
48856162|NCT00047385|157312770|FG001|Overall Study|Eligible for screening but had no screen|492|||
48856163|NCT01286311|157312771|FG000|Overall Study|Physician did not want outreach sent|14|||
48856164|NCT01286311|157312772|FG001|Overall Study|Physician did not want outreach sent|0|||
48856165|NCT01019135|157312775|FG000|Overall Study|Did not receive allocated intervention|12|||
48742810|NCT00799422|156908300|FG003|First Week of Wear|Adverse Event|1|||
48742811|NCT00799422|156908301|FG004|First Week of Wear|Adverse Event|0|||
48742812|NCT00799422|156908302|FG005|First Week of Wear|Adverse Event|0|||
48856166|NCT01019135|157312776|FG001|Overall Study|Did not receive allocated intervention|6|||
48856167|NCT01019135|157312777|FG002|Overall Study|Did not receive allocated intervention|25|||
48856168|NCT01019135|157312775|FG000|Overall Study|Did not attend CR|8|||
48951772|NCT01259492|157654895|FG001|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2|||
48951773|NCT01259492|157654896|FG002|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8|||
48951774|NCT01259492|157654897|FG003|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4|||
48951775|NCT01259492|157654894|FG000|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
48856169|NCT01019135|157312776|FG001|Overall Study|Did not attend CR|13|||
48951776|NCT01259492|157654895|FG001|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
48742813|NCT02151110|156908303|FG000|Overall Study|Withdrawal by Subject|0|||
48742814|NCT02151110|156908304|FG001|Overall Study|Withdrawal by Subject|0|||
48742815|NCT02151110|156908305|FG002|Overall Study|Withdrawal by Subject|0|||
48742816|NCT02151110|156908306|FG003|Overall Study|Withdrawal by Subject|0|||
48742817|NCT02151110|156908307|FG004|Overall Study|Withdrawal by Subject|0|||
48742818|NCT02151110|156908308|FG005|Overall Study|Withdrawal by Subject|0|||
48742819|NCT02151110|156908309|FG006|Overall Study|Withdrawal by Subject|0|||
48742820|NCT02151110|156908310|FG007|Overall Study|Withdrawal by Subject|1|||
48742821|NCT02151110|156908303|FG000|Overall Study|Lost to Follow-up|0|||
48742822|NCT02151110|156908304|FG001|Overall Study|Lost to Follow-up|0|||
48742823|NCT02151110|156908305|FG002|Overall Study|Lost to Follow-up|0|||
48742824|NCT02151110|156908306|FG003|Overall Study|Lost to Follow-up|0|||
48856170|NCT01019135|157312777|FG002|Overall Study|Did not attend CR|6|||
48856171|NCT01205126|157312778|FG000|Titration Phase|Adverse Event|5|||
48742825|NCT02151110|156908307|FG004|Overall Study|Lost to Follow-up|0|||
48742826|NCT02151110|156908308|FG005|Overall Study|Lost to Follow-up|0|||
48856172|NCT01205126|157312779|FG001|Titration Phase|Adverse Event|3|||
48856173|NCT01205126|157312778|FG000|Titration Phase|Withdrawal by Subject|5|||
48856174|NCT01205126|157312779|FG001|Titration Phase|Withdrawal by Subject|5|||
48856175|NCT01205126|157312778|FG000|Titration Phase|Lost to Follow-up|2|||
48856176|NCT01205126|157312779|FG001|Titration Phase|Lost to Follow-up|2|||
48856177|NCT01205126|157312778|FG000|Titration Phase|No stable titration dose|1|||
48856178|NCT01205126|157312779|FG001|Titration Phase|No stable titration dose|0|||
48856179|NCT01205126|157312778|FG000|Titration Phase|More than maximum dosage required|2|||
48856180|NCT01205126|157312779|FG001|Titration Phase|More than maximum dosage required|3|||
48856181|NCT01205126|157312778|FG000|Titration Phase|Other|8|||
48856182|NCT01205126|157312779|FG001|Titration Phase|Other|6|||
48856183|NCT01205126|157312778|FG000|Between Titration & Maintenance Phase|Other|0|||
48856184|NCT01205126|157312779|FG001|Between Titration & Maintenance Phase|Other|4|||
48856185|NCT01205126|157312778|FG000|Maintenance Phase|Adverse Event|3|||
48951777|NCT01259492|157654896|FG002|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1|||
48951778|NCT01259492|157654897|FG003|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
48951779|NCT01259492|157654894|FG000|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
48951780|NCT01259492|157654895|FG001|Period 2 (Week 10 to Week 14)|Protocol Violation|2|||
48951781|NCT01259492|157654896|FG002|Period 2 (Week 10 to Week 14)|Protocol Violation|1|||
48742827|NCT02151110|156908309|FG006|Overall Study|Lost to Follow-up|0|||
48742828|NCT02151110|156908310|FG007|Overall Study|Lost to Follow-up|2|||
48742829|NCT01253408|156908311|FG000|Overall Study|Adverse Event|0|||
48742830|NCT01253408|156908312|FG001|Overall Study|Adverse Event|1|||
48742831|NCT01253408|156908313|FG002|Overall Study|Adverse Event|0|||
48742832|NCT05399641|156908314|FG000|Overall Study|Adverse Event|0|||
48742833|NCT05399641|156908315|FG001|Overall Study|Adverse Event|1|||
48742834|NCT05399641|156908316|FG002|Overall Study|Adverse Event|1|||
48742835|NCT05399641|156908314|FG000|Overall Study|Lost to Follow-up|1|||
48742836|NCT05399641|156908315|FG001|Overall Study|Lost to Follow-up|2|||
48742837|NCT05399641|156908316|FG002|Overall Study|Lost to Follow-up|2|||
48742838|NCT05399641|156908314|FG000|Overall Study|Physician Decision|1|||
48742839|NCT05399641|156908315|FG001|Overall Study|Physician Decision|3|||
48742840|NCT05399641|156908316|FG002|Overall Study|Physician Decision|3|||
48742841|NCT05399641|156908314|FG000|Overall Study|Withdrawal by Subject|4|||
48742842|NCT05399641|156908315|FG001|Overall Study|Withdrawal by Subject|11|||
48742843|NCT05399641|156908316|FG002|Overall Study|Withdrawal by Subject|7|||
48742844|NCT05399641|156908314|FG000|Overall Study|Reason not defined|3|||
48742845|NCT05399641|156908315|FG001|Overall Study|Reason not defined|5|||
48742846|NCT05399641|156908316|FG002|Overall Study|Reason not defined|6|||
48742847|NCT00923156|156908318|FG000|Overall Study|Adverse Event|0|||
48742848|NCT00923156|156908319|FG001|Overall Study|Adverse Event|2|||
48742849|NCT00923156|156908320|FG002|Overall Study|Adverse Event|1|||
48742850|NCT00923156|156908318|FG000|Overall Study|Abnormal laboratory values|0|||
48742851|NCT00923156|156908319|FG001|Overall Study|Abnormal laboratory values|0|||
48742852|NCT00923156|156908320|FG002|Overall Study|Abnormal laboratory values|1|||
48742853|NCT00923156|156908318|FG000|Overall Study|Withdrawal by Subject|0|||
48742854|NCT00923156|156908319|FG001|Overall Study|Withdrawal by Subject|1|||
48742855|NCT00923156|156908320|FG002|Overall Study|Withdrawal by Subject|0|||
48742856|NCT00923156|156908318|FG000|Overall Study|Death|0|||
48742857|NCT00923156|156908319|FG001|Overall Study|Death|1|||
48742858|NCT00923156|156908320|FG002|Overall Study|Death|0|||
48742859|NCT00923156|156908318|FG000|Overall Study|Lack of Efficacy|0|||
48742860|NCT00923156|156908319|FG001|Overall Study|Lack of Efficacy|0|||
48742861|NCT00923156|156908320|FG002|Overall Study|Lack of Efficacy|1|||
48742862|NCT01146665|156908323|FG000|Overall Study|Withdrawal by Subject|10|||
48742863|NCT01146665|156908324|FG001|Overall Study|Withdrawal by Subject|16|||
48742864|NCT00365508|156908332|FG000|Overall Study|Lost to Follow-up|139|||
48742865|NCT00365508|156908333|FG001|Overall Study|Lost to Follow-up|154|||
48742866|NCT00751933|156908334|FG000|Overall Study|Withdrawal by Subject|0|||
48742867|NCT00751933|156908335|FG001|Overall Study|Withdrawal by Subject|1|||
48742868|NCT00751933|156908336|FG002|Overall Study|Withdrawal by Subject|0|||
48742869|NCT00751933|156908337|FG003|Overall Study|Withdrawal by Subject|0|||
48742870|NCT00751933|156908334|FG000|Overall Study|Physician Decision|0|||
48742871|NCT00751933|156908335|FG001|Overall Study|Physician Decision|0|||
48742872|NCT00751933|156908336|FG002|Overall Study|Physician Decision|1|||
48742873|NCT00751933|156908337|FG003|Overall Study|Physician Decision|1|||
48742874|NCT01084083|156908339|FG000|Overall Study|Adverse Event|5|||
48742875|NCT01084083|156908339|FG000|Overall Study|Death|1|||
48742876|NCT01084083|156908339|FG000|Overall Study|Withdrawal by Subject|2|||
48742877|NCT01084083|156908339|FG000|Overall Study|Complicating disease|1|||
48742878|NCT01084083|156908339|FG000|Overall Study|Other|2|||
48742879|NCT01084083|156908339|FG000|Overall Study|Never started assigned therapy|1|||
48742880|NCT00393029|156908341|FG000|Overall Study|Not treated|0|||
48742881|NCT00393029|156908342|FG001|Overall Study|Not treated|1|||
48742882|NCT02197130|156908345|FG000|Overall Study|Adverse Event|13|||
48856186|NCT01205126|157312779|FG001|Maintenance Phase|Adverse Event|7|||
48856187|NCT01205126|157312778|FG000|Maintenance Phase|Death|4|||
48856188|NCT01205126|157312779|FG001|Maintenance Phase|Death|4|||
48856189|NCT01205126|157312778|FG000|Maintenance Phase|More than the maximum dosage required|5|||
48856190|NCT01205126|157312779|FG001|Maintenance Phase|More than the maximum dosage required|5|||
48856191|NCT01205126|157312778|FG000|Maintenance Phase|Prohibited drugs used|1|||
48856192|NCT01205126|157312779|FG001|Maintenance Phase|Prohibited drugs used|0|||
48856193|NCT01205126|157312778|FG000|Maintenance Phase|Other|11|||
48856194|NCT01205126|157312779|FG001|Maintenance Phase|Other|8|||
48856195|NCT01205126|157312778|FG000|Maintenance Phase|Lost to Follow-up|5|||
48742883|NCT02197130|156908346|FG001|Overall Study|Adverse Event|4|||
48742884|NCT02197130|156908347|FG002|Overall Study|Adverse Event|23|||
48742885|NCT02197130|156908345|FG000|Overall Study|Death|0|||
48742886|NCT02197130|156908346|FG001|Overall Study|Death|1|||
48742887|NCT02197130|156908347|FG002|Overall Study|Death|0|||
48742888|NCT02197130|156908345|FG000|Overall Study|Lost to Follow-up|2|||
48742889|NCT02197130|156908346|FG001|Overall Study|Lost to Follow-up|0|||
48856196|NCT01205126|157312779|FG001|Maintenance Phase|Lost to Follow-up|5|||
48856197|NCT01205126|157312778|FG000|Maintenance Phase|Withdrawal by Subject|8|||
48856198|NCT01205126|157312779|FG001|Maintenance Phase|Withdrawal by Subject|11|||
48856199|NCT01428583|157312780|FG000|Overall Study|Adverse Event|75|||
48856200|NCT01428583|157312780|FG000|Overall Study|Withdrawal by Subject|51|||
48856201|NCT01428583|157312780|FG000|Overall Study|Lack of Efficacy|37|||
48856202|NCT01428583|157312780|FG000|Overall Study|Lost to Follow-up|17|||
48856203|NCT01428583|157312780|FG000|Overall Study|Death|1|||
48856204|NCT01428583|157312780|FG000|Overall Study|Pregnancy|1|||
48856205|NCT01428583|157312780|FG000|Overall Study|Protocol Violation|1|||
48856206|NCT01428583|157312780|FG000|Overall Study|Physician Decision|12|||
48856207|NCT01428583|157312780|FG000|Overall Study|Non-compliant|25|||
48856208|NCT01428583|157312780|FG000|Overall Study|Confirmed positive urine drug test|8|||
48856209|NCT01428583|157312780|FG000|Overall Study|Sponsor's request|3|||
48856210|NCT01428583|157312780|FG000|Overall Study|Other|6|||
48856211|NCT00670488|157312783|FG000|Overall Study|Adverse Event|0|||
48856212|NCT00670488|157312784|FG001|Overall Study|Adverse Event|7|||
48856213|NCT00670488|157312785|FG002|Overall Study|Adverse Event|0|||
48856214|NCT00670488|157312786|FG003|Overall Study|Adverse Event|3|||
48856215|NCT00670488|157312787|FG004|Overall Study|Adverse Event|1|||
48856216|NCT00670488|157312788|FG005|Overall Study|Adverse Event|1|||
48856217|NCT00670488|157312789|FG006|Overall Study|Adverse Event|5|||
48856218|NCT00670488|157312790|FG007|Overall Study|Adverse Event|1|||
48856219|NCT00670488|157312791|FG008|Overall Study|Adverse Event|0|||
48856220|NCT00670488|157312792|FG009|Overall Study|Adverse Event|1|||
48856221|NCT00670488|157312783|FG000|Overall Study|Physician Decision|1|||
48856222|NCT00670488|157312784|FG001|Overall Study|Physician Decision|9|||
48856223|NCT00670488|157312785|FG002|Overall Study|Physician Decision|0|||
48856224|NCT00670488|157312786|FG003|Overall Study|Physician Decision|1|||
48856225|NCT00670488|157312787|FG004|Overall Study|Physician Decision|0|||
48856226|NCT00670488|157312788|FG005|Overall Study|Physician Decision|0|||
48856227|NCT00670488|157312789|FG006|Overall Study|Physician Decision|0|||
48856228|NCT00670488|157312790|FG007|Overall Study|Physician Decision|0|||
48856229|NCT00670488|157312791|FG008|Overall Study|Physician Decision|0|||
48856230|NCT00670488|157312792|FG009|Overall Study|Physician Decision|0|||
48856231|NCT00670488|157312783|FG000|Overall Study|Progressive Disease|2|||
48742890|NCT02197130|156908347|FG002|Overall Study|Lost to Follow-up|1|||
48742891|NCT02197130|156908345|FG000|Overall Study|Does not meet entrance criteria|0|||
48742892|NCT02197130|156908346|FG001|Overall Study|Does not meet entrance criteria|0|||
48856232|NCT00670488|157312784|FG001|Overall Study|Progressive Disease|41|||
48856233|NCT00670488|157312785|FG002|Overall Study|Progressive Disease|3|||
48951782|NCT01259492|157654897|FG003|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
48856234|NCT00670488|157312786|FG003|Overall Study|Progressive Disease|2|||
48856235|NCT00670488|157312787|FG004|Overall Study|Progressive Disease|2|||
48856236|NCT00670488|157312788|FG005|Overall Study|Progressive Disease|4|||
48856237|NCT00670488|157312789|FG006|Overall Study|Progressive Disease|11|||
48856238|NCT00670488|157312790|FG007|Overall Study|Progressive Disease|2|||
48856239|NCT00670488|157312791|FG008|Overall Study|Progressive Disease|2|||
48856240|NCT00670488|157312792|FG009|Overall Study|Progressive Disease|1|||
48742893|NCT02197130|156908347|FG002|Overall Study|Does not meet entrance criteria|1|||
48951783|NCT01259492|157654894|FG000|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
48742894|NCT02197130|156908345|FG000|Overall Study|Withdrawal by Subject|0|||
48856241|NCT00670488|157312783|FG000|Overall Study|Withdrawal by Subject|0|||
48951784|NCT01259492|157654895|FG001|Period 3 (Week 15 to End of Week 40)|Adverse Event|11|||
48951785|NCT01259492|157654896|FG002|Period 3 (Week 15 to End of Week 40)|Adverse Event|6|||
48951786|NCT01259492|157654897|FG003|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
48951787|NCT01259492|157654894|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
48951788|NCT01259492|157654895|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
48951789|NCT01259492|157654896|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
48951790|NCT01259492|157654897|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1|||
48742895|NCT02197130|156908346|FG001|Overall Study|Withdrawal by Subject|3|||
48742896|NCT02197130|156908347|FG002|Overall Study|Withdrawal by Subject|4|||
48742897|NCT02197130|156908345|FG000|Overall Study|Other|1|||
48742898|NCT02197130|156908346|FG001|Overall Study|Other|0|||
48951791|NCT01259492|157654894|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
48951792|NCT01259492|157654895|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
48951793|NCT01259492|157654896|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1|||
48951794|NCT01259492|157654897|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
48951795|NCT01259492|157654894|FG000|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28|||
48951796|NCT01259492|157654895|FG001|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42|||
48951797|NCT01259492|157654896|FG002|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29|||
48951798|NCT01259492|157654897|FG003|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62|||
48951799|NCT01259492|157654894|FG000|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1|||
48951800|NCT01259492|157654895|FG001|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
48951801|NCT01259492|157654896|FG002|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
48951802|NCT01259492|157654897|FG003|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
48951803|NCT01259492|157654894|FG000|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12|||
48951804|NCT01259492|157654895|FG001|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6|||
48951805|NCT01259492|157654896|FG002|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4|||
48951806|NCT01259492|157654897|FG003|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3|||
48951807|NCT01259492|157654894|FG000|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
48951808|NCT01259492|157654895|FG001|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4|||
48951809|NCT01259492|157654896|FG002|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6|||
48951810|NCT01259492|157654897|FG003|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
48951811|NCT01259492|157654894|FG000|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
48951812|NCT01259492|157654895|FG001|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
48951813|NCT01259492|157654896|FG002|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1|||
48951814|NCT01259492|157654897|FG003|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
48951815|NCT01259492|157654894|FG000|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5|||
48951816|NCT01259492|157654895|FG001|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6|||
48951817|NCT01259492|157654896|FG002|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3|||
48951818|NCT01259492|157654897|FG003|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7|||
48951819|NCT00950690|157654905|FG000|Overall Study|Death|4|||
48742899|NCT02197130|156908347|FG002|Overall Study|Other|3|||
48742900|NCT01594762|156908348|FG000|Overall Study|Withdrawal by Subject|1|||
48742901|NCT01594762|156908349|FG001|Overall Study|Withdrawal by Subject|0|||
48742902|NCT01594762|156908348|FG000|Overall Study|Lost to Follow-up|10|||
48742903|NCT01594762|156908349|FG001|Overall Study|Lost to Follow-up|10|||
48742904|NCT02280304|156910409|FG000|Overall Study|Lost to Follow-up|7|||
48742905|NCT02280304|156910410|FG001|Overall Study|Lost to Follow-up|8|||
48742906|NCT01606800|156910411|FG000|Overall Study|Adverse Event|3|||
48742907|NCT01606800|156910412|FG001|Overall Study|Adverse Event|1|||
48742908|NCT01606800|156910411|FG000|Overall Study|Participant withdrew consent|0|||
48742909|NCT01606800|156910412|FG001|Overall Study|Participant withdrew consent|1|||
48742910|NCT01606800|156910411|FG000|Overall Study|Missing completion status|2|||
48742911|NCT01606800|156910412|FG001|Overall Study|Missing completion status|0|||
48856242|NCT00670488|157312784|FG001|Overall Study|Withdrawal by Subject|1|||
48856243|NCT00670488|157312785|FG002|Overall Study|Withdrawal by Subject|0|||
48856244|NCT00670488|157312786|FG003|Overall Study|Withdrawal by Subject|1|||
48856245|NCT00670488|157312787|FG004|Overall Study|Withdrawal by Subject|0|||
48856246|NCT00670488|157312788|FG005|Overall Study|Withdrawal by Subject|0|||
48856247|NCT00670488|157312789|FG006|Overall Study|Withdrawal by Subject|1|||
48856248|NCT00670488|157312790|FG007|Overall Study|Withdrawal by Subject|0|||
48856249|NCT00670488|157312791|FG008|Overall Study|Withdrawal by Subject|1|||
48856250|NCT00670488|157312792|FG009|Overall Study|Withdrawal by Subject|0|||
48856251|NCT00638456|157312793|FG000|Overall Study|Withdrawal by Subject|6|||
48856252|NCT00638456|157312794|FG001|Overall Study|Withdrawal by Subject|2|||
48856253|NCT01480258|157312798|FG000|Infant Series|Protocol Violation|2|||
48856254|NCT01480258|157312799|FG001|Infant Series|Protocol Violation|0|||
48856255|NCT01480258|157312798|FG000|Infant Series|Physician Decision|0|||
48743077|NCT00968201|156910495|FG001|Extension Study - (Period III)|Lost to Follow-up|7|||
48743078|NCT00968201|156910496|FG002|Extension Study - (Period III)|Lost to Follow-up|13|||
48743079|NCT00968201|156910494|FG000|Extension Study - (Period III)|Protocol Violation|0|||
48743080|NCT00968201|156910495|FG001|Extension Study - (Period III)|Protocol Violation|17|||
48743081|NCT00968201|156910496|FG002|Extension Study - (Period III)|Protocol Violation|14|||
48743082|NCT00968201|156910494|FG000|Extension Study - (Period III)|Withdrawal by Subject|0|||
48743083|NCT00968201|156910495|FG001|Extension Study - (Period III)|Withdrawal by Subject|20|||
48743084|NCT00968201|156910496|FG002|Extension Study - (Period III)|Withdrawal by Subject|40|||
48743085|NCT00968201|156910494|FG000|Extension Study - (Period III)|Patient Relocated|0|||
48743086|NCT00968201|156910495|FG001|Extension Study - (Period III)|Patient Relocated|1|||
48743087|NCT00968201|156910496|FG002|Extension Study - (Period III)|Patient Relocated|1|||
48743088|NCT00968201|156910494|FG000|Extension Study - (Period III)|Noncompliance|0|||
48743089|NCT00968201|156910495|FG001|Extension Study - (Period III)|Noncompliance|0|||
48743090|NCT00968201|156910496|FG002|Extension Study - (Period III)|Noncompliance|3|||
48743091|NCT00968201|156910494|FG000|Extension Study - (Period III)|Other|0|||
48743092|NCT00968201|156910495|FG001|Extension Study - (Period III)|Other|0|||
48743093|NCT00968201|156910496|FG002|Extension Study - (Period III)|Other|2|||
48743094|NCT00968201|156910494|FG000|Extension Study - (Period III)|Study Terminated for Admin Reasons|0|||
48743095|NCT00968201|156910495|FG001|Extension Study - (Period III)|Study Terminated for Admin Reasons|74|||
48743096|NCT00968201|156910496|FG002|Extension Study - (Period III)|Study Terminated for Admin Reasons|185|||
48743097|NCT00289783|156910498|FG000|Primary Phase|Adverse Event|10|||
48743098|NCT00289783|156910499|FG001|Primary Phase|Adverse Event|1|||
48743099|NCT00289783|156910498|FG000|Primary Phase|Protocol Violation|27|||
48743100|NCT00289783|156910499|FG001|Primary Phase|Protocol Violation|6|||
48743101|NCT00289783|156910498|FG000|Primary Phase|Withdrawal by Subject|93|||
48743102|NCT00289783|156910499|FG001|Primary Phase|Withdrawal by Subject|40|||
48743103|NCT00289783|156910498|FG000|Primary Phase|Lost to Follow-up|60|||
48743104|NCT00289783|156910499|FG001|Primary Phase|Lost to Follow-up|14|||
48743105|NCT00289783|156910498|FG000|Primary Phase|Migration from the study area|26|||
48743106|NCT00289783|156910499|FG001|Primary Phase|Migration from the study area|10|||
48743107|NCT00289783|156910498|FG000|Primary Phase|Other|32|||
48743108|NCT00289783|156910499|FG001|Primary Phase|Other|12|||
48743109|NCT00289783|156910498|FG000|Fourth Dose Phase|Adverse Event|1|||
48743110|NCT00289783|156910499|FG001|Fourth Dose Phase|Adverse Event|0|||
48743111|NCT00289783|156910498|FG000|Fourth Dose Phase|Withdrawal by Subject|10|||
48951869|NCT04760314|157654920|FG006|Maintenance Blinded Period|Withdrawal by Subject|2|||
48743112|NCT00289783|156910499|FG001|Fourth Dose Phase|Withdrawal by Subject|1|||
48743113|NCT00289783|156910498|FG000|Fourth Dose Phase|Lost to Follow-up|53|||
48743114|NCT00289783|156910499|FG001|Fourth Dose Phase|Lost to Follow-up|12|||
48743115|NCT00289783|156910498|FG000|Fourth Dose Phase|Migration from the study area|1|||
48743116|NCT00289783|156910499|FG001|Fourth Dose Phase|Migration from the study area|1|||
48743117|NCT00289783|156910498|FG000|Fourth Dose Phase|Other|22|||
48743118|NCT00289783|156910499|FG001|Fourth Dose Phase|Other|10|||
48743119|NCT03302234|156910500|FG000|Overall Study|Death|191|||
48743120|NCT03302234|156910501|FG001|Overall Study|Death|192|||
48743121|NCT03302234|156910500|FG000|Overall Study|Withdrawal by Subject|2|||
48743122|NCT03302234|156910501|FG001|Overall Study|Withdrawal by Subject|2|||
48743123|NCT03302234|156910500|FG000|Overall Study|Sponsor Decision|90|||
48743124|NCT03302234|156910501|FG001|Overall Study|Sponsor Decision|89|||
48743125|NCT03302234|156910500|FG000|Overall Study|Laryngeal carcinoma|0|||
48743126|NCT03302234|156910501|FG001|Overall Study|Laryngeal carcinoma|1|||
48743127|NCT03302234|156910500|FG000|Overall Study|Not Reported|1|||
48743128|NCT03302234|156910501|FG001|Overall Study|Not Reported|0|||
48743129|NCT00361569|156910502|FG000|Overall Study|Protocol Violation|3|||
48743130|NCT00361569|156910503|FG001|Overall Study|Protocol Violation|2|||
48743131|NCT00361569|156910504|FG002|Overall Study|Protocol Violation|4|||
48743132|NCT00361569|156910505|FG003|Overall Study|Protocol Violation|2|||
48743133|NCT00361569|156910502|FG000|Overall Study|Withdrawal by Subject|2|||
48743134|NCT00361569|156910503|FG001|Overall Study|Withdrawal by Subject|1|||
48743135|NCT00361569|156910504|FG002|Overall Study|Withdrawal by Subject|9|||
48743136|NCT00361569|156910505|FG003|Overall Study|Withdrawal by Subject|14|||
48743137|NCT00361569|156910502|FG000|Overall Study|Adverse Event|3|||
48743138|NCT00361569|156910503|FG001|Overall Study|Adverse Event|5|||
48743139|NCT00361569|156910504|FG002|Overall Study|Adverse Event|2|||
48743140|NCT00361569|156910505|FG003|Overall Study|Adverse Event|2|||
48743141|NCT00361569|156910502|FG000|Overall Study|Lost to Follow-up|2|||
48743142|NCT00361569|156910503|FG001|Overall Study|Lost to Follow-up|3|||
48743143|NCT00361569|156910504|FG002|Overall Study|Lost to Follow-up|3|||
48743144|NCT00361569|156910505|FG003|Overall Study|Lost to Follow-up|2|||
48743145|NCT00361569|156910502|FG000|Overall Study|Not specified by investigator|2|||
48743146|NCT00361569|156910503|FG001|Overall Study|Not specified by investigator|0|||
48743147|NCT00361569|156910504|FG002|Overall Study|Not specified by investigator|0|||
48743148|NCT00361569|156910505|FG003|Overall Study|Not specified by investigator|1|||
48743149|NCT04523220|156910506|FG000|Main Treatment Period|Physician Decision|1|||
48743150|NCT04523220|156910507|FG001|Main Treatment Period|Physician Decision|1|||
48743151|NCT04523220|156910508|FG002|Main Treatment Period|Physician Decision|0|||
48743152|NCT04523220|156910506|FG000|Main Treatment Period|Other|5|||
48743153|NCT04523220|156910507|FG001|Main Treatment Period|Other|2|||
48743154|NCT04523220|156910508|FG002|Main Treatment Period|Other|4|||
48951870|NCT04760314|157654921|FG007|Maintenance Blinded Period|Withdrawal by Subject|0|||
48951871|NCT04760314|157654922|FG008|Maintenance Blinded Period|Withdrawal by Subject|0|||
48951872|NCT04760314|157654923|FG009|Maintenance Blinded Period|Withdrawal by Subject|0|||
48951873|NCT04760314|157654924|FG010|Maintenance Blinded Period|Withdrawal by Subject|0|||
48951874|NCT04760314|157654914|FG000|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
48951875|NCT04760314|157654915|FG001|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
48951876|NCT04760314|157654916|FG002|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
48743155|NCT04523220|156910506|FG000|Main Treatment Period|Subject Decision|5|||
48743156|NCT04523220|156910507|FG001|Main Treatment Period|Subject Decision|7|||
48743157|NCT04523220|156910508|FG002|Main Treatment Period|Subject Decision|3|||
48743158|NCT04523220|156910506|FG000|Main Treatment Period|Death|5|||
48743159|NCT04523220|156910507|FG001|Main Treatment Period|Death|11|||
48743160|NCT04523220|156910508|FG002|Main Treatment Period|Death|4|||
48743161|NCT04523220|156910506|FG000|Main Treatment Period|Adverse Event|11|||
48743162|NCT04523220|156910507|FG001|Main Treatment Period|Adverse Event|9|||
48743163|NCT04523220|156910508|FG002|Main Treatment Period|Adverse Event|9|||
48743164|NCT04523220|156910506|FG000|Main Treatment Period|Withdrawal by Subject|3|||
48743165|NCT04523220|156910507|FG001|Main Treatment Period|Withdrawal by Subject|3|||
48743166|NCT04523220|156910508|FG002|Main Treatment Period|Withdrawal by Subject|4|||
48743167|NCT04523220|156910506|FG000|Main Treatment Period|Study drug never adminstered|10|||
48743168|NCT04523220|156910507|FG001|Main Treatment Period|Study drug never adminstered|3|||
48951877|NCT04760314|157654917|FG003|Maintenance Blinded Period|Enrolled to Escape Arm|1|||
48951878|NCT04760314|157654918|FG004|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
48951879|NCT04760314|157654919|FG005|Maintenance Blinded Period|Enrolled to Escape Arm|4|||
48951880|NCT04760314|157654920|FG006|Maintenance Blinded Period|Enrolled to Escape Arm|3|||
48951881|NCT04760314|157654921|FG007|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
48951882|NCT04760314|157654922|FG008|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
48951883|NCT04760314|157654923|FG009|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
48743169|NCT04523220|156910508|FG002|Main Treatment Period|Study drug never adminstered|5|||
48743170|NCT04523220|156910506|FG000|Extension Treatment Period|Physician Decision|1|||
48743171|NCT04523220|156910507|FG001|Extension Treatment Period|Physician Decision|0|||
48951884|NCT04760314|157654924|FG010|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
48743172|NCT04523220|156910508|FG002|Extension Treatment Period|Physician Decision|3|||
48743173|NCT04523220|156910506|FG000|Extension Treatment Period|Other|2|||
48743174|NCT04523220|156910507|FG001|Extension Treatment Period|Other|6|||
48743175|NCT04523220|156910508|FG002|Extension Treatment Period|Other|6|||
48743176|NCT04523220|156910506|FG000|Extension Treatment Period|Subject Decision|5|||
48743177|NCT04523220|156910507|FG001|Extension Treatment Period|Subject Decision|2|||
48743178|NCT04523220|156910508|FG002|Extension Treatment Period|Subject Decision|4|||
48743179|NCT04523220|156910506|FG000|Extension Treatment Period|Death|6|||
48743180|NCT04523220|156910507|FG001|Extension Treatment Period|Death|4|||
48743181|NCT04523220|156910508|FG002|Extension Treatment Period|Death|7|||
48743182|NCT04523220|156910506|FG000|Extension Treatment Period|Adverse Event|6|||
48743183|NCT04523220|156910507|FG001|Extension Treatment Period|Adverse Event|7|||
48743184|NCT04523220|156910508|FG002|Extension Treatment Period|Adverse Event|9|||
48743185|NCT04523220|156910506|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
48743186|NCT04523220|156910507|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
48743187|NCT04523220|156910508|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
48743188|NCT04523220|156910506|FG000|Extension Treatment Period|Study drug never administered|0|||
48743189|NCT04523220|156910507|FG001|Extension Treatment Period|Study drug never administered|1|||
48743190|NCT04523220|156910508|FG002|Extension Treatment Period|Study drug never administered|0|||
48743191|NCT02605824|156910509|FG000|Overall Study|Physician Decision|1|||
48743192|NCT02605824|156910510|FG001|Overall Study|Physician Decision|0|||
48743193|NCT00481078|156910511|FG000|Overall Study|Progression of disease|11|||
48743194|NCT00481078|156910512|FG001|Overall Study|Progression of disease|11|||
48743195|NCT00481078|156910511|FG000|Overall Study|Adverse Event|15|||
48743196|NCT00481078|156910512|FG001|Overall Study|Adverse Event|3|||
48743197|NCT00481078|156910511|FG000|Overall Study|Death|5|||
48743198|NCT00481078|156910512|FG001|Overall Study|Death|3|||
48743199|NCT00481078|156910511|FG000|Overall Study|Intercurrent illness|1|||
48743200|NCT00481078|156910512|FG001|Overall Study|Intercurrent illness|0|||
48743201|NCT00481078|156910511|FG000|Overall Study|Withdrawal by Subject|7|||
48743202|NCT00481078|156910512|FG001|Overall Study|Withdrawal by Subject|1|||
48743203|NCT00481078|156910511|FG000|Overall Study|Information not available|1|||
48743204|NCT00481078|156910512|FG001|Overall Study|Information not available|0|||
48743205|NCT00481078|156910511|FG000|Overall Study|Received other treatment|2|||
48743206|NCT00481078|156910512|FG001|Overall Study|Received other treatment|1|||
48743207|NCT00481078|156910511|FG000|Overall Study|Brain metastasis|0|||
48743208|NCT00481078|156910512|FG001|Overall Study|Brain metastasis|1|||
48743209|NCT01845831|156910513|FG000|Inpatient Phase|Withdrawal by Subject|1|||
48743210|NCT01845831|156910514|FG001|Inpatient Phase|Withdrawal by Subject|1|||
48743211|NCT01845831|156910515|FG002|Inpatient Phase|Withdrawal by Subject|0|||
48743212|NCT01845831|156910516|FG003|Inpatient Phase|Withdrawal by Subject|0|||
48743213|NCT01845831|156910517|FG004|Inpatient Phase|Withdrawal by Subject|0|||
48743214|NCT00873015|156910518|FG000|Overall Study|Withdrawal by Subject|0|||
48743215|NCT00873015|156910519|FG001|Overall Study|Withdrawal by Subject|1|||
48743216|NCT00873015|156910520|FG002|Overall Study|Withdrawal by Subject|0|||
48743217|NCT00873015|156910521|FG003|Overall Study|Withdrawal by Subject|0|||
48743218|NCT00256750|156910527|FG000|Transplanted Pre-Treatment|Withdrawal by Subject|3|||
48743219|NCT00256750|156910528|FG001|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
48743220|NCT00256750|156910529|FG002|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
48743221|NCT00256750|156910527|FG000|Transplanted Pre-Treatment|Other|2|||
48743222|NCT00256750|156910528|FG001|Transplanted Pre-Treatment|Other|0|||
48743223|NCT00256750|156910529|FG002|Transplanted Pre-Treatment|Other|0|||
48743224|NCT00256750|156910527|FG000|Transplanted Pre-Treatment|Death|1|||
48743225|NCT00256750|156910528|FG001|Transplanted Pre-Treatment|Death|0|||
48743226|NCT00256750|156910529|FG002|Transplanted Pre-Treatment|Death|0|||
48743227|NCT00256750|156910527|FG000|Post-Transplant Treated (12 Months)|Adverse Event|20|||
48856589|NCT01930188|157312883|FG002|Overall Study|Missing follow-up information|3|||
48856590|NCT01930188|157312881|FG000|Overall Study|Lost to Follow-up|5|||
48743228|NCT00256750|156910528|FG001|Post-Transplant Treated (12 Months)|Adverse Event|12|||
48743229|NCT00256750|156910529|FG002|Post-Transplant Treated (12 Months)|Adverse Event|8|||
48743230|NCT00256750|156910527|FG000|Post-Transplant Treated (12 Months)|Death|3|||
48743231|NCT00256750|156910528|FG001|Post-Transplant Treated (12 Months)|Death|2|||
48743232|NCT00256750|156910529|FG002|Post-Transplant Treated (12 Months)|Death|4|||
48743233|NCT00256750|156910527|FG000|Post-Transplant Treated (12 Months)|Lack of Efficacy|10|||
48743234|NCT00256750|156910528|FG001|Post-Transplant Treated (12 Months)|Lack of Efficacy|22|||
48743235|NCT00256750|156910529|FG002|Post-Transplant Treated (12 Months)|Lack of Efficacy|27|||
48743236|NCT00256750|156910527|FG000|Post-Transplant Treated (12 Months)|Lost to Follow-up|1|||
48743237|NCT00256750|156910528|FG001|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
48743238|NCT00256750|156910529|FG002|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
48743239|NCT00256750|156910527|FG000|Post-Transplant Treated (12 Months)|Other|5|||
48743240|NCT00256750|156910528|FG001|Post-Transplant Treated (12 Months)|Other|4|||
48743241|NCT00256750|156910529|FG002|Post-Transplant Treated (12 Months)|Other|2|||
48743242|NCT00256750|156910527|FG000|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0|||
48743243|NCT00256750|156910528|FG001|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3|||
48743244|NCT00256750|156910529|FG002|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5|||
48743245|NCT00256750|156910527|FG000|Post-Transplant Treated (12 Months)|Protocol Violation|2|||
48743246|NCT00256750|156910528|FG001|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
48743247|NCT00256750|156910529|FG002|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
48743248|NCT00256750|156910527|FG000|Post-Transplant Treated (24 Months)|Adverse Event|7|||
48743249|NCT00256750|156910528|FG001|Post-Transplant Treated (24 Months)|Adverse Event|3|||
48743250|NCT00256750|156910529|FG002|Post-Transplant Treated (24 Months)|Adverse Event|6|||
48743251|NCT00256750|156910527|FG000|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5|||
48743252|NCT00256750|156910528|FG001|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1|||
48743253|NCT00256750|156910529|FG002|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0|||
48743254|NCT00256750|156910527|FG000|Post-Transplant Treated (24 Months)|Death|3|||
48743255|NCT00256750|156910528|FG001|Post-Transplant Treated (24 Months)|Death|0|||
48743256|NCT00256750|156910529|FG002|Post-Transplant Treated (24 Months)|Death|0|||
48743257|NCT00256750|156910527|FG000|Post-Transplant Treated (24 Months)|Lack of Efficacy|4|||
48743258|NCT00256750|156910528|FG001|Post-Transplant Treated (24 Months)|Lack of Efficacy|3|||
48743259|NCT00256750|156910529|FG002|Post-Transplant Treated (24 Months)|Lack of Efficacy|2|||
48743260|NCT00256750|156910527|FG000|Post-Transplant Treated (24 Months)|Other|2|||
48743261|NCT00256750|156910528|FG001|Post-Transplant Treated (24 Months)|Other|0|||
48743262|NCT00256750|156910529|FG002|Post-Transplant Treated (24 Months)|Other|1|||
48743263|NCT00256750|156910527|FG000|Post-Transplant Treated (36 Months)|Adverse Event|5|||
48743264|NCT00256750|156910528|FG001|Post-Transplant Treated (36 Months)|Adverse Event|1|||
48743265|NCT00256750|156910529|FG002|Post-Transplant Treated (36 Months)|Adverse Event|2|||
48743266|NCT00256750|156910527|FG000|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
48743267|NCT00256750|156910528|FG001|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0|||
48743268|NCT00256750|156910529|FG002|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
48743269|NCT00256750|156910527|FG000|Post-Transplant Treated (36 Months)|Death|0|||
48743270|NCT00256750|156910528|FG001|Post-Transplant Treated (36 Months)|Death|2|||
48743271|NCT00256750|156910529|FG002|Post-Transplant Treated (36 Months)|Death|1|||
48743272|NCT00256750|156910527|FG000|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
48743273|NCT00256750|156910528|FG001|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
48743274|NCT00256750|156910529|FG002|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1|||
48743275|NCT00256750|156910527|FG000|Post-Transplant Treated (36 Months)|Lack of Efficacy|4|||
48743276|NCT00256750|156910528|FG001|Post-Transplant Treated (36 Months)|Lack of Efficacy|1|||
48743277|NCT00256750|156910529|FG002|Post-Transplant Treated (36 Months)|Lack of Efficacy|0|||
48743278|NCT00256750|156910527|FG000|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
48856591|NCT01930188|157312882|FG001|Overall Study|Lost to Follow-up|2|||
48856592|NCT01930188|157312883|FG002|Overall Study|Lost to Follow-up|2|||
48856593|NCT01930188|157312881|FG000|Overall Study|Death|2|||
48856594|NCT01930188|157312882|FG001|Overall Study|Death|1|||
48856595|NCT01930188|157312883|FG002|Overall Study|Death|3|||
48856596|NCT01930188|157312881|FG000|Overall Study|Withdrawal by Subject|9|||
48856597|NCT01930188|157312882|FG001|Overall Study|Withdrawal by Subject|11|||
48856598|NCT01930188|157312883|FG002|Overall Study|Withdrawal by Subject|8|||
48856599|NCT02170207|157312884|FG000|Overall Study|Case report forms unavailable|5|||
48856600|NCT03122860|157312886|FG000|Overall Study|Discontinued Before Treatment|1|||
48951885|NCT04760314|157654914|FG000|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
48951886|NCT04760314|157654915|FG001|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
48951887|NCT04760314|157654916|FG002|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
48951888|NCT04760314|157654917|FG003|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
48951889|NCT04760314|157654918|FG004|Maintenance Blinded Period|Assigned Treatment by Mistake|1|||
48951890|NCT04760314|157654919|FG005|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
48743279|NCT00256750|156910528|FG001|Post-Transplant Treated (36 Months)|Protocol Violation|1|||
48743280|NCT00256750|156910529|FG002|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
48743281|NCT00256750|156910527|FG000|Post-Transplant Treated (36 Months)|Other|0|||
48951891|NCT04760314|157654920|FG006|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
48951892|NCT04760314|157654921|FG007|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
48951893|NCT04760314|157654922|FG008|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
48951894|NCT04760314|157654923|FG009|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
48951895|NCT04760314|157654924|FG010|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
48951896|NCT04760314|157654914|FG000|Maintenance Blinded Period|Protocol Deviation|0|||
48951897|NCT04760314|157654915|FG001|Maintenance Blinded Period|Protocol Deviation|0|||
48856601|NCT03122860|157312887|FG001|Overall Study|Discontinued Before Treatment|1|||
48856602|NCT03122860|157312888|FG002|Overall Study|Discontinued Before Treatment|2|||
48856603|NCT03122860|157312889|FG003|Overall Study|Discontinued Before Treatment|0|||
48856604|NCT03122860|157312890|FG004|Overall Study|Discontinued Before Treatment|1|||
48856605|NCT03122860|157312891|FG005|Overall Study|Discontinued Before Treatment|0|||
48856606|NCT03122860|157312886|FG000|Overall Study|Adverse Event|1|||
48856607|NCT03122860|157312887|FG001|Overall Study|Adverse Event|0|||
48856608|NCT03122860|157312888|FG002|Overall Study|Adverse Event|1|||
48856609|NCT03122860|157312889|FG003|Overall Study|Adverse Event|1|||
48856610|NCT03122860|157312890|FG004|Overall Study|Adverse Event|0|||
48856611|NCT03122860|157312891|FG005|Overall Study|Adverse Event|0|||
48856612|NCT03122860|157312886|FG000|Overall Study|Lost to Follow-up|5|||
48856613|NCT03122860|157312887|FG001|Overall Study|Lost to Follow-up|2|||
48856614|NCT03122860|157312888|FG002|Overall Study|Lost to Follow-up|3|||
48856615|NCT03122860|157312889|FG003|Overall Study|Lost to Follow-up|3|||
48856616|NCT03122860|157312890|FG004|Overall Study|Lost to Follow-up|5|||
48856617|NCT03122860|157312891|FG005|Overall Study|Lost to Follow-up|4|||
48856618|NCT03122860|157312886|FG000|Overall Study|Subject Non-Compliance|0|||
48856619|NCT03122860|157312887|FG001|Overall Study|Subject Non-Compliance|0|||
48856620|NCT03122860|157312888|FG002|Overall Study|Subject Non-Compliance|1|||
48856621|NCT03122860|157312889|FG003|Overall Study|Subject Non-Compliance|0|||
48856622|NCT03122860|157312890|FG004|Overall Study|Subject Non-Compliance|0|||
48856623|NCT03122860|157312891|FG005|Overall Study|Subject Non-Compliance|0|||
48856624|NCT03122860|157312886|FG000|Overall Study|Withdrawal by Subject|3|||
48856625|NCT03122860|157312887|FG001|Overall Study|Withdrawal by Subject|2|||
48856626|NCT03122860|157312888|FG002|Overall Study|Withdrawal by Subject|5|||
48856627|NCT03122860|157312889|FG003|Overall Study|Withdrawal by Subject|7|||
48856628|NCT03122860|157312890|FG004|Overall Study|Withdrawal by Subject|9|||
48856629|NCT03122860|157312891|FG005|Overall Study|Withdrawal by Subject|8|||
48856630|NCT02764320|157312892|FG000|Overall Study|Withdrawal by Subject|35|||
48856631|NCT02764320|157312893|FG001|Overall Study|Withdrawal by Subject|38|||
48856632|NCT02764320|157312892|FG000|Overall Study|Protocol Violation|11|||
48856633|NCT02764320|157312893|FG001|Overall Study|Protocol Violation|6|||
48856634|NCT02764320|157312892|FG000|Overall Study|Adverse Event|2|||
48856635|NCT02764320|157312893|FG001|Overall Study|Adverse Event|0|||
48856636|NCT02764320|157312892|FG000|Overall Study|Health Issues unable to continue|2|||
48856637|NCT02764320|157312893|FG001|Overall Study|Health Issues unable to continue|0|||
48856638|NCT02764320|157312892|FG000|Overall Study|Did not meet inclusion criteria|1|||
48856639|NCT02764320|157312893|FG001|Overall Study|Did not meet inclusion criteria|0|||
48856640|NCT02764320|157312892|FG000|Overall Study|Subject moved|0|||
48856641|NCT02764320|157312893|FG001|Overall Study|Subject moved|2|||
48856642|NCT02764320|157312892|FG000|Overall Study|Overused medication unavailable|0|||
48856643|NCT02764320|157312893|FG001|Overall Study|Overused medication unavailable|1|||
48856644|NCT02764320|157312892|FG000|Overall Study|Seeking care outside site|0|||
48856645|NCT02764320|157312893|FG001|Overall Study|Seeking care outside site|1|||
48856646|NCT02764320|157312892|FG000|Overall Study|Technology barriers|0|||
48856647|NCT02764320|157312893|FG001|Overall Study|Technology barriers|1|||
48856648|NCT04085614|157312901|FG000|Overall Study|Protocol Violation|9|||
48856649|NCT04085614|157312902|FG001|Overall Study|Protocol Violation|6|||
48856650|NCT01000649|157312907|FG000|Overall Study|Adverse Event|5|||
48856651|NCT01000649|157312908|FG001|Overall Study|Adverse Event|1|||
48856652|NCT01000649|157312909|FG002|Overall Study|Adverse Event|2|||
48856653|NCT01000649|157312910|FG003|Overall Study|Adverse Event|4|||
48856654|NCT01000649|157312907|FG000|Overall Study|Lost to Follow-up|0|||
48856655|NCT01000649|157312908|FG001|Overall Study|Lost to Follow-up|2|||
48856656|NCT01000649|157312909|FG002|Overall Study|Lost to Follow-up|0|||
48856657|NCT01000649|157312910|FG003|Overall Study|Lost to Follow-up|2|||
48856658|NCT02699099|157312911|FG000|Overall Study|Adverse Event|1|||
48856659|NCT02699099|157312912|FG001|Overall Study|Adverse Event|0|||
48856660|NCT02699099|157312913|FG002|Overall Study|Adverse Event|2|||
48856661|NCT02699099|157312911|FG000|Overall Study|Lost to Follow-up|0|||
48856662|NCT02699099|157312912|FG001|Overall Study|Lost to Follow-up|1|||
48856663|NCT02699099|157312913|FG002|Overall Study|Lost to Follow-up|0|||
48856664|NCT02699099|157312911|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7|||
48856665|NCT02699099|157312912|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
48856666|NCT02699099|157312913|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4|||
48856667|NCT01084772|157312914|FG000|Baseline|Withdrawal by Subject|7|||
48856668|NCT01084772|157312915|FG001|Baseline|Withdrawal by Subject|6|||
48856669|NCT01084772|157312914|FG000|3 Months|Death|1|||
48856670|NCT01084772|157312915|FG001|3 Months|Death|0|||
48856671|NCT01084772|157312914|FG000|3 Months|Study Termination|2|||
48856672|NCT01084772|157312915|FG001|3 Months|Study Termination|2|||
48856673|NCT01084772|157312914|FG000|1 Year|Withdrawal by Subject|0|||
48856674|NCT01084772|157312915|FG001|1 Year|Withdrawal by Subject|1|||
48856675|NCT01084772|157312914|FG000|1 Year|Lost to Follow-up|3|||
48856676|NCT01084772|157312915|FG001|1 Year|Lost to Follow-up|0|||
48856677|NCT01084772|157312914|FG000|1 Year|Study Termination|0|||
48856678|NCT01084772|157312915|FG001|1 Year|Study Termination|7|||
48856679|NCT01084772|157312914|FG000|2 Years|Withdrawal by Subject|1|||
48856680|NCT01084772|157312915|FG001|2 Years|Withdrawal by Subject|0|||
48856681|NCT01084772|157312914|FG000|2 Years|Lost to Follow-up|5|||
48856682|NCT01084772|157312915|FG001|2 Years|Lost to Follow-up|2|||
48856683|NCT01084772|157312914|FG000|2 Years|Study Termination|3|||
48856684|NCT01084772|157312915|FG001|2 Years|Study Termination|2|||
48856685|NCT01867307|157312916|FG000|Overall Study|Protocol Violation|2|||
48856686|NCT01867307|157312917|FG001|Overall Study|Protocol Violation|0|||
48856687|NCT01867307|157312916|FG000|Overall Study|Other Adverse Event|1|||
48856688|NCT01867307|157312917|FG001|Overall Study|Other Adverse Event|3|||
48856689|NCT03137459|157314909|FG000|2-month Assessment|Withdrawal by Subject|13|||
48743282|NCT00256750|156910528|FG001|Post-Transplant Treated (36 Months)|Other|1|||
48743283|NCT00256750|156910529|FG002|Post-Transplant Treated (36 Months)|Other|1|||
48743284|NCT00256750|156910527|FG000|Long Term Extension (LTE; 84 Months)|Adverse Event|13|||
48743285|NCT00256750|156910528|FG001|Long Term Extension (LTE; 84 Months)|Adverse Event|11|||
48743286|NCT00256750|156910529|FG002|Long Term Extension (LTE; 84 Months)|Adverse Event|14|||
48743287|NCT00256750|156910527|FG000|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5|||
48856690|NCT03137459|157314910|FG001|2-month Assessment|Withdrawal by Subject|3|||
48856691|NCT03137459|157314909|FG000|2-month Assessment|Unable to reach|42|||
48856692|NCT03137459|157314910|FG001|2-month Assessment|Unable to reach|32|||
48951898|NCT04760314|157654916|FG002|Maintenance Blinded Period|Protocol Deviation|0|||
48951899|NCT04760314|157654917|FG003|Maintenance Blinded Period|Protocol Deviation|0|||
48951900|NCT04760314|157654918|FG004|Maintenance Blinded Period|Protocol Deviation|0|||
48951901|NCT04760314|157654919|FG005|Maintenance Blinded Period|Protocol Deviation|1|||
48951902|NCT04760314|157654920|FG006|Maintenance Blinded Period|Protocol Deviation|0|||
48951903|NCT04760314|157654921|FG007|Maintenance Blinded Period|Protocol Deviation|0|||
48951904|NCT04760314|157654922|FG008|Maintenance Blinded Period|Protocol Deviation|0|||
48856693|NCT03137459|157314909|FG000|2-month Assessment|Refused assessment|7|||
48856694|NCT03137459|157314910|FG001|2-month Assessment|Refused assessment|5|||
48856695|NCT03137459|157314909|FG000|2-month Assessment|Acutely ill|6|||
48856696|NCT03137459|157314910|FG001|2-month Assessment|Acutely ill|2|||
48856697|NCT03137459|157314909|FG000|4-month Assessment|Death|4|||
48856698|NCT03137459|157314910|FG001|4-month Assessment|Death|2|||
48856699|NCT03137459|157314909|FG000|4-month Assessment|Withdrawal by Subject|4|||
48856700|NCT03137459|157314910|FG001|4-month Assessment|Withdrawal by Subject|2|||
48856701|NCT03137459|157314909|FG000|4-month Assessment|Unable to reach|44|||
48856702|NCT03137459|157314910|FG001|4-month Assessment|Unable to reach|29|||
48856703|NCT03137459|157314909|FG000|4-month Assessment|Refused assessment|24|||
48856704|NCT03137459|157314910|FG001|4-month Assessment|Refused assessment|10|||
48856705|NCT03137459|157314909|FG000|4-month Assessment|Acutely ill|2|||
48856706|NCT03137459|157314910|FG001|4-month Assessment|Acutely ill|3|||
48856707|NCT03137459|157314909|FG000|6-months|Lost to Follow-up|14|||
48856708|NCT03137459|157314910|FG001|6-months|Lost to Follow-up|11|||
48856709|NCT03137459|157314909|FG000|6-months|Death|0|||
48856710|NCT03137459|157314910|FG001|6-months|Death|2|||
48856711|NCT03137459|157314909|FG000|6-months|Refused assessment|6|||
48856712|NCT03137459|157314910|FG001|6-months|Refused assessment|3|||
48856713|NCT03137459|157314909|FG000|6-months|Acutely ill|1|||
48856714|NCT03137459|157314910|FG001|6-months|Acutely ill|1|||
48856715|NCT00985088|157314911|FG000|Overall Study|Serious Adverse Event|1|||
48856716|NCT00985088|157314912|FG001|Overall Study|Serious Adverse Event|1|||
48856717|NCT00985088|157314913|FG002|Overall Study|Serious Adverse Event|0|||
48856718|NCT00985088|157314914|FG003|Overall Study|Serious Adverse Event|0|||
48856719|NCT00985088|157314915|FG004|Overall Study|Serious Adverse Event|0|||
48856720|NCT00985088|157314916|FG005|Overall Study|Serious Adverse Event|0|||
48856721|NCT00985088|157314917|FG006|Overall Study|Serious Adverse Event|0|||
48856722|NCT00985088|157314918|FG007|Overall Study|Serious Adverse Event|1|||
48856723|NCT00985088|157314911|FG000|Overall Study|Adverse Event|0|||
48856724|NCT00985088|157314912|FG001|Overall Study|Adverse Event|0|||
48856725|NCT00985088|157314913|FG002|Overall Study|Adverse Event|1|||
48856726|NCT00985088|157314914|FG003|Overall Study|Adverse Event|0|||
48856727|NCT00985088|157314915|FG004|Overall Study|Adverse Event|0|||
48856728|NCT00985088|157314916|FG005|Overall Study|Adverse Event|0|||
48856729|NCT00985088|157314917|FG006|Overall Study|Adverse Event|0|||
48856730|NCT00985088|157314918|FG007|Overall Study|Adverse Event|0|||
48856731|NCT00985088|157314911|FG000|Overall Study|Withdrawal by Subject|4|||
48856732|NCT00985088|157314912|FG001|Overall Study|Withdrawal by Subject|0|||
48856733|NCT00985088|157314913|FG002|Overall Study|Withdrawal by Subject|0|||
48856734|NCT00985088|157314914|FG003|Overall Study|Withdrawal by Subject|1|||
48856735|NCT00985088|157314915|FG004|Overall Study|Withdrawal by Subject|3|||
48856736|NCT00985088|157314916|FG005|Overall Study|Withdrawal by Subject|2|||
48856737|NCT00985088|157314917|FG006|Overall Study|Withdrawal by Subject|1|||
48856738|NCT00985088|157314918|FG007|Overall Study|Withdrawal by Subject|2|||
48856739|NCT00985088|157314911|FG000|Overall Study|Migrated/moved from study area|0|||
48856740|NCT00985088|157314912|FG001|Overall Study|Migrated/moved from study area|0|||
48856741|NCT00985088|157314913|FG002|Overall Study|Migrated/moved from study area|1|||
48856742|NCT00985088|157314914|FG003|Overall Study|Migrated/moved from study area|0|||
48951905|NCT04760314|157654923|FG009|Maintenance Blinded Period|Protocol Deviation|0|||
48856743|NCT00985088|157314915|FG004|Overall Study|Migrated/moved from study area|0|||
48856744|NCT00985088|157314916|FG005|Overall Study|Migrated/moved from study area|0|||
48856745|NCT00985088|157314917|FG006|Overall Study|Migrated/moved from study area|0|||
48743288|NCT00256750|156910528|FG001|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4|||
48856746|NCT00985088|157314918|FG007|Overall Study|Migrated/moved from study area|1|||
48856747|NCT00985088|157314911|FG000|Overall Study|Lost to Follow-up|6|||
48856748|NCT00985088|157314912|FG001|Overall Study|Lost to Follow-up|1|||
48856749|NCT00985088|157314913|FG002|Overall Study|Lost to Follow-up|2|||
48856750|NCT00985088|157314914|FG003|Overall Study|Lost to Follow-up|6|||
48856751|NCT00985088|157314915|FG004|Overall Study|Lost to Follow-up|6|||
48856752|NCT00985088|157314916|FG005|Overall Study|Lost to Follow-up|5|||
48951906|NCT04760314|157654924|FG010|Maintenance Blinded Period|Protocol Deviation|0|||
48951907|NCT04760314|157654914|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
48951908|NCT04760314|157654915|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
48856753|NCT00985088|157314917|FG006|Overall Study|Lost to Follow-up|3|||
48856754|NCT00985088|157314918|FG007|Overall Study|Lost to Follow-up|2|||
48856755|NCT02232737|157314919|FG000|Overall Study|Lost to Follow-up|18|||
48856756|NCT02232737|157314920|FG001|Overall Study|Lost to Follow-up|28|||
48856757|NCT02232737|157314921|FG002|Overall Study|Lost to Follow-up|33|||
48856758|NCT02232737|157314919|FG000|Overall Study|Personal reasons|7|||
48856759|NCT02232737|157314920|FG001|Overall Study|Personal reasons|8|||
48856760|NCT02232737|157314921|FG002|Overall Study|Personal reasons|14|||
48856761|NCT02232737|157314919|FG000|Overall Study|Adverse Event|6|||
48856762|NCT02232737|157314920|FG001|Overall Study|Adverse Event|3|||
48856763|NCT02232737|157314921|FG002|Overall Study|Adverse Event|8|||
48856764|NCT02232737|157314919|FG000|Overall Study|Incarcerated|2|||
48856765|NCT02232737|157314920|FG001|Overall Study|Incarcerated|1|||
48856766|NCT02232737|157314921|FG002|Overall Study|Incarcerated|2|||
48856767|NCT02232737|157314919|FG000|Overall Study|Withdrawal by Subject|0|||
48856768|NCT02232737|157314920|FG001|Overall Study|Withdrawal by Subject|1|||
48856769|NCT02232737|157314921|FG002|Overall Study|Withdrawal by Subject|2|||
48856770|NCT02232737|157314919|FG000|Overall Study|Death|0|||
48856771|NCT02232737|157314920|FG001|Overall Study|Death|1|||
48856772|NCT02232737|157314921|FG002|Overall Study|Death|1|||
48951909|NCT04760314|157654916|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
48951910|NCT04760314|157654917|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
48951911|NCT04760314|157654918|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
48951912|NCT04760314|157654919|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
48951913|NCT04760314|157654920|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
48951914|NCT04760314|157654921|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
48951915|NCT04760314|157654922|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
48951916|NCT04760314|157654923|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
48951917|NCT04760314|157654924|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
48951918|NCT04760314|157654914|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
48951919|NCT04760314|157654915|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
48951920|NCT04760314|157654916|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
48951921|NCT04760314|157654917|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
48951922|NCT04760314|157654918|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
48951923|NCT04760314|157654919|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
48951924|NCT04760314|157654920|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
48951925|NCT04760314|157654921|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
48951926|NCT04760314|157654922|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
48951927|NCT04760314|157654923|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
48951928|NCT04760314|157654924|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
48951929|NCT04760314|157654914|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
48951930|NCT04760314|157654915|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
48951931|NCT04760314|157654916|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
48951932|NCT04760314|157654917|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
48951933|NCT04760314|157654918|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
48951934|NCT04760314|157654919|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
48856773|NCT02232737|157314919|FG000|Overall Study|Physician Decision|1|||
48856774|NCT02232737|157314920|FG001|Overall Study|Physician Decision|3|||
48856775|NCT02232737|157314921|FG002|Overall Study|Physician Decision|1|||
48856776|NCT02232737|157314919|FG000|Overall Study|Protocol Violation|1|||
48856777|NCT02232737|157314920|FG001|Overall Study|Protocol Violation|0|||
48856778|NCT02232737|157314921|FG002|Overall Study|Protocol Violation|1|||
48856779|NCT02232737|157314919|FG000|Overall Study|Reason unknown|1|||
48856780|NCT02232737|157314920|FG001|Overall Study|Reason unknown|0|||
48743289|NCT00256750|156910529|FG002|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1|||
48743290|NCT00256750|156910527|FG000|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4|||
48743291|NCT00256750|156910528|FG001|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
48743292|NCT00256750|156910529|FG002|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
48743293|NCT00256750|156910527|FG000|Long Term Extension (LTE; 84 Months)|Death|9|||
48743294|NCT00256750|156910528|FG001|Long Term Extension (LTE; 84 Months)|Death|4|||
48743295|NCT00256750|156910529|FG002|Long Term Extension (LTE; 84 Months)|Death|4|||
48743296|NCT00256750|156910527|FG000|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6|||
48743297|NCT00256750|156910528|FG001|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3|||
48743298|NCT00256750|156910529|FG002|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0|||
48743299|NCT00256750|156910527|FG000|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4|||
48743300|NCT00256750|156910528|FG001|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
48743301|NCT00256750|156910529|FG002|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
48743302|NCT00256750|156910527|FG000|Long Term Extension (LTE; 84 Months)|Pregnancy|0|||
48743303|NCT00256750|156910528|FG001|Long Term Extension (LTE; 84 Months)|Pregnancy|1|||
48743304|NCT00256750|156910529|FG002|Long Term Extension (LTE; 84 Months)|Pregnancy|2|||
48743305|NCT00256750|156910527|FG000|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
48743306|NCT00256750|156910528|FG001|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
48743307|NCT00256750|156910529|FG002|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0|||
48743308|NCT00256750|156910527|FG000|Long Term Extension (LTE; 84 Months)|Other|5|||
48743309|NCT00256750|156910528|FG001|Long Term Extension (LTE; 84 Months)|Other|4|||
48743310|NCT00256750|156910529|FG002|Long Term Extension (LTE; 84 Months)|Other|5|||
48743311|NCT02610725|156910530|FG000|Overall Study|Lost to Follow-up|197|||
48743312|NCT02610725|156910530|FG000|Overall Study|self-reported contraindication|9|||
48743313|NCT01032837|156910531|FG000|Overall Study|Adverse event/internal illness|0|||
48743314|NCT01032837|156910532|FG001|Overall Study|Adverse event/internal illness|1|||
48743315|NCT01032837|156910533|FG002|Overall Study|Adverse event/internal illness|0|||
48743316|NCT01032837|156910534|FG003|Overall Study|Adverse event/internal illness|1|||
48743317|NCT01032837|156910531|FG000|Overall Study|Withdrew consent|0|||
48743318|NCT01032837|156910532|FG001|Overall Study|Withdrew consent|2|||
48743319|NCT01032837|156910533|FG002|Overall Study|Withdrew consent|0|||
48743320|NCT01032837|156910534|FG003|Overall Study|Withdrew consent|1|||
48743321|NCT01032837|156910531|FG000|Overall Study|Failed to return|0|||
48743322|NCT01032837|156910532|FG001|Overall Study|Failed to return|0|||
48743323|NCT01032837|156910533|FG002|Overall Study|Failed to return|1|||
48743324|NCT01032837|156910534|FG003|Overall Study|Failed to return|0|||
48743325|NCT01032837|156910531|FG000|Overall Study|Refused treatment|0|||
48743326|NCT01032837|156910532|FG001|Overall Study|Refused treatment|0|||
48743327|NCT01032837|156910533|FG002|Overall Study|Refused treatment|0|||
48743328|NCT01032837|156910534|FG003|Overall Study|Refused treatment|1|||
48743329|NCT01382212|156910535|FG000|Overall Study|Kidney transplant|1|||
48743330|NCT01382212|156910535|FG000|Overall Study|Withdrew consent|1|||
48743331|NCT00743483|156910536|FG000|Baseline Period|Physician Decision|1|||
48743332|NCT00743483|156910536|FG000|Treatment Period|Adverse Event|1|||
48743333|NCT01929343|156910537|FG000|Overall Study|Physician Decision|0|||
48743334|NCT01929343|156910538|FG001|Overall Study|Physician Decision|2|||
48743335|NCT01929343|156910539|FG002|Overall Study|Physician Decision|0|||
48743336|NCT01929343|156910537|FG000|Overall Study|Withdrawal by Subject|1|||
48743337|NCT01929343|156910538|FG001|Overall Study|Withdrawal by Subject|0|||
48743338|NCT01929343|156910539|FG002|Overall Study|Withdrawal by Subject|0|||
48743339|NCT03715530|156910540|FG000|Overall Study|Lost to Follow-up|3|||
48743340|NCT03715530|156910541|FG001|Overall Study|Lost to Follow-up|1|||
48743341|NCT03715530|156910542|FG002|Overall Study|Lost to Follow-up|2|||
48743342|NCT00211510|156910548|FG000|Overall Study|Physician Decision|3|||
48743343|NCT00211510|156910549|FG001|Overall Study|Physician Decision|1|||
48743344|NCT00211510|156910548|FG000|Overall Study|Withdrawal by Subject|3|||
48743345|NCT00211510|156910549|FG001|Overall Study|Withdrawal by Subject|1|||
48743346|NCT00833794|156910553|FG000|Open-label Phase|Adverse Event|225|||
48743347|NCT00833794|156910554|FG001|Open-label Phase|Adverse Event|0|||
48743348|NCT00833794|156910553|FG000|Open-label Phase|Lack of Efficacy|28|||
48743349|NCT00833794|156910554|FG001|Open-label Phase|Lack of Efficacy|0|||
48743350|NCT00833794|156910553|FG000|Open-label Phase|Withdrawal by Subject|48|||
48743351|NCT00833794|156910554|FG001|Open-label Phase|Withdrawal by Subject|0|||
48743352|NCT00833794|156910553|FG000|Open-label Phase|Physician Decision|20|||
48743353|NCT00833794|156910554|FG001|Open-label Phase|Physician Decision|0|||
48743354|NCT00833794|156910553|FG000|Open-label Phase|Administrative reason|1|||
48743355|NCT00833794|156910554|FG001|Open-label Phase|Administrative reason|0|||
48743356|NCT00833794|156910553|FG000|Open-label Phase|Protocol Violation|47|||
48743357|NCT00833794|156910554|FG001|Open-label Phase|Protocol Violation|0|||
48856781|NCT02232737|157314921|FG002|Overall Study|Reason unknown|0|||
48856782|NCT00925548|157314931|FG000|Overall Study|Discontinuation of trial by sponsor|10|||
48743358|NCT00833794|156910553|FG000|Open-label Phase|Did not complete wash-out period|12|||
48743359|NCT00833794|156910554|FG001|Open-label Phase|Did not complete wash-out period|0|||
48856783|NCT00925548|157314932|FG001|Overall Study|Discontinuation of trial by sponsor|5|||
48856784|NCT02224755|157314939|FG000|Randomization to Device Implant|Withdrawn prior to implant|7|||
48743360|NCT00833794|156910553|FG000|Open-label Phase|enrolled in error (immediately D/C)|1|||
48743361|NCT00833794|156910554|FG001|Open-label Phase|enrolled in error (immediately D/C)|0|||
48743362|NCT00833794|156910553|FG000|Double-blind Phase|Adverse Event|44|||
48743363|NCT00833794|156910554|FG001|Double-blind Phase|Adverse Event|11|||
48743364|NCT00833794|156910553|FG000|Double-blind Phase|Lack of Efficacy|34|||
48743365|NCT00833794|156910554|FG001|Double-blind Phase|Lack of Efficacy|22|||
48743366|NCT00833794|156910553|FG000|Double-blind Phase|Withdrawal by Subject|23|||
48743367|NCT00833794|156910554|FG001|Double-blind Phase|Withdrawal by Subject|6|||
48743368|NCT00833794|156910553|FG000|Double-blind Phase|Physician Decision|4|||
48743369|NCT00833794|156910554|FG001|Double-blind Phase|Physician Decision|7|||
48743370|NCT00833794|156910553|FG000|Double-blind Phase|Administrative reason|1|||
48743371|NCT00833794|156910554|FG001|Double-blind Phase|Administrative reason|3|||
48743372|NCT02207244|156910555|FG000|Placebo Controlled Period: Week 0-16|Adverse Event|2|||
48743373|NCT02207244|156910556|FG001|Placebo Controlled Period: Week 0-16|Adverse Event|9|||
48743374|NCT02207244|156910557|FG002|Placebo Controlled Period: Week 0-16|Adverse Event|4|||
48743375|NCT02207244|156910558|FG003|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
48743376|NCT02207244|156910559|FG004|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
48743377|NCT02207244|156910560|FG005|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
48743378|NCT02207244|156910561|FG006|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
48743379|NCT02207244|156910562|FG007|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
48743380|NCT02207244|156910563|FG008|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
48743381|NCT02207244|156910564|FG009|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
48743382|NCT02207244|156910565|FG010|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
48743383|NCT02207244|156910555|FG000|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4|||
48743384|NCT02207244|156910556|FG001|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
48743385|NCT02207244|156910557|FG002|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2|||
48743386|NCT02207244|156910558|FG003|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
48743387|NCT02207244|156910559|FG004|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
48743388|NCT02207244|156910560|FG005|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
48743389|NCT02207244|156910561|FG006|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
48743390|NCT02207244|156910562|FG007|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
48743391|NCT02207244|156910563|FG008|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
48743392|NCT02207244|156910564|FG009|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
48743393|NCT02207244|156910565|FG010|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
48743394|NCT02207244|156910555|FG000|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1|||
48743395|NCT02207244|156910556|FG001|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3|||
48743396|NCT02207244|156910557|FG002|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2|||
48743397|NCT02207244|156910558|FG003|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
48743398|NCT02207244|156910559|FG004|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
48743399|NCT02207244|156910560|FG005|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
48743400|NCT02207244|156910561|FG006|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
48743401|NCT02207244|156910562|FG007|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
48743402|NCT02207244|156910563|FG008|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
48743403|NCT02207244|156910564|FG009|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
48743404|NCT02207244|156910565|FG010|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
48743405|NCT02207244|156910555|FG000|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7|||
48743406|NCT02207244|156910556|FG001|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1|||
48743407|NCT02207244|156910557|FG002|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
48743408|NCT02207244|156910558|FG003|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
48743409|NCT02207244|156910559|FG004|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
48856785|NCT02224755|157314940|FG001|Randomization to Device Implant|Withdrawn prior to implant|1|||
48856786|NCT02224755|157314939|FG000|Two Year Follow up Post-implant|Death|103|||
48856787|NCT02224755|157314940|FG001|Two Year Follow up Post-implant|Death|98|||
48856788|NCT02224755|157314939|FG000|Two Year Follow up Post-implant|Heart transplant|137|||
48856789|NCT02224755|157314940|FG001|Two Year Follow up Post-implant|Heart transplant|119|||
48743410|NCT02207244|156910560|FG005|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
48743411|NCT02207244|156910561|FG006|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
48856790|NCT02224755|157314939|FG000|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
48856791|NCT02224755|157314940|FG001|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
48856792|NCT02224755|157314939|FG000|Two Year Follow up Post-implant|Withdrawn post-implant|15|||
48856793|NCT02224755|157314940|FG001|Two Year Follow up Post-implant|Withdrawn post-implant|6|||
48856794|NCT02095145|157314941|FG000|Overall Study|Withdrawal by Subject|1|||
48856795|NCT02095145|157314942|FG001|Overall Study|Withdrawal by Subject|0|||
48856796|NCT00103857|157314949|FG000|54-Week Base Study|Adverse Event|12|||
48856797|NCT00103857|157314950|FG001|54-Week Base Study|Adverse Event|9|||
48856798|NCT00103857|157314951|FG002|54-Week Base Study|Adverse Event|11|||
48856799|NCT00103857|157314952|FG003|54-Week Base Study|Adverse Event|6|||
48856800|NCT00103857|157314953|FG004|54-Week Base Study|Adverse Event|5|||
48856801|NCT00103857|157314954|FG005|54-Week Base Study|Adverse Event|11|||
48856802|NCT00103857|157314955|FG006|54-Week Base Study|Adverse Event|3|||
48856803|NCT00103857|157314949|FG000|54-Week Base Study|Death|0|||
48856804|NCT00103857|157314950|FG001|54-Week Base Study|Death|0|||
48856805|NCT00103857|157314951|FG002|54-Week Base Study|Death|0|||
48856806|NCT00103857|157314952|FG003|54-Week Base Study|Death|0|||
48856807|NCT00103857|157314953|FG004|54-Week Base Study|Death|1|||
48856808|NCT00103857|157314954|FG005|54-Week Base Study|Death|1|||
48856809|NCT00103857|157314955|FG006|54-Week Base Study|Death|0|||
48856810|NCT00103857|157314949|FG000|54-Week Base Study|Lack of Efficacy|11|||
48856811|NCT00103857|157314950|FG001|54-Week Base Study|Lack of Efficacy|14|||
48856812|NCT00103857|157314951|FG002|54-Week Base Study|Lack of Efficacy|8|||
48856813|NCT00103857|157314952|FG003|54-Week Base Study|Lack of Efficacy|4|||
48856814|NCT00103857|157314953|FG004|54-Week Base Study|Lack of Efficacy|3|||
48856815|NCT00103857|157314954|FG005|54-Week Base Study|Lack of Efficacy|14|||
48856816|NCT00103857|157314955|FG006|54-Week Base Study|Lack of Efficacy|19|||
48743412|NCT02207244|156910562|FG007|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
48743413|NCT02207244|156910563|FG008|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
48743414|NCT02207244|156910564|FG009|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
48743415|NCT02207244|156910565|FG010|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
48743416|NCT02207244|156910555|FG000|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
48743417|NCT02207244|156910556|FG001|Placebo Controlled Period: Week 0-16|Protocol Violation|3|||
48743418|NCT02207244|156910557|FG002|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
48743419|NCT02207244|156910558|FG003|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
48743420|NCT02207244|156910559|FG004|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
48856817|NCT00103857|157314949|FG000|54-Week Base Study|Lost to Follow-up|5|||
48856818|NCT00103857|157314950|FG001|54-Week Base Study|Lost to Follow-up|4|||
48856819|NCT00103857|157314951|FG002|54-Week Base Study|Lost to Follow-up|7|||
48856820|NCT00103857|157314952|FG003|54-Week Base Study|Lost to Follow-up|5|||
48856821|NCT00103857|157314953|FG004|54-Week Base Study|Lost to Follow-up|10|||
48856822|NCT00103857|157314954|FG005|54-Week Base Study|Lost to Follow-up|9|||
48856823|NCT00103857|157314955|FG006|54-Week Base Study|Lost to Follow-up|3|||
48856824|NCT00103857|157314949|FG000|54-Week Base Study|Physician Decision|1|||
48856825|NCT00103857|157314950|FG001|54-Week Base Study|Physician Decision|1|||
48856826|NCT00103857|157314951|FG002|54-Week Base Study|Physician Decision|0|||
48856827|NCT00103857|157314952|FG003|54-Week Base Study|Physician Decision|0|||
48856828|NCT00103857|157314953|FG004|54-Week Base Study|Physician Decision|1|||
48856829|NCT00103857|157314954|FG005|54-Week Base Study|Physician Decision|0|||
48856830|NCT00103857|157314955|FG006|54-Week Base Study|Physician Decision|0|||
48856831|NCT00103857|157314949|FG000|54-Week Base Study|Pregnancy|1|||
48856832|NCT00103857|157314950|FG001|54-Week Base Study|Pregnancy|0|||
48856833|NCT00103857|157314951|FG002|54-Week Base Study|Pregnancy|0|||
48856834|NCT00103857|157314952|FG003|54-Week Base Study|Pregnancy|0|||
48856835|NCT00103857|157314953|FG004|54-Week Base Study|Pregnancy|1|||
48856836|NCT00103857|157314954|FG005|54-Week Base Study|Pregnancy|0|||
48856837|NCT00103857|157314955|FG006|54-Week Base Study|Pregnancy|1|||
48856838|NCT00103857|157314949|FG000|54-Week Base Study|Protocol Violation|6|||
48856839|NCT00103857|157314950|FG001|54-Week Base Study|Protocol Violation|4|||
48856840|NCT00103857|157314951|FG002|54-Week Base Study|Protocol Violation|2|||
48856841|NCT00103857|157314952|FG003|54-Week Base Study|Protocol Violation|4|||
48856842|NCT00103857|157314953|FG004|54-Week Base Study|Protocol Violation|0|||
48856843|NCT00103857|157314954|FG005|54-Week Base Study|Protocol Violation|3|||
48856844|NCT00103857|157314955|FG006|54-Week Base Study|Protocol Violation|3|||
48856845|NCT00103857|157314949|FG000|54-Week Base Study|Withdrawal by Subject|17|||
48856846|NCT00103857|157314950|FG001|54-Week Base Study|Withdrawal by Subject|16|||
48856847|NCT00103857|157314951|FG002|54-Week Base Study|Withdrawal by Subject|16|||
48856848|NCT00103857|157314952|FG003|54-Week Base Study|Withdrawal by Subject|15|||
48951935|NCT04760314|157654920|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
48951936|NCT04760314|157654921|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
48856849|NCT00103857|157314953|FG004|54-Week Base Study|Withdrawal by Subject|10|||
48951937|NCT04760314|157654922|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
48951938|NCT04760314|157654923|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
48951939|NCT04760314|157654924|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
48951940|NCT04760314|157654914|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
48951941|NCT04760314|157654915|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
48951942|NCT04760314|157654916|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
48743421|NCT02207244|156910560|FG005|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
48743422|NCT02207244|156910561|FG006|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
48743423|NCT02207244|156910562|FG007|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
48743424|NCT02207244|156910563|FG008|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
48743425|NCT02207244|156910564|FG009|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
48743426|NCT02207244|156910565|FG010|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
48743427|NCT02207244|156910555|FG000|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
48743428|NCT02207244|156910556|FG001|Placebo Controlled Period: Week 0-16|Noncompliance|1|||
48743429|NCT02207244|156910557|FG002|Placebo Controlled Period: Week 0-16|Noncompliance|2|||
48856850|NCT00103857|157314954|FG005|54-Week Base Study|Withdrawal by Subject|15|||
48856851|NCT00103857|157314955|FG006|54-Week Base Study|Withdrawal by Subject|4|||
48856852|NCT00103857|157314949|FG000|54-Week Base Study|protocol discontinuation criteria|2|||
48856853|NCT00103857|157314950|FG001|54-Week Base Study|protocol discontinuation criteria|5|||
48856854|NCT00103857|157314951|FG002|54-Week Base Study|protocol discontinuation criteria|2|||
48856855|NCT00103857|157314952|FG003|54-Week Base Study|protocol discontinuation criteria|6|||
48856856|NCT00103857|157314953|FG004|54-Week Base Study|protocol discontinuation criteria|5|||
48856857|NCT00103857|157314954|FG005|54-Week Base Study|protocol discontinuation criteria|3|||
48856858|NCT00103857|157314955|FG006|54-Week Base Study|protocol discontinuation criteria|5|||
48743430|NCT02207244|156910558|FG003|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
48856859|NCT00103857|157314949|FG000|54-Week Base Study|patient moved|0|||
48856860|NCT00103857|157314950|FG001|54-Week Base Study|patient moved|1|||
48856861|NCT00103857|157314951|FG002|54-Week Base Study|patient moved|1|||
48856862|NCT00103857|157314952|FG003|54-Week Base Study|patient moved|2|||
48856863|NCT00103857|157314953|FG004|54-Week Base Study|patient moved|3|||
48856864|NCT00103857|157314954|FG005|54-Week Base Study|patient moved|1|||
48856865|NCT00103857|157314955|FG006|54-Week Base Study|patient moved|0|||
48856866|NCT00103857|157314949|FG000|54-Week Base Study|non-compliance with study procedures|1|||
48743431|NCT02207244|156910559|FG004|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
48743432|NCT02207244|156910560|FG005|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
48743433|NCT02207244|156910561|FG006|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
48743434|NCT02207244|156910562|FG007|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
48743435|NCT02207244|156910563|FG008|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
48743436|NCT02207244|156910564|FG009|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
48743437|NCT02207244|156910565|FG010|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
48743438|NCT02207244|156910555|FG000|Placebo Controlled Period: Week 0-16|OTHER|0|||
48743439|NCT02207244|156910556|FG001|Placebo Controlled Period: Week 0-16|OTHER|1|||
48743440|NCT02207244|156910557|FG002|Placebo Controlled Period: Week 0-16|OTHER|0|||
48743441|NCT02207244|156910558|FG003|Placebo Controlled Period: Week 0-16|OTHER|0|||
48743442|NCT02207244|156910559|FG004|Placebo Controlled Period: Week 0-16|OTHER|0|||
48743443|NCT02207244|156910560|FG005|Placebo Controlled Period: Week 0-16|OTHER|0|||
48743444|NCT02207244|156910561|FG006|Placebo Controlled Period: Week 0-16|OTHER|0|||
48743445|NCT02207244|156910562|FG007|Placebo Controlled Period: Week 0-16|OTHER|0|||
48743446|NCT02207244|156910563|FG008|Placebo Controlled Period: Week 0-16|OTHER|0|||
48743447|NCT02207244|156910564|FG009|Placebo Controlled Period: Week 0-16|OTHER|0|||
48743448|NCT02207244|156910565|FG010|Placebo Controlled Period: Week 0-16|OTHER|0|||
48743449|NCT02207244|156910555|FG000|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
48743450|NCT02207244|156910556|FG001|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
48743451|NCT02207244|156910557|FG002|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
48743452|NCT02207244|156910558|FG003|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
48743453|NCT02207244|156910559|FG004|Placebo Crossover and ACP: Week 16-28|Adverse Event|3|||
48743454|NCT02207244|156910560|FG005|Placebo Crossover and ACP: Week 16-28|Adverse Event|2|||
48743455|NCT02207244|156910561|FG006|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
48743456|NCT02207244|156910562|FG007|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
48743457|NCT02207244|156910563|FG008|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
48743458|NCT02207244|156910564|FG009|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
48743459|NCT02207244|156910565|FG010|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
48743460|NCT02207244|156910555|FG000|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
48743461|NCT02207244|156910556|FG001|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
48743462|NCT02207244|156910557|FG002|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
48743463|NCT02207244|156910558|FG003|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
48743464|NCT02207244|156910559|FG004|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
48743465|NCT02207244|156910560|FG005|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2|||
48743466|NCT02207244|156910561|FG006|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
48743467|NCT02207244|156910562|FG007|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
48743468|NCT02207244|156910563|FG008|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
48743469|NCT02207244|156910564|FG009|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
48743470|NCT02207244|156910565|FG010|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
48743471|NCT02207244|156910555|FG000|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
48743472|NCT02207244|156910556|FG001|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
48743473|NCT02207244|156910557|FG002|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
48743474|NCT02207244|156910558|FG003|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1|||
48743475|NCT02207244|156910559|FG004|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
48743476|NCT02207244|156910560|FG005|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
48743477|NCT02207244|156910561|FG006|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
48743478|NCT02207244|156910562|FG007|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
48743479|NCT02207244|156910563|FG008|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
48743480|NCT02207244|156910564|FG009|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
48743481|NCT02207244|156910565|FG010|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
48743482|NCT02207244|156910555|FG000|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
48743483|NCT02207244|156910556|FG001|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
48743484|NCT02207244|156910557|FG002|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
48743485|NCT02207244|156910558|FG003|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
48743486|NCT02207244|156910559|FG004|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
48743487|NCT02207244|156910560|FG005|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2|||
48743488|NCT02207244|156910561|FG006|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
48743489|NCT02207244|156910562|FG007|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
48743490|NCT02207244|156910563|FG008|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
48743491|NCT02207244|156910564|FG009|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
48743492|NCT02207244|156910565|FG010|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
48743493|NCT02207244|156910555|FG000|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
48743494|NCT02207244|156910556|FG001|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
48951943|NCT04760314|157654917|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
48951944|NCT04760314|157654918|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
48743495|NCT02207244|156910557|FG002|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
48743496|NCT02207244|156910558|FG003|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
48743497|NCT02207244|156910559|FG004|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
48743498|NCT02207244|156910560|FG005|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
48743499|NCT02207244|156910561|FG006|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
48743500|NCT02207244|156910562|FG007|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
48743501|NCT02207244|156910563|FG008|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
48743502|NCT02207244|156910564|FG009|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
48743503|NCT02207244|156910565|FG010|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
48743504|NCT02207244|156910555|FG000|Placebo Crossover and ACP: Week 16-28|Other|0|||
48743505|NCT02207244|156910556|FG001|Placebo Crossover and ACP: Week 16-28|Other|0|||
48743506|NCT02207244|156910557|FG002|Placebo Crossover and ACP: Week 16-28|Other|0|||
48743507|NCT02207244|156910558|FG003|Placebo Crossover and ACP: Week 16-28|Other|1|||
48743508|NCT02207244|156910559|FG004|Placebo Crossover and ACP: Week 16-28|Other|0|||
48743509|NCT02207244|156910560|FG005|Placebo Crossover and ACP: Week 16-28|Other|0|||
48743510|NCT02207244|156910561|FG006|Placebo Crossover and ACP: Week 16-28|Other|0|||
48951945|NCT04760314|157654919|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
48951946|NCT04760314|157654920|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
48951947|NCT04760314|157654921|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
48951948|NCT04760314|157654922|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
48951949|NCT04760314|157654923|FG009|Maintenance Open Label Escape Arm|Adverse Event|1|||
48951950|NCT04760314|157654924|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
48951951|NCT03242928|157654925|FG000|Overall Study|Adverse Event|2|||
48951952|NCT03242928|157654926|FG001|Overall Study|Adverse Event|1|||
48951953|NCT03242928|157654925|FG000|Overall Study|Lost to Follow-up|2|||
48743511|NCT02207244|156910562|FG007|Placebo Crossover and ACP: Week 16-28|Other|0|||
48743512|NCT02207244|156910563|FG008|Placebo Crossover and ACP: Week 16-28|Other|0|||
48743513|NCT02207244|156910564|FG009|Placebo Crossover and ACP: Week 16-28|Other|0|||
48743514|NCT02207244|156910565|FG010|Placebo Crossover and ACP: Week 16-28|Other|0|||
48743515|NCT02207244|156910555|FG000|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
48743516|NCT02207244|156910556|FG001|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
48743517|NCT02207244|156910557|FG002|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
48743518|NCT02207244|156910558|FG003|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
48743519|NCT02207244|156910559|FG004|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
48951954|NCT03242928|157654926|FG001|Overall Study|Lost to Follow-up|0|||
48951955|NCT03242928|157654925|FG000|Overall Study|Physician Decision|0|||
48951956|NCT03242928|157654926|FG001|Overall Study|Physician Decision|1|||
48951957|NCT03242928|157654925|FG000|Overall Study|Withdrawal by Subject|5|||
48951958|NCT03242928|157654926|FG001|Overall Study|Withdrawal by Subject|3|||
48951959|NCT02750813|157654927|FG000|Period 1, First 14 Days of Wear|Withdrawal by Subject|1|||
48951960|NCT02750813|157654928|FG001|Period 1, First 14 Days of Wear|Withdrawal by Subject|0|||
48951961|NCT02750813|157654927|FG000|Period 1, First 14 Days of Wear|Reason not given|0|||
48856867|NCT00103857|157314950|FG001|54-Week Base Study|non-compliance with study procedures|2|||
48856868|NCT00103857|157314951|FG002|54-Week Base Study|non-compliance with study procedures|0|||
48856869|NCT00103857|157314952|FG003|54-Week Base Study|non-compliance with study procedures|0|||
48856870|NCT00103857|157314953|FG004|54-Week Base Study|non-compliance with study procedures|0|||
48856871|NCT00103857|157314954|FG005|54-Week Base Study|non-compliance with study procedures|2|||
48856872|NCT00103857|157314955|FG006|54-Week Base Study|non-compliance with study procedures|0|||
48856873|NCT00103857|157314949|FG000|54-Week Base Study|patient incarcerated|0|||
48856874|NCT00103857|157314950|FG001|54-Week Base Study|patient incarcerated|0|||
48856875|NCT00103857|157314951|FG002|54-Week Base Study|patient incarcerated|0|||
48856876|NCT00103857|157314952|FG003|54-Week Base Study|patient incarcerated|0|||
48856877|NCT00103857|157314953|FG004|54-Week Base Study|patient incarcerated|1|||
48856878|NCT00103857|157314954|FG005|54-Week Base Study|patient incarcerated|1|||
48856879|NCT00103857|157314955|FG006|54-Week Base Study|patient incarcerated|0|||
48856880|NCT00103857|157314949|FG000|54-Week Base Study|laboratory reporting error|0|||
48856881|NCT00103857|157314950|FG001|54-Week Base Study|laboratory reporting error|0|||
48856882|NCT00103857|157314951|FG002|54-Week Base Study|laboratory reporting error|0|||
48856883|NCT00103857|157314952|FG003|54-Week Base Study|laboratory reporting error|0|||
48856884|NCT00103857|157314953|FG004|54-Week Base Study|laboratory reporting error|1|||
48856885|NCT00103857|157314954|FG005|54-Week Base Study|laboratory reporting error|0|||
48856886|NCT00103857|157314955|FG006|54-Week Base Study|laboratory reporting error|0|||
48951962|NCT02750813|157654928|FG001|Period 1, First 14 Days of Wear|Reason not given|1|||
48743520|NCT02207244|156910560|FG005|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
48743521|NCT02207244|156910561|FG006|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1|||
48743522|NCT02207244|156910562|FG007|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5|||
48743523|NCT02207244|156910563|FG008|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3|||
48743524|NCT02207244|156910564|FG009|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2|||
48743525|NCT02207244|156910565|FG010|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
48743526|NCT02207244|156910555|FG000|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
48743527|NCT02207244|156910556|FG001|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
48743528|NCT02207244|156910557|FG002|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
48743529|NCT02207244|156910558|FG003|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
48743530|NCT02207244|156910559|FG004|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
48743531|NCT02207244|156910560|FG005|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
48743532|NCT02207244|156910561|FG006|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
48743533|NCT02207244|156910562|FG007|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2|||
48743534|NCT02207244|156910563|FG008|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
48743535|NCT02207244|156910564|FG009|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
48743536|NCT02207244|156910565|FG010|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
48743537|NCT02207244|156910555|FG000|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
48743538|NCT02207244|156910556|FG001|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
48743539|NCT02207244|156910557|FG002|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
48743540|NCT02207244|156910558|FG003|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
48743541|NCT02207244|156910559|FG004|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
48743542|NCT02207244|156910560|FG005|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
48743543|NCT02207244|156910561|FG006|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1|||
48743544|NCT02207244|156910562|FG007|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3|||
48743545|NCT02207244|156910563|FG008|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
48743546|NCT02207244|156910564|FG009|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
48743547|NCT02207244|156910565|FG010|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
48743548|NCT02207244|156910555|FG000|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
48743549|NCT02207244|156910556|FG001|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
48856887|NCT00103857|157314949|FG000|54-Week Base Study|site error|0|||
48856888|NCT00103857|157314950|FG001|54-Week Base Study|site error|0|||
48856889|NCT00103857|157314951|FG002|54-Week Base Study|site error|0|||
48856890|NCT00103857|157314952|FG003|54-Week Base Study|site error|0|||
48743550|NCT02207244|156910557|FG002|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
48743551|NCT02207244|156910558|FG003|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
48743552|NCT02207244|156910559|FG004|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
48743553|NCT02207244|156910560|FG005|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
48743554|NCT02207244|156910561|FG006|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
48743555|NCT02207244|156910562|FG007|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7|||
48743556|NCT02207244|156910563|FG008|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
48743557|NCT02207244|156910564|FG009|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
48743558|NCT02207244|156910565|FG010|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
48743559|NCT02207244|156910555|FG000|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
48743560|NCT02207244|156910556|FG001|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
48743561|NCT02207244|156910557|FG002|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
48743562|NCT02207244|156910558|FG003|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
48743563|NCT02207244|156910559|FG004|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
48743564|NCT02207244|156910560|FG005|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
48743565|NCT02207244|156910561|FG006|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
48743566|NCT02207244|156910562|FG007|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7|||
48743567|NCT02207244|156910563|FG008|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
48743568|NCT02207244|156910564|FG009|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
48743569|NCT02207244|156910565|FG010|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
48743570|NCT02207244|156910555|FG000|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
48743571|NCT02207244|156910556|FG001|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
48743572|NCT02207244|156910557|FG002|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
48743573|NCT02207244|156910558|FG003|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
48743574|NCT02207244|156910559|FG004|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
48743575|NCT02207244|156910560|FG005|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
48743576|NCT02207244|156910561|FG006|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
48743577|NCT02207244|156910562|FG007|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
48856891|NCT00103857|157314953|FG004|54-Week Base Study|site error|0|||
48856892|NCT00103857|157314954|FG005|54-Week Base Study|site error|1|||
48856893|NCT00103857|157314955|FG006|54-Week Base Study|site error|0|||
48856894|NCT00103857|157314949|FG000|54-Week Base Study|patient intolerance to rescue therapy|1|||
48856895|NCT00103857|157314950|FG001|54-Week Base Study|patient intolerance to rescue therapy|0|||
48856896|NCT00103857|157314951|FG002|54-Week Base Study|patient intolerance to rescue therapy|0|||
48856897|NCT00103857|157314952|FG003|54-Week Base Study|patient intolerance to rescue therapy|0|||
48856898|NCT00103857|157314953|FG004|54-Week Base Study|patient intolerance to rescue therapy|0|||
48856899|NCT00103857|157314954|FG005|54-Week Base Study|patient intolerance to rescue therapy|0|||
48743578|NCT02207244|156910563|FG008|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
48743579|NCT02207244|156910564|FG009|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
48743580|NCT02207244|156910565|FG010|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
48743581|NCT02207244|156910555|FG000|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
48743582|NCT02207244|156910556|FG001|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
48743583|NCT02207244|156910557|FG002|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
48743584|NCT02207244|156910558|FG003|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
48743585|NCT02207244|156910559|FG004|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
48743586|NCT02207244|156910560|FG005|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
48743587|NCT02207244|156910561|FG006|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
48743588|NCT02207244|156910562|FG007|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
48743589|NCT02207244|156910563|FG008|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1|||
48743590|NCT02207244|156910564|FG009|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
48743591|NCT02207244|156910565|FG010|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
48743592|NCT02207244|156910555|FG000|Withdrawal and Re-treatment: Week 28-72|Other|0|||
48743593|NCT02207244|156910556|FG001|Withdrawal and Re-treatment: Week 28-72|Other|0|||
48743594|NCT02207244|156910557|FG002|Withdrawal and Re-treatment: Week 28-72|Other|0|||
48743595|NCT02207244|156910558|FG003|Withdrawal and Re-treatment: Week 28-72|Other|0|||
48743596|NCT02207244|156910559|FG004|Withdrawal and Re-treatment: Week 28-72|Other|0|||
48743597|NCT02207244|156910560|FG005|Withdrawal and Re-treatment: Week 28-72|Other|0|||
48743598|NCT02207244|156910561|FG006|Withdrawal and Re-treatment: Week 28-72|Other|0|||
48743599|NCT02207244|156910562|FG007|Withdrawal and Re-treatment: Week 28-72|Other|2|||
48743600|NCT02207244|156910563|FG008|Withdrawal and Re-treatment: Week 28-72|Other|0|||
48743601|NCT02207244|156910564|FG009|Withdrawal and Re-treatment: Week 28-72|Other|0|||
48743602|NCT02207244|156910565|FG010|Withdrawal and Re-treatment: Week 28-72|Other|0|||
48743603|NCT02207244|156910555|FG000|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
48743604|NCT02207244|156910556|FG001|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
48743605|NCT02207244|156910557|FG002|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
48743606|NCT02207244|156910558|FG003|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
48743607|NCT02207244|156910559|FG004|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
48743608|NCT02207244|156910560|FG005|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
48743609|NCT02207244|156910561|FG006|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8|||
48743610|NCT02207244|156910562|FG007|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
48743611|NCT02207244|156910563|FG008|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
48743612|NCT02207244|156910564|FG009|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
48743613|NCT02207244|156910565|FG010|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
48743614|NCT02207244|156910555|FG000|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
48743615|NCT02207244|156910556|FG001|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
48743616|NCT02207244|156910557|FG002|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
48743617|NCT02207244|156910558|FG003|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
48743618|NCT02207244|156910559|FG004|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
48743619|NCT02207244|156910560|FG005|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
48743620|NCT02207244|156910561|FG006|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
48743621|NCT02207244|156910562|FG007|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
48743622|NCT02207244|156910563|FG008|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10|||
48743623|NCT02207244|156910564|FG009|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
48743624|NCT02207244|156910565|FG010|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30|||
48743625|NCT02207244|156910555|FG000|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
48743626|NCT02207244|156910556|FG001|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
48743627|NCT02207244|156910557|FG002|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
48743628|NCT02207244|156910558|FG003|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
48856900|NCT00103857|157314955|FG006|54-Week Base Study|patient intolerance to rescue therapy|0|||
48743629|NCT02207244|156910559|FG004|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
48743630|NCT02207244|156910560|FG005|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
48743631|NCT02207244|156910561|FG006|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
48743632|NCT02207244|156910562|FG007|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
48743633|NCT02207244|156910563|FG008|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2|||
48743634|NCT02207244|156910564|FG009|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
48743635|NCT02207244|156910565|FG010|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3|||
48743636|NCT02207244|156910555|FG000|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
48743637|NCT02207244|156910556|FG001|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
48743638|NCT02207244|156910557|FG002|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
48743639|NCT02207244|156910558|FG003|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
48743640|NCT02207244|156910559|FG004|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
48743641|NCT02207244|156910560|FG005|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
48743642|NCT02207244|156910561|FG006|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
48743643|NCT02207244|156910562|FG007|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
48743644|NCT02207244|156910563|FG008|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5|||
48743645|NCT02207244|156910564|FG009|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
48743646|NCT02207244|156910565|FG010|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26|||
48743647|NCT02207244|156910555|FG000|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
48743648|NCT02207244|156910556|FG001|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
48743649|NCT02207244|156910557|FG002|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
48743650|NCT02207244|156910558|FG003|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
48743651|NCT02207244|156910559|FG004|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
48743652|NCT02207244|156910560|FG005|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
48743653|NCT02207244|156910561|FG006|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
48743654|NCT02207244|156910562|FG007|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
48743655|NCT02207244|156910563|FG008|Open-label Guselkumab: Week 72-264|Adverse Event|12|||
48743656|NCT02207244|156910564|FG009|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
48743657|NCT02207244|156910565|FG010|Open-label Guselkumab: Week 72-264|Adverse Event|21|||
48743658|NCT02207244|156910555|FG000|Open-label Guselkumab: Week 72-264|Death|0|||
48743659|NCT02207244|156910556|FG001|Open-label Guselkumab: Week 72-264|Death|0|||
48856901|NCT00103857|157314949|FG000|50-Week Extension Study|Adverse Event|2|||
48856902|NCT00103857|157314950|FG001|50-Week Extension Study|Adverse Event|3|||
48856903|NCT00103857|157314951|FG002|50-Week Extension Study|Adverse Event|2|||
48856904|NCT00103857|157314952|FG003|50-Week Extension Study|Adverse Event|0|||
48856905|NCT00103857|157314953|FG004|50-Week Extension Study|Adverse Event|1|||
48856906|NCT00103857|157314954|FG005|50-Week Extension Study|Adverse Event|1|||
48856907|NCT00103857|157314955|FG006|50-Week Extension Study|Adverse Event|0|||
48856908|NCT00103857|157314949|FG000|50-Week Extension Study|Death|0|||
48856909|NCT00103857|157314950|FG001|50-Week Extension Study|Death|0|||
48856910|NCT00103857|157314951|FG002|50-Week Extension Study|Death|0|||
48856911|NCT00103857|157314952|FG003|50-Week Extension Study|Death|1|||
48856912|NCT00103857|157314953|FG004|50-Week Extension Study|Death|0|||
48856913|NCT00103857|157314954|FG005|50-Week Extension Study|Death|1|||
48856914|NCT00103857|157314955|FG006|50-Week Extension Study|Death|0|||
48856915|NCT00103857|157314949|FG000|50-Week Extension Study|Lack of Efficacy|26|||
48856916|NCT00103857|157314950|FG001|50-Week Extension Study|Lack of Efficacy|15|||
48856917|NCT00103857|157314951|FG002|50-Week Extension Study|Lack of Efficacy|13|||
48856918|NCT00103857|157314952|FG003|50-Week Extension Study|Lack of Efficacy|16|||
48856919|NCT00103857|157314953|FG004|50-Week Extension Study|Lack of Efficacy|8|||
48856920|NCT00103857|157314954|FG005|50-Week Extension Study|Lack of Efficacy|8|||
48856921|NCT00103857|157314955|FG006|50-Week Extension Study|Lack of Efficacy|0|||
48856922|NCT00103857|157314949|FG000|50-Week Extension Study|Lost to Follow-up|4|||
48856923|NCT00103857|157314950|FG001|50-Week Extension Study|Lost to Follow-up|0|||
48856924|NCT00103857|157314951|FG002|50-Week Extension Study|Lost to Follow-up|1|||
48856925|NCT00103857|157314952|FG003|50-Week Extension Study|Lost to Follow-up|4|||
48856926|NCT00103857|157314953|FG004|50-Week Extension Study|Lost to Follow-up|3|||
48856927|NCT00103857|157314954|FG005|50-Week Extension Study|Lost to Follow-up|3|||
48856928|NCT00103857|157314955|FG006|50-Week Extension Study|Lost to Follow-up|0|||
48856929|NCT00103857|157314949|FG000|50-Week Extension Study|Physician Decision|0|||
48856930|NCT00103857|157314950|FG001|50-Week Extension Study|Physician Decision|1|||
48856931|NCT00103857|157314951|FG002|50-Week Extension Study|Physician Decision|1|||
48856932|NCT00103857|157314952|FG003|50-Week Extension Study|Physician Decision|0|||
48856933|NCT00103857|157314953|FG004|50-Week Extension Study|Physician Decision|0|||
48856934|NCT00103857|157314954|FG005|50-Week Extension Study|Physician Decision|0|||
48856935|NCT00103857|157314955|FG006|50-Week Extension Study|Physician Decision|0|||
48856936|NCT00103857|157314949|FG000|50-Week Extension Study|Pregnancy|0|||
48856937|NCT00103857|157314950|FG001|50-Week Extension Study|Pregnancy|0|||
48743660|NCT02207244|156910557|FG002|Open-label Guselkumab: Week 72-264|Death|0|||
48743661|NCT02207244|156910558|FG003|Open-label Guselkumab: Week 72-264|Death|0|||
48743662|NCT02207244|156910559|FG004|Open-label Guselkumab: Week 72-264|Death|0|||
48743663|NCT02207244|156910560|FG005|Open-label Guselkumab: Week 72-264|Death|0|||
48856938|NCT00103857|157314951|FG002|50-Week Extension Study|Pregnancy|1|||
48856939|NCT00103857|157314952|FG003|50-Week Extension Study|Pregnancy|0|||
48856940|NCT00103857|157314953|FG004|50-Week Extension Study|Pregnancy|1|||
48856941|NCT00103857|157314954|FG005|50-Week Extension Study|Pregnancy|0|||
48856942|NCT00103857|157314955|FG006|50-Week Extension Study|Pregnancy|0|||
48856943|NCT00103857|157314949|FG000|50-Week Extension Study|Protocol Violation|1|||
48856944|NCT00103857|157314950|FG001|50-Week Extension Study|Protocol Violation|1|||
48951963|NCT01984346|157654929|FG000|Overall Study|Physician Decision|4|||
48951964|NCT01984346|157654930|FG001|Overall Study|Physician Decision|2|||
48951965|NCT01984346|157654929|FG000|Overall Study|Withdrawal by Subject|2|||
48951966|NCT01984346|157654930|FG001|Overall Study|Withdrawal by Subject|2|||
48951967|NCT01984346|157654929|FG000|Overall Study|Enrollment Closed|8|||
48951968|NCT01984346|157654930|FG001|Overall Study|Enrollment Closed|1|||
48951969|NCT01984346|157654929|FG000|Overall Study|Insurance Coverage|1|||
48951970|NCT01984346|157654930|FG001|Overall Study|Insurance Coverage|0|||
48951971|NCT01984346|157654929|FG000|Overall Study|Intra-operative Exclusion|2|||
48951972|NCT01984346|157654930|FG001|Overall Study|Intra-operative Exclusion|0|||
48951973|NCT02584634|157654931|FG000|Overall Study|Adverse Event|3|||
48951974|NCT02584634|157654932|FG001|Overall Study|Adverse Event|5|||
48951975|NCT02584634|157654931|FG000|Overall Study|Death|0|||
48951976|NCT02584634|157654932|FG001|Overall Study|Death|1|||
48951977|NCT02584634|157654931|FG000|Overall Study|Lost to Follow-up|0|||
48951978|NCT02584634|157654932|FG001|Overall Study|Lost to Follow-up|1|||
48951979|NCT02584634|157654931|FG000|Overall Study|Physician Decision|1|||
48951980|NCT02584634|157654932|FG001|Overall Study|Physician Decision|2|||
48951981|NCT02584634|157654931|FG000|Overall Study|Progressive disease|7|||
48951982|NCT02584634|157654932|FG001|Overall Study|Progressive disease|15|||
48951983|NCT02584634|157654931|FG000|Overall Study|Withdrawal by Subject|1|||
48951984|NCT02584634|157654932|FG001|Overall Study|Withdrawal by Subject|1|||
48951985|NCT02584634|157654931|FG000|Overall Study|Other|0|||
48951986|NCT02584634|157654932|FG001|Overall Study|Other|6|||
48951987|NCT00726323|157654933|FG000|Overall Study|Withdrawal by Subject|3|||
48951988|NCT00726323|157654934|FG001|Overall Study|Withdrawal by Subject|1|||
48951989|NCT00726323|157654933|FG000|Overall Study|Physician Decision|1|||
48951990|NCT00726323|157654934|FG001|Overall Study|Physician Decision|0|||
48951991|NCT00726323|157654933|FG000|Overall Study|Progressive disease|23|||
48951992|NCT00726323|157654934|FG001|Overall Study|Progressive disease|16|||
48951993|NCT00726323|157654933|FG000|Overall Study|Clinical progression|0|||
48951994|NCT00726323|157654934|FG001|Overall Study|Clinical progression|3|||
48951995|NCT00726323|157654933|FG000|Overall Study|Adverse Event|9|||
48951996|NCT00726323|157654934|FG001|Overall Study|Adverse Event|9|||
48951997|NCT00726323|157654933|FG000|Overall Study|Death|1|||
48951998|NCT00726323|157654934|FG001|Overall Study|Death|0|||
48856945|NCT00103857|157314951|FG002|50-Week Extension Study|Protocol Violation|1|||
48856946|NCT00103857|157314952|FG003|50-Week Extension Study|Protocol Violation|2|||
48856947|NCT00103857|157314953|FG004|50-Week Extension Study|Protocol Violation|0|||
48856948|NCT00103857|157314954|FG005|50-Week Extension Study|Protocol Violation|1|||
48856949|NCT00103857|157314955|FG006|50-Week Extension Study|Protocol Violation|0|||
48856950|NCT00103857|157314949|FG000|50-Week Extension Study|Withdrawal by Subject|2|||
48856951|NCT00103857|157314950|FG001|50-Week Extension Study|Withdrawal by Subject|5|||
48856952|NCT00103857|157314951|FG002|50-Week Extension Study|Withdrawal by Subject|2|||
48856953|NCT00103857|157314952|FG003|50-Week Extension Study|Withdrawal by Subject|8|||
48856954|NCT00103857|157314953|FG004|50-Week Extension Study|Withdrawal by Subject|3|||
48856955|NCT00103857|157314954|FG005|50-Week Extension Study|Withdrawal by Subject|3|||
48856956|NCT00103857|157314955|FG006|50-Week Extension Study|Withdrawal by Subject|0|||
48856957|NCT00103857|157314949|FG000|50-Week Extension Study|protocol discontinuation criteria|2|||
48856958|NCT00103857|157314950|FG001|50-Week Extension Study|protocol discontinuation criteria|2|||
48856959|NCT00103857|157314951|FG002|50-Week Extension Study|protocol discontinuation criteria|3|||
48856960|NCT00103857|157314952|FG003|50-Week Extension Study|protocol discontinuation criteria|2|||
48856961|NCT00103857|157314953|FG004|50-Week Extension Study|protocol discontinuation criteria|3|||
48856962|NCT00103857|157314954|FG005|50-Week Extension Study|protocol discontinuation criteria|3|||
48856963|NCT00103857|157314955|FG006|50-Week Extension Study|protocol discontinuation criteria|0|||
48856964|NCT00103857|157314949|FG000|50-Week Extension Study|non-compliance with study procedures|1|||
48856965|NCT00103857|157314950|FG001|50-Week Extension Study|non-compliance with study procedures|0|||
48856966|NCT00103857|157314951|FG002|50-Week Extension Study|non-compliance with study procedures|0|||
48856967|NCT00103857|157314952|FG003|50-Week Extension Study|non-compliance with study procedures|1|||
48856968|NCT00103857|157314953|FG004|50-Week Extension Study|non-compliance with study procedures|1|||
48856969|NCT00103857|157314954|FG005|50-Week Extension Study|non-compliance with study procedures|0|||
48856970|NCT00103857|157314955|FG006|50-Week Extension Study|non-compliance with study procedures|0|||
48951999|NCT00726323|157654933|FG000|Overall Study|Participant wished to discontinue|0|||
48952000|NCT00726323|157654934|FG001|Overall Study|Participant wished to discontinue|1|||
48952001|NCT00726323|157654933|FG000|Overall Study|Metastatic lesions inferred cyst|0|||
48952002|NCT00726323|157654934|FG001|Overall Study|Metastatic lesions inferred cyst|1|||
48952003|NCT02341014|157654935|FG000|Overall Study|Adverse Event|0|||
48952004|NCT02341014|157654936|FG001|Overall Study|Adverse Event|1|||
48952005|NCT02341014|157654937|FG002|Overall Study|Adverse Event|0|||
48952006|NCT02341014|157654938|FG003|Overall Study|Adverse Event|0|||
48952007|NCT02341014|157654939|FG004|Overall Study|Adverse Event|2|||
48952008|NCT01753115|157654940|FG000|Overall Study|Lost to Follow-up|3|||
48856971|NCT00103857|157314949|FG000|50-Week Extension Study|patient moved|0|||
48856972|NCT00103857|157314950|FG001|50-Week Extension Study|patient moved|0|||
48856973|NCT00103857|157314951|FG002|50-Week Extension Study|patient moved|1|||
48856974|NCT00103857|157314952|FG003|50-Week Extension Study|patient moved|2|||
48856975|NCT00103857|157314953|FG004|50-Week Extension Study|patient moved|0|||
48743664|NCT02207244|156910561|FG006|Open-label Guselkumab: Week 72-264|Death|0|||
48743665|NCT02207244|156910562|FG007|Open-label Guselkumab: Week 72-264|Death|0|||
48743666|NCT02207244|156910563|FG008|Open-label Guselkumab: Week 72-264|Death|1|||
48743667|NCT02207244|156910564|FG009|Open-label Guselkumab: Week 72-264|Death|0|||
48743668|NCT02207244|156910565|FG010|Open-label Guselkumab: Week 72-264|Death|1|||
48743669|NCT02207244|156910555|FG000|Open-label Guselkumab: Week 72-264|Other|0|||
48743670|NCT02207244|156910556|FG001|Open-label Guselkumab: Week 72-264|Other|0|||
48743671|NCT02207244|156910557|FG002|Open-label Guselkumab: Week 72-264|Other|0|||
48743672|NCT02207244|156910558|FG003|Open-label Guselkumab: Week 72-264|Other|0|||
48743673|NCT02207244|156910559|FG004|Open-label Guselkumab: Week 72-264|Other|0|||
48743674|NCT02207244|156910560|FG005|Open-label Guselkumab: Week 72-264|Other|0|||
48743675|NCT02207244|156910561|FG006|Open-label Guselkumab: Week 72-264|Other|0|||
48743676|NCT02207244|156910562|FG007|Open-label Guselkumab: Week 72-264|Other|0|||
48743677|NCT02207244|156910563|FG008|Open-label Guselkumab: Week 72-264|Other|8|||
48743678|NCT02207244|156910564|FG009|Open-label Guselkumab: Week 72-264|Other|0|||
48743679|NCT02207244|156910565|FG010|Open-label Guselkumab: Week 72-264|Other|19|||
48743680|NCT02207244|156910555|FG000|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
48743681|NCT02207244|156910556|FG001|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
48743682|NCT02207244|156910557|FG002|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
48743683|NCT02207244|156910558|FG003|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
48743684|NCT02207244|156910559|FG004|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
48743685|NCT02207244|156910560|FG005|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
48743686|NCT02207244|156910561|FG006|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
48743687|NCT02207244|156910562|FG007|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
48743688|NCT02207244|156910563|FG008|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
48743689|NCT02207244|156910564|FG009|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
48743690|NCT02207244|156910565|FG010|Open-label Guselkumab: Week 72-264|Pregnancy|2|||
48743691|NCT01088997|156910568|FG000|Overall Study|Physician Decision|1|||
48743692|NCT01088997|156910569|FG001|Overall Study|Physician Decision|1|||
48743693|NCT01088997|156910568|FG000|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
48743694|NCT01088997|156910569|FG001|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
48743695|NCT01088997|156910568|FG000|Overall Study|Excluded prior to receiving drug|1|||
48743696|NCT01088997|156910569|FG001|Overall Study|Excluded prior to receiving drug|1|||
48743697|NCT00259649|156912376|FG000|Overall Study|Lost to Follow-up|7|||
48743698|NCT00259649|156912376|FG000|Overall Study|irregular menses|3|||
48743699|NCT00042289|156912377|FG000|Overall Study|Lost to Follow-up|3|||
48743700|NCT00042289|156912378|FG001|Overall Study|Lost to Follow-up|0|||
48743701|NCT00042289|156912379|FG002|Overall Study|Lost to Follow-up|0|||
48743702|NCT00042289|156912380|FG003|Overall Study|Lost to Follow-up|1|||
48743703|NCT00042289|156912381|FG004|Overall Study|Lost to Follow-up|3|||
48743704|NCT00042289|156912382|FG005|Overall Study|Lost to Follow-up|3|||
48743705|NCT00042289|156912383|FG006|Overall Study|Lost to Follow-up|6|||
48743706|NCT00042289|156912384|FG007|Overall Study|Lost to Follow-up|1|||
48743707|NCT00042289|156912385|FG008|Overall Study|Lost to Follow-up|1|||
48743708|NCT00042289|156912386|FG009|Overall Study|Lost to Follow-up|0|||
48743709|NCT00042289|156912387|FG010|Overall Study|Lost to Follow-up|0|||
48743710|NCT00042289|156912388|FG011|Overall Study|Lost to Follow-up|0|||
48743711|NCT00042289|156912389|FG012|Overall Study|Lost to Follow-up|0|||
48743712|NCT00042289|156912390|FG013|Overall Study|Lost to Follow-up|0|||
48743713|NCT00042289|156912391|FG014|Overall Study|Lost to Follow-up|0|||
48743714|NCT00042289|156912392|FG015|Overall Study|Lost to Follow-up|1|||
48743715|NCT00042289|156912393|FG016|Overall Study|Lost to Follow-up|1|||
48743716|NCT00042289|156912394|FG017|Overall Study|Lost to Follow-up|0|||
48743717|NCT00042289|156912395|FG018|Overall Study|Lost to Follow-up|3|||
48743718|NCT00042289|156912396|FG019|Overall Study|Lost to Follow-up|2|||
48743719|NCT00042289|156912397|FG020|Overall Study|Lost to Follow-up|0|||
48743720|NCT00042289|156912398|FG021|Overall Study|Lost to Follow-up|0|||
48743721|NCT00042289|156912399|FG022|Overall Study|Lost to Follow-up|0|||
48743722|NCT00042289|156912400|FG023|Overall Study|Lost to Follow-up|0|||
48743723|NCT00042289|156912401|FG024|Overall Study|Lost to Follow-up|0|||
48743724|NCT00042289|156912402|FG025|Overall Study|Lost to Follow-up|0|||
48743725|NCT00042289|156912403|FG026|Overall Study|Lost to Follow-up|2|||
48743726|NCT00042289|156912404|FG027|Overall Study|Lost to Follow-up|2|||
48743727|NCT00042289|156912405|FG028|Overall Study|Lost to Follow-up|2|||
48743728|NCT00042289|156912406|FG029|Overall Study|Lost to Follow-up|0|||
48743729|NCT00042289|156912407|FG030|Overall Study|Lost to Follow-up|0|||
48743730|NCT00042289|156912408|FG031|Overall Study|Lost to Follow-up|2|||
48743731|NCT00042289|156912409|FG032|Overall Study|Lost to Follow-up|1|||
48743732|NCT00042289|156912410|FG033|Overall Study|Lost to Follow-up|1|||
48743733|NCT00042289|156912411|FG034|Overall Study|Lost to Follow-up|1|||
48743734|NCT00042289|156912412|FG035|Overall Study|Lost to Follow-up|2|||
48743735|NCT00042289|156912413|FG036|Overall Study|Lost to Follow-up|1|||
48743736|NCT00042289|156912414|FG037|Overall Study|Lost to Follow-up|1|||
48743737|NCT00042289|156912415|FG038|Overall Study|Lost to Follow-up|0|||
48743738|NCT00042289|156912416|FG039|Overall Study|Lost to Follow-up|5|||
48743739|NCT00042289|156912417|FG040|Overall Study|Lost to Follow-up|0|||
48743740|NCT00042289|156912418|FG041|Overall Study|Lost to Follow-up|2|||
48743741|NCT00042289|156912419|FG042|Overall Study|Lost to Follow-up|2|||
48743742|NCT00042289|156912420|FG043|Overall Study|Lost to Follow-up|0|||
48743743|NCT00042289|156912421|FG044|Overall Study|Lost to Follow-up|0|||
48743744|NCT00042289|156912422|FG045|Overall Study|Lost to Follow-up|1|||
48743745|NCT00042289|156912423|FG046|Overall Study|Lost to Follow-up|0|||
48743746|NCT00042289|156912377|FG000|Overall Study|Other reason|0|||
48743747|NCT00042289|156912378|FG001|Overall Study|Other reason|0|||
48743748|NCT00042289|156912379|FG002|Overall Study|Other reason|0|||
48743749|NCT00042289|156912380|FG003|Overall Study|Other reason|2|||
48743750|NCT00042289|156912381|FG004|Overall Study|Other reason|0|||
48743751|NCT00042289|156912382|FG005|Overall Study|Other reason|0|||
48743752|NCT00042289|156912383|FG006|Overall Study|Other reason|0|||
48743753|NCT00042289|156912384|FG007|Overall Study|Other reason|0|||
48743754|NCT00042289|156912385|FG008|Overall Study|Other reason|0|||
48743755|NCT00042289|156912386|FG009|Overall Study|Other reason|0|||
48743756|NCT00042289|156912387|FG010|Overall Study|Other reason|0|||
48743757|NCT00042289|156912388|FG011|Overall Study|Other reason|0|||
48743758|NCT00042289|156912389|FG012|Overall Study|Other reason|0|||
48743759|NCT00042289|156912390|FG013|Overall Study|Other reason|0|||
48743760|NCT00042289|156912391|FG014|Overall Study|Other reason|0|||
48743761|NCT00042289|156912392|FG015|Overall Study|Other reason|0|||
48743762|NCT00042289|156912393|FG016|Overall Study|Other reason|0|||
48743763|NCT00042289|156912394|FG017|Overall Study|Other reason|0|||
48743764|NCT00042289|156912395|FG018|Overall Study|Other reason|1|||
48743765|NCT00042289|156912396|FG019|Overall Study|Other reason|0|||
48743766|NCT00042289|156912397|FG020|Overall Study|Other reason|0|||
48743767|NCT00042289|156912398|FG021|Overall Study|Other reason|0|||
48743768|NCT00042289|156912399|FG022|Overall Study|Other reason|0|||
48856976|NCT00103857|157314954|FG005|50-Week Extension Study|patient moved|0|||
48743769|NCT00042289|156912400|FG023|Overall Study|Other reason|1|||
48743770|NCT00042289|156912401|FG024|Overall Study|Other reason|0|||
48743771|NCT00042289|156912402|FG025|Overall Study|Other reason|0|||
48743772|NCT00042289|156912403|FG026|Overall Study|Other reason|1|||
48743773|NCT00042289|156912404|FG027|Overall Study|Other reason|0|||
48743774|NCT00042289|156912405|FG028|Overall Study|Other reason|3|||
48856977|NCT00103857|157314955|FG006|50-Week Extension Study|patient moved|0|||
48743775|NCT00042289|156912406|FG029|Overall Study|Other reason|0|||
48743776|NCT00042289|156912407|FG030|Overall Study|Other reason|0|||
48743777|NCT00042289|156912408|FG031|Overall Study|Other reason|1|||
48743778|NCT00042289|156912409|FG032|Overall Study|Other reason|0|||
48743779|NCT00042289|156912410|FG033|Overall Study|Other reason|1|||
48743780|NCT00042289|156912411|FG034|Overall Study|Other reason|0|||
48743781|NCT00042289|156912412|FG035|Overall Study|Other reason|2|||
48743782|NCT00042289|156912413|FG036|Overall Study|Other reason|0|||
48743783|NCT00042289|156912414|FG037|Overall Study|Other reason|0|||
48743784|NCT00042289|156912415|FG038|Overall Study|Other reason|0|||
48743785|NCT00042289|156912416|FG039|Overall Study|Other reason|0|||
48743786|NCT00042289|156912417|FG040|Overall Study|Other reason|0|||
48743787|NCT00042289|156912418|FG041|Overall Study|Other reason|0|||
48743788|NCT00042289|156912419|FG042|Overall Study|Other reason|0|||
48743789|NCT00042289|156912420|FG043|Overall Study|Other reason|1|||
48743790|NCT00042289|156912421|FG044|Overall Study|Other reason|0|||
48743791|NCT00042289|156912422|FG045|Overall Study|Other reason|0|||
48743792|NCT00042289|156912423|FG046|Overall Study|Other reason|0|||
48743793|NCT00042289|156912377|FG000|Overall Study|Severe debilitation, unable to continue|0|||
48743794|NCT00042289|156912378|FG001|Overall Study|Severe debilitation, unable to continue|0|||
48743795|NCT00042289|156912379|FG002|Overall Study|Severe debilitation, unable to continue|0|||
48743796|NCT00042289|156912380|FG003|Overall Study|Severe debilitation, unable to continue|0|||
48743797|NCT00042289|156912381|FG004|Overall Study|Severe debilitation, unable to continue|0|||
48743798|NCT00042289|156912382|FG005|Overall Study|Severe debilitation, unable to continue|0|||
48743799|NCT00042289|156912383|FG006|Overall Study|Severe debilitation, unable to continue|0|||
48743800|NCT00042289|156912384|FG007|Overall Study|Severe debilitation, unable to continue|0|||
48743801|NCT00042289|156912385|FG008|Overall Study|Severe debilitation, unable to continue|0|||
48743802|NCT00042289|156912386|FG009|Overall Study|Severe debilitation, unable to continue|0|||
48743803|NCT00042289|156912387|FG010|Overall Study|Severe debilitation, unable to continue|0|||
48743804|NCT00042289|156912388|FG011|Overall Study|Severe debilitation, unable to continue|0|||
48743805|NCT00042289|156912389|FG012|Overall Study|Severe debilitation, unable to continue|0|||
48743806|NCT00042289|156912390|FG013|Overall Study|Severe debilitation, unable to continue|0|||
48743807|NCT00042289|156912391|FG014|Overall Study|Severe debilitation, unable to continue|0|||
48743808|NCT00042289|156912392|FG015|Overall Study|Severe debilitation, unable to continue|0|||
48743809|NCT00042289|156912393|FG016|Overall Study|Severe debilitation, unable to continue|0|||
48743810|NCT00042289|156912394|FG017|Overall Study|Severe debilitation, unable to continue|0|||
48743811|NCT00042289|156912395|FG018|Overall Study|Severe debilitation, unable to continue|0|||
48743812|NCT00042289|156912396|FG019|Overall Study|Severe debilitation, unable to continue|0|||
48743813|NCT00042289|156912397|FG020|Overall Study|Severe debilitation, unable to continue|0|||
48743814|NCT00042289|156912398|FG021|Overall Study|Severe debilitation, unable to continue|1|||
48743815|NCT00042289|156912399|FG022|Overall Study|Severe debilitation, unable to continue|0|||
48743816|NCT00042289|156912400|FG023|Overall Study|Severe debilitation, unable to continue|1|||
48743817|NCT00042289|156912401|FG024|Overall Study|Severe debilitation, unable to continue|0|||
48743818|NCT00042289|156912402|FG025|Overall Study|Severe debilitation, unable to continue|0|||
48743819|NCT00042289|156912403|FG026|Overall Study|Severe debilitation, unable to continue|0|||
48743820|NCT00042289|156912404|FG027|Overall Study|Severe debilitation, unable to continue|1|||
48743821|NCT00042289|156912405|FG028|Overall Study|Severe debilitation, unable to continue|0|||
48743822|NCT00042289|156912406|FG029|Overall Study|Severe debilitation, unable to continue|0|||
48743823|NCT00042289|156912407|FG030|Overall Study|Severe debilitation, unable to continue|0|||
48743824|NCT00042289|156912408|FG031|Overall Study|Severe debilitation, unable to continue|1|||
48743825|NCT00042289|156912409|FG032|Overall Study|Severe debilitation, unable to continue|1|||
48743826|NCT00042289|156912410|FG033|Overall Study|Severe debilitation, unable to continue|0|||
48743827|NCT00042289|156912411|FG034|Overall Study|Severe debilitation, unable to continue|0|||
48743828|NCT00042289|156912412|FG035|Overall Study|Severe debilitation, unable to continue|0|||
48743829|NCT00042289|156912413|FG036|Overall Study|Severe debilitation, unable to continue|0|||
48743830|NCT00042289|156912414|FG037|Overall Study|Severe debilitation, unable to continue|0|||
48743831|NCT00042289|156912415|FG038|Overall Study|Severe debilitation, unable to continue|0|||
48743832|NCT00042289|156912416|FG039|Overall Study|Severe debilitation, unable to continue|0|||
48743833|NCT00042289|156912417|FG040|Overall Study|Severe debilitation, unable to continue|0|||
48743834|NCT00042289|156912418|FG041|Overall Study|Severe debilitation, unable to continue|0|||
48743835|NCT00042289|156912419|FG042|Overall Study|Severe debilitation, unable to continue|0|||
48743836|NCT00042289|156912420|FG043|Overall Study|Severe debilitation, unable to continue|0|||
48743837|NCT00042289|156912421|FG044|Overall Study|Severe debilitation, unable to continue|0|||
48743838|NCT00042289|156912422|FG045|Overall Study|Severe debilitation, unable to continue|0|||
48743839|NCT00042289|156912423|FG046|Overall Study|Severe debilitation, unable to continue|0|||
48743840|NCT00042289|156912377|FG000|Overall Study|Site closed|0|||
48743841|NCT00042289|156912378|FG001|Overall Study|Site closed|0|||
48743842|NCT00042289|156912379|FG002|Overall Study|Site closed|0|||
48743843|NCT00042289|156912380|FG003|Overall Study|Site closed|0|||
48743844|NCT00042289|156912381|FG004|Overall Study|Site closed|0|||
48743845|NCT00042289|156912382|FG005|Overall Study|Site closed|0|||
48743846|NCT00042289|156912383|FG006|Overall Study|Site closed|0|||
48743847|NCT00042289|156912384|FG007|Overall Study|Site closed|0|||
48743848|NCT00042289|156912385|FG008|Overall Study|Site closed|0|||
48743849|NCT00042289|156912386|FG009|Overall Study|Site closed|0|||
48743850|NCT00042289|156912387|FG010|Overall Study|Site closed|0|||
48743851|NCT00042289|156912388|FG011|Overall Study|Site closed|0|||
48743852|NCT00042289|156912389|FG012|Overall Study|Site closed|0|||
48743853|NCT00042289|156912390|FG013|Overall Study|Site closed|0|||
48743854|NCT00042289|156912391|FG014|Overall Study|Site closed|0|||
48743855|NCT00042289|156912392|FG015|Overall Study|Site closed|0|||
48743856|NCT00042289|156912393|FG016|Overall Study|Site closed|0|||
48743857|NCT00042289|156912394|FG017|Overall Study|Site closed|0|||
48743858|NCT00042289|156912395|FG018|Overall Study|Site closed|0|||
48743859|NCT00042289|156912396|FG019|Overall Study|Site closed|0|||
48743860|NCT00042289|156912397|FG020|Overall Study|Site closed|0|||
48743861|NCT00042289|156912398|FG021|Overall Study|Site closed|0|||
48743862|NCT00042289|156912399|FG022|Overall Study|Site closed|0|||
48743863|NCT00042289|156912400|FG023|Overall Study|Site closed|0|||
48743864|NCT00042289|156912401|FG024|Overall Study|Site closed|0|||
48743865|NCT00042289|156912402|FG025|Overall Study|Site closed|0|||
48743866|NCT00042289|156912403|FG026|Overall Study|Site closed|0|||
48743867|NCT00042289|156912404|FG027|Overall Study|Site closed|0|||
48743868|NCT00042289|156912405|FG028|Overall Study|Site closed|0|||
48743869|NCT00042289|156912406|FG029|Overall Study|Site closed|0|||
48743870|NCT00042289|156912407|FG030|Overall Study|Site closed|0|||
48743871|NCT00042289|156912408|FG031|Overall Study|Site closed|3|||
48743872|NCT00042289|156912409|FG032|Overall Study|Site closed|0|||
48743873|NCT00042289|156912410|FG033|Overall Study|Site closed|0|||
48743874|NCT00042289|156912411|FG034|Overall Study|Site closed|0|||
48743875|NCT00042289|156912412|FG035|Overall Study|Site closed|0|||
48743876|NCT00042289|156912413|FG036|Overall Study|Site closed|1|||
48743877|NCT00042289|156912414|FG037|Overall Study|Site closed|0|||
48743878|NCT00042289|156912415|FG038|Overall Study|Site closed|0|||
48743879|NCT00042289|156912416|FG039|Overall Study|Site closed|0|||
48743880|NCT00042289|156912417|FG040|Overall Study|Site closed|0|||
48743881|NCT00042289|156912418|FG041|Overall Study|Site closed|0|||
48743882|NCT00042289|156912419|FG042|Overall Study|Site closed|1|||
48856978|NCT00103857|157314949|FG000|50-Week Extension Study|patient scheduled for elective surgery|0|||
48856979|NCT00103857|157314950|FG001|50-Week Extension Study|patient scheduled for elective surgery|0|||
48856980|NCT00103857|157314951|FG002|50-Week Extension Study|patient scheduled for elective surgery|1|||
48856981|NCT00103857|157314952|FG003|50-Week Extension Study|patient scheduled for elective surgery|0|||
48856982|NCT00103857|157314953|FG004|50-Week Extension Study|patient scheduled for elective surgery|0|||
48856983|NCT00103857|157314954|FG005|50-Week Extension Study|patient scheduled for elective surgery|0|||
48856984|NCT00103857|157314955|FG006|50-Week Extension Study|patient scheduled for elective surgery|0|||
48856985|NCT00103857|157314949|FG000|50-Week Extension Study|reason unspecified|0|||
48856986|NCT00103857|157314950|FG001|50-Week Extension Study|reason unspecified|0|||
48856987|NCT00103857|157314951|FG002|50-Week Extension Study|reason unspecified|0|||
48856988|NCT00103857|157314952|FG003|50-Week Extension Study|reason unspecified|0|||
48856989|NCT00103857|157314953|FG004|50-Week Extension Study|reason unspecified|1|||
48856990|NCT00103857|157314954|FG005|50-Week Extension Study|reason unspecified|0|||
48856991|NCT00103857|157314955|FG006|50-Week Extension Study|reason unspecified|0|||
48856992|NCT03166215|157314958|FG000|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
48856993|NCT03166215|157314959|FG001|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2|||
48856994|NCT03166215|157314960|FG002|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
48952009|NCT01753115|157654941|FG001|Overall Study|Lost to Follow-up|6|||
48952010|NCT01753115|157654942|FG002|Overall Study|Lost to Follow-up|8|||
48952011|NCT01753115|157654940|FG000|Overall Study|Withdrawal by Subject|6|||
48952012|NCT01753115|157654941|FG001|Overall Study|Withdrawal by Subject|5|||
48952013|NCT01753115|157654942|FG002|Overall Study|Withdrawal by Subject|6|||
48743883|NCT00042289|156912420|FG043|Overall Study|Site closed|0|||
48743884|NCT00042289|156912421|FG044|Overall Study|Site closed|0|||
48952014|NCT01753115|157654940|FG000|Overall Study|Subject non-compliant|3|||
48743885|NCT00042289|156912422|FG045|Overall Study|Site closed|0|||
48743886|NCT00042289|156912423|FG046|Overall Study|Site closed|0|||
48743887|NCT00042289|156912377|FG000|Overall Study|Participant not willing to adhere to requirements|0|||
48743888|NCT00042289|156912378|FG001|Overall Study|Participant not willing to adhere to requirements|0|||
48743889|NCT00042289|156912379|FG002|Overall Study|Participant not willing to adhere to requirements|0|||
48743890|NCT00042289|156912380|FG003|Overall Study|Participant not willing to adhere to requirements|3|||
48743891|NCT00042289|156912381|FG004|Overall Study|Participant not willing to adhere to requirements|0|||
48743892|NCT00042289|156912382|FG005|Overall Study|Participant not willing to adhere to requirements|0|||
48743893|NCT00042289|156912383|FG006|Overall Study|Participant not willing to adhere to requirements|0|||
48743894|NCT00042289|156912384|FG007|Overall Study|Participant not willing to adhere to requirements|0|||
48743895|NCT00042289|156912385|FG008|Overall Study|Participant not willing to adhere to requirements|0|||
48743896|NCT00042289|156912386|FG009|Overall Study|Participant not willing to adhere to requirements|0|||
48743897|NCT00042289|156912387|FG010|Overall Study|Participant not willing to adhere to requirements|0|||
48856995|NCT03166215|157314958|FG000|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
48856996|NCT03166215|157314959|FG001|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
48856997|NCT03166215|157314960|FG002|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2|||
48952015|NCT01753115|157654941|FG001|Overall Study|Subject non-compliant|3|||
48856998|NCT03652610|157314961|FG000|Overall Study|Lost to Follow-up|1|||
48856999|NCT03652610|157314962|FG001|Overall Study|Lost to Follow-up|0|||
48857000|NCT03652610|157314961|FG000|Overall Study|Withdrawal by Subject|3|||
48857001|NCT03652610|157314962|FG001|Overall Study|Withdrawal by Subject|5|||
48857002|NCT02707952|157314963|FG000|Overall Study|Adverse Event|1|||
48857003|NCT02707952|157314964|FG001|Overall Study|Adverse Event|0|||
48857004|NCT02707952|157314965|FG002|Overall Study|Adverse Event|0|||
48743898|NCT00042289|156912388|FG011|Overall Study|Participant not willing to adhere to requirements|0|||
48857005|NCT02707952|157314966|FG003|Overall Study|Adverse Event|0|||
48952016|NCT01753115|157654942|FG002|Overall Study|Subject non-compliant|0|||
48952017|NCT01753115|157654940|FG000|Overall Study|Used excluded drug|0|||
48743899|NCT00042289|156912389|FG012|Overall Study|Participant not willing to adhere to requirements|0|||
48743900|NCT00042289|156912390|FG013|Overall Study|Participant not willing to adhere to requirements|0|||
48743901|NCT00042289|156912391|FG014|Overall Study|Participant not willing to adhere to requirements|0|||
48743902|NCT00042289|156912392|FG015|Overall Study|Participant not willing to adhere to requirements|0|||
48743903|NCT00042289|156912393|FG016|Overall Study|Participant not willing to adhere to requirements|0|||
48743904|NCT00042289|156912394|FG017|Overall Study|Participant not willing to adhere to requirements|0|||
48743905|NCT00042289|156912395|FG018|Overall Study|Participant not willing to adhere to requirements|4|||
48743906|NCT00042289|156912396|FG019|Overall Study|Participant not willing to adhere to requirements|2|||
48743907|NCT00042289|156912397|FG020|Overall Study|Participant not willing to adhere to requirements|0|||
48743908|NCT00042289|156912398|FG021|Overall Study|Participant not willing to adhere to requirements|2|||
48857006|NCT02707952|157314963|FG000|Overall Study|Lost to Follow-up|1|||
48857007|NCT02707952|157314964|FG001|Overall Study|Lost to Follow-up|0|||
48952018|NCT01753115|157654941|FG001|Overall Study|Used excluded drug|1|||
48743909|NCT00042289|156912399|FG022|Overall Study|Participant not willing to adhere to requirements|1|||
48743910|NCT00042289|156912400|FG023|Overall Study|Participant not willing to adhere to requirements|1|||
48743911|NCT00042289|156912401|FG024|Overall Study|Participant not willing to adhere to requirements|0|||
48743912|NCT00042289|156912402|FG025|Overall Study|Participant not willing to adhere to requirements|1|||
48743913|NCT00042289|156912403|FG026|Overall Study|Participant not willing to adhere to requirements|2|||
48857008|NCT02707952|157314965|FG002|Overall Study|Lost to Follow-up|0|||
48857009|NCT02707952|157314966|FG003|Overall Study|Lost to Follow-up|0|||
48857010|NCT02707952|157314963|FG000|Overall Study|Withdrawal by Subject|0|||
48857011|NCT02707952|157314964|FG001|Overall Study|Withdrawal by Subject|1|||
48857012|NCT02707952|157314965|FG002|Overall Study|Withdrawal by Subject|2|||
48952019|NCT01753115|157654942|FG002|Overall Study|Used excluded drug|0|||
48952020|NCT04705597|157654943|FG000|Overall Study|Death|16|||
48952021|NCT04705597|157654944|FG001|Overall Study|Death|9|||
48952022|NCT04705597|157654943|FG000|Overall Study|Lost to Follow-up|1|||
48952023|NCT04705597|157654944|FG001|Overall Study|Lost to Follow-up|0|||
48952024|NCT04705597|157654943|FG000|Overall Study|Withdrawal by Subject|1|||
48952025|NCT04705597|157654944|FG001|Overall Study|Withdrawal by Subject|2|||
48952026|NCT00273858|157654945|FG000|Overall Study|Not completed 24 month observation time|334|||
48952027|NCT00273858|157654945|FG000|Overall Study|Lost to Follow-up|101|||
48952028|NCT00273858|157654945|FG000|Overall Study|Withdrawal by Subject|21|||
48952029|NCT00273858|157654945|FG000|Overall Study|Adverse Event|81|||
48952030|NCT02869867|157654956|FG000|Overall Study|Protocol Violation|1|||
48952031|NCT02869867|157654957|FG001|Overall Study|Protocol Violation|0|||
48857013|NCT02707952|157314966|FG003|Overall Study|Withdrawal by Subject|0|||
48857014|NCT04108858|157314967|FG000|Overall Study|Adverse Event|1|||
48857015|NCT00696241|157314970|FG000|Overall Study|Adverse Event|11|||
48952032|NCT02869867|157654956|FG000|Overall Study|Lost to Follow-up|5|||
48952033|NCT02869867|157654957|FG001|Overall Study|Lost to Follow-up|5|||
48952034|NCT00305006|157654958|FG000|Overall Study|Withdrawal by Subject|1|||
48952035|NCT00305006|157654959|FG001|Overall Study|Withdrawal by Subject|0|||
48952036|NCT00305006|157654958|FG000|Overall Study|Failure to complete pretest|0|||
48952037|NCT00305006|157654959|FG001|Overall Study|Failure to complete pretest|1|||
48952038|NCT02639182|157654960|FG000|Overall Study|Disease Progression|50|||
48857016|NCT00696241|157314971|FG001|Overall Study|Adverse Event|3|||
48857017|NCT00696241|157314972|FG002|Overall Study|Adverse Event|6|||
48857018|NCT00696241|157314973|FG003|Overall Study|Adverse Event|4|||
48743914|NCT00042289|156912404|FG027|Overall Study|Participant not willing to adhere to requirements|0|||
48743915|NCT00042289|156912405|FG028|Overall Study|Participant not willing to adhere to requirements|1|||
48743916|NCT00042289|156912406|FG029|Overall Study|Participant not willing to adhere to requirements|0|||
48743917|NCT00042289|156912407|FG030|Overall Study|Participant not willing to adhere to requirements|0|||
48743918|NCT00042289|156912408|FG031|Overall Study|Participant not willing to adhere to requirements|1|||
48743919|NCT00042289|156912409|FG032|Overall Study|Participant not willing to adhere to requirements|1|||
48743920|NCT00042289|156912410|FG033|Overall Study|Participant not willing to adhere to requirements|3|||
48743921|NCT00042289|156912411|FG034|Overall Study|Participant not willing to adhere to requirements|1|||
48743922|NCT00042289|156912412|FG035|Overall Study|Participant not willing to adhere to requirements|1|||
48743923|NCT00042289|156912413|FG036|Overall Study|Participant not willing to adhere to requirements|2|||
48743924|NCT00042289|156912414|FG037|Overall Study|Participant not willing to adhere to requirements|0|||
48743925|NCT00042289|156912415|FG038|Overall Study|Participant not willing to adhere to requirements|2|||
48743926|NCT00042289|156912416|FG039|Overall Study|Participant not willing to adhere to requirements|0|||
48743927|NCT00042289|156912417|FG040|Overall Study|Participant not willing to adhere to requirements|0|||
48743928|NCT00042289|156912418|FG041|Overall Study|Participant not willing to adhere to requirements|0|||
48743929|NCT00042289|156912419|FG042|Overall Study|Participant not willing to adhere to requirements|2|||
48743930|NCT00042289|156912420|FG043|Overall Study|Participant not willing to adhere to requirements|1|||
48743931|NCT00042289|156912421|FG044|Overall Study|Participant not willing to adhere to requirements|0|||
48743932|NCT00042289|156912422|FG045|Overall Study|Participant not willing to adhere to requirements|0|||
48743933|NCT00042289|156912423|FG046|Overall Study|Participant not willing to adhere to requirements|1|||
48743934|NCT00042289|156912377|FG000|Overall Study|Protocol Violation|0|||
48743935|NCT00042289|156912378|FG001|Overall Study|Protocol Violation|0|||
48743936|NCT00042289|156912379|FG002|Overall Study|Protocol Violation|0|||
48743937|NCT00042289|156912380|FG003|Overall Study|Protocol Violation|0|||
48743938|NCT00042289|156912381|FG004|Overall Study|Protocol Violation|0|||
48743939|NCT00042289|156912382|FG005|Overall Study|Protocol Violation|1|||
48743940|NCT00042289|156912383|FG006|Overall Study|Protocol Violation|0|||
48743941|NCT00042289|156912384|FG007|Overall Study|Protocol Violation|1|||
48743942|NCT00042289|156912385|FG008|Overall Study|Protocol Violation|0|||
48743943|NCT00042289|156912386|FG009|Overall Study|Protocol Violation|0|||
48743944|NCT00042289|156912387|FG010|Overall Study|Protocol Violation|0|||
48743945|NCT00042289|156912388|FG011|Overall Study|Protocol Violation|0|||
48743946|NCT00042289|156912389|FG012|Overall Study|Protocol Violation|0|||
48743947|NCT00042289|156912390|FG013|Overall Study|Protocol Violation|0|||
48857019|NCT00696241|157314974|FG004|Overall Study|Adverse Event|5|||
48857020|NCT00696241|157314970|FG000|Overall Study|Protocol Violation|1|||
48857021|NCT00696241|157314971|FG001|Overall Study|Protocol Violation|1|||
48743948|NCT00042289|156912391|FG014|Overall Study|Protocol Violation|0|||
48743949|NCT00042289|156912392|FG015|Overall Study|Protocol Violation|0|||
48743950|NCT00042289|156912393|FG016|Overall Study|Protocol Violation|0|||
48743951|NCT00042289|156912394|FG017|Overall Study|Protocol Violation|0|||
48743952|NCT00042289|156912395|FG018|Overall Study|Protocol Violation|0|||
48743953|NCT00042289|156912396|FG019|Overall Study|Protocol Violation|0|||
48743954|NCT00042289|156912397|FG020|Overall Study|Protocol Violation|0|||
48743955|NCT00042289|156912398|FG021|Overall Study|Protocol Violation|0|||
48743956|NCT00042289|156912399|FG022|Overall Study|Protocol Violation|0|||
48743957|NCT00042289|156912400|FG023|Overall Study|Protocol Violation|1|||
48743958|NCT00042289|156912401|FG024|Overall Study|Protocol Violation|1|||
48952039|NCT02639182|157654961|FG001|Overall Study|Disease Progression|49|||
48952040|NCT02639182|157654960|FG000|Overall Study|Adverse Event|7|||
48952041|NCT02639182|157654961|FG001|Overall Study|Adverse Event|5|||
48952042|NCT02639182|157654960|FG000|Overall Study|Physician Decision|3|||
48743959|NCT00042289|156912402|FG025|Overall Study|Protocol Violation|0|||
48743960|NCT00042289|156912403|FG026|Overall Study|Protocol Violation|2|||
48743961|NCT00042289|156912404|FG027|Overall Study|Protocol Violation|0|||
48743962|NCT00042289|156912405|FG028|Overall Study|Protocol Violation|0|||
48743963|NCT00042289|156912406|FG029|Overall Study|Protocol Violation|0|||
48743964|NCT00042289|156912407|FG030|Overall Study|Protocol Violation|1|||
48743965|NCT00042289|156912408|FG031|Overall Study|Protocol Violation|0|||
48743966|NCT00042289|156912409|FG032|Overall Study|Protocol Violation|0|||
48743967|NCT00042289|156912410|FG033|Overall Study|Protocol Violation|0|||
48743968|NCT00042289|156912411|FG034|Overall Study|Protocol Violation|0|||
48743969|NCT00042289|156912412|FG035|Overall Study|Protocol Violation|0|||
48743970|NCT00042289|156912413|FG036|Overall Study|Protocol Violation|0|||
48743971|NCT00042289|156912414|FG037|Overall Study|Protocol Violation|0|||
48743972|NCT00042289|156912415|FG038|Overall Study|Protocol Violation|0|||
48743973|NCT00042289|156912416|FG039|Overall Study|Protocol Violation|0|||
48743974|NCT00042289|156912417|FG040|Overall Study|Protocol Violation|0|||
48743975|NCT00042289|156912418|FG041|Overall Study|Protocol Violation|1|||
48743976|NCT00042289|156912419|FG042|Overall Study|Protocol Violation|1|||
48743977|NCT00042289|156912420|FG043|Overall Study|Protocol Violation|1|||
48743978|NCT00042289|156912421|FG044|Overall Study|Protocol Violation|0|||
48743979|NCT00042289|156912422|FG045|Overall Study|Protocol Violation|0|||
48743980|NCT00042289|156912423|FG046|Overall Study|Protocol Violation|0|||
48743981|NCT00042289|156912377|FG000|Overall Study|Withdrawal by Subject|4|||
48952043|NCT02639182|157654961|FG001|Overall Study|Physician Decision|3|||
48952044|NCT02639182|157654960|FG000|Overall Study|Withdrew Consent|5|||
48952045|NCT02639182|157654961|FG001|Overall Study|Withdrew Consent|4|||
48952046|NCT02639182|157654960|FG000|Overall Study|Lost to Follow-up|0|||
48743982|NCT00042289|156912378|FG001|Overall Study|Withdrawal by Subject|1|||
48743983|NCT00042289|156912379|FG002|Overall Study|Withdrawal by Subject|0|||
48743984|NCT00042289|156912380|FG003|Overall Study|Withdrawal by Subject|2|||
48743985|NCT00042289|156912381|FG004|Overall Study|Withdrawal by Subject|0|||
48743986|NCT00042289|156912382|FG005|Overall Study|Withdrawal by Subject|2|||
48743987|NCT00042289|156912383|FG006|Overall Study|Withdrawal by Subject|0|||
48952047|NCT02639182|157654961|FG001|Overall Study|Lost to Follow-up|1|||
48952048|NCT02639182|157654960|FG000|Overall Study|Study Closure|1|||
48952049|NCT02639182|157654961|FG001|Overall Study|Study Closure|2|||
48952050|NCT02639182|157654960|FG000|Overall Study|Sponsor Ended Study|0|||
48952051|NCT02639182|157654961|FG001|Overall Study|Sponsor Ended Study|1|||
48952052|NCT02639182|157654960|FG000|Overall Study|Randomized But Did Not Receive Study Drug|1|||
48952053|NCT02639182|157654961|FG001|Overall Study|Randomized But Did Not Receive Study Drug|1|||
48952054|NCT01234402|157654965|FG000|Overall Study|Lost to Follow-up|0|||
48952055|NCT01234402|157654966|FG001|Overall Study|Lost to Follow-up|1|||
48952056|NCT01234402|157654967|FG002|Overall Study|Lost to Follow-up|3|||
48952057|NCT01234402|157654965|FG000|Overall Study|Withdrawal by Subject|1|||
48952058|NCT01234402|157654966|FG001|Overall Study|Withdrawal by Subject|3|||
48952059|NCT01234402|157654967|FG002|Overall Study|Withdrawal by Subject|4|||
48952060|NCT01234402|157654965|FG000|Overall Study|Never treated: Death|0|||
48952061|NCT01234402|157654966|FG001|Overall Study|Never treated: Death|0|||
48952062|NCT01234402|157654967|FG002|Overall Study|Never treated: Death|1|||
48952063|NCT01234402|157654965|FG000|Overall Study|Never treated: Withdrawal By Subject|0|||
48952064|NCT01234402|157654966|FG001|Overall Study|Never treated: Withdrawal By Subject|1|||
48952065|NCT01234402|157654967|FG002|Overall Study|Never treated: Withdrawal By Subject|0|||
48743988|NCT00042289|156912384|FG007|Overall Study|Withdrawal by Subject|0|||
48743989|NCT00042289|156912385|FG008|Overall Study|Withdrawal by Subject|0|||
48743990|NCT00042289|156912386|FG009|Overall Study|Withdrawal by Subject|1|||
48743991|NCT00042289|156912387|FG010|Overall Study|Withdrawal by Subject|0|||
48743992|NCT00042289|156912388|FG011|Overall Study|Withdrawal by Subject|0|||
48743993|NCT00042289|156912389|FG012|Overall Study|Withdrawal by Subject|2|||
48952066|NCT01234402|157654965|FG000|Overall Study|Never treated: Insurance Denied Xeloda|0|||
48952067|NCT01234402|157654966|FG001|Overall Study|Never treated: Insurance Denied Xeloda|1|||
48952068|NCT01234402|157654967|FG002|Overall Study|Never treated: Insurance Denied Xeloda|0|||
48952069|NCT02564120|157654968|FG000|Overall Study|Did not return release forms|160|||
48952070|NCT02564120|157654968|FG000|Overall Study|Death|58|||
48952071|NCT02564120|157654968|FG000|Overall Study|Withdrawal by Subject|204|||
48952072|NCT02564120|157654968|FG000|Overall Study|Other medical condition|24|||
48952073|NCT01372878|157654971|FG000|Overall Study|Withdrawal by Subject|63|||
48952074|NCT01372878|157654971|FG000|Overall Study|Protocol Violation|17|||
48952075|NCT01372878|157654971|FG000|Overall Study|incomplete study procedure|104|||
48952076|NCT00069095|157654972|FG000|Primary Treatment Phase|Ongoing|0|||
48952077|NCT00069095|157654973|FG001|Primary Treatment Phase|Ongoing|0|||
48952078|NCT00069095|157654974|FG002|Primary Treatment Phase|Ongoing|5|||
48952079|NCT00069095|157654975|FG003|Primary Treatment Phase|Ongoing|7|||
48952080|NCT00069095|157654976|FG004|Primary Treatment Phase|Ongoing|7|||
48952081|NCT00069095|157654977|FG005|Primary Treatment Phase|Ongoing|4|||
48952082|NCT00069095|157654972|FG000|Primary Treatment Phase|Admin/Other|29|||
48743994|NCT00042289|156912390|FG013|Overall Study|Withdrawal by Subject|0|||
48743995|NCT00042289|156912391|FG014|Overall Study|Withdrawal by Subject|0|||
48743996|NCT00042289|156912392|FG015|Overall Study|Withdrawal by Subject|0|||
48743997|NCT00042289|156912393|FG016|Overall Study|Withdrawal by Subject|0|||
48743998|NCT00042289|156912394|FG017|Overall Study|Withdrawal by Subject|0|||
48743999|NCT00042289|156912395|FG018|Overall Study|Withdrawal by Subject|0|||
48744000|NCT00042289|156912396|FG019|Overall Study|Withdrawal by Subject|0|||
48744001|NCT00042289|156912397|FG020|Overall Study|Withdrawal by Subject|0|||
48744002|NCT00042289|156912398|FG021|Overall Study|Withdrawal by Subject|1|||
48744003|NCT00042289|156912399|FG022|Overall Study|Withdrawal by Subject|1|||
48744004|NCT00042289|156912400|FG023|Overall Study|Withdrawal by Subject|1|||
48744005|NCT00042289|156912401|FG024|Overall Study|Withdrawal by Subject|0|||
48744006|NCT00042289|156912402|FG025|Overall Study|Withdrawal by Subject|0|||
48744007|NCT00042289|156912403|FG026|Overall Study|Withdrawal by Subject|1|||
48744008|NCT00042289|156912404|FG027|Overall Study|Withdrawal by Subject|0|||
48744009|NCT00042289|156912405|FG028|Overall Study|Withdrawal by Subject|2|||
48744010|NCT00042289|156912406|FG029|Overall Study|Withdrawal by Subject|0|||
48744011|NCT00042289|156912407|FG030|Overall Study|Withdrawal by Subject|0|||
48744012|NCT00042289|156912408|FG031|Overall Study|Withdrawal by Subject|1|||
48744013|NCT00042289|156912409|FG032|Overall Study|Withdrawal by Subject|2|||
48744014|NCT00042289|156912410|FG033|Overall Study|Withdrawal by Subject|1|||
48744015|NCT00042289|156912411|FG034|Overall Study|Withdrawal by Subject|0|||
48744016|NCT00042289|156912412|FG035|Overall Study|Withdrawal by Subject|0|||
48744017|NCT00042289|156912413|FG036|Overall Study|Withdrawal by Subject|0|||
48744018|NCT00042289|156912414|FG037|Overall Study|Withdrawal by Subject|1|||
48744019|NCT00042289|156912415|FG038|Overall Study|Withdrawal by Subject|0|||
48744020|NCT00042289|156912416|FG039|Overall Study|Withdrawal by Subject|0|||
48744021|NCT00042289|156912417|FG040|Overall Study|Withdrawal by Subject|0|||
48744022|NCT00042289|156912418|FG041|Overall Study|Withdrawal by Subject|0|||
48744023|NCT00042289|156912419|FG042|Overall Study|Withdrawal by Subject|1|||
48744024|NCT00042289|156912420|FG043|Overall Study|Withdrawal by Subject|0|||
48744025|NCT00042289|156912421|FG044|Overall Study|Withdrawal by Subject|0|||
48744026|NCT00042289|156912422|FG045|Overall Study|Withdrawal by Subject|0|||
48744027|NCT00042289|156912423|FG046|Overall Study|Withdrawal by Subject|0|||
48744028|NCT04805541|156912430|FG000|Overall Study|Unable to be retinally photographed with good quality.|35|||
48744029|NCT02195583|156912431|FG000|Overall Study|Lost to Follow-up|1|||
48744030|NCT02195583|156912431|FG000|Overall Study|Withdrawal by Subject|4|||
48744031|NCT02195583|156912431|FG000|Overall Study|Adverse Event|2|||
48744032|NCT02195583|156912431|FG000|Overall Study|Other Reason|2|||
48744033|NCT00395304|156912432|FG000|Treatment Period 1|Withdrawal by Subject|0|||
48744034|NCT00395304|156912433|FG001|Treatment Period 1|Withdrawal by Subject|3|||
48744035|NCT00395304|156912434|FG002|Treatment Period 1|Withdrawal by Subject|0|||
48744036|NCT00395304|156912435|FG003|Treatment Period 1|Withdrawal by Subject|2|||
48744037|NCT00395304|156912436|FG004|Treatment Period 1|Withdrawal by Subject|1|||
48744038|NCT00395304|156912437|FG005|Treatment Period 1|Withdrawal by Subject|1|||
48744039|NCT00395304|156912432|FG000|Treatment Period 1|Lost to Follow-up|1|||
48744040|NCT00395304|156912433|FG001|Treatment Period 1|Lost to Follow-up|0|||
48744041|NCT00395304|156912434|FG002|Treatment Period 1|Lost to Follow-up|0|||
48857022|NCT00696241|157314972|FG002|Overall Study|Protocol Violation|2|||
48857023|NCT00696241|157314973|FG003|Overall Study|Protocol Violation|0|||
48857024|NCT00696241|157314974|FG004|Overall Study|Protocol Violation|3|||
48857025|NCT00696241|157314970|FG000|Overall Study|Lost to Follow-up|1|||
48857026|NCT00696241|157314971|FG001|Overall Study|Lost to Follow-up|4|||
48857027|NCT00696241|157314972|FG002|Overall Study|Lost to Follow-up|1|||
48857028|NCT00696241|157314973|FG003|Overall Study|Lost to Follow-up|2|||
48744042|NCT00395304|156912435|FG003|Treatment Period 1|Lost to Follow-up|1|||
48744043|NCT00395304|156912436|FG004|Treatment Period 1|Lost to Follow-up|0|||
48744044|NCT00395304|156912437|FG005|Treatment Period 1|Lost to Follow-up|1|||
48744045|NCT00395304|156912432|FG000|Treatment Period 1|Physician Decision|0|||
48744046|NCT00395304|156912433|FG001|Treatment Period 1|Physician Decision|1|||
48744047|NCT00395304|156912434|FG002|Treatment Period 1|Physician Decision|0|||
48744048|NCT00395304|156912435|FG003|Treatment Period 1|Physician Decision|0|||
48744049|NCT00395304|156912436|FG004|Treatment Period 1|Physician Decision|0|||
48744050|NCT00395304|156912437|FG005|Treatment Period 1|Physician Decision|0|||
48744051|NCT00395304|156912432|FG000|Treatment Period 2|Withdrawal by Subject|0|||
48744052|NCT00395304|156912433|FG001|Treatment Period 2|Withdrawal by Subject|0|||
48744053|NCT00395304|156912434|FG002|Treatment Period 2|Withdrawal by Subject|0|||
48744054|NCT00395304|156912435|FG003|Treatment Period 2|Withdrawal by Subject|1|||
48744055|NCT00395304|156912436|FG004|Treatment Period 2|Withdrawal by Subject|0|||
48744056|NCT00395304|156912437|FG005|Treatment Period 2|Withdrawal by Subject|2|||
48952083|NCT00069095|157654973|FG001|Primary Treatment Phase|Admin/Other|38|||
48952084|NCT00069095|157654974|FG002|Primary Treatment Phase|Admin/Other|31|||
48952085|NCT00069095|157654975|FG003|Primary Treatment Phase|Admin/Other|45|||
48952086|NCT00069095|157654976|FG004|Primary Treatment Phase|Admin/Other|48|||
48952087|NCT00069095|157654977|FG005|Primary Treatment Phase|Admin/Other|42|||
48952088|NCT00069095|157654972|FG000|Primary Treatment Phase|Adverse Event|99|||
48952089|NCT00069095|157654973|FG001|Primary Treatment Phase|Adverse Event|92|||
48952090|NCT00069095|157654974|FG002|Primary Treatment Phase|Adverse Event|71|||
48952091|NCT00069095|157654975|FG003|Primary Treatment Phase|Adverse Event|72|||
48952092|NCT00069095|157654976|FG004|Primary Treatment Phase|Adverse Event|109|||
48952093|NCT00069095|157654977|FG005|Primary Treatment Phase|Adverse Event|101|||
48952094|NCT00069095|157654972|FG000|Primary Treatment Phase|Death|14|||
48952095|NCT00069095|157654973|FG001|Primary Treatment Phase|Death|8|||
48952096|NCT00069095|157654974|FG002|Primary Treatment Phase|Death|2|||
48952097|NCT00069095|157654975|FG003|Primary Treatment Phase|Death|5|||
48744057|NCT00395304|156912432|FG000|Treatment Period 2|Lost to Follow-up|0|||
48744058|NCT00395304|156912433|FG001|Treatment Period 2|Lost to Follow-up|3|||
48744059|NCT00395304|156912434|FG002|Treatment Period 2|Lost to Follow-up|0|||
48744060|NCT00395304|156912435|FG003|Treatment Period 2|Lost to Follow-up|0|||
48952098|NCT00069095|157654976|FG004|Primary Treatment Phase|Death|8|||
48952099|NCT00069095|157654977|FG005|Primary Treatment Phase|Death|8|||
48952100|NCT00069095|157654972|FG000|Primary Treatment Phase|Failure to return|5|||
48952101|NCT00069095|157654973|FG001|Primary Treatment Phase|Failure to return|5|||
48952102|NCT00069095|157654974|FG002|Primary Treatment Phase|Failure to return|0|||
48744061|NCT00395304|156912436|FG004|Treatment Period 2|Lost to Follow-up|0|||
48744062|NCT00395304|156912437|FG005|Treatment Period 2|Lost to Follow-up|0|||
48744063|NCT00395304|156912432|FG000|Treatment Period 2|Physician Decision|0|||
48744064|NCT00395304|156912433|FG001|Treatment Period 2|Physician Decision|0|||
48744065|NCT00395304|156912434|FG002|Treatment Period 2|Physician Decision|1|||
48744066|NCT00395304|156912435|FG003|Treatment Period 2|Physician Decision|0|||
48744067|NCT00395304|156912436|FG004|Treatment Period 2|Physician Decision|0|||
48744068|NCT00395304|156912437|FG005|Treatment Period 2|Physician Decision|0|||
48952103|NCT00069095|157654975|FG003|Primary Treatment Phase|Failure to return|0|||
48952104|NCT00069095|157654976|FG004|Primary Treatment Phase|Failure to return|0|||
48952105|NCT00069095|157654977|FG005|Primary Treatment Phase|Failure to return|2|||
48744069|NCT00395304|156912432|FG000|Treatment Period 2|Other|0|||
48744070|NCT00395304|156912433|FG001|Treatment Period 2|Other|1|||
48744071|NCT00395304|156912434|FG002|Treatment Period 2|Other|0|||
48952106|NCT00069095|157654972|FG000|Primary Treatment Phase|Insufficient Therapeutic Response|131|||
48952107|NCT00069095|157654973|FG001|Primary Treatment Phase|Insufficient Therapeutic Response|127|||
48952108|NCT00069095|157654974|FG002|Primary Treatment Phase|Insufficient Therapeutic Response|175|||
48952109|NCT00069095|157654975|FG003|Primary Treatment Phase|Insufficient Therapeutic Response|154|||
48952110|NCT00069095|157654976|FG004|Primary Treatment Phase|Insufficient Therapeutic Response|101|||
48952111|NCT00069095|157654977|FG005|Primary Treatment Phase|Insufficient Therapeutic Response|102|||
48952112|NCT00069095|157654972|FG000|Primary Treatment Phase|Refused treatment|15|||
48952113|NCT00069095|157654973|FG001|Primary Treatment Phase|Refused treatment|26|||
48952114|NCT00069095|157654974|FG002|Primary Treatment Phase|Refused treatment|17|||
48952115|NCT00069095|157654975|FG003|Primary Treatment Phase|Refused treatment|31|||
48952116|NCT00069095|157654976|FG004|Primary Treatment Phase|Refused treatment|24|||
48952117|NCT00069095|157654977|FG005|Primary Treatment Phase|Refused treatment|27|||
48952118|NCT00069095|157654972|FG000|Primary Treatment Phase|Withdrew|2|||
48952119|NCT00069095|157654973|FG001|Primary Treatment Phase|Withdrew|3|||
48952120|NCT00069095|157654974|FG002|Primary Treatment Phase|Withdrew|8|||
48952121|NCT00069095|157654975|FG003|Primary Treatment Phase|Withdrew|2|||
48952122|NCT00069095|157654976|FG004|Primary Treatment Phase|Withdrew|4|||
48952123|NCT00069095|157654977|FG005|Primary Treatment Phase|Withdrew|9|||
48952124|NCT00069095|157654972|FG000|Primary Treatment Phase|Other Violation|0|||
48952125|NCT00069095|157654973|FG001|Primary Treatment Phase|Other Violation|1|||
48952126|NCT00069095|157654974|FG002|Primary Treatment Phase|Other Violation|1|||
48952127|NCT00069095|157654975|FG003|Primary Treatment Phase|Other Violation|1|||
48952128|NCT00069095|157654976|FG004|Primary Treatment Phase|Other Violation|0|||
48952129|NCT00069095|157654977|FG005|Primary Treatment Phase|Other Violation|1|||
49015362|NCT00306384|157892156|FG000|Overall Study|Major protocol deviation|43|||
48952130|NCT00069095|157654972|FG000|Primary Treatment Phase|Violation criteria|0|||
48952131|NCT00069095|157654973|FG001|Primary Treatment Phase|Violation criteria|2|||
48952132|NCT00069095|157654974|FG002|Primary Treatment Phase|Violation criteria|4|||
48952133|NCT00069095|157654975|FG003|Primary Treatment Phase|Violation criteria|3|||
48744072|NCT00395304|156912435|FG003|Treatment Period 2|Other|0|||
48744073|NCT00395304|156912436|FG004|Treatment Period 2|Other|0|||
48744074|NCT00395304|156912437|FG005|Treatment Period 2|Other|0|||
48744075|NCT00395304|156912432|FG000|Treatment Period 3|Withdrawal by Subject|0|||
48952134|NCT00069095|157654976|FG004|Primary Treatment Phase|Violation criteria|1|||
48952135|NCT00069095|157654977|FG005|Primary Treatment Phase|Violation criteria|5|||
48744076|NCT00395304|156912433|FG001|Treatment Period 3|Withdrawal by Subject|0|||
48744077|NCT00395304|156912434|FG002|Treatment Period 3|Withdrawal by Subject|0|||
48744078|NCT00395304|156912435|FG003|Treatment Period 3|Withdrawal by Subject|1|||
48744079|NCT00395304|156912436|FG004|Treatment Period 3|Withdrawal by Subject|0|||
48744080|NCT00395304|156912437|FG005|Treatment Period 3|Withdrawal by Subject|1|||
48744081|NCT00395304|156912432|FG000|Treatment Period 3|Lost to Follow-up|1|||
48744082|NCT00395304|156912433|FG001|Treatment Period 3|Lost to Follow-up|1|||
48744083|NCT00395304|156912434|FG002|Treatment Period 3|Lost to Follow-up|0|||
48744084|NCT00395304|156912435|FG003|Treatment Period 3|Lost to Follow-up|0|||
48744085|NCT00395304|156912436|FG004|Treatment Period 3|Lost to Follow-up|0|||
48744086|NCT00395304|156912437|FG005|Treatment Period 3|Lost to Follow-up|0|||
48744087|NCT00395304|156912432|FG000|Treatment Period 3|Physician Decision|0|||
48744088|NCT00395304|156912433|FG001|Treatment Period 3|Physician Decision|1|||
48744089|NCT00395304|156912434|FG002|Treatment Period 3|Physician Decision|0|||
48744090|NCT00395304|156912435|FG003|Treatment Period 3|Physician Decision|0|||
48744091|NCT00395304|156912436|FG004|Treatment Period 3|Physician Decision|0|||
48744092|NCT00395304|156912437|FG005|Treatment Period 3|Physician Decision|0|||
48744093|NCT00395304|156912432|FG000|Treatment Period 3|Other|0|||
48744094|NCT00395304|156912433|FG001|Treatment Period 3|Other|0|||
48744095|NCT00395304|156912434|FG002|Treatment Period 3|Other|0|||
48744096|NCT00395304|156912435|FG003|Treatment Period 3|Other|1|||
48744097|NCT00395304|156912436|FG004|Treatment Period 3|Other|0|||
48744098|NCT00395304|156912437|FG005|Treatment Period 3|Other|0|||
48744099|NCT03486223|156912447|FG000|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|0|||
48744100|NCT03486223|156912448|FG001|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|1|||
48744101|NCT01819831|156912449|FG000|Overall Study|Withdrawal by Subject|1|||
48744102|NCT01749137|156912453|FG000|Overall Study|Adverse Event|4|||
48744103|NCT01749137|156912454|FG001|Overall Study|Adverse Event|4|||
48744104|NCT01749137|156912453|FG000|Overall Study|Lost to Follow-up|2|||
48744105|NCT01749137|156912454|FG001|Overall Study|Lost to Follow-up|3|||
48744106|NCT01749137|156912453|FG000|Overall Study|Physician Decision|1|||
48744107|NCT01749137|156912454|FG001|Overall Study|Physician Decision|0|||
48744108|NCT01749137|156912453|FG000|Overall Study|Withdrawal by Subject|8|||
48744109|NCT01749137|156912454|FG001|Overall Study|Withdrawal by Subject|4|||
48744110|NCT00680017|156912464|FG000|Overall Study|Adverse Event|13|||
48744111|NCT00680017|156912465|FG001|Overall Study|Adverse Event|7|||
48744112|NCT00680017|156912464|FG000|Overall Study|Withdrawal by Subject|2|||
48744113|NCT00680017|156912465|FG001|Overall Study|Withdrawal by Subject|5|||
48744114|NCT00680017|156912464|FG000|Overall Study|Lost to Follow-up|2|||
48744115|NCT00680017|156912465|FG001|Overall Study|Lost to Follow-up|0|||
48744116|NCT01434667|156912469|FG000|Overall Study|Lost to Follow-up|5|||
48744117|NCT01434667|156912470|FG001|Overall Study|Lost to Follow-up|10|||
48744118|NCT01546207|156912471|FG000|Overall Study|Death|1|||
48744119|NCT02601469|156912472|FG000|Overall Study|Enrolled in Error|1|||
48744120|NCT02601469|156912473|FG001|Overall Study|Enrolled in Error|0|||
48744121|NCT02555683|156912474|FG000|Overall Study|Physician Decision|1|||
48744122|NCT02555683|156912475|FG001|Overall Study|Physician Decision|0|||
48744123|NCT02555683|156912476|FG002|Overall Study|Physician Decision|2|||
48744124|NCT02555683|156912474|FG000|Overall Study|Lost to Follow-up|2|||
48744125|NCT02555683|156912475|FG001|Overall Study|Lost to Follow-up|1|||
48744126|NCT02555683|156912476|FG002|Overall Study|Lost to Follow-up|2|||
48744127|NCT02555683|156912474|FG000|Overall Study|Technical Problems|1|||
48744128|NCT02555683|156912475|FG001|Overall Study|Technical Problems|1|||
48744129|NCT02555683|156912476|FG002|Overall Study|Technical Problems|0|||
48744130|NCT02555683|156912474|FG000|Overall Study|Protocol deviation|0|||
48744131|NCT02555683|156912475|FG001|Overall Study|Protocol deviation|1|||
48744132|NCT02555683|156912476|FG002|Overall Study|Protocol deviation|0|||
48744133|NCT02555683|156912474|FG000|Overall Study|Lack of Efficacy|2|||
48744134|NCT02555683|156912475|FG001|Overall Study|Lack of Efficacy|0|||
48744135|NCT02555683|156912476|FG002|Overall Study|Lack of Efficacy|0|||
48744136|NCT02555683|156912474|FG000|Overall Study|Death|0|||
48744137|NCT02555683|156912475|FG001|Overall Study|Death|1|||
48744138|NCT02555683|156912476|FG002|Overall Study|Death|2|||
48744139|NCT02555683|156912474|FG000|Overall Study|Adverse Event|1|||
48744140|NCT02555683|156912475|FG001|Overall Study|Adverse Event|0|||
48744141|NCT02555683|156912476|FG002|Overall Study|Adverse Event|1|||
48744142|NCT02555683|156912474|FG000|Overall Study|Subject/guardian decision|12|||
48744143|NCT02555683|156912475|FG001|Overall Study|Subject/guardian decision|12|||
48744144|NCT02555683|156912476|FG002|Overall Study|Subject/guardian decision|22|||
48857029|NCT00696241|157314974|FG004|Overall Study|Lost to Follow-up|0|||
48857030|NCT00696241|157314970|FG000|Overall Study|Withdrawal by Subject|4|||
48744145|NCT02555683|156912474|FG000|Overall Study|Death post Treatment/safety period|0|||
48744146|NCT02555683|156912475|FG001|Overall Study|Death post Treatment/safety period|1|||
48744147|NCT02555683|156912476|FG002|Overall Study|Death post Treatment/safety period|0|||
48744148|NCT02165215|156912477|FG000|Induction Phase|Adverse Event|1|||
48744149|NCT02165215|156912478|FG001|Induction Phase|Adverse Event|0|||
48744150|NCT02165215|156912479|FG002|Induction Phase|Adverse Event|0|||
48744151|NCT02165215|156912477|FG000|Induction Phase|Withdrawal by Subject|10|||
48744152|NCT02165215|156912478|FG001|Induction Phase|Withdrawal by Subject|0|||
48744153|NCT02165215|156912479|FG002|Induction Phase|Withdrawal by Subject|0|||
48744154|NCT02165215|156912477|FG000|Induction Phase|Protocol Violation|1|||
48744155|NCT02165215|156912478|FG001|Induction Phase|Protocol Violation|0|||
48744156|NCT02165215|156912479|FG002|Induction Phase|Protocol Violation|0|||
48744157|NCT02165215|156912477|FG000|Induction Phase|Physician Decision|1|||
48744158|NCT02165215|156912478|FG001|Induction Phase|Physician Decision|0|||
48744159|NCT02165215|156912479|FG002|Induction Phase|Physician Decision|0|||
48744160|NCT02165215|156912477|FG000|Induction Phase|Lack of Efficacy|2|||
48744161|NCT02165215|156912478|FG001|Induction Phase|Lack of Efficacy|0|||
48744162|NCT02165215|156912479|FG002|Induction Phase|Lack of Efficacy|0|||
48744163|NCT02165215|156912477|FG000|Induction Phase|Non-Compliance|2|||
48744164|NCT02165215|156912478|FG001|Induction Phase|Non-Compliance|0|||
48744165|NCT02165215|156912479|FG002|Induction Phase|Non-Compliance|0|||
48744166|NCT02165215|156912477|FG000|Induction Phase|Lost to Follow-up|6|||
48744167|NCT02165215|156912478|FG001|Induction Phase|Lost to Follow-up|0|||
48744168|NCT02165215|156912479|FG002|Induction Phase|Lost to Follow-up|0|||
48744169|NCT02165215|156912477|FG000|Maintenance Phase|Withdrawal by Subject|0|||
48744170|NCT02165215|156912478|FG001|Maintenance Phase|Withdrawal by Subject|7|||
48744171|NCT02165215|156912479|FG002|Maintenance Phase|Withdrawal by Subject|3|||
48744172|NCT02165215|156912477|FG000|Maintenance Phase|Multiple reasons|0|||
48744173|NCT02165215|156912478|FG001|Maintenance Phase|Multiple reasons|2|||
48744174|NCT02165215|156912479|FG002|Maintenance Phase|Multiple reasons|1|||
48744175|NCT02165215|156912477|FG000|Maintenance Phase|Lost to Follow-up|0|||
48744176|NCT02165215|156912478|FG001|Maintenance Phase|Lost to Follow-up|2|||
48744177|NCT02165215|156912479|FG002|Maintenance Phase|Lost to Follow-up|0|||
48744178|NCT02165215|156912477|FG000|Maintenance Phase|Adverse Event|0|||
48744179|NCT02165215|156912478|FG001|Maintenance Phase|Adverse Event|1|||
48744180|NCT02165215|156912479|FG002|Maintenance Phase|Adverse Event|1|||
48744181|NCT01877265|156912481|FG000|Treatment Period 1|Sponsor Decision|0|||
48744182|NCT01877265|156912482|FG001|Treatment Period 1|Sponsor Decision|0|||
48744183|NCT01877265|156912483|FG002|Treatment Period 1|Sponsor Decision|1|||
48744184|NCT01877265|156912484|FG003|Treatment Period 1|Sponsor Decision|0|||
48744185|NCT01877265|156912485|FG004|Treatment Period 1|Sponsor Decision|0|||
48857031|NCT00696241|157314971|FG001|Overall Study|Withdrawal by Subject|8|||
48857032|NCT00696241|157314972|FG002|Overall Study|Withdrawal by Subject|6|||
48744186|NCT01877265|156912486|FG005|Treatment Period 1|Sponsor Decision|0|||
48744187|NCT01877265|156912481|FG000|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
48744188|NCT01877265|156912482|FG001|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
48744189|NCT01877265|156912483|FG002|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
48744190|NCT01877265|156912484|FG003|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
48744191|NCT01877265|156912485|FG004|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
48744192|NCT01877265|156912486|FG005|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1|||
48857033|NCT00696241|157314973|FG003|Overall Study|Withdrawal by Subject|1|||
48857034|NCT00696241|157314974|FG004|Overall Study|Withdrawal by Subject|0|||
48857035|NCT00696241|157314970|FG000|Overall Study|Lack of Efficacy|1|||
48857036|NCT00696241|157314971|FG001|Overall Study|Lack of Efficacy|5|||
48857037|NCT00696241|157314972|FG002|Overall Study|Lack of Efficacy|4|||
48857038|NCT00696241|157314973|FG003|Overall Study|Lack of Efficacy|5|||
48857039|NCT00696241|157314974|FG004|Overall Study|Lack of Efficacy|3|||
48857040|NCT00696241|157314970|FG000|Overall Study|Other|6|||
48857041|NCT00696241|157314971|FG001|Overall Study|Other|1|||
48857042|NCT00696241|157314972|FG002|Overall Study|Other|5|||
48857043|NCT00696241|157314973|FG003|Overall Study|Other|2|||
48857044|NCT00696241|157314974|FG004|Overall Study|Other|1|||
48857045|NCT02102724|157314976|FG000|Overall Study|Lost to Follow-up|1|||
48857046|NCT02102724|157314977|FG001|Overall Study|Lost to Follow-up|0|||
48857047|NCT02102724|157314976|FG000|Overall Study|surgery for brain aneurysm|1|||
48857048|NCT02102724|157314977|FG001|Overall Study|surgery for brain aneurysm|1|||
48857049|NCT02924051|157314980|FG000|Overall Study|Withdrawal by Subject|1|||
48857050|NCT02924051|157314981|FG001|Overall Study|Withdrawal by Subject|9|||
48857051|NCT00632736|157314982|FG000|Overall Study|Adverse Event|104|||
48857052|NCT00632736|157314982|FG000|Overall Study|Lost to Follow-up|15|||
48857053|NCT00632736|157314982|FG000|Overall Study|Protocol Violation|14|||
48857054|NCT00632736|157314982|FG000|Overall Study|Withdrawal by Subject|99|||
48857055|NCT00632736|157314982|FG000|Overall Study|Lack of Efficacy|5|||
48857056|NCT00632736|157314982|FG000|Overall Study|Sponsor terminated study|5|||
48857057|NCT00632736|157314982|FG000|Overall Study|Non-compliance|10|||
48857058|NCT00632736|157314982|FG000|Overall Study|Other|16|||
48857059|NCT00871715|157314985|FG000|Overall Study|Withdrawal by Subject|6|||
48857060|NCT00871715|157314986|FG001|Overall Study|Withdrawal by Subject|10|||
48857061|NCT00871715|157314987|FG002|Overall Study|Withdrawal by Subject|15|||
48857062|NCT00871715|157314985|FG000|Overall Study|Physician Decision|6|||
48857063|NCT00871715|157314986|FG001|Overall Study|Physician Decision|0|||
48857064|NCT00871715|157314987|FG002|Overall Study|Physician Decision|2|||
48857065|NCT00871715|157314985|FG000|Overall Study|Lost to Follow-up|3|||
48857066|NCT00871715|157314986|FG001|Overall Study|Lost to Follow-up|6|||
48857067|NCT00871715|157314987|FG002|Overall Study|Lost to Follow-up|9|||
48857068|NCT03015220|157314990|FG000|Overall Study|Withdrawal by Subject|3|||
48857069|NCT03015220|157314991|FG001|Overall Study|Withdrawal by Subject|2|||
48857070|NCT03015220|157314992|FG002|Overall Study|Withdrawal by Subject|2|||
48857071|NCT03015220|157314993|FG003|Overall Study|Withdrawal by Subject|2|||
48857072|NCT03015220|157314990|FG000|Overall Study|Lost to Follow-up|0|||
48857073|NCT03015220|157314991|FG001|Overall Study|Lost to Follow-up|0|||
48857074|NCT03015220|157314992|FG002|Overall Study|Lost to Follow-up|1|||
48857075|NCT03015220|157314993|FG003|Overall Study|Lost to Follow-up|0|||
48857076|NCT00512902|157314994|FG000|Overall Study|Adverse Event|7|||
48857077|NCT00512902|157314994|FG000|Overall Study|Lost to Follow-up|1|||
48857078|NCT01794689|157314995|FG000|Intervention 1 (2 Nights)|Withdrawal by Subject|3|||
48857079|NCT01794689|157314996|FG001|Intervention 1 (2 Nights)|Withdrawal by Subject|0|||
48857080|NCT01794689|157314997|FG002|Intervention 1 (2 Nights)|Withdrawal by Subject|2|||
48857081|NCT01794689|157314998|FG003|Intervention 1 (2 Nights)|Withdrawal by Subject|4|||
48857082|NCT01794689|157314995|FG000|Intervention 1 (2 Nights)|Protocol Violation|1|||
48857083|NCT01794689|157314996|FG001|Intervention 1 (2 Nights)|Protocol Violation|0|||
48692648|NCT03001557|156724544|FG003|Extension Phase|Administrative Reason|0|||
48857084|NCT01794689|157314997|FG002|Intervention 1 (2 Nights)|Protocol Violation|1|||
48857085|NCT01794689|157314998|FG003|Intervention 1 (2 Nights)|Protocol Violation|0|||
48857086|NCT01794689|157314995|FG000|Intervention 1 (2 Nights)|Physician Decision|1|||
48857087|NCT01794689|157314996|FG001|Intervention 1 (2 Nights)|Physician Decision|1|||
48857088|NCT01794689|157314997|FG002|Intervention 1 (2 Nights)|Physician Decision|0|||
48857089|NCT01794689|157314998|FG003|Intervention 1 (2 Nights)|Physician Decision|0|||
48857090|NCT01794689|157314995|FG000|Intervention 1 (2 Nights)|Adverse Event|0|||
48857091|NCT01794689|157314996|FG001|Intervention 1 (2 Nights)|Adverse Event|1|||
48857092|NCT01794689|157314997|FG002|Intervention 1 (2 Nights)|Adverse Event|0|||
48857093|NCT01794689|157314998|FG003|Intervention 1 (2 Nights)|Adverse Event|0|||
48857094|NCT01156675|157315000|FG000|Overall Study|Death|5|||
48857095|NCT01156675|157315001|FG001|Overall Study|Death|3|||
48857096|NCT01156675|157315002|FG002|Overall Study|Death|0|||
48857097|NCT01156675|157315000|FG000|Overall Study|No data|29|||
48857098|NCT01156675|157315001|FG001|Overall Study|No data|22|||
48857099|NCT01156675|157315002|FG002|Overall Study|No data|2|||
48857100|NCT01964547|157315016|FG000|Overall Study|Adverse Event|8|||
48857101|NCT01964547|157315017|FG001|Overall Study|Adverse Event|2|||
48857102|NCT01964547|157315016|FG000|Overall Study|Withdrawal by Subject|4|||
48857103|NCT01964547|157315017|FG001|Overall Study|Withdrawal by Subject|7|||
48857104|NCT01964547|157315016|FG000|Overall Study|Lost to Follow-up|0|||
48857105|NCT01964547|157315017|FG001|Overall Study|Lost to Follow-up|1|||
48857106|NCT01964547|157315016|FG000|Overall Study|Withdrawal by Investigator|0|||
48857107|NCT01964547|157315017|FG001|Overall Study|Withdrawal by Investigator|1|||
48857108|NCT01115309|157315018|FG000|Procedure Safety (1-Month)|Lost to Follow-up|2|||
48857109|NCT01115309|157315018|FG000|Procedure Safety (1-Month)|Withdrawal by Subject|1|||
48857110|NCT01115309|157315018|FG000|Long-term Follow-up|Lost to Follow-up|6|||
48744193|NCT01877265|156912481|FG000|Treatment Period 3|Lost to Follow-up|1|||
48744194|NCT01877265|156912482|FG001|Treatment Period 3|Lost to Follow-up|0|||
48744195|NCT01877265|156912483|FG002|Treatment Period 3|Lost to Follow-up|0|||
48744196|NCT01877265|156912484|FG003|Treatment Period 3|Lost to Follow-up|0|||
48744197|NCT01877265|156912485|FG004|Treatment Period 3|Lost to Follow-up|0|||
48744198|NCT01877265|156912486|FG005|Treatment Period 3|Lost to Follow-up|0|||
48744199|NCT01947582|156912487|FG000|Overall Study|Withdrawal by Subject|1|||
48744200|NCT03130257|156912488|FG000|Overall Study|Withdrawal by Subject|1|||
48744201|NCT03130257|156912489|FG001|Overall Study|Withdrawal by Subject|0|||
48744202|NCT03130257|156912490|FG002|Overall Study|Withdrawal by Subject|2|||
48744203|NCT00827502|156912492|FG000|Overall Study|randomized but not treated|11|||
48744204|NCT00827502|156912492|FG000|Overall Study|Adverse Event|1|||
48857111|NCT01549951|157315025|FG000|Overall Study|Adverse Event|15|||
48857112|NCT01549951|157315025|FG000|Overall Study|Withdrawal by Subject|2|||
48857113|NCT01549951|157315025|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
48857114|NCT01549951|157315025|FG000|Overall Study|Progressive disease|29|||
48857115|NCT01549951|157315025|FG000|Overall Study|Symptomatic deterioration|1|||
48857116|NCT01549951|157315025|FG000|Overall Study|Other|2|||
48857117|NCT00689351|157315026|FG000|Infant Series of Dosing|Parent/legal guardian request|5|||
48857118|NCT00689351|157315027|FG001|Infant Series of Dosing|Parent/legal guardian request|0|||
48857119|NCT00689351|157315026|FG000|Infant Series of Dosing|Adverse Event|1|||
48744205|NCT00827502|156912492|FG000|Overall Study|Lost to Follow-up|4|||
48744206|NCT00827502|156912492|FG000|Overall Study|Withdrawal by Subject|5|||
48857120|NCT00689351|157315027|FG001|Infant Series of Dosing|Adverse Event|0|||
48857121|NCT00689351|157315026|FG000|Infant Series of Dosing|Lost to Follow-up|0|||
48857122|NCT00689351|157315027|FG001|Infant Series of Dosing|Lost to Follow-up|1|||
48857123|NCT00689351|157315026|FG000|After Infant Series|Parent/legal guardian request|1|||
48857124|NCT00689351|157315027|FG001|After Infant Series|Parent/legal guardian request|0|||
48857125|NCT02674399|157315028|FG000|Overall Study|Lost to Follow-up|2|||
48857126|NCT02674399|157315029|FG001|Overall Study|Lost to Follow-up|0|||
48857127|NCT01766206|157315030|FG000|Overall Study|Withdrawal by Subject|22|||
48857128|NCT01766206|157315030|FG000|Overall Study|Lost to Follow-up|10|||
48857129|NCT01766206|157315030|FG000|Overall Study|Inappropriate enrollment|18|||
48857130|NCT01766206|157315030|FG000|Overall Study|Withdrawal and inappropriate enrollment|1|||
48857131|NCT01313663|157315031|FG000|Overall Study|Study Closed/Terminated|2|||
48857132|NCT01313663|157315032|FG001|Overall Study|Study Closed/Terminated|4|||
48744207|NCT04390191|156912493|FG000|Overall Study|Withdrawal by Subject|1|||
48744208|NCT04390191|156912494|FG001|Overall Study|Withdrawal by Subject|0|||
48744209|NCT00885846|156912498|FG000|Overall Study|Withdrawal by Subject|2|||
48744210|NCT00885846|156912499|FG001|Overall Study|Withdrawal by Subject|5|||
48744211|NCT00885846|156912500|FG002|Overall Study|Withdrawal by Subject|2|||
48744212|NCT02197247|156912501|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2|||
48744213|NCT02197247|156912501|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2|||
48744214|NCT02197247|156912501|FG000|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5|||
48857133|NCT01313663|157315031|FG000|Overall Study|Lost to Follow-up|0|||
48857134|NCT01313663|157315032|FG001|Overall Study|Lost to Follow-up|1|||
48744215|NCT02197247|156912501|FG000|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2|||
48744216|NCT02197247|156912501|FG000|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2|||
48857135|NCT01313663|157315031|FG000|Overall Study|Physician Decision|0|||
48857136|NCT01313663|157315032|FG001|Overall Study|Physician Decision|2|||
48857137|NCT01313663|157315031|FG000|Overall Study|Withdrawal by Subject|2|||
48857138|NCT01313663|157315032|FG001|Overall Study|Withdrawal by Subject|1|||
48744217|NCT02197247|156912501|FG000|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1|||
48744218|NCT02197247|156912501|FG000|Part B: Day 78 to End Part B (AZD9291)|Death|1|||
48744219|NCT02197247|156912501|FG000|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9|||
48744220|NCT03068455|156912502|FG000|Pre-treatment Period|Disease progression|0|||
48744221|NCT03068455|156912503|FG001|Pre-treatment Period|Disease progression|1|||
48952136|NCT00069095|157654972|FG000|Post-study Treatment Phase|Missing reason|1|||
48952137|NCT00069095|157654973|FG001|Post-study Treatment Phase|Missing reason|3|||
48952138|NCT00069095|157654974|FG002|Post-study Treatment Phase|Missing reason|12|||
48952139|NCT00069095|157654975|FG003|Post-study Treatment Phase|Missing reason|8|||
48952140|NCT00069095|157654976|FG004|Post-study Treatment Phase|Missing reason|18|||
48952141|NCT00069095|157654977|FG005|Post-study Treatment Phase|Missing reason|17|||
48952142|NCT00069095|157654972|FG000|Post-study Treatment Phase|Adverse Event|2|||
48952143|NCT00069095|157654973|FG001|Post-study Treatment Phase|Adverse Event|3|||
48952144|NCT00069095|157654974|FG002|Post-study Treatment Phase|Adverse Event|1|||
48952145|NCT00069095|157654975|FG003|Post-study Treatment Phase|Adverse Event|0|||
48952146|NCT00069095|157654976|FG004|Post-study Treatment Phase|Adverse Event|5|||
48952147|NCT00069095|157654977|FG005|Post-study Treatment Phase|Adverse Event|1|||
48952148|NCT00069095|157654972|FG000|Post-study Treatment Phase|Eligible for surgery|2|||
48952149|NCT00069095|157654973|FG001|Post-study Treatment Phase|Eligible for surgery|0|||
48952150|NCT00069095|157654974|FG002|Post-study Treatment Phase|Eligible for surgery|0|||
48952151|NCT00069095|157654975|FG003|Post-study Treatment Phase|Eligible for surgery|0|||
48952152|NCT00069095|157654976|FG004|Post-study Treatment Phase|Eligible for surgery|0|||
48952153|NCT00069095|157654977|FG005|Post-study Treatment Phase|Eligible for surgery|0|||
48952154|NCT00069095|157654972|FG000|Post-study Treatment Phase|Insufficient therapeutic response|1|||
48952155|NCT00069095|157654973|FG001|Post-study Treatment Phase|Insufficient therapeutic response|4|||
48952156|NCT00069095|157654974|FG002|Post-study Treatment Phase|Insufficient therapeutic response|5|||
48952157|NCT00069095|157654975|FG003|Post-study Treatment Phase|Insufficient therapeutic response|6|||
48857139|NCT01229176|157315034|FG000|Overall Study|Withdrawal by Subject|0|||
48857140|NCT01229176|157315035|FG001|Overall Study|Withdrawal by Subject|0|||
48857141|NCT01229176|157315036|FG002|Overall Study|Withdrawal by Subject|0|||
48857142|NCT01229176|157315037|FG003|Overall Study|Withdrawal by Subject|1|||
48744222|NCT03068455|156912502|FG000|Pre-treatment Period|Participant withdrew consent|1|||
48744223|NCT03068455|156912503|FG001|Pre-treatment Period|Participant withdrew consent|1|||
48952158|NCT00069095|157654976|FG004|Post-study Treatment Phase|Insufficient therapeutic response|7|||
48952159|NCT00069095|157654977|FG005|Post-study Treatment Phase|Insufficient therapeutic response|9|||
48744224|NCT03068455|156912502|FG000|Pre-treatment Period|Poor/non-compliance|0|||
48952160|NCT00069095|157654972|FG000|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
48744225|NCT03068455|156912503|FG001|Pre-treatment Period|Poor/non-compliance|1|||
48744226|NCT03068455|156912502|FG000|Pre-treatment Period|Participant no longer meets study criteria|1|||
48744227|NCT03068455|156912503|FG001|Pre-treatment Period|Participant no longer meets study criteria|3|||
48744228|NCT03068455|156912502|FG000|Pre-treatment Period|Not reported|2|||
48744229|NCT03068455|156912503|FG001|Pre-treatment Period|Not reported|1|||
48744230|NCT03068455|156912502|FG000|Treatment Period|Disease progression|166|||
48744231|NCT03068455|156912503|FG001|Treatment Period|Disease progression|208|||
48744232|NCT03068455|156912502|FG000|Treatment Period|Study drug toxicity|317|||
48952161|NCT00069095|157654973|FG001|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
48744233|NCT03068455|156912503|FG001|Treatment Period|Study drug toxicity|104|||
48744234|NCT03068455|156912502|FG000|Treatment Period|Adverse Event unrelated to study drug|15|||
48744235|NCT03068455|156912503|FG001|Treatment Period|Adverse Event unrelated to study drug|7|||
48744236|NCT03068455|156912502|FG000|Treatment Period|Participant request to stop therapy|33|||
48744237|NCT03068455|156912503|FG001|Treatment Period|Participant request to stop therapy|20|||
48744238|NCT03068455|156912502|FG000|Treatment Period|Participant withdrew consent|5|||
48744239|NCT03068455|156912503|FG001|Treatment Period|Participant withdrew consent|10|||
48744240|NCT03068455|156912502|FG000|Treatment Period|Poor/non-compliance|3|||
48744241|NCT03068455|156912503|FG001|Treatment Period|Poor/non-compliance|0|||
48744242|NCT03068455|156912502|FG000|Treatment Period|Participant no longer meets study criteria|1|||
48744243|NCT03068455|156912503|FG001|Treatment Period|Participant no longer meets study criteria|3|||
48744244|NCT03068455|156912502|FG000|Treatment Period|Other reasons|12|||
48744245|NCT03068455|156912503|FG001|Treatment Period|Other reasons|4|||
48744246|NCT01203098|156912504|FG000|Overall Study|Adverse Event|3|||
48744247|NCT01203098|156912505|FG001|Overall Study|Adverse Event|1|||
48744248|NCT01203098|156912506|FG002|Overall Study|Adverse Event|7|||
48744249|NCT01203098|156912504|FG000|Overall Study|Lost to Follow-up|0|||
48744250|NCT01203098|156912505|FG001|Overall Study|Lost to Follow-up|0|||
48744251|NCT01203098|156912506|FG002|Overall Study|Lost to Follow-up|1|||
48744252|NCT01203098|156912504|FG000|Overall Study|Physician Decision|2|||
48744253|NCT01203098|156912505|FG001|Overall Study|Physician Decision|2|||
48744254|NCT01203098|156912506|FG002|Overall Study|Physician Decision|0|||
48744255|NCT01203098|156912504|FG000|Overall Study|Withdrawal by Subject|1|||
48744256|NCT01203098|156912505|FG001|Overall Study|Withdrawal by Subject|1|||
48744257|NCT01203098|156912506|FG002|Overall Study|Withdrawal by Subject|3|||
48744258|NCT01930123|156912507|FG000|Overall Study|Adverse Event|1|||
48744259|NCT01930123|156912508|FG001|Overall Study|Adverse Event|0|||
48744260|NCT01930123|156912507|FG000|Overall Study|Physician Decision|21|||
48744261|NCT01930123|156912508|FG001|Overall Study|Physician Decision|8|||
48744262|NCT01930123|156912507|FG000|Overall Study|Withdrawal by Subject|1|||
48744263|NCT01930123|156912508|FG001|Overall Study|Withdrawal by Subject|0|||
48744264|NCT01964430|156912509|FG000|Pre-Treatment (Randomization) Period|Protocol Deviation|0|||
48744265|NCT01964430|156912510|FG001|Pre-Treatment (Randomization) Period|Protocol Deviation|2|||
48744266|NCT01964430|156912509|FG000|Pre-Treatment (Randomization) Period|Withdrawal by Subject|2|||
48744267|NCT01964430|156912510|FG001|Pre-Treatment (Randomization) Period|Withdrawal by Subject|9|||
48744268|NCT01964430|156912509|FG000|Pre-Treatment (Randomization) Period|Adverse Event|1|||
48744269|NCT01964430|156912510|FG001|Pre-Treatment (Randomization) Period|Adverse Event|0|||
48744270|NCT01964430|156912509|FG000|Treatment Period|Adverse Event|71|||
48744271|NCT01964430|156912510|FG001|Treatment Period|Adverse Event|37|||
48744272|NCT01964430|156912509|FG000|Treatment Period|Withdrawal by Subject|36|||
48744273|NCT01964430|156912510|FG001|Treatment Period|Withdrawal by Subject|27|||
48744274|NCT01964430|156912509|FG000|Treatment Period|Death|1|||
48744275|NCT01964430|156912510|FG001|Treatment Period|Death|3|||
48744276|NCT01964430|156912509|FG000|Treatment Period|Protocol Deviation|0|||
48857143|NCT01229176|157315038|FG004|Overall Study|Withdrawal by Subject|1|||
48744277|NCT01964430|156912510|FG001|Treatment Period|Protocol Deviation|1|||
48744278|NCT01964430|156912509|FG000|Treatment Period|Physician Decision|5|||
48744279|NCT01964430|156912510|FG001|Treatment Period|Physician Decision|4|||
48744280|NCT01964430|156912509|FG000|Treatment Period|Disease Relapse|28|||
48744281|NCT01964430|156912510|FG001|Treatment Period|Disease Relapse|38|||
48744282|NCT01964430|156912509|FG000|Treatment Period|Other reasons|1|||
48857144|NCT01229176|157315039|FG005|Overall Study|Withdrawal by Subject|1|||
48744283|NCT01964430|156912510|FG001|Treatment Period|Other reasons|3|||
48744284|NCT02591290|156912511|FG000|Overall Study|Withdrawal by Subject|2|||
48744285|NCT04545060|156912512|FG000|Overall Study|Adverse Event|0|||
48744286|NCT04545060|156912513|FG001|Overall Study|Adverse Event|1|||
48744287|NCT04545060|156912512|FG000|Overall Study|Death|0|||
48744288|NCT04545060|156912513|FG001|Overall Study|Death|5|||
48744289|NCT04545060|156912512|FG000|Overall Study|Lost to Follow-up|10|||
48744290|NCT04545060|156912513|FG001|Overall Study|Lost to Follow-up|13|||
48744291|NCT04545060|156912512|FG000|Overall Study|Physician Decision|3|||
48744292|NCT04545060|156912513|FG001|Overall Study|Physician Decision|0|||
48744293|NCT04545060|156912512|FG000|Overall Study|Withdrawal by Subject|17|||
48744294|NCT04545060|156912513|FG001|Overall Study|Withdrawal by Subject|22|||
48744295|NCT01370356|156912514|FG000|Overall Study|Death|1|||
48744296|NCT01370356|156912515|FG001|Overall Study|Death|0|||
48744297|NCT01370356|156912514|FG000|Overall Study|Lack of Efficacy|6|||
48857145|NCT01229176|157315040|FG006|Overall Study|Withdrawal by Subject|0|||
48857146|NCT01229176|157315041|FG007|Overall Study|Withdrawal by Subject|1|||
48857147|NCT01229176|157315034|FG000|Overall Study|Lost to Follow-up|0|||
48857148|NCT01229176|157315035|FG001|Overall Study|Lost to Follow-up|3|||
48857149|NCT01229176|157315036|FG002|Overall Study|Lost to Follow-up|0|||
48857150|NCT01229176|157315037|FG003|Overall Study|Lost to Follow-up|0|||
48857151|NCT01229176|157315038|FG004|Overall Study|Lost to Follow-up|1|||
48857152|NCT01229176|157315039|FG005|Overall Study|Lost to Follow-up|1|||
48744298|NCT01370356|156912515|FG001|Overall Study|Lack of Efficacy|28|||
48744299|NCT01370356|156912514|FG000|Overall Study|Lost to Follow-up|76|||
48744300|NCT01370356|156912515|FG001|Overall Study|Lost to Follow-up|81|||
48744301|NCT01370356|156912514|FG000|Overall Study|Withdrawal by Subject|54|||
48744302|NCT01370356|156912515|FG001|Overall Study|Withdrawal by Subject|59|||
48744303|NCT01370356|156912514|FG000|Overall Study|Reason not specified|39|||
48744304|NCT01370356|156912515|FG001|Overall Study|Reason not specified|43|||
48744305|NCT01370356|156912514|FG000|Overall Study|Protocol Violation|3|||
48744306|NCT01370356|156912515|FG001|Overall Study|Protocol Violation|3|||
48744307|NCT01370356|156912514|FG000|Overall Study|Adverse event (AE) Related to Study Drug|12|||
48744308|NCT01370356|156912515|FG001|Overall Study|Adverse event (AE) Related to Study Drug|9|||
48744309|NCT01370356|156912514|FG000|Overall Study|AE Not Related to Study Drug|1|||
48744310|NCT01370356|156912515|FG001|Overall Study|AE Not Related to Study Drug|4|||
48744311|NCT00702923|156912516|FG000|Overall Study|Adverse Event|1|||
48744312|NCT03408483|156912522|FG000|Overall Study|Physician Decision|3|||
48857153|NCT01229176|157315040|FG006|Overall Study|Lost to Follow-up|0|||
48857154|NCT01229176|157315041|FG007|Overall Study|Lost to Follow-up|2|||
48952162|NCT00069095|157654974|FG002|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
48952163|NCT00069095|157654975|FG003|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
48744313|NCT03408483|156912523|FG001|Overall Study|Physician Decision|3|||
48744314|NCT03408483|156912522|FG000|Overall Study|Lost to Follow-up|3|||
48744315|NCT03408483|156912523|FG001|Overall Study|Lost to Follow-up|0|||
48857155|NCT02138838|157315046|FG000|Overall Study|Study Closure|7|||
48857156|NCT02138838|157315047|FG001|Overall Study|Study Closure|6|||
48857157|NCT02138838|157315046|FG000|Overall Study|Withdrawal by Subject|1|||
48744316|NCT04066023|156912524|FG000|Overall Study|Adverse Event|0|||
48744317|NCT04066023|156912525|FG001|Overall Study|Adverse Event|0|||
48744318|NCT04066023|156912526|FG002|Overall Study|Adverse Event|1|||
48744319|NCT04066023|156912524|FG000|Overall Study|Sponsor decision|3|||
48744320|NCT04066023|156912525|FG001|Overall Study|Sponsor decision|6|||
48744321|NCT04066023|156912526|FG002|Overall Study|Sponsor decision|2|||
48744322|NCT04066023|156912524|FG000|Overall Study|Physician Decision|0|||
48744323|NCT04066023|156912525|FG001|Overall Study|Physician Decision|0|||
48744324|NCT04066023|156912526|FG002|Overall Study|Physician Decision|1|||
48744325|NCT04066023|156912524|FG000|Overall Study|Lost to Follow-up|0|||
48744326|NCT04066023|156912525|FG001|Overall Study|Lost to Follow-up|1|||
48744327|NCT04066023|156912526|FG002|Overall Study|Lost to Follow-up|1|||
48744328|NCT04066023|156912524|FG000|Overall Study|Noncompliance|0|||
48744329|NCT04066023|156912525|FG001|Overall Study|Noncompliance|1|||
48744330|NCT04066023|156912526|FG002|Overall Study|Noncompliance|1|||
48744331|NCT01552694|156912527|FG000|Overall Study|Lost to Follow-up|0|||
48744332|NCT01552694|156912528|FG001|Overall Study|Lost to Follow-up|1|||
48744333|NCT01552694|156912527|FG000|Overall Study|Protocol Violation|0|||
48744334|NCT01552694|156912528|FG001|Overall Study|Protocol Violation|1|||
48744335|NCT03736447|156912529|FG000|Overall Study|Adverse Event|5|||
48744336|NCT03736447|156912530|FG001|Overall Study|Adverse Event|1|||
48744337|NCT03736447|156912529|FG000|Overall Study|Withdrawal by Subject|5|||
48744338|NCT03736447|156912530|FG001|Overall Study|Withdrawal by Subject|1|||
48744339|NCT03736447|156912529|FG000|Overall Study|Lost to Follow-up|1|||
48744340|NCT03736447|156912530|FG001|Overall Study|Lost to Follow-up|0|||
48744341|NCT03736447|156912529|FG000|Overall Study|Physician Decision|1|||
48744342|NCT03736447|156912530|FG001|Overall Study|Physician Decision|0|||
48744343|NCT03736447|156912529|FG000|Overall Study|Continued commitment to study treatment|3|||
48744344|NCT03736447|156912530|FG001|Overall Study|Continued commitment to study treatment|0|||
48744345|NCT03736447|156912529|FG000|Overall Study|Taste aversion to study product|0|||
48744346|NCT03736447|156912530|FG001|Overall Study|Taste aversion to study product|1|||
48744347|NCT02619175|156912531|FG000|Overall Study|Withdrawal by Subject|1|||
48744348|NCT02619175|156912532|FG001|Overall Study|Withdrawal by Subject|0|||
48744349|NCT02619175|156912531|FG000|Overall Study|foot pain|1|||
48744350|NCT02619175|156912532|FG001|Overall Study|foot pain|0|||
48744351|NCT02795832|156912534|FG000|Overall Study|Adverse Event|0|||
48744352|NCT02795832|156912535|FG001|Overall Study|Adverse Event|0|||
48744353|NCT02795832|156912536|FG002|Overall Study|Adverse Event|0|||
48744354|NCT02795832|156912537|FG003|Overall Study|Adverse Event|0|||
48744355|NCT02795832|156912538|FG004|Overall Study|Adverse Event|0|||
48744356|NCT02795832|156912539|FG005|Overall Study|Adverse Event|3|||
48744357|NCT02030041|156912540|FG000|Overall Study|Withdrawal by Subject|2|||
48744358|NCT02030041|156912541|FG001|Overall Study|Withdrawal by Subject|2|||
48744359|NCT02030041|156912542|FG002|Overall Study|Withdrawal by Subject|1|||
48744360|NCT00826943|156912543|FG000|Overall Study|Withdrawal by Subject|0|||
48744361|NCT00826943|156912544|FG001|Overall Study|Withdrawal by Subject|0|||
48744362|NCT00826943|156912545|FG002|Overall Study|Withdrawal by Subject|0|||
48744363|NCT00826943|156912546|FG003|Overall Study|Withdrawal by Subject|0|||
48744364|NCT00826943|156912547|FG004|Overall Study|Withdrawal by Subject|1|||
48744365|NCT00826943|156912548|FG005|Overall Study|Withdrawal by Subject|0|||
48744366|NCT00843024|156912550|FG000|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79|||
48744367|NCT00843024|156912551|FG001|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74|||
48744368|NCT00843024|156912552|FG002|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
48744369|NCT00843024|156912553|FG003|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
48744370|NCT00843024|156912554|FG004|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
48744371|NCT00843024|156912555|FG005|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
48744372|NCT00843024|156912550|FG000|Single-blind Placebo Run-In Phase|Lost to Follow-up|36|||
48744373|NCT00843024|156912551|FG001|Single-blind Placebo Run-In Phase|Lost to Follow-up|31|||
48744374|NCT00843024|156912552|FG002|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
48744375|NCT00843024|156912553|FG003|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
48744376|NCT00843024|156912554|FG004|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
48744377|NCT00843024|156912555|FG005|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
48744378|NCT00843024|156912550|FG000|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19|||
48744379|NCT00843024|156912551|FG001|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18|||
48744380|NCT00843024|156912552|FG002|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
48744381|NCT00843024|156912553|FG003|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
48744382|NCT00843024|156912554|FG004|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
48744383|NCT00843024|156912555|FG005|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
48744384|NCT00843024|156912550|FG000|Single-blind Placebo Run-In Phase|Protocol Violation|4|||
48744385|NCT00843024|156912551|FG001|Single-blind Placebo Run-In Phase|Protocol Violation|5|||
48744386|NCT00843024|156912552|FG002|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
48744387|NCT00843024|156912553|FG003|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
48744388|NCT00843024|156912554|FG004|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
48744389|NCT00843024|156912555|FG005|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
48744390|NCT00843024|156912550|FG000|Single-blind Placebo Run-In Phase|Physician Decision|2|||
48952164|NCT00069095|157654976|FG004|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
48744391|NCT00843024|156912551|FG001|Single-blind Placebo Run-In Phase|Physician Decision|6|||
48744392|NCT00843024|156912552|FG002|Single-blind Placebo Run-In Phase|Physician Decision|0|||
48744393|NCT00843024|156912553|FG003|Single-blind Placebo Run-In Phase|Physician Decision|0|||
48744394|NCT00843024|156912554|FG004|Single-blind Placebo Run-In Phase|Physician Decision|0|||
48744395|NCT00843024|156912555|FG005|Single-blind Placebo Run-In Phase|Physician Decision|0|||
48744396|NCT00843024|156912550|FG000|Single-blind Placebo Run-In Phase|Adverse Event|0|||
48744397|NCT00843024|156912551|FG001|Single-blind Placebo Run-In Phase|Adverse Event|1|||
48744398|NCT00843024|156912552|FG002|Single-blind Placebo Run-In Phase|Adverse Event|0|||
48744399|NCT00843024|156912553|FG003|Single-blind Placebo Run-In Phase|Adverse Event|0|||
48744400|NCT00843024|156912554|FG004|Single-blind Placebo Run-In Phase|Adverse Event|0|||
48744401|NCT00843024|156912555|FG005|Single-blind Placebo Run-In Phase|Adverse Event|0|||
48744402|NCT00843024|156912550|FG000|Single-blind Placebo Run-In Phase|Other|0|||
48744403|NCT00843024|156912551|FG001|Single-blind Placebo Run-In Phase|Other|1|||
48744404|NCT00843024|156912552|FG002|Single-blind Placebo Run-In Phase|Other|0|||
48744405|NCT00843024|156912553|FG003|Single-blind Placebo Run-In Phase|Other|0|||
48744406|NCT00843024|156912554|FG004|Single-blind Placebo Run-In Phase|Other|0|||
48744407|NCT00843024|156912555|FG005|Single-blind Placebo Run-In Phase|Other|0|||
48744408|NCT00843024|156912550|FG000|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
48744409|NCT00843024|156912551|FG001|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
48744410|NCT00843024|156912552|FG002|Double-blind Treatment Phase|No opportunity to treat migraine|20|||
48744411|NCT00843024|156912553|FG003|Double-blind Treatment Phase|No opportunity to treat migraine|10|||
48744412|NCT00843024|156912554|FG004|Double-blind Treatment Phase|No opportunity to treat migraine|13|||
48744413|NCT00843024|156912555|FG005|Double-blind Treatment Phase|No opportunity to treat migraine|14|||
48744414|NCT00843024|156912550|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
48744415|NCT00843024|156912551|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
48744416|NCT00843024|156912552|FG002|Double-blind Treatment Phase|Lost to Follow-up|8|||
48744417|NCT00843024|156912553|FG003|Double-blind Treatment Phase|Lost to Follow-up|4|||
48744418|NCT00843024|156912554|FG004|Double-blind Treatment Phase|Lost to Follow-up|4|||
48744419|NCT00843024|156912555|FG005|Double-blind Treatment Phase|Lost to Follow-up|4|||
48744420|NCT00843024|156912550|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
48744421|NCT00843024|156912551|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
48744422|NCT00843024|156912552|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
48744423|NCT00843024|156912553|FG003|Double-blind Treatment Phase|Withdrawal by Subject|6|||
48744424|NCT00843024|156912554|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
48744425|NCT00843024|156912555|FG005|Double-blind Treatment Phase|Withdrawal by Subject|2|||
48744426|NCT00843024|156912550|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
48744427|NCT00843024|156912551|FG001|Double-blind Treatment Phase|Protocol Violation|0|||
48744428|NCT00843024|156912552|FG002|Double-blind Treatment Phase|Protocol Violation|3|||
48744429|NCT00843024|156912553|FG003|Double-blind Treatment Phase|Protocol Violation|0|||
48857158|NCT02138838|157315047|FG001|Overall Study|Withdrawal by Subject|5|||
48857159|NCT02106325|157315048|FG000|Phase 1|Lost to Follow-up|2|||
48857160|NCT02106325|157315049|FG001|Phase 1|Lost to Follow-up|2|||
48857161|NCT02106325|157315048|FG000|Phase 2|Lost to Follow-up|2|||
48857162|NCT02106325|157315049|FG001|Phase 2|Lost to Follow-up|3|||
48857163|NCT02106325|157315048|FG000|Phase 3|Lost to Follow-up|2|||
48857164|NCT02106325|157315049|FG001|Phase 3|Lost to Follow-up|1|||
48857165|NCT02009865|157315054|FG000|Overall Study|Adverse Event|0|||
48857166|NCT02009865|157315055|FG001|Overall Study|Adverse Event|2|||
48857167|NCT02009865|157315054|FG000|Overall Study|Protocol Violation|0|||
48857168|NCT02009865|157315055|FG001|Overall Study|Protocol Violation|2|||
48857169|NCT02009865|157315054|FG000|Overall Study|Withdrawal by Subject|1|||
48857170|NCT02009865|157315055|FG001|Overall Study|Withdrawal by Subject|1|||
48857171|NCT02935894|157315059|FG000|Overall Study|Subject dismissed|1|||
48857172|NCT01884571|157315062|FG000|Overall Study|Adverse Event|1|||
48857173|NCT01884571|157315062|FG000|Overall Study|Death|2|||
48857174|NCT01884571|157315062|FG000|Overall Study|Withdrawal by Subject|2|||
48857175|NCT01884571|157315062|FG000|Overall Study|Disease progression|3|||
48857176|NCT00091572|157315063|FG000|Overall Study|Lost to Follow-up|1|||
48857177|NCT00091572|157315064|FG001|Overall Study|Lost to Follow-up|1|||
48857178|NCT00091572|157315063|FG000|Overall Study|Subject's Refusal unrelated to toxicity|14|||
48952165|NCT00069095|157654977|FG005|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
48744430|NCT00843024|156912554|FG004|Double-blind Treatment Phase|Protocol Violation|0|||
48744431|NCT00843024|156912555|FG005|Double-blind Treatment Phase|Protocol Violation|3|||
48857179|NCT00091572|157315064|FG001|Overall Study|Subject's Refusal unrelated to toxicity|22|||
48857180|NCT00091572|157315063|FG000|Overall Study|Death not due to malignancy/toxicity|1|||
48744432|NCT00843024|156912550|FG000|Double-blind Treatment Phase|Physician Decision|0|||
48744433|NCT00843024|156912551|FG001|Double-blind Treatment Phase|Physician Decision|0|||
48744434|NCT00843024|156912552|FG002|Double-blind Treatment Phase|Physician Decision|0|||
48744435|NCT00843024|156912553|FG003|Double-blind Treatment Phase|Physician Decision|3|||
48744436|NCT00843024|156912554|FG004|Double-blind Treatment Phase|Physician Decision|1|||
48857181|NCT00091572|157315064|FG001|Overall Study|Death not due to malignancy/toxicity|3|||
48857182|NCT00091572|157315063|FG000|Overall Study|Medical Decision unrelated toxicity/PD|10|||
48857183|NCT00091572|157315064|FG001|Overall Study|Medical Decision unrelated toxicity/PD|22|||
48857184|NCT00091572|157315063|FG000|Overall Study|Other Reason|6|||
48744437|NCT00843024|156912555|FG005|Double-blind Treatment Phase|Physician Decision|1|||
48744438|NCT00843024|156912550|FG000|Double-blind Treatment Phase|Adverse Event|0|||
48744439|NCT00843024|156912551|FG001|Double-blind Treatment Phase|Adverse Event|0|||
48744440|NCT00843024|156912552|FG002|Double-blind Treatment Phase|Adverse Event|0|||
48744441|NCT00843024|156912553|FG003|Double-blind Treatment Phase|Adverse Event|0|||
48744442|NCT00843024|156912554|FG004|Double-blind Treatment Phase|Adverse Event|1|||
48744443|NCT00843024|156912555|FG005|Double-blind Treatment Phase|Adverse Event|1|||
48744444|NCT00843024|156912550|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
48744445|NCT00843024|156912551|FG001|Double-blind Treatment Phase|Lack of Efficacy|0|||
48744446|NCT00843024|156912552|FG002|Double-blind Treatment Phase|Lack of Efficacy|0|||
48744447|NCT00843024|156912553|FG003|Double-blind Treatment Phase|Lack of Efficacy|0|||
48744448|NCT00843024|156912554|FG004|Double-blind Treatment Phase|Lack of Efficacy|1|||
48744449|NCT00843024|156912555|FG005|Double-blind Treatment Phase|Lack of Efficacy|0|||
48744450|NCT02439138|156912556|FG000|Overall Study|Adverse Event|1|||
48744451|NCT02439138|156912556|FG000|Overall Study|PI decision to terminate the study|2|||
48744452|NCT04659161|156912557|FG000|Overall Study|Adverse Event|10|||
48744453|NCT04659161|156912558|FG001|Overall Study|Adverse Event|6|||
48744454|NCT04659161|156912557|FG000|Overall Study|Withdrawal by Subject|13|||
48744455|NCT04659161|156912558|FG001|Overall Study|Withdrawal by Subject|12|||
48744456|NCT04659161|156912557|FG000|Overall Study|Other|9|||
48744457|NCT04659161|156912558|FG001|Overall Study|Other|8|||
48744458|NCT01487200|156912559|FG000|Overall Study|Withdrawal by Subject|0|||
48744459|NCT01487200|156912560|FG001|Overall Study|Withdrawal by Subject|1|||
48857185|NCT00091572|157315064|FG001|Overall Study|Other Reason|13|||
48857186|NCT00091572|157315063|FG000|Overall Study|Ongoing (still on treatment)|8|||
48857187|NCT00091572|157315064|FG001|Overall Study|Ongoing (still on treatment)|12|||
48857188|NCT00091572|157315063|FG000|Overall Study|Major Protocol Violation|2|||
48857189|NCT00091572|157315064|FG001|Overall Study|Major Protocol Violation|0|||
48857190|NCT00091572|157315063|FG000|Overall Study|Toxicity (Related AE)|53|||
48857191|NCT00091572|157315064|FG001|Overall Study|Toxicity (Related AE)|9|||
48857192|NCT01634165|157315066|FG000|Period 2|Adverse Event|0|||
48857193|NCT01634165|157315067|FG001|Period 2|Adverse Event|1|||
48857194|NCT01634165|157315068|FG002|Period 2|Adverse Event|0|||
48857195|NCT01634165|157315069|FG003|Period 2|Adverse Event|0|||
48857196|NCT03070301|157315070|FG000|Overall Study|Progression of disease|16|||
48857197|NCT03070301|157315070|FG000|Overall Study|Physician Decision|3|||
48857198|NCT03070301|157315070|FG000|Overall Study|Withdrawal by Subject|1|||
48857199|NCT00731692|157316205|FG000|Core Study (36 Months)|Lack of Efficacy|11|||
48857200|NCT00731692|157316206|FG001|Core Study (36 Months)|Lack of Efficacy|23|||
48857201|NCT00731692|157316207|FG002|Core Study (36 Months)|Lack of Efficacy|64|||
48857202|NCT00731692|157316205|FG000|Core Study (36 Months)|Physician Decision|1|||
48857203|NCT00731692|157316206|FG001|Core Study (36 Months)|Physician Decision|0|||
48857204|NCT00731692|157316207|FG002|Core Study (36 Months)|Physician Decision|2|||
48857205|NCT00731692|157316205|FG000|Core Study (36 Months)|Death|2|||
48857206|NCT00731692|157316206|FG001|Core Study (36 Months)|Death|1|||
48857207|NCT00731692|157316207|FG002|Core Study (36 Months)|Death|2|||
48857208|NCT00731692|157316205|FG000|Core Study (36 Months)|Lost to Follow-up|1|||
48857209|NCT00731692|157316206|FG001|Core Study (36 Months)|Lost to Follow-up|3|||
48857210|NCT00731692|157316207|FG002|Core Study (36 Months)|Lost to Follow-up|3|||
48857211|NCT00731692|157316205|FG000|Core Study (36 Months)|Administrative|2|||
48857212|NCT00731692|157316206|FG001|Core Study (36 Months)|Administrative|2|||
48857213|NCT00731692|157316207|FG002|Core Study (36 Months)|Administrative|6|||
48857214|NCT00731692|157316205|FG000|Core Study (36 Months)|Abnormal Test Procedure Result|4|||
48952166|NCT00069095|157654972|FG000|Post-study Treatment Phase|Participant had complete response|1|||
48857215|NCT00731692|157316206|FG001|Core Study (36 Months)|Abnormal Test Procedure Result|3|||
48952167|NCT00069095|157654973|FG001|Post-study Treatment Phase|Participant had complete response|1|||
48952168|NCT00069095|157654974|FG002|Post-study Treatment Phase|Participant had complete response|0|||
48744460|NCT01487200|156912561|FG002|Overall Study|Withdrawal by Subject|0|||
48744461|NCT01487200|156912562|FG003|Overall Study|Withdrawal by Subject|0|||
48744462|NCT01858389|156912570|FG000|Overall Study|Death|1|||
48744463|NCT01858389|156912571|FG001|Overall Study|Death|3|||
48744464|NCT01858389|156912570|FG000|Overall Study|Study terminated by sponsor|0|||
48744465|NCT01858389|156912571|FG001|Overall Study|Study terminated by sponsor|2|||
48744466|NCT01858389|156912570|FG000|Overall Study|Withdrawal by Subject|0|||
48744467|NCT01858389|156912571|FG001|Overall Study|Withdrawal by Subject|1|||
48744468|NCT01858389|156912570|FG000|Overall Study|Progressive disease|10|||
48744469|NCT01858389|156912571|FG001|Overall Study|Progressive disease|11|||
48744470|NCT01858389|156912570|FG000|Overall Study|Other|2|||
48744471|NCT01858389|156912571|FG001|Overall Study|Other|4|||
48744472|NCT01858389|156912570|FG000|Overall Study|Adverse Event|3|||
48744473|NCT01858389|156912571|FG001|Overall Study|Adverse Event|1|||
48744474|NCT01858389|156912570|FG000|Overall Study|Did not receive treatment|0|||
48744475|NCT01858389|156912571|FG001|Overall Study|Did not receive treatment|3|||
48744476|NCT01269463|156912572|FG000|First Intervention|Withdrawal by Subject|1|||
48744477|NCT01269463|156912573|FG001|First Intervention|Withdrawal by Subject|0|||
48744478|NCT01269463|156912572|FG000|First Intervention|Adverse Event|1|||
48744479|NCT01269463|156912573|FG001|First Intervention|Adverse Event|0|||
48744480|NCT01269463|156912572|FG000|First Intervention|Lack of Efficacy|0|||
48744481|NCT01269463|156912573|FG001|First Intervention|Lack of Efficacy|1|||
48744482|NCT01269463|156912572|FG000|First Intervention|Physician Decision|0|||
48744483|NCT01269463|156912573|FG001|First Intervention|Physician Decision|1|||
48744484|NCT04404361|156912577|FG000|Overall Study|Death|12|||
48744485|NCT04404361|156912578|FG001|Overall Study|Death|12|||
48744486|NCT04404361|156912577|FG000|Overall Study|Withdrawal by Subject|13|||
48744487|NCT04404361|156912578|FG001|Overall Study|Withdrawal by Subject|5|||
48744488|NCT04404361|156912577|FG000|Overall Study|Lost to Follow-up|6|||
48744489|NCT04404361|156912578|FG001|Overall Study|Lost to Follow-up|3|||
48744490|NCT04404361|156912577|FG000|Overall Study|patient hospitalized and was nonverbal at the end of the study|0|||
48744491|NCT04404361|156912578|FG001|Overall Study|patient hospitalized and was nonverbal at the end of the study|1|||
48744492|NCT00558558|156912579|FG000|Overall Study|Unable to swallow|1|||
48744493|NCT00558558|156912579|FG000|Overall Study|Withdrawal by Subject|1|||
48744494|NCT00558558|156912579|FG000|Overall Study|Lack of Efficacy|4|||
48744495|NCT01744197|156912582|FG000|Overall Study|Received 1 patch|2|||
48744496|NCT01744197|156912583|FG001|Overall Study|Received 1 patch|1|||
48744497|NCT01744197|156912582|FG000|Overall Study|No patch received|2|||
48744498|NCT01744197|156912583|FG001|Overall Study|No patch received|2|||
48744499|NCT04706091|156912588|FG000|Treatment 2|Withdrawal by Subject|1|||
48744500|NCT04706091|156912589|FG001|Treatment 2|Withdrawal by Subject|0|||
48744501|NCT00621153|156912590|FG000|Overall Study|Safety Reason|8|||
48744502|NCT00621153|156912591|FG001|Overall Study|Safety Reason|7|||
48744503|NCT00621153|156912590|FG000|Overall Study|Adverse Event|3|||
48744504|NCT00621153|156912591|FG001|Overall Study|Adverse Event|2|||
48744505|NCT00621153|156912590|FG000|Overall Study|Lost to Follow-up|5|||
48744506|NCT00621153|156912591|FG001|Overall Study|Lost to Follow-up|1|||
48744507|NCT00621153|156912590|FG000|Overall Study|Withdrawal by Subject|4|||
48744508|NCT00621153|156912591|FG001|Overall Study|Withdrawal by Subject|5|||
48744509|NCT02915016|156912592|FG000|Overall Study|Lost to Follow-up|4|||
48744510|NCT02915016|156912593|FG001|Overall Study|Lost to Follow-up|2|||
48744511|NCT02915016|156912594|FG002|Overall Study|Lost to Follow-up|5|||
48744512|NCT02915016|156912595|FG003|Overall Study|Lost to Follow-up|3|||
48744513|NCT02915016|156912596|FG004|Overall Study|Lost to Follow-up|5|||
48744514|NCT02915016|156912597|FG005|Overall Study|Lost to Follow-up|2|||
48744515|NCT02915016|156912598|FG006|Overall Study|Lost to Follow-up|8|||
48744516|NCT02915016|156912599|FG007|Overall Study|Lost to Follow-up|2|||
48744517|NCT02915016|156912592|FG000|Overall Study|Physician Decision|0|||
48744518|NCT02915016|156912593|FG001|Overall Study|Physician Decision|0|||
48744519|NCT02915016|156912594|FG002|Overall Study|Physician Decision|1|||
48744520|NCT02915016|156912595|FG003|Overall Study|Physician Decision|0|||
48744521|NCT02915016|156912596|FG004|Overall Study|Physician Decision|0|||
48744522|NCT02915016|156912597|FG005|Overall Study|Physician Decision|1|||
48744523|NCT02915016|156912598|FG006|Overall Study|Physician Decision|2|||
48744524|NCT02915016|156912599|FG007|Overall Study|Physician Decision|0|||
48744525|NCT02915016|156912592|FG000|Overall Study|Withdrawal by Subject|2|||
48744526|NCT02915016|156912593|FG001|Overall Study|Withdrawal by Subject|0|||
48744527|NCT02915016|156912594|FG002|Overall Study|Withdrawal by Subject|1|||
48744528|NCT02915016|156912595|FG003|Overall Study|Withdrawal by Subject|0|||
48744529|NCT02915016|156912596|FG004|Overall Study|Withdrawal by Subject|1|||
48744530|NCT02915016|156912597|FG005|Overall Study|Withdrawal by Subject|3|||
48744531|NCT02915016|156912598|FG006|Overall Study|Withdrawal by Subject|1|||
48744532|NCT02915016|156912599|FG007|Overall Study|Withdrawal by Subject|1|||
48744533|NCT02915016|156912592|FG000|Overall Study|Elected not to continue|0|||
48744534|NCT02915016|156912593|FG001|Overall Study|Elected not to continue|0|||
48744535|NCT02915016|156912594|FG002|Overall Study|Elected not to continue|0|||
48744536|NCT02915016|156912595|FG003|Overall Study|Elected not to continue|1|||
48744537|NCT02915016|156912596|FG004|Overall Study|Elected not to continue|0|||
48857216|NCT00731692|157316207|FG002|Core Study (36 Months)|Abnormal Test Procedure Result|5|||
48857217|NCT00731692|157316205|FG000|Core Study (36 Months)|Protocol Violation|4|||
48857218|NCT00731692|157316206|FG001|Core Study (36 Months)|Protocol Violation|5|||
48857219|NCT00731692|157316207|FG002|Core Study (36 Months)|Protocol Violation|8|||
48857220|NCT00731692|157316205|FG000|Core Study (36 Months)|Abnormal Lab values|6|||
48857221|NCT00731692|157316206|FG001|Core Study (36 Months)|Abnormal Lab values|19|||
48857222|NCT00731692|157316207|FG002|Core Study (36 Months)|Abnormal Lab values|5|||
48857223|NCT00731692|157316205|FG000|Core Study (36 Months)|Adverse Event|25|||
48857224|NCT00731692|157316206|FG001|Core Study (36 Months)|Adverse Event|28|||
48857225|NCT00731692|157316207|FG002|Core Study (36 Months)|Adverse Event|29|||
48857226|NCT00731692|157316205|FG000|Core Study (36 Months)|Withdrawal by Subject|12|||
48857227|NCT00731692|157316206|FG001|Core Study (36 Months)|Withdrawal by Subject|32|||
48857228|NCT00731692|157316207|FG002|Core Study (36 Months)|Withdrawal by Subject|46|||
48857229|NCT00731692|157316205|FG000|Extension Phase|Admin Problems: Terminated # patients|69|||
48857230|NCT00731692|157316206|FG001|Extension Phase|Admin Problems: Terminated # patients|189|||
48857231|NCT00731692|157316207|FG002|Extension Phase|Admin Problems: Terminated # patients|277|||
48857232|NCT00731692|157316205|FG000|Extension Phase|Abnormal test procedure|0|||
48857233|NCT00731692|157316206|FG001|Extension Phase|Abnormal test procedure|0|||
48857234|NCT00731692|157316207|FG002|Extension Phase|Abnormal test procedure|1|||
48857235|NCT00731692|157316205|FG000|Extension Phase|Abnormal lab values|0|||
48857236|NCT00731692|157316206|FG001|Extension Phase|Abnormal lab values|0|||
48857237|NCT00731692|157316207|FG002|Extension Phase|Abnormal lab values|1|||
48857238|NCT00731692|157316205|FG000|Extension Phase|Lost to Follow-up|0|||
48857239|NCT00731692|157316206|FG001|Extension Phase|Lost to Follow-up|1|||
48857240|NCT00731692|157316207|FG002|Extension Phase|Lost to Follow-up|4|||
48857241|NCT00731692|157316205|FG000|Extension Phase|Withdrawal by Subject|4|||
48857242|NCT00731692|157316206|FG001|Extension Phase|Withdrawal by Subject|5|||
48857243|NCT00731692|157316207|FG002|Extension Phase|Withdrawal by Subject|3|||
48857244|NCT00731692|157316205|FG000|Extension Phase|Adverse Event|1|||
48857245|NCT00731692|157316206|FG001|Extension Phase|Adverse Event|1|||
48857246|NCT00731692|157316207|FG002|Extension Phase|Adverse Event|15|||
48857247|NCT00458783|157316208|FG000|Overall Study|Protocol Violation|1228|||
48857248|NCT00458783|157316209|FG001|Overall Study|Protocol Violation|1220|||
48857249|NCT01737398|157316210|FG000|Overall Study|Adverse event or SAE|16|||
48857250|NCT01737398|157316211|FG001|Overall Study|Adverse event or SAE|1|||
48857251|NCT01737398|157316210|FG000|Overall Study|Stopping rule met|2|||
48857252|NCT01737398|157316211|FG001|Overall Study|Stopping rule met|1|||
48857253|NCT01737398|157316210|FG000|Overall Study|Voluntary withdrawal|2|||
48857254|NCT01737398|157316211|FG001|Overall Study|Voluntary withdrawal|3|||
48857255|NCT01737398|157316210|FG000|Overall Study|Ineligibility|1|||
48857256|NCT01737398|157316211|FG001|Overall Study|Ineligibility|0|||
48857257|NCT01737398|157316210|FG000|Overall Study|Liver transplant|1|||
48857258|NCT01737398|157316211|FG001|Overall Study|Liver transplant|0|||
48857259|NCT01737398|157316210|FG000|Overall Study|Disease progression|2|||
48857260|NCT01737398|157316211|FG001|Overall Study|Disease progression|3|||
48857261|NCT01737398|157316210|FG000|Overall Study|Sponsor's decision|2|||
48857262|NCT01737398|157316211|FG001|Overall Study|Sponsor's decision|0|||
48857263|NCT02038049|157316213|FG000|Overall Study|Lost to Follow-up|1|||
48857264|NCT02038049|157316214|FG001|Overall Study|Lost to Follow-up|0|||
48857265|NCT04938453|157316215|FG000|Washout Period 1|Adverse Event|1|||
48857266|NCT04938453|157316216|FG001|Washout Period 1|Adverse Event|0|||
48857267|NCT04938453|157316215|FG000|Washout Period 1|Physician Decision|0|||
48857268|NCT04938453|157316216|FG001|Washout Period 1|Physician Decision|1|||
48857269|NCT02392507|157316217|FG000|Induction Regimen|Death|3|||
48857270|NCT02392507|157316217|FG000|Induction Regimen|On Study Treatment at Study Conclusion|1|||
48857271|NCT02392507|157316217|FG000|Induction Regimen|Physician Decision|1|||
48857272|NCT02392507|157316217|FG000|Induction Regimen|Withdrawal by Subject|2|||
48857273|NCT02392507|157316217|FG000|Maintenance Regimen|Death|1|||
48857274|NCT02392507|157316217|FG000|Maintenance Regimen|On Study Treatment at Study Conclusion|1|||
48857275|NCT00487240|157316218|FG000|Overall Study|Withdrawal by Subject|12|||
48857276|NCT00487240|157316219|FG001|Overall Study|Withdrawal by Subject|6|||
48857277|NCT00487240|157316218|FG000|Overall Study|Lost to Follow-up|7|||
48857278|NCT00487240|157316219|FG001|Overall Study|Lost to Follow-up|6|||
48857279|NCT00487240|157316218|FG000|Overall Study|Adverse Event|0|||
48857280|NCT00487240|157316219|FG001|Overall Study|Adverse Event|4|||
48857281|NCT00487240|157316218|FG000|Overall Study|Protocol Violation|5|||
48857282|NCT00487240|157316219|FG001|Overall Study|Protocol Violation|5|||
48857283|NCT00487240|157316218|FG000|Overall Study|Entry Criteria Not Met|3|||
48857284|NCT00487240|157316219|FG001|Overall Study|Entry Criteria Not Met|4|||
48857285|NCT00487240|157316218|FG000|Overall Study|Sponsor Decision|2|||
48857286|NCT00487240|157316219|FG001|Overall Study|Sponsor Decision|1|||
48857287|NCT00487240|157316218|FG000|Overall Study|Physician Decision|2|||
48857288|NCT00487240|157316219|FG001|Overall Study|Physician Decision|0|||
48857289|NCT00578344|157316222|FG000|Overall Study|Insurance problems|1|||
48857290|NCT00578344|157316222|FG000|Overall Study|Graft failure|1|||
48857291|NCT03052517|157316223|FG000|Overall Study|Study Terminated By Sponsor|928|||
48857292|NCT03052517|157316224|FG001|Overall Study|Study Terminated By Sponsor|938|||
48857293|NCT03052517|157316225|FG002|Overall Study|Study Terminated By Sponsor|296|||
48857294|NCT03052517|157316223|FG000|Overall Study|Subject/Guardian Decision|50|||
48857295|NCT03052517|157316224|FG001|Overall Study|Subject/Guardian Decision|45|||
48857296|NCT03052517|157316225|FG002|Overall Study|Subject/Guardian Decision|22|||
48857297|NCT03052517|157316223|FG000|Overall Study|Lack of Efficacy|23|||
48857298|NCT03052517|157316224|FG001|Overall Study|Lack of Efficacy|14|||
48857299|NCT03052517|157316225|FG002|Overall Study|Lack of Efficacy|7|||
48857300|NCT03052517|157316223|FG000|Overall Study|Adverse Event|6|||
48857301|NCT03052517|157316224|FG001|Overall Study|Adverse Event|5|||
48857302|NCT03052517|157316225|FG002|Overall Study|Adverse Event|0|||
48857303|NCT03052517|157316223|FG000|Overall Study|Physician Decision|4|||
48857304|NCT03052517|157316224|FG001|Overall Study|Physician Decision|5|||
48857305|NCT03052517|157316225|FG002|Overall Study|Physician Decision|1|||
48857306|NCT03052517|157316223|FG000|Overall Study|Death|3|||
48857307|NCT03052517|157316224|FG001|Overall Study|Death|0|||
48857308|NCT03052517|157316225|FG002|Overall Study|Death|1|||
48857309|NCT03052517|157316223|FG000|Overall Study|Lost to Follow-up|2|||
48857310|NCT03052517|157316224|FG001|Overall Study|Lost to Follow-up|4|||
48857311|NCT03052517|157316225|FG002|Overall Study|Lost to Follow-up|0|||
48857312|NCT03052517|157316223|FG000|Overall Study|Pregnancy|1|||
48857313|NCT03052517|157316224|FG001|Overall Study|Pregnancy|0|||
48857314|NCT03052517|157316225|FG002|Overall Study|Pregnancy|1|||
48857315|NCT03052517|157316223|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
48857316|NCT03052517|157316224|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
48857317|NCT03052517|157316225|FG002|Overall Study|Non-Compliance With Study Treatment|0|||
48857318|NCT03052517|157316223|FG000|Overall Study|Technical Problems|0|||
48857319|NCT03052517|157316224|FG001|Overall Study|Technical Problems|1|||
48857320|NCT03052517|157316225|FG002|Overall Study|Technical Problems|0|||
48857321|NCT01976507|157316236|FG000|Overall Study|Adverse Event|6|||
48744538|NCT02915016|156912597|FG005|Overall Study|Elected not to continue|0|||
48744539|NCT02915016|156912598|FG006|Overall Study|Elected not to continue|1|||
48744540|NCT02915016|156912599|FG007|Overall Study|Elected not to continue|0|||
48744541|NCT02915016|156912592|FG000|Overall Study|HIV infection|1|||
48744542|NCT02915016|156912593|FG001|Overall Study|HIV infection|1|||
48744543|NCT02915016|156912594|FG002|Overall Study|HIV infection|1|||
48744544|NCT02915016|156912595|FG003|Overall Study|HIV infection|0|||
48744545|NCT02915016|156912596|FG004|Overall Study|HIV infection|1|||
48744546|NCT02915016|156912597|FG005|Overall Study|HIV infection|0|||
48744547|NCT02915016|156912598|FG006|Overall Study|HIV infection|0|||
48857322|NCT01976507|157316236|FG000|Overall Study|ablation not done, drug not given|1|||
48744548|NCT02915016|156912599|FG007|Overall Study|HIV infection|0|||
48744549|NCT02915016|156912592|FG000|Overall Study|Participant unable to adhere|0|||
48744550|NCT02915016|156912593|FG001|Overall Study|Participant unable to adhere|0|||
48744551|NCT02915016|156912594|FG002|Overall Study|Participant unable to adhere|0|||
48744552|NCT02915016|156912595|FG003|Overall Study|Participant unable to adhere|0|||
48744553|NCT02915016|156912596|FG004|Overall Study|Participant unable to adhere|0|||
48857323|NCT01722097|157316242|FG000|Overall Study|Patient sheets not returned|6|||
48857324|NCT01722097|157316243|FG001|Overall Study|Patient sheets not returned|5|||
48744554|NCT02915016|156912597|FG005|Overall Study|Participant unable to adhere|0|||
48857325|NCT01757288|157316247|FG000|Overall Study|Consent withdrawal|0|||
48857326|NCT01757288|157316248|FG001|Overall Study|Consent withdrawal|4|||
48857327|NCT01757288|157316249|FG002|Overall Study|Consent withdrawal|4|||
48857328|NCT01757288|157316247|FG000|Overall Study|Patient off study, IRB hold.|0|||
48857329|NCT01757288|157316248|FG001|Overall Study|Patient off study, IRB hold.|0|||
48857330|NCT01757288|157316249|FG002|Overall Study|Patient off study, IRB hold.|1|||
48857331|NCT01757288|157316247|FG000|Overall Study|Patient death prior to starting treatment|0|||
48744555|NCT02915016|156912598|FG006|Overall Study|Participant unable to adhere|0|||
48744556|NCT02915016|156912599|FG007|Overall Study|Participant unable to adhere|1|||
48744557|NCT02200211|156914412|FG000|Overall Study|Lost to Follow-up|7|||
48744558|NCT02200211|156914413|FG001|Overall Study|Lost to Follow-up|7|||
48744559|NCT02200211|156914414|FG002|Overall Study|Lost to Follow-up|1|||
48744560|NCT02200211|156914415|FG003|Overall Study|Lost to Follow-up|2|||
48744561|NCT02200211|156914412|FG000|Overall Study|Withdrawal by Subject|1|||
48744562|NCT02200211|156914413|FG001|Overall Study|Withdrawal by Subject|0|||
48744563|NCT02200211|156914414|FG002|Overall Study|Withdrawal by Subject|0|||
48744564|NCT02200211|156914415|FG003|Overall Study|Withdrawal by Subject|0|||
48744565|NCT01687998|156914416|FG000|Overall Study|Withdrawal by Subject|49|||
48744566|NCT01687998|156914417|FG001|Overall Study|Withdrawal by Subject|51|||
48744567|NCT01687998|156914416|FG000|Overall Study|Known to be Alive at Study End|54|||
48744568|NCT01687998|156914417|FG001|Overall Study|Known to be Alive at Study End|62|||
48744569|NCT01687998|156914416|FG000|Overall Study|Lost to Follow-up|9|||
48744570|NCT01687998|156914417|FG001|Overall Study|Lost to Follow-up|7|||
48744571|NCT03166735|156914420|FG000|Overall Study|Not Treated|1|||
48744572|NCT03166735|156914421|FG001|Overall Study|Not Treated|0|||
48744573|NCT03166735|156914422|FG002|Overall Study|Not Treated|0|||
48744574|NCT03166735|156914423|FG003|Overall Study|Not Treated|0|||
48744575|NCT03166735|156914424|FG004|Overall Study|Not Treated|0|||
48744576|NCT03166735|156914420|FG000|Overall Study|follow-up not completed as planned|0|||
48744577|NCT03166735|156914421|FG001|Overall Study|follow-up not completed as planned|1|||
48744578|NCT03166735|156914422|FG002|Overall Study|follow-up not completed as planned|1|||
48744579|NCT03166735|156914423|FG003|Overall Study|follow-up not completed as planned|0|||
48744580|NCT03166735|156914424|FG004|Overall Study|follow-up not completed as planned|1|||
48744581|NCT03166735|156914420|FG000|Overall Study|Withdrawal by Subject|0|||
48744582|NCT03166735|156914421|FG001|Overall Study|Withdrawal by Subject|0|||
48744583|NCT03166735|156914422|FG002|Overall Study|Withdrawal by Subject|1|||
48744584|NCT03166735|156914423|FG003|Overall Study|Withdrawal by Subject|1|||
48744585|NCT03166735|156914424|FG004|Overall Study|Withdrawal by Subject|2|||
48744586|NCT03166735|156914420|FG000|Overall Study|Lost to Follow-up|0|||
48744587|NCT03166735|156914421|FG001|Overall Study|Lost to Follow-up|2|||
48744588|NCT03166735|156914422|FG002|Overall Study|Lost to Follow-up|1|||
48744589|NCT03166735|156914423|FG003|Overall Study|Lost to Follow-up|0|||
48744590|NCT03166735|156914424|FG004|Overall Study|Lost to Follow-up|1|||
48744591|NCT04401423|156914425|FG000|Overall Study|Withdrawal by Subject|3|||
48744592|NCT04401423|156914426|FG001|Overall Study|Withdrawal by Subject|1|||
48744593|NCT04401423|156914425|FG000|Overall Study|Physician Decision|2|||
48744594|NCT04401423|156914426|FG001|Overall Study|Physician Decision|1|||
48744595|NCT03797014|156914427|FG000|Overall Study|Withdrawal by Subject|1|||
48744596|NCT03797014|156914427|FG000|Overall Study|Lost to Follow-up|1|||
48744597|NCT03797014|156914427|FG000|Overall Study|Protocol Violation|1|||
48744598|NCT03305575|156914431|FG000|Overall Study|Physician Decision|1|||
48744599|NCT03305575|156914432|FG001|Overall Study|Physician Decision|0|||
48744600|NCT05074667|156914437|FG000|Overall Study|Death|1|||
48744601|NCT05074667|156914437|FG000|Overall Study|Withdrawal by Subject|4|||
48744602|NCT05074667|156914437|FG000|Overall Study|Lost to Follow-up|10|||
48744603|NCT00612040|156914444|FG000|Overall Study|Adverse Event|0|||
48744604|NCT00612040|156914445|FG001|Overall Study|Adverse Event|2|||
48744605|NCT00612040|156914446|FG002|Overall Study|Adverse Event|1|||
48744606|NCT00612040|156914444|FG000|Overall Study|Protocol Violation|1|||
48952169|NCT00069095|157654975|FG003|Post-study Treatment Phase|Participant had complete response|0|||
48744607|NCT00612040|156914445|FG001|Overall Study|Protocol Violation|2|||
48744608|NCT00612040|156914446|FG002|Overall Study|Protocol Violation|1|||
48744609|NCT00612040|156914444|FG000|Overall Study|Lack of Efficacy|2|||
48744610|NCT00612040|156914445|FG001|Overall Study|Lack of Efficacy|1|||
48744611|NCT00612040|156914446|FG002|Overall Study|Lack of Efficacy|0|||
48744612|NCT00612040|156914444|FG000|Overall Study|Unclassified|2|||
48744613|NCT00612040|156914445|FG001|Overall Study|Unclassified|2|||
48744614|NCT00612040|156914446|FG002|Overall Study|Unclassified|5|||
48744615|NCT00590720|156914447|FG000|Overall Study|Lost to Follow-up|1|||
48744616|NCT00590720|156914448|FG001|Overall Study|Lost to Follow-up|0|||
48744617|NCT00590720|156914447|FG000|Overall Study|Withdrawal by Subject|0|||
48744618|NCT00590720|156914448|FG001|Overall Study|Withdrawal by Subject|1|||
48744619|NCT00224042|156914449|FG000|Overall Study|Adverse Event|2|||
48744620|NCT00224042|156914450|FG001|Overall Study|Adverse Event|1|||
48744621|NCT00224042|156914449|FG000|Overall Study|Protocol Violation|0|||
48744622|NCT00224042|156914450|FG001|Overall Study|Protocol Violation|1|||
48952170|NCT00069095|157654976|FG004|Post-study Treatment Phase|Participant had complete response|0|||
48952171|NCT00069095|157654977|FG005|Post-study Treatment Phase|Participant had complete response|0|||
48952172|NCT00069095|157654972|FG000|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
48952173|NCT00069095|157654973|FG001|Post-study Treatment Phase|More than 21 days delay between cycles|1|||
48952174|NCT00069095|157654974|FG002|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
48952175|NCT00069095|157654975|FG003|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
48952176|NCT00069095|157654976|FG004|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
48952177|NCT00069095|157654977|FG005|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
48952178|NCT00069095|157654972|FG000|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
48952179|NCT00069095|157654973|FG001|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
48952180|NCT00069095|157654974|FG002|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
48952181|NCT00069095|157654975|FG003|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
48952182|NCT00069095|157654976|FG004|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
48952183|NCT00069095|157654977|FG005|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
48952184|NCT00069095|157654972|FG000|Post-study Treatment Phase|Participant withdrew consent|0|||
48952185|NCT00069095|157654973|FG001|Post-study Treatment Phase|Participant withdrew consent|0|||
48952186|NCT00069095|157654974|FG002|Post-study Treatment Phase|Participant withdrew consent|1|||
48952187|NCT00069095|157654975|FG003|Post-study Treatment Phase|Participant withdrew consent|0|||
48952188|NCT00069095|157654976|FG004|Post-study Treatment Phase|Participant withdrew consent|0|||
48952189|NCT00069095|157654977|FG005|Post-study Treatment Phase|Participant withdrew consent|0|||
48952190|NCT00069095|157654972|FG000|Post-study Treatment Phase|Participant will start new treatment|0|||
48952191|NCT00069095|157654973|FG001|Post-study Treatment Phase|Participant will start new treatment|0|||
48952192|NCT00069095|157654974|FG002|Post-study Treatment Phase|Participant will start new treatment|1|||
48952193|NCT00069095|157654975|FG003|Post-study Treatment Phase|Participant will start new treatment|0|||
48952194|NCT00069095|157654976|FG004|Post-study Treatment Phase|Participant will start new treatment|0|||
48952195|NCT00069095|157654977|FG005|Post-study Treatment Phase|Participant will start new treatment|0|||
49015363|NCT00306384|157892157|FG001|Overall Study|Major protocol deviation|51|||
48952196|NCT00069095|157654972|FG000|Post-study Treatment Phase|Participant wanted break from treatment|0|||
48952197|NCT00069095|157654973|FG001|Post-study Treatment Phase|Participant wanted break from treatment|0|||
48952198|NCT00069095|157654974|FG002|Post-study Treatment Phase|Participant wanted break from treatment|0|||
48952199|NCT00069095|157654975|FG003|Post-study Treatment Phase|Participant wanted break from treatment|1|||
48952200|NCT00069095|157654976|FG004|Post-study Treatment Phase|Participant wanted break from treatment|0|||
48952201|NCT00069095|157654977|FG005|Post-study Treatment Phase|Participant wanted break from treatment|0|||
48952202|NCT00069095|157654972|FG000|Post-study Treatment Phase|Participant completed treatment|0|||
48952203|NCT00069095|157654973|FG001|Post-study Treatment Phase|Participant completed treatment|0|||
48952204|NCT00069095|157654974|FG002|Post-study Treatment Phase|Participant completed treatment|0|||
48952205|NCT00069095|157654975|FG003|Post-study Treatment Phase|Participant completed treatment|1|||
48952206|NCT00069095|157654976|FG004|Post-study Treatment Phase|Participant completed treatment|0|||
48952207|NCT00069095|157654977|FG005|Post-study Treatment Phase|Participant completed treatment|0|||
48952208|NCT00069095|157654972|FG000|Post-study Treatment Phase|Surgery|0|||
48952209|NCT00069095|157654973|FG001|Post-study Treatment Phase|Surgery|0|||
48952210|NCT00069095|157654974|FG002|Post-study Treatment Phase|Surgery|0|||
48952211|NCT00069095|157654975|FG003|Post-study Treatment Phase|Surgery|1|||
48952212|NCT00069095|157654976|FG004|Post-study Treatment Phase|Surgery|1|||
48952213|NCT00069095|157654977|FG005|Post-study Treatment Phase|Surgery|0|||
48952214|NCT00069095|157654972|FG000|Post-study Treatment Phase|Death|0|||
48952215|NCT00069095|157654973|FG001|Post-study Treatment Phase|Death|0|||
48952216|NCT00069095|157654974|FG002|Post-study Treatment Phase|Death|0|||
48952217|NCT00069095|157654975|FG003|Post-study Treatment Phase|Death|0|||
48952218|NCT00069095|157654976|FG004|Post-study Treatment Phase|Death|1|||
48952219|NCT00069095|157654977|FG005|Post-study Treatment Phase|Death|0|||
48952220|NCT00069095|157654972|FG000|Post-study Treatment Phase|Participant had progressive disease|0|||
48952221|NCT00069095|157654973|FG001|Post-study Treatment Phase|Participant had progressive disease|0|||
48952222|NCT00069095|157654974|FG002|Post-study Treatment Phase|Participant had progressive disease|0|||
48952223|NCT00069095|157654975|FG003|Post-study Treatment Phase|Participant had progressive disease|0|||
48952224|NCT00069095|157654976|FG004|Post-study Treatment Phase|Participant had progressive disease|1|||
48952225|NCT00069095|157654977|FG005|Post-study Treatment Phase|Participant had progressive disease|0|||
48952226|NCT00069095|157654972|FG000|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
48952227|NCT00069095|157654973|FG001|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
48952228|NCT00069095|157654974|FG002|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
48952229|NCT00069095|157654975|FG003|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
48952230|NCT00069095|157654976|FG004|Post-study Treatment Phase|Participant/Physician decision to stop|1|||
48952231|NCT00069095|157654977|FG005|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
48952232|NCT00069095|157654972|FG000|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
48952233|NCT00069095|157654973|FG001|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
48952234|NCT00069095|157654974|FG002|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
48744623|NCT00224042|156914449|FG000|Overall Study|Physician Decision|0|||
48744624|NCT00224042|156914450|FG001|Overall Study|Physician Decision|1|||
48744625|NCT00224042|156914449|FG000|Overall Study|Did not meet lab incusion criteria|2|||
48744626|NCT00224042|156914450|FG001|Overall Study|Did not meet lab incusion criteria|3|||
48744627|NCT00224042|156914449|FG000|Overall Study|Other|2|||
48744628|NCT00224042|156914450|FG001|Overall Study|Other|0|||
48744629|NCT01976338|156914453|FG000|Overall Study|Physician Decision|0|||
48744630|NCT01976338|156914454|FG001|Overall Study|Physician Decision|1|||
48744631|NCT01976338|156914453|FG000|Overall Study|Lost to Follow-up|3|||
48952235|NCT00069095|157654975|FG003|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
48952236|NCT00069095|157654976|FG004|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1|||
48952237|NCT00069095|157654977|FG005|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
48952238|NCT00069095|157654972|FG000|Post-study Treatment Phase|Investigator decision|0|||
48952239|NCT00069095|157654973|FG001|Post-study Treatment Phase|Investigator decision|0|||
48952240|NCT00069095|157654974|FG002|Post-study Treatment Phase|Investigator decision|0|||
48952241|NCT00069095|157654975|FG003|Post-study Treatment Phase|Investigator decision|0|||
48952242|NCT00069095|157654976|FG004|Post-study Treatment Phase|Investigator decision|0|||
48952243|NCT00069095|157654977|FG005|Post-study Treatment Phase|Investigator decision|1|||
48952244|NCT00069095|157654972|FG000|Follow-up Phase|Death|174|||
48952245|NCT00069095|157654973|FG001|Follow-up Phase|Death|206|||
48952246|NCT00069095|157654974|FG002|Follow-up Phase|Death|120|||
48952247|NCT00069095|157654975|FG003|Follow-up Phase|Death|112|||
48952248|NCT00069095|157654976|FG004|Follow-up Phase|Death|92|||
48952249|NCT00069095|157654977|FG005|Follow-up Phase|Death|101|||
48952250|NCT00328198|157654978|FG000|Treatment|Adverse Event|21|||
48952251|NCT00328198|157654978|FG000|Treatment|Death|1|||
48952252|NCT00328198|157654978|FG000|Treatment|Physician Decision|5|||
48952253|NCT00328198|157654978|FG000|Treatment|Withdrawal by Subject|5|||
48952254|NCT00328198|157654978|FG000|Treatment|Evidence of disease progression|2|||
48952255|NCT00328198|157654978|FG000|Treatment|Non-compliance|1|||
48952256|NCT00328198|157654978|FG000|Treatment|Confirmed complete response, MRD -|3|||
48952257|NCT00328198|157654978|FG000|Follow-up|Lost to Follow-up|4|||
48744632|NCT01976338|156914454|FG001|Overall Study|Lost to Follow-up|0|||
48952258|NCT00328198|157654978|FG000|Follow-up|Death|31|||
48744633|NCT01976338|156914453|FG000|Overall Study|Withdrawal by Subject|5|||
48744634|NCT01976338|156914454|FG001|Overall Study|Withdrawal by Subject|2|||
48744635|NCT01976338|156914453|FG000|Overall Study|Adverse Event|5|||
48744636|NCT01976338|156914454|FG001|Overall Study|Adverse Event|1|||
48744637|NCT03039283|156914460|FG000|Overall Study|Protocol Violation|2|||
48744638|NCT00520936|156914462|FG000|Overall Study|Physician Decision|0|||
48952259|NCT01809262|157654980|FG000|Period 1 (First Dose + Washout)|Adverse Event|0|||
48952260|NCT01809262|157654981|FG001|Period 1 (First Dose + Washout)|Adverse Event|0|||
48952261|NCT01809262|157654982|FG002|Period 1 (First Dose + Washout)|Adverse Event|0|||
48952262|NCT01809262|157654983|FG003|Period 1 (First Dose + Washout)|Adverse Event|0|||
48952263|NCT01809262|157654984|FG004|Period 1 (First Dose + Washout)|Adverse Event|1|||
48952264|NCT01809262|157654985|FG005|Period 1 (First Dose + Washout)|Adverse Event|0|||
48952265|NCT01809262|157654986|FG006|Period 1 (First Dose + Washout)|Adverse Event|0|||
48952266|NCT01809262|157654987|FG007|Period 1 (First Dose + Washout)|Adverse Event|0|||
48952267|NCT01809262|157654988|FG008|Period 1 (First Dose + Washout)|Adverse Event|0|||
48952268|NCT01809262|157654989|FG009|Period 1 (First Dose + Washout)|Adverse Event|0|||
48952269|NCT01809262|157654980|FG000|Period 3 (Third Dose + Washout)|Adverse Event|0|||
48952270|NCT01809262|157654981|FG001|Period 3 (Third Dose + Washout)|Adverse Event|1|||
48952271|NCT01809262|157654982|FG002|Period 3 (Third Dose + Washout)|Adverse Event|0|||
48744639|NCT00520936|156914463|FG001|Overall Study|Physician Decision|2|||
48744640|NCT00520936|156914464|FG002|Overall Study|Physician Decision|1|||
48744641|NCT00520936|156914465|FG003|Overall Study|Physician Decision|0|||
48744642|NCT00520936|156914466|FG004|Overall Study|Physician Decision|0|||
48744643|NCT00520936|156914467|FG005|Overall Study|Physician Decision|0|||
48744644|NCT00520936|156914468|FG006|Overall Study|Physician Decision|0|||
48744645|NCT00520936|156914469|FG007|Overall Study|Physician Decision|0|||
48744646|NCT00520936|156914462|FG000|Overall Study|Withdrawal by Subject|0|||
48744647|NCT00520936|156914463|FG001|Overall Study|Withdrawal by Subject|0|||
48952272|NCT01809262|157654983|FG003|Period 3 (Third Dose + Washout)|Adverse Event|0|||
48744648|NCT00520936|156914464|FG002|Overall Study|Withdrawal by Subject|0|||
48952273|NCT01809262|157654984|FG004|Period 3 (Third Dose + Washout)|Adverse Event|0|||
48952274|NCT01809262|157654985|FG005|Period 3 (Third Dose + Washout)|Adverse Event|0|||
48744649|NCT00520936|156914465|FG003|Overall Study|Withdrawal by Subject|0|||
48744650|NCT00520936|156914466|FG004|Overall Study|Withdrawal by Subject|0|||
48744651|NCT00520936|156914467|FG005|Overall Study|Withdrawal by Subject|0|||
48952275|NCT01809262|157654986|FG006|Period 3 (Third Dose + Washout)|Adverse Event|0|||
48952276|NCT01809262|157654987|FG007|Period 3 (Third Dose + Washout)|Adverse Event|0|||
48952277|NCT01809262|157654988|FG008|Period 3 (Third Dose + Washout)|Adverse Event|0|||
48952278|NCT01809262|157654989|FG009|Period 3 (Third Dose + Washout)|Adverse Event|0|||
48952279|NCT01505491|157654990|FG000|Overall Study|Other reason not listed|1|||
48952280|NCT01505491|157654991|FG001|Overall Study|Other reason not listed|0|||
48952281|NCT01505491|157654992|FG002|Overall Study|Other reason not listed|0|||
48952282|NCT01505491|157654990|FG000|Overall Study|Withdrawal by Subject|1|||
48952283|NCT01505491|157654991|FG001|Overall Study|Withdrawal by Subject|1|||
48952284|NCT01505491|157654992|FG002|Overall Study|Withdrawal by Subject|4|||
48952285|NCT01505491|157654990|FG000|Overall Study|Lost to Follow-up|0|||
48952286|NCT01505491|157654991|FG001|Overall Study|Lost to Follow-up|0|||
48744652|NCT00520936|156914468|FG006|Overall Study|Withdrawal by Subject|0|||
48744653|NCT00520936|156914469|FG007|Overall Study|Withdrawal by Subject|1|||
48744654|NCT00520936|156914462|FG000|Overall Study|Toxicity Requiring Removal from Study|0|||
48744655|NCT00520936|156914463|FG001|Overall Study|Toxicity Requiring Removal from Study|1|||
48744656|NCT00520936|156914464|FG002|Overall Study|Toxicity Requiring Removal from Study|0|||
48744657|NCT00520936|156914465|FG003|Overall Study|Toxicity Requiring Removal from Study|0|||
48744658|NCT00520936|156914466|FG004|Overall Study|Toxicity Requiring Removal from Study|0|||
48744659|NCT00520936|156914467|FG005|Overall Study|Toxicity Requiring Removal from Study|0|||
48744660|NCT00520936|156914468|FG006|Overall Study|Toxicity Requiring Removal from Study|2|||
48744661|NCT00520936|156914469|FG007|Overall Study|Toxicity Requiring Removal from Study|0|||
48744662|NCT00520936|156914462|FG000|Overall Study|Death|0|||
48744663|NCT00520936|156914463|FG001|Overall Study|Death|0|||
48744664|NCT00520936|156914464|FG002|Overall Study|Death|0|||
48744665|NCT00520936|156914465|FG003|Overall Study|Death|0|||
48744666|NCT00520936|156914466|FG004|Overall Study|Death|0|||
48744667|NCT00520936|156914467|FG005|Overall Study|Death|0|||
48744668|NCT00520936|156914468|FG006|Overall Study|Death|1|||
48744669|NCT00520936|156914469|FG007|Overall Study|Death|0|||
48744670|NCT00520936|156914462|FG000|Overall Study|Protocol Violation|0|||
48744671|NCT00520936|156914463|FG001|Overall Study|Protocol Violation|1|||
48744672|NCT00520936|156914464|FG002|Overall Study|Protocol Violation|1|||
48744673|NCT00520936|156914465|FG003|Overall Study|Protocol Violation|0|||
48744674|NCT00520936|156914466|FG004|Overall Study|Protocol Violation|1|||
48744675|NCT00520936|156914467|FG005|Overall Study|Protocol Violation|0|||
48744676|NCT00520936|156914468|FG006|Overall Study|Protocol Violation|1|||
48744677|NCT00520936|156914469|FG007|Overall Study|Protocol Violation|0|||
48744678|NCT00867568|156914470|FG000|Overall Study|Lack of Efficacy|10|||
48744679|NCT00867568|156914470|FG000|Overall Study|Adverse Event|4|||
48744680|NCT00867568|156914470|FG000|Overall Study|Withdrawal by Subject|1|||
48744681|NCT01056653|156914474|FG000|Overall Study|Lost to Follow-up|0|||
48744682|NCT01056653|156914475|FG001|Overall Study|Lost to Follow-up|0|||
48744683|NCT01056653|156914476|FG002|Overall Study|Lost to Follow-up|2|||
48744684|NCT01061177|156914477|FG000|Overall Study|Adverse Event|117|||
48744685|NCT01061177|156914477|FG000|Overall Study|Withdrawal by Subject|27|||
48744686|NCT01061177|156914477|FG000|Overall Study|Disease progression|17|||
48744687|NCT01061177|156914477|FG000|Overall Study|Protocol Violation|11|||
48744688|NCT01061177|156914477|FG000|Overall Study|Lost to Follow-up|9|||
48744689|NCT01061177|156914477|FG000|Overall Study|New cancer therapy|9|||
48744690|NCT01061177|156914477|FG000|Overall Study|Abnormal laboratory values|6|||
48744691|NCT01061177|156914477|FG000|Overall Study|Abnormal test procedure results|4|||
48744692|NCT01061177|156914477|FG000|Overall Study|Administratie problems|4|||
48744693|NCT01061177|156914477|FG000|Overall Study|Death|4|||
48744694|NCT00299104|156914478|FG000|Treatment Period|Adverse Event|14|||
48744695|NCT00299104|156914479|FG001|Treatment Period|Adverse Event|9|||
48744696|NCT00299104|156914480|FG002|Treatment Period|Adverse Event|7|||
48744697|NCT00299104|156914478|FG000|Treatment Period|Death|1|||
48744698|NCT00299104|156914479|FG001|Treatment Period|Death|1|||
48744699|NCT00299104|156914480|FG002|Treatment Period|Death|1|||
48744700|NCT00299104|156914478|FG000|Treatment Period|Insufficient therapeutic response|34|||
48744701|NCT00299104|156914479|FG001|Treatment Period|Insufficient therapeutic response|13|||
48744702|NCT00299104|156914480|FG002|Treatment Period|Insufficient therapeutic response|8|||
48744703|NCT00299104|156914478|FG000|Treatment Period|Failure to return|9|||
48744704|NCT00299104|156914479|FG001|Treatment Period|Failure to return|8|||
48744705|NCT00299104|156914480|FG002|Treatment Period|Failure to return|8|||
48744706|NCT00299104|156914478|FG000|Treatment Period|Violation of selection criteria|1|||
48952287|NCT01505491|157654992|FG002|Overall Study|Lost to Follow-up|1|||
48952288|NCT04230486|157654993|FG000|Overall Study|Screen Failure|1|||
48744707|NCT00299104|156914479|FG001|Treatment Period|Violation of selection criteria|2|||
48744708|NCT00299104|156914480|FG002|Treatment Period|Violation of selection criteria|0|||
48744709|NCT00299104|156914478|FG000|Treatment Period|Protocol Violation|1|||
48744710|NCT00299104|156914479|FG001|Treatment Period|Protocol Violation|1|||
48744711|NCT00299104|156914480|FG002|Treatment Period|Protocol Violation|0|||
48857332|NCT01757288|157316248|FG001|Overall Study|Patient death prior to starting treatment|0|||
48857333|NCT01757288|157316249|FG002|Overall Study|Patient death prior to starting treatment|1|||
48857334|NCT01757288|157316247|FG000|Overall Study|Wrong medication administered|0|||
48857335|NCT01757288|157316248|FG001|Overall Study|Wrong medication administered|1|||
48857336|NCT01757288|157316249|FG002|Overall Study|Wrong medication administered|0|||
48857337|NCT01757288|157316247|FG000|Overall Study|Liver metastasis identified at CT simulation|0|||
48857338|NCT01757288|157316248|FG001|Overall Study|Liver metastasis identified at CT simulation|1|||
48857339|NCT01757288|157316249|FG002|Overall Study|Liver metastasis identified at CT simulation|0|||
48857340|NCT01757288|157316247|FG000|Overall Study|Not meeting protocol constraints|0|||
48744712|NCT00299104|156914478|FG000|Treatment Period|Refused treatment|9|||
48744713|NCT00299104|156914479|FG001|Treatment Period|Refused treatment|2|||
48744714|NCT00299104|156914480|FG002|Treatment Period|Refused treatment|2|||
48952289|NCT00611455|157654994|FG000|DB Treatment Period (24 Weeks)|Adverse Event|2|||
48952290|NCT00611455|157654995|FG001|DB Treatment Period (24 Weeks)|Adverse Event|8|||
48952291|NCT00611455|157654996|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
48952292|NCT00611455|157654994|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|2|||
48952293|NCT00611455|157654995|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
48952294|NCT00611455|157654996|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
48952295|NCT00611455|157654994|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|4|||
48952296|NCT00611455|157654995|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
48952297|NCT00611455|157654996|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
48952298|NCT00611455|157654994|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
48952299|NCT00611455|157654995|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
48952300|NCT00611455|157654996|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
48952301|NCT00611455|157654994|FG000|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
48952302|NCT00611455|157654995|FG001|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
48952303|NCT00611455|157654996|FG002|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0|||
48952304|NCT00611455|157654994|FG000|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1|||
48744715|NCT00299104|156914478|FG000|Treatment Period|Withdrew consent|14|||
48744716|NCT00299104|156914479|FG001|Treatment Period|Withdrew consent|19|||
48744717|NCT00299104|156914480|FG002|Treatment Period|Withdrew consent|9|||
48744718|NCT00299104|156914478|FG000|Treatment Period|Administrative reasons|106|||
48744719|NCT00299104|156914479|FG001|Treatment Period|Administrative reasons|120|||
48744720|NCT00299104|156914480|FG002|Treatment Period|Administrative reasons|137|||
48744721|NCT00299104|156914478|FG000|Safety Follow-Up (SFU) Period|Death|3|||
48744722|NCT00299104|156914479|FG001|Safety Follow-Up (SFU) Period|Death|2|||
48744723|NCT00299104|156914480|FG002|Safety Follow-Up (SFU) Period|Death|1|||
48744724|NCT00299104|156914478|FG000|Safety Follow-Up (SFU) Period|Lost to Follow-up|9|||
48744725|NCT00299104|156914479|FG001|Safety Follow-Up (SFU) Period|Lost to Follow-up|11|||
48744726|NCT00299104|156914480|FG002|Safety Follow-Up (SFU) Period|Lost to Follow-up|20|||
48744727|NCT00299104|156914478|FG000|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16|||
48744728|NCT00299104|156914479|FG001|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21|||
48744729|NCT00299104|156914480|FG002|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11|||
48744730|NCT00299104|156914478|FG000|Safety Follow-Up (SFU) Period|Administrative reasons|27|||
48744731|NCT00299104|156914479|FG001|Safety Follow-Up (SFU) Period|Administrative reasons|7|||
48744732|NCT00299104|156914480|FG002|Safety Follow-Up (SFU) Period|Administrative reasons|5|||
48744733|NCT00299104|156914478|FG000|Extended Safety Follow-Up (ESFU) Period|Death|0|||
48744734|NCT00299104|156914479|FG001|Extended Safety Follow-Up (ESFU) Period|Death|1|||
48744735|NCT00299104|156914480|FG002|Extended Safety Follow-Up (ESFU) Period|Death|0|||
48744736|NCT00299104|156914478|FG000|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
48744737|NCT00299104|156914479|FG001|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
48744738|NCT00299104|156914480|FG002|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
48744739|NCT00299104|156914478|FG000|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2|||
48744740|NCT00299104|156914479|FG001|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4|||
48744741|NCT00299104|156914480|FG002|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8|||
48744742|NCT00299104|156914478|FG000|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1|||
48744743|NCT00299104|156914479|FG001|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
48744744|NCT00299104|156914480|FG002|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
48744745|NCT03616600|156914483|FG000|Overall Study|Withdrawal by Subject|1|||
48952305|NCT00611455|157654995|FG001|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
48744746|NCT03616600|156914484|FG001|Overall Study|Withdrawal by Subject|0|||
48744747|NCT01651039|156914485|FG000|Overall Study|Non-evaluables|5|||
48744748|NCT01651039|156914485|FG000|Overall Study|Physician Decision|2|||
48744749|NCT01651039|156914485|FG000|Overall Study|Withdrawal by Subject|1|||
48744750|NCT01651039|156914485|FG000|Overall Study|Progressive Disease|22|||
48857341|NCT01757288|157316248|FG001|Overall Study|Not meeting protocol constraints|1|||
48857342|NCT01757288|157316249|FG002|Overall Study|Not meeting protocol constraints|1|||
48857343|NCT01757288|157316247|FG000|Overall Study|Multiple missed appointments|0|||
48857344|NCT01757288|157316248|FG001|Overall Study|Multiple missed appointments|1|||
48952306|NCT00611455|157654996|FG002|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
48952307|NCT00611455|157654994|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
48952308|NCT00611455|157654995|FG001|OL Treatment Period (120 Weeks)|Adverse Event|17|||
48857345|NCT01757288|157316249|FG002|Overall Study|Multiple missed appointments|0|||
48857346|NCT01757288|157316247|FG000|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
48857347|NCT01757288|157316248|FG001|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
48857348|NCT01757288|157316249|FG002|Overall Study|Mulitple hospitalization ( after first week of CRT)|1|||
48857349|NCT01757288|157316247|FG000|Overall Study|>2 weeks treatment break|0|||
48744751|NCT01847274|156914486|FG000|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|22|||
48857350|NCT01757288|157316248|FG001|Overall Study|>2 weeks treatment break|0|||
48857351|NCT01757288|157316249|FG002|Overall Study|>2 weeks treatment break|1|||
48857352|NCT02825550|157316250|FG000|Overall Study|Physician Decision|1|||
48857353|NCT04617847|157316251|FG000|Overall Study|Withdrawal by Subject|1|||
48857354|NCT04617847|157316252|FG001|Overall Study|Withdrawal by Subject|0|||
48857355|NCT04617847|157316251|FG000|Overall Study|Adverse Event|0|||
48857356|NCT04617847|157316252|FG001|Overall Study|Adverse Event|2|||
48857357|NCT04617847|157316251|FG000|Overall Study|Death|0|||
48857358|NCT04617847|157316252|FG001|Overall Study|Death|1|||
48857359|NCT04617847|157316251|FG000|Overall Study|Termination of Study by Sponsor|2|||
48857360|NCT04617847|157316252|FG001|Overall Study|Termination of Study by Sponsor|21|||
48857361|NCT00952523|157316253|FG000|Overall Study|Withdrawal by Subject|7|||
48857362|NCT00346398|157316256|FG000|Overall Study|Lost to Follow-up|3|||
48857363|NCT00346398|157316257|FG001|Overall Study|Lost to Follow-up|0|||
48857364|NCT00346398|157316256|FG000|Overall Study|Withdrawal by Subject|0|||
48857365|NCT00346398|157316257|FG001|Overall Study|Withdrawal by Subject|2|||
48857366|NCT02607956|157316260|FG000|Double-Blinded Phase|Withdrew Consent|17|||
48857367|NCT02607956|157316261|FG001|Double-Blinded Phase|Withdrew Consent|19|||
48857368|NCT02607956|157316262|FG002|Double-Blinded Phase|Withdrew Consent|0|||
48952309|NCT00611455|157654996|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
48952310|NCT00611455|157654994|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
48952311|NCT00611455|157654995|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|9|||
48952312|NCT00611455|157654996|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
48744752|NCT01847274|156914487|FG001|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|8|||
48744753|NCT01847274|156914488|FG002|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|31|||
48744754|NCT01847274|156914489|FG003|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|13|||
48744755|NCT01847274|156914490|FG004|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
48744756|NCT01847274|156914491|FG005|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
48952313|NCT00611455|157654994|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
48952314|NCT00611455|157654995|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|3|||
48952315|NCT00611455|157654996|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
48952316|NCT00611455|157654994|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
48857369|NCT02607956|157316263|FG003|Double-Blinded Phase|Withdrew Consent|0|||
48857370|NCT02607956|157316260|FG000|Double-Blinded Phase|Lost to Follow-up|19|||
48857371|NCT02607956|157316261|FG001|Double-Blinded Phase|Lost to Follow-up|16|||
48857372|NCT02607956|157316262|FG002|Double-Blinded Phase|Lost to Follow-up|0|||
48857373|NCT02607956|157316263|FG003|Double-Blinded Phase|Lost to Follow-up|0|||
48857374|NCT02607956|157316260|FG000|Double-Blinded Phase|Randomized but never treated|7|||
48857375|NCT02607956|157316261|FG001|Double-Blinded Phase|Randomized but never treated|5|||
48857376|NCT02607956|157316262|FG002|Double-Blinded Phase|Randomized but never treated|0|||
48857377|NCT02607956|157316263|FG003|Double-Blinded Phase|Randomized but never treated|0|||
48857378|NCT02607956|157316260|FG000|Double-Blinded Phase|Investigator's Discretion|7|||
48857379|NCT02607956|157316261|FG001|Double-Blinded Phase|Investigator's Discretion|2|||
48857380|NCT02607956|157316262|FG002|Double-Blinded Phase|Investigator's Discretion|0|||
48857381|NCT02607956|157316263|FG003|Double-Blinded Phase|Investigator's Discretion|0|||
48857382|NCT02607956|157316260|FG000|Double-Blinded Phase|Death|4|||
48857383|NCT02607956|157316261|FG001|Double-Blinded Phase|Death|4|||
48857384|NCT02607956|157316262|FG002|Double-Blinded Phase|Death|0|||
48857385|NCT02607956|157316263|FG003|Double-Blinded Phase|Death|0|||
48857386|NCT02607956|157316260|FG000|Double-Blinded Phase|Adverse Event|4|||
48857387|NCT02607956|157316261|FG001|Double-Blinded Phase|Adverse Event|3|||
48857388|NCT02607956|157316262|FG002|Double-Blinded Phase|Adverse Event|0|||
48744757|NCT01847274|156914492|FG006|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
48744758|NCT01847274|156914493|FG007|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
48744759|NCT01847274|156914494|FG008|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
48744760|NCT01847274|156914495|FG009|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
48744761|NCT01847274|156914496|FG010|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
48744762|NCT01847274|156914486|FG000|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|20|||
48744763|NCT01847274|156914487|FG001|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|11|||
48744764|NCT01847274|156914488|FG002|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|29|||
48744765|NCT01847274|156914489|FG003|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|14|||
48744766|NCT01847274|156914490|FG004|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
48744767|NCT01847274|156914491|FG005|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
48744768|NCT01847274|156914492|FG006|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
48744769|NCT01847274|156914493|FG007|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
48744770|NCT01847274|156914494|FG008|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
48744771|NCT01847274|156914495|FG009|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
48744772|NCT01847274|156914496|FG010|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
48744773|NCT01847274|156914486|FG000|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|7|||
48857389|NCT02607956|157316263|FG003|Double-Blinded Phase|Adverse Event|0|||
48857390|NCT02607956|157316260|FG000|Double-Blinded Phase|Protocol Violation|3|||
48857391|NCT02607956|157316261|FG001|Double-Blinded Phase|Protocol Violation|1|||
48857392|NCT02607956|157316262|FG002|Double-Blinded Phase|Protocol Violation|0|||
48857393|NCT02607956|157316263|FG003|Double-Blinded Phase|Protocol Violation|0|||
48857394|NCT02607956|157316260|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
48857395|NCT02607956|157316261|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|3|||
48857396|NCT02607956|157316262|FG002|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
48857397|NCT02607956|157316263|FG003|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
48857398|NCT02607956|157316260|FG000|Open-Label Extension Phase|Withdrew Consent|0|||
48857399|NCT02607956|157316261|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
48857400|NCT02607956|157316262|FG002|Open-Label Extension Phase|Withdrew Consent|10|||
48857401|NCT02607956|157316263|FG003|Open-Label Extension Phase|Withdrew Consent|16|||
48857402|NCT02607956|157316260|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
48952317|NCT00611455|157654995|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12|||
48952318|NCT00611455|157654996|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
48952319|NCT00611455|157654994|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
48952320|NCT00611455|157654995|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110|||
48952321|NCT00611455|157654996|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
48952322|NCT00611455|157654994|FG000|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
48952323|NCT00611455|157654995|FG001|OL Treatment Period (120 Weeks)|Lost to Follow-up|5|||
48952324|NCT00611455|157654996|FG002|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
48952325|NCT00611455|157654994|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
48952326|NCT00611455|157654995|FG001|OL Treatment Period (120 Weeks)|Physician Decision|5|||
48952327|NCT00611455|157654996|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
48952328|NCT00611455|157654994|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
48952329|NCT00611455|157654995|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18|||
48952330|NCT00611455|157654996|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
48952331|NCT00611455|157654994|FG000|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
48952332|NCT00611455|157654995|FG001|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
48952333|NCT00611455|157654996|FG002|Follow-up Period (Approximately 2 Years)|Adverse Event|30|||
48952334|NCT00611455|157654994|FG000|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
48952335|NCT00611455|157654995|FG001|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
48952336|NCT00611455|157654996|FG002|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12|||
48952337|NCT00611455|157654994|FG000|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
48952338|NCT00611455|157654995|FG001|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
48952339|NCT00611455|157654996|FG002|Follow-up Period (Approximately 2 Years)|Protocol Violation|4|||
48952340|NCT00611455|157654994|FG000|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
48952341|NCT00611455|157654995|FG001|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
48952342|NCT00611455|157654996|FG002|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23|||
48952343|NCT00611455|157654994|FG000|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
48952344|NCT00611455|157654995|FG001|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
48952345|NCT00611455|157654996|FG002|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80|||
48952346|NCT00611455|157654994|FG000|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
48952347|NCT00611455|157654995|FG001|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
48952348|NCT00611455|157654996|FG002|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13|||
48744774|NCT01847274|156914487|FG001|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|2|||
48744775|NCT01847274|156914488|FG002|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|5|||
48744776|NCT01847274|156914489|FG003|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|1|||
48744777|NCT01847274|156914490|FG004|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
48744778|NCT01847274|156914491|FG005|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
48744779|NCT01847274|156914492|FG006|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
48744780|NCT01847274|156914493|FG007|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
48952349|NCT00611455|157654994|FG000|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
48952350|NCT00611455|157654995|FG001|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
48952351|NCT00611455|157654996|FG002|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49|||
48952352|NCT03792750|157655002|FG000|Overall Study|Death|3|||
48952353|NCT05232097|157655003|FG000|Overall Study|Physician Decision|1|||
48952354|NCT04983940|157655007|FG000|Overall Study|Lost to Follow-up|14|||
48952355|NCT04983940|157655007|FG000|Overall Study|Lack of Efficacy|2|||
48952356|NCT01097330|157655008|FG000|Overall Study|Study terminated early|7|||
48952357|NCT01097330|157655009|FG001|Overall Study|Study terminated early|5|||
48952358|NCT03485729|157655010|FG000|Overall Study|Withdrawal by Subject|0|||
48952359|NCT03485729|157655011|FG001|Overall Study|Withdrawal by Subject|0|||
48952360|NCT03485729|157655012|FG002|Overall Study|Withdrawal by Subject|1|||
48952361|NCT03485729|157655010|FG000|Overall Study|Disease progression|8|||
48952362|NCT03485729|157655011|FG001|Overall Study|Disease progression|13|||
48952363|NCT03485729|157655012|FG002|Overall Study|Disease progression|1|||
48952364|NCT03485729|157655010|FG000|Overall Study|Hospice care|1|||
48952365|NCT03485729|157655011|FG001|Overall Study|Hospice care|0|||
48952366|NCT03485729|157655012|FG002|Overall Study|Hospice care|0|||
48952367|NCT03485729|157655010|FG000|Overall Study|Poor performance status|1|||
48952368|NCT03485729|157655011|FG001|Overall Study|Poor performance status|0|||
48952369|NCT03485729|157655012|FG002|Overall Study|Poor performance status|0|||
48952370|NCT03485729|157655010|FG000|Overall Study|Illness|0|||
48952371|NCT03485729|157655011|FG001|Overall Study|Illness|1|||
48952372|NCT03485729|157655012|FG002|Overall Study|Illness|0|||
48952373|NCT02086565|157655013|FG000|Overall Study|Lost to Follow-up|9|||
48952374|NCT02086565|157655014|FG001|Overall Study|Lost to Follow-up|7|||
48952375|NCT02086565|157655013|FG000|Overall Study|Withdrawal by Subject|2|||
48744781|NCT01847274|156914494|FG008|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
48744782|NCT01847274|156914495|FG009|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
48744783|NCT01847274|156914496|FG010|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
48952376|NCT02086565|157655014|FG001|Overall Study|Withdrawal by Subject|1|||
48952377|NCT02086565|157655013|FG000|Overall Study|Death|3|||
48744784|NCT01847274|156914486|FG000|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
48857403|NCT02607956|157316261|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
48952378|NCT02086565|157655014|FG001|Overall Study|Death|2|||
48952379|NCT02086565|157655013|FG000|Overall Study|withdrawn by research team|2|||
48952380|NCT02086565|157655014|FG001|Overall Study|withdrawn by research team|2|||
48952381|NCT02137772|157655021|FG000|Overall Study|Adverse Event|6|||
48952382|NCT02137772|157655022|FG001|Overall Study|Adverse Event|3|||
48952383|NCT02137772|157655021|FG000|Overall Study|Death|71|||
48952384|NCT02137772|157655022|FG001|Overall Study|Death|44|||
48952385|NCT02137772|157655021|FG000|Overall Study|Lost to Follow-up|8|||
48952386|NCT02137772|157655022|FG001|Overall Study|Lost to Follow-up|4|||
48952387|NCT02137772|157655021|FG000|Overall Study|Physician Decision|15|||
48952388|NCT02137772|157655022|FG001|Overall Study|Physician Decision|5|||
48952389|NCT02137772|157655021|FG000|Overall Study|Withdrawal by Subject|28|||
48952390|NCT02137772|157655022|FG001|Overall Study|Withdrawal by Subject|17|||
48952391|NCT02137772|157655021|FG000|Overall Study|Non-compliance with study drug|1|||
48952392|NCT02137772|157655022|FG001|Overall Study|Non-compliance with study drug|0|||
48952393|NCT02137772|157655021|FG000|Overall Study|Not treated|3|||
48952394|NCT02137772|157655022|FG001|Overall Study|Not treated|2|||
48952395|NCT01242020|157655025|FG000|Overall Study|Withdrawal by Subject|2|||
48952396|NCT01242020|157655026|FG001|Overall Study|Withdrawal by Subject|0|||
48952397|NCT01242020|157655025|FG000|Overall Study|Failed screening|1|||
48952398|NCT01242020|157655026|FG001|Overall Study|Failed screening|0|||
48744785|NCT01847274|156914487|FG001|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
48744786|NCT01847274|156914488|FG002|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
48744787|NCT01847274|156914489|FG003|Main Study (Upto 7years 7months 6 Days)|Disease progression|2|||
48744788|NCT01847274|156914490|FG004|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
48744789|NCT01847274|156914491|FG005|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
48744790|NCT01847274|156914492|FG006|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
48857404|NCT02607956|157316262|FG002|Open-Label Extension Phase|Lost to Follow-up|14|||
48857405|NCT02607956|157316263|FG003|Open-Label Extension Phase|Lost to Follow-up|6|||
48952399|NCT01844700|157655027|FG000|Overall Study|Lack of Efficacy|1|||
48952400|NCT01844700|157655028|FG001|Overall Study|Lack of Efficacy|0|||
48952401|NCT01844700|157655027|FG000|Overall Study|refused medication switch|1|||
48857406|NCT02607956|157316260|FG000|Open-Label Extension Phase|Death|0|||
48857407|NCT02607956|157316261|FG001|Open-Label Extension Phase|Death|0|||
48857408|NCT02607956|157316262|FG002|Open-Label Extension Phase|Death|1|||
48857409|NCT02607956|157316263|FG003|Open-Label Extension Phase|Death|3|||
48857410|NCT02607956|157316260|FG000|Open-Label Extension Phase|Investigator's Discretion|0|||
48857411|NCT02607956|157316261|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
48857412|NCT02607956|157316262|FG002|Open-Label Extension Phase|Investigator's Discretion|2|||
48857413|NCT02607956|157316263|FG003|Open-Label Extension Phase|Investigator's Discretion|2|||
48857414|NCT02607956|157316260|FG000|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
48857415|NCT02607956|157316261|FG001|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
48952402|NCT01844700|157655028|FG001|Overall Study|refused medication switch|0|||
48952403|NCT01844700|157655027|FG000|Overall Study|Withdrawal by Subject|1|||
48952404|NCT01844700|157655028|FG001|Overall Study|Withdrawal by Subject|0|||
48952405|NCT01844700|157655027|FG000|Overall Study|stopped taking meds|0|||
48952406|NCT01844700|157655028|FG001|Overall Study|stopped taking meds|1|||
48952407|NCT02650284|157655029|FG000|Overall Study|Lost to Follow-up|3|||
48857416|NCT02607956|157316262|FG002|Open-Label Extension Phase|Non Compliance with Study Drug|2|||
48857417|NCT02607956|157316263|FG003|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
48857418|NCT02607956|157316260|FG000|Open-Label Extension Phase|Protocol Violation|0|||
48857419|NCT02607956|157316261|FG001|Open-Label Extension Phase|Protocol Violation|0|||
48857420|NCT02607956|157316262|FG002|Open-Label Extension Phase|Protocol Violation|0|||
48857421|NCT02607956|157316263|FG003|Open-Label Extension Phase|Protocol Violation|2|||
48857422|NCT02607956|157316260|FG000|Open-Label Extension Phase|Pregnancy|0|||
48857423|NCT02607956|157316261|FG001|Open-Label Extension Phase|Pregnancy|0|||
48857424|NCT02607956|157316262|FG002|Open-Label Extension Phase|Pregnancy|0|||
48857425|NCT02607956|157316263|FG003|Open-Label Extension Phase|Pregnancy|1|||
48857426|NCT00636168|157316264|FG000|Randomized to Study Drug|Withdrawal by Subject|2|||
48857427|NCT00636168|157316265|FG001|Randomized to Study Drug|Withdrawal by Subject|2|||
48857428|NCT00636168|157316264|FG000|Randomized to Study Drug|Adverse Event|1|||
48857429|NCT00636168|157316265|FG001|Randomized to Study Drug|Adverse Event|0|||
48857430|NCT00636168|157316264|FG000|Randomized to Study Drug|No longer meets study criteria|1|||
48857431|NCT00636168|157316265|FG001|Randomized to Study Drug|No longer meets study criteria|0|||
48857432|NCT00636168|157316264|FG000|Treated With Study Drug|Recurrence of disease|135|||
48857433|NCT00636168|157316265|FG001|Treated With Study Drug|Recurrence of disease|282|||
48857434|NCT00636168|157316264|FG000|Treated With Study Drug|Adverse Event|250|||
48857435|NCT00636168|157316265|FG001|Treated With Study Drug|Adverse Event|22|||
48857436|NCT00636168|157316264|FG000|Treated With Study Drug|Participant withdrew consent|16|||
48857437|NCT00636168|157316265|FG001|Treated With Study Drug|Participant withdrew consent|21|||
48857438|NCT00636168|157316264|FG000|Treated With Study Drug|Poor/non-compliance|1|||
48857439|NCT00636168|157316265|FG001|Treated With Study Drug|Poor/non-compliance|3|||
48857440|NCT00636168|157316264|FG000|Treated With Study Drug|Death|3|||
48857441|NCT00636168|157316265|FG001|Treated With Study Drug|Death|0|||
48857442|NCT00636168|157316264|FG000|Treated With Study Drug|Pregnancy|1|||
48857443|NCT00636168|157316265|FG001|Treated With Study Drug|Pregnancy|0|||
48857444|NCT00636168|157316264|FG000|Treated With Study Drug|No longer meets study criteria|1|||
48857445|NCT00636168|157316265|FG001|Treated With Study Drug|No longer meets study criteria|0|||
48857446|NCT00636168|157316264|FG000|Treated With Study Drug|Other reason|1|||
48857447|NCT00636168|157316265|FG001|Treated With Study Drug|Other reason|3|||
48857448|NCT00636168|157316264|FG000|Long Term Follow-Up|Lost to Follow-up|3|||
48857449|NCT00636168|157316265|FG001|Long Term Follow-Up|Lost to Follow-up|3|||
48857450|NCT00636168|157316264|FG000|Long Term Follow-Up|Participant withdrew consent|0|||
48857451|NCT00636168|157316265|FG001|Long Term Follow-Up|Participant withdrew consent|2|||
48857452|NCT00636168|157316264|FG000|Long Term Follow-Up|Death|8|||
48857453|NCT00636168|157316265|FG001|Long Term Follow-Up|Death|9|||
48857454|NCT01613599|157316266|FG000|Overall Study|Death|9|||
48857455|NCT01613599|157316266|FG000|Overall Study|Lost to Follow-up|5|||
48857456|NCT01613599|157316266|FG000|Overall Study|Withdrawal by Subject|8|||
48857457|NCT01613599|157316266|FG000|Overall Study|Reason not specified|3|||
48857458|NCT04749797|157316270|FG000|Overall Study|Did not meet I/E criteria after surgery|1|||
48857459|NCT04749797|157316271|FG001|Overall Study|Did not meet I/E criteria after surgery|0|||
48857460|NCT04749797|157316272|FG002|Overall Study|Did not meet I/E criteria after surgery|0|||
48857461|NCT01323790|157316273|FG000|Overall Study|Other|3|||
48857462|NCT01323790|157316274|FG001|Overall Study|Other|2|||
48857463|NCT01323790|157316275|FG002|Overall Study|Other|1|||
48857464|NCT01323790|157316273|FG000|Overall Study|Lost to Follow-up|11|||
48857465|NCT01323790|157316274|FG001|Overall Study|Lost to Follow-up|9|||
48857466|NCT01323790|157316275|FG002|Overall Study|Lost to Follow-up|9|||
48952408|NCT02650284|157655030|FG001|Overall Study|Lost to Follow-up|3|||
48952409|NCT02650284|157655029|FG000|Overall Study|Consent incorrectly taken|0|||
48952410|NCT02650284|157655030|FG001|Overall Study|Consent incorrectly taken|1|||
48952411|NCT00829166|157655031|FG000|Overall Study|Death|305|||
48952412|NCT00829166|157655032|FG001|Overall Study|Death|333|||
48952413|NCT00829166|157655031|FG000|Overall Study|Lost to Follow-up|5|||
48952414|NCT00829166|157655032|FG001|Overall Study|Lost to Follow-up|4|||
48952415|NCT00829166|157655031|FG000|Overall Study|Physician's Decision|4|||
48952416|NCT00829166|157655032|FG001|Overall Study|Physician's Decision|3|||
48952417|NCT00829166|157655031|FG000|Overall Study|Subject's Decision|41|||
48952418|NCT00829166|157655032|FG001|Overall Study|Subject's Decision|55|||
48952419|NCT00829166|157655031|FG000|Overall Study|Sponsor's Decision|137|||
48952420|NCT00829166|157655032|FG001|Overall Study|Sponsor's Decision|98|||
48952421|NCT00829166|157655031|FG000|Overall Study|Reason Not Specified|3|||
48952422|NCT00829166|157655032|FG001|Overall Study|Reason Not Specified|3|||
48952423|NCT03345836|157655033|FG000|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|5|||
48952424|NCT03345836|157655034|FG001|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|17|||
48952425|NCT03345836|157655035|FG002|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|2|||
48952426|NCT03345836|157655036|FG003|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
48952427|NCT03345836|157655037|FG004|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
48952428|NCT03345836|157655038|FG005|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
48952429|NCT03345836|157655033|FG000|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
48952430|NCT03345836|157655034|FG001|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
48744791|NCT01847274|156914493|FG007|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
48744792|NCT01847274|156914494|FG008|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
48744793|NCT01847274|156914495|FG009|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
48744794|NCT01847274|156914496|FG010|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
48744795|NCT01847274|156914486|FG000|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
48744796|NCT01847274|156914487|FG001|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
48744797|NCT01847274|156914488|FG002|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|15|||
48744798|NCT01847274|156914489|FG003|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|14|||
48744799|NCT01847274|156914490|FG004|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
48744800|NCT01847274|156914491|FG005|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
48744801|NCT01847274|156914492|FG006|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
48744802|NCT01847274|156914493|FG007|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
48744803|NCT01847274|156914494|FG008|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
48744804|NCT01847274|156914495|FG009|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
48744805|NCT01847274|156914496|FG010|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
48744806|NCT01847274|156914486|FG000|Main Study (Upto 7years 7months 6 Days)|Death|72|||
48744807|NCT01847274|156914487|FG001|Main Study (Upto 7years 7months 6 Days)|Death|29|||
48744808|NCT01847274|156914488|FG002|Main Study (Upto 7years 7months 6 Days)|Death|146|||
48744809|NCT01847274|156914489|FG003|Main Study (Upto 7years 7months 6 Days)|Death|68|||
48744810|NCT01847274|156914490|FG004|Main Study (Upto 7years 7months 6 Days)|Death|0|||
48744811|NCT01847274|156914491|FG005|Main Study (Upto 7years 7months 6 Days)|Death|0|||
48744812|NCT01847274|156914492|FG006|Main Study (Upto 7years 7months 6 Days)|Death|0|||
48744813|NCT01847274|156914493|FG007|Main Study (Upto 7years 7months 6 Days)|Death|0|||
48744814|NCT01847274|156914494|FG008|Main Study (Upto 7years 7months 6 Days)|Death|0|||
48744815|NCT01847274|156914495|FG009|Main Study (Upto 7years 7months 6 Days)|Death|0|||
48744816|NCT01847274|156914496|FG010|Main Study (Upto 7years 7months 6 Days)|Death|0|||
48744817|NCT01847274|156914486|FG000|Main Study (Upto 7years 7months 6 Days)|Other reasons|5|||
48744818|NCT01847274|156914487|FG001|Main Study (Upto 7years 7months 6 Days)|Other reasons|3|||
48744819|NCT01847274|156914488|FG002|Main Study (Upto 7years 7months 6 Days)|Other reasons|8|||
48744820|NCT01847274|156914489|FG003|Main Study (Upto 7years 7months 6 Days)|Other reasons|4|||
48744821|NCT01847274|156914490|FG004|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
48744822|NCT01847274|156914491|FG005|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
48744823|NCT01847274|156914492|FG006|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
48744824|NCT01847274|156914493|FG007|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
48744825|NCT01847274|156914494|FG008|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
48744826|NCT01847274|156914495|FG009|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
48744827|NCT01847274|156914496|FG010|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
48744828|NCT01847274|156914486|FG000|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
48744829|NCT01847274|156914487|FG001|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
48744830|NCT01847274|156914488|FG002|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
48744831|NCT01847274|156914489|FG003|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
48744832|NCT01847274|156914490|FG004|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
48744833|NCT01847274|156914491|FG005|FE Sub-study, Period1 (Day1)|Adverse Event|1|||
48744834|NCT01847274|156914492|FG006|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
48744835|NCT01847274|156914493|FG007|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
48744836|NCT01847274|156914494|FG008|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
48744837|NCT01847274|156914495|FG009|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
48744838|NCT01847274|156914496|FG010|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
48744839|NCT01847274|156914486|FG000|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
48744840|NCT01847274|156914487|FG001|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
48744841|NCT01847274|156914488|FG002|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
48744842|NCT01847274|156914489|FG003|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
48744843|NCT01847274|156914490|FG004|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|1|||
48744844|NCT01847274|156914491|FG005|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
48744845|NCT01847274|156914492|FG006|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
48744846|NCT01847274|156914493|FG007|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
48744847|NCT01847274|156914494|FG008|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
48744848|NCT01847274|156914495|FG009|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
48744849|NCT01847274|156914496|FG010|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
48744850|NCT01847274|156914486|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
48744851|NCT01847274|156914487|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
48857467|NCT01323790|157316273|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
48857468|NCT01323790|157316274|FG001|Overall Study|Study-Specific Withdrawal Criteria|3|||
48857469|NCT01323790|157316275|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
48857470|NCT01323790|157316273|FG000|Overall Study|Lack of Efficacy|3|||
48857471|NCT01323790|157316274|FG001|Overall Study|Lack of Efficacy|0|||
48744852|NCT01847274|156914488|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
48744853|NCT01847274|156914489|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
48744854|NCT01847274|156914490|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
48744855|NCT01847274|156914491|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
48744856|NCT01847274|156914492|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|4|||
48744857|NCT01847274|156914493|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
48744858|NCT01847274|156914494|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
48744859|NCT01847274|156914495|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
48744860|NCT01847274|156914496|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
48744861|NCT01847274|156914486|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
48744862|NCT01847274|156914487|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
48744863|NCT01847274|156914488|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
48744864|NCT01847274|156914489|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
48744865|NCT01847274|156914490|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
48744866|NCT01847274|156914491|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
48744867|NCT01847274|156914492|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|5|||
48744868|NCT01847274|156914493|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
48744869|NCT01847274|156914494|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
48744870|NCT01847274|156914495|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
48744871|NCT01847274|156914496|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
48744872|NCT01847274|156914486|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
48744873|NCT01847274|156914487|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
48744874|NCT01847274|156914488|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
48744875|NCT01847274|156914489|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
48744876|NCT01847274|156914490|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
48744877|NCT01847274|156914491|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
48744878|NCT01847274|156914492|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|17|||
48744879|NCT01847274|156914493|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
48744880|NCT01847274|156914494|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
48744881|NCT01847274|156914495|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
48744882|NCT01847274|156914496|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
48744883|NCT01847274|156914486|FG000|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
48744884|NCT01847274|156914487|FG001|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
48744885|NCT01847274|156914488|FG002|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
48744886|NCT01847274|156914489|FG003|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
48744887|NCT01847274|156914490|FG004|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
48744888|NCT01847274|156914491|FG005|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
48744889|NCT01847274|156914492|FG006|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
48744890|NCT01847274|156914493|FG007|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|15|||
48744891|NCT01847274|156914494|FG008|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|8|||
48744892|NCT01847274|156914495|FG009|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|18|||
48744893|NCT01847274|156914496|FG010|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|12|||
48744894|NCT01847274|156914486|FG000|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
48744895|NCT01847274|156914487|FG001|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
48744896|NCT01847274|156914488|FG002|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
48744897|NCT01847274|156914489|FG003|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
48744898|NCT01847274|156914490|FG004|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
48744899|NCT01847274|156914491|FG005|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
48744900|NCT01847274|156914492|FG006|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
48744901|NCT01847274|156914493|FG007|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|6|||
48744902|NCT01847274|156914494|FG008|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
48744903|NCT01847274|156914495|FG009|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|9|||
48744904|NCT01847274|156914496|FG010|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
48744905|NCT01847274|156914486|FG000|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
48857472|NCT01323790|157316275|FG002|Overall Study|Lack of Efficacy|3|||
48857473|NCT01323790|157316273|FG000|Overall Study|Adverse Event|11|||
48857474|NCT01323790|157316274|FG001|Overall Study|Adverse Event|24|||
48857475|NCT01323790|157316275|FG002|Overall Study|Adverse Event|12|||
48857476|NCT01323790|157316273|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
48857477|NCT01323790|157316274|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
48857478|NCT01323790|157316275|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
48857479|NCT01323790|157316273|FG000|Overall Study|Withdrawal by Subject|23|||
48744906|NCT01847274|156914487|FG001|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
48744907|NCT01847274|156914488|FG002|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
48744908|NCT01847274|156914489|FG003|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
48744909|NCT01847274|156914490|FG004|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
48744910|NCT01847274|156914491|FG005|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
48744911|NCT01847274|156914492|FG006|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
48744912|NCT01847274|156914493|FG007|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
48744913|NCT01847274|156914494|FG008|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
48744914|NCT01847274|156914495|FG009|Main Study PSU (Up to 8months, 26days)|Other reasons|3|||
48744915|NCT01847274|156914496|FG010|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
48744916|NCT01847274|156914486|FG000|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
48744917|NCT01847274|156914487|FG001|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
48744918|NCT01847274|156914488|FG002|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
48744919|NCT01847274|156914489|FG003|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
48744920|NCT01847274|156914490|FG004|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
48744921|NCT01847274|156914491|FG005|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
48744922|NCT01847274|156914492|FG006|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
48744923|NCT01847274|156914493|FG007|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
48744924|NCT01847274|156914494|FG008|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
48744925|NCT01847274|156914495|FG009|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|1|||
48744926|NCT01847274|156914496|FG010|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
48744927|NCT01180985|156914497|FG000|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1|||
48744928|NCT01180985|156914498|FG001|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0|||
48744929|NCT05209360|156914505|FG000|Overall Study|Withdrawal by Subject|0|||
48744930|NCT05209360|156914506|FG001|Overall Study|Withdrawal by Subject|0|||
48744931|NCT05209360|156914507|FG002|Overall Study|Withdrawal by Subject|1|||
48744932|NCT05209360|156914508|FG003|Overall Study|Withdrawal by Subject|0|||
48744933|NCT05209360|156914509|FG004|Overall Study|Withdrawal by Subject|0|||
48744934|NCT05209360|156914510|FG005|Overall Study|Withdrawal by Subject|0|||
48744935|NCT02969369|156914513|FG000|Study|Adverse Event|1|||
48744936|NCT02969369|156914514|FG001|Study|Adverse Event|6|||
48744937|NCT02969369|156914513|FG000|Study|Lack of Efficacy|0|||
48744938|NCT02969369|156914514|FG001|Study|Lack of Efficacy|1|||
48744939|NCT02969369|156914513|FG000|Study|Lost to Follow-up|0|||
48744940|NCT02969369|156914514|FG001|Study|Lost to Follow-up|1|||
48744941|NCT02969369|156914513|FG000|Study|Withdrawal by Subject|3|||
48744942|NCT02969369|156914514|FG001|Study|Withdrawal by Subject|5|||
48744943|NCT02969369|156914513|FG000|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
48744944|NCT02969369|156914514|FG001|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
48744945|NCT02969369|156914513|FG000|Double-blind Period|Adverse Event|1|||
48744946|NCT02969369|156914514|FG001|Double-blind Period|Adverse Event|5|||
48744947|NCT02969369|156914513|FG000|Double-blind Period|Lost to Follow-up|0|||
48744948|NCT02969369|156914514|FG001|Double-blind Period|Lost to Follow-up|1|||
48744949|NCT02969369|156914513|FG000|Double-blind Period|Withdrawal by Subject|2|||
48744950|NCT02969369|156914514|FG001|Double-blind Period|Withdrawal by Subject|3|||
48744951|NCT02969369|156914513|FG000|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
48744952|NCT02969369|156914514|FG001|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
48744953|NCT02969369|156914513|FG000|Open-label SEP-363856 Period|Adverse Event|0|||
48744954|NCT02969369|156914514|FG001|Open-label SEP-363856 Period|Adverse Event|1|||
48744955|NCT02969369|156914513|FG000|Open-label SEP-363856 Period|Lack of Efficacy|0|||
48744956|NCT02969369|156914514|FG001|Open-label SEP-363856 Period|Lack of Efficacy|1|||
48744957|NCT02969369|156914513|FG000|Open-label SEP-363856 Period|Withdrawal by Subject|1|||
48744958|NCT02969369|156914514|FG001|Open-label SEP-363856 Period|Withdrawal by Subject|2|||
48744959|NCT02849678|156914515|FG000|Overall Study|Protocol Violation|3|||
48744960|NCT02849678|156914516|FG001|Overall Study|Protocol Violation|6|||
48744961|NCT00288054|156914522|FG000|Overall Study|Protocol Violation|2|||
48744962|NCT00288054|156914522|FG000|Overall Study|Lack of Efficacy|16|||
48744963|NCT00288054|156914522|FG000|Overall Study|Adverse Event|3|||
48744964|NCT00288054|156914522|FG000|Overall Study|Withdrawal by Subject|1|||
48744965|NCT00288054|156914522|FG000|Overall Study|Not protocol specified|2|||
48744966|NCT01281865|156914526|FG000|Overall Study|Adverse Event|1|||
48744967|NCT01281865|156914527|FG001|Overall Study|Adverse Event|1|||
48744968|NCT01281865|156914526|FG000|Overall Study|Withdrawal by Subject|1|||
48744969|NCT01281865|156914527|FG001|Overall Study|Withdrawal by Subject|0|||
48744970|NCT01281865|156914526|FG000|Overall Study|Lack of Efficacy|1|||
48744971|NCT01281865|156914527|FG001|Overall Study|Lack of Efficacy|0|||
48744972|NCT01007812|156914530|FG000|Period 1, One Week|Lost to Follow-up|0|||
48744973|NCT01007812|156914531|FG001|Period 1, One Week|Lost to Follow-up|1|||
48744974|NCT01007812|156914530|FG000|Period 1, One Week|Discomfort|1|||
48744975|NCT01007812|156914531|FG001|Period 1, One Week|Discomfort|0|||
48744976|NCT02499783|156914534|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2|||
48744977|NCT02499783|156914535|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4|||
48744978|NCT02499783|156914536|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0|||
48744979|NCT02499783|156914534|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1|||
48744980|NCT02499783|156914535|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
48744981|NCT02499783|156914536|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
48744982|NCT02499783|156914534|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
48952431|NCT03345836|157655035|FG002|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|3|||
48952432|NCT03345836|157655036|FG003|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
48952433|NCT03345836|157655037|FG004|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
48952434|NCT03345836|157655038|FG005|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
48952435|NCT03345836|157655033|FG000|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
48952436|NCT03345836|157655034|FG001|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|1|||
48952437|NCT03345836|157655035|FG002|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
48952438|NCT03345836|157655036|FG003|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
48952439|NCT03345836|157655037|FG004|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
48952440|NCT03345836|157655038|FG005|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
48952441|NCT03345836|157655033|FG000|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|8|||
48952442|NCT03345836|157655034|FG001|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|4|||
48952443|NCT03345836|157655035|FG002|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
48952444|NCT03345836|157655036|FG003|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
48952445|NCT03345836|157655037|FG004|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
48952446|NCT03345836|157655038|FG005|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
48952447|NCT03345836|157655033|FG000|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
48952448|NCT03345836|157655034|FG001|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|3|||
48952449|NCT03345836|157655035|FG002|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
48952450|NCT03345836|157655036|FG003|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
48952451|NCT03345836|157655037|FG004|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
48952452|NCT03345836|157655038|FG005|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
48952453|NCT03345836|157655033|FG000|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
48952454|NCT03345836|157655034|FG001|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
48952455|NCT03345836|157655035|FG002|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
48952456|NCT03345836|157655036|FG003|Period 2: 12-Week Extended Treatment|Adverse Event|8|||
48952457|NCT03345836|157655037|FG004|Period 2: 12-Week Extended Treatment|Adverse Event|5|||
48952458|NCT03345836|157655038|FG005|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
48952459|NCT03345836|157655033|FG000|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
48952460|NCT03345836|157655034|FG001|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
48952461|NCT03345836|157655035|FG002|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
48952462|NCT03345836|157655036|FG003|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
48952463|NCT03345836|157655037|FG004|Period 2: 12-Week Extended Treatment|Withdrew Consent|5|||
48952464|NCT03345836|157655038|FG005|Period 2: 12-Week Extended Treatment|Withdrew Consent|1|||
48952465|NCT03345836|157655033|FG000|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
48952466|NCT03345836|157655034|FG001|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
48952467|NCT03345836|157655035|FG002|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
48952468|NCT03345836|157655036|FG003|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
48952469|NCT03345836|157655037|FG004|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
48952470|NCT03345836|157655038|FG005|Period 2: 12-Week Extended Treatment|Lost to Follow-up|1|||
48952471|NCT03345836|157655033|FG000|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
48952472|NCT03345836|157655034|FG001|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
48952473|NCT03345836|157655035|FG002|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
48952474|NCT03345836|157655036|FG003|Period 2: 12-Week Extended Treatment|Lack of Efficacy|2|||
48952475|NCT03345836|157655037|FG004|Period 2: 12-Week Extended Treatment|Lack of Efficacy|6|||
48952476|NCT03345836|157655038|FG005|Period 2: 12-Week Extended Treatment|Lack of Efficacy|3|||
48952477|NCT03345836|157655033|FG000|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
48952478|NCT03345836|157655034|FG001|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
48952479|NCT03345836|157655035|FG002|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
48952480|NCT03345836|157655036|FG003|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
48952481|NCT03345836|157655037|FG004|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|1|||
48952482|NCT03345836|157655038|FG005|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
48952483|NCT03345836|157655033|FG000|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
48952484|NCT03345836|157655034|FG001|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
48952485|NCT03345836|157655035|FG002|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
48952486|NCT03345836|157655036|FG003|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
48744983|NCT02499783|156914535|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
48744984|NCT02499783|156914536|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Other|0|||
48744985|NCT02499783|156914534|FG000|DB Period: Weeks 0-8|Adverse Event|8|||
48744986|NCT02499783|156914535|FG001|DB Period: Weeks 0-8|Adverse Event|6|||
48744987|NCT02499783|156914536|FG002|DB Period: Weeks 0-8|Adverse Event|0|||
48744988|NCT02499783|156914534|FG000|DB Period: Weeks 0-8|Withdrew Consent|1|||
48744989|NCT02499783|156914535|FG001|DB Period: Weeks 0-8|Withdrew Consent|0|||
48744990|NCT02499783|156914536|FG002|DB Period: Weeks 0-8|Withdrew Consent|0|||
48857480|NCT01323790|157316274|FG001|Overall Study|Withdrawal by Subject|20|||
48857481|NCT01323790|157316275|FG002|Overall Study|Withdrawal by Subject|13|||
48857482|NCT01323790|157316273|FG000|Overall Study|Did Not Receive Treatment|2|||
48857483|NCT01323790|157316274|FG001|Overall Study|Did Not Receive Treatment|0|||
48857484|NCT01323790|157316275|FG002|Overall Study|Did Not Receive Treatment|1|||
48744991|NCT02499783|156914534|FG000|DB Period: Weeks 0-8|Other|1|||
48744992|NCT02499783|156914535|FG001|DB Period: Weeks 0-8|Other|1|||
48744993|NCT02499783|156914536|FG002|DB Period: Weeks 0-8|Other|0|||
48857485|NCT01323790|157316273|FG000|Overall Study|Severe non-compliance with protocol|2|||
48857486|NCT01323790|157316274|FG001|Overall Study|Severe non-compliance with protocol|2|||
48857487|NCT01323790|157316275|FG002|Overall Study|Severe non-compliance with protocol|2|||
48857488|NCT01855399|157316279|FG000|6 Month|Lost to Follow-up|12|||
48857489|NCT01855399|157316280|FG001|6 Month|Lost to Follow-up|9|||
48857490|NCT01855399|157316279|FG000|6 Month|Withdrawal by Subject|8|||
48857491|NCT01855399|157316280|FG001|6 Month|Withdrawal by Subject|6|||
48857492|NCT01855399|157316279|FG000|12 Month|Lost to Follow-up|7|||
48857493|NCT01855399|157316280|FG001|12 Month|Lost to Follow-up|11|||
48952487|NCT03345836|157655037|FG004|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
48952488|NCT03345836|157655038|FG005|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
48952489|NCT01165203|157655044|FG000|Active Phase|Serious Adverse Event|1|||
48744994|NCT02499783|156914534|FG000|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
48744995|NCT02499783|156914535|FG001|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
48744996|NCT02499783|156914536|FG002|Open Label Period: Weeks 8 to 26|Adverse Event|16|||
48744997|NCT02499783|156914534|FG000|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
48744998|NCT02499783|156914535|FG001|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
48744999|NCT02499783|156914536|FG002|Open Label Period: Weeks 8 to 26|Withdrew Consent|2|||
48745000|NCT02499783|156914534|FG000|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
48745001|NCT02499783|156914535|FG001|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
48745002|NCT02499783|156914536|FG002|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9|||
48745003|NCT02499783|156914534|FG000|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
48745004|NCT02499783|156914535|FG001|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
48745005|NCT02499783|156914536|FG002|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2|||
48745006|NCT01626391|156914538|FG000|Overall Study|Physician Decision|1|||
48745007|NCT01626391|156914539|FG001|Overall Study|Physician Decision|0|||
48745008|NCT01626391|156914538|FG000|Overall Study|Withdrawal by Subject|1|||
48745009|NCT01626391|156914539|FG001|Overall Study|Withdrawal by Subject|0|||
48745010|NCT00518284|156914540|FG000|Overall Study|Adverse Event|0|||
48745011|NCT00518284|156914541|FG001|Overall Study|Adverse Event|1|||
48745012|NCT00518284|156914542|FG002|Overall Study|Adverse Event|0|||
48745013|NCT00518284|156914543|FG003|Overall Study|Adverse Event|0|||
48745014|NCT00518284|156914540|FG000|Overall Study|Study Termination|0|||
48745015|NCT00518284|156914541|FG001|Overall Study|Study Termination|2|||
48745016|NCT00518284|156914542|FG002|Overall Study|Study Termination|1|||
48745017|NCT00518284|156914543|FG003|Overall Study|Study Termination|2|||
48745018|NCT01350492|156914544|FG000|Intervention|Lost to Follow-up|2|||
48745019|NCT01350492|156914545|FG001|Intervention|Lost to Follow-up|5|||
48745020|NCT01350492|156914544|FG000|Intervention|Withdrawal by Subject|3|||
48745021|NCT01350492|156914545|FG001|Intervention|Withdrawal by Subject|1|||
48745022|NCT01350492|156914544|FG000|Post Intervention Follow-Up|Lost to Follow-up|6|||
48745023|NCT01350492|156914545|FG001|Post Intervention Follow-Up|Lost to Follow-up|1|||
48745024|NCT01350492|156914544|FG000|Post Intervention Follow-Up|Withdrawal by Subject|0|||
48745025|NCT01350492|156914545|FG001|Post Intervention Follow-Up|Withdrawal by Subject|1|||
48745026|NCT00602797|156914552|FG000|Overall Study|Adverse Event|1|||
48745027|NCT03845985|156914556|FG000|Overall Study|Lost to Follow-up|2|||
48745028|NCT03845985|156914557|FG001|Overall Study|Lost to Follow-up|1|||
48745029|NCT03845985|156914556|FG000|Overall Study|Physician Decision|1|||
48745030|NCT03845985|156914557|FG001|Overall Study|Physician Decision|0|||
48745031|NCT03845985|156914556|FG000|Overall Study|Withdrawal by Subject|4|||
48745032|NCT03845985|156914557|FG001|Overall Study|Withdrawal by Subject|1|||
48745033|NCT01318993|156914558|FG000|Overall Study|Adverse Event|53|||
48745034|NCT01318993|156914558|FG000|Overall Study|Lack of Efficacy|121|||
48745035|NCT01318993|156914558|FG000|Overall Study|Protocol Violation|3|||
48745036|NCT01318993|156914558|FG000|Overall Study|Protocol based stopping criteria|6|||
48745037|NCT01318993|156914558|FG000|Overall Study|Study closed or terminated|174|||
48857494|NCT02312258|157316281|FG000|Overall Study|Lost to Follow-up|8|||
48857495|NCT02312258|157316282|FG001|Overall Study|Lost to Follow-up|8|||
48857496|NCT02312258|157316281|FG000|Overall Study|Withdrawal by Patient|49|||
48857497|NCT02312258|157316282|FG001|Overall Study|Withdrawal by Patient|76|||
48857498|NCT02312258|157316281|FG000|Overall Study|Reason not Specified|107|||
48857499|NCT02312258|157316282|FG001|Overall Study|Reason not Specified|159|||
48857500|NCT02312258|157316281|FG000|Overall Study|Missing|2|||
48857501|NCT02312258|157316282|FG001|Overall Study|Missing|1|||
48857502|NCT02312258|157316281|FG000|Overall Study|Death|115|||
48857503|NCT02312258|157316282|FG001|Overall Study|Death|181|||
48857504|NCT01681511|157316283|FG000|Overall Study|No Treatment Received|1|||
48857505|NCT01681511|157316284|FG001|Overall Study|No Treatment Received|3|||
48857506|NCT01681511|157316283|FG000|Overall Study|Failed Inclusion/Exclusion|3|||
48857507|NCT01681511|157316284|FG001|Overall Study|Failed Inclusion/Exclusion|0|||
48857508|NCT01681511|157316283|FG000|Overall Study|No Baseline Dips Stick & Urine Culture|3|||
48857509|NCT01681511|157316284|FG001|Overall Study|No Baseline Dips Stick & Urine Culture|6|||
48857510|NCT01681511|157316283|FG000|Overall Study|No Daily Urine Sample Collected|0|||
48857511|NCT01681511|157316284|FG001|Overall Study|No Daily Urine Sample Collected|1|||
48857512|NCT01681511|157316283|FG000|Overall Study|No post-catheter sample collected|11|||
48857513|NCT01681511|157316284|FG001|Overall Study|No post-catheter sample collected|4|||
48857514|NCT03560206|157316285|FG000|Overall Study|Lost to Follow-up|19|||
48745038|NCT01318993|156914558|FG000|Overall Study|Lost to Follow-up|4|||
48745039|NCT01318993|156914558|FG000|Overall Study|Physician Decision|13|||
48745040|NCT01318993|156914558|FG000|Overall Study|Withdrawal by Subject|24|||
48745041|NCT00228384|156914562|FG000|Overall Study|Death|9|||
48745042|NCT00228384|156914563|FG001|Overall Study|Death|3|||
48745043|NCT00228384|156914562|FG000|Overall Study|Lost to Follow-up|6|||
48857515|NCT03560206|157316286|FG001|Overall Study|Lost to Follow-up|11|||
48745044|NCT00228384|156914563|FG001|Overall Study|Lost to Follow-up|10|||
48745045|NCT00228384|156914562|FG000|Overall Study|Surgical Intervention (bypass)|5|||
48745046|NCT00228384|156914563|FG001|Overall Study|Surgical Intervention (bypass)|5|||
48745047|NCT00228384|156914562|FG000|Overall Study|Withdrawal by Subject|9|||
48745048|NCT00228384|156914563|FG001|Overall Study|Withdrawal by Subject|10|||
48745049|NCT00228384|156914562|FG000|Overall Study|Physician Decision|0|||
48745050|NCT00228384|156914563|FG001|Overall Study|Physician Decision|1|||
48745051|NCT01962896|156914564|FG000|Overall Study|Lack of Efficacy|4|||
48745052|NCT00458211|156914577|FG000|Overall Study|Lack of Efficacy|12|||
48745053|NCT00458211|156914577|FG000|Overall Study|Withdrawal by Subject|2|||
48745054|NCT00458211|156914577|FG000|Overall Study|Protocol Violation|2|||
48745055|NCT00687323|156914578|FG000|Overall Study|Death|25|||
48745056|NCT00687323|156914578|FG000|Overall Study|Withdrawal by Subject|1|||
48745057|NCT00687323|156914578|FG000|Overall Study|Excluded from efficacy evaluations|6|||
48745058|NCT00687323|156914578|FG000|Overall Study|Screen failure|148|||
48745059|NCT02578316|156914583|FG000|Extension Phase|Progression of disease|6|||
48745060|NCT00217620|156916107|FG000|Overall Study|Adverse Event|2|||
48745061|NCT00217620|156916107|FG000|Overall Study|Progression|31|||
48745062|NCT00217620|156916107|FG000|Overall Study|Not Protocol Specified|4|||
48745063|NCT00217620|156916107|FG000|Overall Study|Ineligible|13|||
48745064|NCT00217620|156916107|FG000|Overall Study|Never received treatment|1|||
48745065|NCT03281577|156916108|FG000|Overall Study|Adverse Event|0|||
48745066|NCT03281577|156916109|FG001|Overall Study|Adverse Event|0|||
48745067|NCT03281577|156916110|FG002|Overall Study|Adverse Event|0|||
48745068|NCT03281577|156916111|FG003|Overall Study|Adverse Event|1|||
48857516|NCT03560206|157316285|FG000|Overall Study|Withdrawal by Subject|2|||
48857517|NCT03560206|157316286|FG001|Overall Study|Withdrawal by Subject|4|||
48745069|NCT03281577|156916108|FG000|Overall Study|Withdrawal by Subject|1|||
48745070|NCT03281577|156916109|FG001|Overall Study|Withdrawal by Subject|0|||
48745071|NCT03281577|156916110|FG002|Overall Study|Withdrawal by Subject|0|||
48745072|NCT03281577|156916111|FG003|Overall Study|Withdrawal by Subject|0|||
48857518|NCT03560206|157316285|FG000|Overall Study|caregivers' health condition and not becoming non-caregiver|5|||
48857519|NCT03560206|157316286|FG001|Overall Study|caregivers' health condition and not becoming non-caregiver|0|||
48745073|NCT01898806|156916119|FG000|Overall Study|Withdrawal by Subject|2|||
48745074|NCT01898806|156916119|FG000|Overall Study|Physician Decision|1|||
48857520|NCT03560206|157316285|FG000|Overall Study|Busy schedule|14|||
48857521|NCT03560206|157316286|FG001|Overall Study|Busy schedule|2|||
48857522|NCT03560206|157316285|FG000|Overall Study|patients' new health condition such as cancer|10|||
48692649|NCT03001557|156724545|FG004|Extension Phase|Administrative Reason|0|||
48692650|NCT03001557|156724546|FG005|Extension Phase|Administrative Reason|1|||
48692651|NCT03001557|156724547|FG006|Extension Phase|Administrative Reason|3|||
48692652|NCT03001557|156724548|FG007|Extension Phase|Administrative Reason|3|||
48692653|NCT03001557|156724541|FG000|Extension Phase|Loss of caregiver|0|||
48692654|NCT03001557|156724542|FG001|Extension Phase|Loss of caregiver|0|||
48692655|NCT03001557|156724543|FG002|Extension Phase|Loss of caregiver|0|||
48692656|NCT03001557|156724544|FG003|Extension Phase|Loss of caregiver|0|||
48692657|NCT03001557|156724545|FG004|Extension Phase|Loss of caregiver|0|||
48692658|NCT03001557|156724546|FG005|Extension Phase|Loss of caregiver|0|||
48692659|NCT03001557|156724547|FG006|Extension Phase|Loss of caregiver|1|||
48692660|NCT03001557|156724548|FG007|Extension Phase|Loss of caregiver|0|||
48692661|NCT03001557|156724541|FG000|Extension Phase|Others|0|||
48692662|NCT03001557|156724542|FG001|Extension Phase|Others|0|||
48692663|NCT03001557|156724543|FG002|Extension Phase|Others|0|||
48692664|NCT03001557|156724544|FG003|Extension Phase|Others|0|||
48692665|NCT03001557|156724545|FG004|Extension Phase|Others|0|||
48692666|NCT03001557|156724546|FG005|Extension Phase|Others|1|||
48692667|NCT03001557|156724547|FG006|Extension Phase|Others|3|||
48692668|NCT03001557|156724548|FG007|Extension Phase|Others|0|||
48692669|NCT01620060|156724550|FG000|Overall Study|Adverse Event|9|||
48692670|NCT01620060|156724550|FG000|Overall Study|Protocol Violation|1|||
48692671|NCT01620060|156724550|FG000|Overall Study|Withdrawal by Subject|1|||
48692672|NCT01620060|156724550|FG000|Overall Study|Did not comply with Study Produre|1|||
48692673|NCT01620060|156724550|FG000|Overall Study|Family emergency|1|||
48692674|NCT01620060|156724550|FG000|Overall Study|Per Sponsor Decision|2|||
48692675|NCT04664153|156724563|FG000|Overall Study|Lack of Efficacy|0|||
48692676|NCT04664153|156724564|FG001|Overall Study|Lack of Efficacy|0|||
48692677|NCT04664153|156724565|FG002|Overall Study|Lack of Efficacy|1|||
48692678|NCT04664153|156724566|FG003|Overall Study|Lack of Efficacy|0|||
48692679|NCT04664153|156724563|FG000|Overall Study|Physician Decision|0|||
48692680|NCT04664153|156724564|FG001|Overall Study|Physician Decision|0|||
48692681|NCT04664153|156724565|FG002|Overall Study|Physician Decision|1|||
48692682|NCT04664153|156724566|FG003|Overall Study|Physician Decision|0|||
48692683|NCT04664153|156724563|FG000|Overall Study|Withdrawal by Subject|3|||
48692684|NCT04664153|156724564|FG001|Overall Study|Withdrawal by Subject|2|||
48692685|NCT04664153|156724565|FG002|Overall Study|Withdrawal by Subject|1|||
48692686|NCT04664153|156724566|FG003|Overall Study|Withdrawal by Subject|2|||
48692687|NCT04664153|156724563|FG000|Overall Study|Other|0|||
48692688|NCT04664153|156724564|FG001|Overall Study|Other|1|||
48692689|NCT04664153|156724565|FG002|Overall Study|Other|0|||
48692690|NCT04664153|156724566|FG003|Overall Study|Other|0|||
48692691|NCT04664153|156724563|FG000|Overall Study|Adverse Event|4|||
48692692|NCT04664153|156724564|FG001|Overall Study|Adverse Event|0|||
48692693|NCT04664153|156724565|FG002|Overall Study|Adverse Event|1|||
48692694|NCT04664153|156724566|FG003|Overall Study|Adverse Event|0|||
48692695|NCT00189540|156724569|FG000|Overall Study|Withdrawal by Subject|3|||
48692696|NCT00189540|156724570|FG001|Overall Study|Withdrawal by Subject|0|||
48692697|NCT00189540|156724569|FG000|Overall Study|Death|4|||
48692698|NCT00189540|156724570|FG001|Overall Study|Death|1|||
48692699|NCT04887129|156724582|FG000|Overall Study|Lost to Follow-up|0|||
48692700|NCT04887129|156724583|FG001|Overall Study|Lost to Follow-up|24|||
48692701|NCT04887129|156724582|FG000|Overall Study|Withdrawal by Subject|9|||
48692702|NCT04887129|156724583|FG001|Overall Study|Withdrawal by Subject|57|||
48692703|NCT04887129|156724582|FG000|Overall Study|Other|2|||
48692704|NCT04887129|156724583|FG001|Overall Study|Other|9|||
48857523|NCT03560206|157316286|FG001|Overall Study|patients' new health condition such as cancer|1|||
48857524|NCT00824850|157316292|FG000|Overall Study|Withdrawal by Subject|0|||
48857525|NCT00824850|157316293|FG001|Overall Study|Withdrawal by Subject|1|||
48857526|NCT02367794|157316294|FG000|Overall Study|Death|252|||
48857527|NCT02367794|157316295|FG001|Overall Study|Death|245|||
48857528|NCT02367794|157316296|FG002|Overall Study|Death|243|||
48857529|NCT02367794|157316294|FG000|Overall Study|Lost to Follow-up|1|||
48857530|NCT02367794|157316295|FG001|Overall Study|Lost to Follow-up|2|||
48857531|NCT02367794|157316296|FG002|Overall Study|Lost to Follow-up|2|||
48857532|NCT02367794|157316294|FG000|Overall Study|Physician Decision|0|||
48857533|NCT02367794|157316295|FG001|Overall Study|Physician Decision|5|||
48857534|NCT02367794|157316296|FG002|Overall Study|Physician Decision|3|||
48857535|NCT02367794|157316294|FG000|Overall Study|Protocol Violation|1|||
48857536|NCT02367794|157316295|FG001|Overall Study|Protocol Violation|0|||
48857537|NCT02367794|157316296|FG002|Overall Study|Protocol Violation|1|||
48857538|NCT02367794|157316294|FG000|Overall Study|Withdrawal by Subject|25|||
48857539|NCT02367794|157316295|FG001|Overall Study|Withdrawal by Subject|12|||
48857540|NCT02367794|157316296|FG002|Overall Study|Withdrawal by Subject|20|||
48857541|NCT02367794|157316294|FG000|Overall Study|Brain metastasis|1|||
48857542|NCT02367794|157316295|FG001|Overall Study|Brain metastasis|0|||
48857543|NCT02367794|157316296|FG002|Overall Study|Brain metastasis|0|||
48857544|NCT02367794|157316294|FG000|Overall Study|Randomized in error|0|||
48857545|NCT02367794|157316295|FG001|Overall Study|Randomized in error|0|||
48857546|NCT02367794|157316296|FG002|Overall Study|Randomized in error|1|||
48857547|NCT02367794|157316294|FG000|Overall Study|Patient unable to receive carboplatin|0|||
48857548|NCT02367794|157316295|FG001|Overall Study|Patient unable to receive carboplatin|0|||
48857549|NCT02367794|157316296|FG002|Overall Study|Patient unable to receive carboplatin|1|||
48857550|NCT02367794|157316294|FG000|Overall Study|Hypercalcemia prior to C1D1|0|||
48857551|NCT02367794|157316295|FG001|Overall Study|Hypercalcemia prior to C1D1|0|||
48952490|NCT01165203|157655045|FG001|Active Phase|Serious Adverse Event|0|||
48952491|NCT01165203|157655044|FG000|Active Phase|Withdrawal by Subject|2|||
48952492|NCT01165203|157655045|FG001|Active Phase|Withdrawal by Subject|1|||
48952493|NCT01165203|157655044|FG000|Active Phase|Migrated/moved from study area|0|||
48952494|NCT01165203|157655045|FG001|Active Phase|Migrated/moved from study area|1|||
48952495|NCT01165203|157655044|FG000|Active Phase|Lost to Follow-up|2|||
48952496|NCT01165203|157655045|FG001|Active Phase|Lost to Follow-up|0|||
48952497|NCT01165203|157655044|FG000|Extended Safety Follow-up Phase|Serious Adverse Event|1|||
48952498|NCT01165203|157655045|FG001|Extended Safety Follow-up Phase|Serious Adverse Event|0|||
48952499|NCT01165203|157655044|FG000|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
48857552|NCT02367794|157316296|FG002|Overall Study|Hypercalcemia prior to C1D1|1|||
48857553|NCT02367794|157316294|FG000|Overall Study|Adverse Event|0|||
48857554|NCT02367794|157316295|FG001|Overall Study|Adverse Event|0|||
48857555|NCT02367794|157316296|FG002|Overall Study|Adverse Event|2|||
48857556|NCT02367794|157316294|FG000|Overall Study|Study Terminated By Sponsor|0|||
48857557|NCT02367794|157316295|FG001|Overall Study|Study Terminated By Sponsor|1|||
48857558|NCT02367794|157316296|FG002|Overall Study|Study Terminated By Sponsor|1|||
48857559|NCT02367794|157316294|FG000|Overall Study|Moved to Roll-Over Study|0|||
48857560|NCT02367794|157316295|FG001|Overall Study|Moved to Roll-Over Study|15|||
48857561|NCT02367794|157316296|FG002|Overall Study|Moved to Roll-Over Study|13|||
48857562|NCT02367794|157316294|FG000|Overall Study|Sponsor Request|60|||
48857563|NCT02367794|157316295|FG001|Overall Study|Sponsor Request|57|||
48857564|NCT02367794|157316296|FG002|Overall Study|Sponsor Request|45|||
48857565|NCT02367794|157316294|FG000|Overall Study|Moved into PTAP Study|0|||
48857566|NCT02367794|157316295|FG001|Overall Study|Moved into PTAP Study|2|||
48857567|NCT02367794|157316296|FG002|Overall Study|Moved into PTAP Study|3|||
48857568|NCT02367794|157316294|FG000|Overall Study|Moved to Commercial Atezolizumab Use|0|||
48857569|NCT02367794|157316295|FG001|Overall Study|Moved to Commercial Atezolizumab Use|2|||
48857570|NCT02367794|157316296|FG002|Overall Study|Moved to Commercial Atezolizumab Use|1|||
48857571|NCT02367794|157316294|FG000|Overall Study|Investigational Product Availability in Commercial Stock|0|||
48857572|NCT02367794|157316295|FG001|Overall Study|Investigational Product Availability in Commercial Stock|1|||
48857573|NCT02367794|157316296|FG002|Overall Study|Investigational Product Availability in Commercial Stock|0|||
48857574|NCT02367794|157316294|FG000|Overall Study|Participant Enrolled in Extended Protocol|0|||
48857575|NCT02367794|157316295|FG001|Overall Study|Participant Enrolled in Extended Protocol|1|||
48857576|NCT02367794|157316296|FG002|Overall Study|Participant Enrolled in Extended Protocol|0|||
48857577|NCT02367794|157316294|FG000|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
48857578|NCT02367794|157316295|FG001|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
48857579|NCT02367794|157316296|FG002|Overall Study|Discontinuation Matched Treatment Discontinuation|1|||
48857580|NCT01828021|157316297|FG000|Overall Study|Adverse Event|5|||
48857581|NCT01828021|157316297|FG000|Overall Study|Lack of Efficacy|17|||
48857582|NCT01828021|157316297|FG000|Overall Study|Withdrawal by Subject|2|||
48857583|NCT01828021|157316297|FG000|Overall Study|Ileal obstruction, unrelated|1|||
48857584|NCT02010684|157316298|FG000|Overall Study|Lost to Follow-up|8|||
48857585|NCT02010684|157316299|FG001|Overall Study|Lost to Follow-up|18|||
48857586|NCT02010684|157316298|FG000|Overall Study|Withdrawal by Subject|4|||
48857587|NCT02010684|157316299|FG001|Overall Study|Withdrawal by Subject|5|||
48857588|NCT00990314|157316302|FG000|Overall Study|Death|2|||
48857589|NCT00990314|157316302|FG000|Overall Study|Adverse Event|2|||
48857590|NCT00990314|157316302|FG000|Overall Study|Withdrawal by Subject|3|||
48857591|NCT00990314|157316302|FG000|Overall Study|Non-Compliance|1|||
48857592|NCT00990314|157316302|FG000|Overall Study|Physician Decision|3|||
48857593|NCT00990314|157316302|FG000|Overall Study|Lack of Efficacy|1|||
48857594|NCT00853957|157316308|FG000|Overall Study|Adverse Event|9|||
48857595|NCT00853957|157316309|FG001|Overall Study|Adverse Event|3|||
48857596|NCT00853957|157316308|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
48857597|NCT00853957|157316309|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
48857598|NCT00853957|157316308|FG000|Overall Study|Subject withdrew consent|4|||
48857599|NCT00853957|157316309|FG001|Overall Study|Subject withdrew consent|5|||
48857600|NCT00853957|157316308|FG000|Overall Study|Lost to Follow-up|1|||
48857601|NCT00853957|157316309|FG001|Overall Study|Lost to Follow-up|6|||
48857602|NCT00853957|157316308|FG000|Overall Study|Protocol deviation|0|||
48857603|NCT00853957|157316309|FG001|Overall Study|Protocol deviation|3|||
48857604|NCT02332889|157316312|FG000|Overall Study|Physician Decision|1|||
48857605|NCT02354417|157317326|FG000|Overall Study|Physician Decision|1|||
48857606|NCT04311983|157317332|FG000|Overall Study|Lost to Follow-up|421|||
48857607|NCT04311983|157317333|FG001|Overall Study|Lost to Follow-up|456|||
48857608|NCT04311983|157317332|FG000|Overall Study|Incomplete survey|7|||
48857609|NCT04311983|157317333|FG001|Overall Study|Incomplete survey|9|||
48857610|NCT04311983|157317332|FG000|Overall Study|Death|1|||
48857611|NCT04311983|157317333|FG001|Overall Study|Death|0|||
48857612|NCT01437540|157317334|FG000|Overall Study|Not listed below|7|||
48857613|NCT01437540|157317335|FG001|Overall Study|Not listed below|6|||
48857614|NCT01437540|157317334|FG000|Overall Study|COPD exacerbation|13|||
48857615|NCT01437540|157317335|FG001|Overall Study|COPD exacerbation|3|||
48857616|NCT01437540|157317334|FG000|Overall Study|Lost to Follow-up|3|||
48952500|NCT01165203|157655045|FG001|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
48857617|NCT01437540|157317335|FG001|Overall Study|Lost to Follow-up|5|||
48857618|NCT01437540|157317334|FG000|Overall Study|Lack of Efficacy|23|||
48857619|NCT01437540|157317335|FG001|Overall Study|Lack of Efficacy|11|||
48857620|NCT01437540|157317334|FG000|Overall Study|Protocol Violation|24|||
48857621|NCT01437540|157317335|FG001|Overall Study|Protocol Violation|12|||
48857622|NCT01437540|157317334|FG000|Overall Study|Adverse Event|26|||
48857623|NCT01437540|157317335|FG001|Overall Study|Adverse Event|13|||
48857624|NCT01437540|157317334|FG000|Overall Study|Withdrawal by Subject|31|||
48857625|NCT01437540|157317335|FG001|Overall Study|Withdrawal by Subject|15|||
48857626|NCT02889900|157317343|FG000|Overall Study|Adverse Event|11|||
48857627|NCT02889900|157317343|FG000|Overall Study|Condition under investigation worsened|32|||
48857628|NCT02889900|157317343|FG000|Overall Study|Other|5|||
48857629|NCT02889900|157317343|FG000|Overall Study|Withdrawal by Subject|7|||
48857630|NCT02889900|157317343|FG000|Overall Study|Not treated|2|||
48857631|NCT03316170|157317344|FG000|Overall Study|Death|1|||
48857632|NCT03316170|157317345|FG001|Overall Study|Death|0|||
48857633|NCT03316170|157317344|FG000|Overall Study|Lost to Follow-up|6|||
48857634|NCT03316170|157317345|FG001|Overall Study|Lost to Follow-up|7|||
48857635|NCT01416285|157317346|FG000|Overall Study|owing to the care model or moving to other cities of the country|0|||
48857636|NCT01416285|157317347|FG001|Overall Study|owing to the care model or moving to other cities of the country|9|||
48857637|NCT01944774|157317350|FG000|Overall Study|Withdrawal by Subject|2|||
48857638|NCT01944774|157317351|FG001|Overall Study|Withdrawal by Subject|3|||
48857639|NCT01944774|157317352|FG002|Overall Study|Withdrawal by Subject|3|||
48857640|NCT01944774|157317350|FG000|Overall Study|Adverse Event|3|||
48857641|NCT01944774|157317351|FG001|Overall Study|Adverse Event|2|||
48857642|NCT01944774|157317352|FG002|Overall Study|Adverse Event|3|||
48857643|NCT01944774|157317350|FG000|Overall Study|Lack of Efficacy|1|||
48857644|NCT01944774|157317351|FG001|Overall Study|Lack of Efficacy|2|||
48857645|NCT01944774|157317352|FG002|Overall Study|Lack of Efficacy|2|||
48857646|NCT01944774|157317350|FG000|Overall Study|Lost to Follow-up|0|||
48857647|NCT01944774|157317351|FG001|Overall Study|Lost to Follow-up|1|||
48857648|NCT01944774|157317352|FG002|Overall Study|Lost to Follow-up|0|||
48857649|NCT00749944|157317355|FG000|Overall Study|Lost to Follow-up|2|||
48857650|NCT00749944|157317356|FG001|Overall Study|Lost to Follow-up|1|||
48857651|NCT00749944|157317355|FG000|Overall Study|Other|1|||
48857652|NCT00749944|157317356|FG001|Overall Study|Other|0|||
48857653|NCT00749944|157317355|FG000|Overall Study|Withdrawal by Subject|2|||
48857654|NCT00749944|157317356|FG001|Overall Study|Withdrawal by Subject|0|||
48857655|NCT00813709|157317357|FG000|Double Blind Period|Adverse Event|4|||
48857656|NCT00813709|157317358|FG001|Double Blind Period|Adverse Event|1|||
48857657|NCT00813709|157317359|FG002|Double Blind Period|Adverse Event|4|||
48857658|NCT00813709|157317360|FG003|Double Blind Period|Adverse Event|0|||
48857659|NCT00813709|157317361|FG004|Double Blind Period|Adverse Event|0|||
48857660|NCT00813709|157317362|FG005|Double Blind Period|Adverse Event|0|||
48857661|NCT00813709|157317357|FG000|Double Blind Period|Lost to Follow-up|3|||
48857662|NCT00813709|157317358|FG001|Double Blind Period|Lost to Follow-up|2|||
48857663|NCT00813709|157317359|FG002|Double Blind Period|Lost to Follow-up|2|||
48857664|NCT00813709|157317360|FG003|Double Blind Period|Lost to Follow-up|0|||
48857665|NCT00813709|157317361|FG004|Double Blind Period|Lost to Follow-up|0|||
48857666|NCT00813709|157317362|FG005|Double Blind Period|Lost to Follow-up|0|||
48857667|NCT00813709|157317357|FG000|Double Blind Period|Switched to open label phase|9|||
48857668|NCT00813709|157317358|FG001|Double Blind Period|Switched to open label phase|26|||
48857669|NCT00813709|157317359|FG002|Double Blind Period|Switched to open label phase|18|||
48857670|NCT00813709|157317360|FG003|Double Blind Period|Switched to open label phase|0|||
48857671|NCT00813709|157317361|FG004|Double Blind Period|Switched to open label phase|0|||
48857672|NCT00813709|157317362|FG005|Double Blind Period|Switched to open label phase|0|||
48857673|NCT00813709|157317357|FG000|Double Blind Period|Randomized but not treated|1|||
48857674|NCT00813709|157317358|FG001|Double Blind Period|Randomized but not treated|3|||
48857675|NCT00813709|157317359|FG002|Double Blind Period|Randomized but not treated|1|||
48857676|NCT00813709|157317360|FG003|Double Blind Period|Randomized but not treated|0|||
48857677|NCT00813709|157317361|FG004|Double Blind Period|Randomized but not treated|0|||
48857678|NCT00813709|157317362|FG005|Double Blind Period|Randomized but not treated|0|||
48857679|NCT00813709|157317357|FG000|Double Blind Period|Other|14|||
48857680|NCT00813709|157317358|FG001|Double Blind Period|Other|9|||
48857681|NCT00813709|157317359|FG002|Double Blind Period|Other|6|||
48857682|NCT00813709|157317360|FG003|Double Blind Period|Other|0|||
48857683|NCT00813709|157317361|FG004|Double Blind Period|Other|0|||
48857684|NCT00813709|157317362|FG005|Double Blind Period|Other|0|||
48745075|NCT03003390|156916120|FG000|Overall Study|Physician Decision|2|||
48745076|NCT03003390|156916121|FG001|Overall Study|Physician Decision|0|||
48745077|NCT03003390|156916120|FG000|Overall Study|Parent refused intervention|2|||
48745078|NCT03003390|156916121|FG001|Overall Study|Parent refused intervention|0|||
48745079|NCT01663532|156916122|FG000|Overall Study|Lost to Follow-up|9|||
48745080|NCT01663532|156916123|FG001|Overall Study|Lost to Follow-up|10|||
48745081|NCT01663532|156916122|FG000|Overall Study|Adverse Event|7|||
48745082|NCT01663532|156916123|FG001|Overall Study|Adverse Event|13|||
48745083|NCT01663532|156916122|FG000|Overall Study|Met Withdrawal Criteria|7|||
48745084|NCT01663532|156916123|FG001|Overall Study|Met Withdrawal Criteria|6|||
48745085|NCT01663532|156916122|FG000|Overall Study|Physician Decision|1|||
48745086|NCT01663532|156916123|FG001|Overall Study|Physician Decision|1|||
48857685|NCT00813709|157317357|FG000|Open Label Period|Adverse Event|0|||
48857686|NCT00813709|157317358|FG001|Open Label Period|Adverse Event|0|||
48857687|NCT00813709|157317359|FG002|Open Label Period|Adverse Event|0|||
48857688|NCT00813709|157317360|FG003|Open Label Period|Adverse Event|5|||
48857689|NCT00813709|157317361|FG004|Open Label Period|Adverse Event|4|||
48857690|NCT00813709|157317362|FG005|Open Label Period|Adverse Event|3|||
48857691|NCT00813709|157317357|FG000|Open Label Period|Lack of Efficacy|0|||
48857692|NCT00813709|157317358|FG001|Open Label Period|Lack of Efficacy|0|||
48857693|NCT00813709|157317359|FG002|Open Label Period|Lack of Efficacy|0|||
48857694|NCT00813709|157317360|FG003|Open Label Period|Lack of Efficacy|3|||
48857695|NCT00813709|157317361|FG004|Open Label Period|Lack of Efficacy|1|||
48857696|NCT00813709|157317362|FG005|Open Label Period|Lack of Efficacy|1|||
48857697|NCT00813709|157317357|FG000|Open Label Period|Randomized but not treated|0|||
48857698|NCT00813709|157317358|FG001|Open Label Period|Randomized but not treated|0|||
48857699|NCT00813709|157317359|FG002|Open Label Period|Randomized but not treated|0|||
48857700|NCT00813709|157317360|FG003|Open Label Period|Randomized but not treated|1|||
48857701|NCT00813709|157317361|FG004|Open Label Period|Randomized but not treated|0|||
48857702|NCT00813709|157317362|FG005|Open Label Period|Randomized but not treated|1|||
48857703|NCT00813709|157317357|FG000|Open Label Period|Other|0|||
48857704|NCT00813709|157317358|FG001|Open Label Period|Other|0|||
48857705|NCT00813709|157317359|FG002|Open Label Period|Other|0|||
48857706|NCT00813709|157317360|FG003|Open Label Period|Other|11|||
48857707|NCT00813709|157317361|FG004|Open Label Period|Other|5|||
48857708|NCT00813709|157317362|FG005|Open Label Period|Other|6|||
48857709|NCT00624377|157317363|FG000|Overall Study|Lost to Follow-up|355|||
48857710|NCT00624377|157317363|FG000|Overall Study|Withdrawal by Subject|100|||
48857711|NCT00624377|157317363|FG000|Overall Study|Adverse Event|14|||
48857712|NCT00624377|157317363|FG000|Overall Study|Other|91|||
48952501|NCT01165203|157655044|FG000|Extended Safety Follow-up Phase|Migrated/moved from study area|2|||
48952502|NCT01165203|157655045|FG001|Extended Safety Follow-up Phase|Migrated/moved from study area|1|||
48952503|NCT01165203|157655044|FG000|Extended Safety Follow-up Phase|Lost to Follow-up|2|||
48952504|NCT01165203|157655045|FG001|Extended Safety Follow-up Phase|Lost to Follow-up|0|||
48952505|NCT01165203|157655044|FG000|Extended Safety Follow-up Phase|Other-subjects business reasons|0|||
48952506|NCT01165203|157655045|FG001|Extended Safety Follow-up Phase|Other-subjects business reasons|1|||
48952507|NCT00222729|157655046|FG000|Overall Study|Adverse Event|3|||
48952508|NCT01963117|157655047|FG000|Overall Study|Death|1|||
48952509|NCT00406640|157655048|FG000|Acute Phase|Adverse Event|18|||
48952510|NCT00406640|157655049|FG001|Acute Phase|Adverse Event|13|||
48952511|NCT00406640|157655048|FG000|Acute Phase|Failed to Return|5|||
48952512|NCT00406640|157655049|FG001|Acute Phase|Failed to Return|1|||
48952513|NCT00406640|157655048|FG000|Acute Phase|Physician Decision|0|||
48952514|NCT00406640|157655049|FG001|Acute Phase|Physician Decision|1|||
48952515|NCT00406640|157655048|FG000|Acute Phase|Lost to Follow-up|7|||
48952516|NCT00406640|157655049|FG001|Acute Phase|Lost to Follow-up|4|||
48952517|NCT00406640|157655048|FG000|Acute Phase|Protocol deviation|4|||
48952518|NCT00406640|157655049|FG001|Acute Phase|Protocol deviation|10|||
48952519|NCT00406640|157655048|FG000|Acute Phase|Protocol Violation|3|||
48952520|NCT00406640|157655049|FG001|Acute Phase|Protocol Violation|2|||
48952521|NCT00406640|157655048|FG000|Acute Phase|Withdrawal by Subject|11|||
48952522|NCT00406640|157655049|FG001|Acute Phase|Withdrawal by Subject|9|||
48952523|NCT00406640|157655048|FG000|Acute Phase|Lack of Efficacy|3|||
48952524|NCT00406640|157655049|FG001|Acute Phase|Lack of Efficacy|3|||
48952525|NCT00406640|157655048|FG000|DB Continuation Phase for Responders|Adverse Event|11|||
48952526|NCT00406640|157655049|FG001|DB Continuation Phase for Responders|Adverse Event|11|||
48952527|NCT00406640|157655048|FG000|DB Continuation Phase for Responders|Death|1|||
48952528|NCT00406640|157655049|FG001|DB Continuation Phase for Responders|Death|0|||
48952529|NCT00406640|157655048|FG000|DB Continuation Phase for Responders|Failed to Return|0|||
48952530|NCT00406640|157655049|FG001|DB Continuation Phase for Responders|Failed to Return|2|||
48952531|NCT00406640|157655048|FG000|DB Continuation Phase for Responders|Physician Decision|2|||
48952532|NCT00406640|157655049|FG001|DB Continuation Phase for Responders|Physician Decision|3|||
48952533|NCT00406640|157655048|FG000|DB Continuation Phase for Responders|Lost to Follow-up|1|||
48952534|NCT00406640|157655049|FG001|DB Continuation Phase for Responders|Lost to Follow-up|7|||
48952535|NCT00406640|157655048|FG000|DB Continuation Phase for Responders|non-compliance|7|||
48952536|NCT00406640|157655049|FG001|DB Continuation Phase for Responders|non-compliance|5|||
48952537|NCT00406640|157655048|FG000|DB Continuation Phase for Responders|Protocol Violation|2|||
48952538|NCT00406640|157655049|FG001|DB Continuation Phase for Responders|Protocol Violation|2|||
48952539|NCT00406640|157655048|FG000|DB Continuation Phase for Responders|Withdrawal by Subject|8|||
48952540|NCT00406640|157655049|FG001|DB Continuation Phase for Responders|Withdrawal by Subject|6|||
48952541|NCT00406640|157655048|FG000|DB Continuation Phase for Responders|Lack of Efficacy|1|||
48952542|NCT00406640|157655049|FG001|DB Continuation Phase for Responders|Lack of Efficacy|1|||
48952543|NCT00406640|157655048|FG000|OL Extension Phase for Non-Responders|Adverse Event|6|||
48952544|NCT00406640|157655049|FG001|OL Extension Phase for Non-Responders|Adverse Event|6|||
48952545|NCT00406640|157655048|FG000|OL Extension Phase for Non-Responders|Failed to Return|1|||
48952546|NCT00406640|157655049|FG001|OL Extension Phase for Non-Responders|Failed to Return|0|||
48952547|NCT00406640|157655048|FG000|OL Extension Phase for Non-Responders|Physician Decision|1|||
48952548|NCT00406640|157655049|FG001|OL Extension Phase for Non-Responders|Physician Decision|0|||
48952549|NCT00406640|157655048|FG000|OL Extension Phase for Non-Responders|Lost to Follow-up|2|||
48952550|NCT00406640|157655049|FG001|OL Extension Phase for Non-Responders|Lost to Follow-up|3|||
48952551|NCT00406640|157655048|FG000|OL Extension Phase for Non-Responders|non-compliance|3|||
48952552|NCT00406640|157655049|FG001|OL Extension Phase for Non-Responders|non-compliance|2|||
48952553|NCT00406640|157655048|FG000|OL Extension Phase for Non-Responders|Withdrawal by Subject|3|||
48952554|NCT00406640|157655049|FG001|OL Extension Phase for Non-Responders|Withdrawal by Subject|6|||
48952555|NCT00406640|157655048|FG000|OL Extension Phase for Non-Responders|Lack of Efficacy|6|||
48952556|NCT00406640|157655049|FG001|OL Extension Phase for Non-Responders|Lack of Efficacy|7|||
48952557|NCT02582749|157655050|FG000|Overall Study|Study terminated by funder|5|||
48952558|NCT02582749|157655051|FG001|Overall Study|Study terminated by funder|10|||
48952559|NCT02582749|157655050|FG000|Overall Study|Withdrawal by Subject|0|||
48952560|NCT02582749|157655051|FG001|Overall Study|Withdrawal by Subject|1|||
48952561|NCT03042611|157656378|FG000|Core Phase|Withdrawal by Subject|13|||
48952562|NCT03042611|157656379|FG001|Core Phase|Withdrawal by Subject|4|||
48952563|NCT03042611|157656380|FG002|Core Phase|Withdrawal by Subject|0|||
48952564|NCT03042611|157656381|FG003|Core Phase|Withdrawal by Subject|0|||
48952565|NCT03042611|157656378|FG000|Core Phase|Death|232|||
48952566|NCT03042611|157656379|FG001|Core Phase|Death|110|||
48952567|NCT03042611|157656380|FG002|Core Phase|Death|0|||
48952568|NCT03042611|157656381|FG003|Core Phase|Death|0|||
48952569|NCT03042611|157656378|FG000|Core Phase|Lost to Follow-up|4|||
48952570|NCT03042611|157656379|FG001|Core Phase|Lost to Follow-up|7|||
48952571|NCT03042611|157656380|FG002|Core Phase|Lost to Follow-up|0|||
48952572|NCT03042611|157656381|FG003|Core Phase|Lost to Follow-up|0|||
48952573|NCT03042611|157656378|FG000|Core Phase|Physician Decision|7|||
48952574|NCT03042611|157656379|FG001|Core Phase|Physician Decision|2|||
48952575|NCT03042611|157656380|FG002|Core Phase|Physician Decision|0|||
48952576|NCT03042611|157656381|FG003|Core Phase|Physician Decision|0|||
48952577|NCT03042611|157656378|FG000|Core Phase|Study Closed|0|||
48952578|NCT03042611|157656379|FG001|Core Phase|Study Closed|1|||
48952579|NCT03042611|157656380|FG002|Core Phase|Study Closed|0|||
48952580|NCT03042611|157656381|FG003|Core Phase|Study Closed|0|||
48952581|NCT03042611|157656378|FG000|Extension Phase|Death|0|||
48952582|NCT03042611|157656379|FG001|Extension Phase|Death|0|||
48745087|NCT01663532|156916122|FG000|Overall Study|Withdrawal by Subject|35|||
48745088|NCT01663532|156916123|FG001|Overall Study|Withdrawal by Subject|17|||
48745089|NCT01663532|156916122|FG000|Overall Study|Lack of Efficacy|15|||
48745090|NCT01663532|156916123|FG001|Overall Study|Lack of Efficacy|60|||
48745091|NCT04669600|156916124|FG000|Overall Study|Withdrawal by Subject|1|||
48745092|NCT04669600|156916124|FG000|Overall Study|Other|6|||
48745093|NCT01897454|156916127|FG000|Overall Study|Withdrawal by Subject|1|||
48745094|NCT01709513|156916128|FG000|Overall Study|Randomized but not treated|0|||
48745095|NCT01709513|156916129|FG001|Overall Study|Randomized but not treated|1|||
48745096|NCT01709513|156916130|FG002|Overall Study|Randomized but not treated|0|||
48745097|NCT01709513|156916128|FG000|Overall Study|Adverse Event|16|||
48745098|NCT01709513|156916129|FG001|Overall Study|Adverse Event|31|||
48745099|NCT01709513|156916130|FG002|Overall Study|Adverse Event|23|||
48745100|NCT01709513|156916128|FG000|Overall Study|Poor compliance to protocol|2|||
48745101|NCT01709513|156916129|FG001|Overall Study|Poor compliance to protocol|0|||
48745102|NCT01709513|156916130|FG002|Overall Study|Poor compliance to protocol|0|||
48745103|NCT01709513|156916128|FG000|Overall Study|Other|3|||
48745104|NCT01709513|156916129|FG001|Overall Study|Other|11|||
48745105|NCT01709513|156916130|FG002|Overall Study|Other|7|||
48745106|NCT00980057|156916136|FG000|Overall Study|Death|13|||
48745107|NCT00980057|156916137|FG001|Overall Study|Death|3|||
48745108|NCT00980057|156916136|FG000|Overall Study|Adverse Event|0|||
48745109|NCT00980057|156916137|FG001|Overall Study|Adverse Event|1|||
48745110|NCT00980057|156916136|FG000|Overall Study|Physician Decision|4|||
48745111|NCT00980057|156916137|FG001|Overall Study|Physician Decision|0|||
48745112|NCT00980057|156916136|FG000|Overall Study|Lost to Follow-up|1|||
48745113|NCT00980057|156916137|FG001|Overall Study|Lost to Follow-up|0|||
48745114|NCT00980057|156916136|FG000|Overall Study|Withdrawal by Subject|1|||
48745115|NCT00980057|156916137|FG001|Overall Study|Withdrawal by Subject|1|||
48745116|NCT01408485|156916138|FG000|Overall Study|Withdrawal by Subject|21|||
48745117|NCT02059395|156916142|FG000|Overall Study|Lost to Follow-up|2|||
48745118|NCT02059395|156916143|FG001|Overall Study|Lost to Follow-up|4|||
48745119|NCT00847379|156916144|FG000|Overall Study|Study terminated by Sponsor|59|||
48745120|NCT00847379|156916145|FG001|Overall Study|Study terminated by Sponsor|57|||
48745121|NCT00847379|156916146|FG002|Overall Study|Study terminated by Sponsor|57|||
48745122|NCT00319553|156916151|FG000|Overall Study|Protocol Violation|1|||
48745123|NCT00319553|156916152|FG001|Overall Study|Protocol Violation|2|||
48745124|NCT00319553|156916151|FG000|Overall Study|Lost to Follow-up|2|||
48857713|NCT00624377|157317363|FG000|Overall Study|Non-evaluable population|84|||
48857714|NCT00603798|157317372|FG000|Overall Study|Adverse Event|4|||
48857715|NCT00603798|157317373|FG001|Overall Study|Adverse Event|2|||
48745125|NCT00319553|156916152|FG001|Overall Study|Lost to Follow-up|1|||
48745126|NCT00319553|156916151|FG000|Overall Study|Withdrawal by Subject|1|||
48745127|NCT00319553|156916152|FG001|Overall Study|Withdrawal by Subject|1|||
48745128|NCT01896102|156916153|FG000|Overall Study|Death|1|||
48745129|NCT01896102|156916153|FG000|Overall Study|Participant to receive allogenic transplant|2|||
48857716|NCT00603798|157317374|FG002|Overall Study|Adverse Event|1|||
48857717|NCT00603798|157317372|FG000|Overall Study|Withdrawal by Subject|4|||
48857718|NCT00603798|157317373|FG001|Overall Study|Withdrawal by Subject|3|||
48857719|NCT00603798|157317374|FG002|Overall Study|Withdrawal by Subject|4|||
48857720|NCT00603798|157317372|FG000|Overall Study|Lost to Follow-up|1|||
48857721|NCT00603798|157317373|FG001|Overall Study|Lost to Follow-up|0|||
48857722|NCT00603798|157317374|FG002|Overall Study|Lost to Follow-up|1|||
48857723|NCT00603798|157317372|FG000|Overall Study|Non-compliance with study procedures|0|||
48857724|NCT00603798|157317373|FG001|Overall Study|Non-compliance with study procedures|1|||
48857725|NCT00603798|157317374|FG002|Overall Study|Non-compliance with study procedures|0|||
48857726|NCT00603798|157317372|FG000|Overall Study|Not due to AE|1|||
48857727|NCT00603798|157317373|FG001|Overall Study|Not due to AE|1|||
48857728|NCT00603798|157317374|FG002|Overall Study|Not due to AE|4|||
48745130|NCT02042183|156916154|FG000|Overall Study|Physician Decision|7|||
48745131|NCT02042183|156916155|FG001|Overall Study|Physician Decision|2|||
48745132|NCT02042183|156916154|FG000|Overall Study|Lack of Efficacy|4|||
48745133|NCT02042183|156916155|FG001|Overall Study|Lack of Efficacy|3|||
48745134|NCT02042183|156916154|FG000|Overall Study|Non-compliance with Study Drug|2|||
48857729|NCT04766996|157317375|FG000|Overall Study|Withdrawal by Subject|1|||
48857730|NCT04766996|157317376|FG001|Overall Study|Withdrawal by Subject|0|||
48857731|NCT04766996|157317377|FG002|Overall Study|Withdrawal by Subject|13|||
48857732|NCT00088166|157317383|FG000|Overall Study|Adverse Event|11|||
48857733|NCT00088166|157317384|FG001|Overall Study|Adverse Event|9|||
48857734|NCT00088166|157317383|FG000|Overall Study|Death|3|||
48857735|NCT00088166|157317384|FG001|Overall Study|Death|1|||
48857736|NCT00088166|157317383|FG000|Overall Study|Lost to Follow-up|0|||
48857737|NCT00088166|157317384|FG001|Overall Study|Lost to Follow-up|1|||
48857738|NCT00088166|157317383|FG000|Overall Study|Physician Decision|4|||
48857739|NCT00088166|157317384|FG001|Overall Study|Physician Decision|1|||
48857740|NCT00088166|157317383|FG000|Overall Study|Protocol Violation|1|||
48857741|NCT00088166|157317384|FG001|Overall Study|Protocol Violation|5|||
48857742|NCT00088166|157317383|FG000|Overall Study|Patient deterioration|29|||
48857743|NCT00088166|157317384|FG001|Overall Study|Patient deterioration|39|||
48857744|NCT00088166|157317383|FG000|Overall Study|Withdrawal by Subject|5|||
48857745|NCT00088166|157317384|FG001|Overall Study|Withdrawal by Subject|5|||
48857746|NCT03693989|157317388|FG000|Overall Study|Protocol Violation|3|||
48857747|NCT03693989|157317389|FG001|Overall Study|Protocol Violation|4|||
48857748|NCT01220999|157317390|FG000|Overall Study|Progressive disease|0|||
48857749|NCT01220999|157317391|FG001|Overall Study|Progressive disease|0|||
48857750|NCT01220999|157317392|FG002|Overall Study|Progressive disease|1|||
48857751|NCT01220999|157317393|FG003|Overall Study|Progressive disease|0|||
48857752|NCT01220999|157317394|FG004|Overall Study|Progressive disease|0|||
48857753|NCT02525744|157317397|FG000|Period 1|Physician Decision|0|||
48857754|NCT02525744|157317398|FG001|Period 1|Physician Decision|0|||
48857755|NCT02525744|157317399|FG002|Period 1|Physician Decision|1|||
48857756|NCT02525744|157317400|FG003|Period 1|Physician Decision|0|||
48857757|NCT02525744|157317397|FG000|Period 3|Adverse Event|0|||
48952583|NCT03042611|157656380|FG002|Extension Phase|Death|34|||
48952584|NCT03042611|157656381|FG003|Extension Phase|Death|16|||
48952585|NCT03042611|157656378|FG000|Extension Phase|Lost to Follow-up|0|||
48952586|NCT03042611|157656379|FG001|Extension Phase|Lost to Follow-up|0|||
48952587|NCT03042611|157656380|FG002|Extension Phase|Lost to Follow-up|1|||
48952588|NCT03042611|157656381|FG003|Extension Phase|Lost to Follow-up|1|||
48952589|NCT03042611|157656378|FG000|Extension Phase|Study Closed|0|||
48952590|NCT03042611|157656379|FG001|Extension Phase|Study Closed|0|||
48952591|NCT03042611|157656380|FG002|Extension Phase|Study Closed|17|||
48952592|NCT03042611|157656381|FG003|Extension Phase|Study Closed|11|||
48952593|NCT01254604|157656382|FG000|Overall Study|Lost to Follow-up|1|||
48952594|NCT01254604|157656383|FG001|Overall Study|Lost to Follow-up|1|||
48952595|NCT01254604|157656382|FG000|Overall Study|Protocol Violation|2|||
48952596|NCT01254604|157656383|FG001|Overall Study|Protocol Violation|2|||
48952597|NCT01254604|157656382|FG000|Overall Study|Withdrawal by Subject|2|||
48952598|NCT01254604|157656383|FG001|Overall Study|Withdrawal by Subject|4|||
48952599|NCT01254604|157656382|FG000|Overall Study|Adverse Event|3|||
48952600|NCT01254604|157656383|FG001|Overall Study|Adverse Event|2|||
48952601|NCT01306058|157656384|FG000|Overall Study|Death|1|||
48952602|NCT01306058|157656384|FG000|Overall Study|Enrolled but did not get treatment|1|||
48952603|NCT01166659|157656385|FG000|Overall Study|Subject Decision|8|||
48952604|NCT01166659|157656385|FG000|Overall Study|Investigator Decision|2|||
48952605|NCT01166659|157656385|FG000|Overall Study|Death|1|||
48952606|NCT01166659|157656385|FG000|Overall Study|Lost to Follow-up|1|||
48952607|NCT01166659|157656385|FG000|Overall Study|Study Closed at Site|1|||
48952608|NCT00536731|157656386|FG000|Overall Study|Adverse Event|3|||
48952609|NCT00536731|157656387|FG001|Overall Study|Adverse Event|2|||
48952610|NCT00536731|157656388|FG002|Overall Study|Adverse Event|3|||
48952611|NCT00536731|157656386|FG000|Overall Study|Withdrawal by Subject|0|||
48952612|NCT00536731|157656387|FG001|Overall Study|Withdrawal by Subject|2|||
48857758|NCT02525744|157317398|FG001|Period 3|Adverse Event|1|||
48952613|NCT00536731|157656388|FG002|Overall Study|Withdrawal by Subject|0|||
48952614|NCT00536731|157656386|FG000|Overall Study|Intake of prohibited conc. medication|0|||
48952615|NCT00536731|157656387|FG001|Overall Study|Intake of prohibited conc. medication|0|||
48952616|NCT00536731|157656388|FG002|Overall Study|Intake of prohibited conc. medication|1|||
48952617|NCT00536731|157656386|FG000|Overall Study|Safety reasons|0|||
48952618|NCT00536731|157656387|FG001|Overall Study|Safety reasons|0|||
48952619|NCT00536731|157656388|FG002|Overall Study|Safety reasons|1|||
48952620|NCT00536731|157656386|FG000|Overall Study|Other|1|||
48952621|NCT00536731|157656387|FG001|Overall Study|Other|1|||
49015364|NCT00306384|157892158|FG002|Overall Study|Major protocol deviation|18|||
48857759|NCT02525744|157317399|FG002|Period 3|Adverse Event|0|||
48857760|NCT02525744|157317400|FG003|Period 3|Adverse Event|0|||
48857761|NCT02525744|157317397|FG000|Period 4|Withdrawal by Subject|1|||
48857762|NCT02525744|157317398|FG001|Period 4|Withdrawal by Subject|0|||
48857763|NCT02525744|157317399|FG002|Period 4|Withdrawal by Subject|0|||
48857764|NCT02525744|157317400|FG003|Period 4|Withdrawal by Subject|0|||
48857765|NCT02525744|157317397|FG000|Period 5|Physician Decision|1|||
48857766|NCT02525744|157317398|FG001|Period 5|Physician Decision|0|||
48952622|NCT00536731|157656388|FG002|Overall Study|Other|0|||
48952623|NCT01103349|157656398|FG000|Overall Study|Adverse Event|8|||
48857767|NCT02525744|157317399|FG002|Period 5|Physician Decision|0|||
48857768|NCT02525744|157317400|FG003|Period 5|Physician Decision|0|||
48857769|NCT03150589|157317403|FG000|Overall Study|Withdrawal by Subject|16|||
48857770|NCT03150589|157317404|FG001|Overall Study|Withdrawal by Subject|9|||
48857771|NCT03150589|157317403|FG000|Overall Study|Adverse Event|7|||
48857772|NCT03150589|157317404|FG001|Overall Study|Adverse Event|6|||
48857773|NCT03150589|157317403|FG000|Overall Study|Protocol Violation|4|||
48857774|NCT03150589|157317404|FG001|Overall Study|Protocol Violation|3|||
48857775|NCT03150589|157317403|FG000|Overall Study|Lost to Follow-up|3|||
48857776|NCT03150589|157317404|FG001|Overall Study|Lost to Follow-up|3|||
48857777|NCT03150589|157317403|FG000|Overall Study|Death|2|||
48857778|NCT03150589|157317404|FG001|Overall Study|Death|3|||
48857779|NCT03150589|157317403|FG000|Overall Study|IP non-compliance and other reasons|12|||
48857780|NCT03150589|157317404|FG001|Overall Study|IP non-compliance and other reasons|3|||
48857781|NCT01020435|157317405|FG000|Overall Study|Lost to Follow-up|0|||
48857782|NCT01020435|157317406|FG001|Overall Study|Lost to Follow-up|1|||
48857783|NCT02006641|157317409|FG000|Overall Study|Withdrawal before treatment|2|||
48857784|NCT02006641|157317410|FG001|Overall Study|Withdrawal before treatment|5|||
48857785|NCT02006641|157317411|FG002|Overall Study|Withdrawal before treatment|3|||
48857786|NCT02006641|157317409|FG000|Overall Study|Adverse Event|15|||
48857787|NCT02006641|157317410|FG001|Overall Study|Adverse Event|11|||
48857788|NCT02006641|157317411|FG002|Overall Study|Adverse Event|15|||
48857789|NCT02006641|157317409|FG000|Overall Study|Protocol Violation|0|||
48857790|NCT02006641|157317410|FG001|Overall Study|Protocol Violation|2|||
48857791|NCT02006641|157317411|FG002|Overall Study|Protocol Violation|2|||
48857792|NCT02006641|157317409|FG000|Overall Study|Lost to Follow-up|0|||
48857793|NCT02006641|157317410|FG001|Overall Study|Lost to Follow-up|1|||
48857794|NCT02006641|157317411|FG002|Overall Study|Lost to Follow-up|0|||
48857795|NCT02006641|157317409|FG000|Overall Study|Withdrawal by Subject|7|||
48857796|NCT02006641|157317410|FG001|Overall Study|Withdrawal by Subject|12|||
48857797|NCT02006641|157317411|FG002|Overall Study|Withdrawal by Subject|11|||
48857798|NCT02006641|157317409|FG000|Overall Study|Other reason: patient didn't show up|1|||
48857799|NCT02006641|157317410|FG001|Overall Study|Other reason: patient didn't show up|0|||
48857800|NCT02006641|157317411|FG002|Overall Study|Other reason: patient didn't show up|0|||
48857801|NCT02006641|157317409|FG000|Overall Study|Other reason:patient didn't want to come|0|||
48857802|NCT02006641|157317410|FG001|Overall Study|Other reason:patient didn't want to come|0|||
48857803|NCT02006641|157317411|FG002|Overall Study|Other reason:patient didn't want to come|1|||
48857804|NCT02006641|157317409|FG000|Overall Study|Other reason: patient has moved|1|||
48857805|NCT02006641|157317410|FG001|Overall Study|Other reason: patient has moved|0|||
48857806|NCT02006641|157317411|FG002|Overall Study|Other reason: patient has moved|1|||
48857807|NCT02006641|157317409|FG000|Overall Study|Other reason: caregiver in hospital|0|||
48857808|NCT02006641|157317410|FG001|Overall Study|Other reason: caregiver in hospital|1|||
48857809|NCT02006641|157317411|FG002|Overall Study|Other reason: caregiver in hospital|0|||
48857810|NCT02006641|157317409|FG000|Overall Study|Other reason: patient's wife has died|0|||
48857811|NCT02006641|157317410|FG001|Overall Study|Other reason: patient's wife has died|0|||
48857812|NCT02006641|157317411|FG002|Overall Study|Other reason: patient's wife has died|1|||
48857813|NCT02006641|157317409|FG000|Overall Study|Other reason: hospitalisation|0|||
48952624|NCT01103349|157656399|FG001|Overall Study|Adverse Event|5|||
48952625|NCT01103349|157656400|FG002|Overall Study|Adverse Event|3|||
48952626|NCT01103349|157656398|FG000|Overall Study|Consent withdrawn|1|||
48952627|NCT01103349|157656399|FG001|Overall Study|Consent withdrawn|0|||
48952628|NCT01103349|157656400|FG002|Overall Study|Consent withdrawn|0|||
48745135|NCT02042183|156916155|FG001|Overall Study|Non-compliance with Study Drug|3|||
48745136|NCT02042183|156916154|FG000|Overall Study|Adverse Event|17|||
48857814|NCT02006641|157317410|FG001|Overall Study|Other reason: hospitalisation|1|||
48857815|NCT02006641|157317411|FG002|Overall Study|Other reason: hospitalisation|0|||
48857816|NCT02006641|157317409|FG000|Overall Study|Other reason: caregiver impossibility|0|||
48857817|NCT02006641|157317410|FG001|Overall Study|Other reason: caregiver impossibility|0|||
48857818|NCT02006641|157317411|FG002|Overall Study|Other reason: caregiver impossibility|1|||
48857819|NCT02006641|157317409|FG000|Overall Study|Other reason: protocol non-compliance|0|||
48857820|NCT02006641|157317410|FG001|Overall Study|Other reason: protocol non-compliance|0|||
48857821|NCT02006641|157317411|FG002|Overall Study|Other reason: protocol non-compliance|1|||
48857822|NCT01970527|157317412|FG000|Pre-treatment/Baseline|Screen fail- participant had brain mets|1|||
48857823|NCT01970527|157317413|FG001|Pre-treatment/Baseline|Screen fail- participant had brain mets|0|||
48857824|NCT01970527|157317412|FG000|Treatment|Disease progression|0|||
48857825|NCT01970527|157317413|FG001|Treatment|Disease progression|1|||
48745137|NCT02042183|156916155|FG001|Overall Study|Adverse Event|6|||
48745138|NCT02042183|156916154|FG000|Overall Study|Other|3|||
48857826|NCT01970527|157317412|FG000|Treatment|Participant did not tolerate Ipilimumab|0|||
48745139|NCT02042183|156916155|FG001|Overall Study|Other|3|||
48745140|NCT02042183|156916154|FG000|Overall Study|Withdrawal by Subject|21|||
48745141|NCT02042183|156916155|FG001|Overall Study|Withdrawal by Subject|16|||
48745142|NCT02042183|156916154|FG000|Overall Study|Site Terminated by Sponsor|2|||
48857827|NCT01970527|157317413|FG001|Treatment|Participant did not tolerate Ipilimumab|1|||
48857828|NCT01970527|157317412|FG000|Treatment|Death|0|||
48857829|NCT01970527|157317413|FG001|Treatment|Death|1|||
48952629|NCT01103349|157656398|FG000|Overall Study|Incorrectly included in the trial|1|||
48745143|NCT02042183|156916155|FG001|Overall Study|Site Terminated by Sponsor|1|||
48857830|NCT01970527|157317412|FG000|Follow-up Clinic Visit|Disease progression|1|||
48857831|NCT01970527|157317413|FG001|Follow-up Clinic Visit|Disease progression|1|||
48952630|NCT01103349|157656399|FG001|Overall Study|Incorrectly included in the trial|0|||
48745144|NCT02042183|156916154|FG000|Overall Study|Lost to Follow-up|9|||
48745145|NCT02042183|156916155|FG001|Overall Study|Lost to Follow-up|2|||
48745146|NCT01081678|156916156|FG000|Overall Study|Ineligibility Determined|0|||
48745147|NCT01081678|156916157|FG001|Overall Study|Ineligibility Determined|0|||
48745148|NCT01081678|156916158|FG002|Overall Study|Ineligibility Determined|1|||
48745149|NCT01081678|156916159|FG003|Overall Study|Ineligibility Determined|1|||
48745150|NCT01081678|156916156|FG000|Overall Study|Noncompliance|3|||
48745151|NCT01081678|156916157|FG001|Overall Study|Noncompliance|4|||
48745152|NCT01081678|156916158|FG002|Overall Study|Noncompliance|5|||
48745153|NCT01081678|156916159|FG003|Overall Study|Noncompliance|2|||
48745154|NCT01081678|156916156|FG000|Overall Study|Adverse Event|2|||
48745155|NCT01081678|156916157|FG001|Overall Study|Adverse Event|1|||
48745156|NCT01081678|156916158|FG002|Overall Study|Adverse Event|2|||
48745157|NCT01081678|156916159|FG003|Overall Study|Adverse Event|2|||
48745158|NCT01081678|156916156|FG000|Overall Study|Withdrawal by Subject|15|||
48745159|NCT01081678|156916157|FG001|Overall Study|Withdrawal by Subject|7|||
48745160|NCT01081678|156916158|FG002|Overall Study|Withdrawal by Subject|17|||
48745161|NCT01081678|156916159|FG003|Overall Study|Withdrawal by Subject|14|||
48745162|NCT01081678|156916156|FG000|Overall Study|Administrative Decision|1|||
48745163|NCT01081678|156916157|FG001|Overall Study|Administrative Decision|0|||
48745164|NCT01081678|156916158|FG002|Overall Study|Administrative Decision|0|||
48745165|NCT01081678|156916159|FG003|Overall Study|Administrative Decision|1|||
48745166|NCT01081678|156916156|FG000|Overall Study|Lost to Follow-up|4|||
48745167|NCT01081678|156916157|FG001|Overall Study|Lost to Follow-up|1|||
48745168|NCT01081678|156916158|FG002|Overall Study|Lost to Follow-up|4|||
48745169|NCT01081678|156916159|FG003|Overall Study|Lost to Follow-up|3|||
48745170|NCT01081678|156916156|FG000|Overall Study|Death|2|||
48745171|NCT01081678|156916157|FG001|Overall Study|Death|2|||
48745172|NCT01081678|156916158|FG002|Overall Study|Death|2|||
48745173|NCT01081678|156916159|FG003|Overall Study|Death|6|||
48745174|NCT01081678|156916156|FG000|Overall Study|Other|0|||
48745175|NCT01081678|156916157|FG001|Overall Study|Other|1|||
48745176|NCT01081678|156916158|FG002|Overall Study|Other|0|||
48745177|NCT01081678|156916159|FG003|Overall Study|Other|0|||
48745178|NCT00378378|156916160|FG000|Overall Study|Withdrawal by Subject|0|||
48745179|NCT00378378|156916161|FG001|Overall Study|Withdrawal by Subject|1|||
48745180|NCT00378378|156916162|FG002|Overall Study|Withdrawal by Subject|0|||
48745181|NCT00378378|156916160|FG000|Overall Study|Treatment Failure|0|||
48745182|NCT00378378|156916161|FG001|Overall Study|Treatment Failure|0|||
48745183|NCT00378378|156916162|FG002|Overall Study|Treatment Failure|1|||
48745184|NCT00378378|156916160|FG000|Overall Study|Non-compliance with protocol|0|||
48857832|NCT01970527|157317412|FG000|Follow-up Clinic Visit|Withdrawal by Subject|0|||
48857833|NCT01970527|157317413|FG001|Follow-up Clinic Visit|Withdrawal by Subject|1|||
48857834|NCT01970527|157317412|FG000|Follow-up Clinic Visit|Lost to Follow-up|0|||
48857835|NCT01970527|157317413|FG001|Follow-up Clinic Visit|Lost to Follow-up|1|||
48857836|NCT03060525|157317414|FG000|Overall Study|moved out of state|1|||
48857837|NCT03060525|157317415|FG001|Overall Study|moved out of state|1|||
48857838|NCT03060525|157317416|FG002|Overall Study|moved out of state|1|||
48857839|NCT03060525|157317417|FG003|Overall Study|moved out of state|1|||
48857840|NCT03060525|157317414|FG000|Overall Study|unable to meet time commitment required of study|2|||
48857841|NCT03060525|157317415|FG001|Overall Study|unable to meet time commitment required of study|3|||
48857842|NCT03060525|157317416|FG002|Overall Study|unable to meet time commitment required of study|3|||
48857843|NCT03060525|157317417|FG003|Overall Study|unable to meet time commitment required of study|1|||
48857844|NCT03060525|157317414|FG000|Overall Study|no longer interested in doing intervention|0|||
48857845|NCT03060525|157317415|FG001|Overall Study|no longer interested in doing intervention|0|||
48857846|NCT03060525|157317416|FG002|Overall Study|no longer interested in doing intervention|0|||
48857847|NCT03060525|157317417|FG003|Overall Study|no longer interested in doing intervention|1|||
48857848|NCT01429285|157317418|FG000|Overall Study|Protocol Violation|9|||
48857849|NCT01429285|157317419|FG001|Overall Study|Protocol Violation|4|||
48857850|NCT01429285|157317418|FG000|Overall Study|Missing Data|5|||
48952631|NCT01103349|157656400|FG002|Overall Study|Incorrectly included in the trial|0|||
48952632|NCT01103349|157656398|FG000|Overall Study|Withdrawal by Subject|1|||
48952633|NCT01103349|157656399|FG001|Overall Study|Withdrawal by Subject|1|||
48952634|NCT01103349|157656400|FG002|Overall Study|Withdrawal by Subject|0|||
48952635|NCT01103349|157656398|FG000|Overall Study|did not want to take trial medication|0|||
48952636|NCT01103349|157656399|FG001|Overall Study|did not want to take trial medication|1|||
48952637|NCT01103349|157656400|FG002|Overall Study|did not want to take trial medication|0|||
48745185|NCT00378378|156916161|FG001|Overall Study|Non-compliance with protocol|0|||
48745186|NCT00378378|156916162|FG002|Overall Study|Non-compliance with protocol|1|||
48745187|NCT00289991|156916165|FG000|Overall Study|Death|35|||
48745188|NCT00289991|156916166|FG001|Overall Study|Death|38|||
48745189|NCT00289991|156916165|FG000|Overall Study|Adverse Event|15|||
48745190|NCT00289991|156916166|FG001|Overall Study|Adverse Event|13|||
48745191|NCT00289991|156916165|FG000|Overall Study|Failure of prophylaxis|1|||
48857851|NCT01429285|157317419|FG001|Overall Study|Missing Data|3|||
48745192|NCT00289991|156916166|FG001|Overall Study|Failure of prophylaxis|1|||
48745193|NCT00289991|156916165|FG000|Overall Study|Fungal breakthrough infection|0|||
48952638|NCT01103349|157656398|FG000|Overall Study|forgot to take medication|0|||
48952639|NCT01103349|157656399|FG001|Overall Study|forgot to take medication|0|||
48952640|NCT01103349|157656400|FG002|Overall Study|forgot to take medication|1|||
48952641|NCT00390780|157656403|FG000|Overall Study|Not completed|10|||
48952642|NCT00390780|157656404|FG001|Overall Study|Not completed|4|||
48745194|NCT00289991|156916166|FG001|Overall Study|Fungal breakthrough infection|1|||
48745195|NCT00289991|156916165|FG000|Overall Study|Lost to Follow-up|0|||
48745196|NCT00289991|156916166|FG001|Overall Study|Lost to Follow-up|1|||
48745197|NCT00289991|156916165|FG000|Overall Study|Withdrawal by Subject|2|||
48745198|NCT00289991|156916166|FG001|Overall Study|Withdrawal by Subject|12|||
48745199|NCT00289991|156916165|FG000|Overall Study|Other|5|||
48745200|NCT00289991|156916166|FG001|Overall Study|Other|14|||
48745201|NCT01606007|156916167|FG000|Overall Study|Reason 'Other' in the protocol|0|||
48857852|NCT01429285|157317418|FG000|Overall Study|Erroneously Enrolled Twice|8|||
48857853|NCT01429285|157317419|FG001|Overall Study|Erroneously Enrolled Twice|2|||
48857854|NCT02340806|157317420|FG000|Overall Study|Protocol Violation|2|||
48857855|NCT02340806|157317421|FG001|Overall Study|Protocol Violation|0|||
48857856|NCT02340806|157317420|FG000|Overall Study|epidural catheter replaced|2|||
48857857|NCT02340806|157317421|FG001|Overall Study|epidural catheter replaced|1|||
48857858|NCT02340806|157317420|FG000|Overall Study|history of chronic pain medication|1|||
48857859|NCT02340806|157317421|FG001|Overall Study|history of chronic pain medication|0|||
48857860|NCT02340806|157317420|FG000|Overall Study|re-dose < 90 min of CSE|1|||
48857861|NCT02340806|157317421|FG001|Overall Study|re-dose < 90 min of CSE|3|||
48745202|NCT01606007|156916168|FG001|Overall Study|Reason 'Other' in the protocol|1|||
48857862|NCT00882050|157317426|FG000|Overall Study|Physician Decision|1|||
48952643|NCT00390780|157656403|FG000|Overall Study|Protocol Violation|6|||
48952644|NCT00390780|157656404|FG001|Overall Study|Protocol Violation|4|||
48745203|NCT01606007|156916169|FG002|Overall Study|Reason 'Other' in the protocol|1|||
48952645|NCT00390780|157656403|FG000|Overall Study|Lost to Follow-up|3|||
48857863|NCT00882050|157317427|FG001|Overall Study|Physician Decision|0|||
48857864|NCT00882050|157317428|FG002|Overall Study|Physician Decision|0|||
48857865|NCT01986348|157317429|FG000|Overall Study|Death|8|||
48857866|NCT01986348|157317430|FG001|Overall Study|Death|22|||
48857867|NCT01986348|157317431|FG002|Overall Study|Death|10|||
48857868|NCT01986348|157317432|FG003|Overall Study|Death|21|||
48857869|NCT01986348|157317429|FG000|Overall Study|Lost to Follow-up|0|||
48857870|NCT01986348|157317430|FG001|Overall Study|Lost to Follow-up|0|||
48857871|NCT01986348|157317431|FG002|Overall Study|Lost to Follow-up|0|||
48857872|NCT01986348|157317432|FG003|Overall Study|Lost to Follow-up|2|||
48857873|NCT01986348|157317429|FG000|Overall Study|Physician Decision|0|||
48857874|NCT01986348|157317430|FG001|Overall Study|Physician Decision|0|||
48857875|NCT01986348|157317431|FG002|Overall Study|Physician Decision|0|||
48857876|NCT01986348|157317432|FG003|Overall Study|Physician Decision|1|||
48857877|NCT01986348|157317429|FG000|Overall Study|Progressive Disease|0|||
48857878|NCT01986348|157317430|FG001|Overall Study|Progressive Disease|0|||
48857879|NCT01986348|157317431|FG002|Overall Study|Progressive Disease|2|||
48857880|NCT01986348|157317432|FG003|Overall Study|Progressive Disease|0|||
48857881|NCT01986348|157317429|FG000|Overall Study|Withdrawal by Participant|0|||
48857882|NCT01986348|157317430|FG001|Overall Study|Withdrawal by Participant|1|||
48857883|NCT01986348|157317431|FG002|Overall Study|Withdrawal by Participant|2|||
48857884|NCT01986348|157317432|FG003|Overall Study|Withdrawal by Participant|1|||
48857885|NCT01986348|157317429|FG000|Overall Study|Study Terminated by Sponsor|0|||
48857886|NCT01986348|157317430|FG001|Overall Study|Study Terminated by Sponsor|0|||
48857887|NCT01986348|157317431|FG002|Overall Study|Study Terminated by Sponsor|0|||
48857888|NCT01986348|157317432|FG003|Overall Study|Study Terminated by Sponsor|3|||
48857889|NCT01986348|157317429|FG000|Overall Study|Other-unspecified|0|||
48857890|NCT01986348|157317430|FG001|Overall Study|Other-unspecified|1|||
48857891|NCT01986348|157317431|FG002|Overall Study|Other-unspecified|0|||
48857892|NCT01986348|157317432|FG003|Overall Study|Other-unspecified|2|||
48857893|NCT01123200|157317433|FG000|Overall Study|Withdrawal by Subject|1|||
48857894|NCT01052714|157317434|FG000|Overall Study|Adverse Event|6|||
48857895|NCT01052714|157317435|FG001|Overall Study|Adverse Event|3|||
48857896|NCT01052714|157317436|FG002|Overall Study|Adverse Event|0|||
48857897|NCT01052714|157317434|FG000|Overall Study|Death|1|||
48857898|NCT01052714|157317435|FG001|Overall Study|Death|2|||
48857899|NCT01052714|157317436|FG002|Overall Study|Death|0|||
48857900|NCT01052714|157317434|FG000|Overall Study|Lost to Follow-up|2|||
48857901|NCT01052714|157317435|FG001|Overall Study|Lost to Follow-up|3|||
48857902|NCT01052714|157317436|FG002|Overall Study|Lost to Follow-up|0|||
48857903|NCT01052714|157317434|FG000|Overall Study|Physician Decision|9|||
48857904|NCT01052714|157317435|FG001|Overall Study|Physician Decision|9|||
48857905|NCT01052714|157317436|FG002|Overall Study|Physician Decision|1|||
48857906|NCT01052714|157317434|FG000|Overall Study|Withdrawal by Subject|7|||
48857907|NCT01052714|157317435|FG001|Overall Study|Withdrawal by Subject|12|||
48857908|NCT01052714|157317436|FG002|Overall Study|Withdrawal by Subject|1|||
48857909|NCT01517282|157317441|FG000|Overall Study|Consent withdrawn|0|||
48857910|NCT01517282|157317442|FG001|Overall Study|Consent withdrawn|1|||
48857911|NCT01517282|157317443|FG002|Overall Study|Consent withdrawn|1|||
48857912|NCT01517282|157317444|FG003|Overall Study|Consent withdrawn|1|||
48857913|NCT01517282|157317441|FG000|Overall Study|Physician Decision|1|||
48857914|NCT01517282|157317442|FG001|Overall Study|Physician Decision|0|||
48857915|NCT01517282|157317443|FG002|Overall Study|Physician Decision|0|||
48857916|NCT01517282|157317444|FG003|Overall Study|Physician Decision|0|||
48857917|NCT03242863|157317445|FG000|Study Week 1|Withdrawal by Subject|0|||
48857918|NCT03242863|157317446|FG001|Study Week 1|Withdrawal by Subject|1|||
48857919|NCT03242863|157317447|FG002|Study Week 1|Withdrawal by Subject|0|||
48857920|NCT03242863|157317448|FG003|Study Week 1|Withdrawal by Subject|0|||
48857921|NCT03242863|157317449|FG004|Study Week 1|Withdrawal by Subject|3|||
48857922|NCT03242863|157317450|FG005|Study Week 1|Withdrawal by Subject|0|||
48857923|NCT01186809|157317453|FG000|Overall Study|Death|30|||
48857924|NCT00383500|157317454|FG000|Overall Study|Withdrawal by Subject|8|||
48857925|NCT00383500|157317455|FG001|Overall Study|Withdrawal by Subject|3|||
48857926|NCT00383500|157317456|FG002|Overall Study|Withdrawal by Subject|0|||
48857927|NCT00383500|157317454|FG000|Overall Study|Lost to Follow-up|0|||
48857928|NCT00383500|157317455|FG001|Overall Study|Lost to Follow-up|0|||
48857929|NCT00383500|157317456|FG002|Overall Study|Lost to Follow-up|2|||
48745204|NCT01606007|156916167|FG000|Overall Study|Pregnancy|0|||
48857930|NCT02196259|157319168|FG000|Overall Study|Researcher choice|0|||
48857931|NCT02196259|157319169|FG001|Overall Study|Researcher choice|0|||
48857932|NCT02196259|157319170|FG002|Overall Study|Researcher choice|1|||
48857933|NCT02196259|157319168|FG000|Overall Study|Partial data analysis|0|||
48857934|NCT02196259|157319169|FG001|Overall Study|Partial data analysis|3|||
48857935|NCT02196259|157319170|FG002|Overall Study|Partial data analysis|0|||
48857936|NCT03823703|157319171|FG000|Overall Study|Sponsor request|0|||
48857937|NCT03823703|157319172|FG001|Overall Study|Sponsor request|3|||
48857938|NCT03823703|157319173|FG002|Overall Study|Sponsor request|4|||
48857939|NCT03823703|157319171|FG000|Overall Study|Adverse Event|3|||
48857940|NCT03823703|157319172|FG001|Overall Study|Adverse Event|1|||
48857941|NCT03823703|157319173|FG002|Overall Study|Adverse Event|0|||
48952646|NCT00390780|157656404|FG001|Overall Study|Lost to Follow-up|6|||
48952647|NCT00390780|157656403|FG000|Overall Study|Adverse Event|2|||
48745205|NCT01606007|156916168|FG001|Overall Study|Pregnancy|1|||
48745206|NCT01606007|156916169|FG002|Overall Study|Pregnancy|1|||
48745207|NCT01606007|156916167|FG000|Overall Study|Withdrawal by Subject|8|||
48745208|NCT01606007|156916168|FG001|Overall Study|Withdrawal by Subject|6|||
48745209|NCT01606007|156916169|FG002|Overall Study|Withdrawal by Subject|1|||
48745210|NCT01606007|156916167|FG000|Overall Study|Adverse Event|0|||
48745211|NCT01606007|156916168|FG001|Overall Study|Adverse Event|1|||
48745212|NCT01606007|156916169|FG002|Overall Study|Adverse Event|1|||
48745213|NCT01606007|156916167|FG000|Overall Study|discontinue study treatment|0|||
48745214|NCT01606007|156916168|FG001|Overall Study|discontinue study treatment|2|||
48745215|NCT01606007|156916169|FG002|Overall Study|discontinue study treatment|1|||
48745216|NCT01606007|156916167|FG000|Overall Study|Lost to Follow-up|6|||
48745217|NCT01606007|156916168|FG001|Overall Study|Lost to Follow-up|8|||
48745218|NCT01606007|156916169|FG002|Overall Study|Lost to Follow-up|5|||
48745219|NCT01606007|156916167|FG000|Overall Study|Poor/Non-compliance|1|||
48745220|NCT01606007|156916168|FG001|Overall Study|Poor/Non-compliance|0|||
48745221|NCT01606007|156916169|FG002|Overall Study|Poor/Non-compliance|0|||
48745222|NCT00119106|156916175|FG000|Overall Study|HIV infected at baseline|179|||
48745223|NCT00119106|156916176|FG001|Overall Study|HIV infected at baseline|178|||
48745224|NCT00730132|156916177|FG000|Overall Study|Protocol Violation|154|||
48745225|NCT00730132|156916177|FG000|Overall Study|Death|1|||
48745226|NCT02130570|156916178|FG000|Overall Study|Death|3|||
48857942|NCT03823703|157319171|FG000|Overall Study|Withdrawal by Subject|0|||
48857943|NCT03823703|157319172|FG001|Overall Study|Withdrawal by Subject|1|||
48857944|NCT03823703|157319173|FG002|Overall Study|Withdrawal by Subject|0|||
48857945|NCT02710669|157319176|FG000|Overall Study|Physician Decision|2|||
48857946|NCT02710669|157319177|FG001|Overall Study|Physician Decision|1|||
48857947|NCT02710669|157319178|FG002|Overall Study|Physician Decision|0|||
48857948|NCT02710669|157319176|FG000|Overall Study|Institutional delays (including COVID)|2|||
48857949|NCT02710669|157319177|FG001|Overall Study|Institutional delays (including COVID)|2|||
48857950|NCT02710669|157319178|FG002|Overall Study|Institutional delays (including COVID)|0|||
48857951|NCT02710669|157319176|FG000|Overall Study|arrived in afib/aflutter|10|||
48857952|NCT02710669|157319177|FG001|Overall Study|arrived in afib/aflutter|8|||
48857953|NCT02710669|157319178|FG002|Overall Study|arrived in afib/aflutter|2|||
48857954|NCT04323800|157319181|FG000|Overall Study|Withdrawal by Subject|4|||
48857955|NCT04323800|157319182|FG001|Overall Study|Withdrawal by Subject|4|||
48857956|NCT04323800|157319181|FG000|Overall Study|Incomplete transfusion|1|||
48857957|NCT04323800|157319182|FG001|Overall Study|Incomplete transfusion|0|||
48857958|NCT04323800|157319181|FG000|Overall Study|Other|0|||
48857959|NCT04323800|157319182|FG001|Overall Study|Other|1|||
48857960|NCT04323800|157319181|FG000|Overall Study|Positive RT-PCR at transfusion|1|||
48857961|NCT04323800|157319182|FG001|Overall Study|Positive RT-PCR at transfusion|1|||
48857962|NCT00489554|157319183|FG000|Overall Study|Adverse Event|2|||
48857963|NCT00489554|157319183|FG000|Overall Study|Withdrawal by Subject|1|||
48857964|NCT00489554|157319183|FG000|Overall Study|Lost to Follow-up|1|||
48857965|NCT00443820|157319184|FG000|Overall Study|Adverse Event|1|||
48857966|NCT00443820|157319185|FG001|Overall Study|Adverse Event|1|||
48857967|NCT00443820|157319186|FG002|Overall Study|Adverse Event|0|||
48857968|NCT00443820|157319187|FG003|Overall Study|Adverse Event|0|||
48857969|NCT00443820|157319184|FG000|Overall Study|Lack of Efficacy|3|||
48857970|NCT00443820|157319185|FG001|Overall Study|Lack of Efficacy|2|||
48857971|NCT00443820|157319186|FG002|Overall Study|Lack of Efficacy|1|||
48857972|NCT00443820|157319187|FG003|Overall Study|Lack of Efficacy|1|||
48857973|NCT00443820|157319184|FG000|Overall Study|Protocol Violation|2|||
48857974|NCT00443820|157319185|FG001|Overall Study|Protocol Violation|1|||
48857975|NCT00443820|157319186|FG002|Overall Study|Protocol Violation|2|||
48857976|NCT00443820|157319187|FG003|Overall Study|Protocol Violation|1|||
48857977|NCT00443820|157319184|FG000|Overall Study|Withdrawal by Subject|6|||
48857978|NCT00443820|157319185|FG001|Overall Study|Withdrawal by Subject|7|||
48857979|NCT00443820|157319186|FG002|Overall Study|Withdrawal by Subject|8|||
48857980|NCT00443820|157319187|FG003|Overall Study|Withdrawal by Subject|9|||
48857981|NCT00443820|157319184|FG000|Overall Study|Lost to Follow-up|9|||
48857982|NCT00443820|157319185|FG001|Overall Study|Lost to Follow-up|8|||
48857983|NCT00443820|157319186|FG002|Overall Study|Lost to Follow-up|6|||
48857984|NCT00443820|157319187|FG003|Overall Study|Lost to Follow-up|5|||
48857985|NCT00443820|157319184|FG000|Overall Study|Administrative problems|0|||
48857986|NCT00443820|157319185|FG001|Overall Study|Administrative problems|0|||
48857987|NCT00443820|157319186|FG002|Overall Study|Administrative problems|0|||
48857988|NCT00443820|157319187|FG003|Overall Study|Administrative problems|1|||
48857989|NCT00443820|157319184|FG000|Overall Study|Death|0|||
48857990|NCT00443820|157319185|FG001|Overall Study|Death|0|||
48857991|NCT00443820|157319186|FG002|Overall Study|Death|1|||
48857992|NCT00443820|157319187|FG003|Overall Study|Death|0|||
48857993|NCT00451906|157319188|FG000|Overall Study|Adverse Event|515|||
48857994|NCT00451906|157319188|FG000|Overall Study|Lost to Follow-up|31|||
48857995|NCT00451906|157319188|FG000|Overall Study|Withdrawal by Subject|111|||
48857996|NCT00451906|157319188|FG000|Overall Study|Protocol Violation|21|||
48857997|NCT00451906|157319188|FG000|Overall Study|Progressive disease|1328|||
48857998|NCT00451906|157319188|FG000|Overall Study|Termination of the study|108|||
48857999|NCT00451906|157319188|FG000|Overall Study|Other Reasons|121|||
48858000|NCT00451906|157319188|FG000|Overall Study|Did not complete final visit|4|||
48858001|NCT04633200|157319190|FG000|Overall Study|Lost to Follow-up|3|||
48858002|NCT04633200|157319191|FG001|Overall Study|Lost to Follow-up|5|||
48858003|NCT02713594|157319192|FG000|Overall Study|Withdrawal by Subject|32|||
48952648|NCT00390780|157656404|FG001|Overall Study|Adverse Event|3|||
48858004|NCT02713594|157319193|FG001|Overall Study|Withdrawal by Subject|22|||
48858005|NCT02713594|157319192|FG000|Overall Study|Lost to Follow-up|358|||
48858006|NCT02713594|157319193|FG001|Overall Study|Lost to Follow-up|374|||
48858007|NCT03493282|157319194|FG000|Primary Double-blind Study (180 Days)|Adverse Event|2|||
48858008|NCT03493282|157319195|FG001|Primary Double-blind Study (180 Days)|Adverse Event|2|||
48858009|NCT03493282|157319196|FG002|Primary Double-blind Study (180 Days)|Adverse Event|1|||
48858010|NCT03493282|157319194|FG000|Primary Double-blind Study (180 Days)|Subject Moved|1|||
48858011|NCT03493282|157319195|FG001|Primary Double-blind Study (180 Days)|Subject Moved|0|||
48858012|NCT03493282|157319196|FG002|Primary Double-blind Study (180 Days)|Subject Moved|0|||
48858013|NCT00413283|157319200|FG000|Overall Study|Withdrawal by Subject|1|||
48858014|NCT00413283|157319201|FG001|Overall Study|Withdrawal by Subject|0|||
48858015|NCT00413283|157319202|FG002|Overall Study|Withdrawal by Subject|0|||
48858016|NCT00413283|157319203|FG003|Overall Study|Withdrawal by Subject|1|||
48858017|NCT00413283|157319200|FG000|Overall Study|Death|0|||
48952649|NCT00390780|157656403|FG000|Overall Study|Death|1|||
48745227|NCT02130570|156916179|FG001|Overall Study|Death|5|||
48745228|NCT02130570|156916178|FG000|Overall Study|Withdrawal by Subject|6|||
48745229|NCT02130570|156916179|FG001|Overall Study|Withdrawal by Subject|3|||
48745230|NCT02130570|156916178|FG000|Overall Study|Part of practice that discontinued study|0|||
48745231|NCT02130570|156916179|FG001|Overall Study|Part of practice that discontinued study|5|||
48745232|NCT00329238|156916180|FG000|Overall Study|Adverse Event|147|||
48745233|NCT00329238|156916181|FG001|Overall Study|Adverse Event|129|||
48745234|NCT00329238|156916180|FG000|Overall Study|Protocol Violation|23|||
48745235|NCT00329238|156916181|FG001|Overall Study|Protocol Violation|34|||
48745236|NCT00329238|156916180|FG000|Overall Study|Lost to Follow-up|2|||
48745237|NCT00329238|156916181|FG001|Overall Study|Lost to Follow-up|6|||
48745238|NCT00329238|156916180|FG000|Overall Study|Withdrawal by Subject|64|||
48745239|NCT00329238|156916181|FG001|Overall Study|Withdrawal by Subject|58|||
48745240|NCT00329238|156916180|FG000|Overall Study|Other reason (not specified)|40|||
48745241|NCT00329238|156916181|FG001|Overall Study|Other reason (not specified)|54|||
48745242|NCT02099708|156916182|FG000|Overall Study|Data Not Available|30|||
48745243|NCT02099708|156916182|FG000|Overall Study|Lost to Follow-up|141|||
48745244|NCT02099708|156916182|FG000|Overall Study|Other|29|||
48745245|NCT00963937|156916191|FG000|Overall Study|Protocol Violation|1|||
48745246|NCT00963937|156916192|FG001|Overall Study|Protocol Violation|1|||
48745247|NCT00963937|156916193|FG002|Overall Study|Protocol Violation|0|||
48745248|NCT00963937|156916191|FG000|Overall Study|Physician Decision|18|||
48745249|NCT00963937|156916192|FG001|Overall Study|Physician Decision|10|||
48745250|NCT00963937|156916193|FG002|Overall Study|Physician Decision|4|||
48745251|NCT03385564|156916202|FG000|Overall Study|Adverse Event|0|||
48745252|NCT03385564|156916203|FG001|Overall Study|Adverse Event|0|||
48745253|NCT03385564|156916204|FG002|Overall Study|Adverse Event|3|||
48745254|NCT03385564|156916205|FG003|Overall Study|Adverse Event|3|||
48745255|NCT03385564|156916202|FG000|Overall Study|Other than listed|0|||
48745256|NCT03385564|156916203|FG001|Overall Study|Other than listed|0|||
48745257|NCT03385564|156916204|FG002|Overall Study|Other than listed|0|||
48745258|NCT03385564|156916205|FG003|Overall Study|Other than listed|5|||
48745259|NCT03385564|156916202|FG000|Overall Study|Withdrawal by Subject|0|||
48745260|NCT03385564|156916203|FG001|Overall Study|Withdrawal by Subject|1|||
48745261|NCT03385564|156916204|FG002|Overall Study|Withdrawal by Subject|1|||
48745262|NCT03385564|156916205|FG003|Overall Study|Withdrawal by Subject|0|||
48745263|NCT03385564|156916202|FG000|Overall Study|Lack of Efficacy|0|||
48745264|NCT03385564|156916203|FG001|Overall Study|Lack of Efficacy|0|||
48745265|NCT03385564|156916204|FG002|Overall Study|Lack of Efficacy|0|||
48745266|NCT03385564|156916205|FG003|Overall Study|Lack of Efficacy|1|||
48745267|NCT03385564|156916202|FG000|Overall Study|Death|0|||
48745268|NCT03385564|156916203|FG001|Overall Study|Death|0|||
48745269|NCT03385564|156916204|FG002|Overall Study|Death|1|||
48745270|NCT03385564|156916205|FG003|Overall Study|Death|0|||
48745271|NCT02256631|156916208|FG000|Overall Study|Lost to Follow-up|1|||
48745272|NCT02256631|156916209|FG001|Overall Study|Lost to Follow-up|1|||
48745273|NCT02256631|156916210|FG002|Overall Study|Lost to Follow-up|0|||
48745274|NCT02256631|156916211|FG003|Overall Study|Lost to Follow-up|2|||
48745275|NCT02256631|156916212|FG004|Overall Study|Lost to Follow-up|0|||
48745276|NCT02256631|156916213|FG005|Overall Study|Lost to Follow-up|4|||
48745277|NCT02256631|156916214|FG006|Overall Study|Lost to Follow-up|1|||
48745278|NCT02256631|156916208|FG000|Overall Study|Withdrawal by Subject|0|||
48745279|NCT02256631|156916209|FG001|Overall Study|Withdrawal by Subject|0|||
48745280|NCT02256631|156916210|FG002|Overall Study|Withdrawal by Subject|0|||
48745281|NCT02256631|156916211|FG003|Overall Study|Withdrawal by Subject|1|||
48745282|NCT02256631|156916212|FG004|Overall Study|Withdrawal by Subject|1|||
48745283|NCT02256631|156916213|FG005|Overall Study|Withdrawal by Subject|0|||
48745284|NCT02256631|156916214|FG006|Overall Study|Withdrawal by Subject|1|||
48745285|NCT02256631|156916208|FG000|Overall Study|Unable to get to clinic|0|||
48745286|NCT02256631|156916209|FG001|Overall Study|Unable to get to clinic|2|||
48745287|NCT02256631|156916210|FG002|Overall Study|Unable to get to clinic|0|||
48745288|NCT02256631|156916211|FG003|Overall Study|Unable to get to clinic|1|||
48745289|NCT02256631|156916212|FG004|Overall Study|Unable to get to clinic|0|||
48745290|NCT02256631|156916213|FG005|Overall Study|Unable to get to clinic|1|||
48745291|NCT02256631|156916214|FG006|Overall Study|Unable to get to clinic|2|||
48745292|NCT01427972|156916216|FG000|Treatment Period 1 (21 Days)|Protocol Violation|0|||
48745293|NCT01427972|156916217|FG001|Treatment Period 1 (21 Days)|Protocol Violation|0|||
48745294|NCT01427972|156916218|FG002|Treatment Period 1 (21 Days)|Protocol Violation|0|||
48745295|NCT01427972|156916219|FG003|Treatment Period 1 (21 Days)|Protocol Violation|0|||
48745296|NCT01427972|156916220|FG004|Treatment Period 1 (21 Days)|Protocol Violation|0|||
48745297|NCT01427972|156916221|FG005|Treatment Period 1 (21 Days)|Protocol Violation|0|||
48745298|NCT01427972|156916222|FG006|Treatment Period 1 (21 Days)|Protocol Violation|0|||
48745299|NCT01427972|156916223|FG007|Treatment Period 1 (21 Days)|Protocol Violation|1|||
48745300|NCT01427972|156916224|FG008|Treatment Period 1 (21 Days)|Protocol Violation|0|||
48745301|NCT01427972|156916225|FG009|Treatment Period 1 (21 Days)|Protocol Violation|0|||
48745302|NCT01427972|156916226|FG010|Treatment Period 1 (21 Days)|Protocol Violation|0|||
48952650|NCT00390780|157656404|FG001|Overall Study|Death|3|||
48858018|NCT00413283|157319201|FG001|Overall Study|Death|0|||
48858019|NCT00413283|157319202|FG002|Overall Study|Death|1|||
48858020|NCT00413283|157319203|FG003|Overall Study|Death|1|||
48858021|NCT00413283|157319200|FG000|Overall Study|Adverse Event|0|||
48858022|NCT00413283|157319201|FG001|Overall Study|Adverse Event|0|||
48858023|NCT00413283|157319202|FG002|Overall Study|Adverse Event|0|||
48858024|NCT00413283|157319203|FG003|Overall Study|Adverse Event|1|||
48858025|NCT00413283|157319200|FG000|Overall Study|Ineligibility determined|0|||
48858026|NCT00413283|157319201|FG001|Overall Study|Ineligibility determined|0|||
48858027|NCT00413283|157319202|FG002|Overall Study|Ineligibility determined|0|||
48858028|NCT00413283|157319203|FG003|Overall Study|Ineligibility determined|1|||
48858029|NCT00413283|157319200|FG000|Overall Study|Protocol deviation|0|||
48858030|NCT00413283|157319201|FG001|Overall Study|Protocol deviation|1|||
48858031|NCT00413283|157319202|FG002|Overall Study|Protocol deviation|0|||
48858032|NCT00413283|157319203|FG003|Overall Study|Protocol deviation|0|||
48858033|NCT00413283|157319200|FG000|Overall Study|Requirement for alternative therapy|0|||
48858034|NCT00413283|157319201|FG001|Overall Study|Requirement for alternative therapy|2|||
48858035|NCT00413283|157319202|FG002|Overall Study|Requirement for alternative therapy|0|||
48858036|NCT00413283|157319203|FG003|Overall Study|Requirement for alternative therapy|0|||
48858037|NCT00413283|157319200|FG000|Overall Study|Other|0|||
48858038|NCT00413283|157319201|FG001|Overall Study|Other|0|||
48858039|NCT00413283|157319202|FG002|Overall Study|Other|1|||
48858040|NCT00413283|157319203|FG003|Overall Study|Other|0|||
48858041|NCT02771366|157319204|FG000|Period 1|Withdrawal by Subject|0|||
48858042|NCT02771366|157319205|FG001|Period 1|Withdrawal by Subject|2|||
48858043|NCT02771366|157319204|FG000|Period 2 (Crossover)|Withdrawal by Subject|2|||
48858044|NCT02771366|157319205|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
48858045|NCT00671853|157319207|FG000|Overall Study|Lack of Efficacy|3|||
48858046|NCT00671853|157319208|FG001|Overall Study|Lack of Efficacy|7|||
48858047|NCT00671853|157319207|FG000|Overall Study|Adverse Event|7|||
48858048|NCT00671853|157319208|FG001|Overall Study|Adverse Event|1|||
48858049|NCT00671853|157319207|FG000|Overall Study|Withdrawal by Subject|1|||
48858050|NCT00671853|157319208|FG001|Overall Study|Withdrawal by Subject|5|||
48858051|NCT00671853|157319207|FG000|Overall Study|Lost to Follow-up|8|||
48858052|NCT00671853|157319208|FG001|Overall Study|Lost to Follow-up|8|||
48858053|NCT00671853|157319207|FG000|Overall Study|Physician Decision|0|||
48858054|NCT00671853|157319208|FG001|Overall Study|Physician Decision|2|||
48858055|NCT00671853|157319207|FG000|Overall Study|Non-adherence with study procedures|1|||
48858056|NCT00671853|157319208|FG001|Overall Study|Non-adherence with study procedures|4|||
48858057|NCT04328467|157319214|FG000|Overall Study|Did not meet inclusion criteria after randomization|4|||
48858058|NCT04328467|157319215|FG001|Overall Study|Did not meet inclusion criteria after randomization|2|||
48858059|NCT04328467|157319216|FG002|Overall Study|Did not meet inclusion criteria after randomization|1|||
48858060|NCT03265132|157319220|FG000|Overall Study|Adverse Event|0|||
48858061|NCT03265132|157319221|FG001|Overall Study|Adverse Event|1|||
48858062|NCT03265132|157319220|FG000|Overall Study|Lack of Efficacy|0|||
48858063|NCT03265132|157319221|FG001|Overall Study|Lack of Efficacy|2|||
48858064|NCT03265132|157319220|FG000|Overall Study|Progressive disease|0|||
48858065|NCT03265132|157319221|FG001|Overall Study|Progressive disease|2|||
48858066|NCT03265132|157319220|FG000|Overall Study|Withdrawal by Subject|0|||
48858067|NCT03265132|157319221|FG001|Overall Study|Withdrawal by Subject|1|||
48858068|NCT01670877|157319225|FG000|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
48858069|NCT01670877|157319226|FG001|Part I and Part 2|Grade 2 vomiting and progressive disease|1|||
48858070|NCT01670877|157319227|FG002|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
48858071|NCT01670877|157319228|FG003|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
48858072|NCT01670877|157319229|FG004|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
48858073|NCT01670877|157319230|FG005|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
48858074|NCT01670877|157319225|FG000|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
48858075|NCT01670877|157319226|FG001|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
48858076|NCT01670877|157319227|FG002|Part I and Part 2|Grade 3 diarrhea and withdrawal|1|||
48858077|NCT01670877|157319228|FG003|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
48858078|NCT01670877|157319229|FG004|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
48952651|NCT00390780|157656403|FG000|Overall Study|Withdrawal by Subject|1|||
48952652|NCT00390780|157656404|FG001|Overall Study|Withdrawal by Subject|2|||
48952653|NCT00390780|157656403|FG000|Overall Study|Inclusion criteria not satisfied|0|||
48858079|NCT01670877|157319230|FG005|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
48858080|NCT01670877|157319225|FG000|Part I and Part 2|Grade 2 vomiting|0|||
48858081|NCT01670877|157319226|FG001|Part I and Part 2|Grade 2 vomiting|0|||
48858082|NCT01670877|157319227|FG002|Part I and Part 2|Grade 2 vomiting|0|||
48858083|NCT01670877|157319228|FG003|Part I and Part 2|Grade 2 vomiting|1|||
48858084|NCT01670877|157319229|FG004|Part I and Part 2|Grade 2 vomiting|0|||
48858085|NCT01670877|157319230|FG005|Part I and Part 2|Grade 2 vomiting|0|||
48858086|NCT01670877|157319225|FG000|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
48858087|NCT01670877|157319226|FG001|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
48952654|NCT00390780|157656404|FG001|Overall Study|Inclusion criteria not satisfied|2|||
48858088|NCT01670877|157319227|FG002|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
48858089|NCT01670877|157319228|FG003|Part I and Part 2|Grade 3 dizziness and progressive disease|1|||
48858090|NCT01670877|157319229|FG004|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
48858091|NCT01670877|157319230|FG005|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
48858092|NCT01670877|157319225|FG000|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
48858093|NCT01670877|157319226|FG001|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
48858094|NCT01670877|157319227|FG002|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
48858095|NCT01670877|157319228|FG003|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|1|||
48858096|NCT01670877|157319229|FG004|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
48858097|NCT01670877|157319230|FG005|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
48858098|NCT00417885|157319231|FG000|Overall Study|Adverse Event|1|||
48858099|NCT00417885|157319231|FG000|Overall Study|Objective Progression or Relapse|3|||
49015365|NCT00306384|157892156|FG000|Overall Study|Lost to Follow-up|57|||
48745303|NCT01427972|156916227|FG011|Treatment Period 1 (21 Days)|Protocol Violation|0|||
48745304|NCT01427972|156916216|FG000|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
48745305|NCT01427972|156916217|FG001|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
48745306|NCT01427972|156916218|FG002|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
48745307|NCT01427972|156916219|FG003|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
48745308|NCT01427972|156916220|FG004|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
48745309|NCT01427972|156916221|FG005|Washout (at Least 28 Days)|Withdrawal by Subject|2|||
48745310|NCT01427972|156916222|FG006|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
48745311|NCT01427972|156916223|FG007|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
48745312|NCT01427972|156916224|FG008|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
48745313|NCT01427972|156916225|FG009|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
48745314|NCT01427972|156916226|FG010|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
48745315|NCT01427972|156916227|FG011|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
48745316|NCT01427972|156916216|FG000|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
48745317|NCT01427972|156916217|FG001|Treatment Period 2 (21 Days)|Withdrawal by Subject|1|||
48745318|NCT01427972|156916218|FG002|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
48745319|NCT01427972|156916219|FG003|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
48745320|NCT01427972|156916220|FG004|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
48858100|NCT00417885|157319231|FG000|Overall Study|Transferred to Another Sunitinib Study|2|||
48858101|NCT04739306|157319232|FG000|Main Study Period|Adverse Event|6|||
48858102|NCT04739306|157319233|FG001|Main Study Period|Adverse Event|7|||
48858103|NCT04739306|157319232|FG000|Main Study Period|Lost to Follow-up|4|||
48858104|NCT04739306|157319233|FG001|Main Study Period|Lost to Follow-up|6|||
48858105|NCT04739306|157319232|FG000|Main Study Period|Physician Decision|1|||
48858106|NCT04739306|157319233|FG001|Main Study Period|Physician Decision|1|||
48858107|NCT04739306|157319232|FG000|Main Study Period|Withdrawal by Subject|8|||
48858108|NCT04739306|157319233|FG001|Main Study Period|Withdrawal by Subject|6|||
48858109|NCT04739306|157319232|FG000|Main Study Period|Protocol Violation|0|||
48858110|NCT04739306|157319233|FG001|Main Study Period|Protocol Violation|1|||
48858111|NCT04739306|157319232|FG000|Main Study Period|War in Ukraine|1|||
48858112|NCT04739306|157319233|FG001|Main Study Period|War in Ukraine|1|||
48858113|NCT02037568|157319237|FG000|Overall Study|Withdrawal by Subject|17|||
48858114|NCT02037568|157319238|FG001|Overall Study|Withdrawal by Subject|24|||
48858115|NCT02037568|157319237|FG000|Overall Study|Lost to Follow-up|16|||
48858116|NCT02037568|157319238|FG001|Overall Study|Lost to Follow-up|13|||
48858117|NCT02037568|157319237|FG000|Overall Study|Screen Failure|3|||
48858118|NCT02037568|157319238|FG001|Overall Study|Screen Failure|1|||
48858119|NCT02037568|157319237|FG000|Overall Study|Patient did not receive transplant|0|||
48858120|NCT02037568|157319238|FG001|Overall Study|Patient did not receive transplant|1|||
48858121|NCT00096278|157319239|FG000|Overall Study|No follow-up data|15|||
48858122|NCT00096278|157319240|FG001|Overall Study|No follow-up data|18|||
48858123|NCT00096278|157319239|FG000|Overall Study|Patient not at risk for primary endpoint|3|||
48858124|NCT00096278|157319240|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
48858125|NCT03875729|157319247|FG000|Overall Study|Adverse Event|0|||
48858126|NCT03875729|157319248|FG001|Overall Study|Adverse Event|5|||
48858127|NCT03875729|157319247|FG000|Overall Study|Withdrawal by Subject|8|||
48858128|NCT03875729|157319248|FG001|Overall Study|Withdrawal by Subject|11|||
48858129|NCT03875729|157319247|FG000|Overall Study|Pregnancy|0|||
48858130|NCT03875729|157319248|FG001|Overall Study|Pregnancy|1|||
48858131|NCT03875729|157319247|FG000|Overall Study|Lost to Follow-up|0|||
48858132|NCT03875729|157319248|FG001|Overall Study|Lost to Follow-up|5|||
48858133|NCT03875729|157319247|FG000|Overall Study|Personal reasons|2|||
48858134|NCT03875729|157319248|FG001|Overall Study|Personal reasons|0|||
48858135|NCT04765046|157319249|FG000|Overall Study|Screen Failure|2|||
48858136|NCT04765046|157319249|FG000|Overall Study|Withdrawal by Subject|4|||
48858137|NCT04765046|157319249|FG000|Overall Study|Physician Decision|4|||
48858138|NCT04765046|157319249|FG000|Overall Study|Surgery Cancelled|8|||
48858139|NCT01029925|157319250|FG000|Completion of Cycle 1 (28 Days)|Death|2|||
48952655|NCT00390780|157656403|FG000|Overall Study|Lost to follow up and other reasons|0|||
48745321|NCT01427972|156916221|FG005|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
48858140|NCT01029925|157319250|FG000|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2|||
48858141|NCT01029925|157319250|FG000|Completion of Cycle 2 (56 Days)|off study due to disease progression|1|||
48858142|NCT01405508|157319251|FG000|Overall Study|AE, non-serious non-fatal|1|||
48952656|NCT00390780|157656404|FG001|Overall Study|Lost to follow up and other reasons|1|||
48952657|NCT00390780|157656403|FG000|Overall Study|Investigator decision, SAE, other reason|0|||
48952658|NCT00390780|157656404|FG001|Overall Study|Investigator decision, SAE, other reason|1|||
48952659|NCT00390780|157656403|FG000|Overall Study|SAE, death|0|||
48952660|NCT00390780|157656404|FG001|Overall Study|SAE, death|1|||
48952661|NCT02232516|157656405|FG000|Study Treatment Period: Cycles 1-3|Adverse Event|6|||
48952662|NCT02232516|157656405|FG000|Study Treatment Period: Cycles 1-3|Withdrawal by Subject|1|||
48952663|NCT02232516|157656405|FG000|Study Treatment Period: Cycles 1-3|No Response|1|||
48952664|NCT02232516|157656405|FG000|Study Treatment Period: Cycles 1-3|Screen failure|1|||
48952665|NCT02232516|157656405|FG000|Study Treatment Period: Cycles 1-3|Disease Progression|1|||
48952666|NCT02232516|157656405|FG000|Study Treatment Period: Cycles 4-6|Disease Progression|4|||
48952667|NCT02232516|157656405|FG000|Study Treatment Period: Cycles 4-6|Adverse Event|1|||
48952668|NCT02232516|157656405|FG000|Study Treatment Period: Cycles 4-6|Withdrawal by Subject|2|||
48952669|NCT02232516|157656405|FG000|Study Treatment Period: Cycles 7-9|Adverse Event|4|||
48952670|NCT02232516|157656405|FG000|Study Treatment Period: Cycles 7-9|Disease Progression|2|||
48952671|NCT02232516|157656405|FG000|Study Treatment Period: Cycles 7-9|Withdrawal by Subject|3|||
48952672|NCT02232516|157656405|FG000|Study Treatment Period: Cycles 7-9|Physician Decision|1|||
48952673|NCT02232516|157656405|FG000|Study Treatment Period: Cycles 10-12|Adverse Event|1|||
48952674|NCT02232516|157656405|FG000|Study Treatment Period: Cycles 10-12|Disease Progression|1|||
48952675|NCT02232516|157656405|FG000|Survival Follow-up|Death|15|||
48952676|NCT02232516|157656405|FG000|Survival Follow-up|Withdrawal by Subject|3|||
48952677|NCT02232516|157656405|FG000|Survival Follow-up|Lost to Follow-up|1|||
48952678|NCT02232516|157656405|FG000|Survival Follow-up|Still in follow-up|5|||
48952679|NCT02284906|157656412|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
48952680|NCT02284906|157656413|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
48952681|NCT02284906|157656414|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
48952682|NCT02284906|157656412|FG000|Overall Study|Major Protocol Deviation|0|||
48952683|NCT02284906|157656413|FG001|Overall Study|Major Protocol Deviation|1|||
48952684|NCT02284906|157656414|FG002|Overall Study|Major Protocol Deviation|0|||
48952685|NCT02284906|157656412|FG000|Overall Study|Voluntary Withdrawal|2|||
48952686|NCT02284906|157656413|FG001|Overall Study|Voluntary Withdrawal|4|||
48858143|NCT01405508|157319252|FG001|Overall Study|AE, non-serious non-fatal|1|||
48858144|NCT01405508|157319253|FG002|Overall Study|AE, non-serious non-fatal|0|||
48858145|NCT01405508|157319254|FG003|Overall Study|AE, non-serious non-fatal|0|||
48858146|NCT00476957|157319257|FG000|Overall Study|Lost to Follow-up|176|||
48858147|NCT00476957|157319258|FG001|Overall Study|Lost to Follow-up|193|||
48858148|NCT02516202|157319259|FG000|Overall Study|Withdrawal by Subject|1|||
48858149|NCT02516202|157319260|FG001|Overall Study|Withdrawal by Subject|0|||
48858150|NCT02516202|157319261|FG002|Overall Study|Withdrawal by Subject|1|||
48858151|NCT02516202|157319259|FG000|Overall Study|Lost to Follow-up|1|||
48858152|NCT02516202|157319260|FG001|Overall Study|Lost to Follow-up|1|||
48858153|NCT02516202|157319261|FG002|Overall Study|Lost to Follow-up|1|||
48858154|NCT02516202|157319259|FG000|Overall Study|Stopped Follow-up|0|||
48858155|NCT02516202|157319260|FG001|Overall Study|Stopped Follow-up|0|||
48858156|NCT02516202|157319261|FG002|Overall Study|Stopped Follow-up|1|||
48858157|NCT00529529|157319267|FG000|Overall Study|Adverse Event|12|||
48858158|NCT00529529|157319268|FG001|Overall Study|Adverse Event|17|||
48858159|NCT00529529|157319269|FG002|Overall Study|Adverse Event|8|||
48858160|NCT00529529|157319267|FG000|Overall Study|Subject withdrew consent|12|||
48858161|NCT00529529|157319268|FG001|Overall Study|Subject withdrew consent|9|||
48858162|NCT00529529|157319269|FG002|Overall Study|Subject withdrew consent|12|||
48858163|NCT00529529|157319267|FG000|Overall Study|Protocol deviation|8|||
48858164|NCT00529529|157319268|FG001|Overall Study|Protocol deviation|12|||
48858165|NCT00529529|157319269|FG002|Overall Study|Protocol deviation|5|||
48858166|NCT00529529|157319267|FG000|Overall Study|Lost to Follow-up|5|||
48858167|NCT00529529|157319268|FG001|Overall Study|Lost to Follow-up|3|||
48858168|NCT00529529|157319269|FG002|Overall Study|Lost to Follow-up|1|||
48858169|NCT00529529|157319267|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
48858170|NCT00529529|157319268|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
48858171|NCT00529529|157319269|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
48858172|NCT00529529|157319267|FG000|Overall Study|Death|2|||
48858173|NCT00529529|157319268|FG001|Overall Study|Death|0|||
48858174|NCT00529529|157319269|FG002|Overall Study|Death|0|||
48858175|NCT00529529|157319267|FG000|Overall Study|Abnormal test procedure result(s)|1|||
48858176|NCT00529529|157319268|FG001|Overall Study|Abnormal test procedure result(s)|0|||
48858177|NCT00529529|157319269|FG002|Overall Study|Abnormal test procedure result(s)|0|||
48858178|NCT00529529|157319267|FG000|Overall Study|Administrative problems|1|||
48952687|NCT02284906|157656414|FG002|Overall Study|Voluntary Withdrawal|5|||
48952688|NCT02284906|157656412|FG000|Overall Study|Study Termination|0|||
48952689|NCT02284906|157656413|FG001|Overall Study|Study Termination|11|||
48952690|NCT02284906|157656414|FG002|Overall Study|Study Termination|14|||
48952691|NCT02284906|157656412|FG000|Overall Study|Reason not Specified|1|||
48952692|NCT02284906|157656413|FG001|Overall Study|Reason not Specified|1|||
48858179|NCT00529529|157319268|FG001|Overall Study|Administrative problems|0|||
48952693|NCT02284906|157656414|FG002|Overall Study|Reason not Specified|0|||
48858180|NCT00529529|157319269|FG002|Overall Study|Administrative problems|3|||
48858181|NCT00409747|157319270|FG000|Overall Study|Withdrawal by Subject|1|||
48858182|NCT03979040|157319271|FG000|Overall Study|Withdrawal by Subject|24|||
48858183|NCT03979040|157319272|FG001|Overall Study|Withdrawal by Subject|32|||
48858184|NCT03979040|157319271|FG000|Overall Study|randomized but never started treatment|32|||
48952694|NCT01594476|157656415|FG000|Overall Study|Protocol Violation|1|||
48952695|NCT01594476|157656416|FG001|Overall Study|Protocol Violation|3|||
48952696|NCT01264965|157656427|FG000|Overall Study|Withdrawal by Subject|10|||
48952697|NCT01671488|157656428|FG000|Overall Study|Withdrawal by Subject|1|||
48952698|NCT01312428|157656429|FG000|Overall Study|Study Termination|3|||
48952699|NCT01312428|157656430|FG001|Overall Study|Study Termination|4|||
48952700|NCT02416908|157656431|FG000|Dose Escalation Phase|Adverse Event|0|||
48952701|NCT02416908|157656432|FG001|Dose Escalation Phase|Adverse Event|0|||
48952702|NCT02416908|157656433|FG002|Dose Escalation Phase|Adverse Event|3|||
48952703|NCT02416908|157656434|FG003|Dose Escalation Phase|Adverse Event|0|||
48745322|NCT01427972|156916222|FG006|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
48745323|NCT01427972|156916223|FG007|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
48745324|NCT01427972|156916224|FG008|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
48952704|NCT02416908|157656431|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
48952705|NCT02416908|157656432|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
48952706|NCT02416908|157656433|FG002|Dose Escalation Phase|Withdrawal by Subject|1|||
48952707|NCT02416908|157656434|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
48952708|NCT01106534|157656435|FG000|Overall Study|Withdrawal by Subject|18|||
48745325|NCT01427972|156916225|FG009|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
48745326|NCT01427972|156916226|FG010|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
48745327|NCT01427972|156916227|FG011|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
48745328|NCT00530946|156916231|FG000|Overall Study|Adverse Event|1|||
48745329|NCT00530946|156916232|FG001|Overall Study|Adverse Event|2|||
48858185|NCT03979040|157319272|FG001|Overall Study|randomized but never started treatment|39|||
48858186|NCT03979040|157319271|FG000|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|0|||
48858187|NCT03979040|157319272|FG001|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|1|||
48952709|NCT01106534|157656435|FG000|Overall Study|Lost to Follow-up|2|||
48952710|NCT01106534|157656435|FG000|Overall Study|Death|16|||
48952711|NCT01106534|157656435|FG000|Overall Study|Physician Decision|1|||
48952712|NCT03123939|157656436|FG000|Overall Study|Lack of Efficacy|6|||
48745330|NCT00530946|156916233|FG002|Overall Study|Adverse Event|1|||
48745331|NCT00530946|156916234|FG003|Overall Study|Adverse Event|1|||
48745332|NCT00530946|156916231|FG000|Overall Study|Protocol Violation|0|||
48745333|NCT00530946|156916232|FG001|Overall Study|Protocol Violation|0|||
48745334|NCT00530946|156916233|FG002|Overall Study|Protocol Violation|0|||
48745335|NCT00530946|156916234|FG003|Overall Study|Protocol Violation|1|||
48745336|NCT00530946|156916231|FG000|Overall Study|Noncompliance|1|||
48745337|NCT00530946|156916232|FG001|Overall Study|Noncompliance|0|||
48745338|NCT00530946|156916233|FG002|Overall Study|Noncompliance|0|||
48745339|NCT00530946|156916234|FG003|Overall Study|Noncompliance|0|||
48745340|NCT03322631|156916237|FG000|Overall Study|Withdrawal by Subject|0|||
48745341|NCT03322631|156916238|FG001|Overall Study|Withdrawal by Subject|1|||
48745342|NCT03322631|156916239|FG002|Overall Study|Withdrawal by Subject|0|||
48745343|NCT03322631|156916240|FG003|Overall Study|Withdrawal by Subject|0|||
48745344|NCT03322631|156916237|FG000|Overall Study|Adverse Event|0|||
48858188|NCT01916109|157319274|FG000|Overall Study|Withdrawal by Subject|1|||
48858189|NCT02691702|157319277|FG000|Overall Study|Adverse Event|1|||
48858190|NCT02691702|157319278|FG001|Overall Study|Adverse Event|0|||
48745345|NCT03322631|156916238|FG001|Overall Study|Adverse Event|0|||
48745346|NCT03322631|156916239|FG002|Overall Study|Adverse Event|1|||
48858191|NCT02691702|157319279|FG002|Overall Study|Adverse Event|0|||
48858192|NCT02691702|157319280|FG003|Overall Study|Adverse Event|0|||
48858193|NCT02691702|157319281|FG004|Overall Study|Adverse Event|0|||
48858194|NCT02691702|157319282|FG005|Overall Study|Adverse Event|0|||
48858195|NCT02691702|157319283|FG006|Overall Study|Adverse Event|0|||
48858196|NCT02691702|157319284|FG007|Overall Study|Adverse Event|0|||
48858197|NCT02691702|157319285|FG008|Overall Study|Adverse Event|1|||
48858198|NCT02691702|157319286|FG009|Overall Study|Adverse Event|0|||
48858199|NCT02691702|157319287|FG010|Overall Study|Adverse Event|1|||
48858200|NCT02691702|157319277|FG000|Overall Study|Lost to Follow-up|0|||
48858201|NCT02691702|157319278|FG001|Overall Study|Lost to Follow-up|0|||
48858202|NCT02691702|157319279|FG002|Overall Study|Lost to Follow-up|1|||
48858203|NCT02691702|157319280|FG003|Overall Study|Lost to Follow-up|0|||
48858204|NCT02691702|157319281|FG004|Overall Study|Lost to Follow-up|0|||
48858205|NCT02691702|157319282|FG005|Overall Study|Lost to Follow-up|2|||
48858206|NCT02691702|157319283|FG006|Overall Study|Lost to Follow-up|0|||
48858207|NCT02691702|157319284|FG007|Overall Study|Lost to Follow-up|0|||
48858208|NCT02691702|157319285|FG008|Overall Study|Lost to Follow-up|0|||
48858209|NCT02691702|157319286|FG009|Overall Study|Lost to Follow-up|0|||
48858210|NCT02691702|157319287|FG010|Overall Study|Lost to Follow-up|1|||
48858211|NCT02691702|157319277|FG000|Overall Study|Withdrawal by Subject|1|||
48858212|NCT02691702|157319278|FG001|Overall Study|Withdrawal by Subject|1|||
48858213|NCT02691702|157319279|FG002|Overall Study|Withdrawal by Subject|0|||
48858214|NCT02691702|157319280|FG003|Overall Study|Withdrawal by Subject|0|||
48858215|NCT02691702|157319281|FG004|Overall Study|Withdrawal by Subject|0|||
48858216|NCT02691702|157319282|FG005|Overall Study|Withdrawal by Subject|1|||
48858217|NCT02691702|157319283|FG006|Overall Study|Withdrawal by Subject|2|||
48858218|NCT02691702|157319284|FG007|Overall Study|Withdrawal by Subject|0|||
48858219|NCT02691702|157319285|FG008|Overall Study|Withdrawal by Subject|0|||
48858220|NCT02691702|157319286|FG009|Overall Study|Withdrawal by Subject|0|||
48858221|NCT02691702|157319287|FG010|Overall Study|Withdrawal by Subject|0|||
48858222|NCT02691702|157319277|FG000|Overall Study|Other|0|||
48858223|NCT02691702|157319278|FG001|Overall Study|Other|0|||
48858224|NCT02691702|157319279|FG002|Overall Study|Other|0|||
48745347|NCT03322631|156916240|FG003|Overall Study|Adverse Event|0|||
48858225|NCT02691702|157319280|FG003|Overall Study|Other|0|||
48745348|NCT02412618|156916241|FG000|Overall Study|Withdrawal by Subject|1|||
48745349|NCT02412618|156916242|FG001|Overall Study|Withdrawal by Subject|1|||
48745350|NCT02412618|156916241|FG000|Overall Study|Expulsion|1|||
48745351|NCT02412618|156916242|FG001|Overall Study|Expulsion|1|||
48745352|NCT02378961|156916243|FG000|Overall Study|Lack of Efficacy|4|||
48745353|NCT02378961|156916244|FG001|Overall Study|Lack of Efficacy|2|||
48745354|NCT02378961|156916245|FG002|Overall Study|Lack of Efficacy|0|||
48745355|NCT02378961|156916246|FG003|Overall Study|Lack of Efficacy|1|||
48745356|NCT02378961|156916243|FG000|Overall Study|Death|0|||
48745357|NCT02378961|156916244|FG001|Overall Study|Death|0|||
48952713|NCT03123939|157656436|FG000|Overall Study|Death|5|||
48952714|NCT03123939|157656436|FG000|Overall Study|Physician Decision|2|||
48745358|NCT02378961|156916245|FG002|Overall Study|Death|1|||
48952715|NCT03123939|157656436|FG000|Overall Study|Subject/guardian decision|2|||
48745359|NCT02378961|156916246|FG003|Overall Study|Death|0|||
48745360|NCT03943147|156916251|FG000|Open-Label MMF Run-in (Part A)|Other reasons|4|||
48745361|NCT03943147|156916252|FG001|Open-Label MMF Run-in (Part A)|Other reasons|0|||
48745362|NCT03943147|156916251|FG000|Open-Label MMF Run-in (Part A)|Adverse Event|1|||
48745363|NCT03943147|156916252|FG001|Open-Label MMF Run-in (Part A)|Adverse Event|0|||
48745364|NCT03943147|156916251|FG000|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|1|||
48745365|NCT03943147|156916252|FG001|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|0|||
48745366|NCT03943147|156916251|FG000|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|1|||
48745367|NCT03943147|156916252|FG001|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|0|||
48745368|NCT03943147|156916251|FG000|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|3|||
48745369|NCT03943147|156916252|FG001|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|0|||
48745370|NCT03943147|156916251|FG000|Blinded Treatment (Part B)|Study terminated by sponsor|3|||
48745371|NCT03943147|156916252|FG001|Blinded Treatment (Part B)|Study terminated by sponsor|0|||
48745372|NCT02784431|156916255|FG000|Overall Study|Unsuccessful Implant Attempt|1|||
48745373|NCT02784431|156916255|FG000|Overall Study|Early Study Termination|19|||
48745374|NCT00345839|156916257|FG000|Overall Study|Withdrawal by Subject|91|||
48745375|NCT00345839|156916258|FG001|Overall Study|Withdrawal by Subject|98|||
48745376|NCT00345839|156916257|FG000|Overall Study|Lost to Follow-up|58|||
48745377|NCT00345839|156916258|FG001|Overall Study|Lost to Follow-up|61|||
48745378|NCT02216591|156916261|FG000|Overall Study|Lost to Follow-up|0|||
48745379|NCT02216591|156916262|FG001|Overall Study|Lost to Follow-up|1|||
48745380|NCT02862171|156916263|FG000|Overall Study|Death|1|||
48745381|NCT02862171|156916263|FG000|Overall Study|Lost to Follow-up|13|||
48745382|NCT02862171|156916263|FG000|Overall Study|Withdrawal by Subject|57|||
48745383|NCT02862171|156916263|FG000|Overall Study|Non-compliance|4|||
48952716|NCT03123939|157656436|FG000|Overall Study|Lost to Follow-up|1|||
48952717|NCT03123939|157656436|FG000|Overall Study|New therapy for study indication|1|||
48952718|NCT03123939|157656436|FG000|Overall Study|Protocol deviation|1|||
48952719|NCT03123939|157656436|FG000|Overall Study|Progressive disease|18|||
48745384|NCT02862171|156916263|FG000|Overall Study|HIV-1 seroconversion|18|||
48745385|NCT02549937|156916264|FG000|Overall Study|Death|0|||
48745386|NCT02549937|156916265|FG001|Overall Study|Death|1|||
48745387|NCT02549937|156916266|FG002|Overall Study|Death|0|||
48952720|NCT03123939|157656436|FG000|Overall Study|Discontinued prior to CTL019 infusion due to death|4|||
48745388|NCT02549937|156916267|FG003|Overall Study|Death|1|||
48745389|NCT02549937|156916268|FG004|Overall Study|Death|0|||
48745390|NCT02549937|156916269|FG005|Overall Study|Death|8|||
48745391|NCT02549937|156916270|FG006|Overall Study|Death|0|||
48745392|NCT02549937|156916271|FG007|Overall Study|Death|0|||
48745393|NCT02549937|156916272|FG008|Overall Study|Death|19|||
48745394|NCT02549937|156916264|FG000|Overall Study|No follow up required|3|||
48745395|NCT02549937|156916265|FG001|Overall Study|No follow up required|6|||
48745396|NCT02549937|156916266|FG002|Overall Study|No follow up required|3|||
48745397|NCT02549937|156916267|FG003|Overall Study|No follow up required|8|||
48745398|NCT02549937|156916268|FG004|Overall Study|No follow up required|12|||
48745399|NCT02549937|156916269|FG005|Overall Study|No follow up required|21|||
48745400|NCT02549937|156916270|FG006|Overall Study|No follow up required|9|||
48745401|NCT02549937|156916271|FG007|Overall Study|No follow up required|11|||
48745402|NCT02549937|156916272|FG008|Overall Study|No follow up required|0|||
48745403|NCT02549937|156916264|FG000|Overall Study|Other|0|||
48745404|NCT02549937|156916265|FG001|Overall Study|Other|0|||
48745405|NCT02549937|156916266|FG002|Overall Study|Other|0|||
48745406|NCT02549937|156916267|FG003|Overall Study|Other|0|||
48745407|NCT02549937|156916268|FG004|Overall Study|Other|1|||
48858226|NCT02691702|157319281|FG004|Overall Study|Other|0|||
48858227|NCT02691702|157319282|FG005|Overall Study|Other|0|||
48858228|NCT02691702|157319283|FG006|Overall Study|Other|1|||
48745408|NCT02549937|156916269|FG005|Overall Study|Other|0|||
48745409|NCT02549937|156916270|FG006|Overall Study|Other|3|||
48745410|NCT02549937|156916271|FG007|Overall Study|Other|2|||
48745411|NCT02549937|156916272|FG008|Overall Study|Other|3|||
48745412|NCT02549937|156916264|FG000|Overall Study|Lost to Follow-up|0|||
48745413|NCT02549937|156916265|FG001|Overall Study|Lost to Follow-up|0|||
48745414|NCT02549937|156916266|FG002|Overall Study|Lost to Follow-up|0|||
48745415|NCT02549937|156916267|FG003|Overall Study|Lost to Follow-up|0|||
48745416|NCT02549937|156916268|FG004|Overall Study|Lost to Follow-up|0|||
48858229|NCT02691702|157319284|FG007|Overall Study|Other|0|||
48858230|NCT02691702|157319285|FG008|Overall Study|Other|1|||
48858231|NCT02691702|157319286|FG009|Overall Study|Other|0|||
48858232|NCT02691702|157319287|FG010|Overall Study|Other|0|||
48858233|NCT02691702|157319277|FG000|Overall Study|Protocol Violation|0|||
48745417|NCT02549937|156916269|FG005|Overall Study|Lost to Follow-up|0|||
48745418|NCT02549937|156916270|FG006|Overall Study|Lost to Follow-up|0|||
48745419|NCT02549937|156916271|FG007|Overall Study|Lost to Follow-up|0|||
48745420|NCT02549937|156916272|FG008|Overall Study|Lost to Follow-up|3|||
48745421|NCT02549937|156916264|FG000|Overall Study|Withdrawal by Subject|0|||
48745422|NCT02549937|156916265|FG001|Overall Study|Withdrawal by Subject|0|||
48745423|NCT02549937|156916266|FG002|Overall Study|Withdrawal by Subject|0|||
48745424|NCT02549937|156916267|FG003|Overall Study|Withdrawal by Subject|0|||
48745425|NCT02549937|156916268|FG004|Overall Study|Withdrawal by Subject|0|||
48745426|NCT02549937|156916269|FG005|Overall Study|Withdrawal by Subject|1|||
48745427|NCT02549937|156916270|FG006|Overall Study|Withdrawal by Subject|4|||
48745428|NCT02549937|156916271|FG007|Overall Study|Withdrawal by Subject|3|||
48745429|NCT02549937|156916272|FG008|Overall Study|Withdrawal by Subject|2|||
48745430|NCT02549937|156916264|FG000|Overall Study|Sponsor Decision|0|||
48745431|NCT02549937|156916265|FG001|Overall Study|Sponsor Decision|0|||
48745432|NCT02549937|156916266|FG002|Overall Study|Sponsor Decision|0|||
48745433|NCT02549937|156916267|FG003|Overall Study|Sponsor Decision|0|||
48745434|NCT02549937|156916268|FG004|Overall Study|Sponsor Decision|0|||
48745435|NCT02549937|156916269|FG005|Overall Study|Sponsor Decision|0|||
48745436|NCT02549937|156916270|FG006|Overall Study|Sponsor Decision|0|||
48745437|NCT02549937|156916271|FG007|Overall Study|Sponsor Decision|0|||
48745438|NCT02549937|156916272|FG008|Overall Study|Sponsor Decision|6|||
48745439|NCT05059600|156916275|FG000|Overall Study|Enrolled but not Treated|10|||
48745440|NCT01385566|156917930|FG000|Overall Study|Lost to Follow-up|1|||
48745441|NCT01385566|156917931|FG001|Overall Study|Lost to Follow-up|0|||
48745442|NCT01385566|156917932|FG002|Overall Study|Lost to Follow-up|0|||
48745443|NCT01385566|156917933|FG003|Overall Study|Lost to Follow-up|0|||
48745444|NCT01385566|156917934|FG004|Overall Study|Lost to Follow-up|0|||
48745445|NCT01385566|156917935|FG005|Overall Study|Lost to Follow-up|0|||
48745446|NCT01385566|156917930|FG000|Overall Study|Withdrawal by Subject|0|||
48745447|NCT01385566|156917931|FG001|Overall Study|Withdrawal by Subject|0|||
48745448|NCT01385566|156917932|FG002|Overall Study|Withdrawal by Subject|0|||
48745449|NCT01385566|156917933|FG003|Overall Study|Withdrawal by Subject|1|||
48745450|NCT01385566|156917934|FG004|Overall Study|Withdrawal by Subject|0|||
48745451|NCT01385566|156917935|FG005|Overall Study|Withdrawal by Subject|0|||
48745452|NCT02025621|156917936|FG000|Overall Study|Withdrawal by Subject|1|||
48745453|NCT02025621|156917937|FG001|Overall Study|Withdrawal by Subject|0|||
48745454|NCT02025621|156917936|FG000|Overall Study|Death|0|||
48745455|NCT02025621|156917937|FG001|Overall Study|Death|1|||
48745456|NCT02025621|156917936|FG000|Overall Study|No longer eligible|10|||
48745457|NCT02025621|156917937|FG001|Overall Study|No longer eligible|15|||
48745458|NCT02025621|156917936|FG000|Overall Study|Surgery initiated before infusion|3|||
48745459|NCT02025621|156917937|FG001|Overall Study|Surgery initiated before infusion|3|||
48745460|NCT01594281|156917938|FG000|Interventional Core Phase|Protocol Deviation|1|||
48745461|NCT01594281|156917939|FG001|Interventional Core Phase|Protocol Deviation|0|||
48745462|NCT01594281|156917940|FG002|Interventional Core Phase|Protocol Deviation|0|||
48745463|NCT01594281|156917938|FG000|Interventional Core Phase|Subject Withdrew Consent|0|||
48745464|NCT01594281|156917939|FG001|Interventional Core Phase|Subject Withdrew Consent|1|||
48745465|NCT01594281|156917940|FG002|Interventional Core Phase|Subject Withdrew Consent|1|||
48745466|NCT01594281|156917938|FG000|Interventional Core Phase|Death|1|||
48745467|NCT01594281|156917939|FG001|Interventional Core Phase|Death|1|||
48745468|NCT01594281|156917940|FG002|Interventional Core Phase|Death|2|||
48745469|NCT01594281|156917938|FG000|Interventional Core Phase|Lost to Follow-up|1|||
48745470|NCT01594281|156917939|FG001|Interventional Core Phase|Lost to Follow-up|4|||
48745471|NCT01594281|156917940|FG002|Interventional Core Phase|Lost to Follow-up|1|||
48745472|NCT01594281|156917938|FG000|Interventional Core Phase|Adverse Event|4|||
48745473|NCT01594281|156917939|FG001|Interventional Core Phase|Adverse Event|4|||
48745474|NCT01594281|156917940|FG002|Interventional Core Phase|Adverse Event|4|||
48745475|NCT01594281|156917938|FG000|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
48745476|NCT01594281|156917939|FG001|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
48745477|NCT01594281|156917940|FG002|Non-Interventional Follow Up Phase|Lost to Follow-up|0|||
48745478|NCT01594281|156917938|FG000|Non-Interventional Follow Up Phase|Administrative Problems|0|||
48745479|NCT01594281|156917939|FG001|Non-Interventional Follow Up Phase|Administrative Problems|0|||
48745480|NCT01594281|156917940|FG002|Non-Interventional Follow Up Phase|Administrative Problems|1|||
48745481|NCT01594281|156917938|FG000|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
48745482|NCT01594281|156917939|FG001|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0|||
48745483|NCT01594281|156917940|FG002|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
48745484|NCT01673867|156917941|FG000|Randomization|Adverse event unrelated to study drug|1|||
48745485|NCT01673867|156917942|FG001|Randomization|Adverse event unrelated to study drug|0|||
48745486|NCT01673867|156917941|FG000|Randomization|Participant request to discontinue study treatment|0|||
48745487|NCT01673867|156917942|FG001|Randomization|Participant request to discontinue study treatment|4|||
48745488|NCT01673867|156917941|FG000|Randomization|Withdrawal by participant|0|||
48745489|NCT01673867|156917942|FG001|Randomization|Withdrawal by participant|12|||
48745490|NCT01673867|156917941|FG000|Randomization|Lost to Follow-up|0|||
48745491|NCT01673867|156917942|FG001|Randomization|Lost to Follow-up|1|||
48745492|NCT01673867|156917941|FG000|Randomization|Participant no longer meets study criteria|4|||
48745493|NCT01673867|156917942|FG001|Randomization|Participant no longer meets study criteria|5|||
48858234|NCT02691702|157319278|FG001|Overall Study|Protocol Violation|0|||
48745494|NCT01673867|156917941|FG000|Treatment|Disease Progression|208|||
48745495|NCT01673867|156917942|FG001|Treatment|Disease Progression|178|||
48745496|NCT01673867|156917941|FG000|Treatment|Study Drug Toxicity|23|||
48745497|NCT01673867|156917942|FG001|Treatment|Study Drug Toxicity|43|||
48745498|NCT01673867|156917941|FG000|Treatment|Death|2|||
48858235|NCT02691702|157319279|FG002|Overall Study|Protocol Violation|0|||
48858236|NCT02691702|157319280|FG003|Overall Study|Protocol Violation|0|||
48858237|NCT02691702|157319281|FG004|Overall Study|Protocol Violation|0|||
48858238|NCT02691702|157319282|FG005|Overall Study|Protocol Violation|0|||
48858239|NCT02691702|157319283|FG006|Overall Study|Protocol Violation|0|||
48858240|NCT02691702|157319284|FG007|Overall Study|Protocol Violation|0|||
48858241|NCT02691702|157319285|FG008|Overall Study|Protocol Violation|0|||
48858242|NCT02691702|157319286|FG009|Overall Study|Protocol Violation|2|||
48858243|NCT02691702|157319287|FG010|Overall Study|Protocol Violation|0|||
48858244|NCT02279732|157319290|FG000|Overall Study|Death|23|||
48858245|NCT02279732|157319291|FG001|Overall Study|Death|20|||
48858246|NCT02279732|157319290|FG000|Overall Study|Disease Progression|13|||
48858247|NCT02279732|157319291|FG001|Overall Study|Disease Progression|3|||
48858248|NCT02279732|157319290|FG000|Overall Study|Withdrawal by Subject|2|||
48858249|NCT02279732|157319291|FG001|Overall Study|Withdrawal by Subject|7|||
48858250|NCT02279732|157319290|FG000|Overall Study|Adverse Event|1|||
48858251|NCT02279732|157319291|FG001|Overall Study|Adverse Event|2|||
48858252|NCT02279732|157319290|FG000|Overall Study|Administrative Reason By Sponsor|0|||
48858253|NCT02279732|157319291|FG001|Overall Study|Administrative Reason By Sponsor|2|||
48858254|NCT02279732|157319290|FG000|Overall Study|Study Drug Toxicity|2|||
48858255|NCT02279732|157319291|FG001|Overall Study|Study Drug Toxicity|0|||
48858256|NCT02279732|157319290|FG000|Overall Study|Lost to Follow-up|0|||
48858257|NCT02279732|157319291|FG001|Overall Study|Lost to Follow-up|1|||
48858258|NCT02279732|157319290|FG000|Overall Study|Maximum Clinical Benefit|1|||
48858259|NCT02279732|157319291|FG001|Overall Study|Maximum Clinical Benefit|0|||
48858260|NCT02279732|157319290|FG000|Overall Study|Subject Requested to Discontinue|0|||
48858261|NCT02279732|157319291|FG001|Overall Study|Subject Requested to Discontinue|1|||
48858262|NCT02279732|157319290|FG000|Overall Study|Other|53|||
48858263|NCT02279732|157319291|FG001|Overall Study|Other|67|||
48858264|NCT02279732|157319290|FG000|Overall Study|Other|3|||
48858265|NCT02279732|157319291|FG001|Overall Study|Other|3|||
48858266|NCT02203513|157319294|FG000|Overall Study|Refused further treatment|2|||
48858267|NCT02203513|157319295|FG001|Overall Study|Refused further treatment|0|||
48858268|NCT02203513|157319296|FG002|Overall Study|Refused further treatment|1|||
48858269|NCT02203513|157319297|FG003|Overall Study|Refused further treatment|0|||
48858270|NCT02203513|157319298|FG004|Overall Study|Refused further treatment|0|||
48858271|NCT02203513|157319294|FG000|Overall Study|Switched to alternative treatment|3|||
48858272|NCT02203513|157319295|FG001|Overall Study|Switched to alternative treatment|4|||
48858273|NCT02203513|157319296|FG002|Overall Study|Switched to alternative treatment|0|||
48952721|NCT03123939|157656436|FG000|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1|||
48952722|NCT01455428|157656442|FG000|Overall Study|Protocol Violation|2|||
48952723|NCT01455428|157656443|FG001|Overall Study|Protocol Violation|1|||
48952724|NCT01455428|157656442|FG000|Overall Study|Adverse Event|6|||
48952725|NCT01455428|157656443|FG001|Overall Study|Adverse Event|2|||
48952726|NCT01455428|157656442|FG000|Overall Study|Lost to Follow-up|1|||
48952727|NCT01455428|157656443|FG001|Overall Study|Lost to Follow-up|1|||
48745499|NCT01673867|156917942|FG001|Treatment|Death|3|||
48745500|NCT01673867|156917941|FG000|Treatment|Adverse event unrelated to study drug|23|||
48952728|NCT01455428|157656442|FG000|Overall Study|Withdrawal by Subject|2|||
48858274|NCT02203513|157319297|FG003|Overall Study|Switched to alternative treatment|0|||
48858275|NCT02203513|157319298|FG004|Overall Study|Switched to alternative treatment|4|||
48858276|NCT02203513|157319294|FG000|Overall Study|Did not receive investigational product (IP)|0|||
48858277|NCT02203513|157319295|FG001|Overall Study|Did not receive investigational product (IP)|1|||
48858278|NCT02203513|157319296|FG002|Overall Study|Did not receive investigational product (IP)|0|||
48858279|NCT02203513|157319297|FG003|Overall Study|Did not receive investigational product (IP)|0|||
48858280|NCT02203513|157319298|FG004|Overall Study|Did not receive investigational product (IP)|0|||
48858281|NCT02203513|157319294|FG000|Overall Study|Death (unrelated to study therapy)|1|||
48858282|NCT02203513|157319295|FG001|Overall Study|Death (unrelated to study therapy)|3|||
48952729|NCT01455428|157656443|FG001|Overall Study|Withdrawal by Subject|5|||
48745501|NCT01673867|156917942|FG001|Treatment|Adverse event unrelated to study drug|10|||
48745502|NCT01673867|156917941|FG000|Treatment|Participant request to discontinue study treatment|7|||
48745503|NCT01673867|156917942|FG001|Treatment|Participant request to discontinue study treatment|17|||
48745504|NCT01673867|156917941|FG000|Treatment|Withdrawal by participant|5|||
48858283|NCT02203513|157319296|FG002|Overall Study|Death (unrelated to study therapy)|1|||
48858284|NCT02203513|157319297|FG003|Overall Study|Death (unrelated to study therapy)|0|||
48858285|NCT02203513|157319298|FG004|Overall Study|Death (unrelated to study therapy)|2|||
48858286|NCT02203513|157319294|FG000|Overall Study|Lost to Follow-up|0|||
48858287|NCT02203513|157319295|FG001|Overall Study|Lost to Follow-up|0|||
48858288|NCT02203513|157319296|FG002|Overall Study|Lost to Follow-up|1|||
48858289|NCT02203513|157319297|FG003|Overall Study|Lost to Follow-up|1|||
48858290|NCT02203513|157319298|FG004|Overall Study|Lost to Follow-up|0|||
48858291|NCT01441596|157319299|FG000|Overall Study|Other reason not defined below|0|||
48858292|NCT01441596|157319300|FG001|Overall Study|Other reason not defined below|2|||
48858293|NCT01441596|157319301|FG002|Overall Study|Other reason not defined below|1|||
48858294|NCT01441596|157319299|FG000|Overall Study|Withdrawal by Subject|4|||
48858295|NCT01441596|157319300|FG001|Overall Study|Withdrawal by Subject|0|||
48858296|NCT01441596|157319301|FG002|Overall Study|Withdrawal by Subject|2|||
48858297|NCT01441596|157319299|FG000|Overall Study|Not treated|0|||
48858298|NCT01441596|157319300|FG001|Overall Study|Not treated|1|||
48858299|NCT01441596|157319301|FG002|Overall Study|Not treated|1|||
48858300|NCT01670526|157319302|FG000|Overall Study|Withdrawal by Subject|3|||
48858301|NCT01670526|157319303|FG001|Overall Study|Withdrawal by Subject|1|||
48858302|NCT01670526|157319302|FG000|Overall Study|Lost to Follow-up|9|||
48858303|NCT01670526|157319303|FG001|Overall Study|Lost to Follow-up|5|||
48858304|NCT03953079|157319304|FG000|Core Study|Withdrawal by Subject|1|||
48858305|NCT03953079|157319305|FG001|Core Study|Withdrawal by Subject|2|||
48858306|NCT03953079|157319306|FG002|Core Study|Withdrawal by Subject|1|||
48858307|NCT03953079|157319304|FG000|Core Study|COVID-19|0|||
48858308|NCT03953079|157319305|FG001|Core Study|COVID-19|1|||
48858309|NCT03953079|157319306|FG002|Core Study|COVID-19|0|||
48745505|NCT01673867|156917942|FG001|Treatment|Withdrawal by participant|5|||
48745506|NCT01673867|156917941|FG000|Treatment|Maximum clinical benefit|1|||
48745507|NCT01673867|156917942|FG001|Treatment|Maximum clinical benefit|10|||
48745508|NCT01673867|156917941|FG000|Treatment|Participant no longer meets study criteria|2|||
48745509|NCT01673867|156917942|FG001|Treatment|Participant no longer meets study criteria|0|||
48858310|NCT03953079|157319304|FG000|Core Study|Difficulties leaving the house|0|||
48858311|NCT03953079|157319305|FG001|Core Study|Difficulties leaving the house|1|||
48858312|NCT03953079|157319306|FG002|Core Study|Difficulties leaving the house|0|||
48858313|NCT03953079|157319304|FG000|Extension Study|Withdrawal by Subject|1|||
48858314|NCT03953079|157319305|FG001|Extension Study|Withdrawal by Subject|0|||
48858315|NCT03953079|157319306|FG002|Extension Study|Withdrawal by Subject|0|||
48858316|NCT03953079|157319304|FG000|Extension Study|Received Rescue Treatment|5|||
48858317|NCT03953079|157319305|FG001|Extension Study|Received Rescue Treatment|6|||
48858318|NCT03953079|157319306|FG002|Extension Study|Received Rescue Treatment|5|||
48858319|NCT02291549|157319307|FG000|Overall Study|Lost to Follow-up|1|||
48858320|NCT02291549|157319308|FG001|Overall Study|Lost to Follow-up|0|||
48858321|NCT02291549|157319307|FG000|Overall Study|Withdrawal by Subject|0|||
48858322|NCT02291549|157319308|FG001|Overall Study|Withdrawal by Subject|1|||
48858323|NCT03019289|157319309|FG000|Overall Study|Adverse Event|1|||
48745510|NCT01673867|156917941|FG000|Treatment|Administrative reason by sponsor|3|||
48745511|NCT01673867|156917942|FG001|Treatment|Administrative reason by sponsor|0|||
48745512|NCT01673867|156917941|FG000|Treatment|Other reason|11|||
48858324|NCT03019289|157319310|FG001|Overall Study|Adverse Event|0|||
48858325|NCT03019289|157319311|FG002|Overall Study|Adverse Event|0|||
48858326|NCT03019289|157319312|FG003|Overall Study|Adverse Event|0|||
48745513|NCT01673867|156917942|FG001|Treatment|Other reason|2|||
48745514|NCT01977794|156917943|FG000|Overall Study|Adverse Event|2|||
48858327|NCT03019289|157319313|FG004|Overall Study|Adverse Event|0|||
48858328|NCT03019289|157319314|FG005|Overall Study|Adverse Event|0|||
48858329|NCT03019289|157319315|FG006|Overall Study|Adverse Event|0|||
48952730|NCT01455428|157656442|FG000|Overall Study|Did not meet entrance criteria|0|||
48952731|NCT01455428|157656443|FG001|Overall Study|Did not meet entrance criteria|2|||
48952732|NCT01455428|157656442|FG000|Overall Study|Insufficient clinical response|0|||
48952733|NCT01455428|157656443|FG001|Overall Study|Insufficient clinical response|2|||
48952734|NCT01455428|157656442|FG000|Overall Study|Did not receive treatment|1|||
48952735|NCT01455428|157656443|FG001|Overall Study|Did not receive treatment|1|||
48952736|NCT01455428|157656442|FG000|Overall Study|Other|2|||
48952737|NCT01455428|157656443|FG001|Overall Study|Other|4|||
48952738|NCT00301067|157656444|FG000|Completed DLT Period/1st Cycle|Progressive Disease|1|||
48952739|NCT00301067|157656445|FG001|Completed DLT Period/1st Cycle|Progressive Disease|0|||
48952740|NCT00301067|157656446|FG002|Completed DLT Period/1st Cycle|Progressive Disease|0|||
48952741|NCT00301067|157656447|FG003|Completed DLT Period/1st Cycle|Progressive Disease|1|||
48952742|NCT00301067|157656444|FG000|Reached 1st Response/2 Cycles|Progressive Disease|2|||
48952743|NCT00301067|157656445|FG001|Reached 1st Response/2 Cycles|Progressive Disease|1|||
48952744|NCT00301067|157656446|FG002|Reached 1st Response/2 Cycles|Progressive Disease|1|||
48952745|NCT00301067|157656447|FG003|Reached 1st Response/2 Cycles|Progressive Disease|2|||
48952746|NCT00301067|157656444|FG000|Completed 4 Cycles of Treatment|Progressive disease|1|||
48952747|NCT00301067|157656445|FG001|Completed 4 Cycles of Treatment|Progressive disease|1|||
48952748|NCT00301067|157656446|FG002|Completed 4 Cycles of Treatment|Progressive disease|2|||
48952749|NCT00301067|157656447|FG003|Completed 4 Cycles of Treatment|Progressive disease|5|||
48952750|NCT00301067|157656444|FG000|Completed 12 Cycles of Treatment|Progressive Disease|0|||
48952751|NCT00301067|157656445|FG001|Completed 12 Cycles of Treatment|Progressive Disease|1|||
48952752|NCT00301067|157656446|FG002|Completed 12 Cycles of Treatment|Progressive Disease|0|||
48952753|NCT00301067|157656447|FG003|Completed 12 Cycles of Treatment|Progressive Disease|1|||
48952754|NCT00301067|157656444|FG000|Completed 12 Cycles of Treatment|Adverse Event|0|||
48952755|NCT00301067|157656445|FG001|Completed 12 Cycles of Treatment|Adverse Event|0|||
48952756|NCT00301067|157656446|FG002|Completed 12 Cycles of Treatment|Adverse Event|0|||
48952757|NCT00301067|157656447|FG003|Completed 12 Cycles of Treatment|Adverse Event|1|||
48952758|NCT00301067|157656444|FG000|Follow up Until Death|Alive at last data cut point|1|||
48952759|NCT00301067|157656445|FG001|Follow up Until Death|Alive at last data cut point|0|||
48952760|NCT00301067|157656446|FG002|Follow up Until Death|Alive at last data cut point|0|||
48952761|NCT00301067|157656447|FG003|Follow up Until Death|Alive at last data cut point|1|||
48952762|NCT00942877|157656450|FG000|Overall Study|Refused further treatment|1|||
48952763|NCT00942877|157656451|FG001|Overall Study|Refused further treatment|1|||
48952764|NCT00942877|157656450|FG000|Overall Study|Patient was not treated|1|||
48952765|NCT00942877|157656451|FG001|Overall Study|Patient was not treated|0|||
48952766|NCT00942877|157656450|FG000|Overall Study|Adverse Event|1|||
48952767|NCT00942877|157656451|FG001|Overall Study|Adverse Event|0|||
48952768|NCT00942877|157656450|FG000|Overall Study|Progressive disease|42|||
48952769|NCT00942877|157656451|FG001|Overall Study|Progressive disease|3|||
48952770|NCT00844428|157656453|FG000|Screening Period|Screen Failure|3|||
48952771|NCT00844428|157656453|FG000|Extension Treatment Period|Death|1|||
48952772|NCT00844428|157656453|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
48952773|NCT02691247|157656454|FG000|Overall Study|Withdrawal by Subject|1|||
48952774|NCT02691247|157656455|FG001|Overall Study|Withdrawal by Subject|2|||
48952775|NCT02691247|157656456|FG002|Overall Study|Withdrawal by Subject|2|||
48952776|NCT02691247|157656454|FG000|Overall Study|Lost to Follow-up|2|||
48952777|NCT02691247|157656455|FG001|Overall Study|Lost to Follow-up|0|||
48952778|NCT02691247|157656456|FG002|Overall Study|Lost to Follow-up|1|||
48952779|NCT02552355|157656459|FG000|Overall Study|Adverse Event|0|||
48952780|NCT02552355|157656460|FG001|Overall Study|Adverse Event|2|||
48952781|NCT02552355|157656461|FG002|Overall Study|Adverse Event|2|||
48952782|NCT02552355|157656462|FG003|Overall Study|Adverse Event|0|||
48952783|NCT02552355|157656459|FG000|Overall Study|Withdrawal by Subject|0|||
48952784|NCT02552355|157656460|FG001|Overall Study|Withdrawal by Subject|0|||
48952785|NCT02552355|157656461|FG002|Overall Study|Withdrawal by Subject|0|||
48745515|NCT01977794|156917944|FG001|Overall Study|Adverse Event|2|||
48952786|NCT02552355|157656462|FG003|Overall Study|Withdrawal by Subject|1|||
48952787|NCT02538666|157656465|FG000|Pre-Treatment|Disease progression|1|||
48745516|NCT01977794|156917943|FG000|Overall Study|Lost to Follow-up|2|||
49015366|NCT00306384|157892157|FG001|Overall Study|Lost to Follow-up|41|||
48745517|NCT01977794|156917944|FG001|Overall Study|Lost to Follow-up|1|||
48745518|NCT01977794|156917943|FG000|Overall Study|Protocol Violation|1|||
48745519|NCT01977794|156917944|FG001|Overall Study|Protocol Violation|0|||
48745520|NCT01977794|156917943|FG000|Overall Study|Death|1|||
48745521|NCT01977794|156917944|FG001|Overall Study|Death|1|||
48745522|NCT01977794|156917943|FG000|Overall Study|Withdrew consent|2|||
48745523|NCT01977794|156917944|FG001|Overall Study|Withdrew consent|1|||
48745524|NCT01977794|156917943|FG000|Overall Study|Other|0|||
48745525|NCT01977794|156917944|FG001|Overall Study|Other|1|||
48745526|NCT04115839|156917947|FG000|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
48745527|NCT04115839|156917948|FG001|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|13|||
48745528|NCT04115839|156917949|FG002|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
48745529|NCT04115839|156917950|FG003|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
48745530|NCT04115839|156917951|FG004|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
48745531|NCT04115839|156917952|FG005|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
48745532|NCT04115839|156917953|FG006|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
48745533|NCT04115839|156917947|FG000|Main Study (Up to 16 Weeks)|Withdrew Consent|2|||
48745534|NCT04115839|156917948|FG001|Main Study (Up to 16 Weeks)|Withdrew Consent|1|||
48745535|NCT04115839|156917949|FG002|Main Study (Up to 16 Weeks)|Withdrew Consent|3|||
48745536|NCT04115839|156917950|FG003|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
48745537|NCT04115839|156917951|FG004|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
48745538|NCT04115839|156917952|FG005|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
48745539|NCT04115839|156917953|FG006|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
48745540|NCT04115839|156917947|FG000|Main Study (Up to 16 Weeks)|Adverse Event|2|||
48858330|NCT03019289|157319316|FG007|Overall Study|Adverse Event|0|||
48858331|NCT03019289|157319317|FG008|Overall Study|Adverse Event|1|||
48858332|NCT03019289|157319309|FG000|Overall Study|Other|1|||
48858333|NCT03019289|157319310|FG001|Overall Study|Other|0|||
48858334|NCT03019289|157319311|FG002|Overall Study|Other|0|||
48858335|NCT03019289|157319312|FG003|Overall Study|Other|0|||
48858336|NCT03019289|157319313|FG004|Overall Study|Other|0|||
48858337|NCT03019289|157319314|FG005|Overall Study|Other|0|||
48858338|NCT03019289|157319315|FG006|Overall Study|Other|0|||
48745541|NCT04115839|156917948|FG001|Main Study (Up to 16 Weeks)|Adverse Event|0|||
48745542|NCT04115839|156917949|FG002|Main Study (Up to 16 Weeks)|Adverse Event|0|||
48745543|NCT04115839|156917950|FG003|Main Study (Up to 16 Weeks)|Adverse Event|0|||
48745544|NCT04115839|156917951|FG004|Main Study (Up to 16 Weeks)|Adverse Event|0|||
48745545|NCT04115839|156917952|FG005|Main Study (Up to 16 Weeks)|Adverse Event|0|||
48745546|NCT04115839|156917953|FG006|Main Study (Up to 16 Weeks)|Adverse Event|0|||
48745547|NCT04115839|156917947|FG000|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
48745548|NCT04115839|156917948|FG001|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
48745549|NCT04115839|156917949|FG002|Main Study (Up to 16 Weeks)|Investigator's Discretion|1|||
48745550|NCT04115839|156917950|FG003|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
48745551|NCT04115839|156917951|FG004|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
48745552|NCT04115839|156917952|FG005|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
48745553|NCT04115839|156917953|FG006|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
48745554|NCT04115839|156917947|FG000|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
48745555|NCT04115839|156917948|FG001|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
48745556|NCT04115839|156917949|FG002|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
48745557|NCT04115839|156917950|FG003|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|17|||
48745558|NCT04115839|156917951|FG004|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|19|||
48745559|NCT04115839|156917952|FG005|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|10|||
48745560|NCT04115839|156917953|FG006|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|8|||
48745561|NCT04115839|156917947|FG000|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
48745562|NCT04115839|156917948|FG001|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
48745563|NCT04115839|156917949|FG002|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
48745564|NCT04115839|156917950|FG003|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
48745565|NCT04115839|156917951|FG004|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
48745566|NCT04115839|156917952|FG005|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
48745567|NCT04115839|156917953|FG006|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
48745568|NCT00506662|156917954|FG000|Overall Study|Adverse Event|0|||
48745569|NCT00506662|156917955|FG001|Overall Study|Adverse Event|2|||
48745570|NCT00506662|156917954|FG000|Overall Study|Lack of Efficacy|1|||
48745571|NCT00506662|156917955|FG001|Overall Study|Lack of Efficacy|0|||
48745572|NCT00506662|156917954|FG000|Overall Study|Protocol Violation|2|||
48745573|NCT00506662|156917955|FG001|Overall Study|Protocol Violation|4|||
48745574|NCT00506662|156917954|FG000|Overall Study|Trial terminated|10|||
48745575|NCT00506662|156917955|FG001|Overall Study|Trial terminated|16|||
48745576|NCT00506662|156917954|FG000|Overall Study|Not recorded|4|||
48745577|NCT00506662|156917955|FG001|Overall Study|Not recorded|6|||
48745578|NCT00491075|156917956|FG000|Overall Study|Withdrawal by Subject|1|||
48745579|NCT00491075|156917956|FG000|Overall Study|Physician Decision|1|||
48745580|NCT04160195|156917957|FG000|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|1|||
48745581|NCT04160195|156917958|FG001|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|0|||
48745582|NCT01731990|156917959|FG000|Overall Study|Adverse Event|1|||
48745583|NCT01731990|156917960|FG001|Overall Study|Adverse Event|5|||
48745584|NCT01731990|156917959|FG000|Overall Study|Withdrawal by Subject|1|||
48745585|NCT01731990|156917960|FG001|Overall Study|Withdrawal by Subject|1|||
48745586|NCT01731990|156917959|FG000|Overall Study|Protocol deviation|1|||
48745587|NCT01731990|156917960|FG001|Overall Study|Protocol deviation|2|||
48745588|NCT01731990|156917959|FG000|Overall Study|Death|1|||
48745589|NCT01731990|156917960|FG001|Overall Study|Death|0|||
48745590|NCT00064337|156917961|FG000|PBSCC or Induction/PBSCC|Not protocol-specified|7|||
48745591|NCT00064337|156917961|FG000|PBSCC or Induction/PBSCC|Adverse Event|6|||
48858339|NCT03019289|157319316|FG007|Overall Study|Other|0|||
48858340|NCT03019289|157319317|FG008|Overall Study|Other|0|||
48858341|NCT00537914|157319318|FG000|Overall Study|Death|1|||
48858342|NCT00537914|157319318|FG000|Overall Study|Adverse Event|7|||
48745592|NCT00064337|156917961|FG000|PBSCC or Induction/PBSCC|Progression|3|||
48745593|NCT00064337|156917961|FG000|PBSCC or Induction/PBSCC|Patient Refusal|2|||
48745594|NCT00064337|156917961|FG000|PBSCC or Induction/PBSCC|Death|2|||
48745595|NCT00064337|156917961|FG000|Transplant|Adverse Event|9|||
48745596|NCT00064337|156917961|FG000|Transplant|Not protocol-specified|5|||
48745597|NCT00064337|156917961|FG000|Transplant|Death|3|||
48745598|NCT00064337|156917961|FG000|Transplant|Patient Refusal|2|||
48745599|NCT00064337|156917961|FG000|Transplant|Progression|2|||
48745600|NCT00064337|156917961|FG000|Maintenance|Adverse Event|3|||
48745601|NCT00064337|156917961|FG000|Maintenance|Progression|2|||
48745602|NCT00064337|156917961|FG000|Maintenance|On treatment at time of analysis|2|||
48745603|NCT00064337|156917961|FG000|Maintenance|Not protocol-specified|2|||
48745604|NCT00064337|156917961|FG000|Maintenance|Death|1|||
48745605|NCT00790023|156917962|FG000|Overall Study|Adverse Event|2|||
48745606|NCT00790023|156917963|FG001|Overall Study|Adverse Event|1|||
48745607|NCT00790023|156917964|FG002|Overall Study|Adverse Event|4|||
48745608|NCT00790023|156917962|FG000|Overall Study|Protocol Violation|2|||
48745609|NCT00790023|156917963|FG001|Overall Study|Protocol Violation|4|||
48745610|NCT00790023|156917964|FG002|Overall Study|Protocol Violation|2|||
48745611|NCT00790023|156917962|FG000|Overall Study|Withdrawal by Subject|2|||
48745612|NCT00790023|156917963|FG001|Overall Study|Withdrawal by Subject|0|||
48745613|NCT00790023|156917964|FG002|Overall Study|Withdrawal by Subject|6|||
48745614|NCT00790023|156917962|FG000|Overall Study|Lost to Follow-up|0|||
48745615|NCT00790023|156917963|FG001|Overall Study|Lost to Follow-up|0|||
48745616|NCT00790023|156917964|FG002|Overall Study|Lost to Follow-up|1|||
48745617|NCT00790023|156917962|FG000|Overall Study|Other|5|||
48745618|NCT00790023|156917963|FG001|Overall Study|Other|5|||
48745619|NCT00790023|156917964|FG002|Overall Study|Other|8|||
48745620|NCT01603355|156917968|FG000|Overall Study|Lack of Efficacy|2|||
48745621|NCT00660023|156917971|FG000|Overall Study|Adverse Event|2|||
48745622|NCT00660023|156917971|FG000|Overall Study|Death|8|||
48745623|NCT00660023|156917971|FG000|Overall Study|Blood Transfusion|5|||
48745624|NCT00660023|156917971|FG000|Overall Study|Renal Transplantation|3|||
48745625|NCT00660023|156917971|FG000|Overall Study|Withdrawal by Subject|1|||
48745626|NCT00660023|156917971|FG000|Overall Study|Missed Pregnancy Test|1|||
48745627|NCT00660023|156917971|FG000|Overall Study|Other Screening Failure|9|||
48745628|NCT03217175|156917972|FG000|Overall Study|Physician Decision|4|||
48745629|NCT03217175|156917973|FG001|Overall Study|Physician Decision|1|||
48745630|NCT00297830|156917974|FG000|6 Month Visit|Death|1|||
48745631|NCT00297830|156917975|FG001|6 Month Visit|Death|0|||
48745632|NCT00297830|156917976|FG002|6 Month Visit|Death|2|||
48745633|NCT00297830|156917974|FG000|6 Month Visit|Withdrawal by Subject|2|||
48745634|NCT00297830|156917975|FG001|6 Month Visit|Withdrawal by Subject|1|||
48745635|NCT00297830|156917976|FG002|6 Month Visit|Withdrawal by Subject|1|||
48745636|NCT00297830|156917974|FG000|6 Month Visit|Adverse Event|0|||
48745637|NCT00297830|156917975|FG001|6 Month Visit|Adverse Event|1|||
48745638|NCT00297830|156917976|FG002|6 Month Visit|Adverse Event|0|||
48858343|NCT00537914|157319318|FG000|Overall Study|Treatment failure|10|||
48858344|NCT00537914|157319318|FG000|Overall Study|patients documented other as reason for study discontinuation|16|||
48858345|NCT00537914|157319318|FG000|Overall Study|Lost to Follow-up|19|||
48745639|NCT00297830|156917974|FG000|12 Month Visit|Lost to Follow-up|1|||
48745640|NCT00297830|156917975|FG001|12 Month Visit|Lost to Follow-up|0|||
48745641|NCT00297830|156917976|FG002|12 Month Visit|Lost to Follow-up|0|||
48745642|NCT00297830|156917974|FG000|12 Month Visit|Adverse Event|0|||
48745643|NCT00297830|156917975|FG001|12 Month Visit|Adverse Event|3|||
48745644|NCT00297830|156917976|FG002|12 Month Visit|Adverse Event|0|||
48745645|NCT00297830|156917974|FG000|12 Month Visit|Withdrawal by Subject|0|||
48745646|NCT00297830|156917975|FG001|12 Month Visit|Withdrawal by Subject|3|||
48745647|NCT00297830|156917976|FG002|12 Month Visit|Withdrawal by Subject|0|||
48745648|NCT01001377|156917977|FG000|Overall Study|Ineligibility determined|2|||
48745649|NCT01001377|156917978|FG001|Overall Study|Ineligibility determined|0|||
48745650|NCT01001377|156917977|FG000|Overall Study|Withdrawal by Subject|19|||
48745651|NCT01001377|156917978|FG001|Overall Study|Withdrawal by Subject|20|||
48745652|NCT01001377|156917977|FG000|Overall Study|Lost to Follow-up|14|||
48745653|NCT01001377|156917978|FG001|Overall Study|Lost to Follow-up|17|||
48745654|NCT01001377|156917977|FG000|Overall Study|Death|391|||
48745655|NCT01001377|156917978|FG001|Overall Study|Death|384|||
48745656|NCT01537393|156917990|FG000|Overall Study|Exclude prior to study|32|||
48745657|NCT01537393|156917991|FG001|Overall Study|Exclude prior to study|44|||
48745658|NCT01537393|156917990|FG000|Overall Study|Death|20|||
48745659|NCT01537393|156917991|FG001|Overall Study|Death|32|||
48858346|NCT00537914|157319318|FG000|Overall Study|Withdrawal of informed consent|59|||
48858347|NCT00655824|157319320|FG000|Overall Study|Adverse Event|3|||
48858348|NCT00655824|157319320|FG000|Overall Study|Early Termination of Study by Sponsor|74|||
48858349|NCT00655824|157319320|FG000|Overall Study|Protocol Violation|1|||
48858350|NCT00655824|157319320|FG000|Overall Study|Withdrawal by Subject|4|||
48858351|NCT00655824|157319320|FG000|Overall Study|Deterioration of Trial Disease|2|||
48858352|NCT00589628|157319321|FG000|Overall Study|Lost to Follow-up|0|||
48858353|NCT00589628|157319322|FG001|Overall Study|Lost to Follow-up|1|||
48858354|NCT02923349|157319323|FG000|Overall Study|Other|1|||
48858355|NCT02923349|157319324|FG001|Overall Study|Other|2|||
48858356|NCT02923349|157319325|FG002|Overall Study|Other|4|||
48858357|NCT02923349|157319326|FG003|Overall Study|Other|1|||
48858358|NCT02923349|157319327|FG004|Overall Study|Other|3|||
48858359|NCT02923349|157319328|FG005|Overall Study|Other|0|||
48858360|NCT02923349|157319329|FG006|Overall Study|Other|1|||
48858361|NCT02923349|157319323|FG000|Overall Study|Withdrawal by Subject|2|||
48952788|NCT02538666|157656466|FG001|Pre-Treatment|Disease progression|0|||
48952789|NCT02538666|157656467|FG002|Pre-Treatment|Disease progression|0|||
48858362|NCT02923349|157319324|FG001|Overall Study|Withdrawal by Subject|2|||
48858363|NCT02923349|157319325|FG002|Overall Study|Withdrawal by Subject|8|||
48858364|NCT02923349|157319326|FG003|Overall Study|Withdrawal by Subject|10|||
48858365|NCT02923349|157319327|FG004|Overall Study|Withdrawal by Subject|12|||
48858366|NCT02923349|157319328|FG005|Overall Study|Withdrawal by Subject|3|||
48858367|NCT02923349|157319329|FG006|Overall Study|Withdrawal by Subject|0|||
48858368|NCT02923349|157319323|FG000|Overall Study|Physician Decision|0|||
48858369|NCT02923349|157319324|FG001|Overall Study|Physician Decision|0|||
48858370|NCT02923349|157319325|FG002|Overall Study|Physician Decision|0|||
48858371|NCT02923349|157319326|FG003|Overall Study|Physician Decision|1|||
48858372|NCT02923349|157319327|FG004|Overall Study|Physician Decision|1|||
48858373|NCT02923349|157319328|FG005|Overall Study|Physician Decision|0|||
48858374|NCT02923349|157319329|FG006|Overall Study|Physician Decision|2|||
48858375|NCT02923349|157319323|FG000|Overall Study|Lost to Follow-up|0|||
48858376|NCT02923349|157319324|FG001|Overall Study|Lost to Follow-up|0|||
48858377|NCT02923349|157319325|FG002|Overall Study|Lost to Follow-up|3|||
48858378|NCT02923349|157319326|FG003|Overall Study|Lost to Follow-up|0|||
48858379|NCT02923349|157319327|FG004|Overall Study|Lost to Follow-up|1|||
48858380|NCT02923349|157319328|FG005|Overall Study|Lost to Follow-up|1|||
48858381|NCT02923349|157319329|FG006|Overall Study|Lost to Follow-up|0|||
48858382|NCT02923349|157319323|FG000|Overall Study|Death|1|||
48858383|NCT02923349|157319324|FG001|Overall Study|Death|0|||
48858384|NCT02923349|157319325|FG002|Overall Study|Death|2|||
48952790|NCT02538666|157656465|FG000|Pre-Treatment|no longer meets study criteria|1|||
48952791|NCT02538666|157656466|FG001|Pre-Treatment|no longer meets study criteria|0|||
48858385|NCT02923349|157319326|FG003|Overall Study|Death|4|||
48858386|NCT02923349|157319327|FG004|Overall Study|Death|2|||
48858387|NCT02923349|157319328|FG005|Overall Study|Death|3|||
48858388|NCT02923349|157319329|FG006|Overall Study|Death|0|||
48858389|NCT01334606|157319330|FG000|Overall Study|Study Terminated due to slow enrolment|18|||
48858390|NCT00508144|157319331|FG000|Overall Study|Not eligible|6|||
48858391|NCT00508144|157319331|FG000|Overall Study|Death|5|||
48858392|NCT01945086|157319336|FG000|Overall Study|Withdrawal by Subject|1|||
48858393|NCT01945086|157319337|FG001|Overall Study|Withdrawal by Subject|0|||
48858394|NCT01945086|157319338|FG002|Overall Study|Withdrawal by Subject|1|||
48858395|NCT01945086|157319336|FG000|Overall Study|Adverse Event|0|||
48858396|NCT01945086|157319337|FG001|Overall Study|Adverse Event|0|||
48858397|NCT01945086|157319338|FG002|Overall Study|Adverse Event|1|||
48858398|NCT03769090|157320949|FG000|Overall Study|Randomized and did not receive randomized study treatment|1|||
48858399|NCT03769090|157320950|FG001|Overall Study|Randomized and did not receive randomized study treatment|2|||
48858400|NCT03769090|157320951|FG002|Overall Study|Randomized and did not receive randomized study treatment|2|||
48858401|NCT03769090|157320949|FG000|Overall Study|Withdrawal by Subject|52|||
48858402|NCT03769090|157320950|FG001|Overall Study|Withdrawal by Subject|62|||
48858403|NCT03769090|157320951|FG002|Overall Study|Withdrawal by Subject|74|||
48858404|NCT03769090|157320949|FG000|Overall Study|Death|4|||
48858405|NCT03769090|157320950|FG001|Overall Study|Death|2|||
48858406|NCT03769090|157320951|FG002|Overall Study|Death|2|||
48858407|NCT03769090|157320949|FG000|Overall Study|Adverse Event|7|||
48858408|NCT03769090|157320950|FG001|Overall Study|Adverse Event|7|||
48858409|NCT03769090|157320951|FG002|Overall Study|Adverse Event|8|||
48858410|NCT03769090|157320949|FG000|Overall Study|A single severe exacerbation event lasting >20 days|0|||
48858411|NCT03769090|157320950|FG001|Overall Study|A single severe exacerbation event lasting >20 days|1|||
48858412|NCT03769090|157320951|FG002|Overall Study|A single severe exacerbation event lasting >20 days|2|||
48858413|NCT03769090|157320949|FG000|Overall Study|>= 3 severe exacerbation events within a 3 month period|1|||
48858414|NCT03769090|157320950|FG001|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
48858415|NCT03769090|157320951|FG002|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
48858416|NCT03769090|157320949|FG000|Overall Study|>= 5 total severe exacerbation events|0|||
48858417|NCT03769090|157320950|FG001|Overall Study|>= 5 total severe exacerbation events|1|||
48858418|NCT03769090|157320951|FG002|Overall Study|>= 5 total severe exacerbation events|1|||
48745660|NCT01537393|156917990|FG000|Overall Study|Withdrawal by Subject|18|||
48745661|NCT01537393|156917991|FG001|Overall Study|Withdrawal by Subject|17|||
48745662|NCT01537393|156917990|FG000|Overall Study|Lost to Follow-up|53|||
48745663|NCT01537393|156917991|FG001|Overall Study|Lost to Follow-up|48|||
48745664|NCT01537393|156917990|FG000|Overall Study|Failure - Regrafted|28|||
48745665|NCT01537393|156917991|FG001|Overall Study|Failure - Regrafted|43|||
48745666|NCT01537393|156917990|FG000|Overall Study|Failure - Not regrafted|2|||
48745667|NCT01537393|156917991|FG001|Overall Study|Failure - Not regrafted|6|||
48745668|NCT01537393|156917990|FG000|Overall Study|Censored (severe event unrelated to PT)|1|||
48745669|NCT01537393|156917991|FG001|Overall Study|Censored (severe event unrelated to PT)|1|||
48745670|NCT01578187|156917992|FG000|Usability Phase|Withdrawal by Subject|1|||
48745671|NCT02197520|156917993|FG000|Period 1|Withdrawal by Subject|1|||
48745672|NCT02197520|156917994|FG001|Period 1|Withdrawal by Subject|0|||
48745673|NCT02197520|156917993|FG000|Period 2|Adverse Event|0|||
48745674|NCT02197520|156917994|FG001|Period 2|Adverse Event|2|||
48745675|NCT02197520|156917993|FG000|Period 2|Withdrawal by Subject|1|||
48745676|NCT02197520|156917994|FG001|Period 2|Withdrawal by Subject|0|||
48745677|NCT00913497|156917995|FG000|Overall Study|Adverse Event|1|||
48745678|NCT00913497|156917995|FG000|Overall Study|Withdrawal by Subject|2|||
48745679|NCT01306942|156917996|FG000|Phase I|Adverse Event|2|||
48745680|NCT01306942|156917997|FG001|Phase I|Adverse Event|2|||
48745681|NCT01306942|156917998|FG002|Phase I|Adverse Event|0|||
48745682|NCT01306942|156917999|FG003|Phase I|Adverse Event|0|||
48745683|NCT01306942|156917996|FG000|Phase I|Physician Decision|3|||
48745684|NCT01306942|156917997|FG001|Phase I|Physician Decision|1|||
48745685|NCT01306942|156917998|FG002|Phase I|Physician Decision|0|||
48745686|NCT01306942|156917999|FG003|Phase I|Physician Decision|0|||
48745687|NCT01306942|156917996|FG000|Phase II|Adverse Event|0|||
48745688|NCT01306942|156917997|FG001|Phase II|Adverse Event|0|||
48745689|NCT01306942|156917998|FG002|Phase II|Adverse Event|0|||
48745690|NCT01306942|156917999|FG003|Phase II|Adverse Event|6|||
48745691|NCT01306942|156917996|FG000|Phase II|Physician Decision|2|||
48745692|NCT01306942|156917997|FG001|Phase II|Physician Decision|0|||
48745693|NCT01306942|156917998|FG002|Phase II|Physician Decision|0|||
48745694|NCT01306942|156917999|FG003|Phase II|Physician Decision|5|||
48745695|NCT01306942|156917996|FG000|Phase II|Withdrawal by Subject|0|||
48745696|NCT01306942|156917997|FG001|Phase II|Withdrawal by Subject|0|||
48745697|NCT01306942|156917998|FG002|Phase II|Withdrawal by Subject|0|||
48745698|NCT01306942|156917999|FG003|Phase II|Withdrawal by Subject|2|||
48745699|NCT01306942|156917996|FG000|Phase II|Death|0|||
48745700|NCT01306942|156917997|FG001|Phase II|Death|0|||
48745701|NCT01306942|156917998|FG002|Phase II|Death|0|||
48745702|NCT01306942|156917999|FG003|Phase II|Death|1|||
48745703|NCT01306942|156917996|FG000|Phase II|Not finished treatment|0|||
48745704|NCT01306942|156917997|FG001|Phase II|Not finished treatment|0|||
48745705|NCT01306942|156917998|FG002|Phase II|Not finished treatment|0|||
48745706|NCT01306942|156917999|FG003|Phase II|Not finished treatment|1|||
48745707|NCT01306942|156917996|FG000|Phase II|Protocol Violation|0|||
48745708|NCT01306942|156917997|FG001|Phase II|Protocol Violation|0|||
48745709|NCT01306942|156917998|FG002|Phase II|Protocol Violation|0|||
48745710|NCT01306942|156917999|FG003|Phase II|Protocol Violation|1|||
48745711|NCT03208244|156918000|FG000|Overall Study|Death|1|||
48745712|NCT01874054|156918001|FG000|Overall Study|Withdrawal by Subject|3|||
48745713|NCT01874054|156918001|FG000|Overall Study|Study Termination by Sponsor|42|||
48858419|NCT03769090|157320949|FG000|Overall Study|Protocol Violation|5|||
48858420|NCT03769090|157320950|FG001|Overall Study|Protocol Violation|6|||
48858421|NCT03769090|157320951|FG002|Overall Study|Protocol Violation|8|||
48858422|NCT03769090|157320949|FG000|Overall Study|Pregnancy|1|||
48858423|NCT03769090|157320950|FG001|Overall Study|Pregnancy|0|||
48858424|NCT03769090|157320951|FG002|Overall Study|Pregnancy|3|||
48952792|NCT02538666|157656467|FG002|Pre-Treatment|no longer meets study criteria|0|||
48952793|NCT02538666|157656465|FG000|Pre-Treatment|Withdrew Consent|0|||
48952794|NCT02538666|157656466|FG001|Pre-Treatment|Withdrew Consent|1|||
48952795|NCT02538666|157656467|FG002|Pre-Treatment|Withdrew Consent|1|||
48745714|NCT01874054|156918001|FG000|Overall Study|Lost to Follow-up|5|||
48745715|NCT01874054|156918001|FG000|Overall Study|Death|5|||
48745716|NCT01637272|156918013|FG000|Overall Study|Adverse Event|6|||
48858425|NCT03769090|157320949|FG000|Overall Study|Lost to Follow-up|19|||
48952796|NCT02538666|157656465|FG000|Treatment|Disease progression|270|||
48952797|NCT02538666|157656466|FG001|Treatment|Disease progression|227|||
48952798|NCT02538666|157656467|FG002|Treatment|Disease progression|165|||
48952799|NCT02538666|157656465|FG000|Treatment|Study drug toxicity|1|||
48952800|NCT02538666|157656466|FG001|Treatment|Study drug toxicity|29|||
48858426|NCT03769090|157320950|FG001|Overall Study|Lost to Follow-up|25|||
48858427|NCT03769090|157320951|FG002|Overall Study|Lost to Follow-up|21|||
48858428|NCT03769090|157320949|FG000|Overall Study|Condition under investigation worsened|2|||
48952801|NCT02538666|157656467|FG002|Treatment|Study drug toxicity|92|||
48952802|NCT02538666|157656465|FG000|Treatment|Death|0|||
48745717|NCT01637272|156918013|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
48858429|NCT03769090|157320950|FG001|Overall Study|Condition under investigation worsened|0|||
48858430|NCT03769090|157320951|FG002|Overall Study|Condition under investigation worsened|1|||
48858431|NCT03769090|157320949|FG000|Overall Study|Lack of Efficacy|1|||
48858432|NCT03769090|157320950|FG001|Overall Study|Lack of Efficacy|2|||
48858433|NCT03769090|157320951|FG002|Overall Study|Lack of Efficacy|2|||
48858434|NCT03769090|157320949|FG000|Overall Study|Other reasons|8|||
48858435|NCT03769090|157320950|FG001|Overall Study|Other reasons|12|||
48858436|NCT03769090|157320951|FG002|Overall Study|Other reasons|15|||
48858437|NCT01970878|157320952|FG000|Overall Study|Withdrawal by Subject|11|||
48858438|NCT01970878|157320953|FG001|Overall Study|Withdrawal by Subject|10|||
48858439|NCT01970878|157320954|FG002|Overall Study|Withdrawal by Subject|14|||
48858440|NCT01970878|157320955|FG003|Overall Study|Withdrawal by Subject|7|||
48858441|NCT01970878|157320952|FG000|Overall Study|Lost to Follow-up|1|||
48858442|NCT01970878|157320953|FG001|Overall Study|Lost to Follow-up|3|||
48858443|NCT01970878|157320954|FG002|Overall Study|Lost to Follow-up|2|||
48858444|NCT01970878|157320955|FG003|Overall Study|Lost to Follow-up|4|||
48858445|NCT01970878|157320952|FG000|Overall Study|Administrative Reasons|1|||
48858446|NCT01970878|157320953|FG001|Overall Study|Administrative Reasons|0|||
48858447|NCT01970878|157320954|FG002|Overall Study|Administrative Reasons|0|||
48858448|NCT01970878|157320955|FG003|Overall Study|Administrative Reasons|4|||
48952803|NCT02538666|157656466|FG001|Treatment|Death|2|||
48952804|NCT02538666|157656467|FG002|Treatment|Death|3|||
48745718|NCT01637272|156918013|FG000|Overall Study|Withdrawal by Subject|3|||
48745719|NCT01637272|156918013|FG000|Overall Study|Lost to Follow-up|2|||
48745720|NCT01637272|156918013|FG000|Overall Study|completed core, did not enter ext. phase|4|||
48745721|NCT01637272|156918013|FG000|Overall Study|Administrative problems|1|||
48745722|NCT01637272|156918013|FG000|Overall Study|Protocol Violation|2|||
48745723|NCT00390468|156918015|FG000|Overall Study|Protocol Violation|2|||
48745724|NCT00390468|156918015|FG000|Overall Study|Lack of Efficacy|1|||
48745725|NCT01201850|156918016|FG000|Overall Study|Tumor progression|4|||
48745726|NCT00571948|156918019|FG000|Overall Study|Lost to Follow-up|2|||
48745727|NCT00571948|156918020|FG001|Overall Study|Lost to Follow-up|0|||
48745728|NCT00571948|156918019|FG000|Overall Study|Withdrawal by Subject|1|||
48858449|NCT01970878|157320952|FG000|Overall Study|Lack of Efficacy|2|||
48858450|NCT01970878|157320953|FG001|Overall Study|Lack of Efficacy|1|||
48858451|NCT01970878|157320954|FG002|Overall Study|Lack of Efficacy|2|||
48952805|NCT02538666|157656465|FG000|Treatment|Adverse event unrelated to study drug|8|||
48952806|NCT02538666|157656466|FG001|Treatment|Adverse event unrelated to study drug|10|||
48952807|NCT02538666|157656467|FG002|Treatment|Adverse event unrelated to study drug|15|||
48952808|NCT02538666|157656465|FG000|Treatment|Participant request to discontinue study treatment|3|||
48952809|NCT02538666|157656466|FG001|Treatment|Participant request to discontinue study treatment|6|||
48952810|NCT02538666|157656467|FG002|Treatment|Participant request to discontinue study treatment|11|||
48952811|NCT02538666|157656465|FG000|Treatment|Participant withdrew consent|2|||
48952812|NCT02538666|157656466|FG001|Treatment|Participant withdrew consent|5|||
48952813|NCT02538666|157656467|FG002|Treatment|Participant withdrew consent|3|||
48952814|NCT02538666|157656465|FG000|Treatment|Lost to Follow-up|0|||
48952815|NCT02538666|157656466|FG001|Treatment|Lost to Follow-up|1|||
48952816|NCT02538666|157656467|FG002|Treatment|Lost to Follow-up|1|||
48952817|NCT02538666|157656465|FG000|Treatment|Maximum clinical benefit|4|||
48952818|NCT02538666|157656466|FG001|Treatment|Maximum clinical benefit|3|||
48952819|NCT02538666|157656467|FG002|Treatment|Maximum clinical benefit|4|||
48952820|NCT02538666|157656465|FG000|Treatment|Poor/non-compliance|0|||
48952821|NCT02538666|157656466|FG001|Treatment|Poor/non-compliance|1|||
48952822|NCT02538666|157656467|FG002|Treatment|Poor/non-compliance|0|||
48952823|NCT02538666|157656465|FG000|Treatment|Participant no longer meets study criteria|0|||
48952824|NCT02538666|157656466|FG001|Treatment|Participant no longer meets study criteria|2|||
49015367|NCT00306384|157892158|FG002|Overall Study|Lost to Follow-up|35|||
48858452|NCT01970878|157320955|FG003|Overall Study|Lack of Efficacy|0|||
48858453|NCT01970878|157320952|FG000|Overall Study|Adverse Event|12|||
48858454|NCT01970878|157320953|FG001|Overall Study|Adverse Event|7|||
48858455|NCT01970878|157320954|FG002|Overall Study|Adverse Event|4|||
48858456|NCT01970878|157320955|FG003|Overall Study|Adverse Event|3|||
48858457|NCT01970878|157320952|FG000|Overall Study|Protocol Specified Criteria|10|||
48858458|NCT01970878|157320953|FG001|Overall Study|Protocol Specified Criteria|4|||
48858459|NCT01970878|157320954|FG002|Overall Study|Protocol Specified Criteria|3|||
48858460|NCT01970878|157320955|FG003|Overall Study|Protocol Specified Criteria|6|||
48858461|NCT01970878|157320952|FG000|Overall Study|Physician Decision|0|||
48858462|NCT01970878|157320953|FG001|Overall Study|Physician Decision|1|||
48858463|NCT01970878|157320954|FG002|Overall Study|Physician Decision|1|||
48858464|NCT01970878|157320955|FG003|Overall Study|Physician Decision|0|||
48858465|NCT01970878|157320952|FG000|Overall Study|No Completion Status|0|||
48858466|NCT01970878|157320953|FG001|Overall Study|No Completion Status|1|||
48858467|NCT01970878|157320954|FG002|Overall Study|No Completion Status|0|||
48858468|NCT01970878|157320955|FG003|Overall Study|No Completion Status|0|||
48858469|NCT00670449|157320956|FG000|Overall Study|Adverse Event|6|||
48858470|NCT00670449|157320957|FG001|Overall Study|Adverse Event|2|||
48858471|NCT00670449|157320958|FG002|Overall Study|Adverse Event|8|||
48858472|NCT00670449|157320959|FG003|Overall Study|Adverse Event|5|||
48858473|NCT00670449|157320956|FG000|Overall Study|Protocol Deviation|1|||
48858474|NCT00670449|157320957|FG001|Overall Study|Protocol Deviation|2|||
48858475|NCT00670449|157320958|FG002|Overall Study|Protocol Deviation|0|||
48858476|NCT00670449|157320959|FG003|Overall Study|Protocol Deviation|1|||
48858477|NCT00670449|157320956|FG000|Overall Study|Administrative Problems|0|||
48858478|NCT00670449|157320957|FG001|Overall Study|Administrative Problems|2|||
48858479|NCT00670449|157320958|FG002|Overall Study|Administrative Problems|0|||
48858480|NCT00670449|157320959|FG003|Overall Study|Administrative Problems|1|||
48858481|NCT00670449|157320956|FG000|Overall Study|Subject Withdrew Consent|0|||
48858482|NCT00670449|157320957|FG001|Overall Study|Subject Withdrew Consent|2|||
48858483|NCT00670449|157320958|FG002|Overall Study|Subject Withdrew Consent|0|||
48858484|NCT00670449|157320959|FG003|Overall Study|Subject Withdrew Consent|1|||
48858485|NCT00670449|157320956|FG000|Overall Study|Unsatisfactory Therapeutic Effect|2|||
48858486|NCT00670449|157320957|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
48858487|NCT00670449|157320958|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
48858488|NCT00670449|157320959|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
48858489|NCT00670449|157320956|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
48858490|NCT00670449|157320957|FG001|Overall Study|Abnormal Laboratory Value(s)|2|||
48858491|NCT00670449|157320958|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
48858492|NCT00670449|157320959|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
48858493|NCT02660086|157320964|FG000|Overall Study- 12-month|Withdrawal by Subject|5|||
48858494|NCT02660086|157320965|FG001|Overall Study- 12-month|Withdrawal by Subject|5|||
48858495|NCT02660086|157320964|FG000|Overall Study- 12-month|Left full-time employment|12|||
48858496|NCT02660086|157320965|FG001|Overall Study- 12-month|Left full-time employment|20|||
48858497|NCT02660086|157320964|FG000|Overall Study- 12-month|Missed 12-month follow-up visit|8|||
48858498|NCT02660086|157320965|FG001|Overall Study- 12-month|Missed 12-month follow-up visit|4|||
48858499|NCT02660086|157320964|FG000|Overall Study- 12-month|Became ineligible: new job in cafeteria|1|||
48858500|NCT02660086|157320965|FG001|Overall Study- 12-month|Became ineligible: new job in cafeteria|0|||
48858501|NCT02660086|157320964|FG000|Overall Study: 24-month Follow-up|Left employment after 12 months|17|||
48858502|NCT02660086|157320965|FG001|Overall Study: 24-month Follow-up|Left employment after 12 months|8|||
48858503|NCT02660086|157320964|FG000|Overall Study: 24-month Follow-up|Missed 24-month follow-up|9|||
48858504|NCT02660086|157320965|FG001|Overall Study: 24-month Follow-up|Missed 24-month follow-up|16|||
48858505|NCT00307489|157320966|FG000|Baseline Through Week 48|Lost to Follow-up|0|||
48858506|NCT00307489|157320967|FG001|Baseline Through Week 48|Lost to Follow-up|1|||
48858507|NCT00307489|157320966|FG000|Baseline Through Week 48|Physician Decision|1|||
48858508|NCT00307489|157320967|FG001|Baseline Through Week 48|Physician Decision|0|||
48858509|NCT00307489|157320966|FG000|Baseline Through Week 48|Withdrawal by Subject|0|||
48858510|NCT00307489|157320967|FG001|Baseline Through Week 48|Withdrawal by Subject|1|||
48858511|NCT00307489|157320966|FG000|Week 48 Through Week 168|Adverse Event|1|||
48952825|NCT02538666|157656467|FG002|Treatment|Participant no longer meets study criteria|0|||
48952826|NCT02538666|157656465|FG000|Treatment|Administrative reason by sponsor|0|||
48952827|NCT02538666|157656466|FG001|Treatment|Administrative reason by sponsor|0|||
48952828|NCT02538666|157656467|FG002|Treatment|Administrative reason by sponsor|1|||
48952829|NCT02538666|157656465|FG000|Treatment|Other reasons|8|||
48952830|NCT02538666|157656466|FG001|Treatment|Other reasons|15|||
48952831|NCT02538666|157656467|FG002|Treatment|Other reasons|5|||
48952832|NCT02538666|157656465|FG000|Treatment|Not reported|2|||
48952833|NCT02538666|157656466|FG001|Treatment|Not reported|2|||
48952834|NCT02538666|157656467|FG002|Treatment|Not reported|2|||
48952835|NCT00515008|157656475|FG000|Overall Study|Lost to Follow-up|1|||
48952836|NCT00515008|157656476|FG001|Overall Study|Lost to Follow-up|0|||
48858512|NCT00307489|157320967|FG001|Week 48 Through Week 168|Adverse Event|0|||
48858513|NCT00307489|157320966|FG000|Week 48 Through Week 168|Physician Decision|1|||
48952837|NCT00515008|157656475|FG000|Overall Study|Declined|0|||
48952838|NCT00515008|157656476|FG001|Overall Study|Declined|3|||
48952839|NCT00515008|157656475|FG000|Overall Study|Left the Boston Area|1|||
48952840|NCT00515008|157656476|FG001|Overall Study|Left the Boston Area|1|||
48952841|NCT00515008|157656475|FG000|Overall Study|Scheduling conflict|1|||
48952842|NCT00515008|157656476|FG001|Overall Study|Scheduling conflict|0|||
48952843|NCT01070784|157656477|FG000|Overall Study|Withdrawal by Subject|6|||
48952844|NCT01070784|157656478|FG001|Overall Study|Withdrawal by Subject|9|||
48952845|NCT01070784|157656477|FG000|Overall Study|Adverse Event|14|||
48952846|NCT01070784|157656478|FG001|Overall Study|Adverse Event|9|||
48952847|NCT01780389|157656479|FG000|Overall Study|Adverse Event|1|||
48952848|NCT00935220|157656480|FG000|Overall Study|Adverse Event|1|||
48952849|NCT00935220|157656480|FG000|Overall Study|Other reason (not specified)|1|||
48952850|NCT01095250|157656483|FG000|Overall Study|administrative reasons|8|||
48952851|NCT01095250|157656484|FG001|Overall Study|administrative reasons|10|||
48952852|NCT01095250|157656485|FG002|Overall Study|administrative reasons|7|||
48952853|NCT01095250|157656486|FG003|Overall Study|administrative reasons|5|||
48952854|NCT01095250|157656483|FG000|Overall Study|Withdrawal by Subject|0|||
48952855|NCT01095250|157656484|FG001|Overall Study|Withdrawal by Subject|0|||
48952856|NCT01095250|157656485|FG002|Overall Study|Withdrawal by Subject|1|||
48952857|NCT01095250|157656486|FG003|Overall Study|Withdrawal by Subject|0|||
48858514|NCT00307489|157320967|FG001|Week 48 Through Week 168|Physician Decision|0|||
48858515|NCT00307489|157320966|FG000|Week 48 Through Week 168|Withdrawal by Subject|1|||
48858516|NCT00307489|157320967|FG001|Week 48 Through Week 168|Withdrawal by Subject|2|||
48858517|NCT00307489|157320966|FG000|Week 48 Through Week 168|Lack of Efficacy|2|||
48858518|NCT00307489|157320967|FG001|Week 48 Through Week 168|Lack of Efficacy|2|||
48858519|NCT00307489|157320966|FG000|Week 48 Through Week 168|Death|0|||
48858520|NCT00307489|157320967|FG001|Week 48 Through Week 168|Death|1|||
48858521|NCT00307489|157320966|FG000|Week 48 Through Week 168|Lost to Follow-up|0|||
48858522|NCT00307489|157320967|FG001|Week 48 Through Week 168|Lost to Follow-up|1|||
48858523|NCT00307489|157320966|FG000|Week 48 Through Week 168|Seroconversion|1|||
48858524|NCT00307489|157320967|FG001|Week 48 Through Week 168|Seroconversion|0|||
48858525|NCT01377844|157320968|FG000|Overall Study|Withdrawal by Subject|25|||
48858526|NCT01377844|157320969|FG001|Overall Study|Withdrawal by Subject|28|||
48858527|NCT01377844|157320968|FG000|Overall Study|Protocol Violation|2|||
48858528|NCT01377844|157320969|FG001|Overall Study|Protocol Violation|3|||
48858529|NCT01377844|157320968|FG000|Overall Study|Adverse Event|3|||
48858530|NCT01377844|157320969|FG001|Overall Study|Adverse Event|0|||
48858531|NCT01377844|157320968|FG000|Overall Study|Physician Decision|6|||
48858532|NCT01377844|157320969|FG001|Overall Study|Physician Decision|3|||
48858533|NCT01377844|157320968|FG000|Overall Study|Study terminated by Sponsor|0|||
48858534|NCT01377844|157320969|FG001|Overall Study|Study terminated by Sponsor|1|||
48858535|NCT01802333|157320976|FG000|Overall Study|Ineligible|2|||
48858536|NCT01802333|157320977|FG001|Overall Study|Ineligible|6|||
48858537|NCT01802333|157320978|FG002|Overall Study|Ineligible|8|||
48858538|NCT01802333|157320976|FG000|Overall Study|Adverse Event|1|||
48858539|NCT01802333|157320977|FG001|Overall Study|Adverse Event|8|||
48858540|NCT01802333|157320978|FG002|Overall Study|Adverse Event|8|||
48858541|NCT01802333|157320976|FG000|Overall Study|Withdrawal by Subject|6|||
48858542|NCT01802333|157320977|FG001|Overall Study|Withdrawal by Subject|6|||
48858543|NCT01802333|157320978|FG002|Overall Study|Withdrawal by Subject|5|||
48858544|NCT01802333|157320976|FG000|Overall Study|Progression/relapse|1|||
48858545|NCT01802333|157320977|FG001|Overall Study|Progression/relapse|3|||
48858546|NCT01802333|157320978|FG002|Overall Study|Progression/relapse|0|||
48858547|NCT01802333|157320976|FG000|Overall Study|Death|7|||
48952858|NCT02815397|157656489|FG000|Overall Study|Physician Decision|2|||
48952859|NCT02213198|157656490|FG000|Baseline|No show for intake|7|||
48952860|NCT02213198|157656491|FG001|Baseline|No show for intake|9|||
48952861|NCT02213198|157656490|FG000|Baseline|Withdrawal by Subject|34|||
48858548|NCT01802333|157320977|FG001|Overall Study|Death|14|||
48952862|NCT02213198|157656491|FG001|Baseline|Withdrawal by Subject|11|||
48858549|NCT01802333|157320978|FG002|Overall Study|Death|13|||
48858550|NCT01802333|157320976|FG000|Overall Study|Other - not protocol specified|32|||
48858551|NCT01802333|157320977|FG001|Overall Study|Other - not protocol specified|22|||
48858552|NCT01802333|157320978|FG002|Overall Study|Other - not protocol specified|24|||
48858553|NCT01802333|157320976|FG000|Overall Study|Did not start treatment|0|||
48858554|NCT01802333|157320977|FG001|Overall Study|Did not start treatment|2|||
48858555|NCT01802333|157320978|FG002|Overall Study|Did not start treatment|5|||
48858556|NCT02708498|157320981|FG000|Overall Study|Death|20|||
48858557|NCT02708498|157320982|FG001|Overall Study|Death|19|||
48858558|NCT02708498|157320983|FG002|Overall Study|Death|0|||
48858559|NCT02708498|157320984|FG003|Overall Study|Death|0|||
48858560|NCT02708498|157320985|FG004|Overall Study|Death|1|||
48858561|NCT02708498|157320986|FG005|Overall Study|Death|0|||
48858562|NCT02708498|157320987|FG006|Overall Study|Death|0|||
48858563|NCT02708498|157320988|FG007|Overall Study|Death|0|||
48858564|NCT02708498|157320981|FG000|Overall Study|Unknown reason, missing data|0|||
48858565|NCT02708498|157320982|FG001|Overall Study|Unknown reason, missing data|0|||
48858566|NCT02708498|157320983|FG002|Overall Study|Unknown reason, missing data|62|||
48858567|NCT02708498|157320984|FG003|Overall Study|Unknown reason, missing data|51|||
48858568|NCT02708498|157320985|FG004|Overall Study|Unknown reason, missing data|195|||
48858569|NCT02708498|157320986|FG005|Overall Study|Unknown reason, missing data|132|||
48858570|NCT02708498|157320987|FG006|Overall Study|Unknown reason, missing data|0|||
48858571|NCT02708498|157320988|FG007|Overall Study|Unknown reason, missing data|0|||
48858572|NCT01381549|157320989|FG000|Overall Study|Ineligible: No organisms isolated|0|||
48858573|NCT01381549|157320990|FG001|Overall Study|Ineligible: No organisms isolated|0|||
48858574|NCT01381549|157320991|FG002|Overall Study|Ineligible: No organisms isolated|1|||
48952863|NCT02213198|157656490|FG000|Baseline|transferred out of clinic|7|||
48952864|NCT02213198|157656491|FG001|Baseline|transferred out of clinic|9|||
48952865|NCT02213198|157656490|FG000|Baseline|Lost to Follow-up|40|||
48952866|NCT02213198|157656491|FG001|Baseline|Lost to Follow-up|21|||
48952867|NCT02213198|157656490|FG000|Baseline|incarcerated,violent|0|||
48952868|NCT02213198|157656491|FG001|Baseline|incarcerated,violent|1|||
48952869|NCT02213198|157656490|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
48952870|NCT02213198|157656491|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
48952871|NCT02213198|157656490|FG000|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3|||
48952872|NCT02213198|157656491|FG001|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2|||
48952873|NCT02213198|157656490|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Death|1|||
48858575|NCT03236779|157320992|FG000|Overall Study|Lost to Follow-up|13|||
48858576|NCT03236779|157320993|FG001|Overall Study|Lost to Follow-up|21|||
48858577|NCT02981953|157320994|FG000|Overall Study|Death|9|||
48858578|NCT02981953|157320994|FG000|Overall Study|Withdrawal by Subject|1|||
48858579|NCT02981953|157320994|FG000|Overall Study|Withdrawal to non-compliance|1|||
48858580|NCT00403845|157320997|FG000|Treatment Period 1|Subject withdrew consent|1|||
48858581|NCT00403845|157320998|FG001|Treatment Period 1|Subject withdrew consent|0|||
48858582|NCT00403845|157320999|FG002|Treatment Period 1|Subject withdrew consent|0|||
48745729|NCT00571948|156918020|FG001|Overall Study|Withdrawal by Subject|2|||
48745730|NCT00571948|156918019|FG000|Overall Study|Protocol Violation|3|||
48745731|NCT00571948|156918020|FG001|Overall Study|Protocol Violation|3|||
48745732|NCT00571948|156918019|FG000|Overall Study|infant refused study meal|3|||
48745733|NCT00571948|156918020|FG001|Overall Study|infant refused study meal|4|||
48745734|NCT00571948|156918019|FG000|Overall Study|Parent were afraid of blood colection|2|||
48745735|NCT00571948|156918020|FG001|Overall Study|Parent were afraid of blood colection|5|||
48745736|NCT01862874|156918022|FG000|Overall Study|Randomized not treated|1|||
48745737|NCT01862874|156918023|FG001|Overall Study|Randomized not treated|0|||
48745738|NCT01862874|156918022|FG000|Overall Study|Adverse Event|0|||
48745739|NCT01862874|156918023|FG001|Overall Study|Adverse Event|3|||
48745740|NCT01862874|156918022|FG000|Overall Study|Lost to Follow-up|26|||
48745741|NCT01862874|156918023|FG001|Overall Study|Lost to Follow-up|29|||
48745742|NCT01862874|156918022|FG000|Overall Study|Physician Decision|5|||
48745743|NCT01862874|156918023|FG001|Overall Study|Physician Decision|3|||
48745744|NCT01862874|156918022|FG000|Overall Study|Withdrawn by parent/guardian|1|||
48745745|NCT01862874|156918023|FG001|Overall Study|Withdrawn by parent/guardian|1|||
48745746|NCT01862874|156918022|FG000|Overall Study|Withdrawal by Subject|46|||
48952874|NCT02213198|157656491|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Death|0|||
48745747|NCT01862874|156918023|FG001|Overall Study|Withdrawal by Subject|40|||
48745748|NCT01862874|156918022|FG000|Overall Study|Death|0|||
48745749|NCT01862874|156918023|FG001|Overall Study|Death|1|||
48745750|NCT05201703|156918025|FG000|Overall Study|Did not understand how to boost medication despite counseling; did not boost|0|||
48745751|NCT05201703|156918026|FG001|Overall Study|Did not understand how to boost medication despite counseling; did not boost|1|||
48745752|NCT05201703|156918025|FG000|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|0|||
48745753|NCT05201703|156918026|FG001|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|1|||
48745754|NCT01782222|156918027|FG000|Overall Study|Adverse Event|4|||
48745755|NCT01782222|156918028|FG001|Overall Study|Adverse Event|5|||
48745756|NCT01782222|156918029|FG002|Overall Study|Adverse Event|3|||
48745757|NCT01782222|156918027|FG000|Overall Study|Lack of Efficacy|2|||
48745758|NCT01782222|156918028|FG001|Overall Study|Lack of Efficacy|1|||
48745759|NCT01782222|156918029|FG002|Overall Study|Lack of Efficacy|0|||
48745760|NCT01782222|156918027|FG000|Overall Study|Protocol Violation|1|||
48745761|NCT01782222|156918028|FG001|Overall Study|Protocol Violation|0|||
48745762|NCT01782222|156918029|FG002|Overall Study|Protocol Violation|0|||
48745763|NCT01782222|156918027|FG000|Overall Study|Withdrawal by Subject|1|||
48745764|NCT01782222|156918028|FG001|Overall Study|Withdrawal by Subject|4|||
48745765|NCT01782222|156918029|FG002|Overall Study|Withdrawal by Subject|1|||
48745766|NCT01782222|156918027|FG000|Overall Study|Moved to other state|0|||
48745767|NCT01782222|156918028|FG001|Overall Study|Moved to other state|1|||
48745768|NCT01782222|156918029|FG002|Overall Study|Moved to other state|0|||
48745769|NCT03727347|156918035|FG000|Overall Study|Withdrawal by Subject|2|||
48745770|NCT03727347|156918035|FG000|Overall Study|Lost to Follow-up|1|||
48952875|NCT02213198|157656490|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68|||
48952876|NCT02213198|157656491|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25|||
48745771|NCT00006237|156918036|FG000|Overall Study|Adverse Event|39|||
48745772|NCT00006237|156918037|FG001|Overall Study|Adverse Event|29|||
48745773|NCT00006237|156918036|FG000|Overall Study|Death|1|||
48745774|NCT00006237|156918037|FG001|Overall Study|Death|0|||
48745775|NCT00006237|156918036|FG000|Overall Study|Refusal unrelated to adverse effects|8|||
48745776|NCT00006237|156918037|FG001|Overall Study|Refusal unrelated to adverse effects|4|||
48745777|NCT00006237|156918036|FG000|Overall Study|Progression/relapse|54|||
48745778|NCT00006237|156918037|FG001|Overall Study|Progression/relapse|2|||
48745779|NCT00006237|156918036|FG000|Overall Study|Not eligible|9|||
48745780|NCT00006237|156918037|FG001|Overall Study|Not eligible|20|||
48745781|NCT00006237|156918036|FG000|Overall Study|Withdrawal by Subject|0|||
48745782|NCT00006237|156918037|FG001|Overall Study|Withdrawal by Subject|1|||
48745783|NCT00006237|156918036|FG000|Overall Study|Not protocol specified|14|||
48745784|NCT00006237|156918037|FG001|Overall Study|Not protocol specified|5|||
48745785|NCT02837783|156918038|FG000|Overall Study|Adverse Event|1|||
48745786|NCT02837783|156918039|FG001|Overall Study|Adverse Event|0|||
48745787|NCT02837783|156918038|FG000|Overall Study|Other, Not Specified|1|||
48745788|NCT02837783|156918039|FG001|Overall Study|Other, Not Specified|2|||
48745789|NCT03338998|156918041|FG000|Treatment Period|Withdrawal by Subject|1|||
48745790|NCT03338998|156918042|FG001|Treatment Period|Withdrawal by Subject|1|||
48745791|NCT03338998|156918041|FG000|Treatment Period|Adverse Event|0|||
48745792|NCT03338998|156918042|FG001|Treatment Period|Adverse Event|2|||
48745793|NCT03338998|156918041|FG000|Treatment Period|Protocol deviation|1|||
48745794|NCT03338998|156918042|FG001|Treatment Period|Protocol deviation|0|||
48745795|NCT03338998|156918041|FG000|Treatment Period|Physician Decision|2|||
48745796|NCT03338998|156918042|FG001|Treatment Period|Physician Decision|0|||
48745797|NCT03338998|156918041|FG000|Treatment Period|Subject failed swallow test|4|||
48745798|NCT03338998|156918042|FG001|Treatment Period|Subject failed swallow test|0|||
48745799|NCT03338998|156918041|FG000|Safety Follow-Up Period|Adverse Event|0|||
48745800|NCT03338998|156918042|FG001|Safety Follow-Up Period|Adverse Event|1|||
48745801|NCT03338998|156918041|FG000|Safety Follow-Up Period|Protocol deviation|1|||
48745802|NCT03338998|156918042|FG001|Safety Follow-Up Period|Protocol deviation|0|||
48745803|NCT03338998|156918041|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
48745804|NCT03338998|156918042|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
48745805|NCT03648983|156918043|FG000|Overall Study|Study was terminated due to PI departure|95|||
48745806|NCT03572062|156918044|FG000|Overall Study|Adverse Event|0|||
48745807|NCT03572062|156918045|FG001|Overall Study|Adverse Event|0|||
48745808|NCT03572062|156918046|FG002|Overall Study|Adverse Event|0|||
48745809|NCT03572062|156918047|FG003|Overall Study|Adverse Event|0|||
48745810|NCT03572062|156918048|FG004|Overall Study|Adverse Event|0|||
48745811|NCT03572062|156918049|FG005|Overall Study|Adverse Event|0|||
48745812|NCT03572062|156918050|FG006|Overall Study|Adverse Event|0|||
48745813|NCT03572062|156918051|FG007|Overall Study|Adverse Event|0|||
48745814|NCT03572062|156918052|FG008|Overall Study|Adverse Event|1|||
48745815|NCT03572062|156918053|FG009|Overall Study|Adverse Event|3|||
48745816|NCT03572062|156918044|FG000|Overall Study|Death|0|||
48745817|NCT03572062|156918045|FG001|Overall Study|Death|0|||
48745818|NCT03572062|156918046|FG002|Overall Study|Death|0|||
48745819|NCT03572062|156918047|FG003|Overall Study|Death|0|||
48745820|NCT03572062|156918048|FG004|Overall Study|Death|0|||
48745821|NCT03572062|156918049|FG005|Overall Study|Death|1|||
48745822|NCT03572062|156918050|FG006|Overall Study|Death|0|||
48745823|NCT03572062|156918051|FG007|Overall Study|Death|0|||
48745824|NCT03572062|156918052|FG008|Overall Study|Death|0|||
48745825|NCT03572062|156918053|FG009|Overall Study|Death|0|||
48745826|NCT03572062|156918044|FG000|Overall Study|Lost to Follow-up|0|||
48745827|NCT03572062|156918045|FG001|Overall Study|Lost to Follow-up|0|||
48745828|NCT03572062|156918046|FG002|Overall Study|Lost to Follow-up|0|||
48952877|NCT02213198|157656490|FG000|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17|||
48952878|NCT02213198|157656491|FG001|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10|||
48952879|NCT02213198|157656490|FG000|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23|||
48952880|NCT02213198|157656491|FG001|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7|||
48952881|NCT02518620|157656492|FG000|Overall Study|Adverse Event|23|||
48952882|NCT02518620|157656493|FG001|Overall Study|Adverse Event|11|||
48952883|NCT02518620|157656492|FG000|Overall Study|Lack of Efficacy|2|||
48952884|NCT02518620|157656493|FG001|Overall Study|Lack of Efficacy|0|||
48952885|NCT02518620|157656492|FG000|Overall Study|Non-Compliance with Study Drug|1|||
48745829|NCT03572062|156918047|FG003|Overall Study|Lost to Follow-up|0|||
48745830|NCT03572062|156918048|FG004|Overall Study|Lost to Follow-up|0|||
48858583|NCT00403845|157321000|FG003|Treatment Period 1|Subject withdrew consent|0|||
48858584|NCT00403845|157320997|FG000|Treatment Period 1|Subject no longer needs study drug|0|||
48858585|NCT00403845|157320998|FG001|Treatment Period 1|Subject no longer needs study drug|0|||
48858586|NCT00403845|157320999|FG002|Treatment Period 1|Subject no longer needs study drug|0|||
48858587|NCT00403845|157321000|FG003|Treatment Period 1|Subject no longer needs study drug|1|||
48858588|NCT00403845|157320997|FG000|Treatment Period 2|Subject withdrew consent|1|||
48858589|NCT00403845|157320998|FG001|Treatment Period 2|Subject withdrew consent|0|||
48858590|NCT00403845|157320999|FG002|Treatment Period 2|Subject withdrew consent|0|||
48858591|NCT00403845|157321000|FG003|Treatment Period 2|Subject withdrew consent|0|||
48858592|NCT00403845|157320997|FG000|Treatment Period 3|Subject withdrew consent|0|||
48858593|NCT00403845|157320998|FG001|Treatment Period 3|Subject withdrew consent|0|||
48858594|NCT00403845|157320999|FG002|Treatment Period 3|Subject withdrew consent|0|||
48858595|NCT00403845|157321000|FG003|Treatment Period 3|Subject withdrew consent|1|||
48858596|NCT00403845|157320997|FG000|Treatment Period 3|Adverse Event|0|||
48858597|NCT00403845|157320998|FG001|Treatment Period 3|Adverse Event|0|||
48858598|NCT00403845|157320999|FG002|Treatment Period 3|Adverse Event|0|||
48858599|NCT00403845|157321000|FG003|Treatment Period 3|Adverse Event|1|||
48858600|NCT00805792|157321001|FG000|Overall Study|Death|3|||
48858601|NCT00805792|157321001|FG000|Overall Study|Lost to Follow-up|2|||
48858602|NCT02935673|157321010|FG000|Overall Study|Adverse Event|0|||
48858603|NCT02935673|157321011|FG001|Overall Study|Adverse Event|1|||
48858604|NCT02935673|157321012|FG002|Overall Study|Adverse Event|0|||
48858605|NCT02935673|157321010|FG000|Overall Study|Withdrawal by Subject|1|||
48745831|NCT03572062|156918049|FG005|Overall Study|Lost to Follow-up|1|||
48952886|NCT02518620|157656493|FG001|Overall Study|Non-Compliance with Study Drug|0|||
48745832|NCT03572062|156918050|FG006|Overall Study|Lost to Follow-up|1|||
48745833|NCT03572062|156918051|FG007|Overall Study|Lost to Follow-up|0|||
48745834|NCT03572062|156918052|FG008|Overall Study|Lost to Follow-up|0|||
48745835|NCT03572062|156918053|FG009|Overall Study|Lost to Follow-up|0|||
48745836|NCT03572062|156918044|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
48952887|NCT02518620|157656492|FG000|Overall Study|Physician Decision|1|||
48952888|NCT02518620|157656493|FG001|Overall Study|Physician Decision|1|||
48952889|NCT02518620|157656492|FG000|Overall Study|Sponsor's Decision|0|||
48952890|NCT02518620|157656493|FG001|Overall Study|Sponsor's Decision|3|||
48952891|NCT02518620|157656492|FG000|Overall Study|Lost to Follow-up|1|||
48952892|NCT02518620|157656493|FG001|Overall Study|Lost to Follow-up|1|||
48952893|NCT02518620|157656492|FG000|Overall Study|Withdrawal by Subject|17|||
48952894|NCT02518620|157656493|FG001|Overall Study|Withdrawal by Subject|9|||
48952895|NCT02518620|157656492|FG000|Overall Study|Death|1|||
48858606|NCT02935673|157321011|FG001|Overall Study|Withdrawal by Subject|2|||
48858607|NCT02935673|157321012|FG002|Overall Study|Withdrawal by Subject|0|||
48858608|NCT01640288|157321013|FG000|Overall Study|Equipment Failure or Poor Image Quality|4|||
48858609|NCT01640288|157321014|FG001|Overall Study|Equipment Failure or Poor Image Quality|5|||
48858610|NCT01640288|157321013|FG000|Overall Study|Screen Failure|20|||
48858611|NCT01640288|157321014|FG001|Overall Study|Screen Failure|18|||
48858612|NCT01640288|157321013|FG000|Overall Study|Withdrawn by PI|5|||
48745837|NCT03572062|156918045|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
48745838|NCT03572062|156918046|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
48745839|NCT03572062|156918047|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
48745840|NCT03572062|156918048|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
48745841|NCT03572062|156918049|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
48745842|NCT03572062|156918050|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
48745843|NCT03572062|156918051|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
48745844|NCT03572062|156918052|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
48745845|NCT03572062|156918053|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
48745846|NCT03572062|156918044|FG000|Overall Study|Study Terminated By Sponsor|0|||
48745847|NCT03572062|156918045|FG001|Overall Study|Study Terminated By Sponsor|0|||
48858613|NCT01640288|157321014|FG001|Overall Study|Withdrawn by PI|0|||
48858614|NCT01640288|157321013|FG000|Overall Study|Withdrawal by Subject|1|||
48858615|NCT01640288|157321014|FG001|Overall Study|Withdrawal by Subject|0|||
48858616|NCT02547974|157321023|FG000|Overall Study|Withdrawal by Subject|1|||
48858617|NCT02547974|157321024|FG001|Overall Study|Withdrawal by Subject|0|||
48858618|NCT02547974|157321025|FG002|Overall Study|Withdrawal by Subject|0|||
48858619|NCT02547974|157321026|FG003|Overall Study|Withdrawal by Subject|0|||
48858620|NCT02753075|157321027|FG000|Overall Study|Adverse Event|2|||
48858621|NCT02753075|157321028|FG001|Overall Study|Adverse Event|1|||
48858622|NCT02753075|157321029|FG002|Overall Study|Adverse Event|0|||
48858623|NCT02753075|157321027|FG000|Overall Study|Lost to Follow-up|2|||
48858624|NCT02753075|157321028|FG001|Overall Study|Lost to Follow-up|0|||
48858625|NCT02753075|157321029|FG002|Overall Study|Lost to Follow-up|0|||
48858626|NCT02753075|157321027|FG000|Overall Study|Withdrawal of Consent|1|||
48858627|NCT02753075|157321028|FG001|Overall Study|Withdrawal of Consent|1|||
48858628|NCT02753075|157321029|FG002|Overall Study|Withdrawal of Consent|3|||
48858629|NCT02753075|157321027|FG000|Overall Study|Physician Decision|3|||
48858630|NCT02753075|157321028|FG001|Overall Study|Physician Decision|1|||
48858631|NCT02753075|157321029|FG002|Overall Study|Physician Decision|0|||
48858632|NCT02109172|157321032|FG000|Overall Study|Withdrawal by Subject|1|||
48858633|NCT02109172|157321033|FG001|Overall Study|Withdrawal by Subject|0|||
48858634|NCT02109172|157321034|FG002|Overall Study|Withdrawal by Subject|0|||
48858635|NCT02109172|157321035|FG003|Overall Study|Withdrawal by Subject|1|||
48858636|NCT02109172|157321036|FG004|Overall Study|Withdrawal by Subject|0|||
48858637|NCT02109172|157321037|FG005|Overall Study|Withdrawal by Subject|0|||
48858638|NCT02109172|157321032|FG000|Overall Study|Adverse Event|0|||
48858639|NCT02109172|157321033|FG001|Overall Study|Adverse Event|0|||
48858640|NCT02109172|157321034|FG002|Overall Study|Adverse Event|1|||
48858641|NCT02109172|157321035|FG003|Overall Study|Adverse Event|0|||
48858642|NCT02109172|157321036|FG004|Overall Study|Adverse Event|0|||
48858643|NCT02109172|157321037|FG005|Overall Study|Adverse Event|1|||
48858644|NCT02109172|157321032|FG000|Overall Study|Death|0|||
48858645|NCT02109172|157321033|FG001|Overall Study|Death|0|||
48858646|NCT02109172|157321034|FG002|Overall Study|Death|0|||
48858647|NCT02109172|157321035|FG003|Overall Study|Death|0|||
48858648|NCT02109172|157321036|FG004|Overall Study|Death|1|||
48858649|NCT02109172|157321037|FG005|Overall Study|Death|0|||
48858650|NCT02446015|157321040|FG000|Overall Study|Adverse Event|0|||
48858651|NCT02446015|157321041|FG001|Overall Study|Adverse Event|1|||
48858652|NCT02446015|157321040|FG000|Overall Study|Withdrawal by Subject|1|||
48858653|NCT02446015|157321041|FG001|Overall Study|Withdrawal by Subject|0|||
48858654|NCT01393600|157321043|FG000|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
48858655|NCT01393600|157321044|FG001|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1|||
48858656|NCT01393600|157321045|FG002|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
48858657|NCT01393600|157321046|FG003|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
48858658|NCT01393600|157321043|FG000|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
48858659|NCT01393600|157321044|FG001|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
48858660|NCT01393600|157321045|FG002|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1|||
48858661|NCT01393600|157321046|FG003|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
48858662|NCT01393600|157321043|FG000|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
48858663|NCT01393600|157321044|FG001|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
48858664|NCT01393600|157321045|FG002|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
48858665|NCT01393600|157321046|FG003|Treatment Period 1 (Day 1 to 14)|Adverse Event|1|||
48858666|NCT01393600|157321043|FG000|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
48858667|NCT01393600|157321044|FG001|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
48858668|NCT01393600|157321045|FG002|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
48952896|NCT02518620|157656493|FG001|Overall Study|Death|0|||
48952897|NCT02518620|157656492|FG000|Overall Study|Pregnancy Wish|3|||
48952898|NCT02518620|157656493|FG001|Overall Study|Pregnancy Wish|0|||
48858669|NCT01393600|157321046|FG003|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1|||
48858670|NCT01393600|157321043|FG000|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
48858671|NCT01393600|157321044|FG001|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
48858672|NCT01393600|157321045|FG002|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1|||
48858673|NCT01393600|157321046|FG003|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
48858674|NCT01393600|157321043|FG000|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
48858675|NCT01393600|157321044|FG001|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
48858676|NCT01393600|157321045|FG002|Treatment Period 2 (Day 15 to 28)|Physician Decision|1|||
48858677|NCT01393600|157321046|FG003|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
48858678|NCT01393600|157321043|FG000|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
48858679|NCT01393600|157321044|FG001|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
48858680|NCT01393600|157321045|FG002|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1|||
48858681|NCT01393600|157321046|FG003|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
48858682|NCT02784834|157321047|FG000|Overall Study|Lack of Efficacy|1|||
48858683|NCT03884478|157321048|FG000|Baseline to 2 Months Post-intervention|Lost to Follow-up|30|||
48858684|NCT03884478|157321049|FG001|Baseline to 2 Months Post-intervention|Lost to Follow-up|33|||
48858685|NCT03884478|157321050|FG002|Baseline to 2 Months Post-intervention|Lost to Follow-up|36|||
48858686|NCT03884478|157321048|FG000|Baseline to 2 Months Post-intervention|Withdrawn by research team|1|||
48858687|NCT03884478|157321049|FG001|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
48858688|NCT03884478|157321050|FG002|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
48858689|NCT03884478|157321048|FG000|Baseline to 4 Months Post-intervention|Lost to Follow-up|42|||
48858690|NCT03884478|157321049|FG001|Baseline to 4 Months Post-intervention|Lost to Follow-up|50|||
48858691|NCT03884478|157321050|FG002|Baseline to 4 Months Post-intervention|Lost to Follow-up|51|||
48858692|NCT03884478|157321048|FG000|Baseline to 4 Months Post-intervention|Withdrawn by research team|1|||
48858693|NCT03884478|157321049|FG001|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
48858694|NCT03884478|157321050|FG002|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
48858695|NCT02291861|157321061|FG000|Overall Study|Adverse Event|2|||
48858696|NCT02291861|157321062|FG001|Overall Study|Adverse Event|4|||
48858697|NCT02291861|157321063|FG002|Overall Study|Adverse Event|1|||
48858698|NCT02291861|157321064|FG003|Overall Study|Adverse Event|2|||
48858699|NCT02291861|157321061|FG000|Overall Study|Death|0|||
48952899|NCT02518620|157656492|FG000|Overall Study|Pregnancy|1|||
48952900|NCT02518620|157656493|FG001|Overall Study|Pregnancy|0|||
48952901|NCT02518620|157656492|FG000|Overall Study|Relocation|2|||
48952902|NCT02518620|157656493|FG001|Overall Study|Relocation|1|||
48952903|NCT01518192|157656494|FG000|Overall Study|Lost to Follow-up|29|||
48952904|NCT01518192|157656495|FG001|Overall Study|Lost to Follow-up|26|||
48952905|NCT01518192|157656496|FG002|Overall Study|Lost to Follow-up|35|||
48952906|NCT00085540|157656497|FG000|Overall Study|Withdrawal by Subject|0|||
48952907|NCT00085540|157656498|FG001|Overall Study|Withdrawal by Subject|1|||
48745848|NCT03572062|156918046|FG002|Overall Study|Study Terminated By Sponsor|0|||
48745849|NCT03572062|156918047|FG003|Overall Study|Study Terminated By Sponsor|0|||
48858700|NCT02291861|157321062|FG001|Overall Study|Death|0|||
48858701|NCT02291861|157321063|FG002|Overall Study|Death|1|||
48858702|NCT02291861|157321064|FG003|Overall Study|Death|1|||
48858703|NCT02291861|157321061|FG000|Overall Study|Protocol Violation|1|||
48952908|NCT00085540|157656497|FG000|Overall Study|Protocol Violation|0|||
48858704|NCT02291861|157321062|FG001|Overall Study|Protocol Violation|0|||
48858705|NCT02291861|157321063|FG002|Overall Study|Protocol Violation|0|||
48858706|NCT02291861|157321064|FG003|Overall Study|Protocol Violation|1|||
48858707|NCT02291861|157321061|FG000|Overall Study|Withdrawal by Subject|1|||
48858708|NCT02291861|157321062|FG001|Overall Study|Withdrawal by Subject|2|||
48858709|NCT02291861|157321063|FG002|Overall Study|Withdrawal by Subject|1|||
48858710|NCT02291861|157321064|FG003|Overall Study|Withdrawal by Subject|4|||
48858711|NCT02291861|157321061|FG000|Overall Study|Noncompliance|1|||
48858712|NCT02291861|157321062|FG001|Overall Study|Noncompliance|1|||
48858713|NCT02291861|157321063|FG002|Overall Study|Noncompliance|2|||
48858714|NCT02291861|157321064|FG003|Overall Study|Noncompliance|1|||
48858715|NCT02291861|157321061|FG000|Overall Study|Lost to Follow-up|2|||
48858716|NCT02291861|157321062|FG001|Overall Study|Lost to Follow-up|1|||
48858717|NCT02291861|157321063|FG002|Overall Study|Lost to Follow-up|4|||
48858718|NCT02291861|157321064|FG003|Overall Study|Lost to Follow-up|0|||
48858719|NCT02291861|157321061|FG000|Overall Study|Other|0|||
48858720|NCT02291861|157321062|FG001|Overall Study|Other|0|||
48858721|NCT02291861|157321063|FG002|Overall Study|Other|0|||
48858722|NCT02291861|157321064|FG003|Overall Study|Other|1|||
48858723|NCT00476151|157321065|FG000|Overall Study|Adverse Event|0|||
48858724|NCT00476151|157321066|FG001|Overall Study|Adverse Event|2|||
48858725|NCT00476151|157321065|FG000|Overall Study|Protocol Violation|1|||
48858726|NCT00476151|157321066|FG001|Overall Study|Protocol Violation|3|||
48858727|NCT00476151|157321065|FG000|Overall Study|Withdrawal by Subject|2|||
48858728|NCT00476151|157321066|FG001|Overall Study|Withdrawal by Subject|0|||
48858729|NCT00476151|157321065|FG000|Overall Study|Physician Decision|0|||
48858730|NCT00476151|157321066|FG001|Overall Study|Physician Decision|2|||
48858731|NCT01767376|157321067|FG000|Overall Study|Lost to Follow-up|3|||
48858732|NCT01767376|157321068|FG001|Overall Study|Lost to Follow-up|2|||
48858733|NCT01767376|157321069|FG002|Overall Study|Lost to Follow-up|0|||
48858734|NCT01767376|157321067|FG000|Overall Study|Withdrawal by Subject|1|||
48858735|NCT01767376|157321068|FG001|Overall Study|Withdrawal by Subject|1|||
48858736|NCT01767376|157321069|FG002|Overall Study|Withdrawal by Subject|0|||
48858737|NCT01393964|157321070|FG000|Overall Study|Disease Progression|4|||
48858738|NCT01393964|157321071|FG001|Overall Study|Disease Progression|3|||
48858739|NCT01393964|157321072|FG002|Overall Study|Disease Progression|5|||
48858740|NCT01393964|157321070|FG000|Overall Study|Study drug toxicity|1|||
48858741|NCT01393964|157321071|FG001|Overall Study|Study drug toxicity|0|||
48858742|NCT01393964|157321072|FG002|Overall Study|Study drug toxicity|0|||
48858743|NCT01393964|157321070|FG000|Overall Study|Withdrawal by Subject|0|||
48858744|NCT01393964|157321071|FG001|Overall Study|Withdrawal by Subject|0|||
48858745|NCT01393964|157321072|FG002|Overall Study|Withdrawal by Subject|1|||
48858746|NCT01393964|157321070|FG000|Overall Study|Adverse event unrelated to study drug|0|||
48858747|NCT01393964|157321071|FG001|Overall Study|Adverse event unrelated to study drug|3|||
48858748|NCT01393964|157321072|FG002|Overall Study|Adverse event unrelated to study drug|0|||
48858749|NCT01393964|157321070|FG000|Overall Study|Subject request stop study treatment|0|||
48858750|NCT01393964|157321071|FG001|Overall Study|Subject request stop study treatment|1|||
48858751|NCT01393964|157321072|FG002|Overall Study|Subject request stop study treatment|0|||
48858752|NCT01393964|157321070|FG000|Overall Study|Subject decided to move to transplant|1|||
48858753|NCT01393964|157321071|FG001|Overall Study|Subject decided to move to transplant|0|||
48858754|NCT01393964|157321072|FG002|Overall Study|Subject decided to move to transplant|0|||
48858755|NCT01393964|157321070|FG000|Overall Study|Subject switched to commercial supply|1|||
48858756|NCT01393964|157321071|FG001|Overall Study|Subject switched to commercial supply|0|||
48858757|NCT01393964|157321072|FG002|Overall Study|Subject switched to commercial supply|2|||
48858758|NCT01393964|157321070|FG000|Overall Study|Subject plateaued in terms of effect|1|||
48858759|NCT01393964|157321071|FG001|Overall Study|Subject plateaued in terms of effect|0|||
48858760|NCT01393964|157321072|FG002|Overall Study|Subject plateaued in terms of effect|0|||
48858761|NCT01393964|157321070|FG000|Overall Study|Investigator removed subject from study|0|||
48858762|NCT01393964|157321071|FG001|Overall Study|Investigator removed subject from study|1|||
48858763|NCT01393964|157321072|FG002|Overall Study|Investigator removed subject from study|0|||
48858764|NCT01393964|157321070|FG000|Overall Study|Subject converted to roll-over study|0|||
48858765|NCT01393964|157321071|FG001|Overall Study|Subject converted to roll-over study|1|||
48858766|NCT01393964|157321072|FG002|Overall Study|Subject converted to roll-over study|0|||
48858767|NCT01393964|157321070|FG000|Overall Study|Subject to receive non-protocol therapy|0|||
48858768|NCT01393964|157321071|FG001|Overall Study|Subject to receive non-protocol therapy|0|||
48858769|NCT01393964|157321072|FG002|Overall Study|Subject to receive non-protocol therapy|1|||
48858770|NCT01322347|157321073|FG000|Overall Study|Adverse Event|7|||
48858771|NCT01322347|157321074|FG001|Overall Study|Adverse Event|2|||
48858772|NCT01322347|157321073|FG000|Overall Study|Death|5|||
48858773|NCT01322347|157321074|FG001|Overall Study|Death|3|||
48858774|NCT01322347|157321073|FG000|Overall Study|Physician Decision|2|||
48858775|NCT01322347|157321074|FG001|Overall Study|Physician Decision|1|||
48858776|NCT01322347|157321073|FG000|Overall Study|Protocol Violation|5|||
48858777|NCT01322347|157321074|FG001|Overall Study|Protocol Violation|2|||
48858778|NCT01322347|157321073|FG000|Overall Study|Withdrawal by Subject|1|||
48952909|NCT00085540|157656498|FG001|Overall Study|Protocol Violation|1|||
48952910|NCT00798967|157656501|FG000|Overall Study|Adverse Event|2|||
48952911|NCT00798967|157656502|FG001|Overall Study|Adverse Event|3|||
48858779|NCT01322347|157321074|FG001|Overall Study|Withdrawal by Subject|4|||
48858780|NCT01322347|157321073|FG000|Overall Study|non-protocol change to ESA or IV iron|14|||
48858781|NCT01322347|157321074|FG001|Overall Study|non-protocol change to ESA or IV iron|6|||
48858782|NCT01322347|157321073|FG000|Overall Study|blood transfusion|5|||
48858783|NCT01322347|157321074|FG001|Overall Study|blood transfusion|5|||
48858784|NCT01322347|157321073|FG000|Overall Study|sponsor decision|1|||
48858785|NCT01322347|157321074|FG001|Overall Study|sponsor decision|3|||
48952912|NCT00798967|157656501|FG000|Overall Study|Withdrawal by Subject|0|||
48952913|NCT00798967|157656502|FG001|Overall Study|Withdrawal by Subject|1|||
48952914|NCT00798967|157656501|FG000|Overall Study|Physician Decision|1|||
48952915|NCT00798967|157656502|FG001|Overall Study|Physician Decision|0|||
48952916|NCT00798967|157656501|FG000|Overall Study|Randomized in error by site|1|||
48952917|NCT00798967|157656502|FG001|Overall Study|Randomized in error by site|0|||
48952918|NCT01605396|157656503|FG000|Overall Study|Adverse Event|5|||
48952919|NCT01605396|157656504|FG001|Overall Study|Adverse Event|3|||
48952920|NCT01605396|157656503|FG000|Overall Study|Lost to Follow-up|1|||
48952921|NCT01605396|157656504|FG001|Overall Study|Lost to Follow-up|0|||
48952922|NCT01605396|157656503|FG000|Overall Study|Non-Compliance With Study Drug|1|||
48952923|NCT01605396|157656504|FG001|Overall Study|Non-Compliance With Study Drug|1|||
48952924|NCT01605396|157656503|FG000|Overall Study|Physician Decision|2|||
48858786|NCT01322347|157321073|FG000|Overall Study|ineligible|6|||
48952925|NCT01605396|157656504|FG001|Overall Study|Physician Decision|2|||
48858787|NCT01322347|157321074|FG001|Overall Study|ineligible|3|||
48858788|NCT01322347|157321073|FG000|Overall Study|kidney transplant|3|||
48952926|NCT01605396|157656503|FG000|Overall Study|Progressive Disease|23|||
48952927|NCT01605396|157656504|FG001|Overall Study|Progressive Disease|27|||
48858789|NCT01322347|157321074|FG001|Overall Study|kidney transplant|1|||
49015368|NCT00306384|157892156|FG000|Overall Study|Voluntary withdrawal|199|||
48952928|NCT01605396|157656503|FG000|Overall Study|Withdrawal by Subject|4|||
48858790|NCT01322347|157321073|FG000|Overall Study|study drug withheld > 12 wks|0|||
48858791|NCT01322347|157321074|FG001|Overall Study|study drug withheld > 12 wks|1|||
48858792|NCT01322347|157321073|FG000|Overall Study|moved/changed dialysis|2|||
48858793|NCT01322347|157321074|FG001|Overall Study|moved/changed dialysis|4|||
48858794|NCT00590759|157321077|FG000|Overall Study|Death|52|||
48858795|NCT00590759|157321077|FG000|Overall Study|Lost to Follow-up|28|||
48858796|NCT01109979|157321079|FG000|Overall Study|Physician Decision|2|||
48858797|NCT01109979|157321080|FG001|Overall Study|Physician Decision|0|||
48858798|NCT01109979|157321079|FG000|Overall Study|Withdrawal by Subject|0|||
48858799|NCT01109979|157321080|FG001|Overall Study|Withdrawal by Subject|1|||
48858800|NCT01494467|157321083|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|1|||
48858801|NCT01494467|157321084|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
48858802|NCT01494467|157321083|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|6|||
48858803|NCT01494467|157321084|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
48858804|NCT01494467|157321083|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9|||
48858805|NCT01494467|157321084|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8|||
48858806|NCT01494467|157321083|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|4|||
48858807|NCT01494467|157321084|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|0|||
48858808|NCT01494467|157321083|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
48858809|NCT01494467|157321084|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
48858810|NCT01494467|157321083|FG000|Part A Vehicle Control (12 Weeks)|Other|1|||
48858811|NCT01494467|157321084|FG001|Part A Vehicle Control (12 Weeks)|Other|1|||
48858812|NCT01494467|157321083|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
48858813|NCT01494467|157321084|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
48858814|NCT01494467|157321083|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|2|||
48858815|NCT01494467|157321084|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|0|||
48858816|NCT01494467|157321083|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1|||
48858817|NCT01494467|157321084|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
48858818|NCT01494467|157321083|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|3|||
48858819|NCT01494467|157321084|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
48858820|NCT01494467|157321083|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32|||
48858821|NCT01494467|157321084|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24|||
48858822|NCT01494467|157321083|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|3|||
48858823|NCT01494467|157321084|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|5|||
48858824|NCT01494467|157321083|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26|||
48858825|NCT01494467|157321084|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
48858826|NCT01494467|157321083|FG000|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8|||
48858827|NCT01494467|157321084|FG001|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2|||
48858828|NCT03136861|157321086|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3|||
48858829|NCT03136861|157321087|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2|||
48858830|NCT03136861|157321088|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
48858831|NCT03136861|157321089|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
48858832|NCT03136861|157321090|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
48858833|NCT03136861|157321091|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
48858834|NCT03136861|157321092|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
48858835|NCT03136861|157321086|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
48858836|NCT03136861|157321087|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
48858837|NCT03136861|157321088|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
48858838|NCT03136861|157321089|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
48952929|NCT01605396|157656504|FG001|Overall Study|Withdrawal by Subject|2|||
48952930|NCT01605396|157656503|FG000|Overall Study|Transfer Off Study|4|||
48952931|NCT01605396|157656504|FG001|Overall Study|Transfer Off Study|5|||
48952932|NCT05243550|157658135|FG000|Overall Study|Ongoing in the Study|171|||
48952933|NCT05243550|157658135|FG000|Overall Study|Withdrawal by Subject|10|||
48952934|NCT05243550|157658135|FG000|Overall Study|Lost to Follow-up|7|||
48952935|NCT05243550|157658135|FG000|Overall Study|Adverse Event|3|||
48952936|NCT05243550|157658135|FG000|Overall Study|Noncompliance|1|||
48952937|NCT05243550|157658135|FG000|Overall Study|Physician Decision|1|||
48952938|NCT05243550|157658135|FG000|Overall Study|Other Reason|4|||
48952939|NCT03391466|157658138|FG000|Overall Study|Death|82|||
48952940|NCT03391466|157658139|FG001|Overall Study|Death|85|||
48952941|NCT03391466|157658138|FG000|Overall Study|Still on study|93|||
48952942|NCT03391466|157658139|FG001|Overall Study|Still on study|74|||
48952943|NCT03391466|157658138|FG000|Overall Study|Subject withdrawal of consent from further follow-up|0|||
48952944|NCT03391466|157658139|FG001|Overall Study|Subject withdrawal of consent from further follow-up|13|||
48952945|NCT03391466|157658138|FG000|Overall Study|Lost to Follow-up|5|||
48952946|NCT03391466|157658139|FG001|Overall Study|Lost to Follow-up|5|||
48952947|NCT03391466|157658138|FG000|Overall Study|Investigator decision|0|||
48952948|NCT03391466|157658139|FG001|Overall Study|Investigator decision|1|||
48952949|NCT03391466|157658138|FG000|Overall Study|Other|0|||
48858839|NCT03136861|157321090|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
48745850|NCT03572062|156918048|FG004|Overall Study|Study Terminated By Sponsor|0|||
48952950|NCT03391466|157658139|FG001|Overall Study|Other|1|||
48952951|NCT01850563|157658140|FG000|Overall Study|Not eligible|3|||
48952952|NCT01850563|157658141|FG001|Overall Study|Not eligible|0|||
48952953|NCT02090114|157658151|FG000|Overall Study|Withdrawal by Subject|3|||
48952954|NCT02090114|157658152|FG001|Overall Study|Withdrawal by Subject|6|||
48952955|NCT02090114|157658153|FG002|Overall Study|Withdrawal by Subject|2|||
48952956|NCT02090114|157658154|FG003|Overall Study|Withdrawal by Subject|1|||
48952957|NCT02090114|157658151|FG000|Overall Study|Physician Decision|5|||
48952958|NCT02090114|157658152|FG001|Overall Study|Physician Decision|0|||
48952959|NCT02090114|157658153|FG002|Overall Study|Physician Decision|1|||
48952960|NCT02090114|157658154|FG003|Overall Study|Physician Decision|1|||
48952961|NCT02090114|157658151|FG000|Overall Study|Adverse Event|1|||
48952962|NCT02090114|157658152|FG001|Overall Study|Adverse Event|2|||
48952963|NCT02090114|157658153|FG002|Overall Study|Adverse Event|2|||
48952964|NCT02090114|157658154|FG003|Overall Study|Adverse Event|0|||
48952965|NCT02090114|157658151|FG000|Overall Study|Progressive Disease|20|||
48952966|NCT02090114|157658152|FG001|Overall Study|Progressive Disease|21|||
48952967|NCT02090114|157658153|FG002|Overall Study|Progressive Disease|23|||
48952968|NCT02090114|157658154|FG003|Overall Study|Progressive Disease|6|||
48952969|NCT02090114|157658151|FG000|Overall Study|Death|1|||
48952970|NCT02090114|157658152|FG001|Overall Study|Death|0|||
48952971|NCT02090114|157658153|FG002|Overall Study|Death|1|||
48952972|NCT02090114|157658154|FG003|Overall Study|Death|0|||
48952973|NCT00500149|157658155|FG000|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3|||
48952974|NCT00500149|157658156|FG001|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0|||
48952975|NCT00500149|157658155|FG000|Enrolled (Dose-optimization Phase)|Adverse Event|8|||
48952976|NCT00500149|157658156|FG001|Enrolled (Dose-optimization Phase)|Adverse Event|0|||
48952977|NCT00500149|157658155|FG000|Enrolled (Dose-optimization Phase)|Protocol Violation|1|||
48952978|NCT00500149|157658156|FG001|Enrolled (Dose-optimization Phase)|Protocol Violation|0|||
48952979|NCT00500149|157658155|FG000|First Intervention (Cross-over Phase)|Adverse Event|0|||
48952980|NCT00500149|157658156|FG001|First Intervention (Cross-over Phase)|Adverse Event|1|||
48952981|NCT00500149|157658155|FG000|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
48952982|NCT00500149|157658156|FG001|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
48952983|NCT00500149|157658155|FG000|First Intervention (Cross-over Phase)|Protocol Violation|1|||
48952984|NCT00500149|157658156|FG001|First Intervention (Cross-over Phase)|Protocol Violation|0|||
48952985|NCT00500149|157658155|FG000|Second Intervention (Cross-over Phase)|Lost to Follow-up|2|||
48952986|NCT00500149|157658156|FG001|Second Intervention (Cross-over Phase)|Lost to Follow-up|0|||
48952987|NCT01356602|157658157|FG000|Overall Study|Protocol Deviation|0|||
48952988|NCT01356602|157658158|FG001|Overall Study|Protocol Deviation|1|||
48952989|NCT01356602|157658159|FG002|Overall Study|Protocol Deviation|1|||
48952990|NCT01356602|157658157|FG000|Overall Study|Administrative Problems|1|||
48952991|NCT01356602|157658158|FG001|Overall Study|Administrative Problems|4|||
48952992|NCT01356602|157658159|FG002|Overall Study|Administrative Problems|5|||
48952993|NCT01356602|157658157|FG000|Overall Study|Lost to Follow-up|4|||
48952994|NCT01356602|157658158|FG001|Overall Study|Lost to Follow-up|5|||
48952995|NCT01356602|157658159|FG002|Overall Study|Lost to Follow-up|6|||
48952996|NCT01356602|157658157|FG000|Overall Study|Withdrawal by Subject|4|||
48952997|NCT01356602|157658158|FG001|Overall Study|Withdrawal by Subject|3|||
48952998|NCT01356602|157658159|FG002|Overall Study|Withdrawal by Subject|7|||
48952999|NCT01356602|157658157|FG000|Overall Study|Lack of Efficacy|0|||
48953000|NCT01356602|157658158|FG001|Overall Study|Lack of Efficacy|1|||
48953001|NCT01356602|157658159|FG002|Overall Study|Lack of Efficacy|4|||
48953002|NCT01356602|157658157|FG000|Overall Study|Adverse Event|0|||
48953003|NCT01356602|157658158|FG001|Overall Study|Adverse Event|1|||
48953004|NCT01356602|157658159|FG002|Overall Study|Adverse Event|1|||
48953005|NCT04353661|157658162|FG000|Overall Study|Protocol Violation|0|||
48953006|NCT04353661|157658163|FG001|Overall Study|Protocol Violation|0|||
48953007|NCT04353661|157658164|FG002|Overall Study|Protocol Violation|1|||
48953008|NCT04353661|157658162|FG000|Overall Study|Study termination by the Sponsor|1|||
48953009|NCT04353661|157658163|FG001|Overall Study|Study termination by the Sponsor|1|||
48953010|NCT04353661|157658164|FG002|Overall Study|Study termination by the Sponsor|1|||
48745851|NCT03572062|156918049|FG005|Overall Study|Study Terminated By Sponsor|0|||
48953011|NCT02778867|157658165|FG000|Phase 1|Withdrawal by Subject|2|||
48953012|NCT02778867|157658166|FG001|Phase 1|Withdrawal by Subject|3|||
48953013|NCT02778867|157658167|FG002|Phase 1|Withdrawal by Subject|0|||
48953014|NCT02778867|157658168|FG003|Phase 1|Withdrawal by Subject|0|||
48953015|NCT02778867|157658165|FG000|Phase 2|Withdrawal by Subject|0|||
49015369|NCT00306384|157892157|FG001|Overall Study|Voluntary withdrawal|187|||
48953016|NCT02778867|157658166|FG001|Phase 2|Withdrawal by Subject|0|||
48953017|NCT02778867|157658167|FG002|Phase 2|Withdrawal by Subject|1|||
48953018|NCT02778867|157658168|FG003|Phase 2|Withdrawal by Subject|0|||
48953019|NCT02778867|157658165|FG000|Phase 2|Physician Decision|0|||
48953020|NCT02778867|157658166|FG001|Phase 2|Physician Decision|0|||
48953021|NCT02778867|157658167|FG002|Phase 2|Physician Decision|0|||
48953022|NCT02778867|157658168|FG003|Phase 2|Physician Decision|1|||
48953023|NCT02778867|157658165|FG000|Phase 2|Adverse Event|0|||
48953024|NCT02778867|157658166|FG001|Phase 2|Adverse Event|0|||
48953025|NCT02778867|157658167|FG002|Phase 2|Adverse Event|0|||
48953026|NCT02778867|157658168|FG003|Phase 2|Adverse Event|1|||
48953027|NCT01539837|157658169|FG000|Overall Study|reduce neutrophil level|0|||
48953028|NCT01539837|157658170|FG001|Overall Study|reduce neutrophil level|1|||
48953029|NCT01539837|157658171|FG002|Overall Study|reduce neutrophil level|1|||
48953030|NCT01539837|157658169|FG000|Overall Study|bad compliance|0|||
48953031|NCT01539837|157658170|FG001|Overall Study|bad compliance|0|||
48953032|NCT01539837|157658171|FG002|Overall Study|bad compliance|1|||
48953033|NCT00960440|157658172|FG000|Overall Study|Death|0|||
48953034|NCT00960440|157658173|FG001|Overall Study|Death|0|||
48953035|NCT00960440|157658174|FG002|Overall Study|Death|0|||
48953036|NCT00960440|157658175|FG003|Overall Study|Death|1|||
48953037|NCT00960440|157658172|FG000|Overall Study|Adverse Event|12|||
48953038|NCT00960440|157658173|FG001|Overall Study|Adverse Event|12|||
48745852|NCT03572062|156918050|FG006|Overall Study|Study Terminated By Sponsor|0|||
48745853|NCT03572062|156918051|FG007|Overall Study|Study Terminated By Sponsor|0|||
48745854|NCT03572062|156918052|FG008|Overall Study|Study Terminated By Sponsor|29|||
48745855|NCT03572062|156918053|FG009|Overall Study|Study Terminated By Sponsor|27|||
48745856|NCT03572062|156918044|FG000|Overall Study|Physician Decision|0|||
48745857|NCT03572062|156918045|FG001|Overall Study|Physician Decision|0|||
48745858|NCT03572062|156918046|FG002|Overall Study|Physician Decision|0|||
48745859|NCT03572062|156918047|FG003|Overall Study|Physician Decision|0|||
48745860|NCT03572062|156918048|FG004|Overall Study|Physician Decision|0|||
48745861|NCT03572062|156918049|FG005|Overall Study|Physician Decision|0|||
48745862|NCT03572062|156918050|FG006|Overall Study|Physician Decision|0|||
48745863|NCT03572062|156918051|FG007|Overall Study|Physician Decision|0|||
48745864|NCT03572062|156918052|FG008|Overall Study|Physician Decision|1|||
48745865|NCT03572062|156918053|FG009|Overall Study|Physician Decision|0|||
48745866|NCT03572062|156918044|FG000|Overall Study|Withdrawal by Subject|0|||
48745867|NCT03572062|156918045|FG001|Overall Study|Withdrawal by Subject|0|||
48745868|NCT03572062|156918046|FG002|Overall Study|Withdrawal by Subject|0|||
48745869|NCT03572062|156918047|FG003|Overall Study|Withdrawal by Subject|0|||
48745870|NCT03572062|156918048|FG004|Overall Study|Withdrawal by Subject|0|||
48745871|NCT03572062|156918049|FG005|Overall Study|Withdrawal by Subject|0|||
48745872|NCT03572062|156918050|FG006|Overall Study|Withdrawal by Subject|0|||
48745873|NCT03572062|156918051|FG007|Overall Study|Withdrawal by Subject|0|||
48745874|NCT03572062|156918052|FG008|Overall Study|Withdrawal by Subject|0|||
48745875|NCT03572062|156918053|FG009|Overall Study|Withdrawal by Subject|1|||
48745876|NCT03572062|156918044|FG000|Overall Study|Randomized But Not Treated|0|||
48745877|NCT03572062|156918045|FG001|Overall Study|Randomized But Not Treated|0|||
48745878|NCT03572062|156918046|FG002|Overall Study|Randomized But Not Treated|0|||
48745879|NCT03572062|156918047|FG003|Overall Study|Randomized But Not Treated|0|||
48745880|NCT03572062|156918048|FG004|Overall Study|Randomized But Not Treated|1|||
48858840|NCT03136861|157321091|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
48858841|NCT03136861|157321092|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
48858842|NCT03136861|157321086|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2|||
48858843|NCT03136861|157321087|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1|||
48858844|NCT03136861|157321088|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
48858845|NCT03136861|157321089|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
48858846|NCT03136861|157321090|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
48858847|NCT03136861|157321091|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
48858848|NCT03136861|157321092|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
48858849|NCT03136861|157321086|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
48858850|NCT03136861|157321087|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1|||
48858851|NCT03136861|157321088|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
48858852|NCT03136861|157321089|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
48858853|NCT03136861|157321090|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
48858854|NCT03136861|157321091|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
48953039|NCT00960440|157658174|FG002|Overall Study|Adverse Event|4|||
48953040|NCT00960440|157658175|FG003|Overall Study|Adverse Event|4|||
48953041|NCT00960440|157658172|FG000|Overall Study|Lack of Efficacy|2|||
48745881|NCT03572062|156918049|FG005|Overall Study|Randomized But Not Treated|2|||
48745882|NCT03572062|156918050|FG006|Overall Study|Randomized But Not Treated|0|||
48745883|NCT03572062|156918051|FG007|Overall Study|Randomized But Not Treated|1|||
48953042|NCT00960440|157658173|FG001|Overall Study|Lack of Efficacy|5|||
48953043|NCT00960440|157658174|FG002|Overall Study|Lack of Efficacy|3|||
48953044|NCT00960440|157658175|FG003|Overall Study|Lack of Efficacy|8|||
48953045|NCT00960440|157658172|FG000|Overall Study|Protocol Violation|2|||
48953046|NCT00960440|157658173|FG001|Overall Study|Protocol Violation|8|||
48953047|NCT00960440|157658174|FG002|Overall Study|Protocol Violation|3|||
48953048|NCT00960440|157658175|FG003|Overall Study|Protocol Violation|4|||
48953049|NCT00960440|157658172|FG000|Overall Study|Withdrawal by Subject|9|||
48953050|NCT00960440|157658173|FG001|Overall Study|Withdrawal by Subject|5|||
48953051|NCT00960440|157658174|FG002|Overall Study|Withdrawal by Subject|2|||
48953052|NCT00960440|157658175|FG003|Overall Study|Withdrawal by Subject|1|||
48953053|NCT00960440|157658172|FG000|Overall Study|Other|1|||
48953054|NCT00960440|157658173|FG001|Overall Study|Other|1|||
48953055|NCT00960440|157658174|FG002|Overall Study|Other|1|||
48953056|NCT00960440|157658175|FG003|Overall Study|Other|0|||
48953057|NCT03623321|157658176|FG000|Overall Study|Adverse Event|32|||
48953058|NCT03623321|157658176|FG000|Overall Study|Death|9|||
48953059|NCT03623321|157658176|FG000|Overall Study|Lack of Efficacy|9|||
48953060|NCT03623321|157658176|FG000|Overall Study|Lost to Follow-up|6|||
48953061|NCT03623321|157658176|FG000|Overall Study|Noncompliance with study drug|6|||
48953062|NCT03623321|157658176|FG000|Overall Study|Use of prohibited medication|3|||
48953063|NCT03623321|157658176|FG000|Overall Study|Physician Decision|5|||
48953064|NCT03623321|157658176|FG000|Overall Study|Protocol Violation|1|||
48953065|NCT03623321|157658176|FG000|Overall Study|Consent withdrawn by patient or legally accepted representative|29|||
48953066|NCT03623321|157658176|FG000|Overall Study|Not further specified|43|||
48953067|NCT01703286|157658177|FG000|Period 1 Including Washout|Withdrawal by Subject|0|||
48953068|NCT01703286|157658178|FG001|Period 1 Including Washout|Withdrawal by Subject|0|||
48953069|NCT01703286|157658179|FG002|Period 1 Including Washout|Withdrawal by Subject|0|||
48953070|NCT01703286|157658180|FG003|Period 1 Including Washout|Withdrawal by Subject|1|||
48953071|NCT01703286|157658181|FG004|Period 1 Including Washout|Withdrawal by Subject|0|||
48953072|NCT01703286|157658182|FG005|Period 1 Including Washout|Withdrawal by Subject|1|||
48953073|NCT01703286|157658177|FG000|Period 2 Including Washout|Adverse Event|0|||
48953074|NCT01703286|157658178|FG001|Period 2 Including Washout|Adverse Event|0|||
48953075|NCT01703286|157658179|FG002|Period 2 Including Washout|Adverse Event|0|||
48953076|NCT01703286|157658180|FG003|Period 2 Including Washout|Adverse Event|1|||
48953077|NCT01703286|157658181|FG004|Period 2 Including Washout|Adverse Event|0|||
48953078|NCT01703286|157658182|FG005|Period 2 Including Washout|Adverse Event|0|||
48953079|NCT00931892|157658183|FG000|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0|||
48953080|NCT00931892|157658184|FG001|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1|||
48953081|NCT02531373|157658185|FG000|Overall Study|Lack of Efficacy|0|||
48953082|NCT02531373|157658186|FG001|Overall Study|Lack of Efficacy|0|||
48953083|NCT02531373|157658187|FG002|Overall Study|Lack of Efficacy|0|||
48953084|NCT02531373|157658188|FG003|Overall Study|Lack of Efficacy|0|||
48953085|NCT02531373|157658189|FG004|Overall Study|Lack of Efficacy|3|||
48953086|NCT02531373|157658190|FG005|Overall Study|Lack of Efficacy|2|||
48953087|NCT02531373|157658191|FG006|Overall Study|Lack of Efficacy|4|||
48953088|NCT02531373|157658192|FG007|Overall Study|Lack of Efficacy|8|||
48953089|NCT02531373|157658193|FG008|Overall Study|Lack of Efficacy|5|||
48953090|NCT02531373|157658185|FG000|Overall Study|Lost to Follow-up|0|||
48953091|NCT02531373|157658186|FG001|Overall Study|Lost to Follow-up|0|||
48953092|NCT02531373|157658187|FG002|Overall Study|Lost to Follow-up|0|||
48953093|NCT02531373|157658188|FG003|Overall Study|Lost to Follow-up|0|||
48953094|NCT02531373|157658189|FG004|Overall Study|Lost to Follow-up|0|||
48953095|NCT02531373|157658190|FG005|Overall Study|Lost to Follow-up|2|||
48953096|NCT02531373|157658191|FG006|Overall Study|Lost to Follow-up|2|||
48953097|NCT02531373|157658192|FG007|Overall Study|Lost to Follow-up|0|||
48953098|NCT02531373|157658193|FG008|Overall Study|Lost to Follow-up|0|||
48953099|NCT02531373|157658185|FG000|Overall Study|Physician Decision|0|||
48953100|NCT02531373|157658186|FG001|Overall Study|Physician Decision|0|||
48953101|NCT02531373|157658187|FG002|Overall Study|Physician Decision|0|||
48953102|NCT02531373|157658188|FG003|Overall Study|Physician Decision|0|||
48953103|NCT02531373|157658189|FG004|Overall Study|Physician Decision|2|||
48953104|NCT02531373|157658190|FG005|Overall Study|Physician Decision|1|||
48953105|NCT02531373|157658191|FG006|Overall Study|Physician Decision|0|||
48953106|NCT02531373|157658192|FG007|Overall Study|Physician Decision|0|||
48953107|NCT02531373|157658193|FG008|Overall Study|Physician Decision|0|||
48953108|NCT02531373|157658185|FG000|Overall Study|Protocol Violation|0|||
48953109|NCT02531373|157658186|FG001|Overall Study|Protocol Violation|0|||
48953110|NCT02531373|157658187|FG002|Overall Study|Protocol Violation|0|||
48953111|NCT02531373|157658188|FG003|Overall Study|Protocol Violation|0|||
48745884|NCT03572062|156918052|FG008|Overall Study|Randomized But Not Treated|0|||
48953112|NCT02531373|157658189|FG004|Overall Study|Protocol Violation|0|||
48953113|NCT02531373|157658190|FG005|Overall Study|Protocol Violation|1|||
48953114|NCT02531373|157658191|FG006|Overall Study|Protocol Violation|1|||
48953115|NCT02531373|157658192|FG007|Overall Study|Protocol Violation|0|||
48953116|NCT02531373|157658193|FG008|Overall Study|Protocol Violation|1|||
48953117|NCT02531373|157658185|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
48745885|NCT03572062|156918053|FG009|Overall Study|Randomized But Not Treated|0|||
48745886|NCT00519831|156918054|FG000|Overall Study|Adverse Event|3|||
48745887|NCT03200860|156918055|FG000|Overall Study|Withdrawal by Subject|1|||
48745888|NCT03200860|156918056|FG001|Overall Study|Withdrawal by Subject|0|||
48745889|NCT00662012|156918057|FG000|Overall Study|Lost to Follow-up|85|||
48745890|NCT00662012|156918057|FG000|Overall Study|Death|1|||
48745891|NCT00662012|156918057|FG000|Overall Study|Withdrawal by Subject|1|||
48745892|NCT02144012|156918058|FG000|Overall Study|Adverse Event|1|||
48745893|NCT02144012|156918059|FG001|Overall Study|Adverse Event|0|||
48745894|NCT02144012|156918058|FG000|Overall Study|Death|1|||
48745895|NCT02144012|156918059|FG001|Overall Study|Death|0|||
48745896|NCT02144012|156918058|FG000|Overall Study|Withdrawal by Subject|11|||
48745897|NCT02144012|156918059|FG001|Overall Study|Withdrawal by Subject|3|||
48745898|NCT02144012|156918058|FG000|Overall Study|Study Terminated by Sponsor|18|||
48745899|NCT02144012|156918059|FG001|Overall Study|Study Terminated by Sponsor|12|||
48745900|NCT02144012|156918058|FG000|Overall Study|Other|3|||
48745901|NCT02144012|156918059|FG001|Overall Study|Other|0|||
48745902|NCT02612727|156918060|FG000|Overall Study|Parent request|4|||
48745903|NCT02612727|156918061|FG001|Overall Study|Parent request|1|||
48745904|NCT02612727|156918060|FG000|Overall Study|Needed treatment incompatible with PT|1|||
48745905|NCT02612727|156918061|FG001|Overall Study|Needed treatment incompatible with PT|1|||
48745906|NCT02612727|156918060|FG000|Overall Study|Direct hyperbilirubinemia|0|||
48745907|NCT02612727|156918061|FG001|Overall Study|Direct hyperbilirubinemia|2|||
48745908|NCT03310775|156918065|FG000|Overall Study|Lost to Follow-up|2|||
48745909|NCT03310775|156918066|FG001|Overall Study|Lost to Follow-up|3|||
48745910|NCT03310775|156918065|FG000|Overall Study|aggravation of depression|0|||
48745911|NCT03310775|156918066|FG001|Overall Study|aggravation of depression|1|||
48745912|NCT03329573|156918067|FG000|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
48745913|NCT03329573|156918068|FG001|Treatment Period 1 (Up to 5 Days)|Adverse Event|1|||
48745914|NCT03329573|156918069|FG002|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
48745915|NCT03329573|156918070|FG003|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
48745916|NCT03329573|156918067|FG000|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
48745917|NCT03329573|156918068|FG001|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2|||
48745918|NCT03329573|156918069|FG002|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
48745919|NCT03329573|156918070|FG003|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
48745920|NCT03329573|156918067|FG000|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1|||
48745921|NCT03329573|156918068|FG001|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
48745922|NCT03329573|156918069|FG002|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
48745923|NCT03329573|156918070|FG003|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
48745924|NCT03329573|156918067|FG000|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
48745925|NCT03329573|156918068|FG001|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1|||
48745926|NCT03329573|156918069|FG002|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
48745927|NCT03329573|156918070|FG003|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
48745928|NCT00837811|156918071|FG000|Overall Study|Adverse Event|4|||
48745929|NCT00837811|156918072|FG001|Overall Study|Adverse Event|6|||
48745930|NCT00837811|156918073|FG002|Overall Study|Adverse Event|0|||
48745931|NCT00837811|156918071|FG000|Overall Study|Death|1|||
48745932|NCT00837811|156918072|FG001|Overall Study|Death|1|||
48745933|NCT00837811|156918073|FG002|Overall Study|Death|0|||
48745934|NCT00837811|156918071|FG000|Overall Study|Lack of Efficacy|0|||
48745935|NCT00837811|156918072|FG001|Overall Study|Lack of Efficacy|11|||
48745936|NCT00837811|156918073|FG002|Overall Study|Lack of Efficacy|0|||
48745937|NCT00837811|156918071|FG000|Overall Study|Lost to Follow-up|1|||
48745938|NCT00837811|156918072|FG001|Overall Study|Lost to Follow-up|3|||
48745939|NCT00837811|156918073|FG002|Overall Study|Lost to Follow-up|0|||
48745940|NCT00837811|156918071|FG000|Overall Study|Physician Decision|0|||
48745941|NCT00837811|156918072|FG001|Overall Study|Physician Decision|2|||
48745942|NCT00837811|156918073|FG002|Overall Study|Physician Decision|1|||
48745943|NCT00837811|156918071|FG000|Overall Study|Withdrawal by Subject|1|||
48745944|NCT00837811|156918072|FG001|Overall Study|Withdrawal by Subject|9|||
48745945|NCT00837811|156918073|FG002|Overall Study|Withdrawal by Subject|0|||
48745946|NCT00837811|156918071|FG000|Overall Study|Sponsor Decision|0|||
48745947|NCT00837811|156918072|FG001|Overall Study|Sponsor Decision|2|||
48745948|NCT00837811|156918073|FG002|Overall Study|Sponsor Decision|0|||
48745949|NCT01405456|156918074|FG000|Overall Study|Lost to Follow-up|2|||
48745950|NCT01405456|156918075|FG001|Overall Study|Lost to Follow-up|1|||
48858855|NCT03136861|157321092|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
48858856|NCT03136861|157321086|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
48745951|NCT01405456|156918074|FG000|Overall Study|Physician Decision|1|||
48745952|NCT01405456|156918075|FG001|Overall Study|Physician Decision|0|||
48745953|NCT01774968|156918076|FG000|Overall Study|Adverse Event|4|||
48745954|NCT01774968|156918077|FG001|Overall Study|Adverse Event|4|||
48745955|NCT01774968|156918076|FG000|Overall Study|Death|0|||
48745956|NCT01774968|156918077|FG001|Overall Study|Death|1|||
48745957|NCT01774968|156918076|FG000|Overall Study|Lost to Follow-up|1|||
48745958|NCT01774968|156918077|FG001|Overall Study|Lost to Follow-up|3|||
48745959|NCT01774968|156918076|FG000|Overall Study|Physician Decision|5|||
48745960|NCT01774968|156918077|FG001|Overall Study|Physician Decision|1|||
48745961|NCT01774968|156918076|FG000|Overall Study|Protocol Violation|14|||
48745962|NCT01774968|156918077|FG001|Overall Study|Protocol Violation|13|||
48745963|NCT01774968|156918076|FG000|Overall Study|Sponsor Decision|0|||
48745964|NCT01774968|156918077|FG001|Overall Study|Sponsor Decision|2|||
48953118|NCT02531373|157658186|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
48953119|NCT02531373|157658187|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
48953120|NCT02531373|157658188|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
48953121|NCT02531373|157658189|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
48953122|NCT02531373|157658190|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
48953123|NCT02531373|157658191|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
48953124|NCT02531373|157658192|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
48953125|NCT02531373|157658193|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
48953126|NCT02531373|157658185|FG000|Overall Study|Withdrawal by Subject|0|||
48953127|NCT02531373|157658186|FG001|Overall Study|Withdrawal by Subject|0|||
48953128|NCT02531373|157658187|FG002|Overall Study|Withdrawal by Subject|0|||
48953129|NCT02531373|157658188|FG003|Overall Study|Withdrawal by Subject|0|||
48953130|NCT02531373|157658189|FG004|Overall Study|Withdrawal by Subject|3|||
48953131|NCT02531373|157658190|FG005|Overall Study|Withdrawal by Subject|0|||
48953132|NCT02531373|157658191|FG006|Overall Study|Withdrawal by Subject|0|||
48953133|NCT02531373|157658192|FG007|Overall Study|Withdrawal by Subject|0|||
48953134|NCT02531373|157658193|FG008|Overall Study|Withdrawal by Subject|0|||
48953135|NCT05523362|157658194|FG000|Phase 1- Blinded (10 Days)|Unable to contact|2|||
48953136|NCT05523362|157658194|FG000|Phase 1- Blinded (10 Days)|High stress, did not want to continue|1|||
48953137|NCT05523362|157658194|FG000|Phase 1- Blinded (10 Days)|Technical issues with device|4|||
48953138|NCT05523362|157658194|FG000|Phase 1- Blinded (10 Days)|did not meet eligibility criteria|2|||
48953139|NCT00769704|157658198|FG000|Overall Study|Lost to Follow-up|3|||
48953140|NCT00769704|157658199|FG001|Overall Study|Lost to Follow-up|2|||
48953141|NCT00769704|157658198|FG000|Overall Study|Death|95|||
48953142|NCT00769704|157658199|FG001|Overall Study|Death|190|||
48953143|NCT00769704|157658198|FG000|Overall Study|Withdrawal by Subject|12|||
48745965|NCT01774968|156918076|FG000|Overall Study|Withdrawal by Subject|6|||
48745966|NCT01774968|156918077|FG001|Overall Study|Withdrawal by Subject|11|||
48745967|NCT01995825|156919684|FG000|Overall Study|Withdrawal by Subject|1|||
48745968|NCT01995825|156919685|FG001|Overall Study|Withdrawal by Subject|0|||
48745969|NCT01367002|156919688|FG000|Overall Study|Withdrawal by Subject|1|||
48745970|NCT01367002|156919689|FG001|Overall Study|Withdrawal by Subject|0|||
48745971|NCT01367002|156919688|FG000|Overall Study|Physician Decision|0|||
48745972|NCT01367002|156919689|FG001|Overall Study|Physician Decision|2|||
48745973|NCT02206048|156919690|FG000|Overall Study|Change in OR schedule and availability of study staff|1|||
48745974|NCT03311724|156919691|FG000|Overall Study|Physician Decision|0|||
48745975|NCT03311724|156919692|FG001|Overall Study|Physician Decision|0|||
48745976|NCT03311724|156919693|FG002|Overall Study|Physician Decision|0|||
48745977|NCT03311724|156919694|FG003|Overall Study|Physician Decision|1|||
48745978|NCT03311724|156919691|FG000|Overall Study|Protocol Violation|1|||
48745979|NCT03311724|156919692|FG001|Overall Study|Protocol Violation|0|||
48745980|NCT03311724|156919693|FG002|Overall Study|Protocol Violation|1|||
48745981|NCT03311724|156919694|FG003|Overall Study|Protocol Violation|0|||
48745982|NCT03311724|156919691|FG000|Overall Study|Withdrawal by Subject|1|||
48745983|NCT03311724|156919692|FG001|Overall Study|Withdrawal by Subject|1|||
48745984|NCT03311724|156919693|FG002|Overall Study|Withdrawal by Subject|0|||
48745985|NCT03311724|156919694|FG003|Overall Study|Withdrawal by Subject|0|||
48745986|NCT03311724|156919691|FG000|Overall Study|Lost to Follow-up|1|||
48745987|NCT03311724|156919692|FG001|Overall Study|Lost to Follow-up|0|||
48745988|NCT03311724|156919693|FG002|Overall Study|Lost to Follow-up|0|||
48745989|NCT03311724|156919694|FG003|Overall Study|Lost to Follow-up|0|||
48745990|NCT03311724|156919691|FG000|Overall Study|Sponsor Decision|0|||
48745991|NCT03311724|156919692|FG001|Overall Study|Sponsor Decision|0|||
48745992|NCT03311724|156919693|FG002|Overall Study|Sponsor Decision|1|||
48745993|NCT03311724|156919694|FG003|Overall Study|Sponsor Decision|0|||
48745994|NCT00777608|156919698|FG000|Overall Study|Lost to Follow-up|1|||
48745995|NCT00777608|156919699|FG001|Overall Study|Lost to Follow-up|1|||
48745996|NCT00777608|156919698|FG000|Overall Study|Withdrawal by Subject|1|||
48745997|NCT00777608|156919699|FG001|Overall Study|Withdrawal by Subject|3|||
48745998|NCT00777608|156919698|FG000|Overall Study|Protocol Violation|1|||
48858857|NCT03136861|157321087|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
48858858|NCT03136861|157321088|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
48745999|NCT00777608|156919699|FG001|Overall Study|Protocol Violation|0|||
48746000|NCT00777608|156919698|FG000|Overall Study|Investigator Decision|1|||
48858859|NCT03136861|157321089|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
48746001|NCT00777608|156919699|FG001|Overall Study|Investigator Decision|2|||
48746002|NCT01909674|156919701|FG000|Overall Study|Withdrawal by Subject|5|||
48746003|NCT01909674|156919702|FG001|Overall Study|Withdrawal by Subject|2|||
48746004|NCT00134082|156919703|FG000|Overall Study|Adverse Event|2|||
48746005|NCT00134082|156919703|FG000|Overall Study|Death|1|||
48746006|NCT00003499|156919704|FG000|Overall Study|Not evaluable|8|||
48746007|NCT00407797|156919705|FG000|Overall Study|Lost to Follow-up|2|||
48746008|NCT00407797|156919705|FG000|Overall Study|Adverse Event|6|||
48746009|NCT00407797|156919705|FG000|Overall Study|Other|7|||
48746010|NCT00407797|156919705|FG000|Overall Study|Withdrawal by Subject|3|||
48746011|NCT05228132|156919708|FG000|Overall Study|Investigation Early Termination by Sponsor|2|||
48746012|NCT05228132|156919708|FG000|Overall Study|Adverse Event|3|||
48746013|NCT05228132|156919708|FG000|Overall Study|Lost to Follow-up|1|||
48746014|NCT05228132|156919708|FG000|Overall Study|Arteriovenous-fistula mature|1|||
48746015|NCT02228460|156919709|FG000|Overall Study|Adverse Event|1|||
48746016|NCT02228460|156919709|FG000|Overall Study|Lost to Follow-up|1|||
48746017|NCT02627144|156919710|FG000|Overall Study|Serious adverse event|32|||
48746018|NCT02627144|156919710|FG000|Overall Study|Cancer progression|171|||
48746019|NCT02627144|156919710|FG000|Overall Study|Death from cancer|20|||
48746020|NCT02627144|156919710|FG000|Overall Study|Death from other cause|8|||
48746021|NCT02627144|156919710|FG000|Overall Study|Refusal of treatment / poor cooperation|38|||
48746022|NCT02627144|156919710|FG000|Overall Study|Administrative reasons|65|||
48746023|NCT02627144|156919710|FG000|Overall Study|Lost to Follow-up|8|||
48746024|NCT02627144|156919710|FG000|Overall Study|Enrolled, not treated|6|||
48746025|NCT02627144|156919710|FG000|Overall Study|Other|17|||
48746026|NCT01010061|156919712|FG000|Overall Study|Adverse Events or Intercurrent Illness|33|||
48746027|NCT01010061|156919713|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
48746028|NCT01010061|156919712|FG000|Overall Study|Disease Progression|2|||
48746029|NCT01010061|156919713|FG001|Overall Study|Disease Progression|8|||
48746030|NCT01010061|156919712|FG000|Overall Study|Withdrew Consent|5|||
48746031|NCT01010061|156919713|FG001|Overall Study|Withdrew Consent|1|||
48746032|NCT01010061|156919712|FG000|Overall Study|Death|3|||
48746033|NCT01010061|156919713|FG001|Overall Study|Death|6|||
48746034|NCT01010061|156919712|FG000|Overall Study|Administrative/Other|0|||
48746035|NCT01010061|156919713|FG001|Overall Study|Administrative/Other|1|||
48746036|NCT01010061|156919712|FG000|Overall Study|Refused Treatment/Did Not Cooperate|2|||
48746037|NCT01010061|156919713|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
48746038|NCT01010061|156919712|FG000|Overall Study|Insufficient Therapeutic Response|1|||
48746039|NCT01010061|156919713|FG001|Overall Study|Insufficient Therapeutic Response|5|||
48746040|NCT01010061|156919712|FG000|Overall Study|Violation of Selection Criteria|0|||
48746041|NCT01010061|156919713|FG001|Overall Study|Violation of Selection Criteria|1|||
48746042|NCT01010061|156919712|FG000|Overall Study|Did Not Receive Treatment|2|||
48746043|NCT01010061|156919713|FG001|Overall Study|Did Not Receive Treatment|2|||
48746044|NCT03470441|156919716|FG000|Overall Study|Death|0|||
48746045|NCT03470441|156919717|FG001|Overall Study|Death|1|||
48746046|NCT03470441|156919718|FG002|Overall Study|Death|1|||
48746047|NCT03470441|156919719|FG003|Overall Study|Death|0|||
48746048|NCT03470441|156919716|FG000|Overall Study|Adverse Event|0|||
48746049|NCT03470441|156919717|FG001|Overall Study|Adverse Event|0|||
48858860|NCT03136861|157321090|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
48746050|NCT03470441|156919718|FG002|Overall Study|Adverse Event|0|||
48746051|NCT03470441|156919719|FG003|Overall Study|Adverse Event|1|||
48746052|NCT03470441|156919716|FG000|Overall Study|Withdrawal by Subject|1|||
48858861|NCT03136861|157321091|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
48746053|NCT03470441|156919717|FG001|Overall Study|Withdrawal by Subject|4|||
48746054|NCT03470441|156919718|FG002|Overall Study|Withdrawal by Subject|1|||
48746055|NCT03470441|156919719|FG003|Overall Study|Withdrawal by Subject|3|||
48746056|NCT03982368|156919724|FG000|Overall Study|Adverse Event|6|||
48746057|NCT03982368|156919725|FG001|Overall Study|Adverse Event|4|||
48746058|NCT03982368|156919726|FG002|Overall Study|Adverse Event|3|||
48746059|NCT03982368|156919724|FG000|Overall Study|Lost to Follow-up|2|||
48858862|NCT03136861|157321092|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
48858863|NCT03136861|157321086|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
48858864|NCT03136861|157321087|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
48858865|NCT03136861|157321088|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
48858866|NCT03136861|157321089|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
48858867|NCT03136861|157321090|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2|||
48858868|NCT03136861|157321091|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
48858869|NCT03136861|157321092|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
48858870|NCT03136861|157321086|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
48858871|NCT03136861|157321087|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
48858872|NCT03136861|157321088|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1|||
48858873|NCT03136861|157321089|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
48858874|NCT03136861|157321090|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
48858875|NCT03136861|157321091|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
48858876|NCT03136861|157321092|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
48858877|NCT03136861|157321086|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
48858878|NCT03136861|157321087|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
48858879|NCT03136861|157321088|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1|||
48858880|NCT03136861|157321089|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
48858881|NCT03136861|157321090|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
48858882|NCT03136861|157321091|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
48953144|NCT00769704|157658199|FG001|Overall Study|Withdrawal by Subject|5|||
48953145|NCT00769704|157658198|FG000|Overall Study|Other|1|||
48953146|NCT00769704|157658199|FG001|Overall Study|Other|2|||
48953147|NCT01295905|157658204|FG000|Overall Study|Did not meet inclusion criteria|1|||
48953148|NCT01295905|157658205|FG001|Overall Study|Did not meet inclusion criteria|0|||
48953149|NCT01295905|157658204|FG000|Overall Study|Met exclusion criteria|1|||
48953150|NCT01295905|157658205|FG001|Overall Study|Met exclusion criteria|0|||
48953151|NCT02606045|157658206|FG000|Overall Study|Study closed before treament could begin|1|||
48953152|NCT02606045|157658207|FG001|Overall Study|Study closed before treament could begin|2|||
48953153|NCT02546856|157658208|FG000|4 Months Evaluation|Death|2|||
48953154|NCT02546856|157658209|FG001|4 Months Evaluation|Death|3|||
48953155|NCT02546856|157658208|FG000|4 Months Evaluation|Withdrawal by Subject|2|||
48858883|NCT03136861|157321092|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
48858884|NCT00584909|157321093|FG000|Overall Study|Adverse Event|4|||
48858885|NCT03345407|157321094|FG000|Overall Study|Withdrawal by Subject|11|||
48858886|NCT03345407|157321095|FG001|Overall Study|Withdrawal by Subject|1|||
48858887|NCT03345407|157321096|FG002|Overall Study|Withdrawal by Subject|5|||
48858888|NCT03345407|157321097|FG003|Overall Study|Withdrawal by Subject|6|||
48858889|NCT03345407|157321098|FG004|Overall Study|Withdrawal by Subject|3|||
48858890|NCT03345407|157321099|FG005|Overall Study|Withdrawal by Subject|6|||
48858891|NCT03345407|157321100|FG006|Overall Study|Withdrawal by Subject|16|||
48858892|NCT03345407|157321094|FG000|Overall Study|Physician Decision|3|||
48858893|NCT03345407|157321095|FG001|Overall Study|Physician Decision|1|||
48858894|NCT03345407|157321096|FG002|Overall Study|Physician Decision|0|||
48858895|NCT03345407|157321097|FG003|Overall Study|Physician Decision|0|||
48858896|NCT03345407|157321098|FG004|Overall Study|Physician Decision|1|||
48858897|NCT03345407|157321099|FG005|Overall Study|Physician Decision|2|||
48858898|NCT03345407|157321100|FG006|Overall Study|Physician Decision|3|||
48858899|NCT03345407|157321094|FG000|Overall Study|Lost to Follow-up|2|||
48953156|NCT02546856|157658209|FG001|4 Months Evaluation|Withdrawal by Subject|3|||
48953157|NCT02546856|157658208|FG000|4 Months Evaluation|Lost to Follow-up|3|||
48953158|NCT02546856|157658209|FG001|4 Months Evaluation|Lost to Follow-up|3|||
48953159|NCT02546856|157658208|FG000|4 Months Evaluation|Physician Decision|3|||
48746060|NCT03982368|156919725|FG001|Overall Study|Lost to Follow-up|1|||
48746061|NCT03982368|156919726|FG002|Overall Study|Lost to Follow-up|0|||
48746062|NCT03982368|156919724|FG000|Overall Study|Withdrawal by Subject|1|||
48746063|NCT03982368|156919725|FG001|Overall Study|Withdrawal by Subject|2|||
48746064|NCT03982368|156919726|FG002|Overall Study|Withdrawal by Subject|0|||
48953160|NCT02546856|157658209|FG001|4 Months Evaluation|Physician Decision|0|||
48953161|NCT02546856|157658208|FG000|4 Months Evaluation|Working or living abroad|5|||
48953162|NCT02546856|157658209|FG001|4 Months Evaluation|Working or living abroad|1|||
48953163|NCT02546856|157658208|FG000|4 Months Evaluation|reasons not due to titration|4|||
48953164|NCT02546856|157658209|FG001|4 Months Evaluation|reasons not due to titration|1|||
48953165|NCT02546856|157658208|FG000|4 Months Evaluation|HF Unit not active in summer|1|||
48953166|NCT02546856|157658209|FG001|4 Months Evaluation|HF Unit not active in summer|0|||
48953167|NCT02546856|157658208|FG000|6 Months Evaluation|Death|1|||
48953168|NCT02546856|157658209|FG001|6 Months Evaluation|Death|1|||
48953169|NCT02546856|157658208|FG000|6 Months Evaluation|Lost to Follow-up|1|||
48953170|NCT02546856|157658209|FG001|6 Months Evaluation|Lost to Follow-up|1|||
48953171|NCT02546856|157658208|FG000|6 Months Evaluation|Working or living abroad|6|||
48953172|NCT02546856|157658209|FG001|6 Months Evaluation|Working or living abroad|4|||
48953173|NCT02546856|157658208|FG000|6 Months Evaluation|reasons not due to titration|0|||
48953174|NCT02546856|157658209|FG001|6 Months Evaluation|reasons not due to titration|1|||
48953175|NCT04492722|157658213|FG000|Overall Study|Adverse Event|7|||
48953176|NCT04492722|157658214|FG001|Overall Study|Adverse Event|2|||
48953177|NCT04492722|157658215|FG002|Overall Study|Adverse Event|3|||
48953178|NCT04492722|157658216|FG003|Overall Study|Adverse Event|0|||
48953179|NCT04492722|157658213|FG000|Overall Study|Death|0|||
48953180|NCT04492722|157658214|FG001|Overall Study|Death|0|||
48953181|NCT04492722|157658215|FG002|Overall Study|Death|0|||
48953182|NCT04492722|157658216|FG003|Overall Study|Death|1|||
48953183|NCT04492722|157658213|FG000|Overall Study|Lost to Follow-up|0|||
48953184|NCT04492722|157658214|FG001|Overall Study|Lost to Follow-up|1|||
48953185|NCT04492722|157658215|FG002|Overall Study|Lost to Follow-up|0|||
48953186|NCT04492722|157658216|FG003|Overall Study|Lost to Follow-up|1|||
48953187|NCT04492722|157658213|FG000|Overall Study|Physician Decision|0|||
48953188|NCT04492722|157658214|FG001|Overall Study|Physician Decision|3|||
48746065|NCT03982368|156919724|FG000|Overall Study|unknow|4|||
48746066|NCT03982368|156919725|FG001|Overall Study|unknow|0|||
48746067|NCT03982368|156919726|FG002|Overall Study|unknow|2|||
48746068|NCT00660309|156919729|FG000|Overall Study|Adverse Event|2|||
48953189|NCT04492722|157658215|FG002|Overall Study|Physician Decision|1|||
48953190|NCT04492722|157658216|FG003|Overall Study|Physician Decision|1|||
48953191|NCT04492722|157658213|FG000|Overall Study|Withdrawal by Subject|6|||
48953192|NCT04492722|157658214|FG001|Overall Study|Withdrawal by Subject|6|||
48953193|NCT04492722|157658215|FG002|Overall Study|Withdrawal by Subject|0|||
48953194|NCT04492722|157658216|FG003|Overall Study|Withdrawal by Subject|3|||
48953195|NCT04492722|157658213|FG000|Overall Study|Development of Study Specific Withdrawal Criteria|3|||
48953196|NCT04492722|157658214|FG001|Overall Study|Development of Study Specific Withdrawal Criteria|1|||
48953197|NCT04492722|157658215|FG002|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
48953198|NCT04492722|157658216|FG003|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
48953199|NCT04492722|157658213|FG000|Overall Study|Due to Covid-19 pandemic|7|||
48953200|NCT04492722|157658214|FG001|Overall Study|Due to Covid-19 pandemic|3|||
48953201|NCT04492722|157658215|FG002|Overall Study|Due to Covid-19 pandemic|7|||
48953202|NCT04492722|157658216|FG003|Overall Study|Due to Covid-19 pandemic|6|||
48953203|NCT04492722|157658213|FG000|Overall Study|Failure to meet randomisation criteria|2|||
48953204|NCT04492722|157658214|FG001|Overall Study|Failure to meet randomisation criteria|3|||
48953205|NCT04492722|157658215|FG002|Overall Study|Failure to meet randomisation criteria|4|||
48953206|NCT04492722|157658216|FG003|Overall Study|Failure to meet randomisation criteria|2|||
48953207|NCT04492722|157658213|FG000|Overall Study|Early termination from the study|54|||
48953208|NCT04492722|157658214|FG001|Overall Study|Early termination from the study|51|||
48953209|NCT04492722|157658215|FG002|Overall Study|Early termination from the study|50|||
48953210|NCT04492722|157658216|FG003|Overall Study|Early termination from the study|50|||
48953211|NCT04492722|157658213|FG000|Overall Study|Missing|3|||
48953212|NCT04492722|157658214|FG001|Overall Study|Missing|0|||
48953213|NCT04492722|157658215|FG002|Overall Study|Missing|0|||
48953214|NCT04492722|157658216|FG003|Overall Study|Missing|5|||
48953215|NCT04492722|157658213|FG000|Overall Study|Participants who did not receive treatment|0|||
48953216|NCT04492722|157658214|FG001|Overall Study|Participants who did not receive treatment|1|||
48953217|NCT04492722|157658215|FG002|Overall Study|Participants who did not receive treatment|4|||
48953218|NCT04492722|157658216|FG003|Overall Study|Participants who did not receive treatment|0|||
48953219|NCT04429503|157658217|FG000|Overall Study|Non-compliance with protocol by the subject|2|||
48953220|NCT04429503|157658218|FG001|Overall Study|Non-compliance with protocol by the subject|1|||
48953221|NCT04429503|157658219|FG002|Overall Study|Non-compliance with protocol by the subject|0|||
48953222|NCT04429503|157658217|FG000|Overall Study|Adverse Event|1|||
48953223|NCT04429503|157658218|FG001|Overall Study|Adverse Event|9|||
48953224|NCT04429503|157658219|FG002|Overall Study|Adverse Event|2|||
48953225|NCT04429503|157658217|FG000|Overall Study|Decision by the investigator/sponsor|2|||
48953226|NCT04429503|157658218|FG001|Overall Study|Decision by the investigator/sponsor|9|||
48953227|NCT04429503|157658219|FG002|Overall Study|Decision by the investigator/sponsor|3|||
48953228|NCT04429503|157658217|FG000|Overall Study|Withdrawal by Subject|9|||
48953229|NCT04429503|157658218|FG001|Overall Study|Withdrawal by Subject|17|||
48953230|NCT04429503|157658219|FG002|Overall Study|Withdrawal by Subject|8|||
48953231|NCT04429503|157658217|FG000|Overall Study|Lost to Follow-up|5|||
48953232|NCT04429503|157658218|FG001|Overall Study|Lost to Follow-up|19|||
48953233|NCT04429503|157658219|FG002|Overall Study|Lost to Follow-up|7|||
48953234|NCT04429503|157658217|FG000|Overall Study|Death|9|||
48953235|NCT04429503|157658218|FG001|Overall Study|Death|18|||
48953236|NCT04429503|157658219|FG002|Overall Study|Death|5|||
48953237|NCT01703819|157658221|FG000|Overall Study|Adverse Event|0|||
48953238|NCT01703819|157658222|FG001|Overall Study|Adverse Event|1|||
48953239|NCT01703819|157658221|FG000|Overall Study|Withdrawal by Subject|0|||
48953240|NCT01703819|157658222|FG001|Overall Study|Withdrawal by Subject|1|||
48953241|NCT02926573|157658228|FG000|Overall Study|Nausea|1|||
48953242|NCT02926573|157658229|FG001|Overall Study|Nausea|0|||
48953243|NCT02926573|157658228|FG000|Overall Study|Remain intubated|2|||
48953244|NCT02926573|157658229|FG001|Overall Study|Remain intubated|2|||
48953245|NCT02926573|157658228|FG000|Overall Study|Change in surgery plan|3|||
48953246|NCT02926573|157658229|FG001|Overall Study|Change in surgery plan|1|||
48953247|NCT02926573|157658228|FG000|Overall Study|Change to outpatient status|5|||
48953248|NCT02926573|157658229|FG001|Overall Study|Change to outpatient status|1|||
48953249|NCT02926573|157658228|FG000|Overall Study|Withdrawal by Subject|0|||
48953250|NCT02926573|157658229|FG001|Overall Study|Withdrawal by Subject|2|||
48953251|NCT02926573|157658228|FG000|Overall Study|Return to operating room|0|||
48953252|NCT02926573|157658229|FG001|Overall Study|Return to operating room|2|||
48953253|NCT02926573|157658228|FG000|Overall Study|Delirium|0|||
48953254|NCT02926573|157658229|FG001|Overall Study|Delirium|1|||
48953255|NCT00406315|157658230|FG000|Overall Study|Death|1|||
48953256|NCT00406315|157658230|FG000|Overall Study|Adverse Event|39|||
48953257|NCT00406315|157658230|FG000|Overall Study|Laboratory Abnormality|4|||
48953258|NCT00406315|157658230|FG000|Overall Study|Lack of Efficacy|13|||
48953259|NCT00406315|157658230|FG000|Overall Study|Other|33|||
48953260|NCT00406315|157658230|FG000|Overall Study|Lost to Follow-up|21|||
48953261|NCT00406315|157658230|FG000|Overall Study|Withdrawal by Subject|30|||
48953262|NCT04314778|157658237|FG000|Overall Study|Lost to Follow-up|5|||
48953263|NCT04314778|157658238|FG001|Overall Study|Lost to Follow-up|3|||
48953264|NCT01734993|157658240|FG000|Overall Study|Adverse Event|1|||
48953265|NCT01734993|157658240|FG000|Overall Study|Lack of Efficacy|1|||
48953266|NCT02619253|157658244|FG000|Overall Study|Adverse Event|0|||
48953267|NCT02619253|157658245|FG001|Overall Study|Adverse Event|0|||
48953268|NCT02619253|157658246|FG002|Overall Study|Adverse Event|1|||
48953269|NCT02619253|157658247|FG003|Overall Study|Adverse Event|1|||
48953270|NCT02619253|157658248|FG004|Overall Study|Adverse Event|3|||
48953271|NCT02619253|157658244|FG000|Overall Study|Alternative Therapy|0|||
48953272|NCT02619253|157658245|FG001|Overall Study|Alternative Therapy|0|||
48953273|NCT02619253|157658246|FG002|Overall Study|Alternative Therapy|1|||
48953274|NCT02619253|157658247|FG003|Overall Study|Alternative Therapy|0|||
48953275|NCT02619253|157658248|FG004|Overall Study|Alternative Therapy|0|||
48953276|NCT02619253|157658244|FG000|Overall Study|Death|0|||
48953277|NCT02619253|157658245|FG001|Overall Study|Death|0|||
48953278|NCT02619253|157658246|FG002|Overall Study|Death|0|||
48953279|NCT02619253|157658247|FG003|Overall Study|Death|1|||
48953280|NCT02619253|157658248|FG004|Overall Study|Death|0|||
48953281|NCT02619253|157658244|FG000|Overall Study|Disease Progression|4|||
48953282|NCT02619253|157658245|FG001|Overall Study|Disease Progression|2|||
48953283|NCT02619253|157658246|FG002|Overall Study|Disease Progression|8|||
48953284|NCT02619253|157658247|FG003|Overall Study|Disease Progression|9|||
48953285|NCT02619253|157658248|FG004|Overall Study|Disease Progression|10|||
48953286|NCT02619253|157658244|FG000|Overall Study|Needed a disqualifying therapy|0|||
48953287|NCT02619253|157658245|FG001|Overall Study|Needed a disqualifying therapy|0|||
48953288|NCT02619253|157658246|FG002|Overall Study|Needed a disqualifying therapy|1|||
48953289|NCT02619253|157658247|FG003|Overall Study|Needed a disqualifying therapy|0|||
48953290|NCT02619253|157658248|FG004|Overall Study|Needed a disqualifying therapy|0|||
48953291|NCT02619253|157658244|FG000|Overall Study|Transferred to hospice|0|||
48953292|NCT02619253|157658245|FG001|Overall Study|Transferred to hospice|0|||
48953293|NCT02619253|157658246|FG002|Overall Study|Transferred to hospice|1|||
48746069|NCT00660309|156919730|FG001|Overall Study|Adverse Event|0|||
48953294|NCT02619253|157658247|FG003|Overall Study|Transferred to hospice|0|||
48953295|NCT02619253|157658248|FG004|Overall Study|Transferred to hospice|0|||
48953296|NCT02619253|157658244|FG000|Overall Study|Physician Decision|0|||
48953297|NCT02619253|157658245|FG001|Overall Study|Physician Decision|1|||
48953298|NCT02619253|157658246|FG002|Overall Study|Physician Decision|2|||
48953299|NCT02619253|157658247|FG003|Overall Study|Physician Decision|3|||
48953300|NCT02619253|157658248|FG004|Overall Study|Physician Decision|0|||
48953301|NCT02619253|157658244|FG000|Overall Study|Withdrawal by Subject|0|||
48953302|NCT02619253|157658245|FG001|Overall Study|Withdrawal by Subject|1|||
48953303|NCT02619253|157658246|FG002|Overall Study|Withdrawal by Subject|0|||
48858900|NCT03345407|157321095|FG001|Overall Study|Lost to Follow-up|0|||
48858901|NCT03345407|157321096|FG002|Overall Study|Lost to Follow-up|1|||
48858902|NCT03345407|157321097|FG003|Overall Study|Lost to Follow-up|0|||
48858903|NCT03345407|157321098|FG004|Overall Study|Lost to Follow-up|1|||
48858904|NCT03345407|157321099|FG005|Overall Study|Lost to Follow-up|2|||
48858905|NCT03345407|157321100|FG006|Overall Study|Lost to Follow-up|3|||
48858906|NCT03345407|157321094|FG000|Overall Study|Protocol-defined stopping criteria|9|||
48858907|NCT03345407|157321095|FG001|Overall Study|Protocol-defined stopping criteria|0|||
48858908|NCT03345407|157321096|FG002|Overall Study|Protocol-defined stopping criteria|0|||
48858909|NCT03345407|157321097|FG003|Overall Study|Protocol-defined stopping criteria|0|||
48858910|NCT03345407|157321098|FG004|Overall Study|Protocol-defined stopping criteria|2|||
48858911|NCT03345407|157321099|FG005|Overall Study|Protocol-defined stopping criteria|1|||
48858912|NCT03345407|157321100|FG006|Overall Study|Protocol-defined stopping criteria|1|||
48858913|NCT03345407|157321094|FG000|Overall Study|Protocol Violation|2|||
48858914|NCT03345407|157321095|FG001|Overall Study|Protocol Violation|0|||
48858915|NCT03345407|157321096|FG002|Overall Study|Protocol Violation|0|||
48858916|NCT03345407|157321097|FG003|Overall Study|Protocol Violation|0|||
48858917|NCT03345407|157321098|FG004|Overall Study|Protocol Violation|1|||
48858918|NCT03345407|157321099|FG005|Overall Study|Protocol Violation|0|||
48858919|NCT03345407|157321100|FG006|Overall Study|Protocol Violation|3|||
48858920|NCT03345407|157321094|FG000|Overall Study|Lack of Efficacy|1|||
48858921|NCT03345407|157321095|FG001|Overall Study|Lack of Efficacy|1|||
48858922|NCT03345407|157321096|FG002|Overall Study|Lack of Efficacy|1|||
48858923|NCT03345407|157321097|FG003|Overall Study|Lack of Efficacy|1|||
48858924|NCT03345407|157321098|FG004|Overall Study|Lack of Efficacy|1|||
48858925|NCT03345407|157321099|FG005|Overall Study|Lack of Efficacy|0|||
48858926|NCT03345407|157321100|FG006|Overall Study|Lack of Efficacy|3|||
48858927|NCT03345407|157321094|FG000|Overall Study|Adverse Event|4|||
48858928|NCT03345407|157321095|FG001|Overall Study|Adverse Event|0|||
48858929|NCT03345407|157321096|FG002|Overall Study|Adverse Event|5|||
48858930|NCT03345407|157321097|FG003|Overall Study|Adverse Event|4|||
48858931|NCT03345407|157321098|FG004|Overall Study|Adverse Event|6|||
48858932|NCT03345407|157321099|FG005|Overall Study|Adverse Event|5|||
48858933|NCT03345407|157321100|FG006|Overall Study|Adverse Event|16|||
48953304|NCT02619253|157658247|FG003|Overall Study|Withdrawal by Subject|0|||
48953305|NCT02619253|157658248|FG004|Overall Study|Withdrawal by Subject|2|||
48953306|NCT02116972|157658249|FG000|Overall Study|Adverse Event|4|||
48953307|NCT02116972|157658250|FG001|Overall Study|Adverse Event|4|||
48953308|NCT02116972|157658251|FG002|Overall Study|Adverse Event|1|||
48953309|NCT02116972|157658249|FG000|Overall Study|Withdrawal by Subject|1|||
48953310|NCT02116972|157658250|FG001|Overall Study|Withdrawal by Subject|1|||
48953311|NCT02116972|157658251|FG002|Overall Study|Withdrawal by Subject|5|||
48953312|NCT02116972|157658249|FG000|Overall Study|Protocol Violation|1|||
48953313|NCT02116972|157658250|FG001|Overall Study|Protocol Violation|0|||
48953314|NCT02116972|157658251|FG002|Overall Study|Protocol Violation|1|||
48953315|NCT02116972|157658249|FG000|Overall Study|Lost to Follow-up|4|||
48953316|NCT02116972|157658250|FG001|Overall Study|Lost to Follow-up|3|||
48953317|NCT02116972|157658251|FG002|Overall Study|Lost to Follow-up|1|||
48953318|NCT02116972|157658249|FG000|Overall Study|Lack of Efficacy|6|||
48953319|NCT02116972|157658250|FG001|Overall Study|Lack of Efficacy|6|||
48953320|NCT02116972|157658251|FG002|Overall Study|Lack of Efficacy|5|||
48953321|NCT02116972|157658249|FG000|Overall Study|scheduling conflicts and relocation|3|||
48953322|NCT02116972|157658250|FG001|Overall Study|scheduling conflicts and relocation|3|||
48953323|NCT02116972|157658251|FG002|Overall Study|scheduling conflicts and relocation|6|||
48953324|NCT01400971|157658252|FG000|Overall Study|Death|82|||
48953325|NCT01400971|157658252|FG000|Overall Study|Lost to Follow-up|196|||
48953326|NCT01400971|157658252|FG000|Overall Study|Lost to follow up + Subject Decision|2|||
48953327|NCT01400971|157658252|FG000|Overall Study|Physician Decision|57|||
48953328|NCT01400971|157658252|FG000|Overall Study|Withdrawal by Subject|158|||
48953329|NCT01400971|157658252|FG000|Overall Study|Other|422|||
48953330|NCT01757704|157658253|FG000|Overall Study|Protocol Violation|1|||
48953331|NCT01757704|157658254|FG001|Overall Study|Protocol Violation|3|||
48953332|NCT01975272|157658261|FG000|Overall Study|Excluded after protocol amendment|1|||
48953333|NCT01975272|157658262|FG001|Overall Study|Excluded after protocol amendment|1|||
48953334|NCT01975272|157658263|FG002|Overall Study|Excluded after protocol amendment|2|||
48953335|NCT00863928|157658264|FG000|Overall Study|Protocol Violation|26|||
48953336|NCT00863928|157658265|FG001|Overall Study|Protocol Violation|0|||
48953337|NCT00863928|157658264|FG000|Overall Study|Withdrawal by Subject|3|||
48953338|NCT00863928|157658265|FG001|Overall Study|Withdrawal by Subject|0|||
48953339|NCT00863928|157658264|FG000|Overall Study|surgery cancellation|4|||
48953340|NCT00863928|157658265|FG001|Overall Study|surgery cancellation|0|||
48953341|NCT00863928|157658264|FG000|Overall Study|medication allergy|3|||
48953342|NCT00863928|157658265|FG001|Overall Study|medication allergy|0|||
48953343|NCT02375698|157658266|FG000|Overall Study|Withdrawal by Subject|0|||
48953344|NCT02375698|157658267|FG001|Overall Study|Withdrawal by Subject|2|||
48953345|NCT02375698|157658266|FG000|Overall Study|Physician Decision|2|||
48953346|NCT02375698|157658267|FG001|Overall Study|Physician Decision|0|||
48953347|NCT00719732|157658270|FG000|Overall Study|Lost to Follow-up|20|||
48953348|NCT00719732|157658270|FG000|Overall Study|Unilateral (not bilateral) implantation|1|||
48953349|NCT00719732|157658270|FG000|Overall Study|Illness not associated with device|1|||
48953350|NCT04598165|157658272|FG000|Completed 6-week Follow-up|Withdrawal by Subject|6|||
48953351|NCT04598165|157658273|FG001|Completed 6-week Follow-up|Withdrawal by Subject|3|||
48953352|NCT04598165|157658272|FG000|Completed 6-week Follow-up|Death|2|||
48953353|NCT04598165|157658273|FG001|Completed 6-week Follow-up|Death|1|||
48953354|NCT04598165|157658272|FG000|Completed 6-week Follow-up|Lost to Follow-up|26|||
48746070|NCT00660309|156919729|FG000|Overall Study|Withdrawal by Subject|0|||
48746071|NCT00660309|156919730|FG001|Overall Study|Withdrawal by Subject|3|||
48746072|NCT00730405|156919733|FG000|Overall Study-Treatment Phase|Adverse Event|5|||
48746073|NCT00730405|156919734|FG001|Overall Study-Treatment Phase|Adverse Event|10|||
48746074|NCT00730405|156919735|FG002|Overall Study-Treatment Phase|Adverse Event|4|||
48746075|NCT00730405|156919736|FG003|Overall Study-Treatment Phase|Adverse Event|8|||
48746076|NCT00730405|156919737|FG004|Overall Study-Treatment Phase|Adverse Event|4|||
48746077|NCT00730405|156919733|FG000|Overall Study-Treatment Phase|Lost to Follow-up|4|||
48746078|NCT00730405|156919734|FG001|Overall Study-Treatment Phase|Lost to Follow-up|5|||
48746079|NCT00730405|156919735|FG002|Overall Study-Treatment Phase|Lost to Follow-up|6|||
48746080|NCT00730405|156919736|FG003|Overall Study-Treatment Phase|Lost to Follow-up|4|||
48746081|NCT00730405|156919737|FG004|Overall Study-Treatment Phase|Lost to Follow-up|4|||
48746082|NCT00730405|156919733|FG000|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
48746083|NCT00730405|156919734|FG001|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
48746084|NCT00730405|156919735|FG002|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5|||
48746085|NCT00730405|156919736|FG003|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
48746086|NCT00730405|156919737|FG004|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
48746087|NCT00730405|156919733|FG000|Overall Study-Treatment Phase|Withdrawal by Subject|7|||
48746088|NCT00730405|156919734|FG001|Overall Study-Treatment Phase|Withdrawal by Subject|1|||
48746089|NCT00730405|156919735|FG002|Overall Study-Treatment Phase|Withdrawal by Subject|2|||
48746090|NCT00730405|156919736|FG003|Overall Study-Treatment Phase|Withdrawal by Subject|5|||
48746091|NCT00730405|156919737|FG004|Overall Study-Treatment Phase|Withdrawal by Subject|8|||
48746092|NCT00730405|156919733|FG000|Overall Study-Treatment Phase|Did not met eligibility|0|||
48746093|NCT00730405|156919734|FG001|Overall Study-Treatment Phase|Did not met eligibility|0|||
48746094|NCT00730405|156919735|FG002|Overall Study-Treatment Phase|Did not met eligibility|1|||
48746095|NCT00730405|156919736|FG003|Overall Study-Treatment Phase|Did not met eligibility|0|||
48746096|NCT00730405|156919737|FG004|Overall Study-Treatment Phase|Did not met eligibility|0|||
48746097|NCT00730405|156919733|FG000|Overall Study-Treatment Phase|Participant meets exclusion|0|||
48746098|NCT00730405|156919734|FG001|Overall Study-Treatment Phase|Participant meets exclusion|0|||
48746099|NCT00730405|156919735|FG002|Overall Study-Treatment Phase|Participant meets exclusion|1|||
48746100|NCT00730405|156919736|FG003|Overall Study-Treatment Phase|Participant meets exclusion|0|||
48746101|NCT00730405|156919737|FG004|Overall Study-Treatment Phase|Participant meets exclusion|0|||
48746102|NCT00730405|156919733|FG000|Overall Study-Treatment Phase|Prohibited concomitant medication|1|||
48746103|NCT00730405|156919734|FG001|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
48746104|NCT00730405|156919735|FG002|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
48746105|NCT00730405|156919736|FG003|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
48746106|NCT00730405|156919737|FG004|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
48746107|NCT00730405|156919733|FG000|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
48746108|NCT00730405|156919734|FG001|Overall Study-Treatment Phase|Withdrew from study treatment|1|||
48746109|NCT00730405|156919735|FG002|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
48746110|NCT00730405|156919736|FG003|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
48746111|NCT00730405|156919737|FG004|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
48746112|NCT00730405|156919733|FG000|Overall Study-Treatment Phase|Use of prohibited medication|0|||
48746113|NCT00730405|156919734|FG001|Overall Study-Treatment Phase|Use of prohibited medication|1|||
48746114|NCT00730405|156919735|FG002|Overall Study-Treatment Phase|Use of prohibited medication|0|||
48746115|NCT00730405|156919736|FG003|Overall Study-Treatment Phase|Use of prohibited medication|0|||
48746116|NCT00730405|156919737|FG004|Overall Study-Treatment Phase|Use of prohibited medication|2|||
48746117|NCT00730405|156919733|FG000|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
48746118|NCT00730405|156919734|FG001|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
48746119|NCT00730405|156919735|FG002|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1|||
48746120|NCT00730405|156919736|FG003|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
48746121|NCT00730405|156919737|FG004|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
48746122|NCT00730405|156919733|FG000|Overall Study-Treatment Phase|Misrandomized|0|||
48746123|NCT00730405|156919734|FG001|Overall Study-Treatment Phase|Misrandomized|1|||
48746124|NCT00730405|156919735|FG002|Overall Study-Treatment Phase|Misrandomized|0|||
48746125|NCT00730405|156919736|FG003|Overall Study-Treatment Phase|Misrandomized|0|||
48746126|NCT00730405|156919737|FG004|Overall Study-Treatment Phase|Misrandomized|0|||
48746127|NCT00730405|156919733|FG000|Overall Study-Treatment Phase|Study drug interrupted|0|||
48746128|NCT00730405|156919734|FG001|Overall Study-Treatment Phase|Study drug interrupted|1|||
48746129|NCT00730405|156919735|FG002|Overall Study-Treatment Phase|Study drug interrupted|0|||
48746130|NCT00730405|156919736|FG003|Overall Study-Treatment Phase|Study drug interrupted|0|||
48746131|NCT00730405|156919737|FG004|Overall Study-Treatment Phase|Study drug interrupted|0|||
48746132|NCT00730405|156919733|FG000|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
48746133|NCT00730405|156919734|FG001|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
48746134|NCT00730405|156919735|FG002|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
48746135|NCT00730405|156919736|FG003|Overall Study-Treatment Phase|Due to in-vitro fertilization|1|||
48746136|NCT00730405|156919737|FG004|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
48746137|NCT00730405|156919733|FG000|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
48746138|NCT00730405|156919734|FG001|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
48746139|NCT00730405|156919735|FG002|Overall Study-Treatment Phase|Protocol violation due to eligibility|1|||
48746140|NCT00730405|156919736|FG003|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
48746141|NCT00730405|156919737|FG004|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
48746142|NCT00730405|156919733|FG000|Overall Study-Treatment Phase|Change of location|0|||
48746143|NCT00730405|156919734|FG001|Overall Study-Treatment Phase|Change of location|0|||
48746144|NCT00730405|156919735|FG002|Overall Study-Treatment Phase|Change of location|0|||
48746145|NCT00730405|156919736|FG003|Overall Study-Treatment Phase|Change of location|1|||
48746146|NCT00730405|156919737|FG004|Overall Study-Treatment Phase|Change of location|0|||
48746147|NCT00730405|156919733|FG000|Overall Study-Treatment Phase|Pregnancy|0|||
48746148|NCT00730405|156919734|FG001|Overall Study-Treatment Phase|Pregnancy|1|||
48858934|NCT01294644|157321101|FG000|Overall Study|Adverse Event|2|||
48858935|NCT01294644|157321102|FG001|Overall Study|Adverse Event|0|||
48858936|NCT01294644|157321103|FG002|Overall Study|Adverse Event|1|||
48858937|NCT01294644|157321101|FG000|Overall Study|Withdrawal by Subject|3|||
48858938|NCT01294644|157321102|FG001|Overall Study|Withdrawal by Subject|7|||
48858939|NCT01294644|157321103|FG002|Overall Study|Withdrawal by Subject|4|||
48858940|NCT01294644|157321101|FG000|Overall Study|Lost to Follow-up|3|||
48858941|NCT01294644|157321102|FG001|Overall Study|Lost to Follow-up|2|||
48746149|NCT00730405|156919735|FG002|Overall Study-Treatment Phase|Pregnancy|0|||
48746150|NCT00730405|156919736|FG003|Overall Study-Treatment Phase|Pregnancy|0|||
48746151|NCT00730405|156919737|FG004|Overall Study-Treatment Phase|Pregnancy|0|||
48746152|NCT00730405|156919733|FG000|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
48746153|NCT00730405|156919734|FG001|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
48746154|NCT00730405|156919735|FG002|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
48746155|NCT00730405|156919736|FG003|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
48746156|NCT00730405|156919737|FG004|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1|||
48746157|NCT00730405|156919733|FG000|Overall Study-Treatment Phase|Atrial fibrillation history|1|||
48746158|NCT00730405|156919734|FG001|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
48746159|NCT00730405|156919735|FG002|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
48746160|NCT00730405|156919736|FG003|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
48746161|NCT00730405|156919737|FG004|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
48746162|NCT00730405|156919733|FG000|Overall Study-follow-up Phase|Adverse Event|2|||
48746163|NCT00730405|156919734|FG001|Overall Study-follow-up Phase|Adverse Event|6|||
48746164|NCT00730405|156919735|FG002|Overall Study-follow-up Phase|Adverse Event|2|||
48746165|NCT00730405|156919736|FG003|Overall Study-follow-up Phase|Adverse Event|3|||
48746166|NCT00730405|156919737|FG004|Overall Study-follow-up Phase|Adverse Event|4|||
48746167|NCT00730405|156919733|FG000|Overall Study-follow-up Phase|Lost to Follow-up|7|||
48746168|NCT00730405|156919734|FG001|Overall Study-follow-up Phase|Lost to Follow-up|6|||
48858942|NCT01294644|157321103|FG002|Overall Study|Lost to Follow-up|5|||
48746169|NCT00730405|156919735|FG002|Overall Study-follow-up Phase|Lost to Follow-up|8|||
48746170|NCT00730405|156919736|FG003|Overall Study-follow-up Phase|Lost to Follow-up|4|||
48858943|NCT01294644|157321101|FG000|Overall Study|Miscellaneous Reason|2|||
48858944|NCT01294644|157321102|FG001|Overall Study|Miscellaneous Reason|1|||
48858945|NCT01294644|157321103|FG002|Overall Study|Miscellaneous Reason|4|||
48858946|NCT02612285|157321104|FG000|Overall Study|Withdrawal by Subject|1|||
48858947|NCT02245620|157322347|FG000|Overall Study|Physician Decision|1|||
48858948|NCT02245620|157322348|FG001|Overall Study|Physician Decision|1|||
48858949|NCT03262389|157322352|FG000|Overall Study|Machine malfunction Day 1, no return Day 2|1|||
48858950|NCT03262389|157322352|FG000|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1|||
48746171|NCT00730405|156919737|FG004|Overall Study-follow-up Phase|Lost to Follow-up|6|||
48746172|NCT00730405|156919733|FG000|Overall Study-follow-up Phase|Withdrawal by Subject|7|||
48746173|NCT00730405|156919734|FG001|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
48746174|NCT00730405|156919735|FG002|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
48746175|NCT00730405|156919736|FG003|Overall Study-follow-up Phase|Withdrawal by Subject|6|||
48746176|NCT00730405|156919737|FG004|Overall Study-follow-up Phase|Withdrawal by Subject|10|||
48746177|NCT00730405|156919733|FG000|Overall Study-follow-up Phase|Death|0|||
48746178|NCT00730405|156919734|FG001|Overall Study-follow-up Phase|Death|1|||
48746179|NCT00730405|156919735|FG002|Overall Study-follow-up Phase|Death|0|||
48746180|NCT00730405|156919736|FG003|Overall Study-follow-up Phase|Death|1|||
48746181|NCT00730405|156919737|FG004|Overall Study-follow-up Phase|Death|0|||
48746182|NCT00730405|156919733|FG000|Overall Study-follow-up Phase|Change of location|1|||
48746183|NCT00730405|156919734|FG001|Overall Study-follow-up Phase|Change of location|1|||
48746184|NCT00730405|156919735|FG002|Overall Study-follow-up Phase|Change of location|0|||
48746185|NCT00730405|156919736|FG003|Overall Study-follow-up Phase|Change of location|1|||
48746186|NCT00730405|156919737|FG004|Overall Study-follow-up Phase|Change of location|0|||
48746187|NCT00730405|156919733|FG000|Overall Study-follow-up Phase|Did not met eligibility|0|||
48746188|NCT00730405|156919734|FG001|Overall Study-follow-up Phase|Did not met eligibility|0|||
48746189|NCT00730405|156919735|FG002|Overall Study-follow-up Phase|Did not met eligibility|1|||
48746190|NCT00730405|156919736|FG003|Overall Study-follow-up Phase|Did not met eligibility|0|||
48746191|NCT00730405|156919737|FG004|Overall Study-follow-up Phase|Did not met eligibility|0|||
48746192|NCT00730405|156919733|FG000|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
48746193|NCT00730405|156919734|FG001|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
48746194|NCT00730405|156919735|FG002|Overall Study-follow-up Phase|Non-compliance with study treatment|1|||
48746195|NCT00730405|156919736|FG003|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
48746196|NCT00730405|156919737|FG004|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
48746197|NCT00730405|156919733|FG000|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
48746198|NCT00730405|156919734|FG001|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
48746199|NCT00730405|156919735|FG002|Overall Study-follow-up Phase|Participant meets exclusion criteria|1|||
48746200|NCT00730405|156919736|FG003|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
48746201|NCT00730405|156919737|FG004|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
48746202|NCT00730405|156919733|FG000|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
48746203|NCT00730405|156919734|FG001|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
48746204|NCT00730405|156919735|FG002|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
48746205|NCT00730405|156919736|FG003|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
48746206|NCT00730405|156919737|FG004|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1|||
48858951|NCT03262389|157322352|FG000|Overall Study|opted out of PET/MR|1|||
48858952|NCT01543204|157322354|FG000|Overall Study|Non-compliance|1|||
48858953|NCT01543204|157322354|FG000|Overall Study|Adverse Event|1|||
48746207|NCT00730405|156919733|FG000|Overall Study-follow-up Phase|Prohibited concomitant medication|1|||
48746208|NCT00730405|156919734|FG001|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
48746209|NCT00730405|156919735|FG002|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
48746210|NCT00730405|156919736|FG003|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
48746211|NCT00730405|156919737|FG004|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
48746212|NCT00730405|156919733|FG000|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
48746213|NCT00730405|156919734|FG001|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
48746214|NCT00730405|156919735|FG002|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
48746215|NCT00730405|156919736|FG003|Overall Study-follow-up Phase|Refused follow-up due to AE|1|||
48746216|NCT00730405|156919737|FG004|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
48746217|NCT00730405|156919733|FG000|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
48746218|NCT00730405|156919734|FG001|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
48746219|NCT00730405|156919735|FG002|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
48746220|NCT00730405|156919736|FG003|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
48746221|NCT00730405|156919737|FG004|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
48746222|NCT00730405|156919733|FG000|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
48746223|NCT00730405|156919734|FG001|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
48746224|NCT00730405|156919735|FG002|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
48746225|NCT00730405|156919736|FG003|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
48746226|NCT00730405|156919737|FG004|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
48746227|NCT00730405|156919733|FG000|Overall Study-follow-up Phase|Use of restricted medication|0|||
48746228|NCT00730405|156919734|FG001|Overall Study-follow-up Phase|Use of restricted medication|1|||
48746229|NCT00730405|156919735|FG002|Overall Study-follow-up Phase|Use of restricted medication|0|||
48746230|NCT00730405|156919736|FG003|Overall Study-follow-up Phase|Use of restricted medication|0|||
48746231|NCT00730405|156919737|FG004|Overall Study-follow-up Phase|Use of restricted medication|0|||
48746232|NCT00730405|156919733|FG000|Overall Study-follow-up Phase|Non-compliance|1|||
48746233|NCT00730405|156919734|FG001|Overall Study-follow-up Phase|Non-compliance|0|||
48746234|NCT00730405|156919735|FG002|Overall Study-follow-up Phase|Non-compliance|2|||
48746235|NCT00730405|156919736|FG003|Overall Study-follow-up Phase|Non-compliance|0|||
48953355|NCT04598165|157658273|FG001|Completed 6-week Follow-up|Lost to Follow-up|33|||
48953356|NCT04598165|157658272|FG000|Completed 6-week Follow-up|Ineligible|4|||
48953357|NCT04598165|157658273|FG001|Completed 6-week Follow-up|Ineligible|3|||
48953358|NCT04598165|157658272|FG000|Completed 6-week Follow-up|Partner refusal|0|||
48953359|NCT04598165|157658273|FG001|Completed 6-week Follow-up|Partner refusal|1|||
48953360|NCT04598165|157658272|FG000|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|67|||
48953361|NCT04598165|157658273|FG001|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|69|||
48953362|NCT01323673|157658274|FG000|Overall Study|Adverse Event|0|||
48953363|NCT01323673|157658275|FG001|Overall Study|Adverse Event|1|||
48953364|NCT01323673|157658274|FG000|Overall Study|Lost to Follow-up|0|||
48953365|NCT01323673|157658275|FG001|Overall Study|Lost to Follow-up|1|||
48953366|NCT01323673|157658274|FG000|Overall Study|Protocol Violation|1|||
48953367|NCT01323673|157658275|FG001|Overall Study|Protocol Violation|0|||
48953368|NCT01323673|157658274|FG000|Overall Study|Withdrawal by Subject|2|||
48953369|NCT01323673|157658275|FG001|Overall Study|Withdrawal by Subject|3|||
48953370|NCT05091060|157658276|FG000|Overall Study|Lost to Follow-up|1|||
48953371|NCT00001262|157658278|FG000|Overall Study|Death|10|||
48953372|NCT00001262|157658279|FG001|Overall Study|Death|11|||
48953373|NCT00001262|157658280|FG002|Overall Study|Death|0|||
48953374|NCT00001262|157658278|FG000|Overall Study|Withdrawal by Subject|0|||
48953375|NCT00001262|157658279|FG001|Overall Study|Withdrawal by Subject|3|||
48953376|NCT00001262|157658280|FG002|Overall Study|Withdrawal by Subject|0|||
48953377|NCT01798706|157658283|FG000|Overall Study|Adverse Event|15|||
48953378|NCT01798706|157658284|FG001|Overall Study|Adverse Event|10|||
48953379|NCT01798706|157658283|FG000|Overall Study|Lack of Efficacy|0|||
48953380|NCT01798706|157658284|FG001|Overall Study|Lack of Efficacy|2|||
48953381|NCT01798706|157658283|FG000|Overall Study|Poor compliance to protocol|1|||
48953382|NCT01798706|157658284|FG001|Overall Study|Poor compliance to protocol|0|||
48953383|NCT01798706|157658283|FG000|Overall Study|Other than specified above|5|||
48953384|NCT01798706|157658284|FG001|Overall Study|Other than specified above|9|||
48953385|NCT01752842|157658285|FG000|Overall Study|Adverse Event|3|||
48746236|NCT00730405|156919737|FG004|Overall Study-follow-up Phase|Non-compliance|0|||
48953386|NCT01752842|157658286|FG001|Overall Study|Adverse Event|0|||
48953387|NCT01752842|157658285|FG000|Overall Study|Withdrawal by Subject|0|||
48953388|NCT01752842|157658286|FG001|Overall Study|Withdrawal by Subject|2|||
48953389|NCT03135028|157658287|FG000|Overall Study|Death|6|||
48953390|NCT03135028|157658287|FG000|Overall Study|Study Terminated by Sponsor|2|||
48746237|NCT00730405|156919733|FG000|Overall Study-follow-up Phase|Missing|0|||
48746238|NCT00730405|156919734|FG001|Overall Study-follow-up Phase|Missing|0|||
48746239|NCT00730405|156919735|FG002|Overall Study-follow-up Phase|Missing|2|||
48746240|NCT00730405|156919736|FG003|Overall Study-follow-up Phase|Missing|0|||
48746241|NCT00730405|156919737|FG004|Overall Study-follow-up Phase|Missing|0|||
48746242|NCT00730405|156919733|FG000|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
48746243|NCT00730405|156919734|FG001|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
48746244|NCT00730405|156919735|FG002|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
48746245|NCT00730405|156919736|FG003|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
48746246|NCT00730405|156919737|FG004|Overall Study-follow-up Phase|Use an exclusionary medication|1|||
48746247|NCT00730405|156919733|FG000|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
48746248|NCT00730405|156919734|FG001|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
48746249|NCT00730405|156919735|FG002|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1|||
48746250|NCT00730405|156919736|FG003|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
48746251|NCT00730405|156919737|FG004|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
48746252|NCT00730405|156919733|FG000|Overall Study-follow-up Phase|Mis-randomized|0|||
48746253|NCT00730405|156919734|FG001|Overall Study-follow-up Phase|Mis-randomized|1|||
48746254|NCT00730405|156919735|FG002|Overall Study-follow-up Phase|Mis-randomized|0|||
48746255|NCT00730405|156919736|FG003|Overall Study-follow-up Phase|Mis-randomized|0|||
48746256|NCT00730405|156919737|FG004|Overall Study-follow-up Phase|Mis-randomized|0|||
48746257|NCT00730405|156919733|FG000|Overall Study-follow-up Phase|Other Protocol violation|0|||
48746258|NCT00730405|156919734|FG001|Overall Study-follow-up Phase|Other Protocol violation|0|||
48746259|NCT00730405|156919735|FG002|Overall Study-follow-up Phase|Other Protocol violation|1|||
48953391|NCT03135028|157658287|FG000|Overall Study|Withdrew Consent|1|||
48953392|NCT00783705|157658290|FG000|Overall Study|Adverse Event|2|||
48953393|NCT00783705|157658291|FG001|Overall Study|Adverse Event|0|||
48953394|NCT00783705|157658290|FG000|Overall Study|Withdrawal by Subject|3|||
48953395|NCT00783705|157658291|FG001|Overall Study|Withdrawal by Subject|2|||
48953396|NCT00783705|157658290|FG000|Overall Study|Lost to Follow-up|1|||
48746260|NCT00730405|156919736|FG003|Overall Study-follow-up Phase|Other Protocol violation|0|||
48746261|NCT00730405|156919737|FG004|Overall Study-follow-up Phase|Other Protocol violation|0|||
48746262|NCT00730405|156919733|FG000|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
48953397|NCT00783705|157658291|FG001|Overall Study|Lost to Follow-up|3|||
48953398|NCT00496873|157658292|FG000|Overall Study|Ineligible|2|||
48953399|NCT00496873|157658292|FG000|Overall Study|Death|2|||
48953400|NCT00496873|157658292|FG000|Overall Study|Withdrawal by Subject|3|||
48953401|NCT03759379|157659589|FG000|Treatment Period|Remained in this Period at Time of Data Cut|119|||
48953402|NCT03759379|157659590|FG001|Treatment Period|Remained in this Period at Time of Data Cut|38|||
48953403|NCT03759379|157659589|FG000|Treatment Period|Death|2|||
48953404|NCT03759379|157659590|FG001|Treatment Period|Death|3|||
48953405|NCT03759379|157659589|FG000|Treatment Period|Lost to Follow-up|1|||
48953406|NCT03759379|157659590|FG001|Treatment Period|Lost to Follow-up|0|||
48953407|NCT03759379|157659589|FG000|Treatment Period|Physician Decision|0|||
48953408|NCT03759379|157659590|FG001|Treatment Period|Physician Decision|1|||
48953409|NCT03762850|157659593|FG000|Overall Study|Death|0|||
48953410|NCT03762850|157659594|FG001|Overall Study|Death|1|||
48953411|NCT03762850|157659593|FG000|Overall Study|Lost to Follow-up|0|||
48953412|NCT03762850|157659594|FG001|Overall Study|Lost to Follow-up|1|||
48953413|NCT03762850|157659593|FG000|Overall Study|Physician Decision|0|||
48953414|NCT03762850|157659594|FG001|Overall Study|Physician Decision|1|||
48953415|NCT03762850|157659593|FG000|Overall Study|Withdrawal by Subject|4|||
48953416|NCT03762850|157659594|FG001|Overall Study|Withdrawal by Subject|9|||
48953417|NCT04267562|157659595|FG000|Assessed for Eligibility|Screen Failure|64|||
48953418|NCT04267562|157659595|FG000|Assessed for Eligibility|Trial enrollment reached|23|||
48746263|NCT00730405|156919734|FG001|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
48746264|NCT00730405|156919735|FG002|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
48746265|NCT00730405|156919736|FG003|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1|||
48746266|NCT00730405|156919737|FG004|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
48746267|NCT00730405|156919733|FG000|Overall Study-follow-up Phase|Atrial fibrillation history|1|||
48746268|NCT00730405|156919734|FG001|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
48746269|NCT00730405|156919735|FG002|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
48746270|NCT00730405|156919736|FG003|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
48746271|NCT00730405|156919737|FG004|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
48746272|NCT01496807|156919741|FG000|Overall Study|Progressive Disease|21|||
48746273|NCT01496807|156919741|FG000|Overall Study|Participant preference/toxicity|8|||
48746274|NCT01496807|156919741|FG000|Overall Study|Change in diagnosis|1|||
48746275|NCT00496470|156919745|FG000|Overall Study|Adverse Event|8|||
48746276|NCT00496470|156919746|FG001|Overall Study|Adverse Event|10|||
48746277|NCT00496470|156919745|FG000|Overall Study|Withdrawal by Subject|5|||
48746278|NCT00496470|156919746|FG001|Overall Study|Withdrawal by Subject|12|||
48746279|NCT00496470|156919745|FG000|Overall Study|Incorrectly enrolled|13|||
48746280|NCT00496470|156919746|FG001|Overall Study|Incorrectly enrolled|5|||
48746281|NCT00496470|156919745|FG000|Overall Study|Other reason|0|||
48746282|NCT00496470|156919746|FG001|Overall Study|Other reason|2|||
48746283|NCT02516163|156919747|FG000|Overall Study|Withdrawal by Subject|1|||
48858954|NCT01543204|157322354|FG000|Overall Study|Withdrawal by Subject|4|||
48858955|NCT01543204|157322354|FG000|Overall Study|Requirement for Alternative Therapy|1|||
48858956|NCT01543204|157322354|FG000|Overall Study|Lost to Follow-up|1|||
48858957|NCT00113529|157322355|FG000|Overall Study|Adverse Event|4|||
48746284|NCT02516163|156919747|FG000|Overall Study|Failed MRI/incorrect MRI protocol|11|||
48746285|NCT02516163|156919747|FG000|Overall Study|Unfit/delay in surgery|3|||
48746286|NCT02516163|156919747|FG000|Overall Study|Use of incorrect measurement technique|5|||
48746287|NCT02516163|156919747|FG000|Overall Study|Data not recorded|2|||
48746288|NCT02516163|156919747|FG000|Overall Study|MRI contraindication exclusion|6|||
48746289|NCT02801396|156919753|FG000|Period 1|Withdrawal by Subject|0|||
48746290|NCT02801396|156919754|FG001|Period 1|Withdrawal by Subject|0|||
48746291|NCT02801396|156919755|FG002|Period 1|Withdrawal by Subject|0|||
48746292|NCT02801396|156919756|FG003|Period 1|Withdrawal by Subject|0|||
48746293|NCT02801396|156919757|FG004|Period 1|Withdrawal by Subject|1|||
48746294|NCT02801396|156919758|FG005|Period 1|Withdrawal by Subject|0|||
48746295|NCT00729651|156919759|FG000|Overall Study|Withdrawal by Subject|5|||
48746296|NCT00729651|156919760|FG001|Overall Study|Withdrawal by Subject|6|||
48746297|NCT00729651|156919759|FG000|Overall Study|Lost to Follow-up|5|||
48746298|NCT00729651|156919760|FG001|Overall Study|Lost to Follow-up|4|||
48746299|NCT00729651|156919759|FG000|Overall Study|Protocol Violation|0|||
48746300|NCT00729651|156919760|FG001|Overall Study|Protocol Violation|1|||
48746301|NCT00729651|156919759|FG000|Overall Study|Adverse Event|7|||
48746302|NCT00729651|156919760|FG001|Overall Study|Adverse Event|3|||
48746303|NCT00729651|156919759|FG000|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0|||
48953419|NCT04267562|157659595|FG000|Assessed for Eligibility|Withdrawal by Subject|9|||
48953420|NCT04267562|157659595|FG000|Assessed for Eligibility|Site closure|6|||
48953421|NCT04267562|157659595|FG000|Assessed for Eligibility|Lost to Follow-up|2|||
48746304|NCT00729651|156919760|FG001|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4|||
48746305|NCT00729651|156919759|FG000|Overall Study|Subject's private reason|2|||
48746306|NCT00729651|156919760|FG001|Overall Study|Subject's private reason|0|||
48746307|NCT00880009|156919761|FG000|Overall Study|Study terminated by sponsor|14|||
48746308|NCT00880009|156919761|FG000|Overall Study|Withdrawal by Subject|1|||
48746309|NCT00880009|156919761|FG000|Overall Study|Protocol Violation|1|||
48746310|NCT01844518|156919762|FG000|Overall Study|Adverse Event|7|||
48746311|NCT01844518|156919763|FG001|Overall Study|Adverse Event|1|||
48746312|NCT01844518|156919762|FG000|Overall Study|Lack of Efficacy|17|||
48746313|NCT01844518|156919763|FG001|Overall Study|Lack of Efficacy|5|||
48746314|NCT01844518|156919762|FG000|Overall Study|Participant's request to discontinue|4|||
48746315|NCT01844518|156919763|FG001|Overall Study|Participant's request to discontinue|1|||
48746316|NCT01844518|156919762|FG000|Overall Study|Poor/Non-compliance|1|||
48746317|NCT01844518|156919763|FG001|Overall Study|Poor/Non-compliance|0|||
48746318|NCT01844518|156919762|FG000|Overall Study|No Longer Met Study Criteria|2|||
48746319|NCT01844518|156919763|FG001|Overall Study|No Longer Met Study Criteria|0|||
48746320|NCT01844518|156919762|FG000|Overall Study|Withdrawal by Subject|9|||
48746321|NCT01844518|156919763|FG001|Overall Study|Withdrawal by Subject|0|||
48746322|NCT01844518|156919762|FG000|Overall Study|Pregnancy|1|||
48953422|NCT04267562|157659595|FG000|Assessed for Eligibility|Physician Decision|1|||
48953423|NCT04267562|157659595|FG000|Month 24|Elective hysterectomy|1|||
48953424|NCT04267562|157659595|FG000|Month 24|Lost to Follow-up|1|||
48746323|NCT01844518|156919763|FG001|Overall Study|Pregnancy|0|||
48746324|NCT02094677|156919764|FG000|Overall Study|Screening|3|||
48746325|NCT02094677|156919765|FG001|Overall Study|Screening|1|||
48746326|NCT00291577|156919766|FG000|Overall Study|Adverse Event|1|||
48746327|NCT00291577|156919766|FG000|Overall Study|Other|4|||
48746328|NCT00291577|156919766|FG000|Overall Study|Withdrawal by Subject|2|||
48953425|NCT04267562|157659595|FG000|Month 36|Elective hysterectomy|2|||
48746329|NCT00291577|156919766|FG000|Overall Study|Lack of Efficacy|14|||
48746330|NCT01365910|156919769|FG000|Overall Study|Withdrawal by Subject|7|||
48746331|NCT01365910|156919769|FG000|Overall Study|disease progression|18|||
48746332|NCT01365910|156919769|FG000|Overall Study|Adverse Event|3|||
48746333|NCT01365910|156919769|FG000|Overall Study|other complicating disease|1|||
48953426|NCT04267562|157659595|FG000|Month 36|Lost to Follow-up|3|||
49015370|NCT00306384|157892158|FG002|Overall Study|Voluntary withdrawal|91|||
48746334|NCT01365910|156919769|FG000|Overall Study|pt did not get tx, nausea/vomiting|1|||
48746335|NCT04502693|156919770|FG000|Overall Study|Adverse Event|7|||
48746336|NCT04502693|156919771|FG001|Overall Study|Adverse Event|6|||
48746337|NCT04502693|156919772|FG002|Overall Study|Adverse Event|11|||
48746338|NCT04502693|156919773|FG003|Overall Study|Adverse Event|1|||
48746339|NCT04502693|156919770|FG000|Overall Study|Lost to Follow-up|32|||
48746340|NCT04502693|156919771|FG001|Overall Study|Lost to Follow-up|36|||
48746341|NCT04502693|156919772|FG002|Overall Study|Lost to Follow-up|69|||
48746342|NCT04502693|156919773|FG003|Overall Study|Lost to Follow-up|4|||
48746343|NCT04502693|156919770|FG000|Overall Study|Protocol Violation|8|||
48746344|NCT04502693|156919771|FG001|Overall Study|Protocol Violation|8|||
48746345|NCT04502693|156919772|FG002|Overall Study|Protocol Violation|16|||
48746346|NCT04502693|156919773|FG003|Overall Study|Protocol Violation|1|||
48746347|NCT04502693|156919770|FG000|Overall Study|Withdrawal by Subject|46|||
48858958|NCT00113529|157322355|FG000|Overall Study|Lack of Efficacy|20|||
48746348|NCT04502693|156919771|FG001|Overall Study|Withdrawal by Subject|38|||
48746349|NCT04502693|156919772|FG002|Overall Study|Withdrawal by Subject|54|||
48746350|NCT04502693|156919773|FG003|Overall Study|Withdrawal by Subject|7|||
48746351|NCT04502693|156919770|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|6|||
48858959|NCT00113529|157322355|FG000|Overall Study|Decision of sponsor|6|||
48858960|NCT00113529|157322355|FG000|Overall Study|Withdrawal by Subject|4|||
48858961|NCT02449902|157322360|FG000|Overall Study|Adverse Event|0|||
48858962|NCT02449902|157322361|FG001|Overall Study|Adverse Event|1|||
48858963|NCT02449902|157322360|FG000|Overall Study|Withdrawal by Subject|0|||
48858964|NCT02449902|157322361|FG001|Overall Study|Withdrawal by Subject|1|||
48858965|NCT02009332|157322362|FG000|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
48858966|NCT02009332|157322363|FG001|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1|||
48858967|NCT02009332|157322364|FG002|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
48858968|NCT02009332|157322365|FG003|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
48858969|NCT02009332|157322366|FG004|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
48858970|NCT02009332|157322367|FG005|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
48858971|NCT02009332|157322362|FG000|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
48858972|NCT02009332|157322363|FG001|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
48858973|NCT02009332|157322364|FG002|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
48858974|NCT02009332|157322365|FG003|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
48858975|NCT02009332|157322366|FG004|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1|||
48858976|NCT02009332|157322367|FG005|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
48858977|NCT02009332|157322362|FG000|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
48858978|NCT02009332|157322363|FG001|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
48858979|NCT02009332|157322364|FG002|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
48858980|NCT02009332|157322365|FG003|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
48858981|NCT02009332|157322366|FG004|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
48858982|NCT02009332|157322367|FG005|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1|||
48858983|NCT01912599|157322368|FG000|Overall Study|Withdrawal by Subject|0|||
48858984|NCT01912599|157322369|FG001|Overall Study|Withdrawal by Subject|1|||
48858985|NCT00648895|157322370|FG000|Overall Study|Lack of Efficacy|0|||
48858986|NCT00648895|157322371|FG001|Overall Study|Lack of Efficacy|1|||
48858987|NCT01280721|157322372|FG000|Overall Study|Adverse Event|4|||
48858988|NCT01280721|157322372|FG000|Overall Study|Physician Decision|3|||
48858989|NCT01280721|157322372|FG000|Overall Study|Withdrawal by Subject|6|||
48858990|NCT01280721|157322372|FG000|Overall Study|eGFR under the withdrawal criteria|7|||
48858991|NCT01280721|157322372|FG000|Overall Study|No tolerability for the lowest dose|2|||
48858992|NCT03326856|157322373|FG000|Overall Study|Lost to Follow-up|1|||
48858993|NCT03326856|157322374|FG001|Overall Study|Lost to Follow-up|1|||
48858994|NCT03326856|157322375|FG002|Overall Study|Lost to Follow-up|0|||
48858995|NCT03326856|157322376|FG003|Overall Study|Lost to Follow-up|0|||
48858996|NCT03326856|157322377|FG004|Overall Study|Lost to Follow-up|0|||
48858997|NCT00042939|157322378|FG000|Overall Study|Adverse Event|6|||
48858998|NCT00042939|157322379|FG001|Overall Study|Adverse Event|7|||
48858999|NCT00042939|157322378|FG000|Overall Study|Death|3|||
48859000|NCT00042939|157322379|FG001|Overall Study|Death|2|||
48859001|NCT00042939|157322378|FG000|Overall Study|Withdrawal by Subject|3|||
48859002|NCT00042939|157322379|FG001|Overall Study|Withdrawal by Subject|4|||
48859003|NCT00042939|157322378|FG000|Overall Study|Other disease|1|||
48859004|NCT00042939|157322379|FG001|Overall Study|Other disease|0|||
48859005|NCT00042939|157322378|FG000|Overall Study|Ineligible|2|||
48859006|NCT00042939|157322379|FG001|Overall Study|Ineligible|2|||
48859007|NCT00042939|157322378|FG000|Overall Study|Deterioration of health|3|||
48859008|NCT00042939|157322379|FG001|Overall Study|Deterioration of health|4|||
48859009|NCT00042939|157322378|FG000|Overall Study|QOL diminished|1|||
48859010|NCT00042939|157322379|FG001|Overall Study|QOL diminished|0|||
48859011|NCT00042939|157322378|FG000|Overall Study|Rising ca 19-9|1|||
48859012|NCT00042939|157322379|FG001|Overall Study|Rising ca 19-9|0|||
48859013|NCT00042939|157322378|FG000|Overall Study|Patient non-compliance|1|||
48859014|NCT00042939|157322379|FG001|Overall Study|Patient non-compliance|0|||
48859015|NCT00042939|157322378|FG000|Overall Study|Still on treatment|1|||
48859016|NCT00042939|157322379|FG001|Overall Study|Still on treatment|0|||
48859017|NCT00042939|157322378|FG000|Overall Study|Treatment break > 4 weeks|0|||
48859018|NCT00042939|157322379|FG001|Overall Study|Treatment break > 4 weeks|1|||
48859019|NCT00042939|157322378|FG000|Overall Study|Did not start treatment|2|||
48859020|NCT00042939|157322379|FG001|Overall Study|Did not start treatment|1|||
48859021|NCT03349476|157322380|FG000|Overall Study|Physician Decision|3|||
48859022|NCT00795639|157322381|FG000|Overall Study|Death|1|||
48859023|NCT00795639|157322382|FG001|Overall Study|Death|6|||
48859024|NCT00795639|157322381|FG000|Overall Study|Withdrawal by Subject|1|||
48859025|NCT00795639|157322382|FG001|Overall Study|Withdrawal by Subject|3|||
48859026|NCT00795639|157322381|FG000|Overall Study|Pregnancy|1|||
48859027|NCT00795639|157322382|FG001|Overall Study|Pregnancy|0|||
48859028|NCT00795639|157322381|FG000|Overall Study|Adverse Event|5|||
48859029|NCT00795639|157322382|FG001|Overall Study|Adverse Event|2|||
48859030|NCT00795639|157322381|FG000|Overall Study|Other|0|||
48859031|NCT00795639|157322382|FG001|Overall Study|Other|2|||
48859032|NCT00795639|157322381|FG000|Overall Study|Terminated by sponsor|13|||
48859033|NCT00795639|157322382|FG001|Overall Study|Terminated by sponsor|12|||
48859034|NCT00795639|157322381|FG000|Overall Study|Randomized and not treated|0|||
48859035|NCT00795639|157322382|FG001|Overall Study|Randomized and not treated|1|||
48859036|NCT00274287|157322385|FG000|Overall Study|Withdrawal by Subject|1|||
48746352|NCT04502693|156919771|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
48746353|NCT04502693|156919772|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|9|||
48746354|NCT04502693|156919773|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
48746355|NCT04502693|156919770|FG000|Overall Study|Other|1|||
48746356|NCT04502693|156919771|FG001|Overall Study|Other|0|||
48746357|NCT04502693|156919772|FG002|Overall Study|Other|1|||
48746358|NCT04502693|156919773|FG003|Overall Study|Other|1|||
48746359|NCT01587001|156919774|FG000|Overall Study|Lost to Follow-up|2|||
48746360|NCT01587001|156919775|FG001|Overall Study|Lost to Follow-up|0|||
48746361|NCT01587001|156919774|FG000|Overall Study|Insufficient samples to complete testing|4|||
48746362|NCT01587001|156919775|FG001|Overall Study|Insufficient samples to complete testing|1|||
48746363|NCT02756013|156919776|FG000|Overall Study|Adverse Event|1|||
48746364|NCT02756013|156919776|FG000|Overall Study|Hypersensitivity|1|||
48746365|NCT00629707|156919777|FG000|Overall Study|Withdrawal by Subject|0|||
48746366|NCT00629707|156919778|FG001|Overall Study|Withdrawal by Subject|1|||
48746367|NCT00629707|156919777|FG000|Overall Study|Physician Decision|0|||
48746368|NCT00629707|156919778|FG001|Overall Study|Physician Decision|1|||
48746369|NCT04974697|156919782|FG000|Overall Study|Unsatisfactory lens fitting due to test article|1|||
48746370|NCT04974697|156919782|FG000|Overall Study|Lens discomfort|1|||
48746371|NCT04112784|156919792|FG000|Overall Study|Did Not Proceed Due to Time Constraints|9|||
48746372|NCT04112784|156919792|FG000|Overall Study|Screen Failures|4|||
48746373|NCT01558271|156919793|FG000|Overall Study|Adverse Event|6|||
48746374|NCT01558271|156919794|FG001|Overall Study|Adverse Event|3|||
48746375|NCT01558271|156919795|FG002|Overall Study|Adverse Event|4|||
48746376|NCT01558271|156919793|FG000|Overall Study|Lost to Follow-up|1|||
48746377|NCT01558271|156919794|FG001|Overall Study|Lost to Follow-up|0|||
48746378|NCT01558271|156919795|FG002|Overall Study|Lost to Follow-up|0|||
48746379|NCT01558271|156919793|FG000|Overall Study|Protocol Violation|1|||
48746380|NCT01558271|156919794|FG001|Overall Study|Protocol Violation|0|||
48746381|NCT01558271|156919795|FG002|Overall Study|Protocol Violation|0|||
48746382|NCT01558271|156919793|FG000|Overall Study|Withdrawal by Subject|10|||
48746383|NCT01558271|156919794|FG001|Overall Study|Withdrawal by Subject|6|||
48746384|NCT01558271|156919795|FG002|Overall Study|Withdrawal by Subject|12|||
48746385|NCT01558271|156919793|FG000|Overall Study|Physician Decision|0|||
48746386|NCT01558271|156919794|FG001|Overall Study|Physician Decision|2|||
48746387|NCT01558271|156919795|FG002|Overall Study|Physician Decision|1|||
48746388|NCT00221403|156919796|FG000|Overall Study|Protocol Violation|1|||
48746389|NCT00221403|156919797|FG001|Overall Study|Protocol Violation|0|||
48746390|NCT00221403|156919798|FG002|Overall Study|Protocol Violation|0|||
48746391|NCT00221403|156919796|FG000|Overall Study|Physician Decision|1|||
48746392|NCT00221403|156919797|FG001|Overall Study|Physician Decision|0|||
48746393|NCT00221403|156919798|FG002|Overall Study|Physician Decision|0|||
48746394|NCT00221403|156919796|FG000|Overall Study|Withdrawal by Subject|0|||
48746395|NCT00221403|156919797|FG001|Overall Study|Withdrawal by Subject|3|||
48746396|NCT00221403|156919798|FG002|Overall Study|Withdrawal by Subject|0|||
48746397|NCT00221403|156919796|FG000|Overall Study|Lack of Efficacy|0|||
48746398|NCT00221403|156919797|FG001|Overall Study|Lack of Efficacy|1|||
48746399|NCT00221403|156919798|FG002|Overall Study|Lack of Efficacy|0|||
48746400|NCT00221403|156919796|FG000|Overall Study|Adverse Event|0|||
48746401|NCT00221403|156919797|FG001|Overall Study|Adverse Event|1|||
48859037|NCT00274287|157322385|FG000|Overall Study|subject non-compliance|1|||
48859038|NCT04421456|157322386|FG000|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
48859039|NCT04421456|157322387|FG001|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
48859040|NCT04421456|157322388|FG002|Randomized Placebo Run-in Period|Placebo Run-in Failures|18|||
48859041|NCT04421456|157322386|FG000|Randomized Treatment Period|Adverse Event|0|||
48859042|NCT04421456|157322387|FG001|Randomized Treatment Period|Adverse Event|1|||
48859043|NCT04421456|157322388|FG002|Randomized Treatment Period|Adverse Event|0|||
48859044|NCT04421456|157322386|FG000|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
48859045|NCT04421456|157322387|FG001|Randomized Treatment Period|Withdrawal of parent/legal representative consent|0|||
48859046|NCT04421456|157322388|FG002|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
48859047|NCT04421456|157322386|FG000|Randomized Treatment Period|Lost to Follow-up|2|||
48859048|NCT04421456|157322387|FG001|Randomized Treatment Period|Lost to Follow-up|2|||
48859049|NCT04421456|157322388|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
48859050|NCT04421456|157322386|FG000|Randomized Treatment Period|Participant non-compliance|1|||
48859051|NCT04421456|157322387|FG001|Randomized Treatment Period|Participant non-compliance|1|||
48859052|NCT04421456|157322388|FG002|Randomized Treatment Period|Participant non-compliance|2|||
48859053|NCT04421456|157322386|FG000|Randomized Treatment Period|Other|0|||
48859054|NCT04421456|157322387|FG001|Randomized Treatment Period|Other|1|||
48859055|NCT04421456|157322388|FG002|Randomized Treatment Period|Other|3|||
48859056|NCT00621842|157322389|FG000|Overall Study|Adverse Event|6|||
48859057|NCT00621842|157322389|FG000|Overall Study|Withdrawal by Subject|7|||
48859058|NCT00621842|157322389|FG000|Overall Study|Protocol Violation|4|||
48859059|NCT00621842|157322389|FG000|Overall Study|Lack of Efficacy|2|||
48859060|NCT02206607|157322392|FG000|Open-Label Run-In|Withdrawal by Subject|3|||
48859061|NCT02206607|157322393|FG001|Open-Label Run-In|Withdrawal by Subject|0|||
48859062|NCT02206607|157322394|FG002|Open-Label Run-In|Withdrawal by Subject|0|||
48859063|NCT02206607|157322395|FG003|Open-Label Run-In|Withdrawal by Subject|0|||
48859064|NCT02206607|157322396|FG004|Open-Label Run-In|Withdrawal by Subject|0|||
48859065|NCT02206607|157322392|FG000|Second Intervention Period|Insufficient Clinical Response|0|||
48859066|NCT02206607|157322393|FG001|Second Intervention Period|Insufficient Clinical Response|0|||
48859067|NCT02206607|157322394|FG002|Second Intervention Period|Insufficient Clinical Response|0|||
48859068|NCT02206607|157322395|FG003|Second Intervention Period|Insufficient Clinical Response|1|||
48859069|NCT02206607|157322396|FG004|Second Intervention Period|Insufficient Clinical Response|0|||
48859070|NCT02077374|157322405|FG000|Overall Study|Withdrawal by Subject|0|||
48859071|NCT02077374|157322406|FG001|Overall Study|Withdrawal by Subject|1|||
48859072|NCT02077374|157322405|FG000|Overall Study|Protocol Violation|0|||
48859073|NCT02077374|157322406|FG001|Overall Study|Protocol Violation|1|||
48859074|NCT00316121|157322407|FG000|Overall Study|Death|1|||
48859075|NCT00316121|157322408|FG001|Overall Study|Death|0|||
48859076|NCT00316121|157322407|FG000|Overall Study|Lost to Follow-up|14|||
48859077|NCT00316121|157322408|FG001|Overall Study|Lost to Follow-up|8|||
48859078|NCT00316121|157322407|FG000|Overall Study|Withdrawal by Subject|2|||
48859079|NCT00316121|157322408|FG001|Overall Study|Withdrawal by Subject|0|||
48859080|NCT00316121|157322407|FG000|Overall Study|Reason is missing|1|||
48859081|NCT00316121|157322408|FG001|Overall Study|Reason is missing|0|||
48859082|NCT00316121|157322407|FG000|Overall Study|Subject relocated|1|||
48859083|NCT00316121|157322408|FG001|Overall Study|Subject relocated|1|||
48859084|NCT00316121|157322407|FG000|Overall Study|Subject refused to return|1|||
48859085|NCT00316121|157322408|FG001|Overall Study|Subject refused to return|0|||
48859086|NCT00316121|157322407|FG000|Overall Study|Subject no show for visit x 3|1|||
48859087|NCT00316121|157322408|FG001|Overall Study|Subject no show for visit x 3|0|||
48859088|NCT00316121|157322407|FG000|Overall Study|Subject did not have 24 month visit|1|||
48859089|NCT00316121|157322408|FG001|Overall Study|Subject did not have 24 month visit|0|||
48859090|NCT03989232|157322411|FG000|Overall Study|Lost to Follow-up|3|||
48859091|NCT03989232|157322412|FG001|Overall Study|Lost to Follow-up|10|||
48859092|NCT03989232|157322411|FG000|Overall Study|Withdrawal by Subject|6|||
48859093|NCT03989232|157322412|FG001|Overall Study|Withdrawal by Subject|6|||
48859094|NCT03989232|157322411|FG000|Overall Study|Death|1|||
48953427|NCT02699515|157659596|FG000|Overall Study|Death|3|||
48859095|NCT03989232|157322412|FG001|Overall Study|Death|2|||
48859096|NCT04930263|157322417|FG000|Overall Study|Withdrawal by Subject|3|||
48859097|NCT04930263|157322418|FG001|Overall Study|Withdrawal by Subject|5|||
48859098|NCT01989156|157322423|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|0|||
48859099|NCT01989156|157322424|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
48859100|NCT01989156|157322425|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|3|||
48859101|NCT01989156|157322423|FG000|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
48859102|NCT01989156|157322424|FG001|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
48859103|NCT01989156|157322425|FG002|Confinement Period (Population at Day 5)|Patient Anxiety|1|||
48859104|NCT01989156|157322423|FG000|Confinement Period (Population at Day 5)|Adverse Event|0|||
48953428|NCT02699515|157659597|FG001|Overall Study|Death|3|||
48859105|NCT01989156|157322424|FG001|Confinement Period (Population at Day 5)|Adverse Event|0|||
48859106|NCT01989156|157322425|FG002|Confinement Period (Population at Day 5)|Adverse Event|1|||
48859107|NCT01989156|157322423|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
48859108|NCT01989156|157322424|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
48859109|NCT01989156|157322425|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
48859110|NCT01989156|157322423|FG000|End of Study (Population at Day 90)|Lost to Follow-up|3|||
48859111|NCT01989156|157322424|FG001|End of Study (Population at Day 90)|Lost to Follow-up|2|||
48859112|NCT01989156|157322425|FG002|End of Study (Population at Day 90)|Lost to Follow-up|0|||
48859113|NCT01989156|157322423|FG000|End of Study (Population at Day 90)|Physician Decision|1|||
48859114|NCT01989156|157322424|FG001|End of Study (Population at Day 90)|Physician Decision|0|||
48859115|NCT01989156|157322425|FG002|End of Study (Population at Day 90)|Physician Decision|1|||
48859116|NCT01989156|157322423|FG000|End of Study (Population at Day 90)|Moved out of state|1|||
48859117|NCT01989156|157322424|FG001|End of Study (Population at Day 90)|Moved out of state|0|||
48859118|NCT01989156|157322425|FG002|End of Study (Population at Day 90)|Moved out of state|0|||
48859119|NCT01989156|157322423|FG000|End of Study (Population at Day 90)|Employment Conflict|0|||
48859120|NCT01989156|157322424|FG001|End of Study (Population at Day 90)|Employment Conflict|1|||
48859121|NCT01989156|157322425|FG002|End of Study (Population at Day 90)|Employment Conflict|0|||
48859122|NCT00742560|157322426|FG000|Overall Study|Adverse Event|0|||
48859123|NCT00742560|157322427|FG001|Overall Study|Adverse Event|0|||
48859124|NCT00742560|157322428|FG002|Overall Study|Adverse Event|1|||
48859125|NCT00742560|157322429|FG003|Overall Study|Adverse Event|1|||
48859126|NCT00742560|157322430|FG004|Overall Study|Adverse Event|1|||
48859127|NCT00742560|157322426|FG000|Overall Study|Death|0|||
48859128|NCT00742560|157322427|FG001|Overall Study|Death|2|||
48859129|NCT00742560|157322428|FG002|Overall Study|Death|0|||
48859130|NCT00742560|157322429|FG003|Overall Study|Death|2|||
48859131|NCT00742560|157322430|FG004|Overall Study|Death|3|||
48859132|NCT00742560|157322426|FG000|Overall Study|Subject's Decision|1|||
48859133|NCT00742560|157322427|FG001|Overall Study|Subject's Decision|0|||
48953429|NCT02699515|157659598|FG002|Overall Study|Death|3|||
48953430|NCT02699515|157659599|FG003|Overall Study|Death|23|||
48953431|NCT02699515|157659600|FG004|Overall Study|Death|22|||
48953432|NCT02699515|157659601|FG005|Overall Study|Death|23|||
48953433|NCT02699515|157659602|FG006|Overall Study|Death|3|||
48953434|NCT02699515|157659603|FG007|Overall Study|Death|5|||
48953435|NCT02699515|157659596|FG000|Overall Study|Withdrawal by Subject|0|||
48953436|NCT02699515|157659597|FG001|Overall Study|Withdrawal by Subject|0|||
48953437|NCT02699515|157659598|FG002|Overall Study|Withdrawal by Subject|3|||
48953438|NCT02699515|157659599|FG003|Overall Study|Withdrawal by Subject|1|||
48953439|NCT02699515|157659600|FG004|Overall Study|Withdrawal by Subject|5|||
48953440|NCT02699515|157659601|FG005|Overall Study|Withdrawal by Subject|3|||
48953441|NCT02699515|157659602|FG006|Overall Study|Withdrawal by Subject|0|||
48953442|NCT02699515|157659603|FG007|Overall Study|Withdrawal by Subject|1|||
48953443|NCT02699515|157659596|FG000|Overall Study|Other|1|||
48953444|NCT02699515|157659597|FG001|Overall Study|Other|0|||
48746402|NCT00221403|156919798|FG002|Overall Study|Adverse Event|0|||
48746403|NCT01846416|156919803|FG000|Treatment Phase|Death|2|||
48746404|NCT01846416|156919804|FG001|Treatment Phase|Death|9|||
48746405|NCT01846416|156919805|FG002|Treatment Phase|Death|1|||
48746406|NCT01846416|156919803|FG000|Treatment Phase|Withdrawal by Subject|2|||
48746407|NCT01846416|156919804|FG001|Treatment Phase|Withdrawal by Subject|4|||
48746408|NCT01846416|156919805|FG002|Treatment Phase|Withdrawal by Subject|2|||
48746409|NCT01846416|156919803|FG000|Treatment Phase|Other|1|||
48746410|NCT01846416|156919804|FG001|Treatment Phase|Other|5|||
48746411|NCT01846416|156919805|FG002|Treatment Phase|Other|1|||
48746412|NCT01846416|156919803|FG000|Treatment Phase|Physician Decision|1|||
48746413|NCT01846416|156919804|FG001|Treatment Phase|Physician Decision|2|||
48746414|NCT01846416|156919805|FG002|Treatment Phase|Physician Decision|0|||
48746415|NCT01846416|156919803|FG000|Treatment Phase|Adverse Event|3|||
48746416|NCT01846416|156919804|FG001|Treatment Phase|Adverse Event|4|||
48746417|NCT01846416|156919805|FG002|Treatment Phase|Adverse Event|0|||
48746418|NCT01846416|156919803|FG000|Treatment Phase|Non-compliance|0|||
48746419|NCT01846416|156919804|FG001|Treatment Phase|Non-compliance|2|||
48746420|NCT01846416|156919805|FG002|Treatment Phase|Non-compliance|0|||
48746421|NCT01846416|156919803|FG000|Treatment Phase|Study Terminated by Sponsor|1|||
48746422|NCT01846416|156919804|FG001|Treatment Phase|Study Terminated by Sponsor|4|||
48746423|NCT01846416|156919805|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
48746424|NCT01846416|156919803|FG000|Treatment Phase|Progressive Disease|21|||
48746425|NCT01846416|156919804|FG001|Treatment Phase|Progressive Disease|63|||
48746426|NCT01846416|156919805|FG002|Treatment Phase|Progressive Disease|9|||
48746427|NCT01846416|156919803|FG000|Survival Follow-up|Death|21|||
48746428|NCT01846416|156919804|FG001|Survival Follow-up|Death|62|||
48746429|NCT01846416|156919805|FG002|Survival Follow-up|Death|9|||
48746430|NCT01846416|156919803|FG000|Survival Follow-up|Lost to Follow-up|0|||
48746431|NCT01846416|156919804|FG001|Survival Follow-up|Lost to Follow-up|2|||
48746432|NCT01846416|156919805|FG002|Survival Follow-up|Lost to Follow-up|2|||
48746433|NCT01846416|156919803|FG000|Survival Follow-up|Withdrawal by Subject|2|||
48746434|NCT01846416|156919804|FG001|Survival Follow-up|Withdrawal by Subject|7|||
48746435|NCT01846416|156919805|FG002|Survival Follow-up|Withdrawal by Subject|0|||
48746436|NCT01846416|156919803|FG000|Survival Follow-up|Study Terminated by Sponsor|2|||
48746437|NCT01846416|156919804|FG001|Survival Follow-up|Study Terminated by Sponsor|8|||
48746438|NCT01846416|156919805|FG002|Survival Follow-up|Study Terminated by Sponsor|0|||
48746439|NCT01846416|156919803|FG000|Survival Follow-up|Other|3|||
48746440|NCT01846416|156919804|FG001|Survival Follow-up|Other|1|||
48746441|NCT01846416|156919805|FG002|Survival Follow-up|Other|1|||
48746442|NCT00039130|156919808|FG000|Overall Study|Adverse Event|11|||
48746443|NCT00039130|156919808|FG000|Overall Study|Death|9|||
48746444|NCT00039130|156919808|FG000|Overall Study|Withdrawal by Subject|3|||
48746445|NCT00039130|156919808|FG000|Overall Study|Progression|2|||
48953445|NCT02699515|157659598|FG002|Overall Study|Other|1|||
48953446|NCT02699515|157659599|FG003|Overall Study|Other|6|||
48953447|NCT02699515|157659600|FG004|Overall Study|Other|4|||
48953448|NCT02699515|157659601|FG005|Overall Study|Other|3|||
48859134|NCT00742560|157322428|FG002|Overall Study|Subject's Decision|2|||
48859135|NCT00742560|157322429|FG003|Overall Study|Subject's Decision|3|||
48859136|NCT00742560|157322430|FG004|Overall Study|Subject's Decision|3|||
48859137|NCT00742560|157322426|FG000|Overall Study|Investigator's Decision|0|||
48859138|NCT00742560|157322427|FG001|Overall Study|Investigator's Decision|0|||
48859139|NCT00742560|157322428|FG002|Overall Study|Investigator's Decision|4|||
48859140|NCT00742560|157322429|FG003|Overall Study|Investigator's Decision|1|||
48746446|NCT00039130|156919808|FG000|Overall Study|Subsequent treatment|2|||
48746447|NCT00039130|156919808|FG000|Overall Study|Physician Decision|3|||
48746448|NCT03288129|156919810|FG000|Overall Study|Adverse Event|10|||
48746449|NCT03288129|156919810|FG000|Overall Study|Lost to Follow-up|3|||
48746450|NCT03288129|156919810|FG000|Overall Study|Withdrawal by Subject|3|||
48953449|NCT02699515|157659602|FG006|Overall Study|Other|0|||
48953450|NCT02699515|157659603|FG007|Overall Study|Other|0|||
48953451|NCT01903811|157659604|FG000|Overall Study|No measurable disease|1|||
48953452|NCT01903811|157659605|FG001|Overall Study|No measurable disease|1|||
48953453|NCT01903811|157659604|FG000|Overall Study|Incomplete/discontinued prior therapy|1|||
48953454|NCT01903811|157659605|FG001|Overall Study|Incomplete/discontinued prior therapy|1|||
48953455|NCT01903811|157659604|FG000|Overall Study|Baseline lab missing/incomplete/untimely|6|||
48953456|NCT01903811|157659605|FG001|Overall Study|Baseline lab missing/incomplete/untimely|11|||
48953457|NCT01903811|157659604|FG000|Overall Study|Withdrawal by Subject|0|||
48953458|NCT01903811|157659605|FG001|Overall Study|Withdrawal by Subject|1|||
48953459|NCT04112316|157659608|FG000|First Period (8 Weeks)|Protocol Violation|1|||
48953460|NCT04112316|157659609|FG001|First Period (8 Weeks)|Protocol Violation|0|||
48953461|NCT04112316|157659608|FG000|First Period (8 Weeks)|Lost to Follow-up|1|||
48953462|NCT04112316|157659609|FG001|First Period (8 Weeks)|Lost to Follow-up|0|||
48953463|NCT04359823|157659610|FG000|Overall Study|Lost to Follow-up|0|||
48953464|NCT04359823|157659611|FG001|Overall Study|Lost to Follow-up|1|||
48746451|NCT03288129|156919810|FG000|Overall Study|Withdrawal of consent/assent|1|||
48746452|NCT03288129|156919810|FG000|Overall Study|Other|5|||
48746453|NCT01866930|156919811|FG000|Treatment Period|Other|1|||
48746454|NCT01866930|156919812|FG001|Treatment Period|Other|0|||
48746455|NCT01866930|156919811|FG000|Treatment Period|Death|0|||
48746456|NCT01866930|156919812|FG001|Treatment Period|Death|2|||
48746457|NCT01866930|156919811|FG000|Treatment Period|Poor/non compliance|0|||
48746458|NCT01866930|156919812|FG001|Treatment Period|Poor/non compliance|2|||
48746459|NCT01866930|156919811|FG000|Treatment Period|No longer meets study criteria|0|||
48746460|NCT01866930|156919812|FG001|Treatment Period|No longer meets study criteria|1|||
48746461|NCT01866930|156919811|FG000|Treatment Period|Withdrawal by Subject|2|||
48746462|NCT01866930|156919812|FG001|Treatment Period|Withdrawal by Subject|8|||
48746463|NCT01866930|156919811|FG000|Treatment Period|Lack of Efficacy|1|||
48746464|NCT01866930|156919812|FG001|Treatment Period|Lack of Efficacy|9|||
48746465|NCT01866930|156919811|FG000|Treatment Period|Adverse Event|4|||
48746466|NCT01866930|156919812|FG001|Treatment Period|Adverse Event|12|||
48746467|NCT01866930|156919811|FG000|Treatment Period|Lost to Follow-up|1|||
48746468|NCT01866930|156919812|FG001|Treatment Period|Lost to Follow-up|1|||
48746469|NCT01866930|156919811|FG000|Follow-up Period|Lost to Follow-up|1|||
48746470|NCT01866930|156919812|FG001|Follow-up Period|Lost to Follow-up|1|||
48859141|NCT00742560|157322430|FG004|Overall Study|Investigator's Decision|0|||
48859142|NCT00742560|157322426|FG000|Overall Study|Disease Progression|1|||
48859143|NCT00742560|157322427|FG001|Overall Study|Disease Progression|0|||
48859144|NCT00742560|157322428|FG002|Overall Study|Disease Progression|5|||
48953465|NCT04359823|157659610|FG000|Overall Study|Withdrawal by Subject|0|||
48953466|NCT04359823|157659611|FG001|Overall Study|Withdrawal by Subject|1|||
48953467|NCT01543490|157659614|FG000|Overall Study|Adverse Event|4|||
48953468|NCT01543490|157659615|FG001|Overall Study|Adverse Event|0|||
48953469|NCT01543490|157659614|FG000|Overall Study|Physician Decision|1|||
48953470|NCT01543490|157659615|FG001|Overall Study|Physician Decision|0|||
48953471|NCT01543490|157659614|FG000|Overall Study|Lack of Efficacy|3|||
48953472|NCT01543490|157659615|FG001|Overall Study|Lack of Efficacy|3|||
48953473|NCT01543490|157659614|FG000|Overall Study|Lost to Follow-up|5|||
48953474|NCT01543490|157659615|FG001|Overall Study|Lost to Follow-up|0|||
48859145|NCT00742560|157322429|FG003|Overall Study|Disease Progression|17|||
48953475|NCT01543490|157659614|FG000|Overall Study|Withdrawal by Subject|2|||
48953476|NCT01543490|157659615|FG001|Overall Study|Withdrawal by Subject|0|||
48953477|NCT01543490|157659614|FG000|Overall Study|Other-Various Administrative Reasons|1|||
49015371|NCT00306384|157892156|FG000|Overall Study|Study termination|1|||
48953478|NCT01543490|157659615|FG001|Overall Study|Other-Various Administrative Reasons|2|||
48953479|NCT01597622|157659616|FG000|Overall Study|Adverse Event|7|||
48953480|NCT01597622|157659616|FG000|Overall Study|Lack of Efficacy|3|||
48953481|NCT01597622|157659616|FG000|Overall Study|Protocol Violation|1|||
48953482|NCT01597622|157659616|FG000|Overall Study|Lost to Follow-up|1|||
48953483|NCT01597622|157659616|FG000|Overall Study|Investigator Discretion|5|||
48953484|NCT01597622|157659616|FG000|Overall Study|Withdrawal by Subject|20|||
48953485|NCT01597622|157659616|FG000|Overall Study|Death|1|||
48953486|NCT04549168|157659617|FG000|Randomization Phase|Adverse Event|0|||
48953487|NCT04549168|157659618|FG001|Randomization Phase|Adverse Event|0|||
48953488|NCT04549168|157659619|FG002|Randomization Phase|Adverse Event|1|||
48953489|NCT04549168|157659617|FG000|Randomization Phase|Other|0|||
48953490|NCT04549168|157659618|FG001|Randomization Phase|Other|2|||
48953491|NCT04549168|157659619|FG002|Randomization Phase|Other|0|||
48953492|NCT04549168|157659617|FG000|Randomization Phase|Withdrawal by Subject|0|||
48859146|NCT00742560|157322430|FG004|Overall Study|Disease Progression|16|||
48859147|NCT00742560|157322426|FG000|Overall Study|New Multiple Myeloma Therapy|1|||
48859148|NCT00742560|157322427|FG001|Overall Study|New Multiple Myeloma Therapy|0|||
48859149|NCT00742560|157322428|FG002|Overall Study|New Multiple Myeloma Therapy|2|||
48859150|NCT00742560|157322429|FG003|Overall Study|New Multiple Myeloma Therapy|3|||
48859151|NCT00742560|157322430|FG004|Overall Study|New Multiple Myeloma Therapy|4|||
48859152|NCT00742560|157322426|FG000|Overall Study|Other|0|||
48859153|NCT00742560|157322427|FG001|Overall Study|Other|1|||
48859154|NCT00742560|157322428|FG002|Overall Study|Other|8|||
48859155|NCT00742560|157322429|FG003|Overall Study|Other|9|||
48859156|NCT00742560|157322430|FG004|Overall Study|Other|9|||
48859157|NCT00742560|157322426|FG000|Overall Study|MIssing|0|||
48859158|NCT00742560|157322427|FG001|Overall Study|MIssing|0|||
48859159|NCT00742560|157322428|FG002|Overall Study|MIssing|0|||
48953493|NCT04549168|157659618|FG001|Randomization Phase|Withdrawal by Subject|2|||
48953494|NCT04549168|157659619|FG002|Randomization Phase|Withdrawal by Subject|1|||
48953495|NCT01981122|157659620|FG000|Overall Study|Withdrawal by Subject|0|||
48953496|NCT01981122|157659621|FG001|Overall Study|Withdrawal by Subject|2|||
48953497|NCT01981122|157659620|FG000|Overall Study|Protocol Violation|0|||
48953498|NCT01981122|157659621|FG001|Overall Study|Protocol Violation|1|||
48953499|NCT01981122|157659620|FG000|Overall Study|Lost to Follow-up|0|||
48953500|NCT01981122|157659621|FG001|Overall Study|Lost to Follow-up|1|||
48953501|NCT01981122|157659620|FG000|Overall Study|Investigator Or Dendreon Discretion|0|||
48953502|NCT01981122|157659621|FG001|Overall Study|Investigator Or Dendreon Discretion|1|||
48953503|NCT01981122|157659620|FG000|Overall Study|Death|14|||
48953504|NCT01981122|157659621|FG001|Overall Study|Death|15|||
48953505|NCT02433210|157659622|FG000|Overall Study|Physician Decision|1|||
48953506|NCT02433210|157659623|FG001|Overall Study|Physician Decision|0|||
48953507|NCT02433210|157659624|FG002|Overall Study|Physician Decision|0|||
48953508|NCT01158534|157659626|FG000|Overall Study|Withdrawal by Subject|1|||
48859160|NCT00742560|157322429|FG003|Overall Study|MIssing|0|||
48859161|NCT00742560|157322430|FG004|Overall Study|MIssing|1|||
48859162|NCT00237809|157322431|FG000|Overall Study|Lost to Follow-up|11|||
48859163|NCT00237809|157322432|FG001|Overall Study|Lost to Follow-up|10|||
48859164|NCT00237809|157322433|FG002|Overall Study|Lost to Follow-up|9|||
48859165|NCT00237809|157322434|FG003|Overall Study|Lost to Follow-up|9|||
48859166|NCT02132195|157322435|FG000|Initial Assignment|Relapsed|14|||
48859167|NCT02132195|157322436|FG001|Initial Assignment|Relapsed|0|||
48953509|NCT01158534|157659626|FG000|Overall Study|Death|1|||
48859168|NCT02132195|157322437|FG002|Initial Assignment|Relapsed|0|||
48859169|NCT02132195|157322435|FG000|Rescue Therapy|Relapsed|0|||
48859170|NCT02132195|157322436|FG001|Rescue Therapy|Relapsed|0|||
48953510|NCT01158534|157659626|FG000|Overall Study|Other|1|||
48859171|NCT02132195|157322437|FG002|Rescue Therapy|Relapsed|7|||
48859172|NCT02132195|157322435|FG000|Rescue Therapy|Physician Decision|0|||
48859173|NCT02132195|157322436|FG001|Rescue Therapy|Physician Decision|0|||
48953511|NCT01988012|157659627|FG000|Overall Study|Adverse Event|5|||
48859174|NCT02132195|157322437|FG002|Rescue Therapy|Physician Decision|1|||
48859175|NCT02132195|157322435|FG000|Rescue Therapy|Withdrawal by Subject|0|||
48859176|NCT02132195|157322436|FG001|Rescue Therapy|Withdrawal by Subject|0|||
48859177|NCT02132195|157322437|FG002|Rescue Therapy|Withdrawal by Subject|1|||
48859178|NCT02132195|157322435|FG000|Rescue Therapy|Adverse Event|0|||
48859179|NCT02132195|157322436|FG001|Rescue Therapy|Adverse Event|0|||
48859180|NCT02132195|157322437|FG002|Rescue Therapy|Adverse Event|2|||
48859181|NCT02058992|157322438|FG000|Overall Study|Lost to Follow-up|4|||
48859182|NCT02058992|157322438|FG000|Overall Study|Protocol Violation|92|||
48859183|NCT02058992|157322438|FG000|Overall Study|CRF Uncollected|20|||
48859184|NCT03503188|157322439|FG000|Overall Study|Non eligible in the sub study|0|||
48859185|NCT03503188|157322440|FG001|Overall Study|Non eligible in the sub study|1|||
48859186|NCT01755598|157322441|FG000|Overall Study|Other|109|||
48859187|NCT01755598|157322442|FG001|Overall Study|Other|109|||
48859188|NCT01755598|157322441|FG000|Overall Study|Lost to Follow-up|32|||
48859189|NCT01755598|157322442|FG001|Overall Study|Lost to Follow-up|43|||
48859190|NCT01755598|157322441|FG000|Overall Study|Migrated/moved from study area|76|||
48859191|NCT01755598|157322442|FG001|Overall Study|Migrated/moved from study area|65|||
48859192|NCT01755598|157322441|FG000|Overall Study|Withdrawal by Subject|22|||
48859193|NCT01755598|157322442|FG001|Overall Study|Withdrawal by Subject|31|||
48859194|NCT01755598|157322441|FG000|Overall Study|Protocol Violation|7|||
48859195|NCT01755598|157322442|FG001|Overall Study|Protocol Violation|7|||
48859196|NCT01755598|157322441|FG000|Overall Study|Adverse Event|19|||
48953512|NCT01988012|157659627|FG000|Overall Study|Insufficient Therapeutic Response|3|||
48859197|NCT01755598|157322442|FG001|Overall Study|Adverse Event|28|||
48953513|NCT01988012|157659627|FG000|Overall Study|Patient Withdrawal of Consent|4|||
48953514|NCT01988012|157659627|FG000|Overall Study|Lost to Follow-up|1|||
48859198|NCT02332824|157322445|FG000|Overall Study|Pretreatment Event/Adverse Event|4|||
48953515|NCT01988012|157659627|FG000|Overall Study|Physician Decision|1|||
48746471|NCT01866930|156919811|FG000|Follow-up Period|Other|1|||
48859199|NCT02332824|157322446|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
48859200|NCT02332824|157322447|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
48859201|NCT02332824|157322448|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
48859202|NCT02332824|157322449|FG004|Overall Study|Pretreatment Event/Adverse Event|4|||
48859203|NCT02332824|157322450|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
48746472|NCT01866930|156919812|FG001|Follow-up Period|Other|5|||
48746473|NCT01866930|156919811|FG000|Follow-up Period|No longer required per protocol|1|||
48746474|NCT01866930|156919812|FG001|Follow-up Period|No longer required per protocol|0|||
48746475|NCT01866930|156919811|FG000|Follow-up Period|Withdrawal by Subject|3|||
48859204|NCT02332824|157322445|FG000|Overall Study|Voluntary Withdrawal|1|||
48859205|NCT02332824|157322446|FG001|Overall Study|Voluntary Withdrawal|0|||
48859206|NCT02332824|157322447|FG002|Overall Study|Voluntary Withdrawal|0|||
48859207|NCT02332824|157322448|FG003|Overall Study|Voluntary Withdrawal|0|||
48859208|NCT02332824|157322449|FG004|Overall Study|Voluntary Withdrawal|0|||
48859209|NCT02332824|157322450|FG005|Overall Study|Voluntary Withdrawal|0|||
48859210|NCT02332824|157322445|FG000|Overall Study|Inconvenient schedule|1|||
48859211|NCT02332824|157322446|FG001|Overall Study|Inconvenient schedule|1|||
48859212|NCT02332824|157322447|FG002|Overall Study|Inconvenient schedule|0|||
48859213|NCT02332824|157322448|FG003|Overall Study|Inconvenient schedule|0|||
48859214|NCT02332824|157322449|FG004|Overall Study|Inconvenient schedule|0|||
48859215|NCT02332824|157322450|FG005|Overall Study|Inconvenient schedule|0|||
48859216|NCT02332824|157322445|FG000|Overall Study|Transfer|0|||
48859217|NCT02332824|157322446|FG001|Overall Study|Transfer|0|||
48859218|NCT02332824|157322447|FG002|Overall Study|Transfer|1|||
48859219|NCT02332824|157322448|FG003|Overall Study|Transfer|1|||
48859220|NCT02332824|157322449|FG004|Overall Study|Transfer|0|||
48859221|NCT02332824|157322450|FG005|Overall Study|Transfer|0|||
48859222|NCT00440037|157322451|FG000|Overall Study|Withdrawal by Subject|6|||
48859223|NCT00440037|157322451|FG000|Overall Study|Administrative decision|3|||
48859224|NCT00498797|157322452|FG000|Overall Study|Withdrawal by Subject|4|||
48859225|NCT00498797|157322453|FG001|Overall Study|Withdrawal by Subject|2|||
48859226|NCT00498797|157322452|FG000|Overall Study|Adverse Event|12|||
48859227|NCT00498797|157322453|FG001|Overall Study|Adverse Event|5|||
48859228|NCT00498797|157322452|FG000|Overall Study|Condition under investigation worsened|19|||
48859229|NCT00498797|157322453|FG001|Overall Study|Condition under investigation worsened|21|||
48859230|NCT00498797|157322452|FG000|Overall Study|Other|3|||
48859231|NCT00498797|157322453|FG001|Overall Study|Other|1|||
48859232|NCT00321672|157322454|FG000|Overall Study|Withdrawal by Subject|5|||
48859233|NCT00321672|157322455|FG001|Overall Study|Withdrawal by Subject|1|||
48859234|NCT00321672|157322456|FG002|Overall Study|Withdrawal by Subject|2|||
48859235|NCT00321672|157322457|FG003|Overall Study|Withdrawal by Subject|0|||
48859236|NCT00321672|157322454|FG000|Overall Study|Noncompliance|1|||
48859237|NCT00321672|157322455|FG001|Overall Study|Noncompliance|2|||
48859238|NCT00321672|157322456|FG002|Overall Study|Noncompliance|1|||
48859239|NCT00321672|157322457|FG003|Overall Study|Noncompliance|0|||
48859240|NCT00321672|157322454|FG000|Overall Study|Adverse Event|1|||
48953516|NCT01988012|157659627|FG000|Overall Study|Protocol Violation|1|||
48953517|NCT01849250|157659630|FG000|Overall Study|Withdrawal by Subject|1|||
48953518|NCT01849250|157659631|FG001|Overall Study|Withdrawal by Subject|0|||
48859241|NCT00321672|157322455|FG001|Overall Study|Adverse Event|1|||
48859242|NCT00321672|157322456|FG002|Overall Study|Adverse Event|0|||
48859243|NCT00321672|157322457|FG003|Overall Study|Adverse Event|0|||
48859244|NCT00321672|157322454|FG000|Overall Study|Lack of Efficacy|1|||
48953519|NCT01849250|157659630|FG000|Overall Study|Not Evaluable|5|||
48953520|NCT01849250|157659631|FG001|Overall Study|Not Evaluable|3|||
48859245|NCT00321672|157322455|FG001|Overall Study|Lack of Efficacy|1|||
48953521|NCT01849250|157659630|FG000|Overall Study|Screen Failure|1|||
48859246|NCT00321672|157322456|FG002|Overall Study|Lack of Efficacy|0|||
48859247|NCT00321672|157322457|FG003|Overall Study|Lack of Efficacy|0|||
48859248|NCT00321672|157322454|FG000|Overall Study|Lost to Follow-up|2|||
48859249|NCT00321672|157322455|FG001|Overall Study|Lost to Follow-up|0|||
48859250|NCT00321672|157322456|FG002|Overall Study|Lost to Follow-up|4|||
48859251|NCT00321672|157322457|FG003|Overall Study|Lost to Follow-up|2|||
48859252|NCT00321672|157322454|FG000|Overall Study|Death|1|||
48859253|NCT00321672|157322455|FG001|Overall Study|Death|0|||
48859254|NCT00321672|157322456|FG002|Overall Study|Death|0|||
48859255|NCT00321672|157322457|FG003|Overall Study|Death|0|||
48859256|NCT00321672|157322454|FG000|Overall Study|Too far to travel for visits|1|||
48859257|NCT00321672|157322455|FG001|Overall Study|Too far to travel for visits|0|||
48859258|NCT00321672|157322456|FG002|Overall Study|Too far to travel for visits|0|||
48859259|NCT00321672|157322457|FG003|Overall Study|Too far to travel for visits|0|||
48859260|NCT00321672|157322454|FG000|Overall Study|Incarcerated|0|||
48859261|NCT00321672|157322455|FG001|Overall Study|Incarcerated|0|||
48859262|NCT00321672|157322456|FG002|Overall Study|Incarcerated|2|||
48859263|NCT00321672|157322457|FG003|Overall Study|Incarcerated|0|||
48859264|NCT00321672|157322454|FG000|Overall Study|Moved out of state|0|||
48859265|NCT00321672|157322455|FG001|Overall Study|Moved out of state|1|||
48859266|NCT00321672|157322456|FG002|Overall Study|Moved out of state|1|||
48859267|NCT00321672|157322457|FG003|Overall Study|Moved out of state|0|||
48859268|NCT00321672|157322454|FG000|Overall Study|Protocol Violation|0|||
48859269|NCT00321672|157322455|FG001|Overall Study|Protocol Violation|0|||
48859270|NCT00321672|157322456|FG002|Overall Study|Protocol Violation|1|||
48859271|NCT00321672|157322457|FG003|Overall Study|Protocol Violation|0|||
48859272|NCT00321672|157322454|FG000|Overall Study|Diagnosis of testicular cancer|0|||
48859273|NCT00321672|157322455|FG001|Overall Study|Diagnosis of testicular cancer|1|||
48859274|NCT00321672|157322456|FG002|Overall Study|Diagnosis of testicular cancer|0|||
48859275|NCT00321672|157322457|FG003|Overall Study|Diagnosis of testicular cancer|0|||
48859276|NCT00321672|157322454|FG000|Overall Study|Extensive travel required for new job|0|||
48859277|NCT00321672|157322455|FG001|Overall Study|Extensive travel required for new job|1|||
48859278|NCT00321672|157322456|FG002|Overall Study|Extensive travel required for new job|0|||
48859279|NCT00321672|157322457|FG003|Overall Study|Extensive travel required for new job|0|||
48859280|NCT04222088|157322458|FG000|Overall Study|Lost to Follow-up|5|||
48859281|NCT04222088|157322459|FG001|Overall Study|Lost to Follow-up|1|||
48859282|NCT04222088|157322458|FG000|Overall Study|Withdrawal by Subject|4|||
48859283|NCT04222088|157322459|FG001|Overall Study|Withdrawal by Subject|0|||
48859284|NCT01071317|157322460|FG000|Overall Study|Lost to Follow-up|2|||
48859285|NCT01071317|157322461|FG001|Overall Study|Lost to Follow-up|2|||
48859286|NCT00936065|157322462|FG000|Overall Study|Adverse Event|1|||
48859287|NCT00936065|157322463|FG001|Overall Study|Adverse Event|0|||
48859288|NCT00936065|157322464|FG002|Overall Study|Adverse Event|1|||
48859289|NCT00936065|157322462|FG000|Overall Study|Lack of Efficacy|1|||
48859290|NCT00936065|157322463|FG001|Overall Study|Lack of Efficacy|0|||
48859291|NCT00936065|157322464|FG002|Overall Study|Lack of Efficacy|1|||
48859292|NCT00936065|157322462|FG000|Overall Study|Lost to Follow-up|1|||
48859293|NCT00936065|157322463|FG001|Overall Study|Lost to Follow-up|0|||
48859294|NCT00936065|157322464|FG002|Overall Study|Lost to Follow-up|0|||
48859295|NCT00936065|157322462|FG000|Overall Study|Protocol Violation|1|||
48859296|NCT00936065|157322463|FG001|Overall Study|Protocol Violation|2|||
48859297|NCT00936065|157322464|FG002|Overall Study|Protocol Violation|1|||
48859298|NCT00936065|157322462|FG000|Overall Study|Withdrawal by Subject|0|||
48859299|NCT00936065|157322463|FG001|Overall Study|Withdrawal by Subject|2|||
48859300|NCT00936065|157322464|FG002|Overall Study|Withdrawal by Subject|4|||
48859301|NCT01207453|157322465|FG000|First Intervention|Adverse Event|2|||
48859302|NCT01207453|157322466|FG001|First Intervention|Adverse Event|1|||
48859303|NCT01207453|157322465|FG000|Washout|Adverse Event|1|||
48859304|NCT01207453|157322466|FG001|Washout|Adverse Event|0|||
48859305|NCT01207453|157322465|FG000|Washout|Lost to Follow-up|1|||
48859306|NCT01207453|157322466|FG001|Washout|Lost to Follow-up|0|||
48859307|NCT01207453|157322465|FG000|2nd Intervention|Adverse Event|1|||
48953522|NCT01849250|157659631|FG001|Overall Study|Screen Failure|0|||
48859308|NCT01207453|157322466|FG001|2nd Intervention|Adverse Event|2|||
48859309|NCT01207453|157322465|FG000|2nd Intervention|Lost to Follow-up|1|||
48859310|NCT01207453|157322466|FG001|2nd Intervention|Lost to Follow-up|0|||
48859311|NCT02144285|157322467|FG000|Overall Study|Withdrawal by Subject|0|||
48859312|NCT02144285|157322468|FG001|Overall Study|Withdrawal by Subject|0|||
48859313|NCT02144285|157322469|FG002|Overall Study|Withdrawal by Subject|0|||
48859314|NCT02144285|157322470|FG003|Overall Study|Withdrawal by Subject|0|||
48859315|NCT02144285|157322471|FG004|Overall Study|Withdrawal by Subject|1|||
48953523|NCT01971476|157659632|FG000|Cohort 1: 2 to <12 Years|Other not defined|3|||
48859316|NCT02144285|157322472|FG005|Overall Study|Withdrawal by Subject|0|||
48859317|NCT02144285|157322473|FG006|Overall Study|Withdrawal by Subject|0|||
48859318|NCT02144285|157322474|FG007|Overall Study|Withdrawal by Subject|0|||
48859319|NCT02144285|157322475|FG008|Overall Study|Withdrawal by Subject|0|||
48859320|NCT02144285|157322476|FG009|Overall Study|Withdrawal by Subject|0|||
48859321|NCT02135445|157322477|FG000|Overall Study|Lost to Follow-up|1|||
48859322|NCT02135445|157322478|FG001|Overall Study|Lost to Follow-up|0|||
48859323|NCT02135445|157322477|FG000|Overall Study|Withdrawal by Subject|1|||
48859324|NCT02135445|157322478|FG001|Overall Study|Withdrawal by Subject|0|||
48859325|NCT01185340|157323742|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24|||
48859326|NCT01185340|157323743|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
48859327|NCT01185340|157323744|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
48859328|NCT01185340|157323745|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
48859329|NCT01185340|157323742|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6|||
48859330|NCT01185340|157323743|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
48859331|NCT01185340|157323744|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
48859332|NCT01185340|157323745|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
48859333|NCT01185340|157323742|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5|||
48859334|NCT01185340|157323743|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
48859335|NCT01185340|157323744|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
48859336|NCT01185340|157323745|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
48859337|NCT01185340|157323742|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
48859338|NCT01185340|157323743|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
48953524|NCT01971476|157659633|FG001|Cohort 1: 2 to <12 Years|Other not defined|3|||
48953525|NCT01971476|157659634|FG002|Cohort 1: 2 to <12 Years|Other not defined|6|||
48953526|NCT01971476|157659632|FG000|Cohort 2: 12 to <18 Years|Other not defined|6|||
48953527|NCT01971476|157659633|FG001|Cohort 2: 12 to <18 Years|Other not defined|3|||
48953528|NCT01971476|157659634|FG002|Cohort 2: 12 to <18 Years|Other not defined|0|||
48953529|NCT01971476|157659632|FG000|Cohort 2: 12 to <18 Years|Adverse Event|0|||
48953530|NCT01971476|157659633|FG001|Cohort 2: 12 to <18 Years|Adverse Event|1|||
48953531|NCT01971476|157659634|FG002|Cohort 2: 12 to <18 Years|Adverse Event|0|||
48953532|NCT00114972|157659635|FG000|Overall Study|Withdrawal by Subject|40|||
48953533|NCT00114972|157659636|FG001|Overall Study|Withdrawal by Subject|7|||
48953534|NCT00114972|157659635|FG000|Overall Study|Lost to Follow-up|8|||
48953535|NCT00114972|157659636|FG001|Overall Study|Lost to Follow-up|5|||
48859339|NCT01185340|157323744|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
48953536|NCT00830037|157659637|FG000|Overall Study|Withdrawal by Subject|2|||
48953537|NCT00830037|157659638|FG001|Overall Study|Withdrawal by Subject|3|||
48953538|NCT00830037|157659637|FG000|Overall Study|Lost to Follow-up|1|||
48859340|NCT01185340|157323745|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
48859341|NCT01185340|157323742|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16|||
48859342|NCT01185340|157323743|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
48859343|NCT01185340|157323744|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
48859344|NCT01185340|157323745|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
48859345|NCT01185340|157323742|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32|||
48859346|NCT01185340|157323743|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
48859347|NCT01185340|157323744|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
48859348|NCT01185340|157323745|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
48859349|NCT01185340|157323742|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3|||
48859350|NCT01185340|157323743|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
48859351|NCT01185340|157323744|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
48859352|NCT01185340|157323745|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
48859353|NCT01185340|157323742|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
48859354|NCT01185340|157323743|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
48859355|NCT01185340|157323744|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8|||
48859356|NCT01185340|157323745|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
48859357|NCT01185340|157323742|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
48859358|NCT01185340|157323743|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
48859359|NCT01185340|157323744|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7|||
48859360|NCT01185340|157323745|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
48859361|NCT01185340|157323742|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
48859362|NCT01185340|157323743|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4|||
48859363|NCT01185340|157323744|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
48859364|NCT01185340|157323745|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7|||
48859365|NCT01185340|157323742|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
48859366|NCT01185340|157323743|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
48859367|NCT01185340|157323744|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
48859368|NCT01185340|157323745|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
48859369|NCT01185340|157323742|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
48859370|NCT01185340|157323743|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
48859371|NCT01185340|157323744|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2|||
48859372|NCT01185340|157323745|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
48859373|NCT01185340|157323742|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
48859374|NCT01185340|157323743|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
48859375|NCT01185340|157323744|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
48953539|NCT00830037|157659638|FG001|Overall Study|Lost to Follow-up|2|||
48953540|NCT00830037|157659637|FG000|Overall Study|Active when terminated by DSMB|15|||
48953541|NCT00830037|157659638|FG001|Overall Study|Active when terminated by DSMB|14|||
48953542|NCT00748540|157659641|FG000|Overall Study|Physician Decision|1|||
48953543|NCT00992446|157659642|FG000|Overall Study|Disease Progression|1|||
48953544|NCT00992446|157659642|FG000|Overall Study|Withdrawal by Subject|2|||
48953545|NCT00992446|157659642|FG000|Overall Study|Maintenance Therapy Screen Fail|5|||
48953546|NCT04743635|157659643|FG000|Overall Study|Lost to Follow-up|2|||
48953547|NCT04743635|157659644|FG001|Overall Study|Lost to Follow-up|0|||
48953548|NCT02775864|157659645|FG000|Overall Study|Data ended end of 2010|1764|||
48953549|NCT02775864|157659646|FG001|Overall Study|Data ended end of 2010|2880|||
48953550|NCT02775864|157659647|FG002|Overall Study|Data ended end of 2010|1140|||
48953551|NCT02775864|157659648|FG003|Overall Study|Data ended end of 2010|1194|||
48953552|NCT02775864|157659645|FG000|Overall Study|Medicaid eligibility discontinued|1478|||
48953553|NCT02775864|157659646|FG001|Overall Study|Medicaid eligibility discontinued|2019|||
48953554|NCT02775864|157659647|FG002|Overall Study|Medicaid eligibility discontinued|720|||
48953555|NCT02775864|157659648|FG003|Overall Study|Medicaid eligibility discontinued|890|||
48859376|NCT01185340|157323745|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
48859377|NCT01185340|157323742|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
48859378|NCT01185340|157323743|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
48859379|NCT01185340|157323744|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3|||
48859380|NCT01185340|157323745|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
48859381|NCT00587171|157323748|FG000|Overall Study|Lost to Follow-up|1|||
48859382|NCT00587171|157323749|FG001|Overall Study|Lost to Follow-up|1|||
48859383|NCT05005247|157323750|FG000|Overall Study|Withdrawal by Subject|0|||
48859384|NCT05005247|157323751|FG001|Overall Study|Withdrawal by Subject|1|||
48859385|NCT05005247|157323752|FG002|Overall Study|Withdrawal by Subject|0|||
48859386|NCT00608959|157323753|FG000|Part 1|Did not meet eligibility criteria|1|||
48859387|NCT00990184|157323755|FG000|Overall Study|Physician Decision|1|||
48859388|NCT00355784|157323756|FG000|Overall Study|Withdrawal by Subject|0|||
48859389|NCT00355784|157323757|FG001|Overall Study|Withdrawal by Subject|0|||
48859390|NCT00355784|157323758|FG002|Overall Study|Withdrawal by Subject|2|||
48859391|NCT01279447|157323762|FG000|Overall Study|Lost to Follow-up|3|||
48859392|NCT01279447|157323763|FG001|Overall Study|Lost to Follow-up|1|||
48953556|NCT00878072|157659649|FG000|Overall Study|Withdrew consent|2|||
48953557|NCT03238235|157659650|FG000|Overall Study|Adverse Event|2|||
48953558|NCT03238235|157659651|FG001|Overall Study|Adverse Event|0|||
48953559|NCT03238235|157659650|FG000|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|2|||
48953560|NCT03238235|157659651|FG001|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|0|||
48953561|NCT02379923|157659659|FG000|Overall Study|Death|5|||
48953562|NCT01954121|157659664|FG000|Overall Study|Lack of Efficacy|94|||
48953563|NCT01954121|157659665|FG001|Overall Study|Lack of Efficacy|41|||
48953564|NCT01954121|157659664|FG000|Overall Study|Protocol Violation|0|||
48953565|NCT01954121|157659665|FG001|Overall Study|Protocol Violation|2|||
48953566|NCT01954121|157659664|FG000|Overall Study|Lost to Follow-up|5|||
48953567|NCT01954121|157659665|FG001|Overall Study|Lost to Follow-up|6|||
48953568|NCT01954121|157659664|FG000|Overall Study|Withdrawal by Subject|18|||
48953569|NCT01954121|157659665|FG001|Overall Study|Withdrawal by Subject|12|||
48953570|NCT01954121|157659664|FG000|Overall Study|Pregnancy|1|||
48953571|NCT01954121|157659665|FG001|Overall Study|Pregnancy|1|||
48953572|NCT01954121|157659664|FG000|Overall Study|AE, serious fatal|1|||
48953573|NCT01954121|157659665|FG001|Overall Study|AE, serious fatal|0|||
48953574|NCT01954121|157659664|FG000|Overall Study|AE, non-serious non-fatal|5|||
48953575|NCT01954121|157659665|FG001|Overall Study|AE, non-serious non-fatal|22|||
48953576|NCT01954121|157659664|FG000|Overall Study|SAE, non-fatal|1|||
48953577|NCT01954121|157659665|FG001|Overall Study|SAE, non-fatal|4|||
49015372|NCT00306384|157892157|FG001|Overall Study|Study termination|0|||
48953578|NCT01954121|157659664|FG000|Overall Study|Non-compliant with study procedures|1|||
48953579|NCT01954121|157659665|FG001|Overall Study|Non-compliant with study procedures|0|||
48953580|NCT01954121|157659664|FG000|Overall Study|Non-compliant patient|1|||
48953581|NCT01954121|157659665|FG001|Overall Study|Non-compliant patient|1|||
48953582|NCT01954121|157659664|FG000|Overall Study|Subject did not follow instructions|0|||
48953583|NCT01954121|157659665|FG001|Overall Study|Subject did not follow instructions|2|||
48953584|NCT03844633|157659668|FG000|1 Week FU|Lost to Follow-up|0|||
48953585|NCT03844633|157659669|FG001|1 Week FU|Lost to Follow-up|1|||
48953586|NCT03844633|157659670|FG002|1 Week FU|Lost to Follow-up|4|||
48953587|NCT03844633|157659668|FG000|12-month Follow-up|Lost to Follow-up|7|||
48953588|NCT03844633|157659669|FG001|12-month Follow-up|Lost to Follow-up|5|||
48953589|NCT03844633|157659670|FG002|12-month Follow-up|Lost to Follow-up|8|||
48953590|NCT01318083|157659671|FG000|Overall Study|Adverse Event|4|||
48953591|NCT01318083|157659672|FG001|Overall Study|Adverse Event|1|||
48953592|NCT01318083|157659673|FG002|Overall Study|Adverse Event|2|||
48953593|NCT01318083|157659671|FG000|Overall Study|Withdrawal by Subject|1|||
48953594|NCT01318083|157659672|FG001|Overall Study|Withdrawal by Subject|0|||
48953595|NCT01318083|157659673|FG002|Overall Study|Withdrawal by Subject|2|||
48953596|NCT01318083|157659671|FG000|Overall Study|Lack of Efficacy|0|||
48953597|NCT01318083|157659672|FG001|Overall Study|Lack of Efficacy|0|||
48953598|NCT01318083|157659673|FG002|Overall Study|Lack of Efficacy|1|||
48953599|NCT01318083|157659671|FG000|Overall Study|Treatment Complications|1|||
48953600|NCT01318083|157659672|FG001|Overall Study|Treatment Complications|0|||
48953601|NCT01318083|157659673|FG002|Overall Study|Treatment Complications|0|||
48953602|NCT01318083|157659671|FG000|Overall Study|Lack of Study Medication Compliance|0|||
48953603|NCT01318083|157659672|FG001|Overall Study|Lack of Study Medication Compliance|1|||
48953604|NCT01318083|157659673|FG002|Overall Study|Lack of Study Medication Compliance|0|||
48953605|NCT05896761|157659674|FG000|Thigh Injection Phase (Up to Week 16)|Adverse Event|1|||
48953606|NCT05896761|157659675|FG001|Thigh Injection Phase (Up to Week 16)|Adverse Event|0|||
49015373|NCT00306384|157892158|FG002|Overall Study|Study termination|1|||
48746476|NCT01866930|156919812|FG001|Follow-up Period|Withdrawal by Subject|3|||
48746477|NCT02521870|156919813|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
48746478|NCT02521870|156919814|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|1|||
48746479|NCT02521870|156919815|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
48746480|NCT02521870|156919816|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
48746481|NCT02521870|156919817|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
48746482|NCT02521870|156919818|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
48746483|NCT02521870|156919819|FG006|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
48746484|NCT02521870|156919820|FG007|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
48746485|NCT02521870|156919821|FG008|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
48746486|NCT02521870|156919822|FG009|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
48746487|NCT02521870|156919823|FG010|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
48746488|NCT02521870|156919824|FG011|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
48746489|NCT02521870|156919813|FG000|Phase 1: Dose Escalation|Adverse Event|2|||
48953607|NCT05896761|157659674|FG000|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|2|||
48953608|NCT05896761|157659675|FG001|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|3|||
48746490|NCT02521870|156919814|FG001|Phase 1: Dose Escalation|Adverse Event|1|||
48746491|NCT02521870|156919815|FG002|Phase 1: Dose Escalation|Adverse Event|0|||
48746492|NCT02521870|156919816|FG003|Phase 1: Dose Escalation|Adverse Event|0|||
48746493|NCT02521870|156919817|FG004|Phase 1: Dose Escalation|Adverse Event|0|||
48746494|NCT02521870|156919818|FG005|Phase 1: Dose Escalation|Adverse Event|0|||
48746495|NCT02521870|156919819|FG006|Phase 1: Dose Escalation|Adverse Event|0|||
48746496|NCT02521870|156919820|FG007|Phase 1: Dose Escalation|Adverse Event|0|||
48746497|NCT02521870|156919821|FG008|Phase 1: Dose Escalation|Adverse Event|0|||
48746498|NCT02521870|156919822|FG009|Phase 1: Dose Escalation|Adverse Event|0|||
48746499|NCT02521870|156919823|FG010|Phase 1: Dose Escalation|Adverse Event|0|||
48746500|NCT02521870|156919824|FG011|Phase 1: Dose Escalation|Adverse Event|0|||
48746501|NCT02521870|156919813|FG000|Phase 1: Dose Escalation|Progressive Disease|3|||
48746502|NCT02521870|156919814|FG001|Phase 1: Dose Escalation|Progressive Disease|2|||
48746503|NCT02521870|156919815|FG002|Phase 1: Dose Escalation|Progressive Disease|4|||
48746504|NCT02521870|156919816|FG003|Phase 1: Dose Escalation|Progressive Disease|6|||
48746505|NCT02521870|156919817|FG004|Phase 1: Dose Escalation|Progressive Disease|0|||
48746506|NCT02521870|156919818|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
48746507|NCT02521870|156919819|FG006|Phase 1: Dose Escalation|Progressive Disease|0|||
48746508|NCT02521870|156919820|FG007|Phase 1: Dose Escalation|Progressive Disease|0|||
48746509|NCT02521870|156919821|FG008|Phase 1: Dose Escalation|Progressive Disease|0|||
48746510|NCT02521870|156919822|FG009|Phase 1: Dose Escalation|Progressive Disease|0|||
48746511|NCT02521870|156919823|FG010|Phase 1: Dose Escalation|Progressive Disease|0|||
48746512|NCT02521870|156919824|FG011|Phase 1: Dose Escalation|Progressive Disease|0|||
48746513|NCT02521870|156919813|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
48746514|NCT02521870|156919814|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
48746515|NCT02521870|156919815|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
48746516|NCT02521870|156919816|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
48746517|NCT02521870|156919817|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|5|||
48746518|NCT02521870|156919818|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
48859393|NCT01919489|157323764|FG000|Overall Study|Rejected the need of injections|4|||
48859394|NCT01919489|157323765|FG001|Overall Study|Rejected the need of injections|7|||
48859395|NCT01919489|157323764|FG000|Overall Study|Adverse Event|10|||
48859396|NCT01919489|157323765|FG001|Overall Study|Adverse Event|0|||
48859397|NCT01919489|157323764|FG000|Overall Study|Hospital readmission|2|||
48859398|NCT01919489|157323765|FG001|Overall Study|Hospital readmission|9|||
48859399|NCT01919489|157323764|FG000|Overall Study|Death|2|||
48859400|NCT01919489|157323765|FG001|Overall Study|Death|1|||
48859401|NCT01919489|157323764|FG000|Overall Study|Lost to Follow-up|38|||
48859402|NCT01919489|157323765|FG001|Overall Study|Lost to Follow-up|27|||
48859403|NCT01322386|157323766|FG000|Overall Study|Protocol Violation|0|||
48859404|NCT01322386|157323767|FG001|Overall Study|Protocol Violation|1|||
48859405|NCT01322386|157323766|FG000|Overall Study|Physician Decision|0|||
48859406|NCT01322386|157323767|FG001|Overall Study|Physician Decision|1|||
48859407|NCT02213094|157323770|FG000|Overall Study|Adverse Event|1|||
48859408|NCT02213094|157323771|FG001|Overall Study|Adverse Event|0|||
48859409|NCT00441168|157323772|FG000|Treatment Period|Death|3|||
48953609|NCT05301322|157659676|FG000|Overall Study|Adverse Event|7|||
48859410|NCT00441168|157323773|FG001|Treatment Period|Death|0|||
48859411|NCT00441168|157323772|FG000|Treatment Period|Adverse Event|1|||
48859412|NCT00441168|157323773|FG001|Treatment Period|Adverse Event|2|||
48859413|NCT00441168|157323772|FG000|Treatment Period|Progressive Disease|0|||
48859414|NCT00441168|157323773|FG001|Treatment Period|Progressive Disease|2|||
48859415|NCT00441168|157323772|FG000|Treatment Period|Protocol Violation|0|||
48859416|NCT00441168|157323773|FG001|Treatment Period|Protocol Violation|1|||
48859417|NCT00441168|157323772|FG000|Treatment Period|Lost to Follow-up|0|||
48859418|NCT00441168|157323773|FG001|Treatment Period|Lost to Follow-up|1|||
48859419|NCT00441168|157323772|FG000|Treatment Period|Withdrawal by Subject|3|||
48859420|NCT00441168|157323773|FG001|Treatment Period|Withdrawal by Subject|0|||
48859421|NCT00441168|157323772|FG000|Treatment Period|qualified for stem-cell transplantation|3|||
48953610|NCT05301322|157659677|FG001|Overall Study|Adverse Event|3|||
48746519|NCT02521870|156919819|FG006|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
48746520|NCT02521870|156919820|FG007|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
48746521|NCT02521870|156919821|FG008|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
48746522|NCT02521870|156919822|FG009|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
48746523|NCT02521870|156919823|FG010|Phase 2: Dose Expansion|Withdrawal by Subject|2|||
48746524|NCT02521870|156919824|FG011|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
48859422|NCT00441168|157323773|FG001|Treatment Period|qualified for stem-cell transplantation|0|||
48859423|NCT00441168|157323772|FG000|Treatment Period|refractory disease|1|||
48859424|NCT00441168|157323773|FG001|Treatment Period|refractory disease|0|||
48859425|NCT00441168|157323772|FG000|Follow-up Period|Death|3|||
48859426|NCT00441168|157323773|FG001|Follow-up Period|Death|0|||
48859427|NCT00441168|157323772|FG000|Follow-up Period|Lost to Follow-up|5|||
48859428|NCT00441168|157323773|FG001|Follow-up Period|Lost to Follow-up|6|||
48859429|NCT00441168|157323772|FG000|Follow-up Period|Withdrawal by Subject|3|||
48859430|NCT00441168|157323773|FG001|Follow-up Period|Withdrawal by Subject|0|||
48859431|NCT00441168|157323772|FG000|Follow-up Period|Other|1|||
48859432|NCT00441168|157323773|FG001|Follow-up Period|Other|3|||
48859433|NCT02511106|157323774|FG000|Overall Study|Lost to Follow-up|6|||
48859434|NCT02511106|157323775|FG001|Overall Study|Lost to Follow-up|4|||
48859435|NCT02511106|157323774|FG000|Overall Study|Withdrawal by Subject|24|||
48746525|NCT02521870|156919813|FG000|Phase 2: Dose Expansion|Adverse Event|0|||
48859436|NCT02511106|157323775|FG001|Overall Study|Withdrawal by Subject|21|||
48859437|NCT02511106|157323774|FG000|Overall Study|Death|42|||
48859438|NCT02511106|157323775|FG001|Overall Study|Death|82|||
48859439|NCT02511106|157323774|FG000|Overall Study|Ongoing study at data cut-off|3|||
48859440|NCT02511106|157323775|FG001|Overall Study|Ongoing study at data cut-off|2|||
48859441|NCT02511106|157323774|FG000|Overall Study|Without specified reason|3|||
48859442|NCT02511106|157323775|FG001|Overall Study|Without specified reason|0|||
48859443|NCT02721147|157323780|FG000|Overall Study|Lost to Follow-up|2|||
48859444|NCT02721147|157323781|FG001|Overall Study|Lost to Follow-up|0|||
48859445|NCT02721147|157323782|FG002|Overall Study|Lost to Follow-up|0|||
48859446|NCT02256553|157323783|FG000|Period I|Adverse Event|5|||
48859447|NCT02256553|157323783|FG000|Period I|Protocol Violation|1|||
48859448|NCT02256553|157323783|FG000|Period II|Adverse Event|1|||
48859449|NCT02256553|157323783|FG000|Period II|Subject Moved|1|||
48859450|NCT02256553|157323783|FG000|Period III|Adverse Event|3|||
48859451|NCT02097056|157323791|FG000|Overall Study|Protocol Violation|2|||
48859452|NCT02097056|157323791|FG000|Overall Study|Withdrawal by Subject|15|||
48859453|NCT02097056|157323791|FG000|Overall Study|Lost to Follow-up|2|||
48859454|NCT02097056|157323791|FG000|Overall Study|Adverse Event|37|||
48859455|NCT02097056|157323791|FG000|Overall Study|Other|2|||
48859456|NCT02604199|157323792|FG000|Overall Study|Pregnancy|0|||
48859457|NCT02604199|157323793|FG001|Overall Study|Pregnancy|0|||
48859458|NCT02604199|157323794|FG002|Overall Study|Pregnancy|0|||
48859459|NCT02604199|157323795|FG003|Overall Study|Pregnancy|1|||
48859460|NCT02604199|157323792|FG000|Overall Study|Study terminated by sponsor|0|||
48859461|NCT02604199|157323793|FG001|Overall Study|Study terminated by sponsor|2|||
48859462|NCT02604199|157323794|FG002|Overall Study|Study terminated by sponsor|0|||
48859463|NCT02604199|157323795|FG003|Overall Study|Study terminated by sponsor|2|||
48859464|NCT02604199|157323792|FG000|Overall Study|Withdrawal by Subject|0|||
48859465|NCT02604199|157323793|FG001|Overall Study|Withdrawal by Subject|1|||
48859466|NCT02604199|157323794|FG002|Overall Study|Withdrawal by Subject|0|||
48859467|NCT02604199|157323795|FG003|Overall Study|Withdrawal by Subject|0|||
48859468|NCT00658632|157323801|FG000|Overall Study|Adverse Event|13|||
48859469|NCT00658632|157323802|FG001|Overall Study|Adverse Event|11|||
48859470|NCT00658632|157323801|FG000|Overall Study|Lost to Follow-up|25|||
48859471|NCT00658632|157323802|FG001|Overall Study|Lost to Follow-up|23|||
48859472|NCT00658632|157323801|FG000|Overall Study|Withdrawal by Subject|10|||
48859473|NCT00658632|157323802|FG001|Overall Study|Withdrawal by Subject|7|||
48859474|NCT00658632|157323801|FG000|Overall Study|Lack of Efficacy|0|||
48859475|NCT00658632|157323802|FG001|Overall Study|Lack of Efficacy|1|||
48859476|NCT00658632|157323801|FG000|Overall Study|Withdrawal of consent|8|||
48859477|NCT00658632|157323802|FG001|Overall Study|Withdrawal of consent|14|||
48859478|NCT00658632|157323801|FG000|Overall Study|Pregnancy|1|||
48859479|NCT00658632|157323802|FG001|Overall Study|Pregnancy|1|||
48859480|NCT00658632|157323801|FG000|Overall Study|Other|7|||
48746526|NCT02521870|156919814|FG001|Phase 2: Dose Expansion|Adverse Event|0|||
48746527|NCT02521870|156919815|FG002|Phase 2: Dose Expansion|Adverse Event|0|||
48746528|NCT02521870|156919816|FG003|Phase 2: Dose Expansion|Adverse Event|0|||
48746529|NCT02521870|156919817|FG004|Phase 2: Dose Expansion|Adverse Event|11|||
48746530|NCT02521870|156919818|FG005|Phase 2: Dose Expansion|Adverse Event|2|||
48746531|NCT02521870|156919819|FG006|Phase 2: Dose Expansion|Adverse Event|0|||
48746532|NCT02521870|156919820|FG007|Phase 2: Dose Expansion|Adverse Event|1|||
48746533|NCT02521870|156919821|FG008|Phase 2: Dose Expansion|Adverse Event|5|||
48746534|NCT02521870|156919822|FG009|Phase 2: Dose Expansion|Adverse Event|0|||
48746535|NCT02521870|156919823|FG010|Phase 2: Dose Expansion|Adverse Event|1|||
48746536|NCT02521870|156919824|FG011|Phase 2: Dose Expansion|Adverse Event|0|||
48746537|NCT02521870|156919813|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
48746538|NCT02521870|156919814|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
48859481|NCT00658632|157323802|FG001|Overall Study|Other|8|||
48859482|NCT02555397|157323803|FG000|Overall Study|Withdrawal by Subject|1|||
48859483|NCT02555397|157323804|FG001|Overall Study|Withdrawal by Subject|0|||
48859484|NCT02555397|157323805|FG002|Overall Study|Withdrawal by Subject|0|||
48859485|NCT02555397|157323806|FG003|Overall Study|Withdrawal by Subject|0|||
48859486|NCT02555397|157323807|FG004|Overall Study|Withdrawal by Subject|0|||
48953611|NCT05301322|157659676|FG000|Overall Study|Death|0|||
48746539|NCT02521870|156919815|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
48746540|NCT02521870|156919816|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
48746541|NCT02521870|156919817|FG004|Phase 2: Dose Expansion|Progressive Disease|22|||
48859487|NCT00617708|157323811|FG000|Overall Study|Adverse Event|0|||
48859488|NCT00617708|157323812|FG001|Overall Study|Adverse Event|6|||
48859489|NCT00617708|157323813|FG002|Overall Study|Adverse Event|9|||
48859490|NCT00617708|157323811|FG000|Overall Study|Withdrawal by Subject|1|||
48859491|NCT00617708|157323812|FG001|Overall Study|Withdrawal by Subject|1|||
48859492|NCT00617708|157323813|FG002|Overall Study|Withdrawal by Subject|7|||
48859493|NCT00617708|157323811|FG000|Overall Study|Death|0|||
48859494|NCT00617708|157323812|FG001|Overall Study|Death|6|||
48859495|NCT00617708|157323813|FG002|Overall Study|Death|5|||
48859496|NCT00617708|157323811|FG000|Overall Study|Progression/Relapse|7|||
48859497|NCT00617708|157323812|FG001|Overall Study|Progression/Relapse|40|||
48859498|NCT00617708|157323813|FG002|Overall Study|Progression/Relapse|36|||
48859499|NCT00617708|157323811|FG000|Overall Study|Not protocol specified|1|||
48859500|NCT00617708|157323812|FG001|Overall Study|Not protocol specified|4|||
48859501|NCT00617708|157323813|FG002|Overall Study|Not protocol specified|2|||
48859502|NCT00617708|157323811|FG000|Overall Study|Not eligible|1|||
48859503|NCT00617708|157323812|FG001|Overall Study|Not eligible|3|||
48859504|NCT00617708|157323813|FG002|Overall Study|Not eligible|5|||
48859505|NCT01287832|157323814|FG000|Overall Study|Adverse Event|1|||
48859506|NCT01287832|157323815|FG001|Overall Study|Adverse Event|0|||
48859507|NCT01287832|157323814|FG000|Overall Study|Death|0|||
48859508|NCT01287832|157323815|FG001|Overall Study|Death|1|||
48859509|NCT00818519|157323816|FG000|Overall Study|Adverse Event|2|||
48859510|NCT00818519|157323817|FG001|Overall Study|Adverse Event|2|||
48859511|NCT00818519|157323816|FG000|Overall Study|Lost to Follow-up|4|||
48859512|NCT00818519|157323817|FG001|Overall Study|Lost to Follow-up|6|||
48859513|NCT00818519|157323816|FG000|Overall Study|Protocol Violation|2|||
48859514|NCT00818519|157323817|FG001|Overall Study|Protocol Violation|1|||
48859515|NCT00818519|157323816|FG000|Overall Study|Pregnancy|0|||
48859516|NCT00818519|157323817|FG001|Overall Study|Pregnancy|1|||
48859517|NCT00818519|157323816|FG000|Overall Study|Withdrawal by Subject|4|||
48859518|NCT00818519|157323817|FG001|Overall Study|Withdrawal by Subject|9|||
48859519|NCT00818519|157323816|FG000|Overall Study|participant recovered completely|1|||
48859520|NCT00818519|157323817|FG001|Overall Study|participant recovered completely|0|||
48859521|NCT00818519|157323816|FG000|Overall Study|participant will leave for long tme|1|||
48859522|NCT00818519|157323817|FG001|Overall Study|participant will leave for long tme|0|||
48859523|NCT03747575|157323818|FG000|Overall Study|Withdrawal by Subject|6|||
48859524|NCT03747575|157323819|FG001|Overall Study|Withdrawal by Subject|3|||
48859525|NCT03747575|157323818|FG000|Overall Study|Lost to Follow-up|3|||
48859526|NCT03747575|157323819|FG001|Overall Study|Lost to Follow-up|3|||
48859527|NCT03747575|157323818|FG000|Overall Study|Adverse Event|0|||
48859528|NCT03747575|157323819|FG001|Overall Study|Adverse Event|1|||
48953612|NCT05301322|157659677|FG001|Overall Study|Death|1|||
48953613|NCT05301322|157659676|FG000|Overall Study|Lost to Follow-up|2|||
48953614|NCT05301322|157659677|FG001|Overall Study|Lost to Follow-up|1|||
48953615|NCT05301322|157659676|FG000|Overall Study|Protocol Violation|3|||
48953616|NCT05301322|157659677|FG001|Overall Study|Protocol Violation|1|||
48953617|NCT05301322|157659676|FG000|Overall Study|Withdrawal by Subject|3|||
48953618|NCT05301322|157659677|FG001|Overall Study|Withdrawal by Subject|0|||
48953619|NCT05301322|157659676|FG000|Overall Study|Other|4|||
48953620|NCT05301322|157659677|FG001|Overall Study|Other|0|||
48953621|NCT00872170|157659679|FG000|Overall Study|Adverse Event|1|||
48953622|NCT00872170|157659680|FG001|Overall Study|Adverse Event|0|||
48953623|NCT00426751|157659681|FG000|Overall Study|Adverse Event|8|||
48953624|NCT00426751|157659682|FG001|Overall Study|Adverse Event|1|||
48953625|NCT00426751|157659681|FG000|Overall Study|Lost to Follow-up|7|||
48953626|NCT00426751|157659682|FG001|Overall Study|Lost to Follow-up|6|||
48953627|NCT00426751|157659681|FG000|Overall Study|Consent Withdrawn|0|||
48953628|NCT00426751|157659682|FG001|Overall Study|Consent Withdrawn|1|||
48953629|NCT00426751|157659681|FG000|Overall Study|Other Reasons|7|||
48953630|NCT00426751|157659682|FG001|Overall Study|Other Reasons|12|||
48953631|NCT02429427|157659683|FG000|Overall Study|Adverse Event|220|||
48953632|NCT02429427|157659684|FG001|Overall Study|Adverse Event|92|||
48953633|NCT02429427|157659683|FG000|Overall Study|Protocol Violation|10|||
48953634|NCT02429427|157659684|FG001|Overall Study|Protocol Violation|6|||
48953635|NCT02429427|157659683|FG000|Overall Study|Lost to Follow-up|15|||
48953636|NCT02429427|157659684|FG001|Overall Study|Lost to Follow-up|6|||
48953637|NCT02429427|157659683|FG000|Overall Study|Withdrawal by Subject|64|||
48953638|NCT02429427|157659684|FG001|Overall Study|Withdrawal by Subject|34|||
48953639|NCT02429427|157659683|FG000|Overall Study|Other|62|||
48953640|NCT02429427|157659684|FG001|Overall Study|Other|41|||
48953641|NCT02028338|157659685|FG000|Overall Study|Withdrawal by Subject|3|||
48953642|NCT02028338|157659686|FG001|Overall Study|Withdrawal by Subject|1|||
48859529|NCT03219216|157323820|FG000|Overall Study|Lost to Follow-up|0|||
48953643|NCT02028338|157659685|FG000|Overall Study|Unable to contact participant|1|||
48859530|NCT03219216|157323821|FG001|Overall Study|Lost to Follow-up|1|||
48953644|NCT02028338|157659686|FG001|Overall Study|Unable to contact participant|0|||
48859531|NCT03615404|157323822|FG000|Overall Study|Death|1|||
48953645|NCT03288779|157659687|FG000|Overall Study|Withdrawal by Subject|3|||
48953646|NCT03552549|157659688|FG000|Overall Study|Disease progression|25|||
48953647|NCT03552549|157659689|FG001|Overall Study|Disease progression|17|||
48953648|NCT03552549|157659688|FG000|Overall Study|Adverse event in first 12 months|12|||
48953649|NCT03552549|157659689|FG001|Overall Study|Adverse event in first 12 months|8|||
48953650|NCT03552549|157659688|FG000|Overall Study|Withdrawal by Subject|7|||
48953651|NCT03552549|157659689|FG001|Overall Study|Withdrawal by Subject|7|||
48746542|NCT02521870|156919818|FG005|Phase 2: Dose Expansion|Progressive Disease|18|||
48859532|NCT03615404|157323822|FG000|Overall Study|vaccine did not pass quality assurance|1|||
48859533|NCT00257556|157323823|FG000|Overall Study|Adverse Event|1|||
48859534|NCT00257556|157323824|FG001|Overall Study|Adverse Event|4|||
48859535|NCT00257556|157323823|FG000|Overall Study|Physician Decision|6|||
48859536|NCT00257556|157323824|FG001|Overall Study|Physician Decision|0|||
48859537|NCT00257556|157323823|FG000|Overall Study|Did not meet hCG criterion|3|||
48859538|NCT00257556|157323824|FG001|Overall Study|Did not meet hCG criterion|0|||
48859539|NCT00257556|157323823|FG000|Overall Study|other reason|4|||
48859540|NCT00257556|157323824|FG001|Overall Study|other reason|6|||
48859541|NCT01697956|157323825|FG000|Overall Study|Protocol Violation|1|||
48859542|NCT01697956|157323826|FG001|Overall Study|Protocol Violation|1|||
48859543|NCT00805441|157323827|FG000|Overall Study|Adverse Event|5|||
48859544|NCT00805441|157323828|FG001|Overall Study|Adverse Event|2|||
48859545|NCT00805441|157323827|FG000|Overall Study|Lack of Efficacy|0|||
48859546|NCT00805441|157323828|FG001|Overall Study|Lack of Efficacy|2|||
48859547|NCT00805441|157323827|FG000|Overall Study|Protocol Violation|4|||
48859548|NCT00805441|157323828|FG001|Overall Study|Protocol Violation|8|||
48953652|NCT03552549|157659688|FG000|Overall Study|Unknown (no reason provided)|4|||
48746543|NCT02521870|156919819|FG006|Phase 2: Dose Expansion|Progressive Disease|17|||
48746544|NCT02521870|156919820|FG007|Phase 2: Dose Expansion|Progressive Disease|7|||
48953653|NCT03552549|157659689|FG001|Overall Study|Unknown (no reason provided)|2|||
48953654|NCT03552549|157659688|FG000|Overall Study|Not in participant's best interest|2|||
48953655|NCT03552549|157659689|FG001|Overall Study|Not in participant's best interest|1|||
48953656|NCT03552549|157659688|FG000|Overall Study|Did not complete study treatment|2|||
48953657|NCT03552549|157659689|FG001|Overall Study|Did not complete study treatment|3|||
48953658|NCT03552549|157659688|FG000|Overall Study|Did not meet eligibility criteria|1|||
48746545|NCT02521870|156919821|FG008|Phase 2: Dose Expansion|Progressive Disease|5|||
48746546|NCT02521870|156919822|FG009|Phase 2: Dose Expansion|Progressive Disease|17|||
48746547|NCT02521870|156919823|FG010|Phase 2: Dose Expansion|Progressive Disease|17|||
48746548|NCT02521870|156919824|FG011|Phase 2: Dose Expansion|Progressive Disease|21|||
48746549|NCT02521870|156919813|FG000|Phase 2: Dose Expansion|Death|0|||
48746550|NCT02521870|156919814|FG001|Phase 2: Dose Expansion|Death|0|||
48746551|NCT02521870|156919815|FG002|Phase 2: Dose Expansion|Death|0|||
48746552|NCT02521870|156919816|FG003|Phase 2: Dose Expansion|Death|0|||
48746553|NCT02521870|156919817|FG004|Phase 2: Dose Expansion|Death|1|||
48746554|NCT02521870|156919818|FG005|Phase 2: Dose Expansion|Death|1|||
48746555|NCT02521870|156919819|FG006|Phase 2: Dose Expansion|Death|3|||
48746556|NCT02521870|156919820|FG007|Phase 2: Dose Expansion|Death|1|||
48746557|NCT02521870|156919821|FG008|Phase 2: Dose Expansion|Death|1|||
48746558|NCT02521870|156919822|FG009|Phase 2: Dose Expansion|Death|5|||
48746559|NCT02521870|156919823|FG010|Phase 2: Dose Expansion|Death|2|||
48746560|NCT02521870|156919824|FG011|Phase 2: Dose Expansion|Death|2|||
48746561|NCT02521870|156919813|FG000|Phase 2: Dose Expansion|Other|0|||
48746562|NCT02521870|156919814|FG001|Phase 2: Dose Expansion|Other|0|||
48746563|NCT02521870|156919815|FG002|Phase 2: Dose Expansion|Other|0|||
48746564|NCT02521870|156919816|FG003|Phase 2: Dose Expansion|Other|0|||
48859549|NCT00805441|157323827|FG000|Overall Study|Lost to Follow-up|10|||
48859550|NCT00805441|157323828|FG001|Overall Study|Lost to Follow-up|13|||
48859551|NCT00805441|157323827|FG000|Overall Study|Withdrawal by Subject|15|||
48953659|NCT03552549|157659689|FG001|Overall Study|Did not meet eligibility criteria|0|||
48953660|NCT03552549|157659688|FG000|Overall Study|Administrative|0|||
48953661|NCT03552549|157659689|FG001|Overall Study|Administrative|14|||
48953662|NCT02588248|157659692|FG000|Overall Study|Physician Decision|4|||
48953663|NCT02588248|157659693|FG001|Overall Study|Physician Decision|3|||
48953664|NCT01355068|157659695|FG000|First Intervention Period|Adverse Event|0|||
48953665|NCT01355068|157659696|FG001|First Intervention Period|Adverse Event|1|||
48953666|NCT01355068|157659695|FG000|First Intervention Period|Withdrawal by Subject|0|||
48953667|NCT01355068|157659696|FG001|First Intervention Period|Withdrawal by Subject|1|||
48953668|NCT02761993|157659702|FG000|Overall Study|Adverse Event|0|||
48953669|NCT02761993|157659703|FG001|Overall Study|Adverse Event|2|||
48953670|NCT02761993|157659704|FG002|Overall Study|Adverse Event|0|||
48953671|NCT02761993|157659702|FG000|Overall Study|Lost to Follow-up|1|||
48953672|NCT02761993|157659703|FG001|Overall Study|Lost to Follow-up|3|||
48859552|NCT00805441|157323828|FG001|Overall Study|Withdrawal by Subject|9|||
48859553|NCT00805441|157323827|FG000|Overall Study|Physician Decision|0|||
48953673|NCT02761993|157659704|FG002|Overall Study|Lost to Follow-up|2|||
48953674|NCT02761993|157659702|FG000|Overall Study|Withdrawal by Subject|1|||
48746565|NCT02521870|156919817|FG004|Phase 2: Dose Expansion|Other|10|||
48746566|NCT02521870|156919818|FG005|Phase 2: Dose Expansion|Other|3|||
48859554|NCT00805441|157323828|FG001|Overall Study|Physician Decision|1|||
48859555|NCT00805441|157323827|FG000|Overall Study|Acute Alcohol Withdrawal|0|||
48859556|NCT00805441|157323828|FG001|Overall Study|Acute Alcohol Withdrawal|1|||
48859557|NCT00141271|157323829|FG000|Overall Study|Adverse Event|31|||
48859558|NCT00141271|157323830|FG001|Overall Study|Adverse Event|19|||
48746567|NCT02521870|156919819|FG006|Phase 2: Dose Expansion|Other|2|||
48746568|NCT02521870|156919820|FG007|Phase 2: Dose Expansion|Other|0|||
48746569|NCT02521870|156919821|FG008|Phase 2: Dose Expansion|Other|10|||
48746570|NCT02521870|156919822|FG009|Phase 2: Dose Expansion|Other|5|||
48859559|NCT00141271|157323831|FG002|Overall Study|Adverse Event|17|||
48859560|NCT00141271|157323829|FG000|Overall Study|Laboratory Abnormality|2|||
48859561|NCT00141271|157323830|FG001|Overall Study|Laboratory Abnormality|1|||
48859562|NCT00141271|157323831|FG002|Overall Study|Laboratory Abnormality|1|||
48859563|NCT00141271|157323829|FG000|Overall Study|Lack of Efficacy|7|||
48953675|NCT02761993|157659703|FG001|Overall Study|Withdrawal by Subject|1|||
48746571|NCT02521870|156919823|FG010|Phase 2: Dose Expansion|Other|1|||
48746572|NCT02521870|156919824|FG011|Phase 2: Dose Expansion|Other|7|||
48746573|NCT02521870|156919813|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
48746574|NCT02521870|156919814|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
48746575|NCT02521870|156919815|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
48953676|NCT02761993|157659704|FG002|Overall Study|Withdrawal by Subject|2|||
48953677|NCT02739594|157659705|FG000|Overall Study|Undesired Event|3|||
48953678|NCT02739594|157659706|FG001|Overall Study|Undesired Event|4|||
48953679|NCT02739594|157659705|FG000|Overall Study|Violation of Eligibility Criteria|1|||
48859564|NCT00141271|157323830|FG001|Overall Study|Lack of Efficacy|7|||
48859565|NCT00141271|157323831|FG002|Overall Study|Lack of Efficacy|3|||
48859566|NCT00141271|157323829|FG000|Overall Study|Lost to Follow-up|15|||
48746576|NCT02521870|156919816|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
48746577|NCT02521870|156919817|FG004|Phase 2: Dose Expansion|Lost to Follow-up|1|||
48746578|NCT02521870|156919818|FG005|Phase 2: Dose Expansion|Lost to Follow-up|0|||
48859567|NCT00141271|157323830|FG001|Overall Study|Lost to Follow-up|15|||
48859568|NCT00141271|157323831|FG002|Overall Study|Lost to Follow-up|21|||
48859569|NCT00141271|157323829|FG000|Overall Study|Withdrawal by Subject|14|||
48859570|NCT00141271|157323830|FG001|Overall Study|Withdrawal by Subject|9|||
48859571|NCT00141271|157323831|FG002|Overall Study|Withdrawal by Subject|10|||
48859572|NCT00141271|157323829|FG000|Overall Study|Other|11|||
48859573|NCT00141271|157323830|FG001|Overall Study|Other|12|||
48859574|NCT00141271|157323831|FG002|Overall Study|Other|5|||
48859575|NCT04382053|157323838|FG000|Overall Study|Death|6|||
48859576|NCT04382053|157323839|FG001|Overall Study|Death|8|||
48859577|NCT04382053|157323838|FG000|Overall Study|Lost to Follow-up|0|||
48859578|NCT04382053|157323839|FG001|Overall Study|Lost to Follow-up|2|||
48859579|NCT04382053|157323838|FG000|Overall Study|Protocol Deviation|1|||
48859580|NCT04382053|157323839|FG001|Overall Study|Protocol Deviation|2|||
48859581|NCT04382053|157323838|FG000|Overall Study|Withdrawal by Subject|2|||
48859582|NCT04382053|157323839|FG001|Overall Study|Withdrawal by Subject|1|||
48859583|NCT00267865|157323849|FG000|Induction Treatment|Died before completing.|2|||
48859584|NCT00267865|157323849|FG000|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1|||
48859585|NCT03686176|157323850|FG000|Overall Study|Procedure cancelled|1|||
48859586|NCT03686176|157323851|FG001|Overall Study|Procedure cancelled|0|||
48859587|NCT03686176|157323852|FG002|Overall Study|Procedure cancelled|0|||
48859588|NCT03686176|157323850|FG000|Overall Study|VR Malfunction|1|||
48859589|NCT03686176|157323851|FG001|Overall Study|VR Malfunction|0|||
48859590|NCT03686176|157323852|FG002|Overall Study|VR Malfunction|0|||
48859591|NCT00390806|157323858|FG000|Overall Study|Lost to Follow-up|7|||
48953680|NCT02739594|157659706|FG001|Overall Study|Violation of Eligibility Criteria|2|||
48953681|NCT02739594|157659705|FG000|Overall Study|Protocol Violation|5|||
48859592|NCT00390806|157323859|FG001|Overall Study|Lost to Follow-up|6|||
48859593|NCT00390806|157323858|FG000|Overall Study|Protocol Violation|2|||
48859594|NCT00390806|157323859|FG001|Overall Study|Protocol Violation|2|||
48859595|NCT00390806|157323858|FG000|Overall Study|Withdrawal by Subject|12|||
48953682|NCT02739594|157659706|FG001|Overall Study|Protocol Violation|6|||
48953683|NCT02739594|157659705|FG000|Overall Study|Death|4|||
48953684|NCT02739594|157659706|FG001|Overall Study|Death|2|||
48953685|NCT02739594|157659705|FG000|Overall Study|Renal Insufficiency|4|||
48953686|NCT02739594|157659706|FG001|Overall Study|Renal Insufficiency|6|||
48953687|NCT02739594|157659705|FG000|Overall Study|Administrative Reasons|1|||
48953688|NCT02739594|157659706|FG001|Overall Study|Administrative Reasons|3|||
48953689|NCT02739594|157659705|FG000|Overall Study|Withdrawal by Subject|1|||
48953690|NCT02739594|157659706|FG001|Overall Study|Withdrawal by Subject|1|||
48953691|NCT02739594|157659705|FG000|Overall Study|Lost to Follow-up|0|||
48953692|NCT02739594|157659706|FG001|Overall Study|Lost to Follow-up|1|||
48953693|NCT02739594|157659705|FG000|Overall Study|Elevated Serum Creatinine|0|||
48953694|NCT02739594|157659706|FG001|Overall Study|Elevated Serum Creatinine|1|||
48953695|NCT02739594|157659705|FG000|Overall Study|Other|6|||
48953696|NCT02739594|157659706|FG001|Overall Study|Other|2|||
48953697|NCT01582282|157660916|FG000|Overall Study|Adverse Event|1|||
48953698|NCT01582282|157660917|FG001|Overall Study|Adverse Event|1|||
48953699|NCT01582282|157660918|FG002|Overall Study|Adverse Event|0|||
48953700|NCT01582282|157660916|FG000|Overall Study|Lost to Follow-up|1|||
48953701|NCT01582282|157660917|FG001|Overall Study|Lost to Follow-up|0|||
48953702|NCT01582282|157660918|FG002|Overall Study|Lost to Follow-up|0|||
48953703|NCT01582282|157660916|FG000|Overall Study|fasting blood glucose outside Protocol|0|||
48953704|NCT01582282|157660917|FG001|Overall Study|fasting blood glucose outside Protocol|1|||
48953705|NCT01582282|157660918|FG002|Overall Study|fasting blood glucose outside Protocol|0|||
48953706|NCT03052608|157660930|FG000|Treatment Phase|Adverse Event|10|||
48953707|NCT03052608|157660931|FG001|Treatment Phase|Adverse Event|12|||
48953708|NCT03052608|157660930|FG000|Treatment Phase|Death|6|||
48953709|NCT03052608|157660931|FG001|Treatment Phase|Death|4|||
48953710|NCT03052608|157660930|FG000|Treatment Phase|Withdrawal by Subject|4|||
48953711|NCT03052608|157660931|FG001|Treatment Phase|Withdrawal by Subject|12|||
48953712|NCT03052608|157660930|FG000|Treatment Phase|Global Deterioration of Health Status|0|||
48859596|NCT00390806|157323859|FG001|Overall Study|Withdrawal by Subject|15|||
48953713|NCT03052608|157660931|FG001|Treatment Phase|Global Deterioration of Health Status|3|||
48953714|NCT03052608|157660930|FG000|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0|||
48953715|NCT03052608|157660931|FG001|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1|||
48953716|NCT03052608|157660930|FG000|Treatment Phase|Subject didn't receive study treatment.|0|||
48953717|NCT03052608|157660931|FG001|Treatment Phase|Subject didn't receive study treatment.|1|||
48953718|NCT03052608|157660930|FG000|Treatment Phase|Ongoing|103|||
48953719|NCT03052608|157660931|FG001|Treatment Phase|Ongoing|31|||
48953720|NCT03052608|157660930|FG000|Long-Term Follow-up Phase|Death|23|||
48953721|NCT03052608|157660931|FG001|Long-Term Follow-up Phase|Death|28|||
48953722|NCT03052608|157660930|FG000|Long-Term Follow-up Phase|Lost to Follow-up|0|||
48953723|NCT03052608|157660931|FG001|Long-Term Follow-up Phase|Lost to Follow-up|2|||
48953724|NCT03052608|157660930|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|4|||
48953725|NCT03052608|157660931|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|18|||
48953726|NCT03052608|157660930|FG000|Long-Term Follow-up Phase|Ongoing|122|||
48953727|NCT03052608|157660931|FG001|Long-Term Follow-up Phase|Ongoing|99|||
48953728|NCT00912015|157660933|FG000|Overall Study|Lack of Efficacy|1|||
48953729|NCT00912015|157660934|FG001|Overall Study|Lack of Efficacy|0|||
48953730|NCT00912015|157660935|FG002|Overall Study|Lack of Efficacy|0|||
48953731|NCT00912015|157660936|FG003|Overall Study|Lack of Efficacy|0|||
48953732|NCT00912015|157660933|FG000|Overall Study|Withdrawal by Subject|8|||
48859597|NCT00390806|157323858|FG000|Overall Study|Investigator Decision|4|||
48859598|NCT00390806|157323859|FG001|Overall Study|Investigator Decision|6|||
48859599|NCT00390806|157323858|FG000|Overall Study|Death|1|||
48859600|NCT00390806|157323859|FG001|Overall Study|Death|0|||
48859601|NCT00390806|157323858|FG000|Overall Study|Physician Decision|0|||
48859602|NCT00390806|157323859|FG001|Overall Study|Physician Decision|1|||
48859603|NCT00390806|157323858|FG000|Overall Study|Ongoing|4|||
48859604|NCT00390806|157323859|FG001|Overall Study|Ongoing|2|||
48859605|NCT02942771|157323860|FG000|Overall Study|Adverse Event|1|||
48859606|NCT02942771|157323861|FG001|Overall Study|Adverse Event|0|||
48859607|NCT02942771|157323862|FG002|Overall Study|Adverse Event|0|||
48859608|NCT02942771|157323863|FG003|Overall Study|Adverse Event|0|||
48859609|NCT02942771|157323864|FG004|Overall Study|Adverse Event|2|||
48859610|NCT02942771|157323860|FG000|Overall Study|Lost to Follow-up|1|||
48859611|NCT02942771|157323861|FG001|Overall Study|Lost to Follow-up|0|||
48859612|NCT02942771|157323862|FG002|Overall Study|Lost to Follow-up|0|||
48859613|NCT02942771|157323863|FG003|Overall Study|Lost to Follow-up|0|||
48859614|NCT02942771|157323864|FG004|Overall Study|Lost to Follow-up|0|||
48859615|NCT02942771|157323860|FG000|Overall Study|Withdrawal by Subject|1|||
48859616|NCT02942771|157323861|FG001|Overall Study|Withdrawal by Subject|0|||
48859617|NCT02942771|157323862|FG002|Overall Study|Withdrawal by Subject|0|||
48859618|NCT02942771|157323863|FG003|Overall Study|Withdrawal by Subject|0|||
48859619|NCT02942771|157323864|FG004|Overall Study|Withdrawal by Subject|2|||
48859620|NCT01199302|157323865|FG000|Overall Study|Adverse Event|1|||
48859621|NCT01199302|157323866|FG001|Overall Study|Adverse Event|1|||
48859622|NCT01199302|157323867|FG002|Overall Study|Adverse Event|2|||
48859623|NCT01199302|157323868|FG003|Overall Study|Adverse Event|0|||
48859624|NCT01199302|157323865|FG000|Overall Study|Withdrawal by Subject|2|||
48859625|NCT01199302|157323866|FG001|Overall Study|Withdrawal by Subject|2|||
48859626|NCT01199302|157323867|FG002|Overall Study|Withdrawal by Subject|3|||
48859627|NCT01199302|157323868|FG003|Overall Study|Withdrawal by Subject|0|||
48859628|NCT01199302|157323865|FG000|Overall Study|Disease Progression|3|||
48859629|NCT01199302|157323866|FG001|Overall Study|Disease Progression|4|||
48859630|NCT01199302|157323867|FG002|Overall Study|Disease Progression|4|||
48859631|NCT01199302|157323868|FG003|Overall Study|Disease Progression|2|||
48859632|NCT01199302|157323865|FG000|Overall Study|Study Termination|13|||
48859633|NCT01199302|157323866|FG001|Overall Study|Study Termination|8|||
48859634|NCT01199302|157323867|FG002|Overall Study|Study Termination|11|||
48953733|NCT00912015|157660934|FG001|Overall Study|Withdrawal by Subject|8|||
48953734|NCT00912015|157660935|FG002|Overall Study|Withdrawal by Subject|3|||
48859635|NCT01199302|157323868|FG003|Overall Study|Study Termination|9|||
48859636|NCT01199302|157323865|FG000|Overall Study|Lost to Follow-up|0|||
48859637|NCT01199302|157323866|FG001|Overall Study|Lost to Follow-up|1|||
48859638|NCT01199302|157323867|FG002|Overall Study|Lost to Follow-up|0|||
48953735|NCT00912015|157660936|FG003|Overall Study|Withdrawal by Subject|0|||
48953736|NCT00912015|157660933|FG000|Overall Study|Protocol Violation|1|||
48953737|NCT00912015|157660934|FG001|Overall Study|Protocol Violation|0|||
48859639|NCT01199302|157323868|FG003|Overall Study|Lost to Follow-up|0|||
48859640|NCT01199302|157323865|FG000|Overall Study|Other|1|||
48859641|NCT01199302|157323866|FG001|Overall Study|Other|0|||
48859642|NCT01199302|157323867|FG002|Overall Study|Other|0|||
48859643|NCT01199302|157323868|FG003|Overall Study|Other|0|||
48859644|NCT04212299|157323872|FG000|42-week Follow up in Sub-ischial Socket|Participant experienced a heart attack|1|||
48859645|NCT00264576|157325410|FG000|Overall Study|Lost to Follow-up|1|||
48859646|NCT00264576|157325411|FG001|Overall Study|Lost to Follow-up|1|||
48859647|NCT01668355|157325414|FG000|Overall Study|Death|3|||
48859648|NCT01668355|157325415|FG001|Overall Study|Death|1|||
48859649|NCT01668355|157325414|FG000|Overall Study|Withdrawal by Subject|6|||
48859650|NCT01668355|157325415|FG001|Overall Study|Withdrawal by Subject|1|||
48859651|NCT01277302|157325416|FG000|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
48859652|NCT01277302|157325417|FG001|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
48859653|NCT01277302|157325418|FG002|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8|||
48859654|NCT01277302|157325416|FG000|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
48859655|NCT01277302|157325417|FG001|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
48859656|NCT01277302|157325418|FG002|7-Month Fixed Treatment Period|Lost to Follow-up|2|||
48859657|NCT01277302|157325416|FG000|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
48859658|NCT01277302|157325417|FG001|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
48859659|NCT01277302|157325418|FG002|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1|||
48859660|NCT01277302|157325416|FG000|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
48859661|NCT01277302|157325417|FG001|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
48859662|NCT01277302|157325418|FG002|7-Month Fixed Treatment Period|Subject Non-compliance|1|||
48953738|NCT00912015|157660935|FG002|Overall Study|Protocol Violation|0|||
48746579|NCT02521870|156919819|FG006|Phase 2: Dose Expansion|Lost to Follow-up|0|||
48746580|NCT02521870|156919820|FG007|Phase 2: Dose Expansion|Lost to Follow-up|0|||
48746581|NCT02521870|156919821|FG008|Phase 2: Dose Expansion|Lost to Follow-up|0|||
48859663|NCT01277302|157325416|FG000|8-Month Alternate Dose Regimen Period|Death|0|||
48859664|NCT01277302|157325417|FG001|8-Month Alternate Dose Regimen Period|Death|1|||
48859665|NCT01277302|157325418|FG002|8-Month Alternate Dose Regimen Period|Death|0|||
48859666|NCT01277302|157325416|FG000|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
48859667|NCT01277302|157325417|FG001|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
48859668|NCT01277302|157325418|FG002|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3|||
48859669|NCT01277302|157325416|FG000|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3|||
48746582|NCT02521870|156919822|FG009|Phase 2: Dose Expansion|Lost to Follow-up|0|||
48746583|NCT02521870|156919823|FG010|Phase 2: Dose Expansion|Lost to Follow-up|0|||
48746584|NCT02521870|156919824|FG011|Phase 2: Dose Expansion|Lost to Follow-up|0|||
48746585|NCT02521870|156919813|FG000|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
48746586|NCT02521870|156919814|FG001|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
48746587|NCT02521870|156919815|FG002|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
48953739|NCT00912015|157660936|FG003|Overall Study|Protocol Violation|1|||
48953740|NCT00912015|157660933|FG000|Overall Study|Adverse Event|6|||
48953741|NCT00912015|157660934|FG001|Overall Study|Adverse Event|0|||
48953742|NCT00912015|157660935|FG002|Overall Study|Adverse Event|0|||
48953743|NCT00912015|157660936|FG003|Overall Study|Adverse Event|1|||
48953744|NCT01520324|157660937|FG000|Overall Study|Subject discontinued (moderate illness)|1|||
48953745|NCT00521339|157660938|FG000|Treatment Phase|Adverse Event|2|||
48953746|NCT00521339|157660939|FG001|Treatment Phase|Adverse Event|0|||
48953747|NCT00521339|157660940|FG002|Treatment Phase|Adverse Event|0|||
48953748|NCT00521339|157660938|FG000|Treatment Phase|Intolerability to study drug|2|||
48746588|NCT02521870|156919816|FG003|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
48746589|NCT02521870|156919817|FG004|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2|||
48746590|NCT02521870|156919818|FG005|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
48746591|NCT02521870|156919819|FG006|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
48746592|NCT02521870|156919820|FG007|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
48746593|NCT02521870|156919821|FG008|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
48746594|NCT02521870|156919822|FG009|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
48746595|NCT02521870|156919823|FG010|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
48746596|NCT02521870|156919824|FG011|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
48746597|NCT00279305|156919825|FG000|Overall Study|Pregnancy|1|||
48746598|NCT00279305|156919826|FG001|Overall Study|Pregnancy|0|||
48746599|NCT00279305|156919825|FG000|Overall Study|Withdrawal by Subject|2|||
48746600|NCT00279305|156919826|FG001|Overall Study|Withdrawal by Subject|0|||
48953749|NCT00521339|157660939|FG001|Treatment Phase|Intolerability to study drug|0|||
48953750|NCT00521339|157660940|FG002|Treatment Phase|Intolerability to study drug|0|||
48746601|NCT00279305|156919825|FG000|Overall Study|Dificulting establishing IV|1|||
48746602|NCT00279305|156919826|FG001|Overall Study|Dificulting establishing IV|0|||
48746603|NCT00279305|156919825|FG000|Overall Study|FDA Safety Alert|4|||
48746604|NCT00279305|156919826|FG001|Overall Study|FDA Safety Alert|1|||
48746605|NCT00471328|156919827|FG000|Core Phase|Adverse Event|18|||
48746606|NCT00471328|156919828|FG001|Core Phase|Adverse Event|6|||
48746607|NCT00471328|156919827|FG000|Core Phase|Death|8|||
48746608|NCT00471328|156919828|FG001|Core Phase|Death|4|||
48746609|NCT00471328|156919827|FG000|Core Phase|Withdrawal by Subject|2|||
48746610|NCT00471328|156919828|FG001|Core Phase|Withdrawal by Subject|2|||
48746611|NCT00471328|156919827|FG000|Core Phase|Abnormal laboratory value|1|||
48746612|NCT00471328|156919828|FG001|Core Phase|Abnormal laboratory value|0|||
48746613|NCT00471328|156919827|FG000|Core Phase|Disease Progression|78|||
48746614|NCT00471328|156919828|FG001|Core Phase|Disease Progression|53|||
48746615|NCT00471328|156919827|FG000|Core Phase|Administrative Problem|0|||
48746616|NCT00471328|156919828|FG001|Core Phase|Administrative Problem|1|||
48746617|NCT00471328|156919827|FG000|Core Phase|Protocol Deviation|0|||
48746618|NCT00471328|156919828|FG001|Core Phase|Protocol Deviation|1|||
48746619|NCT00471328|156919827|FG000|Extension Phase|Adverse Event|3|||
48746620|NCT00471328|156919828|FG001|Extension Phase|Adverse Event|12|||
48953751|NCT00521339|157660938|FG000|Treatment Phase|Lack of Efficacy|3|||
48953752|NCT00521339|157660939|FG001|Treatment Phase|Lack of Efficacy|0|||
48953753|NCT00521339|157660940|FG002|Treatment Phase|Lack of Efficacy|0|||
48746621|NCT00471328|156919827|FG000|Extension Phase|Withdrawal by Subject|0|||
48953754|NCT00521339|157660938|FG000|Treatment Phase|Withdrawal by Subject|3|||
48953755|NCT00521339|157660939|FG001|Treatment Phase|Withdrawal by Subject|0|||
48953756|NCT00521339|157660940|FG002|Treatment Phase|Withdrawal by Subject|0|||
48953757|NCT00521339|157660938|FG000|Treatment Phase|Lost to Follow-up|1|||
48746622|NCT00471328|156919828|FG001|Extension Phase|Withdrawal by Subject|2|||
48746623|NCT00471328|156919827|FG000|Extension Phase|Death|1|||
48746624|NCT00471328|156919828|FG001|Extension Phase|Death|7|||
48746625|NCT00471328|156919827|FG000|Extension Phase|Protocol Deviation|3|||
48746626|NCT00471328|156919828|FG001|Extension Phase|Protocol Deviation|1|||
48746627|NCT00471328|156919827|FG000|Extension Phase|Treatment duration as per protocol|0|||
48746628|NCT00471328|156919828|FG001|Extension Phase|Treatment duration as per protocol|1|||
48746629|NCT00471328|156919827|FG000|Extension Phase|Disease Progression|32|||
48746630|NCT00471328|156919828|FG001|Extension Phase|Disease Progression|44|||
48746631|NCT00471328|156919827|FG000|Extension Phase|New cancer Therapy|1|||
48746632|NCT00471328|156919828|FG001|Extension Phase|New cancer Therapy|0|||
48746633|NCT00471328|156919827|FG000|Extension Phase|Administrative Problem|1|||
48746634|NCT00471328|156919828|FG001|Extension Phase|Administrative Problem|0|||
48746635|NCT00844896|156919829|FG000|Overall Study|Lost to Follow-up|12|||
48746636|NCT00844896|156919830|FG001|Overall Study|Lost to Follow-up|16|||
48746637|NCT00844896|156919829|FG000|Overall Study|Parents did not have time to complete|0|||
48746638|NCT00844896|156919830|FG001|Overall Study|Parents did not have time to complete|1|||
48797668|NCT01410474|157097040|FG001|Overall Study|Withdrawal by Subject|1|||
48797669|NCT02163733|157097041|FG000|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
48797670|NCT02163733|157097042|FG001|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
48797671|NCT02163733|157097043|FG002|Part B: Day 15 to End Part B (AZD9291)|Death|5|||
48797672|NCT02163733|157097041|FG000|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
48797673|NCT02163733|157097042|FG001|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
48797674|NCT02163733|157097043|FG002|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19|||
48797675|NCT00828984|157097046|FG000|Overall Study|Adverse Event|2|||
48797676|NCT00828984|157097047|FG001|Overall Study|Adverse Event|3|||
48797677|NCT00828984|157097048|FG002|Overall Study|Adverse Event|0|||
48797678|NCT00828984|157097046|FG000|Overall Study|Lost to Follow-up|5|||
48797679|NCT00828984|157097047|FG001|Overall Study|Lost to Follow-up|3|||
48797680|NCT00828984|157097048|FG002|Overall Study|Lost to Follow-up|1|||
48953758|NCT00521339|157660939|FG001|Treatment Phase|Lost to Follow-up|0|||
48953759|NCT00521339|157660940|FG002|Treatment Phase|Lost to Follow-up|0|||
48953760|NCT00521339|157660938|FG000|Treatment Phase|Protocol Violation|1|||
48953761|NCT00521339|157660939|FG001|Treatment Phase|Protocol Violation|0|||
48953762|NCT00521339|157660940|FG002|Treatment Phase|Protocol Violation|0|||
48953763|NCT00521339|157660938|FG000|Treatment Extension Phase|Withdrawal by Subject|0|||
48953764|NCT00521339|157660939|FG001|Treatment Extension Phase|Withdrawal by Subject|0|||
48953765|NCT00521339|157660940|FG002|Treatment Extension Phase|Withdrawal by Subject|2|||
48953766|NCT00521339|157660938|FG000|Treatment Extension Phase|Death|0|||
48953767|NCT00521339|157660939|FG001|Treatment Extension Phase|Death|0|||
48953768|NCT00521339|157660940|FG002|Treatment Extension Phase|Death|1|||
48953769|NCT01058369|157660941|FG000|Overall Study|Adverse Event|1|||
48953770|NCT01058369|157660941|FG000|Overall Study|Early termination study|1|||
48953771|NCT00089843|157660944|FG000|Overall Study|Withdrawal by Subject|1|||
48953772|NCT00089843|157660945|FG001|Overall Study|Withdrawal by Subject|4|||
48953773|NCT00089843|157660946|FG002|Overall Study|Withdrawal by Subject|5|||
48953774|NCT00089843|157660947|FG003|Overall Study|Withdrawal by Subject|6|||
48953775|NCT00089843|157660944|FG000|Overall Study|Physician Decision|1|||
48953776|NCT00089843|157660945|FG001|Overall Study|Physician Decision|0|||
48953777|NCT00089843|157660946|FG002|Overall Study|Physician Decision|0|||
48953778|NCT00089843|157660947|FG003|Overall Study|Physician Decision|1|||
48953779|NCT01614769|157660950|FG000|Period 1|Discontinued due to Hypoglycemia|0|||
48953780|NCT01614769|157660951|FG001|Period 1|Discontinued due to Hypoglycemia|0|||
48953781|NCT01614769|157660952|FG002|Period 1|Discontinued due to Hypoglycemia|0|||
48953782|NCT01614769|157660953|FG003|Period 1|Discontinued due to Hypoglycemia|1|||
48953783|NCT01614769|157660954|FG004|Period 1|Discontinued due to Hypoglycemia|0|||
48953784|NCT01614769|157660955|FG005|Period 1|Discontinued due to Hypoglycemia|1|||
48953785|NCT01614769|157660950|FG000|Period 1|Protocol Violation|0|||
48953786|NCT01614769|157660951|FG001|Period 1|Protocol Violation|0|||
48953787|NCT01614769|157660952|FG002|Period 1|Protocol Violation|0|||
48953788|NCT01614769|157660953|FG003|Period 1|Protocol Violation|1|||
48953789|NCT01614769|157660954|FG004|Period 1|Protocol Violation|0|||
48953790|NCT01614769|157660955|FG005|Period 1|Protocol Violation|0|||
48953791|NCT01614769|157660950|FG000|Period 1|Withdrawal by Subject|1|||
48953792|NCT01614769|157660951|FG001|Period 1|Withdrawal by Subject|0|||
48953793|NCT01614769|157660952|FG002|Period 1|Withdrawal by Subject|0|||
48953794|NCT01614769|157660953|FG003|Period 1|Withdrawal by Subject|0|||
48953795|NCT01614769|157660954|FG004|Period 1|Withdrawal by Subject|0|||
48953796|NCT01614769|157660955|FG005|Period 1|Withdrawal by Subject|0|||
48953797|NCT01614769|157660950|FG000|Period 3|Withdrawal by Subject|0|||
48953798|NCT01614769|157660951|FG001|Period 3|Withdrawal by Subject|0|||
48953799|NCT01614769|157660952|FG002|Period 3|Withdrawal by Subject|1|||
48953800|NCT01614769|157660953|FG003|Period 3|Withdrawal by Subject|0|||
48953801|NCT01614769|157660954|FG004|Period 3|Withdrawal by Subject|0|||
48953802|NCT01614769|157660955|FG005|Period 3|Withdrawal by Subject|0|||
48953803|NCT01958671|157660956|FG000|Overall Study|Adverse Event|1|||
48953804|NCT01958671|157660957|FG001|Overall Study|Adverse Event|1|||
48953805|NCT01958671|157660958|FG002|Overall Study|Adverse Event|5|||
48953806|NCT01958671|157660956|FG000|Overall Study|Death|1|||
48859670|NCT01277302|157325417|FG001|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0|||
48859671|NCT01277302|157325418|FG002|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1|||
48859672|NCT01277302|157325416|FG000|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0|||
48859673|NCT01277302|157325417|FG001|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2|||
48859674|NCT01277302|157325418|FG002|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1|||
48859675|NCT01277302|157325416|FG000|8-Month Alternate Dose Regimen Period|Relocation|1|||
48859676|NCT01277302|157325417|FG001|8-Month Alternate Dose Regimen Period|Relocation|0|||
48859677|NCT01277302|157325418|FG002|8-Month Alternate Dose Regimen Period|Relocation|1|||
48859678|NCT03395197|157325419|FG000|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
48859679|NCT03395197|157325420|FG001|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
48859680|NCT03395197|157325421|FG002|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
48859681|NCT03395197|157325422|FG003|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|1|||
48859682|NCT03395197|157325423|FG004|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
48859683|NCT03395197|157325424|FG005|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
48859684|NCT03395197|157325419|FG000|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
48859685|NCT03395197|157325420|FG001|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
48859686|NCT03395197|157325421|FG002|Analysis for Part 1 and Part 2 Cohort 1|Death|8|||
48859687|NCT03395197|157325422|FG003|Analysis for Part 1 and Part 2 Cohort 1|Death|10|||
48859688|NCT03395197|157325423|FG004|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
48859689|NCT03395197|157325424|FG005|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
48859690|NCT03395197|157325419|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
48953807|NCT01958671|157660957|FG001|Overall Study|Death|0|||
48859691|NCT03395197|157325420|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
48859692|NCT03395197|157325421|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|1|||
48859693|NCT03395197|157325422|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
48859694|NCT03395197|157325423|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
48859695|NCT03395197|157325424|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
48859696|NCT03395197|157325419|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
48859697|NCT03395197|157325420|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
48953808|NCT01958671|157660958|FG002|Overall Study|Death|0|||
48953809|NCT01958671|157660956|FG000|Overall Study|Excluded medication|0|||
48746639|NCT01516437|156921063|FG000|Overall Study|Reason not specified|0|||
48746640|NCT01516437|156921064|FG001|Overall Study|Reason not specified|0|||
48746641|NCT01516437|156921065|FG002|Overall Study|Reason not specified|1|||
48746642|NCT01516437|156921066|FG003|Overall Study|Reason not specified|1|||
48746643|NCT00403234|156921067|FG000|Overall Study|Withdrawal by Subject|0|||
48953810|NCT01958671|157660957|FG001|Overall Study|Excluded medication|0|||
48953811|NCT01958671|157660958|FG002|Overall Study|Excluded medication|1|||
48953812|NCT01958671|157660956|FG000|Overall Study|Hyperglycemia|0|||
48953813|NCT01958671|157660957|FG001|Overall Study|Hyperglycemia|0|||
48953814|NCT01958671|157660958|FG002|Overall Study|Hyperglycemia|2|||
48953815|NCT01958671|157660956|FG000|Overall Study|Lost to Follow-up|7|||
48953816|NCT01958671|157660957|FG001|Overall Study|Lost to Follow-up|11|||
48953817|NCT01958671|157660958|FG002|Overall Study|Lost to Follow-up|7|||
48953818|NCT01958671|157660956|FG000|Overall Study|Non-compliance with study drug|1|||
48953819|NCT01958671|157660957|FG001|Overall Study|Non-compliance with study drug|1|||
48953820|NCT01958671|157660958|FG002|Overall Study|Non-compliance with study drug|1|||
48953821|NCT01958671|157660956|FG000|Overall Study|Pregnancy|0|||
48953822|NCT01958671|157660957|FG001|Overall Study|Pregnancy|0|||
48953823|NCT01958671|157660958|FG002|Overall Study|Pregnancy|1|||
48953824|NCT01958671|157660956|FG000|Overall Study|Protocol Violation|0|||
48953825|NCT01958671|157660957|FG001|Overall Study|Protocol Violation|1|||
48953826|NCT01958671|157660958|FG002|Overall Study|Protocol Violation|0|||
48953827|NCT01958671|157660956|FG000|Overall Study|Study site terminated by sponsor|1|||
48953828|NCT01958671|157660957|FG001|Overall Study|Study site terminated by sponsor|0|||
48953829|NCT01958671|157660958|FG002|Overall Study|Study site terminated by sponsor|1|||
48953830|NCT01958671|157660956|FG000|Overall Study|Participant moved|0|||
48953831|NCT01958671|157660957|FG001|Overall Study|Participant moved|0|||
48953832|NCT01958671|157660958|FG002|Overall Study|Participant moved|1|||
48953833|NCT01958671|157660956|FG000|Overall Study|Withdrawal by Subject|8|||
48953834|NCT01958671|157660957|FG001|Overall Study|Withdrawal by Subject|10|||
48953835|NCT01958671|157660958|FG002|Overall Study|Withdrawal by Subject|13|||
48953836|NCT02042404|157660964|FG000|Overall Study|Death|1|||
48953837|NCT02042404|157660965|FG001|Overall Study|Death|0|||
48953838|NCT02042404|157660964|FG000|Overall Study|Unrelated Adverse Event|3|||
48953839|NCT02042404|157660965|FG001|Overall Study|Unrelated Adverse Event|0|||
48953840|NCT02042404|157660964|FG000|Overall Study|Inability to meet time requirements|1|||
48953841|NCT02042404|157660965|FG001|Overall Study|Inability to meet time requirements|0|||
48953842|NCT04009096|157660966|FG000|Overall Study|Withdrawal by Subject|0|||
48746644|NCT00403234|156921068|FG001|Overall Study|Withdrawal by Subject|1|||
48746645|NCT00403234|156921069|FG002|Overall Study|Withdrawal by Subject|0|||
48746646|NCT00403234|156921070|FG003|Overall Study|Withdrawal by Subject|0|||
48746647|NCT00403234|156921067|FG000|Overall Study|Adverse Event|1|||
48746648|NCT00403234|156921068|FG001|Overall Study|Adverse Event|0|||
48746649|NCT00403234|156921069|FG002|Overall Study|Adverse Event|1|||
48746650|NCT00403234|156921070|FG003|Overall Study|Adverse Event|0|||
48746651|NCT00982137|156921071|FG000|Overall Study|Lost to Follow-up|0|||
48746652|NCT00982137|156921072|FG001|Overall Study|Lost to Follow-up|0|||
48746653|NCT00982137|156921073|FG002|Overall Study|Lost to Follow-up|0|||
48746654|NCT00982137|156921074|FG003|Overall Study|Lost to Follow-up|1|||
48746655|NCT00982137|156921071|FG000|Overall Study|Withdrawal by Subject|0|||
48746656|NCT00982137|156921072|FG001|Overall Study|Withdrawal by Subject|1|||
48746657|NCT00982137|156921073|FG002|Overall Study|Withdrawal by Subject|0|||
48746658|NCT00982137|156921074|FG003|Overall Study|Withdrawal by Subject|0|||
48746659|NCT02871297|156921080|FG000|Overall Study|Adverse Event|34|||
48746660|NCT02871297|156921080|FG000|Overall Study|Lack of Efficacy|10|||
48746661|NCT02871297|156921080|FG000|Overall Study|Non-compliance with study drug|15|||
48746662|NCT02871297|156921080|FG000|Overall Study|Protocol Violation|3|||
48746663|NCT02871297|156921080|FG000|Overall Study|Withdrawal by Subject|20|||
48746664|NCT02871297|156921080|FG000|Overall Study|Lost to Follow-up|13|||
48746665|NCT02871297|156921080|FG000|Overall Study|Rolled over to 13546A|2|||
48746666|NCT02871297|156921080|FG000|Overall Study|Other than specified|39|||
48746667|NCT00541931|156921081|FG000|Overall Study|Adverse Event|1|||
48746668|NCT00541931|156921082|FG001|Overall Study|Adverse Event|0|||
48746669|NCT00541931|156921081|FG000|Overall Study|Lost to Follow-up|3|||
48746670|NCT00541931|156921082|FG001|Overall Study|Lost to Follow-up|3|||
48746671|NCT00541931|156921081|FG000|Overall Study|Withdrawal by Subject|1|||
48746672|NCT00541931|156921082|FG001|Overall Study|Withdrawal by Subject|0|||
48746673|NCT00541931|156921081|FG000|Overall Study|Transportation Issue|0|||
48746674|NCT00541931|156921082|FG001|Overall Study|Transportation Issue|1|||
48746675|NCT02161731|156921083|FG000|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0|||
48746676|NCT02161731|156921084|FG001|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1|||
48746677|NCT02161731|156921083|FG000|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0|||
48746678|NCT02161731|156921084|FG001|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1|||
48746679|NCT03633695|156921088|FG000|Overall Study|Lost to Follow-up|4|||
48746680|NCT03633695|156921089|FG001|Overall Study|Lost to Follow-up|5|||
48746681|NCT03633695|156921088|FG000|Overall Study|Discontinued|8|||
48746682|NCT03633695|156921089|FG001|Overall Study|Discontinued|4|||
48746683|NCT00160693|156921092|FG000|Overall Study|Adverse Event|97|||
48746684|NCT00160693|156921092|FG000|Overall Study|Lack of Efficacy|30|||
48746685|NCT00160693|156921092|FG000|Overall Study|Protocol Violation|24|||
48746686|NCT00160693|156921092|FG000|Overall Study|Lost to Follow-up|15|||
48746687|NCT00160693|156921092|FG000|Overall Study|Withdrawal by Subject|54|||
48746688|NCT00160693|156921092|FG000|Overall Study|Study terminated by sponsor|15|||
48859698|NCT03395197|157325421|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|14|||
48859699|NCT03395197|157325422|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|21|||
48859700|NCT03395197|157325423|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
48859701|NCT03395197|157325424|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
48859702|NCT03395197|157325419|FG000|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
48859703|NCT03395197|157325420|FG001|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
48859704|NCT03395197|157325421|FG002|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|5|||
48859705|NCT03395197|157325422|FG003|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|3|||
48859706|NCT03395197|157325423|FG004|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
48859707|NCT03395197|157325424|FG005|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
48859708|NCT03395197|157325419|FG000|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|9|||
48859709|NCT03395197|157325420|FG001|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|3|||
48859710|NCT03395197|157325421|FG002|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|69|||
48859711|NCT03395197|157325422|FG003|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|43|||
48859712|NCT03395197|157325423|FG004|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
48859713|NCT03395197|157325424|FG005|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
48859714|NCT03395197|157325419|FG000|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
48859715|NCT03395197|157325420|FG001|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
48859716|NCT03395197|157325421|FG002|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|76|||
48859717|NCT03395197|157325422|FG003|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|124|||
48859718|NCT03395197|157325423|FG004|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
48859719|NCT03395197|157325424|FG005|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
48859720|NCT03395197|157325419|FG000|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
48859721|NCT03395197|157325420|FG001|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|1|||
48859722|NCT03395197|157325421|FG002|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|29|||
48859723|NCT03395197|157325422|FG003|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|30|||
48859724|NCT03395197|157325423|FG004|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
48859725|NCT03395197|157325424|FG005|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
48859726|NCT03395197|157325419|FG000|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|1|||
48859727|NCT03395197|157325420|FG001|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
48859728|NCT03395197|157325421|FG002|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|44|||
48859729|NCT03395197|157325422|FG003|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|46|||
48859730|NCT03395197|157325423|FG004|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
48859731|NCT03395197|157325424|FG005|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
48859732|NCT03395197|157325419|FG000|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
48859733|NCT03395197|157325420|FG001|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
48859734|NCT03395197|157325421|FG002|Analysis for Part 1 and Part 2 Cohort 1|Other|4|||
48859735|NCT03395197|157325422|FG003|Analysis for Part 1 and Part 2 Cohort 1|Other|5|||
48859736|NCT03395197|157325423|FG004|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
48859737|NCT03395197|157325424|FG005|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
48859738|NCT03395197|157325419|FG000|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|1|||
48859739|NCT03395197|157325420|FG001|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
48953843|NCT04009096|157660967|FG001|Overall Study|Withdrawal by Subject|7|||
48953844|NCT04009096|157660968|FG002|Overall Study|Withdrawal by Subject|0|||
48953845|NCT04009096|157660966|FG000|Overall Study|Physician Decision|0|||
48746689|NCT03052725|156921094|FG000|Overall Study|Adverse Event|2|||
48746690|NCT03052725|156921095|FG001|Overall Study|Adverse Event|0|||
48746691|NCT03052725|156921094|FG000|Overall Study|Withdrawal by Subject|3|||
48746692|NCT03052725|156921095|FG001|Overall Study|Withdrawal by Subject|4|||
48746693|NCT03052725|156921094|FG000|Overall Study|Pregnancy|0|||
48746694|NCT03052725|156921095|FG001|Overall Study|Pregnancy|1|||
48746695|NCT03052725|156921094|FG000|Overall Study|Site closure|0|||
48746696|NCT03052725|156921095|FG001|Overall Study|Site closure|1|||
48746697|NCT03052725|156921094|FG000|Overall Study|Study terminated by sponsor|143|||
48746698|NCT03052725|156921095|FG001|Overall Study|Study terminated by sponsor|144|||
48746699|NCT01867424|156921096|FG000|Overall Study|Patient noncompliance|2|||
48746700|NCT01867424|156921097|FG001|Overall Study|Patient noncompliance|1|||
48953846|NCT04009096|157660967|FG001|Overall Study|Physician Decision|1|||
48953847|NCT04009096|157660968|FG002|Overall Study|Physician Decision|0|||
48953848|NCT03010423|157660972|FG000|Overall Study|Study termination|8|||
48953849|NCT00958568|157660975|FG000|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80|||
48953850|NCT00958568|157660976|FG001|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
48953851|NCT00958568|157660977|FG002|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
48953852|NCT00958568|157660978|FG003|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
48953853|NCT00958568|157660975|FG000|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44|||
48953854|NCT00958568|157660976|FG001|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
48953855|NCT00958568|157660977|FG002|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
48953856|NCT00958568|157660978|FG003|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
48953857|NCT00958568|157660975|FG000|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34|||
48953858|NCT00958568|157660976|FG001|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
48953859|NCT00958568|157660977|FG002|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
48953860|NCT00958568|157660978|FG003|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
48953861|NCT00958568|157660975|FG000|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39|||
48953862|NCT00958568|157660976|FG001|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
48953863|NCT00958568|157660977|FG002|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
48953864|NCT00958568|157660978|FG003|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
48859740|NCT03395197|157325421|FG002|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|152|||
48859741|NCT03395197|157325422|FG003|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|120|||
48859742|NCT03395197|157325423|FG004|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
48859743|NCT03395197|157325424|FG005|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
48859744|NCT03395197|157325419|FG000|Analysis for DDR-Deficient Participants|Death|0|||
48859745|NCT03395197|157325420|FG001|Analysis for DDR-Deficient Participants|Death|0|||
48859746|NCT03395197|157325421|FG002|Analysis for DDR-Deficient Participants|Death|0|||
48859747|NCT03395197|157325422|FG003|Analysis for DDR-Deficient Participants|Death|0|||
48859748|NCT03395197|157325423|FG004|Analysis for DDR-Deficient Participants|Death|1|||
48859749|NCT03395197|157325424|FG005|Analysis for DDR-Deficient Participants|Death|4|||
48953865|NCT00958568|157660975|FG000|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14|||
48953866|NCT00958568|157660976|FG001|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
48953867|NCT00958568|157660977|FG002|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
48953868|NCT00958568|157660978|FG003|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
48953869|NCT00958568|157660975|FG000|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13|||
48953870|NCT00958568|157660976|FG001|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
48953871|NCT00958568|157660977|FG002|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
48953872|NCT00958568|157660978|FG003|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
48953873|NCT00958568|157660975|FG000|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4|||
48953874|NCT00958568|157660976|FG001|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
48953875|NCT00958568|157660977|FG002|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
48953876|NCT00958568|157660978|FG003|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
48953877|NCT00958568|157660975|FG000|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8|||
48953878|NCT00958568|157660976|FG001|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
48953879|NCT00958568|157660977|FG002|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
48953880|NCT00958568|157660978|FG003|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
48953881|NCT00958568|157660975|FG000|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1|||
48953882|NCT00958568|157660976|FG001|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
48953883|NCT00958568|157660977|FG002|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
48953884|NCT00958568|157660978|FG003|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
48953885|NCT00958568|157660975|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
48953886|NCT00958568|157660976|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62|||
48953887|NCT00958568|157660977|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
48953888|NCT00958568|157660978|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
48953889|NCT00958568|157660975|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
48953890|NCT00958568|157660976|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30|||
48953891|NCT00958568|157660977|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
48953892|NCT00958568|157660978|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
48953893|NCT00958568|157660975|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
48953894|NCT00958568|157660976|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28|||
48953895|NCT00958568|157660977|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
48953896|NCT00958568|157660978|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
48953897|NCT00958568|157660975|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
48953898|NCT00958568|157660976|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41|||
48953899|NCT00958568|157660977|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
48953900|NCT00958568|157660978|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
48953901|NCT00958568|157660975|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
48953902|NCT00958568|157660976|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24|||
48953903|NCT00958568|157660977|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
48953904|NCT00958568|157660978|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
48953905|NCT00958568|157660975|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
48953906|NCT00958568|157660976|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9|||
48953907|NCT00958568|157660977|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
48953908|NCT00958568|157660978|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
48953909|NCT00958568|157660975|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
48953910|NCT00958568|157660976|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6|||
48953911|NCT00958568|157660977|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
48953912|NCT00958568|157660978|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
48953913|NCT00958568|157660975|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
48953914|NCT00958568|157660976|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5|||
48953915|NCT00958568|157660977|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
49015374|NCT00306384|157892156|FG000|Overall Study|Pregnancy|3|||
49015375|NCT00306384|157892157|FG001|Overall Study|Pregnancy|1|||
48953916|NCT00958568|157660978|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
48953917|NCT00958568|157660975|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
48953918|NCT00958568|157660976|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4|||
48953919|NCT00958568|157660977|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
48953920|NCT00958568|157660978|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
48953921|NCT00958568|157660975|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
48953922|NCT00958568|157660976|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1|||
48953923|NCT00958568|157660977|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
48953924|NCT00958568|157660978|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
48953925|NCT00958568|157660975|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
48953926|NCT00958568|157660976|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1|||
48953927|NCT00958568|157660977|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
48953928|NCT00958568|157660978|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
48953929|NCT00958568|157660975|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
48953930|NCT00958568|157660976|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
48953931|NCT00958568|157660977|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24|||
48953932|NCT00958568|157660978|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63|||
48953933|NCT00958568|157660975|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
48953934|NCT00958568|157660976|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
48953935|NCT00958568|157660977|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19|||
48953936|NCT00958568|157660978|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10|||
48953937|NCT00958568|157660975|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
48953938|NCT00958568|157660976|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
48953939|NCT00958568|157660977|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16|||
48953940|NCT00958568|157660978|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15|||
48953941|NCT00958568|157660975|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
48953942|NCT00958568|157660976|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
48953943|NCT00958568|157660977|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11|||
48953944|NCT00958568|157660978|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5|||
48746701|NCT02794883|156921098|FG000|Pre-Surgical Treatment|Withdrawal by Subject|0|||
48746702|NCT02794883|156921099|FG001|Pre-Surgical Treatment|Withdrawal by Subject|0|||
48746703|NCT02794883|156921100|FG002|Pre-Surgical Treatment|Withdrawal by Subject|1|||
48746704|NCT02794883|156921098|FG000|Pre-Surgical Treatment|Progressive Disease|0|||
48746705|NCT02794883|156921099|FG001|Pre-Surgical Treatment|Progressive Disease|1|||
48746706|NCT02794883|156921100|FG002|Pre-Surgical Treatment|Progressive Disease|0|||
48746707|NCT02794883|156921098|FG000|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|1|||
48746708|NCT02794883|156921099|FG001|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|4|||
48746709|NCT02794883|156921100|FG002|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|0|||
48746710|NCT02794883|156921098|FG000|Post-Surgery Treatment (Adjuvant)|Protocol Violation|1|||
48746711|NCT02794883|156921099|FG001|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
48746712|NCT02794883|156921100|FG002|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
48746713|NCT02794883|156921098|FG000|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
48746714|NCT02794883|156921099|FG001|Post-Surgery Treatment (Adjuvant)|Progressive Disease|6|||
48746715|NCT02794883|156921100|FG002|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
48746716|NCT02794883|156921098|FG000|Post-Surgery Treatment (Adjuvant)|Adverse Event|0|||
48746717|NCT02794883|156921099|FG001|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
48746718|NCT02794883|156921100|FG002|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
48746719|NCT02794883|156921098|FG000|Follow-up Period (up to 2 Years)|Death|12|||
48746720|NCT02794883|156921099|FG001|Follow-up Period (up to 2 Years)|Death|10|||
48953945|NCT00958568|157660975|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
48953946|NCT00958568|157660976|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
48953947|NCT00958568|157660977|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3|||
48953948|NCT00958568|157660978|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8|||
48953949|NCT00958568|157660975|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
48953950|NCT00958568|157660976|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
48953951|NCT00958568|157660977|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5|||
48953952|NCT00958568|157660978|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4|||
48953953|NCT00958568|157660975|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
48746721|NCT02794883|156921100|FG002|Follow-up Period (up to 2 Years)|Death|10|||
48746722|NCT01751178|156921102|FG000|Overall Study|Adverse Event|2|||
48746723|NCT01751178|156921103|FG001|Overall Study|Adverse Event|0|||
48746724|NCT01751178|156921104|FG002|Overall Study|Adverse Event|0|||
48746725|NCT01751178|156921102|FG000|Overall Study|Other Reason (unknown)|1|||
48746726|NCT01751178|156921103|FG001|Overall Study|Other Reason (unknown)|0|||
48746727|NCT01751178|156921104|FG002|Overall Study|Other Reason (unknown)|2|||
48746728|NCT02864498|156921105|FG000|Overall Study|Unacceptable Adverse Events (AEs)|0|||
48746729|NCT02864498|156921106|FG001|Overall Study|Unacceptable Adverse Events (AEs)|3|||
48746730|NCT02864498|156921107|FG002|Overall Study|Unacceptable Adverse Events (AEs)|1|||
48746731|NCT02864498|156921105|FG000|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|6|||
48746732|NCT02864498|156921106|FG001|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|10|||
48746733|NCT02864498|156921107|FG002|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|4|||
48746734|NCT02864498|156921105|FG000|Overall Study|Investigator Discretion|0|||
48746735|NCT02864498|156921106|FG001|Overall Study|Investigator Discretion|2|||
48746736|NCT02864498|156921107|FG002|Overall Study|Investigator Discretion|1|||
48746737|NCT02864498|156921105|FG000|Overall Study|Lost to Follow-up|8|||
48746738|NCT02864498|156921106|FG001|Overall Study|Lost to Follow-up|6|||
48746739|NCT02864498|156921107|FG002|Overall Study|Lost to Follow-up|3|||
48746740|NCT02864498|156921105|FG000|Overall Study|Lack of Efficacy|5|||
48746741|NCT02864498|156921106|FG001|Overall Study|Lack of Efficacy|3|||
48746742|NCT02864498|156921107|FG002|Overall Study|Lack of Efficacy|3|||
48746743|NCT02864498|156921105|FG000|Overall Study|Other - Subject discontinued following database lock.|1|||
48746744|NCT02864498|156921106|FG001|Overall Study|Other - Subject discontinued following database lock.|0|||
48746745|NCT02864498|156921107|FG002|Overall Study|Other - Subject discontinued following database lock.|0|||
48746746|NCT02864498|156921105|FG000|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
48746747|NCT02864498|156921106|FG001|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|1|||
48746748|NCT02864498|156921107|FG002|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
48746749|NCT02864498|156921105|FG000|Overall Study|Subject moved out of the country.|0|||
48746750|NCT02864498|156921106|FG001|Overall Study|Subject moved out of the country.|0|||
48746751|NCT02864498|156921107|FG002|Overall Study|Subject moved out of the country.|1|||
48746752|NCT01256008|156921108|FG000|Overall Study|Lost to Follow-up|6|||
48746753|NCT01256008|156921109|FG001|Overall Study|Lost to Follow-up|4|||
48746754|NCT01256008|156921110|FG002|Overall Study|Lost to Follow-up|11|||
48746755|NCT01256008|156921108|FG000|Overall Study|Withdrawal by Subject|2|||
48746756|NCT01256008|156921109|FG001|Overall Study|Withdrawal by Subject|3|||
48746757|NCT01256008|156921110|FG002|Overall Study|Withdrawal by Subject|10|||
48746758|NCT04189081|156921111|FG000|Overall Study|Lost to Follow-up|1|||
48746759|NCT04189081|156921112|FG001|Overall Study|Lost to Follow-up|0|||
48953954|NCT00958568|157660976|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
48953955|NCT00958568|157660977|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2|||
48953956|NCT00958568|157660978|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1|||
48953957|NCT00958568|157660975|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
48953958|NCT00958568|157660976|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
48953959|NCT00958568|157660977|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1|||
48953960|NCT00958568|157660978|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
48953961|NCT00958568|157660975|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
48953962|NCT00958568|157660976|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
48953963|NCT00958568|157660977|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1|||
48953964|NCT00958568|157660978|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
48953965|NCT04410042|157660981|FG000|Overall Study|Not Eligible|1|||
48953966|NCT04410042|157660982|FG001|Overall Study|Not Eligible|1|||
48953967|NCT03235544|157660984|FG000|Overall Study|Participants Still Ongoing in the Study|1|||
48953968|NCT03235544|157660985|FG001|Overall Study|Participants Still Ongoing in the Study|13|||
48953969|NCT03235544|157660986|FG002|Overall Study|Participants Still Ongoing in the Study|19|||
48953970|NCT03235544|157660987|FG003|Overall Study|Participants Still Ongoing in the Study|55|||
48953971|NCT03235544|157660984|FG000|Overall Study|Death|11|||
48953972|NCT03235544|157660985|FG001|Overall Study|Death|23|||
48953973|NCT03235544|157660986|FG002|Overall Study|Death|11|||
48953974|NCT03235544|157660987|FG003|Overall Study|Death|20|||
48953975|NCT03235544|157660984|FG000|Overall Study|Lost to Follow-up|0|||
48953976|NCT03235544|157660985|FG001|Overall Study|Lost to Follow-up|1|||
48953977|NCT03235544|157660986|FG002|Overall Study|Lost to Follow-up|0|||
48953978|NCT03235544|157660987|FG003|Overall Study|Lost to Follow-up|1|||
48953979|NCT03235544|157660984|FG000|Overall Study|Withdrawal by Participant|0|||
48953980|NCT03235544|157660985|FG001|Overall Study|Withdrawal by Participant|0|||
48953981|NCT03235544|157660986|FG002|Overall Study|Withdrawal by Participant|1|||
48953982|NCT03235544|157660987|FG003|Overall Study|Withdrawal by Participant|0|||
48953983|NCT03235544|157660984|FG000|Overall Study|Reason not Specified|0|||
48953984|NCT03235544|157660985|FG001|Overall Study|Reason not Specified|4|||
48953985|NCT03235544|157660986|FG002|Overall Study|Reason not Specified|0|||
48746760|NCT04189081|156921113|FG002|Overall Study|Lost to Follow-up|0|||
48746761|NCT04189081|156921111|FG000|Overall Study|Withdrawal by Subject|0|||
48746762|NCT04189081|156921112|FG001|Overall Study|Withdrawal by Subject|0|||
48746763|NCT04189081|156921113|FG002|Overall Study|Withdrawal by Subject|1|||
48746764|NCT02706691|156921117|FG000|Overall Study|Adverse Event|1|||
48746765|NCT03033394|156921118|FG000|Completed Pharmacokinetic Analysis|Missing data|1|||
48746766|NCT03033394|156921118|FG000|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3|||
48746767|NCT03033394|156921118|FG000|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1|||
48746768|NCT03033394|156921118|FG000|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1|||
48746769|NCT03033394|156921118|FG000|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1|||
48746770|NCT01619423|156921119|FG000|Part 1 (Dose Escalation)|High basal Mn|0|||
48746771|NCT01619423|156921120|FG001|Part 1 (Dose Escalation)|High basal Mn|2|||
48746772|NCT01619423|156921121|FG002|Part 1 (Dose Escalation)|High basal Mn|0|||
48746773|NCT01619423|156921122|FG003|Part 1 (Dose Escalation)|High basal Mn|0|||
48746774|NCT00814164|156921124|FG000|Overall Study|Progression|7|||
48746775|NCT00814164|156921124|FG000|Overall Study|not stated|7|||
48746776|NCT00814164|156921124|FG000|Overall Study|Death|5|||
48746777|NCT00851747|156921126|FG000|Overall Study|Physician Decision|6|||
48746778|NCT00851747|156921127|FG001|Overall Study|Physician Decision|6|||
48746779|NCT00851747|156921128|FG002|Overall Study|Physician Decision|6|||
48746780|NCT02321800|156921129|FG000|Overall Study|Withdrawal by Subject|3|||
48746781|NCT02321800|156921130|FG001|Overall Study|Withdrawal by Subject|3|||
48746782|NCT02321800|156921129|FG000|Overall Study|Death|1|||
48746783|NCT02321800|156921130|FG001|Overall Study|Death|0|||
48746784|NCT02321800|156921129|FG000|Overall Study|Protocol Violation|1|||
48859750|NCT03395197|157325419|FG000|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
48859751|NCT03395197|157325420|FG001|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
48859752|NCT03395197|157325421|FG002|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
48859753|NCT03395197|157325422|FG003|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
48859754|NCT03395197|157325423|FG004|Analysis for DDR-Deficient Participants|No longer clinically benefiting|5|||
48859755|NCT03395197|157325424|FG005|Analysis for DDR-Deficient Participants|No longer clinically benefiting|8|||
48859756|NCT03395197|157325419|FG000|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
48859757|NCT03395197|157325420|FG001|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
48859758|NCT03395197|157325421|FG002|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
48859759|NCT03395197|157325422|FG003|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
48859760|NCT03395197|157325423|FG004|Analysis for DDR-Deficient Participants|Not treated with talazoparib|3|||
48859761|NCT03395197|157325424|FG005|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
48859762|NCT03395197|157325419|FG000|Analysis for DDR-Deficient Participants|Adverse Event|0|||
48859763|NCT03395197|157325420|FG001|Analysis for DDR-Deficient Participants|Adverse Event|0|||
48859764|NCT03395197|157325421|FG002|Analysis for DDR-Deficient Participants|Adverse Event|0|||
48859765|NCT03395197|157325422|FG003|Analysis for DDR-Deficient Participants|Adverse Event|0|||
48859766|NCT03395197|157325423|FG004|Analysis for DDR-Deficient Participants|Adverse Event|19|||
48859767|NCT03395197|157325424|FG005|Analysis for DDR-Deficient Participants|Adverse Event|11|||
48859768|NCT03395197|157325419|FG000|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
48859769|NCT03395197|157325420|FG001|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
48859770|NCT03395197|157325421|FG002|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
48859771|NCT03395197|157325422|FG003|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
48859772|NCT03395197|157325423|FG004|Analysis for DDR-Deficient Participants|Progressive Disease|39|||
48859773|NCT03395197|157325424|FG005|Analysis for DDR-Deficient Participants|Progressive Disease|60|||
48859774|NCT03395197|157325419|FG000|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
48859775|NCT03395197|157325420|FG001|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
48859776|NCT03395197|157325421|FG002|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
48859777|NCT03395197|157325422|FG003|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
48859778|NCT03395197|157325423|FG004|Analysis for DDR-Deficient Participants|Withdrawal by Subject|11|||
48746785|NCT02321800|156921130|FG001|Overall Study|Protocol Violation|0|||
48746786|NCT02321800|156921129|FG000|Overall Study|Lost to Follow-up|10|||
48746787|NCT02321800|156921130|FG001|Overall Study|Lost to Follow-up|4|||
48746788|NCT02321800|156921129|FG000|Overall Study|Adverse Event|2|||
48746789|NCT02321800|156921130|FG001|Overall Study|Adverse Event|3|||
48746790|NCT02321800|156921129|FG000|Overall Study|Other, Miscellaneous|3|||
48746791|NCT02321800|156921130|FG001|Overall Study|Other, Miscellaneous|1|||
48746792|NCT02340975|156921131|FG000|Overall Study|Death|6|||
48746793|NCT02340975|156921132|FG001|Overall Study|Death|23|||
48746794|NCT02340975|156921133|FG002|Overall Study|Death|21|||
48746795|NCT02340975|156921134|FG003|Overall Study|Death|7|||
48746796|NCT02340975|156921135|FG004|Overall Study|Death|21|||
48746797|NCT02340975|156921136|FG005|Overall Study|Death|13|||
48746798|NCT02340975|156921131|FG000|Overall Study|Lost to Follow-up|0|||
48746799|NCT02340975|156921132|FG001|Overall Study|Lost to Follow-up|0|||
48746800|NCT02340975|156921133|FG002|Overall Study|Lost to Follow-up|0|||
48746801|NCT02340975|156921134|FG003|Overall Study|Lost to Follow-up|0|||
48746802|NCT02340975|156921135|FG004|Overall Study|Lost to Follow-up|2|||
48746803|NCT02340975|156921136|FG005|Overall Study|Lost to Follow-up|0|||
48746804|NCT02340975|156921131|FG000|Overall Study|Withdrawal by Subject|0|||
48746805|NCT02340975|156921132|FG001|Overall Study|Withdrawal by Subject|0|||
48746806|NCT02340975|156921133|FG002|Overall Study|Withdrawal by Subject|3|||
48746807|NCT02340975|156921134|FG003|Overall Study|Withdrawal by Subject|3|||
48746808|NCT02340975|156921135|FG004|Overall Study|Withdrawal by Subject|2|||
48746809|NCT02340975|156921136|FG005|Overall Study|Withdrawal by Subject|0|||
48746810|NCT02340975|156921131|FG000|Overall Study|Other|0|||
48746811|NCT02340975|156921132|FG001|Overall Study|Other|4|||
48746812|NCT02340975|156921133|FG002|Overall Study|Other|0|||
48746813|NCT02340975|156921134|FG003|Overall Study|Other|2|||
48746814|NCT02340975|156921135|FG004|Overall Study|Other|0|||
48746815|NCT02340975|156921136|FG005|Overall Study|Other|6|||
48746816|NCT04661839|156921139|FG000|Overall Study|Not Treated|0|||
48746817|NCT04661839|156921140|FG001|Overall Study|Not Treated|0|||
48746818|NCT04661839|156921141|FG002|Overall Study|Not Treated|1|||
48746819|NCT04661839|156921142|FG003|Overall Study|Not Treated|0|||
48746820|NCT04661839|156921139|FG000|Overall Study|Lost to Follow-up|1|||
48746821|NCT04661839|156921140|FG001|Overall Study|Lost to Follow-up|0|||
48746822|NCT04661839|156921141|FG002|Overall Study|Lost to Follow-up|0|||
48746823|NCT04661839|156921142|FG003|Overall Study|Lost to Follow-up|1|||
48746824|NCT01169493|156921143|FG000|Period 1 (6 Months)|Withdrawal by Subject|0|||
48746825|NCT01169493|156921144|FG001|Period 1 (6 Months)|Withdrawal by Subject|1|||
48746826|NCT01169493|156921145|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
48746827|NCT01169493|156921146|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
48746828|NCT01169493|156921147|FG004|Period 1 (6 Months)|Withdrawal by Subject|0|||
48746829|NCT01169493|156921148|FG005|Period 1 (6 Months)|Withdrawal by Subject|3|||
48746830|NCT01169493|156921143|FG000|Period 3 (6 Months)|Adverse Event|0|||
48746831|NCT01169493|156921144|FG001|Period 3 (6 Months)|Adverse Event|1|||
48746832|NCT01169493|156921145|FG002|Period 3 (6 Months)|Adverse Event|0|||
48746833|NCT01169493|156921146|FG003|Period 3 (6 Months)|Adverse Event|0|||
48746834|NCT01169493|156921147|FG004|Period 3 (6 Months)|Adverse Event|0|||
48746835|NCT01169493|156921148|FG005|Period 3 (6 Months)|Adverse Event|0|||
48746836|NCT01169493|156921143|FG000|Period 3 (6 Months)|Physician Decision|0|||
48746837|NCT01169493|156921144|FG001|Period 3 (6 Months)|Physician Decision|1|||
48746838|NCT01169493|156921145|FG002|Period 3 (6 Months)|Physician Decision|1|||
48746839|NCT01169493|156921146|FG003|Period 3 (6 Months)|Physician Decision|0|||
48746840|NCT01169493|156921147|FG004|Period 3 (6 Months)|Physician Decision|0|||
48746841|NCT01169493|156921148|FG005|Period 3 (6 Months)|Physician Decision|0|||
48746842|NCT03066804|156921149|FG000|Overall Study|Physician Decision|0|||
48746843|NCT03066804|156921150|FG001|Overall Study|Physician Decision|4|||
48746844|NCT03066804|156921149|FG000|Overall Study|Death|23|||
48746845|NCT03066804|156921150|FG001|Overall Study|Death|17|||
48953986|NCT03235544|157660987|FG003|Overall Study|Reason not Specified|1|||
48953987|NCT00850759|157660988|FG000|Overall Study|Lost to Follow-up|7|||
48746846|NCT03066804|156921149|FG000|Overall Study|Withdrawal by Subject|19|||
48746847|NCT03066804|156921150|FG001|Overall Study|Withdrawal by Subject|25|||
48746848|NCT03066804|156921149|FG000|Overall Study|Lost to Follow-up|2|||
48746849|NCT03066804|156921150|FG001|Overall Study|Lost to Follow-up|0|||
48746850|NCT03066804|156921149|FG000|Overall Study|Adverse Event|2|||
48746851|NCT03066804|156921150|FG001|Overall Study|Adverse Event|3|||
48746852|NCT03066804|156921149|FG000|Overall Study|Technical problems|5|||
48746853|NCT03066804|156921150|FG001|Overall Study|Technical problems|1|||
48746854|NCT00370032|156921151|FG000|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0|||
48746855|NCT00370032|156921152|FG001|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1|||
48746856|NCT00370032|156921151|FG000|Washout Period|Withdrawal by Subject|0|||
48746857|NCT00370032|156921152|FG001|Washout Period|Withdrawal by Subject|1|||
48746858|NCT00370032|156921151|FG000|Washout Period|Lost to Follow-up|0|||
48746859|NCT00370032|156921152|FG001|Washout Period|Lost to Follow-up|1|||
48746860|NCT00370032|156921151|FG000|Washout Period|Adverse Event|1|||
48746861|NCT00370032|156921152|FG001|Washout Period|Adverse Event|0|||
48746862|NCT00370032|156921151|FG000|Follow-up Period|Withdrawal by Subject|1|||
48953988|NCT00850759|157660989|FG001|Overall Study|Lost to Follow-up|5|||
48953989|NCT00850759|157660990|FG002|Overall Study|Lost to Follow-up|5|||
48953990|NCT00850759|157660991|FG003|Overall Study|Lost to Follow-up|3|||
48746863|NCT00370032|156921152|FG001|Follow-up Period|Withdrawal by Subject|0|||
48746864|NCT02220205|156921153|FG000|Overall Study|Withdrawal by Subject|1|||
48746865|NCT02220205|156921154|FG001|Overall Study|Withdrawal by Subject|0|||
48746866|NCT01465997|156921155|FG000|Overall Study|Adverse Event|12|||
48746867|NCT01465997|156921156|FG001|Overall Study|Adverse Event|22|||
48746868|NCT01465997|156921155|FG000|Overall Study|Lack of Efficacy|13|||
48746869|NCT01465997|156921156|FG001|Overall Study|Lack of Efficacy|1|||
48746870|NCT01465997|156921155|FG000|Overall Study|Protocol Violation|1|||
48746871|NCT01465997|156921156|FG001|Overall Study|Protocol Violation|4|||
48746872|NCT01465997|156921155|FG000|Overall Study|Lost to Follow-up|6|||
48859779|NCT03395197|157325424|FG005|Analysis for DDR-Deficient Participants|Withdrawal by Subject|13|||
48859780|NCT03395197|157325419|FG000|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
48746873|NCT01465997|156921156|FG001|Overall Study|Lost to Follow-up|9|||
48746874|NCT01465997|156921155|FG000|Overall Study|Withdrawal by Subject|32|||
48746875|NCT01465997|156921156|FG001|Overall Study|Withdrawal by Subject|35|||
48746876|NCT01465997|156921155|FG000|Overall Study|investigator's decision|1|||
48746877|NCT01465997|156921156|FG001|Overall Study|investigator's decision|1|||
48746878|NCT01465997|156921155|FG000|Overall Study|Death|0|||
48746879|NCT01465997|156921156|FG001|Overall Study|Death|1|||
48746880|NCT01465997|156921155|FG000|Overall Study|sponsor's decision|1|||
48859781|NCT03395197|157325420|FG001|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
48859782|NCT03395197|157325421|FG002|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
48859783|NCT03395197|157325422|FG003|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
48859784|NCT03395197|157325423|FG004|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|24|||
48859785|NCT03395197|157325424|FG005|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|40|||
48859786|NCT03395197|157325419|FG000|Analysis for DDR-Deficient Participants|Other|0|||
48859787|NCT03395197|157325420|FG001|Analysis for DDR-Deficient Participants|Other|0|||
48859788|NCT03395197|157325421|FG002|Analysis for DDR-Deficient Participants|Other|0|||
48859789|NCT03395197|157325422|FG003|Analysis for DDR-Deficient Participants|Other|0|||
48859790|NCT03395197|157325423|FG004|Analysis for DDR-Deficient Participants|Other|3|||
48859791|NCT03395197|157325424|FG005|Analysis for DDR-Deficient Participants|Other|3|||
48859792|NCT03395197|157325419|FG000|Analysis for DDR-Deficient Participants|Ongoing|0|||
48859793|NCT03395197|157325420|FG001|Analysis for DDR-Deficient Participants|Ongoing|0|||
48746881|NCT01465997|156921156|FG001|Overall Study|sponsor's decision|1|||
48859794|NCT03395197|157325421|FG002|Analysis for DDR-Deficient Participants|Ongoing|0|||
48859795|NCT03395197|157325422|FG003|Analysis for DDR-Deficient Participants|Ongoing|0|||
48859796|NCT03395197|157325423|FG004|Analysis for DDR-Deficient Participants|Ongoing|95|||
48859797|NCT03395197|157325424|FG005|Analysis for DDR-Deficient Participants|Ongoing|60|||
48859798|NCT04050722|157325425|FG000|Overall Study|Withdrawal by Subject|1|||
48859799|NCT04050722|157325426|FG001|Overall Study|Withdrawal by Subject|0|||
48859800|NCT04783389|157325427|FG000|Overall Study|Withdrawal by Subject|2|||
48746882|NCT01465997|156921155|FG000|Overall Study|subject withdrew consent|1|||
48746883|NCT01465997|156921156|FG001|Overall Study|subject withdrew consent|0|||
48746884|NCT01465997|156921155|FG000|Overall Study|local lab unblinded site|1|||
48746885|NCT01465997|156921156|FG001|Overall Study|local lab unblinded site|0|||
48746886|NCT01465997|156921155|FG000|Overall Study|withdrew before follow-up|0|||
48746887|NCT01465997|156921156|FG001|Overall Study|withdrew before follow-up|13|||
48746888|NCT01465997|156921155|FG000|Overall Study|decision by site staff|0|||
48746889|NCT01465997|156921156|FG001|Overall Study|decision by site staff|1|||
48746890|NCT01465997|156921155|FG000|Overall Study|subject left participation SP0993|0|||
48746891|NCT01465997|156921156|FG001|Overall Study|subject left participation SP0993|1|||
48746892|NCT00619177|156921158|FG000|Overall Study|Adverse Event|18|||
48746893|NCT00619177|156921158|FG000|Overall Study|Lost to Follow-up|2|||
48746894|NCT00619177|156921158|FG000|Overall Study|Lack of Efficacy|1|||
48746895|NCT00619177|156921158|FG000|Overall Study|Missing termination information|481|||
48746896|NCT00619177|156921158|FG000|Overall Study|Not specified reasons|6|||
48746897|NCT00205881|156921159|FG000|Overall Study|Withdrawal by Subject|16|||
48746898|NCT02083783|156921161|FG000|Overall Study|Withdrawal by Subject|1|||
48746899|NCT02083783|156921162|FG001|Overall Study|Withdrawal by Subject|0|||
48746900|NCT01496612|156921163|FG000|1st Intervention|Adverse Event|1|||
48746901|NCT01496612|156921164|FG001|1st Intervention|Adverse Event|0|||
48746902|NCT01496612|156921163|FG000|1st Intervention|Withdrawal by Subject|1|||
48746903|NCT01496612|156921164|FG001|1st Intervention|Withdrawal by Subject|0|||
48746904|NCT01654536|156921165|FG000|Overall Study|Lost to Follow-up|5|||
48746905|NCT01654536|156921166|FG001|Overall Study|Lost to Follow-up|5|||
48746906|NCT01654536|156921165|FG000|Overall Study|Physician Decision|12|||
48746907|NCT01654536|156921166|FG001|Overall Study|Physician Decision|8|||
48746908|NCT01654536|156921165|FG000|Overall Study|Withdrawal by Subject|27|||
48746909|NCT01654536|156921166|FG001|Overall Study|Withdrawal by Subject|25|||
48746910|NCT03681405|156921172|FG000|Overall Study|Found to be ineligible after randomized|1|||
48746911|NCT03681405|156921173|FG001|Overall Study|Found to be ineligible after randomized|0|||
48746912|NCT05570500|156921176|FG000|Overall Study|Lost to Follow-up|7|||
48746913|NCT05570500|156921177|FG001|Overall Study|Lost to Follow-up|5|||
48746914|NCT01446289|156921180|FG000|Overall Study|Withdrawal by Subject|1|||
48746915|NCT01446289|156921181|FG001|Overall Study|Withdrawal by Subject|0|||
48746916|NCT01446289|156921182|FG002|Overall Study|Withdrawal by Subject|1|||
48746917|NCT01446289|156921183|FG003|Overall Study|Withdrawal by Subject|0|||
48746918|NCT00838578|156921186|FG000|Overall Study|Protocol Violation|2|||
48746919|NCT02760069|156921187|FG000|Overall Study|Withdrawal by Subject|0|||
48746920|NCT02760069|156921188|FG001|Overall Study|Withdrawal by Subject|1|||
48859801|NCT04783389|157325428|FG001|Overall Study|Withdrawal by Subject|0|||
48859802|NCT04783389|157325429|FG002|Overall Study|Withdrawal by Subject|0|||
48746921|NCT02760069|156921189|FG002|Overall Study|Withdrawal by Subject|1|||
48746922|NCT03031678|156921192|FG000|Overall Study|Study closed prior to completion|1|||
48746923|NCT03782116|156921199|FG000|Completed Intervetion|Lost to Follow-up|11|||
48746924|NCT03782116|156921200|FG001|Completed Intervetion|Lost to Follow-up|7|||
48746925|NCT03782116|156921199|FG000|Completed Intervetion|Withdrawal by Subject|6|||
48746926|NCT03782116|156921200|FG001|Completed Intervetion|Withdrawal by Subject|5|||
48953991|NCT00367640|157660992|FG000|Overall Study|Adverse Event|3|||
48746927|NCT03782116|156921199|FG000|Included in Analysis|Protocol Violation|5|||
48746928|NCT03782116|156921200|FG001|Included in Analysis|Protocol Violation|5|||
48746929|NCT00967668|156922840|FG000|Overall Study|Withdrawal by Subject|13|||
48746930|NCT00967668|156922841|FG001|Overall Study|Withdrawal by Subject|8|||
48746931|NCT00967668|156922842|FG002|Overall Study|Withdrawal by Subject|8|||
48859803|NCT04783389|157325427|FG000|Overall Study|Termination of Study by Sponsor|10|||
48859804|NCT04783389|157325428|FG001|Overall Study|Termination of Study by Sponsor|12|||
48859805|NCT04783389|157325429|FG002|Overall Study|Termination of Study by Sponsor|14|||
48859806|NCT02489799|157325432|FG000|Overall Study|Lost to Follow-up|4|||
48859807|NCT02489799|157325433|FG001|Overall Study|Lost to Follow-up|1|||
48859808|NCT02489799|157325432|FG000|Overall Study|Failure to Maintain Eligibility|4|||
48859809|NCT02489799|157325433|FG001|Overall Study|Failure to Maintain Eligibility|6|||
48859810|NCT02489799|157325432|FG000|Overall Study|Withdrawal by Subject|1|||
48859811|NCT02489799|157325433|FG001|Overall Study|Withdrawal by Subject|1|||
48859812|NCT02489799|157325432|FG000|Overall Study|Death|0|||
48859813|NCT02489799|157325433|FG001|Overall Study|Death|1|||
48859814|NCT01018992|157325434|FG000|Overall Study|Adverse Event|8|||
48859815|NCT01018992|157325435|FG001|Overall Study|Adverse Event|3|||
48859816|NCT01018992|157325434|FG000|Overall Study|Withdrawal by Subject|3|||
48859817|NCT01018992|157325435|FG001|Overall Study|Withdrawal by Subject|8|||
48859818|NCT01018992|157325434|FG000|Overall Study|Protocol Violation|0|||
48859819|NCT01018992|157325435|FG001|Overall Study|Protocol Violation|4|||
48859820|NCT01018992|157325434|FG000|Overall Study|Lost to Follow-up|5|||
48859821|NCT01018992|157325435|FG001|Overall Study|Lost to Follow-up|1|||
48859822|NCT03029585|157325436|FG000|Overall Study|Death|1|||
48859823|NCT03029585|157325437|FG001|Overall Study|Death|1|||
48859824|NCT03029585|157325436|FG000|Overall Study|Withdrawal by Subject|1|||
48859825|NCT03029585|157325437|FG001|Overall Study|Withdrawal by Subject|0|||
48859826|NCT02400749|157325438|FG000|Week 0 -16|Withdrawal by Subject|5|||
48859827|NCT02400749|157325439|FG001|Week 0 -16|Withdrawal by Subject|5|||
48859828|NCT02400749|157325438|FG000|Week 0 -16|Adverse Event|3|||
48859829|NCT02400749|157325439|FG001|Week 0 -16|Adverse Event|1|||
48859830|NCT02400749|157325438|FG000|Week 0 -16|Lost to Follow-up|2|||
48859831|NCT02400749|157325439|FG001|Week 0 -16|Lost to Follow-up|0|||
48859832|NCT02400749|157325438|FG000|Week 0 -16|Protocol Violation|1|||
48859833|NCT02400749|157325439|FG001|Week 0 -16|Protocol Violation|0|||
48859834|NCT02400749|157325438|FG000|Week 17 - 32|Withdrawal by Subject|3|||
48859835|NCT02400749|157325439|FG001|Week 17 - 32|Withdrawal by Subject|2|||
48859836|NCT02400749|157325438|FG000|Week 17 - 32|Adverse Event|2|||
48859837|NCT02400749|157325439|FG001|Week 17 - 32|Adverse Event|1|||
48859838|NCT04425252|157325442|FG000|Overall Study|Withdrawal by Subject|2|||
48859839|NCT04425252|157325443|FG001|Overall Study|Withdrawal by Subject|1|||
48859840|NCT04425252|157325442|FG000|Overall Study|Lost to Follow-up|1|||
48859841|NCT04425252|157325443|FG001|Overall Study|Lost to Follow-up|0|||
48859842|NCT04425252|157325442|FG000|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
48859843|NCT04425252|157325443|FG001|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
48859844|NCT03694210|157325445|FG000|Overall Study|Death|1|||
48746932|NCT00967668|156922840|FG000|Overall Study|Death|0|||
48746933|NCT00967668|156922841|FG001|Overall Study|Death|2|||
48746934|NCT00967668|156922842|FG002|Overall Study|Death|4|||
48746935|NCT00967668|156922840|FG000|Overall Study|Removed due to behavior|1|||
48746936|NCT00967668|156922841|FG001|Overall Study|Removed due to behavior|1|||
48746937|NCT00967668|156922842|FG002|Overall Study|Removed due to behavior|2|||
48746938|NCT00967668|156922840|FG000|Overall Study|Refused Year 2|11|||
48746939|NCT00967668|156922841|FG001|Overall Study|Refused Year 2|6|||
48859845|NCT03694210|157325445|FG000|Overall Study|Screen Failure|7|||
48859846|NCT01248715|157325446|FG000|Overall Study|Not influenza positive|501|||
48859847|NCT01248715|157325447|FG001|Overall Study|Not influenza positive|510|||
48859848|NCT02152384|157325450|FG000|Period 1|Withdrawal by Subject|0|||
49015376|NCT00306384|157892158|FG002|Overall Study|Pregnancy|1|||
48746940|NCT00967668|156922842|FG002|Overall Study|Refused Year 2|4|||
48859849|NCT02152384|157325451|FG001|Period 1|Withdrawal by Subject|1|||
48859850|NCT02152384|157325450|FG000|Period 1|Adverse Event|1|||
48859851|NCT02152384|157325451|FG001|Period 1|Adverse Event|1|||
48859852|NCT01102426|157325456|FG000|Overall Study|Randomized but not treated|4|||
48859853|NCT01102426|157325457|FG001|Overall Study|Randomized but not treated|1|||
48859854|NCT01102426|157325456|FG000|Overall Study|Adverse Events (treatment-related)|15|||
48859855|NCT01102426|157325457|FG001|Overall Study|Adverse Events (treatment-related)|8|||
48859856|NCT01102426|157325456|FG000|Overall Study|Physician Decision|9|||
48859857|NCT01102426|157325457|FG001|Overall Study|Physician Decision|6|||
48859858|NCT01102426|157325456|FG000|Overall Study|Progressive Disease|85|||
48859859|NCT01102426|157325457|FG001|Overall Study|Progressive Disease|44|||
48859860|NCT01102426|157325456|FG000|Overall Study|Adverse Events (unrelated to|9|||
48859861|NCT01102426|157325457|FG001|Overall Study|Adverse Events (unrelated to|1|||
48859862|NCT01102426|157325456|FG000|Overall Study|Patient Refusal|24|||
48859863|NCT01102426|157325457|FG001|Overall Study|Patient Refusal|12|||
48859864|NCT01102426|157325456|FG000|Overall Study|Death (due to adverse events|0|||
48859865|NCT01102426|157325457|FG001|Overall Study|Death (due to adverse events|1|||
48859866|NCT01102426|157325456|FG000|Overall Study|Death (non-related to the study|19|||
48859867|NCT01102426|157325457|FG001|Overall Study|Death (non-related to the study|8|||
48859868|NCT01131325|157325461|FG000|Overall Study|Adverse Event|1|||
48859869|NCT01131325|157325461|FG000|Overall Study|The participants discontinued the study as the study got terminated|2|||
48859870|NCT03840993|157325462|FG000|Overall Study|Adverse Event|1|||
48859871|NCT03840993|157325463|FG001|Overall Study|Adverse Event|0|||
48859872|NCT03840993|157325462|FG000|Overall Study|Lost to Follow-up|4|||
48859873|NCT03840993|157325463|FG001|Overall Study|Lost to Follow-up|0|||
48859874|NCT03840993|157325462|FG000|Overall Study|Physician Decision|0|||
48859875|NCT03840993|157325463|FG001|Overall Study|Physician Decision|1|||
48859876|NCT03840993|157325462|FG000|Overall Study|Pregnancy|0|||
48859877|NCT03840993|157325463|FG001|Overall Study|Pregnancy|1|||
48859878|NCT03840993|157325462|FG000|Overall Study|Withdrawal by Subject|1|||
48859879|NCT03840993|157325463|FG001|Overall Study|Withdrawal by Subject|3|||
48953992|NCT00367640|157660993|FG001|Overall Study|Adverse Event|6|||
48953993|NCT00367640|157660994|FG002|Overall Study|Adverse Event|8|||
48953994|NCT00367640|157660995|FG003|Overall Study|Adverse Event|0|||
48953995|NCT00367640|157660992|FG000|Overall Study|Withdrawal by Subject|8|||
48953996|NCT00367640|157660993|FG001|Overall Study|Withdrawal by Subject|11|||
48953997|NCT00367640|157660994|FG002|Overall Study|Withdrawal by Subject|8|||
48953998|NCT00367640|157660995|FG003|Overall Study|Withdrawal by Subject|6|||
48953999|NCT00367640|157660992|FG000|Overall Study|Any other reason not above-mentioned|7|||
48954000|NCT00367640|157660993|FG001|Overall Study|Any other reason not above-mentioned|5|||
48954001|NCT00367640|157660994|FG002|Overall Study|Any other reason not above-mentioned|3|||
48746941|NCT00967668|156922840|FG000|Overall Study|Lost to follow-up at 12-mo|27|||
48746942|NCT00967668|156922841|FG001|Overall Study|Lost to follow-up at 12-mo|29|||
48746943|NCT00967668|156922842|FG002|Overall Study|Lost to follow-up at 12-mo|26|||
48746944|NCT00967668|156922840|FG000|Overall Study|Lost to Follow-up|15|||
48746945|NCT00967668|156922841|FG001|Overall Study|Lost to Follow-up|9|||
48746946|NCT00967668|156922842|FG002|Overall Study|Lost to Follow-up|16|||
48746947|NCT00967668|156922840|FG000|Overall Study|Refused 12-mo assessment|3|||
48859880|NCT03840993|157325462|FG000|Overall Study|Neutrophil count decrease, COVID-19|3|||
48859881|NCT03840993|157325463|FG001|Overall Study|Neutrophil count decrease, COVID-19|2|||
48859882|NCT02005484|157325464|FG000|Overall Study|Death|1|||
48859883|NCT02005484|157325464|FG000|Overall Study|Disease progression|1|||
48859884|NCT02005484|157325464|FG000|Overall Study|Changed to a Different Study|1|||
48859885|NCT02005484|157325464|FG000|Overall Study|Sponsor decision|1|||
48859886|NCT03557307|157325466|FG000|Period 1: To End of OCS Reduction Phase|Withdrawal by Subject|10|||
48859887|NCT03557307|157325466|FG000|Period 1: To End of OCS Reduction Phase|Adverse Event|7|||
48859888|NCT03557307|157325466|FG000|Period 1: To End of OCS Reduction Phase|Protocol Violation|6|||
48859889|NCT03557307|157325466|FG000|Period 1: To End of OCS Reduction Phase|Lost to Follow-up|5|||
48859890|NCT03557307|157325466|FG000|Period 1: To End of OCS Reduction Phase|other|3|||
48859891|NCT03557307|157325466|FG000|Period 1: To End of OCS Reduction Phase|Death|2|||
48859892|NCT03557307|157325466|FG000|Period 1: To End of OCS Reduction Phase|Failure to meet inclusion/exclusion criteria|2|||
48859893|NCT03557307|157325466|FG000|Period 2: Maintenance Phase|Adverse Event|4|||
48859894|NCT03557307|157325466|FG000|Period 2: Maintenance Phase|Death|3|||
48859895|NCT03557307|157325466|FG000|Period 2: Maintenance Phase|Lost to Follow-up|2|||
48859896|NCT03557307|157325466|FG000|Period 2: Maintenance Phase|Pregnancy|2|||
48859897|NCT03557307|157325466|FG000|Period 2: Maintenance Phase|Protocol Violation|11|||
48954002|NCT00367640|157660995|FG003|Overall Study|Any other reason not above-mentioned|4|||
48746948|NCT00967668|156922841|FG001|Overall Study|Refused 12-mo assessment|1|||
48859898|NCT03557307|157325466|FG000|Period 2: Maintenance Phase|Withdrawal by Subject|2|||
48954003|NCT00771030|157660996|FG000|Overall Study|Adverse Event|0|||
48954004|NCT00771030|157660997|FG001|Overall Study|Adverse Event|1|||
48954005|NCT00771030|157660998|FG002|Overall Study|Adverse Event|0|||
48954006|NCT00771030|157660999|FG003|Overall Study|Adverse Event|0|||
48954007|NCT00771030|157661000|FG004|Overall Study|Adverse Event|0|||
48954008|NCT00771030|157661001|FG005|Overall Study|Adverse Event|0|||
48954009|NCT00771030|157661002|FG006|Overall Study|Adverse Event|0|||
48954010|NCT03408873|157661003|FG000|Visit 1 Assessment (Baseline)|Lost to Follow-up|3|||
48954011|NCT03408873|157661003|FG000|Visit 2 Assessment|Lost to Follow-up|1|||
48954012|NCT03408873|157661003|FG000|Visit 3 Assessment|Withdrawal by Subject|1|||
48954013|NCT03408873|157661003|FG000|Visit 4 Assessment|Lost to Follow-up|2|||
48954014|NCT03408873|157661003|FG000|Visit 5 Assessment|Lost to Follow-up|1|||
48954015|NCT03408873|157661003|FG000|Visit 6 Assessment|Withdrawal by Subject|1|||
48954016|NCT02214186|157661009|FG000|Overall Study|Lost to Follow-up|1|||
48954017|NCT02214186|157661010|FG001|Overall Study|Lost to Follow-up|1|||
48954018|NCT02214186|157661009|FG000|Overall Study|Protocol Violation|1|||
48954019|NCT02214186|157661010|FG001|Overall Study|Protocol Violation|1|||
48954020|NCT01651052|157661013|FG000|Overall Study|Death|21|||
48954021|NCT01651052|157661013|FG000|Overall Study|Explant|1|||
48954022|NCT01651052|157661013|FG000|Overall Study|Withdrawal by Subject|1|||
48954023|NCT01651052|157661013|FG000|Overall Study|Lost to Follow-up|3|||
48954024|NCT01024465|157661014|FG000|Overall Study|Adverse Event|2|||
48954025|NCT01024465|157661014|FG000|Overall Study|Physician Decision|1|||
48954026|NCT02677896|157661015|FG000|Double Blind Period (up to 35 Months)|Death|113|||
48954027|NCT02677896|157661016|FG001|Double Blind Period (up to 35 Months)|Death|189|||
48954028|NCT02677896|157661015|FG000|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
48954029|NCT02677896|157661016|FG001|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
48954030|NCT02677896|157661015|FG000|Double Blind Period (up to 35 Months)|Progressive disease|3|||
48954031|NCT02677896|157661016|FG001|Double Blind Period (up to 35 Months)|Progressive disease|4|||
48954032|NCT02677896|157661015|FG000|Double Blind Period (up to 35 Months)|Withdrawal by Subject|41|||
48954033|NCT02677896|157661016|FG001|Double Blind Period (up to 35 Months)|Withdrawal by Subject|69|||
48954034|NCT02677896|157661015|FG000|Double Blind Period (up to 35 Months)|Miscellaneous|9|||
48954035|NCT02677896|157661016|FG001|Double Blind Period (up to 35 Months)|Miscellaneous|14|||
48954036|NCT02677896|157661015|FG000|Double Blind Period (up to 35 Months)|Continued in OLE|365|||
48954037|NCT02677896|157661016|FG001|Double Blind Period (up to 35 Months)|Continued in OLE|180|||
48954038|NCT02677896|157661015|FG000|Double Blind Period (up to 35 Months)|Followed-up for OS|31|||
48954039|NCT02677896|157661016|FG001|Double Blind Period (up to 35 Months)|Followed-up for OS|108|||
48746949|NCT00967668|156922842|FG002|Overall Study|Refused 12-mo assessment|9|||
48746950|NCT00967668|156922840|FG000|Overall Study|Pregnancy|1|||
48954040|NCT02677896|157661015|FG000|Open-Label Extension (up to 25 Months)|Death|40|||
48954041|NCT02677896|157661016|FG001|Open-Label Extension (up to 25 Months)|Death|14|||
48954042|NCT02677896|157661015|FG000|Open-Label Extension (up to 25 Months)|Lost to Follow-up|2|||
48954043|NCT02677896|157661016|FG001|Open-Label Extension (up to 25 Months)|Lost to Follow-up|1|||
48954044|NCT02677896|157661015|FG000|Open-Label Extension (up to 25 Months)|Progressive disease|3|||
48954045|NCT02677896|157661016|FG001|Open-Label Extension (up to 25 Months)|Progressive disease|1|||
48954046|NCT02677896|157661015|FG000|Open-Label Extension (up to 25 Months)|Withdrawal by Subject|10|||
48954047|NCT02677896|157661016|FG001|Open-Label Extension (up to 25 Months)|Withdrawal by Subject|9|||
48954048|NCT02677896|157661015|FG000|Open-Label Extension (up to 25 Months)|Miscellaneous|0|||
48954049|NCT02677896|157661016|FG001|Open-Label Extension (up to 25 Months)|Miscellaneous|1|||
48954050|NCT02677896|157661015|FG000|Open-Label Extension (up to 25 Months)|OLE treatment ongoing|261|||
48954051|NCT02677896|157661016|FG001|Open-Label Extension (up to 25 Months)|OLE treatment ongoing|136|||
48954052|NCT02677896|157661015|FG000|Open-Label Extension (up to 25 Months)|Followed up for OS|49|||
48954053|NCT02677896|157661016|FG001|Open-Label Extension (up to 25 Months)|Followed up for OS|18|||
48954054|NCT01921270|157661017|FG000|Overall Study|Withdrawal by Subject|1|||
48954055|NCT03582033|157661019|FG000|Part A|Other|0|||
48954056|NCT03582033|157661020|FG001|Part A|Other|0|||
48954057|NCT03582033|157661021|FG002|Part A|Other|0|||
48746951|NCT00967668|156922841|FG001|Overall Study|Pregnancy|0|||
48746952|NCT00967668|156922842|FG002|Overall Study|Pregnancy|0|||
48954058|NCT03582033|157661022|FG003|Part A|Other|0|||
48954059|NCT03582033|157661023|FG004|Part A|Other|2|||
48954060|NCT03582033|157661024|FG005|Part A|Other|0|||
48954061|NCT03582033|157661025|FG006|Part A|Other|0|||
48954062|NCT03582033|157661026|FG007|Part A|Other|0|||
48954063|NCT03582033|157661027|FG008|Part A|Other|0|||
48954064|NCT03582033|157661028|FG009|Part A|Other|0|||
48954065|NCT03582033|157661019|FG000|Part A|Death|1|||
48954066|NCT03582033|157661020|FG001|Part A|Death|1|||
48746953|NCT01433991|156922849|FG000|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2|||
48746954|NCT01433991|156922850|FG001|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
48746955|NCT01433991|156922851|FG002|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
48746956|NCT01433991|156922852|FG003|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
48746957|NCT01433991|156922849|FG000|Treatment Phase (Combination Agent)|Adverse Event|1|||
48746958|NCT01433991|156922850|FG001|Treatment Phase (Combination Agent)|Adverse Event|0|||
48859899|NCT03557307|157325466|FG000|Period 2: Maintenance Phase|other|3|||
48746959|NCT01433991|156922851|FG002|Treatment Phase (Combination Agent)|Adverse Event|3|||
48746960|NCT01433991|156922852|FG003|Treatment Phase (Combination Agent)|Adverse Event|1|||
48859900|NCT01535261|157325467|FG000|Overall Study|Physician Decision|8|||
48859901|NCT01535261|157325467|FG000|Overall Study|Protocol Violation|3|||
48859902|NCT01535261|157325467|FG000|Overall Study|Death|5|||
48746961|NCT01433991|156922849|FG000|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
48746962|NCT01433991|156922850|FG001|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
48746963|NCT01433991|156922851|FG002|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
48746964|NCT01433991|156922852|FG003|Treatment Phase (Combination Agent)|Lost to Follow-up|1|||
48954067|NCT03582033|157661021|FG002|Part A|Death|2|||
48954068|NCT03582033|157661022|FG003|Part A|Death|4|||
48746965|NCT01433991|156922849|FG000|Treatment Phase (Combination Agent)|Participant Choice|0|||
48746966|NCT01433991|156922850|FG001|Treatment Phase (Combination Agent)|Participant Choice|0|||
48746967|NCT01433991|156922851|FG002|Treatment Phase (Combination Agent)|Participant Choice|0|||
48746968|NCT01433991|156922852|FG003|Treatment Phase (Combination Agent)|Participant Choice|1|||
48746969|NCT01433991|156922849|FG000|Treatment Phase (Combination Agent)|Clinical progression|0|||
48746970|NCT01433991|156922850|FG001|Treatment Phase (Combination Agent)|Clinical progression|1|||
48746971|NCT01433991|156922851|FG002|Treatment Phase (Combination Agent)|Clinical progression|2|||
48746972|NCT01433991|156922852|FG003|Treatment Phase (Combination Agent)|Clinical progression|3|||
48746973|NCT01433991|156922849|FG000|Treatment Phase (Combination Agent)|Progressive disease|1|||
48746974|NCT01433991|156922850|FG001|Treatment Phase (Combination Agent)|Progressive disease|0|||
48746975|NCT01433991|156922851|FG002|Treatment Phase (Combination Agent)|Progressive disease|0|||
48746976|NCT01433991|156922852|FG003|Treatment Phase (Combination Agent)|Progressive disease|0|||
48746977|NCT01433991|156922849|FG000|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
48746978|NCT01433991|156922850|FG001|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
48746979|NCT01433991|156922851|FG002|Treatment Phase (Combination Agent)|Terminated by sponsor|1|||
48746980|NCT01433991|156922852|FG003|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
48746981|NCT03539081|156922853|FG000|Overall Study|Withdrawal by Subject|2|||
48746982|NCT03539081|156922854|FG001|Overall Study|Withdrawal by Subject|3|||
48746983|NCT03539081|156922855|FG002|Overall Study|Withdrawal by Subject|0|||
48746984|NCT03539081|156922853|FG000|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|1|||
48859903|NCT01535261|157325467|FG000|Overall Study|Lost to Follow-up|8|||
48954069|NCT03582033|157661023|FG004|Part A|Death|11|||
48954070|NCT03582033|157661024|FG005|Part A|Death|0|||
48954071|NCT03582033|157661025|FG006|Part A|Death|0|||
48954072|NCT03582033|157661026|FG007|Part A|Death|0|||
48954073|NCT03582033|157661027|FG008|Part A|Death|0|||
48954074|NCT03582033|157661028|FG009|Part A|Death|0|||
48954075|NCT03582033|157661019|FG000|Part A|Lost to Follow-up|0|||
48954076|NCT03582033|157661020|FG001|Part A|Lost to Follow-up|0|||
48954077|NCT03582033|157661021|FG002|Part A|Lost to Follow-up|0|||
48954078|NCT03582033|157661022|FG003|Part A|Lost to Follow-up|0|||
48954079|NCT03582033|157661023|FG004|Part A|Lost to Follow-up|1|||
48954080|NCT03582033|157661024|FG005|Part A|Lost to Follow-up|0|||
48954081|NCT03582033|157661025|FG006|Part A|Lost to Follow-up|0|||
48954082|NCT03582033|157661026|FG007|Part A|Lost to Follow-up|0|||
49015377|NCT00306384|157892156|FG000|Overall Study|Lack of Efficacy|26|||
48746985|NCT03539081|156922854|FG001|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
48746986|NCT03539081|156922855|FG002|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
48746987|NCT01473836|156922859|FG000|Overall Study|Adverse Event|4|||
48746988|NCT01473836|156922859|FG000|Overall Study|Lack of Efficacy|1|||
48746989|NCT01473836|156922859|FG000|Overall Study|Does not meet entrance criteria|1|||
48859904|NCT01535261|157325467|FG000|Overall Study|Withdrawal by Subject|14|||
48859905|NCT01535261|157325467|FG000|Overall Study|Adverse Event|12|||
48859906|NCT01180400|157325470|FG000|Overall Study|Withdrawal by Subject|5|||
48859907|NCT01180400|157325471|FG001|Overall Study|Withdrawal by Subject|6|||
48859908|NCT01180400|157325470|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
48859909|NCT01180400|157325471|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
48859910|NCT01180400|157325470|FG000|Overall Study|Adverse Event|12|||
48859911|NCT01180400|157325471|FG001|Overall Study|Adverse Event|10|||
48859912|NCT01180400|157325470|FG000|Overall Study|Severe non-compliance to protocol|1|||
48859913|NCT01180400|157325471|FG001|Overall Study|Severe non-compliance to protocol|2|||
48859914|NCT01180400|157325470|FG000|Overall Study|Condition under investigation worsened|2|||
48954083|NCT03582033|157661027|FG008|Part A|Lost to Follow-up|0|||
48954084|NCT03582033|157661028|FG009|Part A|Lost to Follow-up|0|||
48954085|NCT03582033|157661019|FG000|Part A|Study terminated by sponsor|0|||
48954086|NCT03582033|157661020|FG001|Part A|Study terminated by sponsor|0|||
49015378|NCT00306384|157892157|FG001|Overall Study|Lack of Efficacy|40|||
48954087|NCT03582033|157661021|FG002|Part A|Study terminated by sponsor|0|||
48954088|NCT03582033|157661022|FG003|Part A|Study terminated by sponsor|2|||
48954089|NCT03582033|157661023|FG004|Part A|Study terminated by sponsor|1|||
48954090|NCT03582033|157661024|FG005|Part A|Study terminated by sponsor|0|||
48746990|NCT03602482|156922860|FG000|Overall Study|Withdrawal by Subject|6|||
48954091|NCT03582033|157661025|FG006|Part A|Study terminated by sponsor|0|||
48954092|NCT03582033|157661026|FG007|Part A|Study terminated by sponsor|0|||
48954093|NCT03582033|157661027|FG008|Part A|Study terminated by sponsor|0|||
48954094|NCT03582033|157661028|FG009|Part A|Study terminated by sponsor|0|||
48746991|NCT03602482|156922861|FG001|Overall Study|Withdrawal by Subject|7|||
48746992|NCT03602482|156922862|FG002|Overall Study|Withdrawal by Subject|0|||
48746993|NCT03602482|156922863|FG003|Overall Study|Withdrawal by Subject|0|||
48746994|NCT01389817|156922864|FG000|Overall Study|Physician Decision|1|||
48746995|NCT01389817|156922865|FG001|Overall Study|Physician Decision|0|||
48746996|NCT01389817|156922864|FG000|Overall Study|Lost to Follow-up|1|||
48746997|NCT01389817|156922865|FG001|Overall Study|Lost to Follow-up|0|||
48746998|NCT01389817|156922864|FG000|Overall Study|Withdrawal by Subject|2|||
48746999|NCT01389817|156922865|FG001|Overall Study|Withdrawal by Subject|0|||
48747000|NCT00621985|156922869|FG000|Dexamethasone Admission|Adverse Event|1|||
48954095|NCT03582033|157661019|FG000|Part A|Withdrawal by Subject|1|||
48954096|NCT03582033|157661020|FG001|Part A|Withdrawal by Subject|1|||
48954097|NCT03582033|157661021|FG002|Part A|Withdrawal by Subject|0|||
48954098|NCT03582033|157661022|FG003|Part A|Withdrawal by Subject|1|||
48954099|NCT03582033|157661023|FG004|Part A|Withdrawal by Subject|7|||
48954100|NCT03582033|157661024|FG005|Part A|Withdrawal by Subject|0|||
48954101|NCT03582033|157661025|FG006|Part A|Withdrawal by Subject|0|||
48954102|NCT03582033|157661026|FG007|Part A|Withdrawal by Subject|0|||
48954103|NCT03582033|157661027|FG008|Part A|Withdrawal by Subject|0|||
48954104|NCT03582033|157661028|FG009|Part A|Withdrawal by Subject|0|||
48954105|NCT03582033|157661019|FG000|Part B|Death|0|||
48954106|NCT03582033|157661020|FG001|Part B|Death|0|||
48954107|NCT03582033|157661021|FG002|Part B|Death|0|||
48954108|NCT03582033|157661022|FG003|Part B|Death|0|||
48954109|NCT03582033|157661023|FG004|Part B|Death|0|||
48954110|NCT03582033|157661024|FG005|Part B|Death|2|||
48954111|NCT03582033|157661025|FG006|Part B|Death|0|||
48954112|NCT03582033|157661026|FG007|Part B|Death|0|||
48954113|NCT03582033|157661027|FG008|Part B|Death|0|||
48954114|NCT03582033|157661028|FG009|Part B|Death|0|||
48954115|NCT03582033|157661019|FG000|Part B|Study terminated by sponsor|0|||
48954116|NCT03582033|157661020|FG001|Part B|Study terminated by sponsor|0|||
48954117|NCT03582033|157661021|FG002|Part B|Study terminated by sponsor|0|||
48954118|NCT03582033|157661022|FG003|Part B|Study terminated by sponsor|0|||
48954119|NCT03582033|157661023|FG004|Part B|Study terminated by sponsor|0|||
48954120|NCT03582033|157661024|FG005|Part B|Study terminated by sponsor|12|||
48954121|NCT03582033|157661025|FG006|Part B|Study terminated by sponsor|0|||
48954122|NCT03582033|157661026|FG007|Part B|Study terminated by sponsor|0|||
48954123|NCT03582033|157661027|FG008|Part B|Study terminated by sponsor|0|||
48954124|NCT03582033|157661028|FG009|Part B|Study terminated by sponsor|0|||
48747001|NCT00630396|156922874|FG000|Overall Study|Death|4|||
48747002|NCT00630396|156922874|FG000|Overall Study|Lost to Follow-up|3|||
48747003|NCT02155608|156922875|FG000|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0|||
48954125|NCT03582033|157661019|FG000|Part B|Withdrawal by Subject|0|||
48954126|NCT03582033|157661020|FG001|Part B|Withdrawal by Subject|0|||
48954127|NCT03582033|157661021|FG002|Part B|Withdrawal by Subject|0|||
48954128|NCT03582033|157661022|FG003|Part B|Withdrawal by Subject|0|||
48954129|NCT03582033|157661023|FG004|Part B|Withdrawal by Subject|0|||
48954130|NCT03582033|157661024|FG005|Part B|Withdrawal by Subject|6|||
48954131|NCT03582033|157661025|FG006|Part B|Withdrawal by Subject|0|||
48954132|NCT03582033|157661026|FG007|Part B|Withdrawal by Subject|0|||
48954133|NCT03582033|157661027|FG008|Part B|Withdrawal by Subject|0|||
48954134|NCT03582033|157661028|FG009|Part B|Withdrawal by Subject|0|||
48747004|NCT02155608|156922876|FG001|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1|||
48747005|NCT02155608|156922875|FG000|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
48954135|NCT03582033|157661019|FG000|Part C|Other|0|||
48954136|NCT03582033|157661020|FG001|Part C|Other|0|||
48954137|NCT03582033|157661021|FG002|Part C|Other|0|||
48954138|NCT03582033|157661022|FG003|Part C|Other|0|||
48954139|NCT03582033|157661023|FG004|Part C|Other|0|||
48954140|NCT03582033|157661024|FG005|Part C|Other|0|||
48954141|NCT03582033|157661025|FG006|Part C|Other|2|||
48954142|NCT03582033|157661026|FG007|Part C|Other|0|||
48954143|NCT03582033|157661027|FG008|Part C|Other|0|||
48954144|NCT03582033|157661028|FG009|Part C|Other|0|||
48954145|NCT03582033|157661019|FG000|Part C|Death|0|||
48954146|NCT03582033|157661020|FG001|Part C|Death|0|||
48954147|NCT03582033|157661021|FG002|Part C|Death|0|||
48954148|NCT03582033|157661022|FG003|Part C|Death|0|||
48954149|NCT03582033|157661023|FG004|Part C|Death|0|||
48954150|NCT03582033|157661024|FG005|Part C|Death|0|||
48954151|NCT03582033|157661025|FG006|Part C|Death|6|||
48954152|NCT03582033|157661026|FG007|Part C|Death|1|||
48954153|NCT03582033|157661027|FG008|Part C|Death|2|||
48954154|NCT03582033|157661028|FG009|Part C|Death|0|||
48954155|NCT03582033|157661019|FG000|Part C|Study terminated by sponsor|0|||
48954156|NCT03582033|157661020|FG001|Part C|Study terminated by sponsor|0|||
48954157|NCT03582033|157661021|FG002|Part C|Study terminated by sponsor|0|||
48954158|NCT03582033|157661022|FG003|Part C|Study terminated by sponsor|0|||
48954159|NCT03582033|157661023|FG004|Part C|Study terminated by sponsor|0|||
48954160|NCT03582033|157661024|FG005|Part C|Study terminated by sponsor|0|||
48954161|NCT03582033|157661025|FG006|Part C|Study terminated by sponsor|3|||
48954162|NCT03582033|157661026|FG007|Part C|Study terminated by sponsor|3|||
48954163|NCT03582033|157661027|FG008|Part C|Study terminated by sponsor|2|||
48954164|NCT03582033|157661028|FG009|Part C|Study terminated by sponsor|0|||
48954165|NCT03582033|157661019|FG000|Part C|Withdrawal by Subject|0|||
48954166|NCT03582033|157661020|FG001|Part C|Withdrawal by Subject|0|||
48954167|NCT03582033|157661021|FG002|Part C|Withdrawal by Subject|0|||
48954168|NCT03582033|157661022|FG003|Part C|Withdrawal by Subject|0|||
48954169|NCT03582033|157661023|FG004|Part C|Withdrawal by Subject|0|||
48954170|NCT03582033|157661024|FG005|Part C|Withdrawal by Subject|0|||
48954171|NCT03582033|157661025|FG006|Part C|Withdrawal by Subject|1|||
48954172|NCT03582033|157661026|FG007|Part C|Withdrawal by Subject|2|||
48954173|NCT03582033|157661027|FG008|Part C|Withdrawal by Subject|1|||
48954174|NCT03582033|157661028|FG009|Part C|Withdrawal by Subject|0|||
48954175|NCT03582033|157661019|FG000|Part D|Death|0|||
48954176|NCT03582033|157661020|FG001|Part D|Death|0|||
48954177|NCT03582033|157661021|FG002|Part D|Death|0|||
48954178|NCT03582033|157661022|FG003|Part D|Death|0|||
48954179|NCT03582033|157661023|FG004|Part D|Death|0|||
48954180|NCT03582033|157661024|FG005|Part D|Death|0|||
48954181|NCT03582033|157661025|FG006|Part D|Death|0|||
48954182|NCT03582033|157661026|FG007|Part D|Death|0|||
48954183|NCT03582033|157661027|FG008|Part D|Death|0|||
48954184|NCT03582033|157661028|FG009|Part D|Death|1|||
48954185|NCT03582033|157661019|FG000|Part D|Study terminated by sponsor|0|||
48954186|NCT03582033|157661020|FG001|Part D|Study terminated by sponsor|0|||
48954187|NCT03582033|157661021|FG002|Part D|Study terminated by sponsor|0|||
48954188|NCT03582033|157661022|FG003|Part D|Study terminated by sponsor|0|||
48954189|NCT03582033|157661023|FG004|Part D|Study terminated by sponsor|0|||
48954190|NCT03582033|157661024|FG005|Part D|Study terminated by sponsor|0|||
48954191|NCT03582033|157661025|FG006|Part D|Study terminated by sponsor|0|||
48954192|NCT03582033|157661026|FG007|Part D|Study terminated by sponsor|0|||
48954193|NCT03582033|157661027|FG008|Part D|Study terminated by sponsor|0|||
48954194|NCT03582033|157661028|FG009|Part D|Study terminated by sponsor|4|||
48954195|NCT03382899|157661031|FG000|Overall Study|Ineligibility Determined|0|||
48954196|NCT03382899|157661032|FG001|Overall Study|Ineligibility Determined|1|||
48954197|NCT03382899|157661031|FG000|Overall Study|Lost to Follow-up|0|||
48954198|NCT03382899|157661032|FG001|Overall Study|Lost to Follow-up|1|||
48954199|NCT03382899|157661031|FG000|Overall Study|Sponsor's decision|31|||
48954200|NCT03382899|157661032|FG001|Overall Study|Sponsor's decision|28|||
48954201|NCT03382899|157661031|FG000|Overall Study|Withdrawal by Subject|0|||
48954202|NCT03382899|157661032|FG001|Overall Study|Withdrawal by Subject|5|||
48954203|NCT02065869|157661033|FG000|Overall Study|Death|7|||
48954204|NCT02065869|157661033|FG000|Overall Study|Disease relapse|16|||
48954205|NCT02065869|157661033|FG000|Overall Study|Lost to Follow-up|4|||
48747006|NCT02155608|156922876|FG001|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
48747007|NCT02430311|156922877|FG000|Part A|Adverse Event|0|||
48747008|NCT02430311|156922878|FG001|Part A|Adverse Event|1|||
48747009|NCT02430311|156922877|FG000|Part A|Withdrawal by Subject|1|||
48954206|NCT02065869|157661033|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
48747010|NCT02430311|156922878|FG001|Part A|Withdrawal by Subject|0|||
48747011|NCT02430311|156922877|FG000|Part B|Meet study-specific withdrawal criteria|6|||
48747012|NCT02430311|156922878|FG001|Part B|Meet study-specific withdrawal criteria|6|||
48747013|NCT02430311|156922877|FG000|Part B|Withdrawal by Subject|2|||
48747014|NCT02430311|156922878|FG001|Part B|Withdrawal by Subject|2|||
48747015|NCT02430311|156922877|FG000|Part B|Adverse Event|1|||
48747016|NCT02430311|156922878|FG001|Part B|Adverse Event|0|||
48747017|NCT02430311|156922877|FG000|Part B|Death|1|||
48747018|NCT02430311|156922878|FG001|Part B|Death|0|||
48747019|NCT01153347|156922883|FG000|Overall Study|Withdrawal by Subject|7|||
48747020|NCT01153347|156922884|FG001|Overall Study|Withdrawal by Subject|7|||
48747021|NCT01153347|156922885|FG002|Overall Study|Withdrawal by Subject|7|||
48747022|NCT01153347|156922886|FG003|Overall Study|Withdrawal by Subject|7|||
48747023|NCT01153347|156922883|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
48747024|NCT01153347|156922884|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
48747025|NCT01153347|156922885|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
48747026|NCT01153347|156922886|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
48859915|NCT01180400|157325471|FG001|Overall Study|Condition under investigation worsened|1|||
48859916|NCT01180400|157325470|FG000|Overall Study|Lack of Efficacy|2|||
48747027|NCT01153347|156922883|FG000|Overall Study|Adverse Event|3|||
48747028|NCT01153347|156922884|FG001|Overall Study|Adverse Event|9|||
48747029|NCT01153347|156922885|FG002|Overall Study|Adverse Event|21|||
48747030|NCT01153347|156922886|FG003|Overall Study|Adverse Event|7|||
48747031|NCT01153347|156922883|FG000|Overall Study|Severe non-compliance to protocol|6|||
48859917|NCT01180400|157325471|FG001|Overall Study|Lack of Efficacy|0|||
48859918|NCT01180400|157325470|FG000|Overall Study|Study-specific withdrawal criteria|1|||
48859919|NCT01180400|157325471|FG001|Overall Study|Study-specific withdrawal criteria|2|||
48859920|NCT01180400|157325470|FG000|Overall Study|Lost to Follow-up|2|||
48859921|NCT01180400|157325471|FG001|Overall Study|Lost to Follow-up|3|||
48859922|NCT01180400|157325470|FG000|Overall Study|Other|0|||
48859923|NCT01180400|157325471|FG001|Overall Study|Other|1|||
48859924|NCT00472082|157325472|FG000|Overall Study|Study prematurely terminated|5|||
48859925|NCT02727998|157325473|FG000|Overall Study|Lost to Follow-up|3|||
48859926|NCT02727998|157325474|FG001|Overall Study|Lost to Follow-up|3|||
48859927|NCT02727998|157325473|FG000|Overall Study|Withdrawal by Subject|0|||
48859928|NCT02727998|157325474|FG001|Overall Study|Withdrawal by Subject|1|||
48859929|NCT05104242|157325479|FG000|Overall Study|Withdrawal by Subject|1|||
48859930|NCT05104242|157325480|FG001|Overall Study|Withdrawal by Subject|5|||
48859931|NCT05104242|157325479|FG000|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
48859932|NCT05104242|157325480|FG001|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
48859933|NCT00442559|157325481|FG000|Overall Study|Lost to Follow-up|32|||
48859934|NCT00442559|157325482|FG001|Overall Study|Lost to Follow-up|34|||
48859935|NCT00442559|157325481|FG000|Overall Study|Protocol Violation|1|||
48859936|NCT00442559|157325482|FG001|Overall Study|Protocol Violation|1|||
48859937|NCT00442559|157325481|FG000|Overall Study|Withdrawal by Subject|1|||
48859938|NCT00442559|157325482|FG001|Overall Study|Withdrawal by Subject|0|||
48859939|NCT04474691|157325483|FG000|Overall Study|Withdrawal by Subject|9|||
48859940|NCT00134056|157325484|FG000|Randomization|Not eligible for assigned treatment|22|||
48859941|NCT00134056|157325485|FG001|Randomization|Not eligible for assigned treatment|20|||
48859942|NCT00134056|157325484|FG000|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
48859943|NCT00134056|157325485|FG001|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
48747032|NCT01153347|156922884|FG001|Overall Study|Severe non-compliance to protocol|7|||
48747033|NCT01153347|156922885|FG002|Overall Study|Severe non-compliance to protocol|4|||
48747034|NCT01153347|156922886|FG003|Overall Study|Severe non-compliance to protocol|3|||
48859944|NCT00134056|157325484|FG000|Eligible for Protocol Assigned Treatment|Adverse Event|81|||
48859945|NCT00134056|157325485|FG001|Eligible for Protocol Assigned Treatment|Adverse Event|67|||
48747035|NCT01153347|156922883|FG000|Overall Study|Condition under investigation worsened|1|||
48747036|NCT01153347|156922884|FG001|Overall Study|Condition under investigation worsened|1|||
48747037|NCT01153347|156922885|FG002|Overall Study|Condition under investigation worsened|0|||
48747038|NCT01153347|156922886|FG003|Overall Study|Condition under investigation worsened|0|||
48747039|NCT01153347|156922883|FG000|Overall Study|Lack of Efficacy|2|||
48747040|NCT01153347|156922884|FG001|Overall Study|Lack of Efficacy|2|||
48747041|NCT01153347|156922885|FG002|Overall Study|Lack of Efficacy|0|||
48747042|NCT01153347|156922886|FG003|Overall Study|Lack of Efficacy|4|||
48747043|NCT01153347|156922883|FG000|Overall Study|Study-specific withdrawal criteria|4|||
48747044|NCT01153347|156922884|FG001|Overall Study|Study-specific withdrawal criteria|3|||
48747045|NCT01153347|156922885|FG002|Overall Study|Study-specific withdrawal criteria|1|||
48747046|NCT01153347|156922886|FG003|Overall Study|Study-specific withdrawal criteria|2|||
48747047|NCT01153347|156922883|FG000|Overall Study|Lost to Follow-up|4|||
48747048|NCT01153347|156922884|FG001|Overall Study|Lost to Follow-up|9|||
48747049|NCT01153347|156922885|FG002|Overall Study|Lost to Follow-up|11|||
48747050|NCT01153347|156922886|FG003|Overall Study|Lost to Follow-up|8|||
48747051|NCT01153347|156922883|FG000|Overall Study|Other|5|||
48747052|NCT01153347|156922884|FG001|Overall Study|Other|5|||
48747053|NCT01153347|156922885|FG002|Overall Study|Other|4|||
48747054|NCT01153347|156922886|FG003|Overall Study|Other|0|||
48747055|NCT01153347|156922883|FG000|Overall Study|Death|1|||
48747056|NCT01153347|156922884|FG001|Overall Study|Death|0|||
48747057|NCT01153347|156922885|FG002|Overall Study|Death|0|||
48747058|NCT01153347|156922886|FG003|Overall Study|Death|0|||
48747059|NCT02835820|156922887|FG000|Overall Study|Baseline Screen Failure|0|||
48747060|NCT02835820|156922888|FG001|Overall Study|Baseline Screen Failure|3|||
48747061|NCT01396148|156922891|FG000|Overall Study|Patient Decision|1|||
48747062|NCT00840450|156922892|FG000|Overall Study|Adverse Event|1|||
48747063|NCT00840450|156922892|FG000|Overall Study|Lack of Efficacy|2|||
48747064|NCT02495168|156922893|FG000|Overall Study|Other than Specified|18|||
48747065|NCT02495168|156922894|FG001|Overall Study|Other than Specified|22|||
48747066|NCT02495168|156922895|FG002|Overall Study|Other than Specified|5|||
48747067|NCT02495168|156922893|FG000|Overall Study|Did not Complete Final Visit On Time|4|||
48747068|NCT02495168|156922894|FG001|Overall Study|Did not Complete Final Visit On Time|3|||
48747069|NCT02495168|156922895|FG002|Overall Study|Did not Complete Final Visit On Time|2|||
48747070|NCT02495168|156922893|FG000|Overall Study|Physician Decision|1|||
48747071|NCT02495168|156922894|FG001|Overall Study|Physician Decision|1|||
48747072|NCT02495168|156922895|FG002|Overall Study|Physician Decision|0|||
48859946|NCT00134056|157325484|FG000|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20|||
48859947|NCT00134056|157325485|FG001|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21|||
48859948|NCT00134056|157325484|FG000|Eligible for Protocol Assigned Treatment|Other|55|||
48859949|NCT00134056|157325485|FG001|Eligible for Protocol Assigned Treatment|Other|56|||
48859950|NCT01426217|157325486|FG000|Overall Study|lost sample|8|||
48859951|NCT01426217|157325487|FG001|Overall Study|lost sample|14|||
48859952|NCT02588027|157325491|FG000|Overall Study|Withdrawal by Subject|1|||
48859953|NCT02588027|157325492|FG001|Overall Study|Withdrawal by Subject|3|||
48859954|NCT02588027|157325491|FG000|Overall Study|Protocol Violation|4|||
48859955|NCT02588027|157325492|FG001|Overall Study|Protocol Violation|1|||
48859956|NCT04189224|157325493|FG000|Period 2|Adverse Event|0|||
48859957|NCT04189224|157325494|FG001|Period 2|Adverse Event|1|||
48859958|NCT03562117|157325500|FG000|Part 1, Up to 3 Days|Adverse Event|1|||
48859959|NCT03562117|157325501|FG001|Part 1, Up to 3 Days|Adverse Event|0|||
48859960|NCT03562117|157325502|FG002|Part 1, Up to 3 Days|Adverse Event|0|||
48859961|NCT03928821|157325503|FG000|Overall Study|Death|0|||
48859962|NCT03928821|157325504|FG001|Overall Study|Death|1|||
48859963|NCT03928821|157325505|FG002|Overall Study|Death|0|||
48859964|NCT03928821|157325506|FG003|Overall Study|Death|0|||
48859965|NCT03928821|157325503|FG000|Overall Study|Lost to Follow-up|0|||
48859966|NCT03928821|157325504|FG001|Overall Study|Lost to Follow-up|2|||
48859967|NCT03928821|157325505|FG002|Overall Study|Lost to Follow-up|3|||
48859968|NCT03928821|157325506|FG003|Overall Study|Lost to Follow-up|0|||
48859969|NCT03928821|157325503|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
48859970|NCT03928821|157325504|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
48859971|NCT03928821|157325505|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
48859972|NCT03928821|157325506|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
48859973|NCT01911819|157325507|FG000|Overall Study|Adverse Event|0|||
48859974|NCT01911819|157325508|FG001|Overall Study|Adverse Event|1|||
48859975|NCT01911819|157325509|FG002|Overall Study|Adverse Event|0|||
48859976|NCT01911819|157325507|FG000|Overall Study|Withdrawal by Subject|1|||
48859977|NCT01911819|157325508|FG001|Overall Study|Withdrawal by Subject|1|||
48859978|NCT01911819|157325509|FG002|Overall Study|Withdrawal by Subject|0|||
48859979|NCT00595764|157325510|FG000|Overall Study|Protocol Violation|24|||
48859980|NCT00595764|157325511|FG001|Overall Study|Protocol Violation|19|||
48859981|NCT00595764|157325510|FG000|Overall Study|Missed Medication >1 week|10|||
48859982|NCT00595764|157325511|FG001|Overall Study|Missed Medication >1 week|17|||
48747073|NCT02495168|156922893|FG000|Overall Study|Lost to Follow-up|10|||
48747074|NCT02495168|156922894|FG001|Overall Study|Lost to Follow-up|6|||
48747075|NCT02495168|156922895|FG002|Overall Study|Lost to Follow-up|1|||
48747076|NCT02495168|156922893|FG000|Overall Study|Withdrawal by Subject|1|||
48747077|NCT02495168|156922894|FG001|Overall Study|Withdrawal by Subject|4|||
48747078|NCT02495168|156922895|FG002|Overall Study|Withdrawal by Subject|2|||
48747079|NCT02495168|156922893|FG000|Overall Study|Protocol Violation|0|||
48747080|NCT02495168|156922894|FG001|Overall Study|Protocol Violation|10|||
48747081|NCT02495168|156922895|FG002|Overall Study|Protocol Violation|1|||
48747082|NCT02495168|156922893|FG000|Overall Study|Adverse Event|4|||
48747083|NCT02495168|156922894|FG001|Overall Study|Adverse Event|8|||
48747084|NCT02495168|156922895|FG002|Overall Study|Adverse Event|3|||
48747085|NCT02495168|156922893|FG000|Overall Study|Lack of Efficacy|0|||
48747086|NCT02495168|156922894|FG001|Overall Study|Lack of Efficacy|0|||
48747087|NCT02495168|156922895|FG002|Overall Study|Lack of Efficacy|3|||
48747088|NCT00133952|156922896|FG000|Overall Study|Adverse Event|1|||
48747089|NCT00133952|156922897|FG001|Overall Study|Adverse Event|2|||
48747090|NCT00133952|156922896|FG000|Overall Study|Death|3|||
48747091|NCT00133952|156922897|FG001|Overall Study|Death|2|||
48747092|NCT00133952|156922896|FG000|Overall Study|Lost to Follow-up|9|||
48747093|NCT00133952|156922897|FG001|Overall Study|Lost to Follow-up|14|||
48747094|NCT00133952|156922896|FG000|Overall Study|Protocol Entry Criteria Exclusion|4|||
48747095|NCT00133952|156922897|FG001|Overall Study|Protocol Entry Criteria Exclusion|1|||
48747096|NCT00133952|156922896|FG000|Overall Study|Protocol Violation|1|||
48747097|NCT00133952|156922897|FG001|Overall Study|Protocol Violation|1|||
48747098|NCT00133952|156922896|FG000|Overall Study|Withdrawal by Subject|20|||
48954207|NCT02065869|157661033|FG000|Overall Study|Withdrawal by Subject|1|||
48747099|NCT00133952|156922897|FG001|Overall Study|Withdrawal by Subject|4|||
48747100|NCT00133952|156922896|FG000|Overall Study|Physician Decision|4|||
48747101|NCT00133952|156922897|FG001|Overall Study|Physician Decision|3|||
48747102|NCT00133952|156922896|FG000|Overall Study|Sponsor Decision|0|||
48747103|NCT00133952|156922897|FG001|Overall Study|Sponsor Decision|1|||
48747104|NCT00727025|156922902|FG000|Overall Study|Physician Decision|23|||
48747105|NCT00964860|156922903|FG000|Overall Study|Withdrawal by Subject|0|||
48747106|NCT00964860|156922904|FG001|Overall Study|Withdrawal by Subject|1|||
48747107|NCT02585960|156922905|FG000|PK/Safety Assessment Period|Physician Decision|0|||
48954208|NCT00850460|157661038|FG000|Overall Study|Lost to Follow-up|4|||
48747108|NCT02585960|156922906|FG001|PK/Safety Assessment Period|Physician Decision|1|||
48747109|NCT02585960|156922907|FG002|PK/Safety Assessment Period|Physician Decision|0|||
48859983|NCT00595764|157325510|FG000|Overall Study|Missed 3 PM visits|1|||
48859984|NCT00595764|157325511|FG001|Overall Study|Missed 3 PM visits|7|||
48859985|NCT00595764|157325510|FG000|Overall Study|Withdrawal by Subject|4|||
48859986|NCT00595764|157325511|FG001|Overall Study|Withdrawal by Subject|0|||
48859987|NCT00905255|157325512|FG000|Overall Study|Adverse Event|7|||
48859988|NCT00905255|157325513|FG001|Overall Study|Adverse Event|5|||
48859989|NCT00905255|157325512|FG000|Overall Study|Withdrawal by Subject|5|||
48859990|NCT00905255|157325513|FG001|Overall Study|Withdrawal by Subject|4|||
48859991|NCT00905255|157325512|FG000|Overall Study|Familial and Personal Reasons|1|||
48859992|NCT00905255|157325513|FG001|Overall Study|Familial and Personal Reasons|0|||
48859993|NCT01528605|157325514|FG000|Overall Study|Lost to Follow-up|1|||
48859994|NCT01528605|157325515|FG001|Overall Study|Lost to Follow-up|0|||
48859995|NCT01528605|157325516|FG002|Overall Study|Lost to Follow-up|1|||
48859996|NCT01528605|157325517|FG003|Overall Study|Lost to Follow-up|1|||
48859997|NCT01528605|157325518|FG004|Overall Study|Lost to Follow-up|0|||
48859998|NCT01528605|157325519|FG005|Overall Study|Lost to Follow-up|0|||
48859999|NCT01528605|157325514|FG000|Overall Study|Death|1|||
48860000|NCT01528605|157325515|FG001|Overall Study|Death|0|||
48860001|NCT01528605|157325516|FG002|Overall Study|Death|0|||
48860002|NCT01528605|157325517|FG003|Overall Study|Death|0|||
48860003|NCT01528605|157325518|FG004|Overall Study|Death|0|||
48860004|NCT01528605|157325519|FG005|Overall Study|Death|0|||
48860005|NCT02389894|157325520|FG000|Overall Study|Death|4|||
48860006|NCT02389894|157325521|FG001|Overall Study|Death|5|||
48860007|NCT02389894|157325522|FG002|Overall Study|Death|3|||
48860008|NCT02389894|157325520|FG000|Overall Study|Withdrawal by Subject|2|||
48860009|NCT02389894|157325521|FG001|Overall Study|Withdrawal by Subject|4|||
48860010|NCT02389894|157325522|FG002|Overall Study|Withdrawal by Subject|5|||
48860011|NCT02389894|157325520|FG000|Overall Study|Lost to Follow-up|2|||
48860012|NCT02389894|157325521|FG001|Overall Study|Lost to Follow-up|1|||
48860013|NCT02389894|157325522|FG002|Overall Study|Lost to Follow-up|1|||
48860014|NCT02312245|157325523|FG000|Overall Study|Death|0|||
48860015|NCT02312245|157325524|FG001|Overall Study|Death|0|||
48860016|NCT02312245|157325525|FG002|Overall Study|Death|0|||
48860017|NCT02312245|157325526|FG003|Overall Study|Death|1|||
48860018|NCT02312245|157325523|FG000|Overall Study|Withdrawal by Subject|1|||
48860019|NCT02312245|157325524|FG001|Overall Study|Withdrawal by Subject|1|||
48860020|NCT02312245|157325525|FG002|Overall Study|Withdrawal by Subject|0|||
48860021|NCT02312245|157325526|FG003|Overall Study|Withdrawal by Subject|2|||
48860022|NCT02312245|157325523|FG000|Overall Study|Alternative Therapy|1|||
48860023|NCT02312245|157325524|FG001|Overall Study|Alternative Therapy|0|||
48860024|NCT02312245|157325525|FG002|Overall Study|Alternative Therapy|0|||
48860025|NCT02312245|157325526|FG003|Overall Study|Alternative Therapy|0|||
48860026|NCT02312245|157325523|FG000|Overall Study|Progression|0|||
48860027|NCT02312245|157325524|FG001|Overall Study|Progression|0|||
48860028|NCT02312245|157325525|FG002|Overall Study|Progression|0|||
48860029|NCT02312245|157325526|FG003|Overall Study|Progression|5|||
48860030|NCT02312245|157325523|FG000|Overall Study|Patient went to hospice|0|||
48860031|NCT02312245|157325524|FG001|Overall Study|Patient went to hospice|0|||
48860032|NCT02312245|157325525|FG002|Overall Study|Patient went to hospice|0|||
48860033|NCT02312245|157325526|FG003|Overall Study|Patient went to hospice|1|||
48860034|NCT02312245|157325523|FG000|Overall Study|Ineligible|1|||
48860035|NCT02312245|157325524|FG001|Overall Study|Ineligible|0|||
48860036|NCT02312245|157325525|FG002|Overall Study|Ineligible|0|||
48860037|NCT02312245|157325526|FG003|Overall Study|Ineligible|0|||
48860038|NCT02548585|157325529|FG000|Overall Study|Withdrawal by Subject|0|||
48860039|NCT02548585|157325530|FG001|Overall Study|Withdrawal by Subject|0|||
48860040|NCT02548585|157325531|FG002|Overall Study|Withdrawal by Subject|0|||
48860041|NCT02548585|157325532|FG003|Overall Study|Withdrawal by Subject|0|||
48860042|NCT02548585|157325533|FG004|Overall Study|Withdrawal by Subject|0|||
48860043|NCT02548585|157325534|FG005|Overall Study|Withdrawal by Subject|1|||
48860044|NCT02548585|157325535|FG006|Overall Study|Withdrawal by Subject|0|||
48860045|NCT02548585|157325529|FG000|Overall Study|Lost to Follow-up|1|||
48860046|NCT02548585|157325530|FG001|Overall Study|Lost to Follow-up|0|||
48860047|NCT02548585|157325531|FG002|Overall Study|Lost to Follow-up|0|||
48860048|NCT02548585|157325532|FG003|Overall Study|Lost to Follow-up|0|||
48860049|NCT02548585|157325533|FG004|Overall Study|Lost to Follow-up|0|||
48860050|NCT02548585|157325534|FG005|Overall Study|Lost to Follow-up|0|||
48860051|NCT02548585|157325535|FG006|Overall Study|Lost to Follow-up|0|||
48860052|NCT02548585|157325529|FG000|Overall Study|Other|1|||
48860053|NCT02548585|157325530|FG001|Overall Study|Other|0|||
48860054|NCT02548585|157325531|FG002|Overall Study|Other|0|||
48860055|NCT02548585|157325532|FG003|Overall Study|Other|2|||
48860056|NCT02548585|157325533|FG004|Overall Study|Other|3|||
48860057|NCT02548585|157325534|FG005|Overall Study|Other|0|||
48860058|NCT02548585|157325535|FG006|Overall Study|Other|1|||
48860059|NCT02548585|157325529|FG000|Overall Study|Randomized but not treated|0|||
48860060|NCT02548585|157325530|FG001|Overall Study|Randomized but not treated|0|||
48860061|NCT02548585|157325531|FG002|Overall Study|Randomized but not treated|0|||
48860062|NCT02548585|157325532|FG003|Overall Study|Randomized but not treated|0|||
48860063|NCT02548585|157325533|FG004|Overall Study|Randomized but not treated|0|||
48860064|NCT02548585|157325534|FG005|Overall Study|Randomized but not treated|1|||
48860065|NCT02548585|157325535|FG006|Overall Study|Randomized but not treated|0|||
48860066|NCT00535626|157326853|FG000|Overall Study|Death|15|||
48860067|NCT00535626|157326853|FG000|Overall Study|Lost to Follow-up|29|||
48860068|NCT00535626|157326853|FG000|Overall Study|Withdrawal by Subject|20|||
48860069|NCT00535626|157326853|FG000|Overall Study|Removal/revision of study component|8|||
48860070|NCT00535626|157326853|FG000|Overall Study|Subject terminated|31|||
48860071|NCT00535626|157326853|FG000|Overall Study|Unable to return|2|||
48860072|NCT02121808|157326857|FG000|Overall Study|Technical problem|3|||
48860073|NCT01562275|157326858|FG000|Stage 1|Adverse Event|0|||
48860074|NCT01562275|157326859|FG001|Stage 1|Adverse Event|0|||
48860075|NCT01562275|157326860|FG002|Stage 1|Adverse Event|0|||
48860076|NCT01562275|157326861|FG003|Stage 1|Adverse Event|1|||
48860077|NCT01562275|157326862|FG004|Stage 1|Adverse Event|1|||
48860078|NCT01562275|157326863|FG005|Stage 1|Adverse Event|0|||
48860079|NCT01562275|157326864|FG006|Stage 1|Adverse Event|0|||
48860080|NCT01562275|157326865|FG007|Stage 1|Adverse Event|0|||
48860081|NCT01562275|157326866|FG008|Stage 1|Adverse Event|0|||
48860082|NCT01562275|157326867|FG009|Stage 1|Adverse Event|1|||
48860083|NCT01562275|157326868|FG010|Stage 1|Adverse Event|0|||
48860084|NCT01562275|157326869|FG011|Stage 1|Adverse Event|0|||
48860085|NCT01562275|157326870|FG012|Stage 1|Adverse Event|0|||
48860086|NCT01562275|157326858|FG000|Stage 1|Death|1|||
48860087|NCT01562275|157326859|FG001|Stage 1|Death|0|||
48860088|NCT01562275|157326860|FG002|Stage 1|Death|0|||
48860089|NCT01562275|157326861|FG003|Stage 1|Death|0|||
48860090|NCT01562275|157326862|FG004|Stage 1|Death|0|||
48860091|NCT01562275|157326863|FG005|Stage 1|Death|0|||
48860092|NCT01562275|157326864|FG006|Stage 1|Death|0|||
48860093|NCT01562275|157326865|FG007|Stage 1|Death|0|||
48860094|NCT01562275|157326866|FG008|Stage 1|Death|0|||
48860095|NCT01562275|157326867|FG009|Stage 1|Death|0|||
48860096|NCT01562275|157326868|FG010|Stage 1|Death|0|||
48860097|NCT01562275|157326869|FG011|Stage 1|Death|0|||
48747110|NCT02585960|156922905|FG000|PK/Safety Assessment Period|Withdrawal by Subject|1|||
48747111|NCT02585960|156922906|FG001|PK/Safety Assessment Period|Withdrawal by Subject|2|||
48747112|NCT02585960|156922907|FG002|PK/Safety Assessment Period|Withdrawal by Subject|5|||
48747113|NCT02585960|156922905|FG000|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
48747114|NCT02585960|156922906|FG001|PK/Safety Assessment Period|Non-compliance to study procedures|2|||
48747115|NCT02585960|156922907|FG002|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
48747116|NCT02585960|156922905|FG000|PK/Safety Assessment Period|Other|4|||
48747117|NCT02585960|156922906|FG001|PK/Safety Assessment Period|Other|4|||
48747118|NCT02585960|156922907|FG002|PK/Safety Assessment Period|Other|0|||
48747119|NCT02585960|156922905|FG000|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
48747120|NCT02585960|156922906|FG001|PK/Safety Assessment Period|Withdrawn by sponsor|1|||
48747121|NCT02585960|156922907|FG002|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
48747122|NCT02585960|156922905|FG000|PK/Safety Assessment Period|Screen Failure|0|||
48747123|NCT02585960|156922906|FG001|PK/Safety Assessment Period|Screen Failure|0|||
48747124|NCT02585960|156922907|FG002|PK/Safety Assessment Period|Screen Failure|1|||
48747125|NCT02585960|156922905|FG000|Prophylactic Treatment Period|Major protocol deviation|0|||
48747126|NCT02585960|156922906|FG001|Prophylactic Treatment Period|Major protocol deviation|4|||
48747127|NCT02585960|156922907|FG002|Prophylactic Treatment Period|Major protocol deviation|0|||
48747128|NCT02585960|156922905|FG000|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
48747129|NCT02585960|156922906|FG001|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1|||
48747130|NCT02585960|156922907|FG002|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
48747131|NCT02509156|156922908|FG000|Randomized Phase|Death|1|||
48747132|NCT02509156|156922909|FG001|Randomized Phase|Death|0|||
48747133|NCT02509156|156922908|FG000|Randomized Phase|Withdrawal by Subject|1|||
48747134|NCT02509156|156922909|FG001|Randomized Phase|Withdrawal by Subject|1|||
48747135|NCT01083576|156922910|FG000|Overall Study|Treatment Failure|6|||
48747136|NCT01083576|156922911|FG001|Overall Study|Treatment Failure|1|||
48860098|NCT01562275|157326870|FG012|Stage 1|Death|0|||
48860099|NCT01562275|157326858|FG000|Stage 1|Non Compliance|0|||
48860100|NCT01562275|157326859|FG001|Stage 1|Non Compliance|0|||
48954209|NCT00850460|157661039|FG001|Overall Study|Lost to Follow-up|4|||
48747137|NCT01539538|156922922|FG000|Overall Study|Adverse Event|13|||
48747138|NCT01539538|156922923|FG001|Overall Study|Adverse Event|18|||
48860101|NCT01562275|157326860|FG002|Stage 1|Non Compliance|1|||
48860102|NCT01562275|157326861|FG003|Stage 1|Non Compliance|0|||
48860103|NCT01562275|157326862|FG004|Stage 1|Non Compliance|0|||
48954210|NCT00524745|157661040|FG000|Overall Study|subject withdrawal or lost to follow up|34|||
48860104|NCT01562275|157326863|FG005|Stage 1|Non Compliance|0|||
48860105|NCT01562275|157326864|FG006|Stage 1|Non Compliance|0|||
48860106|NCT01562275|157326865|FG007|Stage 1|Non Compliance|0|||
48860107|NCT01562275|157326866|FG008|Stage 1|Non Compliance|0|||
48860108|NCT01562275|157326867|FG009|Stage 1|Non Compliance|0|||
48860109|NCT01562275|157326868|FG010|Stage 1|Non Compliance|0|||
48860110|NCT01562275|157326869|FG011|Stage 1|Non Compliance|0|||
48860111|NCT01562275|157326870|FG012|Stage 1|Non Compliance|0|||
48860112|NCT01562275|157326858|FG000|Stage 1|Physician Decision|0|||
48747139|NCT01539538|156922922|FG000|Overall Study|Lack of Efficacy|13|||
48747140|NCT01539538|156922923|FG001|Overall Study|Lack of Efficacy|16|||
48747141|NCT01539538|156922922|FG000|Overall Study|Withdrawal by Subject|2|||
48747142|NCT01539538|156922923|FG001|Overall Study|Withdrawal by Subject|3|||
48747143|NCT01539538|156922922|FG000|Overall Study|PCA no longer required or PCA problem|3|||
48747144|NCT01539538|156922923|FG001|Overall Study|PCA no longer required or PCA problem|7|||
48747145|NCT01727297|156922924|FG000|Overall Study|Death|13|||
48747146|NCT01727297|156922925|FG001|Overall Study|Death|0|||
48747147|NCT01727297|156922924|FG000|Overall Study|Protocol Violation|1|||
48747148|NCT01727297|156922925|FG001|Overall Study|Protocol Violation|10|||
48747149|NCT01727297|156922924|FG000|Overall Study|Adverse Event|3|||
48747150|NCT01727297|156922925|FG001|Overall Study|Adverse Event|1|||
48747151|NCT01727297|156922924|FG000|Overall Study|Lost to Follow-up|11|||
48747152|NCT01727297|156922925|FG001|Overall Study|Lost to Follow-up|0|||
48747153|NCT01727297|156922924|FG000|Overall Study|Withdrawal by Subject|26|||
48747154|NCT01727297|156922925|FG001|Overall Study|Withdrawal by Subject|27|||
48747155|NCT01727297|156922924|FG000|Overall Study|Physician Decision|19|||
48747156|NCT01727297|156922925|FG001|Overall Study|Physician Decision|5|||
48747157|NCT01727297|156922924|FG000|Overall Study|Other (e.g. AF detection pre-implant)|29|||
48747158|NCT01727297|156922925|FG001|Overall Study|Other (e.g. AF detection pre-implant)|8|||
48747159|NCT01192516|156922926|FG000|Overall Study|Lost to Follow-up|7|||
48747160|NCT01192516|156922927|FG001|Overall Study|Lost to Follow-up|10|||
48747161|NCT01192516|156922928|FG002|Overall Study|Lost to Follow-up|7|||
48747162|NCT01192516|156922926|FG000|Overall Study|Withdrawal by Subject|4|||
48747163|NCT01192516|156922927|FG001|Overall Study|Withdrawal by Subject|4|||
48747164|NCT01192516|156922928|FG002|Overall Study|Withdrawal by Subject|1|||
48747165|NCT01192516|156922926|FG000|Overall Study|started new treatment|5|||
48747166|NCT01192516|156922927|FG001|Overall Study|started new treatment|1|||
48747167|NCT01192516|156922928|FG002|Overall Study|started new treatment|0|||
48747168|NCT01192516|156922926|FG000|Overall Study|Unable to follow Actiwatch instructions|4|||
48954211|NCT00524745|157661041|FG001|Overall Study|subject withdrawal or lost to follow up|13|||
48954212|NCT00524745|157661042|FG002|Overall Study|subject withdrawal or lost to follow up|29|||
48954213|NCT00524745|157661043|FG003|Overall Study|subject withdrawal or lost to follow up|22|||
48747169|NCT01192516|156922927|FG001|Overall Study|Unable to follow Actiwatch instructions|2|||
48954214|NCT01842620|157661044|FG000|Period 1|Withdrawal by Subject|1|||
48747170|NCT01192516|156922928|FG002|Overall Study|Unable to follow Actiwatch instructions|0|||
48954215|NCT01842620|157661045|FG001|Period 1|Withdrawal by Subject|0|||
48954216|NCT04229446|157661046|FG000|Overall Study|Death|12|||
48954217|NCT04229446|157661047|FG001|Overall Study|Death|10|||
48954218|NCT04229446|157661046|FG000|Overall Study|Lost to Follow-up|5|||
48954219|NCT04229446|157661047|FG001|Overall Study|Lost to Follow-up|8|||
48954220|NCT00256867|157661048|FG000|Overall Study|Adverse Event|0|||
48954221|NCT00256867|157661049|FG001|Overall Study|Adverse Event|1|||
48954222|NCT00256867|157661050|FG002|Overall Study|Adverse Event|1|||
48954223|NCT00256867|157661051|FG003|Overall Study|Adverse Event|1|||
48954224|NCT00256867|157661052|FG004|Overall Study|Adverse Event|2|||
48954225|NCT00256867|157661053|FG005|Overall Study|Adverse Event|2|||
48954226|NCT00256867|157661054|FG006|Overall Study|Adverse Event|1|||
48954227|NCT00256867|157661055|FG007|Overall Study|Adverse Event|4|||
48954228|NCT00256867|157661048|FG000|Overall Study|Lost to Follow-up|2|||
48954229|NCT00256867|157661049|FG001|Overall Study|Lost to Follow-up|2|||
48954230|NCT00256867|157661050|FG002|Overall Study|Lost to Follow-up|2|||
48747171|NCT03782792|156922931|FG000|Overall Study|Patient left the country|0|||
48747172|NCT03782792|156922932|FG001|Overall Study|Patient left the country|1|||
48954231|NCT00256867|157661051|FG003|Overall Study|Lost to Follow-up|3|||
48954232|NCT00256867|157661052|FG004|Overall Study|Lost to Follow-up|2|||
48954233|NCT00256867|157661053|FG005|Overall Study|Lost to Follow-up|0|||
48954234|NCT00256867|157661054|FG006|Overall Study|Lost to Follow-up|1|||
48747173|NCT03782792|156922931|FG000|Overall Study|Withdrawal by Subject|1|||
48747174|NCT03782792|156922932|FG001|Overall Study|Withdrawal by Subject|2|||
48954235|NCT00256867|157661055|FG007|Overall Study|Lost to Follow-up|2|||
48954236|NCT00256867|157661048|FG000|Overall Study|Protocol Violation|0|||
48747175|NCT04649060|156922933|FG000|Arm A/Arm B Treatment|Adverse Event|0|||
48747176|NCT04649060|156922934|FG001|Arm A/Arm B Treatment|Adverse Event|3|||
48747177|NCT04649060|156922933|FG000|Arm A/Arm B Treatment|Physician Decision|1|||
48747178|NCT04649060|156922934|FG001|Arm A/Arm B Treatment|Physician Decision|1|||
48747179|NCT04649060|156922933|FG000|Arm A/Arm B Treatment|Progressive Disease|3|||
48747180|NCT04649060|156922934|FG001|Arm A/Arm B Treatment|Progressive Disease|12|||
48747181|NCT04649060|156922933|FG000|Arm A/Arm B Treatment|Study Terminated by Sponsor|17|||
48860113|NCT01562275|157326859|FG001|Stage 1|Physician Decision|0|||
48860114|NCT01562275|157326860|FG002|Stage 1|Physician Decision|0|||
48860115|NCT01562275|157326861|FG003|Stage 1|Physician Decision|0|||
48860116|NCT01562275|157326862|FG004|Stage 1|Physician Decision|1|||
48860117|NCT01562275|157326863|FG005|Stage 1|Physician Decision|0|||
48860118|NCT01562275|157326864|FG006|Stage 1|Physician Decision|1|||
48860119|NCT01562275|157326865|FG007|Stage 1|Physician Decision|0|||
48860120|NCT01562275|157326866|FG008|Stage 1|Physician Decision|1|||
48860121|NCT01562275|157326867|FG009|Stage 1|Physician Decision|0|||
48860122|NCT01562275|157326868|FG010|Stage 1|Physician Decision|0|||
48860123|NCT01562275|157326869|FG011|Stage 1|Physician Decision|0|||
48860124|NCT01562275|157326870|FG012|Stage 1|Physician Decision|0|||
48860125|NCT01562275|157326858|FG000|Stage 1|Progression of Disease|2|||
48860126|NCT01562275|157326859|FG001|Stage 1|Progression of Disease|6|||
48860127|NCT01562275|157326860|FG002|Stage 1|Progression of Disease|2|||
48860128|NCT01562275|157326861|FG003|Stage 1|Progression of Disease|1|||
48860129|NCT01562275|157326862|FG004|Stage 1|Progression of Disease|2|||
48860130|NCT01562275|157326863|FG005|Stage 1|Progression of Disease|4|||
48860131|NCT01562275|157326864|FG006|Stage 1|Progression of Disease|1|||
48860132|NCT01562275|157326865|FG007|Stage 1|Progression of Disease|7|||
48747182|NCT04649060|156922934|FG001|Arm A/Arm B Treatment|Study Terminated by Sponsor|10|||
48747183|NCT04649060|156922933|FG000|Arm A/Arm B Treatment|Patient Request|1|||
48747184|NCT04649060|156922934|FG001|Arm A/Arm B Treatment|Patient Request|0|||
48747185|NCT04649060|156922933|FG000|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|4|||
48747186|NCT04649060|156922934|FG001|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|1|||
48747187|NCT04649060|156922933|FG000|Arm A/Arm B Treatment|Other|1|||
48747188|NCT04649060|156922934|FG001|Arm A/Arm B Treatment|Other|0|||
48747189|NCT04649060|156922933|FG000|Crossover (Arm B)|Adverse Event|0|||
48747190|NCT04649060|156922934|FG001|Crossover (Arm B)|Adverse Event|1|||
48747191|NCT04649060|156922933|FG000|Crossover (Arm B)|Lost to Follow-up|0|||
48747192|NCT04649060|156922934|FG001|Crossover (Arm B)|Lost to Follow-up|1|||
48747193|NCT01243892|156922942|FG000|Overall Study|Did not meet eligibility criteria|2|||
48747194|NCT01243892|156922943|FG001|Overall Study|Did not meet eligibility criteria|0|||
48747195|NCT01051323|156922944|FG000|Overall Study|Discontinuation of treatment|103|||
48747196|NCT01051323|156922944|FG000|Overall Study|Transplantation|28|||
48747197|NCT01051323|156922944|FG000|Overall Study|Dialysis dependency|22|||
48747198|NCT01051323|156922944|FG000|Overall Study|Withdrawal by Subject|13|||
48747199|NCT01051323|156922944|FG000|Overall Study|Lost to Follow-up|31|||
48747200|NCT01051323|156922944|FG000|Overall Study|Death|129|||
48747201|NCT01051323|156922944|FG000|Overall Study|Hospitalization|28|||
48747202|NCT01051323|156922944|FG000|Overall Study|Other|148|||
48747203|NCT01051323|156922944|FG000|Overall Study|Missing|37|||
48747204|NCT00582166|156922945|FG000|Overall Study|Death|1|||
48747205|NCT00582166|156922945|FG000|Overall Study|Ineligible pathology|1|||
48747206|NCT03706456|156922954|FG000|Overall Study|Adverse Event|1|||
48747207|NCT03706456|156922954|FG000|Overall Study|Lack of Efficacy|2|||
48747208|NCT02695329|156922956|FG000|Overall Study|Adverse Event|1|||
48747209|NCT02695329|156922957|FG001|Overall Study|Adverse Event|0|||
48747210|NCT02695329|156922956|FG000|Overall Study|Poor X-ray quality for measurement|4|||
48747211|NCT02695329|156922957|FG001|Overall Study|Poor X-ray quality for measurement|5|||
48747212|NCT00074152|156922958|FG000|Overall Study|Death|21|||
48747213|NCT00074152|156922959|FG001|Overall Study|Death|9|||
48747214|NCT00074152|156922958|FG000|Overall Study|Lack of Efficacy|34|||
48747215|NCT00074152|156922959|FG001|Overall Study|Lack of Efficacy|24|||
48747216|NCT02006719|156922960|FG000|Overall Study|Withdrawal by Subject|10|||
48747217|NCT02006719|156922961|FG001|Overall Study|Withdrawal by Subject|2|||
48747218|NCT02006719|156922960|FG000|Overall Study|Lost to Follow-up|5|||
48747219|NCT02006719|156922961|FG001|Overall Study|Lost to Follow-up|1|||
48747220|NCT02006719|156922960|FG000|Overall Study|Protocol Violation|2|||
48747221|NCT02006719|156922961|FG001|Overall Study|Protocol Violation|0|||
48747222|NCT02006719|156922960|FG000|Overall Study|Adverse Event|1|||
48747223|NCT02006719|156922961|FG001|Overall Study|Adverse Event|1|||
48747224|NCT02006719|156922960|FG000|Overall Study|Other/Unknown|0|||
48747225|NCT02006719|156922961|FG001|Overall Study|Other/Unknown|1|||
48747226|NCT01756898|156922962|FG000|Overall Study|Adverse Event|7|||
48747227|NCT01756898|156922963|FG001|Overall Study|Adverse Event|1|||
48747228|NCT01756898|156922964|FG002|Overall Study|Adverse Event|0|||
48747229|NCT01756898|156922965|FG003|Overall Study|Adverse Event|0|||
48747230|NCT01756898|156922962|FG000|Overall Study|Lack of Efficacy|4|||
48747231|NCT01756898|156922963|FG001|Overall Study|Lack of Efficacy|7|||
48747232|NCT01756898|156922964|FG002|Overall Study|Lack of Efficacy|6|||
48747233|NCT01756898|156922965|FG003|Overall Study|Lack of Efficacy|6|||
48747234|NCT01756898|156922962|FG000|Overall Study|Lost to Follow-up|2|||
48747235|NCT01756898|156922963|FG001|Overall Study|Lost to Follow-up|4|||
48747236|NCT01756898|156922964|FG002|Overall Study|Lost to Follow-up|2|||
48747237|NCT01756898|156922965|FG003|Overall Study|Lost to Follow-up|3|||
48747238|NCT01756898|156922962|FG000|Overall Study|Protocol Violation|1|||
48954237|NCT00256867|157661049|FG001|Overall Study|Protocol Violation|0|||
48747239|NCT01756898|156922963|FG001|Overall Study|Protocol Violation|2|||
48747240|NCT01756898|156922964|FG002|Overall Study|Protocol Violation|2|||
48747241|NCT01756898|156922965|FG003|Overall Study|Protocol Violation|1|||
48747242|NCT01756898|156922962|FG000|Overall Study|Withdrew Consent|5|||
48954238|NCT00256867|157661050|FG002|Overall Study|Protocol Violation|0|||
48747243|NCT01756898|156922963|FG001|Overall Study|Withdrew Consent|3|||
48747244|NCT01756898|156922964|FG002|Overall Study|Withdrew Consent|5|||
48747245|NCT01756898|156922965|FG003|Overall Study|Withdrew Consent|6|||
48747246|NCT01756898|156922962|FG000|Overall Study|Other|0|||
48747247|NCT01756898|156922963|FG001|Overall Study|Other|2|||
48747248|NCT01756898|156922964|FG002|Overall Study|Other|2|||
48747249|NCT01756898|156922965|FG003|Overall Study|Other|0|||
48747250|NCT00353262|156922970|FG000|Overall Study|Adverse Event|8|||
48747251|NCT00353262|156922970|FG000|Overall Study|Withdrawal by Subject|2|||
48747252|NCT00353262|156922970|FG000|Overall Study|Insufficient Therapeutic Response|13|||
48747253|NCT00353262|156922970|FG000|Overall Study|Progression|1|||
48747254|NCT00353262|156922970|FG000|Overall Study|Surgery|4|||
48747255|NCT00353262|156922970|FG000|Overall Study|Break from Chemotherapy|1|||
48747256|NCT02007109|156922971|FG000|Overall Study|Diary not returned or excluded|102|||
48747257|NCT02007109|156922971|FG000|Overall Study|Excluded - Age<7yo|9|||
48747258|NCT00496054|156922972|FG000|Overall Study|Adverse Event|1|||
48747259|NCT00496054|156922972|FG000|Overall Study|Lost to Follow-up|7|||
48747260|NCT01737697|156922973|FG000|Acute Phase-Initial 48 Hours|Adverse Event|0|||
48747261|NCT01737697|156922974|FG001|Acute Phase-Initial 48 Hours|Adverse Event|1|||
48747262|NCT01737697|156922975|FG002|Acute Phase-Initial 48 Hours|Adverse Event|0|||
48747263|NCT01737697|156922976|FG003|Acute Phase-Initial 48 Hours|Adverse Event|1|||
48747264|NCT01737697|156922977|FG004|Acute Phase-Initial 48 Hours|Adverse Event|1|||
48747265|NCT01737697|156922978|FG005|Acute Phase-Initial 48 Hours|Adverse Event|0|||
48860133|NCT01562275|157326866|FG008|Stage 1|Progression of Disease|2|||
48860134|NCT01562275|157326867|FG009|Stage 1|Progression of Disease|5|||
48747266|NCT01737697|156922979|FG006|Acute Phase-Initial 48 Hours|Adverse Event|0|||
48747267|NCT01737697|156922980|FG007|Acute Phase-Initial 48 Hours|Adverse Event|0|||
48747268|NCT01737697|156922981|FG008|Acute Phase-Initial 48 Hours|Adverse Event|0|||
48747269|NCT01737697|156922982|FG009|Acute Phase-Initial 48 Hours|Adverse Event|0|||
48747270|NCT01737697|156922983|FG010|Acute Phase-Initial 48 Hours|Adverse Event|0|||
48747271|NCT01737697|156922984|FG011|Acute Phase-Initial 48 Hours|Adverse Event|0|||
48747272|NCT01737697|156922985|FG012|Acute Phase-Initial 48 Hours|Adverse Event|0|||
48747273|NCT01737697|156922986|FG013|Acute Phase-Initial 48 Hours|Adverse Event|0|||
48747274|NCT01737697|156922987|FG014|Acute Phase-Initial 48 Hours|Adverse Event|0|||
48747275|NCT01737697|156922973|FG000|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
48747276|NCT01737697|156922974|FG001|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
48747277|NCT01737697|156922975|FG002|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3|||
48747278|NCT01737697|156922976|FG003|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
48747279|NCT01737697|156922977|FG004|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
48747280|NCT01737697|156922978|FG005|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
48747281|NCT01737697|156922979|FG006|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
48747282|NCT01737697|156922980|FG007|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
48747283|NCT01737697|156922981|FG008|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
48747284|NCT01737697|156922982|FG009|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
48747285|NCT01737697|156922983|FG010|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
48747286|NCT01737697|156922984|FG011|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
48747287|NCT01737697|156922985|FG012|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
48747288|NCT01737697|156922986|FG013|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
48747289|NCT01737697|156922987|FG014|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
48747290|NCT01737697|156922973|FG000|Acute Phase-Initial 48 Hours|Family emergency|0|||
48747291|NCT01737697|156922974|FG001|Acute Phase-Initial 48 Hours|Family emergency|0|||
48747292|NCT01737697|156922975|FG002|Acute Phase-Initial 48 Hours|Family emergency|0|||
48747293|NCT01737697|156922976|FG003|Acute Phase-Initial 48 Hours|Family emergency|1|||
48747294|NCT01737697|156922977|FG004|Acute Phase-Initial 48 Hours|Family emergency|0|||
48747295|NCT01737697|156922978|FG005|Acute Phase-Initial 48 Hours|Family emergency|0|||
48747296|NCT01737697|156922979|FG006|Acute Phase-Initial 48 Hours|Family emergency|0|||
48747297|NCT01737697|156922980|FG007|Acute Phase-Initial 48 Hours|Family emergency|0|||
48747298|NCT01737697|156922981|FG008|Acute Phase-Initial 48 Hours|Family emergency|0|||
48747299|NCT01737697|156922982|FG009|Acute Phase-Initial 48 Hours|Family emergency|0|||
48747300|NCT01737697|156922983|FG010|Acute Phase-Initial 48 Hours|Family emergency|0|||
48747301|NCT01737697|156922984|FG011|Acute Phase-Initial 48 Hours|Family emergency|0|||
48954239|NCT00256867|157661051|FG003|Overall Study|Protocol Violation|1|||
48954240|NCT00256867|157661052|FG004|Overall Study|Protocol Violation|0|||
48747302|NCT01737697|156922985|FG012|Acute Phase-Initial 48 Hours|Family emergency|0|||
48954241|NCT00256867|157661053|FG005|Overall Study|Protocol Violation|1|||
48954242|NCT00256867|157661054|FG006|Overall Study|Protocol Violation|0|||
48954243|NCT00256867|157661055|FG007|Overall Study|Protocol Violation|1|||
48954244|NCT00256867|157661048|FG000|Overall Study|Withdrawal by Subject|0|||
48954245|NCT00256867|157661049|FG001|Overall Study|Withdrawal by Subject|0|||
48954246|NCT00256867|157661050|FG002|Overall Study|Withdrawal by Subject|1|||
48747303|NCT01737697|156922986|FG013|Acute Phase-Initial 48 Hours|Family emergency|0|||
48747304|NCT01737697|156922987|FG014|Acute Phase-Initial 48 Hours|Family emergency|0|||
48747305|NCT01737697|156922973|FG000|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
48747306|NCT01737697|156922974|FG001|Acute Phase-Initial 48 Hours|Sponsor's decision|1|||
48747307|NCT01737697|156922975|FG002|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
48747308|NCT01737697|156922976|FG003|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
48747309|NCT01737697|156922977|FG004|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
48747310|NCT01737697|156922978|FG005|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
48747311|NCT01737697|156922979|FG006|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
48747312|NCT01737697|156922980|FG007|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
48747313|NCT01737697|156922981|FG008|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
48747314|NCT01737697|156922982|FG009|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
48747315|NCT01737697|156922983|FG010|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
48747316|NCT01737697|156922984|FG011|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
48747317|NCT01737697|156922985|FG012|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
48747318|NCT01737697|156922986|FG013|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
48747319|NCT01737697|156922987|FG014|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
48747320|NCT01737697|156922973|FG000|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
48747321|NCT01737697|156922974|FG001|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
48747322|NCT01737697|156922975|FG002|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
48747323|NCT01737697|156922976|FG003|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
48747324|NCT01737697|156922977|FG004|Acute Phase-Initial 48 Hours|Lost to Follow-up|1|||
48747325|NCT01737697|156922978|FG005|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
48747326|NCT01737697|156922979|FG006|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
48747327|NCT01737697|156922980|FG007|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
48747328|NCT01737697|156922981|FG008|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
48747329|NCT01737697|156922982|FG009|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
48747330|NCT01737697|156922983|FG010|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
48747331|NCT01737697|156922984|FG011|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
48860135|NCT01562275|157326868|FG010|Stage 1|Progression of Disease|3|||
48860136|NCT01562275|157326869|FG011|Stage 1|Progression of Disease|0|||
48860137|NCT01562275|157326870|FG012|Stage 1|Progression of Disease|0|||
48860138|NCT01562275|157326858|FG000|Stage 1|Withdrawal by Subject|0|||
48860139|NCT01562275|157326859|FG001|Stage 1|Withdrawal by Subject|1|||
48860140|NCT01562275|157326860|FG002|Stage 1|Withdrawal by Subject|0|||
48860141|NCT01562275|157326861|FG003|Stage 1|Withdrawal by Subject|2|||
48860142|NCT01562275|157326862|FG004|Stage 1|Withdrawal by Subject|0|||
48860143|NCT01562275|157326863|FG005|Stage 1|Withdrawal by Subject|0|||
48860144|NCT01562275|157326864|FG006|Stage 1|Withdrawal by Subject|1|||
48860145|NCT01562275|157326865|FG007|Stage 1|Withdrawal by Subject|0|||
48860146|NCT01562275|157326866|FG008|Stage 1|Withdrawal by Subject|0|||
48860147|NCT01562275|157326867|FG009|Stage 1|Withdrawal by Subject|1|||
48860148|NCT01562275|157326868|FG010|Stage 1|Withdrawal by Subject|0|||
48860149|NCT01562275|157326869|FG011|Stage 1|Withdrawal by Subject|0|||
48860150|NCT01562275|157326870|FG012|Stage 1|Withdrawal by Subject|0|||
48860151|NCT01562275|157326858|FG000|Stage 2|Death|0|||
48860152|NCT01562275|157326859|FG001|Stage 2|Death|0|||
48860153|NCT01562275|157326860|FG002|Stage 2|Death|0|||
48860154|NCT01562275|157326861|FG003|Stage 2|Death|0|||
48860155|NCT01562275|157326862|FG004|Stage 2|Death|0|||
48860156|NCT01562275|157326863|FG005|Stage 2|Death|0|||
48860157|NCT01562275|157326864|FG006|Stage 2|Death|0|||
48860158|NCT01562275|157326865|FG007|Stage 2|Death|0|||
48860159|NCT01562275|157326866|FG008|Stage 2|Death|0|||
48860160|NCT01562275|157326867|FG009|Stage 2|Death|0|||
48860161|NCT01562275|157326868|FG010|Stage 2|Death|0|||
48860162|NCT01562275|157326869|FG011|Stage 2|Death|2|||
48860163|NCT01562275|157326870|FG012|Stage 2|Death|1|||
48954247|NCT00256867|157661051|FG003|Overall Study|Withdrawal by Subject|1|||
49015379|NCT00306384|157892158|FG002|Overall Study|Lack of Efficacy|38|||
48860164|NCT01562275|157326858|FG000|Stage 2|Progression of Disease|0|||
48860165|NCT01562275|157326859|FG001|Stage 2|Progression of Disease|0|||
48860166|NCT01562275|157326860|FG002|Stage 2|Progression of Disease|0|||
48860167|NCT01562275|157326861|FG003|Stage 2|Progression of Disease|0|||
48860168|NCT01562275|157326862|FG004|Stage 2|Progression of Disease|0|||
48747332|NCT01737697|156922985|FG012|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
48747333|NCT01737697|156922986|FG013|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
48747334|NCT01737697|156922987|FG014|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
48747335|NCT01737697|156922973|FG000|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
48747336|NCT01737697|156922974|FG001|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
48747337|NCT01737697|156922975|FG002|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
48747338|NCT01737697|156922976|FG003|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4|||
48747339|NCT01737697|156922977|FG004|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
48747340|NCT01737697|156922978|FG005|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
48747341|NCT01737697|156922979|FG006|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
48747342|NCT01737697|156922980|FG007|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
48747343|NCT01737697|156922981|FG008|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
48747344|NCT01737697|156922982|FG009|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
48747345|NCT01737697|156922983|FG010|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
48747346|NCT01737697|156922984|FG011|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
48747347|NCT01737697|156922985|FG012|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
48747348|NCT01737697|156922986|FG013|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
48747349|NCT01737697|156922987|FG014|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
48747350|NCT01737697|156922973|FG000|Subacute Phase|Adverse Event|0|||
48747351|NCT01737697|156922974|FG001|Subacute Phase|Adverse Event|0|||
48747352|NCT01737697|156922975|FG002|Subacute Phase|Adverse Event|0|||
48954248|NCT00256867|157661052|FG004|Overall Study|Withdrawal by Subject|2|||
48954249|NCT00256867|157661053|FG005|Overall Study|Withdrawal by Subject|2|||
48954250|NCT00256867|157661054|FG006|Overall Study|Withdrawal by Subject|3|||
48747353|NCT01737697|156922976|FG003|Subacute Phase|Adverse Event|0|||
48747354|NCT01737697|156922977|FG004|Subacute Phase|Adverse Event|0|||
48747355|NCT01737697|156922978|FG005|Subacute Phase|Adverse Event|1|||
48747356|NCT01737697|156922979|FG006|Subacute Phase|Adverse Event|1|||
48747357|NCT01737697|156922980|FG007|Subacute Phase|Adverse Event|1|||
48747358|NCT01737697|156922981|FG008|Subacute Phase|Adverse Event|1|||
48747359|NCT01737697|156922982|FG009|Subacute Phase|Adverse Event|1|||
48747360|NCT01737697|156922983|FG010|Subacute Phase|Adverse Event|4|||
48747361|NCT01737697|156922984|FG011|Subacute Phase|Adverse Event|1|||
48747362|NCT01737697|156922985|FG012|Subacute Phase|Adverse Event|1|||
48747363|NCT01737697|156922986|FG013|Subacute Phase|Adverse Event|0|||
48747364|NCT01737697|156922987|FG014|Subacute Phase|Adverse Event|0|||
48747365|NCT01737697|156922973|FG000|Subacute Phase|Withdrawal by Subject|0|||
48747366|NCT01737697|156922974|FG001|Subacute Phase|Withdrawal by Subject|0|||
48747367|NCT01737697|156922975|FG002|Subacute Phase|Withdrawal by Subject|0|||
48747368|NCT01737697|156922976|FG003|Subacute Phase|Withdrawal by Subject|0|||
48747369|NCT01737697|156922977|FG004|Subacute Phase|Withdrawal by Subject|0|||
48747370|NCT01737697|156922978|FG005|Subacute Phase|Withdrawal by Subject|1|||
48747371|NCT01737697|156922979|FG006|Subacute Phase|Withdrawal by Subject|0|||
48747372|NCT01737697|156922980|FG007|Subacute Phase|Withdrawal by Subject|2|||
48747373|NCT01737697|156922981|FG008|Subacute Phase|Withdrawal by Subject|0|||
48747374|NCT01737697|156922982|FG009|Subacute Phase|Withdrawal by Subject|1|||
48747375|NCT01737697|156922983|FG010|Subacute Phase|Withdrawal by Subject|0|||
48747376|NCT01737697|156922984|FG011|Subacute Phase|Withdrawal by Subject|1|||
48747377|NCT01737697|156922985|FG012|Subacute Phase|Withdrawal by Subject|1|||
48747378|NCT01737697|156922986|FG013|Subacute Phase|Withdrawal by Subject|1|||
48747379|NCT01737697|156922987|FG014|Subacute Phase|Withdrawal by Subject|0|||
48747380|NCT01737697|156922973|FG000|Subacute Phase|Lost to Follow-up|0|||
48747381|NCT01737697|156922974|FG001|Subacute Phase|Lost to Follow-up|0|||
48747382|NCT01737697|156922975|FG002|Subacute Phase|Lost to Follow-up|0|||
48747383|NCT01737697|156922976|FG003|Subacute Phase|Lost to Follow-up|0|||
48747384|NCT01737697|156922977|FG004|Subacute Phase|Lost to Follow-up|0|||
48747385|NCT01737697|156922978|FG005|Subacute Phase|Lost to Follow-up|0|||
48747386|NCT01737697|156922979|FG006|Subacute Phase|Lost to Follow-up|0|||
48747387|NCT01737697|156922980|FG007|Subacute Phase|Lost to Follow-up|0|||
48747388|NCT01737697|156922981|FG008|Subacute Phase|Lost to Follow-up|0|||
48747389|NCT01737697|156922982|FG009|Subacute Phase|Lost to Follow-up|0|||
48747390|NCT01737697|156922983|FG010|Subacute Phase|Lost to Follow-up|0|||
48747391|NCT01737697|156922984|FG011|Subacute Phase|Lost to Follow-up|0|||
48747392|NCT01737697|156922985|FG012|Subacute Phase|Lost to Follow-up|0|||
48747393|NCT01737697|156922986|FG013|Subacute Phase|Lost to Follow-up|0|||
48747394|NCT01737697|156922987|FG014|Subacute Phase|Lost to Follow-up|1|||
48747395|NCT01737697|156922973|FG000|Subacute Phase|Hypo-or hyperkalemia|0|||
48747396|NCT01737697|156922974|FG001|Subacute Phase|Hypo-or hyperkalemia|0|||
48747397|NCT01737697|156922975|FG002|Subacute Phase|Hypo-or hyperkalemia|0|||
48747398|NCT01737697|156922976|FG003|Subacute Phase|Hypo-or hyperkalemia|0|||
48747399|NCT01737697|156922977|FG004|Subacute Phase|Hypo-or hyperkalemia|0|||
48747400|NCT01737697|156922978|FG005|Subacute Phase|Hypo-or hyperkalemia|0|||
48747401|NCT01737697|156922979|FG006|Subacute Phase|Hypo-or hyperkalemia|0|||
48747402|NCT01737697|156922980|FG007|Subacute Phase|Hypo-or hyperkalemia|0|||
48747403|NCT01737697|156922981|FG008|Subacute Phase|Hypo-or hyperkalemia|0|||
48747404|NCT01737697|156922982|FG009|Subacute Phase|Hypo-or hyperkalemia|0|||
48747405|NCT01737697|156922983|FG010|Subacute Phase|Hypo-or hyperkalemia|0|||
48747406|NCT01737697|156922984|FG011|Subacute Phase|Hypo-or hyperkalemia|1|||
48747407|NCT01737697|156922985|FG012|Subacute Phase|Hypo-or hyperkalemia|0|||
48747408|NCT01737697|156922986|FG013|Subacute Phase|Hypo-or hyperkalemia|1|||
48747409|NCT01737697|156922987|FG014|Subacute Phase|Hypo-or hyperkalemia|0|||
48747410|NCT01737697|156922973|FG000|Subacute Phase|Protocol Violation|0|||
48747411|NCT01737697|156922974|FG001|Subacute Phase|Protocol Violation|0|||
48747412|NCT01737697|156922975|FG002|Subacute Phase|Protocol Violation|0|||
48747413|NCT01737697|156922976|FG003|Subacute Phase|Protocol Violation|0|||
48747414|NCT01737697|156922977|FG004|Subacute Phase|Protocol Violation|0|||
48747415|NCT01737697|156922978|FG005|Subacute Phase|Protocol Violation|1|||
48747416|NCT01737697|156922979|FG006|Subacute Phase|Protocol Violation|0|||
48747417|NCT01737697|156922980|FG007|Subacute Phase|Protocol Violation|0|||
48747418|NCT01737697|156922981|FG008|Subacute Phase|Protocol Violation|0|||
48747419|NCT01737697|156922982|FG009|Subacute Phase|Protocol Violation|0|||
48747420|NCT01737697|156922983|FG010|Subacute Phase|Protocol Violation|1|||
48747421|NCT01737697|156922984|FG011|Subacute Phase|Protocol Violation|0|||
48747422|NCT01737697|156922985|FG012|Subacute Phase|Protocol Violation|0|||
48747423|NCT01737697|156922986|FG013|Subacute Phase|Protocol Violation|0|||
48747424|NCT01737697|156922987|FG014|Subacute Phase|Protocol Violation|0|||
48747425|NCT01737697|156922973|FG000|Subacute Phase|Physician Decision|0|||
48747426|NCT01737697|156922974|FG001|Subacute Phase|Physician Decision|0|||
48747427|NCT01737697|156922975|FG002|Subacute Phase|Physician Decision|0|||
48747428|NCT01737697|156922976|FG003|Subacute Phase|Physician Decision|0|||
48747429|NCT01737697|156922977|FG004|Subacute Phase|Physician Decision|0|||
48747430|NCT01737697|156922978|FG005|Subacute Phase|Physician Decision|0|||
48747431|NCT01737697|156922979|FG006|Subacute Phase|Physician Decision|0|||
48747432|NCT01737697|156922980|FG007|Subacute Phase|Physician Decision|0|||
48747433|NCT01737697|156922981|FG008|Subacute Phase|Physician Decision|1|||
48747434|NCT01737697|156922982|FG009|Subacute Phase|Physician Decision|0|||
48747435|NCT01737697|156922983|FG010|Subacute Phase|Physician Decision|0|||
48747436|NCT01737697|156922984|FG011|Subacute Phase|Physician Decision|0|||
48747437|NCT01737697|156922985|FG012|Subacute Phase|Physician Decision|0|||
48747438|NCT01737697|156922986|FG013|Subacute Phase|Physician Decision|0|||
48747439|NCT01737697|156922987|FG014|Subacute Phase|Physician Decision|0|||
48747440|NCT01737697|156922973|FG000|Subacute Phase|Death|0|||
48747441|NCT01737697|156922974|FG001|Subacute Phase|Death|0|||
48747442|NCT01737697|156922975|FG002|Subacute Phase|Death|0|||
48747443|NCT01737697|156922976|FG003|Subacute Phase|Death|0|||
48747444|NCT01737697|156922977|FG004|Subacute Phase|Death|0|||
48747445|NCT01737697|156922978|FG005|Subacute Phase|Death|0|||
48747446|NCT01737697|156922979|FG006|Subacute Phase|Death|0|||
48747447|NCT01737697|156922980|FG007|Subacute Phase|Death|0|||
48747448|NCT01737697|156922981|FG008|Subacute Phase|Death|0|||
48747449|NCT01737697|156922982|FG009|Subacute Phase|Death|0|||
48747450|NCT01737697|156922983|FG010|Subacute Phase|Death|1|||
48747451|NCT01737697|156922984|FG011|Subacute Phase|Death|0|||
48747452|NCT01737697|156922985|FG012|Subacute Phase|Death|0|||
48747453|NCT01737697|156922986|FG013|Subacute Phase|Death|0|||
48747454|NCT01737697|156922987|FG014|Subacute Phase|Death|0|||
48747455|NCT02879305|156922988|FG000|Overall Study|Investigator Site Closed|55|||
48747456|NCT02879305|156922989|FG001|Overall Study|Investigator Site Closed|57|||
48747457|NCT02879305|156922988|FG000|Overall Study|Withdrawal by Subject|44|||
48954251|NCT00256867|157661055|FG007|Overall Study|Withdrawal by Subject|2|||
48747458|NCT02879305|156922989|FG001|Overall Study|Withdrawal by Subject|42|||
48747459|NCT02879305|156922988|FG000|Overall Study|Lost to Follow-up|17|||
48747460|NCT02879305|156922989|FG001|Overall Study|Lost to Follow-up|12|||
48954252|NCT00256867|157661048|FG000|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
48954253|NCT00256867|157661049|FG001|Overall Study|Fasting plasma glucose >240 mg/dL|1|||
48954254|NCT00256867|157661050|FG002|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
48747461|NCT02879305|156922988|FG000|Overall Study|Other|1|||
48747462|NCT02879305|156922989|FG001|Overall Study|Other|0|||
48747463|NCT01950741|156922990|FG000|Overall Study|Lost to Follow-up|1|||
48747464|NCT01950741|156922990|FG000|Overall Study|Death|1|||
48747465|NCT01950741|156922990|FG000|Overall Study|Withdrawal by Subject|1|||
48747466|NCT01405742|156922991|FG000|Overall Study|Lost to Follow-up|1|||
48747467|NCT01405742|156922992|FG001|Overall Study|Lost to Follow-up|0|||
48747468|NCT01063868|156922993|FG000|Overall Study|Adverse Event|9|||
48747469|NCT01063868|156922994|FG001|Overall Study|Adverse Event|7|||
48747470|NCT01063868|156922993|FG000|Overall Study|Withdrawal by Subject|3|||
48747471|NCT01063868|156922994|FG001|Overall Study|Withdrawal by Subject|1|||
48747472|NCT01063868|156922993|FG000|Overall Study|Study Terminated By Sponsor|23|||
48747473|NCT01063868|156922994|FG001|Overall Study|Study Terminated By Sponsor|4|||
48747474|NCT01949506|156922995|FG000|Overall Study|Physician Decision|1|||
48747475|NCT00753415|156922996|FG000|Part A|Disease progression|1|||
48747476|NCT00753415|156922997|FG001|Part A|Disease progression|0|||
48747477|NCT00753415|156922998|FG002|Part A|Disease progression|1|||
48747478|NCT00753415|156922999|FG003|Part A|Disease progression|2|||
48747479|NCT00753415|156923000|FG004|Part A|Disease progression|0|||
48747480|NCT00753415|156923001|FG005|Part A|Disease progression|0|||
48747481|NCT00753415|156923002|FG006|Part A|Disease progression|0|||
48747482|NCT00753415|156923003|FG007|Part A|Disease progression|0|||
48747483|NCT00753415|156923004|FG008|Part A|Disease progression|0|||
48747484|NCT00753415|156923005|FG009|Part A|Disease progression|0|||
48747485|NCT00753415|156922996|FG000|Part A|Withdrawal by Subject|0|||
48747486|NCT00753415|156922997|FG001|Part A|Withdrawal by Subject|0|||
48747487|NCT00753415|156922998|FG002|Part A|Withdrawal by Subject|1|||
48747488|NCT00753415|156922999|FG003|Part A|Withdrawal by Subject|0|||
48747489|NCT00753415|156923000|FG004|Part A|Withdrawal by Subject|0|||
48747490|NCT00753415|156923001|FG005|Part A|Withdrawal by Subject|0|||
48747491|NCT00753415|156923002|FG006|Part A|Withdrawal by Subject|0|||
48747492|NCT00753415|156923003|FG007|Part A|Withdrawal by Subject|0|||
48747493|NCT00753415|156923004|FG008|Part A|Withdrawal by Subject|0|||
48747494|NCT00753415|156923005|FG009|Part A|Withdrawal by Subject|0|||
48747495|NCT00753415|156922996|FG000|Part B|Lost to Follow-up|0|||
48747496|NCT00753415|156922997|FG001|Part B|Lost to Follow-up|0|||
48747497|NCT00753415|156922998|FG002|Part B|Lost to Follow-up|0|||
48747498|NCT00753415|156922999|FG003|Part B|Lost to Follow-up|0|||
48747499|NCT00753415|156923000|FG004|Part B|Lost to Follow-up|0|||
48747500|NCT00753415|156923001|FG005|Part B|Lost to Follow-up|0|||
48747501|NCT00753415|156923002|FG006|Part B|Lost to Follow-up|0|||
48747502|NCT00753415|156923003|FG007|Part B|Lost to Follow-up|1|||
48747503|NCT00753415|156923004|FG008|Part B|Lost to Follow-up|1|||
48747504|NCT00753415|156923005|FG009|Part B|Lost to Follow-up|0|||
48747505|NCT00753415|156922996|FG000|Part B|Disease progression|0|||
48747506|NCT00753415|156922997|FG001|Part B|Disease progression|0|||
48747507|NCT00753415|156922998|FG002|Part B|Disease progression|0|||
48747508|NCT00753415|156922999|FG003|Part B|Disease progression|0|||
48747509|NCT00753415|156923000|FG004|Part B|Disease progression|0|||
48747510|NCT00753415|156923001|FG005|Part B|Disease progression|0|||
48747511|NCT00753415|156923002|FG006|Part B|Disease progression|0|||
48747512|NCT00753415|156923003|FG007|Part B|Disease progression|0|||
48747513|NCT00753415|156923004|FG008|Part B|Disease progression|2|||
48747514|NCT00753415|156923005|FG009|Part B|Disease progression|1|||
48747515|NCT01664533|156924865|FG000|Overall Study|Death|42|||
48747516|NCT01664533|156924865|FG000|Overall Study|Lost to Follow-up|3|||
48747517|NCT01664533|156924865|FG000|Overall Study|Study termination|9|||
48747518|NCT01664533|156924865|FG000|Overall Study|Protocol Violation|3|||
48747519|NCT00739674|156924866|FG000|Overall Study|Screening failures|19|||
48747520|NCT00739674|156924867|FG001|Overall Study|Screening failures|17|||
48747521|NCT00739674|156924866|FG000|Overall Study|Site 212 removal|19|||
48747522|NCT00739674|156924867|FG001|Overall Study|Site 212 removal|13|||
48747523|NCT00739674|156924866|FG000|Overall Study|No follow-up data|33|||
48747524|NCT00739674|156924867|FG001|Overall Study|No follow-up data|18|||
48747525|NCT00739674|156924866|FG000|Overall Study|Dietician consultation >30 days|1|||
48747526|NCT00739674|156924867|FG001|Overall Study|Dietician consultation >30 days|9|||
48747527|NCT00739674|156924866|FG000|Overall Study|Adverse Event|22|||
48747528|NCT00739674|156924867|FG001|Overall Study|Adverse Event|13|||
48747529|NCT00739674|156924866|FG000|Overall Study|Death|1|||
48860169|NCT01562275|157326863|FG005|Stage 2|Progression of Disease|0|||
48860170|NCT01562275|157326864|FG006|Stage 2|Progression of Disease|0|||
48860171|NCT01562275|157326865|FG007|Stage 2|Progression of Disease|0|||
48860172|NCT01562275|157326866|FG008|Stage 2|Progression of Disease|0|||
48860173|NCT01562275|157326867|FG009|Stage 2|Progression of Disease|0|||
48860174|NCT01562275|157326868|FG010|Stage 2|Progression of Disease|0|||
48860175|NCT01562275|157326869|FG011|Stage 2|Progression of Disease|12|||
48860176|NCT01562275|157326870|FG012|Stage 2|Progression of Disease|4|||
48860177|NCT00070707|157326871|FG000|Overall Study|Adverse Event|1|||
48860178|NCT00070707|157326872|FG001|Overall Study|Adverse Event|2|||
48860179|NCT00070707|157326871|FG000|Overall Study|Lack of Efficacy|4|||
48860180|NCT00070707|157326872|FG001|Overall Study|Lack of Efficacy|1|||
48860181|NCT00070707|157326871|FG000|Overall Study|Protocol Violation|8|||
48860182|NCT00070707|157326872|FG001|Overall Study|Protocol Violation|4|||
48860183|NCT00070707|157326871|FG000|Overall Study|Unrelated to Study Medication|1|||
48860184|NCT00070707|157326872|FG001|Overall Study|Unrelated to Study Medication|0|||
48860185|NCT00647699|157326873|FG000|Overall Study|Lost to Follow-up|5|||
48860186|NCT00647699|157326874|FG001|Overall Study|Lost to Follow-up|4|||
48860187|NCT00647699|157326873|FG000|Overall Study|Withdrawal by Subject|3|||
48860188|NCT00647699|157326874|FG001|Overall Study|Withdrawal by Subject|8|||
48860189|NCT04909593|157326875|FG000|Overall Study|Withdrawal by Subject|1|||
48860190|NCT01241448|157326876|FG000|Overall Study|Adverse Event|1|||
48860191|NCT01241448|157326877|FG001|Overall Study|Adverse Event|0|||
48860192|NCT01241448|157326878|FG002|Overall Study|Adverse Event|2|||
48860193|NCT01241448|157326879|FG003|Overall Study|Adverse Event|2|||
48860194|NCT01241448|157326876|FG000|Overall Study|Lost to Follow-up|2|||
48860195|NCT01241448|157326877|FG001|Overall Study|Lost to Follow-up|1|||
48860196|NCT01241448|157326878|FG002|Overall Study|Lost to Follow-up|1|||
48860197|NCT01241448|157326879|FG003|Overall Study|Lost to Follow-up|1|||
48860198|NCT01241448|157326876|FG000|Overall Study|Physician Decision|0|||
48860199|NCT01241448|157326877|FG001|Overall Study|Physician Decision|2|||
48860200|NCT01241448|157326878|FG002|Overall Study|Physician Decision|0|||
48860201|NCT01241448|157326879|FG003|Overall Study|Physician Decision|0|||
48747530|NCT00739674|156924867|FG001|Overall Study|Death|0|||
48747531|NCT00739674|156924866|FG000|Overall Study|Lack of Efficacy|1|||
48747532|NCT00739674|156924867|FG001|Overall Study|Lack of Efficacy|0|||
48860202|NCT01241448|157326876|FG000|Overall Study|Protocol Violation|10|||
48860203|NCT01241448|157326877|FG001|Overall Study|Protocol Violation|5|||
48860204|NCT01241448|157326878|FG002|Overall Study|Protocol Violation|3|||
48860205|NCT01241448|157326879|FG003|Overall Study|Protocol Violation|6|||
48860206|NCT01241448|157326876|FG000|Overall Study|Sponsor Decision|17|||
48954255|NCT00256867|157661051|FG003|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
48747533|NCT00739674|156924866|FG000|Overall Study|Lost to Follow-up|52|||
48747534|NCT00739674|156924867|FG001|Overall Study|Lost to Follow-up|30|||
48747535|NCT00739674|156924866|FG000|Overall Study|Protocol Violation|5|||
48747536|NCT00739674|156924867|FG001|Overall Study|Protocol Violation|5|||
48747537|NCT00739674|156924866|FG000|Overall Study|Withdrawal by Subject|9|||
48860207|NCT01241448|157326877|FG001|Overall Study|Sponsor Decision|14|||
48860208|NCT01241448|157326878|FG002|Overall Study|Sponsor Decision|12|||
48860209|NCT01241448|157326879|FG003|Overall Study|Sponsor Decision|6|||
48860210|NCT01241448|157326876|FG000|Overall Study|Withdrawal by Subject|4|||
48860211|NCT01241448|157326877|FG001|Overall Study|Withdrawal by Subject|5|||
48860212|NCT01241448|157326878|FG002|Overall Study|Withdrawal by Subject|3|||
48860213|NCT01241448|157326879|FG003|Overall Study|Withdrawal by Subject|6|||
48954256|NCT00256867|157661052|FG004|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
48954257|NCT00256867|157661053|FG005|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
48954258|NCT00256867|157661054|FG006|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
48954259|NCT00256867|157661055|FG007|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
48954260|NCT00256867|157661048|FG000|Overall Study|Glycemia over 13.3 millimole per litre|0|||
48954261|NCT00256867|157661049|FG001|Overall Study|Glycemia over 13.3 millimole per litre|0|||
48954262|NCT00256867|157661050|FG002|Overall Study|Glycemia over 13.3 millimole per litre|0|||
48954263|NCT00256867|157661051|FG003|Overall Study|Glycemia over 13.3 millimole per litre|0|||
48747538|NCT00739674|156924867|FG001|Overall Study|Withdrawal by Subject|9|||
48747539|NCT00739674|156924866|FG000|Overall Study|Reason missing|2|||
48747540|NCT00739674|156924867|FG001|Overall Study|Reason missing|0|||
48747541|NCT00739674|156924866|FG000|Overall Study|Clinic closed|6|||
48747542|NCT00739674|156924867|FG001|Overall Study|Clinic closed|4|||
48954264|NCT00256867|157661052|FG004|Overall Study|Glycemia over 13.3 millimole per litre|0|||
48954265|NCT00256867|157661053|FG005|Overall Study|Glycemia over 13.3 millimole per litre|0|||
48954266|NCT00256867|157661054|FG006|Overall Study|Glycemia over 13.3 millimole per litre|0|||
48747543|NCT00739674|156924866|FG000|Overall Study|Patient moved|3|||
48747544|NCT00739674|156924867|FG001|Overall Study|Patient moved|2|||
48747545|NCT00739674|156924866|FG000|Overall Study|Non compliant|4|||
48747546|NCT00739674|156924867|FG001|Overall Study|Non compliant|0|||
48954267|NCT00256867|157661055|FG007|Overall Study|Glycemia over 13.3 millimole per litre|1|||
48954268|NCT00256867|157661048|FG000|Overall Study|Investigator's Decision|0|||
48954269|NCT00256867|157661049|FG001|Overall Study|Investigator's Decision|0|||
48747547|NCT00739674|156924866|FG000|Overall Study|Unable to attend visit|3|||
48954270|NCT00256867|157661050|FG002|Overall Study|Investigator's Decision|0|||
48954271|NCT00256867|157661051|FG003|Overall Study|Investigator's Decision|0|||
48954272|NCT00256867|157661052|FG004|Overall Study|Investigator's Decision|1|||
48954273|NCT00256867|157661053|FG005|Overall Study|Investigator's Decision|0|||
48954274|NCT00256867|157661054|FG006|Overall Study|Investigator's Decision|0|||
48954275|NCT00256867|157661055|FG007|Overall Study|Investigator's Decision|0|||
48954276|NCT00256867|157661048|FG000|Overall Study|Non-compliance with study medication|0|||
48954277|NCT00256867|157661049|FG001|Overall Study|Non-compliance with study medication|0|||
48954278|NCT00256867|157661050|FG002|Overall Study|Non-compliance with study medication|0|||
48954279|NCT00256867|157661051|FG003|Overall Study|Non-compliance with study medication|0|||
48954280|NCT00256867|157661052|FG004|Overall Study|Non-compliance with study medication|0|||
48954281|NCT00256867|157661053|FG005|Overall Study|Non-compliance with study medication|0|||
48954282|NCT00256867|157661054|FG006|Overall Study|Non-compliance with study medication|0|||
48954283|NCT00256867|157661055|FG007|Overall Study|Non-compliance with study medication|1|||
48954284|NCT00256867|157661048|FG000|Overall Study|Participant travelled Overseas|0|||
48954285|NCT00256867|157661049|FG001|Overall Study|Participant travelled Overseas|1|||
48954286|NCT00256867|157661050|FG002|Overall Study|Participant travelled Overseas|0|||
48747548|NCT00739674|156924867|FG001|Overall Study|Unable to attend visit|1|||
48747549|NCT00739674|156924866|FG000|Overall Study|Home monitoring off meds|1|||
48747550|NCT00739674|156924867|FG001|Overall Study|Home monitoring off meds|0|||
48954287|NCT00256867|157661051|FG003|Overall Study|Participant travelled Overseas|0|||
48954288|NCT00256867|157661052|FG004|Overall Study|Participant travelled Overseas|0|||
48954289|NCT00256867|157661053|FG005|Overall Study|Participant travelled Overseas|0|||
48747551|NCT00739674|156924866|FG000|Overall Study|Erectile dysfunction|0|||
48954290|NCT00256867|157661054|FG006|Overall Study|Participant travelled Overseas|0|||
48954291|NCT00256867|157661055|FG007|Overall Study|Participant travelled Overseas|0|||
48747552|NCT00739674|156924867|FG001|Overall Study|Erectile dysfunction|1|||
48747553|NCT00787891|156924868|FG000|Short-term Double-blind Phase (Part 1)|Adverse Event|1|||
48747554|NCT00787891|156924869|FG001|Short-term Double-blind Phase (Part 1)|Adverse Event|2|||
48747555|NCT00787891|156924868|FG000|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
48747556|NCT00787891|156924869|FG001|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
48747557|NCT00787891|156924868|FG000|Short-term Double-blind Phase (Part 1)|Protocol Violation|0|||
48747558|NCT00787891|156924869|FG001|Short-term Double-blind Phase (Part 1)|Protocol Violation|1|||
48747559|NCT00787891|156924868|FG000|Short-term Double-blind Phase (Part 1)|Physician Decision|1|||
48747560|NCT00787891|156924869|FG001|Short-term Double-blind Phase (Part 1)|Physician Decision|0|||
48747561|NCT00787891|156924868|FG000|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6|||
48747562|NCT00787891|156924869|FG001|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2|||
48747563|NCT00787891|156924868|FG000|Short-term Double-blind Phase (Part 1)|Other|0|||
48747564|NCT00787891|156924869|FG001|Short-term Double-blind Phase (Part 1)|Other|2|||
48747565|NCT00787891|156924868|FG000|Maintenance Double-blind Phase (Part 2)|Adverse Event|0|||
48747566|NCT00787891|156924869|FG001|Maintenance Double-blind Phase (Part 2)|Adverse Event|1|||
48747567|NCT00787891|156924868|FG000|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
48747568|NCT00787891|156924869|FG001|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
48747569|NCT00787891|156924868|FG000|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1|||
48747570|NCT00787891|156924869|FG001|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3|||
48747571|NCT00787891|156924868|FG000|Maintenance Double-blind Phase (Part 2)|Other|5|||
48747572|NCT00787891|156924869|FG001|Maintenance Double-blind Phase (Part 2)|Other|2|||
48747573|NCT01575769|156924870|FG000|Overall Study|Adverse Event|1|||
48747574|NCT01575769|156924870|FG000|Overall Study|Study terminated by sponsor|40|||
48747575|NCT02370160|156924871|FG000|Overall Study|Death|3|||
48747576|NCT02370160|156924872|FG001|Overall Study|Death|4|||
48747577|NCT02370160|156924873|FG002|Overall Study|Death|1|||
48747578|NCT01871532|156924874|FG000|Overall Study|Withdrawal by Subject|1|||
48747579|NCT01871532|156924875|FG001|Overall Study|Withdrawal by Subject|2|||
48747580|NCT02550106|156924877|FG000|Overall Study|Adverse Event|1|||
48747581|NCT02550106|156924877|FG000|Overall Study|Lack of Efficacy|3|||
48747582|NCT02550106|156924877|FG000|Overall Study|Protocol Violation|6|||
48747583|NCT02550106|156924877|FG000|Overall Study|Withdrawal by Subject|2|||
48747584|NCT00105469|156924878|FG000|Overall Study|Adverse Event|9|||
48747585|NCT00105469|156924879|FG001|Overall Study|Adverse Event|8|||
48747586|NCT00105469|156924878|FG000|Overall Study|Protocol Violation|4|||
48747587|NCT00105469|156924879|FG001|Overall Study|Protocol Violation|0|||
48747588|NCT00105469|156924878|FG000|Overall Study|Withdrawal by Subject|2|||
48747589|NCT00105469|156924879|FG001|Overall Study|Withdrawal by Subject|3|||
48747590|NCT00105469|156924878|FG000|Overall Study|Lost to Follow-up|1|||
48747591|NCT00105469|156924879|FG001|Overall Study|Lost to Follow-up|0|||
48747592|NCT00105469|156924878|FG000|Overall Study|Lack of Efficacy|2|||
48747593|NCT00105469|156924879|FG001|Overall Study|Lack of Efficacy|0|||
48747594|NCT00105469|156924878|FG000|Overall Study|Other Reason|4|||
48747595|NCT00105469|156924879|FG001|Overall Study|Other Reason|0|||
48747596|NCT01806298|156924883|FG000|Overall Study|Adverse Event|3|||
48747597|NCT01806298|156924883|FG000|Overall Study|Protocol Non-compliance|1|||
48747598|NCT01806298|156924883|FG000|Overall Study|Withdrawal by Subject|1|||
48747599|NCT01806298|156924883|FG000|Overall Study|Other|5|||
48747600|NCT02279420|156924889|FG000|Overall Study|Lost to Follow-up|23|||
48860214|NCT01241448|157326876|FG000|Overall Study|Excluded due to data integrity issues|3|||
48860215|NCT01241448|157326877|FG001|Overall Study|Excluded due to data integrity issues|2|||
48747601|NCT03535844|156924893|FG000|Overall Study|Withdrawal by Subject|0|||
48747602|NCT03535844|156924894|FG001|Overall Study|Withdrawal by Subject|1|||
48747603|NCT03766581|156924904|FG000|Randomization|Other reasons|2|||
48747604|NCT03766581|156924905|FG001|Randomization|Other reasons|1|||
48747605|NCT03766581|156924906|FG002|Randomization|Other reasons|0|||
48747606|NCT03766581|156924907|FG003|Randomization|Other reasons|1|||
48747607|NCT03766581|156924908|FG004|Randomization|Other reasons|0|||
48860216|NCT01241448|157326878|FG002|Overall Study|Excluded due to data integrity issues|2|||
48860217|NCT01241448|157326879|FG003|Overall Study|Excluded due to data integrity issues|2|||
48860218|NCT02092285|157326880|FG000|Induction Phase|Adverse Event|7|||
48860219|NCT02092285|157326880|FG000|Induction Phase|Physician Decision|4|||
48860220|NCT02092285|157326880|FG000|Induction Phase|Pregnancy|1|||
48954292|NCT00256867|157661048|FG000|Overall Study|Participant out of assessment window|0|||
48747608|NCT03766581|156924909|FG005|Randomization|Other reasons|0|||
48954293|NCT00256867|157661049|FG001|Overall Study|Participant out of assessment window|0|||
48954294|NCT00256867|157661050|FG002|Overall Study|Participant out of assessment window|1|||
48954295|NCT00256867|157661051|FG003|Overall Study|Participant out of assessment window|0|||
48954296|NCT00256867|157661052|FG004|Overall Study|Participant out of assessment window|0|||
48954297|NCT00256867|157661053|FG005|Overall Study|Participant out of assessment window|0|||
48954298|NCT00256867|157661054|FG006|Overall Study|Participant out of assessment window|0|||
48692705|NCT04908683|156724584|FG000|Overall Study|Failure to meet continuation criteria|34|||
48692706|NCT04908683|156724585|FG001|Overall Study|Failure to meet continuation criteria|22|||
48692707|NCT04908683|156724584|FG000|Overall Study|Initiated prohibited medication|3|||
48747609|NCT03766581|156924910|FG006|Randomization|Other reasons|0|||
48747610|NCT03766581|156924911|FG007|Randomization|Other reasons|0|||
48747611|NCT03766581|156924904|FG000|Randomization|Participant no longer meets study criteria|5|||
48747612|NCT03766581|156924905|FG001|Randomization|Participant no longer meets study criteria|3|||
48747613|NCT03766581|156924906|FG002|Randomization|Participant no longer meets study criteria|4|||
48747614|NCT03766581|156924907|FG003|Randomization|Participant no longer meets study criteria|0|||
48747615|NCT03766581|156924908|FG004|Randomization|Participant no longer meets study criteria|2|||
48747616|NCT03766581|156924909|FG005|Randomization|Participant no longer meets study criteria|3|||
48747617|NCT03766581|156924910|FG006|Randomization|Participant no longer meets study criteria|0|||
48747618|NCT03766581|156924911|FG007|Randomization|Participant no longer meets study criteria|1|||
48747619|NCT03766581|156924904|FG000|Randomization|Participant request to discontinue study treatment|1|||
48747620|NCT03766581|156924905|FG001|Randomization|Participant request to discontinue study treatment|0|||
48747621|NCT03766581|156924906|FG002|Randomization|Participant request to discontinue study treatment|0|||
48747622|NCT03766581|156924907|FG003|Randomization|Participant request to discontinue study treatment|0|||
48747623|NCT03766581|156924908|FG004|Randomization|Participant request to discontinue study treatment|1|||
48747624|NCT03766581|156924909|FG005|Randomization|Participant request to discontinue study treatment|2|||
48747625|NCT03766581|156924910|FG006|Randomization|Participant request to discontinue study treatment|0|||
48747626|NCT03766581|156924911|FG007|Randomization|Participant request to discontinue study treatment|0|||
48747627|NCT03766581|156924904|FG000|Randomization|Participant withdrew consent|1|||
48747628|NCT03766581|156924905|FG001|Randomization|Participant withdrew consent|0|||
48747629|NCT03766581|156924906|FG002|Randomization|Participant withdrew consent|1|||
48747630|NCT03766581|156924907|FG003|Randomization|Participant withdrew consent|2|||
48747631|NCT03766581|156924908|FG004|Randomization|Participant withdrew consent|1|||
48747632|NCT03766581|156924909|FG005|Randomization|Participant withdrew consent|1|||
48747633|NCT03766581|156924910|FG006|Randomization|Participant withdrew consent|0|||
48747634|NCT03766581|156924911|FG007|Randomization|Participant withdrew consent|0|||
48860221|NCT02092285|157326880|FG000|Induction Phase|Relapse/Recurrence|7|||
48860222|NCT02092285|157326880|FG000|Induction Phase|Withdrawal by Subject|2|||
48860223|NCT02092285|157326880|FG000|Induction Phase|Lack of Efficacy|14|||
48860224|NCT02092285|157326880|FG000|Maintenance Phase & Follow-up|Adverse Event|22|||
48954299|NCT00256867|157661055|FG007|Overall Study|Participant out of assessment window|0|||
48954300|NCT00256867|157661048|FG000|Overall Study|Withdrawal by participant|0|||
48954301|NCT00256867|157661049|FG001|Overall Study|Withdrawal by participant|0|||
48954302|NCT00256867|157661050|FG002|Overall Study|Withdrawal by participant|0|||
48954303|NCT00256867|157661051|FG003|Overall Study|Withdrawal by participant|0|||
48954304|NCT00256867|157661052|FG004|Overall Study|Withdrawal by participant|0|||
48954305|NCT00256867|157661053|FG005|Overall Study|Withdrawal by participant|1|||
48954306|NCT00256867|157661054|FG006|Overall Study|Withdrawal by participant|0|||
48860225|NCT02092285|157326880|FG000|Maintenance Phase & Follow-up|Lost to Follow-up|1|||
48860226|NCT02092285|157326880|FG000|Maintenance Phase & Follow-up|Non-compliance with study drug|2|||
48860227|NCT02092285|157326880|FG000|Maintenance Phase & Follow-up|Physician Decision|10|||
48860228|NCT02092285|157326880|FG000|Maintenance Phase & Follow-up|Pregnancy|1|||
48954307|NCT00256867|157661055|FG007|Overall Study|Withdrawal by participant|0|||
48954308|NCT01937130|157662296|FG000|Overall Study|Withdrawal by Subject|0|||
48954309|NCT01937130|157662297|FG001|Overall Study|Withdrawal by Subject|0|||
48954310|NCT01937130|157662298|FG002|Overall Study|Withdrawal by Subject|0|||
48954311|NCT01937130|157662299|FG003|Overall Study|Withdrawal by Subject|1|||
48954312|NCT01937130|157662296|FG000|Overall Study|Adverse Event|0|||
48954313|NCT01937130|157662297|FG001|Overall Study|Adverse Event|1|||
48954314|NCT01937130|157662298|FG002|Overall Study|Adverse Event|0|||
48954315|NCT01937130|157662299|FG003|Overall Study|Adverse Event|1|||
48954316|NCT01937130|157662296|FG000|Overall Study|Death|1|||
48954317|NCT01937130|157662297|FG001|Overall Study|Death|1|||
48954318|NCT01937130|157662298|FG002|Overall Study|Death|1|||
48954319|NCT01937130|157662299|FG003|Overall Study|Death|0|||
48954320|NCT01937130|157662296|FG000|Overall Study|Lost to Follow-up|2|||
48954321|NCT01937130|157662297|FG001|Overall Study|Lost to Follow-up|0|||
48954322|NCT01937130|157662298|FG002|Overall Study|Lost to Follow-up|2|||
48954323|NCT01937130|157662299|FG003|Overall Study|Lost to Follow-up|0|||
48954324|NCT01937130|157662296|FG000|Overall Study|Physician Decision|0|||
48747635|NCT03766581|156924904|FG000|Treatment|Adverse Event|82|||
48747636|NCT03766581|156924905|FG001|Treatment|Adverse Event|44|||
48747637|NCT03766581|156924906|FG002|Treatment|Adverse Event|47|||
48747638|NCT03766581|156924907|FG003|Treatment|Adverse Event|46|||
48747639|NCT03766581|156924908|FG004|Treatment|Adverse Event|50|||
48747640|NCT03766581|156924909|FG005|Treatment|Adverse Event|77|||
48954325|NCT01937130|157662297|FG001|Overall Study|Physician Decision|1|||
48954326|NCT01937130|157662298|FG002|Overall Study|Physician Decision|0|||
48954327|NCT01937130|157662299|FG003|Overall Study|Physician Decision|0|||
48954328|NCT01937130|157662296|FG000|Overall Study|Patients unable to swallow|0|||
48954329|NCT01937130|157662297|FG001|Overall Study|Patients unable to swallow|1|||
48954330|NCT01937130|157662298|FG002|Overall Study|Patients unable to swallow|0|||
48747641|NCT03766581|156924910|FG006|Treatment|Adverse Event|5|||
48747642|NCT03766581|156924911|FG007|Treatment|Adverse Event|2|||
48747643|NCT03766581|156924904|FG000|Treatment|Participant request to discontinue treatment|34|||
48747644|NCT03766581|156924905|FG001|Treatment|Participant request to discontinue treatment|6|||
48954331|NCT01937130|157662299|FG003|Overall Study|Patients unable to swallow|0|||
48954332|NCT01937130|157662296|FG000|Overall Study|Patient lost to FU due to death|2|||
48954333|NCT01937130|157662297|FG001|Overall Study|Patient lost to FU due to death|0|||
48954334|NCT01937130|157662298|FG002|Overall Study|Patient lost to FU due to death|0|||
48954335|NCT01937130|157662299|FG003|Overall Study|Patient lost to FU due to death|0|||
48954336|NCT01115569|157662300|FG000|Conversion/Titration Phase|Adverse Event|59|||
48954337|NCT01115569|157662301|FG001|Conversion/Titration Phase|Adverse Event|0|||
48954338|NCT01115569|157662300|FG000|Conversion/Titration Phase|Lost to Follow-up|3|||
48954339|NCT01115569|157662301|FG001|Conversion/Titration Phase|Lost to Follow-up|0|||
48954340|NCT01115569|157662300|FG000|Conversion/Titration Phase|Physician Decision|5|||
48954341|NCT01115569|157662301|FG001|Conversion/Titration Phase|Physician Decision|0|||
48954342|NCT01115569|157662300|FG000|Conversion/Titration Phase|Protocol Violation|68|||
48954343|NCT01115569|157662301|FG001|Conversion/Titration Phase|Protocol Violation|0|||
48954344|NCT01115569|157662300|FG000|Conversion/Titration Phase|Withdrawal by Subject|26|||
48954345|NCT01115569|157662301|FG001|Conversion/Titration Phase|Withdrawal by Subject|0|||
48954346|NCT01115569|157662300|FG000|Conversion/Titration Phase|Non-Compliance with Study Drug|53|||
48954347|NCT01115569|157662301|FG001|Conversion/Titration Phase|Non-Compliance with Study Drug|0|||
48954348|NCT01115569|157662300|FG000|Maintenance Phase|Adverse Event|0|||
48954349|NCT01115569|157662301|FG001|Maintenance Phase|Adverse Event|43|||
48954350|NCT01115569|157662300|FG000|Maintenance Phase|Lost to Follow-up|0|||
48954351|NCT01115569|157662301|FG001|Maintenance Phase|Lost to Follow-up|8|||
48954352|NCT01115569|157662300|FG000|Maintenance Phase|Physician Decision|0|||
48954353|NCT01115569|157662301|FG001|Maintenance Phase|Physician Decision|3|||
48954354|NCT01115569|157662300|FG000|Maintenance Phase|Protocol Violation|0|||
48954355|NCT01115569|157662301|FG001|Maintenance Phase|Protocol Violation|9|||
48954356|NCT01115569|157662300|FG000|Maintenance Phase|Withdrawal by Subject|0|||
48954357|NCT01115569|157662301|FG001|Maintenance Phase|Withdrawal by Subject|27|||
48954358|NCT01115569|157662300|FG000|Maintenance Phase|Non-Compliance with Study Drug|0|||
48954359|NCT01115569|157662301|FG001|Maintenance Phase|Non-Compliance with Study Drug|48|||
48954360|NCT01115569|157662300|FG000|Maintenance Phase|Administrative|0|||
48954361|NCT01115569|157662301|FG001|Maintenance Phase|Administrative|1|||
48954362|NCT01701583|157662302|FG000|Overall Study|Withdrawal by Subject|2|||
48954363|NCT01701583|157662303|FG001|Overall Study|Withdrawal by Subject|0|||
48954364|NCT02241512|157662304|FG000|Overall Study|Pump malfunction, drug not delivered|1|||
48954365|NCT02241512|157662305|FG001|Overall Study|Pump malfunction, drug not delivered|0|||
48954366|NCT00450372|157662306|FG000|Overall Study|Physician Decision|1|||
48954367|NCT01070550|157662307|FG000|Overall Study|Adverse Event|43|||
48954368|NCT01070550|157662308|FG001|Overall Study|Adverse Event|1|||
48954369|NCT01070550|157662309|FG002|Overall Study|Adverse Event|3|||
48954370|NCT01070550|157662310|FG003|Overall Study|Adverse Event|0|||
48954371|NCT01070550|157662311|FG004|Overall Study|Adverse Event|0|||
48954372|NCT01070550|157662312|FG005|Overall Study|Adverse Event|0|||
48954373|NCT01070550|157662307|FG000|Overall Study|Death|20|||
48954374|NCT01070550|157662308|FG001|Overall Study|Death|4|||
48954375|NCT01070550|157662309|FG002|Overall Study|Death|3|||
48954376|NCT01070550|157662310|FG003|Overall Study|Death|0|||
48954377|NCT01070550|157662311|FG004|Overall Study|Death|0|||
48954378|NCT01070550|157662312|FG005|Overall Study|Death|0|||
48954379|NCT01070550|157662307|FG000|Overall Study|Not meeting inclusion/exclusion criteria|2|||
48954380|NCT01070550|157662308|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
48954381|NCT01070550|157662309|FG002|Overall Study|Not meeting inclusion/exclusion criteria|1|||
48954382|NCT01070550|157662310|FG003|Overall Study|Not meeting inclusion/exclusion criteria|0|||
48954383|NCT01070550|157662311|FG004|Overall Study|Not meeting inclusion/exclusion criteria|0|||
48954384|NCT01070550|157662312|FG005|Overall Study|Not meeting inclusion/exclusion criteria|0|||
48954385|NCT01070550|157662307|FG000|Overall Study|Early termination|3|||
48954386|NCT01070550|157662308|FG001|Overall Study|Early termination|0|||
48954387|NCT01070550|157662309|FG002|Overall Study|Early termination|0|||
48954388|NCT01070550|157662310|FG003|Overall Study|Early termination|0|||
48954389|NCT01070550|157662311|FG004|Overall Study|Early termination|0|||
48954390|NCT01070550|157662312|FG005|Overall Study|Early termination|0|||
48954391|NCT01070550|157662307|FG000|Overall Study|Failed to return|450|||
48954392|NCT01070550|157662308|FG001|Overall Study|Failed to return|33|||
48954393|NCT01070550|157662309|FG002|Overall Study|Failed to return|144|||
48954394|NCT01070550|157662310|FG003|Overall Study|Failed to return|40|||
48954395|NCT01070550|157662311|FG004|Overall Study|Failed to return|1|||
48954396|NCT01070550|157662312|FG005|Overall Study|Failed to return|2|||
48954397|NCT01070550|157662307|FG000|Overall Study|Incomplete treatment|2|||
48954398|NCT01070550|157662308|FG001|Overall Study|Incomplete treatment|0|||
48954399|NCT01070550|157662309|FG002|Overall Study|Incomplete treatment|0|||
48954400|NCT01070550|157662310|FG003|Overall Study|Incomplete treatment|0|||
48747645|NCT03766581|156924906|FG002|Treatment|Participant request to discontinue treatment|10|||
48954401|NCT01070550|157662311|FG004|Overall Study|Incomplete treatment|0|||
48954402|NCT01070550|157662312|FG005|Overall Study|Incomplete treatment|0|||
48954403|NCT01070550|157662307|FG000|Overall Study|Lab test not done|22|||
48954404|NCT01070550|157662308|FG001|Overall Study|Lab test not done|3|||
48954405|NCT01070550|157662309|FG002|Overall Study|Lab test not done|4|||
48747646|NCT03766581|156924907|FG003|Treatment|Participant request to discontinue treatment|10|||
48747647|NCT03766581|156924908|FG004|Treatment|Participant request to discontinue treatment|14|||
48747648|NCT03766581|156924909|FG005|Treatment|Participant request to discontinue treatment|15|||
48747649|NCT03766581|156924910|FG006|Treatment|Participant request to discontinue treatment|0|||
48747650|NCT03766581|156924911|FG007|Treatment|Participant request to discontinue treatment|1|||
48747651|NCT03766581|156924904|FG000|Treatment|Participant withdrew consent|11|||
48747652|NCT03766581|156924905|FG001|Treatment|Participant withdrew consent|4|||
48747653|NCT03766581|156924906|FG002|Treatment|Participant withdrew consent|5|||
48747654|NCT03766581|156924907|FG003|Treatment|Participant withdrew consent|5|||
48747655|NCT03766581|156924908|FG004|Treatment|Participant withdrew consent|4|||
48747656|NCT03766581|156924909|FG005|Treatment|Participant withdrew consent|4|||
48954406|NCT01070550|157662310|FG003|Overall Study|Lab test not done|1|||
48954407|NCT01070550|157662311|FG004|Overall Study|Lab test not done|0|||
48954408|NCT01070550|157662312|FG005|Overall Study|Lab test not done|1|||
48954409|NCT01070550|157662307|FG000|Overall Study|Lack of Efficacy|65|||
48954410|NCT01070550|157662308|FG001|Overall Study|Lack of Efficacy|1|||
48747657|NCT03766581|156924910|FG006|Treatment|Participant withdrew consent|0|||
48747658|NCT03766581|156924911|FG007|Treatment|Participant withdrew consent|0|||
48747659|NCT03766581|156924904|FG000|Treatment|Death|1|||
48860229|NCT02092285|157326880|FG000|Maintenance Phase & Follow-up|Protocol Violation|11|||
48860230|NCT02092285|157326880|FG000|Maintenance Phase & Follow-up|Relapse/recurrence|29|||
48860231|NCT02092285|157326880|FG000|Maintenance Phase & Follow-up|Withdrawal by Subject|11|||
48860232|NCT02092285|157326880|FG000|Maintenance Phase & Follow-up|Lack of Efficacy|23|||
48860233|NCT01848483|157326881|FG000|Overall Study|Death|2|||
48860234|NCT01848483|157326882|FG001|Overall Study|Death|1|||
48747660|NCT03766581|156924905|FG001|Treatment|Death|0|||
48747661|NCT03766581|156924906|FG002|Treatment|Death|0|||
48747662|NCT03766581|156924907|FG003|Treatment|Death|0|||
48747663|NCT03766581|156924908|FG004|Treatment|Death|0|||
48747664|NCT03766581|156924909|FG005|Treatment|Death|0|||
48860235|NCT01848483|157326881|FG000|Overall Study|Lost to Follow-up|6|||
48860236|NCT01848483|157326882|FG001|Overall Study|Lost to Follow-up|8|||
48860237|NCT01848483|157326881|FG000|Overall Study|Withdrawal by Subject|1|||
48860238|NCT01848483|157326882|FG001|Overall Study|Withdrawal by Subject|0|||
48860239|NCT01848483|157326881|FG000|Overall Study|Incarceration|2|||
48860240|NCT01848483|157326882|FG001|Overall Study|Incarceration|2|||
48860241|NCT00484198|157326883|FG000|Overall Study|Participant Withdrew Consent|12|||
48860242|NCT00484198|157326884|FG001|Overall Study|Participant Withdrew Consent|21|||
48860243|NCT00484198|157326885|FG002|Overall Study|Participant Withdrew Consent|47|||
48860244|NCT00484198|157326886|FG003|Overall Study|Participant Withdrew Consent|59|||
48860245|NCT00484198|157326883|FG000|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16|||
48954411|NCT01070550|157662309|FG002|Overall Study|Lack of Efficacy|5|||
48954412|NCT01070550|157662310|FG003|Overall Study|Lack of Efficacy|5|||
48747665|NCT03766581|156924910|FG006|Treatment|Death|0|||
48747666|NCT03766581|156924911|FG007|Treatment|Death|0|||
48747667|NCT03766581|156924904|FG000|Treatment|Lost to Follow-up|1|||
48747668|NCT03766581|156924905|FG001|Treatment|Lost to Follow-up|0|||
48747669|NCT03766581|156924906|FG002|Treatment|Lost to Follow-up|0|||
48954413|NCT01070550|157662311|FG004|Overall Study|Lack of Efficacy|0|||
48954414|NCT01070550|157662312|FG005|Overall Study|Lack of Efficacy|1|||
48954415|NCT01070550|157662307|FG000|Overall Study|Miscellaneous|12|||
48954416|NCT01070550|157662308|FG001|Overall Study|Miscellaneous|2|||
48954417|NCT01070550|157662309|FG002|Overall Study|Miscellaneous|3|||
48747670|NCT03766581|156924907|FG003|Treatment|Lost to Follow-up|1|||
48860246|NCT00484198|157326884|FG001|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17|||
48954418|NCT01070550|157662310|FG003|Overall Study|Miscellaneous|1|||
48954419|NCT01070550|157662311|FG004|Overall Study|Miscellaneous|0|||
48747671|NCT03766581|156924908|FG004|Treatment|Lost to Follow-up|0|||
48860247|NCT00484198|157326885|FG002|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29|||
48860248|NCT00484198|157326886|FG003|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38|||
48860249|NCT00484198|157326883|FG000|Overall Study|Therapeutic failure/ lack of efficacy|3|||
48860250|NCT00484198|157326884|FG001|Overall Study|Therapeutic failure/ lack of efficacy|2|||
48860251|NCT00484198|157326885|FG002|Overall Study|Therapeutic failure/ lack of efficacy|6|||
48860252|NCT00484198|157326886|FG003|Overall Study|Therapeutic failure/ lack of efficacy|8|||
48860253|NCT00484198|157326883|FG000|Overall Study|Adverse Event|3|||
48860254|NCT00484198|157326884|FG001|Overall Study|Adverse Event|11|||
48860255|NCT00484198|157326885|FG002|Overall Study|Adverse Event|32|||
48860256|NCT00484198|157326886|FG003|Overall Study|Adverse Event|31|||
48860257|NCT00484198|157326883|FG000|Overall Study|Protocol Violation|0|||
48860258|NCT00484198|157326884|FG001|Overall Study|Protocol Violation|5|||
48860259|NCT00484198|157326885|FG002|Overall Study|Protocol Violation|6|||
48860260|NCT00484198|157326886|FG003|Overall Study|Protocol Violation|8|||
48860261|NCT00484198|157326883|FG000|Overall Study|Other|7|||
48860262|NCT00484198|157326884|FG001|Overall Study|Other|10|||
48860263|NCT00484198|157326885|FG002|Overall Study|Other|31|||
48860264|NCT00484198|157326886|FG003|Overall Study|Other|28|||
48860265|NCT03622580|157326890|FG000|Overall Study|Death|16|||
48860266|NCT03622580|157326891|FG001|Overall Study|Death|21|||
48860267|NCT03622580|157326892|FG002|Overall Study|Death|13|||
48860268|NCT03622580|157326890|FG000|Overall Study|Adverse Event|6|||
48860269|NCT03622580|157326891|FG001|Overall Study|Adverse Event|6|||
48860270|NCT03622580|157326892|FG002|Overall Study|Adverse Event|5|||
48860271|NCT03622580|157326890|FG000|Overall Study|Withdrawal by Subject|12|||
48860272|NCT03622580|157326891|FG001|Overall Study|Withdrawal by Subject|7|||
48860273|NCT03622580|157326892|FG002|Overall Study|Withdrawal by Subject|19|||
48860274|NCT03622580|157326890|FG000|Overall Study|Lost to Follow-up|12|||
48860275|NCT03622580|157326891|FG001|Overall Study|Lost to Follow-up|9|||
48860276|NCT03622580|157326892|FG002|Overall Study|Lost to Follow-up|9|||
48860277|NCT03622580|157326890|FG000|Overall Study|Protocol Violation|1|||
48860278|NCT03622580|157326891|FG001|Overall Study|Protocol Violation|0|||
48860279|NCT03622580|157326892|FG002|Overall Study|Protocol Violation|1|||
48860280|NCT03622580|157326890|FG000|Overall Study|Physician Decision|3|||
48860281|NCT03622580|157326891|FG001|Overall Study|Physician Decision|0|||
48860282|NCT03622580|157326892|FG002|Overall Study|Physician Decision|1|||
48860283|NCT03622580|157326890|FG000|Overall Study|Pregnancy|0|||
48860284|NCT03622580|157326891|FG001|Overall Study|Pregnancy|1|||
48860285|NCT03622580|157326892|FG002|Overall Study|Pregnancy|0|||
48860286|NCT03622580|157326890|FG000|Overall Study|Lack of Efficacy|0|||
48860287|NCT03622580|157326891|FG001|Overall Study|Lack of Efficacy|0|||
48954420|NCT01070550|157662312|FG005|Overall Study|Miscellaneous|0|||
48954421|NCT01070550|157662307|FG000|Overall Study|New treatment started|3|||
48954422|NCT01070550|157662308|FG001|Overall Study|New treatment started|1|||
48954423|NCT01070550|157662309|FG002|Overall Study|New treatment started|0|||
48860288|NCT03622580|157326892|FG002|Overall Study|Lack of Efficacy|1|||
48860289|NCT03622580|157326890|FG000|Overall Study|Other|2|||
48860290|NCT03622580|157326891|FG001|Overall Study|Other|0|||
48860291|NCT03622580|157326892|FG002|Overall Study|Other|3|||
48860292|NCT00668746|157326899|FG000|Overall Study|Lost to Follow-up|2|||
48860293|NCT00668746|157326900|FG001|Overall Study|Lost to Follow-up|1|||
48860294|NCT01768572|157326902|FG000|Overall Study|Adverse Event|7|||
48860295|NCT01768572|157326903|FG001|Overall Study|Adverse Event|8|||
48860296|NCT01768572|157326904|FG002|Overall Study|Adverse Event|4|||
48860297|NCT01768572|157326902|FG000|Overall Study|Lack of Efficacy|1|||
48860298|NCT01768572|157326903|FG001|Overall Study|Lack of Efficacy|3|||
48860299|NCT01768572|157326904|FG002|Overall Study|Lack of Efficacy|1|||
48860300|NCT01768572|157326902|FG000|Overall Study|Other, Not due to an adverse event|1|||
48954424|NCT01070550|157662310|FG003|Overall Study|New treatment started|2|||
48860301|NCT01768572|157326903|FG001|Overall Study|Other, Not due to an adverse event|1|||
48860302|NCT01768572|157326904|FG002|Overall Study|Other, Not due to an adverse event|1|||
48860303|NCT03602053|157326907|FG000|Overall Study|Withdrawal by Subject|7|||
48860304|NCT03602053|157326908|FG001|Overall Study|Withdrawal by Subject|9|||
48860305|NCT03602053|157326909|FG002|Overall Study|Withdrawal by Subject|7|||
48954425|NCT01070550|157662311|FG004|Overall Study|New treatment started|0|||
48747672|NCT03766581|156924909|FG005|Treatment|Lost to Follow-up|0|||
48747673|NCT03766581|156924910|FG006|Treatment|Lost to Follow-up|0|||
48747674|NCT03766581|156924911|FG007|Treatment|Lost to Follow-up|0|||
48747675|NCT03766581|156924904|FG000|Treatment|Poor/Non compliance|2|||
48747676|NCT03766581|156924905|FG001|Treatment|Poor/Non compliance|2|||
48747677|NCT03766581|156924906|FG002|Treatment|Poor/Non compliance|1|||
48747678|NCT03766581|156924907|FG003|Treatment|Poor/Non compliance|1|||
48747679|NCT03766581|156924908|FG004|Treatment|Poor/Non compliance|1|||
48747680|NCT03766581|156924909|FG005|Treatment|Poor/Non compliance|1|||
48747681|NCT03766581|156924910|FG006|Treatment|Poor/Non compliance|0|||
48747682|NCT03766581|156924911|FG007|Treatment|Poor/Non compliance|0|||
48747683|NCT03766581|156924904|FG000|Treatment|Participant no longer meets study criteria|9|||
48747684|NCT03766581|156924905|FG001|Treatment|Participant no longer meets study criteria|1|||
48747685|NCT03766581|156924906|FG002|Treatment|Participant no longer meets study criteria|5|||
48747686|NCT03766581|156924907|FG003|Treatment|Participant no longer meets study criteria|4|||
48747687|NCT03766581|156924908|FG004|Treatment|Participant no longer meets study criteria|4|||
48747688|NCT03766581|156924909|FG005|Treatment|Participant no longer meets study criteria|4|||
48747689|NCT03766581|156924910|FG006|Treatment|Participant no longer meets study criteria|2|||
48747690|NCT03766581|156924911|FG007|Treatment|Participant no longer meets study criteria|0|||
48747691|NCT03766581|156924904|FG000|Treatment|Other reasons|13|||
48747692|NCT03766581|156924905|FG001|Treatment|Other reasons|8|||
48747693|NCT03766581|156924906|FG002|Treatment|Other reasons|3|||
48747694|NCT03766581|156924907|FG003|Treatment|Other reasons|7|||
48747695|NCT03766581|156924908|FG004|Treatment|Other reasons|3|||
48747696|NCT03766581|156924909|FG005|Treatment|Other reasons|3|||
48747697|NCT03766581|156924910|FG006|Treatment|Other reasons|0|||
48747698|NCT03766581|156924911|FG007|Treatment|Other reasons|0|||
48747699|NCT02732119|156924912|FG000|Phase I|Adverse Event|1|||
48747700|NCT02732119|156924913|FG001|Phase I|Adverse Event|3|||
48747701|NCT02732119|156924914|FG002|Phase I|Adverse Event|1|||
48747702|NCT02732119|156924915|FG003|Phase I|Adverse Event|0|||
48747703|NCT02732119|156924916|FG004|Phase I|Adverse Event|0|||
48747704|NCT02732119|156924912|FG000|Phase I|Progressive disease|7|||
48747705|NCT02732119|156924913|FG001|Phase I|Progressive disease|3|||
48747706|NCT02732119|156924914|FG002|Phase I|Progressive disease|2|||
48747707|NCT02732119|156924915|FG003|Phase I|Progressive disease|0|||
48747708|NCT02732119|156924916|FG004|Phase I|Progressive disease|0|||
48747709|NCT02732119|156924912|FG000|Phase I|Protocol deviation|0|||
48747710|NCT02732119|156924913|FG001|Phase I|Protocol deviation|1|||
48747711|NCT02732119|156924914|FG002|Phase I|Protocol deviation|0|||
48747712|NCT02732119|156924915|FG003|Phase I|Protocol deviation|0|||
48747713|NCT02732119|156924916|FG004|Phase I|Protocol deviation|0|||
48747714|NCT02732119|156924912|FG000|Phase I|Physician Decision|0|||
48747715|NCT02732119|156924913|FG001|Phase I|Physician Decision|3|||
48747716|NCT02732119|156924914|FG002|Phase I|Physician Decision|4|||
48747717|NCT02732119|156924915|FG003|Phase I|Physician Decision|0|||
48747718|NCT02732119|156924916|FG004|Phase I|Physician Decision|0|||
48747719|NCT02732119|156924912|FG000|Phase II|Adverse Event|0|||
48747720|NCT02732119|156924913|FG001|Phase II|Adverse Event|0|||
48747721|NCT02732119|156924914|FG002|Phase II|Adverse Event|0|||
48747722|NCT02732119|156924915|FG003|Phase II|Adverse Event|3|||
48747723|NCT02732119|156924916|FG004|Phase II|Adverse Event|3|||
48747724|NCT02732119|156924912|FG000|Phase II|Death|0|||
48747725|NCT02732119|156924913|FG001|Phase II|Death|0|||
48747726|NCT02732119|156924914|FG002|Phase II|Death|0|||
48747727|NCT02732119|156924915|FG003|Phase II|Death|1|||
48747728|NCT02732119|156924916|FG004|Phase II|Death|0|||
48747729|NCT02732119|156924912|FG000|Phase II|Progressive dissease|0|||
48747730|NCT02732119|156924913|FG001|Phase II|Progressive dissease|0|||
48860306|NCT03602053|157326907|FG000|Overall Study|Lost to Follow-up|5|||
48860307|NCT03602053|157326908|FG001|Overall Study|Lost to Follow-up|6|||
48860308|NCT03602053|157326909|FG002|Overall Study|Lost to Follow-up|0|||
48860309|NCT03602053|157326907|FG000|Overall Study|Protocol Violation|3|||
48860310|NCT03602053|157326908|FG001|Overall Study|Protocol Violation|0|||
48860311|NCT03602053|157326909|FG002|Overall Study|Protocol Violation|4|||
48860312|NCT03602053|157326907|FG000|Overall Study|Physician Decision|1|||
48860313|NCT03602053|157326908|FG001|Overall Study|Physician Decision|0|||
48860314|NCT03602053|157326909|FG002|Overall Study|Physician Decision|0|||
48860315|NCT03602053|157326907|FG000|Overall Study|migration|2|||
48860316|NCT03602053|157326908|FG001|Overall Study|migration|3|||
48860317|NCT03602053|157326909|FG002|Overall Study|migration|0|||
48860318|NCT03602053|157326907|FG000|Overall Study|Other|1|||
48860319|NCT03602053|157326908|FG001|Overall Study|Other|0|||
48860320|NCT03602053|157326909|FG002|Overall Study|Other|0|||
48860321|NCT00080119|157326910|FG000|Overall Study|Discontinued because of study closure|0|||
48860322|NCT00080119|157326911|FG001|Overall Study|Discontinued because of study closure|0|||
48860323|NCT00080119|157326912|FG002|Overall Study|Discontinued because of study closure|130|||
48860324|NCT00080119|157326913|FG003|Overall Study|Discontinued because of study closure|141|||
48860325|NCT00080119|157326910|FG000|Overall Study|Unable to get to clinic|24|||
48860326|NCT00080119|157326911|FG001|Overall Study|Unable to get to clinic|24|||
48860327|NCT00080119|157326912|FG002|Overall Study|Unable to get to clinic|7|||
48860328|NCT00080119|157326913|FG003|Overall Study|Unable to get to clinic|1|||
48860329|NCT00080119|157326910|FG000|Overall Study|Consent withdrawn|13|||
48860330|NCT00080119|157326911|FG001|Overall Study|Consent withdrawn|17|||
48860331|NCT00080119|157326912|FG002|Overall Study|Consent withdrawn|4|||
48860332|NCT00080119|157326913|FG003|Overall Study|Consent withdrawn|6|||
48860333|NCT00080119|157326910|FG000|Overall Study|Unwilling to adhere to study requirement|3|||
48860334|NCT00080119|157326911|FG001|Overall Study|Unwilling to adhere to study requirement|2|||
48860335|NCT00080119|157326912|FG002|Overall Study|Unwilling to adhere to study requirement|5|||
48860336|NCT00080119|157326913|FG003|Overall Study|Unwilling to adhere to study requirement|1|||
48860337|NCT00080119|157326910|FG000|Overall Study|Lost to Follow-up|16|||
48860338|NCT00080119|157326911|FG001|Overall Study|Lost to Follow-up|19|||
48860339|NCT00080119|157326912|FG002|Overall Study|Lost to Follow-up|19|||
48860340|NCT00080119|157326913|FG003|Overall Study|Lost to Follow-up|14|||
48860341|NCT00889863|157326915|FG000|Part I: Open Label|Death|1|||
48860342|NCT00889863|157326916|FG001|Part I: Open Label|Death|0|||
48860343|NCT00889863|157326915|FG000|Part I: Open Label|Adverse Event|4|||
48860344|NCT00889863|157326916|FG001|Part I: Open Label|Adverse Event|0|||
48860345|NCT00889863|157326915|FG000|Part I: Open Label|Unsatisfactory therapeutic effect|72|||
48860346|NCT00889863|157326916|FG001|Part I: Open Label|Unsatisfactory therapeutic effect|0|||
48860347|NCT00889863|157326915|FG000|Part II: Randomized Double Blind|Adverse Event|0|||
48860348|NCT00889863|157326916|FG001|Part II: Randomized Double Blind|Adverse Event|4|||
48860349|NCT00889863|157326915|FG000|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11|||
48860350|NCT00889863|157326916|FG001|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20|||
48860351|NCT00889863|157326915|FG000|Part II: Randomized Double Blind|Withdrawal by Subject|0|||
48860352|NCT00889863|157326916|FG001|Part II: Randomized Double Blind|Withdrawal by Subject|1|||
48860353|NCT00889863|157326915|FG000|Part II: Randomized Double Blind|Protocol deviation|0|||
48860354|NCT00889863|157326916|FG001|Part II: Randomized Double Blind|Protocol deviation|1|||
48860355|NCT03344458|157326917|FG000|Overall Study|Physician Decision|1|||
48860356|NCT03344458|157326917|FG000|Overall Study|Withdrawal by Subject|16|||
48860357|NCT03344458|157326917|FG000|Overall Study|Other reasons|10|||
48860358|NCT03344458|157326917|FG000|Overall Study|Lost to Follow-up|9|||
48860359|NCT03344458|157326917|FG000|Overall Study|Protocol Violation|3|||
48860360|NCT02964234|157326918|FG000|Overall Study|Lost to Follow-up|22|||
48860361|NCT02964234|157326919|FG001|Overall Study|Lost to Follow-up|13|||
48860362|NCT02163499|157326920|FG000|Acute Phase: ZS 10 g TID|Participant's Compliance|1|||
48860363|NCT02163499|157326920|FG000|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1|||
48860364|NCT02163499|157326920|FG000|Acute Phase: ZS 10 g TID|Protocol Violation|1|||
48860365|NCT02163499|157326920|FG000|Acute Phase: ZS 10 g TID|Physician Decision|1|||
48860366|NCT02163499|157326920|FG000|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1|||
48860367|NCT02163499|157326920|FG000|Extended Dosing Phase: ZS|Adverse Event|51|||
48860368|NCT02163499|157326920|FG000|Extended Dosing Phase: ZS|Expected Progression of CKD|40|||
48860369|NCT02163499|157326920|FG000|Extended Dosing Phase: ZS|Hypokalemia|9|||
48860370|NCT02163499|157326920|FG000|Extended Dosing Phase: ZS|Sponsor's Decision|5|||
48860371|NCT02163499|157326920|FG000|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7|||
48860372|NCT02163499|157326920|FG000|Extended Dosing Phase: ZS|Withdrawal by Subject|81|||
48860373|NCT02163499|157326920|FG000|Extended Dosing Phase: ZS|Physician Decision|8|||
48860374|NCT02163499|157326920|FG000|Extended Dosing Phase: ZS|Lost to Follow-up|31|||
48860375|NCT02163499|157326920|FG000|Extended Dosing Phase: ZS|Protocol Violation|2|||
48860376|NCT02163499|157326920|FG000|Extended Dosing Phase: ZS|Death|8|||
48860377|NCT02163499|157326920|FG000|Extended Dosing Phase: ZS|Subject Compliance|17|||
48860378|NCT02163499|157326920|FG000|Extended Dosing Phase: ZS|Hyperkalemia|5|||
48860379|NCT02163499|157326920|FG000|Extended Dosing Phase: ZS|Various reasons|16|||
48860380|NCT01540474|157326921|FG000|Vaccination Period|Lost to Follow-up|0|||
48860381|NCT01540474|157326922|FG001|Vaccination Period|Lost to Follow-up|1|||
48860382|NCT01540474|157326923|FG002|Vaccination Period|Lost to Follow-up|0|||
48860383|NCT01540474|157326924|FG003|Vaccination Period|Lost to Follow-up|0|||
48860384|NCT03696342|157326925|FG000|Overall Study|Lost to Follow-up|1|||
48860385|NCT03696342|157326926|FG001|Overall Study|Lost to Follow-up|0|||
48860386|NCT01345253|157326927|FG000|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22|||
48860387|NCT01345253|157326928|FG001|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27|||
48860388|NCT01345253|157326927|FG000|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11|||
48860389|NCT01345253|157326928|FG001|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7|||
48860390|NCT01345253|157326927|FG000|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1|||
48860391|NCT01345253|157326928|FG001|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5|||
48860392|NCT01345253|157326927|FG000|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6|||
48860393|NCT01345253|157326928|FG001|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1|||
48860394|NCT01345253|157326927|FG000|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3|||
48860395|NCT01345253|157326928|FG001|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8|||
48860396|NCT01345253|157326927|FG000|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4|||
48954426|NCT01070550|157662312|FG005|Overall Study|New treatment started|0|||
48954427|NCT01070550|157662307|FG000|Overall Study|Non-responders|493|||
48954428|NCT01070550|157662308|FG001|Overall Study|Non-responders|4|||
48954429|NCT01070550|157662309|FG002|Overall Study|Non-responders|21|||
48954430|NCT01070550|157662310|FG003|Overall Study|Non-responders|20|||
48954431|NCT01070550|157662311|FG004|Overall Study|Non-responders|0|||
48954432|NCT01070550|157662312|FG005|Overall Study|Non-responders|2|||
48954433|NCT01070550|157662307|FG000|Overall Study|Not categorized|33|||
48954434|NCT01070550|157662308|FG001|Overall Study|Not categorized|2|||
48954435|NCT01070550|157662309|FG002|Overall Study|Not categorized|6|||
48954436|NCT01070550|157662310|FG003|Overall Study|Not categorized|1|||
48954437|NCT01070550|157662311|FG004|Overall Study|Not categorized|0|||
48954438|NCT01070550|157662312|FG005|Overall Study|Not categorized|1|||
48954439|NCT01070550|157662307|FG000|Overall Study|Protocol Violation|15|||
48954440|NCT01070550|157662308|FG001|Overall Study|Protocol Violation|1|||
48954441|NCT01070550|157662309|FG002|Overall Study|Protocol Violation|1|||
48954442|NCT01070550|157662310|FG003|Overall Study|Protocol Violation|1|||
48954443|NCT01070550|157662311|FG004|Overall Study|Protocol Violation|0|||
48954444|NCT01070550|157662312|FG005|Overall Study|Protocol Violation|0|||
48954445|NCT01070550|157662307|FG000|Overall Study|Relapse|44|||
48954446|NCT01070550|157662308|FG001|Overall Study|Relapse|5|||
48954447|NCT01070550|157662309|FG002|Overall Study|Relapse|14|||
48954448|NCT01070550|157662310|FG003|Overall Study|Relapse|4|||
48954449|NCT01070550|157662311|FG004|Overall Study|Relapse|0|||
48954450|NCT01070550|157662312|FG005|Overall Study|Relapse|0|||
48954451|NCT01070550|157662307|FG000|Overall Study|Result not available|3|||
48954452|NCT01070550|157662308|FG001|Overall Study|Result not available|1|||
48954453|NCT01070550|157662309|FG002|Overall Study|Result not available|3|||
48954454|NCT01070550|157662310|FG003|Overall Study|Result not available|0|||
48954455|NCT01070550|157662311|FG004|Overall Study|Result not available|0|||
48954456|NCT01070550|157662312|FG005|Overall Study|Result not available|0|||
48954457|NCT01070550|157662307|FG000|Overall Study|Screen failure|1|||
48954458|NCT01070550|157662308|FG001|Overall Study|Screen failure|0|||
48954459|NCT01070550|157662309|FG002|Overall Study|Screen failure|0|||
48954460|NCT01070550|157662310|FG003|Overall Study|Screen failure|0|||
48954461|NCT01070550|157662311|FG004|Overall Study|Screen failure|0|||
48954462|NCT01070550|157662312|FG005|Overall Study|Screen failure|0|||
48954463|NCT01070550|157662307|FG000|Overall Study|Sponsor decision|1|||
48860397|NCT01345253|157326928|FG001|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12|||
48860398|NCT01345253|157326927|FG000|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9|||
48860399|NCT01345253|157326928|FG001|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19|||
48860400|NCT01345253|157326927|FG000|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7|||
48860401|NCT01345253|157326928|FG001|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18|||
48860402|NCT01345253|157326927|FG000|Open-label Phase (Up to Year 5 Week 44)|Death|0|||
48860403|NCT01345253|157326928|FG001|Open-label Phase (Up to Year 5 Week 44)|Death|1|||
48860404|NCT01345253|157326927|FG000|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3|||
48860405|NCT01345253|157326928|FG001|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7|||
48860406|NCT01345253|157326927|FG000|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2|||
48860407|NCT01345253|157326928|FG001|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5|||
48860408|NCT01345253|157326927|FG000|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4|||
48860409|NCT01345253|157326928|FG001|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6|||
48860410|NCT01345253|157326927|FG000|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11|||
48860411|NCT01345253|157326928|FG001|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24|||
48860412|NCT01345253|157326927|FG000|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37|||
48860413|NCT01345253|157326928|FG001|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82|||
48860414|NCT01345253|157326927|FG000|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
48860415|NCT01345253|157326928|FG001|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
48860416|NCT00267956|157326929|FG000|Controlled Period|Adverse Event|4|||
48860417|NCT00267956|157326930|FG001|Controlled Period|Adverse Event|1|||
48860418|NCT00267956|157326931|FG002|Controlled Period|Adverse Event|0|||
48860419|NCT00267956|157326932|FG003|Controlled Period|Adverse Event|0|||
48860420|NCT00267956|157326929|FG000|Controlled Period|Lack of Efficacy|4|||
48860421|NCT00267956|157326930|FG001|Controlled Period|Lack of Efficacy|2|||
48860422|NCT00267956|157326931|FG002|Controlled Period|Lack of Efficacy|0|||
48860423|NCT00267956|157326932|FG003|Controlled Period|Lack of Efficacy|0|||
48860424|NCT00267956|157326929|FG000|Controlled Period|Lost to Follow-up|2|||
48860425|NCT00267956|157326930|FG001|Controlled Period|Lost to Follow-up|0|||
48860426|NCT00267956|157326931|FG002|Controlled Period|Lost to Follow-up|0|||
48860427|NCT00267956|157326932|FG003|Controlled Period|Lost to Follow-up|0|||
48860428|NCT00267956|157326929|FG000|Controlled Period|Withdrew consent|3|||
48860429|NCT00267956|157326930|FG001|Controlled Period|Withdrew consent|1|||
48860430|NCT00267956|157326931|FG002|Controlled Period|Withdrew consent|0|||
48954464|NCT01070550|157662308|FG001|Overall Study|Sponsor decision|0|||
48954465|NCT01070550|157662309|FG002|Overall Study|Sponsor decision|0|||
48747731|NCT02732119|156924914|FG002|Phase II|Progressive dissease|0|||
48747732|NCT02732119|156924915|FG003|Phase II|Progressive dissease|30|||
48747733|NCT02732119|156924916|FG004|Phase II|Progressive dissease|23|||
48747734|NCT02732119|156924912|FG000|Phase II|Study terminated by sponsor|0|||
48747735|NCT02732119|156924913|FG001|Phase II|Study terminated by sponsor|0|||
48747736|NCT02732119|156924914|FG002|Phase II|Study terminated by sponsor|0|||
48747737|NCT02732119|156924915|FG003|Phase II|Study terminated by sponsor|2|||
48747738|NCT02732119|156924916|FG004|Phase II|Study terminated by sponsor|2|||
48747739|NCT02732119|156924912|FG000|Phase II|Other|0|||
48747740|NCT02732119|156924913|FG001|Phase II|Other|0|||
48747741|NCT02732119|156924914|FG002|Phase II|Other|0|||
48747742|NCT02732119|156924915|FG003|Phase II|Other|2|||
48747743|NCT02732119|156924916|FG004|Phase II|Other|0|||
48860431|NCT00267956|157326932|FG003|Controlled Period|Withdrew consent|0|||
48860432|NCT00267956|157326929|FG000|After Controlled Period|Adverse Event|0|||
48860433|NCT00267956|157326930|FG001|After Controlled Period|Adverse Event|0|||
48860434|NCT00267956|157326931|FG002|After Controlled Period|Adverse Event|2|||
48860435|NCT00267956|157326932|FG003|After Controlled Period|Adverse Event|1|||
48860436|NCT00267956|157326929|FG000|After Controlled Period|Lack of Efficacy|0|||
48860437|NCT00267956|157326930|FG001|After Controlled Period|Lack of Efficacy|0|||
48860438|NCT00267956|157326931|FG002|After Controlled Period|Lack of Efficacy|1|||
48860439|NCT00267956|157326932|FG003|After Controlled Period|Lack of Efficacy|1|||
48747744|NCT02732119|156924912|FG000|Phase II|Physician Decision|0|||
48747745|NCT02732119|156924913|FG001|Phase II|Physician Decision|0|||
48747746|NCT02732119|156924914|FG002|Phase II|Physician Decision|0|||
48747747|NCT02732119|156924915|FG003|Phase II|Physician Decision|8|||
48747748|NCT02732119|156924916|FG004|Phase II|Physician Decision|5|||
48747749|NCT02193867|156924917|FG000|Overall Study|Death|2|||
48747750|NCT02193867|156924917|FG000|Overall Study|Sponsor Study Termination|2|||
48747751|NCT02270957|156924918|FG000|Overall Study|Lack of Efficacy|2|||
48747752|NCT02270957|156924919|FG001|Overall Study|Lack of Efficacy|4|||
48860440|NCT00267956|157326929|FG000|After Controlled Period|Lost to Follow-up|0|||
48860441|NCT00267956|157326930|FG001|After Controlled Period|Lost to Follow-up|0|||
48860442|NCT00267956|157326931|FG002|After Controlled Period|Lost to Follow-up|1|||
48747753|NCT02270957|156924918|FG000|Overall Study|Adverse Event|2|||
48747754|NCT02270957|156924919|FG001|Overall Study|Adverse Event|0|||
48860443|NCT00267956|157326932|FG003|After Controlled Period|Lost to Follow-up|0|||
48860444|NCT00267956|157326929|FG000|After Controlled Period|Withdrew consent|0|||
48860445|NCT00267956|157326930|FG001|After Controlled Period|Withdrew consent|0|||
48954466|NCT01070550|157662310|FG003|Overall Study|Sponsor decision|0|||
48954467|NCT01070550|157662311|FG004|Overall Study|Sponsor decision|0|||
48954468|NCT01070550|157662312|FG005|Overall Study|Sponsor decision|0|||
48954469|NCT01070550|157662307|FG000|Overall Study|Treatment duration shortened|1|||
48954470|NCT01070550|157662308|FG001|Overall Study|Treatment duration shortened|0|||
48954471|NCT01070550|157662309|FG002|Overall Study|Treatment duration shortened|0|||
48954472|NCT01070550|157662310|FG003|Overall Study|Treatment duration shortened|0|||
48954473|NCT01070550|157662311|FG004|Overall Study|Treatment duration shortened|0|||
48954474|NCT01070550|157662312|FG005|Overall Study|Treatment duration shortened|0|||
48954475|NCT01070550|157662307|FG000|Overall Study|Treatment interrupted|7|||
48954476|NCT01070550|157662308|FG001|Overall Study|Treatment interrupted|0|||
48954477|NCT01070550|157662309|FG002|Overall Study|Treatment interrupted|1|||
48954478|NCT01070550|157662310|FG003|Overall Study|Treatment interrupted|1|||
48954479|NCT01070550|157662311|FG004|Overall Study|Treatment interrupted|0|||
48954480|NCT01070550|157662312|FG005|Overall Study|Treatment interrupted|0|||
48954481|NCT01070550|157662307|FG000|Overall Study|Treatment not started|14|||
48954482|NCT01070550|157662308|FG001|Overall Study|Treatment not started|2|||
48954483|NCT01070550|157662309|FG002|Overall Study|Treatment not started|4|||
48954484|NCT01070550|157662310|FG003|Overall Study|Treatment not started|0|||
48954485|NCT01070550|157662311|FG004|Overall Study|Treatment not started|0|||
48954486|NCT01070550|157662312|FG005|Overall Study|Treatment not started|0|||
48954487|NCT01070550|157662307|FG000|Overall Study|Treatment restarted|0|||
48954488|NCT01070550|157662308|FG001|Overall Study|Treatment restarted|1|||
48954489|NCT01070550|157662309|FG002|Overall Study|Treatment restarted|0|||
48954490|NCT01070550|157662310|FG003|Overall Study|Treatment restarted|0|||
48954491|NCT01070550|157662311|FG004|Overall Study|Treatment restarted|0|||
48954492|NCT01070550|157662312|FG005|Overall Study|Treatment restarted|0|||
48954493|NCT01070550|157662307|FG000|Overall Study|Treatment stopped|3|||
48954494|NCT01070550|157662308|FG001|Overall Study|Treatment stopped|0|||
48954495|NCT01070550|157662309|FG002|Overall Study|Treatment stopped|0|||
48954496|NCT01070550|157662310|FG003|Overall Study|Treatment stopped|0|||
48954497|NCT01070550|157662311|FG004|Overall Study|Treatment stopped|0|||
48954498|NCT01070550|157662312|FG005|Overall Study|Treatment stopped|0|||
48954499|NCT01070550|157662307|FG000|Overall Study|Treatment unavailable|1|||
48954500|NCT01070550|157662308|FG001|Overall Study|Treatment unavailable|0|||
48954501|NCT01070550|157662309|FG002|Overall Study|Treatment unavailable|0|||
48954502|NCT01070550|157662310|FG003|Overall Study|Treatment unavailable|0|||
48954503|NCT01070550|157662311|FG004|Overall Study|Treatment unavailable|0|||
48954504|NCT01070550|157662312|FG005|Overall Study|Treatment unavailable|0|||
48954505|NCT01070550|157662307|FG000|Overall Study|Treatment was stopped early|7|||
48747755|NCT04343261|156924922|FG000|Overall Study|Adverse Event|1|||
48747756|NCT04343261|156924922|FG000|Overall Study|received inadequate amount of antibodies|7|||
48747757|NCT00743340|156924925|FG000|Overall Study|Study medication non-compliance|1|||
48747758|NCT00743340|156924925|FG000|Overall Study|Lost to Follow-up|1|||
48747759|NCT00743340|156924925|FG000|Overall Study|Withdrawal from the Study|5|||
48747760|NCT00743340|156924925|FG000|Overall Study|Protocol Violation|1|||
48954506|NCT01070550|157662308|FG001|Overall Study|Treatment was stopped early|0|||
48954507|NCT01070550|157662309|FG002|Overall Study|Treatment was stopped early|0|||
48954508|NCT01070550|157662310|FG003|Overall Study|Treatment was stopped early|0|||
48954509|NCT01070550|157662311|FG004|Overall Study|Treatment was stopped early|0|||
48954510|NCT01070550|157662312|FG005|Overall Study|Treatment was stopped early|0|||
48954511|NCT01070550|157662307|FG000|Overall Study|Other|5|||
48954512|NCT01070550|157662308|FG001|Overall Study|Other|0|||
48954513|NCT01070550|157662309|FG002|Overall Study|Other|0|||
48954514|NCT01070550|157662310|FG003|Overall Study|Other|1|||
48954515|NCT01070550|157662311|FG004|Overall Study|Other|0|||
48954516|NCT01070550|157662312|FG005|Overall Study|Other|0|||
48954517|NCT01070550|157662307|FG000|Overall Study|Withdrawal by Subject|35|||
48954518|NCT01070550|157662308|FG001|Overall Study|Withdrawal by Subject|0|||
48954519|NCT01070550|157662309|FG002|Overall Study|Withdrawal by Subject|3|||
48954520|NCT01070550|157662310|FG003|Overall Study|Withdrawal by Subject|0|||
48954521|NCT01070550|157662311|FG004|Overall Study|Withdrawal by Subject|0|||
48954522|NCT01070550|157662312|FG005|Overall Study|Withdrawal by Subject|0|||
48954523|NCT00520676|157662313|FG000|Overall Study|Death|84|||
48954524|NCT00520676|157662314|FG001|Overall Study|Death|81|||
48954525|NCT00520676|157662313|FG000|Overall Study|Lost to Follow-up|6|||
48954526|NCT00520676|157662314|FG001|Overall Study|Lost to Follow-up|10|||
48954527|NCT00520676|157662313|FG000|Overall Study|Physician Decision|4|||
48747761|NCT00743340|156924925|FG000|Overall Study|Virologic failure|8|||
48747762|NCT00743340|156924925|FG000|Overall Study|Pregnancy|1|||
48747763|NCT00743340|156924925|FG000|Overall Study|Rolled over to other Gilead Study|23|||
48747764|NCT00743340|156924925|FG000|Overall Study|Participant Relocated|1|||
48747765|NCT00127660|156924926|FG000|Overall Study|Protocol Violation|3|||
48747766|NCT00127660|156924927|FG001|Overall Study|Protocol Violation|3|||
48747767|NCT00127660|156924928|FG002|Overall Study|Protocol Violation|5|||
48747768|NCT00127660|156924929|FG003|Overall Study|Protocol Violation|0|||
48747769|NCT01191801|156924934|FG000|Overall Study|Death|36|||
48747770|NCT01191801|156924935|FG001|Overall Study|Death|12|||
48747771|NCT01191801|156924934|FG000|Overall Study|Lack of Efficacy|176|||
48747772|NCT01191801|156924935|FG001|Overall Study|Lack of Efficacy|258|||
48747773|NCT01191801|156924934|FG000|Overall Study|Adverse Event|9|||
48747774|NCT01191801|156924935|FG001|Overall Study|Adverse Event|8|||
48747775|NCT01191801|156924934|FG000|Overall Study|Protocol Violation|2|||
48954528|NCT00520676|157662314|FG001|Overall Study|Physician Decision|1|||
48954529|NCT00520676|157662313|FG000|Overall Study|Withdrawal by Subject|7|||
48954530|NCT00520676|157662314|FG001|Overall Study|Withdrawal by Subject|11|||
48954531|NCT02179515|157662315|FG000|Overall Study|switched to alternative treatment|0|||
48954532|NCT02179515|157662316|FG001|Overall Study|switched to alternative treatment|1|||
48954533|NCT02179515|157662317|FG002|Overall Study|switched to alternative treatment|1|||
48954534|NCT02179515|157662315|FG000|Overall Study|Death|0|||
48954535|NCT02179515|157662316|FG001|Overall Study|Death|1|||
48954536|NCT02179515|157662317|FG002|Overall Study|Death|1|||
48954537|NCT02179515|157662315|FG000|Overall Study|refused further treatment|0|||
48954538|NCT02179515|157662316|FG001|Overall Study|refused further treatment|3|||
48954539|NCT02179515|157662317|FG002|Overall Study|refused further treatment|4|||
48954540|NCT02179515|157662315|FG000|Overall Study|Disease progression on study|2|||
48954541|NCT02179515|157662316|FG001|Overall Study|Disease progression on study|11|||
48954542|NCT02179515|157662317|FG002|Overall Study|Disease progression on study|8|||
48954543|NCT01585961|157662318|FG000|Overall Study|Death|6|||
48954544|NCT01585961|157662318|FG000|Overall Study|Physician Decision|1|||
48954545|NCT01585961|157662318|FG000|Overall Study|Decision to use non-study catheter|1|||
48954546|NCT01585961|157662318|FG000|Overall Study|Withdrawal by Subject|1|||
48954547|NCT01585961|157662318|FG000|Overall Study|Lost to Follow-up|23|||
48747776|NCT01191801|156924935|FG001|Overall Study|Protocol Violation|4|||
48747777|NCT01191801|156924934|FG000|Overall Study|Physician Decision|47|||
48747778|NCT01191801|156924935|FG001|Overall Study|Physician Decision|24|||
48747779|NCT01191801|156924934|FG000|Overall Study|Withdrawal by Subject|1|||
48747780|NCT01191801|156924935|FG001|Overall Study|Withdrawal by Subject|4|||
48747781|NCT01191801|156924934|FG000|Overall Study|Not Provided|45|||
48747782|NCT01191801|156924935|FG001|Overall Study|Not Provided|27|||
48747783|NCT00587054|156924936|FG000|Overall Study|Patient not treated|9|||
48747784|NCT00521014|156924937|FG000|Overall Study|Inevaluable, not treated|1|||
48747785|NCT01217814|156924944|FG000|Overall Study|Adverse Event|1|||
48747786|NCT01217814|156924945|FG001|Overall Study|Adverse Event|1|||
48747787|NCT01217814|156924946|FG002|Overall Study|Adverse Event|0|||
48747788|NCT01217814|156924944|FG000|Overall Study|Lack of Efficacy|0|||
48747789|NCT01217814|156924945|FG001|Overall Study|Lack of Efficacy|0|||
48747790|NCT01217814|156924946|FG002|Overall Study|Lack of Efficacy|1|||
48747791|NCT02925494|156924947|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
48747792|NCT02925494|156924948|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
48747793|NCT02925494|156924949|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
48747794|NCT02925494|156924950|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|23|||
48747795|NCT02925494|156924947|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
48747796|NCT02925494|156924948|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
48747797|NCT02925494|156924949|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|9|||
48747798|NCT02925494|156924950|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|10|||
48747799|NCT02925494|156924947|FG000|Post-Treatment Follow-Up Period|Other|1|||
48747800|NCT02925494|156924948|FG001|Post-Treatment Follow-Up Period|Other|4|||
48747801|NCT02925494|156924949|FG002|Post-Treatment Follow-Up Period|Other|3|||
48747802|NCT02925494|156924950|FG003|Post-Treatment Follow-Up Period|Other|6|||
48747803|NCT02925494|156924947|FG000|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1|||
48747804|NCT02925494|156924948|FG001|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
48747805|NCT02925494|156924949|FG002|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
48860446|NCT00267956|157326931|FG002|After Controlled Period|Withdrew consent|1|||
48860447|NCT00267956|157326932|FG003|After Controlled Period|Withdrew consent|0|||
48860448|NCT01190436|157326933|FG000|Overall Study|Lost to Follow-up|35|||
48860449|NCT01190436|157326933|FG000|Overall Study|Other|4|||
48860450|NCT00460434|157326934|FG000|Overall Study|Lost to Follow-up|3|||
48860451|NCT00460434|157326935|FG001|Overall Study|Lost to Follow-up|7|||
48860452|NCT02092909|157326937|FG000|Overall Study|Adverse Event|0|||
48860453|NCT02092909|157326938|FG001|Overall Study|Adverse Event|0|||
48860454|NCT02092909|157326939|FG002|Overall Study|Adverse Event|4|||
48860455|NCT02092909|157326940|FG003|Overall Study|Adverse Event|2|||
48860456|NCT02092909|157326937|FG000|Overall Study|Lack of Efficacy|0|||
48860457|NCT02092909|157326938|FG001|Overall Study|Lack of Efficacy|2|||
48860458|NCT02092909|157326939|FG002|Overall Study|Lack of Efficacy|1|||
48747806|NCT02925494|156924950|FG003|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6|||
48747807|NCT02925494|156924947|FG000|Post-Treatment Follow-Up Period|Pregnancy|1|||
48747808|NCT02925494|156924948|FG001|Post-Treatment Follow-Up Period|Pregnancy|0|||
48747809|NCT02925494|156924949|FG002|Post-Treatment Follow-Up Period|Pregnancy|1|||
48747810|NCT02925494|156924950|FG003|Post-Treatment Follow-Up Period|Pregnancy|2|||
49015380|NCT00306384|157892156|FG000|Overall Study|Investigator discretion|28|||
48747811|NCT02925494|156924947|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
48747812|NCT02925494|156924948|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
48747813|NCT02925494|156924949|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
48860459|NCT02092909|157326940|FG003|Overall Study|Lack of Efficacy|0|||
48860460|NCT02092909|157326937|FG000|Overall Study|Withdrawal by Subject|0|||
48860461|NCT02092909|157326938|FG001|Overall Study|Withdrawal by Subject|0|||
48860462|NCT02092909|157326939|FG002|Overall Study|Withdrawal by Subject|2|||
48747814|NCT02925494|156924950|FG003|Post-Treatment Follow-Up Period|Non-Compliance|2|||
48954548|NCT01585961|157662318|FG000|Overall Study|Ablation cancelled for slow-heal wound|1|||
48954549|NCT00109733|157662323|FG000|Overall Study|Protocol Violation|0|||
48954550|NCT00109733|157662324|FG001|Overall Study|Protocol Violation|1|||
48954551|NCT00109733|157662323|FG000|Overall Study|Stopped taking study drug|1|||
48954552|NCT00109733|157662324|FG001|Overall Study|Stopped taking study drug|1|||
48954553|NCT00109733|157662323|FG000|Overall Study|Non-compliant|0|||
48954554|NCT00109733|157662324|FG001|Overall Study|Non-compliant|1|||
48954555|NCT00109733|157662323|FG000|Overall Study|Could not commit time for study|1|||
48954556|NCT00109733|157662324|FG001|Overall Study|Could not commit time for study|1|||
48954557|NCT01728584|157662325|FG000|Overall Study|Adverse Event|1|||
48954558|NCT01728584|157662326|FG001|Overall Study|Adverse Event|0|||
48954559|NCT01728584|157662327|FG002|Overall Study|Adverse Event|0|||
48954560|NCT01728584|157662328|FG003|Overall Study|Adverse Event|0|||
48954561|NCT01728584|157662325|FG000|Overall Study|Physician Decision|4|||
48954562|NCT01728584|157662326|FG001|Overall Study|Physician Decision|0|||
48954563|NCT01728584|157662327|FG002|Overall Study|Physician Decision|1|||
48954564|NCT01728584|157662328|FG003|Overall Study|Physician Decision|0|||
48954565|NCT01728584|157662325|FG000|Overall Study|Withdrawal by Subject|1|||
48954566|NCT01728584|157662326|FG001|Overall Study|Withdrawal by Subject|0|||
48954567|NCT01728584|157662327|FG002|Overall Study|Withdrawal by Subject|0|||
48954568|NCT01728584|157662328|FG003|Overall Study|Withdrawal by Subject|0|||
48954569|NCT01728584|157662325|FG000|Overall Study|Screen failure|1|||
48954570|NCT01728584|157662326|FG001|Overall Study|Screen failure|0|||
48954571|NCT01728584|157662327|FG002|Overall Study|Screen failure|0|||
48954572|NCT01728584|157662328|FG003|Overall Study|Screen failure|0|||
48954573|NCT01728584|157662325|FG000|Overall Study|Other reason (not specified)|1|||
48954574|NCT01728584|157662326|FG001|Overall Study|Other reason (not specified)|0|||
48954575|NCT01728584|157662327|FG002|Overall Study|Other reason (not specified)|0|||
48954576|NCT01728584|157662328|FG003|Overall Study|Other reason (not specified)|1|||
48954577|NCT04964063|157662331|FG000|Overall Study|Adverse Event|4|||
48954578|NCT04964063|157662331|FG000|Overall Study|Lost to Follow-up|47|||
48954579|NCT04964063|157662331|FG000|Overall Study|Withdrawal by Subject|5|||
48954580|NCT04964063|157662331|FG000|Overall Study|Baseline Tasks Expired|41|||
48954581|NCT04964063|157662331|FG000|Overall Study|Participant withdrawn in error|1|||
48954582|NCT01035606|157662332|FG000|Overall Study|change in health, job demands,family|3|||
48954583|NCT01035606|157662333|FG001|Overall Study|change in health, job demands,family|3|||
48954584|NCT01035606|157662334|FG002|Overall Study|change in health, job demands,family|4|||
48954585|NCT03215264|157662336|FG000|Dose Level 2|Adverse Event|0|||
48954586|NCT03215264|157662337|FG001|Dose Level 2|Adverse Event|1|||
48954587|NCT03215264|157662338|FG002|Dose Level 2|Adverse Event|0|||
48954588|NCT03215264|157662336|FG000|Dose Level 3|Withdrawal by Subject|0|||
48954589|NCT03215264|157662337|FG001|Dose Level 3|Withdrawal by Subject|0|||
48954590|NCT03215264|157662338|FG002|Dose Level 3|Withdrawal by Subject|1|||
48747815|NCT02925494|156924947|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
48747816|NCT02925494|156924948|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
48747817|NCT02925494|156924949|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
48747818|NCT02925494|156924950|FG003|Post-Treatment Follow-Up Period|Adverse Event|1|||
48747819|NCT00640601|156924955|FG000|Overall Study|Adverse Event|43|||
48747820|NCT00640601|156924955|FG000|Overall Study|Withdrawal by Subject|20|||
48747821|NCT00640601|156924955|FG000|Overall Study|Protocol Violation|6|||
48747822|NCT00640601|156924955|FG000|Overall Study|Lack of Efficacy|16|||
48747823|NCT00640601|156924955|FG000|Overall Study|Lost to Follow-up|9|||
48747824|NCT00640601|156924955|FG000|Overall Study|Physician Decision|8|||
48747825|NCT00640601|156924955|FG000|Overall Study|treatment naive, combination therapy|10|||
48747826|NCT03060629|156924956|FG000|Overall Study|Death|4|||
48747827|NCT03060629|156924957|FG001|Overall Study|Death|5|||
48747828|NCT03060629|156924956|FG000|Overall Study|Withdrawal by Subject|50|||
48747829|NCT03060629|156924957|FG001|Overall Study|Withdrawal by Subject|35|||
48747830|NCT03060629|156924956|FG000|Overall Study|Unable to Adhere to Visit Schedule|21|||
48747831|NCT03060629|156924957|FG001|Overall Study|Unable to Adhere to Visit Schedule|23|||
48747832|NCT03060629|156924956|FG000|Overall Study|Participant Relocate|15|||
48747833|NCT03060629|156924957|FG001|Overall Study|Participant Relocate|15|||
48747834|NCT03060629|156924956|FG000|Overall Study|Unable to Contact Participant|34|||
48747835|NCT03060629|156924957|FG001|Overall Study|Unable to Contact Participant|23|||
48954591|NCT02433288|157662341|FG000|Overall Study|Severe non-compliance to protocol|13|||
48954592|NCT02433288|157662342|FG001|Overall Study|Severe non-compliance to protocol|7|||
48954593|NCT02433288|157662341|FG000|Overall Study|Eligibility criteria not fullfilled|7|||
48954594|NCT02433288|157662342|FG001|Overall Study|Eligibility criteria not fullfilled|3|||
48954595|NCT02433288|157662341|FG000|Overall Study|Withdrawal by Subject|101|||
48954596|NCT02433288|157662342|FG001|Overall Study|Withdrawal by Subject|99|||
48954597|NCT02433288|157662341|FG000|Overall Study|Lost to Follow-up|2|||
48954598|NCT02433288|157662342|FG001|Overall Study|Lost to Follow-up|14|||
48954599|NCT02433288|157662341|FG000|Overall Study|Death|0|||
48954600|NCT02433288|157662342|FG001|Overall Study|Death|3|||
48954601|NCT02234583|157662345|FG000|Overall Study|Adverse Event|172|||
48954602|NCT02234583|157662346|FG001|Overall Study|Adverse Event|156|||
48747836|NCT03060629|156924956|FG000|Overall Study|Investigator Decision|7|||
48747837|NCT03060629|156924957|FG001|Overall Study|Investigator Decision|7|||
48747838|NCT03060629|156924956|FG000|Overall Study|Study Terminated by Sponsor|1100|||
48747839|NCT03060629|156924957|FG001|Overall Study|Study Terminated by Sponsor|1123|||
48747840|NCT03060629|156924956|FG000|Overall Study|Other|4|||
48954603|NCT02234583|157662345|FG000|Overall Study|Withdrawal by Subject|109|||
48954604|NCT02234583|157662346|FG001|Overall Study|Withdrawal by Subject|157|||
48954605|NCT02234583|157662345|FG000|Overall Study|Lost to Follow-up|0|||
48954606|NCT02234583|157662346|FG001|Overall Study|Lost to Follow-up|1|||
48747841|NCT03060629|156924957|FG001|Overall Study|Other|4|||
48747842|NCT01666782|156924958|FG000|Overall Study|Received 2 doses of vaccine|0|||
48954607|NCT02234583|157662345|FG000|Overall Study|Lack of Efficacy|58|||
48954608|NCT02234583|157662346|FG001|Overall Study|Lack of Efficacy|103|||
48747843|NCT01666782|156924959|FG001|Overall Study|Received 2 doses of vaccine|1|||
48747844|NCT01666782|156924958|FG000|Overall Study|Enrolled both years; year 1 data used|4|||
48747845|NCT01666782|156924959|FG001|Overall Study|Enrolled both years; year 1 data used|0|||
48747846|NCT04786990|156924960|FG000|Overall Study|Withdrawal by Subject|1|||
48954609|NCT02234583|157662345|FG000|Overall Study|Protocol Violation|35|||
48954610|NCT02234583|157662346|FG001|Overall Study|Protocol Violation|42|||
48954611|NCT02234583|157662345|FG000|Overall Study|Other|39|||
48954612|NCT02234583|157662346|FG001|Overall Study|Other|97|||
48954613|NCT00257192|157662349|FG000|Overall Study|Adverse Event|21|||
48954614|NCT00257192|157662350|FG001|Overall Study|Adverse Event|10|||
48954615|NCT00257192|157662349|FG000|Overall Study|Laboratory abnormality|1|||
48954616|NCT00257192|157662350|FG001|Overall Study|Laboratory abnormality|1|||
48954617|NCT00257192|157662349|FG000|Overall Study|Lost to Follow-up|3|||
48954618|NCT00257192|157662350|FG001|Overall Study|Lost to Follow-up|3|||
48954619|NCT00257192|157662349|FG000|Overall Study|Insufficient clinical response|18|||
48954620|NCT00257192|157662350|FG001|Overall Study|Insufficient clinical response|18|||
48954621|NCT00257192|157662349|FG000|Overall Study|Withdrawal by Subject|14|||
48954622|NCT00257192|157662350|FG001|Overall Study|Withdrawal by Subject|2|||
48954623|NCT00257192|157662349|FG000|Overall Study|Randomized but not treated|0|||
48954624|NCT00257192|157662350|FG001|Overall Study|Randomized but not treated|1|||
48954625|NCT00257192|157662349|FG000|Overall Study|Study terminated by sponsor|1|||
48954626|NCT00257192|157662350|FG001|Overall Study|Study terminated by sponsor|0|||
48954627|NCT00257192|157662349|FG000|Overall Study|Miscellaneous|0|||
48954628|NCT00257192|157662350|FG001|Overall Study|Miscellaneous|4|||
48954629|NCT01905397|157662353|FG000|Overall Study|Death|0|||
48954630|NCT01905397|157662354|FG001|Overall Study|Death|1|||
48954631|NCT01905397|157662353|FG000|Overall Study|Withdrawal by Subject|2|||
48954632|NCT01905397|157662354|FG001|Overall Study|Withdrawal by Subject|0|||
48954633|NCT01905397|157662353|FG000|Overall Study|Surgery canceled/aborted|9|||
48954634|NCT01905397|157662354|FG001|Overall Study|Surgery canceled/aborted|5|||
48954635|NCT01905397|157662353|FG000|Overall Study|Incision < 7 cm|2|||
48954636|NCT01905397|157662354|FG001|Overall Study|Incision < 7 cm|0|||
48954637|NCT01905397|157662353|FG000|Overall Study|Wrong treatment|1|||
48954638|NCT01905397|157662354|FG001|Overall Study|Wrong treatment|1|||
48954639|NCT01905397|157662353|FG000|Overall Study|Device not applied|3|||
48954640|NCT01905397|157662354|FG001|Overall Study|Device not applied|0|||
48954641|NCT01905397|157662353|FG000|Overall Study|Dressing not applied in operating room|1|||
48747847|NCT04786990|156924960|FG000|Overall Study|Adverse Event|1|||
48954642|NCT01905397|157662354|FG001|Overall Study|Dressing not applied in operating room|0|||
48747848|NCT04786990|156924960|FG000|Overall Study|Lost to Follow-up|1|||
48747849|NCT04786990|156924960|FG000|Overall Study|Noncompliance|1|||
48747850|NCT04786990|156924960|FG000|Overall Study|Unable to complete site visits|1|||
48747851|NCT04786990|156924960|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
48747852|NCT02615145|156924973|FG000|Overall Study|Did Not Start Treatment|0|||
48747853|NCT02615145|156924974|FG001|Overall Study|Did Not Start Treatment|0|||
48747854|NCT02615145|156924975|FG002|Overall Study|Did Not Start Treatment|1|||
48747855|NCT02615145|156924976|FG003|Overall Study|Did Not Start Treatment|1|||
48747856|NCT02615145|156924973|FG000|Overall Study|Failure to Return|20|||
48747857|NCT02615145|156924974|FG001|Overall Study|Failure to Return|10|||
48747858|NCT02615145|156924975|FG002|Overall Study|Failure to Return|7|||
48860463|NCT02092909|157326940|FG003|Overall Study|Withdrawal by Subject|1|||
48860464|NCT02092909|157326937|FG000|Overall Study|Study terminated by Sponsor|0|||
48860465|NCT02092909|157326938|FG001|Overall Study|Study terminated by Sponsor|0|||
48860466|NCT02092909|157326939|FG002|Overall Study|Study terminated by Sponsor|0|||
48954643|NCT01905397|157662353|FG000|Overall Study|Wound vac turned off due to device alarm|1|||
48954644|NCT01905397|157662354|FG001|Overall Study|Wound vac turned off due to device alarm|0|||
48954645|NCT00938327|157662355|FG000|Overall Study|Adverse Event|2|||
48954646|NCT00938327|157662355|FG000|Overall Study|Protocol Violation|1|||
48954647|NCT00938327|157662355|FG000|Overall Study|Withdrawal by Subject|4|||
48954648|NCT00938327|157662355|FG000|Overall Study|Lost to Follow-up|37|||
48954649|NCT00938327|157662355|FG000|Overall Study|2nd dose received outside of the study|7|||
48954650|NCT00938327|157662355|FG000|Overall Study|Vaccine not received as out of stock|9|||
48954651|NCT04285346|157662356|FG000|Treatment Period (Up to 12 Weeks)|Adverse Event|4|||
48954652|NCT04285346|157662357|FG001|Treatment Period (Up to 12 Weeks)|Adverse Event|0|||
48954653|NCT04285346|157662356|FG000|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|1|||
48954654|NCT04285346|157662357|FG001|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|0|||
48954655|NCT04285346|157662356|FG000|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|1|||
48954656|NCT04285346|157662357|FG001|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
48954657|NCT02680847|157662358|FG000|Overall Study|Other|2|||
48954658|NCT02680847|157662359|FG001|Overall Study|Other|0|||
48954659|NCT02680847|157662360|FG002|Overall Study|Other|0|||
48954660|NCT02680847|157662358|FG000|Overall Study|No longer met eligibility criteria|2|||
48954661|NCT02680847|157662359|FG001|Overall Study|No longer met eligibility criteria|2|||
48747859|NCT02615145|156924976|FG003|Overall Study|Failure to Return|0|||
48747860|NCT02615145|156924973|FG000|Overall Study|Death|2|||
48747861|NCT02615145|156924974|FG001|Overall Study|Death|3|||
48860467|NCT02092909|157326940|FG003|Overall Study|Study terminated by Sponsor|2|||
48860468|NCT02092909|157326937|FG000|Overall Study|Miscellaneous|1|||
48860469|NCT02092909|157326938|FG001|Overall Study|Miscellaneous|1|||
48860470|NCT02092909|157326939|FG002|Overall Study|Miscellaneous|2|||
48860471|NCT02092909|157326940|FG003|Overall Study|Miscellaneous|1|||
48860472|NCT00821093|157326941|FG000|Overall Study|Adverse Event|20|||
48860473|NCT00821093|157326942|FG001|Overall Study|Adverse Event|12|||
48860474|NCT00821093|157326941|FG000|Overall Study|Withdrawal by Subject|9|||
48860475|NCT00821093|157326942|FG001|Overall Study|Withdrawal by Subject|13|||
48860476|NCT00821093|157326941|FG000|Overall Study|Lost to Follow-up|9|||
48860477|NCT00821093|157326942|FG001|Overall Study|Lost to Follow-up|3|||
48860478|NCT00821093|157326941|FG000|Overall Study|Protocol deviation|3|||
48860479|NCT00821093|157326942|FG001|Overall Study|Protocol deviation|6|||
48860480|NCT00821093|157326941|FG000|Overall Study|Abnormal laboratory value(s)|2|||
48860481|NCT00821093|157326942|FG001|Overall Study|Abnormal laboratory value(s)|0|||
48860482|NCT00821093|157326941|FG000|Overall Study|Lack of Efficacy|2|||
48954662|NCT02680847|157662360|FG002|Overall Study|No longer met eligibility criteria|0|||
48747862|NCT02615145|156924975|FG002|Overall Study|Death|0|||
48860483|NCT00821093|157326942|FG001|Overall Study|Lack of Efficacy|2|||
48747863|NCT02615145|156924976|FG003|Overall Study|Death|0|||
48747864|NCT02615145|156924973|FG000|Overall Study|Other, Not Specified|5|||
48747865|NCT02615145|156924974|FG001|Overall Study|Other, Not Specified|2|||
48747866|NCT02615145|156924975|FG002|Overall Study|Other, Not Specified|0|||
48747867|NCT02615145|156924976|FG003|Overall Study|Other, Not Specified|0|||
48747868|NCT00382252|156924977|FG000|Overall Study|Death|4|||
48747869|NCT00382252|156924977|FG000|Overall Study|Protocol Violation|8|||
48954663|NCT02680847|157662358|FG000|Overall Study|Unwilling to participate in study|1|||
48747870|NCT00382252|156924977|FG000|Overall Study|Not treated by RFA|1|||
48747871|NCT02854631|156924979|FG000|Overall Study|Adverse Event|1|||
48747872|NCT02854631|156924980|FG001|Overall Study|Adverse Event|2|||
48747873|NCT02854631|156924979|FG000|Overall Study|Withdrew Consent|3|||
48747874|NCT02854631|156924980|FG001|Overall Study|Withdrew Consent|2|||
48747875|NCT02854631|156924979|FG000|Overall Study|Investigator's Discretion|2|||
48747876|NCT02854631|156924980|FG001|Overall Study|Investigator's Discretion|0|||
48747877|NCT02854631|156924979|FG000|Overall Study|Death|12|||
48747878|NCT02854631|156924980|FG001|Overall Study|Death|8|||
48747879|NCT02854631|156924979|FG000|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2|||
48747880|NCT02854631|156924980|FG001|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0|||
48747881|NCT02854631|156924979|FG000|Overall Study|Protocol Violation|0|||
48747882|NCT02854631|156924980|FG001|Overall Study|Protocol Violation|1|||
48747883|NCT02854631|156924979|FG000|Overall Study|Subjects Randomized but Never Treated|2|||
48747884|NCT02854631|156924980|FG001|Overall Study|Subjects Randomized but Never Treated|0|||
48747885|NCT02854631|156924979|FG000|Overall Study|Lost to Follow-up|4|||
48747886|NCT02854631|156924980|FG001|Overall Study|Lost to Follow-up|2|||
48747887|NCT04051008|156924981|FG000|Overall Study|Withdrawal by Subject|2|||
48747888|NCT04051008|156924982|FG001|Overall Study|Withdrawal by Subject|0|||
48747889|NCT04051008|156924983|FG002|Overall Study|Withdrawal by Subject|1|||
48747890|NCT03930797|156924984|FG000|Overall Study|Lost to Follow-up|3|||
48747891|NCT03930797|156924985|FG001|Overall Study|Lost to Follow-up|10|||
48747892|NCT03334903|156924987|FG000|Overall Study|Use of medical marijuana - determined ineligible later in study|1|||
48747893|NCT03334903|156924988|FG001|Overall Study|Use of medical marijuana - determined ineligible later in study|0|||
48747894|NCT03334903|156924987|FG000|Overall Study|Protocol Violation|1|||
48747895|NCT03334903|156924988|FG001|Overall Study|Protocol Violation|3|||
48747896|NCT03334903|156924987|FG000|Overall Study|Surgery postponed|1|||
48954664|NCT02680847|157662359|FG001|Overall Study|Unwilling to participate in study|1|||
48954665|NCT02680847|157662360|FG002|Overall Study|Unwilling to participate in study|0|||
48954666|NCT02680847|157662358|FG000|Overall Study|Lack of Efficacy|0|||
48954667|NCT02680847|157662359|FG001|Overall Study|Lack of Efficacy|0|||
48954668|NCT02680847|157662360|FG002|Overall Study|Lack of Efficacy|2|||
48954669|NCT02680847|157662358|FG000|Overall Study|Adverse Event|0|||
48954670|NCT02680847|157662359|FG001|Overall Study|Adverse Event|0|||
48954671|NCT02680847|157662360|FG002|Overall Study|Adverse Event|1|||
48954672|NCT00540449|157662366|FG000|Overall Study|Adverse Event|12|||
48954673|NCT00540449|157662367|FG001|Overall Study|Adverse Event|32|||
48747897|NCT03334903|156924988|FG001|Overall Study|Surgery postponed|0|||
48747898|NCT03334903|156924987|FG000|Overall Study|Adverse Event|1|||
48747899|NCT03334903|156924988|FG001|Overall Study|Adverse Event|1|||
48747900|NCT03334903|156924987|FG000|Overall Study|Withdrawal by Subject|0|||
48747901|NCT03334903|156924988|FG001|Overall Study|Withdrawal by Subject|1|||
48747902|NCT00317356|156924989|FG000|Overall Study|Adverse Event|0|||
48747903|NCT00317356|156924990|FG001|Overall Study|Adverse Event|0|||
48747904|NCT00317356|156924991|FG002|Overall Study|Adverse Event|1|||
48747905|NCT00317356|156924992|FG003|Overall Study|Adverse Event|0|||
48954674|NCT00540449|157662366|FG000|Overall Study|Sponsor's Decision|1|||
48954675|NCT00540449|157662367|FG001|Overall Study|Sponsor's Decision|1|||
48860484|NCT00821093|157326941|FG000|Overall Study|Death|2|||
48860485|NCT00821093|157326942|FG001|Overall Study|Death|1|||
48860486|NCT00821093|157326941|FG000|Overall Study|Abnormal test procedure result(s)|1|||
48860487|NCT00821093|157326942|FG001|Overall Study|Abnormal test procedure result(s)|1|||
48747906|NCT00317356|156924989|FG000|Overall Study|Lack of Efficacy|1|||
48747907|NCT00317356|156924990|FG001|Overall Study|Lack of Efficacy|1|||
48860488|NCT00821093|157326941|FG000|Overall Study|Administrative problems|1|||
48860489|NCT00821093|157326942|FG001|Overall Study|Administrative problems|2|||
48860490|NCT01014013|157326943|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
48860491|NCT01014013|157326944|FG001|Overall Study|Inclusion/Exclusion criteria not met|3|||
48860492|NCT01014013|157326943|FG000|Overall Study|Clinical adverse experience|4|||
48860493|NCT01014013|157326944|FG001|Overall Study|Clinical adverse experience|2|||
48860494|NCT01014013|157326943|FG000|Overall Study|Laboratory adverse experience|1|||
48860495|NCT01014013|157326944|FG001|Overall Study|Laboratory adverse experience|1|||
48860496|NCT01014013|157326943|FG000|Overall Study|Protocol Violation|1|||
48860497|NCT01014013|157326944|FG001|Overall Study|Protocol Violation|3|||
48860498|NCT01014013|157326943|FG000|Overall Study|Withdrawal by Subject|7|||
48860499|NCT01014013|157326944|FG001|Overall Study|Withdrawal by Subject|4|||
48860500|NCT01014013|157326943|FG000|Overall Study|Clinical/microbiologic failure|1|||
48860501|NCT01014013|157326944|FG001|Overall Study|Clinical/microbiologic failure|2|||
48860502|NCT01014013|157326943|FG000|Overall Study|Pathogen culture = no growth|26|||
48860503|NCT01014013|157326944|FG001|Overall Study|Pathogen culture = no growth|34|||
48747908|NCT00317356|156924991|FG002|Overall Study|Lack of Efficacy|0|||
48747909|NCT00317356|156924992|FG003|Overall Study|Lack of Efficacy|3|||
48747910|NCT00317356|156924989|FG000|Overall Study|Physician Decision|0|||
48747911|NCT00317356|156924990|FG001|Overall Study|Physician Decision|1|||
48747912|NCT00317356|156924991|FG002|Overall Study|Physician Decision|0|||
48747913|NCT00317356|156924992|FG003|Overall Study|Physician Decision|0|||
48747914|NCT04342897|156924993|FG000|Overall Study|Death|7|||
48747915|NCT04342897|156924994|FG001|Overall Study|Death|4|||
48747916|NCT04342897|156924993|FG000|Overall Study|Lost to Follow-up|6|||
48747917|NCT04342897|156924994|FG001|Overall Study|Lost to Follow-up|6|||
48747918|NCT04342897|156924993|FG000|Overall Study|Withdrawal by Subject|1|||
48860504|NCT01014013|157326943|FG000|Overall Study|Negative urine culture|2|||
48860505|NCT01014013|157326944|FG001|Overall Study|Negative urine culture|0|||
48860506|NCT01014013|157326943|FG000|Overall Study|Pathogen resistant|7|||
48860507|NCT01014013|157326944|FG001|Overall Study|Pathogen resistant|4|||
48860508|NCT01014013|157326943|FG000|Overall Study|Physician Decision|0|||
48860509|NCT01014013|157326944|FG001|Overall Study|Physician Decision|1|||
48860510|NCT01014013|157326943|FG000|Overall Study|Another antibiotic therapy required|0|||
48860511|NCT01014013|157326944|FG001|Overall Study|Another antibiotic therapy required|1|||
48860512|NCT01014013|157326943|FG000|Overall Study|Appendectomy|1|||
48860513|NCT01014013|157326944|FG001|Overall Study|Appendectomy|0|||
48860514|NCT01014013|157326943|FG000|Overall Study|Inappropriate therapy duration, < 7 Days|0|||
48860515|NCT01014013|157326944|FG001|Overall Study|Inappropriate therapy duration, < 7 Days|1|||
48860516|NCT03031782|157326946|FG000|Treatment Period 1|Lack of Efficacy|3|||
48860517|NCT03031782|157326947|FG001|Treatment Period 1|Lack of Efficacy|0|||
48860518|NCT03031782|157326948|FG002|Treatment Period 1|Lack of Efficacy|0|||
48860519|NCT03031782|157326949|FG003|Treatment Period 1|Lack of Efficacy|0|||
48860520|NCT03031782|157326950|FG004|Treatment Period 1|Lack of Efficacy|0|||
48860521|NCT03031782|157326946|FG000|Treatment Period 2|Physician Decision|0|||
48860522|NCT03031782|157326947|FG001|Treatment Period 2|Physician Decision|1|||
48860523|NCT03031782|157326948|FG002|Treatment Period 2|Physician Decision|0|||
48860524|NCT03031782|157326949|FG003|Treatment Period 2|Physician Decision|0|||
48860525|NCT03031782|157326950|FG004|Treatment Period 2|Physician Decision|3|||
48860526|NCT03031782|157326946|FG000|Treatment Period 2|Lack of Efficacy|0|||
48860527|NCT03031782|157326947|FG001|Treatment Period 2|Lack of Efficacy|1|||
48860528|NCT03031782|157326948|FG002|Treatment Period 2|Lack of Efficacy|0|||
48860529|NCT03031782|157326949|FG003|Treatment Period 2|Lack of Efficacy|0|||
48860530|NCT03031782|157326950|FG004|Treatment Period 2|Lack of Efficacy|1|||
48860531|NCT03031782|157326946|FG000|Treatment Period 2|Withdrawal by Subject|0|||
48860532|NCT03031782|157326947|FG001|Treatment Period 2|Withdrawal by Subject|3|||
48860533|NCT03031782|157326948|FG002|Treatment Period 2|Withdrawal by Subject|0|||
48860534|NCT03031782|157326949|FG003|Treatment Period 2|Withdrawal by Subject|0|||
48954676|NCT00540449|157662366|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
48954677|NCT00540449|157662367|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
48860535|NCT03031782|157326950|FG004|Treatment Period 2|Withdrawal by Subject|1|||
48954678|NCT00540449|157662366|FG000|Overall Study|Lost to Follow-up|19|||
48860536|NCT03031782|157326946|FG000|Treatment Period 2|Adverse Event|0|||
48860537|NCT03031782|157326947|FG001|Treatment Period 2|Adverse Event|1|||
48860538|NCT03031782|157326948|FG002|Treatment Period 2|Adverse Event|2|||
48860539|NCT03031782|157326949|FG003|Treatment Period 2|Adverse Event|0|||
48860540|NCT03031782|157326950|FG004|Treatment Period 2|Adverse Event|0|||
48747919|NCT04342897|156924994|FG001|Overall Study|Withdrawal by Subject|2|||
48954679|NCT00540449|157662367|FG001|Overall Study|Lost to Follow-up|17|||
48747920|NCT01835587|156924999|FG000|Overall Study|Disease Recurrence or Relapse|0|||
48860541|NCT03031782|157326946|FG000|Treatment Period 3|Withdrawal by Subject|0|||
48860542|NCT03031782|157326947|FG001|Treatment Period 3|Withdrawal by Subject|0|||
48860543|NCT03031782|157326948|FG002|Treatment Period 3|Withdrawal by Subject|0|||
48860544|NCT03031782|157326949|FG003|Treatment Period 3|Withdrawal by Subject|1|||
48860545|NCT03031782|157326950|FG004|Treatment Period 3|Withdrawal by Subject|0|||
48860546|NCT00901459|157326951|FG000|Overall Study|Withdrawal by Subject|6|||
48860547|NCT00753896|157326952|FG000|Overall Study|Adverse Event|4|||
48860548|NCT00753896|157326952|FG000|Overall Study|Death|1|||
48860549|NCT00753896|157326952|FG000|Overall Study|Lost to Follow-up|2|||
48860550|NCT00753896|157326952|FG000|Overall Study|Protocol Violation|1|||
48860551|NCT00753896|157326952|FG000|Overall Study|Withdrawal by Subject|4|||
48860552|NCT00753896|157326952|FG000|Overall Study|Entry Criteria Not Met|4|||
48860553|NCT01280656|157326953|FG000|Overall Study|Adverse Event|1|||
48860554|NCT01280656|157326954|FG001|Overall Study|Adverse Event|14|||
48860555|NCT01280656|157326955|FG002|Overall Study|Adverse Event|13|||
48860556|NCT01280656|157326953|FG000|Overall Study|Lack of Efficacy|1|||
48860557|NCT01280656|157326954|FG001|Overall Study|Lack of Efficacy|22|||
48860558|NCT01280656|157326955|FG002|Overall Study|Lack of Efficacy|38|||
48860559|NCT01280656|157326953|FG000|Overall Study|Treatment shortening (RGT)|0|||
48860560|NCT01280656|157326954|FG001|Overall Study|Treatment shortening (RGT)|4|||
48860561|NCT01280656|157326955|FG002|Overall Study|Treatment shortening (RGT)|5|||
48860562|NCT01280656|157326953|FG000|Overall Study|Other|1|||
48860563|NCT01280656|157326954|FG001|Overall Study|Other|7|||
48860564|NCT01280656|157326955|FG002|Overall Study|Other|7|||
48860565|NCT03906240|157326956|FG000|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|4|||
48860566|NCT03906240|157326957|FG001|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|0|||
48860567|NCT03906240|157326956|FG000|Overall Study|Lost to Follow-up|1|||
48860568|NCT03906240|157326957|FG001|Overall Study|Lost to Follow-up|0|||
48860569|NCT03906240|157326956|FG000|Overall Study|Withdrawal by Subject|0|||
48860570|NCT03906240|157326957|FG001|Overall Study|Withdrawal by Subject|1|||
48860571|NCT00157209|157326963|FG000|Overall Study|Ongoing at data cut-off|10|||
48860572|NCT00157209|157326964|FG001|Overall Study|Ongoing at data cut-off|0|||
48860573|NCT01721109|157326967|FG000|Overall Study|Lack of Efficacy|1|||
48860574|NCT01721109|157326967|FG000|Overall Study|Non- Compliance with Study Drug|3|||
48860575|NCT01721109|157326967|FG000|Overall Study|Withdrew Consent|1|||
48860576|NCT01721109|157326967|FG000|Overall Study|Lost to Follow-up|2|||
48860577|NCT05522777|157328497|FG000|Overall Study|Lack of Efficacy|1|||
48860578|NCT05522777|157328497|FG000|Overall Study|Withdrawal by Subject|1|||
48860579|NCT04730271|157328498|FG000|Overall Study|Adverse Event|0|||
48860580|NCT04730271|157328499|FG001|Overall Study|Adverse Event|2|||
48954680|NCT00540449|157662366|FG000|Overall Study|Subject Non-Compliant|7|||
48954681|NCT00540449|157662367|FG001|Overall Study|Subject Non-Compliant|5|||
48954682|NCT00540449|157662366|FG000|Overall Study|Subject Reached A Virologic Endpoint|32|||
48954683|NCT00540449|157662367|FG001|Overall Study|Subject Reached A Virologic Endpoint|8|||
48954684|NCT00540449|157662366|FG000|Overall Study|Withdrawal by Subject|10|||
48954685|NCT00540449|157662367|FG001|Overall Study|Withdrawal by Subject|10|||
48954686|NCT00540449|157662366|FG000|Overall Study|Other|1|||
48954687|NCT00540449|157662367|FG001|Overall Study|Other|4|||
48954688|NCT00633139|157662369|FG000|Overall Study|Non compliance|0|||
48954689|NCT00633139|157662370|FG001|Overall Study|Non compliance|0|||
48954690|NCT00633139|157662371|FG002|Overall Study|Non compliance|1|||
48954691|NCT00633139|157662369|FG000|Overall Study|Withdrawal by Subject|0|||
48954692|NCT00633139|157662370|FG001|Overall Study|Withdrawal by Subject|1|||
48954693|NCT00633139|157662371|FG002|Overall Study|Withdrawal by Subject|0|||
48954694|NCT00601523|157662374|FG000|Overall Study|Adverse Event|42|||
48954695|NCT00601523|157662375|FG001|Overall Study|Adverse Event|14|||
48954696|NCT00601523|157662374|FG000|Overall Study|Lack of Efficacy|3|||
48860581|NCT04730271|157328498|FG000|Overall Study|Withdrawal by Subject|1|||
48860582|NCT04730271|157328499|FG001|Overall Study|Withdrawal by Subject|1|||
48860583|NCT04730271|157328498|FG000|Overall Study|Protocol Violation|7|||
48860584|NCT04730271|157328499|FG001|Overall Study|Protocol Violation|13|||
48860585|NCT04730271|157328498|FG000|Overall Study|Lost to Follow-up|3|||
48954697|NCT00601523|157662375|FG001|Overall Study|Lack of Efficacy|0|||
48860586|NCT04730271|157328499|FG001|Overall Study|Lost to Follow-up|3|||
48860587|NCT04730271|157328498|FG000|Overall Study|Death|1|||
48860588|NCT04730271|157328499|FG001|Overall Study|Death|0|||
48860589|NCT01732757|157328500|FG000|Overall Study|Lost to Follow-up|1|||
48860590|NCT01732757|157328501|FG001|Overall Study|Lost to Follow-up|0|||
48860591|NCT01732757|157328502|FG002|Overall Study|Lost to Follow-up|0|||
48860592|NCT01304940|157328508|FG000|Overall Study|not meet symptom severity requirement|3|||
48860593|NCT01304940|157328509|FG001|Overall Study|not meet symptom severity requirement|0|||
48860594|NCT00087516|157328510|FG000|Overall Study|Adverse Event|10|||
48860595|NCT00087516|157328511|FG001|Overall Study|Adverse Event|10|||
48860596|NCT00087516|157328512|FG002|Overall Study|Adverse Event|3|||
48860597|NCT00087516|157328513|FG003|Overall Study|Adverse Event|6|||
48860598|NCT00087516|157328510|FG000|Overall Study|Lack of Efficacy|82|||
48860599|NCT00087516|157328511|FG001|Overall Study|Lack of Efficacy|80|||
48860600|NCT00087516|157328512|FG002|Overall Study|Lack of Efficacy|39|||
48954698|NCT00601523|157662374|FG000|Overall Study|Protocol Violation|5|||
48954699|NCT00601523|157662375|FG001|Overall Study|Protocol Violation|1|||
48954700|NCT00601523|157662374|FG000|Overall Study|Lost to Follow-up|0|||
48954701|NCT00601523|157662375|FG001|Overall Study|Lost to Follow-up|1|||
48954702|NCT00601523|157662374|FG000|Overall Study|Withdrawal by Subject|18|||
48954703|NCT00601523|157662375|FG001|Overall Study|Withdrawal by Subject|9|||
48954704|NCT00601523|157662374|FG000|Overall Study|Other|9|||
48954705|NCT00601523|157662375|FG001|Overall Study|Other|1|||
48954706|NCT03643432|157662376|FG000|Overall Study|Lost to Follow-up|1|||
48954707|NCT03643432|157662377|FG001|Overall Study|Lost to Follow-up|0|||
48860601|NCT00087516|157328513|FG003|Overall Study|Lack of Efficacy|29|||
48860602|NCT00087516|157328510|FG000|Overall Study|Lost to Follow-up|8|||
48954708|NCT00804193|157662378|FG000|Overall Study|Lack of baseline fungus|32|||
48860603|NCT00087516|157328511|FG001|Overall Study|Lost to Follow-up|6|||
48860604|NCT00087516|157328512|FG002|Overall Study|Lost to Follow-up|5|||
48860605|NCT00087516|157328513|FG003|Overall Study|Lost to Follow-up|5|||
48954709|NCT00804193|157662379|FG001|Overall Study|Lack of baseline fungus|31|||
48954710|NCT00804193|157662380|FG002|Overall Study|Lack of baseline fungus|19|||
48747921|NCT01835587|156925000|FG001|Overall Study|Disease Recurrence or Relapse|3|||
48747922|NCT01835587|156925001|FG002|Overall Study|Disease Recurrence or Relapse|0|||
48747923|NCT01835587|156925002|FG003|Overall Study|Disease Recurrence or Relapse|3|||
48747924|NCT01835587|156924999|FG000|Overall Study|Withdrawal by Subject|2|||
48747925|NCT01835587|156925000|FG001|Overall Study|Withdrawal by Subject|0|||
48747926|NCT01835587|156925001|FG002|Overall Study|Withdrawal by Subject|0|||
48747927|NCT01835587|156925002|FG003|Overall Study|Withdrawal by Subject|3|||
48747928|NCT01835587|156924999|FG000|Overall Study|Adverse Event|0|||
48747929|NCT01835587|156925000|FG001|Overall Study|Adverse Event|0|||
48747930|NCT01835587|156925001|FG002|Overall Study|Adverse Event|2|||
48747931|NCT01835587|156925002|FG003|Overall Study|Adverse Event|2|||
48747932|NCT01835587|156924999|FG000|Overall Study|Death|0|||
48747933|NCT01835587|156925000|FG001|Overall Study|Death|0|||
48747934|NCT01835587|156925001|FG002|Overall Study|Death|0|||
48747935|NCT01835587|156925002|FG003|Overall Study|Death|1|||
48747936|NCT01835587|156924999|FG000|Overall Study|Miscellaneous|0|||
48747937|NCT01835587|156925000|FG001|Overall Study|Miscellaneous|1|||
48747938|NCT01835587|156925001|FG002|Overall Study|Miscellaneous|0|||
48747939|NCT01835587|156925002|FG003|Overall Study|Miscellaneous|0|||
48747940|NCT00357968|156925003|FG000|First Maintenance Dose Phase|Not a PCI patient|47|||
48747941|NCT00357968|156925004|FG001|First Maintenance Dose Phase|Not a PCI patient|42|||
48747942|NCT00357968|156925003|FG000|First Maintenance Dose Phase|Withdrawal by Subject|1|||
48747943|NCT00357968|156925004|FG001|First Maintenance Dose Phase|Withdrawal by Subject|2|||
48747944|NCT03919799|156925005|FG000|DB Period (28 Weeks)|Randomized not treated|1|||
48747945|NCT03919799|156925006|FG001|DB Period (28 Weeks)|Randomized not treated|0|||
48747946|NCT03919799|156925007|FG002|DB Period (28 Weeks)|Randomized not treated|0|||
48747947|NCT03919799|156925008|FG003|DB Period (28 Weeks)|Randomized not treated|0|||
48747948|NCT03919799|156925009|FG004|DB Period (28 Weeks)|Randomized not treated|0|||
48747949|NCT03919799|156925005|FG000|DB Period (28 Weeks)|Adverse Event|1|||
48747950|NCT03919799|156925006|FG001|DB Period (28 Weeks)|Adverse Event|1|||
48747951|NCT03919799|156925007|FG002|DB Period (28 Weeks)|Adverse Event|1|||
48747952|NCT03919799|156925008|FG003|DB Period (28 Weeks)|Adverse Event|0|||
48747953|NCT03919799|156925009|FG004|DB Period (28 Weeks)|Adverse Event|0|||
48747954|NCT03919799|156925005|FG000|DB Period (28 Weeks)|Withdrawal by Subject|0|||
48860606|NCT00087516|157328510|FG000|Overall Study|Protocol Violation|4|||
48860607|NCT00087516|157328511|FG001|Overall Study|Protocol Violation|8|||
48860608|NCT00087516|157328512|FG002|Overall Study|Protocol Violation|3|||
48860609|NCT00087516|157328513|FG003|Overall Study|Protocol Violation|6|||
48860610|NCT00087516|157328510|FG000|Overall Study|Withdrawal by Subject|16|||
48860611|NCT00087516|157328511|FG001|Overall Study|Withdrawal by Subject|27|||
48747955|NCT03919799|156925006|FG001|DB Period (28 Weeks)|Withdrawal by Subject|1|||
48747956|NCT03919799|156925007|FG002|DB Period (28 Weeks)|Withdrawal by Subject|0|||
48747957|NCT03919799|156925008|FG003|DB Period (28 Weeks)|Withdrawal by Subject|0|||
48747958|NCT03919799|156925009|FG004|DB Period (28 Weeks)|Withdrawal by Subject|0|||
48747959|NCT03919799|156925005|FG000|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
48747960|NCT03919799|156925006|FG001|OLE Period (24 Weeks)|Withdrawal by Subject|2|||
48860612|NCT00087516|157328512|FG002|Overall Study|Withdrawal by Subject|11|||
48860613|NCT00087516|157328513|FG003|Overall Study|Withdrawal by Subject|12|||
48954711|NCT00804193|157662378|FG000|Overall Study|Adverse Event|0|||
48954712|NCT00804193|157662379|FG001|Overall Study|Adverse Event|0|||
48954713|NCT00804193|157662380|FG002|Overall Study|Adverse Event|2|||
48747961|NCT03919799|156925007|FG002|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
48747962|NCT03919799|156925008|FG003|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
48747963|NCT03919799|156925009|FG004|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
48954714|NCT00804193|157662378|FG000|Overall Study|Lack of Efficacy|1|||
48954715|NCT00804193|157662379|FG001|Overall Study|Lack of Efficacy|1|||
48954716|NCT00804193|157662380|FG002|Overall Study|Lack of Efficacy|3|||
48954717|NCT00804193|157662378|FG000|Overall Study|Protocol Violation|0|||
48954718|NCT00804193|157662379|FG001|Overall Study|Protocol Violation|8|||
48954719|NCT00804193|157662380|FG002|Overall Study|Protocol Violation|2|||
48954720|NCT00804193|157662378|FG000|Overall Study|Lost to Follow-up|3|||
48954721|NCT00804193|157662379|FG001|Overall Study|Lost to Follow-up|3|||
48954722|NCT00804193|157662380|FG002|Overall Study|Lost to Follow-up|4|||
48954723|NCT00804193|157662378|FG000|Overall Study|Withdrawal by Subject|3|||
48954724|NCT00804193|157662379|FG001|Overall Study|Withdrawal by Subject|1|||
48954725|NCT00804193|157662380|FG002|Overall Study|Withdrawal by Subject|2|||
48954726|NCT00237796|157662383|FG000|Overall Study|Baseline and one other ILSS required|10|||
48954727|NCT00237796|157662384|FG001|Overall Study|Baseline and one other ILSS required|5|||
48954728|NCT01193348|157662388|FG000|Screening Period|Screen Failure|5|||
48954729|NCT01193348|157662388|FG000|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1|||
48954730|NCT01193348|157662388|FG000|Treatment Period (26 Weeks)|Serious Adverse Event|1|||
48954731|NCT01193348|157662388|FG000|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1|||
48954732|NCT01193348|157662388|FG000|Extension Treatment Period|Physician Decision|1|||
48954733|NCT01193348|157662388|FG000|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2|||
48954734|NCT04594239|157662389|FG000|Overall Study|Withdrawal by Subject|3|||
48954735|NCT04594239|157662390|FG001|Overall Study|Withdrawal by Subject|4|||
48954736|NCT04594239|157662391|FG002|Overall Study|Withdrawal by Subject|2|||
48954737|NCT04594239|157662392|FG003|Overall Study|Withdrawal by Subject|4|||
48954738|NCT04594239|157662389|FG000|Overall Study|Lost to Follow-up|8|||
48954739|NCT04594239|157662390|FG001|Overall Study|Lost to Follow-up|5|||
48954740|NCT04594239|157662391|FG002|Overall Study|Lost to Follow-up|4|||
48954741|NCT04594239|157662392|FG003|Overall Study|Lost to Follow-up|6|||
48954742|NCT04594239|157662389|FG000|Overall Study|Subject relocated|0|||
48954743|NCT04594239|157662390|FG001|Overall Study|Subject relocated|0|||
48954744|NCT04594239|157662391|FG002|Overall Study|Subject relocated|0|||
48954745|NCT04594239|157662392|FG003|Overall Study|Subject relocated|1|||
48954746|NCT03596177|157662393|FG000|Single Blind Period|Withdrawal by Subject|1|||
48954747|NCT03596177|157662394|FG001|Single Blind Period|Withdrawal by Subject|1|||
48954748|NCT03596177|157662393|FG000|Single Blind Period|Other|1|||
48954749|NCT03596177|157662394|FG001|Single Blind Period|Other|0|||
48954750|NCT03596177|157662393|FG000|Double Blind Period|Withdrawal by Subject|0|||
48954751|NCT03596177|157662394|FG001|Double Blind Period|Withdrawal by Subject|1|||
48954752|NCT03596177|157662393|FG000|Double Blind Period|Other|0|||
48954753|NCT03596177|157662394|FG001|Double Blind Period|Other|4|||
48954754|NCT03596177|157662393|FG000|Double Blind Period|Death during safety follow-up|0|||
48954755|NCT03596177|157662394|FG001|Double Blind Period|Death during safety follow-up|1|||
48954756|NCT00968253|157662396|FG000|Overall Study|Death|0|||
48954757|NCT00968253|157662397|FG001|Overall Study|Death|0|||
48954758|NCT00968253|157662398|FG002|Overall Study|Death|2|||
48954759|NCT00968253|157662396|FG000|Overall Study|Withdrawal by Subject|0|||
48954760|NCT00968253|157662397|FG001|Overall Study|Withdrawal by Subject|0|||
48954761|NCT00968253|157662398|FG002|Overall Study|Withdrawal by Subject|1|||
48747964|NCT03919799|156925005|FG000|OLE Period (24 Weeks)|Other-unspecified|0|||
48747965|NCT03919799|156925006|FG001|OLE Period (24 Weeks)|Other-unspecified|1|||
48747966|NCT03919799|156925007|FG002|OLE Period (24 Weeks)|Other-unspecified|0|||
48747967|NCT03919799|156925008|FG003|OLE Period (24 Weeks)|Other-unspecified|0|||
48747968|NCT03919799|156925009|FG004|OLE Period (24 Weeks)|Other-unspecified|0|||
48747969|NCT02028065|156925010|FG000|Randomization Through Start Treatment|Not treated|1|||
48954762|NCT00968253|157662396|FG000|Overall Study|Disease Progression|0|||
48954763|NCT00968253|157662397|FG001|Overall Study|Disease Progression|3|||
48954764|NCT00968253|157662398|FG002|Overall Study|Disease Progression|3|||
48860614|NCT00087516|157328510|FG000|Overall Study|Site terminated|0|||
48860615|NCT00087516|157328511|FG001|Overall Study|Site terminated|2|||
48860616|NCT00087516|157328512|FG002|Overall Study|Site terminated|1|||
48860617|NCT00087516|157328513|FG003|Overall Study|Site terminated|0|||
48860618|NCT00087516|157328510|FG000|Overall Study|Protocol specified discontinuation|35|||
48860619|NCT00087516|157328511|FG001|Overall Study|Protocol specified discontinuation|33|||
48860620|NCT00087516|157328512|FG002|Overall Study|Protocol specified discontinuation|33|||
48860621|NCT00087516|157328513|FG003|Overall Study|Protocol specified discontinuation|26|||
48860622|NCT00087516|157328510|FG000|Overall Study|Patient moved|3|||
48860623|NCT00087516|157328511|FG001|Overall Study|Patient moved|2|||
48860624|NCT00087516|157328512|FG002|Overall Study|Patient moved|1|||
48860625|NCT00087516|157328513|FG003|Overall Study|Patient moved|0|||
48860626|NCT00087516|157328510|FG000|Overall Study|Patient was non-compliant|3|||
48860627|NCT00087516|157328511|FG001|Overall Study|Patient was non-compliant|1|||
48860628|NCT00087516|157328512|FG002|Overall Study|Patient was non-compliant|0|||
48860629|NCT00087516|157328513|FG003|Overall Study|Patient was non-compliant|0|||
48860630|NCT00087516|157328510|FG000|Overall Study|Recommendation of Primary Care Physician|0|||
48860631|NCT00087516|157328511|FG001|Overall Study|Recommendation of Primary Care Physician|0|||
48860632|NCT00087516|157328512|FG002|Overall Study|Recommendation of Primary Care Physician|0|||
48860633|NCT00087516|157328513|FG003|Overall Study|Recommendation of Primary Care Physician|1|||
48860634|NCT00087516|157328510|FG000|Overall Study|Other|0|||
48860635|NCT00087516|157328511|FG001|Overall Study|Other|0|||
48860636|NCT00087516|157328512|FG002|Overall Study|Other|1|||
48860637|NCT00087516|157328513|FG003|Overall Study|Other|0|||
48954765|NCT00968253|157662396|FG000|Overall Study|Adverse Event|0|||
48954766|NCT00968253|157662397|FG001|Overall Study|Adverse Event|0|||
48954767|NCT00968253|157662398|FG002|Overall Study|Adverse Event|1|||
48954768|NCT01909453|157662399|FG000|Overall Study|Ongoing|118|||
48747970|NCT02028065|156925011|FG001|Randomization Through Start Treatment|Not treated|3|||
48747971|NCT02028065|156925012|FG002|Randomization Through Start Treatment|Not treated|3|||
48747972|NCT02028065|156925010|FG000|Treatment Through Study Completion|Lost to Follow-up|2|||
48747973|NCT02028065|156925011|FG001|Treatment Through Study Completion|Lost to Follow-up|4|||
48747974|NCT02028065|156925012|FG002|Treatment Through Study Completion|Lost to Follow-up|6|||
48747975|NCT02028065|156925010|FG000|Treatment Through Study Completion|Physician Decision|1|||
48747976|NCT02028065|156925011|FG001|Treatment Through Study Completion|Physician Decision|0|||
48747977|NCT02028065|156925012|FG002|Treatment Through Study Completion|Physician Decision|0|||
48747978|NCT02028065|156925010|FG000|Treatment Through Study Completion|Protocol Violation|1|||
48747979|NCT02028065|156925011|FG001|Treatment Through Study Completion|Protocol Violation|4|||
48747980|NCT02028065|156925012|FG002|Treatment Through Study Completion|Protocol Violation|0|||
48747981|NCT02028065|156925010|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
48747982|NCT02028065|156925011|FG001|Treatment Through Study Completion|Withdrawal by Subject|4|||
48747983|NCT02028065|156925012|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
48747984|NCT02028065|156925010|FG000|Treatment Through Study Completion|Adverse Event|3|||
48747985|NCT02028065|156925011|FG001|Treatment Through Study Completion|Adverse Event|3|||
48747986|NCT02028065|156925012|FG002|Treatment Through Study Completion|Adverse Event|5|||
48747987|NCT00439244|156925014|FG000|Overall Study|Adverse Event|5|||
48747988|NCT00439244|156925015|FG001|Overall Study|Adverse Event|2|||
48747989|NCT00439244|156925016|FG002|Overall Study|Adverse Event|3|||
48747990|NCT00439244|156925014|FG000|Overall Study|Withdrawal by Subject|3|||
48747991|NCT00439244|156925015|FG001|Overall Study|Withdrawal by Subject|1|||
48747992|NCT00439244|156925016|FG002|Overall Study|Withdrawal by Subject|2|||
48747993|NCT00439244|156925014|FG000|Overall Study|Lost to Follow-up|2|||
48747994|NCT00439244|156925015|FG001|Overall Study|Lost to Follow-up|1|||
48747995|NCT00439244|156925016|FG002|Overall Study|Lost to Follow-up|2|||
48747996|NCT00439244|156925014|FG000|Overall Study|Death|0|||
48747997|NCT00439244|156925015|FG001|Overall Study|Death|1|||
48860638|NCT00409006|157328514|FG000|Overall Study|Death|15|||
48860639|NCT00409006|157328515|FG001|Overall Study|Death|6|||
48747998|NCT00439244|156925016|FG002|Overall Study|Death|0|||
48747999|NCT00439244|156925014|FG000|Overall Study|Protocol Violation|0|||
48748000|NCT00439244|156925015|FG001|Overall Study|Protocol Violation|1|||
48860640|NCT00409006|157328514|FG000|Overall Study|Lost to Follow-up|1|||
48860641|NCT00409006|157328515|FG001|Overall Study|Lost to Follow-up|2|||
48860642|NCT00409006|157328514|FG000|Overall Study|Withdrawal by Subject|3|||
48860643|NCT00409006|157328515|FG001|Overall Study|Withdrawal by Subject|2|||
48954769|NCT01909453|157662400|FG001|Overall Study|Ongoing|103|||
48954770|NCT01909453|157662401|FG002|Overall Study|Ongoing|83|||
48954771|NCT01909453|157662402|FG003|Overall Study|Ongoing|164|||
48954772|NCT01909453|157662403|FG004|Overall Study|Ongoing|50|||
48954773|NCT01909453|157662399|FG000|Overall Study|Death|69|||
48954774|NCT01909453|157662400|FG001|Overall Study|Death|74|||
48748001|NCT00439244|156925016|FG002|Overall Study|Protocol Violation|0|||
48748002|NCT00439244|156925014|FG000|Overall Study|Administrative problems|1|||
48748003|NCT00439244|156925015|FG001|Overall Study|Administrative problems|0|||
48748004|NCT00439244|156925016|FG002|Overall Study|Administrative problems|0|||
48748005|NCT01325584|156925019|FG000|Overall Study|Death|1|||
48748006|NCT00887978|156925020|FG000|Overall Study|Adverse Event|18|||
48954775|NCT01909453|157662401|FG002|Overall Study|Death|88|||
48954776|NCT01909453|157662402|FG003|Overall Study|Death|86|||
48954777|NCT01909453|157662403|FG004|Overall Study|Death|29|||
48748007|NCT00887978|156925021|FG001|Overall Study|Adverse Event|5|||
48954778|NCT01909453|157662399|FG000|Overall Study|Lost to Follow-up|3|||
48954779|NCT01909453|157662400|FG001|Overall Study|Lost to Follow-up|4|||
48954780|NCT01909453|157662401|FG002|Overall Study|Lost to Follow-up|4|||
48748008|NCT00887978|156925020|FG000|Overall Study|Clinical Worsening|4|||
48748009|NCT00887978|156925021|FG001|Overall Study|Clinical Worsening|4|||
48748010|NCT00887978|156925020|FG000|Overall Study|Death|2|||
48748011|NCT00887978|156925021|FG001|Overall Study|Death|3|||
48748012|NCT00887978|156925020|FG000|Overall Study|Withdrawal by Subject|1|||
48748013|NCT00887978|156925021|FG001|Overall Study|Withdrawal by Subject|2|||
48748014|NCT00887978|156925020|FG000|Overall Study|Lost to Follow-up|0|||
48748015|NCT00887978|156925021|FG001|Overall Study|Lost to Follow-up|1|||
48748016|NCT02617628|156925022|FG000|Overall Study|Withdr, Transfers-other prisons, dropout|62|||
48748017|NCT02617628|156925023|FG001|Overall Study|Withdr, Transfers-other prisons, dropout|61|||
48748018|NCT03064451|156925024|FG000|Overall Study|Lost to Follow-up|1|||
48748019|NCT03064451|156925024|FG000|Overall Study|Mapping Failure|4|||
48748020|NCT03064451|156925024|FG000|Overall Study|Exited prior to procedure|8|||
48748021|NCT03064451|156925024|FG000|Overall Study|Withdrew consent: 3-month FU visit|1|||
48748022|NCT02034110|156926423|FG000|Overall Study|Physician Decision|0|||
48748023|NCT02034110|156926424|FG001|Overall Study|Physician Decision|0|||
48748024|NCT02034110|156926425|FG002|Overall Study|Physician Decision|0|||
48748025|NCT02034110|156926426|FG003|Overall Study|Physician Decision|0|||
48748026|NCT02034110|156926427|FG004|Overall Study|Physician Decision|2|||
48748027|NCT02034110|156926428|FG005|Overall Study|Physician Decision|0|||
48748028|NCT02034110|156926429|FG006|Overall Study|Physician Decision|1|||
48748029|NCT02034110|156926430|FG007|Overall Study|Physician Decision|0|||
48748030|NCT02034110|156926423|FG000|Overall Study|Lost to Follow-up|1|||
48748031|NCT02034110|156926424|FG001|Overall Study|Lost to Follow-up|0|||
48748032|NCT02034110|156926425|FG002|Overall Study|Lost to Follow-up|0|||
48748033|NCT02034110|156926426|FG003|Overall Study|Lost to Follow-up|0|||
48748034|NCT02034110|156926427|FG004|Overall Study|Lost to Follow-up|1|||
48748035|NCT02034110|156926428|FG005|Overall Study|Lost to Follow-up|0|||
48748036|NCT02034110|156926429|FG006|Overall Study|Lost to Follow-up|1|||
48748037|NCT02034110|156926430|FG007|Overall Study|Lost to Follow-up|0|||
48748038|NCT02034110|156926423|FG000|Overall Study|Withdrawal by Subject|5|||
48748039|NCT02034110|156926424|FG001|Overall Study|Withdrawal by Subject|7|||
48748040|NCT02034110|156926425|FG002|Overall Study|Withdrawal by Subject|0|||
48748041|NCT02034110|156926426|FG003|Overall Study|Withdrawal by Subject|3|||
48748042|NCT02034110|156926427|FG004|Overall Study|Withdrawal by Subject|7|||
48748043|NCT02034110|156926428|FG005|Overall Study|Withdrawal by Subject|0|||
48748044|NCT02034110|156926429|FG006|Overall Study|Withdrawal by Subject|3|||
48748045|NCT02034110|156926430|FG007|Overall Study|Withdrawal by Subject|1|||
48748046|NCT02034110|156926423|FG000|Overall Study|Study closed by sponsor|6|||
48748047|NCT02034110|156926424|FG001|Overall Study|Study closed by sponsor|2|||
48748048|NCT02034110|156926425|FG002|Overall Study|Study closed by sponsor|0|||
48748049|NCT02034110|156926426|FG003|Overall Study|Study closed by sponsor|6|||
48748050|NCT02034110|156926427|FG004|Overall Study|Study closed by sponsor|7|||
48748051|NCT02034110|156926428|FG005|Overall Study|Study closed by sponsor|0|||
48748052|NCT02034110|156926429|FG006|Overall Study|Study closed by sponsor|42|||
48748053|NCT02034110|156926430|FG007|Overall Study|Study closed by sponsor|0|||
48748054|NCT02380677|156926432|FG000|Overall Study|Adverse Event|0|||
48748055|NCT02380677|156926433|FG001|Overall Study|Adverse Event|0|||
48748056|NCT02380677|156926434|FG002|Overall Study|Adverse Event|0|||
48748057|NCT02380677|156926435|FG003|Overall Study|Adverse Event|1|||
48748058|NCT02380677|156926436|FG004|Overall Study|Adverse Event|1|||
48748059|NCT02380677|156926437|FG005|Overall Study|Adverse Event|4|||
48748060|NCT02380677|156926438|FG006|Overall Study|Adverse Event|2|||
48748061|NCT02380677|156926439|FG007|Overall Study|Adverse Event|2|||
48748062|NCT02380677|156926440|FG008|Overall Study|Adverse Event|2|||
48748063|NCT02380677|156926441|FG009|Overall Study|Adverse Event|1|||
48748064|NCT02380677|156926442|FG010|Overall Study|Adverse Event|2|||
48748065|NCT02380677|156926443|FG011|Overall Study|Adverse Event|1|||
48748066|NCT02380677|156926432|FG000|Overall Study|Physician Decision|1|||
48748067|NCT02380677|156926433|FG001|Overall Study|Physician Decision|0|||
48748068|NCT02380677|156926434|FG002|Overall Study|Physician Decision|1|||
48748069|NCT02380677|156926435|FG003|Overall Study|Physician Decision|1|||
48748070|NCT02380677|156926436|FG004|Overall Study|Physician Decision|0|||
48748071|NCT02380677|156926437|FG005|Overall Study|Physician Decision|0|||
48748072|NCT02380677|156926438|FG006|Overall Study|Physician Decision|0|||
48748073|NCT02380677|156926439|FG007|Overall Study|Physician Decision|0|||
48748074|NCT02380677|156926440|FG008|Overall Study|Physician Decision|0|||
48748075|NCT02380677|156926441|FG009|Overall Study|Physician Decision|0|||
48748076|NCT02380677|156926442|FG010|Overall Study|Physician Decision|0|||
48748077|NCT02380677|156926443|FG011|Overall Study|Physician Decision|0|||
48748078|NCT02380677|156926432|FG000|Overall Study|Lack of Efficacy|0|||
48748079|NCT02380677|156926433|FG001|Overall Study|Lack of Efficacy|1|||
48748080|NCT02380677|156926434|FG002|Overall Study|Lack of Efficacy|2|||
48748081|NCT02380677|156926435|FG003|Overall Study|Lack of Efficacy|0|||
48748082|NCT02380677|156926436|FG004|Overall Study|Lack of Efficacy|4|||
48748083|NCT02380677|156926437|FG005|Overall Study|Lack of Efficacy|1|||
48748084|NCT02380677|156926438|FG006|Overall Study|Lack of Efficacy|1|||
48748085|NCT02380677|156926439|FG007|Overall Study|Lack of Efficacy|2|||
48748086|NCT02380677|156926440|FG008|Overall Study|Lack of Efficacy|2|||
48748087|NCT02380677|156926441|FG009|Overall Study|Lack of Efficacy|0|||
48748088|NCT02380677|156926442|FG010|Overall Study|Lack of Efficacy|2|||
48748089|NCT02380677|156926443|FG011|Overall Study|Lack of Efficacy|1|||
48748090|NCT02380677|156926432|FG000|Overall Study|Withdrawal by Subject|0|||
48748091|NCT02380677|156926433|FG001|Overall Study|Withdrawal by Subject|0|||
48748092|NCT02380677|156926434|FG002|Overall Study|Withdrawal by Subject|0|||
48748093|NCT02380677|156926435|FG003|Overall Study|Withdrawal by Subject|0|||
48748094|NCT02380677|156926436|FG004|Overall Study|Withdrawal by Subject|0|||
48748095|NCT02380677|156926437|FG005|Overall Study|Withdrawal by Subject|0|||
48748096|NCT02380677|156926438|FG006|Overall Study|Withdrawal by Subject|0|||
48748097|NCT02380677|156926439|FG007|Overall Study|Withdrawal by Subject|0|||
48748098|NCT02380677|156926440|FG008|Overall Study|Withdrawal by Subject|0|||
48860644|NCT00409006|157328514|FG000|Overall Study|Physician Decision|1|||
48860645|NCT00409006|157328515|FG001|Overall Study|Physician Decision|2|||
48860646|NCT00278395|157328516|FG000|Overall Study|Adverse Event|2|||
48860647|NCT00278395|157328516|FG000|Overall Study|Nonevaluable|1|||
48860648|NCT03928743|157328517|FG000|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
48860649|NCT03928743|157328518|FG001|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
48860650|NCT03928743|157328519|FG002|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|0|||
48860651|NCT03928743|157328517|FG000|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|1|||
48860652|NCT03928743|157328518|FG001|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|3|||
48860653|NCT03928743|157328519|FG002|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|0|||
48860654|NCT03928743|157328517|FG000|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
48860655|NCT03928743|157328518|FG001|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|1|||
48860656|NCT03928743|157328519|FG002|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
48860657|NCT03928743|157328517|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
48860658|NCT03928743|157328518|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|2|||
48860659|NCT03928743|157328519|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
48860660|NCT03928743|157328517|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
48860661|NCT03928743|157328518|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|1|||
48860662|NCT03928743|157328519|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
48860663|NCT03928743|157328517|FG000|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
48860664|NCT03928743|157328518|FG001|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
48860665|NCT03928743|157328519|FG002|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|1|||
48860666|NCT03928743|157328517|FG000|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
48860667|NCT03928743|157328518|FG001|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
48860668|NCT03928743|157328519|FG002|Maintenance Period: Weeks 16-52|Withdrawal by Subject|4|||
48860669|NCT03928743|157328517|FG000|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
48860670|NCT03928743|157328518|FG001|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
48860671|NCT03928743|157328519|FG002|Maintenance Period: Weeks 16-52|Lost to Follow-up|2|||
48860672|NCT03928743|157328517|FG000|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
48860673|NCT03928743|157328518|FG001|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
48860674|NCT03928743|157328519|FG002|Maintenance Period: Weeks 16-52|Lack of Efficacy|3|||
48860675|NCT03928743|157328517|FG000|Maintenance Period: Weeks 16-52|Adverse Event|0|||
48860676|NCT03928743|157328518|FG001|Maintenance Period: Weeks 16-52|Adverse Event|0|||
48860677|NCT03928743|157328519|FG002|Maintenance Period: Weeks 16-52|Adverse Event|9|||
48860678|NCT03928743|157328517|FG000|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
48860679|NCT03928743|157328518|FG001|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
48860680|NCT03928743|157328519|FG002|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|2|||
48860681|NCT04025762|157328520|FG000|Crossover Study Period 1 (16 Weeks)|Death|0|||
48860682|NCT04025762|157328521|FG001|Crossover Study Period 1 (16 Weeks)|Death|1|||
48860683|NCT04184622|157328522|FG000|Overall Study|Adverse Event|7|||
48860684|NCT04184622|157328523|FG001|Overall Study|Adverse Event|7|||
48860685|NCT04184622|157328524|FG002|Overall Study|Adverse Event|11|||
48860686|NCT04184622|157328525|FG003|Overall Study|Adverse Event|8|||
48860687|NCT04184622|157328522|FG000|Overall Study|Death|4|||
48860688|NCT04184622|157328523|FG001|Overall Study|Death|4|||
48860689|NCT04184622|157328524|FG002|Overall Study|Death|2|||
48860690|NCT04184622|157328525|FG003|Overall Study|Death|1|||
48860691|NCT04184622|157328522|FG000|Overall Study|Lost to Follow-up|41|||
48860692|NCT04184622|157328523|FG001|Overall Study|Lost to Follow-up|19|||
48860693|NCT04184622|157328524|FG002|Overall Study|Lost to Follow-up|20|||
48860694|NCT04184622|157328525|FG003|Overall Study|Lost to Follow-up|15|||
48860695|NCT04184622|157328522|FG000|Overall Study|Missing Weight at Week 72|1|||
48860696|NCT04184622|157328523|FG001|Overall Study|Missing Weight at Week 72|0|||
48860697|NCT04184622|157328524|FG002|Overall Study|Missing Weight at Week 72|1|||
48860698|NCT04184622|157328525|FG003|Overall Study|Missing Weight at Week 72|0|||
48748099|NCT02380677|156926441|FG009|Overall Study|Withdrawal by Subject|1|||
48748100|NCT02380677|156926442|FG010|Overall Study|Withdrawal by Subject|0|||
48748101|NCT02380677|156926443|FG011|Overall Study|Withdrawal by Subject|3|||
48748102|NCT02380677|156926432|FG000|Overall Study|Other|0|||
48748103|NCT02380677|156926433|FG001|Overall Study|Other|0|||
48748104|NCT02380677|156926434|FG002|Overall Study|Other|0|||
48748105|NCT02380677|156926435|FG003|Overall Study|Other|1|||
48748106|NCT02380677|156926436|FG004|Overall Study|Other|1|||
48748107|NCT02380677|156926437|FG005|Overall Study|Other|1|||
48748108|NCT02380677|156926438|FG006|Overall Study|Other|0|||
48748109|NCT02380677|156926439|FG007|Overall Study|Other|0|||
48748110|NCT02380677|156926440|FG008|Overall Study|Other|0|||
48748111|NCT02380677|156926441|FG009|Overall Study|Other|0|||
48748112|NCT02380677|156926442|FG010|Overall Study|Other|0|||
48748113|NCT02380677|156926443|FG011|Overall Study|Other|0|||
48748114|NCT03902574|156926444|FG000|Overall Study|Urinary drug test was positive on Day 20|0|||
48748115|NCT03902574|156926445|FG001|Overall Study|Urinary drug test was positive on Day 20|0|||
48748116|NCT03902574|156926446|FG002|Overall Study|Urinary drug test was positive on Day 20|1|||
48748117|NCT01806545|156926451|FG000|Overall Study|Adverse Event|2|||
48954781|NCT01909453|157662402|FG003|Overall Study|Lost to Follow-up|3|||
48954782|NCT01909453|157662403|FG004|Overall Study|Lost to Follow-up|3|||
48954783|NCT01909453|157662399|FG000|Overall Study|Withdrawal by Subject|2|||
48954784|NCT01909453|157662400|FG001|Overall Study|Withdrawal by Subject|13|||
48954785|NCT01909453|157662401|FG002|Overall Study|Withdrawal by Subject|16|||
48954786|NCT01909453|157662402|FG003|Overall Study|Withdrawal by Subject|5|||
48954787|NCT01909453|157662403|FG004|Overall Study|Withdrawal by Subject|4|||
48954788|NCT01897441|157662408|FG000|Overall Study|Lost to Follow-up|0|||
48954789|NCT01897441|157662409|FG001|Overall Study|Lost to Follow-up|0|||
48954790|NCT01897441|157662410|FG002|Overall Study|Lost to Follow-up|1|||
48954791|NCT01897441|157662411|FG003|Overall Study|Lost to Follow-up|0|||
48954792|NCT01897441|157662412|FG004|Overall Study|Lost to Follow-up|0|||
48954793|NCT01897441|157662413|FG005|Overall Study|Lost to Follow-up|0|||
48748118|NCT01806545|156926452|FG001|Overall Study|Adverse Event|3|||
48748119|NCT01806545|156926451|FG000|Overall Study|Lost to Follow-up|1|||
48748120|NCT01806545|156926452|FG001|Overall Study|Lost to Follow-up|0|||
48748121|NCT01806545|156926451|FG000|Overall Study|Withdrawal by Subject|3|||
48748122|NCT01806545|156926452|FG001|Overall Study|Withdrawal by Subject|2|||
48748123|NCT02853604|156926455|FG000|Overall Study|Withdrawal by Subject|12|||
48954794|NCT01897441|157662408|FG000|Overall Study|Withdrawal by Subject|0|||
48954795|NCT01897441|157662409|FG001|Overall Study|Withdrawal by Subject|0|||
48748124|NCT02853604|156926456|FG001|Overall Study|Withdrawal by Subject|35|||
48748125|NCT02853604|156926455|FG000|Overall Study|Lost to Follow-up|4|||
48748126|NCT02853604|156926456|FG001|Overall Study|Lost to Follow-up|8|||
48954796|NCT01897441|157662410|FG002|Overall Study|Withdrawal by Subject|0|||
48954797|NCT01897441|157662411|FG003|Overall Study|Withdrawal by Subject|0|||
48954798|NCT01897441|157662412|FG004|Overall Study|Withdrawal by Subject|1|||
48954799|NCT01897441|157662413|FG005|Overall Study|Withdrawal by Subject|0|||
48954800|NCT01897441|157662408|FG000|Overall Study|Withdrawn by Provider|0|||
48954801|NCT01897441|157662409|FG001|Overall Study|Withdrawn by Provider|2|||
48954802|NCT01897441|157662410|FG002|Overall Study|Withdrawn by Provider|0|||
48954803|NCT01897441|157662411|FG003|Overall Study|Withdrawn by Provider|0|||
48954804|NCT01897441|157662412|FG004|Overall Study|Withdrawn by Provider|0|||
48954805|NCT01897441|157662413|FG005|Overall Study|Withdrawn by Provider|0|||
49015381|NCT00306384|157892157|FG001|Overall Study|Investigator discretion|31|||
48748127|NCT02853604|156926455|FG000|Overall Study|Death|1|||
48954806|NCT03422133|157662414|FG000|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|14|||
48748128|NCT02853604|156926456|FG001|Overall Study|Death|5|||
48748129|NCT02853604|156926455|FG000|Overall Study|Miscellaneous|11|||
48748130|NCT02853604|156926456|FG001|Overall Study|Miscellaneous|2|||
48748131|NCT02853604|156926455|FG000|Overall Study|Progressive Disease|0|||
48748132|NCT02853604|156926456|FG001|Overall Study|Progressive Disease|2|||
48748133|NCT02548650|156926457|FG000|Triple Therapy|Adverse Event|1|||
48748134|NCT02548650|156926458|FG001|Triple Therapy|Adverse Event|0|||
48748135|NCT02548650|156926457|FG000|Triple Therapy|Withdrawal by Subject|0|||
48748136|NCT02548650|156926458|FG001|Triple Therapy|Withdrawal by Subject|4|||
48748137|NCT02548650|156926457|FG000|Double Therapy|Adverse Event|1|||
48748138|NCT02548650|156926458|FG001|Double Therapy|Adverse Event|1|||
48748139|NCT02548650|156926457|FG000|Double Therapy|Withdrawal by Subject|0|||
48748140|NCT02548650|156926458|FG001|Double Therapy|Withdrawal by Subject|1|||
48748141|NCT02244606|156926463|FG000|Overall Study|Adverse Event|0|||
48748142|NCT02244606|156926464|FG001|Overall Study|Adverse Event|1|||
48748143|NCT02244606|156926465|FG002|Overall Study|Adverse Event|1|||
48748144|NCT02244606|156926466|FG003|Overall Study|Adverse Event|0|||
48748145|NCT02244606|156926463|FG000|Overall Study|Lost to Follow-up|2|||
48748146|NCT02244606|156926464|FG001|Overall Study|Lost to Follow-up|2|||
48748147|NCT02244606|156926465|FG002|Overall Study|Lost to Follow-up|1|||
48748148|NCT02244606|156926466|FG003|Overall Study|Lost to Follow-up|0|||
48748149|NCT02244606|156926463|FG000|Overall Study|Protocol Violation|0|||
48748150|NCT02244606|156926464|FG001|Overall Study|Protocol Violation|0|||
48748151|NCT02244606|156926465|FG002|Overall Study|Protocol Violation|0|||
48748152|NCT02244606|156926466|FG003|Overall Study|Protocol Violation|1|||
48748153|NCT02244606|156926463|FG000|Overall Study|Withdrawal by Subject|1|||
48748154|NCT02244606|156926464|FG001|Overall Study|Withdrawal by Subject|1|||
48748155|NCT02244606|156926465|FG002|Overall Study|Withdrawal by Subject|0|||
48748156|NCT02244606|156926466|FG003|Overall Study|Withdrawal by Subject|0|||
48748157|NCT02244606|156926463|FG000|Overall Study|Did Not Complete Study for Reason Other:|0|||
48748158|NCT02244606|156926464|FG001|Overall Study|Did Not Complete Study for Reason Other:|1|||
48748159|NCT02244606|156926465|FG002|Overall Study|Did Not Complete Study for Reason Other:|1|||
48748160|NCT02244606|156926466|FG003|Overall Study|Did Not Complete Study for Reason Other:|0|||
48748161|NCT01678911|156926472|FG000|Second Intervention|Lost to Follow-up|2|||
48748162|NCT01678911|156926473|FG001|Second Intervention|Lost to Follow-up|0|||
48748163|NCT02036294|156926474|FG000|Overall Study|Death|7|||
48748164|NCT02036294|156926475|FG001|Overall Study|Death|8|||
48748165|NCT02036294|156926474|FG000|Overall Study|Withdrawal by Subject|2|||
49015382|NCT00306384|157892158|FG002|Overall Study|Investigator discretion|21|||
48748166|NCT02036294|156926475|FG001|Overall Study|Withdrawal by Subject|3|||
48748167|NCT01854710|156926480|FG000|Overall Study|Withdrawal by Subject|2|||
48748168|NCT01854710|156926481|FG001|Overall Study|Withdrawal by Subject|1|||
48748169|NCT01854710|156926482|FG002|Overall Study|Withdrawal by Subject|0|||
48748170|NCT01854710|156926483|FG003|Overall Study|Withdrawal by Subject|0|||
48748171|NCT01854710|156926484|FG004|Overall Study|Withdrawal by Subject|0|||
48748172|NCT01854710|156926485|FG005|Overall Study|Withdrawal by Subject|0|||
48748173|NCT01854710|156926480|FG000|Overall Study|CRI procedural error|2|||
48748174|NCT01854710|156926481|FG001|Overall Study|CRI procedural error|2|||
48748175|NCT01854710|156926482|FG002|Overall Study|CRI procedural error|2|||
48748176|NCT01854710|156926483|FG003|Overall Study|CRI procedural error|2|||
48748177|NCT01854710|156926484|FG004|Overall Study|CRI procedural error|2|||
48954807|NCT03422133|157662415|FG001|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|4|||
48954808|NCT03569293|157664146|FG000|Overall Study|Adverse Event|4|||
48954809|NCT03569293|157664147|FG001|Overall Study|Adverse Event|1|||
48954810|NCT03569293|157664148|FG002|Overall Study|Adverse Event|5|||
48954811|NCT03569293|157664149|FG003|Overall Study|Adverse Event|1|||
48954812|NCT03569293|157664150|FG004|Overall Study|Adverse Event|0|||
48954813|NCT03569293|157664151|FG005|Overall Study|Adverse Event|0|||
48954814|NCT03569293|157664146|FG000|Overall Study|Withdrawal by Subject|16|||
48954815|NCT03569293|157664147|FG001|Overall Study|Withdrawal by Subject|2|||
48954816|NCT03569293|157664148|FG002|Overall Study|Withdrawal by Subject|4|||
48954817|NCT03569293|157664149|FG003|Overall Study|Withdrawal by Subject|1|||
48954818|NCT03569293|157664150|FG004|Overall Study|Withdrawal by Subject|0|||
48954819|NCT03569293|157664151|FG005|Overall Study|Withdrawal by Subject|0|||
48954820|NCT03569293|157664146|FG000|Overall Study|Lost to Follow-up|1|||
48954821|NCT03569293|157664147|FG001|Overall Study|Lost to Follow-up|3|||
48954822|NCT03569293|157664148|FG002|Overall Study|Lost to Follow-up|1|||
48954823|NCT03569293|157664149|FG003|Overall Study|Lost to Follow-up|1|||
48954824|NCT03569293|157664150|FG004|Overall Study|Lost to Follow-up|0|||
48954825|NCT03569293|157664151|FG005|Overall Study|Lost to Follow-up|0|||
48954826|NCT03569293|157664146|FG000|Overall Study|Other|8|||
48954827|NCT03569293|157664147|FG001|Overall Study|Other|2|||
48954828|NCT03569293|157664148|FG002|Overall Study|Other|1|||
48954829|NCT03569293|157664149|FG003|Overall Study|Other|1|||
48954830|NCT03569293|157664150|FG004|Overall Study|Other|0|||
48954831|NCT03569293|157664151|FG005|Overall Study|Other|0|||
48954832|NCT03569293|157664146|FG000|Overall Study|Ongoing at Time of Analysis|8|||
48954833|NCT03569293|157664147|FG001|Overall Study|Ongoing at Time of Analysis|1|||
48954834|NCT03569293|157664148|FG002|Overall Study|Ongoing at Time of Analysis|3|||
48954835|NCT03569293|157664149|FG003|Overall Study|Ongoing at Time of Analysis|0|||
48954836|NCT03569293|157664150|FG004|Overall Study|Ongoing at Time of Analysis|0|||
48954837|NCT03569293|157664151|FG005|Overall Study|Ongoing at Time of Analysis|0|||
48954838|NCT02817555|157664152|FG000|Overall Study|Death|1|||
48954839|NCT02817555|157664153|FG001|Overall Study|Death|3|||
48954840|NCT02817555|157664152|FG000|Overall Study|moved away|1|||
48954841|NCT02817555|157664153|FG001|Overall Study|moved away|0|||
48954842|NCT02817555|157664152|FG000|Overall Study|transplant|1|||
48954843|NCT02817555|157664153|FG001|Overall Study|transplant|1|||
48954844|NCT02817555|157664152|FG000|Overall Study|changed to Peritoneal Dialysis|0|||
48748178|NCT01854710|156926485|FG005|Overall Study|CRI procedural error|2|||
48954845|NCT02817555|157664153|FG001|Overall Study|changed to Peritoneal Dialysis|1|||
48954846|NCT00696657|157664154|FG000|Overall Study|Protocol Violation|0|||
48954847|NCT00696657|157664155|FG001|Overall Study|Protocol Violation|0|||
48954848|NCT00696657|157664156|FG002|Overall Study|Protocol Violation|0|||
48954849|NCT00696657|157664157|FG003|Overall Study|Protocol Violation|0|||
48954850|NCT00696657|157664158|FG004|Overall Study|Protocol Violation|0|||
48748179|NCT00982878|156926486|FG000|Overall Study|Physician Decision|1|||
48748180|NCT03132220|156926487|FG000|Overall Study|Lost to Follow-up|17|||
48748181|NCT03132220|156926488|FG001|Overall Study|Lost to Follow-up|8|||
48748182|NCT03132220|156926487|FG000|Overall Study|Withdrawal by Subject|1|||
48954851|NCT00696657|157664159|FG005|Overall Study|Protocol Violation|1|||
48954852|NCT00696657|157664160|FG006|Overall Study|Protocol Violation|0|||
48954853|NCT00696657|157664161|FG007|Overall Study|Protocol Violation|0|||
48954854|NCT00696657|157664162|FG008|Overall Study|Protocol Violation|1|||
48954855|NCT00696657|157664154|FG000|Overall Study|Lack of Efficacy|0|||
48954856|NCT00696657|157664155|FG001|Overall Study|Lack of Efficacy|1|||
48954857|NCT00696657|157664156|FG002|Overall Study|Lack of Efficacy|0|||
48954858|NCT00696657|157664157|FG003|Overall Study|Lack of Efficacy|0|||
48954859|NCT00696657|157664158|FG004|Overall Study|Lack of Efficacy|0|||
48954860|NCT00696657|157664159|FG005|Overall Study|Lack of Efficacy|0|||
48954861|NCT00696657|157664160|FG006|Overall Study|Lack of Efficacy|0|||
48954862|NCT00696657|157664161|FG007|Overall Study|Lack of Efficacy|0|||
48954863|NCT00696657|157664162|FG008|Overall Study|Lack of Efficacy|0|||
48954864|NCT00696657|157664154|FG000|Overall Study|Withdrawal criteria|1|||
48954865|NCT00696657|157664155|FG001|Overall Study|Withdrawal criteria|3|||
48954866|NCT00696657|157664156|FG002|Overall Study|Withdrawal criteria|2|||
48954867|NCT00696657|157664157|FG003|Overall Study|Withdrawal criteria|2|||
48954868|NCT00696657|157664158|FG004|Overall Study|Withdrawal criteria|0|||
48954869|NCT00696657|157664159|FG005|Overall Study|Withdrawal criteria|0|||
48954870|NCT00696657|157664160|FG006|Overall Study|Withdrawal criteria|1|||
48954871|NCT00696657|157664161|FG007|Overall Study|Withdrawal criteria|1|||
48954872|NCT00696657|157664162|FG008|Overall Study|Withdrawal criteria|2|||
48954873|NCT00696657|157664154|FG000|Overall Study|Unclassified|0|||
48954874|NCT00696657|157664155|FG001|Overall Study|Unclassified|1|||
48954875|NCT00696657|157664156|FG002|Overall Study|Unclassified|3|||
48954876|NCT00696657|157664157|FG003|Overall Study|Unclassified|2|||
48954877|NCT00696657|157664158|FG004|Overall Study|Unclassified|4|||
48954878|NCT00696657|157664159|FG005|Overall Study|Unclassified|2|||
48954879|NCT00696657|157664160|FG006|Overall Study|Unclassified|0|||
48954880|NCT00696657|157664161|FG007|Overall Study|Unclassified|0|||
48954881|NCT00696657|157664162|FG008|Overall Study|Unclassified|1|||
48954882|NCT00696657|157664154|FG000|Overall Study|Adverse Event|0|||
48954883|NCT00696657|157664155|FG001|Overall Study|Adverse Event|0|||
48954884|NCT00696657|157664156|FG002|Overall Study|Adverse Event|3|||
48954885|NCT00696657|157664157|FG003|Overall Study|Adverse Event|7|||
48954886|NCT00696657|157664158|FG004|Overall Study|Adverse Event|6|||
48954887|NCT00696657|157664159|FG005|Overall Study|Adverse Event|9|||
48954888|NCT00696657|157664160|FG006|Overall Study|Adverse Event|14|||
48954889|NCT00696657|157664161|FG007|Overall Study|Adverse Event|2|||
48954890|NCT00696657|157664162|FG008|Overall Study|Adverse Event|5|||
48954891|NCT01808118|157664163|FG000|Period 1|Adverse Event|15|||
48954892|NCT01808118|157664164|FG001|Period 1|Adverse Event|0|||
48954893|NCT01808118|157664165|FG002|Period 1|Adverse Event|0|||
48954894|NCT01808118|157664163|FG000|Period 1|Withdrew consent|24|||
48954895|NCT01808118|157664164|FG001|Period 1|Withdrew consent|0|||
48954896|NCT01808118|157664165|FG002|Period 1|Withdrew consent|0|||
48954897|NCT01808118|157664163|FG000|Period 1|Lost to Follow-up|9|||
48954898|NCT01808118|157664164|FG001|Period 1|Lost to Follow-up|0|||
48954899|NCT01808118|157664165|FG002|Period 1|Lost to Follow-up|0|||
48954900|NCT01808118|157664163|FG000|Period 1|Did not meet criteria for remission|303|||
48954901|NCT01808118|157664164|FG001|Period 1|Did not meet criteria for remission|0|||
48954902|NCT01808118|157664165|FG002|Period 1|Did not meet criteria for remission|0|||
48954903|NCT01808118|157664163|FG000|Period 1|Enrolled in error|7|||
48954904|NCT01808118|157664164|FG001|Period 1|Enrolled in error|0|||
48954905|NCT01808118|157664165|FG002|Period 1|Enrolled in error|0|||
48954906|NCT01808118|157664163|FG000|Period 1|Did not meet inclusion criteria|3|||
48954907|NCT01808118|157664164|FG001|Period 1|Did not meet inclusion criteria|0|||
48954908|NCT01808118|157664165|FG002|Period 1|Did not meet inclusion criteria|0|||
48954909|NCT01808118|157664163|FG000|Period 1|Non-conformance with inclusion criteria|3|||
48954910|NCT01808118|157664164|FG001|Period 1|Non-conformance with inclusion criteria|0|||
48954911|NCT01808118|157664165|FG002|Period 1|Non-conformance with inclusion criteria|0|||
48748183|NCT03132220|156926488|FG001|Overall Study|Withdrawal by Subject|4|||
48954912|NCT01808118|157664163|FG000|Period 1|Investigator decision: site closure|2|||
49015383|NCT00306384|157892156|FG000|Overall Study|Other|80|||
48954913|NCT01808118|157664164|FG001|Period 1|Investigator decision: site closure|0|||
48954914|NCT01808118|157664165|FG002|Period 1|Investigator decision: site closure|0|||
49015384|NCT00306384|157892157|FG001|Overall Study|Other|70|||
48954915|NCT01808118|157664163|FG000|Period 1|Non-compliance per sponsor|1|||
48954916|NCT01808118|157664164|FG001|Period 1|Non-compliance per sponsor|0|||
48954917|NCT01808118|157664165|FG002|Period 1|Non-compliance per sponsor|0|||
48954918|NCT01808118|157664163|FG000|Period 1|Lack of Efficacy|1|||
48954919|NCT01808118|157664164|FG001|Period 1|Lack of Efficacy|0|||
48954920|NCT01808118|157664165|FG002|Period 1|Lack of Efficacy|0|||
48954921|NCT01808118|157664163|FG000|Period 2|Adverse Event|0|||
48954922|NCT01808118|157664164|FG001|Period 2|Adverse Event|4|||
48954923|NCT01808118|157664165|FG002|Period 2|Adverse Event|0|||
48954924|NCT01808118|157664163|FG000|Period 2|Withdrew consent|0|||
48954925|NCT01808118|157664164|FG001|Period 2|Withdrew consent|7|||
48748184|NCT01336764|156926489|FG000|Overall Study|Withdrawal by Subject|5|||
48748185|NCT01336764|156926490|FG001|Overall Study|Withdrawal by Subject|5|||
48748186|NCT03167411|156926491|FG000|Overall Study|Adverse Event|0|||
48748187|NCT03167411|156926492|FG001|Overall Study|Adverse Event|1|||
48748188|NCT01906008|156926493|FG000|Overall Study|Lost to Follow-up|2|||
48748189|NCT01906008|156926494|FG001|Overall Study|Lost to Follow-up|0|||
48748190|NCT01906008|156926493|FG000|Overall Study|Oxaliplatin toxicity|2|||
48748191|NCT01906008|156926494|FG001|Overall Study|Oxaliplatin toxicity|0|||
48748192|NCT01906008|156926493|FG000|Overall Study|Protocol Violation|0|||
48748193|NCT01906008|156926494|FG001|Overall Study|Protocol Violation|1|||
48748194|NCT01906008|156926493|FG000|Overall Study|Withdrawal by Subject|1|||
48748195|NCT01906008|156926494|FG001|Overall Study|Withdrawal by Subject|5|||
48748196|NCT01906008|156926493|FG000|Overall Study|Did not start study med|3|||
48748197|NCT01906008|156926494|FG001|Overall Study|Did not start study med|4|||
48748198|NCT01906008|156926493|FG000|Overall Study|Oxaliplatin stops|10|||
48748199|NCT01906008|156926494|FG001|Overall Study|Oxaliplatin stops|8|||
48748200|NCT01906008|156926493|FG000|Overall Study|Hospice|1|||
48748201|NCT01906008|156926494|FG001|Overall Study|Hospice|0|||
48748202|NCT01906008|156926493|FG000|Overall Study|Physician Decision|3|||
48748203|NCT01906008|156926494|FG001|Overall Study|Physician Decision|3|||
48748204|NCT01906008|156926493|FG000|Overall Study|Lack of compliance of study med|5|||
48954926|NCT01808118|157664165|FG002|Period 2|Withdrew consent|6|||
48748205|NCT01906008|156926494|FG001|Overall Study|Lack of compliance of study med|3|||
48954927|NCT01808118|157664163|FG000|Period 2|Lost to Follow-up|0|||
48954928|NCT01808118|157664164|FG001|Period 2|Lost to Follow-up|0|||
48954929|NCT01808118|157664165|FG002|Period 2|Lost to Follow-up|2|||
48748206|NCT01906008|156926493|FG000|Overall Study|Adverse Event|0|||
48748207|NCT01906008|156926494|FG001|Overall Study|Adverse Event|3|||
48954930|NCT01808118|157664163|FG000|Period 2|Investigator no longer conducting trials|0|||
48954931|NCT01808118|157664164|FG001|Period 2|Investigator no longer conducting trials|1|||
48748208|NCT00673465|156926501|FG000|Part 1/Period 1 (United States)|Protocol Violation|0|||
48748209|NCT00673465|156926502|FG001|Part 1/Period 1 (United States)|Protocol Violation|0|||
48748210|NCT00673465|156926503|FG002|Part 1/Period 1 (United States)|Protocol Violation|0|||
48748211|NCT00673465|156926504|FG003|Part 1/Period 1 (United States)|Protocol Violation|0|||
48748212|NCT00673465|156926505|FG004|Part 1/Period 1 (United States)|Protocol Violation|1|||
48748213|NCT00673465|156926506|FG005|Part 1/Period 1 (United States)|Protocol Violation|1|||
48748214|NCT00673465|156926507|FG006|Part 1/Period 1 (United States)|Protocol Violation|0|||
48748215|NCT00673465|156926508|FG007|Part 1/Period 1 (United States)|Protocol Violation|0|||
48748216|NCT00673465|156926509|FG008|Part 1/Period 1 (United States)|Protocol Violation|0|||
48748217|NCT00673465|156926510|FG009|Part 1/Period 1 (United States)|Protocol Violation|0|||
48954932|NCT01808118|157664165|FG002|Period 2|Investigator no longer conducting trials|0|||
48954933|NCT01808118|157664163|FG000|Period 2|Switched to other therapy|0|||
48954934|NCT01808118|157664164|FG001|Period 2|Switched to other therapy|1|||
48954935|NCT01808118|157664165|FG002|Period 2|Switched to other therapy|0|||
48954936|NCT01441440|157664166|FG000|Overall Study|Death|1|||
48748218|NCT00673465|156926511|FG010|Part 1/Period 1 (United States)|Protocol Violation|0|||
48748219|NCT00673465|156926512|FG011|Part 1/Period 1 (United States)|Protocol Violation|0|||
48748220|NCT00673465|156926501|FG000|Part 1/Period 2 (United States)|Protocol Violation|0|||
48954937|NCT01441440|157664167|FG001|Overall Study|Death|0|||
48954938|NCT01441440|157664168|FG002|Overall Study|Death|1|||
48954939|NCT01441440|157664166|FG000|Overall Study|Adverse Event|2|||
48954940|NCT01441440|157664167|FG001|Overall Study|Adverse Event|9|||
48954941|NCT01441440|157664168|FG002|Overall Study|Adverse Event|9|||
48954942|NCT01441440|157664166|FG000|Overall Study|Lost to Follow-up|0|||
48748221|NCT00673465|156926502|FG001|Part 1/Period 2 (United States)|Protocol Violation|0|||
48748222|NCT00673465|156926503|FG002|Part 1/Period 2 (United States)|Protocol Violation|0|||
48748223|NCT00673465|156926504|FG003|Part 1/Period 2 (United States)|Protocol Violation|0|||
48748224|NCT00673465|156926505|FG004|Part 1/Period 2 (United States)|Protocol Violation|1|||
48748225|NCT00673465|156926506|FG005|Part 1/Period 2 (United States)|Protocol Violation|0|||
48748226|NCT00673465|156926507|FG006|Part 1/Period 2 (United States)|Protocol Violation|0|||
48748227|NCT00673465|156926508|FG007|Part 1/Period 2 (United States)|Protocol Violation|0|||
48748228|NCT00673465|156926509|FG008|Part 1/Period 2 (United States)|Protocol Violation|0|||
48748229|NCT00673465|156926510|FG009|Part 1/Period 2 (United States)|Protocol Violation|0|||
48748230|NCT00673465|156926511|FG010|Part 1/Period 2 (United States)|Protocol Violation|0|||
48748231|NCT00673465|156926512|FG011|Part 1/Period 2 (United States)|Protocol Violation|0|||
48748232|NCT00601458|156926513|FG000|Overall Study|Dosing Error|1|||
48748233|NCT00601458|156926514|FG001|Overall Study|Dosing Error|0|||
48748234|NCT00601458|156926515|FG002|Overall Study|Dosing Error|0|||
48748235|NCT00601458|156926513|FG000|Overall Study|Incomplete Data|0|||
48748236|NCT00601458|156926514|FG001|Overall Study|Incomplete Data|2|||
48748237|NCT00601458|156926515|FG002|Overall Study|Incomplete Data|0|||
48748238|NCT00601458|156926513|FG000|Overall Study|Protocol Violation|3|||
48748239|NCT00601458|156926514|FG001|Overall Study|Protocol Violation|2|||
48748240|NCT00601458|156926515|FG002|Overall Study|Protocol Violation|1|||
48748241|NCT00601458|156926513|FG000|Overall Study|Early Termination|0|||
48748242|NCT00601458|156926514|FG001|Overall Study|Early Termination|1|||
48748243|NCT00601458|156926515|FG002|Overall Study|Early Termination|1|||
48748244|NCT02670837|156926517|FG000|Overall Study|Death|2|||
48748245|NCT02670837|156926518|FG001|Overall Study|Death|0|||
48748246|NCT02670837|156926519|FG002|Overall Study|Death|0|||
48748247|NCT01276353|156926520|FG000|Double-blind|Adverse Event|2|||
48748248|NCT01276353|156926521|FG001|Double-blind|Adverse Event|0|||
48748249|NCT01276353|156926520|FG000|Double-blind|Withdrawal by Subject|1|||
48748250|NCT01276353|156926521|FG001|Double-blind|Withdrawal by Subject|0|||
48748251|NCT01276353|156926520|FG000|Extension|Adverse Event|2|||
48748252|NCT01276353|156926521|FG001|Extension|Adverse Event|5|||
48748253|NCT01276353|156926520|FG000|Extension|Withdrawal by Subject|1|||
48748254|NCT01276353|156926521|FG001|Extension|Withdrawal by Subject|2|||
48748255|NCT01276353|156926520|FG000|Extension|Withdrawal of study drug 4 days in a row|3|||
48748256|NCT01276353|156926521|FG001|Extension|Withdrawal of study drug 4 days in a row|1|||
48748257|NCT01276353|156926520|FG000|Extension|Physician Decision|1|||
48954943|NCT01441440|157664167|FG001|Overall Study|Lost to Follow-up|2|||
48748258|NCT01276353|156926521|FG001|Extension|Physician Decision|0|||
48748259|NCT01276353|156926520|FG000|Extension|Prohibited concomitant medications|0|||
48748260|NCT01276353|156926521|FG001|Extension|Prohibited concomitant medications|1|||
48748261|NCT00801632|156926522|FG000|Overall Study|Re-transplant|1|||
48954944|NCT01441440|157664168|FG002|Overall Study|Lost to Follow-up|1|||
48748262|NCT03851705|156926534|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|2|||
48748263|NCT03851705|156926535|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
49015385|NCT00306384|157892158|FG002|Overall Study|Other|32|||
48748264|NCT03851705|156926536|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
48748265|NCT03851705|156926537|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
48748266|NCT03851705|156926534|FG000|Part 1: Double-Blind Period|Other reason|1|||
48748267|NCT03851705|156926535|FG001|Part 1: Double-Blind Period|Other reason|0|||
48748268|NCT03851705|156926536|FG002|Part 1: Double-Blind Period|Other reason|0|||
48748269|NCT03851705|156926537|FG003|Part 1: Double-Blind Period|Other reason|0|||
48748270|NCT03851705|156926534|FG000|Part 2: Open-Label Period|Other reason|0|||
48860699|NCT04184622|157328522|FG000|Overall Study|Other - as reported by the investigator|22|||
48954945|NCT01441440|157664166|FG000|Overall Study|Withdrawal by Subject|11|||
48954946|NCT01441440|157664167|FG001|Overall Study|Withdrawal by Subject|9|||
48954947|NCT01441440|157664168|FG002|Overall Study|Withdrawal by Subject|9|||
48954948|NCT01441440|157664166|FG000|Overall Study|Pregnancy|1|||
48954949|NCT01441440|157664167|FG001|Overall Study|Pregnancy|0|||
48748271|NCT03851705|156926535|FG001|Part 2: Open-Label Period|Other reason|0|||
48748272|NCT03851705|156926536|FG002|Part 2: Open-Label Period|Other reason|0|||
48748273|NCT03851705|156926537|FG003|Part 2: Open-Label Period|Other reason|1|||
48748274|NCT03851705|156926534|FG000|Part 2: Open-Label Period|Death|0|||
48748275|NCT03851705|156926535|FG001|Part 2: Open-Label Period|Death|0|||
48748276|NCT03851705|156926536|FG002|Part 2: Open-Label Period|Death|3|||
48748277|NCT03851705|156926537|FG003|Part 2: Open-Label Period|Death|0|||
48748278|NCT03851705|156926534|FG000|Part 2: Open-Label Period|Withdrawal by Subject|0|||
48748279|NCT03851705|156926535|FG001|Part 2: Open-Label Period|Withdrawal by Subject|0|||
48748280|NCT03851705|156926536|FG002|Part 2: Open-Label Period|Withdrawal by Subject|2|||
48748281|NCT03851705|156926537|FG003|Part 2: Open-Label Period|Withdrawal by Subject|0|||
48748282|NCT02859454|156926538|FG000|Overall Study|PI discretion/off study prior to trtmt|1|||
48748283|NCT00563381|156926542|FG000|Overall Study|Adverse Event|264|||
48748284|NCT00563381|156926543|FG001|Overall Study|Adverse Event|292|||
48748285|NCT00563381|156926542|FG000|Overall Study|Protocol Violation|66|||
48748286|NCT00563381|156926543|FG001|Overall Study|Protocol Violation|74|||
48748287|NCT00563381|156926542|FG000|Overall Study|Lost to Follow-up|7|||
48748288|NCT00563381|156926543|FG001|Overall Study|Lost to Follow-up|15|||
48748289|NCT00563381|156926542|FG000|Overall Study|Withdrawal by Subject|192|||
48748290|NCT00563381|156926543|FG001|Overall Study|Withdrawal by Subject|209|||
48748291|NCT00563381|156926542|FG000|Overall Study|Lack of Efficacy|32|||
48748292|NCT00563381|156926543|FG001|Overall Study|Lack of Efficacy|24|||
48748293|NCT00563381|156926542|FG000|Overall Study|Individual different reasons|24|||
48748294|NCT00563381|156926543|FG001|Overall Study|Individual different reasons|34|||
48748295|NCT01683383|156926546|FG000|Overall Study|Infant was not transported|1|||
48748296|NCT01683383|156926547|FG001|Overall Study|Infant was not transported|0|||
48748297|NCT00996307|156926548|FG000|Overall Study|Adverse Event|0|||
48748298|NCT00996307|156926549|FG001|Overall Study|Adverse Event|1|||
48748299|NCT00996307|156926550|FG002|Overall Study|Adverse Event|0|||
48748300|NCT00996307|156926551|FG003|Overall Study|Adverse Event|0|||
48748301|NCT00996307|156926548|FG000|Overall Study|Withdrawal by Subject|3|||
48748302|NCT00996307|156926549|FG001|Overall Study|Withdrawal by Subject|2|||
48748303|NCT00996307|156926550|FG002|Overall Study|Withdrawal by Subject|5|||
48748304|NCT00996307|156926551|FG003|Overall Study|Withdrawal by Subject|5|||
48748305|NCT00996307|156926548|FG000|Overall Study|Lost to Follow-up|13|||
48748306|NCT00996307|156926549|FG001|Overall Study|Lost to Follow-up|13|||
48748307|NCT00996307|156926550|FG002|Overall Study|Lost to Follow-up|7|||
48748308|NCT00996307|156926551|FG003|Overall Study|Lost to Follow-up|15|||
48748309|NCT00996307|156926548|FG000|Overall Study|Administrative reason|0|||
48748310|NCT00996307|156926549|FG001|Overall Study|Administrative reason|1|||
48748311|NCT00996307|156926550|FG002|Overall Study|Administrative reason|0|||
48748312|NCT00996307|156926551|FG003|Overall Study|Administrative reason|0|||
48748313|NCT00996307|156926548|FG000|Overall Study|Unable to classify|4|||
48748314|NCT00996307|156926549|FG001|Overall Study|Unable to classify|0|||
48748315|NCT00996307|156926550|FG002|Overall Study|Unable to classify|2|||
48748316|NCT00996307|156926551|FG003|Overall Study|Unable to classify|1|||
48748317|NCT02496611|156926552|FG000|Overall Study|Lost to Follow-up|2|||
48748318|NCT02496611|156926553|FG001|Overall Study|Lost to Follow-up|1|||
48748319|NCT02496611|156926552|FG000|Overall Study|Withdrawal by Subject|5|||
48748320|NCT02496611|156926553|FG001|Overall Study|Withdrawal by Subject|2|||
48748321|NCT02850965|156926554|FG000|Overall Study|Other than listed|3|||
48748322|NCT02850965|156926555|FG001|Overall Study|Other than listed|4|||
48748323|NCT02850965|156926554|FG000|Overall Study|Protocol Violation|0|||
48748324|NCT02850965|156926555|FG001|Overall Study|Protocol Violation|2|||
48748325|NCT02850965|156926554|FG000|Overall Study|Lost to Follow-up|5|||
48748326|NCT02850965|156926555|FG001|Overall Study|Lost to Follow-up|3|||
48748327|NCT02850965|156926554|FG000|Overall Study|Lack of Efficacy|4|||
48748328|NCT02850965|156926555|FG001|Overall Study|Lack of Efficacy|8|||
48748329|NCT02850965|156926554|FG000|Overall Study|Adverse Event|3|||
48748330|NCT02850965|156926555|FG001|Overall Study|Adverse Event|2|||
48748331|NCT02850965|156926554|FG000|Overall Study|Withdrawal by Subject|3|||
48748332|NCT02850965|156926555|FG001|Overall Study|Withdrawal by Subject|4|||
48748333|NCT02850965|156926554|FG000|Overall Study|Physician Decision|0|||
48748334|NCT02850965|156926555|FG001|Overall Study|Physician Decision|1|||
48748335|NCT02850965|156926554|FG000|Overall Study|Randomized but not treated|0|||
48748336|NCT02850965|156926555|FG001|Overall Study|Randomized but not treated|1|||
48748337|NCT01049308|156926556|FG000|Pill Counts|Withdrawal by Subject|83|||
48748338|NCT03129100|156926557|FG000|Lead-In Period (Period 1)|Adverse Event|2|||
48748339|NCT03129100|156926558|FG001|Lead-In Period (Period 1)|Adverse Event|6|||
48748340|NCT03129100|156926559|FG002|Lead-In Period (Period 1)|Adverse Event|0|||
48748341|NCT03129100|156926560|FG003|Lead-In Period (Period 1)|Adverse Event|0|||
48748342|NCT03129100|156926561|FG004|Lead-In Period (Period 1)|Adverse Event|0|||
48748343|NCT03129100|156926562|FG005|Lead-In Period (Period 1)|Adverse Event|0|||
48748344|NCT03129100|156926563|FG006|Lead-In Period (Period 1)|Adverse Event|0|||
48748345|NCT03129100|156926564|FG007|Lead-In Period (Period 1)|Adverse Event|0|||
48748346|NCT03129100|156926565|FG008|Lead-In Period (Period 1)|Adverse Event|0|||
48748347|NCT03129100|156926566|FG009|Lead-In Period (Period 1)|Adverse Event|0|||
48748348|NCT03129100|156926567|FG010|Lead-In Period (Period 1)|Adverse Event|0|||
48748349|NCT03129100|156926568|FG011|Lead-In Period (Period 1)|Adverse Event|0|||
48748350|NCT03129100|156926569|FG012|Lead-In Period (Period 1)|Adverse Event|0|||
48748351|NCT03129100|156926570|FG013|Lead-In Period (Period 1)|Adverse Event|0|||
48748352|NCT03129100|156926571|FG014|Lead-In Period (Period 1)|Adverse Event|0|||
48748353|NCT03129100|156926572|FG015|Lead-In Period (Period 1)|Adverse Event|0|||
48748354|NCT03129100|156926573|FG016|Lead-In Period (Period 1)|Adverse Event|0|||
48748355|NCT03129100|156926574|FG017|Lead-In Period (Period 1)|Adverse Event|0|||
48748356|NCT03129100|156926575|FG018|Lead-In Period (Period 1)|Adverse Event|0|||
48748357|NCT03129100|156926576|FG019|Lead-In Period (Period 1)|Adverse Event|0|||
48860700|NCT04184622|157328523|FG001|Overall Study|Other - as reported by the investigator|7|||
48860701|NCT04184622|157328524|FG002|Overall Study|Other - as reported by the investigator|5|||
48860702|NCT04184622|157328525|FG003|Overall Study|Other - as reported by the investigator|12|||
48860703|NCT04184622|157328522|FG000|Overall Study|Physician Decision|0|||
48860704|NCT04184622|157328523|FG001|Overall Study|Physician Decision|0|||
48860705|NCT04184622|157328524|FG002|Overall Study|Physician Decision|3|||
48860706|NCT04184622|157328525|FG003|Overall Study|Physician Decision|1|||
48860707|NCT04184622|157328522|FG000|Overall Study|Pregnancy|4|||
48860708|NCT04184622|157328523|FG001|Overall Study|Pregnancy|4|||
48860709|NCT04184622|157328524|FG002|Overall Study|Pregnancy|3|||
48860710|NCT04184622|157328525|FG003|Overall Study|Pregnancy|5|||
48860711|NCT04184622|157328522|FG000|Overall Study|Protocol Deviation|1|||
48860712|NCT04184622|157328523|FG001|Overall Study|Protocol Deviation|0|||
48860713|NCT04184622|157328524|FG002|Overall Study|Protocol Deviation|0|||
48860714|NCT04184622|157328525|FG003|Overall Study|Protocol Deviation|0|||
48860715|NCT04184622|157328522|FG000|Overall Study|Withdrawal by Subject|68|||
48860716|NCT04184622|157328523|FG001|Overall Study|Withdrawal by Subject|28|||
48860717|NCT04184622|157328524|FG002|Overall Study|Withdrawal by Subject|29|||
48860718|NCT04184622|157328525|FG003|Overall Study|Withdrawal by Subject|22|||
48860719|NCT02143713|157328527|FG000|Treatment Period (6 Months)|Withdrawal by Subject|1|||
48860720|NCT02143713|157328528|FG001|Treatment Period (6 Months)|Withdrawal by Subject|2|||
48860721|NCT02143713|157328529|FG002|Treatment Period (6 Months)|Withdrawal by Subject|5|||
48860722|NCT02143713|157328530|FG003|Treatment Period (6 Months)|Withdrawal by Subject|4|||
48860723|NCT02143713|157328527|FG000|Treatment Period (6 Months)|Adverse Event|7|||
48860724|NCT02143713|157328528|FG001|Treatment Period (6 Months)|Adverse Event|8|||
48860725|NCT02143713|157328529|FG002|Treatment Period (6 Months)|Adverse Event|8|||
48860726|NCT02143713|157328530|FG003|Treatment Period (6 Months)|Adverse Event|9|||
48860727|NCT02143713|157328527|FG000|Treatment Period (6 Months)|Lost to Follow-up|3|||
48860728|NCT02143713|157328528|FG001|Treatment Period (6 Months)|Lost to Follow-up|0|||
48860729|NCT02143713|157328529|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
48860730|NCT02143713|157328530|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
48860731|NCT02143713|157328527|FG000|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
48860732|NCT02143713|157328528|FG001|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
48860733|NCT02143713|157328529|FG002|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
48860734|NCT02143713|157328530|FG003|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
48860735|NCT02143713|157328527|FG000|Treatment Period (6 Months)|Pregnancy|0|||
48860736|NCT02143713|157328528|FG001|Treatment Period (6 Months)|Pregnancy|2|||
48860737|NCT02143713|157328529|FG002|Treatment Period (6 Months)|Pregnancy|2|||
48860738|NCT02143713|157328530|FG003|Treatment Period (6 Months)|Pregnancy|0|||
48860739|NCT02143713|157328527|FG000|Treatment Period (6 Months)|Non-compliance|1|||
48860740|NCT02143713|157328528|FG001|Treatment Period (6 Months)|Non-compliance|0|||
48860741|NCT02143713|157328529|FG002|Treatment Period (6 Months)|Non-compliance|0|||
48860742|NCT02143713|157328530|FG003|Treatment Period (6 Months)|Non-compliance|3|||
48860743|NCT02143713|157328527|FG000|Treatment Period (6 Months)|Other|3|||
48860744|NCT02143713|157328528|FG001|Treatment Period (6 Months)|Other|0|||
48860745|NCT02143713|157328529|FG002|Treatment Period (6 Months)|Other|3|||
48860746|NCT02143713|157328530|FG003|Treatment Period (6 Months)|Other|2|||
48860747|NCT02143713|157328527|FG000|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
48860748|NCT02143713|157328528|FG001|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
48860749|NCT02143713|157328529|FG002|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
48860750|NCT02143713|157328530|FG003|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4|||
48860751|NCT02143713|157328527|FG000|Treatment Period (6 Months)|Exclusionary Medication|2|||
48860752|NCT02143713|157328528|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
48860753|NCT02143713|157328529|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
48860754|NCT02143713|157328530|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
48860755|NCT02143713|157328527|FG000|Treatment Period (6 Months)|Lack of Efficacy|1|||
48860756|NCT02143713|157328528|FG001|Treatment Period (6 Months)|Lack of Efficacy|0|||
48860757|NCT02143713|157328529|FG002|Treatment Period (6 Months)|Lack of Efficacy|0|||
48860758|NCT02143713|157328530|FG003|Treatment Period (6 Months)|Lack of Efficacy|1|||
48860759|NCT02143713|157328527|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
48860760|NCT02143713|157328528|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7|||
48860761|NCT02143713|157328529|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
48860762|NCT02143713|157328530|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10|||
48860763|NCT02143713|157328527|FG000|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
48860764|NCT02143713|157328528|FG001|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
48860765|NCT02143713|157328529|FG002|Post-treatment Follow-up (12 Months)|Adverse Event|1|||
48860766|NCT02143713|157328530|FG003|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
48860767|NCT02143713|157328527|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3|||
48860768|NCT02143713|157328528|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
48860769|NCT02143713|157328529|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11|||
48860770|NCT02143713|157328530|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
48954950|NCT01441440|157664168|FG002|Overall Study|Pregnancy|0|||
48954951|NCT01441440|157664166|FG000|Overall Study|Lack of Efficacy|1|||
48954952|NCT01441440|157664167|FG001|Overall Study|Lack of Efficacy|0|||
48748358|NCT03129100|156926577|FG020|Lead-In Period (Period 1)|Adverse Event|0|||
48748359|NCT03129100|156926578|FG021|Lead-In Period (Period 1)|Adverse Event|0|||
48748360|NCT03129100|156926579|FG022|Lead-In Period (Period 1)|Adverse Event|0|||
48748361|NCT03129100|156926580|FG023|Lead-In Period (Period 1)|Adverse Event|0|||
48748362|NCT03129100|156926581|FG024|Lead-In Period (Period 1)|Adverse Event|0|||
48748363|NCT03129100|156926582|FG025|Lead-In Period (Period 1)|Adverse Event|0|||
48748364|NCT03129100|156926557|FG000|Lead-In Period (Period 1)|Lost to Follow-up|2|||
48748365|NCT03129100|156926558|FG001|Lead-In Period (Period 1)|Lost to Follow-up|0|||
48748366|NCT03129100|156926559|FG002|Lead-In Period (Period 1)|Lost to Follow-up|0|||
48860771|NCT02143713|157328527|FG000|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2|||
48860772|NCT02143713|157328528|FG001|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
48860773|NCT02143713|157328529|FG002|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
48860774|NCT02143713|157328530|FG003|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1|||
48860775|NCT02143713|157328527|FG000|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
48860776|NCT02143713|157328528|FG001|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
48860777|NCT02143713|157328529|FG002|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
48748367|NCT03129100|156926560|FG003|Lead-In Period (Period 1)|Lost to Follow-up|0|||
48748368|NCT03129100|156926561|FG004|Lead-In Period (Period 1)|Lost to Follow-up|0|||
48748369|NCT03129100|156926562|FG005|Lead-In Period (Period 1)|Lost to Follow-up|0|||
48748370|NCT03129100|156926563|FG006|Lead-In Period (Period 1)|Lost to Follow-up|0|||
48748371|NCT03129100|156926564|FG007|Lead-In Period (Period 1)|Lost to Follow-up|0|||
48748372|NCT03129100|156926565|FG008|Lead-In Period (Period 1)|Lost to Follow-up|0|||
48748373|NCT03129100|156926566|FG009|Lead-In Period (Period 1)|Lost to Follow-up|0|||
48748374|NCT03129100|156926567|FG010|Lead-In Period (Period 1)|Lost to Follow-up|0|||
48748375|NCT03129100|156926568|FG011|Lead-In Period (Period 1)|Lost to Follow-up|0|||
48748376|NCT03129100|156926569|FG012|Lead-In Period (Period 1)|Lost to Follow-up|0|||
48748377|NCT03129100|156926570|FG013|Lead-In Period (Period 1)|Lost to Follow-up|0|||
48748378|NCT03129100|156926571|FG014|Lead-In Period (Period 1)|Lost to Follow-up|0|||
48748379|NCT03129100|156926572|FG015|Lead-In Period (Period 1)|Lost to Follow-up|0|||
48748380|NCT03129100|156926573|FG016|Lead-In Period (Period 1)|Lost to Follow-up|0|||
48748381|NCT03129100|156926574|FG017|Lead-In Period (Period 1)|Lost to Follow-up|0|||
48748382|NCT03129100|156926575|FG018|Lead-In Period (Period 1)|Lost to Follow-up|0|||
48748383|NCT03129100|156926576|FG019|Lead-In Period (Period 1)|Lost to Follow-up|0|||
48748384|NCT03129100|156926577|FG020|Lead-In Period (Period 1)|Lost to Follow-up|0|||
48748385|NCT03129100|156926578|FG021|Lead-In Period (Period 1)|Lost to Follow-up|0|||
48748386|NCT03129100|156926579|FG022|Lead-In Period (Period 1)|Lost to Follow-up|0|||
48748387|NCT03129100|156926580|FG023|Lead-In Period (Period 1)|Lost to Follow-up|0|||
48748388|NCT03129100|156926581|FG024|Lead-In Period (Period 1)|Lost to Follow-up|0|||
48748389|NCT03129100|156926582|FG025|Lead-In Period (Period 1)|Lost to Follow-up|0|||
48748390|NCT03129100|156926557|FG000|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
48748391|NCT03129100|156926558|FG001|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
48748392|NCT03129100|156926559|FG002|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
48860778|NCT02143713|157328530|FG003|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
48860779|NCT02143713|157328527|FG000|Post-treatment Follow-up (12 Months)|Other|3|||
48860780|NCT02143713|157328528|FG001|Post-treatment Follow-up (12 Months)|Other|4|||
48860781|NCT02143713|157328529|FG002|Post-treatment Follow-up (12 Months)|Other|7|||
48860782|NCT02143713|157328530|FG003|Post-treatment Follow-up (12 Months)|Other|7|||
48860783|NCT03672188|157328531|FG000|Overall Study|Withdrawal by Subject|0|||
48860784|NCT03672188|157328532|FG001|Overall Study|Withdrawal by Subject|0|||
48860785|NCT03672188|157328533|FG002|Overall Study|Withdrawal by Subject|0|||
48860786|NCT03672188|157328534|FG003|Overall Study|Withdrawal by Subject|3|||
48860787|NCT03672188|157328535|FG004|Overall Study|Withdrawal by Subject|0|||
48860788|NCT03672188|157328536|FG005|Overall Study|Withdrawal by Subject|0|||
48860789|NCT03672188|157328537|FG006|Overall Study|Withdrawal by Subject|0|||
48860790|NCT03672188|157328538|FG007|Overall Study|Withdrawal by Subject|0|||
48860791|NCT03672188|157328539|FG008|Overall Study|Withdrawal by Subject|0|||
48860792|NCT03672188|157328540|FG009|Overall Study|Withdrawal by Subject|0|||
48860793|NCT03672188|157328541|FG010|Overall Study|Withdrawal by Subject|0|||
48860794|NCT03672188|157328542|FG011|Overall Study|Withdrawal by Subject|0|||
48860795|NCT03672188|157328543|FG012|Overall Study|Withdrawal by Subject|0|||
48860796|NCT03672188|157328544|FG013|Overall Study|Withdrawal by Subject|0|||
48860797|NCT03672188|157328545|FG014|Overall Study|Withdrawal by Subject|0|||
48860798|NCT03672188|157328531|FG000|Overall Study|Death|0|||
48860799|NCT03672188|157328532|FG001|Overall Study|Death|0|||
48860800|NCT03672188|157328533|FG002|Overall Study|Death|0|||
48860801|NCT03672188|157328534|FG003|Overall Study|Death|0|||
48860802|NCT03672188|157328535|FG004|Overall Study|Death|0|||
48860803|NCT03672188|157328536|FG005|Overall Study|Death|0|||
48860804|NCT03672188|157328537|FG006|Overall Study|Death|0|||
48860805|NCT03672188|157328538|FG007|Overall Study|Death|0|||
48860806|NCT03672188|157328539|FG008|Overall Study|Death|0|||
48860807|NCT03672188|157328540|FG009|Overall Study|Death|0|||
48860808|NCT03672188|157328541|FG010|Overall Study|Death|0|||
48860809|NCT03672188|157328542|FG011|Overall Study|Death|0|||
48860810|NCT03672188|157328543|FG012|Overall Study|Death|1|||
48860811|NCT03672188|157328544|FG013|Overall Study|Death|0|||
48860812|NCT03672188|157328545|FG014|Overall Study|Death|0|||
48860813|NCT03672188|157328531|FG000|Overall Study|Lost to Follow-up|0|||
48860814|NCT03672188|157328532|FG001|Overall Study|Lost to Follow-up|0|||
48860815|NCT03672188|157328533|FG002|Overall Study|Lost to Follow-up|1|||
48860816|NCT03672188|157328534|FG003|Overall Study|Lost to Follow-up|0|||
48860817|NCT03672188|157328535|FG004|Overall Study|Lost to Follow-up|0|||
48860818|NCT03672188|157328536|FG005|Overall Study|Lost to Follow-up|0|||
48860819|NCT03672188|157328537|FG006|Overall Study|Lost to Follow-up|0|||
48860820|NCT03672188|157328538|FG007|Overall Study|Lost to Follow-up|0|||
48860821|NCT03672188|157328539|FG008|Overall Study|Lost to Follow-up|0|||
48860822|NCT03672188|157328540|FG009|Overall Study|Lost to Follow-up|0|||
48860823|NCT03672188|157328541|FG010|Overall Study|Lost to Follow-up|0|||
48860824|NCT03672188|157328542|FG011|Overall Study|Lost to Follow-up|0|||
48860825|NCT03672188|157328543|FG012|Overall Study|Lost to Follow-up|0|||
48860826|NCT03672188|157328544|FG013|Overall Study|Lost to Follow-up|0|||
48860827|NCT03672188|157328545|FG014|Overall Study|Lost to Follow-up|0|||
48860828|NCT01714947|157328546|FG000|Part B|Progressive Disease|3|||
48860829|NCT01123356|157328547|FG000|Overall Study|Adverse Event|2|||
48860830|NCT01123356|157328547|FG000|Overall Study|Lack of Efficacy|4|||
48860831|NCT01123356|157328547|FG000|Overall Study|Withdrawal by Subject|1|||
48860832|NCT00402298|157328548|FG000|Overall Study|Withdrawal by Subject|1|||
48860833|NCT00402298|157328549|FG001|Overall Study|Withdrawal by Subject|0|||
48860834|NCT02069379|157328550|FG000|Baseline Measurements|Lost to Follow-up|1|||
48860835|NCT02069379|157328551|FG001|Baseline Measurements|Lost to Follow-up|0|||
48860836|NCT02069379|157328552|FG002|Baseline Measurements|Lost to Follow-up|0|||
48860837|NCT02069379|157328553|FG003|Baseline Measurements|Lost to Follow-up|0|||
48860838|NCT02069379|157328550|FG000|Baseline Measurements|Ineligible based on initial assessments|2|||
48860839|NCT02069379|157328551|FG001|Baseline Measurements|Ineligible based on initial assessments|0|||
48860840|NCT02069379|157328552|FG002|Baseline Measurements|Ineligible based on initial assessments|0|||
48860841|NCT02069379|157328553|FG003|Baseline Measurements|Ineligible based on initial assessments|2|||
48860842|NCT02069379|157328550|FG000|First Treatment Arm|Lost to Follow-up|0|||
48860843|NCT02069379|157328551|FG001|First Treatment Arm|Lost to Follow-up|1|||
48860844|NCT02069379|157328552|FG002|First Treatment Arm|Lost to Follow-up|1|||
48860845|NCT02069379|157328553|FG003|First Treatment Arm|Lost to Follow-up|0|||
48860846|NCT02069379|157328550|FG000|Washout Period (4 Weeks)|Lost to Follow-up|0|||
48860847|NCT02069379|157328551|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
48860848|NCT02069379|157328552|FG002|Washout Period (4 Weeks)|Lost to Follow-up|0|||
48860849|NCT02069379|157328553|FG003|Washout Period (4 Weeks)|Lost to Follow-up|0|||
48860850|NCT02069379|157328550|FG000|Washout Period (4 Weeks)|Unrelated event|0|||
48860851|NCT02069379|157328551|FG001|Washout Period (4 Weeks)|Unrelated event|1|||
48860852|NCT02069379|157328552|FG002|Washout Period (4 Weeks)|Unrelated event|0|||
48860853|NCT02069379|157328553|FG003|Washout Period (4 Weeks)|Unrelated event|0|||
48860854|NCT02069379|157328550|FG000|Second Treatment Arm|Lost to Follow-up|0|||
48860855|NCT02069379|157328551|FG001|Second Treatment Arm|Lost to Follow-up|0|||
48860856|NCT02069379|157328552|FG002|Second Treatment Arm|Lost to Follow-up|1|||
48860857|NCT02069379|157328553|FG003|Second Treatment Arm|Lost to Follow-up|0|||
48860858|NCT01469819|157328554|FG000|Overall Study|Withdrawal by Subject|1|||
48860859|NCT01469819|157328554|FG000|Overall Study|Did not meet inclusionary criteria|2|||
48860860|NCT01469819|157328554|FG000|Overall Study|Could not swallow SmartPill|2|||
48860861|NCT01469819|157328554|FG000|Overall Study|Technical malfunction of SmartPill data|3|||
48860862|NCT03209492|157328555|FG000|Overall Study|Case Report Forms Uncollected|5|||
48860863|NCT00561678|157328556|FG000|Overall Study|Withdrawal by Subject|4|||
48860864|NCT00561678|157328557|FG001|Overall Study|Withdrawal by Subject|3|||
48860865|NCT00561678|157328556|FG000|Overall Study|surgery cancelled|1|||
48860866|NCT00561678|157328557|FG001|Overall Study|surgery cancelled|1|||
48860867|NCT00561678|157328556|FG000|Overall Study|surgery rescheduled to different site|2|||
48860868|NCT00561678|157328557|FG001|Overall Study|surgery rescheduled to different site|2|||
48860869|NCT00561678|157328556|FG000|Overall Study|anesthesia provider refusal|1|||
48860870|NCT00561678|157328557|FG001|Overall Study|anesthesia provider refusal|0|||
48860871|NCT01762345|157328558|FG000|Overall Study|Adverse Event|5|||
48860872|NCT01762345|157328558|FG000|Overall Study|Protocol Violation|2|||
48860873|NCT05072795|157328559|FG000|Overall Study|Lost to Follow-up|5|||
48860874|NCT01894620|157328564|FG000|Overall Study|Withdrawal by Subject|0|||
48860875|NCT01894620|157328565|FG001|Overall Study|Withdrawal by Subject|1|||
48860876|NCT02877680|157328566|FG000|Overall Study|Lost to Follow-up|1|||
48860877|NCT02877680|157328567|FG001|Overall Study|Lost to Follow-up|1|||
48860878|NCT01133678|157328568|FG000|Overall Study|Death|1|||
48860879|NCT01133678|157328569|FG001|Overall Study|Death|1|||
48860880|NCT05647304|157328570|FG000|Overall Study|Withdrawal by Subject|1|||
48860881|NCT05647304|157328571|FG001|Overall Study|Withdrawal by Subject|0|||
48860882|NCT00657709|157328578|FG000|Overall Study|AE or Death|7|||
48860883|NCT00657709|157328579|FG001|Overall Study|AE or Death|7|||
48860884|NCT00657709|157328580|FG002|Overall Study|AE or Death|6|||
48860885|NCT00657709|157328581|FG003|Overall Study|AE or Death|7|||
48860886|NCT00657709|157328582|FG004|Overall Study|AE or Death|1|||
48860887|NCT00657709|157328578|FG000|Overall Study|Withdrawal by Subject|7|||
48860888|NCT00657709|157328579|FG001|Overall Study|Withdrawal by Subject|15|||
48860889|NCT00657709|157328580|FG002|Overall Study|Withdrawal by Subject|15|||
48860890|NCT00657709|157328581|FG003|Overall Study|Withdrawal by Subject|5|||
48860891|NCT00657709|157328582|FG004|Overall Study|Withdrawal by Subject|9|||
48860892|NCT00657709|157328578|FG000|Overall Study|Lost to Follow-up|9|||
48954953|NCT01441440|157664168|FG002|Overall Study|Lack of Efficacy|1|||
48954954|NCT01441440|157664166|FG000|Overall Study|Moving|0|||
48954955|NCT01441440|157664167|FG001|Overall Study|Moving|1|||
48954956|NCT01441440|157664168|FG002|Overall Study|Moving|1|||
48954957|NCT01441440|157664166|FG000|Overall Study|Work-related matter|0|||
48954958|NCT01441440|157664167|FG001|Overall Study|Work-related matter|1|||
48954959|NCT01441440|157664168|FG002|Overall Study|Work-related matter|0|||
48954960|NCT01441440|157664166|FG000|Overall Study|Difficllty in keeping the schedule|1|||
48954961|NCT01441440|157664167|FG001|Overall Study|Difficllty in keeping the schedule|1|||
48954962|NCT01441440|157664168|FG002|Overall Study|Difficllty in keeping the schedule|0|||
48954963|NCT01998581|157664172|FG000|Overall Study|Refused repeat treatment|20|||
48954964|NCT01998581|157664173|FG001|Overall Study|Refused repeat treatment|4|||
48954965|NCT01998581|157664172|FG000|Overall Study|Protocol Violation|1|||
48954966|NCT01998581|157664173|FG001|Overall Study|Protocol Violation|0|||
48954967|NCT01998581|157664172|FG000|Overall Study|Withdrawal by Subject|8|||
48954968|NCT01998581|157664173|FG001|Overall Study|Withdrawal by Subject|1|||
48954969|NCT01998581|157664172|FG000|Overall Study|Lost to Follow-up|12|||
48954970|NCT01998581|157664173|FG001|Overall Study|Lost to Follow-up|4|||
48954971|NCT01998581|157664172|FG000|Overall Study|Adverse Event|1|||
48954972|NCT01998581|157664173|FG001|Overall Study|Adverse Event|1|||
48954973|NCT01998581|157664172|FG000|Overall Study|Other reasons|3|||
48954974|NCT01998581|157664173|FG001|Overall Study|Other reasons|2|||
48954975|NCT01998581|157664172|FG000|Overall Study|Randomized but withdrew before treatment|1|||
48954976|NCT01998581|157664173|FG001|Overall Study|Randomized but withdrew before treatment|0|||
48954977|NCT02043301|157664174|FG000|Overall Study|Discontinued|0|||
48954978|NCT02043301|157664175|FG001|Overall Study|Discontinued|1|||
48954979|NCT02043301|157664176|FG002|Overall Study|Discontinued|0|||
48954980|NCT03097328|157664177|FG000|Overall Study|Still on Therapy|2|||
48954981|NCT03097328|157664177|FG000|Overall Study|Progressive Disease|29|||
48954982|NCT03097328|157664177|FG000|Overall Study|Adverse Event|4|||
48954983|NCT03097328|157664177|FG000|Overall Study|Withdrawal by Subject|1|||
48954984|NCT03097328|157664177|FG000|Overall Study|Physician Decision|1|||
48954985|NCT03097328|157664177|FG000|Overall Study|Patient Decision|1|||
48860893|NCT00657709|157328579|FG001|Overall Study|Lost to Follow-up|9|||
48860894|NCT00657709|157328580|FG002|Overall Study|Lost to Follow-up|7|||
48860895|NCT00657709|157328581|FG003|Overall Study|Lost to Follow-up|1|||
48860896|NCT00657709|157328582|FG004|Overall Study|Lost to Follow-up|21|||
48860897|NCT00657709|157328578|FG000|Overall Study|Protocol Violation|0|||
48954986|NCT03097328|157664177|FG000|Overall Study|Ineligible for Study Drug|1|||
48860898|NCT00657709|157328579|FG001|Overall Study|Protocol Violation|2|||
48860899|NCT00657709|157328580|FG002|Overall Study|Protocol Violation|0|||
48860900|NCT00657709|157328581|FG003|Overall Study|Protocol Violation|1|||
48954987|NCT01798134|157664178|FG000|Overall Study|Lost to Follow-up|1|||
48954988|NCT01798134|157664178|FG000|Overall Study|Withdrawal by Subject|3|||
48954989|NCT01798134|157664178|FG000|Overall Study|Death|2|||
48860901|NCT00657709|157328582|FG004|Overall Study|Protocol Violation|2|||
48860902|NCT02305797|157328583|FG000|Overall Study|Adverse Event|11|||
48860903|NCT02305797|157328584|FG001|Overall Study|Adverse Event|2|||
48860904|NCT02305797|157328583|FG000|Overall Study|Withdrawal by Subject|9|||
48860905|NCT02305797|157328584|FG001|Overall Study|Withdrawal by Subject|10|||
48860906|NCT02305797|157328583|FG000|Overall Study|Lack of Efficacy|6|||
48860907|NCT02305797|157328584|FG001|Overall Study|Lack of Efficacy|0|||
48860908|NCT02305797|157328583|FG000|Overall Study|Lost to Follow-up|5|||
48860909|NCT02305797|157328584|FG001|Overall Study|Lost to Follow-up|11|||
48860910|NCT02305797|157328583|FG000|Overall Study|Pregnancy|0|||
48954990|NCT01798134|157664178|FG000|Overall Study|Adverse Event|3|||
48954991|NCT01798134|157664178|FG000|Overall Study|Physician Decision|3|||
48954992|NCT01798134|157664178|FG000|Overall Study|Liver transplant/surgery|4|||
48954993|NCT03100942|157664184|FG000|Randomized Treatment Period|Withdrew Consent|4|||
48954994|NCT03100942|157664185|FG001|Randomized Treatment Period|Withdrew Consent|5|||
48954995|NCT03100942|157664186|FG002|Randomized Treatment Period|Withdrew Consent|3|||
48954996|NCT03100942|157664187|FG003|Randomized Treatment Period|Withdrew Consent|3|||
48954997|NCT03100942|157664188|FG004|Randomized Treatment Period|Withdrew Consent|0|||
48954998|NCT03100942|157664189|FG005|Randomized Treatment Period|Withdrew Consent|0|||
48954999|NCT03100942|157664190|FG006|Randomized Treatment Period|Withdrew Consent|0|||
48955000|NCT03100942|157664184|FG000|Randomized Treatment Period|Adverse Event|5|||
48955001|NCT03100942|157664185|FG001|Randomized Treatment Period|Adverse Event|2|||
48955002|NCT03100942|157664186|FG002|Randomized Treatment Period|Adverse Event|1|||
48955003|NCT03100942|157664187|FG003|Randomized Treatment Period|Adverse Event|0|||
48955004|NCT03100942|157664188|FG004|Randomized Treatment Period|Adverse Event|0|||
48955005|NCT03100942|157664189|FG005|Randomized Treatment Period|Adverse Event|0|||
48955006|NCT03100942|157664190|FG006|Randomized Treatment Period|Adverse Event|0|||
48955007|NCT03100942|157664184|FG000|Randomized Treatment Period|Investigator's Discretion|2|||
48955008|NCT03100942|157664185|FG001|Randomized Treatment Period|Investigator's Discretion|1|||
48955009|NCT03100942|157664186|FG002|Randomized Treatment Period|Investigator's Discretion|0|||
48955010|NCT03100942|157664187|FG003|Randomized Treatment Period|Investigator's Discretion|0|||
48955011|NCT03100942|157664188|FG004|Randomized Treatment Period|Investigator's Discretion|0|||
48955012|NCT03100942|157664189|FG005|Randomized Treatment Period|Investigator's Discretion|0|||
48955013|NCT03100942|157664190|FG006|Randomized Treatment Period|Investigator's Discretion|0|||
48955014|NCT03100942|157664184|FG000|Randomized Treatment Period|Protocol Violation|0|||
48955015|NCT03100942|157664185|FG001|Randomized Treatment Period|Protocol Violation|1|||
48955016|NCT03100942|157664186|FG002|Randomized Treatment Period|Protocol Violation|1|||
48955017|NCT03100942|157664187|FG003|Randomized Treatment Period|Protocol Violation|1|||
48955018|NCT03100942|157664188|FG004|Randomized Treatment Period|Protocol Violation|0|||
48955019|NCT03100942|157664189|FG005|Randomized Treatment Period|Protocol Violation|0|||
48955020|NCT03100942|157664190|FG006|Randomized Treatment Period|Protocol Violation|0|||
48955021|NCT03100942|157664184|FG000|Randomized Treatment Period|Lost to Follow-up|0|||
48955022|NCT03100942|157664185|FG001|Randomized Treatment Period|Lost to Follow-up|0|||
48955023|NCT03100942|157664186|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
48955024|NCT03100942|157664187|FG003|Randomized Treatment Period|Lost to Follow-up|0|||
48955025|NCT03100942|157664188|FG004|Randomized Treatment Period|Lost to Follow-up|0|||
48955026|NCT03100942|157664189|FG005|Randomized Treatment Period|Lost to Follow-up|0|||
48955027|NCT03100942|157664190|FG006|Randomized Treatment Period|Lost to Follow-up|0|||
48955028|NCT03100942|157664184|FG000|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
48860911|NCT02305797|157328584|FG001|Overall Study|Pregnancy|2|||
48860912|NCT02305797|157328583|FG000|Overall Study|Noncompliance|14|||
48860913|NCT02305797|157328584|FG001|Overall Study|Noncompliance|12|||
48955029|NCT03100942|157664185|FG001|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
48955030|NCT03100942|157664186|FG002|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
48748393|NCT03129100|156926560|FG003|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
48748394|NCT03129100|156926561|FG004|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
48748395|NCT03129100|156926562|FG005|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
48748396|NCT03129100|156926563|FG006|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
48748397|NCT03129100|156926564|FG007|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
48748398|NCT03129100|156926565|FG008|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
48748399|NCT03129100|156926566|FG009|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
48748400|NCT03129100|156926567|FG010|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
48748401|NCT03129100|156926568|FG011|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
48748402|NCT03129100|156926569|FG012|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
48748403|NCT03129100|156926570|FG013|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
48748404|NCT03129100|156926571|FG014|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
48748405|NCT03129100|156926572|FG015|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
48748406|NCT03129100|156926573|FG016|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
48748407|NCT03129100|156926574|FG017|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
48748408|NCT03129100|156926575|FG018|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
48748409|NCT03129100|156926576|FG019|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
48748410|NCT03129100|156926577|FG020|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
48748411|NCT03129100|156926578|FG021|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
48748412|NCT03129100|156926579|FG022|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
48748413|NCT03129100|156926580|FG023|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
48748414|NCT03129100|156926581|FG024|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
48748415|NCT03129100|156926582|FG025|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
48748416|NCT03129100|156926557|FG000|Lead-In Period (Period 1)|Lack of Efficacy|3|||
48748417|NCT03129100|156926558|FG001|Lead-In Period (Period 1)|Lack of Efficacy|2|||
48748418|NCT03129100|156926559|FG002|Lead-In Period (Period 1)|Lack of Efficacy|0|||
48748419|NCT03129100|156926560|FG003|Lead-In Period (Period 1)|Lack of Efficacy|0|||
48748420|NCT03129100|156926561|FG004|Lead-In Period (Period 1)|Lack of Efficacy|0|||
48748421|NCT03129100|156926562|FG005|Lead-In Period (Period 1)|Lack of Efficacy|0|||
48748422|NCT03129100|156926563|FG006|Lead-In Period (Period 1)|Lack of Efficacy|0|||
48748423|NCT03129100|156926564|FG007|Lead-In Period (Period 1)|Lack of Efficacy|0|||
48748424|NCT03129100|156926565|FG008|Lead-In Period (Period 1)|Lack of Efficacy|0|||
48748425|NCT03129100|156926566|FG009|Lead-In Period (Period 1)|Lack of Efficacy|0|||
48748426|NCT03129100|156926567|FG010|Lead-In Period (Period 1)|Lack of Efficacy|0|||
48748427|NCT03129100|156926568|FG011|Lead-In Period (Period 1)|Lack of Efficacy|0|||
48748428|NCT03129100|156926569|FG012|Lead-In Period (Period 1)|Lack of Efficacy|0|||
48748429|NCT03129100|156926570|FG013|Lead-In Period (Period 1)|Lack of Efficacy|0|||
48748430|NCT03129100|156926571|FG014|Lead-In Period (Period 1)|Lack of Efficacy|0|||
48748431|NCT03129100|156926572|FG015|Lead-In Period (Period 1)|Lack of Efficacy|0|||
48748432|NCT03129100|156926573|FG016|Lead-In Period (Period 1)|Lack of Efficacy|0|||
48748433|NCT03129100|156926574|FG017|Lead-In Period (Period 1)|Lack of Efficacy|0|||
48860914|NCT02305797|157328583|FG000|Overall Study|Reason not collected|0|||
48860915|NCT02305797|157328584|FG001|Overall Study|Reason not collected|1|||
48860916|NCT00422162|157328586|FG000|Overall Study|Adverse Event|11|||
48860917|NCT00422162|157328587|FG001|Overall Study|Adverse Event|9|||
48860918|NCT00422162|157328586|FG000|Overall Study|Lack of Efficacy|4|||
48860919|NCT00422162|157328587|FG001|Overall Study|Lack of Efficacy|10|||
48860920|NCT00422162|157328586|FG000|Overall Study|Withdrawal by Subject|7|||
48748434|NCT03129100|156926575|FG018|Lead-In Period (Period 1)|Lack of Efficacy|0|||
48748435|NCT03129100|156926576|FG019|Lead-In Period (Period 1)|Lack of Efficacy|0|||
48748436|NCT03129100|156926577|FG020|Lead-In Period (Period 1)|Lack of Efficacy|0|||
48860921|NCT00422162|157328587|FG001|Overall Study|Withdrawal by Subject|6|||
48860922|NCT00422162|157328586|FG000|Overall Study|Lost to Follow-up|1|||
48955031|NCT03100942|157664187|FG003|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
48955032|NCT03100942|157664188|FG004|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
48955033|NCT03100942|157664189|FG005|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
48955034|NCT03100942|157664190|FG006|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
48955035|NCT03100942|157664184|FG000|Placebo Arm Re-Randomized|Withdrew Consent|0|||
48955036|NCT03100942|157664185|FG001|Placebo Arm Re-Randomized|Withdrew Consent|0|||
48955037|NCT03100942|157664186|FG002|Placebo Arm Re-Randomized|Withdrew Consent|0|||
48955038|NCT03100942|157664187|FG003|Placebo Arm Re-Randomized|Withdrew Consent|0|||
48955039|NCT03100942|157664188|FG004|Placebo Arm Re-Randomized|Withdrew Consent|0|||
48955040|NCT03100942|157664189|FG005|Placebo Arm Re-Randomized|Withdrew Consent|0|||
48955041|NCT03100942|157664190|FG006|Placebo Arm Re-Randomized|Withdrew Consent|1|||
48955042|NCT05058664|157664193|FG000|Overall Study|No follow-up data provided|4|||
48955043|NCT05058664|157664194|FG001|Overall Study|No follow-up data provided|0|||
48860923|NCT00422162|157328587|FG001|Overall Study|Lost to Follow-up|2|||
48955044|NCT05058664|157664195|FG002|Overall Study|No follow-up data provided|2|||
48955045|NCT05058664|157664193|FG000|Overall Study|Withdrawal by Subject|0|||
48955046|NCT05058664|157664194|FG001|Overall Study|Withdrawal by Subject|0|||
48860924|NCT00422162|157328586|FG000|Overall Study|Non-Compliant with Protocol|1|||
48860925|NCT00422162|157328587|FG001|Overall Study|Non-Compliant with Protocol|1|||
48955047|NCT05058664|157664195|FG002|Overall Study|Withdrawal by Subject|1|||
48860926|NCT00422162|157328586|FG000|Overall Study|Other|0|||
48860927|NCT00422162|157328587|FG001|Overall Study|Other|1|||
48860928|NCT00422162|157328586|FG000|Overall Study|Didn't Receive Treatment|0|||
48860929|NCT00422162|157328587|FG001|Overall Study|Didn't Receive Treatment|1|||
48860930|NCT02959866|157328588|FG000|Overall Study|Withdrawal by Subject|1|||
48860931|NCT03529942|157328589|FG000|Overall Study|Withdrawal by Subject|13|||
48860932|NCT03529942|157328589|FG000|Overall Study|Physician Decision|1|||
48860933|NCT03529942|157328589|FG000|Overall Study|Lost to Follow-up|7|||
48860934|NCT03529942|157328589|FG000|Overall Study|Needle inserted but no drug administered|1|||
48860935|NCT03529942|157328589|FG000|Overall Study|Personal reasons|1|||
48860936|NCT03647709|157328593|FG000|Overall Study|Lost to Follow-up|5|||
48860937|NCT03647709|157328593|FG000|Overall Study|Physician Decision|6|||
48860938|NCT03647709|157328593|FG000|Overall Study|Withdrawal by Subject|3|||
48860939|NCT03839355|157328594|FG000|Overall Study|Withdrawal by Subject|1|||
48860940|NCT03839355|157328595|FG001|Overall Study|Withdrawal by Subject|0|||
48748437|NCT03129100|156926578|FG021|Lead-In Period (Period 1)|Lack of Efficacy|0|||
48748438|NCT03129100|156926579|FG022|Lead-In Period (Period 1)|Lack of Efficacy|0|||
48748439|NCT03129100|156926580|FG023|Lead-In Period (Period 1)|Lack of Efficacy|0|||
48748440|NCT03129100|156926581|FG024|Lead-In Period (Period 1)|Lack of Efficacy|0|||
48748441|NCT03129100|156926582|FG025|Lead-In Period (Period 1)|Lack of Efficacy|0|||
48748442|NCT03129100|156926557|FG000|Lead-In Period (Period 1)|Surgery Programmed|0|||
48748443|NCT03129100|156926558|FG001|Lead-In Period (Period 1)|Surgery Programmed|1|||
48748444|NCT03129100|156926559|FG002|Lead-In Period (Period 1)|Surgery Programmed|0|||
48748445|NCT03129100|156926560|FG003|Lead-In Period (Period 1)|Surgery Programmed|0|||
48748446|NCT03129100|156926561|FG004|Lead-In Period (Period 1)|Surgery Programmed|0|||
48748447|NCT03129100|156926562|FG005|Lead-In Period (Period 1)|Surgery Programmed|0|||
48748448|NCT03129100|156926563|FG006|Lead-In Period (Period 1)|Surgery Programmed|0|||
48748449|NCT03129100|156926564|FG007|Lead-In Period (Period 1)|Surgery Programmed|0|||
48748450|NCT03129100|156926565|FG008|Lead-In Period (Period 1)|Surgery Programmed|0|||
48748451|NCT03129100|156926566|FG009|Lead-In Period (Period 1)|Surgery Programmed|0|||
48748452|NCT03129100|156926567|FG010|Lead-In Period (Period 1)|Surgery Programmed|0|||
48748453|NCT03129100|156926568|FG011|Lead-In Period (Period 1)|Surgery Programmed|0|||
48748454|NCT03129100|156926569|FG012|Lead-In Period (Period 1)|Surgery Programmed|0|||
48748455|NCT03129100|156926570|FG013|Lead-In Period (Period 1)|Surgery Programmed|0|||
48748456|NCT03129100|156926571|FG014|Lead-In Period (Period 1)|Surgery Programmed|0|||
48748457|NCT03129100|156926572|FG015|Lead-In Period (Period 1)|Surgery Programmed|0|||
48748458|NCT03129100|156926573|FG016|Lead-In Period (Period 1)|Surgery Programmed|0|||
48748459|NCT03129100|156926574|FG017|Lead-In Period (Period 1)|Surgery Programmed|0|||
48748460|NCT03129100|156926575|FG018|Lead-In Period (Period 1)|Surgery Programmed|0|||
48748461|NCT03129100|156926576|FG019|Lead-In Period (Period 1)|Surgery Programmed|0|||
48748462|NCT03129100|156926577|FG020|Lead-In Period (Period 1)|Surgery Programmed|0|||
48748463|NCT03129100|156926578|FG021|Lead-In Period (Period 1)|Surgery Programmed|0|||
48748464|NCT03129100|156926579|FG022|Lead-In Period (Period 1)|Surgery Programmed|0|||
48748465|NCT03129100|156926580|FG023|Lead-In Period (Period 1)|Surgery Programmed|0|||
48748466|NCT03129100|156926581|FG024|Lead-In Period (Period 1)|Surgery Programmed|0|||
48748467|NCT03129100|156926582|FG025|Lead-In Period (Period 1)|Surgery Programmed|0|||
48748468|NCT03129100|156926557|FG000|Period2 Extension Period (Group A and B)|Adverse Event|0|||
48748469|NCT03129100|156926558|FG001|Period2 Extension Period (Group A and B)|Adverse Event|0|||
48748470|NCT03129100|156926559|FG002|Period2 Extension Period (Group A and B)|Adverse Event|2|||
48748471|NCT03129100|156926560|FG003|Period2 Extension Period (Group A and B)|Adverse Event|1|||
48748472|NCT03129100|156926561|FG004|Period2 Extension Period (Group A and B)|Adverse Event|0|||
48860941|NCT01075815|157328603|FG000|Overall Study|Withdrawal before r-hCG administration|6|||
48860942|NCT01075815|157328604|FG001|Overall Study|Withdrawal before r-hCG administration|1|||
48860943|NCT01075815|157328603|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
48860944|NCT01075815|157328604|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
48860945|NCT01075815|157328603|FG000|Overall Study|Withdrawal between OPU - embryo transfer|3|||
48860946|NCT01075815|157328604|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
48860947|NCT01699178|157328605|FG000|Overall Study|Adverse Event|1|||
48860948|NCT01699178|157328606|FG001|Overall Study|Adverse Event|5|||
48860949|NCT01699178|157328605|FG000|Overall Study|Lost to Follow-up|1|||
48860950|NCT01699178|157328606|FG001|Overall Study|Lost to Follow-up|6|||
48860951|NCT01699178|157328605|FG000|Overall Study|Non-compliance with Study Drug|3|||
48860952|NCT01699178|157328606|FG001|Overall Study|Non-compliance with Study Drug|1|||
48748473|NCT03129100|156926562|FG005|Period2 Extension Period (Group A and B)|Adverse Event|2|||
48748474|NCT03129100|156926563|FG006|Period2 Extension Period (Group A and B)|Adverse Event|0|||
48748475|NCT03129100|156926564|FG007|Period2 Extension Period (Group A and B)|Adverse Event|0|||
48748476|NCT03129100|156926565|FG008|Period2 Extension Period (Group A and B)|Adverse Event|0|||
48748477|NCT03129100|156926566|FG009|Period2 Extension Period (Group A and B)|Adverse Event|0|||
48748478|NCT03129100|156926567|FG010|Period2 Extension Period (Group A and B)|Adverse Event|0|||
48860953|NCT01699178|157328605|FG000|Overall Study|Physician Decision|1|||
48860954|NCT01699178|157328606|FG001|Overall Study|Physician Decision|0|||
48860955|NCT01699178|157328605|FG000|Overall Study|Withdrawal by Subject|4|||
48748479|NCT03129100|156926568|FG011|Period2 Extension Period (Group A and B)|Adverse Event|0|||
48748480|NCT03129100|156926569|FG012|Period2 Extension Period (Group A and B)|Adverse Event|0|||
48748481|NCT03129100|156926570|FG013|Period2 Extension Period (Group A and B)|Adverse Event|0|||
48748482|NCT03129100|156926571|FG014|Period2 Extension Period (Group A and B)|Adverse Event|0|||
48748483|NCT03129100|156926572|FG015|Period2 Extension Period (Group A and B)|Adverse Event|0|||
48748484|NCT03129100|156926573|FG016|Period2 Extension Period (Group A and B)|Adverse Event|0|||
48748485|NCT03129100|156926574|FG017|Period2 Extension Period (Group A and B)|Adverse Event|0|||
48748486|NCT03129100|156926575|FG018|Period2 Extension Period (Group A and B)|Adverse Event|0|||
48748487|NCT03129100|156926576|FG019|Period2 Extension Period (Group A and B)|Adverse Event|0|||
48748488|NCT03129100|156926577|FG020|Period2 Extension Period (Group A and B)|Adverse Event|0|||
48748489|NCT03129100|156926578|FG021|Period2 Extension Period (Group A and B)|Adverse Event|0|||
48748490|NCT03129100|156926579|FG022|Period2 Extension Period (Group A and B)|Adverse Event|0|||
48748491|NCT03129100|156926580|FG023|Period2 Extension Period (Group A and B)|Adverse Event|0|||
48748492|NCT03129100|156926581|FG024|Period2 Extension Period (Group A and B)|Adverse Event|0|||
48748493|NCT03129100|156926582|FG025|Period2 Extension Period (Group A and B)|Adverse Event|0|||
48748494|NCT03129100|156926557|FG000|Period2 Extension Period (Group A and B)|Death|0|||
48748495|NCT03129100|156926558|FG001|Period2 Extension Period (Group A and B)|Death|0|||
48748496|NCT03129100|156926559|FG002|Period2 Extension Period (Group A and B)|Death|1|||
48748497|NCT03129100|156926560|FG003|Period2 Extension Period (Group A and B)|Death|0|||
48860956|NCT01699178|157328606|FG001|Overall Study|Withdrawal by Subject|12|||
48860957|NCT01699178|157328605|FG000|Overall Study|Hematocrit >54%|1|||
48860958|NCT01699178|157328606|FG001|Overall Study|Hematocrit >54%|1|||
48860959|NCT01699178|157328605|FG000|Overall Study|PSA increase of >1.4 ng/mL|4|||
48860960|NCT01699178|157328606|FG001|Overall Study|PSA increase of >1.4 ng/mL|3|||
48860961|NCT01699178|157328605|FG000|Overall Study|ineligible/noncompliant/ subject reason|4|||
48955048|NCT01617681|157664197|FG000|Period 1 Double Blind|Adverse Event|2|||
48955049|NCT01617681|157664198|FG001|Period 1 Double Blind|Adverse Event|0|||
48955050|NCT01617681|157664199|FG002|Period 1 Double Blind|Adverse Event|0|||
48860962|NCT01699178|157328606|FG001|Overall Study|ineligible/noncompliant/ subject reason|4|||
48860963|NCT01261793|157328607|FG000|Overall Study|Lack of Efficacy|44|||
48860964|NCT01261793|157328608|FG001|Overall Study|Lack of Efficacy|37|||
48860965|NCT01261793|157328609|FG002|Overall Study|Lack of Efficacy|32|||
48860966|NCT01261793|157328607|FG000|Overall Study|Protocol Violation|3|||
48860967|NCT01261793|157328608|FG001|Overall Study|Protocol Violation|5|||
48860968|NCT01261793|157328609|FG002|Overall Study|Protocol Violation|6|||
48860969|NCT01261793|157328607|FG000|Overall Study|Lost to Follow-up|10|||
48860970|NCT01261793|157328608|FG001|Overall Study|Lost to Follow-up|3|||
48860971|NCT01261793|157328609|FG002|Overall Study|Lost to Follow-up|7|||
48860972|NCT01261793|157328607|FG000|Overall Study|Withdrawal by Subject|12|||
48860973|NCT01261793|157328608|FG001|Overall Study|Withdrawal by Subject|14|||
48860974|NCT01261793|157328609|FG002|Overall Study|Withdrawal by Subject|14|||
48860975|NCT01261793|157328607|FG000|Overall Study|Death|3|||
48860976|NCT01261793|157328608|FG001|Overall Study|Death|1|||
48955051|NCT01617681|157664200|FG003|Period 1 Double Blind|Adverse Event|2|||
48955052|NCT01617681|157664201|FG004|Period 1 Double Blind|Adverse Event|0|||
48955053|NCT01617681|157664197|FG000|Period 1 Double Blind|Withdrawal by Subject|1|||
48860977|NCT01261793|157328609|FG002|Overall Study|Death|0|||
48860978|NCT01261793|157328607|FG000|Overall Study|Adverse Event|9|||
48860979|NCT01261793|157328608|FG001|Overall Study|Adverse Event|24|||
48860980|NCT01261793|157328609|FG002|Overall Study|Adverse Event|19|||
48955054|NCT01617681|157664198|FG001|Period 1 Double Blind|Withdrawal by Subject|1|||
48955055|NCT01617681|157664199|FG002|Period 1 Double Blind|Withdrawal by Subject|1|||
48955056|NCT01617681|157664200|FG003|Period 1 Double Blind|Withdrawal by Subject|0|||
48955057|NCT01617681|157664201|FG004|Period 1 Double Blind|Withdrawal by Subject|0|||
48955058|NCT01617681|157664197|FG000|Period 2 Open Label|Adverse Event|0|||
48955059|NCT01617681|157664198|FG001|Period 2 Open Label|Adverse Event|0|||
48955060|NCT01617681|157664199|FG002|Period 2 Open Label|Adverse Event|0|||
48955061|NCT01617681|157664200|FG003|Period 2 Open Label|Adverse Event|0|||
48748498|NCT03129100|156926561|FG004|Period2 Extension Period (Group A and B)|Death|0|||
48860981|NCT01261793|157328607|FG000|Overall Study|Patient non-availability|1|||
48955062|NCT01617681|157664201|FG004|Period 2 Open Label|Adverse Event|3|||
48860982|NCT01261793|157328608|FG001|Overall Study|Patient non-availability|1|||
48860983|NCT01261793|157328609|FG002|Overall Study|Patient non-availability|1|||
48860984|NCT01261793|157328607|FG000|Overall Study|Suspected pregnancy|1|||
48860985|NCT01261793|157328608|FG001|Overall Study|Suspected pregnancy|1|||
48860986|NCT01261793|157328609|FG002|Overall Study|Suspected pregnancy|0|||
48860987|NCT01261793|157328607|FG000|Overall Study|Patient non-compliance|1|||
48860988|NCT01261793|157328608|FG001|Overall Study|Patient non-compliance|0|||
48860989|NCT01261793|157328609|FG002|Overall Study|Patient non-compliance|1|||
48860990|NCT01261793|157328607|FG000|Overall Study|Patient pregnant|1|||
48860991|NCT01261793|157328608|FG001|Overall Study|Patient pregnant|0|||
48860992|NCT01261793|157328609|FG002|Overall Study|Patient pregnant|0|||
48860993|NCT01261793|157328607|FG000|Overall Study|Outside the study area|0|||
48860994|NCT01261793|157328608|FG001|Overall Study|Outside the study area|2|||
48860995|NCT01261793|157328609|FG002|Overall Study|Outside the study area|1|||
48860996|NCT01261793|157328607|FG000|Overall Study|Lack of efficacy & patient not available|0|||
48860997|NCT01261793|157328608|FG001|Overall Study|Lack of efficacy & patient not available|1|||
48860998|NCT01261793|157328609|FG002|Overall Study|Lack of efficacy & patient not available|0|||
48860999|NCT01261793|157328607|FG000|Overall Study|Patient withdrew after cardiology visit|0|||
48861000|NCT01261793|157328608|FG001|Overall Study|Patient withdrew after cardiology visit|1|||
48861001|NCT01261793|157328609|FG002|Overall Study|Patient withdrew after cardiology visit|0|||
48861002|NCT01261793|157328607|FG000|Overall Study|Randomization error|0|||
48861003|NCT01261793|157328608|FG001|Overall Study|Randomization error|1|||
48861004|NCT01261793|157328609|FG002|Overall Study|Randomization error|0|||
48861005|NCT01261793|157328607|FG000|Overall Study|Patient unable to start IV line|0|||
48861006|NCT01261793|157328608|FG001|Overall Study|Patient unable to start IV line|0|||
48861007|NCT01261793|157328609|FG002|Overall Study|Patient unable to start IV line|1|||
48861008|NCT01196741|157328610|FG000|Overall Study|Disease progression|34|||
48861009|NCT01196741|157328611|FG001|Overall Study|Disease progression|14|||
48861010|NCT01196741|157328610|FG000|Overall Study|Adverse Event|10|||
48861011|NCT01196741|157328611|FG001|Overall Study|Adverse Event|6|||
48861012|NCT01196741|157328610|FG000|Overall Study|Serious Adverse Event|3|||
48861013|NCT01196741|157328611|FG001|Overall Study|Serious Adverse Event|1|||
48861014|NCT01196741|157328610|FG000|Overall Study|Dose limiting Adverse Event|2|||
48861015|NCT01196741|157328611|FG001|Overall Study|Dose limiting Adverse Event|1|||
48861016|NCT01196741|157328610|FG000|Overall Study|Withdrawal by Subject|3|||
48861017|NCT01196741|157328611|FG001|Overall Study|Withdrawal by Subject|0|||
48861018|NCT01196741|157328610|FG000|Overall Study|Other reason|3|||
48861019|NCT01196741|157328611|FG001|Overall Study|Other reason|3|||
48861020|NCT01196741|157328610|FG000|Overall Study|Other|3|||
48861021|NCT01196741|157328611|FG001|Overall Study|Other|2|||
48861022|NCT01196741|157328610|FG000|Overall Study|Protocol Violation|2|||
48861023|NCT01196741|157328611|FG001|Overall Study|Protocol Violation|1|||
48748499|NCT03129100|156926562|FG005|Period2 Extension Period (Group A and B)|Death|0|||
48748500|NCT03129100|156926563|FG006|Period2 Extension Period (Group A and B)|Death|0|||
48748501|NCT03129100|156926564|FG007|Period2 Extension Period (Group A and B)|Death|0|||
48748502|NCT03129100|156926565|FG008|Period2 Extension Period (Group A and B)|Death|0|||
48748503|NCT03129100|156926566|FG009|Period2 Extension Period (Group A and B)|Death|0|||
48748504|NCT03129100|156926567|FG010|Period2 Extension Period (Group A and B)|Death|0|||
48748505|NCT03129100|156926568|FG011|Period2 Extension Period (Group A and B)|Death|0|||
48748506|NCT03129100|156926569|FG012|Period2 Extension Period (Group A and B)|Death|0|||
48748507|NCT03129100|156926570|FG013|Period2 Extension Period (Group A and B)|Death|0|||
48748508|NCT03129100|156926571|FG014|Period2 Extension Period (Group A and B)|Death|0|||
48748509|NCT03129100|156926572|FG015|Period2 Extension Period (Group A and B)|Death|0|||
48748510|NCT03129100|156926573|FG016|Period2 Extension Period (Group A and B)|Death|0|||
48748511|NCT03129100|156926574|FG017|Period2 Extension Period (Group A and B)|Death|0|||
48748512|NCT03129100|156926575|FG018|Period2 Extension Period (Group A and B)|Death|0|||
48748513|NCT03129100|156926576|FG019|Period2 Extension Period (Group A and B)|Death|0|||
48748514|NCT03129100|156926577|FG020|Period2 Extension Period (Group A and B)|Death|0|||
48748515|NCT03129100|156926578|FG021|Period2 Extension Period (Group A and B)|Death|0|||
48748516|NCT03129100|156926579|FG022|Period2 Extension Period (Group A and B)|Death|0|||
48748517|NCT03129100|156926580|FG023|Period2 Extension Period (Group A and B)|Death|0|||
48748518|NCT03129100|156926581|FG024|Period2 Extension Period (Group A and B)|Death|0|||
48748519|NCT03129100|156926582|FG025|Period2 Extension Period (Group A and B)|Death|0|||
48748520|NCT03129100|156926557|FG000|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
48748521|NCT03129100|156926558|FG001|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
48748522|NCT03129100|156926559|FG002|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13|||
48748523|NCT03129100|156926560|FG003|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5|||
48748524|NCT03129100|156926561|FG004|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
48748525|NCT03129100|156926562|FG005|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
48748526|NCT03129100|156926563|FG006|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2|||
48748527|NCT03129100|156926564|FG007|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
48748528|NCT03129100|156926565|FG008|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
48748529|NCT03129100|156926566|FG009|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
48748530|NCT03129100|156926567|FG010|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
48748531|NCT03129100|156926568|FG011|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
48748532|NCT03129100|156926569|FG012|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
48748533|NCT03129100|156926570|FG013|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
48861024|NCT01468597|157328612|FG000|Overall Study|Found ineligible|17|||
48955063|NCT01617681|157664197|FG000|Period 2 Open Label|Withdrawal by Subject|0|||
48955064|NCT01617681|157664198|FG001|Period 2 Open Label|Withdrawal by Subject|0|||
48955065|NCT01617681|157664199|FG002|Period 2 Open Label|Withdrawal by Subject|0|||
48955066|NCT01617681|157664200|FG003|Period 2 Open Label|Withdrawal by Subject|0|||
48955067|NCT01617681|157664201|FG004|Period 2 Open Label|Withdrawal by Subject|3|||
48955068|NCT03648476|157664209|FG000|Overall Study|Withdrawal by Subject|2|||
48955069|NCT03648476|157664210|FG001|Overall Study|Withdrawal by Subject|1|||
48748534|NCT03129100|156926571|FG014|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
48748535|NCT03129100|156926572|FG015|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
48955070|NCT00879814|157664211|FG000|Overall Study|Adverse Event|0|||
48955071|NCT00879814|157664212|FG001|Overall Study|Adverse Event|1|||
48955072|NCT00879814|157664213|FG002|Overall Study|Adverse Event|0|||
48955073|NCT00879814|157664214|FG003|Overall Study|Adverse Event|0|||
48748536|NCT03129100|156926573|FG016|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
48748537|NCT03129100|156926574|FG017|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
48748538|NCT03129100|156926575|FG018|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
48748539|NCT03129100|156926576|FG019|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
48748540|NCT03129100|156926577|FG020|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
48861025|NCT01468597|157328612|FG000|Overall Study|concomitant valves|12|||
48861026|NCT01468597|157328612|FG000|Overall Study|off-pump CABG|1|||
48861027|NCT01468597|157328612|FG000|Overall Study|no platelet function data|5|||
48861028|NCT00603278|157328613|FG000|Overall Study|Lack of Efficacy|35|||
48955074|NCT00879814|157664211|FG000|Overall Study|Lost to Follow-up|1|||
48955075|NCT00879814|157664212|FG001|Overall Study|Lost to Follow-up|0|||
48955076|NCT00879814|157664213|FG002|Overall Study|Lost to Follow-up|0|||
48955077|NCT00879814|157664214|FG003|Overall Study|Lost to Follow-up|2|||
48955078|NCT00879814|157664211|FG000|Overall Study|Participant Failed to Return|0|||
48955079|NCT00879814|157664212|FG001|Overall Study|Participant Failed to Return|0|||
48955080|NCT00879814|157664213|FG002|Overall Study|Participant Failed to Return|0|||
48955081|NCT00879814|157664214|FG003|Overall Study|Participant Failed to Return|1|||
48955082|NCT00879814|157664211|FG000|Overall Study|Withdrawal by Subject|3|||
48955083|NCT00879814|157664212|FG001|Overall Study|Withdrawal by Subject|1|||
48955084|NCT00879814|157664213|FG002|Overall Study|Withdrawal by Subject|1|||
48955085|NCT00879814|157664214|FG003|Overall Study|Withdrawal by Subject|2|||
48955086|NCT00879814|157664211|FG000|Overall Study|Physician Decision|0|||
48955087|NCT00879814|157664212|FG001|Overall Study|Physician Decision|0|||
48955088|NCT00879814|157664213|FG002|Overall Study|Physician Decision|1|||
48955089|NCT00879814|157664214|FG003|Overall Study|Physician Decision|0|||
48955090|NCT00879814|157664211|FG000|Overall Study|Other|0|||
48955091|NCT00879814|157664212|FG001|Overall Study|Other|0|||
48955092|NCT00879814|157664213|FG002|Overall Study|Other|1|||
48955093|NCT00879814|157664214|FG003|Overall Study|Other|0|||
48955094|NCT05434078|157664215|FG000|Overall Study|Lost to Follow-up|2|||
48955095|NCT05434078|157664216|FG001|Overall Study|Lost to Follow-up|1|||
48955096|NCT05434078|157664215|FG000|Overall Study|Withdrawal by Subject|1|||
48955097|NCT05434078|157664216|FG001|Overall Study|Withdrawal by Subject|0|||
48861029|NCT00603278|157328614|FG001|Overall Study|Lack of Efficacy|10|||
48861030|NCT00603278|157328615|FG002|Overall Study|Lack of Efficacy|11|||
48861031|NCT00603278|157328616|FG003|Overall Study|Lack of Efficacy|8|||
48861032|NCT00603278|157328617|FG004|Overall Study|Lack of Efficacy|7|||
48861033|NCT00603278|157328618|FG005|Overall Study|Lack of Efficacy|14|||
48861034|NCT00603278|157328613|FG000|Overall Study|Adverse Event|0|||
48861035|NCT00603278|157328614|FG001|Overall Study|Adverse Event|3|||
48861036|NCT00603278|157328615|FG002|Overall Study|Adverse Event|1|||
48861037|NCT00603278|157328616|FG003|Overall Study|Adverse Event|0|||
48861038|NCT00603278|157328617|FG004|Overall Study|Adverse Event|2|||
48861039|NCT00603278|157328618|FG005|Overall Study|Adverse Event|1|||
48861040|NCT00603278|157328613|FG000|Overall Study|Withdrawal by Subject|2|||
48861041|NCT00603278|157328614|FG001|Overall Study|Withdrawal by Subject|3|||
48861042|NCT00603278|157328615|FG002|Overall Study|Withdrawal by Subject|1|||
48861043|NCT00603278|157328616|FG003|Overall Study|Withdrawal by Subject|2|||
48861044|NCT00603278|157328617|FG004|Overall Study|Withdrawal by Subject|1|||
48955098|NCT00506077|157664228|FG000|Treatment Period 1|Adverse Event|2|||
48955099|NCT00506077|157664229|FG001|Treatment Period 1|Adverse Event|1|||
48955100|NCT00506077|157664228|FG000|Treatment Period 1|Lost to Follow-up|0|||
48955101|NCT00506077|157664229|FG001|Treatment Period 1|Lost to Follow-up|2|||
48955102|NCT00506077|157664228|FG000|Treatment Period 1|Withdrawal by Subject|2|||
48955103|NCT00506077|157664229|FG001|Treatment Period 1|Withdrawal by Subject|0|||
48955104|NCT00506077|157664228|FG000|Treatment Period 2|Adverse Event|0|||
48955105|NCT00506077|157664229|FG001|Treatment Period 2|Adverse Event|1|||
48955106|NCT00506077|157664228|FG000|Treatment Period 2|Withdrawal by Subject|1|||
48955107|NCT00506077|157664229|FG001|Treatment Period 2|Withdrawal by Subject|0|||
48955108|NCT02064439|157664230|FG000|Overall Study|Adverse Event|51|||
48955109|NCT02064439|157664231|FG001|Overall Study|Adverse Event|47|||
48955110|NCT02064439|157664232|FG002|Overall Study|Adverse Event|46|||
48955111|NCT02064439|157664230|FG000|Overall Study|Death|0|||
48955112|NCT02064439|157664231|FG001|Overall Study|Death|2|||
48955113|NCT02064439|157664232|FG002|Overall Study|Death|3|||
48955114|NCT02064439|157664230|FG000|Overall Study|Withdrawal by Subject|29|||
48955115|NCT02064439|157664231|FG001|Overall Study|Withdrawal by Subject|18|||
48955116|NCT02064439|157664232|FG002|Overall Study|Withdrawal by Subject|26|||
48955117|NCT02064439|157664230|FG000|Overall Study|Protocol Violation|3|||
48955118|NCT02064439|157664231|FG001|Overall Study|Protocol Violation|5|||
48955119|NCT02064439|157664232|FG002|Overall Study|Protocol Violation|3|||
48955120|NCT02064439|157664230|FG000|Overall Study|Lost to Follow-up|1|||
48955121|NCT02064439|157664231|FG001|Overall Study|Lost to Follow-up|3|||
48955122|NCT02064439|157664232|FG002|Overall Study|Lost to Follow-up|4|||
48955123|NCT02064439|157664230|FG000|Overall Study|Non-compliance with study medication|21|||
48955124|NCT02064439|157664231|FG001|Overall Study|Non-compliance with study medication|19|||
48955125|NCT02064439|157664232|FG002|Overall Study|Non-compliance with study medication|23|||
48955126|NCT02064439|157664230|FG000|Overall Study|Physician Decision|0|||
48955127|NCT02064439|157664231|FG001|Overall Study|Physician Decision|1|||
48955128|NCT02064439|157664232|FG002|Overall Study|Physician Decision|1|||
48955129|NCT02064439|157664230|FG000|Overall Study|Logistical difficulties|6|||
48955130|NCT02064439|157664231|FG001|Overall Study|Logistical difficulties|5|||
48955131|NCT02064439|157664232|FG002|Overall Study|Logistical difficulties|2|||
48955132|NCT02064439|157664230|FG000|Overall Study|Efficacy outcome reached|18|||
48955133|NCT02064439|157664231|FG001|Overall Study|Efficacy outcome reached|16|||
48955134|NCT02064439|157664232|FG002|Overall Study|Efficacy outcome reached|57|||
48955135|NCT02064439|157664230|FG000|Overall Study|Safety outcome reached|12|||
48955136|NCT02064439|157664231|FG001|Overall Study|Safety outcome reached|20|||
48955137|NCT02064439|157664232|FG002|Overall Study|Safety outcome reached|10|||
48955138|NCT02064439|157664230|FG000|Overall Study|Other|2|||
48955139|NCT02064439|157664231|FG001|Overall Study|Other|2|||
48955140|NCT02064439|157664232|FG002|Overall Study|Other|7|||
48748541|NCT03129100|156926578|FG021|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
48748542|NCT03129100|156926579|FG022|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
48748543|NCT03129100|156926580|FG023|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
48748544|NCT03129100|156926581|FG024|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
48748545|NCT03129100|156926582|FG025|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
48955141|NCT01740440|157664235|FG000|Overall Study|Lost to Follow-up|3|||
48955142|NCT03196505|157664236|FG000|Overall Study|Physician Decision|26|||
48955143|NCT03196505|157664237|FG001|Overall Study|Physician Decision|26|||
48955144|NCT00940342|157664238|FG000|Overall Study|Adverse Event|0|||
48955145|NCT00940342|157664239|FG001|Overall Study|Adverse Event|2|||
48955146|NCT00940342|157664240|FG002|Overall Study|Adverse Event|1|||
48955147|NCT05485779|157664241|FG000|Treatment Period 1 (Fasted)|Adverse Event|0|||
48955148|NCT05485779|157664242|FG001|Treatment Period 1 (Fasted)|Adverse Event|0|||
48955149|NCT05485779|157664243|FG002|Treatment Period 1 (Fasted)|Adverse Event|0|||
48955150|NCT05485779|157664244|FG003|Treatment Period 1 (Fasted)|Adverse Event|0|||
48955151|NCT05485779|157664245|FG004|Treatment Period 1 (Fasted)|Adverse Event|0|||
48955152|NCT05485779|157664246|FG005|Treatment Period 1 (Fasted)|Adverse Event|0|||
48955153|NCT05485779|157664247|FG006|Treatment Period 1 (Fasted)|Adverse Event|0|||
48955154|NCT05485779|157664248|FG007|Treatment Period 1 (Fasted)|Adverse Event|1|||
48955155|NCT05485779|157664249|FG008|Treatment Period 1 (Fasted)|Adverse Event|1|||
48955156|NCT05485779|157664250|FG009|Treatment Period 1 (Fasted)|Adverse Event|0|||
48955157|NCT05485779|157664251|FG010|Treatment Period 1 (Fasted)|Adverse Event|0|||
48955158|NCT05485779|157664241|FG000|Treatment Period 1 (Fasted)|Physician Decision|0|||
48955159|NCT05485779|157664242|FG001|Treatment Period 1 (Fasted)|Physician Decision|0|||
48955160|NCT05485779|157664243|FG002|Treatment Period 1 (Fasted)|Physician Decision|0|||
48955161|NCT05485779|157664244|FG003|Treatment Period 1 (Fasted)|Physician Decision|0|||
48955162|NCT05485779|157664245|FG004|Treatment Period 1 (Fasted)|Physician Decision|0|||
48955163|NCT05485779|157664246|FG005|Treatment Period 1 (Fasted)|Physician Decision|0|||
48955164|NCT05485779|157664247|FG006|Treatment Period 1 (Fasted)|Physician Decision|0|||
48955165|NCT05485779|157664248|FG007|Treatment Period 1 (Fasted)|Physician Decision|0|||
48955166|NCT05485779|157664249|FG008|Treatment Period 1 (Fasted)|Physician Decision|0|||
48955167|NCT05485779|157664250|FG009|Treatment Period 1 (Fasted)|Physician Decision|0|||
48955168|NCT05485779|157664251|FG010|Treatment Period 1 (Fasted)|Physician Decision|1|||
48955169|NCT05485779|157664241|FG000|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
48955170|NCT05485779|157664242|FG001|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
48861045|NCT00603278|157328618|FG005|Overall Study|Withdrawal by Subject|2|||
48861046|NCT00603278|157328613|FG000|Overall Study|Protocol Violation|3|||
48861047|NCT00603278|157328614|FG001|Overall Study|Protocol Violation|0|||
48861048|NCT00603278|157328615|FG002|Overall Study|Protocol Violation|1|||
48861049|NCT00603278|157328616|FG003|Overall Study|Protocol Violation|1|||
48861050|NCT00603278|157328617|FG004|Overall Study|Protocol Violation|0|||
48861051|NCT00603278|157328618|FG005|Overall Study|Protocol Violation|1|||
48861052|NCT00603278|157328613|FG000|Overall Study|Physician Decision|0|||
48861053|NCT00603278|157328614|FG001|Overall Study|Physician Decision|1|||
48861054|NCT00603278|157328615|FG002|Overall Study|Physician Decision|0|||
48861055|NCT00603278|157328616|FG003|Overall Study|Physician Decision|0|||
48861056|NCT00603278|157328617|FG004|Overall Study|Physician Decision|2|||
48861057|NCT00603278|157328618|FG005|Overall Study|Physician Decision|1|||
48861058|NCT00603278|157328613|FG000|Overall Study|Lost to Follow-up|1|||
48861059|NCT00603278|157328614|FG001|Overall Study|Lost to Follow-up|0|||
48861060|NCT00603278|157328615|FG002|Overall Study|Lost to Follow-up|0|||
48861061|NCT00603278|157328616|FG003|Overall Study|Lost to Follow-up|0|||
48861062|NCT00603278|157328617|FG004|Overall Study|Lost to Follow-up|1|||
48861063|NCT00603278|157328618|FG005|Overall Study|Lost to Follow-up|0|||
48861064|NCT00448344|157328619|FG000|Overall Study|Lost to Follow-up|20|||
48861065|NCT00448344|157328620|FG001|Overall Study|Lost to Follow-up|22|||
48861066|NCT00448344|157328619|FG000|Overall Study|Withdrawal by Subject|6|||
48861067|NCT00448344|157328620|FG001|Overall Study|Withdrawal by Subject|8|||
48861068|NCT00448344|157328619|FG000|Overall Study|Death|3|||
48861069|NCT00448344|157328620|FG001|Overall Study|Death|4|||
48861070|NCT00448344|157328619|FG000|Overall Study|Physician Decision|1|||
48861071|NCT00448344|157328620|FG001|Overall Study|Physician Decision|2|||
48861072|NCT01760876|157328621|FG000|Overall Study|Non-cardiac death (head injury)|1|||
48861073|NCT01760876|157328621|FG000|Overall Study|Carcinoma of prostate|1|||
48861074|NCT01760876|157328621|FG000|Overall Study|Impaired renal function|1|||
48861075|NCT01760876|157328621|FG000|Overall Study|Major depression|1|||
48861076|NCT01760876|157328621|FG000|Overall Study|Very poor baseline OCT quality|2|||
48861077|NCT01288729|157328622|FG000|Overall Study|Withdrawal by Subject|1|||
48861078|NCT01288729|157328623|FG001|Overall Study|Withdrawal by Subject|0|||
49015386|NCT00306384|157892156|FG000|Overall Study|Site closure|2|||
48861079|NCT02577315|157328626|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
48748546|NCT03129100|156926557|FG000|Period2 Extension Period (Group A and B)|Physician Decision|0|||
48861080|NCT02577315|157328627|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
48748547|NCT03129100|156926558|FG001|Period2 Extension Period (Group A and B)|Physician Decision|0|||
48748548|NCT03129100|156926559|FG002|Period2 Extension Period (Group A and B)|Physician Decision|1|||
48748549|NCT03129100|156926560|FG003|Period2 Extension Period (Group A and B)|Physician Decision|0|||
48748550|NCT03129100|156926561|FG004|Period2 Extension Period (Group A and B)|Physician Decision|0|||
48748551|NCT03129100|156926562|FG005|Period2 Extension Period (Group A and B)|Physician Decision|0|||
48748552|NCT03129100|156926563|FG006|Period2 Extension Period (Group A and B)|Physician Decision|0|||
48748553|NCT03129100|156926564|FG007|Period2 Extension Period (Group A and B)|Physician Decision|0|||
48748554|NCT03129100|156926565|FG008|Period2 Extension Period (Group A and B)|Physician Decision|0|||
48748555|NCT03129100|156926566|FG009|Period2 Extension Period (Group A and B)|Physician Decision|0|||
48748556|NCT03129100|156926567|FG010|Period2 Extension Period (Group A and B)|Physician Decision|0|||
48748557|NCT03129100|156926568|FG011|Period2 Extension Period (Group A and B)|Physician Decision|0|||
48748558|NCT03129100|156926569|FG012|Period2 Extension Period (Group A and B)|Physician Decision|0|||
48748559|NCT03129100|156926570|FG013|Period2 Extension Period (Group A and B)|Physician Decision|0|||
48748560|NCT03129100|156926571|FG014|Period2 Extension Period (Group A and B)|Physician Decision|0|||
48748561|NCT03129100|156926572|FG015|Period2 Extension Period (Group A and B)|Physician Decision|0|||
48748562|NCT03129100|156926573|FG016|Period2 Extension Period (Group A and B)|Physician Decision|0|||
48748563|NCT03129100|156926574|FG017|Period2 Extension Period (Group A and B)|Physician Decision|0|||
48748564|NCT03129100|156926575|FG018|Period2 Extension Period (Group A and B)|Physician Decision|0|||
48748565|NCT03129100|156926576|FG019|Period2 Extension Period (Group A and B)|Physician Decision|0|||
48748566|NCT03129100|156926577|FG020|Period2 Extension Period (Group A and B)|Physician Decision|0|||
48748567|NCT03129100|156926578|FG021|Period2 Extension Period (Group A and B)|Physician Decision|0|||
48748568|NCT03129100|156926579|FG022|Period2 Extension Period (Group A and B)|Physician Decision|0|||
48861081|NCT00788671|157329742|FG000|Overall Study|Death|2|||
48861082|NCT00788671|157329742|FG000|Overall Study|Unable to biopsy|1|||
48955171|NCT05485779|157664243|FG002|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
48748569|NCT03129100|156926580|FG023|Period2 Extension Period (Group A and B)|Physician Decision|0|||
48748570|NCT03129100|156926581|FG024|Period2 Extension Period (Group A and B)|Physician Decision|0|||
48748571|NCT03129100|156926582|FG025|Period2 Extension Period (Group A and B)|Physician Decision|0|||
48748572|NCT03129100|156926557|FG000|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
48748573|NCT03129100|156926558|FG001|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
48748574|NCT03129100|156926559|FG002|Period2 Extension Period (Group A and B)|Lack of Efficacy|2|||
48955172|NCT05485779|157664244|FG003|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|1|||
48748575|NCT03129100|156926560|FG003|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
48748576|NCT03129100|156926561|FG004|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
48748577|NCT03129100|156926562|FG005|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
48748578|NCT03129100|156926563|FG006|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
48748579|NCT03129100|156926564|FG007|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
48861083|NCT00788671|157329742|FG000|Overall Study|Withdrawal by Subject|4|||
48861084|NCT00788671|157329742|FG000|Overall Study|IUD expulsed|1|||
48861085|NCT00788671|157329742|FG000|Overall Study|Lost to follow up|2|||
48861086|NCT05487300|157329743|FG000|Overall Study|Withdrawal by Subject|1|||
48861087|NCT05487300|157329744|FG001|Overall Study|Withdrawal by Subject|0|||
48861088|NCT03020914|157329746|FG000|Overall Study|Surgery Cancelled|1|||
48861089|NCT03020914|157329747|FG001|Overall Study|Surgery Cancelled|0|||
48861090|NCT02880293|157329750|FG000|Overall Study|Inevaluable|5|||
48861091|NCT02014402|157329753|FG000|Overall Study|Adverse Event|1|||
48861092|NCT02014402|157329754|FG001|Overall Study|Adverse Event|0|||
48861093|NCT02014402|157329755|FG002|Overall Study|Adverse Event|0|||
48861094|NCT02014402|157329756|FG003|Overall Study|Adverse Event|0|||
48861095|NCT02014402|157329753|FG000|Overall Study|Withdrawal by Subject|1|||
48861096|NCT02014402|157329754|FG001|Overall Study|Withdrawal by Subject|2|||
48861097|NCT02014402|157329755|FG002|Overall Study|Withdrawal by Subject|2|||
48861098|NCT02014402|157329756|FG003|Overall Study|Withdrawal by Subject|1|||
48861099|NCT02014402|157329753|FG000|Overall Study|Subject did not have transportation|0|||
48861100|NCT02014402|157329754|FG001|Overall Study|Subject did not have transportation|1|||
48861101|NCT02014402|157329755|FG002|Overall Study|Subject did not have transportation|0|||
48861102|NCT02014402|157329756|FG003|Overall Study|Subject did not have transportation|0|||
48955173|NCT05485779|157664245|FG004|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
48955174|NCT05485779|157664246|FG005|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
48955175|NCT05485779|157664247|FG006|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
48955176|NCT05485779|157664248|FG007|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
48955177|NCT05485779|157664249|FG008|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
48955178|NCT05485779|157664250|FG009|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
48955179|NCT05485779|157664251|FG010|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
48955180|NCT03116399|157664252|FG000|Overall Study|Death|8|||
48955181|NCT03116399|157664253|FG001|Overall Study|Death|3|||
48861103|NCT02014402|157329753|FG000|Overall Study|Lost to Follow-up|0|||
48861104|NCT02014402|157329754|FG001|Overall Study|Lost to Follow-up|0|||
48861105|NCT02014402|157329755|FG002|Overall Study|Lost to Follow-up|1|||
48861106|NCT02014402|157329756|FG003|Overall Study|Lost to Follow-up|2|||
48861107|NCT01148017|157329757|FG000|Overall Study|Withdrawal by Subject|31|||
48861108|NCT01148017|157329758|FG001|Overall Study|Withdrawal by Subject|14|||
48861109|NCT01148017|157329759|FG002|Overall Study|Withdrawal by Subject|0|||
48861110|NCT01148017|157329760|FG003|Overall Study|Withdrawal by Subject|0|||
48861111|NCT01148017|157329757|FG000|Overall Study|Lost to Follow-up|23|||
48861112|NCT01148017|157329758|FG001|Overall Study|Lost to Follow-up|10|||
48861113|NCT01148017|157329759|FG002|Overall Study|Lost to Follow-up|0|||
48861114|NCT01148017|157329760|FG003|Overall Study|Lost to Follow-up|0|||
48861115|NCT01148017|157329757|FG000|Overall Study|Inappropriate enrollment|1|||
48861116|NCT01148017|157329758|FG001|Overall Study|Inappropriate enrollment|0|||
48861117|NCT01148017|157329759|FG002|Overall Study|Inappropriate enrollment|0|||
48861118|NCT01148017|157329760|FG003|Overall Study|Inappropriate enrollment|0|||
48861119|NCT01148017|157329757|FG000|Overall Study|Administrative reason|22|||
48861120|NCT01148017|157329758|FG001|Overall Study|Administrative reason|9|||
48748580|NCT03129100|156926565|FG008|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
48748581|NCT03129100|156926566|FG009|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
48955182|NCT03116399|157664252|FG000|Overall Study|Lost to Follow-up|7|||
48955183|NCT03116399|157664253|FG001|Overall Study|Lost to Follow-up|11|||
48955184|NCT03116399|157664252|FG000|Overall Study|Investigator Decision|1|||
48955185|NCT03116399|157664253|FG001|Overall Study|Investigator Decision|1|||
48955186|NCT03116399|157664252|FG000|Overall Study|Withdrawal by Subject|24|||
48955187|NCT03116399|157664253|FG001|Overall Study|Withdrawal by Subject|9|||
48955188|NCT00138151|157664256|FG000|Overall Study|Withdrawal by Subject|3|||
48748582|NCT03129100|156926567|FG010|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
48748583|NCT03129100|156926568|FG011|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
48748584|NCT03129100|156926569|FG012|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
48748585|NCT03129100|156926570|FG013|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
48748586|NCT03129100|156926571|FG014|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
48748587|NCT03129100|156926572|FG015|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
48748588|NCT03129100|156926573|FG016|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
48748589|NCT03129100|156926574|FG017|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
48748590|NCT03129100|156926575|FG018|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
48748591|NCT03129100|156926576|FG019|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
48748592|NCT03129100|156926577|FG020|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
48748593|NCT03129100|156926578|FG021|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
48748594|NCT03129100|156926579|FG022|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
48748595|NCT03129100|156926580|FG023|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
48748596|NCT03129100|156926581|FG024|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
48748597|NCT03129100|156926582|FG025|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
48748598|NCT03129100|156926557|FG000|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
48748599|NCT03129100|156926558|FG001|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
48748600|NCT03129100|156926559|FG002|Period2 Extension Period (Group A and B)|Lost to Follow-up|2|||
48748601|NCT03129100|156926560|FG003|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
48748602|NCT03129100|156926561|FG004|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
48748603|NCT03129100|156926562|FG005|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
48748604|NCT03129100|156926563|FG006|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
48748605|NCT03129100|156926564|FG007|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
48748606|NCT03129100|156926565|FG008|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
48748607|NCT03129100|156926566|FG009|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
48748608|NCT03129100|156926567|FG010|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
48748609|NCT03129100|156926568|FG011|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
48748610|NCT03129100|156926569|FG012|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
48748611|NCT03129100|156926570|FG013|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
48748612|NCT03129100|156926571|FG014|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
48861121|NCT01148017|157329759|FG002|Overall Study|Administrative reason|0|||
48861122|NCT01148017|157329760|FG003|Overall Study|Administrative reason|0|||
48861123|NCT01148017|157329757|FG000|Overall Study|Unable to classify|3|||
48861124|NCT01148017|157329758|FG001|Overall Study|Unable to classify|1|||
48861125|NCT01148017|157329759|FG002|Overall Study|Unable to classify|0|||
48861126|NCT01148017|157329760|FG003|Overall Study|Unable to classify|0|||
48861127|NCT01215253|157329768|FG000|Overall Study|Withdrawal by Subject|57|||
48861128|NCT01215253|157329769|FG001|Overall Study|Withdrawal by Subject|35|||
48861129|NCT01215253|157329768|FG000|Overall Study|Physician Decision|9|||
48861130|NCT01215253|157329769|FG001|Overall Study|Physician Decision|12|||
48861131|NCT01215253|157329768|FG000|Overall Study|Lost to Follow-up|6|||
48861132|NCT01215253|157329769|FG001|Overall Study|Lost to Follow-up|4|||
48861133|NCT01215253|157329768|FG000|Overall Study|Other|14|||
48955189|NCT00138151|157664256|FG000|Overall Study|Physician Decision|1|||
48955190|NCT00431847|157664260|FG000|Overall Study|completion of less than two study visits|6|||
48955191|NCT00431847|157664261|FG001|Overall Study|completion of less than two study visits|3|||
48955192|NCT00431847|157664262|FG002|Overall Study|completion of less than two study visits|4|||
48955193|NCT00431847|157664263|FG003|Overall Study|completion of less than two study visits|14|||
48955194|NCT00431847|157664264|FG004|Overall Study|completion of less than two study visits|0|||
48955195|NCT00431847|157664260|FG000|Overall Study|Protocol Violation|0|||
48955196|NCT00431847|157664261|FG001|Overall Study|Protocol Violation|0|||
48955197|NCT00431847|157664262|FG002|Overall Study|Protocol Violation|0|||
48861134|NCT01215253|157329769|FG001|Overall Study|Other|12|||
48861135|NCT00871494|157329771|FG000|Overall Study|Protocol Violation|5|||
48861136|NCT00871494|157329771|FG000|Overall Study|Lack of Efficacy|4|||
48861137|NCT00871494|157329771|FG000|Overall Study|Adverse Event|4|||
48861138|NCT00871494|157329771|FG000|Overall Study|Lost to Follow-up|1|||
48861139|NCT01090739|157329775|FG000|Enrollment|Withdrawal by Subject|24|||
48861140|NCT01090739|157329775|FG000|Enrollment|Protocol Violation|14|||
48861141|NCT01090739|157329775|FG000|Enrollment|Lost to Follow-up|5|||
48861142|NCT01090739|157329775|FG000|Enrollment|Physician Decision|5|||
48861143|NCT01090739|157329775|FG000|Enrollment|Sponsor termination of site|4|||
48861144|NCT01090739|157329775|FG000|Enrollment|Study implant limit reached|2|||
48861145|NCT01090739|157329775|FG000|Enrollment|Adverse Event|1|||
48861146|NCT01090739|157329775|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
48861147|NCT01090739|157329775|FG000|12 Month Follow-up|Lost to Follow-up|1|||
48861148|NCT01090739|157329775|FG000|12 Month Follow-up|Physician Decision|1|||
48861149|NCT01090739|157329775|FG000|12 Month Follow-up|Death|1|||
48861150|NCT01090739|157329775|FG000|24 Month Follow-up|Withdrawal by Subject|7|||
48861151|NCT01090739|157329775|FG000|24 Month Follow-up|Lost to Follow-up|1|||
48861152|NCT01090739|157329775|FG000|24 Month Follow-up|Death|1|||
48861153|NCT01090739|157329775|FG000|36 Month Follow-up|Withdrawal by Subject|6|||
48861154|NCT01090739|157329775|FG000|36 Month Follow-up|Visit still pending|17|||
48861155|NCT01074229|157329776|FG000|Overall Study|Lost to Follow-up|1|||
48861156|NCT01074229|157329777|FG001|Overall Study|Lost to Follow-up|0|||
48861157|NCT01074229|157329778|FG002|Overall Study|Lost to Follow-up|0|||
48861158|NCT01074229|157329776|FG000|Overall Study|Change to open surgical procedure|1|||
48861159|NCT01074229|157329777|FG001|Overall Study|Change to open surgical procedure|3|||
48861160|NCT01074229|157329778|FG002|Overall Study|Change to open surgical procedure|4|||
48861161|NCT01816165|157329779|FG000|Overall Study|Adverse Event|1|||
48861162|NCT01816165|157329780|FG001|Overall Study|Adverse Event|0|||
48861163|NCT01816165|157329781|FG002|Overall Study|Adverse Event|0|||
48861164|NCT01816165|157329782|FG003|Overall Study|Adverse Event|0|||
48861165|NCT01263223|157329787|FG000|Period 2|Withdrawal by Subject|0|||
48861166|NCT01263223|157329788|FG001|Period 2|Withdrawal by Subject|1|||
48861167|NCT01263223|157329787|FG000|7-day Follow-up|Withdrawal by Subject|0|||
48861168|NCT01263223|157329788|FG001|7-day Follow-up|Withdrawal by Subject|1|||
48861169|NCT01263223|157329787|FG000|7-day Follow-up|Lost to Follow-up|1|||
48861170|NCT01263223|157329788|FG001|7-day Follow-up|Lost to Follow-up|0|||
48861171|NCT02246647|157329789|FG000|Overall Study|Withdrawal by Subject|1|||
48861172|NCT02246647|157329790|FG001|Overall Study|Withdrawal by Subject|1|||
48861173|NCT02865083|157329794|FG000|Overall Study|Early Termination|3|||
48861174|NCT02865083|157329795|FG001|Overall Study|Early Termination|1|||
48861175|NCT02722278|157329796|FG000|Overall Study|Withdrawal by Subject|5|||
48861176|NCT02722278|157329797|FG001|Overall Study|Withdrawal by Subject|3|||
48861177|NCT02722278|157329796|FG000|Overall Study|Adverse Event|4|||
48861178|NCT02722278|157329797|FG001|Overall Study|Adverse Event|1|||
48861179|NCT02722278|157329796|FG000|Overall Study|Lost to Follow-up|2|||
48861180|NCT02722278|157329797|FG001|Overall Study|Lost to Follow-up|0|||
48861181|NCT02722278|157329796|FG000|Overall Study|Protocol Violation|1|||
48861182|NCT02722278|157329797|FG001|Overall Study|Protocol Violation|0|||
48861183|NCT02722278|157329796|FG000|Overall Study|High PSA pre-study/ not eligible|0|||
48861184|NCT02722278|157329797|FG001|Overall Study|High PSA pre-study/ not eligible|1|||
48861185|NCT02722278|157329796|FG000|Overall Study|Subject declined after tx assignment|0|||
48861186|NCT02722278|157329797|FG001|Overall Study|Subject declined after tx assignment|1|||
48861187|NCT02722278|157329796|FG000|Overall Study|Site closure not study related|0|||
48861188|NCT02722278|157329797|FG001|Overall Study|Site closure not study related|1|||
48861189|NCT03449979|157329798|FG000|Overall Study|Technical difficulty|0|||
48861190|NCT03449979|157329799|FG001|Overall Study|Technical difficulty|0|||
48861191|NCT03449979|157329800|FG002|Overall Study|Technical difficulty|0|||
48861192|NCT03449979|157329801|FG003|Overall Study|Technical difficulty|1|||
48861193|NCT00379210|157329802|FG000|Overall Study|Withdrawal by Subject|10|||
48861194|NCT00379210|157329803|FG001|Overall Study|Withdrawal by Subject|7|||
48861195|NCT02105688|157329804|FG000|Part A: Double-Blind|Adverse Event|1|||
48861196|NCT02105688|157329805|FG001|Part A: Double-Blind|Adverse Event|0|||
48861197|NCT02105688|157329804|FG000|Part A: Double-Blind|Death|0|||
48861198|NCT02105688|157329805|FG001|Part A: Double-Blind|Death|1|||
48861199|NCT02105688|157329804|FG000|Part A: Double-Blind|Lost to Follow-up|15|||
48861200|NCT02105688|157329805|FG001|Part A: Double-Blind|Lost to Follow-up|11|||
48861201|NCT02105688|157329804|FG000|Part A: Double-Blind|Physician Decision|0|||
48861202|NCT02105688|157329805|FG001|Part A: Double-Blind|Physician Decision|1|||
48861203|NCT02105688|157329804|FG000|Part A: Double-Blind|Status Unknown|0|||
48861204|NCT02105688|157329805|FG001|Part A: Double-Blind|Status Unknown|2|||
48861205|NCT02105688|157329804|FG000|Part A: Double-Blind|Withdrawal by Subject|4|||
48861206|NCT02105688|157329805|FG001|Part A: Double-Blind|Withdrawal by Subject|2|||
48861207|NCT02105688|157329804|FG000|Part B: Observational Follow-up|Death|2|||
48861208|NCT02105688|157329805|FG001|Part B: Observational Follow-up|Death|1|||
48861209|NCT02105688|157329804|FG000|Part B: Observational Follow-up|Lost to Follow-up|23|||
48861210|NCT02105688|157329805|FG001|Part B: Observational Follow-up|Lost to Follow-up|15|||
48748613|NCT03129100|156926572|FG015|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
48748614|NCT03129100|156926573|FG016|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
48748615|NCT03129100|156926574|FG017|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
48748616|NCT03129100|156926575|FG018|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
48748617|NCT03129100|156926576|FG019|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
48748618|NCT03129100|156926577|FG020|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
48748619|NCT03129100|156926578|FG021|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
48748620|NCT03129100|156926579|FG022|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
48748621|NCT03129100|156926580|FG023|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
48748622|NCT03129100|156926581|FG024|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
48748623|NCT03129100|156926582|FG025|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
48748624|NCT03129100|156926557|FG000|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
48748625|NCT03129100|156926558|FG001|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
48748626|NCT03129100|156926559|FG002|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
48748627|NCT03129100|156926560|FG003|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
48748628|NCT03129100|156926561|FG004|Period2 Extension Period (Group A and B)|Experienced Flare|5|||
48748629|NCT03129100|156926562|FG005|Period2 Extension Period (Group A and B)|Experienced Flare|6|||
48748630|NCT03129100|156926563|FG006|Period2 Extension Period (Group A and B)|Experienced Flare|19|||
48748631|NCT03129100|156926564|FG007|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
48748632|NCT03129100|156926565|FG008|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
48748633|NCT03129100|156926566|FG009|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
48861211|NCT02105688|157329804|FG000|Part B: Observational Follow-up|Withdrawal by Subject|9|||
48861212|NCT02105688|157329805|FG001|Part B: Observational Follow-up|Withdrawal by Subject|3|||
48861213|NCT02105688|157329804|FG000|Part B: Observational Follow-up|Physician Decision|3|||
48861214|NCT02105688|157329805|FG001|Part B: Observational Follow-up|Physician Decision|1|||
48861215|NCT00700999|157329806|FG000|Overall Study|Lost to Follow-up|7|||
48861216|NCT00700999|157329807|FG001|Overall Study|Lost to Follow-up|7|||
48861217|NCT00700999|157329806|FG000|Overall Study|Excluded - did not meet study criteria|0|||
48861218|NCT00700999|157329807|FG001|Overall Study|Excluded - did not meet study criteria|1|||
48861219|NCT00700999|157329806|FG000|Overall Study|Withdrawal by Subject|8|||
48861220|NCT00700999|157329807|FG001|Overall Study|Withdrawal by Subject|1|||
48861221|NCT04908488|157329808|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
48861222|NCT04908488|157329809|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
48861223|NCT04908488|157329808|FG000|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
48861224|NCT04908488|157329809|FG001|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
48861225|NCT03444155|157329810|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
48861226|NCT03444155|157329811|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
48861227|NCT02475733|157329818|FG000|Overall Study|Withdrawal by Subject|1|||
48861228|NCT02475733|157329819|FG001|Overall Study|Withdrawal by Subject|0|||
48861229|NCT02475733|157329818|FG000|Overall Study|Physician Decision|1|||
48861230|NCT02475733|157329819|FG001|Overall Study|Physician Decision|0|||
48861231|NCT01864200|157329820|FG000|Overall Study|Lost to Follow-up|1|||
48861232|NCT01864200|157329821|FG001|Overall Study|Lost to Follow-up|3|||
48861233|NCT01864200|157329820|FG000|Overall Study|Protocol Violation|1|||
48861234|NCT01864200|157329821|FG001|Overall Study|Protocol Violation|0|||
48861235|NCT00424476|157329822|FG000|Overall Study|Withdrawal by Subject|7|||
48861236|NCT00424476|157329823|FG001|Overall Study|Withdrawal by Subject|6|||
48861237|NCT00424476|157329824|FG002|Overall Study|Withdrawal by Subject|3|||
48861238|NCT00424476|157329822|FG000|Overall Study|Adverse Event|19|||
48861239|NCT00424476|157329823|FG001|Overall Study|Adverse Event|16|||
48861240|NCT00424476|157329824|FG002|Overall Study|Adverse Event|15|||
48861241|NCT00424476|157329822|FG000|Overall Study|Lack of Efficacy|16|||
48861242|NCT00424476|157329823|FG001|Overall Study|Lack of Efficacy|12|||
48861243|NCT00424476|157329824|FG002|Overall Study|Lack of Efficacy|12|||
48861244|NCT00424476|157329822|FG000|Overall Study|Lack of Compliance|1|||
48861245|NCT00424476|157329823|FG001|Overall Study|Lack of Compliance|1|||
48861246|NCT00424476|157329824|FG002|Overall Study|Lack of Compliance|1|||
48861247|NCT00424476|157329822|FG000|Overall Study|Lost to Follow-up|4|||
48861248|NCT00424476|157329823|FG001|Overall Study|Lost to Follow-up|6|||
48861249|NCT00424476|157329824|FG002|Overall Study|Lost to Follow-up|3|||
48861250|NCT00424476|157329822|FG000|Overall Study|Protocol Violation|7|||
48861251|NCT00424476|157329823|FG001|Overall Study|Protocol Violation|2|||
48861252|NCT00424476|157329824|FG002|Overall Study|Protocol Violation|3|||
48861253|NCT00424476|157329822|FG000|Overall Study|Physician Decision|3|||
48861254|NCT00424476|157329823|FG001|Overall Study|Physician Decision|2|||
48861255|NCT00424476|157329824|FG002|Overall Study|Physician Decision|3|||
48861256|NCT00424476|157329822|FG000|Overall Study|Other|4|||
48861257|NCT00424476|157329823|FG001|Overall Study|Other|3|||
48861258|NCT00424476|157329824|FG002|Overall Study|Other|9|||
48861259|NCT00848198|157329825|FG000|Overall Study|Incomplete Case Report Forms|15|||
48861260|NCT02267746|157329826|FG000|Overall Study|Adverse Event|0|||
48861261|NCT02267746|157329827|FG001|Overall Study|Adverse Event|2|||
48861262|NCT02267746|157329828|FG002|Overall Study|Adverse Event|1|||
48861263|NCT02267746|157329826|FG000|Overall Study|Protocol Violation|8|||
48861264|NCT02267746|157329827|FG001|Overall Study|Protocol Violation|7|||
48861265|NCT02267746|157329828|FG002|Overall Study|Protocol Violation|3|||
48861266|NCT02267746|157329826|FG000|Overall Study|Lack of Efficacy|11|||
48861267|NCT02267746|157329827|FG001|Overall Study|Lack of Efficacy|11|||
48861268|NCT02267746|157329828|FG002|Overall Study|Lack of Efficacy|15|||
48955198|NCT00431847|157664263|FG003|Overall Study|Protocol Violation|0|||
48955199|NCT00431847|157664264|FG004|Overall Study|Protocol Violation|1|||
48861269|NCT02267746|157329826|FG000|Overall Study|Protocol Violation|1|||
48861270|NCT02267746|157329827|FG001|Overall Study|Protocol Violation|2|||
48861271|NCT02267746|157329828|FG002|Overall Study|Protocol Violation|1|||
48955200|NCT00339183|157664265|FG000|Overall Study|Adverse Event|5|||
48861272|NCT02267746|157329826|FG000|Overall Study|Miscellaneous|1|||
48861273|NCT02267746|157329827|FG001|Overall Study|Miscellaneous|0|||
48861274|NCT02267746|157329828|FG002|Overall Study|Miscellaneous|1|||
48861275|NCT04598776|157329829|FG000|Overall Study|Protocol Violation|5|||
48748634|NCT03129100|156926567|FG010|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
48748635|NCT03129100|156926568|FG011|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
48748636|NCT03129100|156926569|FG012|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
48748637|NCT03129100|156926570|FG013|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
48748638|NCT03129100|156926571|FG014|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
48748639|NCT03129100|156926572|FG015|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
48748640|NCT03129100|156926573|FG016|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
48748641|NCT03129100|156926574|FG017|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
48748642|NCT03129100|156926575|FG018|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
48748643|NCT03129100|156926576|FG019|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
48748644|NCT03129100|156926577|FG020|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
48748645|NCT03129100|156926578|FG021|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
48748646|NCT03129100|156926579|FG022|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
48748647|NCT03129100|156926580|FG023|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
48748648|NCT03129100|156926581|FG024|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
48748649|NCT03129100|156926582|FG025|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
48748650|NCT03129100|156926557|FG000|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
48748651|NCT03129100|156926558|FG001|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
48748652|NCT03129100|156926559|FG002|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
48748653|NCT03129100|156926560|FG003|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
48748654|NCT03129100|156926561|FG004|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
48955201|NCT00339183|157664266|FG001|Overall Study|Adverse Event|3|||
48955202|NCT00339183|157664265|FG000|Overall Study|Withdrawal by Subject|16|||
48955203|NCT00339183|157664266|FG001|Overall Study|Withdrawal by Subject|19|||
48955204|NCT00339183|157664265|FG000|Overall Study|Physician Decision|2|||
48955205|NCT00339183|157664266|FG001|Overall Study|Physician Decision|4|||
48955206|NCT00339183|157664265|FG000|Overall Study|Lost to Follow-up|17|||
48955207|NCT00339183|157664266|FG001|Overall Study|Lost to Follow-up|17|||
48955208|NCT00339183|157664265|FG000|Overall Study|Protocol-specified criteria|12|||
48955209|NCT00339183|157664266|FG001|Overall Study|Protocol-specified criteria|8|||
48955210|NCT00339183|157664265|FG000|Overall Study|Missing reason|3|||
48955211|NCT00339183|157664266|FG001|Overall Study|Missing reason|1|||
48955212|NCT00339183|157664265|FG000|Overall Study|Other|46|||
48955213|NCT00339183|157664266|FG001|Overall Study|Other|40|||
48955214|NCT00339183|157664265|FG000|Overall Study|Ongoing|20|||
48955215|NCT00339183|157664266|FG001|Overall Study|Ongoing|13|||
48955216|NCT02702193|157664273|FG000|Baseline Assessment/Randomization|Withdrawal by Subject|1|||
48955217|NCT02702193|157664274|FG001|Baseline Assessment/Randomization|Withdrawal by Subject|0|||
48955218|NCT02702193|157664273|FG000|4 Month Follow up|Withdrawal by Subject|1|||
48955219|NCT02702193|157664274|FG001|4 Month Follow up|Withdrawal by Subject|0|||
48955220|NCT02702193|157664273|FG000|4 Month Follow up|Lost to Follow-up|17|||
48955221|NCT02702193|157664274|FG001|4 Month Follow up|Lost to Follow-up|18|||
48955222|NCT02702193|157664273|FG000|8 Month Follow up|Withdrawal by Subject|1|||
48955223|NCT02702193|157664274|FG001|8 Month Follow up|Withdrawal by Subject|0|||
48955224|NCT02702193|157664273|FG000|8 Month Follow up|Lost to Follow-up|14|||
48955225|NCT02702193|157664274|FG001|8 Month Follow up|Lost to Follow-up|18|||
48955226|NCT02702193|157664273|FG000|12 Month Follow up|Withdrawal by Subject|1|||
48955227|NCT02702193|157664274|FG001|12 Month Follow up|Withdrawal by Subject|0|||
48955228|NCT02702193|157664273|FG000|12 Month Follow up|Lost to Follow-up|16|||
48955229|NCT02702193|157664274|FG001|12 Month Follow up|Lost to Follow-up|18|||
48955230|NCT01879618|157664278|FG000|Overall Study|Does not meet entrance criteria|1|||
48955231|NCT01879618|157664278|FG000|Overall Study|Withdrawal by Subject|1|||
48955232|NCT01879618|157664278|FG000|Overall Study|Surgery;changed schedule; not available|8|||
48748655|NCT03129100|156926562|FG005|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
48748656|NCT03129100|156926563|FG006|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
48955233|NCT01879618|157664278|FG000|Overall Study|Protocol Violation|6|||
48955234|NCT01879618|157664278|FG000|Overall Study|Adverse Event|5|||
48955235|NCT01379534|157664279|FG000|Treatment Phase|Withdrawal by Subject|2|||
48955236|NCT01379534|157664280|FG001|Treatment Phase|Withdrawal by Subject|2|||
48955237|NCT01379534|157664279|FG000|Treatment Phase|Progressive disease|13|||
48748657|NCT03129100|156926564|FG007|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
48748658|NCT03129100|156926565|FG008|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
48748659|NCT03129100|156926566|FG009|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1|||
48748660|NCT03129100|156926567|FG010|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
48748661|NCT03129100|156926568|FG011|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
48748662|NCT03129100|156926569|FG012|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
48748663|NCT03129100|156926570|FG013|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
48955238|NCT01379534|157664280|FG001|Treatment Phase|Progressive disease|22|||
48955239|NCT01379534|157664279|FG000|Treatment Phase|Adverse Event|7|||
48955240|NCT01379534|157664280|FG001|Treatment Phase|Adverse Event|7|||
48955241|NCT01379534|157664279|FG000|Tumor Assessment Follow-up (f/u) Phase|Death|0|||
48955242|NCT01379534|157664280|FG001|Tumor Assessment Follow-up (f/u) Phase|Death|1|||
48955243|NCT01379534|157664279|FG000|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3|||
48955244|NCT01379534|157664280|FG001|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0|||
48955245|NCT01379534|157664279|FG000|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0|||
48955246|NCT01379534|157664280|FG001|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1|||
48955247|NCT01379534|157664279|FG000|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1|||
48955248|NCT01379534|157664280|FG001|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0|||
48955249|NCT04967599|157664284|FG000|Overall Study|Lost to Follow-up|35|||
48955250|NCT04967599|157664285|FG001|Overall Study|Lost to Follow-up|19|||
48955251|NCT04967599|157664286|FG002|Overall Study|Lost to Follow-up|23|||
48955252|NCT03229759|157664287|FG000|Overall Study|Screen Failure|30|||
48955253|NCT01465178|157664288|FG000|Overall Study|Withdrawal by Subject|1|||
48955254|NCT01465178|157664289|FG001|Overall Study|Withdrawal by Subject|0|||
48955255|NCT00527111|157664290|FG000|Overall Study|Adverse Event|14|||
48955256|NCT00527111|157664291|FG001|Overall Study|Adverse Event|13|||
48955257|NCT00527111|157664290|FG000|Overall Study|Death|0|||
48955258|NCT00527111|157664291|FG001|Overall Study|Death|1|||
48955259|NCT00527111|157664290|FG000|Overall Study|Investigator Request|2|||
48955260|NCT00527111|157664291|FG001|Overall Study|Investigator Request|1|||
48748664|NCT03129100|156926571|FG014|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
48955261|NCT00527111|157664290|FG000|Overall Study|Patient Request|2|||
48955262|NCT00527111|157664291|FG001|Overall Study|Patient Request|5|||
48955263|NCT00527111|157664290|FG000|Overall Study|Other|2|||
48955264|NCT00527111|157664291|FG001|Overall Study|Other|2|||
48955265|NCT04072146|157664294|FG000|Overall Study|Adverse Event|0|||
48955266|NCT04072146|157664295|FG001|Overall Study|Adverse Event|1|||
48955267|NCT01987986|157664296|FG000|Overall Study|Lost to Follow-up|1|||
48955268|NCT01987986|157664297|FG001|Overall Study|Lost to Follow-up|0|||
48955269|NCT01987986|157664298|FG002|Overall Study|Lost to Follow-up|0|||
48955270|NCT01987986|157664299|FG003|Overall Study|Lost to Follow-up|0|||
48955271|NCT01987986|157664296|FG000|Overall Study|Adverse Event|1|||
48748665|NCT03129100|156926572|FG015|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
48748666|NCT03129100|156926573|FG016|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
48748667|NCT03129100|156926574|FG017|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
48748668|NCT03129100|156926575|FG018|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
48748669|NCT03129100|156926576|FG019|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
48748670|NCT03129100|156926577|FG020|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
48748671|NCT03129100|156926578|FG021|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
48748672|NCT03129100|156926579|FG022|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
48748673|NCT03129100|156926580|FG023|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
48748674|NCT03129100|156926581|FG024|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
48748675|NCT03129100|156926582|FG025|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
48748676|NCT03129100|156926557|FG000|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
48748677|NCT03129100|156926558|FG001|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
48955272|NCT01987986|157664297|FG001|Overall Study|Adverse Event|0|||
48955273|NCT01987986|157664298|FG002|Overall Study|Adverse Event|2|||
48955274|NCT01987986|157664299|FG003|Overall Study|Adverse Event|0|||
48955275|NCT01617434|157664300|FG000|Overall Study|Adverse Event|12|||
48955276|NCT01617434|157664301|FG001|Overall Study|Adverse Event|3|||
48955277|NCT01617434|157664300|FG000|Overall Study|Protocol Violation|8|||
48955278|NCT01617434|157664301|FG001|Overall Study|Protocol Violation|7|||
48955279|NCT01617434|157664300|FG000|Overall Study|Withdrawal Criteria|12|||
48955280|NCT01617434|157664301|FG001|Overall Study|Withdrawal Criteria|37|||
48955281|NCT01617434|157664300|FG000|Overall Study|Unclassified|3|||
48861276|NCT04598776|157329829|FG000|Overall Study|Physician Decision|4|||
48861277|NCT03873038|157329830|FG000|Part 2|Withdrawal by Subject|0|||
48861278|NCT03873038|157329831|FG001|Part 2|Withdrawal by Subject|0|||
48955282|NCT01617434|157664301|FG001|Overall Study|Unclassified|4|||
48748678|NCT03129100|156926559|FG002|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
48748679|NCT03129100|156926560|FG003|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
48748680|NCT03129100|156926561|FG004|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
48748681|NCT03129100|156926562|FG005|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
48748682|NCT03129100|156926563|FG006|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
48748683|NCT03129100|156926564|FG007|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
48748684|NCT03129100|156926565|FG008|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
48748685|NCT03129100|156926566|FG009|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
48748686|NCT03129100|156926567|FG010|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
48748687|NCT03129100|156926568|FG011|Period3-Long-Term Extension Period A & B|Adverse Event|6|||
48861279|NCT03873038|157329832|FG002|Part 2|Withdrawal by Subject|0|||
48861280|NCT03873038|157329833|FG003|Part 2|Withdrawal by Subject|0|||
48861281|NCT03873038|157329834|FG004|Part 2|Withdrawal by Subject|0|||
48861282|NCT03873038|157329835|FG005|Part 2|Withdrawal by Subject|1|||
48861283|NCT03873038|157329830|FG000|Part 2|Unknon|0|||
48861284|NCT03873038|157329831|FG001|Part 2|Unknon|0|||
48861285|NCT03873038|157329832|FG002|Part 2|Unknon|0|||
48861286|NCT03873038|157329833|FG003|Part 2|Unknon|0|||
48861287|NCT03873038|157329834|FG004|Part 2|Unknon|1|||
48861288|NCT03873038|157329835|FG005|Part 2|Unknon|0|||
48861289|NCT04743999|157329836|FG000|3-month Questionnaire|Death|1|||
48861290|NCT04743999|157329836|FG000|6-month Questionnaire|Study terminated due to low accrual|1|||
48955283|NCT02993224|157664302|FG000|Core Phase - Period 1|Adverse Event|4|||
48861291|NCT04743999|157329836|FG000|12-month Questionnaire|Study terminated due to low accrual|1|||
48861292|NCT04743999|157329836|FG000|24-month Questionnaire|Study terminated due to low accrual|5|||
48955284|NCT02993224|157664302|FG000|Core Phase - Period 1|Withdrawal by Subject|1|||
48748688|NCT03129100|156926569|FG012|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
48748689|NCT03129100|156926570|FG013|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
48748690|NCT03129100|156926571|FG014|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
48748691|NCT03129100|156926572|FG015|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
48748692|NCT03129100|156926573|FG016|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
48748693|NCT03129100|156926574|FG017|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
48748694|NCT03129100|156926575|FG018|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
48748695|NCT03129100|156926576|FG019|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
48748696|NCT03129100|156926577|FG020|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
48748697|NCT03129100|156926578|FG021|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
48748698|NCT03129100|156926579|FG022|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
48748699|NCT03129100|156926580|FG023|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
48748700|NCT03129100|156926581|FG024|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
48748701|NCT03129100|156926582|FG025|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
48748702|NCT03129100|156926557|FG000|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
48748703|NCT03129100|156926558|FG001|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
48748704|NCT03129100|156926559|FG002|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
48748705|NCT03129100|156926560|FG003|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
48748706|NCT03129100|156926561|FG004|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
48748707|NCT03129100|156926562|FG005|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
48748708|NCT03129100|156926563|FG006|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
48748709|NCT03129100|156926564|FG007|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
48748710|NCT03129100|156926565|FG008|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
48748711|NCT03129100|156926566|FG009|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
48748712|NCT03129100|156926567|FG010|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
48748713|NCT03129100|156926568|FG011|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|12|||
48748714|NCT03129100|156926569|FG012|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|7|||
48748715|NCT03129100|156926570|FG013|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|4|||
48748716|NCT03129100|156926571|FG014|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|2|||
48748717|NCT03129100|156926572|FG015|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
48748718|NCT03129100|156926573|FG016|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
48748719|NCT03129100|156926574|FG017|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
48748720|NCT03129100|156926575|FG018|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
48748721|NCT03129100|156926576|FG019|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
48748722|NCT03129100|156926577|FG020|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
48748723|NCT03129100|156926578|FG021|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
48748724|NCT03129100|156926579|FG022|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
48861293|NCT05700851|157329837|FG000|Overall Study|Received a kidney transplant|1|||
48861294|NCT05700851|157329837|FG000|Overall Study|Hospitalisation before starting baseline assessments|1|||
48861295|NCT05700851|157329837|FG000|Overall Study|Withdrawal by Subject|1|||
48861296|NCT02133131|157329838|FG000|Overall Study|Adverse Event|0|||
48861297|NCT02133131|157329839|FG001|Overall Study|Adverse Event|0|||
48861298|NCT02133131|157329840|FG002|Overall Study|Adverse Event|0|||
48861299|NCT02133131|157329841|FG003|Overall Study|Adverse Event|1|||
48861300|NCT02133131|157329842|FG004|Overall Study|Adverse Event|0|||
48861301|NCT02133131|157329843|FG005|Overall Study|Adverse Event|0|||
48861302|NCT02133131|157329844|FG006|Overall Study|Adverse Event|0|||
48861303|NCT02133131|157329838|FG000|Overall Study|Lost to Follow-up|1|||
48861304|NCT02133131|157329839|FG001|Overall Study|Lost to Follow-up|0|||
48861305|NCT02133131|157329840|FG002|Overall Study|Lost to Follow-up|0|||
48861306|NCT02133131|157329841|FG003|Overall Study|Lost to Follow-up|1|||
48748725|NCT03129100|156926580|FG023|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
48748726|NCT03129100|156926581|FG024|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
48748727|NCT03129100|156926582|FG025|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
48748728|NCT03129100|156926557|FG000|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
48748729|NCT03129100|156926558|FG001|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
48748730|NCT03129100|156926559|FG002|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
48748731|NCT03129100|156926560|FG003|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
48748732|NCT03129100|156926561|FG004|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
48748733|NCT03129100|156926562|FG005|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
48748734|NCT03129100|156926563|FG006|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
48748735|NCT03129100|156926564|FG007|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
48748736|NCT03129100|156926565|FG008|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
48748737|NCT03129100|156926566|FG009|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
48748738|NCT03129100|156926567|FG010|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
48748739|NCT03129100|156926568|FG011|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
48748740|NCT03129100|156926569|FG012|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
48748741|NCT03129100|156926570|FG013|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
48748742|NCT03129100|156926571|FG014|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
48748743|NCT03129100|156926572|FG015|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
48748744|NCT03129100|156926573|FG016|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
48748745|NCT03129100|156926574|FG017|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
48748746|NCT03129100|156926575|FG018|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
48748747|NCT03129100|156926576|FG019|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
48748748|NCT03129100|156926577|FG020|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
48748749|NCT03129100|156926578|FG021|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
48748750|NCT03129100|156926579|FG022|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
48748751|NCT03129100|156926580|FG023|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
48748752|NCT03129100|156926581|FG024|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
48748753|NCT03129100|156926582|FG025|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
48748754|NCT03129100|156926557|FG000|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
48748755|NCT03129100|156926558|FG001|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
48748756|NCT03129100|156926559|FG002|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
48748757|NCT03129100|156926560|FG003|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
48748758|NCT03129100|156926561|FG004|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
48748759|NCT03129100|156926562|FG005|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
48748760|NCT03129100|156926563|FG006|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
48748761|NCT03129100|156926564|FG007|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
48748762|NCT03129100|156926565|FG008|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
48748763|NCT03129100|156926566|FG009|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
48748764|NCT03129100|156926567|FG010|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
48748765|NCT03129100|156926568|FG011|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
48748766|NCT03129100|156926569|FG012|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
48748767|NCT03129100|156926570|FG013|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
48748768|NCT03129100|156926571|FG014|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
48748769|NCT03129100|156926572|FG015|Period3-Long-Term Extension Period A & B|Lack of Efficacy|1|||
48861307|NCT02133131|157329842|FG004|Overall Study|Lost to Follow-up|0|||
48861308|NCT02133131|157329843|FG005|Overall Study|Lost to Follow-up|0|||
48861309|NCT02133131|157329844|FG006|Overall Study|Lost to Follow-up|0|||
48861310|NCT02133131|157329838|FG000|Overall Study|Status not recorded|4|||
48861311|NCT02133131|157329839|FG001|Overall Study|Status not recorded|5|||
48861312|NCT02133131|157329840|FG002|Overall Study|Status not recorded|1|||
48861313|NCT02133131|157329841|FG003|Overall Study|Status not recorded|4|||
48861314|NCT02133131|157329842|FG004|Overall Study|Status not recorded|0|||
48861315|NCT02133131|157329843|FG005|Overall Study|Status not recorded|0|||
48861316|NCT02133131|157329844|FG006|Overall Study|Status not recorded|0|||
48861317|NCT02133131|157329838|FG000|Overall Study|Ongoing in study|0|||
48861318|NCT02133131|157329839|FG001|Overall Study|Ongoing in study|0|||
48861319|NCT02133131|157329840|FG002|Overall Study|Ongoing in study|0|||
48861320|NCT02133131|157329841|FG003|Overall Study|Ongoing in study|0|||
48861321|NCT02133131|157329842|FG004|Overall Study|Ongoing in study|15|||
48861322|NCT02133131|157329843|FG005|Overall Study|Ongoing in study|14|||
48861323|NCT02133131|157329844|FG006|Overall Study|Ongoing in study|11|||
48861324|NCT02133131|157329838|FG000|Overall Study|Protocol Violation|0|||
48861325|NCT02133131|157329839|FG001|Overall Study|Protocol Violation|0|||
48861326|NCT02133131|157329840|FG002|Overall Study|Protocol Violation|0|||
48861327|NCT02133131|157329841|FG003|Overall Study|Protocol Violation|0|||
48861328|NCT02133131|157329842|FG004|Overall Study|Protocol Violation|0|||
48861329|NCT02133131|157329843|FG005|Overall Study|Protocol Violation|0|||
48861330|NCT02133131|157329844|FG006|Overall Study|Protocol Violation|1|||
48861331|NCT02481934|157329849|FG000|Overall Study|Death|2|||
48861332|NCT03689452|157329850|FG000|Overall Study|Lost to Follow-up|1|||
48861333|NCT03689452|157329851|FG001|Overall Study|Lost to Follow-up|1|||
48861334|NCT01399905|157329852|FG000|Overall Study|Withdrawal by Subject|1|||
48861335|NCT01399905|157329853|FG001|Overall Study|Withdrawal by Subject|1|||
48861336|NCT02676778|157329854|FG000|Overall Study|Disease Progression|7|||
48861337|NCT02676778|157329855|FG001|Overall Study|Disease Progression|3|||
48861338|NCT02676778|157329856|FG002|Overall Study|Disease Progression|1|||
48861339|NCT02676778|157329854|FG000|Overall Study|Couldn't Start Cycle After Planned Date|1|||
48748770|NCT03129100|156926573|FG016|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
48748771|NCT03129100|156926574|FG017|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
48748772|NCT03129100|156926575|FG018|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
48748773|NCT03129100|156926576|FG019|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
48748774|NCT03129100|156926577|FG020|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
48748775|NCT03129100|156926578|FG021|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
48748776|NCT03129100|156926579|FG022|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
48748777|NCT03129100|156926580|FG023|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
48748778|NCT03129100|156926581|FG024|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
48748779|NCT03129100|156926582|FG025|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
48748780|NCT03129100|156926557|FG000|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
48748781|NCT03129100|156926558|FG001|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
48748782|NCT03129100|156926559|FG002|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
48748783|NCT03129100|156926560|FG003|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
48748784|NCT03129100|156926561|FG004|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
48748785|NCT03129100|156926562|FG005|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
48748786|NCT03129100|156926563|FG006|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
48748787|NCT03129100|156926564|FG007|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
48748788|NCT03129100|156926565|FG008|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
48748789|NCT03129100|156926566|FG009|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
48748790|NCT03129100|156926567|FG010|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
48748791|NCT03129100|156926568|FG011|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
48748792|NCT03129100|156926569|FG012|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|24|||
48748793|NCT03129100|156926570|FG013|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
48748794|NCT03129100|156926571|FG014|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|2|||
48748795|NCT03129100|156926572|FG015|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|8|||
48748796|NCT03129100|156926573|FG016|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
48748797|NCT03129100|156926574|FG017|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
48748798|NCT03129100|156926575|FG018|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
48748799|NCT03129100|156926576|FG019|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
48748800|NCT03129100|156926577|FG020|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
48748801|NCT03129100|156926578|FG021|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
48748802|NCT03129100|156926579|FG022|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
48748803|NCT03129100|156926580|FG023|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
48748804|NCT03129100|156926581|FG024|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
48748805|NCT03129100|156926582|FG025|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
48748806|NCT03129100|156926557|FG000|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
48748807|NCT03129100|156926558|FG001|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
48748808|NCT03129100|156926559|FG002|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
48748809|NCT03129100|156926560|FG003|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
48748810|NCT03129100|156926561|FG004|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
48748811|NCT03129100|156926562|FG005|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
48748812|NCT03129100|156926563|FG006|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
48748813|NCT03129100|156926564|FG007|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
48748814|NCT03129100|156926565|FG008|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
48748815|NCT03129100|156926566|FG009|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
48748816|NCT03129100|156926567|FG010|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
48861340|NCT02676778|157329855|FG001|Overall Study|Couldn't Start Cycle After Planned Date|1|||
48861341|NCT02676778|157329856|FG002|Overall Study|Couldn't Start Cycle After Planned Date|0|||
48861342|NCT02676778|157329854|FG000|Overall Study|Withdrawal by Subject|3|||
48748817|NCT03129100|156926568|FG011|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
48748818|NCT03129100|156926569|FG012|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
48748819|NCT03129100|156926570|FG013|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
48748820|NCT03129100|156926571|FG014|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
48748821|NCT03129100|156926572|FG015|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
48748822|NCT03129100|156926573|FG016|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
48748823|NCT03129100|156926574|FG017|Period 3 (Flare)|Escalated to IXE80Q2W|2|||
48748824|NCT03129100|156926575|FG018|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
48748825|NCT03129100|156926576|FG019|Period 3 (Flare)|Escalated to IXE80Q2W|3|||
48748826|NCT03129100|156926577|FG020|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
48748827|NCT03129100|156926578|FG021|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
48748828|NCT03129100|156926579|FG022|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
48748829|NCT03129100|156926580|FG023|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
48748830|NCT03129100|156926581|FG024|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
48748831|NCT03129100|156926582|FG025|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
48861343|NCT02676778|157329855|FG001|Overall Study|Withdrawal by Subject|2|||
48861344|NCT02676778|157329856|FG002|Overall Study|Withdrawal by Subject|0|||
48748832|NCT03129100|156926557|FG000|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
48748833|NCT03129100|156926558|FG001|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
48861345|NCT02676778|157329854|FG000|Overall Study|Other|4|||
48861346|NCT02676778|157329855|FG001|Overall Study|Other|3|||
48861347|NCT02676778|157329856|FG002|Overall Study|Other|0|||
48861348|NCT02676778|157329854|FG000|Overall Study|Adverse Event|2|||
48861349|NCT02676778|157329855|FG001|Overall Study|Adverse Event|3|||
48861350|NCT02676778|157329856|FG002|Overall Study|Adverse Event|0|||
48861351|NCT00732498|157329857|FG000|Overall Study|Ineligible|1|||
48861352|NCT00732498|157329857|FG000|Overall Study|Adverse Event|2|||
48861353|NCT00732498|157329857|FG000|Overall Study|Physician Decision|3|||
48861354|NCT03394508|157329858|FG000|Overall Study|Protocol Violation|0|||
48861355|NCT03394508|157329859|FG001|Overall Study|Protocol Violation|3|||
48861356|NCT03394508|157329858|FG000|Overall Study|Lost to Follow-up|1|||
48861357|NCT03394508|157329859|FG001|Overall Study|Lost to Follow-up|0|||
48861358|NCT00942188|157329860|FG000|Overall Study|Adverse Event|0|||
48861359|NCT00942188|157329861|FG001|Overall Study|Adverse Event|3|||
48861360|NCT00942188|157329862|FG002|Overall Study|Adverse Event|2|||
48861361|NCT00942188|157329863|FG003|Overall Study|Adverse Event|0|||
48861362|NCT00942188|157329860|FG000|Overall Study|Lack of Efficacy|0|||
48861363|NCT00942188|157329861|FG001|Overall Study|Lack of Efficacy|0|||
48861364|NCT00942188|157329862|FG002|Overall Study|Lack of Efficacy|0|||
48861365|NCT00942188|157329863|FG003|Overall Study|Lack of Efficacy|1|||
48861366|NCT00942188|157329860|FG000|Overall Study|Protocol Violation|1|||
48861367|NCT00942188|157329861|FG001|Overall Study|Protocol Violation|1|||
48861368|NCT00942188|157329862|FG002|Overall Study|Protocol Violation|0|||
48861369|NCT00942188|157329863|FG003|Overall Study|Protocol Violation|0|||
48861370|NCT00942188|157329860|FG000|Overall Study|Lost to Follow-up|2|||
48861371|NCT00942188|157329861|FG001|Overall Study|Lost to Follow-up|1|||
48861372|NCT00942188|157329862|FG002|Overall Study|Lost to Follow-up|2|||
48861373|NCT00942188|157329863|FG003|Overall Study|Lost to Follow-up|0|||
49015387|NCT00306384|157892157|FG001|Overall Study|Site closure|0|||
48748834|NCT03129100|156926559|FG002|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
48861374|NCT00942188|157329860|FG000|Overall Study|Withdrawal by Subject|1|||
49015388|NCT00306384|157892158|FG002|Overall Study|Site closure|0|||
48861375|NCT00942188|157329861|FG001|Overall Study|Withdrawal by Subject|3|||
48861376|NCT00942188|157329862|FG002|Overall Study|Withdrawal by Subject|4|||
48861377|NCT00942188|157329863|FG003|Overall Study|Withdrawal by Subject|2|||
48861378|NCT00942188|157329860|FG000|Overall Study|Physician Decision|0|||
48861379|NCT00942188|157329861|FG001|Overall Study|Physician Decision|0|||
48861380|NCT00942188|157329862|FG002|Overall Study|Physician Decision|1|||
48861381|NCT00942188|157329863|FG003|Overall Study|Physician Decision|0|||
48861382|NCT00942188|157329860|FG000|Overall Study|Sponsor Decision|0|||
48861383|NCT00942188|157329861|FG001|Overall Study|Sponsor Decision|2|||
48861384|NCT00942188|157329862|FG002|Overall Study|Sponsor Decision|0|||
48861385|NCT00942188|157329863|FG003|Overall Study|Sponsor Decision|1|||
48861386|NCT05379400|157331008|FG000|Overall Study|Lost to Follow-up|1|||
48861387|NCT05379400|157331009|FG001|Overall Study|Lost to Follow-up|1|||
48861388|NCT02659059|157331010|FG000|Overall Study|Other reasons|6|||
48861389|NCT02659059|157331011|FG001|Overall Study|Other reasons|1|||
48861390|NCT02659059|157331010|FG000|Overall Study|Disease Progression|143|||
48861391|NCT02659059|157331011|FG001|Overall Study|Disease Progression|16|||
48861392|NCT02659059|157331010|FG000|Overall Study|Study Drug toxicity|56|||
48861393|NCT02659059|157331011|FG001|Overall Study|Study Drug toxicity|9|||
48861394|NCT02659059|157331010|FG000|Overall Study|Death|3|||
48861395|NCT02659059|157331011|FG001|Overall Study|Death|1|||
48861396|NCT02659059|157331010|FG000|Overall Study|Adverse Event unrelated to Study drug|32|||
48861397|NCT02659059|157331011|FG001|Overall Study|Adverse Event unrelated to Study drug|4|||
48861398|NCT02659059|157331010|FG000|Overall Study|Participant request to discontinue study treatment|5|||
48861399|NCT02659059|157331011|FG001|Overall Study|Participant request to discontinue study treatment|0|||
48861400|NCT02659059|157331010|FG000|Overall Study|Participant withdrew consent|6|||
48861401|NCT02659059|157331011|FG001|Overall Study|Participant withdrew consent|1|||
48861402|NCT02830893|157331012|FG000|Overall Study|Relocation to out of the country|1|||
48861403|NCT02830893|157331013|FG001|Overall Study|Relocation to out of the country|0|||
48861404|NCT02830893|157331012|FG000|Overall Study|Lost to Follow-up|0|||
48861405|NCT02830893|157331013|FG001|Overall Study|Lost to Follow-up|2|||
48861406|NCT02830893|157331012|FG000|Overall Study|Discharged to SNF, no transportation.|0|||
48861407|NCT02830893|157331013|FG001|Overall Study|Discharged to SNF, no transportation.|1|||
48861408|NCT03976102|157331014|FG000|Overall Study|Withdrawal by Subject|4|||
48861409|NCT03976102|157331015|FG001|Overall Study|Withdrawal by Subject|4|||
48861410|NCT03976102|157331014|FG000|Overall Study|Adverse Event|2|||
48861411|NCT03976102|157331015|FG001|Overall Study|Adverse Event|4|||
48861412|NCT03976102|157331014|FG000|Overall Study|Not related to Covid-19|9|||
48861413|NCT03976102|157331015|FG001|Overall Study|Not related to Covid-19|13|||
48861414|NCT03976102|157331014|FG000|Overall Study|Lost to Follow-up|0|||
48861415|NCT03976102|157331015|FG001|Overall Study|Lost to Follow-up|2|||
48861416|NCT03976102|157331014|FG000|Overall Study|Death|3|||
48861417|NCT03976102|157331015|FG001|Overall Study|Death|2|||
48861418|NCT03976102|157331014|FG000|Overall Study|Physician Decision|1|||
48861419|NCT03976102|157331015|FG001|Overall Study|Physician Decision|1|||
48861420|NCT00215943|157331019|FG000|Overall Study|Disease Progression|3|||
48861421|NCT00215943|157331020|FG001|Overall Study|Disease Progression|5|||
48861422|NCT00215943|157331019|FG000|Overall Study|Alternate therapy|0|||
48861423|NCT00215943|157331020|FG001|Overall Study|Alternate therapy|1|||
48861424|NCT00215943|157331019|FG000|Overall Study|Adverse Event|3|||
48861425|NCT00215943|157331020|FG001|Overall Study|Adverse Event|6|||
48861426|NCT00215943|157331019|FG000|Overall Study|Other disease|0|||
48861427|NCT00215943|157331020|FG001|Overall Study|Other disease|1|||
48861428|NCT00215943|157331019|FG000|Overall Study|Other complications|3|||
48861429|NCT00215943|157331020|FG001|Overall Study|Other complications|1|||
48861430|NCT04999020|157331021|FG000|Randomized Controlled Period (RCP)|Withdrawal by Subject|1|||
48861431|NCT04999020|157331022|FG001|Randomized Controlled Period (RCP)|Withdrawal by Subject|2|||
48861432|NCT04999020|157331023|FG002|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
48861433|NCT04999020|157331024|FG003|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
48861434|NCT04999020|157331021|FG000|Randomized Controlled Period (RCP)|Physician Decision|1|||
48861435|NCT04999020|157331022|FG001|Randomized Controlled Period (RCP)|Physician Decision|1|||
48861436|NCT04999020|157331023|FG002|Randomized Controlled Period (RCP)|Physician Decision|0|||
48861437|NCT04999020|157331024|FG003|Randomized Controlled Period (RCP)|Physician Decision|0|||
48861438|NCT04999020|157331021|FG000|Randomized Controlled Period (RCP)|Adverse Event|2|||
48861439|NCT04999020|157331022|FG001|Randomized Controlled Period (RCP)|Adverse Event|0|||
48861440|NCT04999020|157331023|FG002|Randomized Controlled Period (RCP)|Adverse Event|0|||
48861441|NCT04999020|157331024|FG003|Randomized Controlled Period (RCP)|Adverse Event|0|||
48861442|NCT04999020|157331021|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
48861443|NCT04999020|157331022|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
48861444|NCT04999020|157331023|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
49015389|NCT01533428|157892161|FG000|Overall Study|Adverse Event|0|||
48861445|NCT04999020|157331024|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
48861446|NCT04999020|157331021|FG000|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
48861447|NCT04999020|157331022|FG001|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
49015390|NCT01533428|157892162|FG001|Overall Study|Adverse Event|1|||
48748835|NCT03129100|156926560|FG003|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
48748836|NCT03129100|156926561|FG004|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
48748837|NCT03129100|156926562|FG005|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
48748838|NCT03129100|156926563|FG006|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
48748839|NCT03129100|156926564|FG007|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
48748840|NCT03129100|156926565|FG008|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
48748841|NCT03129100|156926566|FG009|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
48748842|NCT03129100|156926567|FG010|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
48748843|NCT03129100|156926568|FG011|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
48748844|NCT03129100|156926569|FG012|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
48748845|NCT03129100|156926570|FG013|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
48748846|NCT03129100|156926571|FG014|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
48748847|NCT03129100|156926572|FG015|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
48748848|NCT03129100|156926573|FG016|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
48748849|NCT03129100|156926574|FG017|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
48748850|NCT03129100|156926575|FG018|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
48748851|NCT03129100|156926576|FG019|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
48748852|NCT03129100|156926577|FG020|Period 3 (Dose Escalation)|Withdrawal by Subject|2|||
48748853|NCT03129100|156926578|FG021|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
48748854|NCT03129100|156926579|FG022|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
48748855|NCT03129100|156926580|FG023|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
48748856|NCT03129100|156926581|FG024|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
48748857|NCT03129100|156926582|FG025|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
48748858|NCT03129100|156926557|FG000|Period 3 (Dose Escalation)|Physician Decision|0|||
48748859|NCT03129100|156926558|FG001|Period 3 (Dose Escalation)|Physician Decision|0|||
48748860|NCT03129100|156926559|FG002|Period 3 (Dose Escalation)|Physician Decision|0|||
48748861|NCT03129100|156926560|FG003|Period 3 (Dose Escalation)|Physician Decision|0|||
48748862|NCT03129100|156926561|FG004|Period 3 (Dose Escalation)|Physician Decision|0|||
48748863|NCT03129100|156926562|FG005|Period 3 (Dose Escalation)|Physician Decision|0|||
48748864|NCT03129100|156926563|FG006|Period 3 (Dose Escalation)|Physician Decision|0|||
48748865|NCT03129100|156926564|FG007|Period 3 (Dose Escalation)|Physician Decision|0|||
48748866|NCT03129100|156926565|FG008|Period 3 (Dose Escalation)|Physician Decision|0|||
48748867|NCT03129100|156926566|FG009|Period 3 (Dose Escalation)|Physician Decision|0|||
48748868|NCT03129100|156926567|FG010|Period 3 (Dose Escalation)|Physician Decision|0|||
48748869|NCT03129100|156926568|FG011|Period 3 (Dose Escalation)|Physician Decision|0|||
48748870|NCT03129100|156926569|FG012|Period 3 (Dose Escalation)|Physician Decision|0|||
48748871|NCT03129100|156926570|FG013|Period 3 (Dose Escalation)|Physician Decision|0|||
48748872|NCT03129100|156926571|FG014|Period 3 (Dose Escalation)|Physician Decision|0|||
48748873|NCT03129100|156926572|FG015|Period 3 (Dose Escalation)|Physician Decision|0|||
48748874|NCT03129100|156926573|FG016|Period 3 (Dose Escalation)|Physician Decision|0|||
48748875|NCT03129100|156926574|FG017|Period 3 (Dose Escalation)|Physician Decision|0|||
48748876|NCT03129100|156926575|FG018|Period 3 (Dose Escalation)|Physician Decision|0|||
48748877|NCT03129100|156926576|FG019|Period 3 (Dose Escalation)|Physician Decision|0|||
48748878|NCT03129100|156926577|FG020|Period 3 (Dose Escalation)|Physician Decision|1|||
48748879|NCT03129100|156926578|FG021|Period 3 (Dose Escalation)|Physician Decision|0|||
48748880|NCT03129100|156926579|FG022|Period 3 (Dose Escalation)|Physician Decision|0|||
48748881|NCT03129100|156926580|FG023|Period 3 (Dose Escalation)|Physician Decision|0|||
48748882|NCT03129100|156926581|FG024|Period 3 (Dose Escalation)|Physician Decision|0|||
48748883|NCT03129100|156926582|FG025|Period 3 (Dose Escalation)|Physician Decision|0|||
48748884|NCT03129100|156926557|FG000|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
48748885|NCT03129100|156926558|FG001|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
48748886|NCT03129100|156926559|FG002|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
48748887|NCT03129100|156926560|FG003|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
48748888|NCT03129100|156926561|FG004|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
48748889|NCT03129100|156926562|FG005|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
48748890|NCT03129100|156926563|FG006|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
48748891|NCT03129100|156926564|FG007|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
48748892|NCT03129100|156926565|FG008|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
48748893|NCT03129100|156926566|FG009|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
48748894|NCT03129100|156926567|FG010|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
48748895|NCT03129100|156926568|FG011|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
48748896|NCT03129100|156926569|FG012|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
48748897|NCT03129100|156926570|FG013|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
48748898|NCT03129100|156926571|FG014|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
48861448|NCT04999020|157331023|FG002|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|17|||
48748899|NCT03129100|156926572|FG015|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
48861449|NCT04999020|157331024|FG003|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|4|||
48748900|NCT03129100|156926573|FG016|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
48861450|NCT04999020|157331021|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
48861451|NCT04999020|157331022|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
48861452|NCT04999020|157331023|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
48861453|NCT04999020|157331024|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
48861454|NCT04999020|157331021|FG000|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
48861455|NCT04999020|157331022|FG001|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
48861456|NCT04999020|157331023|FG002|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
48861457|NCT04999020|157331024|FG003|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
48861458|NCT04999020|157331021|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
48861459|NCT04999020|157331022|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
48861460|NCT04999020|157331023|FG002|Open-Label Extension (OLE) Period|Adverse Event|0|||
48861461|NCT04999020|157331024|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
48861462|NCT01072149|157331025|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
48861463|NCT01072149|157331026|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
48861464|NCT01072149|157331027|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
48861465|NCT01072149|157331028|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
48861466|NCT01072149|157331029|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
48861467|NCT01072149|157331030|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
48861468|NCT01072149|157331031|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
48861469|NCT01072149|157331032|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
48861470|NCT01072149|157331033|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
48861471|NCT01072149|157331034|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
48861472|NCT01072149|157331035|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
48861473|NCT01072149|157331036|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
48861474|NCT01072149|157331037|FG012|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
48861475|NCT01072149|157331038|FG013|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
48861476|NCT01072149|157331039|FG014|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
48861477|NCT01072149|157331040|FG015|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
48861478|NCT01072149|157331041|FG016|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
48861479|NCT01072149|157331042|FG017|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
48861480|NCT01072149|157331025|FG000|Treatment Period 1 (28 Days)|Protocol Violation|0|||
48861481|NCT01072149|157331026|FG001|Treatment Period 1 (28 Days)|Protocol Violation|0|||
48861482|NCT01072149|157331027|FG002|Treatment Period 1 (28 Days)|Protocol Violation|0|||
48861483|NCT01072149|157331028|FG003|Treatment Period 1 (28 Days)|Protocol Violation|0|||
48861484|NCT01072149|157331029|FG004|Treatment Period 1 (28 Days)|Protocol Violation|0|||
48861485|NCT01072149|157331030|FG005|Treatment Period 1 (28 Days)|Protocol Violation|0|||
48861486|NCT01072149|157331031|FG006|Treatment Period 1 (28 Days)|Protocol Violation|0|||
48861487|NCT01072149|157331032|FG007|Treatment Period 1 (28 Days)|Protocol Violation|0|||
48861488|NCT01072149|157331033|FG008|Treatment Period 1 (28 Days)|Protocol Violation|0|||
48861489|NCT01072149|157331034|FG009|Treatment Period 1 (28 Days)|Protocol Violation|0|||
48861490|NCT01072149|157331035|FG010|Treatment Period 1 (28 Days)|Protocol Violation|0|||
48861491|NCT01072149|157331036|FG011|Treatment Period 1 (28 Days)|Protocol Violation|0|||
48861492|NCT01072149|157331037|FG012|Treatment Period 1 (28 Days)|Protocol Violation|0|||
48861493|NCT01072149|157331038|FG013|Treatment Period 1 (28 Days)|Protocol Violation|0|||
48861494|NCT01072149|157331039|FG014|Treatment Period 1 (28 Days)|Protocol Violation|0|||
48861495|NCT01072149|157331040|FG015|Treatment Period 1 (28 Days)|Protocol Violation|0|||
48861496|NCT01072149|157331041|FG016|Treatment Period 1 (28 Days)|Protocol Violation|0|||
48861497|NCT01072149|157331042|FG017|Treatment Period 1 (28 Days)|Protocol Violation|1|||
48861498|NCT01072149|157331025|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48861499|NCT01072149|157331026|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48955285|NCT02993224|157664302|FG000|Core Phase - Period 1|Lost to Follow-up|3|||
48955286|NCT02993224|157664302|FG000|Core Phase- Period 2|Adverse Event|1|||
48861500|NCT01072149|157331027|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48861501|NCT01072149|157331028|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48861502|NCT01072149|157331029|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48861503|NCT01072149|157331030|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48861504|NCT01072149|157331031|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48861505|NCT01072149|157331032|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48861506|NCT01072149|157331033|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48861507|NCT01072149|157331034|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48861508|NCT01072149|157331035|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
48861509|NCT01072149|157331036|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48861510|NCT01072149|157331037|FG012|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48861511|NCT01072149|157331038|FG013|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48861512|NCT01072149|157331039|FG014|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48861513|NCT01072149|157331040|FG015|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48861514|NCT01072149|157331041|FG016|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48861515|NCT01072149|157331042|FG017|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48861516|NCT01072149|157331025|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
48861517|NCT01072149|157331026|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|1|||
48861518|NCT01072149|157331027|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
48861519|NCT01072149|157331028|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
48861520|NCT01072149|157331029|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
48861521|NCT01072149|157331030|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
48861522|NCT01072149|157331031|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
48861523|NCT01072149|157331032|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
48861524|NCT01072149|157331033|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
48861525|NCT01072149|157331034|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
48861526|NCT01072149|157331035|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
48861527|NCT01072149|157331036|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
48861528|NCT01072149|157331037|FG012|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
48861529|NCT01072149|157331038|FG013|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
48861530|NCT01072149|157331039|FG014|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
48861531|NCT01072149|157331040|FG015|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
48861532|NCT01072149|157331041|FG016|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
48861533|NCT01072149|157331042|FG017|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
48861534|NCT01072149|157331025|FG000|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
48861535|NCT01072149|157331026|FG001|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
48861536|NCT01072149|157331027|FG002|Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
48861537|NCT01072149|157331028|FG003|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
48861538|NCT01072149|157331029|FG004|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
48861539|NCT01072149|157331030|FG005|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
48861540|NCT01072149|157331031|FG006|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
48861541|NCT01072149|157331032|FG007|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
48861542|NCT01072149|157331033|FG008|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
48861543|NCT01072149|157331034|FG009|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
48861544|NCT01072149|157331035|FG010|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
48861545|NCT01072149|157331036|FG011|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
48861546|NCT01072149|157331037|FG012|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
48861547|NCT01072149|157331038|FG013|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
48861548|NCT01072149|157331039|FG014|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
48861549|NCT01072149|157331040|FG015|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
48861550|NCT01072149|157331041|FG016|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
48861551|NCT01072149|157331042|FG017|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
48861552|NCT01072149|157331025|FG000|Treatment Period 2 (28 Days)|Physician Decision|0|||
48861553|NCT01072149|157331026|FG001|Treatment Period 2 (28 Days)|Physician Decision|0|||
48861554|NCT01072149|157331027|FG002|Treatment Period 2 (28 Days)|Physician Decision|0|||
48861555|NCT01072149|157331028|FG003|Treatment Period 2 (28 Days)|Physician Decision|0|||
48861556|NCT01072149|157331029|FG004|Treatment Period 2 (28 Days)|Physician Decision|0|||
48861557|NCT01072149|157331030|FG005|Treatment Period 2 (28 Days)|Physician Decision|0|||
48861558|NCT01072149|157331031|FG006|Treatment Period 2 (28 Days)|Physician Decision|0|||
48861559|NCT01072149|157331032|FG007|Treatment Period 2 (28 Days)|Physician Decision|1|||
48861560|NCT01072149|157331033|FG008|Treatment Period 2 (28 Days)|Physician Decision|0|||
48861561|NCT01072149|157331034|FG009|Treatment Period 2 (28 Days)|Physician Decision|0|||
48861562|NCT01072149|157331035|FG010|Treatment Period 2 (28 Days)|Physician Decision|0|||
48861563|NCT01072149|157331036|FG011|Treatment Period 2 (28 Days)|Physician Decision|0|||
48861564|NCT01072149|157331037|FG012|Treatment Period 2 (28 Days)|Physician Decision|0|||
48861565|NCT01072149|157331038|FG013|Treatment Period 2 (28 Days)|Physician Decision|0|||
48861566|NCT01072149|157331039|FG014|Treatment Period 2 (28 Days)|Physician Decision|0|||
48861567|NCT01072149|157331040|FG015|Treatment Period 2 (28 Days)|Physician Decision|0|||
48861568|NCT01072149|157331041|FG016|Treatment Period 2 (28 Days)|Physician Decision|0|||
48861569|NCT01072149|157331042|FG017|Treatment Period 2 (28 Days)|Physician Decision|0|||
48861570|NCT01072149|157331025|FG000|Washout Period 2 (14 Days)|Physician Decision|1|||
48955287|NCT02993224|157664302|FG000|Core Phase- Period 2|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|2|||
48955288|NCT02993224|157664302|FG000|Core Phase- Period 2|Allogenic stem cell transplantation|1|||
48955289|NCT02993224|157664302|FG000|Extension Phase|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|1|||
48955290|NCT02993224|157664302|FG000|Extension Phase|Adverse Event|3|||
48955291|NCT02993224|157664302|FG000|Extension Phase|Withdrawal by Subject|3|||
48955292|NCT02993224|157664302|FG000|Extension Phase|Lost to Follow-up|2|||
49015391|NCT01533428|157892161|FG000|Overall Study|Lost to Follow-up|2|||
48748901|NCT03129100|156926574|FG017|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
48748902|NCT03129100|156926575|FG018|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
48748903|NCT03129100|156926576|FG019|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
48748904|NCT03129100|156926577|FG020|Period 3 (Dose Escalation)|Lack of Efficacy|1|||
48748905|NCT03129100|156926578|FG021|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
48748906|NCT03129100|156926579|FG022|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
48748907|NCT03129100|156926580|FG023|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
48748908|NCT03129100|156926581|FG024|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
48748909|NCT03129100|156926582|FG025|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
48748910|NCT03129100|156926557|FG000|Period 4 (Post Treatment Follow-up)|Death|0|||
48748911|NCT03129100|156926558|FG001|Period 4 (Post Treatment Follow-up)|Death|0|||
48748912|NCT03129100|156926559|FG002|Period 4 (Post Treatment Follow-up)|Death|0|||
48748913|NCT03129100|156926560|FG003|Period 4 (Post Treatment Follow-up)|Death|0|||
48748914|NCT03129100|156926561|FG004|Period 4 (Post Treatment Follow-up)|Death|0|||
48748915|NCT03129100|156926562|FG005|Period 4 (Post Treatment Follow-up)|Death|0|||
48748916|NCT03129100|156926563|FG006|Period 4 (Post Treatment Follow-up)|Death|0|||
48748917|NCT03129100|156926564|FG007|Period 4 (Post Treatment Follow-up)|Death|0|||
48748918|NCT03129100|156926565|FG008|Period 4 (Post Treatment Follow-up)|Death|0|||
48748919|NCT03129100|156926566|FG009|Period 4 (Post Treatment Follow-up)|Death|0|||
48748920|NCT03129100|156926567|FG010|Period 4 (Post Treatment Follow-up)|Death|0|||
48748921|NCT03129100|156926568|FG011|Period 4 (Post Treatment Follow-up)|Death|0|||
48748922|NCT03129100|156926569|FG012|Period 4 (Post Treatment Follow-up)|Death|0|||
48748923|NCT03129100|156926570|FG013|Period 4 (Post Treatment Follow-up)|Death|0|||
48748924|NCT03129100|156926571|FG014|Period 4 (Post Treatment Follow-up)|Death|0|||
48748925|NCT03129100|156926572|FG015|Period 4 (Post Treatment Follow-up)|Death|0|||
48748926|NCT03129100|156926573|FG016|Period 4 (Post Treatment Follow-up)|Death|0|||
48748927|NCT03129100|156926574|FG017|Period 4 (Post Treatment Follow-up)|Death|0|||
48748928|NCT03129100|156926575|FG018|Period 4 (Post Treatment Follow-up)|Death|0|||
48748929|NCT03129100|156926576|FG019|Period 4 (Post Treatment Follow-up)|Death|0|||
48748930|NCT03129100|156926577|FG020|Period 4 (Post Treatment Follow-up)|Death|0|||
48748931|NCT03129100|156926578|FG021|Period 4 (Post Treatment Follow-up)|Death|0|||
48748932|NCT03129100|156926579|FG022|Period 4 (Post Treatment Follow-up)|Death|0|||
48861571|NCT01072149|157331026|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
48861572|NCT01072149|157331027|FG002|Washout Period 2 (14 Days)|Physician Decision|0|||
48861573|NCT01072149|157331028|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
48861574|NCT01072149|157331029|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
48861575|NCT01072149|157331030|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
48861576|NCT01072149|157331031|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
48861577|NCT01072149|157331032|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
48861578|NCT01072149|157331033|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
48861579|NCT01072149|157331034|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
48861580|NCT01072149|157331035|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
48861581|NCT01072149|157331036|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
48861582|NCT01072149|157331037|FG012|Washout Period 2 (14 Days)|Physician Decision|0|||
48861583|NCT01072149|157331038|FG013|Washout Period 2 (14 Days)|Physician Decision|0|||
48861584|NCT01072149|157331039|FG014|Washout Period 2 (14 Days)|Physician Decision|0|||
48861585|NCT01072149|157331040|FG015|Washout Period 2 (14 Days)|Physician Decision|0|||
48861586|NCT01072149|157331041|FG016|Washout Period 2 (14 Days)|Physician Decision|0|||
48861587|NCT01072149|157331042|FG017|Washout Period 2 (14 Days)|Physician Decision|0|||
48861588|NCT01072149|157331025|FG000|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
48861589|NCT01072149|157331026|FG001|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
48861590|NCT01072149|157331027|FG002|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
48861591|NCT01072149|157331028|FG003|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
48861592|NCT01072149|157331029|FG004|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
48861593|NCT01072149|157331030|FG005|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
48861594|NCT01072149|157331031|FG006|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
48861595|NCT01072149|157331032|FG007|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
48861596|NCT01072149|157331033|FG008|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
48861597|NCT01072149|157331034|FG009|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
48861598|NCT01072149|157331035|FG010|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
48861599|NCT01072149|157331036|FG011|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
48861600|NCT01072149|157331037|FG012|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
48861601|NCT01072149|157331038|FG013|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
48861602|NCT01072149|157331039|FG014|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
48861603|NCT01072149|157331040|FG015|Washout Period 2 (14 Days)|Withdrawal by Subject|1|||
48861604|NCT01072149|157331041|FG016|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
48861605|NCT01072149|157331042|FG017|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
48861606|NCT01072149|157331025|FG000|Washout Period 2 (14 Days)|Adverse Event|0|||
48861607|NCT01072149|157331026|FG001|Washout Period 2 (14 Days)|Adverse Event|0|||
48955293|NCT02993224|157664302|FG000|Extension Phase|Deferasirox FCT locally reimbursed|27|||
48955294|NCT01096446|157665569|FG000|Overall Study|Death|1|||
48955295|NCT01096446|157665570|FG001|Overall Study|Death|0|||
48955296|NCT01096446|157665569|FG000|Overall Study|Protocol Violation|2|||
48955297|NCT01096446|157665570|FG001|Overall Study|Protocol Violation|0|||
48955298|NCT03132805|157665571|FG000|Overall Study|Lost to Follow-up|142|||
48955299|NCT03132805|157665572|FG001|Overall Study|Lost to Follow-up|141|||
48955300|NCT03132805|157665573|FG002|Overall Study|Lost to Follow-up|113|||
48955301|NCT03493685|157665576|FG000|Overall Study|Death|4|||
48955302|NCT03493685|157665577|FG001|Overall Study|Death|3|||
48955303|NCT03493685|157665576|FG000|Overall Study|Lost to Follow-up|3|||
48955304|NCT03493685|157665577|FG001|Overall Study|Lost to Follow-up|2|||
48955305|NCT03493685|157665576|FG000|Overall Study|Physician Decision|2|||
48955306|NCT03493685|157665577|FG001|Overall Study|Physician Decision|0|||
48955307|NCT03493685|157665576|FG000|Overall Study|Withdrawal by Subject|7|||
48955308|NCT03493685|157665577|FG001|Overall Study|Withdrawal by Subject|11|||
48955309|NCT02115815|157665578|FG000|Overall Study|Withdrawal by Subject|2|||
48955310|NCT02115815|157665579|FG001|Overall Study|Withdrawal by Subject|0|||
48955311|NCT02115815|157665580|FG002|Overall Study|Withdrawal by Subject|0|||
48955312|NCT02115815|157665581|FG003|Overall Study|Withdrawal by Subject|0|||
48748933|NCT03129100|156926580|FG023|Period 4 (Post Treatment Follow-up)|Death|0|||
48748934|NCT03129100|156926581|FG024|Period 4 (Post Treatment Follow-up)|Death|1|||
48748935|NCT03129100|156926582|FG025|Period 4 (Post Treatment Follow-up)|Death|0|||
48748936|NCT03129100|156926557|FG000|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
48748937|NCT03129100|156926558|FG001|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
48748938|NCT03129100|156926559|FG002|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
48748939|NCT03129100|156926560|FG003|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
48955313|NCT02115815|157665582|FG004|Overall Study|Withdrawal by Subject|0|||
48955314|NCT02115815|157665583|FG005|Overall Study|Withdrawal by Subject|0|||
48955315|NCT02115815|157665584|FG006|Overall Study|Withdrawal by Subject|0|||
48955316|NCT02115815|157665578|FG000|Overall Study|Not enough drug to dose participant|0|||
48955317|NCT02115815|157665579|FG001|Overall Study|Not enough drug to dose participant|0|||
48955318|NCT02115815|157665580|FG002|Overall Study|Not enough drug to dose participant|0|||
48955319|NCT02115815|157665581|FG003|Overall Study|Not enough drug to dose participant|0|||
48748940|NCT03129100|156926561|FG004|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
48955320|NCT02115815|157665582|FG004|Overall Study|Not enough drug to dose participant|0|||
48955321|NCT02115815|157665583|FG005|Overall Study|Not enough drug to dose participant|1|||
48955322|NCT02115815|157665584|FG006|Overall Study|Not enough drug to dose participant|0|||
48955323|NCT02115815|157665578|FG000|Overall Study|Missed appointment, randomized in error|0|||
48955324|NCT02115815|157665579|FG001|Overall Study|Missed appointment, randomized in error|0|||
48955325|NCT02115815|157665580|FG002|Overall Study|Missed appointment, randomized in error|0|||
48955326|NCT02115815|157665581|FG003|Overall Study|Missed appointment, randomized in error|0|||
48955327|NCT02115815|157665582|FG004|Overall Study|Missed appointment, randomized in error|0|||
48955328|NCT02115815|157665583|FG005|Overall Study|Missed appointment, randomized in error|1|||
48955329|NCT02115815|157665584|FG006|Overall Study|Missed appointment, randomized in error|0|||
48955330|NCT01605071|157665585|FG000|Overall Study|Withdrawal by Subject|3|||
48955331|NCT01605071|157665586|FG001|Overall Study|Withdrawal by Subject|2|||
48955332|NCT00943319|157665589|FG000|Overall Study|Death|1|||
48955333|NCT00883558|157665590|FG000|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2|||
48955334|NCT00883558|157665591|FG001|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
48955335|NCT00883558|157665592|FG002|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
48955336|NCT00883558|157665590|FG000|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
48955337|NCT00883558|157665591|FG001|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1|||
48955338|NCT00883558|157665592|FG002|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
48955339|NCT00883558|157665590|FG000|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0|||
48955340|NCT00883558|157665591|FG001|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
48955341|NCT00883558|157665592|FG002|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
48955342|NCT00883558|157665590|FG000|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
48955343|NCT00883558|157665591|FG001|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1|||
48955344|NCT00883558|157665592|FG002|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
48955345|NCT00883558|157665590|FG000|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
48955346|NCT00883558|157665591|FG001|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
48955347|NCT00883558|157665592|FG002|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1|||
48955348|NCT00615290|157665593|FG000|Overall Study|Adverse Event|2|||
48955349|NCT00615290|157665593|FG000|Overall Study|Lost to Follow-up|3|||
48955350|NCT00615290|157665593|FG000|Overall Study|Withdrawal by Subject|1|||
48955351|NCT00615290|157665593|FG000|Overall Study|Other|2|||
48955352|NCT03158688|157665596|FG000|Overall Study|Withdrawal by Subject|14|||
48955353|NCT03158688|157665597|FG001|Overall Study|Withdrawal by Subject|28|||
48955354|NCT03158688|157665596|FG000|Overall Study|Decision by sponsor|13|||
48861608|NCT01072149|157331027|FG002|Washout Period 2 (14 Days)|Adverse Event|0|||
48861609|NCT01072149|157331028|FG003|Washout Period 2 (14 Days)|Adverse Event|0|||
48861610|NCT01072149|157331029|FG004|Washout Period 2 (14 Days)|Adverse Event|0|||
48861611|NCT01072149|157331030|FG005|Washout Period 2 (14 Days)|Adverse Event|0|||
48861612|NCT01072149|157331031|FG006|Washout Period 2 (14 Days)|Adverse Event|0|||
48861613|NCT01072149|157331032|FG007|Washout Period 2 (14 Days)|Adverse Event|0|||
48861614|NCT01072149|157331033|FG008|Washout Period 2 (14 Days)|Adverse Event|0|||
48861615|NCT01072149|157331034|FG009|Washout Period 2 (14 Days)|Adverse Event|0|||
48861616|NCT01072149|157331035|FG010|Washout Period 2 (14 Days)|Adverse Event|0|||
48861617|NCT01072149|157331036|FG011|Washout Period 2 (14 Days)|Adverse Event|0|||
48861618|NCT01072149|157331037|FG012|Washout Period 2 (14 Days)|Adverse Event|0|||
48861619|NCT01072149|157331038|FG013|Washout Period 2 (14 Days)|Adverse Event|0|||
48861620|NCT01072149|157331039|FG014|Washout Period 2 (14 Days)|Adverse Event|0|||
48861621|NCT01072149|157331040|FG015|Washout Period 2 (14 Days)|Adverse Event|1|||
48861622|NCT01072149|157331041|FG016|Washout Period 2 (14 Days)|Adverse Event|0|||
48861623|NCT01072149|157331042|FG017|Washout Period 2 (14 Days)|Adverse Event|0|||
48861624|NCT01072149|157331025|FG000|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
48861625|NCT01072149|157331026|FG001|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
48861626|NCT01072149|157331027|FG002|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
48861627|NCT01072149|157331028|FG003|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
48861628|NCT01072149|157331029|FG004|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
48861629|NCT01072149|157331030|FG005|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
48861630|NCT01072149|157331031|FG006|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
48861631|NCT01072149|157331032|FG007|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
48861632|NCT01072149|157331033|FG008|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
48861633|NCT01072149|157331034|FG009|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
48861634|NCT01072149|157331035|FG010|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
48861635|NCT01072149|157331036|FG011|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
48861636|NCT01072149|157331037|FG012|Washout Period 2 (14 Days)|Lack of Efficacy|1|||
48861637|NCT01072149|157331038|FG013|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
48861638|NCT01072149|157331039|FG014|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
48861639|NCT01072149|157331040|FG015|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
48861640|NCT01072149|157331041|FG016|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
48861641|NCT01072149|157331042|FG017|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
48861642|NCT01072149|157331025|FG000|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
48955355|NCT03158688|157665597|FG001|Overall Study|Decision by sponsor|37|||
48955356|NCT03158688|157665596|FG000|Overall Study|Lost to Follow-up|4|||
48955357|NCT03158688|157665597|FG001|Overall Study|Lost to Follow-up|3|||
48861643|NCT01072149|157331026|FG001|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
48861644|NCT01072149|157331027|FG002|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
48861645|NCT01072149|157331028|FG003|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
48955358|NCT03158688|157665596|FG000|Overall Study|Death|74|||
48748941|NCT03129100|156926562|FG005|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
48748942|NCT03129100|156926563|FG006|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
48748943|NCT03129100|156926564|FG007|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
48748944|NCT03129100|156926565|FG008|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
48748945|NCT03129100|156926566|FG009|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
48748946|NCT03129100|156926567|FG010|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
48748947|NCT03129100|156926568|FG011|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
48748948|NCT03129100|156926569|FG012|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
48748949|NCT03129100|156926570|FG013|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
48748950|NCT03129100|156926571|FG014|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
48748951|NCT03129100|156926572|FG015|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
48748952|NCT03129100|156926573|FG016|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
48748953|NCT03129100|156926574|FG017|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
48748954|NCT03129100|156926575|FG018|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
48748955|NCT03129100|156926576|FG019|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
48748956|NCT03129100|156926577|FG020|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
48748957|NCT03129100|156926578|FG021|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
48748958|NCT03129100|156926579|FG022|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
48748959|NCT03129100|156926580|FG023|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
48748960|NCT03129100|156926581|FG024|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
48748961|NCT03129100|156926582|FG025|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
48748962|NCT03129100|156926557|FG000|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
48748963|NCT03129100|156926558|FG001|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
48748964|NCT03129100|156926559|FG002|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
48748965|NCT03129100|156926560|FG003|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
48748966|NCT03129100|156926561|FG004|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
48748967|NCT03129100|156926562|FG005|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
48748968|NCT03129100|156926563|FG006|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
48748969|NCT03129100|156926564|FG007|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
48748970|NCT03129100|156926565|FG008|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
48748971|NCT03129100|156926566|FG009|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
48748972|NCT03129100|156926567|FG010|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
48748973|NCT03129100|156926568|FG011|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
48748974|NCT03129100|156926569|FG012|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
48748975|NCT03129100|156926570|FG013|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
48748976|NCT03129100|156926571|FG014|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
48861646|NCT01072149|157331029|FG004|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
48748977|NCT03129100|156926572|FG015|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
48748978|NCT03129100|156926573|FG016|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
48748979|NCT03129100|156926574|FG017|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
48748980|NCT03129100|156926575|FG018|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
48748981|NCT03129100|156926576|FG019|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
48748982|NCT03129100|156926577|FG020|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
48748983|NCT03129100|156926578|FG021|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
48748984|NCT03129100|156926579|FG022|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
48748985|NCT03129100|156926580|FG023|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|3|||
48861647|NCT01072149|157331030|FG005|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
48861648|NCT01072149|157331031|FG006|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
48955359|NCT03158688|157665597|FG001|Overall Study|Death|142|||
48955360|NCT02273050|157665598|FG000|Overall Study|Adverse Event|4|||
48955361|NCT02273050|157665599|FG001|Overall Study|Adverse Event|3|||
48955362|NCT02273050|157665600|FG002|Overall Study|Adverse Event|3|||
48748986|NCT03129100|156926581|FG024|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|20|||
48955363|NCT02273050|157665598|FG000|Overall Study|Death|0|||
48955364|NCT02273050|157665599|FG001|Overall Study|Death|0|||
48955365|NCT02273050|157665600|FG002|Overall Study|Death|1|||
48955366|NCT02273050|157665598|FG000|Overall Study|Dev. of study spec. withdrawal criteria|0|||
48955367|NCT02273050|157665599|FG001|Overall Study|Dev. of study spec. withdrawal criteria|1|||
48955368|NCT02273050|157665600|FG002|Overall Study|Dev. of study spec. withdrawal criteria|1|||
48955369|NCT02273050|157665598|FG000|Overall Study|Lack of Efficacy|0|||
48955370|NCT02273050|157665599|FG001|Overall Study|Lack of Efficacy|1|||
48955371|NCT02273050|157665600|FG002|Overall Study|Lack of Efficacy|1|||
48955372|NCT02273050|157665598|FG000|Overall Study|Withdrawal by Subject|17|||
48955373|NCT02273050|157665599|FG001|Overall Study|Withdrawal by Subject|14|||
48955374|NCT02273050|157665600|FG002|Overall Study|Withdrawal by Subject|16|||
48955375|NCT02273050|157665598|FG000|Overall Study|Lost to Follow-up|0|||
48955376|NCT02273050|157665599|FG001|Overall Study|Lost to Follow-up|2|||
48955377|NCT02273050|157665600|FG002|Overall Study|Lost to Follow-up|3|||
48955378|NCT02273050|157665598|FG000|Overall Study|Protocol Violation|3|||
48748987|NCT03129100|156926582|FG025|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|37|||
48748988|NCT03129100|156926557|FG000|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
48748989|NCT03129100|156926558|FG001|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
48748990|NCT03129100|156926559|FG002|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
48748991|NCT03129100|156926560|FG003|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
48748992|NCT03129100|156926561|FG004|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
48748993|NCT03129100|156926562|FG005|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
48748994|NCT03129100|156926563|FG006|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
48748995|NCT03129100|156926564|FG007|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
48748996|NCT03129100|156926565|FG008|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
48748997|NCT03129100|156926566|FG009|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
48748998|NCT03129100|156926567|FG010|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
48748999|NCT03129100|156926568|FG011|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
48749000|NCT03129100|156926569|FG012|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
48749001|NCT03129100|156926570|FG013|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
48749002|NCT03129100|156926571|FG014|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
48749003|NCT03129100|156926572|FG015|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
48749004|NCT03129100|156926573|FG016|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
48749005|NCT03129100|156926574|FG017|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
48749006|NCT03129100|156926575|FG018|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
48749007|NCT03129100|156926576|FG019|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
48749008|NCT03129100|156926577|FG020|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
48749009|NCT03129100|156926578|FG021|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
48749010|NCT03129100|156926579|FG022|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
48749011|NCT03129100|156926580|FG023|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
48749012|NCT03129100|156926581|FG024|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|2|||
48749013|NCT03129100|156926582|FG025|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
48861649|NCT01072149|157331032|FG007|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
48955379|NCT02273050|157665599|FG001|Overall Study|Protocol Violation|1|||
48861650|NCT01072149|157331033|FG008|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
48861651|NCT01072149|157331034|FG009|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
48861652|NCT01072149|157331035|FG010|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
48861653|NCT01072149|157331036|FG011|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
48861654|NCT01072149|157331037|FG012|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
48861655|NCT01072149|157331038|FG013|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
48861656|NCT01072149|157331039|FG014|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
48861657|NCT01072149|157331040|FG015|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
48861658|NCT01072149|157331041|FG016|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
48861659|NCT01072149|157331042|FG017|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
48861669|NCT00555620|157331050|FG000|Overall Study|Death|0|||
48861670|NCT00555620|157331051|FG001|Overall Study|Death|1|||
48861671|NCT00555620|157331052|FG002|Overall Study|Death|0|||
48861672|NCT00555620|157331053|FG003|Overall Study|Death|0|||
48861673|NCT00555620|157331054|FG004|Overall Study|Death|0|||
48861674|NCT00555620|157331055|FG005|Overall Study|Death|1|||
48861675|NCT00555620|157331050|FG000|Overall Study|Study terminated by sponsor|0|||
48861676|NCT00555620|157331051|FG001|Overall Study|Study terminated by sponsor|0|||
48861677|NCT00555620|157331052|FG002|Overall Study|Study terminated by sponsor|1|||
48955380|NCT02273050|157665600|FG002|Overall Study|Protocol Violation|4|||
48955381|NCT02577406|157665609|FG000|Randomized Period|Death|1|||
48955382|NCT02577406|157665610|FG001|Randomized Period|Death|0|||
48955383|NCT02577406|157665609|FG000|Randomized Period|Other reasons|0|||
48955384|NCT02577406|157665610|FG001|Randomized Period|Other reasons|20|||
48955385|NCT02577406|157665609|FG000|Treatment Period|Transition to commercially available treatment|1|||
48955386|NCT02577406|157665610|FG001|Treatment Period|Transition to commercially available treatment|0|||
48955387|NCT02577406|157665609|FG000|Treatment Period|Progressive disease|47|||
48955388|NCT02577406|157665610|FG001|Treatment Period|Progressive disease|36|||
48955389|NCT02577406|157665609|FG000|Treatment Period|Death|36|||
48955390|NCT02577406|157665610|FG001|Treatment Period|Death|23|||
48955391|NCT02577406|157665609|FG000|Treatment Period|Other reasons|3|||
48861678|NCT00555620|157331053|FG003|Overall Study|Study terminated by sponsor|0|||
48861679|NCT00555620|157331054|FG004|Overall Study|Study terminated by sponsor|0|||
48861680|NCT00555620|157331055|FG005|Overall Study|Study terminated by sponsor|0|||
48861681|NCT00555620|157331050|FG000|Overall Study|Adverse Event|0|||
48861682|NCT00555620|157331051|FG001|Overall Study|Adverse Event|0|||
48861683|NCT00555620|157331052|FG002|Overall Study|Adverse Event|1|||
48861684|NCT00555620|157331053|FG003|Overall Study|Adverse Event|5|||
48861685|NCT00555620|157331054|FG004|Overall Study|Adverse Event|0|||
48861686|NCT00555620|157331055|FG005|Overall Study|Adverse Event|1|||
48861687|NCT00555620|157331050|FG000|Overall Study|Objective progression or relapse|6|||
48861688|NCT00555620|157331051|FG001|Overall Study|Objective progression or relapse|5|||
48861689|NCT00555620|157331052|FG002|Overall Study|Objective progression or relapse|12|||
48861690|NCT00555620|157331053|FG003|Overall Study|Objective progression or relapse|17|||
48861691|NCT00555620|157331054|FG004|Overall Study|Objective progression or relapse|3|||
48861692|NCT00555620|157331055|FG005|Overall Study|Objective progression or relapse|16|||
48861693|NCT00555620|157331050|FG000|Overall Study|Participant refused treatment|0|||
48861694|NCT00555620|157331051|FG001|Overall Study|Participant refused treatment|1|||
48861695|NCT00555620|157331052|FG002|Overall Study|Participant refused treatment|1|||
48861696|NCT00555620|157331053|FG003|Overall Study|Participant refused treatment|0|||
48861697|NCT00555620|157331054|FG004|Overall Study|Participant refused treatment|0|||
48861698|NCT00555620|157331055|FG005|Overall Study|Participant refused treatment|1|||
48861699|NCT00555620|157331050|FG000|Overall Study|Other|0|||
48861700|NCT00555620|157331051|FG001|Overall Study|Other|0|||
48861701|NCT00555620|157331052|FG002|Overall Study|Other|0|||
48861702|NCT00555620|157331053|FG003|Overall Study|Other|1|||
48861703|NCT00555620|157331054|FG004|Overall Study|Other|0|||
48861704|NCT00555620|157331055|FG005|Overall Study|Other|3|||
48861705|NCT01320683|157331059|FG000|Overall Study|Positive antibody response|1|||
48861706|NCT01877720|157331060|FG000|Overall Study|Adverse Event|1|||
48861707|NCT01877720|157331061|FG001|Overall Study|Adverse Event|0|||
48861708|NCT00447499|157331062|FG000|Overall Study|Adverse Event|1|||
48861709|NCT00447499|157331062|FG000|Overall Study|Patient Decision|4|||
48861710|NCT00447499|157331062|FG000|Overall Study|Sponsor Decision|1|||
48861711|NCT00447499|157331062|FG000|Overall Study|Physician Decision|1|||
48861712|NCT03034772|157331065|FG000|Overall Study|Adverse Event|0|||
48861713|NCT03034772|157331066|FG001|Overall Study|Adverse Event|1|||
48861714|NCT03034772|157331065|FG000|Overall Study|Withdrawal by Subject|0|||
48861715|NCT03034772|157331066|FG001|Overall Study|Withdrawal by Subject|1|||
48861716|NCT03386344|157331073|FG000|Overall Study|Adverse Event|6|||
48861717|NCT03386344|157331074|FG001|Overall Study|Adverse Event|3|||
48861718|NCT03386344|157331075|FG002|Overall Study|Adverse Event|1|||
48861719|NCT03386344|157331073|FG000|Overall Study|Poor Compliance to Protocol|0|||
48861720|NCT03386344|157331074|FG001|Overall Study|Poor Compliance to Protocol|1|||
48861721|NCT03386344|157331075|FG002|Overall Study|Poor Compliance to Protocol|0|||
48861722|NCT03386344|157331073|FG000|Overall Study|Study Terminated by Sponsor|101|||
48861723|NCT03386344|157331074|FG001|Overall Study|Study Terminated by Sponsor|102|||
48861724|NCT03386344|157331075|FG002|Overall Study|Study Terminated by Sponsor|106|||
48861725|NCT03386344|157331073|FG000|Overall Study|Lost to Follow-up|3|||
48861726|NCT03386344|157331074|FG001|Overall Study|Lost to Follow-up|2|||
48861727|NCT03386344|157331075|FG002|Overall Study|Lost to Follow-up|1|||
48861728|NCT03386344|157331073|FG000|Overall Study|At the Participant's own Request|7|||
48861729|NCT03386344|157331074|FG001|Overall Study|At the Participant's own Request|7|||
48861730|NCT03386344|157331075|FG002|Overall Study|At the Participant's own Request|8|||
48861731|NCT03386344|157331073|FG000|Overall Study|Reason not Specified|0|||
48861732|NCT03386344|157331074|FG001|Overall Study|Reason not Specified|1|||
48861733|NCT03386344|157331075|FG002|Overall Study|Reason not Specified|0|||
48861734|NCT04626128|157331076|FG000|Overall Study|Withdrawal by Subject|0|||
48861735|NCT04626128|157331077|FG001|Overall Study|Withdrawal by Subject|1|||
48861736|NCT04626128|157331078|FG002|Overall Study|Withdrawal by Subject|0|||
48861737|NCT04626128|157331079|FG003|Overall Study|Withdrawal by Subject|0|||
48861738|NCT02465866|157331080|FG000|Period 3|Withdrawal by Subject|0|||
48861739|NCT02465866|157331081|FG001|Period 3|Withdrawal by Subject|1|||
48861740|NCT02465866|157331082|FG002|Period 3|Withdrawal by Subject|0|||
48861741|NCT02465866|157331083|FG003|Period 3|Withdrawal by Subject|0|||
48861742|NCT04175392|157331084|FG000|Overall Study|Withdrawal by Subject|3|||
48861743|NCT04175392|157331085|FG001|Overall Study|Withdrawal by Subject|2|||
48955392|NCT02577406|157665610|FG001|Treatment Period|Other reasons|37|||
48955393|NCT02577406|157665609|FG000|Treatment Period|Withdrawal by Subject|10|||
48955394|NCT02577406|157665610|FG001|Treatment Period|Withdrawal by Subject|24|||
48955395|NCT02577406|157665609|FG000|Treatment Period|Adverse Event|17|||
48861744|NCT01525875|157331086|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
48861745|NCT01525875|157331087|FG001|Placebo-controlled Period|Withdrawal by Subject|2|||
48955396|NCT02577406|157665610|FG001|Treatment Period|Adverse Event|12|||
48955397|NCT02577406|157665609|FG000|Treatment Period|Disease relapse|27|||
48861746|NCT01525875|157331086|FG000|Open-label Period|Lost to Follow-up|0|||
48861747|NCT01525875|157331087|FG001|Open-label Period|Lost to Follow-up|2|||
48861748|NCT01106586|157331091|FG000|Overall Study|Adverse Event|9|||
48861749|NCT01106586|157331092|FG001|Overall Study|Adverse Event|15|||
48861750|NCT01106586|157331091|FG000|Overall Study|Death|1|||
48861751|NCT01106586|157331092|FG001|Overall Study|Death|3|||
48861752|NCT01106586|157331091|FG000|Overall Study|Pregnancy|2|||
48861753|NCT01106586|157331092|FG001|Overall Study|Pregnancy|2|||
48861754|NCT01106586|157331091|FG000|Overall Study|Lack of Efficacy|1|||
48955398|NCT02577406|157665610|FG001|Treatment Period|Disease relapse|1|||
48861755|NCT01106586|157331092|FG001|Overall Study|Lack of Efficacy|0|||
48749014|NCT03129100|156926557|FG000|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
48749015|NCT03129100|156926558|FG001|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
48749016|NCT03129100|156926559|FG002|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
48749017|NCT03129100|156926560|FG003|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
48749018|NCT03129100|156926561|FG004|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
48861756|NCT01106586|157331091|FG000|Overall Study|Investigator's Discretion|5|||
48861757|NCT01106586|157331092|FG001|Overall Study|Investigator's Discretion|8|||
48861758|NCT01106586|157331091|FG000|Overall Study|Withdrew Consent|18|||
48861759|NCT01106586|157331092|FG001|Overall Study|Withdrew Consent|30|||
48861760|NCT01106586|157331091|FG000|Overall Study|Lost to Follow-up|24|||
48861761|NCT01106586|157331092|FG001|Overall Study|Lost to Follow-up|20|||
48861762|NCT01106586|157331091|FG000|Overall Study|Participant Noncompliance|12|||
48861763|NCT01106586|157331092|FG001|Overall Study|Participant Noncompliance|10|||
48861764|NCT01106586|157331091|FG000|Overall Study|Protocol Violation|1|||
48861765|NCT01106586|157331092|FG001|Overall Study|Protocol Violation|0|||
48861766|NCT01106586|157331091|FG000|Overall Study|Participant Transferred to Another Study|212|||
48861767|NCT01106586|157331092|FG001|Overall Study|Participant Transferred to Another Study|197|||
48861768|NCT05274906|157331093|FG000|Overall Study|Withdrawal by Subject|2|||
48861769|NCT05274906|157331094|FG001|Overall Study|Withdrawal by Subject|1|||
48861770|NCT05265247|157331095|FG000|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|1|||
48861771|NCT05265247|157331096|FG001|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|3|||
48861772|NCT05265247|157331095|FG000|Washout Period (7 Days)|Withdrawal by Subject|0|||
48861773|NCT05265247|157331096|FG001|Washout Period (7 Days)|Withdrawal by Subject|1|||
48861774|NCT05265247|157331095|FG000|Washout Period (7 Days)|Non-compliance with study requirements|3|||
48861775|NCT05265247|157331096|FG001|Washout Period (7 Days)|Non-compliance with study requirements|3|||
48861776|NCT03508830|157331097|FG000|Overall Study|Withdrawal by Subject|3|||
48861777|NCT03508830|157331098|FG001|Overall Study|Withdrawal by Subject|4|||
48861778|NCT03508830|157331097|FG000|Overall Study|Physician Decision|2|||
48861779|NCT03508830|157331098|FG001|Overall Study|Physician Decision|2|||
48861780|NCT00748098|157331105|FG000|First Treatment Intervention Period|Adverse Event|1|||
48861781|NCT00748098|157331106|FG001|First Treatment Intervention Period|Adverse Event|1|||
48861782|NCT00748098|157331105|FG000|First Treatment Intervention Period|Protocol Violation|1|||
48861783|NCT00748098|157331106|FG001|First Treatment Intervention Period|Protocol Violation|0|||
48861784|NCT00748098|157331105|FG000|First Treatment Intervention Period|Lost to Follow-up|1|||
48955399|NCT02577406|157665609|FG000|Treatment Period|HSCT|6|||
48955400|NCT02577406|157665610|FG001|Treatment Period|HSCT|2|||
48749019|NCT03129100|156926562|FG005|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
48749020|NCT03129100|156926563|FG006|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
48749021|NCT03129100|156926564|FG007|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
48749022|NCT03129100|156926565|FG008|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
48749023|NCT03129100|156926566|FG009|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
48749024|NCT03129100|156926567|FG010|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
48749025|NCT03129100|156926568|FG011|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
48749026|NCT03129100|156926569|FG012|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
48749027|NCT03129100|156926570|FG013|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
48749028|NCT03129100|156926571|FG014|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
48749029|NCT03129100|156926572|FG015|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
48749030|NCT03129100|156926573|FG016|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
48749031|NCT03129100|156926574|FG017|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
48749032|NCT03129100|156926575|FG018|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
48749033|NCT03129100|156926576|FG019|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
48749034|NCT03129100|156926577|FG020|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
48749035|NCT03129100|156926578|FG021|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
48749036|NCT03129100|156926579|FG022|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
48749037|NCT03129100|156926580|FG023|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
48749038|NCT03129100|156926581|FG024|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
48749039|NCT03129100|156926582|FG025|Period 4 (Post Treatment Follow-up)|Missed follow-up|1|||
48749040|NCT03129100|156926557|FG000|Period 4 (Post Treatment Follow-up)|Other|0|||
48749041|NCT03129100|156926558|FG001|Period 4 (Post Treatment Follow-up)|Other|0|||
48749042|NCT03129100|156926559|FG002|Period 4 (Post Treatment Follow-up)|Other|0|||
48749043|NCT03129100|156926560|FG003|Period 4 (Post Treatment Follow-up)|Other|0|||
48749044|NCT03129100|156926561|FG004|Period 4 (Post Treatment Follow-up)|Other|0|||
48861785|NCT00748098|157331106|FG001|First Treatment Intervention Period|Lost to Follow-up|0|||
48861786|NCT00748098|157331105|FG000|First Treatment Intervention Period|Withdrawal by Subject|2|||
48955401|NCT02577406|157665609|FG000|Treatment Period|Lost to Follow-up|0|||
48955402|NCT02577406|157665610|FG001|Treatment Period|Lost to Follow-up|1|||
48861787|NCT00748098|157331106|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
48955403|NCT02577406|157665609|FG000|Treatment Period|Protocol Violation|0|||
48955404|NCT02577406|157665610|FG001|Treatment Period|Protocol Violation|1|||
48749045|NCT03129100|156926562|FG005|Period 4 (Post Treatment Follow-up)|Other|0|||
48749046|NCT03129100|156926563|FG006|Period 4 (Post Treatment Follow-up)|Other|0|||
48749047|NCT03129100|156926564|FG007|Period 4 (Post Treatment Follow-up)|Other|0|||
48749048|NCT03129100|156926565|FG008|Period 4 (Post Treatment Follow-up)|Other|0|||
48749049|NCT03129100|156926566|FG009|Period 4 (Post Treatment Follow-up)|Other|0|||
48749050|NCT03129100|156926567|FG010|Period 4 (Post Treatment Follow-up)|Other|0|||
48749051|NCT03129100|156926568|FG011|Period 4 (Post Treatment Follow-up)|Other|0|||
48749052|NCT03129100|156926569|FG012|Period 4 (Post Treatment Follow-up)|Other|0|||
48749053|NCT03129100|156926570|FG013|Period 4 (Post Treatment Follow-up)|Other|0|||
48749054|NCT03129100|156926571|FG014|Period 4 (Post Treatment Follow-up)|Other|0|||
48749055|NCT03129100|156926572|FG015|Period 4 (Post Treatment Follow-up)|Other|0|||
48749056|NCT03129100|156926573|FG016|Period 4 (Post Treatment Follow-up)|Other|0|||
48749057|NCT03129100|156926574|FG017|Period 4 (Post Treatment Follow-up)|Other|0|||
48749058|NCT03129100|156926575|FG018|Period 4 (Post Treatment Follow-up)|Other|0|||
48749059|NCT03129100|156926576|FG019|Period 4 (Post Treatment Follow-up)|Other|0|||
48749060|NCT03129100|156926577|FG020|Period 4 (Post Treatment Follow-up)|Other|0|||
48749061|NCT03129100|156926578|FG021|Period 4 (Post Treatment Follow-up)|Other|0|||
48749062|NCT03129100|156926579|FG022|Period 4 (Post Treatment Follow-up)|Other|0|||
48749063|NCT03129100|156926580|FG023|Period 4 (Post Treatment Follow-up)|Other|0|||
48861788|NCT00748098|157331105|FG000|First Taper Period|Protocol Violation|1|||
48861789|NCT00748098|157331106|FG001|First Taper Period|Protocol Violation|0|||
48861790|NCT00748098|157331105|FG000|First Taper Period|Withdrawal by Subject|2|||
48861791|NCT00748098|157331106|FG001|First Taper Period|Withdrawal by Subject|0|||
48861792|NCT00748098|157331105|FG000|First Taper Period|Protocol Stopping Criteria Met|0|||
48861793|NCT00748098|157331106|FG001|First Taper Period|Protocol Stopping Criteria Met|1|||
48861794|NCT00748098|157331105|FG000|1-Week Washout Period|Adverse Event|0|||
48861795|NCT00748098|157331106|FG001|1-Week Washout Period|Adverse Event|1|||
48861796|NCT00748098|157331105|FG000|1-Week Washout Period|Withdrawal by Subject|2|||
48861797|NCT00748098|157331106|FG001|1-Week Washout Period|Withdrawal by Subject|0|||
48861798|NCT00748098|157331105|FG000|Second Treatment Intervention Period|Adverse Event|4|||
48861799|NCT00748098|157331106|FG001|Second Treatment Intervention Period|Adverse Event|1|||
48861800|NCT00748098|157331105|FG000|Second Treatment Intervention Period|Lost to Follow-up|1|||
48861801|NCT00748098|157331106|FG001|Second Treatment Intervention Period|Lost to Follow-up|1|||
48861802|NCT00748098|157331105|FG000|Second Treatment Intervention Period|Withdrawal by Subject|1|||
48861803|NCT00748098|157331106|FG001|Second Treatment Intervention Period|Withdrawal by Subject|1|||
48861804|NCT01078571|157331107|FG000|Overall Study|Adverse Event|36|||
48861805|NCT01078571|157331107|FG000|Overall Study|Lack of effectiveness|36|||
48861806|NCT01078571|157331107|FG000|Overall Study|Reason not reported|21|||
48861807|NCT01078571|157331107|FG000|Overall Study|Withdrawal by Subject|12|||
48861808|NCT01078571|157331107|FG000|Overall Study|Lost to Follow-up|8|||
48861809|NCT01078571|157331107|FG000|Overall Study|Protocol Violation|2|||
48861810|NCT02213458|157331116|FG000|Overall Study|No longer meets criteria: caregiver deceased|4|||
48861811|NCT02213458|157331117|FG001|Overall Study|No longer meets criteria: caregiver deceased|0|||
48861812|NCT02213458|157331116|FG000|Overall Study|No longer meets criteria: caregiver no longer caregiving|4|||
48861813|NCT02213458|157331117|FG001|Overall Study|No longer meets criteria: caregiver no longer caregiving|0|||
48861814|NCT02213458|157331116|FG000|Overall Study|No longer meets criteria: caregiver too sick to participate|2|||
48861815|NCT02213458|157331117|FG001|Overall Study|No longer meets criteria: caregiver too sick to participate|0|||
48861816|NCT02213458|157331116|FG000|Overall Study|No longer meets criteria: patient moved out of state|10|||
48861817|NCT02213458|157331117|FG001|Overall Study|No longer meets criteria: patient moved out of state|0|||
48861818|NCT02213458|157331116|FG000|Overall Study|Refused re-consent|6|||
48861819|NCT02213458|157331117|FG001|Overall Study|Refused re-consent|0|||
48861820|NCT02213458|157331116|FG000|Overall Study|Lost to Follow-up|2|||
48861821|NCT02213458|157331117|FG001|Overall Study|Lost to Follow-up|2|||
48861822|NCT02213458|157331116|FG000|Overall Study|Withdrawal by Subject|26|||
48861823|NCT02213458|157331117|FG001|Overall Study|Withdrawal by Subject|8|||
48861824|NCT01257698|157331119|FG000|Overall Study|Protocol Violation|4|||
48861825|NCT01257698|157331120|FG001|Overall Study|Protocol Violation|0|||
48861826|NCT00665392|157331131|FG000|Overall Study|not treated|1|||
48861827|NCT03530345|157331138|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
48861828|NCT03530345|157331139|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0|||
48861829|NCT03530345|157331138|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
48861830|NCT03530345|157331139|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
48861831|NCT03530345|157331138|FG000|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17|||
48861832|NCT03530345|157331139|FG001|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21|||
48861833|NCT03530345|157331138|FG000|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5|||
48861834|NCT03530345|157331139|FG001|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7|||
48861835|NCT03406507|157331140|FG000|Extension Period|Lack of Efficacy|0|||
48861836|NCT03406507|157331141|FG001|Extension Period|Lack of Efficacy|1|||
48861837|NCT00663923|157331142|FG000|Overall Study|Lost to Follow-up|2|||
48861838|NCT05006703|157332998|FG000|Overall Study|Withdrawal by Subject|1|||
48861839|NCT05006703|157332999|FG001|Overall Study|Withdrawal by Subject|0|||
48861840|NCT05006703|157332998|FG000|Overall Study|Lost to Follow-up|13|||
48861841|NCT05006703|157332999|FG001|Overall Study|Lost to Follow-up|5|||
48861842|NCT04049578|157333001|FG000|Overall Study|Physician Decision|1|||
48861843|NCT02065895|157333002|FG000|Overall Study|Protocol Violation|1|||
48861844|NCT02065895|157333003|FG001|Overall Study|Protocol Violation|0|||
48861845|NCT02065895|157333004|FG002|Overall Study|Protocol Violation|0|||
48861846|NCT02065895|157333005|FG003|Overall Study|Protocol Violation|1|||
48861847|NCT02065895|157333006|FG004|Overall Study|Protocol Violation|0|||
48861848|NCT02065895|157333007|FG005|Overall Study|Protocol Violation|0|||
48861849|NCT02065895|157333002|FG000|Overall Study|Scheduling conflicts|0|||
48861850|NCT02065895|157333003|FG001|Overall Study|Scheduling conflicts|1|||
48861851|NCT02065895|157333004|FG002|Overall Study|Scheduling conflicts|0|||
48861852|NCT02065895|157333005|FG003|Overall Study|Scheduling conflicts|0|||
48861853|NCT02065895|157333006|FG004|Overall Study|Scheduling conflicts|0|||
48861854|NCT02065895|157333007|FG005|Overall Study|Scheduling conflicts|0|||
48861855|NCT02011568|157333008|FG000|Overall Study|Withdrawal by Subject|8|||
48861856|NCT02011568|157333009|FG001|Overall Study|Withdrawal by Subject|10|||
48749064|NCT03129100|156926581|FG024|Period 4 (Post Treatment Follow-up)|Other|0|||
48749065|NCT03129100|156926582|FG025|Period 4 (Post Treatment Follow-up)|Other|2|||
48749066|NCT02725710|156926583|FG000|Overall Study|Lost to Follow-up|1|||
48749067|NCT02725710|156926584|FG001|Overall Study|Lost to Follow-up|0|||
48749068|NCT00230607|156926591|FG000|Overall Study|Other|3|||
48749069|NCT03667924|156926599|FG000|Baseline Completed|Lost to Follow-up|0|||
48749070|NCT03667924|156926600|FG001|Baseline Completed|Lost to Follow-up|2|||
48749071|NCT03667924|156926601|FG002|Baseline Completed|Lost to Follow-up|0|||
48749072|NCT03667924|156926599|FG000|1-month Completed/Training (Volunteers)|One client was hospitalized;|1|||
48749073|NCT03667924|156926600|FG001|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
48749074|NCT03667924|156926601|FG002|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
48749075|NCT03667924|156926599|FG000|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
48749076|NCT03667924|156926600|FG001|1-month Completed/Training (Volunteers)|Did not complete full training|16|||
48749077|NCT03667924|156926601|FG002|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
48749078|NCT03667924|156926599|FG000|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
48749079|NCT03667924|156926600|FG001|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
48749080|NCT03667924|156926601|FG002|1-month Completed/Training (Volunteers)|Lost to Follow-up|1|||
48749081|NCT03667924|156926599|FG000|3-month/Volunteers Who Enrolled Clients|Death|1|||
48861857|NCT02011568|157333008|FG000|Overall Study|Physician Decision|1|||
48861858|NCT02011568|157333009|FG001|Overall Study|Physician Decision|3|||
48861859|NCT01807234|157333010|FG000|Overall Study|Lost to Follow-up|2|||
48861860|NCT01807234|157333011|FG001|Overall Study|Lost to Follow-up|5|||
48861861|NCT01807234|157333012|FG002|Overall Study|Lost to Follow-up|1|||
48861862|NCT01807234|157333013|FG003|Overall Study|Lost to Follow-up|1|||
48861863|NCT01807234|157333014|FG004|Overall Study|Lost to Follow-up|1|||
48861864|NCT01807234|157333015|FG005|Overall Study|Lost to Follow-up|2|||
48861865|NCT01807234|157333010|FG000|Overall Study|Withdrawal by Subject|3|||
48861866|NCT01807234|157333011|FG001|Overall Study|Withdrawal by Subject|1|||
48861867|NCT01807234|157333012|FG002|Overall Study|Withdrawal by Subject|1|||
48861868|NCT01807234|157333013|FG003|Overall Study|Withdrawal by Subject|1|||
48861869|NCT01807234|157333014|FG004|Overall Study|Withdrawal by Subject|2|||
48861870|NCT01807234|157333015|FG005|Overall Study|Withdrawal by Subject|1|||
48861871|NCT01807234|157333010|FG000|Overall Study|Lack of Efficacy|0|||
48861872|NCT01807234|157333011|FG001|Overall Study|Lack of Efficacy|0|||
48861873|NCT01807234|157333012|FG002|Overall Study|Lack of Efficacy|0|||
48861874|NCT01807234|157333013|FG003|Overall Study|Lack of Efficacy|0|||
48861875|NCT01807234|157333014|FG004|Overall Study|Lack of Efficacy|1|||
48955405|NCT03484923|157665611|FG000|Overall Study|Adverse Event|3|||
48955406|NCT03484923|157665612|FG001|Overall Study|Adverse Event|3|||
48955407|NCT03484923|157665613|FG002|Overall Study|Adverse Event|5|||
48955408|NCT03484923|157665614|FG003|Overall Study|Adverse Event|11|||
48955409|NCT03484923|157665615|FG004|Overall Study|Adverse Event|1|||
48955410|NCT03484923|157665611|FG000|Overall Study|Death|2|||
48955411|NCT03484923|157665612|FG001|Overall Study|Death|2|||
48955412|NCT03484923|157665613|FG002|Overall Study|Death|3|||
48955413|NCT03484923|157665614|FG003|Overall Study|Death|0|||
48955414|NCT03484923|157665615|FG004|Overall Study|Death|1|||
48955415|NCT03484923|157665611|FG000|Overall Study|Physician Decision|6|||
48955416|NCT03484923|157665612|FG001|Overall Study|Physician Decision|7|||
48955417|NCT03484923|157665613|FG002|Overall Study|Physician Decision|6|||
48955418|NCT03484923|157665614|FG003|Overall Study|Physician Decision|3|||
48955419|NCT03484923|157665615|FG004|Overall Study|Physician Decision|2|||
48955420|NCT03484923|157665611|FG000|Overall Study|Progressive disease|33|||
48955421|NCT03484923|157665612|FG001|Overall Study|Progressive disease|28|||
48955422|NCT03484923|157665613|FG002|Overall Study|Progressive disease|26|||
48955423|NCT03484923|157665614|FG003|Overall Study|Progressive disease|30|||
48955424|NCT03484923|157665615|FG004|Overall Study|Progressive disease|16|||
48955425|NCT03484923|157665611|FG000|Overall Study|Subject Decision|1|||
48955426|NCT03484923|157665612|FG001|Overall Study|Subject Decision|3|||
48955427|NCT03484923|157665613|FG002|Overall Study|Subject Decision|3|||
48955428|NCT03484923|157665614|FG003|Overall Study|Subject Decision|0|||
48749082|NCT03667924|156926600|FG001|3-month/Volunteers Who Enrolled Clients|Death|0|||
48749083|NCT03667924|156926601|FG002|3-month/Volunteers Who Enrolled Clients|Death|0|||
48749084|NCT03667924|156926599|FG000|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
48749085|NCT03667924|156926600|FG001|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|10|||
48749086|NCT03667924|156926601|FG002|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
48749087|NCT03667924|156926599|FG000|Post-study Interview Completed|Lost to Follow-up|0|||
48955429|NCT03484923|157665615|FG004|Overall Study|Subject Decision|1|||
48955430|NCT03439748|157665618|FG000|Overall Study|Withdrawal by Subject|11|||
48955431|NCT03439748|157665619|FG001|Overall Study|Withdrawal by Subject|17|||
48955432|NCT00915005|157665622|FG000|Overall Study|Withdrawal by Subject|4|||
48955433|NCT00915005|157665623|FG001|Overall Study|Withdrawal by Subject|4|||
48955434|NCT00915005|157665622|FG000|Overall Study|Patient preferred protons therapy|6|||
49015392|NCT01533428|157892162|FG001|Overall Study|Lost to Follow-up|1|||
48749088|NCT03667924|156926600|FG001|Post-study Interview Completed|Lost to Follow-up|1|||
48749089|NCT03667924|156926601|FG002|Post-study Interview Completed|Lost to Follow-up|0|||
48749090|NCT00600483|156926604|FG000|Overall Study|Lost to Follow-up|26|||
48749091|NCT00600483|156926605|FG001|Overall Study|Lost to Follow-up|47|||
48749092|NCT00600483|156926604|FG000|Overall Study|Randomized but not treated|10|||
48749093|NCT00600483|156926605|FG001|Overall Study|Randomized but not treated|0|||
48861876|NCT01807234|157333015|FG005|Overall Study|Lack of Efficacy|1|||
48861877|NCT00538629|157333018|FG000|Overall Study|At subject's request|1|||
48861878|NCT00538629|157333018|FG000|Overall Study|Adverse Event|2|||
48861879|NCT00538629|157333018|FG000|Overall Study|Lack of Efficacy|12|||
48861880|NCT00538629|157333018|FG000|Overall Study|Lost to Follow-up|6|||
48861881|NCT00538629|157333018|FG000|Overall Study|Subject's untimely distrust of medicine|1|||
48861882|NCT01587703|157333023|FG000|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1|||
48861883|NCT01587703|157333024|FG001|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
48749094|NCT01317160|156926606|FG000|Overall Study|Incorrect inclusion|1|||
48861884|NCT01587703|157333025|FG002|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
48861885|NCT01587703|157333026|FG003|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
48861886|NCT01587703|157333027|FG004|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
48861887|NCT01587703|157333028|FG005|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
48749095|NCT01317160|156926607|FG001|Overall Study|Incorrect inclusion|1|||
48749096|NCT01317160|156926606|FG000|Overall Study|Lost to Follow-up|3|||
48749097|NCT01317160|156926607|FG001|Overall Study|Lost to Follow-up|3|||
48749098|NCT01317160|156926606|FG000|Overall Study|Withdrawal by Subject|0|||
48749099|NCT01317160|156926607|FG001|Overall Study|Withdrawal by Subject|2|||
48749100|NCT00691015|156928218|FG000|Overall Study|Refused further treatment|1|||
48749101|NCT00062374|156928219|FG000|Overall Study|Not treated|12|||
48749102|NCT00578812|156928220|FG000|Overall Study|Not treated|6|||
48749103|NCT00578812|156928221|FG001|Overall Study|Not treated|7|||
48749104|NCT04532164|156928224|FG000|Overall Study|Adverse Event|1|||
48749105|NCT04532164|156928224|FG000|Overall Study|Protocol Violation|5|||
48749106|NCT04532164|156928224|FG000|Overall Study|Lost to Follow-up|1|||
48749107|NCT04532164|156928224|FG000|Overall Study|Found to be Ineligible|3|||
48749108|NCT04532164|156928224|FG000|Overall Study|Withdrawal by Subject|14|||
48749109|NCT02599129|156928225|FG000|Overall Study|Lack of Efficacy|2|||
48749110|NCT02599129|156928226|FG001|Overall Study|Lack of Efficacy|2|||
48749111|NCT02599129|156928225|FG000|Overall Study|Lost to Follow-up|1|||
48749112|NCT02599129|156928226|FG001|Overall Study|Lost to Follow-up|0|||
48749113|NCT02599129|156928225|FG000|Overall Study|Withdrawal by Subject|2|||
48749114|NCT02599129|156928226|FG001|Overall Study|Withdrawal by Subject|1|||
48749115|NCT01599234|156928228|FG000|Overall Study|Adverse Event|9|||
48749116|NCT01599234|156928229|FG001|Overall Study|Adverse Event|5|||
48861888|NCT01587703|157333029|FG006|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
48861889|NCT01587703|157333030|FG007|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
48861890|NCT01587703|157333031|FG008|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
48861891|NCT01587703|157333032|FG009|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
48861892|NCT01587703|157333033|FG010|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
48861893|NCT01587703|157333034|FG011|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
48861894|NCT01587703|157333035|FG012|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
48861895|NCT01587703|157333036|FG013|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
48861896|NCT01587703|157333037|FG014|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
48861897|NCT01587703|157333038|FG015|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
48861898|NCT01587703|157333039|FG016|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
48861899|NCT01587703|157333040|FG017|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
48861900|NCT01587703|157333041|FG018|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
48861901|NCT01587703|157333023|FG000|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
48861902|NCT01587703|157333024|FG001|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
48861903|NCT01587703|157333025|FG002|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
48861904|NCT01587703|157333026|FG003|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
48861905|NCT01587703|157333027|FG004|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
48861906|NCT01587703|157333028|FG005|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1|||
48861907|NCT01587703|157333029|FG006|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
48861908|NCT01587703|157333030|FG007|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2|||
48861909|NCT01587703|157333031|FG008|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
48861910|NCT01587703|157333032|FG009|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
48861911|NCT01587703|157333033|FG010|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
48861912|NCT01587703|157333034|FG011|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
48861913|NCT01587703|157333035|FG012|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
48861914|NCT01587703|157333036|FG013|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
48861915|NCT01587703|157333037|FG014|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
48861916|NCT01587703|157333038|FG015|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
48861917|NCT01587703|157333039|FG016|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
48861918|NCT01587703|157333040|FG017|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
48861919|NCT01587703|157333041|FG018|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
48861920|NCT01587703|157333023|FG000|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
48861921|NCT01587703|157333024|FG001|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
48861922|NCT01587703|157333025|FG002|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
48861923|NCT01587703|157333026|FG003|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
48861924|NCT01587703|157333027|FG004|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
48861925|NCT01587703|157333028|FG005|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
48861926|NCT01587703|157333029|FG006|Part1 QD(Median Exposure of 1.38months)|Site closed|2|||
48861927|NCT01587703|157333030|FG007|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
48861928|NCT01587703|157333031|FG008|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
48861929|NCT01587703|157333032|FG009|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
48749117|NCT01599234|156928228|FG000|Overall Study|Withdrawal by Subject|2|||
48749118|NCT01599234|156928229|FG001|Overall Study|Withdrawal by Subject|1|||
48749119|NCT01599234|156928228|FG000|Overall Study|Lost to Follow-up|1|||
48749120|NCT01599234|156928229|FG001|Overall Study|Lost to Follow-up|2|||
48749121|NCT01599234|156928228|FG000|Overall Study|Lack of Efficacy|2|||
48955435|NCT00915005|157665623|FG001|Overall Study|Patient preferred protons therapy|0|||
48955436|NCT00915005|157665622|FG000|Overall Study|Insurance denial|3|||
48955437|NCT00915005|157665623|FG001|Overall Study|Insurance denial|15|||
48955438|NCT05131451|157665624|FG000|Overall Study|Protocol Violation|1|||
48955439|NCT05131451|157665625|FG001|Overall Study|Protocol Violation|0|||
48955440|NCT01028651|157665626|FG000|Overall Study|Death|2|||
48955441|NCT01028651|157665626|FG000|Overall Study|Adverse Event|1|||
48955442|NCT03554005|157665627|FG000|Overall Study|Not in participant's best interest|0|||
48955443|NCT03554005|157665628|FG001|Overall Study|Not in participant's best interest|0|||
48955444|NCT03554005|157665629|FG002|Overall Study|Not in participant's best interest|0|||
48955445|NCT03554005|157665630|FG003|Overall Study|Not in participant's best interest|0|||
48955446|NCT03554005|157665631|FG004|Overall Study|Not in participant's best interest|0|||
48955447|NCT03554005|157665632|FG005|Overall Study|Not in participant's best interest|1|||
48955448|NCT03554005|157665627|FG000|Overall Study|Disease Progression|1|||
48955449|NCT03554005|157665628|FG001|Overall Study|Disease Progression|1|||
48955450|NCT03554005|157665629|FG002|Overall Study|Disease Progression|1|||
48955451|NCT03554005|157665630|FG003|Overall Study|Disease Progression|1|||
48955452|NCT03554005|157665631|FG004|Overall Study|Disease Progression|5|||
48955453|NCT03554005|157665632|FG005|Overall Study|Disease Progression|6|||
48955454|NCT03554005|157665627|FG000|Overall Study|Adverse Event|0|||
48955455|NCT03554005|157665628|FG001|Overall Study|Adverse Event|0|||
48955456|NCT03554005|157665629|FG002|Overall Study|Adverse Event|0|||
48955457|NCT03554005|157665630|FG003|Overall Study|Adverse Event|0|||
48955458|NCT03554005|157665631|FG004|Overall Study|Adverse Event|0|||
48955459|NCT03554005|157665632|FG005|Overall Study|Adverse Event|3|||
48955460|NCT03554005|157665627|FG000|Overall Study|Physician Decision|0|||
48955461|NCT03554005|157665628|FG001|Overall Study|Physician Decision|0|||
48955462|NCT03554005|157665629|FG002|Overall Study|Physician Decision|0|||
48955463|NCT03554005|157665630|FG003|Overall Study|Physician Decision|0|||
48955464|NCT03554005|157665631|FG004|Overall Study|Physician Decision|1|||
48955465|NCT03554005|157665632|FG005|Overall Study|Physician Decision|0|||
48955466|NCT03554005|157665627|FG000|Overall Study|Other|0|||
48955467|NCT03554005|157665628|FG001|Overall Study|Other|0|||
48955468|NCT03554005|157665629|FG002|Overall Study|Other|0|||
48955469|NCT03554005|157665630|FG003|Overall Study|Other|0|||
48955470|NCT03554005|157665631|FG004|Overall Study|Other|0|||
48955471|NCT03554005|157665632|FG005|Overall Study|Other|1|||
48955472|NCT00631488|157665636|FG000|Overall Study|Adverse Event|1|||
48955473|NCT00631488|157665637|FG001|Overall Study|Adverse Event|0|||
48955474|NCT00631488|157665638|FG002|Overall Study|Adverse Event|0|||
48955475|NCT00631488|157665636|FG000|Overall Study|Lost to Follow-up|2|||
48955476|NCT00631488|157665637|FG001|Overall Study|Lost to Follow-up|2|||
48955477|NCT00631488|157665638|FG002|Overall Study|Lost to Follow-up|0|||
48955478|NCT00631488|157665636|FG000|Overall Study|Physician Decision|1|||
48955479|NCT00631488|157665637|FG001|Overall Study|Physician Decision|0|||
48955480|NCT00631488|157665638|FG002|Overall Study|Physician Decision|1|||
48955481|NCT00631488|157665636|FG000|Overall Study|Protocol Violation|0|||
48955482|NCT00631488|157665637|FG001|Overall Study|Protocol Violation|0|||
48955483|NCT00631488|157665638|FG002|Overall Study|Protocol Violation|1|||
48955484|NCT02855411|157665643|FG000|Overall Study|Study terminated by sponsor|21|||
48955485|NCT02855411|157665643|FG000|Overall Study|Does not meet entrance criteria|14|||
48955486|NCT00907881|157665644|FG000|Overall Study|Lost to Follow-up|59|||
48955487|NCT00907881|157665644|FG000|Overall Study|Noncompliance|5|||
48955488|NCT00907881|157665644|FG000|Overall Study|Withdrawal by Subject|5|||
48955489|NCT00907881|157665644|FG000|Overall Study|Protocol Violation|1|||
48955490|NCT00907881|157665644|FG000|Overall Study|Missing discontinuation information|15|||
48955491|NCT03430245|157665645|FG000|Overall Study|Withdrawal by Subject|6|||
48955492|NCT03430245|157665645|FG000|Overall Study|Lost to Follow-up|1|||
48955493|NCT01554956|157665646|FG000|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
48955494|NCT01554956|157665647|FG001|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|1|||
48955495|NCT01554956|157665648|FG002|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
48955496|NCT01554956|157665646|FG000|Part 2 (Continuation Segment)|Withdrawal by Subject|0|||
48955497|NCT01554956|157665647|FG001|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
48955498|NCT01554956|157665648|FG002|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
48955499|NCT01554956|157665646|FG000|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|2|||
48955500|NCT01554956|157665647|FG001|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|4|||
48955501|NCT01554956|157665648|FG002|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|0|||
48955502|NCT05603143|157665649|FG000|Overall Study|Withdrew consent|6|||
48955503|NCT05603143|157665650|FG001|Overall Study|Withdrew consent|2|||
48955504|NCT05603143|157665649|FG000|Overall Study|Randomized but never treated|0|||
48955505|NCT05603143|157665650|FG001|Overall Study|Randomized but never treated|3|||
48955506|NCT05603143|157665649|FG000|Overall Study|Adverse Event|2|||
48955507|NCT05603143|157665650|FG001|Overall Study|Adverse Event|0|||
48955508|NCT05603143|157665649|FG000|Overall Study|Death|0|||
48955509|NCT05603143|157665650|FG001|Overall Study|Death|1|||
48955510|NCT05603143|157665649|FG000|Overall Study|Investigator's discretion|1|||
48955511|NCT05603143|157665650|FG001|Overall Study|Investigator's discretion|0|||
48955512|NCT05603143|157665649|FG000|Overall Study|Lost to Follow-up|0|||
48955513|NCT05603143|157665650|FG001|Overall Study|Lost to Follow-up|1|||
48955514|NCT05603143|157665649|FG000|Overall Study|Protocol Violation|0|||
48955515|NCT05603143|157665650|FG001|Overall Study|Protocol Violation|1|||
48955516|NCT03603600|157665651|FG000|Overall Study|Withdrawal by Subject|5|||
48955517|NCT03603600|157665652|FG001|Overall Study|Withdrawal by Subject|7|||
48955518|NCT03603600|157665651|FG000|Overall Study|Lost to Follow-up|2|||
48955519|NCT03603600|157665652|FG001|Overall Study|Lost to Follow-up|3|||
48955520|NCT03603600|157665651|FG000|Overall Study|Death|3|||
48955521|NCT03603600|157665652|FG001|Overall Study|Death|1|||
48955522|NCT03603600|157665651|FG000|Overall Study|Physician Decision|2|||
48955523|NCT03603600|157665652|FG001|Overall Study|Physician Decision|1|||
48955524|NCT03603600|157665651|FG000|Overall Study|Other reason|1|||
48955525|NCT03603600|157665652|FG001|Overall Study|Other reason|0|||
48955526|NCT01576016|157665653|FG000|Lead Safety|Death|132|||
48955527|NCT01576016|157665654|FG001|Lead Safety|Death|0|||
48955528|NCT01576016|157665653|FG000|Lead Safety|Withdrawal by Subject|81|||
48955529|NCT01576016|157665654|FG001|Lead Safety|Withdrawal by Subject|0|||
48955530|NCT01576016|157665653|FG000|Lead Safety|System Explanted without Replacement|24|||
48955531|NCT01576016|157665654|FG001|Lead Safety|System Explanted without Replacement|0|||
48955532|NCT01576016|157665653|FG000|Lead Safety|Physician Decision|14|||
48955533|NCT01576016|157665654|FG001|Lead Safety|Physician Decision|0|||
48955534|NCT01576016|157665653|FG000|Lead Safety|Lost to Follow-up|13|||
48955535|NCT01576016|157665654|FG001|Lead Safety|Lost to Follow-up|0|||
48955536|NCT01576016|157665653|FG000|Lead Safety|Unsuccessful implant|2|||
48955537|NCT01576016|157665654|FG001|Lead Safety|Unsuccessful implant|0|||
48955538|NCT01576016|157665653|FG000|Lead Safety|Sponsor request|1|||
48955539|NCT01576016|157665654|FG001|Lead Safety|Sponsor request|0|||
48955540|NCT01576016|157665653|FG000|Lead Safety|Device replaced with CRT-D|1|||
48955541|NCT01576016|157665654|FG001|Lead Safety|Device replaced with CRT-D|0|||
48955542|NCT01576016|157665653|FG000|Lead Safety|Patient on Palliative Care|1|||
48955543|NCT01576016|157665654|FG001|Lead Safety|Patient on Palliative Care|0|||
48955544|NCT01576016|157665653|FG000|Lead Safety|Patient noncompliance|1|||
48955545|NCT01576016|157665654|FG001|Lead Safety|Patient noncompliance|0|||
48955546|NCT01576016|157665653|FG000|Lead Safety|Too far from study site|1|||
48955547|NCT01576016|157665654|FG001|Lead Safety|Too far from study site|0|||
48955548|NCT01576016|157665653|FG000|Lead Safety|System deactivated|1|||
48955549|NCT01576016|157665654|FG001|Lead Safety|System deactivated|0|||
48955550|NCT01576016|157665653|FG000|Lead Safety|Patient no longer followed by study PI|1|||
48955551|NCT01576016|157665654|FG001|Lead Safety|Patient no longer followed by study PI|0|||
48955552|NCT01576016|157665653|FG000|MRI Safety|Withdrawal by Subject|0|||
48955553|NCT01576016|157665654|FG001|MRI Safety|Withdrawal by Subject|10|||
48955554|NCT01576016|157665653|FG000|MRI Safety|Non-MRI Compatible Device or Material|0|||
48955555|NCT01576016|157665654|FG001|MRI Safety|Non-MRI Compatible Device or Material|5|||
48955556|NCT01576016|157665653|FG000|MRI Safety|Has not yet completed MRI scan|0|||
48955557|NCT01576016|157665654|FG001|MRI Safety|Has not yet completed MRI scan|56|||
48955558|NCT01576016|157665653|FG000|MRI Safety|MRI scan not performed at MRI visit|0|||
48955559|NCT01576016|157665654|FG001|MRI Safety|MRI scan not performed at MRI visit|3|||
48955560|NCT02145156|157665655|FG000|Overall Study|No match to vaccination records|60|||
48955561|NCT02145156|157665656|FG001|Overall Study|No match to vaccination records|52|||
48955562|NCT02145156|157665657|FG002|Overall Study|No match to vaccination records|41|||
48955563|NCT03350750|157665659|FG000|Overall Study|Death|1|||
48955564|NCT03350750|157665660|FG001|Overall Study|Death|1|||
48955565|NCT01120093|157665663|FG000|Treatment Period 1|Adverse Event|0|||
48955566|NCT01120093|157665664|FG001|Treatment Period 1|Adverse Event|0|||
48955567|NCT01120093|157665665|FG002|Treatment Period 1|Adverse Event|1|||
48955568|NCT01120093|157665666|FG003|Treatment Period 1|Adverse Event|0|||
48955569|NCT01120093|157665667|FG004|Treatment Period 1|Adverse Event|1|||
48955570|NCT01120093|157665663|FG000|Treatment Period 1|Withdrawal by Subject|0|||
48955571|NCT01120093|157665664|FG001|Treatment Period 1|Withdrawal by Subject|1|||
48955572|NCT01120093|157665665|FG002|Treatment Period 1|Withdrawal by Subject|0|||
48955573|NCT01120093|157665666|FG003|Treatment Period 1|Withdrawal by Subject|0|||
48955574|NCT01120093|157665667|FG004|Treatment Period 1|Withdrawal by Subject|0|||
48955575|NCT01120093|157665663|FG000|Treatment Period 2|Adverse Event|0|||
48955576|NCT01120093|157665664|FG001|Treatment Period 2|Adverse Event|0|||
48955577|NCT01120093|157665665|FG002|Treatment Period 2|Adverse Event|0|||
48955578|NCT01120093|157665666|FG003|Treatment Period 2|Adverse Event|1|||
48749122|NCT01599234|156928229|FG001|Overall Study|Lack of Efficacy|4|||
48749123|NCT01599234|156928228|FG000|Overall Study|Unable to operate spray|1|||
48749124|NCT01599234|156928229|FG001|Overall Study|Unable to operate spray|0|||
48749125|NCT01599234|156928228|FG000|Overall Study|Sponsor request as creatinine levels <50|0|||
48749126|NCT01599234|156928229|FG001|Overall Study|Sponsor request as creatinine levels <50|1|||
48749127|NCT01599234|156928228|FG000|Overall Study|Death|1|||
48749128|NCT01599234|156928229|FG001|Overall Study|Death|0|||
48749129|NCT01599234|156928228|FG000|Overall Study|Patient would not stop driving|1|||
48749130|NCT01599234|156928229|FG001|Overall Study|Patient would not stop driving|0|||
48749131|NCT01599234|156928228|FG000|Overall Study|Contra-indication discovered|0|||
48749132|NCT01599234|156928229|FG001|Overall Study|Contra-indication discovered|1|||
48749133|NCT01599234|156928228|FG000|Overall Study|Pregnancy|0|||
48749134|NCT01599234|156928229|FG001|Overall Study|Pregnancy|1|||
48749135|NCT01401283|156928230|FG000|Overall Study|surgery cancelled|5|||
48749136|NCT01401283|156928231|FG001|Overall Study|surgery cancelled|8|||
48749137|NCT01401283|156928230|FG000|Overall Study|preoperative arrhythmia|5|||
48749138|NCT01401283|156928231|FG001|Overall Study|preoperative arrhythmia|0|||
48749139|NCT01401283|156928230|FG000|Overall Study|no central venous access|0|||
48749140|NCT01401283|156928231|FG001|Overall Study|no central venous access|1|||
48749141|NCT01401283|156928230|FG000|Overall Study|suspicion of malignant hyperthermia|0|||
48749142|NCT01401283|156928231|FG001|Overall Study|suspicion of malignant hyperthermia|1|||
48749143|NCT02433483|156928232|FG000|Overall Study|Unacceptable toxicity|1|||
48749144|NCT02433483|156928232|FG000|Overall Study|Other antineoplastic therapy/HSCT|1|||
48749145|NCT05035550|156928233|FG000|Overall Study|Withdrawal by Subject|3|||
48749146|NCT05035550|156928234|FG001|Overall Study|Withdrawal by Subject|0|||
48749147|NCT01508650|156928236|FG000|Overall Study|Lost to Follow-up|0|||
48749148|NCT01508650|156928237|FG001|Overall Study|Lost to Follow-up|3|||
48955579|NCT01120093|157665667|FG004|Treatment Period 2|Adverse Event|0|||
48955580|NCT01120093|157665663|FG000|Treatment Period 2|Withdrawal by Subject|0|||
48955581|NCT01120093|157665664|FG001|Treatment Period 2|Withdrawal by Subject|0|||
48955582|NCT01120093|157665665|FG002|Treatment Period 2|Withdrawal by Subject|0|||
48955583|NCT01120093|157665666|FG003|Treatment Period 2|Withdrawal by Subject|0|||
48955584|NCT01120093|157665667|FG004|Treatment Period 2|Withdrawal by Subject|1|||
48955585|NCT01120093|157665663|FG000|Treatment Period 3|Lack of Efficacy|0|||
48749149|NCT02692703|156928238|FG000|Overall Study|Lost to Follow-up|1|||
48749150|NCT02692703|156928238|FG000|Overall Study|Other|1|||
48749151|NCT03521934|156928239|FG000|Overall Study|Death|65|||
48955586|NCT01120093|157665664|FG001|Treatment Period 3|Lack of Efficacy|0|||
48749152|NCT03521934|156928240|FG001|Overall Study|Death|73|||
48749153|NCT03521934|156928239|FG000|Overall Study|Withdrawal by Subject|18|||
48749154|NCT03521934|156928240|FG001|Overall Study|Withdrawal by Subject|23|||
48749155|NCT03521934|156928239|FG000|Overall Study|Site Terminated by Sponsor|39|||
48749156|NCT03521934|156928240|FG001|Overall Study|Site Terminated by Sponsor|35|||
48749157|NCT03521934|156928239|FG000|Overall Study|Study Terminated by Sponsor|483|||
48749158|NCT03521934|156928240|FG001|Overall Study|Study Terminated by Sponsor|477|||
48749159|NCT03521934|156928239|FG000|Overall Study|Reason not Specified|3|||
48749160|NCT03521934|156928240|FG001|Overall Study|Reason not Specified|6|||
48749161|NCT05048784|156928241|FG000|Period 1|Adverse Event|3|||
48749162|NCT05048784|156928242|FG001|Period 1|Adverse Event|1|||
48749163|NCT05048784|156928243|FG002|Period 1|Adverse Event|0|||
48749164|NCT05048784|156928244|FG003|Period 1|Adverse Event|0|||
48749165|NCT05048784|156928241|FG000|Period 2|Lost to Follow-up|0|||
48749166|NCT05048784|156928242|FG001|Period 2|Lost to Follow-up|1|||
48749167|NCT05048784|156928243|FG002|Period 2|Lost to Follow-up|0|||
48749168|NCT05048784|156928244|FG003|Period 2|Lost to Follow-up|0|||
48749169|NCT02101060|156928245|FG000|Overall Study|Adverse Event|1|||
48749170|NCT02101060|156928246|FG001|Overall Study|Adverse Event|0|||
48749171|NCT02101060|156928245|FG000|Overall Study|Withdrawal by Subject|1|||
48749172|NCT02101060|156928246|FG001|Overall Study|Withdrawal by Subject|1|||
48749173|NCT02101060|156928245|FG000|Overall Study|Lost to Follow-up|3|||
48749174|NCT02101060|156928246|FG001|Overall Study|Lost to Follow-up|3|||
48749175|NCT03519932|156928247|FG000|First Intervention|Adverse Event|1|||
48749176|NCT03519932|156928248|FG001|First Intervention|Adverse Event|3|||
48749177|NCT02269241|156928249|FG000|Overall Study|Lost to Follow-up|269|||
48749178|NCT02269241|156928249|FG000|Overall Study|Withdrawal by Subject|155|||
48749179|NCT02269241|156928249|FG000|Overall Study|Protocol Violation|1|||
48749180|NCT02269241|156928249|FG000|Overall Study|Physician Decision|7|||
48749181|NCT02269241|156928249|FG000|Overall Study|Pregnancy|15|||
48749182|NCT02269241|156928249|FG000|Overall Study|Wish for pregnancy|5|||
48749183|NCT02269241|156928249|FG000|Overall Study|Development of an exclusion criteria|16|||
48749184|NCT02269241|156928249|FG000|Overall Study|Adverse Event|113|||
48749185|NCT02269241|156928249|FG000|Overall Study|At the specific request of the sponsor|20|||
48749186|NCT02269241|156928249|FG000|Overall Study|Several reasons not classified|53|||
48749187|NCT02269241|156928249|FG000|Overall Study|Screening failures|546|||
48749188|NCT01513473|156928250|FG000|Main Trial (26 Weeks)|Adverse Event|0|||
48692708|NCT04908683|156724585|FG001|Overall Study|Initiated prohibited medication|0|||
48692709|NCT04908683|156724584|FG000|Overall Study|Randomized by mistake|1|||
48692710|NCT04908683|156724585|FG001|Overall Study|Randomized by mistake|0|||
48692711|NCT04908683|156724584|FG000|Overall Study|Lost to Follow-up|679|||
48692712|NCT04908683|156724585|FG001|Overall Study|Lost to Follow-up|341|||
48692713|NCT04908683|156724584|FG000|Overall Study|Participant met eligibility criteria but were not needed|3|||
48692714|NCT04908683|156724585|FG001|Overall Study|Participant met eligibility criteria but were not needed|1|||
48692715|NCT04908683|156724584|FG000|Overall Study|Physician Decision|44|||
48692716|NCT04908683|156724585|FG001|Overall Study|Physician Decision|35|||
48692717|NCT04908683|156724584|FG000|Overall Study|Technical problems|12|||
48692718|NCT04908683|156724585|FG001|Overall Study|Technical problems|9|||
48692719|NCT04908683|156724584|FG000|Overall Study|Withdrawal by legally authorized representative|1|||
48692720|NCT04908683|156724585|FG001|Overall Study|Withdrawal by legally authorized representative|0|||
48692721|NCT04908683|156724584|FG000|Overall Study|Protocol Violation|2|||
48692722|NCT04908683|156724585|FG001|Overall Study|Protocol Violation|0|||
48749189|NCT01513473|156928251|FG001|Main Trial (26 Weeks)|Adverse Event|2|||
48749190|NCT01513473|156928250|FG000|Main Trial (26 Weeks)|Withdrawal by Subject|4|||
48749191|NCT01513473|156928251|FG001|Main Trial (26 Weeks)|Withdrawal by Subject|7|||
48749192|NCT01513473|156928250|FG000|Main Trial (26 Weeks)|Unclassified|0|||
48749193|NCT01513473|156928251|FG001|Main Trial (26 Weeks)|Unclassified|2|||
48749194|NCT01513473|156928250|FG000|Extension Trial (26 Weeks)|Adverse Event|0|||
48749195|NCT01513473|156928251|FG001|Extension Trial (26 Weeks)|Adverse Event|1|||
48749196|NCT01513473|156928250|FG000|Extension Trial (26 Weeks)|Withdrawal by Subject|1|||
48749197|NCT01513473|156928251|FG001|Extension Trial (26 Weeks)|Withdrawal by Subject|5|||
48861930|NCT01587703|157333033|FG010|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
48861931|NCT01587703|157333034|FG011|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
48692723|NCT04908683|156724584|FG000|Overall Study|Withdrawal by Subject|1188|||
48692724|NCT04908683|156724585|FG001|Overall Study|Withdrawal by Subject|570|||
48692725|NCT04908683|156724584|FG000|Overall Study|Site Closure by Sponsor|6|||
48749198|NCT01350414|156928258|FG000|Overall Study|Lost to Follow-up|13|||
48955587|NCT01120093|157665665|FG002|Treatment Period 3|Lack of Efficacy|0|||
48955588|NCT01120093|157665666|FG003|Treatment Period 3|Lack of Efficacy|1|||
48955589|NCT01120093|157665667|FG004|Treatment Period 3|Lack of Efficacy|0|||
48955590|NCT01120093|157665663|FG000|Treatment Period 3|Adverse Event|0|||
48955591|NCT01120093|157665664|FG001|Treatment Period 3|Adverse Event|0|||
48955592|NCT01120093|157665665|FG002|Treatment Period 3|Adverse Event|0|||
48955593|NCT01120093|157665666|FG003|Treatment Period 3|Adverse Event|0|||
48955594|NCT01120093|157665667|FG004|Treatment Period 3|Adverse Event|1|||
48955595|NCT01120093|157665663|FG000|Treatment Period 3|Withdrawal by Subject|0|||
48955596|NCT01120093|157665664|FG001|Treatment Period 3|Withdrawal by Subject|0|||
48955597|NCT01120093|157665665|FG002|Treatment Period 3|Withdrawal by Subject|1|||
48955598|NCT01120093|157665666|FG003|Treatment Period 3|Withdrawal by Subject|0|||
48955599|NCT01120093|157665667|FG004|Treatment Period 3|Withdrawal by Subject|0|||
48955600|NCT01120093|157665663|FG000|Treatment Period 4|Adverse Event|1|||
48955601|NCT01120093|157665664|FG001|Treatment Period 4|Adverse Event|0|||
48955602|NCT01120093|157665665|FG002|Treatment Period 4|Adverse Event|0|||
48955603|NCT01120093|157665666|FG003|Treatment Period 4|Adverse Event|0|||
48955604|NCT01120093|157665667|FG004|Treatment Period 4|Adverse Event|0|||
48955605|NCT01120093|157665663|FG000|Treatment Period 5|Adverse Event|0|||
48955606|NCT01120093|157665664|FG001|Treatment Period 5|Adverse Event|1|||
48955607|NCT01120093|157665665|FG002|Treatment Period 5|Adverse Event|0|||
48955608|NCT01120093|157665666|FG003|Treatment Period 5|Adverse Event|1|||
48955609|NCT01120093|157665667|FG004|Treatment Period 5|Adverse Event|0|||
48955610|NCT00532948|157665671|FG000|Overall Study|Protocol Violation|1|||
48955611|NCT00532948|157665672|FG001|Overall Study|Protocol Violation|0|||
48955612|NCT00532948|157665673|FG002|Overall Study|Protocol Violation|0|||
48955613|NCT00532948|157665671|FG000|Overall Study|Death|3|||
48955614|NCT00532948|157665672|FG001|Overall Study|Death|3|||
48955615|NCT00532948|157665673|FG002|Overall Study|Death|4|||
48955616|NCT00532948|157665671|FG000|Overall Study|Violation of selection criteria at entry|0|||
48955617|NCT00532948|157665672|FG001|Overall Study|Violation of selection criteria at entry|1|||
48955618|NCT00532948|157665673|FG002|Overall Study|Violation of selection criteria at entry|0|||
48955619|NCT00532948|157665671|FG000|Overall Study|Failure to return|0|||
48955620|NCT00532948|157665672|FG001|Overall Study|Failure to return|1|||
48955621|NCT00532948|157665673|FG002|Overall Study|Failure to return|0|||
48955622|NCT03710603|157665676|FG000|Overall Study|Adverse Event|1|||
48955623|NCT03710603|157665677|FG001|Overall Study|Adverse Event|0|||
48955624|NCT03710603|157665676|FG000|Overall Study|Death|44|||
48955625|NCT03710603|157665677|FG001|Overall Study|Death|34|||
48955626|NCT03710603|157665676|FG000|Overall Study|Lost to Follow-up|3|||
48955627|NCT03710603|157665677|FG001|Overall Study|Lost to Follow-up|5|||
48955628|NCT03710603|157665676|FG000|Overall Study|Withdrawal by Subject|11|||
48955629|NCT03710603|157665677|FG001|Overall Study|Withdrawal by Subject|10|||
48955630|NCT02575079|157665678|FG000|Overall Study|Death|3|||
48955631|NCT02575079|157665679|FG001|Overall Study|Death|0|||
48955632|NCT02575079|157665678|FG000|Overall Study|Withdrawal by Subject|3|||
48955633|NCT02575079|157665679|FG001|Overall Study|Withdrawal by Subject|0|||
48955634|NCT02951988|157665680|FG000|Open-Label Treatment Period|Miscellaneous Reasons|8|||
48955635|NCT02951988|157665681|FG001|Open-Label Treatment Period|Miscellaneous Reasons|0|||
48955636|NCT02951988|157665682|FG002|Open-Label Treatment Period|Miscellaneous Reasons|0|||
48955637|NCT02951988|157665683|FG003|Open-Label Treatment Period|Miscellaneous Reasons|0|||
48955638|NCT02951988|157665680|FG000|Open-Label Treatment Period|Study terminated by sponsor|9|||
48955639|NCT02951988|157665681|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
48955640|NCT02951988|157665682|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
48955641|NCT02951988|157665683|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
48955642|NCT02951988|157665680|FG000|Open-Label Treatment Period|Non-compliance with background ADT|2|||
48955643|NCT02951988|157665681|FG001|Open-Label Treatment Period|Non-compliance with background ADT|0|||
48955644|NCT02951988|157665682|FG002|Open-Label Treatment Period|Non-compliance with background ADT|0|||
48749199|NCT01350414|156928258|FG000|Overall Study|Withdrawal by Subject|4|||
48749200|NCT01350414|156928258|FG000|Overall Study|Physician Decision|2|||
48749201|NCT04016285|156928260|FG000|Overall Study|Did not progress to surgery|2|||
48749202|NCT04016285|156928261|FG001|Overall Study|Did not progress to surgery|5|||
48749203|NCT04016285|156928260|FG000|Overall Study|Failed to collect outcome data|5|||
48749204|NCT04016285|156928261|FG001|Overall Study|Failed to collect outcome data|3|||
48749205|NCT03716024|156928262|FG000|Overall Study|Randomized, not Treated|7|||
48749206|NCT03716024|156928263|FG001|Overall Study|Randomized, not Treated|8|||
48749207|NCT03716024|156928262|FG000|Overall Study|Adverse Event|1|||
48749208|NCT03716024|156928263|FG001|Overall Study|Adverse Event|2|||
48749209|NCT03716024|156928262|FG000|Overall Study|Treatment Failure|1|||
48749210|NCT03716024|156928263|FG001|Overall Study|Treatment Failure|0|||
48749211|NCT03716024|156928262|FG000|Overall Study|Lost to Follow-up|2|||
48749212|NCT03716024|156928263|FG001|Overall Study|Lost to Follow-up|6|||
48749213|NCT03716024|156928262|FG000|Overall Study|Withdrawal by Subject|0|||
48749214|NCT03716024|156928263|FG001|Overall Study|Withdrawal by Subject|1|||
48749215|NCT03716024|156928262|FG000|Overall Study|Missing Reason|0|||
48749216|NCT03716024|156928263|FG001|Overall Study|Missing Reason|1|||
48749217|NCT01218204|156928266|FG000|Part B Washout|Adverse Event|0|||
48749218|NCT01218204|156928267|FG001|Part B Washout|Adverse Event|1|||
48749219|NCT01218204|156928268|FG002|Part B Washout|Adverse Event|0|||
48749220|NCT01218204|156928269|FG003|Part B Washout|Adverse Event|0|||
48749221|NCT01218204|156928266|FG000|Part B Washout|Lost to Follow-up|0|||
48749222|NCT01218204|156928267|FG001|Part B Washout|Lost to Follow-up|2|||
48749223|NCT01218204|156928268|FG002|Part B Washout|Lost to Follow-up|0|||
48749224|NCT01218204|156928269|FG003|Part B Washout|Lost to Follow-up|0|||
48749225|NCT01218204|156928266|FG000|Part B Washout|Physician Decision|0|||
48749226|NCT01218204|156928267|FG001|Part B Washout|Physician Decision|14|||
48749227|NCT01218204|156928268|FG002|Part B Washout|Physician Decision|0|||
48749228|NCT01218204|156928269|FG003|Part B Washout|Physician Decision|0|||
48749229|NCT01218204|156928266|FG000|Part B Washout|Withdrawal by Subject|0|||
48749230|NCT01218204|156928267|FG001|Part B Washout|Withdrawal by Subject|14|||
48749231|NCT01218204|156928268|FG002|Part B Washout|Withdrawal by Subject|0|||
48749232|NCT01218204|156928269|FG003|Part B Washout|Withdrawal by Subject|0|||
48749233|NCT01218204|156928266|FG000|Part B Washout|Reached defined stopping criteria|0|||
48749234|NCT01218204|156928267|FG001|Part B Washout|Reached defined stopping criteria|2|||
48749235|NCT01218204|156928268|FG002|Part B Washout|Reached defined stopping criteria|0|||
48749236|NCT01218204|156928269|FG003|Part B Washout|Reached defined stopping criteria|0|||
48749237|NCT01218204|156928266|FG000|Part B Washout|Did not meet continuation criteria|0|||
48749238|NCT01218204|156928267|FG001|Part B Washout|Did not meet continuation criteria|112|||
48749239|NCT01218204|156928268|FG002|Part B Washout|Did not meet continuation criteria|0|||
48749240|NCT01218204|156928269|FG003|Part B Washout|Did not meet continuation criteria|0|||
48749241|NCT01218204|156928266|FG000|Part B Run-in|Adverse Event|0|||
48749242|NCT01218204|156928267|FG001|Part B Run-in|Adverse Event|0|||
48749243|NCT01218204|156928268|FG002|Part B Run-in|Adverse Event|1|||
48861932|NCT01587703|157333035|FG012|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
48861933|NCT01587703|157333036|FG013|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
48861934|NCT01587703|157333037|FG014|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
48861935|NCT01587703|157333038|FG015|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
48861936|NCT01587703|157333039|FG016|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
48861937|NCT01587703|157333040|FG017|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
48861938|NCT01587703|157333041|FG018|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
48861939|NCT01587703|157333023|FG000|Part1 QD(Median Exposure of 1.38months)|Death|2|||
48861940|NCT01587703|157333024|FG001|Part1 QD(Median Exposure of 1.38months)|Death|4|||
48861941|NCT01587703|157333025|FG002|Part1 QD(Median Exposure of 1.38months)|Death|1|||
48861942|NCT01587703|157333026|FG003|Part1 QD(Median Exposure of 1.38months)|Death|3|||
48861943|NCT01587703|157333027|FG004|Part1 QD(Median Exposure of 1.38months)|Death|4|||
48861944|NCT01587703|157333028|FG005|Part1 QD(Median Exposure of 1.38months)|Death|7|||
48861945|NCT01587703|157333029|FG006|Part1 QD(Median Exposure of 1.38months)|Death|30|||
48955645|NCT02951988|157665683|FG003|Open-Label Treatment Period|Non-compliance with background ADT|0|||
48955646|NCT02951988|157665680|FG000|Open-Label Treatment Period|Non-compliance with study drug|5|||
48955647|NCT02951988|157665681|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
48955648|NCT02951988|157665682|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
48955649|NCT02951988|157665683|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
48955650|NCT02951988|157665680|FG000|Open-Label Treatment Period|Protocol Violation|22|||
48955651|NCT02951988|157665681|FG001|Open-Label Treatment Period|Protocol Violation|0|||
48955652|NCT02951988|157665682|FG002|Open-Label Treatment Period|Protocol Violation|0|||
48955653|NCT02951988|157665683|FG003|Open-Label Treatment Period|Protocol Violation|0|||
48955654|NCT02951988|157665680|FG000|Open-Label Treatment Period|Pregnancy|2|||
48955655|NCT02951988|157665681|FG001|Open-Label Treatment Period|Pregnancy|0|||
48955656|NCT02951988|157665682|FG002|Open-Label Treatment Period|Pregnancy|0|||
48955657|NCT02951988|157665683|FG003|Open-Label Treatment Period|Pregnancy|0|||
48955658|NCT02951988|157665680|FG000|Open-Label Treatment Period|Lost to Follow-up|28|||
48955659|NCT02951988|157665681|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
48955660|NCT02951988|157665682|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
48955661|NCT02951988|157665683|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
48955662|NCT02951988|157665680|FG000|Open-Label Treatment Period|Withdrawal by Subject|78|||
48955663|NCT02951988|157665681|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
48955664|NCT02951988|157665682|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
48955665|NCT02951988|157665683|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
48955666|NCT02951988|157665680|FG000|Open-Label Treatment Period|Lack of Efficacy|49|||
48955667|NCT02951988|157665681|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
48955668|NCT02951988|157665682|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
48861946|NCT01587703|157333030|FG007|Part1 QD(Median Exposure of 1.38months)|Death|7|||
48861947|NCT01587703|157333031|FG008|Part1 QD(Median Exposure of 1.38months)|Death|0|||
48955669|NCT02951988|157665683|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
48955670|NCT02951988|157665680|FG000|Open-Label Treatment Period|Adverse Event|45|||
48955671|NCT02951988|157665681|FG001|Open-Label Treatment Period|Adverse Event|0|||
48749244|NCT01218204|156928269|FG003|Part B Run-in|Adverse Event|0|||
48749245|NCT01218204|156928266|FG000|Part B Run-in|Protocol Violation|0|||
48749246|NCT01218204|156928267|FG001|Part B Run-in|Protocol Violation|0|||
48861948|NCT01587703|157333032|FG009|Part1 QD(Median Exposure of 1.38months)|Death|0|||
48861949|NCT01587703|157333033|FG010|Part1 QD(Median Exposure of 1.38months)|Death|0|||
48861950|NCT01587703|157333034|FG011|Part1 QD(Median Exposure of 1.38months)|Death|0|||
48861951|NCT01587703|157333035|FG012|Part1 QD(Median Exposure of 1.38months)|Death|0|||
48861952|NCT01587703|157333036|FG013|Part1 QD(Median Exposure of 1.38months)|Death|0|||
48861953|NCT01587703|157333037|FG014|Part1 QD(Median Exposure of 1.38months)|Death|0|||
48861954|NCT01587703|157333038|FG015|Part1 QD(Median Exposure of 1.38months)|Death|0|||
48861955|NCT01587703|157333039|FG016|Part1 QD(Median Exposure of 1.38months)|Death|0|||
48861956|NCT01587703|157333040|FG017|Part1 QD(Median Exposure of 1.38months)|Death|0|||
48861957|NCT01587703|157333041|FG018|Part1 QD(Median Exposure of 1.38months)|Death|0|||
48861958|NCT01587703|157333023|FG000|Part1 BID(Median Exposure of 1.41months)|Death|0|||
48861959|NCT01587703|157333024|FG001|Part1 BID(Median Exposure of 1.41months)|Death|0|||
48861960|NCT01587703|157333025|FG002|Part1 BID(Median Exposure of 1.41months)|Death|0|||
48861961|NCT01587703|157333026|FG003|Part1 BID(Median Exposure of 1.41months)|Death|0|||
48861962|NCT01587703|157333027|FG004|Part1 BID(Median Exposure of 1.41months)|Death|0|||
48861963|NCT01587703|157333028|FG005|Part1 BID(Median Exposure of 1.41months)|Death|0|||
48861964|NCT01587703|157333029|FG006|Part1 BID(Median Exposure of 1.41months)|Death|0|||
48861965|NCT01587703|157333030|FG007|Part1 BID(Median Exposure of 1.41months)|Death|0|||
48749247|NCT01218204|156928268|FG002|Part B Run-in|Protocol Violation|2|||
48749248|NCT01218204|156928269|FG003|Part B Run-in|Protocol Violation|0|||
48749249|NCT01218204|156928266|FG000|Part B Run-in|Withdrawal by Subject|0|||
48749250|NCT01218204|156928267|FG001|Part B Run-in|Withdrawal by Subject|0|||
48749251|NCT01218204|156928268|FG002|Part B Run-in|Withdrawal by Subject|3|||
48749252|NCT01218204|156928269|FG003|Part B Run-in|Withdrawal by Subject|0|||
48749253|NCT01218204|156928266|FG000|Part B Pooled Treatment Arm|Adverse Event|0|||
48749254|NCT01218204|156928267|FG001|Part B Pooled Treatment Arm|Adverse Event|0|||
48749255|NCT01218204|156928268|FG002|Part B Pooled Treatment Arm|Adverse Event|0|||
48749256|NCT01218204|156928269|FG003|Part B Pooled Treatment Arm|Adverse Event|2|||
48749257|NCT01218204|156928266|FG000|Part B Pooled Treatment Arm|Protocol Violation|0|||
48749258|NCT01218204|156928267|FG001|Part B Pooled Treatment Arm|Protocol Violation|0|||
48749259|NCT01218204|156928268|FG002|Part B Pooled Treatment Arm|Protocol Violation|0|||
48749260|NCT01218204|156928269|FG003|Part B Pooled Treatment Arm|Protocol Violation|1|||
48749261|NCT02573350|156928270|FG000|Overall Study|Lost to Follow-up|2|||
48749262|NCT02573350|156928271|FG001|Overall Study|Lost to Follow-up|1|||
48749263|NCT02573350|156928270|FG000|Overall Study|Adverse Event|3|||
48749264|NCT02573350|156928271|FG001|Overall Study|Adverse Event|4|||
48749265|NCT02573350|156928270|FG000|Overall Study|Subject met Withdrawal Criteria|1|||
48749266|NCT02573350|156928271|FG001|Overall Study|Subject met Withdrawal Criteria|1|||
48749267|NCT02573350|156928270|FG000|Overall Study|Subject was Withdrawn from Participation by the Investigator|3|||
48749268|NCT02573350|156928271|FG001|Overall Study|Subject was Withdrawn from Participation by the Investigator|1|||
48749269|NCT02573350|156928270|FG000|Overall Study|Subject withdrew consent to participate|6|||
48749270|NCT02573350|156928271|FG001|Overall Study|Subject withdrew consent to participate|1|||
48749271|NCT02573350|156928270|FG000|Overall Study|Protocol Deviation|1|||
48749272|NCT02573350|156928271|FG001|Overall Study|Protocol Deviation|1|||
48749273|NCT02708121|156928274|FG000|Overall Study|Withdrawn by Study Team|1|||
48749274|NCT02708121|156928275|FG001|Overall Study|Withdrawn by Study Team|1|||
48749275|NCT02708121|156928274|FG000|Overall Study|Withdrawal by Subject|0|||
48749276|NCT02708121|156928275|FG001|Overall Study|Withdrawal by Subject|4|||
48749277|NCT01425281|156928278|FG000|At 30-day Clinical Follow-up|Withdrawal by Subject|1|||
48749278|NCT01425281|156928279|FG001|At 30-day Clinical Follow-up|Withdrawal by Subject|0|||
48861966|NCT01587703|157333031|FG008|Part1 BID(Median Exposure of 1.41months)|Death|1|||
48861967|NCT01587703|157333032|FG009|Part1 BID(Median Exposure of 1.41months)|Death|9|||
48861968|NCT01587703|157333033|FG010|Part1 BID(Median Exposure of 1.41months)|Death|3|||
48749279|NCT01425281|156928278|FG000|At 180-day Clinical Follow-up|Withdrawal by Subject|3|||
48861969|NCT01587703|157333034|FG011|Part1 BID(Median Exposure of 1.41months)|Death|0|||
48749280|NCT01425281|156928279|FG001|At 180-day Clinical Follow-up|Withdrawal by Subject|0|||
48749281|NCT01425281|156928278|FG000|At 180-day Clinical Follow-up|Death|0|||
48749282|NCT01425281|156928279|FG001|At 180-day Clinical Follow-up|Death|1|||
48749283|NCT01425281|156928278|FG000|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
48749284|NCT01425281|156928279|FG001|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
48861970|NCT01587703|157333035|FG012|Part1 BID(Median Exposure of 1.41months)|Death|0|||
48861971|NCT01587703|157333036|FG013|Part1 BID(Median Exposure of 1.41months)|Death|0|||
48861972|NCT01587703|157333037|FG014|Part1 BID(Median Exposure of 1.41months)|Death|0|||
48861973|NCT01587703|157333038|FG015|Part1 BID(Median Exposure of 1.41months)|Death|0|||
48861974|NCT01587703|157333039|FG016|Part1 BID(Median Exposure of 1.41months)|Death|0|||
48861975|NCT01587703|157333040|FG017|Part1 BID(Median Exposure of 1.41months)|Death|0|||
48861976|NCT01587703|157333041|FG018|Part1 BID(Median Exposure of 1.41months)|Death|0|||
48861977|NCT01587703|157333023|FG000|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
48861978|NCT01587703|157333024|FG001|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
48861979|NCT01587703|157333025|FG002|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
48861980|NCT01587703|157333026|FG003|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
48861981|NCT01587703|157333027|FG004|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
48861982|NCT01587703|157333028|FG005|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
48861983|NCT01587703|157333029|FG006|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
48861984|NCT01587703|157333030|FG007|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
48861985|NCT01587703|157333031|FG008|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
48861986|NCT01587703|157333032|FG009|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
48861987|NCT01587703|157333033|FG010|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
48861988|NCT01587703|157333034|FG011|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
48861989|NCT01587703|157333035|FG012|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
48861990|NCT01587703|157333036|FG013|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
48861991|NCT01587703|157333037|FG014|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
48861992|NCT01587703|157333038|FG015|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
48861993|NCT01587703|157333039|FG016|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
48861994|NCT01587703|157333040|FG017|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
48861995|NCT01587703|157333041|FG018|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
48861996|NCT01587703|157333023|FG000|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
48861997|NCT01587703|157333024|FG001|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
48861998|NCT01587703|157333025|FG002|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
48861999|NCT01587703|157333026|FG003|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
48862000|NCT01587703|157333027|FG004|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
48862001|NCT01587703|157333028|FG005|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
48862002|NCT01587703|157333029|FG006|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
48862003|NCT01587703|157333030|FG007|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
48862004|NCT01587703|157333031|FG008|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
48862005|NCT01587703|157333032|FG009|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
48862006|NCT01587703|157333033|FG010|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
48862007|NCT01587703|157333034|FG011|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
48862008|NCT01587703|157333035|FG012|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
48862009|NCT01587703|157333036|FG013|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
48862010|NCT01587703|157333037|FG014|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
48862011|NCT01587703|157333038|FG015|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
48862012|NCT01587703|157333039|FG016|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
48862013|NCT01587703|157333040|FG017|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
48862014|NCT01587703|157333041|FG018|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
48862015|NCT01587703|157333023|FG000|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
48862016|NCT01587703|157333024|FG001|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
48862017|NCT01587703|157333025|FG002|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
48862018|NCT01587703|157333026|FG003|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
48862019|NCT01587703|157333027|FG004|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
48862020|NCT01587703|157333028|FG005|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
48862021|NCT01587703|157333029|FG006|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
48862022|NCT01587703|157333030|FG007|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
48862023|NCT01587703|157333031|FG008|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1|||
48862024|NCT01587703|157333032|FG009|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
48862025|NCT01587703|157333033|FG010|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
48749285|NCT01425281|156928278|FG000|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1|||
48749286|NCT01425281|156928279|FG001|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0|||
48749287|NCT01425281|156928278|FG000|At 2-year Clinical Follow-up|Withdrawal by Subject|2|||
48749288|NCT01425281|156928279|FG001|At 2-year Clinical Follow-up|Withdrawal by Subject|1|||
48749289|NCT01425281|156928278|FG000|At 2-year Clinical Follow-up|Death|2|||
48749290|NCT01425281|156928279|FG001|At 2-year Clinical Follow-up|Death|0|||
48749291|NCT01425281|156928278|FG000|At 2-year Clinical Follow-up|Lost to Follow-up|1|||
48749292|NCT01425281|156928279|FG001|At 2-year Clinical Follow-up|Lost to Follow-up|0|||
48749293|NCT01425281|156928278|FG000|At 2-year Clinical Follow-up|Patient did not want to participate in t|1|||
48749294|NCT01425281|156928279|FG001|At 2-year Clinical Follow-up|Patient did not want to participate in t|0|||
48749295|NCT01425281|156928278|FG000|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
48749296|NCT01425281|156928279|FG001|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
48749297|NCT01425281|156928278|FG000|At 3-year Clinical Follow-up|Death|2|||
48749298|NCT01425281|156928279|FG001|At 3-year Clinical Follow-up|Death|3|||
48749299|NCT01425281|156928278|FG000|At 4-year Clinical Follow-up|Death|7|||
48749300|NCT01425281|156928279|FG001|At 4-year Clinical Follow-up|Death|3|||
48749301|NCT01425281|156928278|FG000|At 4-year Clinical Follow-up|Withdrawal by Subject|3|||
48749302|NCT01425281|156928279|FG001|At 4-year Clinical Follow-up|Withdrawal by Subject|2|||
48749303|NCT01425281|156928278|FG000|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
48749304|NCT01425281|156928279|FG001|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
48749305|NCT01425281|156928278|FG000|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6|||
48749306|NCT01425281|156928279|FG001|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5|||
48749307|NCT01425281|156928278|FG000|At 4-year Clinical Follow-up|Lost to Follow-up|4|||
48862026|NCT01587703|157333034|FG011|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
48862027|NCT01587703|157333035|FG012|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
48862028|NCT01587703|157333036|FG013|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
48862029|NCT01587703|157333037|FG014|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
48862030|NCT01587703|157333038|FG015|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
48862031|NCT01587703|157333039|FG016|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
48862032|NCT01587703|157333040|FG017|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
48862033|NCT01587703|157333041|FG018|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
48862034|NCT01587703|157333023|FG000|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
48862035|NCT01587703|157333024|FG001|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
48862036|NCT01587703|157333025|FG002|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
48749308|NCT01425281|156928279|FG001|At 4-year Clinical Follow-up|Lost to Follow-up|1|||
48749309|NCT01425281|156928278|FG000|At 5-year Clinical Follow-up|Death|2|||
48749310|NCT01425281|156928279|FG001|At 5-year Clinical Follow-up|Death|0|||
48749311|NCT01425281|156928278|FG000|At 5-year Clinical Follow-up|Lost to Follow-up|2|||
48749312|NCT01425281|156928279|FG001|At 5-year Clinical Follow-up|Lost to Follow-up|1|||
48955672|NCT02951988|157665682|FG002|Open-Label Treatment Period|Adverse Event|0|||
48749313|NCT01425281|156928278|FG000|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19|||
48749314|NCT01425281|156928279|FG001|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7|||
48749315|NCT01425281|156928278|FG000|At 5-year Clinical Follow-up|Refused/terminated|9|||
48749316|NCT01425281|156928279|FG001|At 5-year Clinical Follow-up|Refused/terminated|3|||
48749317|NCT01833520|156928280|FG000|Overall Study|Lack of Efficacy|3|||
48749318|NCT01833520|156928281|FG001|Overall Study|Lack of Efficacy|3|||
48749319|NCT01833520|156928282|FG002|Overall Study|Lack of Efficacy|8|||
48749320|NCT01833520|156928283|FG003|Overall Study|Lack of Efficacy|3|||
48749321|NCT03247530|156928284|FG000|Overall Study|Withdrawal by caregiver|19|||
48749322|NCT03247530|156928285|FG001|Overall Study|Withdrawal by caregiver|8|||
48749323|NCT03247530|156928286|FG002|Overall Study|Withdrawal by caregiver|10|||
48749324|NCT03247530|156928284|FG000|Overall Study|Lost to Follow-up|3|||
48749325|NCT03247530|156928285|FG001|Overall Study|Lost to Follow-up|9|||
48955673|NCT02951988|157665683|FG003|Open-Label Treatment Period|Adverse Event|0|||
48955674|NCT02951988|157665680|FG000|Double-Blind Treatment Period|Site terminated by sponsor|0|||
48955675|NCT02951988|157665681|FG001|Double-Blind Treatment Period|Site terminated by sponsor|0|||
48955676|NCT02951988|157665682|FG002|Double-Blind Treatment Period|Site terminated by sponsor|1|||
48955677|NCT02951988|157665683|FG003|Double-Blind Treatment Period|Site terminated by sponsor|1|||
48955678|NCT02951988|157665680|FG000|Double-Blind Treatment Period|Study terminated by sponsor|0|||
48749326|NCT03247530|156928286|FG002|Overall Study|Lost to Follow-up|6|||
48749327|NCT03247530|156928284|FG000|Overall Study|Adverse Event|2|||
48749328|NCT03247530|156928285|FG001|Overall Study|Adverse Event|5|||
48749329|NCT03247530|156928286|FG002|Overall Study|Adverse Event|2|||
48955679|NCT02951988|157665681|FG001|Double-Blind Treatment Period|Study terminated by sponsor|58|||
48749330|NCT03247530|156928284|FG000|Overall Study|Failure to follow procedure|1|||
48749331|NCT03247530|156928285|FG001|Overall Study|Failure to follow procedure|1|||
48749332|NCT03247530|156928286|FG002|Overall Study|Failure to follow procedure|1|||
48749333|NCT03247530|156928284|FG000|Overall Study|Withdrawal by Subject|1|||
48955680|NCT02951988|157665682|FG002|Double-Blind Treatment Period|Study terminated by sponsor|54|||
48955681|NCT02951988|157665683|FG003|Double-Blind Treatment Period|Study terminated by sponsor|69|||
48955682|NCT02951988|157665680|FG000|Double-Blind Treatment Period|Non-compliance with study drug|0|||
48955683|NCT02951988|157665681|FG001|Double-Blind Treatment Period|Non-compliance with study drug|1|||
48955684|NCT02951988|157665682|FG002|Double-Blind Treatment Period|Non-compliance with study drug|3|||
48955685|NCT02951988|157665683|FG003|Double-Blind Treatment Period|Non-compliance with study drug|0|||
48955686|NCT02951988|157665680|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
48955687|NCT02951988|157665681|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
48749334|NCT03247530|156928285|FG001|Overall Study|Withdrawal by Subject|1|||
48749335|NCT03247530|156928286|FG002|Overall Study|Withdrawal by Subject|0|||
48749336|NCT03247530|156928284|FG000|Overall Study|Study medication misuse|0|||
48749337|NCT03247530|156928285|FG001|Overall Study|Study medication misuse|1|||
48749338|NCT03247530|156928286|FG002|Overall Study|Study medication misuse|0|||
48749339|NCT03247530|156928284|FG000|Overall Study|Other, multiple categories|1|||
48749340|NCT03247530|156928285|FG001|Overall Study|Other, multiple categories|3|||
48749341|NCT03247530|156928286|FG002|Overall Study|Other, multiple categories|1|||
48749342|NCT01937559|156928287|FG000|Overall Study|Physician Decision|3|||
48749343|NCT01937559|156928288|FG001|Overall Study|Physician Decision|3|||
48749344|NCT01937559|156928289|FG002|Overall Study|Physician Decision|0|||
48749345|NCT01937559|156928287|FG000|Overall Study|Withdrawal by Subject|6|||
48749346|NCT01937559|156928288|FG001|Overall Study|Withdrawal by Subject|4|||
48749347|NCT01937559|156928289|FG002|Overall Study|Withdrawal by Subject|0|||
48749348|NCT01937559|156928287|FG000|Overall Study|screen fail|2|||
48749349|NCT01937559|156928288|FG001|Overall Study|screen fail|4|||
48749350|NCT01937559|156928289|FG002|Overall Study|screen fail|0|||
48749351|NCT02547649|156928292|FG000|Overall Study|Lost to Follow-up|3|||
48749352|NCT02547649|156928293|FG001|Overall Study|Lost to Follow-up|1|||
48749353|NCT02547649|156928294|FG002|Overall Study|Lost to Follow-up|1|||
48749354|NCT02547649|156928292|FG000|Overall Study|Not vaccinated|0|||
48955688|NCT02951988|157665682|FG002|Double-Blind Treatment Period|Protocol Violation|4|||
48749355|NCT02547649|156928293|FG001|Overall Study|Not vaccinated|0|||
48749356|NCT02547649|156928294|FG002|Overall Study|Not vaccinated|1|||
48749357|NCT02547649|156928292|FG000|Overall Study|Withdrawal by Subject|0|||
48749358|NCT02547649|156928293|FG001|Overall Study|Withdrawal by Subject|4|||
48749359|NCT02547649|156928294|FG002|Overall Study|Withdrawal by Subject|2|||
48955689|NCT02951988|157665683|FG003|Double-Blind Treatment Period|Protocol Violation|8|||
48955690|NCT02951988|157665680|FG000|Double-Blind Treatment Period|Pregnancy|0|||
48955691|NCT02951988|157665681|FG001|Double-Blind Treatment Period|Pregnancy|1|||
48955692|NCT02951988|157665682|FG002|Double-Blind Treatment Period|Pregnancy|1|||
48955693|NCT02951988|157665683|FG003|Double-Blind Treatment Period|Pregnancy|0|||
48955694|NCT02951988|157665680|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
48955695|NCT02951988|157665681|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
48955696|NCT02951988|157665682|FG002|Double-Blind Treatment Period|Lost to Follow-up|12|||
48955697|NCT02951988|157665683|FG003|Double-Blind Treatment Period|Lost to Follow-up|3|||
48955698|NCT02951988|157665680|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
48955699|NCT02951988|157665681|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
48955700|NCT02951988|157665682|FG002|Double-Blind Treatment Period|Withdrawal by Subject|22|||
48955701|NCT02951988|157665683|FG003|Double-Blind Treatment Period|Withdrawal by Subject|28|||
48955702|NCT02951988|157665680|FG000|Double-Blind Treatment Period|Adverse Event|0|||
48955703|NCT02951988|157665681|FG001|Double-Blind Treatment Period|Adverse Event|8|||
48749360|NCT03648541|156928295|FG000|Re-induction Period Only|Withdrawal by Subject|1|||
48749361|NCT03648541|156928296|FG001|Re-induction Period Only|Withdrawal by Subject|0|||
48749362|NCT03648541|156928295|FG000|Re-induction Period Only|Lack of Efficacy|7|||
48749363|NCT03648541|156928296|FG001|Re-induction Period Only|Lack of Efficacy|0|||
48749364|NCT03648541|156928295|FG000|Maintenance Period Only|Missing|0|||
48749365|NCT03648541|156928296|FG001|Maintenance Period Only|Missing|1|||
48749366|NCT03648541|156928295|FG000|Maintenance Period Only|Other not listed below|0|||
48749367|NCT03648541|156928296|FG001|Maintenance Period Only|Other not listed below|4|||
48749368|NCT03648541|156928295|FG000|Maintenance Period Only|Withdrawal by Subject|0|||
48749369|NCT03648541|156928296|FG001|Maintenance Period Only|Withdrawal by Subject|3|||
48749370|NCT03648541|156928295|FG000|Maintenance Period Only|Protocol Violation|0|||
48749371|NCT03648541|156928296|FG001|Maintenance Period Only|Protocol Violation|1|||
48749372|NCT03648541|156928295|FG000|Maintenance Period Only|Lack of Efficacy|0|||
48749373|NCT03648541|156928296|FG001|Maintenance Period Only|Lack of Efficacy|18|||
48749374|NCT03648541|156928295|FG000|Maintenance Period Only|Adverse Event|0|||
48749375|NCT03648541|156928296|FG001|Maintenance Period Only|Adverse Event|4|||
48749376|NCT03648541|156928295|FG000|Maintenance Period Only|Stopped maintenance treatment due to study stop|0|||
48749377|NCT03648541|156928296|FG001|Maintenance Period Only|Stopped maintenance treatment due to study stop|3|||
48749378|NCT03230097|156928299|FG000|Overall Study|Adverse Event|2|||
48749379|NCT03230097|156928300|FG001|Overall Study|Adverse Event|1|||
48749380|NCT03230097|156928299|FG000|Overall Study|non-compliance|0|||
48749381|NCT03230097|156928300|FG001|Overall Study|non-compliance|1|||
48749382|NCT03230097|156928299|FG000|Overall Study|Lost to Follow-up|2|||
48749383|NCT03230097|156928300|FG001|Overall Study|Lost to Follow-up|4|||
48749384|NCT03230097|156928299|FG000|Overall Study|Withdrawal by Subject|7|||
48749385|NCT03230097|156928300|FG001|Overall Study|Withdrawal by Subject|3|||
48749386|NCT03230097|156928299|FG000|Overall Study|Trial termination|4|||
48749387|NCT03230097|156928300|FG001|Overall Study|Trial termination|5|||
48749388|NCT03230097|156928299|FG000|Overall Study|Covid-19 pandemic outbreak|0|||
48749389|NCT03230097|156928300|FG001|Overall Study|Covid-19 pandemic outbreak|1|||
48749390|NCT03230097|156928299|FG000|Overall Study|outcome event|0|||
48749391|NCT03230097|156928300|FG001|Overall Study|outcome event|1|||
48749392|NCT01985867|156928306|FG000|Overall Study|Lost to Follow-up|3|||
48749393|NCT01985867|156928307|FG001|Overall Study|Lost to Follow-up|4|||
48749394|NCT01985867|156928306|FG000|Overall Study|Adverse Event|3|||
48749395|NCT01985867|156928307|FG001|Overall Study|Adverse Event|2|||
48749396|NCT01985867|156928306|FG000|Overall Study|Lack of Efficacy|1|||
48749397|NCT01985867|156928307|FG001|Overall Study|Lack of Efficacy|0|||
48749398|NCT04605484|156928310|FG000|Overall Study|Lost to Follow-up|0|||
48749399|NCT04605484|156928311|FG001|Overall Study|Lost to Follow-up|1|||
48749400|NCT04605484|156928312|FG002|Overall Study|Lost to Follow-up|1|||
48749401|NCT04605484|156928310|FG000|Overall Study|Other|0|||
48749402|NCT04605484|156928311|FG001|Overall Study|Other|1|||
48749403|NCT04605484|156928312|FG002|Overall Study|Other|0|||
48749404|NCT01606436|156928315|FG000|Overall Study|Withdrawal by Subject|0|||
48749405|NCT01606436|156928316|FG001|Overall Study|Withdrawal by Subject|0|||
48749406|NCT01606436|156928317|FG002|Overall Study|Withdrawal by Subject|1|||
48749407|NCT01606436|156928318|FG003|Overall Study|Withdrawal by Subject|1|||
48749408|NCT01606436|156928319|FG004|Overall Study|Withdrawal by Subject|1|||
48862037|NCT01587703|157333026|FG003|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
48862038|NCT01587703|157333027|FG004|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
48749409|NCT01606436|156928320|FG005|Overall Study|Withdrawal by Subject|0|||
48749410|NCT01606436|156928315|FG000|Overall Study|Adverse Event|0|||
48749411|NCT01606436|156928316|FG001|Overall Study|Adverse Event|0|||
48749412|NCT01606436|156928317|FG002|Overall Study|Adverse Event|1|||
48749413|NCT01606436|156928318|FG003|Overall Study|Adverse Event|0|||
48749414|NCT01606436|156928319|FG004|Overall Study|Adverse Event|0|||
48749415|NCT01606436|156928320|FG005|Overall Study|Adverse Event|0|||
48749416|NCT01606436|156928315|FG000|Overall Study|Sponsor Decision|0|||
48749417|NCT01606436|156928316|FG001|Overall Study|Sponsor Decision|0|||
48749418|NCT01606436|156928317|FG002|Overall Study|Sponsor Decision|0|||
48749419|NCT01606436|156928318|FG003|Overall Study|Sponsor Decision|1|||
48749420|NCT01606436|156928319|FG004|Overall Study|Sponsor Decision|0|||
48862039|NCT01587703|157333028|FG005|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
49015393|NCT01533428|157892161|FG000|Overall Study|Withdrawal by Subject|7|||
48749421|NCT01606436|156928320|FG005|Overall Study|Sponsor Decision|0|||
48749422|NCT01658072|156928324|FG000|Overall Study|Protocol Violation|4|||
48749423|NCT01658072|156928325|FG001|Overall Study|Protocol Violation|2|||
48749424|NCT04967443|156928328|FG000|Open Label Treatment|Death|1|||
48749425|NCT04967443|156928329|FG001|Open Label Treatment|Death|0|||
48749426|NCT04967443|156928330|FG002|Open Label Treatment|Death|0|||
48749427|NCT04967443|156928331|FG003|Open Label Treatment|Death|0|||
48749428|NCT04967443|156928332|FG004|Open Label Treatment|Death|0|||
48749429|NCT04967443|156928333|FG005|Open Label Treatment|Death|0|||
48749430|NCT04967443|156928334|FG006|Open Label Treatment|Death|0|||
48749431|NCT04967443|156928335|FG007|Open Label Treatment|Death|0|||
48749432|NCT04967443|156928328|FG000|Open Label Treatment|Lost to Follow-up|0|||
48749433|NCT04967443|156928329|FG001|Open Label Treatment|Lost to Follow-up|0|||
48749434|NCT04967443|156928330|FG002|Open Label Treatment|Lost to Follow-up|1|||
48749435|NCT04967443|156928331|FG003|Open Label Treatment|Lost to Follow-up|0|||
48749436|NCT04967443|156928332|FG004|Open Label Treatment|Lost to Follow-up|0|||
48749437|NCT04967443|156928333|FG005|Open Label Treatment|Lost to Follow-up|0|||
48749438|NCT04967443|156928334|FG006|Open Label Treatment|Lost to Follow-up|0|||
48749439|NCT04967443|156928335|FG007|Open Label Treatment|Lost to Follow-up|0|||
48749440|NCT04967443|156928328|FG000|Open Label Treatment|Withdrawal by Subject|0|||
48749441|NCT04967443|156928329|FG001|Open Label Treatment|Withdrawal by Subject|1|||
48749442|NCT04967443|156928330|FG002|Open Label Treatment|Withdrawal by Subject|0|||
48749443|NCT04967443|156928331|FG003|Open Label Treatment|Withdrawal by Subject|1|||
48749444|NCT04967443|156928332|FG004|Open Label Treatment|Withdrawal by Subject|0|||
48749445|NCT04967443|156928333|FG005|Open Label Treatment|Withdrawal by Subject|1|||
48749446|NCT04967443|156928334|FG006|Open Label Treatment|Withdrawal by Subject|2|||
48749447|NCT04967443|156928335|FG007|Open Label Treatment|Withdrawal by Subject|3|||
48749448|NCT04967443|156928328|FG000|Follow-Up|Death|1|||
48749449|NCT04967443|156928329|FG001|Follow-Up|Death|0|||
48749450|NCT04967443|156928330|FG002|Follow-Up|Death|0|||
48749451|NCT04967443|156928331|FG003|Follow-Up|Death|0|||
48749452|NCT04967443|156928332|FG004|Follow-Up|Death|0|||
48749453|NCT04967443|156928333|FG005|Follow-Up|Death|0|||
48862040|NCT01587703|157333029|FG006|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
48862041|NCT01587703|157333030|FG007|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
48862042|NCT01587703|157333031|FG008|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
48862043|NCT01587703|157333032|FG009|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
48862044|NCT01587703|157333033|FG010|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
48749454|NCT04967443|156928334|FG006|Follow-Up|Death|0|||
48749455|NCT04967443|156928335|FG007|Follow-Up|Death|0|||
48749456|NCT04967443|156928328|FG000|Follow-Up|Lost to Follow-up|0|||
48749457|NCT04967443|156928329|FG001|Follow-Up|Lost to Follow-up|0|||
48862045|NCT01587703|157333034|FG011|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
48862046|NCT01587703|157333035|FG012|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
48749458|NCT04967443|156928330|FG002|Follow-Up|Lost to Follow-up|1|||
48749459|NCT04967443|156928331|FG003|Follow-Up|Lost to Follow-up|1|||
48749460|NCT04967443|156928332|FG004|Follow-Up|Lost to Follow-up|0|||
48862047|NCT01587703|157333036|FG013|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
48749461|NCT04967443|156928333|FG005|Follow-Up|Lost to Follow-up|0|||
48749462|NCT04967443|156928334|FG006|Follow-Up|Lost to Follow-up|0|||
48862048|NCT01587703|157333037|FG014|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
48749463|NCT04967443|156928335|FG007|Follow-Up|Lost to Follow-up|0|||
48749464|NCT04967443|156928328|FG000|Follow-Up|Withdrawal by Subject|0|||
48749465|NCT04967443|156928329|FG001|Follow-Up|Withdrawal by Subject|1|||
48749466|NCT04967443|156928330|FG002|Follow-Up|Withdrawal by Subject|0|||
48749467|NCT04967443|156928331|FG003|Follow-Up|Withdrawal by Subject|1|||
48749468|NCT04967443|156928332|FG004|Follow-Up|Withdrawal by Subject|0|||
48749469|NCT04967443|156928333|FG005|Follow-Up|Withdrawal by Subject|1|||
48749470|NCT04967443|156928334|FG006|Follow-Up|Withdrawal by Subject|2|||
48749471|NCT04967443|156928335|FG007|Follow-Up|Withdrawal by Subject|3|||
48749472|NCT04584645|156928336|FG000|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18995|||
48749473|NCT04584645|156928337|FG001|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18906|||
48749474|NCT03798483|156928340|FG000|Overall Study|Lost to Follow-up|2|||
48749475|NCT02289417|156928341|FG000|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3|||
48749476|NCT02289417|156928342|FG001|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
48749477|NCT02289417|156928343|FG002|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1|||
48749478|NCT02289417|156928344|FG003|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
48749479|NCT02289417|156928345|FG004|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
48749480|NCT02289417|156928346|FG005|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
48749481|NCT02289417|156928347|FG006|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
48749482|NCT02289417|156928348|FG007|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
48749483|NCT02289417|156928349|FG008|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
48749484|NCT02289417|156928341|FG000|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1|||
48749485|NCT02289417|156928342|FG001|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3|||
48749486|NCT02289417|156928343|FG002|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2|||
48749487|NCT02289417|156928344|FG003|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
48749488|NCT02289417|156928345|FG004|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
48749489|NCT02289417|156928346|FG005|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
48749490|NCT02289417|156928347|FG006|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
48749491|NCT02289417|156928348|FG007|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
48749492|NCT02289417|156928349|FG008|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
48749493|NCT02289417|156928341|FG000|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
48749494|NCT02289417|156928342|FG001|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1|||
48749495|NCT02289417|156928343|FG002|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
48749496|NCT02289417|156928344|FG003|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
48749497|NCT02289417|156928345|FG004|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
48749498|NCT02289417|156928346|FG005|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
48749499|NCT02289417|156928347|FG006|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
48749500|NCT02289417|156928348|FG007|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
48749501|NCT02289417|156928349|FG008|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
48749502|NCT02289417|156928341|FG000|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3|||
48749503|NCT02289417|156928342|FG001|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
48749504|NCT02289417|156928343|FG002|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
48749505|NCT02289417|156928344|FG003|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
48749506|NCT02289417|156928345|FG004|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
48749507|NCT02289417|156928346|FG005|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
48749508|NCT02289417|156928347|FG006|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
48749509|NCT02289417|156928348|FG007|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
48749510|NCT02289417|156928349|FG008|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
48749511|NCT02289417|156928341|FG000|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
48749512|NCT02289417|156928342|FG001|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
48749513|NCT02289417|156928343|FG002|Active Treatment Phase Weeks 12-52|Adverse Event|4|||
48749514|NCT02289417|156928344|FG003|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
48749515|NCT02289417|156928345|FG004|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
48749516|NCT02289417|156928346|FG005|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
48749517|NCT02289417|156928347|FG006|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
48749518|NCT02289417|156928348|FG007|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
48749519|NCT02289417|156928349|FG008|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
48955704|NCT02951988|157665682|FG002|Double-Blind Treatment Period|Adverse Event|3|||
48749520|NCT02289417|156928341|FG000|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
48749521|NCT02289417|156928342|FG001|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
48749522|NCT02289417|156928343|FG002|Active Treatment Phase Weeks 12-52|Pregnancy|1|||
48749523|NCT02289417|156928344|FG003|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
48749524|NCT02289417|156928345|FG004|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
48749525|NCT02289417|156928346|FG005|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
48749526|NCT02289417|156928347|FG006|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
48749527|NCT02289417|156928348|FG007|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
48749528|NCT02289417|156928349|FG008|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
48749529|NCT02289417|156928341|FG000|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
48749530|NCT02289417|156928342|FG001|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1|||
48749531|NCT02289417|156928343|FG002|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4|||
48749532|NCT02289417|156928344|FG003|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6|||
48749533|NCT02289417|156928345|FG004|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2|||
48749534|NCT02289417|156928346|FG005|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3|||
48749535|NCT02289417|156928347|FG006|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
48749536|NCT02289417|156928348|FG007|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
48749537|NCT02289417|156928349|FG008|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
48749538|NCT02289417|156928341|FG000|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
48749539|NCT02289417|156928342|FG001|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
48749540|NCT02289417|156928343|FG002|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
48749541|NCT02289417|156928344|FG003|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
48749542|NCT02289417|156928345|FG004|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
48749543|NCT02289417|156928346|FG005|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
48749544|NCT02289417|156928347|FG006|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
48749545|NCT02289417|156928348|FG007|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
48749546|NCT02289417|156928349|FG008|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
48749547|NCT02289417|156928341|FG000|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
48749548|NCT02289417|156928342|FG001|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
48749549|NCT02289417|156928343|FG002|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
48749550|NCT02289417|156928344|FG003|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
48749551|NCT02289417|156928345|FG004|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
48749552|NCT02289417|156928346|FG005|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
48749553|NCT02289417|156928347|FG006|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1|||
48749554|NCT02289417|156928348|FG007|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
48749555|NCT02289417|156928349|FG008|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
48749556|NCT02289417|156928341|FG000|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
48749557|NCT02289417|156928342|FG001|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
48749558|NCT02289417|156928343|FG002|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
48749559|NCT02289417|156928344|FG003|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
48749560|NCT02289417|156928345|FG004|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
48749561|NCT02289417|156928346|FG005|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
48749562|NCT02289417|156928347|FG006|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
48749563|NCT02289417|156928348|FG007|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
48749564|NCT02289417|156928349|FG008|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
48749565|NCT02289417|156928341|FG000|Extension Phase Weeks 52-104|Adverse Event|0|||
48749566|NCT02289417|156928342|FG001|Extension Phase Weeks 52-104|Adverse Event|0|||
48749567|NCT02289417|156928343|FG002|Extension Phase Weeks 52-104|Adverse Event|0|||
48955705|NCT02951988|157665683|FG003|Double-Blind Treatment Period|Adverse Event|6|||
48955706|NCT02951988|157665680|FG000|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
48955707|NCT02951988|157665681|FG001|Double-Blind Treatment Period|Miscellaneous Reasons|2|||
48955708|NCT02951988|157665682|FG002|Double-Blind Treatment Period|Miscellaneous Reasons|1|||
48955709|NCT02951988|157665683|FG003|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
48955710|NCT03283163|157665686|FG000|Overall Study|Lost to Follow-up|1|||
48955711|NCT03283163|157665686|FG000|Overall Study|other life commitments|6|||
48955712|NCT03283163|157665686|FG000|Overall Study|COVID-19 institution wide halting|1|||
48955713|NCT03283163|157665686|FG000|Overall Study|Participants tested positive for illicit drugs on the day of the testing and/or training procedures|2|||
48955714|NCT03283163|157665686|FG000|Overall Study|Participant found to not be forthcoming with screening/baseline assessments|1|||
48955715|NCT01599754|157665689|FG000|Overall Study|Anticancer therapy need not in protocol|5|||
48955716|NCT01599754|157665690|FG001|Overall Study|Anticancer therapy need not in protocol|2|||
48955717|NCT01599754|157665689|FG000|Overall Study|Participant noncompliance|4|||
48955718|NCT01599754|157665690|FG001|Overall Study|Participant noncompliance|4|||
48955719|NCT01599754|157665689|FG000|Overall Study|Lost to Follow-up|13|||
48955720|NCT01599754|157665690|FG001|Overall Study|Lost to Follow-up|6|||
48955721|NCT01599754|157665689|FG000|Overall Study|Death|31|||
48955722|NCT01599754|157665690|FG001|Overall Study|Death|33|||
48955723|NCT01599754|157665689|FG000|Overall Study|Adverse Event|3|||
48955724|NCT01599754|157665690|FG001|Overall Study|Adverse Event|2|||
48955725|NCT01599754|157665689|FG000|Overall Study|Investigator decision|1|||
48955726|NCT01599754|157665690|FG001|Overall Study|Investigator decision|3|||
48955727|NCT01599754|157665689|FG000|Overall Study|Withdrawal by Subject|24|||
48955728|NCT01599754|157665690|FG001|Overall Study|Withdrawal by Subject|25|||
48955729|NCT01599754|157665689|FG000|Overall Study|Study terminated by sponsor|282|||
48955730|NCT01599754|157665690|FG001|Overall Study|Study terminated by sponsor|285|||
48955731|NCT00243230|157665695|FG000|Double-Blind Period|Adverse Event|0|||
48955732|NCT00243230|157665696|FG001|Double-Blind Period|Adverse Event|2|||
48955733|NCT00243230|157665697|FG002|Double-Blind Period|Adverse Event|2|||
48955734|NCT00243230|157665698|FG003|Double-Blind Period|Adverse Event|0|||
48955735|NCT00243230|157665695|FG000|Double-Blind Period|Withdrawal by Subject|1|||
48955736|NCT00243230|157665696|FG001|Double-Blind Period|Withdrawal by Subject|0|||
48955737|NCT00243230|157665697|FG002|Double-Blind Period|Withdrawal by Subject|0|||
48955738|NCT00243230|157665698|FG003|Double-Blind Period|Withdrawal by Subject|0|||
48955739|NCT00243230|157665695|FG000|Double-Blind Period|Protocol Violation|0|||
48955740|NCT00243230|157665696|FG001|Double-Blind Period|Protocol Violation|0|||
48955741|NCT00243230|157665697|FG002|Double-Blind Period|Protocol Violation|1|||
48955742|NCT00243230|157665698|FG003|Double-Blind Period|Protocol Violation|0|||
48955743|NCT00243230|157665695|FG000|Double-Blind Period|Randomized but Not Treated|0|||
48955744|NCT00243230|157665696|FG001|Double-Blind Period|Randomized but Not Treated|0|||
48955745|NCT00243230|157665697|FG002|Double-Blind Period|Randomized but Not Treated|2|||
48955746|NCT00243230|157665698|FG003|Double-Blind Period|Randomized but Not Treated|0|||
48955747|NCT00243230|157665695|FG000|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5|||
48955748|NCT00243230|157665696|FG001|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3|||
48955749|NCT00243230|157665697|FG002|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14|||
48955750|NCT00243230|157665698|FG003|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0|||
48955751|NCT00243230|157665695|FG000|Open Label Period|Adverse Event|0|||
48749568|NCT02289417|156928344|FG003|Extension Phase Weeks 52-104|Adverse Event|0|||
48862049|NCT01587703|157333038|FG015|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
48862050|NCT01587703|157333039|FG016|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
48862051|NCT01587703|157333040|FG017|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
48862052|NCT01587703|157333041|FG018|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1|||
48862053|NCT01587703|157333023|FG000|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
48862054|NCT01587703|157333024|FG001|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
48862055|NCT01587703|157333025|FG002|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
48862056|NCT01587703|157333026|FG003|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
48862057|NCT01587703|157333027|FG004|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
48862058|NCT01587703|157333028|FG005|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
48862059|NCT01587703|157333029|FG006|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
48862060|NCT01587703|157333030|FG007|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
48862061|NCT01587703|157333031|FG008|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
48862062|NCT01587703|157333032|FG009|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
48862063|NCT01587703|157333033|FG010|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
48862064|NCT01587703|157333034|FG011|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
48862065|NCT01587703|157333035|FG012|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
48862066|NCT01587703|157333036|FG013|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
48862067|NCT01587703|157333037|FG014|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
48862068|NCT01587703|157333038|FG015|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
48862069|NCT01587703|157333039|FG016|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
48862070|NCT01587703|157333040|FG017|Substudy-P4,Maximum Exposure of 5.5month|Death|5|||
48862071|NCT01587703|157333041|FG018|Substudy-P4,Maximum Exposure of 5.5month|Death|4|||
48862072|NCT01587703|157333023|FG000|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
48862073|NCT01587703|157333024|FG001|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
48862074|NCT01587703|157333025|FG002|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
48862075|NCT01587703|157333026|FG003|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
48862076|NCT01587703|157333027|FG004|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
48862077|NCT01587703|157333028|FG005|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
48862078|NCT01587703|157333029|FG006|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
48862079|NCT01587703|157333030|FG007|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
48862080|NCT01587703|157333031|FG008|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
48862081|NCT01587703|157333032|FG009|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
48955752|NCT00243230|157665696|FG001|Open Label Period|Adverse Event|0|||
48955753|NCT00243230|157665697|FG002|Open Label Period|Adverse Event|0|||
48955754|NCT00243230|157665698|FG003|Open Label Period|Adverse Event|2|||
48955755|NCT00243230|157665695|FG000|Open Label Period|Treatment Failure - Virologic Failure|0|||
48749569|NCT02289417|156928345|FG004|Extension Phase Weeks 52-104|Adverse Event|0|||
48749570|NCT02289417|156928346|FG005|Extension Phase Weeks 52-104|Adverse Event|0|||
48749571|NCT02289417|156928347|FG006|Extension Phase Weeks 52-104|Adverse Event|0|||
48749572|NCT02289417|156928348|FG007|Extension Phase Weeks 52-104|Adverse Event|2|||
48749573|NCT02289417|156928349|FG008|Extension Phase Weeks 52-104|Adverse Event|3|||
48749574|NCT02289417|156928341|FG000|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
48749575|NCT02289417|156928342|FG001|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
48749576|NCT02289417|156928343|FG002|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
48749577|NCT02289417|156928344|FG003|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
48749578|NCT02289417|156928345|FG004|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
48749579|NCT02289417|156928346|FG005|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
48749580|NCT02289417|156928347|FG006|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
48749581|NCT02289417|156928348|FG007|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
48749582|NCT02289417|156928349|FG008|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
48749583|NCT02289417|156928341|FG000|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
48749584|NCT02289417|156928342|FG001|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
48749585|NCT02289417|156928343|FG002|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
48749586|NCT02289417|156928344|FG003|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
48749587|NCT02289417|156928345|FG004|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
48749588|NCT02289417|156928346|FG005|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
48749589|NCT02289417|156928347|FG006|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
48749590|NCT02289417|156928348|FG007|Extension Phase Weeks 52-104|Withdrawal by Subject|2|||
48749591|NCT02289417|156928349|FG008|Extension Phase Weeks 52-104|Withdrawal by Subject|1|||
48749592|NCT02289417|156928341|FG000|Extension Phase Weeks 52-104|Miscellaneous|0|||
48749593|NCT02289417|156928342|FG001|Extension Phase Weeks 52-104|Miscellaneous|0|||
48749594|NCT02289417|156928343|FG002|Extension Phase Weeks 52-104|Miscellaneous|0|||
48749595|NCT02289417|156928344|FG003|Extension Phase Weeks 52-104|Miscellaneous|0|||
48749596|NCT02289417|156928345|FG004|Extension Phase Weeks 52-104|Miscellaneous|0|||
48749597|NCT02289417|156928346|FG005|Extension Phase Weeks 52-104|Miscellaneous|0|||
48749598|NCT02289417|156928347|FG006|Extension Phase Weeks 52-104|Miscellaneous|0|||
48749599|NCT02289417|156928348|FG007|Extension Phase Weeks 52-104|Miscellaneous|1|||
48749600|NCT02289417|156928349|FG008|Extension Phase Weeks 52-104|Miscellaneous|0|||
48749601|NCT00276744|156928350|FG000|PART A|Reason unknown|98|||
48749602|NCT02010775|156928354|FG000|Overall Study|Adverse Event|0|||
48749603|NCT02010775|156928355|FG001|Overall Study|Adverse Event|0|||
48749604|NCT02010775|156928356|FG002|Overall Study|Adverse Event|0|||
48749605|NCT02010775|156928357|FG003|Overall Study|Adverse Event|0|||
48749606|NCT02010775|156928358|FG004|Overall Study|Adverse Event|1|||
48749607|NCT02010775|156928354|FG000|Overall Study|Pregnancy|0|||
48862082|NCT01587703|157333033|FG010|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
48862083|NCT01587703|157333034|FG011|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
48862084|NCT01587703|157333035|FG012|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
48862085|NCT01587703|157333036|FG013|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
48862086|NCT01587703|157333037|FG014|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
48862087|NCT01587703|157333038|FG015|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1|||
48862088|NCT01587703|157333039|FG016|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
48862089|NCT01587703|157333040|FG017|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
48862090|NCT01587703|157333041|FG018|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
48862091|NCT01587703|157333023|FG000|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
48862092|NCT01587703|157333024|FG001|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
48862093|NCT01587703|157333025|FG002|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
48862094|NCT01587703|157333026|FG003|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
48862095|NCT01587703|157333027|FG004|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
48862096|NCT01587703|157333028|FG005|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
48749608|NCT02010775|156928355|FG001|Overall Study|Pregnancy|0|||
48749609|NCT02010775|156928356|FG002|Overall Study|Pregnancy|2|||
48749610|NCT02010775|156928357|FG003|Overall Study|Pregnancy|0|||
48749611|NCT02010775|156928358|FG004|Overall Study|Pregnancy|0|||
48749612|NCT02010775|156928354|FG000|Overall Study|Lost to Follow-up|2|||
48749613|NCT02010775|156928355|FG001|Overall Study|Lost to Follow-up|0|||
48749614|NCT02010775|156928356|FG002|Overall Study|Lost to Follow-up|0|||
48749615|NCT02010775|156928357|FG003|Overall Study|Lost to Follow-up|1|||
48749616|NCT02010775|156928358|FG004|Overall Study|Lost to Follow-up|1|||
48749617|NCT02010775|156928354|FG000|Overall Study|Personal Reasons|3|||
48749618|NCT02010775|156928355|FG001|Overall Study|Personal Reasons|3|||
48749619|NCT02010775|156928356|FG002|Overall Study|Personal Reasons|1|||
48749620|NCT02010775|156928357|FG003|Overall Study|Personal Reasons|2|||
48749621|NCT02010775|156928358|FG004|Overall Study|Personal Reasons|4|||
48749622|NCT02505867|156928359|FG000|Overall Study|Lack of Efficacy|6|||
48749623|NCT02505867|156928360|FG001|Overall Study|Lack of Efficacy|6|||
48749624|NCT02233647|156928367|FG000|Overall Study|Adverse Event|1|||
48749625|NCT01543698|156930143|FG000|Phase 1b|Disease progression|2|||
48749626|NCT01543698|156930144|FG001|Phase 1b|Disease progression|4|||
48749627|NCT01543698|156930145|FG002|Phase 1b|Disease progression|3|||
48749628|NCT01543698|156930146|FG003|Phase 1b|Disease progression|2|||
48749629|NCT01543698|156930147|FG004|Phase 1b|Disease progression|10|||
48749630|NCT01543698|156930148|FG005|Phase 1b|Disease progression|6|||
48749631|NCT01543698|156930149|FG006|Phase 1b|Disease progression|5|||
48749632|NCT01543698|156930150|FG007|Phase 1b|Disease progression|3|||
48749633|NCT01543698|156930151|FG008|Phase 1b|Disease progression|4|||
48749634|NCT01543698|156930152|FG009|Phase 1b|Disease progression|5|||
48749635|NCT01543698|156930153|FG010|Phase 1b|Disease progression|1|||
48749636|NCT01543698|156930154|FG011|Phase 1b|Disease progression|0|||
48749637|NCT01543698|156930155|FG012|Phase 1b|Disease progression|0|||
48862097|NCT01587703|157333029|FG006|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
48862098|NCT01587703|157333030|FG007|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
48862099|NCT01587703|157333031|FG008|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
48749638|NCT01543698|156930156|FG013|Phase 1b|Disease progression|0|||
48749639|NCT01543698|156930157|FG014|Phase 1b|Disease progression|0|||
48749640|NCT01543698|156930143|FG000|Phase 1b|Death|0|||
48749641|NCT01543698|156930144|FG001|Phase 1b|Death|0|||
48749642|NCT01543698|156930145|FG002|Phase 1b|Death|1|||
48749643|NCT01543698|156930146|FG003|Phase 1b|Death|1|||
48749644|NCT01543698|156930147|FG004|Phase 1b|Death|0|||
48749645|NCT01543698|156930148|FG005|Phase 1b|Death|0|||
48749646|NCT01543698|156930149|FG006|Phase 1b|Death|0|||
48749647|NCT01543698|156930150|FG007|Phase 1b|Death|0|||
48749648|NCT01543698|156930151|FG008|Phase 1b|Death|0|||
48749649|NCT01543698|156930152|FG009|Phase 1b|Death|0|||
48749650|NCT01543698|156930153|FG010|Phase 1b|Death|1|||
48955756|NCT00243230|157665696|FG001|Open Label Period|Treatment Failure - Virologic Failure|0|||
48955757|NCT00243230|157665697|FG002|Open Label Period|Treatment Failure - Virologic Failure|0|||
48749651|NCT01543698|156930154|FG011|Phase 1b|Death|0|||
48749652|NCT01543698|156930155|FG012|Phase 1b|Death|0|||
48955758|NCT00243230|157665698|FG003|Open Label Period|Treatment Failure - Virologic Failure|13|||
48955759|NCT00243230|157665695|FG000|Open Label Period|Progressive Disease (AIDS-Event)|0|||
48955760|NCT00243230|157665696|FG001|Open Label Period|Progressive Disease (AIDS-Event)|0|||
48955761|NCT00243230|157665697|FG002|Open Label Period|Progressive Disease (AIDS-Event)|0|||
48749653|NCT01543698|156930156|FG013|Phase 1b|Death|0|||
48749654|NCT01543698|156930157|FG014|Phase 1b|Death|0|||
48749655|NCT01543698|156930143|FG000|Phase 1b|Withdrawal by Subject|0|||
48749656|NCT01543698|156930144|FG001|Phase 1b|Withdrawal by Subject|1|||
48749657|NCT01543698|156930145|FG002|Phase 1b|Withdrawal by Subject|0|||
48749658|NCT01543698|156930146|FG003|Phase 1b|Withdrawal by Subject|1|||
48749659|NCT01543698|156930147|FG004|Phase 1b|Withdrawal by Subject|0|||
48955762|NCT00243230|157665698|FG003|Open Label Period|Progressive Disease (AIDS-Event)|1|||
48955763|NCT00243230|157665695|FG000|Open Label Period|Lost to Follow-up|0|||
48749660|NCT01543698|156930148|FG005|Phase 1b|Withdrawal by Subject|0|||
48749661|NCT01543698|156930149|FG006|Phase 1b|Withdrawal by Subject|1|||
48749662|NCT01543698|156930150|FG007|Phase 1b|Withdrawal by Subject|0|||
48749663|NCT01543698|156930151|FG008|Phase 1b|Withdrawal by Subject|0|||
48749664|NCT01543698|156930152|FG009|Phase 1b|Withdrawal by Subject|0|||
48749665|NCT01543698|156930153|FG010|Phase 1b|Withdrawal by Subject|0|||
48749666|NCT01543698|156930154|FG011|Phase 1b|Withdrawal by Subject|0|||
48862100|NCT01587703|157333032|FG009|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
48862101|NCT01587703|157333033|FG010|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
48862102|NCT01587703|157333034|FG011|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1|||
48862103|NCT01587703|157333035|FG012|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
48862104|NCT01587703|157333036|FG013|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
48862105|NCT01587703|157333037|FG014|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2|||
48862106|NCT01587703|157333038|FG015|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
48862107|NCT01587703|157333039|FG016|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
48862108|NCT01587703|157333040|FG017|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
48862109|NCT01587703|157333041|FG018|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
48862110|NCT01587703|157333023|FG000|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
48862111|NCT01587703|157333024|FG001|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
48862112|NCT01587703|157333025|FG002|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
48862113|NCT01587703|157333026|FG003|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
48862114|NCT01587703|157333027|FG004|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
48862115|NCT01587703|157333028|FG005|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
48862116|NCT01587703|157333029|FG006|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
48862117|NCT01587703|157333030|FG007|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
48862118|NCT01587703|157333031|FG008|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
48862119|NCT01587703|157333032|FG009|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
48862120|NCT01587703|157333033|FG010|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
48862121|NCT01587703|157333034|FG011|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
48862122|NCT01587703|157333035|FG012|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
48862123|NCT01587703|157333036|FG013|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
48862124|NCT01587703|157333037|FG014|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
48862125|NCT01587703|157333038|FG015|Part2(Median Exposure of 1.41 Months)|Site closed|3|||
48862126|NCT01587703|157333039|FG016|Part2(Median Exposure of 1.41 Months)|Site closed|8|||
48862127|NCT01587703|157333040|FG017|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
48862128|NCT01587703|157333041|FG018|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
48862129|NCT01587703|157333023|FG000|Part2(Median Exposure of 1.41 Months)|Death|0|||
48862130|NCT01587703|157333024|FG001|Part2(Median Exposure of 1.41 Months)|Death|0|||
48862131|NCT01587703|157333025|FG002|Part2(Median Exposure of 1.41 Months)|Death|0|||
48862132|NCT01587703|157333026|FG003|Part2(Median Exposure of 1.41 Months)|Death|0|||
48862133|NCT01587703|157333027|FG004|Part2(Median Exposure of 1.41 Months)|Death|0|||
48862134|NCT01587703|157333028|FG005|Part2(Median Exposure of 1.41 Months)|Death|0|||
48862135|NCT01587703|157333029|FG006|Part2(Median Exposure of 1.41 Months)|Death|0|||
48862136|NCT01587703|157333030|FG007|Part2(Median Exposure of 1.41 Months)|Death|0|||
48862137|NCT01587703|157333031|FG008|Part2(Median Exposure of 1.41 Months)|Death|0|||
48862138|NCT01587703|157333032|FG009|Part2(Median Exposure of 1.41 Months)|Death|0|||
48862139|NCT01587703|157333033|FG010|Part2(Median Exposure of 1.41 Months)|Death|0|||
48862140|NCT01587703|157333034|FG011|Part2(Median Exposure of 1.41 Months)|Death|8|||
48862141|NCT01587703|157333035|FG012|Part2(Median Exposure of 1.41 Months)|Death|12|||
48862142|NCT01587703|157333036|FG013|Part2(Median Exposure of 1.41 Months)|Death|21|||
48862143|NCT01587703|157333037|FG014|Part2(Median Exposure of 1.41 Months)|Death|16|||
48862144|NCT01587703|157333038|FG015|Part2(Median Exposure of 1.41 Months)|Death|17|||
48862145|NCT01587703|157333039|FG016|Part2(Median Exposure of 1.41 Months)|Death|5|||
48862146|NCT01587703|157333040|FG017|Part2(Median Exposure of 1.41 Months)|Death|0|||
48862147|NCT01587703|157333041|FG018|Part2(Median Exposure of 1.41 Months)|Death|0|||
48862148|NCT01587703|157333023|FG000|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
48862149|NCT01587703|157333024|FG001|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
48862150|NCT01587703|157333025|FG002|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
48862151|NCT01587703|157333026|FG003|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
48862152|NCT01587703|157333027|FG004|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
48862153|NCT01587703|157333028|FG005|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
48862154|NCT01587703|157333029|FG006|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
48862155|NCT01587703|157333030|FG007|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
48955764|NCT00243230|157665696|FG001|Open Label Period|Lost to Follow-up|0|||
48955765|NCT00243230|157665697|FG002|Open Label Period|Lost to Follow-up|0|||
48955766|NCT00243230|157665698|FG003|Open Label Period|Lost to Follow-up|2|||
48955767|NCT00243230|157665695|FG000|Open Label Period|Withdrawal by Subject|0|||
48955768|NCT00243230|157665696|FG001|Open Label Period|Withdrawal by Subject|0|||
48955769|NCT00243230|157665697|FG002|Open Label Period|Withdrawal by Subject|0|||
48749667|NCT01543698|156930155|FG012|Phase 1b|Withdrawal by Subject|0|||
48749668|NCT01543698|156930156|FG013|Phase 1b|Withdrawal by Subject|0|||
48749669|NCT01543698|156930157|FG014|Phase 1b|Withdrawal by Subject|0|||
48749670|NCT01543698|156930143|FG000|Phase 1b|Adverse Event|1|||
48749671|NCT01543698|156930144|FG001|Phase 1b|Adverse Event|0|||
48749672|NCT01543698|156930145|FG002|Phase 1b|Adverse Event|0|||
48749673|NCT01543698|156930146|FG003|Phase 1b|Adverse Event|1|||
48749674|NCT01543698|156930147|FG004|Phase 1b|Adverse Event|2|||
48749675|NCT01543698|156930148|FG005|Phase 1b|Adverse Event|2|||
48862156|NCT01587703|157333031|FG008|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
48862157|NCT01587703|157333032|FG009|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
48862158|NCT01587703|157333033|FG010|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
48862159|NCT01587703|157333034|FG011|Part2(Median Exposure of 1.41 Months)|Physician Decision|1|||
48862160|NCT01587703|157333035|FG012|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
48862161|NCT01587703|157333036|FG013|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
48862162|NCT01587703|157333037|FG014|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
48862163|NCT01587703|157333038|FG015|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
48862164|NCT01587703|157333039|FG016|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
48862165|NCT01587703|157333040|FG017|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
48862166|NCT01587703|157333041|FG018|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
48862167|NCT00396409|157333042|FG000|Period 1 - 2007|Adverse Event|0|||
48862168|NCT00396409|157333043|FG001|Period 1 - 2007|Adverse Event|1|||
48862169|NCT00396409|157333042|FG000|Period 1 - 2007|Lack of Efficacy|0|||
48862170|NCT00396409|157333043|FG001|Period 1 - 2007|Lack of Efficacy|1|||
48862171|NCT00396409|157333042|FG000|Period 1 - 2007|Withdrawal by Subject|1|||
48862172|NCT00396409|157333043|FG001|Period 1 - 2007|Withdrawal by Subject|1|||
48862173|NCT00396409|157333042|FG000|Period 1 - 2007|Lost to Follow-up|2|||
48862174|NCT00396409|157333043|FG001|Period 1 - 2007|Lost to Follow-up|3|||
48862175|NCT00396409|157333042|FG000|Between Period 1 and Period 2|Withdrawal by Subject|3|||
48862176|NCT00396409|157333043|FG001|Between Period 1 and Period 2|Withdrawal by Subject|2|||
48749676|NCT01543698|156930149|FG006|Phase 1b|Adverse Event|0|||
48749677|NCT01543698|156930150|FG007|Phase 1b|Adverse Event|0|||
48749678|NCT01543698|156930151|FG008|Phase 1b|Adverse Event|1|||
48749679|NCT01543698|156930152|FG009|Phase 1b|Adverse Event|1|||
48749680|NCT01543698|156930153|FG010|Phase 1b|Adverse Event|2|||
48749681|NCT01543698|156930154|FG011|Phase 1b|Adverse Event|0|||
48749682|NCT01543698|156930155|FG012|Phase 1b|Adverse Event|0|||
48749683|NCT01543698|156930156|FG013|Phase 1b|Adverse Event|0|||
48749684|NCT01543698|156930157|FG014|Phase 1b|Adverse Event|0|||
48749685|NCT01543698|156930143|FG000|Phase 1b|Administrative problems|1|||
48749686|NCT01543698|156930144|FG001|Phase 1b|Administrative problems|0|||
48955770|NCT00243230|157665698|FG003|Open Label Period|Withdrawal by Subject|2|||
48955771|NCT00243230|157665695|FG000|Open Label Period|Protocol Violation|0|||
48955772|NCT00243230|157665696|FG001|Open Label Period|Protocol Violation|0|||
48955773|NCT00243230|157665697|FG002|Open Label Period|Protocol Violation|0|||
48955774|NCT00243230|157665698|FG003|Open Label Period|Protocol Violation|2|||
48955775|NCT00243230|157665695|FG000|Open Label Period|Administrative Reason|0|||
48955776|NCT00243230|157665696|FG001|Open Label Period|Administrative Reason|0|||
48955777|NCT00243230|157665697|FG002|Open Label Period|Administrative Reason|0|||
48955778|NCT00243230|157665698|FG003|Open Label Period|Administrative Reason|63|||
48955779|NCT01921257|157665713|FG000|Overall Study|Adverse Event|1|||
48955780|NCT01921257|157665713|FG000|Overall Study|Protocol Violation|1|||
48955781|NCT01921257|157665713|FG000|Overall Study|Withdrawal by Subject|1|||
48955782|NCT02488759|157665714|FG000|Overall Study|Disease progression|73|||
48955783|NCT02488759|157665715|FG001|Overall Study|Disease progression|111|||
48955784|NCT02488759|157665716|FG002|Overall Study|Disease progression|62|||
48955785|NCT02488759|157665717|FG003|Overall Study|Disease progression|7|||
48749687|NCT01543698|156930145|FG002|Phase 1b|Administrative problems|0|||
48749688|NCT01543698|156930146|FG003|Phase 1b|Administrative problems|0|||
48749689|NCT01543698|156930147|FG004|Phase 1b|Administrative problems|1|||
48955786|NCT02488759|157665718|FG004|Overall Study|Disease progression|4|||
48955787|NCT02488759|157665719|FG005|Overall Study|Disease progression|2|||
48955788|NCT02488759|157665714|FG000|Overall Study|Study drug toxicity|11|||
48955789|NCT02488759|157665715|FG001|Overall Study|Study drug toxicity|33|||
48955790|NCT02488759|157665716|FG002|Overall Study|Study drug toxicity|31|||
48955791|NCT02488759|157665717|FG003|Overall Study|Study drug toxicity|0|||
48955792|NCT02488759|157665718|FG004|Overall Study|Study drug toxicity|0|||
48862177|NCT00396409|157333042|FG000|Period 2 - 2008|Protocol Violation|1|||
48862178|NCT00396409|157333043|FG001|Period 2 - 2008|Protocol Violation|0|||
48862179|NCT00396409|157333042|FG000|Period 2 - 2008|Withdrawal by Subject|3|||
48862180|NCT00396409|157333043|FG001|Period 2 - 2008|Withdrawal by Subject|1|||
48862181|NCT00396409|157333042|FG000|Period 2 - 2008|Lost to Follow-up|3|||
48862182|NCT00396409|157333043|FG001|Period 2 - 2008|Lost to Follow-up|1|||
48862183|NCT04271254|157333044|FG000|Overall Study|Withdrawal by Subject|3|||
48862184|NCT00930644|157333046|FG000|Overall Study|Withdrawal by Subject|4|||
48862185|NCT00930644|157333046|FG000|Overall Study|Physician Decision|2|||
48862186|NCT00930644|157333046|FG000|Overall Study|Death|1|||
48862187|NCT00930644|157333046|FG000|Overall Study|Adverse Event|16|||
48862188|NCT02660034|157333047|FG000|Overall Study|Progressive Disease (Radiographic)|3|||
48862189|NCT02660034|157333048|FG001|Overall Study|Progressive Disease (Radiographic)|1|||
48862190|NCT02660034|157333049|FG002|Overall Study|Progressive Disease (Radiographic)|0|||
48862191|NCT02660034|157333050|FG003|Overall Study|Progressive Disease (Radiographic)|1|||
48862192|NCT02660034|157333051|FG004|Overall Study|Progressive Disease (Radiographic)|0|||
48862193|NCT02660034|157333052|FG005|Overall Study|Progressive Disease (Radiographic)|0|||
48862194|NCT02660034|157333053|FG006|Overall Study|Progressive Disease (Radiographic)|0|||
48862195|NCT02660034|157333054|FG007|Overall Study|Progressive Disease (Radiographic)|0|||
48862196|NCT02660034|157333055|FG008|Overall Study|Progressive Disease (Radiographic)|0|||
48862197|NCT02660034|157333056|FG009|Overall Study|Progressive Disease (Radiographic)|0|||
48862198|NCT02660034|157333057|FG010|Overall Study|Progressive Disease (Radiographic)|0|||
48862199|NCT02660034|157333058|FG011|Overall Study|Progressive Disease (Radiographic)|0|||
48862200|NCT02660034|157333059|FG012|Overall Study|Progressive Disease (Radiographic)|0|||
48862201|NCT02660034|157333060|FG013|Overall Study|Progressive Disease (Radiographic)|0|||
48862202|NCT02660034|157333047|FG000|Overall Study|Progressive Disease (Clinical)|7|||
48862203|NCT02660034|157333048|FG001|Overall Study|Progressive Disease (Clinical)|8|||
48862204|NCT02660034|157333049|FG002|Overall Study|Progressive Disease (Clinical)|3|||
48862205|NCT02660034|157333050|FG003|Overall Study|Progressive Disease (Clinical)|9|||
48862206|NCT02660034|157333051|FG004|Overall Study|Progressive Disease (Clinical)|3|||
48862207|NCT02660034|157333052|FG005|Overall Study|Progressive Disease (Clinical)|0|||
48862208|NCT02660034|157333053|FG006|Overall Study|Progressive Disease (Clinical)|0|||
48862209|NCT02660034|157333054|FG007|Overall Study|Progressive Disease (Clinical)|0|||
48862210|NCT02660034|157333055|FG008|Overall Study|Progressive Disease (Clinical)|0|||
48862211|NCT02660034|157333056|FG009|Overall Study|Progressive Disease (Clinical)|0|||
48862212|NCT02660034|157333057|FG010|Overall Study|Progressive Disease (Clinical)|0|||
48862213|NCT02660034|157333058|FG011|Overall Study|Progressive Disease (Clinical)|0|||
48862214|NCT02660034|157333059|FG012|Overall Study|Progressive Disease (Clinical)|0|||
48862215|NCT02660034|157333060|FG013|Overall Study|Progressive Disease (Clinical)|0|||
48862216|NCT02660034|157333047|FG000|Overall Study|Lost to Follow-up|0|||
48862217|NCT02660034|157333048|FG001|Overall Study|Lost to Follow-up|0|||
48862218|NCT02660034|157333049|FG002|Overall Study|Lost to Follow-up|1|||
48862219|NCT02660034|157333050|FG003|Overall Study|Lost to Follow-up|1|||
48862220|NCT02660034|157333051|FG004|Overall Study|Lost to Follow-up|0|||
48862221|NCT02660034|157333052|FG005|Overall Study|Lost to Follow-up|0|||
48862222|NCT02660034|157333053|FG006|Overall Study|Lost to Follow-up|0|||
48862223|NCT02660034|157333054|FG007|Overall Study|Lost to Follow-up|0|||
48862224|NCT02660034|157333055|FG008|Overall Study|Lost to Follow-up|0|||
48862225|NCT02660034|157333056|FG009|Overall Study|Lost to Follow-up|1|||
48749690|NCT01543698|156930148|FG005|Phase 1b|Administrative problems|0|||
48749691|NCT01543698|156930149|FG006|Phase 1b|Administrative problems|0|||
48749692|NCT01543698|156930150|FG007|Phase 1b|Administrative problems|1|||
48749693|NCT01543698|156930151|FG008|Phase 1b|Administrative problems|0|||
48749694|NCT01543698|156930152|FG009|Phase 1b|Administrative problems|0|||
48749695|NCT01543698|156930153|FG010|Phase 1b|Administrative problems|2|||
48862226|NCT02660034|157333057|FG010|Overall Study|Lost to Follow-up|1|||
48862227|NCT02660034|157333058|FG011|Overall Study|Lost to Follow-up|1|||
48862228|NCT02660034|157333059|FG012|Overall Study|Lost to Follow-up|0|||
48862229|NCT02660034|157333060|FG013|Overall Study|Lost to Follow-up|0|||
48862230|NCT02660034|157333047|FG000|Overall Study|Participant moved into special access scheme|1|||
48862231|NCT02660034|157333048|FG001|Overall Study|Participant moved into special access scheme|2|||
48862232|NCT02660034|157333049|FG002|Overall Study|Participant moved into special access scheme|0|||
48862233|NCT02660034|157333050|FG003|Overall Study|Participant moved into special access scheme|0|||
48862234|NCT02660034|157333051|FG004|Overall Study|Participant moved into special access scheme|0|||
48862235|NCT02660034|157333052|FG005|Overall Study|Participant moved into special access scheme|0|||
48862236|NCT02660034|157333053|FG006|Overall Study|Participant moved into special access scheme|0|||
48862237|NCT02660034|157333054|FG007|Overall Study|Participant moved into special access scheme|0|||
48862238|NCT02660034|157333055|FG008|Overall Study|Participant moved into special access scheme|0|||
48862239|NCT02660034|157333056|FG009|Overall Study|Participant moved into special access scheme|0|||
48862240|NCT02660034|157333057|FG010|Overall Study|Participant moved into special access scheme|0|||
48862241|NCT02660034|157333058|FG011|Overall Study|Participant moved into special access scheme|0|||
48862242|NCT02660034|157333059|FG012|Overall Study|Participant moved into special access scheme|0|||
48862243|NCT02660034|157333060|FG013|Overall Study|Participant moved into special access scheme|0|||
48862244|NCT02660034|157333047|FG000|Overall Study|Adverse Event|1|||
48862245|NCT02660034|157333048|FG001|Overall Study|Adverse Event|0|||
48862246|NCT02660034|157333049|FG002|Overall Study|Adverse Event|0|||
48862247|NCT02660034|157333050|FG003|Overall Study|Adverse Event|0|||
48862248|NCT02660034|157333051|FG004|Overall Study|Adverse Event|0|||
48862249|NCT02660034|157333052|FG005|Overall Study|Adverse Event|0|||
48862250|NCT02660034|157333053|FG006|Overall Study|Adverse Event|0|||
48862251|NCT02660034|157333054|FG007|Overall Study|Adverse Event|0|||
48862252|NCT02660034|157333055|FG008|Overall Study|Adverse Event|0|||
48862253|NCT02660034|157333056|FG009|Overall Study|Adverse Event|0|||
48862254|NCT02660034|157333057|FG010|Overall Study|Adverse Event|0|||
48862255|NCT02660034|157333058|FG011|Overall Study|Adverse Event|0|||
48862256|NCT02660034|157333059|FG012|Overall Study|Adverse Event|0|||
48862257|NCT02660034|157333060|FG013|Overall Study|Adverse Event|0|||
48862258|NCT02660034|157333047|FG000|Overall Study|Sponsor Decision|0|||
48862259|NCT02660034|157333048|FG001|Overall Study|Sponsor Decision|1|||
48862260|NCT02660034|157333049|FG002|Overall Study|Sponsor Decision|2|||
48862261|NCT02660034|157333050|FG003|Overall Study|Sponsor Decision|2|||
48862262|NCT02660034|157333051|FG004|Overall Study|Sponsor Decision|3|||
48862263|NCT02660034|157333052|FG005|Overall Study|Sponsor Decision|0|||
48862264|NCT02660034|157333053|FG006|Overall Study|Sponsor Decision|0|||
48862265|NCT02660034|157333054|FG007|Overall Study|Sponsor Decision|0|||
48862266|NCT02660034|157333055|FG008|Overall Study|Sponsor Decision|0|||
48862267|NCT02660034|157333056|FG009|Overall Study|Sponsor Decision|0|||
48862268|NCT02660034|157333057|FG010|Overall Study|Sponsor Decision|0|||
48862269|NCT02660034|157333058|FG011|Overall Study|Sponsor Decision|0|||
48862270|NCT02660034|157333059|FG012|Overall Study|Sponsor Decision|0|||
48862271|NCT02660034|157333060|FG013|Overall Study|Sponsor Decision|1|||
48862272|NCT02660034|157333047|FG000|Overall Study|Withdrawal by Subject|0|||
48862273|NCT02660034|157333048|FG001|Overall Study|Withdrawal by Subject|0|||
48862274|NCT02660034|157333049|FG002|Overall Study|Withdrawal by Subject|0|||
48749696|NCT01543698|156930154|FG011|Phase 1b|Administrative problems|0|||
48749697|NCT01543698|156930155|FG012|Phase 1b|Administrative problems|0|||
48749698|NCT01543698|156930156|FG013|Phase 1b|Administrative problems|0|||
48749699|NCT01543698|156930157|FG014|Phase 1b|Administrative problems|0|||
48749700|NCT01543698|156930143|FG000|Phase 1b|Protocol Violation|2|||
48749701|NCT01543698|156930144|FG001|Phase 1b|Protocol Violation|0|||
48749702|NCT01543698|156930145|FG002|Phase 1b|Protocol Violation|0|||
48749703|NCT01543698|156930146|FG003|Phase 1b|Protocol Violation|0|||
48749704|NCT01543698|156930147|FG004|Phase 1b|Protocol Violation|0|||
48862275|NCT02660034|157333050|FG003|Overall Study|Withdrawal by Subject|0|||
48749705|NCT01543698|156930148|FG005|Phase 1b|Protocol Violation|0|||
48862276|NCT02660034|157333051|FG004|Overall Study|Withdrawal by Subject|0|||
48862277|NCT02660034|157333052|FG005|Overall Study|Withdrawal by Subject|0|||
48862278|NCT02660034|157333053|FG006|Overall Study|Withdrawal by Subject|1|||
48862279|NCT02660034|157333054|FG007|Overall Study|Withdrawal by Subject|1|||
48862280|NCT02660034|157333055|FG008|Overall Study|Withdrawal by Subject|1|||
48862281|NCT02660034|157333056|FG009|Overall Study|Withdrawal by Subject|0|||
48862282|NCT02660034|157333057|FG010|Overall Study|Withdrawal by Subject|0|||
48862283|NCT02660034|157333058|FG011|Overall Study|Withdrawal by Subject|1|||
48862284|NCT02660034|157333059|FG012|Overall Study|Withdrawal by Subject|2|||
48862285|NCT02660034|157333060|FG013|Overall Study|Withdrawal by Subject|0|||
48862286|NCT02660034|157333047|FG000|Overall Study|Death|0|||
48862287|NCT02660034|157333048|FG001|Overall Study|Death|0|||
48862288|NCT02660034|157333049|FG002|Overall Study|Death|0|||
48749706|NCT01543698|156930149|FG006|Phase 1b|Protocol Violation|0|||
48749707|NCT01543698|156930150|FG007|Phase 1b|Protocol Violation|0|||
48749708|NCT01543698|156930151|FG008|Phase 1b|Protocol Violation|0|||
48749709|NCT01543698|156930152|FG009|Phase 1b|Protocol Violation|0|||
48749710|NCT01543698|156930153|FG010|Phase 1b|Protocol Violation|0|||
48749711|NCT01543698|156930154|FG011|Phase 1b|Protocol Violation|0|||
48749712|NCT01543698|156930155|FG012|Phase 1b|Protocol Violation|0|||
48749713|NCT01543698|156930156|FG013|Phase 1b|Protocol Violation|0|||
48749714|NCT01543698|156930157|FG014|Phase 1b|Protocol Violation|0|||
48749715|NCT01543698|156930143|FG000|Phase 2|Protocol Violation|0|||
48749716|NCT01543698|156930144|FG001|Phase 2|Protocol Violation|0|||
48749717|NCT01543698|156930145|FG002|Phase 2|Protocol Violation|0|||
48749718|NCT01543698|156930146|FG003|Phase 2|Protocol Violation|0|||
48749719|NCT01543698|156930147|FG004|Phase 2|Protocol Violation|0|||
48749720|NCT01543698|156930148|FG005|Phase 2|Protocol Violation|0|||
48749721|NCT01543698|156930149|FG006|Phase 2|Protocol Violation|0|||
48749722|NCT01543698|156930150|FG007|Phase 2|Protocol Violation|0|||
48749723|NCT01543698|156930151|FG008|Phase 2|Protocol Violation|0|||
48749724|NCT01543698|156930152|FG009|Phase 2|Protocol Violation|0|||
48749725|NCT01543698|156930153|FG010|Phase 2|Protocol Violation|0|||
48749726|NCT01543698|156930154|FG011|Phase 2|Protocol Violation|0|||
48749727|NCT01543698|156930155|FG012|Phase 2|Protocol Violation|1|||
48749728|NCT01543698|156930156|FG013|Phase 2|Protocol Violation|0|||
48749729|NCT01543698|156930157|FG014|Phase 2|Protocol Violation|0|||
48749730|NCT01543698|156930143|FG000|Phase 2|Disease progression|0|||
48749731|NCT01543698|156930144|FG001|Phase 2|Disease progression|0|||
48749732|NCT01543698|156930145|FG002|Phase 2|Disease progression|0|||
48749733|NCT01543698|156930146|FG003|Phase 2|Disease progression|0|||
48749734|NCT01543698|156930147|FG004|Phase 2|Disease progression|0|||
48955793|NCT02488759|157665719|FG005|Overall Study|Study drug toxicity|2|||
48955794|NCT02488759|157665714|FG000|Overall Study|Adverse event unrelated to study drug|9|||
48955795|NCT02488759|157665715|FG001|Overall Study|Adverse event unrelated to study drug|11|||
48955796|NCT02488759|157665716|FG002|Overall Study|Adverse event unrelated to study drug|7|||
48749735|NCT01543698|156930148|FG005|Phase 2|Disease progression|0|||
48955797|NCT02488759|157665717|FG003|Overall Study|Adverse event unrelated to study drug|0|||
48749736|NCT01543698|156930149|FG006|Phase 2|Disease progression|0|||
48749737|NCT01543698|156930150|FG007|Phase 2|Disease progression|0|||
48749738|NCT01543698|156930151|FG008|Phase 2|Disease progression|0|||
48749739|NCT01543698|156930152|FG009|Phase 2|Disease progression|0|||
48749740|NCT01543698|156930153|FG010|Phase 2|Disease progression|0|||
48749741|NCT01543698|156930154|FG011|Phase 2|Disease progression|10|||
48749742|NCT01543698|156930155|FG012|Phase 2|Disease progression|21|||
48955798|NCT02488759|157665718|FG004|Overall Study|Adverse event unrelated to study drug|1|||
48749743|NCT01543698|156930156|FG013|Phase 2|Disease progression|30|||
48749744|NCT01543698|156930157|FG014|Phase 2|Disease progression|25|||
48749745|NCT01543698|156930143|FG000|Phase 2|Death|0|||
48749746|NCT01543698|156930144|FG001|Phase 2|Death|0|||
48749747|NCT01543698|156930145|FG002|Phase 2|Death|0|||
48749748|NCT01543698|156930146|FG003|Phase 2|Death|0|||
48749749|NCT01543698|156930147|FG004|Phase 2|Death|0|||
48749750|NCT01543698|156930148|FG005|Phase 2|Death|0|||
48749751|NCT01543698|156930149|FG006|Phase 2|Death|0|||
48749752|NCT01543698|156930150|FG007|Phase 2|Death|0|||
48749753|NCT01543698|156930151|FG008|Phase 2|Death|0|||
48749754|NCT01543698|156930152|FG009|Phase 2|Death|0|||
48749755|NCT01543698|156930153|FG010|Phase 2|Death|0|||
48749756|NCT01543698|156930154|FG011|Phase 2|Death|0|||
48749757|NCT01543698|156930155|FG012|Phase 2|Death|1|||
48749758|NCT01543698|156930156|FG013|Phase 2|Death|1|||
48749759|NCT01543698|156930157|FG014|Phase 2|Death|1|||
48749760|NCT01543698|156930143|FG000|Phase 2|Administrative problems|0|||
48749761|NCT01543698|156930144|FG001|Phase 2|Administrative problems|0|||
48955799|NCT02488759|157665719|FG005|Overall Study|Adverse event unrelated to study drug|0|||
48955800|NCT02488759|157665714|FG000|Overall Study|Participant request to discontinue study treatment|6|||
48955801|NCT02488759|157665715|FG001|Overall Study|Participant request to discontinue study treatment|8|||
48955802|NCT02488759|157665716|FG002|Overall Study|Participant request to discontinue study treatment|4|||
48955803|NCT02488759|157665717|FG003|Overall Study|Participant request to discontinue study treatment|0|||
48955804|NCT02488759|157665718|FG004|Overall Study|Participant request to discontinue study treatment|0|||
48955805|NCT02488759|157665719|FG005|Overall Study|Participant request to discontinue study treatment|0|||
48955806|NCT02488759|157665714|FG000|Overall Study|Withdrawal by Subject|4|||
48955807|NCT02488759|157665715|FG001|Overall Study|Withdrawal by Subject|0|||
48955808|NCT02488759|157665716|FG002|Overall Study|Withdrawal by Subject|3|||
48955809|NCT02488759|157665717|FG003|Overall Study|Withdrawal by Subject|0|||
48955810|NCT02488759|157665718|FG004|Overall Study|Withdrawal by Subject|0|||
48955811|NCT02488759|157665719|FG005|Overall Study|Withdrawal by Subject|2|||
48955812|NCT02488759|157665714|FG000|Overall Study|Lost to Follow-up|0|||
48955813|NCT02488759|157665715|FG001|Overall Study|Lost to Follow-up|0|||
48955814|NCT02488759|157665716|FG002|Overall Study|Lost to Follow-up|2|||
48955815|NCT02488759|157665717|FG003|Overall Study|Lost to Follow-up|0|||
48955816|NCT02488759|157665718|FG004|Overall Study|Lost to Follow-up|0|||
48955817|NCT02488759|157665719|FG005|Overall Study|Lost to Follow-up|0|||
48955818|NCT02488759|157665714|FG000|Overall Study|Maximum clinical benefit|3|||
48955819|NCT02488759|157665715|FG001|Overall Study|Maximum clinical benefit|0|||
48955820|NCT02488759|157665716|FG002|Overall Study|Maximum clinical benefit|1|||
48955821|NCT02488759|157665717|FG003|Overall Study|Maximum clinical benefit|0|||
48955822|NCT02488759|157665718|FG004|Overall Study|Maximum clinical benefit|0|||
48955823|NCT02488759|157665719|FG005|Overall Study|Maximum clinical benefit|0|||
48955824|NCT02488759|157665714|FG000|Overall Study|Other reasons|7|||
48955825|NCT02488759|157665715|FG001|Overall Study|Other reasons|32|||
48749762|NCT01543698|156930145|FG002|Phase 2|Administrative problems|0|||
48749763|NCT01543698|156930146|FG003|Phase 2|Administrative problems|0|||
48749764|NCT01543698|156930147|FG004|Phase 2|Administrative problems|0|||
48749765|NCT01543698|156930148|FG005|Phase 2|Administrative problems|0|||
48749766|NCT01543698|156930149|FG006|Phase 2|Administrative problems|0|||
48955826|NCT02488759|157665716|FG002|Overall Study|Other reasons|23|||
48955827|NCT02488759|157665717|FG003|Overall Study|Other reasons|1|||
48955828|NCT02488759|157665718|FG004|Overall Study|Other reasons|1|||
48955829|NCT02488759|157665719|FG005|Overall Study|Other reasons|1|||
48749767|NCT01543698|156930150|FG007|Phase 2|Administrative problems|0|||
48749768|NCT01543698|156930151|FG008|Phase 2|Administrative problems|0|||
48749769|NCT01543698|156930152|FG009|Phase 2|Administrative problems|0|||
48749770|NCT01543698|156930153|FG010|Phase 2|Administrative problems|0|||
48749771|NCT01543698|156930154|FG011|Phase 2|Administrative problems|0|||
48749772|NCT01543698|156930155|FG012|Phase 2|Administrative problems|0|||
48749773|NCT01543698|156930156|FG013|Phase 2|Administrative problems|3|||
48749774|NCT01543698|156930157|FG014|Phase 2|Administrative problems|1|||
48749775|NCT01543698|156930143|FG000|Phase 2|Withdrawal by Subject|0|||
48749776|NCT01543698|156930144|FG001|Phase 2|Withdrawal by Subject|0|||
48749777|NCT01543698|156930145|FG002|Phase 2|Withdrawal by Subject|0|||
48749778|NCT01543698|156930146|FG003|Phase 2|Withdrawal by Subject|0|||
48749779|NCT01543698|156930147|FG004|Phase 2|Withdrawal by Subject|0|||
48749780|NCT01543698|156930148|FG005|Phase 2|Withdrawal by Subject|0|||
48749781|NCT01543698|156930149|FG006|Phase 2|Withdrawal by Subject|0|||
48749782|NCT01543698|156930150|FG007|Phase 2|Withdrawal by Subject|0|||
48749783|NCT01543698|156930151|FG008|Phase 2|Withdrawal by Subject|0|||
48749784|NCT01543698|156930152|FG009|Phase 2|Withdrawal by Subject|0|||
48749785|NCT01543698|156930153|FG010|Phase 2|Withdrawal by Subject|0|||
48749786|NCT01543698|156930154|FG011|Phase 2|Withdrawal by Subject|0|||
48749787|NCT01543698|156930155|FG012|Phase 2|Withdrawal by Subject|0|||
48749788|NCT01543698|156930156|FG013|Phase 2|Withdrawal by Subject|3|||
48749789|NCT01543698|156930157|FG014|Phase 2|Withdrawal by Subject|1|||
48862289|NCT02660034|157333050|FG003|Overall Study|Death|0|||
48862290|NCT02660034|157333051|FG004|Overall Study|Death|0|||
48862291|NCT02660034|157333052|FG005|Overall Study|Death|13|||
48862292|NCT02660034|157333053|FG006|Overall Study|Death|14|||
48862293|NCT02660034|157333054|FG007|Overall Study|Death|10|||
48862294|NCT02660034|157333055|FG008|Overall Study|Death|9|||
48955830|NCT02531035|157667066|FG000|Overall Study|Death|0|||
48955831|NCT02531035|157667067|FG001|Overall Study|Death|1|||
48862295|NCT02660034|157333056|FG009|Overall Study|Death|21|||
48862296|NCT02660034|157333057|FG010|Overall Study|Death|17|||
48955832|NCT02531035|157667066|FG000|Overall Study|Protocol Violation|1|||
48955833|NCT02531035|157667067|FG001|Overall Study|Protocol Violation|1|||
48749790|NCT01543698|156930143|FG000|Phase 2|Adverse Event|0|||
48749791|NCT01543698|156930144|FG001|Phase 2|Adverse Event|0|||
48749792|NCT01543698|156930145|FG002|Phase 2|Adverse Event|0|||
48749793|NCT01543698|156930146|FG003|Phase 2|Adverse Event|0|||
48749794|NCT01543698|156930147|FG004|Phase 2|Adverse Event|0|||
48749795|NCT01543698|156930148|FG005|Phase 2|Adverse Event|0|||
48749796|NCT01543698|156930149|FG006|Phase 2|Adverse Event|0|||
48749797|NCT01543698|156930150|FG007|Phase 2|Adverse Event|0|||
48862297|NCT02660034|157333058|FG011|Overall Study|Death|15|||
48862298|NCT02660034|157333059|FG012|Overall Study|Death|18|||
48955834|NCT02531035|157667066|FG000|Overall Study|Noncompliance with study drug|8|||
48749798|NCT01543698|156930151|FG008|Phase 2|Adverse Event|0|||
48749799|NCT01543698|156930152|FG009|Phase 2|Adverse Event|0|||
48749800|NCT01543698|156930153|FG010|Phase 2|Adverse Event|0|||
48749801|NCT01543698|156930154|FG011|Phase 2|Adverse Event|1|||
48749802|NCT01543698|156930155|FG012|Phase 2|Adverse Event|3|||
48749803|NCT01543698|156930156|FG013|Phase 2|Adverse Event|5|||
48749804|NCT01543698|156930157|FG014|Phase 2|Adverse Event|14|||
48749805|NCT02323113|156930162|FG000|Overall Study|Adverse Event|3|||
48749806|NCT02323113|156930163|FG001|Overall Study|Adverse Event|3|||
48749807|NCT02323113|156930164|FG002|Overall Study|Adverse Event|2|||
48749808|NCT02323113|156930165|FG003|Overall Study|Adverse Event|5|||
48749809|NCT02323113|156930166|FG004|Overall Study|Adverse Event|8|||
48749810|NCT02323113|156930167|FG005|Overall Study|Adverse Event|3|||
48749811|NCT02323113|156930168|FG006|Overall Study|Adverse Event|6|||
48749812|NCT02323113|156930169|FG007|Overall Study|Adverse Event|0|||
48749813|NCT02323113|156930162|FG000|Overall Study|Progressive Disease|0|||
48749814|NCT02323113|156930163|FG001|Overall Study|Progressive Disease|1|||
48749815|NCT02323113|156930164|FG002|Overall Study|Progressive Disease|1|||
48749816|NCT02323113|156930165|FG003|Overall Study|Progressive Disease|0|||
48749817|NCT02323113|156930166|FG004|Overall Study|Progressive Disease|0|||
48749818|NCT02323113|156930167|FG005|Overall Study|Progressive Disease|3|||
48749819|NCT02323113|156930168|FG006|Overall Study|Progressive Disease|0|||
48749820|NCT02323113|156930169|FG007|Overall Study|Progressive Disease|0|||
48749821|NCT02323113|156930162|FG000|Overall Study|Symptomatic Deterioration|0|||
48749822|NCT02323113|156930163|FG001|Overall Study|Symptomatic Deterioration|0|||
48749823|NCT02323113|156930164|FG002|Overall Study|Symptomatic Deterioration|1|||
48749824|NCT02323113|156930165|FG003|Overall Study|Symptomatic Deterioration|0|||
48749825|NCT02323113|156930166|FG004|Overall Study|Symptomatic Deterioration|1|||
48749826|NCT02323113|156930167|FG005|Overall Study|Symptomatic Deterioration|0|||
48749827|NCT02323113|156930168|FG006|Overall Study|Symptomatic Deterioration|0|||
48749828|NCT02323113|156930169|FG007|Overall Study|Symptomatic Deterioration|0|||
48749829|NCT02323113|156930162|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
48749830|NCT02323113|156930163|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
48749831|NCT02323113|156930164|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
48749832|NCT02323113|156930165|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
48749833|NCT02323113|156930166|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
48749834|NCT02323113|156930167|FG005|Overall Study|Unsatisfactory Therapeutic Response|2|||
48749835|NCT02323113|156930168|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
48749836|NCT02323113|156930169|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
48749837|NCT02323113|156930162|FG000|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
48749838|NCT02323113|156930163|FG001|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1|||
48749839|NCT02323113|156930164|FG002|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
48862299|NCT02660034|157333060|FG013|Overall Study|Death|7|||
48862300|NCT02660034|157333047|FG000|Overall Study|Physician Decision|0|||
48862301|NCT02660034|157333048|FG001|Overall Study|Physician Decision|0|||
48862302|NCT02660034|157333049|FG002|Overall Study|Physician Decision|0|||
48862303|NCT02660034|157333050|FG003|Overall Study|Physician Decision|0|||
48749840|NCT02323113|156930165|FG003|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
48749841|NCT02323113|156930166|FG004|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
48749842|NCT02323113|156930167|FG005|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
48749843|NCT02323113|156930168|FG006|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
48749844|NCT02323113|156930169|FG007|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
48749845|NCT00381485|156930174|FG000|Open-Label Run-In Period|Adverse Event|9|||
48749846|NCT00381485|156930175|FG001|Open-Label Run-In Period|Adverse Event|0|||
48749847|NCT00381485|156930176|FG002|Open-Label Run-In Period|Adverse Event|0|||
48749848|NCT00381485|156930177|FG003|Open-Label Run-In Period|Adverse Event|0|||
48749849|NCT00381485|156930174|FG000|Open-Label Run-In Period|Did not meet protocol eligibility|76|||
48749850|NCT00381485|156930175|FG001|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
48749851|NCT00381485|156930176|FG002|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
48749852|NCT00381485|156930177|FG003|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
48749853|NCT00381485|156930174|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16|||
48749854|NCT00381485|156930175|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
48749855|NCT00381485|156930176|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
48749856|NCT00381485|156930177|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
48749857|NCT00381485|156930174|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1|||
48749858|NCT00381485|156930175|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
48749859|NCT00381485|156930176|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
48749860|NCT00381485|156930177|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
48749861|NCT00381485|156930174|FG000|Open-Label Run-In Period|Lost to Follow-up|3|||
48749862|NCT00381485|156930175|FG001|Open-Label Run-In Period|Lost to Follow-up|0|||
48749863|NCT00381485|156930176|FG002|Open-Label Run-In Period|Lost to Follow-up|0|||
48955835|NCT02531035|157667067|FG001|Overall Study|Noncompliance with study drug|3|||
48955836|NCT02531035|157667066|FG000|Overall Study|Physician Decision|1|||
48955837|NCT02531035|157667067|FG001|Overall Study|Physician Decision|0|||
48955838|NCT02531035|157667066|FG000|Overall Study|Adverse Event|16|||
48955839|NCT02531035|157667067|FG001|Overall Study|Adverse Event|45|||
48749864|NCT00381485|156930177|FG003|Open-Label Run-In Period|Lost to Follow-up|0|||
48749865|NCT00381485|156930174|FG000|Open-Label Run-In Period|Treatment failure|1|||
48749866|NCT00381485|156930175|FG001|Open-Label Run-In Period|Treatment failure|0|||
48749867|NCT00381485|156930176|FG002|Open-Label Run-In Period|Treatment failure|0|||
48749868|NCT00381485|156930177|FG003|Open-Label Run-In Period|Treatment failure|0|||
48749869|NCT00381485|156930174|FG000|Double-Blind Treatment Period|Adverse Event|0|||
48749870|NCT00381485|156930175|FG001|Double-Blind Treatment Period|Adverse Event|2|||
48749871|NCT00381485|156930176|FG002|Double-Blind Treatment Period|Adverse Event|2|||
48749872|NCT00381485|156930177|FG003|Double-Blind Treatment Period|Adverse Event|5|||
48749873|NCT00381485|156930174|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
48749874|NCT00381485|156930175|FG001|Double-Blind Treatment Period|Lack of Efficacy|8|||
48749875|NCT00381485|156930176|FG002|Double-Blind Treatment Period|Lack of Efficacy|11|||
48749876|NCT00381485|156930177|FG003|Double-Blind Treatment Period|Lack of Efficacy|13|||
48749877|NCT00381485|156930174|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
48749878|NCT00381485|156930175|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
48749879|NCT00381485|156930176|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
48749880|NCT00381485|156930177|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
48749881|NCT00381485|156930174|FG000|Double-Blind Treatment Period|Noncompliance with protocol|0|||
48749882|NCT00381485|156930175|FG001|Double-Blind Treatment Period|Noncompliance with protocol|9|||
48749883|NCT00381485|156930176|FG002|Double-Blind Treatment Period|Noncompliance with protocol|3|||
48749884|NCT00381485|156930177|FG003|Double-Blind Treatment Period|Noncompliance with protocol|3|||
48749885|NCT00381485|156930174|FG000|Double-Blind Treatment Period|Did not meet protocol eligibility|0|||
48749886|NCT00381485|156930175|FG001|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
48749887|NCT00381485|156930176|FG002|Double-Blind Treatment Period|Did not meet protocol eligibility|7|||
48749888|NCT00381485|156930177|FG003|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
48749889|NCT00381485|156930174|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0|||
48749890|NCT00381485|156930175|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2|||
48749891|NCT00381485|156930176|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1|||
48749892|NCT00381485|156930177|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4|||
48749893|NCT00381485|156930174|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
48749894|NCT00381485|156930175|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
48749895|NCT00381485|156930176|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
48749896|NCT00381485|156930177|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1|||
48749897|NCT00381485|156930174|FG000|Double-Blind Treatment Period|Administrative|0|||
48749898|NCT00381485|156930175|FG001|Double-Blind Treatment Period|Administrative|1|||
48749899|NCT00381485|156930176|FG002|Double-Blind Treatment Period|Administrative|0|||
48749900|NCT00381485|156930177|FG003|Double-Blind Treatment Period|Administrative|1|||
48749901|NCT01235351|156930178|FG000|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10|||
48749902|NCT01235351|156930179|FG001|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4|||
48749903|NCT01918774|156930180|FG000|Overall Study|Lost prior to first CBTw session|4|||
48749904|NCT01918774|156930180|FG000|Overall Study|Lost to Follow-up|1|||
48749905|NCT02324569|156930203|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
48749906|NCT02324569|156930204|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
48749907|NCT02324569|156930203|FG000|Overall Study|Voluntary Withdrawal|3|||
48749908|NCT02324569|156930204|FG001|Overall Study|Voluntary Withdrawal|6|||
48749909|NCT02324569|156930203|FG000|Overall Study|Lack of Efficacy|2|||
48862304|NCT02660034|157333051|FG004|Overall Study|Physician Decision|0|||
48862305|NCT02660034|157333052|FG005|Overall Study|Physician Decision|0|||
48862306|NCT02660034|157333053|FG006|Overall Study|Physician Decision|0|||
48862307|NCT02660034|157333054|FG007|Overall Study|Physician Decision|0|||
48862308|NCT02660034|157333055|FG008|Overall Study|Physician Decision|0|||
48862309|NCT02660034|157333056|FG009|Overall Study|Physician Decision|0|||
48862310|NCT02660034|157333057|FG010|Overall Study|Physician Decision|0|||
48862311|NCT02660034|157333058|FG011|Overall Study|Physician Decision|0|||
48862312|NCT02660034|157333059|FG012|Overall Study|Physician Decision|0|||
48862313|NCT02660034|157333060|FG013|Overall Study|Physician Decision|1|||
48862314|NCT02660034|157333047|FG000|Overall Study|Participants transferred to LTE|0|||
48862315|NCT02660034|157333048|FG001|Overall Study|Participants transferred to LTE|0|||
48862316|NCT02660034|157333049|FG002|Overall Study|Participants transferred to LTE|0|||
48862317|NCT02660034|157333050|FG003|Overall Study|Participants transferred to LTE|0|||
48862318|NCT02660034|157333051|FG004|Overall Study|Participants transferred to LTE|0|||
48749910|NCT02324569|156930204|FG001|Overall Study|Lack of Efficacy|3|||
48749911|NCT02324569|156930203|FG000|Overall Study|Change Insulin Dosage Exceeding Criteria|0|||
48749912|NCT02324569|156930204|FG001|Overall Study|Change Insulin Dosage Exceeding Criteria|2|||
48749913|NCT02324569|156930203|FG000|Overall Study|Inconvenient Schedule|2|||
48749914|NCT02324569|156930204|FG001|Overall Study|Inconvenient Schedule|0|||
48749915|NCT01892293|156930217|FG000|Overall Study|Apheresed but not treated|4|||
48749916|NCT00599924|156930218|FG000|Overall Study|Lack of Efficacy|3|||
48749917|NCT00599924|156930219|FG001|Overall Study|Lack of Efficacy|5|||
48749918|NCT00599924|156930220|FG002|Overall Study|Lack of Efficacy|1|||
48749919|NCT00599924|156930221|FG003|Overall Study|Lack of Efficacy|2|||
48749920|NCT00599924|156930222|FG004|Overall Study|Lack of Efficacy|3|||
48749921|NCT00599924|156930223|FG005|Overall Study|Lack of Efficacy|2|||
48749922|NCT00599924|156930224|FG006|Overall Study|Lack of Efficacy|0|||
48749923|NCT00599924|156930218|FG000|Overall Study|Adverse Event|0|||
48749924|NCT00599924|156930219|FG001|Overall Study|Adverse Event|0|||
48749925|NCT00599924|156930220|FG002|Overall Study|Adverse Event|0|||
48749926|NCT00599924|156930221|FG003|Overall Study|Adverse Event|2|||
48749927|NCT00599924|156930222|FG004|Overall Study|Adverse Event|0|||
48749928|NCT00599924|156930223|FG005|Overall Study|Adverse Event|0|||
48749929|NCT00599924|156930224|FG006|Overall Study|Adverse Event|2|||
48749930|NCT00599924|156930218|FG000|Overall Study|Death|0|||
48749931|NCT00599924|156930219|FG001|Overall Study|Death|0|||
48749932|NCT00599924|156930220|FG002|Overall Study|Death|0|||
48749933|NCT00599924|156930221|FG003|Overall Study|Death|2|||
48749934|NCT00599924|156930222|FG004|Overall Study|Death|0|||
48749935|NCT00599924|156930223|FG005|Overall Study|Death|2|||
48749936|NCT00599924|156930224|FG006|Overall Study|Death|1|||
48749937|NCT00599924|156930218|FG000|Overall Study|Protocol Violation|0|||
48749938|NCT00599924|156930219|FG001|Overall Study|Protocol Violation|0|||
48749939|NCT00599924|156930220|FG002|Overall Study|Protocol Violation|0|||
48749940|NCT00599924|156930221|FG003|Overall Study|Protocol Violation|1|||
48749941|NCT00599924|156930222|FG004|Overall Study|Protocol Violation|0|||
48749942|NCT00599924|156930223|FG005|Overall Study|Protocol Violation|0|||
48749943|NCT00599924|156930224|FG006|Overall Study|Protocol Violation|0|||
48749944|NCT00599924|156930218|FG000|Overall Study|Withdrawal by Subject|0|||
48749945|NCT00599924|156930219|FG001|Overall Study|Withdrawal by Subject|0|||
48749946|NCT00599924|156930220|FG002|Overall Study|Withdrawal by Subject|1|||
48749947|NCT00599924|156930221|FG003|Overall Study|Withdrawal by Subject|0|||
48749948|NCT00599924|156930222|FG004|Overall Study|Withdrawal by Subject|1|||
48749949|NCT00599924|156930223|FG005|Overall Study|Withdrawal by Subject|0|||
48749950|NCT00599924|156930224|FG006|Overall Study|Withdrawal by Subject|0|||
48749951|NCT00599924|156930218|FG000|Overall Study|Other|0|||
48749952|NCT00599924|156930219|FG001|Overall Study|Other|0|||
48749953|NCT00599924|156930220|FG002|Overall Study|Other|0|||
48749954|NCT00599924|156930221|FG003|Overall Study|Other|1|||
48749955|NCT00599924|156930222|FG004|Overall Study|Other|2|||
48749956|NCT00599924|156930223|FG005|Overall Study|Other|0|||
48749957|NCT00599924|156930224|FG006|Overall Study|Other|2|||
48749958|NCT01397084|156930240|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
48955840|NCT02531035|157667066|FG000|Overall Study|Other|3|||
48955841|NCT02531035|157667067|FG001|Overall Study|Other|2|||
48749959|NCT01397084|156930240|FG000|Overall Study|Protocol Violation|2|||
48955842|NCT02531035|157667066|FG000|Overall Study|Withdrawal by Subject|42|||
48749960|NCT01397084|156930240|FG000|Overall Study|Adverse Event|2|||
48749961|NCT01397084|156930240|FG000|Overall Study|Withdrawal by Subject|1|||
48749962|NCT01397084|156930240|FG000|Overall Study|Lost to Follow-up|1|||
48749963|NCT01397084|156930240|FG000|Overall Study|Used other proton pump inhibitor|1|||
48749964|NCT00331682|156930243|FG000|Overall Study|Adverse Event|1|||
48749965|NCT00618072|156930244|FG000|Overall Study|Lost to Follow-up|2|||
48749966|NCT00618072|156930245|FG001|Overall Study|Lost to Follow-up|0|||
48749967|NCT00618072|156930246|FG002|Overall Study|Lost to Follow-up|3|||
48749968|NCT00618072|156930244|FG000|Overall Study|Physician Decision|0|||
48749969|NCT00618072|156930245|FG001|Overall Study|Physician Decision|1|||
48955843|NCT02531035|157667067|FG001|Overall Study|Withdrawal by Subject|32|||
48955844|NCT02531035|157667066|FG000|Overall Study|Lost to Follow-up|8|||
48749970|NCT00618072|156930246|FG002|Overall Study|Physician Decision|1|||
48749971|NCT03292588|156930247|FG000|Overall Study|Death|1|||
48749972|NCT03292588|156930248|FG001|Overall Study|Death|0|||
48749973|NCT03292588|156930247|FG000|Overall Study|Lost to Follow-up|12|||
48749974|NCT03292588|156930248|FG001|Overall Study|Lost to Follow-up|16|||
48749975|NCT03292588|156930247|FG000|Overall Study|Physician Decision|0|||
48749976|NCT03292588|156930248|FG001|Overall Study|Physician Decision|1|||
48749977|NCT03292588|156930247|FG000|Overall Study|Withdrawal by Subject|4|||
48749978|NCT03292588|156930248|FG001|Overall Study|Withdrawal by Subject|4|||
48749979|NCT03292588|156930247|FG000|Overall Study|Move out of town|1|||
48749980|NCT03292588|156930248|FG001|Overall Study|Move out of town|0|||
48749981|NCT03292588|156930247|FG000|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
48749982|NCT03292588|156930248|FG001|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
48749983|NCT00592384|156930249|FG000|Overall Study|Withdrawal by Subject|5|||
48749984|NCT00592384|156930250|FG001|Overall Study|Withdrawal by Subject|6|||
48749985|NCT02014597|156930254|FG000|Overall Study|Unable to record log contrast sensitivity|2|||
48749986|NCT02014597|156930255|FG001|Overall Study|Unable to record log contrast sensitivity|1|||
48749987|NCT03555591|156930256|FG000|Overall Study|Protocol Violation|77|||
48749988|NCT01532414|156930257|FG000|Overall Study|Lost to Follow-up|3|||
48749989|NCT01532414|156930258|FG001|Overall Study|Lost to Follow-up|0|||
48749990|NCT01532414|156930259|FG002|Overall Study|Lost to Follow-up|1|||
48749991|NCT01532414|156930257|FG000|Overall Study|Withdrawal by Subject|3|||
48749992|NCT01532414|156930258|FG001|Overall Study|Withdrawal by Subject|0|||
48749993|NCT01532414|156930259|FG002|Overall Study|Withdrawal by Subject|0|||
48749994|NCT01532414|156930257|FG000|Overall Study|No V6 semen sample|0|||
48749995|NCT01532414|156930258|FG001|Overall Study|No V6 semen sample|1|||
48749996|NCT01532414|156930259|FG002|Overall Study|No V6 semen sample|0|||
48749997|NCT01532414|156930257|FG000|Overall Study|Adverse Event|0|||
48749998|NCT01532414|156930258|FG001|Overall Study|Adverse Event|1|||
48749999|NCT01532414|156930259|FG002|Overall Study|Adverse Event|1|||
48750000|NCT01532414|156930257|FG000|Overall Study|Unable to complete 24 hour PK|0|||
48750001|NCT01532414|156930258|FG001|Overall Study|Unable to complete 24 hour PK|0|||
48750002|NCT01532414|156930259|FG002|Overall Study|Unable to complete 24 hour PK|1|||
48750003|NCT01532414|156930257|FG000|Overall Study|Withdrawn by sponsor|1|||
48750004|NCT01532414|156930258|FG001|Overall Study|Withdrawn by sponsor|0|||
48862319|NCT02660034|157333052|FG005|Overall Study|Participants transferred to LTE|10|||
48862320|NCT02660034|157333053|FG006|Overall Study|Participants transferred to LTE|8|||
48862321|NCT02660034|157333054|FG007|Overall Study|Participants transferred to LTE|8|||
48862322|NCT02660034|157333055|FG008|Overall Study|Participants transferred to LTE|10|||
48862323|NCT02660034|157333056|FG009|Overall Study|Participants transferred to LTE|1|||
48862324|NCT02660034|157333057|FG010|Overall Study|Participants transferred to LTE|2|||
48955845|NCT02531035|157667067|FG001|Overall Study|Lost to Follow-up|10|||
48750005|NCT01532414|156930259|FG002|Overall Study|Withdrawn by sponsor|0|||
48750006|NCT00482612|156930260|FG000|In-treatment Period|No study medication administered|0|||
48750007|NCT00482612|156930261|FG001|In-treatment Period|No study medication administered|0|||
48750008|NCT00482612|156930262|FG002|In-treatment Period|No study medication administered|1|||
48750009|NCT00482612|156930263|FG003|In-treatment Period|No study medication administered|0|||
48750010|NCT00482612|156930260|FG000|Follow-up Period|Other|4|||
48750011|NCT00482612|156930261|FG001|Follow-up Period|Other|2|||
48750012|NCT00482612|156930262|FG002|Follow-up Period|Other|1|||
48750013|NCT00482612|156930263|FG003|Follow-up Period|Other|2|||
48750014|NCT00482612|156930260|FG000|Follow-up Period|Lack of compliance|0|||
48750015|NCT00482612|156930261|FG001|Follow-up Period|Lack of compliance|0|||
48750016|NCT00482612|156930262|FG002|Follow-up Period|Lack of compliance|1|||
48750017|NCT00482612|156930263|FG003|Follow-up Period|Lack of compliance|0|||
48750018|NCT00482612|156930260|FG000|Follow-up Period|Lost to Follow-up|0|||
48750019|NCT00482612|156930261|FG001|Follow-up Period|Lost to Follow-up|4|||
48750020|NCT00482612|156930262|FG002|Follow-up Period|Lost to Follow-up|2|||
48750021|NCT00482612|156930263|FG003|Follow-up Period|Lost to Follow-up|1|||
48750022|NCT00482612|156930260|FG000|Follow-up Period|Adverse Event|4|||
48750023|NCT00482612|156930261|FG001|Follow-up Period|Adverse Event|7|||
48750024|NCT00482612|156930262|FG002|Follow-up Period|Adverse Event|9|||
48750025|NCT00482612|156930263|FG003|Follow-up Period|Adverse Event|0|||
48750026|NCT00482612|156930260|FG000|Follow-up Period|Lack of Efficacy|2|||
48750027|NCT00482612|156930261|FG001|Follow-up Period|Lack of Efficacy|0|||
48862325|NCT02660034|157333058|FG011|Overall Study|Participants transferred to LTE|4|||
48750028|NCT00482612|156930262|FG002|Follow-up Period|Lack of Efficacy|1|||
48750029|NCT00482612|156930263|FG003|Follow-up Period|Lack of Efficacy|0|||
48750030|NCT00482612|156930260|FG000|Follow-up Period|Withdrawal by Subject|3|||
48862326|NCT02660034|157333059|FG012|Overall Study|Participants transferred to LTE|1|||
48862327|NCT02660034|157333060|FG013|Overall Study|Participants transferred to LTE|1|||
48955846|NCT02531035|157667066|FG000|Overall Study|Randomized, not treated|2|||
48955847|NCT02531035|157667067|FG001|Overall Study|Randomized, not treated|1|||
48750031|NCT00482612|156930261|FG001|Follow-up Period|Withdrawal by Subject|5|||
48750032|NCT00482612|156930262|FG002|Follow-up Period|Withdrawal by Subject|7|||
48750033|NCT00482612|156930263|FG003|Follow-up Period|Withdrawal by Subject|2|||
48862328|NCT03184519|157333062|FG000|Overall Study|Lost to Follow-up|6|||
48862329|NCT03184519|157333062|FG000|Overall Study|Physician Decision|21|||
48862330|NCT04879823|157333063|FG000|Overall Study|Physician Decision|3|||
48862331|NCT04879823|157333064|FG001|Overall Study|Physician Decision|1|||
48862332|NCT04879823|157333063|FG000|Overall Study|Protocol Violation|2|||
48862333|NCT04879823|157333064|FG001|Overall Study|Protocol Violation|3|||
48862334|NCT04879823|157333063|FG000|Overall Study|Lost to Follow-up|43|||
48862335|NCT04879823|157333064|FG001|Overall Study|Lost to Follow-up|35|||
48862336|NCT01182285|157333073|FG000|First Intervention Week 1-10|Disease progression|1|||
48862337|NCT01182285|157333074|FG001|First Intervention Week 1-10|Disease progression|0|||
48862338|NCT01182285|157333075|FG002|First Intervention Week 1-10|Disease progression|0|||
48862339|NCT01182285|157333073|FG000|First Intervention Week 1-10|Adverse Event|1|||
48862340|NCT01182285|157333074|FG001|First Intervention Week 1-10|Adverse Event|0|||
48862341|NCT01182285|157333075|FG002|First Intervention Week 1-10|Adverse Event|0|||
48862342|NCT01182285|157333073|FG000|First Intervention Week 1-10|Non-compliance|1|||
48862343|NCT01182285|157333074|FG001|First Intervention Week 1-10|Non-compliance|0|||
48862344|NCT01182285|157333075|FG002|First Intervention Week 1-10|Non-compliance|0|||
48862345|NCT01182285|157333073|FG000|Third Intervention Week 11-52|Disease Progression|0|||
48862346|NCT01182285|157333074|FG001|Third Intervention Week 11-52|Disease Progression|0|||
48955848|NCT01228071|157667072|FG000|Overall Study|Protocol Violation|1|||
48862347|NCT01182285|157333075|FG002|Third Intervention Week 11-52|Disease Progression|6|||
48862348|NCT01182285|157333073|FG000|Third Intervention Week 11-52|Other|0|||
48862349|NCT01182285|157333074|FG001|Third Intervention Week 11-52|Other|0|||
48862350|NCT01182285|157333075|FG002|Third Intervention Week 11-52|Other|2|||
48862351|NCT00841321|157333076|FG000|Overall Study|Lost to Follow-up|1|||
48862352|NCT00841321|157333077|FG001|Overall Study|Lost to Follow-up|1|||
48862353|NCT00841321|157333076|FG000|Overall Study|Adverse Event|0|||
48862354|NCT00841321|157333077|FG001|Overall Study|Adverse Event|2|||
48862355|NCT00248794|157333078|FG000|Overall Study|Lost to Follow-up|6|||
48862356|NCT00248794|157333079|FG001|Overall Study|Lost to Follow-up|8|||
48862357|NCT00248794|157333080|FG002|Overall Study|Lost to Follow-up|3|||
48862358|NCT00244751|157333083|FG000|Overall Study|Adverse Event|7|||
48862359|NCT00244751|157333084|FG001|Overall Study|Adverse Event|7|||
48862360|NCT00244751|157333085|FG002|Overall Study|Adverse Event|5|||
48862361|NCT00244751|157333083|FG000|Overall Study|Lost to Follow-up|0|||
48750034|NCT00482612|156930260|FG000|Follow-up Period|Reasons not related to trial|1|||
48750035|NCT00482612|156930261|FG001|Follow-up Period|Reasons not related to trial|0|||
48750036|NCT00482612|156930262|FG002|Follow-up Period|Reasons not related to trial|1|||
48750037|NCT00482612|156930263|FG003|Follow-up Period|Reasons not related to trial|3|||
48750038|NCT02483520|156930264|FG000|Overall Study|Lost to Follow-up|3|||
48750039|NCT02483520|156930265|FG001|Overall Study|Lost to Follow-up|4|||
48750040|NCT02483520|156930264|FG000|Overall Study|Withdrawal by Subject|4|||
48750041|NCT02483520|156930265|FG001|Overall Study|Withdrawal by Subject|14|||
48750042|NCT02483520|156930264|FG000|Overall Study|Hospitalized|2|||
48750043|NCT02483520|156930265|FG001|Overall Study|Hospitalized|3|||
48750044|NCT02483520|156930264|FG000|Overall Study|Moved to LTC|2|||
48750045|NCT02483520|156930265|FG001|Overall Study|Moved to LTC|3|||
48750046|NCT02057406|156930266|FG000|Overall Study|Physician Decision|0|||
48862362|NCT00244751|157333084|FG001|Overall Study|Lost to Follow-up|1|||
48862363|NCT00244751|157333085|FG002|Overall Study|Lost to Follow-up|0|||
48862364|NCT00244751|157333083|FG000|Overall Study|Protocol Violation|1|||
48862365|NCT00244751|157333084|FG001|Overall Study|Protocol Violation|0|||
48862366|NCT00244751|157333085|FG002|Overall Study|Protocol Violation|1|||
48862367|NCT00244751|157333083|FG000|Overall Study|Withdrawal by Subject|7|||
48862368|NCT00244751|157333084|FG001|Overall Study|Withdrawal by Subject|5|||
48862369|NCT00244751|157333085|FG002|Overall Study|Withdrawal by Subject|3|||
48862370|NCT00244751|157333083|FG000|Overall Study|Elevated liver enzymes|1|||
48862371|NCT00244751|157333084|FG001|Overall Study|Elevated liver enzymes|0|||
48862372|NCT00244751|157333085|FG002|Overall Study|Elevated liver enzymes|0|||
48862373|NCT00244751|157333083|FG000|Overall Study|Lack of compliance with protocol|0|||
48862374|NCT00244751|157333084|FG001|Overall Study|Lack of compliance with protocol|1|||
48862375|NCT00244751|157333085|FG002|Overall Study|Lack of compliance with protocol|0|||
48862376|NCT00244751|157333083|FG000|Overall Study|Safety reasons|0|||
48862377|NCT00244751|157333084|FG001|Overall Study|Safety reasons|1|||
48862378|NCT00244751|157333085|FG002|Overall Study|Safety reasons|0|||
48862379|NCT00244751|157333083|FG000|Overall Study|Participant randomized by mistake|0|||
48862380|NCT00244751|157333084|FG001|Overall Study|Participant randomized by mistake|0|||
48862381|NCT00244751|157333085|FG002|Overall Study|Participant randomized by mistake|1|||
48862382|NCT03651271|157333086|FG000|Overall Study|Death|4|||
48862383|NCT03651271|157333087|FG001|Overall Study|Death|37|||
48862384|NCT03651271|157333088|FG002|Overall Study|Death|0|||
48862385|NCT03651271|157333089|FG003|Overall Study|Death|2|||
48862386|NCT03651271|157333090|FG004|Overall Study|Death|6|||
48862387|NCT03651271|157333086|FG000|Overall Study|Lost to Follow-up|1|||
48862388|NCT03651271|157333087|FG001|Overall Study|Lost to Follow-up|5|||
48862389|NCT03651271|157333088|FG002|Overall Study|Lost to Follow-up|0|||
48862390|NCT03651271|157333089|FG003|Overall Study|Lost to Follow-up|1|||
48862391|NCT03651271|157333090|FG004|Overall Study|Lost to Follow-up|0|||
48862392|NCT03651271|157333086|FG000|Overall Study|Physician Decision|0|||
48750047|NCT02057406|156930267|FG001|Overall Study|Physician Decision|0|||
48862393|NCT03651271|157333087|FG001|Overall Study|Physician Decision|2|||
48862394|NCT03651271|157333088|FG002|Overall Study|Physician Decision|0|||
48862395|NCT03651271|157333089|FG003|Overall Study|Physician Decision|0|||
48862396|NCT03651271|157333090|FG004|Overall Study|Physician Decision|0|||
48862397|NCT03651271|157333086|FG000|Overall Study|Withdrawal by Subject|1|||
48862398|NCT03651271|157333087|FG001|Overall Study|Withdrawal by Subject|15|||
48862399|NCT03651271|157333088|FG002|Overall Study|Withdrawal by Subject|0|||
48862400|NCT03651271|157333089|FG003|Overall Study|Withdrawal by Subject|0|||
48862401|NCT03651271|157333090|FG004|Overall Study|Withdrawal by Subject|1|||
48862402|NCT03651271|157333086|FG000|Overall Study|Patient medically unable to continue|0|||
48862403|NCT03651271|157333087|FG001|Overall Study|Patient medically unable to continue|0|||
48862404|NCT03651271|157333088|FG002|Overall Study|Patient medically unable to continue|0|||
48862405|NCT03651271|157333089|FG003|Overall Study|Patient medically unable to continue|1|||
48862406|NCT03651271|157333090|FG004|Overall Study|Patient medically unable to continue|0|||
48862407|NCT04380688|157333093|FG000|Overall Study|Death|2|||
48862408|NCT04380688|157333094|FG001|Overall Study|Death|2|||
48862409|NCT04380688|157333093|FG000|Overall Study|Lost to Follow-up|2|||
48862410|NCT04380688|157333094|FG001|Overall Study|Lost to Follow-up|4|||
48862411|NCT04380688|157333093|FG000|Overall Study|Withdrawal by Subject|3|||
48862412|NCT04380688|157333094|FG001|Overall Study|Withdrawal by Subject|3|||
48862413|NCT00296504|157333095|FG000|Interim Analysis|Withdrawal by Subject|8|||
48862414|NCT00296504|157333096|FG001|Interim Analysis|Withdrawal by Subject|0|||
48862415|NCT00296504|157333097|FG002|Interim Analysis|Withdrawal by Subject|12|||
48862416|NCT00296504|157333098|FG003|Interim Analysis|Withdrawal by Subject|0|||
48862417|NCT00296504|157333099|FG004|Interim Analysis|Withdrawal by Subject|5|||
48862418|NCT00296504|157333100|FG005|Interim Analysis|Withdrawal by Subject|5|||
48862419|NCT00296504|157333101|FG006|Interim Analysis|Withdrawal by Subject|9|||
48862420|NCT00296504|157333102|FG007|Interim Analysis|Withdrawal by Subject|3|||
48862421|NCT00296504|157333103|FG008|Interim Analysis|Withdrawal by Subject|0|||
48862422|NCT00296504|157333095|FG000|Interim Analysis|Lost to Follow-up|13|||
48862423|NCT00296504|157333096|FG001|Interim Analysis|Lost to Follow-up|3|||
48862424|NCT00296504|157333097|FG002|Interim Analysis|Lost to Follow-up|26|||
48862425|NCT00296504|157333098|FG003|Interim Analysis|Lost to Follow-up|8|||
48862426|NCT00296504|157333099|FG004|Interim Analysis|Lost to Follow-up|14|||
48862427|NCT00296504|157333100|FG005|Interim Analysis|Lost to Follow-up|4|||
48750048|NCT02057406|156930268|FG002|Overall Study|Physician Decision|2|||
48750049|NCT02057406|156930266|FG000|Overall Study|Withdrawal by Subject|0|||
48750050|NCT02057406|156930267|FG001|Overall Study|Withdrawal by Subject|2|||
48750051|NCT02057406|156930268|FG002|Overall Study|Withdrawal by Subject|0|||
48750052|NCT02057406|156930266|FG000|Overall Study|Lost to Follow-up|0|||
48750053|NCT02057406|156930267|FG001|Overall Study|Lost to Follow-up|0|||
48750054|NCT02057406|156930268|FG002|Overall Study|Lost to Follow-up|1|||
48750055|NCT02057406|156930266|FG000|Overall Study|Death|1|||
48750056|NCT02057406|156930267|FG001|Overall Study|Death|0|||
48750057|NCT02057406|156930268|FG002|Overall Study|Death|0|||
48750058|NCT02057406|156930266|FG000|Overall Study|Protocol Violation|0|||
48750059|NCT02057406|156930267|FG001|Overall Study|Protocol Violation|1|||
48750060|NCT02057406|156930268|FG002|Overall Study|Protocol Violation|0|||
48750061|NCT02057406|156930266|FG000|Overall Study|Patient transportation issues|0|||
48750062|NCT02057406|156930267|FG001|Overall Study|Patient transportation issues|0|||
48750063|NCT02057406|156930268|FG002|Overall Study|Patient transportation issues|1|||
48750064|NCT02051608|156930269|FG000|Part 1: Double Blind Treatment|Death|3|||
48750065|NCT02051608|156930270|FG001|Part 1: Double Blind Treatment|Death|3|||
48750066|NCT02051608|156930271|FG002|Part 1: Double Blind Treatment|Death|0|||
48750067|NCT02051608|156930272|FG003|Part 1: Double Blind Treatment|Death|0|||
48750068|NCT02051608|156930269|FG000|Part 1: Double Blind Treatment|Adverse Event|2|||
48750069|NCT02051608|156930270|FG001|Part 1: Double Blind Treatment|Adverse Event|8|||
48750070|NCT02051608|156930271|FG002|Part 1: Double Blind Treatment|Adverse Event|0|||
48750071|NCT02051608|156930272|FG003|Part 1: Double Blind Treatment|Adverse Event|0|||
48750072|NCT02051608|156930269|FG000|Part 1: Double Blind Treatment|Withdrawal by Subject|42|||
48750073|NCT02051608|156930270|FG001|Part 1: Double Blind Treatment|Withdrawal by Subject|29|||
48750074|NCT02051608|156930271|FG002|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
48750075|NCT02051608|156930272|FG003|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
48750076|NCT02051608|156930269|FG000|Part 1: Double Blind Treatment|Physician Decision|2|||
48750077|NCT02051608|156930270|FG001|Part 1: Double Blind Treatment|Physician Decision|4|||
48862428|NCT00296504|157333101|FG006|Interim Analysis|Lost to Follow-up|11|||
48862429|NCT00296504|157333102|FG007|Interim Analysis|Lost to Follow-up|4|||
48862430|NCT00296504|157333103|FG008|Interim Analysis|Lost to Follow-up|0|||
48862431|NCT00296504|157333095|FG000|Interim Analysis|Clinical Progression|1|||
48862432|NCT00296504|157333096|FG001|Interim Analysis|Clinical Progression|0|||
48862433|NCT00296504|157333097|FG002|Interim Analysis|Clinical Progression|1|||
48862434|NCT00296504|157333098|FG003|Interim Analysis|Clinical Progression|1|||
48862435|NCT00296504|157333099|FG004|Interim Analysis|Clinical Progression|0|||
48862436|NCT00296504|157333100|FG005|Interim Analysis|Clinical Progression|2|||
48862437|NCT00296504|157333101|FG006|Interim Analysis|Clinical Progression|1|||
48862438|NCT00296504|157333102|FG007|Interim Analysis|Clinical Progression|2|||
49015394|NCT01533428|157892162|FG001|Overall Study|Withdrawal by Subject|6|||
48750078|NCT02051608|156930271|FG002|Part 1: Double Blind Treatment|Physician Decision|0|||
48955849|NCT01228071|157667072|FG000|Overall Study|Withdrawal by Subject|1|||
48955850|NCT00392171|157667073|FG000|Overall Study|Did not meet inclusion criteria|4|||
48955851|NCT00392171|157667073|FG000|Overall Study|Disease progression|101|||
48955852|NCT01989546|157667074|FG000|Overall Study|Clinical Progression|1|||
48955853|NCT01989546|157667074|FG000|Overall Study|Disease progression on study|8|||
48955854|NCT03123354|157667077|FG000|Overall Study|Physician Decision|6|||
48955855|NCT03041116|157667080|FG000|Double-blind|Death|0|||
48750079|NCT02051608|156930272|FG003|Part 1: Double Blind Treatment|Physician Decision|0|||
48955856|NCT03041116|157667081|FG001|Double-blind|Death|2|||
48955857|NCT03041116|157667080|FG000|Double-blind|Withdrawal by Subject|0|||
48955858|NCT03041116|157667081|FG001|Double-blind|Withdrawal by Subject|4|||
48955859|NCT03041116|157667080|FG000|Open-label|Death|1|||
48955860|NCT03041116|157667081|FG001|Open-label|Death|0|||
48955861|NCT03041116|157667080|FG000|Open-label|Termination of the study by Sponsor|39|||
48955862|NCT03041116|157667081|FG001|Open-label|Termination of the study by Sponsor|37|||
48955863|NCT03041116|157667080|FG000|Open-label|Withdrawal by Subject|1|||
48955864|NCT03041116|157667081|FG001|Open-label|Withdrawal by Subject|0|||
48955865|NCT00833248|157667082|FG000|Overall Study|Adverse Event|3|||
48955866|NCT00833248|157667083|FG001|Overall Study|Adverse Event|0|||
48955867|NCT00833248|157667082|FG000|Overall Study|Protocol Violation|1|||
48955868|NCT00833248|157667083|FG001|Overall Study|Protocol Violation|2|||
48955869|NCT00833248|157667082|FG000|Overall Study|Withdrawal by Subject|0|||
48955870|NCT00833248|157667083|FG001|Overall Study|Withdrawal by Subject|1|||
48955871|NCT01839188|157667085|FG000|Overall Study|Withdrawal by Subject|1|||
48955872|NCT02985450|157667091|FG000|Overall Study|Lost to Follow-up|7|||
48955873|NCT00988559|157667093|FG000|Overall Study|Withdrawal by Subject|1|||
48955874|NCT00988559|157667094|FG001|Overall Study|Withdrawal by Subject|1|||
48955875|NCT00988559|157667095|FG002|Overall Study|Withdrawal by Subject|0|||
48955876|NCT00988559|157667096|FG003|Overall Study|Withdrawal by Subject|1|||
48955877|NCT00988559|157667093|FG000|Overall Study|Pregnancy|0|||
48955878|NCT00988559|157667094|FG001|Overall Study|Pregnancy|1|||
48955879|NCT00988559|157667095|FG002|Overall Study|Pregnancy|1|||
48955880|NCT00988559|157667096|FG003|Overall Study|Pregnancy|0|||
48955881|NCT00988559|157667093|FG000|Overall Study|Lost to Follow-up|0|||
48955882|NCT00988559|157667094|FG001|Overall Study|Lost to Follow-up|0|||
48955883|NCT00988559|157667095|FG002|Overall Study|Lost to Follow-up|1|||
48955884|NCT00988559|157667096|FG003|Overall Study|Lost to Follow-up|0|||
48955885|NCT01519245|157667097|FG000|Overall Study|Met exclusion criteria, not analysed|1|||
48955886|NCT01519245|157667098|FG001|Overall Study|Met exclusion criteria, not analysed|2|||
48955887|NCT00705224|157667099|FG000|Overall Study|Adverse Event|1|||
48955888|NCT00705224|157667099|FG000|Overall Study|Lack of Efficacy|2|||
48955889|NCT00705224|157667099|FG000|Overall Study|Withdrawal by Subject|3|||
48955890|NCT00705224|157667099|FG000|Overall Study|Lost to Follow-up|5|||
48955891|NCT04238663|157667100|FG000|Overall Study|Lost to Follow-up|0|||
48955892|NCT04238663|157667101|FG001|Overall Study|Lost to Follow-up|1|||
48955893|NCT04238663|157667102|FG002|Overall Study|Lost to Follow-up|0|||
48955894|NCT02402218|157667103|FG000|Overall Study|Did not pickup study medication|12|||
48955895|NCT02402218|157667104|FG001|Overall Study|Did not pickup study medication|9|||
48955896|NCT02402218|157667105|FG002|Overall Study|Did not pickup study medication|13|||
48955897|NCT02402218|157667103|FG000|Overall Study|Lack of Efficacy|0|||
48955898|NCT02402218|157667104|FG001|Overall Study|Lack of Efficacy|1|||
48955899|NCT02402218|157667105|FG002|Overall Study|Lack of Efficacy|1|||
48955900|NCT02402218|157667103|FG000|Overall Study|Death|1|||
48955901|NCT02402218|157667104|FG001|Overall Study|Death|0|||
48955902|NCT02402218|157667105|FG002|Overall Study|Death|0|||
48955903|NCT02402218|157667103|FG000|Overall Study|Reinfection|0|||
48955904|NCT02402218|157667104|FG001|Overall Study|Reinfection|0|||
48955905|NCT02402218|157667105|FG002|Overall Study|Reinfection|1|||
48955906|NCT02402218|157667103|FG000|Overall Study|Adverse Event|0|||
48955907|NCT02402218|157667104|FG001|Overall Study|Adverse Event|2|||
48955908|NCT02402218|157667105|FG002|Overall Study|Adverse Event|1|||
48955909|NCT02402218|157667103|FG000|Overall Study|Withdrawal by Subject|1|||
48955910|NCT02402218|157667104|FG001|Overall Study|Withdrawal by Subject|1|||
48955911|NCT02402218|157667105|FG002|Overall Study|Withdrawal by Subject|1|||
48955912|NCT04070378|157667106|FG000|Overall Study|Withdrawal by Subject|2|||
48955913|NCT04070378|157667106|FG000|Overall Study|Screen Failure|6|||
48955914|NCT04070378|157667106|FG000|Overall Study|Physician Decision|1|||
48955915|NCT04070378|157667106|FG000|Overall Study|Adverse Event|1|||
48955916|NCT03827473|157667110|FG000|Overall Study|Withdrawal by Subject|1|||
48955917|NCT03827473|157667111|FG001|Overall Study|Withdrawal by Subject|0|||
48955918|NCT00952289|157667112|FG000|All Participants|Death|9|||
48955919|NCT00952289|157667113|FG001|All Participants|Death|9|||
48955920|NCT00952289|157667112|FG000|All Participants|Adverse Event|8|||
48955921|NCT00952289|157667113|FG001|All Participants|Adverse Event|8|||
48955922|NCT00952289|157667112|FG000|All Participants|Disease progression|3|||
48955923|NCT00952289|157667113|FG001|All Participants|Disease progression|12|||
48955924|NCT00952289|157667112|FG000|All Participants|Withdrawal by Subject|1|||
48862439|NCT00296504|157333103|FG008|Interim Analysis|Clinical Progression|0|||
48862440|NCT00296504|157333095|FG000|Interim Analysis|Insufficient Viral Load Response|5|||
48862441|NCT00296504|157333096|FG001|Interim Analysis|Insufficient Viral Load Response|1|||
48862442|NCT00296504|157333097|FG002|Interim Analysis|Insufficient Viral Load Response|12|||
48862443|NCT00296504|157333098|FG003|Interim Analysis|Insufficient Viral Load Response|2|||
48862444|NCT00296504|157333099|FG004|Interim Analysis|Insufficient Viral Load Response|7|||
48862445|NCT00296504|157333100|FG005|Interim Analysis|Insufficient Viral Load Response|9|||
48862446|NCT00296504|157333101|FG006|Interim Analysis|Insufficient Viral Load Response|2|||
48862447|NCT00296504|157333102|FG007|Interim Analysis|Insufficient Viral Load Response|24|||
48862448|NCT00296504|157333103|FG008|Interim Analysis|Insufficient Viral Load Response|0|||
48862449|NCT00296504|157333095|FG000|Interim Analysis|Adverse Event|0|||
48862450|NCT00296504|157333096|FG001|Interim Analysis|Adverse Event|0|||
48862451|NCT00296504|157333097|FG002|Interim Analysis|Adverse Event|13|||
48862452|NCT00296504|157333098|FG003|Interim Analysis|Adverse Event|4|||
48862453|NCT00296504|157333099|FG004|Interim Analysis|Adverse Event|6|||
48862454|NCT00296504|157333100|FG005|Interim Analysis|Adverse Event|3|||
48862455|NCT00296504|157333101|FG006|Interim Analysis|Adverse Event|4|||
48862456|NCT00296504|157333102|FG007|Interim Analysis|Adverse Event|5|||
48862457|NCT00296504|157333103|FG008|Interim Analysis|Adverse Event|0|||
48862458|NCT00296504|157333095|FG000|Interim Analysis|Protocol Violation|0|||
48862459|NCT00296504|157333096|FG001|Interim Analysis|Protocol Violation|0|||
48862460|NCT00296504|157333097|FG002|Interim Analysis|Protocol Violation|2|||
48862461|NCT00296504|157333098|FG003|Interim Analysis|Protocol Violation|0|||
48955925|NCT00952289|157667113|FG001|All Participants|Withdrawal by Subject|10|||
48955926|NCT00952289|157667112|FG000|All Participants|Data lost during site relocation|0|||
48955927|NCT00952289|157667113|FG001|All Participants|Data lost during site relocation|1|||
48955928|NCT00952289|157667112|FG000|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0|||
48955929|NCT00952289|157667113|FG001|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19|||
48955930|NCT00952289|157667112|FG000|Patients Who Crossed Over to Ruxolitinib|Disease progression|0|||
48862462|NCT00296504|157333099|FG004|Interim Analysis|Protocol Violation|1|||
48862463|NCT00296504|157333100|FG005|Interim Analysis|Protocol Violation|0|||
48955931|NCT00952289|157667113|FG001|Patients Who Crossed Over to Ruxolitinib|Disease progression|15|||
48955932|NCT00952289|157667112|FG000|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0|||
48955933|NCT00952289|157667113|FG001|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11|||
48955934|NCT00952289|157667112|FG000|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0|||
48955935|NCT00952289|157667113|FG001|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2|||
48955936|NCT00952289|157667112|FG000|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0|||
48955937|NCT00952289|157667113|FG001|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7|||
48955938|NCT04436822|157667114|FG000|Overall Study|Physician Decision|2|||
48955939|NCT04436822|157667115|FG001|Overall Study|Physician Decision|0|||
48955940|NCT04436822|157667114|FG000|Overall Study|Sponsor request|1|||
48955941|NCT04436822|157667115|FG001|Overall Study|Sponsor request|0|||
48955942|NCT04436822|157667114|FG000|Overall Study|Withdrawal by parent/guardian|0|||
48955943|NCT04436822|157667115|FG001|Overall Study|Withdrawal by parent/guardian|3|||
48955944|NCT04436822|157667114|FG000|Overall Study|Unsuccessful procedure|0|||
48955945|NCT04436822|157667115|FG001|Overall Study|Unsuccessful procedure|1|||
48955946|NCT04436822|157667114|FG000|Overall Study|Withdrawal due to Covid-19|8|||
48955947|NCT04436822|157667115|FG001|Overall Study|Withdrawal due to Covid-19|1|||
48955948|NCT04436822|157667114|FG000|Overall Study|Withdrawal by Subject|1|||
48955949|NCT04436822|157667115|FG001|Overall Study|Withdrawal by Subject|0|||
48955950|NCT04436822|157667114|FG000|Overall Study|The sponsor was not able to provide the investigational product|0|||
48955951|NCT04436822|157667115|FG001|Overall Study|The sponsor was not able to provide the investigational product|1|||
48955952|NCT03807739|157667116|FG000|Overall Study|Adverse Event|1|||
48955953|NCT03807739|157667117|FG001|Overall Study|Adverse Event|0|||
48955954|NCT03807739|157667118|FG002|Overall Study|Adverse Event|0|||
48955955|NCT03807739|157667119|FG003|Overall Study|Adverse Event|0|||
48955956|NCT03807739|157667116|FG000|Overall Study|Withdrawal by Subject|1|||
48955957|NCT03807739|157667117|FG001|Overall Study|Withdrawal by Subject|0|||
48955958|NCT03807739|157667118|FG002|Overall Study|Withdrawal by Subject|0|||
48955959|NCT03807739|157667119|FG003|Overall Study|Withdrawal by Subject|0|||
48955960|NCT00875017|157667120|FG000|First Intervention|Withdrawal by Subject|1|||
48955961|NCT00875017|157667121|FG001|First Intervention|Withdrawal by Subject|0|||
48955962|NCT00875017|157667122|FG002|First Intervention|Withdrawal by Subject|1|||
48955963|NCT00875017|157667123|FG003|First Intervention|Withdrawal by Subject|0|||
48955964|NCT00875017|157667124|FG004|First Intervention|Withdrawal by Subject|0|||
48955965|NCT00875017|157667125|FG005|First Intervention|Withdrawal by Subject|0|||
48955966|NCT00875017|157667120|FG000|First Intervention|Adverse Event|0|||
48955967|NCT00875017|157667121|FG001|First Intervention|Adverse Event|0|||
48955968|NCT00875017|157667122|FG002|First Intervention|Adverse Event|0|||
48955969|NCT00875017|157667123|FG003|First Intervention|Adverse Event|1|||
48955970|NCT00875017|157667124|FG004|First Intervention|Adverse Event|0|||
48955971|NCT00875017|157667125|FG005|First Intervention|Adverse Event|0|||
48955972|NCT00875017|157667120|FG000|First Intervention|Problems collecting rectal effluent|1|||
48955973|NCT00875017|157667121|FG001|First Intervention|Problems collecting rectal effluent|0|||
48955974|NCT00875017|157667122|FG002|First Intervention|Problems collecting rectal effluent|0|||
48955975|NCT00875017|157667123|FG003|First Intervention|Problems collecting rectal effluent|0|||
48955976|NCT00875017|157667124|FG004|First Intervention|Problems collecting rectal effluent|0|||
48955977|NCT00875017|157667125|FG005|First Intervention|Problems collecting rectal effluent|0|||
48955978|NCT00875017|157667120|FG000|First Intervention|Intolerance to nasogastric tube|0|||
48955979|NCT00875017|157667121|FG001|First Intervention|Intolerance to nasogastric tube|0|||
48955980|NCT00875017|157667122|FG002|First Intervention|Intolerance to nasogastric tube|0|||
48955981|NCT00875017|157667123|FG003|First Intervention|Intolerance to nasogastric tube|0|||
48955982|NCT00875017|157667124|FG004|First Intervention|Intolerance to nasogastric tube|1|||
48955983|NCT00875017|157667125|FG005|First Intervention|Intolerance to nasogastric tube|0|||
48955984|NCT00875017|157667120|FG000|Washout|Problem collecting rectal effluent|0|||
48955985|NCT00875017|157667121|FG001|Washout|Problem collecting rectal effluent|0|||
48955986|NCT00875017|157667122|FG002|Washout|Problem collecting rectal effluent|1|||
48955987|NCT00875017|157667123|FG003|Washout|Problem collecting rectal effluent|0|||
48955988|NCT00875017|157667124|FG004|Washout|Problem collecting rectal effluent|0|||
48955989|NCT00875017|157667125|FG005|Washout|Problem collecting rectal effluent|0|||
48955990|NCT00875017|157667120|FG000|Second Intervention|Adverse Event|0|||
48955991|NCT00875017|157667121|FG001|Second Intervention|Adverse Event|0|||
48955992|NCT00875017|157667122|FG002|Second Intervention|Adverse Event|0|||
48955993|NCT00875017|157667123|FG003|Second Intervention|Adverse Event|1|||
48955994|NCT00875017|157667124|FG004|Second Intervention|Adverse Event|0|||
48955995|NCT00875017|157667125|FG005|Second Intervention|Adverse Event|0|||
48955996|NCT00875017|157667120|FG000|Washout|Problems collecting rectal effluent|0|||
48955997|NCT00875017|157667121|FG001|Washout|Problems collecting rectal effluent|1|||
48955998|NCT00875017|157667122|FG002|Washout|Problems collecting rectal effluent|0|||
48955999|NCT00875017|157667123|FG003|Washout|Problems collecting rectal effluent|0|||
48956000|NCT00875017|157667124|FG004|Washout|Problems collecting rectal effluent|0|||
48956001|NCT00875017|157667125|FG005|Washout|Problems collecting rectal effluent|0|||
48956002|NCT00875017|157667120|FG000|Third Intervention|Adverse Event|0|||
48956003|NCT00875017|157667121|FG001|Third Intervention|Adverse Event|1|||
48956004|NCT00875017|157667122|FG002|Third Intervention|Adverse Event|1|||
48956005|NCT00875017|157667123|FG003|Third Intervention|Adverse Event|0|||
48956006|NCT00875017|157667124|FG004|Third Intervention|Adverse Event|0|||
48956007|NCT00875017|157667125|FG005|Third Intervention|Adverse Event|0|||
48956008|NCT00875017|157667120|FG000|Washout|Withdrawal by Subject|0|||
48956009|NCT00875017|157667121|FG001|Washout|Withdrawal by Subject|0|||
48956010|NCT00875017|157667122|FG002|Washout|Withdrawal by Subject|0|||
48956011|NCT00875017|157667123|FG003|Washout|Withdrawal by Subject|0|||
48956012|NCT00875017|157667124|FG004|Washout|Withdrawal by Subject|1|||
48956013|NCT00875017|157667125|FG005|Washout|Withdrawal by Subject|0|||
48956014|NCT00875017|157667120|FG000|Fourth Intervention|Inability to comply with fasting|0|||
48956015|NCT00875017|157667121|FG001|Fourth Intervention|Inability to comply with fasting|0|||
48956016|NCT00875017|157667122|FG002|Fourth Intervention|Inability to comply with fasting|0|||
48956017|NCT00875017|157667123|FG003|Fourth Intervention|Inability to comply with fasting|0|||
48956018|NCT00875017|157667124|FG004|Fourth Intervention|Inability to comply with fasting|0|||
48956019|NCT00875017|157667125|FG005|Fourth Intervention|Inability to comply with fasting|1|||
48956020|NCT03342469|157667126|FG000|Overall Study|Withdrawal by Subject|0|||
48956021|NCT03342469|157667127|FG001|Overall Study|Withdrawal by Subject|1|||
48956022|NCT03342469|157667128|FG002|Overall Study|Withdrawal by Subject|0|||
48956023|NCT03342469|157667129|FG003|Overall Study|Withdrawal by Subject|0|||
48956024|NCT02689219|157667132|FG000|Overall Study|Death|1|||
48956025|NCT02689219|157667133|FG001|Overall Study|Death|1|||
48956026|NCT02689219|157667132|FG000|Overall Study|Disease Progression|10|||
48956027|NCT02689219|157667133|FG001|Overall Study|Disease Progression|6|||
48956028|NCT03259334|157667134|FG000|Overall Study|Adverse Event|3|||
48956029|NCT03259334|157667135|FG001|Overall Study|Adverse Event|8|||
48956030|NCT03259334|157667136|FG002|Overall Study|Adverse Event|5|||
48956031|NCT03259334|157667134|FG000|Overall Study|Withdrawal by Subject|4|||
48956032|NCT03259334|157667135|FG001|Overall Study|Withdrawal by Subject|2|||
48956033|NCT03259334|157667136|FG002|Overall Study|Withdrawal by Subject|4|||
48956034|NCT03259334|157667134|FG000|Overall Study|Physician Decision|1|||
48956035|NCT03259334|157667135|FG001|Overall Study|Physician Decision|0|||
48956036|NCT03259334|157667136|FG002|Overall Study|Physician Decision|0|||
48956037|NCT03259334|157667134|FG000|Overall Study|Lost to Follow-up|0|||
48956038|NCT03259334|157667135|FG001|Overall Study|Lost to Follow-up|2|||
48956039|NCT03259334|157667136|FG002|Overall Study|Lost to Follow-up|1|||
48956040|NCT03259334|157667134|FG000|Overall Study|Protocol Deviation|0|||
48956041|NCT03259334|157667135|FG001|Overall Study|Protocol Deviation|3|||
48956042|NCT03259334|157667136|FG002|Overall Study|Protocol Deviation|2|||
48956043|NCT03259334|157667134|FG000|Overall Study|Lack of Efficacy|2|||
48956044|NCT03259334|157667135|FG001|Overall Study|Lack of Efficacy|0|||
48956045|NCT03259334|157667136|FG002|Overall Study|Lack of Efficacy|1|||
48956046|NCT03259334|157667134|FG000|Overall Study|Randomized but never treated|0|||
48956047|NCT03259334|157667135|FG001|Overall Study|Randomized but never treated|2|||
48956048|NCT03259334|157667136|FG002|Overall Study|Randomized but never treated|0|||
48956049|NCT02371759|157667137|FG000|Overall Study|Protocol Violation|3|||
48956050|NCT02371759|157667138|FG001|Overall Study|Protocol Violation|1|||
48956051|NCT02371759|157667139|FG002|Overall Study|Protocol Violation|1|||
48956052|NCT02371759|157667140|FG003|Overall Study|Protocol Violation|0|||
48956053|NCT02371759|157667141|FG004|Overall Study|Protocol Violation|3|||
48956054|NCT02371759|157667142|FG005|Overall Study|Protocol Violation|1|||
48956055|NCT02371759|157667143|FG006|Overall Study|Protocol Violation|0|||
48956056|NCT02371759|157667144|FG007|Overall Study|Protocol Violation|3|||
48956057|NCT02371759|157667137|FG000|Overall Study|Withdrawal by Subject|0|||
48956058|NCT02371759|157667138|FG001|Overall Study|Withdrawal by Subject|0|||
48956059|NCT02371759|157667139|FG002|Overall Study|Withdrawal by Subject|0|||
48956060|NCT02371759|157667140|FG003|Overall Study|Withdrawal by Subject|0|||
48956061|NCT02371759|157667141|FG004|Overall Study|Withdrawal by Subject|0|||
48956062|NCT02371759|157667142|FG005|Overall Study|Withdrawal by Subject|0|||
48956063|NCT02371759|157667143|FG006|Overall Study|Withdrawal by Subject|0|||
48956064|NCT02371759|157667144|FG007|Overall Study|Withdrawal by Subject|1|||
48956065|NCT00553059|157667145|FG000|Overall Study|Deemed ineligible|1|||
48956066|NCT00553059|157667146|FG001|Overall Study|Deemed ineligible|1|||
48956067|NCT00553059|157667145|FG000|Overall Study|Drug supply not available|0|||
48956068|NCT00553059|157667146|FG001|Overall Study|Drug supply not available|1|||
48956069|NCT04078152|157667150|FG000|Overall Study|Other|83|||
48956070|NCT04078152|157667151|FG001|Overall Study|Other|22|||
48956071|NCT04078152|157667152|FG002|Overall Study|Other|25|||
48956072|NCT04078152|157667150|FG000|Overall Study|Development of study specific withdrawal criteria|1|||
48956073|NCT04078152|157667151|FG001|Overall Study|Development of study specific withdrawal criteria|1|||
48956074|NCT04078152|157667152|FG002|Overall Study|Development of study specific withdrawal criteria|0|||
48956075|NCT04078152|157667150|FG000|Overall Study|Withdrawal by Subject|5|||
48956076|NCT04078152|157667151|FG001|Overall Study|Withdrawal by Subject|0|||
48956077|NCT04078152|157667152|FG002|Overall Study|Withdrawal by Subject|1|||
48956078|NCT04078152|157667150|FG000|Overall Study|Death|10|||
48956079|NCT04078152|157667151|FG001|Overall Study|Death|2|||
48956080|NCT04078152|157667152|FG002|Overall Study|Death|12|||
48956081|NCT04078152|157667150|FG000|Overall Study|Adverse Event|1|||
48956082|NCT04078152|157667151|FG001|Overall Study|Adverse Event|0|||
48956083|NCT04078152|157667152|FG002|Overall Study|Adverse Event|0|||
48956084|NCT03136185|157667155|FG000|Overall Study|Adverse Event|0|||
48956085|NCT03136185|157667156|FG001|Overall Study|Adverse Event|1|||
48956086|NCT03136185|157667157|FG002|Overall Study|Adverse Event|3|||
48956087|NCT03136185|157667158|FG003|Overall Study|Adverse Event|1|||
48956088|NCT03136185|157667159|FG004|Overall Study|Adverse Event|2|||
48956089|NCT03136185|157667160|FG005|Overall Study|Adverse Event|2|||
48956090|NCT03136185|157667161|FG006|Overall Study|Adverse Event|5|||
48956091|NCT03136185|157667162|FG007|Overall Study|Adverse Event|1|||
48956092|NCT03136185|157667163|FG008|Overall Study|Adverse Event|1|||
48956093|NCT03136185|157667155|FG000|Overall Study|Death|0|||
48956094|NCT03136185|157667156|FG001|Overall Study|Death|0|||
48956095|NCT03136185|157667157|FG002|Overall Study|Death|0|||
48956096|NCT03136185|157667158|FG003|Overall Study|Death|1|||
48956097|NCT03136185|157667159|FG004|Overall Study|Death|1|||
48956098|NCT03136185|157667160|FG005|Overall Study|Death|0|||
48956099|NCT03136185|157667161|FG006|Overall Study|Death|1|||
48956100|NCT03136185|157667162|FG007|Overall Study|Death|0|||
48956101|NCT03136185|157667163|FG008|Overall Study|Death|0|||
48956102|NCT03136185|157667155|FG000|Overall Study|Physician Decision|3|||
48956103|NCT03136185|157667156|FG001|Overall Study|Physician Decision|1|||
48956104|NCT03136185|157667157|FG002|Overall Study|Physician Decision|1|||
48956105|NCT03136185|157667158|FG003|Overall Study|Physician Decision|2|||
48956106|NCT03136185|157667159|FG004|Overall Study|Physician Decision|1|||
48956107|NCT03136185|157667160|FG005|Overall Study|Physician Decision|2|||
48956108|NCT03136185|157667161|FG006|Overall Study|Physician Decision|1|||
48956109|NCT03136185|157667162|FG007|Overall Study|Physician Decision|0|||
48956110|NCT03136185|157667163|FG008|Overall Study|Physician Decision|1|||
48956111|NCT03136185|157667155|FG000|Overall Study|Protocol Defined Disease Progression|0|||
48956112|NCT03136185|157667156|FG001|Overall Study|Protocol Defined Disease Progression|0|||
48750080|NCT02051608|156930269|FG000|Part 1: Double Blind Treatment|Lost to Follow-up|1|||
48750081|NCT02051608|156930270|FG001|Part 1: Double Blind Treatment|Lost to Follow-up|2|||
48956113|NCT03136185|157667157|FG002|Overall Study|Protocol Defined Disease Progression|1|||
48956114|NCT03136185|157667158|FG003|Overall Study|Protocol Defined Disease Progression|0|||
48956115|NCT03136185|157667159|FG004|Overall Study|Protocol Defined Disease Progression|0|||
48956116|NCT03136185|157667160|FG005|Overall Study|Protocol Defined Disease Progression|1|||
48956117|NCT03136185|157667161|FG006|Overall Study|Protocol Defined Disease Progression|0|||
48956118|NCT03136185|157667162|FG007|Overall Study|Protocol Defined Disease Progression|1|||
48956119|NCT03136185|157667163|FG008|Overall Study|Protocol Defined Disease Progression|1|||
48956120|NCT03136185|157667155|FG000|Overall Study|Withdrawal by Subject|1|||
48956121|NCT03136185|157667156|FG001|Overall Study|Withdrawal by Subject|0|||
48956122|NCT03136185|157667157|FG002|Overall Study|Withdrawal by Subject|1|||
48956123|NCT03136185|157667158|FG003|Overall Study|Withdrawal by Subject|1|||
48956124|NCT03136185|157667159|FG004|Overall Study|Withdrawal by Subject|1|||
48956125|NCT03136185|157667160|FG005|Overall Study|Withdrawal by Subject|1|||
48956126|NCT03136185|157667161|FG006|Overall Study|Withdrawal by Subject|2|||
48956127|NCT03136185|157667162|FG007|Overall Study|Withdrawal by Subject|3|||
48956128|NCT03136185|157667163|FG008|Overall Study|Withdrawal by Subject|3|||
48956129|NCT03136185|157667155|FG000|Overall Study|Not Reported|4|||
48750082|NCT02051608|156930271|FG002|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
48750083|NCT02051608|156930272|FG003|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
48750084|NCT02051608|156930269|FG000|Part 1: Double Blind Treatment|Protocol Violation|0|||
48956130|NCT03136185|157667156|FG001|Overall Study|Not Reported|1|||
48956131|NCT03136185|157667157|FG002|Overall Study|Not Reported|0|||
48750085|NCT02051608|156930270|FG001|Part 1: Double Blind Treatment|Protocol Violation|1|||
48750086|NCT02051608|156930271|FG002|Part 1: Double Blind Treatment|Protocol Violation|0|||
48750087|NCT02051608|156930272|FG003|Part 1: Double Blind Treatment|Protocol Violation|0|||
48750088|NCT02051608|156930269|FG000|Part 1: Double Blind Treatment|Non-Compliance|2|||
48750089|NCT02051608|156930270|FG001|Part 1: Double Blind Treatment|Non-Compliance|4|||
48750090|NCT02051608|156930271|FG002|Part 1: Double Blind Treatment|Non-Compliance|0|||
48750091|NCT02051608|156930272|FG003|Part 1: Double Blind Treatment|Non-Compliance|0|||
48750092|NCT02051608|156930269|FG000|Part 1: Double Blind Treatment|Other|6|||
48750093|NCT02051608|156930270|FG001|Part 1: Double Blind Treatment|Other|3|||
48750094|NCT02051608|156930271|FG002|Part 1: Double Blind Treatment|Other|0|||
48750095|NCT02051608|156930272|FG003|Part 1: Double Blind Treatment|Other|0|||
48750096|NCT02051608|156930269|FG000|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|3|||
48750097|NCT02051608|156930270|FG001|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|2|||
48750098|NCT02051608|156930271|FG002|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
48750099|NCT02051608|156930272|FG003|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
48750100|NCT02051608|156930269|FG000|Part 2: Open-label Extension|Adverse Event|0|||
48750101|NCT02051608|156930270|FG001|Part 2: Open-label Extension|Adverse Event|0|||
48750102|NCT02051608|156930271|FG002|Part 2: Open-label Extension|Adverse Event|6|||
48750103|NCT02051608|156930272|FG003|Part 2: Open-label Extension|Adverse Event|8|||
48750104|NCT02051608|156930269|FG000|Part 2: Open-label Extension|Death|0|||
48750105|NCT02051608|156930270|FG001|Part 2: Open-label Extension|Death|0|||
48750106|NCT02051608|156930271|FG002|Part 2: Open-label Extension|Death|7|||
48750107|NCT02051608|156930272|FG003|Part 2: Open-label Extension|Death|4|||
48750108|NCT02051608|156930269|FG000|Part 2: Open-label Extension|Lost to Follow-up|0|||
48750109|NCT02051608|156930270|FG001|Part 2: Open-label Extension|Lost to Follow-up|0|||
48750110|NCT02051608|156930271|FG002|Part 2: Open-label Extension|Lost to Follow-up|0|||
48750111|NCT02051608|156930272|FG003|Part 2: Open-label Extension|Lost to Follow-up|1|||
48750112|NCT02051608|156930269|FG000|Part 2: Open-label Extension|Non-Compliance|0|||
48750113|NCT02051608|156930270|FG001|Part 2: Open-label Extension|Non-Compliance|0|||
48750114|NCT02051608|156930271|FG002|Part 2: Open-label Extension|Non-Compliance|1|||
48750115|NCT02051608|156930272|FG003|Part 2: Open-label Extension|Non-Compliance|1|||
48750116|NCT02051608|156930269|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
48750117|NCT02051608|156930270|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
48750118|NCT02051608|156930271|FG002|Part 2: Open-label Extension|Withdrawal by Subject|39|||
48750119|NCT02051608|156930272|FG003|Part 2: Open-label Extension|Withdrawal by Subject|32|||
48750120|NCT02051608|156930269|FG000|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
48750121|NCT02051608|156930270|FG001|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
48956132|NCT03136185|157667158|FG003|Overall Study|Not Reported|1|||
48956133|NCT03136185|157667159|FG004|Overall Study|Not Reported|0|||
48956134|NCT03136185|157667160|FG005|Overall Study|Not Reported|2|||
48956135|NCT03136185|157667161|FG006|Overall Study|Not Reported|1|||
48956136|NCT03136185|157667162|FG007|Overall Study|Not Reported|1|||
48956137|NCT03136185|157667163|FG008|Overall Study|Not Reported|0|||
48956138|NCT00337467|157667164|FG000|Overall Study|Adverse Event|3|||
48750122|NCT02051608|156930271|FG002|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
48750123|NCT02051608|156930272|FG003|Part 2: Open-label Extension|Study Terminated By Sponsor|1|||
48956139|NCT00337467|157667164|FG000|Overall Study|Subject Withdrew Consent|2|||
48956140|NCT00337467|157667164|FG000|Overall Study|Pregnancy|1|||
48750124|NCT02051608|156930269|FG000|Part 2: Open-label Extension|Physician Decision|0|||
48750125|NCT02051608|156930270|FG001|Part 2: Open-label Extension|Physician Decision|0|||
48750126|NCT02051608|156930271|FG002|Part 2: Open-label Extension|Physician Decision|8|||
48750127|NCT02051608|156930272|FG003|Part 2: Open-label Extension|Physician Decision|5|||
48956141|NCT00337467|157667164|FG000|Overall Study|Lost to Follow-up|2|||
48750128|NCT02051608|156930269|FG000|Part 2: Open-label Extension|Other|0|||
48750129|NCT02051608|156930270|FG001|Part 2: Open-label Extension|Other|0|||
48750130|NCT02051608|156930271|FG002|Part 2: Open-label Extension|Other|9|||
48750131|NCT02051608|156930272|FG003|Part 2: Open-label Extension|Other|9|||
48750132|NCT05131646|156930273|FG000|Overall Study|Withdrawal by Subject|1|||
48750133|NCT05131646|156930274|FG001|Overall Study|Withdrawal by Subject|0|||
48750134|NCT05131646|156930275|FG002|Overall Study|Withdrawal by Subject|0|||
48750135|NCT03266107|156930276|FG000|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1|||
48750136|NCT03266107|156930276|FG000|Enrollment to Procedure|Study stopped prior to Procedure|2|||
48750137|NCT03266107|156930276|FG000|3-Month Follow-up Visit|Lost to Follow-up|1|||
48862464|NCT00296504|157333101|FG006|Interim Analysis|Protocol Violation|0|||
48862465|NCT00296504|157333102|FG007|Interim Analysis|Protocol Violation|1|||
48862466|NCT00296504|157333103|FG008|Interim Analysis|Protocol Violation|0|||
48862467|NCT00296504|157333095|FG000|Interim Analysis|Insufficient CD4 Response|0|||
48862468|NCT00296504|157333096|FG001|Interim Analysis|Insufficient CD4 Response|0|||
48862469|NCT00296504|157333097|FG002|Interim Analysis|Insufficient CD4 Response|0|||
48862470|NCT00296504|157333098|FG003|Interim Analysis|Insufficient CD4 Response|0|||
48862471|NCT00296504|157333099|FG004|Interim Analysis|Insufficient CD4 Response|1|||
48862472|NCT00296504|157333100|FG005|Interim Analysis|Insufficient CD4 Response|1|||
48862473|NCT00296504|157333101|FG006|Interim Analysis|Insufficient CD4 Response|0|||
48862474|NCT00296504|157333102|FG007|Interim Analysis|Insufficient CD4 Response|0|||
48862475|NCT00296504|157333103|FG008|Interim Analysis|Insufficient CD4 Response|0|||
48862476|NCT00296504|157333095|FG000|Interim Analysis|Switched to Commercially Available Drug|2|||
48862477|NCT00296504|157333096|FG001|Interim Analysis|Switched to Commercially Available Drug|0|||
48862478|NCT00296504|157333097|FG002|Interim Analysis|Switched to Commercially Available Drug|4|||
48862479|NCT00296504|157333098|FG003|Interim Analysis|Switched to Commercially Available Drug|1|||
48862480|NCT00296504|157333099|FG004|Interim Analysis|Switched to Commercially Available Drug|0|||
48862481|NCT00296504|157333100|FG005|Interim Analysis|Switched to Commercially Available Drug|5|||
48862482|NCT00296504|157333101|FG006|Interim Analysis|Switched to Commercially Available Drug|3|||
48862483|NCT00296504|157333102|FG007|Interim Analysis|Switched to Commercially Available Drug|4|||
48862484|NCT00296504|157333103|FG008|Interim Analysis|Switched to Commercially Available Drug|0|||
48862485|NCT00296504|157333095|FG000|Interim Analysis|Pregnancy|4|||
48862486|NCT00296504|157333096|FG001|Interim Analysis|Pregnancy|1|||
48862487|NCT00296504|157333097|FG002|Interim Analysis|Pregnancy|4|||
48862488|NCT00296504|157333098|FG003|Interim Analysis|Pregnancy|2|||
48862489|NCT00296504|157333099|FG004|Interim Analysis|Pregnancy|0|||
48862490|NCT00296504|157333100|FG005|Interim Analysis|Pregnancy|1|||
48862491|NCT00296504|157333101|FG006|Interim Analysis|Pregnancy|1|||
48862492|NCT00296504|157333102|FG007|Interim Analysis|Pregnancy|1|||
48862493|NCT00296504|157333103|FG008|Interim Analysis|Pregnancy|0|||
48862494|NCT00296504|157333095|FG000|Interim Analysis|Death|1|||
48862495|NCT00296504|157333096|FG001|Interim Analysis|Death|0|||
48750138|NCT03266107|156930276|FG000|12-Month Follow-up Visit|Lost to Follow-up|1|||
48750139|NCT01812174|156930277|FG000|Overall Study|Death|1|||
48750140|NCT01812174|156930278|FG001|Overall Study|Death|0|||
48750141|NCT01812174|156930277|FG000|Overall Study|Protocol Violation|2|||
48750142|NCT01812174|156930278|FG001|Overall Study|Protocol Violation|0|||
48750143|NCT00171730|156930279|FG000|Overall Study|Adverse Event|3|||
48750144|NCT00171730|156930279|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
48750145|NCT00171730|156930279|FG000|Overall Study|Unsatisfactory Therapeutic Effect|8|||
48750146|NCT00171730|156930279|FG000|Overall Study|Withdrawal by Subject|3|||
48750147|NCT01053221|156930280|FG000|Overall Study|The study was closed prematurely|5|||
48750148|NCT01053221|156930281|FG001|Overall Study|The study was closed prematurely|9|||
48750149|NCT00553514|156930282|FG000|Overall Study|Protocol deviation|0|||
48750150|NCT00553514|156930283|FG001|Overall Study|Protocol deviation|0|||
48862496|NCT00296504|157333097|FG002|Interim Analysis|Death|3|||
48862497|NCT00296504|157333098|FG003|Interim Analysis|Death|0|||
48862498|NCT00296504|157333099|FG004|Interim Analysis|Death|0|||
48862499|NCT00296504|157333100|FG005|Interim Analysis|Death|0|||
48862500|NCT00296504|157333101|FG006|Interim Analysis|Death|0|||
48862501|NCT00296504|157333102|FG007|Interim Analysis|Death|0|||
48862502|NCT00296504|157333103|FG008|Interim Analysis|Death|0|||
48956142|NCT00337467|157667164|FG000|Overall Study|Subject No Longer Met Study Criteria|2|||
48956143|NCT02491073|157667171|FG000|Overall Study|screen failure|1|||
48750151|NCT00553514|156930284|FG002|Overall Study|Protocol deviation|0|||
48750152|NCT00553514|156930285|FG003|Overall Study|Protocol deviation|1|||
48750153|NCT00553514|156930286|FG004|Overall Study|Protocol deviation|0|||
48750154|NCT00553514|156930282|FG000|Overall Study|Lack of ovarian response|4|||
48750155|NCT00553514|156930283|FG001|Overall Study|Lack of ovarian response|5|||
48750156|NCT00553514|156930284|FG002|Overall Study|Lack of ovarian response|5|||
48750157|NCT00553514|156930285|FG003|Overall Study|Lack of ovarian response|5|||
48956144|NCT02491073|157667172|FG001|Overall Study|screen failure|0|||
48750158|NCT00553514|156930286|FG004|Overall Study|Lack of ovarian response|6|||
48750159|NCT00553514|156930282|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
48750160|NCT00553514|156930283|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
48750161|NCT00553514|156930284|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
48750162|NCT00553514|156930285|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
48750163|NCT00553514|156930286|FG004|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
48750164|NCT00553514|156930282|FG000|Overall Study|Risk of multiple pregnancy|0|||
48750165|NCT00553514|156930283|FG001|Overall Study|Risk of multiple pregnancy|2|||
48750166|NCT00553514|156930284|FG002|Overall Study|Risk of multiple pregnancy|0|||
48750167|NCT00553514|156930285|FG003|Overall Study|Risk of multiple pregnancy|1|||
48750168|NCT00553514|156930286|FG004|Overall Study|Risk of multiple pregnancy|0|||
48750169|NCT00553514|156930282|FG000|Overall Study|Other|1|||
48750170|NCT00553514|156930283|FG001|Overall Study|Other|1|||
48750171|NCT00553514|156930284|FG002|Overall Study|Other|0|||
48750172|NCT00553514|156930285|FG003|Overall Study|Other|0|||
48956145|NCT01165021|157667173|FG000|Overall Study|Death|1|||
48750173|NCT00553514|156930286|FG004|Overall Study|Other|1|||
48750174|NCT02246660|156930287|FG000|Overall Study|Withdrawal by Subject|0|||
48750175|NCT02246660|156930288|FG001|Overall Study|Withdrawal by Subject|1|||
48750176|NCT02246660|156930289|FG002|Overall Study|Withdrawal by Subject|0|||
48750177|NCT02246660|156930287|FG000|Overall Study|Death|0|||
48956146|NCT05515601|157667177|FG000|Overall Study|Withdrawal by Subject|1|||
48956147|NCT05515601|157667178|FG001|Overall Study|Withdrawal by Subject|3|||
48956148|NCT05515601|157667179|FG002|Overall Study|Withdrawal by Subject|2|||
48956149|NCT05515601|157667180|FG003|Overall Study|Withdrawal by Subject|1|||
48956150|NCT05515601|157667181|FG004|Overall Study|Withdrawal by Subject|1|||
48750178|NCT02246660|156930288|FG001|Overall Study|Death|0|||
48750179|NCT02246660|156930289|FG002|Overall Study|Death|1|||
48956151|NCT05515601|157667182|FG005|Overall Study|Withdrawal by Subject|1|||
48750180|NCT03018704|156930290|FG000|Overall Study|Lost to Follow-up|1|||
48750181|NCT03018704|156930291|FG001|Overall Study|Lost to Follow-up|1|||
48750182|NCT00320411|156930292|FG000|Overall Study|No investigational product admin.|4|||
48750183|NCT00518986|156930295|FG000|Overall Study|Adverse Event|12|||
48750184|NCT00518986|156930296|FG001|Overall Study|Adverse Event|7|||
48750185|NCT00518986|156930295|FG000|Overall Study|Lack of Efficacy|0|||
48750186|NCT00518986|156930296|FG001|Overall Study|Lack of Efficacy|2|||
48750187|NCT00518986|156930295|FG000|Overall Study|Lost to Follow-up|3|||
48750188|NCT00518986|156930296|FG001|Overall Study|Lost to Follow-up|2|||
48750189|NCT00518986|156930295|FG000|Overall Study|Physician Decision|0|||
48750190|NCT00518986|156930296|FG001|Overall Study|Physician Decision|3|||
48750191|NCT00518986|156930295|FG000|Overall Study|Protocol Violation|5|||
48750192|NCT00518986|156930296|FG001|Overall Study|Protocol Violation|7|||
48750193|NCT00518986|156930295|FG000|Overall Study|Withdrawal by Subject|4|||
48750194|NCT00518986|156930296|FG001|Overall Study|Withdrawal by Subject|4|||
48750195|NCT00518986|156930295|FG000|Overall Study|Non-Specific|2|||
48750196|NCT00518986|156930296|FG001|Overall Study|Non-Specific|1|||
48750197|NCT04997161|156930297|FG000|Overall Study|Study terminated by sponsor|3|||
48750198|NCT04502589|156930298|FG000|Overall Study|Physician Decision|1|||
48750199|NCT04502589|156930299|FG001|Overall Study|Physician Decision|0|||
48750200|NCT00023764|156930303|FG000|Overall Study|Other|1|||
48750201|NCT00023764|156930303|FG000|Overall Study|Adverse Event|4|||
48750202|NCT00023764|156930303|FG000|Overall Study|Withdrawal by Subject|1|||
48750203|NCT00023764|156930303|FG000|Overall Study|Progression of disease|6|||
48750204|NCT00023764|156930303|FG000|Overall Study|patient received other treatment|1|||
48750205|NCT00023764|156930303|FG000|Overall Study|delay in obtaining staging images|1|||
48750206|NCT01709162|156930304|FG000|Overall Study|Disease progression|3|||
48750207|NCT01709162|156930305|FG001|Overall Study|Disease progression|3|||
48750208|NCT01709162|156930304|FG000|Overall Study|Study drug toxicity|2|||
48750209|NCT01709162|156930305|FG001|Overall Study|Study drug toxicity|0|||
48750210|NCT01709162|156930304|FG000|Overall Study|Administrative reason by sponsor|0|||
48750211|NCT01709162|156930305|FG001|Overall Study|Administrative reason by sponsor|1|||
48750212|NCT01709162|156930304|FG000|Overall Study|Other|1|||
48750213|NCT01709162|156930305|FG001|Overall Study|Other|0|||
48750214|NCT01709162|156930304|FG000|Overall Study|Withdrawal by Subject|0|||
48750215|NCT01709162|156930305|FG001|Overall Study|Withdrawal by Subject|1|||
48750216|NCT01500694|156930306|FG000|Overall Study|Adverse Event|4|||
48750217|NCT01500694|156930307|FG001|Overall Study|Adverse Event|3|||
48750218|NCT01500694|156930306|FG000|Overall Study|Protocol Violation|0|||
48750219|NCT01500694|156930307|FG001|Overall Study|Protocol Violation|1|||
48862503|NCT00296504|157333095|FG000|Interim Analysis|Participant Non-compliant|0|||
48862504|NCT00296504|157333096|FG001|Interim Analysis|Participant Non-compliant|1|||
48862505|NCT00296504|157333097|FG002|Interim Analysis|Participant Non-compliant|2|||
48862506|NCT00296504|157333098|FG003|Interim Analysis|Participant Non-compliant|1|||
48862507|NCT00296504|157333099|FG004|Interim Analysis|Participant Non-compliant|1|||
48862508|NCT00296504|157333100|FG005|Interim Analysis|Participant Non-compliant|3|||
48862509|NCT00296504|157333101|FG006|Interim Analysis|Participant Non-compliant|6|||
48862510|NCT00296504|157333102|FG007|Interim Analysis|Participant Non-compliant|2|||
48862511|NCT00296504|157333103|FG008|Interim Analysis|Participant Non-compliant|0|||
48862512|NCT00296504|157333095|FG000|Interim Analysis|Participant Wanted to Become Pregnant|0|||
48862513|NCT00296504|157333096|FG001|Interim Analysis|Participant Wanted to Become Pregnant|0|||
48862514|NCT00296504|157333097|FG002|Interim Analysis|Participant Wanted to Become Pregnant|2|||
48862515|NCT00296504|157333098|FG003|Interim Analysis|Participant Wanted to Become Pregnant|0|||
48862516|NCT00296504|157333099|FG004|Interim Analysis|Participant Wanted to Become Pregnant|0|||
48862517|NCT00296504|157333100|FG005|Interim Analysis|Participant Wanted to Become Pregnant|1|||
48862518|NCT00296504|157333101|FG006|Interim Analysis|Participant Wanted to Become Pregnant|0|||
48862519|NCT00296504|157333102|FG007|Interim Analysis|Participant Wanted to Become Pregnant|0|||
48862520|NCT00296504|157333103|FG008|Interim Analysis|Participant Wanted to Become Pregnant|0|||
48862521|NCT00296504|157333095|FG000|Interim Analysis|To Simplify Treatment|0|||
48862522|NCT00296504|157333096|FG001|Interim Analysis|To Simplify Treatment|0|||
48862523|NCT00296504|157333097|FG002|Interim Analysis|To Simplify Treatment|1|||
48862524|NCT00296504|157333098|FG003|Interim Analysis|To Simplify Treatment|0|||
48862525|NCT00296504|157333099|FG004|Interim Analysis|To Simplify Treatment|0|||
48862526|NCT00296504|157333100|FG005|Interim Analysis|To Simplify Treatment|0|||
48862527|NCT00296504|157333101|FG006|Interim Analysis|To Simplify Treatment|2|||
48862528|NCT00296504|157333102|FG007|Interim Analysis|To Simplify Treatment|0|||
48862529|NCT00296504|157333103|FG008|Interim Analysis|To Simplify Treatment|0|||
48862530|NCT00296504|157333095|FG000|Interim Analysis|Participant Had Problems with Alcohol|0|||
48862531|NCT00296504|157333096|FG001|Interim Analysis|Participant Had Problems with Alcohol|0|||
48862532|NCT00296504|157333097|FG002|Interim Analysis|Participant Had Problems with Alcohol|1|||
48862533|NCT00296504|157333098|FG003|Interim Analysis|Participant Had Problems with Alcohol|0|||
48862534|NCT00296504|157333099|FG004|Interim Analysis|Participant Had Problems with Alcohol|0|||
48862535|NCT00296504|157333100|FG005|Interim Analysis|Participant Had Problems with Alcohol|0|||
48862536|NCT00296504|157333101|FG006|Interim Analysis|Participant Had Problems with Alcohol|0|||
48862537|NCT00296504|157333102|FG007|Interim Analysis|Participant Had Problems with Alcohol|0|||
48862538|NCT00296504|157333103|FG008|Interim Analysis|Participant Had Problems with Alcohol|0|||
48862539|NCT00296504|157333095|FG000|Interim Analysis|Participant Moved|1|||
48862540|NCT00296504|157333096|FG001|Interim Analysis|Participant Moved|0|||
48862541|NCT00296504|157333097|FG002|Interim Analysis|Participant Moved|1|||
48862542|NCT00296504|157333098|FG003|Interim Analysis|Participant Moved|0|||
48862543|NCT00296504|157333099|FG004|Interim Analysis|Participant Moved|0|||
48862544|NCT00296504|157333100|FG005|Interim Analysis|Participant Moved|1|||
48862545|NCT00296504|157333101|FG006|Interim Analysis|Participant Moved|1|||
48862546|NCT00296504|157333102|FG007|Interim Analysis|Participant Moved|0|||
48862547|NCT00296504|157333103|FG008|Interim Analysis|Participant Moved|0|||
48862548|NCT00296504|157333095|FG000|Interim Analysis|Participant Was Incarcerated|2|||
48862549|NCT00296504|157333096|FG001|Interim Analysis|Participant Was Incarcerated|0|||
48862550|NCT00296504|157333097|FG002|Interim Analysis|Participant Was Incarcerated|1|||
48862551|NCT00296504|157333098|FG003|Interim Analysis|Participant Was Incarcerated|0|||
48862552|NCT00296504|157333099|FG004|Interim Analysis|Participant Was Incarcerated|0|||
48862553|NCT00296504|157333100|FG005|Interim Analysis|Participant Was Incarcerated|0|||
48862554|NCT00296504|157333101|FG006|Interim Analysis|Participant Was Incarcerated|0|||
48862555|NCT00296504|157333102|FG007|Interim Analysis|Participant Was Incarcerated|0|||
48862556|NCT00296504|157333103|FG008|Interim Analysis|Participant Was Incarcerated|0|||
48862557|NCT00296504|157333095|FG000|Interim Analysis|Resistance to FPV|0|||
48862558|NCT00296504|157333096|FG001|Interim Analysis|Resistance to FPV|0|||
48862559|NCT00296504|157333097|FG002|Interim Analysis|Resistance to FPV|1|||
48862560|NCT00296504|157333098|FG003|Interim Analysis|Resistance to FPV|0|||
48862561|NCT00296504|157333099|FG004|Interim Analysis|Resistance to FPV|0|||
48862562|NCT00296504|157333100|FG005|Interim Analysis|Resistance to FPV|0|||
48956152|NCT05515601|157667177|FG000|Overall Study|Lost to Follow-up|0|||
48956153|NCT05515601|157667178|FG001|Overall Study|Lost to Follow-up|0|||
48956154|NCT05515601|157667179|FG002|Overall Study|Lost to Follow-up|0|||
48956155|NCT05515601|157667180|FG003|Overall Study|Lost to Follow-up|0|||
48750220|NCT01500694|156930306|FG000|Overall Study|Withdrawal by Subject|23|||
48750221|NCT01500694|156930307|FG001|Overall Study|Withdrawal by Subject|14|||
48750222|NCT01500694|156930306|FG000|Overall Study|Lost to Follow-up|2|||
48750223|NCT01500694|156930307|FG001|Overall Study|Lost to Follow-up|3|||
48750224|NCT01500694|156930306|FG000|Overall Study|Lack of Efficacy|14|||
48750225|NCT01500694|156930307|FG001|Overall Study|Lack of Efficacy|5|||
48750226|NCT01500694|156930306|FG000|Overall Study|Other|9|||
48750227|NCT01500694|156930307|FG001|Overall Study|Other|3|||
48750228|NCT03978520|156930309|FG000|Overall Study|Adverse Event|2|||
48750229|NCT03978520|156930310|FG001|Overall Study|Adverse Event|5|||
48750230|NCT03978520|156930311|FG002|Overall Study|Adverse Event|3|||
48750231|NCT03978520|156930312|FG003|Overall Study|Adverse Event|5|||
48750232|NCT03978520|156930313|FG004|Overall Study|Adverse Event|6|||
48750233|NCT03978520|156930309|FG000|Overall Study|Withdrawal by Subject|10|||
48750234|NCT03978520|156930310|FG001|Overall Study|Withdrawal by Subject|4|||
48750235|NCT03978520|156930311|FG002|Overall Study|Withdrawal by Subject|5|||
48750236|NCT03978520|156930312|FG003|Overall Study|Withdrawal by Subject|6|||
48750237|NCT03978520|156930313|FG004|Overall Study|Withdrawal by Subject|5|||
48750238|NCT03978520|156930309|FG000|Overall Study|Lost to Follow-up|2|||
48750239|NCT03978520|156930310|FG001|Overall Study|Lost to Follow-up|2|||
48750240|NCT03978520|156930311|FG002|Overall Study|Lost to Follow-up|2|||
48750241|NCT03978520|156930312|FG003|Overall Study|Lost to Follow-up|0|||
48750242|NCT03978520|156930313|FG004|Overall Study|Lost to Follow-up|1|||
48750243|NCT03978520|156930309|FG000|Overall Study|COVID-19 infection|0|||
48750244|NCT03978520|156930310|FG001|Overall Study|COVID-19 infection|1|||
48750245|NCT03978520|156930311|FG002|Overall Study|COVID-19 infection|0|||
48750246|NCT03978520|156930312|FG003|Overall Study|COVID-19 infection|0|||
48750247|NCT03978520|156930313|FG004|Overall Study|COVID-19 infection|0|||
48750248|NCT03978520|156930309|FG000|Overall Study|Other, not specified|9|||
48750249|NCT03978520|156930310|FG001|Overall Study|Other, not specified|4|||
48750250|NCT03978520|156930311|FG002|Overall Study|Other, not specified|1|||
48750251|NCT03978520|156930312|FG003|Overall Study|Other, not specified|1|||
48750252|NCT03978520|156930313|FG004|Overall Study|Other, not specified|2|||
48750253|NCT03978520|156930309|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
48956156|NCT05515601|157667181|FG004|Overall Study|Lost to Follow-up|1|||
48956157|NCT05515601|157667182|FG005|Overall Study|Lost to Follow-up|0|||
48956158|NCT01419665|157667183|FG000|Combination Treatment|Adverse Event|7|||
48956159|NCT01419665|157667184|FG001|Combination Treatment|Adverse Event|10|||
48956160|NCT01419665|157667183|FG000|Combination Treatment|Physician Decision|5|||
48956161|NCT01419665|157667184|FG001|Combination Treatment|Physician Decision|8|||
48750254|NCT03978520|156930310|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
48750255|NCT03978520|156930311|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
48956162|NCT01419665|157667183|FG000|Combination Treatment|Protocol Violation|6|||
48750256|NCT03978520|156930312|FG003|Overall Study|Sponsor decision based on interim analysis data review|33|||
48750257|NCT03978520|156930313|FG004|Overall Study|Sponsor decision based on interim analysis data review|24|||
48750258|NCT03672747|156930314|FG000|Overall Study|Lost to Follow-up|1|||
48750259|NCT03672747|156930315|FG001|Overall Study|Lost to Follow-up|1|||
48750260|NCT03672747|156930316|FG002|Overall Study|Lost to Follow-up|2|||
48750261|NCT03672747|156930317|FG003|Overall Study|Lost to Follow-up|2|||
48750262|NCT03672747|156930318|FG004|Overall Study|Lost to Follow-up|2|||
48956163|NCT01419665|157667184|FG001|Combination Treatment|Protocol Violation|2|||
48956164|NCT01419665|157667183|FG000|Combination Treatment|disease progression|10|||
48956165|NCT01419665|157667184|FG001|Combination Treatment|disease progression|9|||
48956166|NCT01419665|157667183|FG000|Combination Treatment|Death|5|||
48956167|NCT01419665|157667184|FG001|Combination Treatment|Death|7|||
48956168|NCT01419665|157667183|FG000|Combination Treatment|administrative problems|0|||
48956169|NCT01419665|157667184|FG001|Combination Treatment|administrative problems|1|||
48956170|NCT01419665|157667183|FG000|Combination Treatment|Withdrawal by Subject|5|||
48956171|NCT01419665|157667184|FG001|Combination Treatment|Withdrawal by Subject|4|||
48956172|NCT01419665|157667183|FG000|Maintenance Treatment and/or Follow up|switch to open label|44|||
48956173|NCT01419665|157667184|FG001|Maintenance Treatment and/or Follow up|switch to open label|39|||
48956174|NCT01419665|157667183|FG000|Maintenance Treatment and/or Follow up|administrative problems|0|||
48956175|NCT01419665|157667184|FG001|Maintenance Treatment and/or Follow up|administrative problems|6|||
48956176|NCT01419665|157667183|FG000|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
48956177|NCT01419665|157667184|FG001|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
48956178|NCT01419665|157667183|FG000|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
48956179|NCT01419665|157667184|FG001|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
48956180|NCT01419665|157667183|FG000|Maintenance Treatment and/or Follow up|Physician Decision|5|||
48956181|NCT01419665|157667184|FG001|Maintenance Treatment and/or Follow up|Physician Decision|2|||
48956182|NCT01419665|157667183|FG000|Maintenance Treatment and/or Follow up|disease progression|53|||
48956183|NCT01419665|157667184|FG001|Maintenance Treatment and/or Follow up|disease progression|37|||
48956184|NCT01419665|157667183|FG000|Maintenance Treatment and/or Follow up|Death|1|||
48956185|NCT01419665|157667184|FG001|Maintenance Treatment and/or Follow up|Death|2|||
48956186|NCT01419665|157667183|FG000|Maintenance Treatment and/or Follow up|Adverse Event|11|||
48956187|NCT01419665|157667184|FG001|Maintenance Treatment and/or Follow up|Adverse Event|7|||
48956188|NCT01419665|157667183|FG000|Maintenance Treatment and/or Follow up|Lost to Follow-up|1|||
48750263|NCT03672747|156930319|FG005|Overall Study|Lost to Follow-up|1|||
48956189|NCT01419665|157667184|FG001|Maintenance Treatment and/or Follow up|Lost to Follow-up|2|||
48750264|NCT00165776|156930320|FG000|Overall Study|Lack of Efficacy|0|||
48956190|NCT01419665|157667183|FG000|Open Label Phase|Death|1|||
48956191|NCT01419665|157667184|FG001|Open Label Phase|Death|0|||
48956192|NCT01419665|157667183|FG000|Open Label Phase|disease progression|0|||
48956193|NCT01419665|157667184|FG001|Open Label Phase|disease progression|1|||
48956194|NCT00777491|157667185|FG000|Overall Study|Protocol Violation|0|||
48956195|NCT00777491|157667186|FG001|Overall Study|Protocol Violation|2|||
48956196|NCT00777491|157667185|FG000|Overall Study|Did not receive any protocol treatment|2|||
48750265|NCT00165776|156930321|FG001|Overall Study|Lack of Efficacy|0|||
48956197|NCT00777491|157667186|FG001|Overall Study|Did not receive any protocol treatment|0|||
48956198|NCT04095286|157667187|FG000|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
48956199|NCT04095286|157667188|FG001|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1|||
48956200|NCT04095286|157667189|FG002|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
48750266|NCT00165776|156930322|FG002|Overall Study|Lack of Efficacy|0|||
48750267|NCT00165776|156930323|FG003|Overall Study|Lack of Efficacy|1|||
48750268|NCT00165776|156930320|FG000|Overall Study|Withdrawal by Subject|4|||
48750269|NCT00165776|156930321|FG001|Overall Study|Withdrawal by Subject|1|||
48750270|NCT00165776|156930322|FG002|Overall Study|Withdrawal by Subject|2|||
48750271|NCT00165776|156930323|FG003|Overall Study|Withdrawal by Subject|0|||
48750272|NCT00165776|156930320|FG000|Overall Study|Worsening of Cervical Dystonia|0|||
48750273|NCT00165776|156930321|FG001|Overall Study|Worsening of Cervical Dystonia|0|||
48750274|NCT00165776|156930322|FG002|Overall Study|Worsening of Cervical Dystonia|0|||
48750275|NCT00165776|156930323|FG003|Overall Study|Worsening of Cervical Dystonia|1|||
48750276|NCT04212650|156930324|FG000|Overall Study|Withdrawal by Subject|1|||
48750277|NCT04212650|156930325|FG001|Overall Study|Withdrawal by Subject|0|||
48750278|NCT02634320|156930329|FG000|Overall Study|Adverse Event|2|||
48750279|NCT02634320|156930329|FG000|Overall Study|Lost to Follow-up|3|||
48750280|NCT02634320|156930329|FG000|Overall Study|Moved out of area|2|||
48750281|NCT02634320|156930329|FG000|Overall Study|Out of window for study visits|1|||
48750282|NCT02634320|156930329|FG000|Overall Study|Protocol Violation|1|||
48750283|NCT02634320|156930329|FG000|Overall Study|Withdrawal by Subject|5|||
48750284|NCT02634320|156930329|FG000|Overall Study|Lack of Efficacy|2|||
48750285|NCT02132130|156930331|FG000|Overall Study|Lost to Follow-up|0|||
48750286|NCT02132130|156930332|FG001|Overall Study|Lost to Follow-up|2|||
48750287|NCT02132130|156930333|FG002|Overall Study|Lost to Follow-up|0|||
48750288|NCT02132130|156930334|FG003|Overall Study|Lost to Follow-up|0|||
48750289|NCT02132130|156930331|FG000|Overall Study|Withdrawal by Subject|0|||
48750290|NCT02132130|156930332|FG001|Overall Study|Withdrawal by Subject|0|||
48750291|NCT02132130|156930333|FG002|Overall Study|Withdrawal by Subject|0|||
48750292|NCT02132130|156930334|FG003|Overall Study|Withdrawal by Subject|1|||
48750293|NCT00598832|156930337|FG000|Overall Study|Lack of Efficacy|3|||
48750294|NCT00598832|156930338|FG001|Overall Study|Lack of Efficacy|7|||
48750295|NCT00598832|156930337|FG000|Overall Study|Adverse Event|6|||
48750296|NCT00598832|156930338|FG001|Overall Study|Adverse Event|2|||
48750297|NCT00598832|156930337|FG000|Overall Study|Withdrawal by Subject|25|||
48750298|NCT00598832|156930338|FG001|Overall Study|Withdrawal by Subject|36|||
48750299|NCT00598832|156930337|FG000|Overall Study|Protocol Violation|0|||
48750300|NCT00598832|156930338|FG001|Overall Study|Protocol Violation|2|||
48750301|NCT00598832|156930337|FG000|Overall Study|Lost to Follow-up|24|||
48750302|NCT00598832|156930338|FG001|Overall Study|Lost to Follow-up|29|||
48750303|NCT00598832|156930337|FG000|Overall Study|Pregnancy|2|||
48750304|NCT00598832|156930338|FG001|Overall Study|Pregnancy|2|||
48750305|NCT00598832|156930337|FG000|Overall Study|Physician Decision|1|||
48750306|NCT00598832|156930338|FG001|Overall Study|Physician Decision|4|||
48750307|NCT00598832|156930337|FG000|Overall Study|Non compliance|1|||
48750308|NCT00598832|156930338|FG001|Overall Study|Non compliance|0|||
48750309|NCT03428360|156930350|FG000|Overall Study|Informed consent withdrawn|5|||
48750310|NCT03428360|156930350|FG000|Overall Study|Withdrawal by Subject|4|||
48862563|NCT00296504|157333101|FG006|Interim Analysis|Resistance to FPV|0|||
48750311|NCT03428360|156930350|FG000|Overall Study|Lost to Follow-up|5|||
48750312|NCT03428360|156930350|FG000|Overall Study|Physician Decision|2|||
48862564|NCT00296504|157333102|FG007|Interim Analysis|Resistance to FPV|0|||
48862565|NCT00296504|157333103|FG008|Interim Analysis|Resistance to FPV|0|||
48862566|NCT00296504|157333095|FG000|Interim Analysis|Physician Decision|0|||
48862567|NCT00296504|157333096|FG001|Interim Analysis|Physician Decision|0|||
48862568|NCT00296504|157333097|FG002|Interim Analysis|Physician Decision|1|||
48862569|NCT00296504|157333098|FG003|Interim Analysis|Physician Decision|0|||
48862570|NCT00296504|157333099|FG004|Interim Analysis|Physician Decision|0|||
48862571|NCT00296504|157333100|FG005|Interim Analysis|Physician Decision|0|||
48862572|NCT00296504|157333101|FG006|Interim Analysis|Physician Decision|0|||
48862573|NCT00296504|157333102|FG007|Interim Analysis|Physician Decision|0|||
48750313|NCT03428360|156930350|FG000|Overall Study|Informed consent withdrawn|5|||
48750314|NCT03428360|156930350|FG000|Overall Study|Study terminated by sponsor|10|||
48750315|NCT03428360|156930350|FG000|Overall Study|Non-compliant with study|1|||
48750316|NCT03428360|156930350|FG000|Overall Study|Non-compliant with study drug|3|||
48750317|NCT03428360|156930350|FG000|Overall Study|Death|3|||
48750318|NCT03428360|156930350|FG000|Overall Study|Adverse Event|1|||
48750319|NCT03428360|156930350|FG000|Overall Study|Not on antiepileptic drug|1|||
48750320|NCT01482884|156930351|FG000|Overall Study|Medical decision due to lack of efficacy|0|||
48750321|NCT01482884|156930352|FG001|Overall Study|Medical decision due to lack of efficacy|1|||
48750322|NCT01482884|156930351|FG000|Overall Study|Protocol Violation|1|||
48750323|NCT01482884|156930352|FG001|Overall Study|Protocol Violation|0|||
48750324|NCT01482884|156930351|FG000|Overall Study|Lost to Follow-up|2|||
48750325|NCT01482884|156930352|FG001|Overall Study|Lost to Follow-up|2|||
48750326|NCT01482884|156930351|FG000|Overall Study|Lack of Efficacy|0|||
48750327|NCT01482884|156930352|FG001|Overall Study|Lack of Efficacy|1|||
48750328|NCT01482884|156930351|FG000|Overall Study|Adverse Event|2|||
48750329|NCT01482884|156930352|FG001|Overall Study|Adverse Event|1|||
48750330|NCT01482884|156930351|FG000|Overall Study|Withdrawal by Subject|8|||
48750331|NCT01482884|156930352|FG001|Overall Study|Withdrawal by Subject|13|||
48750332|NCT00203996|156930353|FG000|Overall Study|Lost to Follow-up|0|||
48750333|NCT00203996|156930354|FG001|Overall Study|Lost to Follow-up|0|||
48750334|NCT00203996|156930355|FG002|Overall Study|Lost to Follow-up|0|||
48750335|NCT00203996|156930356|FG003|Overall Study|Lost to Follow-up|1|||
48750336|NCT00203996|156930357|FG004|Overall Study|Lost to Follow-up|0|||
48750337|NCT00203996|156930358|FG005|Overall Study|Lost to Follow-up|0|||
48750338|NCT00203996|156930359|FG006|Overall Study|Lost to Follow-up|0|||
48956201|NCT04095286|157667190|FG003|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
48956202|NCT04095286|157667191|FG004|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
48750339|NCT00203996|156930360|FG007|Overall Study|Lost to Follow-up|0|||
48750340|NCT00203996|156930361|FG008|Overall Study|Lost to Follow-up|0|||
48750341|NCT00203996|156930362|FG009|Overall Study|Lost to Follow-up|0|||
48750342|NCT00203996|156930353|FG000|Overall Study|Protocol Violation|0|||
48862574|NCT00296504|157333103|FG008|Interim Analysis|Physician Decision|0|||
48862575|NCT00296504|157333095|FG000|Interim Analysis|Principle Investigator Discretion|2|||
48862576|NCT00296504|157333096|FG001|Interim Analysis|Principle Investigator Discretion|0|||
48862577|NCT00296504|157333097|FG002|Interim Analysis|Principle Investigator Discretion|1|||
48862578|NCT00296504|157333098|FG003|Interim Analysis|Principle Investigator Discretion|1|||
48862579|NCT00296504|157333099|FG004|Interim Analysis|Principle Investigator Discretion|0|||
48862580|NCT00296504|157333100|FG005|Interim Analysis|Principle Investigator Discretion|0|||
48862581|NCT00296504|157333101|FG006|Interim Analysis|Principle Investigator Discretion|0|||
48862582|NCT00296504|157333102|FG007|Interim Analysis|Principle Investigator Discretion|0|||
48862583|NCT00296504|157333103|FG008|Interim Analysis|Principle Investigator Discretion|0|||
48862584|NCT00296504|157333095|FG000|Interim Analysis|Principle Investigator Terminated Study|0|||
48862585|NCT00296504|157333096|FG001|Interim Analysis|Principle Investigator Terminated Study|0|||
48862586|NCT00296504|157333097|FG002|Interim Analysis|Principle Investigator Terminated Study|1|||
48862587|NCT00296504|157333098|FG003|Interim Analysis|Principle Investigator Terminated Study|0|||
48862588|NCT00296504|157333099|FG004|Interim Analysis|Principle Investigator Terminated Study|0|||
48862589|NCT00296504|157333100|FG005|Interim Analysis|Principle Investigator Terminated Study|0|||
48862590|NCT00296504|157333101|FG006|Interim Analysis|Principle Investigator Terminated Study|0|||
48862591|NCT00296504|157333102|FG007|Interim Analysis|Principle Investigator Terminated Study|0|||
48862592|NCT00296504|157333103|FG008|Interim Analysis|Principle Investigator Terminated Study|0|||
48862593|NCT00296504|157333095|FG000|Interim Analysis|Non-adherence|2|||
48862594|NCT00296504|157333096|FG001|Interim Analysis|Non-adherence|0|||
48862595|NCT00296504|157333097|FG002|Interim Analysis|Non-adherence|0|||
48862596|NCT00296504|157333098|FG003|Interim Analysis|Non-adherence|0|||
48862597|NCT00296504|157333099|FG004|Interim Analysis|Non-adherence|1|||
48862598|NCT00296504|157333100|FG005|Interim Analysis|Non-adherence|0|||
48862599|NCT00296504|157333101|FG006|Interim Analysis|Non-adherence|0|||
48862600|NCT00296504|157333102|FG007|Interim Analysis|Non-adherence|1|||
48862601|NCT00296504|157333103|FG008|Interim Analysis|Non-adherence|0|||
48862602|NCT00296504|157333095|FG000|Interim Analysis|Site Closing|1|||
48862603|NCT00296504|157333096|FG001|Interim Analysis|Site Closing|0|||
48862604|NCT00296504|157333097|FG002|Interim Analysis|Site Closing|0|||
48862605|NCT00296504|157333098|FG003|Interim Analysis|Site Closing|0|||
48750343|NCT00203996|156930354|FG001|Overall Study|Protocol Violation|0|||
48956203|NCT04095286|157667192|FG005|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
48956204|NCT04095286|157667187|FG000|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1|||
48956205|NCT04095286|157667188|FG001|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
48956206|NCT04095286|157667189|FG002|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
48956207|NCT04095286|157667190|FG003|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
48956208|NCT04095286|157667191|FG004|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
48956209|NCT04095286|157667192|FG005|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
48956210|NCT04095286|157667187|FG000|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
48862606|NCT00296504|157333099|FG004|Interim Analysis|Site Closing|0|||
48862607|NCT00296504|157333100|FG005|Interim Analysis|Site Closing|1|||
48862608|NCT00296504|157333101|FG006|Interim Analysis|Site Closing|2|||
48862609|NCT00296504|157333102|FG007|Interim Analysis|Site Closing|0|||
48862610|NCT00296504|157333103|FG008|Interim Analysis|Site Closing|0|||
48862611|NCT00296504|157333095|FG000|Interim Analysis|Lack of Personnel at Site|1|||
48862612|NCT00296504|157333096|FG001|Interim Analysis|Lack of Personnel at Site|0|||
48862613|NCT00296504|157333097|FG002|Interim Analysis|Lack of Personnel at Site|0|||
48862614|NCT00296504|157333098|FG003|Interim Analysis|Lack of Personnel at Site|0|||
48862615|NCT00296504|157333099|FG004|Interim Analysis|Lack of Personnel at Site|0|||
48750344|NCT00203996|156930355|FG002|Overall Study|Protocol Violation|0|||
48750345|NCT00203996|156930356|FG003|Overall Study|Protocol Violation|6|||
48750346|NCT00203996|156930357|FG004|Overall Study|Protocol Violation|1|||
48750347|NCT00203996|156930358|FG005|Overall Study|Protocol Violation|0|||
48750348|NCT00203996|156930359|FG006|Overall Study|Protocol Violation|0|||
48750349|NCT00203996|156930360|FG007|Overall Study|Protocol Violation|0|||
48750350|NCT00203996|156930361|FG008|Overall Study|Protocol Violation|0|||
48750351|NCT00203996|156930362|FG009|Overall Study|Protocol Violation|0|||
48750352|NCT00203996|156930353|FG000|Overall Study|Physician Decision|0|||
48750353|NCT00203996|156930354|FG001|Overall Study|Physician Decision|0|||
48750354|NCT00203996|156930355|FG002|Overall Study|Physician Decision|0|||
48750355|NCT00203996|156930356|FG003|Overall Study|Physician Decision|2|||
48750356|NCT00203996|156930357|FG004|Overall Study|Physician Decision|0|||
48750357|NCT00203996|156930358|FG005|Overall Study|Physician Decision|0|||
48750358|NCT00203996|156930359|FG006|Overall Study|Physician Decision|0|||
48750359|NCT00203996|156930360|FG007|Overall Study|Physician Decision|0|||
48750360|NCT00203996|156930361|FG008|Overall Study|Physician Decision|0|||
48750361|NCT00203996|156930362|FG009|Overall Study|Physician Decision|1|||
48750362|NCT00203996|156930353|FG000|Overall Study|CPAP machine malfunction|0|||
48750363|NCT00203996|156930354|FG001|Overall Study|CPAP machine malfunction|0|||
48862616|NCT00296504|157333100|FG005|Interim Analysis|Lack of Personnel at Site|0|||
48750364|NCT00203996|156930355|FG002|Overall Study|CPAP machine malfunction|0|||
48862617|NCT00296504|157333101|FG006|Interim Analysis|Lack of Personnel at Site|0|||
48862618|NCT00296504|157333102|FG007|Interim Analysis|Lack of Personnel at Site|0|||
48862619|NCT00296504|157333103|FG008|Interim Analysis|Lack of Personnel at Site|0|||
48862620|NCT00296504|157333095|FG000|Interim Analysis|Missed Schedule Date|1|||
48862621|NCT00296504|157333096|FG001|Interim Analysis|Missed Schedule Date|0|||
48862622|NCT00296504|157333097|FG002|Interim Analysis|Missed Schedule Date|0|||
48862623|NCT00296504|157333098|FG003|Interim Analysis|Missed Schedule Date|0|||
48862624|NCT00296504|157333099|FG004|Interim Analysis|Missed Schedule Date|0|||
48862625|NCT00296504|157333100|FG005|Interim Analysis|Missed Schedule Date|0|||
48862626|NCT00296504|157333101|FG006|Interim Analysis|Missed Schedule Date|0|||
48862627|NCT00296504|157333102|FG007|Interim Analysis|Missed Schedule Date|0|||
48862628|NCT00296504|157333103|FG008|Interim Analysis|Missed Schedule Date|0|||
48862629|NCT00296504|157333095|FG000|Interim Analysis|Inclusion in Other Protocol|0|||
48862630|NCT00296504|157333096|FG001|Interim Analysis|Inclusion in Other Protocol|0|||
48862631|NCT00296504|157333097|FG002|Interim Analysis|Inclusion in Other Protocol|0|||
48862632|NCT00296504|157333098|FG003|Interim Analysis|Inclusion in Other Protocol|1|||
48862633|NCT00296504|157333099|FG004|Interim Analysis|Inclusion in Other Protocol|0|||
48862634|NCT00296504|157333100|FG005|Interim Analysis|Inclusion in Other Protocol|0|||
48862635|NCT00296504|157333101|FG006|Interim Analysis|Inclusion in Other Protocol|0|||
48862636|NCT00296504|157333102|FG007|Interim Analysis|Inclusion in Other Protocol|0|||
48862637|NCT00296504|157333103|FG008|Interim Analysis|Inclusion in Other Protocol|0|||
48862638|NCT00296504|157333095|FG000|Interim Analysis|Participant Stopped|0|||
48862639|NCT00296504|157333096|FG001|Interim Analysis|Participant Stopped|0|||
48862640|NCT00296504|157333097|FG002|Interim Analysis|Participant Stopped|0|||
48862641|NCT00296504|157333098|FG003|Interim Analysis|Participant Stopped|0|||
48862642|NCT00296504|157333099|FG004|Interim Analysis|Participant Stopped|1|||
48862643|NCT00296504|157333100|FG005|Interim Analysis|Participant Stopped|0|||
48862644|NCT00296504|157333101|FG006|Interim Analysis|Participant Stopped|0|||
48862645|NCT00296504|157333102|FG007|Interim Analysis|Participant Stopped|0|||
48862646|NCT00296504|157333103|FG008|Interim Analysis|Participant Stopped|0|||
48862647|NCT00296504|157333095|FG000|Interim Analysis|Physician and Participant Decision|0|||
48862648|NCT00296504|157333096|FG001|Interim Analysis|Physician and Participant Decision|0|||
48862649|NCT00296504|157333097|FG002|Interim Analysis|Physician and Participant Decision|0|||
48862650|NCT00296504|157333098|FG003|Interim Analysis|Physician and Participant Decision|0|||
48862651|NCT00296504|157333099|FG004|Interim Analysis|Physician and Participant Decision|0|||
48862652|NCT00296504|157333100|FG005|Interim Analysis|Physician and Participant Decision|1|||
48862653|NCT00296504|157333101|FG006|Interim Analysis|Physician and Participant Decision|0|||
48862654|NCT00296504|157333102|FG007|Interim Analysis|Physician and Participant Decision|0|||
48862655|NCT00296504|157333103|FG008|Interim Analysis|Physician and Participant Decision|0|||
48862656|NCT00296504|157333095|FG000|Interim Analysis|Participant Stopped HIV Medications|0|||
48862657|NCT00296504|157333096|FG001|Interim Analysis|Participant Stopped HIV Medications|0|||
49015395|NCT01748890|157892165|FG000|Overall Study|Insufficient recruitment for analysis|4|||
48750365|NCT00203996|156930356|FG003|Overall Study|CPAP machine malfunction|1|||
48750366|NCT00203996|156930357|FG004|Overall Study|CPAP machine malfunction|0|||
48750367|NCT00203996|156930358|FG005|Overall Study|CPAP machine malfunction|0|||
48750368|NCT00203996|156930359|FG006|Overall Study|CPAP machine malfunction|0|||
48750369|NCT00203996|156930360|FG007|Overall Study|CPAP machine malfunction|0|||
48750370|NCT00203996|156930361|FG008|Overall Study|CPAP machine malfunction|0|||
48750371|NCT00203996|156930362|FG009|Overall Study|CPAP machine malfunction|0|||
48750372|NCT00203996|156930353|FG000|Overall Study|Scheduling issue|0|||
48750373|NCT00203996|156930354|FG001|Overall Study|Scheduling issue|0|||
48750374|NCT00203996|156930355|FG002|Overall Study|Scheduling issue|0|||
48750375|NCT00203996|156930356|FG003|Overall Study|Scheduling issue|0|||
48750376|NCT00203996|156930357|FG004|Overall Study|Scheduling issue|0|||
48750377|NCT00203996|156930358|FG005|Overall Study|Scheduling issue|0|||
48750378|NCT00203996|156930359|FG006|Overall Study|Scheduling issue|0|||
48750379|NCT00203996|156930360|FG007|Overall Study|Scheduling issue|2|||
48750380|NCT00203996|156930361|FG008|Overall Study|Scheduling issue|0|||
48750381|NCT00203996|156930362|FG009|Overall Study|Scheduling issue|0|||
48750382|NCT02848651|156930363|FG000|Overall Study|Death|85|||
48750383|NCT02848651|156930363|FG000|Overall Study|Lost to Follow-up|1|||
48750384|NCT02848651|156930363|FG000|Overall Study|Non-Compliance|1|||
48750385|NCT02848651|156930363|FG000|Overall Study|Symptomatic Deterioration|1|||
48750386|NCT02848651|156930363|FG000|Overall Study|Physician Decision|4|||
48750387|NCT02848651|156930363|FG000|Overall Study|Withdrawal by Subject|14|||
48750388|NCT01713686|156932277|FG000|Overall Study|Lost to Follow-up|9|||
48750389|NCT01713686|156932277|FG000|Overall Study|Withdrawal by Subject|6|||
48750390|NCT00612690|156932278|FG000|Overall Study|Lost to Follow-up|72|||
48750391|NCT00612690|156932279|FG001|Overall Study|Lost to Follow-up|98|||
48750392|NCT00612690|156932278|FG000|Overall Study|Withdrawal by Subject|32|||
48750393|NCT00612690|156932279|FG001|Overall Study|Withdrawal by Subject|20|||
48956211|NCT04095286|157667188|FG001|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
48956212|NCT04095286|157667189|FG002|Period 1 (4 Days) + Washout (7days)|Adverse Event|1|||
48750394|NCT00612690|156932278|FG000|Overall Study|Withdrawal by Site|11|||
48750395|NCT00612690|156932279|FG001|Overall Study|Withdrawal by Site|0|||
48750396|NCT02980601|156932280|FG000|Overall Study|Lost to Follow-up|2|||
48750397|NCT02980601|156932281|FG001|Overall Study|Lost to Follow-up|2|||
48956213|NCT04095286|157667190|FG003|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
48956214|NCT04095286|157667191|FG004|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
48956215|NCT04095286|157667192|FG005|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
48956216|NCT04095286|157667187|FG000|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
48956217|NCT04095286|157667188|FG001|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
48956218|NCT04095286|157667189|FG002|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2|||
48956219|NCT04095286|157667190|FG003|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
48956220|NCT04095286|157667191|FG004|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
48956221|NCT04095286|157667192|FG005|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
48956222|NCT04095286|157667187|FG000|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
48956223|NCT04095286|157667188|FG001|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
48956224|NCT04095286|157667189|FG002|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
48956225|NCT04095286|157667190|FG003|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
48956226|NCT04095286|157667191|FG004|Period 2 (4 Days) + Washout (7days)|Adverse Event|1|||
48956227|NCT04095286|157667192|FG005|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
48956228|NCT00610935|157667193|FG000|Overall Study|Lost to Follow-up|0|||
48956229|NCT00610935|157667194|FG001|Overall Study|Lost to Follow-up|1|||
48956230|NCT00610935|157667193|FG000|Overall Study|Withdrawal by Subject|0|||
48956231|NCT00610935|157667194|FG001|Overall Study|Withdrawal by Subject|2|||
48750398|NCT02980601|156932280|FG000|Overall Study|Death|0|||
48750399|NCT02980601|156932281|FG001|Overall Study|Death|1|||
48750400|NCT02980601|156932280|FG000|Overall Study|Graft loss|1|||
48750401|NCT02980601|156932281|FG001|Overall Study|Graft loss|0|||
48750402|NCT02980601|156932280|FG000|Overall Study|Failed to sign consent|2|||
48750403|NCT02980601|156932281|FG001|Overall Study|Failed to sign consent|0|||
48750404|NCT00907777|156932283|FG000|Overall Study|Withdrawal by Subject|0|||
48750405|NCT00907777|156932284|FG001|Overall Study|Withdrawal by Subject|1|||
48750406|NCT00674700|156932293|FG000|Year 1|Adverse Event|17|||
48750407|NCT00674700|156932294|FG001|Year 1|Adverse Event|20|||
48750408|NCT00674700|156932295|FG002|Year 1|Adverse Event|5|||
48750409|NCT00674700|156932293|FG000|Year 1|Withdrawal by Subject|7|||
48750410|NCT00674700|156932294|FG001|Year 1|Withdrawal by Subject|7|||
48750411|NCT00674700|156932295|FG002|Year 1|Withdrawal by Subject|6|||
48750412|NCT00674700|156932293|FG000|Year 1|Any other reason not above-mentioned|7|||
48750413|NCT00674700|156932294|FG001|Year 1|Any other reason not above-mentioned|7|||
48750414|NCT00674700|156932295|FG002|Year 1|Any other reason not above-mentioned|6|||
48750415|NCT00674700|156932293|FG000|Year 2 Follow-up Without Treatment|Adverse Event|0|||
48750416|NCT00674700|156932294|FG001|Year 2 Follow-up Without Treatment|Adverse Event|1|||
48750417|NCT00674700|156932295|FG002|Year 2 Follow-up Without Treatment|Adverse Event|1|||
48750418|NCT00674700|156932293|FG000|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
48750419|NCT00674700|156932294|FG001|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
48956232|NCT00610935|157667193|FG000|Overall Study|Sponsor Discontinuation|1|||
48956233|NCT00610935|157667194|FG001|Overall Study|Sponsor Discontinuation|0|||
48956234|NCT01689207|157667196|FG000|Overall Study|Adverse Event|0|||
48956235|NCT01689207|157667197|FG001|Overall Study|Adverse Event|1|||
48956236|NCT01689207|157667198|FG002|Overall Study|Adverse Event|0|||
48956237|NCT01689207|157667199|FG003|Overall Study|Adverse Event|0|||
48956238|NCT01689207|157667200|FG004|Overall Study|Adverse Event|2|||
48956239|NCT01689207|157667201|FG005|Overall Study|Adverse Event|1|||
48750420|NCT00674700|156932295|FG002|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4|||
48750421|NCT00674700|156932293|FG000|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5|||
48956240|NCT01689207|157667202|FG006|Overall Study|Adverse Event|0|||
48956241|NCT01689207|157667203|FG007|Overall Study|Adverse Event|0|||
48956242|NCT01689207|157667204|FG008|Overall Study|Adverse Event|1|||
48862658|NCT00296504|157333097|FG002|Interim Analysis|Participant Stopped HIV Medications|0|||
48862659|NCT00296504|157333098|FG003|Interim Analysis|Participant Stopped HIV Medications|0|||
48862660|NCT00296504|157333099|FG004|Interim Analysis|Participant Stopped HIV Medications|0|||
48862661|NCT00296504|157333100|FG005|Interim Analysis|Participant Stopped HIV Medications|0|||
48862662|NCT00296504|157333101|FG006|Interim Analysis|Participant Stopped HIV Medications|1|||
48862663|NCT00296504|157333102|FG007|Interim Analysis|Participant Stopped HIV Medications|0|||
48862664|NCT00296504|157333103|FG008|Interim Analysis|Participant Stopped HIV Medications|0|||
48862665|NCT00296504|157333095|FG000|Interim Analysis|Study Ended|0|||
48862666|NCT00296504|157333096|FG001|Interim Analysis|Study Ended|0|||
48862667|NCT00296504|157333097|FG002|Interim Analysis|Study Ended|0|||
48862668|NCT00296504|157333098|FG003|Interim Analysis|Study Ended|0|||
48862669|NCT00296504|157333099|FG004|Interim Analysis|Study Ended|0|||
48862670|NCT00296504|157333100|FG005|Interim Analysis|Study Ended|0|||
48862671|NCT00296504|157333101|FG006|Interim Analysis|Study Ended|1|||
48862672|NCT00296504|157333102|FG007|Interim Analysis|Study Ended|0|||
48862673|NCT00296504|157333103|FG008|Interim Analysis|Study Ended|0|||
48862674|NCT00296504|157333095|FG000|Interim Analysis|Participant Needed Interferon|0|||
48862675|NCT00296504|157333096|FG001|Interim Analysis|Participant Needed Interferon|0|||
48862676|NCT00296504|157333097|FG002|Interim Analysis|Participant Needed Interferon|0|||
48862677|NCT00296504|157333098|FG003|Interim Analysis|Participant Needed Interferon|0|||
48956243|NCT01689207|157667205|FG009|Overall Study|Adverse Event|0|||
48862678|NCT00296504|157333099|FG004|Interim Analysis|Participant Needed Interferon|0|||
48956244|NCT01689207|157667206|FG010|Overall Study|Adverse Event|0|||
49015396|NCT02666430|157892166|FG000|Period 1|Lost to Follow-up|1|||
48862679|NCT00296504|157333100|FG005|Interim Analysis|Participant Needed Interferon|0|||
48862680|NCT00296504|157333101|FG006|Interim Analysis|Participant Needed Interferon|0|||
48750422|NCT00674700|156932294|FG001|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10|||
48750423|NCT00674700|156932295|FG002|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7|||
48750424|NCT02954237|156932296|FG000|Overall Study|Withdrawal by Subject|25|||
48750425|NCT02954237|156932296|FG000|Overall Study|Missed visit|16|||
48750426|NCT02954237|156932296|FG000|Overall Study|Death|2|||
48750427|NCT02151591|156932308|FG000|Overall Study|Lost to Follow-up|6|||
48750428|NCT02151591|156932309|FG001|Overall Study|Lost to Follow-up|3|||
48750429|NCT02670083|156932312|FG000|Overall Study|Adverse Event|16|||
48750430|NCT02670083|156932313|FG001|Overall Study|Adverse Event|13|||
48750431|NCT02670083|156932312|FG000|Overall Study|Death|4|||
48750432|NCT02670083|156932313|FG001|Overall Study|Death|6|||
48750433|NCT02670083|156932312|FG000|Overall Study|Lost to Follow-up|2|||
48750434|NCT02670083|156932313|FG001|Overall Study|Lost to Follow-up|2|||
48750435|NCT02670083|156932312|FG000|Overall Study|Multiple Reasons|9|||
48750436|NCT02670083|156932313|FG001|Overall Study|Multiple Reasons|9|||
48750437|NCT02670083|156932312|FG000|Overall Study|Physician Decision|0|||
48750438|NCT02670083|156932313|FG001|Overall Study|Physician Decision|2|||
48750439|NCT02670083|156932312|FG000|Overall Study|Study Terminated By Sponsor|257|||
48750440|NCT02670083|156932313|FG001|Overall Study|Study Terminated By Sponsor|254|||
48750441|NCT02670083|156932312|FG000|Overall Study|Symptomatic Deterioration|0|||
48750442|NCT02670083|156932313|FG001|Overall Study|Symptomatic Deterioration|2|||
48750443|NCT02670083|156932312|FG000|Overall Study|Withdrawal by Subject|32|||
48750444|NCT02670083|156932313|FG001|Overall Study|Withdrawal by Subject|31|||
48750445|NCT02670083|156932312|FG000|Overall Study|Non-Compliance With Study Drug|1|||
48750446|NCT02670083|156932313|FG001|Overall Study|Non-Compliance With Study Drug|0|||
48750447|NCT01549860|156932314|FG000|Overall Study|Withdrawal by Subject|1|||
48750448|NCT01549860|156932315|FG001|Overall Study|Withdrawal by Subject|0|||
48750449|NCT01549860|156932314|FG000|Overall Study|Physician Decision|1|||
48750450|NCT01549860|156932315|FG001|Overall Study|Physician Decision|1|||
48750451|NCT00187486|156932317|FG000|Overall Study|Protocol Violation|1|||
48750452|NCT00684593|156932318|FG000|Overall Study|Adverse Event|0|||
48750453|NCT00684593|156932319|FG001|Overall Study|Adverse Event|2|||
48750454|NCT01366521|156932320|FG000|Overall Study|Adverse Event|1|||
48750455|NCT01366521|156932321|FG001|Overall Study|Adverse Event|0|||
48750456|NCT01366521|156932322|FG002|Overall Study|Adverse Event|0|||
48750457|NCT01366521|156932323|FG003|Overall Study|Adverse Event|0|||
48750458|NCT01366521|156932320|FG000|Overall Study|Protocol Violation|0|||
48750459|NCT01366521|156932321|FG001|Overall Study|Protocol Violation|0|||
48750460|NCT01366521|156932322|FG002|Overall Study|Protocol Violation|1|||
48750461|NCT01366521|156932323|FG003|Overall Study|Protocol Violation|0|||
48750462|NCT01366521|156932320|FG000|Overall Study|Physician Decision|0|||
48750463|NCT01366521|156932321|FG001|Overall Study|Physician Decision|0|||
48750464|NCT01366521|156932322|FG002|Overall Study|Physician Decision|1|||
48750465|NCT01366521|156932323|FG003|Overall Study|Physician Decision|0|||
48750466|NCT01366521|156932320|FG000|Overall Study|Withdrawal by Subject|0|||
48750467|NCT01366521|156932321|FG001|Overall Study|Withdrawal by Subject|1|||
48750468|NCT01366521|156932322|FG002|Overall Study|Withdrawal by Subject|0|||
48750469|NCT01366521|156932323|FG003|Overall Study|Withdrawal by Subject|0|||
48750470|NCT00684307|156932324|FG000|Overall Study|Adverse Event|11|||
48750471|NCT00684307|156932325|FG001|Overall Study|Adverse Event|6|||
48750472|NCT00684307|156932326|FG002|Overall Study|Adverse Event|15|||
48750473|NCT00684307|156932327|FG003|Overall Study|Adverse Event|16|||
48750474|NCT00684307|156932328|FG004|Overall Study|Adverse Event|8|||
48750475|NCT00684307|156932324|FG000|Overall Study|Development of increasing Liver Function|0|||
48750476|NCT00684307|156932325|FG001|Overall Study|Development of increasing Liver Function|2|||
48862681|NCT00296504|157333102|FG007|Interim Analysis|Participant Needed Interferon|1|||
48750477|NCT00684307|156932326|FG002|Overall Study|Development of increasing Liver Function|0|||
48750478|NCT00684307|156932327|FG003|Overall Study|Development of increasing Liver Function|1|||
48862682|NCT00296504|157333103|FG008|Interim Analysis|Participant Needed Interferon|0|||
48750479|NCT00684307|156932328|FG004|Overall Study|Development of increasing Liver Function|0|||
48750480|NCT00684307|156932324|FG000|Overall Study|Fullfillment of exclusion criteria|1|||
48750481|NCT00684307|156932325|FG001|Overall Study|Fullfillment of exclusion criteria|0|||
48750482|NCT00684307|156932326|FG002|Overall Study|Fullfillment of exclusion criteria|0|||
48750483|NCT00684307|156932327|FG003|Overall Study|Fullfillment of exclusion criteria|3|||
48750484|NCT00684307|156932328|FG004|Overall Study|Fullfillment of exclusion criteria|1|||
48750485|NCT00684307|156932324|FG000|Overall Study|Incorrect enrolment or randomization|4|||
48750486|NCT00684307|156932325|FG001|Overall Study|Incorrect enrolment or randomization|0|||
48750487|NCT00684307|156932326|FG002|Overall Study|Incorrect enrolment or randomization|0|||
48750488|NCT00684307|156932327|FG003|Overall Study|Incorrect enrolment or randomization|0|||
48750489|NCT00684307|156932328|FG004|Overall Study|Incorrect enrolment or randomization|0|||
48750490|NCT00684307|156932324|FG000|Overall Study|Interupted IP for more than 7 days|0|||
48750491|NCT00684307|156932325|FG001|Overall Study|Interupted IP for more than 7 days|4|||
48750492|NCT00684307|156932326|FG002|Overall Study|Interupted IP for more than 7 days|1|||
48750493|NCT00684307|156932327|FG003|Overall Study|Interupted IP for more than 7 days|3|||
48750494|NCT00684307|156932328|FG004|Overall Study|Interupted IP for more than 7 days|3|||
48750495|NCT00684307|156932324|FG000|Overall Study|Severe non compliance to protocol|1|||
48750496|NCT00684307|156932325|FG001|Overall Study|Severe non compliance to protocol|0|||
48750497|NCT00684307|156932326|FG002|Overall Study|Severe non compliance to protocol|0|||
48750498|NCT00684307|156932327|FG003|Overall Study|Severe non compliance to protocol|1|||
48750499|NCT00684307|156932328|FG004|Overall Study|Severe non compliance to protocol|2|||
48750500|NCT00684307|156932324|FG000|Overall Study|Participant not willing to continue|7|||
48750501|NCT00684307|156932325|FG001|Overall Study|Participant not willing to continue|10|||
48750502|NCT00684307|156932326|FG002|Overall Study|Participant not willing to continue|11|||
48750503|NCT00684307|156932327|FG003|Overall Study|Participant not willing to continue|5|||
48750504|NCT00684307|156932328|FG004|Overall Study|Participant not willing to continue|8|||
48750505|NCT00684307|156932324|FG000|Overall Study|Criteria from the CSR|0|||
48750506|NCT00684307|156932325|FG001|Overall Study|Criteria from the CSR|0|||
48750507|NCT00684307|156932326|FG002|Overall Study|Criteria from the CSR|1|||
48750508|NCT00684307|156932327|FG003|Overall Study|Criteria from the CSR|3|||
48750509|NCT00684307|156932328|FG004|Overall Study|Criteria from the CSR|3|||
48750510|NCT00759031|156932329|FG000|First Intervention (1 Day)|Physician Decision|1|||
48750511|NCT00759031|156932330|FG001|First Intervention (1 Day)|Physician Decision|0|||
48750512|NCT00759031|156932329|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
48750513|NCT00759031|156932330|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
48750514|NCT00759031|156932329|FG000|First Intervention (1 Day)|Screening failure|1|||
48750515|NCT00759031|156932330|FG001|First Intervention (1 Day)|Screening failure|0|||
48750516|NCT00309387|156932335|FG000|Overall Study|Death|72|||
48750517|NCT00309387|156932336|FG001|Overall Study|Death|73|||
48750518|NCT00309387|156932335|FG000|Overall Study|Lost to Follow-up|70|||
48750519|NCT00309387|156932336|FG001|Overall Study|Lost to Follow-up|86|||
48750520|NCT01224431|156932341|FG000|Overall Study|not randomized|0|||
48750521|NCT01224431|156932342|FG001|Overall Study|not randomized|4|||
48750522|NCT01224431|156932341|FG000|Overall Study|no video record|0|||
48750523|NCT01224431|156932342|FG001|Overall Study|no video record|1|||
48750524|NCT00884312|156932343|FG000|Overall Study|Non-fatal Progressive Disease|0|||
48750525|NCT00884312|156932344|FG001|Overall Study|Non-fatal Progressive Disease|8|||
48750526|NCT00884312|156932343|FG000|Overall Study|Fatal Progressive Disease|0|||
48750527|NCT00884312|156932344|FG001|Overall Study|Fatal Progressive Disease|1|||
48750528|NCT00884312|156932343|FG000|Overall Study|Non-fatal Adverse Event|1|||
48750529|NCT00884312|156932344|FG001|Overall Study|Non-fatal Adverse Event|0|||
48750530|NCT00884312|156932343|FG000|Overall Study|Fatal Adverse Event|1|||
48750531|NCT00884312|156932344|FG001|Overall Study|Fatal Adverse Event|4|||
48750532|NCT00884312|156932343|FG000|Overall Study|Withdrawal by Subject|0|||
48750533|NCT00884312|156932344|FG001|Overall Study|Withdrawal by Subject|6|||
48750534|NCT00884312|156932343|FG000|Overall Study|Physician Decision|0|||
48862683|NCT00296504|157333095|FG000|Interim Analysis|Ongoing|32|||
48862684|NCT00296504|157333096|FG001|Interim Analysis|Ongoing|12|||
48862685|NCT00296504|157333097|FG002|Interim Analysis|Ongoing|16|||
48862686|NCT00296504|157333098|FG003|Interim Analysis|Ongoing|22|||
48862687|NCT00296504|157333099|FG004|Interim Analysis|Ongoing|0|||
48862688|NCT00296504|157333100|FG005|Interim Analysis|Ongoing|0|||
48862689|NCT00296504|157333101|FG006|Interim Analysis|Ongoing|30|||
48862690|NCT00296504|157333102|FG007|Interim Analysis|Ongoing|1|||
48862691|NCT00296504|157333103|FG008|Interim Analysis|Ongoing|0|||
48862692|NCT00296504|157333095|FG000|Final Analysis|Withdrawal by Subject|0|||
48862693|NCT00296504|157333096|FG001|Final Analysis|Withdrawal by Subject|0|||
48862694|NCT00296504|157333097|FG002|Final Analysis|Withdrawal by Subject|0|||
48862695|NCT00296504|157333098|FG003|Final Analysis|Withdrawal by Subject|0|||
48862696|NCT00296504|157333099|FG004|Final Analysis|Withdrawal by Subject|0|||
48862697|NCT00296504|157333100|FG005|Final Analysis|Withdrawal by Subject|0|||
48862698|NCT00296504|157333101|FG006|Final Analysis|Withdrawal by Subject|0|||
48862699|NCT00296504|157333102|FG007|Final Analysis|Withdrawal by Subject|0|||
48862700|NCT00296504|157333103|FG008|Final Analysis|Withdrawal by Subject|1|||
48862701|NCT00296504|157333095|FG000|Final Analysis|Lost to Follow-up|0|||
48750535|NCT00884312|156932344|FG001|Overall Study|Physician Decision|1|||
48750536|NCT00884312|156932343|FG000|Overall Study|Other|0|||
48750537|NCT00884312|156932344|FG001|Overall Study|Other|4|||
48750538|NCT00884312|156932343|FG000|Overall Study|Did Not Receive Study Drug|0|||
48862702|NCT00296504|157333096|FG001|Final Analysis|Lost to Follow-up|0|||
48862703|NCT00296504|157333097|FG002|Final Analysis|Lost to Follow-up|0|||
48862704|NCT00296504|157333098|FG003|Final Analysis|Lost to Follow-up|0|||
48862705|NCT00296504|157333099|FG004|Final Analysis|Lost to Follow-up|0|||
48862706|NCT00296504|157333100|FG005|Final Analysis|Lost to Follow-up|0|||
48862707|NCT00296504|157333101|FG006|Final Analysis|Lost to Follow-up|0|||
48862708|NCT00296504|157333102|FG007|Final Analysis|Lost to Follow-up|0|||
48862709|NCT00296504|157333103|FG008|Final Analysis|Lost to Follow-up|5|||
48862710|NCT00296504|157333095|FG000|Final Analysis|Insufficient Viral Load Response|0|||
48862711|NCT00296504|157333096|FG001|Final Analysis|Insufficient Viral Load Response|0|||
48862712|NCT00296504|157333097|FG002|Final Analysis|Insufficient Viral Load Response|0|||
48862713|NCT00296504|157333098|FG003|Final Analysis|Insufficient Viral Load Response|0|||
48862714|NCT00296504|157333099|FG004|Final Analysis|Insufficient Viral Load Response|0|||
48750539|NCT00884312|156932344|FG001|Overall Study|Did Not Receive Study Drug|1|||
48750540|NCT00284050|156932346|FG000|Overall Study|Adverse Event|1|||
48750541|NCT00284050|156932347|FG001|Overall Study|Adverse Event|1|||
48750542|NCT00284050|156932348|FG002|Overall Study|Adverse Event|1|||
48750543|NCT00284050|156932346|FG000|Overall Study|Lack of Efficacy|0|||
48750544|NCT00284050|156932347|FG001|Overall Study|Lack of Efficacy|1|||
48750545|NCT00284050|156932348|FG002|Overall Study|Lack of Efficacy|3|||
48750546|NCT00284050|156932346|FG000|Overall Study|Protocol Violation|0|||
48750547|NCT00284050|156932347|FG001|Overall Study|Protocol Violation|1|||
48750548|NCT00284050|156932348|FG002|Overall Study|Protocol Violation|2|||
48750549|NCT00284050|156932346|FG000|Overall Study|Withdrawal by Subject|2|||
48750550|NCT00284050|156932347|FG001|Overall Study|Withdrawal by Subject|2|||
48750551|NCT00284050|156932348|FG002|Overall Study|Withdrawal by Subject|2|||
48750552|NCT00284050|156932346|FG000|Overall Study|Lost to Follow-up|1|||
48750553|NCT00284050|156932347|FG001|Overall Study|Lost to Follow-up|0|||
48750554|NCT00284050|156932348|FG002|Overall Study|Lost to Follow-up|1|||
48750555|NCT00284050|156932346|FG000|Overall Study|Death|1|||
48862715|NCT00296504|157333100|FG005|Final Analysis|Insufficient Viral Load Response|0|||
48862716|NCT00296504|157333101|FG006|Final Analysis|Insufficient Viral Load Response|0|||
49015397|NCT02666430|157892167|FG001|Period 1|Lost to Follow-up|0|||
48750556|NCT00284050|156932347|FG001|Overall Study|Death|0|||
48750557|NCT00284050|156932348|FG002|Overall Study|Death|0|||
48750558|NCT02743520|156932349|FG000|Overall Study|Withdrawal by Subject|1|||
48750559|NCT01749514|156932350|FG000|Overall Study|Lost to Follow-up|0|||
48750560|NCT01749514|156932351|FG001|Overall Study|Lost to Follow-up|0|||
48750561|NCT01749514|156932352|FG002|Overall Study|Lost to Follow-up|0|||
48750562|NCT01749514|156932353|FG003|Overall Study|Lost to Follow-up|0|||
48862717|NCT00296504|157333102|FG007|Final Analysis|Insufficient Viral Load Response|0|||
48750563|NCT01749514|156932354|FG004|Overall Study|Lost to Follow-up|0|||
48956245|NCT00408421|157669197|FG000|Treatment Initial Randomization|Adverse Event|5|||
48750564|NCT01749514|156932355|FG005|Overall Study|Lost to Follow-up|0|||
48750565|NCT01749514|156932356|FG006|Overall Study|Lost to Follow-up|0|||
48750566|NCT01749514|156932357|FG007|Overall Study|Lost to Follow-up|1|||
48750567|NCT01749514|156932350|FG000|Overall Study|Withdrawal by Subject|0|||
48750568|NCT01749514|156932351|FG001|Overall Study|Withdrawal by Subject|0|||
48750569|NCT01749514|156932352|FG002|Overall Study|Withdrawal by Subject|0|||
48750570|NCT01749514|156932353|FG003|Overall Study|Withdrawal by Subject|0|||
48750571|NCT01749514|156932354|FG004|Overall Study|Withdrawal by Subject|0|||
48750572|NCT01749514|156932355|FG005|Overall Study|Withdrawal by Subject|1|||
48750573|NCT01749514|156932356|FG006|Overall Study|Withdrawal by Subject|0|||
48750574|NCT01749514|156932357|FG007|Overall Study|Withdrawal by Subject|1|||
48750575|NCT01749514|156932350|FG000|Overall Study|Not Reported|0|||
48750576|NCT01749514|156932351|FG001|Overall Study|Not Reported|0|||
48956246|NCT00408421|157669198|FG001|Treatment Initial Randomization|Adverse Event|9|||
48750577|NCT01749514|156932352|FG002|Overall Study|Not Reported|0|||
48956247|NCT00408421|157669199|FG002|Treatment Initial Randomization|Adverse Event|0|||
48750578|NCT01749514|156932353|FG003|Overall Study|Not Reported|0|||
48750579|NCT01749514|156932354|FG004|Overall Study|Not Reported|0|||
48750580|NCT01749514|156932355|FG005|Overall Study|Not Reported|0|||
48750581|NCT01749514|156932356|FG006|Overall Study|Not Reported|0|||
48750582|NCT01749514|156932357|FG007|Overall Study|Not Reported|5|||
48750583|NCT01402544|156932358|FG000|Overall Study|Withdrawal by Subject|6|||
48750584|NCT01828281|156932359|FG000|Overall Study|Withdrawal by Subject|1|||
48750585|NCT01828281|156932360|FG001|Overall Study|Withdrawal by Subject|0|||
48750586|NCT00299975|156932362|FG000|Overall Study|Adverse Event|1|||
48862718|NCT00296504|157333103|FG008|Final Analysis|Insufficient Viral Load Response|6|||
48750587|NCT00299975|156932363|FG001|Overall Study|Adverse Event|0|||
48750588|NCT00299975|156932364|FG002|Overall Study|Adverse Event|2|||
48750589|NCT00299975|156932362|FG000|Overall Study|Pregnancy|0|||
48750590|NCT00299975|156932363|FG001|Overall Study|Pregnancy|0|||
48750591|NCT00299975|156932364|FG002|Overall Study|Pregnancy|1|||
48750592|NCT00299975|156932362|FG000|Overall Study|Lack of Efficacy|1|||
48750593|NCT00299975|156932363|FG001|Overall Study|Lack of Efficacy|0|||
48750594|NCT00299975|156932364|FG002|Overall Study|Lack of Efficacy|1|||
48750595|NCT00299975|156932362|FG000|Overall Study|Lost to Follow-up|1|||
48750596|NCT00299975|156932363|FG001|Overall Study|Lost to Follow-up|0|||
48750597|NCT00299975|156932364|FG002|Overall Study|Lost to Follow-up|0|||
48750598|NCT00299975|156932362|FG000|Overall Study|Withdrawal by Subject|0|||
48750599|NCT00299975|156932363|FG001|Overall Study|Withdrawal by Subject|1|||
48750600|NCT00299975|156932364|FG002|Overall Study|Withdrawal by Subject|3|||
48750601|NCT00299975|156932362|FG000|Overall Study|Physician Decision|0|||
48750602|NCT00299975|156932363|FG001|Overall Study|Physician Decision|0|||
48750603|NCT00299975|156932364|FG002|Overall Study|Physician Decision|1|||
48750604|NCT01830972|156932369|FG000|Part II|Withdrawal by Subject|2|||
48750605|NCT01830972|156932370|FG001|Part II|Withdrawal by Subject|2|||
48862719|NCT00296504|157333095|FG000|Final Analysis|Adverse Event|0|||
48862720|NCT00296504|157333096|FG001|Final Analysis|Adverse Event|0|||
48862721|NCT00296504|157333097|FG002|Final Analysis|Adverse Event|0|||
48862722|NCT00296504|157333098|FG003|Final Analysis|Adverse Event|0|||
48862723|NCT00296504|157333099|FG004|Final Analysis|Adverse Event|0|||
48862724|NCT00296504|157333100|FG005|Final Analysis|Adverse Event|0|||
48862725|NCT00296504|157333101|FG006|Final Analysis|Adverse Event|0|||
48862726|NCT00296504|157333102|FG007|Final Analysis|Adverse Event|0|||
48862727|NCT00296504|157333103|FG008|Final Analysis|Adverse Event|2|||
48862728|NCT00296504|157333095|FG000|Final Analysis|Pregnancy|0|||
48862729|NCT00296504|157333096|FG001|Final Analysis|Pregnancy|0|||
48862730|NCT00296504|157333097|FG002|Final Analysis|Pregnancy|0|||
48862731|NCT00296504|157333098|FG003|Final Analysis|Pregnancy|0|||
48862732|NCT00296504|157333099|FG004|Final Analysis|Pregnancy|0|||
48862733|NCT00296504|157333100|FG005|Final Analysis|Pregnancy|0|||
48862734|NCT00296504|157333101|FG006|Final Analysis|Pregnancy|0|||
48750606|NCT01830972|156932369|FG000|Part III|Withdrawal by Subject|1|||
48750607|NCT01830972|156932370|FG001|Part III|Withdrawal by Subject|0|||
48862735|NCT00296504|157333102|FG007|Final Analysis|Pregnancy|0|||
48862736|NCT00296504|157333103|FG008|Final Analysis|Pregnancy|4|||
48956248|NCT00408421|157669197|FG000|Treatment Initial Randomization|Lack of Efficacy|2|||
48956249|NCT00408421|157669198|FG001|Treatment Initial Randomization|Lack of Efficacy|2|||
48956250|NCT00408421|157669199|FG002|Treatment Initial Randomization|Lack of Efficacy|0|||
48956251|NCT00408421|157669197|FG000|Treatment Initial Randomization|Lost to Follow-up|0|||
48956252|NCT00408421|157669198|FG001|Treatment Initial Randomization|Lost to Follow-up|3|||
48956253|NCT00408421|157669199|FG002|Treatment Initial Randomization|Lost to Follow-up|0|||
48956254|NCT00408421|157669197|FG000|Treatment Initial Randomization|Physician Decision|1|||
48956255|NCT00408421|157669198|FG001|Treatment Initial Randomization|Physician Decision|0|||
48956256|NCT00408421|157669199|FG002|Treatment Initial Randomization|Physician Decision|0|||
48956257|NCT00408421|157669197|FG000|Treatment Initial Randomization|Protocol Violation|0|||
48956258|NCT00408421|157669198|FG001|Treatment Initial Randomization|Protocol Violation|1|||
48956259|NCT00408421|157669199|FG002|Treatment Initial Randomization|Protocol Violation|0|||
48956260|NCT00408421|157669197|FG000|Treatment Initial Randomization|Withdrawal by Subject|7|||
48956261|NCT00408421|157669198|FG001|Treatment Initial Randomization|Withdrawal by Subject|7|||
48956262|NCT00408421|157669199|FG002|Treatment Initial Randomization|Withdrawal by Subject|0|||
48956263|NCT00408421|157669197|FG000|Treatment Initial Randomization|Entry Criteria Not Met|1|||
48956264|NCT00408421|157669198|FG001|Treatment Initial Randomization|Entry Criteria Not Met|0|||
48956265|NCT00408421|157669199|FG002|Treatment Initial Randomization|Entry Criteria Not Met|0|||
48956266|NCT00408421|157669197|FG000|Treatment Initial Randomization|Sponsor Decision|1|||
48956267|NCT00408421|157669198|FG001|Treatment Initial Randomization|Sponsor Decision|0|||
48956268|NCT00408421|157669199|FG002|Treatment Initial Randomization|Sponsor Decision|0|||
48956269|NCT00408421|157669197|FG000|Treatment Re-Randomization|Adverse Event|2|||
48956270|NCT00408421|157669198|FG001|Treatment Re-Randomization|Adverse Event|2|||
48956271|NCT00408421|157669199|FG002|Treatment Re-Randomization|Adverse Event|4|||
48956272|NCT00408421|157669197|FG000|Treatment Re-Randomization|Lack of Efficacy|1|||
49015398|NCT02666430|157892166|FG000|Period 1|Adverse Event|0|||
49015399|NCT02666430|157892167|FG001|Period 1|Adverse Event|1|||
48750608|NCT01830972|156932369|FG000|Part III|Noncompliance|1|||
49015400|NCT02666430|157892166|FG000|Period 2|Withdrawal by Subject|1|||
48750609|NCT01830972|156932370|FG001|Part III|Noncompliance|0|||
48750610|NCT01830972|156932369|FG000|Part IV|Withdrawal by Subject|2|||
48750611|NCT01830972|156932370|FG001|Part IV|Withdrawal by Subject|1|||
48750612|NCT01830972|156932369|FG000|Part IV|Non-Compliance|1|||
48750613|NCT01830972|156932370|FG001|Part IV|Non-Compliance|0|||
48750614|NCT01366209|156932373|FG000|Overall Study|Adverse Event|6|||
48750615|NCT01366209|156932374|FG001|Overall Study|Adverse Event|7|||
48750616|NCT01366209|156932373|FG000|Overall Study|Withdrawal by Subject|4|||
48750617|NCT01366209|156932374|FG001|Overall Study|Withdrawal by Subject|4|||
48750618|NCT01366209|156932373|FG000|Overall Study|Death|12|||
48750619|NCT01366209|156932374|FG001|Overall Study|Death|19|||
48750620|NCT01366209|156932373|FG000|Overall Study|Lung transplantation|6|||
48750621|NCT01366209|156932374|FG001|Overall Study|Lung transplantation|1|||
48750622|NCT01366209|156932373|FG000|Overall Study|Lost to Follow-up|2|||
48750623|NCT01366209|156932374|FG001|Overall Study|Lost to Follow-up|1|||
48750624|NCT01366209|156932373|FG000|Overall Study|Physician Decision|1|||
48750625|NCT01366209|156932374|FG001|Overall Study|Physician Decision|0|||
48750626|NCT01366209|156932373|FG000|Overall Study|Sponsors decision|0|||
48750627|NCT01366209|156932374|FG001|Overall Study|Sponsors decision|1|||
48750628|NCT01366209|156932373|FG000|Overall Study|Withdrew consent|4|||
48750629|NCT01366209|156932374|FG001|Overall Study|Withdrew consent|3|||
48750630|NCT00420927|156932375|FG000|Period 1|Adverse Event|19|||
48750631|NCT00420927|156932376|FG001|Period 1|Adverse Event|15|||
48750632|NCT00420927|156932377|FG002|Period 1|Adverse Event|0|||
48750633|NCT00420927|156932378|FG003|Period 1|Adverse Event|0|||
48750634|NCT00420927|156932379|FG004|Period 1|Adverse Event|0|||
48750635|NCT00420927|156932380|FG005|Period 1|Adverse Event|0|||
48750636|NCT00420927|156932381|FG006|Period 1|Adverse Event|0|||
48750637|NCT00420927|156932375|FG000|Period 1|Withdrawal by Subject|7|||
48750638|NCT00420927|156932376|FG001|Period 1|Withdrawal by Subject|12|||
48750639|NCT00420927|156932377|FG002|Period 1|Withdrawal by Subject|0|||
48750640|NCT00420927|156932378|FG003|Period 1|Withdrawal by Subject|0|||
48750641|NCT00420927|156932379|FG004|Period 1|Withdrawal by Subject|0|||
48750642|NCT00420927|156932380|FG005|Period 1|Withdrawal by Subject|0|||
48750643|NCT00420927|156932381|FG006|Period 1|Withdrawal by Subject|0|||
48956273|NCT00408421|157669198|FG001|Treatment Re-Randomization|Lack of Efficacy|0|||
48956274|NCT00408421|157669199|FG002|Treatment Re-Randomization|Lack of Efficacy|0|||
48956275|NCT00408421|157669197|FG000|Treatment Re-Randomization|Lost to Follow-up|0|||
48956276|NCT00408421|157669198|FG001|Treatment Re-Randomization|Lost to Follow-up|0|||
48956277|NCT00408421|157669199|FG002|Treatment Re-Randomization|Lost to Follow-up|1|||
48956278|NCT00408421|157669197|FG000|Treatment Re-Randomization|Physician Decision|1|||
48956279|NCT00408421|157669198|FG001|Treatment Re-Randomization|Physician Decision|3|||
48956280|NCT00408421|157669199|FG002|Treatment Re-Randomization|Physician Decision|0|||
48956281|NCT00408421|157669197|FG000|Treatment Re-Randomization|Protocol Violation|1|||
48956282|NCT00408421|157669198|FG001|Treatment Re-Randomization|Protocol Violation|1|||
48956283|NCT00408421|157669199|FG002|Treatment Re-Randomization|Protocol Violation|0|||
48956284|NCT00408421|157669197|FG000|Treatment Re-Randomization|Withdrawal by Subject|2|||
48956285|NCT00408421|157669198|FG001|Treatment Re-Randomization|Withdrawal by Subject|1|||
48750644|NCT00420927|156932375|FG000|Period 1|Lost to Follow-up|8|||
48956286|NCT00408421|157669199|FG002|Treatment Re-Randomization|Withdrawal by Subject|0|||
48956287|NCT02322892|157669200|FG000|Overall Study|Surgery cancelled|1|||
48956288|NCT02322892|157669201|FG001|Overall Study|Surgery cancelled|2|||
48750645|NCT00420927|156932376|FG001|Period 1|Lost to Follow-up|6|||
48750646|NCT00420927|156932377|FG002|Period 1|Lost to Follow-up|0|||
48750647|NCT00420927|156932378|FG003|Period 1|Lost to Follow-up|0|||
48750648|NCT00420927|156932379|FG004|Period 1|Lost to Follow-up|0|||
48956289|NCT02322892|157669200|FG000|Overall Study|Met exclusion criteria|0|||
48956290|NCT02322892|157669201|FG001|Overall Study|Met exclusion criteria|1|||
48750649|NCT00420927|156932380|FG005|Period 1|Lost to Follow-up|0|||
48750650|NCT00420927|156932381|FG006|Period 1|Lost to Follow-up|0|||
48750651|NCT00420927|156932375|FG000|Period 1|Lack of efficacy/Loss of efficacy|1|||
48750652|NCT00420927|156932376|FG001|Period 1|Lack of efficacy/Loss of efficacy|6|||
48750653|NCT00420927|156932377|FG002|Period 1|Lack of efficacy/Loss of efficacy|0|||
48750654|NCT00420927|156932378|FG003|Period 1|Lack of efficacy/Loss of efficacy|0|||
48750655|NCT00420927|156932379|FG004|Period 1|Lack of efficacy/Loss of efficacy|0|||
48750656|NCT00420927|156932380|FG005|Period 1|Lack of efficacy/Loss of efficacy|0|||
48750657|NCT00420927|156932381|FG006|Period 1|Lack of efficacy/Loss of efficacy|0|||
48750658|NCT00420927|156932375|FG000|Period 1|Death|2|||
48750659|NCT00420927|156932376|FG001|Period 1|Death|0|||
48750660|NCT00420927|156932377|FG002|Period 1|Death|0|||
48750661|NCT00420927|156932378|FG003|Period 1|Death|0|||
48750662|NCT00420927|156932379|FG004|Period 1|Death|0|||
48750663|NCT00420927|156932380|FG005|Period 1|Death|0|||
48750664|NCT00420927|156932381|FG006|Period 1|Death|0|||
48750665|NCT00420927|156932375|FG000|Period 1|Subject moved/relocated|0|||
48750666|NCT00420927|156932376|FG001|Period 1|Subject moved/relocated|2|||
48750667|NCT00420927|156932377|FG002|Period 1|Subject moved/relocated|0|||
48750668|NCT00420927|156932378|FG003|Period 1|Subject moved/relocated|0|||
48750669|NCT00420927|156932379|FG004|Period 1|Subject moved/relocated|0|||
48750670|NCT00420927|156932380|FG005|Period 1|Subject moved/relocated|0|||
48750671|NCT00420927|156932381|FG006|Period 1|Subject moved/relocated|0|||
48750672|NCT00420927|156932375|FG000|Period 1|Noncompliant with study drug|1|||
48750673|NCT00420927|156932376|FG001|Period 1|Noncompliant with study drug|1|||
48750674|NCT00420927|156932377|FG002|Period 1|Noncompliant with study drug|0|||
48750675|NCT00420927|156932378|FG003|Period 1|Noncompliant with study drug|0|||
48750676|NCT00420927|156932379|FG004|Period 1|Noncompliant with study drug|0|||
48750677|NCT00420927|156932380|FG005|Period 1|Noncompliant with study drug|0|||
48750678|NCT00420927|156932381|FG006|Period 1|Noncompliant with study drug|0|||
48750679|NCT00420927|156932375|FG000|Period 1|Randomization error|1|||
48750680|NCT00420927|156932376|FG001|Period 1|Randomization error|0|||
48750681|NCT00420927|156932377|FG002|Period 1|Randomization error|0|||
48750682|NCT00420927|156932378|FG003|Period 1|Randomization error|0|||
48750683|NCT00420927|156932379|FG004|Period 1|Randomization error|0|||
48750684|NCT00420927|156932380|FG005|Period 1|Randomization error|0|||
48750685|NCT00420927|156932381|FG006|Period 1|Randomization error|0|||
48750686|NCT00420927|156932375|FG000|Period 1|Suspected tuberculosis/positive test|1|||
48750687|NCT00420927|156932376|FG001|Period 1|Suspected tuberculosis/positive test|1|||
48750688|NCT00420927|156932377|FG002|Period 1|Suspected tuberculosis/positive test|0|||
48750689|NCT00420927|156932378|FG003|Period 1|Suspected tuberculosis/positive test|0|||
48750690|NCT00420927|156932379|FG004|Period 1|Suspected tuberculosis/positive test|0|||
48750691|NCT00420927|156932380|FG005|Period 1|Suspected tuberculosis/positive test|0|||
48750692|NCT00420927|156932381|FG006|Period 1|Suspected tuberculosis/positive test|0|||
48750693|NCT00420927|156932375|FG000|Period 1|Study site closure|0|||
48750694|NCT00420927|156932376|FG001|Period 1|Study site closure|1|||
48750695|NCT00420927|156932377|FG002|Period 1|Study site closure|0|||
48750696|NCT00420927|156932378|FG003|Period 1|Study site closure|0|||
48750697|NCT00420927|156932379|FG004|Period 1|Study site closure|0|||
48750698|NCT00420927|156932380|FG005|Period 1|Study site closure|0|||
48750699|NCT00420927|156932381|FG006|Period 1|Study site closure|0|||
48862737|NCT00296504|157333095|FG000|Final Analysis|Tuberculosis|0|||
48750700|NCT00420927|156932375|FG000|Period 1|Subject received new diagnosis|0|||
48750701|NCT00420927|156932376|FG001|Period 1|Subject received new diagnosis|2|||
48750702|NCT00420927|156932377|FG002|Period 1|Subject received new diagnosis|0|||
48750703|NCT00420927|156932378|FG003|Period 1|Subject received new diagnosis|0|||
48750704|NCT00420927|156932379|FG004|Period 1|Subject received new diagnosis|0|||
48750705|NCT00420927|156932380|FG005|Period 1|Subject received new diagnosis|0|||
48750706|NCT00420927|156932381|FG006|Period 1|Subject received new diagnosis|0|||
48750707|NCT00420927|156932375|FG000|Period 1|Received wrong treatment/incorrect dose|0|||
48750708|NCT00420927|156932376|FG001|Period 1|Received wrong treatment/incorrect dose|1|||
48750709|NCT00420927|156932377|FG002|Period 1|Received wrong treatment/incorrect dose|0|||
48750710|NCT00420927|156932378|FG003|Period 1|Received wrong treatment/incorrect dose|0|||
48750711|NCT00420927|156932379|FG004|Period 1|Received wrong treatment/incorrect dose|0|||
48862738|NCT00296504|157333096|FG001|Final Analysis|Tuberculosis|0|||
48750712|NCT00420927|156932380|FG005|Period 1|Received wrong treatment/incorrect dose|0|||
48750713|NCT00420927|156932381|FG006|Period 1|Received wrong treatment/incorrect dose|0|||
48750714|NCT00420927|156932375|FG000|Period 1|Failed to meet entry criteria|8|||
48750715|NCT00420927|156932376|FG001|Period 1|Failed to meet entry criteria|7|||
48750716|NCT00420927|156932377|FG002|Period 1|Failed to meet entry criteria|0|||
48750717|NCT00420927|156932378|FG003|Period 1|Failed to meet entry criteria|0|||
48750718|NCT00420927|156932379|FG004|Period 1|Failed to meet entry criteria|0|||
48750719|NCT00420927|156932380|FG005|Period 1|Failed to meet entry criteria|0|||
48750720|NCT00420927|156932381|FG006|Period 1|Failed to meet entry criteria|0|||
48750721|NCT00420927|156932375|FG000|Period 1|Took prohibited medication|1|||
48750722|NCT00420927|156932376|FG001|Period 1|Took prohibited medication|3|||
48750723|NCT00420927|156932377|FG002|Period 1|Took prohibited medication|0|||
48750724|NCT00420927|156932378|FG003|Period 1|Took prohibited medication|0|||
48750725|NCT00420927|156932379|FG004|Period 1|Took prohibited medication|0|||
48750726|NCT00420927|156932380|FG005|Period 1|Took prohibited medication|0|||
48750727|NCT00420927|156932381|FG006|Period 1|Took prohibited medication|0|||
48750728|NCT00420927|156932375|FG000|Period 2|Adverse Event|0|||
48750729|NCT00420927|156932376|FG001|Period 2|Adverse Event|0|||
48750730|NCT00420927|156932377|FG002|Period 2|Adverse Event|7|||
48750731|NCT00420927|156932378|FG003|Period 2|Adverse Event|3|||
48750732|NCT00420927|156932379|FG004|Period 2|Adverse Event|17|||
48750733|NCT00420927|156932380|FG005|Period 2|Adverse Event|6|||
48750734|NCT00420927|156932381|FG006|Period 2|Adverse Event|20|||
48750735|NCT00420927|156932375|FG000|Period 2|Withdrawal by Subject|0|||
48750736|NCT00420927|156932376|FG001|Period 2|Withdrawal by Subject|0|||
48750737|NCT00420927|156932377|FG002|Period 2|Withdrawal by Subject|1|||
48750738|NCT00420927|156932378|FG003|Period 2|Withdrawal by Subject|3|||
48750739|NCT00420927|156932379|FG004|Period 2|Withdrawal by Subject|11|||
48750740|NCT00420927|156932380|FG005|Period 2|Withdrawal by Subject|2|||
48750741|NCT00420927|156932381|FG006|Period 2|Withdrawal by Subject|12|||
48750742|NCT00420927|156932375|FG000|Period 2|Lost to Follow-up|0|||
48750743|NCT00420927|156932376|FG001|Period 2|Lost to Follow-up|0|||
48750744|NCT00420927|156932377|FG002|Period 2|Lost to Follow-up|2|||
48750745|NCT00420927|156932378|FG003|Period 2|Lost to Follow-up|2|||
48750746|NCT00420927|156932379|FG004|Period 2|Lost to Follow-up|6|||
48750747|NCT00420927|156932380|FG005|Period 2|Lost to Follow-up|3|||
48750748|NCT00420927|156932381|FG006|Period 2|Lost to Follow-up|9|||
48750749|NCT00420927|156932375|FG000|Period 2|Lack of efficacy/Loss of efficacy|0|||
48862739|NCT00296504|157333097|FG002|Final Analysis|Tuberculosis|0|||
48862740|NCT00296504|157333098|FG003|Final Analysis|Tuberculosis|0|||
48750750|NCT00420927|156932376|FG001|Period 2|Lack of efficacy/Loss of efficacy|0|||
48750751|NCT00420927|156932377|FG002|Period 2|Lack of efficacy/Loss of efficacy|2|||
48862741|NCT00296504|157333099|FG004|Final Analysis|Tuberculosis|0|||
48862742|NCT00296504|157333100|FG005|Final Analysis|Tuberculosis|0|||
48862743|NCT00296504|157333101|FG006|Final Analysis|Tuberculosis|0|||
48862744|NCT00296504|157333102|FG007|Final Analysis|Tuberculosis|0|||
48750752|NCT00420927|156932378|FG003|Period 2|Lack of efficacy/Loss of efficacy|1|||
48750753|NCT00420927|156932379|FG004|Period 2|Lack of efficacy/Loss of efficacy|6|||
48750754|NCT00420927|156932380|FG005|Period 2|Lack of efficacy/Loss of efficacy|2|||
48750755|NCT00420927|156932381|FG006|Period 2|Lack of efficacy/Loss of efficacy|6|||
48750756|NCT00420927|156932375|FG000|Period 2|Received wrong treatment/incorrect dose|0|||
48750757|NCT00420927|156932376|FG001|Period 2|Received wrong treatment/incorrect dose|0|||
48750758|NCT00420927|156932377|FG002|Period 2|Received wrong treatment/incorrect dose|0|||
48750759|NCT00420927|156932378|FG003|Period 2|Received wrong treatment/incorrect dose|0|||
48750760|NCT00420927|156932379|FG004|Period 2|Received wrong treatment/incorrect dose|0|||
48750761|NCT00420927|156932380|FG005|Period 2|Received wrong treatment/incorrect dose|0|||
48750762|NCT00420927|156932381|FG006|Period 2|Received wrong treatment/incorrect dose|1|||
48750763|NCT00420927|156932375|FG000|Period 2|Subject unable to find transportation|0|||
48750764|NCT00420927|156932376|FG001|Period 2|Subject unable to find transportation|0|||
48750765|NCT00420927|156932377|FG002|Period 2|Subject unable to find transportation|0|||
48750766|NCT00420927|156932378|FG003|Period 2|Subject unable to find transportation|0|||
48750767|NCT00420927|156932379|FG004|Period 2|Subject unable to find transportation|0|||
48750768|NCT00420927|156932380|FG005|Period 2|Subject unable to find transportation|0|||
48862745|NCT00296504|157333103|FG008|Final Analysis|Tuberculosis|1|||
48862746|NCT00296504|157333095|FG000|Final Analysis|Participant Moved to Another Country|0|||
48862747|NCT00296504|157333096|FG001|Final Analysis|Participant Moved to Another Country|0|||
48862748|NCT00296504|157333097|FG002|Final Analysis|Participant Moved to Another Country|0|||
48862749|NCT00296504|157333098|FG003|Final Analysis|Participant Moved to Another Country|0|||
48862750|NCT00296504|157333099|FG004|Final Analysis|Participant Moved to Another Country|0|||
48862751|NCT00296504|157333100|FG005|Final Analysis|Participant Moved to Another Country|0|||
48862752|NCT00296504|157333101|FG006|Final Analysis|Participant Moved to Another Country|0|||
48862753|NCT00296504|157333102|FG007|Final Analysis|Participant Moved to Another Country|0|||
48862754|NCT00296504|157333103|FG008|Final Analysis|Participant Moved to Another Country|1|||
48862755|NCT00296504|157333095|FG000|Final Analysis|Poor Adherence|0|||
48862756|NCT00296504|157333096|FG001|Final Analysis|Poor Adherence|0|||
48750769|NCT00420927|156932381|FG006|Period 2|Subject unable to find transportation|1|||
48750770|NCT00420927|156932375|FG000|Period 2|Physician Decision|0|||
48750771|NCT00420927|156932376|FG001|Period 2|Physician Decision|0|||
48750772|NCT00420927|156932377|FG002|Period 2|Physician Decision|0|||
48750773|NCT00420927|156932378|FG003|Period 2|Physician Decision|0|||
48750774|NCT00420927|156932379|FG004|Period 2|Physician Decision|1|||
48750775|NCT00420927|156932380|FG005|Period 2|Physician Decision|1|||
48750776|NCT00420927|156932381|FG006|Period 2|Physician Decision|0|||
48750777|NCT00420927|156932375|FG000|Period 2|Sponsor decision|0|||
48750778|NCT00420927|156932376|FG001|Period 2|Sponsor decision|0|||
48750779|NCT00420927|156932377|FG002|Period 2|Sponsor decision|1|||
48750780|NCT00420927|156932378|FG003|Period 2|Sponsor decision|0|||
48750781|NCT00420927|156932379|FG004|Period 2|Sponsor decision|0|||
48750782|NCT00420927|156932380|FG005|Period 2|Sponsor decision|0|||
48750783|NCT00420927|156932381|FG006|Period 2|Sponsor decision|1|||
48750784|NCT00420927|156932375|FG000|Period 2|Randomization error|0|||
48750785|NCT00420927|156932376|FG001|Period 2|Randomization error|0|||
48862757|NCT00296504|157333097|FG002|Final Analysis|Poor Adherence|0|||
48862758|NCT00296504|157333098|FG003|Final Analysis|Poor Adherence|0|||
48750786|NCT00420927|156932377|FG002|Period 2|Randomization error|0|||
48750787|NCT00420927|156932378|FG003|Period 2|Randomization error|0|||
48750788|NCT00420927|156932379|FG004|Period 2|Randomization error|1|||
48750789|NCT00420927|156932380|FG005|Period 2|Randomization error|1|||
48750790|NCT00420927|156932381|FG006|Period 2|Randomization error|0|||
48750791|NCT00420927|156932375|FG000|Period 2|Noncompliant with study drug|0|||
48750792|NCT00420927|156932376|FG001|Period 2|Noncompliant with study drug|0|||
48750793|NCT00420927|156932377|FG002|Period 2|Noncompliant with study drug|0|||
48750794|NCT00420927|156932378|FG003|Period 2|Noncompliant with study drug|1|||
48750795|NCT00420927|156932379|FG004|Period 2|Noncompliant with study drug|0|||
48750796|NCT00420927|156932380|FG005|Period 2|Noncompliant with study drug|0|||
48750797|NCT00420927|156932381|FG006|Period 2|Noncompliant with study drug|2|||
48750798|NCT00420927|156932375|FG000|Period 2|Methotrexate intolerance|0|||
48750799|NCT00420927|156932376|FG001|Period 2|Methotrexate intolerance|0|||
48750800|NCT00420927|156932377|FG002|Period 2|Methotrexate intolerance|0|||
48750801|NCT00420927|156932378|FG003|Period 2|Methotrexate intolerance|0|||
48750802|NCT00420927|156932379|FG004|Period 2|Methotrexate intolerance|0|||
48750803|NCT00420927|156932380|FG005|Period 2|Methotrexate intolerance|0|||
48750804|NCT00420927|156932381|FG006|Period 2|Methotrexate intolerance|1|||
48750805|NCT00420927|156932375|FG000|Period 2|Took prohibited medication|0|||
48750806|NCT00420927|156932376|FG001|Period 2|Took prohibited medication|0|||
48750807|NCT00420927|156932377|FG002|Period 2|Took prohibited medication|0|||
48750808|NCT00420927|156932378|FG003|Period 2|Took prohibited medication|0|||
48750809|NCT00420927|156932379|FG004|Period 2|Took prohibited medication|1|||
48750810|NCT00420927|156932380|FG005|Period 2|Took prohibited medication|0|||
48750811|NCT00420927|156932381|FG006|Period 2|Took prohibited medication|0|||
48750812|NCT02088047|156932387|FG000|Overall Study|Withdrawal by Subject|1|||
48750813|NCT02088047|156932388|FG001|Overall Study|Withdrawal by Subject|0|||
48750814|NCT01919723|156932393|FG000|Overall Study|Blood Samples Hemolyzed|2|||
48750815|NCT01919723|156932394|FG001|Overall Study|Blood Samples Hemolyzed|2|||
48750816|NCT00752232|156932395|FG000|Overall Study|Protocol Violation|0|||
48750817|NCT00752232|156932396|FG001|Overall Study|Protocol Violation|0|||
48750818|NCT00752232|156932397|FG002|Overall Study|Protocol Violation|0|||
48750819|NCT00752232|156932398|FG003|Overall Study|Protocol Violation|0|||
48750820|NCT00752232|156932399|FG004|Overall Study|Protocol Violation|0|||
48750821|NCT00752232|156932400|FG005|Overall Study|Protocol Violation|1|||
48750822|NCT00752232|156932401|FG006|Overall Study|Protocol Violation|0|||
48750823|NCT00752232|156932395|FG000|Overall Study|Caregiver request|2|||
48750824|NCT00752232|156932396|FG001|Overall Study|Caregiver request|0|||
48750825|NCT00752232|156932397|FG002|Overall Study|Caregiver request|0|||
48750826|NCT00752232|156932398|FG003|Overall Study|Caregiver request|0|||
48750827|NCT00752232|156932399|FG004|Overall Study|Caregiver request|1|||
48750828|NCT00752232|156932400|FG005|Overall Study|Caregiver request|0|||
48750829|NCT00752232|156932401|FG006|Overall Study|Caregiver request|0|||
48750830|NCT00752232|156932395|FG000|Overall Study|Investigator request|0|||
48750831|NCT00752232|156932396|FG001|Overall Study|Investigator request|0|||
48750832|NCT00752232|156932397|FG002|Overall Study|Investigator request|0|||
48750833|NCT00752232|156932398|FG003|Overall Study|Investigator request|0|||
48750834|NCT00752232|156932399|FG004|Overall Study|Investigator request|1|||
48750835|NCT00752232|156932400|FG005|Overall Study|Investigator request|0|||
48750836|NCT00752232|156932401|FG006|Overall Study|Investigator request|0|||
48750837|NCT00752232|156932395|FG000|Overall Study|Subject request|0|||
48862759|NCT00296504|157333099|FG004|Final Analysis|Poor Adherence|0|||
48750838|NCT00752232|156932396|FG001|Overall Study|Subject request|0|||
48750839|NCT00752232|156932397|FG002|Overall Study|Subject request|1|||
48750840|NCT00752232|156932398|FG003|Overall Study|Subject request|0|||
48750841|NCT00752232|156932399|FG004|Overall Study|Subject request|0|||
48750842|NCT00752232|156932400|FG005|Overall Study|Subject request|0|||
48750843|NCT00752232|156932401|FG006|Overall Study|Subject request|0|||
48750844|NCT00752232|156932395|FG000|Overall Study|Group home admission|0|||
48750845|NCT00752232|156932396|FG001|Overall Study|Group home admission|0|||
48750846|NCT00752232|156932397|FG002|Overall Study|Group home admission|0|||
48862760|NCT00296504|157333100|FG005|Final Analysis|Poor Adherence|0|||
48750847|NCT00752232|156932398|FG003|Overall Study|Group home admission|1|||
48750848|NCT00752232|156932399|FG004|Overall Study|Group home admission|0|||
48750849|NCT00752232|156932400|FG005|Overall Study|Group home admission|0|||
48750850|NCT00752232|156932401|FG006|Overall Study|Group home admission|0|||
48750851|NCT00752232|156932395|FG000|Overall Study|Caregiver could not attend the subject|0|||
48750852|NCT00752232|156932396|FG001|Overall Study|Caregiver could not attend the subject|0|||
48862761|NCT00296504|157333101|FG006|Final Analysis|Poor Adherence|0|||
48862762|NCT00296504|157333102|FG007|Final Analysis|Poor Adherence|0|||
48862763|NCT00296504|157333103|FG008|Final Analysis|Poor Adherence|1|||
48862764|NCT05287178|157333104|FG000|Overall Study|Lost to Follow-up|2|||
48862765|NCT01536795|157333105|FG000|Overall Study|Lost to Follow-up|0|||
48862766|NCT01536795|157333106|FG001|Overall Study|Lost to Follow-up|2|||
48862767|NCT01536795|157333105|FG000|Overall Study|Lack of Efficacy|1|||
48862768|NCT01536795|157333106|FG001|Overall Study|Lack of Efficacy|0|||
48862769|NCT00050167|157333108|FG000|Overall Study|not eligible not invasive|1|||
48862770|NCT00050167|157333109|FG001|Overall Study|not eligible not invasive|1|||
48862771|NCT02038803|157333111|FG000|Overall Study|poor adherence of subjects to protocol and withdrawal from study.|4|||
48862772|NCT02038803|157333111|FG000|Overall Study|Lost to Follow-up|1|||
48862773|NCT04754594|157333112|FG000|Blinded Period|Withdrawal by Subject|4|||
48862774|NCT04754594|157333113|FG001|Blinded Period|Withdrawal by Subject|9|||
48862775|NCT04754594|157333114|FG002|Blinded Period|Withdrawal by Subject|0|||
48862776|NCT04754594|157333115|FG003|Blinded Period|Withdrawal by Subject|0|||
48862777|NCT04754594|157333112|FG000|Blinded Period|Protocol Violation|2|||
48862778|NCT04754594|157333113|FG001|Blinded Period|Protocol Violation|2|||
48862779|NCT04754594|157333114|FG002|Blinded Period|Protocol Violation|0|||
48862780|NCT04754594|157333115|FG003|Blinded Period|Protocol Violation|0|||
48862781|NCT04754594|157333112|FG000|Blinded Period|Lost to Follow-up|1|||
48956291|NCT02322892|157669200|FG000|Overall Study|Protocol Violation|1|||
48956292|NCT02322892|157669201|FG001|Overall Study|Protocol Violation|0|||
48956293|NCT02626819|157669204|FG000|Overall Study|Lost to Follow-up|3|||
48956294|NCT02626819|157669205|FG001|Overall Study|Lost to Follow-up|2|||
48956295|NCT02626819|157669204|FG000|Overall Study|Withdrawal by Subject|1|||
48956296|NCT02626819|157669205|FG001|Overall Study|Withdrawal by Subject|0|||
48956297|NCT02626819|157669204|FG000|Overall Study|Diagnosed w/ catastrophic illness|0|||
48956298|NCT02626819|157669205|FG001|Overall Study|Diagnosed w/ catastrophic illness|1|||
48750853|NCT00752232|156932397|FG002|Overall Study|Caregiver could not attend the subject|0|||
48750854|NCT00752232|156932398|FG003|Overall Study|Caregiver could not attend the subject|0|||
48750855|NCT00752232|156932399|FG004|Overall Study|Caregiver could not attend the subject|1|||
48750856|NCT00752232|156932400|FG005|Overall Study|Caregiver could not attend the subject|0|||
48750857|NCT00752232|156932401|FG006|Overall Study|Caregiver could not attend the subject|0|||
48750858|NCT02573311|156932402|FG000|Disposition for Part 1|Withdrawal by Subject|7|||
48750859|NCT02573311|156932403|FG001|Disposition for Part 1|Withdrawal by Subject|3|||
48750860|NCT02573311|156932402|FG000|Disposition for Part 2|Physician Decision|25|||
48750861|NCT02573311|156932403|FG001|Disposition for Part 2|Physician Decision|7|||
48750862|NCT02573311|156932402|FG000|Disposition for Part 2|Adverse Event|36|||
48750863|NCT02573311|156932403|FG001|Disposition for Part 2|Adverse Event|5|||
48750864|NCT02573311|156932402|FG000|Disposition for Part 2|Lost to Follow-up|76|||
48750865|NCT02573311|156932403|FG001|Disposition for Part 2|Lost to Follow-up|7|||
48750866|NCT02573311|156932402|FG000|Disposition for Part 2|Withdrawal by Subject|60|||
48750867|NCT02573311|156932403|FG001|Disposition for Part 2|Withdrawal by Subject|3|||
48750868|NCT02573311|156932402|FG000|Disposition for Part 2|Investigator decision|0|||
48750869|NCT02573311|156932403|FG001|Disposition for Part 2|Investigator decision|1|||
48750870|NCT02573311|156932402|FG000|Disposition for Part 2|Other than specified above|13|||
48862782|NCT04754594|157333113|FG001|Blinded Period|Lost to Follow-up|1|||
48862783|NCT04754594|157333114|FG002|Blinded Period|Lost to Follow-up|0|||
48956299|NCT02340819|157669206|FG000|Overall Study|Adverse Event|1|||
48956300|NCT02340819|157669206|FG000|Overall Study|Withdrawal by Subject|2|||
48862784|NCT04754594|157333115|FG003|Blinded Period|Lost to Follow-up|0|||
48862785|NCT04754594|157333112|FG000|Blinded Period|Unblinded before 1-month postdelivery visit|6|||
48862786|NCT04754594|157333113|FG001|Blinded Period|Unblinded before 1-month postdelivery visit|3|||
48862787|NCT04754594|157333114|FG002|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
48862788|NCT04754594|157333115|FG003|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
48862789|NCT04754594|157333112|FG000|Unblinded Period|Withdrawal by Subject|6|||
48862790|NCT04754594|157333113|FG001|Unblinded Period|Withdrawal by Subject|8|||
48862791|NCT04754594|157333114|FG002|Unblinded Period|Withdrawal by Subject|0|||
48862792|NCT04754594|157333115|FG003|Unblinded Period|Withdrawal by Subject|0|||
48862793|NCT04754594|157333112|FG000|Unblinded Period|Lost to Follow-up|5|||
48862794|NCT04754594|157333113|FG001|Unblinded Period|Lost to Follow-up|3|||
48862795|NCT04754594|157333114|FG002|Unblinded Period|Lost to Follow-up|0|||
48862796|NCT04754594|157333115|FG003|Unblinded Period|Lost to Follow-up|0|||
48862797|NCT04754594|157333112|FG000|Unblinded Period|Protocol Violation|2|||
48862798|NCT04754594|157333113|FG001|Unblinded Period|Protocol Violation|4|||
48750871|NCT02573311|156932403|FG001|Disposition for Part 2|Other than specified above|3|||
48750872|NCT00573534|156932405|FG000|Overall Study|oppositional behavior|3|||
48750873|NCT03926169|156932406|FG000|Period A|Adverse Event|2|||
48750874|NCT03926169|156932407|FG001|Period A|Adverse Event|2|||
48750875|NCT03926169|156932408|FG002|Period A|Adverse Event|1|||
48750876|NCT03926169|156932406|FG000|Period A|Withdrawal by Subject|2|||
48750877|NCT03926169|156932407|FG001|Period A|Withdrawal by Subject|2|||
48750878|NCT03926169|156932408|FG002|Period A|Withdrawal by Subject|2|||
48750879|NCT03926169|156932406|FG000|Period A|Lost to Follow-up|3|||
48750880|NCT03926169|156932407|FG001|Period A|Lost to Follow-up|1|||
48750881|NCT03926169|156932408|FG002|Period A|Lost to Follow-up|0|||
48750882|NCT03926169|156932406|FG000|Period A|Lack of Efficacy|0|||
48750883|NCT03926169|156932407|FG001|Period A|Lack of Efficacy|2|||
48750884|NCT03926169|156932408|FG002|Period A|Lack of Efficacy|2|||
48956301|NCT02340819|157669206|FG000|Overall Study|Discontinued with other reason|1|||
48956302|NCT02361762|157669207|FG000|Overall Study|Withdrawal by Subject|0|||
48750885|NCT03926169|156932406|FG000|Period A|COVID-19 Infection|0|||
48750886|NCT03926169|156932407|FG001|Period A|COVID-19 Infection|1|||
48750887|NCT03926169|156932408|FG002|Period A|COVID-19 Infection|0|||
48750888|NCT03926169|156932406|FG000|Period A|COVID-19 Logistical Restrictions|0|||
48750889|NCT03926169|156932407|FG001|Period A|COVID-19 Logistical Restrictions|2|||
48750890|NCT03926169|156932408|FG002|Period A|COVID-19 Logistical Restrictions|1|||
48750891|NCT03926169|156932406|FG000|Period A|Other, Not Specified|1|||
48750892|NCT03926169|156932407|FG001|Period A|Other, Not Specified|0|||
48750893|NCT03926169|156932408|FG002|Period A|Other, Not Specified|0|||
48750894|NCT03926169|156932406|FG000|Period B|Adverse Event|3|||
48956303|NCT02361762|157669208|FG001|Overall Study|Withdrawal by Subject|1|||
48750895|NCT03926169|156932407|FG001|Period B|Adverse Event|1|||
48750896|NCT03926169|156932408|FG002|Period B|Adverse Event|1|||
48750897|NCT03926169|156932406|FG000|Period B|Withdrawal by Subject|1|||
48750898|NCT03926169|156932407|FG001|Period B|Withdrawal by Subject|3|||
48750899|NCT03926169|156932408|FG002|Period B|Withdrawal by Subject|0|||
48750900|NCT03926169|156932406|FG000|Period B|Lack of Efficacy|3|||
48750901|NCT03926169|156932407|FG001|Period B|Lack of Efficacy|1|||
48862799|NCT04754594|157333114|FG002|Unblinded Period|Protocol Violation|0|||
48862800|NCT04754594|157333115|FG003|Unblinded Period|Protocol Violation|0|||
48862801|NCT04754594|157333112|FG000|Unblinded Period|Other|3|||
48862802|NCT04754594|157333113|FG001|Unblinded Period|Other|0|||
48862803|NCT04754594|157333114|FG002|Unblinded Period|Other|0|||
48750902|NCT03926169|156932408|FG002|Period B|Lack of Efficacy|1|||
48750903|NCT03926169|156932406|FG000|Period B|Lost to Follow-up|1|||
48750904|NCT03926169|156932407|FG001|Period B|Lost to Follow-up|1|||
48750905|NCT03926169|156932408|FG002|Period B|Lost to Follow-up|4|||
48750906|NCT03926169|156932406|FG000|Period B|Other, Not Specified|62|||
48750907|NCT03926169|156932407|FG001|Period B|Other, Not Specified|57|||
48750908|NCT03926169|156932408|FG002|Period B|Other, Not Specified|65|||
48750909|NCT01691781|156932411|FG000|Overall Study|Withdrawal by Subject|4|||
48750910|NCT01691781|156932412|FG001|Overall Study|Withdrawal by Subject|3|||
48750911|NCT01691781|156932411|FG000|Overall Study|Physician Decision|1|||
48750912|NCT01691781|156932412|FG001|Overall Study|Physician Decision|1|||
48750913|NCT01691781|156932411|FG000|Overall Study|Protocol Violation|2|||
48750914|NCT01691781|156932412|FG001|Overall Study|Protocol Violation|2|||
48750915|NCT01691781|156932411|FG000|Overall Study|Adverse Event|0|||
48750916|NCT01691781|156932412|FG001|Overall Study|Adverse Event|1|||
48750917|NCT04359654|156932413|FG000|Overall Study|Withdrawal by Subject|1|||
48750918|NCT04359654|156932414|FG001|Overall Study|Withdrawal by Subject|0|||
48750919|NCT04359654|156932413|FG000|Overall Study|Adverse Event|0|||
48750920|NCT04359654|156932414|FG001|Overall Study|Adverse Event|1|||
48750921|NCT01918085|156932415|FG000|Test Period 1: Strata Strip|Adverse Event|0|||
48750922|NCT01918085|156932416|FG001|Test Period 1: Strata Strip|Adverse Event|1|||
48750923|NCT02056340|156932417|FG000|Overall Study|Lost to Follow-up|5|||
48750924|NCT02056340|156932418|FG001|Overall Study|Lost to Follow-up|5|||
48750925|NCT02056340|156932417|FG000|Overall Study|Withdrawal by Subject|2|||
48750926|NCT02056340|156932418|FG001|Overall Study|Withdrawal by Subject|6|||
48750927|NCT00071513|156932419|FG000|Intervention Component|Withdrawal by Subject|2|||
48750928|NCT00071513|156932420|FG001|Intervention Component|Withdrawal by Subject|3|||
48750929|NCT00071513|156932419|FG000|Follow-up Assessment|Withdrawal by Subject|6|||
48750930|NCT00071513|156932420|FG001|Follow-up Assessment|Withdrawal by Subject|6|||
48750931|NCT02375113|156932421|FG000|Overall Study|Undisclosed Reason(s).|1|||
48750932|NCT02375113|156932422|FG001|Overall Study|Undisclosed Reason(s).|1|||
48750933|NCT02375113|156932421|FG000|Overall Study|Poor adherence (<70%).|1|||
48750934|NCT02375113|156932422|FG001|Overall Study|Poor adherence (<70%).|0|||
48750935|NCT02375113|156932421|FG000|Overall Study|Discomfort of ingesting daily protein sh|0|||
48750936|NCT02375113|156932422|FG001|Overall Study|Discomfort of ingesting daily protein sh|1|||
48750937|NCT01414855|156932427|FG000|Overall Study|Death|17|||
48750938|NCT01414855|156932427|FG000|Overall Study|Lost to Follow-up|5|||
48750939|NCT01414855|156932427|FG000|Overall Study|Withdrawal by Subject|7|||
48750940|NCT00850564|156932447|FG000|Overall Study|Withdrawal by Subject|2|||
48750941|NCT01535053|156932448|FG000|Overall Study|Ineligible|1|||
48750942|NCT01535053|156932449|FG001|Overall Study|Ineligible|2|||
48750943|NCT01031069|156932450|FG000|Overall Study|Serious Adverse Event|0|||
48750944|NCT01031069|156932451|FG001|Overall Study|Serious Adverse Event|1|||
48750945|NCT01031069|156932452|FG002|Overall Study|Serious Adverse Event|0|||
48750946|NCT01031069|156932453|FG003|Overall Study|Serious Adverse Event|0|||
48750947|NCT01031069|156932450|FG000|Overall Study|Withdrawal by Subject|2|||
48750948|NCT01031069|156932451|FG001|Overall Study|Withdrawal by Subject|3|||
48750949|NCT01031069|156932452|FG002|Overall Study|Withdrawal by Subject|18|||
48862804|NCT04754594|157333115|FG003|Unblinded Period|Other|0|||
48862805|NCT04754594|157333112|FG000|Infant Participants|Withdrawal by Subject|0|||
48750950|NCT01031069|156932453|FG003|Overall Study|Withdrawal by Subject|18|||
48750951|NCT01031069|156932450|FG000|Overall Study|Migrated/moved from study area|1|||
48750952|NCT01031069|156932451|FG001|Overall Study|Migrated/moved from study area|2|||
48750953|NCT01031069|156932452|FG002|Overall Study|Migrated/moved from study area|1|||
48750954|NCT01031069|156932453|FG003|Overall Study|Migrated/moved from study area|1|||
48750955|NCT01031069|156932450|FG000|Overall Study|Lost to Follow-up|9|||
48750956|NCT01031069|156932451|FG001|Overall Study|Lost to Follow-up|5|||
48750957|NCT01031069|156932452|FG002|Overall Study|Lost to Follow-up|21|||
48750958|NCT01031069|156932453|FG003|Overall Study|Lost to Follow-up|15|||
48750959|NCT01031069|156932450|FG000|Overall Study|Other|0|||
48750960|NCT01031069|156932451|FG001|Overall Study|Other|0|||
48750961|NCT01031069|156932452|FG002|Overall Study|Other|1|||
48750962|NCT01031069|156932453|FG003|Overall Study|Other|0|||
48750963|NCT03700671|156932454|FG000|Overall Study|Lack of Efficacy|1|||
48750964|NCT03700671|156932455|FG001|Overall Study|Lack of Efficacy|2|||
48750965|NCT00688753|156934379|FG000|Overall Study|Disease progression|55|||
48750966|NCT00688753|156934379|FG000|Overall Study|Missing|1|||
48750967|NCT00688753|156934379|FG000|Overall Study|Death|9|||
48862806|NCT04754594|157333113|FG001|Infant Participants|Withdrawal by Subject|0|||
48862807|NCT04754594|157333114|FG002|Infant Participants|Withdrawal by Subject|9|||
48862808|NCT04754594|157333115|FG003|Infant Participants|Withdrawal by Subject|17|||
48862809|NCT04754594|157333112|FG000|Infant Participants|Lost to Follow-up|0|||
48862810|NCT04754594|157333113|FG001|Infant Participants|Lost to Follow-up|0|||
48862811|NCT04754594|157333114|FG002|Infant Participants|Lost to Follow-up|4|||
48862812|NCT04754594|157333115|FG003|Infant Participants|Lost to Follow-up|10|||
48956304|NCT02361762|157669207|FG000|Overall Study|Lost to Follow-up|0|||
48956305|NCT02361762|157669208|FG001|Overall Study|Lost to Follow-up|1|||
48956306|NCT03314519|157669209|FG000|Overall Study|Protocol Violation|3|||
48956307|NCT03314519|157669210|FG001|Overall Study|Protocol Violation|2|||
48750968|NCT00688753|156934379|FG000|Overall Study|Withdrawal by Subject|3|||
48750969|NCT00688753|156934379|FG000|Overall Study|Adverse Event|20|||
48750970|NCT00688753|156934379|FG000|Overall Study|Protocol Violation|1|||
48750971|NCT00688753|156934379|FG000|Overall Study|Lost to Follow-up|3|||
48750972|NCT02385045|156934382|FG000|Overall Study|Endoscopy could not be completed|4|||
48750973|NCT04840615|156934383|FG000|Overall Study|None of the participants completed all 4 cycles.|0|||
48750974|NCT04840615|156934384|FG001|Overall Study|None of the participants completed all 4 cycles.|2|||
48750975|NCT04840615|156934385|FG002|Overall Study|None of the participants completed all 4 cycles.|0|||
48750976|NCT03032705|156934386|FG000|Overall Study|Lost to Follow-up|16|||
48956308|NCT00414310|157669211|FG000|Overall Study|Not treated|1|||
48956309|NCT00414310|157669212|FG001|Overall Study|Not treated|0|||
48956310|NCT03276936|157669213|FG000|Overall Study|Adverse Event|4|||
48956311|NCT03276936|157669214|FG001|Overall Study|Adverse Event|2|||
48956312|NCT03276936|157669213|FG000|Overall Study|Lost to Follow-up|16|||
48956313|NCT03276936|157669214|FG001|Overall Study|Lost to Follow-up|13|||
48956314|NCT03276936|157669213|FG000|Overall Study|Withdrawal by Subject|30|||
48956315|NCT03276936|157669214|FG001|Overall Study|Withdrawal by Subject|20|||
48956316|NCT03276936|157669213|FG000|Overall Study|Not mentioned|6|||
48956317|NCT03276936|157669214|FG001|Overall Study|Not mentioned|3|||
48956318|NCT01345123|157669215|FG000|Overall Study|participants no longer with health plan|79|||
48956319|NCT01345123|157669216|FG001|Overall Study|participants no longer with health plan|85|||
48956320|NCT01345123|157669217|FG002|Overall Study|participants no longer with health plan|88|||
48956321|NCT03622593|157669218|FG000|Overall Study|Withdrawal by Subject|11|||
48956322|NCT03622593|157669219|FG001|Overall Study|Withdrawal by Subject|9|||
48956323|NCT03622593|157669220|FG002|Overall Study|Withdrawal by Subject|13|||
48956324|NCT03622593|157669218|FG000|Overall Study|Death|12|||
48956325|NCT03622593|157669219|FG001|Overall Study|Death|9|||
48956326|NCT03622593|157669220|FG002|Overall Study|Death|10|||
48956327|NCT03622593|157669218|FG000|Overall Study|Lost to Follow-up|11|||
48750977|NCT03032705|156934387|FG001|Overall Study|Lost to Follow-up|17|||
48862813|NCT04754594|157333112|FG000|Infant Participants|Death|0|||
48862814|NCT04754594|157333113|FG001|Infant Participants|Death|0|||
48862815|NCT04754594|157333114|FG002|Infant Participants|Death|1|||
48862816|NCT04754594|157333115|FG003|Infant Participants|Death|1|||
48862817|NCT04754594|157333112|FG000|Infant Participants|Other|0|||
48956328|NCT03622593|157669219|FG001|Overall Study|Lost to Follow-up|5|||
48956329|NCT03622593|157669220|FG002|Overall Study|Lost to Follow-up|8|||
48956330|NCT03622593|157669218|FG000|Overall Study|Adverse Event|4|||
48956331|NCT03622593|157669219|FG001|Overall Study|Adverse Event|5|||
48956332|NCT03622593|157669220|FG002|Overall Study|Adverse Event|6|||
48956333|NCT03622593|157669218|FG000|Overall Study|Physician Decision|2|||
48956334|NCT03622593|157669219|FG001|Overall Study|Physician Decision|1|||
48750978|NCT03032705|156934386|FG000|Overall Study|did not quality|6|||
48750979|NCT03032705|156934387|FG001|Overall Study|did not quality|6|||
48750980|NCT00911820|156934388|FG000|Overall Study|RECIST progression|12|||
48750981|NCT00911820|156934389|FG001|Overall Study|RECIST progression|8|||
48750982|NCT00911820|156934388|FG000|Overall Study|Adverse Event|8|||
48750983|NCT00911820|156934389|FG001|Overall Study|Adverse Event|8|||
48862818|NCT04754594|157333113|FG001|Infant Participants|Other|0|||
48862819|NCT04754594|157333114|FG002|Infant Participants|Other|1|||
48862820|NCT04754594|157333115|FG003|Infant Participants|Other|1|||
48862821|NCT00495612|157333116|FG000|Overall Study|Lost to Follow-up|1|||
48862822|NCT00495612|157333117|FG001|Overall Study|Lost to Follow-up|0|||
48862823|NCT00495612|157333116|FG000|Overall Study|Subject's Decision to Withdraw|3|||
48862824|NCT00495612|157333117|FG001|Overall Study|Subject's Decision to Withdraw|0|||
48862825|NCT06016127|157333118|FG000|Overall Study|Withdrawal by Subject|4|||
48862826|NCT06016127|157333119|FG001|Overall Study|Withdrawal by Subject|3|||
48862827|NCT02632045|157333124|FG000|Overall Study|Withdrawal by Subject|1|||
48862828|NCT02632045|157333125|FG001|Overall Study|Withdrawal by Subject|2|||
48862837|NCT03340766|157333130|FG000|Overall Study|Withdrawal by Subject|2|||
48862838|NCT03340766|157333131|FG001|Overall Study|Withdrawal by Subject|1|||
48862839|NCT03340766|157333132|FG002|Overall Study|Withdrawal by Subject|3|||
48862840|NCT03340766|157333130|FG000|Overall Study|Lost to Follow-up|0|||
48862841|NCT03340766|157333131|FG001|Overall Study|Lost to Follow-up|0|||
48862842|NCT03340766|157333132|FG002|Overall Study|Lost to Follow-up|1|||
48862843|NCT03340766|157333130|FG000|Overall Study|Death|6|||
48862844|NCT03340766|157333131|FG001|Overall Study|Death|7|||
48862845|NCT03340766|157333132|FG002|Overall Study|Death|4|||
48862846|NCT02268526|157333133|FG000|Overall Study|Adverse Event|0|||
48862847|NCT02268526|157333134|FG001|Overall Study|Adverse Event|2|||
48862848|NCT02268526|157333135|FG002|Overall Study|Adverse Event|1|||
48862849|NCT02268526|157333133|FG000|Overall Study|Death|1|||
48862850|NCT02268526|157333134|FG001|Overall Study|Death|11|||
48862851|NCT02268526|157333135|FG002|Overall Study|Death|0|||
48862852|NCT02268526|157333133|FG000|Overall Study|protocol deviation|0|||
48862853|NCT02268526|157333134|FG001|Overall Study|protocol deviation|1|||
48862854|NCT02268526|157333135|FG002|Overall Study|protocol deviation|0|||
48862855|NCT02268526|157333133|FG000|Overall Study|Physician Decision|0|||
48862856|NCT02268526|157333134|FG001|Overall Study|Physician Decision|0|||
48956335|NCT03622593|157669220|FG002|Overall Study|Physician Decision|6|||
48956336|NCT03622593|157669218|FG000|Overall Study|Other|2|||
48956337|NCT03622593|157669219|FG001|Overall Study|Other|2|||
48956338|NCT03622593|157669220|FG002|Overall Study|Other|3|||
48956339|NCT03622593|157669218|FG000|Overall Study|Protocol Violation|0|||
48956340|NCT03622593|157669219|FG001|Overall Study|Protocol Violation|0|||
48956341|NCT03622593|157669220|FG002|Overall Study|Protocol Violation|1|||
48956342|NCT03622593|157669218|FG000|Overall Study|Pregnancy|0|||
48956343|NCT03622593|157669219|FG001|Overall Study|Pregnancy|0|||
48956344|NCT03622593|157669220|FG002|Overall Study|Pregnancy|1|||
48956345|NCT02849990|157669221|FG000|Overall Study|Adverse Event|1|||
48956346|NCT02849990|157669221|FG000|Overall Study|Withdrawal by Subject|1|||
48956347|NCT01675531|157669222|FG000|Overall Study|Adverse Event|9|||
48956348|NCT01675531|157669222|FG000|Overall Study|Withdrawal by Subject|7|||
48956349|NCT01675531|157669222|FG000|Overall Study|Lack of Efficacy|1|||
48956350|NCT01675531|157669222|FG000|Overall Study|Protocol Violation|8|||
48956351|NCT02345252|157669225|FG000|Double-Blind Phase|Adverse Event|2|||
48956352|NCT02345252|157669226|FG001|Double-Blind Phase|Adverse Event|3|||
48956353|NCT02345252|157669225|FG000|Double-Blind Phase|Death|1|||
48956354|NCT02345252|157669226|FG001|Double-Blind Phase|Death|2|||
48956355|NCT02345252|157669225|FG000|Double-Blind Phase|Lack of Efficacy|1|||
48956356|NCT02345252|157669226|FG001|Double-Blind Phase|Lack of Efficacy|0|||
48956357|NCT02345252|157669225|FG000|Double-Blind Phase|Investigator's Discretion|4|||
48956358|NCT02345252|157669226|FG001|Double-Blind Phase|Investigator's Discretion|6|||
48956359|NCT02345252|157669225|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
48750984|NCT00911820|156934388|FG000|Overall Study|Clinical Progression|7|||
48750985|NCT00911820|156934389|FG001|Overall Study|Clinical Progression|5|||
48750986|NCT00911820|156934388|FG000|Overall Study|Physician Decision|5|||
48750987|NCT00911820|156934389|FG001|Overall Study|Physician Decision|9|||
48956360|NCT02345252|157669226|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
48956361|NCT02345252|157669225|FG000|Double-Blind Phase|Protocol Violation|2|||
48750988|NCT00911820|156934388|FG000|Overall Study|Decline in Performance Status|4|||
48750989|NCT00911820|156934389|FG001|Overall Study|Decline in Performance Status|2|||
48750990|NCT00911820|156934388|FG000|Overall Study|Withdrawal by Subject|3|||
48750991|NCT00911820|156934389|FG001|Overall Study|Withdrawal by Subject|4|||
48750992|NCT00911820|156934388|FG000|Overall Study|Death|1|||
48750993|NCT00911820|156934389|FG001|Overall Study|Death|2|||
48750994|NCT00911820|156934388|FG000|Overall Study|Pursue surgery|1|||
48750995|NCT00911820|156934389|FG001|Overall Study|Pursue surgery|1|||
48750996|NCT00911820|156934388|FG000|Overall Study|Pursue Radiation|1|||
48750997|NCT00911820|156934389|FG001|Overall Study|Pursue Radiation|0|||
48750998|NCT00911820|156934388|FG000|Overall Study|Still on Therapy|2|||
48862857|NCT02268526|157333135|FG002|Overall Study|Physician Decision|1|||
48862858|NCT02268526|157333133|FG000|Overall Study|Subject/guardian decision|0|||
48862859|NCT02268526|157333134|FG001|Overall Study|Subject/guardian decision|7|||
48862860|NCT02268526|157333135|FG002|Overall Study|Subject/guardian decision|3|||
48862861|NCT00596960|157333136|FG000|Overall Study|Death|1|||
48862862|NCT00596960|157333137|FG001|Overall Study|Death|2|||
48862863|NCT00596960|157333136|FG000|Overall Study|Lost to Follow-up|6|||
48862864|NCT00596960|157333137|FG001|Overall Study|Lost to Follow-up|5|||
48862865|NCT00596960|157333136|FG000|Overall Study|Withdrawal by Subject|1|||
48862866|NCT00596960|157333137|FG001|Overall Study|Withdrawal by Subject|0|||
48862867|NCT00596960|157333136|FG000|Overall Study|Incarcerated|2|||
48862868|NCT00596960|157333137|FG001|Overall Study|Incarcerated|0|||
48750999|NCT00911820|156934389|FG001|Overall Study|Still on Therapy|2|||
48751000|NCT00911820|156934388|FG000|Overall Study|Pathology Not Confirmed|1|||
48751001|NCT00911820|156934389|FG001|Overall Study|Pathology Not Confirmed|0|||
48751002|NCT00911820|156934388|FG000|Overall Study|Withdraw before Receive Treatment|0|||
48751003|NCT00911820|156934389|FG001|Overall Study|Withdraw before Receive Treatment|2|||
48751004|NCT03364023|156934390|FG000|Overall Study|Lost to Follow-up|3|||
48751005|NCT03364023|156934390|FG000|Overall Study|Death|14|||
48751006|NCT02397278|156934393|FG000|Overall Study|Withdrawal by Subject|0|||
48751007|NCT02397278|156934394|FG001|Overall Study|Withdrawal by Subject|2|||
48751008|NCT02397278|156934393|FG000|Overall Study|Deemed ineligible following surgery|1|||
48751009|NCT02397278|156934394|FG001|Overall Study|Deemed ineligible following surgery|1|||
48956362|NCT02345252|157669226|FG001|Double-Blind Phase|Protocol Violation|1|||
48956363|NCT02345252|157669225|FG000|Double-Blind Phase|Withdrew Consent|21|||
48956364|NCT02345252|157669226|FG001|Double-Blind Phase|Withdrew Consent|23|||
48956365|NCT02345252|157669225|FG000|Double-Blind Phase|Lost to Follow-up|8|||
48956366|NCT02345252|157669226|FG001|Double-Blind Phase|Lost to Follow-up|10|||
48956367|NCT02345252|157669225|FG000|Double-Blind Phase|Randomized but Never Treated|0|||
48956368|NCT02345252|157669226|FG001|Double-Blind Phase|Randomized but Never Treated|2|||
48956369|NCT02546674|157669227|FG000|Overall Study|Adverse Event|19|||
48956370|NCT02546674|157669227|FG000|Overall Study|Death|1|||
48956371|NCT02546674|157669227|FG000|Overall Study|Lost to Follow-up|1|||
48956372|NCT02546674|157669227|FG000|Overall Study|Physician Decision|13|||
48956373|NCT02546674|157669227|FG000|Overall Study|Pregnancy|1|||
48956374|NCT02546674|157669227|FG000|Overall Study|Progressive Disease|2|||
48956375|NCT02546674|157669227|FG000|Overall Study|Protocol Deviation|2|||
48956376|NCT02546674|157669227|FG000|Overall Study|Subject/Guardian Decision|6|||
48956377|NCT02546674|157669227|FG000|Overall Study|Withdrawal of Informed Consent|3|||
48956378|NCT03885726|157669228|FG000|Overall Study|Staffing issues/lost interest|1|||
48956379|NCT03885726|157669228|FG000|Overall Study|Early discharge from hospital|3|||
48956380|NCT00532883|157669229|FG000|Overall Study|Adverse Event|1|||
48956381|NCT00532883|157669230|FG001|Overall Study|Adverse Event|0|||
48956382|NCT00532883|157669231|FG002|Overall Study|Adverse Event|0|||
48956383|NCT00532883|157669232|FG003|Overall Study|Adverse Event|1|||
48956384|NCT00532883|157669229|FG000|Overall Study|Lost to Follow-up|1|||
48956385|NCT00532883|157669230|FG001|Overall Study|Lost to Follow-up|1|||
48956386|NCT00532883|157669231|FG002|Overall Study|Lost to Follow-up|1|||
48956387|NCT00532883|157669232|FG003|Overall Study|Lost to Follow-up|0|||
48751010|NCT02310568|156934395|FG000|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
48751011|NCT02310568|156934396|FG001|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
48751012|NCT02310568|156934397|FG002|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
48751013|NCT02310568|156934398|FG003|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
48751014|NCT02310568|156934399|FG004|Stage 1 ( 4 Weeks)|Lack of Efficacy|1|||
48751015|NCT02310568|156934395|FG000|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1|||
48751016|NCT02310568|156934396|FG001|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
48751017|NCT02310568|156934397|FG002|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
48751018|NCT02310568|156934398|FG003|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
48751019|NCT02310568|156934399|FG004|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
48751020|NCT02310568|156934395|FG000|Stage 1 ( 4 Weeks)|Other|1|||
48751021|NCT02310568|156934396|FG001|Stage 1 ( 4 Weeks)|Other|1|||
48751022|NCT02310568|156934397|FG002|Stage 1 ( 4 Weeks)|Other|0|||
48751023|NCT02310568|156934398|FG003|Stage 1 ( 4 Weeks)|Other|0|||
48751024|NCT02310568|156934399|FG004|Stage 1 ( 4 Weeks)|Other|0|||
48751025|NCT02310568|156934395|FG000|Stage 1 ( 4 Weeks)|Adverse Event|1|||
48751026|NCT02310568|156934396|FG001|Stage 1 ( 4 Weeks)|Adverse Event|1|||
48751027|NCT02310568|156934397|FG002|Stage 1 ( 4 Weeks)|Adverse Event|1|||
48751028|NCT02310568|156934398|FG003|Stage 1 ( 4 Weeks)|Adverse Event|0|||
48751029|NCT02310568|156934399|FG004|Stage 1 ( 4 Weeks)|Adverse Event|0|||
48751030|NCT02310568|156934395|FG000|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
48751031|NCT02310568|156934396|FG001|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
48751032|NCT02310568|156934397|FG002|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
48751033|NCT02310568|156934398|FG003|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1|||
48751034|NCT02310568|156934399|FG004|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
48751035|NCT02310568|156934395|FG000|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
48956388|NCT00532883|157669229|FG000|Overall Study|Withdrawal by Subject|0|||
48956389|NCT00532883|157669230|FG001|Overall Study|Withdrawal by Subject|1|||
48956390|NCT00532883|157669231|FG002|Overall Study|Withdrawal by Subject|1|||
48956391|NCT00532883|157669232|FG003|Overall Study|Withdrawal by Subject|0|||
48956392|NCT00532883|157669229|FG000|Overall Study|Subject was Nonadherent|0|||
48956393|NCT00532883|157669230|FG001|Overall Study|Subject was Nonadherent|1|||
48956394|NCT00532883|157669231|FG002|Overall Study|Subject was Nonadherent|1|||
48956395|NCT00532883|157669232|FG003|Overall Study|Subject was Nonadherent|0|||
48956396|NCT00532883|157669229|FG000|Overall Study|Early Study Termination|4|||
48956397|NCT00532883|157669230|FG001|Overall Study|Early Study Termination|4|||
48956398|NCT00532883|157669231|FG002|Overall Study|Early Study Termination|1|||
48956399|NCT00532883|157669232|FG003|Overall Study|Early Study Termination|4|||
48956400|NCT02184143|157669233|FG000|Overall Study|Withdrawal by Subject|4|||
48956401|NCT02184143|157669234|FG001|Overall Study|Withdrawal by Subject|4|||
48956402|NCT02184143|157669233|FG000|Overall Study|Lost to Follow-up|5|||
48956403|NCT02184143|157669234|FG001|Overall Study|Lost to Follow-up|3|||
48956404|NCT02184143|157669233|FG000|Overall Study|Death|1|||
48956405|NCT02184143|157669234|FG001|Overall Study|Death|0|||
48956406|NCT00002663|157669235|FG000|Overall Study|Death|4|||
48956407|NCT00002663|157669236|FG001|Overall Study|Death|1|||
48751036|NCT02310568|156934396|FG001|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
48956408|NCT00002663|157669237|FG002|Overall Study|Death|1|||
48956409|NCT00002663|157669238|FG003|Overall Study|Death|0|||
48751037|NCT02310568|156934397|FG002|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
48751038|NCT02310568|156934398|FG003|Stage 1 ( 4 Weeks)|Lost to Follow-up|1|||
48751039|NCT02310568|156934399|FG004|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
48956410|NCT00002663|157669239|FG004|Overall Study|Death|0|||
48956411|NCT00002663|157669240|FG005|Overall Study|Death|13|||
48956412|NCT00002663|157669241|FG006|Overall Study|Death|0|||
48956413|NCT00002663|157669242|FG007|Overall Study|Death|1|||
48956414|NCT00002663|157669243|FG008|Overall Study|Death|1|||
48956415|NCT00002663|157669244|FG009|Overall Study|Death|1|||
48956416|NCT00002663|157669235|FG000|Overall Study|Lost to Follow-up|3|||
48956417|NCT00002663|157669236|FG001|Overall Study|Lost to Follow-up|0|||
48956418|NCT00002663|157669237|FG002|Overall Study|Lost to Follow-up|0|||
48956419|NCT00002663|157669238|FG003|Overall Study|Lost to Follow-up|1|||
48956420|NCT00002663|157669239|FG004|Overall Study|Lost to Follow-up|0|||
48956421|NCT00002663|157669240|FG005|Overall Study|Lost to Follow-up|1|||
48956422|NCT00002663|157669241|FG006|Overall Study|Lost to Follow-up|0|||
48956423|NCT00002663|157669242|FG007|Overall Study|Lost to Follow-up|0|||
48956424|NCT00002663|157669243|FG008|Overall Study|Lost to Follow-up|0|||
48956425|NCT00002663|157669244|FG009|Overall Study|Lost to Follow-up|0|||
48956426|NCT00002663|157669235|FG000|Overall Study|Other|0|||
48956427|NCT00002663|157669236|FG001|Overall Study|Other|1|||
48956428|NCT00002663|157669237|FG002|Overall Study|Other|0|||
48956429|NCT00002663|157669238|FG003|Overall Study|Other|0|||
48956430|NCT00002663|157669239|FG004|Overall Study|Other|0|||
48956431|NCT00002663|157669240|FG005|Overall Study|Other|1|||
48956432|NCT00002663|157669241|FG006|Overall Study|Other|1|||
48956433|NCT00002663|157669242|FG007|Overall Study|Other|0|||
48956434|NCT00002663|157669243|FG008|Overall Study|Other|0|||
48956435|NCT00002663|157669244|FG009|Overall Study|Other|0|||
48956436|NCT00002663|157669235|FG000|Overall Study|Physician Decision|0|||
48956437|NCT00002663|157669236|FG001|Overall Study|Physician Decision|0|||
48956438|NCT00002663|157669237|FG002|Overall Study|Physician Decision|0|||
48956439|NCT00002663|157669238|FG003|Overall Study|Physician Decision|0|||
48956440|NCT00002663|157669239|FG004|Overall Study|Physician Decision|1|||
48956441|NCT00002663|157669240|FG005|Overall Study|Physician Decision|0|||
48956442|NCT00002663|157669241|FG006|Overall Study|Physician Decision|0|||
48956443|NCT00002663|157669242|FG007|Overall Study|Physician Decision|0|||
48751040|NCT02310568|156934395|FG000|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
48956444|NCT00002663|157669243|FG008|Overall Study|Physician Decision|1|||
48956445|NCT00002663|157669244|FG009|Overall Study|Physician Decision|1|||
48956446|NCT00002663|157669235|FG000|Overall Study|Adverse Event|0|||
48956447|NCT00002663|157669236|FG001|Overall Study|Adverse Event|0|||
48956448|NCT00002663|157669237|FG002|Overall Study|Adverse Event|0|||
48956449|NCT00002663|157669238|FG003|Overall Study|Adverse Event|1|||
49015401|NCT02666430|157892167|FG001|Period 2|Withdrawal by Subject|4|||
48956450|NCT00002663|157669239|FG004|Overall Study|Adverse Event|0|||
48956451|NCT00002663|157669240|FG005|Overall Study|Adverse Event|0|||
48956452|NCT00002663|157669241|FG006|Overall Study|Adverse Event|0|||
48956453|NCT00002663|157669242|FG007|Overall Study|Adverse Event|1|||
48956454|NCT00002663|157669243|FG008|Overall Study|Adverse Event|0|||
48956455|NCT00002663|157669244|FG009|Overall Study|Adverse Event|0|||
48956456|NCT00905307|157669245|FG000|Overall Study|Switched to Open Label Rescue|7|||
48956457|NCT00905307|157669246|FG001|Overall Study|Switched to Open Label Rescue|17|||
48956458|NCT00905307|157669247|FG002|Overall Study|Switched to Open Label Rescue|11|||
48862869|NCT00596960|157333136|FG000|Overall Study|Physician Decision|1|||
48862870|NCT00596960|157333137|FG001|Overall Study|Physician Decision|0|||
48862871|NCT00596960|157333136|FG000|Overall Study|Protocol Violation|0|||
48862872|NCT00596960|157333137|FG001|Overall Study|Protocol Violation|1|||
48956459|NCT00905307|157669248|FG003|Overall Study|Switched to Open Label Rescue|11|||
48956460|NCT00905307|157669249|FG004|Overall Study|Switched to Open Label Rescue|4|||
48956461|NCT00905307|157669250|FG005|Overall Study|Switched to Open Label Rescue|15|||
48862873|NCT00596960|157333136|FG000|Overall Study|No alcohol use data|0|||
48862874|NCT00596960|157333137|FG001|Overall Study|No alcohol use data|1|||
48862875|NCT02066389|157333139|FG000|Overall Study|Adverse Event|1|||
48862876|NCT02066389|157333140|FG001|Overall Study|Adverse Event|1|||
48862877|NCT02066389|157333141|FG002|Overall Study|Adverse Event|1|||
48862878|NCT02066389|157333142|FG003|Overall Study|Adverse Event|1|||
48862879|NCT02066389|157333143|FG004|Overall Study|Adverse Event|5|||
48862880|NCT02066389|157333144|FG005|Overall Study|Adverse Event|1|||
48862881|NCT02066389|157333139|FG000|Overall Study|Withdrawal by Subject|4|||
48862882|NCT02066389|157333140|FG001|Overall Study|Withdrawal by Subject|0|||
48862883|NCT02066389|157333141|FG002|Overall Study|Withdrawal by Subject|5|||
48862884|NCT02066389|157333142|FG003|Overall Study|Withdrawal by Subject|1|||
48862885|NCT02066389|157333143|FG004|Overall Study|Withdrawal by Subject|1|||
48862886|NCT02066389|157333144|FG005|Overall Study|Withdrawal by Subject|2|||
48862887|NCT02066389|157333139|FG000|Overall Study|Lost to Follow-up|0|||
48862888|NCT02066389|157333140|FG001|Overall Study|Lost to Follow-up|0|||
48862889|NCT02066389|157333141|FG002|Overall Study|Lost to Follow-up|0|||
48862890|NCT02066389|157333142|FG003|Overall Study|Lost to Follow-up|1|||
48862891|NCT02066389|157333143|FG004|Overall Study|Lost to Follow-up|1|||
48862892|NCT02066389|157333144|FG005|Overall Study|Lost to Follow-up|1|||
48862893|NCT02066389|157333139|FG000|Overall Study|Randomized in Error|0|||
48956462|NCT00905307|157669245|FG000|Overall Study|Lost to Follow-up|0|||
48956463|NCT00905307|157669246|FG001|Overall Study|Lost to Follow-up|0|||
48956464|NCT00905307|157669247|FG002|Overall Study|Lost to Follow-up|0|||
48956465|NCT00905307|157669248|FG003|Overall Study|Lost to Follow-up|0|||
48956466|NCT00905307|157669249|FG004|Overall Study|Lost to Follow-up|1|||
48956467|NCT00905307|157669250|FG005|Overall Study|Lost to Follow-up|1|||
48956468|NCT00905307|157669245|FG000|Overall Study|Adverse Event|3|||
48956469|NCT00905307|157669246|FG001|Overall Study|Adverse Event|4|||
48956470|NCT00905307|157669247|FG002|Overall Study|Adverse Event|5|||
48956471|NCT00905307|157669248|FG003|Overall Study|Adverse Event|11|||
48956472|NCT00905307|157669249|FG004|Overall Study|Adverse Event|3|||
48956473|NCT00905307|157669250|FG005|Overall Study|Adverse Event|5|||
48956474|NCT00905307|157669245|FG000|Overall Study|Withdrawal by Subject|5|||
48862894|NCT02066389|157333140|FG001|Overall Study|Randomized in Error|0|||
48862895|NCT02066389|157333141|FG002|Overall Study|Randomized in Error|0|||
48862896|NCT02066389|157333142|FG003|Overall Study|Randomized in Error|0|||
48862897|NCT02066389|157333143|FG004|Overall Study|Randomized in Error|0|||
48862898|NCT02066389|157333144|FG005|Overall Study|Randomized in Error|1|||
48862899|NCT02374476|157333145|FG000|VT Induced Ablation|Screening Failures|36|||
48862900|NCT02374476|157333146|FG001|VT Induced Ablation|Screening Failures|0|||
48956475|NCT00905307|157669246|FG001|Overall Study|Withdrawal by Subject|13|||
48956476|NCT00905307|157669247|FG002|Overall Study|Withdrawal by Subject|15|||
48956477|NCT00905307|157669248|FG003|Overall Study|Withdrawal by Subject|11|||
48862901|NCT02374476|157333147|FG002|VT Induced Ablation|Screening Failures|0|||
48862902|NCT02374476|157333145|FG000|Arm Assignment|Withdrawal by Subject|0|||
48862903|NCT02374476|157333146|FG001|Arm Assignment|Withdrawal by Subject|0|||
48956478|NCT00905307|157669249|FG004|Overall Study|Withdrawal by Subject|4|||
48956479|NCT00905307|157669250|FG005|Overall Study|Withdrawal by Subject|13|||
48862904|NCT02374476|157333147|FG002|Arm Assignment|Withdrawal by Subject|1|||
48862905|NCT05431543|157333148|FG000|Overall Study|Medical History|1|||
48862906|NCT05431543|157333149|FG001|Overall Study|Medical History|0|||
48862907|NCT05431543|157333150|FG002|Overall Study|Medical History|0|||
48862908|NCT03356145|157333151|FG000|Overall Study|Withdrawal by Subject|2|||
48862909|NCT03356145|157333152|FG001|Overall Study|Withdrawal by Subject|1|||
48862910|NCT03356145|157333151|FG000|Overall Study|Did not meet inclusion criteria|1|||
48862911|NCT03356145|157333152|FG001|Overall Study|Did not meet inclusion criteria|0|||
48862912|NCT04242498|157333153|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
48862913|NCT04242498|157333154|FG001|Initial Treatment Period: Week 0-16|Adverse Event|1|||
48862914|NCT04242498|157333155|FG002|Initial Treatment Period: Week 0-16|Adverse Event|9|||
48862915|NCT04242498|157333156|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
48862916|NCT04242498|157333157|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
48862917|NCT04242498|157333158|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
48862918|NCT04242498|157333159|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
48862919|NCT04242498|157333153|FG000|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
48862920|NCT04242498|157333154|FG001|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
48862921|NCT04242498|157333155|FG002|Initial Treatment Period: Week 0-16|Lack of Efficacy|1|||
48862922|NCT04242498|157333156|FG003|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
48862923|NCT04242498|157333157|FG004|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
48862924|NCT04242498|157333158|FG005|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
48862925|NCT04242498|157333159|FG006|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
48862926|NCT04242498|157333153|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
48862927|NCT04242498|157333154|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
48862928|NCT04242498|157333155|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
48862929|NCT04242498|157333156|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
48862930|NCT04242498|157333157|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
48862931|NCT04242498|157333158|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
48862932|NCT04242498|157333159|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
48862933|NCT04242498|157333153|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
48862934|NCT04242498|157333154|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
48862935|NCT04242498|157333155|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
48862936|NCT04242498|157333156|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
48862937|NCT04242498|157333157|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
48862938|NCT04242498|157333158|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
48862939|NCT04242498|157333159|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
48862940|NCT04242498|157333153|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|2|||
48862941|NCT04242498|157333154|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|8|||
48862942|NCT04242498|157333155|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|12|||
48862943|NCT04242498|157333156|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
48862944|NCT04242498|157333157|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
48862945|NCT04242498|157333158|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
48862946|NCT04242498|157333159|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
48862947|NCT04242498|157333153|FG000|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
48862948|NCT04242498|157333154|FG001|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
48862949|NCT04242498|157333155|FG002|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|1|||
48862950|NCT04242498|157333156|FG003|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
48862951|NCT04242498|157333157|FG004|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
48862952|NCT04242498|157333158|FG005|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
48862953|NCT04242498|157333159|FG006|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
48862954|NCT04242498|157333153|FG000|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
48862955|NCT04242498|157333154|FG001|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
48862956|NCT04242498|157333155|FG002|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|1|||
48862957|NCT04242498|157333156|FG003|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
48862958|NCT04242498|157333157|FG004|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
48956480|NCT00905307|157669245|FG000|Overall Study|Protocol Violation|1|||
48862959|NCT04242498|157333158|FG005|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
48862960|NCT04242498|157333159|FG006|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
48862961|NCT04242498|157333153|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
48862962|NCT04242498|157333154|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|2|||
48862963|NCT04242498|157333155|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
48862964|NCT04242498|157333156|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
48862965|NCT04242498|157333157|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
48862966|NCT04242498|157333158|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
48862967|NCT04242498|157333159|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
48862968|NCT04242498|157333153|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
48862969|NCT04242498|157333154|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
48862970|NCT04242498|157333155|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
48862971|NCT04242498|157333156|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
48862972|NCT04242498|157333157|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
48862973|NCT04242498|157333158|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
48862974|NCT04242498|157333159|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|4|||
48862975|NCT04242498|157333153|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
48862976|NCT04242498|157333154|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
48862977|NCT04242498|157333155|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
48862978|NCT04242498|157333156|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
48862979|NCT04242498|157333157|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|4|||
48862980|NCT04242498|157333158|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
48862981|NCT04242498|157333159|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
48956481|NCT00905307|157669246|FG001|Overall Study|Protocol Violation|0|||
48956482|NCT00905307|157669247|FG002|Overall Study|Protocol Violation|1|||
48956483|NCT00905307|157669248|FG003|Overall Study|Protocol Violation|0|||
48956484|NCT00905307|157669249|FG004|Overall Study|Protocol Violation|0|||
48956485|NCT00905307|157669250|FG005|Overall Study|Protocol Violation|0|||
48956486|NCT00905307|157669245|FG000|Overall Study|Lack of Efficacy|6|||
48956487|NCT00905307|157669246|FG001|Overall Study|Lack of Efficacy|3|||
48956488|NCT00905307|157669247|FG002|Overall Study|Lack of Efficacy|5|||
48956489|NCT00905307|157669248|FG003|Overall Study|Lack of Efficacy|4|||
48956490|NCT00905307|157669249|FG004|Overall Study|Lack of Efficacy|4|||
48956491|NCT00905307|157669250|FG005|Overall Study|Lack of Efficacy|8|||
48956492|NCT02142894|157669251|FG000|Overall Study|Protocol Violation|8|||
48956493|NCT03161678|157669255|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
48956494|NCT03161678|157669256|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
48956495|NCT03161678|157669257|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
48956496|NCT03161678|157669258|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
48956497|NCT03161678|157669259|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
48956498|NCT03161678|157669260|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
48956499|NCT03161678|157669255|FG000|Intervention 1 (8 Days)|Adverse Event|0|||
48956500|NCT03161678|157669256|FG001|Intervention 1 (8 Days)|Adverse Event|0|||
48956501|NCT03161678|157669257|FG002|Intervention 1 (8 Days)|Adverse Event|0|||
48956502|NCT03161678|157669258|FG003|Intervention 1 (8 Days)|Adverse Event|1|||
48956503|NCT03161678|157669259|FG004|Intervention 1 (8 Days)|Adverse Event|0|||
48956504|NCT03161678|157669260|FG005|Intervention 1 (8 Days)|Adverse Event|0|||
48956505|NCT03161678|157669255|FG000|Washout (14 Days)|Withdrawal by Subject|0|||
48956506|NCT03161678|157669256|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
48956507|NCT03161678|157669257|FG002|Washout (14 Days)|Withdrawal by Subject|1|||
48862982|NCT04242498|157333153|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
48862983|NCT04242498|157333154|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
48862984|NCT04242498|157333155|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
48862985|NCT04242498|157333156|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
48862986|NCT04242498|157333157|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
48862987|NCT04242498|157333158|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
48862988|NCT04242498|157333159|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
48862989|NCT04242498|157333153|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
48862990|NCT04242498|157333154|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
48862991|NCT04242498|157333155|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
48862992|NCT04242498|157333156|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
48862993|NCT04242498|157333157|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
48862994|NCT04242498|157333158|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|1|||
48862995|NCT04242498|157333159|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
48862996|NCT04242498|157333153|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
48862997|NCT04242498|157333154|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
48862998|NCT04242498|157333155|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
48862999|NCT04242498|157333156|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|6|||
48863000|NCT04242498|157333157|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|9|||
48863001|NCT04242498|157333158|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|10|||
48863002|NCT04242498|157333159|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
48863003|NCT04242498|157333153|FG000|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
48751041|NCT02310568|156934396|FG001|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
48751042|NCT02310568|156934397|FG002|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
48751043|NCT02310568|156934398|FG003|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
48751044|NCT02310568|156934399|FG004|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
48751045|NCT02310568|156934395|FG000|Stage 2 (4 Weeks)|Other|0|||
48751046|NCT02310568|156934396|FG001|Stage 2 (4 Weeks)|Other|1|||
48751047|NCT02310568|156934397|FG002|Stage 2 (4 Weeks)|Other|1|||
48751048|NCT02310568|156934398|FG003|Stage 2 (4 Weeks)|Other|0|||
48751049|NCT02310568|156934399|FG004|Stage 2 (4 Weeks)|Other|0|||
48751050|NCT02310568|156934395|FG000|Stage 2 (4 Weeks)|Adverse Event|0|||
48751051|NCT02310568|156934396|FG001|Stage 2 (4 Weeks)|Adverse Event|0|||
48751052|NCT02310568|156934397|FG002|Stage 2 (4 Weeks)|Adverse Event|0|||
48751053|NCT02310568|156934398|FG003|Stage 2 (4 Weeks)|Adverse Event|1|||
48751054|NCT02310568|156934399|FG004|Stage 2 (4 Weeks)|Adverse Event|1|||
48751055|NCT02310568|156934395|FG000|Stage 2 (4 Weeks)|Protocol Violation|0|||
48751056|NCT02310568|156934396|FG001|Stage 2 (4 Weeks)|Protocol Violation|0|||
48751057|NCT02310568|156934397|FG002|Stage 2 (4 Weeks)|Protocol Violation|0|||
48751058|NCT02310568|156934398|FG003|Stage 2 (4 Weeks)|Protocol Violation|1|||
48751059|NCT02310568|156934399|FG004|Stage 2 (4 Weeks)|Protocol Violation|0|||
48751060|NCT02310568|156934395|FG000|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
48751061|NCT02310568|156934396|FG001|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
48751062|NCT02310568|156934397|FG002|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
48751063|NCT02310568|156934398|FG003|Stage 2 (4 Weeks)|Lost to Follow-up|2|||
48751064|NCT02310568|156934399|FG004|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
48751065|NCT02966028|156934403|FG000|Overall Study|Adverse Event|7|||
48751066|NCT02966028|156934404|FG001|Overall Study|Adverse Event|13|||
48751067|NCT02966028|156934405|FG002|Overall Study|Adverse Event|10|||
48751068|NCT02966028|156934403|FG000|Overall Study|Physician Decision|1|||
48751069|NCT02966028|156934404|FG001|Overall Study|Physician Decision|0|||
48751070|NCT02966028|156934405|FG002|Overall Study|Physician Decision|2|||
48751071|NCT02966028|156934403|FG000|Overall Study|Withdrawal by Subject|7|||
48751072|NCT02966028|156934404|FG001|Overall Study|Withdrawal by Subject|5|||
48751073|NCT02966028|156934405|FG002|Overall Study|Withdrawal by Subject|5|||
48751074|NCT02966028|156934403|FG000|Overall Study|Kidney transplant Changed dialysis units|9|||
48751075|NCT02966028|156934404|FG001|Overall Study|Kidney transplant Changed dialysis units|16|||
48751076|NCT02966028|156934405|FG002|Overall Study|Kidney transplant Changed dialysis units|14|||
48751077|NCT02990910|156934406|FG000|Overall Study|Lack of Efficacy|6|||
48751078|NCT02990910|156934407|FG001|Overall Study|Lack of Efficacy|10|||
48751079|NCT02468414|156934417|FG000|Overall Study|Early Study Termination by Sponsor|1|||
48751080|NCT02468414|156934418|FG001|Overall Study|Early Study Termination by Sponsor|0|||
48751081|NCT02468414|156934417|FG000|Overall Study|Poor in-vitro secreting TARGTs|1|||
48751082|NCT02468414|156934418|FG001|Overall Study|Poor in-vitro secreting TARGTs|0|||
48751083|NCT02468414|156934417|FG000|Overall Study|Screen Failure|1|||
48751084|NCT02468414|156934418|FG001|Overall Study|Screen Failure|0|||
48751085|NCT03761277|156934419|FG000|Enrollment to Implant|Screen Failure|17|||
48751086|NCT03761277|156934419|FG000|Enrollment to Implant|Withdrawal by Subject|17|||
48751087|NCT03761277|156934419|FG000|Enrollment to Implant|Physician Decision|2|||
48751088|NCT03761277|156934419|FG000|Enrollment to Implant|Site Closure|3|||
48751089|NCT03761277|156934419|FG000|Enrollment to Implant|Sponsor Request|2|||
48751090|NCT03761277|156934419|FG000|Post-Implant to 6 Months|Adverse Event|2|||
48751091|NCT03761277|156934419|FG000|Post-Implant to 6 Months|Death|1|||
48751092|NCT03761277|156934419|FG000|Post-Implant to 6 Months|Site Closure|2|||
48751093|NCT03761277|156934419|FG000|6 Months to 12 Months|Completed Study under Protocol v3|25|||
48751094|NCT03761277|156934419|FG000|6 Months to 12 Months|Physician Decision|2|||
48751095|NCT03761277|156934419|FG000|6 Months to 12 Months|Withdrawal by Subject|1|||
48751096|NCT04160091|156934430|FG000|Overall Study|Terminated by Sponsor|7|||
48751097|NCT04160091|156934431|FG001|Overall Study|Terminated by Sponsor|3|||
48751098|NCT04160091|156934432|FG002|Overall Study|Terminated by Sponsor|5|||
48751099|NCT04160091|156934433|FG003|Overall Study|Terminated by Sponsor|2|||
48751100|NCT04160091|156934430|FG000|Overall Study|Noncompliance|0|||
48751101|NCT04160091|156934431|FG001|Overall Study|Noncompliance|0|||
48751102|NCT04160091|156934432|FG002|Overall Study|Noncompliance|0|||
48751103|NCT04160091|156934433|FG003|Overall Study|Noncompliance|1|||
48751104|NCT04160091|156934430|FG000|Overall Study|Withdrawal by Subject|0|||
48751105|NCT04160091|156934431|FG001|Overall Study|Withdrawal by Subject|0|||
48751106|NCT04160091|156934432|FG002|Overall Study|Withdrawal by Subject|0|||
48863004|NCT04242498|157333154|FG001|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
48863005|NCT04242498|157333155|FG002|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
48863006|NCT04242498|157333156|FG003|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
48863007|NCT04242498|157333157|FG004|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|1|||
48863008|NCT04242498|157333158|FG005|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
48863009|NCT04242498|157333159|FG006|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
48863010|NCT04242498|157333153|FG000|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
48863011|NCT04242498|157333154|FG001|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
48863012|NCT04242498|157333155|FG002|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
48863013|NCT04242498|157333156|FG003|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
48863014|NCT04242498|157333157|FG004|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
48863015|NCT04242498|157333158|FG005|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|1|||
48863016|NCT04242498|157333159|FG006|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
48863017|NCT04242498|157333153|FG000|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
48863018|NCT04242498|157333154|FG001|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
48863019|NCT04242498|157333155|FG002|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
48863020|NCT04242498|157333156|FG003|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
48863021|NCT04242498|157333157|FG004|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
48863022|NCT04242498|157333158|FG005|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
48863023|NCT04242498|157333159|FG006|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
48863024|NCT03849300|157333160|FG000|Overall Study|move out to different area|1|||
48863025|NCT03849300|157333161|FG001|Overall Study|move out to different area|3|||
48863026|NCT03849300|157333162|FG002|Overall Study|move out to different area|1|||
48863027|NCT03849300|157333163|FG003|Overall Study|move out to different area|4|||
48863028|NCT03849300|157333160|FG000|Overall Study|scheduling/transportation conflict|4|||
48863029|NCT03849300|157333161|FG001|Overall Study|scheduling/transportation conflict|4|||
48863030|NCT03849300|157333162|FG002|Overall Study|scheduling/transportation conflict|3|||
48863031|NCT03849300|157333163|FG003|Overall Study|scheduling/transportation conflict|2|||
48863032|NCT02962076|157333164|FG000|Overall Study|MHED tracer not available|5|||
48863033|NCT02962076|157333164|FG000|Overall Study|Protocol Violation|1|||
48863034|NCT02962076|157333164|FG000|Overall Study|Physician Decision|1|||
48863035|NCT01786551|157333171|FG000|Overall Study|Participant withdrew consent|2|||
48863036|NCT02316171|157333172|FG000|Overall Study|difficulties with urinary catheter|1|||
48863037|NCT02316171|157333173|FG001|Overall Study|difficulties with urinary catheter|0|||
48863038|NCT02316171|157333174|FG002|Overall Study|difficulties with urinary catheter|0|||
48863039|NCT02316171|157333175|FG003|Overall Study|difficulties with urinary catheter|0|||
48863040|NCT04853394|157333176|FG000|Follow-up Interviews|Lost to Follow-up|22|||
48863041|NCT04853394|157333177|FG001|Follow-up Interviews|Lost to Follow-up|15|||
48863042|NCT01804140|157333178|FG000|Overall Study|No sampling or biopsy procedures done|114|||
48863043|NCT01524887|157333179|FG000|Overall Study|Withdrawal by Subject|6|||
48863044|NCT01524887|157333180|FG001|Overall Study|Withdrawal by Subject|2|||
48863045|NCT01524887|157333181|FG002|Overall Study|Withdrawal by Subject|3|||
48863046|NCT01524887|157333179|FG000|Overall Study|Adverse Event|5|||
48863047|NCT01524887|157333180|FG001|Overall Study|Adverse Event|1|||
48863048|NCT01524887|157333181|FG002|Overall Study|Adverse Event|1|||
48863049|NCT01524887|157333179|FG000|Overall Study|Protocol Violation|0|||
48863050|NCT01524887|157333180|FG001|Overall Study|Protocol Violation|0|||
48863051|NCT01524887|157333181|FG002|Overall Study|Protocol Violation|1|||
48863052|NCT01524887|157333179|FG000|Overall Study|Study termination|73|||
48863053|NCT01524887|157333180|FG001|Overall Study|Study termination|87|||
48863054|NCT01524887|157333181|FG002|Overall Study|Study termination|79|||
48863055|NCT01524887|157333179|FG000|Overall Study|Withdrawal by Caregiver|0|||
48863056|NCT01524887|157333180|FG001|Overall Study|Withdrawal by Caregiver|0|||
48863057|NCT01524887|157333181|FG002|Overall Study|Withdrawal by Caregiver|2|||
48863058|NCT01524887|157333179|FG000|Overall Study|Use of prohibited medication|1|||
48863059|NCT01524887|157333180|FG001|Overall Study|Use of prohibited medication|0|||
48863060|NCT01524887|157333181|FG002|Overall Study|Use of prohibited medication|0|||
48863061|NCT00547300|157333184|FG000|Overall Study|Study was Administratively Terminated|25|||
48863062|NCT00547300|157333185|FG001|Overall Study|Study was Administratively Terminated|24|||
48863063|NCT00547300|157333184|FG000|Overall Study|Did not Meet Entry Criteria|0|||
48863064|NCT00547300|157333185|FG001|Overall Study|Did not Meet Entry Criteria|2|||
48863065|NCT00755716|157334902|FG000|Overall Study|Adverse Event|1|||
48863066|NCT00755716|157334903|FG001|Overall Study|Adverse Event|4|||
48863067|NCT00755716|157334904|FG002|Overall Study|Adverse Event|1|||
48863068|NCT00755716|157334902|FG000|Overall Study|Lack of Efficacy|2|||
48863069|NCT00755716|157334903|FG001|Overall Study|Lack of Efficacy|0|||
48863070|NCT00755716|157334904|FG002|Overall Study|Lack of Efficacy|0|||
48863071|NCT00755716|157334902|FG000|Overall Study|Lost to Follow-up|5|||
48863072|NCT00755716|157334903|FG001|Overall Study|Lost to Follow-up|3|||
48863073|NCT00755716|157334904|FG002|Overall Study|Lost to Follow-up|1|||
48863074|NCT00755716|157334902|FG000|Overall Study|work schedule issues|0|||
48863075|NCT00755716|157334903|FG001|Overall Study|work schedule issues|1|||
48863076|NCT00755716|157334904|FG002|Overall Study|work schedule issues|1|||
48863077|NCT03786783|157334907|FG000|Overall Study|Death|1|||
48863078|NCT03786783|157334907|FG000|Overall Study|Physician Decision|6|||
48863079|NCT03786783|157334907|FG000|Overall Study|Withdrawal by Subject|2|||
48863080|NCT03786783|157334907|FG000|Overall Study|Disease Progression|7|||
48863081|NCT03786783|157334907|FG000|Overall Study|Patient/Parent Refusal|4|||
48863082|NCT03332589|157334908|FG000|Overall Study|Lack of Efficacy|2|||
48863083|NCT03332589|157334909|FG001|Overall Study|Lack of Efficacy|0|||
48863084|NCT03332589|157334910|FG002|Overall Study|Lack of Efficacy|0|||
48863085|NCT03332589|157334908|FG000|Overall Study|Adverse Event|1|||
48863086|NCT03332589|157334909|FG001|Overall Study|Adverse Event|0|||
48863087|NCT03332589|157334910|FG002|Overall Study|Adverse Event|0|||
48863088|NCT03332589|157334908|FG000|Overall Study|Death|1|||
48863089|NCT03332589|157334909|FG001|Overall Study|Death|0|||
48863090|NCT03332589|157334910|FG002|Overall Study|Death|0|||
48863091|NCT00108355|157334911|FG000|Overall Study|Peritonitis at index paracentesis|1|||
48863092|NCT00108355|157334912|FG001|Overall Study|Peritonitis at index paracentesis|1|||
48751107|NCT04160091|156934433|FG003|Overall Study|Withdrawal by Subject|1|||
48863093|NCT00108355|157334911|FG000|Overall Study|Loculated ascites, limiting paracentesis|1|||
48863094|NCT00108355|157334912|FG001|Overall Study|Loculated ascites, limiting paracentesis|1|||
48863095|NCT02164578|157334913|FG000|Treatment Period|Withdrawal by Subject|3|||
48863096|NCT02164578|157334914|FG001|Treatment Period|Withdrawal by Subject|3|||
48863097|NCT02164578|157334913|FG000|Treatment Period|Adverse Event|13|||
48863098|NCT02164578|157334914|FG001|Treatment Period|Adverse Event|6|||
48863099|NCT02164578|157334913|FG000|Treatment Period|Early termination due to expiry of study medication|1|||
48863100|NCT02164578|157334914|FG001|Treatment Period|Early termination due to expiry of study medication|0|||
48751108|NCT01342796|156934434|FG000|Overall Study|Withdrawal by Subject|2|||
48751109|NCT01342796|156934435|FG001|Overall Study|Withdrawal by Subject|0|||
48751110|NCT01342796|156934434|FG000|Overall Study|Lost to Follow-up|0|||
48751111|NCT01342796|156934435|FG001|Overall Study|Lost to Follow-up|3|||
48751112|NCT01342796|156934434|FG000|Overall Study|Inappropriate enrollment|1|||
48751113|NCT01342796|156934435|FG001|Overall Study|Inappropriate enrollment|0|||
48751114|NCT02692716|156934441|FG000|Overall Study|Lost to Follow-up|2|||
48751115|NCT02692716|156934442|FG001|Overall Study|Lost to Follow-up|5|||
48751116|NCT02692716|156934441|FG000|Overall Study|Withdrawal by Subject|3|||
48751117|NCT02692716|156934442|FG001|Overall Study|Withdrawal by Subject|1|||
48751118|NCT02782780|156934447|FG000|Overall Study|dropped out after randomization.|7|||
48751119|NCT02782780|156934448|FG001|Overall Study|dropped out after randomization.|5|||
48751120|NCT02782780|156934447|FG000|Overall Study|Protocol Violation|0|||
48751121|NCT02782780|156934448|FG001|Overall Study|Protocol Violation|2|||
48751122|NCT01463878|156934452|FG000|Overall Study|no longer met criteria for tube feed|2|||
48751123|NCT01463878|156934453|FG001|Overall Study|no longer met criteria for tube feed|2|||
48751124|NCT00085631|156934454|FG000|Overall Study|Missing Data|4|||
48751125|NCT00085631|156934455|FG001|Overall Study|Missing Data|11|||
48751126|NCT00085631|156934456|FG002|Overall Study|Missing Data|7|||
48751127|NCT04118166|156934457|FG000|Overall Study|Adverse Event|1|||
48751128|NCT01987505|156934462|FG000|Overall Study|Other|9|||
48751129|NCT01987505|156934462|FG000|Overall Study|Withdrawal by Subject|2|||
48751130|NCT01987505|156934462|FG000|Overall Study|Other Reason|2|||
48751131|NCT01987505|156934462|FG000|Overall Study|Lost to Follow-up|15|||
48751132|NCT01987505|156934462|FG000|Overall Study|Investigator Decision|2|||
48751133|NCT01987505|156934462|FG000|Overall Study|Death|4|||
48751134|NCT00546637|156934463|FG000|Overall Study|Adverse Event|46|||
48751135|NCT00546637|156934464|FG001|Overall Study|Adverse Event|20|||
48751136|NCT00546637|156934463|FG000|Overall Study|Lack of Efficacy|5|||
48751137|NCT00546637|156934464|FG001|Overall Study|Lack of Efficacy|5|||
48751138|NCT00546637|156934463|FG000|Overall Study|Lost to Follow-up|2|||
48751139|NCT00546637|156934464|FG001|Overall Study|Lost to Follow-up|2|||
48751140|NCT00546637|156934463|FG000|Overall Study|Other|10|||
48751141|NCT00546637|156934464|FG001|Overall Study|Other|12|||
48751142|NCT00546637|156934463|FG000|Overall Study|Withdrawal by Subject|7|||
48751143|NCT00546637|156934464|FG001|Overall Study|Withdrawal by Subject|9|||
48751144|NCT00546637|156934463|FG000|Overall Study|Randomized, but not treated|3|||
48751145|NCT00546637|156934464|FG001|Overall Study|Randomized, but not treated|1|||
48751146|NCT04983264|156934466|FG000|Part B: Multiple Dose Period|Physician Decision|0|||
48751147|NCT04983264|156934467|FG001|Part B: Multiple Dose Period|Physician Decision|1|||
48751148|NCT04983264|156934468|FG002|Part B: Multiple Dose Period|Physician Decision|0|||
48751149|NCT04983264|156934466|FG000|Part C: Extended Treatment Period|Physician Decision|0|||
48751150|NCT04983264|156934467|FG001|Part C: Extended Treatment Period|Physician Decision|0|||
48751151|NCT04983264|156934468|FG002|Part C: Extended Treatment Period|Physician Decision|1|||
48751152|NCT01484197|156934471|FG000|Treatment Period 1|Adverse Event|1|||
48751153|NCT01484197|156934472|FG001|Treatment Period 1|Adverse Event|0|||
48751154|NCT01484197|156934473|FG002|Treatment Period 1|Adverse Event|0|||
48751155|NCT01484197|156934474|FG003|Treatment Period 1|Adverse Event|0|||
48751156|NCT01484197|156934471|FG000|Treatment Period 2|Subject withdrew consent|0|||
48751157|NCT01484197|156934472|FG001|Treatment Period 2|Subject withdrew consent|0|||
48751158|NCT01484197|156934473|FG002|Treatment Period 2|Subject withdrew consent|0|||
48751159|NCT01484197|156934474|FG003|Treatment Period 2|Subject withdrew consent|1|||
48751160|NCT00160251|156934475|FG000|Prior to Amendment 2|Adverse Event|2|||
48751161|NCT00160251|156934476|FG001|Prior to Amendment 2|Adverse Event|1|||
48751162|NCT00160251|156934477|FG002|Prior to Amendment 2|Adverse Event|3|||
48751163|NCT00160251|156934478|FG003|Prior to Amendment 2|Adverse Event|1|||
48751164|NCT00160251|156934479|FG004|Prior to Amendment 2|Adverse Event|1|||
48751165|NCT00160251|156934480|FG005|Prior to Amendment 2|Adverse Event|1|||
48751166|NCT00160251|156934481|FG006|Prior to Amendment 2|Adverse Event|1|||
48751167|NCT00160251|156934482|FG007|Prior to Amendment 2|Adverse Event|0|||
48751168|NCT00160251|156934475|FG000|Prior to Amendment 2|Lack of Efficacy|0|||
48863101|NCT02164578|157334913|FG000|Treatment Period|Protocol Violation|0|||
48863102|NCT02164578|157334914|FG001|Treatment Period|Protocol Violation|2|||
48863103|NCT02164578|157334913|FG000|Extension Period|Withdrawal by Subject|2|||
48863104|NCT02164578|157334914|FG001|Extension Period|Withdrawal by Subject|0|||
48863105|NCT02164578|157334913|FG000|Extension Period|Adverse Event|4|||
48863106|NCT02164578|157334914|FG001|Extension Period|Adverse Event|0|||
48863107|NCT02164578|157334913|FG000|Extension Period|Expiry of study medication|1|||
48863108|NCT02164578|157334914|FG001|Extension Period|Expiry of study medication|0|||
48863109|NCT02164578|157334913|FG000|Extension Period|Protocol Violation|0|||
48863110|NCT02164578|157334914|FG001|Extension Period|Protocol Violation|1|||
48863111|NCT02136797|157334915|FG000|Overall Study|Not Treated|8|||
48863112|NCT01863368|157334916|FG000|Phase I, Day 0 to Day 35|Adverse Event|2|||
48751169|NCT00160251|156934476|FG001|Prior to Amendment 2|Lack of Efficacy|4|||
48751170|NCT00160251|156934477|FG002|Prior to Amendment 2|Lack of Efficacy|37|||
48751171|NCT00160251|156934478|FG003|Prior to Amendment 2|Lack of Efficacy|35|||
48751172|NCT00160251|156934479|FG004|Prior to Amendment 2|Lack of Efficacy|24|||
48751173|NCT00160251|156934480|FG005|Prior to Amendment 2|Lack of Efficacy|55|||
48751174|NCT00160251|156934481|FG006|Prior to Amendment 2|Lack of Efficacy|0|||
48751175|NCT00160251|156934482|FG007|Prior to Amendment 2|Lack of Efficacy|0|||
48751176|NCT00160251|156934475|FG000|Prior to Amendment 2|Lost to Follow-up|0|||
48956508|NCT03161678|157669258|FG003|Washout (14 Days)|Withdrawal by Subject|0|||
48956509|NCT03161678|157669259|FG004|Washout (14 Days)|Withdrawal by Subject|2|||
48956510|NCT03161678|157669260|FG005|Washout (14 Days)|Withdrawal by Subject|1|||
48956511|NCT03161678|157669255|FG000|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
48956512|NCT03161678|157669256|FG001|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
48956513|NCT03161678|157669257|FG002|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
48956514|NCT03161678|157669258|FG003|Intervention 2 (8 Days)|Withdrawal by Subject|1|||
48956515|NCT03161678|157669259|FG004|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
48956516|NCT03161678|157669260|FG005|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
48956517|NCT03633227|157669263|FG000|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
48956518|NCT03633227|157669264|FG001|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
48956519|NCT03633227|157669263|FG000|Double Blind (DB), up to Week 48|Death|2|||
48956520|NCT03633227|157669264|FG001|Double Blind (DB), up to Week 48|Death|1|||
48751177|NCT00160251|156934476|FG001|Prior to Amendment 2|Lost to Follow-up|0|||
48751178|NCT00160251|156934477|FG002|Prior to Amendment 2|Lost to Follow-up|1|||
48956521|NCT03633227|157669263|FG000|Double Blind (DB), up to Week 48|Adverse Event|0|||
48751179|NCT00160251|156934478|FG003|Prior to Amendment 2|Lost to Follow-up|0|||
48751180|NCT00160251|156934479|FG004|Prior to Amendment 2|Lost to Follow-up|1|||
48751181|NCT00160251|156934480|FG005|Prior to Amendment 2|Lost to Follow-up|1|||
48751182|NCT00160251|156934481|FG006|Prior to Amendment 2|Lost to Follow-up|0|||
48751183|NCT00160251|156934482|FG007|Prior to Amendment 2|Lost to Follow-up|0|||
48751184|NCT00160251|156934475|FG000|Prior to Amendment 2|Withdrawal by Subject|3|||
48751185|NCT00160251|156934476|FG001|Prior to Amendment 2|Withdrawal by Subject|1|||
48751186|NCT00160251|156934477|FG002|Prior to Amendment 2|Withdrawal by Subject|3|||
48751187|NCT00160251|156934478|FG003|Prior to Amendment 2|Withdrawal by Subject|4|||
48751188|NCT00160251|156934479|FG004|Prior to Amendment 2|Withdrawal by Subject|2|||
48751189|NCT00160251|156934480|FG005|Prior to Amendment 2|Withdrawal by Subject|3|||
48751190|NCT00160251|156934481|FG006|Prior to Amendment 2|Withdrawal by Subject|3|||
48751191|NCT00160251|156934482|FG007|Prior to Amendment 2|Withdrawal by Subject|0|||
48751192|NCT00160251|156934475|FG000|Prior to Amendment 2|Noncompliance with protocol|1|||
48751193|NCT00160251|156934476|FG001|Prior to Amendment 2|Noncompliance with protocol|0|||
48751194|NCT00160251|156934477|FG002|Prior to Amendment 2|Noncompliance with protocol|0|||
48751195|NCT00160251|156934478|FG003|Prior to Amendment 2|Noncompliance with protocol|0|||
48751196|NCT00160251|156934479|FG004|Prior to Amendment 2|Noncompliance with protocol|0|||
48751197|NCT00160251|156934480|FG005|Prior to Amendment 2|Noncompliance with protocol|0|||
48751198|NCT00160251|156934481|FG006|Prior to Amendment 2|Noncompliance with protocol|0|||
48751199|NCT00160251|156934482|FG007|Prior to Amendment 2|Noncompliance with protocol|0|||
48863113|NCT01863368|157334917|FG001|Phase I, Day 0 to Day 35|Adverse Event|4|||
48863114|NCT01863368|157334916|FG000|Phase I, Day 0 to Day 35|Lost to Follow-up|1|||
48863115|NCT01863368|157334917|FG001|Phase I, Day 0 to Day 35|Lost to Follow-up|0|||
48863116|NCT01863368|157334916|FG000|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0|||
48863117|NCT01863368|157334917|FG001|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1|||
48863118|NCT01863368|157334916|FG000|Phase I, Day 0 to Day 35|Withdrawal by Subject|0|||
48863119|NCT01863368|157334917|FG001|Phase I, Day 0 to Day 35|Withdrawal by Subject|2|||
48863120|NCT01863368|157334916|FG000|Phase II, Day 35 to Day 90|Adverse Event|1|||
48863121|NCT01863368|157334917|FG001|Phase II, Day 35 to Day 90|Adverse Event|0|||
48863122|NCT01863368|157334916|FG000|Phase II, Day 35 to Day 90|Lost to Follow-up|1|||
48863123|NCT01863368|157334917|FG001|Phase II, Day 35 to Day 90|Lost to Follow-up|0|||
48863124|NCT00304278|157334918|FG000|Overall Study|lack of insurance coverage for chemoRT|1|||
48863125|NCT00304278|157334918|FG000|Overall Study|PT had medical condition preventing TX|1|||
48863126|NCT02854436|157334919|FG000|Overall Study|Adverse Event|1|||
48863127|NCT02854436|157334919|FG000|Overall Study|Death|208|||
48863128|NCT02854436|157334919|FG000|Overall Study|Lost to Follow-up|5|||
48863129|NCT02854436|157334919|FG000|Overall Study|Withdrawal by Subject|24|||
48863130|NCT02854436|157334919|FG000|Overall Study|Other|45|||
48863131|NCT02854436|157334919|FG000|Overall Study|Physician Decision|6|||
48863132|NCT01975701|157334920|FG000|Overall Study|Lost to Follow-up|1|||
48863133|NCT01975701|157334920|FG000|Overall Study|Death|23|||
48863134|NCT01975701|157334920|FG000|Overall Study|Physician Decision|1|||
48863135|NCT01655498|157334921|FG000|Overall Study|Unrelated health issue|2|||
48863136|NCT01655498|157334921|FG000|Overall Study|Protocol Violation|2|||
48863137|NCT01655498|157334921|FG000|Overall Study|Withdrawal by Subject|1|||
48863138|NCT03409276|157334922|FG000|Overall Study|Withdrawal by Subject|0|||
48863139|NCT03409276|157334923|FG001|Overall Study|Withdrawal by Subject|0|||
48863140|NCT03409276|157334924|FG002|Overall Study|Withdrawal by Subject|0|||
48863141|NCT03409276|157334925|FG003|Overall Study|Withdrawal by Subject|0|||
48863142|NCT03409276|157334926|FG004|Overall Study|Withdrawal by Subject|1|||
48863143|NCT03409276|157334922|FG000|Overall Study|Lost to Follow-up|0|||
48863144|NCT03409276|157334923|FG001|Overall Study|Lost to Follow-up|0|||
48863145|NCT03409276|157334924|FG002|Overall Study|Lost to Follow-up|0|||
48863146|NCT03409276|157334925|FG003|Overall Study|Lost to Follow-up|2|||
48863147|NCT03409276|157334926|FG004|Overall Study|Lost to Follow-up|2|||
48863148|NCT03605745|157334927|FG000|Overall Study|Study was terminated for business reasons|47|||
48863149|NCT01038128|157334928|FG000|Overall Study|Lack of Efficacy|1|||
48863150|NCT01038128|157334928|FG000|Overall Study|Lost to Follow-up|1|||
48863151|NCT01038128|157334928|FG000|Overall Study|Withdrawal by Subject|2|||
48863152|NCT03761849|157334929|FG000|Overall Study|transferred to OpenLabelExtension|35|||
48863153|NCT03761849|157334930|FG001|Overall Study|transferred to OpenLabelExtension|34|||
48863154|NCT03761849|157334931|FG002|Overall Study|transferred to OpenLabelExtension|36|||
48863155|NCT03761849|157334932|FG003|Overall Study|transferred to OpenLabelExtension|0|||
48863156|NCT03761849|157334933|FG004|Overall Study|transferred to OpenLabelExtension|0|||
48751200|NCT00160251|156934475|FG000|Prior to Amendment 2|Completed Treatment Phase|3|||
48751201|NCT00160251|156934476|FG001|Prior to Amendment 2|Completed Treatment Phase|0|||
48751202|NCT00160251|156934477|FG002|Prior to Amendment 2|Completed Treatment Phase|0|||
48751203|NCT00160251|156934478|FG003|Prior to Amendment 2|Completed Treatment Phase|0|||
48751204|NCT00160251|156934479|FG004|Prior to Amendment 2|Completed Treatment Phase|0|||
48751205|NCT00160251|156934480|FG005|Prior to Amendment 2|Completed Treatment Phase|23|||
48751206|NCT00160251|156934481|FG006|Prior to Amendment 2|Completed Treatment Phase|0|||
48751207|NCT00160251|156934482|FG007|Prior to Amendment 2|Completed Treatment Phase|0|||
48751208|NCT00160251|156934475|FG000|Post-amendment 2|Adverse Event|0|||
48751209|NCT00160251|156934476|FG001|Post-amendment 2|Adverse Event|0|||
48751210|NCT00160251|156934477|FG002|Post-amendment 2|Adverse Event|0|||
48751211|NCT00160251|156934478|FG003|Post-amendment 2|Adverse Event|0|||
48863157|NCT03761849|157334934|FG005|Overall Study|transferred to OpenLabelExtension|0|||
48863158|NCT03761849|157334929|FG000|Overall Study|Adverse Event|1|||
48863159|NCT03761849|157334930|FG001|Overall Study|Adverse Event|0|||
48863160|NCT03761849|157334931|FG002|Overall Study|Adverse Event|0|||
48863161|NCT03761849|157334932|FG003|Overall Study|Adverse Event|0|||
48863162|NCT03761849|157334933|FG004|Overall Study|Adverse Event|2|||
48863163|NCT03761849|157334934|FG005|Overall Study|Adverse Event|3|||
48863164|NCT03761849|157334929|FG000|Overall Study|Withdrawal by Subject|0|||
48863165|NCT03761849|157334930|FG001|Overall Study|Withdrawal by Subject|0|||
48863166|NCT03761849|157334931|FG002|Overall Study|Withdrawal by Subject|0|||
48863167|NCT03761849|157334932|FG003|Overall Study|Withdrawal by Subject|41|||
48863168|NCT03761849|157334933|FG004|Overall Study|Withdrawal by Subject|43|||
48863169|NCT03761849|157334934|FG005|Overall Study|Withdrawal by Subject|35|||
48863170|NCT03761849|157334929|FG000|Overall Study|Lost to Follow-up|0|||
48863171|NCT03761849|157334930|FG001|Overall Study|Lost to Follow-up|1|||
48863172|NCT03761849|157334931|FG002|Overall Study|Lost to Follow-up|0|||
48863173|NCT03761849|157334932|FG003|Overall Study|Lost to Follow-up|2|||
48863174|NCT03761849|157334933|FG004|Overall Study|Lost to Follow-up|4|||
48863175|NCT03761849|157334934|FG005|Overall Study|Lost to Follow-up|5|||
48863176|NCT03761849|157334929|FG000|Overall Study|Repeated MRI dId not pass QC.|0|||
48863177|NCT03761849|157334930|FG001|Overall Study|Repeated MRI dId not pass QC.|1|||
48863178|NCT03761849|157334931|FG002|Overall Study|Repeated MRI dId not pass QC.|0|||
48863179|NCT03761849|157334932|FG003|Overall Study|Repeated MRI dId not pass QC.|0|||
48751212|NCT00160251|156934479|FG004|Post-amendment 2|Adverse Event|0|||
48751213|NCT00160251|156934480|FG005|Post-amendment 2|Adverse Event|0|||
48956522|NCT03633227|157669264|FG001|Double Blind (DB), up to Week 48|Adverse Event|1|||
48956523|NCT03633227|157669263|FG000|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|2|||
48956524|NCT03633227|157669264|FG001|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|1|||
48751214|NCT00160251|156934481|FG006|Post-amendment 2|Adverse Event|0|||
48751215|NCT00160251|156934482|FG007|Post-amendment 2|Adverse Event|20|||
48751216|NCT00160251|156934475|FG000|Post-amendment 2|Lack of Efficacy|0|||
48751217|NCT00160251|156934476|FG001|Post-amendment 2|Lack of Efficacy|0|||
48751218|NCT00160251|156934477|FG002|Post-amendment 2|Lack of Efficacy|0|||
48751219|NCT00160251|156934478|FG003|Post-amendment 2|Lack of Efficacy|0|||
48751220|NCT00160251|156934479|FG004|Post-amendment 2|Lack of Efficacy|0|||
48751221|NCT00160251|156934480|FG005|Post-amendment 2|Lack of Efficacy|0|||
48751222|NCT00160251|156934481|FG006|Post-amendment 2|Lack of Efficacy|0|||
48751223|NCT00160251|156934482|FG007|Post-amendment 2|Lack of Efficacy|24|||
48751224|NCT00160251|156934475|FG000|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
48751225|NCT00160251|156934476|FG001|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
48751226|NCT00160251|156934477|FG002|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
48751227|NCT00160251|156934478|FG003|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
48751228|NCT00160251|156934479|FG004|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
48751229|NCT00160251|156934480|FG005|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
48751230|NCT00160251|156934481|FG006|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
48751231|NCT00160251|156934482|FG007|Post-amendment 2|Lost to follow-up/withdrawal by subject|11|||
48751232|NCT01025752|156934485|FG000|Overall Study|Lost to Follow-up|7|||
48751233|NCT01025752|156934486|FG001|Overall Study|Lost to Follow-up|10|||
48751234|NCT01025752|156934485|FG000|Overall Study|Physician Decision|1|||
48751235|NCT01025752|156934486|FG001|Overall Study|Physician Decision|3|||
48751236|NCT02407704|156934487|FG000|Overall Study|Lost to Follow-up|0|||
48751237|NCT02407704|156934488|FG001|Overall Study|Lost to Follow-up|0|||
48751238|NCT02407704|156934489|FG002|Overall Study|Lost to Follow-up|0|||
48751239|NCT02407704|156934490|FG003|Overall Study|Lost to Follow-up|2|||
48751240|NCT02407704|156934487|FG000|Overall Study|Protocol Violation|0|||
48863180|NCT03761849|157334933|FG004|Overall Study|Repeated MRI dId not pass QC.|0|||
48863181|NCT03761849|157334934|FG005|Overall Study|Repeated MRI dId not pass QC.|0|||
48863182|NCT03761849|157334929|FG000|Overall Study|Physician Decision|0|||
48863183|NCT03761849|157334930|FG001|Overall Study|Physician Decision|0|||
48863184|NCT03761849|157334931|FG002|Overall Study|Physician Decision|0|||
48863185|NCT03761849|157334932|FG003|Overall Study|Physician Decision|1|||
48863186|NCT03761849|157334933|FG004|Overall Study|Physician Decision|4|||
48863187|NCT03761849|157334934|FG005|Overall Study|Physician Decision|4|||
48863188|NCT03761849|157334929|FG000|Overall Study|Death|0|||
48863189|NCT03761849|157334930|FG001|Overall Study|Death|0|||
48751241|NCT02407704|156934488|FG001|Overall Study|Protocol Violation|0|||
48751242|NCT02407704|156934489|FG002|Overall Study|Protocol Violation|0|||
48751243|NCT02407704|156934490|FG003|Overall Study|Protocol Violation|1|||
48751244|NCT02407704|156934487|FG000|Overall Study|Withdrawal by Subject|0|||
48751245|NCT02407704|156934488|FG001|Overall Study|Withdrawal by Subject|0|||
48751246|NCT02407704|156934489|FG002|Overall Study|Withdrawal by Subject|1|||
48751247|NCT02407704|156934490|FG003|Overall Study|Withdrawal by Subject|0|||
48751248|NCT03310021|156934494|FG000|Overall Study|Withdrawal by Subject|0|||
48751249|NCT03310021|156934495|FG001|Overall Study|Withdrawal by Subject|0|||
48863190|NCT03761849|157334931|FG002|Overall Study|Death|0|||
48863191|NCT03761849|157334932|FG003|Overall Study|Death|1|||
48863192|NCT03761849|157334933|FG004|Overall Study|Death|1|||
48863193|NCT03761849|157334934|FG005|Overall Study|Death|3|||
48863194|NCT03761849|157334929|FG000|Overall Study|Protocol Violation|0|||
48751250|NCT03310021|156934496|FG002|Overall Study|Withdrawal by Subject|0|||
48863195|NCT03761849|157334930|FG001|Overall Study|Protocol Violation|0|||
48863196|NCT03761849|157334931|FG002|Overall Study|Protocol Violation|0|||
48863197|NCT03761849|157334932|FG003|Overall Study|Protocol Violation|2|||
48863198|NCT03761849|157334933|FG004|Overall Study|Protocol Violation|2|||
48863199|NCT03761849|157334934|FG005|Overall Study|Protocol Violation|1|||
49015402|NCT02666430|157892166|FG000|Period 3|Lost to Follow-up|1|||
48863200|NCT03761849|157334929|FG000|Overall Study|Participant could not come to site|0|||
48863201|NCT03761849|157334930|FG001|Overall Study|Participant could not come to site|0|||
48863202|NCT03761849|157334931|FG002|Overall Study|Participant could not come to site|0|||
48863203|NCT03761849|157334932|FG003|Overall Study|Participant could not come to site|0|||
48863204|NCT03761849|157334933|FG004|Overall Study|Participant could not come to site|1|||
48863205|NCT03761849|157334934|FG005|Overall Study|Participant could not come to site|0|||
48863206|NCT03761849|157334929|FG000|Overall Study|SF- safety Finding|0|||
48863207|NCT03761849|157334930|FG001|Overall Study|SF- safety Finding|0|||
48863208|NCT03761849|157334931|FG002|Overall Study|SF- safety Finding|0|||
48863209|NCT03761849|157334932|FG003|Overall Study|SF- safety Finding|0|||
48863210|NCT03761849|157334933|FG004|Overall Study|SF- safety Finding|0|||
48863211|NCT03761849|157334934|FG005|Overall Study|SF- safety Finding|1|||
48863212|NCT03761849|157334929|FG000|Overall Study|Patient did not attend visit|0|||
48863213|NCT03761849|157334930|FG001|Overall Study|Patient did not attend visit|0|||
48863214|NCT03761849|157334931|FG002|Overall Study|Patient did not attend visit|0|||
48863215|NCT03761849|157334932|FG003|Overall Study|Patient did not attend visit|0|||
48863216|NCT03761849|157334933|FG004|Overall Study|Patient did not attend visit|0|||
48863217|NCT03761849|157334934|FG005|Overall Study|Patient did not attend visit|1|||
48863218|NCT00988429|157334941|FG000|Overall Study|Adverse Event|9|||
48863219|NCT00988429|157334942|FG001|Overall Study|Adverse Event|21|||
48863220|NCT00988429|157334943|FG002|Overall Study|Adverse Event|45|||
48863221|NCT00988429|157334941|FG000|Overall Study|Lack of Efficacy|0|||
48863222|NCT00988429|157334942|FG001|Overall Study|Lack of Efficacy|0|||
48863223|NCT00988429|157334943|FG002|Overall Study|Lack of Efficacy|1|||
48863224|NCT00988429|157334941|FG000|Overall Study|Non-Compliance with Study Drug|5|||
48863225|NCT00988429|157334942|FG001|Overall Study|Non-Compliance with Study Drug|1|||
48956525|NCT03633227|157669263|FG000|Double Blind (DB), up to Week 48|Physician Decision|1|||
48956526|NCT03633227|157669264|FG001|Double Blind (DB), up to Week 48|Physician Decision|0|||
48956527|NCT03633227|157669263|FG000|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|1|||
48956528|NCT03633227|157669264|FG001|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|0|||
48956529|NCT03633227|157669263|FG000|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|1|||
48956530|NCT03633227|157669264|FG001|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|0|||
48956531|NCT03633227|157669263|FG000|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|0|||
48956532|NCT03633227|157669264|FG001|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|2|||
48956533|NCT03633227|157669263|FG000|DB Extension, Week 48 up to 3 Years|Death|0|||
48956534|NCT03633227|157669264|FG001|DB Extension, Week 48 up to 3 Years|Death|1|||
48863226|NCT00988429|157334943|FG002|Overall Study|Non-Compliance with Study Drug|3|||
48863227|NCT00988429|157334941|FG000|Overall Study|Physician Decision|1|||
48863228|NCT00988429|157334942|FG001|Overall Study|Physician Decision|0|||
48863229|NCT00988429|157334943|FG002|Overall Study|Physician Decision|3|||
48863230|NCT00988429|157334941|FG000|Overall Study|Pregnancy|2|||
48863231|NCT00988429|157334942|FG001|Overall Study|Pregnancy|1|||
48863232|NCT00988429|157334943|FG002|Overall Study|Pregnancy|0|||
48863233|NCT00988429|157334941|FG000|Overall Study|Protocol Violation|4|||
48956535|NCT03633227|157669263|FG000|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|3|||
48956536|NCT03633227|157669264|FG001|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|2|||
48956537|NCT03633227|157669263|FG000|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|1|||
48956538|NCT03633227|157669264|FG001|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|0|||
48956539|NCT03633227|157669263|FG000|DB Extension, Week 48 up to 3 Years|Physician Decision|0|||
48751251|NCT03310021|156934497|FG003|Overall Study|Withdrawal by Subject|0|||
48863234|NCT00988429|157334942|FG001|Overall Study|Protocol Violation|3|||
48863235|NCT00988429|157334943|FG002|Overall Study|Protocol Violation|3|||
48863236|NCT00988429|157334941|FG000|Overall Study|Withdrawal by Subject|7|||
48956540|NCT03633227|157669264|FG001|DB Extension, Week 48 up to 3 Years|Physician Decision|1|||
48956541|NCT01425190|157669265|FG000|Overall Study|Full dose not consumed.|1|||
48956542|NCT01425190|157669266|FG001|Overall Study|Full dose not consumed.|0|||
48956543|NCT01425190|157669267|FG002|Overall Study|Full dose not consumed.|0|||
48751252|NCT03310021|156934498|FG004|Overall Study|Withdrawal by Subject|0|||
48956544|NCT05460871|157669268|FG000|Overall Study|Withdrawal by Subject|1|||
48956545|NCT05460871|157669269|FG001|Overall Study|Withdrawal by Subject|2|||
48956546|NCT01035255|157669272|FG000|Overall Study|Death|724|||
48956547|NCT01035255|157669273|FG001|Overall Study|Death|844|||
48956548|NCT01035255|157669272|FG000|Overall Study|Lost to Follow-up|2|||
48956549|NCT01035255|157669273|FG001|Overall Study|Lost to Follow-up|5|||
48956550|NCT01035255|157669272|FG000|Overall Study|patient's request|15|||
48956551|NCT01035255|157669273|FG001|Overall Study|patient's request|13|||
48956552|NCT01100307|157669274|FG000|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
48956553|NCT01100307|157669275|FG001|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
48751253|NCT03310021|156934499|FG005|Overall Study|Withdrawal by Subject|0|||
48751254|NCT03310021|156934500|FG006|Overall Study|Withdrawal by Subject|1|||
48751255|NCT03310021|156934501|FG007|Overall Study|Withdrawal by Subject|0|||
48751256|NCT03310021|156934502|FG008|Overall Study|Withdrawal by Subject|0|||
48751257|NCT03310021|156934503|FG009|Overall Study|Withdrawal by Subject|0|||
48751258|NCT03310021|156934504|FG010|Overall Study|Withdrawal by Subject|0|||
48751259|NCT03310021|156934505|FG011|Overall Study|Withdrawal by Subject|0|||
48751260|NCT03310021|156934506|FG012|Overall Study|Withdrawal by Subject|0|||
48751261|NCT03310021|156934507|FG013|Overall Study|Withdrawal by Subject|0|||
48751262|NCT03310021|156934508|FG014|Overall Study|Withdrawal by Subject|0|||
48751263|NCT03310021|156934509|FG015|Overall Study|Withdrawal by Subject|0|||
48751264|NCT03310021|156934510|FG016|Overall Study|Withdrawal by Subject|0|||
48751265|NCT03310021|156934511|FG017|Overall Study|Withdrawal by Subject|0|||
48751266|NCT03310021|156934512|FG018|Overall Study|Withdrawal by Subject|0|||
48751267|NCT03310021|156934513|FG019|Overall Study|Withdrawal by Subject|0|||
48751268|NCT03310021|156934494|FG000|Overall Study|Lost to Follow-up|0|||
48751269|NCT03310021|156934495|FG001|Overall Study|Lost to Follow-up|0|||
48751270|NCT03310021|156934496|FG002|Overall Study|Lost to Follow-up|0|||
48751271|NCT03310021|156934497|FG003|Overall Study|Lost to Follow-up|0|||
48751272|NCT03310021|156934498|FG004|Overall Study|Lost to Follow-up|0|||
48751273|NCT03310021|156934499|FG005|Overall Study|Lost to Follow-up|0|||
48751274|NCT03310021|156934500|FG006|Overall Study|Lost to Follow-up|0|||
48751275|NCT03310021|156934501|FG007|Overall Study|Lost to Follow-up|0|||
48751276|NCT03310021|156934502|FG008|Overall Study|Lost to Follow-up|0|||
48751277|NCT03310021|156934503|FG009|Overall Study|Lost to Follow-up|0|||
48751278|NCT03310021|156934504|FG010|Overall Study|Lost to Follow-up|1|||
48751279|NCT03310021|156934505|FG011|Overall Study|Lost to Follow-up|0|||
48751280|NCT03310021|156934506|FG012|Overall Study|Lost to Follow-up|0|||
48751281|NCT03310021|156934507|FG013|Overall Study|Lost to Follow-up|0|||
48751282|NCT03310021|156934508|FG014|Overall Study|Lost to Follow-up|0|||
48751283|NCT03310021|156934509|FG015|Overall Study|Lost to Follow-up|0|||
48751284|NCT03310021|156934510|FG016|Overall Study|Lost to Follow-up|0|||
48751285|NCT03310021|156934511|FG017|Overall Study|Lost to Follow-up|0|||
48751286|NCT03310021|156934512|FG018|Overall Study|Lost to Follow-up|0|||
48751287|NCT03310021|156934513|FG019|Overall Study|Lost to Follow-up|0|||
48956554|NCT01100307|157669274|FG000|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0|||
48956555|NCT01100307|157669275|FG001|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1|||
48956556|NCT01100307|157669274|FG000|Double Masked Phase (Up to Week 24)|Adverse Event|5|||
49015403|NCT02666430|157892167|FG001|Period 3|Lost to Follow-up|0|||
48751288|NCT03198234|156934521|FG000|Overall Study|Relapse of primary disease|0|||
48863237|NCT00988429|157334942|FG001|Overall Study|Withdrawal by Subject|7|||
48863238|NCT00988429|157334943|FG002|Overall Study|Withdrawal by Subject|12|||
48863239|NCT00988429|157334941|FG000|Overall Study|Administrative Reasons|1|||
48863240|NCT00988429|157334942|FG001|Overall Study|Administrative Reasons|2|||
48863241|NCT00988429|157334943|FG002|Overall Study|Administrative Reasons|1|||
48863242|NCT00988429|157334941|FG000|Overall Study|other reasons|8|||
48863243|NCT00988429|157334942|FG001|Overall Study|other reasons|8|||
48863244|NCT00988429|157334943|FG002|Overall Study|other reasons|1|||
48863245|NCT04454125|157334944|FG000|Overall Study|Lost to Follow-up|0|||
48863246|NCT04454125|157334945|FG001|Overall Study|Lost to Follow-up|1|||
48863247|NCT00331799|157334951|FG000|Overall Study|Withdrawal by Subject|2|||
48863248|NCT00331799|157334951|FG000|Overall Study|Sedation|1|||
48863249|NCT00828139|157334952|FG000|Overall Study|Adverse Event|8|||
48863250|NCT00828139|157334953|FG001|Overall Study|Adverse Event|1|||
48863251|NCT00828139|157334954|FG002|Overall Study|Adverse Event|10|||
48863252|NCT00828139|157334955|FG003|Overall Study|Adverse Event|5|||
48863253|NCT00828139|157334952|FG000|Overall Study|Death|2|||
48863254|NCT00828139|157334953|FG001|Overall Study|Death|1|||
48863255|NCT00828139|157334954|FG002|Overall Study|Death|0|||
48863256|NCT00828139|157334955|FG003|Overall Study|Death|2|||
48863257|NCT00828139|157334952|FG000|Overall Study|Refusal unrelated to toxicity|3|||
48863258|NCT00828139|157334953|FG001|Overall Study|Refusal unrelated to toxicity|4|||
48863259|NCT00828139|157334954|FG002|Overall Study|Refusal unrelated to toxicity|5|||
48863260|NCT00828139|157334955|FG003|Overall Study|Refusal unrelated to toxicity|3|||
48863261|NCT00828139|157334952|FG000|Overall Study|Disease Progression|24|||
48863262|NCT00828139|157334953|FG001|Overall Study|Disease Progression|33|||
48863263|NCT00828139|157334954|FG002|Overall Study|Disease Progression|35|||
48863264|NCT00828139|157334955|FG003|Overall Study|Disease Progression|39|||
48863265|NCT00828139|157334952|FG000|Overall Study|Other|4|||
48863266|NCT00828139|157334953|FG001|Overall Study|Other|2|||
48863267|NCT00828139|157334954|FG002|Overall Study|Other|5|||
48863268|NCT00828139|157334955|FG003|Overall Study|Other|2|||
48863269|NCT01922102|157334956|FG000|Overall Study|Withdrawal by Subject|7|||
48863270|NCT01922102|157334957|FG001|Overall Study|Withdrawal by Subject|3|||
48863271|NCT01922102|157334958|FG002|Overall Study|Withdrawal by Subject|7|||
48863272|NCT01922102|157334956|FG000|Overall Study|Physician Decision|0|||
48863273|NCT01922102|157334957|FG001|Overall Study|Physician Decision|2|||
48863274|NCT01922102|157334958|FG002|Overall Study|Physician Decision|1|||
48863275|NCT01922102|157334956|FG000|Overall Study|Adverse Event|1|||
48863276|NCT01922102|157334957|FG001|Overall Study|Adverse Event|2|||
48863277|NCT01922102|157334958|FG002|Overall Study|Adverse Event|0|||
48863278|NCT01922102|157334956|FG000|Overall Study|Lost to Follow-up|1|||
48863279|NCT01922102|157334957|FG001|Overall Study|Lost to Follow-up|0|||
48863280|NCT01922102|157334958|FG002|Overall Study|Lost to Follow-up|0|||
48863281|NCT01922102|157334956|FG000|Overall Study|Administrative problems|0|||
48863282|NCT01922102|157334957|FG001|Overall Study|Administrative problems|2|||
48863283|NCT01922102|157334958|FG002|Overall Study|Administrative problems|0|||
48863284|NCT05203822|157334959|FG000|Overall Study|Adverse Event|1|||
48863285|NCT05203822|157334959|FG000|Overall Study|Withdrawal by Subject|1|||
48863286|NCT01129011|157334966|FG000|Overall Study|Adverse Event|20|||
48863287|NCT01129011|157334967|FG001|Overall Study|Adverse Event|30|||
48863288|NCT01129011|157334966|FG000|Overall Study|Withdrawal by Subject|24|||
48863289|NCT01129011|157334967|FG001|Overall Study|Withdrawal by Subject|8|||
48863290|NCT01129011|157334966|FG000|Overall Study|Lost to Follow-up|6|||
48863291|NCT01129011|157334967|FG001|Overall Study|Lost to Follow-up|7|||
48863292|NCT01129011|157334966|FG000|Overall Study|Duodenal Ulcer|2|||
48863293|NCT01129011|157334967|FG001|Overall Study|Duodenal Ulcer|8|||
48863294|NCT01129011|157334966|FG000|Overall Study|misc|7|||
49015404|NCT01835145|157892169|FG000|Overall Study|Ineligible prior to treatment|1|||
48863295|NCT01129011|157334967|FG001|Overall Study|misc|4|||
48751289|NCT03198234|156934522|FG001|Overall Study|Relapse of primary disease|1|||
48751290|NCT03198234|156934523|FG002|Overall Study|Relapse of primary disease|0|||
48751291|NCT01648205|156934528|FG000|Placebo|Pregnancy|1|||
48751292|NCT01648205|156934528|FG000|Placebo|Withdrawal by Subject|1|||
48751293|NCT01648205|156934528|FG000|Placebo|Protocol Violation|2|||
48751294|NCT01648205|156934528|FG000|Ranolazine|Death|1|||
48751295|NCT01648205|156934528|FG000|Ranolazine|Withdrawal by Subject|1|||
48751296|NCT01648205|156934528|FG000|Ranolazine|Protocol Violation|3|||
48751297|NCT02622321|156934529|FG000|Overall Study|Withdrawal by Subject|2|||
48956557|NCT01100307|157669275|FG001|Double Masked Phase (Up to Week 24)|Adverse Event|2|||
48956558|NCT01100307|157669274|FG000|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1|||
48956559|NCT01100307|157669275|FG001|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2|||
48956560|NCT01100307|157669274|FG000|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2|||
48956561|NCT01100307|157669275|FG001|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3|||
48956562|NCT01100307|157669274|FG000|Open Phase (Week 24 up to Week 54)|Adverse Event|3|||
48956563|NCT01100307|157669275|FG001|Open Phase (Week 24 up to Week 54)|Adverse Event|8|||
48956564|NCT00740779|157669276|FG000|Overall Study|Adverse Event|4|||
48956565|NCT00740779|157669277|FG001|Overall Study|Adverse Event|6|||
48956566|NCT00740779|157669278|FG002|Overall Study|Adverse Event|3|||
48956567|NCT00740779|157669276|FG000|Overall Study|Protocol Violation|1|||
48956568|NCT00740779|157669277|FG001|Overall Study|Protocol Violation|1|||
48956569|NCT00740779|157669278|FG002|Overall Study|Protocol Violation|1|||
48956570|NCT00740779|157669276|FG000|Overall Study|Lack of Efficacy|0|||
48956571|NCT00740779|157669277|FG001|Overall Study|Lack of Efficacy|0|||
48956572|NCT00740779|157669278|FG002|Overall Study|Lack of Efficacy|2|||
48956573|NCT00740779|157669276|FG000|Overall Study|Withdrawal by Subject|2|||
48956574|NCT00740779|157669277|FG001|Overall Study|Withdrawal by Subject|4|||
48956575|NCT00740779|157669278|FG002|Overall Study|Withdrawal by Subject|2|||
48956576|NCT00740779|157669276|FG000|Overall Study|Lost to Follow-up|2|||
48956577|NCT00740779|157669277|FG001|Overall Study|Lost to Follow-up|3|||
48956578|NCT00740779|157669278|FG002|Overall Study|Lost to Follow-up|5|||
48956579|NCT01477892|157669279|FG000|Overall Study|Withdrawal by Subject|0|||
48956580|NCT01477892|157669280|FG001|Overall Study|Withdrawal by Subject|2|||
48751298|NCT02622321|156934530|FG001|Overall Study|Withdrawal by Subject|0|||
48751299|NCT02622321|156934531|FG002|Overall Study|Withdrawal by Subject|0|||
48956581|NCT03375112|157669288|FG000|Overall Study|Withdrawal by Subject|3|||
48956582|NCT03375112|157669289|FG001|Overall Study|Withdrawal by Subject|0|||
48956583|NCT02566525|157669290|FG000|Overall Study|Protocol Violation|3|||
48956584|NCT02566525|157669291|FG001|Overall Study|Protocol Violation|5|||
48863296|NCT04883541|157334968|FG000|Overall Study|Not attending regular yoga class|16|||
48863297|NCT04883541|157334969|FG001|Overall Study|Not attending regular yoga class|0|||
48863298|NCT04883541|157334968|FG000|Overall Study|Not attending the pregnancy school|0|||
48863299|NCT04883541|157334969|FG001|Overall Study|Not attending the pregnancy school|9|||
48863300|NCT02030847|157334972|FG000|Overall Study|Death|10|||
48863301|NCT02030847|157334972|FG000|Overall Study|Disease Progression|15|||
48751300|NCT02622321|156934532|FG003|Overall Study|Withdrawal by Subject|0|||
48863302|NCT02030847|157334972|FG000|Overall Study|New Cancer Therapy|8|||
48863303|NCT02030847|157334972|FG000|Overall Study|Physician Decision|3|||
48863304|NCT02030847|157334972|FG000|Overall Study|Withdrawal by Subject|1|||
48863305|NCT01358175|157334973|FG000|Overall Study|Death|1|||
48751301|NCT02622321|156934529|FG000|Overall Study|Death|0|||
48751302|NCT02622321|156934530|FG001|Overall Study|Death|0|||
48751303|NCT02622321|156934531|FG002|Overall Study|Death|1|||
48751304|NCT02622321|156934532|FG003|Overall Study|Death|0|||
48751305|NCT02622321|156934529|FG000|Overall Study|Physician Decision|1|||
48751306|NCT02622321|156934530|FG001|Overall Study|Physician Decision|0|||
48751307|NCT02622321|156934531|FG002|Overall Study|Physician Decision|0|||
48751308|NCT02622321|156934532|FG003|Overall Study|Physician Decision|0|||
48751309|NCT00241280|156934533|FG000|Overall Study|Adverse Event|2|||
48751310|NCT00241280|156934534|FG001|Overall Study|Adverse Event|6|||
48751311|NCT00241280|156934533|FG000|Overall Study|Discomfort|11|||
48751312|NCT00241280|156934534|FG001|Overall Study|Discomfort|16|||
48751313|NCT00241280|156934533|FG000|Overall Study|Pregnancy|1|||
48751314|NCT00241280|156934534|FG001|Overall Study|Pregnancy|5|||
48751315|NCT00241280|156934533|FG000|Overall Study|Lost to Follow-up|5|||
48863306|NCT01358175|157334974|FG001|Overall Study|Death|0|||
48863307|NCT01358175|157334975|FG002|Overall Study|Death|1|||
48863308|NCT01358175|157334973|FG000|Overall Study|Withdrawal by Subject|9|||
48863309|NCT01358175|157334974|FG001|Overall Study|Withdrawal by Subject|5|||
48863310|NCT01358175|157334975|FG002|Overall Study|Withdrawal by Subject|10|||
48863311|NCT01358175|157334973|FG000|Overall Study|Technical issues|0|||
48863312|NCT01358175|157334974|FG001|Overall Study|Technical issues|1|||
48863313|NCT01358175|157334975|FG002|Overall Study|Technical issues|0|||
48863314|NCT01358175|157334973|FG000|Overall Study|Pregnancy|0|||
48863315|NCT01358175|157334974|FG001|Overall Study|Pregnancy|1|||
48863316|NCT01358175|157334975|FG002|Overall Study|Pregnancy|0|||
48863317|NCT01358175|157334973|FG000|Overall Study|Physician Decision|1|||
48863318|NCT01358175|157334974|FG001|Overall Study|Physician Decision|0|||
48863319|NCT01358175|157334975|FG002|Overall Study|Physician Decision|0|||
48863320|NCT01358175|157334973|FG000|Overall Study|Non Compliance with Study Treatment|0|||
48863321|NCT01358175|157334974|FG001|Overall Study|Non Compliance with Study Treatment|1|||
48863322|NCT01358175|157334975|FG002|Overall Study|Non Compliance with Study Treatment|1|||
48863323|NCT01358175|157334973|FG000|Overall Study|Lost to Follow-up|1|||
48863324|NCT01358175|157334974|FG001|Overall Study|Lost to Follow-up|1|||
48863325|NCT01358175|157334975|FG002|Overall Study|Lost to Follow-up|3|||
48863326|NCT01358175|157334973|FG000|Overall Study|Lack of Efficacy|3|||
48863327|NCT01358175|157334974|FG001|Overall Study|Lack of Efficacy|8|||
48863328|NCT01358175|157334975|FG002|Overall Study|Lack of Efficacy|6|||
48863329|NCT01358175|157334973|FG000|Overall Study|Adverse Event|6|||
48863330|NCT01358175|157334974|FG001|Overall Study|Adverse Event|11|||
48863331|NCT01358175|157334975|FG002|Overall Study|Adverse Event|11|||
48863332|NCT02446912|157334998|FG000|Overall Study|Adverse Event|3|||
48863333|NCT02446912|157334999|FG001|Overall Study|Adverse Event|13|||
48863334|NCT02446912|157335000|FG002|Overall Study|Adverse Event|5|||
48863335|NCT02446912|157334998|FG000|Overall Study|Condition under investigation worsened|0|||
48863336|NCT02446912|157334999|FG001|Overall Study|Condition under investigation worsened|1|||
48863337|NCT02446912|157335000|FG002|Overall Study|Condition under investigation worsened|1|||
48863338|NCT02446912|157334998|FG000|Overall Study|Study-specific withdrawal criteria|1|||
48863339|NCT02446912|157334999|FG001|Overall Study|Study-specific withdrawal criteria|0|||
48863340|NCT02446912|157335000|FG002|Overall Study|Study-specific withdrawal criteria|0|||
48751316|NCT00241280|156934534|FG001|Overall Study|Lost to Follow-up|8|||
48863341|NCT02446912|157334998|FG000|Overall Study|Lack of Efficacy|1|||
48863342|NCT02446912|157334999|FG001|Overall Study|Lack of Efficacy|4|||
48863343|NCT02446912|157335000|FG002|Overall Study|Lack of Efficacy|7|||
48863344|NCT02446912|157334998|FG000|Overall Study|Lost to Follow-up|0|||
48863345|NCT02446912|157334999|FG001|Overall Study|Lost to Follow-up|0|||
48751317|NCT00241280|156934533|FG000|Overall Study|Withdrawal by Subject|7|||
48863346|NCT02446912|157335000|FG002|Overall Study|Lost to Follow-up|2|||
48863347|NCT02446912|157334998|FG000|Overall Study|Severe non-compliance to protocol|1|||
48863348|NCT02446912|157334999|FG001|Overall Study|Severe non-compliance to protocol|0|||
48863349|NCT02446912|157335000|FG002|Overall Study|Severe non-compliance to protocol|1|||
48863350|NCT02446912|157334998|FG000|Overall Study|Withdrawal by Subject|10|||
48863351|NCT02446912|157334999|FG001|Overall Study|Withdrawal by Subject|15|||
48863352|NCT02446912|157335000|FG002|Overall Study|Withdrawal by Subject|15|||
48863353|NCT02446912|157334998|FG000|Overall Study|Miscellaneous|2|||
48863354|NCT02446912|157334999|FG001|Overall Study|Miscellaneous|2|||
48863355|NCT02446912|157335000|FG002|Overall Study|Miscellaneous|4|||
48863356|NCT01901302|157335001|FG000|Overall Study|Adverse Event|2|||
48863357|NCT01901302|157335002|FG001|Overall Study|Adverse Event|1|||
48863358|NCT01901302|157335001|FG000|Overall Study|Lack of Efficacy|0|||
48751318|NCT00241280|156934534|FG001|Overall Study|Withdrawal by Subject|4|||
48751319|NCT00241280|156934533|FG000|Overall Study|Protocol Violation|4|||
48751320|NCT00241280|156934534|FG001|Overall Study|Protocol Violation|10|||
48751321|NCT00241280|156934533|FG000|Overall Study|Relocation|4|||
48751322|NCT00241280|156934534|FG001|Overall Study|Relocation|4|||
48751323|NCT00241280|156934533|FG000|Overall Study|Unsatisfactory Physiological Response|1|||
48863359|NCT01901302|157335002|FG001|Overall Study|Lack of Efficacy|2|||
48863360|NCT01901302|157335001|FG000|Overall Study|Study Terminated by Sponsor|23|||
48863361|NCT01901302|157335002|FG001|Overall Study|Study Terminated by Sponsor|20|||
48863362|NCT01901302|157335001|FG000|Overall Study|Withdrawal by Subject|2|||
48863363|NCT01901302|157335002|FG001|Overall Study|Withdrawal by Subject|0|||
48863364|NCT00449033|157335006|FG000|Treatment Period|Adverse Event|117|||
48863365|NCT00449033|157335007|FG001|Treatment Period|Adverse Event|83|||
48863366|NCT00449033|157335006|FG000|Treatment Period|Death|21|||
48863367|NCT00449033|157335007|FG001|Treatment Period|Death|12|||
48863368|NCT00449033|157335006|FG000|Treatment Period|Lost to Follow-up|0|||
48863369|NCT00449033|157335007|FG001|Treatment Period|Lost to Follow-up|2|||
48863370|NCT00449033|157335006|FG000|Treatment Period|Physician Decision|4|||
48863371|NCT00449033|157335007|FG001|Treatment Period|Physician Decision|5|||
48863372|NCT00449033|157335006|FG000|Treatment Period|Protocol Violation|8|||
48863373|NCT00449033|157335007|FG001|Treatment Period|Protocol Violation|7|||
48863374|NCT00449033|157335006|FG000|Treatment Period|Disease Progression|231|||
48863375|NCT00449033|157335007|FG001|Treatment Period|Disease Progression|288|||
48863376|NCT00449033|157335006|FG000|Treatment Period|Consent Withdrawn|36|||
48863377|NCT00449033|157335007|FG001|Treatment Period|Consent Withdrawn|20|||
48863378|NCT00449033|157335006|FG000|Treatment Period|Amended Protocol Criteria|22|||
48863379|NCT00449033|157335007|FG001|Treatment Period|Amended Protocol Criteria|18|||
48863380|NCT00449033|157335006|FG000|Treatment Period|Non-compliance|7|||
48863381|NCT00449033|157335007|FG001|Treatment Period|Non-compliance|8|||
48863382|NCT00449033|157335006|FG000|Treatment Period|Second Malignancy|0|||
48863383|NCT00449033|157335007|FG001|Treatment Period|Second Malignancy|1|||
48863384|NCT00449033|157335006|FG000|Treatment Period|Reason Missing|0|||
48863385|NCT00449033|157335007|FG001|Treatment Period|Reason Missing|4|||
48863386|NCT00449033|157335006|FG000|Treatment Period|Treatment Ongoing|6|||
48863387|NCT00449033|157335007|FG001|Treatment Period|Treatment Ongoing|4|||
48863388|NCT00449033|157335006|FG000|Follow-up Period|Death|299|||
48863389|NCT00449033|157335007|FG001|Follow-up Period|Death|311|||
48863390|NCT00449033|157335006|FG000|Follow-up Period|Lost to Follow-up|6|||
48863391|NCT00449033|157335007|FG001|Follow-up Period|Lost to Follow-up|10|||
48956585|NCT05836818|157669296|FG000|Overall Study|Physician Decision|1|||
48956586|NCT05836818|157669297|FG001|Overall Study|Physician Decision|1|||
48751324|NCT00241280|156934534|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
48751325|NCT00241280|156934533|FG000|Overall Study|Unsatisfactory Visual Response|1|||
48751326|NCT00241280|156934534|FG001|Overall Study|Unsatisfactory Visual Response|1|||
48751327|NCT00241280|156934533|FG000|Overall Study|Diabetic|1|||
48751328|NCT00241280|156934534|FG001|Overall Study|Diabetic|0|||
48863392|NCT00449033|157335006|FG000|Follow-up Period|Reason Missing|120|||
48863393|NCT00449033|157335007|FG001|Follow-up Period|Reason Missing|113|||
48863394|NCT04393779|157335008|FG000|Overall Study|Death|1|||
48863395|NCT04393779|157335008|FG000|Overall Study|Device reintervention or explant|4|||
48863396|NCT01648699|157335012|FG000|Overall Study|Death|1|||
48863397|NCT01648699|157335012|FG000|Overall Study|Lost to Follow-up|2|||
48863398|NCT01648699|157335012|FG000|Overall Study|Unspecified/unable to complete 4 visits|2|||
48863399|NCT02116582|157335014|FG000|Overall Study|Enrolled but Never Received Study Drug|1|||
48863400|NCT02116582|157335014|FG000|Overall Study|Adverse Event|22|||
48751329|NCT00241280|156934533|FG000|Overall Study|Subject Ineligible/Dispensed|9|||
48863401|NCT02116582|157335014|FG000|Overall Study|Death|9|||
48863402|NCT02116582|157335014|FG000|Overall Study|Progressive Disease|148|||
48863403|NCT02116582|157335014|FG000|Overall Study|Protocol Violation|3|||
48863404|NCT02116582|157335014|FG000|Overall Study|Withdrawal by Subject|8|||
48863405|NCT02116582|157335014|FG000|Overall Study|Other: Miscellaneous|11|||
48863406|NCT02116582|157335014|FG000|Overall Study|Lost to Follow-up|1|||
48863407|NCT02116582|157335014|FG000|Overall Study|Other: Transitioned to 9785-CL-0123|12|||
48863408|NCT01770509|157335021|FG000|Overall Study|Injury|0|||
48863409|NCT01770509|157335022|FG001|Overall Study|Injury|1|||
48863410|NCT01770509|157335021|FG000|Overall Study|Lost to Follow-up|1|||
48863411|NCT01770509|157335022|FG001|Overall Study|Lost to Follow-up|2|||
48863412|NCT00832650|157335026|FG000|Overall Study|Randomized but not treated|0|||
48863413|NCT00832650|157335027|FG001|Overall Study|Randomized but not treated|0|||
48863414|NCT00832650|157335028|FG002|Overall Study|Randomized but not treated|1|||
48863415|NCT03030599|157335033|FG000|Open Label Treatment and Titration|Protocol deviation|8|||
48863416|NCT03030599|157335034|FG001|Open Label Treatment and Titration|Protocol deviation|0|||
48956587|NCT05836818|157669298|FG002|Overall Study|Physician Decision|0|||
48956588|NCT05836818|157669296|FG000|Overall Study|Withdrawal by Subject|0|||
48956589|NCT05836818|157669297|FG001|Overall Study|Withdrawal by Subject|0|||
48956590|NCT05836818|157669298|FG002|Overall Study|Withdrawal by Subject|1|||
48956591|NCT05836818|157669296|FG000|Overall Study|Later found to be previously vaccinated|0|||
48956592|NCT05836818|157669297|FG001|Overall Study|Later found to be previously vaccinated|1|||
48751330|NCT00241280|156934534|FG001|Overall Study|Subject Ineligible/Dispensed|6|||
48751331|NCT00241280|156934533|FG000|Overall Study|Dispensed incorrect test article|1|||
48751332|NCT00241280|156934534|FG001|Overall Study|Dispensed incorrect test article|2|||
48751333|NCT00241280|156934533|FG000|Overall Study|Unacceptable Fit|0|||
48751334|NCT00241280|156934534|FG001|Overall Study|Unacceptable Fit|1|||
48751335|NCT00241280|156934533|FG000|Overall Study|Scheduling Conflict|0|||
48956593|NCT05836818|157669298|FG002|Overall Study|Later found to be previously vaccinated|3|||
48956594|NCT05836818|157669296|FG000|Overall Study|Pregnancy|0|||
48956595|NCT05836818|157669297|FG001|Overall Study|Pregnancy|1|||
48751336|NCT00241280|156934534|FG001|Overall Study|Scheduling Conflict|2|||
48751337|NCT00241280|156934533|FG000|Overall Study|History of Ocular Surgery|0|||
48751338|NCT00241280|156934534|FG001|Overall Study|History of Ocular Surgery|1|||
48751339|NCT00241280|156934533|FG000|Overall Study|Coating on Lens|1|||
48751340|NCT00241280|156934534|FG001|Overall Study|Coating on Lens|0|||
48751341|NCT00241280|156934533|FG000|Overall Study|Excessive Dryness|0|||
48751342|NCT00241280|156934534|FG001|Overall Study|Excessive Dryness|1|||
48751343|NCT00965718|156934535|FG000|Overall Study|Withdrawal by Subject|4|||
48751344|NCT01958008|156934536|FG000|Overall Study|Worsening of disease under study|0|||
48751345|NCT01958008|156934537|FG001|Overall Study|Worsening of disease under study|0|||
48751346|NCT01958008|156934538|FG002|Overall Study|Worsening of disease under study|1|||
48751347|NCT01958008|156934539|FG003|Overall Study|Worsening of disease under study|0|||
48863417|NCT03030599|157335035|FG002|Open Label Treatment and Titration|Protocol deviation|0|||
48863418|NCT03030599|157335033|FG000|Open Label Treatment and Titration|Other|1|||
48863419|NCT03030599|157335034|FG001|Open Label Treatment and Titration|Other|0|||
48863420|NCT03030599|157335035|FG002|Open Label Treatment and Titration|Other|0|||
48751348|NCT01958008|156934536|FG000|Overall Study|Other adverse event|1|||
48751349|NCT01958008|156934537|FG001|Overall Study|Other adverse event|0|||
48751350|NCT01958008|156934538|FG002|Overall Study|Other adverse event|0|||
48751351|NCT01958008|156934539|FG003|Overall Study|Other adverse event|0|||
48751352|NCT01634360|156934541|FG000|Overall Study|Adverse Event|10|||
48751353|NCT01634360|156934542|FG001|Overall Study|Adverse Event|34|||
48751354|NCT01634360|156934541|FG000|Overall Study|subject withdrew consent|13|||
48751355|NCT01634360|156934542|FG001|Overall Study|subject withdrew consent|23|||
48751356|NCT01634360|156934541|FG000|Overall Study|Protocol Violation|1|||
48751357|NCT01634360|156934542|FG001|Overall Study|Protocol Violation|1|||
48751358|NCT01634360|156934541|FG000|Overall Study|Lack of Efficacy|4|||
48751359|NCT01634360|156934542|FG001|Overall Study|Lack of Efficacy|14|||
48751360|NCT01634360|156934541|FG000|Overall Study|Other|3|||
48751361|NCT01634360|156934542|FG001|Overall Study|Other|20|||
48751362|NCT01634360|156934541|FG000|Overall Study|Study termination by sponsor|18|||
48751363|NCT01634360|156934542|FG001|Overall Study|Study termination by sponsor|44|||
48751364|NCT04851314|156934543|FG000|Overall Study|Unable to complete research set-up procedures|0|||
48751365|NCT04851314|156934544|FG001|Overall Study|Unable to complete research set-up procedures|2|||
48751366|NCT04851314|156934543|FG000|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3|||
48751367|NCT04851314|156934544|FG001|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2|||
48751368|NCT00646776|156934545|FG000|Overall Study|Adverse Event|1|||
48751369|NCT00646776|156934546|FG001|Overall Study|Adverse Event|9|||
48751370|NCT00646776|156934545|FG000|Overall Study|Investigator discretion|0|||
48751371|NCT00646776|156934546|FG001|Overall Study|Investigator discretion|4|||
48863421|NCT03030599|157335033|FG000|Open Label Treatment and Titration|Physician Decision|3|||
48863422|NCT03030599|157335034|FG001|Open Label Treatment and Titration|Physician Decision|0|||
48863423|NCT03030599|157335035|FG002|Open Label Treatment and Titration|Physician Decision|0|||
48863424|NCT03030599|157335033|FG000|Open Label Treatment and Titration|Lack of Efficacy|1|||
48863425|NCT03030599|157335034|FG001|Open Label Treatment and Titration|Lack of Efficacy|0|||
48751372|NCT00576927|156934550|FG000|Clinical Assessment|Lack of Efficacy|24|||
48751373|NCT00576927|156934550|FG000|Clinical Assessment|Death|1|||
48751374|NCT00576927|156934550|FG000|Clinical Assessment|Withdrawal by Subject|10|||
48751375|NCT00576927|156934550|FG000|Clinical Assessment|Physician Decision|1|||
48751376|NCT00576927|156934550|FG000|Baseline|Physician Decision|9|||
48863426|NCT03030599|157335035|FG002|Open Label Treatment and Titration|Lack of Efficacy|0|||
48751377|NCT00576927|156934550|FG000|Baseline|Medication Change by PCP of subject|1|||
48751378|NCT00576927|156934550|FG000|Baseline|Withdrawal by Subject|3|||
48751379|NCT00576927|156934550|FG000|Sleep Hygiene Behavioral Intervention|Responded to intervention|4|||
48751380|NCT00576927|156934550|FG000|Sleep Hygiene Behavioral Intervention|Death|1|||
48751381|NCT00576927|156934550|FG000|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1|||
48751382|NCT00576927|156934550|FG000|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1|||
48751383|NCT00576927|156934550|FG000|Sleep Hygiene With the Placebo|Withdrawal by Subject|1|||
48751384|NCT01753856|156934551|FG000|Overall Study|Adverse Event|1|||
48751385|NCT01753856|156934552|FG001|Overall Study|Adverse Event|0|||
48751386|NCT01753856|156934551|FG000|Overall Study|Withdrawal by Subject|0|||
48751387|NCT01753856|156934552|FG001|Overall Study|Withdrawal by Subject|2|||
48751388|NCT01753856|156934551|FG000|Overall Study|Sponsor Decision|2|||
48751389|NCT01753856|156934552|FG001|Overall Study|Sponsor Decision|0|||
48751390|NCT03171415|156934553|FG000|Overall Study|Lost to Follow-up|0|||
48751391|NCT03171415|156934554|FG001|Overall Study|Lost to Follow-up|0|||
48751392|NCT03171415|156934555|FG002|Overall Study|Lost to Follow-up|0|||
48751393|NCT03171415|156934556|FG003|Overall Study|Lost to Follow-up|0|||
48751394|NCT03171415|156934557|FG004|Overall Study|Lost to Follow-up|2|||
48751395|NCT03694821|156934558|FG000|Overall Study|Study terminated|4|||
48751396|NCT03694821|156934559|FG001|Overall Study|Study terminated|8|||
48751397|NCT03694821|156934560|FG002|Overall Study|Study terminated|4|||
48751398|NCT00897104|156934565|FG000|Overall Study|Lost to Follow-up|12|||
48751399|NCT00897104|156934566|FG001|Overall Study|Lost to Follow-up|17|||
48751400|NCT00897104|156934567|FG002|Overall Study|Lost to Follow-up|2|||
48751401|NCT00897104|156934565|FG000|Overall Study|Pregnancy|0|||
48751402|NCT00897104|156934566|FG001|Overall Study|Pregnancy|1|||
48751403|NCT00897104|156934567|FG002|Overall Study|Pregnancy|0|||
48751404|NCT00897104|156934565|FG000|Overall Study|Protocol Violation|0|||
48751405|NCT00897104|156934566|FG001|Overall Study|Protocol Violation|1|||
48751406|NCT00897104|156934567|FG002|Overall Study|Protocol Violation|0|||
48751407|NCT00897104|156934565|FG000|Overall Study|Withdrawal by Subject|23|||
48751408|NCT00897104|156934566|FG001|Overall Study|Withdrawal by Subject|27|||
48751409|NCT00897104|156934567|FG002|Overall Study|Withdrawal by Subject|3|||
48751410|NCT00897104|156934565|FG000|Overall Study|Abnormal Prestudy Labs|2|||
48751411|NCT00897104|156934566|FG001|Overall Study|Abnormal Prestudy Labs|0|||
48751412|NCT00897104|156934567|FG002|Overall Study|Abnormal Prestudy Labs|0|||
48751413|NCT00897104|156934565|FG000|Overall Study|Abnormal Baseline ECG|2|||
48751414|NCT00897104|156934566|FG001|Overall Study|Abnormal Baseline ECG|2|||
48751415|NCT00897104|156934567|FG002|Overall Study|Abnormal Baseline ECG|0|||
48751416|NCT00897104|156934565|FG000|Overall Study|Need for Concom. Med.|0|||
48751417|NCT00897104|156934566|FG001|Overall Study|Need for Concom. Med.|1|||
48751418|NCT00897104|156934567|FG002|Overall Study|Need for Concom. Med.|1|||
48751419|NCT00897104|156934565|FG000|Overall Study|Lack of Migraine Attack|20|||
48751420|NCT00897104|156934566|FG001|Overall Study|Lack of Migraine Attack|22|||
48751421|NCT00897104|156934567|FG002|Overall Study|Lack of Migraine Attack|1|||
48751422|NCT00897104|156934565|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
48751423|NCT00897104|156934566|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
48751424|NCT00897104|156934567|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
48751425|NCT00897104|156934565|FG000|Overall Study|Other|3|||
48863427|NCT03030599|157335033|FG000|Open Label Treatment and Titration|Non-Compliance with Study Drug|4|||
48863428|NCT03030599|157335034|FG001|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
48863429|NCT03030599|157335035|FG002|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
48863430|NCT03030599|157335033|FG000|Open Label Treatment and Titration|Adverse Event|18|||
48863431|NCT03030599|157335034|FG001|Open Label Treatment and Titration|Adverse Event|0|||
48863432|NCT03030599|157335035|FG002|Open Label Treatment and Titration|Adverse Event|0|||
48863433|NCT03030599|157335033|FG000|Open Label Treatment and Titration|Withdrawal by Subject|6|||
48863434|NCT03030599|157335034|FG001|Open Label Treatment and Titration|Withdrawal by Subject|0|||
48863435|NCT03030599|157335035|FG002|Open Label Treatment and Titration|Withdrawal by Subject|0|||
48863436|NCT03030599|157335033|FG000|Open Label Treatment and Titration|Sponsor decision|2|||
48863437|NCT03030599|157335034|FG001|Open Label Treatment and Titration|Sponsor decision|0|||
48863438|NCT03030599|157335035|FG002|Open Label Treatment and Titration|Sponsor decision|0|||
48863439|NCT03030599|157335033|FG000|Open Label Treatment and Titration|Lost to Follow-up|3|||
48863440|NCT03030599|157335034|FG001|Open Label Treatment and Titration|Lost to Follow-up|0|||
48863441|NCT03030599|157335035|FG002|Open Label Treatment and Titration|Lost to Follow-up|0|||
48751426|NCT00897104|156934566|FG001|Overall Study|Other|0|||
48751427|NCT00897104|156934567|FG002|Overall Study|Other|0|||
48751428|NCT00897104|156934565|FG000|Overall Study|Protocol Violation|1|||
48751429|NCT00897104|156934566|FG001|Overall Study|Protocol Violation|0|||
48751430|NCT00897104|156934567|FG002|Overall Study|Protocol Violation|0|||
48751431|NCT00897104|156934565|FG000|Overall Study|Withdrawal by Subject|0|||
48751432|NCT00897104|156934566|FG001|Overall Study|Withdrawal by Subject|0|||
48751433|NCT00897104|156934567|FG002|Overall Study|Withdrawal by Subject|1|||
48751434|NCT00883116|156934568|FG000|Overall Study|Adverse event unrelated to study drug|5|||
48751435|NCT00883116|156934569|FG001|Overall Study|Adverse event unrelated to study drug|10|||
48751436|NCT00883116|156934568|FG000|Overall Study|Death|6|||
48751437|NCT00883116|156934569|FG001|Overall Study|Death|2|||
48751438|NCT00883116|156934568|FG000|Overall Study|Disease progression|130|||
48751439|NCT00883116|156934569|FG001|Overall Study|Disease progression|128|||
48751440|NCT00883116|156934568|FG000|Overall Study|Lost to Follow-up|0|||
48751441|NCT00883116|156934569|FG001|Overall Study|Lost to Follow-up|1|||
48751442|NCT00883116|156934568|FG000|Overall Study|Maximum clinical benefit|13|||
48751443|NCT00883116|156934569|FG001|Overall Study|Maximum clinical benefit|46|||
48751444|NCT00883116|156934568|FG000|Overall Study|Not identified|3|||
48751445|NCT00883116|156934569|FG001|Overall Study|Not identified|6|||
48751446|NCT00883116|156934568|FG000|Overall Study|Study drug toxicity|36|||
48751447|NCT00883116|156934569|FG001|Overall Study|Study drug toxicity|16|||
48751448|NCT00883116|156934568|FG000|Overall Study|Withdrawal by Subject|14|||
48751449|NCT00883116|156934569|FG001|Overall Study|Withdrawal by Subject|8|||
48751450|NCT00883116|156934568|FG000|Overall Study|No longer meets study criteria|2|||
48751451|NCT00883116|156934569|FG001|Overall Study|No longer meets study criteria|2|||
48751452|NCT00662363|156934570|FG000|Overall Study|Withdrawal by Subject|6|||
48751453|NCT00662363|156934571|FG001|Overall Study|Withdrawal by Subject|5|||
48751454|NCT00662363|156934570|FG000|Overall Study|Adverse Event|0|||
48751455|NCT00662363|156934571|FG001|Overall Study|Adverse Event|3|||
48751456|NCT00662363|156934570|FG000|Overall Study|Discharged early from rehab|4|||
48751457|NCT00662363|156934571|FG001|Overall Study|Discharged early from rehab|1|||
48751458|NCT00662363|156934570|FG000|Overall Study|Protocol Violation|1|||
48751459|NCT00662363|156934571|FG001|Overall Study|Protocol Violation|1|||
48751460|NCT03789318|156934575|FG000|Overall Study|Adverse Event|0|||
48751461|NCT03789318|156934576|FG001|Overall Study|Adverse Event|0|||
48751462|NCT03789318|156934577|FG002|Overall Study|Adverse Event|1|||
48751463|NCT03789318|156934578|FG003|Overall Study|Adverse Event|1|||
48751464|NCT03789318|156934579|FG004|Overall Study|Adverse Event|0|||
48751465|NCT03789318|156934575|FG000|Overall Study|Lost to Follow-up|0|||
48751466|NCT03789318|156934576|FG001|Overall Study|Lost to Follow-up|0|||
48751467|NCT03789318|156934577|FG002|Overall Study|Lost to Follow-up|1|||
48751468|NCT03789318|156934578|FG003|Overall Study|Lost to Follow-up|0|||
48751469|NCT03789318|156934579|FG004|Overall Study|Lost to Follow-up|0|||
48751470|NCT03789318|156934575|FG000|Overall Study|Withdrawal by Subject|0|||
48751471|NCT03789318|156934576|FG001|Overall Study|Withdrawal by Subject|0|||
48751472|NCT03789318|156934577|FG002|Overall Study|Withdrawal by Subject|1|||
48751473|NCT03789318|156934578|FG003|Overall Study|Withdrawal by Subject|0|||
48751474|NCT03789318|156934579|FG004|Overall Study|Withdrawal by Subject|0|||
48751475|NCT02480114|156934580|FG000|Overall Study|Not completing surveys|3|||
48956596|NCT05836818|157669298|FG002|Overall Study|Pregnancy|0|||
48863442|NCT03030599|157335033|FG000|Stable Dose|Protocol deviation|3|||
48863443|NCT03030599|157335034|FG001|Stable Dose|Protocol deviation|0|||
48863444|NCT03030599|157335035|FG002|Stable Dose|Protocol deviation|0|||
48863445|NCT03030599|157335033|FG000|Stable Dose|Adverse Event|1|||
48863446|NCT03030599|157335034|FG001|Stable Dose|Adverse Event|0|||
48863447|NCT03030599|157335035|FG002|Stable Dose|Adverse Event|0|||
48863448|NCT03030599|157335033|FG000|Stable Dose|Lost to Follow-up|1|||
48863449|NCT03030599|157335034|FG001|Stable Dose|Lost to Follow-up|0|||
48863450|NCT03030599|157335035|FG002|Stable Dose|Lost to Follow-up|0|||
48863451|NCT03030599|157335033|FG000|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
48863452|NCT03030599|157335034|FG001|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
48863453|NCT03030599|157335035|FG002|Double Blind Randomized Withdrawal|Lack of Efficacy|2|||
48863454|NCT03030599|157335033|FG000|Double Blind Randomized Withdrawal|Adverse Event|0|||
48863455|NCT03030599|157335034|FG001|Double Blind Randomized Withdrawal|Adverse Event|0|||
48863456|NCT03030599|157335035|FG002|Double Blind Randomized Withdrawal|Adverse Event|3|||
48863457|NCT03030599|157335033|FG000|Double Blind Randomized Withdrawal|Randomized in error|0|||
48863458|NCT03030599|157335034|FG001|Double Blind Randomized Withdrawal|Randomized in error|0|||
48863459|NCT03030599|157335035|FG002|Double Blind Randomized Withdrawal|Randomized in error|2|||
48863460|NCT03030599|157335033|FG000|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
48863461|NCT03030599|157335034|FG001|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
48863462|NCT03030599|157335035|FG002|Double Blind Randomized Withdrawal|Withdrawal by Subject|1|||
48863463|NCT03030599|157335033|FG000|Open-label Extension|Adverse Event|3|||
48863464|NCT03030599|157335034|FG001|Open-label Extension|Adverse Event|0|||
48863465|NCT03030599|157335035|FG002|Open-label Extension|Adverse Event|0|||
48863466|NCT03030599|157335033|FG000|Open-label Extension|Lost to Follow-up|2|||
48863467|NCT03030599|157335034|FG001|Open-label Extension|Lost to Follow-up|0|||
48863468|NCT03030599|157335035|FG002|Open-label Extension|Lost to Follow-up|0|||
48863469|NCT03030599|157335033|FG000|Open-label Extension|Lack of Efficacy|1|||
48863470|NCT03030599|157335034|FG001|Open-label Extension|Lack of Efficacy|0|||
48863471|NCT03030599|157335035|FG002|Open-label Extension|Lack of Efficacy|0|||
48863472|NCT03030599|157335033|FG000|Open-label Extension|Other Reason|1|||
48863473|NCT03030599|157335034|FG001|Open-label Extension|Other Reason|0|||
48863474|NCT03030599|157335035|FG002|Open-label Extension|Other Reason|0|||
48863475|NCT02784535|157335042|FG000|Overall Study|Adverse Event|1|||
48863476|NCT02784535|157335043|FG001|Overall Study|Adverse Event|0|||
48863477|NCT02784535|157335042|FG000|Overall Study|Withdrawal by Subject|0|||
48863478|NCT02784535|157335043|FG001|Overall Study|Withdrawal by Subject|1|||
48863479|NCT02784535|157335042|FG000|Overall Study|Physician Decision|0|||
48863480|NCT02784535|157335043|FG001|Overall Study|Physician Decision|1|||
48863481|NCT00914732|157335044|FG000|Overall Study|Lost to Follow-up|6|||
48863482|NCT00914732|157335045|FG001|Overall Study|Lost to Follow-up|7|||
48863483|NCT00914732|157335046|FG002|Overall Study|Lost to Follow-up|9|||
48863484|NCT00914732|157335044|FG000|Overall Study|Withdrawal by Subject|3|||
48863485|NCT00914732|157335045|FG001|Overall Study|Withdrawal by Subject|0|||
48863486|NCT00914732|157335046|FG002|Overall Study|Withdrawal by Subject|2|||
48863487|NCT00914732|157335044|FG000|Overall Study|Adverse Event|1|||
48863488|NCT00914732|157335045|FG001|Overall Study|Adverse Event|0|||
48863489|NCT00914732|157335046|FG002|Overall Study|Adverse Event|0|||
48863490|NCT03740919|157335047|FG000|Lead-in Period|Lost to Follow-up|1|||
48863491|NCT03740919|157335048|FG001|Lead-in Period|Lost to Follow-up|0|||
48863492|NCT03740919|157335049|FG002|Lead-in Period|Lost to Follow-up|0|||
48863493|NCT03740919|157335050|FG003|Lead-in Period|Lost to Follow-up|0|||
48863494|NCT03740919|157335047|FG000|Lead-in Period|Physician Decision|2|||
48863495|NCT03740919|157335048|FG001|Lead-in Period|Physician Decision|0|||
48863496|NCT03740919|157335049|FG002|Lead-in Period|Physician Decision|0|||
48863497|NCT03740919|157335050|FG003|Lead-in Period|Physician Decision|0|||
48863498|NCT03740919|157335047|FG000|Lead-in Period|Protocol Violation|1|||
48863499|NCT03740919|157335048|FG001|Lead-in Period|Protocol Violation|0|||
48863500|NCT03740919|157335049|FG002|Lead-in Period|Protocol Violation|0|||
48863501|NCT03740919|157335050|FG003|Lead-in Period|Protocol Violation|0|||
48863502|NCT03740919|157335047|FG000|Lead-in Period|Withdrawal by Subject|10|||
48956597|NCT05836818|157669296|FG000|Overall Study|Allergic to vaccines|0|||
48956598|NCT05836818|157669297|FG001|Overall Study|Allergic to vaccines|1|||
48956599|NCT05836818|157669298|FG002|Overall Study|Allergic to vaccines|0|||
48956600|NCT03599141|157669299|FG000|Overall Study|Lost to Follow-up|3|||
48956601|NCT03599141|157669300|FG001|Overall Study|Lost to Follow-up|1|||
48863503|NCT03740919|157335048|FG001|Lead-in Period|Withdrawal by Subject|0|||
48863504|NCT03740919|157335049|FG002|Lead-in Period|Withdrawal by Subject|0|||
48863505|NCT03740919|157335050|FG003|Lead-in Period|Withdrawal by Subject|0|||
48863506|NCT03740919|157335047|FG000|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|18|||
48863507|NCT03740919|157335048|FG001|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
48863508|NCT03740919|157335049|FG002|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
48863509|NCT03740919|157335050|FG003|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
48863510|NCT03740919|157335047|FG000|Lead-in Period|Study Task Too Burdensome|1|||
48863511|NCT03740919|157335048|FG001|Lead-in Period|Study Task Too Burdensome|0|||
48956602|NCT01721408|157669301|FG000|Overall Study|Adverse Event|6|||
48751476|NCT02480114|156934581|FG001|Overall Study|Not completing surveys|2|||
48751477|NCT02480114|156934580|FG000|Overall Study|Withdrawal by Subject|2|||
48751478|NCT02480114|156934581|FG001|Overall Study|Withdrawal by Subject|4|||
48751479|NCT02480114|156934580|FG000|Overall Study|Disease progression|3|||
48751480|NCT02480114|156934581|FG001|Overall Study|Disease progression|0|||
48751481|NCT02480114|156934580|FG000|Overall Study|Improper completion of survey|1|||
48751482|NCT02480114|156934581|FG001|Overall Study|Improper completion of survey|1|||
48751483|NCT02480114|156934580|FG000|Overall Study|Not eligible|0|||
48751484|NCT02480114|156934581|FG001|Overall Study|Not eligible|1|||
48751485|NCT00477971|156934582|FG000|Overall Study|Disease progression|6|||
48751486|NCT00477971|156934583|FG001|Overall Study|Disease progression|0|||
48751487|NCT00477971|156934582|FG000|Overall Study|Withdrawal by Subject|3|||
48751488|NCT00477971|156934583|FG001|Overall Study|Withdrawal by Subject|1|||
48751489|NCT00477971|156934582|FG000|Overall Study|Adverse Event|3|||
48751490|NCT00477971|156934583|FG001|Overall Study|Adverse Event|0|||
48751491|NCT00477971|156934582|FG000|Overall Study|Death|2|||
48751492|NCT00477971|156934583|FG001|Overall Study|Death|4|||
48751493|NCT00477971|156934582|FG000|Overall Study|Alternative treatment|3|||
48751494|NCT00477971|156934583|FG001|Overall Study|Alternative treatment|1|||
48751495|NCT03156543|156936489|FG000|Overall Study|Withdrawal by Subject|1|||
48751496|NCT03156543|156936490|FG001|Overall Study|Withdrawal by Subject|0|||
48751497|NCT03098550|156936491|FG000|Overall Study|Disease Progression|30|||
48751498|NCT03098550|156936492|FG001|Overall Study|Disease Progression|19|||
48751499|NCT03098550|156936493|FG002|Overall Study|Disease Progression|41|||
48751500|NCT03098550|156936491|FG000|Overall Study|Study Drug Toxicity|2|||
48751501|NCT03098550|156936492|FG001|Overall Study|Study Drug Toxicity|1|||
48751502|NCT03098550|156936493|FG002|Overall Study|Study Drug Toxicity|0|||
48751503|NCT03098550|156936491|FG000|Overall Study|Death|1|||
48751504|NCT03098550|156936492|FG001|Overall Study|Death|0|||
48751505|NCT03098550|156936493|FG002|Overall Study|Death|0|||
48751506|NCT03098550|156936491|FG000|Overall Study|Adverse Event unrelated to Study Drug|6|||
48751507|NCT03098550|156936492|FG001|Overall Study|Adverse Event unrelated to Study Drug|0|||
48751508|NCT03098550|156936493|FG002|Overall Study|Adverse Event unrelated to Study Drug|1|||
48751509|NCT03098550|156936491|FG000|Overall Study|Administrative reason by sponsor|0|||
48751510|NCT03098550|156936492|FG001|Overall Study|Administrative reason by sponsor|0|||
48751511|NCT03098550|156936493|FG002|Overall Study|Administrative reason by sponsor|1|||
48751512|NCT03098550|156936491|FG000|Overall Study|Other reasons|2|||
48751513|NCT03098550|156936492|FG001|Overall Study|Other reasons|0|||
48751514|NCT03098550|156936493|FG002|Overall Study|Other reasons|0|||
48751515|NCT01384760|156936497|FG000|Overall Study|Lost to Follow-up|0|||
48751516|NCT01384760|156936498|FG001|Overall Study|Lost to Follow-up|6|||
48751517|NCT01384760|156936497|FG000|Overall Study|Protocol Violation|16|||
48751518|NCT01384760|156936498|FG001|Overall Study|Protocol Violation|0|||
48751519|NCT01411774|156936499|FG000|Overall Study|Withdrawal by Subject|0|||
48751520|NCT01411774|156936500|FG001|Overall Study|Withdrawal by Subject|3|||
48751521|NCT03808545|156936501|FG000|Overall Study|Withdrawal by Subject|1|||
48751522|NCT03808545|156936502|FG001|Overall Study|Withdrawal by Subject|1|||
48751523|NCT00963547|156936503|FG000|Overall Study|Adverse Event|0|||
48751524|NCT00963547|156936504|FG001|Overall Study|Adverse Event|1|||
48751525|NCT00963547|156936505|FG002|Overall Study|Adverse Event|0|||
48751526|NCT00963547|156936506|FG003|Overall Study|Adverse Event|1|||
48751527|NCT00963547|156936507|FG004|Overall Study|Adverse Event|0|||
48751528|NCT00963547|156936508|FG005|Overall Study|Adverse Event|0|||
48751529|NCT00963547|156936509|FG006|Overall Study|Adverse Event|0|||
48751530|NCT00963547|156936503|FG000|Overall Study|Physician Decision|1|||
48751531|NCT00963547|156936504|FG001|Overall Study|Physician Decision|1|||
48751532|NCT00963547|156936505|FG002|Overall Study|Physician Decision|0|||
48751533|NCT00963547|156936506|FG003|Overall Study|Physician Decision|0|||
48751534|NCT00963547|156936507|FG004|Overall Study|Physician Decision|0|||
48863512|NCT03740919|157335049|FG002|Lead-in Period|Study Task Too Burdensome|0|||
48751535|NCT00963547|156936508|FG005|Overall Study|Physician Decision|0|||
48751536|NCT00963547|156936509|FG006|Overall Study|Physician Decision|0|||
48863513|NCT03740919|157335050|FG003|Lead-in Period|Study Task Too Burdensome|0|||
48863514|NCT03740919|157335047|FG000|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|1|||
48751537|NCT00963547|156936503|FG000|Overall Study|Progressive Disease|3|||
48751538|NCT00963547|156936504|FG001|Overall Study|Progressive Disease|8|||
48751539|NCT00963547|156936505|FG002|Overall Study|Progressive Disease|9|||
48751540|NCT00963547|156936506|FG003|Overall Study|Progressive Disease|5|||
48751541|NCT00963547|156936507|FG004|Overall Study|Progressive Disease|0|||
48751542|NCT00963547|156936508|FG005|Overall Study|Progressive Disease|0|||
48751543|NCT00963547|156936509|FG006|Overall Study|Progressive Disease|0|||
48751544|NCT00963547|156936503|FG000|Overall Study|Withdrawal by Subject|0|||
48751545|NCT00963547|156936504|FG001|Overall Study|Withdrawal by Subject|0|||
48751546|NCT00963547|156936505|FG002|Overall Study|Withdrawal by Subject|3|||
48751547|NCT00963547|156936506|FG003|Overall Study|Withdrawal by Subject|0|||
48751548|NCT00963547|156936507|FG004|Overall Study|Withdrawal by Subject|0|||
48863515|NCT03740919|157335048|FG001|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
48956603|NCT01721408|157669302|FG001|Overall Study|Adverse Event|1|||
48863516|NCT03740919|157335049|FG002|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
48863517|NCT03740919|157335050|FG003|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
48863518|NCT03740919|157335047|FG000|Lead-in Period|Withdrew Consent Due to Required Procedures|1|||
48863519|NCT03740919|157335048|FG001|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
48863520|NCT03740919|157335049|FG002|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
48863521|NCT03740919|157335050|FG003|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
48863522|NCT03740919|157335047|FG000|Treatment Period|Adverse Event|0|||
48863523|NCT03740919|157335048|FG001|Treatment Period|Adverse Event|0|||
48863524|NCT03740919|157335049|FG002|Treatment Period|Adverse Event|2|||
48863525|NCT03740919|157335050|FG003|Treatment Period|Adverse Event|0|||
48863526|NCT03740919|157335047|FG000|Treatment Period|Protocol Violation|0|||
48863527|NCT03740919|157335048|FG001|Treatment Period|Protocol Violation|1|||
48863528|NCT03740919|157335049|FG002|Treatment Period|Protocol Violation|0|||
48863529|NCT03740919|157335050|FG003|Treatment Period|Protocol Violation|0|||
48863530|NCT03740919|157335047|FG000|Treatment Period|Withdrawal by Subject|0|||
48863531|NCT03740919|157335048|FG001|Treatment Period|Withdrawal by Subject|7|||
48863532|NCT03740919|157335049|FG002|Treatment Period|Withdrawal by Subject|6|||
48863533|NCT03740919|157335050|FG003|Treatment Period|Withdrawal by Subject|2|||
48863534|NCT03740919|157335047|FG000|Treatment Period|Terminated by Sponsor|0|||
48863535|NCT03740919|157335048|FG001|Treatment Period|Terminated by Sponsor|1|||
48863536|NCT03740919|157335049|FG002|Treatment Period|Terminated by Sponsor|0|||
48863537|NCT03740919|157335050|FG003|Treatment Period|Terminated by Sponsor|0|||
48863538|NCT03740919|157335047|FG000|Treatment Period|Issue with Insulin Pump|0|||
48863539|NCT03740919|157335048|FG001|Treatment Period|Issue with Insulin Pump|1|||
48863540|NCT03740919|157335049|FG002|Treatment Period|Issue with Insulin Pump|0|||
48863541|NCT03740919|157335050|FG003|Treatment Period|Issue with Insulin Pump|0|||
48863542|NCT03740919|157335047|FG000|Treatment Period|Due to COVID-19 Pandemic|0|||
48863543|NCT03740919|157335048|FG001|Treatment Period|Due to COVID-19 Pandemic|0|||
48863544|NCT03740919|157335049|FG002|Treatment Period|Due to COVID-19 Pandemic|3|||
48863545|NCT03740919|157335050|FG003|Treatment Period|Due to COVID-19 Pandemic|1|||
48863546|NCT03740919|157335047|FG000|Treatment Period|Failure of Inclusion Criteria|0|||
48956604|NCT01721408|157669301|FG000|Overall Study|Death|1|||
48956605|NCT01721408|157669302|FG001|Overall Study|Death|0|||
48956606|NCT01721408|157669301|FG000|Overall Study|Insufficient clinical response|15|||
48956607|NCT01721408|157669302|FG001|Overall Study|Insufficient clinical response|6|||
48956608|NCT01721408|157669301|FG000|Overall Study|No longer willing to participate study|9|||
48956609|NCT01721408|157669302|FG001|Overall Study|No longer willing to participate study|10|||
48956610|NCT01721408|157669301|FG000|Overall Study|Protocol Violation|0|||
48956611|NCT01721408|157669302|FG001|Overall Study|Protocol Violation|2|||
48956612|NCT01721408|157669301|FG000|Overall Study|Other|3|||
48956613|NCT01721408|157669302|FG001|Overall Study|Other|3|||
48956614|NCT01721408|157669301|FG000|Overall Study|Lost to Follow-up|1|||
48956615|NCT01721408|157669302|FG001|Overall Study|Lost to Follow-up|2|||
48863547|NCT03740919|157335048|FG001|Treatment Period|Failure of Inclusion Criteria|0|||
48863548|NCT03740919|157335049|FG002|Treatment Period|Failure of Inclusion Criteria|1|||
48863549|NCT03740919|157335050|FG003|Treatment Period|Failure of Inclusion Criteria|0|||
48863550|NCT03740919|157335047|FG000|Treatment Period|Not Completing Diary|0|||
48863551|NCT03740919|157335048|FG001|Treatment Period|Not Completing Diary|0|||
48863552|NCT03740919|157335049|FG002|Treatment Period|Not Completing Diary|1|||
48863553|NCT03740919|157335050|FG003|Treatment Period|Not Completing Diary|0|||
48863554|NCT03740919|157335047|FG000|Treatment Period|Insulin Painful to Participant|0|||
48863555|NCT03740919|157335048|FG001|Treatment Period|Insulin Painful to Participant|0|||
48863556|NCT03740919|157335049|FG002|Treatment Period|Insulin Painful to Participant|1|||
48863557|NCT03740919|157335050|FG003|Treatment Period|Insulin Painful to Participant|0|||
48863558|NCT02418819|157335052|FG000|Overall Study|Adverse Event|0|||
48863559|NCT02418819|157335053|FG001|Overall Study|Adverse Event|0|||
48863560|NCT02418819|157335054|FG002|Overall Study|Adverse Event|1|||
48863561|NCT02418819|157335055|FG003|Overall Study|Adverse Event|0|||
48863562|NCT02418819|157335052|FG000|Overall Study|Lost to Follow-up|1|||
48863563|NCT02418819|157335053|FG001|Overall Study|Lost to Follow-up|0|||
48863564|NCT02418819|157335054|FG002|Overall Study|Lost to Follow-up|0|||
48863565|NCT02418819|157335055|FG003|Overall Study|Lost to Follow-up|0|||
48863566|NCT02418819|157335052|FG000|Overall Study|No longer meets eligibility criteria|0|||
48863567|NCT02418819|157335053|FG001|Overall Study|No longer meets eligibility criteria|0|||
48863568|NCT02418819|157335054|FG002|Overall Study|No longer meets eligibility criteria|1|||
48863569|NCT02418819|157335055|FG003|Overall Study|No longer meets eligibility criteria|0|||
48863570|NCT02418819|157335052|FG000|Overall Study|No longer willing to participate|0|||
48863571|NCT02418819|157335053|FG001|Overall Study|No longer willing to participate|0|||
48863572|NCT02418819|157335054|FG002|Overall Study|No longer willing to participate|2|||
48863573|NCT02418819|157335055|FG003|Overall Study|No longer willing to participate|1|||
48863574|NCT00676663|157335056|FG000|Overall Study|Death|43|||
48863575|NCT00676663|157335057|FG001|Overall Study|Death|27|||
48956616|NCT01721408|157669301|FG000|Overall Study|Does not meet entrance criteria|1|||
48956617|NCT01721408|157669302|FG001|Overall Study|Does not meet entrance criteria|0|||
48956618|NCT00488618|157669304|FG000|Overall Study|Adverse Event|13|||
48956619|NCT00488618|157669305|FG001|Overall Study|Adverse Event|17|||
48956620|NCT00488618|157669304|FG000|Overall Study|Insufficient Therapeutic Response|18|||
48863576|NCT00676663|157335056|FG000|Overall Study|Withdrew Consent|1|||
48863577|NCT00676663|157335057|FG001|Overall Study|Withdrew Consent|8|||
48863578|NCT00676663|157335056|FG000|Overall Study|Lost to Follow-up|1|||
48956621|NCT00488618|157669305|FG001|Overall Study|Insufficient Therapeutic Response|11|||
48863579|NCT00676663|157335057|FG001|Overall Study|Lost to Follow-up|3|||
48863580|NCT03640754|157335061|FG000|Overall Study|Withdrawal by Subject|1|||
48863581|NCT03640754|157335062|FG001|Overall Study|Withdrawal by Subject|0|||
48956622|NCT00488618|157669304|FG000|Overall Study|Protocol Violation|0|||
48956623|NCT00488618|157669305|FG001|Overall Study|Protocol Violation|2|||
48956624|NCT00488618|157669304|FG000|Overall Study|Withdrawal of Consent|15|||
48956625|NCT00488618|157669305|FG001|Overall Study|Withdrawal of Consent|13|||
48956626|NCT00488618|157669304|FG000|Overall Study|Lost to Follow-up|1|||
48956627|NCT00488618|157669305|FG001|Overall Study|Lost to Follow-up|0|||
48956628|NCT00364845|157669306|FG000|Overall Study|Adverse Event|1|||
48956629|NCT00364845|157669307|FG001|Overall Study|Adverse Event|0|||
48956630|NCT00364845|157669306|FG000|Overall Study|Withdrawal by Subject|2|||
48956631|NCT00364845|157669307|FG001|Overall Study|Withdrawal by Subject|1|||
48956632|NCT00364845|157669306|FG000|Overall Study|Physician Decision|8|||
48956633|NCT00364845|157669307|FG001|Overall Study|Physician Decision|8|||
48956634|NCT00364845|157669306|FG000|Overall Study|Lost to Follow-up|0|||
48956635|NCT00364845|157669307|FG001|Overall Study|Lost to Follow-up|1|||
48751549|NCT00963547|156936508|FG005|Overall Study|Withdrawal by Subject|0|||
48751550|NCT00963547|156936509|FG006|Overall Study|Withdrawal by Subject|0|||
48751551|NCT00963547|156936503|FG000|Overall Study|Reason Unknown|0|||
48751552|NCT00963547|156936504|FG001|Overall Study|Reason Unknown|1|||
48751553|NCT00963547|156936505|FG002|Overall Study|Reason Unknown|0|||
48751554|NCT00963547|156936506|FG003|Overall Study|Reason Unknown|0|||
48751555|NCT00963547|156936507|FG004|Overall Study|Reason Unknown|0|||
48751556|NCT00963547|156936508|FG005|Overall Study|Reason Unknown|0|||
48751557|NCT00963547|156936509|FG006|Overall Study|Reason Unknown|0|||
48751558|NCT00056316|156936510|FG000|Overall Study|Withdrawal by Subject|2|||
48751559|NCT00056316|156936511|FG001|Overall Study|Withdrawal by Subject|2|||
48751560|NCT00056316|156936510|FG000|Overall Study|Death/NH placement of pt|1|||
48751561|NCT00056316|156936511|FG001|Overall Study|Death/NH placement of pt|1|||
48751562|NCT04980040|156936512|FG000|Overall Study|Violated the Inclusion Criteria|260|||
48751563|NCT04980040|156936512|FG000|Overall Study|Violated the Administration & Dosage|225|||
48751564|NCT04980040|156936512|FG000|Overall Study|Lost to Safety-Follow-up|4|||
48751565|NCT04980040|156936512|FG000|Overall Study|Administered the study drug prior to signing the informed consent form|3|||
48751566|NCT02820753|156936516|FG000|2 Month|Withdrawal by Subject|3|||
48751567|NCT02820753|156936517|FG001|2 Month|Withdrawal by Subject|3|||
48751568|NCT02820753|156936516|FG000|2 Month|Lost to Follow-up|24|||
48751569|NCT02820753|156936517|FG001|2 Month|Lost to Follow-up|26|||
48751570|NCT02820753|156936516|FG000|2 Month|Stopped per NIH Hold|51|||
48751571|NCT02820753|156936517|FG001|2 Month|Stopped per NIH Hold|13|||
48751572|NCT02820753|156936516|FG000|6 Month|Withdrawal by Subject|2|||
48751573|NCT02820753|156936517|FG001|6 Month|Withdrawal by Subject|2|||
48751574|NCT02820753|156936516|FG000|6 Month|Lost to Follow-up|20|||
48751575|NCT02820753|156936517|FG001|6 Month|Lost to Follow-up|27|||
48751576|NCT02820753|156936516|FG000|6 Month|Stopped per NIH Hold|81|||
48751577|NCT02820753|156936517|FG001|6 Month|Stopped per NIH Hold|81|||
48751578|NCT02820753|156936516|FG000|6 Month|Death|0|||
48751579|NCT02820753|156936517|FG001|6 Month|Death|1|||
48751580|NCT02167893|156936524|FG000|Overall Study|Investigator transferred|85|||
48751581|NCT02167893|156936524|FG000|Overall Study|Investigator health reasons|10|||
48751582|NCT02167893|156936524|FG000|Overall Study|Case report forms not collected|68|||
48751583|NCT01315678|156936525|FG000|Overall Study|Withdrawal by Subject|7|||
48751584|NCT01315678|156936526|FG001|Overall Study|Withdrawal by Subject|3|||
48751585|NCT01315678|156936525|FG000|Overall Study|Adverse Event|3|||
48751586|NCT01315678|156936526|FG001|Overall Study|Adverse Event|1|||
48751587|NCT01315678|156936525|FG000|Overall Study|Lost to Follow-up|1|||
48751588|NCT01315678|156936526|FG001|Overall Study|Lost to Follow-up|0|||
48751589|NCT01315678|156936525|FG000|Overall Study|similar reason to those listed above|3|||
48751590|NCT01315678|156936526|FG001|Overall Study|similar reason to those listed above|2|||
48751591|NCT00543140|156936527|FG000|Overall Study|Lost to Follow-up|33|||
48751592|NCT00543140|156936527|FG000|Overall Study|Withdrawal by Subject|13|||
48751593|NCT00543140|156936527|FG000|Overall Study|Protocol Violation|10|||
48751594|NCT00543140|156936527|FG000|Overall Study|Insufficient weight loss|10|||
48956636|NCT00364845|157669306|FG000|Overall Study|Death|0|||
48956637|NCT00364845|157669307|FG001|Overall Study|Death|1|||
48956638|NCT05118386|157669310|FG000|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
48956639|NCT05118386|157669311|FG001|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
48956640|NCT05118386|157669312|FG002|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
48863582|NCT03640754|157335061|FG000|Overall Study|Lost to Follow-up|0|||
48863583|NCT03640754|157335062|FG001|Overall Study|Lost to Follow-up|1|||
48863584|NCT04435522|157335065|FG000|Overall Study|Withdrawal by Subject|2|||
48863585|NCT02799745|157335066|FG000|Overall Study|Participant moved out of state|1|||
48863586|NCT02799745|157335067|FG001|Overall Study|Participant moved out of state|0|||
48863587|NCT02799745|157335066|FG000|Overall Study|Discontinued due to planned surgery|1|||
48863588|NCT02799745|157335067|FG001|Overall Study|Discontinued due to planned surgery|0|||
48956641|NCT05118386|157669313|FG003|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|2|||
48863589|NCT02799745|157335066|FG000|Overall Study|Withdrawal by Subject|16|||
48863590|NCT02799745|157335067|FG001|Overall Study|Withdrawal by Subject|25|||
48863591|NCT02799745|157335066|FG000|Overall Study|Protocol Deviation|4|||
48863592|NCT02799745|157335067|FG001|Overall Study|Protocol Deviation|5|||
48863593|NCT02799745|157335066|FG000|Overall Study|Progressive Disease|28|||
48863594|NCT02799745|157335067|FG001|Overall Study|Progressive Disease|38|||
48863595|NCT02799745|157335066|FG000|Overall Study|Lost to Follow-up|3|||
48863596|NCT02799745|157335067|FG001|Overall Study|Lost to Follow-up|2|||
48863597|NCT02799745|157335066|FG000|Overall Study|Death|3|||
48863598|NCT02799745|157335067|FG001|Overall Study|Death|0|||
48863599|NCT02799745|157335066|FG000|Overall Study|Adverse Event|0|||
48863600|NCT02799745|157335067|FG001|Overall Study|Adverse Event|1|||
48863601|NCT04853238|157335068|FG000|Overall Study|Death|4|||
48863602|NCT04853238|157335069|FG001|Overall Study|Death|0|||
48863603|NCT04853238|157335070|FG002|Overall Study|Death|2|||
48863604|NCT04853238|157335068|FG000|Overall Study|Lost to Follow-up|16|||
48863605|NCT04853238|157335069|FG001|Overall Study|Lost to Follow-up|2|||
48863606|NCT04853238|157335070|FG002|Overall Study|Lost to Follow-up|37|||
48863607|NCT04853238|157335068|FG000|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
48863608|NCT04853238|157335069|FG001|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
48863609|NCT04853238|157335070|FG002|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|10|||
48863610|NCT04853238|157335068|FG000|Overall Study|Withdrawal by Subject|6|||
48863611|NCT04853238|157335069|FG001|Overall Study|Withdrawal by Subject|0|||
48863612|NCT04853238|157335070|FG002|Overall Study|Withdrawal by Subject|21|||
48863613|NCT04853238|157335068|FG000|Overall Study|Physician Decision|0|||
48956642|NCT05118386|157669314|FG004|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
48863614|NCT04853238|157335069|FG001|Overall Study|Physician Decision|0|||
48956643|NCT05118386|157669315|FG005|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
48956644|NCT05118386|157669310|FG000|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
48863615|NCT04853238|157335070|FG002|Overall Study|Physician Decision|2|||
48863616|NCT04853238|157335068|FG000|Overall Study|Violation of inclusion/exclusion criteria|3|||
48863617|NCT04853238|157335069|FG001|Overall Study|Violation of inclusion/exclusion criteria|0|||
48863618|NCT04853238|157335070|FG002|Overall Study|Violation of inclusion/exclusion criteria|1|||
48863619|NCT02294461|157335071|FG000|Double-blind Period (up to 29.4 Months)|Death|6|||
48863620|NCT02294461|157335072|FG001|Double-blind Period (up to 29.4 Months)|Death|4|||
48863621|NCT02294461|157335071|FG000|Double-blind Period (up to 29.4 Months)|Miscellaneous|30|||
48863622|NCT02294461|157335072|FG001|Double-blind Period (up to 29.4 Months)|Miscellaneous|66|||
48863623|NCT02294461|157335071|FG000|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|27|||
48863624|NCT02294461|157335072|FG001|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|54|||
48863625|NCT02294461|157335071|FG000|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
48863626|NCT02294461|157335072|FG001|Double-blind Period (up to 29.4 Months)|Protocol Deviation|2|||
48863627|NCT02294461|157335071|FG000|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|1|||
48863628|NCT02294461|157335072|FG001|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
48863629|NCT02294461|157335071|FG000|Double-blind Period (up to 29.4 Months)|Progressive Disease|38|||
48863630|NCT02294461|157335072|FG001|Double-blind Period (up to 29.4 Months)|Progressive Disease|51|||
48863631|NCT02294461|157335071|FG000|Double-blind Period (up to 29.4 Months)|Adverse Event|16|||
48863632|NCT02294461|157335072|FG001|Double-blind Period (up to 29.4 Months)|Adverse Event|15|||
48863633|NCT02294461|157335071|FG000|Open-label Period (up to 54.3 Months)|Ongoing|19|||
48863634|NCT02294461|157335072|FG001|Open-label Period (up to 54.3 Months)|Ongoing|9|||
48863635|NCT02294461|157335071|FG000|Open-label Period (up to 54.3 Months)|Miscellaneous|16|||
48863636|NCT02294461|157335072|FG001|Open-label Period (up to 54.3 Months)|Miscellaneous|12|||
48863637|NCT02294461|157335071|FG000|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|18|||
48863638|NCT02294461|157335072|FG001|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|9|||
48863639|NCT02294461|157335071|FG000|Open-label Period (up to 54.3 Months)|Protocol Deviation|2|||
48863640|NCT02294461|157335072|FG001|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
48863641|NCT02294461|157335071|FG000|Open-label Period (up to 54.3 Months)|Lost to Follow-up|3|||
48863642|NCT02294461|157335072|FG001|Open-label Period (up to 54.3 Months)|Lost to Follow-up|1|||
48863643|NCT02294461|157335071|FG000|Open-label Period (up to 54.3 Months)|Progressive Disease|15|||
48863644|NCT02294461|157335072|FG001|Open-label Period (up to 54.3 Months)|Progressive Disease|9|||
48863645|NCT02294461|157335071|FG000|Open-label Period (up to 54.3 Months)|Death|6|||
48863646|NCT02294461|157335072|FG001|Open-label Period (up to 54.3 Months)|Death|5|||
48863647|NCT02294461|157335071|FG000|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
48863648|NCT02294461|157335072|FG001|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
48863649|NCT00747149|157336313|FG000|Overall Study|Adverse Event|0|||
48863650|NCT00747149|157336314|FG001|Overall Study|Adverse Event|15|||
48956645|NCT05118386|157669311|FG001|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
49015405|NCT01835145|157892170|FG001|Overall Study|Ineligible prior to treatment|0|||
48751595|NCT00543140|156936527|FG000|Overall Study|SAE leading to explant of SAGB|3|||
48956646|NCT05118386|157669312|FG002|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
48751596|NCT00543140|156936527|FG000|Overall Study|Death|1|||
48751597|NCT00543140|156936527|FG000|Overall Study|Subject moved|1|||
48751598|NCT00543140|156936527|FG000|Overall Study|Conversion to different procedure|1|||
48751599|NCT01029795|156936528|FG000|Overall Study|Entry Criteria Not Met|2|||
48751600|NCT01029795|156936529|FG001|Overall Study|Entry Criteria Not Met|1|||
48751601|NCT01029795|156936528|FG000|Overall Study|Physician Decision|2|||
48751602|NCT01029795|156936529|FG001|Overall Study|Physician Decision|1|||
48751603|NCT01029795|156936528|FG000|Overall Study|Sponsor Decision|11|||
48751604|NCT01029795|156936529|FG001|Overall Study|Sponsor Decision|17|||
48751605|NCT01029795|156936528|FG000|Overall Study|Withdrawal by Subject|1|||
48751606|NCT01029795|156936529|FG001|Overall Study|Withdrawal by Subject|3|||
48751607|NCT03489720|156936533|FG000|Overall Study|Withdrawal by Subject|2|||
48751608|NCT03489720|156936534|FG001|Overall Study|Withdrawal by Subject|0|||
48751609|NCT02170298|156936535|FG000|Overall Study|Withdrawal by Subject|0|||
48751610|NCT02170298|156936536|FG001|Overall Study|Withdrawal by Subject|1|||
48751611|NCT02170298|156936535|FG000|Overall Study|unblinded, rerandomized to intervention|1|||
48751612|NCT02170298|156936536|FG001|Overall Study|unblinded, rerandomized to intervention|0|||
48751613|NCT00644995|156936537|FG000|Overall Study|Lost to Follow-up|1|||
48751614|NCT00644995|156936538|FG001|Overall Study|Lost to Follow-up|4|||
48751615|NCT00644995|156936537|FG000|Overall Study|Refused|1|||
48751616|NCT00644995|156936538|FG001|Overall Study|Refused|0|||
48751617|NCT03020160|156936539|FG000|Overall Study|Withdrawal by Subject|1|||
48751618|NCT03020160|156936540|FG001|Overall Study|Withdrawal by Subject|0|||
48751619|NCT02254486|156936541|FG000|Overall Study|Adverse Event|1|||
48751620|NCT02254486|156936542|FG001|Overall Study|Adverse Event|1|||
48751621|NCT02254486|156936541|FG000|Overall Study|Lack of Efficacy|1|||
48751622|NCT02254486|156936542|FG001|Overall Study|Lack of Efficacy|0|||
48751623|NCT02254486|156936541|FG000|Overall Study|Lost to Follow-up|2|||
48751624|NCT02254486|156936542|FG001|Overall Study|Lost to Follow-up|4|||
48751625|NCT02254486|156936541|FG000|Overall Study|Protocol Violation|1|||
48751626|NCT02254486|156936542|FG001|Overall Study|Protocol Violation|2|||
48751627|NCT02254486|156936541|FG000|Overall Study|Withdrawal by Subject|17|||
48751628|NCT02254486|156936542|FG001|Overall Study|Withdrawal by Subject|15|||
48751629|NCT02254486|156936541|FG000|Overall Study|GFR<60mL/min|16|||
48751630|NCT02254486|156936542|FG001|Overall Study|GFR<60mL/min|21|||
48751631|NCT02254486|156936541|FG000|Overall Study|Various|12|||
48751632|NCT02254486|156936542|FG001|Overall Study|Various|12|||
48751633|NCT03274440|156936544|FG000|Overall Study|Time commitment too great|1|||
48751634|NCT03274440|156936545|FG001|Overall Study|Time commitment too great|0|||
48751635|NCT03274440|156936546|FG002|Overall Study|Time commitment too great|0|||
48751636|NCT03274440|156936547|FG003|Overall Study|Time commitment too great|1|||
48751637|NCT03274440|156936548|FG004|Overall Study|Time commitment too great|0|||
48956647|NCT05118386|157669313|FG003|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
48751638|NCT03274440|156936549|FG005|Overall Study|Time commitment too great|0|||
48751639|NCT02759471|156936550|FG000|Overall Study|discomfort|2|||
48751640|NCT01291173|156936551|FG000|Overall Study|Adverse Event|0|||
48751641|NCT01291173|156936552|FG001|Overall Study|Adverse Event|3|||
48751642|NCT01291173|156936553|FG002|Overall Study|Adverse Event|1|||
48863651|NCT00747149|157336313|FG000|Overall Study|Lost to Follow-up|0|||
48863652|NCT00747149|157336314|FG001|Overall Study|Lost to Follow-up|10|||
48863653|NCT00747149|157336313|FG000|Overall Study|Withdrawal by Subject|0|||
48751643|NCT01291173|156936554|FG003|Overall Study|Adverse Event|3|||
48751644|NCT01291173|156936551|FG000|Overall Study|Protocol Violation|7|||
48751645|NCT01291173|156936552|FG001|Overall Study|Protocol Violation|2|||
48751646|NCT01291173|156936553|FG002|Overall Study|Protocol Violation|2|||
48751647|NCT01291173|156936554|FG003|Overall Study|Protocol Violation|5|||
48751648|NCT01291173|156936551|FG000|Overall Study|Withdrawal by Subject|6|||
48751649|NCT01291173|156936552|FG001|Overall Study|Withdrawal by Subject|4|||
48863654|NCT00747149|157336314|FG001|Overall Study|Withdrawal by Subject|6|||
48863655|NCT00747149|157336313|FG000|Overall Study|Did not receive treatment|0|||
48863656|NCT00747149|157336314|FG001|Overall Study|Did not receive treatment|1|||
48863657|NCT00747149|157336313|FG000|Overall Study|Incorrect enrollment|0|||
48863658|NCT00747149|157336314|FG001|Overall Study|Incorrect enrollment|6|||
48863659|NCT00747149|157336313|FG000|Overall Study|Severe non-compliance to protocol|0|||
48863660|NCT00747149|157336314|FG001|Overall Study|Severe non-compliance to protocol|1|||
48863661|NCT00747149|157336313|FG000|Overall Study|Not reported|1|||
48956648|NCT05118386|157669314|FG004|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|1|||
48956649|NCT05118386|157669315|FG005|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
48751650|NCT01291173|156936553|FG002|Overall Study|Withdrawal by Subject|4|||
48751651|NCT01291173|156936554|FG003|Overall Study|Withdrawal by Subject|2|||
48863662|NCT00747149|157336314|FG001|Overall Study|Not reported|4|||
48863663|NCT02543294|157336319|FG000|Overall Study|Lost to Follow-up|3|||
48863664|NCT02543294|157336319|FG000|Overall Study|Physician Decision|2|||
48863665|NCT02543294|157336319|FG000|Overall Study|Withdrawal by Subject|7|||
48863666|NCT01799993|157336320|FG000|Overall Study|"Didn't complete CRF page End of FU"|30|||
48751652|NCT01291173|156936551|FG000|Overall Study|Lost to Follow-up|4|||
48863667|NCT01799993|157336321|FG001|Overall Study|"Didn't complete CRF page End of FU"|40|||
49098985|NCT04064411|158197010|FG000|Overall Study|Withdrawal by Subject|25|||
48751653|NCT01291173|156936552|FG001|Overall Study|Lost to Follow-up|6|||
48751654|NCT01291173|156936553|FG002|Overall Study|Lost to Follow-up|3|||
48751655|NCT01291173|156936554|FG003|Overall Study|Lost to Follow-up|2|||
48751656|NCT01291173|156936551|FG000|Overall Study|Unable to meet visit schedule|0|||
48751657|NCT01291173|156936552|FG001|Overall Study|Unable to meet visit schedule|0|||
48751658|NCT01291173|156936553|FG002|Overall Study|Unable to meet visit schedule|1|||
48751659|NCT01291173|156936554|FG003|Overall Study|Unable to meet visit schedule|0|||
48751660|NCT01291173|156936551|FG000|Overall Study|Lack of compliance|0|||
48751661|NCT01291173|156936552|FG001|Overall Study|Lack of compliance|0|||
48751662|NCT01291173|156936553|FG002|Overall Study|Lack of compliance|0|||
48751663|NCT01291173|156936554|FG003|Overall Study|Lack of compliance|1|||
48751664|NCT01291173|156936551|FG000|Overall Study|Subject was unblinded|0|||
48751665|NCT01291173|156936552|FG001|Overall Study|Subject was unblinded|0|||
48751666|NCT01291173|156936553|FG002|Overall Study|Subject was unblinded|1|||
48751667|NCT01291173|156936554|FG003|Overall Study|Subject was unblinded|0|||
48751668|NCT01291173|156936551|FG000|Overall Study|Excluded therapy|0|||
48751669|NCT01291173|156936552|FG001|Overall Study|Excluded therapy|0|||
48751670|NCT01291173|156936553|FG002|Overall Study|Excluded therapy|1|||
48751671|NCT01291173|156936554|FG003|Overall Study|Excluded therapy|0|||
48751672|NCT00938639|156936555|FG000|Overall Study|Moved away from study area|0|||
48751673|NCT00938639|156936556|FG001|Overall Study|Moved away from study area|1|||
48751674|NCT00938639|156936555|FG000|Overall Study|Lost to Follow-up|1|||
48751675|NCT00938639|156936556|FG001|Overall Study|Lost to Follow-up|2|||
48751676|NCT00938639|156936555|FG000|Overall Study|Family issues|1|||
48751677|NCT00938639|156936556|FG001|Overall Study|Family issues|1|||
48751678|NCT00938639|156936555|FG000|Overall Study|Participant noncompliance|1|||
48751679|NCT00938639|156936556|FG001|Overall Study|Participant noncompliance|0|||
48751680|NCT04876274|156936557|FG000|Overall Study|Lost to Follow-up|9|||
48751681|NCT04876274|156936558|FG001|Overall Study|Lost to Follow-up|12|||
48751682|NCT00489541|156936559|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|2|||
48751683|NCT00489541|156936560|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|3|||
48751684|NCT00489541|156936559|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
48751685|NCT00489541|156936560|FG001|12-Month Clinical Follow-up|Lost to Follow-up|0|||
48751686|NCT00489541|156936559|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|2|||
48751687|NCT00489541|156936560|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|0|||
48751688|NCT00489541|156936559|FG000|12-Month Clinical Follow-up|Death|3|||
48751689|NCT00489541|156936560|FG001|12-Month Clinical Follow-up|Death|2|||
48751690|NCT00489541|156936559|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23|||
48751691|NCT00489541|156936560|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12|||
48751692|NCT00489541|156936559|FG000|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4|||
48751693|NCT00489541|156936560|FG001|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5|||
48751694|NCT04326231|156936561|FG000|Overall Study|COVID Withdrawn (limited recruitment within study timeline)|10|||
48751695|NCT00003479|156936562|FG000|Overall Study|Not evaluable|3|||
48751696|NCT02709785|156936563|FG000|Overall Study|Withdrawal by Subject|1|||
48751697|NCT02709785|156936564|FG001|Overall Study|Withdrawal by Subject|2|||
48751698|NCT02709785|156936565|FG002|Overall Study|Withdrawal by Subject|1|||
48751699|NCT01980992|156936580|FG000|52 Weeks Blinded Study Treatment|Dosing Symptoms|0|||
48751700|NCT01980992|156936581|FG001|52 Weeks Blinded Study Treatment|Dosing Symptoms|3|||
48751701|NCT01980992|156936580|FG000|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
48751702|NCT01980992|156936581|FG001|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
48751703|NCT01980992|156936580|FG000|52 Weeks Blinded Study Treatment|Non-compliance|1|||
48751704|NCT01980992|156936581|FG001|52 Weeks Blinded Study Treatment|Non-compliance|0|||
48751705|NCT01980992|156936580|FG000|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2|||
48751706|NCT01980992|156936581|FG001|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0|||
48751707|NCT01980992|156936580|FG000|52 Weeks Open Label Active Wheat OIT|Non-compliance|1|||
48751708|NCT01980992|156936581|FG001|52 Weeks Open Label Active Wheat OIT|Non-compliance|0|||
48751709|NCT01980992|156936580|FG000|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0|||
48751710|NCT01980992|156936581|FG001|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1|||
48751711|NCT02651922|156936582|FG000|Overall Study|due to exclusion criteria|2|||
48751712|NCT01829191|156936583|FG000|Overall Study|Relocation|0|||
48751713|NCT01829191|156936584|FG001|Overall Study|Relocation|1|||
48751714|NCT01829191|156936583|FG000|Overall Study|Lens discomfort|0|||
48751715|NCT01829191|156936584|FG001|Overall Study|Lens discomfort|3|||
48751716|NCT01829191|156936583|FG000|Overall Study|Lens handling difficulty|1|||
48751717|NCT01829191|156936584|FG001|Overall Study|Lens handling difficulty|4|||
48751718|NCT01829191|156936583|FG000|Overall Study|Protocol Violation|4|||
48751719|NCT01829191|156936584|FG001|Overall Study|Protocol Violation|1|||
48751720|NCT01829191|156936583|FG000|Overall Study|Withdrawal by Subject|2|||
48751721|NCT01829191|156936584|FG001|Overall Study|Withdrawal by Subject|3|||
48751722|NCT01829191|156936583|FG000|Overall Study|Lost to Follow-up|0|||
48751723|NCT01829191|156936584|FG001|Overall Study|Lost to Follow-up|1|||
48751724|NCT01829191|156936583|FG000|Overall Study|Subject was fit for ortho - k|0|||
48751725|NCT01829191|156936584|FG001|Overall Study|Subject was fit for ortho - k|1|||
48751726|NCT01426373|156936585|FG000|Overall Study|Adverse Event|6|||
48751727|NCT01426373|156936585|FG000|Overall Study|Lost to Follow-up|14|||
48751728|NCT01426373|156936585|FG000|Overall Study|Participant Convenience|10|||
48751729|NCT01426373|156936585|FG000|Overall Study|Miscellaneous Reasons|4|||
48751730|NCT04952402|156936586|FG000|Overall Study|Lost to Follow-up|1|||
48751731|NCT04952402|156936587|FG001|Overall Study|Lost to Follow-up|3|||
48751732|NCT04952402|156936586|FG000|Overall Study|Lack Of Venous Access|0|||
48751733|NCT04952402|156936587|FG001|Overall Study|Lack Of Venous Access|1|||
48751734|NCT00587639|156936588|FG000|Overall Study|Withdrawal by Subject|1|||
48751735|NCT01896531|156936589|FG000|Overall Study|Death|57|||
48751736|NCT01896531|156936590|FG001|Overall Study|Death|59|||
48751737|NCT01896531|156936589|FG000|Overall Study|Lost to Follow-up|3|||
48751738|NCT01896531|156936590|FG001|Overall Study|Lost to Follow-up|0|||
48751739|NCT01896531|156936589|FG000|Overall Study|Non-compliance|0|||
48751740|NCT01896531|156936590|FG001|Overall Study|Non-compliance|1|||
48751741|NCT01896531|156936589|FG000|Overall Study|Study Ended by Sponsor|7|||
48751742|NCT01896531|156936590|FG001|Overall Study|Study Ended by Sponsor|20|||
48751743|NCT01896531|156936589|FG000|Overall Study|Withdrawal by Subject|3|||
48751744|NCT01896531|156936590|FG001|Overall Study|Withdrawal by Subject|2|||
48751745|NCT01896531|156936589|FG000|Overall Study|Death Prior to Treatment|1|||
48751746|NCT01896531|156936590|FG001|Overall Study|Death Prior to Treatment|0|||
48751747|NCT02532972|156936593|FG000|Overall Study|Withdrawal by Subject|1|||
48751748|NCT00459953|156936595|FG000|Overall Study|not analyzed-household member in study|1|||
48751749|NCT00459953|156936596|FG001|Overall Study|not analyzed-household member in study|1|||
48751750|NCT03944954|156936597|FG000|Overall Study|Withdrawal by Subject|22|||
48751751|NCT03944954|156936598|FG001|Overall Study|Withdrawal by Subject|4|||
48751752|NCT03944954|156936597|FG000|Overall Study|Lost to Follow-up|18|||
48751753|NCT03944954|156936598|FG001|Overall Study|Lost to Follow-up|0|||
48751754|NCT03944954|156936597|FG000|Overall Study|Failed Medical Screening|7|||
48751755|NCT03944954|156936598|FG001|Overall Study|Failed Medical Screening|0|||
48751756|NCT00736723|156936602|FG000|Overall Study|Withdrawal by Subject|4|||
48751757|NCT00736723|156936603|FG001|Overall Study|Withdrawal by Subject|3|||
48751758|NCT02268084|156936604|FG000|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0|||
48751759|NCT02268084|156936605|FG001|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3|||
48751760|NCT02268084|156936604|FG000|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9|||
48751761|NCT02268084|156936605|FG001|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4|||
48751762|NCT05227027|156936606|FG000|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|10|||
48751763|NCT05227027|156936607|FG001|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|11|||
48751764|NCT02603419|156936608|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
48751765|NCT02603419|156936609|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Death|1|||
48751766|NCT02603419|156936610|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
48751767|NCT02603419|156936611|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
48751768|NCT02603419|156936612|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
48751769|NCT02603419|156936613|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
48751770|NCT02603419|156936608|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
48751771|NCT02603419|156936609|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
48751772|NCT02603419|156936610|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
48751773|NCT02603419|156936611|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
48751774|NCT02603419|156936612|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3|||
48751775|NCT02603419|156936613|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0|||
48751776|NCT02603419|156936608|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2|||
48751777|NCT02603419|156936609|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
48751778|NCT02603419|156936610|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3|||
48751779|NCT02603419|156936611|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
48751780|NCT02603419|156936612|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1|||
48751781|NCT02603419|156936613|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
48863668|NCT01799993|157336320|FG000|Overall Study|Death|61|||
48863669|NCT01799993|157336321|FG001|Overall Study|Death|45|||
48863670|NCT01799993|157336320|FG000|Overall Study|Withdrawal by Subject|23|||
48863671|NCT01799993|157336321|FG001|Overall Study|Withdrawal by Subject|24|||
48863672|NCT01799993|157336320|FG000|Overall Study|Lost to Follow-up|5|||
48863673|NCT01799993|157336321|FG001|Overall Study|Lost to Follow-up|8|||
48863674|NCT01799993|157336320|FG000|Overall Study|Withdrawal by parent/guardian/LAR|5|||
48863675|NCT01799993|157336321|FG001|Overall Study|Withdrawal by parent/guardian/LAR|3|||
48863676|NCT01799993|157336320|FG000|Overall Study|Protocol driven decision point|0|||
48863677|NCT01799993|157336321|FG001|Overall Study|Protocol driven decision point|3|||
48863678|NCT01799993|157336320|FG000|Overall Study|Protocol Violation|1|||
48863679|NCT01799993|157336321|FG001|Overall Study|Protocol Violation|1|||
48863680|NCT01799993|157336320|FG000|Overall Study|Deterioration of general conditions|2|||
48863681|NCT01799993|157336321|FG001|Overall Study|Deterioration of general conditions|0|||
48863682|NCT01799993|157336320|FG000|Overall Study|Screen failure|0|||
48863683|NCT01799993|157336321|FG001|Overall Study|Screen failure|1|||
48863684|NCT01799993|157336320|FG000|Overall Study|Adverse Event|1|||
48863685|NCT01799993|157336321|FG001|Overall Study|Adverse Event|0|||
48863686|NCT01799993|157336320|FG000|Overall Study|Lack of Efficacy|1|||
48863687|NCT01799993|157336321|FG001|Overall Study|Lack of Efficacy|0|||
48863688|NCT01799993|157336320|FG000|Overall Study|Recovery|0|||
48751782|NCT02603419|156936608|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
48751783|NCT02603419|156936609|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
48751784|NCT02603419|156936610|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
48751785|NCT02603419|156936611|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
48751786|NCT02603419|156936612|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1|||
48751787|NCT02603419|156936613|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
48751788|NCT02603419|156936608|FG000|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
48751789|NCT02603419|156936609|FG001|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1|||
48751790|NCT02603419|156936610|FG002|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
48863689|NCT01799993|157336321|FG001|Overall Study|Recovery|1|||
48863690|NCT01799993|157336320|FG000|Overall Study|Logistical difficulties|1|||
48863691|NCT01799993|157336321|FG001|Overall Study|Logistical difficulties|0|||
48751791|NCT02603419|156936611|FG003|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
48751792|NCT02603419|156936612|FG004|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
48751793|NCT02603419|156936613|FG005|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
48751794|NCT02603419|156936608|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Other|2|||
48751795|NCT02603419|156936609|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
48751796|NCT02603419|156936610|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
48751797|NCT02603419|156936611|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
48751798|NCT02603419|156936612|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
48751799|NCT02603419|156936613|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
48751800|NCT02603419|156936608|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
48751801|NCT02603419|156936609|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
48751802|NCT02603419|156936610|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
48751803|NCT02603419|156936611|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2|||
48751804|NCT02603419|156936612|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
48751805|NCT02603419|156936613|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
48751806|NCT02603419|156936608|FG000|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
48751807|NCT02603419|156936609|FG001|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
48751808|NCT02603419|156936610|FG002|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
48751809|NCT02603419|156936611|FG003|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
48751810|NCT02603419|156936612|FG004|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
48751811|NCT02603419|156936613|FG005|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1|||
48751812|NCT02603419|156936608|FG000|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
48751813|NCT02603419|156936609|FG001|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
48751814|NCT02603419|156936610|FG002|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
48751815|NCT02603419|156936611|FG003|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
48751816|NCT02603419|156936612|FG004|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
48751817|NCT02603419|156936613|FG005|Expansion Phase:Maximum Exposure:48Weeks|Death|1|||
48751818|NCT02603419|156936608|FG000|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
48751819|NCT02603419|156936609|FG001|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
48751820|NCT02603419|156936610|FG002|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
48751821|NCT02603419|156936611|FG003|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
48751822|NCT02603419|156936612|FG004|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
48751823|NCT02603419|156936613|FG005|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1|||
48751824|NCT02049957|156936614|FG000|Overall Study|Progressive Disease|5|||
48751825|NCT02049957|156936615|FG001|Overall Study|Progressive Disease|4|||
48751826|NCT02049957|156936616|FG002|Overall Study|Progressive Disease|2|||
48751827|NCT02049957|156936617|FG003|Overall Study|Progressive Disease|2|||
48751828|NCT02049957|156936618|FG004|Overall Study|Progressive Disease|6|||
48751829|NCT02049957|156936619|FG005|Overall Study|Progressive Disease|35|||
48751830|NCT02049957|156936620|FG006|Overall Study|Progressive Disease|7|||
48751831|NCT02049957|156936621|FG007|Overall Study|Progressive Disease|26|||
48751832|NCT02049957|156936622|FG008|Overall Study|Progressive Disease|6|||
48751833|NCT02049957|156936614|FG000|Overall Study|Adverse Event|1|||
48751834|NCT02049957|156936615|FG001|Overall Study|Adverse Event|1|||
48751835|NCT02049957|156936616|FG002|Overall Study|Adverse Event|1|||
48751836|NCT02049957|156936617|FG003|Overall Study|Adverse Event|0|||
48751837|NCT02049957|156936618|FG004|Overall Study|Adverse Event|0|||
48751838|NCT02049957|156936619|FG005|Overall Study|Adverse Event|5|||
48751839|NCT02049957|156936620|FG006|Overall Study|Adverse Event|0|||
48751840|NCT02049957|156936621|FG007|Overall Study|Adverse Event|6|||
48751841|NCT02049957|156936622|FG008|Overall Study|Adverse Event|1|||
48751842|NCT02049957|156936614|FG000|Overall Study|Study Terminated by Sponsor|0|||
48751843|NCT02049957|156936615|FG001|Overall Study|Study Terminated by Sponsor|1|||
48751844|NCT02049957|156936616|FG002|Overall Study|Study Terminated by Sponsor|0|||
48863692|NCT01799993|157336320|FG000|Overall Study|Protocol deviation|1|||
48863693|NCT01799993|157336321|FG001|Overall Study|Protocol deviation|0|||
48863694|NCT01799993|157336320|FG000|Overall Study|Non-compliance with medical device|1|||
48863695|NCT01799993|157336321|FG001|Overall Study|Non-compliance with medical device|0|||
48863696|NCT01799993|157336320|FG000|Overall Study|Withdrawal by parent/guardian|0|||
48863697|NCT01799993|157336321|FG001|Overall Study|Withdrawal by parent/guardian|1|||
48863698|NCT01799993|157336320|FG000|Overall Study|Other|1|||
48863699|NCT01799993|157336321|FG001|Overall Study|Other|0|||
48863700|NCT01799993|157336320|FG000|Overall Study|Subject didn't return for follow-up|0|||
48863701|NCT01799993|157336321|FG001|Overall Study|Subject didn't return for follow-up|1|||
48863702|NCT05361304|157336325|FG000|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|1|||
48863703|NCT05361304|157336326|FG001|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|0|||
48863704|NCT05361304|157336325|FG000|Overall Study|COVID-19 Related|1|||
48863705|NCT05361304|157336326|FG001|Overall Study|COVID-19 Related|2|||
48863706|NCT05361304|157336325|FG000|Overall Study|Withdrawal by Subject|1|||
48863707|NCT05361304|157336326|FG001|Overall Study|Withdrawal by Subject|0|||
48863708|NCT02409732|157336327|FG000|Overall Study|Withdrawal by Subject|4|||
48863709|NCT02409732|157336327|FG000|Overall Study|Lost to Follow-up|2|||
48863710|NCT03320941|157336328|FG000|Overall Study|subject/guardian decision|0|||
48863711|NCT03320941|157336329|FG001|Overall Study|subject/guardian decision|0|||
48863712|NCT03320941|157336330|FG002|Overall Study|subject/guardian decision|0|||
48863713|NCT03320941|157336331|FG003|Overall Study|subject/guardian decision|1|||
48863714|NCT03320941|157336332|FG004|Overall Study|subject/guardian decision|0|||
48863715|NCT00376259|157336333|FG000|Overall Study|Sponsor request - study termination|21|||
48863716|NCT00376259|157336334|FG001|Overall Study|Sponsor request - study termination|21|||
48863717|NCT00376259|157336333|FG000|Overall Study|Patient request|1|||
48863718|NCT00376259|157336334|FG001|Overall Study|Patient request|0|||
48863719|NCT03960437|157336337|FG000|Overall Study|Removed by PI|4|||
48863720|NCT03960437|157336337|FG000|Overall Study|Lost to Follow-up|2|||
48863721|NCT03960437|157336337|FG000|Overall Study|Withdrawal by Subject|1|||
48863722|NCT03960437|157336337|FG000|Overall Study|Death|2|||
48863723|NCT03614923|157336346|FG000|Overall Study|Withdrawal by Subject|2|||
48863724|NCT03614923|157336347|FG001|Overall Study|Withdrawal by Subject|1|||
48863725|NCT03614923|157336348|FG002|Overall Study|Withdrawal by Subject|1|||
48863726|NCT03614923|157336346|FG000|Overall Study|Adverse Event|0|||
48751845|NCT02049957|156936617|FG003|Overall Study|Study Terminated by Sponsor|0|||
48751846|NCT02049957|156936618|FG004|Overall Study|Study Terminated by Sponsor|0|||
48751847|NCT02049957|156936619|FG005|Overall Study|Study Terminated by Sponsor|0|||
48751848|NCT02049957|156936620|FG006|Overall Study|Study Terminated by Sponsor|1|||
48751849|NCT02049957|156936621|FG007|Overall Study|Study Terminated by Sponsor|0|||
48751850|NCT02049957|156936622|FG008|Overall Study|Study Terminated by Sponsor|0|||
48751851|NCT02049957|156936614|FG000|Overall Study|Withdrawal by Subject|0|||
48751852|NCT02049957|156936615|FG001|Overall Study|Withdrawal by Subject|0|||
48751853|NCT02049957|156936616|FG002|Overall Study|Withdrawal by Subject|0|||
48751854|NCT02049957|156936617|FG003|Overall Study|Withdrawal by Subject|1|||
48751855|NCT02049957|156936618|FG004|Overall Study|Withdrawal by Subject|0|||
48751856|NCT02049957|156936619|FG005|Overall Study|Withdrawal by Subject|2|||
48751857|NCT02049957|156936620|FG006|Overall Study|Withdrawal by Subject|0|||
48751858|NCT02049957|156936621|FG007|Overall Study|Withdrawal by Subject|3|||
48751859|NCT02049957|156936622|FG008|Overall Study|Withdrawal by Subject|1|||
48751860|NCT02049957|156936614|FG000|Overall Study|Physician Decision|0|||
48751861|NCT02049957|156936615|FG001|Overall Study|Physician Decision|0|||
48751862|NCT02049957|156936616|FG002|Overall Study|Physician Decision|0|||
48751863|NCT02049957|156936617|FG003|Overall Study|Physician Decision|0|||
48751864|NCT02049957|156936618|FG004|Overall Study|Physician Decision|0|||
48751865|NCT02049957|156936619|FG005|Overall Study|Physician Decision|1|||
48751866|NCT02049957|156936620|FG006|Overall Study|Physician Decision|0|||
48751867|NCT02049957|156936621|FG007|Overall Study|Physician Decision|0|||
48751868|NCT02049957|156936622|FG008|Overall Study|Physician Decision|0|||
48751869|NCT03049280|156936623|FG000|Overall Study|Physician Decision|1|||
48751870|NCT00855920|156936624|FG000|Overall Study|Protocol Violation|0|||
48751871|NCT00855920|156936625|FG001|Overall Study|Protocol Violation|0|||
48751872|NCT00855920|156936626|FG002|Overall Study|Protocol Violation|2|||
48863727|NCT03614923|157336347|FG001|Overall Study|Adverse Event|2|||
48863728|NCT03614923|157336348|FG002|Overall Study|Adverse Event|1|||
48863729|NCT03614923|157336346|FG000|Overall Study|Lost to Follow-up|1|||
48863730|NCT03614923|157336347|FG001|Overall Study|Lost to Follow-up|0|||
48863731|NCT03614923|157336348|FG002|Overall Study|Lost to Follow-up|1|||
48751873|NCT00855920|156936624|FG000|Overall Study|Adverse Event|2|||
48863732|NCT03614923|157336346|FG000|Overall Study|Lack of Efficacy|2|||
48751874|NCT00855920|156936625|FG001|Overall Study|Adverse Event|1|||
48751875|NCT00855920|156936626|FG002|Overall Study|Adverse Event|1|||
48751876|NCT00855920|156936624|FG000|Overall Study|Lack of Efficacy|2|||
48751877|NCT00855920|156936625|FG001|Overall Study|Lack of Efficacy|2|||
48751878|NCT00855920|156936626|FG002|Overall Study|Lack of Efficacy|2|||
48751879|NCT00855920|156936624|FG000|Overall Study|Withdrawal by Subject|2|||
48863733|NCT03614923|157336347|FG001|Overall Study|Lack of Efficacy|0|||
48863734|NCT03614923|157336348|FG002|Overall Study|Lack of Efficacy|1|||
48863735|NCT03614923|157336346|FG000|Overall Study|Non-compliance|0|||
48863736|NCT03614923|157336347|FG001|Overall Study|Non-compliance|1|||
48863737|NCT03614923|157336348|FG002|Overall Study|Non-compliance|0|||
48863738|NCT03614923|157336346|FG000|Overall Study|Other|0|||
48863739|NCT03614923|157336347|FG001|Overall Study|Other|1|||
48863740|NCT03614923|157336348|FG002|Overall Study|Other|1|||
48863741|NCT03436797|157336352|FG000|Main Study|Withdrawal by Subject|2|||
48863742|NCT03436797|157336352|FG000|Main Study|Adverse Event|4|||
48863743|NCT03436797|157336352|FG000|Main Study|Lost to Follow-up|1|||
48863744|NCT03436797|157336352|FG000|Main Study|Death|1|||
48863745|NCT03436797|157336352|FG000|Main Study|Non-Specific|2|||
48863746|NCT03436797|157336352|FG000|Extended Dosing|Patient decision|1|||
48863747|NCT01077284|157336355|FG000|Overall Study|Adverse Event|2|||
48863748|NCT01077284|157336356|FG001|Overall Study|Adverse Event|0|||
48863749|NCT01077284|157336357|FG002|Overall Study|Adverse Event|1|||
48863750|NCT01077284|157336355|FG000|Overall Study|Lost to Follow-up|1|||
48863751|NCT01077284|157336356|FG001|Overall Study|Lost to Follow-up|2|||
48863752|NCT01077284|157336357|FG002|Overall Study|Lost to Follow-up|0|||
48863753|NCT01077284|157336355|FG000|Overall Study|Withdrawal by Subject|2|||
48863754|NCT01077284|157336356|FG001|Overall Study|Withdrawal by Subject|3|||
48863755|NCT01077284|157336357|FG002|Overall Study|Withdrawal by Subject|1|||
48863756|NCT01077284|157336355|FG000|Overall Study|Other|0|||
48863757|NCT01077284|157336356|FG001|Overall Study|Other|0|||
48863758|NCT01077284|157336357|FG002|Overall Study|Other|1|||
48863759|NCT02023099|157336358|FG000|Overall Study|Non-fatal Adverse Event (AE)|0|||
48863760|NCT02023099|157336359|FG001|Overall Study|Non-fatal Adverse Event (AE)|0|||
48863761|NCT02023099|157336360|FG002|Overall Study|Non-fatal Adverse Event (AE)|1|||
48956650|NCT01199263|157669316|FG000|Overall Study|Ineligible|0|||
48751880|NCT00855920|156936625|FG001|Overall Study|Withdrawal by Subject|3|||
48751881|NCT00855920|156936626|FG002|Overall Study|Withdrawal by Subject|2|||
48751882|NCT00855920|156936624|FG000|Overall Study|Lost to Follow-up|1|||
48751883|NCT00855920|156936625|FG001|Overall Study|Lost to Follow-up|0|||
48751884|NCT00855920|156936626|FG002|Overall Study|Lost to Follow-up|2|||
48751885|NCT00855920|156936624|FG000|Overall Study|Death|0|||
48751886|NCT00855920|156936625|FG001|Overall Study|Death|1|||
48751887|NCT00855920|156936626|FG002|Overall Study|Death|0|||
48751888|NCT00855920|156936624|FG000|Overall Study|Decision by the sponsor|0|||
48751889|NCT00855920|156936625|FG001|Overall Study|Decision by the sponsor|1|||
48751890|NCT00855920|156936626|FG002|Overall Study|Decision by the sponsor|1|||
48751891|NCT00855920|156936624|FG000|Overall Study|Other than specified above|1|||
48751892|NCT00855920|156936625|FG001|Overall Study|Other than specified above|1|||
48751893|NCT00855920|156936626|FG002|Overall Study|Other than specified above|1|||
48751894|NCT00371137|156936627|FG000|Overall Study|Adverse Event|20|||
48751895|NCT00371137|156936628|FG001|Overall Study|Adverse Event|35|||
48751896|NCT00371137|156936629|FG002|Overall Study|Adverse Event|42|||
48751897|NCT00371137|156936627|FG000|Overall Study|Withdrawal by Subject|11|||
48751898|NCT00371137|156936628|FG001|Overall Study|Withdrawal by Subject|10|||
48751899|NCT00371137|156936629|FG002|Overall Study|Withdrawal by Subject|15|||
48751900|NCT00371137|156936627|FG000|Overall Study|Lost to Follow-up|6|||
48751901|NCT00371137|156936628|FG001|Overall Study|Lost to Follow-up|3|||
48751902|NCT00371137|156936629|FG002|Overall Study|Lost to Follow-up|5|||
48751903|NCT00371137|156936627|FG000|Overall Study|Lack of Efficacy|30|||
48751904|NCT00371137|156936628|FG001|Overall Study|Lack of Efficacy|12|||
48751905|NCT00371137|156936629|FG002|Overall Study|Lack of Efficacy|13|||
48751906|NCT00371137|156936627|FG000|Overall Study|Sponsor Decision|2|||
48751907|NCT00371137|156936628|FG001|Overall Study|Sponsor Decision|1|||
48751908|NCT00371137|156936629|FG002|Overall Study|Sponsor Decision|2|||
48751909|NCT00371137|156936627|FG000|Overall Study|Physician Decision|1|||
48751910|NCT00371137|156936628|FG001|Overall Study|Physician Decision|1|||
48863762|NCT02023099|157336358|FG000|Overall Study|Withdrawn Consent|3|||
48863763|NCT02023099|157336359|FG001|Overall Study|Withdrawn Consent|0|||
48751911|NCT00371137|156936629|FG002|Overall Study|Physician Decision|1|||
48751912|NCT00371137|156936627|FG000|Overall Study|Protocol Violation|2|||
48751913|NCT00371137|156936628|FG001|Overall Study|Protocol Violation|1|||
48751914|NCT00371137|156936629|FG002|Overall Study|Protocol Violation|1|||
48863764|NCT02023099|157336360|FG002|Overall Study|Withdrawn Consent|1|||
48956651|NCT01199263|157669317|FG001|Overall Study|Ineligible|2|||
48863765|NCT02023099|157336358|FG000|Overall Study|Non-treatment-emergent Fatal AE|0|||
48863766|NCT02023099|157336359|FG001|Overall Study|Non-treatment-emergent Fatal AE|0|||
48863767|NCT02023099|157336360|FG002|Overall Study|Non-treatment-emergent Fatal AE|1|||
48863768|NCT02632747|157336361|FG000|Wash-out Period|Adverse Event|1|||
48863769|NCT02632747|157336362|FG001|Wash-out Period|Adverse Event|0|||
48863770|NCT00730925|157336363|FG000|Overall Study|Progressive Disease|21|||
48863771|NCT00730925|157336363|FG000|Overall Study|Dose reducing Event|2|||
48863772|NCT00730925|157336363|FG000|Overall Study|Other Averse Event|7|||
48863773|NCT00730925|157336363|FG000|Overall Study|Protocol Violation|1|||
48863774|NCT00730925|157336363|FG000|Overall Study|Withdrawal by Subject|1|||
48863775|NCT00730925|157336363|FG000|Overall Study|Switch to combination therapy|8|||
48863776|NCT00730925|157336363|FG000|Overall Study|Other|1|||
48863777|NCT03481725|157336364|FG000|Overall Study|Withdrawal by Subject|1|||
48863778|NCT03481725|157336365|FG001|Overall Study|Withdrawal by Subject|0|||
48863779|NCT00472199|157336369|FG000|Overall Study|Adverse Event|19|||
48863780|NCT00472199|157336370|FG001|Overall Study|Adverse Event|23|||
48863781|NCT00472199|157336369|FG000|Overall Study|Lack of Efficacy|4|||
48863782|NCT00472199|157336370|FG001|Overall Study|Lack of Efficacy|25|||
48863783|NCT00472199|157336369|FG000|Overall Study|Lost to Follow-up|2|||
48863784|NCT00472199|157336370|FG001|Overall Study|Lost to Follow-up|4|||
48863785|NCT00472199|157336369|FG000|Overall Study|Protocol Violation|3|||
48863786|NCT00472199|157336370|FG001|Overall Study|Protocol Violation|2|||
48863787|NCT00472199|157336369|FG000|Overall Study|Withdrawal by Subject|6|||
48863788|NCT00472199|157336370|FG001|Overall Study|Withdrawal by Subject|5|||
48863789|NCT00472199|157336369|FG000|Overall Study|personal reason|0|||
48863790|NCT00472199|157336370|FG001|Overall Study|personal reason|1|||
48863791|NCT00472199|157336369|FG000|Overall Study|patient was asymptomatic|1|||
48863792|NCT00472199|157336370|FG001|Overall Study|patient was asymptomatic|0|||
48863793|NCT01107912|157336371|FG000|Period 1|Adverse Event|0|||
48863794|NCT01107912|157336372|FG001|Period 1|Adverse Event|0|||
48863795|NCT01107912|157336373|FG002|Period 1|Adverse Event|0|||
48863796|NCT01107912|157336374|FG003|Period 1|Adverse Event|0|||
48863797|NCT01107912|157336375|FG004|Period 1|Adverse Event|2|||
48863798|NCT01107912|157336376|FG005|Period 1|Adverse Event|0|||
48863799|NCT01107912|157336371|FG000|Period 1|Physician Decision|0|||
48863800|NCT01107912|157336372|FG001|Period 1|Physician Decision|0|||
48863801|NCT01107912|157336373|FG002|Period 1|Physician Decision|0|||
48863802|NCT01107912|157336374|FG003|Period 1|Physician Decision|0|||
48863803|NCT01107912|157336375|FG004|Period 1|Physician Decision|1|||
48863804|NCT01107912|157336376|FG005|Period 1|Physician Decision|0|||
48863805|NCT01107912|157336371|FG000|Period 1|Withdrawal by Subject|1|||
48863806|NCT01107912|157336372|FG001|Period 1|Withdrawal by Subject|0|||
48863807|NCT01107912|157336373|FG002|Period 1|Withdrawal by Subject|0|||
48863808|NCT01107912|157336374|FG003|Period 1|Withdrawal by Subject|0|||
48863809|NCT01107912|157336375|FG004|Period 1|Withdrawal by Subject|0|||
48863810|NCT01107912|157336376|FG005|Period 1|Withdrawal by Subject|0|||
48863811|NCT01107912|157336371|FG000|Period 2|Physician Decision|0|||
48863812|NCT01107912|157336372|FG001|Period 2|Physician Decision|0|||
48863813|NCT01107912|157336373|FG002|Period 2|Physician Decision|1|||
48863814|NCT01107912|157336374|FG003|Period 2|Physician Decision|0|||
48863815|NCT01107912|157336375|FG004|Period 2|Physician Decision|0|||
48863816|NCT01107912|157336376|FG005|Period 2|Physician Decision|0|||
48863817|NCT01107912|157336371|FG000|Period 3|Adverse Event|0|||
48863818|NCT01107912|157336372|FG001|Period 3|Adverse Event|1|||
48956652|NCT01199263|157669316|FG000|Overall Study|Never Treated|6|||
48956653|NCT01199263|157669317|FG001|Overall Study|Never Treated|0|||
48956654|NCT00430521|157669320|FG000|Overall Study|Adverse Event|0|||
48956655|NCT00430521|157669321|FG001|Overall Study|Adverse Event|0|||
48956656|NCT00430521|157669322|FG002|Overall Study|Adverse Event|0|||
48956657|NCT00430521|157669323|FG003|Overall Study|Adverse Event|0|||
48956658|NCT00430521|157669324|FG004|Overall Study|Adverse Event|0|||
48956659|NCT00430521|157669325|FG005|Overall Study|Adverse Event|2|||
48956660|NCT00430521|157669326|FG006|Overall Study|Adverse Event|1|||
48956661|NCT00430521|157669327|FG007|Overall Study|Adverse Event|0|||
48956662|NCT00430521|157669320|FG000|Overall Study|Lost to Follow-up|7|||
48956663|NCT00430521|157669321|FG001|Overall Study|Lost to Follow-up|8|||
48956664|NCT00430521|157669322|FG002|Overall Study|Lost to Follow-up|3|||
48956665|NCT00430521|157669323|FG003|Overall Study|Lost to Follow-up|5|||
48956666|NCT00430521|157669324|FG004|Overall Study|Lost to Follow-up|5|||
48956667|NCT00430521|157669325|FG005|Overall Study|Lost to Follow-up|2|||
48956668|NCT00430521|157669326|FG006|Overall Study|Lost to Follow-up|8|||
48956669|NCT00430521|157669327|FG007|Overall Study|Lost to Follow-up|10|||
48956670|NCT00430521|157669320|FG000|Overall Study|Pregnancy|0|||
48956671|NCT00430521|157669321|FG001|Overall Study|Pregnancy|0|||
48956672|NCT00430521|157669322|FG002|Overall Study|Pregnancy|0|||
48956673|NCT00430521|157669323|FG003|Overall Study|Pregnancy|0|||
48956674|NCT00430521|157669324|FG004|Overall Study|Pregnancy|0|||
48956675|NCT00430521|157669325|FG005|Overall Study|Pregnancy|0|||
48956676|NCT00430521|157669326|FG006|Overall Study|Pregnancy|1|||
48863819|NCT01107912|157336373|FG002|Period 3|Adverse Event|1|||
48863820|NCT01107912|157336374|FG003|Period 3|Adverse Event|0|||
48956677|NCT00430521|157669327|FG007|Overall Study|Pregnancy|0|||
48956678|NCT00430521|157669320|FG000|Overall Study|Vaccine Expired|0|||
48863821|NCT01107912|157336375|FG004|Period 3|Adverse Event|0|||
48956679|NCT00430521|157669321|FG001|Overall Study|Vaccine Expired|0|||
48956680|NCT00430521|157669322|FG002|Overall Study|Vaccine Expired|0|||
48956681|NCT00430521|157669323|FG003|Overall Study|Vaccine Expired|0|||
48956682|NCT00430521|157669324|FG004|Overall Study|Vaccine Expired|0|||
48956683|NCT00430521|157669325|FG005|Overall Study|Vaccine Expired|1|||
48863822|NCT01107912|157336376|FG005|Period 3|Adverse Event|0|||
48863823|NCT01107912|157336371|FG000|Period 3|Withdrawal by Subject|0|||
48956684|NCT00430521|157669326|FG006|Overall Study|Vaccine Expired|0|||
48863824|NCT01107912|157336372|FG001|Period 3|Withdrawal by Subject|0|||
48863825|NCT01107912|157336373|FG002|Period 3|Withdrawal by Subject|0|||
48863826|NCT01107912|157336374|FG003|Period 3|Withdrawal by Subject|1|||
48863827|NCT01107912|157336375|FG004|Period 3|Withdrawal by Subject|0|||
48863828|NCT01107912|157336376|FG005|Period 3|Withdrawal by Subject|0|||
48863829|NCT01601821|157336377|FG000|Overall Study|Death|2|||
48863830|NCT01601821|157336378|FG001|Overall Study|Death|5|||
48863831|NCT01601821|157336377|FG000|Overall Study|Protocol Violation|2|||
48863832|NCT01601821|157336378|FG001|Overall Study|Protocol Violation|2|||
48863833|NCT01601821|157336377|FG000|Overall Study|Lost to Follow-up|6|||
48863834|NCT01601821|157336378|FG001|Overall Study|Lost to Follow-up|14|||
48863835|NCT01601821|157336377|FG000|Overall Study|Withdrawal by Subject|1|||
48863836|NCT01601821|157336378|FG001|Overall Study|Withdrawal by Subject|0|||
48863837|NCT01601821|157336377|FG000|Overall Study|Graft Loss|6|||
48863838|NCT01601821|157336378|FG001|Overall Study|Graft Loss|6|||
48863839|NCT01601821|157336377|FG000|Overall Study|Study Events|7|||
48863840|NCT01601821|157336378|FG001|Overall Study|Study Events|1|||
48863841|NCT01601821|157336377|FG000|Overall Study|Other|5|||
48863842|NCT01601821|157336378|FG001|Overall Study|Other|1|||
48863843|NCT04736602|157336379|FG000|Main Study Phase|Withdrawal by Parent/Guardian|2|||
48863844|NCT04736602|157336379|FG000|Extension Phase|Withdrawal by Parent/Guardian|1|||
48863845|NCT01124916|157336385|FG000|Overall Study|Lost to Follow-up|3|||
48863846|NCT01124916|157336386|FG001|Overall Study|Lost to Follow-up|2|||
48863847|NCT02498418|157336390|FG000|Overall Study|Lack of Efficacy|0|||
48863848|NCT02498418|157336391|FG001|Overall Study|Lack of Efficacy|0|||
48863849|NCT02498418|157336392|FG002|Overall Study|Lack of Efficacy|1|||
48863850|NCT02498418|157336390|FG000|Overall Study|Withdrawal by Subject|2|||
48863851|NCT02498418|157336391|FG001|Overall Study|Withdrawal by Subject|0|||
48863852|NCT02498418|157336392|FG002|Overall Study|Withdrawal by Subject|3|||
48863853|NCT02498418|157336390|FG000|Overall Study|Lost to Follow-up|0|||
48863854|NCT02498418|157336391|FG001|Overall Study|Lost to Follow-up|1|||
48863855|NCT02498418|157336392|FG002|Overall Study|Lost to Follow-up|1|||
48863856|NCT02498418|157336390|FG000|Overall Study|Participant taken prohibited medication|0|||
48863857|NCT02498418|157336391|FG001|Overall Study|Participant taken prohibited medication|1|||
48863858|NCT02498418|157336392|FG002|Overall Study|Participant taken prohibited medication|1|||
48863859|NCT04908800|157336396|FG000|Overall Study|Adverse Event|0|||
48863860|NCT04908800|157336397|FG001|Overall Study|Adverse Event|0|||
48863861|NCT04908800|157336398|FG002|Overall Study|Adverse Event|0|||
48863862|NCT04908800|157336399|FG003|Overall Study|Adverse Event|0|||
48863863|NCT04908800|157336400|FG004|Overall Study|Adverse Event|0|||
48863864|NCT04908800|157336401|FG005|Overall Study|Adverse Event|0|||
48863865|NCT04908800|157336402|FG006|Overall Study|Adverse Event|0|||
48863866|NCT04908800|157336403|FG007|Overall Study|Adverse Event|0|||
48863867|NCT04908800|157336404|FG008|Overall Study|Adverse Event|0|||
48863868|NCT04908800|157336405|FG009|Overall Study|Adverse Event|0|||
48863869|NCT04908800|157336406|FG010|Overall Study|Adverse Event|1|||
48863870|NCT04908800|157336407|FG011|Overall Study|Adverse Event|0|||
48863871|NCT04908800|157336408|FG012|Overall Study|Adverse Event|0|||
48863872|NCT01348763|157336409|FG000|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1|||
48863873|NCT01348763|157336409|FG000|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1|||
48863874|NCT02335242|157336413|FG000|Randomized Phase (20 Weeks)|Withdrawal by Subject|1|||
48863875|NCT02335242|157336414|FG001|Randomized Phase (20 Weeks)|Withdrawal by Subject|0|||
48863876|NCT02335242|157336413|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
48863877|NCT02335242|157336414|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
48863878|NCT02335242|157336413|FG000|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
48863879|NCT02335242|157336414|FG001|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
48863880|NCT04839289|157336415|FG000|Overall Study|Withdrawal by Subject|1|||
48863881|NCT04839289|157336416|FG001|Overall Study|Withdrawal by Subject|0|||
48863882|NCT03214198|157336421|FG000|Overall Study|Case Report Forms Uncollected|18|||
48863883|NCT03214198|157336421|FG000|Overall Study|Protocol Deviation|18|||
48863884|NCT00919061|157336431|FG000|Overall Study|Adverse Event|1|||
48863885|NCT00919061|157336431|FG000|Overall Study|Withdrawal by Subject|1|||
48863886|NCT00308113|157336434|FG000|Overall Study|Protocol closure|0|||
48863887|NCT00308113|157336435|FG001|Overall Study|Protocol closure|0|||
48863888|NCT00308113|157336436|FG002|Overall Study|Protocol closure|0|||
48863889|NCT00308113|157336437|FG003|Overall Study|Protocol closure|1|||
48863890|NCT04944784|157336441|FG000|Double-blind Period|Study Terminated by Sponsor|96|||
48863891|NCT04944784|157336442|FG001|Double-blind Period|Study Terminated by Sponsor|46|||
48863892|NCT04944784|157336443|FG002|Double-blind Period|Study Terminated by Sponsor|0|||
48863893|NCT04944784|157336444|FG003|Double-blind Period|Study Terminated by Sponsor|0|||
48863894|NCT04944784|157336441|FG000|Double-blind Period|Adverse Event|20|||
48863895|NCT04944784|157336442|FG001|Double-blind Period|Adverse Event|4|||
48863896|NCT04944784|157336443|FG002|Double-blind Period|Adverse Event|0|||
48863897|NCT04944784|157336444|FG003|Double-blind Period|Adverse Event|0|||
48863898|NCT04944784|157336441|FG000|Double-blind Period|Withdrawal by Subject|15|||
48863899|NCT04944784|157336442|FG001|Double-blind Period|Withdrawal by Subject|4|||
48863900|NCT04944784|157336443|FG002|Double-blind Period|Withdrawal by Subject|0|||
48863901|NCT04944784|157336444|FG003|Double-blind Period|Withdrawal by Subject|0|||
48863902|NCT04944784|157336441|FG000|Double-blind Period|Death|7|||
48863903|NCT04944784|157336442|FG001|Double-blind Period|Death|2|||
48863904|NCT04944784|157336443|FG002|Double-blind Period|Death|0|||
48863905|NCT04944784|157336444|FG003|Double-blind Period|Death|0|||
48863906|NCT04944784|157336441|FG000|Double-blind Period|Physician Decision|2|||
48863907|NCT04944784|157336442|FG001|Double-blind Period|Physician Decision|1|||
48863908|NCT04944784|157336443|FG002|Double-blind Period|Physician Decision|0|||
48863909|NCT04944784|157336444|FG003|Double-blind Period|Physician Decision|0|||
48863910|NCT04944784|157336441|FG000|Double-blind Period|Lack of Efficacy|0|||
48863911|NCT04944784|157336442|FG001|Double-blind Period|Lack of Efficacy|1|||
48863912|NCT04944784|157336443|FG002|Double-blind Period|Lack of Efficacy|0|||
48863913|NCT04944784|157336444|FG003|Double-blind Period|Lack of Efficacy|0|||
48863914|NCT04944784|157336441|FG000|Double-blind Period|Sponsor Request|2|||
48863915|NCT04944784|157336442|FG001|Double-blind Period|Sponsor Request|1|||
48863916|NCT04944784|157336443|FG002|Double-blind Period|Sponsor Request|0|||
48863917|NCT04944784|157336444|FG003|Double-blind Period|Sponsor Request|0|||
48863918|NCT04944784|157336441|FG000|Double-blind Period|Planned Medical Assistance in Dying|0|||
48863919|NCT04944784|157336442|FG001|Double-blind Period|Planned Medical Assistance in Dying|3|||
48863920|NCT04944784|157336443|FG002|Double-blind Period|Planned Medical Assistance in Dying|0|||
48863921|NCT04944784|157336444|FG003|Double-blind Period|Planned Medical Assistance in Dying|0|||
48863922|NCT04944784|157336441|FG000|Double-blind Period|Participant Choice|1|||
48863923|NCT04944784|157336442|FG001|Double-blind Period|Participant Choice|1|||
48863924|NCT04944784|157336443|FG002|Double-blind Period|Participant Choice|0|||
48863925|NCT04944784|157336444|FG003|Double-blind Period|Participant Choice|0|||
48863926|NCT04944784|157336441|FG000|Double-blind Period|Progressive Disease|2|||
48863927|NCT04944784|157336442|FG001|Double-blind Period|Progressive Disease|2|||
48863928|NCT04944784|157336443|FG002|Double-blind Period|Progressive Disease|0|||
48863929|NCT04944784|157336444|FG003|Double-blind Period|Progressive Disease|0|||
48863930|NCT04944784|157336441|FG000|Active Drug Period|Study Terminated by Sponsor|0|||
48863931|NCT04944784|157336442|FG001|Active Drug Period|Study Terminated by Sponsor|0|||
48863932|NCT04944784|157336443|FG002|Active Drug Period|Study Terminated by Sponsor|49|||
48863933|NCT04944784|157336444|FG003|Active Drug Period|Study Terminated by Sponsor|92|||
48863934|NCT04944784|157336441|FG000|Active Drug Period|Adverse Event|0|||
48863935|NCT04944784|157336442|FG001|Active Drug Period|Adverse Event|0|||
48863936|NCT04944784|157336443|FG002|Active Drug Period|Adverse Event|3|||
48863937|NCT04944784|157336444|FG003|Active Drug Period|Adverse Event|6|||
48863938|NCT04944784|157336441|FG000|Active Drug Period|Withdrawal by Subject|0|||
48863939|NCT04944784|157336442|FG001|Active Drug Period|Withdrawal by Subject|0|||
48863940|NCT04944784|157336443|FG002|Active Drug Period|Withdrawal by Subject|4|||
48863941|NCT04944784|157336444|FG003|Active Drug Period|Withdrawal by Subject|7|||
48863942|NCT04944784|157336441|FG000|Active Drug Period|Death|0|||
48863943|NCT04944784|157336442|FG001|Active Drug Period|Death|0|||
48863944|NCT04944784|157336443|FG002|Active Drug Period|Death|3|||
48863945|NCT04944784|157336444|FG003|Active Drug Period|Death|4|||
48863946|NCT04944784|157336441|FG000|Active Drug Period|Lack of Efficacy|0|||
48863947|NCT04944784|157336442|FG001|Active Drug Period|Lack of Efficacy|0|||
48863948|NCT04944784|157336443|FG002|Active Drug Period|Lack of Efficacy|2|||
48956685|NCT00430521|157669327|FG007|Overall Study|Vaccine Expired|0|||
48863949|NCT04944784|157336444|FG003|Active Drug Period|Lack of Efficacy|2|||
48863950|NCT04944784|157336441|FG000|Active Drug Period|Planned Medical Assistance in Dying|0|||
48863951|NCT04944784|157336442|FG001|Active Drug Period|Planned Medical Assistance in Dying|0|||
48863952|NCT04944784|157336443|FG002|Active Drug Period|Planned Medical Assistance in Dying|0|||
48863953|NCT04944784|157336444|FG003|Active Drug Period|Planned Medical Assistance in Dying|1|||
48863954|NCT04944784|157336441|FG000|Active Drug Period|Participant Choice|0|||
48863955|NCT04944784|157336442|FG001|Active Drug Period|Participant Choice|0|||
48863956|NCT04944784|157336443|FG002|Active Drug Period|Participant Choice|0|||
48956686|NCT00430521|157669320|FG000|Overall Study|Protocol Violation|1|||
48956687|NCT00430521|157669321|FG001|Overall Study|Protocol Violation|0|||
48863957|NCT04944784|157336444|FG003|Active Drug Period|Participant Choice|1|||
48863958|NCT04944784|157336441|FG000|Active Drug Period|Progressive Disease|0|||
48863959|NCT04944784|157336442|FG001|Active Drug Period|Progressive Disease|0|||
48863960|NCT04944784|157336443|FG002|Active Drug Period|Progressive Disease|4|||
48863961|NCT04944784|157336444|FG003|Active Drug Period|Progressive Disease|4|||
48863962|NCT04944784|157336441|FG000|Active Drug Period|Lost to Follow-up|0|||
48863963|NCT04944784|157336442|FG001|Active Drug Period|Lost to Follow-up|0|||
48863964|NCT04944784|157336443|FG002|Active Drug Period|Lost to Follow-up|0|||
48863965|NCT04944784|157336444|FG003|Active Drug Period|Lost to Follow-up|1|||
48863966|NCT04130061|157336445|FG000|Overall Study|OR team forgot to request membrane|1|||
48863967|NCT04130061|157336446|FG001|Overall Study|OR team forgot to request membrane|0|||
48863968|NCT01537120|157337972|FG000|8 Weeks Washout|Inclusion/exclusion criteria not met|1|||
48863969|NCT01537120|157337972|FG000|3 Weeks Placebo|Withdrawal by Subject|1|||
48863970|NCT02392429|157337973|FG000|Screening|Screen failure|15|||
48863971|NCT02392429|157337973|FG000|Enrolled Participants|Ineligible due to disease|3|||
48863972|NCT02392429|157337973|FG000|Enrolled Participants|Withdrawal by Subject|4|||
48863973|NCT02392429|157337973|FG000|Enrolled Participants|Post-treatment FLT PET/CT scan not completed|9|||
48863974|NCT02392429|157337973|FG000|Evaluable|Death|5|||
48863975|NCT02392429|157337973|FG000|Evaluable|Withdrawal by Subject|1|||
48863976|NCT02392429|157337973|FG000|Evaluable|Adverse Event|1|||
48863977|NCT02392429|157337973|FG000|Evaluable|remission bone marrow biopsy|3|||
48863978|NCT01503515|157337975|FG000|Overall Study|Adverse Event|4|||
48863979|NCT01503515|157337976|FG001|Overall Study|Adverse Event|5|||
48863980|NCT01503515|157337975|FG000|Overall Study|Death|0|||
48863981|NCT01503515|157337976|FG001|Overall Study|Death|1|||
48863982|NCT01503515|157337975|FG000|Overall Study|Physician Decision|14|||
48863983|NCT01503515|157337976|FG001|Overall Study|Physician Decision|23|||
48863984|NCT01503515|157337975|FG000|Overall Study|Withdrawal by Subject|0|||
48863985|NCT01503515|157337976|FG001|Overall Study|Withdrawal by Subject|1|||
48863986|NCT01503515|157337975|FG000|Overall Study|Institutional dx of proven/probable IFI|2|||
48863987|NCT01503515|157337976|FG001|Overall Study|Institutional dx of proven/probable IFI|4|||
48863988|NCT01503515|157337975|FG000|Overall Study|Ineligible|1|||
48863989|NCT01503515|157337976|FG001|Overall Study|Ineligible|1|||
48863990|NCT02101554|157337977|FG000|Overall Study|Protocol Violation|0|||
48863991|NCT02101554|157337978|FG001|Overall Study|Protocol Violation|1|||
48863992|NCT02101554|157337979|FG002|Overall Study|Protocol Violation|0|||
48863993|NCT02101554|157337977|FG000|Overall Study|Insufficient Clinical Response|0|||
48863994|NCT02101554|157337978|FG001|Overall Study|Insufficient Clinical Response|2|||
48863995|NCT02101554|157337979|FG002|Overall Study|Insufficient Clinical Response|0|||
48863996|NCT02101554|157337977|FG000|Overall Study|Adverse Event|2|||
48863997|NCT02101554|157337978|FG001|Overall Study|Adverse Event|1|||
48863998|NCT02101554|157337979|FG002|Overall Study|Adverse Event|1|||
48863999|NCT02101554|157337977|FG000|Overall Study|Lost to Follow-up|0|||
48864000|NCT02101554|157337978|FG001|Overall Study|Lost to Follow-up|1|||
48864001|NCT02101554|157337979|FG002|Overall Study|Lost to Follow-up|0|||
48864002|NCT02101554|157337977|FG000|Overall Study|Withdrawl by Parents/Guardians|1|||
48751915|NCT02013791|156936630|FG000|Period 1|Lost to Follow-up|0|||
48751916|NCT02013791|156936631|FG001|Period 1|Lost to Follow-up|0|||
48751917|NCT02013791|156936632|FG002|Period 1|Lost to Follow-up|0|||
48751918|NCT02013791|156936633|FG003|Period 1|Lost to Follow-up|1|||
48751919|NCT02013791|156936634|FG004|Period 1|Lost to Follow-up|0|||
48751920|NCT02013791|156936635|FG005|Period 1|Lost to Follow-up|0|||
48751921|NCT02013791|156936636|FG006|Period 1|Lost to Follow-up|1|||
48751922|NCT02013791|156936637|FG007|Period 1|Lost to Follow-up|1|||
48751923|NCT02013791|156936638|FG008|Period 1|Lost to Follow-up|0|||
48751924|NCT02013791|156936630|FG000|Period 1|Other Miscellaneous Reasons|0|||
48751925|NCT02013791|156936631|FG001|Period 1|Other Miscellaneous Reasons|2|||
48751926|NCT02013791|156936632|FG002|Period 1|Other Miscellaneous Reasons|0|||
48751927|NCT02013791|156936633|FG003|Period 1|Other Miscellaneous Reasons|0|||
48751928|NCT02013791|156936634|FG004|Period 1|Other Miscellaneous Reasons|0|||
48751929|NCT02013791|156936635|FG005|Period 1|Other Miscellaneous Reasons|0|||
48751930|NCT02013791|156936636|FG006|Period 1|Other Miscellaneous Reasons|0|||
48751931|NCT02013791|156936637|FG007|Period 1|Other Miscellaneous Reasons|0|||
48751932|NCT02013791|156936638|FG008|Period 1|Other Miscellaneous Reasons|0|||
48751933|NCT02643082|156936639|FG000|Period 1|Adverse Event|1|||
48751934|NCT02643082|156936640|FG001|Period 1|Adverse Event|0|||
48751935|NCT01324999|156936641|FG000|Overall Study|Adverse Event|3|||
48751936|NCT01324999|156936641|FG000|Overall Study|Withdrawal by Subject|2|||
48751937|NCT01340898|156936644|FG000|Primary Phase|Serious Adverse Events|0|||
48751938|NCT01340898|156936645|FG001|Primary Phase|Serious Adverse Events|0|||
48751939|NCT01340898|156936646|FG002|Primary Phase|Serious Adverse Events|1|||
48751940|NCT01340898|156936644|FG000|Primary Phase|Withdrawal by Subject|8|||
48751941|NCT01340898|156936645|FG001|Primary Phase|Withdrawal by Subject|7|||
48751942|NCT01340898|156936646|FG002|Primary Phase|Withdrawal by Subject|5|||
48751943|NCT01340898|156936644|FG000|Primary Phase|Migrated/moved from study area|4|||
48751944|NCT01340898|156936645|FG001|Primary Phase|Migrated/moved from study area|1|||
48751945|NCT01340898|156936646|FG002|Primary Phase|Migrated/moved from study area|0|||
48751946|NCT01340898|156936644|FG000|Primary Phase|Lost to Follow-up|4|||
48751947|NCT01340898|156936645|FG001|Primary Phase|Lost to Follow-up|1|||
48751948|NCT01340898|156936646|FG002|Primary Phase|Lost to Follow-up|0|||
48751949|NCT01340898|156936644|FG000|Booster Phase|Withdrawal by Subject|3|||
48751950|NCT01340898|156936645|FG001|Booster Phase|Withdrawal by Subject|0|||
48751951|NCT01340898|156936646|FG002|Booster Phase|Withdrawal by Subject|4|||
48751952|NCT01340898|156936644|FG000|Booster Phase|Migrated/moved from study area|3|||
48751953|NCT01340898|156936645|FG001|Booster Phase|Migrated/moved from study area|0|||
48751954|NCT01340898|156936646|FG002|Booster Phase|Migrated/moved from study area|0|||
48751955|NCT01340898|156936644|FG000|Booster Phase|Lost to Follow-up|4|||
48751956|NCT01340898|156936645|FG001|Booster Phase|Lost to Follow-up|2|||
48751957|NCT01340898|156936646|FG002|Booster Phase|Lost to Follow-up|3|||
48751958|NCT01782495|156936651|FG000|Overall Study|Adverse Event|0|||
48864003|NCT02101554|157337978|FG001|Overall Study|Withdrawl by Parents/Guardians|0|||
48864004|NCT02101554|157337979|FG002|Overall Study|Withdrawl by Parents/Guardians|0|||
48864005|NCT00092456|157337980|FG000|Overall Study|Adverse Event|0|||
48864006|NCT00092456|157337981|FG001|Overall Study|Adverse Event|0|||
48864007|NCT00092456|157337982|FG002|Overall Study|Adverse Event|1|||
48864008|NCT00092456|157337983|FG003|Overall Study|Adverse Event|1|||
48864009|NCT00092456|157337980|FG000|Overall Study|Lost to Follow-up|2|||
48864010|NCT00092456|157337981|FG001|Overall Study|Lost to Follow-up|2|||
48864011|NCT00092456|157337982|FG002|Overall Study|Lost to Follow-up|1|||
48864012|NCT00092456|157337983|FG003|Overall Study|Lost to Follow-up|2|||
48864013|NCT00092456|157337980|FG000|Overall Study|Protocol Violation|5|||
48864014|NCT00092456|157337981|FG001|Overall Study|Protocol Violation|7|||
48864015|NCT00092456|157337982|FG002|Overall Study|Protocol Violation|8|||
48864016|NCT00092456|157337983|FG003|Overall Study|Protocol Violation|6|||
48864017|NCT00092456|157337980|FG000|Overall Study|Withdrawal by Subject|13|||
48864018|NCT00092456|157337981|FG001|Overall Study|Withdrawal by Subject|5|||
48864019|NCT00092456|157337982|FG002|Overall Study|Withdrawal by Subject|16|||
48864020|NCT00092456|157337983|FG003|Overall Study|Withdrawal by Subject|6|||
48864021|NCT00092456|157337980|FG000|Overall Study|Moved|1|||
48864022|NCT00092456|157337981|FG001|Overall Study|Moved|1|||
48864023|NCT00092456|157337982|FG002|Overall Study|Moved|0|||
48864024|NCT00092456|157337983|FG003|Overall Study|Moved|1|||
48864025|NCT00092456|157337980|FG000|Overall Study|Other|4|||
48864026|NCT00092456|157337981|FG001|Overall Study|Other|2|||
48864027|NCT00092456|157337982|FG002|Overall Study|Other|3|||
48864028|NCT00092456|157337983|FG003|Overall Study|Other|0|||
48864029|NCT02762500|157337984|FG000|Overall Study|Lack of Efficacy|1|||
48864030|NCT02762500|157337985|FG001|Overall Study|Lack of Efficacy|0|||
48864031|NCT02762500|157337984|FG000|Overall Study|Withdrawal by Subject|1|||
48864032|NCT02762500|157337985|FG001|Overall Study|Withdrawal by Subject|1|||
48864033|NCT02762500|157337984|FG000|Overall Study|Adverse Event|0|||
48864034|NCT02762500|157337985|FG001|Overall Study|Adverse Event|2|||
48864035|NCT01350102|157337986|FG000|Overall Study|Adverse Event|0|||
48864036|NCT01350102|157337987|FG001|Overall Study|Adverse Event|0|||
48864037|NCT01350102|157337988|FG002|Overall Study|Adverse Event|1|||
48751959|NCT01782495|156936652|FG001|Overall Study|Adverse Event|0|||
48751960|NCT01782495|156936653|FG002|Overall Study|Adverse Event|0|||
48751961|NCT01782495|156936654|FG003|Overall Study|Adverse Event|0|||
48751962|NCT01782495|156936655|FG004|Overall Study|Adverse Event|0|||
48751963|NCT01782495|156936656|FG005|Overall Study|Adverse Event|0|||
48751964|NCT01782495|156936657|FG006|Overall Study|Adverse Event|0|||
48751965|NCT01782495|156936658|FG007|Overall Study|Adverse Event|2|||
48751966|NCT01782495|156936659|FG008|Overall Study|Adverse Event|0|||
48751967|NCT01782495|156936660|FG009|Overall Study|Adverse Event|0|||
48956688|NCT00430521|157669322|FG002|Overall Study|Protocol Violation|0|||
48956689|NCT00430521|157669323|FG003|Overall Study|Protocol Violation|0|||
48956690|NCT00430521|157669324|FG004|Overall Study|Protocol Violation|0|||
48751968|NCT01782495|156936661|FG010|Overall Study|Adverse Event|0|||
48751969|NCT01782495|156936651|FG000|Overall Study|Withdrew Consent|0|||
48751970|NCT01782495|156936652|FG001|Overall Study|Withdrew Consent|1|||
48751971|NCT01782495|156936653|FG002|Overall Study|Withdrew Consent|0|||
48751972|NCT01782495|156936654|FG003|Overall Study|Withdrew Consent|0|||
48751973|NCT01782495|156936655|FG004|Overall Study|Withdrew Consent|0|||
48751974|NCT01782495|156936656|FG005|Overall Study|Withdrew Consent|0|||
48751975|NCT01782495|156936657|FG006|Overall Study|Withdrew Consent|0|||
48751976|NCT01782495|156936658|FG007|Overall Study|Withdrew Consent|1|||
48751977|NCT01782495|156936659|FG008|Overall Study|Withdrew Consent|0|||
48751978|NCT01782495|156936660|FG009|Overall Study|Withdrew Consent|0|||
48751979|NCT01782495|156936661|FG010|Overall Study|Withdrew Consent|0|||
48751980|NCT03547687|156936663|FG000|Overall Study|Withdrawal by Subject|1|||
48751981|NCT03547687|156936663|FG000|Overall Study|Death|1|||
48751982|NCT00679302|156936664|FG000|Overall Study|Lost to Follow-up|8|||
48751983|NCT00679302|156936665|FG001|Overall Study|Lost to Follow-up|4|||
48751984|NCT04656691|156936668|FG000|Overall Study|Adverse Event|1|||
48751985|NCT01850524|156936671|FG000|Overall Study|Lost to Follow-up|5|||
48751986|NCT01850524|156936672|FG001|Overall Study|Lost to Follow-up|10|||
48956691|NCT00430521|157669325|FG005|Overall Study|Protocol Violation|0|||
48751987|NCT01850524|156936671|FG000|Overall Study|Withdrawal by Subject|24|||
48751988|NCT01850524|156936672|FG001|Overall Study|Withdrawal by Subject|22|||
48751989|NCT01850524|156936671|FG000|Overall Study|Reason not Specified|142|||
48751990|NCT01850524|156936672|FG001|Overall Study|Reason not Specified|141|||
48751991|NCT00368355|156936673|FG000|Overall Study|Adverse Event|1|||
48751992|NCT00368355|156936674|FG001|Overall Study|Adverse Event|0|||
48751993|NCT00368355|156936673|FG000|Overall Study|Death|2|||
48751994|NCT00368355|156936674|FG001|Overall Study|Death|4|||
48956692|NCT00430521|157669326|FG006|Overall Study|Protocol Violation|0|||
48751995|NCT00368355|156936673|FG000|Overall Study|Relapse|6|||
48751996|NCT00368355|156936674|FG001|Overall Study|Relapse|10|||
48751997|NCT00368355|156936673|FG000|Overall Study|Subsequent transplant|0|||
48751998|NCT00368355|156936674|FG001|Overall Study|Subsequent transplant|3|||
48864038|NCT01350102|157337989|FG003|Overall Study|Adverse Event|0|||
48864039|NCT03924193|157337995|FG000|Overall Study|Adverse Event|10|||
48864040|NCT03924193|157337996|FG001|Overall Study|Adverse Event|0|||
48864041|NCT03924193|157337997|FG002|Overall Study|Adverse Event|10|||
48864042|NCT03924193|157337995|FG000|Overall Study|Withdrawal by Subject|5|||
48864043|NCT03924193|157337996|FG001|Overall Study|Withdrawal by Subject|10|||
48864044|NCT03924193|157337997|FG002|Overall Study|Withdrawal by Subject|2|||
48864045|NCT04523571|157337998|FG000|Received 2 Doses|Withdrawal by Subject|0|||
48864046|NCT04523571|157337999|FG001|Received 2 Doses|Withdrawal by Subject|0|||
48864047|NCT04523571|157338000|FG002|Received 2 Doses|Withdrawal by Subject|0|||
48864048|NCT04523571|157338001|FG003|Received 2 Doses|Withdrawal by Subject|1|||
48864049|NCT04523571|157338002|FG004|Received 2 Doses|Withdrawal by Subject|1|||
48864050|NCT04523571|157338003|FG005|Received 2 Doses|Withdrawal by Subject|0|||
48864051|NCT04523571|157337998|FG000|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
48864052|NCT04523571|157337999|FG001|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
48864053|NCT04523571|157338000|FG002|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
48864054|NCT04523571|157338001|FG003|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
48864055|NCT04523571|157338002|FG004|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
48864056|NCT04523571|157338003|FG005|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
48864057|NCT04523571|157337998|FG000|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
48864058|NCT04523571|157337999|FG001|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
48864059|NCT04523571|157338000|FG002|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
48864060|NCT04523571|157338001|FG003|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
48864061|NCT04523571|157338002|FG004|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
48864062|NCT04523571|157338003|FG005|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|1|||
48864063|NCT04523571|157337998|FG000|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
48864064|NCT04523571|157337999|FG001|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
48864065|NCT04523571|157338000|FG002|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
48864066|NCT04523571|157338001|FG003|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
48864067|NCT04523571|157338002|FG004|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
48864068|NCT04523571|157338003|FG005|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
48864069|NCT03469258|157338004|FG000|Overall Study|Upon surgery, did not meet criteria|4|||
48864070|NCT01234675|157338005|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
48864071|NCT01234675|157338006|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
48864072|NCT01234675|157338005|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
48864073|NCT01234675|157338006|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
48864074|NCT00857311|157338007|FG000|Overall Study|Lost to Follow-up|1|||
48864075|NCT00857311|157338008|FG001|Overall Study|Lost to Follow-up|0|||
48864076|NCT00857311|157338009|FG002|Overall Study|Lost to Follow-up|0|||
48864077|NCT00857311|157338010|FG003|Overall Study|Lost to Follow-up|0|||
48864078|NCT00759681|157338013|FG000|Overall Study|Death|2|||
48864079|NCT00759681|157338014|FG001|Overall Study|Death|5|||
48864080|NCT00759681|157338013|FG000|Overall Study|Lost to Follow-up|8|||
48864081|NCT00759681|157338014|FG001|Overall Study|Lost to Follow-up|5|||
48864082|NCT01636258|157338018|FG000|Overall Study|Lost to Follow-up|1|||
48864083|NCT01636258|157338019|FG001|Overall Study|Lost to Follow-up|0|||
48864084|NCT03360071|157338022|FG000|Overall Study|Lost to Follow-up|1|||
48864085|NCT03360071|157338023|FG001|Overall Study|Lost to Follow-up|0|||
48864086|NCT02798861|157338024|FG000|Overall Study|Lost to Follow-up|22|||
48864087|NCT02798861|157338024|FG000|Overall Study|Withdrawal by Subject|1|||
48864088|NCT00946088|157338028|FG000|Overall Study|Withdrawal by Subject|0|||
48864089|NCT00946088|157338029|FG001|Overall Study|Withdrawal by Subject|1|||
48864090|NCT01882088|157338030|FG000|Overall Study|Intolerance of esophageal manometry|1|||
48864091|NCT01882088|157338030|FG000|Overall Study|no possibility to place the catheter|1|||
48864092|NCT01882088|157338030|FG000|Overall Study|Protocol Violation|1|||
48864093|NCT01882088|157338030|FG000|Overall Study|inadequate pH-impedance tracings|2|||
48864094|NCT00147745|157338036|FG000|Overall Study|Withdrawal by Subject|1|||
48864095|NCT00147745|157338037|FG001|Overall Study|Withdrawal by Subject|0|||
48864096|NCT00147745|157338038|FG002|Overall Study|Withdrawal by Subject|0|||
48864097|NCT01379521|157338039|FG000|Overall Study -Treatment Period|Adverse Event|3|||
48864098|NCT01379521|157338040|FG001|Overall Study -Treatment Period|Adverse Event|0|||
48864099|NCT01379521|157338039|FG000|Overall Study -Treatment Period|Abnormal test procedure results|0|||
48864100|NCT01379521|157338040|FG001|Overall Study -Treatment Period|Abnormal test procedure results|1|||
48864101|NCT01379521|157338039|FG000|Overall Study -Treatment Period|Disease Progression|23|||
48864102|NCT01379521|157338040|FG001|Overall Study -Treatment Period|Disease Progression|22|||
48864103|NCT01379521|157338039|FG000|Overall Study -Treatment Period|New Cancer Therapy|1|||
48864104|NCT01379521|157338040|FG001|Overall Study -Treatment Period|New Cancer Therapy|0|||
48864105|NCT01379521|157338039|FG000|Overall Study -Treatment Period|Protocol Deviation|0|||
48864106|NCT01379521|157338040|FG001|Overall Study -Treatment Period|Protocol Deviation|2|||
48864107|NCT01379521|157338039|FG000|Overall Study -Treatment Period|Withdrawal by Subject|3|||
48864108|NCT01379521|157338040|FG001|Overall Study -Treatment Period|Withdrawal by Subject|0|||
48864109|NCT01379521|157338039|FG000|Overall Study -Treatment Period|Administrative Problems|1|||
48864110|NCT01379521|157338040|FG001|Overall Study -Treatment Period|Administrative Problems|0|||
48864111|NCT01379521|157338039|FG000|Overall Study -Treatment Period|Death|2|||
48864112|NCT01379521|157338040|FG001|Overall Study -Treatment Period|Death|1|||
48864113|NCT01379521|157338039|FG000|Post-Treatment Evaluations|Disease Progression|22|||
48864114|NCT01379521|157338040|FG001|Post-Treatment Evaluations|Disease Progression|20|||
48864115|NCT01379521|157338039|FG000|Post-Treatment Evaluations|Withdrawal by Subject|2|||
48864116|NCT01379521|157338040|FG001|Post-Treatment Evaluations|Withdrawal by Subject|1|||
48864117|NCT01379521|157338039|FG000|Post-Treatment Evaluations|Death|1|||
48864118|NCT01379521|157338040|FG001|Post-Treatment Evaluations|Death|0|||
48864119|NCT01757171|157338041|FG000|Overall Study|Adverse Event|5|||
48864120|NCT01757171|157338042|FG001|Overall Study|Adverse Event|1|||
48864121|NCT01757171|157338041|FG000|Overall Study|Disease Progression|1|||
48864122|NCT01757171|157338042|FG001|Overall Study|Disease Progression|0|||
48864123|NCT01757171|157338041|FG000|Overall Study|Hospitalization|1|||
48956693|NCT00430521|157669327|FG007|Overall Study|Protocol Violation|0|||
48864124|NCT01757171|157338042|FG001|Overall Study|Hospitalization|0|||
48864125|NCT01757171|157338041|FG000|Overall Study|ECOG decline|1|||
48864126|NCT01757171|157338042|FG001|Overall Study|ECOG decline|0|||
48864127|NCT00428441|157338043|FG000|Overall Study|Lost to Follow-up|1|||
48864128|NCT02205476|157338045|FG000|Overall Study|Study termination by Sponsor|7|||
48864129|NCT02205476|157338046|FG001|Overall Study|Study termination by Sponsor|3|||
48864130|NCT03708744|157338050|FG000|Overall Study|Withdrawal by Subject|0|||
48864131|NCT03708744|157338051|FG001|Overall Study|Withdrawal by Subject|0|||
48864132|NCT03708744|157338052|FG002|Overall Study|Withdrawal by Subject|1|||
48864133|NCT03708744|157338053|FG003|Overall Study|Withdrawal by Subject|0|||
48864134|NCT03751280|157338061|FG000|Overall Study|Adverse Event|0|||
48864135|NCT03751280|157338062|FG001|Overall Study|Adverse Event|1|||
48864136|NCT03751280|157338061|FG000|Overall Study|Lost to Follow-up|3|||
48864137|NCT03751280|157338062|FG001|Overall Study|Lost to Follow-up|5|||
48864138|NCT03751280|157338061|FG000|Overall Study|Physician Decision|0|||
48864139|NCT03751280|157338062|FG001|Overall Study|Physician Decision|2|||
48864140|NCT03751280|157338061|FG000|Overall Study|Protocol Violation|0|||
48864141|NCT03751280|157338062|FG001|Overall Study|Protocol Violation|2|||
48864142|NCT03751280|157338061|FG000|Overall Study|Withdrawal by Subject|5|||
48864143|NCT03751280|157338062|FG001|Overall Study|Withdrawal by Subject|2|||
48864144|NCT02625922|157338072|FG000|Overall Study|Non-availability of IMP|1|||
48864145|NCT02625922|157338073|FG001|Overall Study|Non-availability of IMP|1|||
48956694|NCT00430521|157669320|FG000|Overall Study|Withdrawal by Subject|3|||
48864146|NCT02625922|157338072|FG000|Overall Study|Systolic blood pressure < 125 mmHg|1|||
48864147|NCT02625922|157338073|FG001|Overall Study|Systolic blood pressure < 125 mmHg|1|||
48864148|NCT01047306|157338076|FG000|Overall Study|Withdrawal by Subject|2|||
48864149|NCT01047306|157338077|FG001|Overall Study|Withdrawal by Subject|0|||
48864150|NCT01047306|157338076|FG000|Overall Study|Lost to Follow-up|1|||
48864151|NCT01047306|157338077|FG001|Overall Study|Lost to Follow-up|0|||
48864152|NCT01527500|157338078|FG000|Part A|Administrative|11|||
48864153|NCT01527500|157338079|FG001|Part A|Administrative|7|||
48864154|NCT01527500|157338078|FG000|Part A|Adverse Event|4|||
48864155|NCT01527500|157338079|FG001|Part A|Adverse Event|2|||
48864156|NCT01527500|157338078|FG000|Part A|Death|4|||
48864157|NCT01527500|157338079|FG001|Part A|Death|1|||
48864158|NCT01527500|157338078|FG000|Part A|Lost to Follow-up|0|||
48864159|NCT01527500|157338079|FG001|Part A|Lost to Follow-up|1|||
48751999|NCT00368355|156936673|FG000|Overall Study|Treatment - hematopoietic cell product|2|||
48752000|NCT00368355|156936674|FG001|Overall Study|Treatment - hematopoietic cell product|0|||
48752001|NCT03655691|156936675|FG000|Overall Study|Adverse Event|0|||
48752002|NCT03655691|156936676|FG001|Overall Study|Adverse Event|0|||
48752003|NCT03655691|156936677|FG002|Overall Study|Adverse Event|1|||
48752004|NCT03655691|156936675|FG000|Overall Study|Lost to Follow-up|1|||
48752005|NCT03655691|156936676|FG001|Overall Study|Lost to Follow-up|1|||
48752006|NCT03655691|156936677|FG002|Overall Study|Lost to Follow-up|2|||
48752007|NCT03655691|156936675|FG000|Overall Study|Protocol Violation|0|||
48752008|NCT03655691|156936676|FG001|Overall Study|Protocol Violation|1|||
48752009|NCT03655691|156936677|FG002|Overall Study|Protocol Violation|0|||
48752010|NCT03655691|156936675|FG000|Overall Study|Withdrawal by Subject|1|||
48752011|NCT03655691|156936676|FG001|Overall Study|Withdrawal by Subject|1|||
48752012|NCT03655691|156936677|FG002|Overall Study|Withdrawal by Subject|0|||
48864160|NCT01527500|157338078|FG000|Part A|Protocol Deviation|9|||
48864161|NCT01527500|157338079|FG001|Part A|Protocol Deviation|2|||
48864162|NCT01527500|157338078|FG000|Part A|Withdrawal by Subject|2|||
48864163|NCT01527500|157338079|FG001|Part A|Withdrawal by Subject|0|||
48864164|NCT01527500|157338078|FG000|Part B|Adverse Event|1|||
48864165|NCT01527500|157338079|FG001|Part B|Adverse Event|0|||
48864166|NCT00850993|157338082|FG000|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
48864167|NCT00850993|157338083|FG001|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
48956695|NCT00430521|157669321|FG001|Overall Study|Withdrawal by Subject|1|||
48752013|NCT02846779|156936678|FG000|Overall Study|Lost Enrollment|83|||
48752014|NCT02846779|156936679|FG001|Overall Study|Lost Enrollment|82|||
48864168|NCT00850993|157338084|FG002|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
48752015|NCT02846779|156936680|FG002|Overall Study|Lost Enrollment|86|||
48864169|NCT00850993|157338085|FG003|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
48864170|NCT01023022|157338087|FG000|Overall Study|Death|5|||
48864171|NCT01023022|157338087|FG000|Overall Study|Lost to Follow-up|7|||
48864172|NCT01023022|157338087|FG000|Overall Study|due to technical issues|2|||
48752016|NCT02846779|156936678|FG000|Overall Study|Less than 31 days of follow-up|56|||
48752017|NCT02846779|156936679|FG001|Overall Study|Less than 31 days of follow-up|45|||
48752018|NCT02846779|156936680|FG002|Overall Study|Less than 31 days of follow-up|52|||
48752019|NCT01648101|156938200|FG000|Titration Phase (4 Weeks)|Protocol Violation|2|||
48956696|NCT00430521|157669322|FG002|Overall Study|Withdrawal by Subject|0|||
48956697|NCT00430521|157669323|FG003|Overall Study|Withdrawal by Subject|3|||
48956698|NCT00430521|157669324|FG004|Overall Study|Withdrawal by Subject|0|||
48956699|NCT00430521|157669325|FG005|Overall Study|Withdrawal by Subject|0|||
48956700|NCT00430521|157669326|FG006|Overall Study|Withdrawal by Subject|0|||
48956701|NCT00430521|157669327|FG007|Overall Study|Withdrawal by Subject|2|||
48956702|NCT03987620|157669328|FG000|Overall Study|Lack of Efficacy or Use of antifungal therapy|43|||
48956703|NCT03987620|157669329|FG001|Overall Study|Lack of Efficacy or Use of antifungal therapy|41|||
48956704|NCT03987620|157669328|FG000|Overall Study|Adverse Event|3|||
48956705|NCT03987620|157669329|FG001|Overall Study|Adverse Event|0|||
48956706|NCT03987620|157669328|FG000|Overall Study|Lost to Follow-up|1|||
48956707|NCT03987620|157669329|FG001|Overall Study|Lost to Follow-up|2|||
48956708|NCT03987620|157669328|FG000|Overall Study|Physician Decision|0|||
48956709|NCT03987620|157669329|FG001|Overall Study|Physician Decision|1|||
48956710|NCT03987620|157669328|FG000|Overall Study|Pregnancy|1|||
48956711|NCT03987620|157669329|FG001|Overall Study|Pregnancy|0|||
48956712|NCT03987620|157669328|FG000|Overall Study|Withdrawal by Subject|7|||
48956713|NCT03987620|157669329|FG001|Overall Study|Withdrawal by Subject|1|||
48956714|NCT03987620|157669328|FG000|Overall Study|Other|2|||
48956715|NCT03987620|157669329|FG001|Overall Study|Other|5|||
48956716|NCT03255291|157669330|FG000|Overall Study|Determined to be ineligible|10|||
48956717|NCT03255291|157669331|FG001|Overall Study|Determined to be ineligible|12|||
48956718|NCT03255291|157669332|FG002|Overall Study|Determined to be ineligible|6|||
48956719|NCT03255291|157669333|FG003|Overall Study|Determined to be ineligible|6|||
48956720|NCT03255291|157669334|FG004|Overall Study|Determined to be ineligible|5|||
48956721|NCT03255291|157669335|FG005|Overall Study|Determined to be ineligible|10|||
48956722|NCT03255291|157669330|FG000|Overall Study|Baseline data collection issues|3|||
48956723|NCT03255291|157669331|FG001|Overall Study|Baseline data collection issues|0|||
48956724|NCT03255291|157669332|FG002|Overall Study|Baseline data collection issues|0|||
48956725|NCT03255291|157669333|FG003|Overall Study|Baseline data collection issues|0|||
48752020|NCT01648101|156938201|FG001|Titration Phase (4 Weeks)|Protocol Violation|1|||
48752021|NCT01648101|156938202|FG002|Titration Phase (4 Weeks)|Protocol Violation|2|||
48752022|NCT01648101|156938200|FG000|Titration Phase (4 Weeks)|Adverse Event|0|||
48752023|NCT01648101|156938201|FG001|Titration Phase (4 Weeks)|Adverse Event|2|||
48752024|NCT01648101|156938202|FG002|Titration Phase (4 Weeks)|Adverse Event|3|||
48752025|NCT01648101|156938200|FG000|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
48752026|NCT01648101|156938201|FG001|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
48752027|NCT01648101|156938202|FG002|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1|||
48752028|NCT01648101|156938200|FG000|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
48752029|NCT01648101|156938201|FG001|Maintenance Phase (12 Weeks)|Withdrew Consent|0|||
48956726|NCT03255291|157669334|FG004|Overall Study|Baseline data collection issues|2|||
48956727|NCT03255291|157669335|FG005|Overall Study|Baseline data collection issues|0|||
48956728|NCT01655823|157669337|FG000|Overall Study|Lost to Follow-up|0|||
48956729|NCT01655823|157669338|FG001|Overall Study|Lost to Follow-up|1|||
48752030|NCT01648101|156938202|FG002|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
48752031|NCT01648101|156938200|FG000|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
48752032|NCT01648101|156938201|FG001|Maintenance Phase (12 Weeks)|Lack of Efficacy|0|||
48752033|NCT01648101|156938202|FG002|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
48752034|NCT01648101|156938200|FG000|Maintenance Phase (12 Weeks)|Adverse Event|1|||
48752035|NCT01648101|156938201|FG001|Maintenance Phase (12 Weeks)|Adverse Event|3|||
48752036|NCT01648101|156938202|FG002|Maintenance Phase (12 Weeks)|Adverse Event|4|||
48864173|NCT03023878|157338088|FG000|Pre-Study Run-In Period|Protocol-specified criteria|11|||
48752037|NCT01648101|156938200|FG000|Transition Phase (4 Weeks)|Adverse Event|4|||
48752038|NCT01648101|156938201|FG001|Transition Phase (4 Weeks)|Adverse Event|3|||
48752039|NCT01648101|156938202|FG002|Transition Phase (4 Weeks)|Adverse Event|2|||
48752040|NCT01648101|156938200|FG000|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
48752041|NCT01648101|156938201|FG001|Transition Phase (4 Weeks)|Lack of Efficacy|2|||
48752042|NCT01648101|156938202|FG002|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
48752043|NCT01648101|156938200|FG000|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
48752044|NCT01648101|156938201|FG001|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
48752045|NCT01648101|156938202|FG002|Transition Phase (4 Weeks)|Withdrawal by Subject|2|||
48752046|NCT01648101|156938200|FG000|Transition Phase (4 Weeks)|Study Terminated|1|||
48752047|NCT01648101|156938201|FG001|Transition Phase (4 Weeks)|Study Terminated|0|||
48752048|NCT01648101|156938202|FG002|Transition Phase (4 Weeks)|Study Terminated|0|||
48752049|NCT01648101|156938200|FG000|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
48752050|NCT01648101|156938201|FG001|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1|||
48752051|NCT01648101|156938202|FG002|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
48752052|NCT00307294|156938203|FG000|Overall Study|Withdrawal by Subject|1|||
48752053|NCT04203238|156938204|FG000|Overall Study|Withdrawal by Subject|1|||
48752054|NCT04203238|156938205|FG001|Overall Study|Withdrawal by Subject|1|||
48752055|NCT04203238|156938204|FG000|Overall Study|Covid-19|3|||
48752056|NCT04203238|156938205|FG001|Overall Study|Covid-19|0|||
48752057|NCT04221009|156938207|FG000|Overall Study|Withdrawal by Subject|4|||
48752058|NCT01438424|156938208|FG000|Overall Study|Continuing treatment|29|||
48752059|NCT01438424|156938208|FG000|Overall Study|Minimal virologic response|95|||
48752060|NCT01438424|156938208|FG000|Overall Study|Not identified|55|||
48752061|NCT01438424|156938208|FG000|Overall Study|Withdrawal by Subject|104|||
48752062|NCT01438424|156938208|FG000|Overall Study|Progression of chronic hepatitis B|22|||
48752063|NCT01438424|156938208|FG000|Overall Study|Death|22|||
48752064|NCT01438424|156938208|FG000|Overall Study|Adverse Event|17|||
48752065|NCT01438424|156938208|FG000|Overall Study|Lost to Follow-up|17|||
48752066|NCT01438424|156938208|FG000|Overall Study|Abnormal laboratory test result|14|||
48752067|NCT01438424|156938208|FG000|Overall Study|Need for drug prohibited by protocol|14|||
48752068|NCT01438424|156938208|FG000|Overall Study|Pregnancy|7|||
48752069|NCT01438424|156938208|FG000|Overall Study|No longer met inclusion criteria|1|||
48752070|NCT01438424|156938208|FG000|Overall Study|Participant noncompliance|20|||
48752071|NCT04232124|156938211|FG000|Overall Study|Lost to Follow-up|3|||
48752072|NCT02501473|156938220|FG000|Overall Study|Study Terminated|2|||
48752073|NCT02501473|156938221|FG001|Overall Study|Study Terminated|3|||
48752074|NCT02501473|156938222|FG002|Overall Study|Study Terminated|7|||
48752075|NCT02501473|156938223|FG003|Overall Study|Study Terminated|9|||
48752076|NCT02501473|156938224|FG004|Overall Study|Study Terminated|2|||
48752077|NCT02501473|156938225|FG005|Overall Study|Study Terminated|10|||
48752078|NCT02501473|156938226|FG006|Overall Study|Study Terminated|1|||
48752079|NCT02501473|156938227|FG007|Overall Study|Study Terminated|0|||
48752080|NCT02501473|156938220|FG000|Overall Study|Withdrawal by Subject|0|||
48752081|NCT02501473|156938221|FG001|Overall Study|Withdrawal by Subject|0|||
48752082|NCT02501473|156938222|FG002|Overall Study|Withdrawal by Subject|3|||
48752083|NCT02501473|156938223|FG003|Overall Study|Withdrawal by Subject|3|||
48752084|NCT02501473|156938224|FG004|Overall Study|Withdrawal by Subject|2|||
48752085|NCT02501473|156938225|FG005|Overall Study|Withdrawal by Subject|2|||
48752086|NCT02501473|156938226|FG006|Overall Study|Withdrawal by Subject|0|||
48752087|NCT02501473|156938227|FG007|Overall Study|Withdrawal by Subject|0|||
48752088|NCT02501473|156938220|FG000|Overall Study|Death|0|||
48752089|NCT02501473|156938221|FG001|Overall Study|Death|0|||
48752090|NCT02501473|156938222|FG002|Overall Study|Death|1|||
48864174|NCT03023878|157338088|FG000|Pre-Study Run-In Period|Death|1|||
48864175|NCT03023878|157338088|FG000|Pre-Study Run-In Period|Withdrawal by Subject|5|||
48864176|NCT03023878|157338088|FG000|Between Run-In and Treatment Periods|Protocol-specified criteria|2|||
48864177|NCT03023878|157338088|FG000|Treatment Period|Disease Progression|1|||
48864178|NCT03023878|157338088|FG000|Treatment Period|Withdrawal by Subject|1|||
48864179|NCT03023878|157338088|FG000|Treatment Period|Adverse Event|1|||
48752091|NCT02501473|156938223|FG003|Overall Study|Death|1|||
48752092|NCT02501473|156938224|FG004|Overall Study|Death|0|||
48752093|NCT02501473|156938225|FG005|Overall Study|Death|1|||
48752094|NCT02501473|156938226|FG006|Overall Study|Death|0|||
48752095|NCT02501473|156938227|FG007|Overall Study|Death|0|||
48752096|NCT02501473|156938220|FG000|Overall Study|Lost to Follow-up|1|||
48752097|NCT02501473|156938221|FG001|Overall Study|Lost to Follow-up|0|||
48752098|NCT02501473|156938222|FG002|Overall Study|Lost to Follow-up|1|||
48752099|NCT02501473|156938223|FG003|Overall Study|Lost to Follow-up|0|||
48752100|NCT02501473|156938224|FG004|Overall Study|Lost to Follow-up|0|||
48752101|NCT02501473|156938225|FG005|Overall Study|Lost to Follow-up|1|||
48752102|NCT02501473|156938226|FG006|Overall Study|Lost to Follow-up|0|||
48752103|NCT02501473|156938227|FG007|Overall Study|Lost to Follow-up|0|||
48752104|NCT02501473|156938220|FG000|Overall Study|Reason not specified|0|||
48752105|NCT02501473|156938221|FG001|Overall Study|Reason not specified|0|||
48752106|NCT02501473|156938222|FG002|Overall Study|Reason not specified|1|||
48752107|NCT02501473|156938223|FG003|Overall Study|Reason not specified|1|||
48752108|NCT02501473|156938224|FG004|Overall Study|Reason not specified|0|||
48752109|NCT02501473|156938225|FG005|Overall Study|Reason not specified|0|||
48752110|NCT02501473|156938226|FG006|Overall Study|Reason not specified|0|||
48752111|NCT02501473|156938227|FG007|Overall Study|Reason not specified|0|||
48752112|NCT02927080|156938230|FG000|Overall Study|Withdrawal by Subject|0|||
48752113|NCT02927080|156938231|FG001|Overall Study|Withdrawal by Subject|0|||
48752114|NCT02927080|156938232|FG002|Overall Study|Withdrawal by Subject|0|||
48752115|NCT02927080|156938233|FG003|Overall Study|Withdrawal by Subject|0|||
48752116|NCT02927080|156938234|FG004|Overall Study|Withdrawal by Subject|1|||
48752117|NCT02927080|156938235|FG005|Overall Study|Withdrawal by Subject|0|||
48752118|NCT02927080|156938236|FG006|Overall Study|Withdrawal by Subject|1|||
48752119|NCT02927080|156938237|FG007|Overall Study|Withdrawal by Subject|1|||
48752120|NCT02927080|156938238|FG008|Overall Study|Withdrawal by Subject|0|||
48752121|NCT02927080|156938239|FG009|Overall Study|Withdrawal by Subject|2|||
48752122|NCT02927080|156938230|FG000|Overall Study|Willingness to comply with protocol|0|||
48752123|NCT02927080|156938231|FG001|Overall Study|Willingness to comply with protocol|0|||
48752124|NCT02927080|156938232|FG002|Overall Study|Willingness to comply with protocol|0|||
48752125|NCT02927080|156938233|FG003|Overall Study|Willingness to comply with protocol|0|||
48752126|NCT02927080|156938234|FG004|Overall Study|Willingness to comply with protocol|0|||
48956730|NCT01655823|157669339|FG002|Overall Study|Lost to Follow-up|0|||
48752127|NCT02927080|156938235|FG005|Overall Study|Willingness to comply with protocol|0|||
48752128|NCT02927080|156938236|FG006|Overall Study|Willingness to comply with protocol|0|||
48956731|NCT01655823|157669340|FG003|Overall Study|Lost to Follow-up|0|||
48752129|NCT02927080|156938237|FG007|Overall Study|Willingness to comply with protocol|0|||
48752130|NCT02927080|156938238|FG008|Overall Study|Willingness to comply with protocol|0|||
48752131|NCT02927080|156938239|FG009|Overall Study|Willingness to comply with protocol|1|||
48752132|NCT02927080|156938230|FG000|Overall Study|Study terminated by Sponsor|0|||
48752133|NCT02927080|156938231|FG001|Overall Study|Study terminated by Sponsor|0|||
48956732|NCT01655823|157669341|FG004|Overall Study|Lost to Follow-up|1|||
48752134|NCT02927080|156938232|FG002|Overall Study|Study terminated by Sponsor|0|||
48752135|NCT02927080|156938233|FG003|Overall Study|Study terminated by Sponsor|0|||
48752136|NCT02927080|156938234|FG004|Overall Study|Study terminated by Sponsor|0|||
48752137|NCT02927080|156938235|FG005|Overall Study|Study terminated by Sponsor|0|||
48752138|NCT02927080|156938236|FG006|Overall Study|Study terminated by Sponsor|6|||
48956733|NCT01655823|157669337|FG000|Overall Study|Withdrawal by Subject|0|||
48752139|NCT02927080|156938237|FG007|Overall Study|Study terminated by Sponsor|7|||
48864180|NCT03023878|157338088|FG000|Long Term Follow-Up Period|Death|2|||
48864181|NCT01812837|157338089|FG000|Overall Study|Lost to Follow-up|1|||
48864182|NCT01812837|157338090|FG001|Overall Study|Lost to Follow-up|1|||
48864183|NCT01812837|157338091|FG002|Overall Study|Lost to Follow-up|0|||
48864184|NCT01812837|157338089|FG000|Overall Study|Protocol Violation|1|||
48864185|NCT01812837|157338090|FG001|Overall Study|Protocol Violation|0|||
48864186|NCT01812837|157338091|FG002|Overall Study|Protocol Violation|0|||
48864187|NCT03779334|157338092|FG000|Overall Study|Withdrawal by Subject|3|||
48864188|NCT03779334|157338093|FG001|Overall Study|Withdrawal by Subject|0|||
48864189|NCT03779334|157338094|FG002|Overall Study|Withdrawal by Subject|0|||
48864190|NCT03779334|157338092|FG000|Overall Study|Ongoing in Study|5|||
48864191|NCT03779334|157338093|FG001|Overall Study|Ongoing in Study|13|||
48864192|NCT03779334|157338094|FG002|Overall Study|Ongoing in Study|5|||
48864193|NCT02849509|157338095|FG000|Overall Study|Worsening of disease under study|1|||
48864194|NCT02849509|157338096|FG001|Overall Study|Worsening of disease under study|1|||
48864195|NCT02849509|157338097|FG002|Overall Study|Worsening of disease under study|1|||
48864196|NCT02849509|157338095|FG000|Overall Study|Worsening of other pre-existing disease|0|||
48864197|NCT02849509|157338096|FG001|Overall Study|Worsening of other pre-existing disease|1|||
48864198|NCT02849509|157338097|FG002|Overall Study|Worsening of other pre-existing disease|2|||
48864199|NCT02849509|157338095|FG000|Overall Study|Other adverse event|36|||
48864200|NCT02849509|157338096|FG001|Overall Study|Other adverse event|41|||
48864201|NCT02849509|157338097|FG002|Overall Study|Other adverse event|8|||
48864202|NCT02849509|157338095|FG000|Overall Study|Withdrawal by Subject|6|||
48864203|NCT02849509|157338096|FG001|Overall Study|Withdrawal by Subject|17|||
48864204|NCT02849509|157338097|FG002|Overall Study|Withdrawal by Subject|12|||
48864205|NCT02849509|157338095|FG000|Overall Study|Lost to Follow-up|27|||
48864206|NCT02849509|157338096|FG001|Overall Study|Lost to Follow-up|67|||
48864207|NCT02849509|157338097|FG002|Overall Study|Lost to Follow-up|36|||
48864208|NCT02849509|157338095|FG000|Overall Study|Other, reason not specified|14|||
48864209|NCT02849509|157338096|FG001|Overall Study|Other, reason not specified|29|||
48864210|NCT02849509|157338097|FG002|Overall Study|Other, reason not specified|25|||
48864211|NCT02849509|157338095|FG000|Overall Study|No inform. on termination of Pradaxa/VKA|6|||
48864212|NCT02849509|157338096|FG001|Overall Study|No inform. on termination of Pradaxa/VKA|10|||
48864213|NCT02849509|157338097|FG002|Overall Study|No inform. on termination of Pradaxa/VKA|1|||
48864214|NCT00577096|157338098|FG000|Short Term Participation|withdrew from multiple myeloma treatment|3|||
49015406|NCT00860028|157892172|FG000|Placebo Controlled Pretreatment Period|No longer interested in treatment|2|||
48752140|NCT02927080|156938238|FG008|Overall Study|Study terminated by Sponsor|2|||
48752141|NCT02927080|156938239|FG009|Overall Study|Study terminated by Sponsor|3|||
48752142|NCT02927080|156938230|FG000|Overall Study|Adverse Event|0|||
48752143|NCT02927080|156938231|FG001|Overall Study|Adverse Event|1|||
48752144|NCT02927080|156938232|FG002|Overall Study|Adverse Event|0|||
48752145|NCT02927080|156938233|FG003|Overall Study|Adverse Event|0|||
48752146|NCT02927080|156938234|FG004|Overall Study|Adverse Event|0|||
48752147|NCT02927080|156938235|FG005|Overall Study|Adverse Event|0|||
48752148|NCT02927080|156938236|FG006|Overall Study|Adverse Event|0|||
48752149|NCT02927080|156938237|FG007|Overall Study|Adverse Event|1|||
48752150|NCT02927080|156938238|FG008|Overall Study|Adverse Event|0|||
48752151|NCT02927080|156938239|FG009|Overall Study|Adverse Event|1|||
48752152|NCT02927080|156938230|FG000|Overall Study|Other|0|||
48752153|NCT02927080|156938231|FG001|Overall Study|Other|0|||
48752154|NCT02927080|156938232|FG002|Overall Study|Other|0|||
48752155|NCT02927080|156938233|FG003|Overall Study|Other|0|||
48752156|NCT02927080|156938234|FG004|Overall Study|Other|0|||
48752157|NCT02927080|156938235|FG005|Overall Study|Other|0|||
48752158|NCT02927080|156938236|FG006|Overall Study|Other|1|||
48752159|NCT02927080|156938237|FG007|Overall Study|Other|0|||
48752160|NCT02927080|156938238|FG008|Overall Study|Other|1|||
48752161|NCT02927080|156938239|FG009|Overall Study|Other|0|||
48752162|NCT02507505|156938242|FG000|Overall Study|Withdrawal by Subject|13|||
48752163|NCT02507505|156938243|FG001|Overall Study|Withdrawal by Subject|11|||
48752164|NCT02507505|156938242|FG000|Overall Study|Participant unable to be contacted within 60-day interview window|56|||
48752165|NCT02507505|156938243|FG001|Overall Study|Participant unable to be contacted within 60-day interview window|44|||
48752166|NCT02507505|156938242|FG000|Overall Study|Participant contacted but walking status was unknown|14|||
48752167|NCT02507505|156938243|FG001|Overall Study|Participant contacted but walking status was unknown|16|||
48752168|NCT02507505|156938242|FG000|Overall Study|Death before receipt of anesthesia|0|||
48752169|NCT02507505|156938243|FG001|Overall Study|Death before receipt of anesthesia|1|||
48752170|NCT00609492|156938244|FG000|Overall Study|Withdrawal by Subject|0|||
48752171|NCT00609492|156938245|FG001|Overall Study|Withdrawal by Subject|2|||
48956734|NCT01655823|157669338|FG001|Overall Study|Withdrawal by Subject|1|||
48956735|NCT01655823|157669339|FG002|Overall Study|Withdrawal by Subject|0|||
48956736|NCT01655823|157669340|FG003|Overall Study|Withdrawal by Subject|1|||
48956737|NCT01655823|157669341|FG004|Overall Study|Withdrawal by Subject|0|||
48956738|NCT00894413|157669344|FG000|Overall Study|Physician Decision|0|||
48956739|NCT00894413|157669345|FG001|Overall Study|Physician Decision|2|||
48752172|NCT00609492|156938246|FG002|Overall Study|Withdrawal by Subject|3|||
48752173|NCT00609492|156938244|FG000|Overall Study|Lost to Follow-up|1|||
48752174|NCT00609492|156938245|FG001|Overall Study|Lost to Follow-up|1|||
48752175|NCT00609492|156938246|FG002|Overall Study|Lost to Follow-up|4|||
48752176|NCT01104493|156938247|FG000|Overall Study|Lost to Follow-up|0|||
48752177|NCT01104493|156938248|FG001|Overall Study|Lost to Follow-up|2|||
48752178|NCT01414114|156938249|FG000|Overall Study|Adverse Event|2|||
48752179|NCT01414114|156938249|FG000|Overall Study|Withdrawal by Subject|1|||
48752180|NCT01414114|156938249|FG000|Overall Study|Other|2|||
48752181|NCT00010374|156938256|FG000|Overall Study|False positive phrenic nerve test|1|||
48752182|NCT00553644|156938257|FG000|Overall Study|Adverse Event|17|||
48752183|NCT00553644|156938257|FG000|Overall Study|Withdrawal by Subject|4|||
48752184|NCT00553644|156938257|FG000|Overall Study|Physician Decision|1|||
48752185|NCT00553644|156938257|FG000|Overall Study|Alternative therapy|6|||
48752186|NCT01402492|156938258|FG000|Overall Study|Withdrawal by Subject|17|||
48752187|NCT01402492|156938259|FG001|Overall Study|Withdrawal by Subject|11|||
48752188|NCT01402492|156938260|FG002|Overall Study|Withdrawal by Subject|11|||
48752189|NCT01402492|156938258|FG000|Overall Study|Adverse Event|2|||
48752190|NCT01402492|156938259|FG001|Overall Study|Adverse Event|3|||
48752191|NCT01402492|156938260|FG002|Overall Study|Adverse Event|4|||
48752192|NCT01402492|156938258|FG000|Overall Study|Physician Decision|0|||
48752193|NCT01402492|156938259|FG001|Overall Study|Physician Decision|3|||
48752194|NCT01402492|156938260|FG002|Overall Study|Physician Decision|0|||
48752195|NCT01402492|156938258|FG000|Overall Study|Incarcerated (N=3)|2|||
48752196|NCT01402492|156938259|FG001|Overall Study|Incarcerated (N=3)|0|||
48752197|NCT01402492|156938260|FG002|Overall Study|Incarcerated (N=3)|1|||
48752198|NCT02927431|156938261|FG000|Overall Study|Withdrawal by Subject|0|||
48752199|NCT02927431|156938262|FG001|Overall Study|Withdrawal by Subject|0|||
48752200|NCT02927431|156938263|FG002|Overall Study|Withdrawal by Subject|1|||
48752201|NCT02117648|156938264|FG000|Abemaciclib Alone Period 1|Withdrawal by Subject|1|||
48752202|NCT02117648|156938264|FG000|Abemaciclib Alone Period 1|Adverse Event|1|||
48752203|NCT02117648|156938264|FG000|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1|||
48752204|NCT02117648|156938264|FG000|Abemaciclib + Clarithromycin Period 2|Death|1|||
48752205|NCT02117648|156938264|FG000|Abemaciclib + Clarithromycin Period 2|Adverse Event|1|||
48752206|NCT02117648|156938264|FG000|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1|||
48752207|NCT02117648|156938264|FG000|Abemaciclib Safety-Extension Phase|Progressive Disease|12|||
48956740|NCT00894413|157669344|FG000|Overall Study|Adverse Event|0|||
48752208|NCT02117648|156938264|FG000|Abemaciclib Safety-Extension Phase|Physician Decision|1|||
48956741|NCT00894413|157669345|FG001|Overall Study|Adverse Event|2|||
48956742|NCT00894413|157669344|FG000|Overall Study|Withdrawal by Subject|0|||
48752209|NCT02117648|156938264|FG000|Abemaciclib Safety-Extension Phase|Death|3|||
48752210|NCT02117648|156938264|FG000|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2|||
48956743|NCT00894413|157669345|FG001|Overall Study|Withdrawal by Subject|4|||
48956744|NCT01931462|157671077|FG000|Overall Study|Withdrawal by Subject|1|||
48752211|NCT02117648|156938264|FG000|Abemaciclib Safety-Extension Phase|Adverse Event|2|||
48752212|NCT02266225|156938267|FG000|Overall Study|Lost to Follow-up|2|||
48752213|NCT02266225|156938267|FG000|Overall Study|Death|1|||
48752214|NCT02266225|156938267|FG000|Overall Study|Withdrawal by Subject|13|||
48752215|NCT01442675|156938269|FG000|Overall Study|Protocol Violation|6|||
48956745|NCT02819310|157671078|FG000|Overall Study|Withdrawal by Subject|37|||
48864215|NCT00577096|157338099|FG001|Short Term Participation|withdrew from multiple myeloma treatment|2|||
48864216|NCT00577096|157338098|FG000|Short Term Participation|Withdrawal by Subject|3|||
48864217|NCT00577096|157338099|FG001|Short Term Participation|Withdrawal by Subject|5|||
48864218|NCT00577096|157338098|FG000|Short Term Participation|Death|1|||
48864219|NCT00577096|157338099|FG001|Short Term Participation|Death|1|||
48864220|NCT00794573|157338101|FG000|Overall Study|Death|3|||
48864221|NCT00794573|157338102|FG001|Overall Study|Death|0|||
48864222|NCT00794573|157338101|FG000|Overall Study|Withdrawal by Subject|9|||
48864223|NCT00794573|157338102|FG001|Overall Study|Withdrawal by Subject|12|||
48864224|NCT00794573|157338101|FG000|Overall Study|Lost to Follow-up|26|||
48864225|NCT00794573|157338102|FG001|Overall Study|Lost to Follow-up|33|||
48864226|NCT04582864|157338105|FG000|Overall Study|Did not complete cycle 1 due to disease progression|2|||
48864227|NCT04582864|157338105|FG000|Overall Study|Death|1|||
48864228|NCT04374253|157338106|FG000|Overall Study|Adverse Event|0|||
48864229|NCT04374253|157338107|FG001|Overall Study|Adverse Event|26|||
48864230|NCT04374253|157338108|FG002|Overall Study|Adverse Event|2|||
48864231|NCT04374253|157338109|FG003|Overall Study|Adverse Event|12|||
48864232|NCT04374253|157338106|FG000|Overall Study|Study terminated by sponsor|13|||
48864233|NCT04374253|157338107|FG001|Overall Study|Study terminated by sponsor|593|||
48864234|NCT04374253|157338108|FG002|Overall Study|Study terminated by sponsor|21|||
48864235|NCT04374253|157338109|FG003|Overall Study|Study terminated by sponsor|567|||
48864236|NCT04374253|157338106|FG000|Overall Study|Withdrawal by Subject|0|||
48864237|NCT04374253|157338107|FG001|Overall Study|Withdrawal by Subject|55|||
48864238|NCT04374253|157338108|FG002|Overall Study|Withdrawal by Subject|3|||
48864239|NCT04374253|157338109|FG003|Overall Study|Withdrawal by Subject|40|||
48864240|NCT04374253|157338106|FG000|Overall Study|Physician Decision|1|||
48864241|NCT04374253|157338107|FG001|Overall Study|Physician Decision|10|||
48864242|NCT04374253|157338108|FG002|Overall Study|Physician Decision|1|||
48864243|NCT04374253|157338109|FG003|Overall Study|Physician Decision|10|||
48864244|NCT04374253|157338106|FG000|Overall Study|Protocol Violation|0|||
48864245|NCT04374253|157338107|FG001|Overall Study|Protocol Violation|0|||
48864246|NCT04374253|157338108|FG002|Overall Study|Protocol Violation|0|||
48864247|NCT04374253|157338109|FG003|Overall Study|Protocol Violation|2|||
48864248|NCT04374253|157338106|FG000|Overall Study|Death|0|||
48864249|NCT04374253|157338107|FG001|Overall Study|Death|3|||
48864250|NCT04374253|157338108|FG002|Overall Study|Death|1|||
48864251|NCT04374253|157338109|FG003|Overall Study|Death|1|||
48864252|NCT04374253|157338106|FG000|Overall Study|Lack of Efficacy|0|||
48864253|NCT04374253|157338107|FG001|Overall Study|Lack of Efficacy|0|||
48864254|NCT04374253|157338108|FG002|Overall Study|Lack of Efficacy|0|||
48864255|NCT04374253|157338109|FG003|Overall Study|Lack of Efficacy|1|||
48864256|NCT04374253|157338106|FG000|Overall Study|Lost to Follow-up|1|||
48864257|NCT04374253|157338107|FG001|Overall Study|Lost to Follow-up|1|||
48864258|NCT04374253|157338108|FG002|Overall Study|Lost to Follow-up|0|||
48864259|NCT04374253|157338109|FG003|Overall Study|Lost to Follow-up|2|||
48864260|NCT04374253|157338106|FG000|Overall Study|Reason Not Specified|0|||
48864261|NCT04374253|157338107|FG001|Overall Study|Reason Not Specified|8|||
48864262|NCT04374253|157338108|FG002|Overall Study|Reason Not Specified|0|||
48864263|NCT04374253|157338109|FG003|Overall Study|Reason Not Specified|8|||
48864264|NCT01482819|157338110|FG000|Overall Study|Lost to Follow-up|2|||
48864265|NCT01636778|157338113|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3|||
48864266|NCT01636778|157338114|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
48864267|NCT01636778|157338115|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
48864268|NCT01636778|157338113|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1|||
48864269|NCT01636778|157338114|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
48864270|NCT01636778|157338115|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
48864271|NCT01636778|157338113|FG000|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
48864272|NCT01636778|157338114|FG001|Antiviral Treatment Period (Part 2)|Adverse Event|7|||
48864273|NCT01636778|157338115|FG002|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
48864274|NCT01636778|157338113|FG000|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
48864275|NCT01636778|157338114|FG001|Antiviral Treatment Period (Part 2)|Protocol Violation|1|||
48864276|NCT01636778|157338115|FG002|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
48864277|NCT01636778|157338113|FG000|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
48864278|NCT01636778|157338114|FG001|Antiviral Treatment Period (Part 2)|Physician Decision|2|||
48864279|NCT01636778|157338115|FG002|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
48864280|NCT01636778|157338113|FG000|Follow-up Period After Part 2|Other|0|||
48864281|NCT01636778|157338114|FG001|Follow-up Period After Part 2|Other|0|||
48864282|NCT01636778|157338115|FG002|Follow-up Period After Part 2|Other|1|||
48864283|NCT01636778|157338113|FG000|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
48864284|NCT01636778|157338114|FG001|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
48864285|NCT01636778|157338115|FG002|Follow-up Period After Part 2|Not entered FU period after withdrawal|1|||
48864286|NCT01636778|157338113|FG000|Follow-up Period After Part 2|Withdrawal by Subject|0|||
48864287|NCT01636778|157338114|FG001|Follow-up Period After Part 2|Withdrawal by Subject|0|||
48864288|NCT01636778|157338115|FG002|Follow-up Period After Part 2|Withdrawal by Subject|2|||
48864289|NCT03302559|157338118|FG000|Overall Study|Adverse Event|2|||
48864290|NCT03302559|157338118|FG000|Overall Study|Lost to Follow-up|1|||
48864291|NCT03302559|157338118|FG000|Overall Study|Withdrew Consent|3|||
48864292|NCT00714688|157338119|FG000|Overall Study|Lack of Efficacy|14|||
48864293|NCT00714688|157338120|FG001|Overall Study|Lack of Efficacy|1|||
48864294|NCT00714688|157338121|FG002|Overall Study|Lack of Efficacy|4|||
48864295|NCT00714688|157338119|FG000|Overall Study|Withdrawal by Subject|4|||
48864296|NCT00714688|157338120|FG001|Overall Study|Withdrawal by Subject|3|||
48864297|NCT00714688|157338121|FG002|Overall Study|Withdrawal by Subject|3|||
48864298|NCT00714688|157338119|FG000|Overall Study|Lost to Follow-up|5|||
48864299|NCT00714688|157338120|FG001|Overall Study|Lost to Follow-up|2|||
48864300|NCT00714688|157338121|FG002|Overall Study|Lost to Follow-up|0|||
48864301|NCT00714688|157338119|FG000|Overall Study|Adverse Event|2|||
48864302|NCT00714688|157338120|FG001|Overall Study|Adverse Event|15|||
48864303|NCT00714688|157338121|FG002|Overall Study|Adverse Event|19|||
48864304|NCT00714688|157338119|FG000|Overall Study|Subject Non-compliant|3|||
48864305|NCT00714688|157338120|FG001|Overall Study|Subject Non-compliant|5|||
48864306|NCT00714688|157338121|FG002|Overall Study|Subject Non-compliant|5|||
48864307|NCT00714688|157338119|FG000|Overall Study|Ineligible to Continue the Study|0|||
48864308|NCT00714688|157338120|FG001|Overall Study|Ineligible to Continue the Study|1|||
48864309|NCT00714688|157338121|FG002|Overall Study|Ineligible to Continue the Study|1|||
48864310|NCT00714688|157338119|FG000|Overall Study|Sponsor's Decision|0|||
48864311|NCT00714688|157338120|FG001|Overall Study|Sponsor's Decision|2|||
48864312|NCT00714688|157338121|FG002|Overall Study|Sponsor's Decision|0|||
48864313|NCT00714688|157338119|FG000|Overall Study|Other|1|||
48864314|NCT00714688|157338120|FG001|Overall Study|Other|6|||
48864315|NCT00714688|157338121|FG002|Overall Study|Other|5|||
48864316|NCT04150250|157338122|FG000|Overall Study|Lost to Follow-up|0|||
48864317|NCT04150250|157338123|FG001|Overall Study|Lost to Follow-up|2|||
48864318|NCT02154516|157338124|FG000|Overall Study|Withdrawal by Subject|0|||
48864319|NCT02154516|157338125|FG001|Overall Study|Withdrawal by Subject|1|||
48864320|NCT02154516|157338124|FG000|Overall Study|Lost to Follow-up|1|||
48864321|NCT02154516|157338125|FG001|Overall Study|Lost to Follow-up|0|||
48864322|NCT02154516|157338124|FG000|Overall Study|Removal/revision of device|1|||
48864323|NCT02154516|157338125|FG001|Overall Study|Removal/revision of device|0|||
48864324|NCT02154516|157338124|FG000|Overall Study|Death|2|||
48864325|NCT02154516|157338125|FG001|Overall Study|Death|1|||
48864326|NCT04267393|157338126|FG000|Randomization|Adverse Event|1|||
48864327|NCT04267393|157338127|FG001|Randomization|Adverse Event|0|||
48864328|NCT04267393|157338128|FG002|Randomization|Adverse Event|0|||
48864329|NCT04267393|157338126|FG000|Randomization|Administrative Reasons by Sponsor|0|||
48864330|NCT04267393|157338127|FG001|Randomization|Administrative Reasons by Sponsor|1|||
48864331|NCT04267393|157338128|FG002|Randomization|Administrative Reasons by Sponsor|0|||
48864332|NCT04267393|157338126|FG000|Treatment Period|Adverse Event|0|||
48864333|NCT04267393|157338127|FG001|Treatment Period|Adverse Event|2|||
48864334|NCT04267393|157338128|FG002|Treatment Period|Adverse Event|3|||
48864335|NCT04267393|157338126|FG000|Treatment Period|Participant Withdrew Consent|0|||
48864336|NCT04267393|157338127|FG001|Treatment Period|Participant Withdrew Consent|0|||
48864337|NCT04267393|157338128|FG002|Treatment Period|Participant Withdrew Consent|1|||
48864338|NCT04267393|157338126|FG000|Treatment Period|Administrative Reasons by Sponsor|3|||
48864339|NCT04267393|157338127|FG001|Treatment Period|Administrative Reasons by Sponsor|4|||
48864340|NCT04267393|157338128|FG002|Treatment Period|Administrative Reasons by Sponsor|3|||
48864341|NCT02056873|157338129|FG000|Responsive DBS|CDBS parameters of 3 subjects|3|||
48864342|NCT02556918|157340097|FG000|Overall Study|Protocol Violation|5|||
48864343|NCT02556918|157340098|FG001|Overall Study|Protocol Violation|6|||
48864344|NCT02556918|157340097|FG000|Overall Study|Withdrawal by Subject|4|||
48864345|NCT02556918|157340098|FG001|Overall Study|Withdrawal by Subject|4|||
48864346|NCT02081196|157340099|FG000|Overall Study|Lost to Follow-up|1|||
48864347|NCT01276509|157340100|FG000|Overall Study|Adverse Event|9|||
48864348|NCT01276509|157340101|FG001|Overall Study|Adverse Event|8|||
48864349|NCT01276509|157340102|FG002|Overall Study|Adverse Event|4|||
48864350|NCT01276509|157340103|FG003|Overall Study|Adverse Event|3|||
48864351|NCT01276509|157340100|FG000|Overall Study|Lack of Efficacy|2|||
48864352|NCT01276509|157340101|FG001|Overall Study|Lack of Efficacy|1|||
48864353|NCT01276509|157340102|FG002|Overall Study|Lack of Efficacy|1|||
48864354|NCT01276509|157340103|FG003|Overall Study|Lack of Efficacy|2|||
48864355|NCT01276509|157340100|FG000|Overall Study|Pregnancy|1|||
48864356|NCT01276509|157340101|FG001|Overall Study|Pregnancy|0|||
48864357|NCT01276509|157340102|FG002|Overall Study|Pregnancy|0|||
48864358|NCT01276509|157340103|FG003|Overall Study|Pregnancy|0|||
48864359|NCT01276509|157340100|FG000|Overall Study|Withdrawal by Subject|1|||
48864360|NCT01276509|157340101|FG001|Overall Study|Withdrawal by Subject|2|||
48864361|NCT01276509|157340102|FG002|Overall Study|Withdrawal by Subject|0|||
48864362|NCT01276509|157340103|FG003|Overall Study|Withdrawal by Subject|0|||
48864363|NCT01276509|157340100|FG000|Overall Study|Other|0|||
48864364|NCT01276509|157340101|FG001|Overall Study|Other|1|||
48864365|NCT01276509|157340102|FG002|Overall Study|Other|0|||
48864366|NCT01276509|157340103|FG003|Overall Study|Other|0|||
48864367|NCT01020487|157340104|FG000|Part 2 Double-blind Treatment Period|Adverse Event|0|||
48864368|NCT01020487|157340105|FG001|Part 2 Double-blind Treatment Period|Adverse Event|2|||
48864369|NCT01020487|157340106|FG002|Part 2 Double-blind Treatment Period|Adverse Event|1|||
48864370|NCT01020487|157340104|FG000|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
48864371|NCT01020487|157340105|FG001|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
48864372|NCT01020487|157340106|FG002|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1|||
48864373|NCT01020487|157340104|FG000|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
48864374|NCT01020487|157340105|FG001|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
48864375|NCT01020487|157340106|FG002|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3|||
48864376|NCT01020487|157340104|FG000|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
48864377|NCT01020487|157340105|FG001|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
48864378|NCT01020487|157340106|FG002|Part 2 Double-blind Treatment Period|Randomized in Error|1|||
48864379|NCT01020487|157340104|FG000|Part 2 Open-label Period|Adverse Event|0|||
48864380|NCT01020487|157340105|FG001|Part 2 Open-label Period|Adverse Event|4|||
48864381|NCT01020487|157340106|FG002|Part 2 Open-label Period|Adverse Event|1|||
48864382|NCT03050372|157340107|FG000|Adaptation Night (Night #1 PSG)|Adverse Event|1|||
48864383|NCT03050372|157340108|FG001|Adaptation Night (Night #1 PSG)|Adverse Event|0|||
48864384|NCT03050372|157340107|FG000|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0|||
48864385|NCT03050372|157340108|FG001|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1|||
48864386|NCT00228813|157340109|FG000|Overall Study|Death|4|||
48864387|NCT01375777|157340117|FG000|Overall Study|Withdrawal by Subject|0|||
48864388|NCT01375777|157340118|FG001|Overall Study|Withdrawal by Subject|2|||
48864389|NCT01375777|157340119|FG002|Overall Study|Withdrawal by Subject|1|||
48864390|NCT01375777|157340120|FG003|Overall Study|Withdrawal by Subject|0|||
48864391|NCT01375777|157340121|FG004|Overall Study|Withdrawal by Subject|1|||
48864392|NCT01375777|157340122|FG005|Overall Study|Withdrawal by Subject|1|||
48864393|NCT01375777|157340123|FG006|Overall Study|Withdrawal by Subject|1|||
48864394|NCT01375777|157340124|FG007|Overall Study|Withdrawal by Subject|2|||
48864395|NCT01375777|157340125|FG008|Overall Study|Withdrawal by Subject|1|||
48864396|NCT01375777|157340117|FG000|Overall Study|Lost to Follow-up|1|||
48864397|NCT01375777|157340118|FG001|Overall Study|Lost to Follow-up|0|||
48956746|NCT02819310|157671078|FG000|Overall Study|Lost to Follow-up|16|||
48864398|NCT01375777|157340119|FG002|Overall Study|Lost to Follow-up|0|||
48864399|NCT01375777|157340120|FG003|Overall Study|Lost to Follow-up|0|||
48864400|NCT01375777|157340121|FG004|Overall Study|Lost to Follow-up|0|||
48864401|NCT01375777|157340122|FG005|Overall Study|Lost to Follow-up|0|||
48864402|NCT01375777|157340123|FG006|Overall Study|Lost to Follow-up|1|||
48864403|NCT01375777|157340124|FG007|Overall Study|Lost to Follow-up|0|||
48864404|NCT01375777|157340125|FG008|Overall Study|Lost to Follow-up|0|||
48864405|NCT01375777|157340117|FG000|Overall Study|Other|1|||
48864406|NCT01375777|157340118|FG001|Overall Study|Other|1|||
48864407|NCT01375777|157340119|FG002|Overall Study|Other|0|||
48864408|NCT01375777|157340120|FG003|Overall Study|Other|0|||
48752216|NCT01442675|156938269|FG000|Overall Study|Lost to Follow-up|2|||
48752217|NCT01442675|156938269|FG000|Overall Study|Withdrawal by Subject|4|||
48752218|NCT00211809|156938270|FG000|Overall Study|Lack of Efficacy|1|||
48752219|NCT00211809|156938270|FG000|Overall Study|Lost to Follow-up|2|||
48752220|NCT00211809|156938270|FG000|Overall Study|Pregnancy|1|||
48752221|NCT00211809|156938270|FG000|Overall Study|side effects|2|||
48752222|NCT01417234|156938271|FG000|Overall Study|Subject non-compliant|3|||
48752223|NCT01957644|156938276|FG000|Overall Study|Adverse Event|4|||
48752224|NCT01957644|156938277|FG001|Overall Study|Adverse Event|2|||
48752225|NCT01957644|156938278|FG002|Overall Study|Adverse Event|0|||
48752226|NCT01957644|156938279|FG003|Overall Study|Adverse Event|0|||
48752227|NCT01957644|156938280|FG004|Overall Study|Adverse Event|1|||
48752228|NCT01957644|156938276|FG000|Overall Study|Progressive disease / relapse|0|||
48752229|NCT01957644|156938277|FG001|Overall Study|Progressive disease / relapse|1|||
48752230|NCT01957644|156938278|FG002|Overall Study|Progressive disease / relapse|0|||
48752231|NCT01957644|156938279|FG003|Overall Study|Progressive disease / relapse|1|||
48752232|NCT01957644|156938280|FG004|Overall Study|Progressive disease / relapse|0|||
48752233|NCT01957644|156938276|FG000|Overall Study|Other reason|1|||
48752234|NCT01957644|156938277|FG001|Overall Study|Other reason|2|||
48752235|NCT01957644|156938278|FG002|Overall Study|Other reason|1|||
48752236|NCT01957644|156938279|FG003|Overall Study|Other reason|1|||
48752237|NCT01957644|156938280|FG004|Overall Study|Other reason|0|||
48752238|NCT01957644|156938276|FG000|Overall Study|Withdrawal by Subject|1|||
48752239|NCT01957644|156938277|FG001|Overall Study|Withdrawal by Subject|0|||
48752240|NCT01957644|156938278|FG002|Overall Study|Withdrawal by Subject|0|||
48752241|NCT01957644|156938279|FG003|Overall Study|Withdrawal by Subject|0|||
48752242|NCT01957644|156938280|FG004|Overall Study|Withdrawal by Subject|0|||
48752243|NCT01957644|156938276|FG000|Overall Study|Protocol Violation|0|||
48752244|NCT01957644|156938277|FG001|Overall Study|Protocol Violation|1|||
48752245|NCT01957644|156938278|FG002|Overall Study|Protocol Violation|0|||
48752246|NCT01957644|156938279|FG003|Overall Study|Protocol Violation|0|||
48752247|NCT01957644|156938280|FG004|Overall Study|Protocol Violation|0|||
48752248|NCT00040664|156938283|FG000|Overall Study|Adverse Event|12|||
48752249|NCT00040664|156938284|FG001|Overall Study|Adverse Event|3|||
48752250|NCT00040664|156938285|FG002|Overall Study|Adverse Event|2|||
48752251|NCT00040664|156938286|FG003|Overall Study|Adverse Event|7|||
48752252|NCT00040664|156938283|FG000|Overall Study|Lack of Efficacy|9|||
48752253|NCT00040664|156938284|FG001|Overall Study|Lack of Efficacy|2|||
48752254|NCT00040664|156938285|FG002|Overall Study|Lack of Efficacy|3|||
48752255|NCT00040664|156938286|FG003|Overall Study|Lack of Efficacy|4|||
48752256|NCT00040664|156938283|FG000|Overall Study|Insufficient CD4 response|1|||
48752257|NCT00040664|156938284|FG001|Overall Study|Insufficient CD4 response|0|||
48752258|NCT00040664|156938285|FG002|Overall Study|Insufficient CD4 response|1|||
48752259|NCT00040664|156938286|FG003|Overall Study|Insufficient CD4 response|0|||
48752260|NCT00040664|156938283|FG000|Overall Study|Lost to Follow-up|4|||
48752261|NCT00040664|156938284|FG001|Overall Study|Lost to Follow-up|2|||
48752262|NCT00040664|156938285|FG002|Overall Study|Lost to Follow-up|0|||
48752263|NCT00040664|156938286|FG003|Overall Study|Lost to Follow-up|2|||
48752264|NCT00040664|156938283|FG000|Overall Study|Protocol Violation|2|||
48752265|NCT00040664|156938284|FG001|Overall Study|Protocol Violation|1|||
48864409|NCT01375777|157340121|FG004|Overall Study|Other|0|||
48864410|NCT01375777|157340122|FG005|Overall Study|Other|0|||
48752266|NCT00040664|156938285|FG002|Overall Study|Protocol Violation|0|||
48752267|NCT00040664|156938286|FG003|Overall Study|Protocol Violation|1|||
48752268|NCT00040664|156938283|FG000|Overall Study|Withdrawal by Subject|7|||
48752269|NCT00040664|156938284|FG001|Overall Study|Withdrawal by Subject|0|||
48752270|NCT00040664|156938285|FG002|Overall Study|Withdrawal by Subject|3|||
48752271|NCT00040664|156938286|FG003|Overall Study|Withdrawal by Subject|4|||
48752272|NCT00040664|156938283|FG000|Overall Study|Pregnancy|3|||
48752273|NCT00040664|156938284|FG001|Overall Study|Pregnancy|0|||
48752274|NCT00040664|156938285|FG002|Overall Study|Pregnancy|0|||
48752275|NCT00040664|156938286|FG003|Overall Study|Pregnancy|3|||
48752276|NCT00040664|156938283|FG000|Overall Study|Medication adherence/compliance problems|8|||
48752277|NCT00040664|156938284|FG001|Overall Study|Medication adherence/compliance problems|2|||
48752278|NCT00040664|156938285|FG002|Overall Study|Medication adherence/compliance problems|1|||
48752279|NCT00040664|156938286|FG003|Overall Study|Medication adherence/compliance problems|5|||
48752280|NCT00040664|156938283|FG000|Overall Study|Poor taste|2|||
48864411|NCT01375777|157340123|FG006|Overall Study|Other|0|||
48864412|NCT01375777|157340124|FG007|Overall Study|Other|0|||
48864413|NCT01375777|157340125|FG008|Overall Study|Other|1|||
48864414|NCT00839306|157340126|FG000|Overall Study|Adverse Event|3|||
48864415|NCT00839306|157340127|FG001|Overall Study|Adverse Event|5|||
48864416|NCT00839306|157340126|FG000|Overall Study|Lost to Follow-up|6|||
48864417|NCT00839306|157340127|FG001|Overall Study|Lost to Follow-up|9|||
48864418|NCT00839306|157340126|FG000|Overall Study|Withdrawal by Subject|5|||
48864419|NCT00839306|157340127|FG001|Overall Study|Withdrawal by Subject|7|||
48864420|NCT00839306|157340126|FG000|Overall Study|Lack of Efficacy|5|||
48864421|NCT00839306|157340127|FG001|Overall Study|Lack of Efficacy|4|||
48864422|NCT00839306|157340126|FG000|Overall Study|Other|6|||
48864423|NCT00839306|157340127|FG001|Overall Study|Other|18|||
48864424|NCT01090076|157340128|FG000|Overall Study|Death|1|||
48864425|NCT01090076|157340129|FG001|Overall Study|Death|1|||
48864426|NCT01090076|157340128|FG000|Overall Study|Withdrawal by Subject|0|||
48864427|NCT01090076|157340129|FG001|Overall Study|Withdrawal by Subject|1|||
48864428|NCT00473512|157340131|FG000|Period 1 (Phase 1)|Adverse Event|0|||
48864429|NCT00473512|157340132|FG001|Period 1 (Phase 1)|Adverse Event|0|||
48864430|NCT00473512|157340133|FG002|Period 1 (Phase 1)|Adverse Event|0|||
48864431|NCT00473512|157340134|FG003|Period 1 (Phase 1)|Adverse Event|5|||
48864432|NCT00473512|157340135|FG004|Period 1 (Phase 1)|Adverse Event|0|||
48864433|NCT00473512|157340131|FG000|Period 1 (Phase 1)|Death|0|||
48864434|NCT00473512|157340132|FG001|Period 1 (Phase 1)|Death|0|||
48864435|NCT00473512|157340133|FG002|Period 1 (Phase 1)|Death|0|||
48864436|NCT00473512|157340134|FG003|Period 1 (Phase 1)|Death|1|||
48864437|NCT00473512|157340135|FG004|Period 1 (Phase 1)|Death|0|||
48864438|NCT00473512|157340131|FG000|Period 1 (Phase 1)|Disease Progression|1|||
48864439|NCT00473512|157340132|FG001|Period 1 (Phase 1)|Disease Progression|1|||
48864440|NCT00473512|157340133|FG002|Period 1 (Phase 1)|Disease Progression|0|||
48864441|NCT00473512|157340134|FG003|Period 1 (Phase 1)|Disease Progression|10|||
48864442|NCT00473512|157340135|FG004|Period 1 (Phase 1)|Disease Progression|1|||
48864443|NCT00473512|157340131|FG000|Period 1 (Phase 1)|Other|0|||
48864444|NCT00473512|157340132|FG001|Period 1 (Phase 1)|Other|0|||
48864445|NCT00473512|157340133|FG002|Period 1 (Phase 1)|Other|0|||
48864446|NCT00473512|157340134|FG003|Period 1 (Phase 1)|Other|1|||
48864447|NCT00473512|157340135|FG004|Period 1 (Phase 1)|Other|0|||
48864448|NCT00473512|157340131|FG000|Period 2 (Phase 2)|Adverse Event|0|||
48864449|NCT00473512|157340132|FG001|Period 2 (Phase 2)|Adverse Event|0|||
48864450|NCT00473512|157340133|FG002|Period 2 (Phase 2)|Adverse Event|0|||
48864451|NCT00473512|157340134|FG003|Period 2 (Phase 2)|Adverse Event|1|||
48864452|NCT00473512|157340135|FG004|Period 2 (Phase 2)|Adverse Event|0|||
48864453|NCT00473512|157340131|FG000|Period 2 (Phase 2)|Death|0|||
48864454|NCT00473512|157340132|FG001|Period 2 (Phase 2)|Death|0|||
48864455|NCT00473512|157340133|FG002|Period 2 (Phase 2)|Death|0|||
48864456|NCT00473512|157340134|FG003|Period 2 (Phase 2)|Death|1|||
48864457|NCT00473512|157340135|FG004|Period 2 (Phase 2)|Death|1|||
48864458|NCT00473512|157340131|FG000|Period 2 (Phase 2)|Disease Progression|0|||
48864459|NCT00473512|157340132|FG001|Period 2 (Phase 2)|Disease Progression|2|||
48864460|NCT00473512|157340133|FG002|Period 2 (Phase 2)|Disease Progression|2|||
48864461|NCT00473512|157340134|FG003|Period 2 (Phase 2)|Disease Progression|17|||
48864462|NCT00473512|157340135|FG004|Period 2 (Phase 2)|Disease Progression|1|||
48864463|NCT00473512|157340131|FG000|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
48864464|NCT00473512|157340132|FG001|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
48864465|NCT00473512|157340133|FG002|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
48864466|NCT00473512|157340134|FG003|Period 2 (Phase 2)|Symptomatic Deterioration|1|||
48864467|NCT00473512|157340135|FG004|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
48864468|NCT00473512|157340131|FG000|Period 2 (Phase 2)|Other|1|||
48864469|NCT00473512|157340132|FG001|Period 2 (Phase 2)|Other|0|||
48864470|NCT00473512|157340133|FG002|Period 2 (Phase 2)|Other|0|||
48864471|NCT00473512|157340134|FG003|Period 2 (Phase 2)|Other|3|||
48864472|NCT00473512|157340135|FG004|Period 2 (Phase 2)|Other|0|||
48864473|NCT03745651|157340137|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
48864474|NCT03745651|157340138|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
48956747|NCT02819310|157671078|FG000|Overall Study|Adverse Event|13|||
48956748|NCT02819310|157671078|FG000|Overall Study|Lack of Efficacy|5|||
48864475|NCT03745651|157340139|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
48864476|NCT03745651|157340140|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
48864477|NCT03745651|157340141|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
48956749|NCT02819310|157671078|FG000|Overall Study|Physician Decision|8|||
48864478|NCT03745651|157340142|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
48864479|NCT03745651|157340143|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
48956750|NCT02819310|157671078|FG000|Overall Study|Protocol Violation|30|||
48864480|NCT03745651|157340137|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|3|||
48956751|NCT01675011|157671081|FG000|Overall Study|Trial terminated by Sponsor|3|||
48956752|NCT01675011|157671082|FG001|Overall Study|Trial terminated by Sponsor|1|||
48956753|NCT02245568|157671083|FG000|Overall Study|Study terminated by Sponsor|346|||
48956754|NCT02245568|157671083|FG000|Overall Study|Adverse Event|144|||
48956755|NCT02245568|157671083|FG000|Overall Study|Lack of Efficacy|98|||
48956756|NCT02245568|157671083|FG000|Overall Study|Withdrawal by Caregiver|85|||
48956757|NCT02245568|157671083|FG000|Overall Study|Withdrawal by Subject|77|||
48956758|NCT02245568|157671083|FG000|Overall Study|Withdrawal by Legal Representative|31|||
48956759|NCT02245568|157671083|FG000|Overall Study|Missing (Site closure)|16|||
48956760|NCT02245568|157671083|FG000|Overall Study|Physician Decision|14|||
48956761|NCT02245568|157671083|FG000|Overall Study|Non-compliance with study drug|11|||
48956762|NCT02245568|157671083|FG000|Overall Study|Death|9|||
48956763|NCT02245568|157671083|FG000|Overall Study|Blue staining|6|||
48956764|NCT02245568|157671083|FG000|Overall Study|Worsening dementia/caregiver withdrawal|6|||
48956765|NCT02245568|157671083|FG000|Overall Study|Intolerance/dosing issues/interruption|5|||
48956766|NCT02245568|157671083|FG000|Overall Study|Lost to Follow-up|5|||
48956767|NCT01252134|157671084|FG000|Period 1, 8 Hours|Personal Reasons|0|||
48956768|NCT01252134|157671085|FG001|Period 1, 8 Hours|Personal Reasons|1|||
48956769|NCT01252134|157671086|FG002|Period 1, 8 Hours|Personal Reasons|1|||
48956770|NCT01252134|157671087|FG003|Period 1, 8 Hours|Personal Reasons|0|||
48956771|NCT01252134|157671088|FG004|Period 1, 8 Hours|Personal Reasons|0|||
48956772|NCT01252134|157671089|FG005|Period 1, 8 Hours|Personal Reasons|0|||
48956773|NCT03650452|157671090|FG000|Overall Study|Physician Decision|1|||
48956774|NCT03650452|157671091|FG001|Overall Study|Physician Decision|0|||
48956775|NCT03650452|157671090|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
48956776|NCT03650452|157671091|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
48956777|NCT03650452|157671090|FG000|Overall Study|Adverse Event|3|||
48956778|NCT03650452|157671091|FG001|Overall Study|Adverse Event|4|||
48956779|NCT03650452|157671090|FG000|Overall Study|Early Withdrawal from Study Treatment|3|||
48956780|NCT03650452|157671091|FG001|Overall Study|Early Withdrawal from Study Treatment|0|||
48956781|NCT02044159|157671092|FG000|Overall Study|Consent declined (deferred consent)|2|||
48956782|NCT02044159|157671093|FG001|Overall Study|Consent declined (deferred consent)|4|||
48956783|NCT02044159|157671092|FG000|Overall Study|No longer eligible, drug not given|1|||
48956784|NCT02044159|157671093|FG001|Overall Study|No longer eligible, drug not given|0|||
48956785|NCT02044159|157671092|FG000|Overall Study|Nurse declined to give study drug|1|||
48956786|NCT02044159|157671093|FG001|Overall Study|Nurse declined to give study drug|0|||
48956787|NCT00972244|157671100|FG000|Overall Study|Incorrect Enrolment|1|||
48956788|NCT00972244|157671101|FG001|Overall Study|Incorrect Enrolment|0|||
48956789|NCT00972244|157671102|FG002|Overall Study|Incorrect Enrolment|0|||
48956790|NCT00972244|157671103|FG003|Overall Study|Incorrect Enrolment|0|||
48956791|NCT00972244|157671104|FG004|Overall Study|Incorrect Enrolment|0|||
48956792|NCT00972244|157671100|FG000|Overall Study|Adverse Event|0|||
48956793|NCT00972244|157671101|FG001|Overall Study|Adverse Event|1|||
48956794|NCT00972244|157671102|FG002|Overall Study|Adverse Event|1|||
48956795|NCT00972244|157671103|FG003|Overall Study|Adverse Event|0|||
48956796|NCT00972244|157671104|FG004|Overall Study|Adverse Event|0|||
48956797|NCT00972244|157671100|FG000|Overall Study|Subject No Longer Meets Study Criteria|2|||
48956798|NCT00972244|157671101|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
48956799|NCT00972244|157671102|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
48956800|NCT00972244|157671103|FG003|Overall Study|Subject No Longer Meets Study Criteria|0|||
48956801|NCT00972244|157671104|FG004|Overall Study|Subject No Longer Meets Study Criteria|5|||
48956802|NCT00972244|157671100|FG000|Overall Study|Withdrawal by Subject|1|||
48956803|NCT00972244|157671101|FG001|Overall Study|Withdrawal by Subject|2|||
48956804|NCT00972244|157671102|FG002|Overall Study|Withdrawal by Subject|1|||
48956805|NCT00972244|157671103|FG003|Overall Study|Withdrawal by Subject|0|||
48956806|NCT00972244|157671104|FG004|Overall Study|Withdrawal by Subject|1|||
48956807|NCT00972244|157671100|FG000|Overall Study|Safety|0|||
48956808|NCT00972244|157671101|FG001|Overall Study|Safety|0|||
48956809|NCT00972244|157671102|FG002|Overall Study|Safety|0|||
48956810|NCT00972244|157671103|FG003|Overall Study|Safety|0|||
48956811|NCT00972244|157671104|FG004|Overall Study|Safety|1|||
48956812|NCT00972244|157671100|FG000|Overall Study|Death|1|||
48956813|NCT00972244|157671101|FG001|Overall Study|Death|0|||
48956814|NCT00972244|157671102|FG002|Overall Study|Death|0|||
48956815|NCT00972244|157671103|FG003|Overall Study|Death|0|||
48956816|NCT00972244|157671104|FG004|Overall Study|Death|0|||
48956817|NCT00972244|157671100|FG000|Overall Study|Various|0|||
48956818|NCT00972244|157671101|FG001|Overall Study|Various|0|||
48956819|NCT00972244|157671102|FG002|Overall Study|Various|0|||
48956820|NCT00972244|157671103|FG003|Overall Study|Various|0|||
48956821|NCT00972244|157671104|FG004|Overall Study|Various|2|||
48956822|NCT01856595|157671107|FG000|Overall Study|Withdrawal by Subject|0|||
48956823|NCT01856595|157671108|FG001|Overall Study|Withdrawal by Subject|1|||
48956824|NCT01856595|157671109|FG002|Overall Study|Withdrawal by Subject|0|||
48956825|NCT01856595|157671110|FG003|Overall Study|Withdrawal by Subject|0|||
48956826|NCT01856595|157671111|FG004|Overall Study|Withdrawal by Subject|0|||
48956827|NCT01856595|157671112|FG005|Overall Study|Withdrawal by Subject|0|||
48956828|NCT01856595|157671113|FG006|Overall Study|Withdrawal by Subject|1|||
48956829|NCT01856595|157671114|FG007|Overall Study|Withdrawal by Subject|0|||
48956830|NCT01856595|157671115|FG008|Overall Study|Withdrawal by Subject|0|||
48956831|NCT04426825|157671116|FG000|Overall Study|Death|17|||
48956832|NCT04426825|157671116|FG000|Overall Study|Lost to Follow-up|1|||
48956833|NCT04426825|157671116|FG000|Overall Study|Study terminated by sponsor|5|||
48956834|NCT01258348|157671117|FG000|Overall Study|Adverse Event|1|||
48956835|NCT01258348|157671118|FG001|Overall Study|Adverse Event|1|||
48956836|NCT01258348|157671119|FG002|Overall Study|Adverse Event|3|||
48956837|NCT01258348|157671120|FG003|Overall Study|Adverse Event|2|||
48956838|NCT01258348|157671121|FG004|Overall Study|Adverse Event|4|||
48956839|NCT01258348|157671117|FG000|Overall Study|Progressive Disease|0|||
48956840|NCT01258348|157671118|FG001|Overall Study|Progressive Disease|3|||
48956841|NCT01258348|157671119|FG002|Overall Study|Progressive Disease|0|||
48956842|NCT01258348|157671120|FG003|Overall Study|Progressive Disease|2|||
48956843|NCT01258348|157671121|FG004|Overall Study|Progressive Disease|2|||
48956844|NCT01258348|157671117|FG000|Overall Study|Physician Decision|0|||
48956845|NCT01258348|157671118|FG001|Overall Study|Physician Decision|0|||
48956846|NCT01258348|157671119|FG002|Overall Study|Physician Decision|0|||
48956847|NCT01258348|157671120|FG003|Overall Study|Physician Decision|2|||
48956848|NCT01258348|157671121|FG004|Overall Study|Physician Decision|0|||
48752281|NCT00040664|156938284|FG001|Overall Study|Poor taste|0|||
48752282|NCT00040664|156938285|FG002|Overall Study|Poor taste|2|||
48752283|NCT00040664|156938286|FG003|Overall Study|Poor taste|0|||
48956849|NCT01258348|157671117|FG000|Overall Study|Withdrawal by Subject|0|||
48956850|NCT01258348|157671118|FG001|Overall Study|Withdrawal by Subject|1|||
48956851|NCT01258348|157671119|FG002|Overall Study|Withdrawal by Subject|0|||
48956852|NCT01258348|157671120|FG003|Overall Study|Withdrawal by Subject|0|||
48956853|NCT01258348|157671121|FG004|Overall Study|Withdrawal by Subject|0|||
48956854|NCT04346628|157671129|FG000|Overall Study|Lost to Follow-up|4|||
48956855|NCT04346628|157671130|FG001|Overall Study|Lost to Follow-up|4|||
48956856|NCT04346628|157671129|FG000|Overall Study|Withdrew (had personal reasons)|2|||
48956857|NCT04346628|157671130|FG001|Overall Study|Withdrew (had personal reasons)|5|||
48956858|NCT04346628|157671129|FG000|Overall Study|Withdrew (medication intolerant)|0|||
48956859|NCT04346628|157671130|FG001|Overall Study|Withdrew (medication intolerant)|3|||
48956860|NCT04346628|157671129|FG000|Overall Study|Withdrew (declined intervention)|0|||
48956861|NCT04346628|157671130|FG001|Overall Study|Withdrew (declined intervention)|1|||
48956862|NCT01763905|157671131|FG000|Overall Study|Withdrawal by Subject|1|||
48956863|NCT01763905|157671132|FG001|Overall Study|Withdrawal by Subject|1|||
48956864|NCT01763905|157671133|FG002|Overall Study|Withdrawal by Subject|0|||
48956865|NCT01763905|157671134|FG003|Overall Study|Withdrawal by Subject|1|||
48956866|NCT01763905|157671131|FG000|Overall Study|Decision by sponsor|5|||
48956867|NCT01763905|157671132|FG001|Overall Study|Decision by sponsor|0|||
48956868|NCT01763905|157671133|FG002|Overall Study|Decision by sponsor|8|||
48956869|NCT01763905|157671134|FG003|Overall Study|Decision by sponsor|0|||
48956870|NCT01763905|157671131|FG000|Overall Study|Lost to Follow-up|0|||
48956871|NCT01763905|157671132|FG001|Overall Study|Lost to Follow-up|0|||
48956872|NCT01763905|157671133|FG002|Overall Study|Lost to Follow-up|1|||
48956873|NCT01763905|157671134|FG003|Overall Study|Lost to Follow-up|0|||
48956874|NCT00411788|157671136|FG000|Overall Study|Protocol Violation|1|||
48956875|NCT00411788|157671136|FG000|Overall Study|Adverse Event|1|||
48956876|NCT01533935|157671139|FG000|Overall Study|Adverse Event|5|||
48956877|NCT01533935|157671140|FG001|Overall Study|Adverse Event|7|||
48956878|NCT01533935|157671141|FG002|Overall Study|Adverse Event|1|||
48956879|NCT01533935|157671142|FG003|Overall Study|Adverse Event|5|||
48956880|NCT01533935|157671143|FG004|Overall Study|Adverse Event|3|||
48956881|NCT01533935|157671139|FG000|Overall Study|Protocol Violation|0|||
48956882|NCT01533935|157671140|FG001|Overall Study|Protocol Violation|2|||
48956883|NCT01533935|157671141|FG002|Overall Study|Protocol Violation|0|||
48956884|NCT01533935|157671142|FG003|Overall Study|Protocol Violation|0|||
48956885|NCT01533935|157671143|FG004|Overall Study|Protocol Violation|0|||
48956886|NCT01533935|157671139|FG000|Overall Study|Lost to Follow-up|0|||
48956887|NCT01533935|157671140|FG001|Overall Study|Lost to Follow-up|0|||
48956888|NCT01533935|157671141|FG002|Overall Study|Lost to Follow-up|1|||
48956889|NCT01533935|157671142|FG003|Overall Study|Lost to Follow-up|0|||
48956890|NCT01533935|157671143|FG004|Overall Study|Lost to Follow-up|0|||
48956891|NCT01533935|157671139|FG000|Overall Study|Withdrawal by Subject|0|||
48956892|NCT01533935|157671140|FG001|Overall Study|Withdrawal by Subject|4|||
48956893|NCT01533935|157671141|FG002|Overall Study|Withdrawal by Subject|5|||
48956894|NCT01533935|157671142|FG003|Overall Study|Withdrawal by Subject|2|||
48956895|NCT01533935|157671143|FG004|Overall Study|Withdrawal by Subject|4|||
48956896|NCT01533935|157671139|FG000|Overall Study|Other reason not defined above|1|||
48956897|NCT01533935|157671140|FG001|Overall Study|Other reason not defined above|0|||
48956898|NCT01533935|157671141|FG002|Overall Study|Other reason not defined above|1|||
48752284|NCT00040664|156938283|FG000|Overall Study|Pharmacokinetic target not achieved|2|||
48956899|NCT01533935|157671142|FG003|Overall Study|Other reason not defined above|0|||
48956900|NCT01533935|157671143|FG004|Overall Study|Other reason not defined above|1|||
48956901|NCT02411201|157671147|FG000|Overall Study|Adverse Event|2|||
48956902|NCT02411201|157671147|FG000|Overall Study|Withdrawal by Subject|2|||
48956903|NCT02411201|157671147|FG000|Overall Study|Age group completed|2|||
48956904|NCT00316303|157671148|FG000|Overall Study|Lost to Follow-up|11|||
48956905|NCT00316303|157671149|FG001|Overall Study|Lost to Follow-up|16|||
48956906|NCT01005719|157671150|FG000|Period 1|Adverse Event|0|||
48956907|NCT01005719|157671151|FG001|Period 1|Adverse Event|0|||
48956908|NCT01005719|157671152|FG002|Period 1|Adverse Event|0|||
48956909|NCT01005719|157671153|FG003|Period 1|Adverse Event|1|||
48956910|NCT01005719|157671154|FG004|Period 1|Adverse Event|0|||
48956911|NCT01005719|157671155|FG005|Period 1|Adverse Event|0|||
48956912|NCT01005719|157671150|FG000|Period 1|Delay in completing study procedures|0|||
48956913|NCT01005719|157671151|FG001|Period 1|Delay in completing study procedures|0|||
48956914|NCT01005719|157671152|FG002|Period 1|Delay in completing study procedures|0|||
48956915|NCT01005719|157671153|FG003|Period 1|Delay in completing study procedures|0|||
48956916|NCT01005719|157671154|FG004|Period 1|Delay in completing study procedures|0|||
48956917|NCT01005719|157671155|FG005|Period 1|Delay in completing study procedures|1|||
48956918|NCT01005719|157671150|FG000|Period 2|Adverse Event|0|||
48956919|NCT01005719|157671151|FG001|Period 2|Adverse Event|0|||
48956920|NCT01005719|157671152|FG002|Period 2|Adverse Event|0|||
48956921|NCT01005719|157671153|FG003|Period 2|Adverse Event|0|||
48956922|NCT01005719|157671154|FG004|Period 2|Adverse Event|1|||
48956923|NCT01005719|157671155|FG005|Period 2|Adverse Event|1|||
48956924|NCT02918266|157671156|FG000|Part 2: Intervention Period 1 (2 Days)|Study termination|0|||
48956925|NCT02918266|157671157|FG001|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
48956926|NCT02918266|157671158|FG002|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
48956927|NCT02918266|157671159|FG003|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
48956928|NCT02918266|157671160|FG004|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
48956929|NCT02918266|157671161|FG005|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
48956930|NCT02918266|157671162|FG006|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
48956931|NCT02918266|157671163|FG007|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
48956932|NCT02918266|157671164|FG008|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
48956933|NCT02918266|157671165|FG009|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
48956934|NCT02918266|157671166|FG010|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
48956935|NCT00995345|157671167|FG000|Overall Study|Withdrawal by Subject|4|||
48956936|NCT00995345|157671168|FG001|Overall Study|Withdrawal by Subject|2|||
48956937|NCT00995345|157671169|FG002|Overall Study|Withdrawal by Subject|1|||
48956938|NCT00995345|157671170|FG003|Overall Study|Withdrawal by Subject|3|||
48956939|NCT00995345|157671171|FG004|Overall Study|Withdrawal by Subject|1|||
48956940|NCT00995345|157671167|FG000|Overall Study|Adverse Event|3|||
48956941|NCT00995345|157671168|FG001|Overall Study|Adverse Event|1|||
48956942|NCT00995345|157671169|FG002|Overall Study|Adverse Event|2|||
48956943|NCT00995345|157671170|FG003|Overall Study|Adverse Event|0|||
48956944|NCT00995345|157671171|FG004|Overall Study|Adverse Event|1|||
48956945|NCT00995345|157671167|FG000|Overall Study|Lost to Follow-up|2|||
48956946|NCT00995345|157671168|FG001|Overall Study|Lost to Follow-up|2|||
48956947|NCT00995345|157671169|FG002|Overall Study|Lost to Follow-up|2|||
48752285|NCT00040664|156938284|FG001|Overall Study|Pharmacokinetic target not achieved|1|||
48956948|NCT00995345|157671170|FG003|Overall Study|Lost to Follow-up|1|||
48752286|NCT00040664|156938285|FG002|Overall Study|Pharmacokinetic target not achieved|0|||
48956949|NCT00995345|157671171|FG004|Overall Study|Lost to Follow-up|0|||
48956950|NCT00995345|157671167|FG000|Overall Study|all other reasons combined|2|||
48956951|NCT00995345|157671168|FG001|Overall Study|all other reasons combined|2|||
48956952|NCT00995345|157671169|FG002|Overall Study|all other reasons combined|2|||
48956953|NCT00995345|157671170|FG003|Overall Study|all other reasons combined|1|||
48956954|NCT00995345|157671171|FG004|Overall Study|all other reasons combined|3|||
48956955|NCT03649321|157671172|FG000|Overall Study|Withdrawal by Subject|1|||
48956956|NCT03649321|157671173|FG001|Overall Study|Withdrawal by Subject|0|||
48956957|NCT03649321|157671172|FG000|Overall Study|Death|1|||
48956958|NCT03649321|157671173|FG001|Overall Study|Death|0|||
48956959|NCT01163253|157671176|FG000|Overall Study|Withdrawn Due to Pregnancy|12|||
48956960|NCT01163253|157671177|FG001|Overall Study|Withdrawn Due to Pregnancy|2|||
48956961|NCT01163253|157671176|FG000|Overall Study|Study Terminated by Sponsor|978|||
48956962|NCT01163253|157671177|FG001|Overall Study|Study Terminated by Sponsor|349|||
48956963|NCT01163253|157671176|FG000|Overall Study|Protocol Violation|43|||
48956964|NCT01163253|157671177|FG001|Overall Study|Protocol Violation|12|||
48956965|NCT01163253|157671176|FG000|Overall Study|Withdrawal by Subject|199|||
48956966|NCT01163253|157671177|FG001|Overall Study|Withdrawal by Subject|50|||
48956967|NCT01163253|157671176|FG000|Overall Study|Medication Error|1|||
48956968|NCT01163253|157671177|FG001|Overall Study|Medication Error|0|||
48956969|NCT01163253|157671176|FG000|Overall Study|Lost to Follow-up|125|||
48956970|NCT01163253|157671177|FG001|Overall Study|Lost to Follow-up|23|||
48956971|NCT01163253|157671176|FG000|Overall Study|Insufficient Clinical Response|423|||
48956972|NCT01163253|157671177|FG001|Overall Study|Insufficient Clinical Response|29|||
48956973|NCT01163253|157671176|FG000|Overall Study|Adverse Event|300|||
48956974|NCT01163253|157671177|FG001|Overall Study|Adverse Event|78|||
48956975|NCT01163253|157671176|FG000|Overall Study|Death|17|||
48956976|NCT01163253|157671177|FG001|Overall Study|Death|5|||
48956977|NCT01163253|157671176|FG000|Overall Study|Ongoing|13|||
48956978|NCT01163253|157671177|FG001|Overall Study|Ongoing|4|||
48956979|NCT01163253|157671176|FG000|Overall Study|Other Unspecified|170|||
48956980|NCT01163253|157671177|FG001|Overall Study|Other Unspecified|34|||
48956981|NCT02202031|157671178|FG000|Overall Study|Lost to Follow-up|1|||
48956982|NCT02202031|157671179|FG001|Overall Study|Lost to Follow-up|0|||
48956983|NCT02202031|157671178|FG000|Overall Study|Too Busy|1|||
48752287|NCT00040664|156938286|FG003|Overall Study|Pharmacokinetic target not achieved|1|||
48956984|NCT02202031|157671179|FG001|Overall Study|Too Busy|3|||
48956985|NCT02202031|157671178|FG000|Overall Study|Illness/Medical Reason|0|||
48956986|NCT02202031|157671179|FG001|Overall Study|Illness/Medical Reason|2|||
48956987|NCT02202031|157671178|FG000|Overall Study|Intolerance/Lack of Improvement|3|||
48956988|NCT02202031|157671179|FG001|Overall Study|Intolerance/Lack of Improvement|0|||
48956989|NCT01087528|157671180|FG000|Overall Study|Withdrawal by Subject|1|||
48956990|NCT01087528|157671180|FG000|Overall Study|Incomplete CE procedure|6|||
48956991|NCT00862849|157671181|FG000|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
48956992|NCT00862849|157671182|FG001|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1|||
48956993|NCT00862849|157671183|FG002|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
48956994|NCT00862849|157671184|FG003|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
48956995|NCT00862849|157671185|FG004|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
48956996|NCT00862849|157671186|FG005|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
48956997|NCT00862849|157671181|FG000|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
48956998|NCT00862849|157671182|FG001|Washout 2 (3 to 14 Days)|Protocol Violation|1|||
48956999|NCT00862849|157671183|FG002|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
48957000|NCT00862849|157671184|FG003|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
48957001|NCT00862849|157671185|FG004|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
48957002|NCT00862849|157671186|FG005|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
48957003|NCT01201798|157671187|FG000|Overall Study|Adverse Event|2|||
48957004|NCT01201798|157671188|FG001|Overall Study|Adverse Event|0|||
48957005|NCT01201798|157671187|FG000|Overall Study|Lost to Follow-up|3|||
48957006|NCT01201798|157671188|FG001|Overall Study|Lost to Follow-up|5|||
48957007|NCT01201798|157671187|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
48957008|NCT01201798|157671188|FG001|Overall Study|Decision Unrelated to an Adverse Event|1|||
48957009|NCT01201798|157671187|FG000|Overall Study|Noncompliance|1|||
48957010|NCT01201798|157671188|FG001|Overall Study|Noncompliance|0|||
48957011|NCT01201798|157671187|FG000|Overall Study|Protocol Violation|1|||
48957012|NCT01201798|157671188|FG001|Overall Study|Protocol Violation|1|||
48957013|NCT01201798|157671187|FG000|Overall Study|Treatment Failure|1|||
48957014|NCT01201798|157671188|FG001|Overall Study|Treatment Failure|8|||
48957015|NCT01401010|157671192|FG000|Overall Study|Could not interpret assay results|1|||
48957016|NCT01401010|157671193|FG001|Overall Study|Could not interpret assay results|0|||
48957017|NCT01081873|157671196|FG000|Overall Study|Death|86|||
48957018|NCT01081873|157671196|FG000|Overall Study|Withdrawal by Subject|10|||
48957019|NCT01081873|157671196|FG000|Overall Study|Lost to Follow-up|142|||
48957020|NCT01081873|157671196|FG000|Overall Study|Progression of prostate cancer|13|||
48957021|NCT01081873|157671196|FG000|Overall Study|Other|47|||
48957022|NCT03977727|157671197|FG000|Second Treatment|Lost to Follow-up|0|||
48957023|NCT03977727|157671198|FG001|Second Treatment|Lost to Follow-up|3|||
48957024|NCT01683071|157671199|FG000|Part 1|Lack of Efficacy|1|||
48957025|NCT01683071|157671200|FG001|Part 1|Lack of Efficacy|0|||
48957026|NCT01683071|157671201|FG002|Part 1|Lack of Efficacy|0|||
48957027|NCT01683071|157671202|FG003|Part 1|Lack of Efficacy|3|||
48957028|NCT01683071|157671203|FG004|Part 1|Lack of Efficacy|0|||
48957029|NCT01683071|157671204|FG005|Part 1|Lack of Efficacy|0|||
48752288|NCT00040664|156938283|FG000|Overall Study|Change of formulation|2|||
48752289|NCT00040664|156938284|FG001|Overall Study|Change of formulation|2|||
48957030|NCT01683071|157671199|FG000|Part 1|Withdrawal by Subject|1|||
48957031|NCT01683071|157671200|FG001|Part 1|Withdrawal by Subject|2|||
48957032|NCT01683071|157671201|FG002|Part 1|Withdrawal by Subject|2|||
48957033|NCT01683071|157671202|FG003|Part 1|Withdrawal by Subject|1|||
48957034|NCT01683071|157671203|FG004|Part 1|Withdrawal by Subject|0|||
48957035|NCT01683071|157671204|FG005|Part 1|Withdrawal by Subject|0|||
48957036|NCT01683071|157671199|FG000|Part 1|Surgery Cancelled|1|||
48957037|NCT01683071|157671200|FG001|Part 1|Surgery Cancelled|0|||
48957038|NCT01683071|157671201|FG002|Part 1|Surgery Cancelled|0|||
48957039|NCT01683071|157671202|FG003|Part 1|Surgery Cancelled|0|||
48957040|NCT01683071|157671203|FG004|Part 1|Surgery Cancelled|0|||
48957041|NCT01683071|157671204|FG005|Part 1|Surgery Cancelled|0|||
48957042|NCT01683071|157671199|FG000|Part 1|Did not receive study drug|1|||
48957043|NCT01683071|157671200|FG001|Part 1|Did not receive study drug|0|||
48957044|NCT01683071|157671201|FG002|Part 1|Did not receive study drug|0|||
48957045|NCT01683071|157671202|FG003|Part 1|Did not receive study drug|1|||
48957046|NCT01683071|157671203|FG004|Part 1|Did not receive study drug|0|||
48957047|NCT01683071|157671204|FG005|Part 1|Did not receive study drug|0|||
48957048|NCT01683071|157671199|FG000|Part 1|Early termination; met exclusion criteria|0|||
48957049|NCT01683071|157671200|FG001|Part 1|Early termination; met exclusion criteria|2|||
48957050|NCT01683071|157671201|FG002|Part 1|Early termination; met exclusion criteria|1|||
48957051|NCT01683071|157671202|FG003|Part 1|Early termination; met exclusion criteria|0|||
48957052|NCT01683071|157671203|FG004|Part 1|Early termination; met exclusion criteria|0|||
48957053|NCT01683071|157671204|FG005|Part 1|Early termination; met exclusion criteria|0|||
48957054|NCT01683071|157671199|FG000|Part 2|Lack of Efficacy|0|||
48957055|NCT01683071|157671200|FG001|Part 2|Lack of Efficacy|0|||
48957056|NCT01683071|157671201|FG002|Part 2|Lack of Efficacy|0|||
48957057|NCT01683071|157671202|FG003|Part 2|Lack of Efficacy|0|||
48957058|NCT01683071|157671203|FG004|Part 2|Lack of Efficacy|3|||
48957059|NCT01683071|157671204|FG005|Part 2|Lack of Efficacy|4|||
48957060|NCT01683071|157671199|FG000|Part 2|Lost to Follow-up|0|||
48957061|NCT01683071|157671200|FG001|Part 2|Lost to Follow-up|0|||
48957062|NCT01683071|157671201|FG002|Part 2|Lost to Follow-up|0|||
48957063|NCT01683071|157671202|FG003|Part 2|Lost to Follow-up|0|||
48752290|NCT00040664|156938285|FG002|Overall Study|Change of formulation|0|||
48752291|NCT00040664|156938286|FG003|Overall Study|Change of formulation|0|||
48752292|NCT00040664|156938283|FG000|Overall Study|Non-viability of oral suspension|1|||
48752293|NCT00040664|156938284|FG001|Overall Study|Non-viability of oral suspension|0|||
48752294|NCT00040664|156938285|FG002|Overall Study|Non-viability of oral suspension|1|||
48752295|NCT00040664|156938286|FG003|Overall Study|Non-viability of oral suspension|0|||
48752296|NCT00001723|156938289|FG000|Overall Study|Lack of Efficacy|6|||
48752297|NCT00001723|156938290|FG001|Overall Study|Lack of Efficacy|7|||
48752298|NCT00001723|156938289|FG000|Overall Study|Lack of family interest|4|||
48957064|NCT01683071|157671203|FG004|Part 2|Lost to Follow-up|2|||
48752299|NCT00001723|156938290|FG001|Overall Study|Lack of family interest|5|||
48752300|NCT00001723|156938289|FG000|Overall Study|Lost to Follow-up|2|||
48752301|NCT00001723|156938290|FG001|Overall Study|Lost to Follow-up|2|||
48957065|NCT01683071|157671204|FG005|Part 2|Lost to Follow-up|0|||
48957066|NCT01683071|157671199|FG000|Part 2|Withdrawal by Subject|0|||
48957067|NCT01683071|157671200|FG001|Part 2|Withdrawal by Subject|0|||
48957068|NCT01683071|157671201|FG002|Part 2|Withdrawal by Subject|0|||
48957069|NCT01683071|157671202|FG003|Part 2|Withdrawal by Subject|0|||
48957070|NCT01683071|157671203|FG004|Part 2|Withdrawal by Subject|3|||
48957071|NCT01683071|157671204|FG005|Part 2|Withdrawal by Subject|3|||
48957072|NCT01683071|157671199|FG000|Part 2|Surgery cancelled|0|||
48957073|NCT01683071|157671200|FG001|Part 2|Surgery cancelled|0|||
48957074|NCT01683071|157671201|FG002|Part 2|Surgery cancelled|0|||
48957075|NCT01683071|157671202|FG003|Part 2|Surgery cancelled|0|||
48957076|NCT01683071|157671203|FG004|Part 2|Surgery cancelled|4|||
48957077|NCT01683071|157671204|FG005|Part 2|Surgery cancelled|2|||
48957078|NCT01683071|157671199|FG000|Part 2|Did not receive study drug|0|||
48957079|NCT01683071|157671200|FG001|Part 2|Did not receive study drug|0|||
48957080|NCT01683071|157671201|FG002|Part 2|Did not receive study drug|0|||
48957081|NCT01683071|157671202|FG003|Part 2|Did not receive study drug|0|||
48957082|NCT01683071|157671203|FG004|Part 2|Did not receive study drug|2|||
48957083|NCT01683071|157671204|FG005|Part 2|Did not receive study drug|1|||
48957084|NCT01683071|157671199|FG000|Part 2|Met exclusion criterion|0|||
48957085|NCT01683071|157671200|FG001|Part 2|Met exclusion criterion|0|||
48957086|NCT01683071|157671201|FG002|Part 2|Met exclusion criterion|0|||
48957087|NCT01683071|157671202|FG003|Part 2|Met exclusion criterion|0|||
48957088|NCT01683071|157671203|FG004|Part 2|Met exclusion criterion|1|||
48957089|NCT01683071|157671204|FG005|Part 2|Met exclusion criterion|1|||
48957090|NCT01683071|157671199|FG000|Part 2|Protocol deviation|0|||
48957091|NCT01683071|157671200|FG001|Part 2|Protocol deviation|0|||
48957092|NCT01683071|157671201|FG002|Part 2|Protocol deviation|0|||
48957093|NCT01683071|157671202|FG003|Part 2|Protocol deviation|0|||
48957094|NCT01683071|157671203|FG004|Part 2|Protocol deviation|1|||
48957095|NCT01683071|157671204|FG005|Part 2|Protocol deviation|2|||
48957096|NCT01683071|157671199|FG000|Part 2|Withdrawal by investigator decision|0|||
48957097|NCT01683071|157671200|FG001|Part 2|Withdrawal by investigator decision|0|||
48957098|NCT01683071|157671201|FG002|Part 2|Withdrawal by investigator decision|0|||
48957099|NCT01683071|157671202|FG003|Part 2|Withdrawal by investigator decision|0|||
48957100|NCT01683071|157671203|FG004|Part 2|Withdrawal by investigator decision|1|||
48957101|NCT01683071|157671204|FG005|Part 2|Withdrawal by investigator decision|2|||
48957102|NCT02426658|157671207|FG000|Overall Study|Withdrawal by Subject|1|||
48957103|NCT02426658|157671207|FG000|Overall Study|Patient expired before treatment|2|||
48957104|NCT03141086|157671208|FG000|Overall Study|Study Terminated By Sponsor|1|||
48957105|NCT03141086|157671209|FG001|Overall Study|Study Terminated By Sponsor|1|||
48957106|NCT03141086|157671208|FG000|Overall Study|Withdrawal by Subject|0|||
48957107|NCT03141086|157671209|FG001|Overall Study|Withdrawal by Subject|1|||
48957108|NCT03141086|157671208|FG000|Overall Study|Protocol Violation|0|||
48957109|NCT03141086|157671209|FG001|Overall Study|Protocol Violation|1|||
48957110|NCT03141086|157671208|FG000|Overall Study|Adverse Event|0|||
48957111|NCT03141086|157671209|FG001|Overall Study|Adverse Event|2|||
48957112|NCT01402284|157671210|FG000|Overall Study|Withdrawal consent|2|||
48957113|NCT01402284|157671210|FG000|Overall Study|Follows up at Memorial Sloan Kettering|1|||
48957114|NCT01402284|157671210|FG000|Overall Study|Physician Decision|1|||
48957115|NCT01402284|157671210|FG000|Overall Study|Disease progression on study|10|||
48957116|NCT02928406|157671213|FG000|Overall Study|Death|780|||
48957117|NCT02928406|157671213|FG000|Overall Study|Progressive disease|3|||
48957118|NCT02928406|157671213|FG000|Overall Study|Lost to Follow-up|49|||
48957119|NCT02928406|157671213|FG000|Overall Study|Non-compliance|2|||
48957120|NCT02928406|157671213|FG000|Overall Study|Withdrawal by Subject|40|||
48957121|NCT02928406|157671213|FG000|Overall Study|Study terminated by sponsor|57|||
48957122|NCT02928406|157671213|FG000|Overall Study|Physician Decision|1|||
48957123|NCT02928406|157671213|FG000|Overall Study|Various reasons|72|||
48957124|NCT00540436|157671214|FG000|First 12-Week Treatment Period|Adverse Event|1|||
48957125|NCT00540436|157671214|FG000|First 12-Week Treatment Period|Withdrawal by Subject|1|||
48957126|NCT00540436|157671214|FG000|First 12-Week Treatment Period|Initiation of prohibited medication|1|||
48957127|NCT00540436|157671214|FG000|Second 12-Week Treatment Period|Adverse Event|1|||
48957128|NCT00488033|157671215|FG000|Overall Study|Withdrawal by Subject|1|||
48752302|NCT00001723|156938289|FG000|Overall Study|medication intolerance|1|||
48957129|NCT00488033|157671216|FG001|Overall Study|Withdrawal by Subject|0|||
48957130|NCT03260205|157671217|FG000|Overall Study|Adverse Event|2|||
48957131|NCT03260205|157671218|FG001|Overall Study|Adverse Event|0|||
48957132|NCT03260205|157671219|FG002|Overall Study|Adverse Event|2|||
48957133|NCT03260205|157671220|FG003|Overall Study|Adverse Event|2|||
48957134|NCT03260205|157671221|FG004|Overall Study|Adverse Event|4|||
48957135|NCT03260205|157671217|FG000|Overall Study|Lost to Follow-up|2|||
48957136|NCT03260205|157671218|FG001|Overall Study|Lost to Follow-up|2|||
48957137|NCT03260205|157671219|FG002|Overall Study|Lost to Follow-up|1|||
48957138|NCT03260205|157671220|FG003|Overall Study|Lost to Follow-up|1|||
48957139|NCT03260205|157671221|FG004|Overall Study|Lost to Follow-up|5|||
48957140|NCT03260205|157671217|FG000|Overall Study|Protocol Violation|0|||
48957141|NCT03260205|157671218|FG001|Overall Study|Protocol Violation|0|||
48957142|NCT03260205|157671219|FG002|Overall Study|Protocol Violation|2|||
48957143|NCT03260205|157671220|FG003|Overall Study|Protocol Violation|0|||
48957144|NCT03260205|157671221|FG004|Overall Study|Protocol Violation|1|||
48957145|NCT03260205|157671217|FG000|Overall Study|Withdrawal by Participant or Parent/LAR|4|||
48957146|NCT03260205|157671218|FG001|Overall Study|Withdrawal by Participant or Parent/LAR|5|||
48957147|NCT03260205|157671219|FG002|Overall Study|Withdrawal by Participant or Parent/LAR|1|||
48957148|NCT03260205|157671220|FG003|Overall Study|Withdrawal by Participant or Parent/LAR|0|||
48957149|NCT03260205|157671221|FG004|Overall Study|Withdrawal by Participant or Parent/LAR|2|||
48957150|NCT03260205|157671217|FG000|Overall Study|Other: Unspecified|0|||
48957151|NCT03260205|157671218|FG001|Overall Study|Other: Unspecified|0|||
48957152|NCT03260205|157671219|FG002|Overall Study|Other: Unspecified|3|||
48957153|NCT03260205|157671220|FG003|Overall Study|Other: Unspecified|1|||
48957154|NCT03260205|157671221|FG004|Overall Study|Other: Unspecified|1|||
48957155|NCT03260205|157671217|FG000|Overall Study|Participant Who Did Not Received AnyDose|1|||
48957156|NCT03260205|157671218|FG001|Overall Study|Participant Who Did Not Received AnyDose|1|||
48957157|NCT03260205|157671219|FG002|Overall Study|Participant Who Did Not Received AnyDose|2|||
48957158|NCT03260205|157671220|FG003|Overall Study|Participant Who Did Not Received AnyDose|3|||
48957159|NCT03260205|157671221|FG004|Overall Study|Participant Who Did Not Received AnyDose|1|||
48957160|NCT00369668|157671227|FG000|Overall Study|Lack of Efficacy|4|||
48957161|NCT00369668|157671228|FG001|Overall Study|Lack of Efficacy|5|||
48957162|NCT00369668|157671229|FG002|Overall Study|Lack of Efficacy|7|||
48957163|NCT04752189|157671242|FG000|Overall Study|Withdrawal by Subject|0|||
48957164|NCT04752189|157671243|FG001|Overall Study|Withdrawal by Subject|150|||
48957165|NCT04752189|157671242|FG000|Overall Study|Lost to Follow-up|261|||
48957166|NCT04752189|157671243|FG001|Overall Study|Lost to Follow-up|126|||
48957167|NCT03488472|157673130|FG000|Overall Study|disease progression additional mets|1|||
48957168|NCT03504774|157673137|FG000|Overall Study|Adverse Event|2|||
48957169|NCT03504774|157673138|FG001|Overall Study|Adverse Event|0|||
48957170|NCT03504774|157673137|FG000|Overall Study|Lost to Follow-up|0|||
48957171|NCT03504774|157673138|FG001|Overall Study|Lost to Follow-up|1|||
48957172|NCT03504774|157673137|FG000|Overall Study|Protocol Violation|11|||
48957173|NCT03504774|157673138|FG001|Overall Study|Protocol Violation|3|||
48957174|NCT03504774|157673137|FG000|Overall Study|failed wk 52 DBPCFC|1|||
48957175|NCT03504774|157673138|FG001|Overall Study|failed wk 52 DBPCFC|0|||
48957176|NCT04263142|157673139|FG000|Part 2 Period 1 (Day 1)|Adverse Event|0|||
48957177|NCT04263142|157673140|FG001|Part 2 Period 1 (Day 1)|Adverse Event|0|||
48957178|NCT04263142|157673141|FG002|Part 2 Period 1 (Day 1)|Adverse Event|0|||
48957179|NCT04263142|157673142|FG003|Part 2 Period 1 (Day 1)|Adverse Event|0|||
48957180|NCT04263142|157673143|FG004|Part 2 Period 1 (Day 1)|Adverse Event|1|||
48957181|NCT04263142|157673139|FG000|Part 2 Period 2 (Day 1)|Physician Decision|0|||
48957182|NCT04263142|157673140|FG001|Part 2 Period 2 (Day 1)|Physician Decision|0|||
48957183|NCT04263142|157673141|FG002|Part 2 Period 2 (Day 1)|Physician Decision|0|||
48957184|NCT04263142|157673142|FG003|Part 2 Period 2 (Day 1)|Physician Decision|0|||
48957185|NCT04263142|157673143|FG004|Part 2 Period 2 (Day 1)|Physician Decision|1|||
48957186|NCT00372190|157673144|FG000|Overall Study|Lost to Follow-up|3|||
48957187|NCT00372190|157673145|FG001|Overall Study|Lost to Follow-up|1|||
48957188|NCT00718419|157673146|FG000|Overall Study|Adverse Event|2|||
48957189|NCT00718419|157673147|FG001|Overall Study|Adverse Event|1|||
48752303|NCT00001723|156938290|FG001|Overall Study|medication intolerance|2|||
48752304|NCT02788357|156938292|FG000|Overall Study|Lost to Follow-up|3|||
48752305|NCT02788357|156938293|FG001|Overall Study|Lost to Follow-up|0|||
48752306|NCT00536198|156938294|FG000|Overall Study|Lost to Follow-up|15|||
48752307|NCT00536198|156938295|FG001|Overall Study|Lost to Follow-up|14|||
48752308|NCT00536198|156938294|FG000|Overall Study|Withdrawal by Subject|16|||
48752309|NCT00536198|156938295|FG001|Overall Study|Withdrawal by Subject|12|||
48752310|NCT00536198|156938294|FG000|Overall Study|Adverse Event|2|||
48752311|NCT00536198|156938295|FG001|Overall Study|Adverse Event|2|||
48752312|NCT00536198|156938294|FG000|Overall Study|Rescue|3|||
48752313|NCT00536198|156938295|FG001|Overall Study|Rescue|9|||
48752314|NCT00536198|156938294|FG000|Overall Study|Pregnancy|1|||
48752315|NCT00536198|156938295|FG001|Overall Study|Pregnancy|1|||
48752316|NCT00536198|156938294|FG000|Overall Study|Protocol Violation|0|||
48752317|NCT00536198|156938295|FG001|Overall Study|Protocol Violation|1|||
48752318|NCT01714635|156938297|FG000|Overall Study|Discontinued|1|||
48752319|NCT01714635|156938298|FG001|Overall Study|Discontinued|0|||
48752320|NCT01714635|156938299|FG002|Overall Study|Discontinued|2|||
48752321|NCT01714635|156938297|FG000|Overall Study|Missed 6-month exam|1|||
48752322|NCT01714635|156938298|FG001|Overall Study|Missed 6-month exam|0|||
48752323|NCT01714635|156938299|FG002|Overall Study|Missed 6-month exam|0|||
48752324|NCT01927367|156938300|FG000|Overall Study|Withdrawal by Subject|7|||
48752325|NCT01927367|156938301|FG001|Overall Study|Withdrawal by Subject|4|||
48752326|NCT01927367|156938300|FG000|Overall Study|No baseline data|0|||
48752327|NCT01927367|156938301|FG001|Overall Study|No baseline data|1|||
48752328|NCT01214629|156938302|FG000|Overall Study|Progressive Disease|1|||
48752329|NCT01214629|156938303|FG001|Overall Study|Progressive Disease|1|||
48752330|NCT01214629|156938304|FG002|Overall Study|Progressive Disease|0|||
48752331|NCT01214629|156938305|FG003|Overall Study|Progressive Disease|1|||
48752332|NCT01214629|156938306|FG004|Overall Study|Progressive Disease|2|||
48752333|NCT01214629|156938307|FG005|Overall Study|Progressive Disease|3|||
48752334|NCT01214629|156938308|FG006|Overall Study|Progressive Disease|1|||
48752335|NCT01214629|156938309|FG007|Overall Study|Progressive Disease|1|||
48752336|NCT01214629|156938310|FG008|Overall Study|Progressive Disease|1|||
48752337|NCT01214629|156938311|FG009|Overall Study|Progressive Disease|5|||
48752338|NCT01214629|156938312|FG010|Overall Study|Progressive Disease|1|||
48752339|NCT01214629|156938302|FG000|Overall Study|Adverse Event|0|||
48752340|NCT01214629|156938303|FG001|Overall Study|Adverse Event|0|||
48752341|NCT01214629|156938304|FG002|Overall Study|Adverse Event|0|||
48752342|NCT01214629|156938305|FG003|Overall Study|Adverse Event|1|||
48752343|NCT01214629|156938306|FG004|Overall Study|Adverse Event|0|||
48752344|NCT01214629|156938307|FG005|Overall Study|Adverse Event|1|||
48752345|NCT01214629|156938308|FG006|Overall Study|Adverse Event|0|||
48752346|NCT01214629|156938309|FG007|Overall Study|Adverse Event|0|||
48752347|NCT01214629|156938310|FG008|Overall Study|Adverse Event|0|||
48752348|NCT01214629|156938311|FG009|Overall Study|Adverse Event|1|||
48752349|NCT01214629|156938312|FG010|Overall Study|Adverse Event|0|||
48752350|NCT01214629|156938302|FG000|Overall Study|Physician Decision|0|||
48957190|NCT00718419|157673146|FG000|Overall Study|Physician Decision|1|||
48957191|NCT00718419|157673147|FG001|Overall Study|Physician Decision|6|||
48957192|NCT00718419|157673146|FG000|Overall Study|Sponsor decision|0|||
48957193|NCT00718419|157673147|FG001|Overall Study|Sponsor decision|1|||
48957194|NCT00718419|157673146|FG000|Overall Study|Withdrawal by Subject|0|||
48957195|NCT00718419|157673147|FG001|Overall Study|Withdrawal by Subject|5|||
48957196|NCT00718419|157673146|FG000|Overall Study|Progressive Disease|7|||
48957197|NCT00718419|157673147|FG001|Overall Study|Progressive Disease|25|||
48957198|NCT00718419|157673146|FG000|Overall Study|Death Due to Progressive Disease|2|||
48957199|NCT00718419|157673147|FG001|Overall Study|Death Due to Progressive Disease|0|||
48957200|NCT00718419|157673146|FG000|Overall Study|Death Due to Study Drug Related|0|||
48957201|NCT00718419|157673147|FG001|Overall Study|Death Due to Study Drug Related|1|||
48957202|NCT00718419|157673146|FG000|Overall Study|Death Due to Adverse Events|1|||
48957203|NCT00718419|157673147|FG001|Overall Study|Death Due to Adverse Events|0|||
48957204|NCT01814800|157673153|FG000|Overall Study|Adverse Event|2|||
48864481|NCT03745651|157340138|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|13|||
48864482|NCT03745651|157340139|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|4|||
48864483|NCT03745651|157340140|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
48864484|NCT03745651|157340141|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
48864485|NCT03745651|157340142|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
48864486|NCT03745651|157340143|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
48864487|NCT03745651|157340137|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|3|||
48864488|NCT03745651|157340138|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
48864489|NCT03745651|157340139|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
48864490|NCT03745651|157340140|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
48864491|NCT03745651|157340141|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
48864492|NCT03745651|157340142|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
48864493|NCT03745651|157340143|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
48957205|NCT01814800|157673153|FG000|Overall Study|Pregnancy|1|||
48957206|NCT01814800|157673153|FG000|Overall Study|Sponsor decision|1|||
48957207|NCT01814800|157673153|FG000|Overall Study|Subject relocation|1|||
48957208|NCT01597557|157673154|FG000|Overall Study|Did not undergo cardioversion procedure|4|||
48957209|NCT01597557|157673155|FG001|Overall Study|Did not undergo cardioversion procedure|3|||
48957210|NCT01930799|157673156|FG000|Overall Study|Withdrawal by Subject|3|||
48957211|NCT01930799|157673156|FG000|Overall Study|Lost to Follow-up|5|||
48957212|NCT05373706|157673157|FG000|Overall Study|Lost to Follow-up|2|||
48957213|NCT05373706|157673158|FG001|Overall Study|Lost to Follow-up|2|||
48957214|NCT00782418|157673159|FG000|Period 1 Procedure/Treatment Groups|Adverse Event|1|||
48957215|NCT00782418|157673160|FG001|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
48957216|NCT00782418|157673161|FG002|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
48957217|NCT00782418|157673162|FG003|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
48957218|NCT00782418|157673163|FG004|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
48957219|NCT00782418|157673164|FG005|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
48957220|NCT00782418|157673165|FG006|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
48957221|NCT00782418|157673159|FG000|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
48957222|NCT00782418|157673160|FG001|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
48957223|NCT00782418|157673161|FG002|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
48957224|NCT00782418|157673162|FG003|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
48957225|NCT00782418|157673163|FG004|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
48957226|NCT00782418|157673164|FG005|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
48957227|NCT00782418|157673165|FG006|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
48957228|NCT03165721|157673167|FG000|Overall Study|Refused further treatment|3|||
48957229|NCT03165721|157673168|FG001|Overall Study|Refused further treatment|0|||
48957230|NCT03165721|157673169|FG002|Overall Study|Refused further treatment|0|||
48957231|NCT03165721|157673167|FG000|Overall Study|Physician Decision|1|||
48957232|NCT03165721|157673168|FG001|Overall Study|Physician Decision|0|||
48957233|NCT03165721|157673169|FG002|Overall Study|Physician Decision|0|||
48957234|NCT01428063|157673172|FG000|Overall Study|Lack of Efficacy|8|||
48957235|NCT01428063|157673173|FG001|Overall Study|Lack of Efficacy|4|||
48957236|NCT01428063|157673174|FG002|Overall Study|Lack of Efficacy|1|||
48957237|NCT01428063|157673172|FG000|Overall Study|Adverse Event|2|||
48957238|NCT01428063|157673173|FG001|Overall Study|Adverse Event|3|||
48957239|NCT01428063|157673174|FG002|Overall Study|Adverse Event|0|||
48957240|NCT01428063|157673172|FG000|Overall Study|Lost to Follow-up|0|||
48957241|NCT01428063|157673173|FG001|Overall Study|Lost to Follow-up|2|||
48957242|NCT01428063|157673174|FG002|Overall Study|Lost to Follow-up|0|||
48957243|NCT01428063|157673172|FG000|Overall Study|No longer meets study criteria|0|||
48957244|NCT01428063|157673173|FG001|Overall Study|No longer meets study criteria|1|||
48957245|NCT01428063|157673174|FG002|Overall Study|No longer meets study criteria|0|||
48957246|NCT00365716|157673175|FG000|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1|||
48957247|NCT00365716|157673176|FG001|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2|||
48957248|NCT00365716|157673177|FG002|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
48957249|NCT00365716|157673178|FG003|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
48957250|NCT00365716|157673179|FG004|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
48957251|NCT00365716|157673180|FG005|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
48957252|NCT00365716|157673181|FG006|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
48957253|NCT00365716|157673175|FG000|Base Study (Day 1 to Month 7)|Adverse Event|0|||
48957254|NCT00365716|157673176|FG001|Base Study (Day 1 to Month 7)|Adverse Event|2|||
48957255|NCT00365716|157673177|FG002|Base Study (Day 1 to Month 7)|Adverse Event|0|||
48957256|NCT00365716|157673178|FG003|Base Study (Day 1 to Month 7)|Adverse Event|0|||
48957257|NCT00365716|157673179|FG004|Base Study (Day 1 to Month 7)|Adverse Event|1|||
48957258|NCT00365716|157673180|FG005|Base Study (Day 1 to Month 7)|Adverse Event|0|||
48957259|NCT00365716|157673181|FG006|Base Study (Day 1 to Month 7)|Adverse Event|0|||
48957260|NCT00365716|157673175|FG000|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
48957261|NCT00365716|157673176|FG001|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
48957262|NCT00365716|157673177|FG002|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
48957263|NCT00365716|157673178|FG003|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
48957264|NCT00365716|157673179|FG004|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
48957265|NCT00365716|157673180|FG005|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
48752351|NCT01214629|156938303|FG001|Overall Study|Physician Decision|0|||
48957266|NCT00365716|157673181|FG006|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
48864494|NCT03745651|157340137|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
48864495|NCT03745651|157340138|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|2|||
48864496|NCT03745651|157340139|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
48864497|NCT03745651|157340140|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
48864498|NCT03745651|157340141|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
48864499|NCT03745651|157340142|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
48864500|NCT03745651|157340143|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
48864501|NCT03745651|157340137|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
48864502|NCT03745651|157340138|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|21|||
48864503|NCT03745651|157340139|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|15|||
48864504|NCT03745651|157340140|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
48864505|NCT03745651|157340141|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
48957267|NCT00365716|157673175|FG000|Base Study (Day 1 to Month 7)|Other|0|||
48957268|NCT00365716|157673176|FG001|Base Study (Day 1 to Month 7)|Other|1|||
48957269|NCT00365716|157673177|FG002|Base Study (Day 1 to Month 7)|Other|0|||
48957270|NCT00365716|157673178|FG003|Base Study (Day 1 to Month 7)|Other|0|||
48957271|NCT00365716|157673179|FG004|Base Study (Day 1 to Month 7)|Other|0|||
48957272|NCT00365716|157673180|FG005|Base Study (Day 1 to Month 7)|Other|0|||
48957273|NCT00365716|157673181|FG006|Base Study (Day 1 to Month 7)|Other|0|||
48957274|NCT00365716|157673175|FG000|Base Study (Day 1 to Month 7)|Pregnancy|3|||
48752352|NCT01214629|156938304|FG002|Overall Study|Physician Decision|0|||
48752353|NCT01214629|156938305|FG003|Overall Study|Physician Decision|0|||
48752354|NCT01214629|156938306|FG004|Overall Study|Physician Decision|0|||
48752355|NCT01214629|156938307|FG005|Overall Study|Physician Decision|0|||
48752356|NCT01214629|156938308|FG006|Overall Study|Physician Decision|0|||
48752357|NCT01214629|156938309|FG007|Overall Study|Physician Decision|0|||
48752358|NCT01214629|156938310|FG008|Overall Study|Physician Decision|0|||
48752359|NCT01214629|156938311|FG009|Overall Study|Physician Decision|0|||
48752360|NCT01214629|156938312|FG010|Overall Study|Physician Decision|1|||
48752361|NCT01214629|156938302|FG000|Overall Study|Withdrawal by Subject|0|||
48752362|NCT01214629|156938303|FG001|Overall Study|Withdrawal by Subject|0|||
48752363|NCT01214629|156938304|FG002|Overall Study|Withdrawal by Subject|0|||
48752364|NCT01214629|156938305|FG003|Overall Study|Withdrawal by Subject|0|||
48752365|NCT01214629|156938306|FG004|Overall Study|Withdrawal by Subject|0|||
48752366|NCT01214629|156938307|FG005|Overall Study|Withdrawal by Subject|0|||
48752367|NCT01214629|156938308|FG006|Overall Study|Withdrawal by Subject|0|||
48752368|NCT01214629|156938309|FG007|Overall Study|Withdrawal by Subject|0|||
48752369|NCT01214629|156938310|FG008|Overall Study|Withdrawal by Subject|0|||
48752370|NCT01214629|156938311|FG009|Overall Study|Withdrawal by Subject|1|||
48752371|NCT01214629|156938312|FG010|Overall Study|Withdrawal by Subject|0|||
48752372|NCT00126568|156938322|FG000|Overall Study|Death|2|||
48752373|NCT04868890|156938323|FG000|Overall Study|Death|2|||
48752374|NCT04868890|156938324|FG001|Overall Study|Death|1|||
48752375|NCT04868890|156938323|FG000|Overall Study|Withdrawal by Subject|1|||
48752376|NCT04868890|156938324|FG001|Overall Study|Withdrawal by Subject|5|||
48957275|NCT00365716|157673176|FG001|Base Study (Day 1 to Month 7)|Pregnancy|2|||
48752377|NCT02260921|156938325|FG000|Overall Study|Adverse Event|1|||
48752378|NCT02260921|156938326|FG001|Overall Study|Adverse Event|0|||
48752379|NCT02260921|156938325|FG000|Overall Study|Lost to Follow-up|4|||
48752380|NCT02260921|156938326|FG001|Overall Study|Lost to Follow-up|3|||
48752381|NCT02260921|156938325|FG000|Overall Study|Withdraw Consent|4|||
48752382|NCT02260921|156938326|FG001|Overall Study|Withdraw Consent|1|||
48752383|NCT02260921|156938325|FG000|Overall Study|Death|1|||
48752384|NCT02260921|156938326|FG001|Overall Study|Death|0|||
48957276|NCT00365716|157673177|FG002|Base Study (Day 1 to Month 7)|Pregnancy|3|||
48957277|NCT00365716|157673178|FG003|Base Study (Day 1 to Month 7)|Pregnancy|1|||
48957278|NCT00365716|157673179|FG004|Base Study (Day 1 to Month 7)|Pregnancy|1|||
48957279|NCT00365716|157673180|FG005|Base Study (Day 1 to Month 7)|Pregnancy|0|||
48752385|NCT02260921|156938325|FG000|Overall Study|Prohibited Treatment for Knee Pain|4|||
48752386|NCT02260921|156938326|FG001|Overall Study|Prohibited Treatment for Knee Pain|0|||
48957280|NCT00365716|157673181|FG006|Base Study (Day 1 to Month 7)|Pregnancy|0|||
48752387|NCT01244425|156938327|FG000|Overall Study|Withdrawal by Subject|2|||
48752388|NCT01244425|156938328|FG001|Overall Study|Withdrawal by Subject|2|||
48752389|NCT01244425|156938327|FG000|Overall Study|Adverse Event|1|||
48752390|NCT01244425|156938328|FG001|Overall Study|Adverse Event|1|||
48752391|NCT00867009|156938329|FG000|Induction Period|Nonserious Adverse Event|5|||
48752392|NCT00867009|156938329|FG000|Induction Period|Serious Adverse Event|10|||
48752393|NCT00867009|156938329|FG000|Induction Period|Death due to serious adverse event|6|||
48752394|NCT00867009|156938329|FG000|Induction Period|Death due to Study Disease|4|||
48752395|NCT00867009|156938329|FG000|Induction Period|Protocol Violation|1|||
48752396|NCT00867009|156938329|FG000|Induction Period|Withdrawal by Subject|8|||
48752397|NCT00867009|156938329|FG000|Induction Period|Physician Decision|3|||
48752398|NCT00867009|156938329|FG000|Induction Period|Progressive Disease (PD)|25|||
48752399|NCT00867009|156938329|FG000|Maintenance Period|On-going in the Study at Data Cut-off|4|||
48752400|NCT00580606|156938331|FG000|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2|||
48752401|NCT00580606|156938332|FG001|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1|||
48752402|NCT00580606|156938331|FG000|Open Label (OL)|Withdrawal by Subject|4|||
48752403|NCT00580606|156938332|FG001|Open Label (OL)|Withdrawal by Subject|6|||
48752404|NCT00580606|156938331|FG000|Open Label (OL)|Dosing Symptoms|0|||
48752405|NCT00580606|156938332|FG001|Open Label (OL)|Dosing Symptoms|1|||
48752406|NCT00580606|156938331|FG000|Open Label (OL)|Lost to Follow-up|0|||
48752407|NCT00580606|156938332|FG001|Open Label (OL)|Lost to Follow-up|1|||
48752408|NCT00580606|156938331|FG000|Open Label (OL)|Pregnancy|0|||
48752409|NCT00580606|156938332|FG001|Open Label (OL)|Pregnancy|1|||
48752410|NCT00580606|156938331|FG000|Open Label (OL)|Non-compliance|2|||
48752411|NCT00580606|156938332|FG001|Open Label (OL)|Non-compliance|0|||
48752412|NCT00580606|156938331|FG000|Open Label (OL)|Physician Decision|1|||
48752413|NCT00580606|156938332|FG001|Open Label (OL)|Physician Decision|1|||
48752414|NCT00580606|156938331|FG000|Open Label (OL)|Needed Prohibited Medication|0|||
48752415|NCT00580606|156938332|FG001|Open Label (OL)|Needed Prohibited Medication|1|||
48752416|NCT04557371|156938336|FG000|Overall Study|Covid-19-related|0|||
48752417|NCT04557371|156938337|FG001|Overall Study|Covid-19-related|1|||
48752418|NCT04557371|156938338|FG002|Overall Study|Covid-19-related|0|||
48752419|NCT04557371|156938336|FG000|Overall Study|Withdrawal by Subject|0|||
48752420|NCT04557371|156938337|FG001|Overall Study|Withdrawal by Subject|1|||
48752421|NCT04557371|156938338|FG002|Overall Study|Withdrawal by Subject|0|||
48752422|NCT04557371|156938336|FG000|Overall Study|Adverse Event|1|||
48752423|NCT04557371|156938337|FG001|Overall Study|Adverse Event|0|||
48864506|NCT03745651|157340142|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
48864507|NCT03745651|157340143|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
48864508|NCT03745651|157340137|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|1|||
48752424|NCT04557371|156938338|FG002|Overall Study|Adverse Event|0|||
48752425|NCT04140292|156938341|FG000|Overall Study|Restriction on outpatient visits due to COVID-19.|4|||
48752426|NCT04140292|156938342|FG001|Overall Study|Restriction on outpatient visits due to COVID-19.|16|||
48752427|NCT03715764|156938343|FG000|Baseline (Randomized (n=69)|Withdrawal by Subject|2|||
48752428|NCT03715764|156938344|FG001|Baseline (Randomized (n=69)|Withdrawal by Subject|3|||
48752429|NCT03715764|156938343|FG000|3 Month Follow-up|Lost to Follow-up|2|||
48752430|NCT03715764|156938344|FG001|3 Month Follow-up|Lost to Follow-up|2|||
48752431|NCT03715764|156938343|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
48752432|NCT03715764|156938344|FG001|3 Month Follow-up|Withdrawal by Subject|1|||
48752433|NCT03715764|156938343|FG000|6 Month Follow-up|Lost to Follow-up|3|||
48752434|NCT03715764|156938344|FG001|6 Month Follow-up|Lost to Follow-up|0|||
48752435|NCT03715764|156938343|FG000|12 Month Follow-up|Lost to Follow-up|2|||
48752436|NCT03715764|156938344|FG001|12 Month Follow-up|Lost to Follow-up|3|||
48752437|NCT03715764|156938343|FG000|12 Month Follow-up|Pregnancy|0|||
48752438|NCT03715764|156938344|FG001|12 Month Follow-up|Pregnancy|1|||
48752439|NCT03715764|156938343|FG000|12 Month Follow-up|Surgery|2|||
48752440|NCT03715764|156938344|FG001|12 Month Follow-up|Surgery|0|||
48752441|NCT03715764|156938343|FG000|12 Month Follow-up|Wrong address|1|||
48957281|NCT00365716|157673175|FG000|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
48957282|NCT00365716|157673176|FG001|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
48752442|NCT03715764|156938344|FG001|12 Month Follow-up|Wrong address|0|||
48957283|NCT00365716|157673177|FG002|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
48752443|NCT03715764|156938343|FG000|12 Month Follow-up|No symptoms|1|||
48752444|NCT03715764|156938344|FG001|12 Month Follow-up|No symptoms|0|||
48752445|NCT03715764|156938343|FG000|12 Month Follow-up|Changed primary care centre|0|||
48957284|NCT00365716|157673178|FG003|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
48957285|NCT00365716|157673179|FG004|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
48957286|NCT00365716|157673180|FG005|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
48752446|NCT03715764|156938344|FG001|12 Month Follow-up|Changed primary care centre|1|||
48752447|NCT00434330|156938345|FG000|Overall Study|Adverse Event|0|||
48752448|NCT00434330|156938346|FG001|Overall Study|Adverse Event|0|||
48752449|NCT00434330|156938347|FG002|Overall Study|Adverse Event|1|||
48957287|NCT00365716|157673181|FG006|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
48957288|NCT00365716|157673175|FG000|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
48957289|NCT00365716|157673176|FG001|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9|||
48957290|NCT00365716|157673177|FG002|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
48957291|NCT00365716|157673178|FG003|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4|||
48957292|NCT00365716|157673179|FG004|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3|||
48957293|NCT00365716|157673180|FG005|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
48957294|NCT00365716|157673181|FG006|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
48957295|NCT00365716|157673175|FG000|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114|||
48957296|NCT00365716|157673176|FG001|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
48957297|NCT00365716|157673177|FG002|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
48957298|NCT00365716|157673178|FG003|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69|||
48957299|NCT00365716|157673179|FG004|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75|||
48957300|NCT00365716|157673180|FG005|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
48957301|NCT00365716|157673181|FG006|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
48957302|NCT00365716|157673175|FG000|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6|||
48957303|NCT00365716|157673176|FG001|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8|||
48957304|NCT00365716|157673177|FG002|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5|||
48957305|NCT00365716|157673178|FG003|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4|||
48957306|NCT00365716|157673179|FG004|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3|||
48957307|NCT00365716|157673180|FG005|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
48957308|NCT00365716|157673181|FG006|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
48957309|NCT00365716|157673175|FG000|Long Term Follow-up (Month 7 toMonth 36)|Moved|3|||
48957310|NCT00365716|157673176|FG001|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
48957311|NCT00365716|157673177|FG002|Long Term Follow-up (Month 7 toMonth 36)|Moved|1|||
48752450|NCT00434330|156938348|FG003|Overall Study|Adverse Event|0|||
48752451|NCT00434330|156938349|FG004|Overall Study|Adverse Event|0|||
48752452|NCT00434330|156938350|FG005|Overall Study|Adverse Event|0|||
48752453|NCT00434330|156938345|FG000|Overall Study|Death|1|||
48752454|NCT00434330|156938346|FG001|Overall Study|Death|0|||
48752455|NCT00434330|156938347|FG002|Overall Study|Death|0|||
48752456|NCT00434330|156938348|FG003|Overall Study|Death|0|||
48957312|NCT00365716|157673178|FG003|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
48957313|NCT00365716|157673179|FG004|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
48957314|NCT00365716|157673180|FG005|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
48957315|NCT00365716|157673181|FG006|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
48957316|NCT00365716|157673175|FG000|Long Term Follow-up (Month 7 toMonth 36)|Other|2|||
48957317|NCT00365716|157673176|FG001|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
48957318|NCT00365716|157673177|FG002|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
48957319|NCT00365716|157673178|FG003|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
48957320|NCT00365716|157673179|FG004|Long Term Follow-up (Month 7 toMonth 36)|Other|1|||
48957321|NCT00365716|157673180|FG005|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
48957322|NCT00365716|157673181|FG006|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
48957323|NCT00365716|157673175|FG000|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
48957324|NCT00365716|157673176|FG001|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
48957325|NCT00365716|157673177|FG002|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
48957326|NCT00365716|157673178|FG003|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
48957327|NCT00365716|157673179|FG004|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
48957328|NCT00365716|157673180|FG005|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
48957329|NCT00365716|157673181|FG006|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
48957330|NCT00365716|157673175|FG000|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7|||
48957331|NCT00365716|157673176|FG001|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
48957332|NCT00365716|157673177|FG002|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13|||
48957333|NCT00365716|157673178|FG003|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
48957334|NCT00365716|157673179|FG004|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3|||
48957335|NCT00365716|157673180|FG005|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
48752457|NCT00434330|156938349|FG004|Overall Study|Death|1|||
48752458|NCT00434330|156938350|FG005|Overall Study|Death|1|||
48752459|NCT00434330|156938345|FG000|Overall Study|Withdrawal by Subject|0|||
48957336|NCT00365716|157673181|FG006|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
48957337|NCT00365716|157673175|FG000|Extension 1|Lost to Follow-up|0|||
48957338|NCT00365716|157673176|FG001|Extension 1|Lost to Follow-up|0|||
48957339|NCT00365716|157673177|FG002|Extension 1|Lost to Follow-up|0|||
48957340|NCT00365716|157673178|FG003|Extension 1|Lost to Follow-up|0|||
48957341|NCT00365716|157673179|FG004|Extension 1|Lost to Follow-up|0|||
48957342|NCT00365716|157673180|FG005|Extension 1|Lost to Follow-up|1|||
48957343|NCT00365716|157673181|FG006|Extension 1|Lost to Follow-up|0|||
48957344|NCT00365716|157673175|FG000|Extension 1|Other|0|||
48957345|NCT00365716|157673176|FG001|Extension 1|Other|0|||
48957346|NCT00365716|157673177|FG002|Extension 1|Other|0|||
48957347|NCT00365716|157673178|FG003|Extension 1|Other|0|||
48957348|NCT00365716|157673179|FG004|Extension 1|Other|0|||
48957349|NCT00365716|157673180|FG005|Extension 1|Other|9|||
48957350|NCT00365716|157673181|FG006|Extension 1|Other|0|||
48957351|NCT00365716|157673175|FG000|Extension 1|Moved|0|||
48957352|NCT00365716|157673176|FG001|Extension 1|Moved|0|||
48957353|NCT00365716|157673177|FG002|Extension 1|Moved|0|||
48957354|NCT00365716|157673178|FG003|Extension 1|Moved|0|||
48957355|NCT00365716|157673179|FG004|Extension 1|Moved|0|||
48957356|NCT00365716|157673180|FG005|Extension 1|Moved|4|||
48957357|NCT00365716|157673181|FG006|Extension 1|Moved|0|||
48957358|NCT00365716|157673175|FG000|Extension 1|Withdrawal by Subject|0|||
48957359|NCT00365716|157673176|FG001|Extension 1|Withdrawal by Subject|0|||
48957360|NCT00365716|157673177|FG002|Extension 1|Withdrawal by Subject|0|||
48957361|NCT00365716|157673178|FG003|Extension 1|Withdrawal by Subject|0|||
48957362|NCT00365716|157673179|FG004|Extension 1|Withdrawal by Subject|0|||
48957363|NCT00365716|157673180|FG005|Extension 1|Withdrawal by Subject|3|||
48957364|NCT00365716|157673181|FG006|Extension 1|Withdrawal by Subject|0|||
48957365|NCT00365716|157673175|FG000|Extension 1|Pregnancy|0|||
48957366|NCT00365716|157673176|FG001|Extension 1|Pregnancy|0|||
48957367|NCT00365716|157673177|FG002|Extension 1|Pregnancy|0|||
48957368|NCT00365716|157673178|FG003|Extension 1|Pregnancy|0|||
48957369|NCT00365716|157673179|FG004|Extension 1|Pregnancy|0|||
48957370|NCT00365716|157673180|FG005|Extension 1|Pregnancy|4|||
48957371|NCT00365716|157673181|FG006|Extension 1|Pregnancy|0|||
48957372|NCT00365716|157673175|FG000|Extension 1|Protocol Violation|0|||
48957373|NCT00365716|157673176|FG001|Extension 1|Protocol Violation|0|||
48957374|NCT00365716|157673177|FG002|Extension 1|Protocol Violation|0|||
48957375|NCT00365716|157673178|FG003|Extension 1|Protocol Violation|0|||
48957376|NCT00365716|157673179|FG004|Extension 1|Protocol Violation|0|||
48957377|NCT00365716|157673180|FG005|Extension 1|Protocol Violation|1|||
48957378|NCT00365716|157673181|FG006|Extension 1|Protocol Violation|0|||
48957379|NCT00365716|157673175|FG000|Extension 2|Lost to Follow-up|0|||
48957380|NCT00365716|157673176|FG001|Extension 2|Lost to Follow-up|0|||
48957381|NCT00365716|157673177|FG002|Extension 2|Lost to Follow-up|0|||
48957382|NCT00365716|157673178|FG003|Extension 2|Lost to Follow-up|0|||
48957383|NCT00365716|157673179|FG004|Extension 2|Lost to Follow-up|0|||
48957384|NCT00365716|157673180|FG005|Extension 2|Lost to Follow-up|0|||
48957385|NCT00365716|157673181|FG006|Extension 2|Lost to Follow-up|2|||
48957386|NCT00365716|157673175|FG000|Extension 2|Other|0|||
48957387|NCT00365716|157673176|FG001|Extension 2|Other|0|||
48957388|NCT00365716|157673177|FG002|Extension 2|Other|0|||
48957389|NCT00365716|157673178|FG003|Extension 2|Other|0|||
48957390|NCT00365716|157673179|FG004|Extension 2|Other|0|||
48957391|NCT00365716|157673180|FG005|Extension 2|Other|0|||
48957392|NCT00365716|157673181|FG006|Extension 2|Other|3|||
48957393|NCT00365716|157673175|FG000|Extension 2|Withdrawal by Subject|0|||
48864509|NCT03745651|157340138|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
48864510|NCT03745651|157340139|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
48864511|NCT03745651|157340140|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
48864512|NCT03745651|157340141|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
48864513|NCT03745651|157340142|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
48864514|NCT03745651|157340143|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
48864515|NCT03745651|157340137|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
48864516|NCT03745651|157340138|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
48864517|NCT03745651|157340139|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
48864518|NCT03745651|157340140|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
48864519|NCT03745651|157340141|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
48864520|NCT03745651|157340142|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|4|||
48864521|NCT03745651|157340143|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
48957394|NCT00365716|157673176|FG001|Extension 2|Withdrawal by Subject|0|||
48957395|NCT00365716|157673177|FG002|Extension 2|Withdrawal by Subject|0|||
48957396|NCT00365716|157673178|FG003|Extension 2|Withdrawal by Subject|0|||
48957397|NCT00365716|157673179|FG004|Extension 2|Withdrawal by Subject|0|||
48957398|NCT00365716|157673180|FG005|Extension 2|Withdrawal by Subject|0|||
48957399|NCT00365716|157673181|FG006|Extension 2|Withdrawal by Subject|5|||
48957400|NCT01260467|157673183|FG000|Overall Study|Withdrawal by Subject|2|||
48957401|NCT01727713|157673187|FG000|Overall Study|Lost to Follow-up|5|||
48957402|NCT01727713|157673187|FG000|Overall Study|Adverse Event|10|||
48957403|NCT01727713|157673187|FG000|Overall Study|Participant Met Withdrawal Criteria|5|||
48957404|NCT01727713|157673187|FG000|Overall Study|Withdrawal by Subject|13|||
48957405|NCT01727713|157673187|FG000|Overall Study|Protocol Deviation|2|||
48957406|NCT03364608|157673191|FG000|Overall Study|Withdrawal by Subject|4|||
48957407|NCT03364608|157673191|FG000|Overall Study|Protocol Violation|2|||
48957408|NCT03364608|157673191|FG000|Overall Study|Lost to Follow-up|2|||
48957409|NCT01753076|157673196|FG000|Overall Study|Adverse Event|17|||
48957410|NCT01753076|157673197|FG001|Overall Study|Adverse Event|18|||
48957411|NCT01753076|157673196|FG000|Overall Study|Lack of Efficacy|3|||
48957412|NCT01753076|157673197|FG001|Overall Study|Lack of Efficacy|1|||
48957413|NCT01753076|157673196|FG000|Overall Study|Lost to Follow-up|2|||
48957414|NCT01753076|157673197|FG001|Overall Study|Lost to Follow-up|1|||
48957415|NCT01753076|157673196|FG000|Overall Study|Physician Decision|4|||
48957416|NCT01753076|157673197|FG001|Overall Study|Physician Decision|2|||
48957417|NCT01753076|157673196|FG000|Overall Study|Withdrawal by Subject|14|||
48957418|NCT01753076|157673197|FG001|Overall Study|Withdrawal by Subject|24|||
48957419|NCT01753076|157673196|FG000|Overall Study|Other-Reached Protocol-defined Stopping|1|||
48957420|NCT01753076|157673197|FG001|Overall Study|Other-Reached Protocol-defined Stopping|0|||
48957421|NCT00436566|157673198|FG000|Overall Study|Withdrawal by Subject|2|||
48957422|NCT00436566|157673198|FG000|Overall Study|Protocol Violation|1|||
48957423|NCT02389816|157673199|FG000|Overall Study|Randomized but Not Treated|1|||
48957424|NCT02389816|157673200|FG001|Overall Study|Randomized but Not Treated|0|||
48957425|NCT02389816|157673201|FG002|Overall Study|Randomized but Not Treated|0|||
48957426|NCT02389816|157673199|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|4|||
48957427|NCT02389816|157673200|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
48957428|NCT02389816|157673201|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|7|||
48957429|NCT02389816|157673199|FG000|Overall Study|Major Protocol Deviation|1|||
48957430|NCT02389816|157673200|FG001|Overall Study|Major Protocol Deviation|0|||
48957431|NCT02389816|157673201|FG002|Overall Study|Major Protocol Deviation|0|||
48957432|NCT02389816|157673199|FG000|Overall Study|Lost to Follow-up|1|||
48957433|NCT02389816|157673200|FG001|Overall Study|Lost to Follow-up|0|||
48957434|NCT02389816|157673201|FG002|Overall Study|Lost to Follow-up|0|||
48957435|NCT02389816|157673199|FG000|Overall Study|Withdrawal of Consent|6|||
48957436|NCT02389816|157673200|FG001|Overall Study|Withdrawal of Consent|4|||
48957437|NCT02389816|157673201|FG002|Overall Study|Withdrawal of Consent|4|||
48957438|NCT02389816|157673199|FG000|Overall Study|Lack of Efficacy|1|||
48957439|NCT02389816|157673200|FG001|Overall Study|Lack of Efficacy|0|||
48957440|NCT02389816|157673201|FG002|Overall Study|Lack of Efficacy|0|||
48752460|NCT00434330|156938346|FG001|Overall Study|Withdrawal by Subject|0|||
48752461|NCT00434330|156938347|FG002|Overall Study|Withdrawal by Subject|1|||
48752462|NCT00434330|156938348|FG003|Overall Study|Withdrawal by Subject|1|||
48957441|NCT02389816|157673199|FG000|Overall Study|Non Compliance with Study Drug|1|||
48957442|NCT02389816|157673200|FG001|Overall Study|Non Compliance with Study Drug|1|||
48752463|NCT00434330|156938349|FG004|Overall Study|Withdrawal by Subject|0|||
48752464|NCT00434330|156938350|FG005|Overall Study|Withdrawal by Subject|0|||
48752465|NCT00434330|156938345|FG000|Overall Study|Renal transplant|0|||
48752466|NCT00434330|156938346|FG001|Overall Study|Renal transplant|0|||
48752467|NCT00434330|156938347|FG002|Overall Study|Renal transplant|0|||
48752468|NCT00434330|156938348|FG003|Overall Study|Renal transplant|1|||
48752469|NCT00434330|156938349|FG004|Overall Study|Renal transplant|0|||
48752470|NCT00434330|156938350|FG005|Overall Study|Renal transplant|0|||
48752471|NCT00434330|156938345|FG000|Overall Study|Subject Not Compliant With Study|0|||
48752472|NCT00434330|156938346|FG001|Overall Study|Subject Not Compliant With Study|0|||
48752473|NCT00434330|156938347|FG002|Overall Study|Subject Not Compliant With Study|1|||
48752474|NCT00434330|156938348|FG003|Overall Study|Subject Not Compliant With Study|0|||
48752475|NCT00434330|156938349|FG004|Overall Study|Subject Not Compliant With Study|0|||
48752476|NCT00434330|156938350|FG005|Overall Study|Subject Not Compliant With Study|0|||
48752477|NCT00642941|156938351|FG000|Overall Study|Physician Decision|3|||
48752478|NCT00642941|156938352|FG001|Overall Study|Physician Decision|1|||
48752479|NCT00642941|156938353|FG002|Overall Study|Physician Decision|0|||
48752480|NCT00642941|156938354|FG003|Overall Study|Physician Decision|0|||
48752481|NCT00642941|156938355|FG004|Overall Study|Physician Decision|0|||
48752482|NCT00642941|156938356|FG005|Overall Study|Physician Decision|0|||
48752483|NCT00642941|156938357|FG006|Overall Study|Physician Decision|1|||
48957443|NCT02389816|157673201|FG002|Overall Study|Non Compliance with Study Drug|1|||
48752484|NCT00642941|156938358|FG007|Overall Study|Physician Decision|0|||
48752485|NCT00642941|156938359|FG008|Overall Study|Physician Decision|0|||
48752486|NCT00642941|156938360|FG009|Overall Study|Physician Decision|1|||
48752487|NCT00642941|156938361|FG010|Overall Study|Physician Decision|0|||
48752488|NCT00642941|156938362|FG011|Overall Study|Physician Decision|1|||
48752489|NCT00642941|156938351|FG000|Overall Study|Death|4|||
48752490|NCT00642941|156938352|FG001|Overall Study|Death|0|||
48752491|NCT00642941|156938353|FG002|Overall Study|Death|1|||
48752492|NCT00642941|156938354|FG003|Overall Study|Death|1|||
48752493|NCT00642941|156938355|FG004|Overall Study|Death|2|||
48752494|NCT00642941|156938356|FG005|Overall Study|Death|1|||
48752495|NCT00642941|156938357|FG006|Overall Study|Death|0|||
48752496|NCT00642941|156938358|FG007|Overall Study|Death|0|||
48752497|NCT00642941|156938359|FG008|Overall Study|Death|0|||
48752498|NCT00642941|156938360|FG009|Overall Study|Death|0|||
48752499|NCT00642941|156938361|FG010|Overall Study|Death|0|||
48752500|NCT00642941|156938362|FG011|Overall Study|Death|1|||
48752501|NCT00642941|156938351|FG000|Overall Study|Study closed by Sponsor|0|||
48752502|NCT00642941|156938352|FG001|Overall Study|Study closed by Sponsor|1|||
48752503|NCT00642941|156938353|FG002|Overall Study|Study closed by Sponsor|0|||
48864522|NCT03745651|157340137|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
48864523|NCT03745651|157340138|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
48864524|NCT03745651|157340139|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
48864525|NCT03745651|157340140|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
48864526|NCT03745651|157340141|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
48864527|NCT03745651|157340142|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
48864528|NCT03745651|157340143|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
48864529|NCT03745651|157340137|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
48864530|NCT03745651|157340138|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
48864531|NCT03745651|157340139|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
48864532|NCT03745651|157340140|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|4|||
48864533|NCT03745651|157340141|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|2|||
48864534|NCT03745651|157340142|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
48864535|NCT03745651|157340143|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|10|||
48864536|NCT03745651|157340137|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
48864537|NCT03745651|157340138|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
48864538|NCT03745651|157340139|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
48864539|NCT03745651|157340140|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
48864540|NCT03745651|157340141|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
48864541|NCT03745651|157340142|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|4|||
48864542|NCT03745651|157340143|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|2|||
48864543|NCT03745651|157340137|FG000|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
48864544|NCT03745651|157340138|FG001|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
48864545|NCT03745651|157340139|FG002|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
48864546|NCT03745651|157340140|FG003|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
48864547|NCT03745651|157340141|FG004|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
48864548|NCT03745651|157340142|FG005|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
48864549|NCT03745651|157340143|FG006|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
48864550|NCT03745651|157340137|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
48864551|NCT03745651|157340138|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
48864552|NCT03745651|157340139|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
48864553|NCT03745651|157340140|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
48864554|NCT03745651|157340141|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
48752504|NCT00642941|156938354|FG003|Overall Study|Study closed by Sponsor|0|||
48752505|NCT00642941|156938355|FG004|Overall Study|Study closed by Sponsor|0|||
48752506|NCT00642941|156938356|FG005|Overall Study|Study closed by Sponsor|0|||
48752507|NCT00642941|156938357|FG006|Overall Study|Study closed by Sponsor|0|||
48752508|NCT00642941|156938358|FG007|Overall Study|Study closed by Sponsor|0|||
48752509|NCT00642941|156938359|FG008|Overall Study|Study closed by Sponsor|0|||
48752510|NCT00642941|156938360|FG009|Overall Study|Study closed by Sponsor|0|||
48752511|NCT00642941|156938361|FG010|Overall Study|Study closed by Sponsor|0|||
48752512|NCT00642941|156938362|FG011|Overall Study|Study closed by Sponsor|0|||
48752513|NCT00642941|156938351|FG000|Overall Study|Withdrawal by Subject|1|||
48752514|NCT00642941|156938352|FG001|Overall Study|Withdrawal by Subject|0|||
48752515|NCT00642941|156938353|FG002|Overall Study|Withdrawal by Subject|0|||
48752516|NCT00642941|156938354|FG003|Overall Study|Withdrawal by Subject|2|||
48752517|NCT00642941|156938355|FG004|Overall Study|Withdrawal by Subject|0|||
48864555|NCT03745651|157340142|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
48864556|NCT03745651|157340143|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
48752518|NCT00642941|156938356|FG005|Overall Study|Withdrawal by Subject|0|||
48864557|NCT03745651|157340137|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
48864558|NCT03745651|157340138|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
48864559|NCT03745651|157340139|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
48864560|NCT03745651|157340140|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|12|||
48864561|NCT03745651|157340141|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|8|||
48864562|NCT03745651|157340142|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|26|||
48957444|NCT02389816|157673199|FG000|Overall Study|Reason not Specified|0|||
48957445|NCT02389816|157673200|FG001|Overall Study|Reason not Specified|2|||
48957446|NCT02389816|157673201|FG002|Overall Study|Reason not Specified|0|||
48957447|NCT02417233|157673202|FG000|Overall Study|Death|4|||
48957448|NCT02417233|157673203|FG001|Overall Study|Death|10|||
48957449|NCT02417233|157673204|FG002|Overall Study|Death|14|||
48957450|NCT02417233|157673202|FG000|Overall Study|Lost to Follow-up|27|||
48957451|NCT02417233|157673203|FG001|Overall Study|Lost to Follow-up|39|||
48957452|NCT02417233|157673204|FG002|Overall Study|Lost to Follow-up|34|||
48957453|NCT02417233|157673202|FG000|Overall Study|Protocol Violation|2|||
48957454|NCT02417233|157673203|FG001|Overall Study|Protocol Violation|0|||
48957455|NCT02417233|157673204|FG002|Overall Study|Protocol Violation|2|||
48957456|NCT02417233|157673202|FG000|Overall Study|Withdrawal by Subject|2|||
48957457|NCT02417233|157673203|FG001|Overall Study|Withdrawal by Subject|1|||
48864563|NCT03745651|157340143|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|34|||
48864564|NCT03745651|157340137|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
48864565|NCT03745651|157340138|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
48864566|NCT03745651|157340139|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
48864567|NCT03745651|157340140|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
48864568|NCT03745651|157340141|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
48864569|NCT03745651|157340142|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
48864570|NCT03745651|157340143|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
48864571|NCT04175834|157340144|FG000|Overall Study|Withdrawal by Subject|1|||
48864572|NCT04175834|157340145|FG001|Overall Study|Withdrawal by Subject|0|||
48864573|NCT01114217|157340148|FG000|Overall Study|Adverse Event|5|||
48864574|NCT01114217|157340149|FG001|Overall Study|Adverse Event|3|||
48864575|NCT01114217|157340148|FG000|Overall Study|Lost to Follow-up|17|||
48864576|NCT01114217|157340149|FG001|Overall Study|Lost to Follow-up|33|||
48864577|NCT01114217|157340148|FG000|Overall Study|Withdrawal by Subject|21|||
48864578|NCT01114217|157340149|FG001|Overall Study|Withdrawal by Subject|28|||
48864579|NCT01114217|157340148|FG000|Overall Study|Other-Clerical Error|3|||
48864580|NCT01114217|157340149|FG001|Overall Study|Other-Clerical Error|0|||
48864581|NCT01114217|157340148|FG000|Overall Study|Other-Early termination|6|||
48864582|NCT01114217|157340149|FG001|Overall Study|Other-Early termination|10|||
48864583|NCT01114217|157340148|FG000|Overall Study|Other-Procedure|1|||
48864584|NCT01114217|157340149|FG001|Overall Study|Other-Procedure|1|||
48864585|NCT01114217|157340148|FG000|Overall Study|Other-Pregnancy|2|||
48864586|NCT01114217|157340149|FG001|Overall Study|Other-Pregnancy|4|||
48864587|NCT01114217|157340148|FG000|Overall Study|Other-Protocol Violation|1|||
48864588|NCT01114217|157340149|FG001|Overall Study|Other-Protocol Violation|3|||
48864589|NCT01114217|157340148|FG000|Overall Study|Other-Lack of Efficacy|1|||
48864590|NCT01114217|157340149|FG001|Overall Study|Other-Lack of Efficacy|0|||
48864591|NCT01114217|157340148|FG000|Overall Study|Other-Non Compliance|2|||
48864592|NCT01114217|157340149|FG001|Overall Study|Other-Non Compliance|0|||
48864593|NCT01114217|157340148|FG000|Overall Study|Other-Physician Decision|1|||
48864594|NCT01114217|157340149|FG001|Overall Study|Other-Physician Decision|1|||
48864595|NCT01114217|157340148|FG000|Overall Study|Other-Sponsor Decision|10|||
48864596|NCT01114217|157340149|FG001|Overall Study|Other-Sponsor Decision|12|||
48864597|NCT01114217|157340148|FG000|Overall Study|Other-Study Termination|0|||
48864598|NCT01114217|157340149|FG001|Overall Study|Other-Study Termination|1|||
48864599|NCT01114217|157340148|FG000|Overall Study|Other-Study Withdrawn|1|||
48864600|NCT01114217|157340149|FG001|Overall Study|Other-Study Withdrawn|1|||
48864601|NCT01114217|157340148|FG000|Overall Study|Other-Site Stopped Communicating|2|||
48957458|NCT02417233|157673204|FG002|Overall Study|Withdrawal by Subject|8|||
48957459|NCT02417233|157673202|FG000|Overall Study|Relocation out of study area|1|||
48957460|NCT02417233|157673203|FG001|Overall Study|Relocation out of study area|0|||
48957461|NCT02417233|157673204|FG002|Overall Study|Relocation out of study area|1|||
48957462|NCT02417233|157673202|FG000|Overall Study|Mentally unstable|0|||
48957463|NCT02417233|157673203|FG001|Overall Study|Mentally unstable|1|||
48957464|NCT02417233|157673204|FG002|Overall Study|Mentally unstable|0|||
48957465|NCT00471536|157673209|FG000|Overall Study|Withdrawal by Subject|1|||
48957466|NCT02651194|157673210|FG000|Overall Study|Lost to Follow-up|3|||
48957467|NCT02651194|157673210|FG000|Overall Study|Other|2|||
48957468|NCT01259856|157673217|FG000|Overall Study|Adverse Event|12|||
48957469|NCT01259856|157673218|FG001|Overall Study|Adverse Event|9|||
48957470|NCT01259856|157673217|FG000|Overall Study|Death|0|||
48957471|NCT01259856|157673218|FG001|Overall Study|Death|1|||
48957472|NCT01259856|157673217|FG000|Overall Study|Lack of Efficacy|3|||
48957473|NCT01259856|157673218|FG001|Overall Study|Lack of Efficacy|1|||
48752519|NCT00642941|156938357|FG006|Overall Study|Withdrawal by Subject|2|||
48752520|NCT00642941|156938358|FG007|Overall Study|Withdrawal by Subject|0|||
48752521|NCT00642941|156938359|FG008|Overall Study|Withdrawal by Subject|1|||
48957474|NCT01259856|157673217|FG000|Overall Study|Lost to Follow-up|1|||
48752522|NCT00642941|156938360|FG009|Overall Study|Withdrawal by Subject|0|||
48752523|NCT00642941|156938361|FG010|Overall Study|Withdrawal by Subject|0|||
48752524|NCT00642941|156938362|FG011|Overall Study|Withdrawal by Subject|1|||
48752525|NCT00642941|156938351|FG000|Overall Study|Protocol Violation|0|||
48752526|NCT00642941|156938352|FG001|Overall Study|Protocol Violation|0|||
48752527|NCT00642941|156938353|FG002|Overall Study|Protocol Violation|0|||
48752528|NCT00642941|156938354|FG003|Overall Study|Protocol Violation|0|||
48752529|NCT00642941|156938355|FG004|Overall Study|Protocol Violation|0|||
48864602|NCT01114217|157340149|FG001|Overall Study|Other-Site Stopped Communicating|0|||
48864603|NCT01114217|157340148|FG000|Overall Study|Other-Lost to Follow-up|1|||
48864604|NCT01114217|157340149|FG001|Overall Study|Other-Lost to Follow-up|0|||
48864605|NCT01114217|157340148|FG000|Overall Study|Other-Withdrawal by Subject|1|||
48864606|NCT01114217|157340149|FG001|Overall Study|Other-Withdrawal by Subject|1|||
48864607|NCT02592434|157340150|FG000|Open-Label Phase (18 Weeks)|Adverse Event|12|||
48864608|NCT02592434|157340151|FG001|Open-Label Phase (18 Weeks)|Adverse Event|0|||
48864609|NCT02592434|157340152|FG002|Open-Label Phase (18 Weeks)|Adverse Event|0|||
48864610|NCT02592434|157340150|FG000|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21|||
48864611|NCT02592434|157340151|FG001|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
48864612|NCT02592434|157340152|FG002|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
48864613|NCT02592434|157340150|FG000|Open-Label Phase (18 Weeks)|Other|3|||
48864614|NCT02592434|157340151|FG001|Open-Label Phase (18 Weeks)|Other|0|||
48864615|NCT02592434|157340152|FG002|Open-Label Phase (18 Weeks)|Other|0|||
48864616|NCT02592434|157340150|FG000|Open-Label Phase (18 Weeks)|Protocol Deviation|4|||
48864617|NCT02592434|157340151|FG001|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
48864618|NCT02592434|157340152|FG002|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
48864619|NCT02592434|157340150|FG000|Double Blind Phase (26 Weeks)|Adverse Event|0|||
48864620|NCT02592434|157340151|FG001|Double Blind Phase (26 Weeks)|Adverse Event|2|||
48864621|NCT02592434|157340152|FG002|Double Blind Phase (26 Weeks)|Adverse Event|2|||
48864622|NCT02592434|157340150|FG000|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0|||
48752530|NCT00642941|156938356|FG005|Overall Study|Protocol Violation|0|||
48752531|NCT00642941|156938357|FG006|Overall Study|Protocol Violation|1|||
48864623|NCT02592434|157340151|FG001|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22|||
48864624|NCT02592434|157340152|FG002|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44|||
48864625|NCT02592434|157340150|FG000|Double Blind Phase (26 Weeks)|Other|0|||
48957475|NCT01259856|157673218|FG001|Overall Study|Lost to Follow-up|1|||
48957476|NCT01259856|157673217|FG000|Overall Study|Physician Decision|2|||
48957477|NCT01259856|157673218|FG001|Overall Study|Physician Decision|1|||
48957478|NCT01259856|157673217|FG000|Overall Study|Withdrawal by Subject|9|||
48957479|NCT01259856|157673218|FG001|Overall Study|Withdrawal by Subject|10|||
48957480|NCT01259856|157673217|FG000|Overall Study|Treatment never started|0|||
48957481|NCT01259856|157673218|FG001|Overall Study|Treatment never started|6|||
48957482|NCT01259856|157673217|FG000|Overall Study|Study closure by sponsor|40|||
48957483|NCT01259856|157673218|FG001|Overall Study|Study closure by sponsor|41|||
48957484|NCT01259856|157673217|FG000|Overall Study|Patient developed other disease|0|||
48957485|NCT01259856|157673218|FG001|Overall Study|Patient developed other disease|1|||
48957486|NCT01259856|157673217|FG000|Overall Study|Transfer to another study|0|||
48957487|NCT01259856|157673218|FG001|Overall Study|Transfer to another study|1|||
48957488|NCT01259856|157673217|FG000|Overall Study|Unknown/missing|2|||
48957489|NCT01259856|157673218|FG001|Overall Study|Unknown/missing|2|||
48957490|NCT01860534|157673221|FG000|ROP #1|Needed treatment for ROP|0|||
48957491|NCT01860534|157673222|FG001|ROP #1|Needed treatment for ROP|1|||
48957492|NCT01860534|157673221|FG000|ROP #2|discharged prior to ROP #2|1|||
48957493|NCT01860534|157673222|FG001|ROP #2|discharged prior to ROP #2|0|||
48957494|NCT04504032|157673223|FG000|Overall Study|Adverse Event|1|||
48957495|NCT04504032|157673224|FG001|Overall Study|Adverse Event|2|||
48957496|NCT04504032|157673223|FG000|Overall Study|Lost to Follow-up|6|||
48957497|NCT04504032|157673224|FG001|Overall Study|Lost to Follow-up|9|||
48957498|NCT04504032|157673223|FG000|Overall Study|Protocol Violation|2|||
48957499|NCT04504032|157673224|FG001|Overall Study|Protocol Violation|0|||
48957500|NCT04504032|157673223|FG000|Overall Study|Study terminated by sponsor|1|||
48957501|NCT04504032|157673224|FG001|Overall Study|Study terminated by sponsor|2|||
48957502|NCT04504032|157673223|FG000|Overall Study|Withdrawal by Subject|9|||
48957503|NCT04504032|157673224|FG001|Overall Study|Withdrawal by Subject|11|||
48957504|NCT04504032|157673223|FG000|Overall Study|Disease progression prior to dosing|15|||
48957505|NCT04504032|157673224|FG001|Overall Study|Disease progression prior to dosing|3|||
48957506|NCT04504032|157673223|FG000|Overall Study|Drug supply issues|1|||
48957507|NCT04504032|157673224|FG001|Overall Study|Drug supply issues|1|||
48957508|NCT04504032|157673223|FG000|Overall Study|Progressed to moderate/severe COVID-19|1|||
48957509|NCT04504032|157673224|FG001|Overall Study|Progressed to moderate/severe COVID-19|0|||
48957510|NCT00788775|157673227|FG000|Overall Study|Progressive Disease|8|||
48957511|NCT00788775|157673228|FG001|Overall Study|Progressive Disease|6|||
48957512|NCT00788775|157673227|FG000|Overall Study|Withdrawal by Subject|0|||
48957513|NCT00788775|157673228|FG001|Overall Study|Withdrawal by Subject|2|||
48957514|NCT00788775|157673227|FG000|Overall Study|Patient Non-Compliance|1|||
48752532|NCT00642941|156938358|FG007|Overall Study|Protocol Violation|0|||
48957515|NCT00788775|157673228|FG001|Overall Study|Patient Non-Compliance|0|||
48957516|NCT00788775|157673227|FG000|Overall Study|Patient's measurable disease resected.|1|||
48752533|NCT00642941|156938359|FG008|Overall Study|Protocol Violation|0|||
48957517|NCT00788775|157673228|FG001|Overall Study|Patient's measurable disease resected.|0|||
48957518|NCT00578864|157673229|FG000|Overall Study|Death|1|||
48957519|NCT00578864|157673230|FG001|Overall Study|Death|0|||
48957520|NCT01702363|157673231|FG000|Overall Study|Adverse Event|14|||
48957521|NCT01702363|157673231|FG000|Overall Study|Lack of Efficacy|4|||
48957522|NCT01702363|157673231|FG000|Overall Study|Withdrawal by Subject|2|||
48957523|NCT01293032|157673232|FG000|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
48957524|NCT01293032|157673233|FG001|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
48957525|NCT01293032|157673234|FG002|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5|||
48957526|NCT01293032|157673235|FG003|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
48957527|NCT01293032|157673232|FG000|Treatment|Adverse Event|0|||
48957528|NCT01293032|157673233|FG001|Treatment|Adverse Event|0|||
48752534|NCT00642941|156938360|FG009|Overall Study|Protocol Violation|0|||
48752535|NCT00642941|156938361|FG010|Overall Study|Protocol Violation|0|||
48752536|NCT00642941|156938362|FG011|Overall Study|Protocol Violation|0|||
48752537|NCT00642941|156938351|FG000|Overall Study|Adverse Event|1|||
48752538|NCT00642941|156938352|FG001|Overall Study|Adverse Event|1|||
48752539|NCT00642941|156938353|FG002|Overall Study|Adverse Event|0|||
48752540|NCT00642941|156938354|FG003|Overall Study|Adverse Event|0|||
48752541|NCT00642941|156938355|FG004|Overall Study|Adverse Event|0|||
48752542|NCT00642941|156938356|FG005|Overall Study|Adverse Event|0|||
48752543|NCT00642941|156938357|FG006|Overall Study|Adverse Event|1|||
48752544|NCT00642941|156938358|FG007|Overall Study|Adverse Event|1|||
48752545|NCT00642941|156938359|FG008|Overall Study|Adverse Event|0|||
48752546|NCT00642941|156938360|FG009|Overall Study|Adverse Event|1|||
48752547|NCT00642941|156938361|FG010|Overall Study|Adverse Event|0|||
48752548|NCT00642941|156938362|FG011|Overall Study|Adverse Event|0|||
48752549|NCT00642941|156938351|FG000|Overall Study|Other|1|||
48957529|NCT01293032|157673234|FG002|Treatment|Adverse Event|1|||
48957530|NCT01293032|157673235|FG003|Treatment|Adverse Event|1|||
48957531|NCT01293032|157673232|FG000|Treatment|Withdrawal by Subject|2|||
48957532|NCT01293032|157673233|FG001|Treatment|Withdrawal by Subject|4|||
48957533|NCT01293032|157673234|FG002|Treatment|Withdrawal by Subject|0|||
48957534|NCT01293032|157673235|FG003|Treatment|Withdrawal by Subject|0|||
48957535|NCT01293032|157673232|FG000|Treatment|Disease Progression, relapse|0|||
48957536|NCT01293032|157673233|FG001|Treatment|Disease Progression, relapse|1|||
48957537|NCT01293032|157673234|FG002|Treatment|Disease Progression, relapse|0|||
48957538|NCT01293032|157673235|FG003|Treatment|Disease Progression, relapse|0|||
48957539|NCT03799718|157673236|FG000|Overall Study|Adverse Event|2|||
48957540|NCT00321984|157673237|FG000|Overall Study|Adverse Event|9|||
48957541|NCT00321984|157673238|FG001|Overall Study|Adverse Event|6|||
48957542|NCT00321984|157673239|FG002|Overall Study|Adverse Event|8|||
48957543|NCT00321984|157673237|FG000|Overall Study|Protocol Violation|0|||
48957544|NCT00321984|157673238|FG001|Overall Study|Protocol Violation|1|||
48957545|NCT00321984|157673239|FG002|Overall Study|Protocol Violation|1|||
48957546|NCT00321984|157673237|FG000|Overall Study|Lost to Follow-up|2|||
48957547|NCT00321984|157673238|FG001|Overall Study|Lost to Follow-up|4|||
48957548|NCT00321984|157673239|FG002|Overall Study|Lost to Follow-up|2|||
48957549|NCT00321984|157673237|FG000|Overall Study|Withdrawal by Subject|8|||
48957550|NCT00321984|157673238|FG001|Overall Study|Withdrawal by Subject|6|||
48957551|NCT00321984|157673239|FG002|Overall Study|Withdrawal by Subject|5|||
48957552|NCT00321984|157673237|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|3|||
48752550|NCT00642941|156938352|FG001|Overall Study|Other|1|||
48957553|NCT00321984|157673238|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
48957554|NCT00321984|157673239|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
48957555|NCT00321984|157673237|FG000|Overall Study|Lack of Efficacy|3|||
48752551|NCT00642941|156938353|FG002|Overall Study|Other|1|||
48752552|NCT00642941|156938354|FG003|Overall Study|Other|1|||
48752553|NCT00642941|156938355|FG004|Overall Study|Other|0|||
48752554|NCT00642941|156938356|FG005|Overall Study|Other|1|||
48752555|NCT00642941|156938357|FG006|Overall Study|Other|0|||
48957556|NCT00321984|157673238|FG001|Overall Study|Lack of Efficacy|1|||
48957557|NCT00321984|157673239|FG002|Overall Study|Lack of Efficacy|3|||
48957558|NCT00321984|157673237|FG000|Overall Study|Noncompliant|0|||
48957559|NCT00321984|157673238|FG001|Overall Study|Noncompliant|0|||
48957560|NCT00321984|157673239|FG002|Overall Study|Noncompliant|2|||
48957561|NCT00321984|157673237|FG000|Overall Study|Pregnancy|0|||
48957562|NCT00321984|157673238|FG001|Overall Study|Pregnancy|1|||
48957563|NCT00321984|157673239|FG002|Overall Study|Pregnancy|0|||
48957564|NCT00321984|157673237|FG000|Overall Study|Per Subject Request|1|||
48957565|NCT00321984|157673238|FG001|Overall Study|Per Subject Request|0|||
48957566|NCT00321984|157673239|FG002|Overall Study|Per Subject Request|0|||
48957567|NCT00321984|157673237|FG000|Overall Study|Per Investigator Request|1|||
48957568|NCT00321984|157673238|FG001|Overall Study|Per Investigator Request|0|||
48957569|NCT00321984|157673239|FG002|Overall Study|Per Investigator Request|0|||
48957570|NCT00321984|157673237|FG000|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
48957571|NCT00321984|157673238|FG001|Overall Study|Per Sponsor Due to High Baseline Gastrin|1|||
48957572|NCT00321984|157673239|FG002|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
48957573|NCT00069576|157673242|FG000|Original Trial|Lost to Follow-up|25|||
48957574|NCT00069576|157673243|FG001|Original Trial|Lost to Follow-up|33|||
48957575|NCT00069576|157673242|FG000|Follow-up Study at 5-10 Years|Not eligible or did not consent|196|||
48957576|NCT00069576|157673243|FG001|Follow-up Study at 5-10 Years|Not eligible or did not consent|204|||
48957577|NCT00446446|157673244|FG000|Overall Study|Death|10|||
48957578|NCT00446446|157673244|FG000|Overall Study|Withdrawal by Subject|6|||
48957579|NCT00446446|157673244|FG000|Overall Study|Other|4|||
48957580|NCT00446446|157673244|FG000|Overall Study|Disease Progession|2|||
48957581|NCT00446446|157673244|FG000|Overall Study|Adverse Event|1|||
48957582|NCT00446446|157673244|FG000|Overall Study|On Treatment at Time of Data Cut-off|1|||
48957583|NCT02868216|157673245|FG000|Overall Study|Death|0|||
48752556|NCT00642941|156938358|FG007|Overall Study|Other|1|||
48957584|NCT02868216|157673246|FG001|Overall Study|Death|1|||
48957585|NCT02868216|157673245|FG000|Overall Study|coronary artery bypass|1|||
48957586|NCT02868216|157673246|FG001|Overall Study|coronary artery bypass|0|||
48957587|NCT02868216|157673245|FG000|Overall Study|Withdrawal by Subject|7|||
48957588|NCT02868216|157673246|FG001|Overall Study|Withdrawal by Subject|5|||
48957589|NCT00807846|157673250|FG000|Overall Study|Adverse Event|5|||
48957590|NCT00807846|157673251|FG001|Overall Study|Adverse Event|0|||
48957591|NCT00807846|157673250|FG000|Overall Study|Lack of Efficacy|2|||
48957592|NCT00807846|157673251|FG001|Overall Study|Lack of Efficacy|0|||
48957593|NCT00807846|157673250|FG000|Overall Study|Protocol Violation|2|||
48957594|NCT00807846|157673251|FG001|Overall Study|Protocol Violation|1|||
48957595|NCT00807846|157673250|FG000|Overall Study|Withdrawal by Subject|2|||
48957596|NCT00807846|157673251|FG001|Overall Study|Withdrawal by Subject|1|||
48957597|NCT00807846|157673250|FG000|Overall Study|Other|1|||
48957598|NCT00807846|157673251|FG001|Overall Study|Other|2|||
48957599|NCT03011840|157673252|FG000|Overall Study|Not received PIL in post PIL phase|0|||
48957600|NCT03011840|157673253|FG001|Overall Study|Not received PIL in post PIL phase|21|||
48957601|NCT03738566|157673254|FG000|Initial Study Phase|Withdrawal by Subject|1|||
48957602|NCT03738566|157673255|FG001|Initial Study Phase|Withdrawal by Subject|1|||
48957603|NCT03738566|157673256|FG002|Initial Study Phase|Withdrawal by Subject|2|||
48957604|NCT03738566|157673257|FG003|Initial Study Phase|Withdrawal by Subject|0|||
48957605|NCT03738566|157673254|FG000|Initial Study Phase|Death|0|||
48957606|NCT03738566|157673255|FG001|Initial Study Phase|Death|1|||
48957607|NCT03738566|157673256|FG002|Initial Study Phase|Death|0|||
48957608|NCT03738566|157673257|FG003|Initial Study Phase|Death|0|||
48957609|NCT03738566|157673254|FG000|Initial Study Phase|Treatment failure|5|||
48957610|NCT03738566|157673255|FG001|Initial Study Phase|Treatment failure|0|||
48957611|NCT03738566|157673256|FG002|Initial Study Phase|Treatment failure|0|||
48957612|NCT03738566|157673257|FG003|Initial Study Phase|Treatment failure|0|||
48957613|NCT03738566|157673254|FG000|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
48957614|NCT03738566|157673255|FG001|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
48957615|NCT03738566|157673256|FG002|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
48957616|NCT03738566|157673257|FG003|Cross-over for Treatment Failure|Withdrawal by Subject|1|||
48957617|NCT04160468|157673259|FG000|Overall Study|Lost to Follow-up|19|||
48957618|NCT04160468|157673260|FG001|Overall Study|Lost to Follow-up|4|||
48957619|NCT04160468|157673259|FG000|Overall Study|Randomized but not dosed|6|||
48957620|NCT04160468|157673260|FG001|Overall Study|Randomized but not dosed|0|||
48957621|NCT04160468|157673259|FG000|Overall Study|Withdrawal by Subject|4|||
48957622|NCT04160468|157673260|FG001|Overall Study|Withdrawal by Subject|1|||
48957623|NCT04160468|157673259|FG000|Overall Study|Participant unable/unwilling to adhere to protocol|1|||
48957624|NCT04160468|157673260|FG001|Overall Study|Participant unable/unwilling to adhere to protocol|0|||
48957625|NCT04160468|157673259|FG000|Overall Study|Participant incarcerated|1|||
48957626|NCT04160468|157673260|FG001|Overall Study|Participant incarcerated|0|||
48957627|NCT01912768|157673261|FG000|Overall Study|Adverse Event|2|||
48957628|NCT01912768|157673262|FG001|Overall Study|Adverse Event|0|||
48957629|NCT01912768|157673261|FG000|Overall Study|Lost to Follow-up|2|||
48957630|NCT01912768|157673262|FG001|Overall Study|Lost to Follow-up|1|||
48957631|NCT01912768|157673261|FG000|Overall Study|Withdrawal by Subject|5|||
48957632|NCT01912768|157673262|FG001|Overall Study|Withdrawal by Subject|3|||
48957633|NCT01912768|157673261|FG000|Overall Study|Randomized in error|1|||
48957634|NCT01912768|157673262|FG001|Overall Study|Randomized in error|0|||
48957635|NCT01187901|157673263|FG000|Overall Study|Protocol Violation|1|||
48957636|NCT01187901|157673264|FG001|Overall Study|Protocol Violation|0|||
48957637|NCT01187901|157673263|FG000|Overall Study|Lost to Follow-up|1|||
48957638|NCT01187901|157673264|FG001|Overall Study|Lost to Follow-up|2|||
48957639|NCT01187901|157673263|FG000|Overall Study|Unrelated Health Reasons|1|||
48957640|NCT01187901|157673264|FG001|Overall Study|Unrelated Health Reasons|2|||
48957641|NCT01187901|157673263|FG000|Overall Study|Suspected Allergic Reaction|1|||
48957642|NCT01187901|157673264|FG001|Overall Study|Suspected Allergic Reaction|1|||
48957643|NCT01187901|157673263|FG000|Overall Study|Adverse Event|3|||
48752557|NCT00642941|156938359|FG008|Overall Study|Other|0|||
48957644|NCT01187901|157673264|FG001|Overall Study|Adverse Event|0|||
48957645|NCT01187901|157673263|FG000|Overall Study|No Endpoint due to Early Study Halt|2|||
48957646|NCT01187901|157673264|FG001|Overall Study|No Endpoint due to Early Study Halt|3|||
48957647|NCT01187901|157673263|FG000|Overall Study|Pregnancy|0|||
48957648|NCT01187901|157673264|FG001|Overall Study|Pregnancy|2|||
48957649|NCT00524316|157673265|FG000|Overall Study|Withdrawal by Subject|2|||
48957650|NCT00524316|157673265|FG000|Overall Study|Adverse Event|7|||
48957651|NCT00524316|157673265|FG000|Overall Study|Disease Progression|7|||
48957652|NCT01423617|157673268|FG000|Overall Study|Lost to Follow-up|0|||
48957653|NCT01423617|157673269|FG001|Overall Study|Lost to Follow-up|1|||
48957654|NCT01515306|157673270|FG000|Overall Study|Adverse Event|3|||
48957655|NCT01515306|157673271|FG001|Overall Study|Adverse Event|2|||
48957656|NCT01515306|157673270|FG000|Overall Study|Progressive Disease|19|||
48957657|NCT01515306|157673271|FG001|Overall Study|Progressive Disease|9|||
48957658|NCT01515306|157673270|FG000|Overall Study|Withdrawal by Subject|1|||
48957659|NCT01515306|157673271|FG001|Overall Study|Withdrawal by Subject|2|||
48957660|NCT01515306|157673270|FG000|Overall Study|Physician Decision|1|||
48957661|NCT01515306|157673271|FG001|Overall Study|Physician Decision|1|||
48957662|NCT00634244|157673272|FG000|Overall Study|Never started treatment|0|||
48957663|NCT00634244|157673273|FG001|Overall Study|Never started treatment|1|||
48957664|NCT00634244|157673274|FG002|Overall Study|Never started treatment|0|||
48957665|NCT00634244|157673272|FG000|Overall Study|Death|1|||
48957666|NCT00634244|157673273|FG001|Overall Study|Death|6|||
48957667|NCT00634244|157673274|FG002|Overall Study|Death|0|||
48957668|NCT00634244|157673272|FG000|Overall Study|Adverse Event|0|||
48957669|NCT00634244|157673273|FG001|Overall Study|Adverse Event|2|||
48957670|NCT00634244|157673274|FG002|Overall Study|Adverse Event|0|||
48957671|NCT00634244|157673272|FG000|Overall Study|Withdrawal by Subject|0|||
48957672|NCT00634244|157673273|FG001|Overall Study|Withdrawal by Subject|1|||
48957673|NCT00634244|157673274|FG002|Overall Study|Withdrawal by Subject|0|||
48957674|NCT00634244|157673272|FG000|Overall Study|Physician Decision|0|||
48957675|NCT00634244|157673273|FG001|Overall Study|Physician Decision|1|||
48957676|NCT00634244|157673274|FG002|Overall Study|Physician Decision|0|||
48957677|NCT00634244|157673272|FG000|Overall Study|Disease progression/relapse|0|||
48957678|NCT00634244|157673273|FG001|Overall Study|Disease progression/relapse|1|||
48957679|NCT00634244|157673274|FG002|Overall Study|Disease progression/relapse|0|||
48957680|NCT00634244|157673272|FG000|Overall Study|Other complicating disease|0|||
48957681|NCT00634244|157673273|FG001|Overall Study|Other complicating disease|1|||
48957682|NCT00634244|157673274|FG002|Overall Study|Other complicating disease|0|||
48957683|NCT03855137|157673281|FG000|DB Treatment Period (Day 1 to Week 12)|Adverse Event|10|||
48957684|NCT03855137|157673282|FG001|DB Treatment Period (Day 1 to Week 12)|Adverse Event|13|||
48957685|NCT03855137|157673283|FG002|DB Treatment Period (Day 1 to Week 12)|Adverse Event|9|||
48957686|NCT03855137|157673281|FG000|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|5|||
48957687|NCT03855137|157673282|FG001|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|2|||
48957688|NCT03855137|157673283|FG002|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|1|||
48957689|NCT03855137|157673281|FG000|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|8|||
48957690|NCT03855137|157673282|FG001|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|7|||
48957691|NCT03855137|157673283|FG002|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|14|||
48957692|NCT03855137|157673281|FG000|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|0|||
48957693|NCT03855137|157673282|FG001|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|1|||
48957694|NCT03855137|157673283|FG002|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|3|||
48957695|NCT03855137|157673281|FG000|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|5|||
48957696|NCT03855137|157673282|FG001|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|3|||
48957697|NCT03855137|157673283|FG002|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|2|||
48957698|NCT03855137|157673281|FG000|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|1|||
48957699|NCT03855137|157673282|FG001|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
48957700|NCT03855137|157673283|FG002|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
48957701|NCT03855137|157673281|FG000|FU Period (Week 12 to Week 16)|Withdrawal by Subject|5|||
48957702|NCT03855137|157673282|FG001|FU Period (Week 12 to Week 16)|Withdrawal by Subject|6|||
48957703|NCT03855137|157673283|FG002|FU Period (Week 12 to Week 16)|Withdrawal by Subject|3|||
48957704|NCT03855137|157673281|FG000|FU Period (Week 12 to Week 16)|Lost to Follow-up|0|||
48957705|NCT03855137|157673282|FG001|FU Period (Week 12 to Week 16)|Lost to Follow-up|3|||
48957706|NCT03855137|157673283|FG002|FU Period (Week 12 to Week 16)|Lost to Follow-up|1|||
48957707|NCT03855137|157673281|FG000|FU Period (Week 12 to Week 16)|Protocol Deviation|2|||
48957708|NCT03855137|157673282|FG001|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
48957709|NCT03855137|157673283|FG002|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
48957710|NCT03855137|157673281|FG000|FU Period (Week 12 to Week 16)|Reason not Specified|1|||
48957711|NCT03855137|157673282|FG001|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
48957712|NCT03855137|157673283|FG002|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
48957713|NCT01745393|157673285|FG000|Treatment to End-of-treatment Assessment|Lost to Follow-up|20|||
48957714|NCT01745393|157673286|FG001|Treatment to End-of-treatment Assessment|Lost to Follow-up|8|||
48957715|NCT01745393|157673285|FG000|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1|||
48957716|NCT01745393|157673286|FG001|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0|||
48957717|NCT01745393|157673285|FG000|12-month Follow-up|Lost to Follow-up|6|||
48957718|NCT01745393|157673286|FG001|12-month Follow-up|Lost to Follow-up|5|||
48957719|NCT04799405|157673287|FG000|Phase 1 - Acute Stimulation, Daily tDCS|Withdrawal by Subject|2|||
48957720|NCT02427477|157673291|FG000|Period 1|Adverse Event|1|||
48957721|NCT02427477|157673292|FG001|Period 1|Adverse Event|0|||
48957722|NCT00471445|157673293|FG000|Overall Study|Withdrawal by Subject|1|||
48957723|NCT00471445|157673294|FG001|Overall Study|Withdrawal by Subject|1|||
48957724|NCT00471445|157673293|FG000|Overall Study|Ineligible|1|||
48957725|NCT00471445|157673294|FG001|Overall Study|Ineligible|0|||
48957726|NCT00471445|157673293|FG000|Overall Study|Protocol Violation|0|||
48957727|NCT00471445|157673294|FG001|Overall Study|Protocol Violation|1|||
48957728|NCT02280291|157673295|FG000|Overall Study|Lost to Follow-up|2|||
48957729|NCT02280291|157673296|FG001|Overall Study|Lost to Follow-up|1|||
48957730|NCT02280291|157673297|FG002|Overall Study|Lost to Follow-up|3|||
48957731|NCT02280291|157673298|FG003|Overall Study|Lost to Follow-up|8|||
48957732|NCT02280291|157673295|FG000|Overall Study|Protocol Violation|1|||
48957733|NCT02280291|157673296|FG001|Overall Study|Protocol Violation|0|||
48957734|NCT02280291|157673297|FG002|Overall Study|Protocol Violation|0|||
48864626|NCT02592434|157340151|FG001|Double Blind Phase (26 Weeks)|Other|1|||
48864627|NCT02592434|157340152|FG002|Double Blind Phase (26 Weeks)|Other|0|||
48864628|NCT02592434|157340150|FG000|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
48864629|NCT02592434|157340151|FG001|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
48864630|NCT02592434|157340152|FG002|Double Blind Phase (26 Weeks)|Protocol Deviation|1|||
48864631|NCT02592434|157340150|FG000|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
48864632|NCT02592434|157340151|FG001|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1|||
48864633|NCT02592434|157340152|FG002|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
48864634|NCT02592434|157340150|FG000|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
48864635|NCT02592434|157340151|FG001|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1|||
48864636|NCT02592434|157340152|FG002|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
48864637|NCT03794609|157340153|FG000|Overall Study|Other|10|||
48864638|NCT03794609|157340153|FG000|Overall Study|Withdrawal by Subject|66|||
48864639|NCT03794609|157340153|FG000|Overall Study|The child is enrolled in an interventional study|70|||
48864640|NCT03794609|157340153|FG000|Overall Study|Inclusion/exclusion criteria|8|||
48864641|NCT03794609|157340153|FG000|Overall Study|At sponsor's request|151|||
48864642|NCT03794609|157340153|FG000|Overall Study|Physician Decision|1|||
48864643|NCT03794609|157340153|FG000|Overall Study|Lost to Follow-up|5|||
48864644|NCT02812706|157340155|FG000|Phase 1|Adverse Event|0|||
48864645|NCT02812706|157340156|FG001|Phase 1|Adverse Event|2|||
48864646|NCT02812706|157340157|FG002|Phase 1|Adverse Event|0|||
48864647|NCT02812706|157340155|FG000|Phase 1|Progressive disease|3|||
48864648|NCT02812706|157340156|FG001|Phase 1|Progressive disease|3|||
48864649|NCT02812706|157340157|FG002|Phase 1|Progressive disease|0|||
48864650|NCT02812706|157340155|FG000|Phase 2|Adverse Event|0|||
48864651|NCT02812706|157340156|FG001|Phase 2|Adverse Event|0|||
48864652|NCT02812706|157340157|FG002|Phase 2|Adverse Event|2|||
48864653|NCT02812706|157340155|FG000|Phase 2|Progressive disease|0|||
48864654|NCT02812706|157340156|FG001|Phase 2|Progressive disease|0|||
48864655|NCT02812706|157340157|FG002|Phase 2|Progressive disease|22|||
48864656|NCT02812706|157340155|FG000|Phase 2|Other-Unspecified|0|||
48864657|NCT02812706|157340156|FG001|Phase 2|Other-Unspecified|0|||
48864658|NCT02812706|157340157|FG002|Phase 2|Other-Unspecified|4|||
48864659|NCT01323309|157340159|FG000|Overall Study|Death|9|||
48864660|NCT01323309|157340160|FG001|Overall Study|Death|15|||
48864661|NCT01323309|157340161|FG002|Overall Study|Death|5|||
48864662|NCT01323309|157340159|FG000|Overall Study|Lost to Follow-up|11|||
48864663|NCT01323309|157340160|FG001|Overall Study|Lost to Follow-up|14|||
48864664|NCT01323309|157340161|FG002|Overall Study|Lost to Follow-up|24|||
48864665|NCT01323309|157340159|FG000|Overall Study|Withdrawal by Subject|14|||
48864666|NCT01323309|157340160|FG001|Overall Study|Withdrawal by Subject|14|||
48752558|NCT00642941|156938360|FG009|Overall Study|Other|0|||
48752559|NCT00642941|156938361|FG010|Overall Study|Other|0|||
48752560|NCT00642941|156938362|FG011|Overall Study|Other|1|||
48752561|NCT00642941|156938351|FG000|Overall Study|Disease progression|60|||
48752562|NCT00642941|156938352|FG001|Overall Study|Disease progression|50|||
48752563|NCT00642941|156938353|FG002|Overall Study|Disease progression|5|||
48752564|NCT00642941|156938354|FG003|Overall Study|Disease progression|36|||
48752565|NCT00642941|156938355|FG004|Overall Study|Disease progression|23|||
48752566|NCT00642941|156938356|FG005|Overall Study|Disease progression|39|||
48752567|NCT00642941|156938357|FG006|Overall Study|Disease progression|18|||
48752568|NCT00642941|156938358|FG007|Overall Study|Disease progression|12|||
48752569|NCT00642941|156938359|FG008|Overall Study|Disease progression|10|||
48752570|NCT00642941|156938360|FG009|Overall Study|Disease progression|7|||
48752571|NCT00642941|156938361|FG010|Overall Study|Disease progression|12|||
48752572|NCT00642941|156938362|FG011|Overall Study|Disease progression|7|||
48752573|NCT01798004|156940028|FG000|Overall Study|Death|2|||
48752574|NCT01798004|156940028|FG000|Overall Study|Lack of Efficacy|8|||
48752575|NCT01798004|156940028|FG000|Overall Study|Physician Decision|25|||
48752576|NCT01798004|156940028|FG000|Overall Study|Withdrawal by Subject|4|||
48864667|NCT01323309|157340161|FG002|Overall Study|Withdrawal by Subject|18|||
48864668|NCT01323309|157340159|FG000|Overall Study|Disease progression|5|||
48864669|NCT01323309|157340160|FG001|Overall Study|Disease progression|11|||
48864670|NCT01323309|157340161|FG002|Overall Study|Disease progression|4|||
48864671|NCT00139659|157340162|FG000|Overall Study|Adverse Event|12|||
48864672|NCT00139659|157340163|FG001|Overall Study|Adverse Event|1|||
48864673|NCT00139659|157340162|FG000|Overall Study|Lack of Efficacy|1|||
48864674|NCT00139659|157340163|FG001|Overall Study|Lack of Efficacy|1|||
48864675|NCT00139659|157340162|FG000|Overall Study|Lost to Follow-up|7|||
48864676|NCT00139659|157340163|FG001|Overall Study|Lost to Follow-up|3|||
48864677|NCT00139659|157340162|FG000|Overall Study|Reason not Specified|6|||
48957735|NCT02280291|157673298|FG003|Overall Study|Protocol Violation|0|||
48864678|NCT00139659|157340163|FG001|Overall Study|Reason not Specified|3|||
48864679|NCT00139659|157340162|FG000|Overall Study|Withdrawal by Subject|14|||
48864680|NCT00139659|157340163|FG001|Overall Study|Withdrawal by Subject|10|||
48864681|NCT03048058|157340164|FG000|Overall Study|Lost to Follow-up|4|||
48864682|NCT03048058|157340165|FG001|Overall Study|Lost to Follow-up|0|||
48864683|NCT03048058|157340164|FG000|Overall Study|Withdrawal by Subject|0|||
48864684|NCT03048058|157340165|FG001|Overall Study|Withdrawal by Subject|4|||
48864685|NCT05878522|157340179|FG000|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
48864686|NCT05878522|157340180|FG001|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
48864687|NCT05878522|157340181|FG002|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
48864688|NCT05878522|157340182|FG003|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
48864689|NCT05878522|157340183|FG004|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
48864690|NCT05878522|157340184|FG005|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
48864691|NCT05878522|157340185|FG006|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
48864692|NCT05878522|157340186|FG007|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
48864693|NCT05878522|157340187|FG008|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|1|||
48864694|NCT05878522|157340188|FG009|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
48864695|NCT05878522|157340189|FG010|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
48864696|NCT05878522|157340190|FG011|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
48957736|NCT02280291|157673295|FG000|Overall Study|Other|1|||
48752577|NCT01798004|156940028|FG000|Overall Study|Ineligible|4|||
48864697|NCT05878522|157340179|FG000|Treatment Period- 2 (3 Days)|Physician Decision|1|||
48864698|NCT05878522|157340180|FG001|Treatment Period- 2 (3 Days)|Physician Decision|0|||
48864699|NCT05878522|157340181|FG002|Treatment Period- 2 (3 Days)|Physician Decision|0|||
48864700|NCT05878522|157340182|FG003|Treatment Period- 2 (3 Days)|Physician Decision|0|||
48864701|NCT05878522|157340183|FG004|Treatment Period- 2 (3 Days)|Physician Decision|0|||
48864702|NCT05878522|157340184|FG005|Treatment Period- 2 (3 Days)|Physician Decision|0|||
48864703|NCT05878522|157340185|FG006|Treatment Period- 2 (3 Days)|Physician Decision|0|||
48864704|NCT05878522|157340186|FG007|Treatment Period- 2 (3 Days)|Physician Decision|0|||
48864705|NCT05878522|157340187|FG008|Treatment Period- 2 (3 Days)|Physician Decision|0|||
48864706|NCT05878522|157340188|FG009|Treatment Period- 2 (3 Days)|Physician Decision|1|||
48864707|NCT05878522|157340189|FG010|Treatment Period- 2 (3 Days)|Physician Decision|0|||
48864708|NCT05878522|157340190|FG011|Treatment Period- 2 (3 Days)|Physician Decision|0|||
48864709|NCT05878522|157340179|FG000|Treatment Period- 2 (3 Days)|Adverse Event|0|||
48864710|NCT05878522|157340180|FG001|Treatment Period- 2 (3 Days)|Adverse Event|1|||
48864711|NCT05878522|157340181|FG002|Treatment Period- 2 (3 Days)|Adverse Event|0|||
48864712|NCT05878522|157340182|FG003|Treatment Period- 2 (3 Days)|Adverse Event|1|||
48864713|NCT05878522|157340183|FG004|Treatment Period- 2 (3 Days)|Adverse Event|0|||
48864714|NCT05878522|157340184|FG005|Treatment Period- 2 (3 Days)|Adverse Event|0|||
48864715|NCT05878522|157340185|FG006|Treatment Period- 2 (3 Days)|Adverse Event|0|||
48864716|NCT05878522|157340186|FG007|Treatment Period- 2 (3 Days)|Adverse Event|0|||
48864717|NCT05878522|157340187|FG008|Treatment Period- 2 (3 Days)|Adverse Event|0|||
48864718|NCT05878522|157340188|FG009|Treatment Period- 2 (3 Days)|Adverse Event|0|||
48864719|NCT05878522|157340189|FG010|Treatment Period- 2 (3 Days)|Adverse Event|0|||
48864720|NCT05878522|157340190|FG011|Treatment Period- 2 (3 Days)|Adverse Event|0|||
48864721|NCT05878522|157340179|FG000|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
48864722|NCT05878522|157340180|FG001|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
48864723|NCT05878522|157340181|FG002|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
48864724|NCT05878522|157340182|FG003|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
48864725|NCT05878522|157340183|FG004|Treatment Period- 2 (3 Days)|Withdrawal by Subject|1|||
48864726|NCT05878522|157340184|FG005|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
48864727|NCT05878522|157340185|FG006|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
48864728|NCT05878522|157340186|FG007|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
48864729|NCT05878522|157340187|FG008|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
48864730|NCT05878522|157340188|FG009|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
48864731|NCT05878522|157340189|FG010|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
48864732|NCT05878522|157340190|FG011|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
48864733|NCT03861078|157340191|FG000|Overall Study|COVID-19 shut down|4|||
48864734|NCT03861078|157340191|FG000|Overall Study|Lost to Follow-up|1|||
48864735|NCT03861078|157340191|FG000|Overall Study|Protocol Violation|2|||
48864736|NCT03861078|157340191|FG000|Overall Study|lack of venous access|1|||
48864737|NCT00975130|157340192|FG000|Study Part 1|Adverse Event|150|||
48864738|NCT00975130|157340193|FG001|Study Part 1|Adverse Event|0|||
48864739|NCT00975130|157340194|FG002|Study Part 1|Adverse Event|0|||
48864740|NCT00975130|157340192|FG000|Study Part 1|Lost to Follow-up|19|||
48864741|NCT00975130|157340193|FG001|Study Part 1|Lost to Follow-up|0|||
48864742|NCT00975130|157340194|FG002|Study Part 1|Lost to Follow-up|0|||
48864743|NCT00975130|157340192|FG000|Study Part 1|Withdrawal by Subject|61|||
48864744|NCT00975130|157340193|FG001|Study Part 1|Withdrawal by Subject|0|||
48864745|NCT00975130|157340194|FG002|Study Part 1|Withdrawal by Subject|0|||
48864746|NCT00975130|157340192|FG000|Study Part 1|Protocol Violation|13|||
48864747|NCT00975130|157340193|FG001|Study Part 1|Protocol Violation|0|||
48864748|NCT00975130|157340194|FG002|Study Part 1|Protocol Violation|0|||
48864749|NCT00975130|157340192|FG000|Study Part 1|Did Not Meet Protocol Eligibility|9|||
48864750|NCT00975130|157340193|FG001|Study Part 1|Did Not Meet Protocol Eligibility|0|||
48864751|NCT00975130|157340194|FG002|Study Part 1|Did Not Meet Protocol Eligibility|0|||
48864752|NCT00975130|157340192|FG000|Study Part 1|Administrative|4|||
48752578|NCT01798004|156940028|FG000|Overall Study|Patient/parent refusal|7|||
48752579|NCT01798004|156940028|FG000|Overall Study|Initiation of other non-protocol therapy|5|||
48752580|NCT01798004|156940028|FG000|Overall Study|Enrollment another COG therapeutic trial|32|||
48752581|NCT03187197|156940029|FG000|Overall Study|Stopped Pradaxa®/VKA|11|||
48752582|NCT03187197|156940030|FG001|Overall Study|Stopped Pradaxa®/VKA|65|||
48752583|NCT03187197|156940031|FG002|Overall Study|Stopped Pradaxa®/VKA|4|||
48752584|NCT03187197|156940029|FG000|Overall Study|Withdrawal by Subject|8|||
48752585|NCT03187197|156940030|FG001|Overall Study|Withdrawal by Subject|63|||
48752586|NCT03187197|156940031|FG002|Overall Study|Withdrawal by Subject|4|||
48752587|NCT03187197|156940029|FG000|Overall Study|Lost to Follow-up|1|||
48752588|NCT03187197|156940030|FG001|Overall Study|Lost to Follow-up|60|||
48752589|NCT03187197|156940031|FG002|Overall Study|Lost to Follow-up|7|||
48864753|NCT00975130|157340193|FG001|Study Part 1|Administrative|0|||
48864754|NCT00975130|157340194|FG002|Study Part 1|Administrative|0|||
48864755|NCT00975130|157340192|FG000|Study Part 1|Withdrew Consent|24|||
48864756|NCT00975130|157340193|FG001|Study Part 1|Withdrew Consent|0|||
48864757|NCT00975130|157340194|FG002|Study Part 1|Withdrew Consent|0|||
48864758|NCT00975130|157340192|FG000|Study Part 2|Adverse Event|0|||
48864759|NCT00975130|157340193|FG001|Study Part 2|Adverse Event|14|||
48864760|NCT00975130|157340194|FG002|Study Part 2|Adverse Event|7|||
48752590|NCT03187197|156940029|FG000|Overall Study|Adverse Event|6|||
48752591|NCT03187197|156940030|FG001|Overall Study|Adverse Event|29|||
48957737|NCT02280291|157673296|FG001|Overall Study|Other|1|||
48957738|NCT02280291|157673297|FG002|Overall Study|Other|0|||
48957739|NCT02280291|157673298|FG003|Overall Study|Other|0|||
48957740|NCT00986258|157673302|FG000|Observation Period|Not eligible to be dosed|11|||
48957741|NCT00986258|157673302|FG000|Titration and Optimal Dose Period|Adverse Event|15|||
48957742|NCT00986258|157673302|FG000|Titration and Optimal Dose Period|Lack of Efficacy|3|||
48957743|NCT00986258|157673302|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|3|||
48957744|NCT00986258|157673302|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
48957745|NCT00986258|157673302|FG000|Titration and Optimal Dose Period|Other|1|||
48957746|NCT00986258|157673302|FG000|Maintenance Period|Adverse Event|5|||
48957747|NCT00986258|157673302|FG000|Maintenance Period|Lack of Efficacy|2|||
48957748|NCT00986258|157673302|FG000|Maintenance Period|Withdrawal by Subject|2|||
48957749|NCT03591146|157673305|FG000|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
48957750|NCT03591146|157673306|FG001|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
48957751|NCT03591146|157673307|FG002|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
48957752|NCT03591146|157673308|FG003|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
48957753|NCT03591146|157673309|FG004|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1|||
48957754|NCT03591146|157673305|FG000|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
48957755|NCT03591146|157673306|FG001|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1|||
48957756|NCT03591146|157673307|FG002|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
48957757|NCT03591146|157673308|FG003|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
48957758|NCT03591146|157673309|FG004|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
48957759|NCT03591146|157673305|FG000|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
48957760|NCT03591146|157673306|FG001|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
48957761|NCT03591146|157673307|FG002|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
48957762|NCT03591146|157673308|FG003|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
48957763|NCT03591146|157673309|FG004|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1|||
48957764|NCT03591146|157673305|FG000|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
48957765|NCT03591146|157673306|FG001|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
48957766|NCT03591146|157673307|FG002|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
48957767|NCT03591146|157673308|FG003|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
48957768|NCT03591146|157673309|FG004|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
48957769|NCT00603980|157673310|FG000|Study Qualification|Protocol Violation|3|||
48957770|NCT00603980|157673310|FG000|Study Qualification|Inconsistent data reporting|13|||
48957771|NCT00603980|157673310|FG000|Main Study|14th subject completed trial|1|||
48957772|NCT04737031|157673311|FG000|Overall Study|Patients who did not have a treatment visit|0|||
48957773|NCT04737031|157673312|FG001|Overall Study|Patients who did not have a treatment visit|31|||
48957774|NCT04737031|157673313|FG002|Overall Study|Patients who did not have a treatment visit|93|||
48957775|NCT04737031|157673314|FG003|Overall Study|Patients who did not have a treatment visit|227|||
48957776|NCT04369430|157673315|FG000|Overall Study|Adverse Event|2|||
48957777|NCT04369430|157673316|FG001|Overall Study|Adverse Event|3|||
48957778|NCT04369430|157673315|FG000|Overall Study|Death|1|||
48957779|NCT04369430|157673316|FG001|Overall Study|Death|0|||
48957780|NCT04369430|157673315|FG000|Overall Study|Withdrawal by Subject|4|||
48957781|NCT04369430|157673316|FG001|Overall Study|Withdrawal by Subject|3|||
48957782|NCT04369430|157673315|FG000|Overall Study|COVID concern, Sponsor's decision|2|||
48957783|NCT04369430|157673316|FG001|Overall Study|COVID concern, Sponsor's decision|1|||
48957784|NCT04369430|157673315|FG000|Overall Study|Lost to Follow-up|0|||
48957785|NCT04369430|157673316|FG001|Overall Study|Lost to Follow-up|1|||
48957786|NCT02773238|157673317|FG000|Overall Study|Lack of Efficacy|4|||
48957787|NCT02410902|157675139|FG000|Overall Study|Adverse Event|2|||
48957788|NCT02410902|157675140|FG001|Overall Study|Adverse Event|3|||
48957789|NCT02410902|157675139|FG000|Overall Study|Lost to Follow-up|4|||
48957790|NCT02410902|157675140|FG001|Overall Study|Lost to Follow-up|1|||
48957791|NCT02410902|157675139|FG000|Overall Study|Protocol Violation|1|||
48957792|NCT02410902|157675140|FG001|Overall Study|Protocol Violation|4|||
48957793|NCT02410902|157675139|FG000|Overall Study|Withdrawal by Subject|6|||
48957794|NCT02410902|157675140|FG001|Overall Study|Withdrawal by Subject|8|||
48957795|NCT02410902|157675139|FG000|Overall Study|Non-Compliance|8|||
48957796|NCT02410902|157675140|FG001|Overall Study|Non-Compliance|2|||
48957797|NCT02279524|157675141|FG000|Overall Study|Withdrawal by Subject|3|||
48957798|NCT02279524|157675142|FG001|Overall Study|Withdrawal by Subject|6|||
48957799|NCT02279524|157675143|FG002|Overall Study|Withdrawal by Subject|3|||
48957800|NCT02279524|157675141|FG000|Overall Study|Adverse Event|4|||
48957801|NCT02279524|157675142|FG001|Overall Study|Adverse Event|3|||
49098986|NCT04064411|158197011|FG001|Overall Study|Withdrawal by Subject|29|||
49015407|NCT00860028|157892173|FG001|Placebo Controlled Pretreatment Period|No longer interested in treatment|1|||
48864761|NCT00975130|157340192|FG000|Study Part 2|Lost to Follow-up|0|||
48864762|NCT00975130|157340193|FG001|Study Part 2|Lost to Follow-up|0|||
48864763|NCT00975130|157340194|FG002|Study Part 2|Lost to Follow-up|1|||
48752592|NCT03187197|156940031|FG002|Overall Study|Adverse Event|0|||
48752593|NCT03187197|156940029|FG000|Overall Study|Death|0|||
48752594|NCT03187197|156940030|FG001|Overall Study|Death|11|||
48752595|NCT03187197|156940031|FG002|Overall Study|Death|0|||
48752596|NCT03187197|156940029|FG000|Overall Study|Administrative problem|1|||
48752597|NCT03187197|156940030|FG001|Overall Study|Administrative problem|1|||
48752598|NCT03187197|156940031|FG002|Overall Study|Administrative problem|0|||
48752599|NCT03187197|156940029|FG000|Overall Study|Reason not listed|2|||
48752600|NCT03187197|156940030|FG001|Overall Study|Reason not listed|54|||
48752601|NCT03187197|156940031|FG002|Overall Study|Reason not listed|1|||
48752602|NCT03187197|156940029|FG000|Overall Study|Missing|1|||
48752603|NCT03187197|156940030|FG001|Overall Study|Missing|32|||
48752604|NCT03187197|156940031|FG002|Overall Study|Missing|3|||
48752605|NCT03187197|156940029|FG000|Overall Study|Status missing|2|||
48752606|NCT03187197|156940030|FG001|Overall Study|Status missing|33|||
48752607|NCT03187197|156940031|FG002|Overall Study|Status missing|3|||
48752608|NCT03187197|156940029|FG000|Overall Study|NA in incl/excl criteria, not analyzed.|14|||
48752609|NCT03187197|156940030|FG001|Overall Study|NA in incl/excl criteria, not analyzed.|45|||
48752610|NCT03187197|156940031|FG002|Overall Study|NA in incl/excl criteria, not analyzed.|1|||
48752611|NCT01955733|156940032|FG000|Period 1|Lost to Follow-up|1|||
48752612|NCT01955733|156940033|FG001|Period 1|Lost to Follow-up|0|||
48752613|NCT01955733|156940034|FG002|Period 1|Lost to Follow-up|0|||
48752614|NCT01955733|156940032|FG000|Period 2|Adverse Event|1|||
48752615|NCT01955733|156940033|FG001|Period 2|Adverse Event|0|||
48752616|NCT01955733|156940034|FG002|Period 2|Adverse Event|0|||
48752617|NCT01955733|156940032|FG000|Period 2|Physician Decision|0|||
48752618|NCT01955733|156940033|FG001|Period 2|Physician Decision|0|||
48752619|NCT01955733|156940034|FG002|Period 2|Physician Decision|1|||
48752620|NCT01955733|156940032|FG000|Period 2|Withdrawal by Subject|1|||
48864764|NCT00975130|157340192|FG000|Study Part 2|Withdrawal by Subject|0|||
48864765|NCT00975130|157340193|FG001|Study Part 2|Withdrawal by Subject|13|||
48864766|NCT00975130|157340194|FG002|Study Part 2|Withdrawal by Subject|5|||
48864767|NCT00975130|157340192|FG000|Study Part 2|Withdrew Consent|0|||
48864768|NCT00975130|157340193|FG001|Study Part 2|Withdrew Consent|6|||
48864769|NCT00975130|157340194|FG002|Study Part 2|Withdrew Consent|2|||
48864770|NCT00975130|157340192|FG000|Study Part 2|Did Not Meet Protocol Eligibility|0|||
48864771|NCT00975130|157340193|FG001|Study Part 2|Did Not Meet Protocol Eligibility|4|||
48864772|NCT00975130|157340194|FG002|Study Part 2|Did Not Meet Protocol Eligibility|1|||
48864773|NCT00975130|157340192|FG000|Study Part 2|Administrative|0|||
48864774|NCT00975130|157340193|FG001|Study Part 2|Administrative|1|||
48864775|NCT00975130|157340194|FG002|Study Part 2|Administrative|0|||
48864776|NCT00975130|157340192|FG000|Study Part 2|Protocol Violation|0|||
48864777|NCT00975130|157340193|FG001|Study Part 2|Protocol Violation|0|||
48864778|NCT00975130|157340194|FG002|Study Part 2|Protocol Violation|1|||
48864779|NCT00240097|157340195|FG000|Part I|Adverse Event|1|||
48864780|NCT00240097|157340195|FG000|Part I|Death|1|||
48864781|NCT00240097|157340195|FG000|Part I|histology|1|||
48864782|NCT00240097|157340195|FG000|Part I|unevaluable|1|||
48864783|NCT00240097|157340195|FG000|Part II|did not continue from Part I|23|||
48864784|NCT03613454|157340196|FG000|Overall Study|Protocol Violation|1|||
48864785|NCT03613454|157340197|FG001|Overall Study|Protocol Violation|0|||
48864786|NCT03613454|157340196|FG000|Overall Study|Protocol Violation|0|||
48864787|NCT03613454|157340197|FG001|Overall Study|Protocol Violation|1|||
48864788|NCT01332318|157340203|FG000|Overall Study|Adverse Event|0|||
48864789|NCT01332318|157340204|FG001|Overall Study|Adverse Event|3|||
48864790|NCT01332318|157340205|FG002|Overall Study|Adverse Event|0|||
48864791|NCT01332318|157340206|FG003|Overall Study|Adverse Event|0|||
48864792|NCT01332318|157340203|FG000|Overall Study|Withdrawal by Subject|1|||
48864793|NCT01332318|157340204|FG001|Overall Study|Withdrawal by Subject|1|||
48864794|NCT01332318|157340205|FG002|Overall Study|Withdrawal by Subject|0|||
48864795|NCT01332318|157340206|FG003|Overall Study|Withdrawal by Subject|1|||
48864796|NCT01332318|157340203|FG000|Overall Study|Protocol Violation|1|||
48864797|NCT01332318|157340204|FG001|Overall Study|Protocol Violation|0|||
48864798|NCT01332318|157340205|FG002|Overall Study|Protocol Violation|1|||
48957802|NCT02279524|157675143|FG002|Overall Study|Adverse Event|2|||
48957803|NCT02279524|157675141|FG000|Overall Study|Lost to Follow-up|1|||
48957804|NCT02279524|157675142|FG001|Overall Study|Lost to Follow-up|1|||
48957805|NCT02279524|157675143|FG002|Overall Study|Lost to Follow-up|0|||
48957806|NCT02279524|157675141|FG000|Overall Study|Disallowed medication|1|||
48957807|NCT02279524|157675142|FG001|Overall Study|Disallowed medication|1|||
48957808|NCT02279524|157675143|FG002|Overall Study|Disallowed medication|2|||
48752621|NCT01955733|156940033|FG001|Period 2|Withdrawal by Subject|3|||
48752622|NCT01955733|156940034|FG002|Period 2|Withdrawal by Subject|2|||
48752623|NCT01955733|156940032|FG000|Period 2|Study terminated by sponsor|8|||
48752624|NCT01955733|156940033|FG001|Period 2|Study terminated by sponsor|14|||
48752625|NCT01955733|156940034|FG002|Period 2|Study terminated by sponsor|16|||
48752626|NCT01955733|156940032|FG000|Period 2|Lost to Follow-up|2|||
48752627|NCT01955733|156940033|FG001|Period 2|Lost to Follow-up|0|||
48752628|NCT01955733|156940034|FG002|Period 2|Lost to Follow-up|0|||
48864799|NCT01332318|157340206|FG003|Overall Study|Protocol Violation|1|||
48864800|NCT01721759|157340207|FG000|Treatment Period|Disease Progression|85|||
48864801|NCT01721759|157340207|FG000|Treatment Period|Study drug toxicity|14|||
48864802|NCT01721759|157340207|FG000|Treatment Period|Death|1|||
48864803|NCT01721759|157340207|FG000|Treatment Period|Adverse event unrelated to study drug|11|||
48864804|NCT01721759|157340207|FG000|Treatment Period|Participant request to withdraw|3|||
48864805|NCT01721759|157340207|FG000|Treatment Period|Other Reasons|3|||
48864806|NCT01721759|157340207|FG000|End of Study Period|Participant Withdrew Consent|5|||
48864807|NCT01721759|157340207|FG000|End of Study Period|Death|101|||
48864808|NCT01721759|157340207|FG000|End of Study Period|Lost to Follow-up|1|||
48864809|NCT01721759|157340207|FG000|End of Study Period|Other Reasons|10|||
48864810|NCT00464737|157340208|FG000|Overall Study|Adverse Event|12|||
48864811|NCT00464737|157340209|FG001|Overall Study|Adverse Event|17|||
48864812|NCT00464737|157340210|FG002|Overall Study|Adverse Event|33|||
48864813|NCT00464737|157340208|FG000|Overall Study|Lack of Efficacy|7|||
48864814|NCT00464737|157340209|FG001|Overall Study|Lack of Efficacy|7|||
48864815|NCT00464737|157340210|FG002|Overall Study|Lack of Efficacy|4|||
48864816|NCT00464737|157340208|FG000|Overall Study|Withdrawal by Subject|5|||
48864817|NCT00464737|157340209|FG001|Overall Study|Withdrawal by Subject|3|||
48864818|NCT00464737|157340210|FG002|Overall Study|Withdrawal by Subject|5|||
48864819|NCT00464737|157340208|FG000|Overall Study|Protocol Violation|1|||
48957809|NCT02279524|157675141|FG000|Overall Study|Bariatric surgery|1|||
48957810|NCT02279524|157675142|FG001|Overall Study|Bariatric surgery|0|||
48752629|NCT01955733|156940032|FG000|Period 2|Other not defined above|0|||
48752630|NCT01955733|156940033|FG001|Period 2|Other not defined above|2|||
48752631|NCT01955733|156940034|FG002|Period 2|Other not defined above|2|||
48752632|NCT00793598|156940035|FG000|Overall Study|Patient Request|0|||
48752633|NCT00793598|156940036|FG001|Overall Study|Patient Request|1|||
48864820|NCT00464737|157340209|FG001|Overall Study|Protocol Violation|1|||
48864821|NCT00464737|157340210|FG002|Overall Study|Protocol Violation|5|||
48864822|NCT00464737|157340208|FG000|Overall Study|Non-compliance|0|||
48864823|NCT00464737|157340209|FG001|Overall Study|Non-compliance|1|||
48864824|NCT00464737|157340210|FG002|Overall Study|Non-compliance|1|||
48864825|NCT00464737|157340208|FG000|Overall Study|Lost to Follow-up|5|||
48864826|NCT00464737|157340209|FG001|Overall Study|Lost to Follow-up|2|||
48864827|NCT00464737|157340210|FG002|Overall Study|Lost to Follow-up|5|||
48864828|NCT00464737|157340208|FG000|Overall Study|Other: Subject's schedule doesn't permit|1|||
48864829|NCT00464737|157340209|FG001|Overall Study|Other: Subject's schedule doesn't permit|0|||
48864830|NCT00464737|157340210|FG002|Overall Study|Other: Subject's schedule doesn't permit|0|||
48864831|NCT00464737|157340208|FG000|Overall Study|Other: Subject left town; family illness|1|||
48864832|NCT00464737|157340209|FG001|Overall Study|Other: Subject left town; family illness|0|||
48864833|NCT00464737|157340210|FG002|Overall Study|Other: Subject left town; family illness|0|||
48864834|NCT00464737|157340208|FG000|Overall Study|Other: Study demands too great|0|||
48864835|NCT00464737|157340209|FG001|Overall Study|Other: Study demands too great|1|||
48864836|NCT00464737|157340210|FG002|Overall Study|Other: Study demands too great|0|||
48864837|NCT00464737|157340208|FG000|Overall Study|Other: Personal family reasons|0|||
48864838|NCT00464737|157340209|FG001|Overall Study|Other: Personal family reasons|0|||
48864839|NCT00464737|157340210|FG002|Overall Study|Other: Personal family reasons|1|||
48864840|NCT00464737|157340208|FG000|Overall Study|Other: Subject's disability per sponsor|0|||
48864841|NCT00464737|157340209|FG001|Overall Study|Other: Subject's disability per sponsor|0|||
48864842|NCT00464737|157340210|FG002|Overall Study|Other: Subject's disability per sponsor|1|||
48864843|NCT00580047|157340213|FG000|Overall Study|Lost to Follow-up|1|||
48864844|NCT00580047|157340214|FG001|Overall Study|Lost to Follow-up|1|||
48864845|NCT00580047|157340215|FG002|Overall Study|Lost to Follow-up|0|||
48864846|NCT00580047|157340213|FG000|Overall Study|Withdrawal by Subject|1|||
48864847|NCT00580047|157340214|FG001|Overall Study|Withdrawal by Subject|1|||
48864848|NCT00580047|157340215|FG002|Overall Study|Withdrawal by Subject|2|||
48864849|NCT00580047|157340213|FG000|Overall Study|Withdrawal by Subject|1|||
48864850|NCT00580047|157340214|FG001|Overall Study|Withdrawal by Subject|0|||
48864851|NCT00580047|157340215|FG002|Overall Study|Withdrawal by Subject|0|||
48864852|NCT02820298|157340216|FG000|Overall Study|Withdrawal by Subject|0|||
48864853|NCT02820298|157340217|FG001|Overall Study|Withdrawal by Subject|1|||
48864854|NCT02820298|157340216|FG000|Overall Study|Physician Decision|1|||
48864855|NCT02820298|157340217|FG001|Overall Study|Physician Decision|0|||
48864856|NCT02820298|157340216|FG000|Overall Study|Protocol Violation|0|||
48864857|NCT02820298|157340217|FG001|Overall Study|Protocol Violation|1|||
48864858|NCT00702520|157340218|FG000|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
48864859|NCT00702520|157340219|FG001|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1|||
48864860|NCT00702520|157340220|FG002|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
48864861|NCT00702520|157340221|FG003|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
48957811|NCT02279524|157675143|FG002|Overall Study|Bariatric surgery|0|||
48957812|NCT01746732|157675144|FG000|Lead-In Period|Withdrawal by Subject|1|||
48957813|NCT01746732|157675145|FG001|Lead-In Period|Withdrawal by Subject|0|||
48957814|NCT01746732|157675146|FG002|Lead-In Period|Withdrawal by Subject|0|||
48957815|NCT01746732|157675144|FG000|Period 1|Physician Decision|0|||
48957816|NCT01746732|157675145|FG001|Period 1|Physician Decision|1|||
48957817|NCT01746732|157675146|FG002|Period 1|Physician Decision|0|||
48957818|NCT01746732|157675144|FG000|Period 2|Withdrawal by Subject|0|||
48957819|NCT01746732|157675145|FG001|Period 2|Withdrawal by Subject|0|||
48957820|NCT01746732|157675146|FG002|Period 2|Withdrawal by Subject|2|||
48957821|NCT01746732|157675144|FG000|Period 2|Adverse Event|0|||
48957822|NCT01746732|157675145|FG001|Period 2|Adverse Event|0|||
48957823|NCT01746732|157675146|FG002|Period 2|Adverse Event|1|||
48957824|NCT01746732|157675144|FG000|Period 2|Lost to Follow-up|0|||
48957825|NCT01746732|157675145|FG001|Period 2|Lost to Follow-up|0|||
48957826|NCT01746732|157675146|FG002|Period 2|Lost to Follow-up|1|||
48957827|NCT01043185|157675147|FG000|Period 6 - Third Washout Period|Protocol Violation|0|||
48957828|NCT01043185|157675148|FG001|Period 6 - Third Washout Period|Protocol Violation|0|||
48957829|NCT01043185|157675149|FG002|Period 6 - Third Washout Period|Protocol Violation|0|||
48957830|NCT01043185|157675150|FG003|Period 6 - Third Washout Period|Protocol Violation|0|||
48957831|NCT01043185|157675151|FG004|Period 6 - Third Washout Period|Protocol Violation|0|||
48957832|NCT01043185|157675152|FG005|Period 6 - Third Washout Period|Protocol Violation|0|||
48957833|NCT01043185|157675153|FG006|Period 6 - Third Washout Period|Protocol Violation|0|||
48752634|NCT00793598|156940037|FG002|Overall Study|Patient Request|0|||
48752635|NCT00793598|156940038|FG003|Overall Study|Patient Request|0|||
48752636|NCT00793598|156940039|FG004|Overall Study|Patient Request|0|||
48752637|NCT00793598|156940040|FG005|Overall Study|Patient Request|0|||
48752638|NCT00793598|156940041|FG006|Overall Study|Patient Request|0|||
48752639|NCT00793598|156940042|FG007|Overall Study|Patient Request|0|||
48752640|NCT00793598|156940035|FG000|Overall Study|Protocol Violation|0|||
48752641|NCT00793598|156940036|FG001|Overall Study|Protocol Violation|0|||
48752642|NCT00793598|156940037|FG002|Overall Study|Protocol Violation|0|||
48752643|NCT00793598|156940038|FG003|Overall Study|Protocol Violation|0|||
48752644|NCT00793598|156940039|FG004|Overall Study|Protocol Violation|0|||
48752645|NCT00793598|156940040|FG005|Overall Study|Protocol Violation|0|||
48752646|NCT00793598|156940041|FG006|Overall Study|Protocol Violation|0|||
48752647|NCT00793598|156940042|FG007|Overall Study|Protocol Violation|1|||
48752648|NCT00793598|156940035|FG000|Overall Study|Subject not dosed|0|||
48752649|NCT00793598|156940036|FG001|Overall Study|Subject not dosed|0|||
48752650|NCT00793598|156940037|FG002|Overall Study|Subject not dosed|0|||
48752651|NCT00793598|156940038|FG003|Overall Study|Subject not dosed|0|||
48752652|NCT00793598|156940039|FG004|Overall Study|Subject not dosed|0|||
48752653|NCT00793598|156940040|FG005|Overall Study|Subject not dosed|1|||
48752654|NCT00793598|156940041|FG006|Overall Study|Subject not dosed|0|||
48752655|NCT00793598|156940042|FG007|Overall Study|Subject not dosed|0|||
48752656|NCT02239978|156940043|FG000|Overall Study|Withdrawal by Subject|2|||
48752657|NCT02239978|156940044|FG001|Overall Study|Withdrawal by Subject|0|||
48752658|NCT05255068|156940045|FG000|Overall Study|Lost to Follow-up|0|||
48752659|NCT05255068|156940046|FG001|Overall Study|Lost to Follow-up|1|||
48752660|NCT00290888|156940050|FG000|Overall Study|Physician Decision|3|||
48752661|NCT00290888|156940051|FG001|Overall Study|Physician Decision|1|||
48752662|NCT00540514|156940054|FG000|Overall Study|Still on treatment|3|||
48752663|NCT00540514|156940055|FG001|Overall Study|Still on treatment|0|||
48957834|NCT01043185|157675154|FG007|Period 6 - Third Washout Period|Protocol Violation|0|||
48957835|NCT01043185|157675155|FG008|Period 6 - Third Washout Period|Protocol Violation|1|||
48957836|NCT01043185|157675156|FG009|Period 6 - Third Washout Period|Protocol Violation|0|||
48752664|NCT00540514|156940054|FG000|Overall Study|Unacceptable Toxicity|61|||
48957837|NCT02125331|157675159|FG000|Overall Study|Protocol Violation|1|||
48957838|NCT02125331|157675160|FG001|Overall Study|Protocol Violation|0|||
48957839|NCT02125331|157675159|FG000|Overall Study|technical problem|2|||
48957840|NCT02125331|157675160|FG001|Overall Study|technical problem|0|||
48957841|NCT02125331|157675159|FG000|Overall Study|screen failure|2|||
48957842|NCT02125331|157675160|FG001|Overall Study|screen failure|0|||
48957843|NCT00137436|157675161|FG000|Overall Study|Adverse Event|13|||
48957844|NCT00137436|157675161|FG000|Overall Study|Death|2|||
48957845|NCT00137436|157675161|FG000|Overall Study|Lack of Efficacy|17|||
48957846|NCT00137436|157675161|FG000|Overall Study|Withdrawal by Subject|6|||
48957847|NCT00137436|157675161|FG000|Overall Study|Other|5|||
48957848|NCT00165646|157675162|FG000|Overall Study|Adverse Event|1|||
48957849|NCT00165646|157675163|FG001|Overall Study|Adverse Event|1|||
48957850|NCT00165646|157675164|FG002|Overall Study|Adverse Event|1|||
48957851|NCT00165646|157675162|FG000|Overall Study|Lack of Efficacy|1|||
48957852|NCT00165646|157675163|FG001|Overall Study|Lack of Efficacy|2|||
48957853|NCT00165646|157675164|FG002|Overall Study|Lack of Efficacy|0|||
48957854|NCT00165646|157675162|FG000|Overall Study|Withdrawal by Subject|0|||
48957855|NCT00165646|157675163|FG001|Overall Study|Withdrawal by Subject|2|||
48957856|NCT00165646|157675164|FG002|Overall Study|Withdrawal by Subject|1|||
48957857|NCT00165646|157675162|FG000|Overall Study|Physician Decision|2|||
48957858|NCT00165646|157675163|FG001|Overall Study|Physician Decision|0|||
48957859|NCT00165646|157675164|FG002|Overall Study|Physician Decision|2|||
48957860|NCT00165646|157675162|FG000|Overall Study|Protocol Violation|1|||
48957861|NCT00165646|157675163|FG001|Overall Study|Protocol Violation|0|||
48957862|NCT00165646|157675164|FG002|Overall Study|Protocol Violation|0|||
48957863|NCT03009539|157675165|FG000|Overall Study|Lost to Follow-up|132|||
48957864|NCT03009539|157675166|FG001|Overall Study|Lost to Follow-up|113|||
48957865|NCT03009539|157675167|FG002|Overall Study|Lost to Follow-up|132|||
48957866|NCT03009539|157675168|FG003|Overall Study|Lost to Follow-up|113|||
48957867|NCT03151148|157675169|FG000|Overall Study|Lost to Follow-up|1|||
48957868|NCT03151148|157675170|FG001|Overall Study|Lost to Follow-up|0|||
48957869|NCT03151148|157675169|FG000|Overall Study|Withdrawal by Subject|1|||
48957870|NCT03151148|157675170|FG001|Overall Study|Withdrawal by Subject|0|||
48957871|NCT04657016|157675171|FG000|Overall Study|Adverse Event|2|||
48957872|NCT04657016|157675172|FG001|Overall Study|Adverse Event|4|||
48957873|NCT04657016|157675171|FG000|Overall Study|Death|1|||
48957874|NCT04657016|157675172|FG001|Overall Study|Death|1|||
48957875|NCT04657016|157675171|FG000|Overall Study|Lost to Follow-up|24|||
48957876|NCT04657016|157675172|FG001|Overall Study|Lost to Follow-up|12|||
48957877|NCT04657016|157675171|FG000|Overall Study|Physician Decision|1|||
48957878|NCT04657016|157675172|FG001|Overall Study|Physician Decision|2|||
48957879|NCT04657016|157675171|FG000|Overall Study|Pregnancy|2|||
48957880|NCT04657016|157675172|FG001|Overall Study|Pregnancy|2|||
48957881|NCT04657016|157675171|FG000|Overall Study|Protocol Deviation|1|||
48957882|NCT04657016|157675172|FG001|Overall Study|Protocol Deviation|0|||
48752665|NCT00540514|156940055|FG001|Overall Study|Unacceptable Toxicity|62|||
48752666|NCT00540514|156940054|FG000|Overall Study|Adverse Event|20|||
48957883|NCT04657016|157675171|FG000|Overall Study|Withdrawal by Subject|28|||
48957884|NCT04657016|157675172|FG001|Overall Study|Withdrawal by Subject|14|||
48957885|NCT04657016|157675171|FG000|Overall Study|Other - as reported by the investigator|6|||
48957886|NCT04657016|157675172|FG001|Overall Study|Other - as reported by the investigator|0|||
48957887|NCT00710034|157675174|FG000|Completed 6 Weeks of Treatment|Adverse Event|5|||
48957888|NCT00710034|157675175|FG001|Completed 6 Weeks of Treatment|Adverse Event|12|||
48957889|NCT00710034|157675174|FG000|Completed 6 Weeks of Treatment|Lack of Efficacy|12|||
48957890|NCT00710034|157675175|FG001|Completed 6 Weeks of Treatment|Lack of Efficacy|8|||
48752667|NCT00540514|156940055|FG001|Overall Study|Adverse Event|24|||
48957891|NCT00710034|157675174|FG000|Completed 6 Weeks of Treatment|Lost to Follow-up|15|||
48957892|NCT00710034|157675175|FG001|Completed 6 Weeks of Treatment|Lost to Follow-up|17|||
48957893|NCT00710034|157675174|FG000|Completed 6 Weeks of Treatment|Product dissatisfaction|2|||
48957894|NCT00710034|157675175|FG001|Completed 6 Weeks of Treatment|Product dissatisfaction|6|||
48752668|NCT00540514|156940054|FG000|Overall Study|Physician Decision|86|||
48752669|NCT00540514|156940055|FG001|Overall Study|Physician Decision|99|||
48752670|NCT00540514|156940054|FG000|Overall Study|Protocol Deviation|3|||
48957895|NCT00710034|157675174|FG000|Completed 6 Weeks of Treatment|Withdrawal by Subject|6|||
48957896|NCT00710034|157675175|FG001|Completed 6 Weeks of Treatment|Withdrawal by Subject|4|||
48957897|NCT00710034|157675174|FG000|Completed 6 Weeks of Treatment|Physician Decision|1|||
48957898|NCT00710034|157675175|FG001|Completed 6 Weeks of Treatment|Physician Decision|0|||
48957899|NCT00710034|157675174|FG000|Completed 12 Weeks of Treatment|Adverse Event|0|||
48957900|NCT00710034|157675175|FG001|Completed 12 Weeks of Treatment|Adverse Event|1|||
48957901|NCT00710034|157675174|FG000|Completed 12 Weeks of Treatment|Lack of Efficacy|0|||
48957902|NCT00710034|157675175|FG001|Completed 12 Weeks of Treatment|Lack of Efficacy|2|||
48752671|NCT00540514|156940055|FG001|Overall Study|Protocol Deviation|4|||
48752672|NCT00540514|156940054|FG000|Overall Study|Lost to Follow-up|1|||
48752673|NCT00540514|156940055|FG001|Overall Study|Lost to Follow-up|1|||
48752674|NCT00540514|156940054|FG000|Overall Study|Withdrawal by Subject|65|||
48752675|NCT00540514|156940055|FG001|Overall Study|Withdrawal by Subject|67|||
48752676|NCT00540514|156940054|FG000|Overall Study|Excluded prior to treatment|7|||
48752677|NCT00540514|156940055|FG001|Overall Study|Excluded prior to treatment|7|||
48752678|NCT00540514|156940054|FG000|Overall Study|Paclitaxel not available|0|||
48752679|NCT00540514|156940055|FG001|Overall Study|Paclitaxel not available|2|||
48752680|NCT02329730|156940056|FG000|Overall Study|Protocol Violation|0|||
48752681|NCT02329730|156940057|FG001|Overall Study|Protocol Violation|0|||
48752682|NCT02329730|156940058|FG002|Overall Study|Protocol Violation|0|||
48752683|NCT02329730|156940059|FG003|Overall Study|Protocol Violation|0|||
48752684|NCT02329730|156940060|FG004|Overall Study|Protocol Violation|2|||
48957903|NCT00710034|157675174|FG000|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
48752685|NCT02329730|156940061|FG005|Overall Study|Protocol Violation|2|||
48957904|NCT00710034|157675175|FG001|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
48957905|NCT00710034|157675174|FG000|Completed 12 Weeks of Treatment|Product Dissatisfaction|0|||
48957906|NCT00710034|157675175|FG001|Completed 12 Weeks of Treatment|Product Dissatisfaction|1|||
48957907|NCT00710034|157675174|FG000|Completed 12 Weeks of Treatment|Withdrawal by Subject|8|||
48957908|NCT00710034|157675175|FG001|Completed 12 Weeks of Treatment|Withdrawal by Subject|2|||
48752686|NCT02329730|156940062|FG006|Overall Study|Protocol Violation|0|||
48752687|NCT02329730|156940063|FG007|Overall Study|Protocol Violation|0|||
48957909|NCT02078713|157675176|FG000|Overall Study|Lost to Follow-up|49|||
48957910|NCT02078713|157675177|FG001|Overall Study|Lost to Follow-up|55|||
48957911|NCT02078713|157675178|FG002|Overall Study|Lost to Follow-up|0|||
48957912|NCT02078713|157675179|FG003|Overall Study|Lost to Follow-up|0|||
48957913|NCT02078713|157675176|FG000|Overall Study|Pregnant at baseline|3|||
48957914|NCT02078713|157675177|FG001|Overall Study|Pregnant at baseline|5|||
48957915|NCT02078713|157675178|FG002|Overall Study|Pregnant at baseline|0|||
48752688|NCT02329730|156940064|FG008|Overall Study|Protocol Violation|0|||
48957916|NCT02078713|157675179|FG003|Overall Study|Pregnant at baseline|0|||
48752689|NCT02329730|156940065|FG009|Overall Study|Protocol Violation|0|||
48752690|NCT02329730|156940066|FG010|Overall Study|Protocol Violation|0|||
48752691|NCT02329730|156940067|FG011|Overall Study|Protocol Violation|0|||
48752692|NCT02329730|156940056|FG000|Overall Study|Withdrawal by Subject|0|||
48752693|NCT02329730|156940057|FG001|Overall Study|Withdrawal by Subject|0|||
48752694|NCT02329730|156940058|FG002|Overall Study|Withdrawal by Subject|0|||
48752695|NCT02329730|156940059|FG003|Overall Study|Withdrawal by Subject|0|||
48752696|NCT02329730|156940060|FG004|Overall Study|Withdrawal by Subject|1|||
48864862|NCT00702520|157340218|FG000|Base Study P05788 - Embryo Transfer|No embryo transfer|3|||
48864863|NCT00702520|157340219|FG001|Base Study P05788 - Embryo Transfer|No embryo transfer|6|||
48864864|NCT00702520|157340220|FG002|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
48864865|NCT00702520|157340221|FG003|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
48864866|NCT00702520|157340218|FG000|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15|||
48864867|NCT00702520|157340219|FG001|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10|||
48864868|NCT00702520|157340220|FG002|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
48864869|NCT00702520|157340221|FG003|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
48864870|NCT01544153|157340222|FG000|Overall Study|Under 18|0|||
48864871|NCT01544153|157340223|FG001|Overall Study|Under 18|1|||
48864872|NCT01544153|157340224|FG002|Overall Study|Under 18|0|||
48864873|NCT01544153|157340225|FG003|Overall Study|Under 18|0|||
48864874|NCT01544153|157340222|FG000|Overall Study|Non-smoker|0|||
48864875|NCT01544153|157340223|FG001|Overall Study|Non-smoker|0|||
48864876|NCT01544153|157340224|FG002|Overall Study|Non-smoker|1|||
48864877|NCT01544153|157340225|FG003|Overall Study|Non-smoker|0|||
48864878|NCT02188784|157340226|FG000|Overall Study|Death|3|||
48864879|NCT02188784|157340227|FG001|Overall Study|Death|1|||
48864880|NCT02188784|157340226|FG000|Overall Study|Lost to Follow-up|1|||
48864881|NCT02188784|157340227|FG001|Overall Study|Lost to Follow-up|0|||
48864882|NCT02188784|157340226|FG000|Overall Study|Withdrawal by Subject|3|||
49015408|NCT02739984|157892174|FG000|Overall Study|Sponsor Decision|1|||
48752697|NCT02329730|156940061|FG005|Overall Study|Withdrawal by Subject|0|||
48752698|NCT02329730|156940062|FG006|Overall Study|Withdrawal by Subject|1|||
48752699|NCT02329730|156940063|FG007|Overall Study|Withdrawal by Subject|1|||
48752700|NCT02329730|156940064|FG008|Overall Study|Withdrawal by Subject|1|||
48752701|NCT02329730|156940065|FG009|Overall Study|Withdrawal by Subject|1|||
48752702|NCT02329730|156940066|FG010|Overall Study|Withdrawal by Subject|0|||
48752703|NCT02329730|156940067|FG011|Overall Study|Withdrawal by Subject|0|||
48752704|NCT02674529|156940076|FG000|Overall Study|Lost to Follow-up|1|||
48752705|NCT02674529|156940077|FG001|Overall Study|Lost to Follow-up|2|||
48752706|NCT02674529|156940076|FG000|Overall Study|Withdrawal by Subject|2|||
48864883|NCT02188784|157340227|FG001|Overall Study|Withdrawal by Subject|9|||
48864884|NCT02188784|157340226|FG000|Overall Study|Physician Decision|2|||
48752707|NCT02674529|156940077|FG001|Overall Study|Withdrawal by Subject|1|||
48752708|NCT02674529|156940076|FG000|Overall Study|Physician Decision|0|||
48752709|NCT02674529|156940077|FG001|Overall Study|Physician Decision|1|||
48864885|NCT02188784|157340227|FG001|Overall Study|Physician Decision|3|||
48864886|NCT00276016|157340228|FG000|Intervention 1|Withdrawal by Subject|0|||
48864887|NCT00276016|157340229|FG001|Intervention 1|Withdrawal by Subject|1|||
48864888|NCT00276016|157340230|FG002|Intervention 1|Withdrawal by Subject|0|||
48864889|NCT00276016|157340231|FG003|Intervention 1|Withdrawal by Subject|0|||
48864890|NCT00276016|157340232|FG004|Intervention 1|Withdrawal by Subject|0|||
48864891|NCT00276016|157340233|FG005|Intervention 1|Withdrawal by Subject|0|||
48864892|NCT00417989|157340234|FG000|Overall Study|Withdrawal by Subject|13|||
48864893|NCT00417989|157340235|FG001|Overall Study|Withdrawal by Subject|13|||
48864894|NCT00417989|157340234|FG000|Overall Study|Lost to Follow-up|1|||
48864895|NCT00417989|157340235|FG001|Overall Study|Lost to Follow-up|6|||
48864896|NCT00417989|157340234|FG000|Overall Study|Protocol Violation|1|||
48864897|NCT00417989|157340235|FG001|Overall Study|Protocol Violation|0|||
48864898|NCT00417989|157340234|FG000|Overall Study|Death|0|||
48864899|NCT00417989|157340235|FG001|Overall Study|Death|1|||
48864900|NCT00417989|157340234|FG000|Overall Study|Physician Decision|5|||
48864901|NCT00417989|157340235|FG001|Overall Study|Physician Decision|2|||
48864902|NCT02473913|157340238|FG000|Overall Study|Lost to Follow-up|3|||
48864903|NCT02473913|157340239|FG001|Overall Study|Lost to Follow-up|3|||
48864904|NCT00884793|157340240|FG000|Overall Study|Withdrawal by Subject|1|||
48864905|NCT05041439|157340241|FG000|Overall Study|Withdrawal by Subject|1|||
48752710|NCT02674529|156940076|FG000|Overall Study|Protocol Violation|0|||
48864906|NCT05041439|157340242|FG001|Overall Study|Withdrawal by Subject|1|||
48864907|NCT05041439|157340241|FG000|Overall Study|Death|1|||
48752711|NCT02674529|156940077|FG001|Overall Study|Protocol Violation|1|||
48752712|NCT02891850|156940078|FG000|Overall Study|Adverse Event|3|||
48752713|NCT02891850|156940079|FG001|Overall Study|Adverse Event|0|||
48752714|NCT02891850|156940078|FG000|Overall Study|Death|0|||
48752715|NCT02891850|156940079|FG001|Overall Study|Death|4|||
48957917|NCT02078713|157675176|FG000|Overall Study|Enrolled twice|0|||
48957918|NCT02078713|157675177|FG001|Overall Study|Enrolled twice|1|||
48957919|NCT02078713|157675178|FG002|Overall Study|Enrolled twice|0|||
48957920|NCT02078713|157675179|FG003|Overall Study|Enrolled twice|0|||
48957921|NCT00028002|157675185|FG000|Overall Study|Withdrawal by Subject|3|||
48957922|NCT00028002|157675185|FG000|Overall Study|Ineligible|8|||
48957923|NCT01793051|157675186|FG000|Overall Study|Withdrawal by Subject|6|||
48957924|NCT01793051|157675187|FG001|Overall Study|Withdrawal by Subject|4|||
48957925|NCT01793051|157675186|FG000|Overall Study|Adverse Event|0|||
48957926|NCT01793051|157675187|FG001|Overall Study|Adverse Event|2|||
48957927|NCT01793051|157675186|FG000|Overall Study|Too ill to continue|1|||
48957928|NCT01793051|157675187|FG001|Overall Study|Too ill to continue|0|||
48957929|NCT01793051|157675186|FG000|Overall Study|Switched chemo|1|||
48752716|NCT02891850|156940078|FG000|Overall Study|Physician Decision|1|||
48752717|NCT02891850|156940079|FG001|Overall Study|Physician Decision|0|||
48752718|NCT02891850|156940078|FG000|Overall Study|Pregnancy|1|||
48752719|NCT02891850|156940079|FG001|Overall Study|Pregnancy|0|||
48752720|NCT02891850|156940078|FG000|Overall Study|Withdrawal by Subject|2|||
48752721|NCT02891850|156940079|FG001|Overall Study|Withdrawal by Subject|3|||
48752722|NCT02961751|156940088|FG000|Overall Study|Lost to Follow-up|11|||
48752723|NCT02961751|156940088|FG000|Overall Study|Physician Decision|2|||
48752724|NCT02961751|156940088|FG000|Overall Study|Not Eligible at Enrollment|1|||
48752725|NCT02961751|156940088|FG000|Overall Study|Protocol Violation|1|||
48752726|NCT02345850|156940089|FG000|Overall Study|Not transplanted|10|||
48752727|NCT02345850|156940090|FG001|Overall Study|Not transplanted|5|||
48752728|NCT02345850|156940091|FG002|Overall Study|Not transplanted|4|||
48752729|NCT02345850|156940089|FG000|Overall Study|Lost to Follow-up|2|||
48752730|NCT02345850|156940090|FG001|Overall Study|Lost to Follow-up|3|||
48752731|NCT02345850|156940091|FG002|Overall Study|Lost to Follow-up|2|||
48752732|NCT02345850|156940089|FG000|Overall Study|Withdrawal by Subject|1|||
48752733|NCT02345850|156940090|FG001|Overall Study|Withdrawal by Subject|0|||
48957930|NCT01793051|157675187|FG001|Overall Study|Switched chemo|1|||
48957931|NCT01793051|157675186|FG000|Overall Study|Lack of compliance|1|||
48957932|NCT01793051|157675187|FG001|Overall Study|Lack of compliance|0|||
48957933|NCT01793051|157675186|FG000|Overall Study|Requested to be removed from the study|1|||
48752734|NCT02345850|156940091|FG002|Overall Study|Withdrawal by Subject|0|||
48957934|NCT01793051|157675187|FG001|Overall Study|Requested to be removed from the study|1|||
48957935|NCT01328249|157675192|FG000|Overall Study|Adverse Event|3|||
48752735|NCT02373202|156940092|FG000|Overall Study|Adverse Event|2|||
48752736|NCT02373202|156940093|FG001|Overall Study|Adverse Event|5|||
48752737|NCT02373202|156940094|FG002|Overall Study|Adverse Event|2|||
48752738|NCT02373202|156940095|FG003|Overall Study|Adverse Event|1|||
48957936|NCT01328249|157675193|FG001|Overall Study|Adverse Event|0|||
48957937|NCT01328249|157675192|FG000|Overall Study|Disease progression|1|||
48752739|NCT02373202|156940092|FG000|Overall Study|Lack of Efficacy|0|||
48752740|NCT02373202|156940093|FG001|Overall Study|Lack of Efficacy|0|||
48752741|NCT02373202|156940094|FG002|Overall Study|Lack of Efficacy|1|||
48752742|NCT02373202|156940095|FG003|Overall Study|Lack of Efficacy|0|||
48752743|NCT02373202|156940092|FG000|Overall Study|Other|0|||
48752744|NCT02373202|156940093|FG001|Overall Study|Other|1|||
48752745|NCT02373202|156940094|FG002|Overall Study|Other|0|||
48752746|NCT02373202|156940095|FG003|Overall Study|Other|0|||
48752747|NCT02392247|156940096|FG000|Overall Study|Withdrawal by Subject|1|||
48752748|NCT02392247|156940096|FG000|Overall Study|Surgery cancelled; no data|1|||
48752749|NCT01411228|156940097|FG000|Overall Study|Lost to Follow-up|0|||
48752750|NCT01411228|156940098|FG001|Overall Study|Lost to Follow-up|0|||
48752751|NCT01411228|156940099|FG002|Overall Study|Lost to Follow-up|1|||
48752752|NCT01411228|156940097|FG000|Overall Study|Withdrawal by Subject|1|||
48752753|NCT01411228|156940098|FG001|Overall Study|Withdrawal by Subject|0|||
48752754|NCT01411228|156940099|FG002|Overall Study|Withdrawal by Subject|0|||
48752755|NCT03055260|156940104|FG000|Overall Study|Withdrawal by Subject|1|||
48752756|NCT03055260|156940105|FG001|Overall Study|Withdrawal by Subject|0|||
48752757|NCT00573469|156940106|FG000|Overall Study|Adverse Event|1|||
48752758|NCT00573469|156940107|FG001|Overall Study|Adverse Event|1|||
48752759|NCT00573469|156940108|FG002|Overall Study|Adverse Event|1|||
48752760|NCT00573469|156940106|FG000|Overall Study|Withdrawal by Subject|0|||
48752761|NCT00573469|156940107|FG001|Overall Study|Withdrawal by Subject|2|||
48752762|NCT00573469|156940108|FG002|Overall Study|Withdrawal by Subject|0|||
48752763|NCT00573469|156940106|FG000|Overall Study|Other|5|||
48752764|NCT00573469|156940107|FG001|Overall Study|Other|1|||
48752765|NCT00573469|156940108|FG002|Overall Study|Other|3|||
48752766|NCT02825992|156940109|FG000|Overall Study|Withdrawal by Subject|4|||
48752767|NCT02825992|156940109|FG000|Overall Study|Lost to Follow-up|2|||
48752768|NCT02825992|156940109|FG000|Overall Study|Procedure terminated|2|||
48752769|NCT03506815|156940110|FG000|Overall Study|Adverse Event|8|||
48752770|NCT03506815|156940111|FG001|Overall Study|Adverse Event|0|||
48752771|NCT03506815|156940110|FG000|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|5|||
48752772|NCT03506815|156940111|FG001|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|0|||
48752773|NCT03506815|156940110|FG000|Overall Study|Protocol Violation|1|||
48752774|NCT03506815|156940111|FG001|Overall Study|Protocol Violation|0|||
48752775|NCT03506815|156940110|FG000|Overall Study|Elective Surgery|1|||
48752776|NCT03506815|156940111|FG001|Overall Study|Elective Surgery|0|||
48752777|NCT03068130|156940115|FG000|Overall Study|Adverse Event|19|||
48864908|NCT05041439|157340242|FG001|Overall Study|Death|0|||
48864909|NCT04295499|157340243|FG000|Overall Study|moving out of state|1|||
48752778|NCT03068130|156940115|FG000|Overall Study|Death|14|||
48752779|NCT03068130|156940115|FG000|Overall Study|Lost to Follow-up|4|||
48752780|NCT03068130|156940115|FG000|Overall Study|Withdrawal by Subject|26|||
48752781|NCT03068130|156940115|FG000|Overall Study|Administrative Reasons|3|||
48752782|NCT03068130|156940115|FG000|Overall Study|Protocol specified withdrawal criterion|1|||
48752783|NCT03068130|156940115|FG000|Overall Study|Study terminated by sponsor|194|||
48752784|NCT04271605|156940127|FG000|Overall Study|The study was terminated because of the duration of funding was only one year.|5|||
48752785|NCT01438957|156940134|FG000|Overall Study|Physician Decision|1|||
48752786|NCT01438957|156940135|FG001|Overall Study|Physician Decision|1|||
48752787|NCT01438957|156940136|FG002|Overall Study|Physician Decision|0|||
48752788|NCT01438957|156940137|FG003|Overall Study|Physician Decision|1|||
48864910|NCT04295499|157340244|FG001|Overall Study|moving out of state|0|||
48864911|NCT04295499|157340243|FG000|Overall Study|traveling overseas for business prior to the study completion|1|||
48864912|NCT04295499|157340244|FG001|Overall Study|traveling overseas for business prior to the study completion|0|||
48864913|NCT01021683|157340245|FG000|Overall Study|Lack of Efficacy|12|||
48864914|NCT01021683|157340245|FG000|Overall Study|Recovery of neutrophil count|51|||
48864915|NCT01021683|157340245|FG000|Overall Study|Other|8|||
48864916|NCT01374971|157340251|FG000|Overall Study|Withdrawal by Subject|1|||
48864917|NCT01876823|157340258|FG000|Overall Study|Withdrawal by Subject|5|||
48752789|NCT01438957|156940138|FG004|Overall Study|Physician Decision|0|||
48752790|NCT03138889|156940139|FG000|Overall Study|Withdrawal by Subject|5|||
48864918|NCT01876823|157340258|FG000|Overall Study|Physician Decision|2|||
48864919|NCT01876823|157340258|FG000|Overall Study|Patients moved|2|||
48864920|NCT02965599|157340261|FG000|Overall Study|Protocol-defined stop criteria reached|1|||
48864921|NCT02965599|157340262|FG001|Overall Study|Protocol-defined stop criteria reached|0|||
48864922|NCT00170950|157340263|FG000|Overall Study|Death|236|||
48864923|NCT00170950|157340264|FG001|Overall Study|Death|274|||
48864924|NCT00170950|157340263|FG000|Overall Study|Withdrawal by Subject|496|||
48864925|NCT00170950|157340264|FG001|Overall Study|Withdrawal by Subject|498|||
48864926|NCT00170950|157340263|FG000|Overall Study|Lost to Follow-up|134|||
48864927|NCT00170950|157340264|FG001|Overall Study|Lost to Follow-up|115|||
48864928|NCT00170950|157340263|FG000|Overall Study|Missing|2|||
48864929|NCT00170950|157340264|FG001|Overall Study|Missing|1|||
48864930|NCT00170950|157340263|FG000|Overall Study|Termination Data Not Recorded|17|||
48864931|NCT00170950|157340264|FG001|Overall Study|Termination Data Not Recorded|22|||
48864932|NCT05294328|157340269|FG000|Overall Study|Adverse Event|1|||
48864933|NCT05294328|157340270|FG001|Overall Study|Adverse Event|0|||
48864934|NCT05294328|157340271|FG002|Overall Study|Adverse Event|0|||
48864935|NCT05294328|157340269|FG000|Overall Study|Physician Decision|1|||
48864936|NCT05294328|157340270|FG001|Overall Study|Physician Decision|1|||
48864937|NCT05294328|157340271|FG002|Overall Study|Physician Decision|0|||
48864938|NCT05294328|157340269|FG000|Overall Study|Withdrawal by Subject|0|||
48864939|NCT05294328|157340270|FG001|Overall Study|Withdrawal by Subject|2|||
48864940|NCT05294328|157340271|FG002|Overall Study|Withdrawal by Subject|1|||
48864941|NCT05294328|157340269|FG000|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
48864942|NCT05294328|157340270|FG001|Overall Study|Other (Corneal Surface Disease and Distance VA)|1|||
48864943|NCT05294328|157340271|FG002|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
48864944|NCT00489489|157341841|FG000|Overall Study|Not treated due to protocol violation|0|||
48864945|NCT00489489|157341842|FG001|Overall Study|Not treated due to protocol violation|1|||
48864946|NCT00489489|157341843|FG002|Overall Study|Not treated due to protocol violation|1|||
48864947|NCT00489489|157341841|FG000|Overall Study|Adverse Event|1|||
48864948|NCT00489489|157341842|FG001|Overall Study|Adverse Event|1|||
48864949|NCT00489489|157341843|FG002|Overall Study|Adverse Event|1|||
48864950|NCT00489489|157341841|FG000|Overall Study|Protocol Violation|1|||
48864951|NCT00489489|157341842|FG001|Overall Study|Protocol Violation|0|||
48864952|NCT00489489|157341843|FG002|Overall Study|Protocol Violation|1|||
48864953|NCT00489489|157341841|FG000|Overall Study|Progressive disease|0|||
48864954|NCT00489489|157341842|FG001|Overall Study|Progressive disease|1|||
48864955|NCT00489489|157341843|FG002|Overall Study|Progressive disease|0|||
48864956|NCT00489489|157341841|FG000|Overall Study|Participant did not wish to continue|1|||
48864957|NCT00489489|157341842|FG001|Overall Study|Participant did not wish to continue|1|||
48752791|NCT03138889|156940140|FG001|Overall Study|Withdrawal by Subject|5|||
48752792|NCT03138889|156940141|FG002|Overall Study|Withdrawal by Subject|0|||
48752793|NCT03138889|156940142|FG003|Overall Study|Withdrawal by Subject|2|||
48752794|NCT03138889|156940143|FG004|Overall Study|Withdrawal by Subject|1|||
48752795|NCT03138889|156940144|FG005|Overall Study|Withdrawal by Subject|3|||
48752796|NCT03138889|156940145|FG006|Overall Study|Withdrawal by Subject|0|||
48752797|NCT03138889|156940146|FG007|Overall Study|Withdrawal by Subject|1|||
48752798|NCT00936910|156940147|FG000|Overall Study|Lack of Efficacy|3|||
48752799|NCT00105482|156940148|FG000|Overall Study|Adverse Event|1|||
48957938|NCT01328249|157675193|FG001|Overall Study|Disease progression|0|||
48957939|NCT01328249|157675192|FG000|Overall Study|Withdrawal by Subject|1|||
48957940|NCT01328249|157675193|FG001|Overall Study|Withdrawal by Subject|1|||
48752800|NCT00105482|156940149|FG001|Overall Study|Adverse Event|1|||
48957941|NCT01328249|157675192|FG000|Overall Study|Moved before end of treatment visit|1|||
48957942|NCT01328249|157675193|FG001|Overall Study|Moved before end of treatment visit|0|||
48957943|NCT01328249|157675192|FG000|Overall Study|Subject choice|1|||
48957944|NCT01328249|157675193|FG001|Overall Study|Subject choice|1|||
48957945|NCT01328249|157675192|FG000|Overall Study|Protocol Violation|0|||
48957946|NCT01328249|157675193|FG001|Overall Study|Protocol Violation|1|||
48957947|NCT04439838|157675195|FG000|Overall Study|Withdrawal by Subject|0|||
48957948|NCT04439838|157675196|FG001|Overall Study|Withdrawal by Subject|0|||
48957949|NCT04439838|157675197|FG002|Overall Study|Withdrawal by Subject|0|||
48957950|NCT04439838|157675198|FG003|Overall Study|Withdrawal by Subject|0|||
48957951|NCT04439838|157675199|FG004|Overall Study|Withdrawal by Subject|0|||
48957952|NCT04439838|157675200|FG005|Overall Study|Withdrawal by Subject|0|||
48957953|NCT04439838|157675201|FG006|Overall Study|Withdrawal by Subject|0|||
48752801|NCT00105482|156940148|FG000|Overall Study|Lost to Follow-up|26|||
48957954|NCT04439838|157675202|FG007|Overall Study|Withdrawal by Subject|0|||
48957955|NCT04439838|157675203|FG008|Overall Study|Withdrawal by Subject|1|||
48752802|NCT00105482|156940149|FG001|Overall Study|Lost to Follow-up|17|||
48752803|NCT00105482|156940148|FG000|Overall Study|Withdrawal by Subject|0|||
48957956|NCT01361009|157675204|FG000|Overall Study|Protocol Violation|116|||
48957957|NCT01830543|157675205|FG000|Overall Study|Subject Decision|19|||
48752804|NCT00105482|156940149|FG001|Overall Study|Withdrawal by Subject|1|||
48752805|NCT00105482|156940148|FG000|Overall Study|Lost Interest|29|||
48752806|NCT00105482|156940149|FG001|Overall Study|Lost Interest|32|||
48752807|NCT00105482|156940148|FG000|Overall Study|Scheduling Conflict|2|||
48752808|NCT00105482|156940149|FG001|Overall Study|Scheduling Conflict|3|||
48752809|NCT00105482|156940148|FG000|Overall Study|Withdrawn by PI|1|||
48752810|NCT00105482|156940149|FG001|Overall Study|Withdrawn by PI|1|||
48752811|NCT04626297|156940151|FG000|Overall Study|Adverse Event|5|||
48752812|NCT04626297|156940152|FG001|Overall Study|Adverse Event|3|||
48864958|NCT00489489|157341843|FG002|Overall Study|Participant did not wish to continue|0|||
48864959|NCT00489489|157341841|FG000|Overall Study|Other than above|0|||
48864960|NCT00489489|157341842|FG001|Overall Study|Other than above|1|||
48864961|NCT00489489|157341843|FG002|Overall Study|Other than above|0|||
48864962|NCT05066230|157341844|FG000|Primary Study (Through Week 48)|Adverse Event|1|||
48957958|NCT01830543|157675206|FG001|Overall Study|Subject Decision|21|||
48752813|NCT04626297|156940151|FG000|Overall Study|Lost to Follow-up|7|||
48752814|NCT04626297|156940152|FG001|Overall Study|Lost to Follow-up|3|||
48864963|NCT05066230|157341845|FG001|Primary Study (Through Week 48)|Adverse Event|4|||
48864964|NCT05066230|157341844|FG000|Primary Study (Through Week 48)|Non-compliance with study schedule|0|||
48864965|NCT05066230|157341845|FG001|Primary Study (Through Week 48)|Non-compliance with study schedule|1|||
48864966|NCT05066230|157341844|FG000|Primary Study (Through Week 48)|Withdrawal by Subject|4|||
48864967|NCT05066230|157341845|FG001|Primary Study (Through Week 48)|Withdrawal by Subject|2|||
48864968|NCT05066230|157341844|FG000|Primary Study (Through Week 48)|Lost to Follow-up|2|||
48864969|NCT05066230|157341845|FG001|Primary Study (Through Week 48)|Lost to Follow-up|3|||
48864970|NCT05066230|157341844|FG000|Primary Study (Through Week 48)|Participant relocated|1|||
48864971|NCT05066230|157341845|FG001|Primary Study (Through Week 48)|Participant relocated|0|||
48864972|NCT05066230|157341844|FG000|After Week 48|Adverse Event|1|||
48864973|NCT05066230|157341845|FG001|After Week 48|Adverse Event|0|||
48864974|NCT05066230|157341844|FG000|After Week 48|Non-compliance with study schedule|1|||
48864975|NCT05066230|157341845|FG001|After Week 48|Non-compliance with study schedule|0|||
48864976|NCT05066230|157341844|FG000|After Week 48|Withdrawal by Subject|0|||
48864977|NCT05066230|157341845|FG001|After Week 48|Withdrawal by Subject|1|||
48864978|NCT05066230|157341844|FG000|After Week 48|Lost to Follow-up|3|||
48864979|NCT05066230|157341845|FG001|After Week 48|Lost to Follow-up|3|||
48864980|NCT05066230|157341844|FG000|After Week 48|Sponsor Request|115|||
48864981|NCT05066230|157341845|FG001|After Week 48|Sponsor Request|111|||
48864982|NCT02507297|157341846|FG000|Overall Study|Withdrawal by Subject|1|||
48864983|NCT02507297|157341847|FG001|Overall Study|Withdrawal by Subject|0|||
48864984|NCT02507297|157341846|FG000|Overall Study|Lost to Follow-up|0|||
48864985|NCT02507297|157341847|FG001|Overall Study|Lost to Follow-up|1|||
48864986|NCT00515112|157341852|FG000|Overall Study|Death|0|||
48864987|NCT00515112|157341853|FG001|Overall Study|Death|1|||
48864988|NCT00515112|157341852|FG000|Overall Study|The study was terminated|3|||
48864989|NCT00515112|157341853|FG001|Overall Study|The study was terminated|2|||
48864990|NCT01825785|157341854|FG000|Overall Study|Adverse Event|0|||
48864991|NCT01825785|157341855|FG001|Overall Study|Adverse Event|0|||
48864992|NCT01825785|157341856|FG002|Overall Study|Adverse Event|0|||
48864993|NCT01825785|157341857|FG003|Overall Study|Adverse Event|0|||
48864994|NCT01825785|157341858|FG004|Overall Study|Adverse Event|1|||
48864995|NCT01825785|157341859|FG005|Overall Study|Adverse Event|0|||
48864996|NCT01825785|157341860|FG006|Overall Study|Adverse Event|0|||
48864997|NCT01825785|157341854|FG000|Overall Study|Withdrawal by Subject|0|||
48864998|NCT01825785|157341855|FG001|Overall Study|Withdrawal by Subject|0|||
48864999|NCT01825785|157341856|FG002|Overall Study|Withdrawal by Subject|0|||
48865000|NCT01825785|157341857|FG003|Overall Study|Withdrawal by Subject|0|||
48865001|NCT01825785|157341858|FG004|Overall Study|Withdrawal by Subject|1|||
48865002|NCT01825785|157341859|FG005|Overall Study|Withdrawal by Subject|1|||
48865003|NCT01825785|157341860|FG006|Overall Study|Withdrawal by Subject|0|||
48865004|NCT01945593|157341865|FG000|Overall Study|Adverse Event|0|||
48865005|NCT01945593|157341866|FG001|Overall Study|Adverse Event|0|||
48865006|NCT01945593|157341867|FG002|Overall Study|Adverse Event|0|||
48865007|NCT01945593|157341868|FG003|Overall Study|Adverse Event|5|||
48865008|NCT01945593|157341865|FG000|Overall Study|Physician Decision|0|||
48865009|NCT01945593|157341866|FG001|Overall Study|Physician Decision|0|||
48865010|NCT01945593|157341867|FG002|Overall Study|Physician Decision|1|||
48865011|NCT01945593|157341868|FG003|Overall Study|Physician Decision|1|||
48865012|NCT01945593|157341865|FG000|Overall Study|Withdrawal by Subject|0|||
48865013|NCT01945593|157341866|FG001|Overall Study|Withdrawal by Subject|2|||
48865014|NCT01945593|157341867|FG002|Overall Study|Withdrawal by Subject|0|||
48865015|NCT01945593|157341868|FG003|Overall Study|Withdrawal by Subject|4|||
48865016|NCT01945593|157341865|FG000|Overall Study|Protocol Violation|0|||
48865017|NCT01945593|157341866|FG001|Overall Study|Protocol Violation|2|||
48865018|NCT01945593|157341867|FG002|Overall Study|Protocol Violation|1|||
48865019|NCT01945593|157341868|FG003|Overall Study|Protocol Violation|3|||
48865020|NCT01945593|157341865|FG000|Overall Study|Death|0|||
48865021|NCT01945593|157341866|FG001|Overall Study|Death|0|||
48865022|NCT01945593|157341867|FG002|Overall Study|Death|1|||
48865023|NCT01945593|157341868|FG003|Overall Study|Death|0|||
48865024|NCT01945593|157341865|FG000|Overall Study|Other: Terminated|0|||
48865025|NCT01945593|157341866|FG001|Overall Study|Other: Terminated|0|||
48865026|NCT01945593|157341867|FG002|Overall Study|Other: Terminated|0|||
48865027|NCT01945593|157341868|FG003|Overall Study|Other: Terminated|1|||
48957959|NCT01830543|157675207|FG002|Overall Study|Subject Decision|57|||
48957960|NCT01830543|157675205|FG000|Overall Study|Adverse Event|91|||
48957961|NCT01830543|157675206|FG001|Overall Study|Adverse Event|77|||
48957962|NCT01830543|157675207|FG002|Overall Study|Adverse Event|76|||
48957963|NCT01830543|157675205|FG000|Overall Study|Death|20|||
48957964|NCT01830543|157675206|FG001|Overall Study|Death|22|||
48957965|NCT01830543|157675207|FG002|Overall Study|Death|22|||
48752815|NCT04626297|156940151|FG000|Overall Study|Protocol Violation|5|||
48752816|NCT04626297|156940152|FG001|Overall Study|Protocol Violation|1|||
48752817|NCT04626297|156940151|FG000|Overall Study|Withdrawal by Subject|20|||
48752818|NCT04626297|156940152|FG001|Overall Study|Withdrawal by Subject|6|||
48752819|NCT04626297|156940151|FG000|Overall Study|Sponsor decision|2|||
48752820|NCT04626297|156940152|FG001|Overall Study|Sponsor decision|1|||
48752821|NCT03462082|156940155|FG000|Open Label Phase|Symptom worsening (Treatment failure)|0|||
48752822|NCT03462082|156940156|FG001|Open Label Phase|Symptom worsening (Treatment failure)|0|||
48752823|NCT03462082|156940157|FG002|Open Label Phase|Symptom worsening (Treatment failure)|0|||
48752824|NCT03462082|156940158|FG003|Open Label Phase|Symptom worsening (Treatment failure)|0|||
48752825|NCT03462082|156940159|FG004|Open Label Phase|Symptom worsening (Treatment failure)|0|||
48752826|NCT03462082|156940160|FG005|Open Label Phase|Symptom worsening (Treatment failure)|0|||
48752827|NCT03462082|156940161|FG006|Open Label Phase|Symptom worsening (Treatment failure)|1|||
48752828|NCT03462082|156940162|FG007|Open Label Phase|Symptom worsening (Treatment failure)|2|||
48752829|NCT01979016|156940163|FG000|Overall Study|Withdrawal by Subject|2|||
48752830|NCT01979016|156940164|FG001|Overall Study|Withdrawal by Subject|0|||
48752831|NCT01979016|156940163|FG000|Overall Study|Adverse Event|0|||
48752832|NCT01979016|156940164|FG001|Overall Study|Adverse Event|1|||
48752833|NCT03998189|156940165|FG000|Overall Study|Lack of Efficacy|0|||
48752834|NCT03998189|156940166|FG001|Overall Study|Lack of Efficacy|1|||
48752835|NCT01442493|156940167|FG000|Overall Study|withdrawn from study|3|||
48752836|NCT01442493|156940168|FG001|Overall Study|withdrawn from study|2|||
48752837|NCT01750242|156940169|FG000|Overall Study|Unreadable Images|3|||
48752838|NCT02557646|156940171|FG000|Overall Study|Adverse Event|40|||
48752839|NCT02557646|156940171|FG000|Overall Study|Death|1|||
48752840|NCT02557646|156940171|FG000|Overall Study|Lack of Efficacy|186|||
48752841|NCT02557646|156940171|FG000|Overall Study|Withdrawal by Subject|18|||
48752842|NCT02557646|156940171|FG000|Overall Study|Lost to Follow-up|17|||
48752843|NCT02557646|156940171|FG000|Overall Study|Other|14|||
48752844|NCT00927784|156940183|FG000|Overall Study|Death|1|||
48752845|NCT00927784|156940184|FG001|Overall Study|Death|0|||
48752846|NCT00927784|156940183|FG000|Overall Study|Withdrawal by Subject|1|||
48752847|NCT00927784|156940184|FG001|Overall Study|Withdrawal by Subject|0|||
48752848|NCT02860169|156940185|FG000|Part A|Withdrawal by Subject|1|||
48752849|NCT02860169|156940185|FG000|Part A|Other (Screening failure)|6|||
48752850|NCT02860169|156940185|FG000|Part A|Other (Survey not completed)|3|||
48752851|NCT02860169|156940185|FG000|Part A|Other (did not completed consent)|1|||
48957966|NCT01830543|157675205|FG000|Overall Study|Protocol Violation|3|||
48957967|NCT01830543|157675206|FG001|Overall Study|Protocol Violation|7|||
48957968|NCT01830543|157675207|FG002|Overall Study|Protocol Violation|7|||
48957969|NCT01830543|157675205|FG000|Overall Study|Physician Decision|11|||
48752852|NCT02860169|156940185|FG000|Part B|Other (Screening failure)|10|||
48957970|NCT01830543|157675206|FG001|Overall Study|Physician Decision|5|||
48752853|NCT02860169|156940185|FG000|Part B|Withdrawal by Subject|1|||
48752854|NCT02860169|156940185|FG000|Part C|Other (Screening failure)|1|||
48957971|NCT01830543|157675207|FG002|Overall Study|Physician Decision|12|||
48957972|NCT01830543|157675205|FG000|Overall Study|Withdrawal by consent|3|||
48957973|NCT01830543|157675206|FG001|Overall Study|Withdrawal by consent|3|||
48957974|NCT01830543|157675207|FG002|Overall Study|Withdrawal by consent|3|||
48957975|NCT01830543|157675205|FG000|Overall Study|Other|12|||
48957976|NCT01830543|157675206|FG001|Overall Study|Other|17|||
48957977|NCT01830543|157675207|FG002|Overall Study|Other|37|||
48957978|NCT02023164|157675208|FG000|24-Hour Follow-Up|Lost to Follow-up|0|||
48957979|NCT02023164|157675209|FG001|24-Hour Follow-Up|Lost to Follow-up|2|||
48957980|NCT02436577|157675210|FG000|Overall Study|Protocol Deviation|0|||
48957981|NCT02436577|157675211|FG001|Overall Study|Protocol Deviation|1|||
48957982|NCT02436577|157675212|FG002|Overall Study|Protocol Deviation|0|||
48957983|NCT02436577|157675213|FG003|Overall Study|Protocol Deviation|0|||
48957984|NCT02436577|157675214|FG004|Overall Study|Protocol Deviation|0|||
48957985|NCT02436577|157675215|FG005|Overall Study|Protocol Deviation|0|||
48957986|NCT03703375|157675216|FG000|Randomization Period|Withdrawal by Subject|0|||
48957987|NCT03703375|157675217|FG001|Randomization Period|Withdrawal by Subject|0|||
48957988|NCT03703375|157675218|FG002|Randomization Period|Withdrawal by Subject|0|||
48957989|NCT03703375|157675219|FG003|Randomization Period|Withdrawal by Subject|1|||
48957990|NCT03703375|157675216|FG000|Randomization Period|Completed safety run-in treatment|7|||
48957991|NCT03703375|157675217|FG001|Randomization Period|Completed safety run-in treatment|0|||
48957992|NCT03703375|157675218|FG002|Randomization Period|Completed safety run-in treatment|0|||
48957993|NCT03703375|157675219|FG003|Randomization Period|Completed safety run-in treatment|0|||
48957994|NCT03703375|157675216|FG000|Treatment Period|Other Reasons|0|||
48957995|NCT03703375|157675217|FG001|Treatment Period|Other Reasons|1|||
48957996|NCT03703375|157675218|FG002|Treatment Period|Other Reasons|0|||
48957997|NCT03703375|157675219|FG003|Treatment Period|Other Reasons|3|||
48957998|NCT03703375|157675216|FG000|Treatment Period|Consent Withdrawal|0|||
48957999|NCT03703375|157675217|FG001|Treatment Period|Consent Withdrawal|0|||
48958000|NCT03703375|157675218|FG002|Treatment Period|Consent Withdrawal|0|||
48958001|NCT03703375|157675219|FG003|Treatment Period|Consent Withdrawal|1|||
48958002|NCT03703375|157675216|FG000|Treatment Period|Death|1|||
48958003|NCT03703375|157675217|FG001|Treatment Period|Death|0|||
48958004|NCT03703375|157675218|FG002|Treatment Period|Death|1|||
48958005|NCT03703375|157675219|FG003|Treatment Period|Death|2|||
48958006|NCT03703375|157675216|FG000|Treatment Period|Toxicity of Study Treatment|2|||
48958007|NCT03703375|157675217|FG001|Treatment Period|Toxicity of Study Treatment|0|||
48958008|NCT03703375|157675218|FG002|Treatment Period|Toxicity of Study Treatment|4|||
48958009|NCT03703375|157675219|FG003|Treatment Period|Toxicity of Study Treatment|1|||
48958010|NCT03703375|157675216|FG000|Treatment Period|Progression|32|||
48958011|NCT03703375|157675217|FG001|Treatment Period|Progression|1|||
48958012|NCT03703375|157675218|FG002|Treatment Period|Progression|7|||
48958013|NCT03703375|157675219|FG003|Treatment Period|Progression|11|||
48958014|NCT03703375|157675216|FG000|Treatment Period|Completed treatment|7|||
48958015|NCT03703375|157675217|FG001|Treatment Period|Completed treatment|2|||
48958016|NCT03703375|157675218|FG002|Treatment Period|Completed treatment|0|||
48958017|NCT03703375|157675219|FG003|Treatment Period|Completed treatment|0|||
48958018|NCT01725152|157675221|FG000|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|3|||
48958019|NCT01725152|157675222|FG001|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|0|||
48958020|NCT01725152|157675221|FG000|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|1|||
48958021|NCT01725152|157675222|FG001|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|0|||
48958022|NCT01725152|157675221|FG000|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
48958023|NCT01725152|157675222|FG001|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
48958024|NCT01725152|157675221|FG000|Treatment Period 2 (Week 8 to Week 14)|Other|0|||
48958025|NCT01725152|157675222|FG001|Treatment Period 2 (Week 8 to Week 14)|Other|2|||
48958026|NCT01795898|157675223|FG000|Overall Study|Adverse Event|27|||
48958027|NCT01795898|157675223|FG000|Overall Study|Lost to Follow-up|20|||
48958028|NCT01795898|157675223|FG000|Overall Study|Withdrawal of consent|6|||
48958029|NCT01795898|157675223|FG000|Overall Study|Diagnosed with metastasis|1|||
48958030|NCT01795898|157675223|FG000|Overall Study|No pain|1|||
48958031|NCT01795898|157675223|FG000|Overall Study|Death|1|||
48958032|NCT01795898|157675223|FG000|Overall Study|Withdrew consent & had adverse events|3|||
48958033|NCT01795898|157675223|FG000|Overall Study|Physician Decision|1|||
48958034|NCT03539458|157675224|FG000|Overall Study|Death|1|||
48958035|NCT01826422|157675225|FG000|Overall Study|Withdrawal by Subject|1|||
48958036|NCT01826422|157675226|FG001|Overall Study|Withdrawal by Subject|3|||
48958037|NCT01395368|157675230|FG000|Overall Study|Physician Decision|14|||
48958038|NCT01395368|157675230|FG000|Overall Study|Withdrawal by Subject|2|||
48958039|NCT02488551|157675240|FG000|Overall Study|Lost to Follow-up|4|||
48958040|NCT02488551|157675241|FG001|Overall Study|Lost to Follow-up|7|||
48958041|NCT02488551|157675242|FG002|Overall Study|Lost to Follow-up|0|||
48958042|NCT02488551|157675243|FG003|Overall Study|Lost to Follow-up|0|||
48958043|NCT02488551|157675240|FG000|Overall Study|Military Deployment|1|||
48958044|NCT02488551|157675241|FG001|Overall Study|Military Deployment|1|||
48958045|NCT02488551|157675242|FG002|Overall Study|Military Deployment|0|||
48958046|NCT02488551|157675243|FG003|Overall Study|Military Deployment|0|||
48958047|NCT00798694|157675244|FG000|Overall Study|Lost to Follow-up|1|||
48958048|NCT00798694|157675245|FG001|Overall Study|Lost to Follow-up|1|||
48958049|NCT00798694|157675244|FG000|Overall Study|Physician Decision|1|||
48958050|NCT00798694|157675245|FG001|Overall Study|Physician Decision|0|||
48958051|NCT01842308|157675250|FG000|Overall Study|Withdrawal by Subject|0|||
48958052|NCT01842308|157675251|FG001|Overall Study|Withdrawal by Subject|0|||
48958053|NCT01842308|157675252|FG002|Overall Study|Withdrawal by Subject|0|||
48958054|NCT01842308|157675253|FG003|Overall Study|Withdrawal by Subject|0|||
48958055|NCT01842308|157675254|FG004|Overall Study|Withdrawal by Subject|1|||
48958056|NCT02130427|157675259|FG000|Overall Study|Imaging results not interpretable|30|||
48958057|NCT00543569|157675266|FG000|Overall Study|Death|2|||
48958058|NCT00543569|157675267|FG001|Overall Study|Death|2|||
48958059|NCT00543569|157675268|FG002|Overall Study|Death|3|||
48958060|NCT00543569|157675269|FG003|Overall Study|Death|1|||
48958061|NCT00543569|157675266|FG000|Overall Study|Lost to Follow-up|0|||
48958062|NCT00543569|157675267|FG001|Overall Study|Lost to Follow-up|0|||
48958063|NCT00543569|157675268|FG002|Overall Study|Lost to Follow-up|1|||
48958064|NCT00543569|157675269|FG003|Overall Study|Lost to Follow-up|1|||
48958065|NCT00543569|157675266|FG000|Overall Study|Miscellaneous Reasons|7|||
48958066|NCT00543569|157675267|FG001|Overall Study|Miscellaneous Reasons|3|||
48958067|NCT00543569|157675268|FG002|Overall Study|Miscellaneous Reasons|11|||
48958068|NCT00543569|157675269|FG003|Overall Study|Miscellaneous Reasons|4|||
48958069|NCT00543569|157675266|FG000|Overall Study|Randomized but never received study drug|3|||
48958070|NCT00543569|157675267|FG001|Overall Study|Randomized but never received study drug|3|||
48958071|NCT00543569|157675268|FG002|Overall Study|Randomized but never received study drug|5|||
48958072|NCT00543569|157675269|FG003|Overall Study|Randomized but never received study drug|3|||
48958073|NCT02108600|157675270|FG000|Overall Study|Withdrawal by Subject|2|||
48958074|NCT02108600|157675271|FG001|Overall Study|Withdrawal by Subject|0|||
48958075|NCT02108600|157675270|FG000|Overall Study|Lost to Follow-up|1|||
48958076|NCT02108600|157675271|FG001|Overall Study|Lost to Follow-up|1|||
48958077|NCT01525849|157675272|FG000|Overall Study|Lost to Follow-up|3|||
48958078|NCT01525849|157675273|FG001|Overall Study|Lost to Follow-up|2|||
48958079|NCT01525849|157675272|FG000|Overall Study|Withdrawal by Subject|1|||
48958080|NCT01525849|157675273|FG001|Overall Study|Withdrawal by Subject|9|||
48958081|NCT01525849|157675272|FG000|Overall Study|Unrelated medical issue (not treated)|1|||
48958082|NCT01525849|157675273|FG001|Overall Study|Unrelated medical issue (not treated)|2|||
48958083|NCT01525849|157675272|FG000|Overall Study|Anatomic exclusion criteria identified|0|||
48958084|NCT01525849|157675273|FG001|Overall Study|Anatomic exclusion criteria identified|3|||
48958085|NCT01469013|157675277|FG000|Part A (Treatment Period)|Adverse Event|1|||
48958086|NCT01469013|157675278|FG001|Part A (Treatment Period)|Adverse Event|0|||
48958087|NCT01469013|157675279|FG002|Part A (Treatment Period)|Adverse Event|0|||
48958088|NCT01469013|157675280|FG003|Part A (Treatment Period)|Adverse Event|0|||
48958089|NCT01469013|157675281|FG004|Part A (Treatment Period)|Adverse Event|1|||
48958090|NCT01469013|157675282|FG005|Part A (Treatment Period)|Adverse Event|0|||
48958091|NCT01469013|157675283|FG006|Part A (Treatment Period)|Adverse Event|0|||
48958092|NCT01469013|157675284|FG007|Part A (Treatment Period)|Adverse Event|0|||
48958093|NCT01469013|157675285|FG008|Part A (Treatment Period)|Adverse Event|0|||
48958094|NCT01469013|157675286|FG009|Part A (Treatment Period)|Adverse Event|0|||
48958095|NCT01469013|157675287|FG010|Part A (Treatment Period)|Adverse Event|0|||
48958096|NCT01469013|157675288|FG011|Part A (Treatment Period)|Adverse Event|0|||
48958097|NCT01469013|157675289|FG012|Part A (Treatment Period)|Adverse Event|0|||
48958098|NCT01469013|157675277|FG000|Part A (Treatment Period)|Withdrawal by Subject|0|||
48958099|NCT01469013|157675278|FG001|Part A (Treatment Period)|Withdrawal by Subject|0|||
48958100|NCT01469013|157675279|FG002|Part A (Treatment Period)|Withdrawal by Subject|1|||
48958101|NCT01469013|157675280|FG003|Part A (Treatment Period)|Withdrawal by Subject|0|||
48958102|NCT01469013|157675281|FG004|Part A (Treatment Period)|Withdrawal by Subject|0|||
48958103|NCT01469013|157675282|FG005|Part A (Treatment Period)|Withdrawal by Subject|0|||
48958104|NCT01469013|157675283|FG006|Part A (Treatment Period)|Withdrawal by Subject|0|||
48958105|NCT01469013|157675284|FG007|Part A (Treatment Period)|Withdrawal by Subject|0|||
48958106|NCT01469013|157675285|FG008|Part A (Treatment Period)|Withdrawal by Subject|0|||
48958107|NCT01469013|157675286|FG009|Part A (Treatment Period)|Withdrawal by Subject|0|||
48958108|NCT01469013|157675287|FG010|Part A (Treatment Period)|Withdrawal by Subject|0|||
48958109|NCT01469013|157675288|FG011|Part A (Treatment Period)|Withdrawal by Subject|0|||
48958110|NCT01469013|157675289|FG012|Part A (Treatment Period)|Withdrawal by Subject|0|||
48958111|NCT01469013|157675277|FG000|Part B (Extension Period)|Adverse Event|0|||
48958112|NCT01469013|157675278|FG001|Part B (Extension Period)|Adverse Event|0|||
48958113|NCT01469013|157675279|FG002|Part B (Extension Period)|Adverse Event|0|||
48958114|NCT01469013|157675280|FG003|Part B (Extension Period)|Adverse Event|0|||
48958115|NCT01469013|157675281|FG004|Part B (Extension Period)|Adverse Event|0|||
48958116|NCT01469013|157675282|FG005|Part B (Extension Period)|Adverse Event|2|||
48958117|NCT01469013|157675283|FG006|Part B (Extension Period)|Adverse Event|5|||
48958118|NCT01469013|157675284|FG007|Part B (Extension Period)|Adverse Event|5|||
48958119|NCT01469013|157675285|FG008|Part B (Extension Period)|Adverse Event|3|||
48958120|NCT01469013|157675286|FG009|Part B (Extension Period)|Adverse Event|3|||
48958121|NCT01469013|157675287|FG010|Part B (Extension Period)|Adverse Event|1|||
48958122|NCT01469013|157675288|FG011|Part B (Extension Period)|Adverse Event|6|||
48958123|NCT01469013|157675289|FG012|Part B (Extension Period)|Adverse Event|3|||
48958124|NCT01469013|157675277|FG000|Part B (Extension Period)|Withdrawal by Subject|0|||
48958125|NCT01469013|157675278|FG001|Part B (Extension Period)|Withdrawal by Subject|0|||
48958126|NCT01469013|157675279|FG002|Part B (Extension Period)|Withdrawal by Subject|0|||
48958127|NCT01469013|157675280|FG003|Part B (Extension Period)|Withdrawal by Subject|0|||
48958128|NCT01469013|157675281|FG004|Part B (Extension Period)|Withdrawal by Subject|0|||
48958129|NCT01469013|157675282|FG005|Part B (Extension Period)|Withdrawal by Subject|0|||
48958130|NCT01469013|157675283|FG006|Part B (Extension Period)|Withdrawal by Subject|0|||
48958131|NCT01469013|157675284|FG007|Part B (Extension Period)|Withdrawal by Subject|0|||
48958132|NCT01469013|157675285|FG008|Part B (Extension Period)|Withdrawal by Subject|1|||
48958133|NCT01469013|157675286|FG009|Part B (Extension Period)|Withdrawal by Subject|0|||
48958134|NCT01469013|157675287|FG010|Part B (Extension Period)|Withdrawal by Subject|1|||
48958135|NCT01469013|157675288|FG011|Part B (Extension Period)|Withdrawal by Subject|0|||
48958136|NCT01469013|157675289|FG012|Part B (Extension Period)|Withdrawal by Subject|3|||
48958137|NCT02509598|157675291|FG000|Overall Study|Withdrawal by Subject|1|||
48958138|NCT00525148|157675292|FG000|Overall Study|Other Adverse Event|3|||
48958139|NCT00525148|157675293|FG001|Overall Study|Other Adverse Event|5|||
48958140|NCT00525148|157675294|FG002|Overall Study|Other Adverse Event|1|||
48958141|NCT00525148|157675295|FG003|Overall Study|Other Adverse Event|8|||
48958142|NCT00525148|157675292|FG000|Overall Study|Progressive disease|18|||
48958143|NCT00525148|157675293|FG001|Overall Study|Progressive disease|30|||
48958144|NCT00525148|157675294|FG002|Overall Study|Progressive disease|6|||
48958145|NCT00525148|157675295|FG003|Overall Study|Progressive disease|49|||
48958146|NCT00525148|157675292|FG000|Overall Study|Refused continuation of study medication|0|||
48865028|NCT01945593|157341865|FG000|Overall Study|Other: Surgical Procedure|0|||
48865029|NCT01945593|157341866|FG001|Overall Study|Other: Surgical Procedure|2|||
48865030|NCT01945593|157341867|FG002|Overall Study|Other: Surgical Procedure|0|||
48865031|NCT01945593|157341868|FG003|Overall Study|Other: Surgical Procedure|6|||
48865032|NCT01945593|157341865|FG000|Overall Study|Other: Screen Failure|0|||
48865033|NCT01945593|157341866|FG001|Overall Study|Other: Screen Failure|2|||
48865034|NCT01945593|157341867|FG002|Overall Study|Other: Screen Failure|0|||
48865035|NCT01945593|157341868|FG003|Overall Study|Other: Screen Failure|0|||
48865036|NCT00246129|157341869|FG000|Overall Study|Lost to Follow-up|1|||
48865037|NCT00246129|157341870|FG001|Overall Study|Lost to Follow-up|0|||
48865038|NCT00246129|157341869|FG000|Overall Study|Death|2|||
48865039|NCT00246129|157341870|FG001|Overall Study|Death|1|||
48865040|NCT00246129|157341869|FG000|Overall Study|suffered primary non-function|1|||
48865041|NCT00246129|157341870|FG001|Overall Study|suffered primary non-function|0|||
48865042|NCT00246129|157341869|FG000|Overall Study|grafts failed|3|||
48865043|NCT00246129|157341870|FG001|Overall Study|grafts failed|1|||
48865044|NCT01753323|157341874|FG000|Overall Study|Lack of Efficacy|0|||
48865045|NCT01753323|157341875|FG001|Overall Study|Lack of Efficacy|0|||
48865046|NCT01753323|157341876|FG002|Overall Study|Lack of Efficacy|8|||
48865047|NCT01753323|157341874|FG000|Overall Study|Protocol deviation|1|||
48865048|NCT01753323|157341875|FG001|Overall Study|Protocol deviation|0|||
48865049|NCT01753323|157341876|FG002|Overall Study|Protocol deviation|0|||
48865050|NCT01753323|157341874|FG000|Overall Study|Adverse Event|0|||
48865051|NCT01753323|157341875|FG001|Overall Study|Adverse Event|0|||
48865052|NCT01753323|157341876|FG002|Overall Study|Adverse Event|1|||
48865053|NCT00774306|157341881|FG000|Overall Study|Adverse Event|3|||
48865054|NCT00774306|157341882|FG001|Overall Study|Adverse Event|0|||
48865055|NCT00774306|157341883|FG002|Overall Study|Adverse Event|0|||
48865056|NCT00774306|157341884|FG003|Overall Study|Adverse Event|0|||
48865057|NCT00774306|157341881|FG000|Overall Study|Protocol Violation|2|||
48865058|NCT00774306|157341882|FG001|Overall Study|Protocol Violation|0|||
48865059|NCT00774306|157341883|FG002|Overall Study|Protocol Violation|3|||
48865060|NCT00774306|157341884|FG003|Overall Study|Protocol Violation|0|||
48865061|NCT00774306|157341881|FG000|Overall Study|Withdrawal by Subject|6|||
48865062|NCT00774306|157341882|FG001|Overall Study|Withdrawal by Subject|1|||
48865063|NCT00774306|157341883|FG002|Overall Study|Withdrawal by Subject|1|||
48865064|NCT00774306|157341884|FG003|Overall Study|Withdrawal by Subject|0|||
48865065|NCT00774306|157341881|FG000|Overall Study|Lost to Follow-up|6|||
48865066|NCT00774306|157341882|FG001|Overall Study|Lost to Follow-up|0|||
48865067|NCT00774306|157341883|FG002|Overall Study|Lost to Follow-up|4|||
48865068|NCT00774306|157341884|FG003|Overall Study|Lost to Follow-up|5|||
48865069|NCT00774306|157341881|FG000|Overall Study|Death|1|||
48865070|NCT00774306|157341882|FG001|Overall Study|Death|1|||
48865071|NCT00774306|157341883|FG002|Overall Study|Death|0|||
48865072|NCT00774306|157341884|FG003|Overall Study|Death|0|||
48865073|NCT01870999|157341891|FG000|Overall Study|Adverse Event|0|||
48865074|NCT01870999|157341892|FG001|Overall Study|Adverse Event|4|||
48865075|NCT01870999|157341893|FG002|Overall Study|Adverse Event|1|||
48865076|NCT01870999|157341891|FG000|Overall Study|Subject met withdrawal criteria|3|||
48865077|NCT01870999|157341892|FG001|Overall Study|Subject met withdrawal criteria|2|||
48752855|NCT03266094|156940191|FG000|Overall Study|Lost to Follow-up|1|||
48752856|NCT03266094|156940191|FG000|Overall Study|Withdrawal by Subject|1|||
48752857|NCT04128267|156940198|FG000|Overall Study|Withdrawal by Subject|6|||
48752858|NCT04128267|156940198|FG000|Overall Study|Death|2|||
48752859|NCT04128267|156940198|FG000|Overall Study|Disease progression|1|||
48752860|NCT04128267|156940198|FG000|Overall Study|Participant had other medical issues|4|||
48752861|NCT04128267|156940198|FG000|Overall Study|Participant failed to respond to multiple attempts to contact|2|||
48752862|NCT00750204|156940199|FG000|Overall Study|study halted prematurely|1|||
48752863|NCT00750204|156940200|FG001|Overall Study|study halted prematurely|1|||
48752864|NCT01386554|156940209|FG000|Overall Study|Lost to Follow-up|0|||
48752865|NCT01386554|156940210|FG001|Overall Study|Lost to Follow-up|0|||
48752866|NCT01386554|156940211|FG002|Overall Study|Lost to Follow-up|1|||
48752867|NCT01386554|156940209|FG000|Overall Study|Adverse Event|2|||
48865078|NCT01870999|157341893|FG002|Overall Study|Subject met withdrawal criteria|0|||
48865079|NCT01870999|157341891|FG000|Overall Study|Subject withdrawn by Investigator|1|||
48865080|NCT01870999|157341892|FG001|Overall Study|Subject withdrawn by Investigator|0|||
48865081|NCT01870999|157341893|FG002|Overall Study|Subject withdrawn by Investigator|0|||
48865082|NCT01870999|157341891|FG000|Overall Study|Withdrawal by Subject|0|||
48865083|NCT01870999|157341892|FG001|Overall Study|Withdrawal by Subject|2|||
48865084|NCT01870999|157341893|FG002|Overall Study|Withdrawal by Subject|5|||
48865085|NCT01870999|157341891|FG000|Overall Study|Protocol Violation|0|||
48865086|NCT01870999|157341892|FG001|Overall Study|Protocol Violation|0|||
48865087|NCT01870999|157341893|FG002|Overall Study|Protocol Violation|1|||
48865088|NCT01012999|157341894|FG000|Overall Study|Protocol Violation|1|||
48865089|NCT01136733|157341895|FG000|Phase 1b|Adverse Event|0|||
48865090|NCT01136733|157341896|FG001|Phase 1b|Adverse Event|3|||
48865091|NCT01136733|157341897|FG002|Phase 1b|Adverse Event|1|||
48865092|NCT01136733|157341898|FG003|Phase 1b|Adverse Event|0|||
48865093|NCT01136733|157341899|FG004|Phase 1b|Adverse Event|0|||
48865094|NCT01136733|157341900|FG005|Phase 1b|Adverse Event|0|||
48865095|NCT01136733|157341901|FG006|Phase 1b|Adverse Event|0|||
48865096|NCT01136733|157341895|FG000|Phase 1b|Participant Choice|0|||
48865097|NCT01136733|157341896|FG001|Phase 1b|Participant Choice|0|||
48865098|NCT01136733|157341897|FG002|Phase 1b|Participant Choice|1|||
48865099|NCT01136733|157341898|FG003|Phase 1b|Participant Choice|0|||
48865100|NCT01136733|157341899|FG004|Phase 1b|Participant Choice|0|||
48865101|NCT01136733|157341900|FG005|Phase 1b|Participant Choice|0|||
48865102|NCT01136733|157341901|FG006|Phase 1b|Participant Choice|0|||
48865103|NCT01136733|157341895|FG000|Phase 1b|Administrative-Withdrew Consent|0|||
48865104|NCT01136733|157341896|FG001|Phase 1b|Administrative-Withdrew Consent|1|||
48865105|NCT01136733|157341897|FG002|Phase 1b|Administrative-Withdrew Consent|0|||
48865106|NCT01136733|157341898|FG003|Phase 1b|Administrative-Withdrew Consent|0|||
48865107|NCT01136733|157341899|FG004|Phase 1b|Administrative-Withdrew Consent|0|||
48865108|NCT01136733|157341900|FG005|Phase 1b|Administrative-Withdrew Consent|0|||
48865109|NCT01136733|157341901|FG006|Phase 1b|Administrative-Withdrew Consent|0|||
48865110|NCT01136733|157341895|FG000|Phase 1b|Clinical Progression|1|||
48865111|NCT01136733|157341896|FG001|Phase 1b|Clinical Progression|1|||
48865112|NCT01136733|157341897|FG002|Phase 1b|Clinical Progression|0|||
48865113|NCT01136733|157341898|FG003|Phase 1b|Clinical Progression|0|||
48865114|NCT01136733|157341899|FG004|Phase 1b|Clinical Progression|0|||
48865115|NCT01136733|157341900|FG005|Phase 1b|Clinical Progression|0|||
48865116|NCT01136733|157341901|FG006|Phase 1b|Clinical Progression|0|||
48865117|NCT01136733|157341895|FG000|Phase 2|Disease Progression|0|||
48865118|NCT01136733|157341896|FG001|Phase 2|Disease Progression|0|||
48865119|NCT01136733|157341897|FG002|Phase 2|Disease Progression|0|||
48865120|NCT01136733|157341898|FG003|Phase 2|Disease Progression|0|||
48865121|NCT01136733|157341899|FG004|Phase 2|Disease Progression|30|||
48865122|NCT01136733|157341900|FG005|Phase 2|Disease Progression|32|||
48865123|NCT01136733|157341901|FG006|Phase 2|Disease Progression|38|||
48865124|NCT01136733|157341895|FG000|Phase 2|Adverse Event|0|||
48865125|NCT01136733|157341896|FG001|Phase 2|Adverse Event|0|||
48865126|NCT01136733|157341897|FG002|Phase 2|Adverse Event|0|||
48865127|NCT01136733|157341898|FG003|Phase 2|Adverse Event|0|||
48865128|NCT01136733|157341899|FG004|Phase 2|Adverse Event|11|||
48865129|NCT01136733|157341900|FG005|Phase 2|Adverse Event|13|||
48865130|NCT01136733|157341901|FG006|Phase 2|Adverse Event|5|||
48865131|NCT01136733|157341895|FG000|Phase 2|Participant Choice|0|||
48865132|NCT01136733|157341896|FG001|Phase 2|Participant Choice|0|||
48865133|NCT01136733|157341897|FG002|Phase 2|Participant Choice|0|||
48865134|NCT01136733|157341898|FG003|Phase 2|Participant Choice|0|||
48958147|NCT00525148|157675293|FG001|Overall Study|Refused continuation of study medication|2|||
48958148|NCT00525148|157675294|FG002|Overall Study|Refused continuation of study medication|0|||
48958149|NCT00525148|157675295|FG003|Overall Study|Refused continuation of study medication|1|||
48958150|NCT00525148|157675292|FG000|Overall Study|Other than stated|2|||
48958151|NCT00525148|157675293|FG001|Overall Study|Other than stated|1|||
48958152|NCT00525148|157675294|FG002|Overall Study|Other than stated|0|||
48958153|NCT00525148|157675295|FG003|Overall Study|Other than stated|3|||
48958154|NCT00789477|157675305|FG000|Overall Study|Withdrawal by Subject|2|||
48958155|NCT00789477|157675306|FG001|Overall Study|Withdrawal by Subject|1|||
48958156|NCT00789477|157675307|FG002|Overall Study|Withdrawal by Subject|3|||
48958157|NCT00789477|157675308|FG003|Overall Study|Withdrawal by Subject|2|||
48958158|NCT00789477|157675309|FG004|Overall Study|Withdrawal by Subject|3|||
48958159|NCT00789477|157675305|FG000|Overall Study|Protocol Violation|1|||
48958160|NCT00789477|157675306|FG001|Overall Study|Protocol Violation|0|||
48958161|NCT00789477|157675307|FG002|Overall Study|Protocol Violation|0|||
48958162|NCT00789477|157675308|FG003|Overall Study|Protocol Violation|1|||
48865135|NCT01136733|157341899|FG004|Phase 2|Participant Choice|3|||
48865136|NCT01136733|157341900|FG005|Phase 2|Participant Choice|0|||
48865137|NCT01136733|157341901|FG006|Phase 2|Participant Choice|1|||
48865138|NCT01136733|157341895|FG000|Phase 2|Administrative-Withdrew Consent|0|||
48865139|NCT01136733|157341896|FG001|Phase 2|Administrative-Withdrew Consent|0|||
48865140|NCT01136733|157341897|FG002|Phase 2|Administrative-Withdrew Consent|0|||
48865141|NCT01136733|157341898|FG003|Phase 2|Administrative-Withdrew Consent|0|||
48865142|NCT01136733|157341899|FG004|Phase 2|Administrative-Withdrew Consent|1|||
48865143|NCT01136733|157341900|FG005|Phase 2|Administrative-Withdrew Consent|0|||
48865144|NCT01136733|157341901|FG006|Phase 2|Administrative-Withdrew Consent|0|||
48865145|NCT01136733|157341895|FG000|Phase 2|Other|0|||
48865146|NCT01136733|157341896|FG001|Phase 2|Other|0|||
48865147|NCT01136733|157341897|FG002|Phase 2|Other|0|||
48865148|NCT01136733|157341898|FG003|Phase 2|Other|0|||
48865149|NCT01136733|157341899|FG004|Phase 2|Other|6|||
48865150|NCT01136733|157341900|FG005|Phase 2|Other|7|||
48865151|NCT01136733|157341901|FG006|Phase 2|Other|6|||
48865152|NCT03441789|157341902|FG000|Overall Study|Withdrawal by Subject|1|||
48865153|NCT03441789|157341903|FG001|Overall Study|Withdrawal by Subject|1|||
48865154|NCT03441789|157341902|FG000|Overall Study|Adverse Event|0|||
48865155|NCT03441789|157341903|FG001|Overall Study|Adverse Event|1|||
48865156|NCT03441789|157341902|FG000|Overall Study|Protocol Violation|0|||
48865157|NCT03441789|157341903|FG001|Overall Study|Protocol Violation|1|||
48865158|NCT03441789|157341902|FG000|Overall Study|Lost to Follow-up|0|||
48865159|NCT03441789|157341903|FG001|Overall Study|Lost to Follow-up|1|||
48865160|NCT01113541|157341904|FG000|Overall Study|Withdrawal by Subject|1|||
48865161|NCT01113541|157341904|FG000|Overall Study|Protocol Violation|1|||
48865162|NCT01113541|157341904|FG000|Overall Study|Study Terminated by Sponsor|7|||
48865163|NCT01113541|157341904|FG000|Overall Study|Adverse Event|4|||
48865164|NCT03029234|157341905|FG000|Overall Study|Sponsor Decision|1|||
48865165|NCT03029234|157341905|FG000|Overall Study|Withdrawal by Subject|5|||
48958163|NCT00789477|157675309|FG004|Overall Study|Protocol Violation|0|||
48958164|NCT00789477|157675305|FG000|Overall Study|Adverse Event|3|||
48958165|NCT00789477|157675306|FG001|Overall Study|Adverse Event|3|||
48958166|NCT00789477|157675307|FG002|Overall Study|Adverse Event|1|||
48958167|NCT00789477|157675308|FG003|Overall Study|Adverse Event|0|||
48958168|NCT00789477|157675309|FG004|Overall Study|Adverse Event|0|||
48958169|NCT00789477|157675305|FG000|Overall Study|Death|1|||
48958170|NCT00789477|157675306|FG001|Overall Study|Death|1|||
48958171|NCT00789477|157675307|FG002|Overall Study|Death|2|||
48958172|NCT00789477|157675308|FG003|Overall Study|Death|2|||
48958173|NCT00789477|157675309|FG004|Overall Study|Death|0|||
48958174|NCT00789477|157675305|FG000|Overall Study|Lost to Follow-up|0|||
48958175|NCT00789477|157675306|FG001|Overall Study|Lost to Follow-up|1|||
48958176|NCT00789477|157675307|FG002|Overall Study|Lost to Follow-up|4|||
48958177|NCT00789477|157675308|FG003|Overall Study|Lost to Follow-up|2|||
48958178|NCT00789477|157675309|FG004|Overall Study|Lost to Follow-up|4|||
48958179|NCT00789477|157675305|FG000|Overall Study|Lack of Efficacy|2|||
48958180|NCT00789477|157675306|FG001|Overall Study|Lack of Efficacy|0|||
48958181|NCT00789477|157675307|FG002|Overall Study|Lack of Efficacy|0|||
48958182|NCT00789477|157675308|FG003|Overall Study|Lack of Efficacy|0|||
48752868|NCT01386554|156940210|FG001|Overall Study|Adverse Event|5|||
48752869|NCT01386554|156940211|FG002|Overall Study|Adverse Event|2|||
48958183|NCT00789477|157675309|FG004|Overall Study|Lack of Efficacy|0|||
48958184|NCT00789477|157675305|FG000|Overall Study|Other|2|||
48958185|NCT00789477|157675306|FG001|Overall Study|Other|0|||
48958186|NCT00789477|157675307|FG002|Overall Study|Other|1|||
48958187|NCT00789477|157675308|FG003|Overall Study|Other|3|||
48752870|NCT01386554|156940209|FG000|Overall Study|Progressive disease|1|||
48752871|NCT01386554|156940210|FG001|Overall Study|Progressive disease|2|||
48752872|NCT01386554|156940211|FG002|Overall Study|Progressive disease|2|||
48752873|NCT01386554|156940209|FG000|Overall Study|Administration of live vaccines|0|||
48752874|NCT01386554|156940210|FG001|Overall Study|Administration of live vaccines|1|||
48752875|NCT01386554|156940211|FG002|Overall Study|Administration of live vaccines|0|||
48752876|NCT01386554|156940209|FG000|Overall Study|Investigator discretion|0|||
48752877|NCT01386554|156940210|FG001|Overall Study|Investigator discretion|0|||
48865166|NCT03029234|157341905|FG000|Overall Study|Death|91|||
48752878|NCT01386554|156940211|FG002|Overall Study|Investigator discretion|1|||
48752879|NCT01386554|156940209|FG000|Overall Study|Reason not collected|0|||
48752880|NCT01386554|156940210|FG001|Overall Study|Reason not collected|1|||
48752881|NCT01386554|156940211|FG002|Overall Study|Reason not collected|0|||
48865167|NCT03029234|157341905|FG000|Overall Study|Lost to Follow-up|2|||
48865168|NCT01745380|157341906|FG000|Overall Study|Lost to Follow-up|1|||
48865169|NCT01745380|157341907|FG001|Overall Study|Lost to Follow-up|0|||
48865170|NCT01745380|157341906|FG000|Overall Study|Lack of Efficacy|0|||
48865171|NCT01745380|157341907|FG001|Overall Study|Lack of Efficacy|1|||
48958188|NCT00789477|157675309|FG004|Overall Study|Other|0|||
48958189|NCT01952834|157675310|FG000|Overall Study|Adverse Event|1|||
48958190|NCT02399813|157675315|FG000|Overall Study|Progressive Disease-Radiographic|2|||
48958191|NCT02399813|157675315|FG000|Overall Study|Death|20|||
48958192|NCT02399813|157675315|FG000|Overall Study|Withdrawal by Subject|3|||
48958193|NCT02399813|157675315|FG000|Overall Study|Initiating a Non-Study Cancer Treatment|4|||
48958194|NCT02399813|157675315|FG000|Overall Study|Lost to Follow-up|2|||
48958195|NCT02399813|157675315|FG000|Overall Study|Other than specified|5|||
48958196|NCT00303108|157675316|FG000|Overall Study|Adverse Event|5|||
48958197|NCT00303108|157675317|FG001|Overall Study|Adverse Event|6|||
48958198|NCT00303108|157675318|FG002|Overall Study|Adverse Event|7|||
48958199|NCT00303108|157675316|FG000|Overall Study|Patient Request|4|||
48958200|NCT00303108|157675317|FG001|Overall Study|Patient Request|2|||
48958201|NCT00303108|157675318|FG002|Overall Study|Patient Request|8|||
48958202|NCT00303108|157675316|FG000|Overall Study|Failed Entry|1|||
48958203|NCT00303108|157675317|FG001|Overall Study|Failed Entry|0|||
48958204|NCT00303108|157675318|FG002|Overall Study|Failed Entry|1|||
48958205|NCT00303108|157675316|FG000|Overall Study|ineligible|2|||
48958206|NCT00303108|157675317|FG001|Overall Study|ineligible|1|||
48958207|NCT00303108|157675318|FG002|Overall Study|ineligible|0|||
48958208|NCT03201198|157675319|FG000|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|35|||
48958209|NCT03201198|157675320|FG001|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|37|||
48958210|NCT03201198|157675319|FG000|Overall Study|Withdrawal by Subject|2|||
48958211|NCT03201198|157675320|FG001|Overall Study|Withdrawal by Subject|3|||
48958212|NCT02149836|157675321|FG000|Overall Study|Withdrawal by Subject|1|||
48958213|NCT01029002|157675326|FG000|Overall Study|Lost to Follow-up|2|||
48958214|NCT01029002|157675327|FG001|Overall Study|Lost to Follow-up|4|||
48958215|NCT01208038|157675328|FG000|Overall Study|Withdrawal by Subject|1|||
48958216|NCT02683525|157675334|FG000|Overall Study|Lost to Follow-up|1|||
48958217|NCT02683525|157675334|FG000|Overall Study|Physician Decision|1|||
48958218|NCT02683525|157675334|FG000|Overall Study|Disease Progression|6|||
48958219|NCT02164513|157675341|FG000|Overall Study|Adverse Event|162|||
48958220|NCT02164513|157675342|FG001|Overall Study|Adverse Event|180|||
48958221|NCT02164513|157675343|FG002|Overall Study|Adverse Event|111|||
48958222|NCT02164513|157675341|FG000|Overall Study|Other: Study Closed or terminated|5|||
48958223|NCT02164513|157675342|FG001|Overall Study|Other: Study Closed or terminated|2|||
48958224|NCT02164513|157675343|FG002|Overall Study|Other: Study Closed or terminated|4|||
48958225|NCT02164513|157675341|FG000|Overall Study|Lost to Follow-up|30|||
48958226|NCT02164513|157675342|FG001|Overall Study|Lost to Follow-up|36|||
48958227|NCT02164513|157675343|FG002|Overall Study|Lost to Follow-up|22|||
48958228|NCT02164513|157675341|FG000|Overall Study|Physician Decision|47|||
48958229|NCT02164513|157675342|FG001|Overall Study|Physician Decision|57|||
48752882|NCT00733408|156942025|FG000|Overall Study|Adverse Event|4|||
48752883|NCT01134783|156942026|FG000|Overall Study|Pregnancy|16|||
48752884|NCT01134783|156942027|FG001|Overall Study|Pregnancy|8|||
48752885|NCT01134783|156942026|FG000|Overall Study|Withdrawal by Subject|15|||
48752886|NCT01134783|156942027|FG001|Overall Study|Withdrawal by Subject|9|||
48752887|NCT01134783|156942026|FG000|Overall Study|Lost to Follow-up|5|||
48752888|NCT01134783|156942027|FG001|Overall Study|Lost to Follow-up|20|||
48752889|NCT01581931|156942029|FG000|Washout|Adverse Event|0|||
48752890|NCT01581931|156942030|FG001|Washout|Adverse Event|1|||
48752891|NCT03291808|156942033|FG000|Overall Study|Lost to Follow-up|6|||
48752892|NCT03291808|156942033|FG000|Overall Study|Research burden|4|||
48752893|NCT00638378|156942034|FG000|Overall Study|Death|2|||
48752894|NCT00638378|156942034|FG000|Overall Study|Adverse Event|1|||
48752895|NCT00638378|156942034|FG000|Overall Study|Disease progression|15|||
48752896|NCT00638378|156942034|FG000|Overall Study|Physician Decision|4|||
48752897|NCT01852110|156942037|FG000|Overall Study|Adverse Event|12|||
48752898|NCT01852110|156942038|FG001|Overall Study|Adverse Event|5|||
48752899|NCT01852110|156942039|FG002|Overall Study|Adverse Event|0|||
48752900|NCT01852110|156942040|FG003|Overall Study|Adverse Event|0|||
48752901|NCT01852110|156942041|FG004|Overall Study|Adverse Event|0|||
48958230|NCT02164513|157675343|FG002|Overall Study|Physician Decision|28|||
48958231|NCT02164513|157675341|FG000|Overall Study|Withdrawal by Subject|192|||
48958232|NCT02164513|157675342|FG001|Overall Study|Withdrawal by Subject|261|||
48958233|NCT02164513|157675343|FG002|Overall Study|Withdrawal by Subject|130|||
48958234|NCT02164513|157675341|FG000|Overall Study|Other: Reason not provided by site|1|||
48958235|NCT02164513|157675342|FG001|Overall Study|Other: Reason not provided by site|0|||
48958236|NCT02164513|157675343|FG002|Overall Study|Other: Reason not provided by site|0|||
48958237|NCT01005732|157675344|FG000|Overall Study|Lost to Follow-up|10|||
48958238|NCT01005732|157675344|FG000|Overall Study|Death|1|||
48958239|NCT02635737|157675345|FG000|Overall Study|Protocol Violation|1|||
48958240|NCT03215706|157675346|FG000|Randomization|Adverse Event unrelated to study drug|1|||
48958241|NCT03215706|157675347|FG001|Randomization|Adverse Event unrelated to study drug|0|||
48752902|NCT01852110|156942042|FG005|Overall Study|Adverse Event|0|||
48752903|NCT01852110|156942037|FG000|Overall Study|Lost to Follow-up|1|||
48958242|NCT03215706|157675346|FG000|Randomization|participant withdrew consent|1|||
48958243|NCT03215706|157675347|FG001|Randomization|participant withdrew consent|3|||
48958244|NCT03215706|157675346|FG000|Randomization|no longer meets study criteria|1|||
48958245|NCT03215706|157675347|FG001|Randomization|no longer meets study criteria|4|||
48958246|NCT03215706|157675346|FG000|Randomization|other reasons|0|||
48752904|NCT01852110|156942038|FG001|Overall Study|Lost to Follow-up|3|||
48752905|NCT01852110|156942039|FG002|Overall Study|Lost to Follow-up|0|||
48752906|NCT01852110|156942040|FG003|Overall Study|Lost to Follow-up|0|||
48752907|NCT01852110|156942041|FG004|Overall Study|Lost to Follow-up|0|||
48752908|NCT01852110|156942042|FG005|Overall Study|Lost to Follow-up|0|||
48958247|NCT03215706|157675347|FG001|Randomization|other reasons|2|||
48958248|NCT03215706|157675346|FG000|Treatment Period|Disease Progression|150|||
48958249|NCT03215706|157675347|FG001|Treatment Period|Disease Progression|142|||
48752909|NCT01852110|156942037|FG000|Overall Study|Non-compliance with Study Drug|2|||
48752910|NCT01852110|156942038|FG001|Overall Study|Non-compliance with Study Drug|1|||
48958250|NCT03215706|157675346|FG000|Treatment Period|Study Drug Toxicity|53|||
48752911|NCT01852110|156942039|FG002|Overall Study|Non-compliance with Study Drug|0|||
48958251|NCT03215706|157675347|FG001|Treatment Period|Study Drug Toxicity|21|||
48958252|NCT03215706|157675346|FG000|Treatment Period|Death|2|||
48958253|NCT03215706|157675347|FG001|Treatment Period|Death|1|||
48958254|NCT03215706|157675346|FG000|Treatment Period|Adverse event unrelated to study drug|24|||
48958255|NCT03215706|157675347|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
48958256|NCT03215706|157675346|FG000|Treatment Period|Request to D/C treatment|1|||
48958257|NCT03215706|157675347|FG001|Treatment Period|Request to D/C treatment|6|||
48958258|NCT03215706|157675346|FG000|Treatment Period|Participant withdrew consent|3|||
48958259|NCT03215706|157675347|FG001|Treatment Period|Participant withdrew consent|4|||
48958260|NCT03215706|157675346|FG000|Treatment Period|Lost to Follow-up|0|||
48958261|NCT03215706|157675347|FG001|Treatment Period|Lost to Follow-up|1|||
48958262|NCT03215706|157675346|FG000|Treatment Period|Other Reasons|4|||
48958263|NCT03215706|157675347|FG001|Treatment Period|Other Reasons|5|||
48958264|NCT03215706|157675346|FG000|Treatment Period|Ongoing in the treatment period|105|||
48958265|NCT03215706|157675347|FG001|Treatment Period|Ongoing in the treatment period|43|||
48958266|NCT05349838|157675348|FG000|Overall Study|Virological Failure|1|||
48958267|NCT05349838|157675349|FG001|Overall Study|Virological Failure|2|||
48958268|NCT05349838|157675348|FG000|Overall Study|Withdrawal by Subject|2|||
48958269|NCT05349838|157675349|FG001|Overall Study|Withdrawal by Subject|3|||
48958270|NCT05349838|157675348|FG000|Overall Study|Adverse Event|3|||
48958271|NCT05349838|157675349|FG001|Overall Study|Adverse Event|1|||
48958272|NCT05349838|157675348|FG000|Overall Study|Lost to Follow-up|1|||
48958273|NCT05349838|157675349|FG001|Overall Study|Lost to Follow-up|2|||
48958274|NCT05349838|157675348|FG000|Overall Study|Other reasons|5|||
48958275|NCT05349838|157675349|FG001|Overall Study|Other reasons|1|||
48958276|NCT00701727|157676514|FG000|First Treatment Period|Adverse Event|0|||
48958277|NCT00701727|157676515|FG001|First Treatment Period|Adverse Event|0|||
48958278|NCT00701727|157676514|FG000|First Treatment Period|Withdrawal by Subject|1|||
48958279|NCT00701727|157676515|FG001|First Treatment Period|Withdrawal by Subject|0|||
48958280|NCT00701727|157676514|FG000|First Treatment Period|sponsor decision|0|||
48958281|NCT00701727|157676515|FG001|First Treatment Period|sponsor decision|1|||
48958282|NCT00701727|157676514|FG000|First Treatment Period|Lost to Follow-up|0|||
48958283|NCT00701727|157676515|FG001|First Treatment Period|Lost to Follow-up|1|||
48958284|NCT00701727|157676514|FG000|Second Treatment Period|Withdrawal by Subject|2|||
48958285|NCT00701727|157676515|FG001|Second Treatment Period|Withdrawal by Subject|0|||
48958286|NCT00059215|157676516|FG000|Overall Study|Adverse Event|5|||
48958287|NCT00059215|157676517|FG001|Overall Study|Adverse Event|5|||
48958288|NCT00059215|157676518|FG002|Overall Study|Adverse Event|9|||
48958289|NCT00059215|157676519|FG003|Overall Study|Adverse Event|9|||
48958290|NCT00059215|157676516|FG000|Overall Study|Death|0|||
48958291|NCT00059215|157676517|FG001|Overall Study|Death|0|||
48958292|NCT00059215|157676518|FG002|Overall Study|Death|3|||
48958293|NCT00059215|157676519|FG003|Overall Study|Death|0|||
48958294|NCT00059215|157676516|FG000|Overall Study|Lost to Follow-up|1|||
48958295|NCT00059215|157676517|FG001|Overall Study|Lost to Follow-up|2|||
48958296|NCT00059215|157676518|FG002|Overall Study|Lost to Follow-up|0|||
48958297|NCT00059215|157676519|FG003|Overall Study|Lost to Follow-up|0|||
48752912|NCT01852110|156942040|FG003|Overall Study|Non-compliance with Study Drug|0|||
48752913|NCT01852110|156942041|FG004|Overall Study|Non-compliance with Study Drug|0|||
48752914|NCT01852110|156942042|FG005|Overall Study|Non-compliance with Study Drug|0|||
48752915|NCT01852110|156942037|FG000|Overall Study|Physician Decision|1|||
48752916|NCT01852110|156942038|FG001|Overall Study|Physician Decision|0|||
48752917|NCT01852110|156942039|FG002|Overall Study|Physician Decision|0|||
48752918|NCT01852110|156942040|FG003|Overall Study|Physician Decision|0|||
48752919|NCT01852110|156942041|FG004|Overall Study|Physician Decision|0|||
48752920|NCT01852110|156942042|FG005|Overall Study|Physician Decision|0|||
48752921|NCT01852110|156942037|FG000|Overall Study|Protocol Violation|0|||
48958298|NCT00059215|157676516|FG000|Overall Study|Withdrawal by Subject|4|||
48958299|NCT00059215|157676517|FG001|Overall Study|Withdrawal by Subject|4|||
48958300|NCT00059215|157676518|FG002|Overall Study|Withdrawal by Subject|1|||
48958301|NCT00059215|157676519|FG003|Overall Study|Withdrawal by Subject|3|||
48958302|NCT00059215|157676516|FG000|Overall Study|Protocol Violation|1|||
48958303|NCT00059215|157676517|FG001|Overall Study|Protocol Violation|0|||
48958304|NCT00059215|157676518|FG002|Overall Study|Protocol Violation|1|||
48752922|NCT01852110|156942038|FG001|Overall Study|Protocol Violation|1|||
48752923|NCT01852110|156942039|FG002|Overall Study|Protocol Violation|0|||
48958305|NCT00059215|157676519|FG003|Overall Study|Protocol Violation|0|||
48958306|NCT00059215|157676516|FG000|Overall Study|Protocol entry criteria not met|1|||
48958307|NCT00059215|157676517|FG001|Overall Study|Protocol entry criteria not met|1|||
48958308|NCT00059215|157676518|FG002|Overall Study|Protocol entry criteria not met|0|||
48958309|NCT00059215|157676519|FG003|Overall Study|Protocol entry criteria not met|2|||
48958310|NCT00059215|157676516|FG000|Overall Study|Physician Decision|1|||
48958311|NCT00059215|157676517|FG001|Overall Study|Physician Decision|2|||
48958312|NCT00059215|157676518|FG002|Overall Study|Physician Decision|1|||
48958313|NCT00059215|157676519|FG003|Overall Study|Physician Decision|1|||
48958314|NCT00502307|157676520|FG000|Open Label Period (16 Weeks)|Progressive disease|50|||
48958315|NCT00502307|157676521|FG001|Open Label Period (16 Weeks)|Progressive disease|0|||
48958316|NCT00502307|157676522|FG002|Open Label Period (16 Weeks)|Progressive disease|0|||
48958317|NCT00502307|157676520|FG000|Open Label Period (16 Weeks)|Discontinued due to other reasons|26|||
48958318|NCT00502307|157676521|FG001|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
48958319|NCT00502307|157676522|FG002|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
48958320|NCT00502307|157676520|FG000|Double-Blind Period (12 Weeks)|Progressive disease|0|||
48958321|NCT00502307|157676521|FG001|Double-Blind Period (12 Weeks)|Progressive disease|23|||
48958322|NCT00502307|157676522|FG002|Double-Blind Period (12 Weeks)|Progressive disease|2|||
48958323|NCT00502307|157676520|FG000|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0|||
48958324|NCT00502307|157676521|FG001|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3|||
48958325|NCT00502307|157676522|FG002|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7|||
48958326|NCT00502307|157676520|FG000|Maintenance Period|Progressive disease|80|||
48958327|NCT00502307|157676521|FG001|Maintenance Period|Progressive disease|0|||
48958328|NCT00502307|157676522|FG002|Maintenance Period|Progressive disease|0|||
48958329|NCT00502307|157676520|FG000|Maintenance Period|Discontinued due to other reasons|68|||
48958330|NCT00502307|157676521|FG001|Maintenance Period|Discontinued due to other reasons|0|||
48958331|NCT00502307|157676522|FG002|Maintenance Period|Discontinued due to other reasons|0|||
48958332|NCT02678741|157676527|FG000|Overall Study|Death|4|||
48958333|NCT02678741|157676527|FG000|Overall Study|Withdrawal by Subject|1|||
48958334|NCT02678741|157676527|FG000|Overall Study|ineligible|3|||
48958335|NCT02678741|157676527|FG000|Overall Study|Not RECIST Measurable|2|||
48958336|NCT02678741|157676527|FG000|Overall Study|Lack of Efficacy|10|||
48958337|NCT01111539|157676528|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|6|||
48958338|NCT01111539|157676529|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
48958339|NCT01111539|157676530|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
48958340|NCT01111539|157676531|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
48958341|NCT01111539|157676532|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
48958342|NCT01111539|157676528|FG000|Phase B (Day 1 to Week 8)|Adverse Event|5|||
48958343|NCT01111539|157676529|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
48958344|NCT01111539|157676530|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
48958345|NCT01111539|157676531|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
48752924|NCT01852110|156942040|FG003|Overall Study|Protocol Violation|0|||
48752925|NCT01852110|156942041|FG004|Overall Study|Protocol Violation|0|||
48752926|NCT01852110|156942042|FG005|Overall Study|Protocol Violation|0|||
48752927|NCT01852110|156942037|FG000|Overall Study|Study Terminated by Sponsor|30|||
48752928|NCT01852110|156942038|FG001|Overall Study|Study Terminated by Sponsor|32|||
48752929|NCT01852110|156942039|FG002|Overall Study|Study Terminated by Sponsor|0|||
48752930|NCT01852110|156942040|FG003|Overall Study|Study Terminated by Sponsor|0|||
48752931|NCT01852110|156942041|FG004|Overall Study|Study Terminated by Sponsor|0|||
48958346|NCT01111539|157676532|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
48958347|NCT01111539|157676528|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60|||
48958348|NCT01111539|157676529|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
48958349|NCT01111539|157676530|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
48958350|NCT01111539|157676531|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
48958351|NCT01111539|157676532|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
48958352|NCT01111539|157676528|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1|||
48958353|NCT01111539|157676529|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
48958354|NCT01111539|157676530|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
48958355|NCT01111539|157676531|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
48752932|NCT01852110|156942042|FG005|Overall Study|Study Terminated by Sponsor|0|||
48752933|NCT01852110|156942037|FG000|Overall Study|Withdrawal by Subject|4|||
48752934|NCT01852110|156942038|FG001|Overall Study|Withdrawal by Subject|4|||
48752935|NCT01852110|156942039|FG002|Overall Study|Withdrawal by Subject|0|||
48958356|NCT01111539|157676532|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
48958357|NCT01111539|157676528|FG000|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7|||
48958358|NCT01111539|157676529|FG001|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
48958359|NCT01111539|157676530|FG002|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
48958360|NCT01111539|157676531|FG003|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
48958361|NCT01111539|157676532|FG004|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
48958362|NCT01111539|157676528|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|2|||
48958363|NCT01111539|157676529|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
48958364|NCT01111539|157676530|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
48958365|NCT01111539|157676531|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
48958366|NCT01111539|157676532|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
48958367|NCT01111539|157676528|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1|||
48958368|NCT01111539|157676529|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
48958369|NCT01111539|157676530|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
48958370|NCT01111539|157676531|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
48958371|NCT01111539|157676532|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
48958372|NCT01111539|157676528|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
48958373|NCT01111539|157676529|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
48958374|NCT01111539|157676530|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
48958375|NCT01111539|157676531|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
48958376|NCT01111539|157676532|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
48865172|NCT01514864|157341912|FG000|Overall Study|Disease progression|7|||
48865173|NCT01514864|157341913|FG001|Overall Study|Disease progression|5|||
48865174|NCT01514864|157341912|FG000|Overall Study|Study drug toxicity|2|||
48865175|NCT01514864|157341913|FG001|Overall Study|Study drug toxicity|0|||
48865176|NCT01369147|157341914|FG000|Overall Study|All collected data were unintentionally destroyed|0|||
48865177|NCT01369147|157341915|FG001|Overall Study|All collected data were unintentionally destroyed|1|||
48865178|NCT01369147|157341916|FG002|Overall Study|All collected data were unintentionally destroyed|0|||
48865179|NCT01703988|157341917|FG000|Overall Study|Investigator Judgment|0|||
48865180|NCT01703988|157341918|FG001|Overall Study|Investigator Judgment|0|||
48865181|NCT01703988|157341919|FG002|Overall Study|Investigator Judgment|0|||
48752936|NCT01852110|156942040|FG003|Overall Study|Withdrawal by Subject|0|||
48752937|NCT01852110|156942041|FG004|Overall Study|Withdrawal by Subject|0|||
48958377|NCT01111539|157676528|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
48752938|NCT01852110|156942042|FG005|Overall Study|Withdrawal by Subject|0|||
48752939|NCT00793403|156942043|FG000|Overall Study|Other|73|||
48752940|NCT01338792|156942045|FG000|Overall Study|Adverse Event|2|||
48752941|NCT01338792|156942045|FG000|Overall Study|Death|1|||
48752942|NCT01338792|156942045|FG000|Overall Study|Withdrawal by Subject|1|||
48752943|NCT01652703|156942046|FG000|Overall Study|Withdrawal by Subject|0|||
48958378|NCT01111539|157676529|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
48958379|NCT01111539|157676530|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
48958380|NCT01111539|157676531|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
48958381|NCT01111539|157676532|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2|||
48958382|NCT01111539|157676528|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
48958383|NCT01111539|157676529|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
48958384|NCT01111539|157676530|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
48958385|NCT01111539|157676531|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
48958386|NCT01111539|157676532|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
48752944|NCT01652703|156942047|FG001|Overall Study|Withdrawal by Subject|1|||
48752945|NCT01652703|156942048|FG002|Overall Study|Withdrawal by Subject|3|||
48752946|NCT01652703|156942049|FG003|Overall Study|Withdrawal by Subject|1|||
48752947|NCT01652703|156942050|FG004|Overall Study|Withdrawal by Subject|0|||
48752948|NCT01652703|156942051|FG005|Overall Study|Withdrawal by Subject|1|||
48752949|NCT01652703|156942046|FG000|Overall Study|Other|0|||
48752950|NCT01652703|156942047|FG001|Overall Study|Other|0|||
48958387|NCT01111539|157676528|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
48958388|NCT01111539|157676529|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
48752951|NCT01652703|156942048|FG002|Overall Study|Other|0|||
48752952|NCT01652703|156942049|FG003|Overall Study|Other|1|||
48958389|NCT01111539|157676530|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
48958390|NCT01111539|157676531|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
49015409|NCT02739984|157892175|FG001|Overall Study|Sponsor Decision|0|||
48752953|NCT01652703|156942050|FG004|Overall Study|Other|1|||
48752954|NCT01652703|156942051|FG005|Overall Study|Other|1|||
48752955|NCT00903695|156942052|FG000|Overall Study|medical exclusion after 1st testing|1|||
48752956|NCT00903695|156942053|FG001|Overall Study|medical exclusion after 1st testing|0|||
48958391|NCT01111539|157676532|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1|||
48958392|NCT01111539|157676528|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
48958393|NCT01111539|157676529|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
48958394|NCT01111539|157676530|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
48958395|NCT01111539|157676531|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1|||
48958396|NCT01111539|157676532|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
48958397|NCT01111539|157676528|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
48958398|NCT01111539|157676529|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
48958399|NCT01111539|157676530|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
48958400|NCT01111539|157676531|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2|||
48958401|NCT01111539|157676532|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
48752957|NCT00903695|156942052|FG000|Overall Study|lung cancer|1|||
48752958|NCT00903695|156942053|FG001|Overall Study|lung cancer|0|||
48752959|NCT00381095|156942055|FG000|Overall Study|Death|3|||
48752960|NCT00381095|156942056|FG001|Overall Study|Death|4|||
48752961|NCT00381095|156942055|FG000|Overall Study|Lack of Efficacy|2|||
48958402|NCT01111539|157676528|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
48958403|NCT01111539|157676529|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
48958404|NCT01111539|157676530|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
48958405|NCT01111539|157676531|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
48958406|NCT01111539|157676532|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
48958407|NCT05674344|157676533|FG000|Overall Study|Screen Fail|21|||
48958408|NCT05674344|157676533|FG000|Overall Study|Incomplete study procedures|3|||
48958409|NCT03072719|157676534|FG000|Overall Study|Adverse Event|1|||
48958410|NCT03072719|157676535|FG001|Overall Study|Adverse Event|1|||
48958411|NCT01863849|157676536|FG000|Overall Study|Lost to Follow-up|1|||
48958412|NCT01863849|157676537|FG001|Overall Study|Lost to Follow-up|0|||
48958413|NCT02324842|157676538|FG000|Overall Study|Lost to Follow-up|1|||
48958414|NCT02324842|157676539|FG001|Overall Study|Lost to Follow-up|1|||
48958415|NCT02324842|157676540|FG002|Overall Study|Lost to Follow-up|2|||
48958416|NCT02116660|157676542|FG000|Overall Study|Deteriorating renal function|0|||
48958417|NCT02116660|157676543|FG001|Overall Study|Deteriorating renal function|1|||
48958418|NCT02116660|157676542|FG000|Overall Study|Adverse Event|1|||
48958419|NCT02116660|157676543|FG001|Overall Study|Adverse Event|1|||
48958420|NCT02116660|157676542|FG000|Overall Study|Withdrawal by Subject|0|||
48958421|NCT02116660|157676543|FG001|Overall Study|Withdrawal by Subject|2|||
48958422|NCT02116660|157676542|FG000|Overall Study|Organization reason|1|||
48752962|NCT00381095|156942056|FG001|Overall Study|Lack of Efficacy|4|||
48752963|NCT00381095|156942055|FG000|Overall Study|Other|2|||
48752964|NCT00381095|156942056|FG001|Overall Study|Other|2|||
48752965|NCT00381095|156942055|FG000|Overall Study|Protocol Violation|1|||
48752966|NCT00381095|156942056|FG001|Overall Study|Protocol Violation|1|||
48752967|NCT00381095|156942055|FG000|Overall Study|Withdrawal by Subject|3|||
48752968|NCT00381095|156942056|FG001|Overall Study|Withdrawal by Subject|3|||
48958423|NCT02116660|157676543|FG001|Overall Study|Organization reason|0|||
48958424|NCT02433379|157676563|FG000|Overall Study|Screen Failures|55|||
48958425|NCT02433379|157676563|FG000|Overall Study|Death|57|||
48958426|NCT02433379|157676563|FG000|Overall Study|Total Withdrawals|209|||
48958427|NCT01253044|157676569|FG000|Overall Study|Lost to Follow-up|38|||
48958428|NCT01253044|157676570|FG001|Overall Study|Lost to Follow-up|29|||
48958429|NCT00793819|157676571|FG000|Overall Study|Adverse Event|8|||
48958430|NCT00793819|157676572|FG001|Overall Study|Adverse Event|4|||
48958431|NCT00793819|157676571|FG000|Overall Study|Lack of Efficacy|1|||
48958432|NCT00793819|157676572|FG001|Overall Study|Lack of Efficacy|1|||
48752969|NCT00381095|156942055|FG000|Overall Study|Adverse Event|2|||
48958433|NCT00793819|157676571|FG000|Overall Study|Withdrawal by Subject|4|||
48958434|NCT00793819|157676572|FG001|Overall Study|Withdrawal by Subject|3|||
48752970|NCT00381095|156942056|FG001|Overall Study|Adverse Event|7|||
48752971|NCT00754624|156942057|FG000|Overall Study|Adverse Event|16|||
48958435|NCT00793819|157676571|FG000|Overall Study|Lost to Follow-up|1|||
48958436|NCT00793819|157676572|FG001|Overall Study|Lost to Follow-up|1|||
48958437|NCT04056455|157676575|FG000|Overall Study|Adverse Event|1|||
48958438|NCT04056455|157676576|FG001|Overall Study|Adverse Event|0|||
48958439|NCT02196038|157676577|FG000|Overall Study|Death|16|||
48958440|NCT02196038|157676578|FG001|Overall Study|Death|21|||
48958441|NCT02196038|157676577|FG000|Overall Study|Withdrawal by Subject|0|||
48958442|NCT02196038|157676578|FG001|Overall Study|Withdrawal by Subject|1|||
48958443|NCT02196038|157676577|FG000|Overall Study|Lost to Follow-up|1|||
48958444|NCT02196038|157676578|FG001|Overall Study|Lost to Follow-up|0|||
48958445|NCT00421343|157676582|FG000|Overall Study|Death|1|||
48958446|NCT00421343|157676582|FG000|Overall Study|Withdrawal by Subject|2|||
48958447|NCT00421343|157676582|FG000|Overall Study|Lost to Follow-up|3|||
48958448|NCT01810042|157676587|FG000|Overall Study|Lost to Follow-up|10|||
48958449|NCT02512068|157676588|FG000|Overall Study|Pretreatment Event/Adverse Event|8|||
48958450|NCT02512068|157676589|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
48958451|NCT02512068|157676588|FG000|Overall Study|Major Protocol Deviation|1|||
48958452|NCT02512068|157676589|FG001|Overall Study|Major Protocol Deviation|0|||
48958453|NCT02512068|157676588|FG000|Overall Study|Voluntary Withdrawal|0|||
48958454|NCT02512068|157676589|FG001|Overall Study|Voluntary Withdrawal|1|||
48958455|NCT02512068|157676588|FG000|Overall Study|Lack of Efficacy|0|||
48958456|NCT02512068|157676589|FG001|Overall Study|Lack of Efficacy|1|||
48958457|NCT02512068|157676588|FG000|Overall Study|Reason Not Specified|3|||
48958458|NCT02512068|157676589|FG001|Overall Study|Reason Not Specified|5|||
48958459|NCT00702052|157676601|FG000|Overall Study|Adverse Event|23|||
48958460|NCT00702052|157676601|FG000|Overall Study|Disease Progression|30|||
48958461|NCT00702052|157676601|FG000|Overall Study|Withdrawal by Subject|5|||
48958462|NCT01871896|157676602|FG000|Overall Study|Lost to Follow-up|1|||
48958463|NCT01627067|157676605|FG000|Overall Study|Screen Failure|1|||
48958464|NCT00926796|157676606|FG000|Overall Study|Did not receive randomized treatment|4|||
48958465|NCT00926796|157676607|FG001|Overall Study|Did not receive randomized treatment|7|||
48958466|NCT00926796|157676606|FG000|Overall Study|Ineligible, negative for gonorrhea|57|||
48958467|NCT00926796|157676607|FG001|Overall Study|Ineligible, negative for gonorrhea|60|||
48958468|NCT00926796|157676606|FG000|Overall Study|Ineligible, but positive for gonorrhea|1|||
48958469|NCT00926796|157676607|FG001|Overall Study|Ineligible, but positive for gonorrhea|1|||
48958470|NCT00926796|157676606|FG000|Overall Study|Adverse Event|7|||
48958471|NCT00926796|157676607|FG001|Overall Study|Adverse Event|14|||
48958472|NCT00926796|157676606|FG000|Overall Study|Lost to Follow-up|22|||
48958473|NCT00926796|157676607|FG001|Overall Study|Lost to Follow-up|13|||
48958474|NCT00926796|157676606|FG000|Overall Study|Protocol Violation|15|||
48958475|NCT00926796|157676607|FG001|Overall Study|Protocol Violation|11|||
48958476|NCT00926796|157676606|FG000|Overall Study|Withdrawal by Subject|1|||
48958477|NCT00926796|157676607|FG001|Overall Study|Withdrawal by Subject|0|||
48958478|NCT00142519|157676608|FG000|Overall Study|Not Treated|7|||
48958479|NCT00142519|157676609|FG001|Overall Study|Not Treated|9|||
48958480|NCT00142519|157676608|FG000|Overall Study|Protocol Violation|1|||
48958481|NCT00142519|157676609|FG001|Overall Study|Protocol Violation|0|||
48958482|NCT00142519|157676608|FG000|Overall Study|Withdrawal by Subject|10|||
48958483|NCT00142519|157676609|FG001|Overall Study|Withdrawal by Subject|7|||
48958484|NCT01468909|157676617|FG000|Overall Study|Never Treated|2|||
48958485|NCT01468909|157676618|FG001|Overall Study|Never Treated|2|||
48958486|NCT01341652|157676622|FG000|Overall Study|Incorrect Random Assignment|0|||
48958487|NCT01341652|157676623|FG001|Overall Study|Incorrect Random Assignment|1|||
48958488|NCT01341652|157676622|FG000|Overall Study|ineligible; presence metastatic disease|0|||
48958489|NCT01341652|157676623|FG001|Overall Study|ineligible; presence metastatic disease|1|||
48958490|NCT00101192|157676630|FG000|Overall Study|Ineligible|6|||
48958491|NCT00101192|157676630|FG000|Overall Study|Inevaluable|1|||
48958492|NCT01204658|157676633|FG000|Primary Phase|Adverse Event|0|||
48958493|NCT01204658|157676634|FG001|Primary Phase|Adverse Event|0|||
48958494|NCT01204658|157676635|FG002|Primary Phase|Adverse Event|1|||
48958495|NCT01204658|157676636|FG003|Primary Phase|Adverse Event|0|||
48958496|NCT00905021|157676637|FG000|Overall Study|Adverse Event|2|||
48958497|NCT01552928|157676639|FG000|Period 3|Adverse Event|0|||
48958498|NCT01552928|157676640|FG001|Period 3|Adverse Event|0|||
48958499|NCT01552928|157676641|FG002|Period 3|Adverse Event|1|||
48958500|NCT01552928|157676642|FG003|Period 3|Adverse Event|0|||
48958501|NCT00620321|157679082|FG000|Overall Study|Adverse Event|1|||
48958502|NCT00620321|157679083|FG001|Overall Study|Adverse Event|1|||
48958503|NCT00620321|157679082|FG000|Overall Study|Death|1|||
48958504|NCT00620321|157679083|FG001|Overall Study|Death|1|||
48958505|NCT00620321|157679082|FG000|Overall Study|Physician Decision|0|||
48958506|NCT00620321|157679083|FG001|Overall Study|Physician Decision|7|||
48958507|NCT00620321|157679082|FG000|Overall Study|Progressive Disease|5|||
48958508|NCT00620321|157679083|FG001|Overall Study|Progressive Disease|5|||
48958509|NCT00620321|157679082|FG000|Overall Study|Sponsor Decision|0|||
48958510|NCT00620321|157679083|FG001|Overall Study|Sponsor Decision|1|||
48958511|NCT00620321|157679082|FG000|Overall Study|Withdrawal by Subject|1|||
48958512|NCT00620321|157679083|FG001|Overall Study|Withdrawal by Subject|1|||
48958513|NCT01240811|157679084|FG000|Overall Study|Physician Decision|0|||
48958514|NCT01240811|157679085|FG001|Overall Study|Physician Decision|1|||
48958515|NCT01240811|157679086|FG002|Overall Study|Physician Decision|0|||
48958516|NCT01240811|157679084|FG000|Overall Study|Withdrawal by Subject|0|||
48958517|NCT01240811|157679085|FG001|Overall Study|Withdrawal by Subject|0|||
48958518|NCT01240811|157679086|FG002|Overall Study|Withdrawal by Subject|1|||
48958519|NCT01215734|157679093|FG000|Overall Study|Death|0|||
48958520|NCT01215734|157679094|FG001|Overall Study|Death|1|||
48958521|NCT00625365|157679097|FG000|Overall Study|Withdrawal by Subject|1|||
48958522|NCT00625365|157679097|FG000|Overall Study|No IV access|5|||
48958523|NCT00625365|157679097|FG000|Overall Study|VSD|1|||
48958524|NCT00366548|157679098|FG000|Infant Series|Adverse Event|1|||
48958525|NCT00366548|157679099|FG001|Infant Series|Adverse Event|3|||
48958526|NCT00366548|157679098|FG000|Infant Series|Protocol Violation|0|||
49098987|NCT04064411|158197010|FG000|Overall Study|Lost to Follow-up|5|||
48958527|NCT00366548|157679099|FG001|Infant Series|Protocol Violation|1|||
48958528|NCT00366548|157679098|FG000|Infant Series|Withdrawal by Subject|3|||
48958529|NCT00366548|157679099|FG001|Infant Series|Withdrawal by Subject|1|||
48958530|NCT00366548|157679098|FG000|After Infant Series|Withdrawal by Subject|3|||
48958531|NCT00366548|157679099|FG001|After Infant Series|Withdrawal by Subject|1|||
48958532|NCT00366548|157679098|FG000|After Infant Series|Adverse Event|2|||
48958533|NCT00366548|157679099|FG001|After Infant Series|Adverse Event|0|||
48958534|NCT00366548|157679098|FG000|After Infant Series|Lost to Follow-up|1|||
48958535|NCT00366548|157679099|FG001|After Infant Series|Lost to Follow-up|0|||
48958536|NCT01781429|157679101|FG000|Overall Study|Death|0|||
48958537|NCT01781429|157679102|FG001|Overall Study|Death|0|||
48958538|NCT01781429|157679103|FG002|Overall Study|Death|0|||
48958539|NCT01781429|157679104|FG003|Overall Study|Death|0|||
48958540|NCT01781429|157679105|FG004|Overall Study|Death|0|||
48958541|NCT01781429|157679106|FG005|Overall Study|Death|0|||
48958542|NCT01781429|157679107|FG006|Overall Study|Death|0|||
48958543|NCT01781429|157679108|FG007|Overall Study|Death|0|||
48958544|NCT01781429|157679109|FG008|Overall Study|Death|0|||
48958545|NCT01781429|157679110|FG009|Overall Study|Death|1|||
48958546|NCT01781429|157679111|FG010|Overall Study|Death|0|||
48958547|NCT01781429|157679112|FG011|Overall Study|Death|0|||
48958548|NCT01781429|157679113|FG012|Overall Study|Death|1|||
48958549|NCT01781429|157679114|FG013|Overall Study|Death|0|||
48958550|NCT01781429|157679115|FG014|Overall Study|Death|1|||
48958551|NCT01781429|157679116|FG015|Overall Study|Death|0|||
48958552|NCT01781429|157679101|FG000|Overall Study|Withdrawal by Subject|0|||
48958553|NCT01781429|157679102|FG001|Overall Study|Withdrawal by Subject|0|||
48958554|NCT01781429|157679103|FG002|Overall Study|Withdrawal by Subject|0|||
48958555|NCT01781429|157679104|FG003|Overall Study|Withdrawal by Subject|0|||
48958556|NCT01781429|157679105|FG004|Overall Study|Withdrawal by Subject|0|||
48958557|NCT01781429|157679106|FG005|Overall Study|Withdrawal by Subject|0|||
48958558|NCT01781429|157679107|FG006|Overall Study|Withdrawal by Subject|0|||
48958559|NCT01781429|157679108|FG007|Overall Study|Withdrawal by Subject|0|||
48958560|NCT01781429|157679109|FG008|Overall Study|Withdrawal by Subject|1|||
48958561|NCT01781429|157679110|FG009|Overall Study|Withdrawal by Subject|3|||
48958562|NCT01781429|157679111|FG010|Overall Study|Withdrawal by Subject|1|||
48958563|NCT01781429|157679112|FG011|Overall Study|Withdrawal by Subject|1|||
48958564|NCT01781429|157679113|FG012|Overall Study|Withdrawal by Subject|5|||
48958565|NCT01781429|157679114|FG013|Overall Study|Withdrawal by Subject|2|||
48958566|NCT01781429|157679115|FG014|Overall Study|Withdrawal by Subject|3|||
48958567|NCT01781429|157679116|FG015|Overall Study|Withdrawal by Subject|0|||
48958568|NCT01781429|157679101|FG000|Overall Study|Disease Progression|1|||
48958569|NCT01781429|157679102|FG001|Overall Study|Disease Progression|0|||
48958570|NCT01781429|157679103|FG002|Overall Study|Disease Progression|1|||
48958571|NCT01781429|157679104|FG003|Overall Study|Disease Progression|1|||
48958572|NCT01781429|157679105|FG004|Overall Study|Disease Progression|1|||
48958573|NCT01781429|157679106|FG005|Overall Study|Disease Progression|4|||
48958574|NCT01781429|157679107|FG006|Overall Study|Disease Progression|7|||
48958575|NCT01781429|157679108|FG007|Overall Study|Disease Progression|4|||
48958576|NCT01781429|157679109|FG008|Overall Study|Disease Progression|6|||
48958577|NCT01781429|157679110|FG009|Overall Study|Disease Progression|15|||
48958578|NCT01781429|157679111|FG010|Overall Study|Disease Progression|15|||
48958579|NCT01781429|157679112|FG011|Overall Study|Disease Progression|15|||
48958580|NCT01781429|157679113|FG012|Overall Study|Disease Progression|15|||
48958581|NCT01781429|157679114|FG013|Overall Study|Disease Progression|4|||
48958582|NCT01781429|157679115|FG014|Overall Study|Disease Progression|11|||
48958583|NCT01781429|157679116|FG015|Overall Study|Disease Progression|0|||
48958584|NCT01781429|157679101|FG000|Overall Study|Unacceptable Toxicity|0|||
48958585|NCT01781429|157679102|FG001|Overall Study|Unacceptable Toxicity|0|||
48958586|NCT01781429|157679103|FG002|Overall Study|Unacceptable Toxicity|0|||
48958587|NCT01781429|157679104|FG003|Overall Study|Unacceptable Toxicity|0|||
48958588|NCT01781429|157679105|FG004|Overall Study|Unacceptable Toxicity|0|||
48958589|NCT01781429|157679106|FG005|Overall Study|Unacceptable Toxicity|0|||
48958590|NCT01781429|157679107|FG006|Overall Study|Unacceptable Toxicity|0|||
48958591|NCT01781429|157679108|FG007|Overall Study|Unacceptable Toxicity|0|||
48958592|NCT01781429|157679109|FG008|Overall Study|Unacceptable Toxicity|0|||
48958593|NCT01781429|157679110|FG009|Overall Study|Unacceptable Toxicity|0|||
48958594|NCT01781429|157679111|FG010|Overall Study|Unacceptable Toxicity|0|||
48958595|NCT01781429|157679112|FG011|Overall Study|Unacceptable Toxicity|2|||
48958596|NCT01781429|157679113|FG012|Overall Study|Unacceptable Toxicity|0|||
48958597|NCT01781429|157679114|FG013|Overall Study|Unacceptable Toxicity|0|||
48958598|NCT01781429|157679115|FG014|Overall Study|Unacceptable Toxicity|0|||
48958599|NCT01781429|157679116|FG015|Overall Study|Unacceptable Toxicity|0|||
48958600|NCT01781429|157679101|FG000|Overall Study|Patient Condition Changed|0|||
48752972|NCT00754624|156942057|FG000|Overall Study|Death|1|||
48958601|NCT01781429|157679102|FG001|Overall Study|Patient Condition Changed|0|||
48958602|NCT01781429|157679103|FG002|Overall Study|Patient Condition Changed|0|||
48958603|NCT01781429|157679104|FG003|Overall Study|Patient Condition Changed|0|||
48958604|NCT01781429|157679105|FG004|Overall Study|Patient Condition Changed|0|||
48958605|NCT01781429|157679106|FG005|Overall Study|Patient Condition Changed|0|||
48958606|NCT01781429|157679107|FG006|Overall Study|Patient Condition Changed|0|||
48958607|NCT01781429|157679108|FG007|Overall Study|Patient Condition Changed|0|||
48958608|NCT01781429|157679109|FG008|Overall Study|Patient Condition Changed|0|||
48958609|NCT01781429|157679110|FG009|Overall Study|Patient Condition Changed|4|||
48958610|NCT01781429|157679111|FG010|Overall Study|Patient Condition Changed|0|||
48958611|NCT01781429|157679112|FG011|Overall Study|Patient Condition Changed|1|||
48958612|NCT01781429|157679113|FG012|Overall Study|Patient Condition Changed|0|||
48958613|NCT01781429|157679114|FG013|Overall Study|Patient Condition Changed|1|||
48958614|NCT01781429|157679115|FG014|Overall Study|Patient Condition Changed|0|||
48958615|NCT01781429|157679116|FG015|Overall Study|Patient Condition Changed|0|||
48958616|NCT01781429|157679101|FG000|Overall Study|Other - as entered by PI in eCRF|0|||
48958617|NCT01781429|157679102|FG001|Overall Study|Other - as entered by PI in eCRF|1|||
48958618|NCT01781429|157679103|FG002|Overall Study|Other - as entered by PI in eCRF|0|||
48958619|NCT01781429|157679104|FG003|Overall Study|Other - as entered by PI in eCRF|0|||
48958620|NCT01781429|157679105|FG004|Overall Study|Other - as entered by PI in eCRF|0|||
48958621|NCT01781429|157679106|FG005|Overall Study|Other - as entered by PI in eCRF|0|||
48958622|NCT01781429|157679107|FG006|Overall Study|Other - as entered by PI in eCRF|0|||
48958623|NCT01781429|157679108|FG007|Overall Study|Other - as entered by PI in eCRF|0|||
48958624|NCT01781429|157679109|FG008|Overall Study|Other - as entered by PI in eCRF|0|||
48958625|NCT01781429|157679110|FG009|Overall Study|Other - as entered by PI in eCRF|1|||
48958626|NCT01781429|157679111|FG010|Overall Study|Other - as entered by PI in eCRF|1|||
48958627|NCT01781429|157679112|FG011|Overall Study|Other - as entered by PI in eCRF|2|||
48958628|NCT01781429|157679113|FG012|Overall Study|Other - as entered by PI in eCRF|1|||
48958629|NCT01781429|157679114|FG013|Overall Study|Other - as entered by PI in eCRF|1|||
48958630|NCT01781429|157679115|FG014|Overall Study|Other - as entered by PI in eCRF|1|||
48958631|NCT01781429|157679116|FG015|Overall Study|Other - as entered by PI in eCRF|0|||
48958632|NCT01781429|157679101|FG000|Overall Study|Enrolled, but not treated|0|||
48752973|NCT00754624|156942057|FG000|Overall Study|Physician Decision|8|||
48958633|NCT01781429|157679102|FG001|Overall Study|Enrolled, but not treated|0|||
48958634|NCT01781429|157679103|FG002|Overall Study|Enrolled, but not treated|0|||
48958635|NCT01781429|157679104|FG003|Overall Study|Enrolled, but not treated|0|||
48958636|NCT01781429|157679105|FG004|Overall Study|Enrolled, but not treated|0|||
48958637|NCT01781429|157679106|FG005|Overall Study|Enrolled, but not treated|0|||
48752974|NCT00754624|156942057|FG000|Overall Study|Protocol Violation|1|||
48752975|NCT00754624|156942057|FG000|Overall Study|Withdrawal by Subject|28|||
48752976|NCT00754624|156942057|FG000|Overall Study|Various|12|||
48752977|NCT00754624|156942057|FG000|Overall Study|Lost to Follow-up|3|||
48752978|NCT00720434|156942058|FG000|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
48752979|NCT00720434|156942059|FG001|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1|||
48752980|NCT00720434|156942060|FG002|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
48752981|NCT00720434|156942061|FG003|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
48752982|NCT00720434|156942058|FG000|Open-Label Period (Week 5-72)|Adverse Event|0|||
48752983|NCT00720434|156942059|FG001|Open-Label Period (Week 5-72)|Adverse Event|0|||
48752984|NCT00720434|156942060|FG002|Open-Label Period (Week 5-72)|Adverse Event|0|||
48752985|NCT00720434|156942061|FG003|Open-Label Period (Week 5-72)|Adverse Event|2|||
48752986|NCT00720434|156942058|FG000|Open-Label Period (Week 5-72)|Lost to Follow-up|1|||
48752987|NCT00720434|156942059|FG001|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
48752988|NCT00720434|156942060|FG002|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
48752989|NCT00720434|156942061|FG003|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
48752990|NCT00720434|156942058|FG000|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
48752991|NCT00720434|156942059|FG001|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
48752992|NCT00720434|156942060|FG002|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
48752993|NCT00720434|156942061|FG003|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
48752994|NCT00720434|156942058|FG000|Open-Label Period (Week 5-72)|Other|4|||
48752995|NCT00720434|156942059|FG001|Open-Label Period (Week 5-72)|Other|3|||
48752996|NCT00720434|156942060|FG002|Open-Label Period (Week 5-72)|Other|3|||
48752997|NCT00720434|156942061|FG003|Open-Label Period (Week 5-72)|Other|2|||
48752998|NCT02425046|156942063|FG000|Overall Study|Lost to Follow-up|52|||
48752999|NCT02425046|156942064|FG001|Overall Study|Lost to Follow-up|50|||
48753000|NCT02425046|156942065|FG002|Overall Study|Lost to Follow-up|56|||
48753001|NCT02425046|156942063|FG000|Overall Study|Withdrawal by Subject|16|||
48753002|NCT02425046|156942064|FG001|Overall Study|Withdrawal by Subject|12|||
48753003|NCT02425046|156942065|FG002|Overall Study|Withdrawal by Subject|0|||
48753004|NCT01831544|156942066|FG000|Overall Study|Death|1|||
48753005|NCT01831544|156942066|FG000|Overall Study|Still on original MVAD device|2|||
48753006|NCT00931762|156942068|FG000|Overall Study|Abnormal Laboratory Value (s)|2|||
48753007|NCT00931762|156942068|FG000|Overall Study|Administrative Problems|5|||
48753008|NCT00931762|156942068|FG000|Overall Study|Death|1|||
48753009|NCT00931762|156942068|FG000|Overall Study|Disease Progression|3|||
48753010|NCT00931762|156942068|FG000|Overall Study|Adverse Event (s)|11|||
48753011|NCT00931762|156942068|FG000|Overall Study|Subject withdrew consent|13|||
48753012|NCT01320085|156942069|FG000|Overall Study|Disease Progression|26|||
48753013|NCT01320085|156942070|FG001|Overall Study|Disease Progression|93|||
48753014|NCT01320085|156942071|FG002|Overall Study|Disease Progression|17|||
48753015|NCT01320085|156942069|FG000|Overall Study|Adverse Event|12|||
48753016|NCT01320085|156942070|FG001|Overall Study|Adverse Event|20|||
48753017|NCT01320085|156942071|FG002|Overall Study|Adverse Event|5|||
48753018|NCT01320085|156942069|FG000|Overall Study|Withdrawal by Subject|2|||
48753019|NCT01320085|156942070|FG001|Overall Study|Withdrawal by Subject|4|||
48753020|NCT01320085|156942071|FG002|Overall Study|Withdrawal by Subject|1|||
48753021|NCT01320085|156942069|FG000|Overall Study|Protocol Deviation|1|||
48753022|NCT01320085|156942070|FG001|Overall Study|Protocol Deviation|0|||
48958638|NCT01781429|157679107|FG006|Overall Study|Enrolled, but not treated|0|||
48958639|NCT01781429|157679108|FG007|Overall Study|Enrolled, but not treated|0|||
48753023|NCT01320085|156942071|FG002|Overall Study|Protocol Deviation|1|||
48753024|NCT01320085|156942069|FG000|Overall Study|Administrative problems|0|||
48958640|NCT01781429|157679109|FG008|Overall Study|Enrolled, but not treated|0|||
48753025|NCT01320085|156942070|FG001|Overall Study|Administrative problems|0|||
48753026|NCT01320085|156942071|FG002|Overall Study|Administrative problems|1|||
48753027|NCT03070782|156942076|FG000|Overall Study|Adverse Event|3|||
48753028|NCT03070782|156942077|FG001|Overall Study|Adverse Event|0|||
48753029|NCT03070782|156942078|FG002|Overall Study|Adverse Event|3|||
48753030|NCT03070782|156942079|FG003|Overall Study|Adverse Event|1|||
48753031|NCT03070782|156942080|FG004|Overall Study|Adverse Event|6|||
48753032|NCT03070782|156942081|FG005|Overall Study|Adverse Event|2|||
48753033|NCT03070782|156942076|FG000|Overall Study|Withdrawal by Subject|2|||
48753034|NCT03070782|156942077|FG001|Overall Study|Withdrawal by Subject|1|||
48753035|NCT03070782|156942078|FG002|Overall Study|Withdrawal by Subject|1|||
48753036|NCT03070782|156942079|FG003|Overall Study|Withdrawal by Subject|0|||
48753037|NCT03070782|156942080|FG004|Overall Study|Withdrawal by Subject|4|||
48753038|NCT03070782|156942081|FG005|Overall Study|Withdrawal by Subject|3|||
48753039|NCT03070782|156942076|FG000|Overall Study|Reason Not Specified|2|||
48753040|NCT03070782|156942077|FG001|Overall Study|Reason Not Specified|0|||
48753041|NCT03070782|156942078|FG002|Overall Study|Reason Not Specified|0|||
48753042|NCT03070782|156942079|FG003|Overall Study|Reason Not Specified|1|||
48753043|NCT03070782|156942080|FG004|Overall Study|Reason Not Specified|2|||
48753044|NCT03070782|156942081|FG005|Overall Study|Reason Not Specified|1|||
48753045|NCT03070782|156942076|FG000|Overall Study|Ineligibility|0|||
48753046|NCT03070782|156942077|FG001|Overall Study|Ineligibility|0|||
48753047|NCT03070782|156942078|FG002|Overall Study|Ineligibility|0|||
48753048|NCT03070782|156942079|FG003|Overall Study|Ineligibility|1|||
48753049|NCT03070782|156942080|FG004|Overall Study|Ineligibility|0|||
48753050|NCT03070782|156942081|FG005|Overall Study|Ineligibility|1|||
48753051|NCT03070782|156942076|FG000|Overall Study|Pregnancy|0|||
48753052|NCT03070782|156942077|FG001|Overall Study|Pregnancy|0|||
48753053|NCT03070782|156942078|FG002|Overall Study|Pregnancy|0|||
48753054|NCT03070782|156942079|FG003|Overall Study|Pregnancy|1|||
48753055|NCT03070782|156942080|FG004|Overall Study|Pregnancy|0|||
48753056|NCT03070782|156942081|FG005|Overall Study|Pregnancy|0|||
48753057|NCT03070782|156942076|FG000|Overall Study|Investigator Judgement|0|||
48753058|NCT03070782|156942077|FG001|Overall Study|Investigator Judgement|0|||
48753059|NCT03070782|156942078|FG002|Overall Study|Investigator Judgement|0|||
48753060|NCT03070782|156942079|FG003|Overall Study|Investigator Judgement|1|||
48753061|NCT03070782|156942080|FG004|Overall Study|Investigator Judgement|0|||
48753062|NCT03070782|156942081|FG005|Overall Study|Investigator Judgement|0|||
48753063|NCT03510884|156942088|FG000|Double-blind Period (up to Week 24)|Adverse Event|0|||
48753064|NCT03510884|156942089|FG001|Double-blind Period (up to Week 24)|Adverse Event|0|||
48958641|NCT01781429|157679110|FG009|Overall Study|Enrolled, but not treated|0|||
48958642|NCT01781429|157679111|FG010|Overall Study|Enrolled, but not treated|1|||
48958643|NCT01781429|157679112|FG011|Overall Study|Enrolled, but not treated|0|||
48958644|NCT01781429|157679113|FG012|Overall Study|Enrolled, but not treated|0|||
48958645|NCT01781429|157679114|FG013|Overall Study|Enrolled, but not treated|0|||
48958646|NCT01781429|157679115|FG014|Overall Study|Enrolled, but not treated|0|||
48958647|NCT01781429|157679116|FG015|Overall Study|Enrolled, but not treated|0|||
48958648|NCT01051986|157679117|FG000|Overall Study|Death|1|||
48958649|NCT01051986|157679118|FG001|Overall Study|Death|0|||
48958650|NCT01051986|157679117|FG000|Overall Study|Withdrawal by Subject|2|||
48958651|NCT01051986|157679118|FG001|Overall Study|Withdrawal by Subject|1|||
48958652|NCT01051986|157679117|FG000|Overall Study|Protocol Violation|2|||
48958653|NCT01051986|157679118|FG001|Overall Study|Protocol Violation|3|||
48958654|NCT00262080|157679119|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
48958655|NCT00262080|157679120|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
48958656|NCT00262080|157679121|FG002|Double Blind Treatment Period|Lost to Follow-up|0|||
48958657|NCT00262080|157679119|FG000|Repeat Dose Treatment Period|Adverse Event|1|||
48753065|NCT03510884|156942090|FG002|Double-blind Period (up to Week 24)|Adverse Event|0|||
48753066|NCT03510884|156942091|FG003|Double-blind Period (up to Week 24)|Adverse Event|2|||
48753067|NCT03510884|156942088|FG000|Double-blind Period (up to Week 24)|Participant moved|0|||
48958658|NCT00262080|157679120|FG001|Repeat Dose Treatment Period|Adverse Event|0|||
48958659|NCT00262080|157679121|FG002|Repeat Dose Treatment Period|Adverse Event|0|||
48958660|NCT00262080|157679119|FG000|Repeat Dose Treatment Period|Withdrawal by Subject|0|||
48753068|NCT03510884|156942089|FG001|Double-blind Period (up to Week 24)|Participant moved|1|||
48753069|NCT03510884|156942090|FG002|Double-blind Period (up to Week 24)|Participant moved|0|||
48753070|NCT03510884|156942091|FG003|Double-blind Period (up to Week 24)|Participant moved|0|||
48753071|NCT03510884|156942088|FG000|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
48958661|NCT00262080|157679120|FG001|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
48958662|NCT00262080|157679121|FG002|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
48958663|NCT00262080|157679119|FG000|Repeat Dose Treatment Period|Lost to Follow-up|2|||
48958664|NCT00262080|157679120|FG001|Repeat Dose Treatment Period|Lost to Follow-up|0|||
48958665|NCT00262080|157679121|FG002|Repeat Dose Treatment Period|Lost to Follow-up|2|||
48958666|NCT00262080|157679119|FG000|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
48958667|NCT00262080|157679120|FG001|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
48958668|NCT00262080|157679121|FG002|Repeat Dose Treatment Period|Decision to discontinue the study|2|||
48958669|NCT00262080|157679119|FG000|Repeat Dose Treatment Period|enrolled in EDEMA4|1|||
48958670|NCT00262080|157679120|FG001|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
48958671|NCT00262080|157679121|FG002|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
48958672|NCT02273752|157679122|FG000|Overall Study|Trial was terminated early|2|||
48958673|NCT00903032|157679123|FG000|Overall Study|Withdrawal by Subject|5|||
48958674|NCT00903032|157679124|FG001|Overall Study|Withdrawal by Subject|3|||
48958675|NCT00903032|157679123|FG000|Overall Study|Lost to Follow-up|2|||
48958676|NCT00903032|157679124|FG001|Overall Study|Lost to Follow-up|2|||
48958677|NCT03580382|157679128|FG000|Overall Study|Early Termination of Study|0|||
48958678|NCT03580382|157679129|FG001|Overall Study|Early Termination of Study|3|||
48958679|NCT02808312|157679130|FG000|Overall Study|Enrolled but Never Treated|0|||
48958680|NCT02808312|157679131|FG001|Overall Study|Enrolled but Never Treated|0|||
48958681|NCT02808312|157679132|FG002|Overall Study|Enrolled but Never Treated|1|||
48958682|NCT02808312|157679133|FG003|Overall Study|Enrolled but Never Treated|0|||
48958683|NCT02808312|157679134|FG004|Overall Study|Enrolled but Never Treated|0|||
48958684|NCT03628417|157679135|FG000|Overall Study|Death|1|||
48958685|NCT03628417|157679136|FG001|Overall Study|Death|1|||
48958686|NCT01876732|157679137|FG000|Overall Study|MMA was not over 800mg/dL|75|||
48958687|NCT01457118|157679138|FG000|Overall Study|Adverse Event|1|||
48753072|NCT03510884|156942089|FG001|Double-blind Period (up to Week 24)|Life events made continuing too difficult|1|||
48753073|NCT03510884|156942090|FG002|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
48753074|NCT03510884|156942091|FG003|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
48753075|NCT03510884|156942088|FG000|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
48753076|NCT03510884|156942089|FG001|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|2|||
48753077|NCT03510884|156942090|FG002|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
48753078|NCT03510884|156942091|FG003|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
48753079|NCT03510884|156942088|FG000|Double-blind Period (up to Week 24)|Other than specified above|0|||
48753080|NCT03510884|156942089|FG001|Double-blind Period (up to Week 24)|Other than specified above|0|||
48753081|NCT03510884|156942090|FG002|Double-blind Period (up to Week 24)|Other than specified above|1|||
48753082|NCT03510884|156942091|FG003|Double-blind Period (up to Week 24)|Other than specified above|1|||
48753083|NCT03510884|156942088|FG000|Open Label Period (up to Week 104)|Adverse Event|1|||
48753084|NCT03510884|156942089|FG001|Open Label Period (up to Week 104)|Adverse Event|0|||
48753085|NCT03510884|156942090|FG002|Open Label Period (up to Week 104)|Adverse Event|0|||
48753086|NCT03510884|156942091|FG003|Open Label Period (up to Week 104)|Adverse Event|0|||
48753087|NCT03510884|156942088|FG000|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
48753088|NCT03510884|156942089|FG001|Open Label Period (up to Week 104)|Lack of Efficacy|1|||
48753089|NCT03510884|156942090|FG002|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
48753090|NCT03510884|156942091|FG003|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
48753091|NCT03510884|156942088|FG000|Open Label Period (up to Week 104)|Participant moved|1|||
48753092|NCT03510884|156942089|FG001|Open Label Period (up to Week 104)|Participant moved|0|||
48753093|NCT03510884|156942090|FG002|Open Label Period (up to Week 104)|Participant moved|1|||
48753094|NCT03510884|156942091|FG003|Open Label Period (up to Week 104)|Participant moved|0|||
48753095|NCT03510884|156942088|FG000|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
48753096|NCT03510884|156942089|FG001|Open Label Period (up to Week 104)|Life events made continuing too difficult|1|||
48753097|NCT03510884|156942090|FG002|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
48753098|NCT03510884|156942091|FG003|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
48753099|NCT03510884|156942088|FG000|Open Label Period (up to Week 104)|Other than specified above|1|||
48753100|NCT03510884|156942089|FG001|Open Label Period (up to Week 104)|Other than specified above|1|||
48753101|NCT03510884|156942090|FG002|Open Label Period (up to Week 104)|Other than specified above|0|||
48753102|NCT03510884|156942091|FG003|Open Label Period (up to Week 104)|Other than specified above|0|||
48753103|NCT01059825|156942100|FG000|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
48753104|NCT01059825|156942101|FG001|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
48753105|NCT01059825|156942102|FG002|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
48753106|NCT01059825|156942103|FG003|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
48753107|NCT01059825|156942104|FG004|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
48753108|NCT01059825|156942105|FG005|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
48753109|NCT01059825|156942106|FG006|Enrolled, Run-in Period|Adverse event not related to study drug|3|||
48753110|NCT01059825|156942100|FG000|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
48958688|NCT01457118|157679139|FG001|Overall Study|Adverse Event|0|||
48958689|NCT01457118|157679140|FG002|Overall Study|Adverse Event|0|||
48958690|NCT01457118|157679141|FG003|Overall Study|Adverse Event|1|||
48958691|NCT01457118|157679138|FG000|Overall Study|Clinical Progression|0|||
48958692|NCT01457118|157679139|FG001|Overall Study|Clinical Progression|1|||
48958693|NCT01457118|157679140|FG002|Overall Study|Clinical Progression|0|||
48958694|NCT01457118|157679141|FG003|Overall Study|Clinical Progression|1|||
48958695|NCT01457118|157679138|FG000|Overall Study|Physician Decision|2|||
48958696|NCT01457118|157679139|FG001|Overall Study|Physician Decision|0|||
48958697|NCT01457118|157679140|FG002|Overall Study|Physician Decision|0|||
48958698|NCT01457118|157679141|FG003|Overall Study|Physician Decision|0|||
48753111|NCT01059825|156942101|FG001|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
48753112|NCT01059825|156942102|FG002|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
48753113|NCT01059825|156942103|FG003|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
48753114|NCT01059825|156942104|FG004|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
48753115|NCT01059825|156942105|FG005|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
48753116|NCT01059825|156942106|FG006|Enrolled, Run-in Period|Did not meet entrance criteria|14|||
48753117|NCT01059825|156942100|FG000|Enrolled, Run-in Period|Lost to Follow-up|0|||
48753118|NCT01059825|156942101|FG001|Enrolled, Run-in Period|Lost to Follow-up|0|||
48753119|NCT01059825|156942102|FG002|Enrolled, Run-in Period|Lost to Follow-up|0|||
48753120|NCT01059825|156942103|FG003|Enrolled, Run-in Period|Lost to Follow-up|0|||
48753121|NCT01059825|156942104|FG004|Enrolled, Run-in Period|Lost to Follow-up|0|||
48753122|NCT01059825|156942105|FG005|Enrolled, Run-in Period|Lost to Follow-up|0|||
48753123|NCT01059825|156942106|FG006|Enrolled, Run-in Period|Lost to Follow-up|5|||
48753124|NCT01059825|156942100|FG000|Enrolled, Run-in Period|Withdrawal by Subject|0|||
48753125|NCT01059825|156942101|FG001|Enrolled, Run-in Period|Withdrawal by Subject|0|||
48753126|NCT01059825|156942102|FG002|Enrolled, Run-in Period|Withdrawal by Subject|0|||
48753127|NCT01059825|156942103|FG003|Enrolled, Run-in Period|Withdrawal by Subject|0|||
48753128|NCT01059825|156942104|FG004|Enrolled, Run-in Period|Withdrawal by Subject|0|||
48753129|NCT01059825|156942105|FG005|Enrolled, Run-in Period|Withdrawal by Subject|0|||
48753130|NCT01059825|156942106|FG006|Enrolled, Run-in Period|Withdrawal by Subject|13|||
48753131|NCT01059825|156942100|FG000|Enrolled, Run-in Period|Other reason not specified|0|||
48753132|NCT01059825|156942101|FG001|Enrolled, Run-in Period|Other reason not specified|0|||
48753133|NCT01059825|156942102|FG002|Enrolled, Run-in Period|Other reason not specified|0|||
48753134|NCT01059825|156942103|FG003|Enrolled, Run-in Period|Other reason not specified|0|||
48753135|NCT01059825|156942104|FG004|Enrolled, Run-in Period|Other reason not specified|0|||
48753136|NCT01059825|156942105|FG005|Enrolled, Run-in Period|Other reason not specified|0|||
48753137|NCT01059825|156942106|FG006|Enrolled, Run-in Period|Other reason not specified|7|||
48753138|NCT01059825|156942100|FG000|Enrolled, Run-in Period|Protocol Violation|0|||
48753139|NCT01059825|156942101|FG001|Enrolled, Run-in Period|Protocol Violation|0|||
48753140|NCT01059825|156942102|FG002|Enrolled, Run-in Period|Protocol Violation|0|||
48753141|NCT01059825|156942103|FG003|Enrolled, Run-in Period|Protocol Violation|0|||
48753142|NCT01059825|156942104|FG004|Enrolled, Run-in Period|Protocol Violation|0|||
48753143|NCT01059825|156942105|FG005|Enrolled, Run-in Period|Protocol Violation|0|||
48753144|NCT01059825|156942106|FG006|Enrolled, Run-in Period|Protocol Violation|5|||
48753145|NCT01059825|156942100|FG000|Treatment Period|Lost to Follow-up|2|||
48753146|NCT01059825|156942101|FG001|Treatment Period|Lost to Follow-up|1|||
48753147|NCT01059825|156942102|FG002|Treatment Period|Lost to Follow-up|0|||
48753148|NCT01059825|156942103|FG003|Treatment Period|Lost to Follow-up|1|||
48753149|NCT01059825|156942104|FG004|Treatment Period|Lost to Follow-up|2|||
48753150|NCT01059825|156942105|FG005|Treatment Period|Lost to Follow-up|0|||
48753151|NCT01059825|156942106|FG006|Treatment Period|Lost to Follow-up|0|||
48753152|NCT01059825|156942100|FG000|Treatment Period|Withdrawal by Subject|3|||
48753153|NCT01059825|156942101|FG001|Treatment Period|Withdrawal by Subject|0|||
48753154|NCT01059825|156942102|FG002|Treatment Period|Withdrawal by Subject|1|||
48753155|NCT01059825|156942103|FG003|Treatment Period|Withdrawal by Subject|5|||
48753156|NCT01059825|156942104|FG004|Treatment Period|Withdrawal by Subject|4|||
48753157|NCT01059825|156942105|FG005|Treatment Period|Withdrawal by Subject|1|||
48753158|NCT01059825|156942106|FG006|Treatment Period|Withdrawal by Subject|0|||
48753159|NCT01059825|156942100|FG000|Treatment Period|Other reason not specified|1|||
48753160|NCT01059825|156942101|FG001|Treatment Period|Other reason not specified|2|||
48753161|NCT01059825|156942102|FG002|Treatment Period|Other reason not specified|1|||
48865182|NCT01703988|157341920|FG003|Overall Study|Investigator Judgment|1|||
48753162|NCT01059825|156942103|FG003|Treatment Period|Other reason not specified|2|||
48753163|NCT01059825|156942104|FG004|Treatment Period|Other reason not specified|0|||
48753164|NCT01059825|156942105|FG005|Treatment Period|Other reason not specified|0|||
48753165|NCT01059825|156942106|FG006|Treatment Period|Other reason not specified|0|||
48753166|NCT01059825|156942100|FG000|Treatment Period|Protocol Violation|0|||
48753167|NCT01059825|156942101|FG001|Treatment Period|Protocol Violation|0|||
48753168|NCT01059825|156942102|FG002|Treatment Period|Protocol Violation|1|||
48753169|NCT01059825|156942103|FG003|Treatment Period|Protocol Violation|1|||
48753170|NCT01059825|156942104|FG004|Treatment Period|Protocol Violation|1|||
48753171|NCT01059825|156942105|FG005|Treatment Period|Protocol Violation|1|||
48753172|NCT01059825|156942106|FG006|Treatment Period|Protocol Violation|0|||
48753173|NCT01059825|156942100|FG000|Treatment Period|Adverse event related to study drug|1|||
48753174|NCT01059825|156942101|FG001|Treatment Period|Adverse event related to study drug|0|||
48958699|NCT01457118|157679138|FG000|Overall Study|Progressive Disease by RECIST|12|||
48958700|NCT01457118|157679139|FG001|Overall Study|Progressive Disease by RECIST|3|||
48958701|NCT01457118|157679140|FG002|Overall Study|Progressive Disease by RECIST|1|||
48958702|NCT01457118|157679141|FG003|Overall Study|Progressive Disease by RECIST|0|||
48958703|NCT01457118|157679138|FG000|Overall Study|Withdrawal by Subject|5|||
48958704|NCT01457118|157679139|FG001|Overall Study|Withdrawal by Subject|0|||
48958705|NCT01457118|157679140|FG002|Overall Study|Withdrawal by Subject|0|||
48958706|NCT01457118|157679141|FG003|Overall Study|Withdrawal by Subject|0|||
48958707|NCT00115349|157679142|FG000|Overall Study|Study closed due to low enrollment.|11|||
48958708|NCT00115349|157679143|FG001|Overall Study|Study closed due to low enrollment.|9|||
48958709|NCT05142332|157679144|FG000|Overall Study|Withdrawal by Subject|0|||
48958710|NCT05142332|157679145|FG001|Overall Study|Withdrawal by Subject|1|||
48958711|NCT05142332|157679146|FG002|Overall Study|Withdrawal by Subject|2|||
48958712|NCT05142332|157679147|FG003|Overall Study|Withdrawal by Subject|0|||
48958713|NCT05142332|157679148|FG004|Overall Study|Withdrawal by Subject|0|||
48958714|NCT05142332|157679149|FG005|Overall Study|Withdrawal by Subject|2|||
48753175|NCT01059825|156942102|FG002|Treatment Period|Adverse event related to study drug|1|||
48753176|NCT01059825|156942103|FG003|Treatment Period|Adverse event related to study drug|1|||
48753177|NCT01059825|156942104|FG004|Treatment Period|Adverse event related to study drug|0|||
48753178|NCT01059825|156942105|FG005|Treatment Period|Adverse event related to study drug|0|||
48753179|NCT01059825|156942106|FG006|Treatment Period|Adverse event related to study drug|0|||
48753180|NCT01059825|156942100|FG000|Treatment Period|Insufficient clinical response|3|||
48753181|NCT01059825|156942101|FG001|Treatment Period|Insufficient clinical response|0|||
48753182|NCT01059825|156942102|FG002|Treatment Period|Insufficient clinical response|0|||
48753183|NCT01059825|156942103|FG003|Treatment Period|Insufficient clinical response|0|||
48753184|NCT01059825|156942104|FG004|Treatment Period|Insufficient clinical response|0|||
48753185|NCT01059825|156942105|FG005|Treatment Period|Insufficient clinical response|0|||
48753186|NCT01059825|156942106|FG006|Treatment Period|Insufficient clinical response|0|||
48753187|NCT01059825|156942100|FG000|Treatment Period|Adverse event not related to study drug|0|||
48753188|NCT01059825|156942101|FG001|Treatment Period|Adverse event not related to study drug|1|||
48753189|NCT01059825|156942102|FG002|Treatment Period|Adverse event not related to study drug|2|||
48753190|NCT01059825|156942103|FG003|Treatment Period|Adverse event not related to study drug|1|||
48753191|NCT01059825|156942104|FG004|Treatment Period|Adverse event not related to study drug|1|||
48958715|NCT05142332|157679150|FG006|Overall Study|Withdrawal by Subject|6|||
48958716|NCT05142332|157679144|FG000|Overall Study|Left ED|3|||
48958717|NCT05142332|157679145|FG001|Overall Study|Left ED|0|||
48958718|NCT05142332|157679146|FG002|Overall Study|Left ED|4|||
48958719|NCT05142332|157679147|FG003|Overall Study|Left ED|6|||
48958720|NCT05142332|157679148|FG004|Overall Study|Left ED|1|||
48958721|NCT05142332|157679149|FG005|Overall Study|Left ED|2|||
48958722|NCT05142332|157679150|FG006|Overall Study|Left ED|6|||
48958723|NCT05142332|157679144|FG000|Overall Study|Physician Decision|0|||
48958724|NCT05142332|157679145|FG001|Overall Study|Physician Decision|0|||
48958725|NCT05142332|157679146|FG002|Overall Study|Physician Decision|2|||
48958726|NCT05142332|157679147|FG003|Overall Study|Physician Decision|1|||
48958727|NCT05142332|157679148|FG004|Overall Study|Physician Decision|0|||
48958728|NCT05142332|157679149|FG005|Overall Study|Physician Decision|0|||
48958729|NCT05142332|157679150|FG006|Overall Study|Physician Decision|3|||
48958730|NCT05142332|157679144|FG000|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
48958731|NCT05142332|157679145|FG001|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
48958732|NCT05142332|157679146|FG002|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
48753192|NCT01059825|156942105|FG005|Treatment Period|Adverse event not related to study drug|1|||
48753193|NCT01059825|156942106|FG006|Treatment Period|Adverse event not related to study drug|0|||
48958733|NCT05142332|157679147|FG003|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
48958734|NCT05142332|157679148|FG004|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
48958735|NCT05142332|157679149|FG005|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
48958736|NCT05142332|157679150|FG006|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
48958737|NCT02750800|157679151|FG000|Overall Study|Adverse Event|18|||
48958738|NCT02750800|157679151|FG000|Overall Study|Lost to Follow-up|12|||
48958739|NCT02750800|157679151|FG000|Overall Study|Investigator decision|53|||
48958740|NCT02750800|157679151|FG000|Overall Study|Patient request|12|||
48958741|NCT02750800|157679151|FG000|Overall Study|Other, not specified|3|||
48958742|NCT01718509|157679152|FG000|Overall Study|Lost to Follow-up|18|||
48958743|NCT01718509|157679153|FG001|Overall Study|Lost to Follow-up|15|||
48958744|NCT01718509|157679152|FG000|Overall Study|Withdrawal by Subject|7|||
48958745|NCT01718509|157679153|FG001|Overall Study|Withdrawal by Subject|13|||
48958746|NCT01718509|157679152|FG000|Overall Study|Adverse Event|5|||
48958747|NCT01718509|157679153|FG001|Overall Study|Adverse Event|7|||
48958748|NCT01718509|157679152|FG000|Overall Study|Other|13|||
48958749|NCT01718509|157679153|FG001|Overall Study|Other|11|||
48958750|NCT01718509|157679152|FG000|Overall Study|Protocol Violation|4|||
48958751|NCT01718509|157679153|FG001|Overall Study|Protocol Violation|2|||
48958752|NCT01718509|157679152|FG000|Overall Study|Lack of Efficacy|1|||
48958753|NCT01718509|157679153|FG001|Overall Study|Lack of Efficacy|0|||
48958754|NCT02935634|157679157|FG000|Randomization|Participant withdrew consent|0|||
48958755|NCT02935634|157679158|FG001|Randomization|Participant withdrew consent|1|||
48958756|NCT02935634|157679159|FG002|Randomization|Participant withdrew consent|0|||
48958757|NCT02935634|157679160|FG003|Randomization|Participant withdrew consent|0|||
48958758|NCT02935634|157679161|FG004|Randomization|Participant withdrew consent|0|||
48958759|NCT02935634|157679162|FG005|Randomization|Participant withdrew consent|0|||
48958760|NCT02935634|157679157|FG000|Randomization|Death|2|||
48958761|NCT02935634|157679158|FG001|Randomization|Death|1|||
48958762|NCT02935634|157679159|FG002|Randomization|Death|1|||
48958763|NCT02935634|157679160|FG003|Randomization|Death|0|||
48958764|NCT02935634|157679161|FG004|Randomization|Death|0|||
48958765|NCT02935634|157679162|FG005|Randomization|Death|0|||
48958766|NCT02935634|157679157|FG000|Randomization|Other reasons|0|||
48958767|NCT02935634|157679158|FG001|Randomization|Other reasons|2|||
48958768|NCT02935634|157679159|FG002|Randomization|Other reasons|2|||
48958769|NCT02935634|157679160|FG003|Randomization|Other reasons|0|||
48958770|NCT02935634|157679161|FG004|Randomization|Other reasons|0|||
48958771|NCT02935634|157679162|FG005|Randomization|Other reasons|0|||
48958772|NCT02935634|157679157|FG000|Treatment: Track 1|Disease progression|15|||
48958773|NCT02935634|157679158|FG001|Treatment: Track 1|Disease progression|17|||
48958774|NCT02935634|157679159|FG002|Treatment: Track 1|Disease progression|28|||
48958775|NCT02935634|157679160|FG003|Treatment: Track 1|Disease progression|4|||
48958776|NCT02935634|157679161|FG004|Treatment: Track 1|Disease progression|6|||
48958777|NCT02935634|157679162|FG005|Treatment: Track 1|Disease progression|2|||
48958778|NCT02935634|157679157|FG000|Treatment: Track 1|Adverse event unrelated to study drug|1|||
48958779|NCT02935634|157679158|FG001|Treatment: Track 1|Adverse event unrelated to study drug|1|||
48958780|NCT02935634|157679159|FG002|Treatment: Track 1|Adverse event unrelated to study drug|2|||
48958781|NCT02935634|157679160|FG003|Treatment: Track 1|Adverse event unrelated to study drug|3|||
48958782|NCT02935634|157679161|FG004|Treatment: Track 1|Adverse event unrelated to study drug|0|||
48958783|NCT02935634|157679162|FG005|Treatment: Track 1|Adverse event unrelated to study drug|3|||
48958784|NCT02935634|157679157|FG000|Treatment: Track 1|Lost to Follow-up|1|||
48958785|NCT02935634|157679158|FG001|Treatment: Track 1|Lost to Follow-up|0|||
48958786|NCT02935634|157679159|FG002|Treatment: Track 1|Lost to Follow-up|0|||
48958787|NCT02935634|157679160|FG003|Treatment: Track 1|Lost to Follow-up|0|||
48958788|NCT02935634|157679161|FG004|Treatment: Track 1|Lost to Follow-up|0|||
48958789|NCT02935634|157679162|FG005|Treatment: Track 1|Lost to Follow-up|0|||
48958790|NCT02935634|157679157|FG000|Treatment: Track 1|Study drug toxicity|2|||
48958791|NCT02935634|157679158|FG001|Treatment: Track 1|Study drug toxicity|1|||
48958792|NCT02935634|157679159|FG002|Treatment: Track 1|Study drug toxicity|3|||
48958793|NCT02935634|157679160|FG003|Treatment: Track 1|Study drug toxicity|0|||
48958794|NCT02935634|157679161|FG004|Treatment: Track 1|Study drug toxicity|0|||
48958795|NCT02935634|157679162|FG005|Treatment: Track 1|Study drug toxicity|1|||
48958796|NCT02935634|157679157|FG000|Treatment: Track 1|Participant request to discontinue treatment|1|||
48958797|NCT02935634|157679158|FG001|Treatment: Track 1|Participant request to discontinue treatment|0|||
48958798|NCT02935634|157679159|FG002|Treatment: Track 1|Participant request to discontinue treatment|1|||
48958799|NCT02935634|157679160|FG003|Treatment: Track 1|Participant request to discontinue treatment|0|||
48958800|NCT02935634|157679161|FG004|Treatment: Track 1|Participant request to discontinue treatment|1|||
48958801|NCT02935634|157679162|FG005|Treatment: Track 1|Participant request to discontinue treatment|0|||
48958802|NCT02935634|157679157|FG000|Treatment: Track 1|Participant withdrew consent|2|||
48958803|NCT02935634|157679158|FG001|Treatment: Track 1|Participant withdrew consent|0|||
48958804|NCT02935634|157679159|FG002|Treatment: Track 1|Participant withdrew consent|1|||
48958805|NCT02935634|157679160|FG003|Treatment: Track 1|Participant withdrew consent|0|||
48958806|NCT02935634|157679161|FG004|Treatment: Track 1|Participant withdrew consent|1|||
48958807|NCT02935634|157679162|FG005|Treatment: Track 1|Participant withdrew consent|0|||
48958808|NCT02935634|157679157|FG000|Treatment: Track 1|Other reasons|0|||
48958809|NCT02935634|157679158|FG001|Treatment: Track 1|Other reasons|0|||
48958810|NCT02935634|157679159|FG002|Treatment: Track 1|Other reasons|2|||
48958811|NCT02935634|157679160|FG003|Treatment: Track 1|Other reasons|0|||
48958812|NCT02935634|157679161|FG004|Treatment: Track 1|Other reasons|0|||
48958813|NCT02935634|157679162|FG005|Treatment: Track 1|Other reasons|0|||
48958814|NCT02935634|157679157|FG000|Treatment: Track 2|Disease progression|13|||
48958815|NCT02935634|157679158|FG001|Treatment: Track 2|Disease progression|26|||
48958816|NCT02935634|157679159|FG002|Treatment: Track 2|Disease progression|20|||
48958817|NCT02935634|157679160|FG003|Treatment: Track 2|Disease progression|5|||
48958818|NCT02935634|157679161|FG004|Treatment: Track 2|Disease progression|1|||
48958819|NCT02935634|157679162|FG005|Treatment: Track 2|Disease progression|4|||
48958820|NCT02935634|157679157|FG000|Treatment: Track 2|Adverse event unrelated to study drug|2|||
48958821|NCT02935634|157679158|FG001|Treatment: Track 2|Adverse event unrelated to study drug|2|||
48958822|NCT02935634|157679159|FG002|Treatment: Track 2|Adverse event unrelated to study drug|0|||
48958823|NCT02935634|157679160|FG003|Treatment: Track 2|Adverse event unrelated to study drug|0|||
48958824|NCT02935634|157679161|FG004|Treatment: Track 2|Adverse event unrelated to study drug|0|||
48958825|NCT02935634|157679162|FG005|Treatment: Track 2|Adverse event unrelated to study drug|0|||
48958826|NCT02935634|157679157|FG000|Treatment: Track 2|Study drug toxicity|7|||
48958827|NCT02935634|157679158|FG001|Treatment: Track 2|Study drug toxicity|3|||
48958828|NCT02935634|157679159|FG002|Treatment: Track 2|Study drug toxicity|0|||
48958829|NCT02935634|157679160|FG003|Treatment: Track 2|Study drug toxicity|0|||
48958830|NCT02935634|157679161|FG004|Treatment: Track 2|Study drug toxicity|0|||
48958831|NCT02935634|157679162|FG005|Treatment: Track 2|Study drug toxicity|0|||
48958832|NCT02935634|157679157|FG000|Treatment: Track 2|Participant request to discontinue treatment|0|||
48958833|NCT02935634|157679158|FG001|Treatment: Track 2|Participant request to discontinue treatment|2|||
48958834|NCT02935634|157679159|FG002|Treatment: Track 2|Participant request to discontinue treatment|1|||
48958835|NCT02935634|157679160|FG003|Treatment: Track 2|Participant request to discontinue treatment|0|||
48958836|NCT02935634|157679161|FG004|Treatment: Track 2|Participant request to discontinue treatment|0|||
48958837|NCT02935634|157679162|FG005|Treatment: Track 2|Participant request to discontinue treatment|0|||
48958838|NCT02935634|157679157|FG000|Treatment: Track 2|Participant withdrew consent|0|||
48958839|NCT02935634|157679158|FG001|Treatment: Track 2|Participant withdrew consent|1|||
48958840|NCT02935634|157679159|FG002|Treatment: Track 2|Participant withdrew consent|1|||
48958841|NCT02935634|157679160|FG003|Treatment: Track 2|Participant withdrew consent|0|||
48958842|NCT02935634|157679161|FG004|Treatment: Track 2|Participant withdrew consent|1|||
48958843|NCT02935634|157679162|FG005|Treatment: Track 2|Participant withdrew consent|0|||
48958844|NCT00913978|157679165|FG000|Overall Study|Surgeon choice|1|||
48958845|NCT00913978|157679166|FG001|Overall Study|Surgeon choice|3|||
48958846|NCT03150095|157679167|FG000|Overall Study|Death|0|||
48958847|NCT03150095|157679168|FG001|Overall Study|Death|1|||
48958848|NCT03150095|157679167|FG000|Overall Study|Lost to Follow-up|1|||
48958849|NCT03150095|157679168|FG001|Overall Study|Lost to Follow-up|1|||
48958850|NCT03150095|157679167|FG000|Overall Study|Withdrawal by Subject|4|||
48958851|NCT03150095|157679168|FG001|Overall Study|Withdrawal by Subject|0|||
48958852|NCT03150095|157679167|FG000|Overall Study|unable or unwilling to continue health coaching|4|||
48958853|NCT03150095|157679168|FG001|Overall Study|unable or unwilling to continue health coaching|0|||
48958854|NCT03471767|157679171|FG000|Overall Study|Withdrawal by Subject|3|||
48958855|NCT03471767|157679172|FG001|Overall Study|Withdrawal by Subject|1|||
48958856|NCT03471767|157679171|FG000|Overall Study|Adverse Event|1|||
48958857|NCT03471767|157679172|FG001|Overall Study|Adverse Event|0|||
48958858|NCT03471767|157679171|FG000|Overall Study|Lost to Follow-up|1|||
48958859|NCT03471767|157679172|FG001|Overall Study|Lost to Follow-up|0|||
48958860|NCT03471767|157679171|FG000|Overall Study|PI Withdrawal|1|||
48958861|NCT03471767|157679172|FG001|Overall Study|PI Withdrawal|3|||
48958862|NCT01514188|157679173|FG000|Overall Study|Adverse Event|3|||
48958863|NCT01514188|157679174|FG001|Overall Study|Adverse Event|5|||
48958864|NCT01514188|157679173|FG000|Overall Study|Withdrawal by Subject|2|||
48958865|NCT01514188|157679174|FG001|Overall Study|Withdrawal by Subject|4|||
48958866|NCT01514188|157679173|FG000|Overall Study|Protocol Violation|2|||
48958867|NCT01514188|157679174|FG001|Overall Study|Protocol Violation|4|||
48958868|NCT01514188|157679173|FG000|Overall Study|Physician Decision|0|||
48958869|NCT01514188|157679174|FG001|Overall Study|Physician Decision|2|||
48958870|NCT01514188|157679173|FG000|Overall Study|Disease Progression|13|||
48958871|NCT01514188|157679174|FG001|Overall Study|Disease Progression|14|||
48958872|NCT01514188|157679173|FG000|Overall Study|Death|1|||
48958873|NCT01514188|157679174|FG001|Overall Study|Death|3|||
48753194|NCT00429273|156942107|FG000|Overall Study|Lost to Follow-up|1|||
48753195|NCT00429273|156942108|FG001|Overall Study|Lost to Follow-up|2|||
48753196|NCT00429273|156942109|FG002|Overall Study|Lost to Follow-up|2|||
48753197|NCT00429273|156942107|FG000|Overall Study|Physician Decision|6|||
48753198|NCT00429273|156942108|FG001|Overall Study|Physician Decision|5|||
48753199|NCT00429273|156942109|FG002|Overall Study|Physician Decision|5|||
48753200|NCT00429273|156942107|FG000|Overall Study|Adverse Event|1|||
48753201|NCT00429273|156942108|FG001|Overall Study|Adverse Event|1|||
48753202|NCT00429273|156942109|FG002|Overall Study|Adverse Event|2|||
48753203|NCT02259582|156942114|FG000|Overall Study|Physician Decision|0|||
48753204|NCT02259582|156942115|FG001|Overall Study|Physician Decision|1|||
48753205|NCT02259582|156942116|FG002|Overall Study|Physician Decision|0|||
48753206|NCT02259582|156942114|FG000|Overall Study|Death|0|||
48753207|NCT02259582|156942115|FG001|Overall Study|Death|0|||
48753208|NCT02259582|156942116|FG002|Overall Study|Death|1|||
48753209|NCT02259582|156942114|FG000|Overall Study|Adverse Event|1|||
48753210|NCT02259582|156942115|FG001|Overall Study|Adverse Event|0|||
48753211|NCT02259582|156942116|FG002|Overall Study|Adverse Event|1|||
48753212|NCT02259582|156942114|FG000|Overall Study|Withdrawal by Subject|0|||
48753213|NCT02259582|156942115|FG001|Overall Study|Withdrawal by Subject|0|||
48753214|NCT02259582|156942116|FG002|Overall Study|Withdrawal by Subject|1|||
48753215|NCT02259582|156942114|FG000|Overall Study|Disease progression|14|||
48753216|NCT02259582|156942115|FG001|Overall Study|Disease progression|15|||
48753217|NCT02259582|156942116|FG002|Overall Study|Disease progression|17|||
48753218|NCT02259582|156942114|FG000|Overall Study|Lack of Subject Adherence to Protocol|1|||
48753219|NCT02259582|156942115|FG001|Overall Study|Lack of Subject Adherence to Protocol|1|||
48753220|NCT02259582|156942116|FG002|Overall Study|Lack of Subject Adherence to Protocol|1|||
48753221|NCT03585504|156942122|FG000|Overall Study|Lost to Follow-up|26|||
48753222|NCT03585504|156942123|FG001|Overall Study|Lost to Follow-up|29|||
48753223|NCT00617123|156942133|FG000|Referral Screening Period|Did Not Meet Protocol Eligibility|36|||
48753224|NCT00617123|156942134|FG001|Referral Screening Period|Did Not Meet Protocol Eligibility|24|||
48753225|NCT00617123|156942133|FG000|Referral Screening Period|Did Not Wish To Continue|3|||
48753226|NCT00617123|156942134|FG001|Referral Screening Period|Did Not Wish To Continue|1|||
48753227|NCT00617123|156942133|FG000|Referral Screening Period|Adverse Event|0|||
48753228|NCT00617123|156942134|FG001|Referral Screening Period|Adverse Event|1|||
48753229|NCT00617123|156942133|FG000|Study Treatment Period|Withdrawal by Subject|8|||
48753230|NCT00617123|156942134|FG001|Study Treatment Period|Withdrawal by Subject|12|||
48753231|NCT00617123|156942133|FG000|Study Treatment Period|Adverse Event|7|||
48753232|NCT00617123|156942134|FG001|Study Treatment Period|Adverse Event|3|||
48753233|NCT00617123|156942133|FG000|Study Treatment Period|Did Not Meet Protocol Eligibility|2|||
48753234|NCT00617123|156942134|FG001|Study Treatment Period|Did Not Meet Protocol Eligibility|0|||
48753235|NCT00617123|156942133|FG000|Study Treatment Period|Noncompliance with Protocol|0|||
48753236|NCT00617123|156942134|FG001|Study Treatment Period|Noncompliance with Protocol|1|||
48753237|NCT02289898|156942135|FG000|Overall Study|Death|5|||
48958874|NCT01514188|157679173|FG000|Overall Study|Other|2|||
48958875|NCT01514188|157679174|FG001|Overall Study|Other|1|||
48958876|NCT01153763|157679175|FG000|Overall Study|Study Closed|16|||
48958877|NCT01153763|157679175|FG000|Overall Study|Lost to Follow-up|1|||
48958878|NCT01153763|157679175|FG000|Overall Study|Physician Decision|2|||
48958879|NCT01153763|157679175|FG000|Overall Study|Withdrawal by Subject|2|||
48958880|NCT01474746|157679176|FG000|Overall Study|Lost to Follow-up|1|||
48958881|NCT01474746|157679177|FG001|Overall Study|Lost to Follow-up|1|||
48958882|NCT01474746|157679176|FG000|Overall Study|Withdrawal by Subject|2|||
48958883|NCT01474746|157679177|FG001|Overall Study|Withdrawal by Subject|1|||
48753238|NCT02289898|156942136|FG001|Overall Study|Death|4|||
48753239|NCT02289898|156942137|FG002|Overall Study|Death|3|||
48753240|NCT02289898|156942135|FG000|Overall Study|Physician Decision|2|||
48753241|NCT02289898|156942136|FG001|Overall Study|Physician Decision|5|||
48753242|NCT02289898|156942137|FG002|Overall Study|Physician Decision|2|||
48753243|NCT02289898|156942135|FG000|Overall Study|Withdrawal by Subject|0|||
48753244|NCT02289898|156942136|FG001|Overall Study|Withdrawal by Subject|4|||
48753245|NCT02289898|156942137|FG002|Overall Study|Withdrawal by Subject|1|||
48753246|NCT02289898|156942135|FG000|Overall Study|Adverse Event|3|||
48753247|NCT02289898|156942136|FG001|Overall Study|Adverse Event|5|||
48753248|NCT02289898|156942137|FG002|Overall Study|Adverse Event|5|||
48753249|NCT02289898|156942135|FG000|Overall Study|Disease progression|34|||
48753250|NCT02289898|156942136|FG001|Overall Study|Disease progression|28|||
48753251|NCT02289898|156942137|FG002|Overall Study|Disease progression|34|||
48753252|NCT02289898|156942135|FG000|Overall Study|Use of another anticancer therapy|0|||
48753253|NCT02289898|156942136|FG001|Overall Study|Use of another anticancer therapy|0|||
48753254|NCT02289898|156942137|FG002|Overall Study|Use of another anticancer therapy|1|||
48753255|NCT02289898|156942135|FG000|Overall Study|Other|8|||
48753256|NCT02289898|156942136|FG001|Overall Study|Other|7|||
48753257|NCT02289898|156942137|FG002|Overall Study|Other|10|||
48753258|NCT00885105|156942138|FG000|Overall Study|Withdrawal by Subject|0|||
48753259|NCT00885105|156942139|FG001|Overall Study|Withdrawal by Subject|8|||
48753260|NCT00885105|156942138|FG000|Overall Study|Adverse Event|1|||
48753261|NCT00885105|156942139|FG001|Overall Study|Adverse Event|0|||
48753262|NCT00885105|156942138|FG000|Overall Study|Protocol Violation|0|||
48753263|NCT00885105|156942139|FG001|Overall Study|Protocol Violation|2|||
48753264|NCT00166114|156942141|FG000|Overall Study|Protocol Violation|2|||
48753265|NCT00166114|156942142|FG001|Overall Study|Protocol Violation|1|||
48753266|NCT00166114|156942141|FG000|Overall Study|Withdrawal by Subject|10|||
48958884|NCT01766336|157679178|FG000|Overall Study|Adverse Event|11|||
49015410|NCT02739984|157892174|FG000|Overall Study|Withdrawal by Subject|1|||
48958885|NCT01766336|157679179|FG001|Overall Study|Adverse Event|8|||
48865183|NCT02379078|157341928|FG000|Overall Study|Lost to Follow-up|33|||
48865184|NCT02379078|157341929|FG001|Overall Study|Lost to Follow-up|30|||
48865185|NCT02379078|157341928|FG000|Overall Study|Withdrawal by Subject|6|||
48865186|NCT02379078|157341929|FG001|Overall Study|Withdrawal by Subject|5|||
48865187|NCT04057937|157341930|FG000|Placebo-controlled Phase|Adverse Event|3|||
48865188|NCT04057937|157341931|FG001|Placebo-controlled Phase|Adverse Event|0|||
48865189|NCT04057937|157341930|FG000|Active-treatment Phase|Withdrawal by Subject|1|||
48865190|NCT04057937|157341931|FG001|Active-treatment Phase|Withdrawal by Subject|0|||
48865191|NCT04057937|157341930|FG000|Active-treatment Phase|Pregnancy|0|||
48865192|NCT04057937|157341931|FG001|Active-treatment Phase|Pregnancy|1|||
48865193|NCT04057937|157341930|FG000|Active-treatment Phase|Physician Decision|0|||
48865194|NCT04057937|157341931|FG001|Active-treatment Phase|Physician Decision|1|||
48865195|NCT00005908|157341935|FG000|Overall Study|Withdrawal by Subject|1|||
48865196|NCT00005908|157341936|FG001|Overall Study|Withdrawal by Subject|0|||
48865197|NCT01268488|157341937|FG000|Overall Study|Adverse Event|3|||
48865198|NCT01268488|157341937|FG000|Overall Study|Physician Decision|2|||
48865199|NCT00938041|157341940|FG000|Overall Study|Lost to Follow-up|6|||
48865200|NCT00938041|157341940|FG000|Overall Study|Received Alternative Therapy|1|||
48865201|NCT00938041|157341940|FG000|Overall Study|Progressive Disease|5|||
48865202|NCT00938041|157341940|FG000|Overall Study|Death|12|||
48865203|NCT00938041|157341940|FG000|Overall Study|Adrenal Insufficiency|3|||
48865204|NCT00404547|157341941|FG000|Overall Study|Adverse Event|39|||
48865205|NCT00404547|157341942|FG001|Overall Study|Adverse Event|6|||
48865206|NCT00404547|157341941|FG000|Overall Study|Withdrawal by Subject|19|||
48865207|NCT00404547|157341942|FG001|Overall Study|Withdrawal by Subject|2|||
48865208|NCT00404547|157341941|FG000|Overall Study|Protocol Violation|0|||
48865209|NCT00404547|157341942|FG001|Overall Study|Protocol Violation|1|||
48865210|NCT00404547|157341941|FG000|Overall Study|Lost to Follow-up|20|||
48865211|NCT00404547|157341942|FG001|Overall Study|Lost to Follow-up|9|||
48865212|NCT00404547|157341941|FG000|Overall Study|Lack of compliance|5|||
48865213|NCT00404547|157341942|FG001|Overall Study|Lack of compliance|1|||
48865214|NCT00404547|157341941|FG000|Overall Study|Other|4|||
48865215|NCT00404547|157341942|FG001|Overall Study|Other|0|||
48865216|NCT00404547|157341941|FG000|Overall Study|Reason not stated|3|||
48865217|NCT00404547|157341942|FG001|Overall Study|Reason not stated|6|||
48865218|NCT04543942|157341947|FG000|First Intervention (2-3 Days)|Scheduling conflict|2|||
48865219|NCT04543942|157341948|FG001|First Intervention (2-3 Days)|Scheduling conflict|2|||
48865220|NCT04543942|157341947|FG000|Interval Period (2 Weeks)|scheduling conflict|1|||
48958886|NCT01766336|157679178|FG000|Overall Study|Death|4|||
49098988|NCT04064411|158197011|FG001|Overall Study|Lost to Follow-up|2|||
48753267|NCT00166114|156942142|FG001|Overall Study|Withdrawal by Subject|4|||
48753268|NCT00166114|156942141|FG000|Overall Study|Adverse Event|2|||
48753269|NCT00166114|156942142|FG001|Overall Study|Adverse Event|1|||
48753270|NCT01074450|156942153|FG000|First Intervention|Emesis in Dosing Interval|0|||
48753271|NCT01074450|156942154|FG001|First Intervention|Emesis in Dosing Interval|2|||
48753272|NCT01074450|156942153|FG000|Second Intervention|Protocol Violation|1|||
48753273|NCT01074450|156942154|FG001|Second Intervention|Protocol Violation|0|||
48753274|NCT01074450|156942153|FG000|Second Intervention|Physician Decision|0|||
48753275|NCT01074450|156942154|FG001|Second Intervention|Physician Decision|1|||
48753276|NCT01574326|156942155|FG000|Overall Study|Randomized but not treated|0|||
48753277|NCT01574326|156942156|FG001|Overall Study|Randomized but not treated|1|||
48753278|NCT01574326|156942155|FG000|Overall Study|Withdrawal by Participant|2|||
48753279|NCT01574326|156942156|FG001|Overall Study|Withdrawal by Participant|4|||
48753280|NCT01574326|156942155|FG000|Overall Study|Physician Decision|5|||
48753281|NCT01574326|156942156|FG001|Overall Study|Physician Decision|3|||
48753282|NCT01574326|156942155|FG000|Overall Study|Adverse Event|1|||
48753283|NCT01574326|156942156|FG001|Overall Study|Adverse Event|3|||
48753284|NCT01574326|156942155|FG000|Overall Study|Other: Mainly kidney transplant|8|||
48753285|NCT01574326|156942156|FG001|Overall Study|Other: Mainly kidney transplant|8|||
48753286|NCT01195415|156942157|FG000|Overall Study|No repeat biopsy due to progression|2|||
48753287|NCT01585194|156942163|FG000|Overall Study|Withdrawal by Subject|1|||
48753288|NCT01585194|156942163|FG000|Overall Study|Physician Decision|2|||
48753289|NCT01585194|156942163|FG000|Overall Study|Lack of insurance|1|||
48753290|NCT01962207|156942164|FG000|Persistence Phase (5 Years)|Lost to Follow-up|2|||
48753291|NCT01962207|156942165|FG001|Persistence Phase (5 Years)|Lost to Follow-up|1|||
48753292|NCT01962207|156942166|FG002|Persistence Phase (5 Years)|Lost to Follow-up|5|||
48753293|NCT01962207|156942167|FG003|Persistence Phase (5 Years)|Lost to Follow-up|2|||
48753294|NCT01962207|156942164|FG000|Persistence Phase (5 Years)|Migrated/moved from study area|2|||
48753295|NCT01962207|156942165|FG001|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
48753296|NCT01962207|156942166|FG002|Persistence Phase (5 Years)|Migrated/moved from study area|4|||
48753297|NCT01962207|156942167|FG003|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
48753298|NCT01962207|156942164|FG000|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
48753299|NCT01962207|156942165|FG001|Persistence Phase (5 Years)|Withdrawal by Subject|5|||
48865221|NCT04543942|157341948|FG001|Interval Period (2 Weeks)|scheduling conflict|1|||
48865222|NCT02522299|157341949|FG000|Overall Study|Adverse Event|2|||
48865223|NCT02522299|157341950|FG001|Overall Study|Adverse Event|0|||
48865224|NCT02522299|157341949|FG000|Overall Study|Physician Decision|0|||
48865225|NCT02522299|157341950|FG001|Overall Study|Physician Decision|1|||
48865226|NCT02522299|157341949|FG000|Overall Study|Withdrawal by Subject|2|||
48865227|NCT02522299|157341950|FG001|Overall Study|Withdrawal by Subject|0|||
48865228|NCT01446042|157341951|FG000|Overall Study|Withdrawal by Subject|12|||
48865229|NCT01446042|157341952|FG001|Overall Study|Withdrawal by Subject|2|||
48865230|NCT01446042|157341953|FG002|Overall Study|Withdrawal by Subject|4|||
48865231|NCT01446042|157341951|FG000|Overall Study|Adverse Event|1|||
48865232|NCT01446042|157341952|FG001|Overall Study|Adverse Event|0|||
48865233|NCT01446042|157341953|FG002|Overall Study|Adverse Event|4|||
48865234|NCT01446042|157341951|FG000|Overall Study|Lost to Follow-up|5|||
48865235|NCT01446042|157341952|FG001|Overall Study|Lost to Follow-up|0|||
48865236|NCT01446042|157341953|FG002|Overall Study|Lost to Follow-up|0|||
48865237|NCT01446042|157341951|FG000|Overall Study|Other reasons|2|||
48865238|NCT01446042|157341952|FG001|Overall Study|Other reasons|1|||
48865239|NCT01446042|157341953|FG002|Overall Study|Other reasons|1|||
48865240|NCT01622088|157341954|FG000|Overall Study|Adverse Event|20|||
48865241|NCT01622088|157341954|FG000|Overall Study|Lost to Follow-up|1|||
48865242|NCT01622088|157341954|FG000|Overall Study|Withdrawal by Subject|20|||
48865243|NCT01622088|157341954|FG000|Overall Study|Investigator Decision|1|||
48865244|NCT01622088|157341954|FG000|Overall Study|Death|53|||
48865245|NCT01622088|157341954|FG000|Overall Study|STUDY TERMINATED EARLY BY SPONSOR|521|||
48865246|NCT04362176|157341956|FG000|Overall Study|Lost to Follow-up|5|||
48865247|NCT04362176|157341957|FG001|Overall Study|Lost to Follow-up|8|||
48865248|NCT04362176|157341956|FG000|Overall Study|Withdrawn (Participant/PI withdrew consent)|8|||
48865249|NCT04362176|157341957|FG001|Overall Study|Withdrawn (Participant/PI withdrew consent)|6|||
48865250|NCT00607789|157341958|FG000|Overall Study|Adverse Event|3|||
48865251|NCT00607789|157341959|FG001|Overall Study|Adverse Event|0|||
48865252|NCT00607789|157341958|FG000|Overall Study|Lack of Efficacy|0|||
48865253|NCT00607789|157341959|FG001|Overall Study|Lack of Efficacy|1|||
48865254|NCT00607789|157341958|FG000|Overall Study|Inadequate adherence|3|||
48865255|NCT00607789|157341959|FG001|Overall Study|Inadequate adherence|0|||
48865256|NCT00607789|157341958|FG000|Overall Study|Lost to Follow-up|0|||
48865257|NCT00607789|157341959|FG001|Overall Study|Lost to Follow-up|5|||
48865258|NCT00607789|157341958|FG000|Overall Study|Withdrawal by Subject|1|||
48865259|NCT00607789|157341959|FG001|Overall Study|Withdrawal by Subject|0|||
48865260|NCT01313299|157341961|FG000|Overall Study|Adverse Event|3|||
48865261|NCT01313299|157341962|FG001|Overall Study|Adverse Event|1|||
48865262|NCT01313299|157341963|FG002|Overall Study|Adverse Event|1|||
48958887|NCT01766336|157679179|FG001|Overall Study|Death|3|||
48958888|NCT01766336|157679178|FG000|Overall Study|Lost to Follow-up|1|||
48958889|NCT01766336|157679179|FG001|Overall Study|Lost to Follow-up|3|||
48958890|NCT01766336|157679178|FG000|Overall Study|Physician Decision|4|||
48958891|NCT01766336|157679179|FG001|Overall Study|Physician Decision|2|||
48958892|NCT01766336|157679178|FG000|Overall Study|Protocol Violation|0|||
48958893|NCT01766336|157679179|FG001|Overall Study|Protocol Violation|1|||
48958894|NCT01766336|157679178|FG000|Overall Study|Sponsor Decision|52|||
48958895|NCT01766336|157679179|FG001|Overall Study|Sponsor Decision|43|||
48958896|NCT01766336|157679178|FG000|Overall Study|Withdrawal by Subject|18|||
48958897|NCT01766336|157679179|FG001|Overall Study|Withdrawal by Subject|15|||
48958898|NCT04360187|157679180|FG000|Double-Blind Treatment|Adverse Event|9|||
48958899|NCT04360187|157679181|FG001|Double-Blind Treatment|Adverse Event|11|||
48958900|NCT04360187|157679180|FG000|Double-Blind Treatment|Lack of Efficacy|7|||
48958901|NCT04360187|157679181|FG001|Double-Blind Treatment|Lack of Efficacy|2|||
48958902|NCT04360187|157679180|FG000|Double-Blind Treatment|Physician Decision|1|||
48958903|NCT04360187|157679181|FG001|Double-Blind Treatment|Physician Decision|0|||
48958904|NCT04360187|157679180|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
48958905|NCT04360187|157679181|FG001|Double-Blind Treatment|Withdrawal by Subject|2|||
48958906|NCT04360187|157679180|FG000|Double-Blind Treatment|Withdrawal By Parent/Guardian|2|||
48958907|NCT04360187|157679181|FG001|Double-Blind Treatment|Withdrawal By Parent/Guardian|0|||
48958908|NCT04360187|157679180|FG000|Follow-Up|Lost to Follow-up|1|||
48958909|NCT04360187|157679181|FG001|Follow-Up|Lost to Follow-up|0|||
48958910|NCT04544709|157679182|FG000|Overall Study|The study was discontinued due to low enrollment.|3|||
48958911|NCT02435277|157679183|FG000|Overall Study|Adverse Event|1|||
48958912|NCT02435277|157679184|FG001|Overall Study|Adverse Event|1|||
48958913|NCT02435277|157679185|FG002|Overall Study|Adverse Event|0|||
48753300|NCT01962207|156942166|FG002|Persistence Phase (5 Years)|Withdrawal by Subject|18|||
48753301|NCT01962207|156942167|FG003|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
48753302|NCT01962207|156942164|FG000|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
48753303|NCT01962207|156942165|FG001|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
48753304|NCT01962207|156942166|FG002|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3|||
48753305|NCT01962207|156942167|FG003|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1|||
48958914|NCT02435277|157679186|FG003|Overall Study|Adverse Event|0|||
48958915|NCT02435277|157679183|FG000|Overall Study|Withdrawal by Subject|1|||
48958916|NCT02435277|157679184|FG001|Overall Study|Withdrawal by Subject|0|||
48958917|NCT02435277|157679185|FG002|Overall Study|Withdrawal by Subject|0|||
48753306|NCT01962207|156942164|FG000|Persistence Phase (5 Years)|Adverse Event|0|||
48753307|NCT01962207|156942165|FG001|Persistence Phase (5 Years)|Adverse Event|0|||
48753308|NCT01962207|156942166|FG002|Persistence Phase (5 Years)|Adverse Event|1|||
48753309|NCT01962207|156942167|FG003|Persistence Phase (5 Years)|Adverse Event|0|||
48753310|NCT01962207|156942164|FG000|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21|||
48958918|NCT02435277|157679186|FG003|Overall Study|Withdrawal by Subject|0|||
48958919|NCT01577160|157679187|FG000|Overall Study|Adverse Event|9|||
48958920|NCT01577160|157679187|FG000|Overall Study|Lack of Efficacy|15|||
48958921|NCT01577160|157679187|FG000|Overall Study|Lost to Follow-up|40|||
48958922|NCT01577160|157679187|FG000|Overall Study|Withdrawal by Subject|18|||
48958923|NCT01577160|157679187|FG000|Overall Study|Subject Uncooperative|7|||
48958924|NCT01577160|157679187|FG000|Overall Study|Other|9|||
48958925|NCT01067508|157679188|FG000|Overall Study|Physician Decision|0|||
48958926|NCT01067508|157679189|FG001|Overall Study|Physician Decision|1|||
48958927|NCT01067508|157679188|FG000|Overall Study|Withdrawal by Subject|0|||
48958928|NCT01067508|157679189|FG001|Overall Study|Withdrawal by Subject|1|||
48958929|NCT03126539|157679190|FG000|Overall Study|Lost to Follow-up|1|||
48958930|NCT03126539|157679191|FG001|Overall Study|Lost to Follow-up|1|||
48958931|NCT03126539|157679192|FG002|Overall Study|Lost to Follow-up|1|||
49015411|NCT02739984|157892175|FG001|Overall Study|Withdrawal by Subject|1|||
48958932|NCT03126539|157679193|FG003|Overall Study|Lost to Follow-up|0|||
48958933|NCT03126539|157679194|FG004|Overall Study|Lost to Follow-up|0|||
48958934|NCT04715230|157679195|FG000|Overall Study|Withdrawal by Subject|1|||
48958935|NCT04715230|157679196|FG001|Overall Study|Withdrawal by Subject|0|||
48958936|NCT04715230|157679197|FG002|Overall Study|Withdrawal by Subject|0|||
48958937|NCT04715230|157679195|FG000|Overall Study|Lost to Follow-up|0|||
48958938|NCT04715230|157679196|FG001|Overall Study|Lost to Follow-up|5|||
48958939|NCT04715230|157679197|FG002|Overall Study|Lost to Follow-up|1|||
48958940|NCT00444626|157679198|FG000|Initial Treatment Period|Withdrawal by Subject|2|||
48958941|NCT00444626|157679198|FG000|Initial Treatment Period|Adverse Event|1|||
48958942|NCT00444626|157679198|FG000|Initial Treatment Period|Lost to Follow-up|9|||
48958943|NCT01551758|157679201|FG000|Overall Study|Adverse Event|29|||
48958944|NCT01551758|157679202|FG001|Overall Study|Adverse Event|43|||
48958945|NCT01551758|157679201|FG000|Overall Study|Lack of Efficacy|0|||
48958946|NCT01551758|157679202|FG001|Overall Study|Lack of Efficacy|1|||
48958947|NCT01551758|157679201|FG000|Overall Study|Protocol Violation|5|||
48958948|NCT01551758|157679202|FG001|Overall Study|Protocol Violation|6|||
48958949|NCT01551758|157679201|FG000|Overall Study|Met Protocol-defined stopping criteria|8|||
48958950|NCT01551758|157679202|FG001|Overall Study|Met Protocol-defined stopping criteria|10|||
48958951|NCT01551758|157679201|FG000|Overall Study|Lost to Follow-up|29|||
48958952|NCT01551758|157679202|FG001|Overall Study|Lost to Follow-up|25|||
48958953|NCT01551758|157679201|FG000|Overall Study|Physician Decision|9|||
48958954|NCT01551758|157679202|FG001|Overall Study|Physician Decision|3|||
48958955|NCT01551758|157679201|FG000|Overall Study|Withdrawal by Subject|14|||
48958956|NCT01551758|157679202|FG001|Overall Study|Withdrawal by Subject|17|||
48958957|NCT03352414|157679206|FG000|Overall Study|Ineligible by operative criteria|12|||
48958958|NCT03352414|157679207|FG001|Overall Study|Ineligible by operative criteria|10|||
48958959|NCT02632110|157679208|FG000|Overall Study|Withdrawal by Subject|1|||
48958960|NCT02632110|157679209|FG001|Overall Study|Withdrawal by Subject|1|||
48958961|NCT02632110|157679210|FG002|Overall Study|Withdrawal by Subject|0|||
48958962|NCT02632110|157679211|FG003|Overall Study|Withdrawal by Subject|0|||
48958963|NCT02632110|157679212|FG004|Overall Study|Withdrawal by Subject|1|||
48958964|NCT02632110|157679213|FG005|Overall Study|Withdrawal by Subject|1|||
48958965|NCT02632110|157679214|FG006|Overall Study|Withdrawal by Subject|3|||
48958966|NCT02632110|157679215|FG007|Overall Study|Withdrawal by Subject|3|||
48958967|NCT02632110|157679216|FG008|Overall Study|Withdrawal by Subject|1|||
48958968|NCT02632110|157679217|FG009|Overall Study|Withdrawal by Subject|1|||
48958969|NCT00008138|157679220|FG000|Neoadjuvant Chemotherapy|Adverse Event|3|||
48958970|NCT00008138|157679220|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|3|||
48958971|NCT00008138|157679220|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|6|||
48958972|NCT00008138|157679220|FG000|Neoadjuvant Chemotherapy|not protocol specified|8|||
48958973|NCT00008138|157679220|FG000|Interval Debulking|Withdrawal by Subject|2|||
48958974|NCT00008138|157679220|FG000|Post-Cytoreduction Chemotherapy|Adverse Event|6|||
48958975|NCT00008138|157679220|FG000|Post-Cytoreduction Chemotherapy|Progression|1|||
48958976|NCT00008138|157679220|FG000|Post-Cytoreduction Chemotherapy|not protocol specified|1|||
48958977|NCT03453151|157679221|FG000|Overall Study|Withdrawal by Subject|1|||
48958978|NCT03453151|157679221|FG000|Overall Study|Physician Decision|3|||
48958979|NCT00516269|157679222|FG000|Overall Study|Adverse Event|2|||
48958980|NCT00516269|157679223|FG001|Overall Study|Adverse Event|1|||
48958981|NCT00516269|157679222|FG000|Overall Study|Lost to Follow-up|0|||
48958982|NCT00516269|157679223|FG001|Overall Study|Lost to Follow-up|1|||
48958983|NCT00516269|157679222|FG000|Overall Study|Protocol Violation|0|||
48753311|NCT01962207|156942165|FG001|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7|||
48958984|NCT00516269|157679223|FG001|Overall Study|Protocol Violation|1|||
48958985|NCT03213626|157679224|FG000|Overall Study|Adverse Event|1|||
48958986|NCT03213626|157679224|FG000|Overall Study|Progressive Disease|6|||
48958987|NCT02596711|157679225|FG000|Overall Study|Lost to Follow-up|1|||
48958988|NCT02596711|157679226|FG001|Overall Study|Lost to Follow-up|2|||
48958989|NCT02596711|157679227|FG002|Overall Study|Lost to Follow-up|3|||
48958990|NCT02618928|157679228|FG000|Overall Study|Failure to Return|28|||
48958991|NCT02618928|157679228|FG000|Overall Study|Insufficient Virological Response|1|||
48958992|NCT02618928|157679228|FG000|Overall Study|Withdrawal by Subject|2|||
48958993|NCT02618928|157679228|FG000|Overall Study|Death|3|||
48958994|NCT02618928|157679228|FG000|Overall Study|Other|11|||
48958995|NCT02618928|157679228|FG000|Overall Study|Missing|6|||
48958996|NCT02618928|157679228|FG000|Overall Study|Treatment Never Started|7|||
48958997|NCT03670641|157679229|FG000|Overall Study|Lost to Follow-up|3|||
48958998|NCT01511419|157679230|FG000|Dose 2|Physician Decision|1|||
48958999|NCT01511419|157679231|FG001|Dose 2|Physician Decision|0|||
48959000|NCT00586924|157679232|FG000|Overall Study|Adverse event/serious adverse event|0|||
48959001|NCT00586924|157679233|FG001|Overall Study|Adverse event/serious adverse event|0|||
48959002|NCT00586924|157679234|FG002|Overall Study|Adverse event/serious adverse event|0|||
48959003|NCT00586924|157679235|FG003|Overall Study|Adverse event/serious adverse event|1|||
48959004|NCT00586924|157679236|FG004|Overall Study|Adverse event/serious adverse event|0|||
48959005|NCT00586924|157679237|FG005|Overall Study|Adverse event/serious adverse event|2|||
48959006|NCT00586924|157679232|FG000|Overall Study|Initiation of alternative cancer therapy|0|||
48959007|NCT00586924|157679233|FG001|Overall Study|Initiation of alternative cancer therapy|0|||
48959008|NCT00586924|157679234|FG002|Overall Study|Initiation of alternative cancer therapy|0|||
48959009|NCT00586924|157679235|FG003|Overall Study|Initiation of alternative cancer therapy|0|||
48753312|NCT01962207|156942166|FG002|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13|||
48753313|NCT01962207|156942167|FG003|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5|||
48753314|NCT02154490|156944178|FG000|Overall Study|No tissue submitted|23|||
48753315|NCT02154490|156944178|FG000|Overall Study|No biomarker results|167|||
48753316|NCT02154490|156944178|FG000|Overall Study|Not assigned to a sub-study|270|||
48753317|NCT02154490|156944178|FG000|Overall Study|Did not register to a sub-study|749|||
48753318|NCT01991067|156944179|FG000|Overall Study|Lost to Follow-up|6|||
48753319|NCT01991067|156944180|FG001|Overall Study|Lost to Follow-up|5|||
48753320|NCT02989194|156944187|FG000|Overall Study|Study on hold for safety and participant was withdrawn|1|||
48753321|NCT02989194|156944188|FG001|Overall Study|Study on hold for safety and participant was withdrawn|0|||
48753322|NCT02989194|156944189|FG002|Overall Study|Study on hold for safety and participant was withdrawn|0|||
48753323|NCT02989194|156944187|FG000|Overall Study|Lost to Follow-up|0|||
48753324|NCT02989194|156944188|FG001|Overall Study|Lost to Follow-up|1|||
48753325|NCT02989194|156944189|FG002|Overall Study|Lost to Follow-up|0|||
48753326|NCT02989194|156944187|FG000|Overall Study|Withdrawal by Subject|0|||
48753327|NCT02989194|156944188|FG001|Overall Study|Withdrawal by Subject|1|||
48753328|NCT02989194|156944189|FG002|Overall Study|Withdrawal by Subject|0|||
48753329|NCT00004978|156944190|FG000|Overall Study|Death|107|||
48753330|NCT00004978|156944191|FG001|Overall Study|Death|116|||
48753331|NCT00004978|156944190|FG000|Overall Study|Lost to Follow-up|101|||
48753332|NCT00004978|156944191|FG001|Overall Study|Lost to Follow-up|108|||
48753333|NCT00004978|156944190|FG000|Overall Study|Withdrawal by Subject|17|||
48753334|NCT00004978|156944191|FG001|Overall Study|Withdrawal by Subject|26|||
48753335|NCT00004978|156944190|FG000|Overall Study|site closure - not in analysis cohort|19|||
48753336|NCT00004978|156944191|FG001|Overall Study|site closure - not in analysis cohort|20|||
48753337|NCT02064868|156944192|FG000|Overall Study|Lost to Follow-up|14|||
48753338|NCT02064868|156944193|FG001|Overall Study|Lost to Follow-up|8|||
48753339|NCT02064868|156944192|FG000|Overall Study|Physician Decision|1|||
48753340|NCT02064868|156944193|FG001|Overall Study|Physician Decision|0|||
48753341|NCT02064868|156944192|FG000|Overall Study|Withdrawal by Subject|14|||
48753342|NCT02064868|156944193|FG001|Overall Study|Withdrawal by Subject|3|||
48753343|NCT02064868|156944192|FG000|Overall Study|Technical Problems or Missing|5|||
48753344|NCT02064868|156944193|FG001|Overall Study|Technical Problems or Missing|2|||
48753345|NCT00617773|156944196|FG000|Overall Study|Physician Decision|1|||
48753346|NCT00617773|156944196|FG000|Overall Study|Lack of compliance with the protocol|1|||
48959010|NCT00586924|157679236|FG004|Overall Study|Initiation of alternative cancer therapy|0|||
48753347|NCT00617773|156944196|FG000|Overall Study|Withdrawal by Subject|1|||
48753348|NCT00617773|156944196|FG000|Overall Study|Death|1|||
48753349|NCT00617773|156944196|FG000|Overall Study|Progressive disease|19|||
48959011|NCT00586924|157679237|FG005|Overall Study|Initiation of alternative cancer therapy|1|||
48959012|NCT00586924|157679232|FG000|Overall Study|Disease progression|0|||
48959013|NCT00586924|157679233|FG001|Overall Study|Disease progression|0|||
48959014|NCT00586924|157679234|FG002|Overall Study|Disease progression|0|||
48959015|NCT00586924|157679235|FG003|Overall Study|Disease progression|1|||
48959016|NCT00586924|157679236|FG004|Overall Study|Disease progression|1|||
48959017|NCT00586924|157679237|FG005|Overall Study|Disease progression|0|||
48959018|NCT00586924|157679232|FG000|Overall Study|Development of neutralizing antibodies|2|||
48959019|NCT00586924|157679233|FG001|Overall Study|Development of neutralizing antibodies|2|||
48959020|NCT00586924|157679234|FG002|Overall Study|Development of neutralizing antibodies|2|||
48959021|NCT00586924|157679235|FG003|Overall Study|Development of neutralizing antibodies|0|||
48959022|NCT00586924|157679236|FG004|Overall Study|Development of neutralizing antibodies|0|||
48959023|NCT00586924|157679237|FG005|Overall Study|Development of neutralizing antibodies|22|||
48959024|NCT00586924|157679232|FG000|Overall Study|Complete response|0|||
48959025|NCT00586924|157679233|FG001|Overall Study|Complete response|1|||
48959026|NCT00586924|157679234|FG002|Overall Study|Complete response|0|||
48959027|NCT00586924|157679235|FG003|Overall Study|Complete response|0|||
48959028|NCT00586924|157679236|FG004|Overall Study|Complete response|2|||
48959029|NCT00586924|157679237|FG005|Overall Study|Complete response|2|||
48959030|NCT00586924|157679232|FG000|Overall Study|Other|1|||
48959031|NCT00586924|157679233|FG001|Overall Study|Other|0|||
48959032|NCT00586924|157679234|FG002|Overall Study|Other|1|||
48959033|NCT00586924|157679235|FG003|Overall Study|Other|1|||
48959034|NCT00586924|157679236|FG004|Overall Study|Other|1|||
48959035|NCT00586924|157679237|FG005|Overall Study|Other|6|||
48959036|NCT03691610|157679242|FG000|Overall Study|Adverse Event|0|||
48959037|NCT03691610|157679243|FG001|Overall Study|Adverse Event|1|||
48959038|NCT03691610|157679244|FG002|Overall Study|Adverse Event|0|||
48959039|NCT03691610|157679245|FG003|Overall Study|Adverse Event|0|||
48959040|NCT03691610|157679242|FG000|Overall Study|Protocol Deviation|15|||
48959041|NCT03691610|157679243|FG001|Overall Study|Protocol Deviation|8|||
48959042|NCT03691610|157679244|FG002|Overall Study|Protocol Deviation|1|||
48959043|NCT03691610|157679245|FG003|Overall Study|Protocol Deviation|2|||
48959044|NCT03691610|157679242|FG000|Overall Study|Withdrawal by Parent/Guardian|47|||
48959045|NCT03691610|157679243|FG001|Overall Study|Withdrawal by Parent/Guardian|60|||
48959046|NCT03691610|157679244|FG002|Overall Study|Withdrawal by Parent/Guardian|7|||
48959047|NCT03691610|157679245|FG003|Overall Study|Withdrawal by Parent/Guardian|6|||
48959048|NCT03691610|157679242|FG000|Overall Study|Lost to Follow-up|20|||
48959049|NCT03691610|157679243|FG001|Overall Study|Lost to Follow-up|11|||
48959050|NCT03691610|157679244|FG002|Overall Study|Lost to Follow-up|5|||
48959051|NCT03691610|157679245|FG003|Overall Study|Lost to Follow-up|2|||
48959052|NCT00937768|157679247|FG000|Overall Study|Refused Further Treatment|3|||
48959053|NCT00937768|157679248|FG001|Overall Study|Refused Further Treatment|2|||
48959054|NCT00937768|157679247|FG000|Overall Study|Disease Progression|1|||
48959055|NCT00937768|157679248|FG001|Overall Study|Disease Progression|1|||
48959056|NCT00937768|157679247|FG000|Overall Study|Alternate Treatment|0|||
48959057|NCT00937768|157679248|FG001|Overall Study|Alternate Treatment|1|||
48959058|NCT00937768|157679247|FG000|Overall Study|No Further Funding|4|||
48959059|NCT00937768|157679248|FG001|Overall Study|No Further Funding|4|||
48959060|NCT00786838|157679249|FG000|Overall Study|Physician Decision|4|||
48959061|NCT00786838|157679249|FG000|Overall Study|Death|4|||
48959062|NCT00786838|157679249|FG000|Overall Study|Adverse Event|6|||
48959063|NCT00786838|157679249|FG000|Overall Study|Progressive disease|31|||
48959064|NCT00786838|157679249|FG000|Overall Study|Withdrawal by Subject|4|||
48959065|NCT04570657|157679252|FG000|Overall Study|Adverse Event|0|||
48959066|NCT04570657|157679253|FG001|Overall Study|Adverse Event|0|||
48959067|NCT04570657|157679254|FG002|Overall Study|Adverse Event|1|||
48959068|NCT04570657|157679252|FG000|Overall Study|Lost to Follow-up|0|||
48959069|NCT04570657|157679253|FG001|Overall Study|Lost to Follow-up|0|||
48959070|NCT04570657|157679254|FG002|Overall Study|Lost to Follow-up|1|||
48959071|NCT04570657|157679252|FG000|Overall Study|Physician Decision|0|||
48959072|NCT04570657|157679253|FG001|Overall Study|Physician Decision|1|||
48959073|NCT04570657|157679254|FG002|Overall Study|Physician Decision|0|||
48959074|NCT04570657|157679252|FG000|Overall Study|Withdrawal by Subject|1|||
48959075|NCT04570657|157679253|FG001|Overall Study|Withdrawal by Subject|2|||
48959076|NCT04570657|157679254|FG002|Overall Study|Withdrawal by Subject|2|||
48959077|NCT02065622|157679255|FG000|Induction Study|Adverse Event|13|||
48959078|NCT02065622|157679256|FG001|Induction Study|Adverse Event|19|||
48959079|NCT02065622|157679257|FG002|Induction Study|Adverse Event|0|||
48959080|NCT02065622|157679258|FG003|Induction Study|Adverse Event|0|||
48959081|NCT02065622|157679259|FG004|Induction Study|Adverse Event|0|||
48959082|NCT02065622|157679255|FG000|Induction Study|Withdrawal by Subject|3|||
48959083|NCT02065622|157679256|FG001|Induction Study|Withdrawal by Subject|5|||
48959084|NCT02065622|157679257|FG002|Induction Study|Withdrawal by Subject|0|||
48959085|NCT02065622|157679258|FG003|Induction Study|Withdrawal by Subject|0|||
48959086|NCT02065622|157679259|FG004|Induction Study|Withdrawal by Subject|0|||
48959087|NCT02065622|157679255|FG000|Induction Study|Lost to Follow-up|1|||
48959088|NCT02065622|157679256|FG001|Induction Study|Lost to Follow-up|0|||
48959089|NCT02065622|157679257|FG002|Induction Study|Lost to Follow-up|0|||
48959090|NCT02065622|157679258|FG003|Induction Study|Lost to Follow-up|0|||
48959091|NCT02065622|157679259|FG004|Induction Study|Lost to Follow-up|0|||
48959092|NCT02065622|157679255|FG000|Induction Study|Lack of Efficacy|22|||
48959093|NCT02065622|157679256|FG001|Induction Study|Lack of Efficacy|27|||
48959094|NCT02065622|157679257|FG002|Induction Study|Lack of Efficacy|0|||
48959095|NCT02065622|157679258|FG003|Induction Study|Lack of Efficacy|0|||
48959096|NCT02065622|157679259|FG004|Induction Study|Lack of Efficacy|0|||
48959097|NCT02065622|157679255|FG000|Induction Study|Requires Alternative/Prohibited Therapy|4|||
48959098|NCT02065622|157679256|FG001|Induction Study|Requires Alternative/Prohibited Therapy|5|||
48959099|NCT02065622|157679257|FG002|Induction Study|Requires Alternative/Prohibited Therapy|0|||
48959100|NCT02065622|157679258|FG003|Induction Study|Requires Alternative/Prohibited Therapy|0|||
48959101|NCT02065622|157679259|FG004|Induction Study|Requires Alternative/Prohibited Therapy|0|||
48959102|NCT02065622|157679255|FG000|Induction Study|Subject Noncompliance|1|||
48959103|NCT02065622|157679256|FG001|Induction Study|Subject Noncompliance|1|||
48959104|NCT02065622|157679257|FG002|Induction Study|Subject Noncompliance|0|||
48959105|NCT02065622|157679258|FG003|Induction Study|Subject Noncompliance|0|||
48959106|NCT02065622|157679259|FG004|Induction Study|Subject Noncompliance|0|||
48959107|NCT02065622|157679255|FG000|Induction Study|Other, Not Specified|3|||
48959108|NCT02065622|157679256|FG001|Induction Study|Other, Not Specified|2|||
48959109|NCT02065622|157679257|FG002|Induction Study|Other, Not Specified|0|||
48959110|NCT02065622|157679258|FG003|Induction Study|Other, Not Specified|0|||
48959111|NCT02065622|157679259|FG004|Induction Study|Other, Not Specified|0|||
48959112|NCT02065622|157679255|FG000|Maintenance Study|Adverse Event|0|||
48959113|NCT02065622|157679256|FG001|Maintenance Study|Adverse Event|0|||
48959114|NCT02065622|157679257|FG002|Maintenance Study|Adverse Event|25|||
48959115|NCT02065622|157679258|FG003|Maintenance Study|Adverse Event|22|||
48959116|NCT02065622|157679259|FG004|Maintenance Study|Adverse Event|11|||
48959117|NCT02065622|157679255|FG000|Maintenance Study|Withdrawal by Subject|0|||
48959118|NCT02065622|157679256|FG001|Maintenance Study|Withdrawal by Subject|0|||
48959119|NCT02065622|157679257|FG002|Maintenance Study|Withdrawal by Subject|11|||
48959120|NCT02065622|157679258|FG003|Maintenance Study|Withdrawal by Subject|5|||
48959121|NCT02065622|157679259|FG004|Maintenance Study|Withdrawal by Subject|7|||
48959122|NCT02065622|157679255|FG000|Maintenance Study|Lost to Follow-up|0|||
48959123|NCT02065622|157679256|FG001|Maintenance Study|Lost to Follow-up|0|||
48959124|NCT02065622|157679257|FG002|Maintenance Study|Lost to Follow-up|4|||
48959125|NCT02065622|157679258|FG003|Maintenance Study|Lost to Follow-up|1|||
48959126|NCT02065622|157679259|FG004|Maintenance Study|Lost to Follow-up|1|||
48959127|NCT02065622|157679255|FG000|Maintenance Study|Lack of Efficacy|0|||
48959128|NCT02065622|157679256|FG001|Maintenance Study|Lack of Efficacy|0|||
48959129|NCT02065622|157679257|FG002|Maintenance Study|Lack of Efficacy|70|||
48959130|NCT02065622|157679258|FG003|Maintenance Study|Lack of Efficacy|55|||
48959131|NCT02065622|157679259|FG004|Maintenance Study|Lack of Efficacy|19|||
48959132|NCT02065622|157679255|FG000|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
48959133|NCT02065622|157679256|FG001|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
48959134|NCT02065622|157679257|FG002|Maintenance Study|Requires Alternative/Prohibited Therapy|7|||
48959135|NCT02065622|157679258|FG003|Maintenance Study|Requires Alternative/Prohibited Therapy|3|||
48959136|NCT02065622|157679259|FG004|Maintenance Study|Requires Alternative/Prohibited Therapy|4|||
48959137|NCT02065622|157679255|FG000|Maintenance Study|Subject Non-Compliance|0|||
48959138|NCT02065622|157679256|FG001|Maintenance Study|Subject Non-Compliance|0|||
48959139|NCT02065622|157679257|FG002|Maintenance Study|Subject Non-Compliance|1|||
48959140|NCT02065622|157679258|FG003|Maintenance Study|Subject Non-Compliance|3|||
48959141|NCT02065622|157679259|FG004|Maintenance Study|Subject Non-Compliance|2|||
48959142|NCT02065622|157679255|FG000|Maintenance Study|Other, Not Specified|0|||
48959143|NCT02065622|157679256|FG001|Maintenance Study|Other, Not Specified|0|||
48959144|NCT02065622|157679257|FG002|Maintenance Study|Other, Not Specified|6|||
48959145|NCT02065622|157679258|FG003|Maintenance Study|Other, Not Specified|14|||
48959146|NCT02065622|157679259|FG004|Maintenance Study|Other, Not Specified|2|||
48959147|NCT02065622|157679255|FG000|Maintenance Study|Unknown Reason|0|||
48959148|NCT02065622|157679256|FG001|Maintenance Study|Unknown Reason|0|||
48959149|NCT02065622|157679257|FG002|Maintenance Study|Unknown Reason|0|||
48959150|NCT02065622|157679258|FG003|Maintenance Study|Unknown Reason|1|||
48959151|NCT02065622|157679259|FG004|Maintenance Study|Unknown Reason|0|||
48753350|NCT00617773|156944196|FG000|Overall Study|Protocol Violation|1|||
48753351|NCT00418314|156944197|FG000|Overall Study|Withdrawal by Subject|1|||
48753352|NCT00418314|156944198|FG001|Overall Study|Withdrawal by Subject|2|||
48753353|NCT03824912|156944202|FG000|Overall Study|Lost to Follow-up|18|||
48753354|NCT03824912|156944203|FG001|Overall Study|Lost to Follow-up|15|||
48753355|NCT03824912|156944204|FG002|Overall Study|Lost to Follow-up|8|||
48753356|NCT03824912|156944202|FG000|Overall Study|Negative Baseline Culture Result|118|||
48753357|NCT03824912|156944203|FG001|Overall Study|Negative Baseline Culture Result|112|||
48753358|NCT03824912|156944204|FG002|Overall Study|Negative Baseline Culture Result|57|||
48753359|NCT03824912|156944202|FG000|Overall Study|Non-Compliance with Study Drug|0|||
48753360|NCT03824912|156944203|FG001|Overall Study|Non-Compliance with Study Drug|0|||
48753361|NCT03824912|156944204|FG002|Overall Study|Non-Compliance with Study Drug|1|||
48753362|NCT03824912|156944202|FG000|Overall Study|Protocol Violation|1|||
48753363|NCT03824912|156944203|FG001|Overall Study|Protocol Violation|4|||
48753364|NCT03824912|156944204|FG002|Overall Study|Protocol Violation|1|||
48753365|NCT03824912|156944202|FG000|Overall Study|Withdrawal by Subject|3|||
48753366|NCT03824912|156944203|FG001|Overall Study|Withdrawal by Subject|2|||
48753367|NCT03824912|156944204|FG002|Overall Study|Withdrawal by Subject|1|||
48753368|NCT03824912|156944202|FG000|Overall Study|Participation in another study|0|||
48753369|NCT03824912|156944203|FG001|Overall Study|Participation in another study|1|||
48753370|NCT03824912|156944204|FG002|Overall Study|Participation in another study|0|||
48753371|NCT01349803|156944205|FG000|Overall Study|Adverse Event|0|||
48753372|NCT01349803|156944206|FG001|Overall Study|Adverse Event|0|||
48753373|NCT01349803|156944207|FG002|Overall Study|Adverse Event|0|||
48753374|NCT01349803|156944208|FG003|Overall Study|Adverse Event|2|||
48753375|NCT01349803|156944205|FG000|Overall Study|Withdrawal by Subject|1|||
48753376|NCT01349803|156944206|FG001|Overall Study|Withdrawal by Subject|0|||
48753377|NCT01349803|156944207|FG002|Overall Study|Withdrawal by Subject|0|||
48753378|NCT01349803|156944208|FG003|Overall Study|Withdrawal by Subject|0|||
48753379|NCT01349803|156944205|FG000|Overall Study|Protocol-specified criteria|0|||
48753380|NCT01349803|156944206|FG001|Overall Study|Protocol-specified criteria|1|||
48959152|NCT02998554|157679265|FG000|Overall Study|Adverse Event|8|||
48753381|NCT01349803|156944207|FG002|Overall Study|Protocol-specified criteria|3|||
48753382|NCT01349803|156944208|FG003|Overall Study|Protocol-specified criteria|0|||
48753383|NCT01244906|156944209|FG000|Overall Study|Death|2|||
48753384|NCT01244906|156944209|FG000|Overall Study|Progression of disease post treatment|6|||
48753385|NCT03934931|156944210|FG000|Overall Study|Excluded as a duplicate enrollment|1|||
48753386|NCT03934931|156944211|FG001|Overall Study|Excluded as a duplicate enrollment|0|||
48753387|NCT03934931|156944212|FG002|Overall Study|Excluded as a duplicate enrollment|0|||
48959153|NCT02998554|157679266|FG001|Overall Study|Adverse Event|3|||
48959154|NCT02998554|157679265|FG000|Overall Study|Protocol deviation|1|||
48959155|NCT02998554|157679266|FG001|Overall Study|Protocol deviation|0|||
48959156|NCT02998554|157679265|FG000|Overall Study|Withdrawal by Subject|2|||
48959157|NCT02998554|157679266|FG001|Overall Study|Withdrawal by Subject|6|||
48959158|NCT02998554|157679265|FG000|Overall Study|Lost to Follow-up|0|||
48959159|NCT02998554|157679266|FG001|Overall Study|Lost to Follow-up|1|||
48959160|NCT02998554|157679265|FG000|Overall Study|Lack of Efficacy|0|||
48959161|NCT02998554|157679266|FG001|Overall Study|Lack of Efficacy|1|||
48959162|NCT01496430|157679268|FG000|Overall Study|Adverse Event|0|||
48959163|NCT01496430|157679269|FG001|Overall Study|Adverse Event|0|||
48959164|NCT01496430|157679270|FG002|Overall Study|Adverse Event|1|||
48959165|NCT01496430|157679268|FG000|Overall Study|Major Protocol Deviation|0|||
48959166|NCT01496430|157679269|FG001|Overall Study|Major Protocol Deviation|0|||
48959167|NCT01496430|157679270|FG002|Overall Study|Major Protocol Deviation|1|||
48959168|NCT01496430|157679268|FG000|Overall Study|Lost to Follow-up|2|||
48959169|NCT01496430|157679269|FG001|Overall Study|Lost to Follow-up|3|||
48959170|NCT01496430|157679270|FG002|Overall Study|Lost to Follow-up|1|||
48959171|NCT01496430|157679268|FG000|Overall Study|Voluntary Withdrawal|2|||
48959172|NCT01496430|157679269|FG001|Overall Study|Voluntary Withdrawal|1|||
48959173|NCT01496430|157679270|FG002|Overall Study|Voluntary Withdrawal|6|||
48959174|NCT01496430|157679268|FG000|Overall Study|Principal Investigator Discretion|0|||
48959175|NCT01496430|157679269|FG001|Overall Study|Principal Investigator Discretion|1|||
48959176|NCT01496430|157679270|FG002|Overall Study|Principal Investigator Discretion|1|||
48753388|NCT00460408|156944213|FG000|Overall Study|Adverse Event|1|||
48753389|NCT00460408|156944214|FG001|Overall Study|Adverse Event|0|||
48753390|NCT00460408|156944215|FG002|Overall Study|Adverse Event|0|||
48753391|NCT00460408|156944216|FG003|Overall Study|Adverse Event|0|||
48959177|NCT01496430|157679268|FG000|Overall Study|Other|2|||
48959178|NCT01496430|157679269|FG001|Overall Study|Other|0|||
48959179|NCT01496430|157679270|FG002|Overall Study|Other|0|||
48959180|NCT04167306|157679271|FG000|Overall Study|Lost to Follow-up|2|||
48959181|NCT04167306|157679272|FG001|Overall Study|Lost to Follow-up|2|||
48959182|NCT04167306|157679273|FG002|Overall Study|Lost to Follow-up|5|||
48959183|NCT04167306|157679274|FG003|Overall Study|Lost to Follow-up|5|||
48959184|NCT04167306|157679271|FG000|Overall Study|Adverse Event|13|||
48959185|NCT04167306|157679272|FG001|Overall Study|Adverse Event|14|||
48959186|NCT04167306|157679273|FG002|Overall Study|Adverse Event|5|||
48959187|NCT04167306|157679274|FG003|Overall Study|Adverse Event|4|||
48959188|NCT04167306|157679271|FG000|Overall Study|Withdrawal by Subject|4|||
48959189|NCT04167306|157679272|FG001|Overall Study|Withdrawal by Subject|6|||
48959190|NCT04167306|157679273|FG002|Overall Study|Withdrawal by Subject|8|||
48959191|NCT04167306|157679274|FG003|Overall Study|Withdrawal by Subject|3|||
48959192|NCT04167306|157679271|FG000|Overall Study|covid|1|||
48959193|NCT04167306|157679272|FG001|Overall Study|covid|1|||
48753392|NCT00460408|156944213|FG000|Overall Study|Death|7|||
48753393|NCT00460408|156944214|FG001|Overall Study|Death|0|||
48753394|NCT00460408|156944215|FG002|Overall Study|Death|0|||
48753395|NCT00460408|156944216|FG003|Overall Study|Death|0|||
48753396|NCT00460408|156944213|FG000|Overall Study|Lost to Follow-up|11|||
48753397|NCT00460408|156944214|FG001|Overall Study|Lost to Follow-up|0|||
48753398|NCT00460408|156944215|FG002|Overall Study|Lost to Follow-up|1|||
48753399|NCT00460408|156944216|FG003|Overall Study|Lost to Follow-up|0|||
48753400|NCT00460408|156944213|FG000|Overall Study|Withdrawal by Subject|31|||
48753401|NCT00460408|156944214|FG001|Overall Study|Withdrawal by Subject|0|||
48753402|NCT00460408|156944215|FG002|Overall Study|Withdrawal by Subject|0|||
48753403|NCT00460408|156944216|FG003|Overall Study|Withdrawal by Subject|0|||
48959194|NCT04167306|157679273|FG002|Overall Study|covid|2|||
48753404|NCT00460408|156944213|FG000|Overall Study|Insufficient clinical response|5|||
48753405|NCT00460408|156944214|FG001|Overall Study|Insufficient clinical response|1|||
48959195|NCT04167306|157679274|FG003|Overall Study|covid|1|||
48865263|NCT01313299|157341961|FG000|Overall Study|Lost to Follow-up|1|||
48865264|NCT01313299|157341962|FG001|Overall Study|Lost to Follow-up|0|||
48865265|NCT01313299|157341963|FG002|Overall Study|Lost to Follow-up|0|||
48865266|NCT01313299|157341961|FG000|Overall Study|Protocol Violation|2|||
48865267|NCT01313299|157341962|FG001|Overall Study|Protocol Violation|0|||
48865268|NCT01313299|157341963|FG002|Overall Study|Protocol Violation|0|||
48865269|NCT01313299|157341961|FG000|Overall Study|Withdrawal by Subject|1|||
48865270|NCT01313299|157341962|FG001|Overall Study|Withdrawal by Subject|0|||
48865271|NCT01313299|157341963|FG002|Overall Study|Withdrawal by Subject|2|||
48865272|NCT01313299|157341961|FG000|Overall Study|Family reason and moved out of state|0|||
48865273|NCT01313299|157341962|FG001|Overall Study|Family reason and moved out of state|2|||
48865274|NCT01313299|157341963|FG002|Overall Study|Family reason and moved out of state|0|||
48865275|NCT01313299|157341961|FG000|Overall Study|Lack of subject compliance|0|||
48865276|NCT01313299|157341962|FG001|Overall Study|Lack of subject compliance|0|||
48865277|NCT01313299|157341963|FG002|Overall Study|Lack of subject compliance|1|||
48865278|NCT02971683|157341969|FG000|Double-Blind (24 Weeks)|Other reasons|0|||
48865279|NCT02971683|157341970|FG001|Double-Blind (24 Weeks)|Other reasons|1|||
48865280|NCT02971683|157341969|FG000|Double-Blind (24 Weeks)|Poor/Non-Compliance|0|||
48865281|NCT02971683|157341970|FG001|Double-Blind (24 Weeks)|Poor/Non-Compliance|1|||
48865282|NCT02971683|157341969|FG000|Double-Blind (24 Weeks)|Lost to Follow-up|1|||
48865283|NCT02971683|157341970|FG001|Double-Blind (24 Weeks)|Lost to Follow-up|0|||
49015412|NCT02739984|157892174|FG000|Overall Study|Death|0|||
48959196|NCT04167306|157679271|FG000|Overall Study|concomitant medication|0|||
48959197|NCT04167306|157679272|FG001|Overall Study|concomitant medication|0|||
48865284|NCT02971683|157341969|FG000|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
48865285|NCT02971683|157341970|FG001|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
48865286|NCT02971683|157341969|FG000|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
48865287|NCT02971683|157341970|FG001|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
48865288|NCT02971683|157341969|FG000|Double-Blind (24 Weeks)|Adverse Event|0|||
48865289|NCT02971683|157341970|FG001|Double-Blind (24 Weeks)|Adverse Event|2|||
48865290|NCT02971683|157341969|FG000|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
48865291|NCT02971683|157341970|FG001|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
48959198|NCT04167306|157679273|FG002|Overall Study|concomitant medication|0|||
48959199|NCT04167306|157679274|FG003|Overall Study|concomitant medication|1|||
48959200|NCT04167306|157679271|FG000|Overall Study|Alcohol treatment|0|||
48959201|NCT04167306|157679272|FG001|Overall Study|Alcohol treatment|4|||
48959202|NCT04167306|157679273|FG002|Overall Study|Alcohol treatment|3|||
48959203|NCT04167306|157679274|FG003|Overall Study|Alcohol treatment|2|||
48959204|NCT04167306|157679271|FG000|Overall Study|non-compliance|0|||
48959205|NCT04167306|157679272|FG001|Overall Study|non-compliance|0|||
48959206|NCT04167306|157679273|FG002|Overall Study|non-compliance|1|||
48959207|NCT04167306|157679274|FG003|Overall Study|non-compliance|0|||
48753406|NCT00460408|156944215|FG002|Overall Study|Insufficient clinical response|5|||
48753407|NCT00460408|156944216|FG003|Overall Study|Insufficient clinical response|0|||
48753408|NCT00460408|156944213|FG000|Overall Study|Other|12|||
48753409|NCT00460408|156944214|FG001|Overall Study|Other|2|||
48753410|NCT00460408|156944215|FG002|Overall Study|Other|0|||
48753411|NCT00460408|156944216|FG003|Overall Study|Other|0|||
48753412|NCT00865124|156944217|FG000|Overall Study|Physician Decision|2|||
48753413|NCT00865124|156944218|FG001|Overall Study|Physician Decision|1|||
48753414|NCT00865124|156944219|FG002|Overall Study|Physician Decision|0|||
48753415|NCT00865124|156944217|FG000|Overall Study|Withdrawn consent|2|||
48753416|NCT00865124|156944218|FG001|Overall Study|Withdrawn consent|0|||
48753417|NCT00865124|156944219|FG002|Overall Study|Withdrawn consent|0|||
48753418|NCT01601626|156944220|FG000|Overall Study|Death|1|||
48753419|NCT01601626|156944221|FG001|Overall Study|Death|1|||
48753420|NCT01601626|156944222|FG002|Overall Study|Death|1|||
48753421|NCT01601626|156944220|FG000|Overall Study|Lost to Follow-up|1|||
48753422|NCT01601626|156944221|FG001|Overall Study|Lost to Follow-up|2|||
48959208|NCT04167306|157679271|FG000|Overall Study|incorrectly randomized or did not commence study drug|1|||
48753423|NCT01601626|156944222|FG002|Overall Study|Lost to Follow-up|0|||
48753424|NCT01601626|156944220|FG000|Overall Study|Unable to Get to Clinic|0|||
48753425|NCT01601626|156944221|FG001|Overall Study|Unable to Get to Clinic|1|||
48753426|NCT01601626|156944222|FG002|Overall Study|Unable to Get to Clinic|0|||
49015413|NCT02739984|157892175|FG001|Overall Study|Death|1|||
48959209|NCT04167306|157679272|FG001|Overall Study|incorrectly randomized or did not commence study drug|1|||
48959210|NCT04167306|157679273|FG002|Overall Study|incorrectly randomized or did not commence study drug|2|||
48959211|NCT04167306|157679274|FG003|Overall Study|incorrectly randomized or did not commence study drug|0|||
48959212|NCT01232894|157679275|FG000|Overall Study|Lost to Follow-up|0|||
48959213|NCT01232894|157679276|FG001|Overall Study|Lost to Follow-up|1|||
48959214|NCT01232894|157679275|FG000|Overall Study|Death|1|||
48959215|NCT01232894|157679276|FG001|Overall Study|Death|0|||
48959216|NCT01232894|157679275|FG000|Overall Study|Protocol Violation|1|||
48959217|NCT01232894|157679276|FG001|Overall Study|Protocol Violation|1|||
48959218|NCT01232894|157679275|FG000|Overall Study|Withdrawal by Subject|8|||
48959219|NCT01232894|157679276|FG001|Overall Study|Withdrawal by Subject|5|||
48959220|NCT01232894|157679275|FG000|Overall Study|Physician Decision|2|||
48959221|NCT01232894|157679276|FG001|Overall Study|Physician Decision|1|||
48959222|NCT00115804|157679277|FG000|Overall Study|Adverse Event|2|||
48959223|NCT03050359|157680880|FG000|Overall Study|Randomized But Not Treated|2|||
48959224|NCT03050359|157680881|FG001|Overall Study|Randomized But Not Treated|0|||
48959225|NCT03050359|157680880|FG000|Overall Study|Pretreatment Event/Adverse Event|5|||
48959226|NCT03050359|157680881|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
48959227|NCT03050359|157680880|FG000|Overall Study|Significant Protocol Deviation|2|||
48959228|NCT03050359|157680881|FG001|Overall Study|Significant Protocol Deviation|3|||
48959229|NCT03050359|157680880|FG000|Overall Study|Lost to Follow-up|2|||
48959230|NCT03050359|157680881|FG001|Overall Study|Lost to Follow-up|1|||
48959231|NCT03050359|157680880|FG000|Overall Study|Voluntary Withdrawal|4|||
48959232|NCT03050359|157680881|FG001|Overall Study|Voluntary Withdrawal|6|||
48959233|NCT03050359|157680880|FG000|Overall Study|Pregnancy|1|||
48959234|NCT03050359|157680881|FG001|Overall Study|Pregnancy|0|||
48959235|NCT03050359|157680880|FG000|Overall Study|Reason Not Specified|1|||
48959236|NCT03050359|157680881|FG001|Overall Study|Reason Not Specified|0|||
48959237|NCT03509207|157680883|FG000|Overall Study|Death|2|||
48959238|NCT01104558|157680884|FG000|Overall Study|Protocol Violation|6|||
48959239|NCT01104558|157680884|FG000|Overall Study|Missing of primary efficacy assessment|10|||
48959240|NCT01104558|157680884|FG000|Overall Study|Missing of genetic analysis results|1|||
48959241|NCT04494633|157680885|FG000|Overall Study|Lost to Follow-up|5|||
48959242|NCT04494633|157680886|FG001|Overall Study|Lost to Follow-up|3|||
48959243|NCT04494633|157680885|FG000|Overall Study|Protocol Violation|1|||
48959244|NCT04494633|157680886|FG001|Overall Study|Protocol Violation|1|||
48959245|NCT00667251|157680887|FG000|Overall Study|Adverse Event|13|||
48959246|NCT00667251|157680888|FG001|Overall Study|Adverse Event|4|||
48959247|NCT00667251|157680887|FG000|Overall Study|Withdrawal by Subject|6|||
48959248|NCT00667251|157680888|FG001|Overall Study|Withdrawal by Subject|2|||
48959249|NCT00667251|157680887|FG000|Overall Study|Other/missing|46|||
48959250|NCT00667251|157680888|FG001|Overall Study|Other/missing|84|||
48959251|NCT00667251|157680887|FG000|Overall Study|Intercurrent Illness|4|||
48959252|NCT00667251|157680888|FG001|Overall Study|Intercurrent Illness|3|||
48959253|NCT00667251|157680887|FG000|Overall Study|Symptomatic progression|1|||
48959254|NCT00667251|157680888|FG001|Overall Study|Symptomatic progression|2|||
48959255|NCT00315705|157680889|FG000|Phase 1|Refused further treatment|1|||
48959256|NCT00315705|157680889|FG000|Phase 1|Failure to achieve response|8|||
48959257|NCT00315705|157680889|FG000|Phase 1|Disease relapse|4|||
48959258|NCT00315705|157680889|FG000|Phase 1|Scheduled for transplant|9|||
48959259|NCT00315705|157680889|FG000|Phase 1|Death|3|||
48959260|NCT00315705|157680889|FG000|Phase 2|Physician Decision|4|||
48959261|NCT00315705|157680889|FG000|Phase 2|Adverse Event|1|||
48959262|NCT00315705|157680889|FG000|Phase 2|Failure to achieve response|3|||
48959263|NCT00315705|157680889|FG000|Phase 2|Disease relapse|1|||
48959264|NCT00315705|157680889|FG000|Phase 2|Scheduled for transplant|8|||
48959265|NCT00315705|157680889|FG000|Phase 2|Other|1|||
48959266|NCT00315705|157680889|FG000|Phase 2|Death|7|||
48959267|NCT00748553|157680890|FG000|Overall Study|Adverse Event|0|||
48959268|NCT00748553|157680891|FG001|Overall Study|Adverse Event|1|||
48959269|NCT00748553|157680890|FG000|Overall Study|disease progression|2|||
48959270|NCT00748553|157680891|FG001|Overall Study|disease progression|0|||
48959271|NCT00748553|157680890|FG000|Overall Study|noncompliance|1|||
48959272|NCT00748553|157680891|FG001|Overall Study|noncompliance|0|||
48959273|NCT01346371|157680892|FG000|Overall Study|Lost to Follow-up|2|||
48959274|NCT01346371|157680893|FG001|Overall Study|Lost to Follow-up|0|||
48959275|NCT01251276|157680894|FG000|Overall Study|Protocol Violation|1|||
48959276|NCT01251276|157680895|FG001|Overall Study|Protocol Violation|0|||
48959277|NCT01251276|157680894|FG000|Overall Study|Lost to Follow-up|0|||
48959278|NCT01251276|157680895|FG001|Overall Study|Lost to Follow-up|1|||
48959279|NCT02653976|157680896|FG000|Overall Study|Withdrawal by Subject|5|||
48959280|NCT02653976|157680896|FG000|Overall Study|Death|4|||
48959281|NCT00568958|157680897|FG000|Allocation|Withdrawal by Subject|7|||
48959282|NCT00568958|157680898|FG001|Allocation|Withdrawal by Subject|3|||
48959283|NCT00568958|157680897|FG000|Allocation|Physician Decision|2|||
48959284|NCT00568958|157680898|FG001|Allocation|Physician Decision|0|||
48959285|NCT00568958|157680897|FG000|Follow-Up|Withdrawal by Subject|6|||
48959286|NCT00568958|157680898|FG001|Follow-Up|Withdrawal by Subject|6|||
48959287|NCT00568958|157680897|FG000|Follow-Up|Physician Decision|1|||
48959288|NCT00568958|157680898|FG001|Follow-Up|Physician Decision|1|||
48959289|NCT00568958|157680897|FG000|Follow-Up|Family Emergency|1|||
48959290|NCT00568958|157680898|FG001|Follow-Up|Family Emergency|0|||
48959291|NCT00568958|157680897|FG000|Follow-Up|Adverse Event|1|||
48959292|NCT00568958|157680898|FG001|Follow-Up|Adverse Event|0|||
48959293|NCT01640925|157680899|FG000|Overall Study|Withdrawal by Subject|1|||
48959294|NCT01640925|157680900|FG001|Overall Study|Withdrawal by Subject|0|||
48959295|NCT01640925|157680899|FG000|Overall Study|Previously enrolled in this trial|13|||
48959296|NCT01640925|157680900|FG001|Overall Study|Previously enrolled in this trial|11|||
48959297|NCT01754922|157680905|FG000|Overall Study|Adverse Event|0|||
48959298|NCT01754922|157680906|FG001|Overall Study|Adverse Event|1|||
48959299|NCT01944969|157680907|FG000|Overall Study|Adverse Event|1|||
48959300|NCT01944969|157680907|FG000|Overall Study|Lack of Efficacy|1|||
48959301|NCT01944969|157680907|FG000|Overall Study|Non-compliance with IMP|1|||
48959302|NCT01944969|157680907|FG000|Overall Study|Administrative or other reasons|23|||
48959303|NCT00288860|157680908|FG000|Overall Study|Did not complete intake|4|||
48959304|NCT00288860|157680909|FG001|Overall Study|Did not complete intake|8|||
48959305|NCT00288860|157680908|FG000|Overall Study|Death|4|||
48959306|NCT00288860|157680909|FG001|Overall Study|Death|3|||
48959307|NCT00288860|157680908|FG000|Overall Study|Withdrawal by Subject|20|||
48959308|NCT00288860|157680909|FG001|Overall Study|Withdrawal by Subject|15|||
48959309|NCT00288860|157680908|FG000|Overall Study|Lost to Follow-up|74|||
48959310|NCT00288860|157680909|FG001|Overall Study|Lost to Follow-up|71|||
48959311|NCT03298412|157680910|FG000|Run-in Period|Other, Not Specified|1|||
48959312|NCT03298412|157680910|FG000|Run-in Period|Disease Progression|1|||
48959313|NCT03298412|157680910|FG000|Run-in Period|Ineligibility Determined|1|||
48959314|NCT03298412|157680910|FG000|Run-in Period|Decision by Sponsor|6|||
48959315|NCT00882999|157680913|FG000|Overall Study|Adverse Event|0|||
48959316|NCT00882999|157680914|FG001|Overall Study|Adverse Event|0|||
48959317|NCT00882999|157680915|FG002|Overall Study|Adverse Event|0|||
48959318|NCT00882999|157680916|FG003|Overall Study|Adverse Event|0|||
48959319|NCT00882999|157680917|FG004|Overall Study|Adverse Event|1|||
48959320|NCT00882999|157680918|FG005|Overall Study|Adverse Event|0|||
48959321|NCT00882999|157680919|FG006|Overall Study|Adverse Event|0|||
48959322|NCT00882999|157680913|FG000|Overall Study|Death|0|||
48959323|NCT00882999|157680914|FG001|Overall Study|Death|1|||
48959324|NCT00882999|157680915|FG002|Overall Study|Death|0|||
48959325|NCT00882999|157680916|FG003|Overall Study|Death|0|||
48959326|NCT00882999|157680917|FG004|Overall Study|Death|0|||
48959327|NCT00882999|157680918|FG005|Overall Study|Death|0|||
48959328|NCT00882999|157680919|FG006|Overall Study|Death|0|||
48959329|NCT00882999|157680913|FG000|Overall Study|Withdrawal by Subject|7|||
48959330|NCT00882999|157680914|FG001|Overall Study|Withdrawal by Subject|6|||
48959331|NCT00882999|157680915|FG002|Overall Study|Withdrawal by Subject|3|||
48959332|NCT00882999|157680916|FG003|Overall Study|Withdrawal by Subject|3|||
48959333|NCT00882999|157680917|FG004|Overall Study|Withdrawal by Subject|6|||
48959334|NCT00882999|157680918|FG005|Overall Study|Withdrawal by Subject|5|||
48959335|NCT00882999|157680919|FG006|Overall Study|Withdrawal by Subject|5|||
48959336|NCT00882999|157680913|FG000|Overall Study|Lost to Follow-up|0|||
48959337|NCT00882999|157680914|FG001|Overall Study|Lost to Follow-up|1|||
48959338|NCT00882999|157680915|FG002|Overall Study|Lost to Follow-up|1|||
48959339|NCT00882999|157680916|FG003|Overall Study|Lost to Follow-up|2|||
48959340|NCT00882999|157680917|FG004|Overall Study|Lost to Follow-up|1|||
48959341|NCT00882999|157680918|FG005|Overall Study|Lost to Follow-up|1|||
48959342|NCT00882999|157680919|FG006|Overall Study|Lost to Follow-up|2|||
48959343|NCT00882999|157680913|FG000|Overall Study|Physician Decision|1|||
48959344|NCT00882999|157680914|FG001|Overall Study|Physician Decision|0|||
48959345|NCT00882999|157680915|FG002|Overall Study|Physician Decision|0|||
48959346|NCT00882999|157680916|FG003|Overall Study|Physician Decision|0|||
48959347|NCT00882999|157680917|FG004|Overall Study|Physician Decision|0|||
48959348|NCT00882999|157680918|FG005|Overall Study|Physician Decision|1|||
48959349|NCT00882999|157680919|FG006|Overall Study|Physician Decision|1|||
48959350|NCT01911845|157680921|FG000|Overall Study|Adverse Event|2|||
48959351|NCT01911845|157680921|FG000|Overall Study|Lost to Follow-up|1|||
48959352|NCT01911845|157680921|FG000|Overall Study|Other (not specified)|3|||
48959353|NCT03007953|157680922|FG000|Overall Study|Withdrawal by Subject|5|||
48959354|NCT03007953|157680923|FG001|Overall Study|Withdrawal by Subject|2|||
48959355|NCT03007953|157680922|FG000|Overall Study|Death|5|||
48959356|NCT03007953|157680923|FG001|Overall Study|Death|7|||
48959357|NCT03007953|157680922|FG000|Overall Study|Lost to Follow-up|3|||
48959358|NCT03007953|157680923|FG001|Overall Study|Lost to Follow-up|2|||
48959359|NCT03007953|157680922|FG000|Overall Study|Enrolled in Hospice|3|||
48959360|NCT03007953|157680923|FG001|Overall Study|Enrolled in Hospice|2|||
48959361|NCT01409031|157680924|FG000|Overall Study|transferred to other hosp|1|||
48959362|NCT01409031|157680925|FG001|Overall Study|transferred to other hosp|0|||
48959363|NCT04321252|157680926|FG000|Overall Study|Withdrawal by Subject|0|||
48959364|NCT04321252|157680927|FG001|Overall Study|Withdrawal by Subject|0|||
48959365|NCT04321252|157680928|FG002|Overall Study|Withdrawal by Subject|0|||
48959366|NCT04321252|157680929|FG003|Overall Study|Withdrawal by Subject|0|||
48959367|NCT04321252|157680930|FG004|Overall Study|Withdrawal by Subject|0|||
48959368|NCT04321252|157680931|FG005|Overall Study|Withdrawal by Subject|1|||
48959369|NCT04321252|157680932|FG006|Overall Study|Withdrawal by Subject|0|||
48959370|NCT04321252|157680933|FG007|Overall Study|Withdrawal by Subject|0|||
48959371|NCT04321252|157680934|FG008|Overall Study|Withdrawal by Subject|0|||
48959372|NCT02492997|157680941|FG000|Overall Study|Withdrawal by Subject|1|||
48959373|NCT02492997|157680942|FG001|Overall Study|Withdrawal by Subject|0|||
48959374|NCT02492997|157680941|FG000|Overall Study|Gained Weight|1|||
48959375|NCT02492997|157680942|FG001|Overall Study|Gained Weight|0|||
48959376|NCT02492997|157680941|FG000|Overall Study|Lost to Follow-up|0|||
48959377|NCT02492997|157680942|FG001|Overall Study|Lost to Follow-up|1|||
48959378|NCT01934894|157680943|FG000|Overall Study|Adverse Event|1|||
48959379|NCT01934894|157680944|FG001|Overall Study|Adverse Event|2|||
48959380|NCT01934894|157680943|FG000|Overall Study|Death|2|||
48959381|NCT01934894|157680944|FG001|Overall Study|Death|0|||
48959382|NCT01934894|157680943|FG000|Overall Study|Withdrawal by Subject|0|||
48959383|NCT01934894|157680944|FG001|Overall Study|Withdrawal by Subject|1|||
48959384|NCT01934894|157680943|FG000|Overall Study|Progressive Disease|3|||
48959385|NCT01934894|157680944|FG001|Overall Study|Progressive Disease|2|||
48959386|NCT02605447|157680946|FG000|Overall Study|Death|66|||
48959387|NCT02605447|157680946|FG000|Overall Study|Physician Decision|1|||
48959388|NCT02605447|157680946|FG000|Overall Study|Lost to Follow-up|24|||
48959389|NCT02605447|157680946|FG000|Overall Study|Withdrawal by Subject|10|||
48959390|NCT02605447|157680946|FG000|Overall Study|Not disclosed|1|||
48959391|NCT00632463|157680956|FG000|Overall Study|Adverse Event|0|||
48959392|NCT00632463|157680957|FG001|Overall Study|Adverse Event|1|||
48959393|NCT00632463|157680958|FG002|Overall Study|Adverse Event|0|||
48959394|NCT01096849|157680965|FG000|Overall Study|Consent Withdrawn|1|||
48959395|NCT01096849|157680966|FG001|Overall Study|Consent Withdrawn|4|||
48959396|NCT01096849|157680967|FG002|Overall Study|Consent Withdrawn|2|||
48959397|NCT01096849|157680965|FG000|Overall Study|Lack of Efficacy|0|||
48959398|NCT01096849|157680966|FG001|Overall Study|Lack of Efficacy|2|||
48959399|NCT01096849|157680967|FG002|Overall Study|Lack of Efficacy|0|||
48959400|NCT01096849|157680965|FG000|Overall Study|Unacceptable/ Intolerable AE(s)|0|||
48959401|NCT01096849|157680966|FG001|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
48959402|NCT01096849|157680967|FG002|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
48959403|NCT01096849|157680965|FG000|Overall Study|Investigator or Medical Monitor Decision|0|||
48959404|NCT01096849|157680966|FG001|Overall Study|Investigator or Medical Monitor Decision|1|||
48959405|NCT01096849|157680967|FG002|Overall Study|Investigator or Medical Monitor Decision|0|||
48959406|NCT01096849|157680965|FG000|Overall Study|Administrative Reasons|0|||
48959407|NCT01096849|157680966|FG001|Overall Study|Administrative Reasons|1|||
48959408|NCT01096849|157680967|FG002|Overall Study|Administrative Reasons|2|||
48959409|NCT01096849|157680965|FG000|Overall Study|Lost to Follow-up|1|||
48959410|NCT01096849|157680966|FG001|Overall Study|Lost to Follow-up|3|||
48959411|NCT01096849|157680967|FG002|Overall Study|Lost to Follow-up|1|||
48865292|NCT02971683|157341969|FG000|Double-Blind (24 Weeks)|Participant no longer meets study criteria|1|||
48865293|NCT02971683|157341970|FG001|Double-Blind (24 Weeks)|Participant no longer meets study criteria|0|||
48865294|NCT02971683|157341969|FG000|Open-Label|Lost to Follow-up|1|||
48865295|NCT02971683|157341970|FG001|Open-Label|Lost to Follow-up|0|||
48865296|NCT02971683|157341969|FG000|Open-Label|Participants withdrew consent|0|||
48865297|NCT02971683|157341970|FG001|Open-Label|Participants withdrew consent|2|||
48865298|NCT02971683|157341969|FG000|Open-Label|Participant request to discontinue study treatment|1|||
48865299|NCT02971683|157341970|FG001|Open-Label|Participant request to discontinue study treatment|0|||
48865300|NCT02971683|157341969|FG000|Open-Label|Lack of Efficacy|2|||
48865301|NCT02971683|157341970|FG001|Open-Label|Lack of Efficacy|0|||
48865302|NCT02971683|157341969|FG000|Long-Term Open Label|Administrative reason by sponsor|20|||
48865303|NCT02971683|157341970|FG001|Long-Term Open Label|Administrative reason by sponsor|17|||
48865304|NCT02971683|157341969|FG000|Long-Term Open Label|Participant withdrew consent|1|||
48865305|NCT02971683|157341970|FG001|Long-Term Open Label|Participant withdrew consent|0|||
48865306|NCT02971683|157341969|FG000|Long-Term Open Label|Participant request to discontinue study treatment|1|||
48865307|NCT02971683|157341970|FG001|Long-Term Open Label|Participant request to discontinue study treatment|1|||
48865308|NCT02971683|157341969|FG000|Long-Term Open Label|Adverse Event|1|||
48865309|NCT02971683|157341970|FG001|Long-Term Open Label|Adverse Event|2|||
48865310|NCT02971683|157341969|FG000|Long-Term Open Label|Lack of Efficacy|1|||
48865311|NCT02971683|157341970|FG001|Long-Term Open Label|Lack of Efficacy|1|||
48865312|NCT02963922|157341971|FG000|Overall Study|Adverse Event|15|||
48865313|NCT02963922|157341972|FG001|Overall Study|Adverse Event|6|||
48865314|NCT02963922|157341971|FG000|Overall Study|Protocol deviation|6|||
48865315|NCT02963922|157341972|FG001|Overall Study|Protocol deviation|6|||
48865316|NCT02963922|157341971|FG000|Overall Study|Lack of Efficacy|1|||
48865317|NCT02963922|157341972|FG001|Overall Study|Lack of Efficacy|1|||
48865318|NCT02963922|157341971|FG000|Overall Study|Lost to Follow-up|2|||
48865319|NCT02963922|157341972|FG001|Overall Study|Lost to Follow-up|3|||
48865320|NCT02963922|157341971|FG000|Overall Study|Other|8|||
48865321|NCT02963922|157341972|FG001|Overall Study|Other|14|||
48865322|NCT00500539|157341973|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
48865323|NCT00500539|157341973|FG000|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1|||
48865324|NCT00500539|157341973|FG000|Treatment Period (24 Weeks)|Subject withdrew consent|1|||
48865325|NCT00500539|157341973|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|2|||
48865326|NCT00500539|157341973|FG000|Treatment Period (24 Weeks)|Administrative problems|2|||
48865327|NCT00500539|157341973|FG000|Treatment Period (24 Weeks)|Protocol Deviation|5|||
48865328|NCT00500539|157341973|FG000|Follow-up Period (16 Weeks)|Adverse Event|1|||
48865329|NCT00500539|157341973|FG000|Follow-up Period (16 Weeks)|Subject withdrew consent|2|||
48865330|NCT00500539|157341973|FG000|Follow-up Period (16 Weeks)|Lost to Follow-up|3|||
48865331|NCT00500539|157341973|FG000|Follow-up Period (16 Weeks)|Administrative problems|1|||
48865332|NCT00500539|157341973|FG000|Follow-up Period (16 Weeks)|Death|1|||
48865333|NCT00500539|157341973|FG000|Follow-up Period (16 Weeks)|Protocol Deviation|1|||
48865334|NCT00500539|157341973|FG000|Follow-up Period (16 Weeks)|Missing|3|||
48865335|NCT03740737|157343358|FG000|Overall Study|Protocol deviation|13|||
48865336|NCT03740737|157343359|FG001|Overall Study|Protocol deviation|0|||
48865337|NCT03740737|157343358|FG000|Overall Study|Adverse Event|2|||
48865338|NCT03740737|157343359|FG001|Overall Study|Adverse Event|0|||
48865339|NCT03740737|157343358|FG000|Overall Study|Lost to Follow-up|1|||
48865340|NCT03740737|157343359|FG001|Overall Study|Lost to Follow-up|0|||
48865341|NCT03740737|157343358|FG000|Overall Study|Randomization failure|1|||
48865342|NCT03740737|157343359|FG001|Overall Study|Randomization failure|0|||
48865343|NCT03740737|157343358|FG000|Overall Study|Participant withdrew consent|1|||
48865344|NCT03740737|157343359|FG001|Overall Study|Participant withdrew consent|0|||
49015414|NCT02739984|157892174|FG000|Overall Study|Lost to Follow-up|3|||
48865345|NCT03740737|157343358|FG000|Overall Study|Participant withdrew from trial|2|||
48865346|NCT03740737|157343359|FG001|Overall Study|Participant withdrew from trial|1|||
48865347|NCT00507429|157343360|FG000|Treatment Phase|Disease Progression|12|||
48865348|NCT00507429|157343361|FG001|Treatment Phase|Disease Progression|5|||
48865349|NCT00507429|157343360|FG000|Treatment Phase|Adverse Event|12|||
48865350|NCT00507429|157343361|FG001|Treatment Phase|Adverse Event|5|||
48865351|NCT00507429|157343360|FG000|Treatment Phase|Withdrawal by Subject|3|||
48865352|NCT00507429|157343361|FG001|Treatment Phase|Withdrawal by Subject|3|||
48865353|NCT00507429|157343360|FG000|Treatment Phase|Physician Decision|4|||
48865354|NCT00507429|157343361|FG001|Treatment Phase|Physician Decision|2|||
48865355|NCT00507429|157343360|FG000|Treatment Phase|Other|6|||
48865356|NCT00507429|157343361|FG001|Treatment Phase|Other|3|||
48865357|NCT00507429|157343360|FG000|Maintenance Phase|Progressive Disease|14|||
48865358|NCT00507429|157343361|FG001|Maintenance Phase|Progressive Disease|0|||
48865359|NCT02889809|157343367|FG000|Overall Study|Withdrawal by Subject|30|||
48865360|NCT02889809|157343368|FG001|Overall Study|Withdrawal by Subject|21|||
48753427|NCT01601626|156944220|FG000|Overall Study|Withdrawal by Subject|0|||
48753428|NCT01601626|156944221|FG001|Overall Study|Withdrawal by Subject|1|||
48753429|NCT01601626|156944222|FG002|Overall Study|Withdrawal by Subject|1|||
48753430|NCT01601626|156944220|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
48753431|NCT01601626|156944221|FG001|Overall Study|Not Willing to Adhere to Requirements|0|||
48753432|NCT01601626|156944222|FG002|Overall Study|Not Willing to Adhere to Requirements|0|||
48753433|NCT00545168|156944223|FG000|Overall Study|Lost to Follow-up|5|||
48753434|NCT00545168|156944224|FG001|Overall Study|Lost to Follow-up|5|||
48753435|NCT00545168|156944225|FG002|Overall Study|Lost to Follow-up|5|||
48753436|NCT00545168|156944223|FG000|Overall Study|Withdrawal by Subject|9|||
48753437|NCT00545168|156944224|FG001|Overall Study|Withdrawal by Subject|0|||
48959412|NCT00536978|157680968|FG000|Overall Study|Not eligible for Adback Infusion|22|||
48959413|NCT01079962|157680973|FG000|Overall Study|Adverse Event|2|||
48959414|NCT01079962|157680974|FG001|Overall Study|Adverse Event|2|||
48959415|NCT01079962|157680973|FG000|Overall Study|Withdrawal by Subject|5|||
48959416|NCT01079962|157680974|FG001|Overall Study|Withdrawal by Subject|7|||
48959417|NCT01079962|157680973|FG000|Overall Study|Protocol Violation|2|||
48959418|NCT01079962|157680974|FG001|Overall Study|Protocol Violation|2|||
48959419|NCT01079962|157680973|FG000|Overall Study|No blood pressure (BP) control|3|||
48959420|NCT01079962|157680974|FG001|Overall Study|No blood pressure (BP) control|0|||
48959421|NCT01079962|157680973|FG000|Overall Study|Inclusion/exclusion criteria|1|||
48959422|NCT01079962|157680974|FG001|Overall Study|Inclusion/exclusion criteria|3|||
48959423|NCT01079962|157680973|FG000|Overall Study|Participant not returning for next visit|1|||
48959424|NCT01079962|157680974|FG001|Overall Study|Participant not returning for next visit|0|||
48959425|NCT01079962|157680973|FG000|Overall Study|Due to arrhythmia/bradycardia|1|||
48959426|NCT01079962|157680974|FG001|Overall Study|Due to arrhythmia/bradycardia|1|||
48959427|NCT00242580|157680975|FG000|Overall Study|Adverse Event|3|||
48959428|NCT00242580|157680976|FG001|Overall Study|Adverse Event|0|||
48753438|NCT00545168|156944225|FG002|Overall Study|Withdrawal by Subject|13|||
48753439|NCT00545168|156944223|FG000|Overall Study|Protocol Violation|1|||
48753440|NCT00545168|156944224|FG001|Overall Study|Protocol Violation|0|||
48753441|NCT00545168|156944225|FG002|Overall Study|Protocol Violation|1|||
48865361|NCT02889809|157343367|FG000|Overall Study|Lost to Follow-up|1|||
48865362|NCT02889809|157343368|FG001|Overall Study|Lost to Follow-up|1|||
48865363|NCT02889809|157343367|FG000|Overall Study|Site Closed|12|||
48865364|NCT02889809|157343368|FG001|Overall Study|Site Closed|11|||
48865365|NCT01193283|157343371|FG000|Overall Study|Death|1|||
48865366|NCT01103141|157343372|FG000|Overall Study|Death|0|||
48865367|NCT01103141|157343373|FG001|Overall Study|Death|1|||
48865368|NCT01103141|157343372|FG000|Overall Study|Lost to Follow-up|2|||
48865369|NCT01103141|157343373|FG001|Overall Study|Lost to Follow-up|1|||
48865370|NCT01403805|157343374|FG000|Overall Study|Withdrawal by Subject|0|||
48865371|NCT01403805|157343375|FG001|Overall Study|Withdrawal by Subject|4|||
48865372|NCT01403805|157343374|FG000|Overall Study|Lost to Follow-up|0|||
48865373|NCT01403805|157343375|FG001|Overall Study|Lost to Follow-up|2|||
48865374|NCT01403805|157343374|FG000|Overall Study|Death|0|||
48865375|NCT01403805|157343375|FG001|Overall Study|Death|1|||
48865376|NCT01695993|157343376|FG000|Overall Study|Lost to Follow-up|2|||
48865377|NCT01695993|157343377|FG001|Overall Study|Lost to Follow-up|1|||
48865378|NCT01695993|157343378|FG002|Overall Study|Lost to Follow-up|3|||
48865379|NCT01695993|157343376|FG000|Overall Study|Withdrawal by Subject|2|||
48865380|NCT01695993|157343377|FG001|Overall Study|Withdrawal by Subject|2|||
48865381|NCT01695993|157343378|FG002|Overall Study|Withdrawal by Subject|2|||
48865382|NCT01695993|157343376|FG000|Overall Study|To ill to continue|1|||
48865383|NCT01695993|157343377|FG001|Overall Study|To ill to continue|2|||
48865384|NCT01695993|157343378|FG002|Overall Study|To ill to continue|0|||
48865385|NCT01695993|157343376|FG000|Overall Study|Changed Medical Facility|0|||
48865386|NCT01695993|157343377|FG001|Overall Study|Changed Medical Facility|0|||
48865387|NCT01695993|157343378|FG002|Overall Study|Changed Medical Facility|1|||
48865388|NCT02029521|157343379|FG000|Overall Study|Protocol Violation|1|||
48865389|NCT02029521|157343380|FG001|Overall Study|Protocol Violation|0|||
48865390|NCT02029521|157343379|FG000|Overall Study|Withdrawal by Subject|1|||
48753442|NCT00545168|156944223|FG000|Overall Study|Visit for Day 21 was not done in error|1|||
48753443|NCT00545168|156944224|FG001|Overall Study|Visit for Day 21 was not done in error|0|||
48753444|NCT00545168|156944225|FG002|Overall Study|Visit for Day 21 was not done in error|2|||
48753445|NCT02598076|156944226|FG000|Overall Study|Lost to Follow-up|2|||
48753446|NCT02598076|156944227|FG001|Overall Study|Lost to Follow-up|3|||
48753447|NCT03227029|156944228|FG000|Overall Study|Child Wheezed (no treatment)|0|||
48753448|NCT03227029|156944229|FG001|Overall Study|Child Wheezed (no treatment)|1|||
48753449|NCT03227029|156944230|FG002|Overall Study|Child Wheezed (no treatment)|0|||
48753450|NCT03227029|156944228|FG000|Overall Study|No post RSV season visit due to COVID|3|||
48753451|NCT03227029|156944229|FG001|Overall Study|No post RSV season visit due to COVID|3|||
48753452|NCT03227029|156944230|FG002|Overall Study|No post RSV season visit due to COVID|2|||
48959429|NCT00242580|157680977|FG002|Overall Study|Adverse Event|2|||
48959430|NCT00242580|157680975|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
48959431|NCT00242580|157680976|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
48959432|NCT00242580|157680977|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
48959433|NCT00242580|157680975|FG000|Overall Study|Protocol Violation|0|||
48959434|NCT00242580|157680976|FG001|Overall Study|Protocol Violation|0|||
48959435|NCT00242580|157680977|FG002|Overall Study|Protocol Violation|1|||
48959436|NCT00242580|157680975|FG000|Overall Study|Subject withdrew consent|2|||
48959437|NCT00242580|157680976|FG001|Overall Study|Subject withdrew consent|2|||
48959438|NCT00242580|157680977|FG002|Overall Study|Subject withdrew consent|5|||
48959439|NCT00242580|157680975|FG000|Overall Study|Lost to Follow-up|0|||
48959440|NCT00242580|157680976|FG001|Overall Study|Lost to Follow-up|3|||
48959441|NCT00242580|157680977|FG002|Overall Study|Lost to Follow-up|0|||
48959442|NCT00242580|157680975|FG000|Overall Study|Death|1|||
48959443|NCT00242580|157680976|FG001|Overall Study|Death|2|||
48959444|NCT00242580|157680977|FG002|Overall Study|Death|1|||
48959445|NCT01331239|157680979|FG000|Part II: Core Study|Adverse Event|0|||
48959446|NCT01331239|157680980|FG001|Part II: Core Study|Adverse Event|3|||
48959447|NCT01331239|157680981|FG002|Part II: Core Study|Adverse Event|0|||
48959448|NCT01331239|157680979|FG000|Part II: Core Study|Subj's cond. no longer require treatment|0|||
48959449|NCT01331239|157680980|FG001|Part II: Core Study|Subj's cond. no longer require treatment|2|||
48959450|NCT01331239|157680981|FG002|Part II: Core Study|Subj's cond. no longer require treatment|1|||
48959451|NCT01331239|157680979|FG000|Part II: Core Study|Withdrawal by Subject|0|||
48959452|NCT01331239|157680980|FG001|Part II: Core Study|Withdrawal by Subject|2|||
48959453|NCT01331239|157680981|FG002|Part II: Core Study|Withdrawal by Subject|0|||
48959454|NCT01331239|157680979|FG000|Part II: Core Study|Administrative problems|0|||
48753453|NCT03227029|156944228|FG000|Overall Study|Not able to get to clinic|0|||
48959455|NCT01331239|157680980|FG001|Part II: Core Study|Administrative problems|1|||
48959456|NCT01331239|157680981|FG002|Part II: Core Study|Administrative problems|0|||
48959457|NCT01072539|157680984|FG000|Overall Study|Treated prior to the Site Initiation|1|||
48959458|NCT01072539|157680984|FG000|Overall Study|Protocol Violation|2|||
48959459|NCT04937816|157680985|FG000|Overall Study|Study drug stopped, reason missing|5|||
48959460|NCT04937816|157680986|FG001|Overall Study|Study drug stopped, reason missing|3|||
48959461|NCT04937816|157680987|FG002|Overall Study|Study drug stopped, reason missing|4|||
48959462|NCT04937816|157680988|FG003|Overall Study|Study drug stopped, reason missing|6|||
48959463|NCT04937816|157680989|FG004|Overall Study|Study drug stopped, reason missing|1|||
48959464|NCT04937816|157680990|FG005|Overall Study|Study drug stopped, reason missing|0|||
48959465|NCT04937816|157680991|FG006|Overall Study|Study drug stopped, reason missing|0|||
48959466|NCT04937816|157680985|FG000|Overall Study|Other than stated below|173|||
48959467|NCT04937816|157680986|FG001|Overall Study|Other than stated below|143|||
48959468|NCT04937816|157680987|FG002|Overall Study|Other than stated below|125|||
48959469|NCT04937816|157680988|FG003|Overall Study|Other than stated below|44|||
48959470|NCT04937816|157680989|FG004|Overall Study|Other than stated below|45|||
48959471|NCT04937816|157680990|FG005|Overall Study|Other than stated below|28|||
48959472|NCT04937816|157680991|FG006|Overall Study|Other than stated below|31|||
48959473|NCT04937816|157680985|FG000|Overall Study|Patient refusal to continue, not due to AE|172|||
48959474|NCT04937816|157680986|FG001|Overall Study|Patient refusal to continue, not due to AE|118|||
48959475|NCT04937816|157680987|FG002|Overall Study|Patient refusal to continue, not due to AE|122|||
48959476|NCT04937816|157680988|FG003|Overall Study|Patient refusal to continue, not due to AE|304|||
48959477|NCT04937816|157680989|FG004|Overall Study|Patient refusal to continue, not due to AE|284|||
48959478|NCT04937816|157680990|FG005|Overall Study|Patient refusal to continue, not due to AE|124|||
48959479|NCT04937816|157680991|FG006|Overall Study|Patient refusal to continue, not due to AE|92|||
48959480|NCT04937816|157680985|FG000|Overall Study|Lost to Follow-up|15|||
48959481|NCT04937816|157680986|FG001|Overall Study|Lost to Follow-up|9|||
48959482|NCT04937816|157680987|FG002|Overall Study|Lost to Follow-up|6|||
48959483|NCT04937816|157680988|FG003|Overall Study|Lost to Follow-up|6|||
48959484|NCT04937816|157680989|FG004|Overall Study|Lost to Follow-up|16|||
48753454|NCT03227029|156944229|FG001|Overall Study|Not able to get to clinic|0|||
48959485|NCT04937816|157680990|FG005|Overall Study|Lost to Follow-up|11|||
48959486|NCT04937816|157680991|FG006|Overall Study|Lost to Follow-up|17|||
48959487|NCT04937816|157680985|FG000|Overall Study|Protocol Violation|15|||
48753455|NCT03227029|156944230|FG002|Overall Study|Not able to get to clinic|1|||
48959488|NCT04937816|157680986|FG001|Overall Study|Protocol Violation|15|||
48959489|NCT04937816|157680987|FG002|Overall Study|Protocol Violation|12|||
48959490|NCT04937816|157680988|FG003|Overall Study|Protocol Violation|30|||
48959491|NCT04937816|157680989|FG004|Overall Study|Protocol Violation|24|||
48959492|NCT04937816|157680990|FG005|Overall Study|Protocol Violation|5|||
48959493|NCT04937816|157680991|FG006|Overall Study|Protocol Violation|5|||
48959494|NCT04937816|157680985|FG000|Overall Study|Adverse Event|303|||
48959495|NCT04937816|157680986|FG001|Overall Study|Adverse Event|267|||
48959496|NCT04937816|157680987|FG002|Overall Study|Adverse Event|273|||
48959497|NCT04937816|157680988|FG003|Overall Study|Adverse Event|553|||
48959498|NCT04937816|157680989|FG004|Overall Study|Adverse Event|575|||
48959499|NCT04937816|157680990|FG005|Overall Study|Adverse Event|343|||
48959500|NCT04937816|157680991|FG006|Overall Study|Adverse Event|337|||
48959501|NCT04937816|157680985|FG000|Overall Study|Not treated|4|||
48959502|NCT04937816|157680986|FG001|Overall Study|Not treated|2|||
48959503|NCT04937816|157680987|FG002|Overall Study|Not treated|2|||
48959504|NCT04937816|157680988|FG003|Overall Study|Not treated|2|||
48959505|NCT04937816|157680989|FG004|Overall Study|Not treated|1|||
48959506|NCT04937816|157680990|FG005|Overall Study|Not treated|4|||
48959507|NCT04937816|157680991|FG006|Overall Study|Not treated|0|||
48959508|NCT00808249|157680992|FG000|Overall Study|Adverse Event|4|||
48753456|NCT03227029|156944228|FG000|Overall Study|Withdrawal by Subject|1|||
48753457|NCT03227029|156944229|FG001|Overall Study|Withdrawal by Subject|0|||
48753458|NCT03227029|156944230|FG002|Overall Study|Withdrawal by Subject|0|||
48753459|NCT03227029|156944228|FG000|Overall Study|Unable to receive treatment in time (no treatment)|0|||
48959509|NCT00808249|157680993|FG001|Overall Study|Adverse Event|7|||
48959510|NCT00808249|157680994|FG002|Overall Study|Adverse Event|10|||
48959511|NCT00808249|157680995|FG003|Overall Study|Adverse Event|6|||
48959512|NCT00808249|157680992|FG000|Overall Study|Lost to Follow-up|2|||
48959513|NCT00808249|157680993|FG001|Overall Study|Lost to Follow-up|3|||
48959514|NCT00808249|157680994|FG002|Overall Study|Lost to Follow-up|3|||
48959515|NCT00808249|157680995|FG003|Overall Study|Lost to Follow-up|5|||
48959516|NCT00808249|157680992|FG000|Overall Study|Withdrawal by Subject|4|||
48959517|NCT00808249|157680993|FG001|Overall Study|Withdrawal by Subject|0|||
48959518|NCT00808249|157680994|FG002|Overall Study|Withdrawal by Subject|2|||
48959519|NCT00808249|157680995|FG003|Overall Study|Withdrawal by Subject|4|||
48959520|NCT00808249|157680992|FG000|Overall Study|Protocol Violation|3|||
48959521|NCT00808249|157680993|FG001|Overall Study|Protocol Violation|3|||
48959522|NCT00808249|157680994|FG002|Overall Study|Protocol Violation|3|||
48959523|NCT00808249|157680995|FG003|Overall Study|Protocol Violation|0|||
48959524|NCT00808249|157680992|FG000|Overall Study|Lack of Efficacy|1|||
48959525|NCT00808249|157680993|FG001|Overall Study|Lack of Efficacy|1|||
48959526|NCT00808249|157680994|FG002|Overall Study|Lack of Efficacy|0|||
48959527|NCT00808249|157680995|FG003|Overall Study|Lack of Efficacy|0|||
48959528|NCT00808249|157680992|FG000|Overall Study|study specific discontinuation criteria|1|||
48959529|NCT00808249|157680993|FG001|Overall Study|study specific discontinuation criteria|0|||
48753460|NCT03227029|156944229|FG001|Overall Study|Unable to receive treatment in time (no treatment)|0|||
48959530|NCT00808249|157680994|FG002|Overall Study|study specific discontinuation criteria|1|||
48959531|NCT00808249|157680995|FG003|Overall Study|study specific discontinuation criteria|0|||
48959532|NCT00808249|157680992|FG000|Overall Study|All other reasons|2|||
48959533|NCT00808249|157680993|FG001|Overall Study|All other reasons|1|||
48959534|NCT00808249|157680994|FG002|Overall Study|All other reasons|3|||
48959535|NCT00808249|157680995|FG003|Overall Study|All other reasons|1|||
48959536|NCT01687413|157681006|FG000|Overall Study|Withdrawal by Subject|0|||
48959537|NCT01687413|157681007|FG001|Overall Study|Withdrawal by Subject|2|||
48959538|NCT01687413|157681006|FG000|Overall Study|Not eligible|0|||
48959539|NCT01687413|157681007|FG001|Overall Study|Not eligible|2|||
48959540|NCT01687413|157681006|FG000|Overall Study|Patient withdrew before completing all radiotherapy|1|||
48959541|NCT01687413|157681007|FG001|Overall Study|Patient withdrew before completing all radiotherapy|0|||
48959542|NCT00946530|157681008|FG000|Overall Study|Withdrawal by Subject|0|||
48959543|NCT00946530|157681009|FG001|Overall Study|Withdrawal by Subject|3|||
48959544|NCT00946530|157681010|FG002|Overall Study|Withdrawal by Subject|0|||
48959545|NCT00946530|157681011|FG003|Overall Study|Withdrawal by Subject|3|||
48959546|NCT00946530|157681008|FG000|Overall Study|Physician Decision|1|||
48959547|NCT00946530|157681009|FG001|Overall Study|Physician Decision|1|||
48959548|NCT00946530|157681010|FG002|Overall Study|Physician Decision|1|||
48959549|NCT00946530|157681011|FG003|Overall Study|Physician Decision|1|||
48959550|NCT01008995|157681016|FG000|Controlled Period|Adverse Event|1|||
48959551|NCT01008995|157681017|FG001|Controlled Period|Adverse Event|2|||
48959552|NCT01008995|157681018|FG002|Controlled Period|Adverse Event|0|||
48959553|NCT01008995|157681019|FG003|Controlled Period|Adverse Event|0|||
48959554|NCT01008995|157681016|FG000|Controlled Period|Other|2|||
48959555|NCT01008995|157681017|FG001|Controlled Period|Other|1|||
48753461|NCT03227029|156944230|FG002|Overall Study|Unable to receive treatment in time (no treatment)|1|||
48753462|NCT01124422|156944231|FG000|4-Week Open-label Run-in Phase|Withdrawal by Subject|5|||
48753463|NCT01124422|156944232|FG001|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
48753464|NCT01124422|156944233|FG002|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
48753465|NCT01124422|156944231|FG000|4-Week Open-label Run-in Phase|Adverse Event|7|||
48753466|NCT01124422|156944232|FG001|4-Week Open-label Run-in Phase|Adverse Event|0|||
48753467|NCT01124422|156944233|FG002|4-Week Open-label Run-in Phase|Adverse Event|0|||
48753468|NCT01124422|156944231|FG000|4-Week Open-label Run-in Phase|Physician Decision|4|||
48753469|NCT01124422|156944232|FG001|4-Week Open-label Run-in Phase|Physician Decision|0|||
48753470|NCT01124422|156944233|FG002|4-Week Open-label Run-in Phase|Physician Decision|0|||
48753471|NCT01124422|156944231|FG000|4-Week Open-label Run-in Phase|Lost to Follow-up|1|||
48753472|NCT01124422|156944232|FG001|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
48753473|NCT01124422|156944233|FG002|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
48753474|NCT01124422|156944231|FG000|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61|||
48753475|NCT01124422|156944232|FG001|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
48753476|NCT01124422|156944233|FG002|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
48753477|NCT01124422|156944231|FG000|4-Week Open-label Run-in Phase|Protocol Violation|5|||
48753478|NCT01124422|156944232|FG001|4-Week Open-label Run-in Phase|Protocol Violation|0|||
48753479|NCT01124422|156944233|FG002|4-Week Open-label Run-in Phase|Protocol Violation|0|||
48753480|NCT01124422|156944231|FG000|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
48959556|NCT01008995|157681018|FG002|Controlled Period|Other|0|||
48959557|NCT01008995|157681019|FG003|Controlled Period|Other|0|||
48959558|NCT01008995|157681016|FG000|After Controlled Period|Adverse Event|0|||
48959559|NCT01008995|157681017|FG001|After Controlled Period|Adverse Event|0|||
48959560|NCT01008995|157681018|FG002|After Controlled Period|Adverse Event|1|||
48959561|NCT01008995|157681019|FG003|After Controlled Period|Adverse Event|1|||
48959562|NCT01008995|157681016|FG000|After Controlled Period|Other|0|||
48959563|NCT01008995|157681017|FG001|After Controlled Period|Other|0|||
48959564|NCT01008995|157681018|FG002|After Controlled Period|Other|1|||
48959565|NCT01008995|157681019|FG003|After Controlled Period|Other|0|||
48959566|NCT01767194|157681024|FG000|Overall Study|Adverse Event|1|||
48959567|NCT01767194|157681025|FG001|Overall Study|Adverse Event|1|||
48959568|NCT01767194|157681024|FG000|Overall Study|Death|0|||
48959569|NCT01767194|157681025|FG001|Overall Study|Death|1|||
48959570|NCT01767194|157681024|FG000|Overall Study|Lack of Efficacy|12|||
48959571|NCT01767194|157681025|FG001|Overall Study|Lack of Efficacy|11|||
48959572|NCT01767194|157681024|FG000|Overall Study|Physician Decision|2|||
48959573|NCT01767194|157681025|FG001|Overall Study|Physician Decision|23|||
48959574|NCT01767194|157681024|FG000|Overall Study|Withdrawal by Subject|0|||
48959575|NCT01767194|157681025|FG001|Overall Study|Withdrawal by Subject|1|||
48959576|NCT01767194|157681024|FG000|Overall Study|Ineligible|1|||
48959577|NCT01767194|157681025|FG001|Overall Study|Ineligible|1|||
48959578|NCT01767194|157681024|FG000|Overall Study|Refusal by patient/parent|2|||
48959579|NCT01767194|157681025|FG001|Overall Study|Refusal by patient/parent|4|||
48959580|NCT01767194|157681024|FG000|Overall Study|Criteria not met on time for next cycle|0|||
48959581|NCT01767194|157681025|FG001|Overall Study|Criteria not met on time for next cycle|1|||
48959582|NCT02045212|157681026|FG000|Overall Study|Adverse Event|0|||
48959583|NCT02045212|157681027|FG001|Overall Study|Adverse Event|1|||
48959584|NCT02045212|157681026|FG000|Overall Study|Withdrawal by Subject|1|||
48959585|NCT02045212|157681027|FG001|Overall Study|Withdrawal by Subject|0|||
48959586|NCT02045212|157681026|FG000|Overall Study|Finished 13 weeks, chose not to extend|1|||
48959587|NCT02045212|157681027|FG001|Overall Study|Finished 13 weeks, chose not to extend|0|||
48959588|NCT02953782|157681028|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Death|5|||
48959589|NCT02953782|157681029|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Death|2|||
48959590|NCT02953782|157681030|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
48959591|NCT02953782|157681031|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
48959592|NCT02953782|157681032|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Death|4|||
48959593|NCT02953782|157681033|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
48959594|NCT02953782|157681034|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
48959595|NCT02953782|157681035|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
48959596|NCT02953782|157681028|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
48959597|NCT02953782|157681029|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
48959598|NCT02953782|157681030|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2|||
48959599|NCT02953782|157681031|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
48959600|NCT02953782|157681032|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
48959601|NCT02953782|157681033|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
48959602|NCT02953782|157681034|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
48959603|NCT02953782|157681035|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
49015415|NCT02739984|157892175|FG001|Overall Study|Lost to Follow-up|0|||
48959604|NCT02953782|157681028|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
48959605|NCT02953782|157681029|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
48959606|NCT02953782|157681030|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
48959607|NCT02953782|157681031|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
48959608|NCT02953782|157681032|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
48959609|NCT02953782|157681033|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
48959610|NCT02953782|157681034|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
48959611|NCT02953782|157681035|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
48959612|NCT02953782|157681028|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
48959613|NCT02953782|157681029|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
48959614|NCT02953782|157681030|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
48959615|NCT02953782|157681031|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
48959616|NCT02953782|157681032|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
48959617|NCT02953782|157681033|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
48959618|NCT02953782|157681034|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
48959619|NCT02953782|157681035|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
48959620|NCT02953782|157681028|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
48959621|NCT02953782|157681029|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
48959622|NCT02953782|157681030|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
48959623|NCT02953782|157681031|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
48959624|NCT02953782|157681032|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
48959625|NCT02953782|157681033|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Death|14|||
48959626|NCT02953782|157681034|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Death|11|||
48959627|NCT02953782|157681035|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Death|8|||
48959628|NCT02953782|157681028|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
48959629|NCT02953782|157681029|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
48959630|NCT02953782|157681030|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
48959631|NCT02953782|157681031|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
48959632|NCT02953782|157681032|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
48959633|NCT02953782|157681033|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1|||
48959634|NCT02953782|157681034|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2|||
48959635|NCT02953782|157681035|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3|||
48959636|NCT02953782|157681028|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
48959637|NCT02953782|157681029|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
48959638|NCT02953782|157681030|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
48959639|NCT02953782|157681031|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
48959640|NCT02953782|157681032|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
48959641|NCT02953782|157681033|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
48959642|NCT02953782|157681034|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
48959643|NCT02953782|157681035|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4|||
48959644|NCT02953782|157681028|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
48959645|NCT02953782|157681029|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
48959646|NCT02953782|157681030|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
48959647|NCT02953782|157681031|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
48959648|NCT02953782|157681032|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
48959649|NCT02953782|157681033|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
48959650|NCT02953782|157681034|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1|||
48959651|NCT02953782|157681035|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
48959652|NCT00747617|157682510|FG000|Overall Study|Lost to Follow-up|3|||
48959653|NCT00747617|157682511|FG001|Overall Study|Lost to Follow-up|1|||
48959654|NCT00074412|157682512|FG000|Overall Study|Death|30|||
48959655|NCT00074412|157682513|FG001|Overall Study|Death|26|||
48959656|NCT00074412|157682512|FG000|Overall Study|Lost to Follow-up|52|||
48959657|NCT00074412|157682513|FG001|Overall Study|Lost to Follow-up|58|||
48959658|NCT02922634|157682514|FG000|Overall Study|Withdrawal by Subject|5|||
48959659|NCT02922634|157682514|FG000|Overall Study|Did not have their surgery|5|||
48959660|NCT00418834|157682515|FG000|Overall Study|Adverse Event|16|||
48959661|NCT00418834|157682516|FG001|Overall Study|Adverse Event|9|||
48959662|NCT00418834|157682515|FG000|Overall Study|Lost to Follow-up|0|||
48959663|NCT00418834|157682516|FG001|Overall Study|Lost to Follow-up|1|||
48959664|NCT00418834|157682515|FG000|Overall Study|Protocol Violation|4|||
48959665|NCT00418834|157682516|FG001|Overall Study|Protocol Violation|3|||
48959666|NCT00418834|157682515|FG000|Overall Study|Withdrawal by Subject|3|||
48959667|NCT00418834|157682516|FG001|Overall Study|Withdrawal by Subject|7|||
48959668|NCT01432262|157682517|FG000|Overall Study|Withdrawal by Subject|2|||
48959669|NCT01432262|157682518|FG001|Overall Study|Withdrawal by Subject|1|||
48959670|NCT02457182|157682522|FG000|Overall Study|Lost to Follow-up|1|||
48959671|NCT02457182|157682523|FG001|Overall Study|Lost to Follow-up|0|||
48959672|NCT00494871|157682526|FG000|Double-blind (DB) Treatment Period|Adverse Event|73|||
48959673|NCT00494871|157682527|FG001|Double-blind (DB) Treatment Period|Adverse Event|70|||
48959674|NCT00494871|157682526|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|26|||
48959675|NCT00494871|157682527|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|35|||
48959676|NCT00494871|157682526|FG000|Double-blind (DB) Treatment Period|Death|8|||
48959677|NCT00494871|157682527|FG001|Double-blind (DB) Treatment Period|Death|3|||
48959678|NCT00494871|157682526|FG000|Double-blind (DB) Treatment Period|Physician Decision|4|||
48959679|NCT00494871|157682527|FG001|Double-blind (DB) Treatment Period|Physician Decision|13|||
48959680|NCT00494871|157682526|FG000|Double-blind (DB) Treatment Period|Lost to Follow-up|4|||
48959681|NCT00494871|157682527|FG001|Double-blind (DB) Treatment Period|Lost to Follow-up|1|||
48959682|NCT00494871|157682526|FG000|Double-blind (DB) Treatment Period|Protocol Violation|9|||
48959683|NCT00494871|157682527|FG001|Double-blind (DB) Treatment Period|Protocol Violation|9|||
48959684|NCT00494871|157682526|FG000|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18|||
48959685|NCT00494871|157682527|FG001|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28|||
48959686|NCT00494871|157682526|FG000|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3|||
48959687|NCT00494871|157682527|FG001|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1|||
48959688|NCT00494871|157682526|FG000|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12|||
48959689|NCT00494871|157682527|FG001|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8|||
48959690|NCT00494871|157682526|FG000|Double-blind (DB) Treatment Period|Site Closed by Investigator|1|||
48959691|NCT00494871|157682527|FG001|Double-blind (DB) Treatment Period|Site Closed by Investigator|2|||
48865391|NCT02029521|157343380|FG001|Overall Study|Withdrawal by Subject|1|||
48865392|NCT01026103|157343386|FG000|Overall Study|Physician Decision|1|||
48865393|NCT01026103|157343386|FG000|Overall Study|did not receive study device bc of error|1|||
48865394|NCT00762502|157343388|FG000|Baseline to Month 3 (Period 1)|Adverse Event|4|||
48865395|NCT00762502|157343389|FG001|Baseline to Month 3 (Period 1)|Adverse Event|3|||
48865396|NCT00762502|157343390|FG002|Baseline to Month 3 (Period 1)|Adverse Event|6|||
48865397|NCT00762502|157343388|FG000|Baseline to Month 3 (Period 1)|Lost to Follow-up|6|||
48865398|NCT00762502|157343389|FG001|Baseline to Month 3 (Period 1)|Lost to Follow-up|3|||
48865399|NCT00762502|157343390|FG002|Baseline to Month 3 (Period 1)|Lost to Follow-up|13|||
48865400|NCT00762502|157343388|FG000|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
48865401|NCT00762502|157343389|FG001|Month 3 to Month 6 (Period 2)|Pregnancy|1|||
48959692|NCT00494871|157682526|FG000|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
48959693|NCT00494871|157682527|FG001|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
48959694|NCT00494871|157682526|FG000|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
48959695|NCT00494871|157682527|FG001|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
48959696|NCT00494871|157682526|FG000|Follow-up (FU) Period|Adverse Event|1|||
48959697|NCT00494871|157682527|FG001|Follow-up (FU) Period|Adverse Event|1|||
48959698|NCT00494871|157682526|FG000|Follow-up (FU) Period|Death|13|||
48959699|NCT00494871|157682527|FG001|Follow-up (FU) Period|Death|12|||
48959700|NCT00494871|157682526|FG000|Follow-up (FU) Period|Lost to Follow-up|6|||
48959701|NCT00494871|157682527|FG001|Follow-up (FU) Period|Lost to Follow-up|2|||
48959702|NCT00494871|157682526|FG000|Follow-up (FU) Period|Physician Decision|0|||
48959703|NCT00494871|157682527|FG001|Follow-up (FU) Period|Physician Decision|1|||
48959704|NCT00494871|157682526|FG000|Follow-up (FU) Period|Protocol Violation|1|||
48959705|NCT00494871|157682527|FG001|Follow-up (FU) Period|Protocol Violation|0|||
48959706|NCT00494871|157682526|FG000|Follow-up (FU) Period|Withdrawal by Subject|5|||
48959707|NCT00494871|157682527|FG001|Follow-up (FU) Period|Withdrawal by Subject|5|||
48959708|NCT00494871|157682526|FG000|Follow-up (FU) Period|Clinical Endpoint Reached|3|||
49015416|NCT01736553|157892180|FG000|Overall Study|Death|12|||
48865402|NCT00762502|157343390|FG002|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
48865403|NCT02504502|157343391|FG000|Routine Care vs. Enhanced Report|Lost to Follow-up|4|||
48865404|NCT02504502|157343392|FG001|Routine Care vs. Enhanced Report|Lost to Follow-up|7|||
48865405|NCT02504502|157343391|FG000|Crossover to Enhanced Report|Lost to Follow-up|5|||
48865406|NCT02504502|157343392|FG001|Crossover to Enhanced Report|Lost to Follow-up|0|||
48865407|NCT03042559|157343393|FG000|Overall Study|drop out|1|||
48865408|NCT03042559|157343394|FG001|Overall Study|drop out|1|||
48865409|NCT02744898|157343398|FG000|Overall Study|Progressive Disease|2|||
48865410|NCT02744898|157343398|FG000|Overall Study|Physician Decision|1|||
48865411|NCT02744898|157343398|FG000|Overall Study|Toxicity|1|||
48865412|NCT06080438|157343399|FG000|Overall Study|Lost to Follow-up|2|||
48865413|NCT00910871|157343400|FG000|Overall Study|Adverse Event|5|||
48865414|NCT00910871|157343400|FG000|Overall Study|Death|12|||
48865415|NCT00910871|157343400|FG000|Overall Study|Lost to Follow-up|8|||
48865416|NCT00910871|157343400|FG000|Overall Study|Protocol Violation|11|||
48865417|NCT00910871|157343400|FG000|Overall Study|Withdrawal by Subject|12|||
48865418|NCT00910871|157343400|FG000|Overall Study|Subject didn't meet eligibility criteria|5|||
48865419|NCT00910871|157343400|FG000|Overall Study|Undefined|1|||
48865420|NCT02359552|157343405|FG000|Overall Study|Lost to Follow-up|3|||
48865421|NCT02359552|157343406|FG001|Overall Study|Lost to Follow-up|4|||
48865422|NCT02573883|157343407|FG000|Six Month Follow Up|Lost to Follow-up|1|||
48865423|NCT02573883|157343408|FG001|Six Month Follow Up|Lost to Follow-up|0|||
48865424|NCT02573883|157343409|FG002|Six Month Follow Up|Lost to Follow-up|0|||
48865425|NCT02573883|157343410|FG003|Six Month Follow Up|Lost to Follow-up|0|||
48865426|NCT02573883|157343407|FG000|One Year Follow Up|Lost to Follow-up|2|||
48959709|NCT00494871|157682527|FG001|Follow-up (FU) Period|Clinical Endpoint Reached|2|||
48959710|NCT02669862|157682530|FG000|Overall Study|Lost to Follow-up|0|||
48959711|NCT02669862|157682531|FG001|Overall Study|Lost to Follow-up|2|||
48959712|NCT02669862|157682532|FG002|Overall Study|Lost to Follow-up|1|||
48959713|NCT02669862|157682530|FG000|Overall Study|Withdrawal by Subject|2|||
48959714|NCT02669862|157682531|FG001|Overall Study|Withdrawal by Subject|2|||
48959715|NCT02669862|157682532|FG002|Overall Study|Withdrawal by Subject|3|||
48959716|NCT02669862|157682530|FG000|Overall Study|moved|0|||
48959717|NCT02669862|157682531|FG001|Overall Study|moved|1|||
48959718|NCT02669862|157682532|FG002|Overall Study|moved|0|||
48959719|NCT02669862|157682530|FG000|Overall Study|Protocol Violation|0|||
48959720|NCT02669862|157682531|FG001|Overall Study|Protocol Violation|0|||
48959721|NCT02669862|157682532|FG002|Overall Study|Protocol Violation|1|||
48959722|NCT02397694|157682533|FG000|Double-Blinded Phase|Adverse Event|1|||
48959723|NCT02397694|157682534|FG001|Double-Blinded Phase|Adverse Event|0|||
48959724|NCT02397694|157682533|FG000|Double-Blinded Phase|Non-compliance with study drug|0|||
48959725|NCT02397694|157682534|FG001|Double-Blinded Phase|Non-compliance with study drug|2|||
48959726|NCT02397694|157682533|FG000|Double-Blinded Phase|Withdrawal by Subject|1|||
48959727|NCT02397694|157682534|FG001|Double-Blinded Phase|Withdrawal by Subject|0|||
48959728|NCT02397694|157682533|FG000|Double-Blinded Phase|Lost to Follow-up|1|||
48959729|NCT02397694|157682534|FG001|Double-Blinded Phase|Lost to Follow-up|1|||
48959730|NCT02397694|157682533|FG000|Open Label Extension Phase|Protocol Violation|1|||
48959731|NCT02397694|157682534|FG001|Open Label Extension Phase|Protocol Violation|0|||
48959732|NCT02397694|157682533|FG000|Open Label Extension Phase|Withdrew Consent|3|||
48959733|NCT02397694|157682534|FG001|Open Label Extension Phase|Withdrew Consent|1|||
48959734|NCT02397694|157682533|FG000|Open Label Extension Phase|Lost to Follow-up|4|||
48959735|NCT02397694|157682534|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
48959736|NCT04543955|157682537|FG000|Overall Study|Company cancelled study|1|||
48959737|NCT04543955|157682538|FG001|Overall Study|Company cancelled study|0|||
48959738|NCT01694420|157682539|FG000|Overall Study|Lost to Follow-up|3|||
48959739|NCT01755195|157682540|FG000|Overall Study|Participant noncompliance|2|||
48959740|NCT01755195|157682540|FG000|Overall Study|Switched to alternative treatment|4|||
48959741|NCT01755195|157682540|FG000|Overall Study|Withdrawal by Subject|1|||
48959742|NCT01755195|157682540|FG000|Overall Study|Participant refused to start treatment|1|||
48959743|NCT01755195|157682540|FG000|Overall Study|Participant has been consented for another trial|1|||
48959744|NCT01755195|157682540|FG000|Overall Study|Refused further treatment|3|||
48959745|NCT01755195|157682540|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
48959746|NCT00492856|157682541|FG000|Induction|Adverse Event|2|||
48959747|NCT00492856|157682542|FG001|Induction|Adverse Event|0|||
48959748|NCT00492856|157682543|FG002|Induction|Adverse Event|0|||
48959749|NCT00492856|157682544|FG003|Induction|Adverse Event|0|||
48959750|NCT00492856|157682541|FG000|Induction|Withdrawal by Subject|1|||
48959751|NCT00492856|157682542|FG001|Induction|Withdrawal by Subject|0|||
48959752|NCT00492856|157682543|FG002|Induction|Withdrawal by Subject|0|||
48959753|NCT00492856|157682544|FG003|Induction|Withdrawal by Subject|0|||
48959754|NCT00492856|157682541|FG000|Induction|Death|3|||
48959755|NCT00492856|157682542|FG001|Induction|Death|0|||
48959756|NCT00492856|157682543|FG002|Induction|Death|0|||
48959757|NCT00492856|157682544|FG003|Induction|Death|0|||
48959758|NCT00492856|157682541|FG000|Consolidation|Adverse Event|6|||
48959759|NCT00492856|157682542|FG001|Consolidation|Adverse Event|0|||
48959760|NCT00492856|157682543|FG002|Consolidation|Adverse Event|0|||
48959761|NCT00492856|157682544|FG003|Consolidation|Adverse Event|0|||
48959762|NCT00492856|157682541|FG000|Consolidation|Not protocol specified|2|||
48959763|NCT00492856|157682542|FG001|Consolidation|Not protocol specified|0|||
48959764|NCT00492856|157682543|FG002|Consolidation|Not protocol specified|0|||
48959765|NCT00492856|157682544|FG003|Consolidation|Not protocol specified|0|||
48959766|NCT00492856|157682541|FG000|Consolidation|Lost to Follow-up|1|||
48959767|NCT00492856|157682542|FG001|Consolidation|Lost to Follow-up|0|||
48959768|NCT00492856|157682543|FG002|Consolidation|Lost to Follow-up|0|||
48959769|NCT00492856|157682544|FG003|Consolidation|Lost to Follow-up|0|||
48959770|NCT00492856|157682541|FG000|Post-consolidation|Adverse Event|0|||
48959771|NCT00492856|157682542|FG001|Post-consolidation|Adverse Event|4|||
48959772|NCT00492856|157682543|FG002|Post-consolidation|Adverse Event|0|||
48959773|NCT00492856|157682544|FG003|Post-consolidation|Adverse Event|1|||
48959774|NCT00492856|157682541|FG000|Post-consolidation|Withdrawal by Subject|0|||
48753481|NCT01124422|156944232|FG001|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
48753482|NCT01124422|156944233|FG002|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3|||
48753483|NCT01124422|156944231|FG000|4-Week Double-blind Treatment Phase|Adverse Event|0|||
48753484|NCT01124422|156944232|FG001|4-Week Double-blind Treatment Phase|Adverse Event|6|||
48753485|NCT01124422|156944233|FG002|4-Week Double-blind Treatment Phase|Adverse Event|3|||
48753486|NCT01124422|156944231|FG000|4-Week Double-blind Treatment Phase|Physician Decision|0|||
48753487|NCT01124422|156944232|FG001|4-Week Double-blind Treatment Phase|Physician Decision|5|||
48753488|NCT01124422|156944233|FG002|4-Week Double-blind Treatment Phase|Physician Decision|2|||
48753489|NCT01124422|156944231|FG000|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
48753490|NCT01124422|156944232|FG001|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
49015417|NCT01736553|157892181|FG001|Overall Study|Death|0|||
48959775|NCT00492856|157682542|FG001|Post-consolidation|Withdrawal by Subject|4|||
48959776|NCT00492856|157682543|FG002|Post-consolidation|Withdrawal by Subject|0|||
48959777|NCT00492856|157682544|FG003|Post-consolidation|Withdrawal by Subject|0|||
48959778|NCT00492856|157682541|FG000|Post-consolidation|Death|0|||
48959779|NCT00492856|157682542|FG001|Post-consolidation|Death|1|||
48959780|NCT00492856|157682543|FG002|Post-consolidation|Death|0|||
48959781|NCT00492856|157682544|FG003|Post-consolidation|Death|0|||
48959782|NCT00492856|157682541|FG000|Post-consolidation|Not protocol specified|0|||
48959783|NCT00492856|157682542|FG001|Post-consolidation|Not protocol specified|1|||
48959784|NCT00492856|157682543|FG002|Post-consolidation|Not protocol specified|0|||
48959785|NCT00492856|157682544|FG003|Post-consolidation|Not protocol specified|0|||
48959786|NCT00492856|157682541|FG000|Post-consolidation|Lost to Follow-up|0|||
48959787|NCT00492856|157682542|FG001|Post-consolidation|Lost to Follow-up|2|||
48959788|NCT00492856|157682543|FG002|Post-consolidation|Lost to Follow-up|0|||
48959789|NCT00492856|157682544|FG003|Post-consolidation|Lost to Follow-up|0|||
48959790|NCT00492856|157682541|FG000|Post-consolidation|Observation Arm|0|||
48959791|NCT00492856|157682542|FG001|Post-consolidation|Observation Arm|0|||
48959792|NCT00492856|157682543|FG002|Post-consolidation|Observation Arm|27|||
48959793|NCT00492856|157682544|FG003|Post-consolidation|Observation Arm|0|||
48959794|NCT01303380|157682545|FG000|Overall Study|Lack of compliance to study procedures|1|||
48959795|NCT00948818|157682547|FG000|Overall Study|Adverse Event|10|||
48959796|NCT00948818|157682548|FG001|Overall Study|Adverse Event|32|||
48959797|NCT00948818|157682547|FG000|Overall Study|Protocol Violation|9|||
48959798|NCT00948818|157682548|FG001|Overall Study|Protocol Violation|10|||
48959799|NCT00948818|157682547|FG000|Overall Study|Withdrawal by Subject|25|||
48959800|NCT00948818|157682548|FG001|Overall Study|Withdrawal by Subject|25|||
48959801|NCT00948818|157682547|FG000|Overall Study|Lost to Follow-up|10|||
48959802|NCT00948818|157682548|FG001|Overall Study|Lost to Follow-up|17|||
48959803|NCT00948818|157682547|FG000|Overall Study|Lack of Efficacy|4|||
48959804|NCT00948818|157682548|FG001|Overall Study|Lack of Efficacy|5|||
48959805|NCT00948818|157682547|FG000|Overall Study|Other Reason|4|||
48959806|NCT00948818|157682548|FG001|Overall Study|Other Reason|5|||
48959807|NCT01716533|157682549|FG000|Overall Study|Failure of antibiotic treatment to treat|0|||
48753491|NCT01124422|156944233|FG002|4-Week Double-blind Treatment Phase|Lost to Follow-up|1|||
48959808|NCT01716533|157682550|FG001|Overall Study|Failure of antibiotic treatment to treat|0|||
48753492|NCT03958955|156944236|FG000|Overall Study|Adverse Event|1|||
48753493|NCT03454893|156944237|FG000|Overall Study|Study Terminated by the Sponsor|5|||
48753494|NCT03454893|156944237|FG000|Overall Study|Did not pass screening|4|||
48753495|NCT01113801|156944238|FG000|Overall Study|Adverse Event|4|||
48753496|NCT01113801|156944239|FG001|Overall Study|Adverse Event|0|||
48753497|NCT01113801|156944240|FG002|Overall Study|Adverse Event|2|||
48753498|NCT01113801|156944241|FG003|Overall Study|Adverse Event|6|||
48753499|NCT01113801|156944238|FG000|Overall Study|Death|4|||
48753500|NCT01113801|156944239|FG001|Overall Study|Death|5|||
48753501|NCT01113801|156944240|FG002|Overall Study|Death|3|||
48753502|NCT01113801|156944241|FG003|Overall Study|Death|4|||
48753503|NCT01113801|156944238|FG000|Overall Study|Protocol Violation|0|||
48753504|NCT01113801|156944239|FG001|Overall Study|Protocol Violation|1|||
48753505|NCT01113801|156944240|FG002|Overall Study|Protocol Violation|0|||
48753506|NCT01113801|156944241|FG003|Overall Study|Protocol Violation|0|||
48753507|NCT01113801|156944238|FG000|Overall Study|Withdrawal by Subject|9|||
48753508|NCT01113801|156944239|FG001|Overall Study|Withdrawal by Subject|7|||
48865427|NCT02573883|157343408|FG001|One Year Follow Up|Lost to Follow-up|1|||
48865428|NCT02573883|157343409|FG002|One Year Follow Up|Lost to Follow-up|0|||
48753509|NCT01113801|156944240|FG002|Overall Study|Withdrawal by Subject|7|||
48753510|NCT01113801|156944241|FG003|Overall Study|Withdrawal by Subject|8|||
48753511|NCT01113801|156944238|FG000|Overall Study|Physician Decision|2|||
48865429|NCT02573883|157343410|FG003|One Year Follow Up|Lost to Follow-up|0|||
48865430|NCT04089332|157343411|FG000|Overall Study|COVID-19 Pandemic safety issues|6|||
48865431|NCT04089332|157343411|FG000|Overall Study|Moved in the MRI, no analysis possible|1|||
48865432|NCT04089332|157343411|FG000|Overall Study|Completed only OGTT, no analysis possible|1|||
48865433|NCT03120949|157343417|FG000|Overall Study|randomized in error|1|||
48865434|NCT03120949|157343418|FG001|Overall Study|randomized in error|0|||
48865435|NCT03120949|157343417|FG000|Overall Study|Death|13|||
48753512|NCT01113801|156944239|FG001|Overall Study|Physician Decision|2|||
48753513|NCT01113801|156944240|FG002|Overall Study|Physician Decision|3|||
48753514|NCT01113801|156944241|FG003|Overall Study|Physician Decision|3|||
48753515|NCT01113801|156944238|FG000|Overall Study|Sponsor Decision|15|||
48753516|NCT01113801|156944239|FG001|Overall Study|Sponsor Decision|21|||
48753517|NCT01113801|156944240|FG002|Overall Study|Sponsor Decision|20|||
48753518|NCT01113801|156944241|FG003|Overall Study|Sponsor Decision|15|||
48865436|NCT03120949|157343418|FG001|Overall Study|Death|13|||
48753519|NCT01113801|156944238|FG000|Overall Study|Clinical Endpoint (ESRD)|7|||
48753520|NCT01113801|156944239|FG001|Overall Study|Clinical Endpoint (ESRD)|4|||
48753521|NCT01113801|156944240|FG002|Overall Study|Clinical Endpoint (ESRD)|2|||
48753522|NCT01113801|156944241|FG003|Overall Study|Clinical Endpoint (ESRD)|5|||
48865437|NCT03120949|157343417|FG000|Overall Study|Lost to Follow-up|23|||
48865438|NCT03120949|157343418|FG001|Overall Study|Lost to Follow-up|13|||
48865439|NCT03120949|157343417|FG000|Overall Study|Withdrawal by Subject|139|||
48865440|NCT03120949|157343418|FG001|Overall Study|Withdrawal by Subject|124|||
48865441|NCT03120949|157343417|FG000|Overall Study|Covid-19|43|||
48865442|NCT03120949|157343418|FG001|Overall Study|Covid-19|34|||
48865443|NCT03120949|157343417|FG000|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|1|||
48865444|NCT03120949|157343418|FG001|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|3|||
48865445|NCT03120949|157343417|FG000|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|1|||
48865446|NCT03120949|157343418|FG001|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|0|||
48865447|NCT03120949|157343417|FG000|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|1|||
48865448|NCT03120949|157343418|FG001|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|0|||
48865449|NCT03120949|157343417|FG000|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|1|||
48865450|NCT03120949|157343418|FG001|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|0|||
48865451|NCT03120949|157343417|FG000|Overall Study|Site was closed|2|||
48865452|NCT03120949|157343418|FG001|Overall Study|Site was closed|3|||
48865453|NCT03120949|157343417|FG000|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|1|||
48865454|NCT03120949|157343418|FG001|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|0|||
48865455|NCT03120949|157343417|FG000|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|0|||
48865456|NCT03120949|157343418|FG001|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|1|||
48865457|NCT03120949|157343417|FG000|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|1|||
48865458|NCT03120949|157343418|FG001|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|0|||
48865459|NCT03120949|157343417|FG000|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|1|||
48865460|NCT03120949|157343418|FG001|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|0|||
48753523|NCT01949051|156944243|FG000|Treatment Period 1 (7 Days)|Protocol Violation|1|||
48959809|NCT01716533|157682551|FG002|Overall Study|Failure of antibiotic treatment to treat|5|||
48959810|NCT01716533|157682552|FG003|Overall Study|Failure of antibiotic treatment to treat|0|||
48959811|NCT01716533|157682549|FG000|Overall Study|Withdrawal by Subject|0|||
48959812|NCT01716533|157682550|FG001|Overall Study|Withdrawal by Subject|0|||
48959813|NCT01716533|157682551|FG002|Overall Study|Withdrawal by Subject|0|||
48959814|NCT01716533|157682552|FG003|Overall Study|Withdrawal by Subject|5|||
48959815|NCT01716533|157682549|FG000|Overall Study|Death|0|||
48753524|NCT01949051|156944244|FG001|Treatment Period 1 (7 Days)|Protocol Violation|0|||
48753525|NCT01949051|156944245|FG002|Treatment Period 1 (7 Days)|Protocol Violation|0|||
48753526|NCT01949051|156944246|FG003|Treatment Period 1 (7 Days)|Protocol Violation|1|||
48753527|NCT01949051|156944247|FG004|Treatment Period 1 (7 Days)|Protocol Violation|0|||
48753528|NCT01949051|156944248|FG005|Treatment Period 1 (7 Days)|Protocol Violation|0|||
48753529|NCT01949051|156944243|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
48753530|NCT01949051|156944244|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
48753531|NCT01949051|156944245|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
48753532|NCT01949051|156944246|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
48753533|NCT01949051|156944247|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
48753534|NCT01949051|156944248|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
48959816|NCT01716533|157682550|FG001|Overall Study|Death|0|||
48753535|NCT01949051|156944243|FG000|Treatment Period 2 (7 Days)|Protocol Violation|0|||
48753536|NCT01949051|156944244|FG001|Treatment Period 2 (7 Days)|Protocol Violation|0|||
48753537|NCT01949051|156944245|FG002|Treatment Period 2 (7 Days)|Protocol Violation|0|||
48959817|NCT01716533|157682551|FG002|Overall Study|Death|0|||
48959818|NCT01716533|157682552|FG003|Overall Study|Death|2|||
48959819|NCT01716533|157682549|FG000|Overall Study|Immunosuppressants>14days past 6months|0|||
48959820|NCT01716533|157682550|FG001|Overall Study|Immunosuppressants>14days past 6months|0|||
48959821|NCT01716533|157682551|FG002|Overall Study|Immunosuppressants>14days past 6months|0|||
48959822|NCT01716533|157682552|FG003|Overall Study|Immunosuppressants>14days past 6months|1|||
48959823|NCT02006667|157682557|FG000|Overall Study|Adverse Event|3|||
48959824|NCT02006667|157682557|FG000|Overall Study|Death|2|||
48959825|NCT02006667|157682557|FG000|Overall Study|Withdrawal by Subject|1|||
48959826|NCT00960934|157682566|FG000|Overall Study|Adverse Event|2|||
48959827|NCT00960934|157682567|FG001|Overall Study|Adverse Event|3|||
48959828|NCT00960934|157682568|FG002|Overall Study|Adverse Event|3|||
48959829|NCT00960934|157682569|FG003|Overall Study|Adverse Event|2|||
48959830|NCT00960934|157682570|FG004|Overall Study|Adverse Event|4|||
48959831|NCT00960934|157682571|FG005|Overall Study|Adverse Event|3|||
48959832|NCT00960934|157682566|FG000|Overall Study|Lack of Efficacy|1|||
48959833|NCT00960934|157682567|FG001|Overall Study|Lack of Efficacy|0|||
48959834|NCT00960934|157682568|FG002|Overall Study|Lack of Efficacy|0|||
48959835|NCT00960934|157682569|FG003|Overall Study|Lack of Efficacy|0|||
48959836|NCT00960934|157682570|FG004|Overall Study|Lack of Efficacy|0|||
48959837|NCT00960934|157682571|FG005|Overall Study|Lack of Efficacy|0|||
48959838|NCT00960934|157682566|FG000|Overall Study|Lost to Follow-up|0|||
48959839|NCT00960934|157682567|FG001|Overall Study|Lost to Follow-up|1|||
48959840|NCT00960934|157682568|FG002|Overall Study|Lost to Follow-up|0|||
48959841|NCT00960934|157682569|FG003|Overall Study|Lost to Follow-up|0|||
48959842|NCT00960934|157682570|FG004|Overall Study|Lost to Follow-up|0|||
48959843|NCT00960934|157682571|FG005|Overall Study|Lost to Follow-up|0|||
48959844|NCT00960934|157682566|FG000|Overall Study|Other|2|||
48959845|NCT00960934|157682567|FG001|Overall Study|Other|1|||
48959846|NCT00960934|157682568|FG002|Overall Study|Other|5|||
48959847|NCT00960934|157682569|FG003|Overall Study|Other|4|||
48959848|NCT00960934|157682570|FG004|Overall Study|Other|2|||
48959849|NCT00960934|157682571|FG005|Overall Study|Other|2|||
48959850|NCT00960934|157682566|FG000|Overall Study|Physician Decision|0|||
48959851|NCT00960934|157682567|FG001|Overall Study|Physician Decision|1|||
48959852|NCT00960934|157682568|FG002|Overall Study|Physician Decision|0|||
48959853|NCT00960934|157682569|FG003|Overall Study|Physician Decision|0|||
48959854|NCT00960934|157682570|FG004|Overall Study|Physician Decision|0|||
48959855|NCT00960934|157682571|FG005|Overall Study|Physician Decision|0|||
48959856|NCT00960934|157682566|FG000|Overall Study|Progressive Disease|1|||
48959857|NCT00960934|157682567|FG001|Overall Study|Progressive Disease|1|||
48959858|NCT00960934|157682568|FG002|Overall Study|Progressive Disease|0|||
48959859|NCT00960934|157682569|FG003|Overall Study|Progressive Disease|0|||
48959860|NCT00960934|157682570|FG004|Overall Study|Progressive Disease|1|||
48959861|NCT00960934|157682571|FG005|Overall Study|Progressive Disease|1|||
48959862|NCT00960934|157682566|FG000|Overall Study|Protocol Violation|3|||
48959863|NCT00960934|157682567|FG001|Overall Study|Protocol Violation|4|||
48959864|NCT00960934|157682568|FG002|Overall Study|Protocol Violation|0|||
48959865|NCT00960934|157682569|FG003|Overall Study|Protocol Violation|3|||
48959866|NCT00960934|157682570|FG004|Overall Study|Protocol Violation|3|||
48959867|NCT00960934|157682571|FG005|Overall Study|Protocol Violation|2|||
48959868|NCT00960934|157682566|FG000|Overall Study|Withdrawal by Subject|5|||
48959869|NCT00960934|157682567|FG001|Overall Study|Withdrawal by Subject|6|||
48959870|NCT00960934|157682568|FG002|Overall Study|Withdrawal by Subject|4|||
48959871|NCT00960934|157682569|FG003|Overall Study|Withdrawal by Subject|5|||
48959872|NCT00960934|157682570|FG004|Overall Study|Withdrawal by Subject|5|||
48959873|NCT00960934|157682571|FG005|Overall Study|Withdrawal by Subject|7|||
48959874|NCT00960934|157682566|FG000|Overall Study|Study Terminated by Sponsor|50|||
48959875|NCT00960934|157682567|FG001|Overall Study|Study Terminated by Sponsor|46|||
48959876|NCT00960934|157682568|FG002|Overall Study|Study Terminated by Sponsor|52|||
48959877|NCT00960934|157682569|FG003|Overall Study|Study Terminated by Sponsor|50|||
48959878|NCT00960934|157682570|FG004|Overall Study|Study Terminated by Sponsor|49|||
48959879|NCT00960934|157682571|FG005|Overall Study|Study Terminated by Sponsor|49|||
48959880|NCT01429792|157682573|FG000|Overall Study|Other Reasons|67|||
48959881|NCT01429792|157682573|FG000|Overall Study|Unknown Disposition|94|||
48959882|NCT01429792|157682573|FG000|Overall Study|Negative HCV-RNA at Week 4|1|||
48959883|NCT01429792|157682573|FG000|Overall Study|Negative HCV-RNA at Week 12|4|||
48959884|NCT01429792|157682573|FG000|Overall Study|Decrease of less than 2-log in HCV RNA|32|||
48959885|NCT01429792|157682573|FG000|Overall Study|Positive HCV-RNA at Week 24|50|||
48959886|NCT01429792|157682573|FG000|Overall Study|Withdrawal by Subject|70|||
48959887|NCT01429792|157682573|FG000|Overall Study|Lost to Follow-up|88|||
48959888|NCT03456713|157682574|FG000|Overall Study|Lost to Follow-up|1|||
48959889|NCT03456713|157682575|FG001|Overall Study|Lost to Follow-up|0|||
48959890|NCT03456713|157682576|FG002|Overall Study|Lost to Follow-up|0|||
48959891|NCT03456713|157682577|FG003|Overall Study|Lost to Follow-up|0|||
48959892|NCT01104584|157682581|FG000|Overall Study|Study drug never administered|21|||
48959893|NCT01104584|157682581|FG000|Overall Study|Study prematurely discontinued|2|||
48959894|NCT02370498|157682582|FG000|Overall Study|Adverse Event|10|||
48959895|NCT02370498|157682583|FG001|Overall Study|Adverse Event|8|||
48959896|NCT02370498|157682582|FG000|Overall Study|Death|263|||
48959897|NCT02370498|157682583|FG001|Overall Study|Death|265|||
48959898|NCT02370498|157682582|FG000|Overall Study|Protocol Violation|1|||
48959899|NCT02370498|157682583|FG001|Overall Study|Protocol Violation|2|||
48959900|NCT02370498|157682582|FG000|Overall Study|Withdrawal by Subject|7|||
48959901|NCT02370498|157682583|FG001|Overall Study|Withdrawal by Subject|12|||
48959902|NCT02370498|157682582|FG000|Overall Study|Sponsor's decision|15|||
48959903|NCT02370498|157682583|FG001|Overall Study|Sponsor's decision|9|||
48959904|NCT01980706|157682588|FG000|Overall Study|Withdrawal by Subject|9|||
48959905|NCT01980706|157682589|FG001|Overall Study|Withdrawal by Subject|6|||
48959906|NCT01980706|157682590|FG002|Overall Study|Withdrawal by Subject|2|||
48959907|NCT01980706|157682588|FG000|Overall Study|Adverse Event|1|||
48959908|NCT01980706|157682589|FG001|Overall Study|Adverse Event|2|||
48652599|NCT01132651|156581202|FG000|Overall Study|Lost to Follow-up|1|||
48652600|NCT01132651|156581203|FG001|Overall Study|Lost to Follow-up|1|||
48652601|NCT02482428|156581204|FG000|Overall Study|Lost to Follow-up|4|||
48652602|NCT02482428|156581205|FG001|Overall Study|Lost to Follow-up|9|||
48652603|NCT02482428|156581206|FG002|Overall Study|Lost to Follow-up|1|||
48652604|NCT02482428|156581207|FG003|Overall Study|Lost to Follow-up|2|||
48652605|NCT02482428|156581208|FG004|Overall Study|Lost to Follow-up|4|||
48652606|NCT02482428|156581204|FG000|Overall Study|Physician Decision|0|||
48652607|NCT02482428|156581205|FG001|Overall Study|Physician Decision|0|||
48652608|NCT02482428|156581206|FG002|Overall Study|Physician Decision|0|||
48652609|NCT02482428|156581207|FG003|Overall Study|Physician Decision|0|||
48652610|NCT02482428|156581208|FG004|Overall Study|Physician Decision|1|||
48652611|NCT02482428|156581204|FG000|Overall Study|protocol deviation|1|||
48652612|NCT02482428|156581205|FG001|Overall Study|protocol deviation|1|||
48652613|NCT02482428|156581206|FG002|Overall Study|protocol deviation|0|||
48652614|NCT02482428|156581207|FG003|Overall Study|protocol deviation|0|||
48652615|NCT02482428|156581208|FG004|Overall Study|protocol deviation|0|||
48652616|NCT02482428|156581204|FG000|Overall Study|subject/guardian decision|4|||
48652617|NCT02482428|156581205|FG001|Overall Study|subject/guardian decision|2|||
48652618|NCT02482428|156581206|FG002|Overall Study|subject/guardian decision|0|||
48652619|NCT02482428|156581207|FG003|Overall Study|subject/guardian decision|0|||
48652620|NCT02482428|156581208|FG004|Overall Study|subject/guardian decision|2|||
48652621|NCT01893411|156581209|FG000|Overall Study|Protocol Violation|1|||
48652622|NCT01893411|156581210|FG001|Overall Study|Protocol Violation|0|||
48959909|NCT01980706|157682590|FG002|Overall Study|Adverse Event|5|||
48959910|NCT01980706|157682588|FG000|Overall Study|Lost to Follow-up|3|||
48959911|NCT01980706|157682589|FG001|Overall Study|Lost to Follow-up|4|||
48959912|NCT01980706|157682590|FG002|Overall Study|Lost to Follow-up|3|||
48959913|NCT01980706|157682588|FG000|Overall Study|miscellaneous|4|||
48959914|NCT01980706|157682589|FG001|Overall Study|miscellaneous|5|||
48959915|NCT01980706|157682590|FG002|Overall Study|miscellaneous|3|||
48753538|NCT01949051|156944246|FG003|Treatment Period 2 (7 Days)|Protocol Violation|0|||
48753539|NCT01949051|156944247|FG004|Treatment Period 2 (7 Days)|Protocol Violation|0|||
48753540|NCT01949051|156944248|FG005|Treatment Period 2 (7 Days)|Protocol Violation|1|||
48753541|NCT01949051|156944243|FG000|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
48753542|NCT01949051|156944244|FG001|Treatment Period 2 (7 Days)|Lost to Follow-up|1|||
48753543|NCT01949051|156944245|FG002|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
48652623|NCT01893411|156581211|FG002|Overall Study|Protocol Violation|0|||
48652624|NCT01893411|156581209|FG000|Overall Study|Physician Decision|1|||
48652625|NCT01893411|156581210|FG001|Overall Study|Physician Decision|1|||
48652626|NCT01893411|156581211|FG002|Overall Study|Physician Decision|2|||
48652627|NCT01893411|156581209|FG000|Overall Study|Lack of Efficacy|2|||
48652628|NCT01893411|156581210|FG001|Overall Study|Lack of Efficacy|1|||
48652629|NCT01893411|156581211|FG002|Overall Study|Lack of Efficacy|0|||
48652630|NCT01893411|156581209|FG000|Overall Study|Other|3|||
48652631|NCT01893411|156581210|FG001|Overall Study|Other|1|||
48652632|NCT01893411|156581211|FG002|Overall Study|Other|3|||
48652633|NCT01893411|156581209|FG000|Overall Study|Adverse Event|1|||
48652634|NCT01893411|156581210|FG001|Overall Study|Adverse Event|0|||
48652635|NCT01893411|156581211|FG002|Overall Study|Adverse Event|0|||
48652636|NCT01893411|156581209|FG000|Overall Study|Withdrawal by Subject|7|||
48652637|NCT01893411|156581210|FG001|Overall Study|Withdrawal by Subject|4|||
48652638|NCT01893411|156581211|FG002|Overall Study|Withdrawal by Subject|3|||
48652639|NCT01893411|156581209|FG000|Overall Study|Lost to Follow-up|2|||
48652640|NCT01893411|156581210|FG001|Overall Study|Lost to Follow-up|0|||
48652641|NCT01893411|156581211|FG002|Overall Study|Lost to Follow-up|1|||
48652642|NCT02582814|156581213|FG000|Overall Study|Study-specific withdrawal criteria|1|||
48652643|NCT02582814|156581214|FG001|Overall Study|Study-specific withdrawal criteria|0|||
48652644|NCT02582814|156581213|FG000|Overall Study|Withdrawal by Subject|4|||
48652645|NCT02582814|156581214|FG001|Overall Study|Withdrawal by Subject|3|||
48652646|NCT02582814|156581213|FG000|Overall Study|Adverse Event|4|||
48652647|NCT02582814|156581214|FG001|Overall Study|Adverse Event|4|||
48652648|NCT00443872|156581219|FG000|Overall Study|Protocol Violation|7|||
48652649|NCT00443872|156581219|FG000|Overall Study|Lost to Follow-up|2|||
48652650|NCT00443872|156581219|FG000|Overall Study|Adverse Event|8|||
48652651|NCT02789345|156581220|FG000|Overall Study|Adverse Event|0|||
48652652|NCT02789345|156581221|FG001|Overall Study|Adverse Event|0|||
48652653|NCT02789345|156581222|FG002|Overall Study|Adverse Event|1|||
48652654|NCT02789345|156581220|FG000|Overall Study|Death|0|||
48652655|NCT02789345|156581221|FG001|Overall Study|Death|0|||
48652656|NCT02789345|156581222|FG002|Overall Study|Death|1|||
48652657|NCT02789345|156581220|FG000|Overall Study|Physician Decision|2|||
48652658|NCT02789345|156581221|FG001|Overall Study|Physician Decision|0|||
48652659|NCT02789345|156581222|FG002|Overall Study|Physician Decision|1|||
48652660|NCT02789345|156581220|FG000|Overall Study|Progressive Disease|1|||
48652661|NCT02789345|156581221|FG001|Overall Study|Progressive Disease|3|||
48652662|NCT02789345|156581222|FG002|Overall Study|Progressive Disease|14|||
48652663|NCT00654745|156581224|FG000|Overall Study|Adverse Event|12|||
48652664|NCT00654745|156581224|FG000|Overall Study|Lost to Follow-up|7|||
48652665|NCT00654745|156581224|FG000|Overall Study|Protocol Violation|11|||
48652666|NCT00654745|156581224|FG000|Overall Study|Withdrawal by Subject|10|||
48865461|NCT03120949|157343417|FG000|Overall Study|Other: Adverse Event|0|||
48865462|NCT03120949|157343418|FG001|Overall Study|Other: Adverse Event|1|||
48865463|NCT03120949|157343417|FG000|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|0|||
48865464|NCT03120949|157343418|FG001|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|1|||
48865465|NCT03120949|157343417|FG000|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|0|||
48865466|NCT03120949|157343418|FG001|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|2|||
48865467|NCT03120949|157343417|FG000|Overall Study|Subject Refusal To Attend Visit|0|||
48865468|NCT03120949|157343418|FG001|Overall Study|Subject Refusal To Attend Visit|1|||
48865469|NCT03120949|157343417|FG000|Overall Study|Personal Reasons|0|||
48865470|NCT03120949|157343418|FG001|Overall Study|Personal Reasons|1|||
48865471|NCT03120949|157343417|FG000|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|0|||
48865472|NCT03120949|157343418|FG001|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|1|||
48865473|NCT03120949|157343417|FG000|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|0|||
48865474|NCT03120949|157343418|FG001|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|1|||
48865475|NCT03120949|157343417|FG000|Overall Study|Compliance With Medication|0|||
48865476|NCT03120949|157343418|FG001|Overall Study|Compliance With Medication|1|||
48865477|NCT03120949|157343417|FG000|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|0|||
48865478|NCT03120949|157343418|FG001|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|1|||
48865479|NCT03120949|157343417|FG000|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|0|||
48865480|NCT03120949|157343418|FG001|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|1|||
48652667|NCT00654745|156581224|FG000|Overall Study|poor ABPM, noncompliance, lab MAs|3|||
48652668|NCT01200407|156581225|FG000|Overall Study|Lost to Follow-up|56|||
48652669|NCT01200407|156581225|FG000|Overall Study|Adverse Event|3|||
48652670|NCT01200407|156581225|FG000|Overall Study|Withdrawal by Subject|4|||
48652671|NCT01200407|156581225|FG000|Overall Study|Other|19|||
48652672|NCT03470194|156581228|FG000|Overall Study|Lost to Follow-up|11|||
48652673|NCT03470194|156581229|FG001|Overall Study|Lost to Follow-up|17|||
48652674|NCT00104416|156581230|FG000|Double-Blind Phase|Adverse Event|2|||
48652675|NCT00104416|156581231|FG001|Double-Blind Phase|Adverse Event|1|||
48652676|NCT00104416|156581232|FG002|Double-Blind Phase|Adverse Event|0|||
48652677|NCT00104416|156581233|FG003|Double-Blind Phase|Adverse Event|0|||
48652678|NCT00104416|156581234|FG004|Double-Blind Phase|Adverse Event|0|||
48652679|NCT00104416|156581230|FG000|Double-Blind Phase|Lost to Follow-up|0|||
48959916|NCT01188564|157682591|FG000|Double-blind Phase|randomized not treated|1|||
48959917|NCT01188564|157682592|FG001|Double-blind Phase|randomized not treated|0|||
48959918|NCT04580394|157682602|FG000|First Intervention|Incorrectly Randomized|1|||
48959919|NCT04580394|157682602|FG000|First Intervention|Physician Decision|1|||
48959920|NCT04580394|157682602|FG000|First Intervention|Lost to Follow-up|1|||
48959921|NCT04580394|157682602|FG000|Washout (One Week)|Withdrawal by Subject|1|||
48959922|NCT04580394|157682602|FG000|Washout (One Week)|Adverse Event|1|||
48959923|NCT04580394|157682602|FG000|Washout (One Week)|Withdrawal by Subject|2|||
48959924|NCT04580394|157682602|FG000|Third Intervention|Adverse Event|1|||
48959925|NCT04580394|157682602|FG000|Third Intervention|Withdrawal by Subject|1|||
48959926|NCT04580394|157682602|FG000|Washout (One Week)|Withdrawal by Subject|2|||
48959927|NCT00084929|157682603|FG000|Overall Study|ineligible - medical contraindication|1|||
48959928|NCT00084929|157682603|FG000|Overall Study|ineligible - Pre-scheduled procedure not|1|||
48959929|NCT00084929|157682603|FG000|Overall Study|Ineligible - Medical history|6|||
48959930|NCT00084929|157682603|FG000|Overall Study|Withdrawal by Subject|10|||
48959931|NCT00084929|157682603|FG000|Overall Study|Missing/incomplete CTC exam|9|||
48959932|NCT00084929|157682603|FG000|Overall Study|Missing Reference Standard (Colonoscopy)|42|||
48959933|NCT03521687|157682606|FG000|Overall Study|Adverse Event|4|||
48959934|NCT03521687|157682606|FG000|Overall Study|Physician Decision|1|||
48959935|NCT00358917|157682607|FG000|Overall Study|Adverse Event|14|||
48959936|NCT00358917|157682608|FG001|Overall Study|Adverse Event|21|||
48959937|NCT00358917|157682607|FG000|Overall Study|Withdrawal by Subject|5|||
48652680|NCT00104416|156581231|FG001|Double-Blind Phase|Lost to Follow-up|1|||
48652681|NCT00104416|156581232|FG002|Double-Blind Phase|Lost to Follow-up|0|||
48652682|NCT00104416|156581233|FG003|Double-Blind Phase|Lost to Follow-up|0|||
48652683|NCT00104416|156581234|FG004|Double-Blind Phase|Lost to Follow-up|0|||
48652684|NCT00104416|156581230|FG000|Double-Blind Phase|Protocol Violation|0|||
48652685|NCT00104416|156581231|FG001|Double-Blind Phase|Protocol Violation|1|||
48652686|NCT00104416|156581232|FG002|Double-Blind Phase|Protocol Violation|0|||
48652687|NCT00104416|156581233|FG003|Double-Blind Phase|Protocol Violation|0|||
48652688|NCT00104416|156581234|FG004|Double-Blind Phase|Protocol Violation|0|||
48652689|NCT00104416|156581230|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
48652690|NCT00104416|156581231|FG001|Double-Blind Phase|Withdrawal by Subject|3|||
48652691|NCT00104416|156581232|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
48652692|NCT00104416|156581233|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
48652693|NCT00104416|156581234|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
48753544|NCT01949051|156944246|FG003|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
48753545|NCT01949051|156944247|FG004|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
48652694|NCT00104416|156581230|FG000|Double-Blind Phase|Pregnancy|1|||
48652695|NCT00104416|156581231|FG001|Double-Blind Phase|Pregnancy|0|||
48652696|NCT00104416|156581232|FG002|Double-Blind Phase|Pregnancy|0|||
48652697|NCT00104416|156581233|FG003|Double-Blind Phase|Pregnancy|0|||
48652698|NCT00104416|156581234|FG004|Double-Blind Phase|Pregnancy|0|||
48652699|NCT00104416|156581230|FG000|Double-Blind Phase|Participant Did Not Take Drug|3|||
48652700|NCT00104416|156581231|FG001|Double-Blind Phase|Participant Did Not Take Drug|4|||
48652701|NCT00104416|156581232|FG002|Double-Blind Phase|Participant Did Not Take Drug|0|||
48652702|NCT00104416|156581233|FG003|Double-Blind Phase|Participant Did Not Take Drug|0|||
48652703|NCT00104416|156581234|FG004|Double-Blind Phase|Participant Did Not Take Drug|0|||
48652704|NCT00104416|156581230|FG000|Continuation Phase|Adverse Event|0|||
48652705|NCT00104416|156581231|FG001|Continuation Phase|Adverse Event|0|||
48652706|NCT00104416|156581232|FG002|Continuation Phase|Adverse Event|2|||
48652707|NCT00104416|156581233|FG003|Continuation Phase|Adverse Event|0|||
48652708|NCT00104416|156581234|FG004|Continuation Phase|Adverse Event|2|||
48959938|NCT00358917|157682608|FG001|Overall Study|Withdrawal by Subject|7|||
48652709|NCT00104416|156581230|FG000|Continuation Phase|Lost to Follow-up|0|||
48652710|NCT00104416|156581231|FG001|Continuation Phase|Lost to Follow-up|0|||
48652711|NCT00104416|156581232|FG002|Continuation Phase|Lost to Follow-up|1|||
48652712|NCT00104416|156581233|FG003|Continuation Phase|Lost to Follow-up|0|||
48652713|NCT00104416|156581234|FG004|Continuation Phase|Lost to Follow-up|1|||
48959939|NCT00358917|157682607|FG000|Overall Study|Lost to Follow-up|20|||
48959940|NCT00358917|157682608|FG001|Overall Study|Lost to Follow-up|17|||
48959941|NCT00358917|157682607|FG000|Overall Study|Noncompliance|12|||
48959942|NCT00358917|157682608|FG001|Overall Study|Noncompliance|11|||
48959943|NCT00358917|157682607|FG000|Overall Study|Death|2|||
48959944|NCT00358917|157682608|FG001|Overall Study|Death|3|||
48959945|NCT00358917|157682607|FG000|Overall Study|Virologic failure|11|||
48652714|NCT00104416|156581230|FG000|Continuation Phase|Withdrawal by Subject|0|||
48652715|NCT00104416|156581231|FG001|Continuation Phase|Withdrawal by Subject|0|||
48652716|NCT00104416|156581232|FG002|Continuation Phase|Withdrawal by Subject|2|||
48652717|NCT00104416|156581233|FG003|Continuation Phase|Withdrawal by Subject|1|||
48652718|NCT00104416|156581234|FG004|Continuation Phase|Withdrawal by Subject|1|||
48652719|NCT00104416|156581230|FG000|Continuation Phase|Pregnancy|0|||
48652720|NCT00104416|156581231|FG001|Continuation Phase|Pregnancy|0|||
48652721|NCT00104416|156581232|FG002|Continuation Phase|Pregnancy|1|||
48652722|NCT00104416|156581233|FG003|Continuation Phase|Pregnancy|1|||
48652723|NCT00104416|156581234|FG004|Continuation Phase|Pregnancy|0|||
48652724|NCT00104416|156581230|FG000|Continuation Phase|Non-compliance|0|||
48652725|NCT00104416|156581231|FG001|Continuation Phase|Non-compliance|0|||
48652726|NCT00104416|156581232|FG002|Continuation Phase|Non-compliance|0|||
48652727|NCT00104416|156581233|FG003|Continuation Phase|Non-compliance|0|||
48652728|NCT00104416|156581234|FG004|Continuation Phase|Non-compliance|1|||
48652729|NCT01450696|156581235|FG000|Overall Study|Never Treated|1|||
48652730|NCT01450696|156581236|FG001|Overall Study|Never Treated|1|||
48652731|NCT01450696|156581235|FG000|Overall Study|Death|77|||
48652732|NCT01450696|156581236|FG001|Overall Study|Death|84|||
48652733|NCT01450696|156581235|FG000|Overall Study|Lost to Follow-up|3|||
48652734|NCT01450696|156581236|FG001|Overall Study|Lost to Follow-up|3|||
48652735|NCT01450696|156581235|FG000|Overall Study|Non-Compliance|1|||
48652736|NCT01450696|156581236|FG001|Overall Study|Non-Compliance|0|||
48652737|NCT01450696|156581235|FG000|Overall Study|Withdrawal by Subject|13|||
48652738|NCT01450696|156581236|FG001|Overall Study|Withdrawal by Subject|2|||
48652739|NCT01450696|156581235|FG000|Overall Study|Study Terminated by Sponsor|53|||
48652740|NCT01450696|156581236|FG001|Overall Study|Study Terminated by Sponsor|58|||
48652741|NCT00152477|156581239|FG000|Chemotherapy Period|Adverse Event|9|||
48652742|NCT00152477|156581240|FG001|Chemotherapy Period|Adverse Event|4|||
48652743|NCT00152477|156581241|FG002|Chemotherapy Period|Adverse Event|5|||
48652744|NCT00152477|156581239|FG000|Chemotherapy Period|Death|1|||
48652745|NCT00152477|156581240|FG001|Chemotherapy Period|Death|3|||
48652746|NCT00152477|156581241|FG002|Chemotherapy Period|Death|3|||
48652747|NCT00152477|156581239|FG000|Chemotherapy Period|Lack of Efficacy|4|||
48652748|NCT00152477|156581240|FG001|Chemotherapy Period|Lack of Efficacy|5|||
48652749|NCT00152477|156581241|FG002|Chemotherapy Period|Lack of Efficacy|6|||
48652750|NCT00152477|156581239|FG000|Chemotherapy Period|Lost to Follow-up|1|||
48652751|NCT00152477|156581240|FG001|Chemotherapy Period|Lost to Follow-up|0|||
48652752|NCT00152477|156581241|FG002|Chemotherapy Period|Lost to Follow-up|1|||
48652753|NCT00152477|156581239|FG000|Chemotherapy Period|Protocol Violation|1|||
48652754|NCT00152477|156581240|FG001|Chemotherapy Period|Protocol Violation|1|||
48652755|NCT00152477|156581241|FG002|Chemotherapy Period|Protocol Violation|0|||
48652756|NCT00152477|156581239|FG000|Chemotherapy Period|Withdrawal by Subject|5|||
48652757|NCT00152477|156581240|FG001|Chemotherapy Period|Withdrawal by Subject|1|||
48652758|NCT00152477|156581241|FG002|Chemotherapy Period|Withdrawal by Subject|0|||
48652759|NCT00152477|156581239|FG000|Chemotherapy Period|Progression of Disease|6|||
48652760|NCT00152477|156581240|FG001|Chemotherapy Period|Progression of Disease|8|||
48652761|NCT00152477|156581241|FG002|Chemotherapy Period|Progression of Disease|4|||
48652762|NCT00152477|156581239|FG000|Chemotherapy Period|Investigator decision|0|||
48652763|NCT00152477|156581240|FG001|Chemotherapy Period|Investigator decision|0|||
48652764|NCT00152477|156581241|FG002|Chemotherapy Period|Investigator decision|1|||
48652765|NCT00152477|156581239|FG000|Chemotherapy Period|Patient condition worsened|1|||
48652766|NCT00152477|156581240|FG001|Chemotherapy Period|Patient condition worsened|0|||
48652767|NCT00152477|156581241|FG002|Chemotherapy Period|Patient condition worsened|0|||
48652768|NCT00152477|156581239|FG000|Monotherapy Period|Adverse Event|1|||
48652769|NCT00152477|156581240|FG001|Monotherapy Period|Adverse Event|0|||
48652770|NCT00152477|156581241|FG002|Monotherapy Period|Adverse Event|5|||
48652771|NCT00152477|156581239|FG000|Monotherapy Period|Death|2|||
48652772|NCT00152477|156581240|FG001|Monotherapy Period|Death|0|||
48652773|NCT00152477|156581241|FG002|Monotherapy Period|Death|1|||
48652774|NCT00152477|156581239|FG000|Monotherapy Period|Lack of Efficacy|7|||
48652775|NCT00152477|156581240|FG001|Monotherapy Period|Lack of Efficacy|16|||
48652776|NCT00152477|156581241|FG002|Monotherapy Period|Lack of Efficacy|10|||
48652777|NCT00152477|156581239|FG000|Monotherapy Period|Protocol Violation|0|||
48652778|NCT00152477|156581240|FG001|Monotherapy Period|Protocol Violation|1|||
48652779|NCT00152477|156581241|FG002|Monotherapy Period|Protocol Violation|0|||
48652780|NCT00152477|156581239|FG000|Monotherapy Period|Withdrawal by Subject|0|||
48652781|NCT00152477|156581240|FG001|Monotherapy Period|Withdrawal by Subject|0|||
48865481|NCT03120949|157343417|FG000|Overall Study|Study Terminated By Principal Investigator|0|||
48865482|NCT03120949|157343418|FG001|Overall Study|Study Terminated By Principal Investigator|1|||
48652782|NCT00152477|156581241|FG002|Monotherapy Period|Withdrawal by Subject|4|||
48652783|NCT00152477|156581239|FG000|Monotherapy Period|Progression of Disease|5|||
48652784|NCT00152477|156581240|FG001|Monotherapy Period|Progression of Disease|11|||
48652785|NCT00152477|156581241|FG002|Monotherapy Period|Progression of Disease|12|||
48652786|NCT00152477|156581239|FG000|Monotherapy Period|Patient decision|0|||
48652787|NCT00152477|156581240|FG001|Monotherapy Period|Patient decision|1|||
48652788|NCT00152477|156581241|FG002|Monotherapy Period|Patient decision|1|||
48753546|NCT01949051|156944248|FG005|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
48753547|NCT01949051|156944243|FG000|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
48753548|NCT01949051|156944244|FG001|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
48753549|NCT01949051|156944245|FG002|Treatment Period 2 (7 Days)|Withdrawal by Subject|1|||
48753550|NCT01949051|156944246|FG003|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
48753551|NCT01949051|156944247|FG004|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
48753552|NCT01949051|156944248|FG005|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
48753553|NCT01948050|156944249|FG000|Overall Study|Withdrawal by Subject|0|||
48753554|NCT01948050|156944250|FG001|Overall Study|Withdrawal by Subject|1|||
48959946|NCT00358917|157682608|FG001|Overall Study|Virologic failure|8|||
48959947|NCT00358917|157682607|FG000|Overall Study|Unable to Continue Participation|2|||
48959948|NCT00358917|157682608|FG001|Overall Study|Unable to Continue Participation|2|||
48959949|NCT00678587|157682612|FG000|Overall Study|Adverse Event|3|||
48959950|NCT00678587|157682613|FG001|Overall Study|Adverse Event|3|||
48959951|NCT00678587|157682612|FG000|Overall Study|Lack of Efficacy|1|||
48959952|NCT00678587|157682613|FG001|Overall Study|Lack of Efficacy|0|||
48959953|NCT00678587|157682612|FG000|Overall Study|Protocol Violation|2|||
48959954|NCT00678587|157682613|FG001|Overall Study|Protocol Violation|1|||
48959955|NCT00678587|157682612|FG000|Overall Study|Study Closed/Terminated|1|||
48959956|NCT00678587|157682613|FG001|Overall Study|Study Closed/Terminated|0|||
48959957|NCT00678587|157682612|FG000|Overall Study|Lost to Follow-up|3|||
48959958|NCT00678587|157682613|FG001|Overall Study|Lost to Follow-up|5|||
48959959|NCT00678587|157682612|FG000|Overall Study|Investigator Discretion|2|||
48959960|NCT00678587|157682613|FG001|Overall Study|Investigator Discretion|6|||
48959961|NCT00678587|157682612|FG000|Overall Study|Withdrew Consent|8|||
48959962|NCT00678587|157682613|FG001|Overall Study|Withdrew Consent|3|||
48959963|NCT01019486|157682616|FG000|Overall Study|Withdrawal by Subject|1|||
48652789|NCT00152477|156581239|FG000|Monotherapy Period|Study personel decision|0|||
48652790|NCT00152477|156581240|FG001|Monotherapy Period|Study personel decision|0|||
48652791|NCT00152477|156581241|FG002|Monotherapy Period|Study personel decision|1|||
48652792|NCT03985943|156581242|FG000|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
48652793|NCT03985943|156581243|FG001|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|2|||
48652794|NCT03985943|156581244|FG002|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
48652795|NCT03985943|156581245|FG003|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
48652796|NCT03985943|156581246|FG004|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
48652797|NCT03985943|156581247|FG005|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
48652798|NCT03985943|156581242|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|2|||
48652799|NCT03985943|156581243|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|5|||
48652800|NCT03985943|156581244|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
48652801|NCT03985943|156581245|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
48652802|NCT03985943|156581246|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
48652803|NCT03985943|156581247|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
48652804|NCT03985943|156581242|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
48652805|NCT03985943|156581243|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
48652806|NCT03985943|156581244|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
48652807|NCT03985943|156581245|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
48652808|NCT03985943|156581246|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
48652809|NCT03985943|156581247|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
48652810|NCT03985943|156581242|FG000|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|11|||
48652811|NCT03985943|156581243|FG001|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|25|||
48652812|NCT03985943|156581244|FG002|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
48652813|NCT03985943|156581245|FG003|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
48652814|NCT03985943|156581246|FG004|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
48652815|NCT03985943|156581247|FG005|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
48652816|NCT03985943|156581242|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
48652817|NCT03985943|156581243|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|10|||
48652818|NCT03985943|156581244|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
48652819|NCT03985943|156581245|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
48652820|NCT03985943|156581246|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
48652821|NCT03985943|156581247|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
48652822|NCT03985943|156581242|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|3|||
48652823|NCT03985943|156581243|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|4|||
48652824|NCT03985943|156581244|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
48652825|NCT03985943|156581245|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
48753555|NCT01506479|156944252|FG000|Overall Study|Lost to Follow-up|1|||
48959964|NCT01019486|157682617|FG001|Overall Study|Withdrawal by Subject|1|||
48959965|NCT01019486|157682618|FG002|Overall Study|Withdrawal by Subject|1|||
48959966|NCT00752609|157682619|FG000|Overall Study|Adverse Event|2|||
48959967|NCT00752609|157682620|FG001|Overall Study|Adverse Event|2|||
48959968|NCT00752609|157682619|FG000|Overall Study|Withdrawal by Subject|3|||
48652826|NCT03985943|156581246|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
48652827|NCT03985943|156581247|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
48652828|NCT03985943|156581242|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
48652829|NCT03985943|156581243|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|1|||
48652830|NCT03985943|156581244|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
48652831|NCT03985943|156581245|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
48652832|NCT03985943|156581246|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
48652833|NCT03985943|156581247|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
48652834|NCT03985943|156581242|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
48652835|NCT03985943|156581243|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|4|||
48652836|NCT03985943|156581244|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
48652837|NCT03985943|156581245|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
48652838|NCT03985943|156581246|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
48652839|NCT03985943|156581247|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
48652840|NCT03985943|156581242|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
48652841|NCT03985943|156581243|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
48652842|NCT03985943|156581244|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
48652843|NCT03985943|156581245|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
48652844|NCT03985943|156581246|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|12|||
48865483|NCT00348283|157343420|FG000|Induction|Adverse Event|0|||
48865484|NCT00348283|157343421|FG001|Induction|Adverse Event|2|||
48865485|NCT00348283|157343420|FG000|Induction|Protocol Violation|0|||
48865486|NCT00348283|157343421|FG001|Induction|Protocol Violation|4|||
48865487|NCT00348283|157343420|FG000|Double Blind|Adverse Event|2|||
48865488|NCT00348283|157343421|FG001|Double Blind|Adverse Event|5|||
48865489|NCT00348283|157343420|FG000|Double Blind|Withdrawal by Subject|1|||
48865490|NCT00348283|157343421|FG001|Double Blind|Withdrawal by Subject|1|||
48865491|NCT00348283|157343420|FG000|Double Blind|Protocol Violation|0|||
48652845|NCT03985943|156581247|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
48652846|NCT03985943|156581242|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
48652847|NCT03985943|156581243|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
48652848|NCT03985943|156581244|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
48652849|NCT03985943|156581245|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
48652850|NCT03985943|156581246|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
48652851|NCT03985943|156581247|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
48652852|NCT03985943|156581242|FG000|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
48865492|NCT00348283|157343421|FG001|Double Blind|Protocol Violation|1|||
48865493|NCT00348283|157343420|FG000|Double Blind|Lack of Efficacy|2|||
48865494|NCT00348283|157343421|FG001|Double Blind|Lack of Efficacy|2|||
48865495|NCT00348283|157343420|FG000|Double Blind|Pregnancy|0|||
48865496|NCT00348283|157343421|FG001|Double Blind|Pregnancy|1|||
48865497|NCT00348283|157343420|FG000|Open Label|Adverse Event|0|||
48865498|NCT00348283|157343421|FG001|Open Label|Adverse Event|8|||
48865499|NCT00348283|157343420|FG000|Open Label|Withdrawal by Subject|0|||
48865500|NCT00348283|157343421|FG001|Open Label|Withdrawal by Subject|4|||
48865501|NCT00348283|157343420|FG000|Open Label|Lost to Follow-up|0|||
48865502|NCT00348283|157343421|FG001|Open Label|Lost to Follow-up|1|||
48865503|NCT00348283|157343420|FG000|Open Label|Lack of Efficacy|0|||
48865504|NCT00348283|157343421|FG001|Open Label|Lack of Efficacy|13|||
48865505|NCT00348283|157343420|FG000|Open Label|Administrative reasons|0|||
48865506|NCT00348283|157343421|FG001|Open Label|Administrative reasons|5|||
48865507|NCT00348283|157343420|FG000|Open Label|Subject moved to the United States|0|||
48865508|NCT00348283|157343421|FG001|Open Label|Subject moved to the United States|1|||
48865509|NCT00348283|157343420|FG000|Open Label|Pregnancy|0|||
48865510|NCT00348283|157343421|FG001|Open Label|Pregnancy|1|||
48865511|NCT00348283|157343420|FG000|Open Label|Sponsor decision|0|||
48865512|NCT00348283|157343421|FG001|Open Label|Sponsor decision|1|||
48865513|NCT03873714|157343422|FG000|Overall Study|Six (6) were withdrawn, and one (1) was a Screen Failure|7|||
48652853|NCT03985943|156581243|FG001|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
48652854|NCT03985943|156581244|FG002|Maintenance Period (Week 16-Week 48)|Subjects request|6|||
48652855|NCT03985943|156581245|FG003|Maintenance Period (Week 16-Week 48)|Subjects request|4|||
48652856|NCT03985943|156581246|FG004|Maintenance Period (Week 16-Week 48)|Subjects request|5|||
48652857|NCT03985943|156581247|FG005|Maintenance Period (Week 16-Week 48)|Subjects request|9|||
48652858|NCT03985943|156581242|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
48652859|NCT03985943|156581243|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
48652860|NCT03985943|156581244|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
48865514|NCT01247922|157343423|FG000|Overall Study|Disease progression|4|||
48865515|NCT05740371|157343426|FG000|Overall Study|Death|1|||
48865516|NCT01774929|157343430|FG000|Overall Study|Adverse Event|3|||
48865517|NCT02040532|157343431|FG000|Overall Study|Lost to Follow-up|1|||
48652861|NCT03985943|156581245|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
48652862|NCT03985943|156581246|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
48652863|NCT03985943|156581247|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
48652864|NCT03985943|156581242|FG000|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
48652865|NCT03985943|156581243|FG001|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
48652866|NCT03985943|156581244|FG002|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
48652867|NCT03985943|156581245|FG003|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
48652868|NCT03985943|156581246|FG004|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
48652869|NCT03985943|156581247|FG005|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
48652870|NCT03985943|156581242|FG000|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
48652871|NCT03985943|156581243|FG001|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
48652872|NCT03985943|156581244|FG002|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
48652873|NCT03985943|156581245|FG003|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
48652874|NCT03985943|156581246|FG004|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
48652875|NCT03985943|156581247|FG005|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
48652876|NCT03985943|156581242|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
48652877|NCT03985943|156581243|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
48652878|NCT03985943|156581244|FG002|Maintenance Period (Week 16-Week 48)|Other|0|||
48652879|NCT03985943|156581245|FG003|Maintenance Period (Week 16-Week 48)|Other|0|||
48652880|NCT03985943|156581246|FG004|Maintenance Period (Week 16-Week 48)|Other|1|||
48652881|NCT03985943|156581247|FG005|Maintenance Period (Week 16-Week 48)|Other|1|||
48652882|NCT04295681|156581253|FG000|Overall Study|Eligibility error|1|||
48652883|NCT04295681|156581254|FG001|Overall Study|Eligibility error|3|||
48652884|NCT03575065|156581255|FG000|Overall Study|Death|31|||
48652885|NCT03575065|156581256|FG001|Overall Study|Death|12|||
48652886|NCT03575065|156581255|FG000|Overall Study|Sponsor's Decision|28|||
48652887|NCT03575065|156581256|FG001|Overall Study|Sponsor's Decision|13|||
48652888|NCT03575065|156581255|FG000|Overall Study|Withdrawal by Subject|2|||
48652889|NCT03575065|156581256|FG001|Overall Study|Withdrawal by Subject|1|||
48652890|NCT03575065|156581255|FG000|Overall Study|Lost to Follow-up|1|||
48652891|NCT03575065|156581256|FG001|Overall Study|Lost to Follow-up|0|||
48652892|NCT02858440|156581257|FG000|Overall Study|Lost to Follow-up|3|||
48652893|NCT02858440|156581257|FG000|Overall Study|Protocol Violation|2|||
48652894|NCT02858440|156581257|FG000|Overall Study|Consent withdrawal|3|||
48652895|NCT02858440|156581257|FG000|Overall Study|Migrated/moved from study area|4|||
48652896|NCT01054560|156581259|FG000|Overall Study|Death|10|||
48652897|NCT01054560|156581260|FG001|Overall Study|Death|21|||
48652898|NCT01054560|156581259|FG000|Overall Study|Lost to Follow-up|2|||
48652899|NCT01054560|156581260|FG001|Overall Study|Lost to Follow-up|5|||
48652900|NCT01054560|156581259|FG000|Overall Study|Withdrawal by Subject|0|||
48652901|NCT01054560|156581260|FG001|Overall Study|Withdrawal by Subject|2|||
48652902|NCT01054560|156581259|FG000|Overall Study|Physician Decision|1|||
48652903|NCT01054560|156581260|FG001|Overall Study|Physician Decision|0|||
48652904|NCT01262638|156581261|FG000|Overall Study|Adverse Event|3|||
48652905|NCT01262638|156581262|FG001|Overall Study|Adverse Event|4|||
48652906|NCT01262638|156581263|FG002|Overall Study|Adverse Event|3|||
48652907|NCT01262638|156581264|FG003|Overall Study|Adverse Event|4|||
48652908|NCT01262638|156581261|FG000|Overall Study|Protocol Violation|1|||
48652909|NCT01262638|156581262|FG001|Overall Study|Protocol Violation|0|||
48652910|NCT01262638|156581263|FG002|Overall Study|Protocol Violation|0|||
48652911|NCT01262638|156581264|FG003|Overall Study|Protocol Violation|1|||
48652912|NCT01262638|156581261|FG000|Overall Study|Withdrawal by Subject|2|||
48652913|NCT01262638|156581262|FG001|Overall Study|Withdrawal by Subject|1|||
48652914|NCT01262638|156581263|FG002|Overall Study|Withdrawal by Subject|0|||
48652915|NCT01262638|156581264|FG003|Overall Study|Withdrawal by Subject|1|||
48652916|NCT01262638|156581261|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
48652917|NCT01262638|156581262|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
48652918|NCT01262638|156581263|FG002|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
48652919|NCT01262638|156581264|FG003|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
48652920|NCT01262638|156581261|FG000|Overall Study|Lost to Follow-up|1|||
48652921|NCT01262638|156581262|FG001|Overall Study|Lost to Follow-up|1|||
48652922|NCT01262638|156581263|FG002|Overall Study|Lost to Follow-up|1|||
48652923|NCT01262638|156581264|FG003|Overall Study|Lost to Follow-up|1|||
48652924|NCT01262638|156581261|FG000|Overall Study|Participant Went Out of Town|0|||
48652925|NCT01262638|156581262|FG001|Overall Study|Participant Went Out of Town|0|||
48652926|NCT01262638|156581263|FG002|Overall Study|Participant Went Out of Town|1|||
48652927|NCT01262638|156581264|FG003|Overall Study|Participant Went Out of Town|0|||
48652928|NCT00939029|156581267|FG000|Overall Study|Withdrawal by Subject|3|||
48652929|NCT00939029|156581268|FG001|Overall Study|Withdrawal by Subject|7|||
48652930|NCT00939029|156581267|FG000|Overall Study|Lost to Follow-up|3|||
48652931|NCT00939029|156581268|FG001|Overall Study|Lost to Follow-up|4|||
48865518|NCT02040532|157343431|FG000|Overall Study|Physician Decision|4|||
48865519|NCT02040532|157343431|FG000|Overall Study|Adverse Event|4|||
48865520|NCT02040532|157343431|FG000|Overall Study|Withdrawal by Subject|3|||
48753556|NCT01506479|156944253|FG001|Overall Study|Lost to Follow-up|2|||
48753557|NCT01506479|156944254|FG002|Overall Study|Lost to Follow-up|2|||
48753558|NCT01506479|156944252|FG000|Overall Study|Withdrawal by Subject|1|||
48753559|NCT01506479|156944253|FG001|Overall Study|Withdrawal by Subject|2|||
48865521|NCT00145496|157343437|FG000|Overall Study|Adverse Event|42|||
48652932|NCT00939029|156581267|FG000|Overall Study|Adverse Event|0|||
48652933|NCT00939029|156581268|FG001|Overall Study|Adverse Event|1|||
48652934|NCT00487942|156581269|FG000|Overall Study|Adverse Event|1|||
48652935|NCT00487942|156581270|FG001|Overall Study|Adverse Event|1|||
48652936|NCT00487942|156581271|FG002|Overall Study|Adverse Event|1|||
48652937|NCT00487942|156581272|FG003|Overall Study|Adverse Event|1|||
48652938|NCT00487942|156581269|FG000|Overall Study|Lost to Follow-up|1|||
48652939|NCT00487942|156581270|FG001|Overall Study|Lost to Follow-up|0|||
48652940|NCT00487942|156581271|FG002|Overall Study|Lost to Follow-up|0|||
48652941|NCT00487942|156581272|FG003|Overall Study|Lost to Follow-up|1|||
48652942|NCT00487942|156581269|FG000|Overall Study|Protocol Violation|1|||
48652943|NCT00487942|156581270|FG001|Overall Study|Protocol Violation|1|||
48652944|NCT00487942|156581271|FG002|Overall Study|Protocol Violation|0|||
48652945|NCT00487942|156581272|FG003|Overall Study|Protocol Violation|0|||
48652946|NCT00487942|156581269|FG000|Overall Study|Withdrawal by Subject|0|||
48652947|NCT00487942|156581270|FG001|Overall Study|Withdrawal by Subject|1|||
48652948|NCT00487942|156581271|FG002|Overall Study|Withdrawal by Subject|2|||
48652949|NCT00487942|156581272|FG003|Overall Study|Withdrawal by Subject|0|||
48652950|NCT00676520|156581273|FG000|Overall Study|Withdrawal by Subject|163|||
48652951|NCT00676520|156581273|FG000|Overall Study|Lost to Follow-up|162|||
48652952|NCT00676520|156581273|FG000|Overall Study|Death|159|||
48652953|NCT00676520|156581273|FG000|Overall Study|Physician Decision|20|||
48652954|NCT00676520|156581273|FG000|Overall Study|Ineligible for Randomization to DAPT|209|||
48652955|NCT00676520|156581273|FG000|Overall Study|Other Reason|18|||
48652956|NCT00889603|156581288|FG000|Overall Study|Adverse Event|7|||
48652957|NCT00889603|156581288|FG000|Overall Study|Death|3|||
48652958|NCT00889603|156581288|FG000|Overall Study|Lost to Follow-up|19|||
48652959|NCT00889603|156581288|FG000|Overall Study|No longer willing to participant in stud|4|||
48652960|NCT00889603|156581288|FG000|Overall Study|Other|4|||
48652961|NCT00851552|156581289|FG000|Overall Study|Death|2|||
48652962|NCT00851552|156581289|FG000|Overall Study|Adverse Event|1|||
48652963|NCT00851552|156581289|FG000|Overall Study|Disease Progression|4|||
48652964|NCT00177294|156581290|FG000|Overall Study|Withdrawal by Subject|7|||
48753560|NCT01506479|156944254|FG002|Overall Study|Withdrawal by Subject|1|||
48753561|NCT01506479|156944252|FG000|Overall Study|Missing assessment|1|||
48865522|NCT00145496|157343438|FG001|Overall Study|Adverse Event|30|||
48865523|NCT00145496|157343437|FG000|Overall Study|Lack of Efficacy|12|||
48865524|NCT00145496|157343438|FG001|Overall Study|Lack of Efficacy|7|||
48865525|NCT00145496|157343437|FG000|Overall Study|Withdrawal by Subject|32|||
48865526|NCT00145496|157343438|FG001|Overall Study|Withdrawal by Subject|26|||
48865527|NCT00145496|157343437|FG000|Overall Study|Lost to Follow-up|12|||
48865528|NCT00145496|157343438|FG001|Overall Study|Lost to Follow-up|5|||
48865529|NCT00145496|157343437|FG000|Overall Study|Other|25|||
48865530|NCT00145496|157343438|FG001|Overall Study|Other|13|||
48865531|NCT01780584|157343439|FG000|Overall Study|Death|1|||
48865532|NCT01780584|157343440|FG001|Overall Study|Death|0|||
48865533|NCT01780584|157343441|FG002|Overall Study|Death|1|||
48865534|NCT01780584|157343439|FG000|Overall Study|Adverse Event|0|||
48865535|NCT01780584|157343440|FG001|Overall Study|Adverse Event|1|||
48865536|NCT01780584|157343441|FG002|Overall Study|Adverse Event|0|||
48865537|NCT01780584|157343439|FG000|Overall Study|Protocol Violation|0|||
48865538|NCT01780584|157343440|FG001|Overall Study|Protocol Violation|0|||
48865539|NCT01780584|157343441|FG002|Overall Study|Protocol Violation|1|||
48865540|NCT00562484|157343442|FG000|Overall Study|Adverse Event|6|||
48865541|NCT00562484|157343443|FG001|Overall Study|Adverse Event|1|||
48865542|NCT00562484|157343442|FG000|Overall Study|Protocol Violation|11|||
48865543|NCT00562484|157343443|FG001|Overall Study|Protocol Violation|2|||
48865544|NCT00562484|157343442|FG000|Overall Study|Withdrawal by Subject|12|||
48865545|NCT00562484|157343443|FG001|Overall Study|Withdrawal by Subject|9|||
48865546|NCT00562484|157343442|FG000|Overall Study|Moved away from the study area|20|||
48865547|NCT00562484|157343443|FG001|Overall Study|Moved away from the study area|9|||
48865548|NCT00562484|157343442|FG000|Overall Study|Lost to Follow-up|132|||
48865549|NCT00562484|157343443|FG001|Overall Study|Lost to Follow-up|71|||
48865550|NCT00562484|157343442|FG000|Overall Study|Reason not provided or not specified|25|||
48865551|NCT00562484|157343443|FG001|Overall Study|Reason not provided or not specified|12|||
48865552|NCT00525915|157343446|FG000|Overall Study|Non-Compliance|0|||
48865553|NCT00525915|157343447|FG001|Overall Study|Non-Compliance|1|||
48865554|NCT00525915|157343446|FG000|Overall Study|Disease Progression|5|||
48865555|NCT00525915|157343447|FG001|Overall Study|Disease Progression|6|||
48865556|NCT00525915|157343446|FG000|Overall Study|Withdrawal by Subject|1|||
48865557|NCT00525915|157343447|FG001|Overall Study|Withdrawal by Subject|0|||
48865558|NCT00525915|157343446|FG000|Overall Study|Refused Surgery|1|||
48865559|NCT00525915|157343447|FG001|Overall Study|Refused Surgery|2|||
48865560|NCT00525915|157343446|FG000|Overall Study|Unrelated illness|1|||
48959969|NCT00752609|157682620|FG001|Overall Study|Withdrawal by Subject|0|||
48959970|NCT00752609|157682619|FG000|Overall Study|Physician Decision|1|||
48959971|NCT00752609|157682620|FG001|Overall Study|Physician Decision|0|||
48959972|NCT00752609|157682619|FG000|Overall Study|Death|1|||
48959973|NCT00752609|157682620|FG001|Overall Study|Death|0|||
48959974|NCT00752609|157682619|FG000|Overall Study|Met exclusion criteria|1|||
48753562|NCT01506479|156944253|FG001|Overall Study|Missing assessment|0|||
48753563|NCT01506479|156944254|FG002|Overall Study|Missing assessment|0|||
48753564|NCT01506479|156944252|FG000|Overall Study|Adverse Event|0|||
48959975|NCT00752609|157682620|FG001|Overall Study|Met exclusion criteria|0|||
48959976|NCT00752609|157682619|FG000|Overall Study|Received Aranesp in error|1|||
48959977|NCT00752609|157682620|FG001|Overall Study|Received Aranesp in error|0|||
48959978|NCT00195260|157682621|FG000|Part 1: Dose Escalation|Adverse Event|0|||
48959979|NCT00195260|157682622|FG001|Part 1: Dose Escalation|Adverse Event|1|||
48959980|NCT00195260|157682623|FG002|Part 1: Dose Escalation|Adverse Event|0|||
48959981|NCT00195260|157682624|FG003|Part 1: Dose Escalation|Adverse Event|1|||
48959982|NCT00195260|157682625|FG004|Part 1: Dose Escalation|Adverse Event|1|||
48652965|NCT00177294|156581291|FG001|Overall Study|Withdrawal by Subject|5|||
48652966|NCT01813058|156581292|FG000|Overall Study|Withdrawal by Subject|5|||
48652967|NCT01813058|156581293|FG001|Overall Study|Withdrawal by Subject|4|||
48652968|NCT00675441|156581294|FG000|Overall Study|Withdrawal by Subject|2|||
48652969|NCT00675441|156581294|FG000|Overall Study|Death|1|||
48959983|NCT00195260|157682626|FG005|Part 1: Dose Escalation|Adverse Event|0|||
48959984|NCT00195260|157682627|FG006|Part 1: Dose Escalation|Adverse Event|3|||
48959985|NCT00195260|157682628|FG007|Part 1: Dose Escalation|Adverse Event|0|||
48959986|NCT00195260|157682629|FG008|Part 1: Dose Escalation|Adverse Event|0|||
48959987|NCT00195260|157682630|FG009|Part 1: Dose Escalation|Adverse Event|0|||
48959988|NCT00195260|157682631|FG010|Part 1: Dose Escalation|Adverse Event|0|||
48959989|NCT00195260|157682621|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
48959990|NCT00195260|157682622|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
48959991|NCT00195260|157682623|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
48959992|NCT00195260|157682624|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
48753565|NCT01506479|156944253|FG001|Overall Study|Adverse Event|1|||
48959993|NCT00195260|157682625|FG004|Part 1: Dose Escalation|Withdrawal by Subject|2|||
48959994|NCT00195260|157682626|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
48653032|NCT02712983|156583240|FG000|Treatment Phase|Adverse Event|3|||
48653033|NCT02712983|156583241|FG001|Treatment Phase|Adverse Event|1|||
48653034|NCT02712983|156583242|FG002|Treatment Phase|Adverse Event|1|||
48653035|NCT02712983|156583243|FG003|Treatment Phase|Adverse Event|4|||
48653036|NCT02712983|156583244|FG004|Treatment Phase|Adverse Event|3|||
48653037|NCT02712983|156583245|FG005|Treatment Phase|Adverse Event|0|||
48653038|NCT02712983|156583246|FG006|Treatment Phase|Adverse Event|6|||
48653039|NCT02712983|156583247|FG007|Treatment Phase|Adverse Event|6|||
48653040|NCT02712983|156583248|FG008|Treatment Phase|Adverse Event|1|||
48653041|NCT02712983|156583240|FG000|Treatment Phase|Protocol Deviation|0|||
48653042|NCT02712983|156583241|FG001|Treatment Phase|Protocol Deviation|0|||
48653043|NCT02712983|156583242|FG002|Treatment Phase|Protocol Deviation|0|||
48653044|NCT02712983|156583243|FG003|Treatment Phase|Protocol Deviation|2|||
48653045|NCT02712983|156583244|FG004|Treatment Phase|Protocol Deviation|0|||
48653046|NCT02712983|156583245|FG005|Treatment Phase|Protocol Deviation|0|||
48653047|NCT02712983|156583246|FG006|Treatment Phase|Protocol Deviation|1|||
48653048|NCT02712983|156583247|FG007|Treatment Phase|Protocol Deviation|0|||
48653049|NCT02712983|156583248|FG008|Treatment Phase|Protocol Deviation|0|||
48653050|NCT02712983|156583240|FG000|Treatment Phase|Technical Problems|0|||
48653051|NCT02712983|156583241|FG001|Treatment Phase|Technical Problems|0|||
48653052|NCT02712983|156583242|FG002|Treatment Phase|Technical Problems|0|||
48653053|NCT02712983|156583243|FG003|Treatment Phase|Technical Problems|0|||
48653054|NCT02712983|156583244|FG004|Treatment Phase|Technical Problems|0|||
48653055|NCT02712983|156583245|FG005|Treatment Phase|Technical Problems|0|||
48653056|NCT02712983|156583246|FG006|Treatment Phase|Technical Problems|1|||
48653057|NCT02712983|156583247|FG007|Treatment Phase|Technical Problems|0|||
48653058|NCT02712983|156583248|FG008|Treatment Phase|Technical Problems|0|||
48653059|NCT02712983|156583240|FG000|Treatment Phase|Physician Decision|0|||
48653060|NCT02712983|156583241|FG001|Treatment Phase|Physician Decision|0|||
48653061|NCT02712983|156583242|FG002|Treatment Phase|Physician Decision|0|||
48653062|NCT02712983|156583243|FG003|Treatment Phase|Physician Decision|0|||
48653063|NCT02712983|156583244|FG004|Treatment Phase|Physician Decision|0|||
48653064|NCT02712983|156583245|FG005|Treatment Phase|Physician Decision|0|||
48653065|NCT02712983|156583246|FG006|Treatment Phase|Physician Decision|0|||
48653066|NCT02712983|156583247|FG007|Treatment Phase|Physician Decision|1|||
48653067|NCT02712983|156583248|FG008|Treatment Phase|Physician Decision|1|||
48653068|NCT02712983|156583240|FG000|Treatment Phase|Subject Decision|2|||
48653069|NCT02712983|156583241|FG001|Treatment Phase|Subject Decision|0|||
48653070|NCT02712983|156583242|FG002|Treatment Phase|Subject Decision|0|||
48653071|NCT02712983|156583243|FG003|Treatment Phase|Subject Decision|2|||
48653072|NCT02712983|156583244|FG004|Treatment Phase|Subject Decision|1|||
48653073|NCT02712983|156583245|FG005|Treatment Phase|Subject Decision|0|||
48653074|NCT02712983|156583246|FG006|Treatment Phase|Subject Decision|1|||
48653075|NCT02712983|156583247|FG007|Treatment Phase|Subject Decision|2|||
48653076|NCT02712983|156583248|FG008|Treatment Phase|Subject Decision|0|||
48653077|NCT02712983|156583240|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
48653078|NCT02712983|156583241|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
48653079|NCT02712983|156583242|FG002|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
48653080|NCT02712983|156583243|FG003|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
48653081|NCT02712983|156583244|FG004|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
48653082|NCT02712983|156583245|FG005|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
48653083|NCT02712983|156583246|FG006|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
48653084|NCT02712983|156583247|FG007|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
48653085|NCT02712983|156583248|FG008|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
48653086|NCT02712983|156583240|FG000|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
48653087|NCT02712983|156583241|FG001|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
48753566|NCT01506479|156944254|FG002|Overall Study|Adverse Event|0|||
48753567|NCT02005445|156944257|FG000|Overall Study|Dual study enrollment|0|||
48653088|NCT02712983|156583242|FG002|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
48653089|NCT02712983|156583243|FG003|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1|||
48653090|NCT02712983|156583244|FG004|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
48959995|NCT00195260|157682627|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
48653091|NCT02712983|156583245|FG005|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
48653092|NCT02712983|156583246|FG006|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
48653093|NCT02712983|156583247|FG007|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
48653094|NCT02712983|156583248|FG008|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
48959996|NCT00195260|157682628|FG007|Part 1: Dose Escalation|Withdrawal by Subject|1|||
48959997|NCT00195260|157682629|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
48653095|NCT02712983|156583240|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
48653096|NCT02712983|156583241|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
48653097|NCT02712983|156583242|FG002|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
48653098|NCT02712983|156583243|FG003|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
48653099|NCT02712983|156583244|FG004|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
48653100|NCT02712983|156583245|FG005|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
48653101|NCT02712983|156583246|FG006|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
48653102|NCT02712983|156583247|FG007|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
48653103|NCT02712983|156583248|FG008|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
48653104|NCT01340625|156583253|FG000|First Intervention|Adverse Event|1|||
48653105|NCT01340625|156583254|FG001|First Intervention|Adverse Event|0|||
48653106|NCT01340625|156583253|FG000|Washout Period of 28 Days|Withdrawal by Subject|1|||
48653107|NCT01340625|156583254|FG001|Washout Period of 28 Days|Withdrawal by Subject|0|||
48653108|NCT02290691|156583259|FG000|Overall Study|Noncompliance|0|||
48653109|NCT02290691|156583260|FG001|Overall Study|Noncompliance|1|||
48653110|NCT02290691|156583259|FG000|Overall Study|Withdrawal by Subject|1|||
48653111|NCT02290691|156583260|FG001|Overall Study|Withdrawal by Subject|1|||
48653112|NCT02290691|156583259|FG000|Overall Study|Lost to Follow-up|7|||
48653113|NCT02290691|156583260|FG001|Overall Study|Lost to Follow-up|7|||
48653114|NCT00566982|156583261|FG000|Overall Study|Adverse Event|6|||
48653115|NCT00566982|156583262|FG001|Overall Study|Adverse Event|48|||
48653116|NCT00566982|156583261|FG000|Overall Study|Withdrawal by Subject|1|||
48653117|NCT00566982|156583262|FG001|Overall Study|Withdrawal by Subject|14|||
48653118|NCT00566982|156583261|FG000|Overall Study|Protocol Violation|1|||
48653119|NCT00566982|156583262|FG001|Overall Study|Protocol Violation|4|||
48653120|NCT00566982|156583261|FG000|Overall Study|Lost to Follow-up|0|||
48653121|NCT00566982|156583262|FG001|Overall Study|Lost to Follow-up|1|||
48653122|NCT00566982|156583261|FG000|Overall Study|Other-family problems & doctor's request|0|||
48653123|NCT00566982|156583262|FG001|Overall Study|Other-family problems & doctor's request|2|||
48653124|NCT00336284|156583263|FG000|Overall Study|Death|52|||
48653125|NCT00336284|156583264|FG001|Overall Study|Death|26|||
48653126|NCT00336284|156583263|FG000|Overall Study|Lost to Follow-up|82|||
48653127|NCT00336284|156583264|FG001|Overall Study|Lost to Follow-up|61|||
48653128|NCT00336284|156583263|FG000|Overall Study|Withdrawal by Physician or Subject|102|||
48653129|NCT00336284|156583264|FG001|Overall Study|Withdrawal by Physician or Subject|64|||
48653130|NCT03530995|156583265|FG000|Part 1 Period 3|Withdrawal by Subject|2|||
48653131|NCT03530995|156583266|FG001|Part 1 Period 3|Withdrawal by Subject|0|||
48653132|NCT03530995|156583265|FG000|Part 1 Period 3|Protocol Violation|1|||
48653133|NCT03530995|156583266|FG001|Part 1 Period 3|Protocol Violation|0|||
48653134|NCT03530995|156583265|FG000|Part 1 Period 4|Physician Decision|1|||
48653135|NCT03530995|156583266|FG001|Part 1 Period 4|Physician Decision|0|||
48653136|NCT03530995|156583265|FG000|Part 1 Period 4|Withdrawal by Subject|1|||
48753568|NCT02005445|156944258|FG001|Overall Study|Dual study enrollment|1|||
48753569|NCT01881776|156944262|FG000|Overall Study|Lost to Follow-up|1|||
48959998|NCT00195260|157682630|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
48959999|NCT00195260|157682631|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
48960000|NCT00195260|157682621|FG000|Part 1: Dose Escalation|Death|0|||
48960001|NCT00195260|157682622|FG001|Part 1: Dose Escalation|Death|0|||
48960002|NCT00195260|157682623|FG002|Part 1: Dose Escalation|Death|0|||
48960003|NCT00195260|157682624|FG003|Part 1: Dose Escalation|Death|0|||
48960004|NCT00195260|157682625|FG004|Part 1: Dose Escalation|Death|0|||
48960005|NCT00195260|157682626|FG005|Part 1: Dose Escalation|Death|0|||
48960006|NCT00195260|157682627|FG006|Part 1: Dose Escalation|Death|0|||
48960007|NCT00195260|157682628|FG007|Part 1: Dose Escalation|Death|1|||
48653137|NCT03530995|156583266|FG001|Part 1 Period 4|Withdrawal by Subject|0|||
48653138|NCT00218634|156583267|FG000|Overall Study|Lost to Follow-up|8|||
48653139|NCT00218634|156583268|FG001|Overall Study|Lost to Follow-up|15|||
48653140|NCT05243745|156583269|FG000|Overall Study|Withdrawal by Subject|0|||
48653141|NCT05243745|156583270|FG001|Overall Study|Withdrawal by Subject|0|||
48653142|NCT05243745|156583271|FG002|Overall Study|Withdrawal by Subject|0|||
48653143|NCT05243745|156583272|FG003|Overall Study|Withdrawal by Subject|1|||
48960008|NCT00195260|157682629|FG008|Part 1: Dose Escalation|Death|0|||
48960009|NCT00195260|157682630|FG009|Part 1: Dose Escalation|Death|0|||
48960010|NCT00195260|157682631|FG010|Part 1: Dose Escalation|Death|0|||
48960011|NCT00195260|157682621|FG000|Part 1: Dose Escalation|Disease Progression|3|||
48960012|NCT00195260|157682622|FG001|Part 1: Dose Escalation|Disease Progression|2|||
48960013|NCT00195260|157682623|FG002|Part 1: Dose Escalation|Disease Progression|5|||
48960014|NCT00195260|157682624|FG003|Part 1: Dose Escalation|Disease Progression|6|||
48960015|NCT00195260|157682625|FG004|Part 1: Dose Escalation|Disease Progression|4|||
48960016|NCT00195260|157682626|FG005|Part 1: Dose Escalation|Disease Progression|6|||
48960017|NCT00195260|157682627|FG006|Part 1: Dose Escalation|Disease Progression|7|||
48960018|NCT00195260|157682628|FG007|Part 1: Dose Escalation|Disease Progression|4|||
48960019|NCT00195260|157682629|FG008|Part 1: Dose Escalation|Disease Progression|0|||
48960020|NCT00195260|157682630|FG009|Part 1: Dose Escalation|Disease Progression|0|||
48960021|NCT00195260|157682631|FG010|Part 1: Dose Escalation|Disease Progression|0|||
48960022|NCT00195260|157682621|FG000|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
48960023|NCT00195260|157682622|FG001|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
48960024|NCT00195260|157682623|FG002|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
48960025|NCT00195260|157682624|FG003|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
48960026|NCT00195260|157682625|FG004|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
48960027|NCT00195260|157682626|FG005|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
48960028|NCT00195260|157682627|FG006|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
48960029|NCT00195260|157682628|FG007|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
48960030|NCT00195260|157682629|FG008|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
48960031|NCT00195260|157682630|FG009|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
48960032|NCT00195260|157682631|FG010|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
48960033|NCT00195260|157682621|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
48960034|NCT00195260|157682622|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
48960035|NCT00195260|157682623|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
48960036|NCT00195260|157682624|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
48960037|NCT00195260|157682625|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
48960038|NCT00195260|157682626|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
48960039|NCT00195260|157682627|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
48960040|NCT00195260|157682628|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
48960041|NCT00195260|157682629|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21|||
48960042|NCT00195260|157682630|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29|||
48653144|NCT05243745|156583269|FG000|Overall Study|Unable to Attend Visit 6|0|||
48653145|NCT05243745|156583270|FG001|Overall Study|Unable to Attend Visit 6|0|||
48653146|NCT05243745|156583271|FG002|Overall Study|Unable to Attend Visit 6|1|||
48653147|NCT05243745|156583272|FG003|Overall Study|Unable to Attend Visit 6|0|||
48653148|NCT03037476|156583285|FG000|Overall Study|Lost to Follow-up|63|||
48653149|NCT03037476|156583286|FG001|Overall Study|Lost to Follow-up|46|||
48653150|NCT00327015|156583287|FG000|Overall Study|Lack of Efficacy|18|||
48653151|NCT00327015|156583288|FG001|Overall Study|Lack of Efficacy|18|||
48653152|NCT00327015|156583289|FG002|Overall Study|Lack of Efficacy|35|||
48653153|NCT00327015|156583290|FG003|Overall Study|Lack of Efficacy|29|||
48653154|NCT00327015|156583287|FG000|Overall Study|Withdrawal of Consent by Subject|20|||
48653155|NCT00327015|156583288|FG001|Overall Study|Withdrawal of Consent by Subject|24|||
48653156|NCT00327015|156583289|FG002|Overall Study|Withdrawal of Consent by Subject|28|||
48653157|NCT00327015|156583290|FG003|Overall Study|Withdrawal of Consent by Subject|25|||
48653158|NCT00327015|156583287|FG000|Overall Study|Lost to Follow-up|22|||
48653159|NCT00327015|156583288|FG001|Overall Study|Lost to Follow-up|23|||
48653160|NCT00327015|156583289|FG002|Overall Study|Lost to Follow-up|29|||
48653161|NCT00327015|156583290|FG003|Overall Study|Lost to Follow-up|22|||
48653162|NCT00327015|156583287|FG000|Overall Study|Adverse Event|14|||
48653163|NCT00327015|156583288|FG001|Overall Study|Adverse Event|10|||
48653164|NCT00327015|156583289|FG002|Overall Study|Adverse Event|14|||
48653165|NCT00327015|156583290|FG003|Overall Study|Adverse Event|14|||
48653166|NCT00327015|156583287|FG000|Overall Study|Subject no longer meets study criteria|4|||
48653167|NCT00327015|156583288|FG001|Overall Study|Subject no longer meets study criteria|2|||
48653168|NCT00327015|156583289|FG002|Overall Study|Subject no longer meets study criteria|8|||
48653169|NCT00327015|156583290|FG003|Overall Study|Subject no longer meets study criteria|7|||
48653170|NCT00327015|156583287|FG000|Overall Study|Poor/Noncompliance|11|||
48653171|NCT00327015|156583288|FG001|Overall Study|Poor/Noncompliance|8|||
48960043|NCT00195260|157682631|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15|||
48960044|NCT00195260|157682621|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
48653172|NCT00327015|156583289|FG002|Overall Study|Poor/Noncompliance|4|||
48960045|NCT00195260|157682622|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
48960046|NCT00195260|157682623|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
48960047|NCT00195260|157682624|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
48653173|NCT00327015|156583290|FG003|Overall Study|Poor/Noncompliance|5|||
48653174|NCT00327015|156583287|FG000|Overall Study|Physician Decision|0|||
48653175|NCT00327015|156583288|FG001|Overall Study|Physician Decision|1|||
48653176|NCT00327015|156583289|FG002|Overall Study|Physician Decision|3|||
48653177|NCT00327015|156583290|FG003|Overall Study|Physician Decision|2|||
48653178|NCT00327015|156583287|FG000|Overall Study|Death|1|||
48653179|NCT00327015|156583288|FG001|Overall Study|Death|2|||
48653180|NCT00327015|156583289|FG002|Overall Study|Death|2|||
48653181|NCT00327015|156583290|FG003|Overall Study|Death|3|||
48653182|NCT00327015|156583287|FG000|Overall Study|Pregnancy|0|||
48653183|NCT00327015|156583288|FG001|Overall Study|Pregnancy|2|||
48653184|NCT00327015|156583289|FG002|Overall Study|Pregnancy|1|||
48653185|NCT00327015|156583290|FG003|Overall Study|Pregnancy|1|||
48653186|NCT00327015|156583287|FG000|Overall Study|Administrative Reason by Sponsor|1|||
48653187|NCT00327015|156583288|FG001|Overall Study|Administrative Reason by Sponsor|2|||
48653188|NCT00327015|156583289|FG002|Overall Study|Administrative Reason by Sponsor|2|||
48653189|NCT00327015|156583290|FG003|Overall Study|Administrative Reason by Sponsor|1|||
48653190|NCT01986231|156583294|FG000|Overall Study|Adverse Event|1|||
48653191|NCT00837265|156583295|FG000|Pilot Phase|Withdrawal by Subject|0|||
48653192|NCT00837265|156583296|FG001|Pilot Phase|Withdrawal by Subject|2|||
48653193|NCT00837265|156583297|FG002|Pilot Phase|Withdrawal by Subject|3|||
48653194|NCT00837265|156583298|FG003|Pilot Phase|Withdrawal by Subject|2|||
48653195|NCT00837265|156583299|FG004|Pilot Phase|Withdrawal by Subject|0|||
48653196|NCT00837265|156583300|FG005|Pilot Phase|Withdrawal by Subject|0|||
48653197|NCT00837265|156583301|FG006|Pilot Phase|Withdrawal by Subject|0|||
48653198|NCT00837265|156583295|FG000|Pilot Phase|Decision of the investigator|2|||
48653199|NCT00837265|156583296|FG001|Pilot Phase|Decision of the investigator|1|||
48753570|NCT01881776|156944263|FG001|Overall Study|Lost to Follow-up|2|||
48753571|NCT01881776|156944264|FG002|Overall Study|Lost to Follow-up|1|||
48753572|NCT01881776|156944262|FG000|Overall Study|Protocol Violation|0|||
48753573|NCT01881776|156944263|FG001|Overall Study|Protocol Violation|2|||
48753574|NCT01881776|156944264|FG002|Overall Study|Protocol Violation|1|||
48753575|NCT02320149|156944265|FG000|Overall Study|Adverse Event|3|||
48753576|NCT02320149|156944266|FG001|Overall Study|Adverse Event|7|||
48753577|NCT02320149|156944265|FG000|Overall Study|Withdrawal of Consent|28|||
48753578|NCT02320149|156944266|FG001|Overall Study|Withdrawal of Consent|32|||
48753579|NCT02320149|156944265|FG000|Overall Study|Lost to Follow-up|21|||
48753580|NCT02320149|156944266|FG001|Overall Study|Lost to Follow-up|34|||
48753581|NCT02320149|156944265|FG000|Overall Study|Protocol Violation|2|||
48753582|NCT02320149|156944266|FG001|Overall Study|Protocol Violation|1|||
48753583|NCT02320149|156944265|FG000|Overall Study|Noncompliance with Study Treatment|7|||
48753584|NCT02320149|156944266|FG001|Overall Study|Noncompliance with Study Treatment|2|||
48753585|NCT02320149|156944265|FG000|Overall Study|Lack of Efficacy|0|||
48753586|NCT02320149|156944266|FG001|Overall Study|Lack of Efficacy|1|||
48753587|NCT02320149|156944265|FG000|Overall Study|Other Miscellaneous Reasons|2|||
48753588|NCT02320149|156944266|FG001|Overall Study|Other Miscellaneous Reasons|3|||
48753589|NCT00006903|156944268|FG000|Overall Study|Still receiving treatment|0|||
48753590|NCT00006903|156944269|FG001|Overall Study|Still receiving treatment|0|||
48753591|NCT00006903|156944270|FG002|Overall Study|Still receiving treatment|1|||
48753592|NCT00006903|156944268|FG000|Overall Study|Refused further treatment|0|||
48753593|NCT00006903|156944269|FG001|Overall Study|Refused further treatment|2|||
48753594|NCT00006903|156944270|FG002|Overall Study|Refused further treatment|1|||
48753595|NCT00006903|156944268|FG000|Overall Study|Adverse Event|0|||
48753596|NCT00006903|156944269|FG001|Overall Study|Adverse Event|0|||
48753597|NCT00006903|156944270|FG002|Overall Study|Adverse Event|1|||
48753598|NCT00006903|156944268|FG000|Overall Study|Death|0|||
48753599|NCT00006903|156944269|FG001|Overall Study|Death|1|||
48753600|NCT00006903|156944270|FG002|Overall Study|Death|0|||
48753601|NCT00006903|156944268|FG000|Overall Study|Patient never treated|0|||
48753602|NCT00006903|156944269|FG001|Overall Study|Patient never treated|0|||
48753603|NCT00006903|156944270|FG002|Overall Study|Patient never treated|1|||
48753604|NCT00006903|156944268|FG000|Overall Study|Ineligible|10|||
48865561|NCT00525915|157343447|FG001|Overall Study|Unrelated illness|0|||
48865562|NCT01204775|157343450|FG000|Overall Study|Poor/non-compliance|0|||
48865563|NCT01204775|157343451|FG001|Overall Study|Poor/non-compliance|1|||
48865564|NCT01204775|157343450|FG000|Overall Study|Withdrawal by Subject|1|||
48865565|NCT01204775|157343451|FG001|Overall Study|Withdrawal by Subject|0|||
48865566|NCT04783519|157343452|FG000|Overall Study|Withdrawal by Subject|2|||
48865567|NCT04783519|157343453|FG001|Overall Study|Withdrawal by Subject|7|||
48653200|NCT00837265|156583297|FG002|Pilot Phase|Decision of the investigator|0|||
48653201|NCT00837265|156583298|FG003|Pilot Phase|Decision of the investigator|0|||
48653202|NCT00837265|156583299|FG004|Pilot Phase|Decision of the investigator|0|||
48753605|NCT00006903|156944269|FG001|Overall Study|Ineligible|1|||
48753606|NCT00006903|156944270|FG002|Overall Study|Ineligible|2|||
48753607|NCT02393547|156944271|FG000|Overall Study|Adverse Event|2|||
48653203|NCT00837265|156583300|FG005|Pilot Phase|Decision of the investigator|0|||
48653204|NCT00837265|156583301|FG006|Pilot Phase|Decision of the investigator|0|||
48753608|NCT02393547|156944271|FG000|Overall Study|Withdrawal by Subject|3|||
48753609|NCT02393547|156944271|FG000|Overall Study|Lost to Follow-up|1|||
48753610|NCT02707991|156944272|FG000|Overall Study|Protocol Violation|1|||
48753611|NCT02707991|156944273|FG001|Overall Study|Protocol Violation|0|||
48753612|NCT02707991|156944272|FG000|Overall Study|Became ineligible|0|||
48753613|NCT02707991|156944273|FG001|Overall Study|Became ineligible|1|||
48960048|NCT00195260|157682625|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
48960049|NCT00195260|157682626|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
48960050|NCT00195260|157682627|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
48960051|NCT00195260|157682628|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
48960052|NCT00195260|157682629|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5|||
48960053|NCT00195260|157682630|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3|||
48960054|NCT00195260|157682631|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2|||
48960055|NCT00195260|157682621|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
48960056|NCT00195260|157682622|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
48960057|NCT00195260|157682623|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
48960058|NCT00195260|157682624|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
48960059|NCT00195260|157682625|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
48960060|NCT00195260|157682626|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
48653205|NCT00837265|156583295|FG000|Pilot Phase|Adverse Event|1|||
48653206|NCT00837265|156583296|FG001|Pilot Phase|Adverse Event|0|||
48653207|NCT00837265|156583297|FG002|Pilot Phase|Adverse Event|0|||
48653208|NCT00837265|156583298|FG003|Pilot Phase|Adverse Event|0|||
48960061|NCT00195260|157682627|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
48960062|NCT00195260|157682628|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
48960063|NCT00195260|157682629|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1|||
48960064|NCT00195260|157682630|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2|||
48960065|NCT00195260|157682631|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3|||
48653209|NCT00837265|156583299|FG004|Pilot Phase|Adverse Event|0|||
48653210|NCT00837265|156583300|FG005|Pilot Phase|Adverse Event|0|||
48653211|NCT00837265|156583301|FG006|Pilot Phase|Adverse Event|0|||
48653212|NCT00837265|156583295|FG000|Pilot Phase|Disease progression|0|||
48653213|NCT00837265|156583296|FG001|Pilot Phase|Disease progression|0|||
48653214|NCT00837265|156583297|FG002|Pilot Phase|Disease progression|0|||
48653215|NCT00837265|156583298|FG003|Pilot Phase|Disease progression|1|||
48653216|NCT00837265|156583299|FG004|Pilot Phase|Disease progression|0|||
48653217|NCT00837265|156583300|FG005|Pilot Phase|Disease progression|0|||
48653218|NCT00837265|156583301|FG006|Pilot Phase|Disease progression|0|||
48653219|NCT00837265|156583295|FG000|Pilot Phase|Participant left the city|0|||
48653220|NCT00837265|156583296|FG001|Pilot Phase|Participant left the city|0|||
48653221|NCT00837265|156583297|FG002|Pilot Phase|Participant left the city|0|||
48653222|NCT00837265|156583298|FG003|Pilot Phase|Participant left the city|1|||
48653223|NCT00837265|156583299|FG004|Pilot Phase|Participant left the city|0|||
48653224|NCT00837265|156583300|FG005|Pilot Phase|Participant left the city|0|||
48653225|NCT00837265|156583301|FG006|Pilot Phase|Participant left the city|0|||
48653226|NCT00837265|156583295|FG000|Main Phase|Withdrawal by Subject|0|||
48653227|NCT00837265|156583296|FG001|Main Phase|Withdrawal by Subject|0|||
48653228|NCT00837265|156583297|FG002|Main Phase|Withdrawal by Subject|0|||
48653229|NCT00837265|156583298|FG003|Main Phase|Withdrawal by Subject|0|||
48653230|NCT00837265|156583299|FG004|Main Phase|Withdrawal by Subject|4|||
48653231|NCT00837265|156583300|FG005|Main Phase|Withdrawal by Subject|2|||
48653232|NCT00837265|156583301|FG006|Main Phase|Withdrawal by Subject|1|||
48653233|NCT00837265|156583295|FG000|Main Phase|Decision of the investigator|0|||
48653234|NCT00837265|156583296|FG001|Main Phase|Decision of the investigator|0|||
48653235|NCT00837265|156583297|FG002|Main Phase|Decision of the investigator|0|||
48653236|NCT00837265|156583298|FG003|Main Phase|Decision of the investigator|0|||
48653237|NCT00837265|156583299|FG004|Main Phase|Decision of the investigator|0|||
48653238|NCT00837265|156583300|FG005|Main Phase|Decision of the investigator|2|||
48653239|NCT00837265|156583301|FG006|Main Phase|Decision of the investigator|1|||
48960066|NCT00195260|157682621|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
48960067|NCT00195260|157682622|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
48960068|NCT00195260|157682623|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
48960069|NCT00195260|157682624|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
48653240|NCT00837265|156583295|FG000|Main Phase|Adverse Event|0|||
48653241|NCT00837265|156583296|FG001|Main Phase|Adverse Event|0|||
48653242|NCT00837265|156583297|FG002|Main Phase|Adverse Event|0|||
48653243|NCT00837265|156583298|FG003|Main Phase|Adverse Event|0|||
48653244|NCT00837265|156583299|FG004|Main Phase|Adverse Event|0|||
48653245|NCT00837265|156583300|FG005|Main Phase|Adverse Event|1|||
48653246|NCT00837265|156583301|FG006|Main Phase|Adverse Event|0|||
48653247|NCT00837265|156583295|FG000|Main Phase|Death|0|||
48653248|NCT00837265|156583296|FG001|Main Phase|Death|0|||
48960070|NCT00195260|157682625|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
48960071|NCT00195260|157682626|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
48653249|NCT00837265|156583297|FG002|Main Phase|Death|0|||
48653250|NCT00837265|156583298|FG003|Main Phase|Death|0|||
48653251|NCT00837265|156583299|FG004|Main Phase|Death|2|||
48653252|NCT00837265|156583300|FG005|Main Phase|Death|0|||
48653253|NCT00837265|156583301|FG006|Main Phase|Death|1|||
48653254|NCT00837265|156583295|FG000|Main Phase|Lost to Follow-up|0|||
48653255|NCT00837265|156583296|FG001|Main Phase|Lost to Follow-up|0|||
48653256|NCT00837265|156583297|FG002|Main Phase|Lost to Follow-up|0|||
48653257|NCT00837265|156583298|FG003|Main Phase|Lost to Follow-up|0|||
48653258|NCT00837265|156583299|FG004|Main Phase|Lost to Follow-up|1|||
48653259|NCT00837265|156583300|FG005|Main Phase|Lost to Follow-up|0|||
48653260|NCT00837265|156583301|FG006|Main Phase|Lost to Follow-up|0|||
48653261|NCT00837265|156583295|FG000|Main Phase|Principal investigator resignation|0|||
48653262|NCT00837265|156583296|FG001|Main Phase|Principal investigator resignation|0|||
48653263|NCT00837265|156583297|FG002|Main Phase|Principal investigator resignation|0|||
48653264|NCT00837265|156583298|FG003|Main Phase|Principal investigator resignation|0|||
48653265|NCT00837265|156583299|FG004|Main Phase|Principal investigator resignation|2|||
48653266|NCT00837265|156583300|FG005|Main Phase|Principal investigator resignation|0|||
48653267|NCT00837265|156583301|FG006|Main Phase|Principal investigator resignation|0|||
48653268|NCT00837265|156583295|FG000|Main Phase|Participant's personal reason|0|||
48653269|NCT00837265|156583296|FG001|Main Phase|Participant's personal reason|0|||
48653270|NCT00837265|156583297|FG002|Main Phase|Participant's personal reason|0|||
48653271|NCT00837265|156583298|FG003|Main Phase|Participant's personal reason|0|||
48653272|NCT00837265|156583299|FG004|Main Phase|Participant's personal reason|1|||
48653273|NCT00837265|156583300|FG005|Main Phase|Participant's personal reason|0|||
48653274|NCT00837265|156583301|FG006|Main Phase|Participant's personal reason|0|||
48653275|NCT01110330|156583302|FG000|Overall Study|Adverse Event|0|||
48653276|NCT01110330|156583303|FG001|Overall Study|Adverse Event|4|||
48653277|NCT01110330|156583304|FG002|Overall Study|Adverse Event|3|||
48653278|NCT01110330|156583302|FG000|Overall Study|Lack of Efficacy|3|||
48653279|NCT01110330|156583303|FG001|Overall Study|Lack of Efficacy|1|||
48653280|NCT01110330|156583304|FG002|Overall Study|Lack of Efficacy|1|||
48653281|NCT01110330|156583302|FG000|Overall Study|Lost to Follow-up|9|||
48653282|NCT01110330|156583303|FG001|Overall Study|Lost to Follow-up|10|||
48653283|NCT01110330|156583304|FG002|Overall Study|Lost to Follow-up|15|||
48653284|NCT01110330|156583302|FG000|Overall Study|Physician Decision|0|||
48653285|NCT01110330|156583303|FG001|Overall Study|Physician Decision|1|||
48653286|NCT01110330|156583304|FG002|Overall Study|Physician Decision|0|||
48653287|NCT01110330|156583302|FG000|Overall Study|Protocol Violation|2|||
48653288|NCT01110330|156583303|FG001|Overall Study|Protocol Violation|0|||
48653289|NCT01110330|156583304|FG002|Overall Study|Protocol Violation|4|||
48653290|NCT01110330|156583302|FG000|Overall Study|Withdrawal by Subject|0|||
48653291|NCT01110330|156583303|FG001|Overall Study|Withdrawal by Subject|6|||
48653292|NCT01110330|156583304|FG002|Overall Study|Withdrawal by Subject|2|||
48653293|NCT01110330|156583302|FG000|Overall Study|Other|1|||
48653294|NCT01110330|156583303|FG001|Overall Study|Other|1|||
48653295|NCT01110330|156583304|FG002|Overall Study|Other|1|||
48653296|NCT03350035|156583321|FG000|Overall Study|Lack of Efficacy|2|||
48653297|NCT03350035|156583322|FG001|Overall Study|Lack of Efficacy|0|||
48653298|NCT03350035|156583323|FG002|Overall Study|Lack of Efficacy|0|||
48653299|NCT03350035|156583321|FG000|Overall Study|Subject discharged to hospice|0|||
48653300|NCT03350035|156583322|FG001|Overall Study|Subject discharged to hospice|0|||
48653301|NCT03350035|156583323|FG002|Overall Study|Subject discharged to hospice|1|||
48753614|NCT02205814|156944274|FG000|Overall Study|Lost to Follow-up|0|||
48753615|NCT02205814|156944275|FG001|Overall Study|Lost to Follow-up|0|||
48753616|NCT02205814|156944276|FG002|Overall Study|Lost to Follow-up|0|||
48753617|NCT02205814|156944277|FG003|Overall Study|Lost to Follow-up|1|||
48753618|NCT02205814|156944274|FG000|Overall Study|Lack of Efficacy|1|||
48753619|NCT02205814|156944275|FG001|Overall Study|Lack of Efficacy|0|||
48753620|NCT02205814|156944276|FG002|Overall Study|Lack of Efficacy|1|||
48753621|NCT02205814|156944277|FG003|Overall Study|Lack of Efficacy|1|||
48753622|NCT02205814|156944274|FG000|Overall Study|Physician Decision|0|||
48753623|NCT02205814|156944275|FG001|Overall Study|Physician Decision|0|||
48753624|NCT02205814|156944276|FG002|Overall Study|Physician Decision|1|||
48753625|NCT02205814|156944277|FG003|Overall Study|Physician Decision|0|||
48865568|NCT04783519|157343454|FG002|Overall Study|Withdrawal by Subject|3|||
48865569|NCT04783519|157343452|FG000|Overall Study|Lost to Follow-up|9|||
48865570|NCT04783519|157343453|FG001|Overall Study|Lost to Follow-up|7|||
48865571|NCT04783519|157343454|FG002|Overall Study|Lost to Follow-up|6|||
48865572|NCT03169530|157343455|FG000|Overall Study|Study ended by NIH|15|||
48865573|NCT03169530|157343456|FG001|Overall Study|Study ended by NIH|17|||
48865574|NCT01032200|157343457|FG000|Overall Study|Death|1|||
48865575|NCT01032200|157343458|FG001|Overall Study|Death|1|||
49015418|NCT01736553|157892180|FG000|Overall Study|Withdrawal by Subject|5|||
48653302|NCT04115748|156583328|FG000|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
48653303|NCT04115748|156583329|FG001|Main Study (Up to 16 Weeks)|Study terminated by sponsor|16|||
48653304|NCT04115748|156583330|FG002|Main Study (Up to 16 Weeks)|Study terminated by sponsor|7|||
48653305|NCT04115748|156583331|FG003|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
48653306|NCT04115748|156583332|FG004|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
48653307|NCT04115748|156583333|FG005|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
48653308|NCT04115748|156583334|FG006|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
48653309|NCT04115748|156583335|FG007|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
48653310|NCT04115748|156583336|FG008|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
48753626|NCT02205814|156944274|FG000|Overall Study|Protocol Violation|1|||
48865576|NCT01032200|157343457|FG000|Overall Study|Withdrawal by Subject|1|||
48653311|NCT04115748|156583337|FG009|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
48653312|NCT04115748|156583328|FG000|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
48653313|NCT04115748|156583329|FG001|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
48653314|NCT04115748|156583330|FG002|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
48653315|NCT04115748|156583331|FG003|Main Study (Up to 16 Weeks)|Withdrew consent|1|||
48960072|NCT00195260|157682627|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
48960073|NCT00195260|157682628|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
48653316|NCT04115748|156583332|FG004|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
48653317|NCT04115748|156583333|FG005|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
48653318|NCT04115748|156583334|FG006|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
48960074|NCT00195260|157682629|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6|||
48960075|NCT00195260|157682630|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4|||
48960076|NCT00195260|157682631|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3|||
48960077|NCT00118482|157682637|FG000|Overall Study|Lost to Follow-up|7|||
48960078|NCT00118482|157682638|FG001|Overall Study|Lost to Follow-up|7|||
48960079|NCT00118482|157682637|FG000|Overall Study|Withdrawal by Subject|23|||
48653319|NCT04115748|156583335|FG007|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
48653320|NCT04115748|156583336|FG008|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
48653321|NCT04115748|156583337|FG009|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
48653322|NCT04115748|156583328|FG000|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
48653323|NCT04115748|156583329|FG001|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
48653324|NCT04115748|156583330|FG002|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
48653325|NCT04115748|156583331|FG003|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
48653326|NCT04115748|156583332|FG004|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|4|||
48653327|NCT04115748|156583333|FG005|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|3|||
48653328|NCT04115748|156583334|FG006|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
48653329|NCT04115748|156583335|FG007|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
48653330|NCT04115748|156583336|FG008|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
48653331|NCT04115748|156583337|FG009|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|2|||
48653332|NCT04115748|156583328|FG000|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
48653333|NCT04115748|156583329|FG001|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
48960080|NCT00118482|157682638|FG001|Overall Study|Withdrawal by Subject|22|||
48960081|NCT03699631|157682639|FG000|Overall Study|Adverse Event|3|||
48960082|NCT02020031|157684094|FG000|Overall Study|Physician Decision|1|||
48653334|NCT04115748|156583330|FG002|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
48960083|NCT02020031|157684095|FG001|Overall Study|Physician Decision|1|||
48960084|NCT01263691|157684098|FG000|Overall Study|Lost to Follow-up|1|||
48960085|NCT01263691|157684099|FG001|Overall Study|Lost to Follow-up|0|||
48960086|NCT01263691|157684100|FG002|Overall Study|Lost to Follow-up|1|||
48960087|NCT01263691|157684101|FG003|Overall Study|Lost to Follow-up|1|||
48960088|NCT01263691|157684102|FG004|Overall Study|Lost to Follow-up|0|||
48653335|NCT04115748|156583331|FG003|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
48653336|NCT04115748|156583332|FG004|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
48653337|NCT04115748|156583333|FG005|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
48653338|NCT04115748|156583334|FG006|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
48653339|NCT04115748|156583335|FG007|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
48960089|NCT01263691|157684103|FG005|Overall Study|Lost to Follow-up|0|||
48960090|NCT01263691|157684098|FG000|Overall Study|Withdrawal by Subject|1|||
48960091|NCT01263691|157684099|FG001|Overall Study|Withdrawal by Subject|0|||
48960092|NCT01263691|157684100|FG002|Overall Study|Withdrawal by Subject|0|||
48960093|NCT01263691|157684101|FG003|Overall Study|Withdrawal by Subject|0|||
48960094|NCT01263691|157684102|FG004|Overall Study|Withdrawal by Subject|0|||
48960095|NCT01263691|157684103|FG005|Overall Study|Withdrawal by Subject|0|||
48960096|NCT01263691|157684098|FG000|Overall Study|Adverse Event|1|||
48960097|NCT01263691|157684099|FG001|Overall Study|Adverse Event|0|||
48960098|NCT01263691|157684100|FG002|Overall Study|Adverse Event|0|||
48960099|NCT01263691|157684101|FG003|Overall Study|Adverse Event|0|||
48960100|NCT01263691|157684102|FG004|Overall Study|Adverse Event|0|||
48960101|NCT01263691|157684103|FG005|Overall Study|Adverse Event|0|||
48653340|NCT04115748|156583336|FG008|LTE (After 16 Weeks to Week 50)|Adverse Event|1|||
48653341|NCT04115748|156583337|FG009|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
48653342|NCT03379259|156583338|FG000|Overall Study|Commenced new anti-cancer therapy|1|||
48653343|NCT03379259|156583339|FG001|Overall Study|Commenced new anti-cancer therapy|0|||
48653344|NCT03379259|156583340|FG002|Overall Study|Commenced new anti-cancer therapy|0|||
48653345|NCT03379259|156583341|FG003|Overall Study|Commenced new anti-cancer therapy|0|||
48753627|NCT02205814|156944275|FG001|Overall Study|Protocol Violation|0|||
48960102|NCT01994226|157684106|FG000|Overall Study|Protocol Violation|13|||
48960103|NCT01994226|157684107|FG001|Overall Study|Protocol Violation|10|||
48960104|NCT01994226|157684106|FG000|Overall Study|Early Cessation of treatment|6|||
48960105|NCT01994226|157684107|FG001|Overall Study|Early Cessation of treatment|11|||
48960106|NCT01397552|157684109|FG000|Overall Study|Adverse Event|1|||
48960107|NCT01397552|157684110|FG001|Overall Study|Adverse Event|0|||
48960108|NCT01397552|157684109|FG000|Overall Study|Withdrawal by Subject|2|||
48960109|NCT01397552|157684110|FG001|Overall Study|Withdrawal by Subject|1|||
48960110|NCT03888391|157684111|FG000|Overall Study|Lost to Follow-up|15|||
48960111|NCT02108951|157684112|FG000|Overall Study|Lost to Follow-up|1|||
48960112|NCT02108951|157684112|FG000|Overall Study|Patient's/guardian's decision|1|||
48960113|NCT02108951|157684112|FG000|Overall Study|Study Terminated by Sponsor|14|||
48960114|NCT02864940|157684113|FG000|Overall Study|Never took part in intervention or control arm activities or completed post assessments|13|||
48960115|NCT02864940|157684114|FG001|Overall Study|Never took part in intervention or control arm activities or completed post assessments|11|||
48960116|NCT02175771|157684115|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|23|||
48960117|NCT02175771|157684116|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
48960118|NCT02175771|157684117|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
48960119|NCT02175771|157684118|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
48960120|NCT02175771|157684119|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
48960121|NCT02175771|157684120|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
48960122|NCT02175771|157684121|FG006|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
48960123|NCT02175771|157684122|FG007|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
48960124|NCT02175771|157684123|FG008|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
48960125|NCT02175771|157684115|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|20|||
48960126|NCT02175771|157684116|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
48960127|NCT02175771|157684117|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
48960128|NCT02175771|157684118|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
48960129|NCT02175771|157684119|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
48960130|NCT02175771|157684120|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
48960131|NCT02175771|157684121|FG006|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
48960132|NCT02175771|157684122|FG007|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
48753628|NCT02205814|156944276|FG002|Overall Study|Protocol Violation|0|||
48753629|NCT02205814|156944277|FG003|Overall Study|Protocol Violation|1|||
48753630|NCT02205814|156944274|FG000|Overall Study|Withdrawal by Subject|0|||
48753631|NCT02205814|156944275|FG001|Overall Study|Withdrawal by Subject|1|||
48753632|NCT02205814|156944276|FG002|Overall Study|Withdrawal by Subject|2|||
48753633|NCT02205814|156944277|FG003|Overall Study|Withdrawal by Subject|1|||
48753634|NCT02205814|156944274|FG000|Overall Study|not compliant with study procedures|0|||
48753635|NCT02205814|156944275|FG001|Overall Study|not compliant with study procedures|0|||
48753636|NCT02205814|156944276|FG002|Overall Study|not compliant with study procedures|1|||
48753637|NCT02205814|156944277|FG003|Overall Study|not compliant with study procedures|0|||
48753638|NCT03402386|156944280|FG000|Overall Study|Adverse Event|3|||
48753639|NCT03402386|156944280|FG000|Overall Study|Physician Decision|1|||
48753640|NCT03402386|156944280|FG000|Overall Study|Difficult to control Hb|2|||
48753641|NCT01996982|156944281|FG000|Overall Study|PI/team left institution|7|||
48753642|NCT03552198|156944282|FG000|Overall Study|Lost to Follow-up|42|||
48753643|NCT03552198|156944283|FG001|Overall Study|Lost to Follow-up|48|||
48960133|NCT02175771|157684123|FG008|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
48960134|NCT02175771|157684115|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|11|||
48960135|NCT02175771|157684116|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
48960136|NCT02175771|157684117|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
48753644|NCT03552198|156944284|FG002|Overall Study|Lost to Follow-up|15|||
48753645|NCT03552198|156944285|FG003|Overall Study|Lost to Follow-up|19|||
48753646|NCT03552198|156944282|FG000|Overall Study|Incomplete/unmatched questionnaire|6|||
48753647|NCT03552198|156944283|FG001|Overall Study|Incomplete/unmatched questionnaire|7|||
48753648|NCT03552198|156944284|FG002|Overall Study|Incomplete/unmatched questionnaire|2|||
48753649|NCT03552198|156944285|FG003|Overall Study|Incomplete/unmatched questionnaire|2|||
48753650|NCT03552198|156944282|FG000|Overall Study|Did not receive air alerts|1|||
48960137|NCT02175771|157684118|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
48960138|NCT02175771|157684119|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
48960139|NCT02175771|157684120|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
48753651|NCT03552198|156944283|FG001|Overall Study|Did not receive air alerts|0|||
48960140|NCT02175771|157684121|FG006|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
48960141|NCT02175771|157684122|FG007|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
48960142|NCT02175771|157684123|FG008|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
48960143|NCT02175771|157684115|FG000|Run-In Period (Pre-assignment)|Adverse Event|9|||
48960144|NCT02175771|157684116|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
48960145|NCT02175771|157684117|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
48960146|NCT02175771|157684118|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
48960147|NCT02175771|157684119|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
48960148|NCT02175771|157684120|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
48960149|NCT02175771|157684121|FG006|Run-In Period (Pre-assignment)|Adverse Event|0|||
48960150|NCT02175771|157684122|FG007|Run-In Period (Pre-assignment)|Adverse Event|0|||
48960151|NCT02175771|157684123|FG008|Run-In Period (Pre-assignment)|Adverse Event|0|||
48960152|NCT02175771|157684115|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|7|||
48960153|NCT02175771|157684116|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
48960154|NCT02175771|157684117|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
48960155|NCT02175771|157684118|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
48960156|NCT02175771|157684119|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
48960157|NCT02175771|157684120|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
48960158|NCT02175771|157684121|FG006|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
48960159|NCT02175771|157684122|FG007|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
48960160|NCT02175771|157684123|FG008|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
48960161|NCT02175771|157684115|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
48960162|NCT02175771|157684116|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
48960163|NCT02175771|157684117|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
48960164|NCT02175771|157684118|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
48960165|NCT02175771|157684119|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
48960166|NCT02175771|157684120|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
48960167|NCT02175771|157684121|FG006|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
48960168|NCT02175771|157684122|FG007|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
48960169|NCT02175771|157684123|FG008|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
48960170|NCT02175771|157684115|FG000|Run-In Period (Pre-assignment)|Other|8|||
48960171|NCT02175771|157684116|FG001|Run-In Period (Pre-assignment)|Other|0|||
48960172|NCT02175771|157684117|FG002|Run-In Period (Pre-assignment)|Other|0|||
48960173|NCT02175771|157684118|FG003|Run-In Period (Pre-assignment)|Other|0|||
48960174|NCT02175771|157684119|FG004|Run-In Period (Pre-assignment)|Other|0|||
48960175|NCT02175771|157684120|FG005|Run-In Period (Pre-assignment)|Other|0|||
48960176|NCT02175771|157684121|FG006|Run-In Period (Pre-assignment)|Other|0|||
48960177|NCT02175771|157684122|FG007|Run-In Period (Pre-assignment)|Other|0|||
48960178|NCT02175771|157684123|FG008|Run-In Period (Pre-assignment)|Other|0|||
48960179|NCT02175771|157684115|FG000|Treatment Period|Adverse Event|0|||
48960180|NCT02175771|157684116|FG001|Treatment Period|Adverse Event|2|||
48960181|NCT02175771|157684117|FG002|Treatment Period|Adverse Event|1|||
48960182|NCT02175771|157684118|FG003|Treatment Period|Adverse Event|1|||
48960183|NCT02175771|157684119|FG004|Treatment Period|Adverse Event|1|||
48960184|NCT02175771|157684120|FG005|Treatment Period|Adverse Event|3|||
48753652|NCT03552198|156944284|FG002|Overall Study|Did not receive air alerts|0|||
48753653|NCT03552198|156944285|FG003|Overall Study|Did not receive air alerts|1|||
48753654|NCT02170051|156944286|FG000|Overall Study|Withdrawal by Subject|10|||
48753655|NCT02170051|156944287|FG001|Overall Study|Withdrawal by Subject|10|||
48753656|NCT02170051|156944286|FG000|Overall Study|Lost to Follow-up|1|||
48753657|NCT02170051|156944287|FG001|Overall Study|Lost to Follow-up|3|||
48960185|NCT02175771|157684121|FG006|Treatment Period|Adverse Event|2|||
48960186|NCT02175771|157684122|FG007|Treatment Period|Adverse Event|0|||
48960187|NCT02175771|157684123|FG008|Treatment Period|Adverse Event|1|||
48960188|NCT02175771|157684115|FG000|Treatment Period|Withdrawal by Subject|0|||
48960189|NCT02175771|157684116|FG001|Treatment Period|Withdrawal by Subject|9|||
48960190|NCT02175771|157684117|FG002|Treatment Period|Withdrawal by Subject|3|||
48960191|NCT02175771|157684118|FG003|Treatment Period|Withdrawal by Subject|6|||
48960192|NCT02175771|157684119|FG004|Treatment Period|Withdrawal by Subject|2|||
48960193|NCT02175771|157684120|FG005|Treatment Period|Withdrawal by Subject|4|||
48753658|NCT00881712|156944288|FG000|Overall Study|Death|1|||
48960194|NCT02175771|157684121|FG006|Treatment Period|Withdrawal by Subject|2|||
48960195|NCT02175771|157684122|FG007|Treatment Period|Withdrawal by Subject|9|||
48960196|NCT02175771|157684123|FG008|Treatment Period|Withdrawal by Subject|2|||
48960197|NCT02175771|157684115|FG000|Treatment Period|Noncompliance|0|||
48960198|NCT02175771|157684116|FG001|Treatment Period|Noncompliance|1|||
48960199|NCT02175771|157684117|FG002|Treatment Period|Noncompliance|2|||
48960200|NCT02175771|157684118|FG003|Treatment Period|Noncompliance|0|||
48960201|NCT02175771|157684119|FG004|Treatment Period|Noncompliance|0|||
48960202|NCT02175771|157684120|FG005|Treatment Period|Noncompliance|0|||
48960203|NCT02175771|157684121|FG006|Treatment Period|Noncompliance|0|||
48960204|NCT02175771|157684122|FG007|Treatment Period|Noncompliance|0|||
48960205|NCT02175771|157684123|FG008|Treatment Period|Noncompliance|1|||
48960206|NCT02175771|157684115|FG000|Treatment Period|Protocol Violation|0|||
48960207|NCT02175771|157684116|FG001|Treatment Period|Protocol Violation|0|||
48960208|NCT02175771|157684117|FG002|Treatment Period|Protocol Violation|0|||
48960209|NCT02175771|157684118|FG003|Treatment Period|Protocol Violation|0|||
48960210|NCT02175771|157684119|FG004|Treatment Period|Protocol Violation|0|||
48960211|NCT02175771|157684120|FG005|Treatment Period|Protocol Violation|0|||
48960212|NCT02175771|157684121|FG006|Treatment Period|Protocol Violation|0|||
48960213|NCT02175771|157684122|FG007|Treatment Period|Protocol Violation|1|||
48960214|NCT02175771|157684123|FG008|Treatment Period|Protocol Violation|0|||
48960215|NCT02175771|157684115|FG000|Treatment Period|Disease progression|0|||
48960216|NCT02175771|157684116|FG001|Treatment Period|Disease progression|0|||
48960217|NCT02175771|157684117|FG002|Treatment Period|Disease progression|0|||
48960218|NCT02175771|157684118|FG003|Treatment Period|Disease progression|0|||
48960219|NCT02175771|157684119|FG004|Treatment Period|Disease progression|0|||
48960220|NCT02175771|157684120|FG005|Treatment Period|Disease progression|0|||
48960221|NCT02175771|157684121|FG006|Treatment Period|Disease progression|0|||
48753659|NCT00881712|156944289|FG001|Overall Study|Death|0|||
48753660|NCT00881712|156944290|FG002|Overall Study|Death|0|||
48753661|NCT00881712|156944288|FG000|Overall Study|Withdrawal by Subject|1|||
48753662|NCT00881712|156944289|FG001|Overall Study|Withdrawal by Subject|0|||
48753663|NCT00881712|156944290|FG002|Overall Study|Withdrawal by Subject|0|||
48753664|NCT01129960|156944291|FG000|Overall Study|Withdrawal by Subject|3|||
48753665|NCT01129960|156944292|FG001|Overall Study|Withdrawal by Subject|0|||
48753666|NCT01129960|156944293|FG002|Overall Study|Withdrawal by Subject|3|||
48753667|NCT01129960|156944294|FG003|Overall Study|Withdrawal by Subject|2|||
48753668|NCT01129960|156944291|FG000|Overall Study|Lack of Efficacy|1|||
48753669|NCT01129960|156944292|FG001|Overall Study|Lack of Efficacy|1|||
48753670|NCT01129960|156944293|FG002|Overall Study|Lack of Efficacy|1|||
48753671|NCT01129960|156944294|FG003|Overall Study|Lack of Efficacy|1|||
48753672|NCT01129960|156944291|FG000|Overall Study|Adverse Event|23|||
48753673|NCT01129960|156944292|FG001|Overall Study|Adverse Event|16|||
48753674|NCT01129960|156944293|FG002|Overall Study|Adverse Event|16|||
48753675|NCT01129960|156944294|FG003|Overall Study|Adverse Event|7|||
48753676|NCT01129960|156944291|FG000|Overall Study|Protocol Violation|1|||
48753677|NCT01129960|156944292|FG001|Overall Study|Protocol Violation|2|||
48753678|NCT01129960|156944293|FG002|Overall Study|Protocol Violation|3|||
48753679|NCT01129960|156944294|FG003|Overall Study|Protocol Violation|0|||
48753680|NCT01129960|156944291|FG000|Overall Study|Lost to Follow-up|0|||
48753681|NCT01129960|156944292|FG001|Overall Study|Lost to Follow-up|2|||
48753682|NCT01129960|156944293|FG002|Overall Study|Lost to Follow-up|3|||
48753683|NCT01129960|156944294|FG003|Overall Study|Lost to Follow-up|3|||
48753684|NCT01129960|156944291|FG000|Overall Study|Discontinuation of the study by Sponsor|0|||
48753685|NCT01129960|156944292|FG001|Overall Study|Discontinuation of the study by Sponsor|1|||
48753686|NCT01129960|156944293|FG002|Overall Study|Discontinuation of the study by Sponsor|0|||
48753687|NCT01129960|156944294|FG003|Overall Study|Discontinuation of the study by Sponsor|0|||
48753688|NCT01129960|156944291|FG000|Overall Study|Physician Decision|1|||
48960222|NCT02175771|157684122|FG007|Treatment Period|Disease progression|2|||
48960223|NCT02175771|157684123|FG008|Treatment Period|Disease progression|0|||
48960224|NCT02175771|157684115|FG000|Treatment Period|Lost to Follow-up|0|||
48960225|NCT02175771|157684116|FG001|Treatment Period|Lost to Follow-up|3|||
48960226|NCT02175771|157684117|FG002|Treatment Period|Lost to Follow-up|1|||
48960227|NCT02175771|157684118|FG003|Treatment Period|Lost to Follow-up|3|||
48960228|NCT02175771|157684119|FG004|Treatment Period|Lost to Follow-up|1|||
48960229|NCT02175771|157684120|FG005|Treatment Period|Lost to Follow-up|2|||
48960230|NCT02175771|157684121|FG006|Treatment Period|Lost to Follow-up|1|||
48960231|NCT02175771|157684122|FG007|Treatment Period|Lost to Follow-up|2|||
48960232|NCT02175771|157684123|FG008|Treatment Period|Lost to Follow-up|2|||
48753689|NCT01129960|156944292|FG001|Overall Study|Physician Decision|0|||
48753690|NCT01129960|156944293|FG002|Overall Study|Physician Decision|0|||
48753691|NCT01129960|156944294|FG003|Overall Study|Physician Decision|0|||
48753692|NCT01129960|156944291|FG000|Overall Study|Pregnancy|1|||
48753693|NCT01129960|156944292|FG001|Overall Study|Pregnancy|0|||
48753694|NCT01129960|156944293|FG002|Overall Study|Pregnancy|0|||
48753695|NCT01129960|156944294|FG003|Overall Study|Pregnancy|0|||
48960233|NCT02175771|157684115|FG000|Treatment Period|Lack of Efficacy|0|||
48960234|NCT02175771|157684116|FG001|Treatment Period|Lack of Efficacy|0|||
48753696|NCT01605877|156944295|FG000|Overall Study|Withdrawal by Subject|1|||
48753697|NCT04533438|156944296|FG000|Crossover Period|Did not meet Eligibility to Crossover|0|||
48753698|NCT04533438|156944297|FG001|Crossover Period|Did not meet Eligibility to Crossover|11|||
48753699|NCT02547454|156944300|FG000|Overall Study|Due to hemodialysis|53|||
48753700|NCT02547454|156944300|FG000|Overall Study|Due to transplantation|1|||
48753701|NCT02547454|156944300|FG000|Overall Study|Due to no further need to treat|4|||
48753702|NCT02547454|156944300|FG000|Overall Study|Death|38|||
48753703|NCT02547454|156944300|FG000|Overall Study|Lost to Follow-up|26|||
48753704|NCT02547454|156944300|FG000|Overall Study|Other|39|||
48753705|NCT02547454|156944300|FG000|Overall Study|No data|11|||
48753706|NCT01339429|156944304|FG000|Overall Study|Withdrawal by Subject|1|||
48753707|NCT01339429|156944304|FG000|Overall Study|Physician Decision|3|||
48753708|NCT01085591|156944305|FG000|Overall Study|Adverse Event|0|||
48753709|NCT01085591|156944306|FG001|Overall Study|Adverse Event|1|||
48960235|NCT02175771|157684117|FG002|Treatment Period|Lack of Efficacy|0|||
48960236|NCT02175771|157684118|FG003|Treatment Period|Lack of Efficacy|0|||
48960237|NCT02175771|157684119|FG004|Treatment Period|Lack of Efficacy|0|||
48960238|NCT02175771|157684120|FG005|Treatment Period|Lack of Efficacy|1|||
48753710|NCT01085591|156944307|FG002|Overall Study|Adverse Event|3|||
48753711|NCT01085591|156944305|FG000|Overall Study|Physician Decision|1|||
48753712|NCT01085591|156944306|FG001|Overall Study|Physician Decision|0|||
48753713|NCT01085591|156944307|FG002|Overall Study|Physician Decision|1|||
48753714|NCT01085591|156944305|FG000|Overall Study|Withdrawal by Subject|0|||
48753715|NCT01085591|156944306|FG001|Overall Study|Withdrawal by Subject|2|||
48753716|NCT01085591|156944307|FG002|Overall Study|Withdrawal by Subject|1|||
48753717|NCT01085591|156944305|FG000|Overall Study|Lost to Follow-up|0|||
48753718|NCT01085591|156944306|FG001|Overall Study|Lost to Follow-up|1|||
48753719|NCT01085591|156944307|FG002|Overall Study|Lost to Follow-up|1|||
48753720|NCT01085591|156944305|FG000|Overall Study|Protocol Violation|1|||
48753721|NCT01085591|156944306|FG001|Overall Study|Protocol Violation|1|||
48753722|NCT01085591|156944307|FG002|Overall Study|Protocol Violation|1|||
48753723|NCT01085591|156944305|FG000|Overall Study|Other|0|||
48753724|NCT01085591|156944306|FG001|Overall Study|Other|1|||
48753725|NCT01085591|156944307|FG002|Overall Study|Other|0|||
48753726|NCT01085591|156944305|FG000|Overall Study|Not Properly Consented|1|||
48753727|NCT01085591|156944306|FG001|Overall Study|Not Properly Consented|0|||
48753728|NCT01085591|156944307|FG002|Overall Study|Not Properly Consented|0|||
48753729|NCT01059799|156944308|FG000|Overall Study|Adverse Event|2|||
48753730|NCT01059799|156944309|FG001|Overall Study|Adverse Event|3|||
48753731|NCT01059799|156944308|FG000|Overall Study|Lack of Efficacy|1|||
48753732|NCT01059799|156944309|FG001|Overall Study|Lack of Efficacy|0|||
48753733|NCT01059799|156944308|FG000|Overall Study|Protocol Violation|3|||
48753734|NCT01059799|156944309|FG001|Overall Study|Protocol Violation|2|||
48753735|NCT01059799|156944308|FG000|Overall Study|Withdrawal criteria|13|||
48753736|NCT01059799|156944309|FG001|Overall Study|Withdrawal criteria|2|||
48753737|NCT01059799|156944308|FG000|Overall Study|Other|12|||
48753738|NCT01059799|156944309|FG001|Overall Study|Other|3|||
48753739|NCT02625259|156944312|FG000|First Intervention (Day 1)|Other|0|||
48753740|NCT02625259|156944313|FG001|First Intervention (Day 1)|Other|0|||
48753741|NCT02625259|156944314|FG002|First Intervention (Day 1)|Other|1|||
48753742|NCT02625259|156944315|FG003|First Intervention (Day 1)|Other|0|||
48960239|NCT02175771|157684121|FG006|Treatment Period|Lack of Efficacy|0|||
48960240|NCT02175771|157684122|FG007|Treatment Period|Lack of Efficacy|1|||
48960241|NCT02175771|157684123|FG008|Treatment Period|Lack of Efficacy|0|||
48960242|NCT02175771|157684115|FG000|Treatment Period|Other|0|||
48753743|NCT02625259|156944316|FG004|First Intervention (Day 1)|Other|0|||
48753744|NCT02625259|156944312|FG000|First Intervention (Day 1)|Adverse Event|2|||
48753745|NCT02625259|156944313|FG001|First Intervention (Day 1)|Adverse Event|1|||
48753746|NCT02625259|156944314|FG002|First Intervention (Day 1)|Adverse Event|0|||
48753747|NCT02625259|156944315|FG003|First Intervention (Day 1)|Adverse Event|0|||
48753748|NCT02625259|156944316|FG004|First Intervention (Day 1)|Adverse Event|0|||
48753749|NCT02625259|156944312|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
48753750|NCT02625259|156944313|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
48753751|NCT02625259|156944314|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
48960243|NCT02175771|157684116|FG001|Treatment Period|Other|1|||
48960244|NCT02175771|157684117|FG002|Treatment Period|Other|0|||
48960245|NCT02175771|157684118|FG003|Treatment Period|Other|3|||
48960246|NCT02175771|157684119|FG004|Treatment Period|Other|1|||
48960247|NCT02175771|157684120|FG005|Treatment Period|Other|0|||
48960248|NCT02175771|157684121|FG006|Treatment Period|Other|0|||
48960249|NCT02175771|157684122|FG007|Treatment Period|Other|2|||
48960250|NCT02175771|157684123|FG008|Treatment Period|Other|0|||
48960251|NCT03364673|157684124|FG000|Overall Study|Withdrawal by Subject|2|||
48960252|NCT03364673|157684124|FG000|Overall Study|Injury unrelated to study|3|||
48960253|NCT02504268|157684126|FG000|Overall Study|Adverse Event|18|||
48960254|NCT02504268|157684127|FG001|Overall Study|Adverse Event|8|||
48960255|NCT02504268|157684128|FG002|Overall Study|Adverse Event|14|||
48960256|NCT02504268|157684129|FG003|Overall Study|Adverse Event|0|||
48960257|NCT02504268|157684130|FG004|Overall Study|Adverse Event|0|||
48960258|NCT02504268|157684131|FG005|Overall Study|Adverse Event|0|||
48960259|NCT02504268|157684132|FG006|Overall Study|Adverse Event|0|||
48960260|NCT02504268|157684133|FG007|Overall Study|Adverse Event|0|||
48960261|NCT02504268|157684134|FG008|Overall Study|Adverse Event|0|||
48960262|NCT02504268|157684126|FG000|Overall Study|Withdrawal of Consent|11|||
48960263|NCT02504268|157684127|FG001|Overall Study|Withdrawal of Consent|10|||
48960264|NCT02504268|157684128|FG002|Overall Study|Withdrawal of Consent|3|||
48960265|NCT02504268|157684129|FG003|Overall Study|Withdrawal of Consent|0|||
48653346|NCT03379259|156583342|FG004|Overall Study|Commenced new anti-cancer therapy|0|||
48653347|NCT03379259|156583343|FG005|Overall Study|Commenced new anti-cancer therapy|0|||
48653348|NCT03379259|156583338|FG000|Overall Study|Death|0|||
48653349|NCT03379259|156583339|FG001|Overall Study|Death|1|||
48653350|NCT03379259|156583340|FG002|Overall Study|Death|2|||
48653351|NCT03379259|156583341|FG003|Overall Study|Death|1|||
48653352|NCT03379259|156583342|FG004|Overall Study|Death|4|||
48653353|NCT03379259|156583343|FG005|Overall Study|Death|2|||
48653354|NCT03379259|156583338|FG000|Overall Study|Withdrawal by Subject|0|||
48653355|NCT03379259|156583339|FG001|Overall Study|Withdrawal by Subject|0|||
48653356|NCT03379259|156583340|FG002|Overall Study|Withdrawal by Subject|1|||
48653357|NCT03379259|156583341|FG003|Overall Study|Withdrawal by Subject|0|||
48653358|NCT03379259|156583342|FG004|Overall Study|Withdrawal by Subject|2|||
48653359|NCT03379259|156583343|FG005|Overall Study|Withdrawal by Subject|0|||
48653360|NCT03379259|156583338|FG000|Overall Study|Study terminated by sponsor|0|||
48653361|NCT03379259|156583339|FG001|Overall Study|Study terminated by sponsor|0|||
48653362|NCT03379259|156583340|FG002|Overall Study|Study terminated by sponsor|0|||
48653363|NCT03379259|156583341|FG003|Overall Study|Study terminated by sponsor|1|||
48653364|NCT03379259|156583342|FG004|Overall Study|Study terminated by sponsor|1|||
48653365|NCT03379259|156583343|FG005|Overall Study|Study terminated by sponsor|4|||
48653366|NCT03379259|156583338|FG000|Overall Study|Disease progression|0|||
48653367|NCT03379259|156583339|FG001|Overall Study|Disease progression|0|||
48653368|NCT03379259|156583340|FG002|Overall Study|Disease progression|0|||
48653369|NCT03379259|156583341|FG003|Overall Study|Disease progression|1|||
48653370|NCT03379259|156583342|FG004|Overall Study|Disease progression|0|||
48653371|NCT03379259|156583343|FG005|Overall Study|Disease progression|1|||
48653372|NCT03379259|156583338|FG000|Overall Study|Lost to Follow-up|0|||
48653373|NCT03379259|156583339|FG001|Overall Study|Lost to Follow-up|0|||
48653374|NCT03379259|156583340|FG002|Overall Study|Lost to Follow-up|0|||
48653375|NCT03379259|156583341|FG003|Overall Study|Lost to Follow-up|0|||
48653376|NCT03379259|156583342|FG004|Overall Study|Lost to Follow-up|1|||
48653377|NCT03379259|156583343|FG005|Overall Study|Lost to Follow-up|0|||
48653378|NCT03379259|156583338|FG000|Overall Study|Deteriorating condition|0|||
48653379|NCT03379259|156583339|FG001|Overall Study|Deteriorating condition|0|||
48653380|NCT03379259|156583340|FG002|Overall Study|Deteriorating condition|0|||
48653381|NCT03379259|156583341|FG003|Overall Study|Deteriorating condition|0|||
48653382|NCT03379259|156583342|FG004|Overall Study|Deteriorating condition|1|||
48653383|NCT03379259|156583343|FG005|Overall Study|Deteriorating condition|0|||
48653384|NCT00473668|156583344|FG000|Overall Study|Withdrawal by Subject|0|||
48653385|NCT00473668|156583345|FG001|Overall Study|Withdrawal by Subject|2|||
48653386|NCT00473668|156583346|FG002|Overall Study|Withdrawal by Subject|0|||
48653387|NCT00473668|156583344|FG000|Overall Study|Migrated/moved from study area|3|||
48653388|NCT00473668|156583345|FG001|Overall Study|Migrated/moved from study area|2|||
48653389|NCT00473668|156583346|FG002|Overall Study|Migrated/moved from study area|0|||
48653390|NCT00473668|156583344|FG000|Overall Study|Lost to Follow-up|0|||
48653391|NCT00473668|156583345|FG001|Overall Study|Lost to Follow-up|4|||
48653392|NCT00473668|156583346|FG002|Overall Study|Lost to Follow-up|6|||
48653393|NCT00473668|156583344|FG000|Overall Study|Other|2|||
48653394|NCT00473668|156583345|FG001|Overall Study|Other|3|||
48653395|NCT00473668|156583346|FG002|Overall Study|Other|4|||
48653396|NCT00984165|156583347|FG000|Overall Study|Death on study|2|||
48653397|NCT00984165|156583348|FG001|Overall Study|Death on study|0|||
48653398|NCT00984165|156583349|FG002|Overall Study|Death on study|0|||
48653399|NCT00984165|156583350|FG003|Overall Study|Death on study|0|||
48653400|NCT00984165|156583347|FG000|Overall Study|Disease progression on study|5|||
48653401|NCT00984165|156583348|FG001|Overall Study|Disease progression on study|1|||
48653402|NCT00984165|156583349|FG002|Overall Study|Disease progression on study|0|||
48653403|NCT00984165|156583350|FG003|Overall Study|Disease progression on study|0|||
48653404|NCT00984165|156583347|FG000|Overall Study|Death of recipient|0|||
48653405|NCT00984165|156583348|FG001|Overall Study|Death of recipient|0|||
48653406|NCT00984165|156583349|FG002|Overall Study|Death of recipient|0|||
48653407|NCT00984165|156583350|FG003|Overall Study|Death of recipient|1|||
48653408|NCT00984165|156583347|FG000|Overall Study|New protocol|0|||
48653409|NCT00984165|156583348|FG001|Overall Study|New protocol|0|||
48653410|NCT00984165|156583349|FG002|Overall Study|New protocol|0|||
48653411|NCT00984165|156583350|FG003|Overall Study|New protocol|1|||
48653412|NCT00984165|156583347|FG000|Overall Study|P+/donor pair removed from protocol|0|||
48653413|NCT00984165|156583348|FG001|Overall Study|P+/donor pair removed from protocol|0|||
48653414|NCT00984165|156583349|FG002|Overall Study|P+/donor pair removed from protocol|0|||
48653415|NCT00984165|156583350|FG003|Overall Study|P+/donor pair removed from protocol|1|||
48653416|NCT00984165|156583347|FG000|Overall Study|removed with a pair recipient|0|||
48653417|NCT00984165|156583348|FG001|Overall Study|removed with a pair recipient|0|||
48653418|NCT00984165|156583349|FG002|Overall Study|removed with a pair recipient|0|||
48653419|NCT00984165|156583350|FG003|Overall Study|removed with a pair recipient|1|||
48653420|NCT00633074|156583353|FG000|Overall Study|Adverse Event|1|||
48653421|NCT00633074|156583354|FG001|Overall Study|Adverse Event|0|||
48653422|NCT00365105|156583356|FG000|Overall Study|Protocol Violation|5|||
48653423|NCT00365105|156583357|FG001|Overall Study|Protocol Violation|8|||
48653424|NCT01463696|156583359|FG000|Overall Study|Adverse Event|0|||
48653425|NCT01463696|156583360|FG001|Overall Study|Adverse Event|1|||
48653426|NCT01463696|156583361|FG002|Overall Study|Adverse Event|0|||
48653427|NCT01463696|156583362|FG003|Overall Study|Adverse Event|2|||
48653428|NCT01463696|156583363|FG004|Overall Study|Adverse Event|0|||
48653429|NCT01463696|156583364|FG005|Overall Study|Adverse Event|1|||
48653430|NCT01463696|156583365|FG006|Overall Study|Adverse Event|3|||
48653431|NCT01463696|156583366|FG007|Overall Study|Adverse Event|2|||
48653432|NCT01463696|156583359|FG000|Overall Study|Lost to Follow-up|0|||
48653433|NCT01463696|156583360|FG001|Overall Study|Lost to Follow-up|0|||
48653434|NCT01463696|156583361|FG002|Overall Study|Lost to Follow-up|1|||
48653435|NCT01463696|156583362|FG003|Overall Study|Lost to Follow-up|0|||
48653436|NCT01463696|156583363|FG004|Overall Study|Lost to Follow-up|0|||
48653437|NCT01463696|156583364|FG005|Overall Study|Lost to Follow-up|0|||
48653438|NCT01463696|156583365|FG006|Overall Study|Lost to Follow-up|0|||
48653439|NCT01463696|156583366|FG007|Overall Study|Lost to Follow-up|0|||
48653440|NCT01463696|156583359|FG000|Overall Study|Progressive Disease|0|||
48653441|NCT01463696|156583360|FG001|Overall Study|Progressive Disease|1|||
48653442|NCT01463696|156583361|FG002|Overall Study|Progressive Disease|0|||
48653443|NCT01463696|156583362|FG003|Overall Study|Progressive Disease|1|||
48653444|NCT01463696|156583363|FG004|Overall Study|Progressive Disease|0|||
48653445|NCT01463696|156583364|FG005|Overall Study|Progressive Disease|1|||
48653446|NCT01463696|156583365|FG006|Overall Study|Progressive Disease|4|||
48653447|NCT01463696|156583366|FG007|Overall Study|Progressive Disease|2|||
48653448|NCT01463696|156583359|FG000|Overall Study|Withdrawal by Subject|0|||
48653449|NCT01463696|156583360|FG001|Overall Study|Withdrawal by Subject|0|||
48653450|NCT01463696|156583361|FG002|Overall Study|Withdrawal by Subject|0|||
48653451|NCT01463696|156583362|FG003|Overall Study|Withdrawal by Subject|1|||
48653452|NCT01463696|156583363|FG004|Overall Study|Withdrawal by Subject|1|||
48653453|NCT01463696|156583364|FG005|Overall Study|Withdrawal by Subject|1|||
48653454|NCT01463696|156583365|FG006|Overall Study|Withdrawal by Subject|2|||
48653455|NCT01463696|156583366|FG007|Overall Study|Withdrawal by Subject|0|||
48960266|NCT02504268|157684130|FG004|Overall Study|Withdrawal of Consent|0|||
48960267|NCT02504268|157684131|FG005|Overall Study|Withdrawal of Consent|0|||
48960268|NCT02504268|157684132|FG006|Overall Study|Withdrawal of Consent|0|||
48960269|NCT02504268|157684133|FG007|Overall Study|Withdrawal of Consent|0|||
48960270|NCT02504268|157684134|FG008|Overall Study|Withdrawal of Consent|0|||
48960271|NCT02504268|157684126|FG000|Overall Study|Pregnancy|2|||
48960272|NCT02504268|157684127|FG001|Overall Study|Pregnancy|0|||
48960273|NCT02504268|157684128|FG002|Overall Study|Pregnancy|0|||
48960274|NCT02504268|157684129|FG003|Overall Study|Pregnancy|0|||
48960275|NCT02504268|157684130|FG004|Overall Study|Pregnancy|0|||
48960276|NCT02504268|157684131|FG005|Overall Study|Pregnancy|0|||
48960277|NCT02504268|157684132|FG006|Overall Study|Pregnancy|0|||
48960278|NCT02504268|157684133|FG007|Overall Study|Pregnancy|0|||
48960279|NCT02504268|157684134|FG008|Overall Study|Pregnancy|0|||
48653456|NCT01463696|156583359|FG000|Overall Study|Not Treated|0|||
48653457|NCT01463696|156583360|FG001|Overall Study|Not Treated|0|||
48653458|NCT01463696|156583361|FG002|Overall Study|Not Treated|0|||
48653459|NCT01463696|156583362|FG003|Overall Study|Not Treated|0|||
48653460|NCT01463696|156583363|FG004|Overall Study|Not Treated|0|||
48653461|NCT01463696|156583364|FG005|Overall Study|Not Treated|0|||
48653462|NCT01463696|156583365|FG006|Overall Study|Not Treated|1|||
48653463|NCT01463696|156583366|FG007|Overall Study|Not Treated|0|||
48653464|NCT00245050|156583367|FG000|Overall Study|Adverse Event|3|||
48960280|NCT02504268|157684126|FG000|Overall Study|Lost to Follow-up|3|||
48960281|NCT02504268|157684127|FG001|Overall Study|Lost to Follow-up|6|||
48960282|NCT02504268|157684128|FG002|Overall Study|Lost to Follow-up|4|||
48960283|NCT02504268|157684129|FG003|Overall Study|Lost to Follow-up|0|||
48653465|NCT00245050|156583368|FG001|Overall Study|Adverse Event|2|||
48960284|NCT02504268|157684130|FG004|Overall Study|Lost to Follow-up|0|||
48960285|NCT02504268|157684131|FG005|Overall Study|Lost to Follow-up|0|||
48960286|NCT02504268|157684132|FG006|Overall Study|Lost to Follow-up|0|||
48960287|NCT02504268|157684133|FG007|Overall Study|Lost to Follow-up|0|||
48960288|NCT02504268|157684134|FG008|Overall Study|Lost to Follow-up|0|||
48960289|NCT02504268|157684126|FG000|Overall Study|Death|1|||
48960290|NCT02504268|157684127|FG001|Overall Study|Death|1|||
48960291|NCT02504268|157684128|FG002|Overall Study|Death|0|||
48960292|NCT02504268|157684129|FG003|Overall Study|Death|0|||
48960293|NCT02504268|157684130|FG004|Overall Study|Death|0|||
48960294|NCT02504268|157684131|FG005|Overall Study|Death|0|||
48960295|NCT02504268|157684132|FG006|Overall Study|Death|0|||
48960296|NCT02504268|157684133|FG007|Overall Study|Death|0|||
48960297|NCT02504268|157684134|FG008|Overall Study|Death|0|||
48960298|NCT02504268|157684126|FG000|Overall Study|Subject Request to Discontinue|11|||
48653466|NCT00425698|156583369|FG000|Overall Study|Adverse Event|3|||
48653467|NCT00425698|156583370|FG001|Overall Study|Adverse Event|1|||
48653468|NCT00425698|156583369|FG000|Overall Study|Withdrawal by Subject|0|||
48653469|NCT00425698|156583370|FG001|Overall Study|Withdrawal by Subject|1|||
48653470|NCT02957747|156583374|FG000|Overall Study|Withdrawal by Subject|0|||
48653471|NCT02957747|156583375|FG001|Overall Study|Withdrawal by Subject|3|||
48653472|NCT02957747|156583374|FG000|Overall Study|Lost to Follow-up|10|||
48653473|NCT02957747|156583375|FG001|Overall Study|Lost to Follow-up|5|||
48653474|NCT03905265|156583376|FG000|Overall Study|Withdrawal by Subject|1|||
48653475|NCT03905265|156583377|FG001|Overall Study|Withdrawal by Subject|1|||
48653476|NCT03905265|156583378|FG002|Overall Study|Withdrawal by Subject|0|||
48653477|NCT03905265|156583379|FG003|Overall Study|Withdrawal by Subject|0|||
48653478|NCT01164891|156583381|FG000|Overall Study|Disease Progression|5|||
48653479|NCT01164891|156583381|FG000|Overall Study|Adverse Event|1|||
48653480|NCT03632993|156583382|FG000|Overall Study|Withdrawal by Subject|1|||
48653481|NCT03632993|156583383|FG001|Overall Study|Withdrawal by Subject|0|||
48653482|NCT03632993|156583384|FG002|Overall Study|Withdrawal by Subject|0|||
48653483|NCT03632993|156583385|FG003|Overall Study|Withdrawal by Subject|0|||
48653484|NCT03632993|156583386|FG004|Overall Study|Withdrawal by Subject|0|||
48960299|NCT02504268|157684127|FG001|Overall Study|Subject Request to Discontinue|3|||
48960300|NCT02504268|157684128|FG002|Overall Study|Subject Request to Discontinue|6|||
48960301|NCT02504268|157684129|FG003|Overall Study|Subject Request to Discontinue|0|||
48960302|NCT02504268|157684130|FG004|Overall Study|Subject Request to Discontinue|0|||
48960303|NCT02504268|157684131|FG005|Overall Study|Subject Request to Discontinue|0|||
48960304|NCT02504268|157684132|FG006|Overall Study|Subject Request to Discontinue|0|||
48960305|NCT02504268|157684133|FG007|Overall Study|Subject Request to Discontinue|0|||
48960306|NCT02504268|157684134|FG008|Overall Study|Subject Request to Discontinue|0|||
48960307|NCT02504268|157684126|FG000|Overall Study|No Longer Meets Study Criteria|2|||
48653485|NCT03632993|156583387|FG005|Overall Study|Withdrawal by Subject|0|||
48653486|NCT03632993|156583388|FG006|Overall Study|Withdrawal by Subject|0|||
48653487|NCT03632993|156583389|FG007|Overall Study|Withdrawal by Subject|0|||
48653488|NCT03632993|156583390|FG008|Overall Study|Withdrawal by Subject|0|||
48653489|NCT03632993|156583391|FG009|Overall Study|Withdrawal by Subject|1|||
48653490|NCT03632993|156583382|FG000|Overall Study|Protocol Non-compliance|0|||
48653491|NCT03632993|156583383|FG001|Overall Study|Protocol Non-compliance|1|||
48653492|NCT03632993|156583384|FG002|Overall Study|Protocol Non-compliance|0|||
48653493|NCT03632993|156583385|FG003|Overall Study|Protocol Non-compliance|0|||
48653494|NCT03632993|156583386|FG004|Overall Study|Protocol Non-compliance|0|||
48653495|NCT03632993|156583387|FG005|Overall Study|Protocol Non-compliance|0|||
48653496|NCT03632993|156583388|FG006|Overall Study|Protocol Non-compliance|0|||
48653497|NCT03632993|156583389|FG007|Overall Study|Protocol Non-compliance|0|||
48653498|NCT03632993|156583390|FG008|Overall Study|Protocol Non-compliance|0|||
48653499|NCT03632993|156583391|FG009|Overall Study|Protocol Non-compliance|0|||
48653500|NCT03632993|156583382|FG000|Overall Study|Lost to Follow-up|0|||
48653501|NCT03632993|156583383|FG001|Overall Study|Lost to Follow-up|0|||
48653502|NCT03632993|156583384|FG002|Overall Study|Lost to Follow-up|0|||
48653503|NCT03632993|156583385|FG003|Overall Study|Lost to Follow-up|0|||
48653504|NCT03632993|156583386|FG004|Overall Study|Lost to Follow-up|0|||
48653505|NCT03632993|156583387|FG005|Overall Study|Lost to Follow-up|1|||
48653506|NCT03632993|156583388|FG006|Overall Study|Lost to Follow-up|0|||
48653507|NCT03632993|156583389|FG007|Overall Study|Lost to Follow-up|1|||
48653508|NCT03632993|156583390|FG008|Overall Study|Lost to Follow-up|0|||
48653509|NCT03632993|156583391|FG009|Overall Study|Lost to Follow-up|0|||
48653510|NCT03632993|156583382|FG000|Overall Study|Adverse Event|0|||
48653511|NCT03632993|156583383|FG001|Overall Study|Adverse Event|0|||
48653512|NCT03632993|156583384|FG002|Overall Study|Adverse Event|0|||
48653513|NCT03632993|156583385|FG003|Overall Study|Adverse Event|0|||
48653514|NCT03632993|156583386|FG004|Overall Study|Adverse Event|0|||
48653515|NCT03632993|156583387|FG005|Overall Study|Adverse Event|1|||
48653516|NCT03632993|156583388|FG006|Overall Study|Adverse Event|0|||
48653517|NCT03632993|156583389|FG007|Overall Study|Adverse Event|1|||
48653518|NCT03632993|156583390|FG008|Overall Study|Adverse Event|0|||
48653519|NCT03632993|156583391|FG009|Overall Study|Adverse Event|0|||
48653520|NCT03983382|156583392|FG000|Overall Study|Death|1|||
48653521|NCT03983382|156583392|FG000|Overall Study|Lost to Follow-up|3|||
48653522|NCT03983382|156583392|FG000|Overall Study|Physician Decision|2|||
48653523|NCT03983382|156583392|FG000|Overall Study|Withdrawal by Subject|10|||
48653524|NCT03983382|156583392|FG000|Overall Study|Change in cancer treatment|2|||
48653525|NCT02141399|156583393|FG000|Overall Study|Adverse Event|158|||
48653526|NCT02141399|156583393|FG000|Overall Study|Lack of Efficacy|62|||
48653527|NCT02141399|156583393|FG000|Overall Study|Lost to Follow-up|151|||
48653528|NCT02141399|156583393|FG000|Overall Study|Non-compliance with study drug|18|||
48653529|NCT02141399|156583393|FG000|Overall Study|Other|45|||
48653530|NCT02141399|156583393|FG000|Overall Study|Physician Decision|17|||
48653531|NCT02141399|156583393|FG000|Overall Study|Pregnancy|3|||
48653532|NCT02141399|156583393|FG000|Overall Study|Protocol Violation|38|||
48653533|NCT02141399|156583393|FG000|Overall Study|Withdrawal by Subject|238|||
48653534|NCT02141399|156583393|FG000|Overall Study|Failure to meet eligibility criteria|14|||
48653535|NCT00765037|156583396|FG000|Overall Study|Lost to Follow-up|5|||
48653536|NCT00765037|156583396|FG000|Overall Study|Adverse Event|1|||
48653537|NCT03070171|156583401|FG000|Treatment Period 2 + Washout|Other Adverse Event|0|||
48653538|NCT03070171|156583402|FG001|Treatment Period 2 + Washout|Other Adverse Event|1|||
48653539|NCT03070171|156583401|FG000|Treatment Period 4 + Washout|Withdrawal by Subject|0|||
48653540|NCT03070171|156583402|FG001|Treatment Period 4 + Washout|Withdrawal by Subject|1|||
48653541|NCT02851797|156583403|FG000|Overall Study|Withdrawal by Subject|4|||
48653542|NCT02851797|156583404|FG001|Overall Study|Withdrawal by Subject|2|||
48653543|NCT02851797|156583403|FG000|Overall Study|Adverse Event|3|||
48653544|NCT02851797|156583404|FG001|Overall Study|Adverse Event|0|||
48653545|NCT00958347|156583405|FG000|Overall Study|Death|43|||
48653546|NCT00958347|156583405|FG000|Overall Study|Withdrawal by Subject|23|||
48653547|NCT00958347|156583405|FG000|Overall Study|Lost to Follow-up|15|||
48653548|NCT00958347|156583405|FG000|Overall Study|revision/removal|10|||
48653549|NCT00958347|156583405|FG000|Overall Study|study termination|135|||
48653550|NCT00157196|156583406|FG000|Overall Study|Ongoing at data cut-off|9|||
48653551|NCT04091581|156583414|FG000|Overall Study|Lost to Follow-up|0|||
48653552|NCT04091581|156583415|FG001|Overall Study|Lost to Follow-up|1|||
48653553|NCT01271010|156586266|FG000|Overall Study|Reason not specified|11|||
48653554|NCT01271010|156586266|FG000|Overall Study|Start of new CLL therapy|1|||
48653555|NCT01271010|156586266|FG000|Overall Study|Protocol Violation|1|||
48653556|NCT01271010|156586266|FG000|Overall Study|Death|2|||
48653557|NCT01271010|156586266|FG000|Overall Study|Progression and relapse of disease|1|||
48653558|NCT01271010|156586266|FG000|Overall Study|Withdrawal by Subject|18|||
48653559|NCT01271010|156586266|FG000|Overall Study|Disease progression|27|||
48653560|NCT00948857|156586268|FG000|Overall Study|Lost to Follow-up|1|||
48653561|NCT00948857|156586269|FG001|Overall Study|Lost to Follow-up|0|||
48653562|NCT00734604|156586270|FG000|Overall Study|Adverse Event|0|||
48653563|NCT00734604|156586271|FG001|Overall Study|Adverse Event|2|||
48653564|NCT00734604|156586272|FG002|Overall Study|Adverse Event|0|||
48653565|NCT00734604|156586273|FG003|Overall Study|Adverse Event|2|||
48653566|NCT00734604|156586274|FG004|Overall Study|Adverse Event|1|||
48653567|NCT00734604|156586275|FG005|Overall Study|Adverse Event|1|||
48653568|NCT00734604|156586270|FG000|Overall Study|Serious Adverse Event|1|||
48653569|NCT00734604|156586271|FG001|Overall Study|Serious Adverse Event|0|||
48653570|NCT00734604|156586272|FG002|Overall Study|Serious Adverse Event|1|||
48653571|NCT00734604|156586273|FG003|Overall Study|Serious Adverse Event|2|||
48653572|NCT00734604|156586274|FG004|Overall Study|Serious Adverse Event|0|||
48653573|NCT00734604|156586275|FG005|Overall Study|Serious Adverse Event|1|||
48653574|NCT00734604|156586270|FG000|Overall Study|Lost to Follow-up|1|||
48653575|NCT00734604|156586271|FG001|Overall Study|Lost to Follow-up|2|||
48653576|NCT00734604|156586272|FG002|Overall Study|Lost to Follow-up|2|||
48653577|NCT00734604|156586273|FG003|Overall Study|Lost to Follow-up|4|||
48653578|NCT00734604|156586274|FG004|Overall Study|Lost to Follow-up|2|||
48653579|NCT00734604|156586275|FG005|Overall Study|Lost to Follow-up|3|||
48653580|NCT00734604|156586270|FG000|Overall Study|Physician Decision|0|||
48653581|NCT00734604|156586271|FG001|Overall Study|Physician Decision|1|||
48653582|NCT00734604|156586272|FG002|Overall Study|Physician Decision|1|||
48653583|NCT00734604|156586273|FG003|Overall Study|Physician Decision|0|||
48653584|NCT00734604|156586274|FG004|Overall Study|Physician Decision|0|||
48653585|NCT00734604|156586275|FG005|Overall Study|Physician Decision|0|||
48653586|NCT00734604|156586270|FG000|Overall Study|Protocol Violation|0|||
48653587|NCT00734604|156586271|FG001|Overall Study|Protocol Violation|2|||
48653588|NCT00734604|156586272|FG002|Overall Study|Protocol Violation|0|||
48653589|NCT00734604|156586273|FG003|Overall Study|Protocol Violation|0|||
48653590|NCT00734604|156586274|FG004|Overall Study|Protocol Violation|1|||
48653591|NCT00734604|156586275|FG005|Overall Study|Protocol Violation|0|||
48653592|NCT00734604|156586270|FG000|Overall Study|Sponsor Decision|1|||
48653593|NCT00734604|156586271|FG001|Overall Study|Sponsor Decision|2|||
48653594|NCT00734604|156586272|FG002|Overall Study|Sponsor Decision|1|||
48653595|NCT00734604|156586273|FG003|Overall Study|Sponsor Decision|0|||
48653596|NCT00734604|156586274|FG004|Overall Study|Sponsor Decision|2|||
48653597|NCT00734604|156586275|FG005|Overall Study|Sponsor Decision|0|||
48653598|NCT00734604|156586270|FG000|Overall Study|Withdrawal by Subject|0|||
48653599|NCT00734604|156586271|FG001|Overall Study|Withdrawal by Subject|2|||
48653600|NCT00734604|156586272|FG002|Overall Study|Withdrawal by Subject|0|||
48653601|NCT00734604|156586273|FG003|Overall Study|Withdrawal by Subject|1|||
48653602|NCT00734604|156586274|FG004|Overall Study|Withdrawal by Subject|2|||
48653603|NCT00734604|156586275|FG005|Overall Study|Withdrawal by Subject|1|||
48653604|NCT00734604|156586270|FG000|Overall Study|Lack of Efficacy|0|||
48653605|NCT00734604|156586271|FG001|Overall Study|Lack of Efficacy|1|||
48653606|NCT00734604|156586272|FG002|Overall Study|Lack of Efficacy|1|||
48653607|NCT00734604|156586273|FG003|Overall Study|Lack of Efficacy|0|||
48653608|NCT00734604|156586274|FG004|Overall Study|Lack of Efficacy|0|||
48653609|NCT00734604|156586275|FG005|Overall Study|Lack of Efficacy|0|||
48653610|NCT04308239|156586276|FG000|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2|||
48653611|NCT04308239|156586277|FG001|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1|||
48653612|NCT04308239|156586276|FG000|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1|||
48653613|NCT04308239|156586277|FG001|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2|||
48653614|NCT04308239|156586276|FG000|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1|||
48653615|NCT04308239|156586277|FG001|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2|||
48653616|NCT04308239|156586276|FG000|Post-intervention Evaluation (1 Week)|testing error during evaluation|0|||
48653617|NCT04308239|156586277|FG001|Post-intervention Evaluation (1 Week)|testing error during evaluation|2|||
48653618|NCT02141633|156586278|FG000|Overall Study|Physician Decision|1|||
48653619|NCT02141633|156586279|FG001|Overall Study|Physician Decision|0|||
48653620|NCT00176488|156586280|FG000|Overall Study|Initiated Cycle 1 Day 1 only|1|||
48653621|NCT01519791|156586281|FG000|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2|||
48653622|NCT01519791|156586282|FG001|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1|||
48653623|NCT01519791|156586281|FG000|Overall Study|Protocol Violation|6|||
48653624|NCT01519791|156586282|FG001|Overall Study|Protocol Violation|19|||
48653625|NCT01519791|156586281|FG000|Overall Study|Other Reason|87|||
48653626|NCT01519791|156586282|FG001|Overall Study|Other Reason|222|||
48653627|NCT01519791|156586281|FG000|Overall Study|subjects randomized in error|2|||
48653628|NCT01519791|156586282|FG001|Overall Study|subjects randomized in error|0|||
48653629|NCT01519791|156586281|FG000|Overall Study|Lack of Efficacy|16|||
48653630|NCT01519791|156586282|FG001|Overall Study|Lack of Efficacy|20|||
48653631|NCT01519791|156586281|FG000|Overall Study|SAE, non-fatal|6|||
48653632|NCT01519791|156586282|FG001|Overall Study|SAE, non-fatal|22|||
48653633|NCT01519791|156586281|FG000|Overall Study|AE, serious fatal|0|||
48653634|NCT01519791|156586282|FG001|Overall Study|AE, serious fatal|1|||
48653635|NCT01519791|156586281|FG000|Overall Study|SAE, fatal + SAE, non-fatal|0|||
48653636|NCT01519791|156586282|FG001|Overall Study|SAE, fatal + SAE, non-fatal|1|||
48753752|NCT02625259|156944315|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
48653637|NCT01519791|156586281|FG000|Overall Study|AE, non-serious non-fatal|12|||
48653638|NCT01519791|156586282|FG001|Overall Study|AE, non-serious non-fatal|31|||
48653639|NCT01519791|156586281|FG000|Overall Study|Withdrawal by Subject|15|||
48653640|NCT01519791|156586282|FG001|Overall Study|Withdrawal by Subject|37|||
48653641|NCT01519791|156586281|FG000|Overall Study|Lost to Follow-up|6|||
48653642|NCT01519791|156586282|FG001|Overall Study|Lost to Follow-up|14|||
48653643|NCT01751906|156586285|FG000|Overall Study|Lost to Follow-up|151|||
48653644|NCT01751906|156586286|FG001|Overall Study|Lost to Follow-up|68|||
48653645|NCT01751906|156586285|FG000|Overall Study|Withdrawal by Subject|22|||
48653646|NCT01751906|156586286|FG001|Overall Study|Withdrawal by Subject|18|||
48653647|NCT01751906|156586285|FG000|Overall Study|Physician Decision|5|||
48653648|NCT01751906|156586286|FG001|Overall Study|Physician Decision|2|||
48653649|NCT01751906|156586285|FG000|Overall Study|Death|84|||
48653650|NCT01751906|156586286|FG001|Overall Study|Death|43|||
48653651|NCT01751906|156586285|FG000|Overall Study|Denied on premises for follow-up by law|1|||
48653652|NCT01751906|156586286|FG001|Overall Study|Denied on premises for follow-up by law|0|||
48653653|NCT00328562|156586291|FG000|Overall Study|Disease progression|1|||
48653654|NCT00394251|156586295|FG000|Overall Study|Adverse Event|7|||
48960308|NCT02504268|157684127|FG001|Overall Study|No Longer Meets Study Criteria|3|||
48960309|NCT02504268|157684128|FG002|Overall Study|No Longer Meets Study Criteria|0|||
48960310|NCT02504268|157684129|FG003|Overall Study|No Longer Meets Study Criteria|0|||
48960311|NCT02504268|157684130|FG004|Overall Study|No Longer Meets Study Criteria|0|||
48960312|NCT02504268|157684131|FG005|Overall Study|No Longer Meets Study Criteria|0|||
48960313|NCT02504268|157684132|FG006|Overall Study|No Longer Meets Study Criteria|0|||
48960314|NCT02504268|157684133|FG007|Overall Study|No Longer Meets Study Criteria|0|||
48960315|NCT02504268|157684134|FG008|Overall Study|No Longer Meets Study Criteria|0|||
48960316|NCT02504268|157684126|FG000|Overall Study|Lack of Efficacy|11|||
48653655|NCT00394251|156586296|FG001|Overall Study|Adverse Event|5|||
48653656|NCT00394251|156586295|FG000|Overall Study|Unacceptable Toxicity|20|||
48653657|NCT00394251|156586296|FG001|Overall Study|Unacceptable Toxicity|18|||
48653658|NCT00394251|156586295|FG000|Overall Study|Physician Decision|1|||
48653659|NCT00394251|156586296|FG001|Overall Study|Physician Decision|1|||
48653660|NCT00394251|156586295|FG000|Overall Study|Protocol Violation|0|||
48653661|NCT00394251|156586296|FG001|Overall Study|Protocol Violation|1|||
48653662|NCT00394251|156586295|FG000|Overall Study|Withdrawal by Subject|7|||
48653663|NCT00394251|156586296|FG001|Overall Study|Withdrawal by Subject|11|||
48653664|NCT00394251|156586295|FG000|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
48653665|NCT00394251|156586296|FG001|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
48653666|NCT00705250|156586297|FG000|Overall Study|Withdrawal by Subject|1|||
48653667|NCT00705250|156586297|FG000|Overall Study|Patient died in car accident|1|||
48653668|NCT03206970|156586298|FG000|Overall Study|Death|21|||
48653669|NCT03206970|156586298|FG000|Overall Study|Withdrawal by Subject|13|||
48653670|NCT03206970|156586298|FG000|Overall Study|Lost to Follow-up|3|||
48653671|NCT03206970|156586298|FG000|Overall Study|Primary and secondary objectives were met and remaining participants transferred to LTE by sponsor|49|||
48960317|NCT02504268|157684127|FG001|Overall Study|Lack of Efficacy|35|||
48960318|NCT02504268|157684128|FG002|Overall Study|Lack of Efficacy|9|||
48960319|NCT02504268|157684129|FG003|Overall Study|Lack of Efficacy|0|||
48960320|NCT02504268|157684130|FG004|Overall Study|Lack of Efficacy|0|||
48960321|NCT02504268|157684131|FG005|Overall Study|Lack of Efficacy|0|||
48960322|NCT02504268|157684132|FG006|Overall Study|Lack of Efficacy|0|||
48653672|NCT01576146|156586303|FG000|Extension Period 1|Adverse Event|2|||
48653673|NCT01576146|156586303|FG000|Extension Period 1|Death|2|||
48653674|NCT01576146|156586303|FG000|Extension Period 1|Physician Decision|2|||
48653675|NCT01576146|156586303|FG000|Extension Period 1|Withdrawal by Subject|1|||
48653676|NCT01576146|156586303|FG000|Extension Period 1|Lost to Follow-up|1|||
48653677|NCT01576146|156586303|FG000|Extension Period 1|Parathyroidectomy|1|||
48653678|NCT01576146|156586303|FG000|Extension Period 1|Renal Transplant|1|||
48653679|NCT01576146|156586303|FG000|Extension Period 2|Sponsor Decision|13|||
48753753|NCT02625259|156944316|FG004|First Intervention (Day 1)|Withdrawal by Subject|0|||
48653680|NCT01576146|156586303|FG000|Extension Period 2|Death|1|||
48653681|NCT01576146|156586303|FG000|Extension Period 2|Adverse Event|1|||
48653682|NCT01576146|156586303|FG000|Extension Period 2|Renal Transplant|1|||
48653683|NCT01576146|156586303|FG000|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1|||
48653684|NCT00413894|156586305|FG000|Overall Study|Withdrawal by Subject|10|||
48653685|NCT00413894|156586305|FG000|Overall Study|Administrative Reasons|1|||
48653686|NCT00413894|156586305|FG000|Overall Study|Hb <10 grams/deciliter|12|||
48653687|NCT00413894|156586305|FG000|Overall Study|Adverse Event|28|||
48653688|NCT00413894|156586305|FG000|Overall Study|Protocol Violation|11|||
48653689|NCT00413894|156586305|FG000|Overall Study|Other|18|||
48753754|NCT00661622|156944317|FG000|Overall Study|Protocol Violation|1|||
48753755|NCT00661622|156944318|FG001|Overall Study|Protocol Violation|0|||
48753756|NCT01905657|156944319|FG000|Overall Study|Adverse Event|23|||
48653690|NCT00316225|156586313|FG000|Overall Study|Adverse Event|2|||
48653691|NCT00316225|156586313|FG000|Overall Study|Physician Decision|3|||
48653692|NCT00316225|156586313|FG000|Overall Study|Progressive Disease|15|||
48653693|NCT00316225|156586313|FG000|Overall Study|Withdrawal by Subject|3|||
48960323|NCT02504268|157684133|FG007|Overall Study|Lack of Efficacy|0|||
48653694|NCT00316225|156586313|FG000|Overall Study|Death|2|||
48653695|NCT01811485|156586314|FG000|Overall Study|Adverse Event|1|||
48653696|NCT01811485|156586315|FG001|Overall Study|Adverse Event|3|||
48753757|NCT01905657|156944320|FG001|Overall Study|Adverse Event|17|||
48960324|NCT02504268|157684134|FG008|Overall Study|Lack of Efficacy|0|||
48960325|NCT02504268|157684126|FG000|Overall Study|Poor/Non-Compliance|3|||
48653697|NCT01811485|156586316|FG002|Overall Study|Adverse Event|2|||
48653698|NCT01811485|156586314|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
48653699|NCT01811485|156586315|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
48653700|NCT01811485|156586316|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
48653701|NCT01811485|156586314|FG000|Overall Study|Administrative problems|1|||
48653702|NCT01811485|156586315|FG001|Overall Study|Administrative problems|0|||
48653703|NCT01811485|156586316|FG002|Overall Study|Administrative problems|0|||
48653704|NCT01811485|156586314|FG000|Overall Study|Protocol Deviation|0|||
48653705|NCT01811485|156586315|FG001|Overall Study|Protocol Deviation|1|||
48653706|NCT01811485|156586316|FG002|Overall Study|Protocol Deviation|0|||
48653707|NCT01545934|156586317|FG000|Overall Study|Withdrawal by Subject|4|||
48653708|NCT01545934|156586318|FG001|Overall Study|Withdrawal by Subject|3|||
48653709|NCT01545934|156586317|FG000|Overall Study|Lost to Follow-up|1|||
48653710|NCT01545934|156586318|FG001|Overall Study|Lost to Follow-up|0|||
48653711|NCT03654404|156586319|FG000|Overall Study|Death|1|||
48653712|NCT03654404|156586319|FG000|Overall Study|Lost to Follow-up|2|||
48653713|NCT03654404|156586319|FG000|Overall Study|Withdrawal by Subject|5|||
48653714|NCT03215758|156586327|FG000|Overall Study|Technical Problems|1|||
48653715|NCT03215758|156586328|FG001|Overall Study|Technical Problems|0|||
48653716|NCT03215758|156586327|FG000|Overall Study|Protocol deviation|0|||
48653717|NCT03215758|156586328|FG001|Overall Study|Protocol deviation|1|||
48653718|NCT03215758|156586327|FG000|Overall Study|Physician Decision|0|||
48653719|NCT03215758|156586328|FG001|Overall Study|Physician Decision|1|||
48653720|NCT03215758|156586327|FG000|Overall Study|Death|0|||
48653721|NCT03215758|156586328|FG001|Overall Study|Death|1|||
48653722|NCT03215758|156586327|FG000|Overall Study|Adverse Event|1|||
48653723|NCT03215758|156586328|FG001|Overall Study|Adverse Event|2|||
48653724|NCT03215758|156586327|FG000|Overall Study|Subject/Guardian Decision|3|||
48653725|NCT03215758|156586328|FG001|Overall Study|Subject/Guardian Decision|3|||
48653726|NCT04123093|156586329|FG000|Phase 1|Subject did not show up for baseline visit and was replaced|1|||
48653727|NCT04123093|156586330|FG001|Phase 1|Subject did not show up for baseline visit and was replaced|0|||
48653728|NCT04123093|156586329|FG000|Phase 2|Physician Decision|0|||
48653729|NCT04123093|156586330|FG001|Phase 2|Physician Decision|1|||
48653730|NCT04123093|156586329|FG000|Phase 2|Withdrawal by Subject|0|||
48653731|NCT04123093|156586330|FG001|Phase 2|Withdrawal by Subject|1|||
48653732|NCT00223808|156586332|FG000|Overall Study|<5 hrs therapy before discharge|3|||
48653733|NCT00223808|156586333|FG001|Overall Study|<5 hrs therapy before discharge|5|||
48653734|NCT00223808|156586334|FG002|Overall Study|<5 hrs therapy before discharge|5|||
48653735|NCT00606034|156586335|FG000|Overall Study|incarceration|1|||
48653736|NCT01205061|156586336|FG000|Overall Study|Adverse Event|4|||
48653737|NCT01205061|156586336|FG000|Overall Study|Withdrawal by Subject|11|||
48653738|NCT01205061|156586336|FG000|Overall Study|Clinical Investigational Plan Violation|1|||
48653739|NCT01205061|156586336|FG000|Overall Study|Lost to Follow-up|9|||
48653740|NCT01205061|156586336|FG000|Overall Study|Other|1|||
48653741|NCT04537208|156586342|FG000|Overall Study|Adverse Event|0|||
48653742|NCT04537208|156586343|FG001|Overall Study|Adverse Event|0|||
48653743|NCT04537208|156586344|FG002|Overall Study|Adverse Event|0|||
48653744|NCT04537208|156586345|FG003|Overall Study|Adverse Event|0|||
48653745|NCT04537208|156586346|FG004|Overall Study|Adverse Event|0|||
48653746|NCT04537208|156586347|FG005|Overall Study|Adverse Event|0|||
48653747|NCT04537208|156586348|FG006|Overall Study|Adverse Event|0|||
48653748|NCT04537208|156586349|FG007|Overall Study|Adverse Event|0|||
48653749|NCT04537208|156586350|FG008|Overall Study|Adverse Event|1|||
48653750|NCT04537208|156586351|FG009|Overall Study|Adverse Event|0|||
48653751|NCT04537208|156586352|FG010|Overall Study|Adverse Event|0|||
48653752|NCT04537208|156586342|FG000|Overall Study|Protocol deviation|0|||
48653753|NCT04537208|156586343|FG001|Overall Study|Protocol deviation|0|||
48653754|NCT04537208|156586344|FG002|Overall Study|Protocol deviation|2|||
48653755|NCT04537208|156586345|FG003|Overall Study|Protocol deviation|0|||
48653756|NCT04537208|156586346|FG004|Overall Study|Protocol deviation|0|||
48653757|NCT04537208|156586347|FG005|Overall Study|Protocol deviation|2|||
48653758|NCT04537208|156586348|FG006|Overall Study|Protocol deviation|4|||
48653759|NCT04537208|156586349|FG007|Overall Study|Protocol deviation|0|||
48865577|NCT01032200|157343458|FG001|Overall Study|Withdrawal by Subject|3|||
48865578|NCT01032200|157343457|FG000|Overall Study|Toxicity|0|||
48865579|NCT01032200|157343458|FG001|Overall Study|Toxicity|2|||
48653760|NCT04537208|156586350|FG008|Overall Study|Protocol deviation|1|||
48653761|NCT04537208|156586351|FG009|Overall Study|Protocol deviation|0|||
48653762|NCT04537208|156586352|FG010|Overall Study|Protocol deviation|2|||
48653763|NCT04537208|156586342|FG000|Overall Study|Withdrawal by Subject|4|||
48653764|NCT04537208|156586343|FG001|Overall Study|Withdrawal by Subject|2|||
48653765|NCT04537208|156586344|FG002|Overall Study|Withdrawal by Subject|1|||
48653766|NCT04537208|156586345|FG003|Overall Study|Withdrawal by Subject|3|||
48653767|NCT04537208|156586346|FG004|Overall Study|Withdrawal by Subject|5|||
48653768|NCT04537208|156586347|FG005|Overall Study|Withdrawal by Subject|1|||
48653769|NCT04537208|156586348|FG006|Overall Study|Withdrawal by Subject|6|||
48653770|NCT04537208|156586349|FG007|Overall Study|Withdrawal by Subject|1|||
48653771|NCT04537208|156586350|FG008|Overall Study|Withdrawal by Subject|7|||
48960326|NCT02504268|157684127|FG001|Overall Study|Poor/Non-Compliance|2|||
48960327|NCT02504268|157684128|FG002|Overall Study|Poor/Non-Compliance|3|||
48960328|NCT02504268|157684129|FG003|Overall Study|Poor/Non-Compliance|0|||
48960329|NCT02504268|157684130|FG004|Overall Study|Poor/Non-Compliance|0|||
48960330|NCT02504268|157684131|FG005|Overall Study|Poor/Non-Compliance|0|||
48960331|NCT02504268|157684132|FG006|Overall Study|Poor/Non-Compliance|0|||
48960332|NCT02504268|157684133|FG007|Overall Study|Poor/Non-Compliance|0|||
48960333|NCT02504268|157684134|FG008|Overall Study|Poor/Non-Compliance|0|||
48960334|NCT02504268|157684126|FG000|Overall Study|Not Disclosed|1|||
48960335|NCT02504268|157684127|FG001|Overall Study|Not Disclosed|0|||
48960336|NCT02504268|157684128|FG002|Overall Study|Not Disclosed|2|||
48960337|NCT02504268|157684129|FG003|Overall Study|Not Disclosed|0|||
48960338|NCT02504268|157684130|FG004|Overall Study|Not Disclosed|0|||
48960339|NCT02504268|157684131|FG005|Overall Study|Not Disclosed|0|||
48960340|NCT02504268|157684132|FG006|Overall Study|Not Disclosed|0|||
48960341|NCT02504268|157684133|FG007|Overall Study|Not Disclosed|0|||
48960342|NCT02504268|157684134|FG008|Overall Study|Not Disclosed|0|||
48653772|NCT04537208|156586351|FG009|Overall Study|Withdrawal by Subject|2|||
48653773|NCT04537208|156586352|FG010|Overall Study|Withdrawal by Subject|4|||
48653774|NCT04537208|156586342|FG000|Overall Study|Lost to Follow-up|4|||
48653775|NCT04537208|156586343|FG001|Overall Study|Lost to Follow-up|1|||
48653776|NCT04537208|156586344|FG002|Overall Study|Lost to Follow-up|3|||
48653777|NCT04537208|156586345|FG003|Overall Study|Lost to Follow-up|4|||
48653778|NCT04537208|156586346|FG004|Overall Study|Lost to Follow-up|3|||
48653779|NCT04537208|156586347|FG005|Overall Study|Lost to Follow-up|2|||
48653780|NCT04537208|156586348|FG006|Overall Study|Lost to Follow-up|3|||
48653781|NCT04537208|156586349|FG007|Overall Study|Lost to Follow-up|2|||
48653782|NCT04537208|156586350|FG008|Overall Study|Lost to Follow-up|7|||
48653783|NCT04537208|156586351|FG009|Overall Study|Lost to Follow-up|2|||
48653784|NCT04537208|156586352|FG010|Overall Study|Lost to Follow-up|2|||
48653785|NCT02323126|156586355|FG000|Overall Study|Patient / guardian decision|0|||
48653786|NCT02323126|156586356|FG001|Overall Study|Patient / guardian decision|1|||
48653787|NCT02323126|156586357|FG002|Overall Study|Patient / guardian decision|2|||
48653788|NCT02323126|156586355|FG000|Overall Study|Progressive disease|14|||
48653789|NCT02323126|156586356|FG001|Overall Study|Progressive disease|8|||
48653790|NCT02323126|156586357|FG002|Overall Study|Progressive disease|14|||
48653791|NCT02323126|156586355|FG000|Overall Study|Physician Decision|0|||
48653792|NCT02323126|156586356|FG001|Overall Study|Physician Decision|1|||
48653793|NCT02323126|156586357|FG002|Overall Study|Physician Decision|3|||
48653794|NCT02323126|156586355|FG000|Overall Study|Death|1|||
48653795|NCT02323126|156586356|FG001|Overall Study|Death|1|||
48653796|NCT02323126|156586357|FG002|Overall Study|Death|4|||
48653797|NCT02323126|156586355|FG000|Overall Study|Adverse Event|3|||
48653798|NCT02323126|156586356|FG001|Overall Study|Adverse Event|5|||
48653799|NCT02323126|156586357|FG002|Overall Study|Adverse Event|7|||
48653800|NCT00344318|156586366|FG000|Overall Study|Adverse Event|0|||
48653801|NCT00344318|156586367|FG001|Overall Study|Adverse Event|3|||
48653802|NCT00344318|156586368|FG002|Overall Study|Adverse Event|0|||
48653803|NCT00344318|156586369|FG003|Overall Study|Adverse Event|1|||
48653804|NCT00344318|156586366|FG000|Overall Study|Withdrawal by Subject|2|||
48653805|NCT00344318|156586367|FG001|Overall Study|Withdrawal by Subject|2|||
48653806|NCT00344318|156586368|FG002|Overall Study|Withdrawal by Subject|0|||
48653807|NCT00344318|156586369|FG003|Overall Study|Withdrawal by Subject|2|||
48653808|NCT00344318|156586366|FG000|Overall Study|Lost to Follow-up|2|||
48653809|NCT00344318|156586367|FG001|Overall Study|Lost to Follow-up|0|||
48653810|NCT00344318|156586368|FG002|Overall Study|Lost to Follow-up|1|||
48653811|NCT00344318|156586369|FG003|Overall Study|Lost to Follow-up|0|||
48653812|NCT01208961|156586370|FG000|High-Fat Period III|Protocol Violation|1|||
48653813|NCT01208961|156586371|FG001|High-Fat Period III|Protocol Violation|0|||
48653814|NCT00391430|156586372|FG000|Overall Study|Withdrawal by Subject|3|||
48653815|NCT00391430|156586373|FG001|Overall Study|Withdrawal by Subject|0|||
48653816|NCT00391430|156586374|FG002|Overall Study|Withdrawal by Subject|12|||
48653817|NCT02379988|156586377|FG000|Overall Study|Not eligible|1|||
48653818|NCT05479097|156586388|FG000|Overall Study|Withdrawal by Subject|2|||
48653819|NCT02095873|156586389|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
48653820|NCT02095873|156586390|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
48653821|NCT02095873|156586389|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
48653822|NCT02095873|156586390|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
48960343|NCT03025217|157684135|FG000|Overall Study|Pregnancy|1|||
48960344|NCT03025217|157684135|FG000|Overall Study|Lost to Follow-up|1|||
48653823|NCT02095873|156586389|FG000|Second Intervention (8 Weeks)|Protocol Violation|1|||
48653824|NCT02095873|156586390|FG001|Second Intervention (8 Weeks)|Protocol Violation|0|||
48653825|NCT00211757|156586394|FG000|Overall Study|Withdrawal by Subject|1|||
48653826|NCT00211757|156586395|FG001|Overall Study|Withdrawal by Subject|1|||
48653827|NCT00211757|156586394|FG000|Overall Study|Lack of Efficacy|0|||
48653828|NCT00211757|156586395|FG001|Overall Study|Lack of Efficacy|1|||
48653829|NCT00322452|156586396|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
48960345|NCT03025217|157684135|FG000|Overall Study|Not eligible, poor English|2|||
48960346|NCT01958125|157684136|FG000|Overall Study|Missing diary data|2|||
48753758|NCT01905657|156944321|FG002|Overall Study|Adverse Event|18|||
48753759|NCT01905657|156944319|FG000|Overall Study|Clinical Progression|103|||
48653830|NCT00322452|156586397|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
48653831|NCT00322452|156586396|FG000|Overall Study|Lost to Follow-up|5|||
48653832|NCT00322452|156586397|FG001|Overall Study|Lost to Follow-up|2|||
48653833|NCT00322452|156586396|FG000|Overall Study|Withdrawal by Subject|19|||
48753760|NCT01905657|156944320|FG001|Overall Study|Clinical Progression|78|||
48753761|NCT01905657|156944321|FG002|Overall Study|Clinical Progression|59|||
48753762|NCT01905657|156944319|FG000|Overall Study|Death|40|||
48753763|NCT01905657|156944320|FG001|Overall Study|Death|43|||
48753764|NCT01905657|156944321|FG002|Overall Study|Death|47|||
48753765|NCT01905657|156944319|FG000|Overall Study|Excluded Medication|13|||
48753766|NCT01905657|156944320|FG001|Overall Study|Excluded Medication|16|||
48960347|NCT01958125|157684137|FG001|Overall Study|Missing diary data|6|||
48960348|NCT01958125|157684136|FG000|Overall Study|No headache attacks|0|||
48960349|NCT01958125|157684137|FG001|Overall Study|No headache attacks|2|||
48960350|NCT00781599|157684142|FG000|Overall Study|Lost to Follow-up|7|||
48960351|NCT00781599|157684143|FG001|Overall Study|Lost to Follow-up|4|||
48960352|NCT00987623|157684148|FG000|Overall Study|Lost to Follow-up|2|||
48960353|NCT00987623|157684149|FG001|Overall Study|Lost to Follow-up|1|||
48960354|NCT00987623|157684148|FG000|Overall Study|Time/job conflict|2|||
48960355|NCT00987623|157684149|FG001|Overall Study|Time/job conflict|0|||
48960356|NCT00987623|157684148|FG000|Overall Study|Discomfort|1|||
48960357|NCT00987623|157684149|FG001|Overall Study|Discomfort|0|||
48960358|NCT00987623|157684148|FG000|Overall Study|Biomicroscopy|0|||
48960359|NCT00987623|157684149|FG001|Overall Study|Biomicroscopy|1|||
48960360|NCT00987623|157684148|FG000|Overall Study|Influenza|0|||
48653834|NCT00322452|156586397|FG001|Overall Study|Withdrawal by Subject|46|||
48653835|NCT00322452|156586396|FG000|Overall Study|Death|223|||
48653836|NCT00322452|156586397|FG001|Overall Study|Death|227|||
48653837|NCT00526656|156586398|FG000|Overall Study|Death|1|||
48653838|NCT00526656|156586398|FG000|Overall Study|Refused surgery|1|||
48653839|NCT01357161|156586401|FG000|Part 1 (Open Label Run-in)|Death|5|||
48653840|NCT01357161|156586402|FG001|Part 1 (Open Label Run-in)|Death|0|||
48653841|NCT01357161|156586403|FG002|Part 1 (Open Label Run-in)|Death|0|||
48653842|NCT01357161|156586401|FG000|Part 1 (Open Label Run-in)|Lost to Follow-up|3|||
48653843|NCT01357161|156586402|FG001|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
48653844|NCT01357161|156586403|FG002|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
48653845|NCT01357161|156586401|FG000|Part 1 (Open Label Run-in)|Physician Decision|1|||
48653846|NCT01357161|156586402|FG001|Part 1 (Open Label Run-in)|Physician Decision|0|||
48653847|NCT01357161|156586403|FG002|Part 1 (Open Label Run-in)|Physician Decision|0|||
48653848|NCT01357161|156586401|FG000|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5|||
48653849|NCT01357161|156586402|FG001|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
48653850|NCT01357161|156586403|FG002|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
48653851|NCT01357161|156586401|FG000|Part 1 (Open Label Run-in)|Withdrawal by Subject|1|||
48653852|NCT01357161|156586402|FG001|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
48653853|NCT01357161|156586403|FG002|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
48960361|NCT00987623|157684149|FG001|Overall Study|Influenza|1|||
48960362|NCT00668200|157684150|FG000|Overall Study|Withdrawal by Subject|2|||
48960363|NCT00668200|157684150|FG000|Overall Study|Lost to Follow-up|1|||
48960364|NCT03806179|157684153|FG000|Overall Study|Progressive disease|0|||
48960365|NCT03806179|157684154|FG001|Overall Study|Progressive disease|2|||
48960366|NCT01603641|157684155|FG000|Overall Study|Did not Receive Treatment|3|||
48960367|NCT01603641|157684155|FG000|Overall Study|Adverse Event|1|||
48960368|NCT01603641|157684155|FG000|Overall Study|Lack of Efficacy|1|||
48960369|NCT01603641|157684155|FG000|Overall Study|Lost to Follow-up|6|||
48960370|NCT01603641|157684155|FG000|Overall Study|Personal Reasons|18|||
48960371|NCT01603641|157684155|FG000|Overall Study|Other Miscellaneous Reasons|6|||
48960372|NCT01151579|157684158|FG000|Overall Study|Physician Decision|3|||
48960373|NCT01151579|157684159|FG001|Overall Study|Physician Decision|1|||
48960374|NCT01151579|157684158|FG000|Overall Study|Withdrawal by Subject|3|||
48653854|NCT01357161|156586401|FG000|Part 2 (Double-Blind Comparison)|Death|0|||
48653855|NCT01357161|156586402|FG001|Part 2 (Double-Blind Comparison)|Death|22|||
48653856|NCT01357161|156586403|FG002|Part 2 (Double-Blind Comparison)|Death|19|||
48960375|NCT01151579|157684159|FG001|Overall Study|Withdrawal by Subject|2|||
48960376|NCT01151579|157684158|FG000|Overall Study|Not meet inclusion criteria|6|||
48960377|NCT01151579|157684159|FG001|Overall Study|Not meet inclusion criteria|4|||
48960378|NCT01276457|157684162|FG000|Core Study|Adverse Event|6|||
48653857|NCT01357161|156586401|FG000|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0|||
48653858|NCT01357161|156586402|FG001|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1|||
48753767|NCT01905657|156944321|FG002|Overall Study|Excluded Medication|9|||
48753768|NCT01905657|156944319|FG000|Overall Study|Lost to Follow-up|1|||
48753769|NCT01905657|156944320|FG001|Overall Study|Lost to Follow-up|2|||
48960379|NCT01276457|157684163|FG001|Core Study|Adverse Event|3|||
48960380|NCT01276457|157684162|FG000|Core Study|Lost to Follow-up|1|||
48960381|NCT01276457|157684163|FG001|Core Study|Lost to Follow-up|2|||
48960382|NCT01276457|157684162|FG000|Core Study|Administrative problems|1|||
48960383|NCT01276457|157684163|FG001|Core Study|Administrative problems|1|||
48960384|NCT01276457|157684162|FG000|Core Study|Death|2|||
48960385|NCT01276457|157684163|FG001|Core Study|Death|2|||
48960386|NCT01276457|157684162|FG000|Core Study|Lack of Efficacy|3|||
48960387|NCT01276457|157684163|FG001|Core Study|Lack of Efficacy|12|||
48960388|NCT01276457|157684162|FG000|Extension Study|Lost to Follow-up|3|||
48960389|NCT01276457|157684163|FG001|Extension Study|Lost to Follow-up|0|||
48960390|NCT01276457|157684162|FG000|Extension Study|Death|0|||
48960391|NCT01276457|157684163|FG001|Extension Study|Death|1|||
48960392|NCT01276457|157684162|FG000|Extension Study|Lack of Efficacy|3|||
48960393|NCT01276457|157684163|FG001|Extension Study|Lack of Efficacy|1|||
48960394|NCT01952730|157684164|FG000|Overall Study|FDA shut down core lab used by study|1|||
48960395|NCT00608530|157684165|FG000|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11|||
48960396|NCT00608530|157684166|FG001|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5|||
48960397|NCT00608530|157684167|FG002|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
48960398|NCT00608530|157684168|FG003|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
48960399|NCT00608530|157684165|FG000|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
48960400|NCT00608530|157684166|FG001|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
48960401|NCT00608530|157684167|FG002|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
48960402|NCT00608530|157684168|FG003|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
48753770|NCT01905657|156944321|FG002|Overall Study|Lost to Follow-up|1|||
48753771|NCT01905657|156944319|FG000|Overall Study|Physician Decision|5|||
48753772|NCT01905657|156944320|FG001|Overall Study|Physician Decision|8|||
48960403|NCT00608530|157684165|FG000|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
48960404|NCT00608530|157684166|FG001|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
48960405|NCT00608530|157684167|FG002|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2|||
48960406|NCT00608530|157684168|FG003|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3|||
48960407|NCT00608530|157684165|FG000|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
48960408|NCT00608530|157684166|FG001|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
48960409|NCT00608530|157684167|FG002|Study 2 Nurse-delivered Treatments|Protocol Violation|2|||
48960410|NCT00608530|157684168|FG003|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
48960411|NCT00608530|157684165|FG000|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
48960412|NCT00608530|157684166|FG001|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
48960413|NCT00608530|157684167|FG002|Study 2 Nurse-delivered Treatments|Time demands of study|4|||
48960414|NCT00608530|157684168|FG003|Study 2 Nurse-delivered Treatments|Time demands of study|1|||
48960415|NCT00608530|157684165|FG000|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
48960416|NCT00608530|157684166|FG001|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
48960417|NCT00608530|157684167|FG002|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1|||
48960418|NCT00608530|157684168|FG003|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
48960419|NCT02493426|157684169|FG000|Overall Study|Withdrawal by Subject|0|||
48960420|NCT02493426|157684170|FG001|Overall Study|Withdrawal by Subject|1|||
48960421|NCT02237157|157684171|FG000|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3|||
48960422|NCT02237157|157684172|FG001|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
48960423|NCT02237157|157684173|FG002|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
48960424|NCT02237157|157684174|FG003|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
48960425|NCT02237157|157684171|FG000|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1|||
48960426|NCT02237157|157684172|FG001|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
48960427|NCT02237157|157684173|FG002|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
48960428|NCT02237157|157684174|FG003|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
48653859|NCT01357161|156586403|FG002|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6|||
48653860|NCT01357161|156586401|FG000|Part 2 (Double-Blind Comparison)|Physician Decision|0|||
48653861|NCT01357161|156586402|FG001|Part 2 (Double-Blind Comparison)|Physician Decision|1|||
48653862|NCT01357161|156586403|FG002|Part 2 (Double-Blind Comparison)|Physician Decision|4|||
48653863|NCT01357161|156586401|FG000|Part 2 (Double-Blind Comparison)|Progressive Disease|0|||
48653864|NCT01357161|156586402|FG001|Part 2 (Double-Blind Comparison)|Progressive Disease|1|||
48653865|NCT01357161|156586403|FG002|Part 2 (Double-Blind Comparison)|Progressive Disease|3|||
48653866|NCT01357161|156586401|FG000|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0|||
48653867|NCT01357161|156586402|FG001|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29|||
48653868|NCT01357161|156586403|FG002|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26|||
48653869|NCT01357161|156586401|FG000|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0|||
48653870|NCT01357161|156586402|FG001|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5|||
48653871|NCT01357161|156586403|FG002|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4|||
48653872|NCT02910401|156586404|FG000|Overall Study|Study closure Study closure|0|||
48653873|NCT02910401|156586405|FG001|Overall Study|Study closure Study closure|0|||
48653874|NCT02910401|156586406|FG002|Overall Study|Study closure Study closure|2|||
48960429|NCT03628508|157684175|FG000|Overall Study|Lost to Follow-up|1|||
48653875|NCT02910401|156586404|FG000|Overall Study|Physician Decision|1|||
48653876|NCT02910401|156586405|FG001|Overall Study|Physician Decision|0|||
48753773|NCT01905657|156944321|FG002|Overall Study|Physician Decision|12|||
48753774|NCT01905657|156944319|FG000|Overall Study|Protocol Violation|2|||
48653877|NCT02910401|156586406|FG002|Overall Study|Physician Decision|0|||
48653878|NCT03300024|156586409|FG000|Overall Study|Physician Decision|4|||
48653879|NCT03300024|156586410|FG001|Overall Study|Physician Decision|6|||
48653880|NCT04065074|156586411|FG000|Overall Study|Adverse Event|1|||
48653881|NCT04065074|156586411|FG000|Overall Study|Protocol Non-Compliance after injection|1|||
48753775|NCT01905657|156944320|FG001|Overall Study|Protocol Violation|1|||
48753776|NCT01905657|156944321|FG002|Overall Study|Protocol Violation|1|||
48653882|NCT01331837|156586412|FG000|Overall Study|Death|30|||
48653883|NCT01331837|156586413|FG001|Overall Study|Death|34|||
48653884|NCT01331837|156586412|FG000|Overall Study|Lost to Follow-up|3|||
48653885|NCT01331837|156586413|FG001|Overall Study|Lost to Follow-up|1|||
48653886|NCT01331837|156586412|FG000|Overall Study|Info not recorded|10|||
48653887|NCT01331837|156586413|FG001|Overall Study|Info not recorded|16|||
48653888|NCT01331837|156586412|FG000|Overall Study|Withdrawal by Subject|13|||
48653889|NCT01331837|156586413|FG001|Overall Study|Withdrawal by Subject|16|||
48653890|NCT00283803|156588051|FG000|Overall Study|Physician Decision|9|||
48653891|NCT00283803|156588051|FG000|Overall Study|Withdrawal by Subject|4|||
48653892|NCT01127607|156588052|FG000|Phase II (Between Subjects)|Lost to Follow-up|0|||
48653893|NCT01127607|156588053|FG001|Phase II (Between Subjects)|Lost to Follow-up|2|||
48653894|NCT01127607|156588052|FG000|Phase II (Between Subjects)|Withdrawal by Subject|1|||
48653895|NCT01127607|156588053|FG001|Phase II (Between Subjects)|Withdrawal by Subject|0|||
48653896|NCT03419897|156588054|FG000|Overall Study|Death|180|||
48653897|NCT03419897|156588054|FG000|Overall Study|Lost to Follow-up|1|||
48653898|NCT03419897|156588054|FG000|Overall Study|Withdrawal by Subject|6|||
48653899|NCT03419897|156588054|FG000|Overall Study|Sponsor Decision|61|||
48653900|NCT03419897|156588054|FG000|Overall Study|Physician Decision|1|||
48653901|NCT03062280|156588058|FG000|Overall Study|Adverse Event|1|||
48653902|NCT03062280|156588058|FG000|Overall Study|Death|1|||
48653903|NCT03062280|156588058|FG000|Overall Study|Fertility Treatment|2|||
48653904|NCT03062280|156588058|FG000|Overall Study|Physician Decision|2|||
48653905|NCT03062280|156588058|FG000|Overall Study|Pregnancy|5|||
48653906|NCT03062280|156588058|FG000|Overall Study|Withdrawal by Subject|11|||
48653907|NCT02003638|156588061|FG000|Overall Study|Withdrawal by Subject|1|||
48653908|NCT02003638|156588062|FG001|Overall Study|Withdrawal by Subject|0|||
48653909|NCT01289353|156588065|FG000|Overall Study|Lost to Follow-up|2|||
48653910|NCT02301546|156588068|FG000|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7|||
48653911|NCT02301546|156588069|FG001|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8|||
48653912|NCT02301546|156588068|FG000|Short-term Effectiveness (~13 Weeks)|non-compliant|10|||
48653913|NCT02301546|156588069|FG001|Short-term Effectiveness (~13 Weeks)|non-compliant|7|||
48753777|NCT01905657|156944319|FG000|Overall Study|Screen Failure|0|||
48753778|NCT01905657|156944320|FG001|Overall Study|Screen Failure|1|||
48753779|NCT01905657|156944321|FG002|Overall Study|Screen Failure|0|||
48753780|NCT01905657|156944319|FG000|Overall Study|Withdrawal by Subject|15|||
48753781|NCT01905657|156944320|FG001|Overall Study|Withdrawal by Subject|21|||
48753782|NCT01905657|156944321|FG002|Overall Study|Withdrawal by Subject|53|||
48753783|NCT01905657|156944319|FG000|Overall Study|Sponsor Decision|1|||
48753784|NCT01905657|156944320|FG001|Overall Study|Sponsor Decision|0|||
48753785|NCT01905657|156944321|FG002|Overall Study|Sponsor Decision|0|||
48753786|NCT04080297|156944322|FG000|Overall Study|Adverse Event|1|||
48753787|NCT04080297|156944323|FG001|Overall Study|Adverse Event|3|||
48753788|NCT04080297|156944322|FG000|Overall Study|concurrent illness|1|||
48960430|NCT04146467|157684179|FG000|Overall Study|Adverse Event|0|||
48960431|NCT04146467|157684180|FG001|Overall Study|Adverse Event|1|||
48960432|NCT04146467|157684179|FG000|Overall Study|Lost to Follow-up|0|||
48960433|NCT04146467|157684180|FG001|Overall Study|Lost to Follow-up|2|||
48960434|NCT01608724|157684184|FG000|Overall Study|Withdrawal by Subject|131|||
48960435|NCT01608724|157684184|FG000|Overall Study|Lost to Follow-up|41|||
48960436|NCT01608724|157684184|FG000|Overall Study|Study-specific discontinuation criteria|32|||
48960437|NCT01608724|157684184|FG000|Overall Study|Adverse Event|29|||
48960438|NCT01608724|157684184|FG000|Overall Study|Protocol Violation|6|||
48960439|NCT01608724|157684184|FG000|Overall Study|bood sugar too high, etc.|3|||
48653914|NCT02301546|156588068|FG000|Short-term Effectiveness (~13 Weeks)|screen fail|1|||
48653915|NCT02301546|156588069|FG001|Short-term Effectiveness (~13 Weeks)|screen fail|0|||
48653916|NCT02301546|156588068|FG000|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
48653917|NCT02301546|156588069|FG001|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
48653918|NCT02301546|156588068|FG000|Long Term Effectiveness (~1 Year)|Death|2|||
48653919|NCT02301546|156588069|FG001|Long Term Effectiveness (~1 Year)|Death|0|||
48653920|NCT02301546|156588068|FG000|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6|||
48653921|NCT02301546|156588069|FG001|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2|||
48653922|NCT02301546|156588068|FG000|Long Term Effectiveness (~1 Year)|moved away|1|||
48753789|NCT04080297|156944323|FG001|Overall Study|concurrent illness|0|||
48753790|NCT03915496|156944324|FG000|Overall Study|Adverse Event|2|||
48753791|NCT03915496|156944325|FG001|Overall Study|Adverse Event|1|||
48753792|NCT03915496|156944326|FG002|Overall Study|Adverse Event|2|||
48960440|NCT01608724|157684184|FG000|Overall Study|Safety reasons|1|||
48960441|NCT03970395|157684185|FG000|Overall Study|Withdrawal by Subject|3|||
48753793|NCT02663674|156944327|FG000|Overall Study|Lost to Follow-up|5|||
48653923|NCT02301546|156588069|FG001|Long Term Effectiveness (~1 Year)|moved away|2|||
48653924|NCT00433966|156588070|FG000|Pharmacology Intervention/Randomization|Withdrawal by Subject|40|||
48653925|NCT00433966|156588071|FG001|Pharmacology Intervention/Randomization|Withdrawal by Subject|43|||
48653926|NCT00433966|156588072|FG002|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
48653927|NCT00433966|156588073|FG003|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
48653928|NCT00433966|156588070|FG000|Pharmacology Intervention/Randomization|Lost to Follow-up|97|||
48653929|NCT00433966|156588071|FG001|Pharmacology Intervention/Randomization|Lost to Follow-up|103|||
48653930|NCT00433966|156588072|FG002|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
48653931|NCT00433966|156588073|FG003|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
48653932|NCT00433966|156588070|FG000|Pharmacology Intervention/Randomization|Not true myocardial infarction|29|||
48653933|NCT00433966|156588071|FG001|Pharmacology Intervention/Randomization|Not true myocardial infarction|28|||
48653934|NCT00433966|156588072|FG002|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
48653935|NCT00433966|156588073|FG003|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
48653936|NCT00433966|156588070|FG000|Stent Intervention/Randomization|Withdrawal by Subject|0|||
48653937|NCT00433966|156588071|FG001|Stent Intervention/Randomization|Withdrawal by Subject|0|||
48653938|NCT00433966|156588072|FG002|Stent Intervention/Randomization|Withdrawal by Subject|41|||
48653939|NCT00433966|156588073|FG003|Stent Intervention/Randomization|Withdrawal by Subject|15|||
48653940|NCT00433966|156588070|FG000|Stent Intervention/Randomization|Lost to Follow-up|0|||
48653941|NCT00433966|156588071|FG001|Stent Intervention/Randomization|Lost to Follow-up|0|||
48653942|NCT00433966|156588072|FG002|Stent Intervention/Randomization|Lost to Follow-up|113|||
48653943|NCT00433966|156588073|FG003|Stent Intervention/Randomization|Lost to Follow-up|47|||
48653944|NCT00853242|156588074|FG000|Overall Study|Adverse Event|0|||
48653945|NCT00853242|156588075|FG001|Overall Study|Adverse Event|1|||
48653946|NCT00853242|156588076|FG002|Overall Study|Adverse Event|1|||
48653947|NCT00853242|156588077|FG003|Overall Study|Adverse Event|0|||
48653948|NCT00853242|156588078|FG004|Overall Study|Adverse Event|3|||
48653949|NCT00853242|156588079|FG005|Overall Study|Adverse Event|1|||
48653950|NCT00853242|156588080|FG006|Overall Study|Adverse Event|1|||
48653951|NCT00853242|156588074|FG000|Overall Study|Noncompliant|0|||
48653952|NCT00853242|156588075|FG001|Overall Study|Noncompliant|0|||
48653953|NCT00853242|156588076|FG002|Overall Study|Noncompliant|0|||
48653954|NCT00853242|156588077|FG003|Overall Study|Noncompliant|0|||
48653955|NCT00853242|156588078|FG004|Overall Study|Noncompliant|1|||
48653956|NCT00853242|156588079|FG005|Overall Study|Noncompliant|0|||
48653957|NCT00853242|156588080|FG006|Overall Study|Noncompliant|0|||
48653958|NCT00853242|156588074|FG000|Overall Study|Withdrawal by Subject|1|||
48653959|NCT00853242|156588075|FG001|Overall Study|Withdrawal by Subject|2|||
48653960|NCT00853242|156588076|FG002|Overall Study|Withdrawal by Subject|0|||
48653961|NCT00853242|156588077|FG003|Overall Study|Withdrawal by Subject|4|||
48653962|NCT00853242|156588078|FG004|Overall Study|Withdrawal by Subject|0|||
48653963|NCT00853242|156588079|FG005|Overall Study|Withdrawal by Subject|0|||
48653964|NCT00853242|156588080|FG006|Overall Study|Withdrawal by Subject|2|||
48653965|NCT00853242|156588074|FG000|Overall Study|Other|2|||
48653966|NCT00853242|156588075|FG001|Overall Study|Other|0|||
48653967|NCT00853242|156588076|FG002|Overall Study|Other|2|||
48653968|NCT00853242|156588077|FG003|Overall Study|Other|0|||
48653969|NCT00853242|156588078|FG004|Overall Study|Other|0|||
48653970|NCT00853242|156588079|FG005|Overall Study|Other|1|||
48653971|NCT00853242|156588080|FG006|Overall Study|Other|2|||
48653972|NCT00441142|156588081|FG000|Overall Study|Adverse Event|2|||
48653973|NCT00441142|156588082|FG001|Overall Study|Adverse Event|3|||
48653974|NCT00441142|156588083|FG002|Overall Study|Adverse Event|3|||
48653975|NCT00441142|156588084|FG003|Overall Study|Adverse Event|22|||
48653976|NCT00441142|156588081|FG000|Overall Study|Lack of Efficacy|3|||
48653977|NCT00441142|156588082|FG001|Overall Study|Lack of Efficacy|3|||
48653978|NCT00441142|156588083|FG002|Overall Study|Lack of Efficacy|17|||
48653979|NCT00441142|156588084|FG003|Overall Study|Lack of Efficacy|32|||
48653980|NCT00441142|156588081|FG000|Overall Study|Withdrawal by Subject|0|||
48653981|NCT00441142|156588082|FG001|Overall Study|Withdrawal by Subject|0|||
48653982|NCT00441142|156588083|FG002|Overall Study|Withdrawal by Subject|2|||
48653983|NCT00441142|156588084|FG003|Overall Study|Withdrawal by Subject|10|||
48653984|NCT00441142|156588081|FG000|Overall Study|Patient still receiving active study tx|1|||
48653985|NCT00441142|156588082|FG001|Overall Study|Patient still receiving active study tx|0|||
48653986|NCT00441142|156588083|FG002|Overall Study|Patient still receiving active study tx|0|||
48653987|NCT00441142|156588084|FG003|Overall Study|Patient still receiving active study tx|2|||
48653988|NCT00441142|156588081|FG000|Overall Study|Physician Decision|0|||
48865580|NCT01032200|157343457|FG000|Overall Study|Progression|1|||
48653989|NCT00441142|156588082|FG001|Overall Study|Physician Decision|1|||
48653990|NCT00441142|156588083|FG002|Overall Study|Physician Decision|0|||
48653991|NCT00441142|156588084|FG003|Overall Study|Physician Decision|1|||
48653992|NCT00441142|156588081|FG000|Overall Study|Death|0|||
48653993|NCT00441142|156588082|FG001|Overall Study|Death|0|||
48653994|NCT00441142|156588083|FG002|Overall Study|Death|0|||
48653995|NCT00441142|156588084|FG003|Overall Study|Death|1|||
48653996|NCT00338286|156588085|FG000|Overall Study|Withdrawal by Subject|50|||
48653997|NCT00338286|156588086|FG001|Overall Study|Withdrawal by Subject|54|||
48653998|NCT00338286|156588085|FG000|Overall Study|Lost to Follow-up|80|||
48653999|NCT00338286|156588086|FG001|Overall Study|Lost to Follow-up|66|||
48654000|NCT00338286|156588085|FG000|Overall Study|Other|103|||
48960442|NCT03970395|157684186|FG001|Overall Study|Withdrawal by Subject|4|||
48960443|NCT03970395|157684185|FG000|Overall Study|Lost to Follow-up|4|||
48960444|NCT03970395|157684186|FG001|Overall Study|Lost to Follow-up|8|||
48654001|NCT00338286|156588086|FG001|Overall Study|Other|93|||
48654002|NCT00716482|156588087|FG000|Overall Study|Lost to Follow-up|6|||
48654003|NCT00716482|156588087|FG000|Overall Study|Inadequate acquisition or analysis|50|||
48654004|NCT00716482|156588087|FG000|Overall Study|no pathology obtained|10|||
48654005|NCT00716482|156588087|FG000|Overall Study|technical/machine error|28|||
48654006|NCT00716482|156588087|FG000|Overall Study|inclusion/exclusion criteria not met|25|||
48654007|NCT05286658|156588089|FG000|Overall Study|Head circumference too large for MEG scanner (exclusion criterion for the study).|1|||
48654008|NCT05286658|156588089|FG000|Overall Study|Participant did not show SIS (the dependent measure), thus the hypothesis could not be assessed|1|||
48654009|NCT00632827|156588090|FG000|Overall Study|Excluded after GVD (Not evaluable)|2|||
48654010|NCT00632827|156588090|FG000|Overall Study|Death|2|||
48654011|NCT00632827|156588090|FG000|Overall Study|Adverse Event|5|||
48654012|NCT00632827|156588090|FG000|Overall Study|Lost to Follow-up|1|||
48654013|NCT01126437|156588093|FG000|Overall Study|Not treated|11|||
48960445|NCT03731364|157684187|FG000|Overall Study|Adverse Event|0|||
48960446|NCT03731364|157684188|FG001|Overall Study|Adverse Event|0|||
48960447|NCT03731364|157684189|FG002|Overall Study|Adverse Event|1|||
48960448|NCT03731364|157684190|FG003|Overall Study|Adverse Event|2|||
48654014|NCT01126437|156588094|FG001|Overall Study|Not treated|18|||
48654015|NCT01126437|156588095|FG002|Overall Study|Not treated|19|||
48654016|NCT01126437|156588093|FG000|Overall Study|Sites with data irregularities/fraud|6|||
48654017|NCT01126437|156588094|FG001|Overall Study|Sites with data irregularities/fraud|6|||
48654018|NCT01126437|156588095|FG002|Overall Study|Sites with data irregularities/fraud|7|||
48654019|NCT01126437|156588093|FG000|Overall Study|Adverse Event|602|||
48654020|NCT01126437|156588094|FG001|Overall Study|Adverse Event|606|||
48654021|NCT01126437|156588095|FG002|Overall Study|Adverse Event|635|||
48654022|NCT01126437|156588093|FG000|Overall Study|Lack of Efficacy|65|||
48654023|NCT01126437|156588094|FG001|Overall Study|Lack of Efficacy|60|||
48654024|NCT01126437|156588095|FG002|Overall Study|Lack of Efficacy|59|||
48654025|NCT01126437|156588093|FG000|Overall Study|Protocol Violation|64|||
48654026|NCT01126437|156588094|FG001|Overall Study|Protocol Violation|66|||
48654027|NCT01126437|156588095|FG002|Overall Study|Protocol Violation|41|||
48654028|NCT01126437|156588093|FG000|Overall Study|Lost to Follow-up|52|||
48654029|NCT01126437|156588094|FG001|Overall Study|Lost to Follow-up|63|||
48654030|NCT01126437|156588095|FG002|Overall Study|Lost to Follow-up|55|||
48654031|NCT01126437|156588093|FG000|Overall Study|Withdrawal by Subject|331|||
48654032|NCT01126437|156588094|FG001|Overall Study|Withdrawal by Subject|335|||
48654033|NCT01126437|156588095|FG002|Overall Study|Withdrawal by Subject|319|||
48654034|NCT01126437|156588093|FG000|Overall Study|Other reason not specified|210|||
48654035|NCT01126437|156588094|FG001|Overall Study|Other reason not specified|176|||
48654036|NCT01126437|156588095|FG002|Overall Study|Other reason not specified|178|||
48654037|NCT02256384|156588098|FG000|Overall Study|Withdrawal by Subject|12|||
48654038|NCT02256384|156588098|FG000|Overall Study|Equipment not capturing data|2|||
48654039|NCT00842153|156588108|FG000|Overall Study|Adverse Event|0|||
48654040|NCT00842153|156588109|FG001|Overall Study|Adverse Event|1|||
48654041|NCT00842153|156588108|FG000|Overall Study|Lost to Follow-up|1|||
48654042|NCT00842153|156588109|FG001|Overall Study|Lost to Follow-up|2|||
48960449|NCT03731364|157684191|FG004|Overall Study|Adverse Event|1|||
48960450|NCT00125190|157684193|FG000|Overall Study|Subject/Parent Decision|7|||
48960451|NCT00125190|157684193|FG000|Overall Study|Non-compliance|2|||
48960452|NCT00125190|157684193|FG000|Overall Study|Adverse Event|1|||
48960453|NCT00125190|157684193|FG000|Overall Study|Other|1|||
48654043|NCT01071252|156588112|FG000|Overall Study|unsatisfactory therapeutic effect|4|||
48960454|NCT00125190|157684193|FG000|Overall Study|Lost to Follow-up|4|||
48960455|NCT02940626|157684194|FG000|Overall Study|Death|40|||
48960456|NCT02940626|157684195|FG001|Overall Study|Death|32|||
48960457|NCT02940626|157684194|FG000|Overall Study|Lost to Follow-up|5|||
48654044|NCT01071252|156588113|FG001|Overall Study|unsatisfactory therapeutic effect|6|||
48960458|NCT02940626|157684195|FG001|Overall Study|Lost to Follow-up|2|||
48654045|NCT01071252|156588114|FG002|Overall Study|unsatisfactory therapeutic effect|2|||
48654046|NCT01071252|156588115|FG003|Overall Study|unsatisfactory therapeutic effect|0|||
48654047|NCT01071252|156588116|FG004|Overall Study|unsatisfactory therapeutic effect|6|||
48654048|NCT01071252|156588112|FG000|Overall Study|Withdrawal by Subject|8|||
48654049|NCT01071252|156588113|FG001|Overall Study|Withdrawal by Subject|2|||
48753794|NCT02663674|156944328|FG001|Overall Study|Lost to Follow-up|4|||
48654050|NCT01071252|156588114|FG002|Overall Study|Withdrawal by Subject|1|||
48753795|NCT02663674|156944327|FG000|Overall Study|Withdrawal by Subject|1|||
48654051|NCT01071252|156588115|FG003|Overall Study|Withdrawal by Subject|2|||
48753796|NCT02663674|156944328|FG001|Overall Study|Withdrawal by Subject|4|||
48960459|NCT02940626|157684194|FG000|Overall Study|Withdrawal by Subject|1|||
48654052|NCT01071252|156588116|FG004|Overall Study|Withdrawal by Subject|3|||
48654053|NCT01071252|156588112|FG000|Overall Study|administrative problems|1|||
48654054|NCT01071252|156588113|FG001|Overall Study|administrative problems|1|||
48654055|NCT01071252|156588114|FG002|Overall Study|administrative problems|0|||
48654056|NCT01071252|156588115|FG003|Overall Study|administrative problems|2|||
48654057|NCT01071252|156588116|FG004|Overall Study|administrative problems|1|||
48654058|NCT01071252|156588112|FG000|Overall Study|Lost to Follow-up|1|||
48654059|NCT01071252|156588113|FG001|Overall Study|Lost to Follow-up|0|||
48654060|NCT01071252|156588114|FG002|Overall Study|Lost to Follow-up|1|||
48654061|NCT01071252|156588115|FG003|Overall Study|Lost to Follow-up|2|||
48654062|NCT01071252|156588116|FG004|Overall Study|Lost to Follow-up|0|||
48654063|NCT01071252|156588112|FG000|Overall Study|Adverse Event|1|||
48654064|NCT01071252|156588113|FG001|Overall Study|Adverse Event|1|||
48654065|NCT01071252|156588114|FG002|Overall Study|Adverse Event|0|||
48654066|NCT01071252|156588115|FG003|Overall Study|Adverse Event|1|||
48654067|NCT01071252|156588116|FG004|Overall Study|Adverse Event|0|||
48654068|NCT01071252|156588112|FG000|Overall Study|Death|0|||
48654069|NCT01071252|156588113|FG001|Overall Study|Death|0|||
48654070|NCT01071252|156588114|FG002|Overall Study|Death|0|||
48654071|NCT01071252|156588115|FG003|Overall Study|Death|0|||
48654072|NCT01071252|156588116|FG004|Overall Study|Death|1|||
48654073|NCT00712725|156588121|FG000|Overall Study|Adverse Event|1|||
48654074|NCT00712725|156588122|FG001|Overall Study|Adverse Event|0|||
48654075|NCT00712725|156588123|FG002|Overall Study|Adverse Event|0|||
48654076|NCT00712725|156588124|FG003|Overall Study|Adverse Event|1|||
48753797|NCT02663674|156944327|FG000|Overall Study|Physician Decision|1|||
48753798|NCT02663674|156944328|FG001|Overall Study|Physician Decision|1|||
48753799|NCT02663674|156944327|FG000|Overall Study|Other Event (Health Related)|0|||
48960460|NCT02940626|157684195|FG001|Overall Study|Withdrawal by Subject|0|||
48960461|NCT02940626|157684194|FG000|Overall Study|Transfer to Hospice Care|1|||
48960462|NCT02940626|157684195|FG001|Overall Study|Transfer to Hospice Care|0|||
48753800|NCT02663674|156944328|FG001|Overall Study|Other Event (Health Related)|1|||
48960463|NCT02940626|157684194|FG000|Overall Study|Prohibited Concomitant Medication|0|||
48960464|NCT02940626|157684195|FG001|Overall Study|Prohibited Concomitant Medication|1|||
48960465|NCT02128763|157684196|FG000|Overall Study|Death|1|||
48960466|NCT02128763|157684197|FG001|Overall Study|Death|0|||
48960467|NCT02128763|157684196|FG000|Overall Study|Lost to Follow-up|19|||
48960468|NCT02128763|157684197|FG001|Overall Study|Lost to Follow-up|16|||
48960469|NCT01996904|157684200|FG000|Overall Study|Lost to Follow-up|38|||
48960470|NCT01996904|157684201|FG001|Overall Study|Lost to Follow-up|27|||
48960471|NCT03245723|157684202|FG000|Overall Study|Bigeminy precluding hypoxia exposure|1|||
48960472|NCT03245723|157684203|FG001|Overall Study|Bigeminy precluding hypoxia exposure|0|||
48960473|NCT03245723|157684202|FG000|Overall Study|Claustrophobia from wearing the mask|1|||
48960474|NCT03245723|157684203|FG001|Overall Study|Claustrophobia from wearing the mask|0|||
48960475|NCT03245723|157684202|FG000|Overall Study|Having to abruptly stop the scan to use the restroom|2|||
48960476|NCT03245723|157684203|FG001|Overall Study|Having to abruptly stop the scan to use the restroom|0|||
48960477|NCT03245723|157684202|FG000|Overall Study|Image acquisition/reconstruction failure|1|||
48960478|NCT03245723|157684203|FG001|Overall Study|Image acquisition/reconstruction failure|1|||
48960479|NCT00916370|157684205|FG000|Overall Study|Death|3|||
48960480|NCT00916370|157684206|FG001|Overall Study|Death|1|||
48753801|NCT00512707|156944329|FG000|Overall Study|Lost to Follow-up|5|||
48753802|NCT00512707|156944330|FG001|Overall Study|Lost to Follow-up|11|||
48753803|NCT00512707|156944329|FG000|Overall Study|Developed skin irritation|2|||
48753804|NCT00512707|156944330|FG001|Overall Study|Developed skin irritation|1|||
48753805|NCT00512707|156944329|FG000|Overall Study|Developed a hematocrit exceeding 0.54|2|||
48753806|NCT00512707|156944330|FG001|Overall Study|Developed a hematocrit exceeding 0.54|0|||
48753807|NCT00512707|156944329|FG000|Overall Study|Unable to tolerate the smell of the gel|1|||
48753808|NCT00512707|156944330|FG001|Overall Study|Unable to tolerate the smell of the gel|0|||
48753809|NCT00848081|156946528|FG000|Overall Study|Adverse Event|6|||
48753810|NCT00848081|156946529|FG001|Overall Study|Adverse Event|7|||
48753811|NCT00848081|156946528|FG000|Overall Study|Protocol Violation|8|||
48753812|NCT00848081|156946529|FG001|Overall Study|Protocol Violation|5|||
48960481|NCT00916370|157684205|FG000|Overall Study|Withdrawal by Subject|2|||
48960482|NCT00916370|157684206|FG001|Overall Study|Withdrawal by Subject|0|||
48753813|NCT00848081|156946528|FG000|Overall Study|Lost to Follow-up|1|||
48753814|NCT00848081|156946529|FG001|Overall Study|Lost to Follow-up|0|||
48753815|NCT00848081|156946528|FG000|Overall Study|Physician Decision|0|||
48753816|NCT00848081|156946529|FG001|Overall Study|Physician Decision|3|||
48753817|NCT00848081|156946528|FG000|Overall Study|Withdrawal by Subject|5|||
48960483|NCT00916370|157684205|FG000|Overall Study|Physician Decision|0|||
48960484|NCT00916370|157684206|FG001|Overall Study|Physician Decision|1|||
48654077|NCT00712725|156588125|FG004|Overall Study|Adverse Event|0|||
48654078|NCT00712725|156588126|FG005|Overall Study|Adverse Event|0|||
48654079|NCT00712725|156588127|FG006|Overall Study|Adverse Event|0|||
48654080|NCT00712725|156588128|FG007|Overall Study|Adverse Event|0|||
48654081|NCT00712725|156588121|FG000|Overall Study|Lost to Follow-up|3|||
48753818|NCT00848081|156946529|FG001|Overall Study|Withdrawal by Subject|3|||
48960485|NCT05554471|157684207|FG000|Overall Study|Physician Decision|2|||
48960486|NCT05554471|157684208|FG001|Overall Study|Physician Decision|1|||
48960487|NCT05554471|157684207|FG000|Overall Study|Lost to Follow-up|2|||
48960488|NCT05554471|157684208|FG001|Overall Study|Lost to Follow-up|1|||
48960489|NCT05554471|157684207|FG000|Overall Study|Death|0|||
48960490|NCT05554471|157684208|FG001|Overall Study|Death|1|||
48960491|NCT02938585|157684209|FG000|Overall Study|Withdrawal by parent or guardian|0|||
48960492|NCT02938585|157684210|FG001|Overall Study|Withdrawal by parent or guardian|1|||
48960493|NCT02938585|157684211|FG002|Overall Study|Withdrawal by parent or guardian|0|||
48960494|NCT02938585|157684212|FG003|Overall Study|Withdrawal by parent or guardian|0|||
48960495|NCT02938585|157684209|FG000|Overall Study|Withdrawal by Subject|0|||
48960496|NCT02938585|157684210|FG001|Overall Study|Withdrawal by Subject|0|||
48960497|NCT02938585|157684211|FG002|Overall Study|Withdrawal by Subject|0|||
48960498|NCT02938585|157684212|FG003|Overall Study|Withdrawal by Subject|5|||
48960499|NCT01737840|157684213|FG000|Overall Study|Diagnosed with an other pathology|2|||
48960500|NCT01737840|157684214|FG001|Overall Study|Diagnosed with an other pathology|2|||
48960501|NCT01189435|157684216|FG000|Overall Study|Withdrawal by Subject|1|||
48960502|NCT01189435|157684216|FG000|Overall Study|Physician Decision|1|||
48960503|NCT02357849|157684217|FG000|Overall Study|Withdrawal by Subject|2|||
48960504|NCT02357849|157684218|FG001|Overall Study|Withdrawal by Subject|3|||
48960505|NCT00403559|157684221|FG000|Overall Study|Adverse Event|0|||
48960506|NCT00403559|157684222|FG001|Overall Study|Adverse Event|1|||
48960507|NCT00403559|157684221|FG000|Overall Study|Lost to Follow-up|3|||
48960508|NCT00403559|157684222|FG001|Overall Study|Lost to Follow-up|3|||
48654082|NCT00712725|156588122|FG001|Overall Study|Lost to Follow-up|2|||
48654083|NCT00712725|156588123|FG002|Overall Study|Lost to Follow-up|1|||
48654084|NCT00712725|156588124|FG003|Overall Study|Lost to Follow-up|1|||
48654085|NCT00712725|156588125|FG004|Overall Study|Lost to Follow-up|2|||
48654086|NCT00712725|156588126|FG005|Overall Study|Lost to Follow-up|2|||
48654087|NCT00712725|156588127|FG006|Overall Study|Lost to Follow-up|3|||
48654088|NCT00712725|156588128|FG007|Overall Study|Lost to Follow-up|1|||
48865581|NCT01032200|157343458|FG001|Overall Study|Progression|0|||
48865582|NCT01032200|157343457|FG000|Overall Study|Multiple|1|||
48865583|NCT01032200|157343458|FG001|Overall Study|Multiple|1|||
48865584|NCT01568112|157343462|FG000|Overall Study|Randomized But Not Treated|0|||
48865585|NCT01568112|157343463|FG001|Overall Study|Randomized But Not Treated|1|||
48865586|NCT01568112|157343464|FG002|Overall Study|Randomized But Not Treated|0|||
48865587|NCT01568112|157343465|FG003|Overall Study|Randomized But Not Treated|0|||
48865588|NCT01568112|157343462|FG000|Overall Study|Withdrew due to Adverse Event|2|||
48865589|NCT01568112|157343463|FG001|Overall Study|Withdrew due to Adverse Event|4|||
48865590|NCT01568112|157343464|FG002|Overall Study|Withdrew due to Adverse Event|6|||
48865591|NCT01568112|157343465|FG003|Overall Study|Withdrew due to Adverse Event|3|||
48865592|NCT01568112|157343462|FG000|Overall Study|Lost to Follow-up|0|||
48865593|NCT01568112|157343463|FG001|Overall Study|Lost to Follow-up|0|||
48865594|NCT01568112|157343464|FG002|Overall Study|Lost to Follow-up|0|||
48865595|NCT01568112|157343465|FG003|Overall Study|Lost to Follow-up|1|||
48865596|NCT01568112|157343462|FG000|Overall Study|Withdrawal by Subject|2|||
48865597|NCT01568112|157343463|FG001|Overall Study|Withdrawal by Subject|3|||
48865598|NCT01568112|157343464|FG002|Overall Study|Withdrawal by Subject|0|||
48865599|NCT01568112|157343465|FG003|Overall Study|Withdrawal by Subject|7|||
48865600|NCT01568112|157343462|FG000|Overall Study|Withdrawal by Physician|1|||
48865601|NCT01568112|157343463|FG001|Overall Study|Withdrawal by Physician|0|||
48865602|NCT01568112|157343464|FG002|Overall Study|Withdrawal by Physician|1|||
48865603|NCT01568112|157343465|FG003|Overall Study|Withdrawal by Physician|1|||
48865604|NCT00645099|157343466|FG000|Overall Study|Lack of Efficacy|15|||
48865605|NCT00645099|157343467|FG001|Overall Study|Lack of Efficacy|6|||
48865606|NCT00645099|157343466|FG000|Overall Study|Withdrawal by Subject|30|||
48865607|NCT00645099|157343467|FG001|Overall Study|Withdrawal by Subject|22|||
48865608|NCT00645099|157343466|FG000|Overall Study|Lost to Follow-up|6|||
48865609|NCT00645099|157343467|FG001|Overall Study|Lost to Follow-up|4|||
48865610|NCT00645099|157343466|FG000|Overall Study|Adverse Event|11|||
48865611|NCT00645099|157343467|FG001|Overall Study|Adverse Event|5|||
48865612|NCT00645099|157343466|FG000|Overall Study|Other|9|||
48865613|NCT00645099|157343467|FG001|Overall Study|Other|5|||
48865614|NCT04372186|157343469|FG000|Overall Study|Death|24|||
48865615|NCT04372186|157343470|FG001|Overall Study|Death|11|||
48865616|NCT04372186|157343469|FG000|Overall Study|Transferred to a different facility for care|0|||
48865617|NCT04372186|157343470|FG001|Overall Study|Transferred to a different facility for care|2|||
48865618|NCT02785900|157343471|FG000|Overall Study|Study Termination by Sponsor|64|||
48865619|NCT02785900|157343472|FG001|Overall Study|Study Termination by Sponsor|81|||
48865620|NCT02785900|157343471|FG000|Overall Study|Death|46|||
48865621|NCT02785900|157343472|FG001|Overall Study|Death|32|||
48865622|NCT02785900|157343471|FG000|Overall Study|Withdrawal by Subject|4|||
48865623|NCT02785900|157343472|FG001|Overall Study|Withdrawal by Subject|8|||
48865624|NCT02785900|157343471|FG000|Overall Study|Physician Decision|3|||
48960509|NCT00403559|157684221|FG000|Overall Study|Withdrawal by Subject|1|||
48654089|NCT00712725|156588121|FG000|Overall Study|Physician Decision|2|||
48654090|NCT00712725|156588122|FG001|Overall Study|Physician Decision|0|||
48960510|NCT00403559|157684222|FG001|Overall Study|Withdrawal by Subject|0|||
48654091|NCT00712725|156588123|FG002|Overall Study|Physician Decision|0|||
48654092|NCT00712725|156588124|FG003|Overall Study|Physician Decision|0|||
48654093|NCT00712725|156588125|FG004|Overall Study|Physician Decision|1|||
48654094|NCT00712725|156588126|FG005|Overall Study|Physician Decision|0|||
48654095|NCT00712725|156588127|FG006|Overall Study|Physician Decision|2|||
48654096|NCT00712725|156588128|FG007|Overall Study|Physician Decision|0|||
48654097|NCT00712725|156588121|FG000|Overall Study|Pregnancy|0|||
48654098|NCT00712725|156588122|FG001|Overall Study|Pregnancy|1|||
48654099|NCT00712725|156588123|FG002|Overall Study|Pregnancy|0|||
48654100|NCT00712725|156588124|FG003|Overall Study|Pregnancy|0|||
48654101|NCT00712725|156588125|FG004|Overall Study|Pregnancy|1|||
48654102|NCT00712725|156588126|FG005|Overall Study|Pregnancy|0|||
48654103|NCT00712725|156588127|FG006|Overall Study|Pregnancy|2|||
48654104|NCT00712725|156588128|FG007|Overall Study|Pregnancy|0|||
48753819|NCT02899988|156946533|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
48753820|NCT02899988|156946534|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
48753821|NCT02899988|156946535|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
48753822|NCT02899988|156946536|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
48753823|NCT02899988|156946537|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
48753824|NCT02899988|156946538|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
48753825|NCT02899988|156946539|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
48753826|NCT02899988|156946540|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
48753827|NCT02899988|156946541|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
48753828|NCT02899988|156946542|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
48753829|NCT02899988|156946543|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
48753830|NCT02899988|156946533|FG000|Induction Period (16 Weeks)|Adverse Event|0|||
48753831|NCT02899988|156946534|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
48753832|NCT02899988|156946535|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
48753833|NCT02899988|156946536|FG003|Induction Period (16 Weeks)|Adverse Event|2|||
48753834|NCT02899988|156946537|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
48753835|NCT02899988|156946538|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
48753836|NCT02899988|156946539|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
48753837|NCT02899988|156946540|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
48654105|NCT00712725|156588121|FG000|Overall Study|Protocol Violation|2|||
48654106|NCT00712725|156588122|FG001|Overall Study|Protocol Violation|0|||
48654107|NCT00712725|156588123|FG002|Overall Study|Protocol Violation|1|||
48654108|NCT00712725|156588124|FG003|Overall Study|Protocol Violation|3|||
48654109|NCT00712725|156588125|FG004|Overall Study|Protocol Violation|2|||
48654110|NCT00712725|156588126|FG005|Overall Study|Protocol Violation|0|||
48865625|NCT02785900|157343472|FG001|Overall Study|Physician Decision|2|||
48865626|NCT01808144|157343473|FG000|Overall Study|Death|1|||
48865627|NCT01808144|157343474|FG001|Overall Study|Death|0|||
48865628|NCT01808144|157343473|FG000|Overall Study|Withdrawal by Subject|16|||
48865629|NCT01808144|157343474|FG001|Overall Study|Withdrawal by Subject|23|||
48865630|NCT01808144|157343473|FG000|Overall Study|Lost to Follow-up|6|||
48865631|NCT01808144|157343474|FG001|Overall Study|Lost to Follow-up|3|||
48865632|NCT01808144|157343473|FG000|Overall Study|Protocol Violation|6|||
48865633|NCT01808144|157343474|FG001|Overall Study|Protocol Violation|6|||
48865634|NCT01808144|157343473|FG000|Overall Study|Gout flare|0|||
48865635|NCT01808144|157343474|FG001|Overall Study|Gout flare|1|||
48865636|NCT01808144|157343473|FG000|Overall Study|Adverse Event|11|||
48865637|NCT01808144|157343474|FG001|Overall Study|Adverse Event|15|||
48865638|NCT00230971|157343478|FG000|Randomization|No study drug administered|3|||
48865639|NCT00230971|157343479|FG001|Randomization|No study drug administered|3|||
48865640|NCT00230971|157343478|FG000|Baseline Participants|Lost to Follow-up|5|||
48865641|NCT00230971|157343479|FG001|Baseline Participants|Lost to Follow-up|12|||
48865642|NCT00230971|157343478|FG000|Baseline Participants|Death|6|||
48865643|NCT00230971|157343479|FG001|Baseline Participants|Death|5|||
48865644|NCT00230971|157343478|FG000|Baseline Participants|Withdrawal by Subject|7|||
48865645|NCT00230971|157343479|FG001|Baseline Participants|Withdrawal by Subject|1|||
48865646|NCT00230971|157343478|FG000|Baseline Participants|Adverse Event|1|||
48865647|NCT00230971|157343479|FG001|Baseline Participants|Adverse Event|0|||
48865648|NCT00230971|157343478|FG000|Baseline Participants|No bacteria observed|1|||
48865649|NCT00230971|157343479|FG001|Baseline Participants|No bacteria observed|0|||
48865650|NCT00230971|157343478|FG000|Baseline Participants|Failure to return|1|||
48865651|NCT00230971|157343479|FG001|Baseline Participants|Failure to return|1|||
48865652|NCT00230971|157343478|FG000|Baseline Participants|Reintervention|1|||
48654111|NCT00712725|156588127|FG006|Overall Study|Protocol Violation|1|||
48654112|NCT00712725|156588128|FG007|Overall Study|Protocol Violation|1|||
48654113|NCT00712725|156588121|FG000|Overall Study|Withdrawal by Subject|2|||
48654114|NCT00712725|156588122|FG001|Overall Study|Withdrawal by Subject|1|||
48654115|NCT00712725|156588123|FG002|Overall Study|Withdrawal by Subject|1|||
48654116|NCT00712725|156588124|FG003|Overall Study|Withdrawal by Subject|2|||
48654117|NCT00712725|156588125|FG004|Overall Study|Withdrawal by Subject|1|||
48654118|NCT00712725|156588126|FG005|Overall Study|Withdrawal by Subject|1|||
48865653|NCT00230971|157343479|FG001|Baseline Participants|Reintervention|0|||
48865654|NCT03749616|157343480|FG000|Overall Study|Lost to Follow-up|4|||
48865655|NCT03749616|157343481|FG001|Overall Study|Lost to Follow-up|7|||
48865656|NCT03749616|157343480|FG000|Overall Study|Screen Failure|1|||
48865657|NCT03749616|157343481|FG001|Overall Study|Screen Failure|1|||
48865658|NCT03749616|157343480|FG000|Overall Study|Withdrawal by Subject|2|||
48865659|NCT03749616|157343481|FG001|Overall Study|Withdrawal by Subject|0|||
48865660|NCT04491136|157343485|FG000|Overall Study|Patient withdraw informed consent|9|||
48865661|NCT04491136|157343485|FG000|Overall Study|Adverse Event|2|||
48865662|NCT04491136|157343485|FG000|Overall Study|Death|3|||
48865663|NCT04491136|157343485|FG000|Overall Study|Lost to Follow-up|3|||
48865664|NCT04491136|157343485|FG000|Overall Study|Physician Decision|45|||
48865665|NCT04491136|157343485|FG000|Overall Study|sponsor terminated the study early|16|||
48865666|NCT04491136|157343485|FG000|Overall Study|Patient/guardian's decision|1|||
48865667|NCT00705614|157345547|FG000|Initial Intervention|Adverse Event|40|||
48865668|NCT00705614|157345548|FG001|Initial Intervention|Adverse Event|21|||
48865669|NCT00705614|157345547|FG000|Initial Intervention|Lost to Follow-up|310|||
48654119|NCT00712725|156588127|FG006|Overall Study|Withdrawal by Subject|1|||
48865670|NCT00705614|157345548|FG001|Initial Intervention|Lost to Follow-up|191|||
48865671|NCT00705614|157345547|FG000|Initial Intervention|Withdrawal by Subject|114|||
48865672|NCT00705614|157345548|FG001|Initial Intervention|Withdrawal by Subject|71|||
48865673|NCT00705614|157345547|FG000|Initial Intervention|Administrative Reason|51|||
48865674|NCT00705614|157345548|FG001|Initial Intervention|Administrative Reason|38|||
48865675|NCT00705614|157345547|FG000|Initial Intervention|Status completion unknown|3|||
48865676|NCT00705614|157345548|FG001|Initial Intervention|Status completion unknown|0|||
48865677|NCT00705614|157345547|FG000|Switch to Remicade|Adverse Event|0|||
48865678|NCT00705614|157345548|FG001|Switch to Remicade|Adverse Event|5|||
48865679|NCT00705614|157345547|FG000|Switch to Remicade|Lost to Follow-up|0|||
48865680|NCT00705614|157345548|FG001|Switch to Remicade|Lost to Follow-up|23|||
48865681|NCT00705614|157345547|FG000|Switch to Remicade|Withdrawal by Subject|0|||
48865682|NCT00705614|157345548|FG001|Switch to Remicade|Withdrawal by Subject|12|||
48865683|NCT00705614|157345547|FG000|Switch to Remicade|Administrative Reason|0|||
48865684|NCT00705614|157345548|FG001|Switch to Remicade|Administrative Reason|9|||
48865685|NCT02878590|157345549|FG000|Overall Study|Withdrawal by Subject|2|||
48865686|NCT01730118|157345550|FG000|Dose Escalation|Death on study|5|||
48865687|NCT01730118|157345551|FG001|Dose Escalation|Death on study|7|||
48865688|NCT01730118|157345552|FG002|Dose Escalation|Death on study|2|||
48865689|NCT01730118|157345553|FG003|Dose Escalation|Death on study|6|||
48865690|NCT01730118|157345554|FG004|Dose Escalation|Death on study|0|||
48865691|NCT01730118|157345555|FG005|Dose Escalation|Death on study|0|||
48865692|NCT01730118|157345556|FG006|Dose Escalation|Death on study|0|||
48865693|NCT01730118|157345550|FG000|Dose Escalation|Died before treatment|0|||
48865694|NCT01730118|157345551|FG001|Dose Escalation|Died before treatment|0|||
48865695|NCT01730118|157345552|FG002|Dose Escalation|Died before treatment|0|||
48865696|NCT01730118|157345553|FG003|Dose Escalation|Died before treatment|0|||
48865697|NCT01730118|157345554|FG004|Dose Escalation|Died before treatment|0|||
48865698|NCT01730118|157345555|FG005|Dose Escalation|Died before treatment|0|||
48865699|NCT01730118|157345556|FG006|Dose Escalation|Died before treatment|1|||
48865700|NCT01730118|157345550|FG000|Dose Escalation|Chose to start a different treatment|1|||
48865701|NCT01730118|157345551|FG001|Dose Escalation|Chose to start a different treatment|0|||
48654120|NCT00712725|156588128|FG007|Overall Study|Withdrawal by Subject|2|||
48654121|NCT00712725|156588121|FG000|Overall Study|Lack of Qualifying Event|16|||
48654122|NCT00712725|156588122|FG001|Overall Study|Lack of Qualifying Event|2|||
48654123|NCT00712725|156588123|FG002|Overall Study|Lack of Qualifying Event|6|||
48654124|NCT00712725|156588124|FG003|Overall Study|Lack of Qualifying Event|8|||
48654125|NCT00712725|156588125|FG004|Overall Study|Lack of Qualifying Event|11|||
48654126|NCT00712725|156588126|FG005|Overall Study|Lack of Qualifying Event|13|||
48654127|NCT00712725|156588127|FG006|Overall Study|Lack of Qualifying Event|11|||
48654128|NCT00712725|156588128|FG007|Overall Study|Lack of Qualifying Event|6|||
48654129|NCT00712725|156588121|FG000|Overall Study|Protocol Specified Criteria|3|||
48654130|NCT00712725|156588122|FG001|Overall Study|Protocol Specified Criteria|0|||
48654131|NCT00712725|156588123|FG002|Overall Study|Protocol Specified Criteria|1|||
48654132|NCT00712725|156588124|FG003|Overall Study|Protocol Specified Criteria|2|||
48654133|NCT00712725|156588125|FG004|Overall Study|Protocol Specified Criteria|1|||
48654134|NCT00712725|156588126|FG005|Overall Study|Protocol Specified Criteria|0|||
48654135|NCT00712725|156588127|FG006|Overall Study|Protocol Specified Criteria|2|||
48654136|NCT00712725|156588128|FG007|Overall Study|Protocol Specified Criteria|1|||
48654137|NCT02120300|156588129|FG000|Overall Study|Enrolled but Never Treated|2|||
48654138|NCT02120300|156588130|FG001|Overall Study|Enrolled but Never Treated|0|||
48654139|NCT02120300|156588131|FG002|Overall Study|Enrolled but Never Treated|0|||
48654140|NCT02120300|156588132|FG003|Overall Study|Enrolled but Never Treated|0|||
48654141|NCT02120300|156588129|FG000|Overall Study|Lack of Efficacy|0|||
48654142|NCT02120300|156588130|FG001|Overall Study|Lack of Efficacy|0|||
48654143|NCT02120300|156588131|FG002|Overall Study|Lack of Efficacy|0|||
48654144|NCT02120300|156588132|FG003|Overall Study|Lack of Efficacy|1|||
48654145|NCT02120300|156588129|FG000|Overall Study|Lost to Follow-up|1|||
48654146|NCT02120300|156588130|FG001|Overall Study|Lost to Follow-up|0|||
48960511|NCT01253421|157684223|FG000|Assessment and Scheduling|Found to be Ineligible|74|||
48960512|NCT01253421|157684224|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
48960513|NCT01253421|157684225|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
48960514|NCT01253421|157684226|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
48960515|NCT01253421|157684227|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
48960516|NCT01253421|157684223|FG000|Assessment and Scheduling|Lost to Follow-up|17|||
48960517|NCT01253421|157684224|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
48960518|NCT01253421|157684225|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
48960519|NCT01253421|157684226|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
48960520|NCT01253421|157684227|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
48960521|NCT01253421|157684223|FG000|Assessment and Scheduling|Withdrawal by Subject|7|||
48960522|NCT01253421|157684224|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
48960523|NCT01253421|157684225|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
48960524|NCT01253421|157684226|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
48960525|NCT01253421|157684227|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
48960526|NCT01253421|157684223|FG000|Assessment and Scheduling|Physician Decision|1|||
48960527|NCT01253421|157684224|FG001|Assessment and Scheduling|Physician Decision|0|||
48654147|NCT02120300|156588131|FG002|Overall Study|Lost to Follow-up|0|||
48960528|NCT01253421|157684225|FG002|Assessment and Scheduling|Physician Decision|0|||
48960529|NCT01253421|157684226|FG003|Assessment and Scheduling|Physician Decision|0|||
48960530|NCT01253421|157684227|FG004|Assessment and Scheduling|Physician Decision|0|||
48960531|NCT01253421|157684223|FG000|Drug+Scanning Visit|Physician Decision|0|||
48960532|NCT01253421|157684224|FG001|Drug+Scanning Visit|Physician Decision|0|||
48960533|NCT01253421|157684225|FG002|Drug+Scanning Visit|Physician Decision|0|||
48654148|NCT02120300|156588132|FG003|Overall Study|Lost to Follow-up|0|||
48654149|NCT01302834|156588133|FG000|Overall Study|Protocol Violation|17|||
48654150|NCT01302834|156588134|FG001|Overall Study|Protocol Violation|23|||
48654151|NCT01302834|156588133|FG000|Overall Study|HIV positive|1|||
48654152|NCT01302834|156588134|FG001|Overall Study|HIV positive|3|||
48654153|NCT02680041|156588142|FG000|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8|||
48654154|NCT02680041|156588142|FG000|Overall Study|Lost to Follow-up|2|||
48654155|NCT01639339|156588148|FG000|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26|||
48654156|NCT01639339|156588149|FG001|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19|||
48654157|NCT01639339|156588148|FG000|Double-blind Period (Up to Week 104)|Physician Decision|11|||
48654158|NCT01639339|156588149|FG001|Double-blind Period (Up to Week 104)|Physician Decision|5|||
48654159|NCT01639339|156588148|FG000|Double-blind Period (Up to Week 104)|Lost to Follow-up|5|||
48654160|NCT01639339|156588149|FG001|Double-blind Period (Up to Week 104)|Lost to Follow-up|4|||
48654161|NCT01639339|156588148|FG000|Double-blind Period (Up to Week 104)|Protocol Violation|0|||
48654162|NCT01639339|156588149|FG001|Double-blind Period (Up to Week 104)|Protocol Violation|2|||
48654163|NCT01639339|156588148|FG000|Double-blind Period (Up to Week 104)|Lack of Efficacy|2|||
48654164|NCT01639339|156588149|FG001|Double-blind Period (Up to Week 104)|Lack of Efficacy|1|||
48654165|NCT01639339|156588148|FG000|Double-blind Period (Up to Week 104)|Adverse Event|10|||
48654166|NCT01639339|156588149|FG001|Double-blind Period (Up to Week 104)|Adverse Event|7|||
48654167|NCT01639339|156588148|FG000|Open-label Period (Up to Week 28)|Withdrawal by Subject|0|||
48654168|NCT01639339|156588149|FG001|Open-label Period (Up to Week 28)|Withdrawal by Subject|2|||
48654169|NCT01639339|156588148|FG000|Open-label Period (Up to Week 28)|Lost to Follow-up|0|||
48654170|NCT01639339|156588149|FG001|Open-label Period (Up to Week 28)|Lost to Follow-up|1|||
48654171|NCT01639339|156588148|FG000|Open-label Period (Up to Week 28)|Protocol Violation|0|||
48654172|NCT01639339|156588149|FG001|Open-label Period (Up to Week 28)|Protocol Violation|1|||
48654173|NCT01639339|156588148|FG000|Open-label Period (Up to Week 28)|Adverse Event|1|||
48654174|NCT01639339|156588149|FG001|Open-label Period (Up to Week 28)|Adverse Event|4|||
48654175|NCT00349921|156588150|FG000|First Spinal Injection|Physician Decision|1|||
48654176|NCT00349921|156588151|FG001|First Spinal Injection|Physician Decision|0|||
48654177|NCT00349921|156588152|FG002|First Spinal Injection|Physician Decision|0|||
48654178|NCT00349921|156588153|FG003|First Spinal Injection|Physician Decision|0|||
48654179|NCT00349921|156588150|FG000|First Spinal Injection|Adverse Event|0|||
48654180|NCT00349921|156588151|FG001|First Spinal Injection|Adverse Event|0|||
48654181|NCT00349921|156588152|FG002|First Spinal Injection|Adverse Event|1|||
48654182|NCT00349921|156588153|FG003|First Spinal Injection|Adverse Event|0|||
48654183|NCT05145322|156588156|FG000|Overall Study|Lost to Follow-up|4|||
48654184|NCT05145322|156588157|FG001|Overall Study|Lost to Follow-up|5|||
48654185|NCT01271712|156588158|FG000|Double Blind Treatment|Death|2|||
48654186|NCT01271712|156588159|FG001|Double Blind Treatment|Death|0|||
48654187|NCT01271712|156588158|FG000|Double Blind Treatment|Lack of Efficacy|1|||
48654188|NCT01271712|156588159|FG001|Double Blind Treatment|Lack of Efficacy|0|||
48654189|NCT01271712|156588158|FG000|Double Blind Treatment|Adverse Event|9|||
48654190|NCT01271712|156588159|FG001|Double Blind Treatment|Adverse Event|4|||
48654191|NCT01271712|156588158|FG000|Double Blind Treatment|Progressive disease|23|||
48654192|NCT01271712|156588159|FG001|Double Blind Treatment|Progressive disease|3|||
48654193|NCT01271712|156588158|FG000|Double Blind Treatment|Withdrawal by Subject|4|||
48654194|NCT01271712|156588159|FG001|Double Blind Treatment|Withdrawal by Subject|1|||
48960534|NCT01253421|157684226|FG003|Drug+Scanning Visit|Physician Decision|0|||
48960535|NCT01253421|157684227|FG004|Drug+Scanning Visit|Physician Decision|1|||
48960536|NCT00547378|157684238|FG000|Randomized Cohort|Withdrawal by Subject|7|||
48960537|NCT00547378|157684239|FG001|Randomized Cohort|Withdrawal by Subject|5|||
48960538|NCT00547378|157684240|FG002|Randomized Cohort|Withdrawal by Subject|0|||
48960539|NCT00547378|157684238|FG000|Randomized Cohort|Death|0|||
48960540|NCT00547378|157684239|FG001|Randomized Cohort|Death|1|||
48960541|NCT00547378|157684240|FG002|Randomized Cohort|Death|0|||
48960542|NCT00547378|157684238|FG000|Randomized Cohort|Lost to Follow-up|1|||
48960543|NCT00547378|157684239|FG001|Randomized Cohort|Lost to Follow-up|0|||
48960544|NCT00547378|157684240|FG002|Randomized Cohort|Lost to Follow-up|0|||
48960545|NCT00547378|157684238|FG000|Randomized Cohort|Adverse Event|1|||
48960546|NCT00547378|157684239|FG001|Randomized Cohort|Adverse Event|0|||
48960547|NCT00547378|157684240|FG002|Randomized Cohort|Adverse Event|0|||
48960548|NCT00547378|157684238|FG000|Randomized Cohort|Other reasons|2|||
48960549|NCT00547378|157684239|FG001|Randomized Cohort|Other reasons|0|||
48960550|NCT00547378|157684240|FG002|Randomized Cohort|Other reasons|0|||
48960551|NCT00547378|157684238|FG000|All Implanted Cohort|Withdrawal by Subject|5|||
48960552|NCT00547378|157684239|FG001|All Implanted Cohort|Withdrawal by Subject|4|||
48960553|NCT00547378|157684240|FG002|All Implanted Cohort|Withdrawal by Subject|27|||
48960554|NCT00547378|157684238|FG000|All Implanted Cohort|Adverse Event|4|||
48960555|NCT00547378|157684239|FG001|All Implanted Cohort|Adverse Event|10|||
48960556|NCT00547378|157684240|FG002|All Implanted Cohort|Adverse Event|17|||
48960557|NCT00547378|157684238|FG000|All Implanted Cohort|Lost to Follow-up|0|||
48960558|NCT00547378|157684239|FG001|All Implanted Cohort|Lost to Follow-up|1|||
48960559|NCT00547378|157684240|FG002|All Implanted Cohort|Lost to Follow-up|14|||
48654195|NCT01271712|156588158|FG000|Double Blind Treatment|Non compliance with study drug|2|||
48654196|NCT01271712|156588159|FG001|Double Blind Treatment|Non compliance with study drug|0|||
48654197|NCT01271712|156588158|FG000|Double Blind Treatment|receive no study drug|1|||
48654198|NCT01271712|156588159|FG001|Double Blind Treatment|receive no study drug|0|||
48960560|NCT00547378|157684238|FG000|All Implanted Cohort|Death|3|||
48960561|NCT00547378|157684239|FG001|All Implanted Cohort|Death|1|||
48960562|NCT00547378|157684240|FG002|All Implanted Cohort|Death|4|||
48654199|NCT01271712|156588158|FG000|Open Label Treatment|Death|6|||
48654200|NCT01271712|156588159|FG001|Open Label Treatment|Death|5|||
48654201|NCT01271712|156588158|FG000|Open Label Treatment|Withdrawal by Subject|6|||
48654202|NCT01271712|156588159|FG001|Open Label Treatment|Withdrawal by Subject|11|||
48654203|NCT01271712|156588158|FG000|Open Label Treatment|Physician Decision|2|||
48654204|NCT01271712|156588159|FG001|Open Label Treatment|Physician Decision|0|||
48654205|NCT01271712|156588158|FG000|Open Label Treatment|Adverse Event|14|||
48654206|NCT01271712|156588159|FG001|Open Label Treatment|Adverse Event|8|||
48654207|NCT01271712|156588158|FG000|Open Label Treatment|Progressive disease|59|||
48654208|NCT01271712|156588159|FG001|Open Label Treatment|Progressive disease|32|||
48654209|NCT01271712|156588158|FG000|Open Label Treatment|transferred to rollover study|1|||
48654210|NCT01271712|156588159|FG001|Open Label Treatment|transferred to rollover study|0|||
48654211|NCT01271712|156588158|FG000|Open Label Treatment|Non-compliance with study drug|1|||
48654212|NCT01271712|156588159|FG001|Open Label Treatment|Non-compliance with study drug|0|||
48654213|NCT01271712|156588158|FG000|Open Label Treatment|Protocol Violation|0|||
48654214|NCT01271712|156588159|FG001|Open Label Treatment|Protocol Violation|1|||
48654215|NCT01271712|156588158|FG000|Open Label Treatment|Switching to other therapy|2|||
48654216|NCT01271712|156588159|FG001|Open Label Treatment|Switching to other therapy|1|||
48654217|NCT01271712|156588158|FG000|Safety Follow-up|Death|11|||
48654218|NCT01271712|156588159|FG001|Safety Follow-up|Death|7|||
48654219|NCT01271712|156588158|FG000|Safety Follow-up|Withdrawal by Subject|4|||
48654220|NCT01271712|156588159|FG001|Safety Follow-up|Withdrawal by Subject|2|||
48654221|NCT01271712|156588158|FG000|Safety Follow-up|Protocol Violation|1|||
48654222|NCT01271712|156588159|FG001|Safety Follow-up|Protocol Violation|1|||
48654223|NCT01271712|156588158|FG000|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3|||
48654224|NCT01271712|156588159|FG001|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4|||
48654225|NCT01271712|156588158|FG000|Safety Follow-up|No follow-up|1|||
48654226|NCT01271712|156588159|FG001|Safety Follow-up|No follow-up|1|||
48654227|NCT01271712|156588158|FG000|Safety Follow-up|Progressive disease|1|||
48654228|NCT01271712|156588159|FG001|Safety Follow-up|Progressive disease|0|||
48960563|NCT00547378|157684238|FG000|All Implanted Cohort|Physician Decision|0|||
48960564|NCT00547378|157684239|FG001|All Implanted Cohort|Physician Decision|2|||
48960565|NCT00547378|157684240|FG002|All Implanted Cohort|Physician Decision|6|||
48654229|NCT01271712|156588158|FG000|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15|||
48654230|NCT01271712|156588159|FG001|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6|||
48654231|NCT01453205|156588162|FG000|Overall Study|Lost to Follow-up|3|||
48960566|NCT00547378|157684238|FG000|All Implanted Cohort|Site closure|2|||
48654232|NCT01453205|156588163|FG001|Overall Study|Lost to Follow-up|0|||
48960567|NCT00547378|157684239|FG001|All Implanted Cohort|Site closure|0|||
48960568|NCT00547378|157684240|FG002|All Implanted Cohort|Site closure|1|||
48960569|NCT00547378|157684238|FG000|All Implanted Cohort|Other reasons|1|||
48654233|NCT01453205|156588164|FG002|Overall Study|Lost to Follow-up|1|||
48654234|NCT01453205|156588162|FG000|Overall Study|Withdrawal by Subject|8|||
48654235|NCT01453205|156588163|FG001|Overall Study|Withdrawal by Subject|3|||
48654236|NCT01453205|156588164|FG002|Overall Study|Withdrawal by Subject|0|||
48654237|NCT01453205|156588162|FG000|Overall Study|Death|24|||
48654238|NCT01453205|156588163|FG001|Overall Study|Death|22|||
48654239|NCT01453205|156588164|FG002|Overall Study|Death|18|||
48654240|NCT01453205|156588162|FG000|Overall Study|Other|45|||
48654241|NCT01453205|156588163|FG001|Overall Study|Other|27|||
48654242|NCT01453205|156588164|FG002|Overall Study|Other|35|||
48960570|NCT00547378|157684239|FG001|All Implanted Cohort|Other reasons|0|||
48960571|NCT00547378|157684240|FG002|All Implanted Cohort|Other reasons|1|||
48960572|NCT01586156|157684241|FG000|Overall Study|Pregnancy|0|||
48960573|NCT01586156|157684242|FG001|Overall Study|Pregnancy|1|||
48960574|NCT01586156|157684243|FG002|Overall Study|Pregnancy|0|||
48960575|NCT01449682|157684244|FG000|Overall Study|Death|0|||
48960576|NCT01449682|157684245|FG001|Overall Study|Death|1|||
48960577|NCT01449682|157684244|FG000|Overall Study|Adverse Event|1|||
48960578|NCT01449682|157684245|FG001|Overall Study|Adverse Event|0|||
48960579|NCT02112994|157684247|FG000|Overall Study|Progressive Disease|0|||
48960580|NCT02112994|157684248|FG001|Overall Study|Progressive Disease|0|||
48960581|NCT02112994|157684249|FG002|Overall Study|Progressive Disease|1|||
48960582|NCT02112994|157684247|FG000|Overall Study|Pregnancy|0|||
48960583|NCT02112994|157684248|FG001|Overall Study|Pregnancy|1|||
48960584|NCT02112994|157684249|FG002|Overall Study|Pregnancy|1|||
48960585|NCT02112994|157684247|FG000|Overall Study|Liver Transplant|0|||
48960586|NCT02112994|157684248|FG001|Overall Study|Liver Transplant|1|||
48960587|NCT02112994|157684249|FG002|Overall Study|Liver Transplant|0|||
48960588|NCT02112994|157684247|FG000|Overall Study|Withdrawal by Subject|0|||
48960589|NCT02112994|157684248|FG001|Overall Study|Withdrawal by Subject|0|||
48960590|NCT02112994|157684249|FG002|Overall Study|Withdrawal by Subject|1|||
48960591|NCT04105244|157684250|FG000|Overall Study|Withdrawal by Subject|10|||
48960592|NCT04105244|157684251|FG001|Overall Study|Withdrawal by Subject|12|||
48960593|NCT04105244|157684250|FG000|Overall Study|Lost to Follow-up|20|||
48654243|NCT04003207|156588166|FG000|Overall Study|Protocol Violation|1|||
48654244|NCT03635424|156588169|FG000|Overall Study|Adverse Event|1|||
48654245|NCT03635424|156588169|FG000|Overall Study|Death|1|||
48654246|NCT03635424|156588169|FG000|Overall Study|Device not implanted|1|||
48654247|NCT01352221|156588170|FG000|Double-blind Phase|Adverse Event|6|||
48654248|NCT01352221|156588171|FG001|Double-blind Phase|Adverse Event|4|||
48654249|NCT01352221|156588172|FG002|Double-blind Phase|Adverse Event|0|||
48654250|NCT01352221|156588173|FG003|Double-blind Phase|Adverse Event|0|||
48654251|NCT01352221|156588170|FG000|Double-blind Phase|Withdrawal by Subject|3|||
48654252|NCT01352221|156588171|FG001|Double-blind Phase|Withdrawal by Subject|5|||
48654253|NCT01352221|156588172|FG002|Double-blind Phase|Withdrawal by Subject|0|||
48654254|NCT01352221|156588173|FG003|Double-blind Phase|Withdrawal by Subject|0|||
48654255|NCT01352221|156588170|FG000|Double-blind Phase|Lost to Follow-up|0|||
48654256|NCT01352221|156588171|FG001|Double-blind Phase|Lost to Follow-up|1|||
48654257|NCT01352221|156588172|FG002|Double-blind Phase|Lost to Follow-up|0|||
48654258|NCT01352221|156588173|FG003|Double-blind Phase|Lost to Follow-up|0|||
48654259|NCT01352221|156588170|FG000|Double-blind Phase|Protocol Violation|0|||
48654260|NCT01352221|156588171|FG001|Double-blind Phase|Protocol Violation|1|||
48654261|NCT01352221|156588172|FG002|Double-blind Phase|Protocol Violation|0|||
48654262|NCT01352221|156588173|FG003|Double-blind Phase|Protocol Violation|0|||
48654263|NCT01352221|156588170|FG000|Open-label Phase|Physician Decision|0|||
48654264|NCT01352221|156588171|FG001|Open-label Phase|Physician Decision|0|||
48654265|NCT01352221|156588172|FG002|Open-label Phase|Physician Decision|2|||
48654266|NCT01352221|156588173|FG003|Open-label Phase|Physician Decision|1|||
48654267|NCT01352221|156588170|FG000|Open-label Phase|Pregnancy|0|||
48960594|NCT04105244|157684251|FG001|Overall Study|Lost to Follow-up|15|||
48960595|NCT04105244|157684250|FG000|Overall Study|Parent no longer eligible- child not living at home|0|||
48960596|NCT04105244|157684251|FG001|Overall Study|Parent no longer eligible- child not living at home|2|||
48654268|NCT01352221|156588171|FG001|Open-label Phase|Pregnancy|0|||
48654269|NCT01352221|156588172|FG002|Open-label Phase|Pregnancy|1|||
48654270|NCT01352221|156588173|FG003|Open-label Phase|Pregnancy|0|||
48654271|NCT01352221|156588170|FG000|Open-label Phase|Adverse Event|0|||
48654272|NCT01352221|156588171|FG001|Open-label Phase|Adverse Event|0|||
48654273|NCT01352221|156588172|FG002|Open-label Phase|Adverse Event|8|||
48654274|NCT01352221|156588173|FG003|Open-label Phase|Adverse Event|4|||
48654275|NCT01352221|156588170|FG000|Open-label Phase|Withdrawal by Subject|0|||
48960597|NCT04105244|157684250|FG000|Overall Study|Unable to contact to complete the intervention.|0|||
48960598|NCT04105244|157684251|FG001|Overall Study|Unable to contact to complete the intervention.|9|||
48960599|NCT00975195|157684252|FG000|Overall Study|Adverse Event|108|||
48960600|NCT00975195|157684253|FG001|Overall Study|Adverse Event|101|||
48654276|NCT01352221|156588171|FG001|Open-label Phase|Withdrawal by Subject|0|||
48654277|NCT01352221|156588172|FG002|Open-label Phase|Withdrawal by Subject|1|||
48654278|NCT01352221|156588173|FG003|Open-label Phase|Withdrawal by Subject|6|||
48960601|NCT00975195|157684252|FG000|Overall Study|Lack of Efficacy|6|||
48960602|NCT00975195|157684253|FG001|Overall Study|Lack of Efficacy|6|||
48654279|NCT01352221|156588170|FG000|Open-label Phase|Worsening of IBD|0|||
48654280|NCT01352221|156588171|FG001|Open-label Phase|Worsening of IBD|0|||
48654281|NCT01352221|156588172|FG002|Open-label Phase|Worsening of IBD|1|||
48654282|NCT01352221|156588173|FG003|Open-label Phase|Worsening of IBD|0|||
48654283|NCT00079391|156588174|FG000|Overall Study|Withdrawal by Subject|1|||
48865702|NCT01730118|157345552|FG002|Dose Escalation|Chose to start a different treatment|0|||
48865703|NCT01730118|157345553|FG003|Dose Escalation|Chose to start a different treatment|0|||
48654284|NCT01691105|156588175|FG000|1 Month Follow-up|Lost to Follow-up|41|||
48654285|NCT01691105|156588176|FG001|1 Month Follow-up|Lost to Follow-up|38|||
48654286|NCT01691105|156588175|FG000|1 Month Follow-up|Death|2|||
48865704|NCT01730118|157345554|FG004|Dose Escalation|Chose to start a different treatment|0|||
48865705|NCT01730118|157345555|FG005|Dose Escalation|Chose to start a different treatment|0|||
48865706|NCT01730118|157345556|FG006|Dose Escalation|Chose to start a different treatment|0|||
48865707|NCT01730118|157345550|FG000|Dose Escalation|Withdrawal by Subject|0|||
48865708|NCT01730118|157345551|FG001|Dose Escalation|Withdrawal by Subject|0|||
48865709|NCT01730118|157345552|FG002|Dose Escalation|Withdrawal by Subject|1|||
48865710|NCT01730118|157345553|FG003|Dose Escalation|Withdrawal by Subject|0|||
48865711|NCT01730118|157345554|FG004|Dose Escalation|Withdrawal by Subject|0|||
48865712|NCT01730118|157345555|FG005|Dose Escalation|Withdrawal by Subject|0|||
48865713|NCT01730118|157345556|FG006|Dose Escalation|Withdrawal by Subject|0|||
48865714|NCT01730118|157345550|FG000|Dose Escalation|Disease progression prior to treatment|0|||
48865715|NCT01730118|157345551|FG001|Dose Escalation|Disease progression prior to treatment|0|||
48865716|NCT01730118|157345552|FG002|Dose Escalation|Disease progression prior to treatment|0|||
48865717|NCT01730118|157345553|FG003|Dose Escalation|Disease progression prior to treatment|0|||
48865718|NCT01730118|157345554|FG004|Dose Escalation|Disease progression prior to treatment|0|||
48865719|NCT01730118|157345555|FG005|Dose Escalation|Disease progression prior to treatment|0|||
48865720|NCT01730118|157345556|FG006|Dose Escalation|Disease progression prior to treatment|1|||
48865721|NCT01730118|157345550|FG000|Dose Expansion|Death|0|||
48865722|NCT01730118|157345551|FG001|Dose Expansion|Death|0|||
48865723|NCT01730118|157345552|FG002|Dose Expansion|Death|0|||
48865724|NCT01730118|157345553|FG003|Dose Expansion|Death|0|||
48865725|NCT01730118|157345554|FG004|Dose Expansion|Death|1|||
48865726|NCT01730118|157345555|FG005|Dose Expansion|Death|0|||
48865727|NCT01730118|157345556|FG006|Dose Expansion|Death|0|||
48865728|NCT01730118|157345550|FG000|Dose Expansion|Other medical condition|0|||
48865729|NCT01730118|157345551|FG001|Dose Expansion|Other medical condition|0|||
48865730|NCT01730118|157345552|FG002|Dose Expansion|Other medical condition|0|||
48865731|NCT01730118|157345553|FG003|Dose Expansion|Other medical condition|0|||
48865732|NCT01730118|157345554|FG004|Dose Expansion|Other medical condition|1|||
48865733|NCT01730118|157345555|FG005|Dose Expansion|Other medical condition|0|||
48865734|NCT01730118|157345556|FG006|Dose Expansion|Other medical condition|0|||
48865735|NCT01730118|157345550|FG000|Dose Expansion|Withdrawal by Subject|0|||
48865736|NCT01730118|157345551|FG001|Dose Expansion|Withdrawal by Subject|0|||
48865737|NCT01730118|157345552|FG002|Dose Expansion|Withdrawal by Subject|0|||
48865738|NCT01730118|157345553|FG003|Dose Expansion|Withdrawal by Subject|0|||
48865739|NCT01730118|157345554|FG004|Dose Expansion|Withdrawal by Subject|1|||
48865740|NCT01730118|157345555|FG005|Dose Expansion|Withdrawal by Subject|0|||
48865741|NCT01730118|157345556|FG006|Dose Expansion|Withdrawal by Subject|0|||
48865742|NCT01730118|157345550|FG000|Dose Expansion|Disease progression|0|||
48865743|NCT01730118|157345551|FG001|Dose Expansion|Disease progression|0|||
48865744|NCT01730118|157345552|FG002|Dose Expansion|Disease progression|0|||
48865745|NCT01730118|157345553|FG003|Dose Expansion|Disease progression|0|||
48865746|NCT01730118|157345554|FG004|Dose Expansion|Disease progression|0|||
48865747|NCT01730118|157345555|FG005|Dose Expansion|Disease progression|1|||
48865748|NCT01730118|157345556|FG006|Dose Expansion|Disease progression|0|||
48865749|NCT01730118|157345550|FG000|Dose Expansion|Inability to return|0|||
48865750|NCT01730118|157345551|FG001|Dose Expansion|Inability to return|0|||
48865751|NCT01730118|157345552|FG002|Dose Expansion|Inability to return|0|||
48865752|NCT01730118|157345553|FG003|Dose Expansion|Inability to return|0|||
48865753|NCT01730118|157345554|FG004|Dose Expansion|Inability to return|0|||
48865754|NCT01730118|157345555|FG005|Dose Expansion|Inability to return|1|||
48865755|NCT01730118|157345556|FG006|Dose Expansion|Inability to return|0|||
48865756|NCT01730118|157345550|FG000|Dose Expansion|Physician Decision|0|||
48865757|NCT01730118|157345551|FG001|Dose Expansion|Physician Decision|0|||
48865758|NCT01730118|157345552|FG002|Dose Expansion|Physician Decision|0|||
48865759|NCT01730118|157345553|FG003|Dose Expansion|Physician Decision|0|||
48865760|NCT01730118|157345554|FG004|Dose Expansion|Physician Decision|0|||
48865761|NCT01730118|157345555|FG005|Dose Expansion|Physician Decision|1|||
48865762|NCT01730118|157345556|FG006|Dose Expansion|Physician Decision|0|||
48865763|NCT00961298|157345557|FG000|Two Week Placebo Run in|Withdrawal by Subject|1|||
48865764|NCT00961298|157345557|FG000|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2|||
48865765|NCT00961298|157345557|FG000|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1|||
48654287|NCT01691105|156588176|FG001|1 Month Follow-up|Death|3|||
48654288|NCT01691105|156588175|FG000|6 Month Follow-up|Lost to Follow-up|39|||
48654289|NCT01691105|156588176|FG001|6 Month Follow-up|Lost to Follow-up|58|||
48865766|NCT04044352|157345558|FG000|Overall Study|Lost to Follow-up|9|||
48960603|NCT00975195|157684252|FG000|Overall Study|Protocol Violation|27|||
48960604|NCT00975195|157684253|FG001|Overall Study|Protocol Violation|23|||
48960605|NCT00975195|157684252|FG000|Overall Study|Lost to Follow-up|9|||
48960606|NCT00975195|157684253|FG001|Overall Study|Lost to Follow-up|7|||
48960607|NCT00975195|157684252|FG000|Overall Study|Withdrawal by Subject|48|||
48960608|NCT00975195|157684253|FG001|Overall Study|Withdrawal by Subject|61|||
48960609|NCT00975195|157684252|FG000|Overall Study|Other reason not defined above|29|||
48960610|NCT00975195|157684253|FG001|Overall Study|Other reason not defined above|33|||
48960611|NCT00975195|157684252|FG000|Overall Study|Not treated|1|||
48960612|NCT00975195|157684253|FG001|Overall Study|Not treated|2|||
48960613|NCT01318512|157684254|FG000|Maintenance Period (6 Months)|Death|2|||
48960614|NCT01318512|157684254|FG000|Maintenance Period (6 Months)|Protocol Violation|9|||
48960615|NCT02330549|157685701|FG000|Overall Study|Adverse Event|1|||
48960616|NCT02330549|157685702|FG001|Overall Study|Adverse Event|0|||
48960617|NCT02330549|157685701|FG000|Overall Study|Subject withdrew consent|2|||
48960618|NCT02330549|157685702|FG001|Overall Study|Subject withdrew consent|1|||
48960619|NCT02330549|157685701|FG000|Overall Study|Failure to meet randomization criteria|1|||
48960620|NCT02330549|157685702|FG001|Overall Study|Failure to meet randomization criteria|0|||
48960621|NCT00495495|157685708|FG000|Overall Study|Protocol Violation|99|||
48960622|NCT01030458|157685714|FG000|Overall Study|Lost to Follow-up|9|||
48654290|NCT01691105|156588175|FG000|6 Month Follow-up|Death|13|||
48654291|NCT01691105|156588176|FG001|6 Month Follow-up|Death|13|||
48654292|NCT01691105|156588175|FG000|12 Month Follow-up|Lost to Follow-up|50|||
48654293|NCT01691105|156588176|FG001|12 Month Follow-up|Lost to Follow-up|71|||
48960623|NCT01030458|157685715|FG001|Overall Study|Lost to Follow-up|10|||
48960624|NCT01030458|157685714|FG000|Overall Study|Withdrawal by Subject|2|||
48960625|NCT01030458|157685715|FG001|Overall Study|Withdrawal by Subject|3|||
48960626|NCT01030458|157685714|FG000|Overall Study|Logistical reasons|9|||
48960627|NCT01030458|157685715|FG001|Overall Study|Logistical reasons|5|||
48654294|NCT01691105|156588175|FG000|12 Month Follow-up|Death|22|||
48654295|NCT01691105|156588176|FG001|12 Month Follow-up|Death|30|||
48654296|NCT01691105|156588175|FG000|12 Month Biochemical Verification|Death|22|||
48654297|NCT01691105|156588176|FG001|12 Month Biochemical Verification|Death|30|||
48753838|NCT02899988|156946541|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
48654298|NCT01691105|156588175|FG000|12 Month Biochemical Verification|Lost to Follow-up|50|||
48654299|NCT01691105|156588176|FG001|12 Month Biochemical Verification|Lost to Follow-up|71|||
48654300|NCT01691105|156588175|FG000|12 Month Biochemical Verification|subject did not self-report abstinence|352|||
48654301|NCT01691105|156588176|FG001|12 Month Biochemical Verification|subject did not self-report abstinence|401|||
48654302|NCT03255967|156588177|FG000|Overall Study|Adverse Event|26|||
48654303|NCT03255967|156588178|FG001|Overall Study|Adverse Event|30|||
48654304|NCT03255967|156588177|FG000|Overall Study|Withdrawal by Subject|6|||
48654305|NCT03255967|156588178|FG001|Overall Study|Withdrawal by Subject|6|||
48654306|NCT03255967|156588177|FG000|Overall Study|Schedule conflict|6|||
48654307|NCT03255967|156588178|FG001|Overall Study|Schedule conflict|4|||
48654308|NCT03255967|156588177|FG000|Overall Study|POA did not sign consent form|2|||
48654309|NCT03255967|156588178|FG001|Overall Study|POA did not sign consent form|0|||
48654310|NCT02791516|156588179|FG000|Overall Study|Withdrawal by Subject|1|||
48654311|NCT02791516|156588180|FG001|Overall Study|Withdrawal by Subject|1|||
48654312|NCT01202188|156588181|FG000|Overall Study|Protocol deviation|14|||
48654313|NCT01202188|156588182|FG001|Overall Study|Protocol deviation|8|||
48654314|NCT01202188|156588183|FG002|Overall Study|Protocol deviation|12|||
48654315|NCT01202188|156588184|FG003|Overall Study|Protocol deviation|10|||
48654316|NCT01202188|156588185|FG004|Overall Study|Protocol deviation|11|||
48654317|NCT01202188|156588181|FG000|Overall Study|Subject withdrew consent|12|||
48654318|NCT01202188|156588182|FG001|Overall Study|Subject withdrew consent|13|||
48654319|NCT01202188|156588183|FG002|Overall Study|Subject withdrew consent|22|||
48654320|NCT01202188|156588184|FG003|Overall Study|Subject withdrew consent|11|||
48753839|NCT02899988|156946542|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
48960628|NCT01030458|157685714|FG000|Overall Study|Moved or changed job|6|||
48960629|NCT01030458|157685715|FG001|Overall Study|Moved or changed job|13|||
48960630|NCT01030458|157685714|FG000|Overall Study|Side effect of medication|1|||
48654321|NCT01202188|156588185|FG004|Overall Study|Subject withdrew consent|13|||
48654322|NCT01202188|156588181|FG000|Overall Study|Adverse Event|5|||
48960631|NCT01030458|157685715|FG001|Overall Study|Side effect of medication|1|||
48960632|NCT01623531|157685716|FG000|Overall Study|Death|1|||
48960633|NCT01623531|157685717|FG001|Overall Study|Death|0|||
48960634|NCT01623531|157685716|FG000|Overall Study|Protocol Violation|2|||
48960635|NCT01623531|157685717|FG001|Overall Study|Protocol Violation|1|||
48654323|NCT01202188|156588182|FG001|Overall Study|Adverse Event|23|||
48654324|NCT01202188|156588183|FG002|Overall Study|Adverse Event|13|||
48654325|NCT01202188|156588184|FG003|Overall Study|Adverse Event|10|||
48654326|NCT01202188|156588185|FG004|Overall Study|Adverse Event|10|||
48654327|NCT01202188|156588181|FG000|Overall Study|Administrative problems|3|||
48654328|NCT01202188|156588182|FG001|Overall Study|Administrative problems|2|||
48960636|NCT01623531|157685716|FG000|Overall Study|Missing data at primary outcome time poi|1|||
48960637|NCT01623531|157685717|FG001|Overall Study|Missing data at primary outcome time poi|1|||
48753840|NCT02899988|156946543|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
48753841|NCT02899988|156946533|FG000|Induction Period (16 Weeks)|Physician Decision|0|||
48654329|NCT01202188|156588183|FG002|Overall Study|Administrative problems|1|||
48654330|NCT01202188|156588184|FG003|Overall Study|Administrative problems|1|||
48654331|NCT01202188|156588185|FG004|Overall Study|Administrative problems|2|||
48654332|NCT01202188|156588181|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
48654333|NCT01202188|156588182|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
48654334|NCT01202188|156588183|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
48654335|NCT01202188|156588184|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
48654336|NCT01202188|156588185|FG004|Overall Study|Unsatisfactory therapeutic effect|8|||
48654337|NCT01202188|156588181|FG000|Overall Study|Lost to Follow-up|1|||
48654338|NCT01202188|156588182|FG001|Overall Study|Lost to Follow-up|1|||
48654339|NCT01202188|156588183|FG002|Overall Study|Lost to Follow-up|0|||
48654340|NCT01202188|156588184|FG003|Overall Study|Lost to Follow-up|4|||
48654341|NCT01202188|156588185|FG004|Overall Study|Lost to Follow-up|1|||
48654342|NCT01202188|156588181|FG000|Overall Study|Death|1|||
48654343|NCT01202188|156588182|FG001|Overall Study|Death|1|||
48654344|NCT01202188|156588183|FG002|Overall Study|Death|1|||
48654345|NCT01202188|156588184|FG003|Overall Study|Death|1|||
48654346|NCT01202188|156588185|FG004|Overall Study|Death|0|||
48654347|NCT01202188|156588181|FG000|Overall Study|Abnormal test procedure result (s)|0|||
48654348|NCT01202188|156588182|FG001|Overall Study|Abnormal test procedure result (s)|0|||
48654349|NCT01202188|156588183|FG002|Overall Study|Abnormal test procedure result (s)|2|||
48654350|NCT01202188|156588184|FG003|Overall Study|Abnormal test procedure result (s)|0|||
48654351|NCT01202188|156588185|FG004|Overall Study|Abnormal test procedure result (s)|0|||
48654352|NCT02701283|156588187|FG000|Overall Study|Death|25|||
48654353|NCT02701283|156588188|FG001|Overall Study|Death|29|||
48654354|NCT02701283|156588189|FG002|Overall Study|Death|19|||
48654355|NCT02701283|156588187|FG000|Overall Study|Lost to Follow-up|3|||
48654356|NCT02701283|156588188|FG001|Overall Study|Lost to Follow-up|8|||
48654357|NCT02701283|156588189|FG002|Overall Study|Lost to Follow-up|1|||
48654358|NCT02701283|156588187|FG000|Overall Study|Withdrawal by Subject|12|||
48654359|NCT02701283|156588188|FG001|Overall Study|Withdrawal by Subject|41|||
48654360|NCT02701283|156588189|FG002|Overall Study|Withdrawal by Subject|1|||
48654361|NCT02701283|156588187|FG000|Overall Study|Missed 2-year visit|22|||
48654362|NCT02701283|156588188|FG001|Overall Study|Missed 2-year visit|27|||
48654363|NCT02701283|156588189|FG002|Overall Study|Missed 2-year visit|0|||
48654364|NCT02701283|156588187|FG000|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7|||
48654365|NCT02701283|156588188|FG001|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57|||
48654366|NCT02701283|156588189|FG002|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|0|||
48654367|NCT04669262|156588190|FG000|Overall Study|Withdrawal by Subject|0|||
48654368|NCT04669262|156588191|FG001|Overall Study|Withdrawal by Subject|0|||
48654369|NCT04669262|156588192|FG002|Overall Study|Withdrawal by Subject|0|||
48654370|NCT04669262|156588193|FG003|Overall Study|Withdrawal by Subject|1|||
48654371|NCT04669262|156588190|FG000|Overall Study|Randomized but Not Treated|0|||
48654372|NCT04669262|156588191|FG001|Overall Study|Randomized but Not Treated|1|||
48654373|NCT04669262|156588192|FG002|Overall Study|Randomized but Not Treated|0|||
48654374|NCT04669262|156588193|FG003|Overall Study|Randomized but Not Treated|0|||
48654375|NCT05151445|156588194|FG000|Overall Study|Withdrawal by Subject|3|||
48654376|NCT01638013|156588195|FG000|Overall Study|Adverse Event|36|||
48654377|NCT01638013|156588196|FG001|Overall Study|Adverse Event|29|||
48654378|NCT01638013|156588197|FG002|Overall Study|Adverse Event|48|||
48654379|NCT01638013|156588195|FG000|Overall Study|Lack of Efficacy|39|||
48753842|NCT02899988|156946534|FG001|Induction Period (16 Weeks)|Physician Decision|1|||
48753843|NCT02899988|156946535|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
48753844|NCT02899988|156946536|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
48753845|NCT02899988|156946537|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
48753846|NCT02899988|156946538|FG005|Induction Period (16 Weeks)|Physician Decision|0|||
48753847|NCT02899988|156946539|FG006|Induction Period (16 Weeks)|Physician Decision|0|||
48654380|NCT01638013|156588196|FG001|Overall Study|Lack of Efficacy|11|||
48654381|NCT01638013|156588197|FG002|Overall Study|Lack of Efficacy|14|||
48654382|NCT01638013|156588195|FG000|Overall Study|Protocol Violation|10|||
48654383|NCT01638013|156588196|FG001|Overall Study|Protocol Violation|7|||
48654384|NCT01638013|156588197|FG002|Overall Study|Protocol Violation|11|||
48654385|NCT01638013|156588195|FG000|Overall Study|Met discontinuation criteria|4|||
48654386|NCT01638013|156588196|FG001|Overall Study|Met discontinuation criteria|0|||
48654387|NCT01638013|156588197|FG002|Overall Study|Met discontinuation criteria|7|||
48654388|NCT01638013|156588195|FG000|Overall Study|Subject Lost to Follow up|1|||
48654389|NCT01638013|156588196|FG001|Overall Study|Subject Lost to Follow up|0|||
48753848|NCT02899988|156946540|FG007|Induction Period (16 Weeks)|Physician Decision|0|||
48960638|NCT01592409|157685721|FG000|Overall Study|Withdrawal by Subject|0|||
48960639|NCT01592409|157685722|FG001|Overall Study|Withdrawal by Subject|1|||
48654390|NCT01638013|156588197|FG002|Overall Study|Subject Lost to Follow up|1|||
48654391|NCT01638013|156588195|FG000|Overall Study|Miscellaneous|25|||
48753849|NCT02899988|156946541|FG008|Induction Period (16 Weeks)|Physician Decision|0|||
48753850|NCT02899988|156946542|FG009|Induction Period (16 Weeks)|Physician Decision|0|||
48753851|NCT02899988|156946543|FG010|Induction Period (16 Weeks)|Physician Decision|0|||
48753852|NCT02899988|156946533|FG000|Maintenance Period (88 Weeks)|Adverse Event|0|||
48753853|NCT02899988|156946534|FG001|Maintenance Period (88 Weeks)|Adverse Event|0|||
48753854|NCT02899988|156946535|FG002|Maintenance Period (88 Weeks)|Adverse Event|0|||
48753855|NCT02899988|156946536|FG003|Maintenance Period (88 Weeks)|Adverse Event|0|||
48753856|NCT02899988|156946537|FG004|Maintenance Period (88 Weeks)|Adverse Event|1|||
48753857|NCT02899988|156946538|FG005|Maintenance Period (88 Weeks)|Adverse Event|2|||
48753858|NCT02899988|156946539|FG006|Maintenance Period (88 Weeks)|Adverse Event|1|||
48753859|NCT02899988|156946540|FG007|Maintenance Period (88 Weeks)|Adverse Event|2|||
48753860|NCT02899988|156946541|FG008|Maintenance Period (88 Weeks)|Adverse Event|2|||
48753861|NCT02899988|156946542|FG009|Maintenance Period (88 Weeks)|Adverse Event|2|||
48753862|NCT02899988|156946543|FG010|Maintenance Period (88 Weeks)|Adverse Event|1|||
48753863|NCT02899988|156946533|FG000|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
48753864|NCT02899988|156946534|FG001|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
48753865|NCT02899988|156946535|FG002|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
48753866|NCT02899988|156946536|FG003|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
48753867|NCT02899988|156946537|FG004|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
48753868|NCT02899988|156946538|FG005|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
48753869|NCT02899988|156946539|FG006|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
48753870|NCT02899988|156946540|FG007|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
48753871|NCT02899988|156946541|FG008|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
48753872|NCT02899988|156946542|FG009|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
48753873|NCT02899988|156946543|FG010|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
48753874|NCT02899988|156946533|FG000|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
48753875|NCT02899988|156946534|FG001|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
48753876|NCT02899988|156946535|FG002|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
48753877|NCT02899988|156946536|FG003|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
48753878|NCT02899988|156946537|FG004|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
48753879|NCT02899988|156946538|FG005|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
48753880|NCT02899988|156946539|FG006|Maintenance Period (88 Weeks)|Withdrawal by Subject|3|||
48753881|NCT02899988|156946540|FG007|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
48753882|NCT02899988|156946541|FG008|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
48753883|NCT02899988|156946542|FG009|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
48753884|NCT02899988|156946543|FG010|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
48654392|NCT01638013|156588196|FG001|Overall Study|Miscellaneous|19|||
48654393|NCT01638013|156588197|FG002|Overall Study|Miscellaneous|23|||
48654394|NCT01638013|156588195|FG000|Overall Study|Withdrawal of Consent|16|||
48654395|NCT01638013|156588196|FG001|Overall Study|Withdrawal of Consent|12|||
48654396|NCT01638013|156588197|FG002|Overall Study|Withdrawal of Consent|16|||
48654397|NCT01638013|156588195|FG000|Overall Study|Not met inclusion or exclusion criteria|0|||
48654398|NCT01638013|156588196|FG001|Overall Study|Not met inclusion or exclusion criteria|0|||
48654399|NCT01638013|156588197|FG002|Overall Study|Not met inclusion or exclusion criteria|1|||
48654400|NCT01457014|156588198|FG000|First Night|Didn't meet inclusion/exclusion criteria|37|||
48654401|NCT01457014|156588199|FG001|First Night|Didn't meet inclusion/exclusion criteria|0|||
48654402|NCT01457014|156588200|FG002|First Night|Didn't meet inclusion/exclusion criteria|0|||
48654403|NCT01457014|156588201|FG003|First Night|Didn't meet inclusion/exclusion criteria|0|||
48654404|NCT01457014|156588198|FG000|First Night|Withdrawal by Subject|3|||
48654405|NCT01457014|156588199|FG001|First Night|Withdrawal by Subject|0|||
48654406|NCT01457014|156588200|FG002|First Night|Withdrawal by Subject|0|||
48654407|NCT01457014|156588201|FG003|First Night|Withdrawal by Subject|0|||
48654408|NCT02438384|156588204|FG000|Overall Study|Lost to Follow-up|8|||
48753885|NCT01751867|156946544|FG000|Overall Study|Completed treatment,dropped in follow-up|4|||
48753886|NCT01751867|156946545|FG001|Overall Study|Completed treatment,dropped in follow-up|8|||
48753887|NCT01751867|156946544|FG000|Overall Study|Diease Progression|4|||
48753888|NCT01751867|156946545|FG001|Overall Study|Diease Progression|18|||
48960640|NCT00617409|157685729|FG000|Overall Study|Withdrawal by Subject|4|||
48654409|NCT02438384|156588205|FG001|Overall Study|Lost to Follow-up|6|||
48654410|NCT02438384|156588206|FG002|Overall Study|Lost to Follow-up|4|||
48654411|NCT03319953|156588207|FG000|Period 2 (Day 49 to 154)|Withdrawal by Subject|1|||
48654412|NCT03319953|156588208|FG001|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
48654413|NCT03319953|156588209|FG002|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
48654414|NCT03319953|156588210|FG003|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
48654415|NCT03319953|156588207|FG000|Period 2 (Day 49 to 154)|Reason not Specified|0|||
48753889|NCT01751867|156946544|FG000|Overall Study|Adverse Event|8|||
48753890|NCT01751867|156946545|FG001|Overall Study|Adverse Event|15|||
48753891|NCT01751867|156946544|FG000|Overall Study|Poor Compliance|0|||
48654416|NCT03319953|156588208|FG001|Period 2 (Day 49 to 154)|Reason not Specified|0|||
48753892|NCT01751867|156946545|FG001|Overall Study|Poor Compliance|5|||
48753893|NCT01751867|156946544|FG000|Overall Study|Withdrawal by Subject|3|||
48960641|NCT00617409|157685730|FG001|Overall Study|Withdrawal by Subject|1|||
48960642|NCT00617409|157685731|FG002|Overall Study|Withdrawal by Subject|2|||
48960643|NCT00617409|157685729|FG000|Overall Study|Adverse Event|0|||
48654417|NCT03319953|156588209|FG002|Period 2 (Day 49 to 154)|Reason not Specified|1|||
48654418|NCT03319953|156588210|FG003|Period 2 (Day 49 to 154)|Reason not Specified|1|||
48654419|NCT04493424|156589697|FG000|Overall Study|Termination of the trial by the sponsor|89|||
48654420|NCT04493424|156589697|FG000|Overall Study|Withdrawal by Subject|9|||
48654421|NCT04493424|156589697|FG000|Overall Study|Lost to Follow-up|2|||
48654422|NCT04493424|156589697|FG000|Overall Study|Lack of Efficacy|3|||
48654423|NCT04493424|156589697|FG000|Overall Study|Adverse Event|5|||
48654424|NCT02920528|156589700|FG000|Overall Study|Incomplete Data|1|||
48654425|NCT02920528|156589701|FG001|Overall Study|Incomplete Data|1|||
48654426|NCT02920528|156589702|FG002|Overall Study|Incomplete Data|1|||
48654427|NCT02920528|156589700|FG000|Overall Study|Adverse Event|0|||
48654428|NCT02920528|156589701|FG001|Overall Study|Adverse Event|0|||
48654429|NCT02920528|156589702|FG002|Overall Study|Adverse Event|3|||
48654430|NCT02920528|156589700|FG000|Overall Study|Did not meet inclusion criteria|2|||
48654431|NCT02920528|156589701|FG001|Overall Study|Did not meet inclusion criteria|0|||
48654432|NCT02920528|156589702|FG002|Overall Study|Did not meet inclusion criteria|1|||
48654433|NCT03116828|156589703|FG000|Overall Study|Adverse Event|1|||
48654434|NCT03116828|156589704|FG001|Overall Study|Adverse Event|10|||
48654435|NCT03116828|156589703|FG000|Overall Study|Withdrawal by Subject|4|||
48654436|NCT03116828|156589704|FG001|Overall Study|Withdrawal by Subject|8|||
48654437|NCT03116828|156589703|FG000|Overall Study|OTHER|3|||
48654438|NCT03116828|156589704|FG001|Overall Study|OTHER|3|||
48654439|NCT02547038|156589706|FG000|Overall Study|Lost to Follow-up|3|||
48654440|NCT02547038|156589707|FG001|Overall Study|Lost to Follow-up|2|||
48654441|NCT04606199|156589709|FG000|Overall Study|Withdrawal by Subject|2|||
48654442|NCT05425732|156589710|FG000|Overall Study|Death|4|||
48654443|NCT05425732|156589711|FG001|Overall Study|Death|2|||
48654444|NCT05425732|156589712|FG002|Overall Study|Death|0|||
48654445|NCT05425732|156589713|FG003|Overall Study|Death|0|||
48654446|NCT05425732|156589710|FG000|Overall Study|Lost to Follow-up|10|||
48654447|NCT05425732|156589711|FG001|Overall Study|Lost to Follow-up|15|||
48654448|NCT05425732|156589712|FG002|Overall Study|Lost to Follow-up|5|||
48654449|NCT05425732|156589713|FG003|Overall Study|Lost to Follow-up|3|||
48654450|NCT05425732|156589710|FG000|Overall Study|Physician Decision|0|||
48654451|NCT05425732|156589711|FG001|Overall Study|Physician Decision|2|||
48654452|NCT05425732|156589712|FG002|Overall Study|Physician Decision|0|||
48654453|NCT05425732|156589713|FG003|Overall Study|Physician Decision|0|||
48654454|NCT05425732|156589710|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
48654455|NCT05425732|156589711|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
48654456|NCT05425732|156589712|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
48654457|NCT05425732|156589713|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
48654458|NCT05425732|156589710|FG000|Overall Study|Withdrawal by Subject|4|||
48654459|NCT05425732|156589711|FG001|Overall Study|Withdrawal by Subject|8|||
48654460|NCT05425732|156589712|FG002|Overall Study|Withdrawal by Subject|1|||
48654461|NCT05425732|156589713|FG003|Overall Study|Withdrawal by Subject|1|||
48654462|NCT05425732|156589710|FG000|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|2|||
48654463|NCT05425732|156589711|FG001|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
48654464|NCT05425732|156589712|FG002|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
48654465|NCT05425732|156589713|FG003|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
48654466|NCT05935878|156589714|FG000|Overall Study|Death|1|||
48654467|NCT05935878|156589715|FG001|Overall Study|Death|2|||
48654468|NCT05935878|156589714|FG000|Overall Study|Withdrawal by Subject|5|||
48654469|NCT05935878|156589715|FG001|Overall Study|Withdrawal by Subject|5|||
48654470|NCT05935878|156589714|FG000|Overall Study|Revision of implant|1|||
48654471|NCT05935878|156589715|FG001|Overall Study|Revision of implant|1|||
48654472|NCT05935878|156589714|FG000|Overall Study|Mobile bearing dislocation|0|||
48654473|NCT05935878|156589715|FG001|Overall Study|Mobile bearing dislocation|1|||
48654474|NCT00306293|156589717|FG000|Period 1 (Day 1 to Day 60)|Adverse Event|1|||
48654475|NCT00306293|156589718|FG001|Period 1 (Day 1 to Day 60)|Adverse Event|0|||
48654476|NCT00306293|156589717|FG000|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3|||
48654477|NCT00306293|156589718|FG001|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4|||
48654478|NCT00306293|156589717|FG000|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
48654479|NCT00306293|156589718|FG001|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
48654480|NCT00306293|156589717|FG000|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
48654481|NCT00306293|156589718|FG001|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
48654482|NCT00306293|156589717|FG000|Period 2 (Day 67 to Day 126 )|Adverse Event|1|||
48654483|NCT00306293|156589718|FG001|Period 2 (Day 67 to Day 126 )|Adverse Event|0|||
48654484|NCT00306293|156589717|FG000|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1|||
48654485|NCT00306293|156589718|FG001|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0|||
48654486|NCT00306293|156589717|FG000|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0|||
48654487|NCT00306293|156589718|FG001|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1|||
48960644|NCT00617409|157685730|FG001|Overall Study|Adverse Event|2|||
48753894|NCT01751867|156946545|FG001|Overall Study|Withdrawal by Subject|1|||
48753895|NCT01751867|156946544|FG000|Overall Study|Physician Decision|4|||
48753896|NCT01751867|156946545|FG001|Overall Study|Physician Decision|7|||
48753897|NCT01751867|156946544|FG000|Overall Study|Protocol Violation|0|||
48753898|NCT01751867|156946545|FG001|Overall Study|Protocol Violation|2|||
48753899|NCT01751867|156946544|FG000|Overall Study|Death|0|||
48753900|NCT01751867|156946545|FG001|Overall Study|Death|5|||
48753901|NCT01751867|156946544|FG000|Overall Study|Other|11|||
48753902|NCT01751867|156946545|FG001|Overall Study|Other|37|||
48753903|NCT01751867|156946544|FG000|Overall Study|Randomized but not treated.|2|||
48753904|NCT01751867|156946545|FG001|Overall Study|Randomized but not treated.|1|||
48753905|NCT05620563|156946554|FG000|Overall Study|Adverse Event|3|||
48753906|NCT05620563|156946555|FG001|Overall Study|Adverse Event|1|||
48753907|NCT05620563|156946554|FG000|Overall Study|Lost to Follow-up|0|||
48753908|NCT05620563|156946555|FG001|Overall Study|Lost to Follow-up|2|||
48753909|NCT05620563|156946554|FG000|Overall Study|Protocol Deviation|1|||
48753910|NCT05620563|156946555|FG001|Overall Study|Protocol Deviation|2|||
48753911|NCT05620563|156946554|FG000|Overall Study|Withdrawal by Subject|3|||
48753912|NCT05620563|156946555|FG001|Overall Study|Withdrawal by Subject|3|||
48753913|NCT05620563|156946554|FG000|Overall Study|Physician Decision|0|||
48753914|NCT05620563|156946555|FG001|Overall Study|Physician Decision|1|||
48753915|NCT00411645|156946556|FG000|Overall Study|Consent Withdrawn|13|||
48753916|NCT00411645|156946557|FG001|Overall Study|Consent Withdrawn|22|||
48753917|NCT00411645|156946556|FG000|Overall Study|Death|56|||
48753918|NCT00411645|156946557|FG001|Overall Study|Death|135|||
48753919|NCT00411645|156946556|FG000|Overall Study|Investigator/Sponsor Decision|10|||
48753920|NCT00411645|156946557|FG001|Overall Study|Investigator/Sponsor Decision|7|||
48753921|NCT00411645|156946556|FG000|Overall Study|Lost to Follow-up|2|||
48753922|NCT00411645|156946557|FG001|Overall Study|Lost to Follow-up|0|||
48753923|NCT02289690|156946560|FG000|Overall Study|Adverse Event Related to Progression|0|||
48753924|NCT02289690|156946561|FG001|Overall Study|Adverse Event Related to Progression|1|||
48753925|NCT02289690|156946562|FG002|Overall Study|Adverse Event Related to Progression|1|||
48753926|NCT02289690|156946563|FG003|Overall Study|Adverse Event Related to Progression|0|||
48753927|NCT02289690|156946564|FG004|Overall Study|Adverse Event Related to Progression|1|||
48753928|NCT02289690|156946565|FG005|Overall Study|Adverse Event Related to Progression|0|||
48753929|NCT02289690|156946566|FG006|Overall Study|Adverse Event Related to Progression|1|||
48753930|NCT02289690|156946567|FG007|Overall Study|Adverse Event Related to Progression|0|||
48753931|NCT02289690|156946568|FG008|Overall Study|Adverse Event Related to Progression|0|||
48753932|NCT02289690|156946569|FG009|Overall Study|Adverse Event Related to Progression|0|||
48753933|NCT02289690|156946560|FG000|Overall Study|Withdrawal by Subject|1|||
48753934|NCT02289690|156946561|FG001|Overall Study|Withdrawal by Subject|0|||
48960645|NCT00617409|157685731|FG002|Overall Study|Adverse Event|3|||
48654488|NCT00306293|156589717|FG000|Period 2 (Day 67 to Day 126 )|Pregnancy|1|||
48654489|NCT00306293|156589718|FG001|Period 2 (Day 67 to Day 126 )|Pregnancy|0|||
48654490|NCT01892436|156589723|FG000|Overall Study|Withdrawal by Subject|8|||
48654491|NCT01892436|156589724|FG001|Overall Study|Withdrawal by Subject|15|||
48654492|NCT01892436|156589725|FG002|Overall Study|Withdrawal by Subject|4|||
48654493|NCT01892436|156589726|FG003|Overall Study|Withdrawal by Subject|4|||
48654494|NCT01892436|156589723|FG000|Overall Study|Death|1|||
48654495|NCT01892436|156589724|FG001|Overall Study|Death|1|||
48654496|NCT01892436|156589725|FG002|Overall Study|Death|0|||
48654497|NCT01892436|156589726|FG003|Overall Study|Death|0|||
48753935|NCT02289690|156946562|FG002|Overall Study|Withdrawal by Subject|0|||
48753936|NCT02289690|156946563|FG003|Overall Study|Withdrawal by Subject|0|||
48753937|NCT02289690|156946564|FG004|Overall Study|Withdrawal by Subject|1|||
48753938|NCT02289690|156946565|FG005|Overall Study|Withdrawal by Subject|1|||
48753939|NCT02289690|156946566|FG006|Overall Study|Withdrawal by Subject|0|||
48753940|NCT02289690|156946567|FG007|Overall Study|Withdrawal by Subject|0|||
48753941|NCT02289690|156946568|FG008|Overall Study|Withdrawal by Subject|4|||
48753942|NCT02289690|156946569|FG009|Overall Study|Withdrawal by Subject|2|||
48753943|NCT02289690|156946560|FG000|Overall Study|Progressive Disease, Per Protocol|3|||
48960646|NCT00617409|157685729|FG000|Overall Study|Disease Progression|8|||
48960647|NCT00617409|157685730|FG001|Overall Study|Disease Progression|8|||
48960648|NCT00617409|157685731|FG002|Overall Study|Disease Progression|18|||
48654498|NCT01892436|156589723|FG000|Overall Study|Physician Decision|2|||
48654499|NCT01892436|156589724|FG001|Overall Study|Physician Decision|1|||
48654500|NCT01892436|156589725|FG002|Overall Study|Physician Decision|0|||
48753944|NCT02289690|156946561|FG001|Overall Study|Progressive Disease, Per Protocol|2|||
48753945|NCT02289690|156946562|FG002|Overall Study|Progressive Disease, Per Protocol|3|||
48753946|NCT02289690|156946563|FG003|Overall Study|Progressive Disease, Per Protocol|2|||
48753947|NCT02289690|156946564|FG004|Overall Study|Progressive Disease, Per Protocol|5|||
48753948|NCT02289690|156946565|FG005|Overall Study|Progressive Disease, Per Protocol|13|||
48753949|NCT02289690|156946566|FG006|Overall Study|Progressive Disease, Per Protocol|2|||
48753950|NCT02289690|156946567|FG007|Overall Study|Progressive Disease, Per Protocol|0|||
48753951|NCT02289690|156946568|FG008|Overall Study|Progressive Disease, Per Protocol|0|||
48960649|NCT00617409|157685729|FG000|Overall Study|Death|3|||
48960650|NCT00617409|157685730|FG001|Overall Study|Death|5|||
48960651|NCT00617409|157685731|FG002|Overall Study|Death|4|||
48960652|NCT00617409|157685729|FG000|Overall Study|Alternative Therapy|1|||
48960653|NCT00617409|157685730|FG001|Overall Study|Alternative Therapy|2|||
48960654|NCT00617409|157685731|FG002|Overall Study|Alternative Therapy|0|||
48960655|NCT02841787|157685745|FG000|Overall Study|Lost to Follow-up|1|||
48960656|NCT02841787|157685746|FG001|Overall Study|Lost to Follow-up|0|||
48960657|NCT02841787|157685747|FG002|Overall Study|Lost to Follow-up|0|||
48960658|NCT02841787|157685745|FG000|Overall Study|Symptoms dropped below threshold|1|||
48960659|NCT02841787|157685746|FG001|Overall Study|Symptoms dropped below threshold|0|||
48960660|NCT02841787|157685747|FG002|Overall Study|Symptoms dropped below threshold|0|||
48960661|NCT02841787|157685745|FG000|Overall Study|Withdrawal by Subject|1|||
48960662|NCT02841787|157685746|FG001|Overall Study|Withdrawal by Subject|4|||
48960663|NCT02841787|157685747|FG002|Overall Study|Withdrawal by Subject|0|||
48654501|NCT01892436|156589726|FG003|Overall Study|Physician Decision|1|||
48654502|NCT01892436|156589723|FG000|Overall Study|Pregnancy|0|||
48654503|NCT01892436|156589724|FG001|Overall Study|Pregnancy|2|||
48654504|NCT01892436|156589725|FG002|Overall Study|Pregnancy|1|||
48654505|NCT01892436|156589726|FG003|Overall Study|Pregnancy|0|||
48654506|NCT01892436|156589723|FG000|Overall Study|Technical problems|2|||
48654507|NCT01892436|156589724|FG001|Overall Study|Technical problems|1|||
48654508|NCT01892436|156589725|FG002|Overall Study|Technical problems|1|||
48654509|NCT01892436|156589726|FG003|Overall Study|Technical problems|1|||
48654510|NCT01892436|156589723|FG000|Overall Study|Lack of Efficacy|1|||
48654511|NCT01892436|156589724|FG001|Overall Study|Lack of Efficacy|2|||
48654512|NCT01892436|156589725|FG002|Overall Study|Lack of Efficacy|2|||
48654513|NCT01892436|156589726|FG003|Overall Study|Lack of Efficacy|2|||
48654514|NCT01892436|156589723|FG000|Overall Study|Lost to Follow-up|1|||
48654515|NCT01892436|156589724|FG001|Overall Study|Lost to Follow-up|1|||
48654516|NCT01892436|156589725|FG002|Overall Study|Lost to Follow-up|1|||
48654517|NCT01892436|156589726|FG003|Overall Study|Lost to Follow-up|3|||
48654518|NCT01892436|156589723|FG000|Overall Study|non-compliance with treatment|1|||
48654519|NCT01892436|156589724|FG001|Overall Study|non-compliance with treatment|0|||
48654520|NCT01892436|156589725|FG002|Overall Study|non-compliance with treatment|0|||
48654521|NCT01892436|156589726|FG003|Overall Study|non-compliance with treatment|0|||
48654522|NCT01892436|156589723|FG000|Overall Study|Adverse Event|7|||
48654523|NCT01892436|156589724|FG001|Overall Study|Adverse Event|6|||
48654524|NCT01892436|156589725|FG002|Overall Study|Adverse Event|2|||
48654525|NCT01892436|156589726|FG003|Overall Study|Adverse Event|3|||
48654526|NCT00733291|156589727|FG000|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1|||
48654527|NCT00733291|156589728|FG001|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
48654528|NCT00733291|156589729|FG002|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
48654529|NCT00733291|156589730|FG003|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
48654530|NCT05791565|156589732|FG000|Washout Period (Minimum 72 Hours)|Adverse Event|1|||
48654531|NCT05791565|156589733|FG001|Washout Period (Minimum 72 Hours)|Adverse Event|0|||
48654532|NCT01406938|156589734|FG000|Induction Period|Subject/guardian decision|6|||
48654533|NCT01406938|156589735|FG001|Induction Period|Subject/guardian decision|8|||
48654534|NCT01406938|156589736|FG002|Induction Period|Subject/guardian decision|0|||
48654535|NCT01406938|156589737|FG003|Induction Period|Subject/guardian decision|0|||
48654536|NCT01406938|156589738|FG004|Induction Period|Subject/guardian decision|0|||
48654537|NCT01406938|156589739|FG005|Induction Period|Subject/guardian decision|0|||
48654538|NCT01406938|156589734|FG000|Induction Period|Protocol deviation|1|||
48654539|NCT01406938|156589735|FG001|Induction Period|Protocol deviation|0|||
48654540|NCT01406938|156589736|FG002|Induction Period|Protocol deviation|0|||
48654541|NCT01406938|156589737|FG003|Induction Period|Protocol deviation|0|||
48654542|NCT01406938|156589738|FG004|Induction Period|Protocol deviation|0|||
48654543|NCT01406938|156589739|FG005|Induction Period|Protocol deviation|0|||
48654544|NCT01406938|156589734|FG000|Induction Period|Adverse Event|8|||
48654545|NCT01406938|156589735|FG001|Induction Period|Adverse Event|9|||
48654546|NCT01406938|156589736|FG002|Induction Period|Adverse Event|0|||
48654547|NCT01406938|156589737|FG003|Induction Period|Adverse Event|0|||
48654548|NCT01406938|156589738|FG004|Induction Period|Adverse Event|0|||
48654549|NCT01406938|156589739|FG005|Induction Period|Adverse Event|0|||
48654550|NCT01406938|156589734|FG000|Induction Period|Lack of Efficacy|1|||
48654551|NCT01406938|156589735|FG001|Induction Period|Lack of Efficacy|0|||
48654552|NCT01406938|156589736|FG002|Induction Period|Lack of Efficacy|0|||
48654553|NCT01406938|156589737|FG003|Induction Period|Lack of Efficacy|0|||
48654554|NCT01406938|156589738|FG004|Induction Period|Lack of Efficacy|0|||
48654555|NCT01406938|156589739|FG005|Induction Period|Lack of Efficacy|0|||
48654556|NCT01406938|156589734|FG000|Induction Period|Lost to Follow-up|2|||
48654557|NCT01406938|156589735|FG001|Induction Period|Lost to Follow-up|3|||
48654558|NCT01406938|156589736|FG002|Induction Period|Lost to Follow-up|0|||
48654559|NCT01406938|156589737|FG003|Induction Period|Lost to Follow-up|0|||
48654560|NCT01406938|156589738|FG004|Induction Period|Lost to Follow-up|0|||
48960664|NCT01069523|157685748|FG000|Overall Study|Withdrawal by Subject|4|||
48960665|NCT01069523|157685749|FG001|Overall Study|Withdrawal by Subject|7|||
48753952|NCT02289690|156946569|FG009|Overall Study|Progressive Disease, Per Protocol|0|||
48753953|NCT02289690|156946560|FG000|Overall Study|Lost to Follow-up|0|||
48753954|NCT02289690|156946561|FG001|Overall Study|Lost to Follow-up|0|||
48753955|NCT02289690|156946562|FG002|Overall Study|Lost to Follow-up|0|||
48753956|NCT02289690|156946563|FG003|Overall Study|Lost to Follow-up|0|||
48753957|NCT02289690|156946564|FG004|Overall Study|Lost to Follow-up|0|||
48753958|NCT02289690|156946565|FG005|Overall Study|Lost to Follow-up|0|||
48753959|NCT02289690|156946566|FG006|Overall Study|Lost to Follow-up|0|||
48753960|NCT02289690|156946567|FG007|Overall Study|Lost to Follow-up|1|||
48753961|NCT02289690|156946568|FG008|Overall Study|Lost to Follow-up|0|||
48753962|NCT02289690|156946569|FG009|Overall Study|Lost to Follow-up|2|||
48753963|NCT02289690|156946560|FG000|Overall Study|Death|0|||
48753964|NCT02289690|156946561|FG001|Overall Study|Death|0|||
48753965|NCT02289690|156946562|FG002|Overall Study|Death|0|||
48753966|NCT02289690|156946563|FG003|Overall Study|Death|0|||
48753967|NCT02289690|156946564|FG004|Overall Study|Death|0|||
48753968|NCT02289690|156946565|FG005|Overall Study|Death|0|||
48753969|NCT02289690|156946566|FG006|Overall Study|Death|0|||
48753970|NCT02289690|156946567|FG007|Overall Study|Death|49|||
48753971|NCT02289690|156946568|FG008|Overall Study|Death|45|||
48753972|NCT02289690|156946569|FG009|Overall Study|Death|41|||
48753973|NCT02289690|156946560|FG000|Overall Study|Sponsor Discontinued Study|0|||
48753974|NCT02289690|156946561|FG001|Overall Study|Sponsor Discontinued Study|0|||
48753975|NCT02289690|156946562|FG002|Overall Study|Sponsor Discontinued Study|0|||
48753976|NCT02289690|156946563|FG003|Overall Study|Sponsor Discontinued Study|0|||
48753977|NCT02289690|156946564|FG004|Overall Study|Sponsor Discontinued Study|0|||
48753978|NCT02289690|156946565|FG005|Overall Study|Sponsor Discontinued Study|0|||
48753979|NCT02289690|156946566|FG006|Overall Study|Sponsor Discontinued Study|0|||
48753980|NCT02289690|156946567|FG007|Overall Study|Sponsor Discontinued Study|9|||
48753981|NCT02289690|156946568|FG008|Overall Study|Sponsor Discontinued Study|7|||
48654561|NCT01406938|156589739|FG005|Induction Period|Lost to Follow-up|0|||
48654562|NCT01406938|156589734|FG000|Maintenance Period|Adverse Event|0|||
48654563|NCT01406938|156589735|FG001|Maintenance Period|Adverse Event|0|||
48654564|NCT01406938|156589736|FG002|Maintenance Period|Adverse Event|2|||
48654565|NCT01406938|156589737|FG003|Maintenance Period|Adverse Event|8|||
48654566|NCT01406938|156589738|FG004|Maintenance Period|Adverse Event|4|||
48654567|NCT01406938|156589739|FG005|Maintenance Period|Adverse Event|2|||
48753982|NCT02289690|156946569|FG009|Overall Study|Sponsor Discontinued Study|15|||
48753983|NCT02289690|156946560|FG000|Overall Study|Other|0|||
48753984|NCT02289690|156946561|FG001|Overall Study|Other|0|||
48753985|NCT02289690|156946562|FG002|Overall Study|Other|0|||
48753986|NCT02289690|156946563|FG003|Overall Study|Other|1|||
48753987|NCT02289690|156946564|FG004|Overall Study|Other|1|||
48753988|NCT02289690|156946565|FG005|Overall Study|Other|0|||
48753989|NCT02289690|156946566|FG006|Overall Study|Other|1|||
48753990|NCT02289690|156946567|FG007|Overall Study|Other|2|||
48753991|NCT02289690|156946568|FG008|Overall Study|Other|3|||
48753992|NCT02289690|156946569|FG009|Overall Study|Other|1|||
48753993|NCT04273217|156946570|FG000|Overall Study|Lost to Follow-up|0|||
48753994|NCT04273217|156946571|FG001|Overall Study|Lost to Follow-up|0|||
48753995|NCT04273217|156946572|FG002|Overall Study|Lost to Follow-up|0|||
48753996|NCT04273217|156946573|FG003|Overall Study|Lost to Follow-up|0|||
48753997|NCT04273217|156946574|FG004|Overall Study|Lost to Follow-up|0|||
48753998|NCT04273217|156946575|FG005|Overall Study|Lost to Follow-up|1|||
48654568|NCT01406938|156589734|FG000|Maintenance Period|Death|0|||
48654569|NCT01406938|156589735|FG001|Maintenance Period|Death|0|||
48654570|NCT01406938|156589736|FG002|Maintenance Period|Death|0|||
48753999|NCT04273217|156946570|FG000|Overall Study|Participant non-compliance|0|||
48754000|NCT04273217|156946571|FG001|Overall Study|Participant non-compliance|0|||
48754001|NCT04273217|156946572|FG002|Overall Study|Participant non-compliance|0|||
48754002|NCT04273217|156946573|FG003|Overall Study|Participant non-compliance|0|||
48654571|NCT01406938|156589737|FG003|Maintenance Period|Death|0|||
48654572|NCT01406938|156589738|FG004|Maintenance Period|Death|1|||
48754003|NCT04273217|156946574|FG004|Overall Study|Participant non-compliance|1|||
48754004|NCT04273217|156946575|FG005|Overall Study|Participant non-compliance|0|||
48754005|NCT04273217|156946570|FG000|Overall Study|Positive urine drug screen|1|||
48754006|NCT04273217|156946571|FG001|Overall Study|Positive urine drug screen|0|||
48754007|NCT04273217|156946572|FG002|Overall Study|Positive urine drug screen|1|||
48654573|NCT01406938|156589739|FG005|Maintenance Period|Death|0|||
48654574|NCT01406938|156589734|FG000|Maintenance Period|Subject/guardian decision|0|||
48754008|NCT04273217|156946573|FG003|Overall Study|Positive urine drug screen|0|||
48754009|NCT04273217|156946574|FG004|Overall Study|Positive urine drug screen|0|||
48754010|NCT04273217|156946575|FG005|Overall Study|Positive urine drug screen|1|||
48754011|NCT00779467|156946578|FG000|Overall Study|Lack of Efficacy|11|||
48754012|NCT00779467|156946579|FG001|Overall Study|Lack of Efficacy|2|||
48754013|NCT00779467|156946580|FG002|Overall Study|Lack of Efficacy|6|||
48754014|NCT00779467|156946581|FG003|Overall Study|Lack of Efficacy|11|||
48754015|NCT00779467|156946578|FG000|Overall Study|failed inclusion criteria|3|||
48754016|NCT00779467|156946579|FG001|Overall Study|failed inclusion criteria|3|||
48754017|NCT00779467|156946580|FG002|Overall Study|failed inclusion criteria|1|||
48754018|NCT00779467|156946581|FG003|Overall Study|failed inclusion criteria|2|||
48654575|NCT01406938|156589735|FG001|Maintenance Period|Subject/guardian decision|0|||
48654576|NCT01406938|156589736|FG002|Maintenance Period|Subject/guardian decision|11|||
48654577|NCT01406938|156589737|FG003|Maintenance Period|Subject/guardian decision|7|||
48654578|NCT01406938|156589738|FG004|Maintenance Period|Subject/guardian decision|10|||
48654579|NCT01406938|156589739|FG005|Maintenance Period|Subject/guardian decision|7|||
48960666|NCT01912729|157685752|FG000|Overall Study|Withdrawal by Subject|0|||
48960667|NCT01912729|157685753|FG001|Overall Study|Withdrawal by Subject|1|||
48960668|NCT03029650|157685754|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
48960669|NCT03029650|157685755|FG001|Washout (1 Week)|Withdrawal by Subject|1|||
48960670|NCT03029650|157685754|FG000|Washout (1 Week)|Physician Decision|0|||
48960671|NCT03029650|157685755|FG001|Washout (1 Week)|Physician Decision|1|||
48960672|NCT00712322|157685756|FG000|Overall Study|Protocol deviation|0|||
48654580|NCT01406938|156589734|FG000|Maintenance Period|Protocol Violation|0|||
48654581|NCT01406938|156589735|FG001|Maintenance Period|Protocol Violation|0|||
48654582|NCT01406938|156589736|FG002|Maintenance Period|Protocol Violation|2|||
48654583|NCT01406938|156589737|FG003|Maintenance Period|Protocol Violation|2|||
48654584|NCT01406938|156589738|FG004|Maintenance Period|Protocol Violation|2|||
48654585|NCT01406938|156589739|FG005|Maintenance Period|Protocol Violation|2|||
48654586|NCT01406938|156589734|FG000|Maintenance Period|Pregnancy|0|||
48654587|NCT01406938|156589735|FG001|Maintenance Period|Pregnancy|0|||
48654588|NCT01406938|156589736|FG002|Maintenance Period|Pregnancy|0|||
48654589|NCT01406938|156589737|FG003|Maintenance Period|Pregnancy|0|||
48654590|NCT01406938|156589738|FG004|Maintenance Period|Pregnancy|1|||
48654591|NCT01406938|156589739|FG005|Maintenance Period|Pregnancy|0|||
48654592|NCT01406938|156589734|FG000|Maintenance Period|Lost to Follow-up|0|||
48654593|NCT01406938|156589735|FG001|Maintenance Period|Lost to Follow-up|0|||
48654594|NCT01406938|156589736|FG002|Maintenance Period|Lost to Follow-up|0|||
48654595|NCT01406938|156589737|FG003|Maintenance Period|Lost to Follow-up|0|||
48654596|NCT01406938|156589738|FG004|Maintenance Period|Lost to Follow-up|4|||
48654597|NCT01406938|156589739|FG005|Maintenance Period|Lost to Follow-up|0|||
48654598|NCT01406938|156589734|FG000|Maintenance Period|Lack of Efficacy|0|||
48654599|NCT01406938|156589735|FG001|Maintenance Period|Lack of Efficacy|0|||
48654600|NCT01406938|156589736|FG002|Maintenance Period|Lack of Efficacy|2|||
48654601|NCT01406938|156589737|FG003|Maintenance Period|Lack of Efficacy|1|||
48654602|NCT01406938|156589738|FG004|Maintenance Period|Lack of Efficacy|3|||
48654603|NCT01406938|156589739|FG005|Maintenance Period|Lack of Efficacy|5|||
48654604|NCT01406938|156589734|FG000|Follow up|Lack of Efficacy|3|||
48654605|NCT01406938|156589735|FG001|Follow up|Lack of Efficacy|2|||
48654606|NCT01406938|156589736|FG002|Follow up|Lack of Efficacy|1|||
48654607|NCT01406938|156589737|FG003|Follow up|Lack of Efficacy|0|||
48654608|NCT01406938|156589738|FG004|Follow up|Lack of Efficacy|0|||
48654609|NCT01406938|156589739|FG005|Follow up|Lack of Efficacy|0|||
48654610|NCT01406938|156589734|FG000|Follow up|Patient/guardian decision|4|||
48654611|NCT01406938|156589735|FG001|Follow up|Patient/guardian decision|2|||
48654612|NCT01406938|156589736|FG002|Follow up|Patient/guardian decision|4|||
48654613|NCT01406938|156589737|FG003|Follow up|Patient/guardian decision|2|||
48654614|NCT01406938|156589738|FG004|Follow up|Patient/guardian decision|4|||
48654615|NCT01406938|156589739|FG005|Follow up|Patient/guardian decision|1|||
48654616|NCT01406938|156589734|FG000|Follow up|Protocol Violation|0|||
48654617|NCT01406938|156589735|FG001|Follow up|Protocol Violation|0|||
48654618|NCT01406938|156589736|FG002|Follow up|Protocol Violation|1|||
48654619|NCT01406938|156589737|FG003|Follow up|Protocol Violation|0|||
48654620|NCT01406938|156589738|FG004|Follow up|Protocol Violation|0|||
48654621|NCT01406938|156589739|FG005|Follow up|Protocol Violation|0|||
48654622|NCT01406938|156589734|FG000|Follow up|Physician Decision|0|||
48654623|NCT01406938|156589735|FG001|Follow up|Physician Decision|0|||
48654624|NCT01406938|156589736|FG002|Follow up|Physician Decision|2|||
48654625|NCT01406938|156589737|FG003|Follow up|Physician Decision|0|||
48654626|NCT01406938|156589738|FG004|Follow up|Physician Decision|3|||
48654627|NCT01406938|156589739|FG005|Follow up|Physician Decision|1|||
48654628|NCT01406938|156589734|FG000|Follow up|Lost to Follow-up|1|||
48654629|NCT01406938|156589735|FG001|Follow up|Lost to Follow-up|1|||
48654630|NCT01406938|156589736|FG002|Follow up|Lost to Follow-up|0|||
48654631|NCT01406938|156589737|FG003|Follow up|Lost to Follow-up|1|||
48960673|NCT00712322|157685757|FG001|Overall Study|Protocol deviation|1|||
48654632|NCT01406938|156589738|FG004|Follow up|Lost to Follow-up|2|||
48654633|NCT01406938|156589739|FG005|Follow up|Lost to Follow-up|1|||
48654634|NCT00713349|156589740|FG000|Overall Study|Protocol Violation|1|||
48654635|NCT05260073|156589741|FG000|Overall Study|Physician Decision|1|||
48654636|NCT05260073|156589741|FG000|Overall Study|Withdrawal by Subject|6|||
48654637|NCT05260073|156589741|FG000|Overall Study|Lost to Follow-up|14|||
48654638|NCT01885208|156589743|FG000|Overall Study|Unclassified|32|||
48654639|NCT01885208|156589744|FG001|Overall Study|Unclassified|38|||
48654640|NCT02516098|156589747|FG000|Period 1|Protocol Violation|1|||
48654641|NCT02516098|156589748|FG001|Period 1|Protocol Violation|0|||
48654642|NCT02516098|156589747|FG000|Washout After Period 1|Adverse Event|0|||
48960674|NCT00712322|157685758|FG002|Overall Study|Protocol deviation|0|||
48960675|NCT00621855|157685775|FG000|Overall Study|Adverse Event|32|||
48960676|NCT00621855|157685776|FG001|Overall Study|Adverse Event|31|||
48960677|NCT00621855|157685777|FG002|Overall Study|Adverse Event|48|||
48960678|NCT00621855|157685778|FG003|Overall Study|Adverse Event|34|||
48960679|NCT00621855|157685779|FG004|Overall Study|Adverse Event|31|||
48960680|NCT00621855|157685775|FG000|Overall Study|Lost to Follow-up|0|||
48960681|NCT00621855|157685776|FG001|Overall Study|Lost to Follow-up|1|||
48960682|NCT00621855|157685777|FG002|Overall Study|Lost to Follow-up|3|||
48960683|NCT00621855|157685778|FG003|Overall Study|Lost to Follow-up|4|||
48960684|NCT00621855|157685779|FG004|Overall Study|Lost to Follow-up|1|||
48960685|NCT00621855|157685775|FG000|Overall Study|Protocol Violation|16|||
48960686|NCT00621855|157685776|FG001|Overall Study|Protocol Violation|8|||
48960687|NCT00621855|157685777|FG002|Overall Study|Protocol Violation|6|||
48960688|NCT00621855|157685778|FG003|Overall Study|Protocol Violation|7|||
48960689|NCT00621855|157685779|FG004|Overall Study|Protocol Violation|8|||
48960690|NCT00621855|157685775|FG000|Overall Study|Withdrawal by Subject|16|||
48960691|NCT00621855|157685776|FG001|Overall Study|Withdrawal by Subject|11|||
48960692|NCT00621855|157685777|FG002|Overall Study|Withdrawal by Subject|13|||
48960693|NCT00621855|157685778|FG003|Overall Study|Withdrawal by Subject|13|||
48960694|NCT00621855|157685779|FG004|Overall Study|Withdrawal by Subject|9|||
48960695|NCT00621855|157685775|FG000|Overall Study|Other|9|||
48960696|NCT00621855|157685776|FG001|Overall Study|Other|7|||
48960697|NCT00621855|157685777|FG002|Overall Study|Other|6|||
48960698|NCT00621855|157685778|FG003|Overall Study|Other|5|||
48960699|NCT00621855|157685779|FG004|Overall Study|Other|4|||
48960700|NCT00621855|157685775|FG000|Overall Study|Patients did not receive study drug|3|||
48960701|NCT00621855|157685776|FG001|Overall Study|Patients did not receive study drug|3|||
48960702|NCT00621855|157685777|FG002|Overall Study|Patients did not receive study drug|5|||
48960703|NCT00621855|157685778|FG003|Overall Study|Patients did not receive study drug|4|||
48960704|NCT00621855|157685779|FG004|Overall Study|Patients did not receive study drug|2|||
48960705|NCT01934192|157685782|FG000|Overall Study|Protocol Violation|0|||
48960706|NCT01934192|157685783|FG001|Overall Study|Protocol Violation|0|||
48960707|NCT01934192|157685784|FG002|Overall Study|Protocol Violation|0|||
48960708|NCT01934192|157685785|FG003|Overall Study|Protocol Violation|1|||
48960709|NCT01934192|157685782|FG000|Overall Study|Other: reached stopping criteria|6|||
48960710|NCT01934192|157685783|FG001|Overall Study|Other: reached stopping criteria|5|||
48960711|NCT01934192|157685784|FG002|Overall Study|Other: reached stopping criteria|1|||
48960712|NCT01934192|157685785|FG003|Overall Study|Other: reached stopping criteria|0|||
48960713|NCT01934192|157685782|FG000|Overall Study|Physician Decision|3|||
48960714|NCT01934192|157685783|FG001|Overall Study|Physician Decision|2|||
48654643|NCT02516098|156589748|FG001|Washout After Period 1|Adverse Event|1|||
48654644|NCT02516098|156589747|FG000|Period 2|Withdrawal by Subject|0|||
48654645|NCT02516098|156589748|FG001|Period 2|Withdrawal by Subject|1|||
48654646|NCT01126268|156589751|FG000|Overall Study|Adverse Event|1|||
48654647|NCT04026009|156589752|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
48654648|NCT04026009|156589753|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
48654649|NCT04026009|156589754|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
48654650|NCT04026009|156589755|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
48654651|NCT04026009|156589756|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
48654652|NCT04026009|156589752|FG000|Overall Study|Consent withdrawal, not due to adverse event|0|||
48654653|NCT04026009|156589753|FG001|Overall Study|Consent withdrawal, not due to adverse event|0|||
48654654|NCT04026009|156589754|FG002|Overall Study|Consent withdrawal, not due to adverse event|0|||
48654655|NCT04026009|156589755|FG003|Overall Study|Consent withdrawal, not due to adverse event|0|||
48654656|NCT04026009|156589756|FG004|Overall Study|Consent withdrawal, not due to adverse event|1|||
48654657|NCT03425006|156589757|FG000|Overall Study|Withdrawal by Subject|1|||
48654658|NCT03425006|156589757|FG000|Overall Study|Physician Decision|1|||
48654659|NCT03425006|156589757|FG000|Overall Study|Death|1|||
48654660|NCT00778375|156589766|FG000|Overall Study|Ineligible|3|||
48654661|NCT03333252|156589767|FG000|Overall Study|Adverse Event|10|||
48654662|NCT03333252|156589768|FG001|Overall Study|Adverse Event|6|||
48654663|NCT03333252|156589769|FG002|Overall Study|Adverse Event|5|||
48754019|NCT00779467|156946578|FG000|Overall Study|missing data|1|||
48754020|NCT00779467|156946579|FG001|Overall Study|missing data|0|||
48960715|NCT01934192|157685784|FG002|Overall Study|Physician Decision|0|||
48960716|NCT01934192|157685785|FG003|Overall Study|Physician Decision|0|||
48960717|NCT03011034|157685786|FG000|Overall Study|Adverse Event|1|||
48960718|NCT03011034|157685787|FG001|Overall Study|Adverse Event|0|||
48654664|NCT03333252|156589770|FG003|Overall Study|Adverse Event|2|||
48960719|NCT03105700|157685790|FG000|Overall Study|screen fail|3|||
48654665|NCT03333252|156589767|FG000|Overall Study|Death|1|||
48654666|NCT03333252|156589768|FG001|Overall Study|Death|3|||
48654667|NCT03333252|156589769|FG002|Overall Study|Death|0|||
48754021|NCT00779467|156946580|FG002|Overall Study|missing data|1|||
48960720|NCT03105700|157685790|FG000|Overall Study|Lost to Follow-up|4|||
48960721|NCT00929734|157685791|FG000|Overall Study|Lost to Follow-up|2|||
48960722|NCT00929734|157685792|FG001|Overall Study|Lost to Follow-up|1|||
48960723|NCT00929734|157685791|FG000|Overall Study|Withdrawal by Subject|0|||
48960724|NCT00929734|157685792|FG001|Overall Study|Withdrawal by Subject|2|||
48754022|NCT00779467|156946581|FG003|Overall Study|missing data|4|||
48754023|NCT00779467|156946578|FG000|Overall Study|technical issue|0|||
48754024|NCT00779467|156946579|FG001|Overall Study|technical issue|0|||
48754025|NCT00779467|156946580|FG002|Overall Study|technical issue|2|||
48754026|NCT00779467|156946581|FG003|Overall Study|technical issue|1|||
48754027|NCT00779467|156946578|FG000|Overall Study|unavailable research staff|0|||
48754028|NCT00779467|156946579|FG001|Overall Study|unavailable research staff|0|||
48754029|NCT00779467|156946580|FG002|Overall Study|unavailable research staff|0|||
48754030|NCT00779467|156946581|FG003|Overall Study|unavailable research staff|1|||
48754031|NCT00390858|156946594|FG000|Overall Study|Adverse Event|6|||
48754032|NCT00390858|156946595|FG001|Overall Study|Adverse Event|2|||
48754033|NCT00390858|156946594|FG000|Overall Study|Lack of Efficacy|0|||
48754034|NCT00390858|156946595|FG001|Overall Study|Lack of Efficacy|1|||
48754035|NCT00390858|156946594|FG000|Overall Study|Withdrawal by Subject|3|||
48754036|NCT00390858|156946595|FG001|Overall Study|Withdrawal by Subject|4|||
48754037|NCT00450450|156946596|FG000|Overall Study|Death|1|||
48754038|NCT00450450|156946597|FG001|Overall Study|Death|3|||
48754039|NCT00450450|156946596|FG000|Overall Study|Relapse|2|||
48754040|NCT00450450|156946597|FG001|Overall Study|Relapse|0|||
48754041|NCT00450450|156946596|FG000|Overall Study|Missing Data|2|||
48754042|NCT00450450|156946597|FG001|Overall Study|Missing Data|0|||
48754043|NCT01314443|156946598|FG000|Overall Study|Withdrawal by Subject|2|||
48754044|NCT01314443|156946599|FG001|Overall Study|Withdrawal by Subject|1|||
48754045|NCT01314443|156946600|FG002|Overall Study|Withdrawal by Subject|1|||
48754046|NCT01314443|156946601|FG003|Overall Study|Withdrawal by Subject|1|||
48754047|NCT01314443|156946598|FG000|Overall Study|Protocol Violation|2|||
48754048|NCT01314443|156946599|FG001|Overall Study|Protocol Violation|2|||
48754049|NCT01314443|156946600|FG002|Overall Study|Protocol Violation|1|||
48754050|NCT01314443|156946601|FG003|Overall Study|Protocol Violation|1|||
48754051|NCT00759954|156946603|FG000|Overall Study|Personal reason|1|||
48754052|NCT00759954|156946604|FG001|Overall Study|Personal reason|0|||
48754053|NCT00759954|156946603|FG000|Overall Study|Adverse Event|1|||
48754054|NCT00759954|156946604|FG001|Overall Study|Adverse Event|2|||
48754055|NCT02875860|156946605|FG000|Overall Study|Withdrawal by Subject|0|||
48754056|NCT02875860|156946606|FG001|Overall Study|Withdrawal by Subject|1|||
48754057|NCT01156311|156946607|FG000|2-Month Monotherapy Period|Withdrawal by Subject|1|||
48754058|NCT01156311|156946608|FG001|2-Month Monotherapy Period|Withdrawal by Subject|1|||
48754059|NCT01156311|156946609|FG002|2-Month Monotherapy Period|Withdrawal by Subject|0|||
48754060|NCT01156311|156946610|FG003|2-Month Monotherapy Period|Withdrawal by Subject|0|||
48754061|NCT01156311|156946607|FG000|2-Month Monotherapy Period|Physician Decision|0|||
48754062|NCT01156311|156946608|FG001|2-Month Monotherapy Period|Physician Decision|1|||
48754063|NCT01156311|156946609|FG002|2-Month Monotherapy Period|Physician Decision|0|||
48754064|NCT01156311|156946610|FG003|2-Month Monotherapy Period|Physician Decision|0|||
48754065|NCT01156311|156946607|FG000|2-Month Monotherapy Period|Other|1|||
48754066|NCT01156311|156946608|FG001|2-Month Monotherapy Period|Other|0|||
48754067|NCT01156311|156946609|FG002|2-Month Monotherapy Period|Other|0|||
48754068|NCT01156311|156946610|FG003|2-Month Monotherapy Period|Other|0|||
48754069|NCT01156311|156946607|FG000|6-month Add-on Therapy Period|Adverse Event|0|||
48960725|NCT00980980|157685798|FG000|Overall Study|Withdrawal by Hospital|0|||
48960726|NCT00980980|157685799|FG001|Overall Study|Withdrawal by Hospital|1|||
48960727|NCT00980980|157685800|FG002|Overall Study|Withdrawal by Hospital|0|||
48960728|NCT03666858|157685801|FG000|Cohort 1|Adverse Event|1|||
48960729|NCT03666858|157685802|FG001|Cohort 1|Adverse Event|0|||
48654668|NCT03333252|156589770|FG003|Overall Study|Death|0|||
48654669|NCT03333252|156589767|FG000|Overall Study|Lack of Efficacy|8|||
48654670|NCT03333252|156589768|FG001|Overall Study|Lack of Efficacy|4|||
48654671|NCT03333252|156589769|FG002|Overall Study|Lack of Efficacy|0|||
48654672|NCT03333252|156589770|FG003|Overall Study|Lack of Efficacy|7|||
48654673|NCT03333252|156589767|FG000|Overall Study|Lost to Follow-up|0|||
48654674|NCT03333252|156589768|FG001|Overall Study|Lost to Follow-up|5|||
48654675|NCT03333252|156589769|FG002|Overall Study|Lost to Follow-up|9|||
48754070|NCT01156311|156946608|FG001|6-month Add-on Therapy Period|Adverse Event|0|||
48754071|NCT01156311|156946609|FG002|6-month Add-on Therapy Period|Adverse Event|7|||
48754072|NCT01156311|156946610|FG003|6-month Add-on Therapy Period|Adverse Event|6|||
48754073|NCT01156311|156946607|FG000|6-month Add-on Therapy Period|Lost to Follow-up|0|||
48960730|NCT03666858|157685801|FG000|Cohort 2|Adverse Event|0|||
48654676|NCT03333252|156589770|FG003|Overall Study|Lost to Follow-up|3|||
48654677|NCT03333252|156589767|FG000|Overall Study|Withdrawal by Subject|14|||
48654678|NCT03333252|156589768|FG001|Overall Study|Withdrawal by Subject|24|||
48654679|NCT03333252|156589769|FG002|Overall Study|Withdrawal by Subject|11|||
48654680|NCT03333252|156589770|FG003|Overall Study|Withdrawal by Subject|17|||
48654681|NCT01106651|156589772|FG000|Overall Study|Adverse Event|17|||
48754074|NCT01156311|156946608|FG001|6-month Add-on Therapy Period|Lost to Follow-up|0|||
48754075|NCT01156311|156946609|FG002|6-month Add-on Therapy Period|Lost to Follow-up|2|||
48754076|NCT01156311|156946610|FG003|6-month Add-on Therapy Period|Lost to Follow-up|0|||
48754077|NCT01156311|156946607|FG000|6-month Add-on Therapy Period|Disease Activity|0|||
48754078|NCT01156311|156946608|FG001|6-month Add-on Therapy Period|Disease Activity|0|||
48960731|NCT03666858|157685802|FG001|Cohort 2|Adverse Event|1|||
48960732|NCT02921919|157685803|FG000|Overall Study|Other|5|||
48654682|NCT01106651|156589773|FG001|Overall Study|Adverse Event|9|||
48654683|NCT01106651|156589774|FG002|Overall Study|Adverse Event|23|||
48654684|NCT01106651|156589772|FG000|Overall Study|Lost to Follow-up|8|||
48654685|NCT01106651|156589773|FG001|Overall Study|Lost to Follow-up|2|||
48654686|NCT01106651|156589774|FG002|Overall Study|Lost to Follow-up|6|||
48654687|NCT01106651|156589772|FG000|Overall Study|Physician Decision|4|||
48654688|NCT01106651|156589773|FG001|Overall Study|Physician Decision|3|||
48654689|NCT01106651|156589774|FG002|Overall Study|Physician Decision|1|||
48654690|NCT01106651|156589772|FG000|Overall Study|Protocol Violation|1|||
48654691|NCT01106651|156589773|FG001|Overall Study|Protocol Violation|2|||
48654692|NCT01106651|156589774|FG002|Overall Study|Protocol Violation|1|||
48654693|NCT01106651|156589772|FG000|Overall Study|Withdrawal by Subject|14|||
48654694|NCT01106651|156589773|FG001|Overall Study|Withdrawal by Subject|7|||
48654695|NCT01106651|156589774|FG002|Overall Study|Withdrawal by Subject|4|||
48960733|NCT02921919|157685804|FG001|Overall Study|Other|6|||
48960734|NCT02921919|157685803|FG000|Overall Study|Lost to Follow-up|0|||
48960735|NCT02921919|157685804|FG001|Overall Study|Lost to Follow-up|1|||
48960736|NCT02921919|157685803|FG000|Overall Study|Withdrawal by Subject|5|||
48960737|NCT02921919|157685804|FG001|Overall Study|Withdrawal by Subject|1|||
48960738|NCT02921919|157685803|FG000|Overall Study|Disease Progression|47|||
48960739|NCT02921919|157685804|FG001|Overall Study|Disease Progression|38|||
48960740|NCT02921919|157685803|FG000|Overall Study|Physician Decision|3|||
48960741|NCT02921919|157685804|FG001|Overall Study|Physician Decision|2|||
48960742|NCT02921919|157685803|FG000|Overall Study|Adverse Event|6|||
48960743|NCT02921919|157685804|FG001|Overall Study|Adverse Event|4|||
48960744|NCT03442829|157685805|FG000|Overall Study|Scheduling clash|3|||
48960745|NCT03442829|157685806|FG001|Overall Study|Scheduling clash|1|||
48960746|NCT03442829|157685805|FG000|Overall Study|Illness unrelated to study|1|||
48960747|NCT03442829|157685806|FG001|Overall Study|Illness unrelated to study|1|||
48960748|NCT00121992|157685807|FG000|Overall Study|Treatment not received|2|||
48960749|NCT00121992|157685808|FG001|Overall Study|Treatment not received|11|||
48960750|NCT03282357|157685809|FG000|Overall Study|Lost to Follow-up|3|||
48960751|NCT03282357|157685809|FG000|Overall Study|Withdrawal by Subject|4|||
48960752|NCT03282357|157685809|FG000|Overall Study|Adverse Event|1|||
48960753|NCT03282357|157685809|FG000|Overall Study|Other|9|||
48960754|NCT00585923|157685810|FG000|Overall Study|Physician decided not to continue|31|||
48960755|NCT00585923|157685811|FG001|Overall Study|Physician decided not to continue|33|||
48960756|NCT03550131|157685812|FG000|Overall Study|Lost to Follow-up|16|||
48960757|NCT03550131|157685813|FG001|Overall Study|Lost to Follow-up|24|||
48960758|NCT03550131|157685812|FG000|Overall Study|Withdrawal by Subject|36|||
48960759|NCT03550131|157685813|FG001|Overall Study|Withdrawal by Subject|28|||
48960760|NCT03550131|157685812|FG000|Overall Study|Illness of dyad member|10|||
48960761|NCT03550131|157685813|FG001|Overall Study|Illness of dyad member|2|||
48960762|NCT03550131|157685812|FG000|Overall Study|Death of person with dementia|4|||
48960763|NCT03550131|157685813|FG001|Overall Study|Death of person with dementia|8|||
48960764|NCT02768194|157685814|FG000|Period 1|Adverse Event|0|||
48960765|NCT02768194|157685815|FG001|Period 1|Adverse Event|0|||
48960766|NCT02768194|157685816|FG002|Period 1|Adverse Event|0|||
48960767|NCT02768194|157685817|FG003|Period 1|Adverse Event|1|||
48960768|NCT02768194|157685818|FG004|Period 1|Adverse Event|0|||
48960769|NCT02768194|157685819|FG005|Period 1|Adverse Event|0|||
48960770|NCT02768194|157685814|FG000|Period 2|Other (Reason not specified)|1|||
48960771|NCT02768194|157685815|FG001|Period 2|Other (Reason not specified)|0|||
48654696|NCT01106651|156589772|FG000|Overall Study|Noncompliance with study drug|1|||
48654697|NCT01106651|156589773|FG001|Overall Study|Noncompliance with study drug|0|||
48654698|NCT01106651|156589774|FG002|Overall Study|Noncompliance with study drug|2|||
48654699|NCT01106651|156589772|FG000|Overall Study|Other|34|||
48654700|NCT01106651|156589773|FG001|Overall Study|Other|31|||
48654701|NCT01106651|156589774|FG002|Overall Study|Other|21|||
48654702|NCT01106651|156589772|FG000|Overall Study|Death|0|||
48654703|NCT01106651|156589773|FG001|Overall Study|Death|3|||
48654704|NCT01106651|156589774|FG002|Overall Study|Death|0|||
48654705|NCT01779856|156589775|FG000|Overall Study|Withdrawal by Subject|15|||
48960772|NCT02768194|157685816|FG002|Period 2|Other (Reason not specified)|0|||
48960773|NCT02768194|157685817|FG003|Period 2|Other (Reason not specified)|0|||
48960774|NCT02768194|157685818|FG004|Period 2|Other (Reason not specified)|0|||
48960775|NCT02768194|157685819|FG005|Period 2|Other (Reason not specified)|0|||
48960776|NCT02768194|157685814|FG000|Period 3|Other (Reason not specified)|0|||
48960777|NCT02768194|157685815|FG001|Period 3|Other (Reason not specified)|1|||
48960778|NCT02768194|157685816|FG002|Period 3|Other (Reason not specified)|0|||
48960779|NCT02768194|157685817|FG003|Period 3|Other (Reason not specified)|0|||
48960780|NCT02768194|157685818|FG004|Period 3|Other (Reason not specified)|0|||
48960781|NCT02768194|157685819|FG005|Period 3|Other (Reason not specified)|0|||
48654706|NCT01779856|156589775|FG000|Overall Study|Death|3|||
48654707|NCT01779856|156589775|FG000|Overall Study|Physician Decision|1|||
48960782|NCT04863014|157685820|FG000|Overall Study|Lost to Follow-up|3|||
48960783|NCT04863014|157685821|FG001|Overall Study|Lost to Follow-up|2|||
48960784|NCT04863014|157685820|FG000|Overall Study|Subject Decision|0|||
48960785|NCT04863014|157685821|FG001|Overall Study|Subject Decision|4|||
48960786|NCT00264849|157685827|FG000|Overall Study|Adverse Event|7|||
48960787|NCT00264849|157685828|FG001|Overall Study|Adverse Event|2|||
48960788|NCT00264849|157685827|FG000|Overall Study|Withdrawal by Subject|7|||
48960789|NCT00264849|157685828|FG001|Overall Study|Withdrawal by Subject|11|||
48960790|NCT00264849|157685827|FG000|Overall Study|Protocol Violation|5|||
48960791|NCT00264849|157685828|FG001|Overall Study|Protocol Violation|3|||
48960792|NCT00264849|157685827|FG000|Overall Study|Lack of Efficacy|1|||
48960793|NCT00264849|157685828|FG001|Overall Study|Lack of Efficacy|6|||
48960794|NCT00264849|157685827|FG000|Overall Study|Lost to Follow-up|0|||
48960795|NCT00264849|157685828|FG001|Overall Study|Lost to Follow-up|2|||
48960796|NCT00264849|157685827|FG000|Overall Study|Death|0|||
48960797|NCT00264849|157685828|FG001|Overall Study|Death|1|||
48960798|NCT00264849|157685827|FG000|Overall Study|Administrative Problems|2|||
48960799|NCT00264849|157685828|FG001|Overall Study|Administrative Problems|0|||
48960800|NCT04387136|157685830|FG000|Overall Study|Protocol Deviation by SOC staff|1|||
48960801|NCT04387136|157685831|FG001|Overall Study|Protocol Deviation by SOC staff|2|||
48960802|NCT00099359|157685834|FG000|Overall Study|Death|11|||
48960803|NCT00099359|157685835|FG001|Overall Study|Death|15|||
48960804|NCT00099359|157685836|FG002|Overall Study|Death|17|||
48960805|NCT00099359|157685834|FG000|Overall Study|Withdrawal by Subject|19|||
48960806|NCT00099359|157685835|FG001|Overall Study|Withdrawal by Subject|19|||
48960807|NCT00099359|157685836|FG002|Overall Study|Withdrawal by Subject|23|||
48960808|NCT00099359|157685834|FG000|Overall Study|Lost to Follow-up|15|||
48960809|NCT00099359|157685835|FG001|Overall Study|Lost to Follow-up|24|||
48960810|NCT00099359|157685836|FG002|Overall Study|Lost to Follow-up|24|||
48960811|NCT00099359|157685834|FG000|Overall Study|moved out of area|9|||
48960812|NCT00099359|157685835|FG001|Overall Study|moved out of area|7|||
48960813|NCT00099359|157685836|FG002|Overall Study|moved out of area|4|||
48960814|NCT01982773|157685837|FG000|Overall Study|Withdrawal by Subject|1|||
48960815|NCT01982773|157685838|FG001|Overall Study|Withdrawal by Subject|3|||
48960816|NCT01982773|157685837|FG000|Overall Study|Lost to Follow-up|7|||
48960817|NCT01982773|157685838|FG001|Overall Study|Lost to Follow-up|1|||
48960818|NCT01822691|157685839|FG000|Overall Study|Withdrawal by Subject|2|||
48960819|NCT00717366|157685840|FG000|Core Study Period (20 Weeks)|Renal transplant|4|||
48960820|NCT00717366|157685841|FG001|Core Study Period (20 Weeks)|Renal transplant|9|||
48960821|NCT00717366|157685840|FG000|Core Study Period (20 Weeks)|Admin/Other than specified|0|||
48960822|NCT00717366|157685841|FG001|Core Study Period (20 Weeks)|Admin/Other than specified|2|||
48960823|NCT00717366|157685840|FG000|Core Study Period (20 Weeks)|Death|0|||
48960824|NCT00717366|157685841|FG001|Core Study Period (20 Weeks)|Death|1|||
48960825|NCT00717366|157685840|FG000|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0|||
48960826|NCT00717366|157685841|FG001|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1|||
48960827|NCT00717366|157685840|FG000|Extension Period (52 Weeks)|Renal transplant|3|||
48960828|NCT00717366|157685841|FG001|Extension Period (52 Weeks)|Renal transplant|13|||
48960829|NCT00717366|157685840|FG000|Extension Period (52 Weeks)|Admin/Other than specified|0|||
48654708|NCT01779856|156589775|FG000|Overall Study|Inclusion/Exclusion Not Met|2|||
48960830|NCT00717366|157685841|FG001|Extension Period (52 Weeks)|Admin/Other than specified|2|||
48960831|NCT00717366|157685840|FG000|Extension Period (52 Weeks)|Withdrew consent|1|||
48960832|NCT00717366|157685841|FG001|Extension Period (52 Weeks)|Withdrew consent|1|||
48960833|NCT04664855|157685846|FG000|Overall Study|Withdrawal by Subject|0|||
48960834|NCT04664855|157685847|FG001|Overall Study|Withdrawal by Subject|2|||
48960835|NCT05127421|157685849|FG000|4-Week Double-Blind Period|Lost to Follow-up|1|||
48960836|NCT05127421|157685850|FG001|4-Week Double-Blind Period|Lost to Follow-up|0|||
48960837|NCT05127421|157685851|FG002|4-Week Double-Blind Period|Lost to Follow-up|0|||
48960838|NCT05127421|157685852|FG003|4-Week Double-Blind Period|Lost to Follow-up|0|||
48960839|NCT05127421|157685849|FG000|4-Week Double-Blind Period|Physician Decision|1|||
48654709|NCT01779856|156589775|FG000|Overall Study|Delays in scheduling implant|1|||
48654710|NCT01779856|156589775|FG000|Overall Study|Subject ineligible for Implant|2|||
48654711|NCT03276026|156589785|FG000|Overall Study|Protocol Violation|1|||
48654712|NCT03276026|156589786|FG001|Overall Study|Protocol Violation|0|||
48654713|NCT02247011|156589787|FG000|Overall Study|Poor quality of radiological results|125|||
48654714|NCT01944098|156589790|FG000|Overall Study|Physician Decision|1|||
48654715|NCT01944098|156589791|FG001|Overall Study|Physician Decision|0|||
48654716|NCT00920387|156589792|FG000|Stage 1|Adverse Event|1|||
48654717|NCT00920387|156589793|FG001|Stage 1|Adverse Event|0|||
48654718|NCT00920387|156589794|FG002|Stage 1|Adverse Event|0|||
48654719|NCT00503581|156589795|FG000|Overall Study|Study closed|3|||
48654720|NCT00503581|156589796|FG001|Overall Study|Study closed|4|||
48654721|NCT00503581|156589797|FG002|Overall Study|Study closed|2|||
48654722|NCT00724854|156589798|FG000|Overall Study|Lack of Efficacy|187|||
48654723|NCT00724854|156589799|FG001|Overall Study|Lack of Efficacy|13|||
48654724|NCT00724854|156589798|FG000|Overall Study|Lost to Follow-up|87|||
48654725|NCT00724854|156589799|FG001|Overall Study|Lost to Follow-up|10|||
48960840|NCT05127421|157685850|FG001|4-Week Double-Blind Period|Physician Decision|0|||
48960841|NCT05127421|157685851|FG002|4-Week Double-Blind Period|Physician Decision|0|||
48654726|NCT00724854|156589798|FG000|Overall Study|Adverse Event|62|||
48960842|NCT05127421|157685852|FG003|4-Week Double-Blind Period|Physician Decision|0|||
48960843|NCT05127421|157685849|FG000|4-Week Double-Blind Period|Withdrawal by Subject|3|||
48960844|NCT05127421|157685850|FG001|4-Week Double-Blind Period|Withdrawal by Subject|1|||
48960845|NCT05127421|157685851|FG002|4-Week Double-Blind Period|Withdrawal by Subject|0|||
48960846|NCT05127421|157685852|FG003|4-Week Double-Blind Period|Withdrawal by Subject|0|||
48960847|NCT05127421|157685849|FG000|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
48960848|NCT05127421|157685850|FG001|4-Week Double-Blind Period|Withdrawn by Sponsor|4|||
48960849|NCT05127421|157685851|FG002|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
48960850|NCT05127421|157685852|FG003|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
48960851|NCT05127421|157685849|FG000|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
48960852|NCT05127421|157685850|FG001|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|1|||
48960853|NCT05127421|157685851|FG002|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
48960854|NCT05127421|157685852|FG003|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
48960855|NCT05127421|157685849|FG000|4-Week Open-Label Period|Lost to Follow-up|0|||
48960856|NCT05127421|157685850|FG001|4-Week Open-Label Period|Lost to Follow-up|0|||
48960857|NCT05127421|157685851|FG002|4-Week Open-Label Period|Lost to Follow-up|0|||
48960858|NCT05127421|157685852|FG003|4-Week Open-Label Period|Lost to Follow-up|1|||
48960859|NCT05127421|157685849|FG000|4-Week Open-Label Period|Withdrawal by Subject|0|||
48654727|NCT00724854|156589799|FG001|Overall Study|Adverse Event|4|||
48654728|NCT00724854|156589798|FG000|Overall Study|Other|42|||
48654729|NCT00724854|156589799|FG001|Overall Study|Other|3|||
48654730|NCT00724854|156589798|FG000|Overall Study|Death|11|||
48654731|NCT00724854|156589799|FG001|Overall Study|Death|0|||
48654732|NCT00724854|156589798|FG000|Overall Study|Change of treatment|7|||
48654733|NCT00724854|156589799|FG001|Overall Study|Change of treatment|0|||
48654734|NCT00724854|156589798|FG000|Overall Study|Withdrawal by Subject|5|||
48654735|NCT00724854|156589799|FG001|Overall Study|Withdrawal by Subject|0|||
48654736|NCT00724854|156589798|FG000|Overall Study|Adverse event + lack of efficacy|2|||
48654737|NCT00724854|156589799|FG001|Overall Study|Adverse event + lack of efficacy|1|||
48654738|NCT01096368|156589800|FG000|Overall Study|Death|0|||
48654739|NCT01096368|156589801|FG001|Overall Study|Death|1|||
48654740|NCT01096368|156589802|FG002|Overall Study|Death|0|||
48654741|NCT01096368|156589803|FG003|Overall Study|Death|0|||
48654742|NCT01096368|156589804|FG004|Overall Study|Death|0|||
48654743|NCT01096368|156589800|FG000|Overall Study|Physician Decision|0|||
48654744|NCT01096368|156589801|FG001|Overall Study|Physician Decision|13|||
48654745|NCT01096368|156589802|FG002|Overall Study|Physician Decision|2|||
48654746|NCT01096368|156589803|FG003|Overall Study|Physician Decision|4|||
48654747|NCT01096368|156589804|FG004|Overall Study|Physician Decision|6|||
48654748|NCT01096368|156589800|FG000|Overall Study|Withdrawal by Subject|0|||
48654749|NCT01096368|156589801|FG001|Overall Study|Withdrawal by Subject|52|||
48654750|NCT01096368|156589802|FG002|Overall Study|Withdrawal by Subject|0|||
48654751|NCT01096368|156589803|FG003|Overall Study|Withdrawal by Subject|10|||
48654752|NCT01096368|156589804|FG004|Overall Study|Withdrawal by Subject|14|||
48754079|NCT01156311|156946609|FG002|6-month Add-on Therapy Period|Disease Activity|1|||
48754080|NCT01156311|156946610|FG003|6-month Add-on Therapy Period|Disease Activity|2|||
48754081|NCT01156311|156946607|FG000|6-month Add-on Therapy Period|Physician Decision|0|||
48754082|NCT01156311|156946608|FG001|6-month Add-on Therapy Period|Physician Decision|0|||
48754083|NCT01156311|156946609|FG002|6-month Add-on Therapy Period|Physician Decision|1|||
48754084|NCT01156311|156946610|FG003|6-month Add-on Therapy Period|Physician Decision|0|||
48754085|NCT01156311|156946607|FG000|6-month Add-on Therapy Period|Other|0|||
48754086|NCT01156311|156946608|FG001|6-month Add-on Therapy Period|Other|0|||
48754087|NCT01156311|156946609|FG002|6-month Add-on Therapy Period|Other|1|||
48754088|NCT01156311|156946610|FG003|6-month Add-on Therapy Period|Other|2|||
48754089|NCT00372112|156946621|FG000|Overall Study|Adverse Event|0|||
48754090|NCT00372112|156946622|FG001|Overall Study|Adverse Event|1|||
48754091|NCT00372112|156946623|FG002|Overall Study|Adverse Event|1|||
48754092|NCT00372112|156946624|FG003|Overall Study|Adverse Event|1|||
48754093|NCT00372112|156946621|FG000|Overall Study|Withdrawal by Subject|0|||
48754094|NCT00372112|156946622|FG001|Overall Study|Withdrawal by Subject|0|||
48754095|NCT00372112|156946623|FG002|Overall Study|Withdrawal by Subject|2|||
48754096|NCT00372112|156946624|FG003|Overall Study|Withdrawal by Subject|1|||
48754097|NCT00372112|156946621|FG000|Overall Study|Exacerbation|0|||
48960860|NCT05127421|157685850|FG001|4-Week Open-Label Period|Withdrawal by Subject|0|||
48960861|NCT05127421|157685851|FG002|4-Week Open-Label Period|Withdrawal by Subject|1|||
48654753|NCT01096368|156589800|FG000|Overall Study|Ineligible|0|||
48654754|NCT01096368|156589801|FG001|Overall Study|Ineligible|3|||
48654755|NCT01096368|156589802|FG002|Overall Study|Ineligible|2|||
48654756|NCT01096368|156589803|FG003|Overall Study|Ineligible|0|||
48654757|NCT01096368|156589804|FG004|Overall Study|Ineligible|25|||
48654758|NCT01096368|156589800|FG000|Overall Study|Did not start treatment|0|||
48654759|NCT01096368|156589801|FG001|Overall Study|Did not start treatment|4|||
48654760|NCT01096368|156589802|FG002|Overall Study|Did not start treatment|4|||
48754098|NCT00372112|156946622|FG001|Overall Study|Exacerbation|0|||
48960862|NCT05127421|157685852|FG003|4-Week Open-Label Period|Withdrawal by Subject|1|||
48654761|NCT01096368|156589803|FG003|Overall Study|Did not start treatment|0|||
48654762|NCT01096368|156589804|FG004|Overall Study|Did not start treatment|0|||
48654763|NCT01096368|156589800|FG000|Overall Study|Progressive disease|0|||
48654764|NCT01096368|156589801|FG001|Overall Study|Progressive disease|6|||
48960863|NCT05127421|157685849|FG000|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
48960864|NCT05127421|157685850|FG001|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
48960865|NCT05127421|157685851|FG002|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
48960866|NCT05127421|157685852|FG003|4-Week Open-Label Period|Withdrawn by Sponsor|1|||
48960867|NCT02219087|157685853|FG000|Overall Study|Randomization envelope pulled out of seq|0|||
48960868|NCT02219087|157685854|FG001|Overall Study|Randomization envelope pulled out of seq|1|||
48960869|NCT00786032|157687504|FG000|Overall Study|Death|4|||
48960870|NCT00786032|157687504|FG000|Overall Study|Withdrawal by Subject|14|||
48654765|NCT01096368|156589802|FG002|Overall Study|Progressive disease|0|||
48654766|NCT01096368|156589803|FG003|Overall Study|Progressive disease|10|||
48654767|NCT01096368|156589804|FG004|Overall Study|Progressive disease|3|||
48654768|NCT01096368|156589800|FG000|Overall Study|Other|0|||
48654769|NCT01096368|156589801|FG001|Overall Study|Other|0|||
48654770|NCT01096368|156589802|FG002|Overall Study|Other|1|||
48654771|NCT01096368|156589803|FG003|Overall Study|Other|0|||
48654772|NCT01096368|156589804|FG004|Overall Study|Other|0|||
48654773|NCT01096368|156589800|FG000|Overall Study|Treated with institutional review|0|||
48654774|NCT01096368|156589801|FG001|Overall Study|Treated with institutional review|0|||
48654775|NCT01096368|156589802|FG002|Overall Study|Treated with institutional review|0|||
48654776|NCT01096368|156589803|FG003|Overall Study|Treated with institutional review|0|||
48654777|NCT01096368|156589804|FG004|Overall Study|Treated with institutional review|1|||
48654778|NCT03070223|156589805|FG000|Overall Study|Lost to Follow-up|34|||
48654779|NCT03070223|156589806|FG001|Overall Study|Lost to Follow-up|27|||
48654780|NCT03070223|156589805|FG000|Overall Study|Withdrawal by Subject|12|||
48654781|NCT03070223|156589806|FG001|Overall Study|Withdrawal by Subject|22|||
48654782|NCT03070223|156589805|FG000|Overall Study|Protocol Violation|0|||
48654783|NCT03070223|156589806|FG001|Overall Study|Protocol Violation|1|||
48654784|NCT02566785|156589809|FG000|Overall Study|Lost to Follow-up|0|||
48654785|NCT02566785|156589810|FG001|Overall Study|Lost to Follow-up|2|||
48654786|NCT02566785|156589809|FG000|Overall Study|Worsening condition|1|||
48654787|NCT02566785|156589810|FG001|Overall Study|Worsening condition|1|||
48654788|NCT03219034|156589811|FG000|Overall Study|Lost to Follow-up|9|||
48654789|NCT03219034|156589812|FG001|Overall Study|Lost to Follow-up|13|||
48654790|NCT03219034|156589811|FG000|Overall Study|Additional dental work needed|1|||
48654791|NCT03219034|156589812|FG001|Overall Study|Additional dental work needed|0|||
48654792|NCT03219034|156589811|FG000|Overall Study|UPPP Surgery|1|||
48654793|NCT03219034|156589812|FG001|Overall Study|UPPP Surgery|0|||
48654794|NCT03219034|156589811|FG000|Overall Study|Dental sensitivity|0|||
48654795|NCT03219034|156589812|FG001|Overall Study|Dental sensitivity|1|||
48654796|NCT03219034|156589811|FG000|Overall Study|Death in family|0|||
48654797|NCT03219034|156589812|FG001|Overall Study|Death in family|1|||
48654798|NCT00118846|156589813|FG000|Overall Study|Gastrointestinal (GI) intolerance|3|||
48654799|NCT00118846|156589814|FG001|Overall Study|Gastrointestinal (GI) intolerance|3|||
48654800|NCT00118846|156589813|FG000|Overall Study|Started menopausal hormone replacement therapy (HRT)|3|||
48654801|NCT00118846|156589814|FG001|Overall Study|Started menopausal hormone replacement therapy (HRT)|0|||
48654802|NCT00118846|156589813|FG000|Overall Study|Physician Decision|1|||
48654803|NCT00118846|156589814|FG001|Overall Study|Physician Decision|0|||
48654804|NCT00118846|156589813|FG000|Overall Study|Medical condition|2|||
48654805|NCT00118846|156589814|FG001|Overall Study|Medical condition|2|||
48654806|NCT00118846|156589813|FG000|Overall Study|Lost to Follow-up|0|||
48654807|NCT00118846|156589814|FG001|Overall Study|Lost to Follow-up|2|||
48654808|NCT00118846|156589813|FG000|Overall Study|Personal reason|4|||
48654809|NCT00118846|156589814|FG001|Overall Study|Personal reason|5|||
48654810|NCT01597908|156589818|FG000|Randomized Phase|Death|217|||
48654811|NCT01597908|156589819|FG001|Randomized Phase|Death|238|||
48654812|NCT01597908|156589820|FG002|Randomized Phase|Death|0|||
48654813|NCT01597908|156589818|FG000|Randomized Phase|Sponsor Decision|93|||
48654814|NCT01597908|156589819|FG001|Randomized Phase|Sponsor Decision|39|||
48654815|NCT01597908|156589820|FG002|Randomized Phase|Sponsor Decision|0|||
48960871|NCT00786032|157687504|FG000|Overall Study|Did not complete in the timeframe|6|||
48960872|NCT00745368|157687506|FG000|Overall Study|Unable to provide sample|3|||
48654816|NCT01597908|156589818|FG000|Randomized Phase|Lost to Follow-up|9|||
48654817|NCT01597908|156589819|FG001|Randomized Phase|Lost to Follow-up|16|||
48654818|NCT01597908|156589820|FG002|Randomized Phase|Lost to Follow-up|0|||
48654819|NCT01597908|156589818|FG000|Randomized Phase|Physician Decision|6|||
48654820|NCT01597908|156589819|FG001|Randomized Phase|Physician Decision|3|||
48654821|NCT01597908|156589820|FG002|Randomized Phase|Physician Decision|0|||
48960873|NCT02364947|157687507|FG000|Overall Study|Withdrawal by Subject|10|||
48960874|NCT02364947|157687508|FG001|Overall Study|Withdrawal by Subject|8|||
48654822|NCT01597908|156589818|FG000|Randomized Phase|Withdrawal by Subject|26|||
48654823|NCT01597908|156589819|FG001|Randomized Phase|Withdrawal by Subject|22|||
48654824|NCT01597908|156589820|FG002|Randomized Phase|Withdrawal by Subject|0|||
48654825|NCT01597908|156589818|FG000|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
48654826|NCT01597908|156589819|FG001|Randomized Phase|Crossover to Dabrafenib&Trametinib|34|||
48654827|NCT01597908|156589820|FG002|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
48654828|NCT01597908|156589818|FG000|Crossover Phase|Death|0|||
48654829|NCT01597908|156589819|FG001|Crossover Phase|Death|0|||
48654830|NCT01597908|156589820|FG002|Crossover Phase|Death|11|||
48654831|NCT01597908|156589818|FG000|Crossover Phase|Withdrawal by Subject|0|||
48960875|NCT02364947|157687509|FG002|Overall Study|Withdrawal by Subject|9|||
48960876|NCT02364947|157687507|FG000|Overall Study|Adverse Event|45|||
48960877|NCT02364947|157687508|FG001|Overall Study|Adverse Event|33|||
48960878|NCT02364947|157687509|FG002|Overall Study|Adverse Event|11|||
48960879|NCT02364947|157687507|FG000|Overall Study|Protocol Violation|1|||
48960880|NCT02364947|157687508|FG001|Overall Study|Protocol Violation|1|||
48960881|NCT02364947|157687509|FG002|Overall Study|Protocol Violation|1|||
48960882|NCT02364947|157687507|FG000|Overall Study|Physician Decision|3|||
48960883|NCT02364947|157687508|FG001|Overall Study|Physician Decision|2|||
48960884|NCT02364947|157687509|FG002|Overall Study|Physician Decision|5|||
48960885|NCT02364947|157687507|FG000|Overall Study|Death|0|||
48960886|NCT02364947|157687508|FG001|Overall Study|Death|1|||
48960887|NCT02364947|157687509|FG002|Overall Study|Death|0|||
48960888|NCT02939937|157687512|FG000|Overall Study|Adverse Event|5|||
48960889|NCT02939937|157687513|FG001|Overall Study|Adverse Event|0|||
48960890|NCT02939937|157687512|FG000|Overall Study|Lost to Follow-up|1|||
48960891|NCT02939937|157687513|FG001|Overall Study|Lost to Follow-up|3|||
48960892|NCT00441441|157687518|FG000|Overall Study|Adverse Event|2|||
48960893|NCT00441441|157687519|FG001|Overall Study|Adverse Event|1|||
48960894|NCT00441441|157687518|FG000|Overall Study|Protocol Violation|4|||
48960895|NCT00441441|157687519|FG001|Overall Study|Protocol Violation|6|||
48960896|NCT00441441|157687518|FG000|Overall Study|Exacerbation of asthma|1|||
48960897|NCT00441441|157687519|FG001|Overall Study|Exacerbation of asthma|2|||
48960898|NCT00441441|157687518|FG000|Overall Study|Withdrawal by Subject|1|||
48960899|NCT00441441|157687519|FG001|Overall Study|Withdrawal by Subject|2|||
48960900|NCT00441441|157687518|FG000|Overall Study|Other|3|||
48960901|NCT00441441|157687519|FG001|Overall Study|Other|3|||
48960902|NCT01354353|157687520|FG000|Overall Study|Adverse Event|1|||
48960903|NCT01354353|157687521|FG001|Overall Study|Adverse Event|0|||
48960904|NCT01354353|157687522|FG002|Overall Study|Adverse Event|0|||
48960905|NCT01354353|157687523|FG003|Overall Study|Adverse Event|4|||
48960906|NCT01354353|157687524|FG004|Overall Study|Adverse Event|0|||
48960907|NCT01354353|157687525|FG005|Overall Study|Adverse Event|5|||
48960908|NCT01354353|157687520|FG000|Overall Study|Entry Criteria Not Met|0|||
48960909|NCT01354353|157687521|FG001|Overall Study|Entry Criteria Not Met|0|||
48960910|NCT01354353|157687522|FG002|Overall Study|Entry Criteria Not Met|0|||
48960911|NCT01354353|157687523|FG003|Overall Study|Entry Criteria Not Met|1|||
48960912|NCT01354353|157687524|FG004|Overall Study|Entry Criteria Not Met|1|||
48960913|NCT01354353|157687525|FG005|Overall Study|Entry Criteria Not Met|0|||
48960914|NCT01354353|157687520|FG000|Overall Study|Physician Decision|0|||
48960915|NCT01354353|157687521|FG001|Overall Study|Physician Decision|1|||
48960916|NCT01354353|157687522|FG002|Overall Study|Physician Decision|1|||
48960917|NCT01354353|157687523|FG003|Overall Study|Physician Decision|0|||
48960918|NCT01354353|157687524|FG004|Overall Study|Physician Decision|0|||
48960919|NCT01354353|157687525|FG005|Overall Study|Physician Decision|0|||
48960920|NCT01354353|157687520|FG000|Overall Study|Withdrawal by Subject|2|||
48654832|NCT01597908|156589819|FG001|Crossover Phase|Withdrawal by Subject|0|||
48654833|NCT01597908|156589820|FG002|Crossover Phase|Withdrawal by Subject|3|||
48654834|NCT01597908|156589818|FG000|Crossover Phase|Sponsor Decision|0|||
48654835|NCT01597908|156589819|FG001|Crossover Phase|Sponsor Decision|0|||
48654836|NCT01597908|156589820|FG002|Crossover Phase|Sponsor Decision|20|||
48654837|NCT01439971|156589825|FG000|Overall Study|Required number in cohort dosed|0|||
48654838|NCT01439971|156589826|FG001|Overall Study|Required number in cohort dosed|1|||
48654839|NCT01439971|156589827|FG002|Overall Study|Required number in cohort dosed|2|||
48654840|NCT01439971|156589828|FG003|Overall Study|Required number in cohort dosed|0|||
48654841|NCT01439971|156589829|FG004|Overall Study|Required number in cohort dosed|1|||
48654842|NCT01468233|156589830|FG000|Treatment Period 1|Adverse Event|5|||
48654843|NCT01468233|156589831|FG001|Treatment Period 1|Adverse Event|3|||
48960921|NCT01354353|157687521|FG001|Overall Study|Withdrawal by Subject|0|||
48960922|NCT01354353|157687522|FG002|Overall Study|Withdrawal by Subject|1|||
48960923|NCT01354353|157687523|FG003|Overall Study|Withdrawal by Subject|0|||
48960924|NCT01354353|157687524|FG004|Overall Study|Withdrawal by Subject|0|||
48960925|NCT01354353|157687525|FG005|Overall Study|Withdrawal by Subject|1|||
48960926|NCT00831441|157687528|FG000|Randomized|Death|82|||
48960927|NCT00831441|157687529|FG001|Randomized|Death|81|||
48960928|NCT00831441|157687528|FG000|Randomized|Adverse Event|248|||
48654844|NCT01468233|156589832|FG002|Treatment Period 1|Adverse Event|0|||
48754099|NCT00372112|156946623|FG002|Overall Study|Exacerbation|0|||
48960929|NCT00831441|157687529|FG001|Randomized|Adverse Event|321|||
48960930|NCT00831441|157687528|FG000|Randomized|Emergency procedure|2|||
48960931|NCT00831441|157687529|FG001|Randomized|Emergency procedure|2|||
48960932|NCT00831441|157687528|FG000|Randomized|Elective procedure|26|||
48960933|NCT00831441|157687529|FG001|Randomized|Elective procedure|25|||
48960934|NCT00831441|157687528|FG000|Randomized|Physician Decision|26|||
48654845|NCT01468233|156589833|FG003|Treatment Period 1|Adverse Event|0|||
48960935|NCT00831441|157687529|FG001|Randomized|Physician Decision|35|||
48654846|NCT01468233|156589834|FG004|Treatment Period 1|Adverse Event|0|||
48654847|NCT01468233|156589835|FG005|Treatment Period 1|Adverse Event|0|||
48654848|NCT01468233|156589830|FG000|Treatment Period 1|Withdrawal by Subject|3|||
48654849|NCT01468233|156589831|FG001|Treatment Period 1|Withdrawal by Subject|4|||
48654850|NCT01468233|156589832|FG002|Treatment Period 1|Withdrawal by Subject|0|||
48654851|NCT01468233|156589833|FG003|Treatment Period 1|Withdrawal by Subject|0|||
48654852|NCT01468233|156589834|FG004|Treatment Period 1|Withdrawal by Subject|0|||
48654853|NCT01468233|156589835|FG005|Treatment Period 1|Withdrawal by Subject|0|||
48654854|NCT01468233|156589830|FG000|Treatment Period 1|Lost to Follow-up|3|||
48654855|NCT01468233|156589831|FG001|Treatment Period 1|Lost to Follow-up|0|||
48654856|NCT01468233|156589832|FG002|Treatment Period 1|Lost to Follow-up|0|||
48654857|NCT01468233|156589833|FG003|Treatment Period 1|Lost to Follow-up|0|||
48654858|NCT01468233|156589834|FG004|Treatment Period 1|Lost to Follow-up|0|||
48654859|NCT01468233|156589835|FG005|Treatment Period 1|Lost to Follow-up|0|||
48960936|NCT00831441|157687528|FG000|Randomized|No longer met criteria|13|||
48960937|NCT00831441|157687529|FG001|Randomized|No longer met criteria|19|||
48960938|NCT00831441|157687528|FG000|Randomized|Withdrawal by Subject|178|||
48960939|NCT00831441|157687529|FG001|Randomized|Withdrawal by Subject|212|||
48960940|NCT00831441|157687528|FG000|Randomized|Lost to Follow-up|26|||
48960941|NCT00831441|157687529|FG001|Randomized|Lost to Follow-up|35|||
48960942|NCT00831441|157687528|FG000|Randomized|Administrative reason by sponsor|2780|||
48960943|NCT00831441|157687529|FG001|Randomized|Administrative reason by sponsor|2671|||
48654860|NCT01468233|156589830|FG000|Treatment Period 1|Other|1|||
48654861|NCT01468233|156589831|FG001|Treatment Period 1|Other|1|||
48654862|NCT01468233|156589832|FG002|Treatment Period 1|Other|0|||
48654863|NCT01468233|156589833|FG003|Treatment Period 1|Other|0|||
48654864|NCT01468233|156589834|FG004|Treatment Period 1|Other|0|||
48654865|NCT01468233|156589835|FG005|Treatment Period 1|Other|0|||
48654866|NCT01468233|156589830|FG000|Treatment Period 2|Adverse Event|0|||
48654867|NCT01468233|156589831|FG001|Treatment Period 2|Adverse Event|0|||
48654868|NCT01468233|156589832|FG002|Treatment Period 2|Adverse Event|3|||
48654869|NCT01468233|156589833|FG003|Treatment Period 2|Adverse Event|0|||
48654870|NCT01468233|156589834|FG004|Treatment Period 2|Adverse Event|2|||
48654871|NCT01468233|156589835|FG005|Treatment Period 2|Adverse Event|1|||
48654872|NCT01468233|156589830|FG000|Treatment Period 2|Lack of Efficacy|0|||
48654873|NCT01468233|156589831|FG001|Treatment Period 2|Lack of Efficacy|0|||
48654874|NCT01468233|156589832|FG002|Treatment Period 2|Lack of Efficacy|9|||
48654875|NCT01468233|156589833|FG003|Treatment Period 2|Lack of Efficacy|2|||
48654876|NCT01468233|156589834|FG004|Treatment Period 2|Lack of Efficacy|0|||
48654877|NCT01468233|156589835|FG005|Treatment Period 2|Lack of Efficacy|1|||
48654878|NCT01468233|156589830|FG000|Treatment Period 2|Withdrawal by Subject|0|||
48654879|NCT01468233|156589831|FG001|Treatment Period 2|Withdrawal by Subject|0|||
48654880|NCT01468233|156589832|FG002|Treatment Period 2|Withdrawal by Subject|9|||
48654881|NCT01468233|156589833|FG003|Treatment Period 2|Withdrawal by Subject|1|||
48654882|NCT01468233|156589834|FG004|Treatment Period 2|Withdrawal by Subject|1|||
48654883|NCT01468233|156589835|FG005|Treatment Period 2|Withdrawal by Subject|1|||
48654884|NCT01468233|156589830|FG000|Treatment Period 2|Loss/absence of response (per protocol)|0|||
48654885|NCT01468233|156589831|FG001|Treatment Period 2|Loss/absence of response (per protocol)|0|||
48654886|NCT01468233|156589832|FG002|Treatment Period 2|Loss/absence of response (per protocol)|84|||
48654887|NCT01468233|156589833|FG003|Treatment Period 2|Loss/absence of response (per protocol)|25|||
48654888|NCT01468233|156589834|FG004|Treatment Period 2|Loss/absence of response (per protocol)|22|||
48654889|NCT01468233|156589835|FG005|Treatment Period 2|Loss/absence of response (per protocol)|20|||
48654890|NCT01468233|156589830|FG000|Treatment Period 2|Lost to Follow-up|0|||
48654891|NCT01468233|156589831|FG001|Treatment Period 2|Lost to Follow-up|0|||
48654892|NCT01468233|156589832|FG002|Treatment Period 2|Lost to Follow-up|3|||
48654893|NCT01468233|156589833|FG003|Treatment Period 2|Lost to Follow-up|0|||
48654894|NCT01468233|156589834|FG004|Treatment Period 2|Lost to Follow-up|2|||
48654895|NCT01468233|156589835|FG005|Treatment Period 2|Lost to Follow-up|0|||
48654896|NCT01468233|156589830|FG000|Treatment Period 2|Other|0|||
48654897|NCT01468233|156589831|FG001|Treatment Period 2|Other|0|||
48654898|NCT01468233|156589832|FG002|Treatment Period 2|Other|3|||
48654899|NCT01468233|156589833|FG003|Treatment Period 2|Other|0|||
48654900|NCT01468233|156589834|FG004|Treatment Period 2|Other|1|||
48654901|NCT01468233|156589835|FG005|Treatment Period 2|Other|0|||
48654902|NCT00578877|156589836|FG000|Overall Study|Lost to Follow-up|8|||
48960944|NCT00831441|157687528|FG000|Randomized|poor/non-compliance|30|||
48960945|NCT00831441|157687529|FG001|Randomized|poor/non-compliance|38|||
48654903|NCT00578877|156589837|FG001|Overall Study|Lost to Follow-up|10|||
48654904|NCT00578877|156589836|FG000|Overall Study|early discontinue|61|||
48654905|NCT00578877|156589837|FG001|Overall Study|early discontinue|101|||
48960946|NCT00831441|157687528|FG000|Randomized|non-specified|276|||
48960947|NCT00831441|157687529|FG001|Randomized|non-specified|266|||
48960948|NCT00831441|157687528|FG000|Follow Up (30 Days)|Withdrawal by Subject|41|||
48960949|NCT00831441|157687529|FG001|Follow Up (30 Days)|Withdrawal by Subject|34|||
48754100|NCT00372112|156946624|FG003|Overall Study|Exacerbation|1|||
48754101|NCT00372112|156946621|FG000|Overall Study|PR >240 at Visit 3|0|||
48754102|NCT00372112|156946622|FG001|Overall Study|PR >240 at Visit 3|0|||
48754103|NCT00372112|156946623|FG002|Overall Study|PR >240 at Visit 3|0|||
48754104|NCT00372112|156946624|FG003|Overall Study|PR >240 at Visit 3|1|||
48754105|NCT00372112|156946621|FG000|Overall Study|Hepatitis B|1|||
48754106|NCT00372112|156946622|FG001|Overall Study|Hepatitis B|0|||
48754107|NCT00372112|156946623|FG002|Overall Study|Hepatitis B|0|||
48754108|NCT00372112|156946624|FG003|Overall Study|Hepatitis B|0|||
48754109|NCT00372112|156946621|FG000|Overall Study|Other-protocol violation|0|||
48754110|NCT00372112|156946622|FG001|Overall Study|Other-protocol violation|0|||
48754111|NCT00372112|156946623|FG002|Overall Study|Other-protocol violation|1|||
48754112|NCT00372112|156946624|FG003|Overall Study|Other-protocol violation|0|||
48754113|NCT00429104|156946630|FG000|Overall Study|Protocol Violation|1|||
48754114|NCT00642460|156946631|FG000|Part I: 12 Week Double-Blind|Adverse Event|0|||
48754115|NCT00642460|156946632|FG001|Part I: 12 Week Double-Blind|Adverse Event|1|||
48754116|NCT00642460|156946633|FG002|Part I: 12 Week Double-Blind|Adverse Event|1|||
48754117|NCT00642460|156946634|FG003|Part I: 12 Week Double-Blind|Adverse Event|0|||
48754118|NCT00642460|156946635|FG004|Part I: 12 Week Double-Blind|Adverse Event|0|||
48754119|NCT00642460|156946636|FG005|Part I: 12 Week Double-Blind|Adverse Event|0|||
48754120|NCT00642460|156946631|FG000|Part I: 12 Week Double-Blind|Refused Treatment|1|||
48754121|NCT00642460|156946632|FG001|Part I: 12 Week Double-Blind|Refused Treatment|0|||
48754122|NCT00642460|156946633|FG002|Part I: 12 Week Double-Blind|Refused Treatment|0|||
48754123|NCT00642460|156946634|FG003|Part I: 12 Week Double-Blind|Refused Treatment|0|||
48754124|NCT00642460|156946635|FG004|Part I: 12 Week Double-Blind|Refused Treatment|0|||
48754125|NCT00642460|156946636|FG005|Part I: 12 Week Double-Blind|Refused Treatment|0|||
48960950|NCT00831441|157687528|FG000|Follow Up (30 Days)|Lost to Follow-up|13|||
48960951|NCT00831441|157687529|FG001|Follow Up (30 Days)|Lost to Follow-up|27|||
48654906|NCT00578877|156589836|FG000|Overall Study|did not provide follow-up data|12|||
48654907|NCT00578877|156589837|FG001|Overall Study|did not provide follow-up data|17|||
48654908|NCT00721578|156589841|FG000|Overall Study|Death|1|||
48654909|NCT00721578|156589842|FG001|Overall Study|Death|1|||
48654910|NCT00721578|156589841|FG000|Overall Study|Withdrawal by Subject|1|||
48654911|NCT00721578|156589842|FG001|Overall Study|Withdrawal by Subject|1|||
48960952|NCT00831441|157687528|FG000|Follow Up (30 Days)|Death|63|||
48960953|NCT00831441|157687529|FG001|Follow Up (30 Days)|Death|86|||
48960954|NCT00831441|157687528|FG000|Follow Up (30 Days)|non-specified|16|||
48960955|NCT00831441|157687529|FG001|Follow Up (30 Days)|non-specified|26|||
48960956|NCT00831441|157687528|FG000|Follow Up (30 Days)|missing end of study status|0|||
48960957|NCT00831441|157687529|FG001|Follow Up (30 Days)|missing end of study status|1|||
48960958|NCT00798655|157687533|FG000|Overall Study|Did not receive at least one dose of pan|2|||
48960959|NCT00623467|157687535|FG000|Overall Study|Lost to Follow-up|1|||
48960960|NCT00623467|157687535|FG000|Overall Study|Protocol Violation|4|||
48960961|NCT00623467|157687535|FG000|Overall Study|Withdrawal by Subject|2|||
48960962|NCT01202227|157687536|FG000|Overall Study|Adverse Event|16|||
48960963|NCT01202227|157687536|FG000|Overall Study|Withdrawal by Subject|2|||
48654912|NCT00855933|156589843|FG000|Overall Study|Withdrawal by Subject|0|||
48654913|NCT00855933|156589844|FG001|Overall Study|Withdrawal by Subject|1|||
48654914|NCT03372460|156589845|FG000|Overall Study|Discontinued due to stimulation site discomfort|0|||
48654915|NCT03372460|156589846|FG001|Overall Study|Discontinued due to stimulation site discomfort|1|||
48654916|NCT02374814|156589847|FG000|Overall Study|Lost to Follow-up|1|||
48654917|NCT02374814|156589848|FG001|Overall Study|Lost to Follow-up|1|||
48654918|NCT02374814|156589849|FG002|Overall Study|Lost to Follow-up|0|||
48654919|NCT02374814|156589850|FG003|Overall Study|Lost to Follow-up|1|||
48654920|NCT02374814|156589851|FG004|Overall Study|Lost to Follow-up|0|||
48654921|NCT02374814|156589852|FG005|Overall Study|Lost to Follow-up|0|||
48654922|NCT02374814|156589847|FG000|Overall Study|Withdrawal by Subject|0|||
48654923|NCT02374814|156589848|FG001|Overall Study|Withdrawal by Subject|0|||
48654924|NCT02374814|156589849|FG002|Overall Study|Withdrawal by Subject|1|||
48754126|NCT00642460|156946631|FG000|Part II: Open-Label Up to Week 92|Adverse Event|4|||
48754127|NCT00642460|156946632|FG001|Part II: Open-Label Up to Week 92|Adverse Event|2|||
48754128|NCT00642460|156946633|FG002|Part II: Open-Label Up to Week 92|Adverse Event|0|||
48754129|NCT00642460|156946634|FG003|Part II: Open-Label Up to Week 92|Adverse Event|0|||
48960964|NCT01202227|157687536|FG000|Overall Study|Lack of Efficacy|1|||
48960965|NCT00848549|157687539|FG000|E2090-E044-310 (Base Study) Disposition|Adverse Event|31|||
48654925|NCT02374814|156589850|FG003|Overall Study|Withdrawal by Subject|1|||
48654926|NCT02374814|156589851|FG004|Overall Study|Withdrawal by Subject|0|||
48754130|NCT00642460|156946635|FG004|Part II: Open-Label Up to Week 92|Adverse Event|0|||
48754131|NCT00642460|156946636|FG005|Part II: Open-Label Up to Week 92|Adverse Event|0|||
48754132|NCT00642460|156946631|FG000|Part II: Open-Label Up to Week 92|Death|0|||
48754133|NCT00642460|156946632|FG001|Part II: Open-Label Up to Week 92|Death|1|||
48754134|NCT00642460|156946633|FG002|Part II: Open-Label Up to Week 92|Death|0|||
48754135|NCT00642460|156946634|FG003|Part II: Open-Label Up to Week 92|Death|2|||
48960966|NCT00848549|157687540|FG001|E2090-E044-310 (Base Study) Disposition|Adverse Event|35|||
48960967|NCT00848549|157687539|FG000|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35|||
48960968|NCT00848549|157687540|FG001|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24|||
48654927|NCT02374814|156589852|FG005|Overall Study|Withdrawal by Subject|0|||
48654928|NCT02220855|156591383|FG000|Overall Study|Adverse Event|8|||
48654929|NCT02220855|156591383|FG000|Overall Study|Disease Progression|5|||
48654930|NCT02220855|156591383|FG000|Overall Study|Withdrawal by Subject|1|||
48654931|NCT00790868|156591384|FG000|Overall Study|Withdrawal by Subject|4|||
48654932|NCT00790868|156591385|FG001|Overall Study|Withdrawal by Subject|5|||
48754136|NCT00642460|156946635|FG004|Part II: Open-Label Up to Week 92|Death|0|||
48654933|NCT00790868|156591384|FG000|Overall Study|Lost to Follow-up|2|||
48654934|NCT00790868|156591385|FG001|Overall Study|Lost to Follow-up|12|||
48754137|NCT00642460|156946636|FG005|Part II: Open-Label Up to Week 92|Death|0|||
48754138|NCT00642460|156946631|FG000|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2|||
48754139|NCT00642460|156946632|FG001|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3|||
48960969|NCT00848549|157687539|FG000|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
48960970|NCT00848549|157687540|FG001|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
48960971|NCT00848549|157687539|FG000|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3|||
48960972|NCT00848549|157687540|FG001|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8|||
48960973|NCT00848549|157687539|FG000|E2090-E044-310 (Base Study) Disposition|Physician Decision|4|||
48960974|NCT00848549|157687540|FG001|E2090-E044-310 (Base Study) Disposition|Physician Decision|5|||
48960975|NCT00848549|157687539|FG000|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21|||
48960976|NCT00848549|157687540|FG001|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11|||
48960977|NCT00848549|157687539|FG000|E2090-E044-310 (Base Study) Disposition|Other|4|||
48960978|NCT00848549|157687540|FG001|E2090-E044-310 (Base Study) Disposition|Other|3|||
48960979|NCT00848549|157687539|FG000|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24|||
48960980|NCT00848549|157687540|FG001|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34|||
48960981|NCT00848549|157687539|FG000|E2090-E044-314 (Extension Study)|Adverse Event|2|||
48960982|NCT00848549|157687540|FG001|E2090-E044-314 (Extension Study)|Adverse Event|1|||
48960983|NCT00848549|157687539|FG000|E2090-E044-314 (Extension Study)|Protocol Violation|1|||
48960984|NCT00848549|157687540|FG001|E2090-E044-314 (Extension Study)|Protocol Violation|2|||
48960985|NCT00848549|157687539|FG000|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8|||
48654935|NCT02998203|156591386|FG000|First Period (40 Days)|Withdrawal by Subject|24|||
48654936|NCT02998203|156591387|FG001|First Period (40 Days)|Withdrawal by Subject|0|||
48654937|NCT02998203|156591386|FG000|Second Period (40 Days)|Withdrawal by Subject|0|||
48654938|NCT02998203|156591387|FG001|Second Period (40 Days)|Withdrawal by Subject|18|||
48654939|NCT00978380|156591388|FG000|Overall Study|Protocol Violation|2|||
48654940|NCT00978380|156591388|FG000|Overall Study|Withdrawal criteria|9|||
48654941|NCT00978380|156591388|FG000|Overall Study|Unclassified|8|||
48654942|NCT02199314|156591391|FG000|Overall Study|Withdrawal by Subject|6|||
48654943|NCT02199314|156591391|FG000|Overall Study|Physician Decision|10|||
48654944|NCT04187144|156591392|FG000|Overall Study|Lost to Follow-up|12|||
48654945|NCT04187144|156591393|FG001|Overall Study|Lost to Follow-up|11|||
48654946|NCT04187144|156591392|FG000|Overall Study|Withdrawal by Subject|20|||
48654947|NCT04187144|156591393|FG001|Overall Study|Withdrawal by Subject|18|||
48654948|NCT04187144|156591392|FG000|Overall Study|Adverse Event|19|||
48654949|NCT04187144|156591393|FG001|Overall Study|Adverse Event|4|||
48654950|NCT04187144|156591392|FG000|Overall Study|Physician Decision|5|||
48654951|NCT04187144|156591393|FG001|Overall Study|Physician Decision|3|||
48654952|NCT04187144|156591392|FG000|Overall Study|Screening Failure due to creatinine clearance and body mass index|0|||
48654953|NCT04187144|156591393|FG001|Overall Study|Screening Failure due to creatinine clearance and body mass index|1|||
48654954|NCT04187144|156591392|FG000|Overall Study|Protocol Deviation|1|||
48654955|NCT04187144|156591393|FG001|Overall Study|Protocol Deviation|4|||
48654956|NCT01044745|156591394|FG000|Overall Study|Ineiligible|2|||
48654957|NCT04848220|156591395|FG000|Overall Study|Unable to proceed to study procedure|0|||
48654958|NCT04848220|156591396|FG001|Overall Study|Unable to proceed to study procedure|1|||
48654959|NCT04848220|156591397|FG002|Overall Study|Unable to proceed to study procedure|0|||
48654960|NCT04848220|156591395|FG000|Overall Study|Fractional flow not significant|0|||
48654961|NCT04848220|156591396|FG001|Overall Study|Fractional flow not significant|1|||
48654962|NCT04848220|156591397|FG002|Overall Study|Fractional flow not significant|0|||
48654963|NCT02403817|156591398|FG000|Overall Study|Withdrawal by Subject|5|||
48654964|NCT02403817|156591399|FG001|Overall Study|Withdrawal by Subject|0|||
48654965|NCT00559845|156591406|FG000|Overall Study|Withdrew Consent|1|||
48654966|NCT00559845|156591406|FG000|Overall Study|Disease Progression|1|||
48654967|NCT00559845|156591406|FG000|Overall Study|Adverse Event|3|||
48654968|NCT00559845|156591406|FG000|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1|||
48654969|NCT00559845|156591406|FG000|Overall Study|Premature Surgery-Investigator Decision|1|||
48654970|NCT02242435|156591409|FG000|Overall Study|Lost to Follow-up|3|||
48754140|NCT00642460|156946633|FG002|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
48654971|NCT02242435|156591410|FG001|Overall Study|Lost to Follow-up|4|||
48960986|NCT00848549|157687540|FG001|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12|||
48654972|NCT02242435|156591409|FG000|Overall Study|Adverse Event|3|||
48960987|NCT00848549|157687539|FG000|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
48654973|NCT02242435|156591410|FG001|Overall Study|Adverse Event|2|||
48654974|NCT02242435|156591409|FG000|Overall Study|Withdrawal by Subject|13|||
48654975|NCT02242435|156591410|FG001|Overall Study|Withdrawal by Subject|8|||
48654976|NCT02242435|156591409|FG000|Overall Study|Death|0|||
48654977|NCT02242435|156591410|FG001|Overall Study|Death|1|||
48960988|NCT00848549|157687540|FG001|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
48654978|NCT02242435|156591409|FG000|Overall Study|Protocol Violation|1|||
48654979|NCT02242435|156591410|FG001|Overall Study|Protocol Violation|0|||
48960989|NCT00848549|157687539|FG000|E2090-E044-314 (Extension Study)|Physician Decision|0|||
48960990|NCT00848549|157687540|FG001|E2090-E044-314 (Extension Study)|Physician Decision|2|||
48960991|NCT00848549|157687539|FG000|E2090-E044-314 (Extension Study)|Other|5|||
48960992|NCT00848549|157687540|FG001|E2090-E044-314 (Extension Study)|Other|6|||
48960993|NCT01774344|157687543|FG000|Overall Study|Withdrawal by Subject|3|||
48960994|NCT01774344|157687544|FG001|Overall Study|Withdrawal by Subject|10|||
48960995|NCT01774344|157687543|FG000|Overall Study|Protocol Violation|0|||
48654980|NCT02242435|156591409|FG000|Overall Study|Physician Decision|0|||
48654981|NCT02242435|156591410|FG001|Overall Study|Physician Decision|1|||
48654982|NCT03895086|156591413|FG000|Overall Study|Early termination study|1|||
48654983|NCT03895086|156591414|FG001|Overall Study|Early termination study|0|||
48654984|NCT00459875|156591415|FG000|Overall Study|Ineligible participant|1|||
48654985|NCT00459875|156591415|FG000|Overall Study|Adverse Event|2|||
48654986|NCT02513485|156591416|FG000|Overall Study|Adverse Event|1|||
48654987|NCT02513485|156591417|FG001|Overall Study|Adverse Event|0|||
48654988|NCT05289271|156591418|FG000|Overall Study|Mistakenly allocated, untreated|1|||
48654989|NCT05289271|156591419|FG001|Overall Study|Mistakenly allocated, untreated|0|||
48654990|NCT03764631|156591420|FG000|Overall Study|Personal Reasons|3|||
48654991|NCT03764631|156591421|FG001|Overall Study|Personal Reasons|2|||
48654992|NCT03764631|156591420|FG000|Overall Study|Switching Therapy|3|||
48654993|NCT03764631|156591421|FG001|Overall Study|Switching Therapy|3|||
48654994|NCT03764631|156591420|FG000|Overall Study|Adverse Event|0|||
48654995|NCT03764631|156591421|FG001|Overall Study|Adverse Event|1|||
48654996|NCT03764631|156591420|FG000|Overall Study|Lost to Follow-up|33|||
48654997|NCT03764631|156591421|FG001|Overall Study|Lost to Follow-up|41|||
48654998|NCT03764631|156591420|FG000|Overall Study|No data as study site was closed|2|||
48654999|NCT03764631|156591421|FG001|Overall Study|No data as study site was closed|6|||
48655000|NCT03299881|156591422|FG000|Overall Study|Study Termination|17|||
48655001|NCT03299881|156591423|FG001|Overall Study|Study Termination|13|||
48655002|NCT02974855|156591424|FG000|Overall Study|Adverse Event|0|||
48655003|NCT02974855|156591425|FG001|Overall Study|Adverse Event|1|||
48655004|NCT02974855|156591426|FG002|Overall Study|Adverse Event|0|||
48655005|NCT02974855|156591427|FG003|Overall Study|Adverse Event|1|||
48655006|NCT02447250|156591435|FG000|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1|||
48655007|NCT02447250|156591435|FG000|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1|||
48655008|NCT02447250|156591435|FG000|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4|||
48655009|NCT01265563|156591436|FG000|Overall Study|Withdrawal by Subject|0|||
48655010|NCT01265563|156591437|FG001|Overall Study|Withdrawal by Subject|1|||
48655011|NCT01265563|156591438|FG002|Overall Study|Withdrawal by Subject|1|||
48655012|NCT01265563|156591439|FG003|Overall Study|Withdrawal by Subject|0|||
48655013|NCT01265563|156591440|FG004|Overall Study|Withdrawal by Subject|2|||
48655014|NCT00873041|156591441|FG000|Core Study|Adverse Event|2|||
48655015|NCT00873041|156591442|FG001|Core Study|Adverse Event|3|||
48655016|NCT00873041|156591443|FG002|Core Study|Adverse Event|1|||
48655017|NCT00873041|156591441|FG000|Core Study|Withdrawal by Subject|1|||
48655018|NCT00873041|156591442|FG001|Core Study|Withdrawal by Subject|2|||
48655019|NCT00873041|156591443|FG002|Core Study|Withdrawal by Subject|2|||
48655020|NCT00873041|156591441|FG000|Core Study|Lost to Follow-up|3|||
48655021|NCT00873041|156591442|FG001|Core Study|Lost to Follow-up|1|||
48655022|NCT00873041|156591443|FG002|Core Study|Lost to Follow-up|0|||
48655023|NCT00873041|156591441|FG000|Core Study|Abnormal laboratory value|0|||
48655024|NCT00873041|156591442|FG001|Core Study|Abnormal laboratory value|0|||
48655025|NCT00873041|156591443|FG002|Core Study|Abnormal laboratory value|1|||
48655026|NCT00873041|156591441|FG000|Core Study|Protocol deviation|1|||
48655027|NCT00873041|156591442|FG001|Core Study|Protocol deviation|0|||
48655028|NCT00873041|156591443|FG002|Core Study|Protocol deviation|1|||
48655029|NCT00873041|156591441|FG000|Extension Study|Adverse Event|1|||
48655030|NCT00873041|156591442|FG001|Extension Study|Adverse Event|0|||
48655031|NCT00873041|156591443|FG002|Extension Study|Adverse Event|1|||
48655032|NCT00873041|156591441|FG000|Extension Study|Administrative reasons|0|||
48655033|NCT00873041|156591442|FG001|Extension Study|Administrative reasons|0|||
48655034|NCT00873041|156591443|FG002|Extension Study|Administrative reasons|1|||
48655035|NCT03655054|156591444|FG000|Overall Study|Lost to Follow-up|1|||
48655036|NCT00543803|156591445|FG000|Overall Study|Adverse Event|14|||
48655037|NCT00543803|156591445|FG000|Overall Study|Lack of Efficacy|22|||
48655038|NCT00543803|156591445|FG000|Overall Study|Lost to Follow-up|20|||
48655039|NCT00543803|156591445|FG000|Overall Study|Other|86|||
48655040|NCT03359785|156591452|FG000|Overall Study|Protocol Violation|0|||
48960996|NCT01774344|157687544|FG001|Overall Study|Protocol Violation|1|||
48960997|NCT01774344|157687543|FG000|Overall Study|Lost to Follow-up|4|||
48960998|NCT01774344|157687544|FG001|Overall Study|Lost to Follow-up|10|||
48960999|NCT01774344|157687543|FG000|Overall Study|End of survival follow-up not available|2|||
48961000|NCT01774344|157687544|FG001|Overall Study|End of survival follow-up not available|2|||
48961001|NCT01774344|157687543|FG000|Overall Study|Data collection finished|4|||
48961002|NCT01774344|157687544|FG001|Overall Study|Data collection finished|14|||
48961003|NCT01774344|157687543|FG000|Overall Study|Other|0|||
48961004|NCT01774344|157687544|FG001|Overall Study|Other|1|||
48961005|NCT01774344|157687543|FG000|Overall Study|Did not enter Survival Follow up|49|||
48961006|NCT01774344|157687544|FG001|Overall Study|Did not enter Survival Follow up|83|||
48961007|NCT04507867|157687545|FG000|Overall Study|Death|7|||
48961008|NCT04507867|157687546|FG001|Overall Study|Death|1|||
48961009|NCT01094730|157687547|FG000|Period 1 (14 Days)|Lost to Follow-up|0|||
48961010|NCT01094730|157687548|FG001|Period 1 (14 Days)|Lost to Follow-up|1|||
48961011|NCT01094730|157687547|FG000|Period 1 (14 Days)|Withdrawal by Subject|0|||
48961012|NCT01094730|157687548|FG001|Period 1 (14 Days)|Withdrawal by Subject|1|||
48961013|NCT01094730|157687547|FG000|Period 1 (14 Days)|No time for the follow-up visit|1|||
48961014|NCT01094730|157687548|FG001|Period 1 (14 Days)|No time for the follow-up visit|0|||
48961015|NCT01094730|157687547|FG000|Period 1 (14 Days)|Unsatisfactory visual response|1|||
48961016|NCT01094730|157687548|FG001|Period 1 (14 Days)|Unsatisfactory visual response|0|||
48961017|NCT01094730|157687547|FG000|Period 2 (14 Days)|Protocol Violation|2|||
48961018|NCT01094730|157687548|FG001|Period 2 (14 Days)|Protocol Violation|0|||
48961019|NCT01094730|157687547|FG000|Period 2 (14 Days)|No time for the follow-up visit|1|||
48961020|NCT01094730|157687548|FG001|Period 2 (14 Days)|No time for the follow-up visit|0|||
48961021|NCT01094730|157687547|FG000|Period 2 (14 Days)|Adverse Event|0|||
48961022|NCT01094730|157687548|FG001|Period 2 (14 Days)|Adverse Event|1|||
48961023|NCT01094730|157687547|FG000|Period 2 (14 Days)|Unsatisfactory lens fitting|0|||
48961024|NCT01094730|157687548|FG001|Period 2 (14 Days)|Unsatisfactory lens fitting|1|||
48655041|NCT03359785|156591453|FG001|Overall Study|Protocol Violation|1|||
48655042|NCT03359785|156591454|FG002|Overall Study|Protocol Violation|0|||
48655043|NCT03359785|156591455|FG003|Overall Study|Protocol Violation|0|||
48655044|NCT03359785|156591452|FG000|Overall Study|Early study termination due to study pause|0|||
48655045|NCT03359785|156591453|FG001|Overall Study|Early study termination due to study pause|0|||
48655046|NCT03359785|156591454|FG002|Overall Study|Early study termination due to study pause|2|||
48655047|NCT03359785|156591455|FG003|Overall Study|Early study termination due to study pause|0|||
48655048|NCT03359785|156591452|FG000|Overall Study|Withdrawal by Subject|2|||
48655049|NCT03359785|156591453|FG001|Overall Study|Withdrawal by Subject|2|||
48655050|NCT03359785|156591454|FG002|Overall Study|Withdrawal by Subject|0|||
48655051|NCT03359785|156591455|FG003|Overall Study|Withdrawal by Subject|0|||
48655052|NCT00557310|156591456|FG000|Main Study (0 - 18 Months)|Adverse Event|4|||
48655053|NCT00557310|156591456|FG000|Main Study (0 - 18 Months)|Withdrawal by Subject|1|||
48655054|NCT00557310|156591456|FG000|Extension Phase (18 - 24 Months)|Adverse Event|1|||
48655055|NCT00557310|156591456|FG000|Extension Phase (18 - 24 Months)|Lost to Follow-up|1|||
48655056|NCT00557310|156591456|FG000|Extension Phase (18 - 24 Months)|Physician Decision|2|||
48655057|NCT00557310|156591456|FG000|Extension Phase (18 - 24 Months)|Protocol Violation|1|||
48655058|NCT04659174|156591459|FG000|Overall Study|Sponsor decision to discontinue study|0|||
48655059|NCT04659174|156591460|FG001|Overall Study|Sponsor decision to discontinue study|2|||
48655060|NCT04659174|156591459|FG000|Overall Study|Lost to Follow-up|9|||
48655061|NCT04659174|156591460|FG001|Overall Study|Lost to Follow-up|11|||
48655062|NCT04659174|156591459|FG000|Overall Study|Adverse Event|8|||
48655063|NCT04659174|156591460|FG001|Overall Study|Adverse Event|5|||
48655064|NCT04659174|156591459|FG000|Overall Study|Withdrawal by Subject|17|||
48655065|NCT04659174|156591460|FG001|Overall Study|Withdrawal by Subject|33|||
48655066|NCT04659174|156591459|FG000|Overall Study|Progressive disease|0|||
48655067|NCT04659174|156591460|FG001|Overall Study|Progressive disease|2|||
48655068|NCT04659174|156591459|FG000|Overall Study|Other reasons|0|||
48655069|NCT04659174|156591460|FG001|Overall Study|Other reasons|2|||
48655070|NCT04659174|156591459|FG000|Overall Study|Participant fails to adhere to the protocol requirements|14|||
48655071|NCT04659174|156591460|FG001|Overall Study|Participant fails to adhere to the protocol requirements|9|||
48655072|NCT04659174|156591459|FG000|Overall Study|Alcohol or illegal drug use|0|||
48655073|NCT04659174|156591460|FG001|Overall Study|Alcohol or illegal drug use|3|||
48655074|NCT04659174|156591459|FG000|Overall Study|Violation of entry criteria|1|||
48655075|NCT04659174|156591460|FG001|Overall Study|Violation of entry criteria|0|||
48655076|NCT04659174|156591459|FG000|Overall Study|Death|0|||
48655077|NCT04659174|156591460|FG001|Overall Study|Death|1|||
48655078|NCT03650803|156591461|FG000|Overall Study|Lost to Follow-up|6|||
48655079|NCT02839720|156591464|FG000|Overall Study|Adverse Event|2|||
48655080|NCT02839720|156591464|FG000|Overall Study|Non-compliance|2|||
48655081|NCT02839720|156591464|FG000|Overall Study|Intercurrent Illness|1|||
48961025|NCT00423735|157687550|FG000|Overall Study|Ineligible / No protocol treatment|8|||
48961026|NCT00423735|157687551|FG001|Overall Study|Ineligible / No protocol treatment|6|||
48961027|NCT00423735|157687552|FG002|Overall Study|Ineligible / No protocol treatment|0|||
48961028|NCT04550221|157687553|FG000|Overall Study|Lost to Follow-up|0|||
48961029|NCT04550221|157687554|FG001|Overall Study|Lost to Follow-up|4|||
48655082|NCT02839720|156591464|FG000|Overall Study|Non-compliance due to COVID-19 pandemic|2|||
48655083|NCT02649218|156591465|FG000|Overall Study|Adverse Event|8|||
48655084|NCT02649218|156591465|FG000|Overall Study|Lack of Efficacy|8|||
48655085|NCT02649218|156591465|FG000|Overall Study|Pregnancy|3|||
48655086|NCT02649218|156591465|FG000|Overall Study|Protocol Violation|3|||
48655087|NCT02649218|156591465|FG000|Overall Study|Physician Decision|1|||
48655088|NCT02649218|156591465|FG000|Overall Study|Withdrawal by Subject|2|||
48655089|NCT01451931|156591466|FG000|Overall Study|Lost to Follow-up|17|||
48655090|NCT01451931|156591467|FG001|Overall Study|Lost to Follow-up|36|||
48655091|NCT01451931|156591468|FG002|Overall Study|Lost to Follow-up|21|||
48655092|NCT01451931|156591466|FG000|Overall Study|Withdrawal by Subject|16|||
48655093|NCT01451931|156591467|FG001|Overall Study|Withdrawal by Subject|22|||
48655094|NCT01451931|156591468|FG002|Overall Study|Withdrawal by Subject|22|||
48655095|NCT05593913|156591469|FG000|Overall Study|Insufficient image quality|39|||
48655096|NCT04470908|156591470|FG000|Zanubrutinib + Rifabutin on Day 11|Lost to Follow-up|1|||
48655097|NCT00957944|156591479|FG000|First Intervention- 24 Hours|Withdrawal by Subject|0|||
48655098|NCT00957944|156591480|FG001|First Intervention- 24 Hours|Withdrawal by Subject|1|||
48655099|NCT00027378|156591485|FG000|Overall Study|Physician Decision|0|||
48655100|NCT00027378|156591486|FG001|Overall Study|Physician Decision|3|||
48655101|NCT00294645|156591491|FG000|Overall Study|Death|10|||
48655102|NCT00294645|156591492|FG001|Overall Study|Death|18|||
48655103|NCT00294645|156591491|FG000|Overall Study|Lost to Follow-up|1|||
48655104|NCT00294645|156591492|FG001|Overall Study|Lost to Follow-up|10|||
48655105|NCT00294645|156591491|FG000|Overall Study|Withdrawal by Subject|18|||
48655106|NCT00294645|156591492|FG001|Overall Study|Withdrawal by Subject|34|||
48655107|NCT00294645|156591491|FG000|Overall Study|Physician Decision|15|||
48754141|NCT00642460|156946634|FG003|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
48754142|NCT00642460|156946635|FG004|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
48754143|NCT00642460|156946636|FG005|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
48754144|NCT00642460|156946631|FG000|Part II: Open-Label Up to Week 92|Refused treatment|3|||
48754145|NCT00642460|156946632|FG001|Part II: Open-Label Up to Week 92|Refused treatment|1|||
48754146|NCT00642460|156946633|FG002|Part II: Open-Label Up to Week 92|Refused treatment|0|||
48754147|NCT00642460|156946634|FG003|Part II: Open-Label Up to Week 92|Refused treatment|0|||
48754148|NCT00642460|156946635|FG004|Part II: Open-Label Up to Week 92|Refused treatment|0|||
48754149|NCT00642460|156946636|FG005|Part II: Open-Label Up to Week 92|Refused treatment|0|||
48754150|NCT00642460|156946631|FG000|Part II: Open-Label Up to Week 92|Failure to return|0|||
48754151|NCT00642460|156946632|FG001|Part II: Open-Label Up to Week 92|Failure to return|1|||
48754152|NCT00642460|156946633|FG002|Part II: Open-Label Up to Week 92|Failure to return|0|||
48865767|NCT04044352|157345558|FG000|Overall Study|Withdrawal by Subject|2|||
48655108|NCT00294645|156591492|FG001|Overall Study|Physician Decision|20|||
48655109|NCT00294645|156591491|FG000|Overall Study|Other|4|||
48655110|NCT00294645|156591492|FG001|Overall Study|Other|10|||
48655111|NCT01330628|156591493|FG000|Overall Study|Death|2|||
48655112|NCT01330628|156591494|FG001|Overall Study|Death|3|||
48655113|NCT01330628|156591493|FG000|Overall Study|Lost to Follow-up|5|||
48655114|NCT01330628|156591494|FG001|Overall Study|Lost to Follow-up|6|||
48655115|NCT01330628|156591493|FG000|Overall Study|Adverse Event|44|||
48655116|NCT01330628|156591494|FG001|Overall Study|Adverse Event|25|||
48655117|NCT01330628|156591493|FG000|Overall Study|Withdrawn|18|||
48655118|NCT01330628|156591494|FG001|Overall Study|Withdrawn|6|||
48655119|NCT01330628|156591493|FG000|Overall Study|Didn't receive study treatment|1|||
48655120|NCT01330628|156591494|FG001|Overall Study|Didn't receive study treatment|0|||
48655121|NCT00812006|156591495|FG000|Overall Study|Lost to Follow-up|0|||
48655122|NCT00812006|156591496|FG001|Overall Study|Lost to Follow-up|0|||
48655123|NCT00812006|156591497|FG002|Overall Study|Lost to Follow-up|2|||
48655124|NCT00812006|156591495|FG000|Overall Study|Physician Decision|0|||
48655125|NCT00812006|156591496|FG001|Overall Study|Physician Decision|0|||
48655126|NCT00812006|156591497|FG002|Overall Study|Physician Decision|1|||
48655127|NCT00812006|156591495|FG000|Overall Study|Withdrawal by Subject|2|||
48655128|NCT00812006|156591496|FG001|Overall Study|Withdrawal by Subject|1|||
48655129|NCT00812006|156591497|FG002|Overall Study|Withdrawal by Subject|1|||
48655130|NCT00812006|156591495|FG000|Overall Study|Lack of Qualifying Event|4|||
48655131|NCT00812006|156591496|FG001|Overall Study|Lack of Qualifying Event|2|||
48655132|NCT00812006|156591497|FG002|Overall Study|Lack of Qualifying Event|2|||
48655133|NCT01795495|156591498|FG000|Overall Study|Protocol Violation|1|||
48655134|NCT01795495|156591499|FG001|Overall Study|Protocol Violation|0|||
48655135|NCT01795495|156591500|FG002|Overall Study|Protocol Violation|1|||
48655136|NCT01795495|156591498|FG000|Overall Study|Physician Decision|0|||
48655137|NCT01795495|156591499|FG001|Overall Study|Physician Decision|0|||
48865768|NCT03840200|157345562|FG000|Overall Study|Death|6|||
48655138|NCT01795495|156591500|FG002|Overall Study|Physician Decision|1|||
48655139|NCT00098748|156591501|FG000|Assigned to Study Treatment|Randomized, but not treated|0|||
48754153|NCT00642460|156946634|FG003|Part II: Open-Label Up to Week 92|Failure to return|0|||
48655140|NCT00098748|156591502|FG001|Assigned to Study Treatment|Randomized, but not treated|2|||
48655141|NCT00098748|156591503|FG002|Assigned to Study Treatment|Randomized, but not treated|2|||
48754154|NCT00642460|156946635|FG004|Part II: Open-Label Up to Week 92|Failure to return|0|||
48754155|NCT00642460|156946636|FG005|Part II: Open-Label Up to Week 92|Failure to return|0|||
48754156|NCT00642460|156946631|FG000|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
48754157|NCT00642460|156946632|FG001|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
48754158|NCT00642460|156946633|FG002|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
48754159|NCT00642460|156946634|FG003|Part II: Open-Label Up to Week 92|Administrative reasons|1|||
48754160|NCT00642460|156946635|FG004|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
48754161|NCT00642460|156946636|FG005|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
48865769|NCT03840200|157345563|FG001|Overall Study|Death|3|||
48655142|NCT00098748|156591501|FG000|Received Study Treatment|Death|2|||
48655143|NCT00098748|156591502|FG001|Received Study Treatment|Death|1|||
48655144|NCT00098748|156591503|FG002|Received Study Treatment|Death|2|||
48655145|NCT00098748|156591501|FG000|Received Study Treatment|Adverse Event|1|||
48655146|NCT00098748|156591502|FG001|Received Study Treatment|Adverse Event|2|||
48655147|NCT00098748|156591503|FG002|Received Study Treatment|Adverse Event|5|||
48655148|NCT00098748|156591501|FG000|Received Study Treatment|Lack of Efficacy|40|||
48655149|NCT00098748|156591502|FG001|Received Study Treatment|Lack of Efficacy|27|||
48655150|NCT00098748|156591503|FG002|Received Study Treatment|Lack of Efficacy|27|||
48655151|NCT00098748|156591501|FG000|Received Study Treatment|Other|2|||
48655152|NCT00098748|156591502|FG001|Received Study Treatment|Other|2|||
48655153|NCT00098748|156591503|FG002|Received Study Treatment|Other|6|||
48655154|NCT00098748|156591501|FG000|Received Study Treatment|Subject defaulted|3|||
48655155|NCT00098748|156591502|FG001|Received Study Treatment|Subject defaulted|4|||
48655156|NCT00098748|156591503|FG002|Received Study Treatment|Subject defaulted|4|||
48655157|NCT00098748|156591501|FG000|Continued on Open-Label Treatment|Adverse Event|0|||
48655158|NCT00098748|156591502|FG001|Continued on Open-Label Treatment|Adverse Event|1|||
48655159|NCT00098748|156591503|FG002|Continued on Open-Label Treatment|Adverse Event|0|||
48655160|NCT00098748|156591501|FG000|Continued on Open-Label Treatment|Lack of Efficacy|1|||
48655161|NCT00098748|156591502|FG001|Continued on Open-Label Treatment|Lack of Efficacy|2|||
48655162|NCT00098748|156591503|FG002|Continued on Open-Label Treatment|Lack of Efficacy|0|||
48655163|NCT00098748|156591501|FG000|Continued on Open-Label Treatment|Other reason includes protocol violation|6|||
48655164|NCT00098748|156591502|FG001|Continued on Open-Label Treatment|Other reason includes protocol violation|7|||
48655165|NCT00098748|156591503|FG002|Continued on Open-Label Treatment|Other reason includes protocol violation|0|||
48655166|NCT00098748|156591501|FG000|Continued on Open-Label Treatment|Lost to Follow-up|1|||
48655167|NCT00098748|156591502|FG001|Continued on Open-Label Treatment|Lost to Follow-up|1|||
48655168|NCT00098748|156591503|FG002|Continued on Open-Label Treatment|Lost to Follow-up|0|||
48655169|NCT00098748|156591501|FG000|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
48655170|NCT00098748|156591502|FG001|Continued on Open-Label Treatment|Withdrawal by Subject|4|||
48655171|NCT00098748|156591503|FG002|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
48655172|NCT02305849|156591509|FG000|Overall Study|Adverse Event|10|||
48655173|NCT02305849|156591510|FG001|Overall Study|Adverse Event|12|||
48655174|NCT02305849|156591511|FG002|Overall Study|Adverse Event|7|||
48655175|NCT02305849|156591512|FG003|Overall Study|Adverse Event|3|||
48655176|NCT02305849|156591509|FG000|Overall Study|Lack of Efficacy|10|||
48655177|NCT02305849|156591510|FG001|Overall Study|Lack of Efficacy|6|||
48655178|NCT02305849|156591511|FG002|Overall Study|Lack of Efficacy|3|||
48655179|NCT02305849|156591512|FG003|Overall Study|Lack of Efficacy|9|||
48655180|NCT02305849|156591509|FG000|Overall Study|Withdrawal by Subject|2|||
48655181|NCT02305849|156591510|FG001|Overall Study|Withdrawal by Subject|2|||
48655182|NCT02305849|156591511|FG002|Overall Study|Withdrawal by Subject|1|||
48655183|NCT02305849|156591512|FG003|Overall Study|Withdrawal by Subject|4|||
48655184|NCT02305849|156591509|FG000|Overall Study|Lost to Follow-up|0|||
48655185|NCT02305849|156591510|FG001|Overall Study|Lost to Follow-up|2|||
48655186|NCT02305849|156591511|FG002|Overall Study|Lost to Follow-up|0|||
48655187|NCT02305849|156591512|FG003|Overall Study|Lost to Follow-up|0|||
48655188|NCT02305849|156591509|FG000|Overall Study|Protocol Violation|3|||
48655189|NCT02305849|156591510|FG001|Overall Study|Protocol Violation|2|||
48655190|NCT02305849|156591511|FG002|Overall Study|Protocol Violation|1|||
48655191|NCT02305849|156591512|FG003|Overall Study|Protocol Violation|1|||
48865770|NCT03840200|157345564|FG002|Overall Study|Death|6|||
48655192|NCT02305849|156591509|FG000|Overall Study|Lab data met discontinuation criteria|0|||
48655193|NCT02305849|156591510|FG001|Overall Study|Lab data met discontinuation criteria|1|||
48655194|NCT02305849|156591511|FG002|Overall Study|Lab data met discontinuation criteria|2|||
48655195|NCT02305849|156591512|FG003|Overall Study|Lab data met discontinuation criteria|1|||
48655196|NCT02305849|156591509|FG000|Overall Study|Miscellaneous|1|||
48865771|NCT03840200|157345565|FG003|Overall Study|Death|10|||
48865772|NCT03840200|157345562|FG000|Overall Study|Reason Not Specified|2|||
48865773|NCT03840200|157345563|FG001|Overall Study|Reason Not Specified|2|||
48865774|NCT03840200|157345564|FG002|Overall Study|Reason Not Specified|1|||
48865775|NCT03840200|157345565|FG003|Overall Study|Reason Not Specified|15|||
48865776|NCT03840200|157345562|FG000|Overall Study|Physician Decision|0|||
48865777|NCT03840200|157345563|FG001|Overall Study|Physician Decision|0|||
48865778|NCT03840200|157345564|FG002|Overall Study|Physician Decision|0|||
48961030|NCT04550221|157687553|FG000|Overall Study|Withdrawn|3|||
48655197|NCT02305849|156591510|FG001|Overall Study|Miscellaneous|2|||
48655198|NCT02305849|156591511|FG002|Overall Study|Miscellaneous|4|||
48655199|NCT02305849|156591512|FG003|Overall Study|Miscellaneous|1|||
48655200|NCT02305849|156591509|FG000|Overall Study|Not fulfill eligibility criteria|1|||
48655201|NCT02305849|156591510|FG001|Overall Study|Not fulfill eligibility criteria|1|||
48655202|NCT02305849|156591511|FG002|Overall Study|Not fulfill eligibility criteria|0|||
48655203|NCT02305849|156591512|FG003|Overall Study|Not fulfill eligibility criteria|0|||
48655204|NCT02557100|156593311|FG000|Single Blind Treatment Period|Lost to Follow-up|0|||
48655205|NCT02557100|156593312|FG001|Single Blind Treatment Period|Lost to Follow-up|1|||
48655206|NCT02557100|156593313|FG002|Single Blind Treatment Period|Lost to Follow-up|0|||
48655207|NCT02557100|156593311|FG000|Single Blind Treatment Period|Death|0|||
48655208|NCT02557100|156593312|FG001|Single Blind Treatment Period|Death|1|||
48655209|NCT02557100|156593313|FG002|Single Blind Treatment Period|Death|0|||
48655210|NCT02557100|156593311|FG000|Single Blind Treatment Period|Request to Discontinue|0|||
48655211|NCT02557100|156593312|FG001|Single Blind Treatment Period|Request to Discontinue|1|||
48655212|NCT02557100|156593313|FG002|Single Blind Treatment Period|Request to Discontinue|0|||
48655213|NCT02557100|156593311|FG000|Single Blind Treatment Period|Adverse Event|0|||
48655214|NCT02557100|156593312|FG001|Single Blind Treatment Period|Adverse Event|1|||
48655215|NCT02557100|156593313|FG002|Single Blind Treatment Period|Adverse Event|0|||
48655216|NCT02557100|156593311|FG000|Transition to Open Label|Entered Cumulative Abatacept Period|40|||
48655217|NCT02557100|156593312|FG001|Transition to Open Label|Entered Cumulative Abatacept Period|36|||
48655218|NCT02557100|156593313|FG002|Transition to Open Label|Entered Cumulative Abatacept Period|0|||
48655219|NCT02557100|156593311|FG000|Cumulative Abatacept Period|Other Reasons|0|||
48655220|NCT02557100|156593312|FG001|Cumulative Abatacept Period|Other Reasons|0|||
48655221|NCT02557100|156593313|FG002|Cumulative Abatacept Period|Other Reasons|1|||
48655222|NCT02557100|156593311|FG000|Cumulative Abatacept Period|Lost to Follow-up|0|||
48655223|NCT02557100|156593312|FG001|Cumulative Abatacept Period|Lost to Follow-up|0|||
48655224|NCT02557100|156593313|FG002|Cumulative Abatacept Period|Lost to Follow-up|2|||
48655225|NCT02557100|156593311|FG000|Cumulative Abatacept Period|Request to Discontinue|0|||
48655226|NCT02557100|156593312|FG001|Cumulative Abatacept Period|Request to Discontinue|0|||
48655227|NCT02557100|156593313|FG002|Cumulative Abatacept Period|Request to Discontinue|1|||
48655228|NCT00510718|156593314|FG000|Multiple Dose Period: 12 Weeks|Adverse Event|1|||
48655229|NCT00510718|156593315|FG001|Multiple Dose Period: 12 Weeks|Adverse Event|8|||
48655230|NCT00510718|156593314|FG000|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3|||
48655231|NCT00510718|156593315|FG001|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6|||
48655232|NCT00510718|156593314|FG000|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8|||
48655233|NCT00510718|156593315|FG001|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11|||
48655234|NCT00510718|156593314|FG000|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1|||
48655235|NCT00510718|156593315|FG001|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3|||
48655236|NCT00510718|156593314|FG000|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1|||
48655237|NCT00510718|156593315|FG001|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3|||
48655238|NCT00510718|156593314|FG000|Multiple Dose Period: 12 Weeks|Other|1|||
48655239|NCT00510718|156593315|FG001|Multiple Dose Period: 12 Weeks|Other|1|||
48655240|NCT01089413|156593316|FG000|Overall Study|Lost to Follow-up|1|||
48655241|NCT01089413|156593316|FG000|Overall Study|Progressive Disease|93|||
48655242|NCT01089413|156593316|FG000|Overall Study|Participant Withdrew Consent|1|||
48655243|NCT01089413|156593316|FG000|Overall Study|Unacceptable Toxicity|12|||
48655244|NCT01089413|156593316|FG000|Overall Study|Death|10|||
48655245|NCT01089413|156593316|FG000|Overall Study|Metastasectomy|13|||
48655246|NCT01089413|156593316|FG000|Overall Study|Other|71|||
48655247|NCT02264665|156593319|FG000|Overall Study|Other|0|||
48655248|NCT02264665|156593320|FG001|Overall Study|Other|0|||
48655249|NCT02264665|156593321|FG002|Overall Study|Other|3|||
48655250|NCT02264665|156593322|FG003|Overall Study|Other|0|||
48655251|NCT02264665|156593323|FG004|Overall Study|Other|0|||
48655252|NCT02264665|156593324|FG005|Overall Study|Other|0|||
48754162|NCT00642460|156946631|FG000|Part III: Open-Label Up to Week 260|Adverse Event|0|||
48754163|NCT00642460|156946632|FG001|Part III: Open-Label Up to Week 260|Adverse Event|0|||
48754164|NCT00642460|156946633|FG002|Part III: Open-Label Up to Week 260|Adverse Event|0|||
48754165|NCT00642460|156946634|FG003|Part III: Open-Label Up to Week 260|Adverse Event|0|||
48754166|NCT00642460|156946635|FG004|Part III: Open-Label Up to Week 260|Adverse Event|7|||
48961031|NCT04550221|157687554|FG001|Overall Study|Withdrawn|0|||
48961032|NCT04550221|157687553|FG000|Overall Study|Moved from the study area after receiving the intervention|2|||
48655253|NCT02264665|156593325|FG006|Overall Study|Other|0|||
48655254|NCT02264665|156593319|FG000|Overall Study|Death|9|||
48655255|NCT02264665|156593320|FG001|Overall Study|Death|8|||
48655256|NCT02264665|156593321|FG002|Overall Study|Death|13|||
48655257|NCT02264665|156593322|FG003|Overall Study|Death|5|||
48655258|NCT02264665|156593323|FG004|Overall Study|Death|0|||
48655259|NCT02264665|156593324|FG005|Overall Study|Death|0|||
48655260|NCT02264665|156593325|FG006|Overall Study|Death|1|||
48961033|NCT04550221|157687554|FG001|Overall Study|Moved from the study area after receiving the intervention|0|||
48754167|NCT00642460|156946636|FG005|Part III: Open-Label Up to Week 260|Adverse Event|6|||
48754168|NCT00642460|156946631|FG000|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
48754169|NCT00642460|156946632|FG001|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
48754170|NCT00642460|156946633|FG002|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
48754171|NCT00642460|156946634|FG003|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
48754172|NCT00642460|156946635|FG004|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3|||
48754173|NCT00642460|156946636|FG005|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4|||
48754174|NCT00642460|156946631|FG000|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
48754175|NCT00642460|156946632|FG001|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
48754176|NCT00642460|156946633|FG002|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
48754177|NCT00642460|156946634|FG003|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
48754178|NCT00642460|156946635|FG004|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4|||
48754179|NCT00642460|156946636|FG005|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1|||
48754180|NCT00642460|156946631|FG000|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
48754181|NCT00642460|156946632|FG001|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
48754182|NCT00642460|156946633|FG002|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
48754183|NCT00642460|156946634|FG003|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
48754184|NCT00642460|156946635|FG004|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
48754185|NCT00642460|156946636|FG005|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
48754186|NCT00642460|156946631|FG000|Part III: Open-Label Up to Week 260|Other|0|||
48754187|NCT00642460|156946632|FG001|Part III: Open-Label Up to Week 260|Other|0|||
48754188|NCT00642460|156946633|FG002|Part III: Open-Label Up to Week 260|Other|0|||
48754189|NCT00642460|156946634|FG003|Part III: Open-Label Up to Week 260|Other|0|||
48754190|NCT00642460|156946635|FG004|Part III: Open-Label Up to Week 260|Other|2|||
48754191|NCT00642460|156946636|FG005|Part III: Open-Label Up to Week 260|Other|2|||
48754192|NCT00642460|156946631|FG000|Part III: Open-Label Up to Week 260|Death|0|||
48754193|NCT00642460|156946632|FG001|Part III: Open-Label Up to Week 260|Death|0|||
48754194|NCT00642460|156946633|FG002|Part III: Open-Label Up to Week 260|Death|0|||
48754195|NCT00642460|156946634|FG003|Part III: Open-Label Up to Week 260|Death|0|||
48655261|NCT02264665|156593319|FG000|Overall Study|Lost to Follow-up|1|||
48655262|NCT02264665|156593320|FG001|Overall Study|Lost to Follow-up|0|||
48655263|NCT02264665|156593321|FG002|Overall Study|Lost to Follow-up|2|||
48655264|NCT02264665|156593322|FG003|Overall Study|Lost to Follow-up|1|||
48655265|NCT02264665|156593323|FG004|Overall Study|Lost to Follow-up|0|||
48655266|NCT02264665|156593324|FG005|Overall Study|Lost to Follow-up|0|||
48655267|NCT02264665|156593325|FG006|Overall Study|Lost to Follow-up|0|||
48655268|NCT02264665|156593319|FG000|Overall Study|Participant decision|0|||
48655269|NCT02264665|156593320|FG001|Overall Study|Participant decision|0|||
48655270|NCT02264665|156593321|FG002|Overall Study|Participant decision|0|||
48655271|NCT02264665|156593322|FG003|Overall Study|Participant decision|1|||
48655272|NCT02264665|156593323|FG004|Overall Study|Participant decision|0|||
48655273|NCT02264665|156593324|FG005|Overall Study|Participant decision|0|||
48655274|NCT02264665|156593325|FG006|Overall Study|Participant decision|0|||
48655275|NCT02264665|156593319|FG000|Overall Study|Inclusion/non-inclusion criteria not respected|3|||
48655276|NCT02264665|156593320|FG001|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
48655277|NCT02264665|156593321|FG002|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
48655278|NCT02264665|156593322|FG003|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
48655279|NCT02264665|156593323|FG004|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
48655280|NCT02264665|156593324|FG005|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
48655281|NCT02264665|156593325|FG006|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
48655282|NCT02264665|156593319|FG000|Overall Study|Data Missing|0|||
48754196|NCT00642460|156946635|FG004|Part III: Open-Label Up to Week 260|Death|0|||
48754197|NCT00642460|156946636|FG005|Part III: Open-Label Up to Week 260|Death|3|||
48754198|NCT00642460|156946631|FG000|Part III: Open-Label Up to Week 260|Administrative reason|0|||
48754199|NCT00642460|156946632|FG001|Part III: Open-Label Up to Week 260|Administrative reason|0|||
48754200|NCT00642460|156946633|FG002|Part III: Open-Label Up to Week 260|Administrative reason|0|||
48754201|NCT00642460|156946634|FG003|Part III: Open-Label Up to Week 260|Administrative reason|0|||
48754202|NCT00642460|156946635|FG004|Part III: Open-Label Up to Week 260|Administrative reason|0|||
48865779|NCT03840200|157345565|FG003|Overall Study|Physician Decision|2|||
48865780|NCT03840200|157345562|FG000|Overall Study|Progressive Disease|0|||
48865781|NCT03840200|157345563|FG001|Overall Study|Progressive Disease|0|||
48865782|NCT03840200|157345564|FG002|Overall Study|Progressive Disease|0|||
48865783|NCT03840200|157345565|FG003|Overall Study|Progressive Disease|1|||
48865784|NCT03840200|157345562|FG000|Overall Study|Withdrawal by Subject|0|||
48865785|NCT03840200|157345563|FG001|Overall Study|Withdrawal by Subject|1|||
48865786|NCT03840200|157345564|FG002|Overall Study|Withdrawal by Subject|0|||
48655283|NCT02264665|156593320|FG001|Overall Study|Data Missing|0|||
48655284|NCT02264665|156593321|FG002|Overall Study|Data Missing|1|||
48655285|NCT02264665|156593322|FG003|Overall Study|Data Missing|0|||
48655286|NCT02264665|156593323|FG004|Overall Study|Data Missing|0|||
48655287|NCT02264665|156593324|FG005|Overall Study|Data Missing|0|||
48655288|NCT02264665|156593325|FG006|Overall Study|Data Missing|0|||
48655289|NCT00470093|156593326|FG000|Overall Study|Adverse Event|2|||
48655290|NCT01667224|156593327|FG000|Overall Study|Withdrawal by Subject|3|||
48655291|NCT01667224|156593328|FG001|Overall Study|Withdrawal by Subject|1|||
48655292|NCT01667224|156593327|FG000|Overall Study|Protocol Violation|1|||
48655293|NCT01667224|156593328|FG001|Overall Study|Protocol Violation|1|||
48655294|NCT00962741|156593329|FG000|Overall Study|Failed to return|3|||
48655295|NCT00962741|156593329|FG000|Overall Study|Lost to Follow-up|2|||
48655296|NCT00962741|156593329|FG000|Overall Study|Withdrawal by Subject|1|||
48655297|NCT00962741|156593329|FG000|Overall Study|Lack of Efficacy|1|||
48655298|NCT00962741|156593329|FG000|Overall Study|drug ineffective+prohibited drug taken|1|||
48655299|NCT04225676|156593332|FG000|Overall Study|Physician Decision|1|||
48655300|NCT04225676|156593332|FG000|Overall Study|Lack of Efficacy|1|||
48655301|NCT04225676|156593332|FG000|Overall Study|Study terminated by sponsor|3|||
48655302|NCT01942161|156593333|FG000|Overall Study|Adverse Event|1|||
48655303|NCT01942161|156593334|FG001|Overall Study|Adverse Event|2|||
48655304|NCT01942161|156593335|FG002|Overall Study|Adverse Event|5|||
48655305|NCT01942161|156593333|FG000|Overall Study|Physician Decision|3|||
48655306|NCT01942161|156593334|FG001|Overall Study|Physician Decision|1|||
48655307|NCT01942161|156593335|FG002|Overall Study|Physician Decision|0|||
48655308|NCT01942161|156593333|FG000|Overall Study|Protocol Violation|1|||
48655309|NCT01942161|156593334|FG001|Overall Study|Protocol Violation|0|||
48655310|NCT01942161|156593335|FG002|Overall Study|Protocol Violation|0|||
48655311|NCT01942161|156593333|FG000|Overall Study|Withdrawal by Subject|3|||
48655312|NCT01942161|156593334|FG001|Overall Study|Withdrawal by Subject|3|||
48655313|NCT01942161|156593335|FG002|Overall Study|Withdrawal by Subject|1|||
48655314|NCT01814878|156593337|FG000|Overall Study|Adverse Event|16|||
48655315|NCT01814878|156593338|FG001|Overall Study|Adverse Event|5|||
48655316|NCT01814878|156593337|FG000|Overall Study|Withdrawal by Subject|20|||
48655317|NCT01814878|156593338|FG001|Overall Study|Withdrawal by Subject|16|||
48655318|NCT01814878|156593337|FG000|Overall Study|Protocol Violation|5|||
48655319|NCT01814878|156593338|FG001|Overall Study|Protocol Violation|5|||
48655320|NCT01814878|156593337|FG000|Overall Study|Physician Decision|3|||
48655321|NCT01814878|156593338|FG001|Overall Study|Physician Decision|1|||
48655322|NCT01814878|156593337|FG000|Overall Study|Screening failure (drop-out)|0|||
48655323|NCT01814878|156593338|FG001|Overall Study|Screening failure (drop-out)|3|||
48655324|NCT01814878|156593337|FG000|Overall Study|Other|2|||
48655325|NCT01814878|156593338|FG001|Overall Study|Other|0|||
48655326|NCT03645421|156593339|FG000|Overall Study|Adverse Event|0|||
48655327|NCT03645421|156593340|FG001|Overall Study|Adverse Event|0|||
48655328|NCT03645421|156593341|FG002|Overall Study|Adverse Event|4|||
48655329|NCT03645421|156593342|FG003|Overall Study|Adverse Event|1|||
48655330|NCT03645421|156593339|FG000|Overall Study|Withdrawal by patient|0|||
48655331|NCT03645421|156593340|FG001|Overall Study|Withdrawal by patient|0|||
48655332|NCT03645421|156593341|FG002|Overall Study|Withdrawal by patient|0|||
48655333|NCT03645421|156593342|FG003|Overall Study|Withdrawal by patient|3|||
48655334|NCT03645421|156593339|FG000|Overall Study|Study specific withdrawal criteria|0|||
48655335|NCT03645421|156593340|FG001|Overall Study|Study specific withdrawal criteria|0|||
48655336|NCT03645421|156593341|FG002|Overall Study|Study specific withdrawal criteria|1|||
48655337|NCT03645421|156593342|FG003|Overall Study|Study specific withdrawal criteria|0|||
48655338|NCT02379221|156593343|FG000|Overall Study|Lost to Follow-up|1|||
48655339|NCT01257568|156593344|FG000|Overall Study|Lost to Follow-up|2|||
48655340|NCT01257568|156593344|FG000|Overall Study|Withdrawal by Subject|6|||
48655341|NCT01257568|156593344|FG000|Overall Study|Terminated|1|||
48655342|NCT01257568|156593344|FG000|Overall Study|Component Revision|24|||
48655343|NCT02019108|156593345|FG000|Overall Study|Lost to Follow-up|5|||
48655344|NCT02019108|156593346|FG001|Overall Study|Lost to Follow-up|7|||
48655345|NCT01610557|156593347|FG000|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
48655346|NCT01610557|156593348|FG001|36-Week Randomized Crossover Phase|Withdrawal by Subject|1|||
48655347|NCT01610557|156593349|FG002|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
48655348|NCT01610557|156593350|FG003|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
48754203|NCT00642460|156946636|FG005|Part III: Open-Label Up to Week 260|Administrative reason|1|||
48754204|NCT00642460|156946631|FG000|Part III: Open-Label Up to Week 260|Refused treatment|0|||
48754205|NCT00642460|156946632|FG001|Part III: Open-Label Up to Week 260|Refused treatment|0|||
48865787|NCT03840200|157345565|FG003|Overall Study|Withdrawal by Subject|2|||
49015419|NCT01736553|157892181|FG001|Overall Study|Withdrawal by Subject|2|||
48655349|NCT01610557|156593351|FG004|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
48655350|NCT01610557|156593347|FG000|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
48655351|NCT01610557|156593348|FG001|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
48655352|NCT01610557|156593349|FG002|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
48655353|NCT01610557|156593350|FG003|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
48655354|NCT01610557|156593351|FG004|Post-36-Week Extension Phase|Withdrawal by Subject|3|||
48655355|NCT01549886|156593354|FG000|Overall Study|Sponsor's decision|2|||
48655356|NCT01549886|156593355|FG001|Overall Study|Sponsor's decision|3|||
48655357|NCT02039219|156593356|FG000|Treatment|Withdrawal by Subject|1|||
48655358|NCT02039219|156593357|FG001|Treatment|Withdrawal by Subject|0|||
48655359|NCT02039219|156593356|FG000|Treatment|Adverse Event|0|||
48655360|NCT02039219|156593357|FG001|Treatment|Adverse Event|1|||
48655361|NCT02039219|156593356|FG000|Treatment|Physician Decision|1|||
48961034|NCT04032171|157687557|FG000|Overall Study|Study Termination|1|||
48961035|NCT04032171|157687558|FG001|Overall Study|Study Termination|0|||
48961036|NCT02124707|157687561|FG000|Overall Study|Adverse Event|5|||
48961037|NCT02124707|157687561|FG000|Overall Study|Physician Decision|1|||
48961038|NCT02124707|157687561|FG000|Overall Study|Death|1|||
48961039|NCT03491553|157687564|FG000|Main Study (Up to Week 48)|Adverse Event|0|||
48961040|NCT03491553|157687565|FG001|Main Study (Up to Week 48)|Adverse Event|0|||
48961041|NCT03491553|157687566|FG002|Main Study (Up to Week 48)|Adverse Event|0|||
48961042|NCT03491553|157687567|FG003|Main Study (Up to Week 48)|Adverse Event|1|||
48961043|NCT03491553|157687568|FG004|Main Study (Up to Week 48)|Adverse Event|0|||
48961044|NCT03491553|157687569|FG005|Main Study (Up to Week 48)|Adverse Event|0|||
48961045|NCT03491553|157687564|FG000|Main Study (Up to Week 48)|Withdrew Consent|1|||
48961046|NCT03491553|157687565|FG001|Main Study (Up to Week 48)|Withdrew Consent|1|||
48961047|NCT03491553|157687566|FG002|Main Study (Up to Week 48)|Withdrew Consent|0|||
48961048|NCT03491553|157687567|FG003|Main Study (Up to Week 48)|Withdrew Consent|0|||
48961049|NCT03491553|157687568|FG004|Main Study (Up to Week 48)|Withdrew Consent|0|||
48961050|NCT03491553|157687569|FG005|Main Study (Up to Week 48)|Withdrew Consent|0|||
48961051|NCT04633473|157687570|FG000|Overall Study|Withdrawal by Subject|6|||
48961052|NCT00363246|157687571|FG000|Overall Study|Death|40|||
48961053|NCT00363246|157687571|FG000|Overall Study|Withdrawal by Subject|19|||
48961054|NCT00363246|157687571|FG000|Overall Study|Lost to Follow-up|14|||
48961055|NCT00363246|157687571|FG000|Overall Study|Bad health|6|||
48961056|NCT00363246|157687571|FG000|Overall Study|Stopped using wheelchair|11|||
48961057|NCT00363246|157687571|FG000|Overall Study|Subject expressed security concerns|2|||
48655362|NCT02039219|156593357|FG001|Treatment|Physician Decision|0|||
48655363|NCT02039219|156593356|FG000|Treatment|Lost to Follow-up|0|||
48655364|NCT02039219|156593357|FG001|Treatment|Lost to Follow-up|1|||
48655365|NCT02039219|156593356|FG000|Treatment|Protocol Violation|1|||
48655366|NCT02039219|156593357|FG001|Treatment|Protocol Violation|0|||
48655367|NCT02039219|156593356|FG000|Treatment|Death|1|||
48655368|NCT02039219|156593357|FG001|Treatment|Death|0|||
48655369|NCT02039219|156593356|FG000|Follow up|Adverse Event|0|||
48655370|NCT02039219|156593357|FG001|Follow up|Adverse Event|1|||
48655371|NCT04098367|156593358|FG000|Overall Study|Adverse Event|0|||
48655372|NCT04098367|156593359|FG001|Overall Study|Adverse Event|0|||
48655373|NCT04098367|156593360|FG002|Overall Study|Adverse Event|1|||
48655374|NCT04098367|156593358|FG000|Overall Study|Lost to Follow-up|1|||
48655375|NCT04098367|156593359|FG001|Overall Study|Lost to Follow-up|5|||
48655376|NCT04098367|156593360|FG002|Overall Study|Lost to Follow-up|2|||
48655377|NCT04098367|156593358|FG000|Overall Study|Withdrawal by Subject|0|||
48655378|NCT04098367|156593359|FG001|Overall Study|Withdrawal by Subject|0|||
48655379|NCT04098367|156593360|FG002|Overall Study|Withdrawal by Subject|1|||
48655380|NCT04098367|156593358|FG000|Overall Study|Sick . Could not attend visit|1|||
48655381|NCT04098367|156593359|FG001|Overall Study|Sick . Could not attend visit|0|||
48655382|NCT04098367|156593360|FG002|Overall Study|Sick . Could not attend visit|0|||
48655383|NCT00129701|156593361|FG000|Overall Study|Withdrawal by Subject|33|||
48655384|NCT03576066|156593362|FG000|Overall Study|Noncompliance with study drug|0|||
48655385|NCT03576066|156593363|FG001|Overall Study|Noncompliance with study drug|1|||
48655386|NCT02750345|156593364|FG000|Intervention 1|Adverse Event|0|||
48655387|NCT02750345|156593365|FG001|Intervention 1|Adverse Event|0|||
48655388|NCT02750345|156593366|FG002|Intervention 1|Adverse Event|0|||
48655389|NCT02750345|156593367|FG003|Intervention 1|Adverse Event|0|||
48655390|NCT02750345|156593368|FG004|Intervention 1|Adverse Event|1|||
48655391|NCT02750345|156593369|FG005|Intervention 1|Adverse Event|0|||
48655392|NCT01474772|156593370|FG000|Period 1|Adverse Event (AE) Related to Study Drug|6|||
48655393|NCT01474772|156593371|FG001|Period 1|Adverse Event (AE) Related to Study Drug|1|||
48655394|NCT01474772|156593370|FG000|Period 1|AE not Related to Study Drug|1|||
48655395|NCT01474772|156593371|FG001|Period 1|AE not Related to Study Drug|0|||
48655396|NCT01474772|156593370|FG000|Period 1|Withdrawal by Subject|3|||
48655397|NCT01474772|156593371|FG001|Period 1|Withdrawal by Subject|1|||
48655398|NCT01474772|156593370|FG000|Period 1|Lost to Follow-up|1|||
48655399|NCT01474772|156593371|FG001|Period 1|Lost to Follow-up|0|||
48655400|NCT01474772|156593370|FG000|Period 1|Reason not Specified|1|||
48655401|NCT01474772|156593371|FG001|Period 1|Reason not Specified|1|||
48754206|NCT00642460|156946633|FG002|Part III: Open-Label Up to Week 260|Refused treatment|0|||
48655402|NCT01474772|156593370|FG000|Washout|AE not Related to Study Drug|2|||
48655403|NCT01474772|156593371|FG001|Washout|AE not Related to Study Drug|0|||
48655404|NCT01474772|156593370|FG000|Washout|Withdrawal by Subject|1|||
48961058|NCT00363246|157687571|FG000|Overall Study|Eligibility changed due to Hospice move|5|||
48961059|NCT02756650|157687574|FG000|Overall Study|Physician Decision|1|||
48961060|NCT02756650|157687574|FG000|Overall Study|Adverse Event|1|||
48961061|NCT01029886|157687575|FG000|Overall Study|Adverse Event|12|||
48961062|NCT01029886|157687576|FG001|Overall Study|Adverse Event|25|||
48961063|NCT01029886|157687575|FG000|Overall Study|Lost to Follow-up|1|||
48754207|NCT00642460|156946634|FG003|Part III: Open-Label Up to Week 260|Refused treatment|0|||
48754208|NCT00642460|156946635|FG004|Part III: Open-Label Up to Week 260|Refused treatment|8|||
48754209|NCT00642460|156946636|FG005|Part III: Open-Label Up to Week 260|Refused treatment|3|||
48754210|NCT00726661|156946637|FG000|Overall Study|Lost to Follow-up|36|||
48754211|NCT00726661|156946638|FG001|Overall Study|Lost to Follow-up|11|||
48754212|NCT00726661|156946637|FG000|Overall Study|Withdrawal by Subject|17|||
48754213|NCT00726661|156946638|FG001|Overall Study|Withdrawal by Subject|13|||
48754214|NCT00726661|156946637|FG000|Overall Study|Trial terminated by sponsor|214|||
48655405|NCT01474772|156593371|FG001|Washout|Withdrawal by Subject|0|||
48655406|NCT01474772|156593370|FG000|Washout|Lost to Follow-up|0|||
48655407|NCT01474772|156593371|FG001|Washout|Lost to Follow-up|1|||
48655408|NCT01474772|156593370|FG000|Washout|Reason not Specified|0|||
48655409|NCT01474772|156593371|FG001|Washout|Reason not Specified|1|||
48655410|NCT01474772|156593370|FG000|Period 2|Death|0|||
48655411|NCT01474772|156593371|FG001|Period 2|Death|1|||
48655412|NCT01474772|156593370|FG000|Period 2|AE Related to Study Drug|0|||
48754215|NCT00726661|156946638|FG001|Overall Study|Trial terminated by sponsor|187|||
48961064|NCT01029886|157687576|FG001|Overall Study|Lost to Follow-up|0|||
48961065|NCT01029886|157687575|FG000|Overall Study|Physician Decision|2|||
48961066|NCT01029886|157687576|FG001|Overall Study|Physician Decision|6|||
48961067|NCT01029886|157687575|FG000|Overall Study|Protocol Violation|17|||
48655413|NCT01474772|156593371|FG001|Period 2|AE Related to Study Drug|1|||
48655414|NCT01474772|156593370|FG000|Period 2|AE not Related to Study Drug|4|||
48655415|NCT01474772|156593371|FG001|Period 2|AE not Related to Study Drug|1|||
48655416|NCT01474772|156593370|FG000|Period 2|Lack of Efficacy|1|||
48655417|NCT01474772|156593371|FG001|Period 2|Lack of Efficacy|0|||
48655418|NCT01474772|156593370|FG000|Period 2|Withdrawal by Subject|3|||
48655419|NCT01474772|156593371|FG001|Period 2|Withdrawal by Subject|4|||
48961068|NCT01029886|157687576|FG001|Overall Study|Protocol Violation|5|||
48961069|NCT01029886|157687575|FG000|Overall Study|Withdrawal by Subject|8|||
48961070|NCT01029886|157687576|FG001|Overall Study|Withdrawal by Subject|18|||
48961071|NCT01029886|157687575|FG000|Overall Study|Entry Criteria Not Met|13|||
48961072|NCT01029886|157687576|FG001|Overall Study|Entry Criteria Not Met|5|||
48961073|NCT01029886|157687575|FG000|Overall Study|Sponsor Decision|1|||
48961074|NCT01029886|157687576|FG001|Overall Study|Sponsor Decision|0|||
48961075|NCT01029886|157687575|FG000|Overall Study|Loss Glucose Control|7|||
48961076|NCT01029886|157687576|FG001|Overall Study|Loss Glucose Control|1|||
48961077|NCT03294681|157687577|FG000|Overall Study|Withdrawal by Subject|1|||
48961078|NCT03089216|157687578|FG000|Overall Study|Adverse Event|0|||
48961079|NCT03089216|157687579|FG001|Overall Study|Adverse Event|0|||
48961080|NCT03089216|157687580|FG002|Overall Study|Adverse Event|0|||
48961081|NCT03089216|157687581|FG003|Overall Study|Adverse Event|1|||
48961082|NCT04348591|157687586|FG000|Imaging Session (120 Min)|Lost to Follow-up|0|||
48655420|NCT01474772|156593370|FG000|Period 2|Lost to Follow-up|1|||
48655421|NCT01474772|156593371|FG001|Period 2|Lost to Follow-up|1|||
48655422|NCT01474772|156593370|FG000|Period 2|Reason not Specified|0|||
48655423|NCT01474772|156593371|FG001|Period 2|Reason not Specified|2|||
48655424|NCT01474772|156593370|FG000|Follow-up|AE not Related to Study Drug|0|||
48655425|NCT01474772|156593371|FG001|Follow-up|AE not Related to Study Drug|1|||
48655426|NCT04484649|156593372|FG000|Overall Study|Lost to Follow-up|2|||
48655427|NCT04484649|156593373|FG001|Overall Study|Lost to Follow-up|1|||
48655428|NCT04484649|156593372|FG000|Overall Study|Did not submit actigraphy post interc\vention|6|||
48655429|NCT04484649|156593373|FG001|Overall Study|Did not submit actigraphy post interc\vention|4|||
48655430|NCT00730041|156593374|FG000|Overall Study|Lost to Follow-up|0|||
48655431|NCT00730041|156593375|FG001|Overall Study|Lost to Follow-up|2|||
48655432|NCT02570152|156593376|FG000|Overall Study|Protocol Violation|2|||
48655433|NCT02570152|156593376|FG000|Overall Study|Migrated/moved from study area|13|||
48655434|NCT04752566|156593378|FG000|Overall Study|Protocol Violation|0|||
48655435|NCT04752566|156593379|FG001|Overall Study|Protocol Violation|1|||
48655436|NCT04752566|156593378|FG000|Overall Study|Death|1|||
48655437|NCT04752566|156593379|FG001|Overall Study|Death|0|||
48655438|NCT04752566|156593378|FG000|Overall Study|Adverse Event|1|||
48655439|NCT04752566|156593379|FG001|Overall Study|Adverse Event|0|||
48655440|NCT04752566|156593378|FG000|Overall Study|Withdrawal by Subject|2|||
48655441|NCT04752566|156593379|FG001|Overall Study|Withdrawal by Subject|0|||
48961083|NCT04348591|157687587|FG001|Imaging Session (120 Min)|Lost to Follow-up|2|||
48961084|NCT04348591|157687586|FG000|Imaging Session (120 Min)|Physician Decision|0|||
48655442|NCT04752566|156593378|FG000|Overall Study|Physician Decision|1|||
48754216|NCT00726661|156946637|FG000|Overall Study|Death|475|||
48754217|NCT00726661|156946638|FG001|Overall Study|Death|159|||
48754218|NCT00726661|156946637|FG000|Overall Study|Physician Decision|25|||
48655443|NCT04752566|156593379|FG001|Overall Study|Physician Decision|1|||
48961085|NCT04348591|157687587|FG001|Imaging Session (120 Min)|Physician Decision|1|||
48655444|NCT03831191|156593380|FG000|Induction Period (16 Weeks)|Adverse Event|2|||
48655445|NCT03831191|156593381|FG001|Induction Period (16 Weeks)|Adverse Event|1|||
48961086|NCT04348591|157687586|FG000|Imaging Session (120 Min)|Withdrawal by Subject|2|||
48961087|NCT04348591|157687587|FG001|Imaging Session (120 Min)|Withdrawal by Subject|0|||
48961088|NCT00417976|157687589|FG000|Overall Study|Non compliance unrelated to toxicity|1|||
48961089|NCT00417976|157687589|FG000|Overall Study|Treatment -related toxicity|2|||
48961090|NCT01778127|157687594|FG000|Overall Study|Lost to Follow-up|5|||
48961091|NCT01778127|157687595|FG001|Overall Study|Lost to Follow-up|1|||
48961092|NCT01778127|157687596|FG002|Overall Study|Lost to Follow-up|2|||
48961093|NCT01778127|157687594|FG000|Overall Study|Withdrawal by Subject|3|||
48961094|NCT01778127|157687595|FG001|Overall Study|Withdrawal by Subject|1|||
48961095|NCT01778127|157687596|FG002|Overall Study|Withdrawal by Subject|4|||
48961096|NCT01348425|157687597|FG000|Overall Study|Imaging was not taken.|1|||
48961097|NCT01348425|157687598|FG001|Overall Study|Imaging was not taken.|1|||
48961098|NCT02104804|157687599|FG000|Overall Study|Did not take study medication|0|||
48961099|NCT02104804|157687600|FG001|Overall Study|Did not take study medication|1|||
48961100|NCT02104804|157687599|FG000|Overall Study|Study specific discontinuation criteria|6|||
48655446|NCT03831191|156593382|FG002|Induction Period (16 Weeks)|Adverse Event|3|||
48655447|NCT03831191|156593383|FG003|Induction Period (16 Weeks)|Adverse Event|4|||
48655448|NCT03831191|156593384|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
48655449|NCT03831191|156593385|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
48655450|NCT03831191|156593386|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
48655451|NCT03831191|156593387|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
48655452|NCT03831191|156593388|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
48655453|NCT03831191|156593389|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
48655454|NCT03831191|156593390|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
48655455|NCT03831191|156593391|FG011|Induction Period (16 Weeks)|Adverse Event|0|||
48655456|NCT03831191|156593392|FG012|Induction Period (16 Weeks)|Adverse Event|0|||
48655457|NCT03831191|156593393|FG013|Induction Period (16 Weeks)|Adverse Event|0|||
48655458|NCT03831191|156593394|FG014|Induction Period (16 Weeks)|Adverse Event|0|||
48655459|NCT03831191|156593380|FG000|Induction Period (16 Weeks)|Lack of Efficacy|2|||
48655460|NCT03831191|156593381|FG001|Induction Period (16 Weeks)|Lack of Efficacy|3|||
48655461|NCT03831191|156593382|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
48655462|NCT03831191|156593383|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
48655463|NCT03831191|156593384|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
48655464|NCT03831191|156593385|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
48655465|NCT03831191|156593386|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
48655466|NCT03831191|156593387|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
48655467|NCT03831191|156593388|FG008|Induction Period (16 Weeks)|Lack of Efficacy|0|||
48655468|NCT03831191|156593389|FG009|Induction Period (16 Weeks)|Lack of Efficacy|0|||
48655469|NCT03831191|156593390|FG010|Induction Period (16 Weeks)|Lack of Efficacy|0|||
48655470|NCT03831191|156593391|FG011|Induction Period (16 Weeks)|Lack of Efficacy|0|||
48655471|NCT03831191|156593392|FG012|Induction Period (16 Weeks)|Lack of Efficacy|0|||
48655472|NCT03831191|156593393|FG013|Induction Period (16 Weeks)|Lack of Efficacy|0|||
48655473|NCT03831191|156593394|FG014|Induction Period (16 Weeks)|Lack of Efficacy|0|||
48655474|NCT03831191|156593380|FG000|Induction Period (16 Weeks)|Pregnancy|0|||
48961101|NCT02104804|157687600|FG001|Overall Study|Study specific discontinuation criteria|1|||
48961102|NCT02104804|157687599|FG000|Overall Study|Other listed|2|||
48655475|NCT03831191|156593381|FG001|Induction Period (16 Weeks)|Pregnancy|0|||
48655476|NCT03831191|156593382|FG002|Induction Period (16 Weeks)|Pregnancy|1|||
48655477|NCT03831191|156593383|FG003|Induction Period (16 Weeks)|Pregnancy|0|||
48655478|NCT03831191|156593384|FG004|Induction Period (16 Weeks)|Pregnancy|0|||
48655479|NCT03831191|156593385|FG005|Induction Period (16 Weeks)|Pregnancy|0|||
48655480|NCT03831191|156593386|FG006|Induction Period (16 Weeks)|Pregnancy|0|||
48655481|NCT03831191|156593387|FG007|Induction Period (16 Weeks)|Pregnancy|0|||
48655482|NCT03831191|156593388|FG008|Induction Period (16 Weeks)|Pregnancy|0|||
48655483|NCT03831191|156593389|FG009|Induction Period (16 Weeks)|Pregnancy|0|||
48655484|NCT03831191|156593390|FG010|Induction Period (16 Weeks)|Pregnancy|0|||
48655485|NCT03831191|156593391|FG011|Induction Period (16 Weeks)|Pregnancy|0|||
48655486|NCT03831191|156593392|FG012|Induction Period (16 Weeks)|Pregnancy|0|||
48655487|NCT03831191|156593393|FG013|Induction Period (16 Weeks)|Pregnancy|0|||
48655488|NCT03831191|156593394|FG014|Induction Period (16 Weeks)|Pregnancy|0|||
48655489|NCT03831191|156593380|FG000|Induction Period (16 Weeks)|Protocol Violation|0|||
48655490|NCT03831191|156593381|FG001|Induction Period (16 Weeks)|Protocol Violation|0|||
48655491|NCT03831191|156593382|FG002|Induction Period (16 Weeks)|Protocol Violation|0|||
48655492|NCT03831191|156593383|FG003|Induction Period (16 Weeks)|Protocol Violation|2|||
48655493|NCT03831191|156593384|FG004|Induction Period (16 Weeks)|Protocol Violation|0|||
48655494|NCT03831191|156593385|FG005|Induction Period (16 Weeks)|Protocol Violation|0|||
48655495|NCT03831191|156593386|FG006|Induction Period (16 Weeks)|Protocol Violation|0|||
48961103|NCT02104804|157687600|FG001|Overall Study|Other listed|1|||
48655496|NCT03831191|156593387|FG007|Induction Period (16 Weeks)|Protocol Violation|0|||
48655497|NCT03831191|156593388|FG008|Induction Period (16 Weeks)|Protocol Violation|0|||
48655498|NCT03831191|156593389|FG009|Induction Period (16 Weeks)|Protocol Violation|0|||
48655499|NCT03831191|156593390|FG010|Induction Period (16 Weeks)|Protocol Violation|0|||
48655500|NCT03831191|156593391|FG011|Induction Period (16 Weeks)|Protocol Violation|0|||
48655501|NCT03831191|156593392|FG012|Induction Period (16 Weeks)|Protocol Violation|0|||
48655502|NCT03831191|156593393|FG013|Induction Period (16 Weeks)|Protocol Violation|0|||
48961104|NCT02104804|157687599|FG000|Overall Study|Protocol Violation|0|||
48961105|NCT02104804|157687600|FG001|Overall Study|Protocol Violation|1|||
48961106|NCT02104804|157687599|FG000|Overall Study|Adverse Event|4|||
48961107|NCT02104804|157687600|FG001|Overall Study|Adverse Event|3|||
48961108|NCT02104804|157687599|FG000|Overall Study|Withdrawal by Subject|4|||
48961109|NCT02104804|157687600|FG001|Overall Study|Withdrawal by Subject|12|||
48961110|NCT02720016|157687603|FG000|Overall Study|Separation of couple|6|||
48961111|NCT02720016|157687604|FG001|Overall Study|Separation of couple|8|||
48961112|NCT02720016|157687605|FG002|Overall Study|Separation of couple|2|||
48961113|NCT02720016|157687603|FG000|Overall Study|Withdrawal by Subject|6|||
48961114|NCT02720016|157687604|FG001|Overall Study|Withdrawal by Subject|6|||
48961115|NCT02720016|157687605|FG002|Overall Study|Withdrawal by Subject|4|||
48961116|NCT02720016|157687603|FG000|Overall Study|Scheduling issues|2|||
48961117|NCT02720016|157687604|FG001|Overall Study|Scheduling issues|4|||
48961118|NCT02720016|157687605|FG002|Overall Study|Scheduling issues|7|||
48961119|NCT02720016|157687603|FG000|Overall Study|Childcare|2|||
48961120|NCT02720016|157687604|FG001|Overall Study|Childcare|0|||
48961121|NCT02720016|157687605|FG002|Overall Study|Childcare|2|||
48961122|NCT02720016|157687603|FG000|Overall Study|Withdrawal by PI|2|||
48961123|NCT02720016|157687604|FG001|Overall Study|Withdrawal by PI|2|||
48961124|NCT02720016|157687605|FG002|Overall Study|Withdrawal by PI|0|||
48961125|NCT02720016|157687603|FG000|Overall Study|Moved away|2|||
48961126|NCT02720016|157687604|FG001|Overall Study|Moved away|0|||
48961127|NCT02720016|157687605|FG002|Overall Study|Moved away|0|||
48961128|NCT02720016|157687603|FG000|Overall Study|Not Primary Health Concern|0|||
48961129|NCT02720016|157687604|FG001|Overall Study|Not Primary Health Concern|0|||
48961130|NCT02720016|157687605|FG002|Overall Study|Not Primary Health Concern|2|||
48961131|NCT02720016|157687603|FG000|Overall Study|Transportation issues|0|||
48961132|NCT02720016|157687604|FG001|Overall Study|Transportation issues|0|||
48961133|NCT02720016|157687605|FG002|Overall Study|Transportation issues|1|||
48961134|NCT02720016|157687603|FG000|Overall Study|Other|0|||
48961135|NCT02720016|157687604|FG001|Overall Study|Other|0|||
48961136|NCT02720016|157687605|FG002|Overall Study|Other|2|||
48961137|NCT04501679|157687608|FG000|Overall Study|Pregnancy|0|||
48961138|NCT04501679|157687609|FG001|Overall Study|Pregnancy|1|||
48961139|NCT04501679|157687608|FG000|Overall Study|Adverse Event|4|||
48961140|NCT04501679|157687609|FG001|Overall Study|Adverse Event|2|||
48961141|NCT04501679|157687608|FG000|Overall Study|Withdrawal by Subject|2|||
48961142|NCT04501679|157687609|FG001|Overall Study|Withdrawal by Subject|0|||
48961143|NCT04501679|157687608|FG000|Overall Study|Physician Decision|1|||
48961144|NCT04501679|157687609|FG001|Overall Study|Physician Decision|0|||
48961145|NCT04501679|157687608|FG000|Overall Study|Lost to Follow-up|2|||
48961146|NCT04501679|157687609|FG001|Overall Study|Lost to Follow-up|0|||
48961147|NCT01606761|157687612|FG000|Prior to Week 24|Lost to Follow-up|0|||
48961148|NCT01606761|157687613|FG001|Prior to Week 24|Lost to Follow-up|3|||
48961149|NCT01606761|157687614|FG002|Prior to Week 24|Lost to Follow-up|2|||
48961150|NCT01606761|157687615|FG003|Prior to Week 24|Lost to Follow-up|0|||
48961151|NCT01606761|157687616|FG004|Prior to Week 24|Lost to Follow-up|0|||
48961152|NCT01606761|157687612|FG000|Prior to Week 24|Withdrawal by Subject|12|||
48961153|NCT01606761|157687613|FG001|Prior to Week 24|Withdrawal by Subject|10|||
48961154|NCT01606761|157687614|FG002|Prior to Week 24|Withdrawal by Subject|9|||
48961155|NCT01606761|157687615|FG003|Prior to Week 24|Withdrawal by Subject|0|||
48961156|NCT01606761|157687616|FG004|Prior to Week 24|Withdrawal by Subject|0|||
48961157|NCT01606761|157687612|FG000|Prior to Week 24|Adverse Event|11|||
48961158|NCT01606761|157687613|FG001|Prior to Week 24|Adverse Event|18|||
48961159|NCT01606761|157687614|FG002|Prior to Week 24|Adverse Event|22|||
48961160|NCT01606761|157687615|FG003|Prior to Week 24|Adverse Event|0|||
48961161|NCT01606761|157687616|FG004|Prior to Week 24|Adverse Event|0|||
48961162|NCT01606761|157687612|FG000|Prior to Week 24|Lack of Efficacy|15|||
48961163|NCT01606761|157687613|FG001|Prior to Week 24|Lack of Efficacy|14|||
48961164|NCT01606761|157687614|FG002|Prior to Week 24|Lack of Efficacy|8|||
48655503|NCT03831191|156593394|FG014|Induction Period (16 Weeks)|Protocol Violation|0|||
48655504|NCT03831191|156593380|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|7|||
48655505|NCT03831191|156593381|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
48655506|NCT03831191|156593382|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
48655507|NCT03831191|156593383|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
48655508|NCT03831191|156593384|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
48754219|NCT00726661|156946638|FG001|Overall Study|Physician Decision|13|||
48961165|NCT01606761|157687615|FG003|Prior to Week 24|Lack of Efficacy|0|||
48961166|NCT01606761|157687616|FG004|Prior to Week 24|Lack of Efficacy|0|||
48961167|NCT01606761|157687612|FG000|Prior to Week 24|Physician Decision|0|||
48961168|NCT01606761|157687613|FG001|Prior to Week 24|Physician Decision|3|||
48961169|NCT01606761|157687614|FG002|Prior to Week 24|Physician Decision|1|||
48961170|NCT01606761|157687615|FG003|Prior to Week 24|Physician Decision|0|||
48961171|NCT01606761|157687616|FG004|Prior to Week 24|Physician Decision|0|||
48961172|NCT01606761|157687612|FG000|Prior to Week 24|Other|4|||
48961173|NCT01606761|157687613|FG001|Prior to Week 24|Other|7|||
48961174|NCT01606761|157687614|FG002|Prior to Week 24|Other|5|||
48961175|NCT01606761|157687615|FG003|Prior to Week 24|Other|0|||
48961176|NCT01606761|157687616|FG004|Prior to Week 24|Other|0|||
48961177|NCT01606761|157687612|FG000|Week 24 to Week 52|Lost to Follow-up|0|||
48961178|NCT01606761|157687613|FG001|Week 24 to Week 52|Lost to Follow-up|1|||
48961179|NCT01606761|157687614|FG002|Week 24 to Week 52|Lost to Follow-up|1|||
48655509|NCT03831191|156593385|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
48754220|NCT00726661|156946637|FG000|Overall Study|Other|47|||
48754221|NCT00726661|156946638|FG001|Overall Study|Other|35|||
48754222|NCT01285310|156946639|FG000|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3|||
48754223|NCT01285310|156946640|FG001|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4|||
48754224|NCT01285310|156946641|FG002|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6|||
48754225|NCT01285310|156946642|FG003|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
48754226|NCT01285310|156946643|FG004|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
48754227|NCT01285310|156946639|FG000|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1|||
48754228|NCT01285310|156946640|FG001|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7|||
48754229|NCT01285310|156946641|FG002|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3|||
48754230|NCT01285310|156946642|FG003|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
48754231|NCT01285310|156946643|FG004|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
48754232|NCT01285310|156946639|FG000|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1|||
48754233|NCT01285310|156946640|FG001|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
48754234|NCT01285310|156946641|FG002|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2|||
48754235|NCT01285310|156946642|FG003|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
48754236|NCT01285310|156946643|FG004|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
48754237|NCT01285310|156946639|FG000|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
48754238|NCT01285310|156946640|FG001|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
48754239|NCT01285310|156946641|FG002|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2|||
48754240|NCT01285310|156946642|FG003|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
48754241|NCT01285310|156946643|FG004|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
48655510|NCT03831191|156593386|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
48655511|NCT03831191|156593387|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
48655512|NCT03831191|156593388|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
48655513|NCT03831191|156593389|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
48655514|NCT03831191|156593390|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
48655515|NCT03831191|156593391|FG011|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
48655516|NCT03831191|156593392|FG012|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
48655517|NCT03831191|156593393|FG013|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
48754242|NCT01285310|156946639|FG000|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
48754243|NCT01285310|156946640|FG001|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
48754244|NCT01285310|156946641|FG002|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
48754245|NCT01285310|156946642|FG003|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
48754246|NCT01285310|156946643|FG004|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
48754247|NCT01285310|156946639|FG000|Placebo Controlled Phase: Weeks 0-24|Other|1|||
48754248|NCT01285310|156946640|FG001|Placebo Controlled Phase: Weeks 0-24|Other|0|||
48754249|NCT01285310|156946641|FG002|Placebo Controlled Phase: Weeks 0-24|Other|1|||
48754250|NCT01285310|156946642|FG003|Placebo Controlled Phase: Weeks 0-24|Other|0|||
48754251|NCT01285310|156946643|FG004|Placebo Controlled Phase: Weeks 0-24|Other|0|||
48754252|NCT01285310|156946639|FG000|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
48754253|NCT01285310|156946640|FG001|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
48754254|NCT01285310|156946641|FG002|Active Treatment Phase: Weeks 25-52|Adverse Event|3|||
48754255|NCT01285310|156946642|FG003|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
48754256|NCT01285310|156946643|FG004|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
48754257|NCT01285310|156946639|FG000|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
48754258|NCT01285310|156946640|FG001|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4|||
48961180|NCT01606761|157687615|FG003|Week 24 to Week 52|Lost to Follow-up|1|||
48961181|NCT01606761|157687616|FG004|Week 24 to Week 52|Lost to Follow-up|0|||
48961182|NCT01606761|157687612|FG000|Week 24 to Week 52|Withdrawal by Subject|0|||
48961183|NCT01606761|157687613|FG001|Week 24 to Week 52|Withdrawal by Subject|6|||
48655518|NCT03831191|156593394|FG014|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
48655519|NCT03831191|156593380|FG000|Induction Period (16 Weeks)|Study Terminated by Sponsor|12|||
48655520|NCT03831191|156593381|FG001|Induction Period (16 Weeks)|Study Terminated by Sponsor|15|||
48655521|NCT03831191|156593382|FG002|Induction Period (16 Weeks)|Study Terminated by Sponsor|16|||
48655522|NCT03831191|156593383|FG003|Induction Period (16 Weeks)|Study Terminated by Sponsor|13|||
48754259|NCT01285310|156946641|FG002|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3|||
48961184|NCT01606761|157687614|FG002|Week 24 to Week 52|Withdrawal by Subject|3|||
48655523|NCT03831191|156593384|FG004|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
48655524|NCT03831191|156593385|FG005|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
48754260|NCT01285310|156946642|FG003|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1|||
48754261|NCT01285310|156946643|FG004|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
48961185|NCT01606761|157687615|FG003|Week 24 to Week 52|Withdrawal by Subject|0|||
48961186|NCT01606761|157687616|FG004|Week 24 to Week 52|Withdrawal by Subject|0|||
48655525|NCT03831191|156593386|FG006|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
48655526|NCT03831191|156593387|FG007|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
48655527|NCT03831191|156593388|FG008|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
48655528|NCT03831191|156593389|FG009|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
48655529|NCT03831191|156593390|FG010|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
48655530|NCT03831191|156593391|FG011|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
48655531|NCT03831191|156593392|FG012|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
48655532|NCT03831191|156593393|FG013|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
48655533|NCT03831191|156593394|FG014|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
48655534|NCT03831191|156593380|FG000|Induction Period (16 Weeks)|Sponsor Decision|0|||
48961187|NCT01606761|157687612|FG000|Week 24 to Week 52|Adverse Event|0|||
48961188|NCT01606761|157687613|FG001|Week 24 to Week 52|Adverse Event|11|||
48961189|NCT01606761|157687614|FG002|Week 24 to Week 52|Adverse Event|14|||
48961190|NCT01606761|157687615|FG003|Week 24 to Week 52|Adverse Event|3|||
48961191|NCT01606761|157687616|FG004|Week 24 to Week 52|Adverse Event|15|||
48961192|NCT01606761|157687612|FG000|Week 24 to Week 52|Death|0|||
48961193|NCT01606761|157687613|FG001|Week 24 to Week 52|Death|0|||
48961194|NCT01606761|157687614|FG002|Week 24 to Week 52|Death|2|||
48961195|NCT01606761|157687615|FG003|Week 24 to Week 52|Death|1|||
48961196|NCT01606761|157687616|FG004|Week 24 to Week 52|Death|0|||
48961197|NCT01606761|157687612|FG000|Week 24 to Week 52|Lack of Efficacy|0|||
48961198|NCT01606761|157687613|FG001|Week 24 to Week 52|Lack of Efficacy|13|||
48961199|NCT01606761|157687614|FG002|Week 24 to Week 52|Lack of Efficacy|7|||
48961200|NCT01606761|157687615|FG003|Week 24 to Week 52|Lack of Efficacy|10|||
48961201|NCT01606761|157687616|FG004|Week 24 to Week 52|Lack of Efficacy|3|||
48961202|NCT01606761|157687612|FG000|Week 24 to Week 52|Physician Decision|0|||
48961203|NCT01606761|157687613|FG001|Week 24 to Week 52|Physician Decision|1|||
48961204|NCT01606761|157687614|FG002|Week 24 to Week 52|Physician Decision|1|||
48961205|NCT01606761|157687615|FG003|Week 24 to Week 52|Physician Decision|0|||
48961206|NCT01606761|157687616|FG004|Week 24 to Week 52|Physician Decision|0|||
48961207|NCT01606761|157687612|FG000|Week 24 to Week 52|Other|0|||
48961208|NCT01606761|157687613|FG001|Week 24 to Week 52|Other|1|||
48961209|NCT01606761|157687614|FG002|Week 24 to Week 52|Other|5|||
48961210|NCT01606761|157687615|FG003|Week 24 to Week 52|Other|2|||
48961211|NCT01606761|157687616|FG004|Week 24 to Week 52|Other|2|||
48961212|NCT01606761|157687612|FG000|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
48754262|NCT01285310|156946639|FG000|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
48961213|NCT01606761|157687613|FG001|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
48961214|NCT01606761|157687614|FG002|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2|||
48961215|NCT01606761|157687615|FG003|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
48961216|NCT01606761|157687616|FG004|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
48961217|NCT01606761|157687612|FG000|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4|||
48961218|NCT01606761|157687613|FG001|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
48961219|NCT01606761|157687614|FG002|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
48961220|NCT01606761|157687615|FG003|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1|||
48961221|NCT01606761|157687616|FG004|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3|||
48961222|NCT01606761|157687612|FG000|Safety Follow-up Period (Week 52-68)|Death|0|||
48961223|NCT01606761|157687613|FG001|Safety Follow-up Period (Week 52-68)|Death|0|||
48961224|NCT01606761|157687614|FG002|Safety Follow-up Period (Week 52-68)|Death|0|||
48961225|NCT01606761|157687615|FG003|Safety Follow-up Period (Week 52-68)|Death|0|||
48961226|NCT01606761|157687616|FG004|Safety Follow-up Period (Week 52-68)|Death|1|||
48961227|NCT01606761|157687612|FG000|Safety Follow-up Period (Week 52-68)|Other|0|||
48655535|NCT03831191|156593381|FG001|Induction Period (16 Weeks)|Sponsor Decision|0|||
48655536|NCT03831191|156593382|FG002|Induction Period (16 Weeks)|Sponsor Decision|0|||
48655537|NCT03831191|156593383|FG003|Induction Period (16 Weeks)|Sponsor Decision|1|||
48655538|NCT03831191|156593384|FG004|Induction Period (16 Weeks)|Sponsor Decision|0|||
48655539|NCT03831191|156593385|FG005|Induction Period (16 Weeks)|Sponsor Decision|0|||
48655540|NCT03831191|156593386|FG006|Induction Period (16 Weeks)|Sponsor Decision|0|||
48655541|NCT03831191|156593387|FG007|Induction Period (16 Weeks)|Sponsor Decision|0|||
48655542|NCT03831191|156593388|FG008|Induction Period (16 Weeks)|Sponsor Decision|0|||
48655543|NCT03831191|156593389|FG009|Induction Period (16 Weeks)|Sponsor Decision|0|||
48655544|NCT03831191|156593390|FG010|Induction Period (16 Weeks)|Sponsor Decision|0|||
48655545|NCT03831191|156593391|FG011|Induction Period (16 Weeks)|Sponsor Decision|0|||
48655546|NCT03831191|156593392|FG012|Induction Period (16 Weeks)|Sponsor Decision|0|||
48655547|NCT03831191|156593393|FG013|Induction Period (16 Weeks)|Sponsor Decision|0|||
48655548|NCT03831191|156593394|FG014|Induction Period (16 Weeks)|Sponsor Decision|0|||
48655549|NCT03831191|156593380|FG000|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
48655550|NCT03831191|156593381|FG001|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
48655551|NCT03831191|156593382|FG002|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
48754263|NCT01285310|156946640|FG001|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3|||
48961228|NCT01606761|157687613|FG001|Safety Follow-up Period (Week 52-68)|Other|3|||
49015420|NCT01736553|157892180|FG000|Overall Study|Lost to Follow-up|2|||
48961229|NCT01606761|157687614|FG002|Safety Follow-up Period (Week 52-68)|Other|9|||
48961230|NCT01606761|157687615|FG003|Safety Follow-up Period (Week 52-68)|Other|1|||
48961231|NCT01606761|157687616|FG004|Safety Follow-up Period (Week 52-68)|Other|3|||
48961232|NCT02121756|157687619|FG000|Overall Study|Adverse Event|3|||
48961233|NCT02121756|157687620|FG001|Overall Study|Adverse Event|0|||
48961234|NCT02121756|157687619|FG000|Overall Study|Protocol Violation|1|||
48961235|NCT02121756|157687620|FG001|Overall Study|Protocol Violation|1|||
48961236|NCT02121756|157687619|FG000|Overall Study|Physician Decision|2|||
48961237|NCT02121756|157687620|FG001|Overall Study|Physician Decision|1|||
48961238|NCT05319080|157687621|FG000|Overall Study|Withdrawal by Subject|2|||
48961239|NCT05319080|157687621|FG000|Overall Study|Physician Decision|4|||
48961240|NCT00751114|157687622|FG000|Overall Study|Adverse Event|2|||
48961241|NCT00751114|157687623|FG001|Overall Study|Adverse Event|4|||
48961242|NCT00751114|157687622|FG000|Overall Study|Protocol Violation|8|||
48961243|NCT00751114|157687623|FG001|Overall Study|Protocol Violation|9|||
48961244|NCT00751114|157687622|FG000|Overall Study|Withdrawal by Subject|9|||
48961245|NCT00751114|157687623|FG001|Overall Study|Withdrawal by Subject|4|||
48655552|NCT03831191|156593383|FG003|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
48655553|NCT03831191|156593384|FG004|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
48655554|NCT03831191|156593385|FG005|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5|||
48655555|NCT03831191|156593386|FG006|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2|||
48655556|NCT03831191|156593387|FG007|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
48961246|NCT00751114|157687622|FG000|Overall Study|Lost to Follow-up|4|||
48961247|NCT00751114|157687623|FG001|Overall Study|Lost to Follow-up|7|||
48961248|NCT00751114|157687622|FG000|Overall Study|Lack of Efficacy|0|||
48655557|NCT03831191|156593388|FG008|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8|||
48961249|NCT00751114|157687623|FG001|Overall Study|Lack of Efficacy|7|||
48961250|NCT00751114|157687622|FG000|Overall Study|Not Treated|13|||
48961251|NCT00751114|157687623|FG001|Overall Study|Not Treated|1|||
48961252|NCT00751114|157687622|FG000|Overall Study|Out of country for 2 months|1|||
48961253|NCT00751114|157687623|FG001|Overall Study|Out of country for 2 months|0|||
48961254|NCT00751114|157687622|FG000|Overall Study|Move to another city|1|||
48961255|NCT00751114|157687623|FG001|Overall Study|Move to another city|0|||
48961256|NCT04465396|157687624|FG000|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
48961257|NCT04465396|157687625|FG001|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
48961258|NCT04465396|157687626|FG002|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
48961259|NCT04465396|157687627|FG003|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
48961260|NCT02648724|157687628|FG000|Overall Study|Withdrawal by Subject|0|||
48961261|NCT02648724|157687629|FG001|Overall Study|Withdrawal by Subject|1|||
48961262|NCT02648724|157687630|FG002|Overall Study|Withdrawal by Subject|1|||
48961263|NCT02648724|157687631|FG003|Overall Study|Withdrawal by Subject|0|||
48961264|NCT02648724|157687632|FG004|Overall Study|Withdrawal by Subject|1|||
48961265|NCT02648724|157687633|FG005|Overall Study|Withdrawal by Subject|0|||
48961266|NCT02648724|157687634|FG006|Overall Study|Withdrawal by Subject|0|||
48961267|NCT02648724|157687628|FG000|Overall Study|Progressive disease|2|||
48961268|NCT02648724|157687629|FG001|Overall Study|Progressive disease|2|||
48961269|NCT02648724|157687630|FG002|Overall Study|Progressive disease|2|||
48961270|NCT02648724|157687631|FG003|Overall Study|Progressive disease|3|||
48655558|NCT03831191|156593389|FG009|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
48655559|NCT03831191|156593390|FG010|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
48655560|NCT03831191|156593391|FG011|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7|||
48655561|NCT03831191|156593392|FG012|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
48655562|NCT03831191|156593393|FG013|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
48655563|NCT03831191|156593394|FG014|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6|||
48655564|NCT03831191|156593380|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
48655565|NCT03831191|156593381|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
48655566|NCT03831191|156593382|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
48655567|NCT03831191|156593383|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
48655568|NCT03831191|156593384|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
48655569|NCT03831191|156593385|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
48655570|NCT03831191|156593386|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
48655571|NCT03831191|156593387|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
48655572|NCT03831191|156593388|FG008|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
48655573|NCT03831191|156593389|FG009|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
48655574|NCT03831191|156593390|FG010|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
48655575|NCT03831191|156593391|FG011|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
48655576|NCT03831191|156593392|FG012|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
48655577|NCT03831191|156593393|FG013|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
48655578|NCT03831191|156593394|FG014|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
48961271|NCT02648724|157687632|FG004|Overall Study|Progressive disease|22|||
48961272|NCT02648724|157687633|FG005|Overall Study|Progressive disease|7|||
48961273|NCT02648724|157687634|FG006|Overall Study|Progressive disease|8|||
48961274|NCT02648724|157687628|FG000|Overall Study|Other reason (unknown)|1|||
48655579|NCT03831191|156593380|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
48655580|NCT03831191|156593381|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
48655581|NCT03831191|156593382|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
48655582|NCT03831191|156593383|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
48655583|NCT03831191|156593384|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
48655584|NCT03831191|156593385|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
48655585|NCT03831191|156593386|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
48655586|NCT03831191|156593387|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
48655587|NCT03831191|156593388|FG008|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
48655588|NCT03831191|156593389|FG009|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
48655589|NCT03831191|156593390|FG010|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
48655590|NCT03831191|156593391|FG011|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
48655591|NCT03831191|156593392|FG012|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
48754264|NCT01285310|156946641|FG002|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
48754265|NCT01285310|156946642|FG003|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
48754266|NCT01285310|156946643|FG004|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
48754267|NCT01285310|156946639|FG000|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0|||
48754268|NCT01285310|156946640|FG001|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21|||
48754269|NCT01285310|156946641|FG002|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19|||
48754270|NCT01285310|156946642|FG003|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6|||
48754271|NCT01285310|156946643|FG004|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15|||
48754272|NCT01285310|156946639|FG000|Active Treatment Phase: Weeks 25-52|Other|0|||
48961275|NCT02648724|157687629|FG001|Overall Study|Other reason (unknown)|0|||
48961276|NCT02648724|157687630|FG002|Overall Study|Other reason (unknown)|0|||
48961277|NCT02648724|157687631|FG003|Overall Study|Other reason (unknown)|0|||
48961278|NCT02648724|157687632|FG004|Overall Study|Other reason (unknown)|0|||
48961279|NCT02648724|157687633|FG005|Overall Study|Other reason (unknown)|0|||
48961280|NCT02648724|157687634|FG006|Overall Study|Other reason (unknown)|0|||
48961281|NCT02648724|157687628|FG000|Overall Study|Protocol Violation|0|||
48961282|NCT02648724|157687629|FG001|Overall Study|Protocol Violation|0|||
48961283|NCT02648724|157687630|FG002|Overall Study|Protocol Violation|0|||
48961284|NCT02648724|157687631|FG003|Overall Study|Protocol Violation|0|||
48961285|NCT02648724|157687632|FG004|Overall Study|Protocol Violation|1|||
48961286|NCT02648724|157687633|FG005|Overall Study|Protocol Violation|0|||
48961287|NCT02648724|157687634|FG006|Overall Study|Protocol Violation|0|||
48961288|NCT02648724|157687628|FG000|Overall Study|Death|0|||
48961289|NCT02648724|157687629|FG001|Overall Study|Death|0|||
48961290|NCT02648724|157687630|FG002|Overall Study|Death|0|||
48961291|NCT02648724|157687631|FG003|Overall Study|Death|0|||
48961292|NCT02648724|157687632|FG004|Overall Study|Death|0|||
48961293|NCT02648724|157687633|FG005|Overall Study|Death|0|||
48961294|NCT02648724|157687634|FG006|Overall Study|Death|3|||
48961295|NCT02648724|157687628|FG000|Overall Study|Physician Decision|0|||
48961296|NCT02648724|157687629|FG001|Overall Study|Physician Decision|0|||
48961297|NCT02648724|157687630|FG002|Overall Study|Physician Decision|0|||
48961298|NCT02648724|157687631|FG003|Overall Study|Physician Decision|0|||
48655592|NCT03831191|156593393|FG013|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
48961299|NCT02648724|157687632|FG004|Overall Study|Physician Decision|1|||
48961300|NCT02648724|157687633|FG005|Overall Study|Physician Decision|0|||
48655593|NCT03831191|156593394|FG014|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
48655594|NCT01471028|156593398|FG000|VTI-208|Adverse Event|39|||
48655595|NCT01471028|156593399|FG001|VTI-208|Adverse Event|41|||
48754273|NCT01285310|156946640|FG001|Active Treatment Phase: Weeks 25-52|Other|1|||
48754274|NCT01285310|156946641|FG002|Active Treatment Phase: Weeks 25-52|Other|0|||
48754275|NCT01285310|156946642|FG003|Active Treatment Phase: Weeks 25-52|Other|0|||
48754276|NCT01285310|156946643|FG004|Active Treatment Phase: Weeks 25-52|Other|0|||
48754277|NCT01285310|156946639|FG000|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
48961301|NCT02648724|157687634|FG006|Overall Study|Physician Decision|1|||
48961302|NCT02648724|157687628|FG000|Overall Study|Transferred to named patient program|0|||
48961303|NCT02648724|157687629|FG001|Overall Study|Transferred to named patient program|0|||
48655596|NCT01471028|156593398|FG000|VTI-208|Withdrawal by Subject|0|||
48655597|NCT01471028|156593399|FG001|VTI-208|Withdrawal by Subject|2|||
48655598|NCT01471028|156593398|FG000|VTI-208|Lost to Follow-up|1|||
48655599|NCT01471028|156593399|FG001|VTI-208|Lost to Follow-up|1|||
48655600|NCT01471028|156593398|FG000|VTI-208E|Death|7|||
48655601|NCT01471028|156593399|FG001|VTI-208E|Death|10|||
48655602|NCT01471028|156593398|FG000|VTI-208E|Withdrawal by Subject|1|||
48754278|NCT01285310|156946640|FG001|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
48754279|NCT01285310|156946641|FG002|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
48961304|NCT02648724|157687630|FG002|Overall Study|Transferred to named patient program|0|||
48961305|NCT02648724|157687631|FG003|Overall Study|Transferred to named patient program|0|||
48961306|NCT02648724|157687632|FG004|Overall Study|Transferred to named patient program|0|||
48655603|NCT01471028|156593399|FG001|VTI-208E|Withdrawal by Subject|0|||
48961307|NCT02648724|157687633|FG005|Overall Study|Transferred to named patient program|1|||
48655604|NCT01471028|156593398|FG000|VTI-208E|Lost to Follow-up|0|||
48961308|NCT02648724|157687634|FG006|Overall Study|Transferred to named patient program|0|||
48655605|NCT01471028|156593399|FG001|VTI-208E|Lost to Follow-up|2|||
48961309|NCT00618449|157687635|FG000|Overall Study|Lost to Follow-up|98|||
48961310|NCT00618449|157687636|FG001|Overall Study|Lost to Follow-up|110|||
48961311|NCT03076190|157687637|FG000|Overall Study|Lost to Follow-up|9|||
48961312|NCT03076190|157687638|FG001|Overall Study|Lost to Follow-up|34|||
48961313|NCT03076190|157687637|FG000|Overall Study|Excluded from Analysis (zero duration ev|9|||
48961314|NCT03076190|157687638|FG001|Overall Study|Excluded from Analysis (zero duration ev|7|||
48961315|NCT03259490|157687639|FG000|Period 1|Withdrawal by Subject|0|||
48961316|NCT03259490|157687640|FG001|Period 1|Withdrawal by Subject|1|||
48961317|NCT03259490|157687639|FG000|Period 2|Protocol Violation|1|||
48961318|NCT03259490|157687640|FG001|Period 2|Protocol Violation|0|||
48961319|NCT03095521|157687641|FG000|Overall Study|Withdrawal by Subject|0|||
48961320|NCT03095521|157687642|FG001|Overall Study|Withdrawal by Subject|1|||
48961321|NCT03095521|157687641|FG000|Overall Study|Lost to Follow-up|0|||
48961322|NCT03095521|157687642|FG001|Overall Study|Lost to Follow-up|1|||
48961323|NCT00953043|157689708|FG000|Overall Study|Withdrawal by Subject|4|||
48961324|NCT00953043|157689709|FG001|Overall Study|Withdrawal by Subject|0|||
48961325|NCT00953043|157689708|FG000|Overall Study|Physician Decision|0|||
48961326|NCT00953043|157689709|FG001|Overall Study|Physician Decision|2|||
48961327|NCT00683475|157689715|FG000|Overall Study|Withdrawal by Subject|1|||
48961328|NCT00683475|157689716|FG001|Overall Study|Withdrawal by Subject|0|||
48961329|NCT00683475|157689715|FG000|Overall Study|Never Treated: Adverse Event|2|||
48961330|NCT00683475|157689716|FG001|Overall Study|Never Treated: Adverse Event|3|||
48961331|NCT00683475|157689715|FG000|Overall Study|Never Treated: Progressive Disease|1|||
48961332|NCT00683475|157689716|FG001|Overall Study|Never Treated: Progressive Disease|0|||
48961333|NCT02625324|157689717|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
48961334|NCT02625324|157689717|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
48961335|NCT02625324|157689717|FG000|6-Month Follow-up Subject Accountability|Death|5|||
48961336|NCT02625324|157689717|FG000|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2|||
48961337|NCT02625324|157689717|FG000|6-Month Follow-up Subject Accountability|Lost to Follow-up|1|||
48961338|NCT02625324|157689717|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
48961339|NCT02625324|157689717|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
48961340|NCT02625324|157689717|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
48961341|NCT02625324|157689717|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
48961342|NCT02625324|157689717|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
48961343|NCT02625324|157689717|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
48961344|NCT02625324|157689717|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
48961345|NCT02625324|157689717|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
48961346|NCT02625324|157689717|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
48961347|NCT02625324|157689717|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
48961348|NCT02625324|157689717|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
48961349|NCT02625324|157689717|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
48961350|NCT00424528|157689718|FG000|Overall Study|Adverse Event|2|||
48961351|NCT00424528|157689719|FG001|Overall Study|Adverse Event|1|||
48961352|NCT00424528|157689720|FG002|Overall Study|Adverse Event|2|||
48961353|NCT00424528|157689718|FG000|Overall Study|Protocol Violation|1|||
48961354|NCT00424528|157689719|FG001|Overall Study|Protocol Violation|1|||
48961355|NCT00424528|157689720|FG002|Overall Study|Protocol Violation|0|||
48961356|NCT00424528|157689718|FG000|Overall Study|Lost to Follow-up|0|||
48961357|NCT00424528|157689719|FG001|Overall Study|Lost to Follow-up|1|||
48961358|NCT00424528|157689720|FG002|Overall Study|Lost to Follow-up|0|||
48961359|NCT00424528|157689718|FG000|Overall Study|noncompliance with study requirements|2|||
48961360|NCT00424528|157689719|FG001|Overall Study|noncompliance with study requirements|1|||
48961361|NCT00424528|157689720|FG002|Overall Study|noncompliance with study requirements|2|||
48961362|NCT00506948|157689723|FG000|Overall Study|Death|4|||
48961363|NCT00506948|157689723|FG000|Overall Study|Adverse Event|5|||
48961364|NCT00506948|157689723|FG000|Overall Study|Physician Decision|1|||
48961365|NCT00762372|157689724|FG000|Overall Study|Adverse Event|1|||
48961366|NCT00762372|157689725|FG001|Overall Study|Adverse Event|0|||
48961367|NCT00762372|157689726|FG002|Overall Study|Adverse Event|0|||
48961368|NCT03364335|157689727|FG000|Overall Study|Adverse Event|3|||
48961369|NCT03364335|157689728|FG001|Overall Study|Adverse Event|4|||
48961370|NCT03364335|157689729|FG002|Overall Study|Adverse Event|1|||
48961371|NCT03364335|157689730|FG003|Overall Study|Adverse Event|2|||
48655606|NCT03077438|156593403|FG000|Overall Study|Protocol Violation|3|||
48655607|NCT03077438|156593404|FG001|Overall Study|Protocol Violation|5|||
48655608|NCT03077438|156593403|FG000|Overall Study|Withdrawal by Subject|3|||
48655609|NCT03077438|156593404|FG001|Overall Study|Withdrawal by Subject|6|||
48655610|NCT03077438|156593403|FG000|Overall Study|Lost to Follow-up|6|||
48655611|NCT03077438|156593404|FG001|Overall Study|Lost to Follow-up|3|||
48655612|NCT01685801|156593411|FG000|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
48655613|NCT01685801|156593412|FG001|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
48655614|NCT01685801|156593413|FG002|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
48961372|NCT03364335|157689731|FG004|Overall Study|Adverse Event|0|||
48961373|NCT03364335|157689727|FG000|Overall Study|Lost to Follow-up|7|||
48961374|NCT03364335|157689728|FG001|Overall Study|Lost to Follow-up|7|||
48961375|NCT03364335|157689729|FG002|Overall Study|Lost to Follow-up|10|||
48961376|NCT03364335|157689730|FG003|Overall Study|Lost to Follow-up|11|||
48961377|NCT03364335|157689731|FG004|Overall Study|Lost to Follow-up|11|||
48961378|NCT03987919|157689732|FG000|Overall Study|Adverse Event|1|||
48961379|NCT03987919|157689733|FG001|Overall Study|Adverse Event|4|||
48961380|NCT03987919|157689734|FG002|Overall Study|Adverse Event|1|||
48961381|NCT03987919|157689735|FG003|Overall Study|Adverse Event|3|||
48961382|NCT03987919|157689732|FG000|Overall Study|Death|4|||
48961383|NCT03987919|157689733|FG001|Overall Study|Death|4|||
48961384|NCT03987919|157689734|FG002|Overall Study|Death|4|||
48961385|NCT03987919|157689735|FG003|Overall Study|Death|1|||
48961386|NCT03987919|157689732|FG000|Overall Study|Lost to Follow-up|5|||
48961387|NCT03987919|157689733|FG001|Overall Study|Lost to Follow-up|6|||
48655615|NCT01685801|156593414|FG003|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1|||
48655616|NCT01685801|156593411|FG000|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
48655617|NCT01685801|156593412|FG001|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
48655618|NCT01685801|156593413|FG002|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
48655619|NCT01685801|156593414|FG003|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
48655620|NCT00666588|156593415|FG000|Overall Study|ineligible|2|||
48655621|NCT00666588|156593416|FG001|Overall Study|ineligible|0|||
48655622|NCT00666588|156593417|FG002|Overall Study|ineligible|0|||
48655623|NCT00666588|156593418|FG003|Overall Study|ineligible|2|||
48655624|NCT00666588|156593415|FG000|Overall Study|inevaluable|2|||
48655625|NCT00666588|156593416|FG001|Overall Study|inevaluable|0|||
48754280|NCT01285310|156946642|FG003|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
48754281|NCT01285310|156946643|FG004|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
48754282|NCT02733991|156946648|FG000|Overall Study|Adverse Event|1|||
48754283|NCT02733991|156946649|FG001|Overall Study|Adverse Event|0|||
48754284|NCT02733991|156946648|FG000|Overall Study|Withdrawal by Subject|0|||
48754285|NCT02733991|156946649|FG001|Overall Study|Withdrawal by Subject|5|||
48754286|NCT02485574|156946652|FG000|Overall Study|dropped out because they failed to undergo CT scan at postoperative 12 months|4|||
48754287|NCT00555321|156946653|FG000|Treatment Phase up to 12-months|Adverse Event|6|||
48754288|NCT00555321|156946654|FG001|Treatment Phase up to 12-months|Adverse Event|7|||
48754289|NCT00555321|156946655|FG002|Treatment Phase up to 12-months|Adverse Event|11|||
48754290|NCT00555321|156946656|FG003|Treatment Phase up to 12-months|Adverse Event|7|||
48754291|NCT00555321|156946657|FG004|Treatment Phase up to 12-months|Adverse Event|18|||
48754292|NCT00555321|156946653|FG000|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
48754293|NCT00555321|156946654|FG001|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
48754294|NCT00555321|156946655|FG002|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
48754295|NCT00555321|156946656|FG003|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
48754296|NCT00555321|156946657|FG004|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
48754297|NCT00555321|156946653|FG000|Treatment Phase up to 12-months|Death|2|||
48754298|NCT00555321|156946654|FG001|Treatment Phase up to 12-months|Death|1|||
48754299|NCT00555321|156946655|FG002|Treatment Phase up to 12-months|Death|4|||
48754300|NCT00555321|156946656|FG003|Treatment Phase up to 12-months|Death|0|||
48754301|NCT00555321|156946657|FG004|Treatment Phase up to 12-months|Death|0|||
48754302|NCT00555321|156946653|FG000|Treatment Phase up to 12-months|Lack of Efficacy|9|||
48754303|NCT00555321|156946654|FG001|Treatment Phase up to 12-months|Lack of Efficacy|8|||
48754304|NCT00555321|156946655|FG002|Treatment Phase up to 12-months|Lack of Efficacy|5|||
48754305|NCT00555321|156946656|FG003|Treatment Phase up to 12-months|Lack of Efficacy|0|||
48754306|NCT00555321|156946657|FG004|Treatment Phase up to 12-months|Lack of Efficacy|0|||
48754307|NCT00555321|156946653|FG000|Treatment Phase up to 12-months|Other Reason|1|||
48754308|NCT00555321|156946654|FG001|Treatment Phase up to 12-months|Other Reason|3|||
48754309|NCT00555321|156946655|FG002|Treatment Phase up to 12-months|Other Reason|2|||
48754310|NCT00555321|156946656|FG003|Treatment Phase up to 12-months|Other Reason|0|||
48754311|NCT00555321|156946657|FG004|Treatment Phase up to 12-months|Other Reason|0|||
48754312|NCT00555321|156946653|FG000|Treatment Phase up to 12-months|Never treated|2|||
48754313|NCT00555321|156946654|FG001|Treatment Phase up to 12-months|Never treated|3|||
48754314|NCT00555321|156946655|FG002|Treatment Phase up to 12-months|Never treated|1|||
48754315|NCT00555321|156946656|FG003|Treatment Phase up to 12-months|Never treated|0|||
48961388|NCT03987919|157689734|FG002|Overall Study|Lost to Follow-up|8|||
48961389|NCT03987919|157689735|FG003|Overall Study|Lost to Follow-up|12|||
48961390|NCT03987919|157689732|FG000|Overall Study|Physician Decision|0|||
48961391|NCT03987919|157689733|FG001|Overall Study|Physician Decision|2|||
48961392|NCT03987919|157689734|FG002|Overall Study|Physician Decision|0|||
48961393|NCT03987919|157689735|FG003|Overall Study|Physician Decision|4|||
48754316|NCT00555321|156946657|FG004|Treatment Phase up to 12-months|Never treated|4|||
48754317|NCT00555321|156946653|FG000|Long-term Extension Phase|Adverse Event|2|||
48754318|NCT00555321|156946654|FG001|Long-term Extension Phase|Adverse Event|5|||
48961394|NCT03987919|157689732|FG000|Overall Study|Pregnancy|1|||
48961395|NCT03987919|157689733|FG001|Overall Study|Pregnancy|0|||
48655626|NCT00666588|156593417|FG002|Overall Study|inevaluable|0|||
48961396|NCT03987919|157689734|FG002|Overall Study|Pregnancy|1|||
48961397|NCT03987919|157689735|FG003|Overall Study|Pregnancy|1|||
48961398|NCT03987919|157689732|FG000|Overall Study|Protocol Violation|0|||
48961399|NCT03987919|157689733|FG001|Overall Study|Protocol Violation|1|||
48961400|NCT03987919|157689734|FG002|Overall Study|Protocol Violation|0|||
48961401|NCT03987919|157689735|FG003|Overall Study|Protocol Violation|0|||
48961402|NCT03987919|157689732|FG000|Overall Study|Site terminated by Sponsor|0|||
48961403|NCT03987919|157689733|FG001|Overall Study|Site terminated by Sponsor|0|||
48961404|NCT03987919|157689734|FG002|Overall Study|Site terminated by Sponsor|0|||
48961405|NCT03987919|157689735|FG003|Overall Study|Site terminated by Sponsor|1|||
48961406|NCT03987919|157689732|FG000|Overall Study|Withdrawal by Subject|7|||
48961407|NCT03987919|157689733|FG001|Overall Study|Withdrawal by Subject|7|||
48961408|NCT03987919|157689734|FG002|Overall Study|Withdrawal by Subject|8|||
48961409|NCT03987919|157689735|FG003|Overall Study|Withdrawal by Subject|4|||
48961410|NCT03987919|157689732|FG000|Overall Study|Other - as reported by the investigator|1|||
48961411|NCT03987919|157689733|FG001|Overall Study|Other - as reported by the investigator|3|||
48961412|NCT03987919|157689734|FG002|Overall Study|Other - as reported by the investigator|2|||
48961413|NCT03987919|157689735|FG003|Overall Study|Other - as reported by the investigator|0|||
48961414|NCT00523341|157689736|FG000|Overall Study|Withdrawal by Subject|399|||
48961415|NCT00523341|157689737|FG001|Overall Study|Withdrawal by Subject|427|||
48961416|NCT00523341|157689736|FG000|Overall Study|Other|181|||
48655627|NCT00666588|156593418|FG003|Overall Study|inevaluable|0|||
48655628|NCT03466099|156593421|FG000|Overall Study|Adverse Event|1|||
48655629|NCT03466099|156593422|FG001|Overall Study|Adverse Event|1|||
48655630|NCT03466099|156593423|FG002|Overall Study|Adverse Event|1|||
48655631|NCT03466099|156593421|FG000|Overall Study|Withdrawal by Subject|2|||
48655632|NCT03466099|156593422|FG001|Overall Study|Withdrawal by Subject|3|||
48655633|NCT03466099|156593423|FG002|Overall Study|Withdrawal by Subject|1|||
48655634|NCT03466099|156593421|FG000|Overall Study|Use of rescue medication|8|||
48655635|NCT03466099|156593422|FG001|Overall Study|Use of rescue medication|9|||
48655636|NCT03466099|156593423|FG002|Overall Study|Use of rescue medication|13|||
48655637|NCT03466099|156593421|FG000|Overall Study|Rescued without meeting criteria|4|||
48655638|NCT03466099|156593422|FG001|Overall Study|Rescued without meeting criteria|1|||
48655639|NCT03466099|156593423|FG002|Overall Study|Rescued without meeting criteria|1|||
48655640|NCT03466099|156593421|FG000|Overall Study|Subject compliance|2|||
48655641|NCT03466099|156593422|FG001|Overall Study|Subject compliance|0|||
48655642|NCT03466099|156593423|FG002|Overall Study|Subject compliance|0|||
48655643|NCT03466099|156593421|FG000|Overall Study|Worsening disease|0|||
48655644|NCT03466099|156593422|FG001|Overall Study|Worsening disease|0|||
48754319|NCT00555321|156946655|FG002|Long-term Extension Phase|Adverse Event|2|||
48754320|NCT00555321|156946656|FG003|Long-term Extension Phase|Adverse Event|1|||
48754321|NCT00555321|156946657|FG004|Long-term Extension Phase|Adverse Event|0|||
48754322|NCT00555321|156946653|FG000|Long-term Extension Phase|Withdrawal by Subject|2|||
48754323|NCT00555321|156946654|FG001|Long-term Extension Phase|Withdrawal by Subject|1|||
48754324|NCT00555321|156946655|FG002|Long-term Extension Phase|Withdrawal by Subject|2|||
48754325|NCT00555321|156946656|FG003|Long-term Extension Phase|Withdrawal by Subject|3|||
48754326|NCT00555321|156946657|FG004|Long-term Extension Phase|Withdrawal by Subject|2|||
48754327|NCT00555321|156946653|FG000|Long-term Extension Phase|Administrative reason by sponsor|23|||
48754328|NCT00555321|156946654|FG001|Long-term Extension Phase|Administrative reason by sponsor|21|||
48754329|NCT00555321|156946655|FG002|Long-term Extension Phase|Administrative reason by sponsor|18|||
48754330|NCT00555321|156946656|FG003|Long-term Extension Phase|Administrative reason by sponsor|31|||
48754331|NCT00555321|156946657|FG004|Long-term Extension Phase|Administrative reason by sponsor|23|||
48754332|NCT00555321|156946653|FG000|Long-term Extension Phase|Death|2|||
48754333|NCT00555321|156946654|FG001|Long-term Extension Phase|Death|0|||
48754334|NCT00555321|156946655|FG002|Long-term Extension Phase|Death|0|||
48754335|NCT00555321|156946656|FG003|Long-term Extension Phase|Death|3|||
48754336|NCT00555321|156946657|FG004|Long-term Extension Phase|Death|0|||
48754337|NCT00555321|156946653|FG000|Long-term Extension Phase|Participant did not meet study criteria|0|||
48754338|NCT00555321|156946654|FG001|Long-term Extension Phase|Participant did not meet study criteria|0|||
48961417|NCT00523341|157689737|FG001|Overall Study|Other|198|||
48961418|NCT00523341|157689736|FG000|Overall Study|Adverse Event|122|||
48961419|NCT00523341|157689737|FG001|Overall Study|Adverse Event|155|||
48961420|NCT00523341|157689736|FG000|Overall Study|Death|101|||
48961421|NCT00523341|157689737|FG001|Overall Study|Death|110|||
48961422|NCT00523341|157689736|FG000|Overall Study|Lost to Follow-up|73|||
48961423|NCT00523341|157689737|FG001|Overall Study|Lost to Follow-up|61|||
48961424|NCT00523341|157689736|FG000|Overall Study|Non-compliance|20|||
48754339|NCT00555321|156946655|FG002|Long-term Extension Phase|Participant did not meet study criteria|0|||
48754340|NCT00555321|156946656|FG003|Long-term Extension Phase|Participant did not meet study criteria|0|||
48655645|NCT03466099|156593423|FG002|Overall Study|Worsening disease|1|||
48754341|NCT00555321|156946657|FG004|Long-term Extension Phase|Participant did not meet study criteria|1|||
48754342|NCT00555321|156946653|FG000|Long-term Extension Phase|Other Reason|1|||
48655646|NCT00385944|156593426|FG000|1st Maintenance Dose Period|Physician Decision|1|||
48655647|NCT00385944|156593427|FG001|1st Maintenance Dose Period|Physician Decision|0|||
48655648|NCT00385944|156593428|FG002|1st Maintenance Dose Period|Physician Decision|0|||
48655649|NCT00385944|156593426|FG000|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
48655650|NCT00385944|156593427|FG001|1st Maintenance Dose Period|Entry Criteria Exclusion|1|||
48655651|NCT00385944|156593428|FG002|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
48655652|NCT00385944|156593426|FG000|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3|||
48655653|NCT00385944|156593427|FG001|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
48655654|NCT00385944|156593428|FG002|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
48655655|NCT00385944|156593426|FG000|2nd Maintenance Dose Period|Invalid PD Data|2|||
48655656|NCT00385944|156593427|FG001|2nd Maintenance Dose Period|Invalid PD Data|3|||
48655657|NCT00385944|156593428|FG002|2nd Maintenance Dose Period|Invalid PD Data|0|||
48655658|NCT00054327|156593429|FG000|Overall Study|Engraftment failure|1|||
48655659|NCT00054327|156593430|FG001|Overall Study|Engraftment failure|0|||
48655660|NCT00054327|156593431|FG002|Overall Study|Engraftment failure|0|||
48655661|NCT00054327|156593432|FG003|Overall Study|Engraftment failure|0|||
48655662|NCT00054327|156593433|FG004|Overall Study|Engraftment failure|0|||
48655663|NCT00054327|156593434|FG005|Overall Study|Engraftment failure|0|||
48655664|NCT02231892|156593435|FG000|Overall Study|Lost to Follow-up|1|||
48655665|NCT02231892|156593436|FG001|Overall Study|Lost to Follow-up|0|||
48655666|NCT02231892|156593437|FG002|Overall Study|Lost to Follow-up|3|||
48655667|NCT02231892|156593435|FG000|Overall Study|Withdrawal by Subject|4|||
48655668|NCT02231892|156593436|FG001|Overall Study|Withdrawal by Subject|3|||
48655669|NCT02231892|156593437|FG002|Overall Study|Withdrawal by Subject|15|||
48655670|NCT02231892|156593435|FG000|Overall Study|Physician Decision|0|||
48655671|NCT02231892|156593436|FG001|Overall Study|Physician Decision|2|||
48655672|NCT02231892|156593437|FG002|Overall Study|Physician Decision|4|||
48655673|NCT02231892|156593435|FG000|Overall Study|Motor activity when stimulating ante ACC|4|||
48655674|NCT02231892|156593436|FG001|Overall Study|Motor activity when stimulating ante ACC|7|||
48655675|NCT02231892|156593437|FG002|Overall Study|Motor activity when stimulating ante ACC|12|||
48655676|NCT02231892|156593435|FG000|Overall Study|Participant motor threshold was >83%|0|||
48655677|NCT02231892|156593436|FG001|Overall Study|Participant motor threshold was >83%|0|||
48655678|NCT02231892|156593437|FG002|Overall Study|Participant motor threshold was >83%|9|||
48655679|NCT02231892|156593435|FG000|Overall Study|Could not find motor threshold|2|||
48754343|NCT00555321|156946654|FG001|Long-term Extension Phase|Other Reason|0|||
48961425|NCT00523341|157689737|FG001|Overall Study|Non-compliance|13|||
48961426|NCT00523341|157689736|FG000|Overall Study|Physician Decision|14|||
48961427|NCT00523341|157689737|FG001|Overall Study|Physician Decision|13|||
48655680|NCT02231892|156593436|FG001|Overall Study|Could not find motor threshold|0|||
48655681|NCT02231892|156593437|FG002|Overall Study|Could not find motor threshold|1|||
48655682|NCT02231892|156593435|FG000|Overall Study|Could not find reliable motor hotspot|0|||
48655683|NCT02231892|156593436|FG001|Overall Study|Could not find reliable motor hotspot|0|||
48754344|NCT00555321|156946655|FG002|Long-term Extension Phase|Other Reason|2|||
48961428|NCT00523341|157689736|FG000|Overall Study|Requirement for Alternative Therapy|4|||
48655684|NCT02231892|156593437|FG002|Overall Study|Could not find reliable motor hotspot|1|||
48655685|NCT00290771|156593441|FG000|Overall Study|Disease progression|95|||
48655686|NCT00290771|156593442|FG001|Overall Study|Disease progression|73|||
48655687|NCT00290771|156593441|FG000|Overall Study|Death|11|||
48655688|NCT00290771|156593442|FG001|Overall Study|Death|10|||
48655689|NCT00290771|156593441|FG000|Overall Study|Adverse Event|12|||
48655690|NCT00290771|156593442|FG001|Overall Study|Adverse Event|6|||
48655691|NCT00290771|156593441|FG000|Overall Study|Withdrawal by Subject|5|||
48655692|NCT00290771|156593442|FG001|Overall Study|Withdrawal by Subject|6|||
48655693|NCT00290771|156593441|FG000|Overall Study|Administrative problems|2|||
48655694|NCT00290771|156593442|FG001|Overall Study|Administrative problems|1|||
48655695|NCT00290771|156593441|FG000|Overall Study|Protocol Violation|2|||
48655696|NCT00290771|156593442|FG001|Overall Study|Protocol Violation|0|||
48655697|NCT00290771|156593441|FG000|Overall Study|Lost to Follow-up|0|||
48655698|NCT00290771|156593442|FG001|Overall Study|Lost to Follow-up|1|||
48655699|NCT01895543|156593452|FG000|Overall Study|Withdrawal by Subject|43|||
48655700|NCT01895543|156593452|FG000|Overall Study|Lost to Follow-up|25|||
48655701|NCT01895543|156593452|FG000|Overall Study|Adverse Event|28|||
48655702|NCT01895543|156593452|FG000|Overall Study|Subject's substantial non-compliance|6|||
48655703|NCT01895543|156593452|FG000|Overall Study|Protocol Violation|1|||
48655704|NCT01895543|156593452|FG000|Overall Study|Physician Decision|2|||
48655705|NCT01895543|156593452|FG000|Overall Study|Other (Not fulfilling above criteria)|24|||
48655706|NCT04049266|156593457|FG000|Overall Study|Adverse Event|16|||
48655707|NCT04049266|156593458|FG001|Overall Study|Adverse Event|9|||
48655708|NCT04049266|156593457|FG000|Overall Study|Non-compliance with study drug|0|||
48655709|NCT04049266|156593458|FG001|Overall Study|Non-compliance with study drug|3|||
48655710|NCT04049266|156593457|FG000|Overall Study|Withdrawal by Subject|6|||
48961429|NCT00523341|157689737|FG001|Overall Study|Requirement for Alternative Therapy|14|||
48961430|NCT00523341|157689736|FG000|Overall Study|Protocol Deviation|6|||
48655711|NCT04049266|156593458|FG001|Overall Study|Withdrawal by Subject|10|||
48655712|NCT04049266|156593457|FG000|Overall Study|Lost to Follow-up|2|||
48655713|NCT04049266|156593458|FG001|Overall Study|Lost to Follow-up|2|||
48961431|NCT00523341|157689737|FG001|Overall Study|Protocol Deviation|5|||
48754345|NCT00555321|156946656|FG003|Long-term Extension Phase|Other Reason|0|||
48655714|NCT04049266|156593457|FG000|Overall Study|Progressive disease|11|||
48754346|NCT00555321|156946657|FG004|Long-term Extension Phase|Other Reason|0|||
48754347|NCT04294472|156946660|FG000|Overall Study|Adverse Event|0|||
48754348|NCT04294472|156946661|FG001|Overall Study|Adverse Event|1|||
48754349|NCT04294472|156946662|FG002|Overall Study|Adverse Event|1|||
48754350|NCT04294472|156946660|FG000|Overall Study|Randomized but not treated|0|||
48754351|NCT04294472|156946661|FG001|Overall Study|Randomized but not treated|1|||
48754352|NCT04294472|156946662|FG002|Overall Study|Randomized but not treated|1|||
48754353|NCT00667368|156946665|FG000|Overall Study|Lost to Follow-up|176|||
48655715|NCT04049266|156593458|FG001|Overall Study|Progressive disease|2|||
48655716|NCT04049266|156593457|FG000|Overall Study|Physician Decision|1|||
48655717|NCT04049266|156593458|FG001|Overall Study|Physician Decision|0|||
48655718|NCT04049266|156593457|FG000|Overall Study|Patient moved out of state|1|||
48655719|NCT04049266|156593458|FG001|Overall Study|Patient moved out of state|0|||
48655720|NCT00404755|156593459|FG000|Phase I (Bupropion)|Adverse Event|3|||
48655721|NCT00404755|156593459|FG000|Phase I (Bupropion)|Other|1|||
48655722|NCT00404755|156593459|FG000|Phase II (Escitalopram)|Lost to Follow-up|2|||
48655723|NCT00252694|156593460|FG000|Overall Study|Withdrawal by Subject|83|||
48655724|NCT00252694|156593461|FG001|Overall Study|Withdrawal by Subject|91|||
48655725|NCT00252694|156593460|FG000|Overall Study|Death|36|||
48655726|NCT00252694|156593461|FG001|Overall Study|Death|34|||
48655727|NCT00252694|156593460|FG000|Overall Study|Mostly Lost to Follow Up|8|||
48655728|NCT00252694|156593461|FG001|Overall Study|Mostly Lost to Follow Up|13|||
48655729|NCT00252694|156593460|FG000|Overall Study|Patient Moving|17|||
48655730|NCT00252694|156593461|FG001|Overall Study|Patient Moving|16|||
48655731|NCT00096226|156593463|FG000|Overall Study|Ineligible|2|||
48655732|NCT00096226|156593463|FG000|Overall Study|Protocol treatment not started|1|||
48655733|NCT04376684|156593464|FG000|Part 1 (Up to Day 60)|Withdrawal by Subject|7|||
48655734|NCT04376684|156593465|FG001|Part 1 (Up to Day 60)|Withdrawal by Subject|8|||
48655735|NCT04376684|156593466|FG002|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
48655736|NCT04376684|156593467|FG003|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
48655737|NCT04376684|156593464|FG000|Part 1 (Up to Day 60)|Protocol Violation|2|||
48655738|NCT04376684|156593465|FG001|Part 1 (Up to Day 60)|Protocol Violation|3|||
48655739|NCT04376684|156593466|FG002|Part 1 (Up to Day 60)|Protocol Violation|0|||
48655740|NCT04376684|156593467|FG003|Part 1 (Up to Day 60)|Protocol Violation|0|||
48655741|NCT04376684|156593464|FG000|Part 1 (Up to Day 60)|Physician Decision|2|||
48655742|NCT04376684|156593465|FG001|Part 1 (Up to Day 60)|Physician Decision|5|||
48655743|NCT04376684|156593466|FG002|Part 1 (Up to Day 60)|Physician Decision|0|||
48655744|NCT04376684|156593467|FG003|Part 1 (Up to Day 60)|Physician Decision|0|||
48655745|NCT04376684|156593464|FG000|Part 1 (Up to Day 60)|Lost to Follow-up|4|||
48655746|NCT04376684|156593465|FG001|Part 1 (Up to Day 60)|Lost to Follow-up|8|||
48655747|NCT04376684|156593466|FG002|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
48655748|NCT04376684|156593467|FG003|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
48655749|NCT04376684|156593464|FG000|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
48655750|NCT04376684|156593465|FG001|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
48655751|NCT04376684|156593466|FG002|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
48655752|NCT04376684|156593467|FG003|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
48655753|NCT04376684|156593464|FG000|Part 2 (Up to Day 60)|Physician Decision|0|||
48655754|NCT04376684|156593465|FG001|Part 2 (Up to Day 60)|Physician Decision|0|||
48655755|NCT04376684|156593466|FG002|Part 2 (Up to Day 60)|Physician Decision|1|||
48655756|NCT04376684|156593467|FG003|Part 2 (Up to Day 60)|Physician Decision|1|||
48655757|NCT04376684|156593464|FG000|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
48655758|NCT04376684|156593465|FG001|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
48655759|NCT04376684|156593466|FG002|Part 2 (Up to Day 60)|Lost to Follow-up|3|||
48655760|NCT04376684|156593467|FG003|Part 2 (Up to Day 60)|Lost to Follow-up|2|||
48754354|NCT00667368|156946666|FG001|Overall Study|Lost to Follow-up|155|||
48754355|NCT00667368|156946665|FG000|Overall Study|Discontinued early|24|||
48961432|NCT00523341|157689736|FG000|Overall Study|Ineligibility Determined|3|||
48961433|NCT00523341|157689737|FG001|Overall Study|Ineligibility Determined|4|||
48961434|NCT00523341|157689736|FG000|Overall Study|Disease Progression|1|||
48655761|NCT04173260|156593472|FG000|Overall Study|Early termination|4|||
48655762|NCT04644237|156593473|FG000|Overall Study|Death|3|||
48961435|NCT00523341|157689737|FG001|Overall Study|Disease Progression|0|||
48961436|NCT01194804|157689738|FG000|Overall Study|Withdrawal by Subject|1|||
48961437|NCT00051558|157689739|FG000|Overall Study|Adverse Event|30|||
48655763|NCT04644237|156593474|FG001|Overall Study|Death|2|||
48655764|NCT04644237|156593473|FG000|Overall Study|Adverse Event|15|||
48655765|NCT04644237|156593474|FG001|Overall Study|Adverse Event|12|||
48655766|NCT04644237|156593473|FG000|Overall Study|Progressive Disease|47|||
48655767|NCT04644237|156593474|FG001|Overall Study|Progressive Disease|19|||
48655768|NCT04644237|156593473|FG000|Overall Study|Clinical Progression|4|||
48655769|NCT04644237|156593474|FG001|Overall Study|Clinical Progression|1|||
48655770|NCT04644237|156593473|FG000|Overall Study|Withdrawal by Subject|1|||
48754356|NCT00667368|156946666|FG001|Overall Study|Discontinued early|17|||
48754357|NCT01957553|156946669|FG000|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2|||
48961438|NCT00051558|157689740|FG001|Overall Study|Adverse Event|18|||
48655771|NCT04644237|156593474|FG001|Overall Study|Withdrawal by Subject|2|||
48655772|NCT04644237|156593473|FG000|Overall Study|Physician Decision|3|||
48655773|NCT04644237|156593474|FG001|Overall Study|Physician Decision|0|||
48655774|NCT04644237|156593473|FG000|Overall Study|Other|1|||
48655775|NCT04644237|156593474|FG001|Overall Study|Other|0|||
48655776|NCT04644237|156593473|FG000|Overall Study|Randomized but not Treated|1|||
48655777|NCT04644237|156593474|FG001|Overall Study|Randomized but not Treated|0|||
48655778|NCT00090233|156593476|FG000|Overall Study|Randomized Not Vaccinated (Visit 1)|609|||
48655779|NCT00090233|156593477|FG001|Overall Study|Randomized Not Vaccinated (Visit 1)|627|||
48655780|NCT00090233|156593476|FG000|Overall Study|Adverse Event|214|||
48655781|NCT00090233|156593477|FG001|Overall Study|Adverse Event|198|||
48655782|NCT00090233|156593476|FG000|Overall Study|Lost to Follow-up|68|||
48655783|NCT00090233|156593477|FG001|Overall Study|Lost to Follow-up|95|||
48655784|NCT00090233|156593476|FG000|Overall Study|Protocol Violation|960|||
48655785|NCT00090233|156593477|FG001|Overall Study|Protocol Violation|1022|||
48655786|NCT00090233|156593476|FG000|Overall Study|Withdrawal by Subject|182|||
48655787|NCT00090233|156593477|FG001|Overall Study|Withdrawal by Subject|211|||
48655788|NCT00090233|156593476|FG000|Overall Study|Moved|203|||
48655789|NCT00090233|156593477|FG001|Overall Study|Moved|189|||
48655790|NCT00090233|156593476|FG000|Overall Study|Other|1211|||
48754358|NCT01957553|156946670|FG001|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3|||
48961439|NCT00051558|157689739|FG000|Overall Study|Withdrawal by Subject|29|||
48961440|NCT00051558|157689740|FG001|Overall Study|Withdrawal by Subject|42|||
48961441|NCT00051558|157689739|FG000|Overall Study|Death|9|||
48961442|NCT00051558|157689740|FG001|Overall Study|Death|15|||
48655791|NCT00090233|156593477|FG001|Overall Study|Other|1160|||
48655792|NCT00090233|156593476|FG000|Overall Study|Data not available at data cut-off point|1552|||
48655793|NCT00090233|156593477|FG001|Overall Study|Data not available at data cut-off point|1563|||
48655794|NCT01252186|156593478|FG000|Overall Study|Adverse Event|9|||
48655795|NCT01252186|156593479|FG001|Overall Study|Adverse Event|6|||
48655796|NCT01252186|156593480|FG002|Overall Study|Adverse Event|8|||
48655797|NCT01252186|156593478|FG000|Overall Study|Withdrawal by Subject|2|||
48655798|NCT01252186|156593479|FG001|Overall Study|Withdrawal by Subject|5|||
48655799|NCT01252186|156593480|FG002|Overall Study|Withdrawal by Subject|2|||
48655800|NCT01252186|156593478|FG000|Overall Study|Physician Decision|0|||
48655801|NCT01252186|156593479|FG001|Overall Study|Physician Decision|0|||
48655802|NCT01252186|156593480|FG002|Overall Study|Physician Decision|1|||
48655803|NCT01252186|156593478|FG000|Overall Study|Non-compliance|0|||
48655804|NCT01252186|156593479|FG001|Overall Study|Non-compliance|3|||
48655805|NCT01252186|156593480|FG002|Overall Study|Non-compliance|4|||
48655806|NCT01252186|156593478|FG000|Overall Study|Protocol Violation|0|||
48655807|NCT01252186|156593479|FG001|Overall Study|Protocol Violation|0|||
48655808|NCT01252186|156593480|FG002|Overall Study|Protocol Violation|1|||
48655809|NCT01252186|156593478|FG000|Overall Study|Pregnancy|2|||
48655810|NCT01252186|156593479|FG001|Overall Study|Pregnancy|2|||
48655811|NCT01252186|156593480|FG002|Overall Study|Pregnancy|0|||
48655812|NCT01252186|156593478|FG000|Overall Study|Sponsor Request|2|||
48655813|NCT01252186|156593479|FG001|Overall Study|Sponsor Request|1|||
48655814|NCT01252186|156593480|FG002|Overall Study|Sponsor Request|0|||
48655815|NCT01252186|156593478|FG000|Overall Study|Lost to Follow-up|10|||
48655816|NCT01252186|156593479|FG001|Overall Study|Lost to Follow-up|10|||
48655817|NCT01252186|156593480|FG002|Overall Study|Lost to Follow-up|11|||
48655818|NCT01252186|156593478|FG000|Overall Study|Other - Miscellaneous Reasons|5|||
48655819|NCT01252186|156593479|FG001|Overall Study|Other - Miscellaneous Reasons|5|||
48655820|NCT01252186|156593480|FG002|Overall Study|Other - Miscellaneous Reasons|7|||
48655821|NCT00580034|156593482|FG000|Overall Study|Toxicity|10|||
48655822|NCT00580034|156593483|FG001|Overall Study|Toxicity|0|||
48655823|NCT03305081|156593484|FG000|Overall Study|Lost to Follow-up|10|||
48655824|NCT03305081|156593485|FG001|Overall Study|Lost to Follow-up|15|||
48655825|NCT02499900|156593486|FG000|Core Study Period|Other|1|||
48655826|NCT02499900|156593487|FG001|Core Study Period|Other|4|||
48754359|NCT01957553|156946669|FG000|Test Period 1 (21 +- 1 Days)|Adverse Event|2|||
48754360|NCT01957553|156946670|FG001|Test Period 1 (21 +- 1 Days)|Adverse Event|0|||
48655827|NCT02499900|156593486|FG000|Core Study Period|Lost to Follow-up|1|||
48655828|NCT02499900|156593487|FG001|Core Study Period|Lost to Follow-up|2|||
48754361|NCT01957553|156946669|FG000|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2|||
48754362|NCT01957553|156946670|FG001|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0|||
48961443|NCT00051558|157689739|FG000|Overall Study|Lost to Follow-up|4|||
48961444|NCT00051558|157689740|FG001|Overall Study|Lost to Follow-up|13|||
48655829|NCT02499900|156593486|FG000|Core Study Period|Per sponsor request|0|||
48655830|NCT02499900|156593487|FG001|Core Study Period|Per sponsor request|1|||
48655831|NCT02499900|156593486|FG000|Core Study Period|Pregnancy|1|||
48655832|NCT02499900|156593487|FG001|Core Study Period|Pregnancy|0|||
48655833|NCT02499900|156593486|FG000|Core Study Period|Protocol Violation|3|||
48655834|NCT02499900|156593487|FG001|Core Study Period|Protocol Violation|0|||
48655835|NCT02499900|156593486|FG000|Core Study Period|Withdrawal by Subject|11|||
48655836|NCT02499900|156593487|FG001|Core Study Period|Withdrawal by Subject|10|||
48655837|NCT02499900|156593486|FG000|Core Study Period|Adverse Event|18|||
48655838|NCT02499900|156593487|FG001|Core Study Period|Adverse Event|14|||
48754363|NCT01957553|156946669|FG000|Test Period 1 (21 +- 1 Days)|screen failure|1|||
48754364|NCT01957553|156946670|FG001|Test Period 1 (21 +- 1 Days)|screen failure|0|||
48754365|NCT01957553|156946669|FG000|Test Period 2 (21 +- 1 Days)|Adverse Event|1|||
48961445|NCT00051558|157689739|FG000|Overall Study|Protocol Violation|3|||
48655839|NCT02499900|156593486|FG000|Core Study Period|Death|0|||
48655840|NCT02499900|156593487|FG001|Core Study Period|Death|1|||
48655841|NCT02499900|156593486|FG000|Completed Core, Continued Into Extension|Physician Decision|1|||
48655842|NCT02499900|156593487|FG001|Completed Core, Continued Into Extension|Physician Decision|0|||
48655843|NCT02499900|156593486|FG000|Completed Core, Continued Into Extension|Withdrawal by Subject|0|||
48655844|NCT02499900|156593487|FG001|Completed Core, Continued Into Extension|Withdrawal by Subject|2|||
48655845|NCT02499900|156593486|FG000|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1|||
48655846|NCT02499900|156593487|FG001|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0|||
48655847|NCT02499900|156593486|FG000|Completed Core, Continued Into Extension|Personal motivation|1|||
48655848|NCT02499900|156593487|FG001|Completed Core, Continued Into Extension|Personal motivation|0|||
48655849|NCT02499900|156593486|FG000|Extension Study Period|Adverse Event|2|||
48655850|NCT02499900|156593487|FG001|Extension Study Period|Adverse Event|4|||
48655851|NCT02499900|156593486|FG000|Extension Study Period|Withdrawal by Subject|5|||
48655852|NCT02499900|156593487|FG001|Extension Study Period|Withdrawal by Subject|2|||
48655853|NCT02499900|156593486|FG000|Extension Study Period|Physician Decision|2|||
48655854|NCT02499900|156593487|FG001|Extension Study Period|Physician Decision|5|||
48655855|NCT02499900|156593486|FG000|Extension Study Period|Pregnancy|1|||
48655856|NCT02499900|156593487|FG001|Extension Study Period|Pregnancy|2|||
48655857|NCT02499900|156593486|FG000|Extension Study Period|Lost to Follow-up|2|||
48655858|NCT02499900|156593487|FG001|Extension Study Period|Lost to Follow-up|5|||
48655859|NCT02499900|156593486|FG000|Extension Study Period|Other|0|||
48655860|NCT02499900|156593487|FG001|Extension Study Period|Other|2|||
48655861|NCT03222973|156593488|FG000|Part 1 (Week 0 to Week 72)|Adverse Event|3|||
48655862|NCT03222973|156593489|FG001|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
48655863|NCT03222973|156593490|FG002|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
48655864|NCT03222973|156593491|FG003|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
48655865|NCT03222973|156593488|FG000|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
48655866|NCT03222973|156593489|FG001|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
48655867|NCT03222973|156593490|FG002|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
48655868|NCT03222973|156593491|FG003|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
48655869|NCT03222973|156593488|FG000|Part 1 (Week 0 to Week 72)|Consent Withdrawn|12|||
48655870|NCT03222973|156593489|FG001|Part 1 (Week 0 to Week 72)|Consent Withdrawn|9|||
48655871|NCT03222973|156593490|FG002|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
48655872|NCT03222973|156593491|FG003|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
48655873|NCT03222973|156593488|FG000|Part 1 (Week 0 to Week 72)|Death|0|||
48655874|NCT03222973|156593489|FG001|Part 1 (Week 0 to Week 72)|Death|1|||
48655875|NCT03222973|156593490|FG002|Part 1 (Week 0 to Week 72)|Death|0|||
48655876|NCT03222973|156593491|FG003|Part 1 (Week 0 to Week 72)|Death|0|||
48655877|NCT03222973|156593488|FG000|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
48655878|NCT03222973|156593489|FG001|Part 1 (Week 0 to Week 72)|Pregnancy|1|||
48655879|NCT03222973|156593490|FG002|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
48655880|NCT03222973|156593491|FG003|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
48655881|NCT03222973|156593488|FG000|Part 1 (Week 0 to Week 72)|Other|8|||
48655882|NCT03222973|156593489|FG001|Part 1 (Week 0 to Week 72)|Other|2|||
48655883|NCT03222973|156593490|FG002|Part 1 (Week 0 to Week 72)|Other|0|||
48655884|NCT03222973|156593491|FG003|Part 1 (Week 0 to Week 72)|Other|0|||
48655885|NCT03222973|156593488|FG000|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
48655886|NCT03222973|156593489|FG001|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
48655887|NCT03222973|156593490|FG002|Part 2 (Week 73 to Week 168)|Adverse Event|2|||
48655888|NCT03222973|156593491|FG003|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
48655889|NCT03222973|156593488|FG000|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
48655890|NCT03222973|156593489|FG001|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
48655891|NCT03222973|156593490|FG002|Part 2 (Week 73 to Week 168)|Consent Withdrawn|10|||
48655892|NCT03222973|156593491|FG003|Part 2 (Week 73 to Week 168)|Consent Withdrawn|11|||
48655893|NCT03222973|156593488|FG000|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
48655894|NCT03222973|156593489|FG001|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
48655895|NCT03222973|156593490|FG002|Part 2 (Week 73 to Week 168)|Investigator Decision|2|||
48655896|NCT03222973|156593491|FG003|Part 2 (Week 73 to Week 168)|Investigator Decision|1|||
48655897|NCT03222973|156593488|FG000|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
48655898|NCT03222973|156593489|FG001|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
48655899|NCT03222973|156593490|FG002|Part 2 (Week 73 to Week 168)|Pregnancy|2|||
48655900|NCT03222973|156593491|FG003|Part 2 (Week 73 to Week 168)|Pregnancy|1|||
48655901|NCT03222973|156593488|FG000|Part 2 (Week 73 to Week 168)|Other|0|||
48655902|NCT03222973|156593489|FG001|Part 2 (Week 73 to Week 168)|Other|0|||
48655903|NCT03222973|156593490|FG002|Part 2 (Week 73 to Week 168)|Other|84|||
48655904|NCT03222973|156593491|FG003|Part 2 (Week 73 to Week 168)|Other|100|||
48655905|NCT03222973|156593488|FG000|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
48754366|NCT01957553|156946670|FG001|Test Period 2 (21 +- 1 Days)|Adverse Event|3|||
48655906|NCT03222973|156593489|FG001|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
48655907|NCT03222973|156593490|FG002|Part 2 (Week 73 to Week 168)|Participants Not Dosed|1|||
48655908|NCT03222973|156593491|FG003|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
48655909|NCT04027049|156593494|FG000|Overall Study|Withdrawn by family|1|||
48655910|NCT04027049|156593495|FG001|Overall Study|Withdrawn by family|0|||
48754367|NCT01957553|156946669|FG000|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1|||
48754368|NCT01957553|156946670|FG001|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2|||
48754369|NCT01957553|156946669|FG000|Test Period 2 (21 +- 1 Days)|completed early by mistake|0|||
48754370|NCT01957553|156946670|FG001|Test Period 2 (21 +- 1 Days)|completed early by mistake|1|||
48754371|NCT01957553|156946669|FG000|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0|||
48754372|NCT01957553|156946670|FG001|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1|||
48754373|NCT01957553|156946669|FG000|Test Period 2 (21 +- 1 Days)|Other|1|||
48754374|NCT01957553|156946670|FG001|Test Period 2 (21 +- 1 Days)|Other|0|||
48754375|NCT04044716|156946671|FG000|Overall Study|participant stopped treatment but submitted partial data.|1|||
48754376|NCT04044716|156946672|FG001|Overall Study|participant stopped treatment but submitted partial data.|0|||
48754377|NCT04044716|156946673|FG002|Overall Study|participant stopped treatment but submitted partial data.|0|||
48754378|NCT04044716|156946671|FG000|Overall Study|Lost to Follow-up|2|||
48754379|NCT04044716|156946672|FG001|Overall Study|Lost to Follow-up|3|||
48754380|NCT04044716|156946673|FG002|Overall Study|Lost to Follow-up|0|||
48754381|NCT02730455|156946674|FG000|Overall Study|Death|5|||
48754382|NCT02730455|156946675|FG001|Overall Study|Death|6|||
48754383|NCT02730455|156946676|FG002|Overall Study|Death|4|||
48754384|NCT02730455|156946674|FG000|Overall Study|Consent withdrawn|2|||
48754385|NCT02730455|156946675|FG001|Overall Study|Consent withdrawn|4|||
48754386|NCT02730455|156946676|FG002|Overall Study|Consent withdrawn|1|||
48754387|NCT02730455|156946674|FG000|Overall Study|Lost to Follow-up|3|||
48754388|NCT02730455|156946675|FG001|Overall Study|Lost to Follow-up|1|||
48754389|NCT02730455|156946676|FG002|Overall Study|Lost to Follow-up|4|||
48754390|NCT02730455|156946674|FG000|Overall Study|Other|1|||
48754391|NCT02730455|156946675|FG001|Overall Study|Other|1|||
48754392|NCT02730455|156946676|FG002|Overall Study|Other|2|||
48754393|NCT02730455|156946674|FG000|Overall Study|Other|2|||
48754394|NCT02730455|156946675|FG001|Overall Study|Other|2|||
48754395|NCT02730455|156946676|FG002|Overall Study|Other|0|||
48754396|NCT00737282|156946677|FG000|Overall Study|Study prematurely terminated|175|||
48754397|NCT00459108|156946682|FG000|Overall Study|Withdrawal by Subject|5|||
48754398|NCT00459108|156946682|FG000|Overall Study|Adverse Event|3|||
48754399|NCT00459108|156946682|FG000|Overall Study|Death|2|||
48754400|NCT00459108|156946682|FG000|Overall Study|Progression|1|||
48754401|NCT02743871|156946686|FG000|Overall Study|Lost to Follow-up|0|||
48754402|NCT02743871|156946687|FG001|Overall Study|Lost to Follow-up|0|||
48754403|NCT02743871|156946688|FG002|Overall Study|Lost to Follow-up|0|||
48961446|NCT00051558|157689740|FG001|Overall Study|Protocol Violation|4|||
48961447|NCT00051558|157689739|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
48961448|NCT00051558|157689740|FG001|Overall Study|Protocol Entry Criteria Unmet|2|||
48961449|NCT00051558|157689739|FG000|Overall Study|Sponsor Decision|6|||
48961450|NCT00051558|157689740|FG001|Overall Study|Sponsor Decision|1|||
48961451|NCT00051558|157689739|FG000|Overall Study|Other|2|||
48961452|NCT00051558|157689740|FG001|Overall Study|Other|1|||
48961453|NCT00051558|157689739|FG000|Overall Study|Significant Lab Value|2|||
48961454|NCT00051558|157689740|FG001|Overall Study|Significant Lab Value|0|||
48961455|NCT00051558|157689739|FG000|Overall Study|Physician Decision|5|||
48961456|NCT00051558|157689740|FG001|Overall Study|Physician Decision|0|||
48961457|NCT02554253|157689744|FG000|Overall Study|ineligible after enrollment|1|||
48961458|NCT02554253|157689745|FG001|Overall Study|ineligible after enrollment|0|||
48961459|NCT02554253|157689744|FG000|Overall Study|converted to transcatheter procedure|0|||
48961460|NCT02554253|157689745|FG001|Overall Study|converted to transcatheter procedure|1|||
48655911|NCT04027049|156593494|FG000|Overall Study|Participant safety|1|||
48655912|NCT04027049|156593495|FG001|Overall Study|Participant safety|0|||
48961461|NCT02554253|157689744|FG000|Overall Study|received both drugs|0|||
48961462|NCT02554253|157689745|FG001|Overall Study|received both drugs|1|||
48655913|NCT03746600|156593496|FG000|Overall Study|Withdrawal by Subject|3|||
48655914|NCT03746600|156593497|FG001|Overall Study|Withdrawal by Subject|3|||
48961463|NCT00423085|157689746|FG000|24-Week Double-Blind Treatment Phase|Adverse Event|21|||
48961464|NCT00423085|157689747|FG001|24-Week Double-Blind Treatment Phase|Adverse Event|38|||
48961465|NCT00423085|157689748|FG002|24-Week Double-Blind Treatment Phase|Adverse Event|34|||
48961466|NCT00423085|157689749|FG003|24-Week Double-Blind Treatment Phase|Adverse Event|0|||
48961467|NCT00423085|157689746|FG000|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8|||
48961468|NCT00423085|157689747|FG001|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16|||
48961469|NCT00423085|157689748|FG002|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11|||
48655915|NCT03746600|156593496|FG000|Overall Study|dismissed from study|1|||
48961470|NCT00423085|157689749|FG003|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0|||
48754404|NCT02743871|156946689|FG003|Overall Study|Lost to Follow-up|1|||
48754405|NCT02743871|156946690|FG004|Overall Study|Lost to Follow-up|0|||
48754406|NCT02743871|156946691|FG005|Overall Study|Lost to Follow-up|0|||
48961471|NCT00423085|157689746|FG000|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
48655916|NCT03746600|156593497|FG001|Overall Study|dismissed from study|0|||
48961472|NCT00423085|157689747|FG001|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6|||
48961473|NCT00423085|157689748|FG002|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
48961474|NCT00423085|157689749|FG003|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
48655917|NCT03746600|156593496|FG000|Overall Study|Lost to Follow-up|1|||
48655918|NCT03746600|156593497|FG001|Overall Study|Lost to Follow-up|0|||
48655919|NCT04068519|156593498|FG000|Dose Verification|Death|15|||
48655920|NCT04068519|156593498|FG000|Dose Verification|Withdrawal by Subject|1|||
48655921|NCT04068519|156593498|FG000|Pharmacokinetic Sub-study|Death|35|||
48655922|NCT04068519|156593498|FG000|Pharmacokinetic Sub-study|Withdrawal by Subject|1|||
48655923|NCT04068519|156593498|FG000|Pharmacokinetic Sub-study|Lost to Follow-up|4|||
48655924|NCT04068519|156593498|FG000|Pharmacokinetic Sub-study|Other not specified|1|||
48655925|NCT04068519|156593498|FG000|Indication Expansion|Death|152|||
48655926|NCT04068519|156593498|FG000|Indication Expansion|Withdrawal by Subject|10|||
48655927|NCT04068519|156593498|FG000|Indication Expansion|Lost to Follow-up|7|||
48655928|NCT03280303|156595878|FG000|Overall Study|Death|505|||
48655929|NCT03280303|156595878|FG000|Overall Study|Study terminated by sponsor|383|||
48961475|NCT00423085|157689746|FG000|24-Week Double-Blind Treatment Phase|Protocol Violation|8|||
48961476|NCT00423085|157689747|FG001|24-Week Double-Blind Treatment Phase|Protocol Violation|3|||
48961477|NCT00423085|157689748|FG002|24-Week Double-Blind Treatment Phase|Protocol Violation|7|||
48961478|NCT00423085|157689749|FG003|24-Week Double-Blind Treatment Phase|Protocol Violation|0|||
48961479|NCT00423085|157689746|FG000|24-Week Double-Blind Treatment Phase|Death|1|||
48961480|NCT00423085|157689747|FG001|24-Week Double-Blind Treatment Phase|Death|1|||
48961481|NCT00423085|157689748|FG002|24-Week Double-Blind Treatment Phase|Death|0|||
48961482|NCT00423085|157689749|FG003|24-Week Double-Blind Treatment Phase|Death|0|||
48961483|NCT00423085|157689746|FG000|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1|||
48961484|NCT00423085|157689747|FG001|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
48961485|NCT00423085|157689748|FG002|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
48961486|NCT00423085|157689749|FG003|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
48961487|NCT00423085|157689746|FG000|52-Week Open-Label Extension Phase|Adverse Event|0|||
48961488|NCT00423085|157689747|FG001|52-Week Open-Label Extension Phase|Adverse Event|0|||
48961489|NCT00423085|157689748|FG002|52-Week Open-Label Extension Phase|Adverse Event|0|||
48961490|NCT00423085|157689749|FG003|52-Week Open-Label Extension Phase|Adverse Event|97|||
48961491|NCT00423085|157689746|FG000|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
48961492|NCT00423085|157689747|FG001|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
48961493|NCT00423085|157689748|FG002|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
48961494|NCT00423085|157689749|FG003|52-Week Open-Label Extension Phase|Withdrawal by Subject|37|||
48961495|NCT00423085|157689746|FG000|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
48961496|NCT00423085|157689747|FG001|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
48961497|NCT00423085|157689748|FG002|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
48961498|NCT00423085|157689749|FG003|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18|||
48961499|NCT00423085|157689746|FG000|52-Week Open-Label Extension Phase|Protocol deviation|0|||
48961500|NCT00423085|157689747|FG001|52-Week Open-Label Extension Phase|Protocol deviation|0|||
48961501|NCT00423085|157689748|FG002|52-Week Open-Label Extension Phase|Protocol deviation|0|||
48655930|NCT03280303|156595878|FG000|Overall Study|Other|148|||
48655931|NCT03280303|156595878|FG000|Overall Study|No longer willing to participate in study|101|||
48655932|NCT03280303|156595878|FG000|Overall Study|Lost to follow up|39|||
48655933|NCT03280303|156595878|FG000|Overall Study|Adverse Event|20|||
48655934|NCT01631747|156595879|FG000|Randomization Through End of Pregnancy|Lost to Follow-up|1|||
48655935|NCT01631747|156595880|FG001|Randomization Through End of Pregnancy|Lost to Follow-up|0|||
48655936|NCT01631747|156595879|FG000|Live Birth|Pregnancy Termination|1|||
48655937|NCT01631747|156595880|FG001|Live Birth|Pregnancy Termination|0|||
48961502|NCT00423085|157689749|FG003|52-Week Open-Label Extension Phase|Protocol deviation|9|||
48961503|NCT00423085|157689746|FG000|52-Week Open-Label Extension Phase|Death|0|||
48961504|NCT00423085|157689747|FG001|52-Week Open-Label Extension Phase|Death|0|||
48961505|NCT00423085|157689748|FG002|52-Week Open-Label Extension Phase|Death|0|||
48961506|NCT00423085|157689749|FG003|52-Week Open-Label Extension Phase|Death|2|||
48961507|NCT00165841|157689750|FG000|Overall Study|Adverse Event|2|||
48961508|NCT00165841|157689751|FG001|Overall Study|Adverse Event|3|||
48961509|NCT00165841|157689750|FG000|Overall Study|Lack of Efficacy|6|||
48961510|NCT00165841|157689751|FG001|Overall Study|Lack of Efficacy|33|||
48961511|NCT00165841|157689750|FG000|Overall Study|Lost to Follow-up|4|||
48961512|NCT00165841|157689751|FG001|Overall Study|Lost to Follow-up|4|||
48655938|NCT01631747|156595879|FG000|Live Birth|MIscarriage|2|||
48655939|NCT01631747|156595880|FG001|Live Birth|MIscarriage|0|||
48655940|NCT01631747|156595879|FG000|Live Birth|Stillbirth|1|||
48655941|NCT01631747|156595880|FG001|Live Birth|Stillbirth|1|||
48655942|NCT01631747|156595879|FG000|One Year Infant Outcomes|Patient Refused|13|||
48655943|NCT01631747|156595880|FG001|One Year Infant Outcomes|Patient Refused|9|||
48655944|NCT00064259|156595881|FG000|Overall Study|Adverse Event|1|||
48754407|NCT02743871|156946692|FG006|Overall Study|Lost to Follow-up|1|||
48754408|NCT02743871|156946693|FG007|Overall Study|Lost to Follow-up|0|||
48754409|NCT02743871|156946694|FG008|Overall Study|Lost to Follow-up|0|||
48754410|NCT02743871|156946695|FG009|Overall Study|Lost to Follow-up|0|||
48754411|NCT02743871|156946696|FG010|Overall Study|Lost to Follow-up|0|||
48754412|NCT02743871|156946697|FG011|Overall Study|Lost to Follow-up|2|||
48754413|NCT02743871|156946698|FG012|Overall Study|Lost to Follow-up|0|||
48754414|NCT02743871|156946699|FG013|Overall Study|Lost to Follow-up|0|||
48754415|NCT02743871|156946686|FG000|Overall Study|Withdrawal by Subject|0|||
48754416|NCT02743871|156946687|FG001|Overall Study|Withdrawal by Subject|0|||
48754417|NCT02743871|156946688|FG002|Overall Study|Withdrawal by Subject|0|||
48754418|NCT02743871|156946689|FG003|Overall Study|Withdrawal by Subject|0|||
48754419|NCT02743871|156946690|FG004|Overall Study|Withdrawal by Subject|0|||
48754420|NCT02743871|156946691|FG005|Overall Study|Withdrawal by Subject|0|||
48754421|NCT02743871|156946692|FG006|Overall Study|Withdrawal by Subject|0|||
48754422|NCT02743871|156946693|FG007|Overall Study|Withdrawal by Subject|0|||
48754423|NCT02743871|156946694|FG008|Overall Study|Withdrawal by Subject|0|||
48754424|NCT02743871|156946695|FG009|Overall Study|Withdrawal by Subject|0|||
48754425|NCT02743871|156946696|FG010|Overall Study|Withdrawal by Subject|1|||
48754426|NCT02743871|156946697|FG011|Overall Study|Withdrawal by Subject|0|||
48754427|NCT02743871|156946698|FG012|Overall Study|Withdrawal by Subject|12|||
48754428|NCT02743871|156946699|FG013|Overall Study|Withdrawal by Subject|6|||
48754429|NCT02743871|156946686|FG000|Overall Study|Adverse Event|1|||
48754430|NCT02743871|156946687|FG001|Overall Study|Adverse Event|0|||
48754431|NCT02743871|156946688|FG002|Overall Study|Adverse Event|0|||
48754432|NCT02743871|156946689|FG003|Overall Study|Adverse Event|0|||
48754433|NCT02743871|156946690|FG004|Overall Study|Adverse Event|0|||
48754434|NCT02743871|156946691|FG005|Overall Study|Adverse Event|0|||
48754435|NCT02743871|156946692|FG006|Overall Study|Adverse Event|0|||
48754436|NCT02743871|156946693|FG007|Overall Study|Adverse Event|0|||
48754437|NCT02743871|156946694|FG008|Overall Study|Adverse Event|0|||
48754438|NCT02743871|156946695|FG009|Overall Study|Adverse Event|0|||
48754439|NCT02743871|156946696|FG010|Overall Study|Adverse Event|0|||
48754440|NCT02743871|156946697|FG011|Overall Study|Adverse Event|0|||
48754441|NCT02743871|156946698|FG012|Overall Study|Adverse Event|0|||
48754442|NCT02743871|156946699|FG013|Overall Study|Adverse Event|0|||
48754443|NCT02743871|156946686|FG000|Overall Study|Other|0|||
48754444|NCT02743871|156946687|FG001|Overall Study|Other|0|||
48754445|NCT02743871|156946688|FG002|Overall Study|Other|0|||
48754446|NCT02743871|156946689|FG003|Overall Study|Other|0|||
48754447|NCT02743871|156946690|FG004|Overall Study|Other|0|||
48754448|NCT02743871|156946691|FG005|Overall Study|Other|0|||
48754449|NCT02743871|156946692|FG006|Overall Study|Other|0|||
48754450|NCT02743871|156946693|FG007|Overall Study|Other|0|||
48754451|NCT02743871|156946694|FG008|Overall Study|Other|0|||
48754452|NCT02743871|156946695|FG009|Overall Study|Other|0|||
48754453|NCT02743871|156946696|FG010|Overall Study|Other|0|||
48754454|NCT02743871|156946697|FG011|Overall Study|Other|1|||
48754455|NCT02743871|156946698|FG012|Overall Study|Other|1|||
48754456|NCT02743871|156946699|FG013|Overall Study|Other|1|||
48754457|NCT02743871|156946686|FG000|Overall Study|Protocol Violation|0|||
48754458|NCT02743871|156946687|FG001|Overall Study|Protocol Violation|0|||
48754459|NCT02743871|156946688|FG002|Overall Study|Protocol Violation|0|||
48754460|NCT02743871|156946689|FG003|Overall Study|Protocol Violation|0|||
48754461|NCT02743871|156946690|FG004|Overall Study|Protocol Violation|0|||
48754462|NCT02743871|156946691|FG005|Overall Study|Protocol Violation|0|||
48754463|NCT02743871|156946692|FG006|Overall Study|Protocol Violation|0|||
48961513|NCT00165841|157689750|FG000|Overall Study|Withdrawal by Subject|7|||
48961514|NCT00165841|157689751|FG001|Overall Study|Withdrawal by Subject|8|||
48961515|NCT00165841|157689750|FG000|Overall Study|Physician Decision|1|||
48961516|NCT00165841|157689751|FG001|Overall Study|Physician Decision|0|||
48961517|NCT00165841|157689750|FG000|Overall Study|Protocol Violation|6|||
48961518|NCT00165841|157689751|FG001|Overall Study|Protocol Violation|8|||
48961519|NCT00165841|157689750|FG000|Overall Study|Other|3|||
48754464|NCT02743871|156946693|FG007|Overall Study|Protocol Violation|0|||
48754465|NCT02743871|156946694|FG008|Overall Study|Protocol Violation|0|||
48754466|NCT02743871|156946695|FG009|Overall Study|Protocol Violation|0|||
48754467|NCT02743871|156946696|FG010|Overall Study|Protocol Violation|0|||
48754468|NCT02743871|156946697|FG011|Overall Study|Protocol Violation|0|||
48754469|NCT02743871|156946698|FG012|Overall Study|Protocol Violation|2|||
48754470|NCT02743871|156946699|FG013|Overall Study|Protocol Violation|0|||
48754471|NCT03194321|156946705|FG000|Overall Study|Withdrawal by Subject|1|||
48754472|NCT03194321|156946705|FG000|Overall Study|Lost to Follow-up|1|||
48754473|NCT03194321|156946705|FG000|Overall Study|Travel for Follow-up|1|||
48754474|NCT03241342|156946707|FG000|Overall Study|Adverse Event|5|||
48754475|NCT03241342|156946708|FG001|Overall Study|Adverse Event|8|||
48754476|NCT03241342|156946709|FG002|Overall Study|Adverse Event|4|||
48754477|NCT03241342|156946707|FG000|Overall Study|Lack of Efficacy|0|||
48754478|NCT03241342|156946708|FG001|Overall Study|Lack of Efficacy|0|||
48754479|NCT03241342|156946709|FG002|Overall Study|Lack of Efficacy|1|||
48754480|NCT03241342|156946707|FG000|Overall Study|noncompliance with study drug|2|||
48754481|NCT03241342|156946708|FG001|Overall Study|noncompliance with study drug|1|||
48754482|NCT03241342|156946709|FG002|Overall Study|noncompliance with study drug|1|||
48754483|NCT03241342|156946707|FG000|Overall Study|sponsor decision|0|||
48754484|NCT03241342|156946708|FG001|Overall Study|sponsor decision|1|||
48754485|NCT03241342|156946709|FG002|Overall Study|sponsor decision|2|||
48754486|NCT03241342|156946707|FG000|Overall Study|not reported|15|||
48754487|NCT03241342|156946708|FG001|Overall Study|not reported|21|||
48754488|NCT03241342|156946709|FG002|Overall Study|not reported|19|||
48754489|NCT01698801|156946712|FG000|Treatment Phase|Adverse Event|4|||
48754490|NCT01698801|156946712|FG000|Treatment Phase|Protocol Violation|1|||
48754491|NCT01698801|156946712|FG000|Treatment Phase|Other|4|||
48754492|NCT01698801|156946712|FG000|Treatment Phase|Withdrawal by Subject|1|||
48754493|NCT01698801|156946712|FG000|Treatment Phase|Disease progression|1|||
48754494|NCT01698801|156946712|FG000|Follow Up Phase|Withdrawal by Subject|1|||
48754495|NCT01698801|156946712|FG000|Follow Up Phase|Death|4|||
48754496|NCT01705652|156946713|FG000|Overall Study|Adverse Event|1|||
48754497|NCT01705652|156946714|FG001|Overall Study|Adverse Event|0|||
48754498|NCT01705652|156946713|FG000|Overall Study|Withdrawal by Subject|1|||
48754499|NCT01705652|156946714|FG001|Overall Study|Withdrawal by Subject|2|||
48754500|NCT01705652|156946713|FG000|Overall Study|non-compliance|1|||
48754501|NCT01705652|156946714|FG001|Overall Study|non-compliance|1|||
48754502|NCT00847704|156946716|FG000|Overall Study|Withdrawal by Subject|1|||
48754503|NCT03036072|156946717|FG000|Overall Study|Death|0|||
48754504|NCT03036072|156946718|FG001|Overall Study|Death|1|||
48754505|NCT03036072|156946717|FG000|Overall Study|Withdrawal by Subject|0|||
48754506|NCT03036072|156946718|FG001|Overall Study|Withdrawal by Subject|1|||
48754507|NCT03036072|156946717|FG000|Overall Study|Physician Decision|0|||
48754508|NCT03036072|156946718|FG001|Overall Study|Physician Decision|1|||
48961520|NCT00165841|157689751|FG001|Overall Study|Other|5|||
48961521|NCT00165841|157689750|FG000|Overall Study|Medication Noncompliance|1|||
48961522|NCT00165841|157689751|FG001|Overall Study|Medication Noncompliance|1|||
48961523|NCT00254293|157689752|FG000|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
48961524|NCT00254293|157689753|FG001|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
48961525|NCT00254293|157689754|FG002|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
48961526|NCT00254293|157689755|FG003|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
48961527|NCT00254293|157689756|FG004|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
48961528|NCT00254293|157689757|FG005|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
48961529|NCT00254293|157689758|FG006|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
48655945|NCT00064259|156595882|FG001|Overall Study|Adverse Event|0|||
48655946|NCT00064259|156595883|FG002|Overall Study|Adverse Event|0|||
48655947|NCT00064259|156595884|FG003|Overall Study|Adverse Event|1|||
48655948|NCT01579565|156595885|FG000|Randomized|Adverse Event|1|||
48655949|NCT01579565|156595886|FG001|Randomized|Adverse Event|3|||
48655950|NCT01579565|156595885|FG000|Randomized|Withdrawal by Subject|3|||
48655951|NCT01579565|156595886|FG001|Randomized|Withdrawal by Subject|0|||
48655952|NCT01579565|156595885|FG000|Randomized|inadequate preoperative pupil dilation|0|||
48655953|NCT01579565|156595886|FG001|Randomized|inadequate preoperative pupil dilation|1|||
48655954|NCT01579565|156595885|FG000|Randomized|prohibited preoperative eating|1|||
48655955|NCT01579565|156595886|FG001|Randomized|prohibited preoperative eating|0|||
48754509|NCT02111850|156946719|FG000|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
48961530|NCT00254293|157689752|FG000|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
48961531|NCT00254293|157689753|FG001|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
48655956|NCT01579565|156595885|FG000|Randomized|prohibited preoperative medication|0|||
48655957|NCT01579565|156595886|FG001|Randomized|prohibited preoperative medication|1|||
48655958|NCT01579565|156595885|FG000|Treated|Physician Decision|0|||
48655959|NCT01579565|156595886|FG001|Treated|Physician Decision|1|||
48655960|NCT01579565|156595885|FG000|Treated|Lost to Follow-up|2|||
48655961|NCT01579565|156595886|FG001|Treated|Lost to Follow-up|1|||
48655962|NCT01579565|156595885|FG000|Treated|declined to return for final visit|0|||
48655963|NCT01579565|156595886|FG001|Treated|declined to return for final visit|1|||
48655964|NCT01380535|156595887|FG000|Overall Study|Adverse Event|3|||
48655965|NCT01380535|156595888|FG001|Overall Study|Adverse Event|3|||
48655966|NCT01380535|156595887|FG000|Overall Study|Death|3|||
48961532|NCT00254293|157689754|FG002|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1|||
48655967|NCT01380535|156595888|FG001|Overall Study|Death|0|||
48655968|NCT01380535|156595887|FG000|Overall Study|Study site closed|0|||
48961533|NCT00254293|157689755|FG003|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
48655969|NCT01380535|156595888|FG001|Overall Study|Study site closed|5|||
48655970|NCT01380535|156595887|FG000|Overall Study|Withdrawal by Subject|1|||
48655971|NCT01380535|156595888|FG001|Overall Study|Withdrawal by Subject|2|||
48754510|NCT02111850|156946720|FG001|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
48754511|NCT02111850|156946721|FG002|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
48754512|NCT02111850|156946722|FG003|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
48754513|NCT02111850|156946723|FG004|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|1|||
48655972|NCT01380535|156595887|FG000|Overall Study|Protocol Violation|0|||
48655973|NCT01380535|156595888|FG001|Overall Study|Protocol Violation|2|||
48655974|NCT01380535|156595887|FG000|Overall Study|Lack of Efficacy|0|||
48655975|NCT01380535|156595888|FG001|Overall Study|Lack of Efficacy|3|||
48655976|NCT02954406|156595889|FG000|Overall Study|Adverse Event|0|||
48655977|NCT02954406|156595890|FG001|Overall Study|Adverse Event|1|||
48655978|NCT02954406|156595891|FG002|Overall Study|Adverse Event|0|||
48655979|NCT02954406|156595892|FG003|Overall Study|Adverse Event|0|||
48655980|NCT02954406|156595893|FG004|Overall Study|Adverse Event|1|||
48655981|NCT02954406|156595894|FG005|Overall Study|Adverse Event|0|||
48655982|NCT02954406|156595895|FG006|Overall Study|Adverse Event|0|||
48655983|NCT02954406|156595896|FG007|Overall Study|Adverse Event|0|||
48655984|NCT02954406|156595897|FG008|Overall Study|Adverse Event|1|||
48655985|NCT02954406|156595898|FG009|Overall Study|Adverse Event|1|||
48655986|NCT02954406|156595899|FG010|Overall Study|Adverse Event|0|||
48655987|NCT02954406|156595889|FG000|Overall Study|Progressive Disease|3|||
48961534|NCT00254293|157689756|FG004|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
48655988|NCT02954406|156595890|FG001|Overall Study|Progressive Disease|4|||
48655989|NCT02954406|156595891|FG002|Overall Study|Progressive Disease|3|||
48655990|NCT02954406|156595892|FG003|Overall Study|Progressive Disease|4|||
48655991|NCT02954406|156595893|FG004|Overall Study|Progressive Disease|3|||
48655992|NCT02954406|156595894|FG005|Overall Study|Progressive Disease|3|||
48655993|NCT02954406|156595895|FG006|Overall Study|Progressive Disease|2|||
48655994|NCT02954406|156595896|FG007|Overall Study|Progressive Disease|2|||
48655995|NCT02954406|156595897|FG008|Overall Study|Progressive Disease|1|||
48655996|NCT02954406|156595898|FG009|Overall Study|Progressive Disease|1|||
48655997|NCT02954406|156595899|FG010|Overall Study|Progressive Disease|0|||
48655998|NCT02954406|156595889|FG000|Overall Study|Symptomatic Deterioration|0|||
48655999|NCT02954406|156595890|FG001|Overall Study|Symptomatic Deterioration|1|||
48656000|NCT02954406|156595891|FG002|Overall Study|Symptomatic Deterioration|0|||
48656001|NCT02954406|156595892|FG003|Overall Study|Symptomatic Deterioration|0|||
48656002|NCT02954406|156595893|FG004|Overall Study|Symptomatic Deterioration|0|||
48656003|NCT02954406|156595894|FG005|Overall Study|Symptomatic Deterioration|0|||
48656004|NCT02954406|156595895|FG006|Overall Study|Symptomatic Deterioration|0|||
48656005|NCT02954406|156595896|FG007|Overall Study|Symptomatic Deterioration|0|||
48656006|NCT02954406|156595897|FG008|Overall Study|Symptomatic Deterioration|0|||
48656007|NCT02954406|156595898|FG009|Overall Study|Symptomatic Deterioration|0|||
48656008|NCT02954406|156595899|FG010|Overall Study|Symptomatic Deterioration|0|||
48961535|NCT00254293|157689757|FG005|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
48961536|NCT00254293|157689758|FG006|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
48656009|NCT02954406|156595889|FG000|Overall Study|Death|0|||
48656010|NCT02954406|156595890|FG001|Overall Study|Death|0|||
48656011|NCT02954406|156595891|FG002|Overall Study|Death|0|||
48656012|NCT02954406|156595892|FG003|Overall Study|Death|0|||
48656013|NCT02954406|156595893|FG004|Overall Study|Death|1|||
48961537|NCT00254293|157689752|FG000|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
48961538|NCT00254293|157689753|FG001|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
48656014|NCT02954406|156595894|FG005|Overall Study|Death|0|||
48961539|NCT00254293|157689754|FG002|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2|||
48961540|NCT00254293|157689755|FG003|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
48961541|NCT00254293|157689756|FG004|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
48961542|NCT00254293|157689757|FG005|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
48961543|NCT00254293|157689758|FG006|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
48961544|NCT00254293|157689752|FG000|LTE Open Label Variable SC Dosing|Death|0|||
48961545|NCT00254293|157689753|FG001|LTE Open Label Variable SC Dosing|Death|0|||
48656015|NCT02954406|156595895|FG006|Overall Study|Death|0|||
48656016|NCT02954406|156595896|FG007|Overall Study|Death|0|||
48656017|NCT02954406|156595897|FG008|Overall Study|Death|1|||
48656018|NCT02954406|156595898|FG009|Overall Study|Death|1|||
48656019|NCT02954406|156595899|FG010|Overall Study|Death|0|||
48656020|NCT02954406|156595889|FG000|Overall Study|Reason Not Specified|0|||
48656021|NCT02954406|156595890|FG001|Overall Study|Reason Not Specified|0|||
48656022|NCT02954406|156595891|FG002|Overall Study|Reason Not Specified|3|||
48656023|NCT02954406|156595892|FG003|Overall Study|Reason Not Specified|2|||
48656024|NCT02954406|156595893|FG004|Overall Study|Reason Not Specified|2|||
48656025|NCT02954406|156595894|FG005|Overall Study|Reason Not Specified|0|||
48656026|NCT02954406|156595895|FG006|Overall Study|Reason Not Specified|1|||
48656027|NCT02954406|156595896|FG007|Overall Study|Reason Not Specified|0|||
48656028|NCT02954406|156595897|FG008|Overall Study|Reason Not Specified|1|||
48656029|NCT02954406|156595898|FG009|Overall Study|Reason Not Specified|0|||
48656030|NCT02954406|156595899|FG010|Overall Study|Reason Not Specified|0|||
48656031|NCT02867813|156595900|FG000|Overall Study|Withdrawal by Subject|57|||
48656032|NCT02867813|156595901|FG001|Overall Study|Withdrawal by Subject|56|||
48656033|NCT02867813|156595900|FG000|Overall Study|Decision by Sponsor|7|||
48656034|NCT02867813|156595901|FG001|Overall Study|Decision by Sponsor|7|||
48656035|NCT02867813|156595900|FG000|Overall Study|Lost to Follow-up|91|||
48961546|NCT00254293|157689754|FG002|LTE Open Label Variable SC Dosing|Death|1|||
48961547|NCT00254293|157689755|FG003|LTE Open Label Variable SC Dosing|Death|0|||
48961548|NCT00254293|157689756|FG004|LTE Open Label Variable SC Dosing|Death|0|||
48961549|NCT00254293|157689757|FG005|LTE Open Label Variable SC Dosing|Death|0|||
48961550|NCT00254293|157689758|FG006|LTE Open Label Variable SC Dosing|Death|0|||
48961551|NCT00254293|157689752|FG000|LTE Open Label Variable SC Dosing|Adverse Event|1|||
48961552|NCT00254293|157689753|FG001|LTE Open Label Variable SC Dosing|Adverse Event|0|||
48961553|NCT00254293|157689754|FG002|LTE Open Label Variable SC Dosing|Adverse Event|2|||
48961554|NCT00254293|157689755|FG003|LTE Open Label Variable SC Dosing|Adverse Event|0|||
48961555|NCT00254293|157689756|FG004|LTE Open Label Variable SC Dosing|Adverse Event|1|||
48961556|NCT00254293|157689757|FG005|LTE Open Label Variable SC Dosing|Adverse Event|0|||
48961557|NCT00254293|157689758|FG006|LTE Open Label Variable SC Dosing|Adverse Event|0|||
48961558|NCT00254293|157689752|FG000|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
48961559|NCT00254293|157689753|FG001|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
48961560|NCT00254293|157689754|FG002|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
48961561|NCT00254293|157689755|FG003|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
48961562|NCT00254293|157689756|FG004|LTE Open Label Variable SC Dosing|Lack of Efficacy|1|||
48961563|NCT00254293|157689757|FG005|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
48961564|NCT00254293|157689758|FG006|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
48656036|NCT02867813|156595901|FG001|Overall Study|Lost to Follow-up|78|||
48656037|NCT02867813|156595900|FG000|Overall Study|Missing|2|||
48961565|NCT00254293|157689752|FG000|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
48961566|NCT00254293|157689753|FG001|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
48961567|NCT00254293|157689754|FG002|LTE Open Label Variable SC Dosing|Lost to Follow-up|1|||
48961568|NCT00254293|157689755|FG003|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
48961569|NCT00254293|157689756|FG004|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
48961570|NCT00254293|157689757|FG005|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
48961571|NCT00254293|157689758|FG006|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
48961572|NCT00254293|157689752|FG000|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
48961573|NCT00254293|157689753|FG001|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
48961574|NCT00254293|157689754|FG002|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1|||
48961575|NCT00254293|157689755|FG003|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
48961576|NCT00254293|157689756|FG004|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
48961577|NCT00254293|157689757|FG005|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
48961578|NCT00254293|157689758|FG006|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
48961579|NCT00254293|157689752|FG000|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
48961580|NCT00254293|157689753|FG001|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
48961581|NCT00254293|157689754|FG002|LTE Open Label Variable SC Dosing|Poor or non-compliance|1|||
48961582|NCT00254293|157689755|FG003|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
48961583|NCT00254293|157689756|FG004|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
48961584|NCT00254293|157689757|FG005|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
48961585|NCT00254293|157689758|FG006|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
48961586|NCT00254293|157689752|FG000|LTE Open Label Variable SC Dosing|Other|0|||
48961587|NCT00254293|157689753|FG001|LTE Open Label Variable SC Dosing|Other|0|||
48961588|NCT00254293|157689754|FG002|LTE Open Label Variable SC Dosing|Other|2|||
48961589|NCT00254293|157689755|FG003|LTE Open Label Variable SC Dosing|Other|0|||
48961590|NCT00254293|157689756|FG004|LTE Open Label Variable SC Dosing|Other|0|||
48961591|NCT00254293|157689757|FG005|LTE Open Label Variable SC Dosing|Other|0|||
48961592|NCT00254293|157689758|FG006|LTE Open Label Variable SC Dosing|Other|0|||
48961593|NCT00254293|157689752|FG000|LTE Open Label Fixed Dosing|Death|0|||
48961594|NCT00254293|157689753|FG001|LTE Open Label Fixed Dosing|Death|0|||
48961595|NCT00254293|157689754|FG002|LTE Open Label Fixed Dosing|Death|0|||
48961596|NCT00254293|157689755|FG003|LTE Open Label Fixed Dosing|Death|0|||
48961597|NCT00254293|157689756|FG004|LTE Open Label Fixed Dosing|Death|0|||
48961598|NCT00254293|157689757|FG005|LTE Open Label Fixed Dosing|Death|0|||
48961599|NCT00254293|157689758|FG006|LTE Open Label Fixed Dosing|Death|3|||
48961600|NCT00254293|157689752|FG000|LTE Open Label Fixed Dosing|Adverse Event|0|||
48961601|NCT00254293|157689753|FG001|LTE Open Label Fixed Dosing|Adverse Event|0|||
48656038|NCT02867813|156595901|FG001|Overall Study|Missing|1|||
48656039|NCT02867813|156595900|FG000|Overall Study|Death|294|||
48656040|NCT02867813|156595901|FG001|Overall Study|Death|268|||
48961602|NCT00254293|157689754|FG002|LTE Open Label Fixed Dosing|Adverse Event|0|||
48961603|NCT00254293|157689755|FG003|LTE Open Label Fixed Dosing|Adverse Event|0|||
48961604|NCT00254293|157689756|FG004|LTE Open Label Fixed Dosing|Adverse Event|0|||
48961605|NCT00254293|157689757|FG005|LTE Open Label Fixed Dosing|Adverse Event|0|||
48961606|NCT00254293|157689758|FG006|LTE Open Label Fixed Dosing|Adverse Event|1|||
48961607|NCT00254293|157689752|FG000|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
48961608|NCT00254293|157689753|FG001|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
48961609|NCT00254293|157689754|FG002|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
48961610|NCT00254293|157689755|FG003|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
49015421|NCT01736553|157892181|FG001|Overall Study|Lost to Follow-up|2|||
48961611|NCT00254293|157689756|FG004|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
48961612|NCT00254293|157689757|FG005|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
48961613|NCT00254293|157689758|FG006|LTE Open Label Fixed Dosing|Lack of Efficacy|3|||
48961614|NCT00254293|157689752|FG000|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
48961615|NCT00254293|157689753|FG001|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
48961616|NCT00254293|157689754|FG002|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
48961617|NCT00254293|157689755|FG003|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
48961618|NCT00254293|157689756|FG004|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
48961619|NCT00254293|157689757|FG005|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
48961620|NCT00254293|157689758|FG006|LTE Open Label Fixed Dosing|Lost to Follow-up|1|||
48961621|NCT00254293|157689752|FG000|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
48961622|NCT00254293|157689753|FG001|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
48961623|NCT00254293|157689754|FG002|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
48961624|NCT00254293|157689755|FG003|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
48961625|NCT00254293|157689756|FG004|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
48961626|NCT00254293|157689757|FG005|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
48961627|NCT00254293|157689758|FG006|LTE Open Label Fixed Dosing|Withdrawal by Subject|3|||
48961628|NCT00254293|157689752|FG000|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
48961629|NCT00254293|157689753|FG001|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
48961630|NCT00254293|157689754|FG002|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
48961631|NCT00254293|157689755|FG003|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
48961632|NCT00254293|157689756|FG004|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
48961633|NCT00254293|157689757|FG005|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
48961634|NCT00254293|157689758|FG006|LTE Open Label Fixed Dosing|Poor or non-compliance|1|||
48961635|NCT00254293|157689752|FG000|LTE Open Label Fixed Dosing|Other|0|||
48961636|NCT00254293|157689753|FG001|LTE Open Label Fixed Dosing|Other|0|||
48961637|NCT00254293|157689754|FG002|LTE Open Label Fixed Dosing|Other|0|||
48961638|NCT00254293|157689755|FG003|LTE Open Label Fixed Dosing|Other|0|||
48961639|NCT00254293|157689756|FG004|LTE Open Label Fixed Dosing|Other|0|||
48961640|NCT00254293|157689757|FG005|LTE Open Label Fixed Dosing|Other|0|||
48961641|NCT00254293|157689758|FG006|LTE Open Label Fixed Dosing|Other|1|||
48961642|NCT02163993|157689759|FG000|Treatment Period|Adverse Event|0|||
48961643|NCT02163993|157689760|FG001|Treatment Period|Adverse Event|1|||
48961644|NCT02163993|157689761|FG002|Treatment Period|Adverse Event|0|||
48961645|NCT02163993|157689762|FG003|Treatment Period|Adverse Event|0|||
48961646|NCT02163993|157689763|FG004|Treatment Period|Adverse Event|1|||
48961647|NCT02163993|157689759|FG000|Treatment Period|Lost to Follow-up|2|||
48961648|NCT02163993|157689760|FG001|Treatment Period|Lost to Follow-up|3|||
48961649|NCT02163993|157689761|FG002|Treatment Period|Lost to Follow-up|1|||
48961650|NCT02163993|157689762|FG003|Treatment Period|Lost to Follow-up|3|||
48961651|NCT02163993|157689763|FG004|Treatment Period|Lost to Follow-up|1|||
48961652|NCT02163993|157689759|FG000|Treatment Period|Physician Decision|1|||
48961653|NCT02163993|157689760|FG001|Treatment Period|Physician Decision|0|||
48961654|NCT02163993|157689761|FG002|Treatment Period|Physician Decision|0|||
48961655|NCT02163993|157689762|FG003|Treatment Period|Physician Decision|0|||
48961656|NCT02163993|157689763|FG004|Treatment Period|Physician Decision|0|||
48961657|NCT02163993|157689759|FG000|Treatment Period|Protocol Violation|2|||
48961658|NCT02163993|157689760|FG001|Treatment Period|Protocol Violation|1|||
48961659|NCT02163993|157689761|FG002|Treatment Period|Protocol Violation|0|||
48961660|NCT02163993|157689762|FG003|Treatment Period|Protocol Violation|1|||
48961661|NCT02163993|157689763|FG004|Treatment Period|Protocol Violation|2|||
48961662|NCT02163993|157689759|FG000|Treatment Period|Withdrawal by Subject|6|||
48961663|NCT02163993|157689760|FG001|Treatment Period|Withdrawal by Subject|4|||
48961664|NCT02163993|157689761|FG002|Treatment Period|Withdrawal by Subject|1|||
48961665|NCT02163993|157689762|FG003|Treatment Period|Withdrawal by Subject|4|||
48961666|NCT02163993|157689763|FG004|Treatment Period|Withdrawal by Subject|1|||
48961667|NCT02163993|157689759|FG000|Treatment Period|Not treated|1|||
48961668|NCT02163993|157689760|FG001|Treatment Period|Not treated|0|||
48961669|NCT02163993|157689761|FG002|Treatment Period|Not treated|0|||
48961670|NCT02163993|157689762|FG003|Treatment Period|Not treated|1|||
48961671|NCT02163993|157689763|FG004|Treatment Period|Not treated|2|||
48961672|NCT02163993|157689759|FG000|Post-treatment Period|Adverse Event|0|||
48961673|NCT02163993|157689760|FG001|Post-treatment Period|Adverse Event|0|||
48961674|NCT02163993|157689761|FG002|Post-treatment Period|Adverse Event|1|||
48961675|NCT02163993|157689762|FG003|Post-treatment Period|Adverse Event|0|||
48961676|NCT02163993|157689763|FG004|Post-treatment Period|Adverse Event|0|||
48961677|NCT02163993|157689759|FG000|Post-treatment Period|Lost to Follow-up|2|||
48961678|NCT02163993|157689760|FG001|Post-treatment Period|Lost to Follow-up|2|||
49015422|NCT01896297|157892182|FG000|Overall Study|Died in post treatment phase|1|||
48656041|NCT02578680|156595905|FG000|Overall Study|Death|329|||
48961679|NCT02163993|157689761|FG002|Post-treatment Period|Lost to Follow-up|3|||
48961680|NCT02163993|157689762|FG003|Post-treatment Period|Lost to Follow-up|1|||
48961681|NCT02163993|157689763|FG004|Post-treatment Period|Lost to Follow-up|0|||
48961682|NCT02163993|157689759|FG000|Post-treatment Period|Protocol Violation|0|||
48961683|NCT02163993|157689760|FG001|Post-treatment Period|Protocol Violation|0|||
48961684|NCT02163993|157689761|FG002|Post-treatment Period|Protocol Violation|0|||
48961685|NCT02163993|157689762|FG003|Post-treatment Period|Protocol Violation|0|||
48961686|NCT02163993|157689763|FG004|Post-treatment Period|Protocol Violation|1|||
48961687|NCT02163993|157689759|FG000|Post-treatment Period|Withdrawal by Subject|2|||
48961688|NCT02163993|157689760|FG001|Post-treatment Period|Withdrawal by Subject|4|||
48961689|NCT02163993|157689761|FG002|Post-treatment Period|Withdrawal by Subject|0|||
48961690|NCT02163993|157689762|FG003|Post-treatment Period|Withdrawal by Subject|1|||
48961691|NCT02163993|157689763|FG004|Post-treatment Period|Withdrawal by Subject|2|||
48961692|NCT01626352|157689764|FG000|Overall Study|Disease Progression|3|||
48961693|NCT01626352|157689764|FG000|Overall Study|Intercurrent Illness|2|||
48961694|NCT01626352|157689764|FG000|Overall Study|Death|2|||
48961695|NCT01626352|157689764|FG000|Overall Study|Withdrawal by Subject|1|||
48961696|NCT01626352|157689764|FG000|Overall Study|Non-Compliance|1|||
48961697|NCT01626352|157689764|FG000|Overall Study|Never Treated|1|||
48961698|NCT03583372|157689766|FG000|Overall Study|Withdrawal by Subject|6|||
48961699|NCT03583372|157689767|FG001|Overall Study|Withdrawal by Subject|11|||
48961700|NCT03583372|157689768|FG002|Overall Study|Withdrawal by Subject|7|||
48961701|NCT03583372|157689769|FG003|Overall Study|Withdrawal by Subject|8|||
48961702|NCT03583372|157689766|FG000|Overall Study|Lost to Follow-up|4|||
48961703|NCT03583372|157689767|FG001|Overall Study|Lost to Follow-up|6|||
48961704|NCT03583372|157689768|FG002|Overall Study|Lost to Follow-up|3|||
48961705|NCT03583372|157689769|FG003|Overall Study|Lost to Follow-up|2|||
48961706|NCT03583372|157689766|FG000|Overall Study|Adverse Event|1|||
48961707|NCT03583372|157689767|FG001|Overall Study|Adverse Event|3|||
48961708|NCT03583372|157689768|FG002|Overall Study|Adverse Event|4|||
48961709|NCT03583372|157689769|FG003|Overall Study|Adverse Event|4|||
48961710|NCT03583372|157689766|FG000|Overall Study|Physician Decision|0|||
48961711|NCT03583372|157689767|FG001|Overall Study|Physician Decision|1|||
48961712|NCT03583372|157689768|FG002|Overall Study|Physician Decision|1|||
48961713|NCT03583372|157689769|FG003|Overall Study|Physician Decision|1|||
48961714|NCT03583372|157689766|FG000|Overall Study|Lack of Efficacy|0|||
48961715|NCT03583372|157689767|FG001|Overall Study|Lack of Efficacy|1|||
48961716|NCT03583372|157689768|FG002|Overall Study|Lack of Efficacy|0|||
48961717|NCT03583372|157689769|FG003|Overall Study|Lack of Efficacy|1|||
48961718|NCT03583372|157689766|FG000|Overall Study|Death|1|||
48961719|NCT03583372|157689767|FG001|Overall Study|Death|0|||
48961720|NCT03583372|157689768|FG002|Overall Study|Death|0|||
48961721|NCT03583372|157689769|FG003|Overall Study|Death|0|||
48961722|NCT03583372|157689766|FG000|Overall Study|Protocol Violation|0|||
48961723|NCT03583372|157689767|FG001|Overall Study|Protocol Violation|1|||
48961724|NCT03583372|157689768|FG002|Overall Study|Protocol Violation|0|||
48961725|NCT03583372|157689769|FG003|Overall Study|Protocol Violation|0|||
48961726|NCT03583372|157689766|FG000|Overall Study|Subject Withdrawn due to Sponsor|0|||
48961727|NCT03583372|157689767|FG001|Overall Study|Subject Withdrawn due to Sponsor|0|||
48961728|NCT03583372|157689768|FG002|Overall Study|Subject Withdrawn due to Sponsor|0|||
48961729|NCT03583372|157689769|FG003|Overall Study|Subject Withdrawn due to Sponsor|1|||
48961730|NCT03583372|157689766|FG000|Overall Study|Did Not Receive Study Drug|0|||
48961731|NCT03583372|157689767|FG001|Overall Study|Did Not Receive Study Drug|1|||
48961732|NCT03583372|157689768|FG002|Overall Study|Did Not Receive Study Drug|0|||
48656042|NCT02578680|156595906|FG001|Overall Study|Death|181|||
48656043|NCT02578680|156595905|FG000|Overall Study|Lost to Follow-up|3|||
48656044|NCT02578680|156595906|FG001|Overall Study|Lost to Follow-up|1|||
48656045|NCT02578680|156595905|FG000|Overall Study|Physician Decision|0|||
48656046|NCT02578680|156595906|FG001|Overall Study|Physician Decision|1|||
48656047|NCT02578680|156595905|FG000|Overall Study|Protocol Violation|1|||
48656048|NCT02578680|156595906|FG001|Overall Study|Protocol Violation|1|||
48656049|NCT02578680|156595905|FG000|Overall Study|Sponsor Decision|64|||
48656050|NCT02578680|156595906|FG001|Overall Study|Sponsor Decision|13|||
48656051|NCT02578680|156595905|FG000|Overall Study|Withdrawal by Subject|13|||
48656052|NCT02578680|156595906|FG001|Overall Study|Withdrawal by Subject|9|||
48656053|NCT00882583|156595907|FG000|Overall Study|Physician Decision|1|||
48656054|NCT00882583|156595908|FG001|Overall Study|Physician Decision|0|||
48656055|NCT00882583|156595907|FG000|Overall Study|Adverse Event|0|||
48656056|NCT00882583|156595908|FG001|Overall Study|Adverse Event|1|||
48656057|NCT00516893|156595916|FG000|Overall Study|Lost to Follow-up|4|||
48656058|NCT00516893|156595916|FG000|Overall Study|Adverse Event|3|||
48656059|NCT00516893|156595916|FG000|Overall Study|Withdrawal by Subject|2|||
48961733|NCT03583372|157689769|FG003|Overall Study|Did Not Receive Study Drug|0|||
48961734|NCT03583372|157689766|FG000|Overall Study|Captured as Other in the Database|1|||
48961735|NCT03583372|157689767|FG001|Overall Study|Captured as Other in the Database|2|||
48961736|NCT03583372|157689768|FG002|Overall Study|Captured as Other in the Database|4|||
48961737|NCT03583372|157689769|FG003|Overall Study|Captured as Other in the Database|1|||
48961738|NCT02681055|157689770|FG000|Weeks 5-12|Adverse Event|1|||
48961739|NCT04348656|157689774|FG000|Overall Study|Withdrawal by Subject|2|||
49015423|NCT01890707|157892186|FG000|Overall Study|Lost to Follow-up|1|||
48656060|NCT00516893|156595916|FG000|Overall Study|Noncompliance|2|||
48656061|NCT00516893|156595916|FG000|Overall Study|Death|1|||
48656062|NCT00516893|156595916|FG000|Overall Study|Persistent Antibodies per Protocol|6|||
48656063|NCT00516893|156595916|FG000|Overall Study|Relocated|1|||
48656064|NCT00516893|156595916|FG000|Overall Study|Pregnancy|1|||
48656065|NCT00516893|156595916|FG000|Overall Study|Received Medication From Another Study|1|||
48656066|NCT02596958|156595917|FG000|Overall Study|Serious Adverse Drug Reactions|44|||
48656067|NCT02596958|156595917|FG000|Overall Study|Cancer Progression|441|||
48656068|NCT02596958|156595917|FG000|Overall Study|Death From Cancer|112|||
48656069|NCT02596958|156595917|FG000|Overall Study|Death From Other Cause|33|||
48656070|NCT02596958|156595917|FG000|Overall Study|Refusal of Treatment/Poor Cooperation|61|||
48656071|NCT02596958|156595917|FG000|Overall Study|Administrative Reasons/Other|231|||
48656072|NCT02596958|156595917|FG000|Overall Study|Lost to Follow-up|33|||
48656073|NCT02596958|156595917|FG000|Overall Study|Missing|32|||
48656074|NCT02596958|156595917|FG000|Overall Study|Excluded Due to Second Line Treatment|9|||
48656075|NCT03596047|156595921|FG000|Overall Study|Withdrawal by Subject|7|||
48656076|NCT03596047|156595922|FG001|Overall Study|Withdrawal by Subject|4|||
48656077|NCT03596047|156595921|FG000|Overall Study|Lost to Follow-up|0|||
48656078|NCT03596047|156595922|FG001|Overall Study|Lost to Follow-up|2|||
48656079|NCT03727646|156595923|FG000|Overall Study|Adverse Event|1|||
48656080|NCT03727646|156595924|FG001|Overall Study|Adverse Event|0|||
48656081|NCT05659719|156595925|FG000|Overall Study|At sponsor's request|0|||
48656082|NCT05659719|156595926|FG001|Overall Study|At sponsor's request|0|||
48656083|NCT05659719|156595927|FG002|Overall Study|At sponsor's request|0|||
48656084|NCT05659719|156595928|FG003|Overall Study|At sponsor's request|95|||
48656085|NCT05659719|156595925|FG000|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
48656086|NCT05659719|156595926|FG001|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
48656087|NCT05659719|156595927|FG002|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
48656088|NCT05659719|156595928|FG003|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|1|||
48656089|NCT05659719|156595925|FG000|Overall Study|Inclusion/Exclusion criteria|0|||
48656090|NCT05659719|156595926|FG001|Overall Study|Inclusion/Exclusion criteria|0|||
48656091|NCT05659719|156595927|FG002|Overall Study|Inclusion/Exclusion criteria|0|||
48754514|NCT02111850|156946724|FG005|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
48754515|NCT02111850|156946725|FG006|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
48961740|NCT04348656|157689775|FG001|Overall Study|Withdrawal by Subject|0|||
48961741|NCT04348656|157689774|FG000|Overall Study|Lost to Follow-up|11|||
48961742|NCT04348656|157689775|FG001|Overall Study|Lost to Follow-up|6|||
48961743|NCT04017442|157689776|FG000|Overall Study|Withdrawal by Subject|0|||
48961744|NCT04017442|157689777|FG001|Overall Study|Withdrawal by Subject|3|||
48961745|NCT04017442|157689776|FG000|Overall Study|Lost to Follow-up|21|||
48961746|NCT04017442|157689777|FG001|Overall Study|Lost to Follow-up|19|||
48961747|NCT00643487|157689778|FG000|Overall Study|Technical difficulty|3|||
48656092|NCT05659719|156595928|FG003|Overall Study|Inclusion/Exclusion criteria|5|||
48656093|NCT05659719|156595925|FG000|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
48961748|NCT04402008|157689782|FG000|Overall Study|Adverse Event|0|||
48656094|NCT05659719|156595926|FG001|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
48656095|NCT05659719|156595927|FG002|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
48656096|NCT05659719|156595928|FG003|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|27|||
48656097|NCT05659719|156595925|FG000|Overall Study|Lost to Follow-up|0|||
48656098|NCT05659719|156595926|FG001|Overall Study|Lost to Follow-up|0|||
48656099|NCT05659719|156595927|FG002|Overall Study|Lost to Follow-up|0|||
48656100|NCT05659719|156595928|FG003|Overall Study|Lost to Follow-up|2|||
48656101|NCT05659719|156595925|FG000|Overall Study|Moved to another observational study|0|||
48656102|NCT05659719|156595926|FG001|Overall Study|Moved to another observational study|0|||
48656103|NCT05659719|156595927|FG002|Overall Study|Moved to another observational study|0|||
48656104|NCT05659719|156595928|FG003|Overall Study|Moved to another observational study|1|||
48656105|NCT05659719|156595925|FG000|Overall Study|The child was enrolled in an interventional study|0|||
48656106|NCT05659719|156595926|FG001|Overall Study|The child was enrolled in an interventional study|0|||
48656107|NCT05659719|156595927|FG002|Overall Study|The child was enrolled in an interventional study|0|||
48656108|NCT05659719|156595928|FG003|Overall Study|The child was enrolled in an interventional study|55|||
48656109|NCT05659719|156595925|FG000|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
48656110|NCT05659719|156595926|FG001|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
48656111|NCT05659719|156595927|FG002|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
48656112|NCT05659719|156595928|FG003|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|1|||
48656113|NCT05659719|156595925|FG000|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
48961749|NCT04402008|157689783|FG001|Overall Study|Adverse Event|0|||
48961750|NCT04402008|157689784|FG002|Overall Study|Adverse Event|0|||
48961751|NCT04402008|157689785|FG003|Overall Study|Adverse Event|1|||
48961752|NCT04402008|157689786|FG004|Overall Study|Adverse Event|0|||
48961753|NCT04402008|157689787|FG005|Overall Study|Adverse Event|0|||
48961754|NCT04402008|157689788|FG006|Overall Study|Adverse Event|0|||
48961755|NCT04402008|157689782|FG000|Overall Study|Disease Progression|3|||
48961756|NCT04402008|157689783|FG001|Overall Study|Disease Progression|2|||
48961757|NCT04402008|157689784|FG002|Overall Study|Disease Progression|3|||
48961758|NCT04402008|157689785|FG003|Overall Study|Disease Progression|3|||
48961759|NCT04402008|157689786|FG004|Overall Study|Disease Progression|4|||
48961760|NCT04402008|157689787|FG005|Overall Study|Disease Progression|3|||
48961761|NCT04402008|157689788|FG006|Overall Study|Disease Progression|10|||
48961762|NCT04402008|157689782|FG000|Overall Study|Withdrawal by Subject|0|||
48961763|NCT04402008|157689783|FG001|Overall Study|Withdrawal by Subject|1|||
48961764|NCT04402008|157689784|FG002|Overall Study|Withdrawal by Subject|0|||
48961765|NCT04402008|157689785|FG003|Overall Study|Withdrawal by Subject|0|||
48961766|NCT04402008|157689786|FG004|Overall Study|Withdrawal by Subject|1|||
48961767|NCT04402008|157689787|FG005|Overall Study|Withdrawal by Subject|0|||
48961768|NCT04402008|157689788|FG006|Overall Study|Withdrawal by Subject|0|||
48961769|NCT04402008|157689782|FG000|Overall Study|Sponsor Decision|0|||
48961770|NCT04402008|157689783|FG001|Overall Study|Sponsor Decision|0|||
48961771|NCT04402008|157689784|FG002|Overall Study|Sponsor Decision|0|||
48754516|NCT02111850|156946726|FG007|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
48754517|NCT02111850|156946727|FG008|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
48754518|NCT02111850|156946728|FG009|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
48754519|NCT02111850|156946729|FG010|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
48754520|NCT04772755|156946730|FG000|Overall Study|Withdrawal by Subject|1|||
48754521|NCT04772755|156946731|FG001|Overall Study|Withdrawal by Subject|0|||
48754522|NCT04772755|156946730|FG000|Overall Study|Randomized and subsequently determined to be ineligible|2|||
48961772|NCT04402008|157689785|FG003|Overall Study|Sponsor Decision|0|||
48961773|NCT04402008|157689786|FG004|Overall Study|Sponsor Decision|0|||
48961774|NCT04402008|157689787|FG005|Overall Study|Sponsor Decision|0|||
48961775|NCT04402008|157689788|FG006|Overall Study|Sponsor Decision|3|||
48961776|NCT04402008|157689782|FG000|Overall Study|Death|0|||
48961777|NCT04402008|157689783|FG001|Overall Study|Death|0|||
48961778|NCT04402008|157689784|FG002|Overall Study|Death|0|||
48961779|NCT04402008|157689785|FG003|Overall Study|Death|0|||
48961780|NCT04402008|157689786|FG004|Overall Study|Death|1|||
48961781|NCT04402008|157689787|FG005|Overall Study|Death|0|||
48961782|NCT04402008|157689788|FG006|Overall Study|Death|2|||
48754523|NCT04772755|156946731|FG001|Overall Study|Randomized and subsequently determined to be ineligible|3|||
48754524|NCT01189812|156946735|FG000|Overall Study|Withdrawal by Subject|2|||
48754525|NCT01189812|156946736|FG001|Overall Study|Withdrawal by Subject|3|||
48754526|NCT01189812|156946735|FG000|Overall Study|Adverse Event|1|||
48754527|NCT01189812|156946736|FG001|Overall Study|Adverse Event|0|||
48754528|NCT01189812|156946735|FG000|Overall Study|Out of Window|4|||
48961783|NCT04402008|157689782|FG000|Overall Study|Other|0|||
48961784|NCT04402008|157689783|FG001|Overall Study|Other|0|||
48961785|NCT04402008|157689784|FG002|Overall Study|Other|0|||
48961786|NCT04402008|157689785|FG003|Overall Study|Other|0|||
48961787|NCT04402008|157689786|FG004|Overall Study|Other|0|||
48961788|NCT04402008|157689787|FG005|Overall Study|Other|0|||
48961789|NCT04402008|157689788|FG006|Overall Study|Other|5|||
48656114|NCT05659719|156595926|FG001|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
48656115|NCT05659719|156595927|FG002|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
48656116|NCT05659719|156595928|FG003|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|2|||
48656117|NCT00185380|156595936|FG000|Overall Study|Adverse Event|41|||
48656118|NCT00185380|156595937|FG001|Overall Study|Adverse Event|43|||
48656119|NCT00185380|156595938|FG002|Overall Study|Adverse Event|48|||
48656120|NCT00185380|156595936|FG000|Overall Study|Lost to Follow-up|0|||
48656121|NCT00185380|156595937|FG001|Overall Study|Lost to Follow-up|4|||
48656122|NCT00185380|156595938|FG002|Overall Study|Lost to Follow-up|3|||
48656123|NCT00185380|156595936|FG000|Overall Study|Pregnancy|1|||
48656124|NCT00185380|156595937|FG001|Overall Study|Pregnancy|4|||
48656125|NCT00185380|156595938|FG002|Overall Study|Pregnancy|0|||
48656126|NCT00185380|156595936|FG000|Overall Study|Protocol Violation|2|||
48656127|NCT00185380|156595937|FG001|Overall Study|Protocol Violation|2|||
48656128|NCT00185380|156595938|FG002|Overall Study|Protocol Violation|1|||
48656129|NCT00185380|156595936|FG000|Overall Study|Withdrawal by Subject|1|||
48656130|NCT00185380|156595937|FG001|Overall Study|Withdrawal by Subject|2|||
48754529|NCT01189812|156946736|FG001|Overall Study|Out of Window|3|||
48961790|NCT02586233|157689791|FG000|Overall Study|Randomized but did not receive treatment|0|||
48961791|NCT02586233|157689792|FG001|Overall Study|Randomized but did not receive treatment|1|||
48961792|NCT02586233|157689793|FG002|Overall Study|Randomized but did not receive treatment|0|||
48961793|NCT02586233|157689794|FG003|Overall Study|Randomized but did not receive treatment|0|||
48961794|NCT02586233|157689795|FG004|Overall Study|Randomized but did not receive treatment|0|||
48961795|NCT02586233|157689796|FG005|Overall Study|Randomized but did not receive treatment|2|||
49015424|NCT01890707|157892187|FG001|Overall Study|Lost to Follow-up|1|||
48961796|NCT02586233|157689797|FG006|Overall Study|Randomized but did not receive treatment|2|||
48961797|NCT02586233|157689791|FG000|Overall Study|Death|0|||
48961798|NCT02586233|157689792|FG001|Overall Study|Death|1|||
48961799|NCT02586233|157689793|FG002|Overall Study|Death|0|||
48961800|NCT02586233|157689794|FG003|Overall Study|Death|0|||
48961801|NCT02586233|157689795|FG004|Overall Study|Death|2|||
48961802|NCT02586233|157689796|FG005|Overall Study|Death|0|||
48961803|NCT02586233|157689797|FG006|Overall Study|Death|0|||
48961804|NCT00937560|157689800|FG000|Initial Treatment|Death|6|||
48961805|NCT00937560|157689800|FG000|Initial Treatment|Withdraw consent|3|||
48961806|NCT00937560|157689800|FG000|Initial Treatment|Adverse Event|1|||
48961807|NCT00937560|157689800|FG000|Initial Treatment|Lost to Follow-up|1|||
48961808|NCT00937560|157689800|FG000|Initial Treatment|No end of study page|10|||
48961809|NCT00937560|157689800|FG000|Maintenance Treatment|Death|12|||
48961810|NCT00937560|157689800|FG000|Maintenance Treatment|Withdraw consent|5|||
48961811|NCT00937560|157689800|FG000|Maintenance Treatment|According to protocol|1|||
48961812|NCT00579501|157689807|FG000|Overall Study|Death|1|||
48961813|NCT00579501|157689807|FG000|Overall Study|End of neoadjuvant therapy|25|||
48961814|NCT00579501|157689807|FG000|Overall Study|toxicity|1|||
48961815|NCT00579501|157689807|FG000|Overall Study|Secondary lesion|1|||
48961816|NCT00579501|157689807|FG000|Overall Study|Radiation therapy before surgery|1|||
48961817|NCT01089582|157689808|FG000|Overall Study|Death|2|||
48961818|NCT01089582|157689808|FG000|Overall Study|Adverse Event|15|||
48961819|NCT01089582|157689808|FG000|Overall Study|Lost to Follow-up|8|||
48961820|NCT01089582|157689808|FG000|Overall Study|Other|4|||
48961821|NCT01089582|157689808|FG000|Overall Study|Withdrawal by Subject|1|||
48961822|NCT02232087|157689809|FG000|Overall Study|Withdrawal by Subject|2|||
48961823|NCT02232087|157689810|FG001|Overall Study|Withdrawal by Subject|0|||
48961824|NCT02232087|157689811|FG002|Overall Study|Withdrawal by Subject|0|||
48961825|NCT02232087|157689812|FG003|Overall Study|Withdrawal by Subject|0|||
48961826|NCT02232087|157689813|FG004|Overall Study|Withdrawal by Subject|0|||
48961827|NCT02232087|157689814|FG005|Overall Study|Withdrawal by Subject|1|||
48961828|NCT02232087|157689809|FG000|Overall Study|poor inhalation technique|0|||
48961829|NCT02232087|157689810|FG001|Overall Study|poor inhalation technique|1|||
48961830|NCT02232087|157689811|FG002|Overall Study|poor inhalation technique|0|||
48656131|NCT00185380|156595938|FG002|Overall Study|Withdrawal by Subject|0|||
48656132|NCT00185380|156595936|FG000|Overall Study|Failed insertion|1|||
48656133|NCT00185380|156595937|FG001|Overall Study|Failed insertion|1|||
48656134|NCT00185380|156595938|FG002|Overall Study|Failed insertion|2|||
48656135|NCT00185380|156595936|FG000|Overall Study|Planned pregnancy|9|||
48656136|NCT00185380|156595937|FG001|Overall Study|Planned pregnancy|12|||
48656137|NCT00185380|156595938|FG002|Overall Study|Planned pregnancy|12|||
48656138|NCT00185380|156595936|FG000|Overall Study|No need for contraception|3|||
48656139|NCT00185380|156595937|FG001|Overall Study|No need for contraception|3|||
48656140|NCT00185380|156595938|FG002|Overall Study|No need for contraception|3|||
48656141|NCT00185380|156595936|FG000|Overall Study|Could not attend visits|2|||
48656142|NCT00185380|156595937|FG001|Overall Study|Could not attend visits|0|||
48656143|NCT00185380|156595938|FG002|Overall Study|Could not attend visits|4|||
48656144|NCT00185380|156595936|FG000|Overall Study|personal reason|6|||
48656145|NCT00185380|156595937|FG001|Overall Study|personal reason|1|||
48656146|NCT00185380|156595938|FG002|Overall Study|personal reason|1|||
48656147|NCT02589665|156595939|FG000|Induction Period|Did not receive drug|0|||
48656148|NCT02589665|156595940|FG001|Induction Period|Did not receive drug|0|||
48656149|NCT02589665|156595941|FG002|Induction Period|Did not receive drug|0|||
48656150|NCT02589665|156595942|FG003|Induction Period|Did not receive drug|1|||
48656151|NCT02589665|156595943|FG004|Induction Period|Did not receive drug|0|||
48656152|NCT02589665|156595944|FG005|Induction Period|Did not receive drug|0|||
48656153|NCT02589665|156595945|FG006|Induction Period|Did not receive drug|0|||
48656154|NCT02589665|156595946|FG007|Induction Period|Did not receive drug|0|||
48656155|NCT02589665|156595947|FG008|Induction Period|Did not receive drug|0|||
48656156|NCT02589665|156595948|FG009|Induction Period|Did not receive drug|0|||
48656157|NCT02589665|156595939|FG000|Induction Period|Adverse Event|3|||
48656158|NCT02589665|156595940|FG001|Induction Period|Adverse Event|0|||
48656159|NCT02589665|156595941|FG002|Induction Period|Adverse Event|2|||
48961831|NCT02232087|157689812|FG003|Overall Study|poor inhalation technique|0|||
48961832|NCT02232087|157689813|FG004|Overall Study|poor inhalation technique|0|||
48961833|NCT02232087|157689814|FG005|Overall Study|poor inhalation technique|2|||
48961834|NCT02232087|157689809|FG000|Overall Study|protocol stop criteria|0|||
48961835|NCT02232087|157689810|FG001|Overall Study|protocol stop criteria|1|||
48961836|NCT02232087|157689811|FG002|Overall Study|protocol stop criteria|0|||
48961837|NCT02232087|157689812|FG003|Overall Study|protocol stop criteria|1|||
48961838|NCT02232087|157689813|FG004|Overall Study|protocol stop criteria|0|||
48961839|NCT02232087|157689814|FG005|Overall Study|protocol stop criteria|0|||
48961840|NCT02232087|157689809|FG000|Overall Study|Adverse Event|0|||
48656160|NCT02589665|156595942|FG003|Induction Period|Adverse Event|2|||
48656161|NCT02589665|156595943|FG004|Induction Period|Adverse Event|0|||
48656162|NCT02589665|156595944|FG005|Induction Period|Adverse Event|0|||
48961841|NCT02232087|157689810|FG001|Overall Study|Adverse Event|0|||
48961842|NCT02232087|157689811|FG002|Overall Study|Adverse Event|0|||
48961843|NCT02232087|157689812|FG003|Overall Study|Adverse Event|0|||
48961844|NCT02232087|157689813|FG004|Overall Study|Adverse Event|1|||
48961845|NCT02232087|157689814|FG005|Overall Study|Adverse Event|0|||
48961846|NCT02208024|157689815|FG000|Overall Study|Withdrawal by Subject|1|||
48961847|NCT00779324|157689816|FG000|Overall Study|Lost to Follow-up|2|||
48961848|NCT00779324|157689817|FG001|Overall Study|Lost to Follow-up|1|||
48961849|NCT00779324|157689816|FG000|Overall Study|Withdrawal by Subject|4|||
48961850|NCT00779324|157689817|FG001|Overall Study|Withdrawal by Subject|2|||
48961851|NCT00779324|157689816|FG000|Overall Study|Missed visit|1|||
48961852|NCT00779324|157689817|FG001|Overall Study|Missed visit|1|||
48961853|NCT04096326|157689818|FG000|Overall Study|Withdrawal by Subject|0|||
48961854|NCT04096326|157689819|FG001|Overall Study|Withdrawal by Subject|0|||
48961855|NCT04096326|157689820|FG002|Overall Study|Withdrawal by Subject|0|||
48961856|NCT04096326|157689821|FG003|Overall Study|Withdrawal by Subject|0|||
48961857|NCT04096326|157689822|FG004|Overall Study|Withdrawal by Subject|0|||
48961858|NCT04096326|157689823|FG005|Overall Study|Withdrawal by Subject|0|||
48656163|NCT02589665|156595945|FG006|Induction Period|Adverse Event|0|||
48656164|NCT02589665|156595946|FG007|Induction Period|Adverse Event|0|||
48656165|NCT02589665|156595947|FG008|Induction Period|Adverse Event|0|||
48656166|NCT02589665|156595948|FG009|Induction Period|Adverse Event|0|||
48656167|NCT02589665|156595939|FG000|Induction Period|Withdrawal by Subject|0|||
48656168|NCT02589665|156595940|FG001|Induction Period|Withdrawal by Subject|1|||
48656169|NCT02589665|156595941|FG002|Induction Period|Withdrawal by Subject|0|||
48656170|NCT02589665|156595942|FG003|Induction Period|Withdrawal by Subject|1|||
48656171|NCT02589665|156595943|FG004|Induction Period|Withdrawal by Subject|0|||
48656172|NCT02589665|156595944|FG005|Induction Period|Withdrawal by Subject|0|||
48656173|NCT02589665|156595945|FG006|Induction Period|Withdrawal by Subject|0|||
48656174|NCT02589665|156595946|FG007|Induction Period|Withdrawal by Subject|0|||
48656175|NCT02589665|156595947|FG008|Induction Period|Withdrawal by Subject|0|||
48656176|NCT02589665|156595948|FG009|Induction Period|Withdrawal by Subject|0|||
48656177|NCT02589665|156595939|FG000|Induction Period|Protocol Violation|0|||
48656178|NCT02589665|156595940|FG001|Induction Period|Protocol Violation|1|||
48656179|NCT02589665|156595941|FG002|Induction Period|Protocol Violation|0|||
48656180|NCT02589665|156595942|FG003|Induction Period|Protocol Violation|0|||
48656181|NCT02589665|156595943|FG004|Induction Period|Protocol Violation|0|||
48656182|NCT02589665|156595944|FG005|Induction Period|Protocol Violation|0|||
48656183|NCT02589665|156595945|FG006|Induction Period|Protocol Violation|0|||
48656184|NCT02589665|156595946|FG007|Induction Period|Protocol Violation|0|||
48656185|NCT02589665|156595947|FG008|Induction Period|Protocol Violation|0|||
48656186|NCT02589665|156595948|FG009|Induction Period|Protocol Violation|0|||
48656187|NCT02589665|156595939|FG000|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
48656188|NCT02589665|156595940|FG001|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
48656189|NCT02589665|156595941|FG002|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
48656190|NCT02589665|156595942|FG003|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
48656191|NCT02589665|156595943|FG004|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7|||
48656192|NCT02589665|156595944|FG005|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41|||
48656193|NCT02589665|156595945|FG006|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39|||
48656194|NCT02589665|156595946|FG007|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
48656195|NCT02589665|156595947|FG008|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
48656196|NCT02589665|156595948|FG009|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
48656197|NCT02589665|156595939|FG000|Maintenance Period|Withdrawal by Subject|0|||
48656198|NCT02589665|156595940|FG001|Maintenance Period|Withdrawal by Subject|0|||
48656199|NCT02589665|156595941|FG002|Maintenance Period|Withdrawal by Subject|0|||
48656200|NCT02589665|156595942|FG003|Maintenance Period|Withdrawal by Subject|0|||
48961859|NCT04096326|157689824|FG006|Overall Study|Withdrawal by Subject|1|||
48656201|NCT02589665|156595943|FG004|Maintenance Period|Withdrawal by Subject|4|||
48656202|NCT02589665|156595944|FG005|Maintenance Period|Withdrawal by Subject|2|||
48656203|NCT02589665|156595945|FG006|Maintenance Period|Withdrawal by Subject|4|||
48656204|NCT02589665|156595946|FG007|Maintenance Period|Withdrawal by Subject|0|||
48656205|NCT02589665|156595947|FG008|Maintenance Period|Withdrawal by Subject|0|||
48656206|NCT02589665|156595948|FG009|Maintenance Period|Withdrawal by Subject|0|||
48656207|NCT02589665|156595939|FG000|Maintenance Period|Lack of Efficacy|0|||
48656208|NCT02589665|156595940|FG001|Maintenance Period|Lack of Efficacy|0|||
48656209|NCT02589665|156595941|FG002|Maintenance Period|Lack of Efficacy|0|||
48656210|NCT02589665|156595942|FG003|Maintenance Period|Lack of Efficacy|0|||
48656211|NCT02589665|156595943|FG004|Maintenance Period|Lack of Efficacy|2|||
48656212|NCT02589665|156595944|FG005|Maintenance Period|Lack of Efficacy|1|||
48961860|NCT04096326|157689825|FG007|Overall Study|Withdrawal by Subject|0|||
48961861|NCT04096326|157689826|FG008|Overall Study|Withdrawal by Subject|0|||
48656213|NCT02589665|156595945|FG006|Maintenance Period|Lack of Efficacy|0|||
48656214|NCT02589665|156595946|FG007|Maintenance Period|Lack of Efficacy|0|||
48656215|NCT02589665|156595947|FG008|Maintenance Period|Lack of Efficacy|0|||
48961862|NCT04096326|157689827|FG009|Overall Study|Withdrawal by Subject|0|||
48961863|NCT04096326|157689818|FG000|Overall Study|Lost to Follow-up|0|||
48961864|NCT04096326|157689819|FG001|Overall Study|Lost to Follow-up|1|||
48961865|NCT04096326|157689820|FG002|Overall Study|Lost to Follow-up|0|||
48961866|NCT04096326|157689821|FG003|Overall Study|Lost to Follow-up|0|||
48961867|NCT04096326|157689822|FG004|Overall Study|Lost to Follow-up|0|||
48961868|NCT04096326|157689823|FG005|Overall Study|Lost to Follow-up|0|||
48961869|NCT04096326|157689824|FG006|Overall Study|Lost to Follow-up|0|||
48961870|NCT04096326|157689825|FG007|Overall Study|Lost to Follow-up|0|||
48961871|NCT04096326|157689826|FG008|Overall Study|Lost to Follow-up|0|||
48961872|NCT04096326|157689827|FG009|Overall Study|Lost to Follow-up|0|||
48961873|NCT04096326|157689818|FG000|Overall Study|COVID-19-related reasons|0|||
48961874|NCT04096326|157689819|FG001|Overall Study|COVID-19-related reasons|0|||
48961875|NCT04096326|157689820|FG002|Overall Study|COVID-19-related reasons|0|||
48961876|NCT04096326|157689821|FG003|Overall Study|COVID-19-related reasons|0|||
48961877|NCT04096326|157689822|FG004|Overall Study|COVID-19-related reasons|1|||
48961878|NCT04096326|157689823|FG005|Overall Study|COVID-19-related reasons|5|||
48961879|NCT04096326|157689824|FG006|Overall Study|COVID-19-related reasons|0|||
48961880|NCT04096326|157689825|FG007|Overall Study|COVID-19-related reasons|0|||
48961881|NCT04096326|157689826|FG008|Overall Study|COVID-19-related reasons|0|||
48961882|NCT04096326|157689827|FG009|Overall Study|COVID-19-related reasons|0|||
48961883|NCT01106625|157689830|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
48961884|NCT01106625|157689831|FG001|Core Period: Baseline to Week 26|Adverse Event|8|||
48961885|NCT01106625|157689832|FG002|Core Period: Baseline to Week 26|Adverse Event|8|||
48961886|NCT01106625|157689830|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
48961887|NCT01106625|157689831|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
48961888|NCT01106625|157689832|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|4|||
48961889|NCT01106625|157689830|FG000|Core Period: Baseline to Week 26|Physician Decision|1|||
48961890|NCT01106625|157689831|FG001|Core Period: Baseline to Week 26|Physician Decision|0|||
48961891|NCT01106625|157689832|FG002|Core Period: Baseline to Week 26|Physician Decision|0|||
48961892|NCT01106625|157689830|FG000|Core Period: Baseline to Week 26|Protocol Violation|2|||
48961893|NCT01106625|157689831|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
48961894|NCT01106625|157689832|FG002|Core Period: Baseline to Week 26|Protocol Violation|3|||
48961895|NCT01106625|157689830|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
48961896|NCT01106625|157689831|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
48961897|NCT01106625|157689832|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|7|||
48656216|NCT02589665|156595948|FG009|Maintenance Period|Lack of Efficacy|0|||
48656217|NCT02589665|156595939|FG000|Maintenance Period|Adverse Event|0|||
48656218|NCT02589665|156595940|FG001|Maintenance Period|Adverse Event|0|||
48656219|NCT02589665|156595941|FG002|Maintenance Period|Adverse Event|0|||
48656220|NCT02589665|156595942|FG003|Maintenance Period|Adverse Event|0|||
48656221|NCT02589665|156595943|FG004|Maintenance Period|Adverse Event|0|||
48656222|NCT02589665|156595944|FG005|Maintenance Period|Adverse Event|0|||
48656223|NCT02589665|156595945|FG006|Maintenance Period|Adverse Event|2|||
48656224|NCT02589665|156595946|FG007|Maintenance Period|Adverse Event|0|||
48656225|NCT02589665|156595947|FG008|Maintenance Period|Adverse Event|0|||
48656226|NCT02589665|156595948|FG009|Maintenance Period|Adverse Event|0|||
48656227|NCT02589665|156595939|FG000|Maintenance Period|Lost to Follow-up|0|||
48656228|NCT02589665|156595940|FG001|Maintenance Period|Lost to Follow-up|0|||
48656229|NCT02589665|156595941|FG002|Maintenance Period|Lost to Follow-up|0|||
48656230|NCT02589665|156595942|FG003|Maintenance Period|Lost to Follow-up|0|||
48656231|NCT02589665|156595943|FG004|Maintenance Period|Lost to Follow-up|0|||
48656232|NCT02589665|156595944|FG005|Maintenance Period|Lost to Follow-up|1|||
48656233|NCT02589665|156595945|FG006|Maintenance Period|Lost to Follow-up|0|||
48656234|NCT02589665|156595946|FG007|Maintenance Period|Lost to Follow-up|0|||
48656235|NCT02589665|156595947|FG008|Maintenance Period|Lost to Follow-up|0|||
48656236|NCT02589665|156595948|FG009|Maintenance Period|Lost to Follow-up|0|||
48656237|NCT02589665|156595939|FG000|Maintenance Period|Physician Decision|0|||
48656238|NCT02589665|156595940|FG001|Maintenance Period|Physician Decision|0|||
48656239|NCT02589665|156595941|FG002|Maintenance Period|Physician Decision|0|||
48656240|NCT02589665|156595942|FG003|Maintenance Period|Physician Decision|0|||
48656241|NCT02589665|156595943|FG004|Maintenance Period|Physician Decision|0|||
48656242|NCT02589665|156595944|FG005|Maintenance Period|Physician Decision|1|||
48656243|NCT02589665|156595945|FG006|Maintenance Period|Physician Decision|0|||
48656244|NCT02589665|156595946|FG007|Maintenance Period|Physician Decision|0|||
48656245|NCT02589665|156595947|FG008|Maintenance Period|Physician Decision|0|||
48656246|NCT02589665|156595948|FG009|Maintenance Period|Physician Decision|0|||
48656247|NCT02589665|156595939|FG000|Maintenance Period|Reason Not Collected|0|||
48656248|NCT02589665|156595940|FG001|Maintenance Period|Reason Not Collected|0|||
48656249|NCT02589665|156595941|FG002|Maintenance Period|Reason Not Collected|0|||
48656250|NCT02589665|156595942|FG003|Maintenance Period|Reason Not Collected|0|||
48656251|NCT02589665|156595943|FG004|Maintenance Period|Reason Not Collected|0|||
48656252|NCT02589665|156595944|FG005|Maintenance Period|Reason Not Collected|1|||
48961898|NCT01106625|157689830|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|4|||
48656253|NCT02589665|156595945|FG006|Maintenance Period|Reason Not Collected|1|||
48961899|NCT01106625|157689831|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
48961900|NCT01106625|157689832|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
48961901|NCT01106625|157689830|FG000|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0|||
48961902|NCT01106625|157689831|FG001|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
48961903|NCT01106625|157689832|FG002|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
48961904|NCT01106625|157689830|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
48961905|NCT01106625|157689831|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
48961906|NCT01106625|157689832|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
48961907|NCT01106625|157689830|FG000|Core Period: Baseline to Week 26|Other|8|||
48961908|NCT01106625|157689831|FG001|Core Period: Baseline to Week 26|Other|7|||
48961909|NCT01106625|157689832|FG002|Core Period: Baseline to Week 26|Other|4|||
48961910|NCT01106625|157689830|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
48961911|NCT01106625|157689831|FG001|Extension Period: Week 26 to Week 52|Adverse Event|2|||
48961912|NCT01106625|157689832|FG002|Extension Period: Week 26 to Week 52|Adverse Event|3|||
48961913|NCT01106625|157689830|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
48961914|NCT01106625|157689831|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|3|||
48961915|NCT01106625|157689832|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
48961916|NCT01106625|157689830|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
48961917|NCT01106625|157689831|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
48961918|NCT01106625|157689832|FG002|Extension Period: Week 26 to Week 52|Physician Decision|1|||
48961919|NCT01106625|157689830|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
48656254|NCT02589665|156595946|FG007|Maintenance Period|Reason Not Collected|0|||
48656255|NCT02589665|156595947|FG008|Maintenance Period|Reason Not Collected|0|||
48656256|NCT02589665|156595948|FG009|Maintenance Period|Reason Not Collected|0|||
48656257|NCT02589665|156595939|FG000|Induction Extension Period|Adverse Event|0|||
48656258|NCT02589665|156595940|FG001|Induction Extension Period|Adverse Event|0|||
48656259|NCT02589665|156595941|FG002|Induction Extension Period|Adverse Event|0|||
48656260|NCT02589665|156595942|FG003|Induction Extension Period|Adverse Event|0|||
48656261|NCT02589665|156595943|FG004|Induction Extension Period|Adverse Event|0|||
48656262|NCT02589665|156595944|FG005|Induction Extension Period|Adverse Event|0|||
48656263|NCT02589665|156595945|FG006|Induction Extension Period|Adverse Event|0|||
48656264|NCT02589665|156595946|FG007|Induction Extension Period|Adverse Event|0|||
48656265|NCT02589665|156595947|FG008|Induction Extension Period|Adverse Event|4|||
48656266|NCT02589665|156595948|FG009|Induction Extension Period|Adverse Event|0|||
48656267|NCT02589665|156595939|FG000|Induction Extension Period|Lack of Efficacy|0|||
48656268|NCT02589665|156595940|FG001|Induction Extension Period|Lack of Efficacy|0|||
48656269|NCT02589665|156595941|FG002|Induction Extension Period|Lack of Efficacy|0|||
48656270|NCT02589665|156595942|FG003|Induction Extension Period|Lack of Efficacy|0|||
48656271|NCT02589665|156595943|FG004|Induction Extension Period|Lack of Efficacy|0|||
48656272|NCT02589665|156595944|FG005|Induction Extension Period|Lack of Efficacy|0|||
48656273|NCT02589665|156595945|FG006|Induction Extension Period|Lack of Efficacy|0|||
48656274|NCT02589665|156595946|FG007|Induction Extension Period|Lack of Efficacy|0|||
48961920|NCT01106625|157689831|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
48656275|NCT02589665|156595947|FG008|Induction Extension Period|Lack of Efficacy|3|||
48656276|NCT02589665|156595948|FG009|Induction Extension Period|Lack of Efficacy|0|||
48656277|NCT02589665|156595939|FG000|Induction Extension Period|Withdrawal by Subject|0|||
48656278|NCT02589665|156595940|FG001|Induction Extension Period|Withdrawal by Subject|0|||
48656279|NCT02589665|156595941|FG002|Induction Extension Period|Withdrawal by Subject|0|||
48656280|NCT02589665|156595942|FG003|Induction Extension Period|Withdrawal by Subject|0|||
48656281|NCT02589665|156595943|FG004|Induction Extension Period|Withdrawal by Subject|0|||
48656282|NCT02589665|156595944|FG005|Induction Extension Period|Withdrawal by Subject|0|||
48656283|NCT02589665|156595945|FG006|Induction Extension Period|Withdrawal by Subject|0|||
48656284|NCT02589665|156595946|FG007|Induction Extension Period|Withdrawal by Subject|2|||
48656285|NCT02589665|156595947|FG008|Induction Extension Period|Withdrawal by Subject|3|||
48656286|NCT02589665|156595948|FG009|Induction Extension Period|Withdrawal by Subject|0|||
48656287|NCT02589665|156595939|FG000|Induction Extension Period|Physician Decision|0|||
48656288|NCT02589665|156595940|FG001|Induction Extension Period|Physician Decision|0|||
48656289|NCT02589665|156595941|FG002|Induction Extension Period|Physician Decision|0|||
48656290|NCT02589665|156595942|FG003|Induction Extension Period|Physician Decision|0|||
48656291|NCT02589665|156595943|FG004|Induction Extension Period|Physician Decision|0|||
48656292|NCT02589665|156595944|FG005|Induction Extension Period|Physician Decision|0|||
48656293|NCT02589665|156595945|FG006|Induction Extension Period|Physician Decision|0|||
48961921|NCT01106625|157689832|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
48656294|NCT02589665|156595946|FG007|Induction Extension Period|Physician Decision|0|||
48656295|NCT02589665|156595947|FG008|Induction Extension Period|Physician Decision|1|||
48656296|NCT02589665|156595948|FG009|Induction Extension Period|Physician Decision|0|||
48656297|NCT02589665|156595939|FG000|Induction Extension Period|Reason Not Collected|0|||
48656298|NCT02589665|156595940|FG001|Induction Extension Period|Reason Not Collected|0|||
48961922|NCT01106625|157689830|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4|||
48961923|NCT01106625|157689831|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
48961924|NCT01106625|157689832|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
48961925|NCT01106625|157689830|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14|||
48961926|NCT01106625|157689831|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5|||
48961927|NCT01106625|157689832|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4|||
48961928|NCT01106625|157689830|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
48961929|NCT01106625|157689831|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
48961930|NCT01106625|157689832|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
48961931|NCT01106625|157689830|FG000|Extension Period: Week 26 to Week 52|Other|5|||
48961932|NCT01106625|157689831|FG001|Extension Period: Week 26 to Week 52|Other|5|||
48961933|NCT01106625|157689832|FG002|Extension Period: Week 26 to Week 52|Other|4|||
48961934|NCT00844649|157689841|FG000|Overall Study|Progressive Disease|196|||
48961935|NCT00844649|157689842|FG001|Overall Study|Progressive Disease|245|||
48961936|NCT00844649|157689841|FG000|Overall Study|Adverse Event|128|||
48961937|NCT00844649|157689842|FG001|Overall Study|Adverse Event|73|||
48961938|NCT00844649|157689841|FG000|Overall Study|Physician Decision|25|||
48961939|NCT00844649|157689842|FG001|Overall Study|Physician Decision|18|||
48961940|NCT00844649|157689841|FG000|Overall Study|Protocol Violation|10|||
48961941|NCT00844649|157689842|FG001|Overall Study|Protocol Violation|6|||
48961942|NCT00844649|157689841|FG000|Overall Study|Withdrawal by Subject|28|||
48656299|NCT02589665|156595941|FG002|Induction Extension Period|Reason Not Collected|0|||
48656300|NCT02589665|156595942|FG003|Induction Extension Period|Reason Not Collected|0|||
48656301|NCT02589665|156595943|FG004|Induction Extension Period|Reason Not Collected|0|||
48656302|NCT02589665|156595944|FG005|Induction Extension Period|Reason Not Collected|0|||
48656303|NCT02589665|156595945|FG006|Induction Extension Period|Reason Not Collected|0|||
48656304|NCT02589665|156595946|FG007|Induction Extension Period|Reason Not Collected|0|||
48961943|NCT00844649|157689842|FG001|Overall Study|Withdrawal by Subject|39|||
48961944|NCT00844649|157689841|FG000|Overall Study|Other|7|||
48961945|NCT00844649|157689842|FG001|Overall Study|Other|10|||
48961946|NCT00844649|157689841|FG000|Overall Study|Withdrew prior to starting treatment|11|||
48961947|NCT00844649|157689842|FG001|Overall Study|Withdrew prior to starting treatment|27|||
48961948|NCT00077610|157689844|FG000|Overall Study|Adverse Event|9|||
48961949|NCT00077610|157689845|FG001|Overall Study|Adverse Event|7|||
48961950|NCT00077610|157689846|FG002|Overall Study|Adverse Event|1|||
48961951|NCT00077610|157689844|FG000|Overall Study|Lost to Follow-up|0|||
48961952|NCT00077610|157689845|FG001|Overall Study|Lost to Follow-up|1|||
48961953|NCT00077610|157689846|FG002|Overall Study|Lost to Follow-up|2|||
48961954|NCT00077610|157689844|FG000|Overall Study|Withdrawal by Subject|4|||
48961955|NCT00077610|157689845|FG001|Overall Study|Withdrawal by Subject|10|||
48961956|NCT00077610|157689846|FG002|Overall Study|Withdrawal by Subject|6|||
48961957|NCT00077610|157689844|FG000|Overall Study|Death|17|||
48961958|NCT00077610|157689845|FG001|Overall Study|Death|13|||
48961959|NCT00077610|157689846|FG002|Overall Study|Death|13|||
48961960|NCT00077610|157689844|FG000|Overall Study|Renal transplant|12|||
48961961|NCT00077610|157689845|FG001|Overall Study|Renal transplant|15|||
48961962|NCT00077610|157689846|FG002|Overall Study|Renal transplant|11|||
48961963|NCT00077610|157689844|FG000|Overall Study|Withdrew from dialysis care|5|||
48961964|NCT00077610|157689845|FG001|Overall Study|Withdrew from dialysis care|0|||
48961965|NCT00077610|157689846|FG002|Overall Study|Withdrew from dialysis care|3|||
48961966|NCT00077610|157689844|FG000|Overall Study|Insufficient Therapeutic Response|1|||
48961967|NCT00077610|157689845|FG001|Overall Study|Insufficient Therapeutic Response|0|||
48961968|NCT00077610|157689846|FG002|Overall Study|Insufficient Therapeutic Response|0|||
48961969|NCT00077610|157689844|FG000|Overall Study|Multiple blood transfusions|0|||
48961970|NCT00077610|157689845|FG001|Overall Study|Multiple blood transfusions|0|||
48961971|NCT00077610|157689846|FG002|Overall Study|Multiple blood transfusions|1|||
48961972|NCT00077610|157689844|FG000|Overall Study|Principal Investigator's decision|1|||
48656305|NCT02589665|156595947|FG008|Induction Extension Period|Reason Not Collected|1|||
48656306|NCT02589665|156595948|FG009|Induction Extension Period|Reason Not Collected|0|||
48656307|NCT02589665|156595939|FG000|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
48656308|NCT02589665|156595940|FG001|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
48656309|NCT02589665|156595941|FG002|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
48961973|NCT00077610|157689845|FG001|Overall Study|Principal Investigator's decision|0|||
48961974|NCT00077610|157689846|FG002|Overall Study|Principal Investigator's decision|1|||
48961975|NCT00077610|157689844|FG000|Overall Study|Worsening of health condition|1|||
48961976|NCT00077610|157689845|FG001|Overall Study|Worsening of health condition|1|||
48656310|NCT02589665|156595942|FG003|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
48656311|NCT02589665|156595943|FG004|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
48961977|NCT00077610|157689846|FG002|Overall Study|Worsening of health condition|0|||
48961978|NCT00077610|157689844|FG000|Overall Study|Given Epogen in hospital|1|||
48961979|NCT00077610|157689845|FG001|Overall Study|Given Epogen in hospital|0|||
49015425|NCT00385541|157892189|FG000|Overall Study|severe pain, clinician requested unblind|0|||
48961980|NCT00077610|157689846|FG002|Overall Study|Given Epogen in hospital|0|||
48961981|NCT00077610|157689844|FG000|Overall Study|Transferred to other unit|0|||
48961982|NCT00077610|157689845|FG001|Overall Study|Transferred to other unit|0|||
48961983|NCT00077610|157689846|FG002|Overall Study|Transferred to other unit|1|||
48961984|NCT00077610|157689844|FG000|Overall Study|Transferred to nursing home|0|||
48961985|NCT00077610|157689845|FG001|Overall Study|Transferred to nursing home|0|||
48961986|NCT00077610|157689846|FG002|Overall Study|Transferred to nursing home|1|||
48961987|NCT00077610|157689844|FG000|Overall Study|Transfer to satellite unit|1|||
48961988|NCT00077610|157689845|FG001|Overall Study|Transfer to satellite unit|0|||
48961989|NCT00077610|157689846|FG002|Overall Study|Transfer to satellite unit|0|||
48961990|NCT00077610|157689844|FG000|Overall Study|Transfer to other center for surgery|1|||
48961991|NCT00077610|157689845|FG001|Overall Study|Transfer to other center for surgery|0|||
48961992|NCT00077610|157689846|FG002|Overall Study|Transfer to other center for surgery|0|||
48961993|NCT00077610|157689844|FG000|Overall Study|Change in dialysis modality|1|||
48961994|NCT00077610|157689845|FG001|Overall Study|Change in dialysis modality|0|||
48961995|NCT00077610|157689846|FG002|Overall Study|Change in dialysis modality|0|||
48961996|NCT00077610|157689844|FG000|Overall Study|Relocation|0|||
48961997|NCT00077610|157689845|FG001|Overall Study|Relocation|8|||
48961998|NCT00077610|157689846|FG002|Overall Study|Relocation|5|||
48961999|NCT00077610|157689844|FG000|Overall Study|Financial issues|0|||
48962000|NCT00077610|157689845|FG001|Overall Study|Financial issues|1|||
48962001|NCT00077610|157689846|FG002|Overall Study|Financial issues|0|||
48962002|NCT00077610|157689844|FG000|Overall Study|Sponsors decision to withdraw|0|||
48962003|NCT00077610|157689845|FG001|Overall Study|Sponsors decision to withdraw|0|||
48962004|NCT00077610|157689846|FG002|Overall Study|Sponsors decision to withdraw|1|||
48962005|NCT04397718|157689847|FG000|Overall Study|Death|7|||
48962006|NCT04397718|157689848|FG001|Overall Study|Death|11|||
48962007|NCT04397718|157689847|FG000|Overall Study|Lost to Follow-up|0|||
48962008|NCT04397718|157689848|FG001|Overall Study|Lost to Follow-up|4|||
48754530|NCT01189812|156946735|FG000|Overall Study|Moved out of State|1|||
48962009|NCT01025817|157689854|FG000|Completed Study Medication|Adverse Event|66|||
48962010|NCT01025817|157689855|FG001|Completed Study Medication|Adverse Event|39|||
48962011|NCT01025817|157689854|FG000|Completed Study Medication|Protocol Deviation|9|||
48962012|NCT01025817|157689855|FG001|Completed Study Medication|Protocol Deviation|8|||
48962013|NCT01025817|157689854|FG000|Completed Study Medication|Withdrawal by Subject|8|||
48962014|NCT01025817|157689855|FG001|Completed Study Medication|Withdrawal by Subject|9|||
48962015|NCT01025817|157689854|FG000|Completed Study Medication|Administrative problems|7|||
48962016|NCT01025817|157689855|FG001|Completed Study Medication|Administrative problems|5|||
48962017|NCT01025817|157689854|FG000|Completed Study Medication|Unsatisfactory therapeutic effect|7|||
48962018|NCT01025817|157689855|FG001|Completed Study Medication|Unsatisfactory therapeutic effect|0|||
48962019|NCT01025817|157689854|FG000|Completed Study Medication|Abnormal test procedure|4|||
48962020|NCT01025817|157689855|FG001|Completed Study Medication|Abnormal test procedure|0|||
48962021|NCT01025817|157689854|FG000|Completed Study Medication|Graft loss|2|||
48962022|NCT01025817|157689855|FG001|Completed Study Medication|Graft loss|5|||
48962023|NCT01025817|157689854|FG000|Completed Study Medication|Death|2|||
48962024|NCT01025817|157689855|FG001|Completed Study Medication|Death|2|||
48962025|NCT01025817|157689854|FG000|Completed Study Medication|Abnormal lab values|0|||
48962026|NCT01025817|157689855|FG001|Completed Study Medication|Abnormal lab values|2|||
48962027|NCT01025817|157689854|FG000|Completed Study Medication|Subject no longer required study drug|0|||
48962028|NCT01025817|157689855|FG001|Completed Study Medication|Subject no longer required study drug|1|||
48962029|NCT01025817|157689854|FG000|Completed Study Medication|Lost to Follow-up|0|||
48962030|NCT01025817|157689855|FG001|Completed Study Medication|Lost to Follow-up|1|||
48962031|NCT01025817|157689854|FG000|Completed Study|Withdrawal by Subject|8|||
48962032|NCT01025817|157689855|FG001|Completed Study|Withdrawal by Subject|16|||
48962033|NCT01025817|157689854|FG000|Completed Study|Death|6|||
48962034|NCT01025817|157689855|FG001|Completed Study|Death|5|||
48962035|NCT01025817|157689854|FG000|Completed Study|Missing|2|||
48962036|NCT01025817|157689855|FG001|Completed Study|Missing|0|||
48962037|NCT01025817|157689854|FG000|Completed Study|Lost to Follow-up|0|||
48962038|NCT01025817|157689855|FG001|Completed Study|Lost to Follow-up|1|||
48962039|NCT01996748|157689856|FG000|Overall Study|Personal reason|1|||
48962040|NCT01996748|157689857|FG001|Overall Study|Personal reason|0|||
48962041|NCT01996748|157689856|FG000|Overall Study|Physician Decision|2|||
48962042|NCT01996748|157689857|FG001|Overall Study|Physician Decision|0|||
48962043|NCT01996748|157689856|FG000|Overall Study|Adverse Event|1|||
48962044|NCT01996748|157689857|FG001|Overall Study|Adverse Event|4|||
48962045|NCT01996748|157689856|FG000|Overall Study|Withdrawal by Subject|0|||
48962046|NCT01996748|157689857|FG001|Overall Study|Withdrawal by Subject|1|||
48962047|NCT01996748|157689856|FG000|Overall Study|Lost to Follow-up|4|||
48962048|NCT01996748|157689857|FG001|Overall Study|Lost to Follow-up|1|||
48962049|NCT00414960|157689864|FG000|Overall Study|Adverse Event|4|||
48962050|NCT00414960|157689865|FG001|Overall Study|Adverse Event|0|||
48962051|NCT00414960|157689864|FG000|Overall Study|Withdrawal by Subject|3|||
48962052|NCT00414960|157689865|FG001|Overall Study|Withdrawal by Subject|0|||
48962053|NCT00414960|157689864|FG000|Overall Study|Physician Decision|0|||
48962054|NCT00414960|157689865|FG001|Overall Study|Physician Decision|1|||
48962055|NCT01553916|157689871|FG000|Overall Study|Withdrawal by Subject|2|||
48962056|NCT01553916|157689871|FG000|Overall Study|Pre-treatment MRI metastatic disease|1|||
48962057|NCT00171314|157689876|FG000|Overall Study|Adverse Event|44|||
48962058|NCT00171314|157689877|FG001|Overall Study|Adverse Event|41|||
48962059|NCT00171314|157689876|FG000|Overall Study|Lack of Efficacy|19|||
48962060|NCT00171314|157689877|FG001|Overall Study|Lack of Efficacy|14|||
48962061|NCT00171314|157689876|FG000|Overall Study|Withdrawal by Subject|9|||
48962062|NCT00171314|157689877|FG001|Overall Study|Withdrawal by Subject|6|||
48962063|NCT00171314|157689876|FG000|Overall Study|Abnormal Test Procedure Results|9|||
48962064|NCT00171314|157689877|FG001|Overall Study|Abnormal Test Procedure Results|3|||
48962065|NCT00171314|157689876|FG000|Overall Study|Protocol Violation|3|||
48962066|NCT00171314|157689877|FG001|Overall Study|Protocol Violation|7|||
48962067|NCT00171314|157689876|FG000|Overall Study|Administrative Problems|4|||
48962068|NCT00171314|157689877|FG001|Overall Study|Administrative Problems|3|||
48962069|NCT00171314|157689876|FG000|Overall Study|Lost to Follow-up|1|||
48962070|NCT00171314|157689877|FG001|Overall Study|Lost to Follow-up|3|||
48962071|NCT00171314|157689876|FG000|Overall Study|Death|2|||
48962072|NCT00171314|157689877|FG001|Overall Study|Death|1|||
48962073|NCT00077376|157689878|FG000|Overall Study|Adverse Event|8|||
48962074|NCT00077376|157689878|FG000|Overall Study|Withdrawal by Subject|2|||
48962075|NCT00077376|157689878|FG000|Overall Study|Death|1|||
48962076|NCT00077376|157689878|FG000|Overall Study|Physician Decision|1|||
48962077|NCT00077376|157689878|FG000|Overall Study|Alternative therapy|5|||
48962078|NCT00077376|157689878|FG000|Overall Study|Complicating disease|1|||
48962079|NCT00077376|157689878|FG000|Overall Study|Still on treatment|1|||
48962080|NCT00077376|157689878|FG000|Overall Study|Symptomatic deterioration|1|||
48962081|NCT00077376|157689878|FG000|Overall Study|Surgery|1|||
48962082|NCT00077376|157689878|FG000|Overall Study|Insurance ran out|1|||
48962083|NCT00622869|157689879|FG000|Overall Study|Subject Withdrew Consent|13|||
48962084|NCT00622869|157689880|FG001|Overall Study|Subject Withdrew Consent|17|||
48962085|NCT00622869|157689881|FG002|Overall Study|Subject Withdrew Consent|11|||
48962086|NCT00622869|157689879|FG000|Overall Study|Administrative Problems|11|||
48962087|NCT00622869|157689880|FG001|Overall Study|Administrative Problems|17|||
48962088|NCT00622869|157689881|FG002|Overall Study|Administrative Problems|13|||
48962089|NCT00622869|157689879|FG000|Overall Study|Death|12|||
48962090|NCT00622869|157689880|FG001|Overall Study|Death|15|||
48656312|NCT02589665|156595944|FG005|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
48656313|NCT02589665|156595945|FG006|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
48656314|NCT02589665|156595946|FG007|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
48656315|NCT02589665|156595947|FG008|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
48656316|NCT02589665|156595948|FG009|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57|||
48656317|NCT02589665|156595939|FG000|Maintenance Extension Period|Withdrawal by Subject|0|||
48962091|NCT00622869|157689881|FG002|Overall Study|Death|10|||
48962092|NCT00622869|157689879|FG000|Overall Study|Lost to Follow-up|2|||
48962093|NCT00622869|157689880|FG001|Overall Study|Lost to Follow-up|4|||
48754531|NCT01189812|156946736|FG001|Overall Study|Moved out of State|2|||
48754532|NCT00001596|156948085|FG000|Overall Study|Death|1|||
48754533|NCT00001596|156948086|FG001|Overall Study|Death|0|||
48754534|NCT00001596|156948085|FG000|Overall Study|Withdrawal by Subject|3|||
48754535|NCT00001596|156948086|FG001|Overall Study|Withdrawal by Subject|1|||
48754536|NCT00001596|156948085|FG000|Overall Study|Study Termination|12|||
48754537|NCT00001596|156948086|FG001|Overall Study|Study Termination|9|||
48656318|NCT02589665|156595940|FG001|Maintenance Extension Period|Withdrawal by Subject|0|||
48656319|NCT02589665|156595941|FG002|Maintenance Extension Period|Withdrawal by Subject|0|||
48656320|NCT02589665|156595942|FG003|Maintenance Extension Period|Withdrawal by Subject|0|||
48656321|NCT02589665|156595943|FG004|Maintenance Extension Period|Withdrawal by Subject|0|||
48656322|NCT02589665|156595944|FG005|Maintenance Extension Period|Withdrawal by Subject|0|||
48656323|NCT02589665|156595945|FG006|Maintenance Extension Period|Withdrawal by Subject|0|||
48962094|NCT00622869|157689881|FG002|Overall Study|Lost to Follow-up|2|||
48962095|NCT00622869|157689879|FG000|Overall Study|Graft Loss|5|||
48656324|NCT02589665|156595946|FG007|Maintenance Extension Period|Withdrawal by Subject|0|||
48962096|NCT00622869|157689880|FG001|Overall Study|Graft Loss|3|||
48962097|NCT00622869|157689881|FG002|Overall Study|Graft Loss|2|||
48962098|NCT00622869|157689879|FG000|Overall Study|Missing|0|||
48656325|NCT02589665|156595947|FG008|Maintenance Extension Period|Withdrawal by Subject|0|||
48962099|NCT00622869|157689880|FG001|Overall Study|Missing|1|||
48962100|NCT00622869|157689881|FG002|Overall Study|Missing|1|||
48962101|NCT02509494|157689882|FG000|Overall Study|Lost to Follow-up|8|||
48962102|NCT02509494|157689883|FG001|Overall Study|Lost to Follow-up|47|||
48962103|NCT02509494|157689884|FG002|Overall Study|Lost to Follow-up|19|||
48962104|NCT02509494|157689885|FG003|Overall Study|Lost to Follow-up|6|||
48962105|NCT02509494|157689886|FG004|Overall Study|Lost to Follow-up|3|||
48962106|NCT02509494|157689887|FG005|Overall Study|Lost to Follow-up|3|||
48962107|NCT02509494|157689888|FG006|Overall Study|Lost to Follow-up|1|||
48962108|NCT02509494|157689889|FG007|Overall Study|Lost to Follow-up|3|||
48754538|NCT00001596|156948085|FG000|Overall Study|Adverse Event|1|||
48754539|NCT00001596|156948086|FG001|Overall Study|Adverse Event|0|||
48754540|NCT03562481|156948094|FG000|First Intervention|Lost to Follow-up|1|||
48754541|NCT03562481|156948095|FG001|First Intervention|Lost to Follow-up|0|||
48754542|NCT01327885|156948096|FG000|Overall Study|Disease progression-according to RECIST|173|||
48754543|NCT01327885|156948097|FG001|Overall Study|Disease progression-according to RECIST|165|||
48754544|NCT01327885|156948096|FG000|Overall Study|Clinical progression|24|||
48754545|NCT01327885|156948097|FG001|Overall Study|Clinical progression|27|||
48754546|NCT01327885|156948096|FG000|Overall Study|Adverse Event|14|||
48754547|NCT01327885|156948097|FG001|Overall Study|Adverse Event|10|||
48754548|NCT01327885|156948096|FG000|Overall Study|Subject choice|5|||
48962109|NCT02509494|157689890|FG008|Overall Study|Lost to Follow-up|1|||
48962110|NCT02509494|157689882|FG000|Overall Study|Physician Decision|2|||
48962111|NCT02509494|157689883|FG001|Overall Study|Physician Decision|1|||
48962112|NCT02509494|157689884|FG002|Overall Study|Physician Decision|0|||
48962113|NCT02509494|157689885|FG003|Overall Study|Physician Decision|0|||
48962114|NCT02509494|157689886|FG004|Overall Study|Physician Decision|0|||
48962115|NCT02509494|157689887|FG005|Overall Study|Physician Decision|0|||
48962116|NCT02509494|157689888|FG006|Overall Study|Physician Decision|0|||
48962117|NCT02509494|157689889|FG007|Overall Study|Physician Decision|0|||
48962118|NCT02509494|157689890|FG008|Overall Study|Physician Decision|0|||
48962119|NCT02509494|157689882|FG000|Overall Study|Withdrawal by Subject|4|||
48962120|NCT02509494|157689883|FG001|Overall Study|Withdrawal by Subject|17|||
48962121|NCT02509494|157689884|FG002|Overall Study|Withdrawal by Subject|7|||
48962122|NCT02509494|157689885|FG003|Overall Study|Withdrawal by Subject|5|||
48962123|NCT02509494|157689886|FG004|Overall Study|Withdrawal by Subject|0|||
48962124|NCT02509494|157689887|FG005|Overall Study|Withdrawal by Subject|6|||
48962125|NCT02509494|157689888|FG006|Overall Study|Withdrawal by Subject|1|||
48962126|NCT02509494|157689889|FG007|Overall Study|Withdrawal by Subject|2|||
48962127|NCT02509494|157689890|FG008|Overall Study|Withdrawal by Subject|1|||
48962128|NCT02509494|157689882|FG000|Overall Study|Death|0|||
48962129|NCT02509494|157689883|FG001|Overall Study|Death|1|||
48962130|NCT02509494|157689884|FG002|Overall Study|Death|0|||
48962131|NCT02509494|157689885|FG003|Overall Study|Death|0|||
48962132|NCT02509494|157689886|FG004|Overall Study|Death|1|||
48962133|NCT02509494|157689887|FG005|Overall Study|Death|0|||
48962134|NCT02509494|157689888|FG006|Overall Study|Death|0|||
48962135|NCT02509494|157689889|FG007|Overall Study|Death|1|||
48656326|NCT02589665|156595948|FG009|Maintenance Extension Period|Withdrawal by Subject|4|||
48656327|NCT02589665|156595939|FG000|Maintenance Extension Period|Lack of Efficacy|0|||
48656328|NCT02589665|156595940|FG001|Maintenance Extension Period|Lack of Efficacy|0|||
48656329|NCT02589665|156595941|FG002|Maintenance Extension Period|Lack of Efficacy|0|||
48656330|NCT02589665|156595942|FG003|Maintenance Extension Period|Lack of Efficacy|0|||
48656331|NCT02589665|156595943|FG004|Maintenance Extension Period|Lack of Efficacy|0|||
48656332|NCT02589665|156595944|FG005|Maintenance Extension Period|Lack of Efficacy|0|||
48656333|NCT02589665|156595945|FG006|Maintenance Extension Period|Lack of Efficacy|0|||
48656334|NCT02589665|156595946|FG007|Maintenance Extension Period|Lack of Efficacy|0|||
48656335|NCT02589665|156595947|FG008|Maintenance Extension Period|Lack of Efficacy|0|||
48656336|NCT02589665|156595948|FG009|Maintenance Extension Period|Lack of Efficacy|4|||
48656337|NCT02589665|156595939|FG000|Maintenance Extension Period|Adverse Event|0|||
48656338|NCT02589665|156595940|FG001|Maintenance Extension Period|Adverse Event|0|||
48656339|NCT02589665|156595941|FG002|Maintenance Extension Period|Adverse Event|0|||
48656340|NCT02589665|156595942|FG003|Maintenance Extension Period|Adverse Event|0|||
48656341|NCT02589665|156595943|FG004|Maintenance Extension Period|Adverse Event|0|||
48656342|NCT02589665|156595944|FG005|Maintenance Extension Period|Adverse Event|0|||
48656343|NCT02589665|156595945|FG006|Maintenance Extension Period|Adverse Event|0|||
48656344|NCT02589665|156595946|FG007|Maintenance Extension Period|Adverse Event|0|||
48656345|NCT02589665|156595947|FG008|Maintenance Extension Period|Adverse Event|0|||
48656346|NCT02589665|156595948|FG009|Maintenance Extension Period|Adverse Event|2|||
48656347|NCT02589665|156595939|FG000|Maintenance Extension Period|Non-responder|0|||
48656348|NCT02589665|156595940|FG001|Maintenance Extension Period|Non-responder|0|||
48656349|NCT02589665|156595941|FG002|Maintenance Extension Period|Non-responder|0|||
48656350|NCT02589665|156595942|FG003|Maintenance Extension Period|Non-responder|0|||
48656351|NCT02589665|156595943|FG004|Maintenance Extension Period|Non-responder|0|||
48656352|NCT02589665|156595944|FG005|Maintenance Extension Period|Non-responder|0|||
48656353|NCT02589665|156595945|FG006|Maintenance Extension Period|Non-responder|0|||
48754549|NCT01327885|156948097|FG001|Overall Study|Subject choice|10|||
48962136|NCT02509494|157689890|FG008|Overall Study|Death|0|||
48962137|NCT02509494|157689882|FG000|Overall Study|Other|0|||
48962138|NCT02509494|157689883|FG001|Overall Study|Other|4|||
48754550|NCT01327885|156948096|FG000|Overall Study|Other|8|||
48754551|NCT01327885|156948097|FG001|Overall Study|Other|6|||
48962139|NCT02509494|157689884|FG002|Overall Study|Other|5|||
48962140|NCT02509494|157689885|FG003|Overall Study|Other|0|||
48962141|NCT02509494|157689886|FG004|Overall Study|Other|0|||
48962142|NCT02509494|157689887|FG005|Overall Study|Other|0|||
48962143|NCT02509494|157689888|FG006|Overall Study|Other|0|||
48656354|NCT02589665|156595946|FG007|Maintenance Extension Period|Non-responder|0|||
48656355|NCT02589665|156595947|FG008|Maintenance Extension Period|Non-responder|0|||
48656356|NCT02589665|156595948|FG009|Maintenance Extension Period|Non-responder|1|||
48656357|NCT01443364|156595949|FG000|Overall Study|Lack of Efficacy|14|||
48656358|NCT01443364|156595949|FG000|Overall Study|Lost to Follow-up|3|||
48656359|NCT01443364|156595949|FG000|Overall Study|Withdrawal by Subject|5|||
48656360|NCT01443364|156595949|FG000|Overall Study|Other Reason|4|||
48656361|NCT01443364|156595949|FG000|Overall Study|SAE, non-fatal|6|||
48656362|NCT01443364|156595949|FG000|Overall Study|AE, non-serious non-fatal|8|||
48656363|NCT01443364|156595949|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
48656364|NCT01461928|156595951|FG000|Induction (up to 8 Months)|Adverse Event|76|||
48656365|NCT01461928|156595952|FG001|Induction (up to 8 Months)|Adverse Event|0|||
48656366|NCT01461928|156595953|FG002|Induction (up to 8 Months)|Adverse Event|0|||
48656367|NCT01461928|156595951|FG000|Induction (up to 8 Months)|Death|3|||
48656368|NCT01461928|156595952|FG001|Induction (up to 8 Months)|Death|0|||
48656369|NCT01461928|156595953|FG002|Induction (up to 8 Months)|Death|0|||
48656370|NCT01461928|156595951|FG000|Induction (up to 8 Months)|Lost to Follow-up|5|||
48656371|NCT01461928|156595952|FG001|Induction (up to 8 Months)|Lost to Follow-up|0|||
48656372|NCT01461928|156595953|FG002|Induction (up to 8 Months)|Lost to Follow-up|0|||
48656373|NCT01461928|156595951|FG000|Induction (up to 8 Months)|Physician Decision|9|||
48656374|NCT01461928|156595952|FG001|Induction (up to 8 Months)|Physician Decision|0|||
48656375|NCT01461928|156595953|FG002|Induction (up to 8 Months)|Physician Decision|0|||
48656376|NCT01461928|156595951|FG000|Induction (up to 8 Months)|Withdrawal by Subject|18|||
48656377|NCT01461928|156595952|FG001|Induction (up to 8 Months)|Withdrawal by Subject|0|||
48656378|NCT01461928|156595953|FG002|Induction (up to 8 Months)|Withdrawal by Subject|0|||
48656379|NCT01461928|156595951|FG000|Induction (up to 8 Months)|Disease progression|45|||
48656380|NCT01461928|156595952|FG001|Induction (up to 8 Months)|Disease progression|0|||
48656381|NCT01461928|156595953|FG002|Induction (up to 8 Months)|Disease progression|0|||
48656382|NCT01461928|156595951|FG000|Induction (up to 8 Months)|Eligibility criteria deviation|10|||
48656383|NCT01461928|156595952|FG001|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
48656384|NCT01461928|156595953|FG002|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
48656385|NCT01461928|156595951|FG000|Induction (up to 8 Months)|Completed Induction, no Maint I received|11|||
48754552|NCT01327885|156948096|FG000|Overall Study|Withdrawal of consent from study|3|||
48754553|NCT01327885|156948097|FG001|Overall Study|Withdrawal of consent from study|4|||
48656386|NCT01461928|156595952|FG001|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
48754554|NCT01327885|156948096|FG000|Overall Study|Not treated|1|||
48754555|NCT01327885|156948097|FG001|Overall Study|Not treated|1|||
48754556|NCT01327885|156948096|FG000|Overall Study|Administrative decision|0|||
48754557|NCT01327885|156948097|FG001|Overall Study|Administrative decision|1|||
48754558|NCT02041286|156948098|FG000|Overall Study|Adverse Event|1|||
48754559|NCT00549302|156948103|FG000|Double-Blind|Death|2|||
48754560|NCT00549302|156948104|FG001|Double-Blind|Death|9|||
48754561|NCT00549302|156948105|FG002|Double-Blind|Death|0|||
48754562|NCT00549302|156948103|FG000|Double-Blind|Adverse Event|3|||
48754563|NCT00549302|156948104|FG001|Double-Blind|Adverse Event|16|||
48754564|NCT00549302|156948105|FG002|Double-Blind|Adverse Event|0|||
48754565|NCT00549302|156948103|FG000|Double-Blind|Withdrawal by Subject|3|||
48754566|NCT00549302|156948104|FG001|Double-Blind|Withdrawal by Subject|8|||
48754567|NCT00549302|156948105|FG002|Double-Blind|Withdrawal by Subject|0|||
48754568|NCT00549302|156948103|FG000|Double-Blind|Investigator Decision|1|||
48754569|NCT00549302|156948104|FG001|Double-Blind|Investigator Decision|5|||
48754570|NCT00549302|156948105|FG002|Double-Blind|Investigator Decision|0|||
48754571|NCT00549302|156948103|FG000|Double-Blind|Sponsor Decision|0|||
48754572|NCT00549302|156948104|FG001|Double-Blind|Sponsor Decision|1|||
48754573|NCT00549302|156948105|FG002|Double-Blind|Sponsor Decision|0|||
48754574|NCT00549302|156948103|FG000|Double-Blind|Lost to Follow-up|1|||
48754575|NCT00549302|156948104|FG001|Double-Blind|Lost to Follow-up|2|||
48754576|NCT00549302|156948105|FG002|Double-Blind|Lost to Follow-up|0|||
48754577|NCT00549302|156948103|FG000|Double-Blind|New Drug Pulmonary Atrial Hypertension|1|||
48754578|NCT00549302|156948104|FG001|Double-Blind|New Drug Pulmonary Atrial Hypertension|10|||
48754579|NCT00549302|156948105|FG002|Double-Blind|New Drug Pulmonary Atrial Hypertension|0|||
48754580|NCT00549302|156948103|FG000|Double-Blind|New condition or starts new therapy|0|||
48754581|NCT00549302|156948104|FG001|Double-Blind|New condition or starts new therapy|2|||
48754582|NCT00549302|156948105|FG002|Double-Blind|New condition or starts new therapy|0|||
48754583|NCT00549302|156948103|FG000|Open-Label|Adverse Event|0|||
48754584|NCT00549302|156948104|FG001|Open-Label|Adverse Event|0|||
48754585|NCT00549302|156948105|FG002|Open-Label|Adverse Event|11|||
48754586|NCT00549302|156948103|FG000|Open-Label|Death|0|||
48754587|NCT00549302|156948104|FG001|Open-Label|Death|0|||
48754588|NCT00549302|156948105|FG002|Open-Label|Death|40|||
48754589|NCT00549302|156948103|FG000|Open-Label|Investigator Decision|0|||
48754590|NCT00549302|156948104|FG001|Open-Label|Investigator Decision|0|||
48754591|NCT00549302|156948105|FG002|Open-Label|Investigator Decision|5|||
48754592|NCT00549302|156948103|FG000|Open-Label|Lost to Follow-up|0|||
48754593|NCT00549302|156948104|FG001|Open-Label|Lost to Follow-up|0|||
48754594|NCT00549302|156948105|FG002|Open-Label|Lost to Follow-up|2|||
48962144|NCT02509494|157689889|FG007|Overall Study|Other|0|||
48962145|NCT02509494|157689890|FG008|Overall Study|Other|0|||
48962146|NCT02509494|157689882|FG000|Overall Study|Non-Compliance With Study Drug|1|||
48962147|NCT02509494|157689883|FG001|Overall Study|Non-Compliance With Study Drug|11|||
48962148|NCT02509494|157689884|FG002|Overall Study|Non-Compliance With Study Drug|7|||
48962149|NCT02509494|157689885|FG003|Overall Study|Non-Compliance With Study Drug|0|||
48962150|NCT02509494|157689886|FG004|Overall Study|Non-Compliance With Study Drug|1|||
48962151|NCT02509494|157689887|FG005|Overall Study|Non-Compliance With Study Drug|2|||
48962152|NCT02509494|157689888|FG006|Overall Study|Non-Compliance With Study Drug|1|||
48962153|NCT02509494|157689889|FG007|Overall Study|Non-Compliance With Study Drug|1|||
48962154|NCT02509494|157689890|FG008|Overall Study|Non-Compliance With Study Drug|0|||
48962155|NCT03722784|157689896|FG000|Overall Study|Withdrawal by Subject|1|||
48962156|NCT03722784|157689897|FG001|Overall Study|Withdrawal by Subject|0|||
48962157|NCT03722784|157689896|FG000|Overall Study|Physician Decision|1|||
48962158|NCT03722784|157689897|FG001|Overall Study|Physician Decision|1|||
48962159|NCT03722784|157689896|FG000|Overall Study|Protocol Violation|0|||
48962160|NCT03722784|157689897|FG001|Overall Study|Protocol Violation|1|||
48962161|NCT03288493|157689898|FG000|Overall Study|Withdrawal by Subject|4|||
48962162|NCT03288493|157689899|FG001|Overall Study|Withdrawal by Subject|0|||
48962163|NCT03288493|157689900|FG002|Overall Study|Withdrawal by Subject|0|||
48962164|NCT03288493|157689901|FG003|Overall Study|Withdrawal by Subject|0|||
48962165|NCT03288493|157689902|FG004|Overall Study|Withdrawal by Subject|0|||
48962166|NCT03288493|157689903|FG005|Overall Study|Withdrawal by Subject|2|||
48962167|NCT03288493|157689904|FG006|Overall Study|Withdrawal by Subject|0|||
48962168|NCT03288493|157689898|FG000|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|52|||
48962169|NCT03288493|157689899|FG001|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
48962170|NCT03288493|157689900|FG002|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|1|||
48962171|NCT03288493|157689901|FG003|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|6|||
48962172|NCT03288493|157689902|FG004|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|5|||
48962173|NCT03288493|157689903|FG005|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|10|||
48962174|NCT03288493|157689904|FG006|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
48962175|NCT03288493|157689898|FG000|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|6|||
48962176|NCT03288493|157689899|FG001|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
48962177|NCT03288493|157689900|FG002|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
48962178|NCT03288493|157689901|FG003|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|2|||
48962179|NCT03288493|157689902|FG004|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
48962180|NCT03288493|157689903|FG005|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|4|||
48656387|NCT01461928|156595953|FG002|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
48656388|NCT01461928|156595951|FG000|Induction (up to 8 Months)|Not responding to treatment|11|||
48656389|NCT01461928|156595952|FG001|Induction (up to 8 Months)|Not responding to treatment|0|||
48656390|NCT01461928|156595953|FG002|Induction (up to 8 Months)|Not responding to treatment|0|||
48656391|NCT01461928|156595951|FG000|Induction (up to 8 Months)|Termination of study in Switzerland|1|||
48656392|NCT01461928|156595952|FG001|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
48656393|NCT01461928|156595953|FG002|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
48656394|NCT01461928|156595951|FG000|Induction (up to 8 Months)|Treated before eligibility was confirmed|1|||
48656395|NCT01461928|156595952|FG001|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
48656396|NCT01461928|156595953|FG002|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
48656397|NCT01461928|156595951|FG000|Induction (up to 8 Months)|Sponsor decision|1|||
48656398|NCT01461928|156595952|FG001|Induction (up to 8 Months)|Sponsor decision|0|||
48656399|NCT01461928|156595953|FG002|Induction (up to 8 Months)|Sponsor decision|0|||
48656400|NCT01461928|156595951|FG000|Induction (up to 8 Months)|Protocol deviation|2|||
48656401|NCT01461928|156595952|FG001|Induction (up to 8 Months)|Protocol deviation|0|||
48656402|NCT01461928|156595953|FG002|Induction (up to 8 Months)|Protocol deviation|0|||
48656403|NCT01461928|156595951|FG000|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1|||
48656404|NCT01461928|156595952|FG001|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
48656405|NCT01461928|156595953|FG002|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
48656406|NCT01461928|156595951|FG000|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1|||
48656407|NCT01461928|156595952|FG001|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
48656408|NCT01461928|156595953|FG002|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
48656409|NCT01461928|156595951|FG000|Induction (up to 8 Months)|Promotor request|1|||
48656410|NCT01461928|156595952|FG001|Induction (up to 8 Months)|Promotor request|0|||
48754595|NCT00549302|156948103|FG000|Open-Label|Other|0|||
48754596|NCT00549302|156948104|FG001|Open-Label|Other|0|||
48754597|NCT00549302|156948105|FG002|Open-Label|Other|3|||
48754598|NCT00549302|156948103|FG000|Open-Label|New drug pulmonary atrial hypertension|0|||
48754599|NCT00549302|156948104|FG001|Open-Label|New drug pulmonary atrial hypertension|0|||
48754600|NCT00549302|156948105|FG002|Open-Label|New drug pulmonary atrial hypertension|2|||
48754601|NCT00549302|156948103|FG000|Open-Label|Withdrawal by Subject|0|||
48754602|NCT00549302|156948104|FG001|Open-Label|Withdrawal by Subject|0|||
48754603|NCT00549302|156948105|FG002|Open-Label|Withdrawal by Subject|6|||
48754604|NCT02233309|156948109|FG000|Overall Study|Physician Decision|5|||
48754605|NCT02436889|156948113|FG000|Overall Study|No improvement in symptoms|1|||
48754606|NCT02436889|156948114|FG001|Overall Study|No improvement in symptoms|0|||
48754607|NCT02436889|156948113|FG000|Overall Study|Does not like/could not tolerate medicat|0|||
48754608|NCT02436889|156948114|FG001|Overall Study|Does not like/could not tolerate medicat|1|||
48754609|NCT01946425|156948122|FG000|Overall Study|Protocol Violation|1|||
48754610|NCT01946425|156948123|FG001|Overall Study|Protocol Violation|0|||
48754611|NCT01946425|156948122|FG000|Overall Study|Withdrawal by Subject|1|||
48754612|NCT01946425|156948123|FG001|Overall Study|Withdrawal by Subject|0|||
48754613|NCT00142584|156948124|FG000|Overall Study|Sponsor Termination of Study, etc.|72|||
48754614|NCT00142584|156948125|FG001|Overall Study|Sponsor Termination of Study, etc.|16|||
48754615|NCT00142584|156948124|FG000|Overall Study|Withdrawal by Subject|30|||
48754616|NCT00142584|156948125|FG001|Overall Study|Withdrawal by Subject|16|||
48754617|NCT00142584|156948124|FG000|Overall Study|Lost to Follow-up|22|||
48754618|NCT00142584|156948125|FG001|Overall Study|Lost to Follow-up|12|||
48754619|NCT00142584|156948124|FG000|Overall Study|Adverse Event|14|||
48754620|NCT00142584|156948125|FG001|Overall Study|Adverse Event|5|||
48754621|NCT00142584|156948124|FG000|Overall Study|Protocol Violation|4|||
48754622|NCT00142584|156948125|FG001|Overall Study|Protocol Violation|7|||
48754623|NCT00142584|156948124|FG000|Overall Study|Treatment Failure|2|||
48754624|NCT00142584|156948125|FG001|Overall Study|Treatment Failure|0|||
48754625|NCT02551731|156948126|FG000|Overall Study|Withdrawal by Subject|2|||
48754626|NCT01961323|156948127|FG000|Overall Study|Withdrawal by Subject|7|||
48754627|NCT01961323|156948127|FG000|Overall Study|Lost to Follow-up|8|||
48754628|NCT01961323|156948127|FG000|Overall Study|screen failure|34|||
48754629|NCT03336333|156948128|FG000|Overall Study|Remained on study at time of data cut-off|202|||
48754630|NCT03336333|156948129|FG001|Overall Study|Remained on study at time of data cut-off|219|||
48754631|NCT03336333|156948130|FG002|Overall Study|Remained on study at time of data cut-off|102|||
48754632|NCT03336333|156948128|FG000|Overall Study|Death|14|||
48754633|NCT03336333|156948129|FG001|Overall Study|Death|16|||
48754634|NCT03336333|156948130|FG002|Overall Study|Death|8|||
48754635|NCT03336333|156948128|FG000|Overall Study|Withdrawal by Subject|16|||
48754636|NCT03336333|156948129|FG001|Overall Study|Withdrawal by Subject|5|||
48754637|NCT03336333|156948130|FG002|Overall Study|Withdrawal by Subject|1|||
48754638|NCT03336333|156948128|FG000|Overall Study|Physician Decision|5|||
48754639|NCT03336333|156948129|FG001|Overall Study|Physician Decision|1|||
48754640|NCT03336333|156948130|FG002|Overall Study|Physician Decision|0|||
48754641|NCT03336333|156948128|FG000|Overall Study|Lost to Follow-up|1|||
48754642|NCT03336333|156948129|FG001|Overall Study|Lost to Follow-up|0|||
48754643|NCT03336333|156948130|FG002|Overall Study|Lost to Follow-up|0|||
48754644|NCT00770289|156948131|FG000|Overall Study|Other|6|||
48754645|NCT02377466|156948134|FG000|Overall Study|Other: Randomized and not treated|0|||
48754646|NCT02377466|156948135|FG001|Overall Study|Other: Randomized and not treated|2|||
48754647|NCT00137046|156948136|FG000|Overall Study|Death|2|||
48754648|NCT00137046|156948137|FG001|Overall Study|Death|1|||
48656411|NCT01461928|156595953|FG002|Induction (up to 8 Months)|Promotor request|0|||
48656412|NCT01461928|156595951|FG000|Induction (up to 8 Months)|Exceeded time limit for next cycle|1|||
48656413|NCT01461928|156595952|FG001|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
48656414|NCT01461928|156595953|FG002|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
48656415|NCT01461928|156595951|FG000|Induction (up to 8 Months)|Medical advisor request|1|||
48656416|NCT01461928|156595952|FG001|Induction (up to 8 Months)|Medical advisor request|0|||
48656417|NCT01461928|156595953|FG002|Induction (up to 8 Months)|Medical advisor request|0|||
48656418|NCT01461928|156595951|FG000|Maintenance I (24 Months)|Death|3|||
48656419|NCT01461928|156595952|FG001|Maintenance I (24 Months)|Death|0|||
48656420|NCT01461928|156595953|FG002|Maintenance I (24 Months)|Death|0|||
48656421|NCT01461928|156595951|FG000|Maintenance I (24 Months)|Withdrawal by Subject|32|||
48656422|NCT01461928|156595952|FG001|Maintenance I (24 Months)|Withdrawal by Subject|0|||
48754649|NCT00137046|156948136|FG000|Overall Study|Adverse Event|16|||
48754650|NCT00137046|156948137|FG001|Overall Study|Adverse Event|5|||
48754651|NCT00137046|156948136|FG000|Overall Study|Laboratory Abnormality|2|||
48754652|NCT00137046|156948137|FG001|Overall Study|Laboratory Abnormality|0|||
48754653|NCT00137046|156948136|FG000|Overall Study|Lack of Efficacy|13|||
48754654|NCT00137046|156948137|FG001|Overall Study|Lack of Efficacy|1|||
48754655|NCT00137046|156948136|FG000|Overall Study|Lost to Follow-up|8|||
48754656|NCT00137046|156948137|FG001|Overall Study|Lost to Follow-up|24|||
48754657|NCT00137046|156948136|FG000|Overall Study|Other|23|||
48754658|NCT00137046|156948137|FG001|Overall Study|Other|19|||
48754659|NCT00137046|156948136|FG000|Overall Study|Withdrawal by Subject|33|||
48656423|NCT01461928|156595953|FG002|Maintenance I (24 Months)|Withdrawal by Subject|0|||
48656424|NCT01461928|156595951|FG000|Maintenance I (24 Months)|Lost to Follow-up|2|||
48656425|NCT01461928|156595952|FG001|Maintenance I (24 Months)|Lost to Follow-up|0|||
48656426|NCT01461928|156595953|FG002|Maintenance I (24 Months)|Lost to Follow-up|0|||
48656427|NCT01461928|156595951|FG000|Maintenance I (24 Months)|Diseases progression|91|||
48656428|NCT01461928|156595952|FG001|Maintenance I (24 Months)|Diseases progression|0|||
48656429|NCT01461928|156595953|FG002|Maintenance I (24 Months)|Diseases progression|0|||
48656430|NCT01461928|156595951|FG000|Maintenance I (24 Months)|Adverse Event|70|||
48656431|NCT01461928|156595952|FG001|Maintenance I (24 Months)|Adverse Event|0|||
48656432|NCT01461928|156595953|FG002|Maintenance I (24 Months)|Adverse Event|0|||
48656433|NCT01461928|156595951|FG000|Maintenance I (24 Months)|Physician Decision|9|||
48656434|NCT01461928|156595952|FG001|Maintenance I (24 Months)|Physician Decision|0|||
48656435|NCT01461928|156595953|FG002|Maintenance I (24 Months)|Physician Decision|0|||
48656436|NCT01461928|156595951|FG000|Maintenance I (24 Months)|Did not meet randomization criteria|2|||
48656437|NCT01461928|156595952|FG001|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
48656438|NCT01461928|156595953|FG002|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
48656439|NCT01461928|156595951|FG000|Maintenance I (24 Months)|Did not perform scheduled assessment|2|||
48656440|NCT01461928|156595952|FG001|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
48656441|NCT01461928|156595953|FG002|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
48656442|NCT01461928|156595951|FG000|Maintenance I (24 Months)|Delay in rituximab administration|1|||
48656443|NCT01461928|156595952|FG001|Maintenance I (24 Months)|Delay in rituximab administration|0|||
48656444|NCT01461928|156595953|FG002|Maintenance I (24 Months)|Delay in rituximab administration|0|||
48656445|NCT01461928|156595951|FG000|Maintenance I (24 Months)|Not compliant|1|||
48656446|NCT01461928|156595952|FG001|Maintenance I (24 Months)|Not compliant|0|||
48656447|NCT01461928|156595953|FG002|Maintenance I (24 Months)|Not compliant|0|||
48656448|NCT01461928|156595951|FG000|Maintenance I (24 Months)|Did not meet criteria|5|||
48656449|NCT01461928|156595952|FG001|Maintenance I (24 Months)|Did not meet criteria|0|||
48656450|NCT01461928|156595953|FG002|Maintenance I (24 Months)|Did not meet criteria|0|||
48656451|NCT01461928|156595951|FG000|Maintenance II (15 Months)|Adverse Event|0|||
48656452|NCT01461928|156595952|FG001|Maintenance II (15 Months)|Adverse Event|2|||
48656453|NCT01461928|156595953|FG002|Maintenance II (15 Months)|Adverse Event|0|||
48656454|NCT01461928|156595951|FG000|Maintenance II (15 Months)|Death|0|||
48656455|NCT01461928|156595952|FG001|Maintenance II (15 Months)|Death|10|||
48656456|NCT01461928|156595953|FG002|Maintenance II (15 Months)|Death|8|||
48656457|NCT01461928|156595951|FG000|Maintenance II (15 Months)|Physician Decision|0|||
48656458|NCT01461928|156595952|FG001|Maintenance II (15 Months)|Physician Decision|0|||
48656459|NCT01461928|156595953|FG002|Maintenance II (15 Months)|Physician Decision|4|||
48656460|NCT01461928|156595951|FG000|Maintenance II (15 Months)|Lost to Follow-up|0|||
48656461|NCT01461928|156595952|FG001|Maintenance II (15 Months)|Lost to Follow-up|1|||
48656462|NCT01461928|156595953|FG002|Maintenance II (15 Months)|Lost to Follow-up|0|||
48656463|NCT01461928|156595951|FG000|Maintenance II (15 Months)|Moved to another town|0|||
48656464|NCT01461928|156595952|FG001|Maintenance II (15 Months)|Moved to another town|1|||
48656465|NCT01461928|156595953|FG002|Maintenance II (15 Months)|Moved to another town|0|||
48656466|NCT01461928|156595951|FG000|Maintenance II (15 Months)|Disease progression|0|||
48656467|NCT01461928|156595952|FG001|Maintenance II (15 Months)|Disease progression|0|||
48656468|NCT01461928|156595953|FG002|Maintenance II (15 Months)|Disease progression|3|||
48865788|NCT03722485|157345570|FG000|Overall Study|Withdrawal by Subject|1|||
48865789|NCT03722485|157345571|FG001|Overall Study|Withdrawal by Subject|0|||
48865790|NCT03722485|157345570|FG000|Overall Study|Adverse Event|0|||
48865791|NCT03722485|157345571|FG001|Overall Study|Adverse Event|2|||
48865792|NCT03722485|157345570|FG000|Overall Study|subject discharged prior to study completion|1|||
48865793|NCT03722485|157345571|FG001|Overall Study|subject discharged prior to study completion|5|||
48865794|NCT03722485|157345570|FG000|Overall Study|eligibility criteria not met|2|||
48865795|NCT03722485|157345571|FG001|Overall Study|eligibility criteria not met|0|||
48865796|NCT04872101|157345572|FG000|Overall Study|Withdrawal by Subject|10|||
48865797|NCT04872101|157345573|FG001|Overall Study|Withdrawal by Subject|16|||
48865798|NCT04872101|157345572|FG000|Overall Study|Lack of Efficacy|6|||
48865799|NCT04872101|157345573|FG001|Overall Study|Lack of Efficacy|14|||
48865800|NCT04872101|157345572|FG000|Overall Study|Adverse Event|1|||
48865801|NCT04872101|157345573|FG001|Overall Study|Adverse Event|6|||
48865802|NCT04872101|157345572|FG000|Overall Study|Lost to Follow-up|2|||
48865803|NCT04872101|157345573|FG001|Overall Study|Lost to Follow-up|1|||
48865804|NCT04872101|157345572|FG000|Overall Study|Pregnancy|2|||
48865805|NCT04872101|157345573|FG001|Overall Study|Pregnancy|0|||
48865806|NCT04872101|157345572|FG000|Overall Study|Prohibited Medication|1|||
48865807|NCT04872101|157345573|FG001|Overall Study|Prohibited Medication|0|||
48865808|NCT04872101|157345572|FG000|Overall Study|Not dosed|1|||
48865809|NCT04872101|157345573|FG001|Overall Study|Not dosed|0|||
48865810|NCT03997409|157345574|FG000|Overall Study|Protocol Violation|1|||
48865811|NCT03997409|157345575|FG001|Overall Study|Protocol Violation|1|||
48865812|NCT03997409|157345576|FG002|Overall Study|Protocol Violation|0|||
48865813|NCT03997409|157345574|FG000|Overall Study|Withdrawal by Subject|3|||
48656469|NCT01461928|156595951|FG000|Maintenance II (15 Months)|Withdrawal by Subject|0|||
48656470|NCT01461928|156595952|FG001|Maintenance II (15 Months)|Withdrawal by Subject|9|||
48656471|NCT01461928|156595953|FG002|Maintenance II (15 Months)|Withdrawal by Subject|8|||
48656472|NCT01461928|156595951|FG000|Maintenance II (15 Months)|Changed physician in another hospital|0|||
48656473|NCT01461928|156595952|FG001|Maintenance II (15 Months)|Changed physician in another hospital|0|||
48656474|NCT01461928|156595953|FG002|Maintenance II (15 Months)|Changed physician in another hospital|1|||
48656475|NCT01461928|156595951|FG000|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
48656476|NCT01461928|156595952|FG001|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
48656477|NCT01461928|156595953|FG002|Maintenance II (15 Months)|Squamous lung carcinoma|1|||
48656478|NCT01461928|156595951|FG000|Maintenance II (15 Months)|Withdrew informed consent|0|||
48656479|NCT01461928|156595952|FG001|Maintenance II (15 Months)|Withdrew informed consent|0|||
48656480|NCT01461928|156595953|FG002|Maintenance II (15 Months)|Withdrew informed consent|1|||
48656481|NCT01461928|156595951|FG000|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
48656482|NCT01461928|156595952|FG001|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
48656483|NCT01461928|156595953|FG002|Maintenance II (15 Months)|Refused to be transferred to other site|1|||
48656484|NCT02150057|156595967|FG000|Overall Study|Lost to Follow-up|6|||
48656485|NCT02150057|156595968|FG001|Overall Study|Lost to Follow-up|4|||
48656486|NCT00664560|156595969|FG000|Overall Study|Adverse Event|19|||
48754660|NCT00137046|156948137|FG001|Overall Study|Withdrawal by Subject|42|||
48754661|NCT00137046|156948136|FG000|Overall Study|Adverse Event 4 Days after Last Dose|1|||
48754662|NCT00137046|156948137|FG001|Overall Study|Adverse Event 4 Days after Last Dose|0|||
48754663|NCT00137046|156948136|FG000|Overall Study|Withdrew prior to study treatment|1|||
48754664|NCT00137046|156948137|FG001|Overall Study|Withdrew prior to study treatment|1|||
48754665|NCT03187262|156948138|FG000|Induction|Lack of Efficacy|2|||
48754666|NCT03187262|156948138|FG000|Induction|Progressive Disease|4|||
48754667|NCT03187262|156948138|FG000|Consolidation|Progressive Disease|5|||
48754668|NCT00110149|156948139|FG000|Overall Study|Physician Decision|3|||
48754669|NCT00191789|156948142|FG000|Overall Study|Adverse Event|5|||
48754670|NCT00191789|156948142|FG000|Overall Study|Patient: Satisfactory Response|5|||
48754671|NCT00191789|156948142|FG000|Overall Study|Patient/Physician: Satisfactory Response|4|||
48754672|NCT00191789|156948142|FG000|Overall Study|Withdrawal by Subject|4|||
48754673|NCT00191789|156948142|FG000|Overall Study|Death - Possibly Study Drug Related|4|||
48754674|NCT00191789|156948142|FG000|Overall Study|Progressive Disease/Lack of Efficacy|2|||
48754675|NCT00191789|156948142|FG000|Overall Study|Death - Not Study-Drug Related|1|||
48754676|NCT03334448|156948145|FG000|Washout|Personal Reason|0|||
48754677|NCT03334448|156948146|FG001|Washout|Personal Reason|1|||
48754678|NCT03334448|156948147|FG002|Washout|Personal Reason|0|||
48754679|NCT03334448|156948148|FG003|Washout|Personal Reason|0|||
48754680|NCT03334448|156948145|FG000|Washout|Protocol Violation|0|||
48754681|NCT03334448|156948146|FG001|Washout|Protocol Violation|0|||
48754682|NCT03334448|156948147|FG002|Washout|Protocol Violation|0|||
48754683|NCT03334448|156948148|FG003|Washout|Protocol Violation|1|||
48754684|NCT02326025|156948149|FG000|Overall Study|Adverse Event|3|||
48754685|NCT02326025|156948150|FG001|Overall Study|Adverse Event|0|||
48754686|NCT02326025|156948149|FG000|Overall Study|Physician Decision|1|||
48754687|NCT02326025|156948150|FG001|Overall Study|Physician Decision|2|||
48754688|NCT02326025|156948149|FG000|Overall Study|Physician and Participant Decision|1|||
48754689|NCT02326025|156948150|FG001|Overall Study|Physician and Participant Decision|0|||
48754690|NCT02326025|156948149|FG000|Overall Study|Withdrawal by Subject|0|||
48754691|NCT02326025|156948150|FG001|Overall Study|Withdrawal by Subject|2|||
48754692|NCT02326025|156948149|FG000|Overall Study|Protocol Violation|0|||
48754693|NCT02326025|156948150|FG001|Overall Study|Protocol Violation|1|||
48754694|NCT00467259|156948151|FG000|Overall Study|Adverse Event|24|||
48754695|NCT00467259|156948152|FG001|Overall Study|Adverse Event|90|||
48754696|NCT00467259|156948151|FG000|Overall Study|Protocol Violation|1|||
48754697|NCT00467259|156948152|FG001|Overall Study|Protocol Violation|7|||
48754698|NCT00467259|156948151|FG000|Overall Study|Withdrawal by Subject|34|||
48754699|NCT00467259|156948152|FG001|Overall Study|Withdrawal by Subject|108|||
48754700|NCT00467259|156948151|FG000|Overall Study|Physician Decision|0|||
48754701|NCT00467259|156948152|FG001|Overall Study|Physician Decision|2|||
48754702|NCT00467259|156948151|FG000|Overall Study|Lost to Follow-up|14|||
48754703|NCT00467259|156948152|FG001|Overall Study|Lost to Follow-up|34|||
48754704|NCT00467259|156948151|FG000|Overall Study|Site Closed|2|||
48656487|NCT00664560|156595970|FG001|Overall Study|Adverse Event|16|||
48754705|NCT00467259|156948152|FG001|Overall Study|Site Closed|1|||
48754706|NCT03965962|156948155|FG000|Overall Study|Adverse Event|1|||
48754707|NCT03965962|156948156|FG001|Overall Study|Adverse Event|0|||
48754708|NCT03965962|156948157|FG002|Overall Study|Adverse Event|0|||
48754709|NCT03965962|156948158|FG003|Overall Study|Adverse Event|0|||
48754710|NCT03965962|156948155|FG000|Overall Study|Protocol Violation|21|||
48754711|NCT03965962|156948156|FG001|Overall Study|Protocol Violation|4|||
49015426|NCT00385541|157892190|FG001|Overall Study|severe pain, clinician requested unblind|1|||
48754712|NCT03965962|156948157|FG002|Overall Study|Protocol Violation|10|||
48754713|NCT03965962|156948158|FG003|Overall Study|Protocol Violation|5|||
48754714|NCT03965962|156948155|FG000|Overall Study|Lost to Follow-up|0|||
48656488|NCT00664560|156595971|FG002|Overall Study|Adverse Event|7|||
48656489|NCT00664560|156595969|FG000|Overall Study|Withdrawal by Subject|9|||
48656490|NCT00664560|156595970|FG001|Overall Study|Withdrawal by Subject|13|||
48656491|NCT00664560|156595971|FG002|Overall Study|Withdrawal by Subject|7|||
48656492|NCT00664560|156595969|FG000|Overall Study|Lost to Follow-up|0|||
48656493|NCT00664560|156595970|FG001|Overall Study|Lost to Follow-up|2|||
48656494|NCT00664560|156595971|FG002|Overall Study|Lost to Follow-up|0|||
48656495|NCT00664560|156595969|FG000|Overall Study|Other|11|||
48656496|NCT00664560|156595970|FG001|Overall Study|Other|4|||
48656497|NCT00664560|156595971|FG002|Overall Study|Other|5|||
48656498|NCT05312632|156595972|FG000|Overall Study|Adverse Event|12|||
48656499|NCT05312632|156595972|FG000|Overall Study|Withdrawal by Subject|10|||
48656500|NCT05312632|156595972|FG000|Overall Study|Lack of Efficacy|4|||
48656501|NCT05312632|156595972|FG000|Overall Study|Non-compliance with study procedures|9|||
48656502|NCT05312632|156595972|FG000|Overall Study|Other|4|||
48656503|NCT01801436|156595975|FG000|Overall Study|Withdrawal by Subject|3|||
48656504|NCT01801436|156595975|FG000|Overall Study|Adverse Event|2|||
48656505|NCT01801436|156595975|FG000|Overall Study|Progressive disease|4|||
48656506|NCT04085458|156595978|FG000|Overall Study|Other|1|||
48656507|NCT04085458|156595978|FG000|Overall Study|Withdrawal by Subject|2|||
48656508|NCT04085458|156595978|FG000|Overall Study|Adverse Event|2|||
48656509|NCT01005316|156595983|FG000|Overall Study|Adverse Event|0|||
48656510|NCT01005316|156595984|FG001|Overall Study|Adverse Event|0|||
48656511|NCT01005316|156595985|FG002|Overall Study|Adverse Event|0|||
48656512|NCT01005316|156595986|FG003|Overall Study|Adverse Event|1|||
48656513|NCT01005316|156595983|FG000|Overall Study|Death|20|||
48656514|NCT01005316|156595984|FG001|Overall Study|Death|5|||
48656515|NCT01005316|156595985|FG002|Overall Study|Death|1|||
48656516|NCT01005316|156595986|FG003|Overall Study|Death|15|||
48656517|NCT01005316|156595983|FG000|Overall Study|Study Termination|5|||
48656518|NCT01005316|156595984|FG001|Overall Study|Study Termination|63|||
48656519|NCT01005316|156595985|FG002|Overall Study|Study Termination|9|||
48656520|NCT01005316|156595986|FG003|Overall Study|Study Termination|85|||
48656521|NCT01005316|156595983|FG000|Overall Study|Lost to Follow-up|1|||
48656522|NCT01005316|156595984|FG001|Overall Study|Lost to Follow-up|3|||
48656523|NCT01005316|156595985|FG002|Overall Study|Lost to Follow-up|0|||
48656524|NCT01005316|156595986|FG003|Overall Study|Lost to Follow-up|2|||
48656525|NCT01005316|156595983|FG000|Overall Study|Physician Decision|6|||
48656526|NCT01005316|156595984|FG001|Overall Study|Physician Decision|0|||
48656527|NCT01005316|156595985|FG002|Overall Study|Physician Decision|0|||
48656528|NCT01005316|156595986|FG003|Overall Study|Physician Decision|0|||
48656529|NCT01005316|156595983|FG000|Overall Study|Sponsor Decision|6|||
48656530|NCT01005316|156595984|FG001|Overall Study|Sponsor Decision|3|||
48656531|NCT01005316|156595985|FG002|Overall Study|Sponsor Decision|0|||
48656532|NCT01005316|156595986|FG003|Overall Study|Sponsor Decision|0|||
48656533|NCT01005316|156595983|FG000|Overall Study|Withdrawal by Subject|1|||
48656534|NCT01005316|156595984|FG001|Overall Study|Withdrawal by Subject|1|||
48656535|NCT01005316|156595985|FG002|Overall Study|Withdrawal by Subject|0|||
48656536|NCT01005316|156595986|FG003|Overall Study|Withdrawal by Subject|2|||
48656537|NCT01005316|156595983|FG000|Overall Study|Consented to Another Study|2|||
48656538|NCT01005316|156595984|FG001|Overall Study|Consented to Another Study|0|||
48656539|NCT01005316|156595985|FG002|Overall Study|Consented to Another Study|0|||
48656540|NCT01005316|156595986|FG003|Overall Study|Consented to Another Study|0|||
48656541|NCT01005316|156595983|FG000|Overall Study|Delisted|8|||
48656542|NCT01005316|156595984|FG001|Overall Study|Delisted|0|||
48656543|NCT01005316|156595985|FG002|Overall Study|Delisted|0|||
48656544|NCT01005316|156595986|FG003|Overall Study|Delisted|0|||
48656545|NCT01005316|156595983|FG000|Overall Study|Transferred Care|1|||
48656546|NCT01005316|156595984|FG001|Overall Study|Transferred Care|0|||
48656547|NCT01005316|156595985|FG002|Overall Study|Transferred Care|1|||
48656548|NCT01005316|156595986|FG003|Overall Study|Transferred Care|3|||
48656549|NCT01005316|156595983|FG000|Overall Study|Retransplanted|0|||
48656550|NCT01005316|156595984|FG001|Overall Study|Retransplanted|1|||
48656551|NCT01005316|156595985|FG002|Overall Study|Retransplanted|0|||
48656552|NCT01005316|156595986|FG003|Overall Study|Retransplanted|0|||
48656553|NCT00960011|156595987|FG000|Overall Study|Death|5|||
48656554|NCT00960011|156595988|FG001|Overall Study|Death|0|||
48656555|NCT00960011|156595987|FG000|Overall Study|Lost to Follow-up|6|||
48656556|NCT00960011|156595988|FG001|Overall Study|Lost to Follow-up|2|||
48656557|NCT01007435|156595992|FG000|Overall Study|Adverse Event|16|||
48656558|NCT01007435|156595993|FG001|Overall Study|Adverse Event|25|||
49015427|NCT02688608|157892191|FG000|Overall Study|Lost to Follow-up|1|||
48656559|NCT01007435|156595994|FG002|Overall Study|Adverse Event|47|||
48656560|NCT01007435|156595995|FG003|Overall Study|Adverse Event|31|||
48656561|NCT01007435|156595992|FG000|Overall Study|Death|2|||
48656562|NCT01007435|156595993|FG001|Overall Study|Death|4|||
48656563|NCT01007435|156595994|FG002|Overall Study|Death|2|||
48656564|NCT01007435|156595995|FG003|Overall Study|Death|1|||
48656565|NCT01007435|156595992|FG000|Overall Study|Insufficient Therapeutic Response|21|||
48656566|NCT01007435|156595993|FG001|Overall Study|Insufficient Therapeutic Response|7|||
48656567|NCT01007435|156595994|FG002|Overall Study|Insufficient Therapeutic Response|2|||
48656568|NCT01007435|156595995|FG003|Overall Study|Insufficient Therapeutic Response|9|||
48656569|NCT01007435|156595992|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
48656570|NCT01007435|156595993|FG001|Overall Study|Violation of Selection Criteria at Entry|5|||
48656571|NCT01007435|156595994|FG002|Overall Study|Violation of Selection Criteria at Entry|2|||
48656572|NCT01007435|156595995|FG003|Overall Study|Violation of Selection Criteria at Entry|0|||
48656573|NCT01007435|156595992|FG000|Overall Study|Other Protocol Violation|2|||
48656574|NCT01007435|156595993|FG001|Overall Study|Other Protocol Violation|0|||
48656575|NCT01007435|156595994|FG002|Overall Study|Other Protocol Violation|1|||
48656576|NCT01007435|156595995|FG003|Overall Study|Other Protocol Violation|0|||
48656577|NCT01007435|156595992|FG000|Overall Study|Refused Treatment|13|||
48656578|NCT01007435|156595993|FG001|Overall Study|Refused Treatment|13|||
48656579|NCT01007435|156595994|FG002|Overall Study|Refused Treatment|5|||
48656580|NCT01007435|156595995|FG003|Overall Study|Refused Treatment|8|||
48656581|NCT01007435|156595992|FG000|Overall Study|Failure to Return|5|||
48656582|NCT01007435|156595993|FG001|Overall Study|Failure to Return|4|||
48656583|NCT01007435|156595994|FG002|Overall Study|Failure to Return|3|||
48656584|NCT01007435|156595995|FG003|Overall Study|Failure to Return|6|||
48656585|NCT01007435|156595992|FG000|Overall Study|Reason not Specified|1|||
48656586|NCT01007435|156595993|FG001|Overall Study|Reason not Specified|1|||
48656587|NCT01007435|156595994|FG002|Overall Study|Reason not Specified|2|||
48656588|NCT01007435|156595995|FG003|Overall Study|Reason not Specified|1|||
48656589|NCT01734395|156595996|FG000|Overall Study|Other|65|||
48656590|NCT01734395|156595996|FG000|Overall Study|Lost to Follow-up|287|||
48656591|NCT01734395|156595996|FG000|Overall Study|Lack of Efficacy|5|||
48656592|NCT01734395|156595996|FG000|Overall Study|Adverse Event|40|||
48656593|NCT01734395|156595996|FG000|Overall Study|Withdrawal by Subject|10|||
48656594|NCT01734395|156595996|FG000|Overall Study|Missing the reasons for not completed|3|||
48656595|NCT01190475|156595999|FG000|Overall Study|Withdrawal by Subject|0|||
48656596|NCT01190475|156596000|FG001|Overall Study|Withdrawal by Subject|0|||
48656597|NCT01190475|156596001|FG002|Overall Study|Withdrawal by Subject|1|||
48656598|NCT00624585|156596002|FG000|Overall Study|Death|3|||
48656599|NCT00624585|156596002|FG000|Overall Study|Disease Progression|6|||
48656600|NCT00624585|156596002|FG000|Overall Study|Adverse Event|3|||
48656601|NCT00113399|156596008|FG000|Overall Study|Death|1|||
48656602|NCT00113399|156596009|FG001|Overall Study|Death|1|||
48656603|NCT00113399|156596008|FG000|Overall Study|Withdrawal by Subject|1|||
48656604|NCT00113399|156596009|FG001|Overall Study|Withdrawal by Subject|2|||
48962181|NCT03288493|157689904|FG006|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
48656605|NCT00113399|156596008|FG000|Overall Study|Complete Response|0|||
48656606|NCT00113399|156596009|FG001|Overall Study|Complete Response|1|||
48656607|NCT00113399|156596008|FG000|Overall Study|Other|0|||
48656608|NCT00113399|156596009|FG001|Overall Study|Other|1|||
48656609|NCT00396136|156596010|FG000|Overall Study|Death|43|||
48656610|NCT00396136|156596010|FG000|Overall Study|Withdrawal by Subject|59|||
48656611|NCT00396136|156596010|FG000|Overall Study|Lost to Follow-up|15|||
48962182|NCT03288493|157689898|FG000|Overall Study|Death|2|||
48962183|NCT03288493|157689899|FG001|Overall Study|Death|0|||
48962184|NCT03288493|157689900|FG002|Overall Study|Death|0|||
48962185|NCT03288493|157689901|FG003|Overall Study|Death|0|||
48962186|NCT03288493|157689902|FG004|Overall Study|Death|0|||
48962187|NCT03288493|157689903|FG005|Overall Study|Death|0|||
48962188|NCT03288493|157689904|FG006|Overall Study|Death|0|||
48962189|NCT03288493|157689898|FG000|Overall Study|other reason not listed above|2|||
48656612|NCT00396136|156596010|FG000|Overall Study|Study device explanted|8|||
48656613|NCT03350256|156596013|FG000|Overall Study|Inclusion/exclusion violation|4|||
48656614|NCT03350256|156596013|FG000|Overall Study|Recommended for other therapies|2|||
48656615|NCT03350256|156596013|FG000|Overall Study|Protocol Violation|3|||
48656616|NCT03350256|156596013|FG000|Overall Study|Non compliance|2|||
48656617|NCT03350256|156596013|FG000|Overall Study|Denial by insurance|1|||
48656618|NCT03350256|156596013|FG000|Overall Study|Adverse Event|2|||
48656619|NCT03350256|156596013|FG000|Overall Study|Trial failure|12|||
48656620|NCT03350256|156596013|FG000|Overall Study|Did not proceed to permanent implant|3|||
48656621|NCT03350256|156596013|FG000|Overall Study|Withdrawal by Subject|3|||
48656622|NCT03350256|156596013|FG000|Overall Study|Subject moving out of state|1|||
48656623|NCT03350256|156596013|FG000|Overall Study|Lost to Follow-up|1|||
48656624|NCT03350256|156596013|FG000|Overall Study|Lack of Efficacy|2|||
48656625|NCT01425359|156596014|FG000|Overall Study|Randomized but Not Treated|2|||
48656626|NCT01425359|156596015|FG001|Overall Study|Randomized but Not Treated|3|||
48656627|NCT01425359|156596014|FG000|Overall Study|Adverse Event|9|||
48656628|NCT01425359|156596015|FG001|Overall Study|Adverse Event|8|||
48656629|NCT01425359|156596014|FG000|Overall Study|Revascularization|0|||
48656630|NCT01425359|156596015|FG001|Overall Study|Revascularization|1|||
48656631|NCT01425359|156596014|FG000|Overall Study|Death|0|||
48656632|NCT01425359|156596015|FG001|Overall Study|Death|1|||
48656633|NCT01425359|156596014|FG000|Overall Study|Unsatisfactory Response|1|||
48656634|NCT01425359|156596015|FG001|Overall Study|Unsatisfactory Response|0|||
48656635|NCT01425359|156596014|FG000|Overall Study|Protocol Violation|1|||
48656636|NCT01425359|156596015|FG001|Overall Study|Protocol Violation|2|||
48656637|NCT01425359|156596014|FG000|Overall Study|Subject Withdrew Consent|1|||
48656638|NCT01425359|156596015|FG001|Overall Study|Subject Withdrew Consent|2|||
48656639|NCT01425359|156596014|FG000|Overall Study|Investigator's Discretion|2|||
48656640|NCT01425359|156596015|FG001|Overall Study|Investigator's Discretion|0|||
48656641|NCT01425359|156596014|FG000|Overall Study|Did Not Meet Qualifying Criteria|3|||
48656642|NCT01425359|156596015|FG001|Overall Study|Did Not Meet Qualifying Criteria|5|||
48656643|NCT03172325|156596018|FG000|Overall Study|Adverse Event|2|||
48656644|NCT03172325|156596019|FG001|Overall Study|Adverse Event|3|||
48656645|NCT03172325|156596018|FG000|Overall Study|Positive PPD|1|||
48656646|NCT03172325|156596019|FG001|Overall Study|Positive PPD|0|||
48656647|NCT03172325|156596018|FG000|Overall Study|Poor Compliance|1|||
48656648|NCT03172325|156596019|FG001|Overall Study|Poor Compliance|1|||
48656649|NCT04043234|156596020|FG000|Overall Study|Lost to Follow-up|1|||
48656650|NCT04043234|156596020|FG000|Overall Study|Withdrawal by Subject|1|||
48656651|NCT02135029|156596021|FG000|Overall Study|Adverse Event|2|||
48656652|NCT02135029|156596022|FG001|Overall Study|Adverse Event|2|||
48656653|NCT02135029|156596023|FG002|Overall Study|Adverse Event|2|||
48656654|NCT02135029|156596021|FG000|Overall Study|Lost to Follow-up|0|||
48656655|NCT02135029|156596022|FG001|Overall Study|Lost to Follow-up|1|||
48656656|NCT02135029|156596023|FG002|Overall Study|Lost to Follow-up|0|||
48656657|NCT02135029|156596021|FG000|Overall Study|Withdrawal by Subject|2|||
48656658|NCT02135029|156596022|FG001|Overall Study|Withdrawal by Subject|0|||
48656659|NCT02135029|156596023|FG002|Overall Study|Withdrawal by Subject|1|||
48656660|NCT02135029|156596021|FG000|Overall Study|Other|0|||
48656661|NCT02135029|156596022|FG001|Overall Study|Other|1|||
48656662|NCT02135029|156596023|FG002|Overall Study|Other|0|||
48656663|NCT02135029|156596021|FG000|Overall Study|Death|0|||
48656664|NCT02135029|156596022|FG001|Overall Study|Death|1|||
48656665|NCT02135029|156596023|FG002|Overall Study|Death|0|||
48656666|NCT00503776|156596026|FG000|Overall Study|Withdrawal by Subject|1|||
48656667|NCT00503776|156596027|FG001|Overall Study|Withdrawal by Subject|0|||
48656668|NCT00503776|156596028|FG002|Overall Study|Withdrawal by Subject|1|||
48656669|NCT00503776|156596029|FG003|Overall Study|Withdrawal by Subject|1|||
48656670|NCT00503776|156596026|FG000|Overall Study|Physician Decision|0|||
48656671|NCT00503776|156596027|FG001|Overall Study|Physician Decision|0|||
48656672|NCT00503776|156596028|FG002|Overall Study|Physician Decision|1|||
48656673|NCT00503776|156596029|FG003|Overall Study|Physician Decision|1|||
48656674|NCT02778555|156596030|FG000|Overall Study|Withdrawal by Subject|55|||
48656675|NCT02778555|156596031|FG001|Overall Study|Withdrawal by Subject|32|||
48656676|NCT02778555|156596032|FG002|Overall Study|Withdrawal by Subject|107|||
48656677|NCT03403361|156596033|FG000|Overall Study|Not imaged due to issues during the pandemic|16|||
48656678|NCT00107315|156596034|FG000|Overall Study|Disease Progression|9|||
48656679|NCT00107315|156596034|FG000|Overall Study|Adverse Event|4|||
48656680|NCT00107315|156596034|FG000|Overall Study|Withdrawal by Subject|2|||
48656681|NCT02901054|156596037|FG000|Overall Study|Physician Decision|1|||
48656682|NCT02901054|156596037|FG000|Overall Study|Withdrawal by Subject|3|||
48656683|NCT03006848|156596040|FG000|Overall Study|Adverse Event|1|||
48656684|NCT03006848|156596040|FG000|Overall Study|Physician Decision|1|||
48656685|NCT03006848|156596040|FG000|Overall Study|Lack of Efficacy|16|||
48656686|NCT00541866|156596041|FG000|Overall Study|Adverse Event|3|||
48656687|NCT00541866|156596042|FG001|Overall Study|Adverse Event|0|||
48656688|NCT00541866|156596043|FG002|Overall Study|Adverse Event|0|||
48656689|NCT00541866|156596044|FG003|Overall Study|Adverse Event|0|||
48656690|NCT00541866|156596045|FG004|Overall Study|Adverse Event|0|||
48656691|NCT00541866|156596041|FG000|Overall Study|Death|1|||
48656692|NCT00541866|156596042|FG001|Overall Study|Death|0|||
48656693|NCT00541866|156596043|FG002|Overall Study|Death|0|||
48656694|NCT00541866|156596044|FG003|Overall Study|Death|0|||
48656695|NCT00541866|156596045|FG004|Overall Study|Death|0|||
48656696|NCT00541866|156596041|FG000|Overall Study|Lack of Efficacy|19|||
48656697|NCT00541866|156596042|FG001|Overall Study|Lack of Efficacy|15|||
48656698|NCT00541866|156596043|FG002|Overall Study|Lack of Efficacy|10|||
48656699|NCT00541866|156596044|FG003|Overall Study|Lack of Efficacy|12|||
48656700|NCT00541866|156596045|FG004|Overall Study|Lack of Efficacy|14|||
48656701|NCT00541866|156596041|FG000|Overall Study|Not Reported or Other|11|||
48656702|NCT00541866|156596042|FG001|Overall Study|Not Reported or Other|3|||
48656703|NCT00541866|156596043|FG002|Overall Study|Not Reported or Other|3|||
48656704|NCT00541866|156596044|FG003|Overall Study|Not Reported or Other|3|||
48656705|NCT00541866|156596045|FG004|Overall Study|Not Reported or Other|1|||
48656706|NCT00541866|156596041|FG000|Overall Study|Physician Decision|0|||
48656707|NCT00541866|156596042|FG001|Overall Study|Physician Decision|0|||
48656708|NCT00541866|156596043|FG002|Overall Study|Physician Decision|2|||
48656709|NCT00541866|156596044|FG003|Overall Study|Physician Decision|1|||
48656710|NCT00541866|156596045|FG004|Overall Study|Physician Decision|0|||
48656711|NCT00522418|156596046|FG000|Overall Study|Local IRB Consent Violation|5|||
48656712|NCT00522418|156596047|FG001|Overall Study|Local IRB Consent Violation|5|||
48656713|NCT00522418|156596046|FG000|Overall Study|Early Study Termination|46|||
48656714|NCT00522418|156596047|FG001|Overall Study|Early Study Termination|47|||
48656715|NCT00522418|156596046|FG000|Overall Study|Noncompliance|2|||
48656716|NCT00522418|156596047|FG001|Overall Study|Noncompliance|2|||
48656717|NCT00522418|156596046|FG000|Overall Study|Reason Not Specified|3|||
48656718|NCT00522418|156596047|FG001|Overall Study|Reason Not Specified|1|||
48656719|NCT00522418|156596046|FG000|Overall Study|Consent Withdraw|1|||
48656720|NCT00522418|156596047|FG001|Overall Study|Consent Withdraw|2|||
48656721|NCT00522418|156596046|FG000|Overall Study|Lack of Efficacy|0|||
48656722|NCT00522418|156596047|FG001|Overall Study|Lack of Efficacy|1|||
48656723|NCT00433160|156596052|FG000|52-Week Double-Blind (DB) Period|Adverse Event|6|||
48656724|NCT00433160|156596053|FG001|52-Week Double-Blind (DB) Period|Adverse Event|2|||
48656725|NCT00433160|156596052|FG000|52-Week Double-Blind (DB) Period|Death|0|||
48656726|NCT00433160|156596053|FG001|52-Week Double-Blind (DB) Period|Death|0|||
48656727|NCT00433160|156596052|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
48656728|NCT00433160|156596053|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
48656729|NCT00433160|156596052|FG000|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0|||
48656730|NCT00433160|156596053|FG001|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1|||
48656731|NCT00433160|156596052|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
48656732|NCT00433160|156596053|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|2|||
48656733|NCT00433160|156596052|FG000|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6|||
48656734|NCT00433160|156596053|FG001|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1|||
48656735|NCT00433160|156596052|FG000|52-Week Double-Blind (DB) Period|Physician Decision|4|||
48656736|NCT00433160|156596053|FG001|52-Week Double-Blind (DB) Period|Physician Decision|2|||
48962190|NCT03288493|157689899|FG001|Overall Study|other reason not listed above|0|||
48656737|NCT00433160|156596052|FG000|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
48656738|NCT00433160|156596053|FG001|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
48656739|NCT00433160|156596052|FG000|52-Week Double-Blind (DB) Period|Lack of Efficacy|1|||
48656740|NCT00433160|156596053|FG001|52-Week Double-Blind (DB) Period|Lack of Efficacy|2|||
48656741|NCT00433160|156596052|FG000|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3|||
48656742|NCT00433160|156596053|FG001|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1|||
48656743|NCT00433160|156596052|FG000|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1|||
48656744|NCT00433160|156596053|FG001|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2|||
48656745|NCT00433160|156596052|FG000|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2|||
48656746|NCT00433160|156596053|FG001|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0|||
48656747|NCT00433160|156596052|FG000|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0|||
48656748|NCT00433160|156596053|FG001|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1|||
48656749|NCT00433160|156596052|FG000|104 Weeks, 28-Week OL Period|Adverse Event|2|||
48656750|NCT00433160|156596053|FG001|104 Weeks, 28-Week OL Period|Adverse Event|0|||
48656751|NCT00433160|156596052|FG000|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8|||
48656752|NCT00433160|156596053|FG001|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2|||
48656753|NCT00433160|156596052|FG000|104 Weeks, 28-Week OL Period|Physician Decision|0|||
48656754|NCT00433160|156596053|FG001|104 Weeks, 28-Week OL Period|Physician Decision|1|||
48656755|NCT00075725|156596054|FG000|Overall Study|Adverse Event|6|||
48656756|NCT00075725|156596055|FG001|Overall Study|Adverse Event|6|||
48656757|NCT00075725|156596056|FG002|Overall Study|Adverse Event|20|||
48656758|NCT00075725|156596057|FG003|Overall Study|Adverse Event|8|||
48656759|NCT00075725|156596058|FG004|Overall Study|Adverse Event|4|||
48656760|NCT00075725|156596059|FG005|Overall Study|Adverse Event|38|||
48656761|NCT00075725|156596060|FG006|Overall Study|Adverse Event|3|||
48656762|NCT00075725|156596061|FG007|Overall Study|Adverse Event|51|||
48656763|NCT00075725|156596062|FG008|Overall Study|Adverse Event|15|||
48656764|NCT00075725|156596063|FG009|Overall Study|Adverse Event|4|||
48656765|NCT00075725|156596064|FG010|Overall Study|Adverse Event|2|||
48656766|NCT00075725|156596065|FG011|Overall Study|Adverse Event|2|||
48656767|NCT00075725|156596054|FG000|Overall Study|Death|3|||
48656768|NCT00075725|156596055|FG001|Overall Study|Death|5|||
48656769|NCT00075725|156596056|FG002|Overall Study|Death|10|||
48656770|NCT00075725|156596057|FG003|Overall Study|Death|2|||
48656771|NCT00075725|156596058|FG004|Overall Study|Death|3|||
48656772|NCT00075725|156596059|FG005|Overall Study|Death|25|||
48656773|NCT00075725|156596060|FG006|Overall Study|Death|4|||
48656774|NCT00075725|156596061|FG007|Overall Study|Death|22|||
48656775|NCT00075725|156596062|FG008|Overall Study|Death|14|||
48962191|NCT03288493|157689900|FG002|Overall Study|other reason not listed above|0|||
48656776|NCT00075725|156596063|FG009|Overall Study|Death|4|||
48656777|NCT00075725|156596064|FG010|Overall Study|Death|3|||
48656778|NCT00075725|156596065|FG011|Overall Study|Death|0|||
48656779|NCT00075725|156596054|FG000|Overall Study|Lost to Follow-up|1|||
48656780|NCT00075725|156596055|FG001|Overall Study|Lost to Follow-up|1|||
48962192|NCT03288493|157689901|FG003|Overall Study|other reason not listed above|0|||
48656781|NCT00075725|156596056|FG002|Overall Study|Lost to Follow-up|4|||
48656782|NCT00075725|156596057|FG003|Overall Study|Lost to Follow-up|1|||
48656783|NCT00075725|156596058|FG004|Overall Study|Lost to Follow-up|0|||
48656784|NCT00075725|156596059|FG005|Overall Study|Lost to Follow-up|13|||
48656785|NCT00075725|156596060|FG006|Overall Study|Lost to Follow-up|2|||
48656786|NCT00075725|156596061|FG007|Overall Study|Lost to Follow-up|4|||
48656787|NCT00075725|156596062|FG008|Overall Study|Lost to Follow-up|1|||
48656788|NCT00075725|156596063|FG009|Overall Study|Lost to Follow-up|0|||
48656789|NCT00075725|156596064|FG010|Overall Study|Lost to Follow-up|0|||
48656790|NCT00075725|156596065|FG011|Overall Study|Lost to Follow-up|0|||
48656791|NCT00075725|156596054|FG000|Overall Study|Physician Decision|2|||
48656792|NCT00075725|156596055|FG001|Overall Study|Physician Decision|6|||
48656793|NCT00075725|156596056|FG002|Overall Study|Physician Decision|5|||
48656794|NCT00075725|156596057|FG003|Overall Study|Physician Decision|8|||
48656795|NCT00075725|156596058|FG004|Overall Study|Physician Decision|4|||
48656796|NCT00075725|156596059|FG005|Overall Study|Physician Decision|19|||
48656797|NCT00075725|156596060|FG006|Overall Study|Physician Decision|3|||
48656798|NCT00075725|156596061|FG007|Overall Study|Physician Decision|17|||
48656799|NCT00075725|156596062|FG008|Overall Study|Physician Decision|5|||
48656800|NCT00075725|156596063|FG009|Overall Study|Physician Decision|0|||
48656801|NCT00075725|156596064|FG010|Overall Study|Physician Decision|1|||
48656802|NCT00075725|156596065|FG011|Overall Study|Physician Decision|0|||
48656803|NCT00075725|156596054|FG000|Overall Study|Pregnancy|0|||
48656804|NCT00075725|156596055|FG001|Overall Study|Pregnancy|0|||
48656805|NCT00075725|156596056|FG002|Overall Study|Pregnancy|0|||
48656806|NCT00075725|156596057|FG003|Overall Study|Pregnancy|0|||
48656807|NCT00075725|156596058|FG004|Overall Study|Pregnancy|0|||
48656808|NCT00075725|156596059|FG005|Overall Study|Pregnancy|1|||
48656809|NCT00075725|156596060|FG006|Overall Study|Pregnancy|0|||
48754715|NCT03965962|156948156|FG001|Overall Study|Lost to Follow-up|1|||
48656810|NCT00075725|156596061|FG007|Overall Study|Pregnancy|1|||
48754716|NCT03965962|156948157|FG002|Overall Study|Lost to Follow-up|0|||
48754717|NCT03965962|156948158|FG003|Overall Study|Lost to Follow-up|0|||
48754718|NCT03965962|156948155|FG000|Overall Study|Withdrawal by Subject|3|||
48754719|NCT03965962|156948156|FG001|Overall Study|Withdrawal by Subject|0|||
48754720|NCT03965962|156948157|FG002|Overall Study|Withdrawal by Subject|0|||
48754721|NCT03965962|156948158|FG003|Overall Study|Withdrawal by Subject|1|||
48754722|NCT04285879|156948160|FG000|Overall Study|Lost to Follow-up|1|||
48754723|NCT04285879|156948161|FG001|Overall Study|Lost to Follow-up|8|||
48754724|NCT04285879|156948160|FG000|Overall Study|medical/surgical exclusion|16|||
48754725|NCT04285879|156948161|FG001|Overall Study|medical/surgical exclusion|0|||
48754726|NCT04900220|156948162|FG000|Overall Study|Lost to Follow-up|1|||
48962193|NCT03288493|157689902|FG004|Overall Study|other reason not listed above|0|||
48962194|NCT03288493|157689903|FG005|Overall Study|other reason not listed above|0|||
48962195|NCT03288493|157689904|FG006|Overall Study|other reason not listed above|0|||
48962196|NCT00910429|157689905|FG000|Overall Study|Death|18|||
48962197|NCT00910429|157689906|FG001|Overall Study|Death|12|||
48962198|NCT00910429|157689905|FG000|Overall Study|Withdrawal by Subject|3|||
48962199|NCT00910429|157689906|FG001|Overall Study|Withdrawal by Subject|2|||
48962200|NCT00910429|157689905|FG000|Overall Study|Protocol Violation|1|||
48962201|NCT00910429|157689906|FG001|Overall Study|Protocol Violation|0|||
48962202|NCT00910429|157689905|FG000|Overall Study|Lost to Follow-up|2|||
48962203|NCT00910429|157689906|FG001|Overall Study|Lost to Follow-up|1|||
48962204|NCT00910429|157689905|FG000|Overall Study|Adverse Event|10|||
48962205|NCT00910429|157689906|FG001|Overall Study|Adverse Event|5|||
48656811|NCT00075725|156596062|FG008|Overall Study|Pregnancy|0|||
48656812|NCT00075725|156596063|FG009|Overall Study|Pregnancy|0|||
48656813|NCT00075725|156596064|FG010|Overall Study|Pregnancy|0|||
48656814|NCT00075725|156596065|FG011|Overall Study|Pregnancy|0|||
48656815|NCT00075725|156596054|FG000|Overall Study|Protocol Violation|1|||
48656816|NCT00075725|156596055|FG001|Overall Study|Protocol Violation|1|||
48656817|NCT00075725|156596056|FG002|Overall Study|Protocol Violation|0|||
48656818|NCT00075725|156596057|FG003|Overall Study|Protocol Violation|3|||
48656819|NCT00075725|156596058|FG004|Overall Study|Protocol Violation|3|||
48656820|NCT00075725|156596059|FG005|Overall Study|Protocol Violation|2|||
48656821|NCT00075725|156596060|FG006|Overall Study|Protocol Violation|1|||
48656822|NCT00075725|156596061|FG007|Overall Study|Protocol Violation|2|||
48656823|NCT00075725|156596062|FG008|Overall Study|Protocol Violation|3|||
48656824|NCT00075725|156596063|FG009|Overall Study|Protocol Violation|0|||
48656825|NCT00075725|156596064|FG010|Overall Study|Protocol Violation|0|||
48656826|NCT00075725|156596065|FG011|Overall Study|Protocol Violation|1|||
48962206|NCT00910429|157689905|FG000|Overall Study|Drug non-compliance|1|||
48656827|NCT00075725|156596054|FG000|Overall Study|Withdrawal by Subject|12|||
48656828|NCT00075725|156596055|FG001|Overall Study|Withdrawal by Subject|3|||
48656829|NCT00075725|156596056|FG002|Overall Study|Withdrawal by Subject|6|||
48962207|NCT00910429|157689906|FG001|Overall Study|Drug non-compliance|0|||
48962208|NCT00910429|157689905|FG000|Overall Study|Lack of Efficacy|4|||
48962209|NCT00910429|157689906|FG001|Overall Study|Lack of Efficacy|1|||
48656830|NCT00075725|156596057|FG003|Overall Study|Withdrawal by Subject|10|||
48656831|NCT00075725|156596058|FG004|Overall Study|Withdrawal by Subject|6|||
48656832|NCT00075725|156596059|FG005|Overall Study|Withdrawal by Subject|27|||
48656833|NCT00075725|156596060|FG006|Overall Study|Withdrawal by Subject|7|||
48656834|NCT00075725|156596061|FG007|Overall Study|Withdrawal by Subject|31|||
48656835|NCT00075725|156596062|FG008|Overall Study|Withdrawal by Subject|10|||
48656836|NCT00075725|156596063|FG009|Overall Study|Withdrawal by Subject|2|||
48754727|NCT04900220|156948163|FG001|Overall Study|Lost to Follow-up|1|||
48754728|NCT00877383|156948170|FG000|Overall Study|Adverse Event|13|||
48656837|NCT00075725|156596064|FG010|Overall Study|Withdrawal by Subject|0|||
48656838|NCT00075725|156596065|FG011|Overall Study|Withdrawal by Subject|0|||
48962210|NCT01317615|157689907|FG000|Overall Study|Disease progression|25|||
48962211|NCT01317615|157689907|FG000|Overall Study|New cancer therapy|5|||
48656839|NCT00075725|156596054|FG000|Overall Study|Disease Progression, all other reasons|17|||
48656840|NCT00075725|156596055|FG001|Overall Study|Disease Progression, all other reasons|5|||
48656841|NCT00075725|156596056|FG002|Overall Study|Disease Progression, all other reasons|33|||
48656842|NCT00075725|156596057|FG003|Overall Study|Disease Progression, all other reasons|6|||
48656843|NCT00075725|156596058|FG004|Overall Study|Disease Progression, all other reasons|21|||
48656844|NCT00075725|156596059|FG005|Overall Study|Disease Progression, all other reasons|59|||
48656845|NCT00075725|156596060|FG006|Overall Study|Disease Progression, all other reasons|20|||
48656846|NCT00075725|156596061|FG007|Overall Study|Disease Progression, all other reasons|46|||
48656847|NCT00075725|156596062|FG008|Overall Study|Disease Progression, all other reasons|21|||
48656848|NCT00075725|156596063|FG009|Overall Study|Disease Progression, all other reasons|4|||
48656849|NCT00075725|156596064|FG010|Overall Study|Disease Progression, all other reasons|0|||
48656850|NCT00075725|156596065|FG011|Overall Study|Disease Progression, all other reasons|5|||
48656851|NCT00075725|156596054|FG000|Overall Study|Patient off treatment|0|||
48656852|NCT00075725|156596055|FG001|Overall Study|Patient off treatment|0|||
48656853|NCT00075725|156596056|FG002|Overall Study|Patient off treatment|1|||
48656854|NCT00075725|156596057|FG003|Overall Study|Patient off treatment|2|||
48656855|NCT00075725|156596058|FG004|Overall Study|Patient off treatment|1|||
48656856|NCT00075725|156596059|FG005|Overall Study|Patient off treatment|0|||
48656857|NCT00075725|156596060|FG006|Overall Study|Patient off treatment|0|||
48656858|NCT00075725|156596061|FG007|Overall Study|Patient off treatment|2|||
48656859|NCT00075725|156596062|FG008|Overall Study|Patient off treatment|1|||
48656860|NCT00075725|156596063|FG009|Overall Study|Patient off treatment|0|||
48656861|NCT00075725|156596064|FG010|Overall Study|Patient off treatment|0|||
48656862|NCT00075725|156596065|FG011|Overall Study|Patient off treatment|0|||
48656863|NCT00075725|156596054|FG000|Overall Study|Ineligible or wrong diagnosis|8|||
48656864|NCT00075725|156596055|FG001|Overall Study|Ineligible or wrong diagnosis|3|||
48656865|NCT00075725|156596056|FG002|Overall Study|Ineligible or wrong diagnosis|3|||
48656866|NCT00075725|156596057|FG003|Overall Study|Ineligible or wrong diagnosis|10|||
48656867|NCT00075725|156596058|FG004|Overall Study|Ineligible or wrong diagnosis|3|||
48656868|NCT00075725|156596059|FG005|Overall Study|Ineligible or wrong diagnosis|17|||
48656869|NCT00075725|156596060|FG006|Overall Study|Ineligible or wrong diagnosis|6|||
48656870|NCT00075725|156596061|FG007|Overall Study|Ineligible or wrong diagnosis|9|||
48656871|NCT00075725|156596062|FG008|Overall Study|Ineligible or wrong diagnosis|10|||
48656872|NCT00075725|156596063|FG009|Overall Study|Ineligible or wrong diagnosis|1|||
48656873|NCT00075725|156596064|FG010|Overall Study|Ineligible or wrong diagnosis|2|||
48656874|NCT00075725|156596065|FG011|Overall Study|Ineligible or wrong diagnosis|4|||
48656875|NCT00075725|156596054|FG000|Overall Study|Pt/Guardian refused RT therapy|1|||
48656876|NCT00075725|156596055|FG001|Overall Study|Pt/Guardian refused RT therapy|0|||
48656877|NCT00075725|156596056|FG002|Overall Study|Pt/Guardian refused RT therapy|1|||
48656878|NCT00075725|156596057|FG003|Overall Study|Pt/Guardian refused RT therapy|2|||
48656879|NCT00075725|156596058|FG004|Overall Study|Pt/Guardian refused RT therapy|1|||
48656880|NCT00075725|156596059|FG005|Overall Study|Pt/Guardian refused RT therapy|0|||
48656881|NCT00075725|156596060|FG006|Overall Study|Pt/Guardian refused RT therapy|0|||
48656882|NCT00075725|156596061|FG007|Overall Study|Pt/Guardian refused RT therapy|0|||
48656883|NCT00075725|156596062|FG008|Overall Study|Pt/Guardian refused RT therapy|0|||
48656884|NCT00075725|156596063|FG009|Overall Study|Pt/Guardian refused RT therapy|0|||
48656885|NCT00075725|156596064|FG010|Overall Study|Pt/Guardian refused RT therapy|0|||
48656886|NCT00075725|156596065|FG011|Overall Study|Pt/Guardian refused RT therapy|0|||
48656887|NCT00075725|156596054|FG000|Overall Study|Pt non compliant with therapy|2|||
48656888|NCT00075725|156596055|FG001|Overall Study|Pt non compliant with therapy|1|||
48656889|NCT00075725|156596056|FG002|Overall Study|Pt non compliant with therapy|1|||
48656890|NCT00075725|156596057|FG003|Overall Study|Pt non compliant with therapy|0|||
48656891|NCT00075725|156596058|FG004|Overall Study|Pt non compliant with therapy|2|||
48656892|NCT00075725|156596059|FG005|Overall Study|Pt non compliant with therapy|14|||
48656893|NCT00075725|156596060|FG006|Overall Study|Pt non compliant with therapy|2|||
48656894|NCT00075725|156596061|FG007|Overall Study|Pt non compliant with therapy|5|||
48962212|NCT01317615|157689907|FG000|Overall Study|Death|6|||
48656895|NCT00075725|156596062|FG008|Overall Study|Pt non compliant with therapy|3|||
48656896|NCT00075725|156596063|FG009|Overall Study|Pt non compliant with therapy|0|||
48656897|NCT00075725|156596064|FG010|Overall Study|Pt non compliant with therapy|0|||
48656898|NCT00075725|156596065|FG011|Overall Study|Pt non compliant with therapy|0|||
48656899|NCT00075725|156596054|FG000|Overall Study|Pt age out of range for treatment|0|||
48656900|NCT00075725|156596055|FG001|Overall Study|Pt age out of range for treatment|1|||
48656901|NCT00075725|156596056|FG002|Overall Study|Pt age out of range for treatment|0|||
48656902|NCT00075725|156596057|FG003|Overall Study|Pt age out of range for treatment|0|||
48656903|NCT00075725|156596058|FG004|Overall Study|Pt age out of range for treatment|0|||
48962213|NCT01317615|157689907|FG000|Overall Study|Withdrawal by Subject|5|||
48754729|NCT00877383|156948171|FG001|Overall Study|Adverse Event|14|||
48754730|NCT00877383|156948170|FG000|Overall Study|Lost to Follow-up|5|||
48754731|NCT00877383|156948171|FG001|Overall Study|Lost to Follow-up|3|||
48754732|NCT00877383|156948170|FG000|Overall Study|Subject withdrew consent|3|||
48754733|NCT00877383|156948171|FG001|Overall Study|Subject withdrew consent|12|||
48754734|NCT00877383|156948170|FG000|Overall Study|Subject no longer requires study drug|2|||
48754735|NCT00877383|156948171|FG001|Overall Study|Subject no longer requires study drug|0|||
48754736|NCT00877383|156948170|FG000|Overall Study|Administrative problems|2|||
48754737|NCT00877383|156948171|FG001|Overall Study|Administrative problems|0|||
48656904|NCT00075725|156596059|FG005|Overall Study|Pt age out of range for treatment|1|||
48656905|NCT00075725|156596060|FG006|Overall Study|Pt age out of range for treatment|0|||
48656906|NCT00075725|156596061|FG007|Overall Study|Pt age out of range for treatment|1|||
48656907|NCT00075725|156596062|FG008|Overall Study|Pt age out of range for treatment|0|||
48656908|NCT00075725|156596063|FG009|Overall Study|Pt age out of range for treatment|0|||
48656909|NCT00075725|156596064|FG010|Overall Study|Pt age out of range for treatment|0|||
48656910|NCT00075725|156596065|FG011|Overall Study|Pt age out of range for treatment|0|||
48656911|NCT00075725|156596054|FG000|Overall Study|Insurance issues|0|||
48656912|NCT00075725|156596055|FG001|Overall Study|Insurance issues|1|||
48656913|NCT00075725|156596056|FG002|Overall Study|Insurance issues|0|||
48656914|NCT00075725|156596057|FG003|Overall Study|Insurance issues|1|||
48656915|NCT00075725|156596058|FG004|Overall Study|Insurance issues|1|||
48656916|NCT00075725|156596059|FG005|Overall Study|Insurance issues|1|||
48656917|NCT00075725|156596060|FG006|Overall Study|Insurance issues|0|||
48754738|NCT00877383|156948170|FG000|Overall Study|Protocol deviation|2|||
48754739|NCT00877383|156948171|FG001|Overall Study|Protocol deviation|6|||
48754740|NCT00877383|156948170|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
48754741|NCT00877383|156948171|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
48754742|NCT00877383|156948170|FG000|Overall Study|Death|1|||
48754743|NCT00877383|156948171|FG001|Overall Study|Death|2|||
48754747|NCT02669433|156948175|FG000|Overall Study|Protocol Violation|0|||
48754748|NCT02669433|156948176|FG001|Overall Study|Protocol Violation|4|||
48754749|NCT02669433|156948177|FG002|Overall Study|Protocol Violation|1|||
48754750|NCT02669433|156948175|FG000|Overall Study|Disease Progression|1|||
48754751|NCT02669433|156948176|FG001|Overall Study|Disease Progression|0|||
48754752|NCT02669433|156948177|FG002|Overall Study|Disease Progression|0|||
48754753|NCT02669433|156948175|FG000|Overall Study|Physician Decision|1|||
48656918|NCT00075725|156596061|FG007|Overall Study|Insurance issues|1|||
48754754|NCT02669433|156948176|FG001|Overall Study|Physician Decision|1|||
48754755|NCT02669433|156948177|FG002|Overall Study|Physician Decision|0|||
48754756|NCT02669433|156948175|FG000|Overall Study|Adverse Event|6|||
48754757|NCT02669433|156948176|FG001|Overall Study|Adverse Event|7|||
48656919|NCT00075725|156596062|FG008|Overall Study|Insurance issues|0|||
48656920|NCT00075725|156596063|FG009|Overall Study|Insurance issues|0|||
48656921|NCT00075725|156596064|FG010|Overall Study|Insurance issues|0|||
48656922|NCT00075725|156596065|FG011|Overall Study|Insurance issues|0|||
48656923|NCT00075725|156596054|FG000|Overall Study|MRD positive after extended ind|0|||
48656924|NCT00075725|156596055|FG001|Overall Study|MRD positive after extended ind|1|||
48754758|NCT02669433|156948177|FG002|Overall Study|Adverse Event|10|||
48754759|NCT02669433|156948175|FG000|Overall Study|Sponsor Termination|1|||
48754760|NCT02669433|156948176|FG001|Overall Study|Sponsor Termination|0|||
48754761|NCT02669433|156948177|FG002|Overall Study|Sponsor Termination|1|||
48754762|NCT02669433|156948175|FG000|Overall Study|Withdrawal by Subject|5|||
48754763|NCT02669433|156948176|FG001|Overall Study|Withdrawal by Subject|1|||
48754764|NCT02669433|156948177|FG002|Overall Study|Withdrawal by Subject|0|||
48865814|NCT03997409|157345575|FG001|Overall Study|Withdrawal by Subject|0|||
48656925|NCT00075725|156596056|FG002|Overall Study|MRD positive after extended ind|1|||
48656926|NCT00075725|156596057|FG003|Overall Study|MRD positive after extended ind|0|||
48656927|NCT00075725|156596058|FG004|Overall Study|MRD positive after extended ind|1|||
48656928|NCT00075725|156596059|FG005|Overall Study|MRD positive after extended ind|2|||
48656929|NCT00075725|156596060|FG006|Overall Study|MRD positive after extended ind|0|||
48656930|NCT00075725|156596061|FG007|Overall Study|MRD positive after extended ind|1|||
48656931|NCT00075725|156596062|FG008|Overall Study|MRD positive after extended ind|0|||
48754765|NCT02669433|156948175|FG000|Overall Study|Withdrawal by Caregiver|1|||
48754766|NCT02669433|156948176|FG001|Overall Study|Withdrawal by Caregiver|0|||
48754767|NCT02669433|156948177|FG002|Overall Study|Withdrawal by Caregiver|2|||
48865815|NCT03997409|157345576|FG002|Overall Study|Withdrawal by Subject|0|||
48656932|NCT00075725|156596063|FG009|Overall Study|MRD positive after extended ind|0|||
48754768|NCT02669433|156948175|FG000|Overall Study|Death|0|||
48754769|NCT02669433|156948176|FG001|Overall Study|Death|1|||
48754770|NCT02669433|156948177|FG002|Overall Study|Death|1|||
48754771|NCT01170091|156948178|FG000|Overall Study|Missing efficacy evaluation|3|||
48754772|NCT01170091|156948178|FG000|Overall Study|Treatment duration is less than 4 weeks|21|||
48656933|NCT00075725|156596064|FG010|Overall Study|MRD positive after extended ind|0|||
48754773|NCT03128892|156948179|FG000|Overall Study|Withdrawal by Subject|2|||
48962214|NCT01317615|157689907|FG000|Overall Study|Abnormal laboratory value(s)|1|||
48962215|NCT01317615|157689907|FG000|Overall Study|Adverse Event|7|||
48962216|NCT01968954|157689911|FG000|Overall Study|Adverse Event|6|||
48962217|NCT01968954|157689912|FG001|Overall Study|Adverse Event|3|||
48962218|NCT01968954|157689911|FG000|Overall Study|Death|1|||
48962219|NCT01968954|157689912|FG001|Overall Study|Death|2|||
48962220|NCT01968954|157689911|FG000|Overall Study|Lost to Follow-up|6|||
48962221|NCT01968954|157689912|FG001|Overall Study|Lost to Follow-up|4|||
48962222|NCT01968954|157689911|FG000|Overall Study|Withdrawal by Subject|20|||
48962223|NCT01968954|157689912|FG001|Overall Study|Withdrawal by Subject|23|||
48962224|NCT01968954|157689911|FG000|Overall Study|Other|7|||
48962225|NCT01968954|157689912|FG001|Overall Study|Other|8|||
48962226|NCT01968954|157689911|FG000|Overall Study|Protocol Violation|0|||
48962227|NCT01968954|157689912|FG001|Overall Study|Protocol Violation|1|||
48962228|NCT01968954|157689911|FG000|Overall Study|Did not met inclusion criteria|0|||
48962229|NCT01968954|157689912|FG001|Overall Study|Did not met inclusion criteria|2|||
48962230|NCT02723604|157692112|FG000|Overall Study|ineligible|1|||
48962231|NCT02723604|157692112|FG000|Overall Study|never received treatment|1|||
48962232|NCT01953328|157692113|FG000|Overall Study|Withdrawal by Subject|0|||
48962233|NCT01953328|157692114|FG001|Overall Study|Withdrawal by Subject|0|||
48962234|NCT01953328|157692115|FG002|Overall Study|Withdrawal by Subject|0|||
48656934|NCT00075725|156596065|FG011|Overall Study|MRD positive after extended ind|0|||
48656935|NCT00075725|156596054|FG000|Overall Study|Pt has very high risk ALL characteristic|15|||
48656936|NCT00075725|156596055|FG001|Overall Study|Pt has very high risk ALL characteristic|11|||
48656937|NCT00075725|156596056|FG002|Overall Study|Pt has very high risk ALL characteristic|26|||
48656938|NCT00075725|156596057|FG003|Overall Study|Pt has very high risk ALL characteristic|18|||
48656939|NCT00075725|156596058|FG004|Overall Study|Pt has very high risk ALL characteristic|11|||
48656940|NCT00075725|156596059|FG005|Overall Study|Pt has very high risk ALL characteristic|75|||
48656941|NCT00075725|156596060|FG006|Overall Study|Pt has very high risk ALL characteristic|23|||
48656942|NCT00075725|156596061|FG007|Overall Study|Pt has very high risk ALL characteristic|74|||
48656943|NCT00075725|156596062|FG008|Overall Study|Pt has very high risk ALL characteristic|29|||
48656944|NCT00075725|156596063|FG009|Overall Study|Pt has very high risk ALL characteristic|1|||
48656945|NCT00075725|156596064|FG010|Overall Study|Pt has very high risk ALL characteristic|0|||
48656946|NCT00075725|156596065|FG011|Overall Study|Pt has very high risk ALL characteristic|3|||
48656947|NCT00075725|156596054|FG000|Overall Study|Inevaluable|1|||
48656948|NCT00075725|156596055|FG001|Overall Study|Inevaluable|1|||
48962235|NCT01953328|157692116|FG003|Overall Study|Withdrawal by Subject|0|||
48962236|NCT01953328|157692117|FG004|Overall Study|Withdrawal by Subject|1|||
48962237|NCT01953328|157692118|FG005|Overall Study|Withdrawal by Subject|0|||
48962238|NCT01953328|157692119|FG006|Overall Study|Withdrawal by Subject|0|||
48962239|NCT01953328|157692120|FG007|Overall Study|Withdrawal by Subject|0|||
48962240|NCT01953328|157692113|FG000|Overall Study|Lost to Follow-up|0|||
48962241|NCT01953328|157692114|FG001|Overall Study|Lost to Follow-up|0|||
48962242|NCT01953328|157692115|FG002|Overall Study|Lost to Follow-up|0|||
48962243|NCT01953328|157692116|FG003|Overall Study|Lost to Follow-up|0|||
48962244|NCT01953328|157692117|FG004|Overall Study|Lost to Follow-up|1|||
48962245|NCT01953328|157692118|FG005|Overall Study|Lost to Follow-up|0|||
48962246|NCT01953328|157692119|FG006|Overall Study|Lost to Follow-up|0|||
48962247|NCT01953328|157692120|FG007|Overall Study|Lost to Follow-up|0|||
48962248|NCT00352755|157692121|FG000|Overall Study|Physician Decision|1|||
48962249|NCT00352755|157692121|FG000|Overall Study|Adverse Event|1|||
48962250|NCT00311181|157692122|FG000|Overall Study|Final DFTs were not obtained|96|||
48962251|NCT02429258|157692123|FG000|Overall Study|Withdrawal by Subject|2|||
48962252|NCT02429258|157692124|FG001|Overall Study|Withdrawal by Subject|0|||
48962253|NCT02429258|157692123|FG000|Overall Study|Protocol Violation|0|||
48962254|NCT02429258|157692124|FG001|Overall Study|Protocol Violation|1|||
48656949|NCT00075725|156596056|FG002|Overall Study|Inevaluable|4|||
48656950|NCT00075725|156596057|FG003|Overall Study|Inevaluable|2|||
48656951|NCT00075725|156596058|FG004|Overall Study|Inevaluable|2|||
48656952|NCT00075725|156596059|FG005|Overall Study|Inevaluable|9|||
48656953|NCT00075725|156596060|FG006|Overall Study|Inevaluable|1|||
48656954|NCT00075725|156596061|FG007|Overall Study|Inevaluable|11|||
48962255|NCT03497429|157692126|FG000|Overall Study|Progressive disease|3|||
48962256|NCT03497429|157692127|FG001|Overall Study|Progressive disease|4|||
48656955|NCT00075725|156596062|FG008|Overall Study|Inevaluable|2|||
48656956|NCT00075725|156596063|FG009|Overall Study|Inevaluable|0|||
48656957|NCT00075725|156596064|FG010|Overall Study|Inevaluable|1|||
48656958|NCT00075725|156596065|FG011|Overall Study|Inevaluable|0|||
48754774|NCT03128892|156948179|FG000|Overall Study|Physician Decision|1|||
48962257|NCT03497429|157692126|FG000|Overall Study|Adverse Event|0|||
48962258|NCT03497429|157692127|FG001|Overall Study|Adverse Event|2|||
48962259|NCT02702518|157692130|FG000|Overall Study|Lost to Follow-up|3|||
48962260|NCT02702518|157692131|FG001|Overall Study|Lost to Follow-up|4|||
48962261|NCT01670656|157692132|FG000|Overall Study|Non-compliance with study drug|0|||
48962262|NCT01670656|157692133|FG001|Overall Study|Non-compliance with study drug|0|||
48962263|NCT01670656|157692134|FG002|Overall Study|Non-compliance with study drug|3|||
48962264|NCT01670656|157692135|FG003|Overall Study|Non-compliance with study drug|0|||
48754775|NCT01524692|156948182|FG000|Overall Study|Withdrawal by Subject|3|||
48754776|NCT00296374|156948184|FG000|Overall Study|Adverse Event|14|||
48754777|NCT00296374|156948185|FG001|Overall Study|Adverse Event|10|||
48754778|NCT00296374|156948186|FG002|Overall Study|Adverse Event|7|||
48962265|NCT01670656|157692136|FG004|Overall Study|Non-compliance with study drug|1|||
48962266|NCT01670656|157692132|FG000|Overall Study|Pregnancy|0|||
48962267|NCT01670656|157692133|FG001|Overall Study|Pregnancy|0|||
48962268|NCT01670656|157692134|FG002|Overall Study|Pregnancy|0|||
48962269|NCT01670656|157692135|FG003|Overall Study|Pregnancy|0|||
48962270|NCT01670656|157692136|FG004|Overall Study|Pregnancy|1|||
48962271|NCT01670656|157692132|FG000|Overall Study|Withdrawal by Subject|1|||
48962272|NCT01670656|157692133|FG001|Overall Study|Withdrawal by Subject|1|||
48962273|NCT01670656|157692134|FG002|Overall Study|Withdrawal by Subject|0|||
48962274|NCT01670656|157692135|FG003|Overall Study|Withdrawal by Subject|0|||
48962275|NCT01670656|157692136|FG004|Overall Study|Withdrawal by Subject|0|||
48962276|NCT01670656|157692132|FG000|Overall Study|Non-compliance with protocol|0|||
48962277|NCT01670656|157692133|FG001|Overall Study|Non-compliance with protocol|3|||
48962278|NCT01670656|157692134|FG002|Overall Study|Non-compliance with protocol|1|||
48962279|NCT01670656|157692135|FG003|Overall Study|Non-compliance with protocol|1|||
48962280|NCT01670656|157692136|FG004|Overall Study|Non-compliance with protocol|2|||
48962281|NCT01670656|157692132|FG000|Overall Study|Adverse Event|2|||
48962282|NCT01670656|157692133|FG001|Overall Study|Adverse Event|2|||
48962283|NCT01670656|157692134|FG002|Overall Study|Adverse Event|2|||
48962284|NCT01670656|157692135|FG003|Overall Study|Adverse Event|3|||
48962285|NCT01670656|157692136|FG004|Overall Study|Adverse Event|3|||
48962286|NCT01670656|157692132|FG000|Overall Study|Subject withdrew consent|0|||
48962287|NCT01670656|157692133|FG001|Overall Study|Subject withdrew consent|1|||
48962288|NCT01670656|157692134|FG002|Overall Study|Subject withdrew consent|2|||
48962289|NCT01670656|157692135|FG003|Overall Study|Subject withdrew consent|1|||
48962290|NCT01670656|157692136|FG004|Overall Study|Subject withdrew consent|1|||
48962291|NCT01670656|157692132|FG000|Overall Study|Lost to Follow-up|0|||
48962292|NCT01670656|157692133|FG001|Overall Study|Lost to Follow-up|0|||
48962293|NCT01670656|157692134|FG002|Overall Study|Lost to Follow-up|0|||
48962294|NCT01670656|157692135|FG003|Overall Study|Lost to Follow-up|0|||
48962295|NCT01670656|157692136|FG004|Overall Study|Lost to Follow-up|3|||
48962296|NCT01670656|157692132|FG000|Overall Study|Subject moved|0|||
48962297|NCT01670656|157692133|FG001|Overall Study|Subject moved|0|||
48962298|NCT01670656|157692134|FG002|Overall Study|Subject moved|0|||
48962299|NCT01670656|157692135|FG003|Overall Study|Subject moved|1|||
48962300|NCT01670656|157692136|FG004|Overall Study|Subject moved|0|||
48962301|NCT00789958|157692137|FG000|Overall Study|Adverse Event|3|||
48962302|NCT00789958|157692137|FG000|Overall Study|Withdrawal by Subject|4|||
48962303|NCT00789958|157692137|FG000|Overall Study|Progression|3|||
48962304|NCT00789958|157692137|FG000|Overall Study|not protocol specified|1|||
48962305|NCT00789958|157692137|FG000|Overall Study|Not eligible/not analyzable|26|||
48962306|NCT00296725|157692138|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1|||
48962307|NCT00296725|157692138|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4|||
48962308|NCT00296725|157692138|FG000|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1|||
48656959|NCT00075725|156596054|FG000|Overall Study|Other|4|||
48656960|NCT00075725|156596055|FG001|Overall Study|Other|2|||
48656961|NCT00075725|156596056|FG002|Overall Study|Other|1|||
48656962|NCT00075725|156596057|FG003|Overall Study|Other|1|||
48656963|NCT00075725|156596058|FG004|Overall Study|Other|1|||
48656964|NCT00075725|156596059|FG005|Overall Study|Other|4|||
48656965|NCT00075725|156596060|FG006|Overall Study|Other|2|||
48656966|NCT00075725|156596061|FG007|Overall Study|Other|9|||
48656967|NCT00075725|156596062|FG008|Overall Study|Other|2|||
48656968|NCT00075725|156596063|FG009|Overall Study|Other|1|||
48656969|NCT00075725|156596064|FG010|Overall Study|Other|0|||
48656970|NCT00075725|156596065|FG011|Overall Study|Other|3|||
48656971|NCT00075725|156596054|FG000|Overall Study|Pt trying to find a BM donor|0|||
48656972|NCT00075725|156596055|FG001|Overall Study|Pt trying to find a BM donor|1|||
48656973|NCT00075725|156596056|FG002|Overall Study|Pt trying to find a BM donor|0|||
48656974|NCT00075725|156596057|FG003|Overall Study|Pt trying to find a BM donor|0|||
48656975|NCT00075725|156596058|FG004|Overall Study|Pt trying to find a BM donor|0|||
48656976|NCT00075725|156596059|FG005|Overall Study|Pt trying to find a BM donor|0|||
48656977|NCT00075725|156596060|FG006|Overall Study|Pt trying to find a BM donor|0|||
48656978|NCT00075725|156596061|FG007|Overall Study|Pt trying to find a BM donor|0|||
48656979|NCT00075725|156596062|FG008|Overall Study|Pt trying to find a BM donor|0|||
48656980|NCT00075725|156596063|FG009|Overall Study|Pt trying to find a BM donor|0|||
48656981|NCT00075725|156596064|FG010|Overall Study|Pt trying to find a BM donor|0|||
48656982|NCT00075725|156596065|FG011|Overall Study|Pt trying to find a BM donor|0|||
48656983|NCT00075725|156596054|FG000|Overall Study|Clinic chart lost unable to recreate|0|||
48656984|NCT00075725|156596055|FG001|Overall Study|Clinic chart lost unable to recreate|0|||
48656985|NCT00075725|156596056|FG002|Overall Study|Clinic chart lost unable to recreate|1|||
48656986|NCT00075725|156596057|FG003|Overall Study|Clinic chart lost unable to recreate|0|||
48656987|NCT00075725|156596058|FG004|Overall Study|Clinic chart lost unable to recreate|0|||
48656988|NCT00075725|156596059|FG005|Overall Study|Clinic chart lost unable to recreate|0|||
48656989|NCT00075725|156596060|FG006|Overall Study|Clinic chart lost unable to recreate|0|||
48656990|NCT00075725|156596061|FG007|Overall Study|Clinic chart lost unable to recreate|0|||
48656991|NCT00075725|156596062|FG008|Overall Study|Clinic chart lost unable to recreate|0|||
48656992|NCT00075725|156596063|FG009|Overall Study|Clinic chart lost unable to recreate|0|||
48656993|NCT00075725|156596064|FG010|Overall Study|Clinic chart lost unable to recreate|0|||
48656994|NCT00075725|156596065|FG011|Overall Study|Clinic chart lost unable to recreate|0|||
48656995|NCT00075725|156596054|FG000|Overall Study|Unsuccessful institutional transfer|0|||
48656996|NCT00075725|156596055|FG001|Overall Study|Unsuccessful institutional transfer|0|||
48656997|NCT00075725|156596056|FG002|Overall Study|Unsuccessful institutional transfer|2|||
48656998|NCT00075725|156596057|FG003|Overall Study|Unsuccessful institutional transfer|0|||
48656999|NCT00075725|156596058|FG004|Overall Study|Unsuccessful institutional transfer|0|||
48657000|NCT00075725|156596059|FG005|Overall Study|Unsuccessful institutional transfer|0|||
48657001|NCT00075725|156596060|FG006|Overall Study|Unsuccessful institutional transfer|0|||
48657002|NCT00075725|156596061|FG007|Overall Study|Unsuccessful institutional transfer|0|||
48657003|NCT00075725|156596062|FG008|Overall Study|Unsuccessful institutional transfer|0|||
48657004|NCT00075725|156596063|FG009|Overall Study|Unsuccessful institutional transfer|1|||
48657005|NCT00075725|156596064|FG010|Overall Study|Unsuccessful institutional transfer|0|||
48657006|NCT00075725|156596065|FG011|Overall Study|Unsuccessful institutional transfer|0|||
48657007|NCT00075725|156596054|FG000|Overall Study|specimen(s) not submitted|0|||
48657008|NCT00075725|156596055|FG001|Overall Study|specimen(s) not submitted|0|||
48657009|NCT00075725|156596056|FG002|Overall Study|specimen(s) not submitted|2|||
48657010|NCT00075725|156596057|FG003|Overall Study|specimen(s) not submitted|0|||
48657011|NCT00075725|156596058|FG004|Overall Study|specimen(s) not submitted|0|||
48657012|NCT00075725|156596059|FG005|Overall Study|specimen(s) not submitted|0|||
48657013|NCT00075725|156596060|FG006|Overall Study|specimen(s) not submitted|0|||
48657014|NCT00075725|156596061|FG007|Overall Study|specimen(s) not submitted|0|||
48962309|NCT02622724|157692141|FG000|Overall Study|Death|51|||
48962310|NCT02622724|157692142|FG001|Overall Study|Death|53|||
48657015|NCT00075725|156596062|FG008|Overall Study|specimen(s) not submitted|0|||
48657016|NCT00075725|156596063|FG009|Overall Study|specimen(s) not submitted|0|||
48962311|NCT02622724|157692141|FG000|Overall Study|Lost to Follow-UP, withdrawal of consent|4|||
48962312|NCT02622724|157692142|FG001|Overall Study|Lost to Follow-UP, withdrawal of consent|7|||
48962313|NCT02622724|157692141|FG000|Overall Study|Early termination of study|38|||
48657017|NCT00075725|156596064|FG010|Overall Study|specimen(s) not submitted|0|||
48657018|NCT00075725|156596065|FG011|Overall Study|specimen(s) not submitted|0|||
48657019|NCT00075725|156596054|FG000|Overall Study|Pt went to transplant|0|||
48657020|NCT00075725|156596055|FG001|Overall Study|Pt went to transplant|0|||
48657021|NCT00075725|156596056|FG002|Overall Study|Pt went to transplant|0|||
48657022|NCT00075725|156596057|FG003|Overall Study|Pt went to transplant|1|||
48657023|NCT00075725|156596058|FG004|Overall Study|Pt went to transplant|0|||
48657024|NCT00075725|156596059|FG005|Overall Study|Pt went to transplant|1|||
48657025|NCT00075725|156596060|FG006|Overall Study|Pt went to transplant|0|||
48962314|NCT02622724|157692142|FG001|Overall Study|Early termination of study|43|||
48962315|NCT00487084|157692143|FG000|Overall Study|Did not receive intervention|4|||
48962316|NCT00487084|157692144|FG001|Overall Study|Did not receive intervention|3|||
48962317|NCT00487084|157692145|FG002|Overall Study|Did not receive intervention|5|||
48962318|NCT00356863|157692146|FG000|Overall Study|Death|16|||
48962319|NCT00356863|157692147|FG001|Overall Study|Death|32|||
48962320|NCT00356863|157692146|FG000|Overall Study|Lost to Follow-up|76|||
48962321|NCT00356863|157692147|FG001|Overall Study|Lost to Follow-up|43|||
48962322|NCT02796391|157692151|FG000|Overall Study|Lost to Follow-up|2|||
48962323|NCT02796391|157692152|FG001|Overall Study|Lost to Follow-up|2|||
48962324|NCT02796391|157692153|FG002|Overall Study|Lost to Follow-up|13|||
48962325|NCT02796391|157692154|FG003|Overall Study|Lost to Follow-up|8|||
48962326|NCT02796391|157692155|FG004|Overall Study|Lost to Follow-up|14|||
48962327|NCT02796391|157692156|FG005|Overall Study|Lost to Follow-up|13|||
48962328|NCT02796391|157692151|FG000|Overall Study|COVID|0|||
48962329|NCT02796391|157692152|FG001|Overall Study|COVID|0|||
48962330|NCT02796391|157692153|FG002|Overall Study|COVID|5|||
48962331|NCT02796391|157692154|FG003|Overall Study|COVID|5|||
48962332|NCT02796391|157692155|FG004|Overall Study|COVID|2|||
48962333|NCT02796391|157692156|FG005|Overall Study|COVID|4|||
48962334|NCT02796391|157692151|FG000|Overall Study|Participant did not like study cigarettes|0|||
48962335|NCT02796391|157692152|FG001|Overall Study|Participant did not like study cigarettes|0|||
48962336|NCT02796391|157692153|FG002|Overall Study|Participant did not like study cigarettes|3|||
48962337|NCT02796391|157692154|FG003|Overall Study|Participant did not like study cigarettes|0|||
48962338|NCT02796391|157692155|FG004|Overall Study|Participant did not like study cigarettes|0|||
48962339|NCT02796391|157692156|FG005|Overall Study|Participant did not like study cigarettes|0|||
48962340|NCT02796391|157692151|FG000|Overall Study|Withdrawal by Subject|1|||
48962341|NCT02796391|157692152|FG001|Overall Study|Withdrawal by Subject|1|||
48962342|NCT02796391|157692153|FG002|Overall Study|Withdrawal by Subject|4|||
48962343|NCT02796391|157692154|FG003|Overall Study|Withdrawal by Subject|3|||
48962344|NCT02796391|157692155|FG004|Overall Study|Withdrawal by Subject|4|||
48962345|NCT02796391|157692156|FG005|Overall Study|Withdrawal by Subject|3|||
48962346|NCT02796391|157692151|FG000|Overall Study|Adverse Event|0|||
48962347|NCT02796391|157692152|FG001|Overall Study|Adverse Event|0|||
48962348|NCT02796391|157692153|FG002|Overall Study|Adverse Event|0|||
48962349|NCT02796391|157692154|FG003|Overall Study|Adverse Event|1|||
48657026|NCT00075725|156596061|FG007|Overall Study|Pt went to transplant|0|||
48657027|NCT00075725|156596062|FG008|Overall Study|Pt went to transplant|0|||
48657028|NCT00075725|156596063|FG009|Overall Study|Pt went to transplant|0|||
48657029|NCT00075725|156596064|FG010|Overall Study|Pt went to transplant|0|||
48657030|NCT00075725|156596065|FG011|Overall Study|Pt went to transplant|0|||
48657031|NCT00075725|156596054|FG000|Overall Study|Pt received additional steroids|0|||
48657032|NCT00075725|156596055|FG001|Overall Study|Pt received additional steroids|0|||
48657033|NCT00075725|156596056|FG002|Overall Study|Pt received additional steroids|0|||
48657034|NCT00075725|156596057|FG003|Overall Study|Pt received additional steroids|1|||
48962350|NCT02796391|157692155|FG004|Overall Study|Adverse Event|0|||
48962351|NCT02796391|157692156|FG005|Overall Study|Adverse Event|0|||
48962352|NCT02796391|157692151|FG000|Overall Study|Protocol Violation|0|||
48962353|NCT02796391|157692152|FG001|Overall Study|Protocol Violation|0|||
48962354|NCT02796391|157692153|FG002|Overall Study|Protocol Violation|0|||
48962355|NCT02796391|157692154|FG003|Overall Study|Protocol Violation|1|||
48962356|NCT02796391|157692155|FG004|Overall Study|Protocol Violation|0|||
48657035|NCT00075725|156596058|FG004|Overall Study|Pt received additional steroids|0|||
48657036|NCT00075725|156596059|FG005|Overall Study|Pt received additional steroids|0|||
48962357|NCT02796391|157692156|FG005|Overall Study|Protocol Violation|0|||
48962358|NCT02695524|157692157|FG000|Overall Study|Lost to Follow-up|3|||
48657037|NCT00075725|156596060|FG006|Overall Study|Pt received additional steroids|0|||
48962359|NCT02695524|157692158|FG001|Overall Study|Lost to Follow-up|2|||
48962360|NCT02695524|157692157|FG000|Overall Study|Death|0|||
48962361|NCT02695524|157692158|FG001|Overall Study|Death|1|||
48962362|NCT04124692|157692162|FG000|Overall Study|Medical reason|0|||
48962363|NCT04124692|157692163|FG001|Overall Study|Medical reason|1|||
48962364|NCT04124692|157692162|FG000|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|2|||
48962365|NCT04124692|157692163|FG001|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|1|||
48962366|NCT04124692|157692162|FG000|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|1|||
48962367|NCT04124692|157692163|FG001|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|3|||
48962368|NCT04124692|157692162|FG000|Overall Study|Lost to Follow-up|2|||
48962369|NCT04124692|157692163|FG001|Overall Study|Lost to Follow-up|4|||
48962370|NCT04124692|157692162|FG000|Overall Study|Screen failure due to previous use of Radiesse|1|||
48962371|NCT04124692|157692163|FG001|Overall Study|Screen failure due to previous use of Radiesse|0|||
48962372|NCT00756886|157692164|FG000|Overall Study|Lost to Follow-up|1|||
48962373|NCT00756886|157692165|FG001|Overall Study|Lost to Follow-up|0|||
48962374|NCT00756886|157692164|FG000|Overall Study|Adverse Event|0|||
48962375|NCT00756886|157692165|FG001|Overall Study|Adverse Event|3|||
48962376|NCT00756886|157692164|FG000|Overall Study|Lack of Efficacy|1|||
48962377|NCT00756886|157692165|FG001|Overall Study|Lack of Efficacy|0|||
48962378|NCT00756886|157692164|FG000|Overall Study|Ineligible|9|||
48962379|NCT00756886|157692165|FG001|Overall Study|Ineligible|4|||
48962380|NCT01885078|157692166|FG000|Treatment Period|Adverse Event|52|||
48657038|NCT00075725|156596061|FG007|Overall Study|Pt received additional steroids|0|||
48962381|NCT01885078|157692167|FG001|Treatment Period|Adverse Event|136|||
48962382|NCT01885078|157692168|FG002|Treatment Period|Adverse Event|30|||
48962383|NCT01885078|157692169|FG003|Treatment Period|Adverse Event|73|||
48962384|NCT01885078|157692170|FG004|Treatment Period|Adverse Event|17|||
48962385|NCT01885078|157692171|FG005|Treatment Period|Adverse Event|72|||
48962386|NCT01885078|157692172|FG006|Treatment Period|Adverse Event|24|||
48962387|NCT01885078|157692173|FG007|Treatment Period|Adverse Event|5|||
48962388|NCT01885078|157692174|FG008|Treatment Period|Adverse Event|0|||
48962389|NCT01885078|157692175|FG009|Treatment Period|Adverse Event|0|||
48962390|NCT01885078|157692166|FG000|Treatment Period|Death|13|||
48962391|NCT01885078|157692167|FG001|Treatment Period|Death|33|||
48962392|NCT01885078|157692168|FG002|Treatment Period|Death|5|||
48962393|NCT01885078|157692169|FG003|Treatment Period|Death|9|||
48962394|NCT01885078|157692170|FG004|Treatment Period|Death|2|||
48962395|NCT01885078|157692171|FG005|Treatment Period|Death|10|||
48962396|NCT01885078|157692172|FG006|Treatment Period|Death|3|||
48962397|NCT01885078|157692173|FG007|Treatment Period|Death|2|||
48962398|NCT01885078|157692174|FG008|Treatment Period|Death|0|||
48962399|NCT01885078|157692175|FG009|Treatment Period|Death|0|||
48962400|NCT01885078|157692166|FG000|Treatment Period|Lack of Efficacy|12|||
48962401|NCT01885078|157692167|FG001|Treatment Period|Lack of Efficacy|33|||
48962402|NCT01885078|157692168|FG002|Treatment Period|Lack of Efficacy|10|||
48962403|NCT01885078|157692169|FG003|Treatment Period|Lack of Efficacy|23|||
48962404|NCT01885078|157692170|FG004|Treatment Period|Lack of Efficacy|24|||
48962405|NCT01885078|157692171|FG005|Treatment Period|Lack of Efficacy|58|||
48657039|NCT00075725|156596062|FG008|Overall Study|Pt received additional steroids|0|||
48657040|NCT00075725|156596063|FG009|Overall Study|Pt received additional steroids|0|||
48657041|NCT00075725|156596064|FG010|Overall Study|Pt received additional steroids|0|||
48657042|NCT00075725|156596065|FG011|Overall Study|Pt received additional steroids|0|||
48657043|NCT00075725|156596054|FG000|Overall Study|Pt relocated|0|||
48657044|NCT00075725|156596055|FG001|Overall Study|Pt relocated|0|||
48657045|NCT00075725|156596056|FG002|Overall Study|Pt relocated|0|||
48657046|NCT00075725|156596057|FG003|Overall Study|Pt relocated|2|||
48657047|NCT00075725|156596058|FG004|Overall Study|Pt relocated|0|||
48657048|NCT00075725|156596059|FG005|Overall Study|Pt relocated|1|||
48657049|NCT00075725|156596060|FG006|Overall Study|Pt relocated|1|||
48657050|NCT00075725|156596061|FG007|Overall Study|Pt relocated|2|||
48657051|NCT00075725|156596062|FG008|Overall Study|Pt relocated|1|||
48657052|NCT00075725|156596063|FG009|Overall Study|Pt relocated|0|||
48657053|NCT00075725|156596064|FG010|Overall Study|Pt relocated|0|||
48657054|NCT00075725|156596065|FG011|Overall Study|Pt relocated|0|||
48657055|NCT00075725|156596054|FG000|Overall Study|Institution Terminated|0|||
48962406|NCT01885078|157692172|FG006|Treatment Period|Lack of Efficacy|9|||
48962407|NCT01885078|157692173|FG007|Treatment Period|Lack of Efficacy|5|||
48962408|NCT01885078|157692174|FG008|Treatment Period|Lack of Efficacy|0|||
48962409|NCT01885078|157692175|FG009|Treatment Period|Lack of Efficacy|0|||
48657056|NCT00075725|156596055|FG001|Overall Study|Institution Terminated|0|||
48657057|NCT00075725|156596056|FG002|Overall Study|Institution Terminated|0|||
48657058|NCT00075725|156596057|FG003|Overall Study|Institution Terminated|0|||
48962410|NCT01885078|157692166|FG000|Treatment Period|Lost to Follow-up|16|||
48962411|NCT01885078|157692167|FG001|Treatment Period|Lost to Follow-up|19|||
48962412|NCT01885078|157692168|FG002|Treatment Period|Lost to Follow-up|7|||
48962413|NCT01885078|157692169|FG003|Treatment Period|Lost to Follow-up|9|||
48962414|NCT01885078|157692170|FG004|Treatment Period|Lost to Follow-up|2|||
48962415|NCT01885078|157692171|FG005|Treatment Period|Lost to Follow-up|8|||
48962416|NCT01885078|157692172|FG006|Treatment Period|Lost to Follow-up|2|||
48962417|NCT01885078|157692173|FG007|Treatment Period|Lost to Follow-up|0|||
48962418|NCT01885078|157692174|FG008|Treatment Period|Lost to Follow-up|0|||
48657059|NCT00075725|156596058|FG004|Overall Study|Institution Terminated|1|||
48657060|NCT00075725|156596059|FG005|Overall Study|Institution Terminated|0|||
48657061|NCT00075725|156596060|FG006|Overall Study|Institution Terminated|0|||
48962419|NCT01885078|157692175|FG009|Treatment Period|Lost to Follow-up|0|||
48962420|NCT01885078|157692166|FG000|Treatment Period|Physician Decision|19|||
48962421|NCT01885078|157692167|FG001|Treatment Period|Physician Decision|21|||
48962422|NCT01885078|157692168|FG002|Treatment Period|Physician Decision|5|||
48962423|NCT01885078|157692169|FG003|Treatment Period|Physician Decision|12|||
48962424|NCT01885078|157692170|FG004|Treatment Period|Physician Decision|9|||
48962425|NCT01885078|157692171|FG005|Treatment Period|Physician Decision|24|||
48962426|NCT01885078|157692172|FG006|Treatment Period|Physician Decision|4|||
48962427|NCT01885078|157692173|FG007|Treatment Period|Physician Decision|3|||
48962428|NCT01885078|157692174|FG008|Treatment Period|Physician Decision|0|||
48962429|NCT01885078|157692175|FG009|Treatment Period|Physician Decision|0|||
48962430|NCT01885078|157692166|FG000|Treatment Period|Protocol Violation|3|||
48962431|NCT01885078|157692167|FG001|Treatment Period|Protocol Violation|5|||
48962432|NCT01885078|157692168|FG002|Treatment Period|Protocol Violation|0|||
48962433|NCT01885078|157692169|FG003|Treatment Period|Protocol Violation|3|||
48962434|NCT01885078|157692170|FG004|Treatment Period|Protocol Violation|1|||
48962435|NCT01885078|157692171|FG005|Treatment Period|Protocol Violation|6|||
48962436|NCT01885078|157692172|FG006|Treatment Period|Protocol Violation|0|||
48962437|NCT01885078|157692173|FG007|Treatment Period|Protocol Violation|0|||
48962438|NCT01885078|157692174|FG008|Treatment Period|Protocol Violation|0|||
48962439|NCT01885078|157692175|FG009|Treatment Period|Protocol Violation|0|||
48962440|NCT01885078|157692166|FG000|Treatment Period|Sponsor Decision|245|||
48962441|NCT01885078|157692167|FG001|Treatment Period|Sponsor Decision|648|||
48962442|NCT01885078|157692168|FG002|Treatment Period|Sponsor Decision|49|||
48962443|NCT01885078|157692169|FG003|Treatment Period|Sponsor Decision|90|||
48962444|NCT01885078|157692170|FG004|Treatment Period|Sponsor Decision|20|||
48962445|NCT01885078|157692171|FG005|Treatment Period|Sponsor Decision|38|||
48962446|NCT01885078|157692172|FG006|Treatment Period|Sponsor Decision|162|||
48962447|NCT01885078|157692173|FG007|Treatment Period|Sponsor Decision|3|||
48962448|NCT01885078|157692174|FG008|Treatment Period|Sponsor Decision|0|||
48962449|NCT01885078|157692175|FG009|Treatment Period|Sponsor Decision|0|||
48962450|NCT01885078|157692166|FG000|Treatment Period|Withdrawal by Subject|72|||
48962451|NCT01885078|157692167|FG001|Treatment Period|Withdrawal by Subject|132|||
48962452|NCT01885078|157692168|FG002|Treatment Period|Withdrawal by Subject|25|||
48962453|NCT01885078|157692169|FG003|Treatment Period|Withdrawal by Subject|63|||
48962454|NCT01885078|157692170|FG004|Treatment Period|Withdrawal by Subject|15|||
48962455|NCT01885078|157692171|FG005|Treatment Period|Withdrawal by Subject|34|||
48962456|NCT01885078|157692172|FG006|Treatment Period|Withdrawal by Subject|17|||
48962457|NCT01885078|157692173|FG007|Treatment Period|Withdrawal by Subject|10|||
48962458|NCT01885078|157692174|FG008|Treatment Period|Withdrawal by Subject|0|||
48962459|NCT01885078|157692175|FG009|Treatment Period|Withdrawal by Subject|0|||
48962460|NCT01885078|157692166|FG000|Treatment Period|Other|0|||
48962461|NCT01885078|157692167|FG001|Treatment Period|Other|0|||
48962462|NCT01885078|157692168|FG002|Treatment Period|Other|0|||
48962463|NCT01885078|157692169|FG003|Treatment Period|Other|1|||
48962464|NCT01885078|157692170|FG004|Treatment Period|Other|0|||
48962465|NCT01885078|157692171|FG005|Treatment Period|Other|0|||
48962466|NCT01885078|157692172|FG006|Treatment Period|Other|0|||
48962467|NCT01885078|157692173|FG007|Treatment Period|Other|0|||
48962468|NCT01885078|157692174|FG008|Treatment Period|Other|0|||
48962469|NCT01885078|157692175|FG009|Treatment Period|Other|0|||
48962470|NCT01885078|157692166|FG000|Step-down Period|Sponsor Decision|0|||
48962471|NCT01885078|157692167|FG001|Step-down Period|Sponsor Decision|0|||
48962472|NCT01885078|157692168|FG002|Step-down Period|Sponsor Decision|0|||
48962473|NCT01885078|157692169|FG003|Step-down Period|Sponsor Decision|0|||
48962474|NCT01885078|157692170|FG004|Step-down Period|Sponsor Decision|0|||
48962475|NCT01885078|157692171|FG005|Step-down Period|Sponsor Decision|0|||
48962476|NCT01885078|157692172|FG006|Step-down Period|Sponsor Decision|0|||
48962477|NCT01885078|157692173|FG007|Step-down Period|Sponsor Decision|0|||
48962478|NCT01885078|157692174|FG008|Step-down Period|Sponsor Decision|1|||
48962479|NCT01885078|157692175|FG009|Step-down Period|Sponsor Decision|1|||
48962480|NCT01885078|157692166|FG000|Step-down Period|Adverse Event|0|||
48962481|NCT01885078|157692167|FG001|Step-down Period|Adverse Event|0|||
48962482|NCT01885078|157692168|FG002|Step-down Period|Adverse Event|0|||
48962483|NCT01885078|157692169|FG003|Step-down Period|Adverse Event|0|||
48962484|NCT01885078|157692170|FG004|Step-down Period|Adverse Event|0|||
48962485|NCT01885078|157692171|FG005|Step-down Period|Adverse Event|0|||
48962486|NCT01885078|157692172|FG006|Step-down Period|Adverse Event|0|||
48962487|NCT01885078|157692173|FG007|Step-down Period|Adverse Event|0|||
48962488|NCT01885078|157692174|FG008|Step-down Period|Adverse Event|29|||
48962489|NCT01885078|157692175|FG009|Step-down Period|Adverse Event|38|||
48962490|NCT01885078|157692166|FG000|Step-down Period|Withdrawal by Subject|0|||
48962491|NCT01885078|157692167|FG001|Step-down Period|Withdrawal by Subject|0|||
48962492|NCT01885078|157692168|FG002|Step-down Period|Withdrawal by Subject|0|||
48962493|NCT01885078|157692169|FG003|Step-down Period|Withdrawal by Subject|0|||
48962494|NCT01885078|157692170|FG004|Step-down Period|Withdrawal by Subject|0|||
48962495|NCT01885078|157692171|FG005|Step-down Period|Withdrawal by Subject|0|||
48962496|NCT01885078|157692172|FG006|Step-down Period|Withdrawal by Subject|0|||
48962497|NCT01885078|157692173|FG007|Step-down Period|Withdrawal by Subject|0|||
48962498|NCT01885078|157692174|FG008|Step-down Period|Withdrawal by Subject|25|||
48962499|NCT01885078|157692175|FG009|Step-down Period|Withdrawal by Subject|15|||
48962500|NCT01885078|157692166|FG000|Step-down Period|Physician Decision|0|||
48962501|NCT01885078|157692167|FG001|Step-down Period|Physician Decision|0|||
48962502|NCT01885078|157692168|FG002|Step-down Period|Physician Decision|0|||
48962503|NCT01885078|157692169|FG003|Step-down Period|Physician Decision|0|||
48962504|NCT01885078|157692170|FG004|Step-down Period|Physician Decision|0|||
48962505|NCT01885078|157692171|FG005|Step-down Period|Physician Decision|0|||
48962506|NCT01885078|157692172|FG006|Step-down Period|Physician Decision|0|||
48962507|NCT01885078|157692173|FG007|Step-down Period|Physician Decision|0|||
48962508|NCT01885078|157692174|FG008|Step-down Period|Physician Decision|7|||
48962509|NCT01885078|157692175|FG009|Step-down Period|Physician Decision|2|||
48962510|NCT01885078|157692166|FG000|Step-down Period|Death|0|||
48962511|NCT01885078|157692167|FG001|Step-down Period|Death|0|||
48657062|NCT00075725|156596061|FG007|Overall Study|Institution Terminated|3|||
48657063|NCT00075725|156596062|FG008|Overall Study|Institution Terminated|0|||
48657064|NCT00075725|156596063|FG009|Overall Study|Institution Terminated|0|||
48865816|NCT03997409|157345574|FG000|Overall Study|Lost to Follow-up|0|||
48865817|NCT03997409|157345575|FG001|Overall Study|Lost to Follow-up|0|||
48865818|NCT03997409|157345576|FG002|Overall Study|Lost to Follow-up|1|||
48865819|NCT01838499|157345577|FG000|Overall Study|Protocol Violation|0|||
48865820|NCT01838499|157345578|FG001|Overall Study|Protocol Violation|1|||
48865821|NCT01838499|157345577|FG000|Overall Study|Lost to Follow-up|2|||
48865822|NCT01838499|157345578|FG001|Overall Study|Lost to Follow-up|4|||
48865823|NCT01838499|157345577|FG000|Overall Study|Lack of Efficacy|1|||
48865824|NCT01838499|157345578|FG001|Overall Study|Lack of Efficacy|2|||
48865825|NCT01838499|157345577|FG000|Overall Study|Adverse Event|2|||
48865826|NCT01838499|157345578|FG001|Overall Study|Adverse Event|1|||
48865827|NCT01838499|157345577|FG000|Overall Study|Withdrawal by Subject|19|||
48865828|NCT01838499|157345578|FG001|Overall Study|Withdrawal by Subject|9|||
48865829|NCT02368691|157345581|FG000|Overall Study|Death|13|||
48865830|NCT02368691|157345581|FG000|Overall Study|Lack of Efficacy|15|||
48865831|NCT02368691|157345581|FG000|Overall Study|Physician Decision|4|||
48865832|NCT03314233|157345582|FG000|Overall Study|No longer eligible at time of delivery|1|||
48865833|NCT01183013|157345585|FG000|Overall Study|Adverse Event|6|||
48865834|NCT01183013|157345586|FG001|Overall Study|Adverse Event|8|||
48865835|NCT01183013|157345587|FG002|Overall Study|Adverse Event|5|||
48865836|NCT01183013|157345588|FG003|Overall Study|Adverse Event|5|||
48865837|NCT01183013|157345589|FG004|Overall Study|Adverse Event|10|||
48865838|NCT01183013|157345590|FG005|Overall Study|Adverse Event|10|||
48865839|NCT01183013|157345591|FG006|Overall Study|Adverse Event|6|||
48865840|NCT01183013|157345585|FG000|Overall Study|Lack of Efficacy|3|||
48865841|NCT01183013|157345586|FG001|Overall Study|Lack of Efficacy|2|||
48865842|NCT01183013|157345587|FG002|Overall Study|Lack of Efficacy|1|||
48865843|NCT01183013|157345588|FG003|Overall Study|Lack of Efficacy|2|||
48865844|NCT01183013|157345589|FG004|Overall Study|Lack of Efficacy|1|||
48865845|NCT01183013|157345590|FG005|Overall Study|Lack of Efficacy|2|||
48865846|NCT01183013|157345591|FG006|Overall Study|Lack of Efficacy|0|||
48865847|NCT01183013|157345585|FG000|Overall Study|Protocol Violation|5|||
48865848|NCT01183013|157345586|FG001|Overall Study|Protocol Violation|2|||
48865849|NCT01183013|157345587|FG002|Overall Study|Protocol Violation|4|||
48865850|NCT01183013|157345588|FG003|Overall Study|Protocol Violation|0|||
48865851|NCT01183013|157345589|FG004|Overall Study|Protocol Violation|4|||
48865852|NCT01183013|157345590|FG005|Overall Study|Protocol Violation|3|||
48865853|NCT01183013|157345591|FG006|Overall Study|Protocol Violation|3|||
48865854|NCT01183013|157345585|FG000|Overall Study|Lost to Follow-up|7|||
48865855|NCT01183013|157345586|FG001|Overall Study|Lost to Follow-up|3|||
48865856|NCT01183013|157345587|FG002|Overall Study|Lost to Follow-up|4|||
48865857|NCT01183013|157345588|FG003|Overall Study|Lost to Follow-up|3|||
48865858|NCT01183013|157345589|FG004|Overall Study|Lost to Follow-up|2|||
48865859|NCT01183013|157345590|FG005|Overall Study|Lost to Follow-up|6|||
48657065|NCT00075725|156596064|FG010|Overall Study|Institution Terminated|0|||
48865860|NCT01183013|157345591|FG006|Overall Study|Lost to Follow-up|5|||
48865861|NCT01183013|157345585|FG000|Overall Study|Withdrawal by Subject|9|||
48962512|NCT01885078|157692168|FG002|Step-down Period|Death|0|||
48962513|NCT01885078|157692169|FG003|Step-down Period|Death|0|||
48962514|NCT01885078|157692170|FG004|Step-down Period|Death|0|||
48962515|NCT01885078|157692171|FG005|Step-down Period|Death|0|||
48962516|NCT01885078|157692172|FG006|Step-down Period|Death|0|||
48865862|NCT01183013|157345586|FG001|Overall Study|Withdrawal by Subject|13|||
48865863|NCT01183013|157345587|FG002|Overall Study|Withdrawal by Subject|10|||
48865864|NCT01183013|157345588|FG003|Overall Study|Withdrawal by Subject|8|||
48865865|NCT01183013|157345589|FG004|Overall Study|Withdrawal by Subject|7|||
48865866|NCT01183013|157345590|FG005|Overall Study|Withdrawal by Subject|9|||
48865867|NCT01183013|157345591|FG006|Overall Study|Withdrawal by Subject|10|||
48865868|NCT01183013|157345585|FG000|Overall Study|Reasons other than stated above|15|||
48657066|NCT00075725|156596065|FG011|Overall Study|Institution Terminated|0|||
48865869|NCT01183013|157345586|FG001|Overall Study|Reasons other than stated above|11|||
48962517|NCT01885078|157692173|FG007|Step-down Period|Death|0|||
48962518|NCT01885078|157692174|FG008|Step-down Period|Death|4|||
48962519|NCT01885078|157692175|FG009|Step-down Period|Death|3|||
48865870|NCT01183013|157345587|FG002|Overall Study|Reasons other than stated above|17|||
48865871|NCT01183013|157345588|FG003|Overall Study|Reasons other than stated above|12|||
48657067|NCT00075725|156596054|FG000|Overall Study|Study Closure|1|||
48657068|NCT00075725|156596055|FG001|Overall Study|Study Closure|0|||
48657069|NCT00075725|156596056|FG002|Overall Study|Study Closure|0|||
48657070|NCT00075725|156596057|FG003|Overall Study|Study Closure|0|||
48657071|NCT00075725|156596058|FG004|Overall Study|Study Closure|1|||
48657072|NCT00075725|156596059|FG005|Overall Study|Study Closure|3|||
48657073|NCT00075725|156596060|FG006|Overall Study|Study Closure|0|||
48657074|NCT00075725|156596061|FG007|Overall Study|Study Closure|1|||
48657075|NCT00075725|156596062|FG008|Overall Study|Study Closure|0|||
48657076|NCT00075725|156596063|FG009|Overall Study|Study Closure|0|||
48657077|NCT00075725|156596064|FG010|Overall Study|Study Closure|0|||
48657078|NCT00075725|156596065|FG011|Overall Study|Study Closure|0|||
48657079|NCT00075725|156596054|FG000|Overall Study|Other complications|0|||
48657080|NCT00075725|156596055|FG001|Overall Study|Other complications|0|||
48657081|NCT00075725|156596056|FG002|Overall Study|Other complications|0|||
48657082|NCT00075725|156596057|FG003|Overall Study|Other complications|0|||
48657083|NCT00075725|156596058|FG004|Overall Study|Other complications|0|||
48657084|NCT00075725|156596059|FG005|Overall Study|Other complications|1|||
48657085|NCT00075725|156596060|FG006|Overall Study|Other complications|0|||
48865872|NCT01183013|157345589|FG004|Overall Study|Reasons other than stated above|12|||
48865873|NCT01183013|157345590|FG005|Overall Study|Reasons other than stated above|15|||
48865874|NCT01183013|157345591|FG006|Overall Study|Reasons other than stated above|13|||
48865875|NCT02402465|157345595|FG000|Overall Study|Withdrawal by Subject|0|||
48865876|NCT02402465|157345596|FG001|Overall Study|Withdrawal by Subject|0|||
48865877|NCT02402465|157345597|FG002|Overall Study|Withdrawal by Subject|0|||
48865878|NCT02402465|157345598|FG003|Overall Study|Withdrawal by Subject|0|||
48865879|NCT02402465|157345599|FG004|Overall Study|Withdrawal by Subject|0|||
48865880|NCT02402465|157345600|FG005|Overall Study|Withdrawal by Subject|1|||
48865881|NCT02402465|157345595|FG000|Overall Study|Lost to Follow-up|0|||
48962520|NCT01885078|157692166|FG000|Step-down Period|Lost to Follow-up|0|||
48657086|NCT00075725|156596061|FG007|Overall Study|Other complications|0|||
48865882|NCT02402465|157345596|FG001|Overall Study|Lost to Follow-up|1|||
48865883|NCT02402465|157345597|FG002|Overall Study|Lost to Follow-up|0|||
48865884|NCT02402465|157345598|FG003|Overall Study|Lost to Follow-up|0|||
48865885|NCT02402465|157345599|FG004|Overall Study|Lost to Follow-up|1|||
48865886|NCT02402465|157345600|FG005|Overall Study|Lost to Follow-up|0|||
48865887|NCT02720081|157345601|FG000|Overall Study|Adverse Event|0|||
48865888|NCT02720081|157345602|FG001|Overall Study|Adverse Event|3|||
48865889|NCT02720081|157345601|FG000|Overall Study|Protocol Violation|4|||
48865890|NCT02720081|157345602|FG001|Overall Study|Protocol Violation|1|||
48865891|NCT02845375|157345603|FG000|Overall Study|upper airway obstruction|1|||
48865892|NCT02845375|157345604|FG001|Overall Study|upper airway obstruction|2|||
48865893|NCT02845375|157345605|FG002|Overall Study|upper airway obstruction|1|||
48865894|NCT01177137|157345606|FG000|Overall Study|Withdrawal by Subject|10|||
48865895|NCT01177137|157345607|FG001|Overall Study|Withdrawal by Subject|10|||
48865896|NCT01177137|157345608|FG002|Overall Study|Withdrawal by Subject|2|||
48865897|NCT02720198|157345609|FG000|Overall Study|Withdrawal by Subject|0|||
48865898|NCT02720198|157345610|FG001|Overall Study|Withdrawal by Subject|1|||
48865899|NCT04468633|157345611|FG000|Overall Study|Withdrawal by Subject|4|||
48865900|NCT04468633|157345612|FG001|Overall Study|Withdrawal by Subject|0|||
48865901|NCT03845517|157345615|FG000|Treatment Period (52 Weeks)|Adverse Event|12|||
48865902|NCT03845517|157345616|FG001|Treatment Period (52 Weeks)|Adverse Event|7|||
48865903|NCT03845517|157345617|FG002|Treatment Period (52 Weeks)|Adverse Event|10|||
48865904|NCT03845517|157345618|FG003|Treatment Period (52 Weeks)|Adverse Event|17|||
48865905|NCT03845517|157345615|FG000|Treatment Period (52 Weeks)|Death|0|||
48657087|NCT00075725|156596062|FG008|Overall Study|Other complications|0|||
48657088|NCT00075725|156596063|FG009|Overall Study|Other complications|0|||
48657089|NCT00075725|156596064|FG010|Overall Study|Other complications|0|||
48657090|NCT00075725|156596065|FG011|Overall Study|Other complications|0|||
48657091|NCT00075725|156596054|FG000|Overall Study|Pt care terminated due to pt behavior|0|||
48657092|NCT00075725|156596055|FG001|Overall Study|Pt care terminated due to pt behavior|0|||
48657093|NCT00075725|156596056|FG002|Overall Study|Pt care terminated due to pt behavior|0|||
48657094|NCT00075725|156596057|FG003|Overall Study|Pt care terminated due to pt behavior|0|||
48865906|NCT03845517|157345616|FG001|Treatment Period (52 Weeks)|Death|0|||
48865907|NCT03845517|157345617|FG002|Treatment Period (52 Weeks)|Death|1|||
48865908|NCT03845517|157345618|FG003|Treatment Period (52 Weeks)|Death|0|||
48865909|NCT03845517|157345615|FG000|Treatment Period (52 Weeks)|Lack of Efficacy|8|||
48865910|NCT03845517|157345616|FG001|Treatment Period (52 Weeks)|Lack of Efficacy|1|||
48865911|NCT03845517|157345617|FG002|Treatment Period (52 Weeks)|Lack of Efficacy|3|||
48865912|NCT03845517|157345618|FG003|Treatment Period (52 Weeks)|Lack of Efficacy|4|||
48865913|NCT03845517|157345615|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
48657095|NCT00075725|156596058|FG004|Overall Study|Pt care terminated due to pt behavior|0|||
48657096|NCT00075725|156596059|FG005|Overall Study|Pt care terminated due to pt behavior|0|||
48657097|NCT00075725|156596060|FG006|Overall Study|Pt care terminated due to pt behavior|0|||
48865914|NCT03845517|157345616|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
48865915|NCT03845517|157345617|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|1|||
48865916|NCT03845517|157345618|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
48865917|NCT03845517|157345615|FG000|Treatment Period (52 Weeks)|Non-compliance with study drug|1|||
48865918|NCT03845517|157345616|FG001|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
48865919|NCT03845517|157345617|FG002|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
48865920|NCT03845517|157345618|FG003|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
48865921|NCT03845517|157345615|FG000|Treatment Period (52 Weeks)|Physician's decision|0|||
48865922|NCT03845517|157345616|FG001|Treatment Period (52 Weeks)|Physician's decision|0|||
48865923|NCT03845517|157345617|FG002|Treatment Period (52 Weeks)|Physician's decision|1|||
48865924|NCT03845517|157345618|FG003|Treatment Period (52 Weeks)|Physician's decision|0|||
48865925|NCT03845517|157345615|FG000|Treatment Period (52 Weeks)|Site Terminated by Sponsor|2|||
48865926|NCT03845517|157345616|FG001|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
48865927|NCT03845517|157345617|FG002|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
48865928|NCT03845517|157345618|FG003|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
48865929|NCT03845517|157345615|FG000|Treatment Period (52 Weeks)|Other|2|||
48962521|NCT01885078|157692167|FG001|Step-down Period|Lost to Follow-up|0|||
48962522|NCT01885078|157692168|FG002|Step-down Period|Lost to Follow-up|0|||
48962523|NCT01885078|157692169|FG003|Step-down Period|Lost to Follow-up|0|||
48962524|NCT01885078|157692170|FG004|Step-down Period|Lost to Follow-up|0|||
48962525|NCT01885078|157692171|FG005|Step-down Period|Lost to Follow-up|0|||
48962526|NCT01885078|157692172|FG006|Step-down Period|Lost to Follow-up|0|||
48962527|NCT01885078|157692173|FG007|Step-down Period|Lost to Follow-up|0|||
48962528|NCT01885078|157692174|FG008|Step-down Period|Lost to Follow-up|1|||
48962529|NCT01885078|157692175|FG009|Step-down Period|Lost to Follow-up|1|||
48962530|NCT01885078|157692166|FG000|Step-down Period|Lack of Efficacy|0|||
48962531|NCT01885078|157692167|FG001|Step-down Period|Lack of Efficacy|0|||
48962532|NCT01885078|157692168|FG002|Step-down Period|Lack of Efficacy|0|||
48962533|NCT01885078|157692169|FG003|Step-down Period|Lack of Efficacy|0|||
48962534|NCT01885078|157692170|FG004|Step-down Period|Lack of Efficacy|0|||
48962535|NCT01885078|157692171|FG005|Step-down Period|Lack of Efficacy|0|||
48962536|NCT01885078|157692172|FG006|Step-down Period|Lack of Efficacy|0|||
48962537|NCT01885078|157692173|FG007|Step-down Period|Lack of Efficacy|0|||
48962538|NCT01885078|157692174|FG008|Step-down Period|Lack of Efficacy|1|||
48962539|NCT01885078|157692175|FG009|Step-down Period|Lack of Efficacy|0|||
48962540|NCT01885078|157692166|FG000|Step-down Period|Protocol Violation|0|||
48962541|NCT01885078|157692167|FG001|Step-down Period|Protocol Violation|0|||
48962542|NCT01885078|157692168|FG002|Step-down Period|Protocol Violation|0|||
48962543|NCT01885078|157692169|FG003|Step-down Period|Protocol Violation|0|||
48962544|NCT01885078|157692170|FG004|Step-down Period|Protocol Violation|0|||
48962545|NCT01885078|157692171|FG005|Step-down Period|Protocol Violation|0|||
48962546|NCT01885078|157692172|FG006|Step-down Period|Protocol Violation|0|||
48962547|NCT01885078|157692173|FG007|Step-down Period|Protocol Violation|0|||
48962548|NCT01885078|157692174|FG008|Step-down Period|Protocol Violation|1|||
48962549|NCT01885078|157692175|FG009|Step-down Period|Protocol Violation|1|||
48962550|NCT00310388|157692176|FG000|Primary Reporting Phase|Adverse Event|101|||
48962551|NCT00310388|157692177|FG001|Primary Reporting Phase|Adverse Event|0|||
48962552|NCT00310388|157692176|FG000|Primary Reporting Phase|Lack of Efficacy|56|||
48962553|NCT00310388|157692177|FG001|Primary Reporting Phase|Lack of Efficacy|0|||
48962554|NCT00310388|157692176|FG000|Primary Reporting Phase|Withdrawal by Subject|97|||
48962555|NCT00310388|157692177|FG001|Primary Reporting Phase|Withdrawal by Subject|0|||
48962556|NCT00310388|157692176|FG000|Primary Reporting Phase|Protocol Violation|10|||
48962557|NCT00310388|157692177|FG001|Primary Reporting Phase|Protocol Violation|0|||
48962558|NCT00310388|157692176|FG000|Primary Reporting Phase|Pregnancy|3|||
48962559|NCT00310388|157692177|FG001|Primary Reporting Phase|Pregnancy|0|||
48962560|NCT00310388|157692176|FG000|Primary Reporting Phase|Change in participant medical condition|3|||
48962561|NCT00310388|157692177|FG001|Primary Reporting Phase|Change in participant medical condition|0|||
48962562|NCT00310388|157692176|FG000|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3|||
48962563|NCT00310388|157692177|FG001|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0|||
48962564|NCT00310388|157692176|FG000|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3|||
48657098|NCT00075725|156596061|FG007|Overall Study|Pt care terminated due to pt behavior|1|||
48865930|NCT03845517|157345616|FG001|Treatment Period (52 Weeks)|Other|0|||
48865931|NCT03845517|157345617|FG002|Treatment Period (52 Weeks)|Other|0|||
48865932|NCT03845517|157345618|FG003|Treatment Period (52 Weeks)|Other|0|||
48962565|NCT00310388|157692177|FG001|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0|||
48962566|NCT00310388|157692176|FG000|Primary Reporting Phase|Physician Decision|2|||
48962567|NCT00310388|157692177|FG001|Primary Reporting Phase|Physician Decision|0|||
48962568|NCT00310388|157692176|FG000|Primary Reporting Phase|Request of the sponsor|19|||
48962569|NCT00310388|157692177|FG001|Primary Reporting Phase|Request of the sponsor|0|||
48962570|NCT00310388|157692176|FG000|Primary Reporting Phase|Failed to return|8|||
48962571|NCT00310388|157692177|FG001|Primary Reporting Phase|Failed to return|0|||
48962572|NCT00310388|157692176|FG000|Primary Reporting Phase|Participant request unrelated to study|2|||
48962573|NCT00310388|157692177|FG001|Primary Reporting Phase|Participant request unrelated to study|0|||
48962574|NCT00310388|157692176|FG000|Primary Reporting Phase|Participant request|2|||
48962575|NCT00310388|157692177|FG001|Primary Reporting Phase|Participant request|0|||
48962576|NCT00310388|157692176|FG000|Primary Reporting Phase|Ministry of Health decision|25|||
48962577|NCT00310388|157692177|FG001|Primary Reporting Phase|Ministry of Health decision|0|||
48962578|NCT00310388|157692176|FG000|Primary Reporting Phase|Discontinuation of study|1|||
48962579|NCT00310388|157692177|FG001|Primary Reporting Phase|Discontinuation of study|0|||
48962580|NCT00310388|157692176|FG000|Primary Reporting Phase|Participant Immigrated to New Zealand|1|||
48962581|NCT00310388|157692177|FG001|Primary Reporting Phase|Participant Immigrated to New Zealand|0|||
48962582|NCT00310388|157692176|FG000|Primary Reporting Phase|Termination of study at sponsor request|3|||
48754779|NCT00296374|156948184|FG000|Overall Study|Withdrawal by Subject|3|||
48754780|NCT00296374|156948185|FG001|Overall Study|Withdrawal by Subject|5|||
48754781|NCT00296374|156948186|FG002|Overall Study|Withdrawal by Subject|11|||
48754782|NCT00296374|156948184|FG000|Overall Study|Incorrect enrollment|3|||
48754783|NCT00296374|156948185|FG001|Overall Study|Incorrect enrollment|3|||
48754784|NCT00296374|156948186|FG002|Overall Study|Incorrect enrollment|4|||
48754785|NCT00296374|156948184|FG000|Overall Study|Protocol Violation|1|||
48754786|NCT00296374|156948185|FG001|Overall Study|Protocol Violation|2|||
48754787|NCT00296374|156948186|FG002|Overall Study|Protocol Violation|3|||
48754788|NCT00296374|156948184|FG000|Overall Study|Lost to Follow-up|3|||
48962583|NCT00310388|157692177|FG001|Primary Reporting Phase|Termination of study at sponsor request|0|||
48962584|NCT00310388|157692176|FG000|Primary Reporting Phase|Ongoing SAE from parent study|1|||
48962585|NCT00310388|157692177|FG001|Primary Reporting Phase|Ongoing SAE from parent study|0|||
48962586|NCT00310388|157692176|FG000|Primary Reporting Phase|Due to pigmentation risk concerns|2|||
48962587|NCT00310388|157692177|FG001|Primary Reporting Phase|Due to pigmentation risk concerns|0|||
48962588|NCT00310388|157692176|FG000|Primary Reporting Phase|Participant passed away|1|||
48962589|NCT00310388|157692177|FG001|Primary Reporting Phase|Participant passed away|0|||
48657099|NCT00075725|156596062|FG008|Overall Study|Pt care terminated due to pt behavior|0|||
48657100|NCT00075725|156596063|FG009|Overall Study|Pt care terminated due to pt behavior|0|||
48657101|NCT00075725|156596064|FG010|Overall Study|Pt care terminated due to pt behavior|0|||
48657102|NCT00075725|156596065|FG011|Overall Study|Pt care terminated due to pt behavior|0|||
48657103|NCT00075725|156596054|FG000|Overall Study|Pt incarcerated|0|||
48657104|NCT00075725|156596055|FG001|Overall Study|Pt incarcerated|0|||
48657105|NCT00075725|156596056|FG002|Overall Study|Pt incarcerated|0|||
48657106|NCT00075725|156596057|FG003|Overall Study|Pt incarcerated|0|||
48657107|NCT00075725|156596058|FG004|Overall Study|Pt incarcerated|0|||
48657108|NCT00075725|156596059|FG005|Overall Study|Pt incarcerated|0|||
48657109|NCT00075725|156596060|FG006|Overall Study|Pt incarcerated|0|||
48657110|NCT00075725|156596061|FG007|Overall Study|Pt incarcerated|1|||
48657111|NCT00075725|156596062|FG008|Overall Study|Pt incarcerated|0|||
48754789|NCT00296374|156948185|FG001|Overall Study|Lost to Follow-up|1|||
48754790|NCT00296374|156948186|FG002|Overall Study|Lost to Follow-up|1|||
48754791|NCT00296374|156948184|FG000|Overall Study|Relocated to another state|1|||
48754792|NCT00296374|156948185|FG001|Overall Study|Relocated to another state|0|||
48754793|NCT00296374|156948186|FG002|Overall Study|Relocated to another state|0|||
48754794|NCT00296374|156948184|FG000|Overall Study|Stopped drug before end of study visit|0|||
48754795|NCT00296374|156948185|FG001|Overall Study|Stopped drug before end of study visit|1|||
48754796|NCT00296374|156948186|FG002|Overall Study|Stopped drug before end of study visit|0|||
48754797|NCT00296374|156948184|FG000|Overall Study|Nephrologist introduced ACE|0|||
48754798|NCT00296374|156948185|FG001|Overall Study|Nephrologist introduced ACE|1|||
48754799|NCT00296374|156948186|FG002|Overall Study|Nephrologist introduced ACE|0|||
48754800|NCT00296374|156948184|FG000|Overall Study|Pregnancy|0|||
48754801|NCT00296374|156948185|FG001|Overall Study|Pregnancy|0|||
48754802|NCT00296374|156948186|FG002|Overall Study|Pregnancy|2|||
48754803|NCT00296374|156948184|FG000|Overall Study|Other|0|||
48754804|NCT00296374|156948185|FG001|Overall Study|Other|0|||
48865933|NCT03845517|157345615|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
48865934|NCT03845517|157345616|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
48865935|NCT03845517|157345617|FG002|Treatment Period (52 Weeks)|Pregnancy|0|||
48865936|NCT03845517|157345618|FG003|Treatment Period (52 Weeks)|Pregnancy|1|||
48865937|NCT03845517|157345615|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
48865938|NCT03845517|157345616|FG001|Treatment Period (52 Weeks)|Protocol Violation|0|||
48865939|NCT03845517|157345617|FG002|Treatment Period (52 Weeks)|Protocol Violation|1|||
48865940|NCT03845517|157345618|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
48865941|NCT03845517|157345615|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|4|||
48962590|NCT00310388|157692176|FG000|Primary Reporting Phase|Participant retired the informed consent|1|||
48962591|NCT00310388|157692177|FG001|Primary Reporting Phase|Participant retired the informed consent|0|||
48962592|NCT00310388|157692176|FG000|Primary Reporting Phase|Missing|1|||
48754805|NCT00296374|156948186|FG002|Overall Study|Other|1|||
48754806|NCT01721330|156948187|FG000|Overall Study|Withdrawal by Subject|0|||
48754807|NCT01721330|156948188|FG001|Overall Study|Withdrawal by Subject|1|||
48754808|NCT00459667|156948197|FG000|Overall Study|Adverse Event|9|||
48754809|NCT00459667|156948198|FG001|Overall Study|Adverse Event|12|||
48962593|NCT00310388|157692177|FG001|Primary Reporting Phase|Missing|0|||
48962594|NCT00310388|157692176|FG000|Primary Reporting Phase|Other|1|||
48962595|NCT00310388|157692177|FG001|Primary Reporting Phase|Other|0|||
48962596|NCT00310388|157692176|FG000|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0|||
48962597|NCT00310388|157692177|FG001|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5|||
48962598|NCT00310388|157692176|FG000|Safety Follow-up Continuation Phase|Adverse Event|0|||
48962599|NCT00310388|157692177|FG001|Safety Follow-up Continuation Phase|Adverse Event|1|||
48962600|NCT00310388|157692176|FG000|Safety Follow-up Continuation Phase|Withdrawal by Subject|0|||
48962601|NCT00310388|157692177|FG001|Safety Follow-up Continuation Phase|Withdrawal by Subject|5|||
48962602|NCT00310388|157692176|FG000|Safety Follow-up Continuation Phase|Study Closed/Terminated|0|||
48865942|NCT03845517|157345616|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
48865943|NCT03845517|157345617|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
48865944|NCT03845517|157345618|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
48865945|NCT03845517|157345615|FG000|Follow-up Period (4 Weeks)|Adverse Event|4|||
48865946|NCT03845517|157345616|FG001|Follow-up Period (4 Weeks)|Adverse Event|2|||
48865947|NCT03845517|157345617|FG002|Follow-up Period (4 Weeks)|Adverse Event|0|||
48865948|NCT03845517|157345618|FG003|Follow-up Period (4 Weeks)|Adverse Event|2|||
48865949|NCT03845517|157345615|FG000|Follow-up Period (4 Weeks)|Death|0|||
48865950|NCT03845517|157345616|FG001|Follow-up Period (4 Weeks)|Death|0|||
48865951|NCT03845517|157345617|FG002|Follow-up Period (4 Weeks)|Death|1|||
48865952|NCT03845517|157345618|FG003|Follow-up Period (4 Weeks)|Death|1|||
48865953|NCT03845517|157345615|FG000|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
48962603|NCT00310388|157692177|FG001|Safety Follow-up Continuation Phase|Study Closed/Terminated|2|||
48657112|NCT00075725|156596063|FG009|Overall Study|Pt incarcerated|0|||
48657113|NCT00075725|156596064|FG010|Overall Study|Pt incarcerated|0|||
48657114|NCT00075725|156596065|FG011|Overall Study|Pt incarcerated|0|||
48657115|NCT01560637|156596066|FG000|Overall Study|Adverse Event|63|||
48657116|NCT01560637|156596066|FG000|Overall Study|Death|69|||
48657117|NCT01560637|156596066|FG000|Overall Study|Lost to Follow-up|8|||
48657118|NCT01560637|156596066|FG000|Overall Study|Protocol Violation|8|||
48657119|NCT01560637|156596066|FG000|Overall Study|Withdrawal by Subject|24|||
48657120|NCT01560637|156596066|FG000|Overall Study|Progressive Disease|20|||
48657121|NCT01560637|156596066|FG000|Overall Study|Other Reason Not Specified|6|||
48657122|NCT00072293|156596069|FG000|Overall Study|Lost to Follow-up|1|||
48657123|NCT00072293|156596070|FG001|Overall Study|Lost to Follow-up|1|||
48657124|NCT00072293|156596069|FG000|Overall Study|Withdrawal by Subject|0|||
48657125|NCT00072293|156596070|FG001|Overall Study|Withdrawal by Subject|1|||
48657126|NCT01166373|156596073|FG000|Overall Study|Lost to Follow-up|3|||
48657127|NCT01166373|156596074|FG001|Overall Study|Lost to Follow-up|2|||
48657128|NCT01166373|156596075|FG002|Overall Study|Lost to Follow-up|2|||
48657129|NCT01166373|156596076|FG003|Overall Study|Lost to Follow-up|2|||
48657130|NCT01166373|156596073|FG000|Overall Study|Withdrawal by Subject|1|||
48657131|NCT01166373|156596074|FG001|Overall Study|Withdrawal by Subject|2|||
48657132|NCT01166373|156596075|FG002|Overall Study|Withdrawal by Subject|2|||
48657133|NCT01166373|156596076|FG003|Overall Study|Withdrawal by Subject|3|||
48657134|NCT01166373|156596073|FG000|Overall Study|Physician Decision|1|||
48657135|NCT01166373|156596074|FG001|Overall Study|Physician Decision|0|||
48657136|NCT01166373|156596075|FG002|Overall Study|Physician Decision|0|||
48657137|NCT01166373|156596076|FG003|Overall Study|Physician Decision|0|||
48657138|NCT02752958|156596079|FG000|Overall Study|Adverse Event|3|||
48657139|NCT02752958|156596079|FG000|Overall Study|Lost to Follow-up|1|||
48657140|NCT02752958|156596079|FG000|Overall Study|Protocol Violation|1|||
48657141|NCT02752958|156596079|FG000|Overall Study|Withdrawal by Subject|2|||
48657142|NCT02752958|156596079|FG000|Overall Study|Other (Reason not specified)|2|||
48657143|NCT02214225|156596080|FG000|Overall Study|Lost to Follow-up|46|||
48657144|NCT02214225|156596081|FG001|Overall Study|Lost to Follow-up|18|||
48657145|NCT02214225|156596082|FG002|Overall Study|Lost to Follow-up|18|||
48657146|NCT02214225|156596080|FG000|Overall Study|Withdrawal by Subject|2|||
48657147|NCT02214225|156596081|FG001|Overall Study|Withdrawal by Subject|0|||
48657148|NCT02214225|156596082|FG002|Overall Study|Withdrawal by Subject|2|||
48657149|NCT02214225|156596080|FG000|Overall Study|Death|5|||
48657150|NCT02214225|156596081|FG001|Overall Study|Death|0|||
48657151|NCT02214225|156596082|FG002|Overall Study|Death|1|||
48657152|NCT02214225|156596080|FG000|Overall Study|randomized in error, not vaccinated|2|||
48657153|NCT02214225|156596081|FG001|Overall Study|randomized in error, not vaccinated|1|||
48657154|NCT02214225|156596082|FG002|Overall Study|randomized in error, not vaccinated|1|||
48657155|NCT00405964|156596083|FG000|Overall Study|Treatment Failure|17|||
48657156|NCT00405964|156596084|FG001|Overall Study|Treatment Failure|45|||
48657157|NCT00405964|156596083|FG000|Overall Study|Adverse Event|7|||
48657158|NCT00405964|156596084|FG001|Overall Study|Adverse Event|16|||
48865954|NCT03845517|157345616|FG001|Follow-up Period (4 Weeks)|Lost to Follow-up|1|||
48657159|NCT00405964|156596083|FG000|Overall Study|Lost to Follow-up|5|||
48657160|NCT00405964|156596084|FG001|Overall Study|Lost to Follow-up|5|||
48657161|NCT00405964|156596083|FG000|Overall Study|Withdrawal by Subject|19|||
48657162|NCT00405964|156596084|FG001|Overall Study|Withdrawal by Subject|23|||
48657163|NCT00405964|156596083|FG000|Overall Study|Protocol Violation|11|||
48865955|NCT03845517|157345617|FG002|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
48865956|NCT03845517|157345618|FG003|Follow-up Period (4 Weeks)|Lost to Follow-up|0|||
48865957|NCT03845517|157345615|FG000|Follow-up Period (4 Weeks)|Physician's decision|0|||
48865958|NCT03845517|157345616|FG001|Follow-up Period (4 Weeks)|Physician's decision|0|||
48865959|NCT03845517|157345617|FG002|Follow-up Period (4 Weeks)|Physician's decision|1|||
48865960|NCT03845517|157345618|FG003|Follow-up Period (4 Weeks)|Physician's decision|1|||
48865961|NCT03845517|157345615|FG000|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
48865962|NCT03845517|157345616|FG001|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
48865963|NCT03845517|157345617|FG002|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
48865964|NCT03845517|157345618|FG003|Follow-up Period (4 Weeks)|Study terminated by sponsor|1|||
48865965|NCT03845517|157345615|FG000|Follow-up Period (4 Weeks)|Other|1|||
48865966|NCT03845517|157345616|FG001|Follow-up Period (4 Weeks)|Other|0|||
48865967|NCT03845517|157345617|FG002|Follow-up Period (4 Weeks)|Other|1|||
48865968|NCT03845517|157345618|FG003|Follow-up Period (4 Weeks)|Other|0|||
48865969|NCT03845517|157345615|FG000|Follow-up Period (4 Weeks)|Pregnancy|1|||
48865970|NCT03845517|157345616|FG001|Follow-up Period (4 Weeks)|Pregnancy|0|||
48865971|NCT03845517|157345617|FG002|Follow-up Period (4 Weeks)|Pregnancy|0|||
48865972|NCT03845517|157345618|FG003|Follow-up Period (4 Weeks)|Pregnancy|0|||
48865973|NCT03845517|157345615|FG000|Follow-up Period (4 Weeks)|Protocol Violation|0|||
48865974|NCT03845517|157345616|FG001|Follow-up Period (4 Weeks)|Protocol Violation|0|||
48865975|NCT03845517|157345617|FG002|Follow-up Period (4 Weeks)|Protocol Violation|0|||
48865976|NCT03845517|157345618|FG003|Follow-up Period (4 Weeks)|Protocol Violation|1|||
48865977|NCT03845517|157345615|FG000|Follow-up Period (4 Weeks)|Withdrawal by Subject|3|||
48865978|NCT03845517|157345616|FG001|Follow-up Period (4 Weeks)|Withdrawal by Subject|5|||
48865979|NCT03845517|157345617|FG002|Follow-up Period (4 Weeks)|Withdrawal by Subject|7|||
48865980|NCT03845517|157345618|FG003|Follow-up Period (4 Weeks)|Withdrawal by Subject|1|||
48865981|NCT01498445|157345619|FG000|Overall Study|Lack of Efficacy|0|||
48657164|NCT00405964|156596084|FG001|Overall Study|Protocol Violation|6|||
48657165|NCT01510145|156596089|FG000|Overall Study|Adverse Event|6|||
48657166|NCT01510145|156596089|FG000|Overall Study|Lost to Follow-up|5|||
48657167|NCT01510145|156596089|FG000|Overall Study|Withdrawal by Subject|6|||
48657168|NCT01510145|156596089|FG000|Overall Study|Relative reported subject withdrew|1|||
48657169|NCT01360398|156596090|FG000|Overall Study|Withdrawal by Subject|14|||
48657170|NCT01360398|156596090|FG000|Overall Study|Other|7|||
48657171|NCT01360398|156596090|FG000|Overall Study|Migrated/moved from study area|1|||
48657172|NCT03215927|156597641|FG000|Randomized, Placebo-controlled|Lack of Efficacy|0|||
48657173|NCT03215927|156597642|FG001|Randomized, Placebo-controlled|Lack of Efficacy|1|||
48657174|NCT03215927|156597641|FG000|Open Label Extension|Adverse Event|1|||
48657175|NCT03215927|156597642|FG001|Open Label Extension|Adverse Event|0|||
48657176|NCT03215927|156597641|FG000|Open Label Extension|Lack of Efficacy|1|||
48657177|NCT03215927|156597642|FG001|Open Label Extension|Lack of Efficacy|0|||
48657178|NCT03215927|156597641|FG000|Open Label Extension|Death|0|||
48657179|NCT03215927|156597642|FG001|Open Label Extension|Death|1|||
48657180|NCT02013206|156597643|FG000|Overall Study|Progressive disease (PD)|14|||
48657181|NCT02013206|156597644|FG001|Overall Study|Progressive disease (PD)|17|||
48657182|NCT02013206|156597643|FG000|Overall Study|Symptomatic deterioration|3|||
48657183|NCT02013206|156597644|FG001|Overall Study|Symptomatic deterioration|1|||
48657184|NCT02013206|156597643|FG000|Overall Study|Adverse Event|1|||
48657185|NCT02013206|156597644|FG001|Overall Study|Adverse Event|0|||
48657186|NCT02013206|156597643|FG000|Overall Study|Patient refusal|2|||
48657187|NCT02013206|156597644|FG001|Overall Study|Patient refusal|0|||
48657188|NCT02013206|156597643|FG000|Overall Study|Patient non-compliance|1|||
48657189|NCT02013206|156597644|FG001|Overall Study|Patient non-compliance|0|||
48657190|NCT02013206|156597643|FG000|Overall Study|Death|1|||
48657191|NCT02013206|156597644|FG001|Overall Study|Death|2|||
48657192|NCT02013206|156597643|FG000|Overall Study|Other reasons off treatment|5|||
48657193|NCT02013206|156597644|FG001|Overall Study|Other reasons off treatment|2|||
48657194|NCT00519376|156597658|FG000|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
48657195|NCT00519376|156597659|FG001|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
48657196|NCT00519376|156597660|FG002|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
48657197|NCT00519376|156597661|FG003|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
48657198|NCT00519376|156597662|FG004|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
48865982|NCT01498445|157345620|FG001|Overall Study|Lack of Efficacy|0|||
48865983|NCT01498445|157345621|FG002|Overall Study|Lack of Efficacy|1|||
48962604|NCT01894477|157692183|FG000|Overall Study|Protocol Violation|0|||
48865984|NCT01498445|157345622|FG003|Overall Study|Lack of Efficacy|2|||
48865985|NCT01498445|157345623|FG004|Overall Study|Lack of Efficacy|0|||
48865986|NCT01498445|157345624|FG005|Overall Study|Lack of Efficacy|0|||
48962605|NCT01894477|157692184|FG001|Overall Study|Protocol Violation|1|||
48962606|NCT01894477|157692183|FG000|Overall Study|protocol changed due SC changed to cord|0|||
48657199|NCT00519376|156597663|FG005|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
48657200|NCT00519376|156597664|FG006|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
48657201|NCT00519376|156597665|FG007|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
48657202|NCT00519376|156597666|FG008|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
48657203|NCT00519376|156597667|FG009|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
48657204|NCT00519376|156597668|FG010|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
48657205|NCT00519376|156597669|FG011|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
48657206|NCT00519376|156597670|FG012|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1|||
48657207|NCT00519376|156597671|FG013|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
48657208|NCT00519376|156597672|FG014|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
48657209|NCT00519376|156597673|FG015|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
48657210|NCT00519376|156597658|FG000|Treatment Period 4|Lost to Follow-up|0|||
48657211|NCT00519376|156597659|FG001|Treatment Period 4|Lost to Follow-up|0|||
48657212|NCT00519376|156597660|FG002|Treatment Period 4|Lost to Follow-up|1|||
48657213|NCT00519376|156597661|FG003|Treatment Period 4|Lost to Follow-up|0|||
48657214|NCT00519376|156597662|FG004|Treatment Period 4|Lost to Follow-up|0|||
48657215|NCT00519376|156597663|FG005|Treatment Period 4|Lost to Follow-up|0|||
48657216|NCT00519376|156597664|FG006|Treatment Period 4|Lost to Follow-up|0|||
48657217|NCT00519376|156597665|FG007|Treatment Period 4|Lost to Follow-up|0|||
48657218|NCT00519376|156597666|FG008|Treatment Period 4|Lost to Follow-up|0|||
48657219|NCT00519376|156597667|FG009|Treatment Period 4|Lost to Follow-up|0|||
48657220|NCT00519376|156597668|FG010|Treatment Period 4|Lost to Follow-up|0|||
48962607|NCT01894477|157692184|FG001|Overall Study|protocol changed due SC changed to cord|1|||
48962608|NCT02561299|157692185|FG000|Overall Study|Death|2|||
48657221|NCT00519376|156597669|FG011|Treatment Period 4|Lost to Follow-up|0|||
48657222|NCT00519376|156597670|FG012|Treatment Period 4|Lost to Follow-up|0|||
48657223|NCT00519376|156597671|FG013|Treatment Period 4|Lost to Follow-up|0|||
48657224|NCT00519376|156597672|FG014|Treatment Period 4|Lost to Follow-up|0|||
48657225|NCT00519376|156597673|FG015|Treatment Period 4|Lost to Follow-up|0|||
48657226|NCT00006164|156597674|FG000|Overall Study|Withdrew or lost to follow-up|70|||
48657227|NCT00006164|156597675|FG001|Overall Study|Withdrew or lost to follow-up|81|||
48657228|NCT00608023|156597676|FG000|Overall Study|Withdrawal by Subject|8|||
48657229|NCT00608023|156597677|FG001|Overall Study|Withdrawal by Subject|10|||
48657230|NCT00608023|156597678|FG002|Overall Study|Withdrawal by Subject|7|||
48657231|NCT00608023|156597676|FG000|Overall Study|Adverse Event|1|||
48657232|NCT00608023|156597677|FG001|Overall Study|Adverse Event|4|||
48657233|NCT00608023|156597678|FG002|Overall Study|Adverse Event|5|||
48657234|NCT00608023|156597676|FG000|Overall Study|Lost to Follow-up|2|||
48657235|NCT00608023|156597677|FG001|Overall Study|Lost to Follow-up|2|||
48754810|NCT00459667|156948199|FG002|Overall Study|Adverse Event|8|||
48754811|NCT00459667|156948197|FG000|Overall Study|Lost to Follow-up|5|||
48754812|NCT00459667|156948198|FG001|Overall Study|Lost to Follow-up|9|||
48754813|NCT00459667|156948199|FG002|Overall Study|Lost to Follow-up|3|||
48754814|NCT00459667|156948197|FG000|Overall Study|Pregnancy|1|||
48754815|NCT00459667|156948198|FG001|Overall Study|Pregnancy|1|||
48754816|NCT00459667|156948199|FG002|Overall Study|Pregnancy|1|||
48754817|NCT00459667|156948197|FG000|Overall Study|Protocol Violation|1|||
48754818|NCT00459667|156948198|FG001|Overall Study|Protocol Violation|0|||
48754819|NCT00459667|156948199|FG002|Overall Study|Protocol Violation|0|||
48754820|NCT00459667|156948197|FG000|Overall Study|Withdrawal by Subject|3|||
48754821|NCT00459667|156948198|FG001|Overall Study|Withdrawal by Subject|5|||
48754822|NCT00459667|156948199|FG002|Overall Study|Withdrawal by Subject|5|||
48754823|NCT00459667|156948197|FG000|Overall Study|Other disease modifying treatment|1|||
48754824|NCT00459667|156948198|FG001|Overall Study|Other disease modifying treatment|2|||
48754825|NCT00459667|156948199|FG002|Overall Study|Other disease modifying treatment|1|||
48754826|NCT00459667|156948197|FG000|Overall Study|Other reason (incl. 2 missing subjects)|12|||
48754827|NCT00459667|156948198|FG001|Overall Study|Other reason (incl. 2 missing subjects)|15|||
48754828|NCT00459667|156948199|FG002|Overall Study|Other reason (incl. 2 missing subjects)|1|||
48754829|NCT00459667|156948197|FG000|Overall Study|No treatment administered|6|||
48754830|NCT00459667|156948198|FG001|Overall Study|No treatment administered|3|||
48754831|NCT00459667|156948199|FG002|Overall Study|No treatment administered|1|||
48754832|NCT02671422|156948208|FG000|Overall Study|Lost to Follow-up|1|||
48754833|NCT02671422|156948208|FG000|Overall Study|Adverse Event|68|||
48754834|NCT02671422|156948208|FG000|Overall Study|Lack of Efficacy|1|||
48754835|NCT02671422|156948208|FG000|Overall Study|Lost to Follow-up|4|||
48754836|NCT02671422|156948208|FG000|Overall Study|Withdrawal by Subject|7|||
48754837|NCT02671422|156948208|FG000|Overall Study|Progressive Disease|156|||
48754838|NCT02671422|156948208|FG000|Overall Study|Worsening of Disease|4|||
48962609|NCT02561299|157692186|FG001|Overall Study|Death|4|||
48754839|NCT02671422|156948208|FG000|Overall Study|Sponsor decision|5|||
48754840|NCT02671422|156948208|FG000|Overall Study|Adverse Event unrelated to Vargatef®|8|||
48754841|NCT02671422|156948208|FG000|Overall Study|Not treated with Vargatef®|3|||
48754842|NCT02671422|156948208|FG000|Overall Study|Other not defined above|3|||
48754843|NCT02744391|156948209|FG000|Overall Study|Lost to Follow-up|9|||
48754844|NCT02744391|156948209|FG000|Overall Study|Physician Decision|2|||
48657236|NCT00608023|156597678|FG002|Overall Study|Lost to Follow-up|1|||
48657237|NCT00608023|156597676|FG000|Overall Study|Protocol Violation|1|||
48657238|NCT00608023|156597677|FG001|Overall Study|Protocol Violation|3|||
48657239|NCT00608023|156597678|FG002|Overall Study|Protocol Violation|1|||
48657240|NCT00608023|156597676|FG000|Overall Study|Unknown reason|0|||
48657241|NCT00608023|156597677|FG001|Overall Study|Unknown reason|3|||
48657242|NCT00608023|156597678|FG002|Overall Study|Unknown reason|0|||
48657243|NCT01681069|156597681|FG000|Overall Study|Withdrawal by Subject|4|||
48657244|NCT01681069|156597682|FG001|Overall Study|Withdrawal by Subject|5|||
48657245|NCT01681069|156597681|FG000|Overall Study|Protocol Violation|1|||
48657246|NCT01681069|156597682|FG001|Overall Study|Protocol Violation|1|||
48657247|NCT01681069|156597681|FG000|Overall Study|Adverse Event|0|||
48657248|NCT01681069|156597682|FG001|Overall Study|Adverse Event|1|||
48657249|NCT02743949|156597689|FG000|Overall Study|Adverse Event|0|||
48657250|NCT02743949|156597690|FG001|Overall Study|Adverse Event|0|||
48657251|NCT02743949|156597691|FG002|Overall Study|Adverse Event|2|||
48657252|NCT02743949|156597689|FG000|Overall Study|Significant Protocol Deviation|2|||
48657253|NCT02743949|156597690|FG001|Overall Study|Significant Protocol Deviation|0|||
48657254|NCT02743949|156597691|FG002|Overall Study|Significant Protocol Deviation|1|||
48657255|NCT02743949|156597689|FG000|Overall Study|Voluntary Withdrawal|2|||
48657256|NCT02743949|156597690|FG001|Overall Study|Voluntary Withdrawal|1|||
48657257|NCT02743949|156597691|FG002|Overall Study|Voluntary Withdrawal|0|||
48657258|NCT03389555|156597692|FG000|Overall Study|Protocol Violation|1|||
48657259|NCT03389555|156597693|FG001|Overall Study|Protocol Violation|3|||
48657260|NCT03389555|156597692|FG000|Overall Study|Death|1|||
48657261|NCT03389555|156597693|FG001|Overall Study|Death|0|||
48657262|NCT00920218|156597698|FG000|Overall Study|Serious Adverse Event|2|||
48657263|NCT00920218|156597699|FG001|Overall Study|Serious Adverse Event|0|||
48657264|NCT00920218|156597700|FG002|Overall Study|Serious Adverse Event|2|||
48657265|NCT00920218|156597701|FG003|Overall Study|Serious Adverse Event|1|||
48657266|NCT00920218|156597698|FG000|Overall Study|Withdrawal by Subject|0|||
48657267|NCT00920218|156597699|FG001|Overall Study|Withdrawal by Subject|3|||
48657268|NCT00920218|156597700|FG002|Overall Study|Withdrawal by Subject|2|||
48657269|NCT00920218|156597701|FG003|Overall Study|Withdrawal by Subject|0|||
48657270|NCT00920218|156597698|FG000|Overall Study|Migrated/moved from study area|0|||
48657271|NCT00920218|156597699|FG001|Overall Study|Migrated/moved from study area|0|||
48657272|NCT00920218|156597700|FG002|Overall Study|Migrated/moved from study area|1|||
48657273|NCT00920218|156597701|FG003|Overall Study|Migrated/moved from study area|0|||
48657274|NCT00920218|156597698|FG000|Overall Study|Lost to Follow-up|0|||
48657275|NCT00920218|156597699|FG001|Overall Study|Lost to Follow-up|1|||
48657276|NCT00920218|156597700|FG002|Overall Study|Lost to Follow-up|0|||
48657277|NCT00920218|156597701|FG003|Overall Study|Lost to Follow-up|3|||
48657278|NCT00920218|156597698|FG000|Overall Study|Transplant failed/malignancy recurrence|0|||
48657279|NCT00920218|156597699|FG001|Overall Study|Transplant failed/malignancy recurrence|1|||
48657280|NCT00920218|156597700|FG002|Overall Study|Transplant failed/malignancy recurrence|2|||
48657281|NCT00920218|156597701|FG003|Overall Study|Transplant failed/malignancy recurrence|3|||
48657282|NCT00920218|156597698|FG000|Overall Study|Other|0|||
48657283|NCT00920218|156597699|FG001|Overall Study|Other|0|||
48657284|NCT00920218|156597700|FG002|Overall Study|Other|1|||
48657285|NCT00920218|156597701|FG003|Overall Study|Other|0|||
48657286|NCT00923975|156597702|FG000|Overall Study|Did not meet inclusion criteria|1|||
48657287|NCT01328535|156597703|FG000|Overall Study|Ineligible|1|||
48657288|NCT04417218|156597704|FG000|First Intervention (1 Week))|Withdrawal by Subject|1|||
48657289|NCT04417218|156597705|FG001|First Intervention (1 Week))|Withdrawal by Subject|0|||
48657290|NCT03224507|156597706|FG000|Overall Study|Death|3|||
48657291|NCT03224507|156597707|FG001|Overall Study|Death|0|||
48657292|NCT03224507|156597706|FG000|Overall Study|Lack of Efficacy|6|||
48657293|NCT03224507|156597707|FG001|Overall Study|Lack of Efficacy|0|||
48657294|NCT03224507|156597706|FG000|Overall Study|Withdrawal by Subject|6|||
48657295|NCT03224507|156597707|FG001|Overall Study|Withdrawal by Subject|0|||
48657296|NCT00347438|156597710|FG000|Overall Study|Withdrawal by Subject|1|||
48657297|NCT00347438|156597710|FG000|Overall Study|Physician Decision|1|||
48657298|NCT00322023|156597711|FG000|Overall Study|various|0|||
48657299|NCT00322023|156597712|FG001|Overall Study|various|2|||
48865987|NCT01498445|157345619|FG000|Overall Study|Screen Failure|0|||
48865988|NCT01498445|157345620|FG001|Overall Study|Screen Failure|0|||
48657300|NCT00322023|156597713|FG002|Overall Study|various|6|||
48657301|NCT03327220|156597714|FG000|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1|||
48657302|NCT03327220|156597715|FG001|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2|||
48657303|NCT03327220|156597714|FG000|Overall Study|Investigator Decision|2|||
48657304|NCT03327220|156597715|FG001|Overall Study|Investigator Decision|0|||
48657305|NCT03327220|156597714|FG000|Overall Study|Missed Visit 6 (Week 6 Visit)|0|||
48865989|NCT01498445|157345621|FG002|Overall Study|Screen Failure|0|||
48657306|NCT03327220|156597715|FG001|Overall Study|Missed Visit 6 (Week 6 Visit)|1|||
48657307|NCT03327220|156597714|FG000|Overall Study|Fungal infection|1|||
48657308|NCT03327220|156597715|FG001|Overall Study|Fungal infection|0|||
48657309|NCT03327220|156597714|FG000|Overall Study|Discharged to Rehabilitation|0|||
48657310|NCT03327220|156597715|FG001|Overall Study|Discharged to Rehabilitation|1|||
48657311|NCT03327220|156597714|FG000|Overall Study|Missing|1|||
48865990|NCT01498445|157345622|FG003|Overall Study|Screen Failure|0|||
48657312|NCT03327220|156597715|FG001|Overall Study|Missing|0|||
48657313|NCT01177553|156597716|FG000|Overall Study|babies not yet 6 months of age|1|||
48657314|NCT01177553|156597717|FG001|Overall Study|babies not yet 6 months of age|0|||
48657315|NCT02534935|156597720|FG000|Stage 1: 24 Months|Withdrawal by Subject|0|||
48657316|NCT02534935|156597721|FG001|Stage 1: 24 Months|Withdrawal by Subject|3|||
48657317|NCT02534935|156597722|FG002|Stage 1: 24 Months|Withdrawal by Subject|3|||
48657318|NCT02534935|156597720|FG000|Stage 1: 24 Months|No longer willing to participate in study|0|||
48657319|NCT02534935|156597721|FG001|Stage 1: 24 Months|No longer willing to participate in study|1|||
48657320|NCT02534935|156597722|FG002|Stage 1: 24 Months|No longer willing to participate in study|1|||
48657321|NCT02534935|156597720|FG000|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
48657322|NCT02534935|156597721|FG001|Stage 1: 24 Months|No longer meets eligibility criteria|3|||
48657323|NCT02534935|156597722|FG002|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
48657324|NCT02534935|156597720|FG000|Stage 1: 24 Months|Lost to Follow-up|0|||
48657325|NCT02534935|156597721|FG001|Stage 1: 24 Months|Lost to Follow-up|1|||
48657326|NCT02534935|156597722|FG002|Stage 1: 24 Months|Lost to Follow-up|1|||
48657327|NCT02534935|156597720|FG000|Stage 1: 24 Months|Adverse Event|0|||
48657328|NCT02534935|156597721|FG001|Stage 1: 24 Months|Adverse Event|2|||
48657329|NCT02534935|156597722|FG002|Stage 1: 24 Months|Adverse Event|0|||
48657330|NCT02534935|156597720|FG000|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
48657331|NCT02534935|156597721|FG001|Stage 2: 8 Months|Moved away/parents resigned from study|4|||
48657332|NCT02534935|156597722|FG002|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
48657333|NCT02534935|156597720|FG000|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
48657334|NCT02534935|156597721|FG001|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1|||
48657335|NCT02534935|156597722|FG002|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
48657336|NCT01239381|156597723|FG000|Overall Study|Protocol Violation|1|||
48657337|NCT01239381|156597723|FG000|Overall Study|Withdrawal by Subject|1|||
48657338|NCT01082874|156597724|FG000|Overall Study|Lost to Follow-up|10|||
48865991|NCT01498445|157345623|FG004|Overall Study|Screen Failure|1|||
48865992|NCT01498445|157345624|FG005|Overall Study|Screen Failure|1|||
48865993|NCT01061775|157345625|FG000|Overall Study|Physician Decision|2|||
48865994|NCT01061775|157345625|FG000|Overall Study|Lost to Follow-up|1|||
48865995|NCT00784277|157345628|FG000|IR Treatment|Adverse Event|4|||
48865996|NCT00784277|157345629|FG001|IR Treatment|Adverse Event|8|||
48865997|NCT00784277|157345630|FG002|IR Treatment|Adverse Event|19|||
48865998|NCT00784277|157345631|FG003|IR Treatment|Adverse Event|35|||
48865999|NCT00784277|157345632|FG004|IR Treatment|Adverse Event|0|||
48866000|NCT00784277|157345633|FG005|IR Treatment|Adverse Event|0|||
48866001|NCT00784277|157345634|FG006|IR Treatment|Adverse Event|0|||
48866002|NCT00784277|157345628|FG000|IR Treatment|Lack of Efficacy|4|||
48866003|NCT00784277|157345629|FG001|IR Treatment|Lack of Efficacy|4|||
48866004|NCT00784277|157345630|FG002|IR Treatment|Lack of Efficacy|1|||
48866005|NCT00784277|157345631|FG003|IR Treatment|Lack of Efficacy|0|||
48866006|NCT00784277|157345632|FG004|IR Treatment|Lack of Efficacy|0|||
48866007|NCT00784277|157345633|FG005|IR Treatment|Lack of Efficacy|0|||
48962610|NCT02561299|157692185|FG000|Overall Study|Lost to Follow-up|1|||
48962611|NCT02561299|157692186|FG001|Overall Study|Lost to Follow-up|0|||
48962612|NCT02561299|157692185|FG000|Overall Study|Withdrawal by Subject|2|||
48962613|NCT02561299|157692186|FG001|Overall Study|Withdrawal by Subject|2|||
48962614|NCT00630812|157692187|FG000|Randomisation to First Dose|Adverse Event|1|||
48962615|NCT00630812|157692188|FG001|Randomisation to First Dose|Adverse Event|1|||
48962616|NCT00630812|157692187|FG000|Randomisation to First Dose|Withdrawal by Subject|2|||
48962617|NCT00630812|157692188|FG001|Randomisation to First Dose|Withdrawal by Subject|3|||
48962618|NCT00630812|157692187|FG000|Randomisation to First Dose|Lost to Follow-up|1|||
48962619|NCT00630812|157692188|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
48962620|NCT00630812|157692187|FG000|Randomisation to First Dose|Protocol Violation|4|||
48962621|NCT00630812|157692188|FG001|Randomisation to First Dose|Protocol Violation|1|||
48962622|NCT00630812|157692187|FG000|Double Blind Treatment Period|Adverse Event|13|||
48962623|NCT00630812|157692188|FG001|Double Blind Treatment Period|Adverse Event|5|||
48962624|NCT00630812|157692187|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
48962625|NCT00630812|157692188|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
48962626|NCT00630812|157692187|FG000|Double Blind Treatment Period|Physician Decision|2|||
48962627|NCT00630812|157692188|FG001|Double Blind Treatment Period|Physician Decision|1|||
48962628|NCT00630812|157692187|FG000|Double Blind Treatment Period|Protocol Violation|1|||
48866008|NCT00784277|157345634|FG006|IR Treatment|Lack of Efficacy|0|||
48866009|NCT00784277|157345628|FG000|IR Treatment|Lost to Follow-up|1|||
48962629|NCT00630812|157692188|FG001|Double Blind Treatment Period|Protocol Violation|0|||
48962630|NCT00630812|157692187|FG000|Double Blind Treatment Period|Withdrawal by Subject|13|||
48962631|NCT00630812|157692188|FG001|Double Blind Treatment Period|Withdrawal by Subject|7|||
48866010|NCT00784277|157345629|FG001|IR Treatment|Lost to Follow-up|0|||
49015428|NCT01497938|157892192|FG000|Overall Study|Adverse Event|0|||
48657339|NCT01082874|156597725|FG001|Overall Study|Lost to Follow-up|10|||
48657340|NCT01082874|156597726|FG002|Overall Study|Lost to Follow-up|6|||
48657341|NCT01082874|156597727|FG003|Overall Study|Lost to Follow-up|10|||
48866011|NCT00784277|157345630|FG002|IR Treatment|Lost to Follow-up|1|||
48657342|NCT01082874|156597724|FG000|Overall Study|Withdrawal by Subject|1|||
48657343|NCT01082874|156597725|FG001|Overall Study|Withdrawal by Subject|2|||
48657344|NCT01082874|156597726|FG002|Overall Study|Withdrawal by Subject|5|||
48657345|NCT01082874|156597727|FG003|Overall Study|Withdrawal by Subject|3|||
48657346|NCT02442310|156597730|FG000|Overall Study|Adverse Event|2|||
48657347|NCT02442310|156597730|FG000|Overall Study|Withdrawal by Subject|1|||
48657348|NCT00695955|156597731|FG000|Cohort 1|Adverse Event|26|||
48657349|NCT00695955|156597731|FG000|Cohort 1|Protocol Violation|2|||
48657350|NCT00695955|156597731|FG000|Cohort 1|Lost to Follow-up|30|||
48657351|NCT00695955|156597731|FG000|Cohort 1|Withdrawal by Subject|25|||
48657352|NCT00695955|156597731|FG000|Cohort 1|Lack of Efficacy|3|||
48657353|NCT00695955|156597731|FG000|Cohort 1|Other|16|||
48657354|NCT00695955|156597731|FG000|Cohort 2|Adverse Event|24|||
48657355|NCT00695955|156597731|FG000|Cohort 2|Protocol Violation|5|||
48657356|NCT00695955|156597731|FG000|Cohort 2|Lost to Follow-up|38|||
48657357|NCT00695955|156597731|FG000|Cohort 2|Withdrawal by Subject|28|||
48657358|NCT00695955|156597731|FG000|Cohort 2|Lack of Efficacy|4|||
48657359|NCT00695955|156597731|FG000|Cohort 2|Other|5|||
48657360|NCT01972308|156597732|FG000|Overall Study|Withdrawal by Subject|0|||
48657361|NCT01972308|156597733|FG001|Overall Study|Withdrawal by Subject|1|||
48657362|NCT01972308|156597732|FG000|Overall Study|Lost to Follow-up|4|||
48657363|NCT01972308|156597733|FG001|Overall Study|Lost to Follow-up|6|||
48657364|NCT01972308|156597732|FG000|Overall Study|Death|4|||
48657365|NCT01972308|156597733|FG001|Overall Study|Death|1|||
48657366|NCT01562314|156597744|FG000|Overall Study|Adverse Event|10|||
48657367|NCT01562314|156597745|FG001|Overall Study|Adverse Event|5|||
48657368|NCT01562314|156597744|FG000|Overall Study|Met Withdrawal Criteria|3|||
48657369|NCT01562314|156597745|FG001|Overall Study|Met Withdrawal Criteria|2|||
48657370|NCT01562314|156597744|FG000|Overall Study|Withdrawal by Subject|0|||
48657371|NCT01562314|156597745|FG001|Overall Study|Withdrawal by Subject|1|||
48657372|NCT01703208|156597755|FG000|Overall Study|Death|61|||
48657373|NCT01703208|156597756|FG001|Overall Study|Death|48|||
48657374|NCT01703208|156597755|FG000|Overall Study|Lack of Efficacy|1|||
48657375|NCT01703208|156597756|FG001|Overall Study|Lack of Efficacy|2|||
48657376|NCT01703208|156597755|FG000|Overall Study|Lost to Follow-up|68|||
48657377|NCT01703208|156597756|FG001|Overall Study|Lost to Follow-up|62|||
48657378|NCT01703208|156597755|FG000|Overall Study|Non-Compliance with Study Drug|1|||
48657379|NCT01703208|156597756|FG001|Overall Study|Non-Compliance with Study Drug|0|||
48657380|NCT01703208|156597755|FG000|Overall Study|Excluded Medication|1|||
48657381|NCT01703208|156597756|FG001|Overall Study|Excluded Medication|2|||
48657382|NCT01703208|156597755|FG000|Overall Study|Site Discontinued Study Participation|23|||
48657383|NCT01703208|156597756|FG001|Overall Study|Site Discontinued Study Participation|27|||
48657384|NCT01703208|156597755|FG000|Overall Study|Physician Decision|11|||
48657385|NCT01703208|156597756|FG001|Overall Study|Physician Decision|13|||
48657386|NCT01703208|156597755|FG000|Overall Study|Progressive disease|2|||
48657387|NCT01703208|156597756|FG001|Overall Study|Progressive disease|2|||
48657388|NCT01703208|156597755|FG000|Overall Study|Protocol Violation|1|||
48657389|NCT01703208|156597756|FG001|Overall Study|Protocol Violation|1|||
48657390|NCT01703208|156597755|FG000|Overall Study|Study Terminated by Sponsor|1710|||
48657391|NCT01703208|156597756|FG001|Overall Study|Study Terminated by Sponsor|1716|||
48657392|NCT01703208|156597755|FG000|Overall Study|Withdrawal by Subject|205|||
48657393|NCT01703208|156597756|FG001|Overall Study|Withdrawal by Subject|209|||
48657394|NCT01703208|156597755|FG000|Overall Study|Adverse Event|14|||
48657395|NCT01703208|156597756|FG001|Overall Study|Adverse Event|19|||
48657396|NCT01703208|156597755|FG000|Overall Study|Technical Problems|0|||
48657397|NCT01703208|156597756|FG001|Overall Study|Technical Problems|1|||
48657398|NCT01703208|156597755|FG000|Overall Study|Protocol Deviation|2|||
48657399|NCT01703208|156597756|FG001|Overall Study|Protocol Deviation|0|||
48657400|NCT03194568|156597759|FG000|Overall Study|Withdrawn due to need for re-operation related to an anticipated device SAE|4|||
48657401|NCT01349322|156597760|FG000|Overall Study|Protocol Violation|45|||
48657402|NCT01349322|156597761|FG001|Overall Study|Protocol Violation|47|||
48657403|NCT00790647|156597766|FG000|Overall Study|Adverse Event|1|||
48657404|NCT00737568|156597767|FG000|Treatment Period Through Week 240|Investigator's Discretion|6|||
48657405|NCT00737568|156597768|FG001|Treatment Period Through Week 240|Investigator's Discretion|5|||
48657406|NCT00737568|156597767|FG000|Treatment Period Through Week 240|Withdrew Consent|5|||
48657407|NCT00737568|156597768|FG001|Treatment Period Through Week 240|Withdrew Consent|6|||
48657408|NCT00737568|156597767|FG000|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3|||
48657409|NCT00737568|156597768|FG001|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4|||
48657410|NCT00737568|156597767|FG000|Treatment Period Through Week 240|Lost to Follow-up|3|||
48657411|NCT00737568|156597768|FG001|Treatment Period Through Week 240|Lost to Follow-up|3|||
48657412|NCT00737568|156597767|FG000|Treatment Period Through Week 240|Protocol Violation|2|||
48657413|NCT00737568|156597768|FG001|Treatment Period Through Week 240|Protocol Violation|3|||
48657414|NCT00737568|156597767|FG000|Treatment Period Through Week 240|Study Discontinued by Sponsor|1|||
48657415|NCT00737568|156597768|FG001|Treatment Period Through Week 240|Study Discontinued by Sponsor|0|||
48657416|NCT00737568|156597767|FG000|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25|||
48866012|NCT00784277|157345631|FG003|IR Treatment|Lost to Follow-up|0|||
48657417|NCT00737568|156597768|FG001|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17|||
48657418|NCT00737568|156597767|FG000|Treatment-Free Follow-up (TFFU) Period|Death|0|||
48657419|NCT00737568|156597768|FG001|Treatment-Free Follow-up (TFFU) Period|Death|1|||
48754845|NCT02744391|156948209|FG000|Overall Study|Withdrawal by Subject|3|||
48754846|NCT02677987|156948211|FG000|Overall Study|Withdrawal by Subject|3|||
48754847|NCT02677987|156948212|FG001|Overall Study|Withdrawal by Subject|0|||
48754848|NCT02677987|156948211|FG000|Overall Study|Lost to Follow-up|1|||
48754849|NCT02677987|156948212|FG001|Overall Study|Lost to Follow-up|0|||
48754850|NCT04007094|156948213|FG000|Overall Study|Lost to Follow-up|1|||
48754851|NCT04007094|156948214|FG001|Overall Study|Lost to Follow-up|1|||
48754852|NCT02700815|156949680|FG000|Overall Study|Adverse Event|0|||
48754853|NCT02700815|156949681|FG001|Overall Study|Adverse Event|6|||
48754854|NCT02700815|156949682|FG002|Overall Study|Adverse Event|2|||
48754855|NCT02700815|156949683|FG003|Overall Study|Adverse Event|3|||
48754856|NCT02700815|156949680|FG000|Overall Study|Lack of Efficacy|0|||
48754857|NCT02700815|156949681|FG001|Overall Study|Lack of Efficacy|0|||
48754858|NCT02700815|156949682|FG002|Overall Study|Lack of Efficacy|1|||
48754859|NCT02700815|156949683|FG003|Overall Study|Lack of Efficacy|2|||
48866013|NCT00784277|157345632|FG004|IR Treatment|Lost to Follow-up|0|||
48866014|NCT00784277|157345633|FG005|IR Treatment|Lost to Follow-up|0|||
48866015|NCT00784277|157345634|FG006|IR Treatment|Lost to Follow-up|0|||
48657420|NCT00737568|156597767|FG000|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1|||
48657421|NCT00737568|156597768|FG001|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0|||
48657422|NCT03298984|156597769|FG000|Overall Study|Physician Decision|1|||
48657423|NCT03298984|156597770|FG001|Overall Study|Physician Decision|0|||
48657424|NCT03298984|156597771|FG002|Overall Study|Physician Decision|0|||
48657425|NCT03298984|156597772|FG003|Overall Study|Physician Decision|6|||
48657426|NCT03298984|156597769|FG000|Overall Study|Lack of Efficacy|0|||
48657427|NCT03298984|156597770|FG001|Overall Study|Lack of Efficacy|1|||
48657428|NCT03298984|156597771|FG002|Overall Study|Lack of Efficacy|1|||
48657429|NCT03298984|156597772|FG003|Overall Study|Lack of Efficacy|4|||
48657430|NCT03298984|156597769|FG000|Overall Study|Relapsed disease (following remission)|0|||
48657431|NCT03298984|156597770|FG001|Overall Study|Relapsed disease (following remission)|0|||
48657432|NCT03298984|156597771|FG002|Overall Study|Relapsed disease (following remission)|1|||
48657433|NCT03298984|156597772|FG003|Overall Study|Relapsed disease (following remission)|1|||
48657434|NCT03298984|156597769|FG000|Overall Study|Adverse Event|0|||
48657435|NCT03298984|156597770|FG001|Overall Study|Adverse Event|0|||
48657436|NCT03298984|156597771|FG002|Overall Study|Adverse Event|0|||
48657437|NCT03298984|156597772|FG003|Overall Study|Adverse Event|1|||
48657438|NCT03298984|156597769|FG000|Overall Study|Death|0|||
48657439|NCT03298984|156597770|FG001|Overall Study|Death|0|||
48657440|NCT03298984|156597771|FG002|Overall Study|Death|0|||
48657441|NCT03298984|156597772|FG003|Overall Study|Death|2|||
48657442|NCT03298984|156597769|FG000|Overall Study|Insurance Company Decision|0|||
48657443|NCT03298984|156597770|FG001|Overall Study|Insurance Company Decision|0|||
48657444|NCT03298984|156597771|FG002|Overall Study|Insurance Company Decision|0|||
48657445|NCT03298984|156597772|FG003|Overall Study|Insurance Company Decision|1|||
48657446|NCT00570037|156597779|FG000|Overall Study|Could not reach for 6-8 week contact|44|||
48657447|NCT00570037|156597780|FG001|Overall Study|Could not reach for 6-8 week contact|69|||
48657448|NCT01774253|156597781|FG000|Overall Study|Lack of Efficacy|4|||
48657449|NCT01774253|156597781|FG000|Overall Study|Physician Decision|2|||
48657450|NCT01774253|156597781|FG000|Overall Study|Withdrawal by Subject|2|||
48657451|NCT01774253|156597781|FG000|Overall Study|Death|1|||
48754860|NCT02700815|156949680|FG000|Overall Study|Lost to Follow-up|1|||
48754861|NCT02700815|156949681|FG001|Overall Study|Lost to Follow-up|0|||
48866016|NCT00784277|157345628|FG000|IR Treatment|Withdrawal by Subject|5|||
48866017|NCT00784277|157345629|FG001|IR Treatment|Withdrawal by Subject|1|||
48866018|NCT00784277|157345630|FG002|IR Treatment|Withdrawal by Subject|4|||
48866019|NCT00784277|157345631|FG003|IR Treatment|Withdrawal by Subject|6|||
48866020|NCT00784277|157345632|FG004|IR Treatment|Withdrawal by Subject|0|||
48866021|NCT00784277|157345633|FG005|IR Treatment|Withdrawal by Subject|0|||
48866022|NCT00784277|157345634|FG006|IR Treatment|Withdrawal by Subject|0|||
48866023|NCT00784277|157345628|FG000|IR Treatment|Resolution Of Pain|0|||
48866024|NCT00784277|157345629|FG001|IR Treatment|Resolution Of Pain|1|||
48866025|NCT00784277|157345630|FG002|IR Treatment|Resolution Of Pain|0|||
48866026|NCT00784277|157345631|FG003|IR Treatment|Resolution Of Pain|0|||
48866027|NCT00784277|157345632|FG004|IR Treatment|Resolution Of Pain|0|||
48866028|NCT00784277|157345633|FG005|IR Treatment|Resolution Of Pain|0|||
48866029|NCT00784277|157345634|FG006|IR Treatment|Resolution Of Pain|0|||
48866030|NCT00784277|157345628|FG000|IR Treatment|Other|2|||
48866031|NCT00784277|157345629|FG001|IR Treatment|Other|3|||
48866032|NCT00784277|157345630|FG002|IR Treatment|Other|3|||
48866033|NCT00784277|157345631|FG003|IR Treatment|Other|2|||
48657452|NCT05426031|156597782|FG000|Overall Study|Circulatory Arrest|3|||
48657453|NCT05426031|156597783|FG001|Overall Study|Circulatory Arrest|2|||
48657454|NCT02080481|156597786|FG000|Overall Study|Never received a block.|1|||
48754862|NCT02700815|156949682|FG002|Overall Study|Lost to Follow-up|0|||
48866034|NCT00784277|157345632|FG004|IR Treatment|Other|0|||
48754863|NCT02700815|156949683|FG003|Overall Study|Lost to Follow-up|1|||
48754864|NCT02700815|156949680|FG000|Overall Study|Refusal to continue medication|0|||
48754865|NCT02700815|156949681|FG001|Overall Study|Refusal to continue medication|1|||
48754866|NCT02700815|156949682|FG002|Overall Study|Refusal to continue medication|0|||
48754867|NCT02700815|156949683|FG003|Overall Study|Refusal to continue medication|1|||
48754868|NCT02700815|156949680|FG000|Overall Study|Withdrawal by Subject|0|||
48754869|NCT02700815|156949681|FG001|Overall Study|Withdrawal by Subject|0|||
48754870|NCT02700815|156949682|FG002|Overall Study|Withdrawal by Subject|1|||
48754871|NCT02700815|156949683|FG003|Overall Study|Withdrawal by Subject|0|||
48754872|NCT00856284|156949685|FG000|Overall Study|Hyperglycemic rescue|231|||
48754873|NCT00856284|156949686|FG001|Overall Study|Hyperglycemic rescue|201|||
48754874|NCT00856284|156949687|FG002|Overall Study|Hyperglycemic rescue|235|||
48754875|NCT00856284|156949685|FG000|Overall Study|Adverse Event|60|||
48754876|NCT00856284|156949686|FG001|Overall Study|Adverse Event|74|||
48754877|NCT00856284|156949687|FG002|Overall Study|Adverse Event|82|||
48754878|NCT00856284|156949685|FG000|Overall Study|Major protocol deviation|24|||
48754879|NCT00856284|156949686|FG001|Overall Study|Major protocol deviation|16|||
48754880|NCT00856284|156949687|FG002|Overall Study|Major protocol deviation|15|||
48754881|NCT00856284|156949685|FG000|Overall Study|Lost to Follow-up|20|||
48754882|NCT00856284|156949686|FG001|Overall Study|Lost to Follow-up|22|||
48754883|NCT00856284|156949687|FG002|Overall Study|Lost to Follow-up|28|||
48754884|NCT00856284|156949685|FG000|Overall Study|Voluntary withdrawal|48|||
48754885|NCT00856284|156949686|FG001|Overall Study|Voluntary withdrawal|52|||
48754886|NCT00856284|156949687|FG002|Overall Study|Voluntary withdrawal|62|||
48754887|NCT00856284|156949685|FG000|Overall Study|Pregnancy|1|||
48754888|NCT00856284|156949686|FG001|Overall Study|Pregnancy|2|||
48754889|NCT00856284|156949687|FG002|Overall Study|Pregnancy|0|||
48754890|NCT00856284|156949685|FG000|Overall Study|Investigator discretion|9|||
48754891|NCT00856284|156949686|FG001|Overall Study|Investigator discretion|8|||
48754892|NCT00856284|156949687|FG002|Overall Study|Investigator discretion|10|||
48754893|NCT00856284|156949685|FG000|Overall Study|Other|15|||
48754894|NCT00856284|156949686|FG001|Overall Study|Other|17|||
48754895|NCT00856284|156949687|FG002|Overall Study|Other|14|||
48754896|NCT00856284|156949685|FG000|Overall Study|Randomized in error|0|||
48754897|NCT00856284|156949686|FG001|Overall Study|Randomized in error|0|||
48754898|NCT00856284|156949687|FG002|Overall Study|Randomized in error|1|||
48754899|NCT03042533|156949693|FG000|Overall Study|MD left program|1|||
48754900|NCT03042533|156949694|FG001|Overall Study|MD left program|4|||
48962632|NCT00630812|157692187|FG000|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1|||
48657455|NCT02080481|156597787|FG001|Overall Study|Never received a block.|0|||
48657456|NCT02310230|156597793|FG000|Overall Study|Physician Decision|1|||
48657457|NCT02310230|156597794|FG001|Overall Study|Physician Decision|3|||
48657458|NCT02310230|156597793|FG000|Overall Study|monitor baseline taken after induction|2|||
48657459|NCT02310230|156597794|FG001|Overall Study|monitor baseline taken after induction|7|||
48657460|NCT02310230|156597793|FG000|Overall Study|Poor signal quality|5|||
48657461|NCT02310230|156597794|FG001|Overall Study|Poor signal quality|8|||
48657462|NCT02310230|156597793|FG000|Overall Study|Case cancelled|1|||
48657463|NCT02310230|156597794|FG001|Overall Study|Case cancelled|0|||
48657464|NCT00884039|156597795|FG000|Overall Study|Withdrawal by Subject|0|||
48657465|NCT00884039|156597796|FG001|Overall Study|Withdrawal by Subject|1|||
48657466|NCT00884039|156597795|FG000|Overall Study|Lack of Efficacy|2|||
48657467|NCT00884039|156597796|FG001|Overall Study|Lack of Efficacy|0|||
48657468|NCT02826421|156597797|FG000|Overall Study|Adverse Event|1|||
48657469|NCT02826421|156597798|FG001|Overall Study|Adverse Event|0|||
48657470|NCT02826421|156597799|FG002|Overall Study|Adverse Event|0|||
48657471|NCT02826421|156597800|FG003|Overall Study|Adverse Event|1|||
48657472|NCT02826421|156597797|FG000|Overall Study|Withdrawal by Subject|1|||
48657473|NCT02826421|156597798|FG001|Overall Study|Withdrawal by Subject|3|||
48657474|NCT02826421|156597799|FG002|Overall Study|Withdrawal by Subject|1|||
48657475|NCT02826421|156597800|FG003|Overall Study|Withdrawal by Subject|1|||
48657476|NCT02826421|156597797|FG000|Overall Study|Reason not given|1|||
48657477|NCT02826421|156597798|FG001|Overall Study|Reason not given|0|||
48657478|NCT02826421|156597799|FG002|Overall Study|Reason not given|1|||
48657479|NCT02826421|156597800|FG003|Overall Study|Reason not given|0|||
48657480|NCT01456195|156599787|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
48657481|NCT01456195|156599788|FG001|Overall Study|Pretreatment Event/Adverse Event|4|||
48657482|NCT01456195|156599789|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
48657483|NCT01456195|156599787|FG000|Overall Study|Lost to Follow-up|3|||
48657484|NCT01456195|156599788|FG001|Overall Study|Lost to Follow-up|1|||
48754901|NCT03042533|156949695|FG002|Overall Study|MD left program|1|||
48754902|NCT02335489|156949698|FG000|Overall Study|Sponsor terminated study|4|||
48754903|NCT02335489|156949698|FG000|Overall Study|Lost to Follow-up|1|||
48657485|NCT01456195|156599789|FG002|Overall Study|Lost to Follow-up|3|||
48657486|NCT01456195|156599787|FG000|Overall Study|Voluntary Withdrawal|5|||
48657487|NCT01456195|156599788|FG001|Overall Study|Voluntary Withdrawal|3|||
48657488|NCT01456195|156599789|FG002|Overall Study|Voluntary Withdrawal|7|||
48657489|NCT01456195|156599787|FG000|Overall Study|Lack of Efficacy|0|||
48866035|NCT00784277|157345633|FG005|IR Treatment|Other|0|||
48866036|NCT00784277|157345634|FG006|IR Treatment|Other|0|||
48866037|NCT00784277|157345628|FG000|ER Treatment|Adverse Event|0|||
48657490|NCT01456195|156599788|FG001|Overall Study|Lack of Efficacy|1|||
48657491|NCT01456195|156599789|FG002|Overall Study|Lack of Efficacy|0|||
48657492|NCT01456195|156599787|FG000|Overall Study|Other Reasons|2|||
48657493|NCT01456195|156599788|FG001|Overall Study|Other Reasons|1|||
48657494|NCT01456195|156599789|FG002|Overall Study|Other Reasons|3|||
48657495|NCT03300817|156599792|FG000|Overall Study|Withdrawal by Subject|1|||
48657496|NCT03300817|156599792|FG000|Overall Study|Adverse Event|1|||
48657497|NCT03300817|156599792|FG000|Overall Study|Subject Found to be Ineligible|2|||
48657498|NCT03842969|156599793|FG000|Overall Study|Participant declined follow-up visit|0|||
48657499|NCT03842969|156599794|FG001|Overall Study|Participant declined follow-up visit|1|||
48657500|NCT03842969|156599795|FG002|Overall Study|Participant declined follow-up visit|0|||
48657501|NCT03842969|156599793|FG000|Overall Study|Sponsor's decision|12|||
48657502|NCT03842969|156599794|FG001|Overall Study|Sponsor's decision|99|||
48657503|NCT03842969|156599795|FG002|Overall Study|Sponsor's decision|61|||
48657504|NCT03842969|156599793|FG000|Overall Study|Pregnancy|0|||
48657505|NCT03842969|156599794|FG001|Overall Study|Pregnancy|0|||
48657506|NCT03842969|156599795|FG002|Overall Study|Pregnancy|1|||
48657507|NCT03842969|156599793|FG000|Overall Study|Death|1|||
48657508|NCT03842969|156599794|FG001|Overall Study|Death|0|||
48657509|NCT03842969|156599795|FG002|Overall Study|Death|1|||
48657510|NCT03842969|156599793|FG000|Overall Study|Withdrawal by Subject|3|||
48657511|NCT03842969|156599794|FG001|Overall Study|Withdrawal by Subject|30|||
48657512|NCT03842969|156599795|FG002|Overall Study|Withdrawal by Subject|18|||
48657513|NCT03842969|156599793|FG000|Overall Study|Protocol Violation|1|||
48657514|NCT03842969|156599794|FG001|Overall Study|Protocol Violation|1|||
48657515|NCT03842969|156599795|FG002|Overall Study|Protocol Violation|0|||
48657516|NCT03842969|156599793|FG000|Overall Study|Physician Decision|0|||
48657517|NCT03842969|156599794|FG001|Overall Study|Physician Decision|3|||
48657518|NCT03842969|156599795|FG002|Overall Study|Physician Decision|0|||
48657519|NCT03842969|156599793|FG000|Overall Study|Lost to Follow-up|0|||
48657520|NCT03842969|156599794|FG001|Overall Study|Lost to Follow-up|2|||
48657521|NCT03842969|156599795|FG002|Overall Study|Lost to Follow-up|0|||
48657522|NCT03842969|156599793|FG000|Overall Study|Adverse Event|0|||
48657523|NCT03842969|156599794|FG001|Overall Study|Adverse Event|2|||
48657524|NCT03842969|156599795|FG002|Overall Study|Adverse Event|0|||
48657525|NCT00489424|156599797|FG000|Overall Study|Adverse Event|3|||
48657526|NCT00489424|156599798|FG001|Overall Study|Adverse Event|3|||
48657527|NCT00489424|156599799|FG002|Overall Study|Adverse Event|4|||
48657528|NCT00489424|156599797|FG000|Overall Study|Lack of Efficacy|1|||
48657529|NCT00489424|156599798|FG001|Overall Study|Lack of Efficacy|0|||
48657530|NCT00489424|156599799|FG002|Overall Study|Lack of Efficacy|0|||
48657531|NCT00489424|156599797|FG000|Overall Study|Administrative problems|0|||
48657532|NCT00489424|156599798|FG001|Overall Study|Administrative problems|2|||
48657533|NCT00489424|156599799|FG002|Overall Study|Administrative problems|1|||
48657534|NCT01468207|156599800|FG000|Treatment Period 1|Adverse Event|1|||
48657535|NCT01468207|156599801|FG001|Treatment Period 1|Adverse Event|0|||
48657536|NCT01468207|156599802|FG002|Treatment Period 1|Adverse Event|0|||
48657537|NCT01468207|156599803|FG003|Treatment Period 1|Adverse Event|0|||
48657538|NCT01468207|156599804|FG004|Treatment Period 1|Adverse Event|0|||
48657539|NCT01468207|156599805|FG005|Treatment Period 1|Adverse Event|0|||
48657540|NCT01468207|156599800|FG000|Treatment Period 1|Protocol Violation|1|||
48657541|NCT01468207|156599801|FG001|Treatment Period 1|Protocol Violation|1|||
48657542|NCT01468207|156599802|FG002|Treatment Period 1|Protocol Violation|0|||
48657543|NCT01468207|156599803|FG003|Treatment Period 1|Protocol Violation|0|||
48657544|NCT01468207|156599804|FG004|Treatment Period 1|Protocol Violation|0|||
48657545|NCT01468207|156599805|FG005|Treatment Period 1|Protocol Violation|0|||
48657546|NCT01468207|156599800|FG000|Treatment Period 1|Withdrawal by Subject|5|||
48657547|NCT01468207|156599801|FG001|Treatment Period 1|Withdrawal by Subject|4|||
48657548|NCT01468207|156599802|FG002|Treatment Period 1|Withdrawal by Subject|0|||
48657549|NCT01468207|156599803|FG003|Treatment Period 1|Withdrawal by Subject|0|||
48657550|NCT01468207|156599804|FG004|Treatment Period 1|Withdrawal by Subject|0|||
48657551|NCT01468207|156599805|FG005|Treatment Period 1|Withdrawal by Subject|0|||
48657552|NCT01468207|156599800|FG000|Treatment Period 1|Lost to Follow-up|2|||
48657553|NCT01468207|156599801|FG001|Treatment Period 1|Lost to Follow-up|1|||
48657554|NCT01468207|156599802|FG002|Treatment Period 1|Lost to Follow-up|0|||
48657555|NCT01468207|156599803|FG003|Treatment Period 1|Lost to Follow-up|0|||
48657556|NCT01468207|156599804|FG004|Treatment Period 1|Lost to Follow-up|0|||
48657557|NCT01468207|156599805|FG005|Treatment Period 1|Lost to Follow-up|0|||
48657558|NCT01468207|156599800|FG000|Treatment Period 1|Other|0|||
48657559|NCT01468207|156599801|FG001|Treatment Period 1|Other|2|||
48754904|NCT02335489|156949698|FG000|Overall Study|Withdrawal by Subject|2|||
48657560|NCT01468207|156599802|FG002|Treatment Period 1|Other|0|||
48657561|NCT01468207|156599803|FG003|Treatment Period 1|Other|0|||
48657562|NCT01468207|156599804|FG004|Treatment Period 1|Other|0|||
48657563|NCT01468207|156599805|FG005|Treatment Period 1|Other|0|||
48657564|NCT01468207|156599800|FG000|Treatment Period 2|Adverse Event|0|||
48657565|NCT01468207|156599801|FG001|Treatment Period 2|Adverse Event|0|||
48657566|NCT01468207|156599802|FG002|Treatment Period 2|Adverse Event|6|||
48657567|NCT01468207|156599803|FG003|Treatment Period 2|Adverse Event|1|||
48657568|NCT01468207|156599804|FG004|Treatment Period 2|Adverse Event|2|||
48657569|NCT01468207|156599805|FG005|Treatment Period 2|Adverse Event|1|||
48657570|NCT01468207|156599800|FG000|Treatment Period 2|Lack of Efficacy|0|||
48657571|NCT01468207|156599801|FG001|Treatment Period 2|Lack of Efficacy|0|||
48657572|NCT01468207|156599802|FG002|Treatment Period 2|Lack of Efficacy|1|||
48657573|NCT01468207|156599803|FG003|Treatment Period 2|Lack of Efficacy|1|||
48657574|NCT01468207|156599804|FG004|Treatment Period 2|Lack of Efficacy|0|||
48657575|NCT01468207|156599805|FG005|Treatment Period 2|Lack of Efficacy|2|||
48657576|NCT01468207|156599800|FG000|Treatment Period 2|Withdrawal by Subject|0|||
48657577|NCT01468207|156599801|FG001|Treatment Period 2|Withdrawal by Subject|0|||
48657578|NCT01468207|156599802|FG002|Treatment Period 2|Withdrawal by Subject|5|||
48657579|NCT01468207|156599803|FG003|Treatment Period 2|Withdrawal by Subject|0|||
48657580|NCT01468207|156599804|FG004|Treatment Period 2|Withdrawal by Subject|0|||
48657581|NCT01468207|156599805|FG005|Treatment Period 2|Withdrawal by Subject|2|||
48657582|NCT01468207|156599800|FG000|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
48657583|NCT01468207|156599801|FG001|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
48657584|NCT01468207|156599802|FG002|Treatment Period 2|Loss/abscence of response (per protocol)|30|||
48657585|NCT01468207|156599803|FG003|Treatment Period 2|Loss/abscence of response (per protocol)|23|||
48657586|NCT01468207|156599804|FG004|Treatment Period 2|Loss/abscence of response (per protocol)|18|||
48657587|NCT01468207|156599805|FG005|Treatment Period 2|Loss/abscence of response (per protocol)|13|||
48657588|NCT01468207|156599800|FG000|Treatment Period 2|Lost to Follow-up|0|||
48657589|NCT01468207|156599801|FG001|Treatment Period 2|Lost to Follow-up|0|||
48657590|NCT01468207|156599802|FG002|Treatment Period 2|Lost to Follow-up|5|||
48657591|NCT01468207|156599803|FG003|Treatment Period 2|Lost to Follow-up|1|||
48657592|NCT01468207|156599804|FG004|Treatment Period 2|Lost to Follow-up|0|||
48657593|NCT01468207|156599805|FG005|Treatment Period 2|Lost to Follow-up|0|||
48657594|NCT01468207|156599800|FG000|Treatment Period 2|Other|0|||
48657595|NCT01468207|156599801|FG001|Treatment Period 2|Other|0|||
48657596|NCT01468207|156599802|FG002|Treatment Period 2|Other|5|||
48657597|NCT01468207|156599803|FG003|Treatment Period 2|Other|1|||
48657598|NCT01468207|156599804|FG004|Treatment Period 2|Other|1|||
48657599|NCT01468207|156599805|FG005|Treatment Period 2|Other|2|||
48657600|NCT02226562|156599819|FG000|Overall Study|Lost to Follow-up|0|||
48657601|NCT02226562|156599820|FG001|Overall Study|Lost to Follow-up|1|||
48657602|NCT01466660|156599821|FG000|Overall Study|Progressive Disease (RECIST 1.1)|120|||
48657603|NCT01466660|156599822|FG001|Overall Study|Progressive Disease (RECIST 1.1)|127|||
48657604|NCT01466660|156599821|FG000|Overall Study|Worsening of underlying cancer disease|5|||
48657605|NCT01466660|156599822|FG001|Overall Study|Worsening of underlying cancer disease|2|||
48657606|NCT01466660|156599821|FG000|Overall Study|Other adverse event|19|||
48657607|NCT01466660|156599822|FG001|Overall Study|Other adverse event|18|||
48657608|NCT01466660|156599821|FG000|Overall Study|Protocol Violation|2|||
48657609|NCT01466660|156599822|FG001|Overall Study|Protocol Violation|1|||
48657610|NCT01466660|156599821|FG000|Overall Study|Refused continuation of trial medication|4|||
48657611|NCT01466660|156599822|FG001|Overall Study|Refused continuation of trial medication|3|||
48657612|NCT01466660|156599821|FG000|Overall Study|Other reason not defined above|10|||
48657613|NCT01466660|156599822|FG001|Overall Study|Other reason not defined above|8|||
48657614|NCT03195660|156599823|FG000|Overall Study|The study was terminated|2|||
48657615|NCT01413100|156599824|FG000|Overall Study|Withdrawal by Subject|1|||
48657616|NCT02449889|156599825|FG000|Overall Study|Adverse Event|1|||
48657617|NCT02449889|156599826|FG001|Overall Study|Adverse Event|2|||
48657618|NCT02449889|156599827|FG002|Overall Study|Adverse Event|0|||
48657619|NCT02449889|156599825|FG000|Overall Study|Protocol Violation|0|||
48657620|NCT02449889|156599826|FG001|Overall Study|Protocol Violation|4|||
48657621|NCT02449889|156599827|FG002|Overall Study|Protocol Violation|1|||
48657622|NCT01257230|156599828|FG000|Overall Study|Not Treated|0|||
48657623|NCT01257230|156599829|FG001|Overall Study|Not Treated|0|||
48657624|NCT01257230|156599830|FG002|Overall Study|Not Treated|1|||
48657625|NCT01257230|156599828|FG000|Overall Study|Adverse Event|2|||
48657626|NCT01257230|156599829|FG001|Overall Study|Adverse Event|0|||
48657627|NCT01257230|156599830|FG002|Overall Study|Adverse Event|0|||
48657628|NCT01257230|156599828|FG000|Overall Study|Lack of Efficacy|0|||
48657629|NCT01257230|156599829|FG001|Overall Study|Lack of Efficacy|1|||
48657630|NCT01257230|156599830|FG002|Overall Study|Lack of Efficacy|0|||
48657631|NCT01257230|156599828|FG000|Overall Study|Protocol Violation|3|||
48657632|NCT01257230|156599829|FG001|Overall Study|Protocol Violation|0|||
48657633|NCT01257230|156599830|FG002|Overall Study|Protocol Violation|1|||
48754905|NCT02335489|156949698|FG000|Overall Study|Physician Decision|2|||
48657634|NCT01257230|156599828|FG000|Overall Study|Withdrawal by Subject|0|||
48657635|NCT01257230|156599829|FG001|Overall Study|Withdrawal by Subject|4|||
48657636|NCT01257230|156599830|FG002|Overall Study|Withdrawal by Subject|1|||
48657637|NCT01257230|156599828|FG000|Overall Study|Other reason not defined above|1|||
48657638|NCT01257230|156599829|FG001|Overall Study|Other reason not defined above|5|||
48657639|NCT01257230|156599830|FG002|Overall Study|Other reason not defined above|3|||
48754906|NCT02335489|156949698|FG000|Overall Study|Lack of Efficacy|1|||
48754907|NCT02564042|156949699|FG000|Overall Study|Adverse Event|4|||
48754908|NCT02564042|156949700|FG001|Overall Study|Adverse Event|4|||
48754909|NCT02564042|156949701|FG002|Overall Study|Adverse Event|3|||
48657640|NCT01369641|156599833|FG000|Overall Study|Withdrawal by Subject|1|||
48754910|NCT02564042|156949702|FG003|Overall Study|Adverse Event|0|||
48754911|NCT02564042|156949703|FG004|Overall Study|Adverse Event|0|||
48754912|NCT02564042|156949704|FG005|Overall Study|Adverse Event|1|||
48754913|NCT02564042|156949699|FG000|Overall Study|Lost to Follow-up|1|||
48754914|NCT02564042|156949700|FG001|Overall Study|Lost to Follow-up|1|||
48754915|NCT02564042|156949701|FG002|Overall Study|Lost to Follow-up|1|||
48754916|NCT02564042|156949702|FG003|Overall Study|Lost to Follow-up|0|||
48754917|NCT02564042|156949703|FG004|Overall Study|Lost to Follow-up|1|||
48754918|NCT02564042|156949704|FG005|Overall Study|Lost to Follow-up|1|||
48754919|NCT02564042|156949699|FG000|Overall Study|Physician Decision|1|||
48754920|NCT02564042|156949700|FG001|Overall Study|Physician Decision|0|||
48754921|NCT02564042|156949701|FG002|Overall Study|Physician Decision|0|||
48657641|NCT01973387|156599834|FG000|Overall Study|Adverse Event|14|||
48657642|NCT01973387|156599835|FG001|Overall Study|Adverse Event|4|||
48754922|NCT02564042|156949702|FG003|Overall Study|Physician Decision|1|||
48754923|NCT02564042|156949703|FG004|Overall Study|Physician Decision|0|||
48754924|NCT02564042|156949704|FG005|Overall Study|Physician Decision|0|||
48754925|NCT02564042|156949699|FG000|Overall Study|Withdrawal by Subject|5|||
48754926|NCT02564042|156949700|FG001|Overall Study|Withdrawal by Subject|3|||
48754927|NCT02564042|156949701|FG002|Overall Study|Withdrawal by Subject|2|||
48754928|NCT02564042|156949702|FG003|Overall Study|Withdrawal by Subject|2|||
48754929|NCT02564042|156949703|FG004|Overall Study|Withdrawal by Subject|10|||
48754930|NCT02564042|156949704|FG005|Overall Study|Withdrawal by Subject|12|||
48754931|NCT02743806|156949705|FG000|Overall Study|Adverse Event|9|||
48754932|NCT02743806|156949705|FG000|Overall Study|Lost to Follow-up|8|||
48754933|NCT02743806|156949705|FG000|Overall Study|Voluntary Withdrawal|54|||
48754934|NCT02743806|156949705|FG000|Overall Study|Study Termination|65|||
48754935|NCT02743806|156949705|FG000|Overall Study|Pregnancy|6|||
48754936|NCT02743806|156949705|FG000|Overall Study|No Longer Clinically Benefiting|27|||
48754937|NCT02743806|156949705|FG000|Overall Study|Reason Not Specified|12|||
48754938|NCT01349790|156949706|FG000|Overall Study|Investigator Judgement|3|||
48754939|NCT01349790|156949706|FG000|Overall Study|Death|2|||
48754940|NCT01349790|156949706|FG000|Overall Study|Withdrawal by Patient|2|||
48754941|NCT01349790|156949706|FG000|Overall Study|Adverse Event|1|||
48754942|NCT01349790|156949706|FG000|Overall Study|Lost to Follow-up|1|||
48754943|NCT02514447|156949707|FG000|Overall Study|Withdrawal by Subject|3|||
48754944|NCT02514447|156949708|FG001|Overall Study|Withdrawal by Subject|1|||
48754945|NCT02514447|156949709|FG002|Overall Study|Withdrawal by Subject|1|||
48754946|NCT02514447|156949710|FG003|Overall Study|Withdrawal by Subject|0|||
48754947|NCT02514447|156949711|FG004|Overall Study|Withdrawal by Subject|0|||
48754948|NCT02514447|156949712|FG005|Overall Study|Withdrawal by Subject|0|||
48962633|NCT00630812|157692188|FG001|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0|||
48962634|NCT00630812|157692187|FG000|Double Blind Treatment Period|Non-compliance|0|||
48657643|NCT01973387|156599834|FG000|Overall Study|Withdrawal by Subject|7|||
48657644|NCT01973387|156599835|FG001|Overall Study|Withdrawal by Subject|4|||
48754949|NCT02514447|156949713|FG006|Overall Study|Withdrawal by Subject|0|||
48754950|NCT02514447|156949714|FG007|Overall Study|Withdrawal by Subject|1|||
48754951|NCT02514447|156949715|FG008|Overall Study|Withdrawal by Subject|1|||
48754952|NCT02514447|156949707|FG000|Overall Study|Death|24|||
48962635|NCT00630812|157692188|FG001|Double Blind Treatment Period|Non-compliance|1|||
48962636|NCT00259740|157692189|FG000|Overall Study|Physician Decision|1|||
48962637|NCT00259740|157692190|FG001|Overall Study|Physician Decision|1|||
48962638|NCT00259740|157692189|FG000|Overall Study|Adverse Event|0|||
48962639|NCT00259740|157692190|FG001|Overall Study|Adverse Event|2|||
48657645|NCT01973387|156599834|FG000|Overall Study|Study terminated by sponsor|63|||
48657646|NCT01973387|156599835|FG001|Overall Study|Study terminated by sponsor|0|||
48657647|NCT01973387|156599834|FG000|Overall Study|Progressive disease or relapse|16|||
48754953|NCT02514447|156949708|FG001|Overall Study|Death|28|||
48754954|NCT02514447|156949709|FG002|Overall Study|Death|29|||
48754955|NCT02514447|156949710|FG003|Overall Study|Death|0|||
48754956|NCT02514447|156949711|FG004|Overall Study|Death|3|||
48754957|NCT02514447|156949712|FG005|Overall Study|Death|4|||
48754958|NCT02514447|156949713|FG006|Overall Study|Death|8|||
48754959|NCT02514447|156949714|FG007|Overall Study|Death|6|||
48962640|NCT00259740|157692189|FG000|Overall Study|Withdrawal by Subject|2|||
48962641|NCT00259740|157692190|FG001|Overall Study|Withdrawal by Subject|6|||
48754960|NCT02514447|156949715|FG008|Overall Study|Death|5|||
48754961|NCT02514447|156949707|FG000|Overall Study|Lost to Follow-up|1|||
48754962|NCT02514447|156949708|FG001|Overall Study|Lost to Follow-up|0|||
48754963|NCT02514447|156949709|FG002|Overall Study|Lost to Follow-up|0|||
48754964|NCT02514447|156949710|FG003|Overall Study|Lost to Follow-up|0|||
48657648|NCT01973387|156599835|FG001|Overall Study|Progressive disease or relapse|5|||
48754965|NCT02514447|156949711|FG004|Overall Study|Lost to Follow-up|0|||
48754966|NCT02514447|156949712|FG005|Overall Study|Lost to Follow-up|0|||
48754967|NCT02514447|156949713|FG006|Overall Study|Lost to Follow-up|0|||
48754968|NCT02514447|156949714|FG007|Overall Study|Lost to Follow-up|0|||
48754969|NCT02514447|156949715|FG008|Overall Study|Lost to Follow-up|1|||
48754970|NCT02514447|156949707|FG000|Overall Study|Sponsor Termination of Study|0|||
48754971|NCT02514447|156949708|FG001|Overall Study|Sponsor Termination of Study|1|||
48754972|NCT02514447|156949709|FG002|Overall Study|Sponsor Termination of Study|1|||
48754973|NCT02514447|156949710|FG003|Overall Study|Sponsor Termination of Study|0|||
48754974|NCT02514447|156949711|FG004|Overall Study|Sponsor Termination of Study|0|||
48754975|NCT02514447|156949712|FG005|Overall Study|Sponsor Termination of Study|0|||
48754976|NCT02514447|156949713|FG006|Overall Study|Sponsor Termination of Study|0|||
48754977|NCT02514447|156949714|FG007|Overall Study|Sponsor Termination of Study|0|||
48754978|NCT02514447|156949715|FG008|Overall Study|Sponsor Termination of Study|0|||
48754979|NCT02514447|156949707|FG000|Overall Study|Study completion per Investigator|1|||
48754980|NCT02514447|156949708|FG001|Overall Study|Study completion per Investigator|0|||
48754981|NCT02514447|156949709|FG002|Overall Study|Study completion per Investigator|1|||
48754982|NCT02514447|156949710|FG003|Overall Study|Study completion per Investigator|2|||
48754983|NCT02514447|156949711|FG004|Overall Study|Study completion per Investigator|0|||
48754984|NCT02514447|156949712|FG005|Overall Study|Study completion per Investigator|0|||
48657649|NCT01973387|156599834|FG000|Overall Study|Death|4|||
48657650|NCT01973387|156599835|FG001|Overall Study|Death|3|||
48657651|NCT01973387|156599834|FG000|Overall Study|Randomized, not treated|2|||
48657652|NCT01973387|156599835|FG001|Overall Study|Randomized, not treated|2|||
48657653|NCT02545517|156599836|FG000|Overall Study|Death|2|||
48657654|NCT02545517|156599837|FG001|Overall Study|Death|2|||
48657655|NCT02545517|156599838|FG002|Overall Study|Death|1|||
48657656|NCT02545517|156599836|FG000|Overall Study|Lost to Follow-up|14|||
48754985|NCT02514447|156949713|FG006|Overall Study|Study completion per Investigator|0|||
48754986|NCT02514447|156949714|FG007|Overall Study|Study completion per Investigator|0|||
48754987|NCT02514447|156949715|FG008|Overall Study|Study completion per Investigator|1|||
48962642|NCT00259740|157692189|FG000|Overall Study|Death|1|||
48657657|NCT02545517|156599837|FG001|Overall Study|Lost to Follow-up|13|||
48657658|NCT02545517|156599838|FG002|Overall Study|Lost to Follow-up|17|||
48657659|NCT02545517|156599836|FG000|Overall Study|Protocol Violation|0|||
48657660|NCT02545517|156599837|FG001|Overall Study|Protocol Violation|1|||
48657661|NCT02545517|156599838|FG002|Overall Study|Protocol Violation|1|||
48657662|NCT02545517|156599836|FG000|Overall Study|Withdrawal by Subject|5|||
48657663|NCT02545517|156599837|FG001|Overall Study|Withdrawal by Subject|8|||
48657664|NCT02545517|156599838|FG002|Overall Study|Withdrawal by Subject|9|||
48657665|NCT02545517|156599836|FG000|Overall Study|Administrative reason|5|||
48657666|NCT02545517|156599837|FG001|Overall Study|Administrative reason|6|||
48657667|NCT02545517|156599838|FG002|Overall Study|Administrative reason|10|||
48657668|NCT02545517|156599836|FG000|Overall Study|Other|2|||
48657669|NCT02545517|156599837|FG001|Overall Study|Other|4|||
48657670|NCT02545517|156599838|FG002|Overall Study|Other|3|||
48657671|NCT01529515|156599841|FG000|TRANSITION PHASE|Adverse Event|16|||
48657672|NCT01529515|156599842|FG001|TRANSITION PHASE|Adverse Event|0|||
48657673|NCT01529515|156599843|FG002|TRANSITION PHASE|Adverse Event|0|||
48657674|NCT01529515|156599844|FG003|TRANSITION PHASE|Adverse Event|0|||
48657675|NCT01529515|156599841|FG000|TRANSITION PHASE|Death|1|||
48657676|NCT01529515|156599842|FG001|TRANSITION PHASE|Death|0|||
48657677|NCT01529515|156599843|FG002|TRANSITION PHASE|Death|0|||
48657678|NCT01529515|156599844|FG003|TRANSITION PHASE|Death|0|||
48657679|NCT01529515|156599841|FG000|TRANSITION PHASE|Lack of Efficacy|19|||
48657680|NCT01529515|156599842|FG001|TRANSITION PHASE|Lack of Efficacy|0|||
48657681|NCT01529515|156599843|FG002|TRANSITION PHASE|Lack of Efficacy|0|||
48657682|NCT01529515|156599844|FG003|TRANSITION PHASE|Lack of Efficacy|0|||
48657683|NCT01529515|156599841|FG000|TRANSITION PHASE|Lost to Follow-up|19|||
48657684|NCT01529515|156599842|FG001|TRANSITION PHASE|Lost to Follow-up|0|||
48657685|NCT01529515|156599843|FG002|TRANSITION PHASE|Lost to Follow-up|0|||
48657686|NCT01529515|156599844|FG003|TRANSITION PHASE|Lost to Follow-up|0|||
48657687|NCT01529515|156599841|FG000|TRANSITION PHASE|Protocol Violation|4|||
48657688|NCT01529515|156599842|FG001|TRANSITION PHASE|Protocol Violation|0|||
48657689|NCT01529515|156599843|FG002|TRANSITION PHASE|Protocol Violation|0|||
48754988|NCT01986985|156949721|FG000|Overall Study|Withdrawal by Subject|4|||
48754989|NCT01986985|156949721|FG000|Overall Study|Scan not completed due to malfunction|3|||
48754990|NCT00449540|156949723|FG000|Pretreatment Phase|No migraine experienced|66|||
48754991|NCT00449540|156949724|FG001|Pretreatment Phase|No migraine experienced|0|||
48962643|NCT00259740|157692190|FG001|Overall Study|Death|1|||
48657690|NCT01529515|156599844|FG003|TRANSITION PHASE|Protocol Violation|0|||
48657691|NCT01529515|156599841|FG000|TRANSITION PHASE|Withdrawal by Subject|51|||
48657692|NCT01529515|156599842|FG001|TRANSITION PHASE|Withdrawal by Subject|0|||
48657693|NCT01529515|156599843|FG002|TRANSITION PHASE|Withdrawal by Subject|0|||
48657694|NCT01529515|156599844|FG003|TRANSITION PHASE|Withdrawal by Subject|0|||
48657695|NCT01529515|156599841|FG000|TRANSITION PHASE|Failed Maintenance Phase Criteria|8|||
48657696|NCT01529515|156599842|FG001|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
48657697|NCT01529515|156599843|FG002|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
48866038|NCT00784277|157345629|FG001|ER Treatment|Adverse Event|0|||
48866039|NCT00784277|157345630|FG002|ER Treatment|Adverse Event|0|||
48866040|NCT00784277|157345631|FG003|ER Treatment|Adverse Event|0|||
48866041|NCT00784277|157345632|FG004|ER Treatment|Adverse Event|1|||
48866042|NCT00784277|157345633|FG005|ER Treatment|Adverse Event|7|||
48866043|NCT00784277|157345634|FG006|ER Treatment|Adverse Event|7|||
48657698|NCT01529515|156599844|FG003|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
48657699|NCT01529515|156599841|FG000|TRANSITION PHASE|Other|9|||
48657700|NCT01529515|156599842|FG001|TRANSITION PHASE|Other|0|||
48657701|NCT01529515|156599843|FG002|TRANSITION PHASE|Other|0|||
48657702|NCT01529515|156599844|FG003|TRANSITION PHASE|Other|0|||
48657703|NCT01529515|156599841|FG000|MAINTENANCE PHASE|Adverse Event|0|||
48657704|NCT01529515|156599842|FG001|MAINTENANCE PHASE|Adverse Event|10|||
48657705|NCT01529515|156599843|FG002|MAINTENANCE PHASE|Adverse Event|0|||
48657706|NCT01529515|156599844|FG003|MAINTENANCE PHASE|Adverse Event|0|||
48657707|NCT01529515|156599841|FG000|MAINTENANCE PHASE|Lack of Efficacy|0|||
48657708|NCT01529515|156599842|FG001|MAINTENANCE PHASE|Lack of Efficacy|9|||
48657709|NCT01529515|156599843|FG002|MAINTENANCE PHASE|Lack of Efficacy|0|||
48657710|NCT01529515|156599844|FG003|MAINTENANCE PHASE|Lack of Efficacy|0|||
48657711|NCT01529515|156599841|FG000|MAINTENANCE PHASE|Lost to Follow-up|0|||
48657712|NCT01529515|156599842|FG001|MAINTENANCE PHASE|Lost to Follow-up|5|||
48657713|NCT01529515|156599843|FG002|MAINTENANCE PHASE|Lost to Follow-up|0|||
48657714|NCT01529515|156599844|FG003|MAINTENANCE PHASE|Lost to Follow-up|0|||
48657715|NCT01529515|156599841|FG000|MAINTENANCE PHASE|Protocol Violation|0|||
48657716|NCT01529515|156599842|FG001|MAINTENANCE PHASE|Protocol Violation|12|||
48657717|NCT01529515|156599843|FG002|MAINTENANCE PHASE|Protocol Violation|0|||
48657718|NCT01529515|156599844|FG003|MAINTENANCE PHASE|Protocol Violation|0|||
48657719|NCT01529515|156599841|FG000|MAINTENANCE PHASE|Withdrawal by Subject|0|||
48657720|NCT01529515|156599842|FG001|MAINTENANCE PHASE|Withdrawal by Subject|15|||
48657721|NCT01529515|156599843|FG002|MAINTENANCE PHASE|Withdrawal by Subject|0|||
48657722|NCT01529515|156599844|FG003|MAINTENANCE PHASE|Withdrawal by Subject|0|||
48657723|NCT01529515|156599841|FG000|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
48657724|NCT01529515|156599842|FG001|MAINTENANCE PHASE|Failed Randomization Criteria|13|||
48657725|NCT01529515|156599843|FG002|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
48657726|NCT01529515|156599844|FG003|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
48657727|NCT01529515|156599841|FG000|MAINTENANCE PHASE|Other|0|||
48657728|NCT01529515|156599842|FG001|MAINTENANCE PHASE|Other|10|||
48657729|NCT01529515|156599843|FG002|MAINTENANCE PHASE|Other|0|||
48657730|NCT01529515|156599844|FG003|MAINTENANCE PHASE|Other|0|||
48657731|NCT01529515|156599841|FG000|DOUBLE BLIND PHASE|Adverse Event|0|||
48657732|NCT01529515|156599842|FG001|DOUBLE BLIND PHASE|Adverse Event|0|||
48657733|NCT01529515|156599843|FG002|DOUBLE BLIND PHASE|Adverse Event|1|||
48657734|NCT01529515|156599844|FG003|DOUBLE BLIND PHASE|Adverse Event|0|||
48657735|NCT01529515|156599841|FG000|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
48657736|NCT01529515|156599842|FG001|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
48657737|NCT01529515|156599843|FG002|DOUBLE BLIND PHASE|Lost to Follow-up|1|||
48657738|NCT01529515|156599844|FG003|DOUBLE BLIND PHASE|Lost to Follow-up|3|||
48657739|NCT01529515|156599841|FG000|DOUBLE BLIND PHASE|Pregnancy|0|||
48657740|NCT01529515|156599842|FG001|DOUBLE BLIND PHASE|Pregnancy|0|||
48657741|NCT01529515|156599843|FG002|DOUBLE BLIND PHASE|Pregnancy|1|||
48657742|NCT01529515|156599844|FG003|DOUBLE BLIND PHASE|Pregnancy|0|||
48657743|NCT01529515|156599841|FG000|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
48657744|NCT01529515|156599842|FG001|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
48657745|NCT01529515|156599843|FG002|DOUBLE BLIND PHASE|Withdrawal by Subject|10|||
48657746|NCT01529515|156599844|FG003|DOUBLE BLIND PHASE|Withdrawal by Subject|7|||
48657747|NCT01529515|156599841|FG000|DOUBLE BLIND PHASE|Protocol Violation|0|||
48657748|NCT01529515|156599842|FG001|DOUBLE BLIND PHASE|Protocol Violation|0|||
48657749|NCT01529515|156599843|FG002|DOUBLE BLIND PHASE|Protocol Violation|1|||
48657750|NCT01529515|156599844|FG003|DOUBLE BLIND PHASE|Protocol Violation|0|||
48657751|NCT01529515|156599841|FG000|DOUBLE BLIND PHASE|Other|0|||
48657752|NCT01529515|156599842|FG001|DOUBLE BLIND PHASE|Other|0|||
48657753|NCT01529515|156599843|FG002|DOUBLE BLIND PHASE|Other|9|||
48657754|NCT01529515|156599844|FG003|DOUBLE BLIND PHASE|Other|2|||
48657755|NCT00688324|156599845|FG000|Overall Study|Withdrawal by Subject|2|||
48657756|NCT00688324|156599845|FG000|Overall Study|Physician Decision|5|||
48657757|NCT00688324|156599845|FG000|Overall Study|Lost to Follow-up|1|||
48657758|NCT01535599|156599852|FG000|Overall Study|Adverse Event|6|||
48657759|NCT01535599|156599853|FG001|Overall Study|Adverse Event|15|||
48657760|NCT01535599|156599852|FG000|Overall Study|Lost to Follow-up|3|||
48657761|NCT01535599|156599853|FG001|Overall Study|Lost to Follow-up|4|||
48657762|NCT01535599|156599852|FG000|Overall Study|Subj Decision Unrelated to Adverse Event|4|||
48657763|NCT01535599|156599853|FG001|Overall Study|Subj Decision Unrelated to Adverse Event|3|||
48657764|NCT01535599|156599852|FG000|Overall Study|Treatment Failure|33|||
48657765|NCT01535599|156599853|FG001|Overall Study|Treatment Failure|66|||
48657766|NCT01535599|156599852|FG000|Overall Study|BL Culture + for Group A Strep|0|||
48657767|NCT01535599|156599853|FG001|Overall Study|BL Culture + for Group A Strep|1|||
48657768|NCT01535599|156599852|FG000|Overall Study|BL Culture + for Yeast//Fungi|0|||
48866044|NCT00784277|157345628|FG000|ER Treatment|Lack of Efficacy|0|||
48866045|NCT00784277|157345629|FG001|ER Treatment|Lack of Efficacy|0|||
48866046|NCT00784277|157345630|FG002|ER Treatment|Lack of Efficacy|0|||
48866047|NCT00784277|157345631|FG003|ER Treatment|Lack of Efficacy|0|||
48866048|NCT00784277|157345632|FG004|ER Treatment|Lack of Efficacy|3|||
48866049|NCT00784277|157345633|FG005|ER Treatment|Lack of Efficacy|4|||
48866050|NCT00784277|157345634|FG006|ER Treatment|Lack of Efficacy|0|||
48866051|NCT00784277|157345628|FG000|ER Treatment|Lost to Follow-up|0|||
48866052|NCT00784277|157345629|FG001|ER Treatment|Lost to Follow-up|0|||
48866053|NCT00784277|157345630|FG002|ER Treatment|Lost to Follow-up|0|||
48866054|NCT00784277|157345631|FG003|ER Treatment|Lost to Follow-up|0|||
48866055|NCT00784277|157345632|FG004|ER Treatment|Lost to Follow-up|0|||
48866056|NCT00784277|157345633|FG005|ER Treatment|Lost to Follow-up|2|||
48866057|NCT00784277|157345634|FG006|ER Treatment|Lost to Follow-up|0|||
48866058|NCT00784277|157345628|FG000|ER Treatment|Withdrawal by Subject|0|||
48866059|NCT00784277|157345629|FG001|ER Treatment|Withdrawal by Subject|0|||
48866060|NCT00784277|157345630|FG002|ER Treatment|Withdrawal by Subject|0|||
48866061|NCT00784277|157345631|FG003|ER Treatment|Withdrawal by Subject|0|||
48657769|NCT01535599|156599853|FG001|Overall Study|BL Culture + for Yeast//Fungi|1|||
48657770|NCT01535599|156599852|FG000|Overall Study|Randomized in Error|2|||
48657771|NCT01535599|156599853|FG001|Overall Study|Randomized in Error|4|||
48657772|NCT01535599|156599852|FG000|Overall Study|Did not use product|1|||
48657773|NCT01535599|156599853|FG001|Overall Study|Did not use product|0|||
48657774|NCT01535599|156599852|FG000|Overall Study|Other|1|||
48657775|NCT01535599|156599853|FG001|Overall Study|Other|0|||
48657776|NCT01535599|156599852|FG000|Overall Study|Stopped medication|0|||
48657777|NCT01535599|156599853|FG001|Overall Study|Stopped medication|1|||
48657778|NCT01535599|156599852|FG000|Overall Study|Noncompliance|0|||
48657779|NCT01535599|156599853|FG001|Overall Study|Noncompliance|1|||
48657780|NCT01229254|156599854|FG000|Overall Study|Not Continuing Into Safety Extension|3|||
48657781|NCT01229254|156599855|FG001|Overall Study|Not Continuing Into Safety Extension|1|||
48657782|NCT01229254|156599856|FG002|Overall Study|Not Continuing Into Safety Extension|1|||
48657783|NCT01229254|156599854|FG000|Overall Study|Adverse Event|4|||
48657784|NCT01229254|156599855|FG001|Overall Study|Adverse Event|5|||
48657785|NCT01229254|156599856|FG002|Overall Study|Adverse Event|3|||
48657786|NCT01229254|156599854|FG000|Overall Study|Lost to Follow-up|3|||
48657787|NCT01229254|156599855|FG001|Overall Study|Lost to Follow-up|0|||
48657788|NCT01229254|156599856|FG002|Overall Study|Lost to Follow-up|1|||
48657789|NCT01229254|156599854|FG000|Overall Study|Physician Decision|0|||
48657790|NCT01229254|156599855|FG001|Overall Study|Physician Decision|3|||
48657791|NCT01229254|156599856|FG002|Overall Study|Physician Decision|0|||
48657792|NCT01229254|156599854|FG000|Overall Study|Protocol Violation|4|||
48657793|NCT01229254|156599855|FG001|Overall Study|Protocol Violation|6|||
48657794|NCT01229254|156599856|FG002|Overall Study|Protocol Violation|5|||
48657795|NCT01229254|156599854|FG000|Overall Study|Withdrawal by Subject|1|||
48657796|NCT01229254|156599855|FG001|Overall Study|Withdrawal by Subject|0|||
48657797|NCT01229254|156599856|FG002|Overall Study|Withdrawal by Subject|1|||
48657798|NCT01229254|156599854|FG000|Overall Study|Non-compliance with Study Drug|0|||
48657799|NCT01229254|156599855|FG001|Overall Study|Non-compliance with Study Drug|1|||
48657800|NCT01229254|156599856|FG002|Overall Study|Non-compliance with Study Drug|1|||
48657801|NCT00791479|156599859|FG000|Overall Study|Dose Discontinued per Sponsor Decision|0|||
48657802|NCT00791479|156599860|FG001|Overall Study|Dose Discontinued per Sponsor Decision|0|||
48657803|NCT00791479|156599861|FG002|Overall Study|Dose Discontinued per Sponsor Decision|0|||
48657804|NCT00791479|156599862|FG003|Overall Study|Dose Discontinued per Sponsor Decision|0|||
48657805|NCT00791479|156599863|FG004|Overall Study|Dose Discontinued per Sponsor Decision|3|||
48657806|NCT00791479|156599864|FG005|Overall Study|Dose Discontinued per Sponsor Decision|0|||
48657807|NCT00791479|156599859|FG000|Overall Study|Adverse Event|0|||
48657808|NCT00791479|156599860|FG001|Overall Study|Adverse Event|1|||
48657809|NCT00791479|156599861|FG002|Overall Study|Adverse Event|0|||
48657810|NCT00791479|156599862|FG003|Overall Study|Adverse Event|2|||
48657811|NCT00791479|156599863|FG004|Overall Study|Adverse Event|0|||
48657812|NCT00791479|156599864|FG005|Overall Study|Adverse Event|1|||
48657813|NCT00791479|156599859|FG000|Overall Study|Lost to Follow-up|0|||
48866062|NCT00784277|157345632|FG004|ER Treatment|Withdrawal by Subject|2|||
48866063|NCT00784277|157345633|FG005|ER Treatment|Withdrawal by Subject|5|||
48866064|NCT00784277|157345634|FG006|ER Treatment|Withdrawal by Subject|3|||
48657814|NCT00791479|156599860|FG001|Overall Study|Lost to Follow-up|1|||
48657815|NCT00791479|156599861|FG002|Overall Study|Lost to Follow-up|0|||
48657816|NCT00791479|156599862|FG003|Overall Study|Lost to Follow-up|0|||
48657817|NCT00791479|156599863|FG004|Overall Study|Lost to Follow-up|0|||
48657818|NCT00791479|156599864|FG005|Overall Study|Lost to Follow-up|1|||
48657819|NCT00791479|156599859|FG000|Overall Study|Protocol Violation|2|||
48657820|NCT00791479|156599860|FG001|Overall Study|Protocol Violation|1|||
48866065|NCT00784277|157345628|FG000|ER Treatment|Study Medication Non-Compliant|0|||
48657821|NCT00791479|156599861|FG002|Overall Study|Protocol Violation|0|||
48962644|NCT00259740|157692189|FG000|Overall Study|Disease progression|19|||
48657822|NCT00791479|156599862|FG003|Overall Study|Protocol Violation|1|||
48866066|NCT00784277|157345629|FG001|ER Treatment|Study Medication Non-Compliant|0|||
48962645|NCT00259740|157692190|FG001|Overall Study|Disease progression|36|||
48962646|NCT00259740|157692189|FG000|Overall Study|Ongoing|17|||
48962647|NCT00259740|157692190|FG001|Overall Study|Ongoing|3|||
48962648|NCT00259740|157692189|FG000|Overall Study|Other|3|||
48962649|NCT00259740|157692190|FG001|Overall Study|Other|0|||
48962650|NCT00259740|157692189|FG000|Overall Study|Requirement for alternative therapy|0|||
48962651|NCT00259740|157692190|FG001|Overall Study|Requirement for alternative therapy|4|||
48962652|NCT01217190|157692191|FG000|Second Dosing|Withdrawal by Subject|0|||
48962653|NCT01217190|157692192|FG001|Second Dosing|Withdrawal by Subject|2|||
48962654|NCT03558555|157692193|FG000|Overall Study|Lost to Follow-up|2|||
48962655|NCT03558555|157692194|FG001|Overall Study|Lost to Follow-up|1|||
48962656|NCT01658579|157692196|FG000|Treatment Period A|Other|0|||
48657823|NCT00791479|156599863|FG004|Overall Study|Protocol Violation|0|||
48657824|NCT00791479|156599864|FG005|Overall Study|Protocol Violation|0|||
48657825|NCT00791479|156599859|FG000|Overall Study|Withdrawal by Subject|0|||
48657826|NCT00791479|156599860|FG001|Overall Study|Withdrawal by Subject|0|||
48657827|NCT00791479|156599861|FG002|Overall Study|Withdrawal by Subject|0|||
48657828|NCT00791479|156599862|FG003|Overall Study|Withdrawal by Subject|1|||
48657829|NCT00791479|156599863|FG004|Overall Study|Withdrawal by Subject|0|||
48657830|NCT00791479|156599864|FG005|Overall Study|Withdrawal by Subject|1|||
48657831|NCT00244933|156599865|FG000|Overall Study|Not response evaluable|2|||
48657832|NCT00866047|156599866|FG000|Treatment Period|Progressive disease|13|||
48657833|NCT00866047|156599866|FG000|Treatment Period|Adverse Event|16|||
48657834|NCT00866047|156599866|FG000|Treatment Period|Physician Decision|14|||
48657835|NCT00866047|156599866|FG000|Treatment Period|Withdrawal by Subject|5|||
48657836|NCT00866047|156599866|FG000|Follow-up Period|Lost to Follow-up|5|||
48657837|NCT00515294|156599867|FG000|Overall Study|Lost to Follow-up|3|||
48657838|NCT00515294|156599868|FG001|Overall Study|Lost to Follow-up|2|||
48657839|NCT00515294|156599869|FG002|Overall Study|Lost to Follow-up|3|||
48657840|NCT00515294|156599870|FG003|Overall Study|Lost to Follow-up|1|||
48657841|NCT00515294|156599867|FG000|Overall Study|Driver simulator problems|1|||
48657842|NCT00515294|156599868|FG001|Overall Study|Driver simulator problems|1|||
48657843|NCT00515294|156599869|FG002|Overall Study|Driver simulator problems|1|||
48657844|NCT00515294|156599870|FG003|Overall Study|Driver simulator problems|3|||
48657845|NCT00515294|156599867|FG000|Overall Study|Caffeine amount inaccurate|5|||
48657846|NCT00515294|156599868|FG001|Overall Study|Caffeine amount inaccurate|0|||
48657847|NCT00515294|156599869|FG002|Overall Study|Caffeine amount inaccurate|7|||
48657848|NCT00515294|156599870|FG003|Overall Study|Caffeine amount inaccurate|0|||
48657849|NCT01610713|156599871|FG000|Overall Study|Adverse Event|3|||
48657850|NCT01610713|156599872|FG001|Overall Study|Adverse Event|0|||
48657851|NCT01610713|156599871|FG000|Overall Study|Lack of Efficacy|1|||
48657852|NCT01610713|156599872|FG001|Overall Study|Lack of Efficacy|0|||
48657853|NCT01610713|156599871|FG000|Overall Study|low mood and poor motivation|1|||
48657854|NCT01610713|156599872|FG001|Overall Study|low mood and poor motivation|0|||
48657855|NCT01610713|156599871|FG000|Overall Study|adv. to use original dose/amitriptyline|1|||
48657856|NCT01610713|156599872|FG001|Overall Study|adv. to use original dose/amitriptyline|0|||
48657857|NCT01610713|156599871|FG000|Overall Study|Lost to Follow-up|0|||
48657858|NCT01610713|156599872|FG001|Overall Study|Lost to Follow-up|1|||
48657859|NCT02324205|156599873|FG000|Overall Study|Withdrawal by Subject|37|||
48657860|NCT05427539|156599876|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
48657861|NCT05427539|156599877|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
48657862|NCT05427539|156599876|FG000|Period 1|Withdrawal by Subject|1|||
48657863|NCT05427539|156599877|FG001|Period 1|Withdrawal by Subject|0|||
48657864|NCT01774097|156599878|FG000|Overall Study|Withdrawal by Subject|1|||
48657865|NCT01774097|156599879|FG001|Overall Study|Withdrawal by Subject|1|||
48657866|NCT01774097|156599878|FG000|Overall Study|Adverse Event|1|||
48657867|NCT01774097|156599879|FG001|Overall Study|Adverse Event|1|||
48657868|NCT03447314|156599881|FG000|Part 1 (Up to 47 Months and 13 Days)|Death|6|||
48657869|NCT03447314|156599882|FG001|Part 1 (Up to 47 Months and 13 Days)|Death|5|||
48657870|NCT03447314|156599883|FG002|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
48657871|NCT03447314|156599884|FG003|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
48657872|NCT03447314|156599885|FG004|Part 1 (Up to 47 Months and 13 Days)|Death|1|||
48657873|NCT03447314|156599886|FG005|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
48657874|NCT03447314|156599887|FG006|Part 1 (Up to 47 Months and 13 Days)|Death|2|||
48657875|NCT03447314|156599888|FG007|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
48657876|NCT03447314|156599889|FG008|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
48657877|NCT03447314|156599890|FG009|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
48657878|NCT03447314|156599891|FG010|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
48657879|NCT03447314|156599892|FG011|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
48657880|NCT03447314|156599893|FG012|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
48657881|NCT03447314|156599894|FG013|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
48657882|NCT03447314|156599895|FG014|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
48657883|NCT03447314|156599896|FG015|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
48657884|NCT03447314|156599897|FG016|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
48657885|NCT03447314|156599898|FG017|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
48754992|NCT00449540|156949725|FG002|Pretreatment Phase|No migraine experienced|0|||
48754993|NCT00449540|156949723|FG000|Treatment Phase|did not experience or treat migraine|0|||
48754994|NCT00449540|156949724|FG001|Treatment Phase|did not experience or treat migraine|20|||
48754995|NCT00449540|156949725|FG002|Treatment Phase|did not experience or treat migraine|17|||
48754996|NCT02865187|156949726|FG000|Overall Study|Lost to Follow-up|12|||
48754997|NCT02865187|156949727|FG001|Overall Study|Lost to Follow-up|7|||
48754998|NCT02865187|156949726|FG000|Overall Study|Adverse Event|1|||
48754999|NCT02865187|156949727|FG001|Overall Study|Adverse Event|0|||
48755000|NCT02268864|156949732|FG000|Overall Study|Withdrawal by Subject|2|||
48755001|NCT02268864|156949733|FG001|Overall Study|Withdrawal by Subject|0|||
48755002|NCT02268864|156949734|FG002|Overall Study|Withdrawal by Subject|0|||
48755003|NCT02268864|156949732|FG000|Overall Study|Death|0|||
48755004|NCT02268864|156949733|FG001|Overall Study|Death|1|||
48755005|NCT02268864|156949734|FG002|Overall Study|Death|0|||
48755006|NCT00533845|156949735|FG000|Overall Study|Physician Decision|1|||
48755007|NCT00533845|156949736|FG001|Overall Study|Physician Decision|0|||
48755008|NCT01288469|156949739|FG000|Overall Study|Adverse Event|4|||
48755009|NCT01288469|156949740|FG001|Overall Study|Adverse Event|1|||
48755010|NCT01288469|156949741|FG002|Overall Study|Adverse Event|1|||
48755011|NCT01288469|156949739|FG000|Overall Study|Poor compliance to protocol|0|||
48755012|NCT01288469|156949740|FG001|Overall Study|Poor compliance to protocol|1|||
48755013|NCT01288469|156949741|FG002|Overall Study|Poor compliance to protocol|0|||
48755014|NCT01288469|156949739|FG000|Overall Study|Participant Moved|1|||
48755015|NCT01288469|156949740|FG001|Overall Study|Participant Moved|0|||
48755016|NCT01288469|156949741|FG002|Overall Study|Participant Moved|0|||
48755017|NCT01288469|156949739|FG000|Overall Study|Consent withdrawn by subject|1|||
48755018|NCT01288469|156949740|FG001|Overall Study|Consent withdrawn by subject|1|||
48755019|NCT01288469|156949741|FG002|Overall Study|Consent withdrawn by subject|1|||
48755020|NCT01288469|156949739|FG000|Overall Study|Exclusion criteria finally met|1|||
48755021|NCT01288469|156949740|FG001|Overall Study|Exclusion criteria finally met|0|||
48755022|NCT01288469|156949741|FG002|Overall Study|Exclusion criteria finally met|0|||
48755023|NCT02107482|156949751|FG000|Overall Study|inconveinence|2|||
48755024|NCT02107482|156949751|FG000|Overall Study|Lost to Follow-up|1|||
48755025|NCT02107482|156949751|FG000|Overall Study|Lack of Efficacy|1|||
48755026|NCT02157298|156949757|FG000|Overall Study|Adverse Event|1|||
48755027|NCT02157298|156949758|FG001|Overall Study|Adverse Event|0|||
48755028|NCT02157298|156949757|FG000|Overall Study|Subject no longer meets study criteria|1|||
48755029|NCT02157298|156949758|FG001|Overall Study|Subject no longer meets study criteria|2|||
48755030|NCT02157298|156949757|FG000|Overall Study|Poor/Non-compliance|1|||
48755031|NCT02157298|156949758|FG001|Overall Study|Poor/Non-compliance|0|||
48755032|NCT02157298|156949757|FG000|Overall Study|Withdrawal by Subject|1|||
48755033|NCT02157298|156949758|FG001|Overall Study|Withdrawal by Subject|0|||
48755034|NCT03855280|156949759|FG000|Treatment Phase|Adverse Event|1|||
48755035|NCT03855280|156949759|FG000|Treatment Phase|Withdrawal by Subject|1|||
48755036|NCT03855280|156949759|FG000|Continuation Phase|Protocol Violation|1|||
48755037|NCT03855280|156949759|FG000|Continuation Phase|Adverse Event|1|||
48755038|NCT03855280|156949759|FG000|Continuation Phase|Sponsor Concluded Study|1|||
48755039|NCT02999854|156949760|FG000|Active Study Phase (up to 18 Months)|Screen failures|7|||
48755040|NCT02999854|156949761|FG001|Active Study Phase (up to 18 Months)|Screen failures|2|||
48755041|NCT02999854|156949760|FG000|Active Study Phase (up to 18 Months)|Discontinued before HSCT|8|||
48755042|NCT02999854|156949761|FG001|Active Study Phase (up to 18 Months)|Discontinued before HSCT|2|||
48755043|NCT02999854|156949760|FG000|Active Study Phase (up to 18 Months)|Death|7|||
48755044|NCT02999854|156949761|FG001|Active Study Phase (up to 18 Months)|Death|5|||
48755045|NCT02999854|156949760|FG000|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|1|||
48755046|NCT02999854|156949761|FG001|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|0|||
48755047|NCT02999854|156949760|FG000|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|1|||
48755048|NCT02999854|156949761|FG001|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|0|||
48755049|NCT02999854|156949760|FG000|Long Term Safety FU (up to 24 Months)|Death|1|||
48755050|NCT02999854|156949761|FG001|Long Term Safety FU (up to 24 Months)|Death|1|||
48755051|NCT02999854|156949760|FG000|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
48755052|NCT02999854|156949761|FG001|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
48755053|NCT02999854|156949760|FG000|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
48755054|NCT02999854|156949761|FG001|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
48755055|NCT04059094|156949762|FG000|Overall Study|Adverse Event|0|||
48755056|NCT04059094|156949763|FG001|Overall Study|Adverse Event|0|||
48755057|NCT04059094|156949764|FG002|Overall Study|Adverse Event|0|||
48755058|NCT04059094|156949765|FG003|Overall Study|Adverse Event|0|||
48962657|NCT01658579|157692197|FG001|Treatment Period A|Other|0|||
48755059|NCT04059094|156949766|FG004|Overall Study|Adverse Event|1|||
48755060|NCT04059094|156949762|FG000|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
48755061|NCT04059094|156949763|FG001|Overall Study|Not willing to travel due to COVID-19 pandemic|2|||
48962658|NCT01658579|157692198|FG002|Treatment Period A|Other|1|||
48962659|NCT01658579|157692199|FG003|Treatment Period A|Other|1|||
48962660|NCT01658579|157692196|FG000|Treatment Period A|Adverse Event|1|||
48657886|NCT03447314|156599881|FG000|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
48755062|NCT04059094|156949764|FG002|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
48755063|NCT04059094|156949765|FG003|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
48755064|NCT04059094|156949766|FG004|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
48755065|NCT00461682|156949767|FG000|Overall Study|Protocol Violation|1|||
48755066|NCT02953314|156949775|FG000|Overall Study|Adverse Event|0|||
48755067|NCT02953314|156949776|FG001|Overall Study|Adverse Event|1|||
48755068|NCT02953314|156949775|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
48755069|NCT02953314|156949776|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
48755070|NCT00818662|156949777|FG000|Overall Study|Adverse Event|5|||
48657887|NCT03447314|156599882|FG001|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
48657888|NCT03447314|156599883|FG002|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
48657889|NCT03447314|156599884|FG003|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
48657890|NCT03447314|156599885|FG004|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
48657891|NCT03447314|156599886|FG005|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
48657892|NCT03447314|156599887|FG006|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
48755071|NCT00818662|156949778|FG001|Overall Study|Adverse Event|14|||
48755072|NCT00818662|156949779|FG002|Overall Study|Adverse Event|4|||
48755073|NCT00818662|156949780|FG003|Overall Study|Adverse Event|3|||
48755074|NCT00818662|156949777|FG000|Overall Study|Withdrawal by Subject|5|||
48755075|NCT00818662|156949778|FG001|Overall Study|Withdrawal by Subject|4|||
48755076|NCT00818662|156949779|FG002|Overall Study|Withdrawal by Subject|2|||
48755077|NCT00818662|156949780|FG003|Overall Study|Withdrawal by Subject|2|||
48755078|NCT00818662|156949777|FG000|Overall Study|Death|1|||
48755079|NCT00818662|156949778|FG001|Overall Study|Death|3|||
48755080|NCT00818662|156949779|FG002|Overall Study|Death|0|||
48755081|NCT00818662|156949780|FG003|Overall Study|Death|0|||
48755082|NCT00818662|156949777|FG000|Overall Study|Physician Decision|1|||
48755083|NCT00818662|156949778|FG001|Overall Study|Physician Decision|0|||
48962661|NCT01658579|157692197|FG001|Treatment Period A|Adverse Event|0|||
48962662|NCT01658579|157692198|FG002|Treatment Period A|Adverse Event|0|||
48755084|NCT00818662|156949779|FG002|Overall Study|Physician Decision|0|||
48962663|NCT01658579|157692199|FG003|Treatment Period A|Adverse Event|0|||
48962664|NCT01658579|157692196|FG000|Treatment Period B|Other|0|||
48962665|NCT01658579|157692197|FG001|Treatment Period B|Other|0|||
48962666|NCT01658579|157692198|FG002|Treatment Period B|Other|0|||
48962667|NCT01658579|157692199|FG003|Treatment Period B|Other|1|||
48962668|NCT00642746|157692200|FG000|Overall Study|Patient unevaluable|1|||
48962669|NCT00642746|157692201|FG001|Overall Study|Patient unevaluable|0|||
48962670|NCT01357915|157692207|FG000|Overall Study|Lost to Follow-up|3|||
48962671|NCT01357915|157692208|FG001|Overall Study|Lost to Follow-up|0|||
48962672|NCT00305253|157692209|FG000|Overall Study|Withdrawal by Subject|0|||
48962673|NCT00305253|157692210|FG001|Overall Study|Withdrawal by Subject|1|||
48962674|NCT05086289|157692212|FG000|Overall Study|Adverse Event|4|||
48962675|NCT05086289|157692213|FG001|Overall Study|Adverse Event|2|||
48962676|NCT05086289|157692212|FG000|Overall Study|Lost to Follow-up|2|||
48962677|NCT05086289|157692213|FG001|Overall Study|Lost to Follow-up|0|||
48962678|NCT05086289|157692212|FG000|Overall Study|Non-compliance with study drug|2|||
48962679|NCT05086289|157692213|FG001|Overall Study|Non-compliance with study drug|1|||
48962680|NCT05086289|157692212|FG000|Overall Study|Physician Decision|2|||
48962681|NCT05086289|157692213|FG001|Overall Study|Physician Decision|0|||
48962682|NCT05086289|157692212|FG000|Overall Study|Withdrawal by Subject|5|||
48962683|NCT05086289|157692213|FG001|Overall Study|Withdrawal by Subject|2|||
48962684|NCT01963208|157692219|FG000|Treatment Phase 1 (Up to Week 14)|Adverse Event|1|||
48962685|NCT01963208|157692220|FG001|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
48962686|NCT01963208|157692221|FG002|Treatment Phase 1 (Up to Week 14)|Adverse Event|30|||
48962687|NCT01963208|157692222|FG003|Treatment Phase 1 (Up to Week 14)|Adverse Event|11|||
48962688|NCT01963208|157692223|FG004|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
48962689|NCT01963208|157692224|FG005|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
48962690|NCT01963208|157692219|FG000|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
48962691|NCT01963208|157692220|FG001|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|2|||
48962692|NCT01963208|157692221|FG002|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|8|||
48962693|NCT01963208|157692222|FG003|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|9|||
48962694|NCT01963208|157692223|FG004|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
48962695|NCT01963208|157692224|FG005|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
48962696|NCT01963208|157692219|FG000|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
48962697|NCT01963208|157692220|FG001|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
48755085|NCT00818662|156949780|FG003|Overall Study|Physician Decision|0|||
48755086|NCT00818662|156949777|FG000|Overall Study|Lost to Follow-up|0|||
48755087|NCT00818662|156949778|FG001|Overall Study|Lost to Follow-up|0|||
48962698|NCT01963208|157692221|FG002|Treatment Phase 1 (Up to Week 14)|Non-compliance|4|||
48962699|NCT01963208|157692222|FG003|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
48962700|NCT01963208|157692223|FG004|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
48657893|NCT03447314|156599888|FG007|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
48657894|NCT03447314|156599889|FG008|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
48657895|NCT03447314|156599890|FG009|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
48657896|NCT03447314|156599891|FG010|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
48657897|NCT03447314|156599892|FG011|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
48657898|NCT03447314|156599893|FG012|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
48657899|NCT03447314|156599894|FG013|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
48657900|NCT03447314|156599895|FG014|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
48657901|NCT03447314|156599896|FG015|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
48657902|NCT03447314|156599897|FG016|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
48657903|NCT03447314|156599898|FG017|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
48657904|NCT03447314|156599881|FG000|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
48657905|NCT03447314|156599882|FG001|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
48657906|NCT03447314|156599883|FG002|Part 1 (Up to 47 Months and 13 Days)|Disease progression|1|||
48657907|NCT03447314|156599884|FG003|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
48657908|NCT03447314|156599885|FG004|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
48657909|NCT03447314|156599886|FG005|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
48657910|NCT03447314|156599887|FG006|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
48657911|NCT03447314|156599888|FG007|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
48657912|NCT03447314|156599889|FG008|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
48657913|NCT03447314|156599890|FG009|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
48657914|NCT03447314|156599891|FG010|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
48657915|NCT03447314|156599892|FG011|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
48657916|NCT03447314|156599893|FG012|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
48657917|NCT03447314|156599894|FG013|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
48657918|NCT03447314|156599895|FG014|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
48657919|NCT03447314|156599896|FG015|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
48657920|NCT03447314|156599897|FG016|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
48657921|NCT03447314|156599898|FG017|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
48657922|NCT03447314|156599881|FG000|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
48657923|NCT03447314|156599882|FG001|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
48657924|NCT03447314|156599883|FG002|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|1|||
48657925|NCT03447314|156599884|FG003|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
48657926|NCT03447314|156599885|FG004|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
48657927|NCT03447314|156599886|FG005|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
48657928|NCT03447314|156599887|FG006|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
48657929|NCT03447314|156599888|FG007|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
48657930|NCT03447314|156599889|FG008|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
48657931|NCT03447314|156599890|FG009|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
48657932|NCT03447314|156599891|FG010|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
48657933|NCT03447314|156599892|FG011|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
48657934|NCT03447314|156599893|FG012|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
48657935|NCT03447314|156599894|FG013|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
48657936|NCT03447314|156599895|FG014|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
48657937|NCT03447314|156599896|FG015|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
48657938|NCT03447314|156599897|FG016|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
48657939|NCT03447314|156599898|FG017|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
48657940|NCT03447314|156599881|FG000|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
48657941|NCT03447314|156599882|FG001|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
48657942|NCT03447314|156599883|FG002|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
48657943|NCT03447314|156599884|FG003|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
48657944|NCT03447314|156599885|FG004|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
48657945|NCT03447314|156599886|FG005|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
48657946|NCT03447314|156599887|FG006|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
48657947|NCT03447314|156599888|FG007|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
48657948|NCT03447314|156599889|FG008|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
48657949|NCT03447314|156599890|FG009|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
48657950|NCT03447314|156599891|FG010|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|1|||
48657951|NCT03447314|156599892|FG011|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
48657952|NCT03447314|156599893|FG012|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
48657953|NCT03447314|156599894|FG013|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
48657954|NCT03447314|156599895|FG014|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
48657955|NCT03447314|156599896|FG015|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
48657956|NCT03447314|156599897|FG016|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
48657957|NCT03447314|156599898|FG017|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
48755088|NCT00818662|156949779|FG002|Overall Study|Lost to Follow-up|0|||
48755089|NCT00818662|156949780|FG003|Overall Study|Lost to Follow-up|1|||
48962701|NCT01963208|157692224|FG005|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
48962702|NCT01963208|157692219|FG000|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
48962703|NCT01963208|157692220|FG001|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
48962704|NCT01963208|157692221|FG002|Treatment Phase 1 (Up to Week 14)|Protocol Violation|1|||
48962705|NCT01963208|157692222|FG003|Treatment Phase 1 (Up to Week 14)|Protocol Violation|3|||
48962706|NCT01963208|157692223|FG004|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
48962707|NCT01963208|157692224|FG005|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
48962708|NCT01963208|157692219|FG000|Treatment Phase 1 (Up to Week 14)|Other|0|||
48962709|NCT01963208|157692220|FG001|Treatment Phase 1 (Up to Week 14)|Other|1|||
48962710|NCT01963208|157692221|FG002|Treatment Phase 1 (Up to Week 14)|Other|1|||
48962711|NCT01963208|157692222|FG003|Treatment Phase 1 (Up to Week 14)|Other|1|||
48755090|NCT00818662|156949777|FG000|Overall Study|Unwilling or Unable to Participate|4|||
48755091|NCT00818662|156949778|FG001|Overall Study|Unwilling or Unable to Participate|6|||
48657958|NCT03447314|156599881|FG000|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
48755092|NCT00818662|156949779|FG002|Overall Study|Unwilling or Unable to Participate|2|||
48755093|NCT00818662|156949780|FG003|Overall Study|Unwilling or Unable to Participate|4|||
48755094|NCT00818662|156949777|FG000|Overall Study|Protocol Violation|1|||
48962712|NCT01963208|157692223|FG004|Treatment Phase 1 (Up to Week 14)|Other|0|||
48962713|NCT01963208|157692224|FG005|Treatment Phase 1 (Up to Week 14)|Other|0|||
48657959|NCT03447314|156599882|FG001|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
48657960|NCT03447314|156599883|FG002|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
48755095|NCT00818662|156949778|FG001|Overall Study|Protocol Violation|1|||
48755096|NCT00818662|156949779|FG002|Overall Study|Protocol Violation|0|||
48755097|NCT00818662|156949780|FG003|Overall Study|Protocol Violation|0|||
48755098|NCT00818662|156949777|FG000|Overall Study|Requires a Prohibited Medication|1|||
48755099|NCT00818662|156949778|FG001|Overall Study|Requires a Prohibited Medication|0|||
48755100|NCT00818662|156949779|FG002|Overall Study|Requires a Prohibited Medication|0|||
48755101|NCT00818662|156949780|FG003|Overall Study|Requires a Prohibited Medication|0|||
48755102|NCT00818662|156949777|FG000|Overall Study|Safety Risk|1|||
48755103|NCT00818662|156949778|FG001|Overall Study|Safety Risk|1|||
48755104|NCT00818662|156949779|FG002|Overall Study|Safety Risk|0|||
48755105|NCT00818662|156949780|FG003|Overall Study|Safety Risk|1|||
48755106|NCT00818662|156949777|FG000|Overall Study|Study Partner Unwilling or Unable|3|||
48866067|NCT00784277|157345630|FG002|ER Treatment|Study Medication Non-Compliant|0|||
48866068|NCT00784277|157345631|FG003|ER Treatment|Study Medication Non-Compliant|0|||
48866069|NCT00784277|157345632|FG004|ER Treatment|Study Medication Non-Compliant|2|||
48866070|NCT00784277|157345633|FG005|ER Treatment|Study Medication Non-Compliant|3|||
48866071|NCT00784277|157345634|FG006|ER Treatment|Study Medication Non-Compliant|3|||
48866072|NCT00784277|157345628|FG000|ER Treatment|Other|0|||
48866073|NCT00784277|157345629|FG001|ER Treatment|Other|0|||
48866074|NCT00784277|157345630|FG002|ER Treatment|Other|0|||
48755107|NCT00818662|156949778|FG001|Overall Study|Study Partner Unwilling or Unable|2|||
48755108|NCT00818662|156949779|FG002|Overall Study|Study Partner Unwilling or Unable|1|||
48755109|NCT00818662|156949780|FG003|Overall Study|Study Partner Unwilling or Unable|1|||
48755110|NCT00818662|156949777|FG000|Overall Study|Participant's health declined|0|||
48755111|NCT00818662|156949778|FG001|Overall Study|Participant's health declined|0|||
48755112|NCT00818662|156949779|FG002|Overall Study|Participant's health declined|0|||
48755113|NCT00818662|156949780|FG003|Overall Study|Participant's health declined|1|||
48755114|NCT00818662|156949777|FG000|Overall Study|Caregiver to pursue other treatment|0|||
48755115|NCT00818662|156949778|FG001|Overall Study|Caregiver to pursue other treatment|1|||
48755116|NCT00818662|156949779|FG002|Overall Study|Caregiver to pursue other treatment|0|||
48755117|NCT00818662|156949780|FG003|Overall Study|Caregiver to pursue other treatment|0|||
48755118|NCT00818662|156949777|FG000|Overall Study|Moving out of state|0|||
48755119|NCT00818662|156949778|FG001|Overall Study|Moving out of state|0|||
48962714|NCT01963208|157692219|FG000|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
48962715|NCT01963208|157692220|FG001|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
48962716|NCT01963208|157692221|FG002|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
48755120|NCT00818662|156949779|FG002|Overall Study|Moving out of state|0|||
48755121|NCT00818662|156949780|FG003|Overall Study|Moving out of state|1|||
48755122|NCT00818662|156949777|FG000|Overall Study|Declined move to another study site|1|||
48866075|NCT00784277|157345631|FG003|ER Treatment|Other|0|||
48866076|NCT00784277|157345632|FG004|ER Treatment|Other|1|||
48866077|NCT00784277|157345633|FG005|ER Treatment|Other|3|||
48962717|NCT01963208|157692222|FG003|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|1|||
48962718|NCT01963208|157692223|FG004|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
48962719|NCT01963208|157692224|FG005|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
48962720|NCT01963208|157692219|FG000|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
48962721|NCT01963208|157692220|FG001|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
48962722|NCT01963208|157692221|FG002|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
48962723|NCT01963208|157692222|FG003|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|1|||
48962724|NCT01963208|157692223|FG004|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
48962725|NCT01963208|157692224|FG005|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
48962726|NCT01963208|157692219|FG000|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
48962727|NCT01963208|157692220|FG001|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
48962728|NCT01963208|157692221|FG002|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
48962729|NCT01963208|157692222|FG003|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
48962730|NCT01963208|157692223|FG004|Treatment Phase 2 (Up to Week 68)|Adverse Event|16|||
48962731|NCT01963208|157692224|FG005|Treatment Phase 2 (Up to Week 68)|Adverse Event|15|||
48962732|NCT01963208|157692219|FG000|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
48657961|NCT03447314|156599884|FG003|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
48657962|NCT03447314|156599885|FG004|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
48657963|NCT03447314|156599886|FG005|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
48755123|NCT00818662|156949778|FG001|Overall Study|Declined move to another study site|0|||
48755124|NCT00818662|156949779|FG002|Overall Study|Declined move to another study site|0|||
48755125|NCT00818662|156949780|FG003|Overall Study|Declined move to another study site|0|||
48755126|NCT00818662|156949777|FG000|Overall Study|Change in living situation|0|||
48755127|NCT00818662|156949778|FG001|Overall Study|Change in living situation|0|||
48755128|NCT00818662|156949779|FG002|Overall Study|Change in living situation|0|||
48755129|NCT00818662|156949780|FG003|Overall Study|Change in living situation|1|||
48755130|NCT00818662|156949777|FG000|Overall Study|Study partner decision|0|||
48755131|NCT00818662|156949778|FG001|Overall Study|Study partner decision|0|||
48755132|NCT00818662|156949779|FG002|Overall Study|Study partner decision|0|||
48755133|NCT00818662|156949780|FG003|Overall Study|Study partner decision|1|||
48755134|NCT00818662|156949777|FG000|Overall Study|Admitted to long term nursing care|0|||
48755135|NCT00818662|156949778|FG001|Overall Study|Admitted to long term nursing care|1|||
48755136|NCT00818662|156949779|FG002|Overall Study|Admitted to long term nursing care|0|||
48755137|NCT00818662|156949780|FG003|Overall Study|Admitted to long term nursing care|0|||
48755138|NCT01722071|156949781|FG000|Overall Study|Protocol Violation|1|||
48755139|NCT01722071|156949782|FG001|Overall Study|Protocol Violation|0|||
48755140|NCT00656474|156949783|FG000|Overall Study|Other Reason|1|||
48755141|NCT01614067|156949785|FG000|Overall Study|Pregnancy|1|||
48755142|NCT01614067|156949786|FG001|Overall Study|Pregnancy|0|||
48755143|NCT01614067|156949785|FG000|Overall Study|Physician Decision|6|||
48755144|NCT01614067|156949786|FG001|Overall Study|Physician Decision|5|||
48755145|NCT01614067|156949785|FG000|Overall Study|Withdrawal by Subject|0|||
48755146|NCT01614067|156949786|FG001|Overall Study|Withdrawal by Subject|1|||
48755147|NCT01614067|156949785|FG000|Overall Study|Study terminated early by sponsor and was unable to collect data|8|||
48755148|NCT01614067|156949786|FG001|Overall Study|Study terminated early by sponsor and was unable to collect data|9|||
48755149|NCT03061331|156949790|FG000|Washout Period (8 Weeks)|Adverse Event|2|||
49015429|NCT01497938|157892193|FG001|Overall Study|Adverse Event|1|||
48657964|NCT03447314|156599887|FG006|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
48657965|NCT03447314|156599888|FG007|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
48657966|NCT03447314|156599889|FG008|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
48657967|NCT03447314|156599890|FG009|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
48657968|NCT03447314|156599891|FG010|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
48657969|NCT03447314|156599892|FG011|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
48657970|NCT03447314|156599893|FG012|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
48657971|NCT03447314|156599894|FG013|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
48657972|NCT03447314|156599895|FG014|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
48657973|NCT03447314|156599896|FG015|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
48657974|NCT03447314|156599897|FG016|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
48657975|NCT03447314|156599898|FG017|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
48657976|NCT02152371|156599899|FG000|Overall Study|Adverse Event|6|||
48657977|NCT02152371|156599900|FG001|Overall Study|Adverse Event|2|||
48657978|NCT02152371|156599899|FG000|Overall Study|Withdrawal by Subject|3|||
48657979|NCT02152371|156599900|FG001|Overall Study|Withdrawal by Subject|7|||
48755150|NCT03061331|156949791|FG001|Washout Period (8 Weeks)|Adverse Event|1|||
48755151|NCT02998840|156949792|FG000|Overall Study|Lost to Follow-up|1|||
48755152|NCT02998840|156949793|FG001|Overall Study|Lost to Follow-up|1|||
48755153|NCT02998840|156949794|FG002|Overall Study|Lost to Follow-up|2|||
48755154|NCT02998840|156949795|FG003|Overall Study|Lost to Follow-up|3|||
48755155|NCT02998840|156949792|FG000|Overall Study|Withdrawal by Subject|1|||
48755156|NCT02998840|156949793|FG001|Overall Study|Withdrawal by Subject|1|||
48962733|NCT01963208|157692220|FG001|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
48657980|NCT02152371|156599899|FG000|Overall Study|Protocol Violation|2|||
48657981|NCT02152371|156599900|FG001|Overall Study|Protocol Violation|3|||
48657982|NCT02152371|156599899|FG000|Overall Study|Lost to Follow-up|1|||
48657983|NCT02152371|156599900|FG001|Overall Study|Lost to Follow-up|0|||
48657984|NCT02152371|156599899|FG000|Overall Study|Lack of Efficacy|0|||
48657985|NCT02152371|156599900|FG001|Overall Study|Lack of Efficacy|1|||
48657986|NCT02152371|156599899|FG000|Overall Study|Physician Decision|0|||
48657987|NCT02152371|156599900|FG001|Overall Study|Physician Decision|2|||
48657988|NCT02152371|156599899|FG000|Overall Study|Reason Not Given|0|||
48657989|NCT02152371|156599900|FG001|Overall Study|Reason Not Given|1|||
48657990|NCT02099344|156599902|FG000|Overall Study|Physician Decision|1|||
48657991|NCT02099344|156599903|FG001|Overall Study|Physician Decision|0|||
48657992|NCT02151981|156599906|FG000|Overall Study|Death|184|||
48657993|NCT02151981|156599907|FG001|Overall Study|Death|88|||
48657994|NCT02151981|156599906|FG000|Overall Study|Lost to Follow-up|7|||
48657995|NCT02151981|156599907|FG001|Overall Study|Lost to Follow-up|1|||
48657996|NCT02151981|156599906|FG000|Overall Study|Withdrawal by Subject|27|||
48657997|NCT02151981|156599907|FG001|Overall Study|Withdrawal by Subject|21|||
48657998|NCT02151981|156599906|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
48657999|NCT02151981|156599907|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
48658000|NCT02151981|156599906|FG000|Overall Study|Other reasons|1|||
48658001|NCT02151981|156599907|FG001|Overall Study|Other reasons|2|||
48658002|NCT03006458|156599913|FG000|First Intervention|Unsatisfied Vision|0|||
48658003|NCT03006458|156599914|FG001|First Intervention|Unsatisfied Vision|3|||
48658004|NCT01482169|156599915|FG000|Overall Study|Physician Decision|2|||
48658005|NCT00457821|156599921|FG000|Part 2|Withdrawal by Subject|0|||
48658006|NCT00457821|156599922|FG001|Part 2|Withdrawal by Subject|0|||
48658007|NCT00457821|156599923|FG002|Part 2|Withdrawal by Subject|0|||
48658008|NCT00457821|156599924|FG003|Part 2|Withdrawal by Subject|0|||
48658009|NCT00457821|156599925|FG004|Part 2|Withdrawal by Subject|0|||
48658010|NCT00457821|156599926|FG005|Part 2|Withdrawal by Subject|0|||
48658011|NCT00457821|156599927|FG006|Part 2|Withdrawal by Subject|0|||
48658012|NCT00457821|156599928|FG007|Part 2|Withdrawal by Subject|1|||
48658013|NCT00778258|156599929|FG000|Overall Study|Adverse Event|1|||
48658014|NCT00778258|156599930|FG001|Overall Study|Adverse Event|0|||
48658015|NCT00778258|156599931|FG002|Overall Study|Adverse Event|0|||
48658016|NCT00778258|156599932|FG003|Overall Study|Adverse Event|0|||
48658017|NCT00778258|156599933|FG004|Overall Study|Adverse Event|0|||
48658018|NCT00778258|156599934|FG005|Overall Study|Adverse Event|1|||
48658019|NCT00778258|156599935|FG006|Overall Study|Adverse Event|0|||
48658020|NCT00778258|156599936|FG007|Overall Study|Adverse Event|0|||
48658021|NCT00778258|156599937|FG008|Overall Study|Adverse Event|0|||
48658022|NCT00778258|156599929|FG000|Overall Study|Lost to Follow-up|0|||
48658023|NCT00778258|156599930|FG001|Overall Study|Lost to Follow-up|0|||
48658024|NCT00778258|156599931|FG002|Overall Study|Lost to Follow-up|2|||
48658025|NCT00778258|156599932|FG003|Overall Study|Lost to Follow-up|0|||
48658026|NCT00778258|156599933|FG004|Overall Study|Lost to Follow-up|0|||
48658027|NCT00778258|156599934|FG005|Overall Study|Lost to Follow-up|3|||
48658028|NCT00778258|156599935|FG006|Overall Study|Lost to Follow-up|2|||
48658029|NCT00778258|156599936|FG007|Overall Study|Lost to Follow-up|2|||
48658030|NCT00778258|156599937|FG008|Overall Study|Lost to Follow-up|0|||
48658031|NCT00778258|156599929|FG000|Overall Study|Withdrawal by Subject|6|||
48658032|NCT00778258|156599930|FG001|Overall Study|Withdrawal by Subject|2|||
48658033|NCT00778258|156599931|FG002|Overall Study|Withdrawal by Subject|8|||
48658034|NCT00778258|156599932|FG003|Overall Study|Withdrawal by Subject|2|||
48658035|NCT00778258|156599933|FG004|Overall Study|Withdrawal by Subject|0|||
48658036|NCT00778258|156599934|FG005|Overall Study|Withdrawal by Subject|6|||
48658037|NCT00778258|156599935|FG006|Overall Study|Withdrawal by Subject|12|||
48658038|NCT00778258|156599936|FG007|Overall Study|Withdrawal by Subject|12|||
48658039|NCT00778258|156599937|FG008|Overall Study|Withdrawal by Subject|4|||
48658040|NCT00778258|156599929|FG000|Overall Study|New Contraindication|0|||
48962734|NCT01963208|157692221|FG002|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
48658041|NCT00778258|156599930|FG001|Overall Study|New Contraindication|0|||
48658042|NCT00778258|156599931|FG002|Overall Study|New Contraindication|0|||
48658043|NCT00778258|156599932|FG003|Overall Study|New Contraindication|0|||
48658044|NCT00778258|156599933|FG004|Overall Study|New Contraindication|0|||
48658045|NCT00778258|156599934|FG005|Overall Study|New Contraindication|0|||
48962735|NCT01963208|157692222|FG003|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
48962736|NCT01963208|157692223|FG004|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|7|||
48962737|NCT01963208|157692224|FG005|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|19|||
48658046|NCT00778258|156599935|FG006|Overall Study|New Contraindication|0|||
48658047|NCT00778258|156599936|FG007|Overall Study|New Contraindication|1|||
48658048|NCT00778258|156599937|FG008|Overall Study|New Contraindication|0|||
48658049|NCT00778258|156599929|FG000|Overall Study|Non-compliance|0|||
48658050|NCT00778258|156599930|FG001|Overall Study|Non-compliance|0|||
48658051|NCT00778258|156599931|FG002|Overall Study|Non-compliance|0|||
48962738|NCT01963208|157692219|FG000|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
48962739|NCT01963208|157692220|FG001|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
48962740|NCT01963208|157692221|FG002|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
48658052|NCT00778258|156599932|FG003|Overall Study|Non-compliance|1|||
48658053|NCT00778258|156599933|FG004|Overall Study|Non-compliance|0|||
48658054|NCT00778258|156599934|FG005|Overall Study|Non-compliance|0|||
48658055|NCT00778258|156599935|FG006|Overall Study|Non-compliance|0|||
48658056|NCT00778258|156599936|FG007|Overall Study|Non-compliance|0|||
48658057|NCT00778258|156599937|FG008|Overall Study|Non-compliance|0|||
48658058|NCT00778258|156599929|FG000|Overall Study|Other|0|||
48658059|NCT00778258|156599930|FG001|Overall Study|Other|0|||
48658060|NCT00778258|156599931|FG002|Overall Study|Other|0|||
48658061|NCT00778258|156599932|FG003|Overall Study|Other|0|||
48658062|NCT00778258|156599933|FG004|Overall Study|Other|0|||
48658063|NCT00778258|156599934|FG005|Overall Study|Other|0|||
48658064|NCT00778258|156599935|FG006|Overall Study|Other|1|||
48755157|NCT02998840|156949794|FG002|Overall Study|Withdrawal by Subject|0|||
48755158|NCT02998840|156949795|FG003|Overall Study|Withdrawal by Subject|1|||
48755159|NCT02998840|156949792|FG000|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|2|||
48755160|NCT02998840|156949793|FG001|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
48755161|NCT02998840|156949794|FG002|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|0|||
48755162|NCT02998840|156949795|FG003|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
48755163|NCT03338855|156949796|FG000|Overall Study|Withdrawn as birth control pill stopped|1|||
48866078|NCT00784277|157345634|FG006|ER Treatment|Other|2|||
48866079|NCT00203502|157345637|FG000|Overall Study|Death|1|||
48866080|NCT01951105|157345638|FG000|Overall Study|Adverse Event|0|||
48866081|NCT01951105|157345639|FG001|Overall Study|Adverse Event|5|||
48866082|NCT01951105|157345640|FG002|Overall Study|Adverse Event|0|||
48866083|NCT01951105|157345638|FG000|Overall Study|Lost to Follow-up|0|||
48866084|NCT01951105|157345639|FG001|Overall Study|Lost to Follow-up|1|||
48866085|NCT01951105|157345640|FG002|Overall Study|Lost to Follow-up|0|||
48866086|NCT01951105|157345638|FG000|Overall Study|Protocol Violation|1|||
48866087|NCT01951105|157345639|FG001|Overall Study|Protocol Violation|1|||
48866088|NCT01951105|157345640|FG002|Overall Study|Protocol Violation|1|||
48866089|NCT01951105|157345638|FG000|Overall Study|Withdrawal by Subject|0|||
48866090|NCT01951105|157345639|FG001|Overall Study|Withdrawal by Subject|3|||
48866091|NCT01951105|157345640|FG002|Overall Study|Withdrawal by Subject|1|||
48866092|NCT01075100|157345649|FG000|Overall Study|Adverse Event|15|||
48866093|NCT01075100|157345650|FG001|Overall Study|Adverse Event|18|||
48866094|NCT01075100|157345649|FG000|Overall Study|Patient Request|4|||
48866095|NCT01075100|157345650|FG001|Overall Study|Patient Request|4|||
48866096|NCT01075100|157345649|FG000|Overall Study|Investigator Request|2|||
48866097|NCT01075100|157345650|FG001|Overall Study|Investigator Request|1|||
48866098|NCT01075100|157345649|FG000|Overall Study|Disease Progression|25|||
48866099|NCT01075100|157345650|FG001|Overall Study|Disease Progression|29|||
48866100|NCT01075100|157345649|FG000|Overall Study|Other|3|||
48866101|NCT01075100|157345650|FG001|Overall Study|Other|1|||
48866102|NCT03303521|157345651|FG000|Overall Study|Withdrawal by Subject|2|||
48866103|NCT03303521|157345652|FG001|Overall Study|Withdrawal by Subject|0|||
48866104|NCT03303521|157345651|FG000|Overall Study|Death|1|||
48866105|NCT03303521|157345652|FG001|Overall Study|Death|0|||
48866106|NCT03303521|157345651|FG000|Overall Study|Kidney transplantation|0|||
48866107|NCT03303521|157345652|FG001|Overall Study|Kidney transplantation|1|||
48866108|NCT03303521|157345651|FG000|Overall Study|Investigational product discontinuation|0|||
48866109|NCT03303521|157345652|FG001|Overall Study|Investigational product discontinuation|1|||
48866110|NCT03303521|157345651|FG000|Overall Study|Transferred to non-study dialysis center|1|||
48866111|NCT03303521|157345652|FG001|Overall Study|Transferred to non-study dialysis center|0|||
48866112|NCT03303521|157345651|FG000|Overall Study|Non-comliance to study protocol|0|||
48866113|NCT03303521|157345652|FG001|Overall Study|Non-comliance to study protocol|1|||
48866114|NCT03303521|157345651|FG000|Overall Study|Adverse Event|1|||
48962741|NCT01963208|157692222|FG003|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
48658065|NCT00778258|156599936|FG007|Overall Study|Other|0|||
48658066|NCT00778258|156599937|FG008|Overall Study|Other|0|||
48658067|NCT00096174|156599938|FG000|Overall Study|Lack of Efficacy|9|||
48658068|NCT00096174|156599938|FG000|Overall Study|Adverse Event|15|||
48658069|NCT00096174|156599938|FG000|Overall Study|Death|6|||
48658070|NCT00096174|156599938|FG000|Overall Study|Withdrawal by Subject|15|||
48962742|NCT01963208|157692223|FG004|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
48962743|NCT01963208|157692224|FG005|Treatment Phase 2 (Up to Week 68)|Non-Compliance|1|||
48962744|NCT01963208|157692219|FG000|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
48962745|NCT01963208|157692220|FG001|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
48962746|NCT01963208|157692221|FG002|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
48962747|NCT01963208|157692222|FG003|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
48962748|NCT01963208|157692223|FG004|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
48962749|NCT01963208|157692224|FG005|Treatment Phase 2 (Up to Week 68)|Protocol Violation|1|||
48962750|NCT01963208|157692219|FG000|Treatment Phase 2 (Up to Week 68)|Other|0|||
48962751|NCT01963208|157692220|FG001|Treatment Phase 2 (Up to Week 68)|Other|0|||
48962752|NCT01963208|157692221|FG002|Treatment Phase 2 (Up to Week 68)|Other|0|||
48962753|NCT01963208|157692222|FG003|Treatment Phase 2 (Up to Week 68)|Other|0|||
48962754|NCT01963208|157692223|FG004|Treatment Phase 2 (Up to Week 68)|Other|58|||
48962755|NCT01963208|157692224|FG005|Treatment Phase 2 (Up to Week 68)|Other|75|||
48962756|NCT01963208|157692219|FG000|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
48962757|NCT01963208|157692220|FG001|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
48962758|NCT01963208|157692221|FG002|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
48962759|NCT01963208|157692222|FG003|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
48962760|NCT01963208|157692223|FG004|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|20|||
48962761|NCT01963208|157692224|FG005|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|17|||
48962762|NCT01963208|157692219|FG000|Treatment Phase 2 (Up to Week 68)|Death|0|||
48962763|NCT01963208|157692220|FG001|Treatment Phase 2 (Up to Week 68)|Death|0|||
48962764|NCT01963208|157692221|FG002|Treatment Phase 2 (Up to Week 68)|Death|0|||
48962765|NCT01963208|157692222|FG003|Treatment Phase 2 (Up to Week 68)|Death|0|||
48962766|NCT01963208|157692223|FG004|Treatment Phase 2 (Up to Week 68)|Death|0|||
48962767|NCT01963208|157692224|FG005|Treatment Phase 2 (Up to Week 68)|Death|1|||
48962768|NCT01364233|157692227|FG000|Overall Study|Lost to Follow-up|1|||
48962769|NCT00878215|157692228|FG000|Overall Study|Determined to be ineligible|0|||
48962770|NCT00878215|157692229|FG001|Overall Study|Determined to be ineligible|10|||
48962771|NCT00878215|157692230|FG002|Overall Study|Determined to be ineligible|0|||
48962772|NCT00878215|157692231|FG003|Overall Study|Determined to be ineligible|0|||
48962773|NCT04311177|157692242|FG000|Overall Study|Adverse Event|3|||
48962774|NCT04311177|157692243|FG001|Overall Study|Adverse Event|1|||
48962775|NCT04311177|157692242|FG000|Overall Study|Physician Decision|4|||
48962776|NCT04311177|157692243|FG001|Overall Study|Physician Decision|3|||
48962777|NCT04311177|157692242|FG000|Overall Study|Withdrawal by Subject|1|||
48962778|NCT04311177|157692243|FG001|Overall Study|Withdrawal by Subject|0|||
48962779|NCT04191577|157692244|FG000|Overall Study|Withdrawal by Subject|2|||
48658071|NCT00096174|156599938|FG000|Overall Study|Not started protocol therapy|3|||
48962780|NCT04191577|157692245|FG001|Overall Study|Withdrawal by Subject|2|||
48962781|NCT04191577|157692246|FG002|Overall Study|Withdrawal by Subject|1|||
48962782|NCT04191577|157692244|FG000|Overall Study|Physician Decision|1|||
48962783|NCT04191577|157692245|FG001|Overall Study|Physician Decision|1|||
48658072|NCT00096174|156599938|FG000|Overall Study|Ineligible|6|||
48658073|NCT00096174|156599938|FG000|Overall Study|other reason|8|||
48658074|NCT02136680|156599939|FG000|Overall Study|No Longer Interested|1|||
48658075|NCT02136680|156599940|FG001|Overall Study|No Longer Interested|1|||
48658076|NCT02136680|156599939|FG000|Overall Study|No longer receiving care at clinic|3|||
48658077|NCT02136680|156599940|FG001|Overall Study|No longer receiving care at clinic|5|||
48658078|NCT02136680|156599939|FG000|Overall Study|Moved away|5|||
48658079|NCT02136680|156599940|FG001|Overall Study|Moved away|4|||
48962784|NCT04191577|157692246|FG002|Overall Study|Physician Decision|0|||
48658080|NCT02136680|156599939|FG000|Overall Study|Unable to schedule|17|||
48658081|NCT02136680|156599940|FG001|Overall Study|Unable to schedule|16|||
48658082|NCT02136680|156599939|FG000|Overall Study|Study ended before interview due|6|||
48658083|NCT02136680|156599940|FG001|Overall Study|Study ended before interview due|3|||
48658084|NCT02182440|156599950|FG000|Overall Study|Adverse Event|0|||
49015430|NCT01497938|157892192|FG000|Overall Study|Physician Decision|0|||
48658085|NCT02182440|156599951|FG001|Overall Study|Adverse Event|1|||
48962785|NCT04191577|157692244|FG000|Overall Study|Adverse Event|0|||
48962786|NCT04191577|157692245|FG001|Overall Study|Adverse Event|0|||
48658086|NCT02182440|156599952|FG002|Overall Study|Adverse Event|0|||
48658087|NCT02182440|156599953|FG003|Overall Study|Adverse Event|0|||
48658088|NCT02182440|156599950|FG000|Overall Study|Death|31|||
48658089|NCT02182440|156599951|FG001|Overall Study|Death|8|||
48658090|NCT02182440|156599952|FG002|Overall Study|Death|5|||
48658091|NCT02182440|156599953|FG003|Overall Study|Death|16|||
48658092|NCT02182440|156599950|FG000|Overall Study|Protocol Violation|0|||
48658093|NCT02182440|156599951|FG001|Overall Study|Protocol Violation|1|||
48658094|NCT02182440|156599952|FG002|Overall Study|Protocol Violation|0|||
48866115|NCT03303521|157345652|FG001|Overall Study|Adverse Event|0|||
48658095|NCT02182440|156599953|FG003|Overall Study|Protocol Violation|0|||
48658096|NCT02182440|156599950|FG000|Overall Study|Physician Decision|1|||
48658097|NCT02182440|156599951|FG001|Overall Study|Physician Decision|0|||
48658098|NCT02182440|156599952|FG002|Overall Study|Physician Decision|0|||
48658099|NCT02182440|156599953|FG003|Overall Study|Physician Decision|0|||
48658100|NCT02182440|156599950|FG000|Overall Study|Withdrawal by Subject|1|||
48658101|NCT02182440|156599951|FG001|Overall Study|Withdrawal by Subject|1|||
48658102|NCT02182440|156599952|FG002|Overall Study|Withdrawal by Subject|3|||
48658103|NCT02182440|156599953|FG003|Overall Study|Withdrawal by Subject|4|||
48658104|NCT02182440|156599950|FG000|Overall Study|different, e.g adm other hospital|12|||
48658105|NCT02182440|156599951|FG001|Overall Study|different, e.g adm other hospital|3|||
48658106|NCT02182440|156599952|FG002|Overall Study|different, e.g adm other hospital|3|||
48658107|NCT02182440|156599953|FG003|Overall Study|different, e.g adm other hospital|10|||
48658108|NCT00624819|156599954|FG000|Follow-up Period: Year 4|Parents decision|0|||
48658109|NCT00624819|156599955|FG001|Follow-up Period: Year 4|Parents decision|0|||
48658110|NCT00624819|156599956|FG002|Follow-up Period: Year 4|Parents decision|1|||
48658111|NCT00624819|156599957|FG003|Follow-up Period: Year 4|Parents decision|0|||
48658112|NCT00624819|156599954|FG000|Follow-up Period: Year 4|Lost to Follow-up|1|||
48658113|NCT00624819|156599955|FG001|Follow-up Period: Year 4|Lost to Follow-up|1|||
48658114|NCT00624819|156599956|FG002|Follow-up Period: Year 4|Lost to Follow-up|0|||
48658115|NCT00624819|156599957|FG003|Follow-up Period: Year 4|Lost to Follow-up|0|||
48658116|NCT02279719|156599958|FG000|Overall Study|Patients randomized but never treated|0|||
48658117|NCT02279719|156599959|FG001|Overall Study|Patients randomized but never treated|0|||
48658118|NCT02279719|156599960|FG002|Overall Study|Patients randomized but never treated|0|||
48658119|NCT02279719|156599961|FG003|Overall Study|Patients randomized but never treated|0|||
48658120|NCT02279719|156599962|FG004|Overall Study|Patients randomized but never treated|3|||
48658121|NCT02279719|156599963|FG005|Overall Study|Patients randomized but never treated|0|||
48866116|NCT00191984|157345653|FG000|Overall Study|Disease Progression|21|||
48866117|NCT00191984|157345653|FG000|Overall Study|Adverse Event|4|||
48866118|NCT00191984|157345653|FG000|Overall Study|Death|2|||
48866119|NCT00191984|157345653|FG000|Overall Study|Entry Criteria Exclusion|1|||
48866120|NCT00191984|157345653|FG000|Overall Study|Withdrawal by Subject|7|||
48866121|NCT00191984|157345653|FG000|Overall Study|Physician Decision|4|||
48866122|NCT01654289|157345654|FG000|Overall Study|Withdrawal by Subject|10|||
48866123|NCT01654289|157345655|FG001|Overall Study|Withdrawal by Subject|8|||
48866124|NCT01654289|157345656|FG002|Overall Study|Withdrawal by Subject|5|||
48866125|NCT01654289|157345654|FG000|Overall Study|Withdrew from intervention only|17|||
48866126|NCT01654289|157345655|FG001|Overall Study|Withdrew from intervention only|20|||
48866127|NCT01654289|157345656|FG002|Overall Study|Withdrew from intervention only|0|||
48866128|NCT04194541|157345657|FG000|Day 1 Through 13|Lost to Follow-up|3|||
48866129|NCT04194541|157345657|FG000|Day 1 Through 13|Coronavirus Disease of 2019 (COVID-19) shut down|6|||
48866130|NCT04194541|157345657|FG000|Day 15 Through Week 6|Lost to Follow-up|5|||
48866131|NCT02642159|157345658|FG000|Overall Study|Randomized but not treated|1|||
49015431|NCT01497938|157892193|FG001|Overall Study|Physician Decision|1|||
48658122|NCT02279719|156599964|FG006|Overall Study|Patients randomized but never treated|3|||
48658123|NCT00737711|156601570|FG000|Overall Study|Adverse Event|2|||
48658124|NCT00737711|156601570|FG000|Overall Study|Death|8|||
48658125|NCT00737711|156601570|FG000|Overall Study|Failure to return|4|||
48866132|NCT02642159|157345659|FG001|Overall Study|Randomized but not treated|0|||
48866133|NCT02642159|157345658|FG000|Overall Study|Adverse Event|10|||
48962787|NCT04191577|157692246|FG002|Overall Study|Adverse Event|1|||
48962788|NCT04191577|157692244|FG000|Overall Study|Death|0|||
48962789|NCT04191577|157692245|FG001|Overall Study|Death|0|||
48962790|NCT04191577|157692246|FG002|Overall Study|Death|1|||
48962791|NCT00448916|157692254|FG000|Overall Study|Adverse Event|2|||
48962792|NCT00448916|157692255|FG001|Overall Study|Adverse Event|2|||
48658126|NCT00737711|156601570|FG000|Overall Study|Protocol Violation|1|||
48658127|NCT00737711|156601570|FG000|Overall Study|Withdrawal by Subject|5|||
48658128|NCT00737711|156601570|FG000|Overall Study|Blood transfusion|6|||
48658129|NCT00737711|156601570|FG000|Overall Study|Other|5|||
48658130|NCT00420004|156601571|FG000|Overall Study|Adverse Event|4|||
48658131|NCT00420004|156601572|FG001|Overall Study|Adverse Event|1|||
48658132|NCT00420004|156601573|FG002|Overall Study|Adverse Event|1|||
48658133|NCT00420004|156601571|FG000|Overall Study|Lack of Efficacy|5|||
48658134|NCT00420004|156601572|FG001|Overall Study|Lack of Efficacy|4|||
48658135|NCT00420004|156601573|FG002|Overall Study|Lack of Efficacy|1|||
48658136|NCT00420004|156601571|FG000|Overall Study|Lost to Follow-up|31|||
48658137|NCT00420004|156601572|FG001|Overall Study|Lost to Follow-up|12|||
48658138|NCT00420004|156601573|FG002|Overall Study|Lost to Follow-up|10|||
48658139|NCT00420004|156601571|FG000|Overall Study|Entry Criteria Not Met|0|||
48658140|NCT00420004|156601572|FG001|Overall Study|Entry Criteria Not Met|1|||
48658141|NCT00420004|156601573|FG002|Overall Study|Entry Criteria Not Met|0|||
48658142|NCT00420004|156601571|FG000|Overall Study|Physician Decision|14|||
48658143|NCT00420004|156601572|FG001|Overall Study|Physician Decision|4|||
48658144|NCT00420004|156601573|FG002|Overall Study|Physician Decision|2|||
48658145|NCT00420004|156601571|FG000|Overall Study|Protocol Violation|5|||
48658146|NCT00420004|156601572|FG001|Overall Study|Protocol Violation|4|||
48658147|NCT00420004|156601573|FG002|Overall Study|Protocol Violation|3|||
48658148|NCT00420004|156601571|FG000|Overall Study|Withdrawal by Subject|67|||
48658149|NCT00420004|156601572|FG001|Overall Study|Withdrawal by Subject|42|||
48658150|NCT00420004|156601573|FG002|Overall Study|Withdrawal by Subject|14|||
48658151|NCT00420004|156601571|FG000|Overall Study|Sponsor Decision|3|||
48658152|NCT00420004|156601572|FG001|Overall Study|Sponsor Decision|3|||
48658153|NCT00420004|156601573|FG002|Overall Study|Sponsor Decision|1|||
48658154|NCT00132691|156601579|FG000|Overall Study|Lost to Follow-up|5|||
48658155|NCT00132691|156601580|FG001|Overall Study|Lost to Follow-up|8|||
48658156|NCT00132691|156601579|FG000|Overall Study|Missed 2-year visit|4|||
48658157|NCT00132691|156601580|FG001|Overall Study|Missed 2-year visit|4|||
48658158|NCT00132691|156601579|FG000|Overall Study|Death|2|||
48658159|NCT00132691|156601580|FG001|Overall Study|Death|0|||
48658160|NCT01032291|156601587|FG000|Safety Lead-in|Adverse Event|1|||
48658161|NCT01032291|156601588|FG001|Safety Lead-in|Adverse Event|0|||
48658162|NCT01032291|156601589|FG002|Safety Lead-in|Adverse Event|0|||
48658163|NCT01032291|156601587|FG000|Safety Lead-in|Death|1|||
48658164|NCT01032291|156601588|FG001|Safety Lead-in|Death|0|||
48658165|NCT01032291|156601589|FG002|Safety Lead-in|Death|0|||
48658166|NCT01032291|156601587|FG000|Proof of Concept|Adverse Event|0|||
48658167|NCT01032291|156601588|FG001|Proof of Concept|Adverse Event|5|||
48658168|NCT01032291|156601589|FG002|Proof of Concept|Adverse Event|1|||
48658169|NCT01032291|156601587|FG000|Proof of Concept|Death|0|||
48658170|NCT01032291|156601588|FG001|Proof of Concept|Death|1|||
48658171|NCT01032291|156601589|FG002|Proof of Concept|Death|2|||
48658172|NCT01032291|156601587|FG000|Proof of Concept|Lack of Efficacy|0|||
48658173|NCT01032291|156601588|FG001|Proof of Concept|Lack of Efficacy|1|||
48658174|NCT01032291|156601589|FG002|Proof of Concept|Lack of Efficacy|0|||
48658175|NCT01032291|156601587|FG000|Proof of Concept|Never Received Study Drug|0|||
48658176|NCT01032291|156601588|FG001|Proof of Concept|Never Received Study Drug|1|||
48658177|NCT01032291|156601589|FG002|Proof of Concept|Never Received Study Drug|0|||
48658178|NCT00758264|156601593|FG000|Active Phase|Withdrawal by Subject|0|||
48658179|NCT00758264|156601594|FG001|Active Phase|Withdrawal by Subject|0|||
48658180|NCT00758264|156601595|FG002|Active Phase|Withdrawal by Subject|1|||
48658181|NCT00758264|156601593|FG000|Active Phase|Lost to Follow-up|1|||
48658182|NCT00758264|156601594|FG001|Active Phase|Lost to Follow-up|0|||
48658183|NCT00758264|156601595|FG002|Active Phase|Lost to Follow-up|0|||
48755164|NCT03338855|156949797|FG001|Overall Study|Withdrawn as birth control pill stopped|0|||
48755165|NCT01286012|156949802|FG000|Overall Study|Adverse Event|3|||
48658184|NCT00758264|156601593|FG000|Active Phase|Other|0|||
48755166|NCT01286012|156949803|FG001|Overall Study|Adverse Event|3|||
48755167|NCT01286012|156949802|FG000|Overall Study|Death|2|||
48755168|NCT01286012|156949803|FG001|Overall Study|Death|3|||
48755169|NCT01286012|156949802|FG000|Overall Study|Protocol Violation|1|||
48755170|NCT01286012|156949803|FG001|Overall Study|Protocol Violation|1|||
48755171|NCT01286012|156949802|FG000|Overall Study|Withdrawal by Subject|4|||
48755172|NCT01286012|156949803|FG001|Overall Study|Withdrawal by Subject|4|||
48755173|NCT01286012|156949802|FG000|Overall Study|Physician Decision|2|||
48755174|NCT01286012|156949803|FG001|Overall Study|Physician Decision|0|||
48755175|NCT01286012|156949802|FG000|Overall Study|peritoneal dialysis, randomized in error|1|||
48658185|NCT00758264|156601594|FG001|Active Phase|Other|0|||
48658186|NCT00758264|156601595|FG002|Active Phase|Other|4|||
48658187|NCT01988662|156601598|FG000|Overall Study|Subject/guardian decision|1|||
48658188|NCT01988662|156601599|FG001|Overall Study|Subject/guardian decision|1|||
48755176|NCT01286012|156949803|FG001|Overall Study|peritoneal dialysis, randomized in error|3|||
48962793|NCT00448916|157692256|FG002|Overall Study|Adverse Event|3|||
48962794|NCT00448916|157692257|FG003|Overall Study|Adverse Event|2|||
48962795|NCT00448916|157692254|FG000|Overall Study|Lack of Efficacy|1|||
48962796|NCT00448916|157692255|FG001|Overall Study|Lack of Efficacy|0|||
48962797|NCT00448916|157692256|FG002|Overall Study|Lack of Efficacy|2|||
48962798|NCT00448916|157692257|FG003|Overall Study|Lack of Efficacy|1|||
48658189|NCT01988662|156601598|FG000|Overall Study|Adverse Event|3|||
48962799|NCT00448916|157692254|FG000|Overall Study|Withdrawal by Subject|3|||
48962800|NCT00448916|157692255|FG001|Overall Study|Withdrawal by Subject|3|||
48962801|NCT00448916|157692256|FG002|Overall Study|Withdrawal by Subject|1|||
48962802|NCT00448916|157692257|FG003|Overall Study|Withdrawal by Subject|1|||
48962803|NCT00448916|157692254|FG000|Overall Study|Other|1|||
48962804|NCT00448916|157692255|FG001|Overall Study|Other|0|||
48962805|NCT00448916|157692256|FG002|Overall Study|Other|0|||
48962806|NCT00448916|157692257|FG003|Overall Study|Other|0|||
48962807|NCT00448916|157692254|FG000|Overall Study|Lost to Follow-up|0|||
48962808|NCT00448916|157692255|FG001|Overall Study|Lost to Follow-up|1|||
48962809|NCT00448916|157692256|FG002|Overall Study|Lost to Follow-up|0|||
48962810|NCT00448916|157692257|FG003|Overall Study|Lost to Follow-up|1|||
48962811|NCT00448916|157692254|FG000|Overall Study|Protocol Violation|0|||
48962812|NCT00448916|157692255|FG001|Overall Study|Protocol Violation|0|||
48962813|NCT00448916|157692256|FG002|Overall Study|Protocol Violation|0|||
48962814|NCT00448916|157692257|FG003|Overall Study|Protocol Violation|1|||
48962815|NCT03655717|157692261|FG000|Overall Study|Withdrawal by Subject|4|||
48962816|NCT03655717|157692262|FG001|Overall Study|Withdrawal by Subject|8|||
48962817|NCT03655717|157692263|FG002|Overall Study|Withdrawal by Subject|1|||
48962818|NCT03655717|157692264|FG003|Overall Study|Withdrawal by Subject|0|||
48962819|NCT03655717|157692265|FG004|Overall Study|Withdrawal by Subject|0|||
48962820|NCT03655717|157692266|FG005|Overall Study|Withdrawal by Subject|1|||
48962821|NCT03655717|157692267|FG006|Overall Study|Withdrawal by Subject|3|||
48962822|NCT03655717|157692268|FG007|Overall Study|Withdrawal by Subject|1|||
48962823|NCT03655717|157692269|FG008|Overall Study|Withdrawal by Subject|2|||
48962824|NCT03655717|157692270|FG009|Overall Study|Withdrawal by Subject|0|||
48962825|NCT03655717|157692271|FG010|Overall Study|Withdrawal by Subject|0|||
48962826|NCT03655717|157692272|FG011|Overall Study|Withdrawal by Subject|1|||
48962827|NCT03655717|157692273|FG012|Overall Study|Withdrawal by Subject|0|||
48962828|NCT03655717|157692274|FG013|Overall Study|Withdrawal by Subject|3|||
48962829|NCT03655717|157692275|FG014|Overall Study|Withdrawal by Subject|0|||
48658190|NCT01988662|156601599|FG001|Overall Study|Adverse Event|1|||
48658191|NCT01498575|156601602|FG000|Overall Sample|Withdrawal by Subject|60|||
48658192|NCT01498575|156601603|FG001|Overall Sample|Withdrawal by Subject|14|||
48658193|NCT01498575|156601602|FG000|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19|||
48658194|NCT01498575|156601603|FG001|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6|||
48658195|NCT01498575|156601602|FG000|On the Road Driving Assessment (ODA)|Protocol Violation|23|||
48658196|NCT01498575|156601603|FG001|On the Road Driving Assessment (ODA)|Protocol Violation|18|||
48658197|NCT00368836|156601604|FG000|Phase II|Screen Failure|1|||
48658198|NCT00368836|156601604|FG000|Phase II|Withdrawal by Subject|1|||
48658199|NCT00368836|156601604|FG000|Phase II|unable to collect blood and/or breath|17|||
48658200|NCT00368836|156601604|FG000|Phase II|Protocol Violation|2|||
48658201|NCT01345591|156601608|FG000|Overall Study|Lost to Follow-up|1|||
48658202|NCT01165320|156601609|FG000|Overall Study|Clinical adverse experience|2|||
48962830|NCT03655717|157692276|FG015|Overall Study|Withdrawal by Subject|1|||
48658203|NCT01165320|156601610|FG001|Overall Study|Clinical adverse experience|1|||
49015432|NCT01497938|157892192|FG000|Overall Study|Withdrawal by Subject|4|||
48658204|NCT01165320|156601611|FG002|Overall Study|Clinical adverse experience|0|||
48755177|NCT00511667|156949804|FG000|Overall Study|Adverse Event|1|||
48755178|NCT00511667|156949805|FG001|Overall Study|Adverse Event|0|||
48962831|NCT03655717|157692277|FG016|Overall Study|Withdrawal by Subject|0|||
48962832|NCT03655717|157692278|FG017|Overall Study|Withdrawal by Subject|0|||
48962833|NCT03655717|157692279|FG018|Overall Study|Withdrawal by Subject|1|||
48962834|NCT03655717|157692280|FG019|Overall Study|Withdrawal by Subject|0|||
48962835|NCT03655717|157692281|FG020|Overall Study|Withdrawal by Subject|0|||
48755179|NCT00511667|156949804|FG000|Overall Study|Protocol Violation|1|||
48755180|NCT00511667|156949805|FG001|Overall Study|Protocol Violation|1|||
48755181|NCT00511667|156949804|FG000|Overall Study|Withdrawal by Subject|2|||
48755182|NCT00511667|156949805|FG001|Overall Study|Withdrawal by Subject|0|||
48755183|NCT00511667|156949804|FG000|Overall Study|Site terminated|6|||
48755184|NCT00511667|156949805|FG001|Overall Study|Site terminated|1|||
48755185|NCT00511667|156949804|FG000|Overall Study|Other|2|||
48755186|NCT00511667|156949805|FG001|Overall Study|Other|1|||
48755187|NCT00643682|156949806|FG000|Overall Study|did not keep appointment|522|||
48658205|NCT01165320|156601609|FG000|Overall Study|Laboratory adverse experience|1|||
48658206|NCT01165320|156601610|FG001|Overall Study|Laboratory adverse experience|0|||
48658207|NCT01165320|156601611|FG002|Overall Study|Laboratory adverse experience|0|||
48658208|NCT01165320|156601609|FG000|Overall Study|Lack of Efficacy|0|||
48755188|NCT00643682|156949807|FG001|Overall Study|did not keep appointment|509|||
48755189|NCT01165554|156949810|FG000|Overall Study|Withdrawal by Subject|23|||
48755190|NCT00492115|156949811|FG000|Overall Study|Withdrawal by Subject|3|||
48755191|NCT00492115|156949812|FG001|Overall Study|Withdrawal by Subject|4|||
48755192|NCT02200445|156949814|FG000|Overall Study|Lack of Efficacy|1|||
48755193|NCT02200445|156949815|FG001|Overall Study|Lack of Efficacy|2|||
48755194|NCT02200445|156949816|FG002|Overall Study|Lack of Efficacy|2|||
48755195|NCT02200445|156949814|FG000|Overall Study|Adverse Event|0|||
48755196|NCT02200445|156949815|FG001|Overall Study|Adverse Event|2|||
48755197|NCT02200445|156949816|FG002|Overall Study|Adverse Event|0|||
48755198|NCT00323115|156949817|FG000|Vaccine Administration|Adverse Event|1|||
48755199|NCT00323115|156949817|FG000|Adjuvant Therapy & Survival Follow-Up|Death|8|||
48755200|NCT01252940|156949819|FG000|Main Study Phase|Randomized but not treated|4|||
48755201|NCT01252940|156949820|FG001|Main Study Phase|Randomized but not treated|2|||
48755202|NCT01252940|156949819|FG000|Main Study Phase|Adverse Event|3|||
48755203|NCT01252940|156949820|FG001|Main Study Phase|Adverse Event|1|||
48755204|NCT01252940|156949819|FG000|Main Study Phase|Lack of Efficacy|1|||
48755205|NCT01252940|156949820|FG001|Main Study Phase|Lack of Efficacy|0|||
48755206|NCT01252940|156949819|FG000|Main Study Phase|Lost to Follow-up|6|||
48755207|NCT01252940|156949820|FG001|Main Study Phase|Lost to Follow-up|1|||
48755208|NCT01252940|156949819|FG000|Main Study Phase|Physician Decision|1|||
48755209|NCT01252940|156949820|FG001|Main Study Phase|Physician Decision|0|||
48755210|NCT01252940|156949819|FG000|Main Study Phase|Protocol Violation|4|||
48755211|NCT01252940|156949820|FG001|Main Study Phase|Protocol Violation|2|||
48755212|NCT01252940|156949819|FG000|Main Study Phase|Withdrawal by Subject|6|||
48755213|NCT01252940|156949820|FG001|Main Study Phase|Withdrawal by Subject|5|||
48755214|NCT01252940|156949819|FG000|Main Study Phase|Subject Non-compliance|1|||
48658209|NCT01165320|156601610|FG001|Overall Study|Lack of Efficacy|2|||
48658210|NCT01165320|156601611|FG002|Overall Study|Lack of Efficacy|0|||
48755215|NCT01252940|156949820|FG001|Main Study Phase|Subject Non-compliance|1|||
48658211|NCT01165320|156601609|FG000|Overall Study|Reason unknown|0|||
48658212|NCT01165320|156601610|FG001|Overall Study|Reason unknown|1|||
48658213|NCT01165320|156601611|FG002|Overall Study|Reason unknown|0|||
48658214|NCT03515551|156601612|FG000|Overall Study|Death|4|||
48658215|NCT03515551|156601613|FG001|Overall Study|Death|1|||
48658216|NCT03515551|156601614|FG002|Overall Study|Death|2|||
48658217|NCT03515551|156601615|FG003|Overall Study|Death|2|||
48658218|NCT03515551|156601616|FG004|Overall Study|Death|2|||
48658219|NCT03515551|156601617|FG005|Overall Study|Death|4|||
48658220|NCT03515551|156601618|FG006|Overall Study|Death|1|||
48755216|NCT01252940|156949819|FG000|Extension Phase|Adverse Event|2|||
48755217|NCT01252940|156949820|FG001|Extension Phase|Adverse Event|1|||
48755218|NCT01252940|156949819|FG000|Extension Phase|Lack of Efficacy|1|||
48755219|NCT01252940|156949820|FG001|Extension Phase|Lack of Efficacy|0|||
48658221|NCT03515551|156601612|FG000|Overall Study|Lost to Follow-up|0|||
48658222|NCT03515551|156601613|FG001|Overall Study|Lost to Follow-up|0|||
48962836|NCT03655717|157692282|FG021|Overall Study|Withdrawal by Subject|1|||
48658223|NCT03515551|156601614|FG002|Overall Study|Lost to Follow-up|1|||
48658224|NCT03515551|156601615|FG003|Overall Study|Lost to Follow-up|0|||
48962837|NCT03655717|157692283|FG022|Overall Study|Withdrawal by Subject|2|||
48962838|NCT03655717|157692284|FG023|Overall Study|Withdrawal by Subject|1|||
48962839|NCT03655717|157692285|FG024|Overall Study|Withdrawal by Subject|1|||
48962840|NCT03655717|157692286|FG025|Overall Study|Withdrawal by Subject|0|||
48658225|NCT03515551|156601616|FG004|Overall Study|Lost to Follow-up|0|||
48658226|NCT03515551|156601617|FG005|Overall Study|Lost to Follow-up|0|||
48658227|NCT03515551|156601618|FG006|Overall Study|Lost to Follow-up|0|||
48658228|NCT03515551|156601612|FG000|Overall Study|Withdrawal by Subject|0|||
48658229|NCT03515551|156601613|FG001|Overall Study|Withdrawal by Subject|1|||
48658230|NCT03515551|156601614|FG002|Overall Study|Withdrawal by Subject|0|||
48755220|NCT01252940|156949819|FG000|Extension Phase|Lost to Follow-up|5|||
48755221|NCT01252940|156949820|FG001|Extension Phase|Lost to Follow-up|0|||
48962841|NCT03655717|157692261|FG000|Overall Study|Physician Decision|3|||
48658231|NCT03515551|156601615|FG003|Overall Study|Withdrawal by Subject|0|||
48658232|NCT03515551|156601616|FG004|Overall Study|Withdrawal by Subject|0|||
48755222|NCT01252940|156949819|FG000|Extension Phase|Physician Decision|0|||
48962842|NCT03655717|157692262|FG001|Overall Study|Physician Decision|3|||
48755223|NCT01252940|156949820|FG001|Extension Phase|Physician Decision|1|||
48658233|NCT03515551|156601617|FG005|Overall Study|Withdrawal by Subject|0|||
48658234|NCT03515551|156601618|FG006|Overall Study|Withdrawal by Subject|1|||
48658235|NCT03515551|156601612|FG000|Overall Study|Study ended by sponsor|0|||
48658236|NCT03515551|156601613|FG001|Overall Study|Study ended by sponsor|0|||
48658237|NCT03515551|156601614|FG002|Overall Study|Study ended by sponsor|2|||
48658238|NCT03515551|156601615|FG003|Overall Study|Study ended by sponsor|1|||
48658239|NCT03515551|156601616|FG004|Overall Study|Study ended by sponsor|3|||
48658240|NCT03515551|156601617|FG005|Overall Study|Study ended by sponsor|0|||
48658241|NCT03515551|156601618|FG006|Overall Study|Study ended by sponsor|3|||
48658242|NCT03515551|156601612|FG000|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
48658243|NCT03515551|156601613|FG001|Overall Study|Sequential enrollment in 30-100 mcg cohort|1|||
48658244|NCT03515551|156601614|FG002|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
48658245|NCT03515551|156601615|FG003|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
48658246|NCT03515551|156601616|FG004|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
48658247|NCT03515551|156601617|FG005|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
48658248|NCT03515551|156601618|FG006|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
48658249|NCT03305419|156601619|FG000|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
48658250|NCT03305419|156601620|FG001|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1|||
48658251|NCT03305419|156601621|FG002|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
48658252|NCT03305419|156601622|FG003|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
48658253|NCT03305419|156601623|FG004|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
48658254|NCT03305419|156601624|FG005|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
48658255|NCT03305419|156601625|FG006|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
48658256|NCT03305419|156601626|FG007|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
48658257|NCT03305419|156601619|FG000|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1|||
48658258|NCT03305419|156601620|FG001|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
48658259|NCT03305419|156601621|FG002|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
48658260|NCT03305419|156601622|FG003|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
48658261|NCT03305419|156601623|FG004|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
48658262|NCT03305419|156601624|FG005|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
48658263|NCT03305419|156601625|FG006|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
48658264|NCT03305419|156601626|FG007|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
48658265|NCT03305419|156601619|FG000|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1|||
48658266|NCT03305419|156601620|FG001|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
48658267|NCT03305419|156601621|FG002|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
48658268|NCT03305419|156601622|FG003|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
48658269|NCT03305419|156601623|FG004|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
48658270|NCT03305419|156601624|FG005|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
48658271|NCT03305419|156601625|FG006|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
48658272|NCT03305419|156601626|FG007|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
48658273|NCT03305419|156601619|FG000|Part B (14 Days)|Adverse Event|0|||
48658274|NCT03305419|156601620|FG001|Part B (14 Days)|Adverse Event|0|||
48658275|NCT03305419|156601621|FG002|Part B (14 Days)|Adverse Event|0|||
48658276|NCT03305419|156601622|FG003|Part B (14 Days)|Adverse Event|0|||
48658277|NCT03305419|156601623|FG004|Part B (14 Days)|Adverse Event|1|||
48658278|NCT03305419|156601624|FG005|Part B (14 Days)|Adverse Event|2|||
48658279|NCT03305419|156601625|FG006|Part B (14 Days)|Adverse Event|4|||
48658280|NCT03305419|156601626|FG007|Part B (14 Days)|Adverse Event|0|||
48658281|NCT03305419|156601619|FG000|Part B (14 Days)|Physician Decision|0|||
48658282|NCT03305419|156601620|FG001|Part B (14 Days)|Physician Decision|0|||
48658283|NCT03305419|156601621|FG002|Part B (14 Days)|Physician Decision|0|||
48658284|NCT03305419|156601622|FG003|Part B (14 Days)|Physician Decision|0|||
48755224|NCT01252940|156949819|FG000|Extension Phase|Subject Non-compliance|1|||
48866134|NCT02642159|157345659|FG001|Overall Study|Adverse Event|4|||
48866135|NCT02642159|157345658|FG000|Overall Study|Withdrawal by Subject|9|||
48866136|NCT02642159|157345659|FG001|Overall Study|Withdrawal by Subject|1|||
48866137|NCT02642159|157345658|FG000|Overall Study|Poor compliance to study protocol|1|||
48866138|NCT02642159|157345659|FG001|Overall Study|Poor compliance to study protocol|0|||
48866139|NCT02642159|157345658|FG000|Overall Study|Other than specified above|10|||
48866140|NCT02642159|157345659|FG001|Overall Study|Other than specified above|3|||
48866141|NCT02567227|157345660|FG000|9 Weeks|Adverse Event|5|||
48866142|NCT02567227|157345661|FG001|9 Weeks|Adverse Event|5|||
48866143|NCT02567227|157345660|FG000|9 Weeks|Withdrawal by Subject|18|||
48866144|NCT02567227|157345661|FG001|9 Weeks|Withdrawal by Subject|8|||
48866145|NCT02567227|157345660|FG000|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
48866146|NCT02567227|157345661|FG001|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
48866147|NCT02567227|157345660|FG000|6 Month|Death|2|||
48866148|NCT02567227|157345661|FG001|6 Month|Death|0|||
48866149|NCT02567227|157345660|FG000|6 Month|Lost to Follow-up|43|||
48866150|NCT02567227|157345661|FG001|6 Month|Lost to Follow-up|40|||
48658285|NCT03305419|156601623|FG004|Part B (14 Days)|Physician Decision|2|||
48962843|NCT03655717|157692263|FG002|Overall Study|Physician Decision|0|||
48962844|NCT03655717|157692264|FG003|Overall Study|Physician Decision|0|||
48658286|NCT03305419|156601624|FG005|Part B (14 Days)|Physician Decision|8|||
48658287|NCT03305419|156601625|FG006|Part B (14 Days)|Physician Decision|1|||
48658288|NCT03305419|156601626|FG007|Part B (14 Days)|Physician Decision|0|||
48658289|NCT00075946|156601627|FG000|Overall Study|Path ineligible: undetermined histology|0|||
48658290|NCT00075946|156601628|FG001|Overall Study|Path ineligible: undetermined histology|0|||
48658291|NCT00075946|156601629|FG002|Overall Study|Path ineligible: undetermined histology|0|||
48658292|NCT00075946|156601630|FG003|Overall Study|Path ineligible: undetermined histology|0|||
48658293|NCT00075946|156601631|FG004|Overall Study|Path ineligible: undetermined histology|6|||
48658294|NCT00075946|156601627|FG000|Overall Study|Did not achieve response after induction|0|||
48658295|NCT00075946|156601628|FG001|Overall Study|Did not achieve response after induction|0|||
48658296|NCT00075946|156601629|FG002|Overall Study|Did not achieve response after induction|0|||
48658297|NCT00075946|156601630|FG003|Overall Study|Did not achieve response after induction|0|||
48658298|NCT00075946|156601631|FG004|Overall Study|Did not achieve response after induction|182|||
48658299|NCT00075946|156601627|FG000|Overall Study|Incorrectly randomized (no response)|5|||
48658300|NCT00075946|156601628|FG001|Overall Study|Incorrectly randomized (no response)|5|||
48658301|NCT00075946|156601629|FG002|Overall Study|Incorrectly randomized (no response)|5|||
48658302|NCT00075946|156601630|FG003|Overall Study|Incorrectly randomized (no response)|1|||
48658303|NCT00075946|156601631|FG004|Overall Study|Incorrectly randomized (no response)|0|||
48658304|NCT00075946|156601627|FG000|Overall Study|Adverse Event|2|||
48658305|NCT00075946|156601628|FG001|Overall Study|Adverse Event|10|||
48658306|NCT00075946|156601629|FG002|Overall Study|Adverse Event|0|||
48658307|NCT00075946|156601630|FG003|Overall Study|Adverse Event|2|||
48658308|NCT00075946|156601631|FG004|Overall Study|Adverse Event|0|||
48658309|NCT00075946|156601627|FG000|Overall Study|Death|0|||
48658310|NCT00075946|156601628|FG001|Overall Study|Death|1|||
48658311|NCT00075946|156601629|FG002|Overall Study|Death|0|||
48658312|NCT00075946|156601630|FG003|Overall Study|Death|0|||
48962845|NCT03655717|157692265|FG004|Overall Study|Physician Decision|0|||
48962846|NCT03655717|157692266|FG005|Overall Study|Physician Decision|0|||
48962847|NCT03655717|157692267|FG006|Overall Study|Physician Decision|0|||
48962848|NCT03655717|157692268|FG007|Overall Study|Physician Decision|0|||
48962849|NCT03655717|157692269|FG008|Overall Study|Physician Decision|0|||
48962850|NCT03655717|157692270|FG009|Overall Study|Physician Decision|1|||
48962851|NCT03655717|157692271|FG010|Overall Study|Physician Decision|0|||
48962852|NCT03655717|157692272|FG011|Overall Study|Physician Decision|0|||
48962853|NCT03655717|157692273|FG012|Overall Study|Physician Decision|0|||
48962854|NCT03655717|157692274|FG013|Overall Study|Physician Decision|0|||
48962855|NCT03655717|157692275|FG014|Overall Study|Physician Decision|0|||
48962856|NCT03655717|157692276|FG015|Overall Study|Physician Decision|0|||
48962857|NCT03655717|157692277|FG016|Overall Study|Physician Decision|0|||
48962858|NCT03655717|157692278|FG017|Overall Study|Physician Decision|0|||
48962859|NCT03655717|157692279|FG018|Overall Study|Physician Decision|0|||
48962860|NCT03655717|157692280|FG019|Overall Study|Physician Decision|1|||
48962861|NCT03655717|157692281|FG020|Overall Study|Physician Decision|0|||
48962862|NCT03655717|157692282|FG021|Overall Study|Physician Decision|0|||
48962863|NCT03655717|157692283|FG022|Overall Study|Physician Decision|0|||
48962864|NCT03655717|157692284|FG023|Overall Study|Physician Decision|1|||
48962865|NCT03655717|157692285|FG024|Overall Study|Physician Decision|0|||
48962866|NCT03655717|157692286|FG025|Overall Study|Physician Decision|0|||
48658313|NCT00075946|156601631|FG004|Overall Study|Death|0|||
48658314|NCT00075946|156601627|FG000|Overall Study|Withdrawal by Subject|23|||
48658315|NCT00075946|156601628|FG001|Overall Study|Withdrawal by Subject|58|||
48658316|NCT00075946|156601629|FG002|Overall Study|Withdrawal by Subject|4|||
48658317|NCT00075946|156601630|FG003|Overall Study|Withdrawal by Subject|9|||
48658318|NCT00075946|156601631|FG004|Overall Study|Withdrawal by Subject|0|||
48658319|NCT00075946|156601627|FG000|Overall Study|Alternative therapy|16|||
48658320|NCT00075946|156601628|FG001|Overall Study|Alternative therapy|2|||
48658321|NCT00075946|156601629|FG002|Overall Study|Alternative therapy|5|||
48962867|NCT03655717|157692261|FG000|Overall Study|Lost to Follow-up|3|||
48962868|NCT03655717|157692262|FG001|Overall Study|Lost to Follow-up|1|||
48962869|NCT03655717|157692263|FG002|Overall Study|Lost to Follow-up|0|||
48962870|NCT03655717|157692264|FG003|Overall Study|Lost to Follow-up|1|||
48962871|NCT03655717|157692265|FG004|Overall Study|Lost to Follow-up|0|||
48658322|NCT00075946|156601630|FG003|Overall Study|Alternative therapy|0|||
48658323|NCT00075946|156601631|FG004|Overall Study|Alternative therapy|0|||
48658324|NCT00075946|156601627|FG000|Overall Study|Other complicating disease|7|||
48658325|NCT00075946|156601628|FG001|Overall Study|Other complicating disease|13|||
48962872|NCT03655717|157692266|FG005|Overall Study|Lost to Follow-up|1|||
49015433|NCT01497938|157892193|FG001|Overall Study|Withdrawal by Subject|0|||
48658326|NCT00075946|156601629|FG002|Overall Study|Other complicating disease|1|||
48658327|NCT00075946|156601630|FG003|Overall Study|Other complicating disease|4|||
48962873|NCT03655717|157692267|FG006|Overall Study|Lost to Follow-up|0|||
48962874|NCT03655717|157692268|FG007|Overall Study|Lost to Follow-up|0|||
48962875|NCT03655717|157692269|FG008|Overall Study|Lost to Follow-up|0|||
48658328|NCT00075946|156601631|FG004|Overall Study|Other complicating disease|0|||
48658329|NCT00075946|156601627|FG000|Overall Study|No response to retreatment|23|||
48658330|NCT00075946|156601628|FG001|Overall Study|No response to retreatment|0|||
48658331|NCT00075946|156601629|FG002|Overall Study|No response to retreatment|2|||
48658332|NCT00075946|156601630|FG003|Overall Study|No response to retreatment|0|||
48658333|NCT00075946|156601631|FG004|Overall Study|No response to retreatment|0|||
48658334|NCT00075946|156601627|FG000|Overall Study|Time to progression less than 6 months|15|||
48658335|NCT00075946|156601628|FG001|Overall Study|Time to progression less than 6 months|30|||
48658336|NCT00075946|156601629|FG002|Overall Study|Time to progression less than 6 months|8|||
48658337|NCT00075946|156601630|FG003|Overall Study|Time to progression less than 6 months|3|||
48658338|NCT00075946|156601631|FG004|Overall Study|Time to progression less than 6 months|0|||
48658339|NCT00075946|156601627|FG000|Overall Study|Other|57|||
48658340|NCT00075946|156601628|FG001|Overall Study|Other|32|||
48658341|NCT00075946|156601629|FG002|Overall Study|Other|3|||
48658342|NCT00075946|156601630|FG003|Overall Study|Other|11|||
48658343|NCT00075946|156601631|FG004|Overall Study|Other|0|||
48658344|NCT01923363|156601632|FG000|Overall Study|Protocol Violation|1|||
48658345|NCT00521599|156601633|FG000|Overall Study|Adverse Event|5|||
48658346|NCT00521599|156601634|FG001|Overall Study|Adverse Event|7|||
48658347|NCT00521599|156601635|FG002|Overall Study|Adverse Event|6|||
48658348|NCT00521599|156601633|FG000|Overall Study|Treatment Failure|8|||
48658349|NCT00521599|156601634|FG001|Overall Study|Treatment Failure|9|||
48658350|NCT00521599|156601635|FG002|Overall Study|Treatment Failure|22|||
48658351|NCT00521599|156601633|FG000|Overall Study|Lost to Follow-up|2|||
48658352|NCT00521599|156601634|FG001|Overall Study|Lost to Follow-up|1|||
48658353|NCT00521599|156601635|FG002|Overall Study|Lost to Follow-up|2|||
48658354|NCT00521599|156601633|FG000|Overall Study|Withdrawal by Subject|3|||
48658355|NCT00521599|156601634|FG001|Overall Study|Withdrawal by Subject|5|||
48658356|NCT00521599|156601635|FG002|Overall Study|Withdrawal by Subject|1|||
48658357|NCT00521599|156601633|FG000|Overall Study|Withdrawal by subject treatment related|3|||
48658358|NCT00521599|156601634|FG001|Overall Study|Withdrawal by subject treatment related|1|||
48658359|NCT00521599|156601635|FG002|Overall Study|Withdrawal by subject treatment related|2|||
48658360|NCT00521599|156601633|FG000|Overall Study|Protocol Violation|2|||
48658361|NCT00521599|156601634|FG001|Overall Study|Protocol Violation|4|||
48658362|NCT00521599|156601635|FG002|Overall Study|Protocol Violation|2|||
48658363|NCT00521599|156601633|FG000|Overall Study|Did not meet protocol eligibility|2|||
48658364|NCT00521599|156601634|FG001|Overall Study|Did not meet protocol eligibility|2|||
48658365|NCT00521599|156601635|FG002|Overall Study|Did not meet protocol eligibility|1|||
48658366|NCT02359045|156601639|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
48658367|NCT02359045|156601640|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
48658368|NCT02359045|156601639|FG000|Overall Study|Lost to Follow-up|1|||
48658369|NCT02359045|156601640|FG001|Overall Study|Lost to Follow-up|1|||
48658370|NCT02359045|156601639|FG000|Overall Study|Adverse Event|0|||
48658371|NCT02359045|156601640|FG001|Overall Study|Adverse Event|1|||
48658372|NCT05704543|156601642|FG000|Overall Study|Withdrawal by Subject|1|||
48658373|NCT05704543|156601643|FG001|Overall Study|Withdrawal by Subject|1|||
48658374|NCT05704543|156601644|FG002|Overall Study|Withdrawal by Subject|0|||
48658375|NCT05704543|156601645|FG003|Overall Study|Withdrawal by Subject|2|||
48658376|NCT05704543|156601642|FG000|Overall Study|Lost to Follow-up|1|||
48658377|NCT05704543|156601643|FG001|Overall Study|Lost to Follow-up|2|||
48658378|NCT05704543|156601644|FG002|Overall Study|Lost to Follow-up|0|||
48658379|NCT05704543|156601645|FG003|Overall Study|Lost to Follow-up|0|||
48658380|NCT02780856|156601648|FG000|Overall Study|Lost to Follow-up|1|||
48658381|NCT04239222|156601649|FG000|Baseline|Withdrawal by Subject|0|||
48658382|NCT04239222|156601650|FG001|Baseline|Withdrawal by Subject|0|||
48658383|NCT04239222|156601651|FG002|Baseline|Withdrawal by Subject|1|||
48658384|NCT04239222|156601652|FG003|Baseline|Withdrawal by Subject|1|||
48658385|NCT04239222|156601649|FG000|First Foot Assignment|Withdrawal by Subject|0|||
48658386|NCT04239222|156601650|FG001|First Foot Assignment|Withdrawal by Subject|0|||
48658387|NCT04239222|156601651|FG002|First Foot Assignment|Withdrawal by Subject|1|||
48658388|NCT04239222|156601652|FG003|First Foot Assignment|Withdrawal by Subject|0|||
48658389|NCT04239222|156601649|FG000|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
48658390|NCT04239222|156601650|FG001|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
48658391|NCT04239222|156601651|FG002|Crossover to Alternate Foot Assignment|Protocol Violation|1|||
48658392|NCT04239222|156601652|FG003|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
48658393|NCT05232864|156601655|FG000|Overall Study|Adverse Event|0|||
48658394|NCT05232864|156601656|FG001|Overall Study|Adverse Event|1|||
48658395|NCT05232864|156601655|FG000|Overall Study|Study terminated by sponsor|16|||
48658396|NCT05232864|156601656|FG001|Overall Study|Study terminated by sponsor|14|||
48658397|NCT05032690|156601658|FG000|Period 1|Adverse Event|0|||
48658398|NCT05032690|156601659|FG001|Period 1|Adverse Event|1|||
48658399|NCT05032690|156601660|FG002|Period 1|Adverse Event|0|||
48658400|NCT05032690|156601661|FG003|Period 1|Adverse Event|0|||
48658401|NCT05032690|156601658|FG000|Period 1|Withdrawal by Subject|1|||
48658402|NCT05032690|156601659|FG001|Period 1|Withdrawal by Subject|0|||
48658403|NCT05032690|156601660|FG002|Period 1|Withdrawal by Subject|0|||
48658404|NCT05032690|156601661|FG003|Period 1|Withdrawal by Subject|0|||
48658405|NCT05032690|156601658|FG000|Period 1|No longer meets eligibility criteria|0|||
48658406|NCT05032690|156601659|FG001|Period 1|No longer meets eligibility criteria|1|||
48658407|NCT05032690|156601660|FG002|Period 1|No longer meets eligibility criteria|0|||
48658408|NCT05032690|156601661|FG003|Period 1|No longer meets eligibility criteria|0|||
48658409|NCT05032690|156601658|FG000|Period 2|Adverse Event|1|||
48658410|NCT05032690|156601659|FG001|Period 2|Adverse Event|0|||
48658411|NCT05032690|156601660|FG002|Period 2|Adverse Event|0|||
48658412|NCT05032690|156601661|FG003|Period 2|Adverse Event|0|||
48658413|NCT05032690|156601658|FG000|Period 2|Withdrawal by Subject|0|||
48658414|NCT05032690|156601659|FG001|Period 2|Withdrawal by Subject|1|||
48658415|NCT05032690|156601660|FG002|Period 2|Withdrawal by Subject|0|||
48658416|NCT05032690|156601661|FG003|Period 2|Withdrawal by Subject|0|||
48658417|NCT05032690|156601658|FG000|Period 2|No longer meets eligibility criteria|0|||
48658418|NCT05032690|156601659|FG001|Period 2|No longer meets eligibility criteria|1|||
48658419|NCT05032690|156601660|FG002|Period 2|No longer meets eligibility criteria|0|||
48658420|NCT05032690|156601661|FG003|Period 2|No longer meets eligibility criteria|0|||
48658421|NCT05032690|156601658|FG000|Period 3|Adverse Event|0|||
48658422|NCT05032690|156601659|FG001|Period 3|Adverse Event|1|||
48658423|NCT05032690|156601660|FG002|Period 3|Adverse Event|0|||
48658424|NCT05032690|156601661|FG003|Period 3|Adverse Event|0|||
48658425|NCT00951080|156601664|FG000|Overall Study|Adverse Event|3|||
48658426|NCT00951080|156601665|FG001|Overall Study|Adverse Event|3|||
48658427|NCT00951080|156601664|FG000|Overall Study|Lost to Follow-up|0|||
48658428|NCT00951080|156601665|FG001|Overall Study|Lost to Follow-up|1|||
48658429|NCT00951080|156601664|FG000|Overall Study|Physician Decision|4|||
48658430|NCT00951080|156601665|FG001|Overall Study|Physician Decision|1|||
48658431|NCT00951080|156601664|FG000|Overall Study|Other|19|||
48658432|NCT00951080|156601665|FG001|Overall Study|Other|22|||
48658433|NCT01960998|156601666|FG000|Overall Study|Lost to Follow-up|3|||
48658434|NCT01960998|156601667|FG001|Overall Study|Lost to Follow-up|7|||
48658435|NCT01960998|156601666|FG000|Overall Study|Death|0|||
48658436|NCT01960998|156601667|FG001|Overall Study|Death|1|||
48658437|NCT01960998|156601666|FG000|Overall Study|Withdrawal by Subject|8|||
48658438|NCT01960998|156601667|FG001|Overall Study|Withdrawal by Subject|2|||
48755225|NCT01252940|156949820|FG001|Extension Phase|Subject Non-compliance|0|||
48755226|NCT01252940|156949819|FG000|Extension Phase|Withdrawal by Subject|1|||
48755227|NCT01252940|156949820|FG001|Extension Phase|Withdrawal by Subject|1|||
48755228|NCT01943292|156951199|FG000|Overall Study|Withdrawal by Subject|1|||
48755229|NCT01943292|156951200|FG001|Overall Study|Withdrawal by Subject|0|||
48755230|NCT01943292|156951201|FG002|Overall Study|Withdrawal by Subject|0|||
48755231|NCT00996216|156951202|FG000|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1|||
48962876|NCT03655717|157692270|FG009|Overall Study|Lost to Follow-up|0|||
48962877|NCT03655717|157692271|FG010|Overall Study|Lost to Follow-up|0|||
48962878|NCT03655717|157692272|FG011|Overall Study|Lost to Follow-up|1|||
48962879|NCT03655717|157692273|FG012|Overall Study|Lost to Follow-up|0|||
48962880|NCT03655717|157692274|FG013|Overall Study|Lost to Follow-up|0|||
48962881|NCT03655717|157692275|FG014|Overall Study|Lost to Follow-up|0|||
48962882|NCT03655717|157692276|FG015|Overall Study|Lost to Follow-up|0|||
48962883|NCT03655717|157692277|FG016|Overall Study|Lost to Follow-up|0|||
48962884|NCT03655717|157692278|FG017|Overall Study|Lost to Follow-up|0|||
48962885|NCT03655717|157692279|FG018|Overall Study|Lost to Follow-up|0|||
48962886|NCT03655717|157692280|FG019|Overall Study|Lost to Follow-up|0|||
48962887|NCT03655717|157692281|FG020|Overall Study|Lost to Follow-up|0|||
48962888|NCT03655717|157692282|FG021|Overall Study|Lost to Follow-up|0|||
48962889|NCT03655717|157692283|FG022|Overall Study|Lost to Follow-up|0|||
48962890|NCT03655717|157692284|FG023|Overall Study|Lost to Follow-up|0|||
48962891|NCT03655717|157692285|FG024|Overall Study|Lost to Follow-up|0|||
48962892|NCT03655717|157692286|FG025|Overall Study|Lost to Follow-up|0|||
48962893|NCT02365584|157692287|FG000|Overall Study|Adverse Event|2|||
48962894|NCT02365584|157692288|FG001|Overall Study|Adverse Event|2|||
48962895|NCT02365584|157692287|FG000|Overall Study|Withdrawal by Subject|1|||
48962896|NCT02365584|157692288|FG001|Overall Study|Withdrawal by Subject|0|||
48962897|NCT02365584|157692287|FG000|Overall Study|Disease Progression|9|||
48658439|NCT01960998|156601666|FG000|Overall Study|lost computer access|0|||
48658440|NCT01960998|156601667|FG001|Overall Study|lost computer access|1|||
48658441|NCT00759356|156601668|FG000|Overall Study|Adverse Event|0|||
48658442|NCT00759356|156601669|FG001|Overall Study|Adverse Event|1|||
48658443|NCT00759356|156601668|FG000|Overall Study|Withdrawal by Subject|0|||
48755232|NCT00996216|156951202|FG000|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3|||
48755233|NCT00996216|156951202|FG000|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1|||
48962898|NCT02365584|157692288|FG001|Overall Study|Disease Progression|12|||
48658444|NCT00759356|156601669|FG001|Overall Study|Withdrawal by Subject|2|||
48962899|NCT00302718|157692289|FG000|Overall Study|Participant left the hospital|1|||
48658445|NCT00759356|156601668|FG000|Overall Study|Subject was unable to return|1|||
48962900|NCT00302718|157692290|FG001|Overall Study|Participant left the hospital|0|||
48962901|NCT00302718|157692291|FG002|Overall Study|Participant left the hospital|0|||
48962902|NCT00302718|157692292|FG003|Overall Study|Participant left the hospital|1|||
48962903|NCT00302718|157692289|FG000|Overall Study|Withdrawal by Subject|0|||
48658446|NCT00759356|156601669|FG001|Overall Study|Subject was unable to return|0|||
48658447|NCT01713283|156601673|FG000|Overall Study|Lack of Efficacy|10|||
48658448|NCT01713283|156601674|FG001|Overall Study|Lack of Efficacy|2|||
48658449|NCT01713283|156601673|FG000|Overall Study|Lost to Follow-up|1|||
48658450|NCT01713283|156601674|FG001|Overall Study|Lost to Follow-up|1|||
48658451|NCT02585830|156601675|FG000|Overall Study|Withdrawal by Subject|3|||
48658452|NCT00585221|156601676|FG000|Overall Study|Protocol Violation|8|||
48658453|NCT02509052|156601677|FG000|Overall Study|Non compliance|0|||
48658454|NCT02509052|156601678|FG001|Overall Study|Non compliance|0|||
48658455|NCT02509052|156601679|FG002|Overall Study|Non compliance|1|||
48658456|NCT00835640|156601680|FG000|Second Intervention|Protocol Violation|1|||
48658457|NCT00835640|156601681|FG001|Second Intervention|Protocol Violation|0|||
48658458|NCT00350272|156601682|FG000|Blinded 12-Week Treatment|Adverse Event|1|||
48658459|NCT00350272|156601683|FG001|Blinded 12-Week Treatment|Adverse Event|0|||
48658460|NCT00350272|156601682|FG000|Blinded 12-Week Treatment|Death|1|||
48658461|NCT00350272|156601683|FG001|Blinded 12-Week Treatment|Death|0|||
48658462|NCT00350272|156601682|FG000|Blinded 12-Week Treatment|Lost to Follow-up|2|||
48658463|NCT00350272|156601683|FG001|Blinded 12-Week Treatment|Lost to Follow-up|0|||
48658464|NCT00350272|156601682|FG000|Blinded 12-Week Treatment|Withdrawal by Subject|3|||
48658465|NCT00350272|156601683|FG001|Blinded 12-Week Treatment|Withdrawal by Subject|0|||
48658466|NCT00350272|156601682|FG000|Blinded 12-Week Treatment|Physician Decision|2|||
48658467|NCT00350272|156601683|FG001|Blinded 12-Week Treatment|Physician Decision|1|||
48658468|NCT00350272|156601682|FG000|Blinded 12-Week Treatment|Sponsor decision|0|||
48658469|NCT00350272|156601683|FG001|Blinded 12-Week Treatment|Sponsor decision|1|||
48658470|NCT00350272|156601682|FG000|Open-Label 84 Week Treatment|Adverse Event|2|||
48658471|NCT00350272|156601683|FG001|Open-Label 84 Week Treatment|Adverse Event|1|||
48658472|NCT00350272|156601682|FG000|Open-Label 84 Week Treatment|Lost to Follow-up|3|||
48658473|NCT00350272|156601683|FG001|Open-Label 84 Week Treatment|Lost to Follow-up|2|||
48658474|NCT00350272|156601682|FG000|Open-Label 84 Week Treatment|Withdrawal by Subject|1|||
48658475|NCT00350272|156601683|FG001|Open-Label 84 Week Treatment|Withdrawal by Subject|2|||
48658476|NCT00350272|156601682|FG000|Open-Label 84 Week Treatment|Physician Decision|1|||
48658477|NCT00350272|156601683|FG001|Open-Label 84 Week Treatment|Physician Decision|2|||
48658478|NCT00350272|156601682|FG000|Open-Label 84 Week Treatment|Sponsor decision|2|||
48866151|NCT02567227|157345660|FG000|12 Months|Lost to Follow-up|31|||
48658479|NCT00350272|156601683|FG001|Open-Label 84 Week Treatment|Sponsor decision|1|||
48658480|NCT03349645|156601684|FG000|Overall Study|Sponsor Terminated Study|75|||
48658481|NCT03349645|156601684|FG000|Overall Study|Withdrawal by Subject|4|||
48658482|NCT03349645|156601684|FG000|Overall Study|Protocol Violation|1|||
48658483|NCT03349645|156601684|FG000|Overall Study|Other|2|||
48658484|NCT01939002|156601695|FG000|Overall Study|Adverse Event|13|||
48658485|NCT01939002|156601696|FG001|Overall Study|Adverse Event|13|||
48658486|NCT01939002|156601695|FG000|Overall Study|Withdrawal by Subject|5|||
48658487|NCT01939002|156601696|FG001|Overall Study|Withdrawal by Subject|3|||
48658488|NCT01939002|156601695|FG000|Overall Study|Other|1|||
48658489|NCT01939002|156601696|FG001|Overall Study|Other|2|||
48866152|NCT02567227|157345661|FG001|12 Months|Lost to Follow-up|32|||
48866153|NCT02567227|157345660|FG000|12 Months|Death|0|||
48866154|NCT02567227|157345661|FG001|12 Months|Death|2|||
48866155|NCT01732627|157345662|FG000|Overall Study|Withdrawal by Subject|1|||
48866156|NCT01732627|157345663|FG001|Overall Study|Withdrawal by Subject|0|||
48866157|NCT02131155|157345665|FG000|Overall Study|Adverse Event|1|||
48866158|NCT02131155|157345666|FG001|Overall Study|Adverse Event|0|||
48866159|NCT02131155|157345665|FG000|Overall Study|Treatment completed|1|||
48866160|NCT02131155|157345666|FG001|Overall Study|Treatment completed|0|||
48866161|NCT02131155|157345665|FG000|Overall Study|Primary tumour recurrence|2|||
48866162|NCT02131155|157345666|FG001|Overall Study|Primary tumour recurrence|1|||
48866163|NCT02131155|157345665|FG000|Overall Study|Refused to continue study medication|1|||
48866164|NCT02131155|157345666|FG001|Overall Study|Refused to continue study medication|0|||
48866165|NCT02131155|157345665|FG000|Overall Study|Study early termination|20|||
48866166|NCT02131155|157345666|FG001|Overall Study|Study early termination|10|||
48866167|NCT01887418|157345667|FG000|Overall Study|Travelling difficulties|0|||
48866168|NCT01887418|157345668|FG001|Overall Study|Travelling difficulties|0|||
48866169|NCT01887418|157345669|FG002|Overall Study|Travelling difficulties|1|||
48658490|NCT01133405|156601697|FG000|Period 1|Withdrawal by Subject|0|||
48658491|NCT01133405|156601698|FG001|Period 1|Withdrawal by Subject|1|||
48658492|NCT01133405|156601699|FG002|Period 1|Withdrawal by Subject|0|||
48658493|NCT01133405|156601700|FG003|Period 1|Withdrawal by Subject|1|||
48658494|NCT01133405|156601701|FG004|Period 1|Withdrawal by Subject|0|||
48658495|NCT01133405|156601702|FG005|Period 1|Withdrawal by Subject|1|||
48658496|NCT01133405|156601703|FG006|Period 1|Withdrawal by Subject|0|||
48866170|NCT00084747|157345670|FG000|Overall Study|Relapsed|8|||
48866171|NCT00084747|157345670|FG000|Overall Study|Death|3|||
48866172|NCT00084747|157345670|FG000|Overall Study|Withdrawal by Subject|2|||
48866173|NCT02382406|157345671|FG000|Study Treatment|Disease Progression|8|||
48866174|NCT02382406|157345672|FG001|Study Treatment|Disease Progression|0|||
48658497|NCT01133405|156601704|FG007|Period 1|Withdrawal by Subject|0|||
48658498|NCT01133405|156601705|FG008|Period 1|Withdrawal by Subject|0|||
48658499|NCT01133405|156601706|FG009|Period 1|Withdrawal by Subject|0|||
48658500|NCT01133405|156601697|FG000|Period 1|Physician Decision|0|||
48658501|NCT01133405|156601698|FG001|Period 1|Physician Decision|0|||
48658502|NCT01133405|156601699|FG002|Period 1|Physician Decision|0|||
48658503|NCT01133405|156601700|FG003|Period 1|Physician Decision|1|||
48658504|NCT01133405|156601701|FG004|Period 1|Physician Decision|0|||
48658505|NCT01133405|156601702|FG005|Period 1|Physician Decision|0|||
48658506|NCT01133405|156601703|FG006|Period 1|Physician Decision|0|||
48658507|NCT01133405|156601704|FG007|Period 1|Physician Decision|0|||
48658508|NCT01133405|156601705|FG008|Period 1|Physician Decision|0|||
48658509|NCT01133405|156601706|FG009|Period 1|Physician Decision|0|||
48658510|NCT01133405|156601697|FG000|Period 1|Discontinued after randomization|1|||
48755234|NCT00842712|156951203|FG000|Safety Run-in Part|Adverse Event|0|||
48755235|NCT00842712|156951204|FG001|Safety Run-in Part|Adverse Event|1|||
48755236|NCT00842712|156951205|FG002|Safety Run-in Part|Adverse Event|0|||
48755237|NCT00842712|156951206|FG003|Safety Run-in Part|Adverse Event|0|||
48755238|NCT00842712|156951207|FG004|Safety Run-in Part|Adverse Event|0|||
48755239|NCT00842712|156951208|FG005|Safety Run-in Part|Adverse Event|0|||
48755240|NCT00842712|156951209|FG006|Safety Run-in Part|Adverse Event|0|||
48755241|NCT00842712|156951203|FG000|Safety Run-in Part|Progressive disease|3|||
48755242|NCT00842712|156951204|FG001|Safety Run-in Part|Progressive disease|1|||
48755243|NCT00842712|156951205|FG002|Safety Run-in Part|Progressive disease|0|||
48755244|NCT00842712|156951206|FG003|Safety Run-in Part|Progressive disease|1|||
48755245|NCT00842712|156951207|FG004|Safety Run-in Part|Progressive disease|0|||
48755246|NCT00842712|156951208|FG005|Safety Run-in Part|Progressive disease|0|||
48755247|NCT00842712|156951209|FG006|Safety Run-in Part|Progressive disease|0|||
48755248|NCT00842712|156951203|FG000|Randomized Part|Randomized but not treated|0|||
48755249|NCT00842712|156951204|FG001|Randomized Part|Randomized but not treated|0|||
48755250|NCT00842712|156951205|FG002|Randomized Part|Randomized but not treated|0|||
48755251|NCT00842712|156951206|FG003|Randomized Part|Randomized but not treated|0|||
48755252|NCT00842712|156951207|FG004|Randomized Part|Randomized but not treated|0|||
48755253|NCT00842712|156951208|FG005|Randomized Part|Randomized but not treated|1|||
48755254|NCT00842712|156951209|FG006|Randomized Part|Randomized but not treated|4|||
48755255|NCT00842712|156951203|FG000|Randomized Part|Ongoing at cut-off date|0|||
48755256|NCT00842712|156951204|FG001|Randomized Part|Ongoing at cut-off date|0|||
48755257|NCT00842712|156951205|FG002|Randomized Part|Ongoing at cut-off date|0|||
48755258|NCT00842712|156951206|FG003|Randomized Part|Ongoing at cut-off date|0|||
48755259|NCT00842712|156951207|FG004|Randomized Part|Ongoing at cut-off date|0|||
48658511|NCT01133405|156601698|FG001|Period 1|Discontinued after randomization|0|||
48658512|NCT01133405|156601699|FG002|Period 1|Discontinued after randomization|0|||
48658513|NCT01133405|156601700|FG003|Period 1|Discontinued after randomization|0|||
48658514|NCT01133405|156601701|FG004|Period 1|Discontinued after randomization|0|||
48658515|NCT01133405|156601702|FG005|Period 1|Discontinued after randomization|0|||
48658516|NCT01133405|156601703|FG006|Period 1|Discontinued after randomization|1|||
48658517|NCT01133405|156601704|FG007|Period 1|Discontinued after randomization|0|||
48658518|NCT01133405|156601705|FG008|Period 1|Discontinued after randomization|0|||
48658519|NCT01133405|156601706|FG009|Period 1|Discontinued after randomization|0|||
48658520|NCT01133405|156601697|FG000|Period 1|Received drug only in period 2|0|||
48658521|NCT01133405|156601698|FG001|Period 1|Received drug only in period 2|1|||
48658522|NCT01133405|156601699|FG002|Period 1|Received drug only in period 2|0|||
48658523|NCT01133405|156601700|FG003|Period 1|Received drug only in period 2|2|||
48658524|NCT01133405|156601701|FG004|Period 1|Received drug only in period 2|0|||
48755260|NCT00842712|156951208|FG005|Randomized Part|Ongoing at cut-off date|0|||
48755261|NCT00842712|156951209|FG006|Randomized Part|Ongoing at cut-off date|2|||
48755262|NCT04492618|156951214|FG000|Overall Study|Withdrawal by Subject|1|||
48755263|NCT02664441|156951215|FG000|Randomization|Withdrawal by Subject|0|||
48755264|NCT02664441|156951216|FG001|Randomization|Withdrawal by Subject|1|||
48755265|NCT02664441|156951215|FG000|36-week Randomized Trial|Adverse Event|2|||
48755266|NCT02664441|156951216|FG001|36-week Randomized Trial|Adverse Event|0|||
48755267|NCT02664441|156951215|FG000|36-week Randomized Trial|Lost to Follow-up|1|||
48755268|NCT02664441|156951216|FG001|36-week Randomized Trial|Lost to Follow-up|0|||
48866175|NCT02382406|157345673|FG002|Study Treatment|Disease Progression|20|||
48866176|NCT02382406|157345671|FG000|Study Treatment|AE/ Side Effects/ Complications|4|||
48866177|NCT02382406|157345672|FG001|Study Treatment|AE/ Side Effects/ Complications|0|||
48866178|NCT02382406|157345673|FG002|Study Treatment|AE/ Side Effects/ Complications|6|||
48866179|NCT02382406|157345671|FG000|Study Treatment|Patient withdrawal after therapy start|1|||
48866180|NCT02382406|157345672|FG001|Study Treatment|Patient withdrawal after therapy start|0|||
48658525|NCT01133405|156601702|FG005|Period 1|Received drug only in period 2|1|||
48658526|NCT01133405|156601703|FG006|Period 1|Received drug only in period 2|0|||
48658527|NCT01133405|156601704|FG007|Period 1|Received drug only in period 2|0|||
48755269|NCT02664441|156951215|FG000|36-week Randomized Trial|Withdrawal by Subject|0|||
48755270|NCT02664441|156951216|FG001|36-week Randomized Trial|Withdrawal by Subject|3|||
48755271|NCT02664441|156951215|FG000|18-week Open Label Extension|Adverse Event|1|||
48755272|NCT02664441|156951216|FG001|18-week Open Label Extension|Adverse Event|0|||
48755273|NCT02664441|156951215|FG000|18-week Open Label Extension|Physician Decision|1|||
48658528|NCT01133405|156601705|FG008|Period 1|Received drug only in period 2|0|||
48658529|NCT01133405|156601706|FG009|Period 1|Received drug only in period 2|0|||
48658530|NCT01133405|156601697|FG000|Period 1|Received drug only in period 3|0|||
48658531|NCT01133405|156601698|FG001|Period 1|Received drug only in period 3|1|||
48658532|NCT01133405|156601699|FG002|Period 1|Received drug only in period 3|1|||
48658533|NCT01133405|156601700|FG003|Period 1|Received drug only in period 3|0|||
48658534|NCT01133405|156601701|FG004|Period 1|Received drug only in period 3|0|||
48658535|NCT01133405|156601702|FG005|Period 1|Received drug only in period 3|0|||
48658536|NCT01133405|156601703|FG006|Period 1|Received drug only in period 3|0|||
48658537|NCT01133405|156601704|FG007|Period 1|Received drug only in period 3|0|||
48658538|NCT01133405|156601705|FG008|Period 1|Received drug only in period 3|0|||
48658539|NCT01133405|156601706|FG009|Period 1|Received drug only in period 3|0|||
48755274|NCT02664441|156951216|FG001|18-week Open Label Extension|Physician Decision|0|||
48755275|NCT02664441|156951215|FG000|18-week Open Label Extension|Death|1|||
48755276|NCT02664441|156951216|FG001|18-week Open Label Extension|Death|0|||
48755277|NCT02664441|156951215|FG000|18-week Open Label Extension|Lost to Follow-up|0|||
48755278|NCT02664441|156951216|FG001|18-week Open Label Extension|Lost to Follow-up|1|||
48755279|NCT01413191|156951217|FG000|Overall Study|Lost to Follow-up|5|||
48755280|NCT01413191|156951217|FG000|Overall Study|Disease Progression|5|||
48755281|NCT01413191|156951217|FG000|Overall Study|Death|1|||
48755282|NCT03654651|156951218|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
48658540|NCT01133405|156601697|FG000|Period 2|Adverse Event|0|||
48658541|NCT01133405|156601698|FG001|Period 2|Adverse Event|0|||
48658542|NCT01133405|156601699|FG002|Period 2|Adverse Event|1|||
48658543|NCT01133405|156601700|FG003|Period 2|Adverse Event|0|||
48658544|NCT01133405|156601701|FG004|Period 2|Adverse Event|0|||
48658545|NCT01133405|156601702|FG005|Period 2|Adverse Event|0|||
48658546|NCT01133405|156601703|FG006|Period 2|Adverse Event|0|||
48658547|NCT01133405|156601704|FG007|Period 2|Adverse Event|0|||
48658548|NCT01133405|156601705|FG008|Period 2|Adverse Event|0|||
48755283|NCT03654651|156951219|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
48755284|NCT03045328|156951220|FG000|Overall Study|Withdrawal by Subject|2|||
48658549|NCT01133405|156601706|FG009|Period 2|Adverse Event|0|||
48658550|NCT01133405|156601697|FG000|Period 2|Withdrawal by Subject|0|||
48658551|NCT01133405|156601698|FG001|Period 2|Withdrawal by Subject|0|||
48658552|NCT01133405|156601699|FG002|Period 2|Withdrawal by Subject|0|||
48658553|NCT01133405|156601700|FG003|Period 2|Withdrawal by Subject|1|||
48658554|NCT01133405|156601701|FG004|Period 2|Withdrawal by Subject|0|||
48658555|NCT01133405|156601702|FG005|Period 2|Withdrawal by Subject|1|||
48658556|NCT01133405|156601703|FG006|Period 2|Withdrawal by Subject|0|||
48658557|NCT01133405|156601704|FG007|Period 2|Withdrawal by Subject|0|||
48658558|NCT01133405|156601705|FG008|Period 2|Withdrawal by Subject|0|||
48658559|NCT01133405|156601706|FG009|Period 2|Withdrawal by Subject|0|||
48658560|NCT01133405|156601697|FG000|Period 2|Entry Criteria Not Met|0|||
48658561|NCT01133405|156601698|FG001|Period 2|Entry Criteria Not Met|1|||
48658562|NCT01133405|156601699|FG002|Period 2|Entry Criteria Not Met|0|||
48658563|NCT01133405|156601700|FG003|Period 2|Entry Criteria Not Met|0|||
48658564|NCT01133405|156601701|FG004|Period 2|Entry Criteria Not Met|0|||
48658565|NCT01133405|156601702|FG005|Period 2|Entry Criteria Not Met|0|||
48658566|NCT01133405|156601703|FG006|Period 2|Entry Criteria Not Met|0|||
48658567|NCT01133405|156601704|FG007|Period 2|Entry Criteria Not Met|0|||
48658568|NCT01133405|156601705|FG008|Period 2|Entry Criteria Not Met|0|||
48658569|NCT01133405|156601706|FG009|Period 2|Entry Criteria Not Met|0|||
48658570|NCT01133405|156601697|FG000|Period 2|Physician Decision|0|||
48658571|NCT01133405|156601698|FG001|Period 2|Physician Decision|0|||
48658572|NCT01133405|156601699|FG002|Period 2|Physician Decision|0|||
48658573|NCT01133405|156601700|FG003|Period 2|Physician Decision|0|||
48755285|NCT00715078|156951223|FG000|Overall Study|Death|29|||
48755286|NCT00715078|156951224|FG001|Overall Study|Death|36|||
48962904|NCT00302718|157692290|FG001|Overall Study|Withdrawal by Subject|1|||
48962905|NCT00302718|157692291|FG002|Overall Study|Withdrawal by Subject|0|||
48962906|NCT00302718|157692292|FG003|Overall Study|Withdrawal by Subject|0|||
48658574|NCT01133405|156601701|FG004|Period 2|Physician Decision|0|||
48658575|NCT01133405|156601702|FG005|Period 2|Physician Decision|1|||
48755287|NCT00715078|156951225|FG002|Overall Study|Death|36|||
48755288|NCT00715078|156951223|FG000|Overall Study|Withdrawal by Subject|1|||
49015434|NCT01497938|157892192|FG000|Overall Study|Device Violation|1|||
48658576|NCT01133405|156601703|FG006|Period 2|Physician Decision|0|||
48658577|NCT01133405|156601704|FG007|Period 2|Physician Decision|0|||
48658578|NCT01133405|156601705|FG008|Period 2|Physician Decision|0|||
48658579|NCT01133405|156601706|FG009|Period 2|Physician Decision|0|||
48658580|NCT01865812|156601710|FG000|Primary Treatment Phase|Adverse Event|2|||
48658581|NCT01865812|156601711|FG001|Primary Treatment Phase|Adverse Event|0|||
48658582|NCT01865812|156601710|FG000|Long-term Safety Extension Phase|Withdrawal by Subject|0|||
48658583|NCT01865812|156601711|FG001|Long-term Safety Extension Phase|Withdrawal by Subject|1|||
48755289|NCT00715078|156951224|FG001|Overall Study|Withdrawal by Subject|0|||
48755290|NCT00715078|156951225|FG002|Overall Study|Withdrawal by Subject|1|||
48658584|NCT01865812|156601710|FG000|Long-term Safety Extension Phase|Pruritus|0|||
48658585|NCT01865812|156601711|FG001|Long-term Safety Extension Phase|Pruritus|3|||
48658586|NCT01865812|156601710|FG000|Long-term Safety Extension Phase|Physician Decision|0|||
48658587|NCT01865812|156601711|FG001|Long-term Safety Extension Phase|Physician Decision|1|||
48658588|NCT01865812|156601710|FG000|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|0|||
48658589|NCT01865812|156601711|FG001|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|1|||
48658590|NCT02692040|156601712|FG000|Overall Study|Protocol Violation|0|||
48658591|NCT02692040|156601713|FG001|Overall Study|Protocol Violation|0|||
48658592|NCT02692040|156601714|FG002|Overall Study|Protocol Violation|0|||
48658593|NCT02692040|156601715|FG003|Overall Study|Protocol Violation|0|||
48658594|NCT02692040|156601716|FG004|Overall Study|Protocol Violation|0|||
48658595|NCT02692040|156601717|FG005|Overall Study|Protocol Violation|0|||
48658596|NCT02692040|156601718|FG006|Overall Study|Protocol Violation|0|||
48962907|NCT00302718|157692289|FG000|Overall Study|Participant left primary care setting|0|||
48962908|NCT00302718|157692290|FG001|Overall Study|Participant left primary care setting|0|||
48962909|NCT00302718|157692291|FG002|Overall Study|Participant left primary care setting|2|||
48962910|NCT00302718|157692292|FG003|Overall Study|Participant left primary care setting|1|||
48962911|NCT01185249|157692293|FG000|Overall Study|Patients discharged or change in status|42|||
48962912|NCT01973452|157692298|FG000|Overall Study|Lack of Efficacy|0|||
48962913|NCT01973452|157692299|FG001|Overall Study|Lack of Efficacy|1|||
48962914|NCT01973452|157692298|FG000|Overall Study|Lost to Follow-up|1|||
48962915|NCT01973452|157692299|FG001|Overall Study|Lost to Follow-up|0|||
48962916|NCT01973452|157692298|FG000|Overall Study|Withdrawal by Subject|10|||
48962917|NCT01973452|157692299|FG001|Overall Study|Withdrawal by Subject|9|||
48962918|NCT01973452|157692298|FG000|Overall Study|Ineligible|1|||
48962919|NCT01973452|157692299|FG001|Overall Study|Ineligible|1|||
48962920|NCT01973452|157692298|FG000|Overall Study|Surgery canceled by participant|5|||
48962921|NCT01973452|157692299|FG001|Overall Study|Surgery canceled by participant|3|||
48962922|NCT00349752|157692300|FG000|Overall Study|Adverse Event|8|||
48962923|NCT00349752|157692301|FG001|Overall Study|Adverse Event|12|||
48962924|NCT00349752|157692300|FG000|Overall Study|Lack of Efficacy|37|||
48962925|NCT00349752|157692301|FG001|Overall Study|Lack of Efficacy|42|||
48962926|NCT00349752|157692300|FG000|Overall Study|Lost to Follow-up|4|||
48962927|NCT00349752|157692301|FG001|Overall Study|Lost to Follow-up|2|||
48962928|NCT00349752|157692300|FG000|Overall Study|Personal reasons|6|||
48962929|NCT00349752|157692301|FG001|Overall Study|Personal reasons|5|||
48962930|NCT00349752|157692300|FG000|Overall Study|Other: Required exclusionary medication|0|||
48658597|NCT02692040|156601719|FG007|Overall Study|Protocol Violation|0|||
48658598|NCT02692040|156601720|FG008|Overall Study|Protocol Violation|0|||
48658599|NCT02692040|156601721|FG009|Overall Study|Protocol Violation|0|||
48658600|NCT02692040|156601722|FG010|Overall Study|Protocol Violation|0|||
48658601|NCT02692040|156601723|FG011|Overall Study|Protocol Violation|0|||
48658602|NCT02692040|156601724|FG012|Overall Study|Protocol Violation|1|||
48658603|NCT02692040|156601725|FG013|Overall Study|Protocol Violation|0|||
48658604|NCT02692040|156601726|FG014|Overall Study|Protocol Violation|0|||
48658605|NCT02692040|156601727|FG015|Overall Study|Protocol Violation|0|||
48658606|NCT02692040|156601728|FG016|Overall Study|Protocol Violation|0|||
48658607|NCT02692040|156601712|FG000|Overall Study|Adverse Event|0|||
48658608|NCT02692040|156601713|FG001|Overall Study|Adverse Event|0|||
48658609|NCT02692040|156601714|FG002|Overall Study|Adverse Event|0|||
48658610|NCT02692040|156601715|FG003|Overall Study|Adverse Event|0|||
48658611|NCT02692040|156601716|FG004|Overall Study|Adverse Event|0|||
48658612|NCT02692040|156601717|FG005|Overall Study|Adverse Event|0|||
48658613|NCT02692040|156601718|FG006|Overall Study|Adverse Event|0|||
48658614|NCT02692040|156601719|FG007|Overall Study|Adverse Event|0|||
48658615|NCT02692040|156601720|FG008|Overall Study|Adverse Event|0|||
48658616|NCT02692040|156601721|FG009|Overall Study|Adverse Event|0|||
48658617|NCT02692040|156601722|FG010|Overall Study|Adverse Event|0|||
48658618|NCT02692040|156601723|FG011|Overall Study|Adverse Event|0|||
48658619|NCT02692040|156601724|FG012|Overall Study|Adverse Event|0|||
48658620|NCT02692040|156601725|FG013|Overall Study|Adverse Event|3|||
48658621|NCT02692040|156601726|FG014|Overall Study|Adverse Event|1|||
48658622|NCT02692040|156601727|FG015|Overall Study|Adverse Event|1|||
48658623|NCT02692040|156601728|FG016|Overall Study|Adverse Event|0|||
48962931|NCT00349752|157692301|FG001|Overall Study|Other: Required exclusionary medication|1|||
48962932|NCT00349752|157692300|FG000|Overall Study|Other: Non compliance|0|||
48658624|NCT02640625|156603664|FG000|Overall Study|Adverse Event|1|||
48658625|NCT02109432|156603665|FG000|Overall Study|Withdrawal by Subject|1|||
48658626|NCT01945216|156603667|FG000|Overall Study|Case report forms (CRF) uncollected|52|||
48658627|NCT01945216|156603667|FG000|Overall Study|Protocol Violation|42|||
48658628|NCT01945216|156603667|FG000|Overall Study|CRF not assured by investigators|5|||
48658629|NCT02791191|156603668|FG000|Overall Study|Adverse Event|2|||
48962933|NCT00349752|157692301|FG001|Overall Study|Other: Non compliance|1|||
48962934|NCT00349752|157692300|FG000|Overall Study|Other: Patient stopped steroids|0|||
48658630|NCT02791191|156603669|FG001|Overall Study|Adverse Event|4|||
48658631|NCT02791191|156603670|FG002|Overall Study|Adverse Event|5|||
48658632|NCT02791191|156603668|FG000|Overall Study|Lack of Efficacy|0|||
48962935|NCT00349752|157692301|FG001|Overall Study|Other: Patient stopped steroids|1|||
48962936|NCT00349752|157692300|FG000|Overall Study|Other: Patient's steroid use|1|||
48962937|NCT00349752|157692301|FG001|Overall Study|Other: Patient's steroid use|0|||
48962938|NCT00349752|157692300|FG000|Overall Study|Other: Ineligible|1|||
48962939|NCT00349752|157692301|FG001|Overall Study|Other: Ineligible|0|||
48962940|NCT00349752|157692300|FG000|Overall Study|Other: Inadvertently unblinded|1|||
48962941|NCT00349752|157692301|FG001|Overall Study|Other: Inadvertently unblinded|0|||
48962942|NCT00349752|157692300|FG000|Overall Study|Other:History of squamous cell carcinoma|1|||
48962943|NCT00349752|157692301|FG001|Overall Study|Other:History of squamous cell carcinoma|0|||
48962944|NCT00819585|157692302|FG000|Core Study|Adverse Event|2|||
48962945|NCT00819585|157692303|FG001|Core Study|Adverse Event|1|||
48962946|NCT00819585|157692304|FG002|Core Study|Adverse Event|1|||
48962947|NCT00819585|157692305|FG003|Core Study|Adverse Event|4|||
48962948|NCT00819585|157692306|FG004|Core Study|Adverse Event|1|||
48962949|NCT00819585|157692307|FG005|Core Study|Adverse Event|0|||
48962950|NCT00819585|157692308|FG006|Core Study|Adverse Event|2|||
48962951|NCT00819585|157692309|FG007|Core Study|Adverse Event|0|||
48962952|NCT00819585|157692310|FG008|Core Study|Adverse Event|0|||
48962953|NCT00819585|157692311|FG009|Core Study|Adverse Event|0|||
48962954|NCT00819585|157692312|FG010|Core Study|Adverse Event|0|||
48962955|NCT00819585|157692302|FG000|Core Study|Abnormal Laboratory Value(s)|2|||
48962956|NCT00819585|157692303|FG001|Core Study|Abnormal Laboratory Value(s)|0|||
48962957|NCT00819585|157692304|FG002|Core Study|Abnormal Laboratory Value(s)|0|||
48962958|NCT00819585|157692305|FG003|Core Study|Abnormal Laboratory Value(s)|0|||
48962959|NCT00819585|157692306|FG004|Core Study|Abnormal Laboratory Value(s)|0|||
48962960|NCT00819585|157692307|FG005|Core Study|Abnormal Laboratory Value(s)|0|||
48962961|NCT00819585|157692308|FG006|Core Study|Abnormal Laboratory Value(s)|0|||
48962962|NCT00819585|157692309|FG007|Core Study|Abnormal Laboratory Value(s)|0|||
48962963|NCT00819585|157692310|FG008|Core Study|Abnormal Laboratory Value(s)|0|||
48962964|NCT00819585|157692311|FG009|Core Study|Abnormal Laboratory Value(s)|0|||
48962965|NCT00819585|157692312|FG010|Core Study|Abnormal Laboratory Value(s)|0|||
48962966|NCT00819585|157692302|FG000|Core Study|Unsatisfactory Therapeutic Effect|0|||
48962967|NCT00819585|157692303|FG001|Core Study|Unsatisfactory Therapeutic Effect|1|||
48962968|NCT00819585|157692304|FG002|Core Study|Unsatisfactory Therapeutic Effect|0|||
48962969|NCT00819585|157692305|FG003|Core Study|Unsatisfactory Therapeutic Effect|0|||
48962970|NCT00819585|157692306|FG004|Core Study|Unsatisfactory Therapeutic Effect|0|||
48962971|NCT00819585|157692307|FG005|Core Study|Unsatisfactory Therapeutic Effect|0|||
48962972|NCT00819585|157692308|FG006|Core Study|Unsatisfactory Therapeutic Effect|1|||
48962973|NCT00819585|157692309|FG007|Core Study|Unsatisfactory Therapeutic Effect|0|||
48962974|NCT00819585|157692310|FG008|Core Study|Unsatisfactory Therapeutic Effect|0|||
48962975|NCT00819585|157692311|FG009|Core Study|Unsatisfactory Therapeutic Effect|0|||
48962976|NCT00819585|157692312|FG010|Core Study|Unsatisfactory Therapeutic Effect|0|||
48962977|NCT00819585|157692302|FG000|Core Study|Subject No Longer Requires Study Drug|0|||
48962978|NCT00819585|157692303|FG001|Core Study|Subject No Longer Requires Study Drug|0|||
48962979|NCT00819585|157692304|FG002|Core Study|Subject No Longer Requires Study Drug|0|||
48962980|NCT00819585|157692305|FG003|Core Study|Subject No Longer Requires Study Drug|0|||
48962981|NCT00819585|157692306|FG004|Core Study|Subject No Longer Requires Study Drug|1|||
48962982|NCT00819585|157692307|FG005|Core Study|Subject No Longer Requires Study Drug|0|||
48962983|NCT00819585|157692308|FG006|Core Study|Subject No Longer Requires Study Drug|0|||
48962984|NCT00819585|157692309|FG007|Core Study|Subject No Longer Requires Study Drug|0|||
48962985|NCT00819585|157692310|FG008|Core Study|Subject No Longer Requires Study Drug|0|||
48962986|NCT00819585|157692311|FG009|Core Study|Subject No Longer Requires Study Drug|0|||
48962987|NCT00819585|157692312|FG010|Core Study|Subject No Longer Requires Study Drug|0|||
48962988|NCT00819585|157692302|FG000|Core Study|Subject Withdrew Consent|0|||
48962989|NCT00819585|157692303|FG001|Core Study|Subject Withdrew Consent|3|||
48962990|NCT00819585|157692304|FG002|Core Study|Subject Withdrew Consent|2|||
48962991|NCT00819585|157692305|FG003|Core Study|Subject Withdrew Consent|1|||
48962992|NCT00819585|157692306|FG004|Core Study|Subject Withdrew Consent|0|||
48962993|NCT00819585|157692307|FG005|Core Study|Subject Withdrew Consent|0|||
48658633|NCT02791191|156603669|FG001|Overall Study|Lack of Efficacy|1|||
48658634|NCT02791191|156603670|FG002|Overall Study|Lack of Efficacy|0|||
48658635|NCT02791191|156603668|FG000|Overall Study|Study Drug Non-Compliance|0|||
48658636|NCT02791191|156603669|FG001|Overall Study|Study Drug Non-Compliance|2|||
48658637|NCT02791191|156603670|FG002|Overall Study|Study Drug Non-Compliance|0|||
48658638|NCT02791191|156603668|FG000|Overall Study|Site Closed by Sponsor|1|||
48658639|NCT02791191|156603669|FG001|Overall Study|Site Closed by Sponsor|1|||
48658640|NCT02791191|156603670|FG002|Overall Study|Site Closed by Sponsor|3|||
48658641|NCT02791191|156603668|FG000|Overall Study|Progressive Disease|1|||
48658642|NCT02791191|156603669|FG001|Overall Study|Progressive Disease|0|||
48658643|NCT02791191|156603670|FG002|Overall Study|Progressive Disease|0|||
48658644|NCT02791191|156603668|FG000|Overall Study|Study Terminated by Sponsor|29|||
48755291|NCT00715078|156951223|FG000|Overall Study|Unable to start due to disease prog.|0|||
48962994|NCT00819585|157692308|FG006|Core Study|Subject Withdrew Consent|3|||
48962995|NCT00819585|157692309|FG007|Core Study|Subject Withdrew Consent|0|||
48962996|NCT00819585|157692310|FG008|Core Study|Subject Withdrew Consent|0|||
48962997|NCT00819585|157692311|FG009|Core Study|Subject Withdrew Consent|0|||
48962998|NCT00819585|157692312|FG010|Core Study|Subject Withdrew Consent|0|||
48962999|NCT00819585|157692302|FG000|Core Study|Lost to Follow-up|2|||
48963000|NCT00819585|157692303|FG001|Core Study|Lost to Follow-up|1|||
48963001|NCT00819585|157692304|FG002|Core Study|Lost to Follow-up|2|||
48963002|NCT00819585|157692305|FG003|Core Study|Lost to Follow-up|0|||
48963003|NCT00819585|157692306|FG004|Core Study|Lost to Follow-up|1|||
48963004|NCT00819585|157692307|FG005|Core Study|Lost to Follow-up|1|||
48963005|NCT00819585|157692308|FG006|Core Study|Lost to Follow-up|1|||
48963006|NCT00819585|157692309|FG007|Core Study|Lost to Follow-up|0|||
48963007|NCT00819585|157692310|FG008|Core Study|Lost to Follow-up|0|||
48963008|NCT00819585|157692311|FG009|Core Study|Lost to Follow-up|0|||
48963009|NCT00819585|157692312|FG010|Core Study|Lost to Follow-up|0|||
48963010|NCT00819585|157692302|FG000|Core Study|Administrative Problems|0|||
48963011|NCT00819585|157692303|FG001|Core Study|Administrative Problems|0|||
48963012|NCT00819585|157692304|FG002|Core Study|Administrative Problems|0|||
48963013|NCT00819585|157692305|FG003|Core Study|Administrative Problems|0|||
48963014|NCT00819585|157692306|FG004|Core Study|Administrative Problems|0|||
48963015|NCT00819585|157692307|FG005|Core Study|Administrative Problems|0|||
48963016|NCT00819585|157692308|FG006|Core Study|Administrative Problems|2|||
48963017|NCT00819585|157692309|FG007|Core Study|Administrative Problems|0|||
48963018|NCT00819585|157692310|FG008|Core Study|Administrative Problems|0|||
48963019|NCT00819585|157692311|FG009|Core Study|Administrative Problems|0|||
48963020|NCT00819585|157692312|FG010|Core Study|Administrative Problems|0|||
48963021|NCT00819585|157692302|FG000|Core Study|Death|0|||
48963022|NCT00819585|157692303|FG001|Core Study|Death|0|||
48963023|NCT00819585|157692304|FG002|Core Study|Death|0|||
48963024|NCT00819585|157692305|FG003|Core Study|Death|0|||
48963025|NCT00819585|157692306|FG004|Core Study|Death|0|||
48963026|NCT00819585|157692307|FG005|Core Study|Death|0|||
48963027|NCT00819585|157692308|FG006|Core Study|Death|1|||
48963028|NCT00819585|157692309|FG007|Core Study|Death|0|||
48963029|NCT00819585|157692310|FG008|Core Study|Death|0|||
48963030|NCT00819585|157692311|FG009|Core Study|Death|0|||
48963031|NCT00819585|157692312|FG010|Core Study|Death|0|||
48963032|NCT00819585|157692302|FG000|Core Study|Protocol Violation|0|||
48963033|NCT00819585|157692303|FG001|Core Study|Protocol Violation|0|||
48963034|NCT00819585|157692304|FG002|Core Study|Protocol Violation|1|||
48963035|NCT00819585|157692305|FG003|Core Study|Protocol Violation|0|||
48963036|NCT00819585|157692306|FG004|Core Study|Protocol Violation|0|||
48963037|NCT00819585|157692307|FG005|Core Study|Protocol Violation|1|||
48963038|NCT00819585|157692308|FG006|Core Study|Protocol Violation|3|||
48963039|NCT00819585|157692309|FG007|Core Study|Protocol Violation|0|||
48963040|NCT00819585|157692310|FG008|Core Study|Protocol Violation|0|||
48963041|NCT00819585|157692311|FG009|Core Study|Protocol Violation|0|||
48963042|NCT00819585|157692312|FG010|Core Study|Protocol Violation|0|||
48963043|NCT00819585|157692302|FG000|Extension Study|Abnormal Laboratory Value(s)|0|||
48963044|NCT00819585|157692303|FG001|Extension Study|Abnormal Laboratory Value(s)|0|||
48963045|NCT00819585|157692304|FG002|Extension Study|Abnormal Laboratory Value(s)|0|||
48963046|NCT00819585|157692305|FG003|Extension Study|Abnormal Laboratory Value(s)|0|||
48963047|NCT00819585|157692306|FG004|Extension Study|Abnormal Laboratory Value(s)|0|||
48963048|NCT00819585|157692307|FG005|Extension Study|Abnormal Laboratory Value(s)|0|||
48963049|NCT00819585|157692308|FG006|Extension Study|Abnormal Laboratory Value(s)|0|||
48963050|NCT00819585|157692309|FG007|Extension Study|Abnormal Laboratory Value(s)|0|||
48963051|NCT00819585|157692310|FG008|Extension Study|Abnormal Laboratory Value(s)|1|||
48963052|NCT00819585|157692311|FG009|Extension Study|Abnormal Laboratory Value(s)|0|||
48963053|NCT00819585|157692312|FG010|Extension Study|Abnormal Laboratory Value(s)|0|||
48963054|NCT00819585|157692302|FG000|Extension Study|Subject Withdrew Consent|0|||
48963055|NCT00819585|157692303|FG001|Extension Study|Subject Withdrew Consent|0|||
48963056|NCT00819585|157692304|FG002|Extension Study|Subject Withdrew Consent|0|||
48963057|NCT00819585|157692305|FG003|Extension Study|Subject Withdrew Consent|0|||
48963058|NCT00819585|157692306|FG004|Extension Study|Subject Withdrew Consent|0|||
48963059|NCT00819585|157692307|FG005|Extension Study|Subject Withdrew Consent|0|||
48963060|NCT00819585|157692308|FG006|Extension Study|Subject Withdrew Consent|0|||
48963061|NCT00819585|157692309|FG007|Extension Study|Subject Withdrew Consent|0|||
48963062|NCT00819585|157692310|FG008|Extension Study|Subject Withdrew Consent|3|||
48963063|NCT00819585|157692311|FG009|Extension Study|Subject Withdrew Consent|0|||
48963064|NCT00819585|157692312|FG010|Extension Study|Subject Withdrew Consent|1|||
48963065|NCT00819585|157692302|FG000|Extension Study|Lost to Follow-up|0|||
48963066|NCT00819585|157692303|FG001|Extension Study|Lost to Follow-up|0|||
48963067|NCT00819585|157692304|FG002|Extension Study|Lost to Follow-up|0|||
48963068|NCT00819585|157692305|FG003|Extension Study|Lost to Follow-up|0|||
48963069|NCT00819585|157692306|FG004|Extension Study|Lost to Follow-up|0|||
48963070|NCT00819585|157692307|FG005|Extension Study|Lost to Follow-up|0|||
48963071|NCT00819585|157692308|FG006|Extension Study|Lost to Follow-up|0|||
48963072|NCT00819585|157692309|FG007|Extension Study|Lost to Follow-up|0|||
48963073|NCT00819585|157692310|FG008|Extension Study|Lost to Follow-up|2|||
48963074|NCT00819585|157692311|FG009|Extension Study|Lost to Follow-up|1|||
48963075|NCT00819585|157692312|FG010|Extension Study|Lost to Follow-up|1|||
48963076|NCT00819585|157692302|FG000|Extension Study|Death|0|||
48963077|NCT00819585|157692303|FG001|Extension Study|Death|0|||
48963078|NCT00819585|157692304|FG002|Extension Study|Death|0|||
48963079|NCT00819585|157692305|FG003|Extension Study|Death|0|||
48963080|NCT00819585|157692306|FG004|Extension Study|Death|0|||
48963081|NCT00819585|157692307|FG005|Extension Study|Death|0|||
48963082|NCT00819585|157692308|FG006|Extension Study|Death|0|||
48963083|NCT00819585|157692309|FG007|Extension Study|Death|0|||
48963084|NCT00819585|157692310|FG008|Extension Study|Death|2|||
48963085|NCT00819585|157692311|FG009|Extension Study|Death|0|||
48963086|NCT00819585|157692312|FG010|Extension Study|Death|0|||
48963087|NCT03521193|157692314|FG000|Overall Study|Withdrawal by Subject|8|||
48963088|NCT03521193|157692315|FG001|Overall Study|Withdrawal by Subject|0|||
48963089|NCT03521193|157692314|FG000|Overall Study|non compliant to ASA treatment|8|||
48963090|NCT03521193|157692315|FG001|Overall Study|non compliant to ASA treatment|0|||
48963091|NCT04191967|157694124|FG000|Screening & Thermocoagulation (Ablation)|Not considered candidates for thermocoagulation|86|||
48963092|NCT04191967|157694124|FG000|12 Month Follow-up|Pathology results for 12 month treatment efficacy not available for these participants|4|||
48963093|NCT01431144|157694127|FG000|Overall Study|Implant mobility and removal|2|||
48963094|NCT01431144|157694128|FG001|Overall Study|Implant mobility and removal|0|||
48963095|NCT00755846|157694129|FG000|Overall Study|Adverse Event|0|||
48963096|NCT00755846|157694130|FG001|Overall Study|Adverse Event|0|||
48963097|NCT00755846|157694131|FG002|Overall Study|Adverse Event|0|||
48963098|NCT00755846|157694132|FG003|Overall Study|Adverse Event|1|||
48963099|NCT00755846|157694133|FG004|Overall Study|Adverse Event|3|||
48963100|NCT00755846|157694134|FG005|Overall Study|Adverse Event|2|||
48963101|NCT00755846|157694129|FG000|Overall Study|Protocol Violation|1|||
48963102|NCT00755846|157694130|FG001|Overall Study|Protocol Violation|1|||
48963103|NCT00755846|157694131|FG002|Overall Study|Protocol Violation|1|||
48963104|NCT00755846|157694132|FG003|Overall Study|Protocol Violation|1|||
48658645|NCT02791191|156603669|FG001|Overall Study|Study Terminated by Sponsor|101|||
48658646|NCT02791191|156603670|FG002|Overall Study|Study Terminated by Sponsor|109|||
48658647|NCT02791191|156603668|FG000|Overall Study|Withdrawal by Subject|3|||
48658648|NCT02791191|156603669|FG001|Overall Study|Withdrawal by Subject|1|||
48658649|NCT02791191|156603670|FG002|Overall Study|Withdrawal by Subject|3|||
48658650|NCT02791191|156603668|FG000|Overall Study|Subject Withdrew Caregiver Circumstances|2|||
48658651|NCT02791191|156603669|FG001|Overall Study|Subject Withdrew Caregiver Circumstances|1|||
48658652|NCT02791191|156603670|FG002|Overall Study|Subject Withdrew Caregiver Circumstances|0|||
48658653|NCT00782171|156603671|FG000|Overall Study|Lost to Follow-up|2|||
48658654|NCT00782171|156603672|FG001|Overall Study|Lost to Follow-up|2|||
48658655|NCT00782171|156603671|FG000|Overall Study|Withdrawal by Subject|2|||
48658656|NCT00782171|156603672|FG001|Overall Study|Withdrawal by Subject|1|||
48658657|NCT00782171|156603671|FG000|Overall Study|complications|3|||
48658658|NCT00782171|156603672|FG001|Overall Study|complications|1|||
48658659|NCT00782171|156603671|FG000|Overall Study|others|7|||
48658660|NCT00782171|156603672|FG001|Overall Study|others|9|||
48658661|NCT00782171|156603671|FG000|Overall Study|not eligible|8|||
48658662|NCT00782171|156603672|FG001|Overall Study|not eligible|6|||
48658663|NCT05032157|156603674|FG000|Overall Study|Adverse Event|12|||
48658664|NCT05032157|156603675|FG001|Overall Study|Adverse Event|7|||
48658665|NCT05032157|156603674|FG000|Overall Study|Pregnancy|0|||
48658666|NCT05032157|156603675|FG001|Overall Study|Pregnancy|2|||
48658667|NCT05032157|156603674|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
48658668|NCT05032157|156603675|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
48658669|NCT05032157|156603674|FG000|Overall Study|Protocol Deviation|8|||
48658670|NCT05032157|156603675|FG001|Overall Study|Protocol Deviation|4|||
48658671|NCT05032157|156603674|FG000|Overall Study|Lost to Follow-up|1|||
48658672|NCT05032157|156603675|FG001|Overall Study|Lost to Follow-up|3|||
48658673|NCT05032157|156603674|FG000|Overall Study|Physician Decision|7|||
48963105|NCT00755846|157694133|FG004|Overall Study|Protocol Violation|1|||
48963106|NCT00755846|157694134|FG005|Overall Study|Protocol Violation|1|||
48658674|NCT05032157|156603675|FG001|Overall Study|Physician Decision|2|||
48658675|NCT05032157|156603674|FG000|Overall Study|Patient Decision|38|||
48658676|NCT05032157|156603675|FG001|Overall Study|Patient Decision|19|||
48658677|NCT01559259|156603679|FG000|Overall Study|Withdrawal by Subject|0|||
48658678|NCT01559259|156603680|FG001|Overall Study|Withdrawal by Subject|0|||
48658679|NCT01559259|156603681|FG002|Overall Study|Withdrawal by Subject|0|||
48658680|NCT01559259|156603682|FG003|Overall Study|Withdrawal by Subject|1|||
48658681|NCT01559259|156603683|FG004|Overall Study|Withdrawal by Subject|0|||
48658682|NCT01559259|156603679|FG000|Overall Study|Adverse Event|0|||
48658683|NCT01559259|156603680|FG001|Overall Study|Adverse Event|1|||
48658684|NCT01559259|156603681|FG002|Overall Study|Adverse Event|1|||
48755292|NCT00715078|156951224|FG001|Overall Study|Unable to start due to disease prog.|0|||
48658685|NCT01559259|156603682|FG003|Overall Study|Adverse Event|0|||
48658686|NCT01559259|156603683|FG004|Overall Study|Adverse Event|0|||
48658687|NCT04753658|156603684|FG000|Overall Study|Progressive disease|7|||
48963107|NCT00755846|157694129|FG000|Overall Study|Lost to Follow-up|0|||
48963108|NCT00755846|157694130|FG001|Overall Study|Lost to Follow-up|2|||
48963109|NCT00755846|157694131|FG002|Overall Study|Lost to Follow-up|1|||
48658688|NCT04753658|156603684|FG000|Overall Study|Other|7|||
48658689|NCT04753658|156603684|FG000|Overall Study|Adverse Event|1|||
48658690|NCT00549900|156603688|FG000|Overall Study|Adverse Event|1|||
48658691|NCT01145352|156603693|FG000|Overall Study|Found to have been registered twice|6|||
48658692|NCT01145352|156603693|FG000|Overall Study|Treated before marketing approval|4|||
48658693|NCT01145352|156603693|FG000|Overall Study|Syringe formulation was used|1|||
48658694|NCT04984876|156603698|FG000|Overall Study|Subject decision|2|||
48658695|NCT04984876|156603699|FG001|Overall Study|Subject decision|10|||
48658696|NCT04984876|156603700|FG002|Overall Study|Subject decision|3|||
48658697|NCT04984876|156603701|FG003|Overall Study|Subject decision|3|||
48658698|NCT04984876|156603702|FG004|Overall Study|Subject decision|3|||
48658699|NCT04984876|156603703|FG005|Overall Study|Subject decision|0|||
48658700|NCT04984876|156603698|FG000|Overall Study|Guardian decision|0|||
48658701|NCT04984876|156603699|FG001|Overall Study|Guardian decision|1|||
48658702|NCT04984876|156603700|FG002|Overall Study|Guardian decision|0|||
48658703|NCT04984876|156603701|FG003|Overall Study|Guardian decision|2|||
48658704|NCT04984876|156603702|FG004|Overall Study|Guardian decision|0|||
48658705|NCT04984876|156603703|FG005|Overall Study|Guardian decision|1|||
48658706|NCT04984876|156603698|FG000|Overall Study|Lost to Follow-up|0|||
48658707|NCT04984876|156603699|FG001|Overall Study|Lost to Follow-up|0|||
48658708|NCT04984876|156603700|FG002|Overall Study|Lost to Follow-up|1|||
48658709|NCT04984876|156603701|FG003|Overall Study|Lost to Follow-up|1|||
48658710|NCT04984876|156603702|FG004|Overall Study|Lost to Follow-up|0|||
48658711|NCT04984876|156603703|FG005|Overall Study|Lost to Follow-up|0|||
48658712|NCT04984876|156603698|FG000|Overall Study|Physician Decision|1|||
48658713|NCT04984876|156603699|FG001|Overall Study|Physician Decision|0|||
48658714|NCT04984876|156603700|FG002|Overall Study|Physician Decision|0|||
48658715|NCT04984876|156603701|FG003|Overall Study|Physician Decision|1|||
48658716|NCT04984876|156603702|FG004|Overall Study|Physician Decision|0|||
48658717|NCT04984876|156603703|FG005|Overall Study|Physician Decision|0|||
48658718|NCT04984876|156603698|FG000|Overall Study|Adverse Event|0|||
48658719|NCT04984876|156603699|FG001|Overall Study|Adverse Event|0|||
48658720|NCT04984876|156603700|FG002|Overall Study|Adverse Event|1|||
48658721|NCT04984876|156603701|FG003|Overall Study|Adverse Event|0|||
48658722|NCT04984876|156603702|FG004|Overall Study|Adverse Event|0|||
48658723|NCT04984876|156603703|FG005|Overall Study|Adverse Event|0|||
48658724|NCT03457142|156603704|FG000|Overall Study|Death|1|||
48658725|NCT03392883|156603709|FG000|Overall Study|Lost to Follow-up|122|||
48658726|NCT03392883|156603710|FG001|Overall Study|Lost to Follow-up|13|||
48658727|NCT03392883|156603711|FG002|Overall Study|Lost to Follow-up|9|||
48658728|NCT03392883|156603709|FG000|Overall Study|Death|4|||
48658729|NCT03392883|156603710|FG001|Overall Study|Death|0|||
48658730|NCT03392883|156603711|FG002|Overall Study|Death|0|||
48658731|NCT03392883|156603709|FG000|Overall Study|Lack of Efficacy|29|||
48658732|NCT03392883|156603710|FG001|Overall Study|Lack of Efficacy|0|||
48658733|NCT03392883|156603711|FG002|Overall Study|Lack of Efficacy|0|||
48658734|NCT03392883|156603709|FG000|Overall Study|Withdrawal by Subject|180|||
48658735|NCT03392883|156603710|FG001|Overall Study|Withdrawal by Subject|0|||
48658736|NCT03392883|156603711|FG002|Overall Study|Withdrawal by Subject|0|||
48658737|NCT03392883|156603709|FG000|Overall Study|Adverse Event|1|||
48658738|NCT03392883|156603710|FG001|Overall Study|Adverse Event|0|||
48658739|NCT03392883|156603711|FG002|Overall Study|Adverse Event|0|||
48658740|NCT00090142|156603712|FG000|Treatment Period I|Lost to Follow-up|1|||
48658741|NCT00090142|156603713|FG001|Treatment Period I|Lost to Follow-up|2|||
48963110|NCT00755846|157694132|FG003|Overall Study|Lost to Follow-up|0|||
48963111|NCT00755846|157694133|FG004|Overall Study|Lost to Follow-up|4|||
48963112|NCT00755846|157694134|FG005|Overall Study|Lost to Follow-up|2|||
48658742|NCT00090142|156603712|FG000|Treatment Period I|Protocol Violation|2|||
48658743|NCT00090142|156603713|FG001|Treatment Period I|Protocol Violation|0|||
48658744|NCT00090142|156603712|FG000|Treatment Period I|Withdrawal by Subject|2|||
48658745|NCT00090142|156603713|FG001|Treatment Period I|Withdrawal by Subject|0|||
48658746|NCT00090142|156603712|FG000|Treatment Period I|Other|0|||
48658747|NCT00090142|156603713|FG001|Treatment Period I|Other|1|||
48658748|NCT00090142|156603712|FG000|Treatment Period II|Other|1|||
48658749|NCT00090142|156603713|FG001|Treatment Period II|Other|0|||
48658750|NCT02300558|156603714|FG000|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6|||
48658751|NCT02300558|156603714|FG000|Open-Label (OL) Extension Phase|Lack of Efficacy|2|||
48963113|NCT00755846|157694129|FG000|Overall Study|Withdrawal by Subject|2|||
48658752|NCT02300558|156603714|FG000|Open-Label (OL) Extension Phase|Withdrew Consent|1|||
48658753|NCT02300558|156603714|FG000|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29|||
48658754|NCT01846663|156603715|FG000|Overall Study|Hepatic encephalopathy breakthrough|1|||
48658755|NCT01846663|156603716|FG001|Overall Study|Hepatic encephalopathy breakthrough|0|||
48658756|NCT01846663|156603715|FG000|Overall Study|Withdrawal by Subject|1|||
48658757|NCT01846663|156603716|FG001|Overall Study|Withdrawal by Subject|0|||
48658758|NCT01846663|156603715|FG000|Overall Study|Adverse Event|1|||
48658759|NCT01846663|156603716|FG001|Overall Study|Adverse Event|2|||
48658760|NCT00813865|156603718|FG000|Overall Study|Failure to Respond|3|||
48658761|NCT00813865|156603718|FG000|Overall Study|Lost to Follow-up|3|||
48658762|NCT00813865|156603718|FG000|Overall Study|Withdrawal by Subject|1|||
48963114|NCT00755846|157694130|FG001|Overall Study|Withdrawal by Subject|3|||
48963115|NCT00755846|157694131|FG002|Overall Study|Withdrawal by Subject|5|||
48658763|NCT02754141|156603719|FG000|Overall Study|Disease progression|11|||
48658764|NCT02754141|156603720|FG001|Overall Study|Disease progression|7|||
48658765|NCT02754141|156603721|FG002|Overall Study|Disease progression|8|||
48658766|NCT02754141|156603722|FG003|Overall Study|Disease progression|5|||
48658767|NCT02754141|156603723|FG004|Overall Study|Disease progression|7|||
48658768|NCT02754141|156603724|FG005|Overall Study|Disease progression|7|||
48658769|NCT02754141|156603725|FG006|Overall Study|Disease progression|7|||
48658770|NCT02754141|156603726|FG007|Overall Study|Disease progression|6|||
48658771|NCT02754141|156603727|FG008|Overall Study|Disease progression|11|||
48658772|NCT02754141|156603728|FG009|Overall Study|Disease progression|16|||
48658773|NCT02754141|156603729|FG010|Overall Study|Disease progression|18|||
48658774|NCT02754141|156603730|FG011|Overall Study|Disease progression|13|||
48658775|NCT02754141|156603731|FG012|Overall Study|Disease progression|10|||
48658776|NCT02754141|156603732|FG013|Overall Study|Disease progression|12|||
48658777|NCT02754141|156603733|FG014|Overall Study|Disease progression|12|||
48658778|NCT02754141|156603734|FG015|Overall Study|Disease progression|14|||
48658779|NCT02754141|156603735|FG016|Overall Study|Disease progression|0|||
48658780|NCT02754141|156603736|FG017|Overall Study|Disease progression|1|||
48658781|NCT02754141|156603719|FG000|Overall Study|Study drug toxicity|1|||
48658782|NCT02754141|156603720|FG001|Overall Study|Study drug toxicity|1|||
48658783|NCT02754141|156603721|FG002|Overall Study|Study drug toxicity|0|||
48658784|NCT02754141|156603722|FG003|Overall Study|Study drug toxicity|0|||
48658785|NCT02754141|156603723|FG004|Overall Study|Study drug toxicity|0|||
48658786|NCT02754141|156603724|FG005|Overall Study|Study drug toxicity|0|||
48658787|NCT02754141|156603725|FG006|Overall Study|Study drug toxicity|0|||
48658788|NCT02754141|156603726|FG007|Overall Study|Study drug toxicity|0|||
48658789|NCT02754141|156603727|FG008|Overall Study|Study drug toxicity|0|||
48658790|NCT02754141|156603728|FG009|Overall Study|Study drug toxicity|0|||
48658791|NCT02754141|156603729|FG010|Overall Study|Study drug toxicity|2|||
48658792|NCT02754141|156603730|FG011|Overall Study|Study drug toxicity|1|||
48658793|NCT02754141|156603731|FG012|Overall Study|Study drug toxicity|1|||
48658794|NCT02754141|156603732|FG013|Overall Study|Study drug toxicity|0|||
48658795|NCT02754141|156603733|FG014|Overall Study|Study drug toxicity|0|||
48658796|NCT02754141|156603734|FG015|Overall Study|Study drug toxicity|0|||
48658797|NCT02754141|156603735|FG016|Overall Study|Study drug toxicity|0|||
48658798|NCT02754141|156603736|FG017|Overall Study|Study drug toxicity|0|||
48658799|NCT02754141|156603719|FG000|Overall Study|AE unrelated to study drug|1|||
48658800|NCT02754141|156603720|FG001|Overall Study|AE unrelated to study drug|1|||
48658801|NCT02754141|156603721|FG002|Overall Study|AE unrelated to study drug|0|||
48658802|NCT02754141|156603722|FG003|Overall Study|AE unrelated to study drug|1|||
48658803|NCT02754141|156603723|FG004|Overall Study|AE unrelated to study drug|3|||
48658804|NCT02754141|156603724|FG005|Overall Study|AE unrelated to study drug|2|||
48658805|NCT02754141|156603725|FG006|Overall Study|AE unrelated to study drug|1|||
48658806|NCT02754141|156603726|FG007|Overall Study|AE unrelated to study drug|0|||
48658807|NCT02754141|156603727|FG008|Overall Study|AE unrelated to study drug|0|||
48658808|NCT02754141|156603728|FG009|Overall Study|AE unrelated to study drug|0|||
48658809|NCT02754141|156603729|FG010|Overall Study|AE unrelated to study drug|0|||
48658810|NCT02754141|156603730|FG011|Overall Study|AE unrelated to study drug|0|||
48658811|NCT02754141|156603731|FG012|Overall Study|AE unrelated to study drug|0|||
48658812|NCT02754141|156603732|FG013|Overall Study|AE unrelated to study drug|0|||
48658813|NCT02754141|156603733|FG014|Overall Study|AE unrelated to study drug|0|||
48658814|NCT02754141|156603734|FG015|Overall Study|AE unrelated to study drug|0|||
48658815|NCT02754141|156603735|FG016|Overall Study|AE unrelated to study drug|0|||
48658816|NCT02754141|156603736|FG017|Overall Study|AE unrelated to study drug|0|||
48658817|NCT02754141|156603719|FG000|Overall Study|Request to discontinue|0|||
48658818|NCT02754141|156603720|FG001|Overall Study|Request to discontinue|0|||
48658819|NCT02754141|156603721|FG002|Overall Study|Request to discontinue|0|||
48658820|NCT02754141|156603722|FG003|Overall Study|Request to discontinue|0|||
48658821|NCT02754141|156603723|FG004|Overall Study|Request to discontinue|0|||
48658822|NCT02754141|156603724|FG005|Overall Study|Request to discontinue|0|||
48658823|NCT02754141|156603725|FG006|Overall Study|Request to discontinue|0|||
48658824|NCT02754141|156603726|FG007|Overall Study|Request to discontinue|0|||
48866181|NCT02382406|157345673|FG002|Study Treatment|Patient withdrawal after therapy start|1|||
48866182|NCT02382406|157345671|FG000|Study Treatment|symptomatic deterioration|1|||
48866183|NCT02382406|157345672|FG001|Study Treatment|symptomatic deterioration|0|||
48866184|NCT02382406|157345673|FG002|Study Treatment|symptomatic deterioration|1|||
48866185|NCT02382406|157345671|FG000|Study Treatment|Death|0|||
48866186|NCT02382406|157345672|FG001|Study Treatment|Death|0|||
48866187|NCT02382406|157345673|FG002|Study Treatment|Death|2|||
48866188|NCT02382406|157345671|FG000|Follow up|Death|11|||
48658825|NCT02754141|156603727|FG008|Overall Study|Request to discontinue|1|||
48658826|NCT02754141|156603728|FG009|Overall Study|Request to discontinue|0|||
48658827|NCT02754141|156603729|FG010|Overall Study|Request to discontinue|0|||
48658828|NCT02754141|156603730|FG011|Overall Study|Request to discontinue|0|||
48658829|NCT02754141|156603731|FG012|Overall Study|Request to discontinue|0|||
48866189|NCT02382406|157345672|FG001|Follow up|Death|0|||
48866190|NCT02382406|157345673|FG002|Follow up|Death|19|||
48658830|NCT02754141|156603732|FG013|Overall Study|Request to discontinue|1|||
48963116|NCT00755846|157694132|FG003|Overall Study|Withdrawal by Subject|2|||
48963117|NCT00755846|157694133|FG004|Overall Study|Withdrawal by Subject|0|||
48963118|NCT00755846|157694134|FG005|Overall Study|Withdrawal by Subject|1|||
48963119|NCT00755846|157694129|FG000|Overall Study|Hyperglycemic Rescue|21|||
48963120|NCT00755846|157694130|FG001|Overall Study|Hyperglycemic Rescue|7|||
48963121|NCT00755846|157694131|FG002|Overall Study|Hyperglycemic Rescue|5|||
48658831|NCT02754141|156603733|FG014|Overall Study|Request to discontinue|1|||
48658832|NCT02754141|156603734|FG015|Overall Study|Request to discontinue|0|||
48658833|NCT02754141|156603735|FG016|Overall Study|Request to discontinue|0|||
48658834|NCT02754141|156603736|FG017|Overall Study|Request to discontinue|0|||
48658835|NCT02754141|156603719|FG000|Overall Study|Withdrew consent|0|||
48658836|NCT02754141|156603720|FG001|Overall Study|Withdrew consent|0|||
48658837|NCT02754141|156603721|FG002|Overall Study|Withdrew consent|0|||
48658838|NCT02754141|156603722|FG003|Overall Study|Withdrew consent|0|||
48658839|NCT02754141|156603723|FG004|Overall Study|Withdrew consent|0|||
48658840|NCT02754141|156603724|FG005|Overall Study|Withdrew consent|0|||
48658841|NCT02754141|156603725|FG006|Overall Study|Withdrew consent|0|||
48658842|NCT02754141|156603726|FG007|Overall Study|Withdrew consent|0|||
48658843|NCT02754141|156603727|FG008|Overall Study|Withdrew consent|0|||
48658844|NCT02754141|156603728|FG009|Overall Study|Withdrew consent|1|||
48658845|NCT02754141|156603729|FG010|Overall Study|Withdrew consent|0|||
48658846|NCT02754141|156603730|FG011|Overall Study|Withdrew consent|0|||
48658847|NCT02754141|156603731|FG012|Overall Study|Withdrew consent|0|||
48658848|NCT02754141|156603732|FG013|Overall Study|Withdrew consent|0|||
48658849|NCT02754141|156603733|FG014|Overall Study|Withdrew consent|0|||
48658850|NCT02754141|156603734|FG015|Overall Study|Withdrew consent|0|||
48658851|NCT02754141|156603735|FG016|Overall Study|Withdrew consent|0|||
48658852|NCT02754141|156603736|FG017|Overall Study|Withdrew consent|0|||
48658853|NCT02754141|156603719|FG000|Overall Study|Maximum clinical benefit|0|||
48658854|NCT02754141|156603720|FG001|Overall Study|Maximum clinical benefit|0|||
48658855|NCT02754141|156603721|FG002|Overall Study|Maximum clinical benefit|0|||
48658856|NCT02754141|156603722|FG003|Overall Study|Maximum clinical benefit|1|||
48658857|NCT02754141|156603723|FG004|Overall Study|Maximum clinical benefit|0|||
48658858|NCT02754141|156603724|FG005|Overall Study|Maximum clinical benefit|0|||
48658859|NCT02754141|156603725|FG006|Overall Study|Maximum clinical benefit|0|||
48658860|NCT02754141|156603726|FG007|Overall Study|Maximum clinical benefit|0|||
48658861|NCT02754141|156603727|FG008|Overall Study|Maximum clinical benefit|0|||
48658862|NCT02754141|156603728|FG009|Overall Study|Maximum clinical benefit|0|||
48658863|NCT02754141|156603729|FG010|Overall Study|Maximum clinical benefit|0|||
48963122|NCT00755846|157694132|FG003|Overall Study|Hyperglycemic Rescue|8|||
48963123|NCT00755846|157694133|FG004|Overall Study|Hyperglycemic Rescue|8|||
48963124|NCT00755846|157694134|FG005|Overall Study|Hyperglycemic Rescue|7|||
48963125|NCT00755846|157694129|FG000|Overall Study|Physician Decision|1|||
48658864|NCT02754141|156603730|FG011|Overall Study|Maximum clinical benefit|0|||
48658865|NCT02754141|156603731|FG012|Overall Study|Maximum clinical benefit|0|||
48658866|NCT02754141|156603732|FG013|Overall Study|Maximum clinical benefit|0|||
48658867|NCT02754141|156603733|FG014|Overall Study|Maximum clinical benefit|0|||
48658868|NCT02754141|156603734|FG015|Overall Study|Maximum clinical benefit|0|||
48658869|NCT02754141|156603735|FG016|Overall Study|Maximum clinical benefit|0|||
48658870|NCT02754141|156603736|FG017|Overall Study|Maximum clinical benefit|0|||
48963126|NCT00755846|157694130|FG001|Overall Study|Physician Decision|3|||
48963127|NCT00755846|157694131|FG002|Overall Study|Physician Decision|0|||
48963128|NCT00755846|157694132|FG003|Overall Study|Physician Decision|1|||
48963129|NCT00755846|157694133|FG004|Overall Study|Physician Decision|0|||
48963130|NCT00755846|157694134|FG005|Overall Study|Physician Decision|1|||
48963131|NCT00755846|157694129|FG000|Overall Study|Administrative Error|0|||
48963132|NCT00755846|157694130|FG001|Overall Study|Administrative Error|1|||
48963133|NCT00755846|157694131|FG002|Overall Study|Administrative Error|0|||
48963134|NCT00755846|157694132|FG003|Overall Study|Administrative Error|0|||
48963135|NCT00755846|157694133|FG004|Overall Study|Administrative Error|0|||
48963136|NCT00755846|157694134|FG005|Overall Study|Administrative Error|0|||
48963137|NCT00755846|157694129|FG000|Overall Study|Participant Non-compliance|0|||
48963138|NCT00755846|157694130|FG001|Overall Study|Participant Non-compliance|0|||
48963139|NCT00755846|157694131|FG002|Overall Study|Participant Non-compliance|0|||
48658871|NCT02754141|156603719|FG000|Overall Study|No longer meets study criteria|0|||
48658872|NCT02754141|156603720|FG001|Overall Study|No longer meets study criteria|0|||
48658873|NCT02754141|156603721|FG002|Overall Study|No longer meets study criteria|0|||
48658874|NCT02754141|156603722|FG003|Overall Study|No longer meets study criteria|1|||
48658875|NCT02754141|156603723|FG004|Overall Study|No longer meets study criteria|0|||
48963140|NCT00755846|157694132|FG003|Overall Study|Participant Non-compliance|0|||
48963141|NCT00755846|157694133|FG004|Overall Study|Participant Non-compliance|1|||
48658876|NCT02754141|156603724|FG005|Overall Study|No longer meets study criteria|0|||
48658877|NCT02754141|156603725|FG006|Overall Study|No longer meets study criteria|0|||
48658878|NCT02754141|156603726|FG007|Overall Study|No longer meets study criteria|0|||
48658879|NCT02754141|156603727|FG008|Overall Study|No longer meets study criteria|0|||
48658880|NCT02754141|156603728|FG009|Overall Study|No longer meets study criteria|0|||
48658881|NCT02754141|156603729|FG010|Overall Study|No longer meets study criteria|0|||
48658882|NCT02754141|156603730|FG011|Overall Study|No longer meets study criteria|0|||
48658883|NCT02754141|156603731|FG012|Overall Study|No longer meets study criteria|0|||
48658884|NCT02754141|156603732|FG013|Overall Study|No longer meets study criteria|0|||
48658885|NCT02754141|156603733|FG014|Overall Study|No longer meets study criteria|0|||
48658886|NCT02754141|156603734|FG015|Overall Study|No longer meets study criteria|0|||
48658887|NCT02754141|156603735|FG016|Overall Study|No longer meets study criteria|0|||
48658888|NCT02754141|156603736|FG017|Overall Study|No longer meets study criteria|0|||
48658889|NCT02754141|156603719|FG000|Overall Study|Other reasons|0|||
48658890|NCT02754141|156603720|FG001|Overall Study|Other reasons|0|||
48658891|NCT02754141|156603721|FG002|Overall Study|Other reasons|0|||
48658892|NCT02754141|156603722|FG003|Overall Study|Other reasons|0|||
48658893|NCT02754141|156603723|FG004|Overall Study|Other reasons|0|||
48658894|NCT02754141|156603724|FG005|Overall Study|Other reasons|0|||
48658895|NCT02754141|156603725|FG006|Overall Study|Other reasons|0|||
48658896|NCT02754141|156603726|FG007|Overall Study|Other reasons|1|||
48658897|NCT02754141|156603727|FG008|Overall Study|Other reasons|0|||
48658898|NCT02754141|156603728|FG009|Overall Study|Other reasons|0|||
48866191|NCT02382406|157345671|FG000|Follow up|Symptomatic deterioration|1|||
48658899|NCT02754141|156603729|FG010|Overall Study|Other reasons|0|||
48658900|NCT02754141|156603730|FG011|Overall Study|Other reasons|0|||
48658901|NCT02754141|156603731|FG012|Overall Study|Other reasons|2|||
48658902|NCT02754141|156603732|FG013|Overall Study|Other reasons|0|||
48658903|NCT02754141|156603733|FG014|Overall Study|Other reasons|0|||
48658904|NCT02754141|156603734|FG015|Overall Study|Other reasons|0|||
48658905|NCT02754141|156603735|FG016|Overall Study|Other reasons|0|||
48658906|NCT02754141|156603736|FG017|Overall Study|Other reasons|0|||
48658907|NCT02754141|156603719|FG000|Overall Study|Completed treatment as per protocol|0|||
48658908|NCT02754141|156603720|FG001|Overall Study|Completed treatment as per protocol|1|||
48658909|NCT02754141|156603721|FG002|Overall Study|Completed treatment as per protocol|0|||
48658910|NCT02754141|156603722|FG003|Overall Study|Completed treatment as per protocol|0|||
48658911|NCT02754141|156603723|FG004|Overall Study|Completed treatment as per protocol|0|||
48658912|NCT02754141|156603724|FG005|Overall Study|Completed treatment as per protocol|0|||
48658913|NCT02754141|156603725|FG006|Overall Study|Completed treatment as per protocol|0|||
48658914|NCT02754141|156603726|FG007|Overall Study|Completed treatment as per protocol|0|||
48658915|NCT02754141|156603727|FG008|Overall Study|Completed treatment as per protocol|0|||
48658916|NCT02754141|156603728|FG009|Overall Study|Completed treatment as per protocol|0|||
48658917|NCT02754141|156603729|FG010|Overall Study|Completed treatment as per protocol|0|||
48658918|NCT02754141|156603730|FG011|Overall Study|Completed treatment as per protocol|0|||
48658919|NCT02754141|156603731|FG012|Overall Study|Completed treatment as per protocol|1|||
48658920|NCT02754141|156603732|FG013|Overall Study|Completed treatment as per protocol|0|||
48658921|NCT02754141|156603733|FG014|Overall Study|Completed treatment as per protocol|0|||
48658922|NCT02754141|156603734|FG015|Overall Study|Completed treatment as per protocol|0|||
48658923|NCT02754141|156603735|FG016|Overall Study|Completed treatment as per protocol|0|||
48658924|NCT02754141|156603736|FG017|Overall Study|Completed treatment as per protocol|0|||
48658925|NCT02754141|156603719|FG000|Overall Study|Not completing monotherapy|0|||
48658926|NCT02754141|156603720|FG001|Overall Study|Not completing monotherapy|0|||
48658927|NCT02754141|156603721|FG002|Overall Study|Not completing monotherapy|0|||
48658928|NCT02754141|156603722|FG003|Overall Study|Not completing monotherapy|0|||
48658929|NCT02754141|156603723|FG004|Overall Study|Not completing monotherapy|0|||
48658930|NCT02754141|156603724|FG005|Overall Study|Not completing monotherapy|0|||
48658931|NCT02754141|156603725|FG006|Overall Study|Not completing monotherapy|0|||
48658932|NCT02754141|156603726|FG007|Overall Study|Not completing monotherapy|0|||
48658933|NCT02754141|156603727|FG008|Overall Study|Not completing monotherapy|0|||
48658934|NCT02754141|156603728|FG009|Overall Study|Not completing monotherapy|0|||
48658935|NCT02754141|156603729|FG010|Overall Study|Not completing monotherapy|0|||
48866192|NCT02382406|157345672|FG001|Follow up|Symptomatic deterioration|0|||
48866193|NCT02382406|157345673|FG002|Follow up|Symptomatic deterioration|1|||
48866194|NCT02382406|157345671|FG000|Follow up|Patient Refused Follow-up|1|||
48866195|NCT02382406|157345672|FG001|Follow up|Patient Refused Follow-up|0|||
48866196|NCT02382406|157345673|FG002|Follow up|Patient Refused Follow-up|0|||
48866197|NCT02382406|157345671|FG000|Follow up|Study Terminated|1|||
48866198|NCT02382406|157345672|FG001|Follow up|Study Terminated|0|||
48866199|NCT02382406|157345673|FG002|Follow up|Study Terminated|8|||
48866200|NCT02382406|157345671|FG000|Follow up|Withdrawal by Subject|0|||
48866201|NCT02382406|157345672|FG001|Follow up|Withdrawal by Subject|0|||
48866202|NCT02382406|157345673|FG002|Follow up|Withdrawal by Subject|2|||
48866203|NCT02350127|157345674|FG000|4-Month Assessment|Withdrawal by Subject|10|||
48866204|NCT02350127|157345675|FG001|4-Month Assessment|Withdrawal by Subject|9|||
48866205|NCT02350127|157345674|FG000|4-Month Assessment|Death|1|||
48866206|NCT02350127|157345675|FG001|4-Month Assessment|Death|0|||
48866207|NCT02350127|157345674|FG000|8-Month Assessment|Death|1|||
48866208|NCT02350127|157345675|FG001|8-Month Assessment|Death|1|||
48866209|NCT02350127|157345674|FG000|8-Month Assessment|Withdrawal by Subject|5|||
48866210|NCT02350127|157345675|FG001|8-Month Assessment|Withdrawal by Subject|8|||
48658936|NCT02754141|156603730|FG011|Overall Study|Not completing monotherapy|0|||
48658937|NCT02754141|156603731|FG012|Overall Study|Not completing monotherapy|0|||
48658938|NCT02754141|156603732|FG013|Overall Study|Not completing monotherapy|1|||
48658939|NCT02754141|156603733|FG014|Overall Study|Not completing monotherapy|0|||
48658940|NCT02754141|156603734|FG015|Overall Study|Not completing monotherapy|0|||
48658941|NCT02754141|156603735|FG016|Overall Study|Not completing monotherapy|0|||
48658942|NCT02754141|156603736|FG017|Overall Study|Not completing monotherapy|0|||
48658943|NCT03031470|156603739|FG000|Overall Study|Adverse Event|3|||
48658944|NCT03031470|156603740|FG001|Overall Study|Adverse Event|0|||
48658945|NCT03031470|156603739|FG000|Overall Study|Death|3|||
48658946|NCT03031470|156603740|FG001|Overall Study|Death|1|||
48658947|NCT03031470|156603739|FG000|Overall Study|Lost to Follow-up|1|||
48658948|NCT03031470|156603740|FG001|Overall Study|Lost to Follow-up|1|||
48658949|NCT03031470|156603739|FG000|Overall Study|Withdrawal by Subject|1|||
48658950|NCT03031470|156603740|FG001|Overall Study|Withdrawal by Subject|0|||
48658951|NCT03031470|156603739|FG000|Overall Study|Protocol entry criteria not met|0|||
48658952|NCT03031470|156603740|FG001|Overall Study|Protocol entry criteria not met|1|||
48658953|NCT03031470|156603739|FG000|Overall Study|Cancel the operation|0|||
48658954|NCT03031470|156603740|FG001|Overall Study|Cancel the operation|1|||
48658955|NCT03505788|156603741|FG000|Overall Study|Lost to Follow-up|2|||
48658956|NCT03505788|156603742|FG001|Overall Study|Lost to Follow-up|1|||
48658957|NCT03505788|156603741|FG000|Overall Study|Withdrawal by Subject|1|||
48658958|NCT03505788|156603742|FG001|Overall Study|Withdrawal by Subject|3|||
48658959|NCT03505788|156603741|FG000|Overall Study|Physician Decision|0|||
48658960|NCT03505788|156603742|FG001|Overall Study|Physician Decision|1|||
48658961|NCT01421303|156603743|FG000|Overall Study|Lost to Follow-up|13|||
48658962|NCT01421303|156603743|FG000|Overall Study|Non compliance with study procedure|1|||
48658963|NCT01421303|156603743|FG000|Overall Study|Other|7|||
48658964|NCT01421303|156603743|FG000|Overall Study|Withdrawal by Subject|1|||
48658965|NCT03960580|156603744|FG000|Overall Study|Adverse Event|2|||
48658966|NCT03960580|156603745|FG001|Overall Study|Adverse Event|1|||
48658967|NCT03960580|156603746|FG002|Overall Study|Adverse Event|1|||
48658968|NCT03960580|156603744|FG000|Overall Study|Lost to Follow-up|1|||
48658969|NCT03960580|156603745|FG001|Overall Study|Lost to Follow-up|0|||
48658970|NCT03960580|156603746|FG002|Overall Study|Lost to Follow-up|0|||
48658971|NCT03960580|156603744|FG000|Overall Study|Lack of Efficacy|2|||
48658972|NCT03960580|156603745|FG001|Overall Study|Lack of Efficacy|1|||
48658973|NCT03960580|156603746|FG002|Overall Study|Lack of Efficacy|0|||
48658974|NCT03960580|156603744|FG000|Overall Study|Protocol Violation|0|||
48658975|NCT03960580|156603745|FG001|Overall Study|Protocol Violation|0|||
48658976|NCT03960580|156603746|FG002|Overall Study|Protocol Violation|1|||
48658977|NCT03960580|156603744|FG000|Overall Study|Withdrawal by Subject|1|||
48658978|NCT03960580|156603745|FG001|Overall Study|Withdrawal by Subject|1|||
48658979|NCT03960580|156603746|FG002|Overall Study|Withdrawal by Subject|1|||
48658980|NCT03960580|156603744|FG000|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
48658981|NCT03960580|156603745|FG001|Overall Study|Marked Randomized in error (patient did not receive study drug)|1|||
48658982|NCT03960580|156603746|FG002|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
48658983|NCT04600076|156603747|FG000|Overall Study|Lost to Follow-up|3|||
48658984|NCT02701777|156603748|FG000|Overall Study|Some subjects did not like the stimulation.|4|||
48658985|NCT02701777|156603749|FG001|Overall Study|Some subjects did not like the stimulation.|0|||
48658986|NCT02701777|156603750|FG002|Overall Study|Some subjects did not like the stimulation.|0|||
48658987|NCT02701777|156603751|FG003|Overall Study|Some subjects did not like the stimulation.|2|||
48658988|NCT02701777|156603748|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
48658989|NCT02701777|156603749|FG001|Overall Study|Some subjects were unable to commit to the training study.|3|||
48866211|NCT00460577|157345676|FG000|Overall Study|Protocol Violation|2|||
48866212|NCT00460577|157345677|FG001|Overall Study|Protocol Violation|6|||
48866213|NCT00776984|157345680|FG000|Overall Study|Adverse Event|8|||
48866214|NCT00776984|157345681|FG001|Overall Study|Adverse Event|2|||
48866215|NCT00776984|157345680|FG000|Overall Study|Protocol Violation|4|||
48866216|NCT00776984|157345681|FG001|Overall Study|Protocol Violation|2|||
48866217|NCT00776984|157345680|FG000|Overall Study|Lost to Follow-up|2|||
48866218|NCT00776984|157345681|FG001|Overall Study|Lost to Follow-up|0|||
48866219|NCT00776984|157345680|FG000|Overall Study|Withdrawal by Subject|12|||
48866220|NCT00776984|157345681|FG001|Overall Study|Withdrawal by Subject|7|||
48866221|NCT00776984|157345680|FG000|Overall Study|Lack of Efficacy|0|||
48866222|NCT00776984|157345681|FG001|Overall Study|Lack of Efficacy|1|||
48866223|NCT00776984|157345680|FG000|Overall Study|Other|5|||
48866224|NCT00776984|157345681|FG001|Overall Study|Other|9|||
48866225|NCT03802513|157345686|FG000|Overall Study|Lost to Follow-up|1|||
48866226|NCT00274846|157345690|FG000|Overall Study|Did not receive adequate NK cells|1|||
48866227|NCT01190228|157345691|FG000|Overall Study|Protocol Violation|4|||
48866228|NCT01190228|157345692|FG001|Overall Study|Protocol Violation|0|||
48866229|NCT01190228|157345693|FG002|Overall Study|Protocol Violation|0|||
48866230|NCT01190228|157345691|FG000|Overall Study|Withdrawal by Subject|1|||
48866231|NCT01190228|157345692|FG001|Overall Study|Withdrawal by Subject|0|||
48963142|NCT00755846|157694134|FG005|Overall Study|Participant Non-compliance|0|||
48963143|NCT00853489|157694135|FG000|Overall Study|Lost to Follow-up|5|||
48963144|NCT00853489|157694136|FG001|Overall Study|Lost to Follow-up|2|||
48963145|NCT03331666|157694137|FG000|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
48963146|NCT03331666|157694138|FG001|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
48963147|NCT02326467|157694139|FG000|Overall Study|Withdrawal by Subject|1|||
48963148|NCT00434512|157694140|FG000|Overall Study|Migrated/moved from study area|0|||
48963149|NCT00434512|157694141|FG001|Overall Study|Migrated/moved from study area|0|||
48963150|NCT00434512|157694142|FG002|Overall Study|Migrated/moved from study area|0|||
48963151|NCT00434512|157694143|FG003|Overall Study|Migrated/moved from study area|1|||
48963152|NCT00434512|157694144|FG004|Overall Study|Migrated/moved from study area|1|||
48963153|NCT00434512|157694145|FG005|Overall Study|Migrated/moved from study area|1|||
48963154|NCT00434512|157694140|FG000|Overall Study|Other|0|||
48963155|NCT00434512|157694141|FG001|Overall Study|Other|1|||
48963156|NCT00434512|157694142|FG002|Overall Study|Other|0|||
48963157|NCT00434512|157694143|FG003|Overall Study|Other|0|||
48963158|NCT00434512|157694144|FG004|Overall Study|Other|0|||
48963159|NCT00434512|157694145|FG005|Overall Study|Other|0|||
48963160|NCT01000727|157694152|FG000|Overall Study|Lost to Follow-up|41|||
48963161|NCT01000727|157694153|FG001|Overall Study|Lost to Follow-up|43|||
48963162|NCT01000727|157694152|FG000|Overall Study|Withdrawal by Subject|111|||
48963163|NCT01000727|157694153|FG001|Overall Study|Withdrawal by Subject|109|||
48963164|NCT01000727|157694152|FG000|Overall Study|Study closed/terminated|23|||
48963165|NCT01000727|157694153|FG001|Overall Study|Study closed/terminated|24|||
48963166|NCT00836277|157694156|FG000|Overall Study|Not evaluable for response|6|||
48963167|NCT00377611|157694159|FG000|Overall Study|Adverse Event|2|||
48963168|NCT00377611|157694160|FG001|Overall Study|Adverse Event|9|||
48963169|NCT00377611|157694159|FG000|Overall Study|Protocol Violation|2|||
48963170|NCT00377611|157694160|FG001|Overall Study|Protocol Violation|0|||
48963171|NCT00377611|157694159|FG000|Overall Study|Withdrawal by Subject|0|||
48963172|NCT00377611|157694160|FG001|Overall Study|Withdrawal by Subject|5|||
48963173|NCT00377611|157694159|FG000|Overall Study|Lost to Follow-up|18|||
48963174|NCT00377611|157694160|FG001|Overall Study|Lost to Follow-up|16|||
48963175|NCT00377611|157694159|FG000|Overall Study|Other|0|||
48963176|NCT00377611|157694160|FG001|Overall Study|Other|3|||
48658990|NCT02701777|156603750|FG002|Overall Study|Some subjects were unable to commit to the training study.|4|||
48658991|NCT02701777|156603751|FG003|Overall Study|Some subjects were unable to commit to the training study.|0|||
48658992|NCT01327053|156603752|FG000|Overall Study|Adverse Event|23|||
48658993|NCT01327053|156603753|FG001|Overall Study|Adverse Event|57|||
48755293|NCT00715078|156951225|FG002|Overall Study|Unable to start due to disease prog.|1|||
48658994|NCT01327053|156603752|FG000|Overall Study|Patient/guardian decision|11|||
48658995|NCT01327053|156603753|FG001|Overall Study|Patient/guardian decision|35|||
48658996|NCT01327053|156603752|FG000|Overall Study|Physician Decision|10|||
48658997|NCT01327053|156603753|FG001|Overall Study|Physician Decision|14|||
48658998|NCT01327053|156603752|FG000|Overall Study|Death|1|||
48658999|NCT01327053|156603753|FG001|Overall Study|Death|5|||
48755294|NCT00386776|156951226|FG000|Overall Study|Withdrawal by Subject|8|||
48755295|NCT00788151|156951227|FG000|Overall Study|Other adverse event|0|||
48755296|NCT00788151|156951228|FG001|Overall Study|Other adverse event|2|||
48755297|NCT00788151|156951227|FG000|Overall Study|Protocol Violation|0|||
48755298|NCT00788151|156951228|FG001|Overall Study|Protocol Violation|1|||
48755299|NCT00788151|156951227|FG000|Overall Study|Withdrawal by Subject|13|||
48755300|NCT00788151|156951228|FG001|Overall Study|Withdrawal by Subject|6|||
48755301|NCT00788151|156951227|FG000|Overall Study|Enrolled but not treated|1|||
48755302|NCT00788151|156951228|FG001|Overall Study|Enrolled but not treated|1|||
48755303|NCT00498602|156951234|FG000|Overall Study|Death|0|||
48755304|NCT00498602|156951235|FG001|Overall Study|Death|0|||
48755305|NCT00498602|156951236|FG002|Overall Study|Death|0|||
48755306|NCT00498602|156951237|FG003|Overall Study|Death|0|||
48963177|NCT04831515|157694163|FG000|First Intervention|Adverse Event|0|||
48963178|NCT04831515|157694164|FG001|First Intervention|Adverse Event|1|||
48755307|NCT00498602|156951238|FG004|Overall Study|Death|0|||
48755308|NCT00498602|156951239|FG005|Overall Study|Death|1|||
48963179|NCT02338492|157694165|FG000|Overall Study|Death|32|||
48963180|NCT02338492|157694165|FG000|Overall Study|Adverse Event|3|||
48963181|NCT02338492|157694165|FG000|Overall Study|Lost to Follow-up|4|||
48963182|NCT02338492|157694165|FG000|Overall Study|Reason not captured above|6|||
48659000|NCT01327053|156603752|FG000|Overall Study|Lost to Follow-up|2|||
48659001|NCT01327053|156603753|FG001|Overall Study|Lost to Follow-up|4|||
48755309|NCT00498602|156951240|FG006|Overall Study|Death|0|||
48659002|NCT01327053|156603752|FG000|Overall Study|Non-compliance with study treatment|0|||
48659003|NCT01327053|156603753|FG001|Overall Study|Non-compliance with study treatment|5|||
48963183|NCT00650091|157694166|FG000|Amended Study Design|Withdrawal by Subject|12|||
48963184|NCT00650091|157694167|FG001|Amended Study Design|Withdrawal by Subject|11|||
48963185|NCT00650091|157694168|FG002|Amended Study Design|Withdrawal by Subject|0|||
48963186|NCT00650091|157694166|FG000|Amended Study Design|Physician Decision|5|||
48963187|NCT00650091|157694167|FG001|Amended Study Design|Physician Decision|0|||
48659004|NCT01327053|156603752|FG000|Overall Study|Study terminated by Sponsor|1|||
48659005|NCT01327053|156603753|FG001|Overall Study|Study terminated by Sponsor|3|||
48659006|NCT01327053|156603752|FG000|Overall Study|Progressive disease|31|||
48659007|NCT01327053|156603753|FG001|Overall Study|Progressive disease|26|||
48659008|NCT01327053|156603752|FG000|Overall Study|Protocol Violation|0|||
48659009|NCT01327053|156603753|FG001|Overall Study|Protocol Violation|1|||
48659010|NCT01327053|156603752|FG000|Overall Study|Untreated|0|||
48659011|NCT01327053|156603753|FG001|Overall Study|Untreated|1|||
48659012|NCT01574157|156603754|FG000|Overall Study|Withdrawal by Subject|4|||
48659013|NCT01574157|156603755|FG001|Overall Study|Withdrawal by Subject|5|||
48659014|NCT01574157|156603754|FG000|Overall Study|Lost to Follow-up|0|||
48659015|NCT01574157|156603755|FG001|Overall Study|Lost to Follow-up|3|||
48659016|NCT02298179|156603756|FG000|Overall Study|Lost to Follow-up|0|||
48659017|NCT02298179|156603757|FG001|Overall Study|Lost to Follow-up|0|||
48659018|NCT02298179|156603758|FG002|Overall Study|Lost to Follow-up|1|||
48659019|NCT02298179|156603759|FG003|Overall Study|Lost to Follow-up|0|||
48659020|NCT02298179|156603760|FG004|Overall Study|Lost to Follow-up|0|||
48659021|NCT02298179|156603761|FG005|Overall Study|Lost to Follow-up|0|||
48659022|NCT02298179|156603762|FG006|Overall Study|Lost to Follow-up|0|||
48659023|NCT02298179|156603763|FG007|Overall Study|Lost to Follow-up|1|||
48659024|NCT02298179|156603764|FG008|Overall Study|Lost to Follow-up|0|||
48659025|NCT02298179|156603765|FG009|Overall Study|Lost to Follow-up|0|||
48659026|NCT02298179|156603766|FG010|Overall Study|Lost to Follow-up|0|||
48963188|NCT00650091|157694168|FG002|Amended Study Design|Physician Decision|0|||
48659027|NCT02298179|156603767|FG011|Overall Study|Lost to Follow-up|0|||
48659028|NCT01824823|156603775|FG000|Overall Study|Lack of Efficacy|1|||
48659029|NCT01824823|156603776|FG001|Overall Study|Lack of Efficacy|1|||
48659030|NCT01824823|156603775|FG000|Overall Study|Off-treatment reason not submitted|1|||
48659031|NCT01824823|156603776|FG001|Overall Study|Off-treatment reason not submitted|0|||
48659032|NCT01170065|156603787|FG000|Overall Study|Adverse Event|17|||
48659033|NCT01170065|156603788|FG001|Overall Study|Adverse Event|50|||
48659034|NCT01170065|156603789|FG002|Overall Study|Adverse Event|10|||
48659035|NCT01170065|156603787|FG000|Overall Study|Lost to Follow-up|1|||
48659036|NCT01170065|156603788|FG001|Overall Study|Lost to Follow-up|4|||
48659037|NCT01170065|156603789|FG002|Overall Study|Lost to Follow-up|1|||
48659038|NCT01170065|156603787|FG000|Overall Study|Consent withdrawn, not due to AE|2|||
48659039|NCT01170065|156603788|FG001|Overall Study|Consent withdrawn, not due to AE|4|||
48659040|NCT01170065|156603789|FG002|Overall Study|Consent withdrawn, not due to AE|2|||
48659041|NCT01170065|156603787|FG000|Overall Study|Reason other than specified|3|||
48659042|NCT01170065|156603788|FG001|Overall Study|Reason other than specified|8|||
48659043|NCT01170065|156603789|FG002|Overall Study|Reason other than specified|3|||
48659044|NCT01170065|156603787|FG000|Overall Study|Ongoing after planned observation time|5|||
48659045|NCT01170065|156603788|FG001|Overall Study|Ongoing after planned observation time|26|||
48659046|NCT01170065|156603789|FG002|Overall Study|Ongoing after planned observation time|10|||
48659047|NCT01089023|156603790|FG000|Overall Study|Lost to Follow-up|3|||
48659048|NCT01089023|156603790|FG000|Overall Study|Adverse Event|1|||
48659049|NCT01089023|156603790|FG000|Overall Study|Withdrawal by Subject|1|||
48659050|NCT01089023|156603790|FG000|Overall Study|Protocol Violation|1|||
48659051|NCT01089023|156603790|FG000|Overall Study|Lack of Efficacy|1|||
48659052|NCT02323204|156603794|FG000|Baseline Survey Completion|Withdrawal by Subject|10|||
48659053|NCT02323204|156603795|FG001|Baseline Survey Completion|Withdrawal by Subject|9|||
48659054|NCT02323204|156603796|FG002|Baseline Survey Completion|Withdrawal by Subject|5|||
48963189|NCT00650091|157694166|FG000|Amended Study Design|Adverse Event|1|||
48659055|NCT02323204|156603797|FG003|Baseline Survey Completion|Withdrawal by Subject|3|||
48659056|NCT02323204|156603794|FG000|6-week Follow-up Survey Completion|Lost to Follow-up|29|||
48963190|NCT00650091|157694167|FG001|Amended Study Design|Adverse Event|4|||
48659057|NCT02323204|156603795|FG001|6-week Follow-up Survey Completion|Lost to Follow-up|28|||
48659058|NCT02323204|156603796|FG002|6-week Follow-up Survey Completion|Lost to Follow-up|39|||
48659059|NCT02323204|156603797|FG003|6-week Follow-up Survey Completion|Lost to Follow-up|35|||
48659060|NCT02323204|156603794|FG000|6-week Follow-up Survey Completion|Withdrawal by Subject|12|||
48659061|NCT02323204|156603795|FG001|6-week Follow-up Survey Completion|Withdrawal by Subject|8|||
48963191|NCT00650091|157694168|FG002|Amended Study Design|Adverse Event|0|||
48659062|NCT02323204|156603796|FG002|6-week Follow-up Survey Completion|Withdrawal by Subject|3|||
48659063|NCT02323204|156603797|FG003|6-week Follow-up Survey Completion|Withdrawal by Subject|2|||
48659064|NCT02323204|156603794|FG000|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
48659065|NCT02323204|156603795|FG001|6-week Follow-up Intervention Booster|Lost to Follow-up|35|||
48659066|NCT02323204|156603796|FG002|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
48659067|NCT02323204|156603797|FG003|6-week Follow-up Intervention Booster|Lost to Follow-up|34|||
48659068|NCT02323204|156603794|FG000|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
48659069|NCT02323204|156603795|FG001|6-week Follow-up Intervention Booster|Withdrawal by Subject|8|||
48659070|NCT02323204|156603796|FG002|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
48659071|NCT02323204|156603797|FG003|6-week Follow-up Intervention Booster|Withdrawal by Subject|2|||
48659072|NCT02323204|156603794|FG000|3-month Follow-up Survey Completion|Lost to Follow-up|54|||
48963192|NCT00650091|157694166|FG000|Amended Study Design|Lung transplantation|4|||
48659073|NCT02323204|156603795|FG001|3-month Follow-up Survey Completion|Lost to Follow-up|45|||
48659074|NCT02323204|156603796|FG002|3-month Follow-up Survey Completion|Lost to Follow-up|41|||
48659075|NCT02323204|156603797|FG003|3-month Follow-up Survey Completion|Lost to Follow-up|42|||
48659076|NCT02323204|156603794|FG000|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
48659077|NCT02323204|156603795|FG001|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
48659078|NCT02323204|156603796|FG002|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
48659079|NCT02323204|156603797|FG003|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
48659080|NCT02323204|156603794|FG000|6-month Follow-up Survey Completion|Lost to Follow-up|49|||
48659081|NCT02323204|156603795|FG001|6-month Follow-up Survey Completion|Lost to Follow-up|50|||
48659082|NCT02323204|156603796|FG002|6-month Follow-up Survey Completion|Lost to Follow-up|38|||
48659083|NCT02323204|156603797|FG003|6-month Follow-up Survey Completion|Lost to Follow-up|43|||
48659084|NCT02323204|156603794|FG000|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
48659085|NCT02323204|156603795|FG001|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
48659086|NCT02323204|156603796|FG002|6-month Follow-up Survey Completion|Withdrawal by Subject|3|||
48659087|NCT02323204|156603797|FG003|6-month Follow-up Survey Completion|Withdrawal by Subject|1|||
48659088|NCT03158012|156603799|FG000|Overall Study|Withdrawal by Subject|0|||
48659089|NCT03158012|156603800|FG001|Overall Study|Withdrawal by Subject|1|||
48659090|NCT02141490|156603808|FG000|Overall Study|Screening failures|4|||
48659091|NCT02141490|156603809|FG001|Overall Study|Screening failures|0|||
48659092|NCT02141490|156603810|FG002|Overall Study|Screening failures|0|||
48659093|NCT00191724|156605133|FG000|Overall Study|Adverse Event|0|||
48659094|NCT00191724|156605134|FG001|Overall Study|Adverse Event|0|||
48659095|NCT00191724|156605135|FG002|Overall Study|Adverse Event|1|||
48659096|NCT00191724|156605136|FG003|Overall Study|Adverse Event|0|||
48659097|NCT00191724|156605137|FG004|Overall Study|Adverse Event|0|||
48659098|NCT00191724|156605133|FG000|Overall Study|Lost to Follow-up|1|||
48659099|NCT00191724|156605134|FG001|Overall Study|Lost to Follow-up|1|||
48659100|NCT00191724|156605135|FG002|Overall Study|Lost to Follow-up|0|||
48659101|NCT00191724|156605136|FG003|Overall Study|Lost to Follow-up|2|||
48659102|NCT00191724|156605137|FG004|Overall Study|Lost to Follow-up|3|||
48659103|NCT00191724|156605133|FG000|Overall Study|Withdrawal by Subject|0|||
48659104|NCT00191724|156605134|FG001|Overall Study|Withdrawal by Subject|0|||
48659105|NCT00191724|156605135|FG002|Overall Study|Withdrawal by Subject|0|||
48963193|NCT00650091|157694167|FG001|Amended Study Design|Lung transplantation|2|||
48963194|NCT00650091|157694168|FG002|Amended Study Design|Lung transplantation|0|||
48963195|NCT00650091|157694166|FG000|Amended Study Design|Other|1|||
48963196|NCT00650091|157694167|FG001|Amended Study Design|Other|3|||
48963197|NCT00650091|157694168|FG002|Amended Study Design|Other|0|||
48963198|NCT02106455|157694169|FG000|Overall Study|Case Report Form Uncollected|6|||
48963199|NCT02106455|157694169|FG000|Overall Study|Protocol Deviation|2|||
48963200|NCT00997321|157694170|FG000|Overall Study|did not undergo sedation after enrollmen|0|||
48963201|NCT00997321|157694171|FG001|Overall Study|did not undergo sedation after enrollmen|3|||
48963202|NCT01088438|157694186|FG000|Overall Study|Withdrawal by Subject|11|||
48963203|NCT01088438|157694187|FG001|Overall Study|Withdrawal by Subject|6|||
48963204|NCT01088438|157694186|FG000|Overall Study|Lost to Follow-up|18|||
48963205|NCT01088438|157694187|FG001|Overall Study|Lost to Follow-up|30|||
48963206|NCT01363713|157694188|FG000|Overall Study|Adverse Event|1|||
48963207|NCT01363713|157694188|FG000|Overall Study|Protocol Violation|3|||
48963208|NCT01363713|157694188|FG000|Overall Study|Withdrawal by Subject|2|||
48963209|NCT03198754|157694189|FG000|Overall Study|Withdrawal by Subject|5|||
48963210|NCT03198754|157694190|FG001|Overall Study|Withdrawal by Subject|4|||
48963211|NCT03198754|157694189|FG000|Overall Study|Lost to Follow-up|4|||
48963212|NCT03198754|157694190|FG001|Overall Study|Lost to Follow-up|3|||
48963213|NCT03198754|157694189|FG000|Overall Study|Ineligible|2|||
48963214|NCT03198754|157694190|FG001|Overall Study|Ineligible|1|||
48963215|NCT01594333|157694191|FG000|Overall Study|Death|96|||
48963216|NCT01594333|157694192|FG001|Overall Study|Death|83|||
48963217|NCT01594333|157694191|FG000|Overall Study|Lost to Follow-up|5|||
48963218|NCT01594333|157694192|FG001|Overall Study|Lost to Follow-up|5|||
48963219|NCT01594333|157694191|FG000|Overall Study|Withdrawal by Subject|60|||
48963220|NCT01594333|157694192|FG001|Overall Study|Withdrawal by Subject|63|||
48963221|NCT01797965|157694193|FG000|Overall Study|Adverse Event|104|||
48963222|NCT01797965|157694194|FG001|Overall Study|Adverse Event|129|||
48963223|NCT01797965|157694195|FG002|Overall Study|Adverse Event|4|||
48963224|NCT01797965|157694196|FG003|Overall Study|Adverse Event|21|||
48963225|NCT01797965|157694193|FG000|Overall Study|Lost to Follow-up|9|||
48963226|NCT01797965|157694194|FG001|Overall Study|Lost to Follow-up|8|||
49015435|NCT01497938|157892193|FG001|Overall Study|Device Violation|0|||
48659106|NCT00191724|156605136|FG003|Overall Study|Withdrawal by Subject|1|||
48963227|NCT01797965|157694195|FG002|Overall Study|Lost to Follow-up|1|||
48963228|NCT01797965|157694196|FG003|Overall Study|Lost to Follow-up|2|||
48963229|NCT01797965|157694193|FG000|Overall Study|Consent withdrawn|130|||
48963230|NCT01797965|157694194|FG001|Overall Study|Consent withdrawn|117|||
48963231|NCT01797965|157694195|FG002|Overall Study|Consent withdrawn|3|||
48963232|NCT01797965|157694196|FG003|Overall Study|Consent withdrawn|35|||
48963233|NCT01797965|157694193|FG000|Overall Study|Investigator decision|21|||
48963234|NCT01797965|157694194|FG001|Overall Study|Investigator decision|15|||
48963235|NCT01797965|157694195|FG002|Overall Study|Investigator decision|0|||
48963236|NCT01797965|157694196|FG003|Overall Study|Investigator decision|0|||
48963237|NCT01797965|157694193|FG000|Overall Study|Death|2|||
48963238|NCT01797965|157694194|FG001|Overall Study|Death|4|||
48963239|NCT01797965|157694195|FG002|Overall Study|Death|0|||
48963240|NCT01797965|157694196|FG003|Overall Study|Death|0|||
48963241|NCT01797965|157694193|FG000|Overall Study|Disease progression, defined by protocol|3|||
48963242|NCT01797965|157694194|FG001|Overall Study|Disease progression, defined by protocol|1|||
48963243|NCT01797965|157694195|FG002|Overall Study|Disease progression, defined by protocol|0|||
48963244|NCT01797965|157694196|FG003|Overall Study|Disease progression, defined by protocol|0|||
48963245|NCT01797965|157694193|FG000|Overall Study|Reason Not Specified|280|||
48963246|NCT01797965|157694194|FG001|Overall Study|Reason Not Specified|295|||
48963247|NCT01797965|157694195|FG002|Overall Study|Reason Not Specified|0|||
48963248|NCT01797965|157694196|FG003|Overall Study|Reason Not Specified|15|||
48963249|NCT01479374|157694197|FG000|Overall Study|Adverse Event|2|||
48963250|NCT01479374|157694198|FG001|Overall Study|Adverse Event|1|||
48963251|NCT01479374|157694199|FG002|Overall Study|Adverse Event|0|||
48963252|NCT01479374|157694197|FG000|Overall Study|Lost to Follow-up|1|||
48963253|NCT01479374|157694198|FG001|Overall Study|Lost to Follow-up|2|||
48963254|NCT01479374|157694199|FG002|Overall Study|Lost to Follow-up|0|||
48963255|NCT01479374|157694197|FG000|Overall Study|Decision Unrelated to Adverse Event|0|||
48963256|NCT01479374|157694198|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
48963257|NCT01479374|157694199|FG002|Overall Study|Decision Unrelated to Adverse Event|0|||
48963258|NCT01479374|157694197|FG000|Overall Study|Other|0|||
48963259|NCT01479374|157694198|FG001|Overall Study|Other|4|||
48963260|NCT01479374|157694199|FG002|Overall Study|Other|5|||
48963261|NCT01397448|157694200|FG000|Overall Study|Adverse Event|4|||
48963262|NCT01397448|157694201|FG001|Overall Study|Adverse Event|4|||
48963263|NCT01397448|157694202|FG002|Overall Study|Adverse Event|6|||
48963264|NCT01397448|157694200|FG000|Overall Study|Withdrawal by Subject|4|||
48963265|NCT01397448|157694201|FG001|Overall Study|Withdrawal by Subject|4|||
48963266|NCT01397448|157694202|FG002|Overall Study|Withdrawal by Subject|3|||
48963267|NCT01397448|157694200|FG000|Overall Study|Lack of Efficacy|2|||
48963268|NCT01397448|157694201|FG001|Overall Study|Lack of Efficacy|0|||
48963269|NCT01397448|157694202|FG002|Overall Study|Lack of Efficacy|5|||
48963270|NCT01397448|157694200|FG000|Overall Study|Other|8|||
48963271|NCT01397448|157694201|FG001|Overall Study|Other|7|||
48963272|NCT01397448|157694202|FG002|Overall Study|Other|4|||
48963273|NCT00973921|157694203|FG000|Overall Study|IVUS results were not available|9|||
48963274|NCT03115476|157694209|FG000|LP0084-1369|Death|1|||
48963275|NCT03115476|157694210|FG001|LP0084-1369|Death|0|||
48963276|NCT03115476|157694211|FG002|LP0084-1369|Death|2|||
48963277|NCT03115476|157694209|FG000|LP0084-1369|Trial terminated by Sponsor|190|||
48963278|NCT03115476|157694210|FG001|LP0084-1369|Trial terminated by Sponsor|210|||
48963279|NCT03115476|157694211|FG002|LP0084-1369|Trial terminated by Sponsor|160|||
48963280|NCT00229203|157694212|FG000|Overall Study|Progressive disease|18|||
48963281|NCT00229203|157694213|FG001|Overall Study|Progressive disease|9|||
48963282|NCT00229203|157694212|FG000|Overall Study|Toxicity|6|||
48963283|NCT00229203|157694213|FG001|Overall Study|Toxicity|1|||
48963284|NCT00229203|157694212|FG000|Overall Study|Death|4|||
48963285|NCT00229203|157694213|FG001|Overall Study|Death|2|||
48963286|NCT00229203|157694212|FG000|Overall Study|Other|3|||
48963287|NCT00229203|157694213|FG001|Overall Study|Other|3|||
48963288|NCT00229203|157694212|FG000|Overall Study|Withdrawal by Subject|1|||
48963289|NCT00229203|157694213|FG001|Overall Study|Withdrawal by Subject|4|||
48963290|NCT00488592|157694216|FG000|Overall Study|Withdrawal by Subject|1|||
48963291|NCT00488592|157694216|FG000|Overall Study|Disease progression|1|||
48963292|NCT00488592|157694216|FG000|Overall Study|Enrolled but not treated|1|||
48963293|NCT02785952|157694217|FG000|Overall Study|Adverse Event|31|||
48963294|NCT02785952|157694218|FG001|Overall Study|Adverse Event|19|||
48963295|NCT02785952|157694217|FG000|Overall Study|Refusal unrelated to adverse events|10|||
48963296|NCT02785952|157694218|FG001|Overall Study|Refusal unrelated to adverse events|5|||
48963297|NCT02785952|157694217|FG000|Overall Study|Disease progression/relapse|61|||
48963298|NCT02785952|157694218|FG001|Overall Study|Disease progression/relapse|89|||
48963299|NCT02785952|157694217|FG000|Overall Study|Death|11|||
49015436|NCT03322462|157893769|FG000|Overall Study|Technical difficulties|2|||
48963300|NCT02785952|157694218|FG001|Overall Study|Death|7|||
48963301|NCT02785952|157694217|FG000|Overall Study|Other- not protocol specified|6|||
48963302|NCT02785952|157694218|FG001|Overall Study|Other- not protocol specified|4|||
48963303|NCT02785952|157694217|FG000|Overall Study|On protocol treatment|6|||
48963304|NCT02785952|157694218|FG001|Overall Study|On protocol treatment|3|||
48963305|NCT01324622|157694219|FG000|Overall Study|Lost to Follow-up|7|||
48963306|NCT01324622|157694220|FG001|Overall Study|Lost to Follow-up|7|||
48963307|NCT01324622|157694219|FG000|Overall Study|Death|1|||
48963308|NCT01324622|157694220|FG001|Overall Study|Death|0|||
48963309|NCT01324622|157694219|FG000|Overall Study|Lack of Efficacy|1|||
48963310|NCT01324622|157694220|FG001|Overall Study|Lack of Efficacy|0|||
48963311|NCT00645567|157694223|FG000|Overall Study|Adverse Event|1|||
48963312|NCT02358369|157694224|FG000|Pre-Randomization Washout Period|Not Qualified for Randomization|35|||
48963313|NCT02358369|157694225|FG001|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
48963314|NCT02358369|157694226|FG002|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
48659107|NCT00191724|156605137|FG004|Overall Study|Withdrawal by Subject|0|||
48659108|NCT01772472|156605138|FG000|Overall Study|Death|56|||
48659109|NCT01772472|156605139|FG001|Overall Study|Death|42|||
48659110|NCT01772472|156605138|FG000|Overall Study|Physician Decision|1|||
48659111|NCT01772472|156605139|FG001|Overall Study|Physician Decision|3|||
48659112|NCT01772472|156605138|FG000|Overall Study|Other|5|||
48659113|NCT01772472|156605139|FG001|Overall Study|Other|5|||
48659114|NCT01772472|156605138|FG000|Overall Study|Lost to Follow-up|12|||
48659115|NCT01772472|156605139|FG001|Overall Study|Lost to Follow-up|8|||
48659116|NCT01772472|156605138|FG000|Overall Study|Withdrawal by Subject|72|||
48659117|NCT01772472|156605139|FG001|Overall Study|Withdrawal by Subject|50|||
48659118|NCT01772472|156605138|FG000|Overall Study|Ongoing|597|||
48659119|NCT01772472|156605139|FG001|Overall Study|Ongoing|635|||
48659120|NCT03334851|156605140|FG000|Overall Study|Other|0|||
48659121|NCT03334851|156605141|FG001|Overall Study|Other|0|||
48659122|NCT03334851|156605142|FG002|Overall Study|Other|0|||
48659123|NCT03334851|156605143|FG003|Overall Study|Other|0|||
48659124|NCT03334851|156605144|FG004|Overall Study|Other|0|||
48659125|NCT03334851|156605145|FG005|Overall Study|Other|0|||
48659126|NCT03334851|156605146|FG006|Overall Study|Other|0|||
48659127|NCT03334851|156605147|FG007|Overall Study|Other|1|||
48659128|NCT03334851|156605148|FG008|Overall Study|Other|0|||
48659129|NCT03334851|156605149|FG009|Overall Study|Other|0|||
48659130|NCT03334851|156605150|FG010|Overall Study|Other|0|||
48659131|NCT03334851|156605151|FG011|Overall Study|Other|0|||
48659132|NCT03334851|156605152|FG012|Overall Study|Other|0|||
48659133|NCT03334851|156605140|FG000|Overall Study|Adverse Event|0|||
48659134|NCT03334851|156605141|FG001|Overall Study|Adverse Event|0|||
48659135|NCT03334851|156605142|FG002|Overall Study|Adverse Event|0|||
48659136|NCT03334851|156605143|FG003|Overall Study|Adverse Event|0|||
48659137|NCT03334851|156605144|FG004|Overall Study|Adverse Event|0|||
48659138|NCT03334851|156605145|FG005|Overall Study|Adverse Event|0|||
48659139|NCT03334851|156605146|FG006|Overall Study|Adverse Event|0|||
48659140|NCT03334851|156605147|FG007|Overall Study|Adverse Event|1|||
48659141|NCT03334851|156605148|FG008|Overall Study|Adverse Event|0|||
48659142|NCT03334851|156605149|FG009|Overall Study|Adverse Event|0|||
48659143|NCT03334851|156605150|FG010|Overall Study|Adverse Event|0|||
48659144|NCT03334851|156605151|FG011|Overall Study|Adverse Event|0|||
48659145|NCT03334851|156605152|FG012|Overall Study|Adverse Event|0|||
48659146|NCT03334851|156605140|FG000|Overall Study|Withdrawal by Subject|0|||
48659147|NCT03334851|156605141|FG001|Overall Study|Withdrawal by Subject|0|||
48659148|NCT03334851|156605142|FG002|Overall Study|Withdrawal by Subject|0|||
48659149|NCT03334851|156605143|FG003|Overall Study|Withdrawal by Subject|0|||
48659150|NCT03334851|156605144|FG004|Overall Study|Withdrawal by Subject|0|||
48659151|NCT03334851|156605145|FG005|Overall Study|Withdrawal by Subject|0|||
48659152|NCT03334851|156605146|FG006|Overall Study|Withdrawal by Subject|0|||
48659153|NCT03334851|156605147|FG007|Overall Study|Withdrawal by Subject|0|||
48659154|NCT03334851|156605148|FG008|Overall Study|Withdrawal by Subject|0|||
48659155|NCT03334851|156605149|FG009|Overall Study|Withdrawal by Subject|0|||
48659156|NCT03334851|156605150|FG010|Overall Study|Withdrawal by Subject|1|||
48659157|NCT03334851|156605151|FG011|Overall Study|Withdrawal by Subject|0|||
48659158|NCT03334851|156605152|FG012|Overall Study|Withdrawal by Subject|1|||
48659159|NCT03334851|156605140|FG000|Overall Study|Lost to Follow-up|0|||
48659160|NCT03334851|156605141|FG001|Overall Study|Lost to Follow-up|0|||
48659161|NCT03334851|156605142|FG002|Overall Study|Lost to Follow-up|0|||
48659162|NCT03334851|156605143|FG003|Overall Study|Lost to Follow-up|0|||
48659163|NCT03334851|156605144|FG004|Overall Study|Lost to Follow-up|0|||
48659164|NCT03334851|156605145|FG005|Overall Study|Lost to Follow-up|0|||
48659165|NCT03334851|156605146|FG006|Overall Study|Lost to Follow-up|0|||
48659166|NCT03334851|156605147|FG007|Overall Study|Lost to Follow-up|0|||
48659167|NCT03334851|156605148|FG008|Overall Study|Lost to Follow-up|0|||
48963315|NCT02358369|157694227|FG003|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
48659168|NCT03334851|156605149|FG009|Overall Study|Lost to Follow-up|0|||
48659169|NCT03334851|156605150|FG010|Overall Study|Lost to Follow-up|2|||
48659170|NCT03334851|156605151|FG011|Overall Study|Lost to Follow-up|1|||
48659171|NCT03334851|156605152|FG012|Overall Study|Lost to Follow-up|0|||
48659172|NCT00523705|156605153|FG000|Overall Study|No time for study.|0|||
48659173|NCT00523705|156605154|FG001|Overall Study|No time for study.|1|||
48659174|NCT00596154|156605155|FG000|Overall Study|Not Evaluable|2|||
48659175|NCT01534260|156605162|FG000|Overall Study|Adverse Event|1|||
48659176|NCT01534260|156605163|FG001|Overall Study|Adverse Event|8|||
48659177|NCT01534260|156605162|FG000|Overall Study|Death|2|||
48659178|NCT01534260|156605163|FG001|Overall Study|Death|0|||
48659179|NCT01534260|156605162|FG000|Overall Study|Lack of Efficacy|1|||
48659180|NCT01534260|156605163|FG001|Overall Study|Lack of Efficacy|1|||
48659181|NCT01534260|156605162|FG000|Overall Study|Withdrawal by Subject|1|||
48659182|NCT01534260|156605163|FG001|Overall Study|Withdrawal by Subject|3|||
48963316|NCT02358369|157694228|FG004|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
48963317|NCT02358369|157694224|FG000|Treatment Period A/B|Adverse Event|0|||
48963318|NCT02358369|157694225|FG001|Treatment Period A/B|Adverse Event|0|||
48963319|NCT02358369|157694226|FG002|Treatment Period A/B|Adverse Event|1|||
48963320|NCT02358369|157694227|FG003|Treatment Period A/B|Adverse Event|2|||
48963321|NCT02358369|157694228|FG004|Treatment Period A/B|Adverse Event|0|||
48659183|NCT01534260|156605162|FG000|Overall Study|Disease Progression|8|||
48659184|NCT01534260|156605163|FG001|Overall Study|Disease Progression|6|||
48659185|NCT01534260|156605162|FG000|Overall Study|Physician Decision|3|||
48659186|NCT01534260|156605163|FG001|Overall Study|Physician Decision|1|||
48659187|NCT01534260|156605162|FG000|Overall Study|No treatment, per protocol|0|||
48659188|NCT01534260|156605163|FG001|Overall Study|No treatment, per protocol|1|||
48659189|NCT00856206|156605168|FG000|Overall Study|Protocol Violation|6|||
48659190|NCT00856206|156605169|FG001|Overall Study|Protocol Violation|18|||
48659191|NCT00856206|156605168|FG000|Overall Study|Adverse Event|10|||
48659192|NCT00856206|156605169|FG001|Overall Study|Adverse Event|46|||
48659193|NCT00856206|156605168|FG000|Overall Study|Lack of Efficacy|1|||
48659194|NCT00856206|156605169|FG001|Overall Study|Lack of Efficacy|2|||
48659195|NCT00856206|156605168|FG000|Overall Study|Withdrawal by Subject|15|||
48659196|NCT00856206|156605169|FG001|Overall Study|Withdrawal by Subject|36|||
48659197|NCT00856206|156605168|FG000|Overall Study|Lost to Follow-up|13|||
48659198|NCT00856206|156605169|FG001|Overall Study|Lost to Follow-up|39|||
48659199|NCT00856206|156605168|FG000|Overall Study|Death|2|||
48659200|NCT00856206|156605169|FG001|Overall Study|Death|2|||
48659201|NCT00856206|156605168|FG000|Overall Study|Decision by the Sponsor|4|||
48659202|NCT00856206|156605169|FG001|Overall Study|Decision by the Sponsor|8|||
48659203|NCT00856206|156605168|FG000|Overall Study|Other than specified above|3|||
48659204|NCT00856206|156605169|FG001|Overall Study|Other than specified above|10|||
48659205|NCT04068181|156605170|FG000|Overall Study|Death|17|||
48659206|NCT04068181|156605171|FG001|Overall Study|Death|12|||
48659207|NCT04068181|156605172|FG002|Overall Study|Death|4|||
48659208|NCT04068181|156605173|FG003|Overall Study|Death|7|||
48659209|NCT04068181|156605170|FG000|Overall Study|Lost to Follow-up|1|||
48659210|NCT04068181|156605171|FG001|Overall Study|Lost to Follow-up|0|||
48659211|NCT04068181|156605172|FG002|Overall Study|Lost to Follow-up|0|||
48659212|NCT04068181|156605173|FG003|Overall Study|Lost to Follow-up|0|||
48659213|NCT04068181|156605170|FG000|Overall Study|Withdrawal of consent from study|3|||
48659214|NCT04068181|156605171|FG001|Overall Study|Withdrawal of consent from study|0|||
48659215|NCT04068181|156605172|FG002|Overall Study|Withdrawal of consent from study|0|||
48659216|NCT04068181|156605173|FG003|Overall Study|Withdrawal of consent from study|0|||
48659217|NCT01553149|156605174|FG000|Overall Study|Adverse Event|0|||
48659218|NCT01553149|156605175|FG001|Overall Study|Adverse Event|9|||
48659219|NCT01553149|156605174|FG000|Overall Study|Physician Decision|5|||
48659220|NCT01553149|156605175|FG001|Overall Study|Physician Decision|10|||
48659221|NCT01553149|156605174|FG000|Overall Study|Ineligible|0|||
48659222|NCT01553149|156605175|FG001|Overall Study|Ineligible|1|||
48659223|NCT00468676|156605176|FG000|Overall Study|Lost to Follow-up|14|||
48755310|NCT00498602|156951234|FG000|Overall Study|Lack of Efficacy|1|||
48755311|NCT00498602|156951235|FG001|Overall Study|Lack of Efficacy|0|||
48659224|NCT00468676|156605177|FG001|Overall Study|Lost to Follow-up|11|||
48659225|NCT00468676|156605176|FG000|Overall Study|Death|2|||
48755312|NCT00498602|156951236|FG002|Overall Study|Lack of Efficacy|0|||
48755313|NCT00498602|156951237|FG003|Overall Study|Lack of Efficacy|0|||
48755314|NCT00498602|156951238|FG004|Overall Study|Lack of Efficacy|0|||
48755315|NCT00498602|156951239|FG005|Overall Study|Lack of Efficacy|0|||
48755316|NCT00498602|156951240|FG006|Overall Study|Lack of Efficacy|0|||
48963322|NCT02358369|157694224|FG000|Treatment Period A/B|Death|0|||
48659226|NCT00468676|156605177|FG001|Overall Study|Death|1|||
48659227|NCT05100628|156605183|FG000|Overall Study|Progressive Disease|1|||
48659228|NCT05100628|156605184|FG001|Overall Study|Progressive Disease|0|||
48659229|NCT05100628|156605185|FG002|Overall Study|Progressive Disease|0|||
48659230|NCT05100628|156605186|FG003|Overall Study|Progressive Disease|0|||
48659231|NCT05100628|156605183|FG000|Overall Study|Study Terminated by Sponsor|0|||
48659232|NCT05100628|156605184|FG001|Overall Study|Study Terminated by Sponsor|0|||
48659233|NCT05100628|156605185|FG002|Overall Study|Study Terminated by Sponsor|3|||
48659234|NCT05100628|156605186|FG003|Overall Study|Study Terminated by Sponsor|0|||
48755317|NCT00498602|156951234|FG000|Overall Study|Lost to Follow-up|0|||
48963323|NCT02358369|157694225|FG001|Treatment Period A/B|Death|0|||
48963324|NCT02358369|157694226|FG002|Treatment Period A/B|Death|1|||
48963325|NCT02358369|157694227|FG003|Treatment Period A/B|Death|0|||
49015437|NCT03322462|157893769|FG000|Overall Study|Other|1|||
48659235|NCT05100628|156605183|FG000|Overall Study|unkown|0|||
48659236|NCT05100628|156605184|FG001|Overall Study|unkown|1|||
48755318|NCT00498602|156951235|FG001|Overall Study|Lost to Follow-up|2|||
48755319|NCT00498602|156951236|FG002|Overall Study|Lost to Follow-up|0|||
48659237|NCT05100628|156605185|FG002|Overall Study|unkown|0|||
48659238|NCT05100628|156605186|FG003|Overall Study|unkown|0|||
48659239|NCT00068250|156605197|FG000|Phase I: Dose Level 2|Protocol Violation|0|||
48963326|NCT02358369|157694228|FG004|Treatment Period A/B|Death|0|||
48963327|NCT02358369|157694224|FG000|Treatment Period A/B|Withdrawal by Subject|0|||
48659240|NCT00068250|156605198|FG001|Phase I: Dose Level 2|Protocol Violation|1|||
48659241|NCT00068250|156605199|FG002|Phase I: Dose Level 2|Protocol Violation|0|||
48659242|NCT00068250|156605200|FG003|Phase I: Dose Level 2|Protocol Violation|0|||
48659243|NCT03352557|156605209|FG000|PC Period: Day 1 to Week 78|Death|1|||
48659244|NCT03352557|156605210|FG001|PC Period: Day 1 to Week 78|Death|1|||
48659245|NCT03352557|156605211|FG002|PC Period: Day 1 to Week 78|Death|0|||
48659246|NCT03352557|156605212|FG003|PC Period: Day 1 to Week 78|Death|0|||
48659247|NCT03352557|156605213|FG004|PC Period: Day 1 to Week 78|Death|1|||
48659248|NCT03352557|156605214|FG005|PC Period: Day 1 to Week 78|Death|0|||
48659249|NCT03352557|156605215|FG006|PC Period: Day 1 to Week 78|Death|0|||
48659250|NCT03352557|156605216|FG007|PC Period: Day 1 to Week 78|Death|0|||
48659251|NCT03352557|156605217|FG008|PC Period: Day 1 to Week 78|Death|0|||
48659252|NCT03352557|156605218|FG009|PC Period: Day 1 to Week 78|Death|0|||
48659253|NCT03352557|156605209|FG000|PC Period: Day 1 to Week 78|Adverse Event|10|||
48659254|NCT03352557|156605210|FG001|PC Period: Day 1 to Week 78|Adverse Event|1|||
48659255|NCT03352557|156605211|FG002|PC Period: Day 1 to Week 78|Adverse Event|1|||
48659256|NCT03352557|156605212|FG003|PC Period: Day 1 to Week 78|Adverse Event|0|||
48659257|NCT03352557|156605213|FG004|PC Period: Day 1 to Week 78|Adverse Event|5|||
48659258|NCT03352557|156605214|FG005|PC Period: Day 1 to Week 78|Adverse Event|0|||
48659259|NCT03352557|156605215|FG006|PC Period: Day 1 to Week 78|Adverse Event|0|||
48963328|NCT02358369|157694225|FG001|Treatment Period A/B|Withdrawal by Subject|2|||
48963329|NCT02358369|157694226|FG002|Treatment Period A/B|Withdrawal by Subject|0|||
48963330|NCT02358369|157694227|FG003|Treatment Period A/B|Withdrawal by Subject|2|||
48963331|NCT02358369|157694228|FG004|Treatment Period A/B|Withdrawal by Subject|0|||
48963332|NCT02358369|157694224|FG000|Treatment Period C|Adverse Event|0|||
48963333|NCT02358369|157694225|FG001|Treatment Period C|Adverse Event|0|||
48963334|NCT02358369|157694226|FG002|Treatment Period C|Adverse Event|0|||
48963335|NCT02358369|157694227|FG003|Treatment Period C|Adverse Event|0|||
48963336|NCT02358369|157694228|FG004|Treatment Period C|Adverse Event|7|||
48963337|NCT01021852|157694229|FG000|Treatment Period 1|Adverse Event|3|||
48963338|NCT01021852|157694230|FG001|Treatment Period 1|Adverse Event|1|||
48963339|NCT01021852|157694231|FG002|Treatment Period 1|Adverse Event|1|||
48963340|NCT01021852|157694232|FG003|Treatment Period 1|Adverse Event|0|||
48963341|NCT01021852|157694233|FG004|Treatment Period 1|Adverse Event|2|||
48963342|NCT01021852|157694234|FG005|Treatment Period 1|Adverse Event|2|||
48963343|NCT01021852|157694235|FG006|Treatment Period 1|Adverse Event|0|||
48963344|NCT01021852|157694236|FG007|Treatment Period 1|Adverse Event|0|||
48963345|NCT01021852|157694229|FG000|Treatment Period 1|Pregnancy|0|||
48963346|NCT01021852|157694230|FG001|Treatment Period 1|Pregnancy|0|||
48963347|NCT01021852|157694231|FG002|Treatment Period 1|Pregnancy|1|||
48963348|NCT01021852|157694232|FG003|Treatment Period 1|Pregnancy|0|||
48963349|NCT01021852|157694233|FG004|Treatment Period 1|Pregnancy|0|||
48963350|NCT01021852|157694234|FG005|Treatment Period 1|Pregnancy|0|||
48963351|NCT01021852|157694235|FG006|Treatment Period 1|Pregnancy|0|||
48963352|NCT01021852|157694236|FG007|Treatment Period 1|Pregnancy|0|||
48963353|NCT01021852|157694229|FG000|Treatment Period 1|Withdrawal by Subject|0|||
48963354|NCT01021852|157694230|FG001|Treatment Period 1|Withdrawal by Subject|0|||
48963355|NCT01021852|157694231|FG002|Treatment Period 1|Withdrawal by Subject|0|||
48963356|NCT01021852|157694232|FG003|Treatment Period 1|Withdrawal by Subject|0|||
48963357|NCT01021852|157694233|FG004|Treatment Period 1|Withdrawal by Subject|1|||
48963358|NCT01021852|157694234|FG005|Treatment Period 1|Withdrawal by Subject|0|||
48963359|NCT01021852|157694235|FG006|Treatment Period 1|Withdrawal by Subject|0|||
48963360|NCT01021852|157694236|FG007|Treatment Period 1|Withdrawal by Subject|1|||
48963361|NCT01021852|157694229|FG000|Treatment Period 1|Not Treated|0|||
48963362|NCT01021852|157694230|FG001|Treatment Period 1|Not Treated|0|||
48963363|NCT01021852|157694231|FG002|Treatment Period 1|Not Treated|0|||
48659260|NCT03352557|156605216|FG007|PC Period: Day 1 to Week 78|Adverse Event|0|||
48659261|NCT03352557|156605217|FG008|PC Period: Day 1 to Week 78|Adverse Event|0|||
48659262|NCT03352557|156605218|FG009|PC Period: Day 1 to Week 78|Adverse Event|0|||
48659263|NCT03352557|156605209|FG000|PC Period: Day 1 to Week 78|Progressive Disease|0|||
48659264|NCT03352557|156605210|FG001|PC Period: Day 1 to Week 78|Progressive Disease|0|||
48659265|NCT03352557|156605211|FG002|PC Period: Day 1 to Week 78|Progressive Disease|0|||
48659266|NCT03352557|156605212|FG003|PC Period: Day 1 to Week 78|Progressive Disease|0|||
48659267|NCT03352557|156605213|FG004|PC Period: Day 1 to Week 78|Progressive Disease|1|||
48659268|NCT03352557|156605214|FG005|PC Period: Day 1 to Week 78|Progressive Disease|0|||
48659269|NCT03352557|156605215|FG006|PC Period: Day 1 to Week 78|Progressive Disease|0|||
48963364|NCT01021852|157694232|FG003|Treatment Period 1|Not Treated|2|||
48659270|NCT03352557|156605216|FG007|PC Period: Day 1 to Week 78|Progressive Disease|0|||
48963365|NCT01021852|157694233|FG004|Treatment Period 1|Not Treated|0|||
48963366|NCT01021852|157694234|FG005|Treatment Period 1|Not Treated|0|||
48963367|NCT01021852|157694235|FG006|Treatment Period 1|Not Treated|0|||
48963368|NCT01021852|157694236|FG007|Treatment Period 1|Not Treated|0|||
48963369|NCT01021852|157694229|FG000|Washout Period-Placebo|Adverse Event|0|||
48963370|NCT01021852|157694230|FG001|Washout Period-Placebo|Adverse Event|0|||
48963371|NCT01021852|157694231|FG002|Washout Period-Placebo|Adverse Event|0|||
48963372|NCT01021852|157694232|FG003|Washout Period-Placebo|Adverse Event|1|||
48963373|NCT01021852|157694233|FG004|Washout Period-Placebo|Adverse Event|0|||
48963374|NCT01021852|157694234|FG005|Washout Period-Placebo|Adverse Event|1|||
48963375|NCT01021852|157694235|FG006|Washout Period-Placebo|Adverse Event|0|||
48963376|NCT01021852|157694236|FG007|Washout Period-Placebo|Adverse Event|0|||
48963377|NCT01021852|157694229|FG000|Washout Period-Placebo|Lost to Follow-up|0|||
48963378|NCT01021852|157694230|FG001|Washout Period-Placebo|Lost to Follow-up|0|||
48963379|NCT01021852|157694231|FG002|Washout Period-Placebo|Lost to Follow-up|0|||
48963380|NCT01021852|157694232|FG003|Washout Period-Placebo|Lost to Follow-up|0|||
48963381|NCT01021852|157694233|FG004|Washout Period-Placebo|Lost to Follow-up|1|||
48963382|NCT01021852|157694234|FG005|Washout Period-Placebo|Lost to Follow-up|0|||
48963383|NCT01021852|157694235|FG006|Washout Period-Placebo|Lost to Follow-up|0|||
48963384|NCT01021852|157694236|FG007|Washout Period-Placebo|Lost to Follow-up|0|||
48963385|NCT01021852|157694229|FG000|Washout Period-Placebo|Protocol Violation|0|||
48659271|NCT03352557|156605217|FG008|PC Period: Day 1 to Week 78|Progressive Disease|0|||
48659272|NCT03352557|156605218|FG009|PC Period: Day 1 to Week 78|Progressive Disease|0|||
48659273|NCT03352557|156605209|FG000|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|1|||
48659274|NCT03352557|156605210|FG001|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
48659275|NCT03352557|156605211|FG002|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
48659276|NCT03352557|156605212|FG003|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
48659277|NCT03352557|156605213|FG004|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
48659278|NCT03352557|156605214|FG005|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
48659279|NCT03352557|156605215|FG006|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
48659280|NCT03352557|156605216|FG007|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
48659281|NCT03352557|156605217|FG008|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
48659282|NCT03352557|156605218|FG009|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
48659283|NCT03352557|156605209|FG000|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
48659284|NCT03352557|156605210|FG001|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
48659285|NCT03352557|156605211|FG002|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
48659286|NCT03352557|156605212|FG003|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
48659287|NCT03352557|156605213|FG004|PC Period: Day 1 to Week 78|Protocol Deviation|2|||
48659288|NCT03352557|156605214|FG005|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
48659289|NCT03352557|156605215|FG006|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
48659290|NCT03352557|156605216|FG007|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
48659291|NCT03352557|156605217|FG008|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
48659292|NCT03352557|156605218|FG009|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
48659293|NCT03352557|156605209|FG000|PC Period: Day 1 to Week 78|Randomized by Mistake|2|||
48659294|NCT03352557|156605210|FG001|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
48659295|NCT03352557|156605211|FG002|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
48659296|NCT03352557|156605212|FG003|PC Period: Day 1 to Week 78|Randomized by Mistake|1|||
48659297|NCT03352557|156605213|FG004|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
48659298|NCT03352557|156605214|FG005|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
48659299|NCT03352557|156605215|FG006|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
48659300|NCT03352557|156605216|FG007|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
48659301|NCT03352557|156605217|FG008|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
48659302|NCT03352557|156605218|FG009|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
48659303|NCT03352557|156605209|FG000|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
48659304|NCT03352557|156605210|FG001|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
48659305|NCT03352557|156605211|FG002|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
48659306|NCT03352557|156605212|FG003|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
48659307|NCT03352557|156605213|FG004|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
48659308|NCT03352557|156605214|FG005|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
48659309|NCT03352557|156605215|FG006|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
48659310|NCT03352557|156605216|FG007|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
48659311|NCT03352557|156605217|FG008|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
48659312|NCT03352557|156605218|FG009|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
48659313|NCT03352557|156605209|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|7|||
48659314|NCT03352557|156605210|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
48659315|NCT03352557|156605211|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
48659316|NCT03352557|156605212|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
48659317|NCT03352557|156605213|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
48659318|NCT03352557|156605214|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
48659319|NCT03352557|156605215|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
48659320|NCT03352557|156605216|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
48963386|NCT01021852|157694230|FG001|Washout Period-Placebo|Protocol Violation|0|||
48963387|NCT01021852|157694231|FG002|Washout Period-Placebo|Protocol Violation|0|||
48963388|NCT01021852|157694232|FG003|Washout Period-Placebo|Protocol Violation|0|||
48963389|NCT01021852|157694233|FG004|Washout Period-Placebo|Protocol Violation|0|||
48963390|NCT01021852|157694234|FG005|Washout Period-Placebo|Protocol Violation|0|||
48963391|NCT01021852|157694235|FG006|Washout Period-Placebo|Protocol Violation|1|||
48963392|NCT01021852|157694236|FG007|Washout Period-Placebo|Protocol Violation|0|||
48963393|NCT01021852|157694229|FG000|Washout Period-No Drug|Adverse Event|1|||
48963394|NCT01021852|157694230|FG001|Washout Period-No Drug|Adverse Event|0|||
48963395|NCT01021852|157694231|FG002|Washout Period-No Drug|Adverse Event|0|||
48963396|NCT01021852|157694232|FG003|Washout Period-No Drug|Adverse Event|0|||
48963397|NCT01021852|157694233|FG004|Washout Period-No Drug|Adverse Event|0|||
48963398|NCT01021852|157694234|FG005|Washout Period-No Drug|Adverse Event|1|||
48963399|NCT01021852|157694235|FG006|Washout Period-No Drug|Adverse Event|0|||
48963400|NCT01021852|157694236|FG007|Washout Period-No Drug|Adverse Event|0|||
48963401|NCT01021852|157694229|FG000|Treatment Period 2|Adverse Event|0|||
48963402|NCT01021852|157694230|FG001|Treatment Period 2|Adverse Event|1|||
48963403|NCT01021852|157694231|FG002|Treatment Period 2|Adverse Event|0|||
48963404|NCT01021852|157694232|FG003|Treatment Period 2|Adverse Event|0|||
48963405|NCT01021852|157694233|FG004|Treatment Period 2|Adverse Event|1|||
48963406|NCT01021852|157694234|FG005|Treatment Period 2|Adverse Event|0|||
48963407|NCT01021852|157694235|FG006|Treatment Period 2|Adverse Event|1|||
48963408|NCT01021852|157694236|FG007|Treatment Period 2|Adverse Event|0|||
48963409|NCT01021852|157694229|FG000|Treatment Period 2|Lack of Efficacy|0|||
48963410|NCT01021852|157694230|FG001|Treatment Period 2|Lack of Efficacy|0|||
48963411|NCT01021852|157694231|FG002|Treatment Period 2|Lack of Efficacy|0|||
48963412|NCT01021852|157694232|FG003|Treatment Period 2|Lack of Efficacy|0|||
48963413|NCT01021852|157694233|FG004|Treatment Period 2|Lack of Efficacy|0|||
48963414|NCT01021852|157694234|FG005|Treatment Period 2|Lack of Efficacy|1|||
48963415|NCT01021852|157694235|FG006|Treatment Period 2|Lack of Efficacy|0|||
48963416|NCT01021852|157694236|FG007|Treatment Period 2|Lack of Efficacy|0|||
48963417|NCT01021852|157694229|FG000|Treatment Period 2|Physician Decision|0|||
48963418|NCT01021852|157694230|FG001|Treatment Period 2|Physician Decision|0|||
48963419|NCT01021852|157694231|FG002|Treatment Period 2|Physician Decision|1|||
48963420|NCT01021852|157694232|FG003|Treatment Period 2|Physician Decision|0|||
48963421|NCT01021852|157694233|FG004|Treatment Period 2|Physician Decision|0|||
48963422|NCT01021852|157694234|FG005|Treatment Period 2|Physician Decision|0|||
48963423|NCT01021852|157694235|FG006|Treatment Period 2|Physician Decision|0|||
48963424|NCT01021852|157694236|FG007|Treatment Period 2|Physician Decision|0|||
48963425|NCT01021852|157694229|FG000|Treatment Period 2|Protocol Violation|0|||
48963426|NCT01021852|157694230|FG001|Treatment Period 2|Protocol Violation|0|||
48963427|NCT01021852|157694231|FG002|Treatment Period 2|Protocol Violation|0|||
48963428|NCT01021852|157694232|FG003|Treatment Period 2|Protocol Violation|0|||
48963429|NCT01021852|157694233|FG004|Treatment Period 2|Protocol Violation|1|||
48963430|NCT01021852|157694234|FG005|Treatment Period 2|Protocol Violation|0|||
48963431|NCT01021852|157694235|FG006|Treatment Period 2|Protocol Violation|1|||
48963432|NCT01021852|157694236|FG007|Treatment Period 2|Protocol Violation|0|||
48963433|NCT01021852|157694229|FG000|Treatment Period 2|Withdrawal by Subject|0|||
48963434|NCT01021852|157694230|FG001|Treatment Period 2|Withdrawal by Subject|0|||
48963435|NCT01021852|157694231|FG002|Treatment Period 2|Withdrawal by Subject|0|||
48963436|NCT01021852|157694232|FG003|Treatment Period 2|Withdrawal by Subject|0|||
48963437|NCT01021852|157694233|FG004|Treatment Period 2|Withdrawal by Subject|0|||
48963438|NCT01021852|157694234|FG005|Treatment Period 2|Withdrawal by Subject|0|||
48963439|NCT01021852|157694235|FG006|Treatment Period 2|Withdrawal by Subject|1|||
48963440|NCT01021852|157694236|FG007|Treatment Period 2|Withdrawal by Subject|2|||
48963441|NCT01441115|157694239|FG000|Overall Study|Taken off study - Principal Investigator discretion|1|||
48963442|NCT00434122|157694241|FG000|Overall Study|Non-compliance with protocol|0|||
48963443|NCT00434122|157694242|FG001|Overall Study|Non-compliance with protocol|1|||
48963444|NCT00434122|157694241|FG000|Overall Study|loss of subject contact|1|||
48963445|NCT00434122|157694242|FG001|Overall Study|loss of subject contact|1|||
48963446|NCT00434122|157694241|FG000|Overall Study|Personal reasons|1|||
48963447|NCT00434122|157694242|FG001|Overall Study|Personal reasons|1|||
48963448|NCT00434122|157694241|FG000|Overall Study|Large follicle size|2|||
48963449|NCT00434122|157694242|FG001|Overall Study|Large follicle size|2|||
48963450|NCT00434122|157694241|FG000|Overall Study|Low follicular response.|1|||
48963451|NCT00434122|157694242|FG001|Overall Study|Low follicular response.|2|||
48659321|NCT03352557|156605217|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
48659322|NCT03352557|156605218|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
48659323|NCT03352557|156605209|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
48963452|NCT00434122|157694241|FG000|Overall Study|Travelling of subject.|1|||
48963453|NCT00434122|157694242|FG001|Overall Study|Travelling of subject.|0|||
48963454|NCT00255086|157694243|FG000|Overall Study|Adverse Event|1|||
48963455|NCT00255086|157694244|FG001|Overall Study|Adverse Event|1|||
48963456|NCT00255086|157694243|FG000|Overall Study|Protocol Violation|1|||
48963457|NCT00255086|157694244|FG001|Overall Study|Protocol Violation|1|||
48963458|NCT02559206|157694245|FG000|Overall Study|Adverse Event|0|||
48963459|NCT02559206|157694246|FG001|Overall Study|Adverse Event|4|||
48963460|NCT02559206|157694247|FG002|Overall Study|Adverse Event|1|||
48963461|NCT02559206|157694248|FG003|Overall Study|Adverse Event|5|||
48963462|NCT02559206|157694249|FG004|Overall Study|Adverse Event|3|||
48963463|NCT02559206|157694250|FG005|Overall Study|Adverse Event|0|||
48963464|NCT02559206|157694251|FG006|Overall Study|Adverse Event|1|||
48963465|NCT02559206|157694252|FG007|Overall Study|Adverse Event|0|||
48963466|NCT02559206|157694245|FG000|Overall Study|Protocol Violation|1|||
48963467|NCT02559206|157694246|FG001|Overall Study|Protocol Violation|0|||
48963468|NCT02559206|157694247|FG002|Overall Study|Protocol Violation|1|||
48963469|NCT02559206|157694248|FG003|Overall Study|Protocol Violation|0|||
48963470|NCT02559206|157694249|FG004|Overall Study|Protocol Violation|0|||
48963471|NCT02559206|157694250|FG005|Overall Study|Protocol Violation|2|||
48963472|NCT02559206|157694251|FG006|Overall Study|Protocol Violation|0|||
48963473|NCT02559206|157694252|FG007|Overall Study|Protocol Violation|0|||
48963474|NCT02559206|157694245|FG000|Overall Study|Withdrawal by Subject|3|||
48963475|NCT02559206|157694246|FG001|Overall Study|Withdrawal by Subject|3|||
48963476|NCT02559206|157694247|FG002|Overall Study|Withdrawal by Subject|1|||
48963477|NCT02559206|157694248|FG003|Overall Study|Withdrawal by Subject|3|||
48963478|NCT02559206|157694249|FG004|Overall Study|Withdrawal by Subject|5|||
48963479|NCT02559206|157694250|FG005|Overall Study|Withdrawal by Subject|4|||
49015438|NCT01393990|157893770|FG000|Overall Study|Adverse Event|0|||
48659324|NCT03352557|156605210|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
48659325|NCT03352557|156605211|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
48659326|NCT03352557|156605212|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
48659327|NCT03352557|156605213|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|2|||
48659328|NCT03352557|156605214|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
48659329|NCT03352557|156605215|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
48659330|NCT03352557|156605216|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
48659331|NCT03352557|156605217|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
48659332|NCT03352557|156605218|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
48659333|NCT03352557|156605209|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
48659334|NCT03352557|156605210|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
48659335|NCT03352557|156605211|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
48659336|NCT03352557|156605212|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
48659337|NCT03352557|156605213|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
48659338|NCT03352557|156605214|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
48659339|NCT03352557|156605215|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
48659340|NCT03352557|156605216|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
48659341|NCT03352557|156605217|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
48755320|NCT00498602|156951237|FG003|Overall Study|Lost to Follow-up|2|||
48755321|NCT00498602|156951238|FG004|Overall Study|Lost to Follow-up|0|||
48755322|NCT00498602|156951239|FG005|Overall Study|Lost to Follow-up|0|||
48755323|NCT00498602|156951240|FG006|Overall Study|Lost to Follow-up|0|||
48755324|NCT00498602|156951234|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
48755325|NCT00498602|156951235|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
48755326|NCT00498602|156951236|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
48755327|NCT00498602|156951237|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
48755328|NCT00498602|156951238|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
48755329|NCT00498602|156951239|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
48755330|NCT00498602|156951240|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
48755331|NCT00498602|156951234|FG000|Overall Study|AE not related to Study Drug|1|||
48755332|NCT00498602|156951235|FG001|Overall Study|AE not related to Study Drug|3|||
48755333|NCT00498602|156951236|FG002|Overall Study|AE not related to Study Drug|0|||
48755334|NCT00498602|156951237|FG003|Overall Study|AE not related to Study Drug|0|||
48755335|NCT00498602|156951238|FG004|Overall Study|AE not related to Study Drug|2|||
48755336|NCT00498602|156951239|FG005|Overall Study|AE not related to Study Drug|2|||
48755337|NCT00498602|156951240|FG006|Overall Study|AE not related to Study Drug|1|||
48755338|NCT00498602|156951234|FG000|Overall Study|Caregiver Request|2|||
48755339|NCT00498602|156951235|FG001|Overall Study|Caregiver Request|2|||
48755340|NCT00498602|156951236|FG002|Overall Study|Caregiver Request|2|||
48755341|NCT00498602|156951237|FG003|Overall Study|Caregiver Request|0|||
48755342|NCT00498602|156951238|FG004|Overall Study|Caregiver Request|1|||
48755343|NCT00498602|156951239|FG005|Overall Study|Caregiver Request|2|||
48755344|NCT00498602|156951240|FG006|Overall Study|Caregiver Request|0|||
48755345|NCT00498602|156951234|FG000|Overall Study|Investigator Request|0|||
48963480|NCT02559206|157694251|FG006|Overall Study|Withdrawal by Subject|1|||
48963481|NCT02559206|157694252|FG007|Overall Study|Withdrawal by Subject|2|||
48963482|NCT02559206|157694245|FG000|Overall Study|Lost to Follow-up|3|||
48963483|NCT02559206|157694246|FG001|Overall Study|Lost to Follow-up|5|||
48963484|NCT02559206|157694247|FG002|Overall Study|Lost to Follow-up|3|||
48963485|NCT02559206|157694248|FG003|Overall Study|Lost to Follow-up|3|||
48963486|NCT02559206|157694249|FG004|Overall Study|Lost to Follow-up|2|||
48963487|NCT02559206|157694250|FG005|Overall Study|Lost to Follow-up|5|||
48963488|NCT02559206|157694251|FG006|Overall Study|Lost to Follow-up|1|||
48963489|NCT02559206|157694252|FG007|Overall Study|Lost to Follow-up|4|||
48963490|NCT02559206|157694245|FG000|Overall Study|Lack of Efficacy|1|||
48963491|NCT02559206|157694246|FG001|Overall Study|Lack of Efficacy|0|||
48963492|NCT02559206|157694247|FG002|Overall Study|Lack of Efficacy|3|||
48963493|NCT02559206|157694248|FG003|Overall Study|Lack of Efficacy|2|||
48963494|NCT02559206|157694249|FG004|Overall Study|Lack of Efficacy|2|||
48963495|NCT02559206|157694250|FG005|Overall Study|Lack of Efficacy|3|||
48963496|NCT02559206|157694251|FG006|Overall Study|Lack of Efficacy|3|||
48963497|NCT02559206|157694252|FG007|Overall Study|Lack of Efficacy|3|||
48963498|NCT02559206|157694245|FG000|Overall Study|Other Not Specified|0|||
48963499|NCT02559206|157694246|FG001|Overall Study|Other Not Specified|0|||
48963500|NCT02559206|157694247|FG002|Overall Study|Other Not Specified|0|||
48963501|NCT02559206|157694248|FG003|Overall Study|Other Not Specified|1|||
48963502|NCT02559206|157694249|FG004|Overall Study|Other Not Specified|0|||
48963503|NCT02559206|157694250|FG005|Overall Study|Other Not Specified|0|||
48963504|NCT02559206|157694251|FG006|Overall Study|Other Not Specified|0|||
48963505|NCT02559206|157694252|FG007|Overall Study|Other Not Specified|0|||
48963506|NCT00438399|157694254|FG000|Overall Study|Lost to Follow-up|2|||
48659342|NCT03352557|156605218|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
48659343|NCT03352557|156605209|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
48659344|NCT03352557|156605210|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
48659345|NCT03352557|156605211|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
48659346|NCT03352557|156605212|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
48659347|NCT03352557|156605213|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
48659348|NCT03352557|156605214|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
48659349|NCT03352557|156605215|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
48659350|NCT03352557|156605216|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
48659351|NCT03352557|156605217|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
48659352|NCT03352557|156605218|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
48659353|NCT03352557|156605209|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|6|||
48659354|NCT03352557|156605210|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
48659355|NCT03352557|156605211|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
48659356|NCT03352557|156605212|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|5|||
48659357|NCT03352557|156605213|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|7|||
48659358|NCT03352557|156605214|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
48659359|NCT03352557|156605215|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
48659360|NCT03352557|156605216|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
48659361|NCT03352557|156605217|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
48659362|NCT03352557|156605218|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
48659363|NCT03352557|156605209|FG000|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
48659364|NCT03352557|156605210|FG001|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
48659365|NCT03352557|156605211|FG002|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
48659366|NCT03352557|156605212|FG003|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
48659367|NCT03352557|156605213|FG004|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|3|||
48659368|NCT03352557|156605214|FG005|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
48659369|NCT03352557|156605215|FG006|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
48659370|NCT03352557|156605216|FG007|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
48659371|NCT03352557|156605217|FG008|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
48659372|NCT03352557|156605218|FG009|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
48659373|NCT03352557|156605209|FG000|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
48659374|NCT03352557|156605210|FG001|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
48963507|NCT00438399|157694255|FG001|Overall Study|Lost to Follow-up|2|||
48963508|NCT00438399|157694256|FG002|Overall Study|Lost to Follow-up|1|||
48963509|NCT00438399|157694257|FG003|Overall Study|Lost to Follow-up|1|||
48963510|NCT00438399|157694258|FG004|Overall Study|Lost to Follow-up|1|||
48963511|NCT00438399|157694259|FG005|Overall Study|Lost to Follow-up|1|||
48963512|NCT00438399|157694254|FG000|Overall Study|Adverse Event|0|||
48963513|NCT00438399|157694255|FG001|Overall Study|Adverse Event|0|||
48963514|NCT00438399|157694256|FG002|Overall Study|Adverse Event|1|||
48963515|NCT00438399|157694257|FG003|Overall Study|Adverse Event|1|||
48963516|NCT00438399|157694258|FG004|Overall Study|Adverse Event|0|||
48963517|NCT00438399|157694259|FG005|Overall Study|Adverse Event|1|||
48963518|NCT00438399|157694254|FG000|Overall Study|Withdrawal by Subject|5|||
48963519|NCT00438399|157694255|FG001|Overall Study|Withdrawal by Subject|6|||
48963520|NCT00438399|157694256|FG002|Overall Study|Withdrawal by Subject|3|||
48963521|NCT00438399|157694257|FG003|Overall Study|Withdrawal by Subject|2|||
48963522|NCT00438399|157694258|FG004|Overall Study|Withdrawal by Subject|2|||
48963523|NCT00438399|157694259|FG005|Overall Study|Withdrawal by Subject|2|||
48963524|NCT00438399|157694254|FG000|Overall Study|Protocol Violation|0|||
48963525|NCT00438399|157694255|FG001|Overall Study|Protocol Violation|0|||
48963526|NCT00438399|157694256|FG002|Overall Study|Protocol Violation|1|||
48963527|NCT00438399|157694257|FG003|Overall Study|Protocol Violation|0|||
48963528|NCT00438399|157694258|FG004|Overall Study|Protocol Violation|0|||
48963529|NCT00438399|157694259|FG005|Overall Study|Protocol Violation|1|||
48963530|NCT00438399|157694254|FG000|Overall Study|Subje stopped study|0|||
48963531|NCT00438399|157694255|FG001|Overall Study|Subje stopped study|0|||
48963532|NCT00438399|157694256|FG002|Overall Study|Subje stopped study|1|||
48963533|NCT00438399|157694257|FG003|Overall Study|Subje stopped study|0|||
48963534|NCT00438399|157694258|FG004|Overall Study|Subje stopped study|0|||
48963535|NCT00438399|157694259|FG005|Overall Study|Subje stopped study|0|||
48963536|NCT00438399|157694254|FG000|Overall Study|Pregnancy|0|||
48963537|NCT00438399|157694255|FG001|Overall Study|Pregnancy|0|||
48963538|NCT00438399|157694256|FG002|Overall Study|Pregnancy|0|||
48963539|NCT00438399|157694257|FG003|Overall Study|Pregnancy|0|||
48963540|NCT00438399|157694258|FG004|Overall Study|Pregnancy|0|||
48963541|NCT00438399|157694259|FG005|Overall Study|Pregnancy|1|||
48963542|NCT00438399|157694254|FG000|Overall Study|Patien stopped study at visit 4 by error|1|||
48963543|NCT00438399|157694255|FG001|Overall Study|Patien stopped study at visit 4 by error|0|||
48963544|NCT00438399|157694256|FG002|Overall Study|Patien stopped study at visit 4 by error|0|||
48963545|NCT00438399|157694257|FG003|Overall Study|Patien stopped study at visit 4 by error|0|||
48963546|NCT00438399|157694258|FG004|Overall Study|Patien stopped study at visit 4 by error|0|||
48963547|NCT00438399|157694259|FG005|Overall Study|Patien stopped study at visit 4 by error|0|||
48963548|NCT01999946|157694260|FG000|Overall Study|Participant not released from jail|2|||
48963549|NCT01999946|157694261|FG001|Overall Study|Participant not released from jail|2|||
48963550|NCT01999946|157694262|FG002|Overall Study|Participant not released from jail|0|||
48963551|NCT01999946|157694260|FG000|Overall Study|Not included in primary outcome analysis|0|||
48963552|NCT01999946|157694261|FG001|Overall Study|Not included in primary outcome analysis|0|||
48963553|NCT01999946|157694262|FG002|Overall Study|Not included in primary outcome analysis|79|||
48963554|NCT00479557|157694263|FG000|Overall Study|Death|0|||
48963555|NCT00479557|157694264|FG001|Overall Study|Death|0|||
48963556|NCT00479557|157694265|FG002|Overall Study|Death|0|||
48963557|NCT00479557|157694266|FG003|Overall Study|Death|0|||
48963558|NCT00479557|157694267|FG004|Overall Study|Death|0|||
48963559|NCT00479557|157694268|FG005|Overall Study|Death|1|||
48963560|NCT00479557|157694269|FG006|Overall Study|Death|0|||
48963561|NCT00479557|157694263|FG000|Overall Study|Lack of Efficacy|1|||
48963562|NCT00479557|157694264|FG001|Overall Study|Lack of Efficacy|0|||
48963563|NCT00479557|157694265|FG002|Overall Study|Lack of Efficacy|0|||
48963564|NCT00479557|157694266|FG003|Overall Study|Lack of Efficacy|0|||
48963565|NCT00479557|157694267|FG004|Overall Study|Lack of Efficacy|0|||
48963566|NCT00479557|157694268|FG005|Overall Study|Lack of Efficacy|0|||
48963567|NCT00479557|157694269|FG006|Overall Study|Lack of Efficacy|0|||
48963568|NCT00479557|157694263|FG000|Overall Study|Lost to Follow-up|0|||
48963569|NCT00479557|157694264|FG001|Overall Study|Lost to Follow-up|2|||
48963570|NCT00479557|157694265|FG002|Overall Study|Lost to Follow-up|0|||
48963571|NCT00479557|157694266|FG003|Overall Study|Lost to Follow-up|2|||
48963572|NCT00479557|157694267|FG004|Overall Study|Lost to Follow-up|0|||
48963573|NCT00479557|157694268|FG005|Overall Study|Lost to Follow-up|0|||
48963574|NCT00479557|157694269|FG006|Overall Study|Lost to Follow-up|0|||
48963575|NCT00479557|157694263|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
48963576|NCT00479557|157694264|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
48963577|NCT00479557|157694265|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
48963578|NCT00479557|157694266|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
48963579|NCT00479557|157694267|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
48963580|NCT00479557|157694268|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
48963581|NCT00479557|157694269|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
48963582|NCT00479557|157694263|FG000|Overall Study|AE not related to Study Drug|1|||
48963583|NCT00479557|157694264|FG001|Overall Study|AE not related to Study Drug|3|||
48963584|NCT00479557|157694265|FG002|Overall Study|AE not related to Study Drug|0|||
48963585|NCT00479557|157694266|FG003|Overall Study|AE not related to Study Drug|0|||
48963586|NCT00479557|157694267|FG004|Overall Study|AE not related to Study Drug|2|||
48963587|NCT00479557|157694268|FG005|Overall Study|AE not related to Study Drug|2|||
49015439|NCT01393990|157893771|FG001|Overall Study|Adverse Event|0|||
48963588|NCT00479557|157694269|FG006|Overall Study|AE not related to Study Drug|1|||
48659375|NCT03352557|156605211|FG002|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
48659376|NCT03352557|156605212|FG003|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
48659377|NCT03352557|156605213|FG004|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
48659378|NCT03352557|156605214|FG005|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
48659379|NCT03352557|156605215|FG006|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
48659380|NCT03352557|156605216|FG007|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
48963589|NCT00479557|157694263|FG000|Overall Study|Caregiver Request|2|||
48963590|NCT00479557|157694264|FG001|Overall Study|Caregiver Request|2|||
48963591|NCT00479557|157694265|FG002|Overall Study|Caregiver Request|2|||
48963592|NCT00479557|157694266|FG003|Overall Study|Caregiver Request|0|||
48963593|NCT00479557|157694267|FG004|Overall Study|Caregiver Request|1|||
48963594|NCT00479557|157694268|FG005|Overall Study|Caregiver Request|2|||
48963595|NCT00479557|157694269|FG006|Overall Study|Caregiver Request|0|||
48963596|NCT00479557|157694263|FG000|Overall Study|Investigator Request|0|||
48963597|NCT00479557|157694264|FG001|Overall Study|Investigator Request|0|||
48963598|NCT00479557|157694265|FG002|Overall Study|Investigator Request|1|||
48963599|NCT00479557|157694266|FG003|Overall Study|Investigator Request|0|||
48963600|NCT00479557|157694267|FG004|Overall Study|Investigator Request|0|||
48963601|NCT00479557|157694268|FG005|Overall Study|Investigator Request|0|||
48963602|NCT00479557|157694269|FG006|Overall Study|Investigator Request|0|||
48963603|NCT00479557|157694263|FG000|Overall Study|Subject Request|3|||
48659381|NCT03352557|156605217|FG008|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
48659382|NCT03352557|156605218|FG009|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
48659383|NCT03352557|156605209|FG000|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
48659384|NCT03352557|156605210|FG001|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
48659385|NCT03352557|156605211|FG002|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
48963604|NCT00479557|157694264|FG001|Overall Study|Subject Request|0|||
48963605|NCT00479557|157694265|FG002|Overall Study|Subject Request|1|||
48963606|NCT00479557|157694266|FG003|Overall Study|Subject Request|1|||
48963607|NCT00479557|157694267|FG004|Overall Study|Subject Request|1|||
48963608|NCT00479557|157694268|FG005|Overall Study|Subject Request|4|||
48963609|NCT00479557|157694269|FG006|Overall Study|Subject Request|1|||
48963610|NCT00479557|157694263|FG000|Overall Study|Other|2|||
48963611|NCT00479557|157694264|FG001|Overall Study|Other|3|||
48963612|NCT00479557|157694265|FG002|Overall Study|Other|1|||
48963613|NCT00479557|157694266|FG003|Overall Study|Other|0|||
48963614|NCT00479557|157694267|FG004|Overall Study|Other|0|||
48963615|NCT00479557|157694268|FG005|Overall Study|Other|3|||
48963616|NCT00479557|157694269|FG006|Overall Study|Other|0|||
48963617|NCT01536119|157694270|FG000|Overall Study|Lost to Follow-up|17|||
48963618|NCT01536119|157694271|FG001|Overall Study|Lost to Follow-up|14|||
48963619|NCT01669811|157694272|FG000|Overall Study|Investigator decision|0|||
48963620|NCT01669811|157694273|FG001|Overall Study|Investigator decision|1|||
48659386|NCT03352557|156605212|FG003|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
48963621|NCT01669811|157694272|FG000|Overall Study|Withdrawal by Subject|1|||
48963622|NCT01669811|157694273|FG001|Overall Study|Withdrawal by Subject|2|||
48963623|NCT01669811|157694272|FG000|Overall Study|Adverse Event|2|||
48963624|NCT01669811|157694273|FG001|Overall Study|Adverse Event|6|||
48963625|NCT01669811|157694272|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
48963626|NCT01669811|157694273|FG001|Overall Study|Eligibility Criteria Not Fulfilled|2|||
48963627|NCT00986427|157694274|FG000|Overall Study|Lost to Follow-up|2|||
48659387|NCT03352557|156605213|FG004|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
48659388|NCT03352557|156605214|FG005|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
48659389|NCT03352557|156605215|FG006|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
48659390|NCT03352557|156605216|FG007|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
48659391|NCT03352557|156605217|FG008|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
48659392|NCT03352557|156605218|FG009|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
48659393|NCT03352557|156605209|FG000|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
48659394|NCT03352557|156605210|FG001|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
48659395|NCT03352557|156605211|FG002|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
48692726|NCT04908683|156724585|FG001|Overall Study|Site Closure by Sponsor|3|||
48963628|NCT00986427|157694275|FG001|Overall Study|Lost to Follow-up|0|||
48963629|NCT00986427|157694274|FG000|Overall Study|Lack of Efficacy|1|||
48963630|NCT00986427|157694275|FG001|Overall Study|Lack of Efficacy|0|||
48963631|NCT00986427|157694274|FG000|Overall Study|Withdrawal by Subject|1|||
48963632|NCT00986427|157694275|FG001|Overall Study|Withdrawal by Subject|0|||
48963633|NCT01265420|157694276|FG000|Overall Study|Lost to Follow-up|1|||
48963634|NCT00574496|157694277|FG000|Overall Study|Withdrawal by Subject|1|||
48659396|NCT03352557|156605212|FG003|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
48963635|NCT00413062|157694278|FG000|Overall Study|Adverse event/serious adverse event|289|||
48963636|NCT00413062|157694279|FG001|Overall Study|Adverse event/serious adverse event|56|||
48963637|NCT00413062|157694278|FG000|Overall Study|Pre-treatment (serious) adverse event|1|||
48659397|NCT03352557|156605213|FG004|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
48659398|NCT03352557|156605214|FG005|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
48659399|NCT03352557|156605215|FG006|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
48659400|NCT03352557|156605216|FG007|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
48659401|NCT03352557|156605217|FG008|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
48659402|NCT03352557|156605218|FG009|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
48659403|NCT03352557|156605209|FG000|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
48659404|NCT03352557|156605210|FG001|PC Period: Day 1 to Week 78|WBP/G-Other|2|||
48659405|NCT03352557|156605211|FG002|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
48659406|NCT03352557|156605212|FG003|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
48659407|NCT03352557|156605213|FG004|PC Period: Day 1 to Week 78|WBP/G-Other|3|||
48659408|NCT03352557|156605214|FG005|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
48659409|NCT03352557|156605215|FG006|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
48659410|NCT03352557|156605216|FG007|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
48963638|NCT00413062|157694279|FG001|Overall Study|Pre-treatment (serious) adverse event|0|||
48963639|NCT00413062|157694278|FG000|Overall Study|Withdrawal of informed consent|111|||
48963640|NCT00413062|157694279|FG001|Overall Study|Withdrawal of informed consent|36|||
48963641|NCT00413062|157694278|FG000|Overall Study|Pregnancy|15|||
48963642|NCT00413062|157694279|FG001|Overall Study|Pregnancy|5|||
48963643|NCT00413062|157694278|FG000|Overall Study|Pregnancy wish|17|||
48963644|NCT00413062|157694279|FG001|Overall Study|Pregnancy wish|6|||
48963645|NCT00413062|157694278|FG000|Overall Study|Lost to Follow-up|175|||
48963646|NCT00413062|157694279|FG001|Overall Study|Lost to Follow-up|73|||
48963647|NCT00413062|157694278|FG000|Overall Study|Other reason|70|||
48963648|NCT00413062|157694279|FG001|Overall Study|Other reason|34|||
48963649|NCT02176291|157694280|FG000|Overall Study|Death|1|||
48963650|NCT02176291|157694281|FG001|Overall Study|Death|0|||
48963651|NCT02176291|157694280|FG000|Overall Study|non compliance with protocol|2|||
48659411|NCT03352557|156605217|FG008|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
48659412|NCT03352557|156605218|FG009|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
48659413|NCT03352557|156605209|FG000|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|2|||
48659414|NCT03352557|156605210|FG001|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
48659415|NCT03352557|156605211|FG002|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
48659416|NCT03352557|156605212|FG003|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
48659417|NCT03352557|156605213|FG004|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|1|||
48659418|NCT03352557|156605214|FG005|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
48659419|NCT03352557|156605215|FG006|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
48659420|NCT03352557|156605216|FG007|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
48659421|NCT03352557|156605217|FG008|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
48659422|NCT03352557|156605218|FG009|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
48659423|NCT03352557|156605209|FG000|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
48659424|NCT03352557|156605210|FG001|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
48659425|NCT03352557|156605211|FG002|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
48659426|NCT03352557|156605212|FG003|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
48659427|NCT03352557|156605213|FG004|PC Period: Day 1 to Week 78|Lost to Follow-up|2|||
48963652|NCT02176291|157694281|FG001|Overall Study|non compliance with protocol|0|||
48963653|NCT02176291|157694280|FG000|Overall Study|Withdrawal by Subject|2|||
48963654|NCT02176291|157694281|FG001|Overall Study|Withdrawal by Subject|0|||
48963655|NCT00632541|157694282|FG000|Overall Study|Adverse Event|7|||
48963656|NCT00501046|157694285|FG000|Overall Study|Adverse Event|21|||
48963657|NCT00501046|157694286|FG001|Overall Study|Adverse Event|25|||
48963658|NCT00501046|157694285|FG000|Overall Study|Death|23|||
48963659|NCT00501046|157694286|FG001|Overall Study|Death|30|||
48963660|NCT00501046|157694285|FG000|Overall Study|Lost to Follow-up|14|||
48963661|NCT00501046|157694286|FG001|Overall Study|Lost to Follow-up|13|||
48963662|NCT00501046|157694285|FG000|Overall Study|Physician Decision|7|||
48963663|NCT00501046|157694286|FG001|Overall Study|Physician Decision|2|||
48659428|NCT03352557|156605214|FG005|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
48963664|NCT00501046|157694285|FG000|Overall Study|Pregnancy|0|||
48963665|NCT00501046|157694286|FG001|Overall Study|Pregnancy|3|||
48963666|NCT00501046|157694285|FG000|Overall Study|Protocol Violation|2|||
48963667|NCT00501046|157694286|FG001|Overall Study|Protocol Violation|1|||
48963668|NCT00501046|157694285|FG000|Overall Study|Withdrawal by Subject|84|||
48963669|NCT00501046|157694286|FG001|Overall Study|Withdrawal by Subject|83|||
49015440|NCT01393990|157893772|FG002|Overall Study|Adverse Event|0|||
48963670|NCT00501046|157694285|FG000|Overall Study|Reaching endpoints,Noncompliance,etc|119|||
48963671|NCT00501046|157694286|FG001|Overall Study|Reaching endpoints,Noncompliance,etc|137|||
48963672|NCT00006604|157694287|FG000|Overall Study|Met study objective - no further FU|1|||
48963673|NCT00006604|157694288|FG001|Overall Study|Met study objective - no further FU|0|||
48963674|NCT00006604|157694289|FG002|Overall Study|Met study objective - no further FU|0|||
48963675|NCT00006604|157694290|FG003|Overall Study|Met study objective - no further FU|0|||
48963676|NCT00006604|157694291|FG004|Overall Study|Met study objective - no further FU|0|||
48963677|NCT00006604|157694292|FG005|Overall Study|Met study objective - no further FU|0|||
48963678|NCT00006604|157694293|FG006|Overall Study|Met study objective - no further FU|0|||
48659429|NCT03352557|156605215|FG006|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
48659430|NCT03352557|156605216|FG007|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
48659431|NCT03352557|156605217|FG008|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
48659432|NCT03352557|156605218|FG009|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
48659433|NCT03352557|156605209|FG000|PC Period: Day 1 to Week 78|Other|5|||
48659434|NCT03352557|156605210|FG001|PC Period: Day 1 to Week 78|Other|1|||
48659435|NCT03352557|156605211|FG002|PC Period: Day 1 to Week 78|Other|0|||
48659436|NCT03352557|156605212|FG003|PC Period: Day 1 to Week 78|Other|3|||
48659437|NCT03352557|156605213|FG004|PC Period: Day 1 to Week 78|Other|0|||
48659438|NCT03352557|156605214|FG005|PC Period: Day 1 to Week 78|Other|0|||
48659439|NCT03352557|156605215|FG006|PC Period: Day 1 to Week 78|Other|0|||
48659440|NCT03352557|156605216|FG007|PC Period: Day 1 to Week 78|Other|0|||
48659441|NCT03352557|156605217|FG008|PC Period: Day 1 to Week 78|Other|0|||
48659442|NCT03352557|156605218|FG009|PC Period: Day 1 to Week 78|Other|0|||
48659443|NCT03352557|156605209|FG000|PC Period: Day 1 to Week 78|Not Dosed|0|||
48659444|NCT03352557|156605210|FG001|PC Period: Day 1 to Week 78|Not Dosed|0|||
48659445|NCT03352557|156605211|FG002|PC Period: Day 1 to Week 78|Not Dosed|0|||
48659446|NCT03352557|156605212|FG003|PC Period: Day 1 to Week 78|Not Dosed|0|||
48659447|NCT03352557|156605213|FG004|PC Period: Day 1 to Week 78|Not Dosed|4|||
48659448|NCT03352557|156605214|FG005|PC Period: Day 1 to Week 78|Not Dosed|0|||
48659449|NCT03352557|156605215|FG006|PC Period: Day 1 to Week 78|Not Dosed|0|||
48659450|NCT03352557|156605216|FG007|PC Period: Day 1 to Week 78|Not Dosed|0|||
48659451|NCT03352557|156605217|FG008|PC Period: Day 1 to Week 78|Not Dosed|0|||
48659452|NCT03352557|156605218|FG009|PC Period: Day 1 to Week 78|Not Dosed|0|||
48659453|NCT03352557|156605209|FG000|LTE Period: Week 80 to Week 173|Death|0|||
48659454|NCT03352557|156605210|FG001|LTE Period: Week 80 to Week 173|Death|0|||
48659455|NCT03352557|156605211|FG002|LTE Period: Week 80 to Week 173|Death|0|||
48963679|NCT00006604|157694294|FG007|Overall Study|Met study objective - no further FU|0|||
48963680|NCT00006604|157694295|FG008|Overall Study|Met study objective - no further FU|0|||
48963681|NCT00006604|157694296|FG009|Overall Study|Met study objective - no further FU|0|||
48963682|NCT00006604|157694297|FG010|Overall Study|Met study objective - no further FU|0|||
48963683|NCT00006604|157694298|FG011|Overall Study|Met study objective - no further FU|0|||
48963684|NCT00006604|157694299|FG012|Overall Study|Met study objective - no further FU|0|||
48963685|NCT00006604|157694300|FG013|Overall Study|Met study objective - no further FU|0|||
48963686|NCT00006604|157694301|FG014|Overall Study|Met study objective - no further FU|1|||
48963687|NCT00006604|157694302|FG015|Overall Study|Met study objective - no further FU|1|||
48963688|NCT00006604|157694303|FG016|Overall Study|Met study objective - no further FU|0|||
48963689|NCT00006604|157694287|FG000|Overall Study|Randomization entry error-no RX, no FU|0|||
48963690|NCT00006604|157694288|FG001|Overall Study|Randomization entry error-no RX, no FU|0|||
48963691|NCT00006604|157694289|FG002|Overall Study|Randomization entry error-no RX, no FU|0|||
48963692|NCT00006604|157694290|FG003|Overall Study|Randomization entry error-no RX, no FU|0|||
48963693|NCT00006604|157694291|FG004|Overall Study|Randomization entry error-no RX, no FU|0|||
48963694|NCT00006604|157694292|FG005|Overall Study|Randomization entry error-no RX, no FU|0|||
48963695|NCT00006604|157694293|FG006|Overall Study|Randomization entry error-no RX, no FU|0|||
48963696|NCT00006604|157694294|FG007|Overall Study|Randomization entry error-no RX, no FU|0|||
48963697|NCT00006604|157694295|FG008|Overall Study|Randomization entry error-no RX, no FU|0|||
48963698|NCT00006604|157694296|FG009|Overall Study|Randomization entry error-no RX, no FU|0|||
48963699|NCT00006604|157694297|FG010|Overall Study|Randomization entry error-no RX, no FU|0|||
48963700|NCT00006604|157694298|FG011|Overall Study|Randomization entry error-no RX, no FU|1|||
48963701|NCT00006604|157694299|FG012|Overall Study|Randomization entry error-no RX, no FU|0|||
48963702|NCT00006604|157694300|FG013|Overall Study|Randomization entry error-no RX, no FU|0|||
48963703|NCT00006604|157694301|FG014|Overall Study|Randomization entry error-no RX, no FU|0|||
48963704|NCT00006604|157694302|FG015|Overall Study|Randomization entry error-no RX, no FU|0|||
48963705|NCT00006604|157694303|FG016|Overall Study|Randomization entry error-no RX, no FU|0|||
48963706|NCT00006604|157694287|FG000|Overall Study|Death|0|||
48659456|NCT03352557|156605212|FG003|LTE Period: Week 80 to Week 173|Death|0|||
48659457|NCT03352557|156605213|FG004|LTE Period: Week 80 to Week 173|Death|0|||
48659458|NCT03352557|156605214|FG005|LTE Period: Week 80 to Week 173|Death|1|||
48659459|NCT03352557|156605215|FG006|LTE Period: Week 80 to Week 173|Death|0|||
48692727|NCT04908683|156724584|FG000|Overall Study|Adverse Event|21|||
48963707|NCT00006604|157694288|FG001|Overall Study|Death|0|||
48963708|NCT00006604|157694289|FG002|Overall Study|Death|0|||
48963709|NCT00006604|157694290|FG003|Overall Study|Death|0|||
48963710|NCT00006604|157694291|FG004|Overall Study|Death|0|||
48963711|NCT00006604|157694292|FG005|Overall Study|Death|0|||
48963712|NCT00006604|157694293|FG006|Overall Study|Death|0|||
48963713|NCT00006604|157694294|FG007|Overall Study|Death|0|||
48963714|NCT00006604|157694295|FG008|Overall Study|Death|0|||
48963715|NCT00006604|157694296|FG009|Overall Study|Death|1|||
48963716|NCT00006604|157694297|FG010|Overall Study|Death|1|||
48963717|NCT00006604|157694298|FG011|Overall Study|Death|1|||
48963718|NCT00006604|157694299|FG012|Overall Study|Death|0|||
48963719|NCT00006604|157694300|FG013|Overall Study|Death|0|||
48963720|NCT00006604|157694301|FG014|Overall Study|Death|0|||
48963721|NCT00006604|157694302|FG015|Overall Study|Death|0|||
48963722|NCT00006604|157694303|FG016|Overall Study|Death|0|||
48963723|NCT00006604|157694287|FG000|Overall Study|Severe debilitation, unable to continue|0|||
48963724|NCT00006604|157694288|FG001|Overall Study|Severe debilitation, unable to continue|0|||
48963725|NCT00006604|157694289|FG002|Overall Study|Severe debilitation, unable to continue|0|||
48963726|NCT00006604|157694290|FG003|Overall Study|Severe debilitation, unable to continue|0|||
48963727|NCT00006604|157694291|FG004|Overall Study|Severe debilitation, unable to continue|0|||
48963728|NCT00006604|157694292|FG005|Overall Study|Severe debilitation, unable to continue|0|||
48963729|NCT00006604|157694293|FG006|Overall Study|Severe debilitation, unable to continue|3|||
48963730|NCT00006604|157694294|FG007|Overall Study|Severe debilitation, unable to continue|0|||
48963731|NCT00006604|157694295|FG008|Overall Study|Severe debilitation, unable to continue|0|||
48963732|NCT00006604|157694296|FG009|Overall Study|Severe debilitation, unable to continue|5|||
48963733|NCT00006604|157694297|FG010|Overall Study|Severe debilitation, unable to continue|0|||
48963734|NCT00006604|157694298|FG011|Overall Study|Severe debilitation, unable to continue|2|||
48963735|NCT00006604|157694299|FG012|Overall Study|Severe debilitation, unable to continue|1|||
48963736|NCT00006604|157694300|FG013|Overall Study|Severe debilitation, unable to continue|0|||
48963737|NCT00006604|157694301|FG014|Overall Study|Severe debilitation, unable to continue|2|||
48963738|NCT00006604|157694302|FG015|Overall Study|Severe debilitation, unable to continue|0|||
48963739|NCT00006604|157694303|FG016|Overall Study|Severe debilitation, unable to continue|0|||
48963740|NCT00006604|157694287|FG000|Overall Study|Subj/Parent not able to get to clinic|0|||
48963741|NCT00006604|157694288|FG001|Overall Study|Subj/Parent not able to get to clinic|0|||
48963742|NCT00006604|157694289|FG002|Overall Study|Subj/Parent not able to get to clinic|0|||
48963743|NCT00006604|157694290|FG003|Overall Study|Subj/Parent not able to get to clinic|1|||
48963744|NCT00006604|157694291|FG004|Overall Study|Subj/Parent not able to get to clinic|1|||
48963745|NCT00006604|157694292|FG005|Overall Study|Subj/Parent not able to get to clinic|0|||
48963746|NCT00006604|157694293|FG006|Overall Study|Subj/Parent not able to get to clinic|1|||
48963747|NCT00006604|157694294|FG007|Overall Study|Subj/Parent not able to get to clinic|0|||
48963748|NCT00006604|157694295|FG008|Overall Study|Subj/Parent not able to get to clinic|0|||
48963749|NCT00006604|157694296|FG009|Overall Study|Subj/Parent not able to get to clinic|1|||
48963750|NCT00006604|157694297|FG010|Overall Study|Subj/Parent not able to get to clinic|2|||
48963751|NCT00006604|157694298|FG011|Overall Study|Subj/Parent not able to get to clinic|1|||
48963752|NCT00006604|157694299|FG012|Overall Study|Subj/Parent not able to get to clinic|1|||
48963753|NCT00006604|157694300|FG013|Overall Study|Subj/Parent not able to get to clinic|1|||
48963754|NCT00006604|157694301|FG014|Overall Study|Subj/Parent not able to get to clinic|3|||
48963755|NCT00006604|157694302|FG015|Overall Study|Subj/Parent not able to get to clinic|0|||
48963756|NCT00006604|157694303|FG016|Overall Study|Subj/Parent not able to get to clinic|0|||
48963757|NCT00006604|157694287|FG000|Overall Study|Site closing|0|||
48963758|NCT00006604|157694288|FG001|Overall Study|Site closing|0|||
48963759|NCT00006604|157694289|FG002|Overall Study|Site closing|1|||
48963760|NCT00006604|157694290|FG003|Overall Study|Site closing|1|||
48963761|NCT00006604|157694291|FG004|Overall Study|Site closing|0|||
48963762|NCT00006604|157694292|FG005|Overall Study|Site closing|0|||
48963763|NCT00006604|157694293|FG006|Overall Study|Site closing|0|||
48963764|NCT00006604|157694294|FG007|Overall Study|Site closing|1|||
48963765|NCT00006604|157694295|FG008|Overall Study|Site closing|0|||
48963766|NCT00006604|157694296|FG009|Overall Study|Site closing|0|||
48963767|NCT00006604|157694297|FG010|Overall Study|Site closing|0|||
48963768|NCT00006604|157694298|FG011|Overall Study|Site closing|1|||
48963769|NCT00006604|157694299|FG012|Overall Study|Site closing|1|||
48963770|NCT00006604|157694300|FG013|Overall Study|Site closing|1|||
48963771|NCT00006604|157694301|FG014|Overall Study|Site closing|0|||
48963772|NCT00006604|157694302|FG015|Overall Study|Site closing|0|||
48963773|NCT00006604|157694303|FG016|Overall Study|Site closing|1|||
48963774|NCT00006604|157694287|FG000|Overall Study|Withdrawal by Subject|1|||
48963775|NCT00006604|157694288|FG001|Overall Study|Withdrawal by Subject|0|||
48963776|NCT00006604|157694289|FG002|Overall Study|Withdrawal by Subject|2|||
48963777|NCT00006604|157694290|FG003|Overall Study|Withdrawal by Subject|0|||
48963778|NCT00006604|157694291|FG004|Overall Study|Withdrawal by Subject|1|||
48963779|NCT00006604|157694292|FG005|Overall Study|Withdrawal by Subject|2|||
48963780|NCT00006604|157694293|FG006|Overall Study|Withdrawal by Subject|2|||
48963781|NCT00006604|157694294|FG007|Overall Study|Withdrawal by Subject|0|||
48963782|NCT00006604|157694295|FG008|Overall Study|Withdrawal by Subject|1|||
48963783|NCT00006604|157694296|FG009|Overall Study|Withdrawal by Subject|3|||
48963784|NCT00006604|157694297|FG010|Overall Study|Withdrawal by Subject|2|||
48963785|NCT00006604|157694298|FG011|Overall Study|Withdrawal by Subject|0|||
48963786|NCT00006604|157694299|FG012|Overall Study|Withdrawal by Subject|1|||
48963787|NCT00006604|157694300|FG013|Overall Study|Withdrawal by Subject|2|||
48963788|NCT00006604|157694301|FG014|Overall Study|Withdrawal by Subject|1|||
48963789|NCT00006604|157694302|FG015|Overall Study|Withdrawal by Subject|0|||
48963790|NCT00006604|157694303|FG016|Overall Study|Withdrawal by Subject|1|||
48963791|NCT00006604|157694287|FG000|Overall Study|Subj/parent not willing to adhere to req|0|||
48963792|NCT00006604|157694288|FG001|Overall Study|Subj/parent not willing to adhere to req|0|||
48963793|NCT00006604|157694289|FG002|Overall Study|Subj/parent not willing to adhere to req|1|||
48963794|NCT00006604|157694290|FG003|Overall Study|Subj/parent not willing to adhere to req|3|||
48963795|NCT00006604|157694291|FG004|Overall Study|Subj/parent not willing to adhere to req|0|||
48963796|NCT00006604|157694292|FG005|Overall Study|Subj/parent not willing to adhere to req|0|||
48963797|NCT00006604|157694293|FG006|Overall Study|Subj/parent not willing to adhere to req|3|||
48963798|NCT00006604|157694294|FG007|Overall Study|Subj/parent not willing to adhere to req|1|||
48963799|NCT00006604|157694295|FG008|Overall Study|Subj/parent not willing to adhere to req|0|||
48963800|NCT00006604|157694296|FG009|Overall Study|Subj/parent not willing to adhere to req|6|||
48963801|NCT00006604|157694297|FG010|Overall Study|Subj/parent not willing to adhere to req|3|||
48963802|NCT00006604|157694298|FG011|Overall Study|Subj/parent not willing to adhere to req|0|||
48963803|NCT00006604|157694299|FG012|Overall Study|Subj/parent not willing to adhere to req|0|||
48659460|NCT03352557|156605216|FG007|LTE Period: Week 80 to Week 173|Death|1|||
48963804|NCT00006604|157694300|FG013|Overall Study|Subj/parent not willing to adhere to req|2|||
48659461|NCT03352557|156605217|FG008|LTE Period: Week 80 to Week 173|Death|1|||
48659462|NCT03352557|156605218|FG009|LTE Period: Week 80 to Week 173|Death|1|||
48659463|NCT03352557|156605209|FG000|LTE Period: Week 80 to Week 173|Adverse Event|0|||
48659464|NCT03352557|156605210|FG001|LTE Period: Week 80 to Week 173|Adverse Event|0|||
48963805|NCT00006604|157694301|FG014|Overall Study|Subj/parent not willing to adhere to req|3|||
48963806|NCT00006604|157694302|FG015|Overall Study|Subj/parent not willing to adhere to req|3|||
48963807|NCT00006604|157694303|FG016|Overall Study|Subj/parent not willing to adhere to req|4|||
48963808|NCT00006604|157694287|FG000|Overall Study|Lost to Follow-up|0|||
48963809|NCT00006604|157694288|FG001|Overall Study|Lost to Follow-up|0|||
48963810|NCT00006604|157694289|FG002|Overall Study|Lost to Follow-up|0|||
48963811|NCT00006604|157694290|FG003|Overall Study|Lost to Follow-up|0|||
48963812|NCT00006604|157694291|FG004|Overall Study|Lost to Follow-up|0|||
48963813|NCT00006604|157694292|FG005|Overall Study|Lost to Follow-up|0|||
48659465|NCT03352557|156605211|FG002|LTE Period: Week 80 to Week 173|Adverse Event|0|||
48659466|NCT03352557|156605212|FG003|LTE Period: Week 80 to Week 173|Adverse Event|0|||
48659467|NCT03352557|156605213|FG004|LTE Period: Week 80 to Week 173|Adverse Event|0|||
48659468|NCT03352557|156605214|FG005|LTE Period: Week 80 to Week 173|Adverse Event|3|||
48659469|NCT03352557|156605215|FG006|LTE Period: Week 80 to Week 173|Adverse Event|0|||
48659470|NCT03352557|156605216|FG007|LTE Period: Week 80 to Week 173|Adverse Event|0|||
48659471|NCT03352557|156605217|FG008|LTE Period: Week 80 to Week 173|Adverse Event|0|||
48659472|NCT03352557|156605218|FG009|LTE Period: Week 80 to Week 173|Adverse Event|0|||
48659473|NCT03352557|156605209|FG000|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
48659474|NCT03352557|156605210|FG001|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
48659475|NCT03352557|156605211|FG002|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
48659476|NCT03352557|156605212|FG003|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
48659477|NCT03352557|156605213|FG004|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
48659478|NCT03352557|156605214|FG005|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
48659479|NCT03352557|156605215|FG006|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
48659480|NCT03352557|156605216|FG007|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
48659481|NCT03352557|156605217|FG008|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|2|||
48659482|NCT03352557|156605218|FG009|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
48659483|NCT03352557|156605209|FG000|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
48659484|NCT03352557|156605210|FG001|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
48659485|NCT03352557|156605211|FG002|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
48659486|NCT03352557|156605212|FG003|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
48659487|NCT03352557|156605213|FG004|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
48659488|NCT03352557|156605214|FG005|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|38|||
48755346|NCT00498602|156951235|FG001|Overall Study|Investigator Request|0|||
48755347|NCT00498602|156951236|FG002|Overall Study|Investigator Request|1|||
48963814|NCT00006604|157694293|FG006|Overall Study|Lost to Follow-up|0|||
48963815|NCT00006604|157694294|FG007|Overall Study|Lost to Follow-up|1|||
48963816|NCT00006604|157694295|FG008|Overall Study|Lost to Follow-up|0|||
48963817|NCT00006604|157694296|FG009|Overall Study|Lost to Follow-up|2|||
48963818|NCT00006604|157694297|FG010|Overall Study|Lost to Follow-up|0|||
49015441|NCT01393990|157893773|FG003|Overall Study|Adverse Event|0|||
48659489|NCT03352557|156605215|FG006|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|49|||
48659490|NCT03352557|156605216|FG007|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|75|||
48963819|NCT00006604|157694298|FG011|Overall Study|Lost to Follow-up|0|||
48659491|NCT03352557|156605217|FG008|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|151|||
48659492|NCT03352557|156605218|FG009|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|154|||
48659493|NCT03352557|156605209|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
48659494|NCT03352557|156605210|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
48659495|NCT03352557|156605211|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
48659496|NCT03352557|156605212|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
48659497|NCT03352557|156605213|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
48659498|NCT03352557|156605214|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
48659499|NCT03352557|156605215|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
48659500|NCT03352557|156605216|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
48659501|NCT03352557|156605217|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
48659502|NCT03352557|156605218|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
48659503|NCT03352557|156605209|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
48659504|NCT03352557|156605210|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
48659505|NCT03352557|156605211|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
48659506|NCT03352557|156605212|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
48659507|NCT03352557|156605213|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
48659508|NCT03352557|156605214|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
48659509|NCT03352557|156605215|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
48659510|NCT03352557|156605216|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
48963820|NCT00006604|157694299|FG012|Overall Study|Lost to Follow-up|0|||
48659511|NCT03352557|156605217|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
48659512|NCT03352557|156605218|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
48659513|NCT03352557|156605209|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
48659514|NCT03352557|156605210|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
48659515|NCT03352557|156605211|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
48659516|NCT03352557|156605212|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
48659517|NCT03352557|156605213|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
48659518|NCT03352557|156605214|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
48659519|NCT03352557|156605215|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
48659520|NCT03352557|156605216|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
48659521|NCT03352557|156605217|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
48659522|NCT03352557|156605218|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|4|||
48659523|NCT03352557|156605209|FG000|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
48659524|NCT03352557|156605210|FG001|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
48659525|NCT03352557|156605211|FG002|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
48659526|NCT03352557|156605212|FG003|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
48659527|NCT03352557|156605213|FG004|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
48659528|NCT03352557|156605214|FG005|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
48659529|NCT03352557|156605215|FG006|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
48659530|NCT03352557|156605216|FG007|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
48659531|NCT03352557|156605217|FG008|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|2|||
48692728|NCT04908683|156724585|FG001|Overall Study|Adverse Event|11|||
48963821|NCT00006604|157694300|FG013|Overall Study|Lost to Follow-up|0|||
48963822|NCT00006604|157694301|FG014|Overall Study|Lost to Follow-up|0|||
48963823|NCT00006604|157694302|FG015|Overall Study|Lost to Follow-up|1|||
48963824|NCT00006604|157694303|FG016|Overall Study|Lost to Follow-up|3|||
48963825|NCT00006604|157694287|FG000|Overall Study|Other Reason|0|||
48963826|NCT00006604|157694288|FG001|Overall Study|Other Reason|0|||
48963827|NCT00006604|157694289|FG002|Overall Study|Other Reason|0|||
48963828|NCT00006604|157694290|FG003|Overall Study|Other Reason|0|||
48963829|NCT00006604|157694291|FG004|Overall Study|Other Reason|0|||
48963830|NCT00006604|157694292|FG005|Overall Study|Other Reason|1|||
48963831|NCT00006604|157694293|FG006|Overall Study|Other Reason|0|||
48963832|NCT00006604|157694294|FG007|Overall Study|Other Reason|0|||
48963833|NCT00006604|157694295|FG008|Overall Study|Other Reason|0|||
48963834|NCT00006604|157694296|FG009|Overall Study|Other Reason|1|||
48963835|NCT00006604|157694297|FG010|Overall Study|Other Reason|0|||
48659532|NCT03352557|156605218|FG009|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
48659533|NCT03352557|156605209|FG000|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
48659534|NCT03352557|156605210|FG001|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
48659535|NCT03352557|156605211|FG002|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
48659536|NCT03352557|156605212|FG003|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
48963836|NCT00006604|157694298|FG011|Overall Study|Other Reason|0|||
48963837|NCT00006604|157694299|FG012|Overall Study|Other Reason|0|||
48963838|NCT00006604|157694300|FG013|Overall Study|Other Reason|0|||
48963839|NCT00006604|157694301|FG014|Overall Study|Other Reason|0|||
48659537|NCT03352557|156605213|FG004|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
48659538|NCT03352557|156605214|FG005|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
48659539|NCT03352557|156605215|FG006|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
48659540|NCT03352557|156605216|FG007|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
48659541|NCT03352557|156605217|FG008|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
48659542|NCT03352557|156605218|FG009|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
48659543|NCT03352557|156605209|FG000|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
48659544|NCT03352557|156605210|FG001|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
48659545|NCT03352557|156605211|FG002|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
48659546|NCT03352557|156605212|FG003|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
48659547|NCT03352557|156605213|FG004|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
48659548|NCT03352557|156605214|FG005|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
48659549|NCT03352557|156605215|FG006|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
48659550|NCT03352557|156605216|FG007|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|2|||
48659551|NCT03352557|156605217|FG008|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
48659552|NCT03352557|156605218|FG009|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
48659553|NCT03352557|156605209|FG000|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
48659554|NCT03352557|156605210|FG001|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
48659555|NCT03352557|156605211|FG002|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
48659556|NCT03352557|156605212|FG003|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
48659557|NCT03352557|156605213|FG004|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
48659558|NCT03352557|156605214|FG005|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
48659559|NCT03352557|156605215|FG006|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
48659560|NCT03352557|156605216|FG007|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|2|||
48659561|NCT03352557|156605217|FG008|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
48659562|NCT03352557|156605218|FG009|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
48659563|NCT03352557|156605209|FG000|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
48659564|NCT03352557|156605210|FG001|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
48659565|NCT03352557|156605211|FG002|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
48659566|NCT03352557|156605212|FG003|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
48659567|NCT03352557|156605213|FG004|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
48659568|NCT03352557|156605214|FG005|LTE Period: Week 80 to Week 173|WBP/G-Other|1|||
48659569|NCT03352557|156605215|FG006|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
48659570|NCT03352557|156605216|FG007|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
48659571|NCT03352557|156605217|FG008|LTE Period: Week 80 to Week 173|WBP/G-Other|2|||
48659572|NCT03352557|156605218|FG009|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
48659573|NCT03352557|156605209|FG000|LTE Period: Week 80 to Week 173|Physician Decision|0|||
48659574|NCT03352557|156605210|FG001|LTE Period: Week 80 to Week 173|Physician Decision|0|||
48659575|NCT03352557|156605211|FG002|LTE Period: Week 80 to Week 173|Physician Decision|0|||
48659576|NCT03352557|156605212|FG003|LTE Period: Week 80 to Week 173|Physician Decision|0|||
48659577|NCT03352557|156605213|FG004|LTE Period: Week 80 to Week 173|Physician Decision|0|||
48659578|NCT03352557|156605214|FG005|LTE Period: Week 80 to Week 173|Physician Decision|0|||
48659579|NCT03352557|156605215|FG006|LTE Period: Week 80 to Week 173|Physician Decision|0|||
48659580|NCT03352557|156605216|FG007|LTE Period: Week 80 to Week 173|Physician Decision|0|||
48659581|NCT03352557|156605217|FG008|LTE Period: Week 80 to Week 173|Physician Decision|0|||
48659582|NCT03352557|156605218|FG009|LTE Period: Week 80 to Week 173|Physician Decision|3|||
48659583|NCT03352557|156605209|FG000|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
48963840|NCT00006604|157694302|FG015|Overall Study|Other Reason|0|||
48963841|NCT00006604|157694303|FG016|Overall Study|Other Reason|0|||
48659584|NCT03352557|156605210|FG001|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
48659585|NCT03352557|156605211|FG002|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
48659586|NCT03352557|156605212|FG003|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
48659587|NCT03352557|156605213|FG004|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
48659588|NCT03352557|156605214|FG005|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
48659589|NCT03352557|156605215|FG006|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
48659590|NCT03352557|156605216|FG007|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
48659591|NCT03352557|156605217|FG008|LTE Period: Week 80 to Week 173|Lost to Follow-up|3|||
48659592|NCT03352557|156605218|FG009|LTE Period: Week 80 to Week 173|Lost to Follow-up|1|||
48659593|NCT03352557|156605209|FG000|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
48659594|NCT03352557|156605210|FG001|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
48659595|NCT03352557|156605211|FG002|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
48659596|NCT03352557|156605212|FG003|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
48659597|NCT03352557|156605213|FG004|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
48659598|NCT03352557|156605214|FG005|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
48659599|NCT03352557|156605215|FG006|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
48659600|NCT03352557|156605216|FG007|LTE Period: Week 80 to Week 173|Progressive Disease|1|||
48659601|NCT03352557|156605217|FG008|LTE Period: Week 80 to Week 173|Progressive Disease|2|||
48659602|NCT03352557|156605218|FG009|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
48659603|NCT03352557|156605209|FG000|LTE Period: Week 80 to Week 173|Other|0|||
48659604|NCT03352557|156605210|FG001|LTE Period: Week 80 to Week 173|Other|0|||
48659605|NCT03352557|156605211|FG002|LTE Period: Week 80 to Week 173|Other|0|||
48659606|NCT03352557|156605212|FG003|LTE Period: Week 80 to Week 173|Other|0|||
48659607|NCT03352557|156605213|FG004|LTE Period: Week 80 to Week 173|Other|0|||
48659608|NCT03352557|156605214|FG005|LTE Period: Week 80 to Week 173|Other|0|||
48659609|NCT03352557|156605215|FG006|LTE Period: Week 80 to Week 173|Other|0|||
48659610|NCT03352557|156605216|FG007|LTE Period: Week 80 to Week 173|Other|1|||
48659611|NCT03352557|156605217|FG008|LTE Period: Week 80 to Week 173|Other|0|||
48659612|NCT03352557|156605218|FG009|LTE Period: Week 80 to Week 173|Other|0|||
48659613|NCT00907803|156605219|FG000|Overall Study|Withdrawal of consent - long commute|1|||
48659614|NCT00907803|156605220|FG001|Overall Study|Withdrawal of consent - long commute|0|||
48659615|NCT00907803|156605221|FG002|Overall Study|Withdrawal of consent - long commute|0|||
48659616|NCT00907803|156605219|FG000|Overall Study|Adverse Event|2|||
48659617|NCT00907803|156605220|FG001|Overall Study|Adverse Event|0|||
48659618|NCT00907803|156605221|FG002|Overall Study|Adverse Event|0|||
48659619|NCT00907803|156605219|FG000|Overall Study|Withdrawal by Subject|0|||
48659620|NCT00907803|156605220|FG001|Overall Study|Withdrawal by Subject|1|||
48659621|NCT00907803|156605221|FG002|Overall Study|Withdrawal by Subject|0|||
48659622|NCT00907803|156605219|FG000|Overall Study|Lost to Follow-up|0|||
48659623|NCT00907803|156605220|FG001|Overall Study|Lost to Follow-up|1|||
48659624|NCT00907803|156605221|FG002|Overall Study|Lost to Follow-up|0|||
48659625|NCT00907803|156605219|FG000|Overall Study|Protocol Violation|0|||
48659626|NCT00907803|156605220|FG001|Overall Study|Protocol Violation|1|||
48963842|NCT02431468|157694306|FG000|Overall Study|Adverse Event|2|||
48963843|NCT02431468|157694307|FG001|Overall Study|Adverse Event|4|||
48963844|NCT02431468|157694308|FG002|Overall Study|Adverse Event|5|||
48963845|NCT02431468|157694306|FG000|Overall Study|Withdrawal by Subject|4|||
48963846|NCT02431468|157694307|FG001|Overall Study|Withdrawal by Subject|12|||
48963847|NCT02431468|157694308|FG002|Overall Study|Withdrawal by Subject|2|||
48963848|NCT02431468|157694306|FG000|Overall Study|noncompliance, investigator termination,|2|||
48659627|NCT00907803|156605221|FG002|Overall Study|Protocol Violation|0|||
48659628|NCT00916058|156605226|FG000|Phase 1|Screen Failure|0|||
48659629|NCT00916058|156605227|FG001|Phase 1|Screen Failure|0|||
48659630|NCT00916058|156605228|FG002|Phase 1|Screen Failure|0|||
48659631|NCT00916058|156605229|FG003|Phase 1|Screen Failure|0|||
48659632|NCT00916058|156605230|FG004|Phase 1|Screen Failure|0|||
48659633|NCT00916058|156605231|FG005|Phase 1|Screen Failure|1|||
48659634|NCT00916058|156605232|FG006|Phase 1|Screen Failure|0|||
48659635|NCT00916058|156605226|FG000|Phase 2|Screen Failure|0|||
48659636|NCT00916058|156605227|FG001|Phase 2|Screen Failure|0|||
48659637|NCT00916058|156605228|FG002|Phase 2|Screen Failure|0|||
48659638|NCT00916058|156605229|FG003|Phase 2|Screen Failure|0|||
48659639|NCT00916058|156605230|FG004|Phase 2|Screen Failure|0|||
48659640|NCT00916058|156605231|FG005|Phase 2|Screen Failure|0|||
48659641|NCT00916058|156605232|FG006|Phase 2|Screen Failure|3|||
48659642|NCT03385265|156605234|FG000|Overall Study|Withdrawal by Subject|5|||
48659643|NCT03385265|156605235|FG001|Overall Study|Withdrawal by Subject|2|||
48659644|NCT03385265|156605236|FG002|Overall Study|Withdrawal by Subject|5|||
48659645|NCT03385265|156605237|FG003|Overall Study|Withdrawal by Subject|2|||
48659646|NCT00241631|156605238|FG000|Run in (2 Weeks)|Physician Decision|3|||
48659647|NCT00241631|156605239|FG001|Run in (2 Weeks)|Physician Decision|3|||
48659648|NCT00241631|156605238|FG000|Phase 1 (4 Weeks)|sore throat|1|||
48963849|NCT02431468|157694307|FG001|Overall Study|noncompliance, investigator termination,|2|||
48659649|NCT00241631|156605239|FG001|Phase 1 (4 Weeks)|sore throat|0|||
48659650|NCT00241631|156605238|FG000|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
48659651|NCT00241631|156605239|FG001|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
48659652|NCT00241631|156605238|FG000|Phase 1 (4 Weeks)|Lost to Follow-up|3|||
48659653|NCT00241631|156605239|FG001|Phase 1 (4 Weeks)|Lost to Follow-up|0|||
48659654|NCT00241631|156605238|FG000|Phase 1 (4 Weeks)|Lack of Efficacy|0|||
48659655|NCT00241631|156605239|FG001|Phase 1 (4 Weeks)|Lack of Efficacy|1|||
48659656|NCT02437305|156605240|FG000|Overall Study|Lost to Follow-up|18|||
48963850|NCT02431468|157694308|FG002|Overall Study|noncompliance, investigator termination,|2|||
48963851|NCT03629041|157694314|FG000|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
48963852|NCT03629041|157694315|FG001|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1|||
48963853|NCT03629041|157694316|FG002|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
48963854|NCT03629041|157694317|FG003|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
48963855|NCT01361919|157694318|FG000|Overall Study|technical issues|10|||
48963856|NCT01361919|157694319|FG001|Overall Study|technical issues|12|||
48963857|NCT01361919|157694320|FG002|Overall Study|technical issues|10|||
48963858|NCT01391819|157694321|FG000|Overall Study|Withdrawal by Subject|56|||
48963859|NCT01391819|157694321|FG000|Overall Study|Migrated/moved from study area|82|||
48963860|NCT01391819|157694321|FG000|Overall Study|Lost to Follow-up|252|||
48963861|NCT01391819|157694321|FG000|Overall Study|Death|3|||
48963862|NCT01391819|157694321|FG000|Overall Study|Other|9|||
48963863|NCT00393913|157694323|FG000|Initial Assessment|diagnosed with other sleep disorder|21|||
48963864|NCT00393913|157694323|FG000|Initial Assessment|Withdrawal by Subject|16|||
48963865|NCT00393913|157694323|FG000|CPAP|Withdrawal by Subject|3|||
48963866|NCT00393913|157694323|FG000|CPAP|Physician Decision|1|||
48963867|NCT00393913|157694323|FG000|CPAP|TEchnical problem with CPAP|3|||
48963868|NCT01927419|157694324|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
48963869|NCT01927419|157694325|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
48963870|NCT01927419|157694324|FG000|Pre-Treatment Period|Participants no longer meeting study criteria|1|||
48963871|NCT01927419|157694325|FG001|Pre-Treatment Period|Participants no longer meeting study criteria|0|||
48963872|NCT01927419|157694324|FG000|Treatment Period|Disease progression|17|||
48963873|NCT01927419|157694325|FG001|Treatment Period|Disease progression|20|||
48963874|NCT01927419|157694324|FG000|Treatment Period|Study drug toxicity|48|||
48963875|NCT01927419|157694325|FG001|Treatment Period|Study drug toxicity|10|||
48659657|NCT02437305|156605241|FG001|Overall Study|Lost to Follow-up|12|||
48659658|NCT01118520|156605242|FG000|Overall Study|AAA repair|9|||
48659659|NCT01118520|156605243|FG001|Overall Study|AAA repair|7|||
48659660|NCT01118520|156605244|FG002|Overall Study|AAA repair|9|||
48659661|NCT01118520|156605242|FG000|Overall Study|Adverse Event|3|||
48659662|NCT01118520|156605243|FG001|Overall Study|Adverse Event|3|||
48659663|NCT01118520|156605244|FG002|Overall Study|Adverse Event|3|||
48659664|NCT01118520|156605242|FG000|Overall Study|Withdrawal by Subject|8|||
48659665|NCT01118520|156605243|FG001|Overall Study|Withdrawal by Subject|13|||
48659666|NCT01118520|156605244|FG002|Overall Study|Withdrawal by Subject|8|||
48659667|NCT02439450|156605245|FG000|Overall Study|Adverse Event|4|||
48659668|NCT02439450|156605246|FG001|Overall Study|Adverse Event|1|||
48659669|NCT02439450|156605247|FG002|Overall Study|Adverse Event|0|||
48963876|NCT01927419|157694324|FG000|Treatment Period|Death|0|||
48963877|NCT01927419|157694325|FG001|Treatment Period|Death|1|||
48963878|NCT01927419|157694324|FG000|Treatment Period|Adverse event unrelated to study drug|6|||
48963879|NCT01927419|157694325|FG001|Treatment Period|Adverse event unrelated to study drug|3|||
48963880|NCT01927419|157694324|FG000|Treatment Period|Participant request to discontinue|12|||
48963881|NCT01927419|157694325|FG001|Treatment Period|Participant request to discontinue|4|||
48963882|NCT01927419|157694324|FG000|Treatment Period|Withdrawal by Subject|1|||
48963883|NCT01927419|157694325|FG001|Treatment Period|Withdrawal by Subject|1|||
48963884|NCT01927419|157694324|FG000|Treatment Period|Maximum Clinical Benefit|6|||
48963885|NCT01927419|157694325|FG001|Treatment Period|Maximum Clinical Benefit|2|||
48963886|NCT01927419|157694324|FG000|Treatment Period|Other reasons|3|||
48963887|NCT01927419|157694325|FG001|Treatment Period|Other reasons|4|||
48963888|NCT01927419|157694324|FG000|Treatment Period|Not Reported|1|||
48963889|NCT01927419|157694325|FG001|Treatment Period|Not Reported|1|||
48963890|NCT03488251|157694328|FG000|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|1|||
48963891|NCT03488251|157694329|FG001|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
48963892|NCT03488251|157694330|FG002|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
48659670|NCT02439450|156605248|FG003|Overall Study|Adverse Event|0|||
48659671|NCT02439450|156605245|FG000|Overall Study|Withdrawal by Subject|1|||
48659672|NCT02439450|156605246|FG001|Overall Study|Withdrawal by Subject|2|||
48963893|NCT03488251|157694331|FG003|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
48963894|NCT03488251|157694328|FG000|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|1|||
48963895|NCT03488251|157694329|FG001|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
48963896|NCT03488251|157694330|FG002|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
48963897|NCT03488251|157694331|FG003|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
49015442|NCT01393990|157893774|FG004|Overall Study|Adverse Event|0|||
48659673|NCT02439450|156605247|FG002|Overall Study|Withdrawal by Subject|0|||
48659674|NCT02439450|156605248|FG003|Overall Study|Withdrawal by Subject|0|||
48659675|NCT02439450|156605245|FG000|Overall Study|Death|3|||
48963898|NCT03488251|157694328|FG000|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|4|||
48963899|NCT03488251|157694329|FG001|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
48963900|NCT03488251|157694330|FG002|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
48963901|NCT03488251|157694331|FG003|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
48963902|NCT03488251|157694328|FG000|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|1|||
48963903|NCT03488251|157694329|FG001|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
48963904|NCT03488251|157694330|FG002|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
48963905|NCT03488251|157694331|FG003|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
48963906|NCT03488251|157694328|FG000|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|1|||
48963907|NCT03488251|157694329|FG001|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
48963908|NCT03488251|157694330|FG002|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
48963909|NCT03488251|157694331|FG003|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
48963910|NCT01681576|157694332|FG000|Period 1|Adverse Event|1|||
48963911|NCT01681576|157694333|FG001|Period 1|Adverse Event|0|||
48963912|NCT01681576|157694332|FG000|Period 1|Protocol Deviation|1|||
48963913|NCT01681576|157694333|FG001|Period 1|Protocol Deviation|0|||
48963914|NCT01681576|157694332|FG000|Period 2|subject/guardian decision|3|||
48963915|NCT01681576|157694333|FG001|Period 2|subject/guardian decision|1|||
48963916|NCT01681576|157694332|FG000|Period 2|Non-compliance with study treatment|1|||
48963917|NCT01681576|157694333|FG001|Period 2|Non-compliance with study treatment|0|||
48963918|NCT03730194|157694334|FG000|First Stage Treatment|Withdrawal by Subject|1|||
48963919|NCT03730194|157694335|FG001|First Stage Treatment|Withdrawal by Subject|1|||
48963920|NCT03730194|157694336|FG002|First Stage Treatment|Withdrawal by Subject|0|||
48963921|NCT03730194|157694337|FG003|First Stage Treatment|Withdrawal by Subject|0|||
48963922|NCT03730194|157694338|FG004|First Stage Treatment|Withdrawal by Subject|0|||
48963923|NCT03730194|157694339|FG005|First Stage Treatment|Withdrawal by Subject|0|||
48963924|NCT03730194|157694334|FG000|First Stage Treatment|Protocol Violation|3|||
48963925|NCT03730194|157694335|FG001|First Stage Treatment|Protocol Violation|3|||
48963926|NCT03730194|157694336|FG002|First Stage Treatment|Protocol Violation|0|||
48963927|NCT03730194|157694337|FG003|First Stage Treatment|Protocol Violation|0|||
48963928|NCT03730194|157694338|FG004|First Stage Treatment|Protocol Violation|0|||
48963929|NCT03730194|157694339|FG005|First Stage Treatment|Protocol Violation|0|||
48963930|NCT02349789|157695978|FG000|Overall Study|Withdrawal by Subject|2|||
48963931|NCT01575197|157695990|FG000|Overall Study|Migration out of study area|1|||
48963932|NCT01575197|157695991|FG001|Overall Study|Migration out of study area|5|||
48963933|NCT01575197|157695992|FG002|Overall Study|Migration out of study area|4|||
48963934|NCT01575197|157695990|FG000|Overall Study|SAE|0|||
48963935|NCT01575197|157695991|FG001|Overall Study|SAE|1|||
48963936|NCT01575197|157695992|FG002|Overall Study|SAE|0|||
48963937|NCT01575197|157695990|FG000|Overall Study|Lost to Follow-up|0|||
48963938|NCT01575197|157695991|FG001|Overall Study|Lost to Follow-up|1|||
48963939|NCT01575197|157695992|FG002|Overall Study|Lost to Follow-up|0|||
48963940|NCT01575197|157695990|FG000|Overall Study|Withdrawal by Subject|0|||
48963941|NCT01575197|157695991|FG001|Overall Study|Withdrawal by Subject|1|||
48963942|NCT01575197|157695992|FG002|Overall Study|Withdrawal by Subject|1|||
48963943|NCT01575197|157695990|FG000|Overall Study|Protocol Violation|2|||
48963944|NCT01575197|157695991|FG001|Overall Study|Protocol Violation|1|||
48963945|NCT01575197|157695992|FG002|Overall Study|Protocol Violation|1|||
48963946|NCT03137121|157695996|FG000|Overall Study|Withdrawal by Subject|0|||
48963947|NCT03137121|157695997|FG001|Overall Study|Withdrawal by Subject|1|||
48963948|NCT03196193|157696000|FG000|Overall Study|Adverse Event|1|||
48963949|NCT03196193|157696001|FG001|Overall Study|Adverse Event|0|||
48963950|NCT03196193|157696000|FG000|Overall Study|Computed Tomography (CT) data missing|2|||
48963951|NCT03196193|157696001|FG001|Overall Study|Computed Tomography (CT) data missing|0|||
48963952|NCT02709083|157696005|FG000|Overall Study|Original PI left institution|7|||
48963953|NCT00111475|157696006|FG000|Overall Study|Lost to Follow-up|0|||
48963954|NCT00111475|157696007|FG001|Overall Study|Lost to Follow-up|0|||
48963955|NCT00111475|157696008|FG002|Overall Study|Lost to Follow-up|0|||
48963956|NCT00111475|157696009|FG003|Overall Study|Lost to Follow-up|0|||
48963957|NCT00111475|157696010|FG004|Overall Study|Lost to Follow-up|0|||
48963958|NCT00111475|157696011|FG005|Overall Study|Lost to Follow-up|1|||
48963959|NCT00111475|157696012|FG006|Overall Study|Lost to Follow-up|0|||
48963960|NCT00111475|157696013|FG007|Overall Study|Lost to Follow-up|0|||
48963961|NCT00111475|157696014|FG008|Overall Study|Lost to Follow-up|0|||
48963962|NCT00111475|157696015|FG009|Overall Study|Lost to Follow-up|0|||
48963963|NCT03303092|157696017|FG000|Overall Study|Adverse Event|1|||
48963964|NCT03303092|157696018|FG001|Overall Study|Adverse Event|0|||
48963965|NCT03303092|157696019|FG002|Overall Study|Adverse Event|1|||
48963966|NCT03303092|157696017|FG000|Overall Study|Protocol Violation|1|||
48963967|NCT03303092|157696018|FG001|Overall Study|Protocol Violation|5|||
48963968|NCT03303092|157696019|FG002|Overall Study|Protocol Violation|1|||
48963969|NCT03303092|157696017|FG000|Overall Study|Withdrawal by Subject|1|||
48963970|NCT03303092|157696018|FG001|Overall Study|Withdrawal by Subject|1|||
48963971|NCT03303092|157696019|FG002|Overall Study|Withdrawal by Subject|3|||
48659676|NCT02439450|156605246|FG001|Overall Study|Death|0|||
48659677|NCT02439450|156605247|FG002|Overall Study|Death|0|||
48659678|NCT02439450|156605248|FG003|Overall Study|Death|1|||
48659679|NCT02439450|156605245|FG000|Overall Study|Progressive Disease|18|||
48659680|NCT02439450|156605246|FG001|Overall Study|Progressive Disease|41|||
48659681|NCT02439450|156605247|FG002|Overall Study|Progressive Disease|2|||
48963972|NCT00111917|157696026|FG000|Overall Study|Withdrawal by Subject|1|||
48963973|NCT00111917|157696027|FG001|Overall Study|Withdrawal by Subject|1|||
48963974|NCT03446651|157696028|FG000|Overall Study|Lost to Follow-up|4|||
48963975|NCT03446651|157696029|FG001|Overall Study|Lost to Follow-up|0|||
48963976|NCT03446651|157696028|FG000|Overall Study|Open Label Participants|5|||
48963977|NCT03446651|157696029|FG001|Overall Study|Open Label Participants|0|||
48963978|NCT00343291|157696030|FG000|Overall Study|Adverse Event|13|||
48963979|NCT00343291|157696031|FG001|Overall Study|Adverse Event|13|||
48963980|NCT00343291|157696030|FG000|Overall Study|Death|3|||
48963981|NCT00343291|157696031|FG001|Overall Study|Death|2|||
48963982|NCT00343291|157696030|FG000|Overall Study|Progressive disease|33|||
48963983|NCT00343291|157696031|FG001|Overall Study|Progressive disease|34|||
48963984|NCT00343291|157696030|FG000|Overall Study|Withdrawal by Subject|0|||
48659682|NCT02439450|156605248|FG003|Overall Study|Progressive Disease|3|||
48659683|NCT02763254|156605249|FG000|Overall Study|Adverse Event|1|||
48659684|NCT01819129|156605250|FG000|Overall Study|Other, Subject wanted HbA1c to be > 7%|1|||
48659685|NCT01819129|156605251|FG001|Overall Study|Other, Subject wanted HbA1c to be > 7%|0|||
48659686|NCT01819129|156605250|FG000|Overall Study|Other, weight gain, hypoglycaemic events|1|||
48659687|NCT01819129|156605251|FG001|Overall Study|Other, weight gain, hypoglycaemic events|0|||
48659688|NCT01819129|156605250|FG000|Overall Study|Other, Subject moved out of the country|0|||
48659689|NCT01819129|156605251|FG001|Overall Study|Other, Subject moved out of the country|1|||
48659690|NCT01819129|156605250|FG000|Overall Study|Withdrawal by Subject|15|||
48659691|NCT01819129|156605251|FG001|Overall Study|Withdrawal by Subject|15|||
48659692|NCT01819129|156605250|FG000|Overall Study|Lost to Follow-up|5|||
48659693|NCT01819129|156605251|FG001|Overall Study|Lost to Follow-up|2|||
48659694|NCT01819129|156605250|FG000|Overall Study|Lack of Efficacy|0|||
48659695|NCT01819129|156605251|FG001|Overall Study|Lack of Efficacy|1|||
48659696|NCT01819129|156605250|FG000|Overall Study|Adverse Event|1|||
48659697|NCT01819129|156605251|FG001|Overall Study|Adverse Event|4|||
48659698|NCT01819129|156605250|FG000|Overall Study|Death|1|||
48659699|NCT01819129|156605251|FG001|Overall Study|Death|1|||
48659700|NCT01819129|156605250|FG000|Overall Study|Withdrawal Criteria|20|||
48659701|NCT01819129|156605251|FG001|Overall Study|Withdrawal Criteria|15|||
48659702|NCT01646645|156605257|FG000|Overall Study|No Treated|1|||
48659703|NCT01646645|156605257|FG000|Overall Study|Inevaluable Donor|29|||
48659704|NCT01874275|156605258|FG000|Overall Study|Lost to Follow-up|1|||
48659705|NCT01874275|156605259|FG001|Overall Study|Lost to Follow-up|0|||
48659706|NCT00066469|156605260|FG000|Overall Study|Death|3|||
48659707|NCT00066469|156605260|FG000|Overall Study|Lack of Efficacy|9|||
48659708|NCT00066469|156605260|FG000|Overall Study|Lost to Follow-up|1|||
48659709|NCT00066469|156605260|FG000|Overall Study|Physician Decision|1|||
48659710|NCT00066469|156605260|FG000|Overall Study|Withdrawal by Subject|1|||
48659711|NCT00066469|156605260|FG000|Overall Study|ineligible|1|||
48659712|NCT04070326|156605266|FG000|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|1|||
48659713|NCT04070326|156605267|FG001|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|0|||
48659714|NCT01886690|156605268|FG000|Overall Study|Protocol Violation|0|||
48659715|NCT01886690|156605269|FG001|Overall Study|Protocol Violation|1|||
48659716|NCT01886690|156605268|FG000|Overall Study|Personal Reasons|0|||
48659717|NCT01886690|156605269|FG001|Overall Study|Personal Reasons|1|||
48659718|NCT04096820|156605270|FG000|Overall Study|Did not return for intervention|2|||
48659719|NCT04096820|156605270|FG000|Overall Study|Death|1|||
48659720|NCT04941807|156605271|FG000|Overall Study|Lost to Follow-up|1|||
48755348|NCT00498602|156951237|FG003|Overall Study|Investigator Request|0|||
48755349|NCT00498602|156951238|FG004|Overall Study|Investigator Request|0|||
48755350|NCT00498602|156951239|FG005|Overall Study|Investigator Request|0|||
48755351|NCT00498602|156951240|FG006|Overall Study|Investigator Request|0|||
48755352|NCT00498602|156951234|FG000|Overall Study|Subject Request|3|||
48755353|NCT00498602|156951235|FG001|Overall Study|Subject Request|0|||
48755354|NCT00498602|156951236|FG002|Overall Study|Subject Request|1|||
48755355|NCT00498602|156951237|FG003|Overall Study|Subject Request|1|||
48659721|NCT04941807|156605272|FG001|Overall Study|Lost to Follow-up|1|||
48963985|NCT00343291|157696031|FG001|Overall Study|Withdrawal by Subject|2|||
48963986|NCT00343291|157696030|FG000|Overall Study|Other|8|||
48659722|NCT02725593|156605273|FG000|Blinded Treatment Period|Withdrawal by Subject|4|||
48963987|NCT00343291|157696031|FG001|Overall Study|Other|5|||
48659723|NCT02725593|156605274|FG001|Blinded Treatment Period|Withdrawal by Subject|3|||
48659724|NCT02725593|156605273|FG000|Blinded Treatment Period|Withdrawal by Parent/Guardian|0|||
48659725|NCT02725593|156605274|FG001|Blinded Treatment Period|Withdrawal by Parent/Guardian|2|||
48755356|NCT00498602|156951238|FG004|Overall Study|Subject Request|1|||
48755357|NCT00498602|156951239|FG005|Overall Study|Subject Request|4|||
48963988|NCT01956240|157696038|FG000|Overall Study|Lost to Follow-up|6|||
48963989|NCT01956240|157696039|FG001|Overall Study|Lost to Follow-up|20|||
48963990|NCT01956240|157696038|FG000|Overall Study|Adverse Event|17|||
48963991|NCT01956240|157696039|FG001|Overall Study|Adverse Event|4|||
48963992|NCT02387372|157696045|FG000|Overall Study|Not Treated|1|||
48963993|NCT02387372|157696046|FG001|Overall Study|Not Treated|0|||
48963994|NCT01757405|157696048|FG000|Overall Study|Lost to Follow-up|1|||
48963995|NCT01757405|157696049|FG001|Overall Study|Lost to Follow-up|1|||
48963996|NCT01757405|157696048|FG000|Overall Study|Withdrawal by Subject|0|||
48963997|NCT01757405|157696049|FG001|Overall Study|Withdrawal by Subject|1|||
48963998|NCT02168803|157696051|FG000|Overall Study|Lost to Follow-up|1|||
48963999|NCT02168803|157696052|FG001|Overall Study|Lost to Follow-up|0|||
48964000|NCT02168803|157696053|FG002|Overall Study|Lost to Follow-up|1|||
48964001|NCT02168803|157696051|FG000|Overall Study|Withdrawal by Subject|1|||
48964002|NCT02168803|157696052|FG001|Overall Study|Withdrawal by Subject|1|||
48964003|NCT02168803|157696053|FG002|Overall Study|Withdrawal by Subject|2|||
48964004|NCT02168803|157696051|FG000|Overall Study|Physician Decision|0|||
48659726|NCT02725593|156605273|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
48659727|NCT02725593|156605274|FG001|Blinded Treatment Period|Lost to Follow-up|1|||
48659728|NCT02725593|156605273|FG000|Long Term Extension|Withdrawal by Subject|1|||
48659729|NCT02725593|156605274|FG001|Long Term Extension|Withdrawal by Subject|3|||
48659730|NCT04199104|156607084|FG000|Overall Study|Death|148|||
48659731|NCT04199104|156607085|FG001|Overall Study|Death|134|||
48659732|NCT04199104|156607084|FG000|Overall Study|Lost to Follow-up|1|||
48659733|NCT04199104|156607085|FG001|Overall Study|Lost to Follow-up|1|||
48659734|NCT04199104|156607084|FG000|Overall Study|Withdrawal by Subject|4|||
48659735|NCT04199104|156607085|FG001|Overall Study|Withdrawal by Subject|4|||
48659736|NCT04199104|156607084|FG000|Overall Study|Participants Ongoing|103|||
48659737|NCT04199104|156607085|FG001|Overall Study|Participants Ongoing|116|||
48659738|NCT03724981|156607090|FG000|First Device|Protocol Violation|1|||
48659739|NCT03724981|156607091|FG001|First Device|Protocol Violation|1|||
48659740|NCT04817670|156607095|FG000|Overall Study|Withdrawal by Subject|1|||
48659741|NCT04817670|156607096|FG001|Overall Study|Withdrawal by Subject|0|||
48659742|NCT04817670|156607097|FG002|Overall Study|Withdrawal by Subject|0|||
48659743|NCT04817670|156607098|FG003|Overall Study|Withdrawal by Subject|0|||
48659744|NCT04817670|156607099|FG004|Overall Study|Withdrawal by Subject|0|||
48659745|NCT04817670|156607095|FG000|Overall Study|Lost to Follow-up|0|||
48964005|NCT02168803|157696052|FG001|Overall Study|Physician Decision|1|||
48659746|NCT04817670|156607096|FG001|Overall Study|Lost to Follow-up|0|||
48659747|NCT04817670|156607097|FG002|Overall Study|Lost to Follow-up|1|||
48659748|NCT04817670|156607098|FG003|Overall Study|Lost to Follow-up|0|||
48964006|NCT02168803|157696053|FG002|Overall Study|Physician Decision|0|||
48659749|NCT04817670|156607099|FG004|Overall Study|Lost to Follow-up|0|||
48659750|NCT03312907|156607100|FG000|Overall Study|Adverse Event|1|||
48659751|NCT03312907|156607101|FG001|Overall Study|Adverse Event|6|||
48659752|NCT03312907|156607102|FG002|Overall Study|Adverse Event|1|||
48964007|NCT02168803|157696051|FG000|Overall Study|Adverse Event|0|||
48659753|NCT03312907|156607100|FG000|Overall Study|Protocol Violation|2|||
48964008|NCT02168803|157696052|FG001|Overall Study|Adverse Event|1|||
48964009|NCT02168803|157696053|FG002|Overall Study|Adverse Event|1|||
48964010|NCT02168803|157696051|FG000|Overall Study|Death|0|||
48964011|NCT02168803|157696052|FG001|Overall Study|Death|0|||
48964012|NCT02168803|157696053|FG002|Overall Study|Death|1|||
48964013|NCT02168803|157696051|FG000|Overall Study|Sponsor Decision|0|||
48964014|NCT02168803|157696052|FG001|Overall Study|Sponsor Decision|0|||
48964015|NCT02168803|157696053|FG002|Overall Study|Sponsor Decision|1|||
48964016|NCT00082758|157696055|FG000|Overall Study|Adverse Event|0|||
48964017|NCT00082758|157696056|FG001|Overall Study|Adverse Event|2|||
48964018|NCT00082758|157696057|FG002|Overall Study|Adverse Event|0|||
48659754|NCT03312907|156607101|FG001|Overall Study|Protocol Violation|3|||
48659755|NCT03312907|156607102|FG002|Overall Study|Protocol Violation|4|||
48659756|NCT03312907|156607100|FG000|Overall Study|Lost to Follow-up|2|||
48659757|NCT03312907|156607101|FG001|Overall Study|Lost to Follow-up|3|||
48659758|NCT03312907|156607102|FG002|Overall Study|Lost to Follow-up|2|||
48659759|NCT03312907|156607100|FG000|Overall Study|Physician Decision|3|||
48659760|NCT03312907|156607101|FG001|Overall Study|Physician Decision|4|||
48659761|NCT03312907|156607102|FG002|Overall Study|Physician Decision|2|||
48659762|NCT03312907|156607100|FG000|Overall Study|Withdrawal by Subject|9|||
48659763|NCT03312907|156607101|FG001|Overall Study|Withdrawal by Subject|14|||
48659764|NCT03312907|156607102|FG002|Overall Study|Withdrawal by Subject|10|||
48659765|NCT02358031|156607103|FG000|Overall Study|Death|253|||
48659766|NCT02358031|156607104|FG001|Overall Study|Death|237|||
48964019|NCT00082758|157696055|FG000|Overall Study|Lack of Efficacy|12|||
48964020|NCT00082758|157696056|FG001|Overall Study|Lack of Efficacy|13|||
48964021|NCT00082758|157696057|FG002|Overall Study|Lack of Efficacy|0|||
48964022|NCT00082758|157696055|FG000|Overall Study|Physician Decision|0|||
48659767|NCT02358031|156607105|FG002|Overall Study|Death|266|||
48659768|NCT02358031|156607103|FG000|Overall Study|Lost to Follow-up|1|||
48659769|NCT02358031|156607104|FG001|Overall Study|Lost to Follow-up|1|||
48964023|NCT00082758|157696056|FG001|Overall Study|Physician Decision|1|||
48964024|NCT00082758|157696057|FG002|Overall Study|Physician Decision|0|||
48964025|NCT00082758|157696055|FG000|Overall Study|Withdrawal by Subject|3|||
48659770|NCT02358031|156607105|FG002|Overall Study|Lost to Follow-up|0|||
48659771|NCT02358031|156607103|FG000|Overall Study|Withdrawal by Subject|19|||
48659772|NCT02358031|156607104|FG001|Overall Study|Withdrawal by Subject|14|||
48659773|NCT02358031|156607105|FG002|Overall Study|Withdrawal by Subject|18|||
48659774|NCT02358031|156607103|FG000|Overall Study|Sponsor Decision|26|||
48659775|NCT02358031|156607104|FG001|Overall Study|Sponsor Decision|28|||
48659776|NCT02358031|156607105|FG002|Overall Study|Sponsor Decision|16|||
48659777|NCT05104697|156607109|FG000|Overall Study|Withdrawal by Subject|0|||
48659778|NCT05104697|156607110|FG001|Overall Study|Withdrawal by Subject|1|||
48659779|NCT04714320|156607111|FG000|Overall Study|Voluntary Withdrawal|4|||
48659780|NCT04714320|156607112|FG001|Overall Study|Voluntary Withdrawal|1|||
48659781|NCT04714320|156607113|FG002|Overall Study|Voluntary Withdrawal|2|||
48659782|NCT04714320|156607111|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
48659783|NCT04714320|156607112|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
48659784|NCT04714320|156607113|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
48659785|NCT04714320|156607111|FG000|Overall Study|Reason Not Specified|1|||
48659786|NCT04714320|156607112|FG001|Overall Study|Reason Not Specified|3|||
48659787|NCT04714320|156607113|FG002|Overall Study|Reason Not Specified|3|||
48659788|NCT05656911|156607114|FG000|Treatment Phase|Physician Decision|2|||
48659789|NCT05656911|156607115|FG001|Treatment Phase|Physician Decision|0|||
48659790|NCT05656911|156607114|FG000|Treatment Phase|Lack of Efficacy|6|||
48659791|NCT05656911|156607115|FG001|Treatment Phase|Lack of Efficacy|3|||
48659792|NCT05656911|156607114|FG000|Treatment Phase|Subject Decision|4|||
48659793|NCT05656911|156607115|FG001|Treatment Phase|Subject Decision|2|||
48659794|NCT05656911|156607114|FG000|Treatment Phase|Other Reasons|1|||
48659795|NCT05656911|156607115|FG001|Treatment Phase|Other Reasons|0|||
48964026|NCT00082758|157696056|FG001|Overall Study|Withdrawal by Subject|0|||
48964027|NCT00082758|157696057|FG002|Overall Study|Withdrawal by Subject|0|||
48964028|NCT00082758|157696055|FG000|Overall Study|Protocol Violation|0|||
48964029|NCT00082758|157696056|FG001|Overall Study|Protocol Violation|1|||
48659796|NCT05656911|156607114|FG000|Treatment Phase|Adverse Event|3|||
48659797|NCT05656911|156607115|FG001|Treatment Phase|Adverse Event|1|||
48659798|NCT05656911|156607114|FG000|Follow-up Phase|Subject Decision|0|||
48659799|NCT05656911|156607115|FG001|Follow-up Phase|Subject Decision|1|||
48659800|NCT05656911|156607114|FG000|Follow-up Phase|Missing|1|||
48659801|NCT05656911|156607115|FG001|Follow-up Phase|Missing|0|||
48659802|NCT00567580|156607117|FG000|Overall Study|Protocol Violation|28|||
48659803|NCT00567580|156607118|FG001|Overall Study|Protocol Violation|24|||
48659804|NCT00567580|156607119|FG002|Overall Study|Protocol Violation|24|||
48659805|NCT05030233|156607122|FG000|Overall Study|withdrawn for transfer|1|||
48659806|NCT05030233|156607123|FG001|Overall Study|withdrawn for transfer|0|||
48659807|NCT01159171|156607124|FG000|Overall Study|Adverse Event|11|||
48659808|NCT01159171|156607124|FG000|Overall Study|Progression of Disease|28|||
48659809|NCT01159171|156607124|FG000|Overall Study|Protocol Violation|1|||
48659810|NCT01159171|156607124|FG000|Overall Study|Need for Surgery|5|||
48659811|NCT01159171|156607124|FG000|Overall Study|Medical Decision|4|||
48659812|NCT01159171|156607124|FG000|Overall Study|Death|1|||
48659813|NCT00896363|156607125|FG000|Overall Study|Adverse Event|3|||
48659814|NCT00896363|156607126|FG001|Overall Study|Adverse Event|4|||
48659815|NCT00896363|156607127|FG002|Overall Study|Adverse Event|2|||
48659816|NCT00896363|156607125|FG000|Overall Study|Lack of Efficacy|0|||
48659817|NCT00896363|156607126|FG001|Overall Study|Lack of Efficacy|2|||
48659818|NCT00896363|156607127|FG002|Overall Study|Lack of Efficacy|1|||
48659819|NCT00896363|156607125|FG000|Overall Study|Withdrawal by Subject|3|||
48755358|NCT00498602|156951240|FG006|Overall Study|Subject Request|1|||
48755359|NCT00498602|156951234|FG000|Overall Study|Other|2|||
48755360|NCT00498602|156951235|FG001|Overall Study|Other|3|||
48755361|NCT00498602|156951236|FG002|Overall Study|Other|1|||
48755362|NCT00498602|156951237|FG003|Overall Study|Other|0|||
48755363|NCT00498602|156951238|FG004|Overall Study|Other|0|||
48755364|NCT00498602|156951239|FG005|Overall Study|Other|3|||
48755365|NCT00498602|156951240|FG006|Overall Study|Other|0|||
48755366|NCT00456521|156951242|FG000|Overall Study|Adverse Event|150|||
48755367|NCT00456521|156951243|FG001|Overall Study|Adverse Event|25|||
48755368|NCT00456521|156951242|FG000|Overall Study|Withdrawal by Subject|43|||
48659820|NCT00896363|156607126|FG001|Overall Study|Withdrawal by Subject|5|||
48659821|NCT00896363|156607127|FG002|Overall Study|Withdrawal by Subject|5|||
48659822|NCT02759107|156607128|FG000|Overall Study|Adverse Event|0|||
48659823|NCT02759107|156607129|FG001|Overall Study|Adverse Event|0|||
48659824|NCT02759107|156607130|FG002|Overall Study|Adverse Event|0|||
48659825|NCT02759107|156607131|FG003|Overall Study|Adverse Event|0|||
48755369|NCT00456521|156951243|FG001|Overall Study|Withdrawal by Subject|24|||
48755370|NCT00456521|156951242|FG000|Overall Study|Lost to Follow-up|22|||
48755371|NCT00456521|156951243|FG001|Overall Study|Lost to Follow-up|17|||
48659826|NCT02759107|156607132|FG004|Overall Study|Adverse Event|0|||
48659827|NCT02759107|156607133|FG005|Overall Study|Adverse Event|0|||
48659828|NCT02759107|156607134|FG006|Overall Study|Adverse Event|0|||
48659829|NCT02759107|156607135|FG007|Overall Study|Adverse Event|0|||
48755372|NCT00456521|156951242|FG000|Overall Study|Lack of Efficacy|3|||
48659830|NCT02759107|156607136|FG008|Overall Study|Adverse Event|0|||
48659831|NCT02759107|156607137|FG009|Overall Study|Adverse Event|0|||
48659832|NCT02759107|156607138|FG010|Overall Study|Adverse Event|0|||
48659833|NCT02759107|156607139|FG011|Overall Study|Adverse Event|0|||
48659834|NCT02759107|156607140|FG012|Overall Study|Adverse Event|2|||
48659835|NCT02759107|156607141|FG013|Overall Study|Adverse Event|0|||
48659836|NCT02759107|156607142|FG014|Overall Study|Adverse Event|0|||
48659837|NCT02759107|156607143|FG015|Overall Study|Adverse Event|1|||
48659838|NCT02759107|156607144|FG016|Overall Study|Adverse Event|0|||
48659839|NCT02759107|156607145|FG017|Overall Study|Adverse Event|2|||
48659840|NCT02759107|156607128|FG000|Overall Study|Scheduling Conflict|0|||
48659841|NCT02759107|156607129|FG001|Overall Study|Scheduling Conflict|0|||
48659842|NCT02759107|156607130|FG002|Overall Study|Scheduling Conflict|0|||
48659843|NCT02759107|156607131|FG003|Overall Study|Scheduling Conflict|0|||
48659844|NCT02759107|156607132|FG004|Overall Study|Scheduling Conflict|0|||
48659845|NCT02759107|156607133|FG005|Overall Study|Scheduling Conflict|0|||
48659846|NCT02759107|156607134|FG006|Overall Study|Scheduling Conflict|0|||
48659847|NCT02759107|156607135|FG007|Overall Study|Scheduling Conflict|0|||
48659848|NCT02759107|156607136|FG008|Overall Study|Scheduling Conflict|0|||
48659849|NCT02759107|156607137|FG009|Overall Study|Scheduling Conflict|1|||
48659850|NCT02759107|156607138|FG010|Overall Study|Scheduling Conflict|0|||
48659851|NCT02759107|156607139|FG011|Overall Study|Scheduling Conflict|0|||
48659852|NCT02759107|156607140|FG012|Overall Study|Scheduling Conflict|0|||
48659853|NCT02759107|156607141|FG013|Overall Study|Scheduling Conflict|0|||
48659854|NCT02759107|156607142|FG014|Overall Study|Scheduling Conflict|0|||
48659855|NCT02759107|156607143|FG015|Overall Study|Scheduling Conflict|0|||
48659856|NCT02759107|156607144|FG016|Overall Study|Scheduling Conflict|0|||
48659857|NCT02759107|156607145|FG017|Overall Study|Scheduling Conflict|0|||
48659858|NCT03095027|156607146|FG000|Period 2, Second Week of Wear|Adverse Event|1|||
48659859|NCT03095027|156607147|FG001|Period 2, Second Week of Wear|Adverse Event|0|||
48659860|NCT00591149|156607150|FG000|Overall Study|Adverse Event|4|||
48659861|NCT00591149|156607150|FG000|Overall Study|Withdrawal by Subject|1|||
48659862|NCT00539513|156607151|FG000|Overall Study|Withdrawal by Subject|2|||
48659863|NCT00539513|156607152|FG001|Overall Study|Withdrawal by Subject|1|||
48659864|NCT00539513|156607151|FG000|Overall Study|Lost to Follow-up|0|||
48659865|NCT00539513|156607152|FG001|Overall Study|Lost to Follow-up|1|||
48659866|NCT03920293|156607154|FG000|Randomized-Controlled Period|Withdrawal by Subject|2|||
48659867|NCT03920293|156607155|FG001|Randomized-Controlled Period|Withdrawal by Subject|1|||
48659868|NCT03920293|156607154|FG000|Randomized-Controlled Period|Physician Decision|1|||
48659869|NCT03920293|156607155|FG001|Randomized-Controlled Period|Physician Decision|2|||
48659870|NCT03920293|156607154|FG000|Randomized-Controlled Period|Adverse Event|0|||
48659871|NCT03920293|156607155|FG001|Randomized-Controlled Period|Adverse Event|2|||
48659872|NCT03920293|156607154|FG000|Randomized-Controlled Period|Sponsor Decision|0|||
48659873|NCT03920293|156607155|FG001|Randomized-Controlled Period|Sponsor Decision|1|||
48659874|NCT03920293|156607154|FG000|Randomized-Controlled Period|Death|2|||
48659875|NCT03920293|156607155|FG001|Randomized-Controlled Period|Death|0|||
48659876|NCT03920293|156607154|FG000|Randomized-Controlled Period|Protocol Violation|1|||
48659877|NCT03920293|156607155|FG001|Randomized-Controlled Period|Protocol Violation|0|||
48659878|NCT03920293|156607154|FG000|Randomized-Controlled Period|Noncompliance|1|||
48659879|NCT03920293|156607155|FG001|Randomized-Controlled Period|Noncompliance|0|||
48659880|NCT03920293|156607154|FG000|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|3|||
48659881|NCT03920293|156607155|FG001|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|5|||
48659882|NCT03920293|156607154|FG000|Open- Label Extension Period|Death|3|||
48659883|NCT03920293|156607155|FG001|Open- Label Extension Period|Death|3|||
48659884|NCT03920293|156607154|FG000|Open- Label Extension Period|Physician Decision|5|||
48659885|NCT03920293|156607155|FG001|Open- Label Extension Period|Physician Decision|3|||
48659886|NCT03920293|156607154|FG000|Open- Label Extension Period|Withdrawal by Subject|7|||
48659887|NCT03920293|156607155|FG001|Open- Label Extension Period|Withdrawal by Subject|9|||
48659888|NCT03524612|156607156|FG000|Overall Study|Lack of Efficacy|10|||
48659889|NCT03524612|156607156|FG000|Overall Study|Physician Decision (Patient non-compliant)|1|||
48659890|NCT03524612|156607156|FG000|Overall Study|Adverse Event|10|||
48659891|NCT03524612|156607156|FG000|Overall Study|Withdrawal by Subject|7|||
48659892|NCT03524612|156607156|FG000|Overall Study|Patient Decision (Patient Changed Her Address)|1|||
48659893|NCT03524612|156607156|FG000|Overall Study|Patient Decision (Personal Reasons)|1|||
48659894|NCT03524612|156607156|FG000|Overall Study|New therapy for study indication|6|||
48659895|NCT03524612|156607156|FG000|Overall Study|Death|3|||
48659896|NCT03524612|156607156|FG000|Overall Study|Lost to Follow-up|2|||
48659897|NCT03524612|156607156|FG000|Overall Study|Protocol Violation|1|||
48659898|NCT00744978|156607160|FG000|Period 1|Lost to Follow-up|1|||
48659899|NCT00744978|156607161|FG001|Period 1|Lost to Follow-up|0|||
48659900|NCT00744978|156607160|FG000|Period 1|Withdrawal by Subject|0|||
48659901|NCT00744978|156607161|FG001|Period 1|Withdrawal by Subject|2|||
48659902|NCT00744978|156607160|FG000|Period 1|Other|0|||
48659903|NCT00744978|156607161|FG001|Period 1|Other|2|||
48659904|NCT00744978|156607160|FG000|Period 1|Adverse Event|4|||
48659905|NCT00744978|156607161|FG001|Period 1|Adverse Event|0|||
48659906|NCT00744978|156607160|FG000|Period 1|Randomized but not Treated|1|||
48659907|NCT00744978|156607161|FG001|Period 1|Randomized but not Treated|1|||
48659908|NCT00744978|156607160|FG000|Period 2|Adverse Event|0|||
48659909|NCT00744978|156607161|FG001|Period 2|Adverse Event|1|||
48659910|NCT03770728|156607162|FG000|Overall Study|Adverse Event|1|||
48659911|NCT03770728|156607163|FG001|Overall Study|Adverse Event|0|||
48659912|NCT03770728|156607164|FG002|Overall Study|Adverse Event|1|||
48659913|NCT03770728|156607165|FG003|Overall Study|Adverse Event|0|||
48659914|NCT03770728|156607162|FG000|Overall Study|Poor compliance to protocol|0|||
48659915|NCT03770728|156607163|FG001|Overall Study|Poor compliance to protocol|0|||
48659916|NCT03770728|156607164|FG002|Overall Study|Poor compliance to protocol|1|||
48659917|NCT03770728|156607165|FG003|Overall Study|Poor compliance to protocol|0|||
48755373|NCT00456521|156951243|FG001|Overall Study|Lack of Efficacy|6|||
48659918|NCT03770728|156607162|FG000|Overall Study|Withdrawal by Subject|13|||
48659919|NCT03770728|156607163|FG001|Overall Study|Withdrawal by Subject|8|||
48659920|NCT03770728|156607164|FG002|Overall Study|Withdrawal by Subject|9|||
48659921|NCT03770728|156607165|FG003|Overall Study|Withdrawal by Subject|13|||
48755374|NCT00456521|156951242|FG000|Overall Study|Protocol Violation|4|||
48755375|NCT00456521|156951243|FG001|Overall Study|Protocol Violation|0|||
48755376|NCT00456521|156951242|FG000|Overall Study|Pregnancy|1|||
48659922|NCT03770728|156607162|FG000|Overall Study|Other than specified|24|||
48659923|NCT03770728|156607163|FG001|Overall Study|Other than specified|23|||
48659924|NCT03770728|156607164|FG002|Overall Study|Other than specified|21|||
48659925|NCT03770728|156607165|FG003|Overall Study|Other than specified|22|||
48659926|NCT03703817|156607166|FG000|Overall Study|Not meeting eligibility criteria|7|||
48659927|NCT03703817|156607167|FG001|Overall Study|Not meeting eligibility criteria|4|||
48659928|NCT04195438|156607168|FG000|Overall Study|Withdrawal by Subject|1|||
48659929|NCT00223977|156607169|FG000|Overall Study|Adverse Event|7|||
48659930|NCT00223977|156607170|FG001|Overall Study|Adverse Event|10|||
48659931|NCT00223977|156607171|FG002|Overall Study|Adverse Event|0|||
48659932|NCT00223977|156607169|FG000|Overall Study|Protocol Violation|0|||
48659933|NCT00223977|156607170|FG001|Overall Study|Protocol Violation|0|||
48964030|NCT00082758|157696057|FG002|Overall Study|Protocol Violation|0|||
48964031|NCT01114373|157696058|FG000|Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
48964032|NCT01114373|157696059|FG001|Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
48964033|NCT01114373|157696058|FG000|Intervention 1 (4 Weeks)|Incarceration|1|||
48964034|NCT01114373|157696059|FG001|Intervention 1 (4 Weeks)|Incarceration|0|||
48964035|NCT01114373|157696058|FG000|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1|||
48964036|NCT01114373|157696059|FG001|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0|||
48964037|NCT01114373|157696058|FG000|Intervention 2 (4 Weeks)|Lost to Follow-up|0|||
48964038|NCT01114373|157696059|FG001|Intervention 2 (4 Weeks)|Lost to Follow-up|1|||
48964039|NCT00848250|157696060|FG000|Overall Study|surgery was completed without cardiopulm|0|||
48964040|NCT00848250|157696061|FG001|Overall Study|surgery was completed without cardiopulm|1|||
48964041|NCT05631548|157696062|FG000|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|0|||
48964042|NCT05631548|157696063|FG001|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|1|||
48964043|NCT00390416|157696064|FG000|Overall Study|Withdrawal by Subject|1|||
48659934|NCT00223977|156607171|FG002|Overall Study|Protocol Violation|1|||
48659935|NCT00223977|156607169|FG000|Overall Study|Withdrawal by Subject|1|||
48659936|NCT00223977|156607170|FG001|Overall Study|Withdrawal by Subject|1|||
48659937|NCT00223977|156607171|FG002|Overall Study|Withdrawal by Subject|2|||
48659938|NCT00223977|156607169|FG000|Overall Study|Other|1|||
48659939|NCT00223977|156607170|FG001|Overall Study|Other|0|||
48659940|NCT00223977|156607171|FG002|Overall Study|Other|0|||
48659941|NCT01920568|156607172|FG000|Overall Study|Adverse Event|27|||
48659942|NCT01920568|156607173|FG001|Overall Study|Adverse Event|8|||
48659943|NCT01920568|156607172|FG000|Overall Study|Protocol Violation|5|||
48659944|NCT01920568|156607173|FG001|Overall Study|Protocol Violation|3|||
48659945|NCT01920568|156607172|FG000|Overall Study|Lost to Follow-up|2|||
48659946|NCT01920568|156607173|FG001|Overall Study|Lost to Follow-up|2|||
48659947|NCT01920568|156607172|FG000|Overall Study|Physician Decision|13|||
48659948|NCT01920568|156607173|FG001|Overall Study|Physician Decision|4|||
48659949|NCT01920568|156607172|FG000|Overall Study|Withdrawal by Subject|79|||
48659950|NCT01920568|156607173|FG001|Overall Study|Withdrawal by Subject|55|||
48964044|NCT00390416|157696064|FG000|Overall Study|Not treated|3|||
48659951|NCT01920568|156607172|FG000|Overall Study|Death due to disease progression|25|||
48659952|NCT01920568|156607173|FG001|Overall Study|Death due to disease progression|12|||
48659953|NCT00683917|156607176|FG000|Overall Study|Study prematurely terminated|10|||
48659954|NCT03199053|156607177|FG000|ST Period|Withdrawal by Subject|2|||
48659955|NCT03199053|156607178|FG001|ST Period|Withdrawal by Subject|4|||
48659956|NCT03199053|156607179|FG002|ST Period|Withdrawal by Subject|6|||
48755377|NCT00456521|156951243|FG001|Overall Study|Pregnancy|1|||
48659957|NCT03199053|156607177|FG000|ST Period|Withdrawal by parent/guardian|1|||
48659958|NCT03199053|156607178|FG001|ST Period|Withdrawal by parent/guardian|1|||
48659959|NCT03199053|156607179|FG002|ST Period|Withdrawal by parent/guardian|1|||
48659960|NCT03199053|156607177|FG000|ST Period|Lost to Follow-up|2|||
48659961|NCT03199053|156607178|FG001|ST Period|Lost to Follow-up|0|||
48659962|NCT03199053|156607179|FG002|ST Period|Lost to Follow-up|1|||
48659963|NCT03199053|156607177|FG000|LT Period|Withdrawal by Subject|1|||
48659964|NCT03199053|156607178|FG001|LT Period|Withdrawal by Subject|3|||
48659965|NCT03199053|156607179|FG002|LT Period|Withdrawal by Subject|3|||
48659966|NCT03199053|156607177|FG000|LT Period|Withdrawal by parent/guardian|0|||
48659967|NCT03199053|156607178|FG001|LT Period|Withdrawal by parent/guardian|0|||
48659968|NCT03199053|156607179|FG002|LT Period|Withdrawal by parent/guardian|1|||
48659969|NCT03199053|156607177|FG000|LT Period|Lost to Follow-up|0|||
48659970|NCT03199053|156607178|FG001|LT Period|Lost to Follow-up|1|||
48659971|NCT03199053|156607179|FG002|LT Period|Lost to Follow-up|1|||
48659972|NCT03199053|156607177|FG000|LT Period|Miscellaneous|0|||
48659973|NCT03199053|156607178|FG001|LT Period|Miscellaneous|0|||
48659974|NCT03199053|156607179|FG002|LT Period|Miscellaneous|2|||
48659975|NCT03199053|156607177|FG000|Non-treatment Follow-up Period|Withdrawal by Subject|2|||
48659976|NCT03199053|156607178|FG001|Non-treatment Follow-up Period|Withdrawal by Subject|1|||
48659977|NCT03199053|156607179|FG002|Non-treatment Follow-up Period|Withdrawal by Subject|0|||
48964045|NCT02207556|157696076|FG000|Overall Study|Physician Decision|1|||
48964046|NCT02207556|157696077|FG001|Overall Study|Physician Decision|0|||
48659978|NCT03199053|156607177|FG000|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
48659979|NCT03199053|156607178|FG001|Non-treatment Follow-up Period|Withdrawal by parent/guardian|3|||
48659980|NCT03199053|156607179|FG002|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
48659981|NCT03199053|156607177|FG000|Non-treatment Follow-up Period|Lost to Follow-up|3|||
48659982|NCT03199053|156607178|FG001|Non-treatment Follow-up Period|Lost to Follow-up|4|||
48659983|NCT03199053|156607179|FG002|Non-treatment Follow-up Period|Lost to Follow-up|5|||
48659984|NCT03199053|156607177|FG000|Non-treatment Follow-up Period|Miscellaneous|0|||
48659985|NCT03199053|156607178|FG001|Non-treatment Follow-up Period|Miscellaneous|1|||
48659986|NCT03199053|156607179|FG002|Non-treatment Follow-up Period|Miscellaneous|0|||
48659987|NCT01323270|156607180|FG000|Overall Study|Withdrawal by Subject|19|||
48659988|NCT01323270|156607181|FG001|Overall Study|Withdrawal by Subject|10|||
48659989|NCT01323270|156607180|FG000|Overall Study|Protocol Violation|9|||
48659990|NCT01323270|156607181|FG001|Overall Study|Protocol Violation|7|||
48659991|NCT01323270|156607180|FG000|Overall Study|Lost to Follow-up|4|||
48659992|NCT01323270|156607181|FG001|Overall Study|Lost to Follow-up|6|||
48659993|NCT01323270|156607180|FG000|Overall Study|Adverse Event|8|||
48659994|NCT01323270|156607181|FG001|Overall Study|Adverse Event|0|||
48659995|NCT01323270|156607180|FG000|Overall Study|Other|0|||
48659996|NCT01323270|156607181|FG001|Overall Study|Other|3|||
48659997|NCT01323270|156607180|FG000|Overall Study|Physician Decision|0|||
48659998|NCT01323270|156607181|FG001|Overall Study|Physician Decision|2|||
48659999|NCT01323270|156607180|FG000|Overall Study|Not eligible|1|||
48660000|NCT01323270|156607181|FG001|Overall Study|Not eligible|1|||
48660001|NCT01323270|156607180|FG000|Overall Study|Death|1|||
48660002|NCT01323270|156607181|FG001|Overall Study|Death|0|||
48660003|NCT01323270|156607180|FG000|Overall Study|Randomized, but not vaccinated|1|||
48660004|NCT01323270|156607181|FG001|Overall Study|Randomized, but not vaccinated|0|||
48660005|NCT02229214|156607183|FG000|Overall Study|Adverse Event|2|||
48660006|NCT02229214|156607184|FG001|Overall Study|Adverse Event|0|||
48660007|NCT02229214|156607183|FG000|Overall Study|Withdrawal by Subject|4|||
48660008|NCT02229214|156607184|FG001|Overall Study|Withdrawal by Subject|0|||
48660009|NCT00246025|156607185|FG000|Overall Study|Adverse Event|7|||
48660010|NCT00246025|156607186|FG001|Overall Study|Adverse Event|9|||
48660011|NCT00246025|156607187|FG002|Overall Study|Adverse Event|9|||
48660012|NCT00246025|156607188|FG003|Overall Study|Adverse Event|10|||
48660013|NCT00246025|156607185|FG000|Overall Study|Withdrawal by Subject|3|||
48660014|NCT00246025|156607186|FG001|Overall Study|Withdrawal by Subject|0|||
48660015|NCT00246025|156607187|FG002|Overall Study|Withdrawal by Subject|1|||
48660016|NCT00246025|156607188|FG003|Overall Study|Withdrawal by Subject|2|||
48660017|NCT00246025|156607185|FG000|Overall Study|unsuitable medical history was found|0|||
48660018|NCT00246025|156607186|FG001|Overall Study|unsuitable medical history was found|0|||
48660019|NCT00246025|156607187|FG002|Overall Study|unsuitable medical history was found|0|||
48660020|NCT00246025|156607188|FG003|Overall Study|unsuitable medical history was found|1|||
48660021|NCT00931723|156607189|FG000|Overall Study|Withdrawal by Subject|11|||
48660022|NCT00931723|156607190|FG001|Overall Study|Withdrawal by Subject|13|||
48660023|NCT00931723|156607189|FG000|Overall Study|Adverse Event|6|||
48660024|NCT00931723|156607190|FG001|Overall Study|Adverse Event|13|||
48660025|NCT00931723|156607189|FG000|Overall Study|Lithium found in blood|0|||
48660026|NCT00931723|156607190|FG001|Overall Study|Lithium found in blood|1|||
48660027|NCT00931723|156607189|FG000|Overall Study|Condition under investigation worsened|1|||
48660028|NCT00931723|156607190|FG001|Overall Study|Condition under investigation worsened|2|||
48660029|NCT00931723|156607189|FG000|Overall Study|Lost to Follow-up|1|||
48660030|NCT00931723|156607190|FG001|Overall Study|Lost to Follow-up|2|||
48660031|NCT00931723|156607189|FG000|Overall Study|Study-specific discontinuation criteria|1|||
48660032|NCT00931723|156607190|FG001|Overall Study|Study-specific discontinuation criteria|1|||
48660033|NCT00931723|156607189|FG000|Overall Study|Severe non-compliance to protocol|2|||
49015443|NCT01393990|157893775|FG005|Overall Study|Adverse Event|0|||
48964047|NCT02207556|157696076|FG000|Overall Study|Withdrawal by Subject|1|||
48964048|NCT02207556|157696077|FG001|Overall Study|Withdrawal by Subject|0|||
48964049|NCT02207556|157696076|FG000|Overall Study|Death|0|||
48964050|NCT02207556|157696077|FG001|Overall Study|Death|5|||
48964051|NCT00502320|157696078|FG000|Overall Study|Lost to Follow-up|1|||
48964052|NCT00502320|157696079|FG001|Overall Study|Lost to Follow-up|1|||
48964053|NCT00502320|157696078|FG000|Overall Study|Withdrew Consent|1|||
48964054|NCT00502320|157696079|FG001|Overall Study|Withdrew Consent|0|||
48964055|NCT00502320|157696078|FG000|Overall Study|No longer met criteria|1|||
48964056|NCT00502320|157696079|FG001|Overall Study|No longer met criteria|0|||
48964057|NCT00502320|157696078|FG000|Overall Study|Screen Failure|0|||
48964058|NCT00502320|157696079|FG001|Overall Study|Screen Failure|1|||
48964059|NCT00502320|157696078|FG000|Overall Study|Adverse Event|3|||
48964060|NCT00502320|157696079|FG001|Overall Study|Adverse Event|5|||
48964061|NCT00194025|157696081|FG000|Overall Study|Adverse Event|1|||
48964062|NCT00194025|157696081|FG000|Overall Study|non-adherence with study medication|4|||
48964063|NCT00992784|157696082|FG000|Overall Study|Adverse Event|2|||
48964064|NCT00992784|157696083|FG001|Overall Study|Adverse Event|1|||
48964065|NCT00992784|157696084|FG002|Overall Study|Adverse Event|0|||
48964066|NCT00992784|157696082|FG000|Overall Study|Withdrawal by Subject|1|||
48964067|NCT00992784|157696083|FG001|Overall Study|Withdrawal by Subject|1|||
48866232|NCT01190228|157345693|FG002|Overall Study|Withdrawal by Subject|0|||
48866233|NCT02282917|157345694|FG000|Overall Study|Withdrawal by Subject|1|||
48866234|NCT02282917|157345694|FG000|Overall Study|Screen Failure/Not Eligible|1|||
48866235|NCT02809677|157345697|FG000|Overall Study|Withdrawal by Subject|8|||
48866236|NCT02256488|157345698|FG000|Overall Study|Lost to Follow-up|6|||
48866237|NCT02256488|157345699|FG001|Overall Study|Lost to Follow-up|6|||
48866238|NCT02256488|157345700|FG002|Overall Study|Lost to Follow-up|9|||
48866239|NCT02256488|157345701|FG003|Overall Study|Lost to Follow-up|3|||
48866240|NCT02256488|157345698|FG000|Overall Study|OTHER|1|||
48866241|NCT02256488|157345699|FG001|Overall Study|OTHER|0|||
48866242|NCT02256488|157345700|FG002|Overall Study|OTHER|1|||
48866243|NCT02256488|157345701|FG003|Overall Study|OTHER|1|||
48866244|NCT02256488|157345698|FG000|Overall Study|Withdrawal by Subject|1|||
48866245|NCT02256488|157345699|FG001|Overall Study|Withdrawal by Subject|0|||
48866246|NCT02256488|157345700|FG002|Overall Study|Withdrawal by Subject|0|||
48866247|NCT02256488|157345701|FG003|Overall Study|Withdrawal by Subject|2|||
48866248|NCT00734851|157345706|FG000|Overall Study|Withdrawal by Subject|2|||
48866249|NCT00734851|157345706|FG000|Overall Study|Lost to Follow-up|1|||
48866250|NCT00734851|157345706|FG000|Overall Study|Physician Decision|18|||
48866251|NCT01294358|157345715|FG000|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
48866252|NCT01294358|157345716|FG001|Cohort 2: 6/9/11-9/17/12|Disease progression|2|||
48866253|NCT01294358|157345717|FG002|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
48866254|NCT01294358|157345718|FG003|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
48866255|NCT01294358|157345719|FG004|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
48866256|NCT01294358|157345715|FG000|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
48866257|NCT01294358|157345716|FG001|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
48866258|NCT01294358|157345717|FG002|Cohort 3: 12/1/11-10/6/12|Disease progression|2|||
48866259|NCT01294358|157345718|FG003|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
48866260|NCT01294358|157345719|FG004|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
48866261|NCT01294358|157345715|FG000|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
48866262|NCT01294358|157345716|FG001|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
48866263|NCT01294358|157345717|FG002|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
48866264|NCT01294358|157345718|FG003|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1|||
48866265|NCT01294358|157345719|FG004|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
48964068|NCT00992784|157696084|FG002|Overall Study|Withdrawal by Subject|1|||
48964069|NCT03943953|157696088|FG000|Trial of ITG 1|Lost to Follow-up|19|||
48964070|NCT03943953|157696089|FG001|Trial of ITG 1|Lost to Follow-up|1|||
48964071|NCT03943953|157696088|FG000|Trial of ITG 2|Lost to Follow-up|8|||
48964072|NCT03943953|157696089|FG001|Trial of ITG 2|Lost to Follow-up|0|||
48964073|NCT03943953|157696088|FG000|Trial of ITG 3|Lost to Follow-up|2|||
48964074|NCT03943953|157696089|FG001|Trial of ITG 3|Lost to Follow-up|0|||
48660034|NCT00931723|156607190|FG001|Overall Study|Severe non-compliance to protocol|0|||
48964075|NCT03943953|157696088|FG000|Trial of ITG 4|Lost to Follow-up|2|||
48964076|NCT03943953|157696089|FG001|Trial of ITG 4|Lost to Follow-up|0|||
48964077|NCT00289185|157696092|FG000|Overall Study|Withdrawal by Subject|4|||
48866266|NCT01294358|157345715|FG000|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
48866267|NCT01294358|157345716|FG001|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
48866268|NCT01294358|157345717|FG002|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
48866269|NCT01294358|157345718|FG003|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
48866270|NCT01294358|157345719|FG004|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1|||
48964078|NCT00289185|157696093|FG001|Overall Study|Withdrawal by Subject|8|||
48964079|NCT00289185|157696092|FG000|Overall Study|Lost to Follow-up|23|||
48964080|NCT00289185|157696093|FG001|Overall Study|Lost to Follow-up|17|||
48964081|NCT00289185|157696092|FG000|Overall Study|Death|1|||
48964082|NCT00289185|157696093|FG001|Overall Study|Death|1|||
48964083|NCT03341923|157696094|FG000|Period 2, Second 14 Days of Wear|Adverse Event|0|||
48964084|NCT03341923|157696095|FG001|Period 2, Second 14 Days of Wear|Adverse Event|1|||
48964085|NCT00511342|157696096|FG000|Overall Study|Unacceptable vaginal bleeding|2|||
48964086|NCT00511342|157696097|FG001|Overall Study|Unacceptable vaginal bleeding|1|||
48964087|NCT00511342|157696096|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|8|||
48964088|NCT00511342|157696097|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|12|||
48964089|NCT00511342|157696096|FG000|Overall Study|Pregnancy|0|||
48964090|NCT00511342|157696097|FG001|Overall Study|Pregnancy|1|||
48660035|NCT00931723|156607189|FG000|Overall Study|Safety reasons|0|||
48660036|NCT00931723|156607190|FG001|Overall Study|Safety reasons|1|||
48660037|NCT00931723|156607189|FG000|Overall Study|Took prohibited concomitant medication|0|||
48660038|NCT00931723|156607190|FG001|Overall Study|Took prohibited concomitant medication|1|||
48660039|NCT00931723|156607189|FG000|Overall Study|Lack or insufficient theraputic response|2|||
48660040|NCT00931723|156607190|FG001|Overall Study|Lack or insufficient theraputic response|5|||
48660041|NCT00931723|156607189|FG000|Overall Study|Sponsor decision|1|||
48660042|NCT00931723|156607190|FG001|Overall Study|Sponsor decision|0|||
48660043|NCT00931723|156607189|FG000|Overall Study|Late hospital discharge|1|||
48660044|NCT00931723|156607190|FG001|Overall Study|Late hospital discharge|0|||
48660045|NCT01571284|156607193|FG000|Overall Study|Participant's decision|84|||
48660046|NCT01571284|156607193|FG000|Overall Study|Lost to Follow-up|3|||
48964091|NCT00511342|157696096|FG000|Overall Study|Pregnancy wish|0|||
48964092|NCT00511342|157696097|FG001|Overall Study|Pregnancy wish|1|||
48964093|NCT00511342|157696096|FG000|Overall Study|Lost to Follow-up|1|||
48964094|NCT00511342|157696097|FG001|Overall Study|Lost to Follow-up|5|||
48964095|NCT00511342|157696096|FG000|Overall Study|Other Reason|2|||
48964096|NCT00511342|157696097|FG001|Overall Study|Other Reason|2|||
48964097|NCT01124448|157696100|FG000|Overall Study|Lost to Follow-up|0|||
48964098|NCT01124448|157696101|FG001|Overall Study|Lost to Follow-up|3|||
48964099|NCT01124448|157696100|FG000|Overall Study|Protocol Violation|2|||
48964100|NCT01124448|157696101|FG001|Overall Study|Protocol Violation|0|||
48964101|NCT02432040|157696102|FG000|Overall Study|Lack of Efficacy|3|||
48964102|NCT02432040|157696103|FG001|Overall Study|Lack of Efficacy|0|||
48964103|NCT02432040|157696102|FG000|Overall Study|Lost to Follow-up|4|||
48660047|NCT01571284|156607193|FG000|Overall Study|Enrolled but not treated|2|||
48660048|NCT01571284|156607193|FG000|Overall Study|Other than specified above|80|||
48660049|NCT03510468|156607194|FG000|Overall Study|Lost to Follow-up|1|||
48660050|NCT03510468|156607194|FG000|Overall Study|Adverse Event|5|||
48660051|NCT03510468|156607194|FG000|Overall Study|Physician Decision|1|||
48660052|NCT03510468|156607194|FG000|Overall Study|non-compliant with treatment|2|||
48660053|NCT03510468|156607194|FG000|Overall Study|Missed visit|1|||
48660054|NCT03754582|156607197|FG000|Treatment Phase|Adverse Event|0|||
48660055|NCT03754582|156607198|FG001|Treatment Phase|Adverse Event|1|||
48660056|NCT03754582|156607199|FG002|Treatment Phase|Adverse Event|0|||
48660057|NCT03754582|156607197|FG000|Follow-up Phase|Other|0|||
48660058|NCT03754582|156607198|FG001|Follow-up Phase|Other|0|||
48660059|NCT03754582|156607199|FG002|Follow-up Phase|Other|1|||
48660060|NCT00435162|156607202|FG000|Period 2 (2 Weeks)|Adverse Event|0|||
48660061|NCT00435162|156607203|FG001|Period 2 (2 Weeks)|Adverse Event|1|||
48660062|NCT00435162|156607204|FG002|Period 2 (2 Weeks)|Adverse Event|0|||
48660063|NCT00435162|156607205|FG003|Period 2 (2 Weeks)|Adverse Event|0|||
48660064|NCT00435162|156607206|FG004|Period 2 (2 Weeks)|Adverse Event|0|||
48660065|NCT00435162|156607207|FG005|Period 2 (2 Weeks)|Adverse Event|0|||
48660066|NCT02460783|156607210|FG000|Overall Study|Withdrawal by Subject|1|||
48660067|NCT02460783|156607211|FG001|Overall Study|Withdrawal by Subject|3|||
48660068|NCT02460783|156607210|FG000|Overall Study|Lost to Follow-up|1|||
48660069|NCT02460783|156607211|FG001|Overall Study|Lost to Follow-up|1|||
48660070|NCT00394901|156607215|FG000|Baseline Phase|Protocol Violation|0|||
48660071|NCT00394901|156607216|FG001|Baseline Phase|Protocol Violation|0|||
48660072|NCT00394901|156607217|FG002|Baseline Phase|Protocol Violation|1|||
48660073|NCT00394901|156607218|FG003|Baseline Phase|Protocol Violation|0|||
48660074|NCT00394901|156607215|FG000|Double-blind Phase|Adverse Event|5|||
48660075|NCT00394901|156607216|FG001|Double-blind Phase|Adverse Event|7|||
48660076|NCT00394901|156607217|FG002|Double-blind Phase|Adverse Event|16|||
48660077|NCT00394901|156607218|FG003|Double-blind Phase|Adverse Event|20|||
48660078|NCT00394901|156607215|FG000|Double-blind Phase|Lack of Efficacy|6|||
48660079|NCT00394901|156607216|FG001|Double-blind Phase|Lack of Efficacy|4|||
48660080|NCT00394901|156607217|FG002|Double-blind Phase|Lack of Efficacy|1|||
48660081|NCT00394901|156607218|FG003|Double-blind Phase|Lack of Efficacy|3|||
48964104|NCT02432040|157696103|FG001|Overall Study|Lost to Follow-up|5|||
48660082|NCT00394901|156607215|FG000|Double-blind Phase|Withdrawal by Subject|2|||
48660083|NCT00394901|156607216|FG001|Double-blind Phase|Withdrawal by Subject|0|||
48660084|NCT00394901|156607217|FG002|Double-blind Phase|Withdrawal by Subject|0|||
48660085|NCT00394901|156607218|FG003|Double-blind Phase|Withdrawal by Subject|0|||
48964105|NCT02432040|157696102|FG000|Overall Study|Physician Decision|1|||
48964106|NCT02432040|157696103|FG001|Overall Study|Physician Decision|1|||
48660086|NCT00394901|156607215|FG000|Double-blind Phase|Lost to Follow-up|0|||
48660087|NCT00394901|156607216|FG001|Double-blind Phase|Lost to Follow-up|0|||
48866271|NCT00985621|157345728|FG000|Overall Study|Adverse Event|2|||
48866272|NCT00985621|157345729|FG001|Overall Study|Adverse Event|3|||
48866273|NCT00985621|157345730|FG002|Overall Study|Adverse Event|4|||
48866274|NCT00985621|157345731|FG003|Overall Study|Adverse Event|16|||
48866275|NCT00985621|157345728|FG000|Overall Study|Lack of Efficacy|10|||
48866276|NCT00985621|157345729|FG001|Overall Study|Lack of Efficacy|6|||
48866277|NCT00985621|157345730|FG002|Overall Study|Lack of Efficacy|5|||
48866278|NCT00985621|157345731|FG003|Overall Study|Lack of Efficacy|12|||
48866279|NCT00985621|157345728|FG000|Overall Study|Lost to Follow-up|2|||
48866280|NCT00985621|157345729|FG001|Overall Study|Lost to Follow-up|3|||
48866281|NCT00985621|157345730|FG002|Overall Study|Lost to Follow-up|4|||
48866282|NCT00985621|157345731|FG003|Overall Study|Lost to Follow-up|4|||
48866283|NCT00985621|157345728|FG000|Overall Study|Study Terminated by Sponsor|89|||
48866284|NCT00985621|157345729|FG001|Overall Study|Study Terminated by Sponsor|108|||
48866285|NCT00985621|157345730|FG002|Overall Study|Study Terminated by Sponsor|99|||
48866286|NCT00985621|157345731|FG003|Overall Study|Study Terminated by Sponsor|92|||
48866287|NCT00985621|157345728|FG000|Overall Study|Protocol Violation|1|||
48866288|NCT00985621|157345729|FG001|Overall Study|Protocol Violation|1|||
48866289|NCT00985621|157345730|FG002|Overall Study|Protocol Violation|1|||
48964107|NCT00138424|157696110|FG000|Overall Study|Physician Decision|0|||
48964108|NCT00138424|157696111|FG001|Overall Study|Physician Decision|1|||
48964109|NCT00138424|157696112|FG002|Overall Study|Physician Decision|0|||
48964110|NCT00138424|157696113|FG003|Overall Study|Physician Decision|0|||
48866290|NCT00985621|157345731|FG003|Overall Study|Protocol Violation|0|||
48866291|NCT00985621|157345728|FG000|Overall Study|Withdrawal by Subject|8|||
48866292|NCT00985621|157345729|FG001|Overall Study|Withdrawal by Subject|10|||
48866293|NCT00985621|157345730|FG002|Overall Study|Withdrawal by Subject|8|||
48866294|NCT00985621|157345731|FG003|Overall Study|Withdrawal by Subject|12|||
48866295|NCT00985621|157345728|FG000|Overall Study|Other|1|||
48866296|NCT00985621|157345729|FG001|Overall Study|Other|0|||
48866297|NCT00985621|157345730|FG002|Overall Study|Other|0|||
48866298|NCT00985621|157345731|FG003|Overall Study|Other|0|||
48964111|NCT03101514|157696118|FG000|Overall Study|Withdrawal by Subject|4|||
48964112|NCT03101514|157696118|FG000|Overall Study|Protocol Violation|2|||
48660088|NCT00394901|156607217|FG002|Double-blind Phase|Lost to Follow-up|0|||
48660089|NCT00394901|156607218|FG003|Double-blind Phase|Lost to Follow-up|1|||
48660090|NCT00394901|156607215|FG000|Double-blind Phase|Protocol Violation|0|||
48660091|NCT00394901|156607216|FG001|Double-blind Phase|Protocol Violation|0|||
48660092|NCT00394901|156607217|FG002|Double-blind Phase|Protocol Violation|0|||
48660093|NCT00394901|156607218|FG003|Double-blind Phase|Protocol Violation|1|||
48660094|NCT00394901|156607215|FG000|Double-blind Phase|Death|1|||
48660095|NCT00394901|156607216|FG001|Double-blind Phase|Death|0|||
48660096|NCT00394901|156607217|FG002|Double-blind Phase|Death|0|||
48660097|NCT00394901|156607218|FG003|Double-blind Phase|Death|0|||
48660098|NCT00394901|156607215|FG000|Double-blind Phase|Subject's Personal Reason|1|||
48660099|NCT00394901|156607216|FG001|Double-blind Phase|Subject's Personal Reason|0|||
48660100|NCT00394901|156607217|FG002|Double-blind Phase|Subject's Personal Reason|0|||
48660101|NCT00394901|156607218|FG003|Double-blind Phase|Subject's Personal Reason|1|||
48660102|NCT00394901|156607215|FG000|Double-blind Phase|Lack of Compliance|0|||
48660103|NCT00394901|156607216|FG001|Double-blind Phase|Lack of Compliance|3|||
48660104|NCT00394901|156607217|FG002|Double-blind Phase|Lack of Compliance|0|||
48660105|NCT00394901|156607218|FG003|Double-blind Phase|Lack of Compliance|0|||
48660106|NCT00394901|156607215|FG000|Double-blind Phase|Entry into another study was found|0|||
48660107|NCT00394901|156607216|FG001|Double-blind Phase|Entry into another study was found|0|||
48660108|NCT00394901|156607217|FG002|Double-blind Phase|Entry into another study was found|1|||
48660109|NCT00394901|156607218|FG003|Double-blind Phase|Entry into another study was found|0|||
48660110|NCT00394901|156607215|FG000|Double-blind Phase|Found not to meet entrance criteria|0|||
48660111|NCT00394901|156607216|FG001|Double-blind Phase|Found not to meet entrance criteria|0|||
48660112|NCT00394901|156607217|FG002|Double-blind Phase|Found not to meet entrance criteria|0|||
48660113|NCT00394901|156607218|FG003|Double-blind Phase|Found not to meet entrance criteria|1|||
48660114|NCT05028517|156607219|FG000|Overall Study|Lost to Follow-up|13|||
48660115|NCT05028517|156607220|FG001|Overall Study|Lost to Follow-up|20|||
48660116|NCT05028517|156607221|FG002|Overall Study|Lost to Follow-up|12|||
48660117|NCT05028517|156607219|FG000|Overall Study|Withdrawal by Subject|0|||
48660118|NCT05028517|156607220|FG001|Overall Study|Withdrawal by Subject|0|||
48660119|NCT05028517|156607221|FG002|Overall Study|Withdrawal by Subject|1|||
48660120|NCT03651895|156608630|FG000|First Drug Assignment|Adverse Event|4|||
48660121|NCT03651895|156608631|FG001|First Drug Assignment|Adverse Event|5|||
48660122|NCT03651895|156608630|FG000|Second Drug Assignment - Crossover|Adverse Event|1|||
48866299|NCT00985621|157345728|FG000|Overall Study|Randomized but not Treated|1|||
48866300|NCT00985621|157345729|FG001|Overall Study|Randomized but not Treated|0|||
48660123|NCT03651895|156608631|FG001|Second Drug Assignment - Crossover|Adverse Event|1|||
48660124|NCT04920084|156608634|FG000|Overall Study|Adverse Event|1|||
48866301|NCT00985621|157345730|FG002|Overall Study|Randomized but not Treated|2|||
48866302|NCT00985621|157345731|FG003|Overall Study|Randomized but not Treated|1|||
48866303|NCT00990821|157345737|FG000|Overall Study|Withdrawal by Subject|0|||
49015444|NCT01393990|157893776|FG006|Overall Study|Adverse Event|0|||
48660125|NCT04920084|156608634|FG000|Overall Study|Lost to Follow-up|2|||
48660126|NCT04920084|156608634|FG000|Overall Study|Withdrawal by Subject|2|||
48660127|NCT04896476|156608635|FG000|Overall Study|Withdrawal by Subject|1|||
48660128|NCT04896476|156608635|FG000|Overall Study|Lost to Follow-up|2|||
48660129|NCT02903368|156608637|FG000|Part 1|Adverse Event|3|||
48660130|NCT02903368|156608638|FG001|Part 1|Adverse Event|0|||
48660131|NCT02903368|156608639|FG002|Part 1|Adverse Event|0|||
48660132|NCT02903368|156608640|FG003|Part 1|Adverse Event|0|||
48660133|NCT02903368|156608637|FG000|Part 1|Withdrawal by Subject|1|||
48660134|NCT02903368|156608638|FG001|Part 1|Withdrawal by Subject|0|||
48660135|NCT02903368|156608639|FG002|Part 1|Withdrawal by Subject|0|||
48660136|NCT02903368|156608640|FG003|Part 1|Withdrawal by Subject|0|||
48660137|NCT02903368|156608637|FG000|Part 2|Adverse Event|0|||
48660138|NCT02903368|156608638|FG001|Part 2|Adverse Event|0|||
48660139|NCT02903368|156608639|FG002|Part 2|Adverse Event|5|||
48964113|NCT03101514|157696118|FG000|Overall Study|patient's information was incomplete|1|||
48964114|NCT00738374|157696119|FG000|Induction Treatment Phase|Adverse Event|14|||
48964115|NCT00738374|157696120|FG001|Induction Treatment Phase|Adverse Event|0|||
48964116|NCT00738374|157696121|FG002|Induction Treatment Phase|Adverse Event|0|||
48964117|NCT00738374|157696122|FG003|Induction Treatment Phase|Adverse Event|0|||
48964118|NCT00738374|157696119|FG000|Induction Treatment Phase|Disease progression/relapse/stable|4|||
48964119|NCT00738374|157696120|FG001|Induction Treatment Phase|Disease progression/relapse/stable|0|||
48964120|NCT00738374|157696121|FG002|Induction Treatment Phase|Disease progression/relapse/stable|0|||
48964121|NCT00738374|157696122|FG003|Induction Treatment Phase|Disease progression/relapse/stable|0|||
48964122|NCT00738374|157696119|FG000|Induction Treatment Phase|Physician Decision|2|||
48964123|NCT00738374|157696120|FG001|Induction Treatment Phase|Physician Decision|0|||
48964124|NCT00738374|157696121|FG002|Induction Treatment Phase|Physician Decision|0|||
48964125|NCT00738374|157696122|FG003|Induction Treatment Phase|Physician Decision|0|||
48964126|NCT00738374|157696119|FG000|Induction Treatment Phase|Protocol Violation|2|||
48964127|NCT00738374|157696120|FG001|Induction Treatment Phase|Protocol Violation|0|||
48964128|NCT00738374|157696121|FG002|Induction Treatment Phase|Protocol Violation|0|||
48964129|NCT00738374|157696122|FG003|Induction Treatment Phase|Protocol Violation|0|||
48964130|NCT00738374|157696119|FG000|Induction Treatment Phase|Non-compliance|1|||
48964131|NCT00738374|157696120|FG001|Induction Treatment Phase|Non-compliance|0|||
48964132|NCT00738374|157696121|FG002|Induction Treatment Phase|Non-compliance|0|||
48964133|NCT00738374|157696122|FG003|Induction Treatment Phase|Non-compliance|0|||
48964134|NCT00738374|157696119|FG000|Induction Treatment Phase|Withdrawal by Subject|1|||
48964135|NCT00738374|157696120|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
48964136|NCT00738374|157696121|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
48964137|NCT00738374|157696122|FG003|Induction Treatment Phase|Withdrawal by Subject|0|||
48964138|NCT00738374|157696119|FG000|Maintenance Treatment/Observation Phase|Adverse Event|0|||
48964139|NCT00738374|157696120|FG001|Maintenance Treatment/Observation Phase|Adverse Event|1|||
48964140|NCT00738374|157696121|FG002|Maintenance Treatment/Observation Phase|Adverse Event|2|||
48964141|NCT00738374|157696122|FG003|Maintenance Treatment/Observation Phase|Adverse Event|0|||
48964142|NCT00738374|157696119|FG000|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0|||
48964143|NCT00738374|157696120|FG001|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4|||
48964144|NCT00738374|157696121|FG002|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5|||
48964145|NCT00738374|157696122|FG003|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11|||
48964146|NCT00738374|157696119|FG000|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
48964147|NCT00738374|157696120|FG001|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
48964148|NCT00738374|157696121|FG002|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
48964149|NCT00738374|157696122|FG003|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1|||
48964150|NCT00738374|157696119|FG000|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
48964151|NCT00738374|157696120|FG001|Maintenance Treatment/Observation Phase|Protocol Violation|1|||
48964152|NCT00738374|157696121|FG002|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
48964153|NCT00738374|157696122|FG003|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
48964154|NCT00738374|157696119|FG000|Maintenance Treatment/Observation Phase|Other|0|||
48964155|NCT00738374|157696120|FG001|Maintenance Treatment/Observation Phase|Other|1|||
48964156|NCT00738374|157696121|FG002|Maintenance Treatment/Observation Phase|Other|0|||
48964157|NCT00738374|157696122|FG003|Maintenance Treatment/Observation Phase|Other|0|||
48964158|NCT01617187|157696123|FG000|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
48964159|NCT01617187|157696124|FG001|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
48964160|NCT01617187|157696125|FG002|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
48964161|NCT01617187|157696126|FG003|Randomization Through Start Treatment|Not Treated: Administrative Reason|1|||
49015445|NCT01393990|157893777|FG007|Overall Study|Adverse Event|0|||
48660140|NCT02903368|156608640|FG003|Part 2|Adverse Event|0|||
48660141|NCT02903368|156608637|FG000|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
48660142|NCT02903368|156608638|FG001|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
48660143|NCT02903368|156608639|FG002|Part 2|Subject withdrew after 6 cycles of protocol therapy.|1|||
48660144|NCT02903368|156608640|FG003|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
48660145|NCT02903368|156608637|FG000|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
48660146|NCT02903368|156608638|FG001|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
48660147|NCT02903368|156608639|FG002|Part 2|Subject withdrew after part-2 randomization and remained on observation.|4|||
48660148|NCT02903368|156608640|FG003|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
48660149|NCT02903368|156608637|FG000|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
48660150|NCT02903368|156608638|FG001|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
48660151|NCT02903368|156608639|FG002|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|1|||
48660152|NCT02903368|156608640|FG003|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|2|||
48660153|NCT05948670|156608641|FG000|Overall Study|Protocol Violation|6|||
48660154|NCT05948670|156608642|FG001|Overall Study|Protocol Violation|8|||
48660155|NCT05948670|156608641|FG000|Overall Study|Withdrawal by Subject|0|||
48660156|NCT05948670|156608642|FG001|Overall Study|Withdrawal by Subject|1|||
48660157|NCT02576535|156608643|FG000|Overall Study|Withdrawal by Subject|2|||
48660158|NCT02962895|156608644|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
48660159|NCT02962895|156608645|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
48660160|NCT02962895|156608646|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|2|||
48660161|NCT02962895|156608647|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
48660162|NCT02962895|156608648|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
48660163|NCT02962895|156608649|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
48660164|NCT02962895|156608650|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
48660165|NCT02962895|156608644|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
48660166|NCT02962895|156608645|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|1|||
48660167|NCT02962895|156608646|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
48660168|NCT02962895|156608647|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
48660169|NCT02962895|156608648|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
48660170|NCT02962895|156608649|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
48660171|NCT02962895|156608650|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
48660172|NCT02962895|156608644|FG000|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
48660173|NCT02962895|156608645|FG001|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
48660174|NCT02962895|156608646|FG002|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
48660175|NCT02962895|156608647|FG003|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
48660176|NCT02962895|156608648|FG004|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
48660177|NCT02962895|156608649|FG005|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
48660178|NCT02962895|156608650|FG006|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
48660179|NCT02962895|156608644|FG000|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|1|||
48660180|NCT02962895|156608645|FG001|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
48660181|NCT02962895|156608646|FG002|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
48660182|NCT02962895|156608647|FG003|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
48660183|NCT02962895|156608648|FG004|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
48660184|NCT02962895|156608649|FG005|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
48660185|NCT02962895|156608650|FG006|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
48660186|NCT02962895|156608644|FG000|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
48660187|NCT02962895|156608645|FG001|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|1|||
48660188|NCT02962895|156608646|FG002|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
48660189|NCT02962895|156608647|FG003|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
48660190|NCT02962895|156608648|FG004|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
48660191|NCT02962895|156608649|FG005|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
48660192|NCT02962895|156608650|FG006|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
48660193|NCT02962895|156608644|FG000|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
48660194|NCT02962895|156608645|FG001|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
48660195|NCT02962895|156608646|FG002|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
48660196|NCT02962895|156608647|FG003|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|1|||
48660197|NCT02962895|156608648|FG004|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
48660198|NCT02962895|156608649|FG005|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
48660199|NCT02962895|156608650|FG006|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
48660200|NCT02962895|156608644|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
48964162|NCT01617187|157696123|FG000|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
48964163|NCT01617187|157696124|FG001|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
48660201|NCT02962895|156608645|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
48692729|NCT04908683|156724584|FG000|Overall Study|Death|101|||
48866304|NCT00990821|157345738|FG001|Overall Study|Withdrawal by Subject|2|||
48866305|NCT00990821|157345739|FG002|Overall Study|Withdrawal by Subject|0|||
48866306|NCT00990821|157345740|FG003|Overall Study|Withdrawal by Subject|0|||
48866307|NCT00990821|157345741|FG004|Overall Study|Withdrawal by Subject|3|||
48660202|NCT02962895|156608646|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
48660203|NCT02962895|156608647|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
48660204|NCT02962895|156608648|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
48660205|NCT02962895|156608649|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
48660206|NCT02962895|156608650|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|1|||
48660207|NCT02962895|156608644|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
48660208|NCT02962895|156608645|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
48660209|NCT02962895|156608646|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
48660210|NCT02962895|156608647|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
48660211|NCT02962895|156608648|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|5|||
48660212|NCT02962895|156608649|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
48660213|NCT02962895|156608650|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|2|||
48660214|NCT02962895|156608644|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
48660215|NCT02962895|156608645|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
48660216|NCT02962895|156608646|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
48660217|NCT02962895|156608647|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
48660218|NCT02962895|156608648|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
48660219|NCT02962895|156608649|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
48660220|NCT02962895|156608650|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|1|||
48660221|NCT02962895|156608644|FG000|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
48866308|NCT00990821|157345742|FG005|Overall Study|Withdrawal by Subject|3|||
48866309|NCT00990821|157345743|FG006|Overall Study|Withdrawal by Subject|1|||
48866310|NCT00990821|157345744|FG007|Overall Study|Withdrawal by Subject|0|||
48866311|NCT00990821|157345745|FG008|Overall Study|Withdrawal by Subject|0|||
48866312|NCT00990821|157345746|FG009|Overall Study|Withdrawal by Subject|1|||
48866313|NCT00990821|157345747|FG010|Overall Study|Withdrawal by Subject|3|||
48866314|NCT00990821|157345748|FG011|Overall Study|Withdrawal by Subject|5|||
48866315|NCT00990821|157345749|FG012|Overall Study|Withdrawal by Subject|2|||
48866316|NCT00990821|157345750|FG013|Overall Study|Withdrawal by Subject|1|||
48866317|NCT02273180|157345751|FG000|Overall Study|Adverse Event|2|||
48866318|NCT02273180|157345752|FG001|Overall Study|Adverse Event|2|||
48866319|NCT02273180|157345751|FG000|Overall Study|Lack of Efficacy|1|||
48866320|NCT02273180|157345752|FG001|Overall Study|Lack of Efficacy|0|||
48866321|NCT02273180|157345751|FG000|Overall Study|Protocol Violation|1|||
48866322|NCT02273180|157345752|FG001|Overall Study|Protocol Violation|7|||
48866323|NCT02273180|157345751|FG000|Overall Study|Randomized but not treated|1|||
48866324|NCT02273180|157345752|FG001|Overall Study|Randomized but not treated|0|||
48866325|NCT02273180|157345751|FG000|Overall Study|Hypoglycemia(not reported as serious AE)|1|||
48866326|NCT02273180|157345752|FG001|Overall Study|Hypoglycemia(not reported as serious AE)|0|||
48866327|NCT02273180|157345751|FG000|Overall Study|Other than specified above|21|||
48866328|NCT02273180|157345752|FG001|Overall Study|Other than specified above|10|||
48866329|NCT04369664|157347466|FG000|Overall Study|Physician Decision|1|||
48866330|NCT04369664|157347467|FG001|Overall Study|Physician Decision|0|||
48866331|NCT03087851|157347475|FG000|Overall Study|Withdraw on medical grounds|0|||
48866332|NCT03087851|157347476|FG001|Overall Study|Withdraw on medical grounds|1|||
48866333|NCT03087851|157347477|FG002|Overall Study|Withdraw on medical grounds|2|||
48866334|NCT02679079|157347478|FG000|Overall Study|Adverse Event|2|||
48866335|NCT02679079|157347479|FG001|Overall Study|Adverse Event|0|||
48866336|NCT02679079|157347480|FG002|Overall Study|Adverse Event|2|||
48866337|NCT02679079|157347478|FG000|Overall Study|Protocol Violation|0|||
48866338|NCT02679079|157347479|FG001|Overall Study|Protocol Violation|1|||
48866339|NCT02679079|157347480|FG002|Overall Study|Protocol Violation|0|||
48866340|NCT02679079|157347478|FG000|Overall Study|Withdrawal by Subject|2|||
48866341|NCT02679079|157347479|FG001|Overall Study|Withdrawal by Subject|1|||
48866342|NCT02679079|157347480|FG002|Overall Study|Withdrawal by Subject|0|||
48866343|NCT00443755|157347483|FG000|Overall Study|Withdrawal by Subject|2|||
48866344|NCT00443755|157347484|FG001|Overall Study|Withdrawal by Subject|1|||
48866345|NCT00377312|157347485|FG000|Overall Study|Adverse Event|1|||
48866346|NCT00377312|157347486|FG001|Overall Study|Adverse Event|1|||
48866347|NCT00762723|157347488|FG000|Overall Study|Study Terminated slow enrollement|5|||
48866348|NCT00762723|157347489|FG001|Overall Study|Study Terminated slow enrollement|5|||
48866349|NCT00762723|157347490|FG002|Overall Study|Study Terminated slow enrollement|3|||
48866350|NCT00627523|157347491|FG000|Overall Study|Lack of Efficacy|1|||
48866351|NCT00627523|157347492|FG001|Overall Study|Lack of Efficacy|0|||
48866352|NCT00627523|157347491|FG000|Overall Study|Withdrawal by Subject|0|||
48866353|NCT00627523|157347492|FG001|Overall Study|Withdrawal by Subject|2|||
48866354|NCT00627523|157347491|FG000|Overall Study|Other|1|||
48866355|NCT00627523|157347492|FG001|Overall Study|Other|0|||
48660222|NCT02962895|156608645|FG001|Period 4 (Safety Follow-Up)|Lack of Efficacy|1|||
48660223|NCT02962895|156608646|FG002|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
48660224|NCT02962895|156608647|FG003|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
48660225|NCT02962895|156608648|FG004|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
48660226|NCT02962895|156608649|FG005|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
48660227|NCT02962895|156608650|FG006|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
48660228|NCT02962895|156608644|FG000|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
48660229|NCT02962895|156608645|FG001|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
48660230|NCT02962895|156608646|FG002|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
48660231|NCT02962895|156608647|FG003|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
48660232|NCT02962895|156608648|FG004|Period 4 (Safety Follow-Up)|Lost to Follow-up|1|||
48660233|NCT02962895|156608649|FG005|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
48660234|NCT02962895|156608650|FG006|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
48660235|NCT02962895|156608644|FG000|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
48660236|NCT02962895|156608645|FG001|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
48660237|NCT02962895|156608646|FG002|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
48660238|NCT02962895|156608647|FG003|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
48660239|NCT02962895|156608648|FG004|Period 4 (Safety Follow-Up)|New therapy for indication|1|||
48660240|NCT02962895|156608649|FG005|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
48660241|NCT02962895|156608650|FG006|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
48660242|NCT02962895|156608644|FG000|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
48660243|NCT02962895|156608645|FG001|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|3|||
48660244|NCT02962895|156608646|FG002|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|1|||
48660245|NCT02962895|156608647|FG003|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|2|||
48660246|NCT02962895|156608648|FG004|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
48660247|NCT02962895|156608649|FG005|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
48660248|NCT02962895|156608650|FG006|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
48660249|NCT02962895|156608644|FG000|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
48660250|NCT02962895|156608645|FG001|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
48660251|NCT02962895|156608646|FG002|Period 4 (Safety Follow-Up)|Withdrawal by Subject|3|||
48660252|NCT02962895|156608647|FG003|Period 4 (Safety Follow-Up)|Withdrawal by Subject|1|||
48660253|NCT02962895|156608648|FG004|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
48660254|NCT02962895|156608649|FG005|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
48660255|NCT02962895|156608650|FG006|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
48660256|NCT04509674|156608651|FG000|Overall Study|Not treated|33|||
48964164|NCT01617187|157696125|FG002|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
48964165|NCT01617187|157696126|FG003|Randomization Through Start Treatment|Not Treated: Adverse Event|1|||
48964166|NCT01617187|157696123|FG000|Randomization Through Start Treatment|Not Treated: Completed study in database|1|||
48964167|NCT01617187|157696124|FG001|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
48660257|NCT04509674|156608652|FG001|Overall Study|Not treated|26|||
48660258|NCT04509674|156608651|FG000|Overall Study|Protocol Violation|9|||
48660259|NCT04509674|156608652|FG001|Overall Study|Protocol Violation|10|||
48660260|NCT04509674|156608651|FG000|Overall Study|Lost to Follow-up|31|||
48660261|NCT04509674|156608652|FG001|Overall Study|Lost to Follow-up|39|||
48660262|NCT04509674|156608651|FG000|Overall Study|Patient refusal to continue, not due to adverse event|452|||
48660263|NCT04509674|156608652|FG001|Overall Study|Patient refusal to continue, not due to adverse event|418|||
48660264|NCT04509674|156608651|FG000|Overall Study|Adverse event, serious fatal event|11|||
48660265|NCT04509674|156608652|FG001|Overall Study|Adverse event, serious fatal event|4|||
48660266|NCT04509674|156608651|FG000|Overall Study|Adverse event, non-fatal event|107|||
48660267|NCT04509674|156608652|FG001|Overall Study|Adverse event, non-fatal event|118|||
48660268|NCT04509674|156608651|FG000|Overall Study|Other reason than listed|106|||
48660269|NCT04509674|156608652|FG001|Overall Study|Other reason than listed|95|||
48660270|NCT00888329|156608654|FG000|Overall Study|Physician Decision|6|||
48660271|NCT00888329|156608655|FG001|Overall Study|Physician Decision|9|||
48660272|NCT03519971|156608656|FG000|Overall Study|Death|142|||
48660273|NCT03519971|156608657|FG001|Overall Study|Death|69|||
48964168|NCT01617187|157696125|FG002|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
48964169|NCT01617187|157696126|FG003|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
48964170|NCT01617187|157696123|FG000|Treatment Through Study Completion|Adverse Event|1|||
48660274|NCT03519971|156608656|FG000|Overall Study|Lost to Follow-up|0|||
48964171|NCT01617187|157696124|FG001|Treatment Through Study Completion|Adverse Event|1|||
48660275|NCT03519971|156608657|FG001|Overall Study|Lost to Follow-up|1|||
48660276|NCT03519971|156608656|FG000|Overall Study|Ongoing treatment and in follow-up at data cut off|73|||
48660277|NCT03519971|156608657|FG001|Overall Study|Ongoing treatment and in follow-up at data cut off|37|||
48660278|NCT03519971|156608656|FG000|Overall Study|Withdrawal by Subject|3|||
48660279|NCT03519971|156608657|FG001|Overall Study|Withdrawal by Subject|2|||
48660280|NCT03519971|156608656|FG000|Overall Study|Other|1|||
48660281|NCT03519971|156608657|FG001|Overall Study|Other|0|||
48964172|NCT01617187|157696125|FG002|Treatment Through Study Completion|Adverse Event|0|||
48660282|NCT01208662|156608658|FG000|Induction and Consolidation|Disease Progression|23|||
48660283|NCT01208662|156608659|FG001|Induction and Consolidation|Disease Progression|13|||
48660284|NCT01208662|156608660|FG002|Induction and Consolidation|Disease Progression|0|||
48660285|NCT01208662|156608658|FG000|Induction and Consolidation|Adverse Event|16|||
48660286|NCT01208662|156608659|FG001|Induction and Consolidation|Adverse Event|18|||
48660287|NCT01208662|156608660|FG002|Induction and Consolidation|Adverse Event|2|||
48660288|NCT01208662|156608658|FG000|Induction and Consolidation|MD or Participant Decision|16|||
48660289|NCT01208662|156608659|FG001|Induction and Consolidation|MD or Participant Decision|34|||
48660290|NCT01208662|156608660|FG002|Induction and Consolidation|MD or Participant Decision|4|||
48660291|NCT01208662|156608658|FG000|Induction and Consolidation|Death|1|||
48660292|NCT01208662|156608659|FG001|Induction and Consolidation|Death|3|||
48755378|NCT00456521|156951242|FG000|Overall Study|Drug non-compliance, moved, other|26|||
48755379|NCT00456521|156951243|FG001|Overall Study|Drug non-compliance, moved, other|11|||
48660293|NCT01208662|156608660|FG002|Induction and Consolidation|Death|1|||
48660294|NCT01208662|156608658|FG000|Induction and Consolidation|Discontinued for other reasons|10|||
48660295|NCT01208662|156608659|FG001|Induction and Consolidation|Discontinued for other reasons|8|||
48964173|NCT01617187|157696126|FG003|Treatment Through Study Completion|Adverse Event|1|||
48964174|NCT01617187|157696123|FG000|Treatment Through Study Completion|Lost to Follow-up|4|||
48964175|NCT01617187|157696124|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
48964176|NCT01617187|157696125|FG002|Treatment Through Study Completion|Lost to Follow-up|2|||
48964177|NCT01617187|157696126|FG003|Treatment Through Study Completion|Lost to Follow-up|2|||
48964178|NCT01617187|157696123|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
48964179|NCT01617187|157696124|FG001|Treatment Through Study Completion|Withdrawal by Subject|8|||
48964180|NCT01617187|157696125|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
48964181|NCT01617187|157696126|FG003|Treatment Through Study Completion|Withdrawal by Subject|6|||
48964182|NCT01617187|157696123|FG000|Treatment Through Study Completion|Protocol Violation|1|||
48964183|NCT01617187|157696124|FG001|Treatment Through Study Completion|Protocol Violation|0|||
48964184|NCT01617187|157696125|FG002|Treatment Through Study Completion|Protocol Violation|0|||
48964185|NCT01617187|157696126|FG003|Treatment Through Study Completion|Protocol Violation|1|||
48964186|NCT01842607|157696127|FG000|Overall Study|Adverse Event|11|||
48964187|NCT01842607|157696127|FG000|Overall Study|Lack of Efficacy|19|||
48964188|NCT01842607|157696127|FG000|Overall Study|Protocol Violation|8|||
48964189|NCT01842607|157696127|FG000|Overall Study|Protocol defined stopping criteria|2|||
48964190|NCT01842607|157696127|FG000|Overall Study|Lost to Follow-up|3|||
48660296|NCT01208662|156608660|FG002|Induction and Consolidation|Discontinued for other reasons|0|||
48755380|NCT03779204|156951244|FG000|Overall Study|Lost to Follow-up|2|||
48755381|NCT03779204|156951245|FG001|Overall Study|Lost to Follow-up|0|||
48755382|NCT00558025|156951248|FG000|Overall Study|Adverse Event|1|||
48866356|NCT00678899|157347493|FG000|Overall Study|Adverse Event|1|||
48866357|NCT05878990|157347494|FG000|Overall Study|Lost to Follow-up|7|||
48866358|NCT05878990|157347494|FG000|Overall Study|Withdrawal by Subject|1|||
48866359|NCT03341312|157347495|FG000|Period 1|Withdrawal by Subject|0|||
48866360|NCT03341312|157347496|FG001|Period 1|Withdrawal by Subject|1|||
48866361|NCT03341312|157347497|FG002|Period 1|Withdrawal by Subject|0|||
48866362|NCT03341312|157347498|FG003|Period 1|Withdrawal by Subject|0|||
48866363|NCT01812707|157347499|FG000|Overall Study|Adverse Event|0|||
48866364|NCT01812707|157347500|FG001|Overall Study|Adverse Event|0|||
48866365|NCT01812707|157347501|FG002|Overall Study|Adverse Event|0|||
48866366|NCT01812707|157347502|FG003|Overall Study|Adverse Event|2|||
48866367|NCT01812707|157347499|FG000|Overall Study|Poor compliance to protocol|1|||
48866368|NCT01812707|157347500|FG001|Overall Study|Poor compliance to protocol|0|||
48866369|NCT01812707|157347501|FG002|Overall Study|Poor compliance to protocol|0|||
48866370|NCT01812707|157347502|FG003|Overall Study|Poor compliance to protocol|0|||
48755383|NCT00558025|156951249|FG001|Overall Study|Adverse Event|1|||
48755384|NCT00558025|156951248|FG000|Overall Study|Withdrawal by Subject|2|||
48755385|NCT00558025|156951249|FG001|Overall Study|Withdrawal by Subject|2|||
48755386|NCT00558025|156951248|FG000|Overall Study|Protocol Violation|1|||
48755387|NCT00558025|156951249|FG001|Overall Study|Protocol Violation|0|||
48755388|NCT02288559|156951250|FG000|Overall Study|Adverse Event|1|||
48755389|NCT02288559|156951251|FG001|Overall Study|Adverse Event|1|||
48755390|NCT02288559|156951252|FG002|Overall Study|Adverse Event|5|||
48755391|NCT02288559|156951253|FG003|Overall Study|Adverse Event|0|||
48755392|NCT02288559|156951250|FG000|Overall Study|Death|0|||
48755393|NCT02288559|156951251|FG001|Overall Study|Death|0|||
48866371|NCT01812707|157347499|FG000|Overall Study|Consent withdrawn by participant|1|||
48964191|NCT01842607|157696127|FG000|Overall Study|Physician Decision|9|||
48964192|NCT01842607|157696127|FG000|Overall Study|Withdrawal by Subject|14|||
48964193|NCT01056341|157696128|FG000|Overall Study|Treatment Intolerance|0|||
48660297|NCT01208662|156608658|FG000|Maintenance|Disease Progression|156|||
48660298|NCT01208662|156608659|FG001|Maintenance|Disease Progression|102|||
48755394|NCT02288559|156951252|FG002|Overall Study|Death|1|||
48866372|NCT01812707|157347500|FG001|Overall Study|Consent withdrawn by participant|0|||
48755395|NCT02288559|156951253|FG003|Overall Study|Death|0|||
48866373|NCT01812707|157347501|FG002|Overall Study|Consent withdrawn by participant|0|||
48964194|NCT01056341|157696129|FG001|Overall Study|Treatment Intolerance|2|||
48964195|NCT01056341|157696130|FG002|Overall Study|Treatment Intolerance|0|||
48964196|NCT01056341|157696131|FG003|Overall Study|Treatment Intolerance|2|||
48964197|NCT01056341|157696132|FG004|Overall Study|Treatment Intolerance|0|||
48964198|NCT01056341|157696128|FG000|Overall Study|Lack of Efficacy|32|||
48964199|NCT01056341|157696129|FG001|Overall Study|Lack of Efficacy|30|||
48964200|NCT01056341|157696130|FG002|Overall Study|Lack of Efficacy|7|||
48964201|NCT01056341|157696131|FG003|Overall Study|Lack of Efficacy|25|||
48660299|NCT01208662|156608660|FG002|Maintenance|Disease Progression|0|||
48660300|NCT01208662|156608658|FG000|Maintenance|Adverse Event|12|||
48660301|NCT01208662|156608659|FG001|Maintenance|Adverse Event|28|||
48660302|NCT01208662|156608660|FG002|Maintenance|Adverse Event|0|||
48660303|NCT01208662|156608658|FG000|Maintenance|MD or Participant Decision|24|||
48660304|NCT01208662|156608659|FG001|Maintenance|MD or Participant Decision|36|||
48660305|NCT01208662|156608660|FG002|Maintenance|MD or Participant Decision|0|||
48660306|NCT01208662|156608658|FG000|Maintenance|Death|0|||
48660307|NCT01208662|156608659|FG001|Maintenance|Death|3|||
48660308|NCT01208662|156608660|FG002|Maintenance|Death|0|||
48660309|NCT01208662|156608658|FG000|Maintenance|Discontinued for other reasons|21|||
48660310|NCT01208662|156608659|FG001|Maintenance|Discontinued for other reasons|31|||
48660311|NCT01208662|156608660|FG002|Maintenance|Discontinued for other reasons|0|||
48660312|NCT01208662|156608658|FG000|Maintenance|Still on Treatment|78|||
48660313|NCT01208662|156608659|FG001|Maintenance|Still on Treatment|89|||
48660314|NCT01208662|156608660|FG002|Maintenance|Still on Treatment|0|||
48660315|NCT04795167|156608661|FG000|Overall Study|Death|1|||
48660316|NCT04795167|156608662|FG001|Overall Study|Death|18|||
48660317|NCT04795167|156608663|FG002|Overall Study|Death|1|||
48660318|NCT04795167|156608661|FG000|Overall Study|Remained in-hospital for >/= 45 Days|4|||
48660319|NCT04795167|156608662|FG001|Overall Study|Remained in-hospital for >/= 45 Days|0|||
48660320|NCT04795167|156608663|FG002|Overall Study|Remained in-hospital for >/= 45 Days|0|||
48660321|NCT04039113|156608664|FG000|Overall Study|Withdrawal by Subject|8|||
48660322|NCT04039113|156608665|FG001|Overall Study|Withdrawal by Subject|11|||
48660323|NCT04039113|156608664|FG000|Overall Study|Lost to Follow-up|1|||
48660324|NCT04039113|156608665|FG001|Overall Study|Lost to Follow-up|1|||
48660325|NCT04039113|156608664|FG000|Overall Study|Adverse Event|2|||
48660326|NCT04039113|156608665|FG001|Overall Study|Adverse Event|2|||
48660327|NCT04039113|156608664|FG000|Overall Study|Death|2|||
48660328|NCT04039113|156608665|FG001|Overall Study|Death|4|||
48660329|NCT04039113|156608664|FG000|Overall Study|Site Closure|6|||
48660330|NCT04039113|156608665|FG001|Overall Study|Site Closure|0|||
48660331|NCT04039113|156608664|FG000|Overall Study|Failure to meet randomisation criteria|4|||
48660332|NCT04039113|156608665|FG001|Overall Study|Failure to meet randomisation criteria|0|||
48964202|NCT01056341|157696132|FG004|Overall Study|Lack of Efficacy|9|||
48964203|NCT01056341|157696128|FG000|Overall Study|Other reasons|4|||
48964204|NCT01056341|157696129|FG001|Overall Study|Other reasons|4|||
48964205|NCT01056341|157696130|FG002|Overall Study|Other reasons|8|||
48964206|NCT01056341|157696131|FG003|Overall Study|Other reasons|9|||
48964207|NCT01056341|157696132|FG004|Overall Study|Other reasons|5|||
48964208|NCT02475395|157696133|FG000|Overall Study|Protocol Violation|30|||
48964209|NCT02475395|157696134|FG001|Overall Study|Protocol Violation|3|||
48964210|NCT03454412|157696135|FG000|Baseline Assesment|Physician Decision|12|||
48964211|NCT01086150|157696136|FG000|Overall Study|Withdrawal by Subject|0|||
48964212|NCT01086150|157696137|FG001|Overall Study|Withdrawal by Subject|4|||
48964213|NCT01086150|157696138|FG002|Overall Study|Withdrawal by Subject|1|||
48964214|NCT01086150|157696136|FG000|Overall Study|Lost to Follow-up|0|||
48964215|NCT01086150|157696137|FG001|Overall Study|Lost to Follow-up|1|||
48964216|NCT01086150|157696138|FG002|Overall Study|Lost to Follow-up|0|||
48964217|NCT01086150|157696136|FG000|Overall Study|Screen Failure|0|||
48964218|NCT01086150|157696137|FG001|Overall Study|Screen Failure|1|||
48964219|NCT01086150|157696138|FG002|Overall Study|Screen Failure|0|||
48964220|NCT01167582|157696139|FG000|Overall Study|Lost to Follow-up|0|||
48660333|NCT04826471|156608666|FG000|Overall Study|Lost to Follow-up|2|||
48964221|NCT01167582|157696140|FG001|Overall Study|Lost to Follow-up|1|||
48660334|NCT04826471|156608666|FG000|Overall Study|Protocol Violation|3|||
48964222|NCT01026389|157697988|FG000|Overall Study|Withdrawal by Subject|1|||
48660335|NCT04826471|156608666|FG000|Overall Study|Withdrawal by Subject|1|||
48660336|NCT01864018|156608668|FG000|Overall Study|Ineligible|3|||
48660337|NCT01864018|156608669|FG001|Overall Study|Ineligible|1|||
48660338|NCT00645528|156608670|FG000|Overall Study|Did not show up for Visit 2|7|||
48964223|NCT01026389|157697989|FG001|Overall Study|Withdrawal by Subject|3|||
48964224|NCT01026389|157697988|FG000|Overall Study|change of treatment, patient moved|4|||
48964225|NCT01026389|157697989|FG001|Overall Study|change of treatment, patient moved|2|||
48964226|NCT01995136|157697990|FG000|Overall Study|Change in residence|1|||
48964227|NCT01697267|157697991|FG000|Overall Study|Death|3|||
48660339|NCT04132518|156608671|FG000|Overall Study|Prematurely withdrawn from the study|0|||
48660340|NCT04132518|156608672|FG001|Overall Study|Prematurely withdrawn from the study|9|||
48692730|NCT04908683|156724585|FG001|Overall Study|Death|61|||
48692731|NCT04908683|156724584|FG000|Overall Study|Sponsor's decision|14398|||
48692732|NCT04908683|156724585|FG001|Overall Study|Sponsor's decision|7205|||
48866374|NCT01812707|157347502|FG003|Overall Study|Consent withdrawn by participant|0|||
48866375|NCT02339506|157347507|FG000|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0|||
48866376|NCT02339506|157347508|FG001|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1|||
48866377|NCT02339506|157347507|FG000|Washout (Period 2)|Withdrawal by Subject|2|||
48866378|NCT02339506|157347508|FG001|Washout (Period 2)|Withdrawal by Subject|0|||
48866379|NCT00609245|157347509|FG000|Overall Study|Adverse Event|1|||
48866380|NCT01066897|157347510|FG000|Overall Study|Withdrawal by Subject|1|||
48866381|NCT01066897|157347511|FG001|Overall Study|Withdrawal by Subject|0|||
48866382|NCT01066897|157347510|FG000|Overall Study|stopped study after developing the flu.|1|||
48866383|NCT01066897|157347511|FG001|Overall Study|stopped study after developing the flu.|0|||
48866384|NCT01697592|157347514|FG000|Phase A (Up to 24 Weeks)|Lost to Follow-up|1|||
48866385|NCT01697592|157347515|FG001|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
48866386|NCT01697592|157347516|FG002|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
48866387|NCT01697592|157347517|FG003|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
48866388|NCT01697592|157347518|FG004|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
48866389|NCT01697592|157347519|FG005|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
48866390|NCT01697592|157347520|FG006|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
48866391|NCT01697592|157347521|FG007|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
48866392|NCT01697592|157347522|FG008|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
48866393|NCT01697592|157347523|FG009|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
48866394|NCT01697592|157347514|FG000|Phase A (Up to 24 Weeks)|Physician Decision|0|||
48866395|NCT01697592|157347515|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
48866396|NCT01697592|157347516|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
48866397|NCT01697592|157347517|FG003|Phase A (Up to 24 Weeks)|Physician Decision|0|||
48866398|NCT01697592|157347518|FG004|Phase A (Up to 24 Weeks)|Physician Decision|0|||
48866399|NCT01697592|157347519|FG005|Phase A (Up to 24 Weeks)|Physician Decision|1|||
48866400|NCT01697592|157347520|FG006|Phase A (Up to 24 Weeks)|Physician Decision|0|||
48866401|NCT01697592|157347521|FG007|Phase A (Up to 24 Weeks)|Physician Decision|0|||
48866402|NCT01697592|157347522|FG008|Phase A (Up to 24 Weeks)|Physician Decision|0|||
48866403|NCT01697592|157347523|FG009|Phase A (Up to 24 Weeks)|Physician Decision|0|||
48866404|NCT01697592|157347514|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
48866405|NCT01697592|157347515|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
48866406|NCT01697592|157347516|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
48866407|NCT01697592|157347517|FG003|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
48866408|NCT01697592|157347518|FG004|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
48866409|NCT01697592|157347519|FG005|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
48866410|NCT01697592|157347520|FG006|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
48866411|NCT01697592|157347521|FG007|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
48866412|NCT01697592|157347522|FG008|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
48866413|NCT01697592|157347523|FG009|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
48866414|NCT01697592|157347514|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
48866415|NCT01697592|157347515|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
48964228|NCT01697267|157697992|FG001|Overall Study|Death|1|||
48660341|NCT04132518|156608673|FG002|Overall Study|Prematurely withdrawn from the study|1|||
48660342|NCT04863248|156608674|FG000|Overall Study|Sponsor Terminated|4|||
48660343|NCT04863248|156608675|FG001|Overall Study|Sponsor Terminated|1|||
48660344|NCT04863248|156608674|FG000|Overall Study|Death|0|||
48660345|NCT04863248|156608675|FG001|Overall Study|Death|1|||
48660346|NCT04863248|156608674|FG000|Overall Study|Withdrawal by Subject|0|||
48660347|NCT04863248|156608675|FG001|Overall Study|Withdrawal by Subject|1|||
48660348|NCT05205161|156608681|FG000|Overall Study|Study terminated by sponsor|3|||
48660349|NCT05205161|156608682|FG001|Overall Study|Study terminated by sponsor|3|||
48660350|NCT05205161|156608683|FG002|Overall Study|Study terminated by sponsor|1|||
48660351|NCT03263923|156608686|FG000|Overall Study|Withdrawal by Subject|10|||
48660352|NCT03263923|156608687|FG001|Overall Study|Withdrawal by Subject|8|||
48660353|NCT03263923|156608686|FG000|Overall Study|Lost to Follow-up|15|||
48660354|NCT03263923|156608687|FG001|Overall Study|Lost to Follow-up|13|||
48660355|NCT03362931|156608689|FG000|Overall Study|Adverse Event|1|||
48660356|NCT03362931|156608689|FG000|Overall Study|Death|2|||
48660357|NCT02927925|156608696|FG000|Overall Study|Death|16|||
48964229|NCT01697267|157697991|FG000|Overall Study|Withdrawal by Subject|5|||
48660358|NCT02927925|156608696|FG000|Overall Study|Physician Decision|1|||
48866416|NCT01697592|157347516|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
48660359|NCT02927925|156608696|FG000|Overall Study|Withdrawal by Subject|11|||
48660360|NCT02927925|156608696|FG000|Overall Study|Other|3|||
48660361|NCT02927925|156608696|FG000|Overall Study|Disease progression at clinical cutoff|1|||
48866417|NCT01697592|157347517|FG003|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
48964230|NCT01697267|157697992|FG001|Overall Study|Withdrawal by Subject|5|||
48660362|NCT00969761|156608697|FG000|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
48660363|NCT00969761|156608698|FG001|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
48660364|NCT00969761|156608699|FG002|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
48660365|NCT00969761|156608700|FG003|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
48964231|NCT01697267|157697991|FG000|Overall Study|Adverse Event|2|||
48964232|NCT01697267|157697992|FG001|Overall Study|Adverse Event|1|||
48964233|NCT01697267|157697991|FG000|Overall Study|Lost to Follow-up|2|||
48964234|NCT01697267|157697992|FG001|Overall Study|Lost to Follow-up|4|||
48964235|NCT01697267|157697991|FG000|Overall Study|Physician Decision|2|||
48964236|NCT01697267|157697992|FG001|Overall Study|Physician Decision|4|||
48964237|NCT03544268|157697993|FG000|Overall Study|Did not meet full criteria for inclusion after enrollment|2|||
48964238|NCT03544268|157697994|FG001|Overall Study|Did not meet full criteria for inclusion after enrollment|0|||
48964239|NCT03225716|157697997|FG000|Overall Study|Withdrawal by Subject|2|||
48964240|NCT03225716|157697998|FG001|Overall Study|Withdrawal by Subject|2|||
48660366|NCT00969761|156608701|FG004|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
48660367|NCT00969761|156608702|FG005|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
48660368|NCT00969761|156608703|FG006|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
48660369|NCT00969761|156608704|FG007|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
48660370|NCT00969761|156608705|FG008|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
48660371|NCT00969761|156608706|FG009|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
48660372|NCT00969761|156608707|FG010|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
48660373|NCT00969761|156608708|FG011|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
48660374|NCT00969761|156608697|FG000|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
48660375|NCT00969761|156608698|FG001|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
48660376|NCT00969761|156608699|FG002|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1|||
48660377|NCT00969761|156608700|FG003|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
48660378|NCT00969761|156608701|FG004|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
48660379|NCT00969761|156608702|FG005|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
48660380|NCT00969761|156608703|FG006|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
48660381|NCT00969761|156608704|FG007|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
48660382|NCT00969761|156608705|FG008|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
48660383|NCT00969761|156608706|FG009|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
48660384|NCT00969761|156608707|FG010|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
48660385|NCT00969761|156608708|FG011|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
48660386|NCT00969761|156608697|FG000|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
48660387|NCT00969761|156608698|FG001|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
48660388|NCT00969761|156608699|FG002|Discont. Before Start of Treat. Cycle 2|Other adverse events|1|||
48660389|NCT00969761|156608700|FG003|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
48660390|NCT00969761|156608701|FG004|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
48660391|NCT00969761|156608702|FG005|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
48660392|NCT00969761|156608703|FG006|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
48660393|NCT00969761|156608704|FG007|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
48660394|NCT00969761|156608705|FG008|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
48660395|NCT00969761|156608706|FG009|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
48660396|NCT00969761|156608707|FG010|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
48660397|NCT00969761|156608708|FG011|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
48660398|NCT00969761|156608697|FG000|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
48660399|NCT00969761|156608698|FG001|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
48660400|NCT00969761|156608699|FG002|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
48660401|NCT00969761|156608700|FG003|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
48660402|NCT00969761|156608701|FG004|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
48660403|NCT00969761|156608702|FG005|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
48660404|NCT00969761|156608703|FG006|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
48660405|NCT00969761|156608704|FG007|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
48660406|NCT00969761|156608705|FG008|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1|||
48660407|NCT00969761|156608706|FG009|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
48660408|NCT00969761|156608707|FG010|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
48660409|NCT00969761|156608708|FG011|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
48660410|NCT00969761|156608697|FG000|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
48660411|NCT00969761|156608698|FG001|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
48660412|NCT00969761|156608699|FG002|Treated in and Beyond Treat. Cycle 2|Progressive disease|10|||
48660413|NCT00969761|156608700|FG003|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
48660414|NCT00969761|156608701|FG004|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
48660415|NCT00969761|156608702|FG005|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
48692733|NCT04908683|156724584|FG000|Overall Study|Other|92|||
48964241|NCT03225716|157697999|FG002|Overall Study|Withdrawal by Subject|0|||
48964242|NCT03225716|157697997|FG000|Overall Study|Lack of Efficacy|1|||
48964243|NCT03225716|157697998|FG001|Overall Study|Lack of Efficacy|0|||
48964244|NCT03225716|157697999|FG002|Overall Study|Lack of Efficacy|0|||
48660416|NCT00969761|156608703|FG006|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
48964245|NCT03225716|157697997|FG000|Overall Study|Adverse Event|2|||
48964246|NCT03225716|157697998|FG001|Overall Study|Adverse Event|0|||
48964247|NCT03225716|157697999|FG002|Overall Study|Adverse Event|1|||
48964248|NCT03225716|157697997|FG000|Overall Study|Study early termination by Sponsor|0|||
48964249|NCT03225716|157697998|FG001|Overall Study|Study early termination by Sponsor|0|||
48964250|NCT03225716|157697999|FG002|Overall Study|Study early termination by Sponsor|2|||
48964251|NCT02527148|157698004|FG000|Overall Study|Did not receive study intervention|1|||
48964252|NCT02527148|157698005|FG001|Overall Study|Did not receive study intervention|0|||
48964253|NCT01107405|157698006|FG000|Overall Study|Adverse Event|1|||
48660417|NCT00969761|156608704|FG007|Treated in and Beyond Treat. Cycle 2|Progressive disease|6|||
48660418|NCT00969761|156608705|FG008|Treated in and Beyond Treat. Cycle 2|Progressive disease|9|||
48660419|NCT00969761|156608706|FG009|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
48660420|NCT00969761|156608707|FG010|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
48660421|NCT00969761|156608708|FG011|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
48660422|NCT00969761|156608697|FG000|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
48660423|NCT00969761|156608698|FG001|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
48660424|NCT00969761|156608699|FG002|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
48660425|NCT00969761|156608700|FG003|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
48660426|NCT00969761|156608701|FG004|Treated in and Beyond Treat. Cycle 2|Other adverse events|1|||
48660427|NCT00969761|156608702|FG005|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
48660428|NCT00969761|156608703|FG006|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
48660429|NCT00969761|156608704|FG007|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
48660430|NCT00969761|156608705|FG008|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
48660431|NCT00969761|156608706|FG009|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
48660432|NCT00969761|156608707|FG010|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
48660433|NCT00969761|156608708|FG011|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
48660434|NCT01643850|156608711|FG000|Overall Study|Withdrawal by Subject|0|||
48660435|NCT01643850|156608712|FG001|Overall Study|Withdrawal by Subject|0|||
48660436|NCT01643850|156608713|FG002|Overall Study|Withdrawal by Subject|0|||
48660437|NCT01643850|156608714|FG003|Overall Study|Withdrawal by Subject|0|||
48866418|NCT01697592|157347518|FG004|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
48866419|NCT01697592|157347519|FG005|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
48660438|NCT01643850|156608715|FG004|Overall Study|Withdrawal by Subject|1|||
48660439|NCT01643850|156608716|FG005|Overall Study|Withdrawal by Subject|0|||
48660440|NCT01643850|156608717|FG006|Overall Study|Withdrawal by Subject|0|||
48660441|NCT01643850|156608718|FG007|Overall Study|Withdrawal by Subject|0|||
48660442|NCT01643850|156608719|FG008|Overall Study|Withdrawal by Subject|0|||
48660443|NCT01643850|156608711|FG000|Overall Study|Lost to Follow-up|0|||
48660444|NCT01643850|156608712|FG001|Overall Study|Lost to Follow-up|0|||
48660445|NCT01643850|156608713|FG002|Overall Study|Lost to Follow-up|0|||
48660446|NCT01643850|156608714|FG003|Overall Study|Lost to Follow-up|0|||
48660447|NCT01643850|156608715|FG004|Overall Study|Lost to Follow-up|0|||
48660448|NCT01643850|156608716|FG005|Overall Study|Lost to Follow-up|0|||
48660449|NCT01643850|156608717|FG006|Overall Study|Lost to Follow-up|1|||
48660450|NCT01643850|156608718|FG007|Overall Study|Lost to Follow-up|0|||
48660451|NCT01643850|156608719|FG008|Overall Study|Lost to Follow-up|1|||
48660452|NCT01643850|156608711|FG000|Overall Study|Adverse Event|0|||
48660453|NCT01643850|156608712|FG001|Overall Study|Adverse Event|0|||
48660454|NCT01643850|156608713|FG002|Overall Study|Adverse Event|0|||
48866420|NCT01697592|157347520|FG006|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
48866421|NCT01697592|157347521|FG007|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
48866422|NCT01697592|157347522|FG008|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
48866423|NCT01697592|157347523|FG009|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
48866424|NCT01697592|157347514|FG000|Phase A (Up to 24 Weeks)|Adverse Event|0|||
48866425|NCT01697592|157347515|FG001|Phase A (Up to 24 Weeks)|Adverse Event|2|||
48866426|NCT01697592|157347516|FG002|Phase A (Up to 24 Weeks)|Adverse Event|1|||
48866427|NCT01697592|157347517|FG003|Phase A (Up to 24 Weeks)|Adverse Event|2|||
48866428|NCT01697592|157347518|FG004|Phase A (Up to 24 Weeks)|Adverse Event|0|||
48866429|NCT01697592|157347519|FG005|Phase A (Up to 24 Weeks)|Adverse Event|0|||
48866430|NCT01697592|157347520|FG006|Phase A (Up to 24 Weeks)|Adverse Event|1|||
48866431|NCT01697592|157347521|FG007|Phase A (Up to 24 Weeks)|Adverse Event|0|||
48866432|NCT01697592|157347522|FG008|Phase A (Up to 24 Weeks)|Adverse Event|0|||
48866433|NCT01697592|157347523|FG009|Phase A (Up to 24 Weeks)|Adverse Event|1|||
48660455|NCT01643850|156608714|FG003|Overall Study|Adverse Event|0|||
48660456|NCT01643850|156608715|FG004|Overall Study|Adverse Event|1|||
48660457|NCT01643850|156608716|FG005|Overall Study|Adverse Event|0|||
48660458|NCT01643850|156608717|FG006|Overall Study|Adverse Event|0|||
48660459|NCT01643850|156608718|FG007|Overall Study|Adverse Event|0|||
48660460|NCT01643850|156608719|FG008|Overall Study|Adverse Event|0|||
48660461|NCT01643850|156608711|FG000|Overall Study|Administrative Problems|0|||
48866434|NCT01697592|157347514|FG000|Phase B (Week 25 to Week 52)|Physician Decision|1|||
48964254|NCT01107405|157698007|FG001|Overall Study|Adverse Event|1|||
48964255|NCT01107405|157698008|FG002|Overall Study|Adverse Event|0|||
48964256|NCT01107405|157698009|FG003|Overall Study|Adverse Event|0|||
48964257|NCT01107405|157698010|FG004|Overall Study|Adverse Event|2|||
48964258|NCT01107405|157698006|FG000|Overall Study|Withdrawal by Subject|1|||
48964259|NCT01107405|157698007|FG001|Overall Study|Withdrawal by Subject|0|||
48964260|NCT01107405|157698008|FG002|Overall Study|Withdrawal by Subject|1|||
48964261|NCT01107405|157698009|FG003|Overall Study|Withdrawal by Subject|2|||
48964262|NCT01107405|157698010|FG004|Overall Study|Withdrawal by Subject|1|||
48964263|NCT01107405|157698006|FG000|Overall Study|Protocol Violation|0|||
48964264|NCT01107405|157698007|FG001|Overall Study|Protocol Violation|0|||
48964265|NCT01107405|157698008|FG002|Overall Study|Protocol Violation|1|||
48964266|NCT01107405|157698009|FG003|Overall Study|Protocol Violation|1|||
48964267|NCT01107405|157698010|FG004|Overall Study|Protocol Violation|0|||
48964268|NCT00238303|157698017|FG000|Overall Study|Withdrawal by Subject|11|||
48964269|NCT00238303|157698018|FG001|Overall Study|Withdrawal by Subject|1|||
48964270|NCT00238303|157698019|FG002|Overall Study|Withdrawal by Subject|2|||
48964271|NCT00238303|157698017|FG000|Overall Study|Death|1|||
48964272|NCT00238303|157698018|FG001|Overall Study|Death|0|||
48964273|NCT00238303|157698019|FG002|Overall Study|Death|1|||
48964274|NCT00238303|157698017|FG000|Overall Study|Other Medical Problems|2|||
48964275|NCT00238303|157698018|FG001|Overall Study|Other Medical Problems|0|||
48964276|NCT00238303|157698019|FG002|Overall Study|Other Medical Problems|2|||
48964277|NCT00238303|157698017|FG000|Overall Study|Poor tolerance of study treatment|1|||
48964278|NCT00238303|157698018|FG001|Overall Study|Poor tolerance of study treatment|0|||
48964279|NCT00238303|157698019|FG002|Overall Study|Poor tolerance of study treatment|1|||
48964280|NCT00238303|157698017|FG000|Overall Study|Adverse Event|0|||
48964281|NCT00238303|157698018|FG001|Overall Study|Adverse Event|1|||
48964282|NCT00238303|157698019|FG002|Overall Study|Adverse Event|3|||
48964283|NCT01895452|157698020|FG000|Overall Study|Adverse Event|1|||
48964284|NCT01895452|157698021|FG001|Overall Study|Adverse Event|4|||
48964285|NCT01895452|157698020|FG000|Overall Study|Lost to Follow-up|1|||
48660462|NCT01643850|156608712|FG001|Overall Study|Administrative Problems|0|||
48660463|NCT01643850|156608713|FG002|Overall Study|Administrative Problems|1|||
48660464|NCT01643850|156608714|FG003|Overall Study|Administrative Problems|0|||
48964286|NCT01895452|157698021|FG001|Overall Study|Lost to Follow-up|5|||
48964287|NCT01895452|157698020|FG000|Overall Study|Pregnancy|0|||
48964288|NCT01895452|157698021|FG001|Overall Study|Pregnancy|1|||
48964289|NCT01895452|157698020|FG000|Overall Study|Withdrawal by Subject|2|||
48964290|NCT01895452|157698021|FG001|Overall Study|Withdrawal by Subject|14|||
48964291|NCT01895452|157698020|FG000|Overall Study|Underlying disease|0|||
48964292|NCT01895452|157698021|FG001|Overall Study|Underlying disease|3|||
48964293|NCT01895452|157698020|FG000|Overall Study|Noncompliance with study drug|0|||
48964294|NCT01895452|157698021|FG001|Overall Study|Noncompliance with study drug|1|||
48964295|NCT01653158|157698022|FG000|Overall Study|Death|0|||
48964296|NCT01653158|157698023|FG001|Overall Study|Death|0|||
48964297|NCT01653158|157698024|FG002|Overall Study|Death|0|||
48660465|NCT01643850|156608715|FG004|Overall Study|Administrative Problems|1|||
48660466|NCT01643850|156608716|FG005|Overall Study|Administrative Problems|0|||
48660467|NCT01643850|156608717|FG006|Overall Study|Administrative Problems|0|||
48660468|NCT01643850|156608718|FG007|Overall Study|Administrative Problems|0|||
48660469|NCT01643850|156608719|FG008|Overall Study|Administrative Problems|0|||
48660470|NCT00772369|156608722|FG000|Overall Study|Did not return record release form|1|||
48964298|NCT01653158|157698025|FG003|Overall Study|Death|1|||
48660471|NCT02446418|156608723|FG000|Overall Study|Adverse Event|4|||
48660472|NCT02446418|156608724|FG001|Overall Study|Adverse Event|8|||
48660473|NCT02446418|156608723|FG000|Overall Study|Physician Decision|5|||
48660474|NCT02446418|156608724|FG001|Overall Study|Physician Decision|1|||
48660475|NCT02446418|156608723|FG000|Overall Study|Withdrawal by Subject|3|||
48660476|NCT02446418|156608724|FG001|Overall Study|Withdrawal by Subject|3|||
48660477|NCT02446418|156608723|FG000|Overall Study|Lost to Follow-up|2|||
48964299|NCT01653158|157698026|FG004|Overall Study|Death|0|||
48964300|NCT01653158|157698027|FG005|Overall Study|Death|0|||
48964301|NCT01653158|157698028|FG006|Overall Study|Death|0|||
48660478|NCT02446418|156608724|FG001|Overall Study|Lost to Follow-up|2|||
48660479|NCT02446418|156608723|FG000|Overall Study|Protocol Violation|1|||
48660480|NCT02446418|156608724|FG001|Overall Study|Protocol Violation|2|||
48660481|NCT02446418|156608723|FG000|Overall Study|Lack of Efficacy|2|||
48660482|NCT02446418|156608724|FG001|Overall Study|Lack of Efficacy|0|||
48660483|NCT02446418|156608723|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
48660484|NCT02446418|156608724|FG001|Overall Study|Protocol defined stopping criteria reach|0|||
48660485|NCT02210221|156608730|FG000|Overall Study|Lack of Efficacy|7|||
48660486|NCT02210221|156608730|FG000|Overall Study|Withdrawal by Subject|43|||
48660487|NCT01866423|156608731|FG000|Overall Study|Lack of Efficacy|3|||
48964302|NCT01653158|157698029|FG007|Overall Study|Death|2|||
48964303|NCT01653158|157698022|FG000|Overall Study|Adverse Event|0|||
48964304|NCT01653158|157698023|FG001|Overall Study|Adverse Event|0|||
48964305|NCT01653158|157698024|FG002|Overall Study|Adverse Event|0|||
48964306|NCT01653158|157698025|FG003|Overall Study|Adverse Event|1|||
48660488|NCT01866423|156608731|FG000|Overall Study|Sponsor Decision|1|||
48660489|NCT01174004|156608738|FG000|Overall Study|Adverse Event|2|||
48660490|NCT01174004|156608739|FG001|Overall Study|Adverse Event|10|||
48660491|NCT01174004|156608738|FG000|Overall Study|Withdrawal by Subject|2|||
48660492|NCT01174004|156608739|FG001|Overall Study|Withdrawal by Subject|3|||
48660493|NCT01174004|156608738|FG000|Overall Study|At Discretion of Sponsor|2|||
48660494|NCT01174004|156608739|FG001|Overall Study|At Discretion of Sponsor|2|||
48660495|NCT01174004|156608738|FG000|Overall Study|Protocol Violation|0|||
48660496|NCT01174004|156608739|FG001|Overall Study|Protocol Violation|1|||
48660497|NCT01174004|156608738|FG000|Overall Study|Physician Decision|1|||
48660498|NCT01174004|156608739|FG001|Overall Study|Physician Decision|0|||
48660499|NCT03481660|156609479|FG000|Overall Study|Adverse Event|5|||
48660500|NCT03481660|156609480|FG001|Overall Study|Adverse Event|4|||
48660501|NCT03481660|156609479|FG000|Overall Study|Death|13|||
48660502|NCT03481660|156609480|FG001|Overall Study|Death|9|||
48660503|NCT03481660|156609479|FG000|Overall Study|Lost to Follow-up|2|||
48660504|NCT03481660|156609480|FG001|Overall Study|Lost to Follow-up|2|||
48660505|NCT03481660|156609479|FG000|Overall Study|Physician Decision|2|||
48660506|NCT03481660|156609480|FG001|Overall Study|Physician Decision|3|||
48660507|NCT03481660|156609479|FG000|Overall Study|Withdrawal by Subject|14|||
48660508|NCT03481660|156609480|FG001|Overall Study|Withdrawal by Subject|7|||
48660509|NCT04755660|156609487|FG000|Overall Study|Lost to Follow-up|1|||
48660510|NCT04755660|156609488|FG001|Overall Study|Lost to Follow-up|1|||
48660511|NCT04755660|156609489|FG002|Overall Study|Lost to Follow-up|0|||
48660512|NCT04755660|156609487|FG000|Overall Study|Withdrawal by Subject|0|||
48660513|NCT04755660|156609488|FG001|Overall Study|Withdrawal by Subject|1|||
48660514|NCT04755660|156609489|FG002|Overall Study|Withdrawal by Subject|1|||
48660515|NCT04755660|156609487|FG000|Overall Study|Physician Decision|0|||
48660516|NCT04755660|156609488|FG001|Overall Study|Physician Decision|0|||
48660517|NCT04755660|156609489|FG002|Overall Study|Physician Decision|1|||
48660518|NCT03245736|156609505|FG000|Overall Study|Adverse Event|1|||
48660519|NCT03245736|156609505|FG000|Overall Study|Progressive Disease|4|||
48660520|NCT05438602|156609506|FG000|Treatment (15 Days)|Adverse Event|2|||
48660521|NCT05438602|156609507|FG001|Treatment (15 Days)|Adverse Event|1|||
48660522|NCT05438602|156609508|FG002|Treatment (15 Days)|Adverse Event|3|||
48660523|NCT05438602|156609506|FG000|Treatment (15 Days)|No longer met eligibility criteria|0|||
48660524|NCT05438602|156609507|FG001|Treatment (15 Days)|No longer met eligibility criteria|1|||
48660525|NCT05438602|156609508|FG002|Treatment (15 Days)|No longer met eligibility criteria|0|||
48660526|NCT05438602|156609506|FG000|Treatment (15 Days)|Other|0|||
48660527|NCT05438602|156609507|FG001|Treatment (15 Days)|Other|0|||
48660528|NCT05438602|156609508|FG002|Treatment (15 Days)|Other|1|||
48660529|NCT05438602|156609506|FG000|Treatment (15 Days)|Withdrawal by Subject|2|||
48866435|NCT01697592|157347515|FG001|Phase B (Week 25 to Week 52)|Physician Decision|0|||
48866436|NCT01697592|157347516|FG002|Phase B (Week 25 to Week 52)|Physician Decision|0|||
48866437|NCT01697592|157347517|FG003|Phase B (Week 25 to Week 52)|Physician Decision|1|||
48866438|NCT01697592|157347518|FG004|Phase B (Week 25 to Week 52)|Physician Decision|0|||
48866439|NCT01697592|157347519|FG005|Phase B (Week 25 to Week 52)|Physician Decision|0|||
48866440|NCT01697592|157347520|FG006|Phase B (Week 25 to Week 52)|Physician Decision|0|||
48866441|NCT01697592|157347521|FG007|Phase B (Week 25 to Week 52)|Physician Decision|0|||
48866442|NCT01697592|157347522|FG008|Phase B (Week 25 to Week 52)|Physician Decision|0|||
48866443|NCT01697592|157347523|FG009|Phase B (Week 25 to Week 52)|Physician Decision|0|||
48866444|NCT01697592|157347514|FG000|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2|||
48866445|NCT01697592|157347515|FG001|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
48866446|NCT01697592|157347516|FG002|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
48866447|NCT01697592|157347517|FG003|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
48866448|NCT01697592|157347518|FG004|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
48866449|NCT01697592|157347519|FG005|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
48866450|NCT01697592|157347520|FG006|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
48866451|NCT01697592|157347521|FG007|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
48866452|NCT01697592|157347522|FG008|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
48866453|NCT01697592|157347523|FG009|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
48866454|NCT01697592|157347514|FG000|Phase B (Week 25 to Week 52)|Adverse Event|2|||
48866455|NCT01697592|157347515|FG001|Phase B (Week 25 to Week 52)|Adverse Event|1|||
48866456|NCT01697592|157347516|FG002|Phase B (Week 25 to Week 52)|Adverse Event|1|||
48866457|NCT01697592|157347517|FG003|Phase B (Week 25 to Week 52)|Adverse Event|2|||
48866458|NCT01697592|157347518|FG004|Phase B (Week 25 to Week 52)|Adverse Event|0|||
48866459|NCT01697592|157347519|FG005|Phase B (Week 25 to Week 52)|Adverse Event|1|||
48866460|NCT01697592|157347520|FG006|Phase B (Week 25 to Week 52)|Adverse Event|1|||
48866461|NCT01697592|157347521|FG007|Phase B (Week 25 to Week 52)|Adverse Event|0|||
48866462|NCT01697592|157347522|FG008|Phase B (Week 25 to Week 52)|Adverse Event|2|||
48660530|NCT05438602|156609507|FG001|Treatment (15 Days)|Withdrawal by Subject|1|||
48660531|NCT05438602|156609508|FG002|Treatment (15 Days)|Withdrawal by Subject|4|||
48660532|NCT05438602|156609506|FG000|Follow-up (Through Day 44)|Adverse Event|1|||
48660533|NCT05438602|156609507|FG001|Follow-up (Through Day 44)|Adverse Event|0|||
48964307|NCT01653158|157698026|FG004|Overall Study|Adverse Event|0|||
48964308|NCT01653158|157698027|FG005|Overall Study|Adverse Event|0|||
48964309|NCT01653158|157698028|FG006|Overall Study|Adverse Event|0|||
48964310|NCT01653158|157698029|FG007|Overall Study|Adverse Event|3|||
48964311|NCT01653158|157698022|FG000|Overall Study|Other|0|||
48964312|NCT01653158|157698023|FG001|Overall Study|Other|0|||
48964313|NCT01653158|157698024|FG002|Overall Study|Other|0|||
48964314|NCT01653158|157698025|FG003|Overall Study|Other|0|||
48964315|NCT01653158|157698026|FG004|Overall Study|Other|0|||
48964316|NCT01653158|157698027|FG005|Overall Study|Other|0|||
48964317|NCT01653158|157698028|FG006|Overall Study|Other|0|||
48964318|NCT01653158|157698029|FG007|Overall Study|Other|1|||
48964319|NCT01653158|157698022|FG000|Overall Study|Progressive disease|0|||
48964320|NCT01653158|157698023|FG001|Overall Study|Progressive disease|0|||
48660534|NCT05438602|156609508|FG002|Follow-up (Through Day 44)|Adverse Event|0|||
48660535|NCT05438602|156609506|FG000|Follow-up (Through Day 44)|Withdrawal by Subject|3|||
48660536|NCT05438602|156609507|FG001|Follow-up (Through Day 44)|Withdrawal by Subject|2|||
48660537|NCT05438602|156609508|FG002|Follow-up (Through Day 44)|Withdrawal by Subject|6|||
48660538|NCT05438602|156609506|FG000|Long-term Follow-up (Through Week 24)|Other|1|||
48660539|NCT05438602|156609507|FG001|Long-term Follow-up (Through Week 24)|Other|0|||
48660540|NCT05438602|156609508|FG002|Long-term Follow-up (Through Week 24)|Other|0|||
48660541|NCT05438602|156609506|FG000|Long-term Follow-up (Through Week 24)|Lost to Follow-up|1|||
48660542|NCT05438602|156609507|FG001|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
48660543|NCT05438602|156609508|FG002|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
48660544|NCT05438602|156609506|FG000|Long-term Follow-up (Through Week 24)|Death|1|||
48660545|NCT05438602|156609507|FG001|Long-term Follow-up (Through Week 24)|Death|0|||
48660546|NCT05438602|156609508|FG002|Long-term Follow-up (Through Week 24)|Death|1|||
48660547|NCT05438602|156609506|FG000|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|4|||
48964321|NCT01653158|157698024|FG002|Overall Study|Progressive disease|0|||
48964322|NCT01653158|157698025|FG003|Overall Study|Progressive disease|0|||
48964323|NCT01653158|157698026|FG004|Overall Study|Progressive disease|1|||
48660548|NCT05438602|156609507|FG001|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|5|||
48660549|NCT05438602|156609508|FG002|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|6|||
48660550|NCT05275010|156609509|FG000|Overall Study|Reason Not Specified|4|||
48660551|NCT05275010|156609510|FG001|Overall Study|Reason Not Specified|1|||
48660552|NCT05275010|156609509|FG000|Overall Study|Withdrawal by Subject|1|||
48964324|NCT01653158|157698027|FG005|Overall Study|Progressive disease|1|||
48660553|NCT05275010|156609510|FG001|Overall Study|Withdrawal by Subject|0|||
48660554|NCT05275010|156609509|FG000|Overall Study|Lost to Follow-up|0|||
48660555|NCT05275010|156609510|FG001|Overall Study|Lost to Follow-up|1|||
48660556|NCT04059406|156609518|FG000|Overall Study|Early Treatment Termination|5|||
48660557|NCT04059406|156609519|FG001|Overall Study|Early Treatment Termination|5|||
48660558|NCT04059406|156609520|FG002|Overall Study|Early Treatment Termination|15|||
48660559|NCT04727554|156609523|FG000|Overall Study|Lost to Follow-up|0|||
48660560|NCT04727554|156609524|FG001|Overall Study|Lost to Follow-up|1|||
48660561|NCT04727554|156609523|FG000|Overall Study|Death|2|||
48660562|NCT04727554|156609524|FG001|Overall Study|Death|6|||
48660563|NCT04727554|156609523|FG000|Overall Study|Withdrawal by Subject|1|||
48660564|NCT04727554|156609524|FG001|Overall Study|Withdrawal by Subject|0|||
48660565|NCT03272828|156609527|FG000|Overall Study|Lost to Follow-up|7|||
48755396|NCT02288559|156951250|FG000|Overall Study|Lost to Follow-up|0|||
48755397|NCT02288559|156951251|FG001|Overall Study|Lost to Follow-up|0|||
48755398|NCT02288559|156951252|FG002|Overall Study|Lost to Follow-up|0|||
48660566|NCT03272828|156609528|FG001|Overall Study|Lost to Follow-up|7|||
48660567|NCT03272828|156609527|FG000|Overall Study|Withdrawal by Subject|2|||
48660568|NCT03272828|156609528|FG001|Overall Study|Withdrawal by Subject|0|||
48660569|NCT03272828|156609527|FG000|Overall Study|Deceased|1|||
48755399|NCT02288559|156951253|FG003|Overall Study|Lost to Follow-up|1|||
48660570|NCT03272828|156609528|FG001|Overall Study|Deceased|1|||
48660571|NCT03272828|156609527|FG000|Overall Study|Failed implant|1|||
48660572|NCT03272828|156609528|FG001|Overall Study|Failed implant|2|||
48660573|NCT03822468|156609532|FG000|Treatment Period|Treatment on-going at the data cut-off date (11-Jun-2021)|110|||
48660574|NCT03822468|156609533|FG001|Treatment Period|Treatment on-going at the data cut-off date (11-Jun-2021)|107|||
48660575|NCT03822468|156609532|FG000|Treatment Period|Progressive disease|50|||
48660576|NCT03822468|156609533|FG001|Treatment Period|Progressive disease|51|||
48755400|NCT02288559|156951250|FG000|Overall Study|Withdrawal by Subject|0|||
48755401|NCT02288559|156951251|FG001|Overall Study|Withdrawal by Subject|0|||
48660577|NCT03822468|156609532|FG000|Treatment Period|Adverse Event|16|||
48660578|NCT03822468|156609533|FG001|Treatment Period|Adverse Event|18|||
48964325|NCT01653158|157698028|FG006|Overall Study|Progressive disease|2|||
48964326|NCT01653158|157698029|FG007|Overall Study|Progressive disease|9|||
48964327|NCT01653158|157698022|FG000|Overall Study|Withdrawal by Subject|1|||
48964328|NCT01653158|157698023|FG001|Overall Study|Withdrawal by Subject|0|||
48964329|NCT01653158|157698024|FG002|Overall Study|Withdrawal by Subject|0|||
48964330|NCT01653158|157698025|FG003|Overall Study|Withdrawal by Subject|0|||
48964331|NCT01653158|157698026|FG004|Overall Study|Withdrawal by Subject|0|||
48660579|NCT03822468|156609532|FG000|Treatment Period|Patient decision|4|||
48660580|NCT03822468|156609533|FG001|Treatment Period|Patient decision|5|||
48660581|NCT03822468|156609532|FG000|Treatment Period|Physician Decision|4|||
48660582|NCT03822468|156609533|FG001|Treatment Period|Physician Decision|5|||
48660583|NCT03822468|156609532|FG000|Treatment Period|Protocol deviation|2|||
48660584|NCT03822468|156609533|FG001|Treatment Period|Protocol deviation|1|||
48660585|NCT03822468|156609532|FG000|Treatment Period|Death|1|||
48660586|NCT03822468|156609533|FG001|Treatment Period|Death|1|||
48660587|NCT03822468|156609532|FG000|Treatment Period|Lost to Follow-up|1|||
48660588|NCT03822468|156609533|FG001|Treatment Period|Lost to Follow-up|0|||
48660589|NCT03822468|156609532|FG000|Post-treatment Efficacy Follow-up|Continue to be followed in post-treatment efficacy follow-up at the data cut-off date (11-Jun-2021)|12|||
48660590|NCT03822468|156609533|FG001|Post-treatment Efficacy Follow-up|Continue to be followed in post-treatment efficacy follow-up at the data cut-off date (11-Jun-2021)|13|||
48660591|NCT03822468|156609532|FG000|Post-treatment Efficacy Follow-up|Progressive disease|3|||
48660592|NCT03822468|156609533|FG001|Post-treatment Efficacy Follow-up|Progressive disease|6|||
48660593|NCT03822468|156609532|FG000|Post-treatment Efficacy Follow-up|Patient decision|3|||
48660594|NCT03822468|156609533|FG001|Post-treatment Efficacy Follow-up|Patient decision|1|||
48660595|NCT03822468|156609532|FG000|Post-treatment Efficacy Follow-up|Death|1|||
48660596|NCT03822468|156609533|FG001|Post-treatment Efficacy Follow-up|Death|0|||
48660597|NCT03822468|156609532|FG000|Post-treatment Efficacy Follow-up|Physician Decision|0|||
48964332|NCT01653158|157698027|FG005|Overall Study|Withdrawal by Subject|0|||
48964333|NCT01653158|157698028|FG006|Overall Study|Withdrawal by Subject|0|||
48964334|NCT01653158|157698029|FG007|Overall Study|Withdrawal by Subject|0|||
48660598|NCT03822468|156609533|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
48660599|NCT03580356|156609534|FG000|Treatment Period|Withdrawal by Subject|13|||
48660600|NCT03580356|156609535|FG001|Treatment Period|Withdrawal by Subject|0|||
48660601|NCT03580356|156609536|FG002|Treatment Period|Withdrawal by Subject|13|||
48660602|NCT03580356|156609537|FG003|Treatment Period|Withdrawal by Subject|1|||
48660603|NCT03580356|156609538|FG004|Treatment Period|Withdrawal by Subject|17|||
48660604|NCT03580356|156609539|FG005|Treatment Period|Withdrawal by Subject|0|||
48660605|NCT03580356|156609540|FG006|Treatment Period|Withdrawal by Subject|5|||
48660606|NCT03580356|156609541|FG007|Treatment Period|Withdrawal by Subject|0|||
48660607|NCT03580356|156609534|FG000|Treatment Period|Adverse Event|10|||
48660608|NCT03580356|156609535|FG001|Treatment Period|Adverse Event|0|||
48660609|NCT03580356|156609536|FG002|Treatment Period|Adverse Event|13|||
48660610|NCT03580356|156609537|FG003|Treatment Period|Adverse Event|0|||
48660611|NCT03580356|156609538|FG004|Treatment Period|Adverse Event|5|||
48660612|NCT03580356|156609539|FG005|Treatment Period|Adverse Event|0|||
48660613|NCT03580356|156609540|FG006|Treatment Period|Adverse Event|8|||
48964335|NCT01205451|157698032|FG000|Overall Study|Lost to Follow-up|1|||
48964336|NCT01205451|157698033|FG001|Overall Study|Lost to Follow-up|1|||
48964337|NCT01205451|157698032|FG000|Overall Study|Withdrawal by Subject|5|||
48964338|NCT01205451|157698033|FG001|Overall Study|Withdrawal by Subject|9|||
48964339|NCT03457103|157698035|FG000|Overall Study|illness/hospitalization|4|||
48964340|NCT03457103|157698036|FG001|Overall Study|illness/hospitalization|2|||
48964341|NCT03457103|157698035|FG000|Overall Study|Lost to Follow-up|2|||
48964342|NCT03457103|157698036|FG001|Overall Study|Lost to Follow-up|1|||
48964343|NCT03457103|157698035|FG000|Overall Study|Withdrawal by Subject|1|||
48964344|NCT03457103|157698036|FG001|Overall Study|Withdrawal by Subject|2|||
48660614|NCT03580356|156609541|FG007|Treatment Period|Adverse Event|0|||
48660615|NCT03580356|156609534|FG000|Treatment Period|Protocol Violation|5|||
48660616|NCT03580356|156609535|FG001|Treatment Period|Protocol Violation|0|||
48660617|NCT03580356|156609536|FG002|Treatment Period|Protocol Violation|6|||
48660618|NCT03580356|156609537|FG003|Treatment Period|Protocol Violation|1|||
48660619|NCT03580356|156609538|FG004|Treatment Period|Protocol Violation|9|||
48964345|NCT03457103|157698035|FG000|Overall Study|financial/ insurance issues|1|||
48660620|NCT03580356|156609539|FG005|Treatment Period|Protocol Violation|1|||
48660621|NCT03580356|156609540|FG006|Treatment Period|Protocol Violation|1|||
48660622|NCT03580356|156609541|FG007|Treatment Period|Protocol Violation|0|||
48660623|NCT03580356|156609534|FG000|Treatment Period|Lack of Efficacy|6|||
48660624|NCT03580356|156609535|FG001|Treatment Period|Lack of Efficacy|0|||
48660625|NCT03580356|156609536|FG002|Treatment Period|Lack of Efficacy|2|||
48660626|NCT03580356|156609537|FG003|Treatment Period|Lack of Efficacy|0|||
48660627|NCT03580356|156609538|FG004|Treatment Period|Lack of Efficacy|3|||
48660628|NCT03580356|156609539|FG005|Treatment Period|Lack of Efficacy|0|||
48660629|NCT03580356|156609540|FG006|Treatment Period|Lack of Efficacy|3|||
48660630|NCT03580356|156609541|FG007|Treatment Period|Lack of Efficacy|0|||
48660631|NCT03580356|156609534|FG000|Treatment Period|Pregnancy|1|||
48660632|NCT03580356|156609535|FG001|Treatment Period|Pregnancy|0|||
48660633|NCT03580356|156609536|FG002|Treatment Period|Pregnancy|7|||
48660634|NCT03580356|156609537|FG003|Treatment Period|Pregnancy|0|||
48964346|NCT03457103|157698036|FG001|Overall Study|financial/ insurance issues|1|||
48964347|NCT00190983|157698037|FG000|Overall Study|Inevaluable (never treated)|2|||
48964348|NCT02287402|157698038|FG000|Treatment Period|Adverse Event|17|||
48964349|NCT02287402|157698038|FG000|Treatment Period|Voluntary Withdrawal|10|||
48964350|NCT02287402|157698038|FG000|Follow-up|Lost to Follow-up|1|||
48660635|NCT03580356|156609538|FG004|Treatment Period|Pregnancy|2|||
48660636|NCT03580356|156609539|FG005|Treatment Period|Pregnancy|0|||
48660637|NCT03580356|156609540|FG006|Treatment Period|Pregnancy|1|||
48660638|NCT03580356|156609541|FG007|Treatment Period|Pregnancy|0|||
48660639|NCT03580356|156609534|FG000|Treatment Period|Physician Decision|2|||
48660640|NCT03580356|156609535|FG001|Treatment Period|Physician Decision|0|||
48660641|NCT03580356|156609536|FG002|Treatment Period|Physician Decision|1|||
48660642|NCT03580356|156609537|FG003|Treatment Period|Physician Decision|0|||
48660643|NCT03580356|156609538|FG004|Treatment Period|Physician Decision|4|||
48660644|NCT03580356|156609539|FG005|Treatment Period|Physician Decision|0|||
48660645|NCT03580356|156609540|FG006|Treatment Period|Physician Decision|2|||
48660646|NCT03580356|156609541|FG007|Treatment Period|Physician Decision|0|||
48660647|NCT03580356|156609534|FG000|Treatment Period|Lost to Follow-up|1|||
48660648|NCT03580356|156609535|FG001|Treatment Period|Lost to Follow-up|1|||
48660649|NCT03580356|156609536|FG002|Treatment Period|Lost to Follow-up|1|||
48660650|NCT03580356|156609537|FG003|Treatment Period|Lost to Follow-up|0|||
48660651|NCT03580356|156609538|FG004|Treatment Period|Lost to Follow-up|3|||
48660652|NCT03580356|156609539|FG005|Treatment Period|Lost to Follow-up|0|||
48660653|NCT03580356|156609540|FG006|Treatment Period|Lost to Follow-up|1|||
48660654|NCT03580356|156609541|FG007|Treatment Period|Lost to Follow-up|0|||
48660655|NCT03580356|156609534|FG000|Treatment Period|Death|0|||
48660656|NCT03580356|156609535|FG001|Treatment Period|Death|0|||
48660657|NCT03580356|156609536|FG002|Treatment Period|Death|1|||
48660658|NCT03580356|156609537|FG003|Treatment Period|Death|0|||
48660659|NCT03580356|156609538|FG004|Treatment Period|Death|0|||
48660660|NCT03580356|156609539|FG005|Treatment Period|Death|0|||
48660661|NCT03580356|156609540|FG006|Treatment Period|Death|0|||
48660662|NCT03580356|156609541|FG007|Treatment Period|Death|0|||
48660663|NCT03580356|156609534|FG000|Treatment Period|Technical problems|0|||
48755402|NCT02288559|156951252|FG002|Overall Study|Withdrawal by Subject|2|||
48660664|NCT03580356|156609535|FG001|Treatment Period|Technical problems|0|||
48660665|NCT03580356|156609536|FG002|Treatment Period|Technical problems|0|||
48660666|NCT03580356|156609537|FG003|Treatment Period|Technical problems|0|||
48660667|NCT03580356|156609538|FG004|Treatment Period|Technical problems|1|||
48660668|NCT03580356|156609539|FG005|Treatment Period|Technical problems|0|||
48755403|NCT02288559|156951253|FG003|Overall Study|Withdrawal by Subject|1|||
48755404|NCT02288559|156951250|FG000|Overall Study|Reason Not Specified|0|||
48755405|NCT02288559|156951251|FG001|Overall Study|Reason Not Specified|0|||
48755406|NCT02288559|156951252|FG002|Overall Study|Reason Not Specified|3|||
48755407|NCT02288559|156951253|FG003|Overall Study|Reason Not Specified|0|||
48755408|NCT01782859|156951255|FG000|Overall Study|Protocol Violation|6|||
48755409|NCT01782859|156951256|FG001|Overall Study|Protocol Violation|6|||
48755410|NCT01782859|156951255|FG000|Overall Study|Withdrawal by Subject|0|||
48755411|NCT01782859|156951256|FG001|Overall Study|Withdrawal by Subject|1|||
48755412|NCT01907815|156951259|FG000|Overall Study|Withdrawal by Subject|1|||
48755413|NCT01907815|156951260|FG001|Overall Study|Withdrawal by Subject|0|||
48755414|NCT00143403|156951263|FG000|Overall Study|Adverse Event|3|||
48755415|NCT00143403|156951264|FG001|Overall Study|Adverse Event|8|||
48866463|NCT01697592|157347523|FG009|Phase B (Week 25 to Week 52)|Adverse Event|0|||
48866464|NCT03568708|157347524|FG000|Overall Study|Withdrawal by Subject|1|||
48866465|NCT03568708|157347525|FG001|Overall Study|Withdrawal by Subject|1|||
48866466|NCT03568708|157347524|FG000|Overall Study|Lost to Follow-up|0|||
48866467|NCT03568708|157347525|FG001|Overall Study|Lost to Follow-up|1|||
48866468|NCT05109117|157347528|FG000|Overall Study|Lost to Follow-up|1|||
48866469|NCT05109117|157347528|FG000|Overall Study|Discontinued for non-compliance|1|||
48866470|NCT01126879|157347529|FG000|Overall Study|Progressive Disease|3|||
48866471|NCT01126879|157347530|FG001|Overall Study|Progressive Disease|1|||
48866472|NCT01126879|157347529|FG000|Overall Study|Withdrawal by Subject|1|||
48866473|NCT01126879|157347530|FG001|Overall Study|Withdrawal by Subject|0|||
48866474|NCT01126879|157347529|FG000|Overall Study|Adverse Event|0|||
48866475|NCT01126879|157347530|FG001|Overall Study|Adverse Event|1|||
48866476|NCT01126879|157347529|FG000|Overall Study|Physician Decision|1|||
48866477|NCT01126879|157347530|FG001|Overall Study|Physician Decision|0|||
48866478|NCT00511147|157347533|FG000|Overall Study|Withdrawal by Subject|1|||
48866479|NCT00511147|157347533|FG000|Overall Study|Disease progression|5|||
48866480|NCT00511147|157347533|FG000|Overall Study|Required platelet transfusion|1|||
48866481|NCT01107353|157347544|FG000|Overall Study|Positive Drug Screen|1|||
48660669|NCT03580356|156609540|FG006|Treatment Period|Technical problems|0|||
48660670|NCT03580356|156609541|FG007|Treatment Period|Technical problems|0|||
48660671|NCT03580356|156609534|FG000|Treatment Period|Misrandomized, no treatment|0|||
48755416|NCT00143403|156951263|FG000|Overall Study|Death|1|||
48660672|NCT03580356|156609535|FG001|Treatment Period|Misrandomized, no treatment|0|||
48660673|NCT03580356|156609536|FG002|Treatment Period|Misrandomized, no treatment|1|||
48660674|NCT03580356|156609537|FG003|Treatment Period|Misrandomized, no treatment|0|||
48755417|NCT00143403|156951264|FG001|Overall Study|Death|0|||
48866482|NCT01107353|157347545|FG001|Overall Study|Positive Drug Screen|0|||
48866483|NCT00116584|157347546|FG000|Overall Study|Withdrawal by Subject|1|||
48964351|NCT02287402|157698038|FG000|Follow-up|Voluntary Withdrawal|2|||
48755418|NCT00143403|156951263|FG000|Overall Study|Withdrawal by Subject|3|||
48964352|NCT01844830|157698039|FG000|Overall Study|Withdrawal by Subject|1|||
48964353|NCT01844830|157698040|FG001|Overall Study|Withdrawal by Subject|0|||
48964354|NCT04247815|157698041|FG000|Overall Study|Adverse Event|1|||
48964355|NCT04247815|157698042|FG001|Overall Study|Adverse Event|0|||
48964356|NCT04247815|157698041|FG000|Overall Study|Withdrawal by Subject|1|||
48964357|NCT04247815|157698042|FG001|Overall Study|Withdrawal by Subject|0|||
48964358|NCT04247815|157698041|FG000|Overall Study|Protocol Violation|0|||
48964359|NCT04247815|157698042|FG001|Overall Study|Protocol Violation|1|||
48964360|NCT00448760|157698048|FG000|Overall Study|Death|3|||
48964361|NCT03247413|157698054|FG000|Overall Study|Lost to Follow-up|28|||
48964362|NCT00664209|157698055|FG000|Motor Fluctuations Screen|Negative for motor fluctuation|7|||
48964363|NCT00664209|157698055|FG000|Study Treatment Period|Physician Decision|4|||
48964364|NCT00664209|157698055|FG000|Study Treatment Period|Withdrawal by Subject|2|||
48964365|NCT02767856|157698066|FG000|Overall Study|Lost to Follow-up|9|||
48964366|NCT02767856|157698067|FG001|Overall Study|Lost to Follow-up|1|||
48964367|NCT02767856|157698066|FG000|Overall Study|Withdrawal by Subject|2|||
48964368|NCT02767856|157698067|FG001|Overall Study|Withdrawal by Subject|1|||
48964369|NCT01464788|157698070|FG000|Overall Study|Lost to Follow-up|0|||
48964370|NCT01464788|157698071|FG001|Overall Study|Lost to Follow-up|1|||
48964371|NCT01464788|157698072|FG002|Overall Study|Lost to Follow-up|0|||
48660675|NCT03580356|156609538|FG004|Treatment Period|Misrandomized, no treatment|2|||
48660676|NCT03580356|156609539|FG005|Treatment Period|Misrandomized, no treatment|0|||
48660677|NCT03580356|156609540|FG006|Treatment Period|Misrandomized, no treatment|0|||
48660678|NCT03580356|156609541|FG007|Treatment Period|Misrandomized, no treatment|0|||
48660679|NCT03580356|156609534|FG000|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
48660680|NCT03580356|156609535|FG001|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
48660681|NCT03580356|156609536|FG002|Post-treatment Follow Up Period|Withdrawal by Subject|12|||
48660682|NCT03580356|156609537|FG003|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
48660683|NCT03580356|156609538|FG004|Post-treatment Follow Up Period|Withdrawal by Subject|4|||
48660684|NCT03580356|156609539|FG005|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
48660685|NCT03580356|156609540|FG006|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
48660686|NCT03580356|156609541|FG007|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
48660687|NCT03580356|156609534|FG000|Post-treatment Follow Up Period|Lost to Follow-up|3|||
48660688|NCT03580356|156609535|FG001|Post-treatment Follow Up Period|Lost to Follow-up|0|||
48660689|NCT03580356|156609536|FG002|Post-treatment Follow Up Period|Lost to Follow-up|2|||
48660690|NCT03580356|156609537|FG003|Post-treatment Follow Up Period|Lost to Follow-up|0|||
48660691|NCT03580356|156609538|FG004|Post-treatment Follow Up Period|Lost to Follow-up|1|||
48660692|NCT03580356|156609539|FG005|Post-treatment Follow Up Period|Lost to Follow-up|0|||
48660693|NCT03580356|156609540|FG006|Post-treatment Follow Up Period|Lost to Follow-up|0|||
48755419|NCT00143403|156951264|FG001|Overall Study|Withdrawal by Subject|12|||
48755420|NCT00143403|156951263|FG000|Overall Study|Relapse|15|||
48755421|NCT00143403|156951264|FG001|Overall Study|Relapse|7|||
48755422|NCT00143403|156951263|FG000|Overall Study|Protocol Violation|2|||
48755423|NCT00143403|156951264|FG001|Overall Study|Protocol Violation|2|||
48755424|NCT00143403|156951263|FG000|Overall Study|specified by site|4|||
48755425|NCT00143403|156951264|FG001|Overall Study|specified by site|9|||
48755426|NCT00143403|156951263|FG000|Overall Study|Randomized Not Treated|7|||
48755427|NCT00143403|156951264|FG001|Overall Study|Randomized Not Treated|8|||
48755428|NCT00005937|156951265|FG000|Overall Study|Lack of Efficacy|5|||
48755429|NCT00742001|156951266|FG000|Overall Study|Withdrawn; health exclusion (flu)|0|||
48755430|NCT00742001|156951267|FG001|Overall Study|Withdrawn; health exclusion (flu)|0|||
48964372|NCT01464788|157698070|FG000|Overall Study|Patient had hemorrhage after tPA started|0|||
48964373|NCT01464788|157698071|FG001|Overall Study|Patient had hemorrhage after tPA started|1|||
48964374|NCT01464788|157698072|FG002|Overall Study|Patient had hemorrhage after tPA started|0|||
48964375|NCT01764256|157698076|FG000|Received All Vaccinations|Adverse Event|1|||
48964376|NCT01764256|157698077|FG001|Received All Vaccinations|Adverse Event|1|||
48964377|NCT01764256|157698078|FG002|Received All Vaccinations|Adverse Event|0|||
48964378|NCT01764256|157698079|FG003|Received All Vaccinations|Adverse Event|0|||
48964379|NCT01764256|157698076|FG000|Received All Vaccinations|Did not meet inclusion criteria|0|||
48964380|NCT01764256|157698077|FG001|Received All Vaccinations|Did not meet inclusion criteria|0|||
48964381|NCT01764256|157698078|FG002|Received All Vaccinations|Did not meet inclusion criteria|1|||
48964382|NCT01764256|157698079|FG003|Received All Vaccinations|Did not meet inclusion criteria|0|||
48964383|NCT01764256|157698076|FG000|Received All Vaccinations|Lost to Follow-up|1|||
48660694|NCT03580356|156609541|FG007|Post-treatment Follow Up Period|Lost to Follow-up|0|||
48660695|NCT03580356|156609534|FG000|Post-treatment Follow Up Period|Adverse Event|1|||
48755431|NCT00742001|156951268|FG002|Overall Study|Withdrawn; health exclusion (flu)|1|||
48964384|NCT01764256|157698077|FG001|Received All Vaccinations|Lost to Follow-up|0|||
48964385|NCT01764256|157698078|FG002|Received All Vaccinations|Lost to Follow-up|0|||
48964386|NCT01764256|157698079|FG003|Received All Vaccinations|Lost to Follow-up|0|||
48964387|NCT01764256|157698076|FG000|Completed Study|Lost to Follow-up|0|||
48964388|NCT01764256|157698077|FG001|Completed Study|Lost to Follow-up|0|||
48964389|NCT01764256|157698078|FG002|Completed Study|Lost to Follow-up|0|||
48964390|NCT01764256|157698079|FG003|Completed Study|Lost to Follow-up|1|||
48964391|NCT01098461|157698080|FG000|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10|||
48964392|NCT01098461|157698081|FG001|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2|||
48964393|NCT01098461|157698082|FG002|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
48964394|NCT01098461|157698083|FG003|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
48964395|NCT01098461|157698080|FG000|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
48964396|NCT01098461|157698081|FG001|Treatment Period (TP) (16 Weeks)|Adverse Event|2|||
48964397|NCT01098461|157698082|FG002|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
48964398|NCT01098461|157698083|FG003|Treatment Period (TP) (16 Weeks)|Adverse Event|3|||
48964399|NCT01098461|157698080|FG000|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1|||
48964400|NCT01098461|157698081|FG001|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2|||
48964401|NCT01098461|157698082|FG002|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
48964402|NCT01098461|157698083|FG003|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
48964403|NCT01098461|157698080|FG000|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
48964404|NCT01098461|157698081|FG001|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1|||
48964405|NCT01098461|157698082|FG002|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
48660696|NCT03580356|156609535|FG001|Post-treatment Follow Up Period|Adverse Event|0|||
48660697|NCT03580356|156609536|FG002|Post-treatment Follow Up Period|Adverse Event|3|||
48660698|NCT03580356|156609537|FG003|Post-treatment Follow Up Period|Adverse Event|0|||
48660699|NCT03580356|156609538|FG004|Post-treatment Follow Up Period|Adverse Event|0|||
48964406|NCT01098461|157698083|FG003|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
48964407|NCT01098461|157698080|FG000|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
48964408|NCT01098461|157698081|FG001|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1|||
48964409|NCT01098461|157698082|FG002|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
48964410|NCT01098461|157698083|FG003|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
48964411|NCT01098461|157698080|FG000|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
48964412|NCT01098461|157698081|FG001|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1|||
48964413|NCT01098461|157698082|FG002|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
48964414|NCT01098461|157698083|FG003|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
48964415|NCT01098461|157698080|FG000|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
48964416|NCT01098461|157698081|FG001|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
48964417|NCT01098461|157698082|FG002|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
48964418|NCT01098461|157698083|FG003|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
48964419|NCT04587453|157698084|FG000|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|0|||
48964420|NCT04587453|157698085|FG001|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|1|||
48964421|NCT02662985|157698086|FG000|Treatment Period 1|Adverse Event|0|||
48964422|NCT02662985|157698087|FG001|Treatment Period 1|Adverse Event|2|||
48964423|NCT02662985|157698086|FG000|Treatment Period 1|Protocol Violation|0|||
48964424|NCT02662985|157698087|FG001|Treatment Period 1|Protocol Violation|1|||
48964425|NCT02662985|157698086|FG000|Treatment Period 1|Physician Decision|1|||
48964426|NCT02662985|157698087|FG001|Treatment Period 1|Physician Decision|0|||
48964427|NCT02662985|157698086|FG000|Treatment Period 1|Withdrawal by Subject|0|||
48964428|NCT02662985|157698087|FG001|Treatment Period 1|Withdrawal by Subject|1|||
48660700|NCT03580356|156609539|FG005|Post-treatment Follow Up Period|Adverse Event|0|||
48660701|NCT03580356|156609540|FG006|Post-treatment Follow Up Period|Adverse Event|0|||
48660702|NCT03580356|156609541|FG007|Post-treatment Follow Up Period|Adverse Event|0|||
48964429|NCT02662985|157698086|FG000|Treatment Period 2|Lack of Efficacy|0|||
48660703|NCT03580356|156609534|FG000|Post-treatment Follow Up Period|Lack of Efficacy|0|||
48964430|NCT02662985|157698087|FG001|Treatment Period 2|Lack of Efficacy|1|||
48964431|NCT02662985|157698086|FG000|Treatment Period 2|Lost to Follow-up|1|||
48964432|NCT02662985|157698087|FG001|Treatment Period 2|Lost to Follow-up|0|||
48964433|NCT02662985|157698086|FG000|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
48660704|NCT03580356|156609535|FG001|Post-treatment Follow Up Period|Lack of Efficacy|0|||
48660705|NCT03580356|156609536|FG002|Post-treatment Follow Up Period|Lack of Efficacy|1|||
48660706|NCT03580356|156609537|FG003|Post-treatment Follow Up Period|Lack of Efficacy|0|||
48660707|NCT03580356|156609538|FG004|Post-treatment Follow Up Period|Lack of Efficacy|1|||
48660708|NCT03580356|156609539|FG005|Post-treatment Follow Up Period|Lack of Efficacy|0|||
48660709|NCT03580356|156609540|FG006|Post-treatment Follow Up Period|Lack of Efficacy|0|||
48660710|NCT03580356|156609541|FG007|Post-treatment Follow Up Period|Lack of Efficacy|0|||
48692734|NCT04908683|156724585|FG001|Overall Study|Other|50|||
48692735|NCT04908683|156724584|FG000|Overall Study|Randomized not vaccinated|108|||
48692736|NCT04908683|156724585|FG001|Overall Study|Randomized not vaccinated|52|||
48692737|NCT02542865|156724586|FG000|Overall Study|Identified as screen failure|1|||
48692738|NCT02542865|156724587|FG001|Overall Study|Identified as screen failure|0|||
48692739|NCT02542865|156724586|FG000|Overall Study|Withdrawal by Subject|16|||
48692740|NCT02542865|156724587|FG001|Overall Study|Withdrawal by Subject|0|||
48692741|NCT01339689|156724588|FG000|Overall Study|Adverse Event|1|||
48692742|NCT01339689|156724589|FG001|Overall Study|Adverse Event|2|||
48660711|NCT03580356|156609534|FG000|Post-treatment Follow Up Period|Protocol Violation|1|||
48660712|NCT03580356|156609535|FG001|Post-treatment Follow Up Period|Protocol Violation|0|||
48660713|NCT03580356|156609536|FG002|Post-treatment Follow Up Period|Protocol Violation|1|||
48660714|NCT03580356|156609537|FG003|Post-treatment Follow Up Period|Protocol Violation|0|||
48660715|NCT03580356|156609538|FG004|Post-treatment Follow Up Period|Protocol Violation|0|||
48660716|NCT03580356|156609539|FG005|Post-treatment Follow Up Period|Protocol Violation|0|||
48660717|NCT03580356|156609540|FG006|Post-treatment Follow Up Period|Protocol Violation|0|||
48660718|NCT03580356|156609541|FG007|Post-treatment Follow Up Period|Protocol Violation|0|||
48660719|NCT03580356|156609534|FG000|Post-treatment Follow Up Period|Physician Decision|0|||
48660720|NCT03580356|156609535|FG001|Post-treatment Follow Up Period|Physician Decision|0|||
48660721|NCT03580356|156609536|FG002|Post-treatment Follow Up Period|Physician Decision|0|||
48660722|NCT03580356|156609537|FG003|Post-treatment Follow Up Period|Physician Decision|0|||
48660723|NCT03580356|156609538|FG004|Post-treatment Follow Up Period|Physician Decision|0|||
48660724|NCT03580356|156609539|FG005|Post-treatment Follow Up Period|Physician Decision|0|||
48660725|NCT03580356|156609540|FG006|Post-treatment Follow Up Period|Physician Decision|1|||
48660726|NCT03580356|156609541|FG007|Post-treatment Follow Up Period|Physician Decision|0|||
48660727|NCT03580356|156609534|FG000|Post-treatment Follow Up Period|Pregnancy|1|||
48660728|NCT03580356|156609535|FG001|Post-treatment Follow Up Period|Pregnancy|0|||
48660729|NCT03580356|156609536|FG002|Post-treatment Follow Up Period|Pregnancy|0|||
48660730|NCT03580356|156609537|FG003|Post-treatment Follow Up Period|Pregnancy|0|||
48660731|NCT03580356|156609538|FG004|Post-treatment Follow Up Period|Pregnancy|0|||
48660732|NCT03580356|156609539|FG005|Post-treatment Follow Up Period|Pregnancy|0|||
48660733|NCT03580356|156609540|FG006|Post-treatment Follow Up Period|Pregnancy|0|||
48660734|NCT03580356|156609541|FG007|Post-treatment Follow Up Period|Pregnancy|0|||
48660735|NCT01080768|156609542|FG000|Overall Study|Protocol Deviation|2|||
48660736|NCT01080768|156609543|FG001|Overall Study|Protocol Deviation|1|||
48660737|NCT04181788|156609544|FG000|TREATMENT|Adverse Event|0|||
48660738|NCT04181788|156609545|FG001|TREATMENT|Adverse Event|2|||
48660739|NCT04181788|156609546|FG002|TREATMENT|Adverse Event|1|||
48660740|NCT04181788|156609547|FG003|TREATMENT|Adverse Event|0|||
48660741|NCT04181788|156609548|FG004|TREATMENT|Adverse Event|1|||
48660742|NCT04181788|156609549|FG005|TREATMENT|Adverse Event|3|||
48660743|NCT04181788|156609544|FG000|TREATMENT|Death|0|||
48660744|NCT04181788|156609545|FG001|TREATMENT|Death|0|||
48660745|NCT04181788|156609546|FG002|TREATMENT|Death|0|||
48660746|NCT04181788|156609547|FG003|TREATMENT|Death|0|||
48660747|NCT04181788|156609548|FG004|TREATMENT|Death|8|||
48660748|NCT04181788|156609549|FG005|TREATMENT|Death|8|||
48660749|NCT04181788|156609544|FG000|TREATMENT|Physician Decision|0|||
48660750|NCT04181788|156609545|FG001|TREATMENT|Physician Decision|0|||
48660751|NCT04181788|156609546|FG002|TREATMENT|Physician Decision|0|||
48660752|NCT04181788|156609547|FG003|TREATMENT|Physician Decision|0|||
48660753|NCT04181788|156609548|FG004|TREATMENT|Physician Decision|0|||
48660754|NCT04181788|156609549|FG005|TREATMENT|Physician Decision|1|||
48660755|NCT04181788|156609544|FG000|TREATMENT|Progressive disease|3|||
48660756|NCT04181788|156609545|FG001|TREATMENT|Progressive disease|3|||
48660757|NCT04181788|156609546|FG002|TREATMENT|Progressive disease|5|||
48660758|NCT04181788|156609547|FG003|TREATMENT|Progressive disease|7|||
48660759|NCT04181788|156609548|FG004|TREATMENT|Progressive disease|20|||
48660760|NCT04181788|156609549|FG005|TREATMENT|Progressive disease|38|||
48660761|NCT04181788|156609544|FG000|TREATMENT|Global deterioration of health status|0|||
48660762|NCT04181788|156609545|FG001|TREATMENT|Global deterioration of health status|2|||
48660763|NCT04181788|156609546|FG002|TREATMENT|Global deterioration of health status|0|||
48660764|NCT04181788|156609547|FG003|TREATMENT|Global deterioration of health status|0|||
48660765|NCT04181788|156609548|FG004|TREATMENT|Global deterioration of health status|2|||
48660766|NCT04181788|156609549|FG005|TREATMENT|Global deterioration of health status|8|||
48660767|NCT04181788|156609544|FG000|TREATMENT|Withdrawal by Subject|1|||
48660768|NCT04181788|156609545|FG001|TREATMENT|Withdrawal by Subject|2|||
48660769|NCT04181788|156609546|FG002|TREATMENT|Withdrawal by Subject|0|||
48964434|NCT02662985|157698087|FG001|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
48964435|NCT02662985|157698086|FG000|Treatment Period 3 (Extension Period)|Adverse Event|1|||
48660770|NCT04181788|156609547|FG003|TREATMENT|Withdrawal by Subject|0|||
48660771|NCT04181788|156609548|FG004|TREATMENT|Withdrawal by Subject|3|||
48660772|NCT04181788|156609549|FG005|TREATMENT|Withdrawal by Subject|5|||
48660773|NCT04181788|156609544|FG000|TREATMENT|Other unspecified|0|||
48660774|NCT04181788|156609545|FG001|TREATMENT|Other unspecified|0|||
48660775|NCT04181788|156609546|FG002|TREATMENT|Other unspecified|0|||
48660776|NCT04181788|156609547|FG003|TREATMENT|Other unspecified|0|||
48660777|NCT04181788|156609548|FG004|TREATMENT|Other unspecified|0|||
48660778|NCT04181788|156609549|FG005|TREATMENT|Other unspecified|2|||
48660779|NCT04181788|156609544|FG000|TREATMENT|Ongoing|0|||
48660780|NCT04181788|156609545|FG001|TREATMENT|Ongoing|3|||
48660781|NCT04181788|156609546|FG002|TREATMENT|Ongoing|0|||
48660782|NCT04181788|156609547|FG003|TREATMENT|Ongoing|5|||
48660783|NCT04181788|156609548|FG004|TREATMENT|Ongoing|7|||
48660784|NCT04181788|156609549|FG005|TREATMENT|Ongoing|15|||
48660785|NCT04181788|156609544|FG000|FOLLOW-UP|Death|0|||
48660786|NCT04181788|156609545|FG001|FOLLOW-UP|Death|0|||
48964436|NCT02662985|157698087|FG001|Treatment Period 3 (Extension Period)|Adverse Event|1|||
48964437|NCT02662985|157698086|FG000|Treatment Period 3 (Extension Period)|Lack of Efficacy|0|||
48964438|NCT02662985|157698087|FG001|Treatment Period 3 (Extension Period)|Lack of Efficacy|1|||
48964439|NCT02662985|157698086|FG000|Treatment Period 3 (Extension Period)|Withdrawal by Subject|1|||
48964440|NCT02662985|157698087|FG001|Treatment Period 3 (Extension Period)|Withdrawal by Subject|2|||
48964441|NCT02662985|157698086|FG000|Treatment Period 3 (Extension Period)|Death|0|||
48964442|NCT02662985|157698087|FG001|Treatment Period 3 (Extension Period)|Death|1|||
48964443|NCT02932332|157698088|FG000|Overall Study|Withdrawal by Subject|1|||
48964444|NCT02932332|157698089|FG001|Overall Study|Withdrawal by Subject|1|||
48964445|NCT02932332|157698090|FG002|Overall Study|Withdrawal by Subject|0|||
48964446|NCT02932332|157698091|FG003|Overall Study|Withdrawal by Subject|1|||
48964447|NCT02932332|157698088|FG000|Overall Study|Chest pain|0|||
48964448|NCT02932332|157698089|FG001|Overall Study|Chest pain|0|||
48964449|NCT02932332|157698090|FG002|Overall Study|Chest pain|0|||
48964450|NCT02932332|157698091|FG003|Overall Study|Chest pain|1|||
48964451|NCT02932332|157698088|FG000|Overall Study|Not Dyspneic cough|1|||
48964452|NCT02932332|157698089|FG001|Overall Study|Not Dyspneic cough|2|||
48964453|NCT02932332|157698090|FG002|Overall Study|Not Dyspneic cough|1|||
48964454|NCT02932332|157698091|FG003|Overall Study|Not Dyspneic cough|0|||
48964455|NCT01486784|157698093|FG000|Overall Study|Withdrawal by Subject|0|||
48964456|NCT01486784|157698094|FG001|Overall Study|Withdrawal by Subject|0|||
48964457|NCT01486784|157698095|FG002|Overall Study|Withdrawal by Subject|1|||
48660787|NCT04181788|156609546|FG002|FOLLOW-UP|Death|1|||
48660788|NCT04181788|156609547|FG003|FOLLOW-UP|Death|2|||
48964458|NCT01486784|157698096|FG003|Overall Study|Withdrawal by Subject|0|||
48964459|NCT01486784|157698097|FG004|Overall Study|Withdrawal by Subject|1|||
48964460|NCT01486784|157698098|FG005|Overall Study|Withdrawal by Subject|2|||
48964461|NCT01486784|157698093|FG000|Overall Study|Subject did not meet entry criteria|0|||
48964462|NCT01486784|157698094|FG001|Overall Study|Subject did not meet entry criteria|0|||
48964463|NCT01486784|157698095|FG002|Overall Study|Subject did not meet entry criteria|0|||
48964464|NCT01486784|157698096|FG003|Overall Study|Subject did not meet entry criteria|0|||
48964465|NCT01486784|157698097|FG004|Overall Study|Subject did not meet entry criteria|1|||
48964466|NCT01486784|157698098|FG005|Overall Study|Subject did not meet entry criteria|0|||
48964467|NCT01486784|157698093|FG000|Overall Study|Death|0|||
48964468|NCT01486784|157698094|FG001|Overall Study|Death|0|||
48964469|NCT01486784|157698095|FG002|Overall Study|Death|0|||
48964470|NCT01486784|157698096|FG003|Overall Study|Death|0|||
48964471|NCT01486784|157698097|FG004|Overall Study|Death|0|||
48964472|NCT01486784|157698098|FG005|Overall Study|Death|1|||
48964473|NCT02670330|157698102|FG000|Overall Study|Protocol Deviation|1|||
48964474|NCT02670330|157698103|FG001|Overall Study|Protocol Deviation|0|||
48964475|NCT02670330|157698102|FG000|Overall Study|Study Terminated By Sponsor|36|||
48964476|NCT02670330|157698103|FG001|Overall Study|Study Terminated By Sponsor|43|||
48964477|NCT02670330|157698102|FG000|Overall Study|Adverse Event|1|||
48964478|NCT02670330|157698103|FG001|Overall Study|Adverse Event|3|||
48964479|NCT02670330|157698102|FG000|Overall Study|Withdrawal by Subject|34|||
48964480|NCT02670330|157698103|FG001|Overall Study|Withdrawal by Subject|29|||
48964481|NCT02670330|157698102|FG000|Overall Study|Lost to Follow-up|3|||
48964482|NCT02670330|157698103|FG001|Overall Study|Lost to Follow-up|2|||
48964483|NCT01561560|157698104|FG000|First Two Weeks of Wear|Time/job conflict|0|||
48964484|NCT01561560|157698105|FG001|First Two Weeks of Wear|Time/job conflict|1|||
48964485|NCT01561560|157698104|FG000|First Two Weeks of Wear|Adverse Event|0|||
48964486|NCT01561560|157698105|FG001|First Two Weeks of Wear|Adverse Event|1|||
48964487|NCT01561560|157698104|FG000|Second Two Weeks of Wear|Adverse Event|0|||
48964488|NCT01561560|157698105|FG001|Second Two Weeks of Wear|Adverse Event|1|||
48964489|NCT03176277|157698106|FG000|Part A Dose Escalation Study|Adverse Event|1|||
48964490|NCT03176277|157698107|FG001|Part A Dose Escalation Study|Adverse Event|0|||
48964491|NCT03176277|157698108|FG002|Part A Dose Escalation Study|Adverse Event|1|||
48964492|NCT03176277|157698109|FG003|Part A Dose Escalation Study|Adverse Event|0|||
48964493|NCT03176277|157698106|FG000|Part A Dose Escalation Study|Physician Decision|1|||
48660789|NCT04181788|156609548|FG004|FOLLOW-UP|Death|8|||
48660790|NCT04181788|156609549|FG005|FOLLOW-UP|Death|20|||
48660791|NCT04181788|156609544|FG000|FOLLOW-UP|Lost to Follow-up|0|||
48660792|NCT04181788|156609545|FG001|FOLLOW-UP|Lost to Follow-up|0|||
48660793|NCT04181788|156609546|FG002|FOLLOW-UP|Lost to Follow-up|0|||
48660794|NCT04181788|156609547|FG003|FOLLOW-UP|Lost to Follow-up|0|||
48660795|NCT04181788|156609548|FG004|FOLLOW-UP|Lost to Follow-up|0|||
48755432|NCT01348347|156951271|FG000|Overall Study|Withdrawal by Subject|1|||
48964494|NCT03176277|157698107|FG001|Part A Dose Escalation Study|Physician Decision|1|||
48964495|NCT03176277|157698108|FG002|Part A Dose Escalation Study|Physician Decision|2|||
48964496|NCT03176277|157698109|FG003|Part A Dose Escalation Study|Physician Decision|0|||
48964497|NCT03176277|157698106|FG000|Part A Dose Escalation Study|Withdrawal by Subject|5|||
48964498|NCT03176277|157698107|FG001|Part A Dose Escalation Study|Withdrawal by Subject|1|||
48660796|NCT04181788|156609549|FG005|FOLLOW-UP|Lost to Follow-up|2|||
48755433|NCT01348347|156951272|FG001|Overall Study|Withdrawal by Subject|1|||
48660797|NCT04181788|156609544|FG000|FOLLOW-UP|Withdrawal by Subject|0|||
48964499|NCT03176277|157698108|FG002|Part A Dose Escalation Study|Withdrawal by Subject|1|||
48964500|NCT03176277|157698109|FG003|Part A Dose Escalation Study|Withdrawal by Subject|0|||
48964501|NCT03176277|157698106|FG000|Part A Dose Escalation Study|Progressive disease|3|||
48660798|NCT04181788|156609545|FG001|FOLLOW-UP|Withdrawal by Subject|0|||
48660799|NCT04181788|156609546|FG002|FOLLOW-UP|Withdrawal by Subject|0|||
48660800|NCT04181788|156609547|FG003|FOLLOW-UP|Withdrawal by Subject|0|||
48660801|NCT04181788|156609548|FG004|FOLLOW-UP|Withdrawal by Subject|1|||
48660802|NCT04181788|156609549|FG005|FOLLOW-UP|Withdrawal by Subject|0|||
48660803|NCT04181788|156609544|FG000|FOLLOW-UP|Other unspecified|0|||
48660804|NCT04181788|156609545|FG001|FOLLOW-UP|Other unspecified|1|||
48660805|NCT04181788|156609546|FG002|FOLLOW-UP|Other unspecified|0|||
48660806|NCT04181788|156609547|FG003|FOLLOW-UP|Other unspecified|0|||
48660807|NCT04181788|156609548|FG004|FOLLOW-UP|Other unspecified|0|||
48660808|NCT04181788|156609549|FG005|FOLLOW-UP|Other unspecified|3|||
48660809|NCT04181788|156609544|FG000|FOLLOW-UP|Ongoing|0|||
48660810|NCT04181788|156609545|FG001|FOLLOW-UP|Ongoing|0|||
48660811|NCT04181788|156609546|FG002|FOLLOW-UP|Ongoing|1|||
48660812|NCT04181788|156609547|FG003|FOLLOW-UP|Ongoing|3|||
48660813|NCT04181788|156609548|FG004|FOLLOW-UP|Ongoing|2|||
48660814|NCT04181788|156609549|FG005|FOLLOW-UP|Ongoing|2|||
48964502|NCT03176277|157698107|FG001|Part A Dose Escalation Study|Progressive disease|1|||
48964503|NCT03176277|157698108|FG002|Part A Dose Escalation Study|Progressive disease|3|||
48964504|NCT03176277|157698109|FG003|Part A Dose Escalation Study|Progressive disease|0|||
48964505|NCT05294211|157698112|FG000|Overall Study|Withdrawal by Subject|3|||
48964506|NCT05294211|157698112|FG000|Overall Study|Physician Decision|2|||
48964507|NCT05294211|157698112|FG000|Overall Study|Progressed to active labor|1|||
48964508|NCT05294211|157698112|FG000|Overall Study|Did not complete 5-minute monitoring session|15|||
48964509|NCT05294211|157698112|FG000|Overall Study|Did not have ≥ 1 minute of concurrent data|19|||
48964510|NCT00406783|157698113|FG000|Overall Study|Adverse Event|4|||
48964511|NCT00406783|157698114|FG001|Overall Study|Adverse Event|4|||
48964512|NCT00406783|157698113|FG000|Overall Study|Treatment Failure|2|||
48964513|NCT00406783|157698114|FG001|Overall Study|Treatment Failure|3|||
48964514|NCT00406783|157698113|FG000|Overall Study|Lost to Follow-up|3|||
48964515|NCT00406783|157698114|FG001|Overall Study|Lost to Follow-up|0|||
48964516|NCT00406783|157698113|FG000|Overall Study|Withdrawal by Subject|1|||
48964517|NCT00406783|157698114|FG001|Overall Study|Withdrawal by Subject|4|||
48964518|NCT00406783|157698113|FG000|Overall Study|Protocol Violation|4|||
48964519|NCT00406783|157698114|FG001|Overall Study|Protocol Violation|4|||
48964520|NCT00064350|157698115|FG000|Induction Treatment|Disease Progression|5|||
48964521|NCT00064350|157698116|FG001|Induction Treatment|Disease Progression|1|||
48964522|NCT00064350|157698117|FG002|Induction Treatment|Disease Progression|110|||
48964523|NCT00064350|157698115|FG000|Induction Treatment|Adverse Event|0|||
48964524|NCT00064350|157698116|FG001|Induction Treatment|Adverse Event|2|||
48964525|NCT00064350|157698117|FG002|Induction Treatment|Adverse Event|49|||
48964526|NCT00064350|157698115|FG000|Induction Treatment|Death|0|||
48964527|NCT00064350|157698116|FG001|Induction Treatment|Death|0|||
48964528|NCT00064350|157698117|FG002|Induction Treatment|Death|9|||
48964529|NCT00064350|157698115|FG000|Induction Treatment|Withdrawal by Subject|0|||
48964530|NCT00064350|157698116|FG001|Induction Treatment|Withdrawal by Subject|0|||
48964531|NCT00064350|157698117|FG002|Induction Treatment|Withdrawal by Subject|21|||
48964532|NCT00064350|157698115|FG000|Induction Treatment|Ineligible or never started treatment|3|||
48964533|NCT00064350|157698116|FG001|Induction Treatment|Ineligible or never started treatment|6|||
48964534|NCT00064350|157698117|FG002|Induction Treatment|Ineligible or never started treatment|34|||
48964535|NCT00064350|157698115|FG000|Induction Treatment|Other|0|||
48964536|NCT00064350|157698116|FG001|Induction Treatment|Other|0|||
48660815|NCT02456636|156611034|FG000|Overall Study|Death|0|||
48660816|NCT02456636|156611035|FG001|Overall Study|Death|3|||
48660817|NCT02456636|156611036|FG002|Overall Study|Death|0|||
48660818|NCT02456636|156611034|FG000|Overall Study|Pregnancy|1|||
48660819|NCT02456636|156611035|FG001|Overall Study|Pregnancy|3|||
48660820|NCT02456636|156611036|FG002|Overall Study|Pregnancy|5|||
48660821|NCT02456636|156611034|FG000|Overall Study|Physician Decision|4|||
48660822|NCT02456636|156611035|FG001|Overall Study|Physician Decision|5|||
48660823|NCT02456636|156611036|FG002|Overall Study|Physician Decision|4|||
48660824|NCT02456636|156611034|FG000|Overall Study|Withdrawal by Subject|13|||
48660825|NCT02456636|156611035|FG001|Overall Study|Withdrawal by Subject|14|||
48660826|NCT02456636|156611036|FG002|Overall Study|Withdrawal by Subject|16|||
48964537|NCT00064350|157698117|FG002|Induction Treatment|Other|13|||
48964538|NCT00064350|157698115|FG000|Randomization|Adverse Event|8|||
48660827|NCT02456636|156611034|FG000|Overall Study|Lost to Follow-up|50|||
48660828|NCT02456636|156611035|FG001|Overall Study|Lost to Follow-up|44|||
48964539|NCT00064350|157698116|FG001|Randomization|Adverse Event|3|||
48964540|NCT00064350|157698117|FG002|Randomization|Adverse Event|0|||
48964541|NCT00064350|157698115|FG000|Randomization|Death|3|||
48964542|NCT00064350|157698116|FG001|Randomization|Death|0|||
48964543|NCT00064350|157698117|FG002|Randomization|Death|0|||
48964544|NCT00064350|157698115|FG000|Randomization|Withdrawal by Subject|1|||
48660829|NCT02456636|156611036|FG002|Overall Study|Lost to Follow-up|50|||
48660830|NCT03555981|156611037|FG000|Overall Study|Lost to Follow-up|0|||
48964545|NCT00064350|157698116|FG001|Randomization|Withdrawal by Subject|0|||
48660831|NCT03555981|156611038|FG001|Overall Study|Lost to Follow-up|2|||
48660832|NCT00585546|156611044|FG000|Clenbuterol Treatment - up to 12 Months|Death|1|||
48660833|NCT00585546|156611044|FG000|Clenbuterol Treatment - up to 12 Months|Adverse Event|3|||
48660834|NCT01626118|156611045|FG000|Overall Study|Lack of Efficacy|1|||
48660835|NCT01626118|156611046|FG001|Overall Study|Lack of Efficacy|0|||
48660836|NCT01626118|156611047|FG002|Overall Study|Lack of Efficacy|1|||
48660837|NCT01626118|156611048|FG003|Overall Study|Lack of Efficacy|3|||
48660838|NCT01626118|156611045|FG000|Overall Study|Lost to Follow-up|1|||
48660839|NCT01626118|156611046|FG001|Overall Study|Lost to Follow-up|0|||
48660840|NCT01626118|156611047|FG002|Overall Study|Lost to Follow-up|0|||
48660841|NCT01626118|156611048|FG003|Overall Study|Lost to Follow-up|0|||
48660842|NCT01626118|156611045|FG000|Overall Study|Adverse Event|0|||
48660843|NCT01626118|156611046|FG001|Overall Study|Adverse Event|1|||
48660844|NCT01626118|156611047|FG002|Overall Study|Adverse Event|1|||
48660845|NCT01626118|156611048|FG003|Overall Study|Adverse Event|0|||
48660846|NCT01626118|156611045|FG000|Overall Study|Investigator Decision|0|||
48660847|NCT01626118|156611046|FG001|Overall Study|Investigator Decision|1|||
48660848|NCT01626118|156611047|FG002|Overall Study|Investigator Decision|0|||
48660849|NCT01626118|156611048|FG003|Overall Study|Investigator Decision|0|||
48660850|NCT03344549|156611055|FG000|Overall Study|Withdrawal by Subject|3|||
48660851|NCT03344549|156611056|FG001|Overall Study|Withdrawal by Subject|2|||
48660852|NCT03344549|156611055|FG000|Overall Study|Dialysis|2|||
48660853|NCT03344549|156611056|FG001|Overall Study|Dialysis|0|||
48660854|NCT03344549|156611055|FG000|Overall Study|Cancer|1|||
48660855|NCT03344549|156611056|FG001|Overall Study|Cancer|0|||
48660856|NCT03344549|156611055|FG000|Overall Study|Lack of electronic device|1|||
48660857|NCT03344549|156611056|FG001|Overall Study|Lack of electronic device|0|||
48964546|NCT00064350|157698117|FG002|Randomization|Withdrawal by Subject|0|||
48964547|NCT00064350|157698115|FG000|Randomization|Ineligible or never started treatment|9|||
48964548|NCT00064350|157698116|FG001|Randomization|Ineligible or never started treatment|15|||
48964549|NCT00064350|157698117|FG002|Randomization|Ineligible or never started treatment|0|||
48660858|NCT03344549|156611055|FG000|Overall Study|Transportation difficulty|0|||
48964550|NCT00064350|157698115|FG000|Randomization|Other|5|||
48964551|NCT00064350|157698116|FG001|Randomization|Other|0|||
48964552|NCT00064350|157698117|FG002|Randomization|Other|0|||
48964553|NCT00064350|157698115|FG000|Cross-Over|Adverse Event|0|||
48964554|NCT00064350|157698116|FG001|Cross-Over|Adverse Event|1|||
48660859|NCT03344549|156611056|FG001|Overall Study|Transportation difficulty|13|||
48660860|NCT04686084|156611057|FG000|Overall Study|Lost to Follow-up|1|||
48660861|NCT04065841|156611058|FG000|Overall Study|Adverse Event|4|||
48660862|NCT04065841|156611059|FG001|Overall Study|Adverse Event|2|||
48660863|NCT04065841|156611060|FG002|Overall Study|Adverse Event|10|||
48660864|NCT04065841|156611061|FG003|Overall Study|Adverse Event|1|||
48964555|NCT00064350|157698117|FG002|Cross-Over|Adverse Event|0|||
48964556|NCT00064350|157698115|FG000|Cross-Over|Death|1|||
48964557|NCT00064350|157698116|FG001|Cross-Over|Death|3|||
48964558|NCT00064350|157698117|FG002|Cross-Over|Death|0|||
48964559|NCT00064350|157698115|FG000|Cross-Over|Withdrawal by Subject|2|||
48964560|NCT00064350|157698116|FG001|Cross-Over|Withdrawal by Subject|2|||
48964561|NCT00064350|157698117|FG002|Cross-Over|Withdrawal by Subject|0|||
48964562|NCT00064350|157698115|FG000|Cross-Over|Ineligible or never started treatment|3|||
48964563|NCT00064350|157698116|FG001|Cross-Over|Ineligible or never started treatment|6|||
48964564|NCT00064350|157698117|FG002|Cross-Over|Ineligible or never started treatment|0|||
48964565|NCT00064350|157698115|FG000|Cross-Over|Other|0|||
48964566|NCT00064350|157698116|FG001|Cross-Over|Other|2|||
48964567|NCT00064350|157698117|FG002|Cross-Over|Other|0|||
48964568|NCT03334396|157698118|FG000|Overall Study|Adverse Event|1|||
48964569|NCT03334396|157698119|FG001|Overall Study|Adverse Event|0|||
48964570|NCT03334396|157698120|FG002|Overall Study|Adverse Event|1|||
48964571|NCT03334396|157698121|FG003|Overall Study|Adverse Event|0|||
48964572|NCT03334396|157698122|FG004|Overall Study|Adverse Event|0|||
48964573|NCT03334396|157698123|FG005|Overall Study|Adverse Event|0|||
48964574|NCT03334396|157698124|FG006|Overall Study|Adverse Event|0|||
48964575|NCT03334396|157698125|FG007|Overall Study|Adverse Event|0|||
48964576|NCT03334396|157698118|FG000|Overall Study|Lack of Efficacy|10|||
48964577|NCT03334396|157698119|FG001|Overall Study|Lack of Efficacy|4|||
48964578|NCT03334396|157698120|FG002|Overall Study|Lack of Efficacy|1|||
48964579|NCT03334396|157698121|FG003|Overall Study|Lack of Efficacy|3|||
48964580|NCT03334396|157698122|FG004|Overall Study|Lack of Efficacy|1|||
48964581|NCT03334396|157698123|FG005|Overall Study|Lack of Efficacy|0|||
48964582|NCT03334396|157698124|FG006|Overall Study|Lack of Efficacy|0|||
48964583|NCT03334396|157698125|FG007|Overall Study|Lack of Efficacy|1|||
48964584|NCT03334396|157698118|FG000|Overall Study|Lost to Follow-up|0|||
48964585|NCT03334396|157698119|FG001|Overall Study|Lost to Follow-up|0|||
48964586|NCT03334396|157698120|FG002|Overall Study|Lost to Follow-up|1|||
48660865|NCT04065841|156611058|FG000|Overall Study|Lost to Follow-up|1|||
48660866|NCT04065841|156611059|FG001|Overall Study|Lost to Follow-up|2|||
48660867|NCT04065841|156611060|FG002|Overall Study|Lost to Follow-up|2|||
48660868|NCT04065841|156611061|FG003|Overall Study|Lost to Follow-up|2|||
48964587|NCT03334396|157698121|FG003|Overall Study|Lost to Follow-up|0|||
48660869|NCT04065841|156611058|FG000|Overall Study|Physician Decision|1|||
48660870|NCT04065841|156611059|FG001|Overall Study|Physician Decision|0|||
48660871|NCT04065841|156611060|FG002|Overall Study|Physician Decision|0|||
48660872|NCT04065841|156611061|FG003|Overall Study|Physician Decision|0|||
48660873|NCT04065841|156611058|FG000|Overall Study|Protocol Violation|0|||
48660874|NCT04065841|156611059|FG001|Overall Study|Protocol Violation|1|||
48660875|NCT04065841|156611060|FG002|Overall Study|Protocol Violation|0|||
48660876|NCT04065841|156611061|FG003|Overall Study|Protocol Violation|0|||
48660877|NCT04065841|156611058|FG000|Overall Study|Study terminated by Sponsor|22|||
48660878|NCT04065841|156611059|FG001|Overall Study|Study terminated by Sponsor|16|||
48660879|NCT04065841|156611060|FG002|Overall Study|Study terminated by Sponsor|28|||
48660880|NCT04065841|156611061|FG003|Overall Study|Study terminated by Sponsor|17|||
48660881|NCT04065841|156611058|FG000|Overall Study|Withdrawal by Subject|1|||
48660882|NCT04065841|156611059|FG001|Overall Study|Withdrawal by Subject|1|||
48660883|NCT04065841|156611060|FG002|Overall Study|Withdrawal by Subject|2|||
48660884|NCT04065841|156611061|FG003|Overall Study|Withdrawal by Subject|0|||
48660885|NCT02210689|156611062|FG000|Overall Study|Withdrawal by Subject|7|||
48660886|NCT02210689|156611063|FG001|Overall Study|Withdrawal by Subject|4|||
48660887|NCT02210689|156611064|FG002|Overall Study|Withdrawal by Subject|2|||
48660888|NCT02210689|156611062|FG000|Overall Study|Adverse Event|0|||
48660889|NCT02210689|156611063|FG001|Overall Study|Adverse Event|1|||
48660890|NCT02210689|156611064|FG002|Overall Study|Adverse Event|0|||
48660891|NCT02210689|156611062|FG000|Overall Study|Protocol Violation|1|||
48660892|NCT02210689|156611063|FG001|Overall Study|Protocol Violation|0|||
48660893|NCT02210689|156611064|FG002|Overall Study|Protocol Violation|0|||
48660894|NCT02210689|156611062|FG000|Overall Study|Lost to Follow-up|11|||
48660895|NCT02210689|156611063|FG001|Overall Study|Lost to Follow-up|9|||
48660896|NCT02210689|156611064|FG002|Overall Study|Lost to Follow-up|5|||
48660897|NCT02210689|156611062|FG000|Overall Study|Pregnancy|0|||
48660898|NCT02210689|156611063|FG001|Overall Study|Pregnancy|1|||
48660899|NCT02210689|156611064|FG002|Overall Study|Pregnancy|0|||
48660900|NCT02210689|156611062|FG000|Overall Study|Lack of Efficacy|0|||
48660901|NCT02210689|156611063|FG001|Overall Study|Lack of Efficacy|1|||
48660902|NCT02210689|156611064|FG002|Overall Study|Lack of Efficacy|5|||
48660903|NCT02210689|156611062|FG000|Overall Study|Prohibited medication|2|||
48660904|NCT02210689|156611063|FG001|Overall Study|Prohibited medication|8|||
48660905|NCT02210689|156611064|FG002|Overall Study|Prohibited medication|1|||
48660906|NCT02210689|156611062|FG000|Overall Study|Negative Nugent score at baseline|6|||
48660907|NCT02210689|156611063|FG001|Overall Study|Negative Nugent score at baseline|2|||
48660908|NCT02210689|156611064|FG002|Overall Study|Negative Nugent score at baseline|2|||
48660909|NCT02210689|156611062|FG000|Overall Study|Other|25|||
48660910|NCT02210689|156611063|FG001|Overall Study|Other|21|||
48660911|NCT02210689|156611064|FG002|Overall Study|Other|8|||
48660912|NCT02365467|156611065|FG000|Overall Study|Death|3|||
48660913|NCT02186652|156611066|FG000|Overall Study|Lost to Follow-up|2|||
48660914|NCT02186652|156611067|FG001|Overall Study|Lost to Follow-up|0|||
48660915|NCT02928029|156611068|FG000|Overall Study|Withdrawal by Subject|0|||
48660916|NCT02928029|156611069|FG001|Overall Study|Withdrawal by Subject|1|||
48660917|NCT02928029|156611068|FG000|Overall Study|Radiological progression|1|||
48660918|NCT02928029|156611069|FG001|Overall Study|Radiological progression|0|||
48660919|NCT02928029|156611068|FG000|Overall Study|Clinical progression|1|||
48660920|NCT02928029|156611069|FG001|Overall Study|Clinical progression|2|||
48660921|NCT02928029|156611068|FG000|Overall Study|AE not related to clinical progression|1|||
48660922|NCT02928029|156611069|FG001|Overall Study|AE not related to clinical progression|1|||
48660923|NCT00613925|156611070|FG000|Overall Study|1 did not tolerate outpatient biopsy|0|||
48660924|NCT00613925|156611071|FG001|Overall Study|1 did not tolerate outpatient biopsy|1|||
48660925|NCT01467427|156611072|FG000|Overall Study|Withdrawal by Subject|1|||
48660926|NCT01467427|156611073|FG001|Overall Study|Withdrawal by Subject|0|||
48660927|NCT01467427|156611072|FG000|Overall Study|Not continuing in extension phase|0|||
48660928|NCT01467427|156611073|FG001|Overall Study|Not continuing in extension phase|2|||
48660929|NCT01467427|156611072|FG000|Overall Study|Withdrawal during extension phase,- Non-compliance|0|||
48660930|NCT01467427|156611073|FG001|Overall Study|Withdrawal during extension phase,- Non-compliance|1|||
48660931|NCT01467427|156611072|FG000|Overall Study|Withdrawal during extension phase, Withdrawal criteria|0|||
48660932|NCT01467427|156611073|FG001|Overall Study|Withdrawal during extension phase, Withdrawal criteria|2|||
48660933|NCT01467427|156611072|FG000|Overall Study|Withdrawal during extension phase, Withdrawal of consent|2|||
48660934|NCT01467427|156611073|FG001|Overall Study|Withdrawal during extension phase, Withdrawal of consent|1|||
48660935|NCT01467427|156611072|FG000|Overall Study|Withdrawal during extension phase, Other|3|||
48660936|NCT01467427|156611073|FG001|Overall Study|Withdrawal during extension phase, Other|3|||
48866484|NCT00116584|157347547|FG001|Overall Study|Withdrawal by Subject|0|||
48866485|NCT00116584|157347546|FG000|Overall Study|Protocol Violation|1|||
48866486|NCT00116584|157347547|FG001|Overall Study|Protocol Violation|1|||
48866487|NCT00809783|157347550|FG000|Overall Study|Death|1|||
48866488|NCT00809783|157347551|FG001|Overall Study|Death|0|||
48866489|NCT00809783|157347552|FG002|Overall Study|Death|0|||
48866490|NCT00809783|157347550|FG000|Overall Study|Adverse Event|34|||
48866491|NCT00809783|157347551|FG001|Overall Study|Adverse Event|52|||
48660937|NCT03881696|156611074|FG000|Overall Study|Adverse Event|2|||
48660938|NCT03881696|156611075|FG001|Overall Study|Adverse Event|0|||
48660939|NCT03881696|156611074|FG000|Overall Study|Withdrawal by Subject|2|||
48660940|NCT03881696|156611075|FG001|Overall Study|Withdrawal by Subject|0|||
48660941|NCT03881696|156611074|FG000|Overall Study|Subject withdrawal by parent or guardian|1|||
48660942|NCT03881696|156611075|FG001|Overall Study|Subject withdrawal by parent or guardian|0|||
48660943|NCT03881696|156611074|FG000|Overall Study|Failure to meet continuation criteria|1|||
48660944|NCT03881696|156611075|FG001|Overall Study|Failure to meet continuation criteria|0|||
48660945|NCT01818258|156611076|FG000|Overall Study|Death|3|||
48660946|NCT01818258|156611077|FG001|Overall Study|Death|0|||
48660947|NCT01818258|156611076|FG000|Overall Study|Withdrawal by Subject|0|||
48660948|NCT01818258|156611077|FG001|Overall Study|Withdrawal by Subject|1|||
48660949|NCT01818258|156611076|FG000|Overall Study|Lost to Follow-up|0|||
48660950|NCT01818258|156611077|FG001|Overall Study|Lost to Follow-up|1|||
48660951|NCT01818258|156611076|FG000|Overall Study|Unable to Travel to Clinic|0|||
48660952|NCT01818258|156611077|FG001|Overall Study|Unable to Travel to Clinic|1|||
48660953|NCT05299723|156611078|FG000|Overall Study|Withdrawal by Subject|0|||
48660954|NCT05299723|156611079|FG001|Overall Study|Withdrawal by Subject|2|||
48660955|NCT05299723|156611080|FG002|Overall Study|Withdrawal by Subject|0|||
48660956|NCT02606422|156611081|FG000|Phase 1: Immediate Follow up|Withdrawal by Subject|2|||
48660957|NCT02606422|156611082|FG001|Phase 1: Immediate Follow up|Withdrawal by Subject|0|||
48660958|NCT02606422|156611081|FG000|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|2|||
48660959|NCT02606422|156611082|FG001|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
48660960|NCT02606422|156611081|FG000|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
48660961|NCT02606422|156611082|FG001|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
48660962|NCT02606422|156611081|FG000|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
48660963|NCT02606422|156611082|FG001|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|1|||
48660964|NCT02891681|156611083|FG000|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
48660965|NCT02891681|156611084|FG001|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
48660966|NCT02891681|156611085|FG002|Overall Study|Did not complete all timepoints in Endocrine Cohort|1|||
48660967|NCT02891681|156611083|FG000|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2|||
48660968|NCT02891681|156611084|FG001|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
48660969|NCT02891681|156611085|FG002|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
48660970|NCT02891681|156611083|FG000|Overall Study|Taken off study after first imaging appointment|1|||
48660971|NCT02891681|156611084|FG001|Overall Study|Taken off study after first imaging appointment|0|||
48660972|NCT02891681|156611085|FG002|Overall Study|Taken off study after first imaging appointment|0|||
48660973|NCT02685748|156611090|FG000|Overall Study|Withdrawal by Subject|3|||
48660974|NCT02685748|156611091|FG001|Overall Study|Withdrawal by Subject|2|||
48660975|NCT03500172|156611092|FG000|Period 1: Baseline Randomization|Death|0|||
48660976|NCT03500172|156611093|FG001|Period 1: Baseline Randomization|Death|0|||
48660977|NCT03500172|156611094|FG002|Period 1: Baseline Randomization|Death|0|||
48660978|NCT03500172|156611095|FG003|Period 1: Baseline Randomization|Death|0|||
48660979|NCT03500172|156611096|FG004|Period 1: Baseline Randomization|Death|0|||
48660980|NCT03500172|156611097|FG005|Period 1: Baseline Randomization|Death|0|||
48660981|NCT03500172|156611098|FG006|Period 1: Baseline Randomization|Death|0|||
48660982|NCT03500172|156611099|FG007|Period 1: Baseline Randomization|Death|0|||
48660983|NCT03500172|156611100|FG008|Period 1: Baseline Randomization|Death|0|||
48660984|NCT03500172|156611101|FG009|Period 1: Baseline Randomization|Death|2|||
48660985|NCT03500172|156611102|FG010|Period 1: Baseline Randomization|Death|0|||
48660986|NCT03500172|156611092|FG000|Period 1: Baseline Randomization|Protocol Violation|0|||
48755434|NCT01348347|156951273|FG002|Overall Study|Withdrawal by Subject|1|||
48755435|NCT01348347|156951271|FG000|Overall Study|Progressive disease|2|||
48755436|NCT01348347|156951272|FG001|Overall Study|Progressive disease|5|||
48755437|NCT01348347|156951273|FG002|Overall Study|Progressive disease|5|||
48755438|NCT02763189|156951274|FG000|Overall Study|Device failure|0|||
48755439|NCT02763189|156951275|FG001|Overall Study|Device failure|2|||
48755440|NCT01018186|156951276|FG000|2-week Run-in Period|Protocol Violation|1|||
48755441|NCT01018186|156951277|FG001|2-week Run-in Period|Protocol Violation|0|||
48755442|NCT01018186|156951278|FG002|2-week Run-in Period|Protocol Violation|0|||
48755443|NCT01018186|156951279|FG003|2-week Run-in Period|Protocol Violation|0|||
48755444|NCT01018186|156951276|FG000|2-week Run-in Period|Lost to Follow-up|2|||
48755445|NCT01018186|156951277|FG001|2-week Run-in Period|Lost to Follow-up|0|||
48755446|NCT01018186|156951278|FG002|2-week Run-in Period|Lost to Follow-up|0|||
48755447|NCT01018186|156951279|FG003|2-week Run-in Period|Lost to Follow-up|0|||
48755448|NCT01018186|156951276|FG000|2-week Run-in Period|Physician Decision|3|||
48755449|NCT01018186|156951277|FG001|2-week Run-in Period|Physician Decision|0|||
48755450|NCT01018186|156951278|FG002|2-week Run-in Period|Physician Decision|0|||
48755451|NCT01018186|156951279|FG003|2-week Run-in Period|Physician Decision|0|||
48755452|NCT01018186|156951276|FG000|2-week Run-in Period|Withdrawal by Subject|11|||
48755453|NCT01018186|156951277|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
48866492|NCT00809783|157347552|FG002|Overall Study|Adverse Event|71|||
48866493|NCT00809783|157347550|FG000|Overall Study|Lack of Efficacy|39|||
48755454|NCT01018186|156951278|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
48755455|NCT01018186|156951279|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
48755456|NCT01018186|156951276|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|97|||
48755457|NCT01018186|156951277|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
48755458|NCT01018186|156951278|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
48755459|NCT01018186|156951279|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
48755460|NCT01018186|156951276|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
48755461|NCT01018186|156951277|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
48755462|NCT01018186|156951278|FG002|52-week Double-blind Treatment Period|Adverse Event|3|||
48755463|NCT01018186|156951279|FG003|52-week Double-blind Treatment Period|Adverse Event|6|||
48755464|NCT01018186|156951276|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
48755465|NCT01018186|156951277|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
48964588|NCT03334396|157698122|FG004|Overall Study|Lost to Follow-up|0|||
48964589|NCT03334396|157698123|FG005|Overall Study|Lost to Follow-up|0|||
48964590|NCT03334396|157698124|FG006|Overall Study|Lost to Follow-up|1|||
48964591|NCT03334396|157698125|FG007|Overall Study|Lost to Follow-up|0|||
48964592|NCT03334396|157698118|FG000|Overall Study|Physician Decision|1|||
48964593|NCT03334396|157698119|FG001|Overall Study|Physician Decision|0|||
48660987|NCT03500172|156611093|FG001|Period 1: Baseline Randomization|Protocol Violation|0|||
48660988|NCT03500172|156611094|FG002|Period 1: Baseline Randomization|Protocol Violation|0|||
48660989|NCT03500172|156611095|FG003|Period 1: Baseline Randomization|Protocol Violation|0|||
48660990|NCT03500172|156611096|FG004|Period 1: Baseline Randomization|Protocol Violation|0|||
48660991|NCT03500172|156611097|FG005|Period 1: Baseline Randomization|Protocol Violation|0|||
48660992|NCT03500172|156611098|FG006|Period 1: Baseline Randomization|Protocol Violation|0|||
48660993|NCT03500172|156611099|FG007|Period 1: Baseline Randomization|Protocol Violation|0|||
48660994|NCT03500172|156611100|FG008|Period 1: Baseline Randomization|Protocol Violation|0|||
48660995|NCT03500172|156611101|FG009|Period 1: Baseline Randomization|Protocol Violation|1|||
48660996|NCT03500172|156611102|FG010|Period 1: Baseline Randomization|Protocol Violation|0|||
48660997|NCT03500172|156611092|FG000|Period 2: Re-Randomization|Lost to Follow-up|8|||
48660998|NCT03500172|156611093|FG001|Period 2: Re-Randomization|Lost to Follow-up|6|||
48660999|NCT03500172|156611094|FG002|Period 2: Re-Randomization|Lost to Follow-up|87|||
48661000|NCT03500172|156611095|FG003|Period 2: Re-Randomization|Lost to Follow-up|68|||
48661001|NCT03500172|156611096|FG004|Period 2: Re-Randomization|Lost to Follow-up|4|||
48661002|NCT03500172|156611097|FG005|Period 2: Re-Randomization|Lost to Follow-up|6|||
48661003|NCT03500172|156611098|FG006|Period 2: Re-Randomization|Lost to Follow-up|63|||
48661004|NCT03500172|156611099|FG007|Period 2: Re-Randomization|Lost to Follow-up|74|||
48661005|NCT03500172|156611100|FG008|Period 2: Re-Randomization|Lost to Follow-up|0|||
48661006|NCT03500172|156611101|FG009|Period 2: Re-Randomization|Lost to Follow-up|0|||
48661007|NCT03500172|156611102|FG010|Period 2: Re-Randomization|Lost to Follow-up|0|||
48661008|NCT03500172|156611092|FG000|Period 2: Re-Randomization|Death|0|||
48661009|NCT03500172|156611093|FG001|Period 2: Re-Randomization|Death|0|||
48661010|NCT03500172|156611094|FG002|Period 2: Re-Randomization|Death|0|||
48661011|NCT03500172|156611095|FG003|Period 2: Re-Randomization|Death|4|||
48661012|NCT03500172|156611096|FG004|Period 2: Re-Randomization|Death|2|||
48661013|NCT03500172|156611097|FG005|Period 2: Re-Randomization|Death|0|||
48661014|NCT03500172|156611098|FG006|Period 2: Re-Randomization|Death|5|||
48661015|NCT03500172|156611099|FG007|Period 2: Re-Randomization|Death|2|||
48661016|NCT03500172|156611100|FG008|Period 2: Re-Randomization|Death|0|||
48661017|NCT03500172|156611101|FG009|Period 2: Re-Randomization|Death|0|||
48661018|NCT03500172|156611102|FG010|Period 2: Re-Randomization|Death|0|||
48661019|NCT03549871|156611103|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|0|||
48661020|NCT03549871|156611104|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|2|||
48661021|NCT03549871|156611103|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|1|||
48661022|NCT03549871|156611104|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|0|||
48661023|NCT03549871|156611103|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|1|||
48661024|NCT03549871|156611104|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|0|||
48661025|NCT03549871|156611103|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|4|||
48661026|NCT03549871|156611104|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|0|||
48661027|NCT03549871|156611103|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|1|||
48661028|NCT03549871|156611104|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|0|||
48661029|NCT03549871|156611103|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|0|||
48661030|NCT03549871|156611104|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|2|||
48661031|NCT03549871|156611103|FG000|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|1|||
48661032|NCT03549871|156611104|FG001|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|0|||
48755466|NCT01018186|156951278|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|4|||
48755467|NCT01018186|156951279|FG003|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
48755468|NCT01018186|156951276|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
48964594|NCT03334396|157698120|FG002|Overall Study|Physician Decision|0|||
48964595|NCT03334396|157698121|FG003|Overall Study|Physician Decision|0|||
48661033|NCT03549871|156611103|FG000|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|1|||
48661034|NCT03549871|156611104|FG001|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|0|||
48661035|NCT03549871|156611103|FG000|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|4|||
48661036|NCT03549871|156611104|FG001|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|5|||
48661037|NCT03549871|156611103|FG000|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|0|||
48661038|NCT03549871|156611104|FG001|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|2|||
48661039|NCT03549871|156611103|FG000|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|0|||
48661040|NCT03549871|156611104|FG001|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|2|||
48661041|NCT04439201|156611111|FG000|Overall Study|Ineligible|2|||
48661042|NCT04439201|156611111|FG000|Overall Study|Never start protocol therapy|1|||
48661043|NCT04439201|156611111|FG000|Overall Study|Ineligible and never start protocol therapy|1|||
48661044|NCT04439201|156611111|FG000|Overall Study|Mutation status not confirmed|4|||
48661045|NCT04439201|156611111|FG000|Overall Study|Adverse Event|1|||
48661046|NCT04439201|156611111|FG000|Overall Study|Death|7|||
48661047|NCT04439201|156611111|FG000|Overall Study|Withdrawal by Subject|2|||
48661048|NCT04439201|156611111|FG000|Overall Study|Disease progression|20|||
48661049|NCT04439201|156611111|FG000|Overall Study|Alternative therapy|1|||
48661050|NCT04439201|156611111|FG000|Overall Study|Physician Decision|1|||
48661051|NCT02118766|156611112|FG000|Overall Study|Adverse Event|7|||
48661052|NCT02118766|156611113|FG001|Overall Study|Adverse Event|2|||
48661053|NCT02118766|156611112|FG000|Overall Study|Withdrawal by Subject|3|||
48661054|NCT02118766|156611113|FG001|Overall Study|Withdrawal by Subject|6|||
48661055|NCT02118766|156611112|FG000|Overall Study|Lost to Follow-up|5|||
48661056|NCT02118766|156611113|FG001|Overall Study|Lost to Follow-up|4|||
48661057|NCT02118766|156611112|FG000|Overall Study|Withdrawal by parent/guardian|12|||
48661058|NCT02118766|156611113|FG001|Overall Study|Withdrawal by parent/guardian|18|||
48661059|NCT02118766|156611112|FG000|Overall Study|Other|3|||
48661060|NCT02118766|156611113|FG001|Overall Study|Other|1|||
48661061|NCT02403635|156611114|FG000|Overall Study|Not eligible|9|||
48661062|NCT02240368|156611117|FG000|Overall Study|Surgery lasted less then 20 minutes|1|||
48661063|NCT02240368|156611118|FG001|Overall Study|Surgery lasted less then 20 minutes|0|||
48661064|NCT02240368|156611119|FG002|Overall Study|Surgery lasted less then 20 minutes|0|||
48661065|NCT02240368|156611117|FG000|Overall Study|Entropy failed to detect more than 50%|0|||
48661066|NCT02240368|156611118|FG001|Overall Study|Entropy failed to detect more than 50%|0|||
48661067|NCT02240368|156611119|FG002|Overall Study|Entropy failed to detect more than 50%|1|||
48661068|NCT03946124|156611120|FG000|Overall Study|Withdrawal by Subject|19|||
48661069|NCT02334683|156611127|FG000|First 12 Week Period|Lost to Follow-up|1|||
48661070|NCT02334683|156611128|FG001|First 12 Week Period|Lost to Follow-up|0|||
48661071|NCT02334683|156611127|FG000|Second 12 Week Period|Adverse Event|0|||
48661072|NCT02334683|156611128|FG001|Second 12 Week Period|Adverse Event|1|||
48661073|NCT00871117|156611129|FG000|Overall Study|Lost to Follow-up|5|||
48661074|NCT00871117|156611130|FG001|Overall Study|Lost to Follow-up|6|||
48661075|NCT00871117|156611129|FG000|Overall Study|Other|0|||
48661076|NCT00871117|156611130|FG001|Overall Study|Other|4|||
48866494|NCT00809783|157347551|FG001|Overall Study|Lack of Efficacy|52|||
48661077|NCT01218100|156611131|FG000|Overall Study|Did not meet InclusionExclusion criteria|1|||
48661078|NCT01218100|156611132|FG001|Overall Study|Did not meet InclusionExclusion criteria|1|||
48661079|NCT01218100|156611133|FG002|Overall Study|Did not meet InclusionExclusion criteria|1|||
48661080|NCT01218100|156611134|FG003|Overall Study|Did not meet InclusionExclusion criteria|2|||
48661081|NCT01218100|156611131|FG000|Overall Study|Adverse Event|4|||
48661082|NCT01218100|156611132|FG001|Overall Study|Adverse Event|6|||
48866495|NCT00809783|157347552|FG002|Overall Study|Lack of Efficacy|63|||
48866496|NCT00809783|157347550|FG000|Overall Study|Lost to Follow-up|0|||
48866497|NCT00809783|157347551|FG001|Overall Study|Lost to Follow-up|3|||
48866498|NCT00809783|157347552|FG002|Overall Study|Lost to Follow-up|4|||
48866499|NCT00809783|157347550|FG000|Overall Study|Withdrawal by Subject|47|||
48866500|NCT00809783|157347551|FG001|Overall Study|Withdrawal by Subject|72|||
48866501|NCT00809783|157347552|FG002|Overall Study|Withdrawal by Subject|64|||
48866502|NCT00809783|157347550|FG000|Overall Study|Protocol Violation|2|||
48866503|NCT00809783|157347551|FG001|Overall Study|Protocol Violation|6|||
48866504|NCT00809783|157347552|FG002|Overall Study|Protocol Violation|5|||
48866505|NCT00809783|157347550|FG000|Overall Study|Randomized, but not treated|3|||
48866506|NCT00809783|157347551|FG001|Overall Study|Randomized, but not treated|0|||
48866507|NCT00809783|157347552|FG002|Overall Study|Randomized, but not treated|2|||
48866508|NCT00809783|157347550|FG000|Overall Study|Study Terminated by Sponsor|378|||
48866509|NCT00809783|157347551|FG001|Overall Study|Study Terminated by Sponsor|626|||
48866510|NCT00809783|157347552|FG002|Overall Study|Study Terminated by Sponsor|565|||
48866511|NCT00809783|157347550|FG000|Overall Study|Other|21|||
48866512|NCT00809783|157347551|FG001|Overall Study|Other|21|||
48866513|NCT00809783|157347552|FG002|Overall Study|Other|16|||
48866514|NCT00126555|157347553|FG000|Overall Study|Withdrawal by Subject|1|||
48866515|NCT00126555|157347553|FG000|Overall Study|Adverse Event|2|||
48866516|NCT00126555|157347553|FG000|Overall Study|Progressive Disease|3|||
48866517|NCT01838447|157347563|FG000|Overall Study|Change in surgical plan|1|||
48964596|NCT03334396|157698122|FG004|Overall Study|Physician Decision|0|||
48964597|NCT03334396|157698123|FG005|Overall Study|Physician Decision|0|||
48964598|NCT03334396|157698124|FG006|Overall Study|Physician Decision|0|||
48964599|NCT03334396|157698125|FG007|Overall Study|Physician Decision|0|||
48964600|NCT03334396|157698118|FG000|Overall Study|Withdrawal by Subject|10|||
48964601|NCT03334396|157698119|FG001|Overall Study|Withdrawal by Subject|5|||
48964602|NCT03334396|157698120|FG002|Overall Study|Withdrawal by Subject|7|||
48964603|NCT03334396|157698121|FG003|Overall Study|Withdrawal by Subject|2|||
48964604|NCT03334396|157698122|FG004|Overall Study|Withdrawal by Subject|2|||
48964605|NCT03334396|157698123|FG005|Overall Study|Withdrawal by Subject|1|||
48964606|NCT03334396|157698124|FG006|Overall Study|Withdrawal by Subject|2|||
48964607|NCT03334396|157698125|FG007|Overall Study|Withdrawal by Subject|0|||
48964608|NCT03334396|157698118|FG000|Overall Study|Pregnancy|0|||
48661083|NCT01218100|156611133|FG002|Overall Study|Adverse Event|6|||
48661084|NCT01218100|156611134|FG003|Overall Study|Adverse Event|7|||
48661085|NCT01218100|156611131|FG000|Overall Study|Lack of Efficacy|9|||
48661086|NCT01218100|156611132|FG001|Overall Study|Lack of Efficacy|6|||
48661087|NCT01218100|156611133|FG002|Overall Study|Lack of Efficacy|5|||
48661088|NCT01218100|156611134|FG003|Overall Study|Lack of Efficacy|12|||
48661089|NCT01218100|156611131|FG000|Overall Study|Protocol Violation|0|||
48661090|NCT01218100|156611132|FG001|Overall Study|Protocol Violation|0|||
48661091|NCT01218100|156611133|FG002|Overall Study|Protocol Violation|1|||
48661092|NCT01218100|156611134|FG003|Overall Study|Protocol Violation|1|||
48661093|NCT01218100|156611131|FG000|Overall Study|Withdrawal by Subject|5|||
48661094|NCT01218100|156611132|FG001|Overall Study|Withdrawal by Subject|2|||
48661095|NCT01218100|156611133|FG002|Overall Study|Withdrawal by Subject|6|||
48661096|NCT01218100|156611134|FG003|Overall Study|Withdrawal by Subject|7|||
48661097|NCT01218100|156611131|FG000|Overall Study|Lost to Follow-up|3|||
48661098|NCT01218100|156611132|FG001|Overall Study|Lost to Follow-up|8|||
48661099|NCT01218100|156611133|FG002|Overall Study|Lost to Follow-up|2|||
48661100|NCT01218100|156611134|FG003|Overall Study|Lost to Follow-up|1|||
48661101|NCT01218100|156611131|FG000|Overall Study|Other Reason|2|||
48661102|NCT01218100|156611132|FG001|Overall Study|Other Reason|2|||
48661103|NCT01218100|156611133|FG002|Overall Study|Other Reason|6|||
48661104|NCT01218100|156611134|FG003|Overall Study|Other Reason|4|||
48661105|NCT03730961|156611153|FG000|Overall Study|Adverse Event|0|||
48661106|NCT03730961|156611154|FG001|Overall Study|Adverse Event|1|||
48661107|NCT01767493|156611157|FG000|Overall Study|screen failures|3|||
48661108|NCT01457950|156611158|FG000|Double-Blind Phase|Continuation Criteria Not Met|1|||
48661109|NCT01457950|156611159|FG001|Double-Blind Phase|Continuation Criteria Not Met|0|||
48661110|NCT01457950|156611160|FG002|Double-Blind Phase|Continuation Criteria Not Met|0|||
48661111|NCT01457950|156611161|FG003|Double-Blind Phase|Continuation Criteria Not Met|0|||
48661112|NCT01457950|156611158|FG000|Double-Blind Phase|Protocol Violation|2|||
48661113|NCT01457950|156611159|FG001|Double-Blind Phase|Protocol Violation|1|||
48661114|NCT01457950|156611160|FG002|Double-Blind Phase|Protocol Violation|0|||
48661115|NCT01457950|156611161|FG003|Double-Blind Phase|Protocol Violation|0|||
48661116|NCT01457950|156611158|FG000|Double-Blind Phase|Withdrawal by Subject|6|||
48661117|NCT01457950|156611159|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
48661118|NCT01457950|156611160|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
48661119|NCT01457950|156611161|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
48661120|NCT01457950|156611158|FG000|Open-Label Phase|Adverse Event|0|||
48661121|NCT01457950|156611159|FG001|Open-Label Phase|Adverse Event|0|||
48661122|NCT01457950|156611160|FG002|Open-Label Phase|Adverse Event|0|||
48661123|NCT01457950|156611161|FG003|Open-Label Phase|Adverse Event|1|||
48661124|NCT01457950|156611158|FG000|Open-Label Phase|Protocol Violation|0|||
48661125|NCT01457950|156611159|FG001|Open-Label Phase|Protocol Violation|0|||
48661126|NCT01457950|156611160|FG002|Open-Label Phase|Protocol Violation|0|||
48661127|NCT01457950|156611161|FG003|Open-Label Phase|Protocol Violation|1|||
48661128|NCT01457950|156611158|FG000|Open-Label Phase|Withdrawal by Subject|0|||
48755469|NCT01018186|156951277|FG001|52-week Double-blind Treatment Period|Protocol Violation|8|||
48755470|NCT01018186|156951278|FG002|52-week Double-blind Treatment Period|Protocol Violation|8|||
48755471|NCT01018186|156951279|FG003|52-week Double-blind Treatment Period|Protocol Violation|2|||
48755472|NCT01018186|156951276|FG000|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
48755473|NCT01018186|156951277|FG001|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14|||
48755474|NCT01018186|156951278|FG002|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16|||
48755475|NCT01018186|156951279|FG003|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
48755476|NCT01018186|156951276|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
48755477|NCT01018186|156951277|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|1|||
48755478|NCT01018186|156951278|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|3|||
48755479|NCT01018186|156951279|FG003|52-week Double-blind Treatment Period|Lost to Follow-up|4|||
48755480|NCT01018186|156951276|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
48755481|NCT01018186|156951277|FG001|52-week Double-blind Treatment Period|Physician Decision|1|||
48755482|NCT01018186|156951278|FG002|52-week Double-blind Treatment Period|Physician Decision|0|||
48755483|NCT01018186|156951279|FG003|52-week Double-blind Treatment Period|Physician Decision|3|||
48964609|NCT03334396|157698119|FG001|Overall Study|Pregnancy|1|||
48964610|NCT03334396|157698120|FG002|Overall Study|Pregnancy|0|||
48964611|NCT03334396|157698121|FG003|Overall Study|Pregnancy|0|||
48964612|NCT03334396|157698122|FG004|Overall Study|Pregnancy|0|||
48964613|NCT03334396|157698123|FG005|Overall Study|Pregnancy|0|||
48661129|NCT01457950|156611159|FG001|Open-Label Phase|Withdrawal by Subject|0|||
48661130|NCT01457950|156611160|FG002|Open-Label Phase|Withdrawal by Subject|2|||
48661131|NCT01457950|156611161|FG003|Open-Label Phase|Withdrawal by Subject|0|||
48661132|NCT03593681|156611162|FG000|Overall Study|Inadequate sample collected|12|||
48661133|NCT03593681|156611162|FG000|Overall Study|Hysteroscope attempted but unable to find ostia|11|||
48661134|NCT03593681|156611162|FG000|Overall Study|Protocol Violation|3|||
48661135|NCT03593681|156611162|FG000|Overall Study|Withdrawal by Subject|3|||
48661136|NCT03593681|156611162|FG000|Overall Study|Procedure not attempted|3|||
48661137|NCT03593681|156611162|FG000|Overall Study|Adverse Event|2|||
48661138|NCT03593681|156611162|FG000|Overall Study|Physician Decision|1|||
48661139|NCT00717522|156611163|FG000|Overall Study|Disease Progression|5|||
48661140|NCT00717522|156611163|FG000|Overall Study|Adverse Event|1|||
48755484|NCT01018186|156951276|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
48755485|NCT01018186|156951277|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|10|||
48755486|NCT01018186|156951278|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|7|||
48755487|NCT01018186|156951279|FG003|52-week Double-blind Treatment Period|Withdrawal by Subject|9|||
48755488|NCT01414075|156951284|FG000|Overall Study|Adverse Event|1|||
48964614|NCT03334396|157698124|FG006|Overall Study|Pregnancy|0|||
48964615|NCT03334396|157698125|FG007|Overall Study|Pregnancy|0|||
48661141|NCT00717522|156611163|FG000|Overall Study|Death|1|||
48661142|NCT01166958|156611164|FG000|Overall Study|Withdrawal by Subject|1|||
48964616|NCT03334396|157698118|FG000|Overall Study|Ineligible|0|||
48964617|NCT03334396|157698119|FG001|Overall Study|Ineligible|1|||
48964618|NCT03334396|157698120|FG002|Overall Study|Ineligible|0|||
48964619|NCT03334396|157698121|FG003|Overall Study|Ineligible|0|||
48964620|NCT03334396|157698122|FG004|Overall Study|Ineligible|0|||
48964621|NCT03334396|157698123|FG005|Overall Study|Ineligible|0|||
48964622|NCT03334396|157698124|FG006|Overall Study|Ineligible|0|||
48661143|NCT01166958|156611165|FG001|Overall Study|Withdrawal by Subject|0|||
48661144|NCT02185014|156611170|FG000|Overall Study|Adverse Event|18|||
48661145|NCT02185014|156611170|FG000|Overall Study|Withdrew Consent|8|||
48661146|NCT02185014|156611170|FG000|Overall Study|Lost to Follow-up|4|||
48661147|NCT02185014|156611170|FG000|Overall Study|Lack of Efficacy|14|||
48661148|NCT02185014|156611170|FG000|Overall Study|Requires Alternative/Prohibited Therapy|5|||
48661149|NCT02185014|156611170|FG000|Overall Study|Subject Noncompliance|1|||
48661150|NCT02185014|156611170|FG000|Overall Study|Other|4|||
48661151|NCT01140568|156611175|FG000|Overall Study|disease progression|31|||
48661152|NCT01140568|156611175|FG000|Overall Study|Withdrawal by Subject|1|||
48661153|NCT01140568|156611175|FG000|Overall Study|Screen Fail|4|||
48661154|NCT03618628|156611176|FG000|Overall Study|Death|1|||
48661155|NCT03618628|156611176|FG000|Overall Study|Lost to Follow-up|1|||
48661156|NCT00493636|156611177|FG000|Overall Study|Withdrawal by Subject|1|||
48661157|NCT00493636|156611178|FG001|Overall Study|Withdrawal by Subject|0|||
48661158|NCT00493636|156611177|FG000|Overall Study|Disease progression/recurrence/relapse|0|||
48661159|NCT00493636|156611178|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
48661160|NCT00493636|156611177|FG000|Overall Study|Mis-randomization|1|||
48661161|NCT00493636|156611178|FG001|Overall Study|Mis-randomization|1|||
48661162|NCT01741532|156611179|FG000|Overall Study|Adverse Event|4|||
48661163|NCT01741532|156611180|FG001|Overall Study|Adverse Event|0|||
48964623|NCT03334396|157698125|FG007|Overall Study|Ineligible|0|||
48964624|NCT03334396|157698118|FG000|Overall Study|Started New Job|1|||
48964625|NCT03334396|157698119|FG001|Overall Study|Started New Job|0|||
48964626|NCT03334396|157698120|FG002|Overall Study|Started New Job|0|||
48964627|NCT03334396|157698121|FG003|Overall Study|Started New Job|0|||
48964628|NCT03334396|157698122|FG004|Overall Study|Started New Job|0|||
48964629|NCT03334396|157698123|FG005|Overall Study|Started New Job|0|||
48964630|NCT03334396|157698124|FG006|Overall Study|Started New Job|0|||
48661164|NCT01741532|156611179|FG000|Overall Study|Withdrawal by Subject|1|||
48661165|NCT01741532|156611180|FG001|Overall Study|Withdrawal by Subject|1|||
48661166|NCT01741532|156611179|FG000|Overall Study|Protocol Violation|0|||
48661167|NCT01741532|156611180|FG001|Overall Study|Protocol Violation|1|||
48661168|NCT01741532|156611179|FG000|Overall Study|Worsening of the disease|3|||
48964631|NCT03334396|157698125|FG007|Overall Study|Started New Job|0|||
48964632|NCT00353496|157698127|FG000|Overall Study|Adverse Event|1|||
48964633|NCT00353496|157698128|FG001|Overall Study|Adverse Event|0|||
48964634|NCT00353496|157698127|FG000|Overall Study|Protocol Violation|2|||
48964635|NCT00353496|157698128|FG001|Overall Study|Protocol Violation|2|||
48661169|NCT01741532|156611180|FG001|Overall Study|Worsening of the disease|1|||
48661170|NCT01741532|156611179|FG000|Overall Study|Sponsor decision|1|||
48661171|NCT01741532|156611180|FG001|Overall Study|Sponsor decision|0|||
48661172|NCT01741532|156611179|FG000|Overall Study|Medical event|1|||
48661173|NCT01741532|156611180|FG001|Overall Study|Medical event|0|||
48964636|NCT00353496|157698127|FG000|Overall Study|Withdrawal by Subject|3|||
48964637|NCT00353496|157698128|FG001|Overall Study|Withdrawal by Subject|4|||
48661174|NCT01453946|156611181|FG000|Overall Study|Did not receive drug for the taper phase|1|||
48661175|NCT01453946|156611181|FG000|Overall Study|Protocol Violation|2|||
48661176|NCT01453946|156611181|FG000|Overall Study|Lack of Efficacy|3|||
48661177|NCT01453946|156611181|FG000|Overall Study|Adverse Event|3|||
48661178|NCT03352453|156611182|FG000|Overall Study|Miscellaneous Reasons|1|||
48661179|NCT03352453|156611183|FG001|Overall Study|Miscellaneous Reasons|2|||
48661180|NCT03352453|156611182|FG000|Overall Study|Lack of Efficacy|1|||
48661181|NCT03352453|156611183|FG001|Overall Study|Lack of Efficacy|0|||
48661182|NCT03352453|156611182|FG000|Overall Study|Withdrawal by Subject|8|||
48661183|NCT03352453|156611183|FG001|Overall Study|Withdrawal by Subject|14|||
48661184|NCT03352453|156611182|FG000|Overall Study|Study Terminated by Sponsor|2|||
48661185|NCT03352453|156611183|FG001|Overall Study|Study Terminated by Sponsor|1|||
48964638|NCT00353496|157698127|FG000|Overall Study|Physician Decision|6|||
48964639|NCT00353496|157698128|FG001|Overall Study|Physician Decision|9|||
48964640|NCT00353496|157698127|FG000|Overall Study|Not otherwise specified|4|||
48964641|NCT00353496|157698128|FG001|Overall Study|Not otherwise specified|2|||
48964642|NCT01969799|157698129|FG000|Overall Study|Adverse Event|0|||
48661186|NCT03352453|156611182|FG000|Overall Study|Protocol Deviation|1|||
48661187|NCT03352453|156611183|FG001|Overall Study|Protocol Deviation|0|||
48661188|NCT03352453|156611182|FG000|Overall Study|Lost to Follow-up|7|||
48661189|NCT03352453|156611183|FG001|Overall Study|Lost to Follow-up|6|||
48964643|NCT01969799|157698130|FG001|Overall Study|Adverse Event|1|||
48964644|NCT01969799|157698129|FG000|Overall Study|Death|16|||
48964645|NCT01969799|157698130|FG001|Overall Study|Death|11|||
48964646|NCT01969799|157698129|FG000|Overall Study|Lost to Follow-up|0|||
48964647|NCT01969799|157698130|FG001|Overall Study|Lost to Follow-up|2|||
48964648|NCT01969799|157698129|FG000|Overall Study|Physician Decision|1|||
48964649|NCT01969799|157698130|FG001|Overall Study|Physician Decision|0|||
48964650|NCT02815293|157698133|FG000|Overall Study|Study termination by sponsor|10|||
48661190|NCT03352453|156611182|FG000|Overall Study|Adverse Event|2|||
48661191|NCT03352453|156611183|FG001|Overall Study|Adverse Event|9|||
48964651|NCT02815293|157698134|FG001|Overall Study|Study termination by sponsor|7|||
48964652|NCT02815293|157698135|FG002|Overall Study|Study termination by sponsor|0|||
48661192|NCT03158272|156611186|FG000|Overall Study|Disease progression|3|||
48661193|NCT03158272|156611187|FG001|Overall Study|Disease progression|3|||
48661194|NCT03158272|156611188|FG002|Overall Study|Disease progression|4|||
48661195|NCT03158272|156611189|FG003|Overall Study|Disease progression|6|||
48661196|NCT03158272|156611186|FG000|Overall Study|Death|0|||
48661197|NCT03158272|156611187|FG001|Overall Study|Death|0|||
48661198|NCT03158272|156611188|FG002|Overall Study|Death|1|||
48661199|NCT03158272|156611189|FG003|Overall Study|Death|0|||
48661200|NCT03158272|156611186|FG000|Overall Study|Other reasons|0|||
48661201|NCT03158272|156611187|FG001|Overall Study|Other reasons|0|||
48661202|NCT03158272|156611188|FG002|Overall Study|Other reasons|1|||
48661203|NCT03158272|156611189|FG003|Overall Study|Other reasons|0|||
48661204|NCT03158272|156611186|FG000|Overall Study|Adverse event unrelated to the drug|0|||
48661205|NCT03158272|156611187|FG001|Overall Study|Adverse event unrelated to the drug|1|||
48661206|NCT03158272|156611188|FG002|Overall Study|Adverse event unrelated to the drug|0|||
48661207|NCT03158272|156611189|FG003|Overall Study|Adverse event unrelated to the drug|0|||
48661208|NCT03089944|156611190|FG000|Overall Study|Lost to Follow-up|8|||
48661209|NCT03089944|156611190|FG000|Overall Study|Withdrew Consent|2|||
48661210|NCT03089944|156611190|FG000|Overall Study|Adverse Event|1|||
48661211|NCT03089944|156611190|FG000|Overall Study|Other|1|||
48661212|NCT04294225|156612417|FG000|Anastrozole 1 mg/Day|Discontinued due to COVID|1|||
48661213|NCT04294225|156612417|FG000|Anastrozole 1 mg/Day|Discontinued due to adverse events|3|||
48661214|NCT04294225|156612417|FG000|Anastrozole 1 mg/Day|Withdrawal by Subject|5|||
48661215|NCT04294225|156612417|FG000|Anastrozole 1 mg/Day|Ineligible|2|||
48661216|NCT04294225|156612417|FG000|Anastrozole 10 mg/Day|Withdrawal by Subject|1|||
48661217|NCT01691885|156612420|FG000|Treatment Period 1(7-14 Days)|Adverse Event|1|||
48661218|NCT01691885|156612421|FG001|Treatment Period 1(7-14 Days)|Adverse Event|1|||
48661219|NCT01691885|156612420|FG000|Washout Period (7-9 Days)|Adverse Event|0|||
48661220|NCT01691885|156612421|FG001|Washout Period (7-9 Days)|Adverse Event|1|||
48661221|NCT00590824|156612437|FG000|Overall Study|Disease could not be resected|0|||
48661222|NCT00590824|156612438|FG001|Overall Study|Disease could not be resected|2|||
48661223|NCT00590824|156612439|FG002|Overall Study|Disease could not be resected|1|||
48661224|NCT00590824|156612440|FG003|Overall Study|Disease could not be resected|0|||
48661225|NCT00590824|156612437|FG000|Overall Study|Adverse Event|0|||
48661226|NCT00590824|156612438|FG001|Overall Study|Adverse Event|0|||
48964653|NCT02815293|157698133|FG000|Overall Study|Participants not randomized|0|||
48964654|NCT02815293|157698134|FG001|Overall Study|Participants not randomized|0|||
48661227|NCT00590824|156612439|FG002|Overall Study|Adverse Event|0|||
48661228|NCT00590824|156612440|FG003|Overall Study|Adverse Event|1|||
48661229|NCT05048342|156612441|FG000|Overall Study|Adverse Event|1|||
48661230|NCT05048342|156612441|FG000|Overall Study|Subject decision|2|||
48661231|NCT01175356|156612442|FG000|Overall Study|Death|1|||
48661232|NCT01175356|156612442|FG000|Overall Study|Lack of Efficacy|12|||
48661233|NCT01175356|156612442|FG000|Overall Study|Lost to Follow-up|1|||
48661234|NCT01175356|156612442|FG000|Overall Study|Physician Decision|23|||
48964655|NCT02815293|157698135|FG002|Overall Study|Participants not randomized|18|||
48964656|NCT02815293|157698133|FG000|Overall Study|Adverse Event|0|||
48964657|NCT02815293|157698134|FG001|Overall Study|Adverse Event|1|||
48964658|NCT02815293|157698135|FG002|Overall Study|Adverse Event|0|||
48964659|NCT00012012|157698138|FG000|Overall Study|Protocol Violation|1|||
48964660|NCT00012012|157698139|FG001|Overall Study|Protocol Violation|1|||
48964661|NCT00012012|157698138|FG000|Overall Study|Withdrawal by Subject|0|||
48964662|NCT00012012|157698139|FG001|Overall Study|Withdrawal by Subject|2|||
48964663|NCT02159469|157698140|FG000|Overall Study|Missing Completion status|1|||
48964664|NCT02159469|157698140|FG000|Overall Study|Adverse Event|5|||
48964665|NCT02159469|157698140|FG000|Overall Study|Non-compliance|2|||
48661235|NCT01175356|156612442|FG000|Overall Study|Ineligible|1|||
48661236|NCT01175356|156612442|FG000|Overall Study|Treatment Slot Not Available|18|||
48661237|NCT01175356|156612442|FG000|Overall Study|Refusal by patient/parent/guardian|6|||
48661238|NCT01175356|156612442|FG000|Overall Study|Pts MIBG non-avid after enrollment|2|||
48661239|NCT01175356|156612442|FG000|Overall Study|On other COG study w/tumor tx intent|7|||
48661240|NCT01175356|156612442|FG000|Overall Study|Inadequate stem cell for transplant|1|||
48661241|NCT01175356|156612442|FG000|Overall Study|Initiation other tx prior to completion|9|||
48661242|NCT03020199|156612443|FG000|Treatment Period|Adverse Event|0|||
48661243|NCT03020199|156612444|FG001|Treatment Period|Adverse Event|2|||
48661244|NCT03020199|156612443|FG000|Treatment Period|Lack of Efficacy|1|||
48661245|NCT03020199|156612444|FG001|Treatment Period|Lack of Efficacy|6|||
48661246|NCT03020199|156612443|FG000|Treatment Period|Lost to Follow-up|1|||
48661247|NCT03020199|156612444|FG001|Treatment Period|Lost to Follow-up|6|||
48661248|NCT03020199|156612443|FG000|Treatment Period|Physician Decision|0|||
48661249|NCT03020199|156612444|FG001|Treatment Period|Physician Decision|1|||
48661250|NCT03020199|156612443|FG000|Treatment Period|Subject/guardian decision|8|||
48661251|NCT03020199|156612444|FG001|Treatment Period|Subject/guardian decision|15|||
48661252|NCT03020199|156612443|FG000|Treatment Period|Subjects not treated|3|||
48661253|NCT03020199|156612444|FG001|Treatment Period|Subjects not treated|4|||
48661254|NCT03020199|156612443|FG000|Follow-up Period|Disease relapse|32|||
48661255|NCT03020199|156612444|FG001|Follow-up Period|Disease relapse|7|||
48661256|NCT03020199|156612443|FG000|Follow-up Period|Lack of Efficacy|1|||
48661257|NCT03020199|156612444|FG001|Follow-up Period|Lack of Efficacy|2|||
48661258|NCT03020199|156612443|FG000|Follow-up Period|Lost to Follow-up|4|||
48661259|NCT03020199|156612444|FG001|Follow-up Period|Lost to Follow-up|6|||
48661260|NCT03020199|156612443|FG000|Follow-up Period|Physician Decision|2|||
48661261|NCT03020199|156612444|FG001|Follow-up Period|Physician Decision|2|||
48661262|NCT03020199|156612443|FG000|Follow-up Period|Protocol Violation|1|||
48661263|NCT03020199|156612444|FG001|Follow-up Period|Protocol Violation|2|||
48661264|NCT03020199|156612443|FG000|Follow-up Period|Study terminated by Sponsor|6|||
48661265|NCT03020199|156612444|FG001|Follow-up Period|Study terminated by Sponsor|3|||
48661266|NCT03020199|156612443|FG000|Follow-up Period|Subject/guardian decision|14|||
48661267|NCT03020199|156612444|FG001|Follow-up Period|Subject/guardian decision|9|||
48661268|NCT05234632|156612445|FG000|Overall Study|Participant Withdrawn: Non-Compliance|1|||
48661269|NCT05234632|156612446|FG001|Overall Study|Participant Withdrawn: Non-Compliance|0|||
48661270|NCT05234632|156612445|FG000|Overall Study|Withdrawal by Subject|2|||
48661271|NCT05234632|156612446|FG001|Overall Study|Withdrawal by Subject|0|||
48661272|NCT05234632|156612445|FG000|Overall Study|Adverse Event|0|||
48661273|NCT05234632|156612446|FG001|Overall Study|Adverse Event|4|||
48661274|NCT05234632|156612445|FG000|Overall Study|Physician Decision|1|||
48661275|NCT05234632|156612446|FG001|Overall Study|Physician Decision|1|||
48661276|NCT05234632|156612445|FG000|Overall Study|Participant tested positive for COVID-19 and is in isolation|0|||
48661277|NCT05234632|156612446|FG001|Overall Study|Participant tested positive for COVID-19 and is in isolation|1|||
48661278|NCT05234632|156612445|FG000|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|1|||
48661279|NCT05234632|156612446|FG001|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|0|||
48661280|NCT01778049|156612447|FG000|Open Label Treatment Period|Adverse Event|5|||
48661281|NCT01778049|156612448|FG001|Open Label Treatment Period|Adverse Event|15|||
48755489|NCT01414075|156951285|FG001|Overall Study|Adverse Event|0|||
48755490|NCT01414075|156951286|FG002|Overall Study|Adverse Event|1|||
48755491|NCT01414075|156951287|FG003|Overall Study|Adverse Event|0|||
48755492|NCT01414075|156951284|FG000|Overall Study|Death|1|||
48755493|NCT01414075|156951285|FG001|Overall Study|Death|0|||
48755494|NCT01414075|156951286|FG002|Overall Study|Death|0|||
48755495|NCT01414075|156951287|FG003|Overall Study|Death|1|||
48755496|NCT01414075|156951284|FG000|Overall Study|Withdrawal by Subject|0|||
48755497|NCT01414075|156951285|FG001|Overall Study|Withdrawal by Subject|0|||
48755498|NCT01414075|156951286|FG002|Overall Study|Withdrawal by Subject|0|||
48755499|NCT01414075|156951287|FG003|Overall Study|Withdrawal by Subject|1|||
48755500|NCT01414075|156951284|FG000|Overall Study|Other than specified|1|||
48755501|NCT01414075|156951285|FG001|Overall Study|Other than specified|0|||
48755502|NCT01414075|156951286|FG002|Overall Study|Other than specified|1|||
48755503|NCT01414075|156951287|FG003|Overall Study|Other than specified|0|||
48755504|NCT03235154|156951290|FG000|Overall Study|Withdrawal by Subject|1|||
48755505|NCT03235154|156951290|FG000|Overall Study|Adverse Event|1|||
48964666|NCT02159469|157698140|FG000|Overall Study|Withdrawal by Subject|9|||
48964667|NCT02159469|157698140|FG000|Overall Study|Lost to Follow-up|1|||
48964668|NCT02159469|157698140|FG000|Overall Study|Sponsor's request|2|||
48964669|NCT02159469|157698140|FG000|Overall Study|Met Stopping Criteria|3|||
48964670|NCT02159469|157698140|FG000|Overall Study|Other|1|||
48964671|NCT02159469|157698140|FG000|Overall Study|Multiple|29|||
48964672|NCT02927873|157698141|FG000|Overall Study|Lost to Follow-up|0|||
48964673|NCT02927873|157698142|FG001|Overall Study|Lost to Follow-up|1|||
48964674|NCT02927873|157698143|FG002|Overall Study|Lost to Follow-up|0|||
48964675|NCT02927873|157698144|FG003|Overall Study|Lost to Follow-up|0|||
48964676|NCT02927873|157698145|FG004|Overall Study|Lost to Follow-up|0|||
48964677|NCT02927873|157698146|FG005|Overall Study|Lost to Follow-up|0|||
48964678|NCT02927873|157698141|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
48964679|NCT02927873|157698142|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
48964680|NCT02927873|157698143|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
48964681|NCT02927873|157698144|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
48964682|NCT02927873|157698145|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
48964683|NCT02927873|157698146|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
48964684|NCT02927873|157698141|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48964685|NCT02927873|157698142|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48964686|NCT02927873|157698143|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48964687|NCT02927873|157698144|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48964688|NCT02927873|157698145|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48964689|NCT02927873|157698146|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
48964690|NCT02927873|157698141|FG000|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
48964691|NCT02927873|157698142|FG001|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1|||
48964692|NCT02927873|157698143|FG002|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
48964693|NCT02927873|157698144|FG003|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
48964694|NCT02927873|157698145|FG004|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
48964695|NCT02927873|157698146|FG005|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
48964696|NCT02927873|157698141|FG000|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1|||
48964697|NCT02927873|157698142|FG001|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
48964698|NCT02927873|157698143|FG002|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
48964699|NCT02927873|157698144|FG003|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
48964700|NCT02927873|157698145|FG004|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
48964701|NCT02927873|157698146|FG005|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
48964702|NCT02927873|157698141|FG000|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1|||
48964703|NCT02927873|157698142|FG001|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
48964704|NCT02927873|157698143|FG002|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
48964705|NCT02927873|157698144|FG003|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
48964706|NCT02927873|157698145|FG004|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
48964707|NCT02927873|157698146|FG005|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
48964708|NCT00115765|157698147|FG000|Overall Study|Withdrawal by Subject|22|||
48964709|NCT00115765|157698148|FG001|Overall Study|Withdrawal by Subject|53|||
48964710|NCT00115765|157698149|FG002|Overall Study|Withdrawal by Subject|76|||
48964711|NCT00115765|157698150|FG003|Overall Study|Withdrawal by Subject|15|||
48964712|NCT00115765|157698147|FG000|Overall Study|Physician Decision|4|||
48964713|NCT00115765|157698148|FG001|Overall Study|Physician Decision|15|||
48964714|NCT00115765|157698149|FG002|Overall Study|Physician Decision|18|||
48964715|NCT00115765|157698150|FG003|Overall Study|Physician Decision|13|||
48964716|NCT00115765|157698147|FG000|Overall Study|Lost to Follow-up|3|||
48964717|NCT00115765|157698148|FG001|Overall Study|Lost to Follow-up|20|||
48661282|NCT01778049|156612449|FG002|Open Label Treatment Period|Adverse Event|0|||
48964718|NCT00115765|157698149|FG002|Overall Study|Lost to Follow-up|18|||
48964719|NCT00115765|157698150|FG003|Overall Study|Lost to Follow-up|1|||
48964720|NCT00115765|157698147|FG000|Overall Study|Other|6|||
48964721|NCT00115765|157698148|FG001|Overall Study|Other|12|||
48964722|NCT00115765|157698149|FG002|Overall Study|Other|9|||
48964723|NCT00115765|157698150|FG003|Overall Study|Other|2|||
48964724|NCT03337139|157698153|FG000|Phase I|Withdrawal by Subject|10|||
48964725|NCT03337139|157698154|FG001|Phase I|Withdrawal by Subject|0|||
48661283|NCT01778049|156612450|FG003|Open Label Treatment Period|Adverse Event|0|||
48661284|NCT01778049|156612451|FG004|Open Label Treatment Period|Adverse Event|0|||
48661285|NCT01778049|156612452|FG005|Open Label Treatment Period|Adverse Event|0|||
48661286|NCT01778049|156612447|FG000|Open Label Treatment Period|Lack of Efficacy|1|||
48964726|NCT01518244|157698155|FG000|Overall Study|Adverse Event|3|||
48964727|NCT02227108|157698156|FG000|Overall Study|Did not receive treatment|2|||
48964728|NCT02227108|157698156|FG000|Overall Study|Other|3|||
48964729|NCT02227108|157698156|FG000|Overall Study|Progressive disease|17|||
48964730|NCT02227108|157698156|FG000|Overall Study|Initiation of alternative therapy|2|||
48964731|NCT02227108|157698156|FG000|Overall Study|Investigator discretion|1|||
48964732|NCT02227108|157698156|FG000|Overall Study|Adverse Event|6|||
48964733|NCT01928485|157698158|FG000|Overall Study|Physician Decision|0|||
48964734|NCT01928485|157698159|FG001|Overall Study|Physician Decision|1|||
48964735|NCT00675103|157698160|FG000|Overall Study|Lack of Efficacy|2|||
48964736|NCT00675103|157698160|FG000|Overall Study|Adverse Event|1|||
48964737|NCT01935336|157698161|FG000|Overall Study|Adverse Event|1|||
48964738|NCT01935336|157698162|FG001|Overall Study|Adverse Event|0|||
48964739|NCT01935336|157698163|FG002|Overall Study|Adverse Event|0|||
48964740|NCT01935336|157698164|FG003|Overall Study|Adverse Event|0|||
48964741|NCT01935336|157698161|FG000|Overall Study|Progressive disease|5|||
48964742|NCT01935336|157698162|FG001|Overall Study|Progressive disease|3|||
48964743|NCT01935336|157698163|FG002|Overall Study|Progressive disease|47|||
48964744|NCT01935336|157698164|FG003|Overall Study|Progressive disease|66|||
48964745|NCT00239837|157698165|FG000|Overall Study|Lost to Follow-up|3|||
48964746|NCT00239837|157698166|FG001|Overall Study|Lost to Follow-up|7|||
48964747|NCT00964158|157698167|FG000|Overall Study|Lost to Follow-up|0|||
48964748|NCT00964158|157698168|FG001|Overall Study|Lost to Follow-up|1|||
48964749|NCT00964158|157698169|FG002|Overall Study|Lost to Follow-up|2|||
48964750|NCT00964158|157698167|FG000|Overall Study|Withdrawal by Subject|0|||
48964751|NCT00964158|157698168|FG001|Overall Study|Withdrawal by Subject|0|||
48964752|NCT00964158|157698169|FG002|Overall Study|Withdrawal by Subject|6|||
48964753|NCT00843843|157700187|FG000|Overall Study|Physician Decision|1|||
48964754|NCT00843843|157700188|FG001|Overall Study|Physician Decision|1|||
48964755|NCT00843843|157700187|FG000|Overall Study|Protocol Violation|1|||
48964756|NCT00843843|157700188|FG001|Overall Study|Protocol Violation|1|||
48964757|NCT03712345|157700191|FG000|Overall Study|Failure to meet randomization criteria|0|||
48661287|NCT01778049|156612448|FG001|Open Label Treatment Period|Lack of Efficacy|1|||
48661288|NCT01778049|156612449|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
48661289|NCT01778049|156612450|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
48661290|NCT01778049|156612451|FG004|Open Label Treatment Period|Lack of Efficacy|0|||
48661291|NCT01778049|156612452|FG005|Open Label Treatment Period|Lack of Efficacy|0|||
48964758|NCT03712345|157700192|FG001|Overall Study|Failure to meet randomization criteria|0|||
48964759|NCT03712345|157700193|FG002|Overall Study|Failure to meet randomization criteria|1|||
48964760|NCT05254613|157700196|FG000|Overall Study|Lost to Follow-up|0|||
48964761|NCT05254613|157700197|FG001|Overall Study|Lost to Follow-up|0|||
48964762|NCT05254613|157700198|FG002|Overall Study|Lost to Follow-up|1|||
48964763|NCT02420223|157700199|FG000|Overall Study|Adverse Event|1|||
48964764|NCT02420223|157700200|FG001|Overall Study|Adverse Event|0|||
48964765|NCT02420223|157700199|FG000|Overall Study|Physician Decision|0|||
48964766|NCT02420223|157700200|FG001|Overall Study|Physician Decision|2|||
48964767|NCT01071096|157700201|FG000|First Intervention (90 Days)|Lost to Follow-up|1|||
48964768|NCT01071096|157700202|FG001|First Intervention (90 Days)|Lost to Follow-up|0|||
48964769|NCT00871377|157700204|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
48964770|NCT00871377|157700205|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
48964771|NCT00871377|157700206|FG002|First Intervention (10 Weeks)|Withdrawal by Subject|1|||
48964772|NCT00871377|157700207|FG003|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
48964773|NCT00871377|157700208|FG004|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
48661292|NCT01778049|156612447|FG000|Open Label Treatment Period|Protocol Violation|5|||
48661293|NCT01778049|156612448|FG001|Open Label Treatment Period|Protocol Violation|5|||
48661294|NCT01778049|156612449|FG002|Open Label Treatment Period|Protocol Violation|0|||
48661295|NCT01778049|156612450|FG003|Open Label Treatment Period|Protocol Violation|0|||
48661296|NCT01778049|156612451|FG004|Open Label Treatment Period|Protocol Violation|0|||
48661297|NCT01778049|156612452|FG005|Open Label Treatment Period|Protocol Violation|0|||
48661298|NCT01778049|156612447|FG000|Open Label Treatment Period|Lost to Follow-up|4|||
48661299|NCT01778049|156612448|FG001|Open Label Treatment Period|Lost to Follow-up|3|||
48661300|NCT01778049|156612449|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
48661301|NCT01778049|156612450|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
48661302|NCT01778049|156612451|FG004|Open Label Treatment Period|Lost to Follow-up|0|||
48661303|NCT01778049|156612452|FG005|Open Label Treatment Period|Lost to Follow-up|0|||
48661304|NCT01778049|156612447|FG000|Open Label Treatment Period|Withdrawal by Subject|4|||
48661305|NCT01778049|156612448|FG001|Open Label Treatment Period|Withdrawal by Subject|10|||
48661306|NCT01778049|156612449|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
48661307|NCT01778049|156612450|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
48661308|NCT01778049|156612451|FG004|Open Label Treatment Period|Withdrawal by Subject|0|||
48964774|NCT00871377|157700209|FG005|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
48964775|NCT00871377|157700204|FG000|First Intervention (10 Weeks)|Lost to Follow-up|0|||
48964776|NCT00871377|157700205|FG001|First Intervention (10 Weeks)|Lost to Follow-up|0|||
48964777|NCT00871377|157700206|FG002|First Intervention (10 Weeks)|Lost to Follow-up|0|||
48964778|NCT00871377|157700207|FG003|First Intervention (10 Weeks)|Lost to Follow-up|0|||
48964779|NCT00871377|157700208|FG004|First Intervention (10 Weeks)|Lost to Follow-up|0|||
48964780|NCT00871377|157700209|FG005|First Intervention (10 Weeks)|Lost to Follow-up|1|||
48661309|NCT01778049|156612452|FG005|Open Label Treatment Period|Withdrawal by Subject|0|||
48661310|NCT01778049|156612447|FG000|Open Label Treatment Period|Not treated|2|||
48692743|NCT01339689|156724588|FG000|Overall Study|Lost to Follow-up|9|||
48661311|NCT01778049|156612448|FG001|Open Label Treatment Period|Not treated|1|||
48661312|NCT01778049|156612449|FG002|Open Label Treatment Period|Not treated|0|||
48661313|NCT01778049|156612450|FG003|Open Label Treatment Period|Not treated|0|||
48661314|NCT01778049|156612451|FG004|Open Label Treatment Period|Not treated|0|||
48661315|NCT01778049|156612452|FG005|Open Label Treatment Period|Not treated|0|||
48661316|NCT01778049|156612447|FG000|Open Label Treatment Period|Other reason not defined above|77|||
48661317|NCT01778049|156612448|FG001|Open Label Treatment Period|Other reason not defined above|94|||
48661318|NCT01778049|156612449|FG002|Open Label Treatment Period|Other reason not defined above|0|||
48661319|NCT01778049|156612450|FG003|Open Label Treatment Period|Other reason not defined above|0|||
48661320|NCT01778049|156612451|FG004|Open Label Treatment Period|Other reason not defined above|0|||
48661321|NCT01778049|156612452|FG005|Open Label Treatment Period|Other reason not defined above|0|||
48661322|NCT01778049|156612447|FG000|Double Blind Treatment Period|Adverse Event|0|||
48661323|NCT01778049|156612448|FG001|Double Blind Treatment Period|Adverse Event|0|||
48661324|NCT01778049|156612449|FG002|Double Blind Treatment Period|Adverse Event|4|||
48661325|NCT01778049|156612450|FG003|Double Blind Treatment Period|Adverse Event|5|||
48661326|NCT01778049|156612451|FG004|Double Blind Treatment Period|Adverse Event|3|||
48661327|NCT01778049|156612452|FG005|Double Blind Treatment Period|Adverse Event|2|||
48661328|NCT01778049|156612447|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
48661329|NCT01778049|156612448|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
48661330|NCT01778049|156612449|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
48661331|NCT01778049|156612450|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
48661332|NCT01778049|156612451|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
48661333|NCT01778049|156612452|FG005|Double Blind Treatment Period|Lack of Efficacy|1|||
48661334|NCT01778049|156612447|FG000|Double Blind Treatment Period|Protocol Violation|0|||
48661335|NCT01778049|156612448|FG001|Double Blind Treatment Period|Protocol Violation|0|||
48661336|NCT01778049|156612449|FG002|Double Blind Treatment Period|Protocol Violation|2|||
48661337|NCT01778049|156612450|FG003|Double Blind Treatment Period|Protocol Violation|0|||
48964781|NCT00871377|157700204|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
48964782|NCT00871377|157700205|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
48964783|NCT00871377|157700206|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
48964784|NCT00871377|157700207|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
48964785|NCT00871377|157700208|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
48964786|NCT00871377|157700209|FG005|Washout (6 Weeks)|Withdrawal by Subject|0|||
48964787|NCT00871377|157700204|FG000|Washout (6 Weeks)|Withdrawal by Subject|0|||
48964788|NCT00871377|157700205|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
48964789|NCT00871377|157700206|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
48964790|NCT00871377|157700207|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
48964791|NCT00871377|157700208|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
48964792|NCT00871377|157700209|FG005|Washout (6 Weeks)|Withdrawal by Subject|1|||
48964793|NCT00871377|157700204|FG000|Third Intervention (10 Weeks)|Death|0|||
48964794|NCT00871377|157700205|FG001|Third Intervention (10 Weeks)|Death|0|||
48964795|NCT00871377|157700206|FG002|Third Intervention (10 Weeks)|Death|0|||
48964796|NCT00871377|157700207|FG003|Third Intervention (10 Weeks)|Death|1|||
48964797|NCT00871377|157700208|FG004|Third Intervention (10 Weeks)|Death|0|||
48964798|NCT00871377|157700209|FG005|Third Intervention (10 Weeks)|Death|0|||
48964799|NCT01061736|157700212|FG000|Overall Study|Dose regimen not selected|0|||
48964800|NCT01061736|157700213|FG001|Overall Study|Dose regimen not selected|0|||
48964801|NCT01061736|157700214|FG002|Overall Study|Dose regimen not selected|0|||
48964802|NCT01061736|157700215|FG003|Overall Study|Dose regimen not selected|0|||
48964803|NCT01061736|157700216|FG004|Overall Study|Dose regimen not selected|0|||
48964804|NCT01061736|157700217|FG005|Overall Study|Dose regimen not selected|0|||
48964805|NCT01061736|157700218|FG006|Overall Study|Dose regimen not selected|79|||
48964806|NCT01061736|157700219|FG007|Overall Study|Dose regimen not selected|0|||
48964807|NCT01061736|157700220|FG008|Overall Study|Dose regimen not selected|0|||
48964808|NCT01061736|157700221|FG009|Overall Study|Dose regimen not selected|0|||
48964809|NCT01061736|157700212|FG000|Overall Study|Adverse Event|13|||
48964810|NCT01061736|157700213|FG001|Overall Study|Adverse Event|1|||
48661338|NCT01778049|156612451|FG004|Double Blind Treatment Period|Protocol Violation|0|||
48661339|NCT01778049|156612452|FG005|Double Blind Treatment Period|Protocol Violation|0|||
48661340|NCT01778049|156612447|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
48661341|NCT01778049|156612448|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
48661342|NCT01778049|156612449|FG002|Double Blind Treatment Period|Lost to Follow-up|4|||
48964811|NCT01061736|157700214|FG002|Overall Study|Adverse Event|3|||
48964812|NCT01061736|157700215|FG003|Overall Study|Adverse Event|2|||
48964813|NCT01061736|157700216|FG004|Overall Study|Adverse Event|4|||
48964814|NCT01061736|157700217|FG005|Overall Study|Adverse Event|1|||
48964815|NCT01061736|157700218|FG006|Overall Study|Adverse Event|4|||
48661343|NCT01778049|156612450|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
48661344|NCT01778049|156612451|FG004|Double Blind Treatment Period|Lost to Follow-up|5|||
48661345|NCT01778049|156612452|FG005|Double Blind Treatment Period|Lost to Follow-up|2|||
48692744|NCT01339689|156724589|FG001|Overall Study|Lost to Follow-up|3|||
48964816|NCT01061736|157700219|FG007|Overall Study|Adverse Event|63|||
48964817|NCT01061736|157700220|FG008|Overall Study|Adverse Event|67|||
48964818|NCT01061736|157700221|FG009|Overall Study|Adverse Event|34|||
48964819|NCT01061736|157700212|FG000|Overall Study|Lack of Efficacy|0|||
48964820|NCT01061736|157700213|FG001|Overall Study|Lack of Efficacy|2|||
48964821|NCT01061736|157700214|FG002|Overall Study|Lack of Efficacy|1|||
48964822|NCT01061736|157700215|FG003|Overall Study|Lack of Efficacy|1|||
48964823|NCT01061736|157700216|FG004|Overall Study|Lack of Efficacy|1|||
48964824|NCT01061736|157700217|FG005|Overall Study|Lack of Efficacy|2|||
48964825|NCT01061736|157700218|FG006|Overall Study|Lack of Efficacy|1|||
48964826|NCT01061736|157700219|FG007|Overall Study|Lack of Efficacy|9|||
48964827|NCT01061736|157700220|FG008|Overall Study|Lack of Efficacy|9|||
48964828|NCT01061736|157700221|FG009|Overall Study|Lack of Efficacy|10|||
48964829|NCT01061736|157700212|FG000|Overall Study|Poor compliance to protocol|0|||
48964830|NCT01061736|157700213|FG001|Overall Study|Poor compliance to protocol|0|||
48964831|NCT01061736|157700214|FG002|Overall Study|Poor compliance to protocol|0|||
48964832|NCT01061736|157700215|FG003|Overall Study|Poor compliance to protocol|0|||
48964833|NCT01061736|157700216|FG004|Overall Study|Poor compliance to protocol|0|||
48964834|NCT01061736|157700217|FG005|Overall Study|Poor compliance to protocol|0|||
48964835|NCT01061736|157700218|FG006|Overall Study|Poor compliance to protocol|0|||
48964836|NCT01061736|157700219|FG007|Overall Study|Poor compliance to protocol|2|||
48964837|NCT01061736|157700220|FG008|Overall Study|Poor compliance to protocol|5|||
48964838|NCT01061736|157700221|FG009|Overall Study|Poor compliance to protocol|9|||
48964839|NCT01061736|157700212|FG000|Overall Study|Not treated|0|||
48964840|NCT01061736|157700213|FG001|Overall Study|Not treated|0|||
48964841|NCT01061736|157700214|FG002|Overall Study|Not treated|0|||
48964842|NCT01061736|157700215|FG003|Overall Study|Not treated|0|||
48964843|NCT01061736|157700216|FG004|Overall Study|Not treated|1|||
48964844|NCT01061736|157700217|FG005|Overall Study|Not treated|0|||
48964845|NCT01061736|157700218|FG006|Overall Study|Not treated|0|||
48964846|NCT01061736|157700219|FG007|Overall Study|Not treated|2|||
48964847|NCT01061736|157700220|FG008|Overall Study|Not treated|1|||
48964848|NCT01061736|157700221|FG009|Overall Study|Not treated|0|||
48755506|NCT03235154|156951290|FG000|Overall Study|Lost to Follow-up|2|||
48755507|NCT01922089|156951291|FG000|Overall Study|Adverse Event|18|||
48755508|NCT01922089|156951292|FG001|Overall Study|Adverse Event|13|||
48755509|NCT01922089|156951291|FG000|Overall Study|Protocol Deviation|10|||
48755510|NCT01922089|156951292|FG001|Overall Study|Protocol Deviation|7|||
48755511|NCT01922089|156951291|FG000|Overall Study|Withdrawal by Subject|3|||
48755512|NCT01922089|156951292|FG001|Overall Study|Withdrawal by Subject|4|||
48755513|NCT01922089|156951291|FG000|Overall Study|administrative problems|4|||
48755514|NCT01922089|156951292|FG001|Overall Study|administrative problems|1|||
48755515|NCT01922089|156951291|FG000|Overall Study|Physician Decision|2|||
48755516|NCT01922089|156951292|FG001|Overall Study|Physician Decision|3|||
48755517|NCT01922089|156951291|FG000|Overall Study|Death|2|||
48755518|NCT01922089|156951292|FG001|Overall Study|Death|1|||
48755519|NCT01922089|156951291|FG000|Overall Study|Lost to Follow-up|0|||
48755520|NCT01922089|156951292|FG001|Overall Study|Lost to Follow-up|1|||
48755521|NCT04200456|156951293|FG000|Overall Study|Physician Decision|0|||
48755522|NCT04200456|156951294|FG001|Overall Study|Physician Decision|1|||
48755523|NCT04200456|156951293|FG000|Overall Study|Withdrawal by Subject|2|||
48755524|NCT04200456|156951294|FG001|Overall Study|Withdrawal by Subject|2|||
48755525|NCT04200456|156951293|FG000|Overall Study|Lack of Efficacy|1|||
48755526|NCT04200456|156951294|FG001|Overall Study|Lack of Efficacy|1|||
48964849|NCT01061736|157700212|FG000|Overall Study|Other than specified above|0|||
48964850|NCT01061736|157700213|FG001|Overall Study|Other than specified above|1|||
48964851|NCT01061736|157700214|FG002|Overall Study|Other than specified above|2|||
48964852|NCT01061736|157700215|FG003|Overall Study|Other than specified above|0|||
48964853|NCT01061736|157700216|FG004|Overall Study|Other than specified above|1|||
48964854|NCT01061736|157700217|FG005|Overall Study|Other than specified above|0|||
48964855|NCT01061736|157700218|FG006|Overall Study|Other than specified above|0|||
48661346|NCT01778049|156612447|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
48661347|NCT01778049|156612448|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
48661348|NCT01778049|156612449|FG002|Double Blind Treatment Period|Withdrawal by Subject|1|||
48661349|NCT01778049|156612450|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
48661350|NCT01778049|156612451|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
48661351|NCT01778049|156612452|FG005|Double Blind Treatment Period|Withdrawal by Subject|1|||
48661352|NCT01778049|156612447|FG000|Double Blind Treatment Period|Not treated|0|||
48661353|NCT01778049|156612448|FG001|Double Blind Treatment Period|Not treated|0|||
48755527|NCT04200456|156951293|FG000|Overall Study|Adverse event, non-fatal|0|||
48964856|NCT01061736|157700219|FG007|Overall Study|Other than specified above|18|||
48964857|NCT01061736|157700220|FG008|Overall Study|Other than specified above|15|||
48964858|NCT01061736|157700221|FG009|Overall Study|Other than specified above|21|||
48964859|NCT00980343|157700225|FG000|Overall Study|no tumor at surgery - treatment effect|1|||
49015446|NCT01393990|157893778|FG008|Overall Study|Adverse Event|0|||
48755528|NCT04200456|156951294|FG001|Overall Study|Adverse event, non-fatal|1|||
48755529|NCT04200456|156951293|FG000|Overall Study|Administration of Rescue and concern about IMP|0|||
48964860|NCT00980343|157700226|FG001|Overall Study|no tumor at surgery - treatment effect|3|||
48964861|NCT00718666|157700229|FG000|Booster Phase Year 5|No active participation request|0|||
48964862|NCT00718666|157700230|FG001|Booster Phase Year 5|No active participation request|0|||
48964863|NCT00718666|157700231|FG002|Booster Phase Year 5|No active participation request|1|||
48964864|NCT00718666|157700229|FG000|Booster Phase Year 5|Declined v-4 serology|1|||
48964865|NCT00718666|157700230|FG001|Booster Phase Year 5|Declined v-4 serology|0|||
48964866|NCT00718666|157700231|FG002|Booster Phase Year 5|Declined v-4 serology|0|||
48964867|NCT00718666|157700229|FG000|Booster Phase Year 5|Withdrawal by Subject|0|||
48964868|NCT00718666|157700230|FG001|Booster Phase Year 5|Withdrawal by Subject|0|||
48964869|NCT00718666|157700231|FG002|Booster Phase Year 5|Withdrawal by Subject|1|||
48964870|NCT00718666|157700229|FG000|Booster Phase Year 5|Lost to Follow-up|1|||
48964871|NCT00718666|157700230|FG001|Booster Phase Year 5|Lost to Follow-up|0|||
48964872|NCT00718666|157700231|FG002|Booster Phase Year 5|Lost to Follow-up|4|||
48964873|NCT03337152|157700232|FG000|Overall Study|Physician Decision|1|||
48964874|NCT03337152|157700233|FG001|Overall Study|Physician Decision|0|||
48964875|NCT03337152|157700232|FG000|Overall Study|Lost to Follow-up|1|||
48964876|NCT03337152|157700233|FG001|Overall Study|Lost to Follow-up|3|||
48964877|NCT03337152|157700232|FG000|Overall Study|Adverse Event|3|||
48964878|NCT03337152|157700233|FG001|Overall Study|Adverse Event|1|||
48964879|NCT03337152|157700232|FG000|Overall Study|Stopped drug dosing due to study halt|6|||
48964880|NCT03337152|157700233|FG001|Overall Study|Stopped drug dosing due to study halt|7|||
48964881|NCT03004469|157700236|FG000|Overall Study|Adverse Event|6|||
48964882|NCT03004469|157700237|FG001|Overall Study|Adverse Event|4|||
48964883|NCT03004469|157700238|FG002|Overall Study|Adverse Event|6|||
48964884|NCT03004469|157700236|FG000|Overall Study|Lack of Efficacy|1|||
48964885|NCT03004469|157700237|FG001|Overall Study|Lack of Efficacy|0|||
48964886|NCT03004469|157700238|FG002|Overall Study|Lack of Efficacy|1|||
48964887|NCT03004469|157700236|FG000|Overall Study|Lost to Follow-up|23|||
48661354|NCT01778049|156612449|FG002|Double Blind Treatment Period|Not treated|0|||
48661355|NCT01778049|156612450|FG003|Double Blind Treatment Period|Not treated|2|||
48661356|NCT01778049|156612451|FG004|Double Blind Treatment Period|Not treated|2|||
48661357|NCT01778049|156612452|FG005|Double Blind Treatment Period|Not treated|0|||
48661358|NCT01778049|156612447|FG000|Double Blind Treatment Period|Other reason not defined above|0|||
48661359|NCT01778049|156612448|FG001|Double Blind Treatment Period|Other reason not defined above|0|||
48661360|NCT01778049|156612449|FG002|Double Blind Treatment Period|Other reason not defined above|4|||
48661361|NCT01778049|156612450|FG003|Double Blind Treatment Period|Other reason not defined above|2|||
48661362|NCT01778049|156612451|FG004|Double Blind Treatment Period|Other reason not defined above|2|||
48866518|NCT01838447|157347564|FG001|Overall Study|Change in surgical plan|2|||
48866519|NCT01838447|157347563|FG000|Overall Study|Withdrawal by Subject|1|||
48661363|NCT01778049|156612452|FG005|Double Blind Treatment Period|Other reason not defined above|1|||
48661364|NCT00496197|156612453|FG000|Overall Study|Discontinued study due to death|43|||
48661365|NCT00496197|156612453|FG000|Overall Study|Adverse Event|13|||
48661366|NCT00496197|156612453|FG000|Overall Study|Does not meet entrance criteria|5|||
48661367|NCT00496197|156612453|FG000|Overall Study|Insufficient clinical response|3|||
48661368|NCT00496197|156612453|FG000|Overall Study|Insufficient bacteriological response|10|||
48661369|NCT00496197|156612453|FG000|Overall Study|Lost to Follow-up|11|||
48661370|NCT00496197|156612453|FG000|Overall Study|Withdrawal by Subject|11|||
48661371|NCT00496197|156612453|FG000|Overall Study|Pathogen not isolated baseline specimen|4|||
48661372|NCT00496197|156612453|FG000|Overall Study|Other|14|||
48661373|NCT00496197|156612453|FG000|Overall Study|Protocol Violation|8|||
48661374|NCT03773133|156612454|FG000|Overall Study|Screen Failure|8|||
48661375|NCT01344538|156612455|FG000|Overall Study|Adverse Event|1|||
48661376|NCT01344538|156612456|FG001|Overall Study|Adverse Event|1|||
48661377|NCT01344538|156612455|FG000|Overall Study|Lost to Follow-up|1|||
48661378|NCT01344538|156612456|FG001|Overall Study|Lost to Follow-up|0|||
48661379|NCT04564027|156612458|FG000|Overall Study|Ongoing treatment at Data cut off|0|||
48661380|NCT04564027|156612459|FG001|Overall Study|Ongoing treatment at Data cut off|3|||
48661381|NCT04564027|156612460|FG002|Overall Study|Ongoing treatment at Data cut off|0|||
48661382|NCT04564027|156612461|FG003|Overall Study|Ongoing treatment at Data cut off|0|||
48661383|NCT02509039|156612465|FG000|Overall Study|Adverse Event|0|||
48866520|NCT01838447|157347564|FG001|Overall Study|Withdrawal by Subject|1|||
48866521|NCT02490878|157347565|FG000|Overall Study|deemed ineligible|0|||
48866522|NCT02490878|157347566|FG001|Overall Study|deemed ineligible|1|||
48866523|NCT02490878|157347565|FG000|Overall Study|progression prior to treatment|0|||
48866524|NCT02490878|157347566|FG001|Overall Study|progression prior to treatment|1|||
48866525|NCT02490878|157347565|FG000|Overall Study|only submitted baseline QOL|0|||
48866526|NCT02490878|157347566|FG001|Overall Study|only submitted baseline QOL|1|||
48866527|NCT02544113|157347567|FG000|Overall Study|Death|3|||
48866528|NCT02544113|157347568|FG001|Overall Study|Death|4|||
48866529|NCT00168805|157347569|FG000|Overall Study|Adverse Event|7|||
48866530|NCT00168805|157347570|FG001|Overall Study|Adverse Event|11|||
48964888|NCT03004469|157700237|FG001|Overall Study|Lost to Follow-up|14|||
48964889|NCT03004469|157700238|FG002|Overall Study|Lost to Follow-up|6|||
48964890|NCT03004469|157700236|FG000|Overall Study|Non-Compliance with Study Drug|2|||
48964891|NCT03004469|157700237|FG001|Overall Study|Non-Compliance with Study Drug|0|||
48964892|NCT03004469|157700238|FG002|Overall Study|Non-Compliance with Study Drug|0|||
48964893|NCT03004469|157700236|FG000|Overall Study|Protocol Violation|0|||
48964894|NCT03004469|157700237|FG001|Overall Study|Protocol Violation|0|||
48964895|NCT03004469|157700238|FG002|Overall Study|Protocol Violation|1|||
48964896|NCT03004469|157700236|FG000|Overall Study|Withdrawal by Subject|29|||
48964897|NCT03004469|157700237|FG001|Overall Study|Withdrawal by Subject|27|||
48964898|NCT03004469|157700238|FG002|Overall Study|Withdrawal by Subject|10|||
48661384|NCT02509039|156612466|FG001|Overall Study|Adverse Event|1|||
48661385|NCT02509039|156612467|FG002|Overall Study|Adverse Event|1|||
48964899|NCT03004469|157700236|FG000|Overall Study|Other unspecified reason|0|||
48964900|NCT03004469|157700237|FG001|Overall Study|Other unspecified reason|4|||
48964901|NCT03004469|157700238|FG002|Overall Study|Other unspecified reason|1|||
48964902|NCT01954251|157700239|FG000|Overall Study|Adverse Event|5|||
48964903|NCT01954251|157700240|FG001|Overall Study|Adverse Event|7|||
48964904|NCT01954251|157700239|FG000|Overall Study|Lost to Follow-up|6|||
48964905|NCT01954251|157700240|FG001|Overall Study|Lost to Follow-up|6|||
48964906|NCT01954251|157700239|FG000|Overall Study|Withdrawal by Subject|2|||
48964907|NCT01954251|157700240|FG001|Overall Study|Withdrawal by Subject|6|||
48964908|NCT03654755|157700243|FG000|Overall Study|Early Termination of study due to COVID-19|42|||
48964909|NCT03654755|157700244|FG001|Overall Study|Early Termination of study due to COVID-19|33|||
48964910|NCT03654755|157700245|FG002|Overall Study|Early Termination of study due to COVID-19|56|||
48964911|NCT03654755|157700243|FG000|Overall Study|Withdrawal by Subject|2|||
48964912|NCT03654755|157700244|FG001|Overall Study|Withdrawal by Subject|4|||
48964913|NCT03654755|157700245|FG002|Overall Study|Withdrawal by Subject|8|||
48964914|NCT03654755|157700243|FG000|Overall Study|Lost to Follow-up|1|||
48964915|NCT03654755|157700244|FG001|Overall Study|Lost to Follow-up|3|||
48964916|NCT03654755|157700245|FG002|Overall Study|Lost to Follow-up|7|||
48964917|NCT03654755|157700243|FG000|Overall Study|Physician Decision|0|||
48964918|NCT03654755|157700244|FG001|Overall Study|Physician Decision|1|||
48964919|NCT03654755|157700245|FG002|Overall Study|Physician Decision|0|||
48964920|NCT03654755|157700243|FG000|Overall Study|Adverse Event|0|||
48964921|NCT03654755|157700244|FG001|Overall Study|Adverse Event|0|||
48964922|NCT03654755|157700245|FG002|Overall Study|Adverse Event|4|||
48964923|NCT03654755|157700243|FG000|Overall Study|Lack of Efficacy|0|||
48964924|NCT03654755|157700244|FG001|Overall Study|Lack of Efficacy|0|||
48964925|NCT03654755|157700245|FG002|Overall Study|Lack of Efficacy|1|||
48964926|NCT01429077|157700246|FG000|Overall Study|Lost to Follow-up|0|||
48964927|NCT01429077|157700247|FG001|Overall Study|Lost to Follow-up|3|||
48964928|NCT00976950|157700251|FG000|Overall Study|Adverse Event|3|||
48964929|NCT00976950|157700251|FG000|Overall Study|Events with no relationship to Aptivus|3|||
48964930|NCT00441103|157700254|FG000|Overall Study|Adverse Event|2|||
48964931|NCT00441103|157700255|FG001|Overall Study|Adverse Event|1|||
48964932|NCT00441103|157700254|FG000|Overall Study|Death|1|||
48964933|NCT00441103|157700255|FG001|Overall Study|Death|0|||
48964934|NCT00441103|157700254|FG000|Overall Study|Disease Progression|2|||
48964935|NCT00441103|157700255|FG001|Overall Study|Disease Progression|0|||
48964936|NCT00441103|157700254|FG000|Overall Study|Lost to Follow-up|1|||
48964937|NCT00441103|157700255|FG001|Overall Study|Lost to Follow-up|0|||
48964938|NCT00441103|157700254|FG000|Overall Study|Protocol Violation|1|||
48964939|NCT00441103|157700255|FG001|Overall Study|Protocol Violation|0|||
48964940|NCT00441103|157700254|FG000|Overall Study|Participant unable to use Rebiject II|1|||
48964941|NCT00441103|157700255|FG001|Overall Study|Participant unable to use Rebiject II|0|||
48964942|NCT00441103|157700254|FG000|Overall Study|Participant refused MRI|1|||
48964943|NCT00441103|157700255|FG001|Overall Study|Participant refused MRI|0|||
48964944|NCT00441103|157700254|FG000|Overall Study|Inclusion criteria absent|1|||
48964945|NCT00441103|157700255|FG001|Overall Study|Inclusion criteria absent|0|||
48964946|NCT00441103|157700254|FG000|Overall Study|Non-compliant|0|||
48964947|NCT00441103|157700255|FG001|Overall Study|Non-compliant|1|||
48964948|NCT00441103|157700254|FG000|Overall Study|Participant decided to withdraw|1|||
48964949|NCT00441103|157700255|FG001|Overall Study|Participant decided to withdraw|0|||
48964950|NCT00441103|157700254|FG000|Overall Study|Participant's reason|0|||
48661386|NCT02509039|156612468|FG003|Overall Study|Adverse Event|1|||
48661387|NCT02509039|156612465|FG000|Overall Study|Withdrawal by Subject|0|||
48964951|NCT00441103|157700255|FG001|Overall Study|Participant's reason|1|||
48964952|NCT00441103|157700254|FG000|Overall Study|Participant decided to stop|0|||
48964953|NCT00441103|157700255|FG001|Overall Study|Participant decided to stop|1|||
48964954|NCT00838916|157700258|FG000|Treatment Period (156 Weeks)|Adverse Event|50|||
48964955|NCT00838916|157700259|FG001|Treatment Period (156 Weeks)|Adverse Event|11|||
48964956|NCT00838916|157700258|FG000|Treatment Period (156 Weeks)|Protocol Violation|12|||
48964957|NCT00838916|157700259|FG001|Treatment Period (156 Weeks)|Protocol Violation|3|||
48661388|NCT02509039|156612466|FG001|Overall Study|Withdrawal by Subject|0|||
48964958|NCT00838916|157700258|FG000|Treatment Period (156 Weeks)|Noncompliance|21|||
48964959|NCT00838916|157700259|FG001|Treatment Period (156 Weeks)|Noncompliance|14|||
48964960|NCT00838916|157700258|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
48964961|NCT00838916|157700259|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
48964962|NCT00838916|157700258|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|19|||
48964963|NCT00838916|157700259|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|18|||
48964964|NCT00838916|157700258|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|81|||
48964965|NCT00838916|157700259|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|29|||
48964966|NCT00838916|157700258|FG000|Treatment Period (156 Weeks)|Physician Decision|6|||
48964967|NCT00838916|157700259|FG001|Treatment Period (156 Weeks)|Physician Decision|1|||
48964968|NCT00838916|157700258|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1|||
48964969|NCT00838916|157700259|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0|||
48964970|NCT00838916|157700258|FG000|Treatment Period (156 Weeks)|Missing|3|||
48964971|NCT00838916|157700259|FG001|Treatment Period (156 Weeks)|Missing|1|||
48964972|NCT00838916|157700258|FG000|Treatment Period (156 Weeks)|Pregnancy|2|||
48964973|NCT00838916|157700259|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
48964974|NCT00838916|157700258|FG000|Follow-up Period (8 Weeks)|Adverse Event|10|||
48964975|NCT00838916|157700259|FG001|Follow-up Period (8 Weeks)|Adverse Event|5|||
48964976|NCT00838916|157700258|FG000|Follow-up Period (8 Weeks)|Noncompliance|6|||
48964977|NCT00838916|157700259|FG001|Follow-up Period (8 Weeks)|Noncompliance|5|||
48964978|NCT00838916|157700258|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|38|||
48964979|NCT00838916|157700259|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
48964980|NCT00838916|157700258|FG000|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
48964981|NCT00838916|157700259|FG001|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
48964982|NCT00838916|157700258|FG000|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26|||
48964983|NCT00838916|157700259|FG001|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12|||
48964984|NCT00838916|157700258|FG000|Follow-up Period (8 Weeks)|Physician Decision|2|||
48964985|NCT00838916|157700259|FG001|Follow-up Period (8 Weeks)|Physician Decision|0|||
48964986|NCT00838916|157700258|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2|||
48964987|NCT00838916|157700259|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
48964988|NCT00838916|157700258|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
48964989|NCT00838916|157700259|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|0|||
48964990|NCT00838916|157700258|FG000|Follow-up Period (8 Weeks)|Missing|3|||
48964991|NCT00838916|157700259|FG001|Follow-up Period (8 Weeks)|Missing|0|||
48964992|NCT02034474|157700263|FG000|Overall Study|Adverse Event|3|||
48964993|NCT02034474|157700264|FG001|Overall Study|Adverse Event|2|||
48964994|NCT02034474|157700263|FG000|Overall Study|Withdrawal by Subject|1|||
48964995|NCT02034474|157700264|FG001|Overall Study|Withdrawal by Subject|2|||
48964996|NCT02947022|157700266|FG000|Overall Study|Study Stopped|1|||
48964997|NCT03543358|157700267|FG000|Overall Study|Death|1|||
48964998|NCT03543358|157700268|FG001|Overall Study|Death|0|||
48964999|NCT03543358|157700267|FG000|Overall Study|Disease Progression|1|||
48965000|NCT03543358|157700268|FG001|Overall Study|Disease Progression|0|||
48965001|NCT03543358|157700267|FG000|Overall Study|Parent Study Closure|1|||
48965002|NCT03543358|157700268|FG001|Overall Study|Parent Study Closure|0|||
48965003|NCT02559713|157700272|FG000|Overall Study|Pretreatment Event/ Adverse Event|1|||
48965004|NCT00178464|157700273|FG000|Overall Study|Withdrawal by Subject|1|||
48965005|NCT00178464|157700273|FG000|Overall Study|Physician Decision|1|||
48965006|NCT00870818|157700277|FG000|Overall Study|Lost to Follow-up|3|||
48965007|NCT00870818|157700278|FG001|Overall Study|Lost to Follow-up|2|||
48965008|NCT00870818|157700279|FG002|Overall Study|Lost to Follow-up|1|||
48965009|NCT00870818|157700280|FG003|Overall Study|Lost to Follow-up|0|||
48965010|NCT00870818|157700281|FG004|Overall Study|Lost to Follow-up|0|||
48965011|NCT00870818|157700277|FG000|Overall Study|Withdrawal by Subject|0|||
48965012|NCT00870818|157700278|FG001|Overall Study|Withdrawal by Subject|0|||
48965013|NCT00870818|157700279|FG002|Overall Study|Withdrawal by Subject|1|||
48965014|NCT00870818|157700280|FG003|Overall Study|Withdrawal by Subject|2|||
48965015|NCT00870818|157700281|FG004|Overall Study|Withdrawal by Subject|0|||
48965016|NCT00870818|157700277|FG000|Overall Study|Terminated by sponsor|29|||
48965017|NCT00870818|157700278|FG001|Overall Study|Terminated by sponsor|70|||
48965018|NCT00870818|157700279|FG002|Overall Study|Terminated by sponsor|36|||
48965019|NCT00870818|157700280|FG003|Overall Study|Terminated by sponsor|36|||
48965020|NCT00870818|157700281|FG004|Overall Study|Terminated by sponsor|38|||
48965021|NCT00870818|157700277|FG000|Overall Study|Other|0|||
48965022|NCT00870818|157700278|FG001|Overall Study|Other|1|||
48965023|NCT00870818|157700279|FG002|Overall Study|Other|0|||
48965024|NCT00870818|157700280|FG003|Overall Study|Other|0|||
48965025|NCT00870818|157700281|FG004|Overall Study|Other|0|||
48965026|NCT01766817|157700282|FG000|Overall Study|Drug-related adverse event|1|||
48965027|NCT01766817|157700283|FG001|Overall Study|Drug-related adverse event|2|||
48965028|NCT01766817|157700284|FG002|Overall Study|Drug-related adverse event|1|||
48965029|NCT01766817|157700282|FG000|Overall Study|Drug-unrelated adverse event|3|||
48965030|NCT01766817|157700283|FG001|Overall Study|Drug-unrelated adverse event|3|||
48965031|NCT01766817|157700284|FG002|Overall Study|Drug-unrelated adverse event|3|||
48965032|NCT01766817|157700282|FG000|Overall Study|Death|1|||
48965033|NCT01766817|157700283|FG001|Overall Study|Death|1|||
48965034|NCT01766817|157700284|FG002|Overall Study|Death|0|||
48965035|NCT01766817|157700282|FG000|Overall Study|Unable to take study drug|0|||
48965036|NCT01766817|157700283|FG001|Overall Study|Unable to take study drug|1|||
48965037|NCT01766817|157700284|FG002|Overall Study|Unable to take study drug|0|||
48965038|NCT01766817|157700282|FG000|Overall Study|Withdrawal by Subject|2|||
48965039|NCT01766817|157700283|FG001|Overall Study|Withdrawal by Subject|0|||
48965040|NCT01766817|157700284|FG002|Overall Study|Withdrawal by Subject|3|||
48965041|NCT01766817|157700282|FG000|Overall Study|Subject non-compliance|0|||
48965042|NCT01766817|157700283|FG001|Overall Study|Subject non-compliance|1|||
48965043|NCT01766817|157700284|FG002|Overall Study|Subject non-compliance|2|||
48965044|NCT01766817|157700282|FG000|Overall Study|Physician Decision|3|||
48965045|NCT01766817|157700283|FG001|Overall Study|Physician Decision|3|||
48965046|NCT01766817|157700284|FG002|Overall Study|Physician Decision|4|||
48965047|NCT01766817|157700282|FG000|Overall Study|Other|1|||
48965048|NCT01766817|157700283|FG001|Overall Study|Other|0|||
48965049|NCT01766817|157700284|FG002|Overall Study|Other|0|||
48965050|NCT04900038|157700285|FG000|Overall Study|Adverse Event|1|||
48965051|NCT04900038|157700286|FG001|Overall Study|Adverse Event|0|||
48965052|NCT04900038|157700287|FG002|Overall Study|Adverse Event|1|||
48965053|NCT04900038|157700288|FG003|Overall Study|Adverse Event|1|||
48965054|NCT04900038|157700285|FG000|Overall Study|Withdrawal by Subject|0|||
48965055|NCT04900038|157700286|FG001|Overall Study|Withdrawal by Subject|1|||
48965056|NCT04900038|157700287|FG002|Overall Study|Withdrawal by Subject|0|||
48965057|NCT04900038|157700288|FG003|Overall Study|Withdrawal by Subject|0|||
48965058|NCT04900038|157700285|FG000|Overall Study|Study terminated by sponsor|18|||
48965059|NCT04900038|157700286|FG001|Overall Study|Study terminated by sponsor|15|||
48965060|NCT04900038|157700287|FG002|Overall Study|Study terminated by sponsor|17|||
48965061|NCT04900038|157700288|FG003|Overall Study|Study terminated by sponsor|14|||
48965062|NCT04900038|157700285|FG000|Overall Study|Protocol Deviation|1|||
48965063|NCT04900038|157700286|FG001|Overall Study|Protocol Deviation|1|||
48965064|NCT04900038|157700287|FG002|Overall Study|Protocol Deviation|0|||
48965065|NCT04900038|157700288|FG003|Overall Study|Protocol Deviation|0|||
48965066|NCT04900038|157700285|FG000|Overall Study|Participant reached protocol-defined stoping criteria|0|||
48965067|NCT04900038|157700286|FG001|Overall Study|Participant reached protocol-defined stoping criteria|0|||
48965068|NCT04900038|157700287|FG002|Overall Study|Participant reached protocol-defined stoping criteria|2|||
48965069|NCT04900038|157700288|FG003|Overall Study|Participant reached protocol-defined stoping criteria|2|||
48965070|NCT04900038|157700285|FG000|Overall Study|Lost to Follow-up|0|||
48965071|NCT04900038|157700286|FG001|Overall Study|Lost to Follow-up|0|||
48965072|NCT04900038|157700287|FG002|Overall Study|Lost to Follow-up|0|||
48965073|NCT04900038|157700288|FG003|Overall Study|Lost to Follow-up|1|||
48965074|NCT00995670|157700289|FG000|Overall Study|Failed arterial cannulation|1|||
48965075|NCT00995670|157700290|FG001|Overall Study|Failed arterial cannulation|0|||
48965076|NCT00995670|157700291|FG002|Overall Study|Failed arterial cannulation|3|||
48965077|NCT02486952|157700294|FG000|Overall Study|Not Started Induction Therapy|3|||
48965078|NCT02486952|157700294|FG000|Overall Study|Adverse Event|1|||
48965079|NCT02486952|157700294|FG000|Overall Study|Death|15|||
48661389|NCT02509039|156612467|FG002|Overall Study|Withdrawal by Subject|1|||
48661390|NCT02509039|156612468|FG003|Overall Study|Withdrawal by Subject|0|||
48661391|NCT02509039|156612465|FG000|Overall Study|Progressive disease|2|||
48661392|NCT02509039|156612466|FG001|Overall Study|Progressive disease|2|||
48661393|NCT02509039|156612467|FG002|Overall Study|Progressive disease|1|||
48661394|NCT02509039|156612468|FG003|Overall Study|Progressive disease|5|||
48661395|NCT02509039|156612465|FG000|Overall Study|Study terminated by Sponsor|1|||
48965080|NCT02486952|157700294|FG000|Overall Study|Lack of Efficacy|3|||
48965081|NCT02486952|157700294|FG000|Overall Study|Lost to Follow-up|26|||
48661396|NCT02509039|156612466|FG001|Overall Study|Study terminated by Sponsor|0|||
48661397|NCT02509039|156612467|FG002|Overall Study|Study terminated by Sponsor|0|||
48661398|NCT02509039|156612468|FG003|Overall Study|Study terminated by Sponsor|0|||
48661399|NCT04979897|156612471|FG000|Overall Study|Death|1|||
48661400|NCT04979897|156612472|FG001|Overall Study|Death|8|||
48661401|NCT04979897|156612471|FG000|Overall Study|Lost to Follow-up|111|||
48661402|NCT04979897|156612472|FG001|Overall Study|Lost to Follow-up|56|||
48661403|NCT04979897|156612471|FG000|Overall Study|Withdrawal by Subject|7|||
48661404|NCT04979897|156612472|FG001|Overall Study|Withdrawal by Subject|2|||
48661405|NCT03943550|156612475|FG000|Overall Study|Adverse Event|0|||
48661406|NCT03943550|156612476|FG001|Overall Study|Adverse Event|0|||
48661407|NCT03943550|156612477|FG002|Overall Study|Adverse Event|1|||
48661408|NCT03943550|156612475|FG000|Overall Study|Lost to Follow-up|0|||
48661409|NCT03943550|156612476|FG001|Overall Study|Lost to Follow-up|0|||
48661410|NCT03943550|156612477|FG002|Overall Study|Lost to Follow-up|1|||
48661411|NCT03943550|156612475|FG000|Overall Study|Progressive Disease|0|||
48661412|NCT03943550|156612476|FG001|Overall Study|Progressive Disease|0|||
48965082|NCT02486952|157700294|FG000|Overall Study|Other|2|||
48965083|NCT04111107|157700295|FG000|Overall Study|Withdrawal by Subject|6|||
48965084|NCT04111107|157700295|FG000|Overall Study|Declining Health|5|||
48965085|NCT03589885|157700296|FG000|Treatment Period 1-Randomized Set|Adverse Event|0|||
48661413|NCT03943550|156612477|FG002|Overall Study|Progressive Disease|2|||
48965086|NCT03589885|157700297|FG001|Treatment Period 1-Randomized Set|Adverse Event|1|||
48661414|NCT03943550|156612475|FG000|Overall Study|Participant Moved Out of the Country|0|||
48661415|NCT03943550|156612476|FG001|Overall Study|Participant Moved Out of the Country|1|||
48965087|NCT03589885|157700298|FG002|Treatment Period 1-Randomized Set|Adverse Event|0|||
48661416|NCT03943550|156612477|FG002|Overall Study|Participant Moved Out of the Country|0|||
48661417|NCT03664674|156612482|FG000|Overall Study|Adverse Event|1|||
48661418|NCT03664674|156612483|FG001|Overall Study|Adverse Event|1|||
48661419|NCT03664674|156612482|FG000|Overall Study|Physician Decision|0|||
48661420|NCT03664674|156612483|FG001|Overall Study|Physician Decision|1|||
48661421|NCT03664674|156612482|FG000|Overall Study|Withdrawal by Subject|2|||
48661422|NCT03664674|156612483|FG001|Overall Study|Withdrawal by Subject|0|||
48755530|NCT04200456|156951294|FG001|Overall Study|Administration of Rescue and concern about IMP|1|||
48755531|NCT01867021|156951298|FG000|Overall Study|Adverse Event|0|||
48755532|NCT01867021|156951299|FG001|Overall Study|Adverse Event|1|||
48755533|NCT01867021|156951298|FG000|Overall Study|Not Eligible|0|||
48661423|NCT00592852|156612484|FG000|Overall Study|Non-compliance|1|||
48661424|NCT00592852|156612484|FG000|Overall Study|Adverse Event|3|||
48661425|NCT00592852|156612484|FG000|Overall Study|Found ineligible|1|||
48661426|NCT00592852|156612484|FG000|Overall Study|Withdrawal by Subject|1|||
48661427|NCT04422561|156612485|FG000|Overall Study|Lost to Follow-up|25|||
48661428|NCT04422561|156612486|FG001|Overall Study|Lost to Follow-up|11|||
48661429|NCT03834519|156612491|FG000|Overall Study|Lost to Follow-up|2|||
48661430|NCT03834519|156612492|FG001|Overall Study|Lost to Follow-up|1|||
48661431|NCT03834519|156612491|FG000|Overall Study|Withdrawal by Subject|5|||
48661432|NCT03834519|156612492|FG001|Overall Study|Withdrawal by Subject|8|||
48661433|NCT03834519|156612491|FG000|Overall Study|Death|368|||
48661434|NCT03834519|156612492|FG001|Overall Study|Death|174|||
48661435|NCT03834519|156612491|FG000|Overall Study|Physician Decision|5|||
48661436|NCT03834519|156612492|FG001|Overall Study|Physician Decision|1|||
48661437|NCT03834519|156612491|FG000|Overall Study|Sponsor decision|149|||
48661438|NCT03834519|156612492|FG001|Overall Study|Sponsor decision|80|||
48661439|NCT01071200|156612504|FG000|Overall Study|Lack of ovarian response|1|||
48661440|NCT01071200|156612505|FG001|Overall Study|Lack of ovarian response|1|||
48661441|NCT01071200|156612504|FG000|Overall Study|No fertilization|4|||
48661442|NCT01071200|156612505|FG001|Overall Study|No fertilization|0|||
48661443|NCT01071200|156612504|FG000|Overall Study|No oocytes retrieved|1|||
48965088|NCT03589885|157700299|FG003|Treatment Period 1-Randomized Set|Adverse Event|0|||
48965089|NCT03589885|157700300|FG004|Treatment Period 1-Randomized Set|Adverse Event|0|||
48965090|NCT03589885|157700296|FG000|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
48965091|NCT03589885|157700297|FG001|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
48965092|NCT03589885|157700298|FG002|Treatment Period 1-Randomized Set|Lack of Efficacy|2|||
48965093|NCT03589885|157700299|FG003|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
48965094|NCT03589885|157700300|FG004|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
48965095|NCT03589885|157700296|FG000|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
48965096|NCT03589885|157700297|FG001|Treatment Period 1-Randomized Set|Lost to Follow-up|1|||
48965097|NCT03589885|157700298|FG002|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
48965098|NCT03589885|157700299|FG003|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
48965099|NCT03589885|157700300|FG004|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
48965100|NCT03589885|157700296|FG000|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
48965101|NCT03589885|157700297|FG001|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
48965102|NCT03589885|157700298|FG002|Treatment Period 1-Randomized Set|Withdrawal by Subject|1|||
48965103|NCT03589885|157700299|FG003|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
48661444|NCT01071200|156612505|FG001|Overall Study|No oocytes retrieved|1|||
48661445|NCT01071200|156612504|FG000|Overall Study|Ovarian Hyper Stimulation Syndrome|1|||
48661446|NCT01071200|156612505|FG001|Overall Study|Ovarian Hyper Stimulation Syndrome|0|||
48661447|NCT01071200|156612504|FG000|Overall Study|No viable embryos|0|||
48661448|NCT01071200|156612505|FG001|Overall Study|No viable embryos|1|||
48661449|NCT01146652|156612506|FG000|Overall Study|Adverse Event|506|||
48661450|NCT01146652|156612507|FG001|Overall Study|Adverse Event|15|||
48661451|NCT01146652|156612506|FG000|Overall Study|Lack of Efficacy|91|||
48661452|NCT01146652|156612507|FG001|Overall Study|Lack of Efficacy|7|||
48661453|NCT01146652|156612506|FG000|Overall Study|Poor compliance to protocol|38|||
48661454|NCT01146652|156612507|FG001|Overall Study|Poor compliance to protocol|1|||
48661455|NCT01146652|156612506|FG000|Overall Study|Other unspecified reasons|314|||
48661456|NCT01146652|156612507|FG001|Overall Study|Other unspecified reasons|22|||
48661457|NCT01146652|156612506|FG000|Overall Study|Enrolled but not treated|2|||
48661458|NCT01146652|156612507|FG001|Overall Study|Enrolled but not treated|0|||
48661459|NCT03440918|156612513|FG000|Overall Study|Protocol Violation|0|||
48661460|NCT03440918|156612514|FG001|Overall Study|Protocol Violation|16|||
48661461|NCT02046226|156612515|FG000|Overall Study|Lost to Follow-up|7|||
48755534|NCT01867021|156951299|FG001|Overall Study|Not Eligible|1|||
48755535|NCT01867021|156951298|FG000|Overall Study|Death|1|||
48755536|NCT01867021|156951299|FG001|Overall Study|Death|0|||
48755537|NCT01867021|156951298|FG000|Overall Study|Lost to Follow-up|0|||
48755538|NCT01867021|156951299|FG001|Overall Study|Lost to Follow-up|2|||
48755539|NCT01867021|156951298|FG000|Overall Study|Withdrawal by Subject|1|||
48755540|NCT01867021|156951299|FG001|Overall Study|Withdrawal by Subject|6|||
48661462|NCT01390779|156612516|FG000|Overall Study|Physician Decision|1|||
48661463|NCT01665430|156612520|FG000|Overall Study|Adverse Event|1|||
48755541|NCT00619801|156951300|FG000|Overall Study|Lack of Efficacy|0|||
48755542|NCT00619801|156951301|FG001|Overall Study|Lack of Efficacy|1|||
48661464|NCT01665430|156612520|FG000|Overall Study|Withdrawal by Subject|6|||
48661465|NCT01665430|156612520|FG000|Overall Study|Other Unspecified|2|||
48661466|NCT00168103|156612521|FG000|Overall Study|Withdrawal by Subject|1|||
48661467|NCT00168103|156612522|FG001|Overall Study|Withdrawal by Subject|2|||
48661468|NCT00168103|156612523|FG002|Overall Study|Withdrawal by Subject|1|||
48866531|NCT00168805|157347571|FG002|Overall Study|Adverse Event|16|||
48661469|NCT00168103|156612524|FG003|Overall Study|Withdrawal by Subject|0|||
48661470|NCT00168103|156612521|FG000|Overall Study|Lost to Follow-up|1|||
48661471|NCT00168103|156612522|FG001|Overall Study|Lost to Follow-up|3|||
48661472|NCT00168103|156612523|FG002|Overall Study|Lost to Follow-up|0|||
48661473|NCT00168103|156612524|FG003|Overall Study|Lost to Follow-up|0|||
48661474|NCT02981407|156612529|FG000|Overall Study|Withdrawal by Subject|2|||
48661475|NCT02981407|156612530|FG001|Overall Study|Withdrawal by Subject|0|||
48661476|NCT00536874|156612533|FG000|Overall Study|Adverse Event|1|||
48661477|NCT00536874|156612533|FG000|Overall Study|Death|2|||
48661478|NCT00536874|156612533|FG000|Overall Study|Withdrawal by Subject|1|||
48661479|NCT00610441|156612534|FG000|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
48661480|NCT00610441|156612535|FG001|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
48661481|NCT00610441|156612536|FG002|Treatment Period 1 - 3 Weeks|Adverse Event|4|||
48661482|NCT00610441|156612537|FG003|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
48661483|NCT00610441|156612534|FG000|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
48661484|NCT00610441|156612535|FG001|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
48661485|NCT00610441|156612536|FG002|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1|||
48661486|NCT00610441|156612537|FG003|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
48661487|NCT00610441|156612534|FG000|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
48661488|NCT00610441|156612535|FG001|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
48661489|NCT00610441|156612536|FG002|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
48661490|NCT00610441|156612537|FG003|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0|||
48661491|NCT00610441|156612534|FG000|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
48661492|NCT00610441|156612535|FG001|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0|||
48661493|NCT00610441|156612536|FG002|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
48661494|NCT00610441|156612537|FG003|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
48661495|NCT00610441|156612534|FG000|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
48661496|NCT00610441|156612535|FG001|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
48866532|NCT00168805|157347569|FG000|Overall Study|Protocol Violation|12|||
48866533|NCT00168805|157347570|FG001|Overall Study|Protocol Violation|11|||
48866534|NCT00168805|157347571|FG002|Overall Study|Protocol Violation|8|||
48661497|NCT00610441|156612536|FG002|Placebo Washout Period - 2 Weeks|Adverse Event|2|||
48866535|NCT00168805|157347569|FG000|Overall Study|Lost to Follow-up|12|||
48866536|NCT00168805|157347570|FG001|Overall Study|Lost to Follow-up|17|||
48866537|NCT00168805|157347571|FG002|Overall Study|Lost to Follow-up|11|||
48866538|NCT00168805|157347569|FG000|Overall Study|Withdrawal by Subject|16|||
48965104|NCT03589885|157700300|FG004|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
48965105|NCT03589885|157700296|FG000|Treatment Period 2-Randomized Set|Adverse Event|0|||
48965106|NCT03589885|157700297|FG001|Treatment Period 2-Randomized Set|Adverse Event|1|||
48965107|NCT03589885|157700298|FG002|Treatment Period 2-Randomized Set|Adverse Event|0|||
48965108|NCT03589885|157700299|FG003|Treatment Period 2-Randomized Set|Adverse Event|0|||
48965109|NCT03589885|157700300|FG004|Treatment Period 2-Randomized Set|Adverse Event|0|||
48965110|NCT03589885|157700296|FG000|Treatment Period 2-Randomized Set|Pregnancy|1|||
48965111|NCT03589885|157700297|FG001|Treatment Period 2-Randomized Set|Pregnancy|0|||
48965112|NCT03589885|157700298|FG002|Treatment Period 2-Randomized Set|Pregnancy|0|||
48965113|NCT03589885|157700299|FG003|Treatment Period 2-Randomized Set|Pregnancy|0|||
48965114|NCT03589885|157700300|FG004|Treatment Period 2-Randomized Set|Pregnancy|0|||
48965115|NCT03589885|157700296|FG000|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
48965116|NCT03589885|157700297|FG001|Treatment Period 2-Randomized Set|Lost to Follow-up|3|||
48965117|NCT03589885|157700298|FG002|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
48965118|NCT03589885|157700299|FG003|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
48965119|NCT03589885|157700300|FG004|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
48965120|NCT03589885|157700296|FG000|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
48965121|NCT03589885|157700297|FG001|Treatment Period 2-Randomized Set|Withdrawal by Subject|1|||
48965122|NCT03589885|157700298|FG002|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
48661498|NCT00610441|156612537|FG003|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
48661499|NCT00610441|156612534|FG000|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
48965123|NCT03589885|157700299|FG003|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
49015447|NCT01393990|157893779|FG009|Overall Study|Adverse Event|0|||
48661500|NCT00610441|156612535|FG001|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1|||
48661501|NCT00610441|156612536|FG002|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
48661502|NCT00610441|156612537|FG003|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
48866539|NCT00168805|157347570|FG001|Overall Study|Withdrawal by Subject|18|||
48661503|NCT00610441|156612534|FG000|Treatment Period 2 - 3 Weeks|Other|1|||
48661504|NCT00610441|156612535|FG001|Treatment Period 2 - 3 Weeks|Other|1|||
48866540|NCT00168805|157347571|FG002|Overall Study|Withdrawal by Subject|21|||
48661505|NCT00610441|156612536|FG002|Treatment Period 2 - 3 Weeks|Other|0|||
48661506|NCT00610441|156612537|FG003|Treatment Period 2 - 3 Weeks|Other|1|||
48661507|NCT00610441|156612534|FG000|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
48661508|NCT00610441|156612535|FG001|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
48661509|NCT00610441|156612536|FG002|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
48661510|NCT00610441|156612537|FG003|Treatment Period 2 - 3 Weeks|Adverse Event|1|||
48661511|NCT00610441|156612534|FG000|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1|||
48661512|NCT00610441|156612535|FG001|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
48661513|NCT00610441|156612536|FG002|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
48661514|NCT00610441|156612537|FG003|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
48661515|NCT00787930|156612546|FG000|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3|||
48661516|NCT05985044|156614093|FG000|Overall Study|Death|6|||
48661517|NCT05985044|156614093|FG000|Overall Study|Lost to Follow-up|4|||
48661518|NCT05985044|156614093|FG000|Overall Study|Incapacitation|3|||
48661519|NCT05985044|156614093|FG000|Overall Study|Withdrawal by Subject|2|||
48661520|NCT00511433|156614094|FG000|Overall Study|Adverse Event|5|||
48661521|NCT00511433|156614095|FG001|Overall Study|Adverse Event|0|||
48661522|NCT00511433|156614094|FG000|Overall Study|Other Reason|1|||
48661523|NCT00511433|156614095|FG001|Overall Study|Other Reason|1|||
48661524|NCT02723006|156614096|FG000|Overall Study|Withdrawal by Subject|0|||
48661525|NCT02723006|156614097|FG001|Overall Study|Withdrawal by Subject|1|||
48661526|NCT02723006|156614098|FG002|Overall Study|Withdrawal by Subject|1|||
48661527|NCT02723006|156614096|FG000|Overall Study|Study Terminated by Sponsor|1|||
48661528|NCT02723006|156614097|FG001|Overall Study|Study Terminated by Sponsor|6|||
48661529|NCT02723006|156614098|FG002|Overall Study|Study Terminated by Sponsor|6|||
48661530|NCT00496483|156614099|FG000|Overall Study|Not dosed|9|||
48661531|NCT00496483|156614099|FG000|Overall Study|Adverse Event|2|||
48661532|NCT00496483|156614099|FG000|Overall Study|Lack of Efficacy|1|||
48661533|NCT01448824|156614100|FG000|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
48661534|NCT01448824|156614101|FG001|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
48661535|NCT01448824|156614102|FG002|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
48661536|NCT01448824|156614103|FG003|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
48661537|NCT01448824|156614104|FG004|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
48661538|NCT01448824|156614105|FG005|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
48661539|NCT01448824|156614106|FG006|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1|||
48661540|NCT01448824|156614107|FG007|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
48661541|NCT01448824|156614100|FG000|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
48661542|NCT01448824|156614101|FG001|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
48661543|NCT01448824|156614102|FG002|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
48661544|NCT01448824|156614103|FG003|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
48661545|NCT01448824|156614104|FG004|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2|||
48661546|NCT01448824|156614105|FG005|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
48661547|NCT01448824|156614106|FG006|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
48661548|NCT01448824|156614107|FG007|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
48661549|NCT01448824|156614100|FG000|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
48661550|NCT01448824|156614101|FG001|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
48661551|NCT01448824|156614102|FG002|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
48661552|NCT01448824|156614103|FG003|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
48661553|NCT01448824|156614104|FG004|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
48661554|NCT01448824|156614105|FG005|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1|||
48661555|NCT01448824|156614106|FG006|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
48661556|NCT01448824|156614107|FG007|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
48661557|NCT01448824|156614100|FG000|Part 1: Washout Period|Lost to Follow-up|1|||
48661558|NCT01448824|156614101|FG001|Part 1: Washout Period|Lost to Follow-up|0|||
48661559|NCT01448824|156614102|FG002|Part 1: Washout Period|Lost to Follow-up|0|||
48661560|NCT01448824|156614103|FG003|Part 1: Washout Period|Lost to Follow-up|0|||
48661561|NCT01448824|156614104|FG004|Part 1: Washout Period|Lost to Follow-up|0|||
48661562|NCT01448824|156614105|FG005|Part 1: Washout Period|Lost to Follow-up|0|||
48661563|NCT01448824|156614106|FG006|Part 1: Washout Period|Lost to Follow-up|0|||
48661564|NCT01448824|156614107|FG007|Part 1: Washout Period|Lost to Follow-up|0|||
48965124|NCT03589885|157700300|FG004|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
48661565|NCT01448824|156614100|FG000|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
48965125|NCT03600714|157700302|FG000|Overall Study|Out of country and could not return for post-treatment visits|1|||
48965126|NCT00383721|157700305|FG000|26-Week Double-Blind Treatment Period|Adverse Event|11|||
48965127|NCT00383721|157700306|FG001|26-Week Double-Blind Treatment Period|Adverse Event|5|||
48661566|NCT01448824|156614101|FG001|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
48661567|NCT01448824|156614102|FG002|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
48661568|NCT01448824|156614103|FG003|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
48755543|NCT00619801|156951300|FG000|Overall Study|Withdrawal by Subject|1|||
48661569|NCT01448824|156614104|FG004|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
48661570|NCT01448824|156614105|FG005|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
48661571|NCT01448824|156614106|FG006|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
48661572|NCT01448824|156614107|FG007|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1|||
48661573|NCT01448824|156614100|FG000|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
48661574|NCT01448824|156614101|FG001|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
48661575|NCT01448824|156614102|FG002|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
48661576|NCT01448824|156614103|FG003|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
48661577|NCT01448824|156614104|FG004|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
48661578|NCT01448824|156614105|FG005|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
48661579|NCT01448824|156614106|FG006|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
48661580|NCT01448824|156614107|FG007|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1|||
48661581|NCT01448824|156614100|FG000|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
48661582|NCT01448824|156614101|FG001|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
48661583|NCT01448824|156614102|FG002|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
48661584|NCT01448824|156614103|FG003|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
48661585|NCT01448824|156614104|FG004|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
48661586|NCT01448824|156614105|FG005|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
48661587|NCT01448824|156614106|FG006|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
48661588|NCT01448824|156614107|FG007|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1|||
48661589|NCT01448824|156614100|FG000|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
48661590|NCT01448824|156614101|FG001|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
48661591|NCT01448824|156614102|FG002|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
48661592|NCT01448824|156614103|FG003|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
48661593|NCT01448824|156614104|FG004|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
48661594|NCT01448824|156614105|FG005|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
48661595|NCT01448824|156614106|FG006|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
48661596|NCT01448824|156614107|FG007|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1|||
48661597|NCT04883645|156614108|FG000|Overall Study|Death|1|||
48661598|NCT03948763|156614109|FG000|Overall Study|Sponsor's decision|0|||
48661599|NCT03948763|156614110|FG001|Overall Study|Sponsor's decision|2|||
48661600|NCT03948763|156614111|FG002|Overall Study|Sponsor's decision|6|||
48661601|NCT03948763|156614112|FG003|Overall Study|Sponsor's decision|4|||
48661602|NCT03948763|156614113|FG004|Overall Study|Sponsor's decision|0|||
48661603|NCT03948763|156614109|FG000|Overall Study|Physician Decision|0|||
48661604|NCT03948763|156614110|FG001|Overall Study|Physician Decision|0|||
48661605|NCT03948763|156614111|FG002|Overall Study|Physician Decision|1|||
48661606|NCT03948763|156614112|FG003|Overall Study|Physician Decision|0|||
48661607|NCT03948763|156614113|FG004|Overall Study|Physician Decision|0|||
48661608|NCT03948763|156614109|FG000|Overall Study|Lost to Follow-up|0|||
48661609|NCT03948763|156614110|FG001|Overall Study|Lost to Follow-up|0|||
48661610|NCT03948763|156614111|FG002|Overall Study|Lost to Follow-up|0|||
48661611|NCT03948763|156614112|FG003|Overall Study|Lost to Follow-up|0|||
48661612|NCT03948763|156614113|FG004|Overall Study|Lost to Follow-up|1|||
48661613|NCT03948763|156614109|FG000|Overall Study|Death|2|||
48661614|NCT03948763|156614110|FG001|Overall Study|Death|12|||
48661615|NCT03948763|156614111|FG002|Overall Study|Death|13|||
48661616|NCT03948763|156614112|FG003|Overall Study|Death|10|||
48661617|NCT03948763|156614113|FG004|Overall Study|Death|11|||
48661618|NCT03948763|156614109|FG000|Overall Study|Withdrawal by Subject|1|||
48661619|NCT03948763|156614110|FG001|Overall Study|Withdrawal by Subject|1|||
48661620|NCT03948763|156614111|FG002|Overall Study|Withdrawal by Subject|0|||
48661621|NCT03948763|156614112|FG003|Overall Study|Withdrawal by Subject|2|||
48661622|NCT03948763|156614113|FG004|Overall Study|Withdrawal by Subject|4|||
48661623|NCT00789581|156614114|FG000|AC Therapy|Adverse Event|2|||
48661624|NCT00789581|156614115|FG001|AC Therapy|Adverse Event|3|||
48661625|NCT00789581|156614114|FG000|AC Therapy|Withdrawal by Subject|4|||
48661626|NCT00789581|156614115|FG001|AC Therapy|Withdrawal by Subject|7|||
48661627|NCT00789581|156614114|FG000|AC Therapy|Disease recurrence|3|||
48661628|NCT00789581|156614115|FG001|AC Therapy|Disease recurrence|1|||
48661629|NCT00789581|156614114|FG000|AC Therapy|Intercurrent Illness|1|||
48661630|NCT00789581|156614115|FG001|AC Therapy|Intercurrent Illness|0|||
48661631|NCT00789581|156614114|FG000|AC Therapy|Never Treated|1|||
48661632|NCT00789581|156614115|FG001|AC Therapy|Never Treated|4|||
48661633|NCT00789581|156614114|FG000|AC Therapy|Other|0|||
48661634|NCT00789581|156614115|FG001|AC Therapy|Other|2|||
48661635|NCT00789581|156614114|FG000|Adjuvant Therapy|Never treated|2|||
48661636|NCT00789581|156614115|FG001|Adjuvant Therapy|Never treated|2|||
48661637|NCT00789581|156614114|FG000|Adjuvant Therapy|Adverse Event|20|||
48661638|NCT00789581|156614115|FG001|Adjuvant Therapy|Adverse Event|44|||
48661639|NCT00789581|156614114|FG000|Adjuvant Therapy|Withdrawal by Subject|14|||
48661640|NCT00789581|156614115|FG001|Adjuvant Therapy|Withdrawal by Subject|5|||
48661641|NCT00789581|156614114|FG000|Adjuvant Therapy|Disease recurrence|2|||
48661642|NCT00789581|156614115|FG001|Adjuvant Therapy|Disease recurrence|1|||
48661643|NCT00789581|156614114|FG000|Adjuvant Therapy|Intercurrent Illness|1|||
48661644|NCT00789581|156614115|FG001|Adjuvant Therapy|Intercurrent Illness|3|||
48661645|NCT00789581|156614114|FG000|Adjuvant Therapy|Protocol Violation|1|||
48661646|NCT00789581|156614115|FG001|Adjuvant Therapy|Protocol Violation|1|||
48661647|NCT00789581|156614114|FG000|Adjuvant Therapy|Other|0|||
48661648|NCT00789581|156614115|FG001|Adjuvant Therapy|Other|1|||
48661649|NCT04229992|156614120|FG000|Overall Study|Withdrawal by Subject|0|||
48661650|NCT04229992|156614121|FG001|Overall Study|Withdrawal by Subject|2|||
48965128|NCT00383721|157700307|FG002|26-Week Double-Blind Treatment Period|Adverse Event|7|||
48661651|NCT04229992|156614122|FG002|Overall Study|Withdrawal by Subject|1|||
48661652|NCT04229992|156614123|FG003|Overall Study|Withdrawal by Subject|1|||
48661653|NCT04229992|156614120|FG000|Overall Study|Adverse Event|1|||
48661654|NCT04229992|156614121|FG001|Overall Study|Adverse Event|1|||
48661655|NCT04229992|156614122|FG002|Overall Study|Adverse Event|3|||
48661656|NCT04229992|156614123|FG003|Overall Study|Adverse Event|1|||
48661657|NCT04229992|156614120|FG000|Overall Study|Lost to Follow-up|0|||
48661658|NCT04229992|156614121|FG001|Overall Study|Lost to Follow-up|0|||
48661659|NCT04229992|156614122|FG002|Overall Study|Lost to Follow-up|0|||
48661660|NCT04229992|156614123|FG003|Overall Study|Lost to Follow-up|1|||
48661661|NCT04533347|156614130|FG000|Overall Study|Adverse Event|1|||
48661662|NCT04533347|156614131|FG001|Overall Study|Adverse Event|2|||
48661663|NCT04533347|156614130|FG000|Overall Study|Lost to Follow-up|2|||
48661664|NCT04533347|156614131|FG001|Overall Study|Lost to Follow-up|0|||
48661665|NCT04533347|156614130|FG000|Overall Study|Withdrawal by Subject|1|||
48661666|NCT04533347|156614131|FG001|Overall Study|Withdrawal by Subject|0|||
48661667|NCT01573442|156614137|FG000|Overall Study|Cancels|9|||
48661668|NCT01573442|156614138|FG001|Overall Study|Cancels|10|||
48661669|NCT04391894|156614141|FG000|Overall Study|Adverse Event|1|||
48661670|NCT04391894|156614142|FG001|Overall Study|Adverse Event|1|||
48661671|NCT04391894|156614143|FG002|Overall Study|Adverse Event|1|||
48661672|NCT04391894|156614144|FG003|Overall Study|Adverse Event|1|||
48661673|NCT04391894|156614145|FG004|Overall Study|Adverse Event|1|||
48661674|NCT04391894|156614141|FG000|Overall Study|Lost to Follow-up|1|||
48661675|NCT04391894|156614142|FG001|Overall Study|Lost to Follow-up|0|||
48661676|NCT04391894|156614143|FG002|Overall Study|Lost to Follow-up|0|||
48661677|NCT04391894|156614144|FG003|Overall Study|Lost to Follow-up|0|||
48661678|NCT04391894|156614145|FG004|Overall Study|Lost to Follow-up|0|||
48661679|NCT04391894|156614141|FG000|Overall Study|Protocol Violation|0|||
48661680|NCT04391894|156614142|FG001|Overall Study|Protocol Violation|0|||
48661681|NCT04391894|156614143|FG002|Overall Study|Protocol Violation|0|||
48661682|NCT04391894|156614144|FG003|Overall Study|Protocol Violation|1|||
48661683|NCT04391894|156614145|FG004|Overall Study|Protocol Violation|0|||
48661684|NCT04391894|156614141|FG000|Overall Study|Withdrawal by Subject|2|||
48661685|NCT04391894|156614142|FG001|Overall Study|Withdrawal by Subject|0|||
48661686|NCT04391894|156614143|FG002|Overall Study|Withdrawal by Subject|3|||
48661687|NCT04391894|156614144|FG003|Overall Study|Withdrawal by Subject|0|||
48661688|NCT04391894|156614145|FG004|Overall Study|Withdrawal by Subject|1|||
48661689|NCT04391894|156614141|FG000|Overall Study|Unsatisfactory Therapeutic effect|0|||
48661690|NCT04391894|156614142|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
48661691|NCT04391894|156614143|FG002|Overall Study|Unsatisfactory Therapeutic effect|0|||
48661692|NCT04391894|156614144|FG003|Overall Study|Unsatisfactory Therapeutic effect|0|||
48661693|NCT04391894|156614145|FG004|Overall Study|Unsatisfactory Therapeutic effect|1|||
48661694|NCT03766009|156614146|FG000|Usual Care|Death|0|||
48661695|NCT03766009|156614147|FG001|Usual Care|Death|0|||
48661696|NCT03766009|156614148|FG002|Usual Care|Death|0|||
48661697|NCT03766009|156614149|FG003|Usual Care|Death|1|||
48661698|NCT03766009|156614150|FG004|Usual Care|Death|0|||
48661699|NCT03766009|156614151|FG005|Usual Care|Death|0|||
48661700|NCT03766009|156614146|FG000|Usual Care|Lost to Follow-up|0|||
48965129|NCT00383721|157700308|FG003|26-Week Double-Blind Treatment Period|Adverse Event|14|||
48965130|NCT00383721|157700309|FG004|26-Week Double-Blind Treatment Period|Adverse Event|13|||
48661701|NCT03766009|156614147|FG001|Usual Care|Lost to Follow-up|0|||
48661702|NCT03766009|156614148|FG002|Usual Care|Lost to Follow-up|0|||
48965131|NCT00383721|157700305|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|1|||
48965132|NCT00383721|157700306|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
48661703|NCT03766009|156614149|FG003|Usual Care|Lost to Follow-up|1|||
48661704|NCT03766009|156614150|FG004|Usual Care|Lost to Follow-up|0|||
48661705|NCT03766009|156614151|FG005|Usual Care|Lost to Follow-up|0|||
48661706|NCT03766009|156614146|FG000|Usual Care|Treatment goals changed due to metastatic disease|0|||
48661707|NCT03766009|156614147|FG001|Usual Care|Treatment goals changed due to metastatic disease|0|||
48661708|NCT03766009|156614148|FG002|Usual Care|Treatment goals changed due to metastatic disease|2|||
48661709|NCT03766009|156614149|FG003|Usual Care|Treatment goals changed due to metastatic disease|0|||
49015448|NCT01393990|157893780|FG010|Overall Study|Adverse Event|0|||
48661710|NCT03766009|156614150|FG004|Usual Care|Treatment goals changed due to metastatic disease|1|||
48661711|NCT03766009|156614151|FG005|Usual Care|Treatment goals changed due to metastatic disease|0|||
48661712|NCT03766009|156614146|FG000|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
48692745|NCT01339689|156724588|FG000|Overall Study|Withdrawal by Subject|3|||
48661713|NCT03766009|156614147|FG001|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
48661714|NCT03766009|156614148|FG002|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
48661715|NCT03766009|156614149|FG003|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
48661716|NCT03766009|156614150|FG004|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
48661717|NCT03766009|156614151|FG005|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
48661718|NCT03766009|156614146|FG000|Usual Care|No treatment or declined surgery|0|||
48661719|NCT03766009|156614147|FG001|Usual Care|No treatment or declined surgery|0|||
48661720|NCT03766009|156614148|FG002|Usual Care|No treatment or declined surgery|0|||
48661721|NCT03766009|156614149|FG003|Usual Care|No treatment or declined surgery|2|||
48661722|NCT03766009|156614150|FG004|Usual Care|No treatment or declined surgery|0|||
48661723|NCT03766009|156614151|FG005|Usual Care|No treatment or declined surgery|0|||
48661724|NCT03766009|156614146|FG000|Usual Care|No surgery but had lymph node dissection instead|0|||
48661725|NCT03766009|156614147|FG001|Usual Care|No surgery but had lymph node dissection instead|0|||
48661726|NCT03766009|156614148|FG002|Usual Care|No surgery but had lymph node dissection instead|0|||
48661727|NCT03766009|156614149|FG003|Usual Care|No surgery but had lymph node dissection instead|1|||
48661728|NCT03766009|156614150|FG004|Usual Care|No surgery but had lymph node dissection instead|0|||
48661729|NCT03766009|156614151|FG005|Usual Care|No surgery but had lymph node dissection instead|0|||
48661730|NCT03766009|156614146|FG000|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
48661731|NCT03766009|156614147|FG001|Usual Care|No surgery since patient had a good response to endocrine therapy|1|||
48661732|NCT03766009|156614148|FG002|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
48661733|NCT03766009|156614149|FG003|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
48661734|NCT03766009|156614150|FG004|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
48661735|NCT03766009|156614151|FG005|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
48661736|NCT03766009|156614146|FG000|Usual Care|Ineligible|0|||
48661737|NCT03766009|156614147|FG001|Usual Care|Ineligible|1|||
48661738|NCT03766009|156614148|FG002|Usual Care|Ineligible|0|||
48755544|NCT00619801|156951301|FG001|Overall Study|Withdrawal by Subject|1|||
48755545|NCT00619801|156951300|FG000|Overall Study|Loss of efficacy|0|||
48755546|NCT00619801|156951301|FG001|Overall Study|Loss of efficacy|1|||
48755547|NCT02196558|156951304|FG000|Treatment Phase (12 Weeks)|Adverse Event|0|||
48755548|NCT02196558|156951305|FG001|Treatment Phase (12 Weeks)|Adverse Event|2|||
48755549|NCT02196558|156951306|FG002|Treatment Phase (12 Weeks)|Adverse Event|0|||
48755550|NCT02196558|156951304|FG000|Treatment Phase (12 Weeks)|Participant Choice|0|||
48755551|NCT02196558|156951305|FG001|Treatment Phase (12 Weeks)|Participant Choice|1|||
48755552|NCT02196558|156951306|FG002|Treatment Phase (12 Weeks)|Participant Choice|1|||
48755553|NCT02196558|156951304|FG000|Treatment Phase (12 Weeks)|Progression of Disease|0|||
48755554|NCT02196558|156951305|FG001|Treatment Phase (12 Weeks)|Progression of Disease|0|||
48755555|NCT02196558|156951306|FG002|Treatment Phase (12 Weeks)|Progression of Disease|1|||
48755556|NCT02196558|156951304|FG000|Extension Phase (40 Weeks)|Adverse Event|1|||
48755557|NCT02196558|156951305|FG001|Extension Phase (40 Weeks)|Adverse Event|2|||
48755558|NCT02196558|156951306|FG002|Extension Phase (40 Weeks)|Adverse Event|0|||
48755559|NCT02196558|156951304|FG000|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
48755560|NCT02196558|156951305|FG001|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
48755561|NCT02196558|156951306|FG002|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
48755562|NCT00396591|156951314|FG000|Overall Study|Disease Progression|13|||
48755563|NCT00396591|156951314|FG000|Overall Study|Adverse Event|2|||
48755564|NCT00396591|156951314|FG000|Overall Study|Participant request|1|||
48755565|NCT03406104|156951315|FG000|Overall Study|Lost to Follow-up|2|||
48755566|NCT03406104|156951315|FG000|Overall Study|Withdrawal by Subject|2|||
48755567|NCT03406104|156951315|FG000|Overall Study|due to Covid patient did not want to travel|1|||
48755568|NCT03406104|156951315|FG000|Overall Study|Death|2|||
48755569|NCT01013701|156951316|FG000|Overall Study|study prematurely terminated|7|||
48755570|NCT00556712|156951317|FG000|Overall Study|Adverse Event|7|||
48755571|NCT00556712|156951318|FG001|Overall Study|Adverse Event|19|||
48755572|NCT00556712|156951317|FG000|Overall Study|Death|5|||
48755573|NCT00556712|156951318|FG001|Overall Study|Death|10|||
48755574|NCT00556712|156951317|FG000|Overall Study|Progressive Disease|383|||
48755575|NCT00556712|156951318|FG001|Overall Study|Progressive Disease|320|||
48755576|NCT00556712|156951317|FG000|Overall Study|Protocol Violation|3|||
48755577|NCT00556712|156951318|FG001|Overall Study|Protocol Violation|2|||
48755578|NCT00556712|156951317|FG000|Overall Study|Refused Treatment|17|||
48755579|NCT00556712|156951318|FG001|Overall Study|Refused Treatment|16|||
48755580|NCT00556712|156951317|FG000|Overall Study|Failure to Return|2|||
48755581|NCT00556712|156951318|FG001|Overall Study|Failure to Return|3|||
48755582|NCT00556712|156951317|FG000|Overall Study|Other|2|||
48755583|NCT00556712|156951318|FG001|Overall Study|Other|2|||
48755584|NCT00556712|156951317|FG000|Overall Study|Ongoing at Data Cutoff|32|||
48755585|NCT00556712|156951318|FG001|Overall Study|Ongoing at Data Cutoff|66|||
48755586|NCT01361464|156951319|FG000|Overall Study|Death|1|||
48755587|NCT01361464|156951319|FG000|Overall Study|Withdrawal by Subject|2|||
48661739|NCT03766009|156614149|FG003|Usual Care|Ineligible|0|||
48661740|NCT03766009|156614150|FG004|Usual Care|Ineligible|0|||
48661741|NCT03766009|156614151|FG005|Usual Care|Ineligible|0|||
48661742|NCT03766009|156614146|FG000|Usual Care|Other: Staff turnover|0|||
48661743|NCT03766009|156614147|FG001|Usual Care|Other: Staff turnover|0|||
48755588|NCT04501666|156951322|FG000|Overall Study|Physician Decision|0|||
48755589|NCT04501666|156951323|FG001|Overall Study|Physician Decision|1|||
48755590|NCT04501666|156951322|FG000|Overall Study|Adverse Event|12|||
48755591|NCT04501666|156951323|FG001|Overall Study|Adverse Event|4|||
48755592|NCT04501666|156951322|FG000|Overall Study|Subject's request|10|||
48755593|NCT04501666|156951323|FG001|Overall Study|Subject's request|6|||
48755594|NCT04501666|156951322|FG000|Overall Study|Protocol Deviation|2|||
48755595|NCT04501666|156951323|FG001|Overall Study|Protocol Deviation|1|||
48755596|NCT04501666|156951322|FG000|Overall Study|Other-- site permanently closing|0|||
48755597|NCT04501666|156951323|FG001|Overall Study|Other-- site permanently closing|1|||
48755598|NCT04690751|156951324|FG000|Overall Study|Protocol Violation|0|||
48755599|NCT04690751|156951325|FG001|Overall Study|Protocol Violation|1|||
48755600|NCT04690751|156951326|FG002|Overall Study|Protocol Violation|0|||
48755601|NCT04690751|156951327|FG003|Overall Study|Protocol Violation|1|||
48755602|NCT04690751|156951328|FG004|Overall Study|Protocol Violation|2|||
48755603|NCT04690751|156951329|FG005|Overall Study|Protocol Violation|0|||
48755604|NCT04690751|156951324|FG000|Overall Study|Adverse Event|0|||
48755605|NCT04690751|156951325|FG001|Overall Study|Adverse Event|0|||
48755606|NCT04690751|156951326|FG002|Overall Study|Adverse Event|1|||
48755607|NCT04690751|156951327|FG003|Overall Study|Adverse Event|0|||
48755608|NCT04690751|156951328|FG004|Overall Study|Adverse Event|0|||
48661744|NCT03766009|156614148|FG002|Usual Care|Other: Staff turnover|0|||
48661745|NCT03766009|156614149|FG003|Usual Care|Other: Staff turnover|0|||
48661746|NCT03766009|156614150|FG004|Usual Care|Other: Staff turnover|0|||
48661747|NCT03766009|156614151|FG005|Usual Care|Other: Staff turnover|2|||
48755609|NCT04690751|156951329|FG005|Overall Study|Adverse Event|0|||
48661748|NCT02737436|156614154|FG000|Washout Period|Lost to Follow-up|5|||
48661749|NCT02737436|156614155|FG001|Washout Period|Lost to Follow-up|11|||
48661750|NCT02737436|156614154|FG000|Data Analysis|Scanning data problems|5|||
48661751|NCT02737436|156614155|FG001|Data Analysis|Scanning data problems|8|||
48661752|NCT01069861|156614157|FG000|Overall Study|Death|1|||
48661753|NCT01069861|156614157|FG000|Overall Study|Adverse Event|1|||
48661754|NCT01069861|156614157|FG000|Overall Study|Did not meet entrance criteria|1|||
48661755|NCT03781414|156614160|FG000|Overall Study|Study terminated by sponsor|39|||
48661756|NCT03781414|156614161|FG001|Overall Study|Study terminated by sponsor|34|||
48661757|NCT03781414|156614162|FG002|Overall Study|Study terminated by sponsor|25|||
48661758|NCT03781414|156614160|FG000|Overall Study|Adverse Event|3|||
48661759|NCT03781414|156614161|FG001|Overall Study|Adverse Event|6|||
48661760|NCT03781414|156614162|FG002|Overall Study|Adverse Event|3|||
48661761|NCT03781414|156614160|FG000|Overall Study|Physician Decision|2|||
48661762|NCT03781414|156614161|FG001|Overall Study|Physician Decision|0|||
48661763|NCT03781414|156614162|FG002|Overall Study|Physician Decision|1|||
48661764|NCT03781414|156614160|FG000|Overall Study|Withdrawal by Subject|2|||
48661765|NCT03781414|156614161|FG001|Overall Study|Withdrawal by Subject|3|||
48661766|NCT03781414|156614162|FG002|Overall Study|Withdrawal by Subject|3|||
48661767|NCT03781414|156614160|FG000|Overall Study|Death|1|||
48661768|NCT03781414|156614161|FG001|Overall Study|Death|4|||
48661769|NCT03781414|156614162|FG002|Overall Study|Death|0|||
48661770|NCT03781414|156614160|FG000|Overall Study|Lost to Follow-up|1|||
48661771|NCT03781414|156614161|FG001|Overall Study|Lost to Follow-up|1|||
48661772|NCT03781414|156614162|FG002|Overall Study|Lost to Follow-up|0|||
48661773|NCT04568603|156614163|FG000|Overall Study|Physician Decision|1|||
48661774|NCT02841579|156614164|FG000|Overall Study|Death|1|||
48661775|NCT02841579|156614164|FG000|Overall Study|Adverse Event|1|||
48661776|NCT02841579|156614164|FG000|Overall Study|Lack of Efficacy|9|||
48661777|NCT03622112|156614165|FG000|Overall Study|Withdrawal by Subject|6|||
48661778|NCT03622112|156614166|FG001|Overall Study|Withdrawal by Subject|2|||
48661779|NCT03622112|156614167|FG002|Overall Study|Withdrawal by Subject|4|||
48661780|NCT03622112|156614168|FG003|Overall Study|Withdrawal by Subject|2|||
48661781|NCT03622112|156614169|FG004|Overall Study|Withdrawal by Subject|1|||
48661782|NCT03622112|156614170|FG005|Overall Study|Withdrawal by Subject|2|||
48661783|NCT03622112|156614171|FG006|Overall Study|Withdrawal by Subject|2|||
48661784|NCT03622112|156614165|FG000|Overall Study|Death|0|||
48661785|NCT03622112|156614166|FG001|Overall Study|Death|0|||
48661786|NCT03622112|156614167|FG002|Overall Study|Death|0|||
48661787|NCT03622112|156614168|FG003|Overall Study|Death|1|||
48661788|NCT03622112|156614169|FG004|Overall Study|Death|0|||
48661789|NCT03622112|156614170|FG005|Overall Study|Death|0|||
48755610|NCT04690751|156951324|FG000|Overall Study|Positive urine drug screen test|0|||
48755611|NCT04690751|156951325|FG001|Overall Study|Positive urine drug screen test|0|||
48755612|NCT04690751|156951326|FG002|Overall Study|Positive urine drug screen test|0|||
48755613|NCT04690751|156951327|FG003|Overall Study|Positive urine drug screen test|0|||
48755614|NCT04690751|156951328|FG004|Overall Study|Positive urine drug screen test|1|||
48661790|NCT03622112|156614171|FG006|Overall Study|Death|0|||
48661791|NCT03622112|156614165|FG000|Overall Study|Lost to Follow-up|1|||
48661792|NCT03622112|156614166|FG001|Overall Study|Lost to Follow-up|1|||
48661793|NCT03622112|156614167|FG002|Overall Study|Lost to Follow-up|0|||
48661794|NCT03622112|156614168|FG003|Overall Study|Lost to Follow-up|0|||
48661795|NCT03622112|156614169|FG004|Overall Study|Lost to Follow-up|0|||
48661796|NCT03622112|156614170|FG005|Overall Study|Lost to Follow-up|0|||
48661797|NCT03622112|156614171|FG006|Overall Study|Lost to Follow-up|0|||
48661798|NCT03622112|156614165|FG000|Overall Study|Study-specific withdrawal criteria|10|||
48661799|NCT03622112|156614166|FG001|Overall Study|Study-specific withdrawal criteria|8|||
48661800|NCT03622112|156614167|FG002|Overall Study|Study-specific withdrawal criteria|7|||
48661801|NCT03622112|156614168|FG003|Overall Study|Study-specific withdrawal criteria|6|||
48661802|NCT03622112|156614169|FG004|Overall Study|Study-specific withdrawal criteria|4|||
48661803|NCT03622112|156614170|FG005|Overall Study|Study-specific withdrawal criteria|18|||
48661804|NCT03622112|156614171|FG006|Overall Study|Study-specific withdrawal criteria|4|||
48661805|NCT03622112|156614165|FG000|Overall Study|Protocol Violation|2|||
48661806|NCT03622112|156614166|FG001|Overall Study|Protocol Violation|0|||
48661807|NCT03622112|156614167|FG002|Overall Study|Protocol Violation|1|||
48661808|NCT03622112|156614168|FG003|Overall Study|Protocol Violation|1|||
48661809|NCT03622112|156614169|FG004|Overall Study|Protocol Violation|0|||
48661810|NCT03622112|156614170|FG005|Overall Study|Protocol Violation|0|||
48661811|NCT03622112|156614171|FG006|Overall Study|Protocol Violation|0|||
48661812|NCT03622112|156614165|FG000|Overall Study|Adverse Event|6|||
48661813|NCT03622112|156614166|FG001|Overall Study|Adverse Event|8|||
48661814|NCT03622112|156614167|FG002|Overall Study|Adverse Event|4|||
48661815|NCT03622112|156614168|FG003|Overall Study|Adverse Event|11|||
48661816|NCT03622112|156614169|FG004|Overall Study|Adverse Event|4|||
48661817|NCT03622112|156614170|FG005|Overall Study|Adverse Event|20|||
48661818|NCT03622112|156614171|FG006|Overall Study|Adverse Event|2|||
48661819|NCT03622112|156614165|FG000|Overall Study|Reason not specified|0|||
48755615|NCT04690751|156951329|FG005|Overall Study|Positive urine drug screen test|0|||
48755616|NCT02289079|156951330|FG000|Overall Study|Physician Decision|2|||
48755617|NCT02289079|156951331|FG001|Overall Study|Physician Decision|0|||
48755618|NCT02289079|156951330|FG000|Overall Study|Lost to Follow-up|0|||
48755619|NCT02289079|156951331|FG001|Overall Study|Lost to Follow-up|1|||
48755620|NCT00680043|156951332|FG000|Overall Study|Withdrawal by Subject|1|||
48755621|NCT00680043|156951333|FG001|Overall Study|Withdrawal by Subject|0|||
48755622|NCT00680043|156951334|FG002|Overall Study|Withdrawal by Subject|0|||
48755623|NCT00680043|156951332|FG000|Overall Study|Patient Not Compliant With Study Reqs.|0|||
48755624|NCT00680043|156951333|FG001|Overall Study|Patient Not Compliant With Study Reqs.|1|||
48755625|NCT00680043|156951334|FG002|Overall Study|Patient Not Compliant With Study Reqs.|0|||
48755626|NCT00680043|156951332|FG000|Overall Study|Renal Transplant|1|||
48755627|NCT00680043|156951333|FG001|Overall Study|Renal Transplant|0|||
48755628|NCT00680043|156951334|FG002|Overall Study|Renal Transplant|4|||
48755629|NCT03559257|156951336|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
48755630|NCT03559257|156951337|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
48755631|NCT03559257|156951336|FG000|Double Blind Treatment Period|Protocol Violation|1|||
48755632|NCT03559257|156951337|FG001|Double Blind Treatment Period|Protocol Violation|4|||
48755633|NCT03559257|156951336|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
48755634|NCT03559257|156951337|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
48755635|NCT03559257|156951336|FG000|Double Blind Treatment Period|Adverse Event|0|||
48755636|NCT03559257|156951337|FG001|Double Blind Treatment Period|Adverse Event|1|||
48755637|NCT03559257|156951336|FG000|Double Blind Treatment Period|Screen Failure|0|||
48755638|NCT03559257|156951337|FG001|Double Blind Treatment Period|Screen Failure|1|||
48755639|NCT03559257|156951336|FG000|Open-label Treatment Period|Adverse Event|1|||
48755640|NCT03559257|156951337|FG001|Open-label Treatment Period|Adverse Event|4|||
48755641|NCT03559257|156951336|FG000|Open-label Treatment Period|Lack of Efficacy|3|||
48755642|NCT03559257|156951337|FG001|Open-label Treatment Period|Lack of Efficacy|2|||
48755643|NCT03559257|156951336|FG000|Open-label Treatment Period|Withdrawal by Subject|3|||
48866541|NCT00168805|157347569|FG000|Overall Study|Other|24|||
48866542|NCT00168805|157347570|FG001|Overall Study|Other|21|||
48866543|NCT00168805|157347571|FG002|Overall Study|Other|22|||
48661820|NCT03622112|156614166|FG001|Overall Study|Reason not specified|1|||
48661821|NCT03622112|156614167|FG002|Overall Study|Reason not specified|0|||
48661822|NCT03622112|156614168|FG003|Overall Study|Reason not specified|1|||
48661823|NCT03622112|156614169|FG004|Overall Study|Reason not specified|1|||
48661824|NCT03622112|156614170|FG005|Overall Study|Reason not specified|2|||
48661825|NCT03622112|156614171|FG006|Overall Study|Reason not specified|1|||
48661826|NCT01155466|156614172|FG000|Overall Study|Adverse Event|13|||
48661827|NCT01155466|156614173|FG001|Overall Study|Adverse Event|15|||
48755644|NCT03559257|156951337|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
48755645|NCT03559257|156951336|FG000|Open-label Treatment Period|Protocol Violation|2|||
48755646|NCT03559257|156951337|FG001|Open-label Treatment Period|Protocol Violation|0|||
48755647|NCT03559257|156951336|FG000|Open-label Treatment Period|Lost to Follow-up|1|||
48755648|NCT03559257|156951337|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
48755649|NCT03559257|156951336|FG000|Open-label Treatment Period|Physician Decision|0|||
48755650|NCT03559257|156951337|FG001|Open-label Treatment Period|Physician Decision|1|||
48661828|NCT01155466|156614174|FG002|Overall Study|Adverse Event|6|||
48661829|NCT01155466|156614175|FG003|Overall Study|Adverse Event|17|||
48755651|NCT01026792|156951341|FG000|Overall Study|Protocol Violation|1|||
48755652|NCT00399360|156951344|FG000|Overall Study|Lost to Follow-up|2|||
48755653|NCT00399360|156951345|FG001|Overall Study|Lost to Follow-up|1|||
48755654|NCT00399360|156951346|FG002|Overall Study|Lost to Follow-up|2|||
48755655|NCT00399360|156951347|FG003|Overall Study|Lost to Follow-up|4|||
48755656|NCT00399360|156951344|FG000|Overall Study|Adverse Event|0|||
48755657|NCT00399360|156951345|FG001|Overall Study|Adverse Event|0|||
48755658|NCT00399360|156951346|FG002|Overall Study|Adverse Event|1|||
48755659|NCT00399360|156951347|FG003|Overall Study|Adverse Event|0|||
48755660|NCT00399360|156951344|FG000|Overall Study|Withdrawal by Subject|0|||
48755661|NCT00399360|156951345|FG001|Overall Study|Withdrawal by Subject|2|||
48755662|NCT00399360|156951346|FG002|Overall Study|Withdrawal by Subject|0|||
48755663|NCT00399360|156951347|FG003|Overall Study|Withdrawal by Subject|2|||
48755664|NCT03564145|156951348|FG000|Overall Study|Adverse Event|4|||
48755665|NCT03564145|156951348|FG000|Overall Study|Lost to Follow-up|21|||
48755666|NCT03564145|156951348|FG000|Overall Study|Protocol Violation|2|||
48755667|NCT03564145|156951348|FG000|Overall Study|Withdrawal by Subject|48|||
48755668|NCT03564145|156951348|FG000|Overall Study|Study Terminated by Sponsor|146|||
48755669|NCT03564145|156951348|FG000|Overall Study|Physician Decision|1|||
48755670|NCT03564145|156951348|FG000|Overall Study|Other Than Specified|1|||
48755671|NCT03564145|156951348|FG000|Overall Study|Pregnancy|1|||
48755672|NCT02446990|156951354|FG000|Overall Study|Death|485|||
48755673|NCT02446990|156951355|FG001|Overall Study|Death|458|||
48755674|NCT02446990|156951354|FG000|Overall Study|Lost to Follow-up|3|||
48755675|NCT02446990|156951355|FG001|Overall Study|Lost to Follow-up|1|||
48755676|NCT02446990|156951354|FG000|Overall Study|Physician Decision|1|||
48755677|NCT02446990|156951355|FG001|Overall Study|Physician Decision|0|||
48755678|NCT02446990|156951354|FG000|Overall Study|Withdrawal by Subject|231|||
48755679|NCT02446990|156951355|FG001|Overall Study|Withdrawal by Subject|199|||
48755680|NCT01064401|156951356|FG000|Overall Study|Adverse Event|47|||
48755681|NCT01064401|156951357|FG001|Overall Study|Adverse Event|56|||
48755682|NCT01064401|156951356|FG000|Overall Study|Lack of Efficacy|46|||
48755683|NCT01064401|156951357|FG001|Overall Study|Lack of Efficacy|23|||
48755684|NCT01064401|156951356|FG000|Overall Study|Lost to Follow-up|12|||
48755685|NCT01064401|156951357|FG001|Overall Study|Lost to Follow-up|9|||
48755686|NCT01064401|156951356|FG000|Overall Study|Consent Withdrawn|98|||
48755687|NCT01064401|156951357|FG001|Overall Study|Consent Withdrawn|80|||
48755688|NCT01064401|156951356|FG000|Overall Study|Investigator Decision|4|||
48755689|NCT01064401|156951357|FG001|Overall Study|Investigator Decision|6|||
48755690|NCT01064401|156951356|FG000|Overall Study|Death|4|||
48755691|NCT01064401|156951357|FG001|Overall Study|Death|0|||
48755692|NCT01064401|156951356|FG000|Overall Study|Pregnancy|4|||
48755693|NCT01064401|156951357|FG001|Overall Study|Pregnancy|7|||
48755694|NCT01064401|156951356|FG000|Overall Study|Noncompliance|7|||
48755695|NCT01064401|156951357|FG001|Overall Study|Noncompliance|8|||
48661830|NCT01155466|156614176|FG004|Overall Study|Adverse Event|18|||
48661831|NCT01155466|156614172|FG000|Overall Study|Lost to Follow-up|0|||
48661832|NCT01155466|156614173|FG001|Overall Study|Lost to Follow-up|0|||
48661833|NCT01155466|156614174|FG002|Overall Study|Lost to Follow-up|0|||
48661834|NCT01155466|156614175|FG003|Overall Study|Lost to Follow-up|0|||
48661835|NCT01155466|156614176|FG004|Overall Study|Lost to Follow-up|2|||
48661836|NCT01155466|156614172|FG000|Overall Study|Withdrawal by Subject|7|||
48755696|NCT01064401|156951356|FG000|Overall Study|Site Closure|4|||
48755697|NCT01064401|156951357|FG001|Overall Study|Site Closure|5|||
48755698|NCT01064401|156951356|FG000|Overall Study|Other|2|||
48755699|NCT01064401|156951357|FG001|Overall Study|Other|1|||
48755700|NCT04977583|156954147|FG000|Overall Study|Lost to Follow-up|8|||
48755701|NCT04977583|156954148|FG001|Overall Study|Lost to Follow-up|4|||
48866544|NCT00168805|157347569|FG000|Treatment|Adverse Event|25|||
48866545|NCT00168805|157347570|FG001|Treatment|Adverse Event|26|||
48866546|NCT00168805|157347571|FG002|Treatment|Adverse Event|32|||
48866547|NCT00168805|157347569|FG000|Treatment|Protocol Violation|3|||
48866548|NCT00168805|157347570|FG001|Treatment|Protocol Violation|5|||
48866549|NCT00168805|157347571|FG002|Treatment|Protocol Violation|5|||
48755702|NCT04977583|156954149|FG002|Overall Study|Lost to Follow-up|13|||
48755703|NCT04977583|156954147|FG000|Overall Study|Withdrawal by Subject|3|||
48755704|NCT04977583|156954148|FG001|Overall Study|Withdrawal by Subject|2|||
48755705|NCT04977583|156954149|FG002|Overall Study|Withdrawal by Subject|1|||
48755706|NCT01572909|156954150|FG000|Overall Study|Adverse Event|7|||
48755707|NCT01572909|156954151|FG001|Overall Study|Adverse Event|2|||
48755708|NCT01572909|156954150|FG000|Overall Study|Death|3|||
48755709|NCT01572909|156954151|FG001|Overall Study|Death|1|||
48755710|NCT01572909|156954150|FG000|Overall Study|Lost to Follow-up|8|||
48755711|NCT01572909|156954151|FG001|Overall Study|Lost to Follow-up|7|||
48755712|NCT01572909|156954150|FG000|Overall Study|Physician Decision|1|||
48755713|NCT01572909|156954151|FG001|Overall Study|Physician Decision|1|||
48866550|NCT00168805|157347569|FG000|Treatment|Withdrawal by Subject|3|||
48866551|NCT00168805|157347570|FG001|Treatment|Withdrawal by Subject|7|||
48661837|NCT01155466|156614173|FG001|Overall Study|Withdrawal by Subject|5|||
48965133|NCT00383721|157700307|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
48965134|NCT00383721|157700308|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
48965135|NCT00383721|157700309|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
48965136|NCT00383721|157700305|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
48965137|NCT00383721|157700306|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
48965138|NCT00383721|157700307|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
48965139|NCT00383721|157700308|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
48965140|NCT00383721|157700309|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|4|||
48965141|NCT00383721|157700305|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4|||
48965142|NCT00383721|157700306|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
48965143|NCT00383721|157700307|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15|||
48965144|NCT00383721|157700308|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
48965145|NCT00383721|157700309|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11|||
48965146|NCT00383721|157700305|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|5|||
48965147|NCT00383721|157700306|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
48965148|NCT00383721|157700307|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|6|||
48965149|NCT00383721|157700308|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|8|||
48965150|NCT00383721|157700309|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|9|||
48965151|NCT00383721|157700305|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7|||
48965152|NCT00383721|157700306|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
48965153|NCT00383721|157700307|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
48661838|NCT01155466|156614174|FG002|Overall Study|Withdrawal by Subject|9|||
48661839|NCT01155466|156614175|FG003|Overall Study|Withdrawal by Subject|4|||
48661840|NCT01155466|156614176|FG004|Overall Study|Withdrawal by Subject|4|||
48661841|NCT01155466|156614172|FG000|Overall Study|Protocol Violation|0|||
48661842|NCT01155466|156614173|FG001|Overall Study|Protocol Violation|0|||
48661843|NCT01155466|156614174|FG002|Overall Study|Protocol Violation|2|||
48661844|NCT01155466|156614175|FG003|Overall Study|Protocol Violation|0|||
48661845|NCT01155466|156614176|FG004|Overall Study|Protocol Violation|1|||
48661846|NCT01155466|156614172|FG000|Overall Study|Administrative|0|||
48661847|NCT01155466|156614173|FG001|Overall Study|Administrative|3|||
48661848|NCT01155466|156614174|FG002|Overall Study|Administrative|0|||
48661849|NCT01155466|156614175|FG003|Overall Study|Administrative|0|||
48661850|NCT01155466|156614176|FG004|Overall Study|Administrative|0|||
48965154|NCT00383721|157700308|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
48965155|NCT00383721|157700309|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
48965156|NCT00383721|157700305|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
48661851|NCT01155466|156614172|FG000|Overall Study|Randomized not treated|2|||
48661852|NCT01155466|156614173|FG001|Overall Study|Randomized not treated|2|||
48661853|NCT01155466|156614174|FG002|Overall Study|Randomized not treated|3|||
48661854|NCT01155466|156614175|FG003|Overall Study|Randomized not treated|0|||
48661855|NCT01155466|156614176|FG004|Overall Study|Randomized not treated|2|||
48661856|NCT02174523|156614179|FG000|Overall Study|Withdrawal by Subject|1|||
48661857|NCT02174523|156614180|FG001|Overall Study|Withdrawal by Subject|0|||
48661858|NCT03640052|156614181|FG000|Overall Study|Lost to Follow-up|0|||
48661859|NCT03640052|156614182|FG001|Overall Study|Lost to Follow-up|1|||
48661860|NCT03640052|156614183|FG002|Overall Study|Lost to Follow-up|0|||
48661861|NCT03640052|156614184|FG003|Overall Study|Lost to Follow-up|0|||
48661862|NCT03640052|156614185|FG004|Overall Study|Lost to Follow-up|0|||
48661863|NCT00230282|156614186|FG000|Fludarabine + Cyclophosphamide|Lost to Follow-up|4|||
48661864|NCT00230282|156614186|FG000|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1|||
48661865|NCT00230282|156614186|FG000|Fludarabine + Cyclophosphamide|Change in diagnosis|1|||
48661866|NCT00230282|156614186|FG000|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2|||
48661867|NCT03431350|156614187|FG000|Overall Study|ONGOING|0|||
48661868|NCT03431350|156614188|FG001|Overall Study|ONGOING|0|||
48661869|NCT03431350|156614189|FG002|Overall Study|ONGOING|2|||
48661870|NCT03431350|156614190|FG003|Overall Study|ONGOING|0|||
48661871|NCT03431350|156614191|FG004|Overall Study|ONGOING|1|||
48661872|NCT03431350|156614192|FG005|Overall Study|ONGOING|3|||
48661873|NCT03431350|156614193|FG006|Overall Study|ONGOING|0|||
48661874|NCT03431350|156614194|FG007|Overall Study|ONGOING|1|||
48661875|NCT03431350|156614195|FG008|Overall Study|ONGOING|3|||
48661876|NCT03431350|156614196|FG009|Overall Study|ONGOING|4|||
48661877|NCT03431350|156614197|FG010|Overall Study|ONGOING|2|||
48661878|NCT03431350|156614198|FG011|Overall Study|ONGOING|1|||
48661879|NCT03431350|156614187|FG000|Overall Study|Death|6|||
48661880|NCT03431350|156614188|FG001|Overall Study|Death|5|||
48661881|NCT03431350|156614189|FG002|Overall Study|Death|18|||
48661882|NCT03431350|156614190|FG003|Overall Study|Death|7|||
48661883|NCT03431350|156614191|FG004|Overall Study|Death|4|||
48661884|NCT03431350|156614192|FG005|Overall Study|Death|3|||
48661885|NCT03431350|156614193|FG006|Overall Study|Death|2|||
48866552|NCT00168805|157347571|FG002|Treatment|Withdrawal by Subject|8|||
48866553|NCT00168805|157347569|FG000|Treatment|Other|18|||
48866554|NCT00168805|157347570|FG001|Treatment|Other|18|||
48866555|NCT00168805|157347571|FG002|Treatment|Other|17|||
48866556|NCT01837719|157347574|FG000|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1|||
48866557|NCT01837719|157347574|FG000|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1|||
48866558|NCT01878253|157347577|FG000|Overall Study|Death|1|||
48866559|NCT01878253|157347577|FG000|Overall Study|SIdus System Removal|3|||
48866560|NCT01878253|157347577|FG000|Overall Study|Withdrawal by Subject|1|||
48866561|NCT01878253|157347577|FG000|Overall Study|Lost to Follow-up|2|||
48866562|NCT01878253|157347577|FG000|Overall Study|Completed Study w/o Follow-up Data|2|||
48866563|NCT02391116|157347578|FG000|Treatment|Withdrawal by Subject|1|||
48965157|NCT00383721|157700306|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
48965158|NCT00383721|157700307|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11|||
48965159|NCT00383721|157700308|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4|||
48965160|NCT00383721|157700309|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13|||
48965161|NCT00383721|157700305|FG000|26-Week Double-Blind Treatment Period|Administrative|1|||
48965162|NCT00383721|157700306|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
48965163|NCT00383721|157700307|FG002|26-Week Double-Blind Treatment Period|Administrative|3|||
48965164|NCT00383721|157700308|FG003|26-Week Double-Blind Treatment Period|Administrative|3|||
48965165|NCT00383721|157700309|FG004|26-Week Double-Blind Treatment Period|Administrative|3|||
48965166|NCT00383721|157700305|FG000|26-Week Double-Blind Treatment Period|Ongoing|1|||
48965167|NCT00383721|157700306|FG001|26-Week Double-Blind Treatment Period|Ongoing|0|||
48965168|NCT00383721|157700307|FG002|26-Week Double-Blind Treatment Period|Ongoing|0|||
48965169|NCT00383721|157700308|FG003|26-Week Double-Blind Treatment Period|Ongoing|0|||
48965170|NCT00383721|157700309|FG004|26-Week Double-Blind Treatment Period|Ongoing|0|||
48965171|NCT00383721|157700305|FG000|26-Week Treatment Safety Extension|Adverse Event|6|||
48965172|NCT00383721|157700306|FG001|26-Week Treatment Safety Extension|Adverse Event|7|||
48965173|NCT00383721|157700307|FG002|26-Week Treatment Safety Extension|Adverse Event|10|||
48965174|NCT00383721|157700308|FG003|26-Week Treatment Safety Extension|Adverse Event|1|||
48965175|NCT00383721|157700309|FG004|26-Week Treatment Safety Extension|Adverse Event|0|||
48965176|NCT00383721|157700305|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
48965177|NCT00383721|157700306|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|2|||
48965178|NCT00383721|157700307|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|4|||
48661886|NCT03431350|156614194|FG007|Overall Study|Death|0|||
48661887|NCT03431350|156614195|FG008|Overall Study|Death|0|||
48661888|NCT03431350|156614196|FG009|Overall Study|Death|0|||
48661889|NCT03431350|156614197|FG010|Overall Study|Death|4|||
48661890|NCT03431350|156614198|FG011|Overall Study|Death|0|||
48661891|NCT03431350|156614187|FG000|Overall Study|Lost to Follow-up|0|||
48661892|NCT03431350|156614188|FG001|Overall Study|Lost to Follow-up|1|||
48661893|NCT03431350|156614189|FG002|Overall Study|Lost to Follow-up|0|||
48661894|NCT03431350|156614190|FG003|Overall Study|Lost to Follow-up|0|||
48661895|NCT03431350|156614191|FG004|Overall Study|Lost to Follow-up|0|||
48965179|NCT00383721|157700308|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
48965180|NCT00383721|157700309|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
48965181|NCT00383721|157700305|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
48965182|NCT00383721|157700306|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
48965183|NCT00383721|157700307|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
48965184|NCT00383721|157700308|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
48965185|NCT00383721|157700309|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
48965186|NCT00383721|157700305|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
48965187|NCT00383721|157700306|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4|||
48965188|NCT00383721|157700307|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
48965189|NCT00383721|157700308|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7|||
48965190|NCT00383721|157700309|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
48965191|NCT00383721|157700305|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
48965192|NCT00383721|157700306|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
48965193|NCT00383721|157700307|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
48965194|NCT00383721|157700308|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
49015449|NCT01393990|157893781|FG011|Overall Study|Adverse Event|0|||
48661896|NCT03431350|156614192|FG005|Overall Study|Lost to Follow-up|0|||
48661897|NCT03431350|156614193|FG006|Overall Study|Lost to Follow-up|0|||
48661898|NCT03431350|156614194|FG007|Overall Study|Lost to Follow-up|0|||
48866564|NCT02391116|157347578|FG000|Treatment|Protocol Violation|1|||
48866565|NCT02391116|157347578|FG000|Treatment|Adverse Event (AE) Without Clinical PD|9|||
48866566|NCT02391116|157347578|FG000|Treatment|AE with Clinical PD|3|||
48866567|NCT02391116|157347578|FG000|Safety Follow-up|Adverse Event|1|||
48866568|NCT02391116|157347578|FG000|Safety Follow-up|Withdrawal by Subject|4|||
48661899|NCT03431350|156614195|FG008|Overall Study|Lost to Follow-up|0|||
48661900|NCT03431350|156614196|FG009|Overall Study|Lost to Follow-up|0|||
48661901|NCT03431350|156614197|FG010|Overall Study|Lost to Follow-up|0|||
48661902|NCT03431350|156614198|FG011|Overall Study|Lost to Follow-up|0|||
48661903|NCT03431350|156614187|FG000|Overall Study|Withdrawal by Subject|0|||
48661904|NCT03431350|156614188|FG001|Overall Study|Withdrawal by Subject|0|||
48661905|NCT03431350|156614189|FG002|Overall Study|Withdrawal by Subject|0|||
48661906|NCT03431350|156614190|FG003|Overall Study|Withdrawal by Subject|1|||
48661907|NCT03431350|156614191|FG004|Overall Study|Withdrawal by Subject|1|||
48661908|NCT03431350|156614192|FG005|Overall Study|Withdrawal by Subject|1|||
48661909|NCT03431350|156614193|FG006|Overall Study|Withdrawal by Subject|0|||
48661910|NCT03431350|156614194|FG007|Overall Study|Withdrawal by Subject|0|||
48661911|NCT03431350|156614195|FG008|Overall Study|Withdrawal by Subject|0|||
48866569|NCT02391116|157347578|FG000|Safety Follow-up|Switching to Other Therapy|4|||
48866570|NCT02391116|157347578|FG000|Safety Follow-up|No Follow Up|1|||
48866571|NCT02391116|157347578|FG000|Safety Follow-up|Deterioration of General Conditions|3|||
48866572|NCT02391116|157347578|FG000|Active Follow-up|Withdrawal by Subject|1|||
48866573|NCT02391116|157347578|FG000|Active Follow-up|Switching to Other Therapy|2|||
48866574|NCT02391116|157347578|FG000|Survival Follow-up|Withdrawal by Subject|3|||
48866575|NCT02391116|157347578|FG000|Survival Follow-up|Switching to Other Therapy|1|||
48661912|NCT03431350|156614196|FG009|Overall Study|Withdrawal by Subject|2|||
48661913|NCT03431350|156614197|FG010|Overall Study|Withdrawal by Subject|0|||
48661914|NCT03431350|156614198|FG011|Overall Study|Withdrawal by Subject|1|||
48866576|NCT03078751|157347579|FG000|Overall Study|Adverse Event|4|||
48866577|NCT03078751|157347580|FG001|Overall Study|Adverse Event|0|||
48866578|NCT03078751|157347579|FG000|Overall Study|Physician Decision|1|||
48866579|NCT03078751|157347580|FG001|Overall Study|Physician Decision|0|||
48965195|NCT00383721|157700309|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
48661915|NCT03431350|156614187|FG000|Overall Study|Other|0|||
48661916|NCT03431350|156614188|FG001|Overall Study|Other|0|||
48661917|NCT03431350|156614189|FG002|Overall Study|Other|1|||
48661918|NCT03431350|156614190|FG003|Overall Study|Other|3|||
48661919|NCT03431350|156614191|FG004|Overall Study|Other|2|||
48661920|NCT03431350|156614192|FG005|Overall Study|Other|2|||
48661921|NCT03431350|156614193|FG006|Overall Study|Other|4|||
48661922|NCT03431350|156614194|FG007|Overall Study|Other|0|||
48661923|NCT03431350|156614195|FG008|Overall Study|Other|14|||
48661924|NCT03431350|156614196|FG009|Overall Study|Other|11|||
48661925|NCT03431350|156614197|FG010|Overall Study|Other|11|||
48661926|NCT03431350|156614198|FG011|Overall Study|Other|15|||
48661927|NCT04706273|156614200|FG000|Overall Study|Withdrawal by Subject|27|||
48661928|NCT04706273|156614200|FG000|Overall Study|Physician Decision|1|||
48661929|NCT04706273|156614200|FG000|Overall Study|Lost to Follow-up|42|||
48661930|NCT04706273|156614200|FG000|Overall Study|Death|85|||
48661931|NCT04706273|156614200|FG000|Overall Study|Amputation that removes study device|2|||
48661932|NCT04706273|156614200|FG000|Overall Study|Surgical bypass|3|||
48661933|NCT04706273|156614200|FG000|Overall Study|Changing hospital|23|||
48661934|NCT04706273|156614200|FG000|Overall Study|Unable to attend hospital|2|||
48661935|NCT01438853|156614204|FG000|Overall Study|Death|0|||
48661936|NCT01438853|156614205|FG001|Overall Study|Death|0|||
48661937|NCT01438853|156614206|FG002|Overall Study|Death|0|||
48661938|NCT01438853|156614207|FG003|Overall Study|Death|1|||
48661939|NCT01438853|156614204|FG000|Overall Study|Withdrawal by Subject|0|||
48661940|NCT01438853|156614205|FG001|Overall Study|Withdrawal by Subject|0|||
48661941|NCT01438853|156614206|FG002|Overall Study|Withdrawal by Subject|1|||
48661942|NCT01438853|156614207|FG003|Overall Study|Withdrawal by Subject|0|||
48661943|NCT02624050|156614208|FG000|Overall Study|Physician Decision|4|||
48661944|NCT02624050|156614209|FG001|Overall Study|Physician Decision|0|||
48661945|NCT02624050|156614208|FG000|Overall Study|Protocol Violation|2|||
48661946|NCT02624050|156614209|FG001|Overall Study|Protocol Violation|0|||
48661947|NCT01904149|156614210|FG000|Overall Study|Adverse Event|3|||
48661948|NCT01904149|156614211|FG001|Overall Study|Adverse Event|4|||
48661949|NCT01904149|156614212|FG002|Overall Study|Adverse Event|0|||
48661950|NCT01904149|156614213|FG003|Overall Study|Adverse Event|1|||
48661951|NCT01904149|156614214|FG004|Overall Study|Adverse Event|1|||
48661952|NCT01904149|156614215|FG005|Overall Study|Adverse Event|2|||
48661953|NCT01904149|156614210|FG000|Overall Study|Lack of Efficacy|0|||
48661954|NCT01904149|156614211|FG001|Overall Study|Lack of Efficacy|3|||
48755714|NCT01572909|156954150|FG000|Overall Study|Technical Issues|1|||
48755715|NCT01572909|156954151|FG001|Overall Study|Technical Issues|0|||
48755716|NCT01572909|156954150|FG000|Overall Study|Withdrawal by Subject|12|||
48755717|NCT01572909|156954151|FG001|Overall Study|Withdrawal by Subject|11|||
48755718|NCT01572909|156954150|FG000|Overall Study|Infarct, comorbidity, Pt refusal of exam|0|||
48755719|NCT01572909|156954151|FG001|Overall Study|Infarct, comorbidity, Pt refusal of exam|3|||
48755720|NCT00410046|156954152|FG000|Overall Study|Adverse Event|3|||
48755721|NCT00410046|156954152|FG000|Overall Study|Withdrawal by Subject|1|||
48755722|NCT00410046|156954152|FG000|Overall Study|Lost to Follow-up|1|||
48755723|NCT01059786|156954153|FG000|Overall Study|Did not receive 6 cycles.|0|||
48755724|NCT01059786|156954154|FG001|Overall Study|Did not receive 6 cycles.|0|||
48755725|NCT01059786|156954155|FG002|Overall Study|Did not receive 6 cycles.|4|||
48755726|NCT01059786|156954156|FG003|Overall Study|Did not receive 6 cycles.|1|||
48755727|NCT01059786|156954157|FG004|Overall Study|Did not receive 6 cycles.|0|||
48755728|NCT05286307|156954164|FG000|Overall Study|Incomplete outcome assessments|2|||
48755729|NCT05286307|156954165|FG001|Overall Study|Incomplete outcome assessments|1|||
48755730|NCT05286307|156954164|FG000|Overall Study|Discovery of multi-ligamentous injury intra-operatively|0|||
48755731|NCT05286307|156954165|FG001|Overall Study|Discovery of multi-ligamentous injury intra-operatively|1|||
48755732|NCT05286307|156954164|FG000|Overall Study|Lost to follow up at 6 months|25|||
48755733|NCT05286307|156954165|FG001|Overall Study|Lost to follow up at 6 months|35|||
48755734|NCT05286307|156954164|FG000|Overall Study|Study medication not available|1|||
48755735|NCT05286307|156954165|FG001|Overall Study|Study medication not available|1|||
48755736|NCT00613938|156954166|FG000|Overall Study|Withdrawal by Subject|2|||
48755737|NCT00613938|156954167|FG001|Overall Study|Withdrawal by Subject|4|||
48755738|NCT00613938|156954168|FG002|Overall Study|Withdrawal by Subject|9|||
48755739|NCT00613938|156954169|FG003|Overall Study|Withdrawal by Subject|9|||
48755740|NCT00613938|156954166|FG000|Overall Study|Adverse Event|1|||
48755741|NCT00613938|156954167|FG001|Overall Study|Adverse Event|4|||
48755742|NCT00613938|156954168|FG002|Overall Study|Adverse Event|8|||
48755743|NCT00613938|156954169|FG003|Overall Study|Adverse Event|5|||
48755744|NCT00613938|156954166|FG000|Overall Study|Lack of Efficacy|16|||
48755745|NCT00613938|156954167|FG001|Overall Study|Lack of Efficacy|18|||
48755746|NCT00613938|156954168|FG002|Overall Study|Lack of Efficacy|5|||
48755747|NCT00613938|156954169|FG003|Overall Study|Lack of Efficacy|9|||
48755748|NCT00613938|156954166|FG000|Overall Study|Other|1|||
48755749|NCT00613938|156954167|FG001|Overall Study|Other|2|||
48755750|NCT00613938|156954168|FG002|Overall Study|Other|1|||
48755751|NCT00613938|156954169|FG003|Overall Study|Other|3|||
48755752|NCT00224055|156954176|FG000|Overall Study|Adverse Event|9|||
48755753|NCT00224055|156954177|FG001|Overall Study|Adverse Event|3|||
48866580|NCT03078751|157347579|FG000|Overall Study|Terminated by Sponsor = early terminated recruitment|0|||
48866581|NCT03078751|157347580|FG001|Overall Study|Terminated by Sponsor = early terminated recruitment|23|||
48866582|NCT03078751|157347579|FG000|Overall Study|Subject/guardian decision|8|||
48661955|NCT01904149|156614212|FG002|Overall Study|Lack of Efficacy|1|||
48661956|NCT01904149|156614213|FG003|Overall Study|Lack of Efficacy|3|||
48661957|NCT01904149|156614214|FG004|Overall Study|Lack of Efficacy|3|||
48755754|NCT00224055|156954176|FG000|Overall Study|Lost to Follow-up|1|||
48755755|NCT00224055|156954177|FG001|Overall Study|Lost to Follow-up|2|||
48755756|NCT00224055|156954176|FG000|Overall Study|Protocol Violation|1|||
48755757|NCT00224055|156954177|FG001|Overall Study|Protocol Violation|1|||
48755758|NCT00224055|156954176|FG000|Overall Study|Inclusion Violation|3|||
48755759|NCT00224055|156954177|FG001|Overall Study|Inclusion Violation|6|||
48755760|NCT00224055|156954176|FG000|Overall Study|Withdrawal by Subject|0|||
48866583|NCT03078751|157347580|FG001|Overall Study|Subject/guardian decision|1|||
48661958|NCT01904149|156614215|FG005|Overall Study|Lack of Efficacy|1|||
48661959|NCT01904149|156614210|FG000|Overall Study|Withdrawal by Subject|1|||
48661960|NCT01904149|156614211|FG001|Overall Study|Withdrawal by Subject|3|||
48661961|NCT01904149|156614212|FG002|Overall Study|Withdrawal by Subject|1|||
48661962|NCT01904149|156614213|FG003|Overall Study|Withdrawal by Subject|0|||
48661963|NCT01904149|156614214|FG004|Overall Study|Withdrawal by Subject|1|||
48661964|NCT01904149|156614215|FG005|Overall Study|Withdrawal by Subject|0|||
48661965|NCT01904149|156614210|FG000|Overall Study|Protocol Violation|0|||
48661966|NCT01904149|156614211|FG001|Overall Study|Protocol Violation|1|||
48661967|NCT01904149|156614212|FG002|Overall Study|Protocol Violation|0|||
48661968|NCT01904149|156614213|FG003|Overall Study|Protocol Violation|0|||
48661969|NCT01904149|156614214|FG004|Overall Study|Protocol Violation|0|||
48661970|NCT01904149|156614215|FG005|Overall Study|Protocol Violation|0|||
48661971|NCT01904149|156614210|FG000|Overall Study|non compliance with study drug|1|||
48661972|NCT01904149|156614211|FG001|Overall Study|non compliance with study drug|0|||
48661973|NCT01904149|156614212|FG002|Overall Study|non compliance with study drug|0|||
48866584|NCT03078751|157347579|FG000|Overall Study|Untreated|0|||
48866585|NCT03078751|157347580|FG001|Overall Study|Untreated|4|||
48866586|NCT04088136|157347588|FG000|Overall Study|Withdrawal by Subject|5|||
48866587|NCT04088136|157347589|FG001|Overall Study|Withdrawal by Subject|0|||
48866588|NCT04088136|157347588|FG000|Overall Study|Lack of Efficacy|0|||
48866589|NCT04088136|157347589|FG001|Overall Study|Lack of Efficacy|1|||
48866590|NCT01177228|157347590|FG000|Overall Study|Positive tuberculosis test|0|||
48755761|NCT00224055|156954177|FG001|Overall Study|Withdrawal by Subject|2|||
48755762|NCT00224055|156954176|FG000|Overall Study|Other|1|||
48755763|NCT00224055|156954177|FG001|Overall Study|Other|0|||
48755764|NCT01752907|156954186|FG000|Overall Study|Withdrawal by Subject|4|||
48866591|NCT01177228|157347591|FG001|Overall Study|Positive tuberculosis test|1|||
48866592|NCT01177228|157347592|FG002|Overall Study|Positive tuberculosis test|0|||
48866593|NCT01177228|157347593|FG003|Overall Study|Positive tuberculosis test|0|||
48866594|NCT01177228|157347590|FG000|Overall Study|Worsening disease activity|1|||
48866595|NCT01177228|157347591|FG001|Overall Study|Worsening disease activity|0|||
48661974|NCT01904149|156614213|FG003|Overall Study|non compliance with study drug|0|||
48661975|NCT01904149|156614214|FG004|Overall Study|non compliance with study drug|0|||
48661976|NCT01904149|156614215|FG005|Overall Study|non compliance with study drug|0|||
48661977|NCT01598753|156614216|FG000|Overall Study|Adverse Event|1|||
48661978|NCT01598753|156614217|FG001|Overall Study|Adverse Event|9|||
48661979|NCT01598753|156614218|FG002|Overall Study|Adverse Event|1|||
48661980|NCT01598753|156614219|FG003|Overall Study|Adverse Event|7|||
48661981|NCT01598753|156614216|FG000|Overall Study|Lost to Follow-up|4|||
48661982|NCT01598753|156614217|FG001|Overall Study|Lost to Follow-up|3|||
48661983|NCT01598753|156614218|FG002|Overall Study|Lost to Follow-up|7|||
48755765|NCT01752907|156954187|FG001|Overall Study|Withdrawal by Subject|10|||
48755766|NCT01752907|156954186|FG000|Overall Study|Lost to Follow-up|2|||
48755767|NCT01752907|156954187|FG001|Overall Study|Lost to Follow-up|1|||
48755768|NCT01752907|156954186|FG000|Overall Study|Decision by Sponsor|6|||
48755769|NCT01752907|156954187|FG001|Overall Study|Decision by Sponsor|9|||
48755770|NCT00696696|156954188|FG000|Overall Study|Adverse Event|5|||
48755771|NCT00696696|156954188|FG000|Overall Study|Withdrawal by Subject|8|||
48755772|NCT00696696|156954188|FG000|Overall Study|Physician Decision|2|||
48755773|NCT00696696|156954188|FG000|Overall Study|Death|3|||
48755774|NCT02642614|156954189|FG000|Overall Study|Adverse Event|1|||
48755775|NCT02642614|156954190|FG001|Overall Study|Adverse Event|1|||
48755776|NCT02642614|156954191|FG002|Overall Study|Adverse Event|2|||
48755777|NCT02642614|156954192|FG003|Overall Study|Adverse Event|2|||
48755778|NCT02642614|156954189|FG000|Overall Study|Lost to Follow-up|1|||
48755779|NCT02642614|156954190|FG001|Overall Study|Lost to Follow-up|0|||
48755780|NCT02642614|156954191|FG002|Overall Study|Lost to Follow-up|0|||
48755781|NCT02642614|156954192|FG003|Overall Study|Lost to Follow-up|0|||
48755782|NCT02642614|156954189|FG000|Overall Study|Withdrawal by Subject|1|||
48755783|NCT02642614|156954190|FG001|Overall Study|Withdrawal by Subject|1|||
48755784|NCT02642614|156954191|FG002|Overall Study|Withdrawal by Subject|0|||
48866596|NCT01177228|157347592|FG002|Overall Study|Worsening disease activity|0|||
48866597|NCT01177228|157347593|FG003|Overall Study|Worsening disease activity|0|||
48866598|NCT01177228|157347590|FG000|Overall Study|Withdrawal by Subject|0|||
48866599|NCT01177228|157347591|FG001|Overall Study|Withdrawal by Subject|1|||
48755785|NCT02642614|156954192|FG003|Overall Study|Withdrawal by Subject|0|||
48755786|NCT02450903|156954193|FG000|Overall Study|Adverse Event|3|||
48755787|NCT02450903|156954193|FG000|Overall Study|Progressive disease|15|||
48755788|NCT02450903|156954193|FG000|Overall Study|Switched to commercial drug|1|||
48755789|NCT02450903|156954193|FG000|Overall Study|Subject/guardian decision|1|||
48755790|NCT02279173|156954194|FG000|Overall Study|Protocol-specified Criteria|67|||
48755791|NCT02279173|156954194|FG000|Overall Study|Withdrawal by Subject|20|||
48755792|NCT02279173|156954194|FG000|Overall Study|Decision by Sponsor|4|||
48755793|NCT02279173|156954194|FG000|Overall Study|Lost to Follow-up|3|||
48755794|NCT00464087|156954197|FG000|Overall Study|No PCI per inclusion criteria|0|||
48755795|NCT00464087|156954198|FG001|Overall Study|No PCI per inclusion criteria|0|||
48755796|NCT00464087|156954199|FG002|Overall Study|No PCI per inclusion criteria|29|||
48755797|NCT03316131|156954200|FG000|Treatment Period 2|Protocol deviation|1|||
48866600|NCT01177228|157347592|FG002|Overall Study|Withdrawal by Subject|0|||
48866601|NCT01177228|157347593|FG003|Overall Study|Withdrawal by Subject|0|||
48866602|NCT00655668|157347594|FG000|Overall Study|Adverse Event|6|||
48866603|NCT00655668|157347594|FG000|Overall Study|Death|5|||
48866604|NCT00655668|157347594|FG000|Overall Study|Disease Progression|27|||
48866605|NCT00655668|157347594|FG000|Overall Study|Study Terminated|9|||
48866606|NCT00655668|157347594|FG000|Overall Study|Other|1|||
48866607|NCT00655668|157347594|FG000|Overall Study|New Lymphoma Treatment Started|4|||
48866608|NCT00655668|157347594|FG000|Overall Study|Withdrawal by Subject|2|||
48866609|NCT00006436|157347599|FG000|Overall Study|Refused further treatment|2|||
48866610|NCT00006436|157347599|FG000|Overall Study|Declined to participate (before treatment started)|1|||
48866611|NCT00316589|157347600|FG000|Overall Study|Withdrawal by Subject|0|||
48866612|NCT00316589|157347601|FG001|Overall Study|Withdrawal by Subject|5|||
48866613|NCT00316589|157347602|FG002|Overall Study|Withdrawal by Subject|0|||
48866614|NCT00316589|157347603|FG003|Overall Study|Withdrawal by Subject|1|||
48866615|NCT00316589|157347600|FG000|Overall Study|Subject unwilling/unable to comply|0|||
48866616|NCT00316589|157347601|FG001|Overall Study|Subject unwilling/unable to comply|6|||
48866617|NCT00316589|157347602|FG002|Overall Study|Subject unwilling/unable to comply|0|||
48866618|NCT00316589|157347603|FG003|Overall Study|Subject unwilling/unable to comply|2|||
48866619|NCT00316589|157347600|FG000|Overall Study|Adverse Event|1|||
48866620|NCT00316589|157347601|FG001|Overall Study|Adverse Event|0|||
48866621|NCT00316589|157347602|FG002|Overall Study|Adverse Event|0|||
48866622|NCT00316589|157347603|FG003|Overall Study|Adverse Event|1|||
48866623|NCT00316589|157347600|FG000|Overall Study|Physician Decision|0|||
48866624|NCT00316589|157347601|FG001|Overall Study|Physician Decision|1|||
48866625|NCT00316589|157347602|FG002|Overall Study|Physician Decision|0|||
48866626|NCT00316589|157347603|FG003|Overall Study|Physician Decision|0|||
48866627|NCT00316589|157347600|FG000|Overall Study|Other reason|0|||
48866628|NCT00316589|157347601|FG001|Overall Study|Other reason|12|||
48866629|NCT00316589|157347602|FG002|Overall Study|Other reason|1|||
48866630|NCT00316589|157347603|FG003|Overall Study|Other reason|1|||
48661984|NCT01598753|156614219|FG003|Overall Study|Lost to Follow-up|5|||
48661985|NCT01598753|156614216|FG000|Overall Study|Physician Decision|0|||
48661986|NCT01598753|156614217|FG001|Overall Study|Physician Decision|1|||
48755798|NCT03316131|156954201|FG001|Treatment Period 2|Protocol deviation|0|||
48755799|NCT01409564|156954202|FG000|Overall Study|low medication compliance|4|||
48965196|NCT00383721|157700305|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|2|||
48965197|NCT00383721|157700306|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
48661987|NCT01598753|156614218|FG002|Overall Study|Physician Decision|0|||
48661988|NCT01598753|156614219|FG003|Overall Study|Physician Decision|2|||
48661989|NCT01598753|156614216|FG000|Overall Study|Withdrawal by Subject|7|||
48661990|NCT01598753|156614217|FG001|Overall Study|Withdrawal by Subject|2|||
48661991|NCT01598753|156614218|FG002|Overall Study|Withdrawal by Subject|0|||
48661992|NCT01598753|156614219|FG003|Overall Study|Withdrawal by Subject|1|||
48661993|NCT00953524|156614220|FG000|Overall Study|Adverse Event|2|||
48661994|NCT00953524|156614221|FG001|Overall Study|Adverse Event|0|||
48661995|NCT00953524|156614222|FG002|Overall Study|Adverse Event|1|||
48661996|NCT00953524|156614223|FG003|Overall Study|Adverse Event|2|||
48661997|NCT00953524|156614220|FG000|Overall Study|Protocol Violation|18|||
48661998|NCT00953524|156614221|FG001|Overall Study|Protocol Violation|10|||
48661999|NCT00953524|156614222|FG002|Overall Study|Protocol Violation|11|||
48662000|NCT00953524|156614223|FG003|Overall Study|Protocol Violation|6|||
48662001|NCT00953524|156614220|FG000|Overall Study|Lost to Follow-up|0|||
48662002|NCT00953524|156614221|FG001|Overall Study|Lost to Follow-up|1|||
48662003|NCT00953524|156614222|FG002|Overall Study|Lost to Follow-up|1|||
48662004|NCT00953524|156614223|FG003|Overall Study|Lost to Follow-up|0|||
48662005|NCT00953524|156614220|FG000|Overall Study|Withdrawal by Subject|2|||
48662006|NCT00953524|156614221|FG001|Overall Study|Withdrawal by Subject|4|||
48662007|NCT00953524|156614222|FG002|Overall Study|Withdrawal by Subject|1|||
48662008|NCT00953524|156614223|FG003|Overall Study|Withdrawal by Subject|0|||
48662009|NCT01371643|156614224|FG000|Overall Study|Withdrawal by Subject|3|||
48662010|NCT01371643|156614225|FG001|Overall Study|Withdrawal by Subject|0|||
48662011|NCT02699450|156614226|FG000|Overall Study|Death|2|||
48662012|NCT02699450|156614227|FG001|Overall Study|Death|1|||
48662013|NCT02699450|156614228|FG002|Overall Study|Death|2|||
48662014|NCT02699450|156614226|FG000|Overall Study|Met Criteria for Study Exit|0|||
48662015|NCT02699450|156614227|FG001|Overall Study|Met Criteria for Study Exit|0|||
48662016|NCT02699450|156614228|FG002|Overall Study|Met Criteria for Study Exit|1|||
48662017|NCT02699450|156614226|FG000|Overall Study|Protocol Violation|4|||
48662018|NCT02699450|156614227|FG001|Overall Study|Protocol Violation|3|||
48662019|NCT02699450|156614228|FG002|Overall Study|Protocol Violation|5|||
48662020|NCT02699450|156614226|FG000|Overall Study|Lost to Follow-up|3|||
48662021|NCT02699450|156614227|FG001|Overall Study|Lost to Follow-up|0|||
48662022|NCT02699450|156614228|FG002|Overall Study|Lost to Follow-up|5|||
48662023|NCT02699450|156614226|FG000|Overall Study|Physician Decision|2|||
48662024|NCT02699450|156614227|FG001|Overall Study|Physician Decision|0|||
48662025|NCT02699450|156614228|FG002|Overall Study|Physician Decision|0|||
48662026|NCT02699450|156614226|FG000|Overall Study|Withdrawal by Subject|3|||
48662027|NCT02699450|156614227|FG001|Overall Study|Withdrawal by Subject|1|||
48662028|NCT02699450|156614228|FG002|Overall Study|Withdrawal by Subject|2|||
48662029|NCT02699450|156614226|FG000|Overall Study|Adverse Event|1|||
48662030|NCT02699450|156614227|FG001|Overall Study|Adverse Event|0|||
48662031|NCT02699450|156614228|FG002|Overall Study|Adverse Event|0|||
48662032|NCT00033540|156614229|FG000|Overall Study|Adverse Event|14|||
48662033|NCT00033540|156614229|FG000|Overall Study|Death|1|||
48662034|NCT00033540|156614229|FG000|Overall Study|Progression|26|||
48662035|NCT00033540|156614229|FG000|Overall Study|Withdrawal by Subject|6|||
48662036|NCT00033540|156614229|FG000|Overall Study|Other|5|||
48755800|NCT01409564|156954203|FG001|Overall Study|low medication compliance|3|||
48755801|NCT01409564|156954202|FG000|Overall Study|brain abnormalities found in T1 MR|1|||
48755802|NCT01409564|156954203|FG001|Overall Study|brain abnormalities found in T1 MR|2|||
48755803|NCT00592839|156954204|FG000|Overall Study|Withdrawal by Subject|1|||
48755804|NCT00592839|156954205|FG001|Overall Study|Withdrawal by Subject|1|||
48755805|NCT00592839|156954206|FG002|Overall Study|Withdrawal by Subject|3|||
48755806|NCT00592839|156954204|FG000|Overall Study|Protocol Violation|1|||
48755807|NCT00592839|156954205|FG001|Overall Study|Protocol Violation|1|||
48662037|NCT00033540|156614229|FG000|Overall Study|Ineligible|3|||
48662038|NCT00033540|156614229|FG000|Overall Study|Never received treatment|2|||
48662039|NCT00042432|156614232|FG000|Overall Study|Adverse Event|4|||
48662040|NCT00042432|156614233|FG001|Overall Study|Adverse Event|1|||
48662041|NCT00042432|156614232|FG000|Overall Study|Withdrawal by Subject|1|||
48755808|NCT00592839|156954206|FG002|Overall Study|Protocol Violation|2|||
48662042|NCT00042432|156614233|FG001|Overall Study|Withdrawal by Subject|3|||
48662043|NCT00042432|156614232|FG000|Overall Study|Death|0|||
48662044|NCT00042432|156614233|FG001|Overall Study|Death|2|||
48662045|NCT00042432|156614232|FG000|Overall Study|Ineligibility determined|1|||
48662046|NCT00042432|156614233|FG001|Overall Study|Ineligibility determined|0|||
48662047|NCT00042432|156614232|FG000|Overall Study|Initiation of maintenance dialysis|1|||
48662048|NCT00042432|156614233|FG001|Overall Study|Initiation of maintenance dialysis|1|||
48662049|NCT00042432|156614232|FG000|Overall Study|Other|2|||
48662050|NCT00042432|156614233|FG001|Overall Study|Other|0|||
48662051|NCT02653495|156614238|FG000|Overall Study|Lost to Follow-up|2|||
48866631|NCT00443599|157347606|FG000|Overall Study|Physician Decision|2|||
48866632|NCT00443599|157347607|FG001|Overall Study|Physician Decision|1|||
48866633|NCT00443599|157347606|FG000|Overall Study|Death|1|||
48866634|NCT00443599|157347607|FG001|Overall Study|Death|1|||
48866635|NCT00443599|157347606|FG000|Overall Study|Cardiopulmonary bypass canceled|3|||
48866636|NCT00443599|157347607|FG001|Overall Study|Cardiopulmonary bypass canceled|1|||
48866637|NCT01064856|157347608|FG000|Double-blind (DB) Period|Adverse Event|1|||
48866638|NCT01064856|157347609|FG001|Double-blind (DB) Period|Adverse Event|0|||
48866639|NCT01064856|157347610|FG002|Double-blind (DB) Period|Adverse Event|0|||
48866640|NCT01064856|157347611|FG003|Double-blind (DB) Period|Adverse Event|0|||
48866641|NCT01064856|157347608|FG000|Double-blind (DB) Period|Consent withdrawn by participant|1|||
48866642|NCT01064856|157347609|FG001|Double-blind (DB) Period|Consent withdrawn by participant|0|||
48965198|NCT00383721|157700307|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
48965199|NCT00383721|157700308|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
48662052|NCT02653495|156614239|FG001|Overall Study|Lost to Follow-up|0|||
48662053|NCT02653495|156614238|FG000|Overall Study|Screening Failure|10|||
48662054|NCT02653495|156614239|FG001|Overall Study|Screening Failure|0|||
48662055|NCT02256267|156614240|FG000|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1|||
48662056|NCT02256267|156614240|FG000|Period 2 (Day 7 to Day 14)|Adverse Event|1|||
48662059|NCT02908685|156615787|FG000|Part 1 OLE|Withdrawal by Subject|0|||
48662060|NCT02908685|156615788|FG001|Part 1 OLE|Withdrawal by Subject|0|||
48662061|NCT02908685|156615789|FG002|Part 1 OLE|Withdrawal by Subject|0|||
48662062|NCT02908685|156615790|FG003|Part 1 OLE|Withdrawal by Subject|0|||
48662063|NCT02908685|156615791|FG004|Part 1 OLE|Withdrawal by Subject|0|||
48662064|NCT02908685|156615792|FG005|Part 1 OLE|Withdrawal by Subject|0|||
48662065|NCT02908685|156615793|FG006|Part 1 OLE|Withdrawal by Subject|0|||
48662066|NCT02908685|156615794|FG007|Part 1 OLE|Withdrawal by Subject|0|||
48662067|NCT02908685|156615795|FG008|Part 1 OLE|Withdrawal by Subject|0|||
48662068|NCT02908685|156615796|FG009|Part 1 OLE|Withdrawal by Subject|0|||
48662069|NCT02908685|156615797|FG010|Part 1 OLE|Withdrawal by Subject|2|||
48662070|NCT02908685|156615798|FG011|Part 1 OLE|Withdrawal by Subject|1|||
48662071|NCT02908685|156615799|FG012|Part 1 OLE|Withdrawal by Subject|0|||
48662072|NCT02908685|156615800|FG013|Part 1 OLE|Withdrawal by Subject|0|||
48662073|NCT02908685|156615787|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
48662074|NCT02908685|156615788|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
48662075|NCT02908685|156615789|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
48662076|NCT02908685|156615790|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
48662077|NCT02908685|156615791|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
48662078|NCT02908685|156615792|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
48662079|NCT02908685|156615793|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
48662080|NCT02908685|156615794|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
48662081|NCT02908685|156615795|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
48662082|NCT02908685|156615796|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
48662083|NCT02908685|156615797|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
48662084|NCT02908685|156615798|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
48662085|NCT02908685|156615799|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|2|||
48662086|NCT02908685|156615800|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|1|||
48662087|NCT02908685|156615787|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
48662088|NCT02908685|156615788|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
48662089|NCT02908685|156615789|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
48662090|NCT02908685|156615790|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
48662091|NCT02908685|156615791|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
48662092|NCT02908685|156615792|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
48662093|NCT02908685|156615793|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
48662094|NCT02908685|156615794|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
48662095|NCT02908685|156615795|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
48662096|NCT02908685|156615796|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
48662097|NCT02908685|156615797|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
48662098|NCT02908685|156615798|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
48662099|NCT02908685|156615799|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|1|||
48662100|NCT02908685|156615800|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
48662101|NCT02908685|156615787|FG000|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
48662102|NCT02908685|156615788|FG001|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
48662103|NCT02908685|156615789|FG002|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
48662104|NCT02908685|156615790|FG003|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
48662105|NCT02908685|156615791|FG004|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
48662106|NCT02908685|156615792|FG005|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
48662107|NCT02908685|156615793|FG006|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
48965200|NCT00383721|157700309|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
48965201|NCT00383721|157700305|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
48965202|NCT00383721|157700306|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
48965203|NCT00383721|157700307|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
48965204|NCT00383721|157700308|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
48965205|NCT00383721|157700309|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
48965206|NCT00383721|157700305|FG000|26-Week Treatment Safety Extension|Administrative|1|||
49015450|NCT01393990|157893782|FG012|Overall Study|Adverse Event|0|||
48755809|NCT00592839|156954204|FG000|Overall Study|Adverse Event|0|||
48755810|NCT00592839|156954205|FG001|Overall Study|Adverse Event|1|||
48755811|NCT00592839|156954206|FG002|Overall Study|Adverse Event|0|||
48755812|NCT00592839|156954204|FG000|Overall Study|Lost to Follow-up|0|||
48755813|NCT00592839|156954205|FG001|Overall Study|Lost to Follow-up|1|||
48755814|NCT00592839|156954206|FG002|Overall Study|Lost to Follow-up|1|||
48755815|NCT02511184|156954207|FG000|Overall Study|Death|1|||
48755816|NCT02511184|156954208|FG001|Overall Study|Death|0|||
48755817|NCT02511184|156954207|FG000|Overall Study|Lost to Follow-up|0|||
48755818|NCT02511184|156954208|FG001|Overall Study|Lost to Follow-up|1|||
48755819|NCT02511184|156954207|FG000|Overall Study|Study terminated by sponsor|1|||
48755820|NCT02511184|156954208|FG001|Overall Study|Study terminated by sponsor|5|||
48755821|NCT02511184|156954207|FG000|Overall Study|Withdrawal by Subject|0|||
48755822|NCT02511184|156954208|FG001|Overall Study|Withdrawal by Subject|1|||
48755823|NCT00157950|156954211|FG000|Overall Study|Death|1|||
48755824|NCT00157950|156954212|FG001|Overall Study|Death|0|||
48755825|NCT01529346|156954213|FG000|Overall Study|Lost to Follow-up|2|||
48755826|NCT01529346|156954214|FG001|Overall Study|Lost to Follow-up|0|||
48755827|NCT01529346|156954215|FG002|Overall Study|Lost to Follow-up|1|||
48755828|NCT01529346|156954216|FG003|Overall Study|Lost to Follow-up|0|||
48755829|NCT01529346|156954217|FG004|Overall Study|Lost to Follow-up|0|||
48755830|NCT01529346|156954213|FG000|Overall Study|Other|0|||
48755831|NCT01529346|156954214|FG001|Overall Study|Other|1|||
48755832|NCT01529346|156954215|FG002|Overall Study|Other|1|||
48755833|NCT01529346|156954216|FG003|Overall Study|Other|0|||
48755834|NCT01529346|156954217|FG004|Overall Study|Other|0|||
48755835|NCT02554812|156954230|FG000|Overall Study|Adverse Event|2|||
48755836|NCT02554812|156954231|FG001|Overall Study|Adverse Event|5|||
48755837|NCT02554812|156954232|FG002|Overall Study|Adverse Event|3|||
48755838|NCT02554812|156954233|FG003|Overall Study|Adverse Event|0|||
48755839|NCT02554812|156954234|FG004|Overall Study|Adverse Event|5|||
48755840|NCT02554812|156954235|FG005|Overall Study|Adverse Event|0|||
48755841|NCT02554812|156954236|FG006|Overall Study|Adverse Event|1|||
48755842|NCT02554812|156954237|FG007|Overall Study|Adverse Event|6|||
48755843|NCT02554812|156954238|FG008|Overall Study|Adverse Event|2|||
48755844|NCT02554812|156954239|FG009|Overall Study|Adverse Event|2|||
48755845|NCT02554812|156954240|FG010|Overall Study|Adverse Event|1|||
48755846|NCT02554812|156954241|FG011|Overall Study|Adverse Event|2|||
48755847|NCT02554812|156954242|FG012|Overall Study|Adverse Event|0|||
48755848|NCT02554812|156954243|FG013|Overall Study|Adverse Event|3|||
48755849|NCT02554812|156954244|FG014|Overall Study|Adverse Event|2|||
48755850|NCT02554812|156954245|FG015|Overall Study|Adverse Event|1|||
48755851|NCT02554812|156954246|FG016|Overall Study|Adverse Event|0|||
48755852|NCT02554812|156954247|FG017|Overall Study|Adverse Event|1|||
48755853|NCT02554812|156954248|FG018|Overall Study|Adverse Event|0|||
48755854|NCT02554812|156954249|FG019|Overall Study|Adverse Event|0|||
48755855|NCT02554812|156954250|FG020|Overall Study|Adverse Event|0|||
48755856|NCT02554812|156954251|FG021|Overall Study|Adverse Event|2|||
48755857|NCT02554812|156954252|FG022|Overall Study|Adverse Event|1|||
48755858|NCT02554812|156954253|FG023|Overall Study|Adverse Event|1|||
48755859|NCT02554812|156954254|FG024|Overall Study|Adverse Event|1|||
48755860|NCT02554812|156954255|FG025|Overall Study|Adverse Event|2|||
48755861|NCT02554812|156954256|FG026|Overall Study|Adverse Event|1|||
48755862|NCT02554812|156954230|FG000|Overall Study|Death|1|||
48755863|NCT02554812|156954231|FG001|Overall Study|Death|2|||
48755864|NCT02554812|156954232|FG002|Overall Study|Death|2|||
48755865|NCT02554812|156954233|FG003|Overall Study|Death|2|||
48755866|NCT02554812|156954234|FG004|Overall Study|Death|0|||
48755867|NCT02554812|156954235|FG005|Overall Study|Death|1|||
48755868|NCT02554812|156954236|FG006|Overall Study|Death|1|||
48755869|NCT02554812|156954237|FG007|Overall Study|Death|1|||
48755870|NCT02554812|156954238|FG008|Overall Study|Death|0|||
48755871|NCT02554812|156954239|FG009|Overall Study|Death|0|||
48755872|NCT02554812|156954240|FG010|Overall Study|Death|0|||
48755873|NCT02554812|156954241|FG011|Overall Study|Death|0|||
48755874|NCT02554812|156954242|FG012|Overall Study|Death|0|||
48755875|NCT02554812|156954243|FG013|Overall Study|Death|0|||
48755876|NCT02554812|156954244|FG014|Overall Study|Death|1|||
48755877|NCT02554812|156954245|FG015|Overall Study|Death|1|||
48755878|NCT02554812|156954246|FG016|Overall Study|Death|1|||
48755879|NCT02554812|156954247|FG017|Overall Study|Death|0|||
48755880|NCT02554812|156954248|FG018|Overall Study|Death|1|||
48755881|NCT02554812|156954249|FG019|Overall Study|Death|2|||
48755882|NCT02554812|156954250|FG020|Overall Study|Death|0|||
48965207|NCT00383721|157700306|FG001|26-Week Treatment Safety Extension|Administrative|2|||
48965208|NCT00383721|157700307|FG002|26-Week Treatment Safety Extension|Administrative|3|||
48965209|NCT00383721|157700308|FG003|26-Week Treatment Safety Extension|Administrative|1|||
48965210|NCT00383721|157700309|FG004|26-Week Treatment Safety Extension|Administrative|0|||
48965211|NCT03814590|157700310|FG000|Overall Study|Adverse Event|0|||
48965212|NCT03814590|157700311|FG001|Overall Study|Adverse Event|0|||
48965213|NCT03814590|157700312|FG002|Overall Study|Adverse Event|0|||
48965214|NCT03814590|157700313|FG003|Overall Study|Adverse Event|0|||
48965215|NCT03814590|157700314|FG004|Overall Study|Adverse Event|0|||
48965216|NCT03814590|157700315|FG005|Overall Study|Adverse Event|1|||
48662108|NCT02908685|156615794|FG007|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
48662109|NCT02908685|156615795|FG008|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
48662110|NCT02908685|156615796|FG009|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
48662111|NCT02908685|156615797|FG010|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
48662112|NCT02908685|156615798|FG011|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
48662113|NCT02908685|156615799|FG012|Part 2 OLT: Month 12-24|Withdrawal by Subject|1|||
48662114|NCT02908685|156615800|FG013|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
48662115|NCT02908685|156615787|FG000|Part 2 OLE: > Month 24|Death|0|||
48662116|NCT02908685|156615788|FG001|Part 2 OLE: > Month 24|Death|0|||
48662117|NCT02908685|156615789|FG002|Part 2 OLE: > Month 24|Death|0|||
48662118|NCT02908685|156615790|FG003|Part 2 OLE: > Month 24|Death|0|||
48662119|NCT02908685|156615791|FG004|Part 2 OLE: > Month 24|Death|0|||
48662120|NCT02908685|156615792|FG005|Part 2 OLE: > Month 24|Death|0|||
48662121|NCT02908685|156615793|FG006|Part 2 OLE: > Month 24|Death|0|||
48662122|NCT02908685|156615794|FG007|Part 2 OLE: > Month 24|Death|0|||
48662123|NCT02908685|156615795|FG008|Part 2 OLE: > Month 24|Death|0|||
48662124|NCT02908685|156615796|FG009|Part 2 OLE: > Month 24|Death|0|||
48662125|NCT02908685|156615797|FG010|Part 2 OLE: > Month 24|Death|0|||
48662126|NCT02908685|156615798|FG011|Part 2 OLE: > Month 24|Death|0|||
48662127|NCT02908685|156615799|FG012|Part 2 OLE: > Month 24|Death|1|||
48662128|NCT02908685|156615800|FG013|Part 2 OLE: > Month 24|Death|0|||
48662129|NCT02908685|156615787|FG000|Part 2 OLE: > Month 24|Reason not specified|0|||
48662130|NCT02908685|156615788|FG001|Part 2 OLE: > Month 24|Reason not specified|0|||
48662131|NCT02908685|156615789|FG002|Part 2 OLE: > Month 24|Reason not specified|0|||
48662132|NCT02908685|156615790|FG003|Part 2 OLE: > Month 24|Reason not specified|0|||
48662133|NCT02908685|156615791|FG004|Part 2 OLE: > Month 24|Reason not specified|0|||
48662134|NCT02908685|156615792|FG005|Part 2 OLE: > Month 24|Reason not specified|0|||
48662135|NCT02908685|156615793|FG006|Part 2 OLE: > Month 24|Reason not specified|0|||
48662136|NCT02908685|156615794|FG007|Part 2 OLE: > Month 24|Reason not specified|0|||
48662137|NCT02908685|156615795|FG008|Part 2 OLE: > Month 24|Reason not specified|0|||
48662138|NCT02908685|156615796|FG009|Part 2 OLE: > Month 24|Reason not specified|0|||
48662139|NCT02908685|156615797|FG010|Part 2 OLE: > Month 24|Reason not specified|0|||
48662140|NCT02908685|156615798|FG011|Part 2 OLE: > Month 24|Reason not specified|0|||
48662141|NCT02908685|156615799|FG012|Part 2 OLE: > Month 24|Reason not specified|2|||
48662142|NCT02908685|156615800|FG013|Part 2 OLE: > Month 24|Reason not specified|1|||
48662143|NCT02908685|156615787|FG000|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
48662144|NCT02908685|156615788|FG001|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
48662145|NCT02908685|156615789|FG002|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
48662146|NCT02908685|156615790|FG003|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
48662147|NCT02908685|156615791|FG004|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
48662148|NCT02908685|156615792|FG005|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
48662149|NCT02908685|156615793|FG006|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
48662150|NCT02908685|156615794|FG007|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
48662151|NCT02908685|156615795|FG008|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
48662152|NCT02908685|156615796|FG009|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
48662153|NCT02908685|156615797|FG010|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
48662154|NCT02908685|156615798|FG011|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
48662155|NCT02908685|156615799|FG012|Part 2 OLE: > Month 24|Withdrawal by Subject|10|||
48662156|NCT02908685|156615800|FG013|Part 2 OLE: > Month 24|Withdrawal by Subject|5|||
48662157|NCT00983515|156615801|FG000|Ritonavir Alone|liver panel out of range|6|||
48662158|NCT00983515|156615801|FG000|Colchicine With Ritonavir|Lost to Follow-up|1|||
48662159|NCT01730339|156615803|FG000|Overall Study|Withdrawal by Subject|3|||
48662160|NCT01730339|156615804|FG001|Overall Study|Withdrawal by Subject|2|||
48662161|NCT01730339|156615803|FG000|Overall Study|Lost to Follow-up|1|||
48662162|NCT01730339|156615804|FG001|Overall Study|Lost to Follow-up|1|||
48662163|NCT01730339|156615803|FG000|Overall Study|Un-specified|1|||
48662164|NCT01730339|156615804|FG001|Overall Study|Un-specified|0|||
48662165|NCT03733028|156615808|FG000|Overall Study|Study was stopped by PI|1|||
48662166|NCT03733028|156615809|FG001|Overall Study|Study was stopped by PI|2|||
48662167|NCT04569136|156615810|FG000|Overall Study|Lost to Follow-up|2|||
48965217|NCT03814590|157700316|FG006|Overall Study|Adverse Event|1|||
48662168|NCT04569136|156615811|FG001|Overall Study|Lost to Follow-up|0|||
48662169|NCT04569136|156615812|FG002|Overall Study|Lost to Follow-up|1|||
48662170|NCT02116530|156615815|FG000|Overall Study|Withdrawal by Subject|1|||
48662171|NCT02116530|156615816|FG001|Overall Study|Withdrawal by Subject|2|||
48662172|NCT02116530|156615815|FG000|Overall Study|Adverse Event|4|||
48662173|NCT02116530|156615816|FG001|Overall Study|Adverse Event|0|||
48662174|NCT02116530|156615815|FG000|Overall Study|Physician Decision|1|||
48662175|NCT02116530|156615816|FG001|Overall Study|Physician Decision|0|||
48662176|NCT02116530|156615815|FG000|Overall Study|Lost to Follow-up|1|||
48662177|NCT02116530|156615816|FG001|Overall Study|Lost to Follow-up|0|||
48662178|NCT02116530|156615815|FG000|Overall Study|Other Medical Problems|2|||
48662179|NCT02116530|156615816|FG001|Overall Study|Other Medical Problems|2|||
48662180|NCT02233738|156615821|FG000|Overall Study|Lost to Follow-up|5|||
48662181|NCT02233738|156615822|FG001|Overall Study|Lost to Follow-up|12|||
48755883|NCT02554812|156954251|FG021|Overall Study|Death|1|||
48755884|NCT02554812|156954252|FG022|Overall Study|Death|1|||
48755885|NCT02554812|156954253|FG023|Overall Study|Death|0|||
48755886|NCT02554812|156954254|FG024|Overall Study|Death|0|||
48755887|NCT02554812|156954255|FG025|Overall Study|Death|0|||
48755888|NCT02554812|156954256|FG026|Overall Study|Death|0|||
48755889|NCT02554812|156954230|FG000|Overall Study|Lost to Follow-up|0|||
48755890|NCT02554812|156954231|FG001|Overall Study|Lost to Follow-up|1|||
48755891|NCT02554812|156954232|FG002|Overall Study|Lost to Follow-up|0|||
48755892|NCT02554812|156954233|FG003|Overall Study|Lost to Follow-up|0|||
48755893|NCT02554812|156954234|FG004|Overall Study|Lost to Follow-up|0|||
48755894|NCT02554812|156954235|FG005|Overall Study|Lost to Follow-up|0|||
48755895|NCT02554812|156954236|FG006|Overall Study|Lost to Follow-up|0|||
48755896|NCT02554812|156954237|FG007|Overall Study|Lost to Follow-up|0|||
48755897|NCT02554812|156954238|FG008|Overall Study|Lost to Follow-up|0|||
48755898|NCT02554812|156954239|FG009|Overall Study|Lost to Follow-up|0|||
48755899|NCT02554812|156954240|FG010|Overall Study|Lost to Follow-up|0|||
48755900|NCT02554812|156954241|FG011|Overall Study|Lost to Follow-up|0|||
48755901|NCT02554812|156954242|FG012|Overall Study|Lost to Follow-up|0|||
48755902|NCT02554812|156954243|FG013|Overall Study|Lost to Follow-up|0|||
48755903|NCT02554812|156954244|FG014|Overall Study|Lost to Follow-up|0|||
48755904|NCT02554812|156954245|FG015|Overall Study|Lost to Follow-up|0|||
48965218|NCT03814590|157700317|FG007|Overall Study|Adverse Event|1|||
48965219|NCT03814590|157700318|FG008|Overall Study|Adverse Event|0|||
48965220|NCT03814590|157700319|FG009|Overall Study|Adverse Event|0|||
48965221|NCT03814590|157700320|FG010|Overall Study|Adverse Event|1|||
48965222|NCT03814590|157700321|FG011|Overall Study|Adverse Event|0|||
48965223|NCT03814590|157700322|FG012|Overall Study|Adverse Event|3|||
48965224|NCT03814590|157700323|FG013|Overall Study|Adverse Event|0|||
48662182|NCT02233738|156615821|FG000|Overall Study|Death|0|||
48662183|NCT02233738|156615822|FG001|Overall Study|Death|1|||
48662184|NCT02233738|156615821|FG000|Overall Study|Withdrawal by Subject|0|||
48662185|NCT02233738|156615822|FG001|Overall Study|Withdrawal by Subject|1|||
48662186|NCT02233738|156615821|FG000|Overall Study|Did not return after Baseline|3|||
48662187|NCT02233738|156615822|FG001|Overall Study|Did not return after Baseline|2|||
48662188|NCT03028480|156615823|FG000|Overall Study|No revisit after the first prescription date|2|||
48662189|NCT03028480|156615823|FG000|Overall Study|Did not use the drug|1|||
48662190|NCT03028480|156615823|FG000|Overall Study|Violation of the enrollment deadline|10|||
48662191|NCT03028480|156615823|FG000|Overall Study|Case report forms were not collected|21|||
48965225|NCT03814590|157700310|FG000|Overall Study|Lost to Follow-up|0|||
48965226|NCT03814590|157700311|FG001|Overall Study|Lost to Follow-up|2|||
48965227|NCT03814590|157700312|FG002|Overall Study|Lost to Follow-up|1|||
48662192|NCT01062841|156615825|FG000|Overall Study|Indwelling Device Removed|41|||
48662193|NCT01062841|156615826|FG001|Overall Study|Indwelling Device Removed|48|||
48662194|NCT01062841|156615825|FG000|Overall Study|Death|3|||
48662195|NCT01062841|156615826|FG001|Overall Study|Death|5|||
48662196|NCT01062841|156615825|FG000|Overall Study|Withdrawal by Subject|2|||
48662197|NCT01062841|156615826|FG001|Overall Study|Withdrawal by Subject|0|||
48965228|NCT03814590|157700313|FG003|Overall Study|Lost to Follow-up|0|||
48662198|NCT01062841|156615825|FG000|Overall Study|Withdrawal by Study|3|||
48662199|NCT01062841|156615826|FG001|Overall Study|Withdrawal by Study|0|||
48755905|NCT02554812|156954246|FG016|Overall Study|Lost to Follow-up|0|||
48755906|NCT02554812|156954247|FG017|Overall Study|Lost to Follow-up|0|||
48755907|NCT02554812|156954248|FG018|Overall Study|Lost to Follow-up|0|||
48755908|NCT02554812|156954249|FG019|Overall Study|Lost to Follow-up|0|||
48662200|NCT02046174|156615827|FG000|Overall Study|Too many adhesions to receive implant (at time of surgery).|1|||
48662201|NCT02046174|156615828|FG001|Overall Study|Too many adhesions to receive implant (at time of surgery).|0|||
48662202|NCT01367704|156615832|FG000|Overall Study|Lost to Follow-up|47|||
48662203|NCT01367704|156615833|FG001|Overall Study|Lost to Follow-up|161|||
48755909|NCT02554812|156954250|FG020|Overall Study|Lost to Follow-up|0|||
48755910|NCT02554812|156954251|FG021|Overall Study|Lost to Follow-up|0|||
48755911|NCT02554812|156954252|FG022|Overall Study|Lost to Follow-up|0|||
48965229|NCT03814590|157700314|FG004|Overall Study|Lost to Follow-up|1|||
48965230|NCT03814590|157700315|FG005|Overall Study|Lost to Follow-up|1|||
48662204|NCT03220581|156615834|FG000|Overall Study|Withdrawal by Subject|0|||
48755912|NCT02554812|156954253|FG023|Overall Study|Lost to Follow-up|0|||
48755913|NCT02554812|156954254|FG024|Overall Study|Lost to Follow-up|0|||
48965231|NCT03814590|157700316|FG006|Overall Study|Lost to Follow-up|1|||
48965232|NCT03814590|157700317|FG007|Overall Study|Lost to Follow-up|1|||
48965233|NCT03814590|157700318|FG008|Overall Study|Lost to Follow-up|0|||
48965234|NCT03814590|157700319|FG009|Overall Study|Lost to Follow-up|0|||
48662205|NCT03220581|156615835|FG001|Overall Study|Withdrawal by Subject|1|||
48662206|NCT03220581|156615834|FG000|Overall Study|Lost to Follow-up|3|||
48662207|NCT03220581|156615835|FG001|Overall Study|Lost to Follow-up|6|||
48662208|NCT03831880|156615839|FG000|Period 1 (12 Weeks)|Adverse event, not serious|0|||
48662209|NCT03831880|156615840|FG001|Period 1 (12 Weeks)|Adverse event, not serious|1|||
48662210|NCT03831880|156615839|FG000|Period 2 (12 Weeks)|Protocol Deviation|0|||
48662211|NCT03831880|156615840|FG001|Period 2 (12 Weeks)|Protocol Deviation|1|||
48662212|NCT03958656|156615841|FG000|Overall Study|Received anti-myeloma prescription (Rx)|0|||
48662213|NCT03958656|156615842|FG001|Overall Study|Received anti-myeloma prescription (Rx)|1|||
48662214|NCT03958656|156615843|FG002|Overall Study|Received anti-myeloma prescription (Rx)|0|||
48965235|NCT03814590|157700320|FG010|Overall Study|Lost to Follow-up|1|||
48965236|NCT03814590|157700321|FG011|Overall Study|Lost to Follow-up|0|||
48965237|NCT03814590|157700322|FG012|Overall Study|Lost to Follow-up|0|||
48965238|NCT03814590|157700323|FG013|Overall Study|Lost to Follow-up|1|||
48965239|NCT03814590|157700310|FG000|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
48965240|NCT03814590|157700311|FG001|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
48965241|NCT03814590|157700312|FG002|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
48965242|NCT03814590|157700313|FG003|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
48965243|NCT03814590|157700314|FG004|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
48965244|NCT03814590|157700315|FG005|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
48965245|NCT03814590|157700316|FG006|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
48965246|NCT03814590|157700317|FG007|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
48662215|NCT03958656|156615844|FG003|Overall Study|Received anti-myeloma prescription (Rx)|0|||
48662216|NCT03958656|156615841|FG000|Overall Study|No longer meets eligibility criteria|0|||
48662217|NCT03958656|156615842|FG001|Overall Study|No longer meets eligibility criteria|0|||
48662218|NCT03958656|156615843|FG002|Overall Study|No longer meets eligibility criteria|1|||
48662219|NCT03958656|156615844|FG003|Overall Study|No longer meets eligibility criteria|0|||
48662220|NCT03958656|156615841|FG000|Overall Study|Started anti-cancer treatment|0|||
48662221|NCT03958656|156615842|FG001|Overall Study|Started anti-cancer treatment|0|||
48662222|NCT03958656|156615843|FG002|Overall Study|Started anti-cancer treatment|1|||
48662223|NCT03958656|156615844|FG003|Overall Study|Started anti-cancer treatment|0|||
48662224|NCT04346108|156615845|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
48662225|NCT04346108|156615846|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|1|||
48662226|NCT04346108|156615847|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
48662227|NCT04346108|156615845|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
48662228|NCT04346108|156615846|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|1|||
48662229|NCT04346108|156615847|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
48662230|NCT00694096|156615848|FG000|Overall Study|Withdrawal by Subject|5|||
48662231|NCT03023826|156615849|FG000|Period 1|Withdrawal by Subject|0|||
48662232|NCT03023826|156615850|FG001|Period 1|Withdrawal by Subject|0|||
48662233|NCT03023826|156615851|FG002|Period 1|Withdrawal by Subject|0|||
48662234|NCT03023826|156615852|FG003|Period 1|Withdrawal by Subject|0|||
48965247|NCT03814590|157700318|FG008|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
48965248|NCT03814590|157700319|FG009|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|1|||
48965249|NCT03814590|157700320|FG010|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
48965250|NCT03814590|157700321|FG011|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
48965251|NCT03814590|157700322|FG012|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
48965252|NCT03814590|157700323|FG013|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
48965253|NCT03814590|157700310|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
48965254|NCT03814590|157700311|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
48965255|NCT03814590|157700312|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
48965256|NCT03814590|157700313|FG003|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
48965257|NCT03814590|157700314|FG004|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
48965258|NCT03814590|157700315|FG005|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
48965259|NCT03814590|157700316|FG006|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
48662235|NCT03023826|156615853|FG004|Period 1|Withdrawal by Subject|1|||
48965260|NCT03814590|157700317|FG007|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
48662236|NCT03023826|156615854|FG005|Period 1|Withdrawal by Subject|0|||
48755914|NCT02554812|156954255|FG025|Overall Study|Lost to Follow-up|0|||
48755915|NCT02554812|156954256|FG026|Overall Study|Lost to Follow-up|0|||
48662237|NCT02142283|156615855|FG000|Overall Study|Death|20|||
48866643|NCT01064856|157347610|FG002|Double-blind (DB) Period|Consent withdrawn by participant|0|||
48866644|NCT01064856|157347611|FG003|Double-blind (DB) Period|Consent withdrawn by participant|0|||
48866645|NCT01064856|157347608|FG000|Open-label (OL) Period|Adverse Event|0|||
48866646|NCT01064856|157347609|FG001|Open-label (OL) Period|Adverse Event|0|||
48866647|NCT01064856|157347610|FG002|Open-label (OL) Period|Adverse Event|12|||
48866648|NCT01064856|157347611|FG003|Open-label (OL) Period|Adverse Event|6|||
48866649|NCT01064856|157347608|FG000|Open-label (OL) Period|Consent withdrawn by participant|0|||
48866650|NCT01064856|157347609|FG001|Open-label (OL) Period|Consent withdrawn by participant|0|||
48866651|NCT01064856|157347610|FG002|Open-label (OL) Period|Consent withdrawn by participant|5|||
48866652|NCT01064856|157347611|FG003|Open-label (OL) Period|Consent withdrawn by participant|6|||
48866653|NCT01064856|157347608|FG000|Open-label (OL) Period|Lost to Follow-up|0|||
48866654|NCT01064856|157347609|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
48866655|NCT01064856|157347610|FG002|Open-label (OL) Period|Lost to Follow-up|2|||
48866656|NCT01064856|157347611|FG003|Open-label (OL) Period|Lost to Follow-up|1|||
48866657|NCT01064856|157347608|FG000|Open-label (OL) Period|Other|0|||
48866658|NCT01064856|157347609|FG001|Open-label (OL) Period|Other|0|||
48866659|NCT01064856|157347610|FG002|Open-label (OL) Period|Other|7|||
48965261|NCT03814590|157700318|FG008|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
48965262|NCT03814590|157700319|FG009|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
48965263|NCT03814590|157700320|FG010|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
48965264|NCT03814590|157700321|FG011|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
48965265|NCT03814590|157700322|FG012|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
48965266|NCT03814590|157700323|FG013|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
48965267|NCT03814590|157700310|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48965268|NCT03814590|157700311|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48965269|NCT03814590|157700312|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48965270|NCT03814590|157700313|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48965271|NCT03814590|157700314|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48965272|NCT03814590|157700315|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48965273|NCT03814590|157700316|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48965274|NCT03814590|157700317|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
48965275|NCT03814590|157700318|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48965276|NCT03814590|157700319|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
48965277|NCT03814590|157700320|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48965278|NCT03814590|157700321|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48965279|NCT03814590|157700322|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48965280|NCT03814590|157700323|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48965281|NCT03814590|157700310|FG000|Overall Study|UNKNOWN REASON|0|||
48965282|NCT03814590|157700311|FG001|Overall Study|UNKNOWN REASON|0|||
48965283|NCT03814590|157700312|FG002|Overall Study|UNKNOWN REASON|0|||
48965284|NCT03814590|157700313|FG003|Overall Study|UNKNOWN REASON|0|||
48965285|NCT03814590|157700314|FG004|Overall Study|UNKNOWN REASON|0|||
48965286|NCT03814590|157700315|FG005|Overall Study|UNKNOWN REASON|0|||
48965287|NCT03814590|157700316|FG006|Overall Study|UNKNOWN REASON|0|||
48965288|NCT03814590|157700317|FG007|Overall Study|UNKNOWN REASON|1|||
48965289|NCT03814590|157700318|FG008|Overall Study|UNKNOWN REASON|0|||
48965290|NCT03814590|157700319|FG009|Overall Study|UNKNOWN REASON|0|||
48965291|NCT03814590|157700320|FG010|Overall Study|UNKNOWN REASON|0|||
48965292|NCT03814590|157700321|FG011|Overall Study|UNKNOWN REASON|0|||
48965293|NCT03814590|157700322|FG012|Overall Study|UNKNOWN REASON|0|||
48965294|NCT03814590|157700323|FG013|Overall Study|UNKNOWN REASON|0|||
48965295|NCT00594204|157700327|FG000|Overall Study|Adverse Event|15|||
48965296|NCT00594204|157700328|FG001|Overall Study|Adverse Event|3|||
48965297|NCT00594204|157700327|FG000|Overall Study|Lost to Follow-up|9|||
48965298|NCT00594204|157700328|FG001|Overall Study|Lost to Follow-up|5|||
48965299|NCT00594204|157700327|FG000|Overall Study|Withdrawal by Subject|23|||
48965300|NCT00594204|157700328|FG001|Overall Study|Withdrawal by Subject|29|||
48965301|NCT00594204|157700327|FG000|Overall Study|Other|4|||
48965302|NCT00594204|157700328|FG001|Overall Study|Other|3|||
48965303|NCT00594204|157700327|FG000|Overall Study|Lack of Efficacy|3|||
48965304|NCT00594204|157700328|FG001|Overall Study|Lack of Efficacy|4|||
48965305|NCT00594204|157700327|FG000|Overall Study|Randomized but not treated|4|||
48965306|NCT00594204|157700328|FG001|Overall Study|Randomized but not treated|1|||
48965307|NCT01767519|157700329|FG000|Overall Study|Other Reasons|4|||
48662238|NCT02142283|156615856|FG001|Overall Study|Death|18|||
48866660|NCT01064856|157347611|FG003|Open-label (OL) Period|Other|7|||
48866661|NCT01894256|157347612|FG000|Part A|Adverse Event|0|||
48866662|NCT01894256|157347613|FG001|Part A|Adverse Event|1|||
48866663|NCT01894256|157347614|FG002|Part A|Adverse Event|0|||
48866664|NCT01894256|157347612|FG000|Part B|Death|0|||
48866665|NCT01894256|157347613|FG001|Part B|Death|1|||
48866666|NCT01894256|157347614|FG002|Part B|Death|1|||
48866667|NCT01894256|157347612|FG000|Part B|Withdrawal by Subject|0|||
48965308|NCT01767519|157700330|FG001|Overall Study|Other Reasons|4|||
48965309|NCT01767519|157700331|FG002|Overall Study|Other Reasons|2|||
48965310|NCT01767519|157700329|FG000|Overall Study|Protocol Violation|0|||
48965311|NCT01767519|157700330|FG001|Overall Study|Protocol Violation|3|||
48965312|NCT01767519|157700331|FG002|Overall Study|Protocol Violation|0|||
48965313|NCT01767519|157700329|FG000|Overall Study|Personal Reasons|1|||
48965314|NCT01767519|157700330|FG001|Overall Study|Personal Reasons|0|||
48965315|NCT01767519|157700331|FG002|Overall Study|Personal Reasons|0|||
48965316|NCT01767519|157700329|FG000|Overall Study|Lost to Follow-up|3|||
48965317|NCT01767519|157700330|FG001|Overall Study|Lost to Follow-up|1|||
48965318|NCT01767519|157700331|FG002|Overall Study|Lost to Follow-up|2|||
48965319|NCT01767519|157700329|FG000|Overall Study|Lack of Efficacy|1|||
48965320|NCT01767519|157700330|FG001|Overall Study|Lack of Efficacy|0|||
48965321|NCT01767519|157700331|FG002|Overall Study|Lack of Efficacy|0|||
48965322|NCT01767519|157700329|FG000|Overall Study|Adverse Event|5|||
48965323|NCT01767519|157700330|FG001|Overall Study|Adverse Event|5|||
48965324|NCT01767519|157700331|FG002|Overall Study|Adverse Event|1|||
48965325|NCT02293902|157700334|FG000|Double-Blind Period (Up to Week 24)|Adverse Event|5|||
48965326|NCT02293902|157700335|FG001|Double-Blind Period (Up to Week 24)|Adverse Event|6|||
48965327|NCT02293902|157700336|FG002|Double-Blind Period (Up to Week 24)|Adverse Event|8|||
48965328|NCT02293902|157700337|FG003|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
48965329|NCT02293902|157700338|FG004|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
48965330|NCT02293902|157700334|FG000|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5|||
48965331|NCT02293902|157700335|FG001|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1|||
48965332|NCT02293902|157700336|FG002|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2|||
48965333|NCT02293902|157700337|FG003|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
48965334|NCT02293902|157700338|FG004|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
48965335|NCT02293902|157700334|FG000|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1|||
48965336|NCT02293902|157700335|FG001|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
48965337|NCT02293902|157700336|FG002|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
48965338|NCT02293902|157700337|FG003|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
48965339|NCT02293902|157700338|FG004|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
48965340|NCT02293902|157700334|FG000|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0|||
48965341|NCT02293902|157700335|FG001|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7|||
48965342|NCT02293902|157700336|FG002|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
48965343|NCT02293902|157700337|FG003|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
48965344|NCT02293902|157700338|FG004|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6|||
48965345|NCT02293902|157700334|FG000|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
48965346|NCT02293902|157700335|FG001|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
48965347|NCT02293902|157700336|FG002|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
48965348|NCT02293902|157700337|FG003|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
48965349|NCT02293902|157700338|FG004|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
48965350|NCT03519516|157700339|FG000|Overall Study|Adverse Event|0|||
48965351|NCT03519516|157700340|FG001|Overall Study|Adverse Event|1|||
48965352|NCT00293423|157700341|FG000|Surgical Resection|Less than a 90% extent of resection|0|||
48965353|NCT00293423|157700342|FG001|Surgical Resection|Less than a 90% extent of resection|1|||
48965354|NCT00293423|157700341|FG000|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0|||
48965355|NCT00293423|157700342|FG001|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4|||
48965356|NCT00293423|157700341|FG000|Surgical Resection|Insufficient tumor obtained to generate vaccine|9|||
48965357|NCT00293423|157700342|FG001|Surgical Resection|Insufficient tumor obtained to generate vaccine|13|||
48965358|NCT00293423|157700341|FG000|Surgical Resection|disease progression prior to initial vaccination|2|||
48965359|NCT00293423|157700342|FG001|Surgical Resection|disease progression prior to initial vaccination|9|||
48662239|NCT02142283|156615855|FG000|Overall Study|Withdrawal by Subject|1|||
48662240|NCT02142283|156615856|FG001|Overall Study|Withdrawal by Subject|3|||
48662241|NCT00747344|156615857|FG000|Controlled Period|Adverse Event|3|||
48662242|NCT00747344|156615858|FG001|Controlled Period|Adverse Event|0|||
48662243|NCT00747344|156615859|FG002|Controlled Period|Adverse Event|0|||
48662244|NCT00747344|156615860|FG003|Controlled Period|Adverse Event|0|||
48662245|NCT00747344|156615857|FG000|Controlled Period|Lack of Efficacy|2|||
48662246|NCT00747344|156615858|FG001|Controlled Period|Lack of Efficacy|1|||
48662247|NCT00747344|156615859|FG002|Controlled Period|Lack of Efficacy|0|||
48662248|NCT00747344|156615860|FG003|Controlled Period|Lack of Efficacy|0|||
48662249|NCT00747344|156615857|FG000|Controlled Period|Other|0|||
48662250|NCT00747344|156615858|FG001|Controlled Period|Other|3|||
48662251|NCT00747344|156615859|FG002|Controlled Period|Other|0|||
48755916|NCT02554812|156954230|FG000|Overall Study|Global deterioration of health status|4|||
48965360|NCT00293423|157700341|FG000|Surgical Resection|processing error during surgical resection|1|||
48662252|NCT00747344|156615860|FG003|Controlled Period|Other|0|||
48662253|NCT00747344|156615857|FG000|After Controlled Period|Adverse Event|0|||
48662254|NCT00747344|156615858|FG001|After Controlled Period|Adverse Event|0|||
48662255|NCT00747344|156615859|FG002|After Controlled Period|Adverse Event|0|||
48965361|NCT00293423|157700342|FG001|Surgical Resection|processing error during surgical resection|0|||
48965362|NCT00293423|157700341|FG000|Surgical Resection|Withdrawal by Subject|4|||
48965363|NCT00293423|157700342|FG001|Surgical Resection|Withdrawal by Subject|0|||
48965364|NCT00293423|157700341|FG000|Vaccination Treatment Period|Received < 4 required vaccinations|0|||
48965365|NCT00293423|157700342|FG001|Vaccination Treatment Period|Received < 4 required vaccinations|3|||
48965366|NCT00507416|157700343|FG000|Overall Study|Adverse Event|58|||
48662256|NCT00747344|156615860|FG003|After Controlled Period|Adverse Event|1|||
48662257|NCT00765882|156615861|FG000|Overall Study|Adverse Event|10|||
48662258|NCT00765882|156615862|FG001|Overall Study|Adverse Event|21|||
48662259|NCT00765882|156615863|FG002|Overall Study|Adverse Event|20|||
48662260|NCT00765882|156615861|FG000|Overall Study|Lack of Efficacy|4|||
48662261|NCT00765882|156615862|FG001|Overall Study|Lack of Efficacy|0|||
48662262|NCT00765882|156615863|FG002|Overall Study|Lack of Efficacy|1|||
48662263|NCT00765882|156615861|FG000|Overall Study|Protocol Violation|4|||
48662264|NCT00765882|156615862|FG001|Overall Study|Protocol Violation|3|||
48965367|NCT00507416|157700344|FG001|Overall Study|Adverse Event|67|||
48965368|NCT00507416|157700345|FG002|Overall Study|Adverse Event|65|||
48965369|NCT00507416|157700343|FG000|Overall Study|Protocol Violation|1|||
48965370|NCT00507416|157700344|FG001|Overall Study|Protocol Violation|2|||
48965371|NCT00507416|157700345|FG002|Overall Study|Protocol Violation|0|||
48965372|NCT00507416|157700343|FG000|Overall Study|Lack ofEfficacy / Physician Decision|7|||
48965373|NCT00507416|157700344|FG001|Overall Study|Lack ofEfficacy / Physician Decision|7|||
48965374|NCT00507416|157700345|FG002|Overall Study|Lack ofEfficacy / Physician Decision|8|||
48965375|NCT00507416|157700343|FG000|Overall Study|Progressive Disease|20|||
48965376|NCT00507416|157700344|FG001|Overall Study|Progressive Disease|10|||
48965377|NCT00507416|157700345|FG002|Overall Study|Progressive Disease|13|||
48965378|NCT00507416|157700343|FG000|Overall Study|Patient declined further treatment|18|||
48965379|NCT00507416|157700344|FG001|Overall Study|Patient declined further treatment|14|||
48965380|NCT00507416|157700345|FG002|Overall Study|Patient declined further treatment|11|||
48965381|NCT00507416|157700343|FG000|Overall Study|Other|11|||
48965382|NCT00507416|157700344|FG001|Overall Study|Other|16|||
48965383|NCT00507416|157700345|FG002|Overall Study|Other|13|||
48965384|NCT00507416|157700343|FG000|Overall Study|Did not Receive Study Treatment|3|||
48965385|NCT00507416|157700344|FG001|Overall Study|Did not Receive Study Treatment|9|||
48965386|NCT00507416|157700345|FG002|Overall Study|Did not Receive Study Treatment|4|||
48965387|NCT02157506|157700350|FG000|Overall Study|Adverse Event|0|||
48965388|NCT02157506|157700351|FG001|Overall Study|Adverse Event|1|||
48965389|NCT02157506|157700352|FG002|Overall Study|Adverse Event|0|||
48965390|NCT02157506|157700353|FG003|Overall Study|Adverse Event|0|||
48965391|NCT02157506|157700354|FG004|Overall Study|Adverse Event|0|||
48965392|NCT02157506|157700350|FG000|Overall Study|Lost to Follow-up|0|||
48965393|NCT02157506|157700351|FG001|Overall Study|Lost to Follow-up|0|||
48662265|NCT00765882|156615863|FG002|Overall Study|Protocol Violation|1|||
48662266|NCT00765882|156615861|FG000|Overall Study|Withdrawal by Subject|2|||
48662267|NCT00765882|156615862|FG001|Overall Study|Withdrawal by Subject|6|||
48662268|NCT00765882|156615863|FG002|Overall Study|Withdrawal by Subject|6|||
48662269|NCT00765882|156615861|FG000|Overall Study|Lost to Follow-up|1|||
48662270|NCT00765882|156615862|FG001|Overall Study|Lost to Follow-up|9|||
48662271|NCT00765882|156615863|FG002|Overall Study|Lost to Follow-up|6|||
48662272|NCT00765882|156615861|FG000|Overall Study|Other Reason|3|||
48662273|NCT00765882|156615862|FG001|Overall Study|Other Reason|1|||
48965394|NCT02157506|157700352|FG002|Overall Study|Lost to Follow-up|1|||
48965395|NCT02157506|157700353|FG003|Overall Study|Lost to Follow-up|0|||
48965396|NCT02157506|157700354|FG004|Overall Study|Lost to Follow-up|0|||
48965397|NCT01401465|157700355|FG000|Treatment Period 1|Adverse Event|4|||
48965398|NCT01401465|157700356|FG001|Treatment Period 1|Adverse Event|1|||
48965399|NCT01401465|157700355|FG000|Treatment Period 1|Pregnancy|0|||
48965400|NCT01401465|157700356|FG001|Treatment Period 1|Pregnancy|1|||
48965401|NCT01401465|157700355|FG000|Treatment Period 1|Protocol Violation|5|||
48965402|NCT01401465|157700356|FG001|Treatment Period 1|Protocol Violation|0|||
48965403|NCT01401465|157700355|FG000|Treatment Period 1|Withdrawal by Subject|1|||
48965404|NCT01401465|157700356|FG001|Treatment Period 1|Withdrawal by Subject|4|||
48965405|NCT01401465|157700355|FG000|Treatment Period 1|Non-Compliance to Study Drug|1|||
48965406|NCT01401465|157700356|FG001|Treatment Period 1|Non-Compliance to Study Drug|0|||
48662274|NCT00765882|156615863|FG002|Overall Study|Other Reason|2|||
48965407|NCT01401465|157700355|FG000|Treatment Period 1|Inability to Meet Continuation Criteria|3|||
48965408|NCT01401465|157700356|FG001|Treatment Period 1|Inability to Meet Continuation Criteria|9|||
48965409|NCT01401465|157700355|FG000|Treatment Period 1|Scheduling Difficulties|1|||
48965410|NCT01401465|157700356|FG001|Treatment Period 1|Scheduling Difficulties|1|||
48662275|NCT03249935|156615870|FG000|Overall Study|Discharged from facility early|36|||
48662276|NCT03249935|156615870|FG000|Overall Study|Negative for chlamydia at enrollment|4|||
48662277|NCT03249935|156615870|FG000|Overall Study|Protocol Violation|5|||
48662278|NCT01669421|156615871|FG000|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1|||
48965411|NCT01401465|157700355|FG000|Treatment Period 2|Lost to Follow-up|0|||
48662279|NCT01669421|156615871|FG000|Phase 1: Standard Dose Therapy|Physician Decision|1|||
48965412|NCT01401465|157700356|FG001|Treatment Period 2|Lost to Follow-up|1|||
48662280|NCT01799239|156615872|FG000|Period 1 (7 Days)|Lack of Efficacy|1|||
48662281|NCT01799239|156615873|FG001|Period 1 (7 Days)|Lack of Efficacy|0|||
48662282|NCT01799239|156615872|FG000|Period 1 (7 Days)|Withdrawal by Subject|2|||
48662283|NCT01799239|156615873|FG001|Period 1 (7 Days)|Withdrawal by Subject|0|||
48662284|NCT01799239|156615872|FG000|Period 1 (7 Days)|Protocol Violation|0|||
48662285|NCT01799239|156615873|FG001|Period 1 (7 Days)|Protocol Violation|1|||
48662286|NCT01799239|156615872|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
48662287|NCT01799239|156615873|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
48662288|NCT01799239|156615872|FG000|Period 2 (7 Days)|Protocol Violation|1|||
48662289|NCT01799239|156615873|FG001|Period 2 (7 Days)|Protocol Violation|0|||
48662290|NCT01561755|156615874|FG000|Overall Study|Lost to Follow-up|0|||
48662291|NCT01561755|156615875|FG001|Overall Study|Lost to Follow-up|1|||
48662292|NCT01605227|156615876|FG000|Overall Study|Did not receive study treatment|2|||
48662293|NCT01605227|156615877|FG001|Overall Study|Did not receive study treatment|3|||
48662294|NCT01605227|156615876|FG000|Overall Study|Adverse Event|228|||
48662295|NCT01605227|156615877|FG001|Overall Study|Adverse Event|42|||
48662296|NCT01605227|156615876|FG000|Overall Study|Progressive Disease|132|||
48965413|NCT01401465|157700355|FG000|Treatment Period 2|Withdrawal by Subject|0|||
48965414|NCT01401465|157700356|FG001|Treatment Period 2|Withdrawal by Subject|1|||
48965415|NCT01021813|157700365|FG000|DB Treatment Phase|Adverse Event|60|||
48965416|NCT01021813|157700366|FG001|DB Treatment Phase|Adverse Event|22|||
48965417|NCT01021813|157700367|FG002|DB Treatment Phase|Adverse Event|0|||
48965418|NCT01021813|157700368|FG003|DB Treatment Phase|Adverse Event|0|||
48965419|NCT01021813|157700369|FG004|DB Treatment Phase|Adverse Event|0|||
48965420|NCT01021813|157700365|FG000|DB Treatment Phase|Lack of Efficacy|44|||
48965421|NCT01021813|157700366|FG001|DB Treatment Phase|Lack of Efficacy|28|||
48965422|NCT01021813|157700367|FG002|DB Treatment Phase|Lack of Efficacy|0|||
48965423|NCT01021813|157700368|FG003|DB Treatment Phase|Lack of Efficacy|0|||
48965424|NCT01021813|157700369|FG004|DB Treatment Phase|Lack of Efficacy|0|||
48965425|NCT01021813|157700365|FG000|DB Treatment Phase|Lost to Follow-up|14|||
48965426|NCT01021813|157700366|FG001|DB Treatment Phase|Lost to Follow-up|12|||
48965427|NCT01021813|157700367|FG002|DB Treatment Phase|Lost to Follow-up|0|||
48965428|NCT01021813|157700368|FG003|DB Treatment Phase|Lost to Follow-up|0|||
48965429|NCT01021813|157700369|FG004|DB Treatment Phase|Lost to Follow-up|0|||
48965430|NCT01021813|157700365|FG000|DB Treatment Phase|Physician Decision|17|||
48965431|NCT01021813|157700366|FG001|DB Treatment Phase|Physician Decision|8|||
48965432|NCT01021813|157700367|FG002|DB Treatment Phase|Physician Decision|0|||
48965433|NCT01021813|157700368|FG003|DB Treatment Phase|Physician Decision|0|||
48965434|NCT01021813|157700369|FG004|DB Treatment Phase|Physician Decision|0|||
48965435|NCT01021813|157700365|FG000|DB Treatment Phase|Pregnancy|1|||
48965436|NCT01021813|157700366|FG001|DB Treatment Phase|Pregnancy|0|||
48965437|NCT01021813|157700367|FG002|DB Treatment Phase|Pregnancy|0|||
48965438|NCT01021813|157700368|FG003|DB Treatment Phase|Pregnancy|0|||
48965439|NCT01021813|157700369|FG004|DB Treatment Phase|Pregnancy|0|||
48965440|NCT01021813|157700365|FG000|DB Treatment Phase|Protocol Violation|4|||
48965441|NCT01021813|157700366|FG001|DB Treatment Phase|Protocol Violation|3|||
48965442|NCT01021813|157700367|FG002|DB Treatment Phase|Protocol Violation|0|||
48965443|NCT01021813|157700368|FG003|DB Treatment Phase|Protocol Violation|0|||
48965444|NCT01021813|157700369|FG004|DB Treatment Phase|Protocol Violation|0|||
48965445|NCT01021813|157700365|FG000|DB Treatment Phase|Withdrawal by Subject|60|||
48965446|NCT01021813|157700366|FG001|DB Treatment Phase|Withdrawal by Subject|24|||
48965447|NCT01021813|157700367|FG002|DB Treatment Phase|Withdrawal by Subject|0|||
48965448|NCT01021813|157700368|FG003|DB Treatment Phase|Withdrawal by Subject|0|||
48965449|NCT01021813|157700369|FG004|DB Treatment Phase|Withdrawal by Subject|0|||
48965450|NCT01021813|157700365|FG000|DB Randomized Discontinuation Phase|Adverse Event|0|||
48965451|NCT01021813|157700366|FG001|DB Randomized Discontinuation Phase|Adverse Event|0|||
48965452|NCT01021813|157700367|FG002|DB Randomized Discontinuation Phase|Adverse Event|0|||
48965453|NCT01021813|157700368|FG003|DB Randomized Discontinuation Phase|Adverse Event|3|||
48965454|NCT01021813|157700369|FG004|DB Randomized Discontinuation Phase|Adverse Event|1|||
48965455|NCT01021813|157700365|FG000|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
48965456|NCT01021813|157700366|FG001|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
48662297|NCT01605227|156615877|FG001|Overall Study|Progressive Disease|128|||
48662298|NCT01605227|156615876|FG000|Overall Study|Clinical Deterioration|227|||
48662299|NCT01605227|156615877|FG001|Overall Study|Clinical Deterioration|133|||
48662300|NCT01605227|156615876|FG000|Overall Study|Lost to Follow-up|1|||
48965457|NCT01021813|157700367|FG002|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
48662301|NCT01605227|156615877|FG001|Overall Study|Lost to Follow-up|0|||
48662302|NCT01605227|156615876|FG000|Overall Study|Protocol Violation|1|||
48965458|NCT01021813|157700368|FG003|DB Randomized Discontinuation Phase|Lack of Efficacy|1|||
48965459|NCT01021813|157700369|FG004|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
48965460|NCT01021813|157700365|FG000|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
48965461|NCT01021813|157700366|FG001|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
48965462|NCT01021813|157700367|FG002|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
48662303|NCT01605227|156615877|FG001|Overall Study|Protocol Violation|0|||
48662304|NCT01605227|156615876|FG000|Overall Study|Physician Decision|9|||
48662305|NCT01605227|156615877|FG001|Overall Study|Physician Decision|7|||
48662306|NCT01605227|156615876|FG000|Overall Study|Withdrawal by Subject|18|||
48662307|NCT01605227|156615877|FG001|Overall Study|Withdrawal by Subject|14|||
48662308|NCT01605227|156615876|FG000|Overall Study|Sponsor Decision|2|||
48662309|NCT01605227|156615877|FG001|Overall Study|Sponsor Decision|0|||
48662310|NCT01605227|156615876|FG000|Overall Study|Started New Therapy|1|||
48662311|NCT01605227|156615877|FG001|Overall Study|Started New Therapy|0|||
48662312|NCT01605227|156615876|FG000|Overall Study|Subject Decision|0|||
48965463|NCT01021813|157700368|FG003|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
48965464|NCT01021813|157700369|FG004|DB Randomized Discontinuation Phase|Lost to Follow-up|1|||
48965465|NCT01021813|157700365|FG000|DB Randomized Discontinuation Phase|Protocol Violation|0|||
48965466|NCT01021813|157700366|FG001|DB Randomized Discontinuation Phase|Protocol Violation|0|||
48965467|NCT01021813|157700367|FG002|DB Randomized Discontinuation Phase|Protocol Violation|1|||
48965468|NCT01021813|157700368|FG003|DB Randomized Discontinuation Phase|Protocol Violation|0|||
48965469|NCT01021813|157700369|FG004|DB Randomized Discontinuation Phase|Protocol Violation|0|||
48965470|NCT01021813|157700365|FG000|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
48965471|NCT01021813|157700366|FG001|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
48965472|NCT01021813|157700367|FG002|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
48965473|NCT01021813|157700368|FG003|DB Randomized Discontinuation Phase|Withdrawal by Subject|1|||
48965474|NCT01021813|157700369|FG004|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
48965475|NCT03103906|157700370|FG000|Overall Study|Adverse Event|2|||
48965476|NCT03103906|157700371|FG001|Overall Study|Adverse Event|3|||
48965477|NCT03103906|157700370|FG000|Overall Study|Other|2|||
48965478|NCT03103906|157700371|FG001|Overall Study|Other|0|||
48965479|NCT04876599|157700372|FG000|Overall Study|Missed|2|||
48965480|NCT04876599|157700373|FG001|Overall Study|Missed|0|||
48965481|NCT04876599|157700372|FG000|Overall Study|Declined|2|||
48965482|NCT04876599|157700373|FG001|Overall Study|Declined|3|||
48965483|NCT02294318|157701735|FG000|Overall Study|Worsening of drinking|3|||
48965484|NCT02294318|157701736|FG001|Overall Study|Worsening of drinking|0|||
48965485|NCT02294318|157701735|FG000|Overall Study|Not exposed to intervention|0|||
48965486|NCT02294318|157701736|FG001|Overall Study|Not exposed to intervention|2|||
48965487|NCT01677624|157701737|FG000|Overall Study|Insuf Resp: intra-articular hemorrhage|1|||
48965488|NCT02616185|157701741|FG000|Overall Study|Death|0|||
48965489|NCT02616185|157701742|FG001|Overall Study|Death|0|||
48965490|NCT02616185|157701743|FG002|Overall Study|Death|0|||
48965491|NCT02616185|157701744|FG003|Overall Study|Death|1|||
48965492|NCT02616185|157701745|FG004|Overall Study|Death|2|||
48965493|NCT02616185|157701746|FG005|Overall Study|Death|0|||
48965494|NCT02616185|157701747|FG006|Overall Study|Death|0|||
48965495|NCT02616185|157701748|FG007|Overall Study|Death|2|||
48965496|NCT02616185|157701749|FG008|Overall Study|Death|1|||
48965497|NCT02616185|157701741|FG000|Overall Study|Study terminated by sponsor|0|||
48965498|NCT02616185|157701742|FG001|Overall Study|Study terminated by sponsor|0|||
48965499|NCT02616185|157701743|FG002|Overall Study|Study terminated by sponsor|1|||
48965500|NCT02616185|157701744|FG003|Overall Study|Study terminated by sponsor|0|||
48965501|NCT02616185|157701745|FG004|Overall Study|Study terminated by sponsor|0|||
48965502|NCT02616185|157701746|FG005|Overall Study|Study terminated by sponsor|0|||
48965503|NCT02616185|157701747|FG006|Overall Study|Study terminated by sponsor|5|||
48965504|NCT02616185|157701748|FG007|Overall Study|Study terminated by sponsor|2|||
48965505|NCT02616185|157701749|FG008|Overall Study|Study terminated by sponsor|0|||
48965506|NCT02616185|157701741|FG000|Overall Study|Participant refused further follow-up|1|||
48965507|NCT02616185|157701742|FG001|Overall Study|Participant refused further follow-up|1|||
48965508|NCT02616185|157701743|FG002|Overall Study|Participant refused further follow-up|2|||
48965509|NCT02616185|157701744|FG003|Overall Study|Participant refused further follow-up|3|||
48965510|NCT02616185|157701745|FG004|Overall Study|Participant refused further follow-up|4|||
48965511|NCT02616185|157701746|FG005|Overall Study|Participant refused further follow-up|0|||
48965512|NCT02616185|157701747|FG006|Overall Study|Participant refused further follow-up|3|||
48965513|NCT02616185|157701748|FG007|Overall Study|Participant refused further follow-up|4|||
48965514|NCT02616185|157701749|FG008|Overall Study|Participant refused further follow-up|3|||
48965515|NCT02616185|157701741|FG000|Overall Study|Not reported|0|||
48662313|NCT01605227|156615877|FG001|Overall Study|Subject Decision|1|||
48662314|NCT01605227|156615876|FG000|Overall Study|Dose Held >6 weeks|0|||
48965516|NCT02616185|157701742|FG001|Overall Study|Not reported|0|||
48965517|NCT02616185|157701743|FG002|Overall Study|Not reported|0|||
48965518|NCT02616185|157701744|FG003|Overall Study|Not reported|1|||
48965519|NCT02616185|157701745|FG004|Overall Study|Not reported|3|||
48662315|NCT01605227|156615877|FG001|Overall Study|Dose Held >6 weeks|1|||
48965520|NCT02616185|157701746|FG005|Overall Study|Not reported|1|||
48965521|NCT02616185|157701747|FG006|Overall Study|Not reported|0|||
48662316|NCT04209114|156615878|FG000|Pre-Treatment Phase|Completed without radical cystectomy|0|||
48662317|NCT04209114|156615879|FG001|Pre-Treatment Phase|Completed without radical cystectomy|0|||
48965522|NCT02616185|157701748|FG007|Overall Study|Not reported|5|||
48965523|NCT02616185|157701749|FG008|Overall Study|Not reported|2|||
48965524|NCT00574119|157701750|FG000|Overall Study|Adverse Event|1|||
48755917|NCT02554812|156954231|FG001|Overall Study|Global deterioration of health status|3|||
48755918|NCT02554812|156954232|FG002|Overall Study|Global deterioration of health status|3|||
48755919|NCT02554812|156954233|FG003|Overall Study|Global deterioration of health status|2|||
48755920|NCT02554812|156954234|FG004|Overall Study|Global deterioration of health status|5|||
48755921|NCT02554812|156954235|FG005|Overall Study|Global deterioration of health status|0|||
48755922|NCT02554812|156954236|FG006|Overall Study|Global deterioration of health status|2|||
48755923|NCT02554812|156954237|FG007|Overall Study|Global deterioration of health status|1|||
48755924|NCT02554812|156954238|FG008|Overall Study|Global deterioration of health status|1|||
48755925|NCT02554812|156954239|FG009|Overall Study|Global deterioration of health status|1|||
48755926|NCT02554812|156954240|FG010|Overall Study|Global deterioration of health status|2|||
48755927|NCT02554812|156954241|FG011|Overall Study|Global deterioration of health status|1|||
48755928|NCT02554812|156954242|FG012|Overall Study|Global deterioration of health status|0|||
48755929|NCT02554812|156954243|FG013|Overall Study|Global deterioration of health status|0|||
48755930|NCT02554812|156954244|FG014|Overall Study|Global deterioration of health status|0|||
48755931|NCT02554812|156954245|FG015|Overall Study|Global deterioration of health status|1|||
48755932|NCT02554812|156954246|FG016|Overall Study|Global deterioration of health status|0|||
48755933|NCT02554812|156954247|FG017|Overall Study|Global deterioration of health status|0|||
48755934|NCT02554812|156954248|FG018|Overall Study|Global deterioration of health status|0|||
48755935|NCT02554812|156954249|FG019|Overall Study|Global deterioration of health status|0|||
48755936|NCT02554812|156954250|FG020|Overall Study|Global deterioration of health status|0|||
48755937|NCT02554812|156954251|FG021|Overall Study|Global deterioration of health status|0|||
48755938|NCT02554812|156954252|FG022|Overall Study|Global deterioration of health status|0|||
48755939|NCT02554812|156954253|FG023|Overall Study|Global deterioration of health status|0|||
48662318|NCT04209114|156615880|FG002|Pre-Treatment Phase|Completed without radical cystectomy|5|||
48662319|NCT04209114|156615878|FG000|Pre-Treatment Phase|Other reasons|0|||
48662320|NCT04209114|156615879|FG001|Pre-Treatment Phase|Other reasons|0|||
48662321|NCT04209114|156615880|FG002|Pre-Treatment Phase|Other reasons|1|||
48662322|NCT04209114|156615878|FG000|Pre-Treatment Phase|Death|0|||
48662323|NCT04209114|156615879|FG001|Pre-Treatment Phase|Death|0|||
48755940|NCT02554812|156954254|FG024|Overall Study|Global deterioration of health status|0|||
48755941|NCT02554812|156954255|FG025|Overall Study|Global deterioration of health status|0|||
48755942|NCT02554812|156954256|FG026|Overall Study|Global deterioration of health status|0|||
48965525|NCT00574119|157701750|FG000|Overall Study|Protocol Violation|1|||
48662324|NCT04209114|156615880|FG002|Pre-Treatment Phase|Death|1|||
48662325|NCT04209114|156615878|FG000|Pre-Treatment Phase|Participant withdrew consent|0|||
48662326|NCT04209114|156615879|FG001|Pre-Treatment Phase|Participant withdrew consent|0|||
48662327|NCT04209114|156615880|FG002|Pre-Treatment Phase|Participant withdrew consent|1|||
48662328|NCT04209114|156615878|FG000|Treatment Phase|Other reasons|5|||
48662329|NCT04209114|156615879|FG001|Treatment Phase|Other reasons|3|||
48662330|NCT04209114|156615880|FG002|Treatment Phase|Other reasons|0|||
48662331|NCT04209114|156615878|FG000|Treatment Phase|Lost to Follow-up|1|||
48662332|NCT04209114|156615879|FG001|Treatment Phase|Lost to Follow-up|0|||
48662333|NCT04209114|156615880|FG002|Treatment Phase|Lost to Follow-up|0|||
48662334|NCT04209114|156615878|FG000|Treatment Phase|Participant withdrew consent|1|||
48662335|NCT04209114|156615879|FG001|Treatment Phase|Participant withdrew consent|0|||
48662336|NCT04209114|156615880|FG002|Treatment Phase|Participant withdrew consent|0|||
48662337|NCT04209114|156615878|FG000|Treatment Phase|Adverse event unrelated to study drug|1|||
48662338|NCT04209114|156615879|FG001|Treatment Phase|Adverse event unrelated to study drug|5|||
48662339|NCT04209114|156615880|FG002|Treatment Phase|Adverse event unrelated to study drug|0|||
48662340|NCT04209114|156615878|FG000|Treatment Phase|Death|4|||
48662341|NCT04209114|156615879|FG001|Treatment Phase|Death|1|||
48662342|NCT04209114|156615880|FG002|Treatment Phase|Death|0|||
48662343|NCT04209114|156615878|FG000|Treatment Phase|Study drug toxicity|4|||
48662344|NCT04209114|156615879|FG001|Treatment Phase|Study drug toxicity|6|||
48662345|NCT04209114|156615880|FG002|Treatment Phase|Study drug toxicity|0|||
48662346|NCT04209114|156615878|FG000|Treatment Phase|Disease progression|6|||
48662347|NCT04209114|156615879|FG001|Treatment Phase|Disease progression|9|||
48662348|NCT04209114|156615880|FG002|Treatment Phase|Disease progression|0|||
48662349|NCT02813668|156615881|FG000|Overall Study|Death|4|||
48662350|NCT02813668|156615881|FG000|Overall Study|Lost to Follow-up|509|||
48662351|NCT02813668|156615881|FG000|Overall Study|Withdrawal by Subject|148|||
48662352|NCT02813668|156615881|FG000|Overall Study|No longer at worksite|85|||
48662353|NCT02813668|156615881|FG000|Overall Study|Medical reasons not related to the study|4|||
48662354|NCT03366103|156615882|FG000|Overall Study|Disease Progression|3|||
48662355|NCT03366103|156615883|FG001|Overall Study|Disease Progression|1|||
48662356|NCT03366103|156615884|FG002|Overall Study|Disease Progression|0|||
48662357|NCT03366103|156615882|FG000|Overall Study|Adverse Event|0|||
48662358|NCT03366103|156615883|FG001|Overall Study|Adverse Event|1|||
48662359|NCT03366103|156615884|FG002|Overall Study|Adverse Event|0|||
48662360|NCT01028716|156615886|FG000|Overall Study|Physician Decision|1|||
48662361|NCT02549352|156615887|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
48662362|NCT02549352|156615888|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
48965526|NCT00574119|157701750|FG000|Overall Study|Withdrawal by Subject|1|||
48965527|NCT00574119|157701750|FG000|Overall Study|Physician Decision|1|||
48965528|NCT00333619|157701751|FG000|Overall Study|Death|12|||
48965529|NCT00333619|157701752|FG001|Overall Study|Death|6|||
48965530|NCT00333619|157701751|FG000|Overall Study|Withdrawal by Subject|6|||
48965531|NCT00333619|157701752|FG001|Overall Study|Withdrawal by Subject|1|||
48965532|NCT00333619|157701751|FG000|Overall Study|Lost to Follow-up|3|||
48662363|NCT02549352|156615887|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
48662364|NCT02549352|156615888|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
48662365|NCT02549352|156615887|FG000|3-day Treatment and 8-week Follow-up|Other|0|||
48662366|NCT02549352|156615888|FG001|3-day Treatment and 8-week Follow-up|Other|2|||
48662367|NCT02549352|156615887|FG000|12-month Follow-up|Withdrawal by Subject|4|||
48662368|NCT02549352|156615888|FG001|12-month Follow-up|Withdrawal by Subject|5|||
48662369|NCT02549352|156615887|FG000|12-month Follow-up|Lost to Follow-up|3|||
48662370|NCT02549352|156615888|FG001|12-month Follow-up|Lost to Follow-up|2|||
48965533|NCT00333619|157701752|FG001|Overall Study|Lost to Follow-up|3|||
48965534|NCT00280150|157701753|FG000|Overall Study|Adverse Event|0|||
48965535|NCT00280150|157701754|FG001|Overall Study|Adverse Event|1|||
48662371|NCT02549352|156615887|FG000|12-month Follow-up|Death|0|||
48662372|NCT02549352|156615888|FG001|12-month Follow-up|Death|1|||
48662373|NCT02549352|156615887|FG000|12-month Follow-up|Protocol Violation|0|||
48662374|NCT02549352|156615888|FG001|12-month Follow-up|Protocol Violation|1|||
48662375|NCT02549352|156615887|FG000|12-month Follow-up|Other|1|||
48662376|NCT02549352|156615888|FG001|12-month Follow-up|Other|3|||
48662377|NCT02818036|156615889|FG000|Overall Study|head did not fit in fMRI scanner headres|1|||
48662378|NCT02818036|156615890|FG001|Overall Study|head did not fit in fMRI scanner headres|0|||
48755943|NCT02554812|156954230|FG000|Overall Study|Progressive disease|20|||
48755944|NCT02554812|156954231|FG001|Overall Study|Progressive disease|16|||
48755945|NCT02554812|156954232|FG002|Overall Study|Progressive disease|19|||
48755946|NCT02554812|156954233|FG003|Overall Study|Progressive disease|18|||
48755947|NCT02554812|156954234|FG004|Overall Study|Progressive disease|21|||
48755948|NCT02554812|156954235|FG005|Overall Study|Progressive disease|15|||
48755949|NCT02554812|156954236|FG006|Overall Study|Progressive disease|6|||
48755950|NCT02554812|156954237|FG007|Overall Study|Progressive disease|13|||
48755951|NCT02554812|156954238|FG008|Overall Study|Progressive disease|6|||
48755952|NCT02554812|156954239|FG009|Overall Study|Progressive disease|6|||
48755953|NCT02554812|156954240|FG010|Overall Study|Progressive disease|8|||
48755954|NCT02554812|156954241|FG011|Overall Study|Progressive disease|8|||
48755955|NCT02554812|156954242|FG012|Overall Study|Progressive disease|6|||
48662379|NCT02818036|156615889|FG000|Overall Study|Withdrawal by Subject|1|||
48662380|NCT02818036|156615890|FG001|Overall Study|Withdrawal by Subject|0|||
48662381|NCT01154283|156615891|FG000|0-6 Weeks|Withdrawal by Subject|7|||
48662382|NCT01154283|156615892|FG001|0-6 Weeks|Withdrawal by Subject|2|||
48662383|NCT01154283|156615891|FG000|0-6 Weeks|Death|0|||
48662384|NCT01154283|156615892|FG001|0-6 Weeks|Death|1|||
48662385|NCT01154283|156615891|FG000|7-12 Weeks|Death|1|||
48662386|NCT01154283|156615892|FG001|7-12 Weeks|Death|0|||
48965536|NCT00280150|157701755|FG002|Overall Study|Adverse Event|2|||
48662387|NCT01154283|156615891|FG000|7-12 Weeks|Withdrawal by Subject|0|||
48662388|NCT01154283|156615892|FG001|7-12 Weeks|Withdrawal by Subject|1|||
48662389|NCT01816906|156615893|FG000|Six Months|Did Not Show Up for Baseline Measurement|7|||
48662390|NCT01816906|156615894|FG001|Six Months|Did Not Show Up for Baseline Measurement|6|||
48662391|NCT01816906|156615893|FG000|Six Months|Lost to Follow-up|14|||
48662392|NCT01816906|156615894|FG001|Six Months|Lost to Follow-up|16|||
48662393|NCT01816906|156615893|FG000|12 Months|Adverse Event|2|||
48662394|NCT01816906|156615894|FG001|12 Months|Adverse Event|2|||
48662395|NCT01816906|156615893|FG000|12 Months|Death|0|||
48662396|NCT01816906|156615894|FG001|12 Months|Death|2|||
48662397|NCT01816906|156615893|FG000|12 Months|Lost to Follow-up|2|||
48662398|NCT01816906|156615894|FG001|12 Months|Lost to Follow-up|1|||
48755956|NCT02554812|156954243|FG013|Overall Study|Progressive disease|10|||
48755957|NCT02554812|156954244|FG014|Overall Study|Progressive disease|20|||
48755958|NCT02554812|156954245|FG015|Overall Study|Progressive disease|6|||
49015451|NCT01393990|157893783|FG013|Overall Study|Adverse Event|0|||
48662399|NCT00869050|156615895|FG000|Overall Study|Screen Failure|3|||
48662400|NCT02966795|156615898|FG000|Overall Study|Patient Left the Country|0|||
48662401|NCT02966795|156615899|FG001|Overall Study|Patient Left the Country|1|||
48662402|NCT01515475|156615900|FG000|Overall Study|Lost to Follow-up|20|||
48662403|NCT01515475|156615901|FG001|Overall Study|Lost to Follow-up|15|||
48662404|NCT01515475|156615902|FG002|Overall Study|Lost to Follow-up|12|||
48662405|NCT01515475|156615903|FG003|Overall Study|Lost to Follow-up|12|||
48662406|NCT01352741|156615904|FG000|Open-label Tapentadol Titration Period|Protocol Violation|4|||
48662407|NCT01352741|156615905|FG001|Open-label Tapentadol Titration Period|Protocol Violation|0|||
48662408|NCT01352741|156615904|FG000|Open-label Tapentadol Titration Period|Lack of Efficacy|19|||
48755959|NCT02554812|156954246|FG016|Overall Study|Progressive disease|3|||
48755960|NCT02554812|156954247|FG017|Overall Study|Progressive disease|3|||
48755961|NCT02554812|156954248|FG018|Overall Study|Progressive disease|11|||
48965537|NCT00280150|157701756|FG003|Overall Study|Adverse Event|3|||
48965538|NCT00280150|157701753|FG000|Overall Study|Lack of Efficacy|0|||
48662409|NCT01352741|156615905|FG001|Open-label Tapentadol Titration Period|Lack of Efficacy|0|||
48662410|NCT01352741|156615904|FG000|Open-label Tapentadol Titration Period|Adverse Event|34|||
48662411|NCT01352741|156615905|FG001|Open-label Tapentadol Titration Period|Adverse Event|0|||
48662412|NCT01352741|156615904|FG000|Open-label Tapentadol Titration Period|Withdrawal of consent|7|||
48662413|NCT01352741|156615905|FG001|Open-label Tapentadol Titration Period|Withdrawal of consent|0|||
48662414|NCT01352741|156615904|FG000|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5|||
48662415|NCT01352741|156615905|FG001|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0|||
48662416|NCT01352741|156615904|FG000|Open-label Tapentadol Titration Period|Other|4|||
48662417|NCT01352741|156615905|FG001|Open-label Tapentadol Titration Period|Other|0|||
48662418|NCT01352741|156615904|FG000|Double-blind Comparative Period|Protocol Violation|2|||
48866668|NCT01894256|157347613|FG001|Part B|Withdrawal by Subject|1|||
48866669|NCT01894256|157347614|FG002|Part B|Withdrawal by Subject|0|||
48866670|NCT01894256|157347612|FG000|Part B|Lack of Efficacy|15|||
48866671|NCT01894256|157347613|FG001|Part B|Lack of Efficacy|12|||
48866672|NCT01894256|157347614|FG002|Part B|Lack of Efficacy|13|||
48866673|NCT03036124|157347615|FG000|Overall Study|Lost to Follow-up|0|||
48866674|NCT03036124|157347616|FG001|Overall Study|Lost to Follow-up|2|||
48866675|NCT03036124|157347615|FG000|Overall Study|Withdrawal by Subject|5|||
48866676|NCT03036124|157347616|FG001|Overall Study|Withdrawal by Subject|4|||
48866677|NCT01283971|157347617|FG000|Overall Study|Adverse Event|3|||
48866678|NCT01283971|157347618|FG001|Overall Study|Adverse Event|5|||
48866679|NCT01283971|157347617|FG000|Overall Study|Insufficient therapeutic responses|3|||
48866680|NCT01283971|157347618|FG001|Overall Study|Insufficient therapeutic responses|3|||
48866681|NCT01283971|157347617|FG000|Overall Study|Protocol Violation|5|||
48866682|NCT01283971|157347618|FG001|Overall Study|Protocol Violation|1|||
48866683|NCT01283971|157347617|FG000|Overall Study|Refused treatment|3|||
48866684|NCT01283971|157347618|FG001|Overall Study|Refused treatment|1|||
48866685|NCT01283971|157347617|FG000|Overall Study|Failure to return|0|||
48866686|NCT01283971|157347618|FG001|Overall Study|Failure to return|1|||
48866687|NCT01283971|157347617|FG000|Overall Study|Administrative reasons|1|||
48866688|NCT01283971|157347618|FG001|Overall Study|Administrative reasons|1|||
48866689|NCT01946529|157347620|FG000|End of Window Therapy (2 Courses)|Physician Decision|0|||
48866690|NCT01946529|157347621|FG001|End of Window Therapy (2 Courses)|Physician Decision|1|||
48866691|NCT01946529|157347622|FG002|End of Window Therapy (2 Courses)|Physician Decision|0|||
48866692|NCT01946529|157347620|FG000|Completion of All Therapy|Some pts. still receiving study therapy|1|||
48866693|NCT01946529|157347621|FG001|Completion of All Therapy|Some pts. still receiving study therapy|16|||
48866694|NCT01946529|157347622|FG002|Completion of All Therapy|Some pts. still receiving study therapy|6|||
48866695|NCT03049306|157347623|FG000|First Intervention (1 Night)|Lost to Follow-up|1|||
48866696|NCT03049306|157347624|FG001|First Intervention (1 Night)|Lost to Follow-up|1|||
48866697|NCT03151551|157347626|FG000|Open-Label Treatment Period|Adverse Event|0|||
48866698|NCT03151551|157347627|FG001|Open-Label Treatment Period|Adverse Event|2|||
48866699|NCT03151551|157347626|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
48866700|NCT03151551|157347627|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
48866701|NCT03151551|157347626|FG000|Open-Label Treatment Period|Withdrawal by Subject|12|||
48866702|NCT03151551|157347627|FG001|Open-Label Treatment Period|Withdrawal by Subject|18|||
48866703|NCT03151551|157347626|FG000|Open-Label Treatment Period|Lack of Efficacy|1|||
48866704|NCT03151551|157347627|FG001|Open-Label Treatment Period|Lack of Efficacy|1|||
48866705|NCT03151551|157347626|FG000|Open-Label Treatment Period|Physician Decision|3|||
48866706|NCT03151551|157347627|FG001|Open-Label Treatment Period|Physician Decision|0|||
48866707|NCT03151551|157347626|FG000|Open-Label Treatment Period|Protocol Deviation|1|||
48866708|NCT03151551|157347627|FG001|Open-Label Treatment Period|Protocol Deviation|2|||
48866709|NCT03151551|157347626|FG000|Post-Treatment Follow-Up Period|Adverse Event|1|||
48866710|NCT03151551|157347627|FG001|Post-Treatment Follow-Up Period|Adverse Event|3|||
48866711|NCT03151551|157347626|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
48866712|NCT03151551|157347627|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
48866713|NCT03151551|157347626|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|20|||
48866714|NCT03151551|157347627|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|22|||
48866715|NCT03151551|157347626|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
48866716|NCT03151551|157347627|FG001|Post-Treatment Follow-Up Period|Physician Decision|1|||
48866717|NCT00711555|157349074|FG000|Overall Study|Adverse Event|3|||
48866718|NCT00676195|157349075|FG000|Overall Study|Lost to Follow-up|1|||
48866719|NCT00676195|157349075|FG000|Overall Study|Adverse Event|1|||
48866720|NCT00676195|157349075|FG000|Overall Study|Physician Decision|1|||
48866721|NCT03675308|157349078|FG000|Overall Study|Adverse Event|3|||
48866722|NCT03675308|157349079|FG001|Overall Study|Adverse Event|2|||
48866723|NCT03675308|157349078|FG000|Overall Study|Withdrawal by Subject|6|||
48866724|NCT03675308|157349079|FG001|Overall Study|Withdrawal by Subject|4|||
48866725|NCT03675308|157349078|FG000|Overall Study|Lost to Follow-up|3|||
48866726|NCT03675308|157349079|FG001|Overall Study|Lost to Follow-up|0|||
48866727|NCT03675308|157349078|FG000|Overall Study|Lack of Efficacy|1|||
48866728|NCT03675308|157349079|FG001|Overall Study|Lack of Efficacy|1|||
48866729|NCT03675308|157349078|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|1|||
48965539|NCT00280150|157701754|FG001|Overall Study|Lack of Efficacy|0|||
48965540|NCT00280150|157701755|FG002|Overall Study|Lack of Efficacy|0|||
48965541|NCT00280150|157701756|FG003|Overall Study|Lack of Efficacy|3|||
48965542|NCT00280150|157701753|FG000|Overall Study|Physician Decision|0|||
48965543|NCT00280150|157701754|FG001|Overall Study|Physician Decision|0|||
48965544|NCT00280150|157701755|FG002|Overall Study|Physician Decision|0|||
48965545|NCT00280150|157701756|FG003|Overall Study|Physician Decision|1|||
48965546|NCT00280150|157701753|FG000|Overall Study|Protocol Violation|0|||
48965547|NCT00280150|157701754|FG001|Overall Study|Protocol Violation|0|||
48965548|NCT00280150|157701755|FG002|Overall Study|Protocol Violation|0|||
48965549|NCT00280150|157701756|FG003|Overall Study|Protocol Violation|1|||
48965550|NCT00280150|157701753|FG000|Overall Study|Withdrawal by Subject|0|||
48965551|NCT00280150|157701754|FG001|Overall Study|Withdrawal by Subject|0|||
48965552|NCT00280150|157701755|FG002|Overall Study|Withdrawal by Subject|0|||
48965553|NCT00280150|157701756|FG003|Overall Study|Withdrawal by Subject|1|||
48965554|NCT00280150|157701753|FG000|Overall Study|Did not get consolidation therapy|3|||
48965555|NCT00280150|157701754|FG001|Overall Study|Did not get consolidation therapy|0|||
48965556|NCT00280150|157701755|FG002|Overall Study|Did not get consolidation therapy|3|||
48965557|NCT00280150|157701756|FG003|Overall Study|Did not get consolidation therapy|0|||
48965558|NCT00280150|157701753|FG000|Overall Study|Declining Performance Status|0|||
48965559|NCT00280150|157701754|FG001|Overall Study|Declining Performance Status|0|||
48965560|NCT00280150|157701755|FG002|Overall Study|Declining Performance Status|0|||
48965561|NCT00280150|157701756|FG003|Overall Study|Declining Performance Status|1|||
48965562|NCT02690207|157701761|FG000|Overall Study|Lost to Follow-up|48|||
48965563|NCT02690207|157701761|FG000|Overall Study|Withdrawal by Subject|46|||
48965564|NCT02690207|157701761|FG000|Overall Study|Protocol Violation|2|||
48965565|NCT02690207|157701761|FG000|Overall Study|Serious adverse event|110|||
48965566|NCT02690207|157701761|FG000|Overall Study|Non-serious Adverse Event|18|||
48965567|NCT02690207|157701761|FG000|Overall Study|Migrated/moved from study area|5|||
48965568|NCT02690207|157701761|FG000|Overall Study|Suspected HZ Episode|1|||
48965569|NCT02690207|157701761|FG000|Overall Study|Other reasons for withdrawal|23|||
48965570|NCT02156492|157701769|FG000|Period 1|No Reason Given|0|||
48965571|NCT02156492|157701770|FG001|Period 1|No Reason Given|1|||
48965572|NCT02156492|157701771|FG002|Period 1|No Reason Given|0|||
48965573|NCT02156492|157701769|FG000|Period 3|Adverse Event|0|||
48965574|NCT02156492|157701770|FG001|Period 3|Adverse Event|1|||
48965575|NCT02156492|157701771|FG002|Period 3|Adverse Event|0|||
48965576|NCT00174785|157701779|FG000|Overall Study|Adverse Event|293|||
48965577|NCT00174785|157701780|FG001|Overall Study|Adverse Event|191|||
48965578|NCT00174785|157701779|FG000|Overall Study|Protocol Violation|14|||
48662419|NCT01352741|156615905|FG001|Double-blind Comparative Period|Protocol Violation|0|||
48662420|NCT01352741|156615904|FG000|Double-blind Comparative Period|Lack of Efficacy|0|||
48662421|NCT01352741|156615905|FG001|Double-blind Comparative Period|Lack of Efficacy|3|||
48662422|NCT01352741|156615904|FG000|Double-blind Comparative Period|Adverse Event|16|||
48662423|NCT01352741|156615905|FG001|Double-blind Comparative Period|Adverse Event|17|||
48965579|NCT00174785|157701780|FG001|Overall Study|Protocol Violation|14|||
48965580|NCT00174785|157701779|FG000|Overall Study|Withdrawal by Subject|173|||
48965581|NCT00174785|157701780|FG001|Overall Study|Withdrawal by Subject|175|||
48965582|NCT00174785|157701779|FG000|Overall Study|Atrial Fibrillation/Flutter recurrence|110|||
48965583|NCT00174785|157701780|FG001|Overall Study|Atrial Fibrillation/Flutter recurrence|167|||
48965584|NCT00174785|157701779|FG000|Overall Study|Prohibited antiarrhythmic medication|39|||
48965585|NCT00174785|157701780|FG001|Overall Study|Prohibited antiarrhythmic medication|88|||
48965586|NCT00174785|157701779|FG000|Overall Study|Other prohibited medication|5|||
48965587|NCT00174785|157701780|FG001|Overall Study|Other prohibited medication|3|||
48965588|NCT00174785|157701779|FG000|Overall Study|Family request|6|||
48965589|NCT00174785|157701780|FG001|Overall Study|Family request|8|||
48965590|NCT00174785|157701779|FG000|Overall Study|Not pre-specified/Not coded|56|||
48662424|NCT01352741|156615904|FG000|Double-blind Comparative Period|Lost to Follow-up|1|||
48662425|NCT01352741|156615905|FG001|Double-blind Comparative Period|Lost to Follow-up|0|||
48662426|NCT01352741|156615904|FG000|Double-blind Comparative Period|Death|0|||
48662427|NCT01352741|156615905|FG001|Double-blind Comparative Period|Death|1|||
48965591|NCT00174785|157701780|FG001|Overall Study|Not pre-specified/Not coded|70|||
48965592|NCT01093755|157701781|FG000|Overall Study|Withdrawal by Subject|3|||
48965593|NCT01093755|157701782|FG001|Overall Study|Withdrawal by Subject|4|||
48965594|NCT03444870|157701783|FG000|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
48965595|NCT03444870|157701784|FG001|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
48965596|NCT03444870|157701785|FG002|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|30|||
48965597|NCT03444870|157701786|FG003|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|35|||
48965598|NCT03444870|157701787|FG004|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
48965599|NCT03444870|157701788|FG005|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
48965600|NCT03444870|157701783|FG000|Double-Blind Treatment (DBT) Period|Reason not Specified|17|||
48965601|NCT03444870|157701784|FG001|Double-Blind Treatment (DBT) Period|Reason not Specified|16|||
48965602|NCT03444870|157701785|FG002|Double-Blind Treatment (DBT) Period|Reason not Specified|1|||
48662428|NCT01352741|156615904|FG000|Double-blind Comparative Period|Withdrawal of consent|8|||
48662429|NCT01352741|156615905|FG001|Double-blind Comparative Period|Withdrawal of consent|3|||
48965603|NCT03444870|157701786|FG003|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
48662430|NCT01352741|156615904|FG000|Double-blind Comparative Period|Other|1|||
48662431|NCT01352741|156615905|FG001|Double-blind Comparative Period|Other|2|||
48965604|NCT03444870|157701787|FG004|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
48965605|NCT03444870|157701788|FG005|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
48965606|NCT03444870|157701783|FG000|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|56|||
48965607|NCT03444870|157701784|FG001|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|63|||
48965608|NCT03444870|157701785|FG002|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|2|||
48965609|NCT03444870|157701786|FG003|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
48965610|NCT03444870|157701787|FG004|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
48965611|NCT03444870|157701788|FG005|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
48965612|NCT03444870|157701783|FG000|Double-Blind Treatment (DBT) Period|Protocol Deviation|4|||
48965613|NCT03444870|157701784|FG001|Double-Blind Treatment (DBT) Period|Protocol Deviation|3|||
48965614|NCT03444870|157701785|FG002|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
48965615|NCT03444870|157701786|FG003|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
48965616|NCT03444870|157701787|FG004|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
48965617|NCT03444870|157701788|FG005|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
48965618|NCT03444870|157701783|FG000|Double-Blind Treatment (DBT) Period|Physician Decision|3|||
48965619|NCT03444870|157701784|FG001|Double-Blind Treatment (DBT) Period|Physician Decision|11|||
48965620|NCT03444870|157701785|FG002|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
48965621|NCT03444870|157701786|FG003|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
48965622|NCT03444870|157701787|FG004|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
48965623|NCT03444870|157701788|FG005|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
48965624|NCT03444870|157701783|FG000|Double-Blind Treatment (DBT) Period|Lost to Follow-up|1|||
48965625|NCT03444870|157701784|FG001|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
48965626|NCT03444870|157701785|FG002|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
48965627|NCT03444870|157701786|FG003|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
48965628|NCT03444870|157701787|FG004|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
48662432|NCT01352741|156615904|FG000|Open-Label Tapentadol Continuation Arm|Adverse Event|4|||
48662433|NCT01352741|156615905|FG001|Open-Label Tapentadol Continuation Arm|Adverse Event|0|||
48662434|NCT01352741|156615904|FG000|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1|||
48662435|NCT01352741|156615905|FG001|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0|||
48965629|NCT03444870|157701788|FG005|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
48965630|NCT03444870|157701783|FG000|Double-Blind Treatment (DBT) Period|Death|10|||
48965631|NCT03444870|157701784|FG001|Double-Blind Treatment (DBT) Period|Death|2|||
48965632|NCT03444870|157701785|FG002|Double-Blind Treatment (DBT) Period|Death|0|||
48965633|NCT03444870|157701786|FG003|Double-Blind Treatment (DBT) Period|Death|0|||
48965634|NCT03444870|157701787|FG004|Double-Blind Treatment (DBT) Period|Death|0|||
48965635|NCT03444870|157701788|FG005|Double-Blind Treatment (DBT) Period|Death|0|||
48965636|NCT03444870|157701783|FG000|Double-Blind Treatment (DBT) Period|Adverse Event|7|||
48662436|NCT01352741|156615904|FG000|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2|||
48662437|NCT01352741|156615905|FG001|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0|||
48662438|NCT01352741|156615904|FG000|Open-Label Tapentadol Continuation Arm|Protocol Violation|1|||
48662439|NCT01352741|156615905|FG001|Open-Label Tapentadol Continuation Arm|Protocol Violation|0|||
48662440|NCT02463032|156615909|FG000|Overall Study|Lack of Efficacy|61|||
48662441|NCT02463032|156615910|FG001|Overall Study|Lack of Efficacy|50|||
48662442|NCT02463032|156615909|FG000|Overall Study|Death|8|||
48662443|NCT02463032|156615910|FG001|Overall Study|Death|8|||
48662444|NCT02463032|156615909|FG000|Overall Study|Adverse Event|2|||
48662445|NCT02463032|156615910|FG001|Overall Study|Adverse Event|6|||
48662446|NCT00846040|156615911|FG000|Baseline: Days 1-5|Withdrawal by Subject|1|||
48662447|NCT00846040|156615912|FG001|Baseline: Days 1-5|Withdrawal by Subject|0|||
48662448|NCT00846040|156615913|FG002|Baseline: Days 1-5|Withdrawal by Subject|0|||
48662449|NCT00846040|156615911|FG000|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
48662450|NCT00846040|156615912|FG001|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2|||
48662451|NCT00846040|156615913|FG002|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
48662452|NCT02153346|156615914|FG000|Overall Study|Lost to Follow-up|11|||
48662453|NCT01710527|156615915|FG000|Period 2: Washout Period (7 Days)|Personal reasons|0|||
48662454|NCT01710527|156615916|FG001|Period 2: Washout Period (7 Days)|Personal reasons|1|||
48662455|NCT02635347|156615917|FG000|Overall Study|Failed screening|20|||
48662456|NCT02635347|156615918|FG001|Overall Study|Failed screening|7|||
48662457|NCT00546260|156615919|FG000|Overall Study|Drug not given pre diagnostic angiogr|8|||
48662458|NCT00546260|156615920|FG001|Overall Study|Drug not given pre diagnostic angiogr|2|||
48662459|NCT01688921|156615923|FG000|Overall Study|Lost to Follow-up|7|||
48662460|NCT01688921|156615924|FG001|Overall Study|Lost to Follow-up|13|||
48662461|NCT01688921|156615923|FG000|Overall Study|Physician Decision|6|||
48662462|NCT01688921|156615924|FG001|Overall Study|Physician Decision|1|||
48662463|NCT01688921|156615923|FG000|Overall Study|Protocol Violation|0|||
48662464|NCT01688921|156615924|FG001|Overall Study|Protocol Violation|1|||
48755962|NCT02554812|156954249|FG019|Overall Study|Progressive disease|7|||
48755963|NCT02554812|156954250|FG020|Overall Study|Progressive disease|11|||
48755964|NCT02554812|156954251|FG021|Overall Study|Progressive disease|6|||
48755965|NCT02554812|156954252|FG022|Overall Study|Progressive disease|9|||
48755966|NCT02554812|156954253|FG023|Overall Study|Progressive disease|9|||
48755967|NCT02554812|156954254|FG024|Overall Study|Progressive disease|4|||
48755968|NCT02554812|156954255|FG025|Overall Study|Progressive disease|5|||
48755969|NCT02554812|156954256|FG026|Overall Study|Progressive disease|5|||
48755970|NCT02554812|156954230|FG000|Overall Study|Other|0|||
48662465|NCT01688921|156615923|FG000|Overall Study|informed consent|3|||
48662466|NCT01688921|156615924|FG001|Overall Study|informed consent|0|||
48662467|NCT00197145|156617592|FG000|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
48662468|NCT00197145|156617593|FG001|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
48662469|NCT00197145|156617592|FG000|Period 1: Randomized Treatment Phase|Sponsor terminated study|10|||
48755971|NCT02554812|156954231|FG001|Overall Study|Other|0|||
48755972|NCT02554812|156954232|FG002|Overall Study|Other|2|||
48755973|NCT02554812|156954233|FG003|Overall Study|Other|3|||
48755974|NCT02554812|156954234|FG004|Overall Study|Other|2|||
48755975|NCT02554812|156954235|FG005|Overall Study|Other|1|||
48755976|NCT02554812|156954236|FG006|Overall Study|Other|0|||
48755977|NCT02554812|156954237|FG007|Overall Study|Other|0|||
48965637|NCT03444870|157701784|FG001|Double-Blind Treatment (DBT) Period|Adverse Event|29|||
48965638|NCT03444870|157701785|FG002|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
48965639|NCT03444870|157701786|FG003|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
48965640|NCT03444870|157701787|FG004|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
48662470|NCT00197145|156617593|FG001|Period 1: Randomized Treatment Phase|Sponsor terminated study|8|||
48662471|NCT00197145|156617592|FG000|Period 1: Randomized Treatment Phase|Other|2|||
48662472|NCT00197145|156617593|FG001|Period 1: Randomized Treatment Phase|Other|2|||
48662473|NCT00197145|156617592|FG000|Period 2 : Open Label Phase|Insufficient viral load response|1|||
48662474|NCT00197145|156617593|FG001|Period 2 : Open Label Phase|Insufficient viral load response|0|||
48662475|NCT00197145|156617592|FG000|Period 2 : Open Label Phase|Protocol defined virological failure|3|||
48662476|NCT00197145|156617593|FG001|Period 2 : Open Label Phase|Protocol defined virological failure|0|||
48662477|NCT00197145|156617592|FG000|Period 2 : Open Label Phase|Availability of alternative ART|2|||
48662478|NCT00197145|156617593|FG001|Period 2 : Open Label Phase|Availability of alternative ART|0|||
48662479|NCT00197145|156617592|FG000|Period 2 : Open Label Phase|Were ongoing till data freeze|3|||
48662480|NCT00197145|156617593|FG001|Period 2 : Open Label Phase|Were ongoing till data freeze|0|||
48662481|NCT00197145|156617592|FG000|Period 2 : Open Label Phase|Other|1|||
48662482|NCT00197145|156617593|FG001|Period 2 : Open Label Phase|Other|0|||
48662483|NCT01691014|156617596|FG000|Overall Study|Premature Termination|1|||
48662484|NCT01691014|156617597|FG001|Overall Study|Premature Termination|6|||
48662485|NCT01691014|156617598|FG002|Overall Study|Premature Termination|0|||
48662486|NCT01691014|156617599|FG003|Overall Study|Premature Termination|3|||
48662487|NCT01691014|156617596|FG000|Overall Study|Other|0|||
48662488|NCT01691014|156617597|FG001|Overall Study|Other|0|||
48662489|NCT01691014|156617598|FG002|Overall Study|Other|2|||
48662490|NCT01691014|156617599|FG003|Overall Study|Other|0|||
48662491|NCT01691014|156617596|FG000|Overall Study|Withdrawal by Subject|0|||
48662492|NCT01691014|156617597|FG001|Overall Study|Withdrawal by Subject|1|||
48662493|NCT01691014|156617598|FG002|Overall Study|Withdrawal by Subject|1|||
48662494|NCT01691014|156617599|FG003|Overall Study|Withdrawal by Subject|1|||
48662495|NCT01691014|156617596|FG000|Overall Study|Adverse Event|0|||
48662496|NCT01691014|156617597|FG001|Overall Study|Adverse Event|5|||
48662497|NCT01691014|156617598|FG002|Overall Study|Adverse Event|1|||
48662498|NCT01691014|156617599|FG003|Overall Study|Adverse Event|1|||
48662499|NCT01691014|156617596|FG000|Overall Study|Lack of Efficacy|2|||
48662500|NCT01691014|156617597|FG001|Overall Study|Lack of Efficacy|3|||
48662501|NCT01691014|156617598|FG002|Overall Study|Lack of Efficacy|7|||
48662502|NCT01691014|156617599|FG003|Overall Study|Lack of Efficacy|0|||
48662503|NCT02370537|156617600|FG000|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
48662504|NCT02370537|156617601|FG001|Part A (Open-label Recruitment)|Withdrawal by Subject|1|||
48662505|NCT02370537|156617602|FG002|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
48662506|NCT02370537|156617600|FG000|Part A (Open-label Recruitment)|Adverse Event|0|||
48965641|NCT03444870|157701788|FG005|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
48662507|NCT02370537|156617601|FG001|Part A (Open-label Recruitment)|Adverse Event|0|||
48662508|NCT02370537|156617602|FG002|Part A (Open-label Recruitment)|Adverse Event|1|||
48662509|NCT02370537|156617600|FG000|Part B|Not randomised to receive treatment|1|||
48662510|NCT02370537|156617601|FG001|Part B|Not randomised to receive treatment|2|||
48662511|NCT02370537|156617602|FG002|Part B|Not randomised to receive treatment|259|||
48662512|NCT02370537|156617600|FG000|Part B|Withdrawal by Subject|0|||
48662513|NCT02370537|156617601|FG001|Part B|Withdrawal by Subject|1|||
48755978|NCT02554812|156954238|FG008|Overall Study|Other|1|||
48755979|NCT02554812|156954239|FG009|Overall Study|Other|1|||
48755980|NCT02554812|156954240|FG010|Overall Study|Other|0|||
48755981|NCT02554812|156954241|FG011|Overall Study|Other|0|||
48755982|NCT02554812|156954242|FG012|Overall Study|Other|1|||
48662514|NCT02370537|156617602|FG002|Part B|Withdrawal by Subject|0|||
48662515|NCT01718743|156617603|FG000|Overall Study|Physician Decision|7|||
48662516|NCT01718743|156617603|FG000|Overall Study|Withdrawal by Subject|14|||
48662517|NCT01718743|156617603|FG000|Overall Study|Progressive Disease|22|||
48662518|NCT01718743|156617603|FG000|Overall Study|Toxicity|1|||
48662519|NCT01718743|156617603|FG000|Overall Study|Malignancy|1|||
48662520|NCT00642174|156617605|FG000|Period 1 - Initial Drug|Entry Criteria Not Met|0|||
48662521|NCT00642174|156617606|FG001|Period 1 - Initial Drug|Entry Criteria Not Met|1|||
48662522|NCT02526524|156617619|FG000|Overall Study|Withdrawal by Subject|3|||
48662523|NCT02526524|156617620|FG001|Overall Study|Withdrawal by Subject|3|||
48662524|NCT02526524|156617621|FG002|Overall Study|Withdrawal by Subject|6|||
48662525|NCT02526524|156617622|FG003|Overall Study|Withdrawal by Subject|1|||
48662526|NCT02526524|156617623|FG004|Overall Study|Withdrawal by Subject|9|||
48662527|NCT02526524|156617624|FG005|Overall Study|Withdrawal by Subject|5|||
48755983|NCT02554812|156954243|FG013|Overall Study|Other|0|||
48755984|NCT02554812|156954244|FG014|Overall Study|Other|1|||
48755985|NCT02554812|156954245|FG015|Overall Study|Other|0|||
48755986|NCT02554812|156954246|FG016|Overall Study|Other|0|||
48755987|NCT02554812|156954247|FG017|Overall Study|Other|0|||
48755988|NCT02554812|156954248|FG018|Overall Study|Other|0|||
48755989|NCT02554812|156954249|FG019|Overall Study|Other|0|||
48755990|NCT02554812|156954250|FG020|Overall Study|Other|0|||
48755991|NCT02554812|156954251|FG021|Overall Study|Other|2|||
48755992|NCT02554812|156954252|FG022|Overall Study|Other|0|||
48755993|NCT02554812|156954253|FG023|Overall Study|Other|0|||
48755994|NCT02554812|156954254|FG024|Overall Study|Other|0|||
48755995|NCT02554812|156954255|FG025|Overall Study|Other|0|||
48755996|NCT02554812|156954256|FG026|Overall Study|Other|0|||
48755997|NCT02554812|156954230|FG000|Overall Study|Withdrawal by Subject|1|||
48755998|NCT02554812|156954231|FG001|Overall Study|Withdrawal by Subject|0|||
48755999|NCT02554812|156954232|FG002|Overall Study|Withdrawal by Subject|0|||
48756000|NCT02554812|156954233|FG003|Overall Study|Withdrawal by Subject|2|||
48756001|NCT02554812|156954234|FG004|Overall Study|Withdrawal by Subject|2|||
48756002|NCT02554812|156954235|FG005|Overall Study|Withdrawal by Subject|3|||
48756003|NCT02554812|156954236|FG006|Overall Study|Withdrawal by Subject|0|||
48756004|NCT02554812|156954237|FG007|Overall Study|Withdrawal by Subject|0|||
48756005|NCT02554812|156954238|FG008|Overall Study|Withdrawal by Subject|1|||
48756006|NCT02554812|156954239|FG009|Overall Study|Withdrawal by Subject|1|||
48756007|NCT02554812|156954240|FG010|Overall Study|Withdrawal by Subject|0|||
48756008|NCT02554812|156954241|FG011|Overall Study|Withdrawal by Subject|1|||
48756009|NCT02554812|156954242|FG012|Overall Study|Withdrawal by Subject|1|||
48756010|NCT02554812|156954243|FG013|Overall Study|Withdrawal by Subject|1|||
48756011|NCT02554812|156954244|FG014|Overall Study|Withdrawal by Subject|1|||
48756012|NCT02554812|156954245|FG015|Overall Study|Withdrawal by Subject|1|||
48756013|NCT02554812|156954246|FG016|Overall Study|Withdrawal by Subject|3|||
48756014|NCT02554812|156954247|FG017|Overall Study|Withdrawal by Subject|1|||
48756015|NCT02554812|156954248|FG018|Overall Study|Withdrawal by Subject|0|||
48756016|NCT02554812|156954249|FG019|Overall Study|Withdrawal by Subject|2|||
48662528|NCT02526524|156617619|FG000|Overall Study|Adverse Event|3|||
48662529|NCT02526524|156617620|FG001|Overall Study|Adverse Event|2|||
48662530|NCT02526524|156617621|FG002|Overall Study|Adverse Event|4|||
48662531|NCT02526524|156617622|FG003|Overall Study|Adverse Event|2|||
48662532|NCT02526524|156617623|FG004|Overall Study|Adverse Event|6|||
48662533|NCT02526524|156617624|FG005|Overall Study|Adverse Event|8|||
48662534|NCT02526524|156617619|FG000|Overall Study|Lost to Follow-up|2|||
48662535|NCT02526524|156617620|FG001|Overall Study|Lost to Follow-up|3|||
48662536|NCT02526524|156617621|FG002|Overall Study|Lost to Follow-up|8|||
48662537|NCT02526524|156617622|FG003|Overall Study|Lost to Follow-up|1|||
48662538|NCT02526524|156617623|FG004|Overall Study|Lost to Follow-up|2|||
48662539|NCT02526524|156617624|FG005|Overall Study|Lost to Follow-up|5|||
48756017|NCT02554812|156954250|FG020|Overall Study|Withdrawal by Subject|0|||
48756018|NCT02554812|156954251|FG021|Overall Study|Withdrawal by Subject|1|||
48756019|NCT02554812|156954252|FG022|Overall Study|Withdrawal by Subject|0|||
48756020|NCT02554812|156954253|FG023|Overall Study|Withdrawal by Subject|1|||
48756021|NCT02554812|156954254|FG024|Overall Study|Withdrawal by Subject|0|||
48756022|NCT02554812|156954255|FG025|Overall Study|Withdrawal by Subject|0|||
48756023|NCT02554812|156954256|FG026|Overall Study|Withdrawal by Subject|1|||
48662540|NCT02526524|156617619|FG000|Overall Study|Protocol Violation|3|||
48662541|NCT02526524|156617620|FG001|Overall Study|Protocol Violation|1|||
48662542|NCT02526524|156617621|FG002|Overall Study|Protocol Violation|5|||
48662543|NCT02526524|156617622|FG003|Overall Study|Protocol Violation|3|||
48662544|NCT02526524|156617623|FG004|Overall Study|Protocol Violation|4|||
48662545|NCT02526524|156617624|FG005|Overall Study|Protocol Violation|3|||
48756024|NCT02554812|156954230|FG000|Overall Study|Physician Decision|1|||
48756025|NCT02554812|156954231|FG001|Overall Study|Physician Decision|0|||
48756026|NCT02554812|156954232|FG002|Overall Study|Physician Decision|0|||
48756027|NCT02554812|156954233|FG003|Overall Study|Physician Decision|1|||
48756028|NCT02554812|156954234|FG004|Overall Study|Physician Decision|0|||
48756029|NCT02554812|156954235|FG005|Overall Study|Physician Decision|1|||
48756030|NCT02554812|156954236|FG006|Overall Study|Physician Decision|0|||
48756031|NCT02554812|156954237|FG007|Overall Study|Physician Decision|0|||
48756032|NCT02554812|156954238|FG008|Overall Study|Physician Decision|0|||
48756033|NCT02554812|156954239|FG009|Overall Study|Physician Decision|0|||
48756034|NCT02554812|156954240|FG010|Overall Study|Physician Decision|1|||
48756035|NCT02554812|156954241|FG011|Overall Study|Physician Decision|0|||
48756036|NCT02554812|156954242|FG012|Overall Study|Physician Decision|0|||
48756037|NCT02554812|156954243|FG013|Overall Study|Physician Decision|0|||
48756038|NCT02554812|156954244|FG014|Overall Study|Physician Decision|0|||
48756039|NCT02554812|156954245|FG015|Overall Study|Physician Decision|0|||
48965642|NCT03444870|157701783|FG000|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|1|||
48965643|NCT03444870|157701784|FG001|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
48965644|NCT03444870|157701785|FG002|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
48662546|NCT02526524|156617619|FG000|Overall Study|Loss of Glucose Control|0|||
48756040|NCT02554812|156954246|FG016|Overall Study|Physician Decision|1|||
48965645|NCT03444870|157701786|FG003|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
48965646|NCT03444870|157701787|FG004|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
48965647|NCT03444870|157701788|FG005|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
48965648|NCT03444870|157701783|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
48965649|NCT03444870|157701784|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
48965650|NCT03444870|157701785|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
48965651|NCT03444870|157701786|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
48965652|NCT03444870|157701787|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
48965653|NCT03444870|157701788|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
48965654|NCT03444870|157701783|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
48965655|NCT03444870|157701784|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
48965656|NCT03444870|157701785|FG002|Open-Label Extension (OLE) Period|Physician Decision|0|||
48965657|NCT03444870|157701786|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
48965658|NCT03444870|157701787|FG004|Open-Label Extension (OLE) Period|Physician Decision|1|||
48965659|NCT03444870|157701788|FG005|Open-Label Extension (OLE) Period|Physician Decision|0|||
48965660|NCT03444870|157701783|FG000|Open-Label Extension (OLE) Period|Death|0|||
48965661|NCT03444870|157701784|FG001|Open-Label Extension (OLE) Period|Death|0|||
48965662|NCT03444870|157701785|FG002|Open-Label Extension (OLE) Period|Death|0|||
48965663|NCT03444870|157701786|FG003|Open-Label Extension (OLE) Period|Death|0|||
48965664|NCT03444870|157701787|FG004|Open-Label Extension (OLE) Period|Death|1|||
48965665|NCT03444870|157701788|FG005|Open-Label Extension (OLE) Period|Death|0|||
48965666|NCT01736254|157701789|FG000|Period 2 (Days 2 to 12)|Adverse Event|3|||
48965667|NCT01736254|157701789|FG000|Period 3 (Days 13 to 23)|Adverse Event|1|||
48965668|NCT01204697|157701790|FG000|Overall Study|Death|26|||
48965669|NCT01204697|157701791|FG001|Overall Study|Death|27|||
48662547|NCT02526524|156617620|FG001|Overall Study|Loss of Glucose Control|0|||
48662548|NCT02526524|156617621|FG002|Overall Study|Loss of Glucose Control|3|||
48965670|NCT01204697|157701790|FG000|Overall Study|Lost to Follow-up|3|||
48965671|NCT01204697|157701791|FG001|Overall Study|Lost to Follow-up|4|||
48965672|NCT01204697|157701790|FG000|Overall Study|Withdrawal by Subject|2|||
48965673|NCT01204697|157701791|FG001|Overall Study|Withdrawal by Subject|4|||
48965674|NCT01204697|157701790|FG000|Overall Study|Randomized, but not treated|0|||
48965675|NCT01204697|157701791|FG001|Overall Study|Randomized, but not treated|1|||
48965676|NCT03372603|157701802|FG000|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1|||
48965677|NCT03372603|157701803|FG001|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0|||
48965678|NCT03372603|157701802|FG000|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1|||
48965679|NCT03372603|157701803|FG001|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0|||
48965680|NCT01199055|157701804|FG000|Overall Study|Death|0|||
48662549|NCT02526524|156617622|FG003|Overall Study|Loss of Glucose Control|0|||
48662550|NCT02526524|156617623|FG004|Overall Study|Loss of Glucose Control|2|||
48662551|NCT02526524|156617624|FG005|Overall Study|Loss of Glucose Control|0|||
48662552|NCT02526524|156617619|FG000|Overall Study|Physician Decision|0|||
48662553|NCT02526524|156617620|FG001|Overall Study|Physician Decision|0|||
48662554|NCT02526524|156617621|FG002|Overall Study|Physician Decision|0|||
48662555|NCT02526524|156617622|FG003|Overall Study|Physician Decision|0|||
48662556|NCT02526524|156617623|FG004|Overall Study|Physician Decision|1|||
48662557|NCT02526524|156617624|FG005|Overall Study|Physician Decision|0|||
48662558|NCT02526524|156617619|FG000|Overall Study|Sponsor Decision|1|||
48662559|NCT02526524|156617620|FG001|Overall Study|Sponsor Decision|0|||
48662560|NCT02526524|156617621|FG002|Overall Study|Sponsor Decision|0|||
48662561|NCT02526524|156617622|FG003|Overall Study|Sponsor Decision|0|||
48965681|NCT01199055|157701805|FG001|Overall Study|Death|1|||
48662562|NCT02526524|156617623|FG004|Overall Study|Sponsor Decision|0|||
48662563|NCT02526524|156617624|FG005|Overall Study|Sponsor Decision|0|||
48662564|NCT02281955|156617628|FG000|Overall Study|Death|1|||
48662565|NCT00445939|156617636|FG000|Period A - Week 0 - Week 4|Adverse Event|1|||
48662566|NCT00445939|156617637|FG001|Period A - Week 0 - Week 4|Adverse Event|2|||
48756041|NCT02554812|156954247|FG017|Overall Study|Physician Decision|1|||
48756042|NCT02554812|156954248|FG018|Overall Study|Physician Decision|0|||
48756043|NCT02554812|156954249|FG019|Overall Study|Physician Decision|1|||
48756044|NCT02554812|156954250|FG020|Overall Study|Physician Decision|1|||
48756045|NCT02554812|156954251|FG021|Overall Study|Physician Decision|0|||
48756046|NCT02554812|156954252|FG022|Overall Study|Physician Decision|1|||
48756047|NCT02554812|156954253|FG023|Overall Study|Physician Decision|0|||
48756048|NCT02554812|156954254|FG024|Overall Study|Physician Decision|0|||
48756049|NCT02554812|156954255|FG025|Overall Study|Physician Decision|0|||
48756050|NCT02554812|156954256|FG026|Overall Study|Physician Decision|0|||
48756051|NCT02554812|156954230|FG000|Overall Study|Study terminated by sponsor|0|||
48756052|NCT02554812|156954231|FG001|Overall Study|Study terminated by sponsor|0|||
48756053|NCT02554812|156954232|FG002|Overall Study|Study terminated by sponsor|0|||
48756054|NCT02554812|156954233|FG003|Overall Study|Study terminated by sponsor|0|||
48756055|NCT02554812|156954234|FG004|Overall Study|Study terminated by sponsor|0|||
48756056|NCT02554812|156954235|FG005|Overall Study|Study terminated by sponsor|0|||
48756057|NCT02554812|156954236|FG006|Overall Study|Study terminated by sponsor|0|||
48756058|NCT02554812|156954237|FG007|Overall Study|Study terminated by sponsor|0|||
48756059|NCT02554812|156954238|FG008|Overall Study|Study terminated by sponsor|0|||
48756060|NCT02554812|156954239|FG009|Overall Study|Study terminated by sponsor|0|||
48756061|NCT02554812|156954240|FG010|Overall Study|Study terminated by sponsor|0|||
48756062|NCT02554812|156954241|FG011|Overall Study|Study terminated by sponsor|0|||
48756063|NCT02554812|156954242|FG012|Overall Study|Study terminated by sponsor|0|||
48756064|NCT02554812|156954243|FG013|Overall Study|Study terminated by sponsor|0|||
48756065|NCT02554812|156954244|FG014|Overall Study|Study terminated by sponsor|0|||
48756066|NCT02554812|156954245|FG015|Overall Study|Study terminated by sponsor|0|||
48756067|NCT02554812|156954246|FG016|Overall Study|Study terminated by sponsor|0|||
48756068|NCT02554812|156954247|FG017|Overall Study|Study terminated by sponsor|0|||
48756069|NCT02554812|156954248|FG018|Overall Study|Study terminated by sponsor|0|||
48756070|NCT02554812|156954249|FG019|Overall Study|Study terminated by sponsor|0|||
48756071|NCT02554812|156954250|FG020|Overall Study|Study terminated by sponsor|0|||
48756072|NCT02554812|156954251|FG021|Overall Study|Study terminated by sponsor|0|||
48756073|NCT02554812|156954252|FG022|Overall Study|Study terminated by sponsor|0|||
48756074|NCT02554812|156954253|FG023|Overall Study|Study terminated by sponsor|0|||
48756075|NCT02554812|156954254|FG024|Overall Study|Study terminated by sponsor|1|||
48756076|NCT02554812|156954255|FG025|Overall Study|Study terminated by sponsor|0|||
48756077|NCT02554812|156954256|FG026|Overall Study|Study terminated by sponsor|0|||
48756078|NCT02554812|156954230|FG000|Overall Study|No longer meets eligibility criteria|0|||
48756079|NCT02554812|156954231|FG001|Overall Study|No longer meets eligibility criteria|1|||
48756080|NCT02554812|156954232|FG002|Overall Study|No longer meets eligibility criteria|0|||
48756081|NCT02554812|156954233|FG003|Overall Study|No longer meets eligibility criteria|0|||
48756082|NCT02554812|156954234|FG004|Overall Study|No longer meets eligibility criteria|0|||
48756083|NCT02554812|156954235|FG005|Overall Study|No longer meets eligibility criteria|0|||
48756084|NCT02554812|156954236|FG006|Overall Study|No longer meets eligibility criteria|0|||
48756085|NCT02554812|156954237|FG007|Overall Study|No longer meets eligibility criteria|0|||
48756086|NCT02554812|156954238|FG008|Overall Study|No longer meets eligibility criteria|0|||
48756087|NCT02554812|156954239|FG009|Overall Study|No longer meets eligibility criteria|0|||
48756088|NCT02554812|156954240|FG010|Overall Study|No longer meets eligibility criteria|0|||
48756089|NCT02554812|156954241|FG011|Overall Study|No longer meets eligibility criteria|0|||
48756090|NCT02554812|156954242|FG012|Overall Study|No longer meets eligibility criteria|0|||
48756091|NCT02554812|156954243|FG013|Overall Study|No longer meets eligibility criteria|0|||
48756092|NCT02554812|156954244|FG014|Overall Study|No longer meets eligibility criteria|0|||
48756093|NCT02554812|156954245|FG015|Overall Study|No longer meets eligibility criteria|0|||
48756094|NCT02554812|156954246|FG016|Overall Study|No longer meets eligibility criteria|0|||
48756095|NCT02554812|156954247|FG017|Overall Study|No longer meets eligibility criteria|0|||
48756096|NCT02554812|156954248|FG018|Overall Study|No longer meets eligibility criteria|0|||
48756097|NCT02554812|156954249|FG019|Overall Study|No longer meets eligibility criteria|0|||
48756098|NCT02554812|156954250|FG020|Overall Study|No longer meets eligibility criteria|0|||
48756099|NCT02554812|156954251|FG021|Overall Study|No longer meets eligibility criteria|0|||
48756100|NCT02554812|156954252|FG022|Overall Study|No longer meets eligibility criteria|0|||
48965682|NCT01199055|157701806|FG002|Overall Study|Death|0|||
48965683|NCT01199055|157701804|FG000|Overall Study|Physician Decision|0|||
48965684|NCT01199055|157701805|FG001|Overall Study|Physician Decision|1|||
48965685|NCT01199055|157701806|FG002|Overall Study|Physician Decision|1|||
48965686|NCT01199055|157701804|FG000|Overall Study|Progressive disease|2|||
48965687|NCT01199055|157701805|FG001|Overall Study|Progressive disease|1|||
48756101|NCT02554812|156954253|FG023|Overall Study|No longer meets eligibility criteria|0|||
48756102|NCT02554812|156954254|FG024|Overall Study|No longer meets eligibility criteria|0|||
48756103|NCT02554812|156954255|FG025|Overall Study|No longer meets eligibility criteria|0|||
48756104|NCT02554812|156954256|FG026|Overall Study|No longer meets eligibility criteria|0|||
48756105|NCT03342690|156954257|FG000|Overall Study|Missing Information|9|||
48756106|NCT03342690|156954257|FG000|Overall Study|Protocol Violation|16|||
48756107|NCT01500629|156954258|FG000|Washout Period of 14 to 30 Days|Pregnancy|1|||
48965688|NCT01199055|157701806|FG002|Overall Study|Progressive disease|2|||
49015452|NCT01393990|157893784|FG014|Overall Study|Adverse Event|1|||
48756108|NCT01500629|156954259|FG001|Washout Period of 14 to 30 Days|Pregnancy|0|||
48756109|NCT00588848|156954260|FG000|Overall Study|Physician Decision|0|||
48756110|NCT00588848|156954261|FG001|Overall Study|Physician Decision|3|||
48756111|NCT02064894|156954264|FG000|Overall Study|Withdrawal by Subject|43|||
48756112|NCT02064894|156954265|FG001|Overall Study|Withdrawal by Subject|102|||
48756113|NCT02064894|156954266|FG002|Overall Study|Withdrawal by Subject|115|||
48756114|NCT02902965|156954270|FG000|Overall Study|Withdrawal by Subject|10|||
48756115|NCT00293254|156954271|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
48965689|NCT01199055|157701804|FG000|Overall Study|Withdrawal by Subject|0|||
48965690|NCT01199055|157701805|FG001|Overall Study|Withdrawal by Subject|0|||
48965691|NCT01199055|157701806|FG002|Overall Study|Withdrawal by Subject|1|||
48965692|NCT03986190|157701807|FG000|Overall Study|Withdrawal by Subject|12|||
48965693|NCT03986190|157701808|FG001|Overall Study|Withdrawal by Subject|0|||
48662567|NCT00445939|156617638|FG002|Period A - Week 0 - Week 4|Adverse Event|0|||
48662568|NCT00445939|156617639|FG003|Period A - Week 0 - Week 4|Adverse Event|0|||
48662569|NCT00445939|156617636|FG000|Period B - Week 4 - Week 8|Adverse Event|2|||
48662570|NCT00445939|156617637|FG001|Period B - Week 4 - Week 8|Adverse Event|0|||
48662571|NCT00445939|156617638|FG002|Period B - Week 4 - Week 8|Adverse Event|0|||
48662572|NCT00445939|156617639|FG003|Period B - Week 4 - Week 8|Adverse Event|1|||
48662573|NCT03812185|156617640|FG000|TEE Imaging Before Suctioning|Physician Decision|3|||
48662574|NCT00006046|156617641|FG000|Overall Study|Adverse Event|3|||
48662575|NCT00006046|156617642|FG001|Overall Study|Adverse Event|0|||
48662576|NCT00006046|156617643|FG002|Overall Study|Adverse Event|0|||
48662577|NCT00006046|156617644|FG003|Overall Study|Adverse Event|0|||
48662578|NCT00006046|156617645|FG004|Overall Study|Adverse Event|0|||
48662579|NCT00006046|156617641|FG000|Overall Study|Disease Progression|2|||
48662580|NCT00006046|156617642|FG001|Overall Study|Disease Progression|0|||
48662581|NCT00006046|156617643|FG002|Overall Study|Disease Progression|0|||
48662582|NCT00006046|156617644|FG003|Overall Study|Disease Progression|0|||
48662583|NCT00006046|156617645|FG004|Overall Study|Disease Progression|0|||
48662584|NCT03176472|156617646|FG000|Double Blind Treatment Period|Withdrawal by Subject|5|||
48662585|NCT03176472|156617647|FG001|Double Blind Treatment Period|Withdrawal by Subject|10|||
48662586|NCT03176472|156617646|FG000|Double Blind Treatment Period|Adverse Event|0|||
48662587|NCT03176472|156617647|FG001|Double Blind Treatment Period|Adverse Event|5|||
48662588|NCT03176472|156617646|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
48662589|NCT03176472|156617647|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
48662590|NCT03176472|156617646|FG000|Double Blind Treatment Period|Physician Decision|0|||
48662591|NCT03176472|156617647|FG001|Double Blind Treatment Period|Physician Decision|1|||
48662592|NCT03176472|156617646|FG000|Double Blind Treatment Period|Protocol Violation|1|||
48662593|NCT03176472|156617647|FG001|Double Blind Treatment Period|Protocol Violation|0|||
48662594|NCT03176472|156617646|FG000|Double Blind Treatment Period|Not Provided|1|||
48662595|NCT03176472|156617647|FG001|Double Blind Treatment Period|Not Provided|0|||
48662596|NCT03176472|156617646|FG000|Open Label Extension|Withdrawal by Subject|3|||
48662597|NCT03176472|156617647|FG001|Open Label Extension|Withdrawal by Subject|4|||
48662598|NCT03176472|156617646|FG000|Open Label Extension|Adverse Event|2|||
48662599|NCT03176472|156617647|FG001|Open Label Extension|Adverse Event|4|||
48662600|NCT03176472|156617646|FG000|Open Label Extension|Lost to Follow-up|1|||
48662601|NCT03176472|156617647|FG001|Open Label Extension|Lost to Follow-up|2|||
48662602|NCT03176472|156617646|FG000|Open Label Extension|Protocol Violation|0|||
48662603|NCT03176472|156617647|FG001|Open Label Extension|Protocol Violation|1|||
48662604|NCT03176472|156617646|FG000|Open Label Extension|Not Provided|2|||
48662605|NCT03176472|156617647|FG001|Open Label Extension|Not Provided|1|||
48662606|NCT00996281|156617648|FG000|Overall Study|Adverse Event|75|||
48662607|NCT00996281|156617649|FG001|Overall Study|Adverse Event|37|||
48662608|NCT00996281|156617648|FG000|Overall Study|Major Protocol Deviation|6|||
48662609|NCT00996281|156617649|FG001|Overall Study|Major Protocol Deviation|7|||
48662610|NCT00996281|156617648|FG000|Overall Study|Lost to Follow-up|14|||
48965694|NCT04511819|157701809|FG000|Overall Study|Non-compliance with study drug|5|||
48965695|NCT04511819|157701810|FG001|Overall Study|Non-compliance with study drug|1|||
48965696|NCT04511819|157701809|FG000|Overall Study|Withdrawal by Subject|0|||
48662611|NCT00996281|156617649|FG001|Overall Study|Lost to Follow-up|16|||
48756116|NCT00293254|156954272|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
48756117|NCT00293254|156954271|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|2|||
48756118|NCT00293254|156954272|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
48965697|NCT04511819|157701810|FG001|Overall Study|Withdrawal by Subject|3|||
48965698|NCT04511819|157701809|FG000|Overall Study|Adverse Event|0|||
48662612|NCT00996281|156617648|FG000|Overall Study|Withdrawal by Subject|31|||
48662613|NCT00996281|156617649|FG001|Overall Study|Withdrawal by Subject|20|||
48662614|NCT00996281|156617648|FG000|Overall Study|Lack of Efficacy|0|||
48662615|NCT00996281|156617649|FG001|Overall Study|Lack of Efficacy|2|||
48662616|NCT00996281|156617648|FG000|Overall Study|Other|5|||
48662617|NCT00996281|156617649|FG001|Overall Study|Other|7|||
48662618|NCT01187446|156617650|FG000|Overall Study|Patient started non-protocol therapy|0|||
48662619|NCT01187446|156617651|FG001|Overall Study|Patient started non-protocol therapy|1|||
48662620|NCT01007123|156617652|FG000|Overall Study|Adverse Event|3|||
48756119|NCT00293254|156954271|FG000|Primary Study - Double-Blind Week 0-48|Death|5|||
48756120|NCT00293254|156954272|FG001|Primary Study - Double-Blind Week 0-48|Death|2|||
48756121|NCT00293254|156954271|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
48756122|NCT00293254|156954272|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
48756123|NCT00293254|156954271|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3|||
48756124|NCT00293254|156954272|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
48756125|NCT00293254|156954271|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5|||
48756126|NCT00293254|156954272|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
48756127|NCT00293254|156954271|FG000|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1|||
48756128|NCT00293254|156954272|FG001|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0|||
48866730|NCT03675308|157349079|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|2|||
48866731|NCT03675308|157349078|FG000|Overall Study|Other|0|||
48866732|NCT03675308|157349079|FG001|Overall Study|Other|1|||
48866733|NCT05244226|157349080|FG000|Overall Study|Adverse Event|1|||
48866734|NCT05244226|157349081|FG001|Overall Study|Adverse Event|0|||
48866735|NCT05244226|157349082|FG002|Overall Study|Adverse Event|0|||
48866736|NCT05244226|157349080|FG000|Overall Study|Lost to Follow-up|0|||
48662621|NCT01007123|156617653|FG001|Overall Study|Adverse Event|4|||
48662622|NCT01007123|156617654|FG002|Overall Study|Adverse Event|7|||
48662623|NCT01007123|156617655|FG003|Overall Study|Adverse Event|1|||
48662624|NCT01007123|156617652|FG000|Overall Study|Lack of Efficacy|1|||
48662625|NCT01007123|156617653|FG001|Overall Study|Lack of Efficacy|0|||
48662626|NCT01007123|156617654|FG002|Overall Study|Lack of Efficacy|1|||
48662627|NCT01007123|156617655|FG003|Overall Study|Lack of Efficacy|4|||
48662628|NCT01007123|156617652|FG000|Overall Study|Protocol Violation|1|||
48662629|NCT01007123|156617653|FG001|Overall Study|Protocol Violation|1|||
48662630|NCT01007123|156617654|FG002|Overall Study|Protocol Violation|2|||
48662631|NCT01007123|156617655|FG003|Overall Study|Protocol Violation|1|||
48662632|NCT01007123|156617652|FG000|Overall Study|Withdrawal by Subject|1|||
48662633|NCT01007123|156617653|FG001|Overall Study|Withdrawal by Subject|0|||
48662634|NCT01007123|156617654|FG002|Overall Study|Withdrawal by Subject|1|||
48662635|NCT01007123|156617655|FG003|Overall Study|Withdrawal by Subject|0|||
48662636|NCT01007123|156617652|FG000|Overall Study|Lost to Follow-up|0|||
48662637|NCT01007123|156617653|FG001|Overall Study|Lost to Follow-up|1|||
48662638|NCT01007123|156617654|FG002|Overall Study|Lost to Follow-up|0|||
48662639|NCT01007123|156617655|FG003|Overall Study|Lost to Follow-up|0|||
48662640|NCT00524589|156617656|FG000|Overall Study|Withdrawal by Subject|2|||
48662641|NCT00524589|156617656|FG000|Overall Study|Disease Progression|16|||
48662642|NCT04299464|156617670|FG000|Overall Study|Adverse Event|1|||
48662643|NCT04299464|156617671|FG001|Overall Study|Adverse Event|0|||
48662644|NCT04299464|156617672|FG002|Overall Study|Adverse Event|2|||
48662645|NCT04299464|156617670|FG000|Overall Study|Non-compliance with Study Drug|1|||
48662646|NCT04299464|156617671|FG001|Overall Study|Non-compliance with Study Drug|0|||
48662647|NCT04299464|156617672|FG002|Overall Study|Non-compliance with Study Drug|0|||
48662648|NCT04299464|156617670|FG000|Overall Study|Reason not Specified|0|||
48662649|NCT04299464|156617671|FG001|Overall Study|Reason not Specified|1|||
48662650|NCT04299464|156617672|FG002|Overall Study|Reason not Specified|3|||
48662651|NCT04299464|156617670|FG000|Overall Study|Physician Decision|0|||
48662652|NCT04299464|156617671|FG001|Overall Study|Physician Decision|1|||
48662653|NCT04299464|156617672|FG002|Overall Study|Physician Decision|1|||
48662654|NCT04299464|156617670|FG000|Overall Study|Withdrawal by Subject|0|||
48662655|NCT04299464|156617671|FG001|Overall Study|Withdrawal by Subject|2|||
48662656|NCT04299464|156617672|FG002|Overall Study|Withdrawal by Subject|1|||
48662657|NCT00937404|156617675|FG000|Overall Study|Protocol Violation|1|||
48662658|NCT00937404|156617675|FG000|Overall Study|Withdrawal by Subject|1|||
48662659|NCT03894969|156617676|FG000|Overall Study|Adverse Event|0|||
48662660|NCT03894969|156617677|FG001|Overall Study|Adverse Event|2|||
48662661|NCT03894969|156617678|FG002|Overall Study|Adverse Event|0|||
48662662|NCT03894969|156617679|FG003|Overall Study|Adverse Event|1|||
48662663|NCT03894969|156617680|FG004|Overall Study|Adverse Event|2|||
48662664|NCT03894969|156617676|FG000|Overall Study|Lost to Follow-up|3|||
48662665|NCT03894969|156617677|FG001|Overall Study|Lost to Follow-up|1|||
48662666|NCT03894969|156617678|FG002|Overall Study|Lost to Follow-up|1|||
48662667|NCT03894969|156617679|FG003|Overall Study|Lost to Follow-up|0|||
48866737|NCT05244226|157349081|FG001|Overall Study|Lost to Follow-up|0|||
48866738|NCT05244226|157349082|FG002|Overall Study|Lost to Follow-up|1|||
48662668|NCT03894969|156617680|FG004|Overall Study|Lost to Follow-up|0|||
48662669|NCT03894969|156617676|FG000|Overall Study|Withdrawal by Subject|2|||
48662670|NCT03894969|156617677|FG001|Overall Study|Withdrawal by Subject|1|||
48662671|NCT03894969|156617678|FG002|Overall Study|Withdrawal by Subject|3|||
48662672|NCT03894969|156617679|FG003|Overall Study|Withdrawal by Subject|4|||
48662673|NCT03894969|156617680|FG004|Overall Study|Withdrawal by Subject|8|||
48662674|NCT03894969|156617676|FG000|Overall Study|Other|0|||
48662675|NCT03894969|156617677|FG001|Overall Study|Other|0|||
48662676|NCT03894969|156617678|FG002|Overall Study|Other|0|||
48662677|NCT03894969|156617679|FG003|Overall Study|Other|0|||
48662678|NCT03894969|156617680|FG004|Overall Study|Other|3|||
48965699|NCT04511819|157701810|FG001|Overall Study|Adverse Event|1|||
48965700|NCT04511819|157701809|FG000|Overall Study|Protocol deviation|1|||
48965701|NCT04511819|157701810|FG001|Overall Study|Protocol deviation|0|||
48965702|NCT01742078|157701811|FG000|Overall Study|Withdrawal by Subject|0|||
48965703|NCT01742078|157701812|FG001|Overall Study|Withdrawal by Subject|0|||
48965704|NCT01742078|157701813|FG002|Overall Study|Withdrawal by Subject|0|||
48965705|NCT01742078|157701814|FG003|Overall Study|Withdrawal by Subject|1|||
48662679|NCT03894969|156617676|FG000|Overall Study|Unsolicited Non-Serious Advers Event|0|||
48662680|NCT03894969|156617677|FG001|Overall Study|Unsolicited Non-Serious Advers Event|0|||
48662681|NCT03894969|156617678|FG002|Overall Study|Unsolicited Non-Serious Advers Event|0|||
48662682|NCT03894969|156617679|FG003|Overall Study|Unsolicited Non-Serious Advers Event|2|||
48662683|NCT03894969|156617680|FG004|Overall Study|Unsolicited Non-Serious Advers Event|1|||
48662684|NCT03894969|156617676|FG000|Overall Study|Solicited Adverse Event|0|||
48662685|NCT03894969|156617677|FG001|Overall Study|Solicited Adverse Event|1|||
48662686|NCT03894969|156617678|FG002|Overall Study|Solicited Adverse Event|0|||
48662687|NCT03894969|156617679|FG003|Overall Study|Solicited Adverse Event|0|||
48662688|NCT03894969|156617680|FG004|Overall Study|Solicited Adverse Event|0|||
48662689|NCT03834506|156617683|FG000|Overall Study|Death|336|||
48662690|NCT03834506|156617684|FG001|Overall Study|Death|326|||
48662691|NCT03834506|156617683|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
48662692|NCT03834506|156617684|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
48662693|NCT03834506|156617683|FG000|Overall Study|Withdrawal by Subject|10|||
48662694|NCT03834506|156617684|FG001|Overall Study|Withdrawal by Subject|8|||
48662695|NCT03834506|156617683|FG000|Overall Study|Sponsor decision|165|||
48662696|NCT03834506|156617684|FG001|Overall Study|Sponsor decision|178|||
48662697|NCT03834506|156617683|FG000|Overall Study|Physician Decision|3|||
48662698|NCT03834506|156617684|FG001|Overall Study|Physician Decision|1|||
48662699|NCT03834506|156617683|FG000|Overall Study|Lost to Follow-up|0|||
48662700|NCT03834506|156617684|FG001|Overall Study|Lost to Follow-up|1|||
48662701|NCT03054350|156617691|FG000|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
48662702|NCT03054350|156617692|FG001|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
48662703|NCT03054350|156617693|FG002|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1|||
48662704|NCT03054350|156617694|FG003|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
48662705|NCT03054350|156617695|FG004|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
48662706|NCT03054350|156617696|FG005|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3|||
48662707|NCT03054350|156617691|FG000|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
48662708|NCT03054350|156617692|FG001|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
48662709|NCT03054350|156617693|FG002|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1|||
48662710|NCT03054350|156617694|FG003|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
48662711|NCT03054350|156617695|FG004|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
48662712|NCT03054350|156617696|FG005|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
48662713|NCT03054350|156617691|FG000|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
48662714|NCT03054350|156617692|FG001|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
48662715|NCT03054350|156617693|FG002|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
48662716|NCT03054350|156617694|FG003|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
48662717|NCT03054350|156617695|FG004|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
48662718|NCT03054350|156617696|FG005|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
48662719|NCT03054350|156617691|FG000|Dose Adjustment and Maintenance Period|Captured as Other|0|||
48662720|NCT03054350|156617692|FG001|Dose Adjustment and Maintenance Period|Captured as Other|0|||
48662721|NCT03054350|156617693|FG002|Dose Adjustment and Maintenance Period|Captured as Other|1|||
48662722|NCT03054350|156617694|FG003|Dose Adjustment and Maintenance Period|Captured as Other|0|||
48662723|NCT03054350|156617695|FG004|Dose Adjustment and Maintenance Period|Captured as Other|0|||
48662724|NCT03054350|156617696|FG005|Dose Adjustment and Maintenance Period|Captured as Other|0|||
48662725|NCT00867087|156617701|FG000|Overall Study|Other|1|||
48662726|NCT00867087|156617701|FG000|Overall Study|Withdrawal by Subject|4|||
48662727|NCT00867087|156617701|FG000|Overall Study|Death|37|||
48662728|NCT01238835|156617704|FG000|Overall Study|Death|124|||
48662729|NCT01238835|156617704|FG000|Overall Study|Withdrawal by Subject|9|||
48662730|NCT01238835|156617704|FG000|Overall Study|Lost to Follow-up|1|||
48662731|NCT01238835|156617704|FG000|Overall Study|Site early discontinuation|2|||
48965706|NCT01742078|157701815|FG004|Overall Study|Withdrawal by Subject|0|||
48965707|NCT01742078|157701816|FG005|Overall Study|Withdrawal by Subject|0|||
48965708|NCT01742078|157701817|FG006|Overall Study|Withdrawal by Subject|0|||
48965709|NCT01742078|157701818|FG007|Overall Study|Withdrawal by Subject|0|||
48965710|NCT01742078|157701819|FG008|Overall Study|Withdrawal by Subject|0|||
48662732|NCT00293709|156617705|FG000|Overall Study|Other|47|||
48662733|NCT02088073|156617706|FG000|Acute Phase|Withdrawal by Subject|5|||
48965711|NCT01875367|157701821|FG000|Overall Study|Not complete at least 2 questionaries|4|||
48662734|NCT02088073|156617707|FG001|Acute Phase|Withdrawal by Subject|0|||
48662735|NCT02088073|156617708|FG002|Acute Phase|Withdrawal by Subject|0|||
48662736|NCT02088073|156617709|FG003|Acute Phase|Withdrawal by Subject|0|||
48662737|NCT02088073|156617710|FG004|Acute Phase|Withdrawal by Subject|0|||
48662738|NCT02088073|156617706|FG000|Acute Phase|Hyperkalemia|2|||
48662739|NCT02088073|156617707|FG001|Acute Phase|Hyperkalemia|0|||
48662740|NCT02088073|156617708|FG002|Acute Phase|Hyperkalemia|0|||
48662741|NCT02088073|156617709|FG003|Acute Phase|Hyperkalemia|0|||
48756129|NCT00293254|156954271|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35|||
48756130|NCT00293254|156954272|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57|||
48756131|NCT00293254|156954271|FG000|Extension - Double-Blind Week 49-156|Adverse Event|4|||
48756132|NCT00293254|156954272|FG001|Extension - Double-Blind Week 49-156|Adverse Event|1|||
48756133|NCT00293254|156954271|FG000|Extension - Double-Blind Week 49-156|Death|4|||
48756134|NCT00293254|156954272|FG001|Extension - Double-Blind Week 49-156|Death|1|||
48756135|NCT00293254|156954271|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|3|||
48756136|NCT00293254|156954272|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|4|||
48756137|NCT00293254|156954271|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
48756138|NCT00293254|156954272|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
48756139|NCT00293254|156954271|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12|||
48756140|NCT00293254|156954272|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8|||
48662742|NCT02088073|156617710|FG004|Acute Phase|Hyperkalemia|0|||
48662743|NCT02088073|156617706|FG000|Maintanance Phase|Withdrawal by Subject|0|||
48662744|NCT02088073|156617707|FG001|Maintanance Phase|Withdrawal by Subject|2|||
48756141|NCT00293254|156954271|FG000|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6|||
48662745|NCT02088073|156617708|FG002|Maintanance Phase|Withdrawal by Subject|0|||
48662746|NCT02088073|156617709|FG003|Maintanance Phase|Withdrawal by Subject|0|||
48662747|NCT02088073|156617710|FG004|Maintanance Phase|Withdrawal by Subject|0|||
48662748|NCT02088073|156617706|FG000|Maintanance Phase|Adverse Event|0|||
48662749|NCT02088073|156617707|FG001|Maintanance Phase|Adverse Event|0|||
48662750|NCT02088073|156617708|FG002|Maintanance Phase|Adverse Event|3|||
48662751|NCT02088073|156617709|FG003|Maintanance Phase|Adverse Event|0|||
48662752|NCT02088073|156617710|FG004|Maintanance Phase|Adverse Event|1|||
48662753|NCT02088073|156617706|FG000|Maintanance Phase|Physician Decision|0|||
48662754|NCT02088073|156617707|FG001|Maintanance Phase|Physician Decision|0|||
48662755|NCT02088073|156617708|FG002|Maintanance Phase|Physician Decision|0|||
48662756|NCT02088073|156617709|FG003|Maintanance Phase|Physician Decision|0|||
48756142|NCT00293254|156954272|FG001|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3|||
48756143|NCT00293254|156954271|FG000|Extension - Double-Blind Week 49-156|Other Reason|10|||
48756144|NCT00293254|156954272|FG001|Extension - Double-Blind Week 49-156|Other Reason|2|||
48756145|NCT00293254|156954271|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
48756146|NCT00293254|156954272|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7|||
48756147|NCT00293254|156954271|FG000|Extension - Open-Label Week 157-240|Adverse Event|2|||
48756148|NCT00293254|156954272|FG001|Extension - Open-Label Week 157-240|Adverse Event|1|||
48756149|NCT00293254|156954271|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|1|||
48756150|NCT00293254|156954272|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
48756151|NCT00293254|156954271|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
48756152|NCT00293254|156954272|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|0|||
48866739|NCT05244226|157349080|FG000|Overall Study|Protocol Violation|0|||
48866740|NCT05244226|157349081|FG001|Overall Study|Protocol Violation|2|||
48866741|NCT05244226|157349082|FG002|Overall Study|Protocol Violation|2|||
48866742|NCT02388932|157349085|FG000|Overall Study|Death|1|||
48866743|NCT01902381|157349086|FG000|Overall Study|Withdrawal by Subject|1|||
48866744|NCT04250883|157349087|FG000|Overall Study|Lost to Follow-up|1|||
48866745|NCT04250883|157349088|FG001|Overall Study|Lost to Follow-up|0|||
48866746|NCT00837096|157349090|FG000|Overall Study|Physician Decision|1|||
48866747|NCT00837096|157349091|FG001|Overall Study|Physician Decision|1|||
48866748|NCT00837096|157349090|FG000|Overall Study|Not reported|9|||
48866749|NCT00837096|157349091|FG001|Overall Study|Not reported|8|||
48866750|NCT04620733|157349094|FG000|Overall Study|Adverse Event|4|||
48866751|NCT04620733|157349095|FG001|Overall Study|Adverse Event|3|||
48866752|NCT04620733|157349094|FG000|Overall Study|Withdrawal by Subject|2|||
48866753|NCT04620733|157349095|FG001|Overall Study|Withdrawal by Subject|5|||
48866754|NCT04620733|157349094|FG000|Overall Study|Lost to Follow-up|1|||
48866755|NCT04620733|157349095|FG001|Overall Study|Lost to Follow-up|1|||
48866756|NCT04620733|157349094|FG000|Overall Study|Protocol Deviation|1|||
48866757|NCT04620733|157349095|FG001|Overall Study|Protocol Deviation|1|||
48866758|NCT04620733|157349094|FG000|Overall Study|Reason Not Specified|0|||
48866759|NCT04620733|157349095|FG001|Overall Study|Reason Not Specified|1|||
48866760|NCT05335005|157349096|FG000|Overall Study|Lost to Follow-up|1|||
48866761|NCT02123797|157349107|FG000|Baseline Intervention|Death|9|||
48866762|NCT02123797|157349108|FG001|Baseline Intervention|Death|16|||
48866763|NCT02123797|157349109|FG002|Baseline Intervention|Death|0|||
48662757|NCT02088073|156617710|FG004|Maintanance Phase|Physician Decision|1|||
48662758|NCT02088073|156617706|FG000|Maintanance Phase|Sponsor's decision|0|||
48866764|NCT02123797|157349110|FG003|Baseline Intervention|Death|0|||
48866765|NCT02123797|157349111|FG004|Baseline Intervention|Death|0|||
48756153|NCT00293254|156954271|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|2|||
48756154|NCT00293254|156954272|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
48756155|NCT00293254|156954271|FG000|Extension - Open-Label Week 157-240|Other Reason|4|||
48756156|NCT00293254|156954272|FG001|Extension - Open-Label Week 157-240|Other Reason|0|||
48756157|NCT00293254|156954271|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|4|||
48756158|NCT00293254|156954272|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|7|||
48756159|NCT00293254|156954271|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16|||
48756160|NCT00293254|156954272|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14|||
48756161|NCT00293254|156954271|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6|||
48756162|NCT00293254|156954272|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3|||
48756163|NCT00293254|156954271|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3|||
48756164|NCT00293254|156954272|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0|||
48756165|NCT00293254|156954271|FG000|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
48756166|NCT00293254|156954272|FG001|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
48756167|NCT00293254|156954271|FG000|Open-Label Post Virologic Failure Phase|Other Reason|1|||
48756168|NCT00293254|156954272|FG001|Open-Label Post Virologic Failure Phase|Other Reason|2|||
48756169|NCT01963403|156954273|FG000|Overall Study|Lost to Follow-up|2|||
48756170|NCT01963403|156954274|FG001|Overall Study|Lost to Follow-up|3|||
48756171|NCT01963403|156954273|FG000|Overall Study|Implant removal|0|||
48756172|NCT01963403|156954274|FG001|Overall Study|Implant removal|1|||
48756173|NCT00589914|156954276|FG000|Overall Study|Adverse Event|19|||
48756174|NCT00589914|156954277|FG001|Overall Study|Adverse Event|10|||
48756175|NCT00589914|156954276|FG000|Overall Study|Death|2|||
48756176|NCT00589914|156954277|FG001|Overall Study|Death|0|||
48756177|NCT00589914|156954276|FG000|Overall Study|Lack of Efficacy|40|||
48756178|NCT00589914|156954277|FG001|Overall Study|Lack of Efficacy|43|||
48756179|NCT00589914|156954276|FG000|Overall Study|Lost to Follow-up|11|||
48756180|NCT00589914|156954277|FG001|Overall Study|Lost to Follow-up|18|||
48756181|NCT00589914|156954276|FG000|Overall Study|Pregnancy|1|||
48756182|NCT00589914|156954277|FG001|Overall Study|Pregnancy|0|||
48756183|NCT00589914|156954276|FG000|Overall Study|Withdrawal by Subject|55|||
48756184|NCT00589914|156954277|FG001|Overall Study|Withdrawal by Subject|49|||
48756185|NCT00589914|156954276|FG000|Overall Study|Other|22|||
48756186|NCT00589914|156954277|FG001|Overall Study|Other|17|||
48756187|NCT04483011|156954278|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
48756188|NCT04483011|156954279|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
48756189|NCT00799487|156954280|FG000|Dose Adjustment Period|Lost to Follow-up|1|||
48756190|NCT00799487|156954281|FG001|Dose Adjustment Period|Lost to Follow-up|0|||
48756191|NCT00799487|156954282|FG002|Dose Adjustment Period|Lost to Follow-up|0|||
48756192|NCT00799487|156954280|FG000|Dose Adjustment Period|Adverse Event|2|||
48756193|NCT00799487|156954281|FG001|Dose Adjustment Period|Adverse Event|0|||
48756194|NCT00799487|156954282|FG002|Dose Adjustment Period|Adverse Event|0|||
48756195|NCT00799487|156954280|FG000|Dose Adjustment Period|Optimal Dose Not Achieved|8|||
48756196|NCT00799487|156954281|FG001|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
48756197|NCT00799487|156954282|FG002|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
48756198|NCT00799487|156954280|FG000|Dose Adjustment Period|Investigator Discretion|2|||
48756199|NCT00799487|156954281|FG001|Dose Adjustment Period|Investigator Discretion|0|||
48756200|NCT00799487|156954282|FG002|Dose Adjustment Period|Investigator Discretion|0|||
48756201|NCT00799487|156954280|FG000|Dose Adjustment Period|Withdrawal by Subject|3|||
48965712|NCT01875367|157701822|FG001|Overall Study|Not complete at least 2 questionaries|2|||
48756202|NCT00799487|156954281|FG001|Dose Adjustment Period|Withdrawal by Subject|0|||
48756203|NCT00799487|156954282|FG002|Dose Adjustment Period|Withdrawal by Subject|0|||
48756204|NCT00799487|156954280|FG000|Dose Adjustment Period|Parent to home school child (exclusion)|1|||
48756205|NCT00799487|156954281|FG001|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
48756206|NCT00799487|156954282|FG002|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
48756207|NCT00799487|156954280|FG000|Dose Adjustment Period|Child too young (exclusion)|1|||
48756208|NCT00799487|156954281|FG001|Dose Adjustment Period|Child too young (exclusion)|0|||
48756209|NCT00799487|156954282|FG002|Dose Adjustment Period|Child too young (exclusion)|0|||
48965713|NCT01875367|157701821|FG000|Overall Study|Not receive study treatment|1|||
48965714|NCT01875367|157701822|FG001|Overall Study|Not receive study treatment|0|||
48965715|NCT02855450|157701823|FG000|Overall Study|Adverse Event|1|||
48965716|NCT02855450|157701824|FG001|Overall Study|Adverse Event|0|||
48965717|NCT02855450|157701823|FG000|Overall Study|Lost to Follow-up|4|||
48965718|NCT02855450|157701824|FG001|Overall Study|Lost to Follow-up|0|||
48756210|NCT00799487|156954280|FG000|Dose Adjustment Period|Missed laboratory day 1|1|||
48965719|NCT02120157|157701825|FG000|Overall Study|Death|8|||
48756211|NCT00799487|156954281|FG001|Dose Adjustment Period|Missed laboratory day 1|0|||
48756212|NCT00799487|156954282|FG002|Dose Adjustment Period|Missed laboratory day 1|0|||
48756213|NCT00799487|156954280|FG000|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2|||
48756214|NCT00799487|156954281|FG001|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
48756215|NCT00799487|156954282|FG002|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
48965720|NCT03956225|157701826|FG000|Overall Study|Lack of Efficacy|1|||
48662759|NCT02088073|156617707|FG001|Maintanance Phase|Sponsor's decision|2|||
48662760|NCT02088073|156617708|FG002|Maintanance Phase|Sponsor's decision|0|||
48662761|NCT02088073|156617709|FG003|Maintanance Phase|Sponsor's decision|2|||
48662762|NCT02088073|156617710|FG004|Maintanance Phase|Sponsor's decision|1|||
48662763|NCT02088073|156617706|FG000|Maintanance Phase|Hypo- or hyperkalemia|0|||
48662764|NCT02088073|156617707|FG001|Maintanance Phase|Hypo- or hyperkalemia|3|||
48756216|NCT00799487|156954280|FG000|Double-Blind Assessment Period|Lost to Follow-up|0|||
48756217|NCT00799487|156954281|FG001|Double-Blind Assessment Period|Lost to Follow-up|0|||
48756218|NCT00799487|156954282|FG002|Double-Blind Assessment Period|Lost to Follow-up|1|||
48756219|NCT00799487|156954280|FG000|Double-Blind Assessment Period|Subject was out of the state|0|||
48756220|NCT00799487|156954281|FG001|Double-Blind Assessment Period|Subject was out of the state|0|||
48756221|NCT00799487|156954282|FG002|Double-Blind Assessment Period|Subject was out of the state|1|||
48756222|NCT00799487|156954280|FG000|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
48756223|NCT00799487|156954281|FG001|Double-Blind Assessment Period|Overslept and missed lab day 2|1|||
48756224|NCT00799487|156954282|FG002|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
48756225|NCT04481750|156954283|FG000|Period 1 (Fasted)|Adverse Event|0|||
48756226|NCT04481750|156954284|FG001|Period 1 (Fasted)|Adverse Event|0|||
48756227|NCT04481750|156954285|FG002|Period 1 (Fasted)|Adverse Event|1|||
48756228|NCT04481750|156954286|FG003|Period 1 (Fasted)|Adverse Event|0|||
48756229|NCT04481750|156954287|FG004|Period 1 (Fasted)|Adverse Event|0|||
48756230|NCT04481750|156954288|FG005|Period 1 (Fasted)|Adverse Event|0|||
48756231|NCT04481750|156954289|FG006|Period 1 (Fasted)|Adverse Event|0|||
48756232|NCT04481750|156954290|FG007|Period 1 (Fasted)|Adverse Event|0|||
48756233|NCT04481750|156954291|FG008|Period 1 (Fasted)|Adverse Event|0|||
48756234|NCT04481750|156954292|FG009|Period 1 (Fasted)|Adverse Event|0|||
48756235|NCT04481750|156954293|FG010|Period 1 (Fasted)|Adverse Event|0|||
48756236|NCT03263442|156954294|FG000|Inpatient Phase|Death|1|||
48756237|NCT03263442|156954295|FG001|Inpatient Phase|Death|0|||
48965721|NCT03956225|157701827|FG001|Overall Study|Lack of Efficacy|1|||
48965722|NCT03956225|157701826|FG000|Overall Study|Lost to Follow-up|0|||
48965723|NCT03956225|157701827|FG001|Overall Study|Lost to Follow-up|1|||
48965724|NCT03956225|157701826|FG000|Overall Study|Withdrawal by Subject|2|||
48965725|NCT03956225|157701827|FG001|Overall Study|Withdrawal by Subject|1|||
48965726|NCT03956225|157701826|FG000|Overall Study|Other Reasons|2|||
48965727|NCT03956225|157701827|FG001|Overall Study|Other Reasons|1|||
48965728|NCT02260648|157701828|FG000|Overall Study|Adverse Event|3|||
48965729|NCT02260648|157701829|FG001|Overall Study|Adverse Event|0|||
48965730|NCT02260648|157701830|FG002|Overall Study|Adverse Event|1|||
48965731|NCT02260648|157701828|FG000|Overall Study|Withdrawal by Subject|1|||
48965732|NCT02260648|157701829|FG001|Overall Study|Withdrawal by Subject|1|||
48662765|NCT02088073|156617708|FG002|Maintanance Phase|Hypo- or hyperkalemia|0|||
48662766|NCT02088073|156617709|FG003|Maintanance Phase|Hypo- or hyperkalemia|3|||
48662767|NCT02088073|156617710|FG004|Maintanance Phase|Hypo- or hyperkalemia|1|||
48662768|NCT02088073|156617706|FG000|Maintanance Phase|Miscellaneous|0|||
48662769|NCT02088073|156617707|FG001|Maintanance Phase|Miscellaneous|2|||
48662770|NCT02088073|156617708|FG002|Maintanance Phase|Miscellaneous|1|||
48662771|NCT02088073|156617709|FG003|Maintanance Phase|Miscellaneous|2|||
48662772|NCT02088073|156617710|FG004|Maintanance Phase|Miscellaneous|1|||
48662773|NCT02088073|156617706|FG000|Maintanance Phase|Met ECG withdrawal criteria|0|||
48662774|NCT02088073|156617707|FG001|Maintanance Phase|Met ECG withdrawal criteria|0|||
48662775|NCT02088073|156617708|FG002|Maintanance Phase|Met ECG withdrawal criteria|1|||
48662776|NCT02088073|156617709|FG003|Maintanance Phase|Met ECG withdrawal criteria|0|||
48662777|NCT02088073|156617710|FG004|Maintanance Phase|Met ECG withdrawal criteria|2|||
48662778|NCT02088073|156617706|FG000|Maintanance Phase|Subject compliance|0|||
48662779|NCT02088073|156617707|FG001|Maintanance Phase|Subject compliance|1|||
48662780|NCT02088073|156617708|FG002|Maintanance Phase|Subject compliance|0|||
48662781|NCT02088073|156617709|FG003|Maintanance Phase|Subject compliance|0|||
48662782|NCT02088073|156617710|FG004|Maintanance Phase|Subject compliance|0|||
48662783|NCT04612842|156617713|FG000|Overall Study|Lost to Follow-up|20|||
48662784|NCT04612842|156617714|FG001|Overall Study|Lost to Follow-up|11|||
48662785|NCT04612842|156617713|FG000|Overall Study|Withdrawal by Subject|26|||
48662786|NCT04612842|156617714|FG001|Overall Study|Withdrawal by Subject|15|||
48756238|NCT03263442|156954294|FG000|Inpatient Phase|Withdrawal by Subject|1|||
48756239|NCT03263442|156954295|FG001|Inpatient Phase|Withdrawal by Subject|0|||
48756240|NCT03263442|156954294|FG000|Inpatient Phase|Inadequate Drug Exposure|0|||
48965733|NCT02260648|157701830|FG002|Overall Study|Withdrawal by Subject|0|||
48965734|NCT02260648|157701828|FG000|Overall Study|Protocol Violation|1|||
48965735|NCT02260648|157701829|FG001|Overall Study|Protocol Violation|0|||
48662787|NCT04612842|156617713|FG000|Overall Study|Death|2|||
48662788|NCT04612842|156617714|FG001|Overall Study|Death|2|||
48662789|NCT02419131|156617715|FG000|Consent and Randomization|Did not receive treatment after randomization|10|||
48662790|NCT02419131|156617716|FG001|Consent and Randomization|Did not receive treatment after randomization|16|||
48756241|NCT03263442|156954295|FG001|Inpatient Phase|Inadequate Drug Exposure|1|||
48965736|NCT02260648|157701830|FG002|Overall Study|Protocol Violation|0|||
48662791|NCT02419131|156617717|FG002|Consent and Randomization|Did not receive treatment after randomization|7|||
48965737|NCT02260648|157701828|FG000|Overall Study|Discontinue Due to Study Termination|13|||
48965738|NCT02260648|157701829|FG001|Overall Study|Discontinue Due to Study Termination|12|||
48965739|NCT02260648|157701830|FG002|Overall Study|Discontinue Due to Study Termination|7|||
48965740|NCT04093258|157701831|FG000|Period 2|Subject no longer meets the eligibility criteria|1|||
48965741|NCT04093258|157701832|FG001|Period 2|Subject no longer meets the eligibility criteria|0|||
48965742|NCT00567541|157701834|FG000|Overall Study|Adverse Event|0|||
48965743|NCT00567541|157701835|FG001|Overall Study|Adverse Event|1|||
48965744|NCT00039741|157701836|FG000|Overall Study|Death|0|||
48965745|NCT00039741|157701837|FG001|Overall Study|Death|1|||
48662792|NCT02419131|156617715|FG000|Randomization and Treatment|Withdrawn or lost to follow-up|22|||
48662793|NCT02419131|156617716|FG001|Randomization and Treatment|Withdrawn or lost to follow-up|25|||
48662794|NCT02419131|156617717|FG002|Randomization and Treatment|Withdrawn or lost to follow-up|9|||
48662795|NCT03762616|156617718|FG000|Overall Study|Protocol Violation|2|||
48662796|NCT04465877|156617719|FG000|Overall Study|Noncompliant with study requirements|0|||
48662797|NCT04465877|156617720|FG001|Overall Study|Noncompliant with study requirements|0|||
48662798|NCT04465877|156617721|FG002|Overall Study|Noncompliant with study requirements|1|||
48662799|NCT04465877|156617722|FG003|Overall Study|Noncompliant with study requirements|0|||
48965746|NCT00039741|157701838|FG002|Overall Study|Death|0|||
48965747|NCT00039741|157701839|FG003|Overall Study|Death|0|||
48965748|NCT00039741|157701836|FG000|Overall Study|Lost to Follow-up|3|||
48965749|NCT00039741|157701837|FG001|Overall Study|Lost to Follow-up|1|||
48965750|NCT00039741|157701838|FG002|Overall Study|Lost to Follow-up|5|||
48965751|NCT00039741|157701839|FG003|Overall Study|Lost to Follow-up|2|||
48965752|NCT00039741|157701836|FG000|Overall Study|Confounding medical condition|1|||
48965753|NCT00039741|157701837|FG001|Overall Study|Confounding medical condition|0|||
48965754|NCT00039741|157701838|FG002|Overall Study|Confounding medical condition|0|||
48965755|NCT00039741|157701839|FG003|Overall Study|Confounding medical condition|0|||
48965756|NCT00039741|157701836|FG000|Overall Study|Not able to get to clinic|5|||
48965757|NCT00039741|157701837|FG001|Overall Study|Not able to get to clinic|2|||
48965758|NCT00039741|157701838|FG002|Overall Study|Not able to get to clinic|0|||
48965759|NCT00039741|157701839|FG003|Overall Study|Not able to get to clinic|3|||
48965760|NCT00039741|157701836|FG000|Overall Study|Moved|3|||
48965761|NCT00039741|157701837|FG001|Overall Study|Moved|2|||
48756242|NCT03263442|156954294|FG000|1-month Follow-Up|Lost to Follow-up|1|||
48756243|NCT03263442|156954295|FG001|1-month Follow-Up|Lost to Follow-up|0|||
48965762|NCT00039741|157701838|FG002|Overall Study|Moved|3|||
48965763|NCT00039741|157701839|FG003|Overall Study|Moved|6|||
48965764|NCT00039741|157701836|FG000|Overall Study|Non-compliance with protocol|1|||
48756244|NCT03263442|156954294|FG000|3-month Follow-Up|Lost to Follow-up|1|||
48756245|NCT03263442|156954295|FG001|3-month Follow-Up|Lost to Follow-up|3|||
48756246|NCT03263442|156954294|FG000|6-month Follow-Up|Lost to Follow-up|2|||
48756247|NCT03263442|156954295|FG001|6-month Follow-Up|Lost to Follow-up|2|||
48756248|NCT03804879|156954296|FG000|Overall Study|Adverse Event|3|||
48756249|NCT03804879|156954297|FG001|Overall Study|Adverse Event|0|||
48756250|NCT03804879|156954296|FG000|Overall Study|Study Terminated By Sponsor|10|||
48756251|NCT03804879|156954297|FG001|Overall Study|Study Terminated By Sponsor|12|||
48756252|NCT03804879|156954296|FG000|Overall Study|Withdrawal by Subject|3|||
48756253|NCT03804879|156954297|FG001|Overall Study|Withdrawal by Subject|1|||
48756254|NCT01585428|156954298|FG000|Overall Study|Death during treatment|1|||
48756255|NCT01585428|156954299|FG001|Overall Study|Death during treatment|0|||
48965765|NCT00039741|157701837|FG001|Overall Study|Non-compliance with protocol|0|||
48965766|NCT00039741|157701838|FG002|Overall Study|Non-compliance with protocol|1|||
48965767|NCT00039741|157701839|FG003|Overall Study|Non-compliance with protocol|0|||
48965768|NCT00039741|157701836|FG000|Overall Study|Withdrew consent|0|||
48965769|NCT00039741|157701837|FG001|Overall Study|Withdrew consent|5|||
48965770|NCT00039741|157701838|FG002|Overall Study|Withdrew consent|0|||
48965771|NCT00039741|157701839|FG003|Overall Study|Withdrew consent|1|||
48756256|NCT01084174|156954300|FG000|Overall Study|gastrointestinal symptoms|1|||
48756257|NCT01084174|156954301|FG001|Overall Study|gastrointestinal symptoms|1|||
48756258|NCT01084174|156954300|FG000|Overall Study|Eosinophilic esophagitis|0|||
48756259|NCT01084174|156954301|FG001|Overall Study|Eosinophilic esophagitis|1|||
48756260|NCT01084174|156954300|FG000|Overall Study|Anaphylaxis|0|||
48965772|NCT00039741|157701836|FG000|Overall Study|Missed final visit|2|||
48965773|NCT00039741|157701837|FG001|Overall Study|Missed final visit|1|||
48965774|NCT00039741|157701838|FG002|Overall Study|Missed final visit|2|||
48965775|NCT00039741|157701839|FG003|Overall Study|Missed final visit|2|||
48662800|NCT01396265|156617723|FG000|Rifa+Afatinib|Withdrawal by Subject|1|||
48662801|NCT02118597|156617724|FG000|Overall Study|Sponsor terminated the study|14|||
48662802|NCT02118597|156617724|FG000|Overall Study|Serious Adverse Event|1|||
48662803|NCT02118597|156617724|FG000|Overall Study|Investigator's decision|1|||
48756261|NCT01084174|156954301|FG001|Overall Study|Anaphylaxis|1|||
48965776|NCT01890512|157701844|FG000|Overall Study|Physician Decision|1|||
48965777|NCT01890512|157701844|FG000|Overall Study|Withdrawal by Subject|1|||
48965778|NCT01890512|157701844|FG000|Overall Study|Protocol Violation|1|||
48965779|NCT00946881|157701845|FG000|First Treatment|Withdrawal by Subject|1|||
48756262|NCT01084174|156954300|FG000|Overall Study|Participant noncompliance|0|||
48756263|NCT01084174|156954301|FG001|Overall Study|Participant noncompliance|1|||
48756264|NCT01034462|156954302|FG000|Overall Study|Adverse Event|7|||
48756265|NCT01034462|156954303|FG001|Overall Study|Adverse Event|17|||
48756266|NCT01034462|156954302|FG000|Overall Study|Lack of Efficacy|4|||
48756267|NCT01034462|156954303|FG001|Overall Study|Lack of Efficacy|4|||
48756268|NCT01034462|156954302|FG000|Overall Study|Protocol Violation|10|||
48756269|NCT01034462|156954303|FG001|Overall Study|Protocol Violation|7|||
48756270|NCT01034462|156954302|FG000|Overall Study|Withdrawal by Subject|9|||
48756271|NCT01034462|156954303|FG001|Overall Study|Withdrawal by Subject|8|||
48965780|NCT00946881|157701845|FG000|First Treatment|Patient relocated to another state|1|||
48965781|NCT00946881|157701845|FG000|Retreatment|Withdrawal by Subject|1|||
48965782|NCT00405821|157701846|FG000|Overall Study|Death|5|||
48965783|NCT00405821|157701847|FG001|Overall Study|Death|7|||
48965784|NCT00405821|157701846|FG000|Overall Study|Lost to Follow-up|7|||
48965785|NCT00405821|157701847|FG001|Overall Study|Lost to Follow-up|7|||
48662804|NCT03444766|156617725|FG000|Overall Study|Other Reasons|2|||
48662805|NCT03444766|156617725|FG000|Overall Study|Participant Withdrew Consent|5|||
48662806|NCT03444766|156617725|FG000|Overall Study|Lost to Follow-up|2|||
48662807|NCT03444766|156617725|FG000|Overall Study|Death|2|||
48662808|NCT03444766|156617725|FG000|Overall Study|Adverse Event Unrelated to Study Drug|6|||
48662809|NCT03444766|156617725|FG000|Overall Study|Disease Progression|49|||
48662810|NCT02275117|156617728|FG000|Overall Study|Adverse Event|0|||
48662811|NCT02275117|156617729|FG001|Overall Study|Adverse Event|0|||
48662812|NCT02275117|156617730|FG002|Overall Study|Adverse Event|0|||
48965786|NCT00405821|157701846|FG000|Overall Study|Protocol Violation|1|||
48965787|NCT00405821|157701847|FG001|Overall Study|Protocol Violation|0|||
48965788|NCT00405821|157701846|FG000|Overall Study|initiated ART|9|||
48965789|NCT00405821|157701847|FG001|Overall Study|initiated ART|8|||
48965790|NCT01529385|157701850|FG000|Overall Study|Lost to Follow-up|2|||
48965791|NCT01529385|157701851|FG001|Overall Study|Lost to Follow-up|1|||
48965792|NCT00592553|157701852|FG000|Overall Study|Protocol Noncompliance|1|||
48662813|NCT02275117|156617731|FG003|Overall Study|Adverse Event|0|||
48662814|NCT02275117|156617732|FG004|Overall Study|Adverse Event|1|||
48662815|NCT02275117|156617728|FG000|Overall Study|Lack of Efficacy|6|||
48662816|NCT02275117|156617729|FG001|Overall Study|Lack of Efficacy|7|||
48662817|NCT02275117|156617730|FG002|Overall Study|Lack of Efficacy|5|||
48662818|NCT02275117|156617731|FG003|Overall Study|Lack of Efficacy|2|||
48662819|NCT02275117|156617732|FG004|Overall Study|Lack of Efficacy|10|||
48662820|NCT02275117|156617728|FG000|Overall Study|Lost to Follow-up|11|||
48662821|NCT02275117|156617729|FG001|Overall Study|Lost to Follow-up|16|||
48662822|NCT02275117|156617730|FG002|Overall Study|Lost to Follow-up|15|||
48662823|NCT02275117|156617731|FG003|Overall Study|Lost to Follow-up|16|||
48662824|NCT02275117|156617732|FG004|Overall Study|Lost to Follow-up|8|||
48662825|NCT02275117|156617728|FG000|Overall Study|Physician Decision|0|||
48662826|NCT02275117|156617729|FG001|Overall Study|Physician Decision|1|||
48662827|NCT02275117|156617730|FG002|Overall Study|Physician Decision|1|||
48662828|NCT02275117|156617731|FG003|Overall Study|Physician Decision|0|||
48662829|NCT02275117|156617732|FG004|Overall Study|Physician Decision|1|||
48662830|NCT02275117|156617728|FG000|Overall Study|Protocol Violation|1|||
48662831|NCT02275117|156617729|FG001|Overall Study|Protocol Violation|0|||
48662832|NCT02275117|156617730|FG002|Overall Study|Protocol Violation|1|||
48662833|NCT02275117|156617731|FG003|Overall Study|Protocol Violation|1|||
48662834|NCT02275117|156617732|FG004|Overall Study|Protocol Violation|0|||
48662835|NCT02275117|156617728|FG000|Overall Study|Withdrawal by Subject|6|||
48662836|NCT02275117|156617729|FG001|Overall Study|Withdrawal by Subject|4|||
48662837|NCT02275117|156617730|FG002|Overall Study|Withdrawal by Subject|7|||
48662838|NCT02275117|156617731|FG003|Overall Study|Withdrawal by Subject|3|||
48756272|NCT01034462|156954302|FG000|Overall Study|Lost to Follow-up|14|||
48756273|NCT01034462|156954303|FG001|Overall Study|Lost to Follow-up|16|||
48756274|NCT01034462|156954302|FG000|Overall Study|Other reasons|1|||
48965793|NCT00592553|157701853|FG001|Overall Study|Protocol Noncompliance|0|||
48662839|NCT02275117|156617732|FG004|Overall Study|Withdrawal by Subject|3|||
48756275|NCT01034462|156954303|FG001|Overall Study|Other reasons|2|||
48756276|NCT00708162|156954306|FG000|Randomized Phase|Randomized but Not Treated|7|||
48965794|NCT00592553|157701854|FG002|Overall Study|Protocol Noncompliance|0|||
48965795|NCT00805545|157701857|FG000|Overall Study|Protocol Violation|3|||
48965796|NCT00805545|157701858|FG001|Overall Study|Protocol Violation|2|||
48965797|NCT00805545|157701857|FG000|Overall Study|Protocol Violation|3|||
48662840|NCT02275117|156617728|FG000|Overall Study|Terminated by Sponsor|4|||
48662841|NCT02275117|156617729|FG001|Overall Study|Terminated by Sponsor|4|||
48662842|NCT02275117|156617730|FG002|Overall Study|Terminated by Sponsor|4|||
48662843|NCT02275117|156617731|FG003|Overall Study|Terminated by Sponsor|6|||
48662844|NCT02275117|156617732|FG004|Overall Study|Terminated by Sponsor|4|||
48662845|NCT02275117|156617728|FG000|Overall Study|Worsening of Study Indication|0|||
48965798|NCT00805545|157701858|FG001|Overall Study|Protocol Violation|1|||
48965799|NCT01182337|157701861|FG000|Overall Study|Withdrawal by Subject|3|||
48965800|NCT01182337|157701862|FG001|Overall Study|Withdrawal by Subject|1|||
48965801|NCT01182337|157701861|FG000|Overall Study|Lost to Follow-up|0|||
48756277|NCT00708162|156954307|FG001|Randomized Phase|Randomized but Not Treated|5|||
48756278|NCT00708162|156954306|FG000|Randomized Phase|Participant Noncompliance|40|||
48756279|NCT00708162|156954307|FG001|Randomized Phase|Participant Noncompliance|32|||
48756280|NCT00708162|156954306|FG000|Randomized Phase|Lost to Follow-up|34|||
48756281|NCT00708162|156954307|FG001|Randomized Phase|Lost to Follow-up|34|||
48756282|NCT00708162|156954306|FG000|Randomized Phase|Withdrew Consent|31|||
48756283|NCT00708162|156954307|FG001|Randomized Phase|Withdrew Consent|22|||
48756284|NCT00708162|156954306|FG000|Randomized Phase|Lack of Efficacy|14|||
48756285|NCT00708162|156954307|FG001|Randomized Phase|Lack of Efficacy|19|||
48756286|NCT00708162|156954306|FG000|Randomized Phase|Protocol Violation|10|||
48756287|NCT00708162|156954307|FG001|Randomized Phase|Protocol Violation|11|||
48756288|NCT00708162|156954306|FG000|Randomized Phase|Adverse Event|8|||
48756289|NCT00708162|156954307|FG001|Randomized Phase|Adverse Event|12|||
48756290|NCT00708162|156954306|FG000|Randomized Phase|Investigator's Discretion|7|||
48756291|NCT00708162|156954307|FG001|Randomized Phase|Investigator's Discretion|10|||
48756292|NCT00708162|156954306|FG000|Randomized Phase|Death|2|||
48756293|NCT00708162|156954307|FG001|Randomized Phase|Death|9|||
48756294|NCT00708162|156954306|FG000|Randomized Phase|Pregnancy|3|||
48756295|NCT00708162|156954307|FG001|Randomized Phase|Pregnancy|0|||
48756296|NCT00708162|156954306|FG000|Open-Label Phase|Lost to Follow-up|10|||
48756297|NCT00708162|156954307|FG001|Open-Label Phase|Lost to Follow-up|8|||
48756298|NCT00708162|156954306|FG000|Open-Label Phase|Withdrew Consent|12|||
48756299|NCT00708162|156954307|FG001|Open-Label Phase|Withdrew Consent|6|||
48756300|NCT00708162|156954306|FG000|Open-Label Phase|Participant Noncompliance|7|||
48756301|NCT00708162|156954307|FG001|Open-Label Phase|Participant Noncompliance|7|||
48756302|NCT00708162|156954306|FG000|Open-Label Phase|Lack of Efficacy|7|||
48756303|NCT00708162|156954307|FG001|Open-Label Phase|Lack of Efficacy|4|||
48756304|NCT00708162|156954306|FG000|Open-Label Phase|Investigator's Discretion|3|||
48756305|NCT00708162|156954307|FG001|Open-Label Phase|Investigator's Discretion|2|||
48756306|NCT00708162|156954306|FG000|Open-Label Phase|Death|3|||
48756307|NCT00708162|156954307|FG001|Open-Label Phase|Death|1|||
48756308|NCT00708162|156954306|FG000|Open-Label Phase|Adverse Event|1|||
48756309|NCT00708162|156954307|FG001|Open-Label Phase|Adverse Event|2|||
48756310|NCT00708162|156954306|FG000|Open-Label Phase|Other|1|||
48756311|NCT00708162|156954307|FG001|Open-Label Phase|Other|0|||
48756312|NCT00503009|156954308|FG000|Overall Study|Protocol Violation|1|||
48756313|NCT00503009|156954309|FG001|Overall Study|Protocol Violation|0|||
48756314|NCT00503009|156954310|FG002|Overall Study|Protocol Violation|1|||
48756315|NCT00503009|156954308|FG000|Overall Study|Withdrawal by Subject|0|||
48756316|NCT00503009|156954309|FG001|Overall Study|Withdrawal by Subject|1|||
48756317|NCT00503009|156954310|FG002|Overall Study|Withdrawal by Subject|1|||
48756318|NCT00503009|156954308|FG000|Overall Study|Physician Decision|0|||
48756319|NCT00503009|156954309|FG001|Overall Study|Physician Decision|1|||
48756320|NCT00503009|156954310|FG002|Overall Study|Physician Decision|1|||
48756321|NCT00065507|156954311|FG000|Overall Study|Death|16|||
48756322|NCT00065507|156954312|FG001|Overall Study|Death|17|||
48756323|NCT00065507|156954311|FG000|Overall Study|Adverse Event|4|||
48756324|NCT00065507|156954312|FG001|Overall Study|Adverse Event|3|||
48965802|NCT01182337|157701862|FG001|Overall Study|Lost to Follow-up|1|||
48965803|NCT01115738|157701863|FG000|Overall Study|Death|1|||
48662846|NCT02275117|156617729|FG001|Overall Study|Worsening of Study Indication|1|||
48662847|NCT02275117|156617730|FG002|Overall Study|Worsening of Study Indication|2|||
48662848|NCT02275117|156617731|FG003|Overall Study|Worsening of Study Indication|0|||
48662849|NCT02275117|156617732|FG004|Overall Study|Worsening of Study Indication|0|||
48662850|NCT02275117|156617728|FG000|Overall Study|Study Burden|5|||
48662851|NCT02275117|156617729|FG001|Overall Study|Study Burden|4|||
48662852|NCT02275117|156617730|FG002|Overall Study|Study Burden|7|||
48662853|NCT02275117|156617731|FG003|Overall Study|Study Burden|5|||
48662854|NCT02275117|156617732|FG004|Overall Study|Study Burden|7|||
48662855|NCT02275117|156617728|FG000|Overall Study|Other|1|||
48662856|NCT02275117|156617729|FG001|Overall Study|Other|0|||
48662857|NCT02275117|156617730|FG002|Overall Study|Other|0|||
48662858|NCT02275117|156617731|FG003|Overall Study|Other|0|||
48662859|NCT02275117|156617732|FG004|Overall Study|Other|2|||
48662860|NCT04508751|156617734|FG000|Overall Study|Discontinued study early due to maternal discomfort|0|||
48662861|NCT04508751|156617735|FG001|Overall Study|Discontinued study early due to maternal discomfort|0|||
48662862|NCT04508751|156617736|FG002|Overall Study|Discontinued study early due to maternal discomfort|2|||
48662863|NCT02014480|156617737|FG000|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
48662864|NCT02014480|156617738|FG001|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
48756325|NCT00065507|156954311|FG000|Overall Study|Lack of Efficacy|0|||
48756326|NCT00065507|156954312|FG001|Overall Study|Lack of Efficacy|6|||
48756327|NCT00065507|156954311|FG000|Overall Study|Poor/Non-compliance|3|||
48756328|NCT00065507|156954312|FG001|Overall Study|Poor/Non-compliance|2|||
48756329|NCT00065507|156954311|FG000|Overall Study|Lost to Follow-up|3|||
48756330|NCT00065507|156954312|FG001|Overall Study|Lost to Follow-up|0|||
48756331|NCT00065507|156954311|FG000|Overall Study|Subject Withdrew Consent|2|||
48756332|NCT00065507|156954312|FG001|Overall Study|Subject Withdrew Consent|1|||
48965804|NCT01115738|157701864|FG001|Overall Study|Death|0|||
48756333|NCT00065507|156954311|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
48756334|NCT00065507|156954312|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
48756335|NCT01846507|156954316|FG000|Overall Study|Lost to Follow-up|4|||
48756336|NCT01846507|156954316|FG000|Overall Study|Protocol Violation|1|||
48756337|NCT01846507|156954316|FG000|Overall Study|Missing data|2|||
48756338|NCT01741701|156954322|FG000|Overall Study|Adverse Event|5|||
48756339|NCT01741701|156954323|FG001|Overall Study|Adverse Event|1|||
48756340|NCT01741701|156954322|FG000|Overall Study|Withdrawal by Subject|0|||
48756341|NCT01741701|156954323|FG001|Overall Study|Withdrawal by Subject|1|||
48756342|NCT00487747|156954324|FG000|Overall Study|Adverse Event|1|||
48756343|NCT00487747|156954324|FG000|Overall Study|Lost to Follow-up|9|||
48756344|NCT00487747|156954324|FG000|Overall Study|Lack of Efficacy|1|||
48756345|NCT03108027|156954325|FG000|Period 1|Subject/Guardian Decision|0|||
48756346|NCT03108027|156954326|FG001|Period 1|Subject/Guardian Decision|0|||
48662865|NCT02014480|156617739|FG002|Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
48662866|NCT02014480|156617740|FG003|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
48662867|NCT02014480|156617741|FG004|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
48662868|NCT02014480|156617742|FG005|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
48662869|NCT02014480|156617737|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
48662870|NCT02014480|156617738|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
48662871|NCT02014480|156617739|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
48662872|NCT02014480|156617740|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
48662873|NCT02014480|156617741|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
48662874|NCT02014480|156617742|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
48662875|NCT02014480|156617737|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
48662876|NCT02014480|156617738|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
48662877|NCT02014480|156617739|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
48662878|NCT02014480|156617740|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
48662879|NCT02014480|156617741|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
48662880|NCT02014480|156617742|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
48662881|NCT02014480|156617737|FG000|Treatment Period 2 (14 Days)|Protocol Violation|1|||
48662882|NCT02014480|156617738|FG001|Treatment Period 2 (14 Days)|Protocol Violation|1|||
48662883|NCT02014480|156617739|FG002|Treatment Period 2 (14 Days)|Protocol Violation|2|||
48662884|NCT02014480|156617740|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
48662885|NCT02014480|156617741|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
48662886|NCT02014480|156617742|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
48662887|NCT02014480|156617737|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
48662888|NCT02014480|156617738|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
48662889|NCT02014480|156617739|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
48662890|NCT02014480|156617740|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
48662891|NCT02014480|156617741|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
48756347|NCT03108027|156954327|FG002|Period 1|Subject/Guardian Decision|0|||
48756348|NCT03108027|156954328|FG003|Period 1|Subject/Guardian Decision|2|||
48756349|NCT03108027|156954329|FG004|Period 1|Subject/Guardian Decision|0|||
48756350|NCT03108027|156954330|FG005|Period 1|Subject/Guardian Decision|0|||
48756351|NCT03108027|156954325|FG000|Period 3|Adverse Event|0|||
48756352|NCT03108027|156954326|FG001|Period 3|Adverse Event|1|||
48756353|NCT03108027|156954327|FG002|Period 3|Adverse Event|0|||
48756354|NCT03108027|156954328|FG003|Period 3|Adverse Event|0|||
48756355|NCT03108027|156954329|FG004|Period 3|Adverse Event|0|||
48756356|NCT03108027|156954330|FG005|Period 3|Adverse Event|0|||
48756357|NCT02069366|156954331|FG000|Overall Study|Lost to Follow-up|0|||
48756358|NCT02069366|156954332|FG001|Overall Study|Lost to Follow-up|0|||
48965805|NCT01115738|157701865|FG002|Overall Study|Death|0|||
48662892|NCT02014480|156617742|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
48662893|NCT02014480|156617737|FG000|Treatment Period 3 (14 Days)|Adverse Event|0|||
48662894|NCT02014480|156617738|FG001|Treatment Period 3 (14 Days)|Adverse Event|0|||
48662895|NCT02014480|156617739|FG002|Treatment Period 3 (14 Days)|Adverse Event|1|||
48662896|NCT02014480|156617740|FG003|Treatment Period 3 (14 Days)|Adverse Event|0|||
48662897|NCT02014480|156617741|FG004|Treatment Period 3 (14 Days)|Adverse Event|0|||
48662898|NCT02014480|156617742|FG005|Treatment Period 3 (14 Days)|Adverse Event|1|||
48662899|NCT02014480|156617737|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
48662900|NCT02014480|156617738|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
48965806|NCT01115738|157701863|FG000|Overall Study|Lost to Follow-up|0|||
48662901|NCT02014480|156617739|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
48756359|NCT02069366|156954333|FG002|Overall Study|Lost to Follow-up|1|||
48756360|NCT02069366|156954334|FG003|Overall Study|Lost to Follow-up|0|||
48662902|NCT02014480|156617740|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
48662903|NCT02014480|156617741|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
48756361|NCT02069366|156954335|FG004|Overall Study|Lost to Follow-up|0|||
48756362|NCT02069366|156954336|FG005|Overall Study|Lost to Follow-up|2|||
48756363|NCT02069366|156954331|FG000|Overall Study|Protocol Violation|0|||
48965807|NCT01115738|157701864|FG001|Overall Study|Lost to Follow-up|0|||
48662904|NCT02014480|156617742|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
48662905|NCT03294135|156617743|FG000|Overall Study|Serious Adverse Event|1|||
48662906|NCT03294135|156617744|FG001|Overall Study|Serious Adverse Event|0|||
48662907|NCT03294135|156617745|FG002|Overall Study|Serious Adverse Event|0|||
48662908|NCT03294135|156617743|FG000|Overall Study|Lost to Follow-up|1|||
48662909|NCT03294135|156617744|FG001|Overall Study|Lost to Follow-up|0|||
48662910|NCT03294135|156617745|FG002|Overall Study|Lost to Follow-up|1|||
48662911|NCT03294135|156617743|FG000|Overall Study|Withdrawal by Subject|0|||
48662912|NCT03294135|156617744|FG001|Overall Study|Withdrawal by Subject|0|||
48662913|NCT03294135|156617745|FG002|Overall Study|Withdrawal by Subject|1|||
48662914|NCT03294135|156617743|FG000|Overall Study|Other|2|||
48662915|NCT03294135|156617744|FG001|Overall Study|Other|0|||
48662916|NCT03294135|156617745|FG002|Overall Study|Other|0|||
48662917|NCT01095653|156617746|FG000|Overall Study|Lack of Efficacy|3|||
48662918|NCT01095653|156617747|FG001|Overall Study|Lack of Efficacy|0|||
48662919|NCT01095653|156617748|FG002|Overall Study|Lack of Efficacy|0|||
48662920|NCT01095653|156617746|FG000|Overall Study|Adverse Event|1|||
48662921|NCT01095653|156617747|FG001|Overall Study|Adverse Event|4|||
48662922|NCT01095653|156617748|FG002|Overall Study|Adverse Event|4|||
48662923|NCT01095653|156617746|FG000|Overall Study|Lost to Follow-up|1|||
48662924|NCT01095653|156617747|FG001|Overall Study|Lost to Follow-up|0|||
48662925|NCT01095653|156617748|FG002|Overall Study|Lost to Follow-up|4|||
48662926|NCT01095653|156617746|FG000|Overall Study|Withdrawal by Subject|4|||
48662927|NCT01095653|156617747|FG001|Overall Study|Withdrawal by Subject|5|||
48662928|NCT01095653|156617748|FG002|Overall Study|Withdrawal by Subject|3|||
48662929|NCT01095653|156617746|FG000|Overall Study|non-compliance, not met criteria, etc.|10|||
48662930|NCT01095653|156617747|FG001|Overall Study|non-compliance, not met criteria, etc.|6|||
48662931|NCT01095653|156617748|FG002|Overall Study|non-compliance, not met criteria, etc.|5|||
48662932|NCT00853125|156617752|FG000|Overall Study|Study participant's donor was CMV +|1|||
48662933|NCT04662073|156617758|FG000|Overall Study|Withdrawal by Subject|1|||
48662934|NCT04662073|156617759|FG001|Overall Study|Withdrawal by Subject|0|||
48662935|NCT01813721|156617760|FG000|Overall Study|Ineligibility determined|63|||
48662936|NCT01813721|156617760|FG000|Overall Study|Withdrawal by Subject|1|||
48662937|NCT01133275|156617761|FG000|Overall Study|Withdrawal by Subject|1|||
48662938|NCT01133275|156617761|FG000|Overall Study|Cerebrovascular accident (CVA)|1|||
48662939|NCT00495521|156617762|FG000|Overall Study|Physician Decision|0|||
48662940|NCT00495521|156617763|FG001|Overall Study|Physician Decision|1|||
48662941|NCT00276094|156617764|FG000|Overall Study|Adverse Event|15|||
48662942|NCT00276094|156617765|FG001|Overall Study|Adverse Event|13|||
48662943|NCT00276094|156617766|FG002|Overall Study|Adverse Event|11|||
48662944|NCT00276094|156617764|FG000|Overall Study|Withdrawal by Subject|14|||
48662945|NCT00276094|156617765|FG001|Overall Study|Withdrawal by Subject|14|||
48662946|NCT00276094|156617766|FG002|Overall Study|Withdrawal by Subject|12|||
48662947|NCT00276094|156617764|FG000|Overall Study|Protocol Violation|16|||
48662948|NCT00276094|156617765|FG001|Overall Study|Protocol Violation|7|||
48662949|NCT00276094|156617766|FG002|Overall Study|Protocol Violation|10|||
48662950|NCT00276094|156617764|FG000|Overall Study|Lost to Follow-up|8|||
48662951|NCT00276094|156617765|FG001|Overall Study|Lost to Follow-up|6|||
48662952|NCT00276094|156617766|FG002|Overall Study|Lost to Follow-up|4|||
48662953|NCT00276094|156617764|FG000|Overall Study|Other-Subject moved out of country|1|||
48662954|NCT00276094|156617765|FG001|Overall Study|Other-Subject moved out of country|0|||
48662955|NCT00276094|156617766|FG002|Overall Study|Other-Subject moved out of country|0|||
48662956|NCT00276094|156617764|FG000|Overall Study|Other-Scheduled gastroplasty|1|||
48662957|NCT00276094|156617765|FG001|Overall Study|Other-Scheduled gastroplasty|0|||
48662958|NCT00276094|156617766|FG002|Overall Study|Other-Scheduled gastroplasty|0|||
48662959|NCT00276094|156617764|FG000|Overall Study|Other-Lack of efficacy|1|||
48662960|NCT00276094|156617765|FG001|Overall Study|Other-Lack of efficacy|0|||
48662961|NCT00276094|156617766|FG002|Overall Study|Other-Lack of efficacy|0|||
48662962|NCT00276094|156617764|FG000|Overall Study|Other-Refused follow-up visit|1|||
48662963|NCT00276094|156617765|FG001|Overall Study|Other-Refused follow-up visit|0|||
48662964|NCT00276094|156617766|FG002|Overall Study|Other-Refused follow-up visit|0|||
48662965|NCT00276094|156617764|FG000|Overall Study|Other-Repeat safety labs-exclusionary|0|||
48662966|NCT00276094|156617765|FG001|Overall Study|Other-Repeat safety labs-exclusionary|1|||
48866766|NCT02123797|157349107|FG000|Baseline Intervention|Withdrawal by Subject|2|||
48662967|NCT00276094|156617766|FG002|Overall Study|Other-Repeat safety labs-exclusionary|0|||
48662968|NCT00276094|156617764|FG000|Overall Study|Other-Relocation|0|||
48662969|NCT00276094|156617765|FG001|Overall Study|Other-Relocation|1|||
48662970|NCT00276094|156617766|FG002|Overall Study|Other-Relocation|0|||
48662971|NCT00276094|156617764|FG000|Overall Study|Other-Study medication lost|0|||
48662972|NCT00276094|156617765|FG001|Overall Study|Other-Study medication lost|0|||
48662973|NCT00276094|156617766|FG002|Overall Study|Other-Study medication lost|1|||
48662974|NCT01999218|156617767|FG000|Overall Study|Hyperglycemia|18|||
48662975|NCT01999218|156617768|FG001|Overall Study|Hyperglycemia|17|||
48662976|NCT01999218|156617769|FG002|Overall Study|Hyperglycemia|17|||
48662977|NCT01999218|156617767|FG000|Overall Study|Lack of Efficacy|1|||
48866767|NCT02123797|157349108|FG001|Baseline Intervention|Withdrawal by Subject|8|||
48662978|NCT01999218|156617768|FG001|Overall Study|Lack of Efficacy|0|||
48662979|NCT01999218|156617769|FG002|Overall Study|Lack of Efficacy|1|||
48662980|NCT01999218|156617767|FG000|Overall Study|Lost to Follow-up|22|||
48965808|NCT01115738|157701865|FG002|Overall Study|Lost to Follow-up|1|||
48965809|NCT01115738|157701863|FG000|Overall Study|Physician Decision|18|||
48662981|NCT01999218|156617768|FG001|Overall Study|Lost to Follow-up|17|||
48662982|NCT01999218|156617769|FG002|Overall Study|Lost to Follow-up|18|||
48662983|NCT01999218|156617767|FG000|Overall Study|Non-Compliance With Study Drug|6|||
48662984|NCT01999218|156617768|FG001|Overall Study|Non-Compliance With Study Drug|4|||
48662985|NCT01999218|156617769|FG002|Overall Study|Non-Compliance With Study Drug|1|||
48662986|NCT01999218|156617767|FG000|Overall Study|Physician Decision|1|||
48662987|NCT01999218|156617768|FG001|Overall Study|Physician Decision|4|||
48662988|NCT01999218|156617769|FG002|Overall Study|Physician Decision|6|||
48662989|NCT01999218|156617767|FG000|Overall Study|Protocol Violation|4|||
48662990|NCT01999218|156617768|FG001|Overall Study|Protocol Violation|5|||
48662991|NCT01999218|156617769|FG002|Overall Study|Protocol Violation|4|||
48662992|NCT01999218|156617767|FG000|Overall Study|Screen failure|0|||
48662993|NCT01999218|156617768|FG001|Overall Study|Screen failure|1|||
48662994|NCT01999218|156617769|FG002|Overall Study|Screen failure|0|||
48662995|NCT01999218|156617767|FG000|Overall Study|Study Terminated By Sponsor|7|||
48662996|NCT01999218|156617768|FG001|Overall Study|Study Terminated By Sponsor|5|||
48662997|NCT01999218|156617769|FG002|Overall Study|Study Terminated By Sponsor|12|||
48662998|NCT01999218|156617767|FG000|Overall Study|Participant moves|2|||
48662999|NCT01999218|156617768|FG001|Overall Study|Participant moves|5|||
48663000|NCT01999218|156617769|FG002|Overall Study|Participant moves|3|||
48663001|NCT01999218|156617767|FG000|Overall Study|Withdrawal by Subject|28|||
48663002|NCT01999218|156617768|FG001|Overall Study|Withdrawal by Subject|29|||
48663003|NCT01999218|156617769|FG002|Overall Study|Withdrawal by Subject|34|||
48663004|NCT01999218|156617767|FG000|Overall Study|Creatinine/eGFR|0|||
48663005|NCT01999218|156617768|FG001|Overall Study|Creatinine/eGFR|0|||
48663006|NCT01999218|156617769|FG002|Overall Study|Creatinine/eGFR|1|||
48663007|NCT01999218|156617767|FG000|Overall Study|Death|7|||
48663008|NCT01999218|156617768|FG001|Overall Study|Death|1|||
48663009|NCT01999218|156617769|FG002|Overall Study|Death|2|||
48663010|NCT01999218|156617767|FG000|Overall Study|Excluded Medication|1|||
48663011|NCT01999218|156617768|FG001|Overall Study|Excluded Medication|1|||
48663012|NCT01999218|156617769|FG002|Overall Study|Excluded Medication|2|||
48663013|NCT01999218|156617767|FG000|Overall Study|Adverse Event|9|||
48663014|NCT01999218|156617768|FG001|Overall Study|Adverse Event|7|||
48663015|NCT01999218|156617769|FG002|Overall Study|Adverse Event|7|||
48663016|NCT01999218|156617767|FG000|Overall Study|Treated but excluded at 1 trial site|3|||
48663017|NCT01999218|156617768|FG001|Overall Study|Treated but excluded at 1 trial site|5|||
48663018|NCT01999218|156617769|FG002|Overall Study|Treated but excluded at 1 trial site|2|||
48663019|NCT02967692|156619477|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|3|||
48663020|NCT02967692|156619478|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|1|||
48663021|NCT02967692|156619479|FG002|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|86|||
48663022|NCT02967692|156619480|FG003|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|82|||
48663023|NCT02967692|156619477|FG000|Overall Study|Progressive disease|3|||
48663024|NCT02967692|156619478|FG001|Overall Study|Progressive disease|15|||
48663025|NCT02967692|156619479|FG002|Overall Study|Progressive disease|99|||
48663026|NCT02967692|156619480|FG003|Overall Study|Progressive disease|128|||
48663027|NCT02967692|156619477|FG000|Overall Study|Subject/guardian decision|1|||
48663028|NCT02967692|156619478|FG001|Overall Study|Subject/guardian decision|1|||
48663029|NCT02967692|156619479|FG002|Overall Study|Subject/guardian decision|6|||
48663030|NCT02967692|156619480|FG003|Overall Study|Subject/guardian decision|13|||
48663031|NCT02967692|156619477|FG000|Overall Study|Death|0|||
48663032|NCT02967692|156619478|FG001|Overall Study|Death|1|||
48663033|NCT02967692|156619479|FG002|Overall Study|Death|10|||
48663034|NCT02967692|156619480|FG003|Overall Study|Death|9|||
48663035|NCT02967692|156619477|FG000|Overall Study|Protocol deviation|1|||
48663036|NCT02967692|156619478|FG001|Overall Study|Protocol deviation|0|||
48663037|NCT02967692|156619479|FG002|Overall Study|Protocol deviation|1|||
48663038|NCT02967692|156619480|FG003|Overall Study|Protocol deviation|1|||
48663039|NCT02967692|156619477|FG000|Overall Study|Lost to Follow-up|0|||
48663040|NCT02967692|156619478|FG001|Overall Study|Lost to Follow-up|0|||
48663041|NCT02967692|156619479|FG002|Overall Study|Lost to Follow-up|1|||
48663042|NCT02967692|156619480|FG003|Overall Study|Lost to Follow-up|0|||
48663043|NCT02967692|156619477|FG000|Overall Study|Physician Decision|0|||
48663044|NCT02967692|156619478|FG001|Overall Study|Physician Decision|0|||
48663045|NCT02967692|156619479|FG002|Overall Study|Physician Decision|13|||
48663046|NCT02967692|156619480|FG003|Overall Study|Physician Decision|9|||
48663047|NCT02967692|156619477|FG000|Overall Study|Adverse Event|1|||
48663048|NCT02967692|156619478|FG001|Overall Study|Adverse Event|9|||
48663049|NCT02967692|156619479|FG002|Overall Study|Adverse Event|51|||
48663050|NCT02967692|156619480|FG003|Overall Study|Adverse Event|23|||
48692746|NCT01339689|156724589|FG001|Overall Study|Withdrawal by Subject|0|||
48692747|NCT01339689|156724588|FG000|Overall Study|Noncompliance|1|||
48965810|NCT01115738|157701864|FG001|Overall Study|Physician Decision|15|||
48965811|NCT01115738|157701865|FG002|Overall Study|Physician Decision|17|||
48965812|NCT01115738|157701863|FG000|Overall Study|Withdrawal by Subject|6|||
48756364|NCT02069366|156954332|FG001|Overall Study|Protocol Violation|0|||
48756365|NCT02069366|156954333|FG002|Overall Study|Protocol Violation|1|||
48756366|NCT02069366|156954334|FG003|Overall Study|Protocol Violation|0|||
48756367|NCT02069366|156954335|FG004|Overall Study|Protocol Violation|0|||
48756368|NCT02069366|156954336|FG005|Overall Study|Protocol Violation|0|||
48756369|NCT02069366|156954331|FG000|Overall Study|Withdrawal by Subject|1|||
48756370|NCT02069366|156954332|FG001|Overall Study|Withdrawal by Subject|0|||
48756371|NCT02069366|156954333|FG002|Overall Study|Withdrawal by Subject|1|||
48756372|NCT02069366|156954334|FG003|Overall Study|Withdrawal by Subject|2|||
48756373|NCT02069366|156954335|FG004|Overall Study|Withdrawal by Subject|0|||
48756374|NCT02069366|156954336|FG005|Overall Study|Withdrawal by Subject|0|||
48756375|NCT00268996|156954338|FG000|Overall Study|Adverse Event|11|||
48756376|NCT00268996|156954339|FG001|Overall Study|Adverse Event|7|||
48756377|NCT00268996|156954338|FG000|Overall Study|Lost to Follow-up|3|||
48965813|NCT01115738|157701864|FG001|Overall Study|Withdrawal by Subject|6|||
48965814|NCT01115738|157701865|FG002|Overall Study|Withdrawal by Subject|9|||
48965815|NCT02270684|157701866|FG000|Overall Study|Lost to Follow-up|0|||
48663051|NCT01967823|156619481|FG000|Overall Study|Died prior to completing therapy (before the six-week mark).|1|||
48663052|NCT03283098|156619482|FG000|Overall Study|Withdrawal by Subject|0|||
48756378|NCT00268996|156954339|FG001|Overall Study|Lost to Follow-up|1|||
48756379|NCT00268996|156954338|FG000|Overall Study|Withdrawal by Subject|5|||
48756380|NCT00268996|156954339|FG001|Overall Study|Withdrawal by Subject|11|||
48756381|NCT00268996|156954338|FG000|Overall Study|Non-compliance|1|||
48756382|NCT00268996|156954339|FG001|Overall Study|Non-compliance|0|||
48756383|NCT00268996|156954338|FG000|Overall Study|Other|1|||
48756384|NCT00268996|156954339|FG001|Overall Study|Other|1|||
48756385|NCT00330616|156954340|FG000|Overall Study|Adverse Event|13|||
48965816|NCT02270684|157701867|FG001|Overall Study|Lost to Follow-up|3|||
48965817|NCT02270684|157701866|FG000|Overall Study|Study terminated|1|||
48965818|NCT02270684|157701867|FG001|Overall Study|Study terminated|0|||
48965819|NCT00772382|157701870|FG000|Overall Study|Adverse Event|19|||
48965820|NCT00772382|157701870|FG000|Overall Study|Death|6|||
48965821|NCT00772382|157701870|FG000|Overall Study|Lack of Efficacy|4|||
48965822|NCT00772382|157701870|FG000|Overall Study|Physician Decision|5|||
48965823|NCT00772382|157701870|FG000|Overall Study|Protocol Violation|1|||
48965824|NCT00772382|157701870|FG000|Overall Study|Withdrawal by Subject|10|||
48965825|NCT00772382|157701870|FG000|Overall Study|Other Reasons|10|||
48965826|NCT02702011|157701874|FG000|Overall Study|Withdrawal by Subject|0|||
48965827|NCT02702011|157701875|FG001|Overall Study|Withdrawal by Subject|1|||
48965828|NCT02702011|157701876|FG002|Overall Study|Withdrawal by Subject|0|||
48965829|NCT02702011|157701877|FG003|Overall Study|Withdrawal by Subject|0|||
48965830|NCT04092816|157703665|FG000|Overall Study|Lost to Follow-up|1|||
48965831|NCT04092816|157703666|FG001|Overall Study|Lost to Follow-up|2|||
48965832|NCT02115113|157703667|FG000|Participants in Run-in Period|Death|0|||
48965833|NCT02115113|157703668|FG001|Participants in Run-in Period|Death|0|||
48965834|NCT02115113|157703669|FG002|Participants in Run-in Period|Death|1|||
48965835|NCT02115113|157703667|FG000|Participants in Run-in Period|Administrative problems|0|||
48965836|NCT02115113|157703668|FG001|Participants in Run-in Period|Administrative problems|0|||
48965837|NCT02115113|157703669|FG002|Participants in Run-in Period|Administrative problems|1|||
48965838|NCT02115113|157703667|FG000|Participants in Run-in Period|Lost to Follow-up|0|||
48965839|NCT02115113|157703668|FG001|Participants in Run-in Period|Lost to Follow-up|0|||
48965840|NCT02115113|157703669|FG002|Participants in Run-in Period|Lost to Follow-up|5|||
48663053|NCT03283098|156619483|FG001|Overall Study|Withdrawal by Subject|1|||
48663054|NCT00711113|156619484|FG000|Overall Study|Lost to Follow-up|9|||
48663055|NCT00711113|156619484|FG000|Overall Study|Implant lost|2|||
48663056|NCT00693017|156619495|FG000|Overall Study|Sponsor Decision|2|||
48663057|NCT00693017|156619496|FG001|Overall Study|Sponsor Decision|1|||
48663058|NCT00693017|156619495|FG000|Overall Study|Death|0|||
48663059|NCT00693017|156619496|FG001|Overall Study|Death|1|||
48663060|NCT00642369|156619499|FG000|Overall Study|Adverse Event|2|||
48663061|NCT00642369|156619500|FG001|Overall Study|Adverse Event|3|||
48663062|NCT00642369|156619499|FG000|Overall Study|Withdrawal by Subject|1|||
48663063|NCT00642369|156619500|FG001|Overall Study|Withdrawal by Subject|0|||
48663064|NCT00642369|156619499|FG000|Overall Study|misdiagnosis|0|||
48663065|NCT00642369|156619500|FG001|Overall Study|misdiagnosis|1|||
48663066|NCT00642369|156619499|FG000|Overall Study|Lack of Efficacy|2|||
48756386|NCT00330616|156954340|FG000|Overall Study|Lack of Efficacy|1|||
48756387|NCT00330616|156954340|FG000|Overall Study|Lost to Follow-up|2|||
48965841|NCT02115113|157703667|FG000|Participants in Run-in Period|Withdrawal by Subject|0|||
48965842|NCT02115113|157703668|FG001|Participants in Run-in Period|Withdrawal by Subject|0|||
48965843|NCT02115113|157703669|FG002|Participants in Run-in Period|Withdrawal by Subject|3|||
48965844|NCT02115113|157703667|FG000|Participants Randomized|Lost to Follow-up|1|||
48965845|NCT02115113|157703668|FG001|Participants Randomized|Lost to Follow-up|0|||
48965846|NCT02115113|157703669|FG002|Participants Randomized|Lost to Follow-up|0|||
48756388|NCT00330616|156954340|FG000|Overall Study|Withdrawal by Subject|4|||
48756389|NCT00330616|156954340|FG000|Overall Study|Other|1|||
48756390|NCT00730912|156954343|FG000|Overall Study|Discontinued|0|||
48756391|NCT00730912|156954344|FG001|Overall Study|Discontinued|0|||
48756392|NCT00730912|156954345|FG002|Overall Study|Discontinued|1|||
48756393|NCT00732615|156954346|FG000|Overall Study|Withdrawal by Subject|3|||
48663067|NCT00642369|156619500|FG001|Overall Study|Lack of Efficacy|2|||
48663068|NCT00847665|156619501|FG000|Overall Study|Withdrawal by Subject|1|||
48663069|NCT00847665|156619502|FG001|Overall Study|Withdrawal by Subject|0|||
48663070|NCT02536300|156619506|FG000|Overall Study|Investigator's Discretion|17|||
48663071|NCT02536300|156619507|FG001|Overall Study|Investigator's Discretion|11|||
48663072|NCT02536300|156619508|FG002|Overall Study|Investigator's Discretion|2|||
48663073|NCT02536300|156619506|FG000|Overall Study|Progressive Disease|11|||
48663074|NCT02536300|156619507|FG001|Overall Study|Progressive Disease|7|||
48663075|NCT02536300|156619508|FG002|Overall Study|Progressive Disease|6|||
48663076|NCT02536300|156619506|FG000|Overall Study|Study Terminated by Sponsor|6|||
48663077|NCT02536300|156619507|FG001|Overall Study|Study Terminated by Sponsor|4|||
48663078|NCT02536300|156619508|FG002|Overall Study|Study Terminated by Sponsor|7|||
48663079|NCT02536300|156619506|FG000|Overall Study|Death|7|||
48663080|NCT02536300|156619507|FG001|Overall Study|Death|0|||
48663081|NCT02536300|156619508|FG002|Overall Study|Death|5|||
48663082|NCT02536300|156619506|FG000|Overall Study|Withdrew Consent|4|||
48663083|NCT02536300|156619507|FG001|Overall Study|Withdrew Consent|2|||
48663084|NCT02536300|156619508|FG002|Overall Study|Withdrew Consent|0|||
48663085|NCT02536300|156619506|FG000|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
48663086|NCT02536300|156619507|FG001|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|2|||
48663087|NCT02536300|156619508|FG002|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
48663088|NCT02536300|156619506|FG000|Overall Study|Enrolled but Never Treated|0|||
48663089|NCT02536300|156619507|FG001|Overall Study|Enrolled but Never Treated|0|||
48663090|NCT02536300|156619508|FG002|Overall Study|Enrolled but Never Treated|1|||
48663091|NCT02536300|156619506|FG000|Overall Study|Non-compliance With Study Drug|1|||
48663092|NCT02536300|156619507|FG001|Overall Study|Non-compliance With Study Drug|0|||
48663093|NCT02536300|156619508|FG002|Overall Study|Non-compliance With Study Drug|0|||
48663094|NCT02536300|156619506|FG000|Overall Study|Protocol Violation|0|||
48663095|NCT02536300|156619507|FG001|Overall Study|Protocol Violation|1|||
48663096|NCT02536300|156619508|FG002|Overall Study|Protocol Violation|0|||
48663097|NCT01779869|156619509|FG000|Overall Study|Physician Decision|2|||
48663098|NCT02435680|156619511|FG000|Overall Study|Physician Decision|3|||
48663099|NCT02435680|156619512|FG001|Overall Study|Physician Decision|0|||
48663100|NCT02435680|156619513|FG002|Overall Study|Physician Decision|0|||
48663101|NCT02435680|156619511|FG000|Overall Study|subject / guardian decision|0|||
48663102|NCT02435680|156619512|FG001|Overall Study|subject / guardian decision|3|||
48756394|NCT00732615|156954347|FG001|Overall Study|Withdrawal by Subject|1|||
48756395|NCT00732615|156954346|FG000|Overall Study|Lost to Follow-up|0|||
48756396|NCT00732615|156954347|FG001|Overall Study|Lost to Follow-up|1|||
48663103|NCT02435680|156619513|FG002|Overall Study|subject / guardian decision|2|||
48663104|NCT02435680|156619511|FG000|Overall Study|Adverse Event|8|||
48663105|NCT02435680|156619512|FG001|Overall Study|Adverse Event|3|||
48663106|NCT02435680|156619513|FG002|Overall Study|Adverse Event|2|||
48663107|NCT02435680|156619511|FG000|Overall Study|progressive disease|10|||
48663108|NCT02435680|156619512|FG001|Overall Study|progressive disease|7|||
48663109|NCT02435680|156619513|FG002|Overall Study|progressive disease|11|||
48663110|NCT02435680|156619511|FG000|Overall Study|not treated|0|||
48663111|NCT02435680|156619512|FG001|Overall Study|not treated|0|||
48663112|NCT02435680|156619513|FG002|Overall Study|not treated|1|||
48663113|NCT01632241|156619514|FG000|Double-blinded (Up to Week 52)|Site Closed|3|||
48663114|NCT01632241|156619515|FG001|Double-blinded (Up to Week 52)|Site Closed|5|||
48663115|NCT01632241|156619514|FG000|Double-blinded (Up to Week 52)|Protocol Violation|2|||
48663116|NCT01632241|156619515|FG001|Double-blinded (Up to Week 52)|Protocol Violation|6|||
48756397|NCT00732615|156954346|FG000|Overall Study|Adverse Event|0|||
48663117|NCT01632241|156619514|FG000|Double-blinded (Up to Week 52)|Lost to Follow-up|1|||
48756398|NCT00732615|156954347|FG001|Overall Study|Adverse Event|2|||
48756399|NCT00732615|156954346|FG000|Overall Study|Physician Decision|3|||
48866768|NCT02123797|157349109|FG002|Baseline Intervention|Withdrawal by Subject|0|||
48866769|NCT02123797|157349110|FG003|Baseline Intervention|Withdrawal by Subject|0|||
48866770|NCT02123797|157349111|FG004|Baseline Intervention|Withdrawal by Subject|0|||
48866771|NCT02123797|157349107|FG000|Baseline Intervention|Relocation|2|||
48663118|NCT01632241|156619515|FG001|Double-blinded (Up to Week 52)|Lost to Follow-up|8|||
48663119|NCT01632241|156619514|FG000|Double-blinded (Up to Week 52)|Physician Decision|9|||
48663120|NCT01632241|156619515|FG001|Double-blinded (Up to Week 52)|Physician Decision|12|||
48663121|NCT01632241|156619514|FG000|Double-blinded (Up to Week 52)|Lack of Efficacy|9|||
48663122|NCT01632241|156619515|FG001|Double-blinded (Up to Week 52)|Lack of Efficacy|15|||
48663123|NCT01632241|156619514|FG000|Double-blinded (Up to Week 52)|Withdrawal by Subject|10|||
48663124|NCT01632241|156619515|FG001|Double-blinded (Up to Week 52)|Withdrawal by Subject|14|||
48663125|NCT01632241|156619514|FG000|Double-blinded (Up to Week 52)|Adverse Event|10|||
48663126|NCT01632241|156619515|FG001|Double-blinded (Up to Week 52)|Adverse Event|19|||
48663127|NCT01632241|156619514|FG000|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5|||
48663128|NCT01632241|156619515|FG001|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2|||
48663129|NCT01632241|156619514|FG000|Open-label (Week 52 to Week 76)|Physician Decision|1|||
48663130|NCT01632241|156619515|FG001|Open-label (Week 52 to Week 76)|Physician Decision|4|||
48663131|NCT01632241|156619514|FG000|Open-label (Week 52 to Week 76)|Lost to Follow-up|1|||
48663132|NCT01632241|156619515|FG001|Open-label (Week 52 to Week 76)|Lost to Follow-up|4|||
48663133|NCT01632241|156619514|FG000|Open-label (Week 52 to Week 76)|Site Closed|2|||
48663134|NCT01632241|156619515|FG001|Open-label (Week 52 to Week 76)|Site Closed|8|||
48663135|NCT01632241|156619514|FG000|Open-label (Week 52 to Week 76)|Protocol Violation|0|||
48663136|NCT01632241|156619515|FG001|Open-label (Week 52 to Week 76)|Protocol Violation|2|||
48663137|NCT01632241|156619514|FG000|Open-label (Week 52 to Week 76)|Lack of Efficacy|0|||
48663138|NCT01632241|156619515|FG001|Open-label (Week 52 to Week 76)|Lack of Efficacy|2|||
48663139|NCT01632241|156619514|FG000|Open-label (Week 52 to Week 76)|Adverse Event|1|||
48663140|NCT01632241|156619515|FG001|Open-label (Week 52 to Week 76)|Adverse Event|0|||
48663141|NCT04490109|156619516|FG000|Overall Study|Lost to Follow-up|3|||
48663142|NCT04490109|156619517|FG001|Overall Study|Lost to Follow-up|10|||
48663143|NCT04490109|156619518|FG002|Overall Study|Lost to Follow-up|4|||
48663144|NCT04490109|156619516|FG000|Overall Study|Withdrawal by Subject|8|||
48663145|NCT04490109|156619517|FG001|Overall Study|Withdrawal by Subject|6|||
48663146|NCT04490109|156619518|FG002|Overall Study|Withdrawal by Subject|9|||
48663147|NCT04490109|156619516|FG000|Overall Study|Physician Decision|0|||
48663148|NCT04490109|156619517|FG001|Overall Study|Physician Decision|2|||
48663149|NCT04490109|156619518|FG002|Overall Study|Physician Decision|3|||
48663150|NCT04490109|156619516|FG000|Overall Study|Adverse Event|2|||
48663151|NCT04490109|156619517|FG001|Overall Study|Adverse Event|1|||
48663152|NCT04490109|156619518|FG002|Overall Study|Adverse Event|0|||
48663153|NCT04490109|156619516|FG000|Overall Study|Significant Non-Compliance|2|||
48663154|NCT04490109|156619517|FG001|Overall Study|Significant Non-Compliance|4|||
48663155|NCT04490109|156619518|FG002|Overall Study|Significant Non-Compliance|4|||
48663156|NCT04490109|156619516|FG000|Overall Study|Significant Clinical Event|0|||
48663157|NCT04490109|156619517|FG001|Overall Study|Significant Clinical Event|1|||
48663158|NCT04490109|156619518|FG002|Overall Study|Significant Clinical Event|0|||
48663159|NCT04490109|156619516|FG000|Overall Study|Other Reason|4|||
48663160|NCT04490109|156619517|FG001|Overall Study|Other Reason|1|||
48663161|NCT04490109|156619518|FG002|Overall Study|Other Reason|1|||
48663162|NCT02851407|156619519|FG000|Overall Study|Withdrawal by parent/guardian|2|||
48663163|NCT02851407|156619520|FG001|Overall Study|Withdrawal by parent/guardian|7|||
48663164|NCT02851407|156619519|FG000|Overall Study|Protocol deviation|0|||
48663165|NCT02851407|156619520|FG001|Overall Study|Protocol deviation|1|||
48663166|NCT02851407|156619519|FG000|Overall Study|Transferred to another hospital to continue|1|||
48663167|NCT02851407|156619520|FG001|Overall Study|Transferred to another hospital to continue|0|||
48663168|NCT02851407|156619519|FG000|Overall Study|Other Death|30|||
48663169|NCT02851407|156619520|FG001|Overall Study|Other Death|20|||
48663170|NCT02851407|156619519|FG000|Overall Study|Adverse event, serious fatal|6|||
48663171|NCT02851407|156619520|FG001|Overall Study|Adverse event, serious fatal|8|||
48663172|NCT02851407|156619519|FG000|Overall Study|Consent withdrawn by participant|5|||
48663173|NCT02851407|156619520|FG001|Overall Study|Consent withdrawn by participant|3|||
48663174|NCT02851407|156619519|FG000|Overall Study|Screen failure|2|||
48663175|NCT02851407|156619520|FG001|Overall Study|Screen failure|1|||
48663176|NCT02851407|156619519|FG000|Overall Study|Disease relapse|9|||
48663177|NCT02851407|156619520|FG001|Overall Study|Disease relapse|6|||
48663178|NCT02851407|156619519|FG000|Overall Study|Physician Decision|7|||
48663179|NCT02851407|156619520|FG001|Overall Study|Physician Decision|6|||
48663180|NCT02851407|156619519|FG000|Overall Study|Transferred to hospital closer to home|0|||
48663181|NCT02851407|156619520|FG001|Overall Study|Transferred to hospital closer to home|1|||
48663182|NCT02851407|156619519|FG000|Overall Study|Enrolled in an investigational study|0|||
48663183|NCT02851407|156619520|FG001|Overall Study|Enrolled in an investigational study|1|||
48663184|NCT02851407|156619519|FG000|Overall Study|Early recovery|1|||
48663185|NCT02851407|156619520|FG001|Overall Study|Early recovery|0|||
48663186|NCT02851407|156619519|FG000|Overall Study|Adverse event, non-fatal|7|||
49015453|NCT01393990|157893785|FG015|Overall Study|Adverse Event|1|||
48663187|NCT02851407|156619520|FG001|Overall Study|Adverse event, non-fatal|5|||
48663188|NCT02851407|156619519|FG000|Overall Study|Lost to Follow-up|0|||
48663189|NCT02851407|156619520|FG001|Overall Study|Lost to Follow-up|2|||
48663190|NCT00235391|156619523|FG000|Overall Study|Adverse Event|4|||
48663191|NCT00235391|156619524|FG001|Overall Study|Adverse Event|5|||
48663192|NCT00235391|156619525|FG002|Overall Study|Adverse Event|10|||
48663193|NCT00235391|156619526|FG003|Overall Study|Adverse Event|72|||
48663194|NCT00235391|156619527|FG004|Overall Study|Adverse Event|5|||
48663195|NCT00235391|156619528|FG005|Overall Study|Adverse Event|2|||
48663196|NCT00235391|156619523|FG000|Overall Study|Abnormal laboratory value(s)|3|||
48663197|NCT00235391|156619524|FG001|Overall Study|Abnormal laboratory value(s)|5|||
48663198|NCT00235391|156619525|FG002|Overall Study|Abnormal laboratory value(s)|4|||
48663199|NCT00235391|156619526|FG003|Overall Study|Abnormal laboratory value(s)|27|||
48965847|NCT02115113|157703667|FG000|Participants Randomized|Death|1|||
48965848|NCT02115113|157703668|FG001|Participants Randomized|Death|0|||
48965849|NCT02115113|157703669|FG002|Participants Randomized|Death|0|||
48965850|NCT00789191|157703671|FG000|Overall Study|Adverse Event|2|||
48965851|NCT00789191|157703672|FG001|Overall Study|Adverse Event|4|||
48965852|NCT00789191|157703671|FG000|Overall Study|Lack of Efficacy|0|||
48663200|NCT00235391|156619527|FG004|Overall Study|Abnormal laboratory value(s)|1|||
48663201|NCT00235391|156619528|FG005|Overall Study|Abnormal laboratory value(s)|2|||
48663202|NCT00235391|156619523|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
48663203|NCT00235391|156619524|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
48663204|NCT00235391|156619525|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
48663205|NCT00235391|156619526|FG003|Overall Study|Unsatisfactory therapeutic effect|17|||
48663206|NCT00235391|156619527|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
48663207|NCT00235391|156619528|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
48965853|NCT00789191|157703672|FG001|Overall Study|Lack of Efficacy|5|||
48965854|NCT00789191|157703671|FG000|Overall Study|Protocol Violation|5|||
48965855|NCT00789191|157703672|FG001|Overall Study|Protocol Violation|3|||
48965856|NCT00789191|157703671|FG000|Overall Study|Withdrawal Criteria|2|||
48965857|NCT00789191|157703672|FG001|Overall Study|Withdrawal Criteria|4|||
48965858|NCT00789191|157703671|FG000|Overall Study|Unclassified|5|||
48965859|NCT00789191|157703672|FG001|Overall Study|Unclassified|3|||
48965860|NCT01009983|157703673|FG000|Overall Study|necessary scans not completed|1|||
48965861|NCT02494778|157703674|FG000|Overall Study|Death|3|||
48965862|NCT02494778|157703674|FG000|Overall Study|Other|173|||
48965863|NCT02494778|157703674|FG000|Overall Study|Lack of Efficacy|4|||
48965864|NCT02494778|157703674|FG000|Overall Study|Adverse Event|18|||
48965865|NCT02494778|157703674|FG000|Overall Study|Withdrawal by Subject|20|||
48965866|NCT02494778|157703674|FG000|Overall Study|Lost to Follow-up|2|||
48965867|NCT02494778|157703674|FG000|Overall Study|Noncompliant with study drug admin.|1|||
48965868|NCT04410198|157703677|FG000|Overall Study|Death|10|||
48965869|NCT04410198|157703677|FG000|Overall Study|Withdrawal by Subject|7|||
48965870|NCT04410198|157703677|FG000|Overall Study|Transferred/Relocation|4|||
48965871|NCT04410198|157703677|FG000|Overall Study|Kidney Transplant|9|||
48965872|NCT04410198|157703677|FG000|Overall Study|Adverse Event|4|||
48965873|NCT04410198|157703677|FG000|Overall Study|Physician Decision|2|||
48965874|NCT04410198|157703677|FG000|Overall Study|Other than specified|1|||
48965875|NCT00600028|157703678|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
48965876|NCT00600028|157703679|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
48965877|NCT00600028|157703678|FG000|First Intervention (12 Weeks)|Adverse Event|0|||
48965878|NCT00600028|157703679|FG001|First Intervention (12 Weeks)|Adverse Event|1|||
48965879|NCT00600028|157703678|FG000|Second Intervention (12 Weeks)|Adverse Event|0|||
48965880|NCT00600028|157703679|FG001|Second Intervention (12 Weeks)|Adverse Event|2|||
48965881|NCT00485589|157703680|FG000|Overall Study|Death|2|||
48965882|NCT00485589|157703681|FG001|Overall Study|Death|2|||
48965883|NCT00485589|157703682|FG002|Overall Study|Death|0|||
48965884|NCT00485589|157703680|FG000|Overall Study|Failure to return|6|||
48965885|NCT00485589|157703681|FG001|Overall Study|Failure to return|5|||
48965886|NCT00485589|157703682|FG002|Overall Study|Failure to return|1|||
48965887|NCT00485589|157703680|FG000|Overall Study|Protocol Violation|1|||
48965888|NCT00485589|157703681|FG001|Overall Study|Protocol Violation|0|||
48965889|NCT00485589|157703682|FG002|Overall Study|Protocol Violation|0|||
48965890|NCT00485589|157703680|FG000|Overall Study|Violation of selection criteria at entry|0|||
48663208|NCT00235391|156619523|FG000|Overall Study|Condition no longer requires treatment|3|||
48663209|NCT00235391|156619524|FG001|Overall Study|Condition no longer requires treatment|0|||
48965891|NCT00485589|157703681|FG001|Overall Study|Violation of selection criteria at entry|3|||
48965892|NCT00485589|157703682|FG002|Overall Study|Violation of selection criteria at entry|1|||
48965893|NCT00485589|157703680|FG000|Overall Study|Administrative/Other|1|||
48965894|NCT00485589|157703681|FG001|Overall Study|Administrative/Other|2|||
48965895|NCT00485589|157703682|FG002|Overall Study|Administrative/Other|1|||
48965896|NCT00485589|157703680|FG000|Overall Study|Insufficient therapeutic response|10|||
48965897|NCT00485589|157703681|FG001|Overall Study|Insufficient therapeutic response|3|||
48965898|NCT00485589|157703682|FG002|Overall Study|Insufficient therapeutic response|1|||
48965899|NCT00485589|157703680|FG000|Overall Study|Refused treatment/did not cooperate|1|||
48965900|NCT00485589|157703681|FG001|Overall Study|Refused treatment/did not cooperate|0|||
48965901|NCT00485589|157703682|FG002|Overall Study|Refused treatment/did not cooperate|2|||
48663210|NCT00235391|156619525|FG002|Overall Study|Condition no longer requires treatment|0|||
48692748|NCT01339689|156724589|FG001|Overall Study|Noncompliance|0|||
48692749|NCT01339689|156724588|FG000|Overall Study|Relocated out of area|0|||
48692750|NCT01339689|156724589|FG001|Overall Study|Relocated out of area|1|||
48692751|NCT01339689|156724588|FG000|Overall Study|Other|2|||
48692752|NCT01339689|156724589|FG001|Overall Study|Other|2|||
48692753|NCT01339689|156724588|FG000|Overall Study|multiple reasons|1|||
48692754|NCT01339689|156724589|FG001|Overall Study|multiple reasons|1|||
48692755|NCT01469221|156724590|FG000|Double Blind Phase|Protocol Violation|1|||
48692756|NCT01469221|156724591|FG001|Double Blind Phase|Protocol Violation|0|||
48965902|NCT00485589|157703680|FG000|Overall Study|Withdrawal by Subject|3|||
48866772|NCT02123797|157349108|FG001|Baseline Intervention|Relocation|0|||
48866773|NCT02123797|157349109|FG002|Baseline Intervention|Relocation|0|||
48866774|NCT02123797|157349110|FG003|Baseline Intervention|Relocation|0|||
48866775|NCT02123797|157349111|FG004|Baseline Intervention|Relocation|0|||
48866776|NCT02123797|157349107|FG000|Baseline Intervention|Out of window for initial survey|6|||
48866777|NCT02123797|157349108|FG001|Baseline Intervention|Out of window for initial survey|13|||
48866778|NCT02123797|157349109|FG002|Baseline Intervention|Out of window for initial survey|0|||
48866779|NCT02123797|157349110|FG003|Baseline Intervention|Out of window for initial survey|0|||
48866780|NCT02123797|157349111|FG004|Baseline Intervention|Out of window for initial survey|0|||
48866781|NCT02123797|157349107|FG000|Baseline Intervention|Lost to Follow-up|0|||
48866782|NCT02123797|157349108|FG001|Baseline Intervention|Lost to Follow-up|5|||
48866783|NCT02123797|157349109|FG002|Baseline Intervention|Lost to Follow-up|0|||
48866784|NCT02123797|157349110|FG003|Baseline Intervention|Lost to Follow-up|0|||
48866785|NCT02123797|157349111|FG004|Baseline Intervention|Lost to Follow-up|0|||
48866786|NCT02123797|157349107|FG000|Baseline Intervention|Other Disease|3|||
48866787|NCT02123797|157349108|FG001|Baseline Intervention|Other Disease|0|||
48866788|NCT02123797|157349109|FG002|Baseline Intervention|Other Disease|0|||
48866789|NCT02123797|157349110|FG003|Baseline Intervention|Other Disease|0|||
48866790|NCT02123797|157349111|FG004|Baseline Intervention|Other Disease|0|||
48866791|NCT02123797|157349107|FG000|3-month Follow up (Cumulative Counts)|Death|33|||
48866792|NCT02123797|157349108|FG001|3-month Follow up (Cumulative Counts)|Death|57|||
48866793|NCT02123797|157349109|FG002|3-month Follow up (Cumulative Counts)|Death|0|||
48866794|NCT02123797|157349110|FG003|3-month Follow up (Cumulative Counts)|Death|0|||
48866795|NCT02123797|157349111|FG004|3-month Follow up (Cumulative Counts)|Death|0|||
48866796|NCT02123797|157349107|FG000|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2|||
48866797|NCT02123797|157349108|FG001|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7|||
48866798|NCT02123797|157349109|FG002|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50|||
48866799|NCT02123797|157349110|FG003|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82|||
48866800|NCT02123797|157349111|FG004|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
48866801|NCT02123797|157349107|FG000|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6|||
48866802|NCT02123797|157349108|FG001|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16|||
48866803|NCT02123797|157349109|FG002|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
48866804|NCT02123797|157349110|FG003|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
48866805|NCT02123797|157349111|FG004|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
48866806|NCT02123797|157349107|FG000|3-month Follow up (Cumulative Counts)|Relocation|0|||
48866807|NCT02123797|157349108|FG001|3-month Follow up (Cumulative Counts)|Relocation|1|||
48866808|NCT02123797|157349109|FG002|3-month Follow up (Cumulative Counts)|Relocation|0|||
48866809|NCT02123797|157349110|FG003|3-month Follow up (Cumulative Counts)|Relocation|0|||
48866810|NCT02123797|157349111|FG004|3-month Follow up (Cumulative Counts)|Relocation|0|||
48866811|NCT02123797|157349107|FG000|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16|||
48866812|NCT02123797|157349108|FG001|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36|||
48866813|NCT02123797|157349109|FG002|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
48866814|NCT02123797|157349110|FG003|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
48866815|NCT02123797|157349111|FG004|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
48866816|NCT02123797|157349107|FG000|6-month Follow up (Cumulative Counts)|Death|51|||
48866817|NCT02123797|157349108|FG001|6-month Follow up (Cumulative Counts)|Death|97|||
48866818|NCT02123797|157349109|FG002|6-month Follow up (Cumulative Counts)|Death|0|||
48866819|NCT02123797|157349110|FG003|6-month Follow up (Cumulative Counts)|Death|0|||
48866820|NCT02123797|157349111|FG004|6-month Follow up (Cumulative Counts)|Death|0|||
48866821|NCT02123797|157349107|FG000|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
48866822|NCT02123797|157349108|FG001|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20|||
48866823|NCT02123797|157349109|FG002|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66|||
48866824|NCT02123797|157349110|FG003|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113|||
48866825|NCT02123797|157349111|FG004|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
48866826|NCT02123797|157349107|FG000|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1|||
48866827|NCT02123797|157349108|FG001|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9|||
48866828|NCT02123797|157349109|FG002|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
48866829|NCT02123797|157349110|FG003|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
48866830|NCT02123797|157349111|FG004|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
48866831|NCT02123797|157349107|FG000|6-month Follow up (Cumulative Counts)|Relocation|0|||
48866832|NCT02123797|157349108|FG001|6-month Follow up (Cumulative Counts)|Relocation|2|||
48866833|NCT02123797|157349109|FG002|6-month Follow up (Cumulative Counts)|Relocation|0|||
48866834|NCT02123797|157349110|FG003|6-month Follow up (Cumulative Counts)|Relocation|0|||
48866835|NCT02123797|157349111|FG004|6-month Follow up (Cumulative Counts)|Relocation|0|||
48866836|NCT02775214|157349114|FG000|Overall Study|Withdrawal by Subject|2|||
48866837|NCT02775214|157349115|FG001|Overall Study|Withdrawal by Subject|0|||
48866838|NCT02706834|157349116|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
48866839|NCT02706834|157349117|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
48965903|NCT00485589|157703681|FG001|Overall Study|Withdrawal by Subject|2|||
48965904|NCT00485589|157703682|FG002|Overall Study|Withdrawal by Subject|2|||
48965905|NCT00485589|157703680|FG000|Overall Study|Adverse Event|3|||
48663211|NCT00235391|156619526|FG003|Overall Study|Condition no longer requires treatment|11|||
48965906|NCT00485589|157703681|FG001|Overall Study|Adverse Event|3|||
48965907|NCT00485589|157703682|FG002|Overall Study|Adverse Event|10|||
48965908|NCT03115112|157703687|FG000|Overall Study|Adverse Event|5|||
48965909|NCT03115112|157703688|FG001|Overall Study|Adverse Event|1|||
48965910|NCT03115112|157703687|FG000|Overall Study|Withdrawal by Subject|4|||
48663212|NCT00235391|156619527|FG004|Overall Study|Condition no longer requires treatment|1|||
48663213|NCT00235391|156619528|FG005|Overall Study|Condition no longer requires treatment|0|||
48965911|NCT03115112|157703688|FG001|Overall Study|Withdrawal by Subject|2|||
48965912|NCT03115112|157703687|FG000|Overall Study|Lost to Follow-up|0|||
48965913|NCT03115112|157703688|FG001|Overall Study|Lost to Follow-up|1|||
48965914|NCT03115112|157703687|FG000|Overall Study|Death|1|||
48965915|NCT03115112|157703688|FG001|Overall Study|Death|0|||
48965916|NCT03115112|157703687|FG000|Overall Study|Pregnancy|1|||
48965917|NCT03115112|157703688|FG001|Overall Study|Pregnancy|0|||
48965918|NCT03115112|157703687|FG000|Overall Study|Site closure|1|||
48965919|NCT03115112|157703688|FG001|Overall Study|Site closure|1|||
48965920|NCT00868166|157703689|FG000|Overall Study|Death|58|||
48965921|NCT00868166|157703690|FG001|Overall Study|Death|65|||
48965922|NCT00868166|157703689|FG000|Overall Study|Withdrawal by Subject|33|||
48965923|NCT00868166|157703690|FG001|Overall Study|Withdrawal by Subject|25|||
48965924|NCT00868166|157703689|FG000|Overall Study|Protocol Violation|1|||
48965925|NCT00868166|157703690|FG001|Overall Study|Protocol Violation|0|||
48663214|NCT00235391|156619523|FG000|Overall Study|Protocol deviation|0|||
48663215|NCT00235391|156619524|FG001|Overall Study|Protocol deviation|0|||
48663216|NCT00235391|156619525|FG002|Overall Study|Protocol deviation|1|||
48663217|NCT00235391|156619526|FG003|Overall Study|Protocol deviation|11|||
48663218|NCT00235391|156619527|FG004|Overall Study|Protocol deviation|0|||
48663219|NCT00235391|156619528|FG005|Overall Study|Protocol deviation|0|||
48663220|NCT00235391|156619523|FG000|Overall Study|Withdrawal by Subject|2|||
48663221|NCT00235391|156619524|FG001|Overall Study|Withdrawal by Subject|3|||
48663222|NCT00235391|156619525|FG002|Overall Study|Withdrawal by Subject|3|||
48663223|NCT00235391|156619526|FG003|Overall Study|Withdrawal by Subject|61|||
48663224|NCT00235391|156619527|FG004|Overall Study|Withdrawal by Subject|5|||
48663225|NCT00235391|156619528|FG005|Overall Study|Withdrawal by Subject|0|||
48663226|NCT00235391|156619523|FG000|Overall Study|Lost to Follow-up|0|||
48663227|NCT00235391|156619524|FG001|Overall Study|Lost to Follow-up|3|||
48663228|NCT00235391|156619525|FG002|Overall Study|Lost to Follow-up|3|||
48663229|NCT00235391|156619526|FG003|Overall Study|Lost to Follow-up|16|||
48663230|NCT00235391|156619527|FG004|Overall Study|Lost to Follow-up|0|||
48866840|NCT02706834|157349118|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
48866841|NCT02706834|157349119|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
48866842|NCT02706834|157349120|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
48866843|NCT02706834|157349121|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
48866844|NCT02706834|157349122|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
48866845|NCT02706834|157349123|FG007|Overall Study|Pretreatment Event/Adverse Event|0|||
48866846|NCT02706834|157349124|FG008|Overall Study|Pretreatment Event/Adverse Event|0|||
48866847|NCT02706834|157349125|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
48866848|NCT02706834|157349126|FG010|Overall Study|Pretreatment Event/Adverse Event|1|||
48866849|NCT02706834|157349116|FG000|Overall Study|Lost to Follow-up|0|||
48866850|NCT02706834|157349117|FG001|Overall Study|Lost to Follow-up|0|||
48866851|NCT02706834|157349118|FG002|Overall Study|Lost to Follow-up|1|||
48866852|NCT02706834|157349119|FG003|Overall Study|Lost to Follow-up|0|||
48866853|NCT02706834|157349120|FG004|Overall Study|Lost to Follow-up|0|||
48866854|NCT02706834|157349121|FG005|Overall Study|Lost to Follow-up|0|||
48866855|NCT02706834|157349122|FG006|Overall Study|Lost to Follow-up|0|||
48866856|NCT02706834|157349123|FG007|Overall Study|Lost to Follow-up|0|||
48866857|NCT02706834|157349124|FG008|Overall Study|Lost to Follow-up|0|||
48866858|NCT02706834|157349125|FG009|Overall Study|Lost to Follow-up|0|||
48866859|NCT02706834|157349126|FG010|Overall Study|Lost to Follow-up|0|||
48866860|NCT02706834|157349116|FG000|Overall Study|Voluntary Withdrawal|1|||
48663231|NCT00235391|156619528|FG005|Overall Study|Lost to Follow-up|0|||
48663232|NCT00235391|156619523|FG000|Overall Study|Administrative problems|0|||
48663233|NCT00235391|156619524|FG001|Overall Study|Administrative problems|0|||
48866861|NCT02706834|157349117|FG001|Overall Study|Voluntary Withdrawal|0|||
48866862|NCT02706834|157349118|FG002|Overall Study|Voluntary Withdrawal|0|||
48866863|NCT02706834|157349119|FG003|Overall Study|Voluntary Withdrawal|0|||
48866864|NCT02706834|157349120|FG004|Overall Study|Voluntary Withdrawal|0|||
48866865|NCT02706834|157349121|FG005|Overall Study|Voluntary Withdrawal|0|||
48866866|NCT02706834|157349122|FG006|Overall Study|Voluntary Withdrawal|0|||
48866867|NCT02706834|157349123|FG007|Overall Study|Voluntary Withdrawal|0|||
48866868|NCT02706834|157349124|FG008|Overall Study|Voluntary Withdrawal|0|||
48866869|NCT02706834|157349125|FG009|Overall Study|Voluntary Withdrawal|1|||
48866870|NCT02706834|157349126|FG010|Overall Study|Voluntary Withdrawal|0|||
48965926|NCT00868166|157703689|FG000|Overall Study|Lost to Follow-up|1|||
48663234|NCT00235391|156619525|FG002|Overall Study|Administrative problems|0|||
48663235|NCT00235391|156619526|FG003|Overall Study|Administrative problems|1|||
48866871|NCT02706834|157349116|FG000|Overall Study|Other Reason Not Specified|1|||
48866872|NCT02706834|157349117|FG001|Overall Study|Other Reason Not Specified|0|||
48866873|NCT02706834|157349118|FG002|Overall Study|Other Reason Not Specified|0|||
48866874|NCT02706834|157349119|FG003|Overall Study|Other Reason Not Specified|0|||
48866875|NCT02706834|157349120|FG004|Overall Study|Other Reason Not Specified|1|||
48866876|NCT02706834|157349121|FG005|Overall Study|Other Reason Not Specified|0|||
48866877|NCT02706834|157349122|FG006|Overall Study|Other Reason Not Specified|0|||
48866878|NCT02706834|157349123|FG007|Overall Study|Other Reason Not Specified|0|||
48866879|NCT02706834|157349124|FG008|Overall Study|Other Reason Not Specified|0|||
48866880|NCT02706834|157349125|FG009|Overall Study|Other Reason Not Specified|0|||
48866881|NCT02706834|157349126|FG010|Overall Study|Other Reason Not Specified|0|||
48866882|NCT02815735|157349127|FG000|First Intervention (4 Weeks)|Discomfort|1|||
48866883|NCT02815735|157349128|FG001|First Intervention (4 Weeks)|Discomfort|0|||
48866884|NCT02815735|157349127|FG000|First Intervention (4 Weeks)|Lost to Follow-up|1|||
48866885|NCT02815735|157349128|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
48866886|NCT02815735|157349127|FG000|First Intervention (4 Weeks)|Poor fitting characteristics|0|||
48866887|NCT02815735|157349128|FG001|First Intervention (4 Weeks)|Poor fitting characteristics|1|||
48866888|NCT02815735|157349127|FG000|Second Intervention (4 Weeks)|Protocol Violation|1|||
48866889|NCT02815735|157349128|FG001|Second Intervention (4 Weeks)|Protocol Violation|0|||
48866890|NCT00382408|157349129|FG000|Overall Study|Did not meet protocol requirement|3|||
48866891|NCT00382408|157349130|FG001|Overall Study|Did not meet protocol requirement|3|||
48866892|NCT00382408|157349129|FG000|Overall Study|Protocol Violation|2|||
48866893|NCT00382408|157349130|FG001|Overall Study|Protocol Violation|2|||
48866894|NCT00382408|157349129|FG000|Overall Study|Physician Decision|1|||
48866895|NCT00382408|157349130|FG001|Overall Study|Physician Decision|0|||
48866896|NCT00382408|157349129|FG000|Overall Study|Withdrawal by Subject|17|||
48866897|NCT00382408|157349130|FG001|Overall Study|Withdrawal by Subject|6|||
48866898|NCT00382408|157349129|FG000|Overall Study|Pregnancy|2|||
48866899|NCT00382408|157349130|FG001|Overall Study|Pregnancy|0|||
48866900|NCT00382408|157349129|FG000|Overall Study|Lost to Follow-up|19|||
48866901|NCT00382408|157349130|FG001|Overall Study|Lost to Follow-up|8|||
48866902|NCT00382408|157349129|FG000|Overall Study|Other|100|||
48866903|NCT00382408|157349130|FG001|Overall Study|Other|35|||
48866904|NCT04385849|157349131|FG000|Overall Study|Lost to Follow-up|1|||
48866905|NCT04385849|157349132|FG001|Overall Study|Lost to Follow-up|0|||
48866906|NCT04121741|157349133|FG000|Overall Study|Protocol Violation|1|||
48866907|NCT04121741|157349134|FG001|Overall Study|Protocol Violation|0|||
48866908|NCT04121741|157349135|FG002|Overall Study|Protocol Violation|0|||
48866909|NCT04121741|157349136|FG003|Overall Study|Protocol Violation|0|||
48866910|NCT04121741|157349137|FG004|Overall Study|Protocol Violation|0|||
48866911|NCT04121741|157349138|FG005|Overall Study|Protocol Violation|0|||
48866912|NCT03853746|157349139|FG000|Overall Study|Withdrawal by Subject|1|||
48866913|NCT01572493|157349143|FG000|Overall Study|Physician Decision|1|||
48866914|NCT01572493|157349144|FG001|Overall Study|Physician Decision|0|||
48866915|NCT01572493|157349145|FG002|Overall Study|Physician Decision|0|||
48866916|NCT01572493|157349146|FG003|Overall Study|Physician Decision|0|||
48866917|NCT01572493|157349147|FG004|Overall Study|Physician Decision|0|||
48866918|NCT01572493|157349148|FG005|Overall Study|Physician Decision|0|||
48866919|NCT01572493|157349149|FG006|Overall Study|Physician Decision|0|||
48866920|NCT01572493|157349150|FG007|Overall Study|Physician Decision|0|||
48866921|NCT01572493|157349151|FG008|Overall Study|Physician Decision|0|||
48965927|NCT00868166|157703690|FG001|Overall Study|Lost to Follow-up|3|||
48866922|NCT01572493|157349143|FG000|Overall Study|Switched to alternative treatment|0|||
48866923|NCT01572493|157349144|FG001|Overall Study|Switched to alternative treatment|1|||
48866924|NCT01572493|157349145|FG002|Overall Study|Switched to alternative treatment|2|||
48866925|NCT01572493|157349146|FG003|Overall Study|Switched to alternative treatment|1|||
48866926|NCT01572493|157349147|FG004|Overall Study|Switched to alternative treatment|2|||
48866927|NCT01572493|157349148|FG005|Overall Study|Switched to alternative treatment|0|||
48866928|NCT01572493|157349149|FG006|Overall Study|Switched to alternative treatment|2|||
48866929|NCT01572493|157349150|FG007|Overall Study|Switched to alternative treatment|0|||
48866930|NCT01572493|157349151|FG008|Overall Study|Switched to alternative treatment|2|||
48866931|NCT01572493|157349143|FG000|Overall Study|Death|0|||
48866932|NCT01572493|157349144|FG001|Overall Study|Death|0|||
48866933|NCT01572493|157349145|FG002|Overall Study|Death|0|||
48866934|NCT01572493|157349146|FG003|Overall Study|Death|1|||
48866935|NCT01572493|157349147|FG004|Overall Study|Death|0|||
48866936|NCT01572493|157349148|FG005|Overall Study|Death|1|||
48866937|NCT01572493|157349149|FG006|Overall Study|Death|0|||
48866938|NCT01572493|157349150|FG007|Overall Study|Death|0|||
48866939|NCT01572493|157349151|FG008|Overall Study|Death|0|||
48866940|NCT01572493|157349143|FG000|Overall Study|Adverse Event|0|||
48866941|NCT01572493|157349144|FG001|Overall Study|Adverse Event|0|||
48866942|NCT01572493|157349145|FG002|Overall Study|Adverse Event|0|||
48866943|NCT01572493|157349146|FG003|Overall Study|Adverse Event|0|||
48866944|NCT01572493|157349147|FG004|Overall Study|Adverse Event|0|||
48866945|NCT01572493|157349148|FG005|Overall Study|Adverse Event|0|||
48663236|NCT00235391|156619527|FG004|Overall Study|Administrative problems|0|||
48663237|NCT00235391|156619528|FG005|Overall Study|Administrative problems|0|||
48663238|NCT00235391|156619523|FG000|Overall Study|Death|0|||
48663239|NCT00235391|156619524|FG001|Overall Study|Death|0|||
48663240|NCT00235391|156619525|FG002|Overall Study|Death|1|||
48663241|NCT00235391|156619526|FG003|Overall Study|Death|4|||
48663242|NCT00235391|156619527|FG004|Overall Study|Death|0|||
48663243|NCT00235391|156619528|FG005|Overall Study|Death|0|||
48663244|NCT02098369|156619529|FG000|Overall Study|Withdrawal by Subject|1|||
48663245|NCT02098369|156619530|FG001|Overall Study|Withdrawal by Subject|5|||
48663246|NCT02098369|156619531|FG002|Overall Study|Withdrawal by Subject|0|||
48663247|NCT02098369|156619529|FG000|Overall Study|Lost to Follow-up|5|||
48663248|NCT02098369|156619530|FG001|Overall Study|Lost to Follow-up|1|||
48663249|NCT02098369|156619531|FG002|Overall Study|Lost to Follow-up|3|||
48663250|NCT02098369|156619529|FG000|Overall Study|Death|1|||
48663251|NCT02098369|156619530|FG001|Overall Study|Death|1|||
48663252|NCT02098369|156619531|FG002|Overall Study|Death|1|||
48663253|NCT02098369|156619529|FG000|Overall Study|Other|0|||
48663254|NCT02098369|156619530|FG001|Overall Study|Other|2|||
48663255|NCT02098369|156619531|FG002|Overall Study|Other|1|||
48663256|NCT03276052|156619533|FG000|Overall Study|Withdrawal by Subject|5|||
48663257|NCT03276052|156619533|FG000|Overall Study|Screening failure (non-fulfilment of inclusion/exclusion criteria)|18|||
48663258|NCT03784846|156619534|FG000|Pre-COVID Study|Lost to Follow-up|3|||
48663259|NCT03784846|156619535|FG001|Pre-COVID Study|Lost to Follow-up|3|||
48663260|NCT03784846|156619536|FG002|Pre-COVID Study|Lost to Follow-up|2|||
48663261|NCT03784846|156619534|FG000|Pre-COVID Study|Withdrawal by Subject|1|||
48663262|NCT03784846|156619535|FG001|Pre-COVID Study|Withdrawal by Subject|2|||
48663263|NCT03784846|156619536|FG002|Pre-COVID Study|Withdrawal by Subject|1|||
48663264|NCT03784846|156619534|FG000|Pre-COVID Study|Discontinued by Researchers|7|||
48663265|NCT03784846|156619535|FG001|Pre-COVID Study|Discontinued by Researchers|6|||
48663266|NCT03784846|156619536|FG002|Pre-COVID Study|Discontinued by Researchers|2|||
48663267|NCT03784846|156619534|FG000|Post-COVID Study|Lost to Follow-up|3|||
48663268|NCT03784846|156619535|FG001|Post-COVID Study|Lost to Follow-up|5|||
48663269|NCT03784846|156619536|FG002|Post-COVID Study|Lost to Follow-up|1|||
48663270|NCT03784846|156619534|FG000|Post-COVID Study|Withdrawal by Subject|1|||
48663271|NCT03784846|156619535|FG001|Post-COVID Study|Withdrawal by Subject|2|||
48663272|NCT03784846|156619536|FG002|Post-COVID Study|Withdrawal by Subject|0|||
48663273|NCT00554619|156619537|FG000|Overall Study|Adverse Event|1|||
48663274|NCT00554619|156619537|FG000|Overall Study|Physician Decision|1|||
48663275|NCT00554619|156619537|FG000|Overall Study|Liver Function Test Abnormality|1|||
48663276|NCT04224272|156619538|FG000|Part 1 - Dose Finding|Death|4|||
48663277|NCT04224272|156619538|FG000|Part 1 - Dose Finding|Withdrawal by Subject|2|||
48663278|NCT04224272|156619538|FG000|Part 1 - Dose Finding|Lost to Follow-up|1|||
48663279|NCT04224272|156619538|FG000|Part 2 - Dose Expansion|Death|10|||
48663280|NCT04224272|156619538|FG000|Part 2 - Dose Expansion|Withdrawal by Subject|3|||
48663281|NCT03242772|156619539|FG000|Overall Study|Lost to Follow-up|2|||
48663282|NCT03242772|156619540|FG001|Overall Study|Lost to Follow-up|0|||
48663283|NCT03242772|156619539|FG000|Overall Study|Physician Decision|0|||
48663284|NCT03242772|156619540|FG001|Overall Study|Physician Decision|1|||
48663285|NCT03242772|156619539|FG000|Overall Study|Withdrawal by Subject|1|||
48663286|NCT03242772|156619540|FG001|Overall Study|Withdrawal by Subject|0|||
48663287|NCT04677660|156619543|FG000|Overall Study|Lost to Follow-up|0|||
48663288|NCT04677660|156619544|FG001|Overall Study|Lost to Follow-up|2|||
48663289|NCT04677660|156619543|FG000|Overall Study|Withdrawal by Subject|0|||
48663290|NCT04677660|156619544|FG001|Overall Study|Withdrawal by Subject|1|||
48663291|NCT04677660|156619543|FG000|Overall Study|Chose Publicly Available Vaccine|43|||
48663292|NCT04677660|156619544|FG001|Overall Study|Chose Publicly Available Vaccine|10|||
48756400|NCT00732615|156954347|FG001|Overall Study|Physician Decision|0|||
48756401|NCT00732615|156954346|FG000|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
48756402|NCT00732615|156954347|FG001|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
48756403|NCT03566823|156954348|FG000|Overall Study|Lack of Efficacy|0|||
48756404|NCT03566823|156954349|FG001|Overall Study|Lack of Efficacy|1|||
48756405|NCT03566823|156954350|FG002|Overall Study|Lack of Efficacy|0|||
48756406|NCT03566823|156954348|FG000|Overall Study|Withdrawal by Subject|1|||
48866946|NCT01572493|157349149|FG006|Overall Study|Adverse Event|1|||
48663293|NCT03060512|156619545|FG000|Overall Study|Adverse Event|4|||
48663294|NCT03060512|156619546|FG001|Overall Study|Adverse Event|6|||
48663295|NCT03060512|156619545|FG000|Overall Study|Lost to Follow-up|1|||
48663296|NCT03060512|156619546|FG001|Overall Study|Lost to Follow-up|1|||
48663297|NCT03060512|156619545|FG000|Overall Study|Withdrawal by Subject|1|||
48663298|NCT03060512|156619546|FG001|Overall Study|Withdrawal by Subject|0|||
48663299|NCT03060512|156619545|FG000|Overall Study|Non-compliance with study medication|1|||
48663300|NCT03060512|156619546|FG001|Overall Study|Non-compliance with study medication|2|||
48663301|NCT02785458|156619547|FG000|1 Month|Withdrawal by Subject|2|||
48663302|NCT02785458|156619548|FG001|1 Month|Withdrawal by Subject|1|||
48866947|NCT01572493|157349150|FG007|Overall Study|Adverse Event|0|||
48866948|NCT01572493|157349151|FG008|Overall Study|Adverse Event|0|||
48663303|NCT02785458|156619547|FG000|1 Month|Lost to Follow-up|38|||
48663304|NCT02785458|156619548|FG001|1 Month|Lost to Follow-up|31|||
48663305|NCT02785458|156619547|FG000|1 Month|Deemed Ineligible|1|||
48663306|NCT02785458|156619548|FG001|1 Month|Deemed Ineligible|0|||
48663307|NCT02785458|156619547|FG000|1 Month|Completed Evaluation by Baseline|42|||
48663308|NCT02785458|156619548|FG001|1 Month|Completed Evaluation by Baseline|39|||
48663309|NCT02785458|156619547|FG000|1 Month|Partial Interview|0|||
48663310|NCT02785458|156619548|FG001|1 Month|Partial Interview|4|||
48663311|NCT02785458|156619547|FG000|3 Months|Withdrawal by Subject|3|||
48663312|NCT02785458|156619548|FG001|3 Months|Withdrawal by Subject|1|||
48663313|NCT02785458|156619547|FG000|3 Months|Lost to Follow-up|25|||
48663314|NCT02785458|156619548|FG001|3 Months|Lost to Follow-up|21|||
48663315|NCT02785458|156619547|FG000|3 Months|Completed Evaluation at 1 Month|100|||
48663316|NCT02785458|156619548|FG001|3 Months|Completed Evaluation at 1 Month|89|||
48663317|NCT00089986|156619549|FG000|Overall Study|Adverse Event|6|||
48756407|NCT03566823|156954349|FG001|Overall Study|Withdrawal by Subject|2|||
48756408|NCT03566823|156954350|FG002|Overall Study|Withdrawal by Subject|0|||
48756409|NCT03566823|156954348|FG000|Overall Study|Adverse Event|1|||
48756410|NCT03566823|156954349|FG001|Overall Study|Adverse Event|0|||
48756411|NCT03566823|156954350|FG002|Overall Study|Adverse Event|2|||
48756412|NCT01528254|156954351|FG000|Overall Study|Administrative problems|96|||
48756413|NCT01528254|156954352|FG001|Overall Study|Administrative problems|94|||
48756414|NCT01528254|156954351|FG000|Overall Study|Adverse Event|28|||
48756415|NCT01528254|156954352|FG001|Overall Study|Adverse Event|44|||
48756416|NCT01528254|156954351|FG000|Overall Study|Lost to Follow-up|17|||
48663318|NCT00089986|156619550|FG001|Overall Study|Adverse Event|9|||
48663319|NCT00089986|156619551|FG002|Overall Study|Adverse Event|6|||
48663320|NCT00089986|156619549|FG000|Overall Study|Lost to Follow-up|3|||
48663321|NCT00089986|156619550|FG001|Overall Study|Lost to Follow-up|1|||
48756417|NCT01528254|156954352|FG001|Overall Study|Lost to Follow-up|24|||
48756418|NCT01528254|156954351|FG000|Overall Study|Death|13|||
48756419|NCT01528254|156954352|FG001|Overall Study|Death|9|||
48756420|NCT01528254|156954351|FG000|Overall Study|Protocol deviation|9|||
48756421|NCT01528254|156954352|FG001|Overall Study|Protocol deviation|19|||
48756422|NCT01528254|156954351|FG000|Overall Study|New therapy for study indication|8|||
48756423|NCT01528254|156954352|FG001|Overall Study|New therapy for study indication|6|||
48756424|NCT01528254|156954351|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
48756425|NCT01528254|156954352|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
48756426|NCT01528254|156954351|FG000|Overall Study|Withdrawal by Subject|5|||
48756427|NCT01528254|156954352|FG001|Overall Study|Withdrawal by Subject|4|||
48756428|NCT01528254|156954351|FG000|Overall Study|Abnormal laboratory value(s)|3|||
48756429|NCT01528254|156954352|FG001|Overall Study|Abnormal laboratory value(s)|7|||
48756430|NCT01528254|156954351|FG000|Overall Study|Abnormal test procedure result(s)|1|||
48756431|NCT01528254|156954352|FG001|Overall Study|Abnormal test procedure result(s)|0|||
48756432|NCT01528254|156954351|FG000|Overall Study|No longer requires study drug|1|||
48756433|NCT01528254|156954352|FG001|Overall Study|No longer requires study drug|1|||
48756434|NCT00748033|156954353|FG000|Overall Study|Adverse Event|0|||
48756435|NCT00748033|156954354|FG001|Overall Study|Adverse Event|1|||
48756436|NCT01344161|156954355|FG000|Overall Study|Lost to Follow-up|4|||
48663322|NCT00089986|156619551|FG002|Overall Study|Lost to Follow-up|1|||
48663323|NCT00089986|156619549|FG000|Overall Study|Protocol Violation|0|||
48663324|NCT00089986|156619550|FG001|Overall Study|Protocol Violation|1|||
48756437|NCT01344161|156954356|FG001|Overall Study|Lost to Follow-up|1|||
48756438|NCT01344161|156954355|FG000|Overall Study|Pregnancy|0|||
48756439|NCT01344161|156954356|FG001|Overall Study|Pregnancy|1|||
48756440|NCT01344161|156954355|FG000|Overall Study|Protocol Violation|1|||
48756441|NCT01344161|156954356|FG001|Overall Study|Protocol Violation|1|||
48756442|NCT02496533|156954357|FG000|Overall Study|Lack of data on outcome|3|||
48756443|NCT02496533|156954358|FG001|Overall Study|Lack of data on outcome|0|||
48756444|NCT02496533|156954357|FG000|Overall Study|Patient did not complete all measures|0|||
48756445|NCT02496533|156954358|FG001|Overall Study|Patient did not complete all measures|4|||
48756446|NCT02496533|156954357|FG000|Overall Study|Late for radiologic testing|0|||
48756447|NCT02496533|156954358|FG001|Overall Study|Late for radiologic testing|2|||
48756448|NCT03021265|156954359|FG000|Overall Study|Adverse Event|29|||
48756449|NCT03021265|156954359|FG000|Overall Study|Lack of Efficacy|3|||
48756450|NCT03021265|156954359|FG000|Overall Study|Improved|17|||
48756451|NCT03021265|156954359|FG000|Overall Study|Lost to Follow-up|67|||
48756452|NCT03021265|156954359|FG000|Overall Study|No reason given|2|||
48663325|NCT00089986|156619551|FG002|Overall Study|Protocol Violation|0|||
48756453|NCT03021265|156954359|FG000|Overall Study|No visit since the first visit|4|||
48756454|NCT02484729|156954360|FG000|Overall Study|Failure of IntelliCap Error|0|||
48756455|NCT02484729|156954361|FG001|Overall Study|Failure of IntelliCap Error|0|||
48756456|NCT02484729|156954362|FG002|Overall Study|Failure of IntelliCap Error|0|||
48756457|NCT02484729|156954363|FG003|Overall Study|Failure of IntelliCap Error|0|||
48756458|NCT02484729|156954364|FG004|Overall Study|Failure of IntelliCap Error|0|||
48663326|NCT00089986|156619549|FG000|Overall Study|Patient transferred to another hospital|2|||
48663327|NCT00089986|156619550|FG001|Overall Study|Patient transferred to another hospital|1|||
48663328|NCT00089986|156619551|FG002|Overall Study|Patient transferred to another hospital|0|||
48756459|NCT02484729|156954365|FG005|Overall Study|Failure of IntelliCap Error|0|||
48756460|NCT02484729|156954366|FG006|Overall Study|Failure of IntelliCap Error|0|||
48756461|NCT02484729|156954367|FG007|Overall Study|Failure of IntelliCap Error|0|||
48756462|NCT02484729|156954368|FG008|Overall Study|Failure of IntelliCap Error|0|||
48756463|NCT02484729|156954369|FG009|Overall Study|Failure of IntelliCap Error|1|||
48756464|NCT02738450|156954370|FG000|Overall Study|Withdrawal by Subject|0|||
48756465|NCT02738450|156954371|FG001|Overall Study|Withdrawal by Subject|2|||
48756466|NCT02738450|156954372|FG002|Overall Study|Withdrawal by Subject|0|||
48756467|NCT02626520|156954374|FG000|Overall Study|Physician Decision|1|||
48756468|NCT02626520|156954375|FG001|Overall Study|Physician Decision|1|||
48756469|NCT02626520|156954374|FG000|Overall Study|Adverse Event|0|||
48756470|NCT02626520|156954375|FG001|Overall Study|Adverse Event|4|||
48756471|NCT02626520|156954374|FG000|Overall Study|Lack of Efficacy|0|||
48756472|NCT02626520|156954375|FG001|Overall Study|Lack of Efficacy|2|||
48756473|NCT02626520|156954374|FG000|Overall Study|Did not start protocol therapy|0|||
48756474|NCT02626520|156954375|FG001|Overall Study|Did not start protocol therapy|2|||
48756475|NCT02626520|156954374|FG000|Overall Study|Study terminated|0|||
48756476|NCT02626520|156954375|FG001|Overall Study|Study terminated|1|||
48756477|NCT01082965|156954376|FG000|Overall Study|Protocol Violation|0|||
48756478|NCT01082965|156954377|FG001|Overall Study|Protocol Violation|1|||
48756479|NCT01082965|156954376|FG000|Overall Study|Other|1|||
48756480|NCT01082965|156954377|FG001|Overall Study|Other|1|||
48756481|NCT04350788|156954385|FG000|Overall Study|Lost to Follow-up|6|||
48756482|NCT04350788|156954386|FG001|Overall Study|Lost to Follow-up|2|||
48866949|NCT01631825|157349152|FG000|Overall Study|Adverse Event|42|||
48866950|NCT01631825|157349152|FG000|Overall Study|Lack of Efficacy|7|||
48866951|NCT01631825|157349152|FG000|Overall Study|Withdrawal by Subject|9|||
48866952|NCT01631825|157349152|FG000|Overall Study|Protocol Violation|4|||
48866953|NCT01631825|157349152|FG000|Overall Study|Discontinuation criteria|1|||
48866954|NCT01631825|157349152|FG000|Overall Study|Physician Decision|2|||
48866955|NCT02110225|157349153|FG000|Overall Study|Lost to Follow-up|0|||
48866956|NCT02110225|157349154|FG001|Overall Study|Lost to Follow-up|1|||
48866957|NCT02110225|157349155|FG002|Overall Study|Lost to Follow-up|0|||
48866958|NCT02176018|157349156|FG000|Overall Study|Adverse Event|0|||
48663329|NCT00089986|156619549|FG000|Overall Study|Subject withdrew but agreed follow up|1|||
48663330|NCT00089986|156619550|FG001|Overall Study|Subject withdrew but agreed follow up|2|||
48663331|NCT00089986|156619551|FG002|Overall Study|Subject withdrew but agreed follow up|0|||
48663332|NCT00089986|156619549|FG000|Overall Study|Hemohlobin stopping rule|0|||
48663333|NCT00089986|156619550|FG001|Overall Study|Hemohlobin stopping rule|1|||
48663334|NCT00089986|156619551|FG002|Overall Study|Hemohlobin stopping rule|0|||
48663335|NCT00089986|156619549|FG000|Overall Study|Investigator decision to withdrew|0|||
48663336|NCT00089986|156619550|FG001|Overall Study|Investigator decision to withdrew|1|||
48663337|NCT00089986|156619551|FG002|Overall Study|Investigator decision to withdrew|0|||
48663338|NCT00089986|156619549|FG000|Overall Study|Enrollment in another study|0|||
48663339|NCT00089986|156619550|FG001|Overall Study|Enrollment in another study|1|||
48663340|NCT00089986|156619551|FG002|Overall Study|Enrollment in another study|0|||
48663341|NCT00089986|156619549|FG000|Overall Study|Family decision|0|||
48663342|NCT00089986|156619550|FG001|Overall Study|Family decision|1|||
48663343|NCT00089986|156619551|FG002|Overall Study|Family decision|0|||
48663344|NCT00089986|156619549|FG000|Overall Study|Do not resuscitate (DNR)|0|||
48663345|NCT00089986|156619550|FG001|Overall Study|Do not resuscitate (DNR)|0|||
48663346|NCT00089986|156619551|FG002|Overall Study|Do not resuscitate (DNR)|1|||
48663347|NCT00089986|156619549|FG000|Overall Study|Withdrawal by Subject|3|||
48663348|NCT00089986|156619550|FG001|Overall Study|Withdrawal by Subject|6|||
48663349|NCT00089986|156619551|FG002|Overall Study|Withdrawal by Subject|2|||
48663350|NCT02825420|156619552|FG000|Overall Study|Death|30|||
48663351|NCT02825420|156619553|FG001|Overall Study|Death|12|||
48663352|NCT02825420|156619552|FG000|Overall Study|Progressive disease|6|||
48663353|NCT02825420|156619553|FG001|Overall Study|Progressive disease|1|||
48663354|NCT02825420|156619552|FG000|Overall Study|Lost to Follow-up|2|||
48663355|NCT02825420|156619553|FG001|Overall Study|Lost to Follow-up|2|||
48663356|NCT02825420|156619552|FG000|Overall Study|Withdrawal by Subject|1|||
48756483|NCT04350788|156954385|FG000|Overall Study|Withdrawal by Subject|2|||
48756484|NCT04350788|156954386|FG001|Overall Study|Withdrawal by Subject|4|||
48756485|NCT04350788|156954385|FG000|Overall Study|Protocol Violation|4|||
48756486|NCT04350788|156954386|FG001|Overall Study|Protocol Violation|0|||
48866959|NCT02176018|157349157|FG001|Overall Study|Adverse Event|2|||
48663357|NCT02825420|156619553|FG001|Overall Study|Withdrawal by Subject|1|||
48663358|NCT02825420|156619552|FG000|Overall Study|Protocol amendment not signed|1|||
48663359|NCT02825420|156619553|FG001|Overall Study|Protocol amendment not signed|1|||
48663360|NCT02825420|156619552|FG000|Overall Study|Physician Decision|1|||
48663361|NCT02825420|156619553|FG001|Overall Study|Physician Decision|0|||
48663362|NCT02825420|156619552|FG000|Overall Study|Did not receive PLD|2|||
48756487|NCT00524368|156956111|FG000|Overall Study|Adverse Event|10|||
48756488|NCT00524368|156956112|FG001|Overall Study|Adverse Event|12|||
48756489|NCT00524368|156956111|FG000|Overall Study|Lost to Follow-up|9|||
48756490|NCT00524368|156956112|FG001|Overall Study|Lost to Follow-up|13|||
48866960|NCT02176018|157349156|FG000|Overall Study|Lost to Follow-up|3|||
48663363|NCT02825420|156619553|FG001|Overall Study|Did not receive PLD|0|||
48663364|NCT00413920|156619554|FG000|Overall Study|Adverse Event|9|||
48663365|NCT00413920|156619555|FG001|Overall Study|Adverse Event|11|||
48663366|NCT00413920|156619554|FG000|Overall Study|Lack of Efficacy|11|||
48663367|NCT00413920|156619555|FG001|Overall Study|Lack of Efficacy|9|||
48663368|NCT00413920|156619554|FG000|Overall Study|Death|3|||
48663369|NCT00413920|156619555|FG001|Overall Study|Death|5|||
48663370|NCT00413920|156619554|FG000|Overall Study|Graft Loss|5|||
48663371|NCT00413920|156619555|FG001|Overall Study|Graft Loss|3|||
48663372|NCT02434354|156619556|FG000|Overall Study|screen fail|3|||
48663373|NCT01185964|156619557|FG000|Phase 1b and Phase 2|Withdrawal by Subject|1|||
48663374|NCT01185964|156619558|FG001|Phase 1b and Phase 2|Withdrawal by Subject|6|||
48663375|NCT01185964|156619559|FG002|Phase 1b and Phase 2|Withdrawal by Subject|2|||
48663376|NCT01185964|156619560|FG003|Phase 1b and Phase 2|Withdrawal by Subject|0|||
48663377|NCT01185964|156619557|FG000|Phase 1b and Phase 2|Other Therapy Started|0|||
48663378|NCT01185964|156619558|FG001|Phase 1b and Phase 2|Other Therapy Started|3|||
48756491|NCT00524368|156956111|FG000|Overall Study|Withdrawal by Subject|4|||
48756492|NCT00524368|156956112|FG001|Overall Study|Withdrawal by Subject|5|||
48663379|NCT01185964|156619559|FG002|Phase 1b and Phase 2|Other Therapy Started|3|||
48663380|NCT01185964|156619560|FG003|Phase 1b and Phase 2|Other Therapy Started|0|||
48663381|NCT01185964|156619557|FG000|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
48663382|NCT01185964|156619558|FG001|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
48663383|NCT01185964|156619559|FG002|Phase 1b and Phase 2|Participant was beyond maximum weight|1|||
48663384|NCT01185964|156619560|FG003|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
48663385|NCT01185964|156619557|FG000|Phase 1b and Phase 2|Adverse Event|1|||
48663386|NCT01185964|156619558|FG001|Phase 1b and Phase 2|Adverse Event|0|||
48663387|NCT01185964|156619559|FG002|Phase 1b and Phase 2|Adverse Event|2|||
48663388|NCT01185964|156619560|FG003|Phase 1b and Phase 2|Adverse Event|0|||
48756493|NCT00524368|156956111|FG000|Overall Study|Non-compliant|8|||
48756494|NCT00524368|156956112|FG001|Overall Study|Non-compliant|9|||
48663389|NCT01185964|156619557|FG000|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
48663390|NCT01185964|156619558|FG001|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
48663391|NCT01185964|156619559|FG002|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
48663392|NCT01185964|156619560|FG003|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
48663393|NCT01185964|156619557|FG000|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
48663394|NCT01185964|156619558|FG001|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
48663395|NCT01185964|156619559|FG002|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
48663396|NCT01185964|156619560|FG003|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2|||
48663397|NCT01185964|156619557|FG000|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
48663398|NCT01185964|156619558|FG001|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
48663399|NCT01185964|156619559|FG002|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
48663400|NCT01185964|156619560|FG003|Optional Olaratumab Monotherapy on Dox|Adverse Event|1|||
48663401|NCT01185964|156619557|FG000|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
48663402|NCT01185964|156619558|FG001|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
48663403|NCT01185964|156619559|FG002|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
48663404|NCT01185964|156619560|FG003|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2|||
48663405|NCT01852825|156619561|FG000|Overall Study|Withdrawal by Subject|2|||
48663406|NCT01852825|156619562|FG001|Overall Study|Withdrawal by Subject|0|||
48663407|NCT01852825|156619563|FG002|Overall Study|Withdrawal by Subject|0|||
48663408|NCT03351114|156619573|FG000|Overall Study|Withdrawal by Subject|1|||
48663409|NCT01479595|156619585|FG000|Overall Study|Protocol deviation|0|||
48663410|NCT01479595|156619586|FG001|Overall Study|Protocol deviation|1|||
48663411|NCT01479595|156619585|FG000|Overall Study|Adverse Event|2|||
48663412|NCT01479595|156619586|FG001|Overall Study|Adverse Event|1|||
48663413|NCT01628367|156619587|FG000|Overall Study|Adverse Event|1|||
48663414|NCT01628367|156619588|FG001|Overall Study|Adverse Event|0|||
48663415|NCT02726880|156619593|FG000|Overall Study|Withdrawal by Subject|2|||
48756495|NCT00524368|156956111|FG000|Overall Study|Reached a Virologic Endpoint|3|||
48756496|NCT00524368|156956112|FG001|Overall Study|Reached a Virologic Endpoint|2|||
48756497|NCT00524368|156956111|FG000|Overall Study|Sponsor's Decision|2|||
48663416|NCT02726880|156619594|FG001|Overall Study|Withdrawal by Subject|0|||
48663417|NCT02726880|156619593|FG000|Overall Study|Lost to Follow-up|1|||
48663418|NCT02726880|156619594|FG001|Overall Study|Lost to Follow-up|3|||
48663419|NCT00966719|156619595|FG000|Overall Study|Lost to Follow-up|6|||
48663420|NCT00966719|156619596|FG001|Overall Study|Lost to Follow-up|11|||
48663421|NCT02741570|156619599|FG000|Pre-Treatment Period|Other reasons|0|||
48663422|NCT02741570|156619600|FG001|Pre-Treatment Period|Other reasons|3|||
48663423|NCT02741570|156619599|FG000|Pre-Treatment Period|Participant no longer meets study criteria|3|||
48663424|NCT02741570|156619600|FG001|Pre-Treatment Period|Participant no longer meets study criteria|6|||
48663425|NCT02741570|156619599|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
48663426|NCT02741570|156619600|FG001|Pre-Treatment Period|Poor/non-compliance|1|||
48663427|NCT02741570|156619599|FG000|Pre-Treatment Period|Lost to Follow-up|0|||
48756498|NCT00524368|156956112|FG001|Overall Study|Sponsor's Decision|0|||
48965928|NCT00868166|157703689|FG000|Overall Study|Adverse Event|9|||
48965929|NCT00868166|157703690|FG001|Overall Study|Adverse Event|10|||
48965930|NCT00868166|157703689|FG000|Overall Study|Lack of efficacy, logistics, unwell|9|||
48965931|NCT00868166|157703690|FG001|Overall Study|Lack of efficacy, logistics, unwell|10|||
48965932|NCT00868166|157703689|FG000|Overall Study|Non-compliance with IMP|1|||
48965933|NCT00868166|157703690|FG001|Overall Study|Non-compliance with IMP|1|||
48965934|NCT01588353|157703691|FG000|Step2|Withdrawal by Subject|0|||
48965935|NCT01588353|157703692|FG001|Step2|Withdrawal by Subject|1|||
48965936|NCT01588353|157703693|FG002|Step2|Withdrawal by Subject|0|||
48965937|NCT01588353|157703691|FG000|Step3|Adverse Event|0|||
48965938|NCT01588353|157703692|FG001|Step3|Adverse Event|0|||
48965939|NCT01588353|157703693|FG002|Step3|Adverse Event|2|||
48965940|NCT00634114|157703698|FG000|Overall Study|Adverse Event|6|||
48965941|NCT00634114|157703699|FG001|Overall Study|Adverse Event|8|||
48965942|NCT00634114|157703700|FG002|Overall Study|Adverse Event|3|||
48965943|NCT00634114|157703698|FG000|Overall Study|Withdrawal by Subject|9|||
48965944|NCT00634114|157703699|FG001|Overall Study|Withdrawal by Subject|6|||
48663428|NCT02741570|156619600|FG001|Pre-Treatment Period|Lost to Follow-up|2|||
48663429|NCT02741570|156619599|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
48663430|NCT02741570|156619600|FG001|Pre-Treatment Period|Participant withdrew consent|18|||
48663431|NCT02741570|156619599|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
48663432|NCT02741570|156619600|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|2|||
48663433|NCT02741570|156619599|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
48663434|NCT02741570|156619600|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
48663435|NCT02741570|156619599|FG000|Pre-Treatment Period|Death|0|||
48663436|NCT02741570|156619600|FG001|Pre-Treatment Period|Death|1|||
48663437|NCT02741570|156619599|FG000|Pre-Treatment Period|Disease progression|0|||
48663438|NCT02741570|156619600|FG001|Pre-Treatment Period|Disease progression|1|||
48663439|NCT02741570|156619599|FG000|Treatment Period|Other reasons|47|||
48663440|NCT02741570|156619600|FG001|Treatment Period|Other reasons|12|||
48663441|NCT02741570|156619599|FG000|Treatment Period|Poor/non-compliance|0|||
48663442|NCT02741570|156619600|FG001|Treatment Period|Poor/non-compliance|2|||
48663443|NCT02741570|156619599|FG000|Treatment Period|Maximum clinical benefit|4|||
48663444|NCT02741570|156619600|FG001|Treatment Period|Maximum clinical benefit|6|||
48663445|NCT02741570|156619599|FG000|Treatment Period|Lost to Follow-up|1|||
48663446|NCT02741570|156619600|FG001|Treatment Period|Lost to Follow-up|3|||
48663447|NCT02741570|156619599|FG000|Treatment Period|Participant withdrew consent|9|||
48663448|NCT02741570|156619600|FG001|Treatment Period|Participant withdrew consent|13|||
48663449|NCT02741570|156619599|FG000|Treatment Period|Participant request to discontinue treatment|8|||
48663450|NCT02741570|156619600|FG001|Treatment Period|Participant request to discontinue treatment|23|||
48663451|NCT02741570|156619599|FG000|Treatment Period|Adverse event unrelated to study drug|41|||
48663452|NCT02741570|156619600|FG001|Treatment Period|Adverse event unrelated to study drug|26|||
48663453|NCT02741570|156619599|FG000|Treatment Period|Death|9|||
48663454|NCT02741570|156619600|FG001|Treatment Period|Death|7|||
48663455|NCT02741570|156619599|FG000|Treatment Period|Study drug toxicity|55|||
48663456|NCT02741570|156619600|FG001|Treatment Period|Study drug toxicity|47|||
48663457|NCT02741570|156619599|FG000|Treatment Period|Disease progression|294|||
48663458|NCT02741570|156619600|FG001|Treatment Period|Disease progression|301|||
48663459|NCT02741570|156619599|FG000|Treatment Period|Administrative reason by sponsor|0|||
48663460|NCT02741570|156619600|FG001|Treatment Period|Administrative reason by sponsor|1|||
48663461|NCT02581930|156619602|FG000|Overall Study|Withdrawal by Subject|1|||
48663462|NCT02581930|156619602|FG000|Overall Study|patient declined further treatment|1|||
48663463|NCT01822535|156619604|FG000|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2|||
48663464|NCT01822535|156619605|FG001|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0|||
48663465|NCT01822535|156619604|FG000|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4|||
48663466|NCT01822535|156619605|FG001|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2|||
48663467|NCT01822535|156619604|FG000|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1|||
48663468|NCT01822535|156619605|FG001|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0|||
48965945|NCT00634114|157703700|FG002|Overall Study|Withdrawal by Subject|11|||
48965946|NCT00634114|157703698|FG000|Overall Study|Lost to Follow-up|0|||
48965947|NCT00634114|157703699|FG001|Overall Study|Lost to Follow-up|0|||
48965948|NCT00634114|157703700|FG002|Overall Study|Lost to Follow-up|1|||
49015454|NCT01393990|157893786|FG016|Overall Study|Adverse Event|0|||
48663469|NCT02278614|156619606|FG000|Overall Study|Withdrawal by Subject|3|||
48663470|NCT02278614|156619607|FG001|Overall Study|Withdrawal by Subject|5|||
48663471|NCT02278614|156619606|FG000|Overall Study|Adverse Event|1|||
48663472|NCT02278614|156619607|FG001|Overall Study|Adverse Event|0|||
48663473|NCT02278614|156619606|FG000|Overall Study|left eye was not eligible|1|||
48663474|NCT02278614|156619607|FG001|Overall Study|left eye was not eligible|0|||
48663475|NCT04384107|156619608|FG000|Overall Study|Withdrawal By Parent/Guardian|8|||
48663476|NCT04384107|156619609|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
48756499|NCT00524368|156956111|FG000|Overall Study|Ineligible to Continue the study|2|||
48965949|NCT00634114|157703698|FG000|Overall Study|Protocol Violation|3|||
48965950|NCT00634114|157703699|FG001|Overall Study|Protocol Violation|3|||
48663477|NCT04384107|156619608|FG000|Overall Study|Lost to Follow-up|1|||
48663478|NCT04384107|156619609|FG001|Overall Study|Lost to Follow-up|0|||
48663479|NCT00525824|156619610|FG000|Overall Study|Adverse Event|7|||
48663480|NCT00525824|156619611|FG001|Overall Study|Adverse Event|11|||
48663481|NCT00525824|156619612|FG002|Overall Study|Adverse Event|6|||
48663482|NCT00525824|156619613|FG003|Overall Study|Adverse Event|7|||
48663483|NCT00525824|156619610|FG000|Overall Study|Withdrawal by Subject|5|||
48663484|NCT00525824|156619611|FG001|Overall Study|Withdrawal by Subject|9|||
48663485|NCT00525824|156619612|FG002|Overall Study|Withdrawal by Subject|3|||
48663486|NCT00525824|156619613|FG003|Overall Study|Withdrawal by Subject|4|||
48663487|NCT00525824|156619610|FG000|Overall Study|Lost to Follow-up|4|||
48663488|NCT00525824|156619611|FG001|Overall Study|Lost to Follow-up|2|||
48663489|NCT00525824|156619612|FG002|Overall Study|Lost to Follow-up|4|||
48663490|NCT00525824|156619613|FG003|Overall Study|Lost to Follow-up|0|||
48663491|NCT00525824|156619610|FG000|Overall Study|Incorrect enrolment/mis-randomisation|1|||
48663492|NCT00525824|156619611|FG001|Overall Study|Incorrect enrolment/mis-randomisation|2|||
48663493|NCT00525824|156619612|FG002|Overall Study|Incorrect enrolment/mis-randomisation|1|||
48663494|NCT00525824|156619613|FG003|Overall Study|Incorrect enrolment/mis-randomisation|2|||
48663495|NCT00525824|156619610|FG000|Overall Study|Severe non-compliance|0|||
48663496|NCT00525824|156619611|FG001|Overall Study|Severe non-compliance|1|||
48663497|NCT00525824|156619612|FG002|Overall Study|Severe non-compliance|1|||
48663498|NCT00525824|156619613|FG003|Overall Study|Severe non-compliance|1|||
48663499|NCT00525824|156619610|FG000|Overall Study|Safety reasons|1|||
48663500|NCT00525824|156619611|FG001|Overall Study|Safety reasons|0|||
48663501|NCT00525824|156619612|FG002|Overall Study|Safety reasons|1|||
48663502|NCT00525824|156619613|FG003|Overall Study|Safety reasons|0|||
48663503|NCT00525824|156619610|FG000|Overall Study|Other|1|||
48663504|NCT00525824|156619611|FG001|Overall Study|Other|3|||
48663505|NCT00525824|156619612|FG002|Overall Study|Other|3|||
48663506|NCT00525824|156619613|FG003|Overall Study|Other|1|||
48663507|NCT02366767|156619616|FG000|Overall Study|left for home after 1 day at camp|1|||
48663508|NCT02366767|156619617|FG001|Overall Study|left for home after 1 day at camp|0|||
48663509|NCT05599451|156621213|FG000|Overall Study|Not randomized|11|||
48663510|NCT05599451|156621214|FG001|Overall Study|Not randomized|0|||
48663511|NCT05599451|156621215|FG002|Overall Study|Not randomized|0|||
48663512|NCT05599451|156621216|FG003|Overall Study|Not randomized|0|||
48663513|NCT05599451|156621217|FG004|Overall Study|Not randomized|0|||
48663514|NCT05599451|156621213|FG000|Overall Study|Physician Decision|0|||
48663515|NCT05599451|156621214|FG001|Overall Study|Physician Decision|0|||
48663516|NCT05599451|156621215|FG002|Overall Study|Physician Decision|0|||
48663517|NCT05599451|156621216|FG003|Overall Study|Physician Decision|1|||
48663518|NCT05599451|156621217|FG004|Overall Study|Physician Decision|0|||
48663519|NCT01740089|156621218|FG000|First 12 Weeks of Treatment|Adverse Event|0|||
48663520|NCT01740089|156621219|FG001|First 12 Weeks of Treatment|Adverse Event|1|||
48663521|NCT01740089|156621220|FG002|First 12 Weeks of Treatment|Adverse Event|2|||
48663522|NCT01740089|156621218|FG000|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
48663523|NCT01740089|156621219|FG001|First 12 Weeks of Treatment|Withdrawal by Subject|1|||
48663524|NCT01740089|156621220|FG002|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
48663525|NCT01740089|156621218|FG000|After 12 Weeks|Lack of Efficacy|3|||
48663526|NCT01740089|156621219|FG001|After 12 Weeks|Lack of Efficacy|1|||
48663527|NCT01740089|156621220|FG002|After 12 Weeks|Lack of Efficacy|4|||
48663528|NCT01740089|156621218|FG000|After 12 Weeks|Adverse Event|2|||
48663529|NCT01740089|156621219|FG001|After 12 Weeks|Adverse Event|0|||
48663530|NCT01740089|156621220|FG002|After 12 Weeks|Adverse Event|5|||
48663531|NCT01740089|156621218|FG000|After 12 Weeks|Protocol Violation|1|||
48663532|NCT01740089|156621219|FG001|After 12 Weeks|Protocol Violation|1|||
48663533|NCT01740089|156621220|FG002|After 12 Weeks|Protocol Violation|1|||
48663534|NCT01740089|156621218|FG000|After 12 Weeks|Withdrawal by Subject|1|||
48663535|NCT01740089|156621219|FG001|After 12 Weeks|Withdrawal by Subject|1|||
48663536|NCT01740089|156621220|FG002|After 12 Weeks|Withdrawal by Subject|1|||
48663537|NCT03372551|156621221|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
48756500|NCT00524368|156956112|FG001|Overall Study|Ineligible to Continue the study|5|||
48756501|NCT00524368|156956111|FG000|Overall Study|Other|3|||
48756502|NCT00524368|156956112|FG001|Overall Study|Other|2|||
48663538|NCT03372551|156621222|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
48663539|NCT04258995|156621223|FG000|Overall Study|Lost to Follow-up|1|||
48663540|NCT04258995|156621224|FG001|Overall Study|Lost to Follow-up|1|||
48663541|NCT03100539|156621225|FG000|Overall Study|Lost to Follow-up|60|||
48663542|NCT03100539|156621226|FG001|Overall Study|Lost to Follow-up|54|||
48663543|NCT03100539|156621227|FG002|Overall Study|Lost to Follow-up|17|||
48663544|NCT03100539|156621225|FG000|Overall Study|Uncollected|8|||
48663545|NCT03100539|156621226|FG001|Overall Study|Uncollected|8|||
48663546|NCT03100539|156621227|FG002|Overall Study|Uncollected|0|||
48663547|NCT03100539|156621225|FG000|Overall Study|Ally Health|0|||
48663548|NCT03100539|156621226|FG001|Overall Study|Ally Health|0|||
48663549|NCT03100539|156621227|FG002|Overall Study|Ally Health|3|||
48663550|NCT03100539|156621225|FG000|Overall Study|Disinterest|0|||
48663551|NCT03100539|156621226|FG001|Overall Study|Disinterest|0|||
48756503|NCT00180414|156956118|FG000|Overall Study|Study cancellation due to lack of overall enrollments|4|||
48965951|NCT00634114|157703700|FG002|Overall Study|Protocol Violation|1|||
48965952|NCT00634114|157703698|FG000|Overall Study|Pregnancy|1|||
48965953|NCT00634114|157703699|FG001|Overall Study|Pregnancy|0|||
48965954|NCT00634114|157703700|FG002|Overall Study|Pregnancy|0|||
48965955|NCT00634114|157703698|FG000|Overall Study|Incorrect enrolment|0|||
48965956|NCT00634114|157703699|FG001|Overall Study|Incorrect enrolment|1|||
48965957|NCT00634114|157703700|FG002|Overall Study|Incorrect enrolment|0|||
48965958|NCT00634114|157703698|FG000|Overall Study|Recurrence of reflux esophagitis|5|||
48965959|NCT00634114|157703699|FG001|Overall Study|Recurrence of reflux esophagitis|15|||
48965960|NCT00634114|157703700|FG002|Overall Study|Recurrence of reflux esophagitis|21|||
48965961|NCT00634114|157703698|FG000|Overall Study|Difficult to continue|3|||
48965962|NCT00634114|157703699|FG001|Overall Study|Difficult to continue|1|||
48965963|NCT00634114|157703700|FG002|Overall Study|Difficult to continue|1|||
48965964|NCT00634114|157703698|FG000|Overall Study|Other reason|1|||
48965965|NCT00634114|157703699|FG001|Overall Study|Other reason|1|||
48965966|NCT00634114|157703700|FG002|Overall Study|Other reason|1|||
48965967|NCT00400712|157703704|FG000|Overall Study|Death|1|||
48965968|NCT00400712|157703705|FG001|Overall Study|Death|0|||
48965969|NCT00400712|157703704|FG000|Overall Study|Withdrawal by Subject|11|||
48965970|NCT00400712|157703705|FG001|Overall Study|Withdrawal by Subject|12|||
48965971|NCT00400712|157703704|FG000|Overall Study|Physician Decision|5|||
48965972|NCT00400712|157703705|FG001|Overall Study|Physician Decision|4|||
48965973|NCT00126581|157703706|FG000|Overall Study|Adverse Event|3|||
48965974|NCT00126581|157703707|FG001|Overall Study|Adverse Event|7|||
48965975|NCT00126581|157703706|FG000|Overall Study|Death|3|||
48663552|NCT03100539|156621227|FG002|Overall Study|Disinterest|22|||
48965976|NCT00126581|157703707|FG001|Overall Study|Death|2|||
48965977|NCT00126581|157703706|FG000|Overall Study|Withdrawal by Subject|1|||
48965978|NCT00126581|157703707|FG001|Overall Study|Withdrawal by Subject|4|||
48965979|NCT00126581|157703706|FG000|Overall Study|Alternative therapy|3|||
48663553|NCT03100539|156621225|FG000|Overall Study|Veteran Health|0|||
48663554|NCT03100539|156621226|FG001|Overall Study|Veteran Health|0|||
48663555|NCT03100539|156621227|FG002|Overall Study|Veteran Health|8|||
48663556|NCT03100539|156621225|FG000|Overall Study|Moved|0|||
48663557|NCT03100539|156621226|FG001|Overall Study|Moved|0|||
48663558|NCT03100539|156621227|FG002|Overall Study|Moved|1|||
48663559|NCT03100539|156621225|FG000|Overall Study|Scheduling Conflicts|0|||
48663560|NCT03100539|156621226|FG001|Overall Study|Scheduling Conflicts|0|||
48663561|NCT03100539|156621227|FG002|Overall Study|Scheduling Conflicts|12|||
48663562|NCT04511702|156621228|FG000|Overall Study|Lost to Follow-up|3|||
48663563|NCT04511702|156621229|FG001|Overall Study|Lost to Follow-up|0|||
48663564|NCT04511702|156621230|FG002|Overall Study|Lost to Follow-up|4|||
48663565|NCT04511702|156621228|FG000|Overall Study|Withdrawal by Subject|17|||
48663566|NCT04511702|156621229|FG001|Overall Study|Withdrawal by Subject|1|||
48663567|NCT04511702|156621230|FG002|Overall Study|Withdrawal by Subject|8|||
48663568|NCT03356977|156621234|FG000|Overall Study|Lost to Follow-up|3|||
48663569|NCT03356977|156621234|FG000|Overall Study|Withdrawal by parent/guardian|2|||
48663570|NCT01728077|156621239|FG000|Overall Study|Lack of Efficacy|3|||
48663571|NCT01728077|156621240|FG001|Overall Study|Lack of Efficacy|1|||
48663572|NCT01728077|156621239|FG000|Overall Study|Lost to Follow-up|1|||
48663573|NCT01728077|156621240|FG001|Overall Study|Lost to Follow-up|0|||
48663574|NCT01728077|156621239|FG000|Overall Study|Subject choice|2|||
48663575|NCT01728077|156621240|FG001|Overall Study|Subject choice|3|||
48663576|NCT01728077|156621239|FG000|Overall Study|Death|0|||
48965980|NCT00126581|157703707|FG001|Overall Study|Alternative therapy|3|||
48965981|NCT00126581|157703706|FG000|Overall Study|Other illness/MD discretion|3|||
48965982|NCT00126581|157703707|FG001|Overall Study|Other illness/MD discretion|4|||
48965983|NCT03325556|157703708|FG000|Open-label Period|Lack of Response in OL period|70|||
48965984|NCT03325556|157703709|FG001|Open-label Period|Lack of Response in OL period|0|||
48965985|NCT03325556|157703710|FG002|Open-label Period|Lack of Response in OL period|0|||
48965986|NCT03325556|157703708|FG000|Open-label Period|Adverse Event|27|||
48965987|NCT03325556|157703709|FG001|Open-label Period|Adverse Event|0|||
48965988|NCT03325556|157703710|FG002|Open-label Period|Adverse Event|0|||
48965989|NCT03325556|157703708|FG000|Open-label Period|Death|1|||
48663577|NCT01728077|156621240|FG001|Overall Study|Death|1|||
48663578|NCT01728077|156621239|FG000|Overall Study|Patient moving|1|||
48663579|NCT01728077|156621240|FG001|Overall Study|Patient moving|0|||
48663580|NCT01728077|156621239|FG000|Overall Study|Non compliance|1|||
48663581|NCT01728077|156621240|FG001|Overall Study|Non compliance|0|||
48663582|NCT00378599|156621244|FG000|Overall Study|Adverse Event|38|||
48663583|NCT00378599|156621244|FG000|Overall Study|Protocol Violation|2|||
48663584|NCT00378599|156621244|FG000|Overall Study|Treatment failure|7|||
48663585|NCT00378599|156621244|FG000|Overall Study|Withdrawal by Subject|5|||
48663586|NCT00489736|156621245|FG000|Overall Study|Lack of Efficacy|53|||
48965990|NCT03325556|157703709|FG001|Open-label Period|Death|0|||
48965991|NCT03325556|157703710|FG002|Open-label Period|Death|0|||
48965992|NCT03325556|157703708|FG000|Open-label Period|Lost to Follow-up|1|||
48965993|NCT03325556|157703709|FG001|Open-label Period|Lost to Follow-up|0|||
48965994|NCT03325556|157703710|FG002|Open-label Period|Lost to Follow-up|0|||
48965995|NCT03325556|157703708|FG000|Open-label Period|Non-compliance with study drug|5|||
48663587|NCT00489736|156621246|FG001|Overall Study|Lack of Efficacy|14|||
48663588|NCT00489736|156621245|FG000|Overall Study|Adverse Event|32|||
48663589|NCT00489736|156621246|FG001|Overall Study|Adverse Event|45|||
48663590|NCT00489736|156621245|FG000|Overall Study|Poor compliance|6|||
48663591|NCT00489736|156621246|FG001|Overall Study|Poor compliance|2|||
48663592|NCT00489736|156621245|FG000|Overall Study|Not coded/ Not pre-specified|5|||
48663593|NCT00489736|156621246|FG001|Overall Study|Not coded/ Not pre-specified|8|||
48663594|NCT05368103|156621247|FG000|Overall Study|Withdrawal by Subject|4|||
48663595|NCT05368103|156621247|FG000|Overall Study|Lost to Follow-up|1|||
48663596|NCT05368103|156621247|FG000|Overall Study|Lack of Efficacy|3|||
48663597|NCT00320255|156621248|FG000|Overall Study|Lack of Efficacy|1|||
48663598|NCT00320255|156621249|FG001|Overall Study|Lack of Efficacy|0|||
48663599|NCT00320255|156621250|FG002|Overall Study|Lack of Efficacy|0|||
48663600|NCT00320255|156621251|FG003|Overall Study|Lack of Efficacy|0|||
48663601|NCT00320255|156621252|FG004|Overall Study|Lack of Efficacy|0|||
48663602|NCT00320255|156621253|FG005|Overall Study|Lack of Efficacy|0|||
48663603|NCT00320255|156621248|FG000|Overall Study|Adverse Event|5|||
48663604|NCT00320255|156621249|FG001|Overall Study|Adverse Event|2|||
48663605|NCT00320255|156621250|FG002|Overall Study|Adverse Event|3|||
48663606|NCT00320255|156621251|FG003|Overall Study|Adverse Event|2|||
48663607|NCT00320255|156621252|FG004|Overall Study|Adverse Event|0|||
48663608|NCT00320255|156621253|FG005|Overall Study|Adverse Event|0|||
48866961|NCT02176018|157349157|FG001|Overall Study|Lost to Follow-up|1|||
48866962|NCT02176018|157349156|FG000|Overall Study|Protocol Violation|1|||
48866963|NCT02176018|157349157|FG001|Overall Study|Protocol Violation|1|||
48866964|NCT02176018|157349156|FG000|Overall Study|Withdrawal by Subject|1|||
48866965|NCT02176018|157349157|FG001|Overall Study|Withdrawal by Subject|2|||
48866966|NCT02068352|157349158|FG000|Overall Study|Lost to Follow-up|0|||
48866967|NCT02068352|157349159|FG001|Overall Study|Lost to Follow-up|2|||
48866968|NCT02068352|157349160|FG002|Overall Study|Lost to Follow-up|0|||
48866969|NCT02068352|157349158|FG000|Overall Study|Adverse Event|4|||
48866970|NCT02068352|157349159|FG001|Overall Study|Adverse Event|2|||
48866971|NCT02068352|157349160|FG002|Overall Study|Adverse Event|7|||
48866972|NCT02068352|157349158|FG000|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
48866973|NCT02068352|157349159|FG001|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|1|||
48866974|NCT02068352|157349160|FG002|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
48866975|NCT02068352|157349158|FG000|Overall Study|Participant Withdrew Consent to Participate|6|||
48866976|NCT02068352|157349159|FG001|Overall Study|Participant Withdrew Consent to Participate|3|||
48866977|NCT02068352|157349160|FG002|Overall Study|Participant Withdrew Consent to Participate|1|||
48866978|NCT02068352|157349158|FG000|Overall Study|Protocol Deviation|0|||
48866979|NCT02068352|157349159|FG001|Overall Study|Protocol Deviation|0|||
48866980|NCT02068352|157349160|FG002|Overall Study|Protocol Deviation|1|||
48866981|NCT05153499|157349161|FG000|Overall Study|Withdrawal by Subject|1|||
48866982|NCT05153499|157349162|FG001|Overall Study|Withdrawal by Subject|0|||
48866983|NCT05153499|157349161|FG000|Overall Study|Clinical Hold|1|||
48866984|NCT05153499|157349162|FG001|Overall Study|Clinical Hold|0|||
48866985|NCT05153499|157349161|FG000|Overall Study|Study Termination|6|||
48866986|NCT05153499|157349162|FG001|Overall Study|Study Termination|5|||
48866987|NCT01116440|157349163|FG000|Treatment|Withdrawal by Subject|2|||
48866988|NCT01116440|157349164|FG001|Treatment|Withdrawal by Subject|2|||
48866989|NCT01116440|157349163|FG000|Treatment|Lost to Follow-up|1|||
48866990|NCT01116440|157349164|FG001|Treatment|Lost to Follow-up|1|||
48866991|NCT01116440|157349163|FG000|Treatment|Protocol Violation|0|||
48866992|NCT01116440|157349164|FG001|Treatment|Protocol Violation|2|||
48866993|NCT01116440|157349163|FG000|Treatment|Lack of Efficacy|0|||
48866994|NCT01116440|157349164|FG001|Treatment|Lack of Efficacy|1|||
48866995|NCT01116440|157349163|FG000|Treatment|Adverse Event|0|||
48866996|NCT01116440|157349164|FG001|Treatment|Adverse Event|1|||
48866997|NCT01116440|157349163|FG000|Withdrawal|Withdrawal by Subject|0|||
48866998|NCT01116440|157349164|FG001|Withdrawal|Withdrawal by Subject|1|||
48866999|NCT01116440|157349163|FG000|Withdrawal|Lost to Follow-up|0|||
48867000|NCT01116440|157349164|FG001|Withdrawal|Lost to Follow-up|1|||
48867001|NCT01116440|157349163|FG000|Follow-up|Lost to Follow-up|0|||
48867002|NCT01116440|157349164|FG001|Follow-up|Lost to Follow-up|1|||
48867003|NCT01116440|157349163|FG000|Follow-up|Withdrawal by Subject|0|||
48867004|NCT01116440|157349164|FG001|Follow-up|Withdrawal by Subject|1|||
48867005|NCT05600036|157349165|FG000|Overall Study|Adverse Event|0|||
48867006|NCT05600036|157349166|FG001|Overall Study|Adverse Event|2|||
48867007|NCT05600036|157349167|FG002|Overall Study|Adverse Event|1|||
48867008|NCT05600036|157349168|FG003|Overall Study|Adverse Event|0|||
48663609|NCT00320255|156621248|FG000|Overall Study|Withdrawal by Subject|1|||
48663610|NCT00320255|156621249|FG001|Overall Study|Withdrawal by Subject|2|||
48867009|NCT05600036|157349169|FG004|Overall Study|Adverse Event|1|||
48867010|NCT05600036|157349170|FG005|Overall Study|Adverse Event|0|||
48867011|NCT05600036|157349165|FG000|Overall Study|Lost to Follow-up|0|||
48867012|NCT05600036|157349166|FG001|Overall Study|Lost to Follow-up|2|||
48867013|NCT05600036|157349167|FG002|Overall Study|Lost to Follow-up|1|||
48867014|NCT05600036|157349168|FG003|Overall Study|Lost to Follow-up|1|||
48867015|NCT05600036|157349169|FG004|Overall Study|Lost to Follow-up|0|||
48663611|NCT00320255|156621250|FG002|Overall Study|Withdrawal by Subject|2|||
48663612|NCT00320255|156621251|FG003|Overall Study|Withdrawal by Subject|4|||
48663613|NCT00320255|156621252|FG004|Overall Study|Withdrawal by Subject|0|||
48663614|NCT00320255|156621253|FG005|Overall Study|Withdrawal by Subject|0|||
48663615|NCT00320255|156621248|FG000|Overall Study|Poor compliance/noncompliance|1|||
48663616|NCT00320255|156621249|FG001|Overall Study|Poor compliance/noncompliance|1|||
48663617|NCT00320255|156621250|FG002|Overall Study|Poor compliance/noncompliance|0|||
48663618|NCT00320255|156621251|FG003|Overall Study|Poor compliance/noncompliance|1|||
48867016|NCT05600036|157349170|FG005|Overall Study|Lost to Follow-up|0|||
48867017|NCT05600036|157349165|FG000|Overall Study|Protocol Violation|0|||
48867018|NCT05600036|157349166|FG001|Overall Study|Protocol Violation|0|||
48867019|NCT05600036|157349167|FG002|Overall Study|Protocol Violation|2|||
48867020|NCT05600036|157349168|FG003|Overall Study|Protocol Violation|0|||
48867021|NCT05600036|157349169|FG004|Overall Study|Protocol Violation|0|||
48867022|NCT05600036|157349170|FG005|Overall Study|Protocol Violation|0|||
48867023|NCT05600036|157349165|FG000|Overall Study|Withdrawal by Subject|0|||
48867024|NCT05600036|157349166|FG001|Overall Study|Withdrawal by Subject|1|||
48867025|NCT05600036|157349167|FG002|Overall Study|Withdrawal by Subject|2|||
48867026|NCT05600036|157349168|FG003|Overall Study|Withdrawal by Subject|0|||
48867027|NCT05600036|157349169|FG004|Overall Study|Withdrawal by Subject|3|||
48867028|NCT05600036|157349170|FG005|Overall Study|Withdrawal by Subject|5|||
48867029|NCT05600036|157349165|FG000|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
48867030|NCT05600036|157349166|FG001|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
48867031|NCT05600036|157349167|FG002|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
48867032|NCT05600036|157349168|FG003|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|1|||
48867033|NCT05600036|157349169|FG004|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
48867034|NCT05600036|157349170|FG005|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
48867035|NCT05600036|157349165|FG000|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
48867036|NCT05600036|157349166|FG001|Overall Study|Subject Can't Continue With Week 16 Visit|1|||
48867037|NCT05600036|157349167|FG002|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
48867038|NCT05600036|157349168|FG003|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
48867039|NCT05600036|157349169|FG004|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
48867040|NCT05600036|157349170|FG005|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
48867041|NCT05600036|157349165|FG000|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
48867042|NCT05600036|157349166|FG001|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
48867043|NCT05600036|157349167|FG002|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
48867044|NCT05600036|157349168|FG003|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|1|||
48867045|NCT05600036|157349169|FG004|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
48867046|NCT05600036|157349170|FG005|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
48867047|NCT02262364|157349171|FG000|Blood Draw for Device Processing|Insufficient blood could be drawn|1|||
48867048|NCT00396097|157349173|FG000|Overall Study|Withdrawal by Subject|17|||
48867049|NCT00396097|157349174|FG001|Overall Study|Withdrawal by Subject|17|||
48867050|NCT00396097|157349173|FG000|Overall Study|Lost to Follow-up|4|||
48867051|NCT00396097|157349174|FG001|Overall Study|Lost to Follow-up|9|||
48867052|NCT00396097|157349173|FG000|Overall Study|Other|3|||
48867053|NCT00396097|157349174|FG001|Overall Study|Other|5|||
48867054|NCT00396097|157349173|FG000|Overall Study|Protocol Violation|0|||
48867055|NCT00396097|157349174|FG001|Overall Study|Protocol Violation|6|||
48867056|NCT00396097|157349173|FG000|Overall Study|Adverse Event|1|||
48867057|NCT00396097|157349174|FG001|Overall Study|Adverse Event|5|||
48867058|NCT00396097|157349173|FG000|Overall Study|Insufficient Clinical Response|1|||
48867059|NCT00396097|157349174|FG001|Overall Study|Insufficient Clinical Response|4|||
48867060|NCT02005029|157349175|FG000|First Intervention (1 Day)|participant withdrawn for noncompliance|1|||
48867061|NCT02005029|157349176|FG001|First Intervention (1 Day)|participant withdrawn for noncompliance|0|||
48867062|NCT03334747|157349177|FG000|Treatment Phase|Technical problems|0|||
48867063|NCT03334747|157349178|FG001|Treatment Phase|Technical problems|0|||
48867064|NCT03334747|157349179|FG002|Treatment Phase|Technical problems|0|||
48867065|NCT03334747|157349180|FG003|Treatment Phase|Technical problems|0|||
48867066|NCT03334747|157349181|FG004|Treatment Phase|Technical problems|1|||
48867067|NCT03334747|157349182|FG005|Treatment Phase|Technical problems|0|||
48867068|NCT03334747|157349183|FG006|Treatment Phase|Technical problems|0|||
48867069|NCT03334747|157349184|FG007|Treatment Phase|Technical problems|0|||
48867070|NCT03334747|157349185|FG008|Treatment Phase|Technical problems|0|||
48867071|NCT03334747|157349177|FG000|Treatment Phase|Subject/guardian decision|1|||
48867072|NCT03334747|157349178|FG001|Treatment Phase|Subject/guardian decision|0|||
48867073|NCT03334747|157349179|FG002|Treatment Phase|Subject/guardian decision|0|||
48867074|NCT03334747|157349180|FG003|Treatment Phase|Subject/guardian decision|0|||
48867075|NCT03334747|157349181|FG004|Treatment Phase|Subject/guardian decision|0|||
48867076|NCT03334747|157349182|FG005|Treatment Phase|Subject/guardian decision|1|||
48756504|NCT00180414|156956119|FG001|Overall Study|Study cancellation due to lack of overall enrollments|4|||
48756505|NCT03641651|156956124|FG000|Overall Study|organizational issues at one study site|1|||
48756506|NCT03010254|156956125|FG000|Overall Study|Adverse Event|0|||
48756507|NCT03010254|156956126|FG001|Overall Study|Adverse Event|1|||
48756508|NCT03010254|156956125|FG000|Overall Study|Lost to Follow-up|4|||
48756509|NCT03010254|156956126|FG001|Overall Study|Lost to Follow-up|0|||
48756510|NCT03010254|156956125|FG000|Overall Study|Withdrawal by Subject|1|||
48756511|NCT03010254|156956126|FG001|Overall Study|Withdrawal by Subject|1|||
48756512|NCT03010254|156956125|FG000|Overall Study|Other|2|||
48756513|NCT03010254|156956126|FG001|Overall Study|Other|3|||
48756514|NCT03909295|156956127|FG000|Overall Study|Adverse Event|2|||
48756515|NCT03909295|156956127|FG000|Overall Study|Study terminated by sponsor|50|||
48756516|NCT01702454|156956130|FG000|Overall Study|Consent withdrawal|0|||
48756517|NCT01702454|156956131|FG001|Overall Study|Consent withdrawal|1|||
48756518|NCT01702454|156956130|FG000|Overall Study|Migrated/moved from study area|0|||
48756519|NCT01702454|156956131|FG001|Overall Study|Migrated/moved from study area|1|||
48756520|NCT01702454|156956130|FG000|Overall Study|Lost to Follow-up|3|||
48756521|NCT01702454|156956131|FG001|Overall Study|Lost to Follow-up|6|||
48756522|NCT00710710|156956132|FG000|Overall Study|Consent withdrawn|2|||
48756523|NCT00710710|156956133|FG001|Overall Study|Consent withdrawn|2|||
48756524|NCT00710710|156956132|FG000|Overall Study|Protocol Violation|0|||
48756525|NCT00710710|156956133|FG001|Overall Study|Protocol Violation|1|||
48756526|NCT00710710|156956132|FG000|Overall Study|Adverse Event|3|||
48756527|NCT00710710|156956133|FG001|Overall Study|Adverse Event|3|||
48756528|NCT00710710|156956132|FG000|Overall Study|Progressive disease|40|||
48756529|NCT00710710|156956133|FG001|Overall Study|Progressive disease|38|||
48756530|NCT01313767|156956136|FG000|Overall Study|Adverse Event|1|||
48756531|NCT01313767|156956137|FG001|Overall Study|Adverse Event|0|||
48663619|NCT00320255|156621252|FG004|Overall Study|Poor compliance/noncompliance|0|||
48663620|NCT00320255|156621253|FG005|Overall Study|Poor compliance/noncompliance|0|||
48663621|NCT00320255|156621248|FG000|Overall Study|No longer meets study criteria|0|||
48663622|NCT00320255|156621249|FG001|Overall Study|No longer meets study criteria|0|||
48663623|NCT00320255|156621250|FG002|Overall Study|No longer meets study criteria|0|||
48663624|NCT00320255|156621251|FG003|Overall Study|No longer meets study criteria|1|||
48663625|NCT00320255|156621252|FG004|Overall Study|No longer meets study criteria|0|||
48663626|NCT00320255|156621253|FG005|Overall Study|No longer meets study criteria|0|||
48663627|NCT00320255|156621248|FG000|Overall Study|Other|3|||
48663628|NCT00320255|156621249|FG001|Overall Study|Other|2|||
48663629|NCT00320255|156621250|FG002|Overall Study|Other|1|||
48663630|NCT00320255|156621251|FG003|Overall Study|Other|0|||
48663631|NCT00320255|156621252|FG004|Overall Study|Other|0|||
48663632|NCT00320255|156621253|FG005|Overall Study|Other|0|||
48663633|NCT00543296|156621254|FG000|Overall Study|Physician Decision|7|||
48663634|NCT00367744|156621260|FG000|Overall Study|Lost to Follow-up|4|||
48663635|NCT00367744|156621261|FG001|Overall Study|Lost to Follow-up|5|||
48663636|NCT01703117|156621262|FG000|Overall Study|Adverse Event|4|||
48663637|NCT01703117|156621263|FG001|Overall Study|Adverse Event|3|||
48663638|NCT01703117|156621262|FG000|Overall Study|Withdrawal by Subject|0|||
48663639|NCT01703117|156621263|FG001|Overall Study|Withdrawal by Subject|1|||
48663640|NCT01340937|156621266|FG000|Period 1: Infant Series|Other protocol criterion not met|0|||
48663641|NCT01340937|156621267|FG001|Period 1: Infant Series|Other protocol criterion not met|1|||
48663642|NCT01340937|156621268|FG002|Period 1: Infant Series|Other protocol criterion not met|1|||
48663643|NCT01340937|156621269|FG003|Period 1: Infant Series|Other protocol criterion not met|0|||
48663644|NCT01340937|156621266|FG000|Period 1: Infant Series|Adverse Event|0|||
48663645|NCT01340937|156621267|FG001|Period 1: Infant Series|Adverse Event|1|||
48663646|NCT01340937|156621268|FG002|Period 1: Infant Series|Adverse Event|4|||
48663647|NCT01340937|156621269|FG003|Period 1: Infant Series|Adverse Event|0|||
48663648|NCT01340937|156621266|FG000|Period 1: Infant Series|Death|2|||
48663649|NCT01340937|156621267|FG001|Period 1: Infant Series|Death|0|||
48663650|NCT01340937|156621268|FG002|Period 1: Infant Series|Death|2|||
48663651|NCT01340937|156621269|FG003|Period 1: Infant Series|Death|0|||
48663652|NCT01340937|156621266|FG000|Period 1: Infant Series|Lost to Follow-up|20|||
48663653|NCT01340937|156621267|FG001|Period 1: Infant Series|Lost to Follow-up|14|||
48663654|NCT01340937|156621268|FG002|Period 1: Infant Series|Lost to Follow-up|12|||
48663655|NCT01340937|156621269|FG003|Period 1: Infant Series|Lost to Follow-up|13|||
48663656|NCT01340937|156621266|FG000|Period 1: Infant Series|Physician Decision|2|||
48663657|NCT01340937|156621267|FG001|Period 1: Infant Series|Physician Decision|3|||
48663658|NCT01340937|156621268|FG002|Period 1: Infant Series|Physician Decision|1|||
48663659|NCT01340937|156621269|FG003|Period 1: Infant Series|Physician Decision|0|||
48663660|NCT01340937|156621266|FG000|Period 1: Infant Series|Protocol Violation|1|||
48663661|NCT01340937|156621267|FG001|Period 1: Infant Series|Protocol Violation|4|||
48663662|NCT01340937|156621268|FG002|Period 1: Infant Series|Protocol Violation|4|||
48663663|NCT01340937|156621269|FG003|Period 1: Infant Series|Protocol Violation|3|||
48756532|NCT01313767|156956136|FG000|Overall Study|Lost to Follow-up|1|||
48756533|NCT01313767|156956137|FG001|Overall Study|Lost to Follow-up|0|||
48756534|NCT01313767|156956136|FG000|Overall Study|Withdrawal by Subject|2|||
48663664|NCT01340937|156621266|FG000|Period 1: Infant Series|Withdrawal by Subject|33|||
48663665|NCT01340937|156621267|FG001|Period 1: Infant Series|Withdrawal by Subject|32|||
48663666|NCT01340937|156621268|FG002|Period 1: Infant Series|Withdrawal by Subject|30|||
48663667|NCT01340937|156621269|FG003|Period 1: Infant Series|Withdrawal by Subject|15|||
48663668|NCT01340937|156621266|FG000|Period 1: Infant Series|Randomized but not vaccinated|0|||
48756535|NCT01313767|156956137|FG001|Overall Study|Withdrawal by Subject|1|||
48756536|NCT01313767|156956136|FG000|Overall Study|Protocol Violation|3|||
48756537|NCT01313767|156956137|FG001|Overall Study|Protocol Violation|1|||
48965996|NCT03325556|157703709|FG001|Open-label Period|Non-compliance with study drug|0|||
48965997|NCT03325556|157703710|FG002|Open-label Period|Non-compliance with study drug|0|||
48965998|NCT03325556|157703708|FG000|Open-label Period|Use of prohibited medication|1|||
48756538|NCT02904512|156956138|FG000|Overall Study|Withdrawal by Subject|1|||
48756539|NCT02904512|156956139|FG001|Overall Study|Withdrawal by Subject|0|||
48756540|NCT02904512|156956138|FG000|Overall Study|Transferred to ICU|1|||
48756541|NCT02904512|156956139|FG001|Overall Study|Transferred to ICU|0|||
48756542|NCT02904512|156956138|FG000|Overall Study|Minor Bleeding at site of device insertion|1|||
48756543|NCT02904512|156956139|FG001|Overall Study|Minor Bleeding at site of device insertion|0|||
48756544|NCT02485301|156956140|FG000|Overall Study|Serious Adverse Events|2|||
48756545|NCT02485301|156956141|FG001|Overall Study|Serious Adverse Events|1|||
48756546|NCT02485301|156956140|FG000|Overall Study|Protocol Violation|0|||
48756547|NCT02485301|156956141|FG001|Overall Study|Protocol Violation|1|||
48756548|NCT02485301|156956140|FG000|Overall Study|Withdrawal by Subject|6|||
48756549|NCT02485301|156956141|FG001|Overall Study|Withdrawal by Subject|7|||
48756550|NCT02485301|156956140|FG000|Overall Study|Migrated/moved from study area|10|||
48756551|NCT02485301|156956141|FG001|Overall Study|Migrated/moved from study area|19|||
48756552|NCT02485301|156956140|FG000|Overall Study|Lost to Follow-up|17|||
48756553|NCT02485301|156956141|FG001|Overall Study|Lost to Follow-up|17|||
48756554|NCT02485301|156956140|FG000|Overall Study|Other|3|||
48756555|NCT02485301|156956141|FG001|Overall Study|Other|4|||
48756556|NCT02282020|156956142|FG000|Overall Study|Objective Disease Progression|128|||
48756557|NCT02282020|156956143|FG001|Overall Study|Objective Disease Progression|30|||
48756558|NCT02282020|156956142|FG000|Overall Study|Adverse Event|18|||
48756559|NCT02282020|156956143|FG001|Overall Study|Adverse Event|15|||
48756560|NCT02282020|156956142|FG000|Overall Study|Withdrawal by Subject|7|||
48756561|NCT02282020|156956143|FG001|Overall Study|Withdrawal by Subject|10|||
48756562|NCT02282020|156956142|FG000|Overall Study|Miscellaneous|5|||
48756563|NCT02282020|156956143|FG001|Overall Study|Miscellaneous|19|||
48756564|NCT02282020|156956142|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
48756565|NCT02282020|156956143|FG001|Overall Study|Severe Non-compliance to Protocol|0|||
48756566|NCT02282020|156956142|FG000|Overall Study|Developed Discontinuation Criteria|0|||
48756567|NCT02282020|156956143|FG001|Overall Study|Developed Discontinuation Criteria|2|||
48756568|NCT02282020|156956142|FG000|Overall Study|Withdrew Consent Prior to Dosing|0|||
48756569|NCT02282020|156956143|FG001|Overall Study|Withdrew Consent Prior to Dosing|12|||
48756570|NCT00475176|156956144|FG000|Overall Study|Adverse Event|2|||
48756571|NCT00475176|156956144|FG000|Overall Study|Withdrawal by Subject|1|||
48756572|NCT00475176|156956144|FG000|Overall Study|Protocol Violation|1|||
48756573|NCT01594125|156956146|FG000|Overall Study|Withdrawal by Subject|1|||
48756574|NCT01594125|156956147|FG001|Overall Study|Withdrawal by Subject|0|||
48756575|NCT01594125|156956148|FG002|Overall Study|Withdrawal by Subject|0|||
48756576|NCT01594125|156956149|FG003|Overall Study|Withdrawal by Subject|1|||
48756577|NCT01594125|156956150|FG004|Overall Study|Withdrawal by Subject|0|||
48756578|NCT01594125|156956146|FG000|Overall Study|Progressive Disease|3|||
48965999|NCT03325556|157703709|FG001|Open-label Period|Use of prohibited medication|0|||
48966000|NCT03325556|157703710|FG002|Open-label Period|Use of prohibited medication|0|||
48966001|NCT03325556|157703708|FG000|Open-label Period|Protocol Violation|4|||
48966002|NCT03325556|157703709|FG001|Open-label Period|Protocol Violation|0|||
48966003|NCT03325556|157703710|FG002|Open-label Period|Protocol Violation|0|||
48966004|NCT03325556|157703708|FG000|Open-label Period|Withdrawal by Subject|17|||
48966005|NCT03325556|157703709|FG001|Open-label Period|Withdrawal by Subject|0|||
48966006|NCT03325556|157703710|FG002|Open-label Period|Withdrawal by Subject|0|||
48663669|NCT01340937|156621267|FG001|Period 1: Infant Series|Randomized but not vaccinated|5|||
48663670|NCT01340937|156621268|FG002|Period 1: Infant Series|Randomized but not vaccinated|2|||
48663671|NCT01340937|156621269|FG003|Period 1: Infant Series|Randomized but not vaccinated|1|||
48663672|NCT01340937|156621266|FG000|Period 2: Interim Period|Withdrawal by Subject|28|||
48756579|NCT01594125|156956147|FG001|Overall Study|Progressive Disease|12|||
48966007|NCT03325556|157703708|FG000|Open-label Period|Not otherwise specified|8|||
48966008|NCT03325556|157703709|FG001|Open-label Period|Not otherwise specified|0|||
48663673|NCT01340937|156621267|FG001|Period 2: Interim Period|Withdrawal by Subject|23|||
48756580|NCT01594125|156956148|FG002|Overall Study|Progressive Disease|3|||
48756581|NCT01594125|156956149|FG003|Overall Study|Progressive Disease|3|||
48756582|NCT01594125|156956150|FG004|Overall Study|Progressive Disease|7|||
48756583|NCT03635957|156956153|FG000|Run-In Period|Lost to Follow-up|1|||
48756584|NCT03635957|156956153|FG000|Pegloticase + IMM Period|Lack of Efficacy|3|||
48756585|NCT01549392|156956154|FG000|Overall Study|Withdrawal by Subject|1|||
49015455|NCT01393990|157893787|FG017|Overall Study|Adverse Event|0|||
48756586|NCT01549392|156956155|FG001|Overall Study|Withdrawal by Subject|0|||
48756587|NCT00227903|156956157|FG000|Overall Study|Withdrawal by Subject|2|||
48756588|NCT00227903|156956158|FG001|Overall Study|Withdrawal by Subject|5|||
48756589|NCT00227903|156956157|FG000|Overall Study|Subject moved out of area|1|||
48756590|NCT00227903|156956158|FG001|Overall Study|Subject moved out of area|2|||
48756591|NCT00227903|156956157|FG000|Overall Study|Lost to Follow-up|1|||
48756592|NCT00227903|156956158|FG001|Overall Study|Lost to Follow-up|3|||
48756593|NCT00227903|156956157|FG000|Overall Study|Miscarriage|1|||
48756594|NCT00227903|156956158|FG001|Overall Study|Miscarriage|0|||
48756595|NCT01103284|156956159|FG000|Overall Study|Death|2|||
48756596|NCT01103284|156956160|FG001|Overall Study|Death|0|||
48756597|NCT01103284|156956159|FG000|Overall Study|Lost to Follow-up|9|||
48867077|NCT03334747|157349183|FG006|Treatment Phase|Subject/guardian decision|0|||
48867078|NCT03334747|157349184|FG007|Treatment Phase|Subject/guardian decision|0|||
48867079|NCT03334747|157349185|FG008|Treatment Phase|Subject/guardian decision|0|||
48867080|NCT03334747|157349177|FG000|Follow-Up Phase|Subject/guardian decision|0|||
48867081|NCT03334747|157349178|FG001|Follow-Up Phase|Subject/guardian decision|0|||
48867082|NCT03334747|157349179|FG002|Follow-Up Phase|Subject/guardian decision|0|||
48867083|NCT03334747|157349180|FG003|Follow-Up Phase|Subject/guardian decision|0|||
48867084|NCT03334747|157349181|FG004|Follow-Up Phase|Subject/guardian decision|0|||
48663674|NCT01340937|156621268|FG002|Period 2: Interim Period|Withdrawal by Subject|17|||
48663675|NCT01340937|156621269|FG003|Period 2: Interim Period|Withdrawal by Subject|12|||
48663676|NCT01340937|156621266|FG000|Period 2: Interim Period|Adverse Event|1|||
48663677|NCT01340937|156621267|FG001|Period 2: Interim Period|Adverse Event|0|||
48663678|NCT01340937|156621268|FG002|Period 2: Interim Period|Adverse Event|1|||
48663679|NCT01340937|156621269|FG003|Period 2: Interim Period|Adverse Event|0|||
48663680|NCT01340937|156621266|FG000|Period 2: Interim Period|Lost to Follow-up|29|||
48663681|NCT01340937|156621267|FG001|Period 2: Interim Period|Lost to Follow-up|48|||
48663682|NCT01340937|156621268|FG002|Period 2: Interim Period|Lost to Follow-up|53|||
48663683|NCT01340937|156621269|FG003|Period 2: Interim Period|Lost to Follow-up|23|||
48663684|NCT01340937|156621266|FG000|Period 2: Interim Period|Physician Decision|0|||
48663685|NCT01340937|156621267|FG001|Period 2: Interim Period|Physician Decision|1|||
48663686|NCT01340937|156621268|FG002|Period 2: Interim Period|Physician Decision|1|||
48663687|NCT01340937|156621269|FG003|Period 2: Interim Period|Physician Decision|0|||
48663688|NCT01340937|156621266|FG000|Period 2: Interim Period|Protocol Violation|5|||
48663689|NCT01340937|156621267|FG001|Period 2: Interim Period|Protocol Violation|3|||
48867085|NCT03334747|157349182|FG005|Follow-Up Phase|Subject/guardian decision|0|||
48867086|NCT03334747|157349183|FG006|Follow-Up Phase|Subject/guardian decision|1|||
48867087|NCT03334747|157349184|FG007|Follow-Up Phase|Subject/guardian decision|0|||
48867088|NCT03334747|157349185|FG008|Follow-Up Phase|Subject/guardian decision|1|||
48867089|NCT02137239|157349186|FG000|Overall Study|Discontinued Study Treatment|0|||
48867090|NCT02137239|157349187|FG001|Overall Study|Discontinued Study Treatment|3|||
48663690|NCT01340937|156621268|FG002|Period 2: Interim Period|Protocol Violation|6|||
48663691|NCT01340937|156621269|FG003|Period 2: Interim Period|Protocol Violation|3|||
48663692|NCT01340937|156621266|FG000|Period 2: Interim Period|Technical problems|4|||
48663693|NCT01340937|156621267|FG001|Period 2: Interim Period|Technical problems|4|||
48663694|NCT01340937|156621268|FG002|Period 2: Interim Period|Technical problems|6|||
48663695|NCT01340937|156621269|FG003|Period 2: Interim Period|Technical problems|3|||
48663696|NCT01340937|156621266|FG000|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
48663697|NCT01340937|156621267|FG001|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
48663698|NCT01340937|156621268|FG002|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
48663699|NCT01340937|156621269|FG003|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
48663700|NCT01340937|156621266|FG000|Period 3: Toddler Vaccinations|Lost to Follow-up|6|||
48663701|NCT01340937|156621267|FG001|Period 3: Toddler Vaccinations|Lost to Follow-up|14|||
48663702|NCT01340937|156621268|FG002|Period 3: Toddler Vaccinations|Lost to Follow-up|7|||
48663703|NCT01340937|156621269|FG003|Period 3: Toddler Vaccinations|Lost to Follow-up|8|||
48663704|NCT01340937|156621266|FG000|Period 3: Toddler Vaccinations|Protocol Violation|0|||
48663705|NCT01340937|156621267|FG001|Period 3: Toddler Vaccinations|Protocol Violation|0|||
48663706|NCT01340937|156621268|FG002|Period 3: Toddler Vaccinations|Protocol Violation|0|||
48663707|NCT01340937|156621269|FG003|Period 3: Toddler Vaccinations|Protocol Violation|1|||
48867091|NCT02137239|157349186|FG000|Overall Study|Withdrew Consent|1|||
48867092|NCT02137239|157349187|FG001|Overall Study|Withdrew Consent|1|||
48663708|NCT01340937|156621266|FG000|Period 3: Toddler Vaccinations|Technical problem|1|||
48756598|NCT01103284|156956160|FG001|Overall Study|Lost to Follow-up|10|||
48756599|NCT01103284|156956159|FG000|Overall Study|Pregnancy|3|||
48756600|NCT01103284|156956160|FG001|Overall Study|Pregnancy|1|||
48663709|NCT01340937|156621267|FG001|Period 3: Toddler Vaccinations|Technical problem|1|||
48756601|NCT01103284|156956159|FG000|Overall Study|Protocol Violation|12|||
48867093|NCT02137239|157349186|FG000|Overall Study|Adverse Event|2|||
48867094|NCT02137239|157349187|FG001|Overall Study|Adverse Event|2|||
48867095|NCT01072396|157349188|FG000|Period One|Adverse Event|1|||
48867096|NCT01072396|157349189|FG001|Period One|Adverse Event|1|||
48756602|NCT01103284|156956160|FG001|Overall Study|Protocol Violation|5|||
48756603|NCT01103284|156956159|FG000|Overall Study|Adverse Event|0|||
48966009|NCT03325556|157703710|FG002|Open-label Period|Not otherwise specified|0|||
48966010|NCT03325556|157703708|FG000|Open-label Period|Administrative discont. at study termination|41|||
48966011|NCT03325556|157703709|FG001|Open-label Period|Administrative discont. at study termination|0|||
48966012|NCT03325556|157703710|FG002|Open-label Period|Administrative discont. at study termination|0|||
48966013|NCT03325556|157703708|FG000|Double-blind Period|Relapse|0|||
48966014|NCT03325556|157703709|FG001|Double-blind Period|Relapse|15|||
48966015|NCT03325556|157703710|FG002|Double-blind Period|Relapse|34|||
48966016|NCT03325556|157703708|FG000|Double-blind Period|Adverse Event|0|||
48966017|NCT03325556|157703709|FG001|Double-blind Period|Adverse Event|3|||
48966018|NCT03325556|157703710|FG002|Double-blind Period|Adverse Event|1|||
48966019|NCT03325556|157703708|FG000|Double-blind Period|Noncompliance with study drug|0|||
48966020|NCT03325556|157703709|FG001|Double-blind Period|Noncompliance with study drug|0|||
48663710|NCT01340937|156621268|FG002|Period 3: Toddler Vaccinations|Technical problem|1|||
48663711|NCT01340937|156621269|FG003|Period 3: Toddler Vaccinations|Technical problem|0|||
48663712|NCT00794365|156621270|FG000|Overall Study|Lost to Follow-up|38|||
48663713|NCT00794365|156621270|FG000|Overall Study|Other|17|||
48663714|NCT00794365|156621270|FG000|Overall Study|Poor Compliance|11|||
48663715|NCT00794365|156621270|FG000|Overall Study|Adverse Event|10|||
48663716|NCT00794365|156621270|FG000|Overall Study|Lack of Efficacy|3|||
48663717|NCT04584346|156621277|FG000|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|0|||
48663718|NCT04584346|156621278|FG001|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|1|||
48663719|NCT03538444|156621279|FG000|Overall Study|opioid withdrawal|1|||
48663720|NCT03538444|156621280|FG001|Overall Study|opioid withdrawal|0|||
48663721|NCT00350623|156621283|FG000|Overall Study|Lost to Follow-up|8|||
48663722|NCT00350623|156621284|FG001|Overall Study|Lost to Follow-up|3|||
48663723|NCT00350623|156621285|FG002|Overall Study|Lost to Follow-up|4|||
48663724|NCT00350623|156621283|FG000|Overall Study|Withdrawal by Subject|0|||
48663725|NCT00350623|156621284|FG001|Overall Study|Withdrawal by Subject|1|||
48663726|NCT00350623|156621285|FG002|Overall Study|Withdrawal by Subject|1|||
48663727|NCT00350623|156621283|FG000|Overall Study|patient traveling outside the country|0|||
48663728|NCT00350623|156621284|FG001|Overall Study|patient traveling outside the country|0|||
48663729|NCT00350623|156621285|FG002|Overall Study|patient traveling outside the country|1|||
48663730|NCT01666119|156621290|FG000|Overall Study|Adverse Event|6|||
48663731|NCT01666119|156621290|FG000|Overall Study|Withdrawal by Subject|16|||
48663732|NCT01666119|156621290|FG000|Overall Study|Lost to Follow-up|7|||
48663733|NCT01666119|156621290|FG000|Overall Study|non compliance with study medication, pa|18|||
48663734|NCT01666119|156621290|FG000|Overall Study|Subject experiencing withdrawal symptoms|5|||
48663735|NCT02437409|156621301|FG000|Overall Study|Withdrawal by Subject|3|||
48663736|NCT02437409|156621301|FG000|Overall Study|Screening failure|12|||
48663737|NCT01777542|156621302|FG000|Second Intervention (20 Weeks)|Adverse Event|0|||
48663738|NCT01777542|156621303|FG001|Second Intervention (20 Weeks)|Adverse Event|1|||
48663739|NCT01133626|156621304|FG000|Overall Study|Adverse Event|0|||
48663740|NCT01133626|156621305|FG001|Overall Study|Adverse Event|1|||
48663741|NCT01133626|156621306|FG002|Overall Study|Adverse Event|0|||
48663742|NCT01133626|156621304|FG000|Overall Study|Withdrawal by Subject|1|||
48663743|NCT01133626|156621305|FG001|Overall Study|Withdrawal by Subject|2|||
48663744|NCT01133626|156621306|FG002|Overall Study|Withdrawal by Subject|2|||
48663745|NCT01133626|156621304|FG000|Overall Study|Other|0|||
48663746|NCT01133626|156621305|FG001|Overall Study|Other|2|||
48663747|NCT01133626|156621306|FG002|Overall Study|Other|0|||
48663748|NCT00520013|156621309|FG000|Overall Study|Withdrawal by Subject|0|||
48663749|NCT00520013|156621310|FG001|Overall Study|Withdrawal by Subject|0|||
48663750|NCT00520013|156621311|FG002|Overall Study|Withdrawal by Subject|1|||
48663751|NCT00520013|156621309|FG000|Overall Study|Adverse Event|2|||
48663752|NCT00520013|156621310|FG001|Overall Study|Adverse Event|10|||
48663753|NCT00520013|156621311|FG002|Overall Study|Adverse Event|7|||
48756604|NCT01103284|156956160|FG001|Overall Study|Adverse Event|5|||
48756605|NCT01103284|156956159|FG000|Overall Study|Withdrawal by Subject|14|||
48756606|NCT01103284|156956160|FG001|Overall Study|Withdrawal by Subject|18|||
48756607|NCT01103284|156956159|FG000|Overall Study|Dermal Hypersensitivity|0|||
48756608|NCT01103284|156956160|FG001|Overall Study|Dermal Hypersensitivity|1|||
48756609|NCT01103284|156956159|FG000|Overall Study|Termination by the Sponsor|0|||
48756610|NCT01103284|156956160|FG001|Overall Study|Termination by the Sponsor|1|||
48756611|NCT01103284|156956159|FG000|Overall Study|Not described|2|||
48756612|NCT01103284|156956160|FG001|Overall Study|Not described|1|||
48756613|NCT01103284|156956159|FG000|Overall Study|Missing CRF entries for study completion|0|||
48663754|NCT00520013|156621309|FG000|Overall Study|Progressive Disease|7|||
48663755|NCT00520013|156621310|FG001|Overall Study|Progressive Disease|3|||
48663756|NCT00520013|156621311|FG002|Overall Study|Progressive Disease|0|||
48756614|NCT01103284|156956160|FG001|Overall Study|Missing CRF entries for study completion|2|||
48756615|NCT03226392|156956165|FG000|Overall Study|Protocol Deviation|1|||
48756616|NCT03226392|156956166|FG001|Overall Study|Protocol Deviation|0|||
48966021|NCT03325556|157703710|FG002|Double-blind Period|Noncompliance with study drug|1|||
48663757|NCT00520013|156621309|FG000|Overall Study|Clinical Progression|3|||
48663758|NCT00520013|156621310|FG001|Overall Study|Clinical Progression|1|||
48756617|NCT03226392|156956165|FG000|Overall Study|Physician Decision|1|||
48663759|NCT00520013|156621311|FG002|Overall Study|Clinical Progression|0|||
48663760|NCT00520013|156621309|FG000|Overall Study|Death|0|||
48663761|NCT00520013|156621310|FG001|Overall Study|Death|1|||
48663762|NCT00520013|156621311|FG002|Overall Study|Death|0|||
48663763|NCT00520013|156621309|FG000|Overall Study|Physician Decision|0|||
48663764|NCT00520013|156621310|FG001|Overall Study|Physician Decision|0|||
48663765|NCT00520013|156621311|FG002|Overall Study|Physician Decision|3|||
48663766|NCT02788201|156621312|FG000|Overall Study|Death|1|||
48867097|NCT01072396|157349188|FG000|Period One|Protocol Violation|2|||
48663767|NCT02788201|156621313|FG001|Overall Study|Death|1|||
48663768|NCT02788201|156621314|FG002|Overall Study|Death|1|||
48663769|NCT02788201|156621315|FG003|Overall Study|Death|1|||
48663770|NCT02788201|156621316|FG004|Overall Study|Death|0|||
48867098|NCT01072396|157349189|FG001|Period One|Protocol Violation|1|||
48867099|NCT01072396|157349188|FG000|Period One|Withdrawal by Subject|2|||
48867100|NCT01072396|157349189|FG001|Period One|Withdrawal by Subject|0|||
48867101|NCT01072396|157349188|FG000|Washout Period|Missing termination information|0|||
48867102|NCT01072396|157349189|FG001|Washout Period|Missing termination information|1|||
48867103|NCT01072396|157349188|FG000|Period Two|Adverse Event|0|||
48867104|NCT01072396|157349189|FG001|Period Two|Adverse Event|3|||
48867105|NCT01072396|157349188|FG000|Period Two|Lost to Follow-up|1|||
48867106|NCT01072396|157349189|FG001|Period Two|Lost to Follow-up|0|||
48867107|NCT01475370|157349198|FG000|Overall Study|Exacerbation of primary disease|2|||
48867108|NCT01475370|157349199|FG001|Overall Study|Exacerbation of primary disease|2|||
48867109|NCT01475370|157349200|FG002|Overall Study|Exacerbation of primary disease|2|||
48867110|NCT01475370|157349198|FG000|Overall Study|Study drug administration difficult|0|||
48867111|NCT01475370|157349199|FG001|Overall Study|Study drug administration difficult|1|||
48867112|NCT01475370|157349200|FG002|Overall Study|Study drug administration difficult|1|||
48867113|NCT01475370|157349198|FG000|Overall Study|Other than specified|1|||
48867114|NCT01475370|157349199|FG001|Overall Study|Other than specified|0|||
48867115|NCT01475370|157349200|FG002|Overall Study|Other than specified|0|||
48867116|NCT05177770|157349203|FG000|Overall Study|Death|4|||
48867117|NCT05177770|157349203|FG000|Overall Study|Withdrawal by Subject|1|||
48867118|NCT05177770|157349203|FG000|Overall Study|Adverse Event prior to dosing|1|||
48867119|NCT02515097|157349207|FG000|Overall Study|Lost to Follow-up|4|||
48867120|NCT02515097|157349208|FG001|Overall Study|Lost to Follow-up|2|||
48867121|NCT02515097|157349207|FG000|Overall Study|Withdrawal by Subject|1|||
48867122|NCT02515097|157349208|FG001|Overall Study|Withdrawal by Subject|3|||
48867123|NCT02515097|157349207|FG000|Overall Study|Adverse Event|2|||
48867124|NCT02515097|157349208|FG001|Overall Study|Adverse Event|1|||
48867125|NCT00424177|157349216|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8|||
48867126|NCT00424177|157349216|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1|||
48867127|NCT00424177|157349216|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1|||
48867128|NCT00424177|157349216|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1|||
48867129|NCT00424177|157349216|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2|||
48867130|NCT00424177|157349216|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1|||
48867131|NCT00424177|157349216|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
48867132|NCT00424177|157349216|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1|||
48867133|NCT00424177|157349216|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
48867134|NCT00424177|157349216|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1|||
48867135|NCT03325608|157349217|FG000|Overall Study|Lost to Follow-up|23|||
48867136|NCT03325608|157349218|FG001|Overall Study|Lost to Follow-up|23|||
48867137|NCT03325608|157349219|FG002|Overall Study|Lost to Follow-up|30|||
48867138|NCT03325608|157349220|FG003|Overall Study|Lost to Follow-up|30|||
48867139|NCT03325608|157349217|FG000|Overall Study|Death of Caregiver|0|||
48867140|NCT03325608|157349218|FG001|Overall Study|Death of Caregiver|0|||
48867141|NCT03325608|157349219|FG002|Overall Study|Death of Caregiver|2|||
48867142|NCT03325608|157349220|FG003|Overall Study|Death of Caregiver|2|||
48867143|NCT03325608|157349217|FG000|Overall Study|Death of Care Recipient|34|||
48867144|NCT03325608|157349218|FG001|Overall Study|Death of Care Recipient|34|||
48867145|NCT03325608|157349219|FG002|Overall Study|Death of Care Recipient|28|||
48867146|NCT03325608|157349220|FG003|Overall Study|Death of Care Recipient|28|||
48867147|NCT03325608|157349217|FG000|Overall Study|Withdrawal by Subject|49|||
48867148|NCT03325608|157349218|FG001|Overall Study|Withdrawal by Subject|49|||
48867149|NCT03325608|157349219|FG002|Overall Study|Withdrawal by Subject|35|||
48867150|NCT03325608|157349220|FG003|Overall Study|Withdrawal by Subject|35|||
48867151|NCT03325608|157349217|FG000|Overall Study|Ineligible|7|||
48867152|NCT03325608|157349218|FG001|Overall Study|Ineligible|7|||
48867153|NCT03325608|157349219|FG002|Overall Study|Ineligible|5|||
48867154|NCT03325608|157349220|FG003|Overall Study|Ineligible|5|||
48867155|NCT00760877|157350735|FG000|Overall Study|Protocol Violation|1|||
48867156|NCT00760877|157350736|FG001|Overall Study|Protocol Violation|0|||
48867157|NCT00760877|157350735|FG000|Overall Study|Non-compliance with protocol treatment|2|||
48663771|NCT02788201|156621317|FG005|Overall Study|Death|1|||
48663772|NCT02788201|156621312|FG000|Overall Study|Ineligible|0|||
48663773|NCT02788201|156621313|FG001|Overall Study|Ineligible|0|||
48663774|NCT02788201|156621314|FG002|Overall Study|Ineligible|0|||
48867158|NCT00760877|157350736|FG001|Overall Study|Non-compliance with protocol treatment|1|||
48867159|NCT00760877|157350735|FG000|Overall Study|Pregnancy|1|||
48867160|NCT00760877|157350736|FG001|Overall Study|Pregnancy|4|||
48867161|NCT00760877|157350735|FG000|Overall Study|Death|2|||
48867162|NCT00760877|157350736|FG001|Overall Study|Death|1|||
48867163|NCT00760877|157350735|FG000|Overall Study|Withdrawal by Subject|7|||
48867164|NCT00760877|157350736|FG001|Overall Study|Withdrawal by Subject|3|||
48867165|NCT00760877|157350735|FG000|Overall Study|Adverse Event|19|||
48867166|NCT00760877|157350736|FG001|Overall Study|Adverse Event|12|||
48867167|NCT00760877|157350735|FG000|Overall Study|Participant diagnosed with AML|0|||
48867168|NCT00760877|157350736|FG001|Overall Study|Participant diagnosed with AML|1|||
48867169|NCT00760877|157350735|FG000|Overall Study|Participant not eligible to cross-over|0|||
48867170|NCT00760877|157350736|FG001|Overall Study|Participant not eligible to cross-over|1|||
48867171|NCT00760877|157350735|FG000|Overall Study|Physician Decision|1|||
48867172|NCT00760877|157350736|FG001|Overall Study|Physician Decision|2|||
48867173|NCT00760877|157350735|FG000|Overall Study|Participants transferred to AMN107A2408|11|||
48966022|NCT03325556|157703708|FG000|Double-blind Period|Use of prohibited medication|0|||
48966023|NCT03325556|157703709|FG001|Double-blind Period|Use of prohibited medication|1|||
48966024|NCT03325556|157703710|FG002|Double-blind Period|Use of prohibited medication|0|||
48966025|NCT03325556|157703708|FG000|Double-blind Period|Physician Decision|0|||
48966026|NCT03325556|157703709|FG001|Double-blind Period|Physician Decision|0|||
48966027|NCT03325556|157703710|FG002|Double-blind Period|Physician Decision|1|||
48966028|NCT03325556|157703708|FG000|Double-blind Period|Withdrawal by Subject|0|||
48966029|NCT03325556|157703709|FG001|Double-blind Period|Withdrawal by Subject|6|||
48966030|NCT03325556|157703710|FG002|Double-blind Period|Withdrawal by Subject|4|||
48966031|NCT03325556|157703708|FG000|Double-blind Period|Not otherwise specified|0|||
48966032|NCT03325556|157703709|FG001|Double-blind Period|Not otherwise specified|1|||
48966033|NCT03325556|157703710|FG002|Double-blind Period|Not otherwise specified|5|||
48966034|NCT03325556|157703708|FG000|Double-blind Period|Administrative discont. at study termination|0|||
48663775|NCT02788201|156621315|FG003|Overall Study|Ineligible|0|||
48663776|NCT02788201|156621316|FG004|Overall Study|Ineligible|0|||
48663777|NCT02788201|156621317|FG005|Overall Study|Ineligible|1|||
48663778|NCT02788201|156621312|FG000|Overall Study|Withdrawal by Subject|0|||
48663779|NCT02788201|156621313|FG001|Overall Study|Withdrawal by Subject|0|||
48663780|NCT02788201|156621314|FG002|Overall Study|Withdrawal by Subject|0|||
48663781|NCT02788201|156621315|FG003|Overall Study|Withdrawal by Subject|0|||
48663782|NCT02788201|156621316|FG004|Overall Study|Withdrawal by Subject|0|||
48663783|NCT02788201|156621317|FG005|Overall Study|Withdrawal by Subject|1|||
48663784|NCT00824005|156621318|FG000|Overall Study|Death|0|||
48663785|NCT00824005|156621319|FG001|Overall Study|Death|1|||
48663786|NCT00824005|156621318|FG000|Overall Study|Lost to Follow-up|0|||
48966035|NCT03325556|157703709|FG001|Double-blind Period|Administrative discont. at study termination|35|||
48966036|NCT03325556|157703710|FG002|Double-blind Period|Administrative discont. at study termination|31|||
48966037|NCT01170702|157703711|FG000|Overall Study|Exclusion criteria met after consent|1|||
48966038|NCT01170702|157703712|FG001|Overall Study|Exclusion criteria met after consent|2|||
48966039|NCT01170702|157703713|FG002|Overall Study|Exclusion criteria met after consent|0|||
48663787|NCT00824005|156621319|FG001|Overall Study|Lost to Follow-up|1|||
48966040|NCT01170702|157703714|FG003|Overall Study|Exclusion criteria met after consent|2|||
48966041|NCT00881361|157703722|FG000|Overall Study|Terminated prior to surgery|27|||
48663788|NCT01510184|156621320|FG000|Overall Study|Sponsor discretion|28|||
48756618|NCT03226392|156956166|FG001|Overall Study|Physician Decision|0|||
48663789|NCT01510184|156621321|FG001|Overall Study|Sponsor discretion|28|||
48663790|NCT01510184|156621320|FG000|Overall Study|Death|1|||
48663791|NCT01510184|156621321|FG001|Overall Study|Death|2|||
48756619|NCT03226392|156956165|FG000|Overall Study|Lost to Follow-up|1|||
48756620|NCT03226392|156956166|FG001|Overall Study|Lost to Follow-up|0|||
48756621|NCT03226392|156956165|FG000|Overall Study|Adverse Event|1|||
48756622|NCT03226392|156956166|FG001|Overall Study|Adverse Event|0|||
48756623|NCT03226392|156956165|FG000|Overall Study|Technical Problems|0|||
48756624|NCT03226392|156956166|FG001|Overall Study|Technical Problems|2|||
48756625|NCT03226392|156956165|FG000|Overall Study|Subject/Guardian Decision|7|||
48756626|NCT03226392|156956166|FG001|Overall Study|Subject/Guardian Decision|6|||
48756627|NCT03414424|156956167|FG000|Overall Study|Screened out after consent|0|||
48756628|NCT03414424|156956168|FG001|Overall Study|Screened out after consent|2|||
48756629|NCT03414424|156956167|FG000|Overall Study|Lost to Follow-up|0|||
48663792|NCT01510184|156621320|FG000|Overall Study|Withdrawal by Subject|1|||
48663793|NCT01510184|156621321|FG001|Overall Study|Withdrawal by Subject|4|||
48663794|NCT01510184|156621320|FG000|Overall Study|Other|0|||
48663795|NCT01510184|156621321|FG001|Overall Study|Other|1|||
48756630|NCT03414424|156956168|FG001|Overall Study|Lost to Follow-up|1|||
48756631|NCT02728895|156956169|FG000|Overall Study|Other|1|||
48867174|NCT00760877|157350736|FG001|Overall Study|Participants transferred to AMN107A2408|1|||
48867175|NCT00760877|157350735|FG000|Overall Study|Treatment failure|1|||
48867176|NCT00760877|157350736|FG001|Overall Study|Treatment failure|0|||
48867177|NCT04413149|157350739|FG000|Overall Study|Death|10|||
48966042|NCT00881361|157703723|FG001|Overall Study|Terminated prior to surgery|7|||
48867178|NCT04413149|157350740|FG001|Overall Study|Death|5|||
48867179|NCT04413149|157350739|FG000|Overall Study|Lung transplantation|1|||
48756632|NCT02728895|156956170|FG001|Overall Study|Other|2|||
48756633|NCT02728895|156956169|FG000|Overall Study|Withdrawal by Subject|0|||
48756634|NCT02728895|156956170|FG001|Overall Study|Withdrawal by Subject|3|||
48756635|NCT03527966|156956173|FG000|Overall Study|Lost to Follow-up|3|||
48756636|NCT03527966|156956174|FG001|Overall Study|Lost to Follow-up|0|||
48756637|NCT00937157|156956175|FG000|Overall Study|Pregnancy|1|||
48756638|NCT00937157|156956175|FG000|Overall Study|Lost to Follow-up|3|||
48756639|NCT03303079|156956176|FG000|Overall Study|Adverse Event|0|||
48756640|NCT03303079|156956177|FG001|Overall Study|Adverse Event|1|||
48756641|NCT03303079|156956178|FG002|Overall Study|Adverse Event|3|||
48756642|NCT03303079|156956176|FG000|Overall Study|Protocol Violation|5|||
48756643|NCT03303079|156956177|FG001|Overall Study|Protocol Violation|4|||
48756644|NCT03303079|156956178|FG002|Overall Study|Protocol Violation|7|||
48756645|NCT03303079|156956176|FG000|Overall Study|Withdrawal by Subject|2|||
48756646|NCT03303079|156956177|FG001|Overall Study|Withdrawal by Subject|4|||
48756647|NCT03303079|156956178|FG002|Overall Study|Withdrawal by Subject|2|||
48756648|NCT03303079|156956176|FG000|Overall Study|Other than specified|0|||
48756649|NCT03303079|156956177|FG001|Overall Study|Other than specified|2|||
48756650|NCT03303079|156956178|FG002|Overall Study|Other than specified|0|||
48756651|NCT01111149|156956179|FG000|Overall Study|Protocol Violation|1|||
48756652|NCT01111149|156956180|FG001|Overall Study|Protocol Violation|1|||
48867180|NCT04413149|157350740|FG001|Overall Study|Lung transplantation|0|||
48867181|NCT02661490|157350745|FG000|Overall Study|Lost to Follow-up|0|||
48867182|NCT02661490|157350746|FG001|Overall Study|Lost to Follow-up|1|||
48867183|NCT02661490|157350747|FG002|Overall Study|Lost to Follow-up|0|||
48867184|NCT02661490|157350748|FG003|Overall Study|Lost to Follow-up|0|||
48867185|NCT02661490|157350749|FG004|Overall Study|Lost to Follow-up|2|||
48867186|NCT02661490|157350745|FG000|Overall Study|Withdrawal by Subject|2|||
48867187|NCT02661490|157350746|FG001|Overall Study|Withdrawal by Subject|0|||
48867188|NCT02661490|157350747|FG002|Overall Study|Withdrawal by Subject|2|||
48867189|NCT02661490|157350748|FG003|Overall Study|Withdrawal by Subject|0|||
48867190|NCT02661490|157350749|FG004|Overall Study|Withdrawal by Subject|0|||
48867191|NCT02661490|157350745|FG000|Overall Study|Death|1|||
48867192|NCT02661490|157350746|FG001|Overall Study|Death|1|||
48867193|NCT02661490|157350747|FG002|Overall Study|Death|0|||
48867194|NCT02661490|157350748|FG003|Overall Study|Death|1|||
48867195|NCT02661490|157350749|FG004|Overall Study|Death|0|||
48867196|NCT02661490|157350745|FG000|Overall Study|Reason not Specified|0|||
48867197|NCT02661490|157350746|FG001|Overall Study|Reason not Specified|0|||
48867198|NCT02661490|157350747|FG002|Overall Study|Reason not Specified|0|||
48867199|NCT02661490|157350748|FG003|Overall Study|Reason not Specified|0|||
48867200|NCT02661490|157350749|FG004|Overall Study|Reason not Specified|1|||
48867201|NCT02600897|157350750|FG000|Overall Study|Death|1|||
48867202|NCT02600897|157350751|FG001|Overall Study|Death|2|||
48867203|NCT02600897|157350752|FG002|Overall Study|Death|1|||
48867204|NCT02600897|157350753|FG003|Overall Study|Death|2|||
48867205|NCT02600897|157350754|FG004|Overall Study|Death|3|||
48867206|NCT02600897|157350755|FG005|Overall Study|Death|2|||
48867207|NCT02600897|157350756|FG006|Overall Study|Death|10|||
48867208|NCT02600897|157350757|FG007|Overall Study|Death|7|||
48867209|NCT02600897|157350758|FG008|Overall Study|Death|20|||
48867210|NCT02600897|157350750|FG000|Overall Study|Lost to Follow-up|1|||
48867211|NCT02600897|157350751|FG001|Overall Study|Lost to Follow-up|0|||
48867212|NCT02600897|157350752|FG002|Overall Study|Lost to Follow-up|0|||
48867213|NCT02600897|157350753|FG003|Overall Study|Lost to Follow-up|0|||
48867214|NCT02600897|157350754|FG004|Overall Study|Lost to Follow-up|0|||
48867215|NCT02600897|157350755|FG005|Overall Study|Lost to Follow-up|0|||
48867216|NCT02600897|157350756|FG006|Overall Study|Lost to Follow-up|0|||
48867217|NCT02600897|157350757|FG007|Overall Study|Lost to Follow-up|1|||
48867218|NCT02600897|157350758|FG008|Overall Study|Lost to Follow-up|0|||
48867219|NCT02600897|157350750|FG000|Overall Study|Withdrawal by Subject|0|||
48867220|NCT02600897|157350751|FG001|Overall Study|Withdrawal by Subject|0|||
48867221|NCT02600897|157350752|FG002|Overall Study|Withdrawal by Subject|0|||
48867222|NCT02600897|157350753|FG003|Overall Study|Withdrawal by Subject|0|||
48867223|NCT02600897|157350754|FG004|Overall Study|Withdrawal by Subject|0|||
48867224|NCT02600897|157350755|FG005|Overall Study|Withdrawal by Subject|0|||
48867225|NCT02600897|157350756|FG006|Overall Study|Withdrawal by Subject|0|||
48867226|NCT02600897|157350757|FG007|Overall Study|Withdrawal by Subject|4|||
48867227|NCT02600897|157350758|FG008|Overall Study|Withdrawal by Subject|2|||
48867228|NCT02600897|157350750|FG000|Overall Study|Reason Not Specified|0|||
48867229|NCT02600897|157350751|FG001|Overall Study|Reason Not Specified|0|||
48867230|NCT02600897|157350752|FG002|Overall Study|Reason Not Specified|0|||
48867231|NCT02600897|157350753|FG003|Overall Study|Reason Not Specified|0|||
48867232|NCT02600897|157350754|FG004|Overall Study|Reason Not Specified|0|||
48867233|NCT02600897|157350755|FG005|Overall Study|Reason Not Specified|0|||
48867234|NCT02600897|157350756|FG006|Overall Study|Reason Not Specified|0|||
48867235|NCT02600897|157350757|FG007|Overall Study|Reason Not Specified|0|||
48867236|NCT02600897|157350758|FG008|Overall Study|Reason Not Specified|1|||
48663796|NCT01143051|156621322|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
48663797|NCT01143051|156621323|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
48663798|NCT01143051|156621324|FG002|3-14 Day Washout|Withdrawal by Subject|1|||
48663799|NCT01143051|156621325|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
48663800|NCT01143051|156621326|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
48663801|NCT01143051|156621327|FG005|3-14 Day Washout|Withdrawal by Subject|0|||
48663802|NCT01143051|156621322|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
48663803|NCT01143051|156621323|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
48663804|NCT01143051|156621324|FG002|3-14 Day Washout|Withdrawal by Subject|0|||
48663805|NCT01143051|156621325|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
48663806|NCT01143051|156621326|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
48663807|NCT01143051|156621327|FG005|3-14 Day Washout|Withdrawal by Subject|1|||
48663808|NCT02836873|156621328|FG000|Overall Study|Protocol Violation|0|||
48663809|NCT02836873|156621329|FG001|Overall Study|Protocol Violation|1|||
48663810|NCT02836873|156621328|FG000|Overall Study|Adverse Event|1|||
48663811|NCT02836873|156621329|FG001|Overall Study|Adverse Event|4|||
48663812|NCT02836873|156621328|FG000|Overall Study|Withdrawal by Subject|2|||
48663813|NCT02836873|156621329|FG001|Overall Study|Withdrawal by Subject|2|||
48663814|NCT02836873|156621328|FG000|Overall Study|Lost to Follow-up|1|||
48663815|NCT02836873|156621329|FG001|Overall Study|Lost to Follow-up|3|||
48663816|NCT02836873|156621328|FG000|Overall Study|Physician Decision|0|||
48663817|NCT02836873|156621329|FG001|Overall Study|Physician Decision|1|||
48663818|NCT02836873|156621328|FG000|Overall Study|Other|1|||
48663819|NCT02836873|156621329|FG001|Overall Study|Other|0|||
48663820|NCT02594098|156621334|FG000|Overall Study|Lack of Efficacy|17|||
48663821|NCT02594098|156621335|FG001|Overall Study|Lack of Efficacy|6|||
48756653|NCT01111149|156956181|FG002|Overall Study|Protocol Violation|2|||
48867237|NCT03322514|157350759|FG000|Overall Study|Withdrawal by Subject|1|||
48867238|NCT03322514|157350760|FG001|Overall Study|Withdrawal by Subject|1|||
48867239|NCT02093897|157350764|FG000|Overall Study|Physician Decision|1|||
48867240|NCT02093897|157350764|FG000|Overall Study|Planned age group closure - no's reached|17|||
48867241|NCT02093897|157350764|FG000|Overall Study|Adverse event, non-fatal|1|||
48867242|NCT00946998|157350765|FG000|Overall Study|Exited prior to first outcome assessment|5|||
48867243|NCT00946998|157350766|FG001|Overall Study|Exited prior to first outcome assessment|3|||
48867244|NCT03721978|157350767|FG000|Overall Study|Withdrawal by Subject|6|||
48867245|NCT03721978|157350768|FG001|Overall Study|Withdrawal by Subject|1|||
48867246|NCT03721978|157350767|FG000|Overall Study|Adverse Event|1|||
48867247|NCT03721978|157350768|FG001|Overall Study|Adverse Event|1|||
48867248|NCT03721978|157350767|FG000|Overall Study|Progressive Disease|1|||
48867249|NCT03721978|157350768|FG001|Overall Study|Progressive Disease|0|||
48867250|NCT03721978|157350767|FG000|Overall Study|Lost to Follow-up|5|||
48867251|NCT03721978|157350768|FG001|Overall Study|Lost to Follow-up|1|||
48867252|NCT03721978|157350767|FG000|Overall Study|Reason not Specified|0|||
48867253|NCT03721978|157350768|FG001|Overall Study|Reason not Specified|2|||
48867254|NCT04774237|157350775|FG000|Visit 2 First Intervention|Withdrawal by Subject|0|||
48867255|NCT04774237|157350776|FG001|Visit 2 First Intervention|Withdrawal by Subject|0|||
48867256|NCT04774237|157350777|FG002|Visit 2 First Intervention|Withdrawal by Subject|0|||
48867257|NCT04774237|157350778|FG003|Visit 2 First Intervention|Withdrawal by Subject|0|||
48867258|NCT04774237|157350779|FG004|Visit 2 First Intervention|Withdrawal by Subject|1|||
48867259|NCT04774237|157350780|FG005|Visit 2 First Intervention|Withdrawal by Subject|0|||
48867260|NCT00111839|157350781|FG000|Overall Study|Disease Progression|30|||
48867261|NCT00111839|157350782|FG001|Overall Study|Disease Progression|33|||
48867262|NCT00111839|157350783|FG002|Overall Study|Disease Progression|33|||
48867263|NCT00111839|157350781|FG000|Overall Study|Adverse Event|5|||
48867264|NCT00111839|157350782|FG001|Overall Study|Adverse Event|3|||
48867265|NCT00111839|157350783|FG002|Overall Study|Adverse Event|1|||
48867266|NCT00111839|157350781|FG000|Overall Study|Protocol Violation|2|||
48867267|NCT00111839|157350782|FG001|Overall Study|Protocol Violation|4|||
48867268|NCT00111839|157350783|FG002|Overall Study|Protocol Violation|2|||
48867269|NCT00111839|157350781|FG000|Overall Study|Death|1|||
48867270|NCT00111839|157350782|FG001|Overall Study|Death|1|||
48867271|NCT00111839|157350783|FG002|Overall Study|Death|6|||
48867272|NCT00111839|157350781|FG000|Overall Study|Withdrawal by Subject|2|||
48867273|NCT00111839|157350782|FG001|Overall Study|Withdrawal by Subject|2|||
48867274|NCT00111839|157350783|FG002|Overall Study|Withdrawal by Subject|2|||
48867275|NCT00111839|157350781|FG000|Overall Study|Lost to Follow-up|1|||
48867276|NCT00111839|157350782|FG001|Overall Study|Lost to Follow-up|0|||
48867277|NCT00111839|157350783|FG002|Overall Study|Lost to Follow-up|0|||
48867278|NCT00111839|157350781|FG000|Overall Study|Logistical Constraint|1|||
48867279|NCT00111839|157350782|FG001|Overall Study|Logistical Constraint|0|||
48867280|NCT00111839|157350783|FG002|Overall Study|Logistical Constraint|0|||
48867281|NCT00111839|157350781|FG000|Overall Study|Other|6|||
48867282|NCT00111839|157350782|FG001|Overall Study|Other|3|||
48663822|NCT02594098|156621334|FG000|Overall Study|Withdrawal by Subject|1|||
48663823|NCT02594098|156621335|FG001|Overall Study|Withdrawal by Subject|3|||
48663824|NCT02594098|156621334|FG000|Overall Study|Terminated participation|6|||
48663825|NCT02594098|156621335|FG001|Overall Study|Terminated participation|2|||
48663826|NCT02594098|156621334|FG000|Overall Study|Seek alternative treatment|2|||
48663827|NCT02594098|156621335|FG001|Overall Study|Seek alternative treatment|1|||
48663828|NCT02594098|156621334|FG000|Overall Study|Other|0|||
48663829|NCT02594098|156621335|FG001|Overall Study|Other|1|||
48663830|NCT01996592|156621336|FG000|Overall Study|no response to text/no diary entry|32|||
48663831|NCT01996592|156621336|FG000|Overall Study|change in surgical date|4|||
48663832|NCT01996592|156621336|FG000|Overall Study|Withdrawal by Subject|5|||
48663833|NCT01996592|156621336|FG000|Overall Study|change in mode of delivery|4|||
48663834|NCT03532932|156621337|FG000|Overall Study|Protocol Deviation|33|||
48663835|NCT03532932|156621338|FG001|Overall Study|Protocol Deviation|31|||
48663836|NCT03532932|156621337|FG000|Overall Study|Appearance of Exclusion Criteria|9|||
48966043|NCT00881361|157703724|FG002|Overall Study|Terminated prior to surgery|0|||
48966044|NCT00881361|157703722|FG000|Overall Study|Ineligible|17|||
48663837|NCT03532932|156621338|FG001|Overall Study|Appearance of Exclusion Criteria|11|||
48663838|NCT03532932|156621337|FG000|Overall Study|Withdrawal by Subject|2|||
48663839|NCT03532932|156621338|FG001|Overall Study|Withdrawal by Subject|0|||
48663840|NCT03532932|156621337|FG000|Overall Study|Lost to Follow-up|15|||
48663841|NCT03532932|156621338|FG001|Overall Study|Lost to Follow-up|9|||
48867283|NCT00111839|157350783|FG002|Overall Study|Other|3|||
48867284|NCT00111839|157350781|FG000|Overall Study|Randomized but Not Treated|0|||
48867285|NCT00111839|157350782|FG001|Overall Study|Randomized but Not Treated|0|||
48867286|NCT00111839|157350783|FG002|Overall Study|Randomized but Not Treated|2|||
48867287|NCT00352053|157350784|FG000|Double-Blind Phase (Through Week 48)|Virologic Failure|14|||
48867288|NCT00352053|157350785|FG001|Double-Blind Phase (Through Week 48)|Virologic Failure|10|||
48867289|NCT00352053|157350784|FG000|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
48867290|NCT00352053|157350785|FG001|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
48867291|NCT00352053|157350784|FG000|Double-Blind Phase (Through Week 48)|Adverse Event|1|||
48867292|NCT00352053|157350785|FG001|Double-Blind Phase (Through Week 48)|Adverse Event|0|||
48867293|NCT00352053|157350784|FG000|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0|||
48867294|NCT00352053|157350785|FG001|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1|||
48867295|NCT00352053|157350784|FG000|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1|||
48867296|NCT00352053|157350785|FG001|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0|||
48867297|NCT00352053|157350784|FG000|First Extension Phase (Weeks 48-144)|Physician Decision|9|||
48867298|NCT00352053|157350785|FG001|First Extension Phase (Weeks 48-144)|Physician Decision|13|||
48867299|NCT00352053|157350784|FG000|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1|||
48867300|NCT00352053|157350785|FG001|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4|||
48867301|NCT00352053|157350784|FG000|First Extension Phase (Weeks 48-144)|Pregnancy|1|||
48867302|NCT00352053|157350785|FG001|First Extension Phase (Weeks 48-144)|Pregnancy|0|||
48867303|NCT00352053|157350784|FG000|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1|||
48867304|NCT00352053|157350785|FG001|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0|||
48867305|NCT00352053|157350784|FG000|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
48867306|NCT00352053|157350785|FG001|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
48867307|NCT00352053|157350784|FG000|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
48867308|NCT00352053|157350785|FG001|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
48867309|NCT00352053|157350784|FG000|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
48867310|NCT00352053|157350785|FG001|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
48867311|NCT00352053|157350784|FG000|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0|||
48867312|NCT00352053|157350785|FG001|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1|||
48867313|NCT04203199|157350786|FG000|First Intervention Period|Lost to Follow-up|0|||
48867314|NCT04203199|157350787|FG001|First Intervention Period|Lost to Follow-up|1|||
48867315|NCT04203199|157350786|FG000|Second Intervention Period|Medication change|1|||
48867316|NCT04203199|157350787|FG001|Second Intervention Period|Medication change|0|||
48867317|NCT02186015|157350793|FG000|Overall Study|Physician Decision|1|||
48867318|NCT02186015|157350794|FG001|Overall Study|Physician Decision|0|||
48867319|NCT00907517|157350795|FG000|Overall Study|Progressive Disease|3|||
48867320|NCT00907517|157350796|FG001|Overall Study|Progressive Disease|3|||
48867321|NCT00907517|157350797|FG002|Overall Study|Progressive Disease|4|||
48867322|NCT00907517|157350798|FG003|Overall Study|Progressive Disease|4|||
48867323|NCT00907517|157350799|FG004|Overall Study|Progressive Disease|4|||
48867324|NCT00907517|157350795|FG000|Overall Study|Symptomatic Deterioration|0|||
48867325|NCT00907517|157350796|FG001|Overall Study|Symptomatic Deterioration|0|||
48867326|NCT00907517|157350797|FG002|Overall Study|Symptomatic Deterioration|0|||
48867327|NCT00907517|157350798|FG003|Overall Study|Symptomatic Deterioration|0|||
48867328|NCT00907517|157350799|FG004|Overall Study|Symptomatic Deterioration|1|||
48867329|NCT01732926|157350804|FG000|Overall Study|Study Terminated by Sponsor|168|||
48867330|NCT01732926|157350805|FG001|Overall Study|Study Terminated by Sponsor|80|||
48867331|NCT01732926|157350804|FG000|Overall Study|Withdrawal by Subject|46|||
48966045|NCT00881361|157703723|FG001|Overall Study|Ineligible|2|||
48966046|NCT00881361|157703724|FG002|Overall Study|Ineligible|2|||
48663842|NCT03532932|156621337|FG000|Overall Study|Adverse Event|4|||
48663843|NCT03532932|156621338|FG001|Overall Study|Adverse Event|3|||
48663844|NCT03532932|156621337|FG000|Overall Study|Death|0|||
48663845|NCT03532932|156621338|FG001|Overall Study|Death|2|||
48663846|NCT03532932|156621337|FG000|Overall Study|Other|11|||
48663847|NCT03532932|156621338|FG001|Overall Study|Other|16|||
48663848|NCT02255565|156621339|FG000|Overall Study|Withdrawal by Subject|0|||
48663849|NCT02255565|156621340|FG001|Overall Study|Withdrawal by Subject|1|||
48663850|NCT02255565|156621341|FG002|Overall Study|Withdrawal by Subject|0|||
48663851|NCT01344629|156621348|FG000|Crossover Period 2|Withdrawal by Subject|0|||
48663852|NCT01344629|156621349|FG001|Crossover Period 2|Withdrawal by Subject|1|||
48663853|NCT02782325|156621353|FG000|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4|||
48663854|NCT02782325|156621354|FG001|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2|||
48663855|NCT02782325|156621355|FG002|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0|||
48663856|NCT02782325|156621353|FG000|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
48663857|NCT02782325|156621354|FG001|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
48663858|NCT02782325|156621355|FG002|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4|||
48663859|NCT02242981|156621373|FG000|Overall Study|Withdrawal by Subject|1|||
48663860|NCT00303446|156623142|FG000|Overall Study|Withdrawal by Subject|2|||
48663861|NCT00303446|156623143|FG001|Overall Study|Withdrawal by Subject|2|||
48663862|NCT00303446|156623142|FG000|Overall Study|Death|0|||
48663863|NCT00303446|156623143|FG001|Overall Study|Death|1|||
48663864|NCT00303446|156623142|FG000|Overall Study|Physician Decision|0|||
48663865|NCT00303446|156623143|FG001|Overall Study|Physician Decision|1|||
48663866|NCT03002818|156623144|FG000|Overall Study|Decision of the investigator|1|||
48663867|NCT01739933|156623151|FG000|Overall Study|Death|89|||
48663868|NCT01739933|156623152|FG001|Overall Study|Death|86|||
48663869|NCT01739933|156623151|FG000|Overall Study|Withdrawal by Subject|10|||
48756654|NCT01111149|156956179|FG000|Overall Study|Withdrawal by Subject|1|||
48756655|NCT01111149|156956180|FG001|Overall Study|Withdrawal by Subject|0|||
48756656|NCT01111149|156956181|FG002|Overall Study|Withdrawal by Subject|2|||
48756657|NCT01110707|156956182|FG000|Overall Study|Protocol Violation|0|||
48756658|NCT01110707|156956183|FG001|Overall Study|Protocol Violation|3|||
48756659|NCT01998633|156956184|FG000|Overall Study|Death|1|||
48756660|NCT03315208|156956185|FG000|Overall Study|Lost to Follow-up|11|||
48756661|NCT03315208|156956186|FG001|Overall Study|Lost to Follow-up|6|||
48756662|NCT03315208|156956185|FG000|Overall Study|Withdrawal by Subject|2|||
48756663|NCT03315208|156956186|FG001|Overall Study|Withdrawal by Subject|0|||
48756664|NCT02746874|156956190|FG000|Overall Study|Withdrawal by Subject|0|||
48756665|NCT02746874|156956191|FG001|Overall Study|Withdrawal by Subject|1|||
48756666|NCT02746874|156956190|FG000|Overall Study|Surgery Date Changed|0|||
48756667|NCT02746874|156956191|FG001|Overall Study|Surgery Date Changed|2|||
48756668|NCT02255981|156956192|FG000|Overall Study|Lost to Follow-up|3|||
48756669|NCT02255981|156956192|FG000|Overall Study|Withdrawal by Subject|1|||
48756670|NCT02278263|156956196|FG000|Overall Study|Protocol Violation|7|||
48756671|NCT02278263|156956197|FG001|Overall Study|Protocol Violation|0|||
48756672|NCT02278263|156956198|FG002|Overall Study|Protocol Violation|9|||
48756673|NCT00022633|156956199|FG000|Overall Study|Adverse Event|11|||
48756674|NCT00022633|156956200|FG001|Overall Study|Adverse Event|1|||
48756675|NCT00022633|156956199|FG000|Overall Study|Refusal unrelated to adverse event|1|||
48756676|NCT00022633|156956200|FG001|Overall Study|Refusal unrelated to adverse event|0|||
48756677|NCT00022633|156956199|FG000|Overall Study|Progression/relapse|9|||
48663870|NCT01739933|156623152|FG001|Overall Study|Withdrawal by Subject|8|||
48663871|NCT01739933|156623151|FG000|Overall Study|Lost to Follow-up|3|||
48663872|NCT01739933|156623152|FG001|Overall Study|Lost to Follow-up|10|||
48663873|NCT01739933|156623151|FG000|Overall Study|Did not speak English required for neurospychological testing|4|||
48663874|NCT01739933|156623152|FG001|Overall Study|Did not speak English required for neurospychological testing|3|||
48663875|NCT02251717|156623153|FG000|Overall Study|Adverse Event|0|||
48663876|NCT02251717|156623154|FG001|Overall Study|Adverse Event|1|||
48663877|NCT02251717|156623153|FG000|Overall Study|Withdrew Consent|1|||
48663878|NCT02251717|156623154|FG001|Overall Study|Withdrew Consent|0|||
48663879|NCT02688088|156623159|FG000|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
48663880|NCT02688088|156623160|FG001|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|1|||
48663881|NCT02688088|156623161|FG002|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
48663882|NCT02688088|156623162|FG003|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
48663883|NCT02688088|156623163|FG004|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
48663884|NCT02688088|156623159|FG000|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
48663885|NCT02688088|156623160|FG001|Abemaciclib + Drug Cocktail - Period 2|Death|1|||
48663886|NCT02688088|156623161|FG002|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
48756678|NCT00022633|156956200|FG001|Overall Study|Progression/relapse|2|||
48756679|NCT00022633|156956199|FG000|Overall Study|Death|4|||
48663887|NCT02688088|156623162|FG003|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
48663888|NCT02688088|156623163|FG004|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
48663889|NCT02688088|156623159|FG000|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
48756680|NCT00022633|156956200|FG001|Overall Study|Death|0|||
48756681|NCT00022633|156956199|FG000|Overall Study|Other - not protocol specified|3|||
48756682|NCT00022633|156956200|FG001|Overall Study|Other - not protocol specified|2|||
48756683|NCT00022633|156956199|FG000|Overall Study|Ineligible|4|||
48663890|NCT02688088|156623160|FG001|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|3|||
48663891|NCT02688088|156623161|FG002|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
48663892|NCT02688088|156623162|FG003|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
48663893|NCT02688088|156623163|FG004|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
48663894|NCT02688088|156623159|FG000|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
48663895|NCT02688088|156623160|FG001|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|2|||
48756684|NCT00022633|156956200|FG001|Overall Study|Ineligible|0|||
48756685|NCT00674661|156956205|FG000|Overall Study|Other|5|||
48756686|NCT00674661|156956206|FG001|Overall Study|Other|7|||
48756687|NCT00674661|156956205|FG000|Overall Study|Lost to Follow-up|6|||
48756688|NCT00674661|156956206|FG001|Overall Study|Lost to Follow-up|3|||
48756689|NCT00674661|156956205|FG000|Overall Study|Withdrawal by Subject|0|||
48756690|NCT00674661|156956206|FG001|Overall Study|Withdrawal by Subject|5|||
48756691|NCT02410954|156956212|FG000|Overall Study|Unable to collect usable data due to initial protocol issues|6|||
48756692|NCT02410954|156956213|FG001|Overall Study|Unable to collect usable data due to initial protocol issues|0|||
48756693|NCT02410954|156956212|FG000|Overall Study|Instrument malfunction generated unusable data|8|||
48756694|NCT02410954|156956213|FG001|Overall Study|Instrument malfunction generated unusable data|0|||
48756695|NCT02452398|156956217|FG000|Overall Study|Adverse Event|1|||
48756696|NCT02452398|156956217|FG000|Overall Study|Lost to Follow-up|28|||
48663896|NCT02688088|156623161|FG002|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
48663897|NCT02688088|156623162|FG003|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
48663898|NCT02688088|156623163|FG004|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
48663899|NCT02688088|156623159|FG000|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
48663900|NCT02688088|156623160|FG001|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
48663901|NCT02688088|156623161|FG002|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|7|||
48663902|NCT02688088|156623162|FG003|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
48663903|NCT02688088|156623163|FG004|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
48663904|NCT02688088|156623159|FG000|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
48663905|NCT02688088|156623160|FG001|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
48663906|NCT02688088|156623161|FG002|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|1|||
48663907|NCT02688088|156623162|FG003|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
48663908|NCT02688088|156623163|FG004|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
48663909|NCT02688088|156623159|FG000|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
48663910|NCT02688088|156623160|FG001|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
48663911|NCT02688088|156623161|FG002|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
48663912|NCT02688088|156623162|FG003|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|7|||
48663913|NCT02688088|156623163|FG004|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
48663914|NCT02688088|156623159|FG000|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
48663915|NCT02688088|156623160|FG001|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
48663916|NCT02688088|156623161|FG002|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
48663917|NCT02688088|156623162|FG003|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|1|||
48663918|NCT02688088|156623163|FG004|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
48663919|NCT02688088|156623159|FG000|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
48663920|NCT02688088|156623160|FG001|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
48663921|NCT02688088|156623161|FG002|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
48663922|NCT02688088|156623162|FG003|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
48663923|NCT02688088|156623163|FG004|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|18|||
48756697|NCT02452398|156956217|FG000|Overall Study|Physician Decision|2|||
48756698|NCT02452398|156956217|FG000|Overall Study|Withdrawal by Subject|6|||
48756699|NCT02452398|156956217|FG000|Overall Study|Moved away|4|||
48756700|NCT01333059|156956218|FG000|Overall Study|Physician Decision|3|||
48756701|NCT01333059|156956219|FG001|Overall Study|Physician Decision|3|||
48756702|NCT01333059|156956218|FG000|Overall Study|Protocol Violation|3|||
48756703|NCT01333059|156956219|FG001|Overall Study|Protocol Violation|0|||
48756704|NCT00450333|156956220|FG000|Overall Study|Study terminated|47|||
48756705|NCT00450333|156956221|FG001|Overall Study|Study terminated|54|||
48756706|NCT00450333|156956222|FG002|Overall Study|Study terminated|16|||
48756707|NCT00450333|156956223|FG003|Overall Study|Study terminated|21|||
48966047|NCT01840228|157703725|FG000|Overall Study|Lost to Follow-up|1|||
48966048|NCT01840228|157703726|FG001|Overall Study|Lost to Follow-up|1|||
48663924|NCT04021524|156623169|FG000|Overall Study|Change in surgical intervention|0|||
48663925|NCT04021524|156623170|FG001|Overall Study|Change in surgical intervention|1|||
48663926|NCT01921218|156623171|FG000|Overall Study|Death|2|||
48756708|NCT00450333|156956220|FG000|Overall Study|Adverse Event|1|||
48756709|NCT00450333|156956221|FG001|Overall Study|Adverse Event|7|||
48756710|NCT00450333|156956222|FG002|Overall Study|Adverse Event|2|||
48756711|NCT00450333|156956223|FG003|Overall Study|Adverse Event|2|||
48756712|NCT00450333|156956220|FG000|Overall Study|Protocol Violation|1|||
48756713|NCT00450333|156956221|FG001|Overall Study|Protocol Violation|0|||
48756714|NCT00450333|156956222|FG002|Overall Study|Protocol Violation|1|||
48756715|NCT00450333|156956223|FG003|Overall Study|Protocol Violation|0|||
48756716|NCT00450333|156956220|FG000|Overall Study|Withdrawal by Subject|1|||
48756717|NCT00450333|156956221|FG001|Overall Study|Withdrawal by Subject|0|||
48756718|NCT00450333|156956222|FG002|Overall Study|Withdrawal by Subject|3|||
48756719|NCT00450333|156956223|FG003|Overall Study|Withdrawal by Subject|0|||
48756720|NCT00450333|156956220|FG000|Overall Study|Kidney transplant|1|||
48756721|NCT00450333|156956221|FG001|Overall Study|Kidney transplant|0|||
48756722|NCT00450333|156956222|FG002|Overall Study|Kidney transplant|1|||
48756723|NCT00450333|156956223|FG003|Overall Study|Kidney transplant|3|||
48756724|NCT00450333|156956220|FG000|Overall Study|Death|3|||
48756725|NCT00450333|156956221|FG001|Overall Study|Death|2|||
48756726|NCT00450333|156956222|FG002|Overall Study|Death|2|||
48966049|NCT01381718|157703727|FG000|Overall Study|Withdrawal by Subject|2|||
48966050|NCT01381718|157703728|FG001|Overall Study|Withdrawal by Subject|5|||
48663927|NCT01921218|156623172|FG001|Overall Study|Death|1|||
48663928|NCT01921218|156623171|FG000|Overall Study|Withdrawal by Subject|0|||
48966051|NCT01381718|157703727|FG000|Overall Study|Lost to Follow-up|3|||
48966052|NCT01381718|157703728|FG001|Overall Study|Lost to Follow-up|5|||
48966053|NCT01381718|157703727|FG000|Overall Study|Toxicity, side effects or complications related to study|0|||
48966054|NCT01381718|157703728|FG001|Overall Study|Toxicity, side effects or complications related to study|3|||
48966055|NCT01413542|157703733|FG000|Overall Study|Physician Decision|1|||
48966056|NCT01413542|157703734|FG001|Overall Study|Physician Decision|0|||
48966057|NCT01413542|157703735|FG002|Overall Study|Physician Decision|3|||
48966058|NCT01413542|157703736|FG003|Overall Study|Physician Decision|0|||
48966059|NCT01413542|157703733|FG000|Overall Study|Adverse Event|0|||
48966060|NCT01413542|157703734|FG001|Overall Study|Adverse Event|0|||
48663929|NCT01921218|156623172|FG001|Overall Study|Withdrawal by Subject|2|||
48966061|NCT01413542|157703735|FG002|Overall Study|Adverse Event|0|||
48966062|NCT01413542|157703736|FG003|Overall Study|Adverse Event|1|||
48966063|NCT04603391|157703737|FG000|First Intervention (4 Days)|Adverse Event|1|||
48966064|NCT04603391|157703738|FG001|First Intervention (4 Days)|Adverse Event|0|||
48966065|NCT04603391|157703737|FG000|First Intervention (4 Days)|Lost to Follow-up|1|||
48966066|NCT04603391|157703738|FG001|First Intervention (4 Days)|Lost to Follow-up|0|||
48966067|NCT02505542|157703739|FG000|Part A: Open-Label Period|Adverse Event|31|||
48966068|NCT02505542|157703740|FG001|Part A: Open-Label Period|Adverse Event|0|||
48966069|NCT02505542|157703741|FG002|Part A: Open-Label Period|Adverse Event|0|||
48966070|NCT02505542|157703742|FG003|Part A: Open-Label Period|Adverse Event|0|||
48966071|NCT02505542|157703739|FG000|Part A: Open-Label Period|Lack of Efficacy|5|||
48966072|NCT02505542|157703740|FG001|Part A: Open-Label Period|Lack of Efficacy|0|||
48966073|NCT02505542|157703741|FG002|Part A: Open-Label Period|Lack of Efficacy|0|||
48966074|NCT02505542|157703742|FG003|Part A: Open-Label Period|Lack of Efficacy|0|||
48966075|NCT02505542|157703739|FG000|Part A: Open-Label Period|Protocol Violation|1|||
48966076|NCT02505542|157703740|FG001|Part A: Open-Label Period|Protocol Violation|0|||
48966077|NCT02505542|157703741|FG002|Part A: Open-Label Period|Protocol Violation|0|||
48966078|NCT02505542|157703742|FG003|Part A: Open-Label Period|Protocol Violation|0|||
48966079|NCT02505542|157703739|FG000|Part A: Open-Label Period|Lost to Follow-up|5|||
48966080|NCT02505542|157703740|FG001|Part A: Open-Label Period|Lost to Follow-up|0|||
48966081|NCT02505542|157703741|FG002|Part A: Open-Label Period|Lost to Follow-up|0|||
48966082|NCT02505542|157703742|FG003|Part A: Open-Label Period|Lost to Follow-up|0|||
48966083|NCT02505542|157703739|FG000|Part A: Open-Label Period|Withdrawal by Subject|27|||
48966084|NCT02505542|157703740|FG001|Part A: Open-Label Period|Withdrawal by Subject|0|||
48966085|NCT02505542|157703741|FG002|Part A: Open-Label Period|Withdrawal by Subject|0|||
48966086|NCT02505542|157703742|FG003|Part A: Open-Label Period|Withdrawal by Subject|0|||
48966087|NCT02505542|157703739|FG000|Part A: Open-Label Period|New medical history available|1|||
48966088|NCT02505542|157703740|FG001|Part A: Open-Label Period|New medical history available|0|||
48966089|NCT02505542|157703741|FG002|Part A: Open-Label Period|New medical history available|0|||
48966090|NCT02505542|157703742|FG003|Part A: Open-Label Period|New medical history available|0|||
48663930|NCT01921218|156623171|FG000|Overall Study|Kidney transplant|1|||
48663931|NCT01921218|156623172|FG001|Overall Study|Kidney transplant|1|||
48756727|NCT00450333|156956223|FG003|Overall Study|Death|2|||
48756728|NCT03473808|156956227|FG000|Overall Study|Withdrawal by Subject|1|||
48756729|NCT04814433|156956231|FG000|Overall Study|Survey not returned|4|||
48756730|NCT04814433|156956232|FG001|Overall Study|Survey not returned|8|||
48756731|NCT04814433|156956233|FG002|Overall Study|Survey not returned|4|||
48756732|NCT04814433|156956234|FG003|Overall Study|Survey not returned|5|||
48756733|NCT00513474|156956235|FG000|Overall Study|Death|6|||
48756734|NCT00513474|156956236|FG001|Overall Study|Death|9|||
48966091|NCT02505542|157703739|FG000|Part A: Open-Label Period|Participant did not attend week 48 visit|1|||
48966092|NCT02505542|157703740|FG001|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
48966093|NCT02505542|157703741|FG002|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
49015456|NCT01393990|157893770|FG000|Overall Study|Progressive Disease|1|||
48663932|NCT00354107|156623173|FG000|Overall Study|Adverse Event|2|||
48663933|NCT00354107|156623173|FG000|Overall Study|Physician Decision|2|||
48663934|NCT00354107|156623173|FG000|Overall Study|Withdrawal by Subject|1|||
48663935|NCT02838901|156623181|FG000|Overall Study|Withdrawal by Subject|1|||
48966094|NCT02505542|157703742|FG003|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
48966095|NCT02505542|157703739|FG000|Part A: Open-Label Period|Pregnancy|2|||
48966096|NCT02505542|157703740|FG001|Part A: Open-Label Period|Pregnancy|0|||
48966097|NCT02505542|157703741|FG002|Part A: Open-Label Period|Pregnancy|0|||
48966098|NCT02505542|157703742|FG003|Part A: Open-Label Period|Pregnancy|0|||
48966099|NCT02505542|157703739|FG000|Part A: Open-Label Period|Sponsor directive|1|||
48966100|NCT02505542|157703740|FG001|Part A: Open-Label Period|Sponsor directive|0|||
48966101|NCT02505542|157703741|FG002|Part A: Open-Label Period|Sponsor directive|0|||
48966102|NCT02505542|157703742|FG003|Part A: Open-Label Period|Sponsor directive|0|||
48966103|NCT02505542|157703739|FG000|Part A: Open-Label Period|Medical monitor decision|1|||
48966104|NCT02505542|157703740|FG001|Part A: Open-Label Period|Medical monitor decision|0|||
48966105|NCT02505542|157703741|FG002|Part A: Open-Label Period|Medical monitor decision|0|||
48966106|NCT02505542|157703742|FG003|Part A: Open-Label Period|Medical monitor decision|0|||
48966107|NCT02505542|157703739|FG000|Part A: Open-Label Period|Screening failure (detected too late)|1|||
48966108|NCT02505542|157703740|FG001|Part A: Open-Label Period|Screening failure (detected too late)|0|||
48966109|NCT02505542|157703741|FG002|Part A: Open-Label Period|Screening failure (detected too late)|0|||
48663936|NCT02838901|156623182|FG001|Overall Study|Withdrawal by Subject|1|||
48663937|NCT02838901|156623181|FG000|Overall Study|Lost to Follow-up|1|||
48663938|NCT02838901|156623182|FG001|Overall Study|Lost to Follow-up|1|||
48663939|NCT00076336|156623183|FG000|Overall Study|Death|13|||
48663940|NCT00076336|156623184|FG001|Overall Study|Death|17|||
48663941|NCT00076336|156623183|FG000|Overall Study|Adverse Event|4|||
48663942|NCT00076336|156623184|FG001|Overall Study|Adverse Event|4|||
48663943|NCT00076336|156623183|FG000|Overall Study|Lost to Follow-up|4|||
48663944|NCT00076336|156623184|FG001|Overall Study|Lost to Follow-up|4|||
48663945|NCT00076336|156623183|FG000|Overall Study|Non-Compliance|2|||
48663946|NCT00076336|156623184|FG001|Overall Study|Non-Compliance|0|||
48663947|NCT00076336|156623183|FG000|Overall Study|Creatinine Clearance < 30 or Dialysis|0|||
48663948|NCT00076336|156623184|FG001|Overall Study|Creatinine Clearance < 30 or Dialysis|1|||
48663949|NCT00076336|156623183|FG000|Overall Study|Patient, Investigator, Sponsor request|8|||
48663950|NCT00076336|156623184|FG001|Overall Study|Patient, Investigator, Sponsor request|6|||
48663951|NCT00076336|156623183|FG000|Overall Study|Liver Transplantation|3|||
48663952|NCT00076336|156623184|FG001|Overall Study|Liver Transplantation|3|||
48663953|NCT00076336|156623183|FG000|Overall Study|Virologic Breakthrough|14|||
48663954|NCT00076336|156623184|FG001|Overall Study|Virologic Breakthrough|16|||
48663955|NCT00076336|156623183|FG000|Overall Study|Treatment failure|4|||
48663956|NCT00076336|156623184|FG001|Overall Study|Treatment failure|5|||
48663957|NCT02075047|156623185|FG000|Treatment Phase (4 Weeks)|Adverse Event|14|||
48663958|NCT02075047|156623186|FG001|Treatment Phase (4 Weeks)|Adverse Event|4|||
48663959|NCT02075047|156623185|FG000|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
48663960|NCT02075047|156623186|FG001|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
48663961|NCT02075047|156623185|FG000|Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
48663962|NCT02075047|156623186|FG001|Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
48663963|NCT02075047|156623185|FG000|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1|||
48663964|NCT02075047|156623186|FG001|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0|||
48663965|NCT02075047|156623185|FG000|Treatment Phase (4 Weeks)|Screen Failure|1|||
48663966|NCT02075047|156623186|FG001|Treatment Phase (4 Weeks)|Screen Failure|0|||
48663967|NCT02075047|156623185|FG000|Treatment Phase (4 Weeks)|Other|1|||
48663968|NCT02075047|156623186|FG001|Treatment Phase (4 Weeks)|Other|1|||
48663969|NCT02075047|156623185|FG000|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4|||
48663970|NCT02075047|156623186|FG001|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2|||
48663971|NCT02075047|156623185|FG000|Follow up Phase (5 Weeks)|Adverse Event|14|||
48663972|NCT02075047|156623186|FG001|Follow up Phase (5 Weeks)|Adverse Event|4|||
48663973|NCT02075047|156623185|FG000|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
48663974|NCT02075047|156623186|FG001|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
48663975|NCT02075047|156623185|FG000|Follow up Phase (5 Weeks)|Lost to Follow-up|0|||
48663976|NCT02075047|156623186|FG001|Follow up Phase (5 Weeks)|Lost to Follow-up|1|||
48663977|NCT02075047|156623185|FG000|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1|||
48663978|NCT02075047|156623186|FG001|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0|||
48663979|NCT02075047|156623185|FG000|Follow up Phase (5 Weeks)|Screen Failure|1|||
48663980|NCT02075047|156623186|FG001|Follow up Phase (5 Weeks)|Screen Failure|0|||
48663981|NCT02075047|156623185|FG000|Follow up Phase (5 Weeks)|Other|1|||
48663982|NCT02075047|156623186|FG001|Follow up Phase (5 Weeks)|Other|2|||
48663983|NCT02075047|156623185|FG000|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7|||
48663984|NCT02075047|156623186|FG001|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4|||
48663985|NCT01156389|156623189|FG000|Overall Study|Elevated liver enzymes|4|||
48663986|NCT01156389|156623190|FG001|Overall Study|Elevated liver enzymes|0|||
48663987|NCT01156389|156623189|FG000|Overall Study|Vomiting|0|||
48663988|NCT01156389|156623190|FG001|Overall Study|Vomiting|1|||
48663989|NCT04126564|156623191|FG000|Overall Study|Withdrawal by Subject|0|||
48663990|NCT04126564|156623192|FG001|Overall Study|Withdrawal by Subject|2|||
49015457|NCT01393990|157893771|FG001|Overall Study|Progressive Disease|0|||
48756735|NCT00513474|156956235|FG000|Overall Study|Participant Withdrew Consent|1|||
48756736|NCT00513474|156956236|FG001|Overall Study|Participant Withdrew Consent|0|||
48756737|NCT01686633|156956237|FG000|Overall Study|Lack of Efficacy|33|||
48756738|NCT01686633|156956238|FG001|Overall Study|Lack of Efficacy|13|||
48756739|NCT01686633|156956239|FG002|Overall Study|Lack of Efficacy|11|||
48756740|NCT01686633|156956237|FG000|Overall Study|Withdrawal by Subject|8|||
48756741|NCT01686633|156956238|FG001|Overall Study|Withdrawal by Subject|8|||
48756742|NCT01686633|156956239|FG002|Overall Study|Withdrawal by Subject|5|||
48756743|NCT01686633|156956237|FG000|Overall Study|Physician Decision|3|||
48756744|NCT01686633|156956238|FG001|Overall Study|Physician Decision|4|||
48756745|NCT01686633|156956239|FG002|Overall Study|Physician Decision|4|||
48756746|NCT01686633|156956237|FG000|Overall Study|Adverse Event|4|||
48756747|NCT01686633|156956238|FG001|Overall Study|Adverse Event|3|||
48756748|NCT01686633|156956239|FG002|Overall Study|Adverse Event|3|||
48756749|NCT01686633|156956237|FG000|Overall Study|Protocol Violation|2|||
48756750|NCT01686633|156956238|FG001|Overall Study|Protocol Violation|3|||
48756751|NCT01686633|156956239|FG002|Overall Study|Protocol Violation|0|||
48756752|NCT01686633|156956237|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
48756753|NCT01686633|156956238|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
48756754|NCT01686633|156956239|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
48756755|NCT01686633|156956237|FG000|Overall Study|Lost to Follow-up|0|||
48756756|NCT01686633|156956238|FG001|Overall Study|Lost to Follow-up|1|||
48756757|NCT01686633|156956239|FG002|Overall Study|Lost to Follow-up|1|||
48756758|NCT02045797|156956240|FG000|Overall Study|Adverse Event|3|||
48756759|NCT02045797|156956241|FG001|Overall Study|Adverse Event|1|||
48756760|NCT02045797|156956242|FG002|Overall Study|Adverse Event|0|||
48756761|NCT02045797|156956240|FG000|Overall Study|Lack of Efficacy|1|||
48756762|NCT02045797|156956241|FG001|Overall Study|Lack of Efficacy|0|||
48756763|NCT02045797|156956242|FG002|Overall Study|Lack of Efficacy|0|||
48756764|NCT02045797|156956240|FG000|Overall Study|Lost to Follow-up|2|||
48756765|NCT02045797|156956241|FG001|Overall Study|Lost to Follow-up|3|||
48756766|NCT02045797|156956242|FG002|Overall Study|Lost to Follow-up|1|||
48756767|NCT02045797|156956240|FG000|Overall Study|Physician Decision|0|||
48756768|NCT02045797|156956241|FG001|Overall Study|Physician Decision|1|||
48756769|NCT02045797|156956242|FG002|Overall Study|Physician Decision|0|||
48756770|NCT02045797|156956240|FG000|Overall Study|Withdrawal by Subject|1|||
48756771|NCT02045797|156956241|FG001|Overall Study|Withdrawal by Subject|2|||
48756772|NCT02045797|156956242|FG002|Overall Study|Withdrawal by Subject|0|||
48756773|NCT02738151|156956243|FG000|Overall Study|Randomized but not treated|4|||
48756774|NCT02738151|156956244|FG001|Overall Study|Randomized but not treated|1|||
48756775|NCT02738151|156956243|FG000|Overall Study|Adverse Event|4|||
48756776|NCT02738151|156956244|FG001|Overall Study|Adverse Event|5|||
48756777|NCT02738151|156956243|FG000|Overall Study|Hypoglycemia|0|||
48756778|NCT02738151|156956244|FG001|Overall Study|Hypoglycemia|1|||
48756779|NCT02738151|156956243|FG000|Overall Study|Poor Compliance to Protocol|4|||
48756780|NCT02738151|156956244|FG001|Overall Study|Poor Compliance to Protocol|3|||
48756781|NCT02738151|156956243|FG000|Overall Study|Other than specified above|11|||
48756782|NCT02738151|156956244|FG001|Overall Study|Other than specified above|21|||
48756783|NCT03649711|156956245|FG000|Overall Study|Adverse Event|0|||
48756784|NCT03649711|156956246|FG001|Overall Study|Adverse Event|1|||
48756785|NCT03649711|156956247|FG002|Overall Study|Adverse Event|0|||
48756786|NCT03649711|156956245|FG000|Overall Study|Kidney Transplant|1|||
48756787|NCT03649711|156956246|FG001|Overall Study|Kidney Transplant|0|||
48663991|NCT04126564|156623191|FG000|Overall Study|Lost to Follow-up|0|||
48663992|NCT04126564|156623192|FG001|Overall Study|Lost to Follow-up|1|||
48663993|NCT00445848|156623193|FG000|Overall Study|Adverse Event|14|||
48663994|NCT00445848|156623193|FG000|Overall Study|Withdrawal by Subject|4|||
48663995|NCT00445848|156623193|FG000|Overall Study|Progression|62|||
48663996|NCT00445848|156623193|FG000|Overall Study|Other-Not protocol specified|5|||
48663997|NCT01920893|156623194|FG000|Overall Study|Adverse Event|5|||
48663998|NCT01920893|156623195|FG001|Overall Study|Adverse Event|2|||
48663999|NCT01920893|156623194|FG000|Overall Study|Lack of Efficacy|2|||
48664000|NCT01920893|156623195|FG001|Overall Study|Lack of Efficacy|0|||
48664001|NCT00159913|156623196|FG000|Overall Study|Adverse Event|1|||
48756788|NCT03649711|156956247|FG002|Overall Study|Kidney Transplant|0|||
48756789|NCT01988103|156958101|FG000|Placebo-Controlled Phase Week 0-16|Adverse Event|3|||
48756790|NCT01988103|156958102|FG001|Placebo-Controlled Phase Week 0-16|Adverse Event|10|||
48756791|NCT01988103|156958103|FG002|Placebo-Controlled Phase Week 0-16|Adverse Event|6|||
48756792|NCT01988103|156958104|FG003|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
48756793|NCT01988103|156958105|FG004|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
48756794|NCT01988103|156958101|FG000|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1|||
48756795|NCT01988103|156958102|FG001|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
48756796|NCT01988103|156958103|FG002|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
48664002|NCT00159913|156623197|FG001|Overall Study|Adverse Event|0|||
48756797|NCT01988103|156958104|FG003|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
48756798|NCT01988103|156958105|FG004|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
48664003|NCT00159913|156623198|FG002|Overall Study|Adverse Event|1|||
48664004|NCT00159913|156623199|FG003|Overall Study|Adverse Event|0|||
48664005|NCT00159913|156623196|FG000|Overall Study|Withdrawal by Subject|0|||
48664006|NCT00159913|156623197|FG001|Overall Study|Withdrawal by Subject|0|||
48756799|NCT01988103|156958101|FG000|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8|||
48756800|NCT01988103|156958102|FG001|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4|||
48756801|NCT01988103|156958103|FG002|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1|||
48756802|NCT01988103|156958104|FG003|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
48756803|NCT01988103|156958105|FG004|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
48756804|NCT01988103|156958101|FG000|Active Treatment Phase (Weeks 16-68)|Adverse Event|0|||
48756805|NCT01988103|156958102|FG001|Active Treatment Phase (Weeks 16-68)|Adverse Event|6|||
48756806|NCT01988103|156958103|FG002|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
48756807|NCT01988103|156958104|FG003|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
48756808|NCT01988103|156958105|FG004|Active Treatment Phase (Weeks 16-68)|Adverse Event|2|||
48756809|NCT01988103|156958101|FG000|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
48756810|NCT01988103|156958102|FG001|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1|||
48756811|NCT01988103|156958103|FG002|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2|||
48756812|NCT01988103|156958104|FG003|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
48756813|NCT01988103|156958105|FG004|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
48756814|NCT01988103|156958101|FG000|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
48756815|NCT01988103|156958102|FG001|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5|||
48756816|NCT01988103|156958103|FG002|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4|||
48756817|NCT01988103|156958104|FG003|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
48756818|NCT01988103|156958105|FG004|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1|||
48756819|NCT01988103|156958101|FG000|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
48756820|NCT01988103|156958102|FG001|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1|||
48756821|NCT01988103|156958103|FG002|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
48756822|NCT01988103|156958104|FG003|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
48756823|NCT01988103|156958105|FG004|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
48756824|NCT04166435|156958106|FG000|Overall Study|2 patients ineligible for response|2|||
48756825|NCT00267046|156958107|FG000|Overall Study|Disease progression|4|||
48756826|NCT00267046|156958108|FG001|Overall Study|Disease progression|2|||
48756827|NCT00267046|156958107|FG000|Overall Study|Chemotoxicity|2|||
48756828|NCT00267046|156958108|FG001|Overall Study|Chemotoxicity|0|||
48756829|NCT00267046|156958107|FG000|Overall Study|Open-label palifermin|2|||
48756830|NCT00267046|156958108|FG001|Overall Study|Open-label palifermin|7|||
48756831|NCT00267046|156958107|FG000|Overall Study|Surgery|3|||
48756832|NCT00267046|156958108|FG001|Overall Study|Surgery|1|||
48756833|NCT00267046|156958107|FG000|Overall Study|Withdrawal by Subject|1|||
48756834|NCT00267046|156958108|FG001|Overall Study|Withdrawal by Subject|0|||
48756835|NCT00267046|156958107|FG000|Overall Study|Radiation|0|||
48756836|NCT00267046|156958108|FG001|Overall Study|Radiation|1|||
48756837|NCT02066233|156958111|FG000|EG Scan II (Day 1)|difficulty intubating subject|6|||
48756838|NCT02066233|156958112|FG001|EG Scan II (Day 1)|difficulty intubating subject|6|||
48756839|NCT00103142|156958113|FG000|Overall Study|Adverse Event|1|||
48867332|NCT01732926|157350805|FG001|Overall Study|Withdrawal by Subject|8|||
48664007|NCT00159913|156623198|FG002|Overall Study|Withdrawal by Subject|0|||
48664008|NCT00159913|156623199|FG003|Overall Study|Withdrawal by Subject|1|||
48664009|NCT00159913|156623196|FG000|Overall Study|Lost to Follow-up|0|||
48756840|NCT00103142|156958114|FG001|Overall Study|Adverse Event|0|||
48756841|NCT00103142|156958113|FG000|Overall Study|Progression of disease|2|||
48756842|NCT00103142|156958114|FG001|Overall Study|Progression of disease|1|||
48867333|NCT01732926|157350804|FG000|Overall Study|Physician Decision|24|||
48867334|NCT01732926|157350805|FG001|Overall Study|Physician Decision|11|||
48867335|NCT01732926|157350804|FG000|Overall Study|Other Reason|21|||
48867336|NCT01732926|157350805|FG001|Overall Study|Other Reason|4|||
48867337|NCT01732926|157350804|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|7|||
48867338|NCT01732926|157350805|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|6|||
48867339|NCT01732926|157350804|FG000|Overall Study|Blind Broken by Subject or Study Site|1|||
48867340|NCT01732926|157350805|FG001|Overall Study|Blind Broken by Subject or Study Site|1|||
48867341|NCT03785210|157350806|FG000|Overall Study|Principal investigator decision - clinical progression|1|||
48867342|NCT03785210|157350807|FG001|Overall Study|Principal investigator decision - clinical progression|6|||
48867343|NCT00187135|157350810|FG000|Visit One|Withdrawal by Subject|1|||
48867344|NCT00187135|157350811|FG001|Visit One|Withdrawal by Subject|0|||
48867345|NCT00187135|157350812|FG002|Visit One|Withdrawal by Subject|0|||
48867346|NCT00187135|157350813|FG003|Visit One|Withdrawal by Subject|0|||
48867347|NCT00187135|157350814|FG004|Visit One|Withdrawal by Subject|0|||
48867348|NCT00187135|157350815|FG005|Visit One|Withdrawal by Subject|1|||
48664010|NCT00159913|156623197|FG001|Overall Study|Lost to Follow-up|0|||
48664011|NCT00159913|156623198|FG002|Overall Study|Lost to Follow-up|0|||
48664012|NCT00159913|156623199|FG003|Overall Study|Lost to Follow-up|1|||
48756843|NCT02432846|156958115|FG000|Overall Study (4 Arms/Strata)|Death|3|||
48756844|NCT02432846|156958116|FG001|Overall Study (4 Arms/Strata)|Death|2|||
48756845|NCT02432846|156958117|FG002|Overall Study (4 Arms/Strata)|Death|4|||
48756846|NCT02432846|156958118|FG003|Overall Study (4 Arms/Strata)|Death|3|||
48756847|NCT02432846|156958119|FG004|Overall Study (4 Arms/Strata)|Death|0|||
48756848|NCT02432846|156958120|FG005|Overall Study (4 Arms/Strata)|Death|0|||
48756849|NCT02432846|156958115|FG000|Overall Study (4 Arms/Strata)|Adverse Event|0|||
48756850|NCT02432846|156958116|FG001|Overall Study (4 Arms/Strata)|Adverse Event|1|||
48756851|NCT02432846|156958117|FG002|Overall Study (4 Arms/Strata)|Adverse Event|1|||
48756852|NCT02432846|156958118|FG003|Overall Study (4 Arms/Strata)|Adverse Event|0|||
48756853|NCT02432846|156958119|FG004|Overall Study (4 Arms/Strata)|Adverse Event|0|||
48756854|NCT02432846|156958120|FG005|Overall Study (4 Arms/Strata)|Adverse Event|0|||
48756855|NCT02432846|156958115|FG000|Overall Study (4 Arms/Strata)|Physician Decision|2|||
48756856|NCT02432846|156958116|FG001|Overall Study (4 Arms/Strata)|Physician Decision|0|||
48756857|NCT02432846|156958117|FG002|Overall Study (4 Arms/Strata)|Physician Decision|0|||
48756858|NCT02432846|156958118|FG003|Overall Study (4 Arms/Strata)|Physician Decision|0|||
48756859|NCT02432846|156958119|FG004|Overall Study (4 Arms/Strata)|Physician Decision|0|||
48756860|NCT02432846|156958120|FG005|Overall Study (4 Arms/Strata)|Physician Decision|0|||
48756861|NCT02432846|156958115|FG000|Overall Study (4 Arms/Strata)|Withdrawal by Subject|2|||
48756862|NCT02432846|156958116|FG001|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
48756863|NCT02432846|156958117|FG002|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
48756864|NCT02432846|156958118|FG003|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
48756865|NCT02432846|156958119|FG004|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
48756866|NCT02432846|156958120|FG005|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
48756867|NCT02432846|156958115|FG000|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
48756868|NCT02432846|156958116|FG001|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
48664013|NCT00159913|156623196|FG000|Overall Study|Protocol Violation|1|||
48664014|NCT00159913|156623197|FG001|Overall Study|Protocol Violation|0|||
48664015|NCT00159913|156623198|FG002|Overall Study|Protocol Violation|1|||
48664016|NCT00159913|156623199|FG003|Overall Study|Protocol Violation|0|||
48664017|NCT01081301|156623200|FG000|Overall Study|Bereaved|3|||
48664018|NCT01081301|156623200|FG000|Overall Study|Too busy|5|||
48664019|NCT01081301|156623200|FG000|Overall Study|Patient too ill|2|||
48664020|NCT01081301|156623200|FG000|Overall Study|Lost to Follow-up|4|||
48664021|NCT01765426|156623201|FG000|Overall Study|Lost to Follow-up|0|||
48664022|NCT01765426|156623202|FG001|Overall Study|Lost to Follow-up|1|||
48756869|NCT02432846|156958117|FG002|Overall Study (4 Arms/Strata)|Other (reason not specified)|2|||
48867349|NCT00187135|157350810|FG000|Visit One|Physician Decision|3|||
48664023|NCT01765426|156623203|FG002|Overall Study|Lost to Follow-up|0|||
48664024|NCT01765426|156623204|FG003|Overall Study|Lost to Follow-up|0|||
48664025|NCT00989235|156623205|FG000|Overall Study|Death|0|||
48664026|NCT00989235|156623206|FG001|Overall Study|Death|1|||
48664027|NCT00989235|156623205|FG000|Overall Study|Adverse Event|0|||
48664028|NCT00989235|156623206|FG001|Overall Study|Adverse Event|1|||
48664029|NCT00989235|156623205|FG000|Overall Study|Lack of Efficacy|1|||
48664030|NCT00989235|156623206|FG001|Overall Study|Lack of Efficacy|0|||
48664031|NCT00989235|156623205|FG000|Overall Study|Withdrawal of Consent|1|||
48664032|NCT00989235|156623206|FG001|Overall Study|Withdrawal of Consent|1|||
48664033|NCT00989235|156623205|FG000|Overall Study|Desire to Become Pregnant|1|||
48664034|NCT00989235|156623206|FG001|Overall Study|Desire to Become Pregnant|0|||
48664035|NCT00989235|156623205|FG000|Overall Study|Randomized by Mistake|0|||
48664036|NCT00989235|156623206|FG001|Overall Study|Randomized by Mistake|2|||
48664037|NCT00989235|156623205|FG000|Overall Study|Lost to Follow-up|0|||
48867350|NCT00187135|157350811|FG001|Visit One|Physician Decision|1|||
48867351|NCT00187135|157350812|FG002|Visit One|Physician Decision|0|||
48664038|NCT00989235|156623206|FG001|Overall Study|Lost to Follow-up|1|||
48664039|NCT00545532|156623207|FG000|Overall Study|Withdrawal by Subject|1|||
48664040|NCT00545532|156623208|FG001|Overall Study|Withdrawal by Subject|3|||
48664041|NCT00545532|156623207|FG000|Overall Study|Lost to Follow-up|5|||
48664042|NCT00545532|156623208|FG001|Overall Study|Lost to Follow-up|6|||
48867352|NCT00187135|157350813|FG003|Visit One|Physician Decision|0|||
48867353|NCT00187135|157350814|FG004|Visit One|Physician Decision|0|||
48664043|NCT00545532|156623207|FG000|Overall Study|Death|0|||
48664044|NCT00545532|156623208|FG001|Overall Study|Death|1|||
48664045|NCT02680574|156623214|FG000|Overall Study|Death|137|||
48867354|NCT00187135|157350815|FG005|Visit One|Physician Decision|1|||
48867355|NCT00187135|157350810|FG000|Visit Two|Death|0|||
48867356|NCT00187135|157350811|FG001|Visit Two|Death|0|||
48867357|NCT00187135|157350812|FG002|Visit Two|Death|0|||
48867358|NCT00187135|157350813|FG003|Visit Two|Death|1|||
48867359|NCT00187135|157350814|FG004|Visit Two|Death|0|||
48867360|NCT00187135|157350815|FG005|Visit Two|Death|1|||
48867361|NCT00187135|157350810|FG000|Visit Two|Physician Decision|1|||
48867362|NCT00187135|157350811|FG001|Visit Two|Physician Decision|0|||
48867363|NCT00187135|157350812|FG002|Visit Two|Physician Decision|0|||
48867364|NCT00187135|157350813|FG003|Visit Two|Physician Decision|0|||
48867365|NCT00187135|157350814|FG004|Visit Two|Physician Decision|0|||
48756870|NCT02432846|156958118|FG003|Overall Study (4 Arms/Strata)|Other (reason not specified)|1|||
48756871|NCT02432846|156958119|FG004|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
48756872|NCT02432846|156958120|FG005|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
48756873|NCT02432846|156958115|FG000|Overall Study (4 Arms/Strata)|Disease progression|8|||
48756874|NCT02432846|156958116|FG001|Overall Study (4 Arms/Strata)|Disease progression|5|||
48756875|NCT02432846|156958117|FG002|Overall Study (4 Arms/Strata)|Disease progression|15|||
48756876|NCT02432846|156958118|FG003|Overall Study (4 Arms/Strata)|Disease progression|9|||
48756877|NCT02432846|156958119|FG004|Overall Study (4 Arms/Strata)|Disease progression|0|||
48756878|NCT02432846|156958120|FG005|Overall Study (4 Arms/Strata)|Disease progression|0|||
48756879|NCT02432846|156958115|FG000|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
48756880|NCT02432846|156958116|FG001|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
48756881|NCT02432846|156958117|FG002|Overall Study (4 Arms/Strata)|Lost to Follow-up|1|||
48756882|NCT02432846|156958118|FG003|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
48966110|NCT02505542|157703742|FG003|Part A: Open-Label Period|Screening failure (detected too late)|0|||
48966111|NCT02505542|157703739|FG000|Part A: Open-Label Period|Non-compliance|1|||
48966112|NCT02505542|157703740|FG001|Part A: Open-Label Period|Non-compliance|0|||
48966113|NCT02505542|157703741|FG002|Part A: Open-Label Period|Non-compliance|0|||
48966114|NCT02505542|157703742|FG003|Part A: Open-Label Period|Non-compliance|0|||
48966115|NCT02505542|157703739|FG000|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2|||
48966116|NCT02505542|157703740|FG001|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
48966117|NCT02505542|157703741|FG002|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
48966118|NCT02505542|157703742|FG003|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
48966119|NCT02505542|157703739|FG000|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3|||
48966120|NCT02505542|157703740|FG001|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
48756883|NCT02432846|156958119|FG004|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
48756884|NCT02432846|156958120|FG005|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
48966121|NCT02505542|157703741|FG002|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
48966122|NCT02505542|157703742|FG003|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
48966123|NCT02505542|157703739|FG000|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341|||
48966124|NCT02505542|157703740|FG001|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
48966125|NCT02505542|157703741|FG002|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
48966126|NCT02505542|157703742|FG003|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
48966127|NCT02505542|157703739|FG000|Part B: Double-Blind Period|Adverse Event|0|||
48966128|NCT02505542|157703740|FG001|Part B: Double-Blind Period|Adverse Event|0|||
48664046|NCT02680574|156623215|FG001|Overall Study|Death|137|||
48664047|NCT02680574|156623214|FG000|Overall Study|Withdrawal by Subject|17|||
48664048|NCT02680574|156623215|FG001|Overall Study|Withdrawal by Subject|9|||
48664049|NCT02680574|156623214|FG000|Overall Study|Lost to Follow-up|4|||
48664050|NCT02680574|156623215|FG001|Overall Study|Lost to Follow-up|6|||
48664051|NCT01514240|156623216|FG000|Overall Study|Adverse Event|4|||
48664052|NCT01514240|156623217|FG001|Overall Study|Adverse Event|4|||
48664053|NCT01514240|156623216|FG000|Overall Study|Subject Decision|2|||
48664054|NCT01514240|156623217|FG001|Overall Study|Subject Decision|7|||
48664055|NCT01286987|156623222|FG000|Part 1: Dose Escalation|Clinical Progression|1|||
48664056|NCT01286987|156623223|FG001|Part 1: Dose Escalation|Clinical Progression|1|||
48664057|NCT01286987|156623224|FG002|Part 1: Dose Escalation|Clinical Progression|0|||
48664058|NCT01286987|156623225|FG003|Part 1: Dose Escalation|Clinical Progression|1|||
48664059|NCT01286987|156623226|FG004|Part 1: Dose Escalation|Clinical Progression|1|||
48664060|NCT01286987|156623227|FG005|Part 1: Dose Escalation|Clinical Progression|1|||
48664061|NCT01286987|156623228|FG006|Part 1: Dose Escalation|Clinical Progression|0|||
48966129|NCT02505542|157703741|FG002|Part B: Double-Blind Period|Adverse Event|1|||
48966130|NCT02505542|157703742|FG003|Part B: Double-Blind Period|Adverse Event|3|||
48966131|NCT02505542|157703739|FG000|Part B: Double-Blind Period|Lost to Follow-up|0|||
48966132|NCT02505542|157703740|FG001|Part B: Double-Blind Period|Lost to Follow-up|0|||
48756885|NCT02432846|156958115|FG000|Overall Study (2 Total/Combined Groups)|Death|0|||
48756886|NCT02432846|156958116|FG001|Overall Study (2 Total/Combined Groups)|Death|0|||
48966133|NCT02505542|157703741|FG002|Part B: Double-Blind Period|Lost to Follow-up|0|||
48966134|NCT02505542|157703742|FG003|Part B: Double-Blind Period|Lost to Follow-up|1|||
48966135|NCT02505542|157703739|FG000|Part B: Double-Blind Period|Withdrawal by Subject|0|||
48966136|NCT02505542|157703740|FG001|Part B: Double-Blind Period|Withdrawal by Subject|8|||
48966137|NCT02505542|157703741|FG002|Part B: Double-Blind Period|Withdrawal by Subject|7|||
48966138|NCT02505542|157703742|FG003|Part B: Double-Blind Period|Withdrawal by Subject|2|||
48966139|NCT02505542|157703739|FG000|Part B: Double-Blind Period|Planning pregnancy|0|||
48664062|NCT01286987|156623229|FG007|Part 1: Dose Escalation|Clinical Progression|2|||
48664063|NCT01286987|156623230|FG008|Part 1: Dose Escalation|Clinical Progression|1|||
48966140|NCT02505542|157703740|FG001|Part B: Double-Blind Period|Planning pregnancy|1|||
48664064|NCT01286987|156623231|FG009|Part 1: Dose Escalation|Clinical Progression|0|||
48664065|NCT01286987|156623232|FG010|Part 1: Dose Escalation|Clinical Progression|0|||
48664066|NCT01286987|156623233|FG011|Part 1: Dose Escalation|Clinical Progression|0|||
48664067|NCT01286987|156623234|FG012|Part 1: Dose Escalation|Clinical Progression|0|||
48664068|NCT01286987|156623235|FG013|Part 1: Dose Escalation|Clinical Progression|0|||
48664069|NCT01286987|156623236|FG014|Part 1: Dose Escalation|Clinical Progression|0|||
48664070|NCT01286987|156623222|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
48664071|NCT01286987|156623223|FG001|Part 1: Dose Escalation|Progressive Disease|2|||
48664072|NCT01286987|156623224|FG002|Part 1: Dose Escalation|Progressive Disease|3|||
48664073|NCT01286987|156623225|FG003|Part 1: Dose Escalation|Progressive Disease|2|||
48756887|NCT02432846|156958117|FG002|Overall Study (2 Total/Combined Groups)|Death|0|||
48756888|NCT02432846|156958118|FG003|Overall Study (2 Total/Combined Groups)|Death|0|||
48756889|NCT02432846|156958119|FG004|Overall Study (2 Total/Combined Groups)|Death|7|||
48756890|NCT02432846|156958120|FG005|Overall Study (2 Total/Combined Groups)|Death|5|||
48664074|NCT01286987|156623226|FG004|Part 1: Dose Escalation|Progressive Disease|1|||
48664075|NCT01286987|156623227|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
48664076|NCT01286987|156623228|FG006|Part 1: Dose Escalation|Progressive Disease|5|||
48664077|NCT01286987|156623229|FG007|Part 1: Dose Escalation|Progressive Disease|3|||
48664078|NCT01286987|156623230|FG008|Part 1: Dose Escalation|Progressive Disease|5|||
48664079|NCT01286987|156623231|FG009|Part 1: Dose Escalation|Progressive Disease|0|||
48664080|NCT01286987|156623232|FG010|Part 1: Dose Escalation|Progressive Disease|0|||
48664081|NCT01286987|156623233|FG011|Part 1: Dose Escalation|Progressive Disease|0|||
48664082|NCT01286987|156623234|FG012|Part 1: Dose Escalation|Progressive Disease|0|||
48966141|NCT02505542|157703741|FG002|Part B: Double-Blind Period|Planning pregnancy|0|||
48966142|NCT02505542|157703742|FG003|Part B: Double-Blind Period|Planning pregnancy|0|||
48966143|NCT02505542|157703739|FG000|Part B: Double-Blind Period|Week 94 missed|0|||
48966144|NCT02505542|157703740|FG001|Part B: Double-Blind Period|Week 94 missed|0|||
48966145|NCT02505542|157703741|FG002|Part B: Double-Blind Period|Week 94 missed|1|||
48966146|NCT02505542|157703742|FG003|Part B: Double-Blind Period|Week 94 missed|0|||
48966147|NCT02505542|157703739|FG000|Part B: Double-Blind Period|Patient was moved from the country|0|||
48966148|NCT02505542|157703740|FG001|Part B: Double-Blind Period|Patient was moved from the country|0|||
48966149|NCT02505542|157703741|FG002|Part B: Double-Blind Period|Patient was moved from the country|0|||
48966150|NCT02505542|157703742|FG003|Part B: Double-Blind Period|Patient was moved from the country|1|||
48966151|NCT02505542|157703739|FG000|Part B: Double-Blind Period|Lack of Efficacy|0|||
48966152|NCT02505542|157703740|FG001|Part B: Double-Blind Period|Lack of Efficacy|1|||
48966153|NCT02505542|157703741|FG002|Part B: Double-Blind Period|Lack of Efficacy|0|||
48966154|NCT02505542|157703742|FG003|Part B: Double-Blind Period|Lack of Efficacy|0|||
48966155|NCT02505542|157703739|FG000|Part B: Double-Blind Period|Miscalculation|0|||
48966156|NCT02505542|157703740|FG001|Part B: Double-Blind Period|Miscalculation|1|||
48966157|NCT02505542|157703741|FG002|Part B: Double-Blind Period|Miscalculation|0|||
48966158|NCT02505542|157703742|FG003|Part B: Double-Blind Period|Miscalculation|0|||
48966159|NCT02505542|157703739|FG000|Part B: Double-Blind Period|Subject did not complete all visits|0|||
48966160|NCT02505542|157703740|FG001|Part B: Double-Blind Period|Subject did not complete all visits|1|||
48664083|NCT01286987|156623235|FG013|Part 1: Dose Escalation|Progressive Disease|0|||
48664084|NCT01286987|156623236|FG014|Part 1: Dose Escalation|Progressive Disease|0|||
48756891|NCT02432846|156958115|FG000|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
48756892|NCT02432846|156958116|FG001|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
48966161|NCT02505542|157703741|FG002|Part B: Double-Blind Period|Subject did not complete all visits|0|||
48966162|NCT02505542|157703742|FG003|Part B: Double-Blind Period|Subject did not complete all visits|0|||
48966163|NCT03084718|157703743|FG000|Overall Study|Withdrawal by Subject|4|||
48966164|NCT03084718|157703744|FG001|Overall Study|Withdrawal by Subject|3|||
48966165|NCT03084718|157703745|FG002|Overall Study|Withdrawal by Subject|4|||
48966166|NCT03084718|157703746|FG003|Overall Study|Withdrawal by Subject|0|||
48664085|NCT01286987|156623222|FG000|Part 1: Dose Escalation|Physician Decision|0|||
48664086|NCT01286987|156623223|FG001|Part 1: Dose Escalation|Physician Decision|0|||
48966167|NCT03084718|157703747|FG004|Overall Study|Withdrawal by Subject|0|||
48664087|NCT01286987|156623224|FG002|Part 1: Dose Escalation|Physician Decision|0|||
48664088|NCT01286987|156623225|FG003|Part 1: Dose Escalation|Physician Decision|0|||
48664089|NCT01286987|156623226|FG004|Part 1: Dose Escalation|Physician Decision|1|||
48664090|NCT01286987|156623227|FG005|Part 1: Dose Escalation|Physician Decision|0|||
48664091|NCT01286987|156623228|FG006|Part 1: Dose Escalation|Physician Decision|0|||
48664092|NCT01286987|156623229|FG007|Part 1: Dose Escalation|Physician Decision|0|||
48664093|NCT01286987|156623230|FG008|Part 1: Dose Escalation|Physician Decision|0|||
48664094|NCT01286987|156623231|FG009|Part 1: Dose Escalation|Physician Decision|0|||
48664095|NCT01286987|156623232|FG010|Part 1: Dose Escalation|Physician Decision|0|||
48664096|NCT01286987|156623233|FG011|Part 1: Dose Escalation|Physician Decision|0|||
48664097|NCT01286987|156623234|FG012|Part 1: Dose Escalation|Physician Decision|0|||
48664098|NCT01286987|156623235|FG013|Part 1: Dose Escalation|Physician Decision|0|||
48664099|NCT01286987|156623236|FG014|Part 1: Dose Escalation|Physician Decision|0|||
48664100|NCT01286987|156623222|FG000|Part 2: Dose Expansion|Death|0|||
48664101|NCT01286987|156623223|FG001|Part 2: Dose Expansion|Death|0|||
48664102|NCT01286987|156623224|FG002|Part 2: Dose Expansion|Death|0|||
48664103|NCT01286987|156623225|FG003|Part 2: Dose Expansion|Death|0|||
48664104|NCT01286987|156623226|FG004|Part 2: Dose Expansion|Death|0|||
48664105|NCT01286987|156623227|FG005|Part 2: Dose Expansion|Death|0|||
48664106|NCT01286987|156623228|FG006|Part 2: Dose Expansion|Death|0|||
48664107|NCT01286987|156623229|FG007|Part 2: Dose Expansion|Death|0|||
48664108|NCT01286987|156623230|FG008|Part 2: Dose Expansion|Death|0|||
48664109|NCT01286987|156623231|FG009|Part 2: Dose Expansion|Death|0|||
48664110|NCT01286987|156623232|FG010|Part 2: Dose Expansion|Death|0|||
48664111|NCT01286987|156623233|FG011|Part 2: Dose Expansion|Death|0|||
48664112|NCT01286987|156623234|FG012|Part 2: Dose Expansion|Death|1|||
48756893|NCT02432846|156958117|FG002|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
48756894|NCT02432846|156958118|FG003|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
48664113|NCT01286987|156623235|FG013|Part 2: Dose Expansion|Death|1|||
48664114|NCT01286987|156623236|FG014|Part 2: Dose Expansion|Death|0|||
48756895|NCT02432846|156958119|FG004|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
48966168|NCT03084718|157703743|FG000|Overall Study|Physician Decision|1|||
48966169|NCT03084718|157703744|FG001|Overall Study|Physician Decision|0|||
48966170|NCT03084718|157703745|FG002|Overall Study|Physician Decision|0|||
48966171|NCT03084718|157703746|FG003|Overall Study|Physician Decision|0|||
48966172|NCT03084718|157703747|FG004|Overall Study|Physician Decision|0|||
48966173|NCT03084718|157703743|FG000|Overall Study|Adverse Event|3|||
48756896|NCT02432846|156958120|FG005|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
48966174|NCT03084718|157703744|FG001|Overall Study|Adverse Event|5|||
48966175|NCT03084718|157703745|FG002|Overall Study|Adverse Event|5|||
48664115|NCT01286987|156623222|FG000|Part 2: Dose Expansion|Physician Decision|0|||
48664116|NCT01286987|156623223|FG001|Part 2: Dose Expansion|Physician Decision|0|||
48664117|NCT01286987|156623224|FG002|Part 2: Dose Expansion|Physician Decision|0|||
48664118|NCT01286987|156623225|FG003|Part 2: Dose Expansion|Physician Decision|0|||
48664119|NCT01286987|156623226|FG004|Part 2: Dose Expansion|Physician Decision|0|||
48664120|NCT01286987|156623227|FG005|Part 2: Dose Expansion|Physician Decision|0|||
48664121|NCT01286987|156623228|FG006|Part 2: Dose Expansion|Physician Decision|0|||
48664122|NCT01286987|156623229|FG007|Part 2: Dose Expansion|Physician Decision|0|||
48664123|NCT01286987|156623230|FG008|Part 2: Dose Expansion|Physician Decision|0|||
48756897|NCT02432846|156958115|FG000|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
48756898|NCT02432846|156958116|FG001|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
48756899|NCT02432846|156958117|FG002|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
48756900|NCT02432846|156958118|FG003|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
48756901|NCT02432846|156958119|FG004|Overall Study (2 Total/Combined Groups)|Physician Decision|2|||
48756902|NCT02432846|156958120|FG005|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
48756903|NCT02432846|156958115|FG000|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
48756904|NCT02432846|156958116|FG001|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
48756905|NCT02432846|156958117|FG002|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
48756906|NCT02432846|156958118|FG003|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
48966176|NCT03084718|157703746|FG003|Overall Study|Adverse Event|8|||
48966177|NCT03084718|157703747|FG004|Overall Study|Adverse Event|2|||
48966178|NCT03084718|157703743|FG000|Overall Study|Lack of Efficacy|2|||
48966179|NCT03084718|157703744|FG001|Overall Study|Lack of Efficacy|0|||
48966180|NCT03084718|157703745|FG002|Overall Study|Lack of Efficacy|1|||
48966181|NCT03084718|157703746|FG003|Overall Study|Lack of Efficacy|4|||
48966182|NCT03084718|157703747|FG004|Overall Study|Lack of Efficacy|0|||
48966183|NCT03084718|157703743|FG000|Overall Study|Lost to Follow-up|0|||
48966184|NCT03084718|157703744|FG001|Overall Study|Lost to Follow-up|1|||
48966185|NCT03084718|157703745|FG002|Overall Study|Lost to Follow-up|0|||
48966186|NCT03084718|157703746|FG003|Overall Study|Lost to Follow-up|0|||
48966187|NCT03084718|157703747|FG004|Overall Study|Lost to Follow-up|2|||
48966188|NCT03084718|157703743|FG000|Overall Study|Protocol Violation|0|||
48966189|NCT03084718|157703744|FG001|Overall Study|Protocol Violation|0|||
48966190|NCT03084718|157703745|FG002|Overall Study|Protocol Violation|1|||
48756907|NCT02432846|156958119|FG004|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|3|||
48756908|NCT02432846|156958120|FG005|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|1|||
48966191|NCT03084718|157703746|FG003|Overall Study|Protocol Violation|0|||
48966192|NCT03084718|157703747|FG004|Overall Study|Protocol Violation|0|||
48966193|NCT03084718|157703743|FG000|Overall Study|Death|0|||
48756909|NCT02432846|156958115|FG000|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
48966194|NCT03084718|157703744|FG001|Overall Study|Death|1|||
48966195|NCT03084718|157703745|FG002|Overall Study|Death|0|||
48966196|NCT03084718|157703746|FG003|Overall Study|Death|0|||
48966197|NCT03084718|157703747|FG004|Overall Study|Death|0|||
48966198|NCT03084718|157703743|FG000|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
48966199|NCT03084718|157703744|FG001|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
48664124|NCT01286987|156623231|FG009|Part 2: Dose Expansion|Physician Decision|0|||
48664125|NCT01286987|156623232|FG010|Part 2: Dose Expansion|Physician Decision|1|||
48664126|NCT01286987|156623233|FG011|Part 2: Dose Expansion|Physician Decision|1|||
48664127|NCT01286987|156623234|FG012|Part 2: Dose Expansion|Physician Decision|0|||
48664128|NCT01286987|156623235|FG013|Part 2: Dose Expansion|Physician Decision|1|||
48664129|NCT01286987|156623236|FG014|Part 2: Dose Expansion|Physician Decision|0|||
48664130|NCT01286987|156623222|FG000|Part 2: Dose Expansion|Other|0|||
48664131|NCT01286987|156623223|FG001|Part 2: Dose Expansion|Other|0|||
48664132|NCT01286987|156623224|FG002|Part 2: Dose Expansion|Other|0|||
48664133|NCT01286987|156623225|FG003|Part 2: Dose Expansion|Other|0|||
48664134|NCT01286987|156623226|FG004|Part 2: Dose Expansion|Other|0|||
48664135|NCT01286987|156623227|FG005|Part 2: Dose Expansion|Other|0|||
48664136|NCT01286987|156623228|FG006|Part 2: Dose Expansion|Other|0|||
48664137|NCT01286987|156623229|FG007|Part 2: Dose Expansion|Other|0|||
48664138|NCT01286987|156623230|FG008|Part 2: Dose Expansion|Other|0|||
48664139|NCT01286987|156623231|FG009|Part 2: Dose Expansion|Other|0|||
48664140|NCT01286987|156623232|FG010|Part 2: Dose Expansion|Other|0|||
48664141|NCT01286987|156623233|FG011|Part 2: Dose Expansion|Other|0|||
48664142|NCT01286987|156623234|FG012|Part 2: Dose Expansion|Other|0|||
48664143|NCT01286987|156623235|FG013|Part 2: Dose Expansion|Other|1|||
48664144|NCT01286987|156623236|FG014|Part 2: Dose Expansion|Other|0|||
48664145|NCT01286987|156623222|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
48664146|NCT01286987|156623223|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
48966200|NCT03084718|157703745|FG002|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
48966201|NCT03084718|157703746|FG003|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|2|||
48966202|NCT03084718|157703747|FG004|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
48966203|NCT00589979|157703751|FG000|Run-In Period|Adverse Event|5|||
48966204|NCT00589979|157703752|FG001|Run-In Period|Adverse Event|0|||
48966205|NCT00589979|157703753|FG002|Run-In Period|Adverse Event|0|||
48966206|NCT00589979|157703751|FG000|Run-In Period|Protocol Violation|3|||
48966207|NCT00589979|157703752|FG001|Run-In Period|Protocol Violation|0|||
48966208|NCT00589979|157703753|FG002|Run-In Period|Protocol Violation|0|||
48966209|NCT00589979|157703751|FG000|Run-In Period|Did not qualify for randomization|54|||
48966210|NCT00589979|157703752|FG001|Run-In Period|Did not qualify for randomization|0|||
48966211|NCT00589979|157703753|FG002|Run-In Period|Did not qualify for randomization|0|||
48966212|NCT00589979|157703751|FG000|Run-In Period|Withdrawal by Subject|10|||
48966213|NCT00589979|157703752|FG001|Run-In Period|Withdrawal by Subject|0|||
48966214|NCT00589979|157703753|FG002|Run-In Period|Withdrawal by Subject|0|||
48966215|NCT00589979|157703751|FG000|Run-In Period|Informed Consent Withdrawn|4|||
48966216|NCT00589979|157703752|FG001|Run-In Period|Informed Consent Withdrawn|0|||
48966217|NCT00589979|157703753|FG002|Run-In Period|Informed Consent Withdrawn|0|||
48966218|NCT00589979|157703751|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
48966219|NCT00589979|157703752|FG001|Double-Blind Treatment Period 1|Adverse Event|1|||
48966220|NCT00589979|157703753|FG002|Double-Blind Treatment Period 1|Adverse Event|0|||
48966221|NCT00589979|157703751|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
48966222|NCT00589979|157703752|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
48966223|NCT00589979|157703753|FG002|Double-Blind Treatment Period 1|Protocol Violation|1|||
48966224|NCT00589979|157703751|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
48966225|NCT00589979|157703752|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
48966226|NCT00589979|157703753|FG002|Double-Blind Treatment Period 1|Withdrawal by Subject|1|||
48966227|NCT00589979|157703751|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
48966228|NCT00589979|157703752|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
48966229|NCT00589979|157703753|FG002|Double-Blind Treatment Period 2|Adverse Event|0|||
48966230|NCT00589979|157703751|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
48966231|NCT00589979|157703752|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
48966232|NCT00589979|157703753|FG002|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
48966233|NCT00589979|157703751|FG000|Double-Blind Treatment Period 2|Other|0|||
48966234|NCT00589979|157703752|FG001|Double-Blind Treatment Period 2|Other|0|||
48966235|NCT00589979|157703753|FG002|Double-Blind Treatment Period 2|Other|1|||
48966236|NCT00589979|157703751|FG000|Double-Blind Treatment Period 3|Protocol Violation|0|||
48966237|NCT00589979|157703752|FG001|Double-Blind Treatment Period 3|Protocol Violation|1|||
48664147|NCT01286987|156623224|FG002|Part 2: Dose Expansion|Progressive Disease|0|||
48664148|NCT01286987|156623225|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
48664149|NCT01286987|156623226|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
48664150|NCT01286987|156623227|FG005|Part 2: Dose Expansion|Progressive Disease|0|||
48664151|NCT01286987|156623228|FG006|Part 2: Dose Expansion|Progressive Disease|0|||
48664152|NCT01286987|156623229|FG007|Part 2: Dose Expansion|Progressive Disease|0|||
48756910|NCT02432846|156958116|FG001|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
48756911|NCT02432846|156958117|FG002|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
48756912|NCT02432846|156958118|FG003|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
48756913|NCT02432846|156958119|FG004|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|2|||
48756914|NCT02432846|156958120|FG005|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|1|||
48756915|NCT02432846|156958115|FG000|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
48756916|NCT02432846|156958116|FG001|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
48756917|NCT02432846|156958117|FG002|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
48966238|NCT00589979|157703753|FG002|Double-Blind Treatment Period 3|Protocol Violation|0|||
48966239|NCT00589979|157703751|FG000|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
48966240|NCT00589979|157703752|FG001|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
48664153|NCT01286987|156623230|FG008|Part 2: Dose Expansion|Progressive Disease|0|||
48664154|NCT01286987|156623231|FG009|Part 2: Dose Expansion|Progressive Disease|11|||
48664155|NCT01286987|156623232|FG010|Part 2: Dose Expansion|Progressive Disease|6|||
48664156|NCT01286987|156623233|FG011|Part 2: Dose Expansion|Progressive Disease|7|||
48664157|NCT01286987|156623234|FG012|Part 2: Dose Expansion|Progressive Disease|11|||
48664158|NCT01286987|156623235|FG013|Part 2: Dose Expansion|Progressive Disease|19|||
48664159|NCT01286987|156623236|FG014|Part 2: Dose Expansion|Progressive Disease|2|||
48664160|NCT01286987|156623222|FG000|Part 2: Dose Expansion|Clinical Progression|0|||
48664161|NCT01286987|156623223|FG001|Part 2: Dose Expansion|Clinical Progression|0|||
48664162|NCT01286987|156623224|FG002|Part 2: Dose Expansion|Clinical Progression|0|||
48664163|NCT01286987|156623225|FG003|Part 2: Dose Expansion|Clinical Progression|0|||
48664164|NCT01286987|156623226|FG004|Part 2: Dose Expansion|Clinical Progression|0|||
48867366|NCT00187135|157350815|FG005|Visit Two|Physician Decision|0|||
48867367|NCT00187135|157350810|FG000|Visit Two|Withdrawal by Subject|1|||
48867368|NCT00187135|157350811|FG001|Visit Two|Withdrawal by Subject|1|||
48867369|NCT00187135|157350812|FG002|Visit Two|Withdrawal by Subject|1|||
48867370|NCT00187135|157350813|FG003|Visit Two|Withdrawal by Subject|0|||
48867371|NCT00187135|157350814|FG004|Visit Two|Withdrawal by Subject|1|||
48867372|NCT00187135|157350815|FG005|Visit Two|Withdrawal by Subject|1|||
48867373|NCT00187135|157350810|FG000|Visit Two|Study Discontinued|3|||
48867374|NCT00187135|157350811|FG001|Visit Two|Study Discontinued|2|||
48867375|NCT00187135|157350812|FG002|Visit Two|Study Discontinued|1|||
48867376|NCT00187135|157350813|FG003|Visit Two|Study Discontinued|7|||
48867377|NCT00187135|157350814|FG004|Visit Two|Study Discontinued|5|||
48867378|NCT00187135|157350815|FG005|Visit Two|Study Discontinued|6|||
48867379|NCT00187135|157350810|FG000|Visit Three|Death|0|||
48867380|NCT00187135|157350811|FG001|Visit Three|Death|0|||
48867381|NCT00187135|157350812|FG002|Visit Three|Death|1|||
48867382|NCT00187135|157350813|FG003|Visit Three|Death|0|||
48867383|NCT00187135|157350814|FG004|Visit Three|Death|1|||
48867384|NCT00187135|157350815|FG005|Visit Three|Death|0|||
48867385|NCT00187135|157350810|FG000|Visit Three|Withdrawal by Subject|0|||
48867386|NCT00187135|157350811|FG001|Visit Three|Withdrawal by Subject|1|||
48867387|NCT00187135|157350812|FG002|Visit Three|Withdrawal by Subject|1|||
48867388|NCT00187135|157350813|FG003|Visit Three|Withdrawal by Subject|2|||
48867389|NCT00187135|157350814|FG004|Visit Three|Withdrawal by Subject|0|||
48867390|NCT00187135|157350815|FG005|Visit Three|Withdrawal by Subject|0|||
48867391|NCT00187135|157350810|FG000|Visit Three|Study Discontinued|7|||
48867392|NCT00187135|157350811|FG001|Visit Three|Study Discontinued|6|||
48867393|NCT00187135|157350812|FG002|Visit Three|Study Discontinued|7|||
48867394|NCT00187135|157350813|FG003|Visit Three|Study Discontinued|7|||
48867395|NCT00187135|157350814|FG004|Visit Three|Study Discontinued|7|||
48867396|NCT00187135|157350815|FG005|Visit Three|Study Discontinued|6|||
48867397|NCT04748445|157350818|FG000|Overall Study|No longer met eligibility criteria|12|||
48867398|NCT04748445|157350818|FG000|Overall Study|Other|36|||
48867399|NCT04748445|157350818|FG000|Overall Study|Withdrawal by Subject|553|||
48867400|NCT04748445|157350818|FG000|Overall Study|Lost to Follow-up|30|||
48867401|NCT03635775|157350820|FG000|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
48867402|NCT03635775|157350821|FG001|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
48867403|NCT03635775|157350822|FG002|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
48867404|NCT03635775|157350823|FG003|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1|||
48867405|NCT00105521|157350824|FG000|Overall Study|Other|1|||
48867406|NCT00105521|157350825|FG001|Overall Study|Other|1|||
48867407|NCT00105521|157350826|FG002|Overall Study|Other|2|||
48867408|NCT00105521|157350827|FG003|Overall Study|Other|0|||
48867409|NCT00105521|157350824|FG000|Overall Study|Adverse Event|10|||
48867410|NCT00105521|157350825|FG001|Overall Study|Adverse Event|4|||
48867411|NCT00105521|157350826|FG002|Overall Study|Adverse Event|10|||
48867412|NCT00105521|157350827|FG003|Overall Study|Adverse Event|8|||
48867413|NCT00105521|157350824|FG000|Overall Study|Withdrawal by Subject|1|||
48867414|NCT00105521|157350825|FG001|Overall Study|Withdrawal by Subject|0|||
48867415|NCT00105521|157350826|FG002|Overall Study|Withdrawal by Subject|1|||
48867416|NCT00105521|157350827|FG003|Overall Study|Withdrawal by Subject|4|||
48867417|NCT00105521|157350824|FG000|Overall Study|Lack of Efficacy|0|||
48867418|NCT00105521|157350825|FG001|Overall Study|Lack of Efficacy|0|||
48867419|NCT00105521|157350826|FG002|Overall Study|Lack of Efficacy|0|||
48867420|NCT00105521|157350827|FG003|Overall Study|Lack of Efficacy|1|||
48867421|NCT00105521|157350824|FG000|Overall Study|Protocol Violation|3|||
48867422|NCT00105521|157350825|FG001|Overall Study|Protocol Violation|5|||
48867423|NCT00105521|157350826|FG002|Overall Study|Protocol Violation|4|||
48867424|NCT00105521|157350827|FG003|Overall Study|Protocol Violation|4|||
48867425|NCT00105521|157350824|FG000|Overall Study|Lost to Follow-up|0|||
48867426|NCT00105521|157350825|FG001|Overall Study|Lost to Follow-up|1|||
48867427|NCT00105521|157350826|FG002|Overall Study|Lost to Follow-up|0|||
48664165|NCT01286987|156623227|FG005|Part 2: Dose Expansion|Clinical Progression|0|||
48664166|NCT01286987|156623228|FG006|Part 2: Dose Expansion|Clinical Progression|0|||
48664167|NCT01286987|156623229|FG007|Part 2: Dose Expansion|Clinical Progression|0|||
48664168|NCT01286987|156623230|FG008|Part 2: Dose Expansion|Clinical Progression|0|||
48664169|NCT01286987|156623231|FG009|Part 2: Dose Expansion|Clinical Progression|0|||
48664170|NCT01286987|156623232|FG010|Part 2: Dose Expansion|Clinical Progression|2|||
48664171|NCT01286987|156623233|FG011|Part 2: Dose Expansion|Clinical Progression|2|||
48664172|NCT01286987|156623234|FG012|Part 2: Dose Expansion|Clinical Progression|0|||
48664173|NCT01286987|156623235|FG013|Part 2: Dose Expansion|Clinical Progression|2|||
48664174|NCT01286987|156623236|FG014|Part 2: Dose Expansion|Clinical Progression|0|||
48664175|NCT01286987|156623222|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
48664176|NCT01286987|156623223|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
48664177|NCT01286987|156623224|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
48664178|NCT01286987|156623225|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
48664179|NCT01286987|156623226|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
48664180|NCT01286987|156623227|FG005|Part 2: Dose Expansion|Withdrawal by Subject|0|||
48664181|NCT01286987|156623228|FG006|Part 2: Dose Expansion|Withdrawal by Subject|0|||
48664182|NCT01286987|156623229|FG007|Part 2: Dose Expansion|Withdrawal by Subject|0|||
48664183|NCT01286987|156623230|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
48664184|NCT01286987|156623231|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
48664185|NCT01286987|156623232|FG010|Part 2: Dose Expansion|Withdrawal by Subject|1|||
48664186|NCT01286987|156623233|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
48664187|NCT01286987|156623234|FG012|Part 2: Dose Expansion|Withdrawal by Subject|0|||
48664188|NCT01286987|156623235|FG013|Part 2: Dose Expansion|Withdrawal by Subject|0|||
48664189|NCT01286987|156623236|FG014|Part 2: Dose Expansion|Withdrawal by Subject|0|||
48664190|NCT02961790|156623239|FG000|Overall Study|Canceled|4|||
48664191|NCT02961790|156623240|FG001|Overall Study|Canceled|5|||
48664192|NCT02961790|156623241|FG002|Overall Study|Canceled|1|||
48664193|NCT02961790|156623242|FG003|Overall Study|Canceled|4|||
48664194|NCT02961790|156623239|FG000|Overall Study|without baseline data|4|||
48664195|NCT02961790|156623240|FG001|Overall Study|without baseline data|0|||
48664196|NCT02961790|156623241|FG002|Overall Study|without baseline data|1|||
48664197|NCT02961790|156623242|FG003|Overall Study|without baseline data|0|||
48664198|NCT02961790|156623239|FG000|Overall Study|without post baseline data|7|||
48664199|NCT02961790|156623240|FG001|Overall Study|without post baseline data|6|||
48664200|NCT02961790|156623241|FG002|Overall Study|without post baseline data|4|||
48664201|NCT02961790|156623242|FG003|Overall Study|without post baseline data|1|||
48664202|NCT00711802|156623246|FG000|Overall Study|Not treated (no further detail)|2|||
48664203|NCT00711802|156623247|FG001|Overall Study|Not treated (no further detail)|1|||
48664204|NCT00711802|156623248|FG002|Overall Study|Not treated (no further detail)|2|||
48664205|NCT00711802|156623249|FG003|Overall Study|Not treated (no further detail)|0|||
48664206|NCT00711802|156623250|FG004|Overall Study|Not treated (no further detail)|2|||
48664207|NCT00711802|156623251|FG005|Overall Study|Not treated (no further detail)|0|||
48664208|NCT00711802|156623252|FG006|Overall Study|Not treated (no further detail)|0|||
48664209|NCT00711802|156623253|FG007|Overall Study|Not treated (no further detail)|0|||
48664210|NCT00711802|156623246|FG000|Overall Study|Adverse Event|0|||
48664211|NCT00711802|156623247|FG001|Overall Study|Adverse Event|0|||
48664212|NCT00711802|156623248|FG002|Overall Study|Adverse Event|0|||
48664213|NCT00711802|156623249|FG003|Overall Study|Adverse Event|0|||
48664214|NCT00711802|156623250|FG004|Overall Study|Adverse Event|1|||
48664215|NCT00711802|156623251|FG005|Overall Study|Adverse Event|1|||
48664216|NCT00711802|156623252|FG006|Overall Study|Adverse Event|0|||
48664217|NCT00711802|156623253|FG007|Overall Study|Adverse Event|0|||
48664218|NCT00711802|156623246|FG000|Overall Study|Microbiological failure|0|||
48664219|NCT00711802|156623247|FG001|Overall Study|Microbiological failure|1|||
48664220|NCT00711802|156623248|FG002|Overall Study|Microbiological failure|0|||
48664221|NCT00711802|156623249|FG003|Overall Study|Microbiological failure|0|||
48664222|NCT00711802|156623250|FG004|Overall Study|Microbiological failure|0|||
48867428|NCT00105521|157350827|FG003|Overall Study|Lost to Follow-up|0|||
48867429|NCT01536535|157350828|FG000|Overall Study|Withdrawal by Subject|10|||
48867430|NCT01536535|157350829|FG001|Overall Study|Withdrawal by Subject|5|||
48867431|NCT01536535|157350828|FG000|Overall Study|Lost to Follow-up|4|||
48867432|NCT01536535|157350829|FG001|Overall Study|Lost to Follow-up|6|||
48867433|NCT01536535|157350828|FG000|Overall Study|Physician Decision|1|||
48867434|NCT01536535|157350829|FG001|Overall Study|Physician Decision|1|||
48867435|NCT01536535|157350828|FG000|Overall Study|Participant moved|0|||
48867436|NCT01536535|157350829|FG001|Overall Study|Participant moved|1|||
48867437|NCT01485991|157350832|FG000|Overall Study|Adverse Event|0|||
48867438|NCT01485991|157350833|FG001|Overall Study|Adverse Event|4|||
48867439|NCT01485991|157350832|FG000|Overall Study|Lost to Follow-up|13|||
48867440|NCT01485991|157350833|FG001|Overall Study|Lost to Follow-up|10|||
48867441|NCT01485991|157350832|FG000|Overall Study|Withdrawal by Subject|13|||
48867442|NCT01485991|157350833|FG001|Overall Study|Withdrawal by Subject|20|||
48867443|NCT01485991|157350832|FG000|Overall Study|randomized but not treated|6|||
48756918|NCT02432846|156958118|FG003|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
48756919|NCT02432846|156958119|FG004|Overall Study (2 Total/Combined Groups)|Disease progression|23|||
48756920|NCT02432846|156958120|FG005|Overall Study (2 Total/Combined Groups)|Disease progression|14|||
48966241|NCT00589979|157703753|FG002|Double-Blind Treatment Period 3|Withdrawal by Subject|1|||
48966242|NCT01511107|157703759|FG000|Overall Study|Ineligible|3|||
48966243|NCT01511107|157703760|FG001|Overall Study|Ineligible|2|||
48966244|NCT01511107|157703759|FG000|Overall Study|Lost to Follow-up|10|||
48966245|NCT01511107|157703760|FG001|Overall Study|Lost to Follow-up|19|||
48966246|NCT01511107|157703759|FG000|Overall Study|Withdrawal by Subject|9|||
48966247|NCT01511107|157703760|FG001|Overall Study|Withdrawal by Subject|20|||
48966248|NCT04404010|157703764|FG000|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1|||
48966249|NCT04404010|157703765|FG001|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0|||
48966250|NCT03448224|157703766|FG000|Overall Study|Provided same answer to every question|1|||
48966251|NCT03448224|157703767|FG001|Overall Study|Provided same answer to every question|0|||
48966252|NCT02379390|157703768|FG000|Overall Study|Adverse Event|1|||
48664223|NCT00711802|156623251|FG005|Overall Study|Microbiological failure|1|||
48966253|NCT02379390|157703769|FG001|Overall Study|Adverse Event|1|||
48664224|NCT00711802|156623252|FG006|Overall Study|Microbiological failure|0|||
48664225|NCT00711802|156623253|FG007|Overall Study|Microbiological failure|0|||
48664226|NCT00711802|156623246|FG000|Overall Study|Protocol Violation|0|||
48664227|NCT00711802|156623247|FG001|Overall Study|Protocol Violation|0|||
48664228|NCT00711802|156623248|FG002|Overall Study|Protocol Violation|0|||
48664229|NCT00711802|156623249|FG003|Overall Study|Protocol Violation|1|||
48664230|NCT00711802|156623250|FG004|Overall Study|Protocol Violation|0|||
48664231|NCT00711802|156623251|FG005|Overall Study|Protocol Violation|0|||
48664232|NCT00711802|156623252|FG006|Overall Study|Protocol Violation|0|||
48664233|NCT00711802|156623253|FG007|Overall Study|Protocol Violation|0|||
48966254|NCT02379390|157703768|FG000|Overall Study|Investigator's decision|1|||
48966255|NCT02379390|157703769|FG001|Overall Study|Investigator's decision|0|||
48966256|NCT02379390|157703768|FG000|Overall Study|Study Termination|0|||
48966257|NCT02379390|157703769|FG001|Overall Study|Study Termination|1|||
48966258|NCT00575094|157703770|FG000|Overall Study|Adverse Event|2|||
48664234|NCT00711802|156623246|FG000|Overall Study|Physician Decision|0|||
48664235|NCT00711802|156623247|FG001|Overall Study|Physician Decision|2|||
48664236|NCT00711802|156623248|FG002|Overall Study|Physician Decision|0|||
48664237|NCT00711802|156623249|FG003|Overall Study|Physician Decision|0|||
48664238|NCT00711802|156623250|FG004|Overall Study|Physician Decision|0|||
48756921|NCT02432846|156958115|FG000|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
48756922|NCT02432846|156958116|FG001|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
48756923|NCT02432846|156958117|FG002|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
48966259|NCT00575094|157703770|FG000|Overall Study|Withdrawal by Subject|1|||
48966260|NCT00643604|157703771|FG000|Overall Study|Death|1|||
48966261|NCT01309841|157703776|FG000|Overall Study|Other|0|||
48966262|NCT01309841|157703777|FG001|Overall Study|Other|1|||
48966263|NCT01309841|157703778|FG002|Overall Study|Other|1|||
48756924|NCT02432846|156958118|FG003|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
48756925|NCT02432846|156958119|FG004|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|1|||
48756926|NCT02432846|156958120|FG005|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
48756927|NCT02769247|156958121|FG000|Overall Study|Withdrawal by Subject|1|||
48756928|NCT02769247|156958122|FG001|Overall Study|Withdrawal by Subject|0|||
48756929|NCT02769247|156958123|FG002|Overall Study|Withdrawal by Subject|0|||
48756930|NCT02769247|156958124|FG003|Overall Study|Withdrawal by Subject|1|||
48756931|NCT02769247|156958121|FG000|Overall Study|Protocol Violation|0|||
48756932|NCT02769247|156958122|FG001|Overall Study|Protocol Violation|0|||
48966264|NCT01309841|157703776|FG000|Overall Study|Lost to Follow-up|7|||
48966265|NCT01309841|157703777|FG001|Overall Study|Lost to Follow-up|6|||
48966266|NCT01309841|157703778|FG002|Overall Study|Lost to Follow-up|4|||
48966267|NCT01309841|157703776|FG000|Overall Study|Study-Specific Withdrawal Criteria|3|||
48966268|NCT01309841|157703777|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
48966269|NCT01309841|157703778|FG002|Overall Study|Study-Specific Withdrawal Criteria|2|||
48966270|NCT01309841|157703776|FG000|Overall Study|Lack of Efficacy|0|||
48664239|NCT00711802|156623251|FG005|Overall Study|Physician Decision|0|||
48664240|NCT00711802|156623252|FG006|Overall Study|Physician Decision|0|||
48756933|NCT02769247|156958123|FG002|Overall Study|Protocol Violation|1|||
48756934|NCT02769247|156958124|FG003|Overall Study|Protocol Violation|0|||
48756935|NCT02769247|156958121|FG000|Overall Study|Physician Decision|1|||
48756936|NCT02769247|156958122|FG001|Overall Study|Physician Decision|0|||
48756937|NCT02769247|156958123|FG002|Overall Study|Physician Decision|0|||
48966271|NCT01309841|157703777|FG001|Overall Study|Lack of Efficacy|0|||
48966272|NCT01309841|157703778|FG002|Overall Study|Lack of Efficacy|2|||
48966273|NCT01309841|157703776|FG000|Overall Study|Adverse Event|9|||
48966274|NCT01309841|157703777|FG001|Overall Study|Adverse Event|22|||
48966275|NCT01309841|157703778|FG002|Overall Study|Adverse Event|11|||
48966276|NCT01309841|157703776|FG000|Overall Study|Death|1|||
48664241|NCT00711802|156623253|FG007|Overall Study|Physician Decision|0|||
48664242|NCT00711802|156623246|FG000|Overall Study|Withdrawal by Subject|0|||
48966277|NCT01309841|157703777|FG001|Overall Study|Death|0|||
48966278|NCT01309841|157703778|FG002|Overall Study|Death|0|||
48966279|NCT01309841|157703776|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
48664243|NCT00711802|156623247|FG001|Overall Study|Withdrawal by Subject|1|||
48966280|NCT01309841|157703777|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
48966281|NCT01309841|157703778|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
48966282|NCT01309841|157703776|FG000|Overall Study|Withdrawal by Subject|17|||
48966283|NCT01309841|157703777|FG001|Overall Study|Withdrawal by Subject|6|||
48966284|NCT01309841|157703778|FG002|Overall Study|Withdrawal by Subject|13|||
48966285|NCT01309841|157703776|FG000|Overall Study|Did Not Receive Treatment|2|||
48966286|NCT01309841|157703777|FG001|Overall Study|Did Not Receive Treatment|0|||
48966287|NCT01309841|157703778|FG002|Overall Study|Did Not Receive Treatment|1|||
48966288|NCT01309841|157703776|FG000|Overall Study|Severe non-compliance with protocol|0|||
48664244|NCT00711802|156623248|FG002|Overall Study|Withdrawal by Subject|0|||
48664245|NCT00711802|156623249|FG003|Overall Study|Withdrawal by Subject|1|||
48664246|NCT00711802|156623250|FG004|Overall Study|Withdrawal by Subject|0|||
48664247|NCT00711802|156623251|FG005|Overall Study|Withdrawal by Subject|0|||
48664248|NCT00711802|156623252|FG006|Overall Study|Withdrawal by Subject|0|||
48664249|NCT00711802|156623253|FG007|Overall Study|Withdrawal by Subject|0|||
48664250|NCT00711802|156623246|FG000|Overall Study|Lost to Follow-up|0|||
48664251|NCT00711802|156623247|FG001|Overall Study|Lost to Follow-up|0|||
48664252|NCT00711802|156623248|FG002|Overall Study|Lost to Follow-up|3|||
48664253|NCT00711802|156623249|FG003|Overall Study|Lost to Follow-up|1|||
48664254|NCT00711802|156623250|FG004|Overall Study|Lost to Follow-up|10|||
48664255|NCT00711802|156623251|FG005|Overall Study|Lost to Follow-up|6|||
48756938|NCT02769247|156958124|FG003|Overall Study|Physician Decision|0|||
48756939|NCT02426892|156958127|FG000|Overall Study|Adverse Event|2|||
48756940|NCT02426892|156958127|FG000|Overall Study|Lack of Efficacy|17|||
48756941|NCT02426892|156958127|FG000|Overall Study|Withdrawal by Subject|1|||
48756942|NCT00227305|156958128|FG000|Overall Study|Adverse Event|40|||
48756943|NCT00227305|156958128|FG000|Overall Study|Withdrawal by Subject|42|||
48756944|NCT00227305|156958128|FG000|Overall Study|Lost to Follow-up|33|||
48756945|NCT00227305|156958128|FG000|Overall Study|Study specific discontinuation|13|||
48756946|NCT00227305|156958128|FG000|Overall Study|MOVED OUT OF AREA|3|||
48756947|NCT00227305|156958128|FG000|Overall Study|Lack of Efficacy|7|||
48756948|NCT00227305|156958128|FG000|Overall Study|Physician Decision|3|||
48756949|NCT00227305|156958128|FG000|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1|||
48756950|NCT00227305|156958128|FG000|Overall Study|LEAVING TOWN FOR 6 WEEKS|1|||
48756951|NCT00227305|156958128|FG000|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1|||
48756952|NCT02118012|156958129|FG000|Overall Study|Adverse Event|0|||
48756953|NCT02118012|156958130|FG001|Overall Study|Adverse Event|1|||
48756954|NCT02118012|156958129|FG000|Overall Study|Physician Decision|0|||
48756955|NCT02118012|156958130|FG001|Overall Study|Physician Decision|1|||
48756956|NCT03325075|156958134|FG000|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|2|||
48756957|NCT03325075|156958135|FG001|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
48756958|NCT03325075|156958136|FG002|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
48756959|NCT03325075|156958137|FG003|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
48756960|NCT03325075|156958134|FG000|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
48756961|NCT03325075|156958135|FG001|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|1|||
48756962|NCT03325075|156958136|FG002|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
48756963|NCT03325075|156958137|FG003|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
48756964|NCT03325075|156958134|FG000|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
48756965|NCT03325075|156958135|FG001|Part B: Follow-up (Up to 364 Days)|Other than specified|1|||
48756966|NCT03325075|156958136|FG002|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
48756967|NCT03325075|156958137|FG003|Part B: Follow-up (Up to 364 Days)|Other than specified|2|||
48756968|NCT02659631|156958140|FG000|Overall Study|Lost to Follow-up|0|||
48756969|NCT02659631|156958141|FG001|Overall Study|Lost to Follow-up|0|||
48756970|NCT02659631|156958142|FG002|Overall Study|Lost to Follow-up|2|||
48756971|NCT02659631|156958143|FG003|Overall Study|Lost to Follow-up|0|||
48756972|NCT02659631|156958144|FG004|Overall Study|Lost to Follow-up|0|||
48756973|NCT02659631|156958145|FG005|Overall Study|Lost to Follow-up|1|||
48966289|NCT01309841|157703777|FG001|Overall Study|Severe non-compliance with protocol|5|||
48664256|NCT00711802|156623252|FG006|Overall Study|Lost to Follow-up|4|||
48756974|NCT02659631|156958146|FG006|Overall Study|Lost to Follow-up|0|||
48756975|NCT02659631|156958147|FG007|Overall Study|Lost to Follow-up|0|||
48756976|NCT02659631|156958148|FG008|Overall Study|Lost to Follow-up|0|||
48756977|NCT02659631|156958149|FG009|Overall Study|Lost to Follow-up|0|||
48756978|NCT02659631|156958140|FG000|Overall Study|Withdrawal prior to treatment|0|||
48756979|NCT02659631|156958141|FG001|Overall Study|Withdrawal prior to treatment|0|||
48756980|NCT02659631|156958142|FG002|Overall Study|Withdrawal prior to treatment|0|||
48756981|NCT02659631|156958143|FG003|Overall Study|Withdrawal prior to treatment|0|||
48966290|NCT01309841|157703778|FG002|Overall Study|Severe non-compliance with protocol|2|||
48966291|NCT02921763|157703785|FG000|Overall Study|Adverse Event|4|||
48664257|NCT00711802|156623253|FG007|Overall Study|Lost to Follow-up|2|||
48664258|NCT00711802|156623246|FG000|Overall Study|Reason not reported|0|||
48966292|NCT02921763|157703785|FG000|Overall Study|Lost to Follow-up|4|||
48966293|NCT02921763|157703785|FG000|Overall Study|Lack of Efficacy|3|||
48966294|NCT02921763|157703785|FG000|Overall Study|Protocol Violation|2|||
48966295|NCT02921763|157703785|FG000|Overall Study|Withdrawal by Subject|2|||
48966296|NCT02921763|157703785|FG000|Overall Study|Physician Decision|1|||
48966297|NCT02921763|157703785|FG000|Overall Study|No data obtained|2|||
48966298|NCT01374217|157703786|FG000|Overall Study|Lack of Efficacy|13|||
48966299|NCT03495817|157703787|FG000|26 Week Open Label|Adverse Event|3|||
48966300|NCT03495817|157703787|FG000|26 Week Open Label|Withdrawal by Subject|4|||
48966301|NCT03495817|157703787|FG000|26 Week Open Label|Lost to Follow-up|1|||
48966302|NCT03495817|157703787|FG000|26 Week Extension|Lost to Follow-up|2|||
48966303|NCT01740388|157703788|FG000|Overall Study|Withdrawal by Subject|1|||
48867444|NCT01485991|157350833|FG001|Overall Study|randomized but not treated|2|||
48867445|NCT02538471|157350834|FG000|Overall Study|Progression of disease|2|||
48867446|NCT01675050|157350835|FG000|Period One Treatment|Withdrawal by Subject|1|||
48867447|NCT01675050|157350836|FG001|Period One Treatment|Withdrawal by Subject|0|||
48867448|NCT02025985|157350837|FG000|Overall Study|Consent withdrawn|0|||
48867449|NCT02025985|157350838|FG001|Overall Study|Consent withdrawn|0|||
48867450|NCT02025985|157350839|FG002|Overall Study|Consent withdrawn|1|||
48867451|NCT02025985|157350840|FG003|Overall Study|Consent withdrawn|0|||
48867452|NCT02025985|157350841|FG004|Overall Study|Consent withdrawn|0|||
48867453|NCT02025985|157350837|FG000|Overall Study|Termination of study by Sponsor|4|||
48867454|NCT02025985|157350838|FG001|Overall Study|Termination of study by Sponsor|3|||
48867455|NCT02025985|157350839|FG002|Overall Study|Termination of study by Sponsor|1|||
48867456|NCT02025985|157350840|FG003|Overall Study|Termination of study by Sponsor|1|||
48867457|NCT02025985|157350841|FG004|Overall Study|Termination of study by Sponsor|3|||
48867458|NCT02025985|157350837|FG000|Overall Study|Death|21|||
48867459|NCT02025985|157350838|FG001|Overall Study|Death|20|||
48867460|NCT02025985|157350839|FG002|Overall Study|Death|23|||
48867461|NCT02025985|157350840|FG003|Overall Study|Death|20|||
48867462|NCT02025985|157350841|FG004|Overall Study|Death|17|||
48867463|NCT03041701|157350842|FG000|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
48867464|NCT03041701|157350843|FG001|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
48867465|NCT03041701|157350844|FG002|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|0|||
48867466|NCT03041701|157350842|FG000|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
48867467|NCT03041701|157350843|FG001|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
48867468|NCT03041701|157350844|FG002|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|1|||
48966304|NCT01740388|157703789|FG001|Overall Study|Withdrawal by Subject|2|||
48966305|NCT01740388|157703788|FG000|Overall Study|Lost to Follow-up|2|||
48966306|NCT01740388|157703789|FG001|Overall Study|Lost to Follow-up|0|||
48966307|NCT01740388|157703788|FG000|Overall Study|Physician Decision|2|||
48966308|NCT01740388|157703789|FG001|Overall Study|Physician Decision|6|||
48966309|NCT01740388|157703788|FG000|Overall Study|Subjects missing data, completed|41|||
48966310|NCT01740388|157703789|FG001|Overall Study|Subjects missing data, completed|36|||
48966311|NCT00862121|157703793|FG000|Overall Study|Adverse Event|1|||
48756982|NCT02659631|156958144|FG004|Overall Study|Withdrawal prior to treatment|1|||
48756983|NCT02659631|156958145|FG005|Overall Study|Withdrawal prior to treatment|0|||
48756984|NCT02659631|156958146|FG006|Overall Study|Withdrawal prior to treatment|0|||
48756985|NCT02659631|156958147|FG007|Overall Study|Withdrawal prior to treatment|0|||
48756986|NCT02659631|156958148|FG008|Overall Study|Withdrawal prior to treatment|0|||
48756987|NCT02659631|156958149|FG009|Overall Study|Withdrawal prior to treatment|0|||
48756988|NCT02659631|156958140|FG000|Overall Study|Participant refused further follow-up|0|||
48756989|NCT02659631|156958141|FG001|Overall Study|Participant refused further follow-up|0|||
48756990|NCT02659631|156958142|FG002|Overall Study|Participant refused further follow-up|0|||
48756991|NCT02659631|156958143|FG003|Overall Study|Participant refused further follow-up|1|||
48756992|NCT02659631|156958144|FG004|Overall Study|Participant refused further follow-up|0|||
48756993|NCT02659631|156958145|FG005|Overall Study|Participant refused further follow-up|0|||
48756994|NCT02659631|156958146|FG006|Overall Study|Participant refused further follow-up|0|||
48756995|NCT02659631|156958147|FG007|Overall Study|Participant refused further follow-up|0|||
48756996|NCT02659631|156958148|FG008|Overall Study|Participant refused further follow-up|1|||
48756997|NCT02659631|156958149|FG009|Overall Study|Participant refused further follow-up|0|||
48756998|NCT02659631|156958140|FG000|Overall Study|Death (follow-up phase)|1|||
48756999|NCT02659631|156958141|FG001|Overall Study|Death (follow-up phase)|2|||
48757000|NCT02659631|156958142|FG002|Overall Study|Death (follow-up phase)|1|||
48757001|NCT02659631|156958143|FG003|Overall Study|Death (follow-up phase)|1|||
48966312|NCT00862121|157703794|FG001|Overall Study|Adverse Event|2|||
48966313|NCT00862121|157703793|FG000|Overall Study|Lack of Efficacy|0|||
48757002|NCT02659631|156958144|FG004|Overall Study|Death (follow-up phase)|3|||
48757003|NCT02659631|156958145|FG005|Overall Study|Death (follow-up phase)|2|||
48757004|NCT02659631|156958146|FG006|Overall Study|Death (follow-up phase)|0|||
48966314|NCT00862121|157703794|FG001|Overall Study|Lack of Efficacy|3|||
48966315|NCT00862121|157703793|FG000|Overall Study|Protocol Violation|0|||
48966316|NCT00862121|157703794|FG001|Overall Study|Protocol Violation|1|||
48966317|NCT00862121|157703793|FG000|Overall Study|Exclusion criterion violation|0|||
48966318|NCT00862121|157703794|FG001|Overall Study|Exclusion criterion violation|1|||
48966319|NCT00862121|157703793|FG000|Overall Study|Incorrect randomisation|0|||
48966320|NCT00862121|157703794|FG001|Overall Study|Incorrect randomisation|1|||
48966321|NCT01582971|157703795|FG000|Overall Study|Death|2|||
48966322|NCT01582971|157703796|FG001|Overall Study|Death|1|||
48966323|NCT01582971|157703795|FG000|Overall Study|Lost to Follow-up|18|||
48966324|NCT01582971|157703796|FG001|Overall Study|Lost to Follow-up|21|||
48966325|NCT01582971|157703795|FG000|Overall Study|Withdrawal by Subject|4|||
48966326|NCT01582971|157703796|FG001|Overall Study|Withdrawal by Subject|2|||
48966327|NCT01582971|157703795|FG000|Overall Study|Other|15|||
48867469|NCT00527514|157350846|FG000|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1|||
48867470|NCT00527514|157350846|FG000|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2|||
48867471|NCT00527514|157350846|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1|||
48867472|NCT00527514|157350846|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1|||
48867473|NCT00527514|157350846|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1|||
48867474|NCT00527514|157350846|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1|||
48867475|NCT00527514|157350846|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1|||
48867476|NCT03410108|157350848|FG000|Overall Study|Ongoing|41|||
48867477|NCT03410108|157350848|FG000|Overall Study|Adverse Event|4|||
48867478|NCT03410108|157350848|FG000|Overall Study|Progressive Disease|58|||
48867479|NCT03410108|157350848|FG000|Overall Study|Withdrawal by Subject|1|||
48966328|NCT01582971|157703796|FG001|Overall Study|Other|13|||
48966329|NCT03695393|157703797|FG000|Overall Study|Death|3|||
48966330|NCT03695393|157703798|FG001|Overall Study|Death|1|||
48966331|NCT03695393|157703797|FG000|Overall Study|Lost to Follow-up|0|||
48966332|NCT03695393|157703798|FG001|Overall Study|Lost to Follow-up|1|||
48966333|NCT04169061|157703801|FG000|Overall Study|Adverse Event|2|||
48966334|NCT04169061|157703801|FG000|Overall Study|Death|1|||
48966335|NCT04169061|157703801|FG000|Overall Study|Withdrawal by Subject|1|||
48966336|NCT04169061|157703801|FG000|Overall Study|Protocol Violation|1|||
48966337|NCT02007954|157703804|FG000|Overall Study|Received liver transplant|3|||
48966338|NCT02007954|157703804|FG000|Overall Study|Switch in treatment modality|2|||
48966339|NCT02007954|157703804|FG000|Overall Study|Disease progression and unrelated AE|1|||
48966340|NCT02007954|157703804|FG000|Overall Study|Death|1|||
48966341|NCT04585451|157703810|FG000|Overall Study|Withdrawal by Subject|26|||
48966342|NCT04585451|157703811|FG001|Overall Study|Withdrawal by Subject|0|||
48966343|NCT01641991|157703812|FG000|Overall Study|Physician Decision|0|||
48966344|NCT01641991|157703813|FG001|Overall Study|Physician Decision|1|||
48966345|NCT01641991|157703814|FG002|Overall Study|Physician Decision|7|||
48966346|NCT01641991|157703815|FG003|Overall Study|Physician Decision|5|||
48966347|NCT01641991|157703812|FG000|Overall Study|Withdrawal by Subject|4|||
48966348|NCT01641991|157703813|FG001|Overall Study|Withdrawal by Subject|2|||
48966349|NCT01641991|157703814|FG002|Overall Study|Withdrawal by Subject|1|||
48966350|NCT01641991|157703815|FG003|Overall Study|Withdrawal by Subject|5|||
48664259|NCT00711802|156623247|FG001|Overall Study|Reason not reported|1|||
48664260|NCT00711802|156623248|FG002|Overall Study|Reason not reported|1|||
48966351|NCT01641991|157703812|FG000|Overall Study|Adverse Event|2|||
48966352|NCT01641991|157703813|FG001|Overall Study|Adverse Event|1|||
48966353|NCT01641991|157703814|FG002|Overall Study|Adverse Event|2|||
48966354|NCT01641991|157703815|FG003|Overall Study|Adverse Event|1|||
48966355|NCT01641991|157703812|FG000|Overall Study|Lost to Follow-up|0|||
48966356|NCT01641991|157703813|FG001|Overall Study|Lost to Follow-up|2|||
48966357|NCT01641991|157703814|FG002|Overall Study|Lost to Follow-up|3|||
48966358|NCT01641991|157703815|FG003|Overall Study|Lost to Follow-up|1|||
48966359|NCT01641991|157703812|FG000|Overall Study|Protocol Violation|1|||
48664261|NCT00711802|156623249|FG003|Overall Study|Reason not reported|0|||
48664262|NCT00711802|156623250|FG004|Overall Study|Reason not reported|1|||
48664263|NCT00711802|156623251|FG005|Overall Study|Reason not reported|0|||
48664264|NCT00711802|156623252|FG006|Overall Study|Reason not reported|1|||
48664265|NCT00711802|156623253|FG007|Overall Study|Reason not reported|0|||
48664266|NCT02370095|156623254|FG000|Overall Study|Withdrawal by Subject|0|||
48664267|NCT02370095|156623255|FG001|Overall Study|Withdrawal by Subject|1|||
48664268|NCT00900146|156623256|FG000|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
48966360|NCT01641991|157703813|FG001|Overall Study|Protocol Violation|1|||
48966361|NCT01641991|157703814|FG002|Overall Study|Protocol Violation|3|||
48966362|NCT01641991|157703815|FG003|Overall Study|Protocol Violation|0|||
48664269|NCT00900146|156623257|FG001|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
48664270|NCT00900146|156623258|FG002|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5|||
48664271|NCT00900146|156623259|FG003|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1|||
48966363|NCT01641991|157703812|FG000|Overall Study|Pregnancy|0|||
48966364|NCT01641991|157703813|FG001|Overall Study|Pregnancy|0|||
48966365|NCT01641991|157703814|FG002|Overall Study|Pregnancy|1|||
48966366|NCT01641991|157703815|FG003|Overall Study|Pregnancy|0|||
48966367|NCT01641991|157703812|FG000|Overall Study|no longer eligible|2|||
48966368|NCT01641991|157703813|FG001|Overall Study|no longer eligible|1|||
48664272|NCT00900146|156623260|FG004|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9|||
48664273|NCT00900146|156623256|FG000|Dose Finding: Period II (4 Months)|Lost to Follow-up|2|||
48664274|NCT00900146|156623257|FG001|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
48664275|NCT00900146|156623258|FG002|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
48664276|NCT00900146|156623259|FG003|Dose Finding: Period II (4 Months)|Lost to Follow-up|1|||
48664277|NCT00900146|156623260|FG004|Dose Finding: Period II (4 Months)|Lost to Follow-up|3|||
48664278|NCT00900146|156623256|FG000|Dose Finding: Period II (4 Months)|Administrative problems|1|||
48664279|NCT00900146|156623257|FG001|Dose Finding: Period II (4 Months)|Administrative problems|0|||
48664280|NCT00900146|156623258|FG002|Dose Finding: Period II (4 Months)|Administrative problems|0|||
48664281|NCT00900146|156623259|FG003|Dose Finding: Period II (4 Months)|Administrative problems|0|||
48664282|NCT00900146|156623260|FG004|Dose Finding: Period II (4 Months)|Administrative problems|0|||
48664283|NCT00900146|156623256|FG000|Intermediate: Period III|Withdrawal by Subject|0|||
48664284|NCT00900146|156623257|FG001|Intermediate: Period III|Withdrawal by Subject|1|||
48664285|NCT00900146|156623258|FG002|Intermediate: Period III|Withdrawal by Subject|0|||
48664286|NCT00900146|156623259|FG003|Intermediate: Period III|Withdrawal by Subject|0|||
48664287|NCT00900146|156623260|FG004|Intermediate: Period III|Withdrawal by Subject|3|||
48966369|NCT01641991|157703814|FG002|Overall Study|no longer eligible|0|||
48664288|NCT00900146|156623256|FG000|Intermediate: Period III|Lost to Follow-up|2|||
48664289|NCT00900146|156623257|FG001|Intermediate: Period III|Lost to Follow-up|0|||
48664290|NCT00900146|156623258|FG002|Intermediate: Period III|Lost to Follow-up|0|||
48664291|NCT00900146|156623259|FG003|Intermediate: Period III|Lost to Follow-up|0|||
48664292|NCT00900146|156623260|FG004|Intermediate: Period III|Lost to Follow-up|1|||
48664293|NCT00900146|156623256|FG000|Intermediate: Period III|Administrative problems|85|||
48664294|NCT00900146|156623257|FG001|Intermediate: Period III|Administrative problems|92|||
48664295|NCT00900146|156623258|FG002|Intermediate: Period III|Administrative problems|84|||
48664296|NCT00900146|156623259|FG003|Intermediate: Period III|Administrative problems|90|||
48664297|NCT00900146|156623260|FG004|Intermediate: Period III|Administrative problems|163|||
48664298|NCT01129882|156623265|FG000|Overall Study|Adverse Event|39|||
48664299|NCT01129882|156623265|FG000|Overall Study|Death|6|||
48664300|NCT01129882|156623265|FG000|Overall Study|Lack of Efficacy|5|||
48966370|NCT01641991|157703815|FG003|Overall Study|no longer eligible|4|||
48966371|NCT01295580|157703816|FG000|Overall Study|Protocol Violation|4|||
48966372|NCT01295580|157703817|FG001|Overall Study|Protocol Violation|2|||
48966373|NCT01295580|157703816|FG000|Overall Study|Withdrawal by Subject|1|||
48966374|NCT01295580|157703817|FG001|Overall Study|Withdrawal by Subject|4|||
48966375|NCT01295580|157703816|FG000|Overall Study|Adverse Event|2|||
48966376|NCT01295580|157703817|FG001|Overall Study|Adverse Event|1|||
48966377|NCT01295580|157703816|FG000|Overall Study|Lost to Follow-up|1|||
48966378|NCT01295580|157703817|FG001|Overall Study|Lost to Follow-up|0|||
48966379|NCT01295580|157703816|FG000|Overall Study|Lack of Efficacy|1|||
48966380|NCT01295580|157703817|FG001|Overall Study|Lack of Efficacy|0|||
48966381|NCT01295580|157703816|FG000|Overall Study|Other: inconvenience|1|||
48966382|NCT01295580|157703817|FG001|Overall Study|Other: inconvenience|0|||
48966383|NCT01295580|157703816|FG000|Overall Study|Other: family objection|0|||
48664301|NCT01129882|156623265|FG000|Overall Study|Lost to Follow-up|13|||
48664302|NCT01129882|156623265|FG000|Overall Study|Physician Decision|27|||
48664303|NCT01129882|156623265|FG000|Overall Study|Protocol Deviation|3|||
48664304|NCT01129882|156623265|FG000|Overall Study|Withdrawal Criteria Met|19|||
48664305|NCT01129882|156623265|FG000|Overall Study|Trial Termination by Sponsor|6|||
48664306|NCT01129882|156623265|FG000|Overall Study|Withdrawal by Subject|160|||
48664307|NCT00355342|156623266|FG000|Overall Study|Adverse Event|13|||
48664308|NCT00355342|156623267|FG001|Overall Study|Adverse Event|15|||
48664309|NCT00355342|156623266|FG000|Overall Study|Lost to Follow-up|4|||
48664310|NCT00355342|156623267|FG001|Overall Study|Lost to Follow-up|2|||
48664311|NCT00355342|156623266|FG000|Overall Study|Withdrawal by Subject|14|||
48664312|NCT00355342|156623267|FG001|Overall Study|Withdrawal by Subject|11|||
48664313|NCT00355342|156623266|FG000|Overall Study|Sponsor terminated study|2|||
48664314|NCT00355342|156623267|FG001|Overall Study|Sponsor terminated study|2|||
48664315|NCT00355342|156623266|FG000|Overall Study|Overcompliant-PI discretion|1|||
48664316|NCT00355342|156623267|FG001|Overall Study|Overcompliant-PI discretion|0|||
48664317|NCT00355342|156623266|FG000|Overall Study|Use of prohibited medication|1|||
48664318|NCT00355342|156623267|FG001|Overall Study|Use of prohibited medication|0|||
48664319|NCT00355342|156623266|FG000|Overall Study|COPD exacerbation|1|||
48664320|NCT00355342|156623267|FG001|Overall Study|COPD exacerbation|1|||
48664321|NCT00355342|156623266|FG000|Overall Study|Dispensed wrong study drug kit|1|||
48664322|NCT00355342|156623267|FG001|Overall Study|Dispensed wrong study drug kit|0|||
48664323|NCT00355342|156623266|FG000|Overall Study|Non-compliance with Dexa scans|1|||
48664324|NCT00355342|156623267|FG001|Overall Study|Non-compliance with Dexa scans|0|||
48664325|NCT00355342|156623266|FG000|Overall Study|Withdrawal by participant and physician|1|||
48664326|NCT00355342|156623267|FG001|Overall Study|Withdrawal by participant and physician|0|||
48664327|NCT00355342|156623266|FG000|Overall Study|Participant relocated|0|||
48966384|NCT01295580|157703817|FG001|Overall Study|Other: family objection|1|||
48966385|NCT00673894|157703818|FG000|First Intervention 4 Weeks|Withdrawal by Subject|1|||
48966386|NCT00673894|157703819|FG001|First Intervention 4 Weeks|Withdrawal by Subject|0|||
48757005|NCT02659631|156958147|FG007|Overall Study|Death (follow-up phase)|3|||
48757006|NCT02659631|156958148|FG008|Overall Study|Death (follow-up phase)|1|||
48757007|NCT02659631|156958149|FG009|Overall Study|Death (follow-up phase)|0|||
48757008|NCT02659631|156958140|FG000|Overall Study|Death (treatment phase)|0|||
48757009|NCT02659631|156958141|FG001|Overall Study|Death (treatment phase)|0|||
48757010|NCT02659631|156958142|FG002|Overall Study|Death (treatment phase)|0|||
48757011|NCT02659631|156958143|FG003|Overall Study|Death (treatment phase)|0|||
48757012|NCT02659631|156958144|FG004|Overall Study|Death (treatment phase)|1|||
48757013|NCT02659631|156958145|FG005|Overall Study|Death (treatment phase)|0|||
48757014|NCT02659631|156958146|FG006|Overall Study|Death (treatment phase)|1|||
48757015|NCT02659631|156958147|FG007|Overall Study|Death (treatment phase)|0|||
48757016|NCT02659631|156958148|FG008|Overall Study|Death (treatment phase)|0|||
48757017|NCT02659631|156958149|FG009|Overall Study|Death (treatment phase)|0|||
48757018|NCT00495170|156958150|FG000|Overall Study|Lost to Follow-up|9|||
48757019|NCT00495170|156958150|FG000|Overall Study|Withdrawal by Subject|3|||
48757020|NCT00495170|156958150|FG000|Overall Study|Inappropriate staging|8|||
48757021|NCT01408914|156958153|FG000|Overall Study|Could not complete tx in protocol period|5|||
48757022|NCT01408914|156958154|FG001|Overall Study|Could not complete tx in protocol period|5|||
48664328|NCT00355342|156623267|FG001|Overall Study|Participant relocated|1|||
48664329|NCT00355342|156623266|FG000|Overall Study|Participant discontinued study drug|0|||
48664330|NCT00355342|156623267|FG001|Overall Study|Participant discontinued study drug|1|||
48664331|NCT00355342|156623266|FG000|Overall Study|Study management|0|||
48664332|NCT00355342|156623267|FG001|Overall Study|Study management|1|||
48664333|NCT00355342|156623266|FG000|Overall Study|Protocol Violation|0|||
48664334|NCT00355342|156623267|FG001|Overall Study|Protocol Violation|1|||
48664335|NCT00355342|156623266|FG000|Overall Study|Use of protocol excluded medication|0|||
48664336|NCT00355342|156623267|FG001|Overall Study|Use of protocol excluded medication|1|||
48664337|NCT02436408|156623268|FG000|Overall Study|Death|1|||
48664338|NCT02649855|156623269|FG000|Overall Study|Refused further treatment|2|||
48664339|NCT02649855|156623270|FG001|Overall Study|Refused further treatment|1|||
48664340|NCT02649855|156623271|FG002|Overall Study|Refused further treatment|1|||
48664341|NCT02649855|156623269|FG000|Overall Study|Withdrew consent|0|||
48664342|NCT02649855|156623270|FG001|Overall Study|Withdrew consent|1|||
48664343|NCT02649855|156623271|FG002|Overall Study|Withdrew consent|0|||
48664344|NCT02649855|156623269|FG000|Overall Study|Switched to alternative treatment|0|||
48664345|NCT02649855|156623270|FG001|Overall Study|Switched to alternative treatment|1|||
48664346|NCT02649855|156623271|FG002|Overall Study|Switched to alternative treatment|1|||
48664347|NCT02649855|156623269|FG000|Overall Study|Principal investigator discretion|0|||
48664348|NCT02649855|156623270|FG001|Overall Study|Principal investigator discretion|1|||
48664349|NCT02649855|156623271|FG002|Overall Study|Principal investigator discretion|1|||
48664350|NCT02649855|156623269|FG000|Overall Study|No treatment, per protocol|1|||
48664351|NCT02649855|156623270|FG001|Overall Study|No treatment, per protocol|0|||
48664352|NCT02649855|156623271|FG002|Overall Study|No treatment, per protocol|0|||
48664353|NCT02649855|156623269|FG000|Overall Study|Initiate new treatment|1|||
48664354|NCT02649855|156623270|FG001|Overall Study|Initiate new treatment|0|||
48664355|NCT02649855|156623271|FG002|Overall Study|Initiate new treatment|0|||
48664356|NCT03777917|156623275|FG000|Overall Study|Withdrawal by Subject|1|||
48664357|NCT03777917|156623276|FG001|Overall Study|Withdrawal by Subject|0|||
48664358|NCT03777917|156623275|FG000|Overall Study|Physician Decision|1|||
48664359|NCT03777917|156623276|FG001|Overall Study|Physician Decision|0|||
48664360|NCT03777917|156623275|FG000|Overall Study|Lost to Follow-up|6|||
48664361|NCT03777917|156623276|FG001|Overall Study|Lost to Follow-up|2|||
48664362|NCT03777917|156623275|FG000|Overall Study|Other|1|||
48664363|NCT03777917|156623276|FG001|Overall Study|Other|0|||
48664364|NCT01287221|156623278|FG000|Overall Study|Lack of Perceived Benefit|1|||
48664365|NCT01287221|156623279|FG001|Overall Study|Lack of Perceived Benefit|1|||
48664366|NCT01287221|156623278|FG000|Overall Study|Adverse Event|3|||
48664367|NCT01287221|156623279|FG001|Overall Study|Adverse Event|3|||
48664368|NCT01287221|156623278|FG000|Overall Study|Withdrawal by Subject|0|||
48757023|NCT01408914|156958155|FG002|Overall Study|Could not complete tx in protocol period|6|||
48757024|NCT01408914|156958153|FG000|Overall Study|Lost to Follow-up|4|||
48757025|NCT01408914|156958154|FG001|Overall Study|Lost to Follow-up|1|||
48757026|NCT01408914|156958155|FG002|Overall Study|Lost to Follow-up|2|||
48867480|NCT02161185|157350849|FG000|Treatment Phase|Administrative/Other|7|||
48867481|NCT03575572|157350850|FG000|Overall Study|Withdrawal by Subject|2|||
48867482|NCT03575572|157350850|FG000|Overall Study|Physician Decision|2|||
48757027|NCT01408914|156958153|FG000|Overall Study|Physician Decision|1|||
48867483|NCT02162771|157350851|FG000|Core Study Period (Part 2)|Progressive Disease|2|||
48664369|NCT01287221|156623279|FG001|Overall Study|Withdrawal by Subject|1|||
48664370|NCT03515941|156623284|FG000|Overall Study|Adverse Event|1|||
48664371|NCT03515941|156623285|FG001|Overall Study|Adverse Event|0|||
48664372|NCT00283868|156623286|FG000|Overall Study|Lost to Follow-up|7|||
48664373|NCT00283868|156623287|FG001|Overall Study|Lost to Follow-up|8|||
48664374|NCT00353873|156623288|FG000|Overall Study|Protocol Violation|1|||
48664375|NCT00353873|156623289|FG001|Overall Study|Protocol Violation|2|||
48664376|NCT00353873|156623288|FG000|Overall Study|Exacerbation|1|||
48867484|NCT02162771|157350852|FG001|Core Study Period (Part 2)|Progressive Disease|3|||
48867485|NCT02162771|157350851|FG000|Core Study Period (Part 2)|Adverse Event|4|||
48867486|NCT02162771|157350852|FG001|Core Study Period (Part 2)|Adverse Event|1|||
48867487|NCT02162771|157350851|FG000|Core Study Period (Part 2)|Withdrawal by Subject|1|||
48867488|NCT02162771|157350852|FG001|Core Study Period (Part 2)|Withdrawal by Subject|2|||
48867489|NCT02162771|157350851|FG000|Core Study Period (Part 2)|Physician Decision|0|||
48867490|NCT02162771|157350852|FG001|Core Study Period (Part 2)|Physician Decision|2|||
48867491|NCT02162771|157350851|FG000|Core Study Period (Part 2)|Death|1|||
48867492|NCT02162771|157350852|FG001|Core Study Period (Part 2)|Death|0|||
48867493|NCT02162771|157350851|FG000|Maintenance Study Period (Part 2)|Progressive Disease|11|||
48664377|NCT00353873|156623289|FG001|Overall Study|Exacerbation|0|||
48664378|NCT00353873|156623288|FG000|Overall Study|Adverse Event|1|||
48664379|NCT00353873|156623289|FG001|Overall Study|Adverse Event|0|||
48664380|NCT00353873|156623288|FG000|Overall Study|Physician Decision|2|||
48664381|NCT00353873|156623289|FG001|Overall Study|Physician Decision|0|||
48664382|NCT00353873|156623288|FG000|Overall Study|Withdrawal by Subject|1|||
48664383|NCT00353873|156623289|FG001|Overall Study|Withdrawal by Subject|1|||
48664384|NCT02743780|156623294|FG000|Part 3 (7 Days)|Adverse Event|0|||
48664385|NCT02743780|156623295|FG001|Part 3 (7 Days)|Adverse Event|0|||
48664386|NCT02743780|156623296|FG002|Part 3 (7 Days)|Adverse Event|1|||
48664387|NCT02743780|156623297|FG003|Part 3 (7 Days)|Adverse Event|0|||
48664388|NCT02743780|156623298|FG004|Part 3 (7 Days)|Adverse Event|0|||
48664389|NCT01294462|156623299|FG000|Overall Study|Lost to Follow-up|1|||
48664390|NCT01294462|156623300|FG001|Overall Study|Lost to Follow-up|0|||
48664391|NCT01294462|156623299|FG000|Overall Study|Withdrawal by Subject|65|||
48664392|NCT01294462|156623300|FG001|Overall Study|Withdrawal by Subject|63|||
48664393|NCT00953680|156623303|FG000|Period 1|Withdrawal by Subject|0|||
48664394|NCT00953680|156623304|FG001|Period 1|Withdrawal by Subject|1|||
48664395|NCT01873729|156623305|FG000|Overall Study|Withdrawal by Subject|1|||
48664396|NCT02312219|156623307|FG000|Overall Study|Withdrawal by Subject|1|||
48664397|NCT02312219|156623308|FG001|Overall Study|Withdrawal by Subject|2|||
48664398|NCT02312219|156623307|FG000|Overall Study|could not schedule imaging in time|0|||
48664399|NCT02312219|156623308|FG001|Overall Study|could not schedule imaging in time|2|||
48664400|NCT02312219|156623307|FG000|Overall Study|Other|0|||
48664401|NCT02312219|156623308|FG001|Overall Study|Other|1|||
48664402|NCT02312219|156623307|FG000|Overall Study|Not randomized. Ineligible|0|||
48664403|NCT02312219|156623308|FG001|Overall Study|Not randomized. Ineligible|1|||
48664404|NCT03553498|156623310|FG000|Overall Study|Missing primary outcome|1|||
48664405|NCT03553498|156623311|FG001|Overall Study|Missing primary outcome|2|||
48664406|NCT02226198|156625078|FG000|Lead-in Phase|Protocol Violation|1|||
48664407|NCT02226198|156625079|FG001|Lead-in Phase|Protocol Violation|0|||
48664408|NCT02226198|156625080|FG002|Lead-in Phase|Protocol Violation|0|||
48664409|NCT02226198|156625078|FG000|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
48664410|NCT02226198|156625079|FG001|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1|||
48664411|NCT02226198|156625080|FG002|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
48664412|NCT02744612|156625082|FG000|Overall Study|Withdrawal by Subject|0|||
48664413|NCT02744612|156625083|FG001|Overall Study|Withdrawal by Subject|2|||
48664414|NCT00871923|156625086|FG000|Overall Study|Death|1|||
48664415|NCT00871923|156625086|FG000|Overall Study|Withdrawal by Subject|1|||
48664416|NCT01952665|156625090|FG000|Overall Study|Physician Decision|3|||
48664417|NCT01952665|156625091|FG001|Overall Study|Physician Decision|2|||
48664418|NCT01952665|156625090|FG000|Overall Study|Lost to Follow-up|1|||
48664419|NCT01952665|156625091|FG001|Overall Study|Lost to Follow-up|2|||
48664420|NCT01952665|156625090|FG000|Overall Study|Adverse Event|2|||
48664421|NCT01952665|156625091|FG001|Overall Study|Adverse Event|1|||
48664422|NCT01952665|156625090|FG000|Overall Study|Protocol Violation|0|||
48664423|NCT01952665|156625091|FG001|Overall Study|Protocol Violation|1|||
48664424|NCT01463111|156625103|FG000|Overall Study|Withdrawal by Subject|2|||
48664425|NCT01463111|156625103|FG000|Overall Study|Lost to Follow-up|5|||
48664426|NCT01463111|156625103|FG000|Overall Study|Physician Decision|2|||
48664427|NCT04143217|156625104|FG000|Overall Study|Withdrawal by Subject|42|||
48664428|NCT04143217|156625104|FG000|Overall Study|Adverse Event|29|||
48664429|NCT04143217|156625104|FG000|Overall Study|Lost to Follow-up|29|||
48664430|NCT04143217|156625104|FG000|Overall Study|Lack of Efficacy|15|||
48664431|NCT04143217|156625104|FG000|Overall Study|Physician Decision|1|||
48664432|NCT04143217|156625104|FG000|Overall Study|Non-Compliance With Study Drug|6|||
48664433|NCT04143217|156625104|FG000|Overall Study|Other, Multiple Categories|11|||
48664434|NCT01962987|156625106|FG000|Overall Study|Adverse Event|4|||
48664435|NCT01962987|156625107|FG001|Overall Study|Adverse Event|4|||
48664436|NCT01962987|156625108|FG002|Overall Study|Adverse Event|0|||
48664437|NCT01962987|156625106|FG000|Overall Study|Lost to Follow-up|0|||
48664438|NCT01962987|156625107|FG001|Overall Study|Lost to Follow-up|0|||
48664439|NCT01962987|156625108|FG002|Overall Study|Lost to Follow-up|1|||
48664440|NCT01962987|156625106|FG000|Overall Study|Non compliance with dosing requirements|4|||
48664441|NCT01962987|156625107|FG001|Overall Study|Non compliance with dosing requirements|2|||
48757028|NCT01408914|156958154|FG001|Overall Study|Physician Decision|1|||
48757029|NCT01408914|156958155|FG002|Overall Study|Physician Decision|0|||
48757030|NCT01408914|156958153|FG000|Overall Study|Withdrawal by Subject|1|||
48757031|NCT01408914|156958154|FG001|Overall Study|Withdrawal by Subject|0|||
48757032|NCT01408914|156958155|FG002|Overall Study|Withdrawal by Subject|1|||
48757033|NCT01408914|156958153|FG000|Overall Study|Moved out of study jurisdiction|1|||
48757034|NCT01408914|156958154|FG001|Overall Study|Moved out of study jurisdiction|1|||
48757035|NCT01408914|156958155|FG002|Overall Study|Moved out of study jurisdiction|0|||
48757036|NCT01408914|156958153|FG000|Overall Study|Late exclusion|0|||
48757037|NCT01408914|156958154|FG001|Overall Study|Late exclusion|3|||
48757038|NCT01408914|156958155|FG002|Overall Study|Late exclusion|3|||
48757039|NCT01408914|156958153|FG000|Overall Study|Change in local TB/HIV norms|0|||
48757040|NCT01408914|156958154|FG001|Overall Study|Change in local TB/HIV norms|1|||
48757041|NCT01408914|156958155|FG002|Overall Study|Change in local TB/HIV norms|1|||
48757042|NCT00137423|156958156|FG000|Overall Study|Adverse Event|7|||
48757043|NCT00137423|156958157|FG001|Overall Study|Adverse Event|9|||
48757044|NCT00137423|156958156|FG000|Overall Study|consent withdrawn|1|||
48757045|NCT00137423|156958157|FG001|Overall Study|consent withdrawn|1|||
48757046|NCT00137423|156958156|FG000|Overall Study|Lack of Efficacy|31|||
48757047|NCT00137423|156958157|FG001|Overall Study|Lack of Efficacy|33|||
48757048|NCT00137423|156958156|FG000|Overall Study|Death|0|||
48757049|NCT00137423|156958157|FG001|Overall Study|Death|1|||
48757050|NCT01928329|156958158|FG000|Overall Study|Withdrew Consent Prior to Receiving Drug|1|||
48757051|NCT01928329|156958159|FG001|Overall Study|Withdrew Consent Prior to Receiving Drug|3|||
48757052|NCT01928329|156958158|FG000|Overall Study|Removed from Study Prior to Receiving Dr|0|||
48757053|NCT01928329|156958159|FG001|Overall Study|Removed from Study Prior to Receiving Dr|1|||
48757054|NCT01928329|156958158|FG000|Overall Study|Adverse Event|5|||
48757055|NCT01928329|156958159|FG001|Overall Study|Adverse Event|3|||
48757056|NCT01928329|156958158|FG000|Overall Study|Stopping Rule: Lost Greater than 5kg|4|||
48757057|NCT01928329|156958159|FG001|Overall Study|Stopping Rule: Lost Greater than 5kg|1|||
48757058|NCT01928329|156958158|FG000|Overall Study|Withdrawal by Subject|1|||
48757059|NCT01928329|156958159|FG001|Overall Study|Withdrawal by Subject|5|||
48757060|NCT01928329|156958158|FG000|Overall Study|Physician Decision|1|||
48757061|NCT01928329|156958159|FG001|Overall Study|Physician Decision|1|||
48757062|NCT01119131|156958164|FG000|Overall Study|Adverse Event|1|||
48757063|NCT01119131|156958165|FG001|Overall Study|Adverse Event|1|||
48757064|NCT01119131|156958166|FG002|Overall Study|Adverse Event|1|||
48757065|NCT01119131|156958164|FG000|Overall Study|Non-Compliance|1|||
48757066|NCT01119131|156958165|FG001|Overall Study|Non-Compliance|0|||
48757067|NCT01119131|156958166|FG002|Overall Study|Non-Compliance|4|||
48757068|NCT01119131|156958164|FG000|Overall Study|Physician Decision|0|||
48757069|NCT01119131|156958165|FG001|Overall Study|Physician Decision|0|||
48757070|NCT01119131|156958166|FG002|Overall Study|Physician Decision|1|||
48757071|NCT00909389|156958170|FG000|Overall Study|Adverse Event|6|||
48757072|NCT00909389|156958170|FG000|Overall Study|Death|4|||
48757073|NCT00909389|156958170|FG000|Overall Study|Poor Compliance|16|||
48757074|NCT00909389|156958170|FG000|Overall Study|Lost to Follow-up|4|||
48757075|NCT00909389|156958170|FG000|Overall Study|No Information|103|||
48757076|NCT00003492|156958171|FG000|Overall Study|Not evaluable|6|||
48664442|NCT01962987|156625108|FG002|Overall Study|Non compliance with dosing requirements|0|||
48664443|NCT01962987|156625106|FG000|Overall Study|Miscellaneous|1|||
48664444|NCT01962987|156625107|FG001|Overall Study|Miscellaneous|9|||
48664445|NCT01962987|156625108|FG002|Overall Study|Miscellaneous|2|||
48664446|NCT01962987|156625106|FG000|Overall Study|Restricted medication|5|||
48664447|NCT01962987|156625107|FG001|Overall Study|Restricted medication|1|||
48664448|NCT01962987|156625108|FG002|Overall Study|Restricted medication|1|||
48757077|NCT00597766|156958174|FG000|Follow-up 1, Week 4|Withdrawal by Subject|1|||
48757078|NCT00597766|156958175|FG001|Follow-up 1, Week 4|Withdrawal by Subject|0|||
48757079|NCT00597766|156958176|FG002|Follow-up 1, Week 4|Withdrawal by Subject|0|||
48757080|NCT00597766|156958174|FG000|Follow-up 2, Week 8|Lost to Follow-up|0|||
48757081|NCT00597766|156958175|FG001|Follow-up 2, Week 8|Lost to Follow-up|0|||
48757082|NCT00597766|156958176|FG002|Follow-up 2, Week 8|Lost to Follow-up|1|||
48757083|NCT02733367|156958177|FG000|Overall Study|Withdrawal by Subject|6|||
48757084|NCT01166763|156958178|FG000|Overall Study|Withdrawal by Subject|3|||
48664449|NCT01962987|156625106|FG000|Overall Study|Serious Adverse Event|1|||
48757085|NCT01909479|156958179|FG000|From Baseline to Week 26|Adverse Event|3|||
48757086|NCT01909479|156958180|FG001|From Baseline to Week 26|Adverse Event|2|||
48867494|NCT02162771|157350852|FG001|Maintenance Study Period (Part 2)|Progressive Disease|13|||
48867495|NCT02162771|157350851|FG000|Maintenance Study Period (Part 2)|Adverse Event|3|||
48757087|NCT01909479|156958179|FG000|From Baseline to Week 26|Withdrawal by Subject|3|||
48867496|NCT02162771|157350852|FG001|Maintenance Study Period (Part 2)|Adverse Event|3|||
48867497|NCT02162771|157350851|FG000|Maintenance Study Period (Part 2)|Death|2|||
48664450|NCT01962987|156625107|FG001|Overall Study|Serious Adverse Event|0|||
48757088|NCT01909479|156958180|FG001|From Baseline to Week 26|Withdrawal by Subject|6|||
48757089|NCT01909479|156958179|FG000|From Baseline to Week 26|Site and study closed by PI|0|||
48757090|NCT01909479|156958180|FG001|From Baseline to Week 26|Site and study closed by PI|1|||
48757091|NCT01909479|156958179|FG000|26 - 52 Weeks|Adverse Event|0|||
48757092|NCT01909479|156958180|FG001|26 - 52 Weeks|Adverse Event|1|||
48757093|NCT01909479|156958179|FG000|26 - 52 Weeks|Withdrawal by Subject|2|||
48757094|NCT01909479|156958180|FG001|26 - 52 Weeks|Withdrawal by Subject|1|||
48757095|NCT01909479|156958179|FG000|26 - 52 Weeks|Lost to Follow-up|1|||
48757096|NCT01909479|156958180|FG001|26 - 52 Weeks|Lost to Follow-up|0|||
48757097|NCT01909479|156958179|FG000|52 Weeks to End of Study|Withdrawal by Subject|18|||
48757098|NCT01909479|156958180|FG001|52 Weeks to End of Study|Withdrawal by Subject|8|||
48757099|NCT01909479|156958179|FG000|52 Weeks to End of Study|Adverse Event|2|||
48757100|NCT01909479|156958180|FG001|52 Weeks to End of Study|Adverse Event|1|||
48757101|NCT01909479|156958179|FG000|52 Weeks to End of Study|Death|0|||
48757102|NCT01909479|156958180|FG001|52 Weeks to End of Study|Death|1|||
48757103|NCT01909479|156958179|FG000|52 Weeks to End of Study|Lost to Follow-up|1|||
48757104|NCT01909479|156958180|FG001|52 Weeks to End of Study|Lost to Follow-up|0|||
48757105|NCT01909479|156958179|FG000|52 Weeks to End of Study|Protocol Violation|1|||
48757106|NCT01909479|156958180|FG001|52 Weeks to End of Study|Protocol Violation|0|||
48757107|NCT01909479|156958179|FG000|52 Weeks to End of Study|Progressive disease|1|||
48757108|NCT01909479|156958180|FG001|52 Weeks to End of Study|Progressive disease|1|||
48757109|NCT01909479|156958179|FG000|52 Weeks to End of Study|Personal reasons|2|||
48757110|NCT01909479|156958180|FG001|52 Weeks to End of Study|Personal reasons|1|||
48757111|NCT01909479|156958179|FG000|52 Weeks to End of Study|Sponsor's decision|1|||
48757112|NCT01909479|156958180|FG001|52 Weeks to End of Study|Sponsor's decision|1|||
48757113|NCT01909479|156958179|FG000|52 Weeks to End of Study|Study termination by sponsor|0|||
48757114|NCT01909479|156958180|FG001|52 Weeks to End of Study|Study termination by sponsor|1|||
48757115|NCT01909479|156958179|FG000|52 Weeks to End of Study|Lack of contact|1|||
48757116|NCT01909479|156958180|FG001|52 Weeks to End of Study|Lack of contact|0|||
48757117|NCT01909479|156958179|FG000|52 Weeks to End of Study|Occurrence of malignancy|1|||
48757118|NCT01909479|156958180|FG001|52 Weeks to End of Study|Occurrence of malignancy|0|||
48757119|NCT01909479|156958179|FG000|52 Weeks to End of Study|Diabetes not controlled|0|||
48757120|NCT01909479|156958180|FG001|52 Weeks to End of Study|Diabetes not controlled|1|||
48757121|NCT04446377|156958181|FG000|Overall Study|Withdrawal by Subject|6|||
48757122|NCT04446377|156958182|FG001|Overall Study|Withdrawal by Subject|1|||
48757123|NCT04446377|156958181|FG000|Overall Study|Physician Decision|1|||
48757124|NCT04446377|156958182|FG001|Overall Study|Physician Decision|1|||
48757125|NCT04446377|156958181|FG000|Overall Study|Lost to Follow-up|0|||
48757126|NCT04446377|156958182|FG001|Overall Study|Lost to Follow-up|2|||
48757127|NCT04446377|156958181|FG000|Overall Study|Not eligible|0|||
48757128|NCT04446377|156958182|FG001|Overall Study|Not eligible|1|||
48757129|NCT03557151|156958184|FG000|Randomization to 3 Months|Lost to Follow-up|2|||
48757130|NCT03557151|156958185|FG001|Randomization to 3 Months|Lost to Follow-up|2|||
48757131|NCT03557151|156958184|FG000|6 to 9 Months|moved out of state/discontinued care at Nemours|2|||
48757132|NCT03557151|156958185|FG001|6 to 9 Months|moved out of state/discontinued care at Nemours|0|||
48757133|NCT03557151|156958184|FG000|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|0|||
48757134|NCT03557151|156958185|FG001|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|2|||
48757135|NCT00840294|156958186|FG000|Overall Study|Withdrawal by Subject|2|||
48757136|NCT00840294|156958187|FG001|Overall Study|Withdrawal by Subject|1|||
48757137|NCT00840294|156958186|FG000|Overall Study|Protocol Violation|1|||
48757138|NCT00840294|156958187|FG001|Overall Study|Protocol Violation|3|||
48757139|NCT00840294|156958186|FG000|Overall Study|Illness|0|||
48757140|NCT00840294|156958187|FG001|Overall Study|Illness|1|||
48757141|NCT04256785|156958190|FG000|Overall Study|Adverse Event|8|||
48757142|NCT04256785|156958191|FG001|Overall Study|Adverse Event|6|||
48757143|NCT04256785|156958190|FG000|Overall Study|Lack of Efficacy|3|||
48757144|NCT04256785|156958191|FG001|Overall Study|Lack of Efficacy|4|||
48757145|NCT04256785|156958190|FG000|Overall Study|Lost to Follow-up|7|||
48757146|NCT04256785|156958191|FG001|Overall Study|Lost to Follow-up|7|||
48757147|NCT04256785|156958190|FG000|Overall Study|Protocol Violation|1|||
48757148|NCT04256785|156958191|FG001|Overall Study|Protocol Violation|0|||
48757149|NCT04256785|156958190|FG000|Overall Study|Withdrawal by Subject|4|||
48757150|NCT04256785|156958191|FG001|Overall Study|Withdrawal by Subject|1|||
48757151|NCT04256785|156958190|FG000|Overall Study|Surgery or quarantined due to Covid-19|5|||
48757152|NCT04256785|156958191|FG001|Overall Study|Surgery or quarantined due to Covid-19|7|||
48757153|NCT03721276|156958192|FG000|Overall Study|Lost to Follow-up|5|||
48966387|NCT00673894|157703818|FG000|First Intervention 4 Weeks|Adverse Event|1|||
48757154|NCT03721276|156958193|FG001|Overall Study|Lost to Follow-up|3|||
48757155|NCT03721276|156958192|FG000|Overall Study|Adverse Event|0|||
48757156|NCT03721276|156958193|FG001|Overall Study|Adverse Event|1|||
48757157|NCT03358290|156958194|FG000|Overall Study|Study discontinued by Sponsor|0|||
48757158|NCT03358290|156958195|FG001|Overall Study|Study discontinued by Sponsor|1|||
48757159|NCT03358290|156958196|FG002|Overall Study|Study discontinued by Sponsor|1|||
48757160|NCT03358290|156958197|FG003|Overall Study|Study discontinued by Sponsor|0|||
48757161|NCT03358290|156958198|FG004|Overall Study|Study discontinued by Sponsor|0|||
48757162|NCT03358290|156958194|FG000|Overall Study|Adverse Event|0|||
48757163|NCT03358290|156958195|FG001|Overall Study|Adverse Event|0|||
48966388|NCT00673894|157703819|FG001|First Intervention 4 Weeks|Adverse Event|0|||
48966389|NCT01054976|157703820|FG000|Overall Study|Adverse Event|16|||
48966390|NCT01054976|157703820|FG000|Overall Study|Uncooperative participations to study|7|||
48966391|NCT01054976|157703820|FG000|Overall Study|Withdrawal by Subject|4|||
48966392|NCT01054976|157703820|FG000|Overall Study|Other|8|||
48966393|NCT00213980|157703821|FG000|Overall Study|Withdrawal by Subject|3|||
48966394|NCT00213980|157703822|FG001|Overall Study|Withdrawal by Subject|1|||
48966395|NCT00213980|157703821|FG000|Overall Study|Adverse Event|1|||
48966396|NCT00213980|157703822|FG001|Overall Study|Adverse Event|1|||
48966397|NCT00213980|157703821|FG000|Overall Study|Disease progression|0|||
48966398|NCT00213980|157703822|FG001|Overall Study|Disease progression|2|||
48966399|NCT00213980|157703821|FG000|Overall Study|Developed ovarian cancer|1|||
48966400|NCT00213980|157703822|FG001|Overall Study|Developed ovarian cancer|0|||
48966401|NCT00213980|157703821|FG000|Overall Study|Failed to obtain all 3 DXAs|1|||
48966402|NCT00213980|157703822|FG001|Overall Study|Failed to obtain all 3 DXAs|3|||
48966403|NCT00493974|157703824|FG000|Overall Study|Death|1|||
48966404|NCT00493974|157703825|FG001|Overall Study|Death|2|||
48966405|NCT00493974|157703824|FG000|Overall Study|Withdrawal by Subject|8|||
48867498|NCT02162771|157350852|FG001|Maintenance Study Period (Part 2)|Death|1|||
48867499|NCT02162771|157350851|FG000|Maintenance Study Period (Part 2)|Withdrawal by Subject|0|||
48867500|NCT02162771|157350852|FG001|Maintenance Study Period (Part 2)|Withdrawal by Subject|3|||
48867501|NCT02162771|157350851|FG000|Maintenance Study Period (Part 2)|Protocol Violation|0|||
48867502|NCT02162771|157350852|FG001|Maintenance Study Period (Part 2)|Protocol Violation|1|||
48867503|NCT02162771|157350851|FG000|Maintenance Study Period (Part 2)|Stable Disease|0|||
48867504|NCT02162771|157350852|FG001|Maintenance Study Period (Part 2)|Stable Disease|1|||
48867505|NCT02391545|157350864|FG000|Overall Study|Death|0|||
48867506|NCT02391545|157350865|FG001|Overall Study|Death|2|||
48867507|NCT02391545|157350864|FG000|Overall Study|Lost to Follow-up|0|||
48867508|NCT02391545|157350865|FG001|Overall Study|Lost to Follow-up|1|||
48867509|NCT02391545|157350864|FG000|Overall Study|Termination of study by sponsor|20|||
48867510|NCT02391545|157350865|FG001|Overall Study|Termination of study by sponsor|20|||
48867511|NCT02391545|157350864|FG000|Overall Study|Withdrawal by Subject|0|||
48867512|NCT02391545|157350865|FG001|Overall Study|Withdrawal by Subject|1|||
48867513|NCT02391545|157350864|FG000|Overall Study|Other Reasons|6|||
48867514|NCT02391545|157350865|FG001|Overall Study|Other Reasons|4|||
48867515|NCT03213691|157350870|FG000|Overall Study|Adverse Event|2|||
48867516|NCT03213691|157350870|FG000|Overall Study|Death|3|||
48867517|NCT03213691|157350870|FG000|Overall Study|Physician Decision|1|||
48867518|NCT03213691|157350870|FG000|Overall Study|Progressive Disease|14|||
48867519|NCT03213691|157350870|FG000|Overall Study|Ineligible|1|||
48867520|NCT03816332|157350871|FG000|Nivolumab, Tacrolimus, and Prednisone|Did not receive Nivolumab|2|||
48867521|NCT03816332|157350871|FG000|Nivolumab, Tacrolimus, and Prednisone|Death|2|||
48867522|NCT00853021|157350875|FG000|Overall Study|Adverse Event|2|||
48867523|NCT00853021|157350875|FG000|Overall Study|Withdrawal by Subject|2|||
48867524|NCT00853021|157350875|FG000|Overall Study|Death|1|||
48867525|NCT04088500|157350879|FG000|Overall Study|Reason unknown|1|||
48867526|NCT04088500|157350879|FG000|Overall Study|Participant withdrew consent|1|||
48867527|NCT04088500|157350879|FG000|Overall Study|Disease progression|3|||
48867528|NCT00981578|157350880|FG000|Overall Study|Death|1|||
48867529|NCT00981578|157350880|FG000|Overall Study|Withdrawal by Subject|2|||
48867530|NCT01502371|157350885|FG000|Overall Study|Withdrawal by Subject|1|||
48867531|NCT01502371|157350886|FG001|Overall Study|Withdrawal by Subject|2|||
48867532|NCT01502371|157350887|FG002|Overall Study|Withdrawal by Subject|1|||
48867533|NCT01502371|157350888|FG003|Overall Study|Withdrawal by Subject|1|||
48867534|NCT01502371|157350889|FG004|Overall Study|Withdrawal by Subject|1|||
48867535|NCT01502371|157350885|FG000|Overall Study|Adverse Event|2|||
48867536|NCT01502371|157350886|FG001|Overall Study|Adverse Event|1|||
48867537|NCT01502371|157350887|FG002|Overall Study|Adverse Event|0|||
48867538|NCT01502371|157350888|FG003|Overall Study|Adverse Event|4|||
48867539|NCT01502371|157350889|FG004|Overall Study|Adverse Event|3|||
48867540|NCT01502371|157350885|FG000|Overall Study|Treatment Failure|22|||
48867541|NCT01502371|157350886|FG001|Overall Study|Treatment Failure|20|||
48867542|NCT01502371|157350887|FG002|Overall Study|Treatment Failure|12|||
48867543|NCT01502371|157350888|FG003|Overall Study|Treatment Failure|19|||
48867544|NCT01502371|157350889|FG004|Overall Study|Treatment Failure|30|||
48867545|NCT01502371|157350885|FG000|Overall Study|Lack of Efficacy|3|||
48867546|NCT01502371|157350886|FG001|Overall Study|Lack of Efficacy|3|||
48867547|NCT01502371|157350887|FG002|Overall Study|Lack of Efficacy|2|||
48867548|NCT01502371|157350888|FG003|Overall Study|Lack of Efficacy|2|||
48867549|NCT01502371|157350889|FG004|Overall Study|Lack of Efficacy|4|||
48867550|NCT01502371|157350885|FG000|Overall Study|Physician Decision|3|||
48867551|NCT01502371|157350886|FG001|Overall Study|Physician Decision|0|||
48867552|NCT01502371|157350887|FG002|Overall Study|Physician Decision|0|||
48867553|NCT01502371|157350888|FG003|Overall Study|Physician Decision|0|||
48867554|NCT01502371|157350889|FG004|Overall Study|Physician Decision|1|||
48867555|NCT01502371|157350885|FG000|Overall Study|Noncompliance with Study Drug|0|||
48867556|NCT01502371|157350886|FG001|Overall Study|Noncompliance with Study Drug|0|||
48966406|NCT00493974|157703825|FG001|Overall Study|Withdrawal by Subject|6|||
48664451|NCT01962987|156625108|FG002|Overall Study|Serious Adverse Event|0|||
48664452|NCT01962987|156625106|FG000|Overall Study|Withdrawal by Subject|11|||
48664453|NCT01962987|156625107|FG001|Overall Study|Withdrawal by Subject|10|||
48664454|NCT01962987|156625108|FG002|Overall Study|Withdrawal by Subject|6|||
48664455|NCT01962987|156625106|FG000|Overall Study|Randomized in Error|4|||
48757164|NCT03358290|156958196|FG002|Overall Study|Adverse Event|1|||
48757165|NCT03358290|156958197|FG003|Overall Study|Adverse Event|2|||
48757166|NCT03358290|156958198|FG004|Overall Study|Adverse Event|0|||
48757167|NCT03358290|156958194|FG000|Overall Study|Withdrawal by Subject|0|||
48757168|NCT03358290|156958195|FG001|Overall Study|Withdrawal by Subject|0|||
48757169|NCT03358290|156958196|FG002|Overall Study|Withdrawal by Subject|0|||
48757170|NCT03358290|156958197|FG003|Overall Study|Withdrawal by Subject|0|||
48757171|NCT03358290|156958198|FG004|Overall Study|Withdrawal by Subject|1|||
48757172|NCT00416078|156958199|FG000|Overall Study|Death|3|||
48757173|NCT00416078|156958200|FG001|Overall Study|Death|4|||
48757174|NCT00416078|156958199|FG000|Overall Study|Withdrawal by Subject|3|||
48757175|NCT00416078|156958200|FG001|Overall Study|Withdrawal by Subject|2|||
48757176|NCT00416078|156958199|FG000|Overall Study|Physician Decision|1|||
48757177|NCT00416078|156958200|FG001|Overall Study|Physician Decision|0|||
48757178|NCT00416078|156958199|FG000|Overall Study|Lost to Follow-up|4|||
48757179|NCT00416078|156958200|FG001|Overall Study|Lost to Follow-up|2|||
48757180|NCT01829230|156958201|FG000|Overall Study|Protocol Violation|0|||
48757181|NCT01829230|156958202|FG001|Overall Study|Protocol Violation|2|||
48757182|NCT01829230|156958201|FG000|Overall Study|Withdrawal by Subject|0|||
48757183|NCT01829230|156958202|FG001|Overall Study|Withdrawal by Subject|1|||
48757184|NCT01829230|156958201|FG000|Overall Study|Lost to Follow-up|1|||
48664456|NCT01962987|156625107|FG001|Overall Study|Randomized in Error|2|||
48757185|NCT01829230|156958202|FG001|Overall Study|Lost to Follow-up|1|||
48966407|NCT00493974|157703824|FG000|Overall Study|Lost to Follow-up|4|||
48664457|NCT01962987|156625108|FG002|Overall Study|Randomized in Error|2|||
48664458|NCT03361189|156625117|FG000|Overall Study|Received heart transplant|1|||
48664459|NCT03361189|156625118|FG001|Overall Study|Received heart transplant|0|||
48664460|NCT03361189|156625117|FG000|Overall Study|Pacemake replacement|0|||
48664461|NCT03361189|156625118|FG001|Overall Study|Pacemake replacement|1|||
48664462|NCT01338610|156625132|FG000|Overall Study|Patient Decision Unrelated to Advs Event|1|||
48664463|NCT01338610|156625133|FG001|Overall Study|Patient Decision Unrelated to Advs Event|1|||
48664464|NCT01338610|156625134|FG002|Overall Study|Patient Decision Unrelated to Advs Event|0|||
48664465|NCT01338610|156625132|FG000|Overall Study|Protocol Violation|1|||
48664466|NCT01338610|156625133|FG001|Overall Study|Protocol Violation|0|||
48664467|NCT01338610|156625134|FG002|Overall Study|Protocol Violation|1|||
48664468|NCT01338610|156625132|FG000|Overall Study|Adverse Event|3|||
48664469|NCT01338610|156625133|FG001|Overall Study|Adverse Event|0|||
48664470|NCT01338610|156625134|FG002|Overall Study|Adverse Event|0|||
48664471|NCT00171925|156625135|FG000|Overall Study|Adverse Event|10|||
48664472|NCT00171925|156625136|FG001|Overall Study|Adverse Event|6|||
48664473|NCT00171925|156625135|FG000|Overall Study|Protocol Violation|1|||
48664474|NCT00171925|156625136|FG001|Overall Study|Protocol Violation|1|||
48664475|NCT00171925|156625135|FG000|Overall Study|Withdrawal by Subject|6|||
48664476|NCT00171925|156625136|FG001|Overall Study|Withdrawal by Subject|9|||
48664477|NCT00171925|156625135|FG000|Overall Study|Lost to Follow-up|2|||
48664478|NCT00171925|156625136|FG001|Overall Study|Lost to Follow-up|2|||
48664479|NCT00171925|156625135|FG000|Overall Study|Administrative problems|10|||
48664480|NCT00171925|156625136|FG001|Overall Study|Administrative problems|11|||
48664481|NCT00171925|156625135|FG000|Overall Study|Death|1|||
48664482|NCT00171925|156625136|FG001|Overall Study|Death|2|||
48664483|NCT02590562|156625143|FG000|Overall Study|Did Not Meet the Inclusion Criteria|6|||
48664484|NCT00977938|156625146|FG000|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132|||
48664485|NCT00977938|156625147|FG001|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116|||
48664486|NCT00977938|156625148|FG002|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13|||
48664487|NCT00977938|156625149|FG003|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20|||
48664488|NCT00977938|156625146|FG000|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88|||
48664489|NCT00977938|156625147|FG001|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91|||
48757186|NCT00969150|156958203|FG000|Overall Study|Adverse Event|4|||
48757187|NCT00969150|156958204|FG001|Overall Study|Adverse Event|14|||
48757188|NCT00969150|156958203|FG000|Overall Study|Lack of Efficacy|1|||
48757189|NCT00969150|156958204|FG001|Overall Study|Lack of Efficacy|1|||
48966408|NCT00493974|157703825|FG001|Overall Study|Lost to Follow-up|6|||
48664490|NCT00977938|156625148|FG002|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30|||
48664491|NCT00977938|156625149|FG003|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37|||
48664492|NCT00977938|156625146|FG000|Treatment (12-30 mo. Post Procedure)|Other|17|||
48664493|NCT00977938|156625147|FG001|Treatment (12-30 mo. Post Procedure)|Other|18|||
48664494|NCT00977938|156625148|FG002|Treatment (12-30 mo. Post Procedure)|Other|3|||
48664495|NCT00977938|156625149|FG003|Treatment (12-30 mo. Post Procedure)|Other|4|||
48664496|NCT00977938|156625146|FG000|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9|||
48757190|NCT00969150|156958203|FG000|Overall Study|Protocol Violation|9|||
48757191|NCT00969150|156958204|FG001|Overall Study|Protocol Violation|12|||
48966409|NCT00892957|157703826|FG000|Between Postoperative Day 1 and Day 14|Death|0|||
48966410|NCT00892957|157703827|FG001|Between Postoperative Day 1 and Day 14|Death|2|||
48966411|NCT00892957|157703826|FG000|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0|||
48966412|NCT00892957|157703827|FG001|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2|||
48966413|NCT00326417|157703829|FG000|Overall Study|Withdrawal by Subject|0|||
48664497|NCT00977938|156625147|FG001|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12|||
48664498|NCT00977938|156625148|FG002|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2|||
48664499|NCT00977938|156625149|FG003|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0|||
48664500|NCT00977938|156625146|FG000|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34|||
48664501|NCT00977938|156625147|FG001|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42|||
48664502|NCT00977938|156625148|FG002|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10|||
48664503|NCT00977938|156625149|FG003|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3|||
48664504|NCT00977938|156625146|FG000|Observation (30-33 mo. Post Procedure)|Other|8|||
48664505|NCT00977938|156625147|FG001|Observation (30-33 mo. Post Procedure)|Other|4|||
48664506|NCT00977938|156625148|FG002|Observation (30-33 mo. Post Procedure)|Other|0|||
48664507|NCT00977938|156625149|FG003|Observation (30-33 mo. Post Procedure)|Other|0|||
48664508|NCT02498067|156625150|FG000|Overall Study|Lost to Follow-up|22|||
48664509|NCT02498067|156625150|FG000|Overall Study|Did not meet inclusion criteria|11|||
48664510|NCT01697462|156625151|FG000|Overall Study|Disease Progression|1|||
48664511|NCT01697462|156625151|FG000|Overall Study|Adverse Event|6|||
48664512|NCT01697462|156625151|FG000|Overall Study|Lost to Follow-up|21|||
48664513|NCT01697462|156625151|FG000|Overall Study|Withdrawal by Subject|12|||
48664514|NCT01697462|156625151|FG000|Overall Study|Investigator Decision|21|||
48664515|NCT01697462|156625151|FG000|Overall Study|Death|1|||
48664516|NCT01697462|156625151|FG000|Overall Study|Other|10|||
48664517|NCT01697462|156625151|FG000|Overall Study|Missing|5|||
48664518|NCT00598078|156625152|FG000|Period 2 (Day 2)|Adverse Event|1|||
48664519|NCT00598078|156625153|FG001|Period 2 (Day 2)|Adverse Event|0|||
48664520|NCT02387164|156625154|FG000|Overall Study|Lost to Follow-up|2|||
48664521|NCT02387164|156625155|FG001|Overall Study|Lost to Follow-up|0|||
48664522|NCT02387164|156625154|FG000|Overall Study|Diagnosed|1|||
48664523|NCT02387164|156625155|FG001|Overall Study|Diagnosed|2|||
48664524|NCT02370641|156625158|FG000|Overall Study|dropped study|4|||
48664525|NCT02370641|156625159|FG001|Overall Study|dropped study|2|||
48664526|NCT02133664|156625161|FG000|Overall Study|Lost to Follow-up|2|||
48664527|NCT02133664|156625162|FG001|Overall Study|Lost to Follow-up|1|||
48664528|NCT02133664|156625161|FG000|Overall Study|Adverse Event|3|||
48664529|NCT02133664|156625162|FG001|Overall Study|Adverse Event|6|||
48664530|NCT01253265|156625163|FG000|Overall Study|Met Predefined Discontinuation Criteria|1|||
48664531|NCT01253265|156625164|FG001|Overall Study|Met Predefined Discontinuation Criteria|0|||
48664532|NCT01253265|156625165|FG002|Overall Study|Met Predefined Discontinuation Criteria|0|||
48664533|NCT01253265|156625166|FG003|Overall Study|Met Predefined Discontinuation Criteria|0|||
48664534|NCT01253265|156625167|FG004|Overall Study|Met Predefined Discontinuation Criteria|0|||
48664535|NCT01253265|156625163|FG000|Overall Study|Withdrawal by Subject|0|||
48664536|NCT01253265|156625164|FG001|Overall Study|Withdrawal by Subject|0|||
48664537|NCT01253265|156625165|FG002|Overall Study|Withdrawal by Subject|0|||
48664538|NCT01253265|156625166|FG003|Overall Study|Withdrawal by Subject|0|||
48664539|NCT01253265|156625167|FG004|Overall Study|Withdrawal by Subject|1|||
48664540|NCT00541099|156625168|FG000|Overall Study|Ineligible|3|||
48664541|NCT02956850|156625169|FG000|Overall Study|Withdrawal by Subject|0|||
48664542|NCT02956850|156625170|FG001|Overall Study|Withdrawal by Subject|0|||
48664543|NCT02956850|156625171|FG002|Overall Study|Withdrawal by Subject|0|||
48664544|NCT02956850|156625172|FG003|Overall Study|Withdrawal by Subject|0|||
48664545|NCT02956850|156625173|FG004|Overall Study|Withdrawal by Subject|0|||
48664546|NCT02956850|156625174|FG005|Overall Study|Withdrawal by Subject|0|||
48664547|NCT02956850|156625175|FG006|Overall Study|Withdrawal by Subject|0|||
48664548|NCT02956850|156625176|FG007|Overall Study|Withdrawal by Subject|0|||
48664549|NCT02956850|156625177|FG008|Overall Study|Withdrawal by Subject|0|||
48664550|NCT02956850|156625178|FG009|Overall Study|Withdrawal by Subject|0|||
48664551|NCT02956850|156625179|FG010|Overall Study|Withdrawal by Subject|0|||
48664552|NCT02956850|156625180|FG011|Overall Study|Withdrawal by Subject|0|||
48664553|NCT02956850|156625181|FG012|Overall Study|Withdrawal by Subject|0|||
48664554|NCT02956850|156625182|FG013|Overall Study|Withdrawal by Subject|0|||
48664555|NCT02956850|156625183|FG014|Overall Study|Withdrawal by Subject|0|||
48664556|NCT02956850|156625184|FG015|Overall Study|Withdrawal by Subject|0|||
48664557|NCT02956850|156625185|FG016|Overall Study|Withdrawal by Subject|0|||
48664558|NCT02956850|156625186|FG017|Overall Study|Withdrawal by Subject|1|||
48664559|NCT00392808|156625187|FG000|Overall Study|Lost to Follow-up|3|||
48966414|NCT00326417|157703830|FG001|Overall Study|Withdrawal by Subject|0|||
48664560|NCT00392808|156625188|FG001|Overall Study|Lost to Follow-up|2|||
48664561|NCT00392808|156625189|FG002|Overall Study|Lost to Follow-up|1|||
48664562|NCT00392808|156625190|FG003|Overall Study|Lost to Follow-up|2|||
48664563|NCT00392808|156625187|FG000|Overall Study|Unable to withdraw blood|3|||
48664564|NCT00392808|156625188|FG001|Overall Study|Unable to withdraw blood|1|||
48664565|NCT00392808|156625189|FG002|Overall Study|Unable to withdraw blood|1|||
48757192|NCT00969150|156958203|FG000|Overall Study|Withdrawal by Subject|13|||
48757193|NCT00969150|156958204|FG001|Overall Study|Withdrawal by Subject|9|||
48757194|NCT00969150|156958203|FG000|Overall Study|Lost to Follow-up|5|||
48757195|NCT00969150|156958204|FG001|Overall Study|Lost to Follow-up|4|||
48757196|NCT00969150|156958203|FG000|Overall Study|Other reasons|1|||
48757197|NCT00969150|156958204|FG001|Overall Study|Other reasons|0|||
48757198|NCT00391274|156958205|FG000|Overall Study|Death Due to Study Disease|55|||
48757199|NCT00391274|156958206|FG001|Overall Study|Death Due to Study Disease|45|||
48757200|NCT00391274|156958205|FG000|Overall Study|Lost to Follow-up|0|||
48757201|NCT00391274|156958206|FG001|Overall Study|Lost to Follow-up|3|||
48757202|NCT00391274|156958205|FG000|Overall Study|Physician Decision|4|||
48757203|NCT00391274|156958206|FG001|Overall Study|Physician Decision|2|||
48757204|NCT00391274|156958205|FG000|Overall Study|Withdrawal by Subject|0|||
48757205|NCT00391274|156958206|FG001|Overall Study|Withdrawal by Subject|3|||
48757206|NCT00391274|156958205|FG000|Overall Study|Death Due to Adverse Event|1|||
48757207|NCT00391274|156958206|FG001|Overall Study|Death Due to Adverse Event|3|||
48757208|NCT00391274|156958205|FG000|Overall Study|Death Due to Indeterminate Cause|1|||
48757209|NCT00391274|156958206|FG001|Overall Study|Death Due to Indeterminate Cause|0|||
48757210|NCT00391274|156958205|FG000|Overall Study|Death Not Study Related|0|||
48757211|NCT00391274|156958206|FG001|Overall Study|Death Not Study Related|1|||
48757212|NCT01106898|156958209|FG000|Overall Study|Adverse Event|6|||
48757213|NCT01338493|156958210|FG000|Enrolled|Withdrawal by Subject|1|||
48757214|NCT01338493|156958210|FG000|Enrolled|Patient not implanted|4|||
48757215|NCT01338493|156958210|FG000|Discharge|Death|1|||
48757216|NCT01338493|156958210|FG000|Discharge|Missed visit|1|||
48757217|NCT01338493|156958210|FG000|6 Months Follow up|Lost to Follow-up|11|||
48757218|NCT01338493|156958210|FG000|6 Months Follow up|Missed visit|8|||
48757219|NCT01338493|156958210|FG000|12 Months Follow up|Lost to Follow-up|9|||
48757220|NCT01472081|156958211|FG000|Overall Study|Continuing treatment at time of analysis|1|||
48757221|NCT01472081|156958212|FG001|Overall Study|Continuing treatment at time of analysis|4|||
48757222|NCT01472081|156958213|FG002|Overall Study|Continuing treatment at time of analysis|1|||
48757223|NCT01472081|156958214|FG003|Overall Study|Continuing treatment at time of analysis|8|||
48757224|NCT01472081|156958215|FG004|Overall Study|Continuing treatment at time of analysis|9|||
48757225|NCT01472081|156958216|FG005|Overall Study|Continuing treatment at time of analysis|0|||
48757226|NCT01472081|156958211|FG000|Overall Study|Disease Progression|4|||
48757227|NCT01472081|156958212|FG001|Overall Study|Disease Progression|10|||
48757228|NCT01472081|156958213|FG002|Overall Study|Disease Progression|12|||
48757229|NCT01472081|156958214|FG003|Overall Study|Disease Progression|31|||
48757230|NCT01472081|156958215|FG004|Overall Study|Disease Progression|22|||
48664566|NCT00392808|156625190|FG003|Overall Study|Unable to withdraw blood|2|||
48664567|NCT01416441|156625193|FG000|Overall Study|Lost to Follow-up|5|||
48664568|NCT01416441|156625193|FG000|Overall Study|Adverse Event|6|||
48664569|NCT01416441|156625193|FG000|Overall Study|Sponsor Discontinued Trial Site|43|||
48664570|NCT01416441|156625193|FG000|Overall Study|Subject Met Withdrawal Criteria|10|||
48664571|NCT01416441|156625193|FG000|Overall Study|Investigator Withdrew Subject|2|||
48664572|NCT01416441|156625193|FG000|Overall Study|Subject Withdrew Consent|12|||
48664573|NCT01416441|156625193|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|3|||
48664574|NCT01945775|156625194|FG000|Overall Study|Death|214|||
48757231|NCT01472081|156958216|FG005|Overall Study|Disease Progression|3|||
48757232|NCT01472081|156958211|FG000|Overall Study|Study drug toxicity|2|||
48757233|NCT01472081|156958212|FG001|Overall Study|Study drug toxicity|9|||
48757234|NCT01472081|156958213|FG002|Overall Study|Study drug toxicity|4|||
48757235|NCT01472081|156958214|FG003|Overall Study|Study drug toxicity|6|||
48757236|NCT01472081|156958215|FG004|Overall Study|Study drug toxicity|13|||
48757237|NCT01472081|156958216|FG005|Overall Study|Study drug toxicity|2|||
48757238|NCT01472081|156958211|FG000|Overall Study|Death|0|||
48757239|NCT01472081|156958212|FG001|Overall Study|Death|0|||
48757240|NCT01472081|156958213|FG002|Overall Study|Death|0|||
48867557|NCT01502371|157350887|FG002|Overall Study|Noncompliance with Study Drug|1|||
48867558|NCT01502371|157350888|FG003|Overall Study|Noncompliance with Study Drug|2|||
48867559|NCT01502371|157350889|FG004|Overall Study|Noncompliance with Study Drug|1|||
48867560|NCT01502371|157350885|FG000|Overall Study|Technical Problems|1|||
48867561|NCT01502371|157350886|FG001|Overall Study|Technical Problems|0|||
48867562|NCT01502371|157350887|FG002|Overall Study|Technical Problems|2|||
48867563|NCT01502371|157350888|FG003|Overall Study|Technical Problems|4|||
48867564|NCT01502371|157350889|FG004|Overall Study|Technical Problems|1|||
48867565|NCT01502371|157350885|FG000|Overall Study|Protocol Violation|9|||
48867566|NCT01502371|157350886|FG001|Overall Study|Protocol Violation|5|||
48867567|NCT01502371|157350887|FG002|Overall Study|Protocol Violation|6|||
48867568|NCT01502371|157350888|FG003|Overall Study|Protocol Violation|5|||
48757241|NCT01472081|156958214|FG003|Overall Study|Death|0|||
48757242|NCT01472081|156958215|FG004|Overall Study|Death|1|||
48757243|NCT01472081|156958216|FG005|Overall Study|Death|0|||
48757244|NCT01472081|156958211|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
48757245|NCT01472081|156958212|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
48867569|NCT01502371|157350889|FG004|Overall Study|Protocol Violation|10|||
48867570|NCT01502371|157350885|FG000|Overall Study|Excluded Medication|0|||
48966415|NCT00326417|157703831|FG002|Overall Study|Withdrawal by Subject|1|||
48966416|NCT00326417|157703832|FG003|Overall Study|Withdrawal by Subject|0|||
48966417|NCT00326417|157703829|FG000|Overall Study|Arm Closed|7|||
48966418|NCT00326417|157703830|FG001|Overall Study|Arm Closed|0|||
48966419|NCT00326417|157703831|FG002|Overall Study|Arm Closed|0|||
48966420|NCT00326417|157703832|FG003|Overall Study|Arm Closed|3|||
48966421|NCT00326417|157703829|FG000|Overall Study|Death|7|||
48966422|NCT00326417|157703830|FG001|Overall Study|Death|0|||
48966423|NCT00326417|157703831|FG002|Overall Study|Death|0|||
48966424|NCT00326417|157703832|FG003|Overall Study|Death|0|||
48966425|NCT02807363|157703833|FG000|Dosing Period|Adverse Event|0|||
48966426|NCT02807363|157703834|FG001|Dosing Period|Adverse Event|1|||
48966427|NCT02807363|157703835|FG002|Dosing Period|Adverse Event|0|||
48966428|NCT02807363|157703836|FG003|Dosing Period|Adverse Event|0|||
48966429|NCT01195363|157703837|FG000|Overall Study|Lost to Follow-up|7|||
48966430|NCT01195363|157703838|FG001|Overall Study|Lost to Follow-up|4|||
48757246|NCT01472081|156958213|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
48664575|NCT01945775|156625195|FG001|Overall Study|Death|98|||
48664576|NCT01945775|156625194|FG000|Overall Study|Lost to Follow-up|12|||
48664577|NCT01945775|156625195|FG001|Overall Study|Lost to Follow-up|7|||
48664578|NCT01945775|156625194|FG000|Overall Study|Withdrawal by Subject|11|||
48664579|NCT01945775|156625195|FG001|Overall Study|Withdrawal by Subject|21|||
48664580|NCT01945775|156625194|FG000|Overall Study|Other|50|||
48664581|NCT01945775|156625195|FG001|Overall Study|Other|18|||
48664582|NCT01420627|156625196|FG000|EZN-2279 Treatment Period|Adverse Event|1|||
48664583|NCT00787137|156625198|FG000|Overall Study|Study Termination|0|||
48664584|NCT00787137|156625199|FG001|Overall Study|Study Termination|0|||
48664585|NCT00787137|156625200|FG002|Overall Study|Study Termination|1|||
48664586|NCT03464422|156625201|FG000|Overall Study|Lost to Follow-up|2|||
48757247|NCT01472081|156958214|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
48757248|NCT01472081|156958215|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
48966431|NCT01195363|157703837|FG000|Overall Study|Adverse Event|3|||
48966432|NCT01195363|157703838|FG001|Overall Study|Adverse Event|1|||
48966433|NCT01195363|157703837|FG000|Overall Study|Lack of Efficacy|0|||
48966434|NCT01195363|157703838|FG001|Overall Study|Lack of Efficacy|4|||
48966435|NCT01195363|157703837|FG000|Overall Study|incarceration|1|||
48966436|NCT01195363|157703838|FG001|Overall Study|incarceration|0|||
48966437|NCT02188719|157703840|FG000|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
48966438|NCT02188719|157703841|FG001|Overall Study|Screen B Ineligible (Page 55, Protocol)|1|||
48966439|NCT02188719|157703842|FG002|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
48966440|NCT02188719|157703843|FG003|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
48966441|NCT02614287|157705198|FG000|Open Label (OL) Treatment Phase|Adverse Event|7|||
48966442|NCT02614287|157705199|FG001|Open Label (OL) Treatment Phase|Adverse Event|6|||
48966443|NCT02614287|157705198|FG000|Open Label (OL) Treatment Phase|Lack of Efficacy|13|||
48664587|NCT03464422|156625201|FG000|Overall Study|Withdrawal by Subject|2|||
48757249|NCT01472081|156958216|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
48757250|NCT01472081|156958211|FG000|Overall Study|Withdrawal by Subject|0|||
48757251|NCT01472081|156958212|FG001|Overall Study|Withdrawal by Subject|0|||
48757252|NCT01472081|156958213|FG002|Overall Study|Withdrawal by Subject|0|||
48757253|NCT01472081|156958214|FG003|Overall Study|Withdrawal by Subject|0|||
48966444|NCT02614287|157705199|FG001|Open Label (OL) Treatment Phase|Lack of Efficacy|5|||
48664588|NCT03353922|156625203|FG000|Overall Study|Withdrawal by Subject|1|||
48664589|NCT03353922|156625204|FG001|Overall Study|Withdrawal by Subject|0|||
48664590|NCT03353922|156625205|FG002|Overall Study|Withdrawal by Subject|1|||
48664591|NCT03353922|156625206|FG003|Overall Study|Withdrawal by Subject|1|||
48664592|NCT03353922|156625207|FG004|Overall Study|Withdrawal by Subject|0|||
48664593|NCT03353922|156625208|FG005|Overall Study|Withdrawal by Subject|0|||
48664594|NCT03353922|156625203|FG000|Overall Study|Adverse Event|0|||
48664595|NCT03353922|156625204|FG001|Overall Study|Adverse Event|1|||
48664596|NCT03353922|156625205|FG002|Overall Study|Adverse Event|0|||
48664597|NCT03353922|156625206|FG003|Overall Study|Adverse Event|0|||
48664598|NCT03353922|156625207|FG004|Overall Study|Adverse Event|0|||
48664599|NCT03353922|156625208|FG005|Overall Study|Adverse Event|0|||
48664600|NCT00868530|156625209|FG000|Overall Study|Adverse Event|3|||
48966445|NCT02614287|157705198|FG000|Open Label (OL) Treatment Phase|Lost to Follow-up|7|||
48966446|NCT02614287|157705199|FG001|Open Label (OL) Treatment Phase|Lost to Follow-up|4|||
48966447|NCT02614287|157705198|FG000|Open Label (OL) Treatment Phase|Physician Decision|1|||
48966448|NCT02614287|157705199|FG001|Open Label (OL) Treatment Phase|Physician Decision|0|||
48664601|NCT00868530|156625209|FG000|Overall Study|Lost to Follow-up|1|||
48664602|NCT00886119|156625210|FG000|Period 1|Did not meet inclusion criteria|1|||
48757254|NCT01472081|156958215|FG004|Overall Study|Withdrawal by Subject|0|||
48757255|NCT01472081|156958216|FG005|Overall Study|Withdrawal by Subject|1|||
48966449|NCT02614287|157705198|FG000|Open Label (OL) Treatment Phase|Withdrawal by Subject|10|||
48966450|NCT02614287|157705199|FG001|Open Label (OL) Treatment Phase|Withdrawal by Subject|7|||
48664603|NCT00886119|156625211|FG001|Period 1|Did not meet inclusion criteria|0|||
48664604|NCT01902888|156625212|FG000|Overall Study|Study Terminated|3|||
48664605|NCT02616393|156625216|FG000|Overall Study|Death|5|||
48966451|NCT02614287|157705198|FG000|Post Treatment Follow-up Phase|Adverse Event|1|||
48966452|NCT02614287|157705199|FG001|Post Treatment Follow-up Phase|Adverse Event|0|||
48966453|NCT02614287|157705198|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
48966454|NCT02614287|157705199|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
48966455|NCT02614287|157705198|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|6|||
48966456|NCT02614287|157705199|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|3|||
48966457|NCT02395653|157705200|FG000|Overall Study|Exclusion Criteria Met at Screening|4|||
48966458|NCT02395653|157705200|FG000|Overall Study|Consent Withdrawn at Screening|1|||
48966459|NCT02395653|157705200|FG000|Overall Study|SSEC Application But With 0 Dose|1|||
48966460|NCT02395653|157705200|FG000|Overall Study|Investigator Decision at Screening|1|||
48966461|NCT02395653|157705200|FG000|Overall Study|Inclusion Criteria Not Met at Screening|3|||
48966462|NCT02395653|157705200|FG000|Overall Study|Withdrawal by Subject|1|||
48966463|NCT02395653|157705200|FG000|Overall Study|Lost to Follow-up|1|||
48966464|NCT02871401|157705216|FG000|Overall Study|Adverse Event|1|||
48966465|NCT02871401|157705217|FG001|Overall Study|Adverse Event|0|||
48966466|NCT01120379|157705220|FG000|One Year Timepoint|Withdrawal by Subject|41|||
48966467|NCT01120379|157705220|FG000|One Year Timepoint|Lost to Follow-up|115|||
48966468|NCT01120379|157705220|FG000|One Year Timepoint|Death|108|||
48966469|NCT01120379|157705220|FG000|One Year Timepoint|Physician Decision|9|||
48966470|NCT01120379|157705220|FG000|One Year Timepoint|Any other reason for early termination|5|||
48966471|NCT01120379|157705220|FG000|Two Year Timepoint|Withdrawal by Subject|11|||
48966472|NCT01120379|157705220|FG000|Two Year Timepoint|Lost to Follow-up|87|||
48966473|NCT01120379|157705220|FG000|Two Year Timepoint|Death|123|||
48966474|NCT01120379|157705220|FG000|Two Year Timepoint|Physician Decision|12|||
48966475|NCT01120379|157705220|FG000|Two Year Timepoint|Any other reason for early termination|4|||
48966476|NCT01120379|157705220|FG000|Three Year Timepoint|Withdrawal by Subject|25|||
48966477|NCT01120379|157705220|FG000|Three Year Timepoint|Lost to Follow-up|43|||
48966478|NCT01120379|157705220|FG000|Three Year Timepoint|Death|120|||
48966479|NCT01120379|157705220|FG000|Three Year Timepoint|Physician Decision|9|||
48966480|NCT01120379|157705220|FG000|Three Year Timepoint|Any other reason for early termination|17|||
48966481|NCT01120379|157705220|FG000|Four Year Timepoint|Withdrawal by Subject|5|||
48966482|NCT01120379|157705220|FG000|Four Year Timepoint|Lost to Follow-up|10|||
48966483|NCT01120379|157705220|FG000|Four Year Timepoint|Death|131|||
48966484|NCT01120379|157705220|FG000|Four Year Timepoint|Physician Decision|5|||
48966485|NCT01120379|157705220|FG000|Four Year Timepoint|Any other reason for early termination|217|||
48966486|NCT04656418|157705221|FG000|Overall Study|Withdrawal by Subject|1|||
48966487|NCT04656418|157705222|FG001|Overall Study|Withdrawal by Subject|3|||
48966488|NCT02062463|157705223|FG000|Crossover Stage 1|Withdrawals during stage 1 were not captured|3|||
48966489|NCT02062463|157705224|FG001|Crossover Stage 1|Withdrawals during stage 1 were not captured|1|||
48966490|NCT02062463|157705225|FG002|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
48966491|NCT02062463|157705226|FG003|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
48966492|NCT02062463|157705223|FG000|Stage 2|Adverse Event|0|||
48966493|NCT02062463|157705224|FG001|Stage 2|Adverse Event|0|||
48966494|NCT02062463|157705225|FG002|Stage 2|Adverse Event|12|||
48966495|NCT02062463|157705226|FG003|Stage 2|Adverse Event|20|||
48966496|NCT02062463|157705223|FG000|Stage 2|Lack of Efficacy|0|||
48966497|NCT02062463|157705224|FG001|Stage 2|Lack of Efficacy|0|||
48966498|NCT02062463|157705225|FG002|Stage 2|Lack of Efficacy|3|||
48966499|NCT02062463|157705226|FG003|Stage 2|Lack of Efficacy|4|||
48966500|NCT02062463|157705223|FG000|Stage 2|Lost to Follow-up|0|||
48966501|NCT02062463|157705224|FG001|Stage 2|Lost to Follow-up|0|||
48966502|NCT02062463|157705225|FG002|Stage 2|Lost to Follow-up|20|||
48966503|NCT02062463|157705226|FG003|Stage 2|Lost to Follow-up|20|||
48966504|NCT02062463|157705223|FG000|Stage 2|Non-Compliance|0|||
48966505|NCT02062463|157705224|FG001|Stage 2|Non-Compliance|0|||
48966506|NCT02062463|157705225|FG002|Stage 2|Non-Compliance|0|||
48966507|NCT02062463|157705226|FG003|Stage 2|Non-Compliance|1|||
48966508|NCT02062463|157705223|FG000|Stage 2|Other than specified|0|||
48867571|NCT01502371|157350886|FG001|Overall Study|Excluded Medication|1|||
48867572|NCT01502371|157350887|FG002|Overall Study|Excluded Medication|1|||
48867573|NCT01502371|157350888|FG003|Overall Study|Excluded Medication|0|||
48867574|NCT01502371|157350889|FG004|Overall Study|Excluded Medication|1|||
48867575|NCT00509925|157350890|FG000|Overall Study|Personal reasons|0|||
48867576|NCT00509925|157350891|FG001|Overall Study|Personal reasons|1|||
48867577|NCT00497198|157350892|FG000|Overall Study|Adverse Event|4|||
48867578|NCT00497198|157350893|FG001|Overall Study|Adverse Event|2|||
48966509|NCT02062463|157705224|FG001|Stage 2|Other than specified|0|||
48966510|NCT02062463|157705225|FG002|Stage 2|Other than specified|3|||
48966511|NCT02062463|157705226|FG003|Stage 2|Other than specified|1|||
48966512|NCT02062463|157705223|FG000|Stage 2|Withdrawal by Subject|0|||
48867579|NCT00497198|157350892|FG000|Overall Study|Physician Decision|1|||
48966513|NCT02062463|157705224|FG001|Stage 2|Withdrawal by Subject|0|||
48966514|NCT02062463|157705225|FG002|Stage 2|Withdrawal by Subject|15|||
48966515|NCT02062463|157705226|FG003|Stage 2|Withdrawal by Subject|10|||
48966516|NCT02716194|157705229|FG000|Period 1 - ADVATE|Withdrawal by Subject|1|||
48867580|NCT00497198|157350893|FG001|Overall Study|Physician Decision|2|||
48867581|NCT00497198|157350892|FG000|Overall Study|Withdrawal by Subject|0|||
48664606|NCT02616393|156625217|FG001|Overall Study|Death|12|||
48664607|NCT02616393|156625218|FG002|Overall Study|Death|1|||
48867582|NCT00497198|157350893|FG001|Overall Study|Withdrawal by Subject|1|||
48664608|NCT02616393|156625216|FG000|Overall Study|Termination by Sponsor|4|||
48664609|NCT02616393|156625217|FG001|Overall Study|Termination by Sponsor|5|||
48664610|NCT02616393|156625218|FG002|Overall Study|Termination by Sponsor|2|||
48664611|NCT02616393|156625216|FG000|Overall Study|Other|3|||
48664612|NCT02616393|156625217|FG001|Overall Study|Other|0|||
48664613|NCT02616393|156625218|FG002|Overall Study|Other|0|||
48664614|NCT02616393|156625216|FG000|Overall Study|Withdrawal by Subject|1|||
48664615|NCT02616393|156625217|FG001|Overall Study|Withdrawal by Subject|1|||
48664616|NCT02616393|156625218|FG002|Overall Study|Withdrawal by Subject|0|||
48664617|NCT02616393|156625216|FG000|Overall Study|Lost to Follow-up|0|||
48664618|NCT02616393|156625217|FG001|Overall Study|Lost to Follow-up|2|||
48664619|NCT02616393|156625218|FG002|Overall Study|Lost to Follow-up|0|||
48664620|NCT01460407|156625219|FG000|Period 2: Day 6 to Day 14|Adverse Event|0|||
48664621|NCT01460407|156625220|FG001|Period 2: Day 6 to Day 14|Adverse Event|1|||
48867583|NCT01190449|157350894|FG000|Overall Study|Ineligible|0|||
48867584|NCT01190449|157350895|FG001|Overall Study|Ineligible|4|||
48867585|NCT04490915|157351880|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
48867586|NCT04490915|157351881|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
48867587|NCT04490915|157351880|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
48867588|NCT04490915|157351881|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
48867589|NCT04490915|157351880|FG000|DB Treatment Period (24 Weeks)|Adverse Event|0|||
48867590|NCT04490915|157351881|FG001|DB Treatment Period (24 Weeks)|Adverse Event|1|||
48867591|NCT04490915|157351880|FG000|OL Treatment Period (6 Months)|Withdrawal by Subject|1|||
48867592|NCT04490915|157351881|FG001|OL Treatment Period (6 Months)|Withdrawal by Subject|0|||
48867593|NCT04490915|157351880|FG000|OL Treatment Period (6 Months)|Lost to Follow-up|0|||
48867594|NCT04490915|157351881|FG001|OL Treatment Period (6 Months)|Lost to Follow-up|1|||
48867595|NCT04490915|157351880|FG000|OL Treatment Period (6 Months)|Adverse Event|0|||
48867596|NCT04490915|157351881|FG001|OL Treatment Period (6 Months)|Adverse Event|1|||
48867597|NCT04490915|157351880|FG000|OL Treatment Period (6 Months)|Ongoing in the Study|34|||
48664622|NCT00526110|156625231|FG000|Overall Study|Adverse Event|2|||
48664623|NCT00526110|156625232|FG001|Overall Study|Adverse Event|9|||
48664624|NCT00526110|156625231|FG000|Overall Study|Disease Progression|0|||
48664625|NCT00526110|156625232|FG001|Overall Study|Disease Progression|19|||
48664626|NCT00526110|156625231|FG000|Overall Study|Maximal Response|0|||
48664627|NCT00526110|156625232|FG001|Overall Study|Maximal Response|6|||
48664628|NCT00526110|156625231|FG000|Overall Study|Withdrawal by Subject|0|||
48664629|NCT00526110|156625232|FG001|Overall Study|Withdrawal by Subject|2|||
48664630|NCT00526110|156625231|FG000|Overall Study|Poor Tolerance|0|||
48664631|NCT00526110|156625232|FG001|Overall Study|Poor Tolerance|5|||
48664632|NCT01011933|156625233|FG000|Overall Study|Wrong cell type|1|||
48664633|NCT01011933|156625233|FG000|Overall Study|Improper pre-protocol Rx|1|||
48664634|NCT01011933|156625233|FG000|Overall Study|Inadequate pathology|1|||
48664635|NCT01011933|156625233|FG000|Overall Study|Never treated|1|||
48664636|NCT01439074|156625236|FG000|Overall Study|Lost to Follow-up|3|||
48664637|NCT01439074|156625237|FG001|Overall Study|Lost to Follow-up|4|||
48664638|NCT01439074|156625236|FG000|Overall Study|Subject shedding|1|||
48664639|NCT01439074|156625237|FG001|Overall Study|Subject shedding|0|||
48664640|NCT01439074|156625236|FG000|Overall Study|Withdrawal by Subject|1|||
48664641|NCT01439074|156625237|FG001|Overall Study|Withdrawal by Subject|5|||
48664642|NCT01439074|156625236|FG000|Overall Study|Other|4|||
48664643|NCT01439074|156625237|FG001|Overall Study|Other|4|||
48664644|NCT02193087|156625238|FG000|Overall Study|Adverse Event|2|||
48664645|NCT02193087|156625239|FG001|Overall Study|Adverse Event|0|||
48664646|NCT02193087|156625240|FG002|Overall Study|Adverse Event|0|||
48664647|NCT02193087|156625241|FG003|Overall Study|Adverse Event|11|||
48664648|NCT02193087|156625238|FG000|Overall Study|Lost to Follow-up|14|||
48664649|NCT02193087|156625239|FG001|Overall Study|Lost to Follow-up|6|||
48664650|NCT02193087|156625240|FG002|Overall Study|Lost to Follow-up|4|||
48664651|NCT02193087|156625241|FG003|Overall Study|Lost to Follow-up|37|||
48664652|NCT02193087|156625238|FG000|Overall Study|Protocol Violation|2|||
48664653|NCT02193087|156625239|FG001|Overall Study|Protocol Violation|0|||
48664654|NCT02193087|156625240|FG002|Overall Study|Protocol Violation|1|||
48664655|NCT02193087|156625241|FG003|Overall Study|Protocol Violation|2|||
48664656|NCT02193087|156625238|FG000|Overall Study|Withdrawal by Subject|10|||
48664657|NCT02193087|156625239|FG001|Overall Study|Withdrawal by Subject|3|||
48664658|NCT02193087|156625240|FG002|Overall Study|Withdrawal by Subject|1|||
48664659|NCT02193087|156625241|FG003|Overall Study|Withdrawal by Subject|19|||
48664660|NCT02193087|156625238|FG000|Overall Study|Other Reason Not Specified|7|||
48664661|NCT02193087|156625239|FG001|Overall Study|Other Reason Not Specified|2|||
48664662|NCT02193087|156625240|FG002|Overall Study|Other Reason Not Specified|1|||
48664663|NCT02193087|156625241|FG003|Overall Study|Other Reason Not Specified|9|||
48664664|NCT02193087|156625238|FG000|Overall Study|Did Not Receive Any Vaccination|2|||
48664665|NCT02193087|156625239|FG001|Overall Study|Did Not Receive Any Vaccination|3|||
48867598|NCT04490915|157351881|FG001|OL Treatment Period (6 Months)|Ongoing in the Study|58|||
48664666|NCT02193087|156625240|FG002|Overall Study|Did Not Receive Any Vaccination|0|||
48664667|NCT02193087|156625241|FG003|Overall Study|Did Not Receive Any Vaccination|1|||
48664668|NCT01100567|156625242|FG000|Overall Study|Withdrawal by Subject|5|||
48664669|NCT01100567|156625243|FG001|Overall Study|Withdrawal by Subject|8|||
48664670|NCT01100567|156625242|FG000|Overall Study|Early Hospital Discharge|6|||
48664671|NCT01100567|156625243|FG001|Overall Study|Early Hospital Discharge|4|||
48664672|NCT01100567|156625242|FG000|Overall Study|Lost to Follow-up|1|||
48757256|NCT01472081|156958211|FG000|Overall Study|Poor/non-compliance|0|||
48757257|NCT01472081|156958212|FG001|Overall Study|Poor/non-compliance|0|||
48757258|NCT01472081|156958213|FG002|Overall Study|Poor/non-compliance|1|||
48757259|NCT01472081|156958214|FG003|Overall Study|Poor/non-compliance|0|||
48757260|NCT01472081|156958215|FG004|Overall Study|Poor/non-compliance|1|||
48757261|NCT01472081|156958216|FG005|Overall Study|Poor/non-compliance|0|||
48757262|NCT01472081|156958211|FG000|Overall Study|No longer meets study criteria|0|||
48757263|NCT01472081|156958212|FG001|Overall Study|No longer meets study criteria|0|||
48757264|NCT01472081|156958213|FG002|Overall Study|No longer meets study criteria|1|||
48757265|NCT01472081|156958214|FG003|Overall Study|No longer meets study criteria|0|||
48757266|NCT01472081|156958215|FG004|Overall Study|No longer meets study criteria|0|||
48757267|NCT01472081|156958216|FG005|Overall Study|No longer meets study criteria|0|||
48757268|NCT01472081|156958211|FG000|Overall Study|Subject request to discontinue treatment|0|||
48757269|NCT01472081|156958212|FG001|Overall Study|Subject request to discontinue treatment|3|||
48757270|NCT01472081|156958213|FG002|Overall Study|Subject request to discontinue treatment|1|||
48757271|NCT01472081|156958214|FG003|Overall Study|Subject request to discontinue treatment|1|||
48757272|NCT01472081|156958215|FG004|Overall Study|Subject request to discontinue treatment|0|||
48757273|NCT01472081|156958216|FG005|Overall Study|Subject request to discontinue treatment|0|||
48757274|NCT00541034|156958218|FG000|Overall Study|Non-Compliance|3|||
48757275|NCT00975481|156958221|FG000|Second Intervention Period|Adverse Event|2|||
48757276|NCT00975481|156958222|FG001|Second Intervention Period|Adverse Event|1|||
48757277|NCT00975481|156958223|FG002|Second Intervention Period|Adverse Event|0|||
48757278|NCT00975481|156958224|FG003|Second Intervention Period|Adverse Event|0|||
48757279|NCT00975481|156958225|FG004|Second Intervention Period|Adverse Event|0|||
48757280|NCT00975481|156958226|FG005|Second Intervention Period|Adverse Event|0|||
48757281|NCT00975481|156958221|FG000|Second Intervention Period|Withdrawal by Subject|0|||
48757282|NCT00975481|156958222|FG001|Second Intervention Period|Withdrawal by Subject|0|||
48757283|NCT00975481|156958223|FG002|Second Intervention Period|Withdrawal by Subject|1|||
48757284|NCT00975481|156958224|FG003|Second Intervention Period|Withdrawal by Subject|0|||
48757285|NCT00975481|156958225|FG004|Second Intervention Period|Withdrawal by Subject|0|||
48757286|NCT00975481|156958226|FG005|Second Intervention Period|Withdrawal by Subject|0|||
48757287|NCT00975481|156958221|FG000|Fourth Intervention Period|Withdrawal by Subject|0|||
48757288|NCT00975481|156958222|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
48757289|NCT00975481|156958223|FG002|Fourth Intervention Period|Withdrawal by Subject|1|||
48757290|NCT00975481|156958224|FG003|Fourth Intervention Period|Withdrawal by Subject|1|||
48757291|NCT00975481|156958225|FG004|Fourth Intervention Period|Withdrawal by Subject|0|||
48757292|NCT00975481|156958226|FG005|Fourth Intervention Period|Withdrawal by Subject|0|||
48757293|NCT00975481|156958221|FG000|Fifth Intervention Period|Withdrawal by Subject|0|||
48757294|NCT00975481|156958222|FG001|Fifth Intervention Period|Withdrawal by Subject|0|||
48757295|NCT00975481|156958223|FG002|Fifth Intervention Period|Withdrawal by Subject|0|||
48757296|NCT00975481|156958224|FG003|Fifth Intervention Period|Withdrawal by Subject|0|||
48757297|NCT00975481|156958225|FG004|Fifth Intervention Period|Withdrawal by Subject|1|||
48757298|NCT00975481|156958226|FG005|Fifth Intervention Period|Withdrawal by Subject|0|||
48757299|NCT00056407|156958227|FG000|Overall Study|Adverse Event|282|||
48757300|NCT00056407|156958228|FG001|Overall Study|Adverse Event|364|||
48757301|NCT00056407|156958227|FG000|Overall Study|Withdrawal by Subject|377|||
48757302|NCT00056407|156958228|FG001|Overall Study|Withdrawal by Subject|361|||
48757303|NCT00056407|156958227|FG000|Overall Study|Lost to Follow-up|123|||
48757304|NCT00056407|156958228|FG001|Overall Study|Lost to Follow-up|113|||
48757305|NCT00056407|156958227|FG000|Overall Study|Protocol Violation|104|||
48757306|NCT00056407|156958228|FG001|Overall Study|Protocol Violation|95|||
48757307|NCT00056407|156958227|FG000|Overall Study|Diagnosed with Prostate Cancer|202|||
48757308|NCT00056407|156958228|FG001|Overall Study|Diagnosed with Prostate Cancer|166|||
48757309|NCT00056407|156958227|FG000|Overall Study|"Listed as Other on Case Report Form"|98|||
48757310|NCT00056407|156958228|FG001|Overall Study|"Listed as Other on Case Report Form"|60|||
48867599|NCT03456076|157351882|FG000|Overall Study|Withdrawal by Subject|5|||
48867600|NCT03456076|157351883|FG001|Overall Study|Withdrawal by Subject|9|||
48867601|NCT03456076|157351882|FG000|Overall Study|Protocol deviation|0|||
48867602|NCT03456076|157351883|FG001|Overall Study|Protocol deviation|1|||
48867603|NCT03456076|157351882|FG000|Overall Study|Lost to Follow-up|0|||
48867604|NCT03456076|157351883|FG001|Overall Study|Lost to Follow-up|1|||
48867605|NCT03456076|157351882|FG000|Overall Study|Death|2|||
48867606|NCT03456076|157351883|FG001|Overall Study|Death|5|||
48867607|NCT03456076|157351882|FG000|Overall Study|Study ongoing|123|||
48867608|NCT03456076|157351883|FG001|Overall Study|Study ongoing|111|||
48664673|NCT01100567|156625243|FG001|Overall Study|Lost to Follow-up|2|||
48664674|NCT01100567|156625242|FG000|Overall Study|Physician Decision|0|||
48664675|NCT01100567|156625243|FG001|Overall Study|Physician Decision|1|||
48664676|NCT01100567|156625242|FG000|Overall Study|Deemed ineligible after consent|0|||
48664677|NCT01100567|156625243|FG001|Overall Study|Deemed ineligible after consent|1|||
48664678|NCT01498185|156625245|FG000|Overall Study|Adverse Event|0|||
48664679|NCT01498185|156625246|FG001|Overall Study|Adverse Event|0|||
48664680|NCT01498185|156625247|FG002|Overall Study|Adverse Event|0|||
48664681|NCT01498185|156625248|FG003|Overall Study|Adverse Event|1|||
48664682|NCT01498185|156625249|FG004|Overall Study|Adverse Event|0|||
48664683|NCT01498185|156625245|FG000|Overall Study|Withdrawal by Subject|1|||
48664684|NCT01498185|156625246|FG001|Overall Study|Withdrawal by Subject|1|||
48664685|NCT01498185|156625247|FG002|Overall Study|Withdrawal by Subject|0|||
48664686|NCT01498185|156625248|FG003|Overall Study|Withdrawal by Subject|2|||
48664687|NCT01498185|156625249|FG004|Overall Study|Withdrawal by Subject|1|||
48664688|NCT01498185|156625245|FG000|Overall Study|No longer met criteria, etc|0|||
48966517|NCT02716194|157705230|FG001|Period 1 - ADVATE|Withdrawal by Subject|1|||
48966518|NCT02716194|157705231|FG002|Period 1 - ADVATE|Withdrawal by Subject|0|||
48966519|NCT01332019|157705235|FG000|Overall Study|Was Not Dosed|1|||
48966520|NCT01332019|157705236|FG001|Overall Study|Was Not Dosed|0|||
48966521|NCT01332019|157705235|FG000|Overall Study|Other|16|||
48966522|NCT01332019|157705236|FG001|Overall Study|Other|18|||
48966523|NCT01332019|157705235|FG000|Overall Study|Death|2|||
48966524|NCT01332019|157705236|FG001|Overall Study|Death|1|||
48966525|NCT01332019|157705235|FG000|Overall Study|Physician Decision|4|||
48966526|NCT01332019|157705236|FG001|Overall Study|Physician Decision|3|||
48966527|NCT01332019|157705235|FG000|Overall Study|Withdrawal by Subject|73|||
48966528|NCT01332019|157705236|FG001|Overall Study|Withdrawal by Subject|71|||
48966529|NCT01332019|157705235|FG000|Overall Study|Lost to Follow-up|4|||
48966530|NCT01332019|157705236|FG001|Overall Study|Lost to Follow-up|7|||
48966531|NCT01332019|157705235|FG000|Overall Study|Adverse Event|13|||
48966532|NCT01332019|157705236|FG001|Overall Study|Adverse Event|22|||
48966533|NCT01369849|157705237|FG000|Overall Study|Ineligible prior to treatment|0|||
48966534|NCT01369849|157705238|FG001|Overall Study|Ineligible prior to treatment|0|||
48966535|NCT01369849|157705239|FG002|Overall Study|Ineligible prior to treatment|1|||
48966536|NCT01369849|157705237|FG000|Overall Study|Ineligible after receiving treatment|0|||
48966537|NCT01369849|157705238|FG001|Overall Study|Ineligible after receiving treatment|1|||
48966538|NCT01369849|157705239|FG002|Overall Study|Ineligible after receiving treatment|0|||
48966539|NCT00205699|157705240|FG000|Overall Study|Lost to Follow-up|1|||
48966540|NCT00205699|157705241|FG001|Overall Study|Lost to Follow-up|3|||
48966541|NCT00205699|157705242|FG002|Overall Study|Lost to Follow-up|5|||
48966542|NCT00205699|157705240|FG000|Overall Study|Adverse Event|1|||
48966543|NCT00205699|157705241|FG001|Overall Study|Adverse Event|0|||
48966544|NCT00205699|157705242|FG002|Overall Study|Adverse Event|0|||
48966545|NCT00205699|157705240|FG000|Overall Study|Withdrawal by Subject|1|||
48966546|NCT00205699|157705241|FG001|Overall Study|Withdrawal by Subject|2|||
48966547|NCT00205699|157705242|FG002|Overall Study|Withdrawal by Subject|1|||
48966548|NCT00205699|157705240|FG000|Overall Study|Lack of Efficacy|0|||
48966549|NCT00205699|157705241|FG001|Overall Study|Lack of Efficacy|1|||
48966550|NCT00205699|157705242|FG002|Overall Study|Lack of Efficacy|0|||
48966551|NCT01957709|157705243|FG000|Overall Study|Patient refused to complete post-tx bx|1|||
48966552|NCT01610076|157705248|FG000|Overall Study|Technical issue with video|0|||
48966553|NCT01610076|157705249|FG001|Overall Study|Technical issue with video|1|||
48966554|NCT01610076|157705248|FG000|Overall Study|Lost to Follow-up|3|||
48966555|NCT01610076|157705249|FG001|Overall Study|Lost to Follow-up|4|||
48966556|NCT00817206|157705251|FG000|Overall Study|Adverse Event|10|||
48966557|NCT00817206|157705252|FG001|Overall Study|Adverse Event|3|||
48966558|NCT00817206|157705251|FG000|Overall Study|Protocol Violation|0|||
48966559|NCT00817206|157705252|FG001|Overall Study|Protocol Violation|2|||
48966560|NCT00817206|157705251|FG000|Overall Study|Lost to Follow-up|0|||
48966561|NCT00817206|157705252|FG001|Overall Study|Lost to Follow-up|1|||
48966562|NCT00817206|157705251|FG000|Overall Study|Death|2|||
48966563|NCT00817206|157705252|FG001|Overall Study|Death|0|||
48966564|NCT00817206|157705251|FG000|Overall Study|Withdrawal by Subject|7|||
48966565|NCT00817206|157705252|FG001|Overall Study|Withdrawal by Subject|3|||
48966566|NCT00817206|157705251|FG000|Overall Study|Physician Decision|2|||
48966567|NCT00817206|157705252|FG001|Overall Study|Physician Decision|0|||
48966568|NCT00793182|157705253|FG000|Overall Study|Adverse Event|0|||
48966569|NCT00793182|157705254|FG001|Overall Study|Adverse Event|1|||
48966570|NCT02394808|157705259|FG000|Period 1|Unsatisfactory lens fitting|0|||
48966571|NCT02394808|157705260|FG001|Period 1|Unsatisfactory lens fitting|1|||
48966572|NCT02394808|157705259|FG000|Period 2|Lost to Follow-up|1|||
48664689|NCT01498185|156625246|FG001|Overall Study|No longer met criteria, etc|0|||
48664690|NCT01498185|156625247|FG002|Overall Study|No longer met criteria, etc|0|||
48664691|NCT01498185|156625248|FG003|Overall Study|No longer met criteria, etc|0|||
48664692|NCT01498185|156625249|FG004|Overall Study|No longer met criteria, etc|2|||
48966573|NCT02394808|157705260|FG001|Period 2|Lost to Follow-up|0|||
48966574|NCT01879319|157705262|FG000|Overall Study|Withdrawal by Subject|1|||
48966575|NCT01879319|157705263|FG001|Overall Study|Withdrawal by Subject|0|||
48966576|NCT01879319|157705262|FG000|Overall Study|Lost to Follow-up|1|||
48664693|NCT02608450|156625252|FG000|Overall Study|Lost to Follow-up|39|||
48664694|NCT02608450|156625253|FG001|Overall Study|Lost to Follow-up|32|||
48664695|NCT02608450|156625252|FG000|Overall Study|Withdrawal by Subject|21|||
48664696|NCT02608450|156625253|FG001|Overall Study|Withdrawal by Subject|15|||
48664697|NCT02608450|156625252|FG000|Overall Study|Adverse Event|3|||
48664698|NCT02608450|156625253|FG001|Overall Study|Adverse Event|6|||
48664699|NCT02608450|156625252|FG000|Overall Study|Withdrawal by parent|2|||
48664700|NCT02608450|156625253|FG001|Overall Study|Withdrawal by parent|3|||
48664701|NCT02608450|156625252|FG000|Overall Study|Lack of Efficacy|0|||
48664702|NCT02608450|156625253|FG001|Overall Study|Lack of Efficacy|3|||
48664703|NCT02608450|156625252|FG000|Overall Study|Noncompliance with study drug|0|||
48664704|NCT02608450|156625253|FG001|Overall Study|Noncompliance with study drug|2|||
48664705|NCT02608450|156625252|FG000|Overall Study|Physician Decision|0|||
48664706|NCT02608450|156625253|FG001|Overall Study|Physician Decision|1|||
48664707|NCT02608450|156625252|FG000|Overall Study|Pregnancy|0|||
48664708|NCT02608450|156625253|FG001|Overall Study|Pregnancy|1|||
48664709|NCT02608450|156625252|FG000|Overall Study|Progressive disease|1|||
48664710|NCT02608450|156625253|FG001|Overall Study|Progressive disease|0|||
48664711|NCT02608450|156625252|FG000|Overall Study|Multiple reasons|0|||
48664712|NCT02608450|156625253|FG001|Overall Study|Multiple reasons|2|||
48664713|NCT00276614|156625258|FG000|Overall Study|Progression of disease under study|3|||
48757311|NCT00056407|156958227|FG000|Overall Study|Missing|25|||
48757312|NCT00056407|156958228|FG001|Overall Study|Missing|34|||
48757313|NCT03251079|156958229|FG000|Overall Study|Withdrawal by Subject|1|||
48757314|NCT01428453|156958230|FG000|Overall Study|Adverse Event|2|||
48757315|NCT01428453|156958231|FG001|Overall Study|Adverse Event|7|||
48757316|NCT01428453|156958230|FG000|Overall Study|Protocol Violation|1|||
48757317|NCT01428453|156958231|FG001|Overall Study|Protocol Violation|0|||
48757318|NCT01428453|156958230|FG000|Overall Study|Lost to Follow-up|0|||
48757319|NCT01428453|156958231|FG001|Overall Study|Lost to Follow-up|1|||
48757320|NCT01428453|156958230|FG000|Overall Study|Withdrawal by Subject|3|||
48757321|NCT01428453|156958231|FG001|Overall Study|Withdrawal by Subject|1|||
48757322|NCT01996709|156958236|FG000|Overall Study|Withdrawal by Subject|1|||
48757323|NCT01996709|156958237|FG001|Overall Study|Withdrawal by Subject|0|||
48757324|NCT01996709|156958236|FG000|Overall Study|Lost to Follow-up|3|||
48757325|NCT01996709|156958237|FG001|Overall Study|Lost to Follow-up|0|||
48757326|NCT01996709|156958236|FG000|Overall Study|Subject Non-Compliant|1|||
48757327|NCT01996709|156958237|FG001|Overall Study|Subject Non-Compliant|0|||
48757328|NCT01996709|156958236|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
48757329|NCT01996709|156958237|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
48757330|NCT05517382|156958240|FG000|Overall Study|Lost to Follow-up|0|||
48757331|NCT05517382|156958241|FG001|Overall Study|Lost to Follow-up|1|||
48757332|NCT02677922|156958248|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
48867609|NCT03319719|157351891|FG000|Overall Study|Lost to Follow-up|1|||
48867610|NCT01960114|157351892|FG000|Overall Study|Adverse Event|1|||
48867611|NCT01960114|157351893|FG001|Overall Study|Adverse Event|0|||
48867612|NCT01960114|157351892|FG000|Overall Study|Could not swallow study medication|0|||
48867613|NCT01960114|157351893|FG001|Overall Study|Could not swallow study medication|1|||
48867614|NCT02253147|157351894|FG000|Overall Study|Protocol Violation|30|||
48867615|NCT02253147|157351894|FG000|Overall Study|Did not consent to study extension|9|||
48867616|NCT02253147|157351894|FG000|Overall Study|Conditional re-treatment at W52|5|||
48867617|NCT02253147|157351894|FG000|Overall Study|Lost to Follow-up|2|||
48867618|NCT02253147|157351894|FG000|Overall Study|Withdrawal by Subject|1|||
48867619|NCT01685047|157351895|FG000|Overall Study|Withdrawal by Subject|20|||
48867620|NCT01685047|157351895|FG000|Overall Study|Death|26|||
48867621|NCT01685047|157351895|FG000|Overall Study|Lost to Follow-up|8|||
48867622|NCT01685047|157351895|FG000|Overall Study|Physician Decision|25|||
48867623|NCT01685047|157351895|FG000|Overall Study|Adverse Event|5|||
48867624|NCT01685047|157351895|FG000|Overall Study|patient withdrawn by sponsor|1|||
48867625|NCT01533181|157351896|FG000|Overall Study|Disease progression pre-active treatment|0|||
48867626|NCT01533181|157351897|FG001|Overall Study|Disease progression pre-active treatment|1|||
48867627|NCT01533181|157351896|FG000|Overall Study|Patient withdrawal pre-active treatment|1|||
48867628|NCT01533181|157351897|FG001|Overall Study|Patient withdrawal pre-active treatment|0|||
48867629|NCT02847637|157351898|FG000|Overall Study|Withdrawal by Subject|0|||
48867630|NCT02847637|157351899|FG001|Overall Study|Withdrawal by Subject|1|||
48867631|NCT02847637|157351900|FG002|Overall Study|Withdrawal by Subject|1|||
48867632|NCT02847637|157351901|FG003|Overall Study|Withdrawal by Subject|0|||
48867633|NCT02847637|157351898|FG000|Overall Study|Lost to Follow-up|1|||
48867634|NCT02847637|157351899|FG001|Overall Study|Lost to Follow-up|1|||
48867635|NCT02847637|157351900|FG002|Overall Study|Lost to Follow-up|0|||
48867636|NCT02847637|157351901|FG003|Overall Study|Lost to Follow-up|0|||
48867637|NCT02469077|157351902|FG000|Post Randomization/Intervention Period|Scheduling issues|3|||
48867638|NCT02469077|157351903|FG001|Post Randomization/Intervention Period|Scheduling issues|2|||
48867639|NCT02469077|157351902|FG000|Post Randomization/Intervention Period|Relocated|1|||
48867640|NCT02469077|157351903|FG001|Post Randomization/Intervention Period|Relocated|1|||
48757333|NCT02677922|156958249|FG001|Pre-Treatment Period|Withdrawal by Subject|0|||
48664714|NCT02449018|156625259|FG000|Overall Study|Abnormal laboratory value|0|||
48664715|NCT02449018|156625260|FG001|Overall Study|Abnormal laboratory value|1|||
48664716|NCT02449018|156625259|FG000|Overall Study|Administrative problems|1|||
48664717|NCT02449018|156625260|FG001|Overall Study|Administrative problems|0|||
48664718|NCT02449018|156625259|FG000|Overall Study|Adverse Event|5|||
48966577|NCT01879319|157705263|FG001|Overall Study|Lost to Follow-up|5|||
48966578|NCT01103778|157705264|FG000|Overall Study|Lost to Follow-up|1|||
48966579|NCT01103778|157705264|FG000|Overall Study|Proteinuria improved prior to enrollment|1|||
48966580|NCT01103778|157705264|FG000|Overall Study|Screen failure|1|||
48966581|NCT03067129|157705265|FG000|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
48966582|NCT03067129|157705266|FG001|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
48966583|NCT03067129|157705267|FG002|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
48966584|NCT03067129|157705268|FG003|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|1|||
48966585|NCT03067129|157705265|FG000|Overall Study|Withdrawal by Subject|0|||
48966586|NCT03067129|157705266|FG001|Overall Study|Withdrawal by Subject|0|||
48966587|NCT03067129|157705267|FG002|Overall Study|Withdrawal by Subject|1|||
48966588|NCT03067129|157705268|FG003|Overall Study|Withdrawal by Subject|2|||
48966589|NCT03067129|157705265|FG000|Overall Study|Lost to Follow-up|5|||
48966590|NCT03067129|157705266|FG001|Overall Study|Lost to Follow-up|5|||
48966591|NCT03067129|157705267|FG002|Overall Study|Lost to Follow-up|4|||
48966592|NCT03067129|157705268|FG003|Overall Study|Lost to Follow-up|3|||
48966593|NCT05590767|157705271|FG000|Overall Study|Protocol Violation|1|||
48966594|NCT05590767|157705271|FG000|Overall Study|surgery canceled|1|||
48966595|NCT05590767|157705271|FG000|Overall Study|interscalene brachial block not performed|1|||
48966596|NCT00424294|157705272|FG000|Overall Study|Adverse Event|4|||
48966597|NCT00424294|157705273|FG001|Overall Study|Adverse Event|10|||
48966598|NCT00424294|157705272|FG000|Overall Study|Lack of Efficacy|2|||
48966599|NCT00424294|157705273|FG001|Overall Study|Lack of Efficacy|1|||
48966600|NCT00424294|157705272|FG000|Overall Study|Withdrawal by Subject|1|||
48966601|NCT00424294|157705273|FG001|Overall Study|Withdrawal by Subject|2|||
48966602|NCT00424294|157705272|FG000|Overall Study|Other|0|||
48966603|NCT00424294|157705273|FG001|Overall Study|Other|2|||
48966604|NCT00424294|157705272|FG000|Overall Study|Randomized but not Treated|1|||
48966605|NCT00424294|157705273|FG001|Overall Study|Randomized but not Treated|0|||
48966606|NCT01409993|157705277|FG000|Overall Study|Adverse Event|4|||
48966607|NCT01409993|157705278|FG001|Overall Study|Adverse Event|4|||
48966608|NCT01409993|157705279|FG002|Overall Study|Adverse Event|3|||
48966609|NCT01409993|157705280|FG003|Overall Study|Adverse Event|1|||
48966610|NCT01409993|157705277|FG000|Overall Study|Withdrawal by Subject|0|||
48966611|NCT01409993|157705278|FG001|Overall Study|Withdrawal by Subject|0|||
48966612|NCT01409993|157705279|FG002|Overall Study|Withdrawal by Subject|0|||
48966613|NCT01409993|157705280|FG003|Overall Study|Withdrawal by Subject|4|||
48966614|NCT01409993|157705277|FG000|Overall Study|Lost to Follow-up|0|||
48966615|NCT01409993|157705278|FG001|Overall Study|Lost to Follow-up|1|||
48966616|NCT01409993|157705279|FG002|Overall Study|Lost to Follow-up|0|||
48966617|NCT01409993|157705280|FG003|Overall Study|Lost to Follow-up|0|||
48966618|NCT01700985|157705281|FG000|Overall Study|Incarcerated|0|||
48966619|NCT01700985|157705282|FG001|Overall Study|Incarcerated|1|||
48966620|NCT04533815|157705283|FG000|Overall Study|Adverse Event|2|||
48966621|NCT04533815|157705283|FG000|Overall Study|Site withdrew|5|||
48966622|NCT02677220|157705284|FG000|Overall Study|Adverse Event|1|||
48966623|NCT00965146|157705286|FG000|Overall Study|Death|7|||
48966624|NCT00965146|157705286|FG000|Overall Study|Lost to Follow-up|22|||
48966625|NCT00965146|157705286|FG000|Overall Study|Withdrawal by Subject|17|||
48966626|NCT00965146|157705286|FG000|Overall Study|Unable to return|1|||
48966627|NCT00965146|157705286|FG000|Overall Study|Unwilling to return|11|||
48966628|NCT00965146|157705286|FG000|Overall Study|Intercurrent illness|1|||
48966629|NCT00965146|157705286|FG000|Overall Study|Revision / Removal of Study Implant|6|||
48966630|NCT00965146|157705286|FG000|Overall Study|Overall Study Termination|145|||
48966631|NCT00067470|157705289|FG000|Overall Study|Withdrawal by Subject|0|||
48966632|NCT00067470|157705290|FG001|Overall Study|Withdrawal by Subject|1|||
48966633|NCT01074658|157705291|FG000|Overall Study|No implant attempted|19|||
48966634|NCT01181102|157705292|FG000|Overall Study|Adverse Event|28|||
48966635|NCT01181102|157705293|FG001|Overall Study|Adverse Event|26|||
48966636|NCT01181102|157705292|FG000|Overall Study|Lack of Efficacy|3|||
48966637|NCT01181102|157705293|FG001|Overall Study|Lack of Efficacy|1|||
48664719|NCT02449018|156625260|FG001|Overall Study|Adverse Event|1|||
48664720|NCT02449018|156625259|FG000|Overall Study|Protocol deviation|4|||
48664721|NCT02449018|156625260|FG001|Overall Study|Protocol deviation|0|||
48966638|NCT01181102|157705292|FG000|Overall Study|Lost to Follow-up|2|||
48966639|NCT01181102|157705293|FG001|Overall Study|Lost to Follow-up|0|||
48966640|NCT01181102|157705292|FG000|Overall Study|Physician Decision|3|||
48966641|NCT01181102|157705293|FG001|Overall Study|Physician Decision|1|||
48966642|NCT01181102|157705292|FG000|Overall Study|Protocol Violation|5|||
48966643|NCT01181102|157705293|FG001|Overall Study|Protocol Violation|6|||
48966644|NCT01181102|157705292|FG000|Overall Study|Withdrawal by Subject|10|||
48966645|NCT01181102|157705293|FG001|Overall Study|Withdrawal by Subject|12|||
48966646|NCT02180217|157705295|FG000|Overall Study|Adverse Event|3|||
48757334|NCT02677922|156958250|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
48757335|NCT02677922|156958251|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
48757336|NCT02677922|156958252|FG004|Pre-Treatment Period|Withdrawal by Subject|0|||
48757337|NCT02677922|156958253|FG005|Pre-Treatment Period|Withdrawal by Subject|1|||
48757338|NCT02677922|156958248|FG000|Treatment Period|Adverse Event|0|||
48757339|NCT02677922|156958249|FG001|Treatment Period|Adverse Event|0|||
48757340|NCT02677922|156958250|FG002|Treatment Period|Adverse Event|1|||
48757341|NCT02677922|156958251|FG003|Treatment Period|Adverse Event|3|||
48757342|NCT02677922|156958252|FG004|Treatment Period|Adverse Event|5|||
48757343|NCT02677922|156958253|FG005|Treatment Period|Adverse Event|2|||
48757344|NCT02677922|156958248|FG000|Treatment Period|Progressive Disease|1|||
48757345|NCT02677922|156958249|FG001|Treatment Period|Progressive Disease|1|||
48757346|NCT02677922|156958250|FG002|Treatment Period|Progressive Disease|0|||
48757347|NCT02677922|156958251|FG003|Treatment Period|Progressive Disease|0|||
48757348|NCT02677922|156958252|FG004|Treatment Period|Progressive Disease|8|||
48757349|NCT02677922|156958253|FG005|Treatment Period|Progressive Disease|7|||
48757350|NCT02677922|156958248|FG000|Treatment Period|Lack of Efficacy|0|||
48757351|NCT02677922|156958249|FG001|Treatment Period|Lack of Efficacy|0|||
48757352|NCT02677922|156958250|FG002|Treatment Period|Lack of Efficacy|0|||
48757353|NCT02677922|156958251|FG003|Treatment Period|Lack of Efficacy|1|||
48757354|NCT02677922|156958252|FG004|Treatment Period|Lack of Efficacy|1|||
48757355|NCT02677922|156958253|FG005|Treatment Period|Lack of Efficacy|6|||
48757356|NCT02677922|156958248|FG000|Treatment Period|Withdrawal by Subject|0|||
48757357|NCT02677922|156958249|FG001|Treatment Period|Withdrawal by Subject|0|||
48757358|NCT02677922|156958250|FG002|Treatment Period|Withdrawal by Subject|1|||
48757359|NCT02677922|156958251|FG003|Treatment Period|Withdrawal by Subject|3|||
48757360|NCT02677922|156958252|FG004|Treatment Period|Withdrawal by Subject|5|||
48757361|NCT02677922|156958253|FG005|Treatment Period|Withdrawal by Subject|5|||
48757362|NCT02677922|156958248|FG000|Treatment Period|Transition to Commercially Available Treatment|0|||
48757363|NCT02677922|156958249|FG001|Treatment Period|Transition to Commercially Available Treatment|1|||
48757364|NCT02677922|156958250|FG002|Treatment Period|Transition to Commercially Available Treatment|1|||
48757365|NCT02677922|156958251|FG003|Treatment Period|Transition to Commercially Available Treatment|1|||
48757366|NCT02677922|156958252|FG004|Treatment Period|Transition to Commercially Available Treatment|1|||
48757367|NCT02677922|156958253|FG005|Treatment Period|Transition to Commercially Available Treatment|2|||
48966647|NCT02180217|157705296|FG001|Overall Study|Adverse Event|2|||
48664722|NCT02449018|156625259|FG000|Overall Study|Patient decision|2|||
48664723|NCT02449018|156625260|FG001|Overall Study|Patient decision|0|||
48664724|NCT01288612|156626902|FG000|Overall Study|Unable to contact|11|||
48664725|NCT01288612|156626903|FG001|Overall Study|Unable to contact|16|||
48664726|NCT01288612|156626904|FG002|Overall Study|Unable to contact|20|||
48664727|NCT01288612|156626902|FG000|Overall Study|Declined|78|||
48664728|NCT01288612|156626903|FG001|Overall Study|Declined|63|||
48664729|NCT01288612|156626904|FG002|Overall Study|Declined|62|||
48664730|NCT01288612|156626902|FG000|Overall Study|Unable to intubate|0|||
48664731|NCT01288612|156626903|FG001|Overall Study|Unable to intubate|3|||
48664732|NCT01288612|156626904|FG002|Overall Study|Unable to intubate|0|||
48664733|NCT00428220|156626905|FG000|Overall Study|Participant died|8|||
48664734|NCT00428220|156626905|FG000|Overall Study|Global deterioration of health status|7|||
48664735|NCT00428220|156626905|FG000|Overall Study|Lost to Follow-up|4|||
48664736|NCT00428220|156626905|FG000|Overall Study|Objective progression or relapse|123|||
48664737|NCT00428220|156626905|FG000|Overall Study|Participant refused continued treatment|7|||
48664738|NCT00428220|156626905|FG000|Overall Study|Adverse Event|51|||
48664739|NCT00428220|156626905|FG000|Overall Study|Other|23|||
48664740|NCT01328041|156626907|FG000|Overall Study|Adverse Event|7|||
48664741|NCT01328041|156626907|FG000|Overall Study|Lack of Efficacy|27|||
48664742|NCT01328041|156626907|FG000|Overall Study|Protocol Violation|7|||
48664743|NCT01328041|156626907|FG000|Overall Study|Lost to Follow-up|7|||
48664744|NCT01328041|156626907|FG000|Overall Study|Physician Decision|2|||
48664745|NCT01328041|156626907|FG000|Overall Study|Withdrawal by Subject|7|||
48664746|NCT01460719|156626911|FG000|Overall Study|Adverse Event|1|||
48664747|NCT01460719|156626911|FG000|Overall Study|Withdrawal by Subject|1|||
48757368|NCT02677922|156958248|FG000|Treatment Period|Disease Relapse|0|||
48757369|NCT02677922|156958249|FG001|Treatment Period|Disease Relapse|0|||
48757370|NCT02677922|156958250|FG002|Treatment Period|Disease Relapse|0|||
48664748|NCT00823212|156626912|FG000|Overall Study|Death|8|||
48664749|NCT00823212|156626913|FG001|Overall Study|Death|10|||
48664750|NCT00823212|156626912|FG000|Overall Study|Withdrawal by Subject|6|||
48664751|NCT00823212|156626913|FG001|Overall Study|Withdrawal by Subject|1|||
48664752|NCT00823212|156626912|FG000|Overall Study|Incarcerated|0|||
48664753|NCT00823212|156626913|FG001|Overall Study|Incarcerated|1|||
48664754|NCT00823212|156626912|FG000|Overall Study|Missed 12-month visit|21|||
48757371|NCT02677922|156958251|FG003|Treatment Period|Disease Relapse|3|||
48757372|NCT02677922|156958252|FG004|Treatment Period|Disease Relapse|6|||
48757373|NCT02677922|156958253|FG005|Treatment Period|Disease Relapse|1|||
48757374|NCT02677922|156958248|FG000|Treatment Period|Allogeneic HSCT|1|||
48757375|NCT02677922|156958249|FG001|Treatment Period|Allogeneic HSCT|0|||
48757376|NCT02677922|156958250|FG002|Treatment Period|Allogeneic HSCT|0|||
48966648|NCT02180217|157705297|FG002|Overall Study|Adverse Event|22|||
48664755|NCT00823212|156626913|FG001|Overall Study|Missed 12-month visit|21|||
48664756|NCT00149994|156626914|FG000|Overall Study|Administrative problems:|1|||
48966649|NCT02180217|157705295|FG000|Overall Study|Death|1|||
48757377|NCT02677922|156958251|FG003|Treatment Period|Allogeneic HSCT|1|||
48757378|NCT02677922|156958252|FG004|Treatment Period|Allogeneic HSCT|4|||
48757379|NCT02677922|156958253|FG005|Treatment Period|Allogeneic HSCT|1|||
48757380|NCT02677922|156958248|FG000|Treatment Period|Other Reasons|0|||
48757381|NCT02677922|156958249|FG001|Treatment Period|Other Reasons|0|||
48757382|NCT02677922|156958250|FG002|Treatment Period|Other Reasons|0|||
48757383|NCT02677922|156958251|FG003|Treatment Period|Other Reasons|1|||
48757384|NCT02677922|156958252|FG004|Treatment Period|Other Reasons|3|||
48757385|NCT02677922|156958253|FG005|Treatment Period|Other Reasons|5|||
48757386|NCT02677922|156958248|FG000|Treatment Period|Death|0|||
48757387|NCT02677922|156958249|FG001|Treatment Period|Death|0|||
48757388|NCT02677922|156958250|FG002|Treatment Period|Death|0|||
48757389|NCT02677922|156958251|FG003|Treatment Period|Death|0|||
48757390|NCT02677922|156958252|FG004|Treatment Period|Death|12|||
48757391|NCT02677922|156958253|FG005|Treatment Period|Death|1|||
48757392|NCT02677922|156958248|FG000|Treatment Period|Non-compliance with Study Drug|0|||
48757393|NCT02677922|156958249|FG001|Treatment Period|Non-compliance with Study Drug|0|||
48757394|NCT02677922|156958250|FG002|Treatment Period|Non-compliance with Study Drug|0|||
48757395|NCT02677922|156958251|FG003|Treatment Period|Non-compliance with Study Drug|0|||
48757396|NCT02677922|156958252|FG004|Treatment Period|Non-compliance with Study Drug|1|||
48757397|NCT02677922|156958253|FG005|Treatment Period|Non-compliance with Study Drug|0|||
48757398|NCT02677922|156958248|FG000|Treatment Period|Physician Decision|0|||
48757399|NCT02677922|156958249|FG001|Treatment Period|Physician Decision|0|||
48757400|NCT02677922|156958250|FG002|Treatment Period|Physician Decision|0|||
48966650|NCT02180217|157705296|FG001|Overall Study|Death|1|||
48966651|NCT02180217|157705297|FG002|Overall Study|Death|0|||
48966652|NCT02180217|157705295|FG000|Overall Study|Withdrawal by Subject|1|||
48757401|NCT02677922|156958251|FG003|Treatment Period|Physician Decision|0|||
48966653|NCT02180217|157705296|FG001|Overall Study|Withdrawal by Subject|1|||
48966654|NCT02180217|157705297|FG002|Overall Study|Withdrawal by Subject|4|||
48966655|NCT02180217|157705295|FG000|Overall Study|Subject/Guardian decision|5|||
48966656|NCT02180217|157705296|FG001|Overall Study|Subject/Guardian decision|3|||
48966657|NCT02180217|157705297|FG002|Overall Study|Subject/Guardian decision|6|||
48966658|NCT02180217|157705295|FG000|Overall Study|Physician Decision|1|||
48664757|NCT00149994|156626915|FG001|Overall Study|Administrative problems:|0|||
48664758|NCT00149994|156626914|FG000|Overall Study|Protocol Violation|0|||
48664759|NCT00149994|156626915|FG001|Overall Study|Protocol Violation|1|||
48664760|NCT00098722|156626916|FG000|Double Blind Phase|Adverse Event|7|||
48664761|NCT00098722|156626917|FG001|Double Blind Phase|Adverse Event|7|||
48664762|NCT00098722|156626918|FG002|Double Blind Phase|Adverse Event|3|||
48664763|NCT00098722|156626919|FG003|Double Blind Phase|Adverse Event|0|||
48664764|NCT00098722|156626920|FG004|Double Blind Phase|Adverse Event|0|||
48664765|NCT00098722|156626921|FG005|Double Blind Phase|Adverse Event|0|||
48664766|NCT00098722|156626922|FG006|Double Blind Phase|Adverse Event|0|||
48664767|NCT00098722|156626916|FG000|Double Blind Phase|Death|2|||
48664768|NCT00098722|156626917|FG001|Double Blind Phase|Death|5|||
48664769|NCT00098722|156626918|FG002|Double Blind Phase|Death|0|||
48664770|NCT00098722|156626919|FG003|Double Blind Phase|Death|0|||
48664771|NCT00098722|156626920|FG004|Double Blind Phase|Death|0|||
48664772|NCT00098722|156626921|FG005|Double Blind Phase|Death|0|||
48664773|NCT00098722|156626922|FG006|Double Blind Phase|Death|0|||
48664774|NCT00098722|156626916|FG000|Double Blind Phase|Lack of Efficacy|21|||
48664775|NCT00098722|156626917|FG001|Double Blind Phase|Lack of Efficacy|23|||
48757402|NCT02677922|156958252|FG004|Treatment Period|Physician Decision|0|||
48757403|NCT02677922|156958253|FG005|Treatment Period|Physician Decision|1|||
48757404|NCT02677922|156958248|FG000|Treatment Period|Symptomatic Deterioration|0|||
48966659|NCT02180217|157705296|FG001|Overall Study|Physician Decision|1|||
48966660|NCT02180217|157705297|FG002|Overall Study|Physician Decision|6|||
48966661|NCT02180217|157705295|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
48966662|NCT02180217|157705296|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
48664776|NCT00098722|156626918|FG002|Double Blind Phase|Lack of Efficacy|15|||
48664777|NCT00098722|156626919|FG003|Double Blind Phase|Lack of Efficacy|0|||
48664778|NCT00098722|156626920|FG004|Double Blind Phase|Lack of Efficacy|0|||
48664779|NCT00098722|156626921|FG005|Double Blind Phase|Lack of Efficacy|0|||
48664780|NCT00098722|156626922|FG006|Double Blind Phase|Lack of Efficacy|0|||
48664781|NCT00098722|156626916|FG000|Double Blind Phase|Participant defaulted|16|||
48664782|NCT00098722|156626917|FG001|Double Blind Phase|Participant defaulted|11|||
48664783|NCT00098722|156626918|FG002|Double Blind Phase|Participant defaulted|9|||
48757405|NCT02677922|156958249|FG001|Treatment Period|Symptomatic Deterioration|0|||
48757406|NCT02677922|156958250|FG002|Treatment Period|Symptomatic Deterioration|0|||
48757407|NCT02677922|156958251|FG003|Treatment Period|Symptomatic Deterioration|0|||
48757408|NCT02677922|156958252|FG004|Treatment Period|Symptomatic Deterioration|1|||
48966663|NCT02180217|157705297|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
48664784|NCT00098722|156626919|FG003|Double Blind Phase|Participant defaulted|0|||
48966664|NCT02721251|157705298|FG000|Overall Study|Withdrawal by Subject|8|||
48966665|NCT02721251|157705299|FG001|Overall Study|Withdrawal by Subject|7|||
48966666|NCT02721251|157705300|FG002|Overall Study|Withdrawal by Subject|9|||
48966667|NCT02721251|157705298|FG000|Overall Study|poor adherence|2|||
48966668|NCT02721251|157705299|FG001|Overall Study|poor adherence|2|||
48966669|NCT02721251|157705300|FG002|Overall Study|poor adherence|2|||
48966670|NCT01714817|157705301|FG000|Year 1 Period|Lack of Efficacy|11|||
48966671|NCT01714817|157705302|FG001|Year 1 Period|Lack of Efficacy|9|||
48966672|NCT01714817|157705301|FG000|Year 1 Period|Adverse Event|20|||
48966673|NCT01714817|157705302|FG001|Year 1 Period|Adverse Event|17|||
48966674|NCT01714817|157705301|FG000|Year 1 Period|Withdrawal by Subject|6|||
48966675|NCT01714817|157705302|FG001|Year 1 Period|Withdrawal by Subject|7|||
48966676|NCT01714817|157705301|FG000|Year 1 Period|Death|1|||
48966677|NCT01714817|157705302|FG001|Year 1 Period|Death|1|||
48966678|NCT01714817|157705301|FG000|Year 1 Period|Lost to Follow-up|0|||
48664785|NCT00098722|156626920|FG004|Double Blind Phase|Participant defaulted|0|||
48966679|NCT01714817|157705302|FG001|Year 1 Period|Lost to Follow-up|2|||
48966680|NCT01714817|157705301|FG000|Year 1 Period|Poor / non-compliance|0|||
48966681|NCT01714817|157705302|FG001|Year 1 Period|Poor / non-compliance|1|||
48966682|NCT01714817|157705301|FG000|Year 1 Period|Pregnancy|2|||
48966683|NCT01714817|157705302|FG001|Year 1 Period|Pregnancy|0|||
48966684|NCT01714817|157705301|FG000|Year 1 Period|Participant no longer meets criteria|6|||
48966685|NCT01714817|157705302|FG001|Year 1 Period|Participant no longer meets criteria|2|||
48966686|NCT01714817|157705301|FG000|Year 1 Period|Not treated- received ACE inhibition|1|||
48966687|NCT01714817|157705302|FG001|Year 1 Period|Not treated- received ACE inhibition|0|||
48966688|NCT01714817|157705301|FG000|Year 1 Period|Change in Concomitant Medication|0|||
48966689|NCT01714817|157705302|FG001|Year 1 Period|Change in Concomitant Medication|1|||
48966690|NCT01714817|157705301|FG000|Year 1 Period|Need of use of Prohibited Medications|1|||
48966691|NCT01714817|157705302|FG001|Year 1 Period|Need of use of Prohibited Medications|0|||
48966692|NCT01714817|157705301|FG000|Year 1 Period|Antiproteinuric changed/dose increased|0|||
48966693|NCT01714817|157705302|FG001|Year 1 Period|Antiproteinuric changed/dose increased|1|||
48966694|NCT01714817|157705301|FG000|Year 1 Period|Hypersensitivity to the medication|0|||
48966695|NCT01714817|157705302|FG001|Year 1 Period|Hypersensitivity to the medication|1|||
48966696|NCT01714817|157705301|FG000|Year 2 Period|Lack of Efficacy|4|||
48966697|NCT01714817|157705302|FG001|Year 2 Period|Lack of Efficacy|12|||
48966698|NCT01714817|157705301|FG000|Year 2 Period|Adverse Event|7|||
48966699|NCT01714817|157705302|FG001|Year 2 Period|Adverse Event|6|||
48966700|NCT01714817|157705301|FG000|Year 2 Period|Participant request to stop treatment|4|||
48966701|NCT01714817|157705302|FG001|Year 2 Period|Participant request to stop treatment|4|||
48966702|NCT01714817|157705301|FG000|Year 2 Period|Administrative reason by Sponsor|4|||
48966703|NCT01714817|157705302|FG001|Year 2 Period|Administrative reason by Sponsor|3|||
48966704|NCT01714817|157705301|FG000|Year 2 Period|Participant withdrew consent|1|||
48966705|NCT01714817|157705302|FG001|Year 2 Period|Participant withdrew consent|5|||
48966706|NCT01714817|157705301|FG000|Year 2 Period|Participant no longer meets criteria|1|||
48966707|NCT01714817|157705302|FG001|Year 2 Period|Participant no longer meets criteria|4|||
48966708|NCT01714817|157705301|FG000|Year 2 Period|Lost to Follow-up|2|||
48966709|NCT01714817|157705302|FG001|Year 2 Period|Lost to Follow-up|0|||
48966710|NCT01714817|157705301|FG000|Year 2 Period|Participant went to US stopped treatment|0|||
48966711|NCT01714817|157705302|FG001|Year 2 Period|Participant went to US stopped treatment|1|||
48966712|NCT01714817|157705301|FG000|Year 2 Period|Pregnancy|1|||
48966713|NCT01714817|157705302|FG001|Year 2 Period|Pregnancy|1|||
48966714|NCT01714817|157705301|FG000|Year 2 Period|Completed Year 1, did not enter Year 2|2|||
48664786|NCT00098722|156626921|FG005|Double Blind Phase|Participant defaulted|0|||
48664787|NCT00098722|156626922|FG006|Double Blind Phase|Participant defaulted|0|||
48664788|NCT00098722|156626916|FG000|Double Blind Phase|Pregnancy|1|||
48664789|NCT00098722|156626917|FG001|Double Blind Phase|Pregnancy|0|||
48664790|NCT00098722|156626918|FG002|Double Blind Phase|Pregnancy|0|||
48664791|NCT00098722|156626919|FG003|Double Blind Phase|Pregnancy|0|||
48664792|NCT00098722|156626920|FG004|Double Blind Phase|Pregnancy|0|||
48664793|NCT00098722|156626921|FG005|Double Blind Phase|Pregnancy|0|||
48664794|NCT00098722|156626922|FG006|Double Blind Phase|Pregnancy|0|||
48757409|NCT02677922|156958253|FG005|Treatment Period|Symptomatic Deterioration|0|||
48966715|NCT01714817|157705302|FG001|Year 2 Period|Completed Year 1, did not enter Year 2|1|||
48966716|NCT01714817|157705301|FG000|Year 2 Period|Given cyclophosphamide, corticosteroids|0|||
48966717|NCT01714817|157705302|FG001|Year 2 Period|Given cyclophosphamide, corticosteroids|1|||
48966718|NCT01714817|157705301|FG000|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27|||
48966719|NCT01714817|157705302|FG001|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21|||
48966720|NCT01714817|157705301|FG000|Long-Term Extension (LTE) Period|Disease progression|1|||
48966721|NCT01714817|157705302|FG001|Long-Term Extension (LTE) Period|Disease progression|4|||
48966722|NCT01714817|157705301|FG000|Long-Term Extension (LTE) Period|Not effective|0|||
48966723|NCT01714817|157705302|FG001|Long-Term Extension (LTE) Period|Not effective|1|||
48966724|NCT01714817|157705301|FG000|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
48966725|NCT01714817|157705302|FG001|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
48757410|NCT01782664|156958262|FG000|Overall Study|Adverse Event|2|||
48757411|NCT01782664|156958263|FG001|Overall Study|Adverse Event|2|||
48757412|NCT01782664|156958264|FG002|Overall Study|Adverse Event|2|||
48757413|NCT01782664|156958265|FG003|Overall Study|Adverse Event|2|||
48757414|NCT01782664|156958266|FG004|Overall Study|Adverse Event|0|||
48757415|NCT01782664|156958267|FG005|Overall Study|Adverse Event|0|||
48757416|NCT01782664|156958262|FG000|Overall Study|Lack of Efficacy|2|||
48757417|NCT01782664|156958263|FG001|Overall Study|Lack of Efficacy|0|||
48757418|NCT01782664|156958264|FG002|Overall Study|Lack of Efficacy|2|||
48757419|NCT01782664|156958265|FG003|Overall Study|Lack of Efficacy|2|||
48757420|NCT01782664|156958266|FG004|Overall Study|Lack of Efficacy|0|||
48757421|NCT01782664|156958267|FG005|Overall Study|Lack of Efficacy|0|||
48757422|NCT01782664|156958262|FG000|Overall Study|Protocol Violation|0|||
48757423|NCT01782664|156958263|FG001|Overall Study|Protocol Violation|1|||
48757424|NCT01782664|156958264|FG002|Overall Study|Protocol Violation|0|||
48757425|NCT01782664|156958265|FG003|Overall Study|Protocol Violation|1|||
48757426|NCT01782664|156958266|FG004|Overall Study|Protocol Violation|0|||
48757427|NCT01782664|156958267|FG005|Overall Study|Protocol Violation|0|||
48757428|NCT01782664|156958262|FG000|Overall Study|Withdrawal by Subject|2|||
48757429|NCT01782664|156958263|FG001|Overall Study|Withdrawal by Subject|2|||
48867641|NCT02469077|157351902|FG000|Post Randomization/Intervention Period|Conflicting health issues|0|||
48867642|NCT02469077|157351903|FG001|Post Randomization/Intervention Period|Conflicting health issues|1|||
48867643|NCT02469077|157351902|FG000|Post Intervention /Followup|Withdrawal by Subject|2|||
49015458|NCT01393990|157893772|FG002|Overall Study|Progressive Disease|0|||
48664795|NCT00098722|156626916|FG000|Double Blind Phase|Randomized, not treated|4|||
48664796|NCT00098722|156626917|FG001|Double Blind Phase|Randomized, not treated|3|||
48664797|NCT00098722|156626918|FG002|Double Blind Phase|Randomized, not treated|3|||
48664798|NCT00098722|156626919|FG003|Double Blind Phase|Randomized, not treated|0|||
48664799|NCT00098722|156626920|FG004|Double Blind Phase|Randomized, not treated|0|||
48664800|NCT00098722|156626921|FG005|Double Blind Phase|Randomized, not treated|0|||
48664801|NCT00098722|156626922|FG006|Double Blind Phase|Randomized, not treated|0|||
48664802|NCT00098722|156626916|FG000|Double Blind Phase|Ongoing at cut-off date|128|||
48664803|NCT00098722|156626917|FG001|Double Blind Phase|Ongoing at cut-off date|137|||
48664804|NCT00098722|156626918|FG002|Double Blind Phase|Ongoing at cut-off date|57|||
48664805|NCT00098722|156626919|FG003|Double Blind Phase|Ongoing at cut-off date|0|||
48664806|NCT00098722|156626920|FG004|Double Blind Phase|Ongoing at cut-off date|0|||
48664807|NCT00098722|156626921|FG005|Double Blind Phase|Ongoing at cut-off date|0|||
48664808|NCT00098722|156626922|FG006|Double Blind Phase|Ongoing at cut-off date|0|||
48664809|NCT00098722|156626916|FG000|Double Blind Phase|Other|7|||
48664810|NCT00098722|156626917|FG001|Double Blind Phase|Other|8|||
48664811|NCT00098722|156626918|FG002|Double Blind Phase|Other|7|||
48664812|NCT00098722|156626919|FG003|Double Blind Phase|Other|0|||
48664813|NCT00098722|156626920|FG004|Double Blind Phase|Other|0|||
48664814|NCT00098722|156626921|FG005|Double Blind Phase|Other|0|||
48664815|NCT00098722|156626922|FG006|Double Blind Phase|Other|0|||
48664816|NCT00098722|156626916|FG000|Open Label Phase|Adverse Event|0|||
48664817|NCT00098722|156626917|FG001|Open Label Phase|Adverse Event|0|||
48664818|NCT00098722|156626918|FG002|Open Label Phase|Adverse Event|0|||
48664819|NCT00098722|156626919|FG003|Open Label Phase|Adverse Event|5|||
48664820|NCT00098722|156626920|FG004|Open Label Phase|Adverse Event|0|||
48664821|NCT00098722|156626921|FG005|Open Label Phase|Adverse Event|0|||
48664822|NCT00098722|156626922|FG006|Open Label Phase|Adverse Event|0|||
48664823|NCT00098722|156626916|FG000|Open Label Phase|Death|0|||
48664824|NCT00098722|156626917|FG001|Open Label Phase|Death|0|||
48664825|NCT00098722|156626918|FG002|Open Label Phase|Death|0|||
48664826|NCT00098722|156626919|FG003|Open Label Phase|Death|2|||
48664827|NCT00098722|156626920|FG004|Open Label Phase|Death|0|||
48757430|NCT01782664|156958264|FG002|Overall Study|Withdrawal by Subject|0|||
48757431|NCT01782664|156958265|FG003|Overall Study|Withdrawal by Subject|0|||
48757432|NCT01782664|156958266|FG004|Overall Study|Withdrawal by Subject|0|||
48757433|NCT01782664|156958267|FG005|Overall Study|Withdrawal by Subject|0|||
48867644|NCT02469077|157351903|FG001|Post Intervention /Followup|Withdrawal by Subject|1|||
48867645|NCT02995733|157351904|FG000|Overall Study|Study site closed|9|||
48867646|NCT02995733|157351905|FG001|Overall Study|Study site closed|10|||
48867647|NCT02995733|157351904|FG000|Overall Study|Death|3|||
48867648|NCT02995733|157351905|FG001|Overall Study|Death|4|||
48867649|NCT02995733|157351904|FG000|Overall Study|Withdrawal by Subject|6|||
48867650|NCT02995733|157351905|FG001|Overall Study|Withdrawal by Subject|2|||
48664828|NCT00098722|156626921|FG005|Open Label Phase|Death|0|||
48664829|NCT00098722|156626922|FG006|Open Label Phase|Death|0|||
48664830|NCT00098722|156626916|FG000|Open Label Phase|Lack of Efficacy|0|||
48664831|NCT00098722|156626917|FG001|Open Label Phase|Lack of Efficacy|0|||
48664832|NCT00098722|156626918|FG002|Open Label Phase|Lack of Efficacy|0|||
48664833|NCT00098722|156626919|FG003|Open Label Phase|Lack of Efficacy|8|||
48664834|NCT00098722|156626920|FG004|Open Label Phase|Lack of Efficacy|0|||
48664835|NCT00098722|156626921|FG005|Open Label Phase|Lack of Efficacy|0|||
48664836|NCT00098722|156626922|FG006|Open Label Phase|Lack of Efficacy|0|||
48664837|NCT00098722|156626916|FG000|Open Label Phase|Pregnancy|0|||
48757434|NCT00529542|156958268|FG000|Overall Study|Withdrawal by Subject|1|||
48966726|NCT01714817|157705301|FG000|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
48966727|NCT01714817|157705302|FG001|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
48966728|NCT01714817|157705301|FG000|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1|||
48966729|NCT01714817|157705302|FG001|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0|||
48664838|NCT00098722|156626917|FG001|Open Label Phase|Pregnancy|0|||
48664839|NCT00098722|156626918|FG002|Open Label Phase|Pregnancy|0|||
48664840|NCT00098722|156626919|FG003|Open Label Phase|Pregnancy|1|||
48664841|NCT00098722|156626920|FG004|Open Label Phase|Pregnancy|0|||
48664842|NCT00098722|156626921|FG005|Open Label Phase|Pregnancy|0|||
48966730|NCT01714817|157705301|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
48966731|NCT01714817|157705302|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
48966732|NCT01714817|157705301|FG000|Long-Term Extension (LTE) Period|Pregnancy|1|||
48966733|NCT01714817|157705302|FG001|Long-Term Extension (LTE) Period|Pregnancy|0|||
48966734|NCT01714817|157705301|FG000|Long-Term Extension (LTE) Period|Study drug toxicity|1|||
48966735|NCT01714817|157705302|FG001|Long-Term Extension (LTE) Period|Study drug toxicity|0|||
48966736|NCT01714817|157705301|FG000|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1|||
48966737|NCT01714817|157705302|FG001|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0|||
48966738|NCT01714817|157705301|FG000|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33|||
48966739|NCT01714817|157705302|FG001|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38|||
48966740|NCT01714817|157705301|FG000|Long-Term Extension (LTE) Period|Absence of renal response|0|||
48966741|NCT01714817|157705302|FG001|Long-Term Extension (LTE) Period|Absence of renal response|1|||
48966742|NCT01714817|157705301|FG000|Long-Term Extension (LTE) Period|Investigator decision, study termination|0|||
48966743|NCT01714817|157705302|FG001|Long-Term Extension (LTE) Period|Investigator decision, study termination|1|||
48966744|NCT01714817|157705301|FG000|Long-Term Extension (LTE) Period|Study was terminated|0|||
48966745|NCT01714817|157705302|FG001|Long-Term Extension (LTE) Period|Study was terminated|1|||
48966746|NCT00642018|157705303|FG000|Overall Study|Adverse Event|11|||
48966747|NCT00642018|157705304|FG001|Overall Study|Adverse Event|36|||
48966748|NCT00642018|157705303|FG000|Overall Study|Withdrawal by Subject|4|||
48966749|NCT00642018|157705304|FG001|Overall Study|Withdrawal by Subject|10|||
48966750|NCT00642018|157705303|FG000|Overall Study|Progressive Disease|13|||
48664843|NCT00098722|156626922|FG006|Open Label Phase|Pregnancy|0|||
48664844|NCT00098722|156626916|FG000|Open Label Phase|Participant defaulted|0|||
48664845|NCT00098722|156626917|FG001|Open Label Phase|Participant defaulted|0|||
48664846|NCT00098722|156626918|FG002|Open Label Phase|Participant defaulted|0|||
48664847|NCT00098722|156626919|FG003|Open Label Phase|Participant defaulted|18|||
48664848|NCT00098722|156626920|FG004|Open Label Phase|Participant defaulted|0|||
48664849|NCT00098722|156626921|FG005|Open Label Phase|Participant defaulted|0|||
48966751|NCT00642018|157705304|FG001|Overall Study|Progressive Disease|18|||
48966752|NCT00642018|157705303|FG000|Overall Study|Physician Decision|0|||
48966753|NCT00642018|157705304|FG001|Overall Study|Physician Decision|10|||
48966754|NCT00642018|157705303|FG000|Overall Study|Protocol Violation|0|||
48966755|NCT00642018|157705304|FG001|Overall Study|Protocol Violation|1|||
48966756|NCT00642018|157705303|FG000|Overall Study|Death|0|||
48966757|NCT00642018|157705304|FG001|Overall Study|Death|3|||
48966758|NCT00642018|157705303|FG000|Overall Study|Entry Criteria Not Met|0|||
48966759|NCT00642018|157705304|FG001|Overall Study|Entry Criteria Not Met|1|||
48966760|NCT05200455|157705305|FG000|Overall Study|These patients were not implanted with intracranial electrodes for clinical reasons .|4|||
48966761|NCT02555657|157705306|FG000|Overall Study|Death|274|||
48966762|NCT02555657|157705307|FG001|Overall Study|Death|262|||
48664850|NCT00098722|156626922|FG006|Open Label Phase|Participant defaulted|0|||
48664851|NCT00098722|156626916|FG000|Open Label Phase|Ongoing at cut-off date|0|||
48664852|NCT00098722|156626917|FG001|Open Label Phase|Ongoing at cut-off date|0|||
48664853|NCT00098722|156626918|FG002|Open Label Phase|Ongoing at cut-off date|0|||
48664854|NCT00098722|156626919|FG003|Open Label Phase|Ongoing at cut-off date|220|||
48664855|NCT00098722|156626920|FG004|Open Label Phase|Ongoing at cut-off date|50|||
48664856|NCT00098722|156626921|FG005|Open Label Phase|Ongoing at cut-off date|0|||
48664857|NCT00098722|156626922|FG006|Open Label Phase|Ongoing at cut-off date|0|||
48664858|NCT00098722|156626916|FG000|Open Label Phase|Other|0|||
48664859|NCT00098722|156626917|FG001|Open Label Phase|Other|0|||
48966763|NCT02555657|157705306|FG000|Overall Study|Physician Decision|0|||
48966764|NCT02555657|157705307|FG001|Overall Study|Physician Decision|1|||
48966765|NCT02555657|157705306|FG000|Overall Study|Sponsor Decision|27|||
48966766|NCT02555657|157705307|FG001|Overall Study|Sponsor Decision|15|||
48966767|NCT02555657|157705306|FG000|Overall Study|Withdrawal by Subject|11|||
48966768|NCT02555657|157705307|FG001|Overall Study|Withdrawal by Subject|32|||
48966769|NCT00966693|157705308|FG000|Overall Study|Adverse Event|0|||
48664860|NCT00098722|156626918|FG002|Open Label Phase|Other|0|||
48664861|NCT00098722|156626919|FG003|Open Label Phase|Other|18|||
48664862|NCT00098722|156626920|FG004|Open Label Phase|Other|0|||
48664863|NCT00098722|156626921|FG005|Open Label Phase|Other|0|||
48664864|NCT00098722|156626922|FG006|Open Label Phase|Other|0|||
48664865|NCT00098722|156626916|FG000|Observation Phase|Death|0|||
48664866|NCT00098722|156626917|FG001|Observation Phase|Death|0|||
48966770|NCT00966693|157705309|FG001|Overall Study|Adverse Event|0|||
48966771|NCT00966693|157705310|FG002|Overall Study|Adverse Event|1|||
48966772|NCT00966693|157705311|FG003|Overall Study|Adverse Event|2|||
48966773|NCT00966693|157705308|FG000|Overall Study|Death|0|||
48966774|NCT00966693|157705309|FG001|Overall Study|Death|0|||
48966775|NCT00966693|157705310|FG002|Overall Study|Death|1|||
48966776|NCT00966693|157705311|FG003|Overall Study|Death|0|||
48966777|NCT00966693|157705308|FG000|Overall Study|Withdrawal by Subject|1|||
48966778|NCT00966693|157705309|FG001|Overall Study|Withdrawal by Subject|0|||
48966779|NCT00966693|157705310|FG002|Overall Study|Withdrawal by Subject|0|||
48966780|NCT00966693|157705311|FG003|Overall Study|Withdrawal by Subject|5|||
48966781|NCT00966693|157705308|FG000|Overall Study|Disease Progression|0|||
48966782|NCT00966693|157705309|FG001|Overall Study|Disease Progression|0|||
48966783|NCT00966693|157705310|FG002|Overall Study|Disease Progression|1|||
48966784|NCT00966693|157705311|FG003|Overall Study|Disease Progression|16|||
48966785|NCT03136367|157705316|FG000|T1 Consultation|discontinued mistakenly included|2|||
48966786|NCT03136367|157705317|FG001|T1 Consultation|discontinued mistakenly included|6|||
48966787|NCT03136367|157705318|FG002|T1 Consultation|discontinued mistakenly included|1|||
48966788|NCT03136367|157705316|FG000|T1 Consultation|Discontinued other|0|||
48966789|NCT03136367|157705317|FG001|T1 Consultation|Discontinued other|1|||
48966790|NCT03136367|157705318|FG002|T1 Consultation|Discontinued other|0|||
48966791|NCT03136367|157705316|FG000|T2 Post-consultation|Withdrawal by Subject|1|||
48966792|NCT03136367|157705317|FG001|T2 Post-consultation|Withdrawal by Subject|1|||
48966793|NCT03136367|157705318|FG002|T2 Post-consultation|Withdrawal by Subject|5|||
48966794|NCT03136367|157705316|FG000|T2 Post-consultation|discontinued mistakenly included|2|||
48966795|NCT03136367|157705317|FG001|T2 Post-consultation|discontinued mistakenly included|2|||
48966796|NCT03136367|157705318|FG002|T2 Post-consultation|discontinued mistakenly included|17|||
48966797|NCT03136367|157705316|FG000|T2 Post-consultation|Discontinued other|0|||
48966798|NCT03136367|157705317|FG001|T2 Post-consultation|Discontinued other|2|||
48966799|NCT03136367|157705318|FG002|T2 Post-consultation|Discontinued other|6|||
48966800|NCT03136367|157705316|FG000|T2 Post-consultation|Discontinued transferred care|0|||
48966801|NCT03136367|157705317|FG001|T2 Post-consultation|Discontinued transferred care|0|||
48966802|NCT03136367|157705318|FG002|T2 Post-consultation|Discontinued transferred care|3|||
48966803|NCT03136367|157705316|FG000|T2 Post-consultation|Discontinued lost contact|0|||
48966804|NCT03136367|157705317|FG001|T2 Post-consultation|Discontinued lost contact|1|||
48966805|NCT03136367|157705318|FG002|T2 Post-consultation|Discontinued lost contact|0|||
48966806|NCT03136367|157705316|FG000|T3 1 Week After Surgery|Discontinued mistakenly included|5|||
48966807|NCT03136367|157705317|FG001|T3 1 Week After Surgery|Discontinued mistakenly included|9|||
48966808|NCT03136367|157705318|FG002|T3 1 Week After Surgery|Discontinued mistakenly included|8|||
48966809|NCT03136367|157705316|FG000|T3 1 Week After Surgery|Discontinued transferred care|2|||
48966810|NCT03136367|157705317|FG001|T3 1 Week After Surgery|Discontinued transferred care|11|||
48966811|NCT03136367|157705318|FG002|T3 1 Week After Surgery|Discontinued transferred care|14|||
48966812|NCT03136367|157705316|FG000|T3 1 Week After Surgery|other discontinued|2|||
48966813|NCT03136367|157705317|FG001|T3 1 Week After Surgery|other discontinued|4|||
48966814|NCT03136367|157705318|FG002|T3 1 Week After Surgery|other discontinued|3|||
48966815|NCT03136367|157705316|FG000|T3 1 Week After Surgery|Withdrawal by Subject|0|||
48966816|NCT03136367|157705317|FG001|T3 1 Week After Surgery|Withdrawal by Subject|6|||
48966817|NCT03136367|157705318|FG002|T3 1 Week After Surgery|Withdrawal by Subject|2|||
48966818|NCT03136367|157705316|FG000|T3 1 Week After Surgery|Discontinued lost contact|1|||
48966819|NCT03136367|157705317|FG001|T3 1 Week After Surgery|Discontinued lost contact|2|||
48966820|NCT03136367|157705318|FG002|T3 1 Week After Surgery|Discontinued lost contact|4|||
48966821|NCT03136367|157705316|FG000|T4 12 Weeks After Surgery|Withdrawal by Subject|1|||
48966822|NCT03136367|157705317|FG001|T4 12 Weeks After Surgery|Withdrawal by Subject|3|||
48966823|NCT03136367|157705318|FG002|T4 12 Weeks After Surgery|Withdrawal by Subject|0|||
48966824|NCT03136367|157705316|FG000|T4 12 Weeks After Surgery|Death|0|||
48966825|NCT03136367|157705317|FG001|T4 12 Weeks After Surgery|Death|1|||
48966826|NCT03136367|157705318|FG002|T4 12 Weeks After Surgery|Death|3|||
48966827|NCT03136367|157705316|FG000|T4 12 Weeks After Surgery|discontinued lost contact|1|||
48966828|NCT03136367|157705317|FG001|T4 12 Weeks After Surgery|discontinued lost contact|0|||
48966829|NCT03136367|157705318|FG002|T4 12 Weeks After Surgery|discontinued lost contact|0|||
48966830|NCT03136367|157705316|FG000|T4 12 Weeks After Surgery|discontinued transferred care|0|||
48966831|NCT03136367|157705317|FG001|T4 12 Weeks After Surgery|discontinued transferred care|1|||
48966832|NCT03136367|157705318|FG002|T4 12 Weeks After Surgery|discontinued transferred care|5|||
48966833|NCT03136367|157705316|FG000|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
48966834|NCT03136367|157705317|FG001|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
48966835|NCT03136367|157705318|FG002|T4 12 Weeks After Surgery|discontinued mistakenly included|1|||
48966836|NCT03136367|157705316|FG000|T5 1 Year After Surgery|discontinued mistakenly included|1|||
48966837|NCT03136367|157705317|FG001|T5 1 Year After Surgery|discontinued mistakenly included|1|||
48966838|NCT03136367|157705318|FG002|T5 1 Year After Surgery|discontinued mistakenly included|1|||
48966839|NCT03136367|157705316|FG000|T5 1 Year After Surgery|Withdrawal by Subject|1|||
48966840|NCT03136367|157705317|FG001|T5 1 Year After Surgery|Withdrawal by Subject|0|||
48966841|NCT03136367|157705318|FG002|T5 1 Year After Surgery|Withdrawal by Subject|0|||
48966842|NCT03136367|157705316|FG000|T5 1 Year After Surgery|Death|0|||
48966843|NCT03136367|157705317|FG001|T5 1 Year After Surgery|Death|0|||
48664867|NCT00098722|156626918|FG002|Observation Phase|Death|0|||
48664868|NCT00098722|156626919|FG003|Observation Phase|Death|0|||
48664869|NCT00098722|156626920|FG004|Observation Phase|Death|0|||
48664870|NCT00098722|156626921|FG005|Observation Phase|Death|5|||
48664871|NCT00098722|156626922|FG006|Observation Phase|Death|3|||
48664872|NCT00098722|156626916|FG000|Observation Phase|Lack of Efficacy|0|||
48664873|NCT00098722|156626917|FG001|Observation Phase|Lack of Efficacy|0|||
48664874|NCT00098722|156626918|FG002|Observation Phase|Lack of Efficacy|0|||
48664875|NCT00098722|156626919|FG003|Observation Phase|Lack of Efficacy|0|||
48966844|NCT03136367|157705318|FG002|T5 1 Year After Surgery|Death|1|||
48966845|NCT03136367|157705316|FG000|T5 1 Year After Surgery|Discontinued lost contact|1|||
48966846|NCT03136367|157705317|FG001|T5 1 Year After Surgery|Discontinued lost contact|6|||
48966847|NCT03136367|157705318|FG002|T5 1 Year After Surgery|Discontinued lost contact|0|||
48966848|NCT03136367|157705316|FG000|T5 1 Year After Surgery|Lost to Follow-up|2|||
48966849|NCT03136367|157705317|FG001|T5 1 Year After Surgery|Lost to Follow-up|22|||
48966850|NCT03136367|157705318|FG002|T5 1 Year After Surgery|Lost to Follow-up|15|||
48966851|NCT03136367|157705316|FG000|T5 1 Year After Surgery|study ended before due|31|||
48966852|NCT03136367|157705317|FG001|T5 1 Year After Surgery|study ended before due|103|||
48966853|NCT03136367|157705318|FG002|T5 1 Year After Surgery|study ended before due|110|||
48966854|NCT03136367|157705316|FG000|T5 1 Year After Surgery|logistical issues prevented contact|0|||
48966855|NCT03136367|157705317|FG001|T5 1 Year After Surgery|logistical issues prevented contact|4|||
48966856|NCT03136367|157705318|FG002|T5 1 Year After Surgery|logistical issues prevented contact|2|||
48966857|NCT00818207|157707071|FG000|Overall Study|Adverse Event|6|||
48966858|NCT00818207|157707072|FG001|Overall Study|Adverse Event|0|||
48966859|NCT00818207|157707071|FG000|Overall Study|Lost to Follow-up|160|||
48966860|NCT00818207|157707072|FG001|Overall Study|Lost to Follow-up|146|||
48966861|NCT00818207|157707071|FG000|Overall Study|Multiple reasons|11|||
48966862|NCT00818207|157707072|FG001|Overall Study|Multiple reasons|12|||
48966863|NCT00818207|157707071|FG000|Overall Study|Withdrawal by Subject|42|||
48966864|NCT00818207|157707072|FG001|Overall Study|Withdrawal by Subject|104|||
48966865|NCT00818207|157707071|FG000|Overall Study|Death|3|||
48966866|NCT00818207|157707072|FG001|Overall Study|Death|5|||
48966867|NCT03287245|157707073|FG000|Overall Study|Study terminated by sponsor|3|||
48966868|NCT03287245|157707074|FG001|Overall Study|Study terminated by sponsor|0|||
48966869|NCT03287245|157707075|FG002|Overall Study|Study terminated by sponsor|3|||
48966870|NCT03287245|157707076|FG003|Overall Study|Study terminated by sponsor|1|||
48966871|NCT03287245|157707073|FG000|Overall Study|Adverse Event|1|||
48966872|NCT03287245|157707074|FG001|Overall Study|Adverse Event|0|||
48966873|NCT03287245|157707075|FG002|Overall Study|Adverse Event|0|||
48664876|NCT00098722|156626920|FG004|Observation Phase|Lack of Efficacy|0|||
48664877|NCT00098722|156626921|FG005|Observation Phase|Lack of Efficacy|2|||
48664878|NCT00098722|156626922|FG006|Observation Phase|Lack of Efficacy|0|||
48664879|NCT00098722|156626916|FG000|Observation Phase|Participant defaulted|0|||
48664880|NCT00098722|156626917|FG001|Observation Phase|Participant defaulted|0|||
48664881|NCT00098722|156626918|FG002|Observation Phase|Participant defaulted|0|||
48664882|NCT00098722|156626919|FG003|Observation Phase|Participant defaulted|0|||
48664883|NCT00098722|156626920|FG004|Observation Phase|Participant defaulted|0|||
48664884|NCT00098722|156626921|FG005|Observation Phase|Participant defaulted|17|||
48664885|NCT00098722|156626922|FG006|Observation Phase|Participant defaulted|4|||
48664886|NCT00098722|156626916|FG000|Observation Phase|Other|0|||
48664887|NCT00098722|156626917|FG001|Observation Phase|Other|0|||
48757435|NCT00529542|156958269|FG001|Overall Study|Withdrawal by Subject|0|||
48966874|NCT03287245|157707076|FG003|Overall Study|Adverse Event|0|||
48966875|NCT03287245|157707073|FG000|Overall Study|Withdrawal by Subject|8|||
48966876|NCT03287245|157707074|FG001|Overall Study|Withdrawal by Subject|3|||
48966877|NCT03287245|157707075|FG002|Overall Study|Withdrawal by Subject|3|||
48966878|NCT03287245|157707076|FG003|Overall Study|Withdrawal by Subject|0|||
48966879|NCT03287245|157707073|FG000|Overall Study|Physician Decision|3|||
48966880|NCT03287245|157707074|FG001|Overall Study|Physician Decision|2|||
48966881|NCT03287245|157707075|FG002|Overall Study|Physician Decision|0|||
48966882|NCT03287245|157707076|FG003|Overall Study|Physician Decision|0|||
48966883|NCT02586077|157707077|FG000|Overall Study|Withdrawal by Subject|1|||
48966884|NCT02586077|157707077|FG000|Overall Study|Physician Decision|4|||
48664888|NCT00098722|156626918|FG002|Observation Phase|Other|0|||
48664889|NCT00098722|156626919|FG003|Observation Phase|Other|0|||
48966885|NCT02586077|157707077|FG000|Overall Study|Lost to Follow-up|3|||
48966886|NCT04031404|157707078|FG000|Baseline|Lost to Follow-up|0|||
48966887|NCT04031404|157707079|FG001|Baseline|Lost to Follow-up|1|||
48664890|NCT00098722|156626920|FG004|Observation Phase|Other|0|||
48664891|NCT00098722|156626921|FG005|Observation Phase|Other|21|||
48664892|NCT00098722|156626922|FG006|Observation Phase|Other|10|||
48664893|NCT00934947|156626923|FG000|Overall Study|Adverse Event|0|||
48664894|NCT00934947|156626924|FG001|Overall Study|Adverse Event|2|||
48664895|NCT01342965|156626925|FG000|Overall Study|Death|58|||
48664896|NCT01342965|156626926|FG001|Overall Study|Death|57|||
48664897|NCT01342965|156626925|FG000|Overall Study|Lost to Follow-up|5|||
48664898|NCT01342965|156626926|FG001|Overall Study|Lost to Follow-up|3|||
48664899|NCT01342965|156626925|FG000|Overall Study|Other Reasons- Unspecified|44|||
48664900|NCT01342965|156626926|FG001|Overall Study|Other Reasons- Unspecified|38|||
48664901|NCT01342965|156626925|FG000|Overall Study|Withdrawal by Subject|2|||
48664902|NCT01342965|156626926|FG001|Overall Study|Withdrawal by Subject|9|||
48664903|NCT00623545|156626927|FG000|Overall Study|Adverse Event|6|||
48757436|NCT00529542|156958268|FG000|Overall Study|Lost to Follow-up|0|||
48757437|NCT00529542|156958269|FG001|Overall Study|Lost to Follow-up|1|||
48757438|NCT00501293|156960714|FG000|Optimization Period|Enrolled in error|1|||
48757439|NCT00501293|156960715|FG001|Optimization Period|Enrolled in error|0|||
48757440|NCT00501293|156960714|FG000|Maintenance Period|Withdrawal by Subject|14|||
48757441|NCT00501293|156960715|FG001|Maintenance Period|Withdrawal by Subject|13|||
48757442|NCT00501293|156960714|FG000|Maintenance Period|Lost to Follow-up|12|||
48966888|NCT04031404|157707078|FG000|Baseline|Did not meet full inclusion/exclusion.|2|||
48664904|NCT00623545|156626927|FG000|Overall Study|Withdrawal by Subject|4|||
48664905|NCT01804582|156626929|FG000|Overall Study|Lost to Follow-up|47|||
48664906|NCT01804582|156626930|FG001|Overall Study|Lost to Follow-up|56|||
48664907|NCT01804582|156626929|FG000|Overall Study|Physician Decision|2|||
48664908|NCT01804582|156626930|FG001|Overall Study|Physician Decision|0|||
48664909|NCT00919867|156626931|FG000|First Intervention|Withdrawal by Subject|0|||
48757443|NCT00501293|156960715|FG001|Maintenance Period|Lost to Follow-up|7|||
48867651|NCT02995733|157351904|FG000|Overall Study|Removed by study team due to inappropriate behavior|1|||
48664910|NCT00919867|156626932|FG001|First Intervention|Withdrawal by Subject|0|||
48664911|NCT00919867|156626933|FG002|First Intervention|Withdrawal by Subject|1|||
48664912|NCT00919867|156626934|FG003|First Intervention|Withdrawal by Subject|0|||
48664913|NCT00919867|156626935|FG004|First Intervention|Withdrawal by Subject|0|||
48664914|NCT00919867|156626936|FG005|First Intervention|Withdrawal by Subject|0|||
48664915|NCT00919867|156626931|FG000|First Intervention|Physician Decision|0|||
48664916|NCT00919867|156626932|FG001|First Intervention|Physician Decision|0|||
48664917|NCT00919867|156626933|FG002|First Intervention|Physician Decision|0|||
48664918|NCT00919867|156626934|FG003|First Intervention|Physician Decision|0|||
48664919|NCT00919867|156626935|FG004|First Intervention|Physician Decision|0|||
48664920|NCT00919867|156626936|FG005|First Intervention|Physician Decision|1|||
48664921|NCT04962230|156626937|FG000|Carbamazepine+PF-07321332/Ritonavir|Withdrawal by Subject|1|||
48664922|NCT04962230|156626937|FG000|Carbamazepine+PF-07321332/Ritonavir|Adverse Event|1|||
48757444|NCT00501293|156960714|FG000|Maintenance Period|Adverse Event|6|||
48757445|NCT00501293|156960715|FG001|Maintenance Period|Adverse Event|6|||
48867652|NCT02995733|157351905|FG001|Overall Study|Removed by study team due to inappropriate behavior|0|||
48867653|NCT02995733|157351904|FG000|Overall Study|Lost to Follow-up|48|||
48867654|NCT02995733|157351905|FG001|Overall Study|Lost to Follow-up|37|||
48867655|NCT02995733|157351904|FG000|Overall Study|Other|0|||
48867656|NCT02995733|157351905|FG001|Overall Study|Other|1|||
48867657|NCT01287416|157351908|FG000|Pre-post Training|Withdrawal by Subject|17|||
48867658|NCT01287416|157351909|FG001|Pre-post Training|Withdrawal by Subject|24|||
48867659|NCT01287416|157351908|FG000|Pre-post Training|Lost to Follow-up|5|||
48867660|NCT01287416|157351909|FG001|Pre-post Training|Lost to Follow-up|1|||
48867661|NCT01287416|157351908|FG000|6 Month Follow-up|Lost to Follow-up|3|||
48867662|NCT01287416|157351909|FG001|6 Month Follow-up|Lost to Follow-up|2|||
48867663|NCT02864342|157351910|FG000|Overall Study|Eligibility Criteria Deviation|2|||
48867664|NCT02864342|157351911|FG001|Overall Study|Eligibility Criteria Deviation|3|||
48867665|NCT02864342|157351910|FG000|Overall Study|Withdrawal by Subject|4|||
48867666|NCT02864342|157351911|FG001|Overall Study|Withdrawal by Subject|2|||
48867667|NCT02864342|157351910|FG000|Overall Study|Device Technology Issue|6|||
48867668|NCT02864342|157351911|FG001|Overall Study|Device Technology Issue|7|||
48867669|NCT02864342|157351910|FG000|Overall Study|Death|0|||
48867670|NCT02864342|157351911|FG001|Overall Study|Death|1|||
48867671|NCT02864342|157351910|FG000|Overall Study|Did Not Start Treatment with Symbicort|0|||
48867672|NCT02864342|157351911|FG001|Overall Study|Did Not Start Treatment with Symbicort|1|||
48867673|NCT02864342|157351910|FG000|Overall Study|Lost to Follow-up|1|||
48867674|NCT02864342|157351911|FG001|Overall Study|Lost to Follow-up|5|||
48867675|NCT02864342|157351910|FG000|Overall Study|Lost Device|1|||
48867676|NCT02864342|157351911|FG001|Overall Study|Lost Device|0|||
48867677|NCT02864342|157351910|FG000|Overall Study|Adverse Event|1|||
48867678|NCT02864342|157351911|FG001|Overall Study|Adverse Event|0|||
48867679|NCT01424189|157351915|FG000|Overall Study|Adverse Event|1|||
48867680|NCT01424189|157351916|FG001|Overall Study|Adverse Event|0|||
48867681|NCT01424189|157351915|FG000|Overall Study|Lost to Follow-up|4|||
48867682|NCT01424189|157351916|FG001|Overall Study|Lost to Follow-up|1|||
48867683|NCT01424189|157351915|FG000|Overall Study|Withdrawal by Subject|4|||
48966889|NCT04031404|157707079|FG001|Baseline|Did not meet full inclusion/exclusion.|4|||
48867684|NCT01424189|157351916|FG001|Overall Study|Withdrawal by Subject|4|||
48867685|NCT01424189|157351915|FG000|Overall Study|Subject moved|1|||
48867686|NCT01424189|157351916|FG001|Overall Study|Subject moved|0|||
48867687|NCT01424189|157351915|FG000|Overall Study|Death|3|||
48867688|NCT01424189|157351916|FG001|Overall Study|Death|1|||
48867689|NCT04688086|157351917|FG000|Overall Study|Lost to Follow-up|164|||
48664923|NCT02969590|156626938|FG000|Screening Period|Hormones not suppressed post Lupron|1|||
48664924|NCT02969590|156626939|FG001|Screening Period|Hormones not suppressed post Lupron|0|||
48664925|NCT02969590|156626940|FG002|Screening Period|Hormones not suppressed post Lupron|0|||
48664926|NCT01149486|156626941|FG000|First Intervention|Adverse Event|0|||
48664927|NCT01149486|156626942|FG001|First Intervention|Adverse Event|1|||
48664928|NCT03630302|156626946|FG000|Surgery|hardware issue prevented LFP recordings|1|||
48664929|NCT03630302|156626946|FG000|3 Month Visit|Adverse Event|2|||
48664930|NCT03630302|156626946|FG000|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2|||
48664931|NCT00681564|156626947|FG000|Overall Study|Lost to Follow-up|6|||
48664932|NCT00681564|156626948|FG001|Overall Study|Lost to Follow-up|6|||
48664933|NCT00681564|156626947|FG000|Overall Study|Withdrawal by Subject|0|||
48664934|NCT00681564|156626948|FG001|Overall Study|Withdrawal by Subject|1|||
48664935|NCT00681564|156626947|FG000|Overall Study|Death|0|||
48664936|NCT00681564|156626948|FG001|Overall Study|Death|1|||
48664937|NCT01135914|156626949|FG000|Overall Study|Withdrawal by Subject|1|||
48664938|NCT01135914|156626950|FG001|Overall Study|Withdrawal by Subject|3|||
48664939|NCT01135914|156626951|FG002|Overall Study|Withdrawal by Subject|6|||
48664940|NCT01135914|156626949|FG000|Overall Study|Lost to Follow-up|1|||
48664941|NCT01135914|156626950|FG001|Overall Study|Lost to Follow-up|0|||
48966890|NCT04031404|157707078|FG000|Pre-randomization|Withdrawn for COVID19 precautions|1|||
48966891|NCT04031404|157707079|FG001|Pre-randomization|Withdrawn for COVID19 precautions|3|||
48966892|NCT04031404|157707078|FG000|Pre-randomization|Disqualified by TMS safety screening|1|||
48966893|NCT04031404|157707079|FG001|Pre-randomization|Disqualified by TMS safety screening|0|||
48966894|NCT04031404|157707078|FG000|Washout (5 Day Min)|Lost to Follow-up|1|||
48966895|NCT04031404|157707079|FG001|Washout (5 Day Min)|Lost to Follow-up|0|||
48966896|NCT02701192|157707080|FG000|Overall Study|Protocol Violation|2|||
48966897|NCT02701192|157707080|FG000|Overall Study|Lost to Follow-up|4|||
48966898|NCT02924688|157707084|FG000|Overall Study|Adverse Event|9|||
48966899|NCT02924688|157707085|FG001|Overall Study|Adverse Event|3|||
48966900|NCT02924688|157707086|FG002|Overall Study|Adverse Event|2|||
48966901|NCT02924688|157707087|FG003|Overall Study|Adverse Event|2|||
48966902|NCT02924688|157707088|FG004|Overall Study|Adverse Event|3|||
48966903|NCT02924688|157707089|FG005|Overall Study|Adverse Event|2|||
48966904|NCT02924688|157707084|FG000|Overall Study|Lack of Efficacy|2|||
48966905|NCT02924688|157707085|FG001|Overall Study|Lack of Efficacy|3|||
48966906|NCT02924688|157707086|FG002|Overall Study|Lack of Efficacy|4|||
48966907|NCT02924688|157707087|FG003|Overall Study|Lack of Efficacy|2|||
48966908|NCT02924688|157707088|FG004|Overall Study|Lack of Efficacy|1|||
48966909|NCT02924688|157707089|FG005|Overall Study|Lack of Efficacy|1|||
48966910|NCT02924688|157707084|FG000|Overall Study|Protocol Violation|3|||
48966911|NCT02924688|157707085|FG001|Overall Study|Protocol Violation|7|||
48966912|NCT02924688|157707086|FG002|Overall Study|Protocol Violation|5|||
48966913|NCT02924688|157707087|FG003|Overall Study|Protocol Violation|6|||
48966914|NCT02924688|157707088|FG004|Overall Study|Protocol Violation|2|||
48966915|NCT02924688|157707089|FG005|Overall Study|Protocol Violation|2|||
48966916|NCT02924688|157707084|FG000|Overall Study|Protocol defined withdrawal criteria met|1|||
48966917|NCT02924688|157707085|FG001|Overall Study|Protocol defined withdrawal criteria met|0|||
48966918|NCT02924688|157707086|FG002|Overall Study|Protocol defined withdrawal criteria met|1|||
48966919|NCT02924688|157707087|FG003|Overall Study|Protocol defined withdrawal criteria met|1|||
48966920|NCT02924688|157707088|FG004|Overall Study|Protocol defined withdrawal criteria met|1|||
48966921|NCT02924688|157707089|FG005|Overall Study|Protocol defined withdrawal criteria met|0|||
48966922|NCT02924688|157707084|FG000|Overall Study|Lost to Follow-up|2|||
48966923|NCT02924688|157707085|FG001|Overall Study|Lost to Follow-up|4|||
48966924|NCT02924688|157707086|FG002|Overall Study|Lost to Follow-up|2|||
48966925|NCT02924688|157707087|FG003|Overall Study|Lost to Follow-up|4|||
48966926|NCT02924688|157707088|FG004|Overall Study|Lost to Follow-up|2|||
48966927|NCT02924688|157707089|FG005|Overall Study|Lost to Follow-up|4|||
48966928|NCT02924688|157707084|FG000|Overall Study|Physician Decision|2|||
48966929|NCT02924688|157707085|FG001|Overall Study|Physician Decision|1|||
48966930|NCT02924688|157707086|FG002|Overall Study|Physician Decision|0|||
48966931|NCT02924688|157707087|FG003|Overall Study|Physician Decision|1|||
48966932|NCT02924688|157707088|FG004|Overall Study|Physician Decision|1|||
48966933|NCT02924688|157707089|FG005|Overall Study|Physician Decision|1|||
48664942|NCT01135914|156626951|FG002|Overall Study|Lost to Follow-up|1|||
48664943|NCT01135914|156626949|FG000|Overall Study|Protocol Violation|0|||
48664944|NCT01135914|156626950|FG001|Overall Study|Protocol Violation|0|||
48664945|NCT01135914|156626951|FG002|Overall Study|Protocol Violation|3|||
48664946|NCT01135914|156626949|FG000|Overall Study|Lack of Efficacy|2|||
48664947|NCT01135914|156626950|FG001|Overall Study|Lack of Efficacy|1|||
48664948|NCT01135914|156626951|FG002|Overall Study|Lack of Efficacy|10|||
48664949|NCT01135914|156626949|FG000|Overall Study|Adverse Event|0|||
48966934|NCT02924688|157707084|FG000|Overall Study|Withdrawal by Subject|14|||
48966935|NCT02924688|157707085|FG001|Overall Study|Withdrawal by Subject|13|||
48966936|NCT02924688|157707086|FG002|Overall Study|Withdrawal by Subject|9|||
48966937|NCT02924688|157707087|FG003|Overall Study|Withdrawal by Subject|12|||
48966938|NCT02924688|157707088|FG004|Overall Study|Withdrawal by Subject|13|||
48966939|NCT02924688|157707089|FG005|Overall Study|Withdrawal by Subject|14|||
48664950|NCT01135914|156626950|FG001|Overall Study|Adverse Event|1|||
48664951|NCT01135914|156626951|FG002|Overall Study|Adverse Event|2|||
48664952|NCT02078102|156626952|FG000|Overall Study|Adverse Event|1|||
48664953|NCT02078102|156626953|FG001|Overall Study|Adverse Event|0|||
48664954|NCT02078102|156626952|FG000|Overall Study|Withdrawal by Subject|1|||
48664955|NCT02078102|156626953|FG001|Overall Study|Withdrawal by Subject|0|||
48664956|NCT02078102|156626952|FG000|Overall Study|Physician Decision|0|||
48664957|NCT02078102|156626953|FG001|Overall Study|Physician Decision|1|||
48664958|NCT03906656|156626958|FG000|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|1|||
48664959|NCT03906656|156626959|FG001|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|0|||
48664960|NCT03906656|156626958|FG000|Fitting/Assessment Prior to Home Use 1|Adverse Event|0|||
48664961|NCT03906656|156626959|FG001|Fitting/Assessment Prior to Home Use 1|Adverse Event|1|||
48664962|NCT03906656|156626958|FG000|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|0|||
48664963|NCT03906656|156626959|FG001|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|1|||
48966940|NCT02293993|157707090|FG000|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
48966941|NCT02293993|157707091|FG001|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
48664964|NCT03906656|156626958|FG000|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|0|||
48664965|NCT03906656|156626959|FG001|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|1|||
48664966|NCT03906656|156626958|FG000|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|1|||
48664967|NCT03906656|156626959|FG001|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|0|||
48757446|NCT00501293|156960714|FG000|Maintenance Period|Protocol Violation|2|||
48757447|NCT00501293|156960715|FG001|Maintenance Period|Protocol Violation|1|||
48757448|NCT00501293|156960714|FG000|Maintenance Period|Lack of Efficacy|4|||
48757449|NCT00501293|156960715|FG001|Maintenance Period|Lack of Efficacy|1|||
48664968|NCT03906656|156626958|FG000|Home Use 1 (3 Months)|Adverse Event|1|||
48664969|NCT03906656|156626959|FG001|Home Use 1 (3 Months)|Adverse Event|2|||
48757450|NCT00501293|156960714|FG000|Maintenance Period|Noncompliant with study medication|5|||
48757451|NCT00501293|156960715|FG001|Maintenance Period|Noncompliant with study medication|0|||
48757452|NCT00501293|156960714|FG000|Maintenance Period|Went into rehabilitation|1|||
48757453|NCT00501293|156960715|FG001|Maintenance Period|Went into rehabilitation|0|||
48757454|NCT00501293|156960714|FG000|Maintenance Period|Would not wear patch|1|||
48757455|NCT00501293|156960715|FG001|Maintenance Period|Would not wear patch|0|||
48757456|NCT00501293|156960714|FG000|Maintenance Period|Application site reaction|1|||
48757457|NCT00501293|156960715|FG001|Maintenance Period|Application site reaction|0|||
48757458|NCT01164956|156960718|FG000|Overall Study|Side Effects|1|||
48757459|NCT01164956|156960719|FG001|Overall Study|Side Effects|0|||
48867690|NCT04688086|157351917|FG000|Overall Study|Imaging error;|64|||
48867691|NCT00728884|157351920|FG000|Permanent Prosthesis Placement|Lost to Follow-up|13|||
48867692|NCT00728884|157351920|FG000|One Year Post Placement Follow-up|Lost to Follow-up|4|||
48867693|NCT03915951|157351921|FG000|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|25|||
48867694|NCT03915951|157351922|FG001|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|8|||
48867695|NCT03915951|157351921|FG000|Overall Study|Adverse Event|12|||
48867696|NCT03915951|157351922|FG001|Overall Study|Adverse Event|6|||
48867697|NCT03915951|157351921|FG000|Overall Study|Disease progression (radiological)|17|||
48867698|NCT03915951|157351922|FG001|Overall Study|Disease progression (radiological)|15|||
48867699|NCT03915951|157351921|FG000|Overall Study|Disease progression (clinical)|4|||
48867700|NCT03915951|157351922|FG001|Overall Study|Disease progression (clinical)|1|||
48867701|NCT03915951|157351921|FG000|Overall Study|Patient decision|0|||
48867702|NCT03915951|157351922|FG001|Overall Study|Patient decision|4|||
48867703|NCT03915951|157351921|FG000|Overall Study|Investigator decision|0|||
48867704|NCT03915951|157351922|FG001|Overall Study|Investigator decision|1|||
48867705|NCT03915951|157351921|FG000|Overall Study|Consent withdrawn|1|||
48867706|NCT03915951|157351922|FG001|Overall Study|Consent withdrawn|1|||
48867707|NCT03915951|157351921|FG000|Overall Study|Death|0|||
48867708|NCT03915951|157351922|FG001|Overall Study|Death|3|||
48867709|NCT01329419|157351923|FG000|Overall Study|Protocol Violation|235|||
48867710|NCT01592383|157351931|FG000|Overall Study|Adverse Event|1|||
48867711|NCT02930837|157351932|FG000|Overall Study|Adverse Event|6|||
48867712|NCT02930837|157351932|FG000|Overall Study|Lost to Follow-up|5|||
48867713|NCT02930837|157351932|FG000|Overall Study|Withdrawal by Subject|1|||
48867714|NCT04167085|157351933|FG000|Baseline|Withdrawal by Subject|2|||
48867715|NCT04167085|157351934|FG001|Baseline|Withdrawal by Subject|1|||
48867716|NCT04167085|157351933|FG000|Washout (1 Month)|Withdrawal by Subject|1|||
48867717|NCT04167085|157351934|FG001|Washout (1 Month)|Withdrawal by Subject|0|||
48867718|NCT05970861|157351948|FG000|Overall Study|Physician Decision|4|||
48867719|NCT05970861|157351949|FG001|Overall Study|Physician Decision|4|||
48867720|NCT05970861|157351948|FG000|Overall Study|Lost to Follow-up|4|||
48867721|NCT05970861|157351949|FG001|Overall Study|Lost to Follow-up|3|||
48867722|NCT03282799|157351952|FG000|Overall Study|Pregnancy|1|||
48867723|NCT03282799|157351953|FG001|Overall Study|Pregnancy|0|||
48867724|NCT03282799|157351952|FG000|Overall Study|Physician Decision|1|||
48867725|NCT03282799|157351953|FG001|Overall Study|Physician Decision|0|||
48867726|NCT05451693|157351959|FG000|Overall Study|Withdrawal by Subject|1|||
48966942|NCT02293993|157707092|FG002|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
48966943|NCT02293993|157707093|FG003|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
48966944|NCT02293993|157707090|FG000|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
48966945|NCT02293993|157707091|FG001|Course ≥2 (Extended Treatment Period)|Physician Decision|2|||
48966946|NCT02293993|157707092|FG002|Course ≥2 (Extended Treatment Period)|Physician Decision|1|||
48966947|NCT02293993|157707093|FG003|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
48966948|NCT02293993|157707090|FG000|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
48966949|NCT02293993|157707091|FG001|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
48664970|NCT03906656|156626958|FG000|Home Use 1 (3 Months)|Withdrawal by Subject|1|||
48664971|NCT03906656|156626959|FG001|Home Use 1 (3 Months)|Withdrawal by Subject|0|||
48664972|NCT03906656|156626958|FG000|Home Use 1 (3 Months)|Lack of Efficacy|0|||
48664973|NCT03906656|156626959|FG001|Home Use 1 (3 Months)|Lack of Efficacy|1|||
48664974|NCT03906656|156626958|FG000|Home Use 1 (3 Months)|Protocol Violation|1|||
48757460|NCT01164956|156960720|FG002|Overall Study|Side Effects|1|||
48664975|NCT03906656|156626959|FG001|Home Use 1 (3 Months)|Protocol Violation|0|||
48664976|NCT03906656|156626958|FG000|Fitting/Assessment Prior to Home Use 2|Adverse Event|2|||
48664977|NCT03906656|156626959|FG001|Fitting/Assessment Prior to Home Use 2|Adverse Event|0|||
48664978|NCT03906656|156626958|FG000|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|1|||
48664979|NCT03906656|156626959|FG001|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|0|||
48664980|NCT03906656|156626958|FG000|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|1|||
48664981|NCT03906656|156626959|FG001|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|0|||
48664982|NCT03906656|156626958|FG000|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|1|||
48664983|NCT03906656|156626959|FG001|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|0|||
48664984|NCT03906656|156626958|FG000|Fitting/Assessment Prior to Home Use 2|Personal problems|0|||
48664985|NCT03906656|156626959|FG001|Fitting/Assessment Prior to Home Use 2|Personal problems|1|||
48664986|NCT03906656|156626958|FG000|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|1|||
48664987|NCT03906656|156626959|FG001|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|0|||
48664988|NCT03906656|156626958|FG000|Home Use 2 (3 Months)|Adverse Event|1|||
48664989|NCT03906656|156626959|FG001|Home Use 2 (3 Months)|Adverse Event|1|||
48664990|NCT03906656|156626958|FG000|Home Use 2 (3 Months)|Lost to Follow-up|2|||
48664991|NCT03906656|156626959|FG001|Home Use 2 (3 Months)|Lost to Follow-up|0|||
48664992|NCT03906656|156626958|FG000|Home Use 2 (3 Months)|Death|2|||
48664993|NCT03906656|156626959|FG001|Home Use 2 (3 Months)|Death|0|||
48664994|NCT03906656|156626958|FG000|Home Use 2 (3 Months)|Lack of Efficacy|1|||
48664995|NCT03906656|156626959|FG001|Home Use 2 (3 Months)|Lack of Efficacy|0|||
48664996|NCT03906656|156626958|FG000|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|0|||
48664997|NCT03906656|156626959|FG001|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|1|||
48664998|NCT00882908|156626960|FG000|Overall Study|Adverse Event|0|||
48664999|NCT00882908|156626961|FG001|Overall Study|Adverse Event|0|||
48665000|NCT00882908|156626962|FG002|Overall Study|Adverse Event|1|||
48665001|NCT00882908|156626963|FG003|Overall Study|Adverse Event|0|||
48665002|NCT00882908|156626964|FG004|Overall Study|Adverse Event|1|||
48665003|NCT00882908|156626960|FG000|Overall Study|Lost to Follow-up|3|||
48665004|NCT00882908|156626961|FG001|Overall Study|Lost to Follow-up|5|||
48665005|NCT00882908|156626962|FG002|Overall Study|Lost to Follow-up|3|||
48665006|NCT00882908|156626963|FG003|Overall Study|Lost to Follow-up|1|||
48665007|NCT00882908|156626964|FG004|Overall Study|Lost to Follow-up|2|||
48665008|NCT00882908|156626960|FG000|Overall Study|Protocol Violation|0|||
48665009|NCT00882908|156626961|FG001|Overall Study|Protocol Violation|1|||
48665010|NCT00882908|156626962|FG002|Overall Study|Protocol Violation|0|||
48665011|NCT00882908|156626963|FG003|Overall Study|Protocol Violation|0|||
48665012|NCT00882908|156626964|FG004|Overall Study|Protocol Violation|0|||
48665013|NCT00882908|156626960|FG000|Overall Study|Withdrawal by Subject|0|||
48665014|NCT00882908|156626961|FG001|Overall Study|Withdrawal by Subject|0|||
48665015|NCT00882908|156626962|FG002|Overall Study|Withdrawal by Subject|3|||
48665016|NCT00882908|156626963|FG003|Overall Study|Withdrawal by Subject|5|||
48665017|NCT00882908|156626964|FG004|Overall Study|Withdrawal by Subject|2|||
48665018|NCT00882908|156626960|FG000|Overall Study|Subject reached a virologic endpoint|0|||
48665019|NCT00882908|156626961|FG001|Overall Study|Subject reached a virologic endpoint|0|||
48665020|NCT00882908|156626962|FG002|Overall Study|Subject reached a virologic endpoint|0|||
48665021|NCT00882908|156626963|FG003|Overall Study|Subject reached a virologic endpoint|0|||
48665022|NCT00882908|156626964|FG004|Overall Study|Subject reached a virologic endpoint|1|||
48966950|NCT02293993|157707092|FG002|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1|||
49015459|NCT01393990|157893773|FG003|Overall Study|Progressive Disease|1|||
48665023|NCT00882908|156626960|FG000|Overall Study|Study terminated in error|0|||
48665024|NCT00882908|156626961|FG001|Overall Study|Study terminated in error|0|||
48665025|NCT00882908|156626962|FG002|Overall Study|Study terminated in error|0|||
48665026|NCT00882908|156626963|FG003|Overall Study|Study terminated in error|1|||
48665027|NCT00882908|156626964|FG004|Overall Study|Study terminated in error|0|||
48665028|NCT02130986|156626965|FG000|Overall Study|Withdrawal by Subject|4|||
48665029|NCT02130986|156626966|FG001|Overall Study|Withdrawal by Subject|4|||
48665030|NCT02130986|156626965|FG000|Overall Study|Lost to Follow-up|151|||
48665031|NCT02130986|156626966|FG001|Overall Study|Lost to Follow-up|160|||
48665032|NCT02689076|156626967|FG000|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172|||
48665033|NCT02689076|156626968|FG001|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213|||
48665034|NCT02689076|156626969|FG002|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0|||
48665035|NCT02689076|156626967|FG000|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3|||
48665036|NCT02689076|156626968|FG001|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1|||
48665037|NCT02689076|156626969|FG002|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0|||
48665038|NCT02689076|156626967|FG000|Overall Study|Did not have an HIE match|2|||
48665039|NCT02689076|156626968|FG001|Overall Study|Did not have an HIE match|0|||
48665040|NCT02689076|156626969|FG002|Overall Study|Did not have an HIE match|0|||
48665041|NCT02689076|156626967|FG000|Overall Study|Death during non-VA encounter|2|||
48665042|NCT02689076|156626968|FG001|Overall Study|Death during non-VA encounter|5|||
48665043|NCT02689076|156626969|FG002|Overall Study|Death during non-VA encounter|0|||
48665044|NCT02689076|156626967|FG000|Overall Study|Provider declined to participate after participant assignment|1|||
48665045|NCT02689076|156626968|FG001|Overall Study|Provider declined to participate after participant assignment|1|||
48665046|NCT02689076|156626969|FG002|Overall Study|Provider declined to participate after participant assignment|0|||
48665047|NCT02689076|156626967|FG000|Overall Study|Participant no longer active in VA system|1|||
48665048|NCT02689076|156626968|FG001|Overall Study|Participant no longer active in VA system|0|||
48665049|NCT02689076|156626969|FG002|Overall Study|Participant no longer active in VA system|0|||
48665050|NCT02689076|156626967|FG000|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
48665051|NCT02689076|156626968|FG001|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2|||
48665052|NCT02689076|156626969|FG002|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
48665053|NCT00320372|156626974|FG000|Overall Study|Physician Decision|4|||
48665054|NCT00320372|156626975|FG001|Overall Study|Physician Decision|7|||
48665055|NCT00320372|156626974|FG000|Overall Study|Death|7|||
48665056|NCT00320372|156626975|FG001|Overall Study|Death|8|||
48665057|NCT00320372|156626974|FG000|Overall Study|Withdrawal by Subject|55|||
48966951|NCT02293993|157707093|FG003|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
48966952|NCT02293993|157707090|FG000|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
48966953|NCT02293993|157707091|FG001|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
48966954|NCT02293993|157707092|FG002|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3|||
48966955|NCT02293993|157707093|FG003|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1|||
48966956|NCT02293993|157707090|FG000|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
48966957|NCT02293993|157707091|FG001|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1|||
48665058|NCT00320372|156626975|FG001|Overall Study|Withdrawal by Subject|37|||
48665059|NCT00320372|156626974|FG000|Overall Study|Non-Compliance|40|||
48665060|NCT00320372|156626975|FG001|Overall Study|Non-Compliance|39|||
48665061|NCT00320372|156626974|FG000|Overall Study|Did not Meet (I/E)|3|||
48665062|NCT00320372|156626975|FG001|Overall Study|Did not Meet (I/E)|1|||
48665063|NCT00320372|156626974|FG000|Overall Study|Other (i.e. lost to f/u, site closure)|86|||
48665064|NCT00320372|156626975|FG001|Overall Study|Other (i.e. lost to f/u, site closure)|71|||
48966958|NCT02293993|157707092|FG002|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
48665065|NCT00106691|156626985|FG000|Overall Study|Adverse Event|60|||
48665066|NCT00106691|156626986|FG001|Overall Study|Adverse Event|64|||
48665067|NCT00106691|156626985|FG000|Overall Study|Lost to Follow-up|23|||
48665068|NCT00106691|156626986|FG001|Overall Study|Lost to Follow-up|18|||
48665069|NCT00106691|156626985|FG000|Overall Study|Physician Decision|18|||
48665070|NCT00106691|156626986|FG001|Overall Study|Physician Decision|21|||
48665071|NCT00106691|156626985|FG000|Overall Study|Protocol Violation|13|||
48665072|NCT00106691|156626986|FG001|Overall Study|Protocol Violation|18|||
48665073|NCT00106691|156626985|FG000|Overall Study|Withdrawal by Subject|75|||
48665074|NCT00106691|156626986|FG001|Overall Study|Withdrawal by Subject|70|||
48665075|NCT00106691|156626985|FG000|Overall Study|Failure to comply w/dosing regimen|6|||
48665076|NCT00106691|156626986|FG001|Overall Study|Failure to comply w/dosing regimen|4|||
48665077|NCT00106691|156626985|FG000|Overall Study|QTc>480|3|||
48665078|NCT00106691|156626986|FG001|Overall Study|QTc>480|1|||
48665079|NCT00106691|156626985|FG000|Overall Study|mililtary deployment|2|||
48665080|NCT00106691|156626986|FG001|Overall Study|mililtary deployment|0|||
48665081|NCT00106691|156626985|FG000|Overall Study|Study Site Closing/PI Moved|1|||
48757461|NCT00967798|156960721|FG000|Overall Study|Withdrawal by Subject|5|||
48665082|NCT00106691|156626986|FG001|Overall Study|Study Site Closing/PI Moved|2|||
48665083|NCT00106691|156626985|FG000|Overall Study|Cardiologist recommendation|1|||
48665084|NCT00106691|156626986|FG001|Overall Study|Cardiologist recommendation|0|||
48665085|NCT00106691|156626985|FG000|Overall Study|Pt. moved to another state|1|||
48757462|NCT00967798|156960722|FG001|Overall Study|Withdrawal by Subject|2|||
48757463|NCT00967798|156960721|FG000|Overall Study|Lost to Follow-up|4|||
48757464|NCT00967798|156960722|FG001|Overall Study|Lost to Follow-up|1|||
48757465|NCT00531050|156960725|FG000|Part 1: Period 1|Adverse Event|0|||
48757466|NCT00531050|156960726|FG001|Part 1: Period 1|Adverse Event|1|||
48757467|NCT00531050|156960727|FG002|Part 1: Period 1|Adverse Event|0|||
48757468|NCT00531050|156960728|FG003|Part 1: Period 1|Adverse Event|0|||
48757469|NCT00531050|156960729|FG004|Part 1: Period 1|Adverse Event|0|||
48757470|NCT00531050|156960730|FG005|Part 1: Period 1|Adverse Event|0|||
48757471|NCT00531050|156960725|FG000|Part 1: Period 1|Protocol Deviation|0|||
48757472|NCT00531050|156960726|FG001|Part 1: Period 1|Protocol Deviation|0|||
48757473|NCT00531050|156960727|FG002|Part 1: Period 1|Protocol Deviation|0|||
48757474|NCT00531050|156960728|FG003|Part 1: Period 1|Protocol Deviation|1|||
48757475|NCT00531050|156960729|FG004|Part 1: Period 1|Protocol Deviation|0|||
48757476|NCT00531050|156960730|FG005|Part 1: Period 1|Protocol Deviation|0|||
48757477|NCT00531050|156960725|FG000|Part 1: Period 3|Adverse Event|1|||
48757478|NCT00531050|156960726|FG001|Part 1: Period 3|Adverse Event|0|||
48757479|NCT00531050|156960727|FG002|Part 1: Period 3|Adverse Event|0|||
48757480|NCT00531050|156960728|FG003|Part 1: Period 3|Adverse Event|0|||
48757481|NCT00531050|156960729|FG004|Part 1: Period 3|Adverse Event|0|||
48757482|NCT00531050|156960730|FG005|Part 1: Period 3|Adverse Event|0|||
48757483|NCT00531050|156960725|FG000|Part 2: Period 1|Adverse Event|0|||
48665086|NCT00106691|156626986|FG001|Overall Study|Pt. moved to another state|0|||
48665087|NCT00106691|156626985|FG000|Overall Study|Taking exclusionary avodart|1|||
48665088|NCT00106691|156626986|FG001|Overall Study|Taking exclusionary avodart|0|||
48665089|NCT00106691|156626985|FG000|Overall Study|Not able to discontinue plavix|0|||
48665090|NCT00106691|156626986|FG001|Overall Study|Not able to discontinue plavix|1|||
48757484|NCT00531050|156960726|FG001|Part 2: Period 1|Adverse Event|0|||
48757485|NCT00531050|156960727|FG002|Part 2: Period 1|Adverse Event|0|||
48757486|NCT00531050|156960728|FG003|Part 2: Period 1|Adverse Event|0|||
48757487|NCT00531050|156960729|FG004|Part 2: Period 1|Adverse Event|0|||
48757488|NCT00531050|156960730|FG005|Part 2: Period 1|Adverse Event|1|||
48757489|NCT00531050|156960725|FG000|Part 2: Period 3|Abnormal test procedure|1|||
48757490|NCT00531050|156960726|FG001|Part 2: Period 3|Abnormal test procedure|0|||
48757491|NCT00531050|156960727|FG002|Part 2: Period 3|Abnormal test procedure|0|||
48757492|NCT00531050|156960728|FG003|Part 2: Period 3|Abnormal test procedure|0|||
48757493|NCT00531050|156960729|FG004|Part 2: Period 3|Abnormal test procedure|0|||
48757494|NCT00531050|156960730|FG005|Part 2: Period 3|Abnormal test procedure|1|||
48757495|NCT00232817|156960731|FG000|Overall Study|Protocol Violation|2|||
48757496|NCT00232817|156960732|FG001|Overall Study|Protocol Violation|1|||
48757497|NCT03518073|156960733|FG000|Overall Study|Adverse Event|2|||
48757498|NCT03518073|156960734|FG001|Overall Study|Adverse Event|4|||
48757499|NCT03518073|156960735|FG002|Overall Study|Adverse Event|2|||
48757500|NCT03518073|156960733|FG000|Overall Study|Death|2|||
48757501|NCT03518073|156960734|FG001|Overall Study|Death|1|||
48757502|NCT03518073|156960735|FG002|Overall Study|Death|3|||
49015460|NCT01393990|157893774|FG004|Overall Study|Progressive Disease|1|||
48665091|NCT02761694|156626987|FG000|Overall Study|Lack of Efficacy|0|||
48665092|NCT02761694|156626988|FG001|Overall Study|Lack of Efficacy|0|||
48665093|NCT02761694|156626989|FG002|Overall Study|Lack of Efficacy|0|||
48665094|NCT02761694|156626990|FG003|Overall Study|Lack of Efficacy|0|||
48665095|NCT02761694|156626991|FG004|Overall Study|Lack of Efficacy|0|||
48665096|NCT02761694|156626992|FG005|Overall Study|Lack of Efficacy|0|||
48665097|NCT02761694|156626993|FG006|Overall Study|Lack of Efficacy|6|||
48665098|NCT02761694|156626994|FG007|Overall Study|Lack of Efficacy|0|||
48665099|NCT02761694|156626995|FG008|Overall Study|Lack of Efficacy|0|||
48665100|NCT02761694|156626996|FG009|Overall Study|Lack of Efficacy|1|||
48665101|NCT02761694|156626997|FG010|Overall Study|Lack of Efficacy|1|||
48665102|NCT02761694|156626998|FG011|Overall Study|Lack of Efficacy|4|||
48665103|NCT02761694|156626987|FG000|Overall Study|Death|0|||
48665104|NCT02761694|156626988|FG001|Overall Study|Death|0|||
48665105|NCT02761694|156626989|FG002|Overall Study|Death|0|||
48665106|NCT02761694|156626990|FG003|Overall Study|Death|0|||
48757503|NCT03518073|156960733|FG000|Overall Study|Lost to Follow-up|1|||
48757504|NCT03518073|156960734|FG001|Overall Study|Lost to Follow-up|0|||
48757505|NCT03518073|156960735|FG002|Overall Study|Lost to Follow-up|1|||
48757506|NCT03518073|156960733|FG000|Overall Study|Physician Decision|5|||
48757507|NCT03518073|156960734|FG001|Overall Study|Physician Decision|0|||
48757508|NCT03518073|156960735|FG002|Overall Study|Physician Decision|2|||
48757509|NCT03518073|156960733|FG000|Overall Study|Progressive disease|1|||
48757510|NCT03518073|156960734|FG001|Overall Study|Progressive disease|1|||
48665107|NCT02761694|156626991|FG004|Overall Study|Death|0|||
48665108|NCT02761694|156626992|FG005|Overall Study|Death|0|||
48665109|NCT02761694|156626993|FG006|Overall Study|Death|2|||
48665110|NCT02761694|156626994|FG007|Overall Study|Death|0|||
48665111|NCT02761694|156626995|FG008|Overall Study|Death|2|||
48665112|NCT02761694|156626996|FG009|Overall Study|Death|2|||
48665113|NCT02761694|156626997|FG010|Overall Study|Death|1|||
48665114|NCT02761694|156626998|FG011|Overall Study|Death|0|||
48757511|NCT03518073|156960735|FG002|Overall Study|Progressive disease|1|||
48757512|NCT03518073|156960733|FG000|Overall Study|Protocol Violation|1|||
48665115|NCT02761694|156626987|FG000|Overall Study|Physician Decision|0|||
48665116|NCT02761694|156626988|FG001|Overall Study|Physician Decision|0|||
48665117|NCT02761694|156626989|FG002|Overall Study|Physician Decision|0|||
48665118|NCT02761694|156626990|FG003|Overall Study|Physician Decision|0|||
48665119|NCT02761694|156626991|FG004|Overall Study|Physician Decision|0|||
48665120|NCT02761694|156626992|FG005|Overall Study|Physician Decision|0|||
48665121|NCT02761694|156626993|FG006|Overall Study|Physician Decision|1|||
48665122|NCT02761694|156626994|FG007|Overall Study|Physician Decision|0|||
48665123|NCT02761694|156626995|FG008|Overall Study|Physician Decision|0|||
48665124|NCT02761694|156626996|FG009|Overall Study|Physician Decision|0|||
48665125|NCT02761694|156626997|FG010|Overall Study|Physician Decision|0|||
48665126|NCT02761694|156626998|FG011|Overall Study|Physician Decision|0|||
48665127|NCT02761694|156626987|FG000|Overall Study|Withdrawal by Subject|0|||
48665128|NCT02761694|156626988|FG001|Overall Study|Withdrawal by Subject|0|||
48665129|NCT02761694|156626989|FG002|Overall Study|Withdrawal by Subject|0|||
48665130|NCT02761694|156626990|FG003|Overall Study|Withdrawal by Subject|1|||
48665131|NCT02761694|156626991|FG004|Overall Study|Withdrawal by Subject|0|||
48665132|NCT02761694|156626992|FG005|Overall Study|Withdrawal by Subject|0|||
48665133|NCT02761694|156626993|FG006|Overall Study|Withdrawal by Subject|4|||
48665134|NCT02761694|156626994|FG007|Overall Study|Withdrawal by Subject|0|||
48665135|NCT02761694|156626995|FG008|Overall Study|Withdrawal by Subject|2|||
48665136|NCT02761694|156626996|FG009|Overall Study|Withdrawal by Subject|1|||
48665137|NCT02761694|156626997|FG010|Overall Study|Withdrawal by Subject|0|||
48665138|NCT02761694|156626998|FG011|Overall Study|Withdrawal by Subject|0|||
48665139|NCT02761694|156626987|FG000|Overall Study|Lost to Follow-up|0|||
48757513|NCT03518073|156960734|FG001|Overall Study|Protocol Violation|0|||
48966959|NCT02293993|157707093|FG003|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
48966960|NCT03587584|157707094|FG000|Overall Study|SOC deviations|4|||
48966961|NCT03587584|157707095|FG001|Overall Study|SOC deviations|6|||
48966962|NCT03587584|157707094|FG000|Overall Study|Incomplete data|0|||
48966963|NCT03587584|157707095|FG001|Overall Study|Incomplete data|3|||
48966964|NCT03728140|157707098|FG000|Overall Study|Abnormal embryo transfer operation|10|||
48966965|NCT03728140|157707099|FG001|Overall Study|Abnormal embryo transfer operation|7|||
48665140|NCT02761694|156626988|FG001|Overall Study|Lost to Follow-up|0|||
48665141|NCT02761694|156626989|FG002|Overall Study|Lost to Follow-up|0|||
48665142|NCT02761694|156626990|FG003|Overall Study|Lost to Follow-up|0|||
48665143|NCT02761694|156626991|FG004|Overall Study|Lost to Follow-up|0|||
48665144|NCT02761694|156626992|FG005|Overall Study|Lost to Follow-up|0|||
48665145|NCT02761694|156626993|FG006|Overall Study|Lost to Follow-up|1|||
48665146|NCT02761694|156626994|FG007|Overall Study|Lost to Follow-up|0|||
48665147|NCT02761694|156626995|FG008|Overall Study|Lost to Follow-up|0|||
48665148|NCT02761694|156626996|FG009|Overall Study|Lost to Follow-up|0|||
48665149|NCT02761694|156626997|FG010|Overall Study|Lost to Follow-up|0|||
48665150|NCT02761694|156626998|FG011|Overall Study|Lost to Follow-up|1|||
48665151|NCT02761694|156626987|FG000|Overall Study|Adverse Event|0|||
48665152|NCT02761694|156626988|FG001|Overall Study|Adverse Event|0|||
48665153|NCT02761694|156626989|FG002|Overall Study|Adverse Event|0|||
48665154|NCT02761694|156626990|FG003|Overall Study|Adverse Event|0|||
48665155|NCT02761694|156626991|FG004|Overall Study|Adverse Event|0|||
48757514|NCT03518073|156960735|FG002|Overall Study|Protocol Violation|0|||
48757515|NCT03518073|156960733|FG000|Overall Study|Withdrawal by Subject|30|||
48757516|NCT03518073|156960734|FG001|Overall Study|Withdrawal by Subject|34|||
48757517|NCT03518073|156960735|FG002|Overall Study|Withdrawal by Subject|29|||
48966966|NCT00418379|157707102|FG000|Year 1|Adverse Event|9|||
48966967|NCT00418379|157707103|FG001|Year 1|Adverse Event|15|||
48966968|NCT00418379|157707104|FG002|Year 1|Adverse Event|3|||
48966969|NCT00418379|157707102|FG000|Year 1|Withdrawal by Subject|7|||
48966970|NCT00418379|157707103|FG001|Year 1|Withdrawal by Subject|8|||
48966971|NCT00418379|157707104|FG002|Year 1|Withdrawal by Subject|5|||
48966972|NCT00418379|157707102|FG000|Year 1|Any other reason not above-mentioned|2|||
48665156|NCT02761694|156626992|FG005|Overall Study|Adverse Event|0|||
48665157|NCT02761694|156626993|FG006|Overall Study|Adverse Event|1|||
48665158|NCT02761694|156626994|FG007|Overall Study|Adverse Event|0|||
48665159|NCT02761694|156626995|FG008|Overall Study|Adverse Event|1|||
48665160|NCT02761694|156626996|FG009|Overall Study|Adverse Event|0|||
48665161|NCT02761694|156626997|FG010|Overall Study|Adverse Event|0|||
48665162|NCT02761694|156626998|FG011|Overall Study|Adverse Event|1|||
48757518|NCT03518073|156960733|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
48966973|NCT00418379|157707103|FG001|Year 1|Any other reason not above-mentioned|5|||
48966974|NCT00418379|157707104|FG002|Year 1|Any other reason not above-mentioned|7|||
48665163|NCT02761694|156626987|FG000|Overall Study|Other|4|||
48665164|NCT02761694|156626988|FG001|Overall Study|Other|4|||
48665165|NCT02761694|156626989|FG002|Overall Study|Other|1|||
48665166|NCT02761694|156626990|FG003|Overall Study|Other|2|||
48665167|NCT02761694|156626991|FG004|Overall Study|Other|3|||
48665168|NCT02761694|156626992|FG005|Overall Study|Other|3|||
48665169|NCT02761694|156626993|FG006|Overall Study|Other|18|||
48665170|NCT02761694|156626994|FG007|Overall Study|Other|8|||
48665171|NCT02761694|156626995|FG008|Overall Study|Other|0|||
48665172|NCT02761694|156626996|FG009|Overall Study|Other|1|||
48665173|NCT02761694|156626997|FG010|Overall Study|Other|1|||
48665174|NCT02761694|156626998|FG011|Overall Study|Other|0|||
48665175|NCT00787202|156626999|FG000|Overall Study|Adverse Event|3|||
48665176|NCT00787202|156627000|FG001|Overall Study|Adverse Event|2|||
48665177|NCT00787202|156627001|FG002|Overall Study|Adverse Event|0|||
48665178|NCT00787202|156627002|FG003|Overall Study|Adverse Event|0|||
48665179|NCT00787202|156627003|FG004|Overall Study|Adverse Event|2|||
48665180|NCT00787202|156626999|FG000|Overall Study|Lack of Efficacy|5|||
48665181|NCT00787202|156627000|FG001|Overall Study|Lack of Efficacy|6|||
48665182|NCT00787202|156627001|FG002|Overall Study|Lack of Efficacy|5|||
48665183|NCT00787202|156627002|FG003|Overall Study|Lack of Efficacy|2|||
48665184|NCT00787202|156627003|FG004|Overall Study|Lack of Efficacy|1|||
48665185|NCT00787202|156626999|FG000|Overall Study|Lost to Follow-up|1|||
48665186|NCT00787202|156627000|FG001|Overall Study|Lost to Follow-up|0|||
48665187|NCT00787202|156627001|FG002|Overall Study|Lost to Follow-up|0|||
48665188|NCT00787202|156627002|FG003|Overall Study|Lost to Follow-up|0|||
48665189|NCT00787202|156627003|FG004|Overall Study|Lost to Follow-up|0|||
48665190|NCT00787202|156626999|FG000|Overall Study|Withdrawal by Subject|2|||
48665191|NCT00787202|156627000|FG001|Overall Study|Withdrawal by Subject|2|||
48665192|NCT00787202|156627001|FG002|Overall Study|Withdrawal by Subject|2|||
48665193|NCT00787202|156627002|FG003|Overall Study|Withdrawal by Subject|0|||
48665194|NCT00787202|156627003|FG004|Overall Study|Withdrawal by Subject|0|||
48665195|NCT00787202|156626999|FG000|Overall Study|Protocol Violation|2|||
48665196|NCT00787202|156627000|FG001|Overall Study|Protocol Violation|1|||
48665197|NCT00787202|156627001|FG002|Overall Study|Protocol Violation|0|||
48665198|NCT00787202|156627002|FG003|Overall Study|Protocol Violation|0|||
48665199|NCT00787202|156627003|FG004|Overall Study|Protocol Violation|1|||
48665200|NCT00787202|156626999|FG000|Overall Study|Randomized, not treated|1|||
48665201|NCT00787202|156627000|FG001|Overall Study|Randomized, not treated|0|||
48665202|NCT00787202|156627001|FG002|Overall Study|Randomized, not treated|0|||
48665203|NCT00787202|156627002|FG003|Overall Study|Randomized, not treated|0|||
48665204|NCT00787202|156627003|FG004|Overall Study|Randomized, not treated|0|||
48665205|NCT01442064|156627004|FG000|Overall Study|Adverse Event|2|||
48665206|NCT01442064|156627005|FG001|Overall Study|Adverse Event|2|||
48665207|NCT01442064|156627006|FG002|Overall Study|Adverse Event|2|||
48665208|NCT01442064|156627007|FG003|Overall Study|Adverse Event|1|||
48665209|NCT01442064|156627008|FG004|Overall Study|Adverse Event|2|||
48665210|NCT01442064|156627009|FG005|Overall Study|Adverse Event|0|||
48665211|NCT01442064|156627004|FG000|Overall Study|Death|0|||
48665212|NCT01442064|156627005|FG001|Overall Study|Death|1|||
48665213|NCT01442064|156627006|FG002|Overall Study|Death|3|||
48665214|NCT01442064|156627007|FG003|Overall Study|Death|3|||
48665215|NCT01442064|156627008|FG004|Overall Study|Death|1|||
48966975|NCT00418379|157707102|FG000|Year 2|Adverse Event|5|||
48966976|NCT00418379|157707103|FG001|Year 2|Adverse Event|2|||
48966977|NCT00418379|157707104|FG002|Year 2|Adverse Event|1|||
48665216|NCT01442064|156627009|FG005|Overall Study|Death|3|||
48665217|NCT01442064|156627004|FG000|Overall Study|Lost to Follow-up|5|||
48665218|NCT01442064|156627005|FG001|Overall Study|Lost to Follow-up|5|||
48966978|NCT00418379|157707102|FG000|Year 2|Withdrawal by Subject|1|||
48665219|NCT01442064|156627006|FG002|Overall Study|Lost to Follow-up|1|||
48665220|NCT01442064|156627007|FG003|Overall Study|Lost to Follow-up|1|||
48665221|NCT01442064|156627008|FG004|Overall Study|Lost to Follow-up|3|||
48665222|NCT01442064|156627009|FG005|Overall Study|Lost to Follow-up|3|||
48665223|NCT01442064|156627004|FG000|Overall Study|Physician Decision|1|||
48665224|NCT01442064|156627005|FG001|Overall Study|Physician Decision|1|||
48665225|NCT01442064|156627006|FG002|Overall Study|Physician Decision|2|||
48665226|NCT01442064|156627007|FG003|Overall Study|Physician Decision|3|||
48665227|NCT01442064|156627008|FG004|Overall Study|Physician Decision|3|||
48665228|NCT01442064|156627009|FG005|Overall Study|Physician Decision|1|||
48665229|NCT01442064|156627004|FG000|Overall Study|Withdrawal by Subject|6|||
48665230|NCT01442064|156627005|FG001|Overall Study|Withdrawal by Subject|3|||
48665231|NCT01442064|156627006|FG002|Overall Study|Withdrawal by Subject|2|||
48665232|NCT01442064|156627007|FG003|Overall Study|Withdrawal by Subject|2|||
48966979|NCT00418379|157707103|FG001|Year 2|Withdrawal by Subject|1|||
48665233|NCT01442064|156627008|FG004|Overall Study|Withdrawal by Subject|2|||
48665234|NCT01442064|156627009|FG005|Overall Study|Withdrawal by Subject|1|||
48665235|NCT01442064|156627004|FG000|Overall Study|Sponsor decision|82|||
48665236|NCT01442064|156627005|FG001|Overall Study|Sponsor decision|88|||
48665237|NCT01442064|156627006|FG002|Overall Study|Sponsor decision|92|||
48665238|NCT01442064|156627007|FG003|Overall Study|Sponsor decision|88|||
48665239|NCT01442064|156627008|FG004|Overall Study|Sponsor decision|95|||
48665240|NCT01442064|156627009|FG005|Overall Study|Sponsor decision|87|||
48665241|NCT01442064|156627004|FG000|Overall Study|Subject non-compliance|0|||
48665242|NCT01442064|156627005|FG001|Overall Study|Subject non-compliance|0|||
48966980|NCT00418379|157707104|FG002|Year 2|Withdrawal by Subject|3|||
48665243|NCT01442064|156627006|FG002|Overall Study|Subject non-compliance|0|||
48665244|NCT01442064|156627007|FG003|Overall Study|Subject non-compliance|0|||
48665245|NCT01442064|156627008|FG004|Overall Study|Subject non-compliance|0|||
48757519|NCT03518073|156960734|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|6|||
48757520|NCT03518073|156960735|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|7|||
48665246|NCT01442064|156627009|FG005|Overall Study|Subject non-compliance|2|||
48665247|NCT01442064|156627004|FG000|Overall Study|Condition mandated other intervention|1|||
48665248|NCT01442064|156627005|FG001|Overall Study|Condition mandated other intervention|1|||
48665249|NCT01442064|156627006|FG002|Overall Study|Condition mandated other intervention|2|||
48665250|NCT01442064|156627007|FG003|Overall Study|Condition mandated other intervention|0|||
48665251|NCT01442064|156627008|FG004|Overall Study|Condition mandated other intervention|0|||
48665252|NCT01442064|156627009|FG005|Overall Study|Condition mandated other intervention|2|||
48665253|NCT01269385|156627010|FG000|Overall Study|Adverse Event|1|||
48665254|NCT01269385|156627011|FG001|Overall Study|Adverse Event|1|||
48665255|NCT01269385|156627012|FG002|Overall Study|Adverse Event|0|||
48665256|NCT01269385|156627013|FG003|Overall Study|Adverse Event|0|||
48665257|NCT01958021|156627014|FG000|Overall Study|Progressive disease|87|||
48665258|NCT01958021|156627015|FG001|Overall Study|Progressive disease|146|||
48665259|NCT01958021|156627014|FG000|Overall Study|Adverse Event|25|||
48665260|NCT01958021|156627015|FG001|Overall Study|Adverse Event|7|||
48665261|NCT01958021|156627014|FG000|Overall Study|Subject/guardian decision|12|||
48665262|NCT01958021|156627015|FG001|Overall Study|Subject/guardian decision|13|||
48665263|NCT01958021|156627014|FG000|Overall Study|Physician Decision|10|||
48665264|NCT01958021|156627015|FG001|Overall Study|Physician Decision|13|||
48665265|NCT01958021|156627014|FG000|Overall Study|Protocol Violation|3|||
48665266|NCT01958021|156627015|FG001|Overall Study|Protocol Violation|1|||
48665267|NCT01958021|156627014|FG000|Overall Study|Death|2|||
48665268|NCT01958021|156627015|FG001|Overall Study|Death|0|||
48665269|NCT03242018|156627016|FG000|Overall Study|Adverse Event|7|||
48665270|NCT03242018|156627017|FG001|Overall Study|Adverse Event|7|||
48665271|NCT03242018|156627018|FG002|Overall Study|Adverse Event|6|||
48665272|NCT03242018|156627016|FG000|Overall Study|Lost to Follow-up|2|||
48665273|NCT03242018|156627017|FG001|Overall Study|Lost to Follow-up|2|||
48665274|NCT03242018|156627018|FG002|Overall Study|Lost to Follow-up|2|||
48665275|NCT03242018|156627016|FG000|Overall Study|At the Participant's Own Request|5|||
48665276|NCT03242018|156627017|FG001|Overall Study|At the Participant's Own Request|1|||
48665277|NCT03242018|156627018|FG002|Overall Study|At the Participant's Own Request|4|||
48665278|NCT03242018|156627016|FG000|Overall Study|Reason Not Specified|3|||
48665279|NCT03242018|156627017|FG001|Overall Study|Reason Not Specified|4|||
48665280|NCT03242018|156627018|FG002|Overall Study|Reason Not Specified|1|||
48665281|NCT03242018|156627016|FG000|Overall Study|Study Terminated by Sponsor|1|||
48665282|NCT03242018|156627017|FG001|Overall Study|Study Terminated by Sponsor|0|||
48665283|NCT03242018|156627018|FG002|Overall Study|Study Terminated by Sponsor|1|||
48665284|NCT00946322|156627019|FG000|Pre-treatment|participant failure to follow up|1|||
48665285|NCT00946322|156627019|FG000|Post-treatment|participant failure to follow up|2|||
48665286|NCT00687609|156627020|FG000|Overall Study|Physician Decision|1|||
48665287|NCT00687609|156627020|FG000|Overall Study|Withdrawal by Subject|2|||
48665288|NCT01617447|156627021|FG000|Overall Study|Adverse Event|0|||
48665289|NCT01617447|156627022|FG001|Overall Study|Adverse Event|1|||
48665290|NCT01617447|156627021|FG000|Overall Study|Physician Decision|0|||
48665291|NCT01617447|156627022|FG001|Overall Study|Physician Decision|2|||
48665292|NCT02713529|156627023|FG000|Overall Study|Withdrawal by Subject|3|||
48665293|NCT02713529|156627024|FG001|Overall Study|Withdrawal by Subject|1|||
48665294|NCT02713529|156627025|FG002|Overall Study|Withdrawal by Subject|4|||
48665295|NCT02713529|156627026|FG003|Overall Study|Withdrawal by Subject|2|||
48665296|NCT02713529|156627027|FG004|Overall Study|Withdrawal by Subject|0|||
48757521|NCT03518073|156960733|FG000|Overall Study|Covid-19|1|||
48757522|NCT03518073|156960734|FG001|Overall Study|Covid-19|2|||
48757523|NCT03518073|156960735|FG002|Overall Study|Covid-19|1|||
48757524|NCT02169739|156960737|FG000|Overall Study|Lost to Follow-up|0|||
48757525|NCT02169739|156960738|FG001|Overall Study|Lost to Follow-up|4|||
48757526|NCT01484873|156960739|FG000|Overall Study|Withdrawal by Subject|2|||
48757527|NCT01356966|156960740|FG000|Overall Study|Withdrawal by Subject|1|||
48757528|NCT01356966|156960741|FG001|Overall Study|Withdrawal by Subject|2|||
48757529|NCT01356966|156960740|FG000|Overall Study|Physician Decision|1|||
48757530|NCT01356966|156960741|FG001|Overall Study|Physician Decision|0|||
48757531|NCT01647282|156960742|FG000|Overall Study|Physician Decision|7|||
48757532|NCT01647282|156960743|FG001|Overall Study|Physician Decision|5|||
48757533|NCT01475331|156960744|FG000|Overall Study|Osteophyte obstruction of the proximal|1|||
48757534|NCT01475331|156960745|FG001|Overall Study|Osteophyte obstruction of the proximal|0|||
48757535|NCT01475331|156960744|FG000|Overall Study|excessive main duct communication|1|||
48757536|NCT01475331|156960745|FG001|Overall Study|excessive main duct communication|1|||
48757537|NCT01475331|156960744|FG000|Overall Study|Loss of needle positioning due pt. cough|1|||
48757538|NCT01475331|156960745|FG001|Overall Study|Loss of needle positioning due pt. cough|0|||
48757539|NCT01475331|156960744|FG000|Overall Study|Sign of malignancy during the procedure|2|||
48757540|NCT01475331|156960745|FG001|Overall Study|Sign of malignancy during the procedure|0|||
48665297|NCT02713529|156627028|FG005|Overall Study|Withdrawal by Subject|1|||
48665298|NCT02713529|156627029|FG006|Overall Study|Withdrawal by Subject|1|||
48665299|NCT02713529|156627023|FG000|Overall Study|Lost to Follow-up|1|||
48665300|NCT02713529|156627024|FG001|Overall Study|Lost to Follow-up|0|||
48665301|NCT02713529|156627025|FG002|Overall Study|Lost to Follow-up|1|||
48665302|NCT02713529|156627026|FG003|Overall Study|Lost to Follow-up|0|||
48665303|NCT02713529|156627027|FG004|Overall Study|Lost to Follow-up|0|||
48665304|NCT02713529|156627028|FG005|Overall Study|Lost to Follow-up|0|||
48665305|NCT02713529|156627029|FG006|Overall Study|Lost to Follow-up|0|||
48665306|NCT02713529|156627023|FG000|Overall Study|Death|3|||
48665307|NCT02713529|156627024|FG001|Overall Study|Death|3|||
48665308|NCT02713529|156627025|FG002|Overall Study|Death|26|||
48665309|NCT02713529|156627026|FG003|Overall Study|Death|27|||
48665310|NCT02713529|156627027|FG004|Overall Study|Death|3|||
48665311|NCT02713529|156627028|FG005|Overall Study|Death|13|||
48665312|NCT02713529|156627029|FG006|Overall Study|Death|3|||
48665313|NCT00477269|156627030|FG000|Core Study|Adverse Event|6|||
48665314|NCT00477269|156627031|FG001|Core Study|Adverse Event|4|||
48757541|NCT01475331|156960744|FG000|Overall Study|cyst found to be prohibitively small|0|||
48757542|NCT01475331|156960745|FG001|Overall Study|cyst found to be prohibitively small|1|||
48757543|NCT01525550|156960746|FG000|Overall Study|Lost to Follow-up|8|||
48757544|NCT01525550|156960747|FG001|Overall Study|Lost to Follow-up|2|||
48757545|NCT01525550|156960746|FG000|Overall Study|Death|19|||
48757546|NCT01525550|156960747|FG001|Overall Study|Death|28|||
48757547|NCT01525550|156960746|FG000|Overall Study|Other|0|||
48757548|NCT01525550|156960747|FG001|Overall Study|Other|4|||
48757549|NCT01525550|156960746|FG000|Overall Study|Sponsor's Decision|30|||
48757550|NCT01525550|156960747|FG001|Overall Study|Sponsor's Decision|11|||
48757551|NCT01525550|156960746|FG000|Overall Study|Withdrawal by Subject|4|||
48757552|NCT01525550|156960747|FG001|Overall Study|Withdrawal by Subject|0|||
48757553|NCT02345811|156960748|FG000|First Intervention|Withdrawal by Subject|1|||
48757554|NCT02345811|156960749|FG001|First Intervention|Withdrawal by Subject|1|||
48757555|NCT01541969|156960750|FG000|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0|||
48757556|NCT01541969|156960751|FG001|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1|||
48757557|NCT01541969|156960750|FG000|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
48757558|NCT01541969|156960751|FG001|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
48757559|NCT01541969|156960750|FG000|Double-blind (0-12 Weeks)|Withdrawal by Subject|2|||
48757560|NCT01541969|156960751|FG001|Double-blind (0-12 Weeks)|Withdrawal by Subject|0|||
48757561|NCT01541969|156960750|FG000|Double-blind (0-12 Weeks)|Lost to Follow-up|1|||
48757562|NCT01541969|156960751|FG001|Double-blind (0-12 Weeks)|Lost to Follow-up|0|||
48757563|NCT01541969|156960750|FG000|Double-blind (0-12 Weeks)|Adverse Event|2|||
48757564|NCT01541969|156960751|FG001|Double-blind (0-12 Weeks)|Adverse Event|0|||
48757565|NCT01541969|156960750|FG000|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
48757566|NCT01541969|156960751|FG001|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
48757567|NCT01541969|156960750|FG000|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1|||
48757568|NCT01541969|156960751|FG001|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0|||
48757569|NCT01541969|156960750|FG000|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
48757570|NCT01541969|156960751|FG001|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
48757571|NCT01541969|156960750|FG000|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6|||
48757572|NCT01541969|156960751|FG001|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8|||
48757573|NCT01541969|156960750|FG000|Open Label Extension (12-36 Weeks)|Adverse Event|2|||
48757574|NCT01541969|156960751|FG001|Open Label Extension (12-36 Weeks)|Adverse Event|3|||
48757575|NCT03480750|156960753|FG000|Overall Study|Withdrawal by Subject|0|||
48757576|NCT03480750|156960754|FG001|Overall Study|Withdrawal by Subject|1|||
48757577|NCT03480750|156960755|FG002|Overall Study|Withdrawal by Subject|0|||
48757578|NCT03480750|156960756|FG003|Overall Study|Withdrawal by Subject|0|||
48665315|NCT00477269|156627032|FG002|Core Study|Adverse Event|0|||
48665316|NCT00477269|156627030|FG000|Core Study|Death|3|||
48665317|NCT00477269|156627031|FG001|Core Study|Death|3|||
48665318|NCT00477269|156627032|FG002|Core Study|Death|0|||
48665319|NCT00477269|156627030|FG000|Core Study|Withdrawn Consent|0|||
48665320|NCT00477269|156627031|FG001|Core Study|Withdrawn Consent|1|||
48665321|NCT00477269|156627032|FG002|Core Study|Withdrawn Consent|0|||
48665322|NCT00477269|156627030|FG000|Open Label Extension|Adverse Event|0|||
48665323|NCT00477269|156627031|FG001|Open Label Extension|Adverse Event|0|||
48665324|NCT00477269|156627032|FG002|Open Label Extension|Adverse Event|4|||
48665325|NCT00477269|156627030|FG000|Open Label Extension|Abnormal laboratory values|0|||
48665326|NCT00477269|156627031|FG001|Open Label Extension|Abnormal laboratory values|0|||
48665327|NCT00477269|156627032|FG002|Open Label Extension|Abnormal laboratory values|1|||
48665328|NCT00477269|156627030|FG000|Open Label Extension|unsatisfactory therapeutic effects|0|||
48757579|NCT03480750|156960757|FG004|Overall Study|Withdrawal by Subject|0|||
48757580|NCT03480750|156960758|FG005|Overall Study|Withdrawal by Subject|0|||
48665329|NCT00477269|156627031|FG001|Open Label Extension|unsatisfactory therapeutic effects|0|||
48665330|NCT00477269|156627032|FG002|Open Label Extension|unsatisfactory therapeutic effects|2|||
48757581|NCT03480750|156960753|FG000|Overall Study|The interruption in Trientine shippment|0|||
48665331|NCT00477269|156627030|FG000|Open Label Extension|Adminiatrative problems|0|||
48757582|NCT03480750|156960754|FG001|Overall Study|The interruption in Trientine shippment|0|||
48757583|NCT03480750|156960755|FG002|Overall Study|The interruption in Trientine shippment|0|||
48757584|NCT03480750|156960756|FG003|Overall Study|The interruption in Trientine shippment|0|||
48757585|NCT03480750|156960757|FG004|Overall Study|The interruption in Trientine shippment|0|||
48757586|NCT03480750|156960758|FG005|Overall Study|The interruption in Trientine shippment|1|||
48757587|NCT00518323|156960762|FG000|Overall Study|Lack of Efficacy|14|||
48757588|NCT00518323|156960763|FG001|Overall Study|Lack of Efficacy|2|||
48757589|NCT00518323|156960764|FG002|Overall Study|Lack of Efficacy|4|||
48757590|NCT00518323|156960765|FG003|Overall Study|Lack of Efficacy|20|||
48757591|NCT00518323|156960762|FG000|Overall Study|Withdrawal by Subject|1|||
48757592|NCT00518323|156960763|FG001|Overall Study|Withdrawal by Subject|2|||
48757593|NCT00518323|156960764|FG002|Overall Study|Withdrawal by Subject|4|||
48757594|NCT00518323|156960765|FG003|Overall Study|Withdrawal by Subject|2|||
48757595|NCT00518323|156960762|FG000|Overall Study|Lost to Follow-up|0|||
48757596|NCT00518323|156960763|FG001|Overall Study|Lost to Follow-up|2|||
48757597|NCT00518323|156960764|FG002|Overall Study|Lost to Follow-up|1|||
48757598|NCT00518323|156960765|FG003|Overall Study|Lost to Follow-up|3|||
48757599|NCT00518323|156960762|FG000|Overall Study|Adverse Event|1|||
48757600|NCT00518323|156960763|FG001|Overall Study|Adverse Event|1|||
48757601|NCT00518323|156960764|FG002|Overall Study|Adverse Event|1|||
48757602|NCT00518323|156960765|FG003|Overall Study|Adverse Event|0|||
48757603|NCT00518323|156960762|FG000|Overall Study|Prohibited medication and others|3|||
48757604|NCT00518323|156960763|FG001|Overall Study|Prohibited medication and others|1|||
48757605|NCT00518323|156960764|FG002|Overall Study|Prohibited medication and others|1|||
48757606|NCT00518323|156960765|FG003|Overall Study|Prohibited medication and others|0|||
48757607|NCT00356369|156960766|FG000|Active Phase|Withdrawal by Subject|2|||
48665332|NCT00477269|156627031|FG001|Open Label Extension|Adminiatrative problems|0|||
48757608|NCT00356369|156960767|FG001|Active Phase|Withdrawal by Subject|1|||
49015461|NCT01393990|157893775|FG005|Overall Study|Progressive Disease|1|||
48665333|NCT00477269|156627032|FG002|Open Label Extension|Adminiatrative problems|2|||
48665334|NCT00477269|156627030|FG000|Open Label Extension|Death|0|||
48665335|NCT00477269|156627031|FG001|Open Label Extension|Death|0|||
48665336|NCT00477269|156627032|FG002|Open Label Extension|Death|4|||
48665337|NCT01565564|156627045|FG000|Overall Study|Lost to Follow-up|5|||
48665338|NCT01565564|156627046|FG001|Overall Study|Lost to Follow-up|1|||
48665339|NCT03759041|156627047|FG000|Overall Study|Withdrawal by Subject|4|||
48665340|NCT03759041|156627048|FG001|Overall Study|Withdrawal by Subject|10|||
48665341|NCT03759041|156627049|FG002|Overall Study|Withdrawal by Subject|10|||
48665342|NCT03759041|156627047|FG000|Overall Study|Adverse Event|1|||
48665343|NCT03759041|156627048|FG001|Overall Study|Adverse Event|3|||
48665344|NCT03759041|156627049|FG002|Overall Study|Adverse Event|4|||
48665345|NCT03759041|156627047|FG000|Overall Study|Lack of Efficacy|0|||
48665346|NCT03759041|156627048|FG001|Overall Study|Lack of Efficacy|0|||
48665347|NCT03759041|156627049|FG002|Overall Study|Lack of Efficacy|1|||
48665348|NCT03759041|156627047|FG000|Overall Study|Study Terminated by Sponsor|15|||
48665349|NCT03759041|156627048|FG001|Overall Study|Study Terminated by Sponsor|16|||
48665350|NCT03759041|156627049|FG002|Overall Study|Study Terminated by Sponsor|10|||
48665351|NCT03759041|156627047|FG000|Overall Study|Other reason for discontinuation|0|||
48665352|NCT03759041|156627048|FG001|Overall Study|Other reason for discontinuation|2|||
48665353|NCT03759041|156627049|FG002|Overall Study|Other reason for discontinuation|1|||
48665354|NCT03759041|156627047|FG000|Overall Study|Lost to Follow-up|7|||
48665355|NCT03759041|156627048|FG001|Overall Study|Lost to Follow-up|2|||
48665356|NCT03759041|156627049|FG002|Overall Study|Lost to Follow-up|2|||
48665357|NCT03759041|156627047|FG000|Overall Study|Subjects did not have a discontinuation page completed|0|||
48665358|NCT03759041|156627048|FG001|Overall Study|Subjects did not have a discontinuation page completed|1|||
48665359|NCT03759041|156627049|FG002|Overall Study|Subjects did not have a discontinuation page completed|0|||
48665360|NCT03831945|156627052|FG000|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
48665361|NCT03831945|156627053|FG001|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
48665362|NCT03831945|156627052|FG000|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
48665363|NCT03831945|156627053|FG001|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
48665364|NCT03831945|156627052|FG000|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2|||
48665365|NCT03831945|156627053|FG001|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1|||
48665366|NCT00806442|156627054|FG000|Overall Study|Lost to Follow-up|3|||
48665367|NCT00806442|156627055|FG001|Overall Study|Lost to Follow-up|2|||
48665368|NCT00806442|156627054|FG000|Overall Study|Withdrawal by Subject|1|||
48665369|NCT00806442|156627055|FG001|Overall Study|Withdrawal by Subject|5|||
48665370|NCT01522404|156627060|FG000|First Intervention (up to Week 29)|Withdrawal by Subject|1|||
48665371|NCT01522404|156627061|FG001|First Intervention (up to Week 29)|Withdrawal by Subject|0|||
48757609|NCT00255047|156960789|FG000|Overall Study|Serious Adverse Events|2|||
48757610|NCT00255047|156960790|FG001|Overall Study|Serious Adverse Events|1|||
48757611|NCT00255047|156960791|FG002|Overall Study|Serious Adverse Events|2|||
48665372|NCT01522404|156627060|FG000|First Intervention (up to Week 29)|Adverse Event|1|||
48665373|NCT01522404|156627061|FG001|First Intervention (up to Week 29)|Adverse Event|0|||
48665374|NCT01522404|156627060|FG000|Second Intervention (up to Week 58)|Withdrawal by Subject|1|||
48665375|NCT01522404|156627061|FG001|Second Intervention (up to Week 58)|Withdrawal by Subject|0|||
48665376|NCT03734029|156627064|FG000|Overall Study|Progressive disease as per RECIST v1.1|220|||
48665377|NCT03734029|156627065|FG001|Overall Study|Progressive disease as per RECIST v1.1|130|||
48665378|NCT03734029|156627064|FG000|Overall Study|Adverse Event|60|||
48665379|NCT03734029|156627065|FG001|Overall Study|Adverse Event|14|||
48665380|NCT03734029|156627064|FG000|Overall Study|Withdrawal by Subject|12|||
48665381|NCT03734029|156627065|FG001|Overall Study|Withdrawal by Subject|11|||
48665382|NCT03734029|156627064|FG000|Overall Study|Clinical progression by investigator|10|||
48665383|NCT03734029|156627065|FG001|Overall Study|Clinical progression by investigator|8|||
48665384|NCT03734029|156627064|FG000|Overall Study|Death|5|||
48665385|NCT03734029|156627065|FG001|Overall Study|Death|2|||
48665386|NCT03734029|156627064|FG000|Overall Study|Physician Decision|4|||
48665387|NCT03734029|156627065|FG001|Overall Study|Physician Decision|3|||
48665388|NCT03734029|156627064|FG000|Overall Study|Other|2|||
48665389|NCT03734029|156627065|FG001|Overall Study|Other|0|||
48665390|NCT03734029|156627064|FG000|Overall Study|Lost to Follow-up|0|||
48665391|NCT03734029|156627065|FG001|Overall Study|Lost to Follow-up|1|||
48665392|NCT03734029|156627064|FG000|Overall Study|Randomized, but not treated|2|||
48665393|NCT03734029|156627065|FG001|Overall Study|Randomized, but not treated|12|||
48665394|NCT03582813|156627066|FG000|Overall Study|Lost to Follow-up|18|||
48665395|NCT03582813|156627067|FG001|Overall Study|Lost to Follow-up|21|||
48665396|NCT03582813|156627066|FG000|Overall Study|Withdrawal by Subject|1|||
48665397|NCT03582813|156627067|FG001|Overall Study|Withdrawal by Subject|0|||
48665398|NCT02739321|156627084|FG000|Overall Study|Lack of Efficacy|1|||
48665399|NCT02739321|156627085|FG001|Overall Study|Lack of Efficacy|1|||
48665400|NCT02739321|156627084|FG000|Overall Study|Lost to Follow-up|1|||
48665401|NCT02739321|156627085|FG001|Overall Study|Lost to Follow-up|1|||
48665402|NCT02739321|156627084|FG000|Overall Study|Withdrawal by Subject|1|||
48665403|NCT02739321|156627085|FG001|Overall Study|Withdrawal by Subject|2|||
48665404|NCT01440517|156628450|FG000|Overall Study|Subject withdrawn prior to dosing|1|||
48665405|NCT01537081|156628451|FG000|Overall Study|Adverse Event|5|||
48665406|NCT01537081|156628452|FG001|Overall Study|Adverse Event|2|||
48665407|NCT01537081|156628453|FG002|Overall Study|Adverse Event|2|||
48665408|NCT01537081|156628451|FG000|Overall Study|Lack of Efficacy|2|||
48665409|NCT01537081|156628452|FG001|Overall Study|Lack of Efficacy|1|||
48665410|NCT01537081|156628453|FG002|Overall Study|Lack of Efficacy|0|||
48665411|NCT01537081|156628451|FG000|Overall Study|Lost to Follow-up|17|||
48665412|NCT01537081|156628452|FG001|Overall Study|Lost to Follow-up|15|||
48665413|NCT01537081|156628453|FG002|Overall Study|Lost to Follow-up|9|||
48665414|NCT01537081|156628451|FG000|Overall Study|Protocol Violation|3|||
48665415|NCT01537081|156628452|FG001|Overall Study|Protocol Violation|2|||
48665416|NCT01537081|156628453|FG002|Overall Study|Protocol Violation|2|||
48665417|NCT01537081|156628451|FG000|Overall Study|Withdrawal by Subject|6|||
48665418|NCT01537081|156628452|FG001|Overall Study|Withdrawal by Subject|11|||
48665419|NCT01537081|156628453|FG002|Overall Study|Withdrawal by Subject|3|||
48665420|NCT01537081|156628451|FG000|Overall Study|Physician Decision|5|||
48665421|NCT01537081|156628452|FG001|Overall Study|Physician Decision|6|||
48665422|NCT01537081|156628453|FG002|Overall Study|Physician Decision|0|||
48966981|NCT00418379|157707102|FG000|Year 2|Any other reason not above-mentioned|2|||
48966982|NCT00418379|157707103|FG001|Year 2|Any other reason not above-mentioned|1|||
48966983|NCT00418379|157707104|FG002|Year 2|Any other reason not above-mentioned|6|||
48966984|NCT00418379|157707102|FG000|Year 3|Withdrawal by Subject|1|||
48966985|NCT00418379|157707103|FG001|Year 3|Withdrawal by Subject|1|||
48966986|NCT00418379|157707104|FG002|Year 3|Withdrawal by Subject|2|||
48966987|NCT00418379|157707102|FG000|Year 3|Any other reason not above-mentioned|2|||
48966988|NCT00418379|157707103|FG001|Year 3|Any other reason not above-mentioned|1|||
48966989|NCT00418379|157707104|FG002|Year 3|Any other reason not above-mentioned|1|||
48966990|NCT00418379|157707102|FG000|Year 4|Adverse Event|0|||
48966991|NCT00418379|157707103|FG001|Year 4|Adverse Event|1|||
48966992|NCT00418379|157707104|FG002|Year 4|Adverse Event|0|||
48966993|NCT00418379|157707102|FG000|Year 4|Withdrawal by Subject|2|||
48966994|NCT00418379|157707103|FG001|Year 4|Withdrawal by Subject|3|||
48966995|NCT00418379|157707104|FG002|Year 4|Withdrawal by Subject|2|||
48665423|NCT01537081|156628451|FG000|Overall Study|Sponsor decision|0|||
48665424|NCT01537081|156628452|FG001|Overall Study|Sponsor decision|1|||
48665425|NCT01537081|156628453|FG002|Overall Study|Sponsor decision|0|||
48665426|NCT01537081|156628451|FG000|Overall Study|Assigned but never dosed|1|||
48665427|NCT01537081|156628452|FG001|Overall Study|Assigned but never dosed|0|||
48665428|NCT01537081|156628453|FG002|Overall Study|Assigned but never dosed|0|||
48665429|NCT03285958|156628456|FG000|Overall Study|Lost to Follow-up|1|||
48665430|NCT03285958|156628457|FG001|Overall Study|Lost to Follow-up|1|||
48665431|NCT03285958|156628456|FG000|Overall Study|Withdrawal by Subject|1|||
48665432|NCT03285958|156628457|FG001|Overall Study|Withdrawal by Subject|0|||
48966996|NCT00418379|157707102|FG000|Year 4|Any other reason not above-mentioned|1|||
48867727|NCT05451693|157351960|FG001|Overall Study|Withdrawal by Subject|1|||
48867728|NCT05129501|157351963|FG000|Overall Study|Lost to Follow-up|54|||
48867729|NCT05129501|157351964|FG001|Overall Study|Lost to Follow-up|41|||
48867730|NCT03326193|157351965|FG000|Overall Study|Treatment ongoing at the time of analysis|26|||
48867731|NCT03326193|157351965|FG000|Overall Study|Death|19|||
48867732|NCT03326193|157351965|FG000|Overall Study|Withdrawal by Subject|8|||
48966997|NCT00418379|157707103|FG001|Year 4|Any other reason not above-mentioned|1|||
48966998|NCT00418379|157707104|FG002|Year 4|Any other reason not above-mentioned|0|||
48966999|NCT00418379|157707102|FG000|Year 5|Adverse Event|0|||
48967000|NCT00418379|157707103|FG001|Year 5|Adverse Event|1|||
48665433|NCT03285958|156628456|FG000|Overall Study|Not able to attend required orientation|3|||
48665434|NCT03285958|156628457|FG001|Overall Study|Not able to attend required orientation|0|||
48665435|NCT03405935|156628458|FG000|Overall Study|Adverse Event|3|||
48665436|NCT03405935|156628458|FG000|Overall Study|Death|2|||
48665437|NCT03405935|156628458|FG000|Overall Study|Withdrawal by Subject|1|||
48665438|NCT03405935|156628458|FG000|Overall Study|Lost to Follow-up|2|||
48665439|NCT03383783|156628465|FG000|Overall Study|Withdrawal by Subject|2|||
48665440|NCT01224821|156628466|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
48665441|NCT01224821|156628466|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|38|||
48665442|NCT01224821|156628466|FG000|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3|||
48665443|NCT01224821|156628466|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
48665444|NCT01224821|156628466|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1|||
48665445|NCT01224821|156628466|FG000|Dosimetric and Therapeutic Treatment|Started Other Treatment|1|||
48665446|NCT01224821|156628466|FG000|Long-Term Follow-Up|Death|2|||
48665447|NCT01224821|156628466|FG000|Long-Term Follow-Up|Completion of 10 Year Follow-up|9|||
48665448|NCT01170598|156628467|FG000|Overall Study|Withdrawal by Subject|1|||
48665449|NCT01170598|156628467|FG000|Overall Study|Death|3|||
48665450|NCT01170598|156628467|FG000|Overall Study|Lost to Follow-up|1|||
48665451|NCT01170598|156628467|FG000|Overall Study|Refused|1|||
48665452|NCT03761394|156628472|FG000|14-day Intervention & Control Period|Lost to Follow-up|0|||
48665453|NCT03761394|156628473|FG001|14-day Intervention & Control Period|Lost to Follow-up|1|||
48665454|NCT03761394|156628474|FG002|14-day Intervention & Control Period|Lost to Follow-up|0|||
48665455|NCT03761394|156628475|FG003|14-day Intervention & Control Period|Lost to Follow-up|0|||
48665456|NCT03761394|156628472|FG000|14-day Intervention & Control Period|Withdrawal by Subject|3|||
48665457|NCT03761394|156628473|FG001|14-day Intervention & Control Period|Withdrawal by Subject|1|||
48665458|NCT03761394|156628474|FG002|14-day Intervention & Control Period|Withdrawal by Subject|0|||
48757612|NCT00255047|156960792|FG003|Overall Study|Serious Adverse Events|1|||
48867733|NCT03662659|157351976|FG000|Pre-treatment|Participant no longer met study criteria|1|||
48867734|NCT03662659|157351977|FG001|Pre-treatment|Participant no longer met study criteria|1|||
48867735|NCT03662659|157351976|FG000|Pre-treatment|Other reasons|1|||
48867736|NCT03662659|157351977|FG001|Pre-treatment|Other reasons|0|||
48867737|NCT03662659|157351976|FG000|Treatment|Completed Treatment|0|||
48867738|NCT03662659|157351977|FG001|Treatment|Completed Treatment|2|||
48867739|NCT03662659|157351976|FG000|Treatment|Disease Progression|85|||
48867740|NCT03662659|157351977|FG001|Treatment|Disease Progression|97|||
48867741|NCT03662659|157351976|FG000|Treatment|Study Drug Toxicity|19|||
48867742|NCT03662659|157351977|FG001|Treatment|Study Drug Toxicity|9|||
48867743|NCT03662659|157351976|FG000|Treatment|Death|11|||
48867744|NCT03662659|157351977|FG001|Treatment|Death|9|||
48867745|NCT03662659|157351976|FG000|Treatment|Adverse Event unrelated to Study Drug|7|||
48867746|NCT03662659|157351977|FG001|Treatment|Adverse Event unrelated to Study Drug|6|||
48867747|NCT03662659|157351976|FG000|Treatment|Withdrawal by Subject|1|||
48867748|NCT03662659|157351977|FG001|Treatment|Withdrawal by Subject|1|||
48867749|NCT03662659|157351976|FG000|Treatment|Poor/Non-compliance|1|||
48867750|NCT03662659|157351977|FG001|Treatment|Poor/Non-compliance|0|||
48867751|NCT03662659|157351976|FG000|Treatment|Participant no longer meets study criteria|1|||
48867752|NCT03662659|157351977|FG001|Treatment|Participant no longer meets study criteria|0|||
48867753|NCT03662659|157351976|FG000|Treatment|Other reasons|10|||
48867754|NCT03662659|157351977|FG001|Treatment|Other reasons|8|||
48867755|NCT03662659|157351976|FG000|Treatment|Administrative reasons by sponsor|1|||
48867756|NCT03662659|157351977|FG001|Treatment|Administrative reasons by sponsor|0|||
48867757|NCT03662659|157351976|FG000|Treatment|maximum clinical benefit|0|||
48867758|NCT03662659|157351977|FG001|Treatment|maximum clinical benefit|2|||
48867759|NCT04572997|157353055|FG000|Overall Study|Adverse Event|1|||
48867760|NCT01904019|157353056|FG000|1 Year Follow-up|Withdrawal by Subject|4|||
48867761|NCT01904019|157353056|FG000|1 Year Follow-up|Impossibility to contact patient|5|||
48867762|NCT01904019|157353056|FG000|3 Year Follow-up|Withdrawal by Subject|1|||
48867763|NCT01904019|157353056|FG000|3 Year Follow-up|Impossibility to contact patient|14|||
48867764|NCT01904019|157353056|FG000|5 Year Follow-up|Withdrawal by Subject|2|||
48867765|NCT01904019|157353056|FG000|5 Year Follow-up|Impossibility to contact patient|4|||
48867766|NCT00814632|157353057|FG000|Overall Study|Lack of Efficacy|2|||
48867767|NCT00733226|157353060|FG000|Overall Study|Withdrawal by Subject|1|||
48867768|NCT00733226|157353061|FG001|Overall Study|Withdrawal by Subject|0|||
48867769|NCT00733226|157353060|FG000|Overall Study|Lost to Follow-up|2|||
48665459|NCT03761394|156628475|FG003|14-day Intervention & Control Period|Withdrawal by Subject|0|||
48665460|NCT03761394|156628472|FG000|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
48665461|NCT03761394|156628473|FG001|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
48665462|NCT03761394|156628474|FG002|30-day Period (Extension 44 Days)|Lost to Follow-up|2|||
48665463|NCT03761394|156628475|FG003|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
48665464|NCT03761394|156628472|FG000|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
48665465|NCT03761394|156628473|FG001|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
48665466|NCT03761394|156628474|FG002|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
48665467|NCT03761394|156628475|FG003|30-day Period (Extension 44 Days)|Withdrawal by Subject|3|||
48665468|NCT01145053|156628476|FG000|Overall Study|Adverse Event|22|||
48665469|NCT01145053|156628476|FG000|Overall Study|Lost to Follow-up|28|||
48665470|NCT01145053|156628476|FG000|Overall Study|Withdrawal by Subject|25|||
48867770|NCT00733226|157353061|FG001|Overall Study|Lost to Follow-up|0|||
48867771|NCT00733226|157353060|FG000|Overall Study|moved to another place|2|||
48867772|NCT00733226|157353061|FG001|Overall Study|moved to another place|0|||
48867773|NCT03438188|157353062|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
48867774|NCT03438188|157353063|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
48665471|NCT01145053|156628476|FG000|Overall Study|Other|18|||
48665472|NCT01891344|156628490|FG000|Overall Study|Ongoing|6|||
48665473|NCT01891344|156628491|FG001|Overall Study|Ongoing|2|||
48867775|NCT03438188|157353064|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
48867776|NCT03438188|157353062|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|4|||
48867777|NCT03438188|157353063|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|3|||
48867778|NCT03438188|157353064|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|2|||
48867779|NCT03438188|157353062|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|3|||
48867780|NCT03438188|157353063|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|4|||
48867781|NCT03438188|157353064|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|1|||
48967001|NCT00418379|157707104|FG002|Year 5|Adverse Event|0|||
48967002|NCT00418379|157707102|FG000|Year 5|Any other reason not above-mentioned|2|||
48967003|NCT00418379|157707103|FG001|Year 5|Any other reason not above-mentioned|4|||
48967004|NCT00418379|157707104|FG002|Year 5|Any other reason not above-mentioned|3|||
48967005|NCT02034552|157707105|FG000|Overall Study|Never treated|3|||
48967006|NCT02034552|157707106|FG001|Overall Study|Never treated|2|||
48967007|NCT02034552|157707107|FG002|Overall Study|Never treated|0|||
48967008|NCT02034552|157707105|FG000|Overall Study|Radiological progression|3|||
48967009|NCT02034552|157707106|FG001|Overall Study|Radiological progression|5|||
48967010|NCT02034552|157707107|FG002|Overall Study|Radiological progression|4|||
48967011|NCT02034552|157707105|FG000|Overall Study|AE not assoc. with disease progression|1|||
48967012|NCT02034552|157707106|FG001|Overall Study|AE not assoc. with disease progression|4|||
48967013|NCT02034552|157707107|FG002|Overall Study|AE not assoc. with disease progression|2|||
48967014|NCT02034552|157707105|FG000|Overall Study|AE associated with disease progression|0|||
48967015|NCT02034552|157707106|FG001|Overall Study|AE associated with disease progression|1|||
48967016|NCT02034552|157707107|FG002|Overall Study|AE associated with disease progression|0|||
48967017|NCT02034552|157707105|FG000|Overall Study|Withdrawal by Subject|2|||
48967018|NCT02034552|157707106|FG001|Overall Study|Withdrawal by Subject|1|||
48967019|NCT02034552|157707107|FG002|Overall Study|Withdrawal by Subject|1|||
48967020|NCT02034552|157707105|FG000|Overall Study|Non-compliance with study drug|0|||
48967021|NCT02034552|157707106|FG001|Overall Study|Non-compliance with study drug|0|||
48967022|NCT02034552|157707107|FG002|Overall Study|Non-compliance with study drug|1|||
48967023|NCT02034552|157707105|FG000|Overall Study|Clinical progression|5|||
48967024|NCT02034552|157707106|FG001|Overall Study|Clinical progression|7|||
48967025|NCT02034552|157707107|FG002|Overall Study|Clinical progression|9|||
48967026|NCT01419015|157707108|FG000|Overall Study|Death|2|||
48967027|NCT01677507|157707109|FG000|Initial Assignment|Adverse Event|0|||
48967028|NCT01677507|157707110|FG001|Initial Assignment|Adverse Event|1|||
48967029|NCT01677507|157707109|FG000|Initial Assignment|Protocol Violation|0|||
48967030|NCT01677507|157707110|FG001|Initial Assignment|Protocol Violation|1|||
48967031|NCT01677507|157707109|FG000|Second Assigment|Withdrawal by Subject|2|||
48967032|NCT01677507|157707110|FG001|Second Assigment|Withdrawal by Subject|2|||
48967033|NCT01677507|157707109|FG000|Second Assigment|Adverse Event|1|||
48967034|NCT01677507|157707110|FG001|Second Assigment|Adverse Event|3|||
48967035|NCT01082367|157707118|FG000|Double-blind Period|Administrative problems|0|||
48967036|NCT01082367|157707119|FG001|Double-blind Period|Administrative problems|1|||
48967037|NCT01082367|157707118|FG000|Double-blind Period|Lack of Efficacy|5|||
48967038|NCT01082367|157707119|FG001|Double-blind Period|Lack of Efficacy|11|||
48967039|NCT01082367|157707118|FG000|Double-blind Period|Adverse Event|0|||
48665474|NCT01891344|156628492|FG002|Overall Study|Ongoing|0|||
48665475|NCT01891344|156628493|FG003|Overall Study|Ongoing|1|||
48967040|NCT01082367|157707119|FG001|Double-blind Period|Adverse Event|1|||
48967041|NCT01082367|157707118|FG000|Follow-up (F-U) Period|Administrative problems|1|||
48967042|NCT01082367|157707119|FG001|Follow-up (F-U) Period|Administrative problems|0|||
48967043|NCT01082367|157707118|FG000|Follow-up (F-U) Period|Abnormal lab values|1|||
48665476|NCT01891344|156628494|FG004|Overall Study|Ongoing|4|||
48665477|NCT01891344|156628495|FG005|Overall Study|Ongoing|1|||
48757613|NCT00255047|156960789|FG000|Overall Study|Adverse Event|0|||
48967044|NCT01082367|157707119|FG001|Follow-up (F-U) Period|Abnormal lab values|0|||
48967045|NCT01082367|157707118|FG000|Follow-up (F-U) Period|Adverse Event|0|||
48967046|NCT01082367|157707119|FG001|Follow-up (F-U) Period|Adverse Event|1|||
48665478|NCT01891344|156628496|FG006|Overall Study|Ongoing|0|||
48665479|NCT01891344|156628497|FG007|Overall Study|Ongoing|0|||
48665480|NCT01414205|156628503|FG000|Overall Study|Death|5|||
48665481|NCT01414205|156628504|FG001|Overall Study|Death|1|||
48665482|NCT01414205|156628503|FG000|Overall Study|Lost to Follow-up|1|||
48665483|NCT01414205|156628504|FG001|Overall Study|Lost to Follow-up|4|||
48665484|NCT01414205|156628503|FG000|Overall Study|Physician Decision|0|||
48665485|NCT01414205|156628504|FG001|Overall Study|Physician Decision|1|||
48665486|NCT01414205|156628503|FG000|Overall Study|Randomized but not Treated|1|||
48665487|NCT01414205|156628504|FG001|Overall Study|Randomized but not Treated|1|||
48665488|NCT00054691|156628506|FG000|Overall Study|Unmeasurable Disease|2|||
48665489|NCT00054691|156628506|FG000|Overall Study|Noncompliant|1|||
48665490|NCT02914548|156628507|FG000|Overall Study|Adverse Event|15|||
48665491|NCT02914548|156628508|FG001|Overall Study|Adverse Event|7|||
48665492|NCT02914548|156628509|FG002|Overall Study|Adverse Event|15|||
48757614|NCT00255047|156960790|FG001|Overall Study|Adverse Event|3|||
48757615|NCT00255047|156960791|FG002|Overall Study|Adverse Event|2|||
48757616|NCT00255047|156960792|FG003|Overall Study|Adverse Event|1|||
48757617|NCT00255047|156960789|FG000|Overall Study|Protocol Violation|13|||
48757618|NCT00255047|156960790|FG001|Overall Study|Protocol Violation|13|||
48757619|NCT00255047|156960791|FG002|Overall Study|Protocol Violation|16|||
48757620|NCT00255047|156960792|FG003|Overall Study|Protocol Violation|20|||
48757621|NCT00255047|156960789|FG000|Overall Study|Lost to Follow-up|9|||
48757622|NCT00255047|156960790|FG001|Overall Study|Lost to Follow-up|8|||
48757623|NCT00255047|156960791|FG002|Overall Study|Lost to Follow-up|5|||
48757624|NCT00255047|156960792|FG003|Overall Study|Lost to Follow-up|6|||
48757625|NCT00255047|156960789|FG000|Overall Study|Withdrawal by Subject|24|||
48757626|NCT00255047|156960790|FG001|Overall Study|Withdrawal by Subject|23|||
48757627|NCT00255047|156960791|FG002|Overall Study|Withdrawal by Subject|25|||
48757628|NCT00255047|156960792|FG003|Overall Study|Withdrawal by Subject|18|||
48757629|NCT00811473|156960793|FG000|Overall Study|Adverse Event|3|||
48757630|NCT00811473|156960794|FG001|Overall Study|Adverse Event|12|||
48757631|NCT00811473|156960793|FG000|Overall Study|Lost to Follow-up|5|||
48757632|NCT00811473|156960794|FG001|Overall Study|Lost to Follow-up|1|||
48757633|NCT00811473|156960793|FG000|Overall Study|Withdrawal by Subject|2|||
48757634|NCT00811473|156960794|FG001|Overall Study|Withdrawal by Subject|4|||
48757635|NCT00811473|156960793|FG000|Overall Study|Severe non-compliance to protocol|2|||
48757636|NCT00811473|156960794|FG001|Overall Study|Severe non-compliance to protocol|4|||
48757637|NCT00811473|156960793|FG000|Overall Study|Lack of therapeutic response|4|||
48757638|NCT00811473|156960794|FG001|Overall Study|Lack of therapeutic response|1|||
48757639|NCT00811473|156960793|FG000|Overall Study|Condition under investigation worsened|1|||
48757640|NCT00811473|156960794|FG001|Overall Study|Condition under investigation worsened|3|||
48757641|NCT00811473|156960793|FG000|Overall Study|Other 2|4|||
48757642|NCT00811473|156960794|FG001|Overall Study|Other 2|1|||
48757643|NCT00811473|156960793|FG000|Overall Study|Incorrect Enrollment|1|||
48757644|NCT00811473|156960794|FG001|Overall Study|Incorrect Enrollment|0|||
48757645|NCT00811473|156960793|FG000|Overall Study|Safety Reasons|1|||
48757646|NCT00811473|156960794|FG001|Overall Study|Safety Reasons|0|||
48757647|NCT04053023|156960800|FG000|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1|||
48757648|NCT04053023|156960801|FG001|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0|||
48757649|NCT00383149|156960802|FG000|Overall Study|Adverse Event not Related to Study Drug|3|||
48757650|NCT00383149|156960802|FG000|Overall Study|Death|2|||
48757651|NCT00383149|156960802|FG000|Overall Study|Disease Progression|38|||
48757652|NCT00383149|156960802|FG000|Overall Study|Lost to Follow-up|1|||
48757653|NCT00383149|156960802|FG000|Overall Study|Other|1|||
48757654|NCT00383149|156960802|FG000|Overall Study|Study Drug Toxicity|4|||
48757655|NCT00383149|156960802|FG000|Overall Study|Request to Discontinue Treatment|4|||
48757656|NCT00383149|156960802|FG000|Overall Study|Participant Withdrew Consent|1|||
48757657|NCT01558752|156960811|FG000|Overall Study|Physician Decision|2|||
48665493|NCT02914548|156628507|FG000|Overall Study|Physician Decision|2|||
48665494|NCT02914548|156628508|FG001|Overall Study|Physician Decision|2|||
48665495|NCT02914548|156628509|FG002|Overall Study|Physician Decision|0|||
48665496|NCT02914548|156628507|FG000|Overall Study|Protocol Violation|1|||
48665497|NCT02914548|156628508|FG001|Overall Study|Protocol Violation|0|||
48665498|NCT02914548|156628509|FG002|Overall Study|Protocol Violation|0|||
48665499|NCT02914548|156628507|FG000|Overall Study|Withdrawal by Subject|3|||
48665500|NCT02914548|156628508|FG001|Overall Study|Withdrawal by Subject|4|||
48665501|NCT02914548|156628509|FG002|Overall Study|Withdrawal by Subject|4|||
48665502|NCT02914548|156628507|FG000|Overall Study|>40% of body surface area|0|||
48757658|NCT01558752|156960812|FG001|Overall Study|Physician Decision|0|||
48757659|NCT00553150|156960815|FG000|Overall Study|Withdrawal by Subject|0|||
48757660|NCT00553150|156960816|FG001|Overall Study|Withdrawal by Subject|0|||
48867782|NCT03438188|157353062|FG000|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
48867783|NCT03438188|157353063|FG001|Washout Period (Smoking or Abstinent)|Lost to Follow-up|2|||
48867784|NCT03438188|157353064|FG002|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
48867785|NCT03438188|157353062|FG000|Washout Period (Smoking or Abstinent)|change in eligibility|3|||
48867786|NCT03438188|157353063|FG001|Washout Period (Smoking or Abstinent)|change in eligibility|2|||
48867787|NCT03438188|157353064|FG002|Washout Period (Smoking or Abstinent)|change in eligibility|0|||
48867788|NCT00451555|157353065|FG000|Overall Study|Protocol Violation|2|||
48867789|NCT00451555|157353066|FG001|Overall Study|Protocol Violation|2|||
48867790|NCT00451555|157353065|FG000|Overall Study|Adverse Event|3|||
48867791|NCT00451555|157353066|FG001|Overall Study|Adverse Event|1|||
48867792|NCT00451555|157353065|FG000|Overall Study|Withdrawal by Subject|6|||
48867793|NCT00451555|157353066|FG001|Overall Study|Withdrawal by Subject|0|||
48967047|NCT00699842|157707120|FG000|Overall Study|Death|0|||
48967048|NCT00699842|157707121|FG001|Overall Study|Death|1|||
48967049|NCT00699842|157707122|FG002|Overall Study|Death|0|||
48967050|NCT00098020|157707123|FG000|Overall Study|Adverse Event|2|||
48967051|NCT00098020|157707123|FG000|Overall Study|Lost to Follow-up|1|||
48967052|NCT00098020|157707123|FG000|Overall Study|elevated liver enzymes|1|||
48967053|NCT00098020|157707123|FG000|Overall Study|Low urine PCR|1|||
48967054|NCT00098020|157707123|FG000|Overall Study|Low epidermal growth factor receptor|1|||
48967055|NCT01360762|157707126|FG000|Main Study Period (12-month Treatment)|Lost to Follow-up|7|||
48967056|NCT01360762|157707126|FG000|Main Study Period (12-month Treatment)|Death|5|||
48967057|NCT01360762|157707126|FG000|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1|||
48967058|NCT01360762|157707126|FG000|Main Study Period (12-month Treatment)|Patient relapsed|15|||
48967059|NCT01360762|157707126|FG000|Main Study Period (12-month Treatment)|Discontinuation|1|||
48967060|NCT01360762|157707126|FG000|Whole Study Period|Lost to Follow-up|10|||
48967061|NCT01360762|157707126|FG000|Whole Study Period|Death|7|||
48967062|NCT01360762|157707126|FG000|Whole Study Period|Patient relapsed|18|||
48967063|NCT01360762|157707126|FG000|Whole Study Period|Discontinuation of study drug for safety|1|||
48967064|NCT00992186|157707131|FG000|Overall Study|Withdrawal by Subject|2|||
48967065|NCT00992186|157707131|FG000|Overall Study|Protocol Violation|1|||
48967066|NCT00992186|157707131|FG000|Overall Study|Physician Decision|1|||
48967067|NCT00992186|157707131|FG000|Overall Study|Adverse Event|9|||
48967068|NCT00992186|157707131|FG000|Overall Study|Progressive Disease|30|||
48967069|NCT00992186|157707131|FG000|Overall Study|Refusal To Receive Study Agent|3|||
48967070|NCT03428997|157707132|FG000|Overall Study|Sponsor decision.|1|||
48967071|NCT03428997|157707132|FG000|Overall Study|Withdrawal by Subject|3|||
48967072|NCT03428997|157707132|FG000|Overall Study|Lost to Follow-up|4|||
48967073|NCT00318565|157707133|FG000|Overall Study|Excluded per protocol|24|||
48967074|NCT00936117|157707138|FG000|Overall Study|Adverse Event|7|||
48967075|NCT00936117|157707138|FG000|Overall Study|Unable to continue oral medication|3|||
48967076|NCT00764478|157707139|FG000|Overall Study|Adverse Event|1|||
48967077|NCT00764478|157707140|FG001|Overall Study|Adverse Event|1|||
48967078|NCT00764478|157707141|FG002|Overall Study|Adverse Event|1|||
48757661|NCT00553150|156960817|FG002|Overall Study|Withdrawal by Subject|0|||
48757662|NCT00553150|156960818|FG003|Overall Study|Withdrawal by Subject|2|||
48757663|NCT00553150|156960815|FG000|Overall Study|Protocol Violation|0|||
48757664|NCT00553150|156960816|FG001|Overall Study|Protocol Violation|0|||
48757665|NCT00553150|156960817|FG002|Overall Study|Protocol Violation|0|||
48757666|NCT00553150|156960818|FG003|Overall Study|Protocol Violation|1|||
48757667|NCT00553150|156960815|FG000|Overall Study|Ineligible|0|||
48757668|NCT00553150|156960816|FG001|Overall Study|Ineligible|0|||
48757669|NCT00553150|156960817|FG002|Overall Study|Ineligible|0|||
48757670|NCT00553150|156960818|FG003|Overall Study|Ineligible|1|||
48757671|NCT01980875|156960819|FG000|Overall Study|Withdrew Consent|1|||
48757672|NCT01980875|156960820|FG001|Overall Study|Withdrew Consent|1|||
48757673|NCT01980875|156960821|FG002|Overall Study|Withdrew Consent|1|||
48757674|NCT01980875|156960819|FG000|Overall Study|Study Terminated by Sponsor|7|||
48757675|NCT01980875|156960820|FG001|Overall Study|Study Terminated by Sponsor|24|||
48757676|NCT01980875|156960821|FG002|Overall Study|Study Terminated by Sponsor|22|||
48757677|NCT01980875|156960819|FG000|Overall Study|Lost to Follow-up|0|||
48757678|NCT01980875|156960820|FG001|Overall Study|Lost to Follow-up|0|||
48757679|NCT01980875|156960821|FG002|Overall Study|Lost to Follow-up|1|||
48867794|NCT00451555|157353065|FG000|Overall Study|Physician Decision|2|||
48967079|NCT00764478|157707139|FG000|Overall Study|Withdrawal by Subject|7|||
48967080|NCT00764478|157707140|FG001|Overall Study|Withdrawal by Subject|12|||
48967081|NCT00764478|157707141|FG002|Overall Study|Withdrawal by Subject|1|||
48967082|NCT00764478|157707139|FG000|Overall Study|Lost to Follow-up|7|||
48967083|NCT00764478|157707140|FG001|Overall Study|Lost to Follow-up|8|||
48967084|NCT00764478|157707141|FG002|Overall Study|Lost to Follow-up|5|||
48757680|NCT00665847|156960822|FG000|Overall Study|Adverse Event|8|||
48757681|NCT00665847|156960822|FG000|Overall Study|Withdrawal by Subject|2|||
48757682|NCT00665847|156960822|FG000|Overall Study|Subject non-compliant|8|||
48757683|NCT00665847|156960822|FG000|Overall Study|Subject reached a virologic endpoint|4|||
48757684|NCT00665847|156960822|FG000|Overall Study|Resistance to TMC125|1|||
48757685|NCT00665847|156960822|FG000|Overall Study|Subject ineligible to continue the trial|1|||
48665503|NCT02914548|156628508|FG001|Overall Study|>40% of body surface area|1|||
48665504|NCT02914548|156628509|FG002|Overall Study|>40% of body surface area|1|||
48665505|NCT00260065|156628510|FG000|Overall Study|Progressive Disease|22|||
48665506|NCT00260065|156628510|FG000|Overall Study|Adverse Event|17|||
48665507|NCT00260065|156628510|FG000|Overall Study|Death|13|||
48665508|NCT00260065|156628510|FG000|Overall Study|Withdrawal by Subject|13|||
48665509|NCT00260065|156628510|FG000|Overall Study|Physician Decision|19|||
48665510|NCT00260065|156628510|FG000|Overall Study|Not otherwise specified|8|||
48665511|NCT00260065|156628510|FG000|Overall Study|Medication Noncompliance|1|||
48665512|NCT02847858|156628511|FG000|Overall Study|Lost to Follow-up|401|||
48665513|NCT02847858|156628512|FG001|Overall Study|Lost to Follow-up|269|||
48665514|NCT01036529|156628513|FG000|Overall Study|Adverse Event|0|||
48665515|NCT01036529|156628514|FG001|Overall Study|Adverse Event|1|||
48665516|NCT01036529|156628513|FG000|Overall Study|Lost to Follow-up|0|||
48665517|NCT01036529|156628514|FG001|Overall Study|Lost to Follow-up|1|||
48665518|NCT01036529|156628513|FG000|Overall Study|Physician Decision|1|||
48665519|NCT01036529|156628514|FG001|Overall Study|Physician Decision|0|||
48665520|NCT01036529|156628513|FG000|Overall Study|Withdrawal by Subject|1|||
48665521|NCT01036529|156628514|FG001|Overall Study|Withdrawal by Subject|1|||
48665522|NCT01036529|156628513|FG000|Overall Study|Sponsor study termination|11|||
48665523|NCT01036529|156628514|FG001|Overall Study|Sponsor study termination|12|||
48665524|NCT03968159|156628524|FG000|Overall Study|Adverse Event|4|||
48757686|NCT00665847|156960822|FG000|Overall Study|Switch to Commercial Medication|1|||
48757687|NCT00195676|156960831|FG000|Period O - Open-label Treatment|Adverse Event|82|||
48757688|NCT00195676|156960831|FG000|Period O - Open-label Treatment|Death|6|||
48867795|NCT00451555|157353066|FG001|Overall Study|Physician Decision|1|||
48665525|NCT03968159|156628525|FG001|Overall Study|Adverse Event|4|||
48665526|NCT03968159|156628524|FG000|Overall Study|Lost to Follow-up|1|||
48665527|NCT03968159|156628525|FG001|Overall Study|Lost to Follow-up|1|||
48665528|NCT03968159|156628524|FG000|Overall Study|Use of prohibited medication|0|||
48665529|NCT03968159|156628525|FG001|Overall Study|Use of prohibited medication|1|||
48665530|NCT03968159|156628524|FG000|Overall Study|Protocol Violation|2|||
48665531|NCT03968159|156628525|FG001|Overall Study|Protocol Violation|2|||
48665532|NCT03968159|156628524|FG000|Overall Study|Withdrawal by Subject|4|||
48665533|NCT03968159|156628525|FG001|Overall Study|Withdrawal by Subject|6|||
48665534|NCT03968159|156628524|FG000|Overall Study|Lack of Efficacy|0|||
48665535|NCT03968159|156628525|FG001|Overall Study|Lack of Efficacy|1|||
48665536|NCT03968159|156628524|FG000|Overall Study|Not further specified|2|||
48665537|NCT03968159|156628525|FG001|Overall Study|Not further specified|0|||
48665538|NCT00581828|156628527|FG000|Overall Study|Protocol Violation|1|||
48665539|NCT00160199|156628529|FG000|Overall Study|Adverse Event|5|||
48665540|NCT00160199|156628530|FG001|Overall Study|Adverse Event|14|||
48665541|NCT00160199|156628529|FG000|Overall Study|Lack of Efficacy|0|||
48665542|NCT00160199|156628530|FG001|Overall Study|Lack of Efficacy|1|||
48665543|NCT00160199|156628529|FG000|Overall Study|Lost to Follow-up|7|||
48665544|NCT00160199|156628530|FG001|Overall Study|Lost to Follow-up|7|||
48665545|NCT00160199|156628529|FG000|Overall Study|Withdrawal by Subject|4|||
48665546|NCT00160199|156628530|FG001|Overall Study|Withdrawal by Subject|6|||
48665547|NCT00160199|156628529|FG000|Overall Study|Administrative|0|||
48665548|NCT00160199|156628530|FG001|Overall Study|Administrative|1|||
48757689|NCT00195676|156960831|FG000|Period O - Open-label Treatment|Lack of Efficacy|198|||
48867796|NCT03468218|157353067|FG000|Overall Study|Adverse Event|5|||
48867797|NCT03468218|157353067|FG000|Overall Study|Progressive Disease|16|||
48867798|NCT03468218|157353067|FG000|Overall Study|Death|1|||
48867799|NCT03468218|157353067|FG000|Overall Study|Alternate therapy|1|||
48867800|NCT03468218|157353067|FG000|Overall Study|Withdrawal by Subject|2|||
48867801|NCT06247488|157353069|FG000|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|1|||
48867802|NCT06247488|157353070|FG001|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
48867803|NCT06247488|157353071|FG002|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
48867804|NCT06247488|157353072|FG003|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
48867805|NCT06247488|157353073|FG004|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
48867806|NCT06247488|157353074|FG005|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
48867807|NCT06247488|157353069|FG000|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
48867808|NCT06247488|157353070|FG001|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
48867809|NCT06247488|157353071|FG002|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
48867810|NCT06247488|157353072|FG003|Washout From 2nd Dose (3 Days)|Physician Decision|1|||
48867811|NCT06247488|157353073|FG004|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
48867812|NCT06247488|157353074|FG005|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
48867813|NCT06247488|157353069|FG000|Washout of Third Dose (3 Days)|Withdrawal by Subject|1|||
48867814|NCT06247488|157353070|FG001|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
48867815|NCT06247488|157353071|FG002|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
48867816|NCT06247488|157353072|FG003|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
48867817|NCT06247488|157353073|FG004|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
48867818|NCT06247488|157353074|FG005|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
48867819|NCT06247488|157353069|FG000|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
48867820|NCT06247488|157353070|FG001|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
48867821|NCT06247488|157353071|FG002|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
48867822|NCT06247488|157353072|FG003|Washout of Fourth Dose (3 Days)|Physician Decision|1|||
48867823|NCT06247488|157353073|FG004|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
48867824|NCT06247488|157353074|FG005|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
48867825|NCT06247488|157353069|FG000|Washout of 5th Dose (3 Days)|Pregnancy|0|||
48867826|NCT06247488|157353070|FG001|Washout of 5th Dose (3 Days)|Pregnancy|0|||
48867827|NCT06247488|157353071|FG002|Washout of 5th Dose (3 Days)|Pregnancy|0|||
48867828|NCT06247488|157353072|FG003|Washout of 5th Dose (3 Days)|Pregnancy|0|||
48867829|NCT06247488|157353073|FG004|Washout of 5th Dose (3 Days)|Pregnancy|0|||
48867830|NCT06247488|157353074|FG005|Washout of 5th Dose (3 Days)|Pregnancy|1|||
48867831|NCT06247488|157353069|FG000|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
48867832|NCT06247488|157353070|FG001|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
48867833|NCT06247488|157353071|FG002|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
48867834|NCT06247488|157353072|FG003|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
48867835|NCT06247488|157353073|FG004|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
48867836|NCT06247488|157353074|FG005|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
48867837|NCT06247488|157353069|FG000|Washout of 5th Dose (3 Days)|Adverse Event|0|||
48867838|NCT06247488|157353070|FG001|Washout of 5th Dose (3 Days)|Adverse Event|0|||
48867839|NCT06247488|157353071|FG002|Washout of 5th Dose (3 Days)|Adverse Event|0|||
48867840|NCT06247488|157353072|FG003|Washout of 5th Dose (3 Days)|Adverse Event|0|||
48867841|NCT06247488|157353073|FG004|Washout of 5th Dose (3 Days)|Adverse Event|0|||
48867842|NCT06247488|157353074|FG005|Washout of 5th Dose (3 Days)|Adverse Event|1|||
48867843|NCT01040403|157353075|FG000|Overall Study|Adverse Event|10|||
48867844|NCT01040403|157353075|FG000|Overall Study|Protocol Violation|2|||
48867845|NCT01040403|157353075|FG000|Overall Study|Lost to Follow-up|1|||
48867846|NCT01040403|157353075|FG000|Overall Study|Not treated|1|||
48867847|NCT01040403|157353075|FG000|Overall Study|Other reason not defined above|6|||
48867848|NCT01284634|157353076|FG000|Overall Study|Adverse Event|1|||
48867849|NCT01284634|157353077|FG001|Overall Study|Adverse Event|0|||
48867850|NCT01284634|157353078|FG002|Overall Study|Adverse Event|2|||
48867851|NCT01284634|157353079|FG003|Overall Study|Adverse Event|1|||
48867852|NCT00317603|157353080|FG000|Overall Study|Progressive Disease|3|||
48867853|NCT01732588|157353081|FG000|First Intervention (7 Days)|Adverse Event|0|||
48867854|NCT01732588|157353082|FG001|First Intervention (7 Days)|Adverse Event|1|||
48867855|NCT01732588|157353083|FG002|First Intervention (7 Days)|Adverse Event|0|||
48867856|NCT00570921|157353084|FG000|Overall Study|Protocol Violation|1|||
48867857|NCT00570921|157353084|FG000|Overall Study|Physician Decision|1|||
48867858|NCT04806451|157353086|FG000|DB Treatment Period (28 Weeks)|Withdrawal by Subject|3|||
48867859|NCT04806451|157353087|FG001|DB Treatment Period (28 Weeks)|Withdrawal by Subject|1|||
48867860|NCT04806451|157353086|FG000|DB Treatment Period (28 Weeks)|Adverse Event|0|||
48867861|NCT04806451|157353087|FG001|DB Treatment Period (28 Weeks)|Adverse Event|2|||
48867862|NCT04806451|157353086|FG000|OL Treatment Period (24 Weeks)|Ongoing in the Study|16|||
48867863|NCT04806451|157353087|FG001|OL Treatment Period (24 Weeks)|Ongoing in the Study|37|||
48867864|NCT04772313|157353088|FG000|Pegloticase + MTX Treatment Period|Lost to Follow-up|3|||
48867865|NCT04772313|157353088|FG000|Pegloticase + MTX Treatment Period|Withdrawal by Subject|3|||
48867866|NCT03503162|157353089|FG000|Overall Study|did not meet eligibility|1|||
48867867|NCT00588341|157353091|FG000|Overall Study|Withdrawal by Subject|3|||
48867868|NCT00588341|157353091|FG000|Overall Study|Not treated due to metastatic disease|1|||
48867869|NCT00588341|157353091|FG000|Overall Study|Patient ineligible|1|||
48867870|NCT04473222|157353092|FG000|Overall Study|Lost to Follow-up|13|||
48867871|NCT04473222|157353093|FG001|Overall Study|Lost to Follow-up|13|||
48867872|NCT04473222|157353092|FG000|Overall Study|Withdrawal by Subject|0|||
48867873|NCT04473222|157353093|FG001|Overall Study|Withdrawal by Subject|1|||
48867874|NCT04473222|157353092|FG000|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|0|||
48867875|NCT04473222|157353093|FG001|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|1|||
48867876|NCT01670188|157353094|FG000|Overall Study|Death|0|||
48867877|NCT01670188|157353095|FG001|Overall Study|Death|1|||
48867878|NCT01954771|157353096|FG000|Overall Study|Missing HbA1c of end-point|1|||
48867879|NCT01954771|157353097|FG001|Overall Study|Missing HbA1c of end-point|1|||
48867880|NCT01954771|157353098|FG002|Overall Study|Missing HbA1c of end-point|0|||
48867881|NCT01954771|157353096|FG000|Overall Study|Missing CGMS of end-point|1|||
48867882|NCT01954771|157353097|FG001|Overall Study|Missing CGMS of end-point|1|||
48867883|NCT01954771|157353098|FG002|Overall Study|Missing CGMS of end-point|0|||
48867884|NCT01954771|157353096|FG000|Overall Study|Missing HbA1c and CGMS of end-point|5|||
48867885|NCT01954771|157353097|FG001|Overall Study|Missing HbA1c and CGMS of end-point|1|||
48867886|NCT01954771|157353098|FG002|Overall Study|Missing HbA1c and CGMS of end-point|3|||
48867887|NCT00385697|157353101|FG000|Open-label Segment 1|Withdrawal by Subject|2|||
48867888|NCT00385697|157353102|FG001|Open-label Segment 1|Withdrawal by Subject|0|||
48867889|NCT00385697|157353103|FG002|Open-label Segment 1|Withdrawal by Subject|0|||
48867890|NCT00385697|157353104|FG003|Open-label Segment 1|Withdrawal by Subject|0|||
48967085|NCT00764478|157707139|FG000|Overall Study|Protocol Violation|0|||
48757690|NCT00195676|156960831|FG000|Period O - Open-label Treatment|Lost to Follow-up|91|||
48757691|NCT00195676|156960831|FG000|Period O - Open-label Treatment|Protocol Violation|12|||
48757692|NCT00195676|156960831|FG000|Period O - Open-label Treatment|Withdrawal by Subject|147|||
48757693|NCT00195676|156960831|FG000|Period O - Open-label Treatment|Administrative reasons|2|||
48757694|NCT00195676|156960831|FG000|Period O - Open-label Treatment|Other reasons|68|||
48757695|NCT00195676|156960831|FG000|Period W (Withdrawal) - No Treatment|Adverse Event|4|||
48757696|NCT00195676|156960831|FG000|Period W (Withdrawal) - No Treatment|Death|2|||
48757697|NCT00195676|156960831|FG000|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11|||
48757698|NCT00195676|156960831|FG000|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46|||
48757699|NCT00195676|156960831|FG000|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397|||
48757700|NCT00195676|156960831|FG000|Period W (Withdrawal) - No Treatment|Period W Close-out|129|||
48757701|NCT00195676|156960831|FG000|Period W (Withdrawal) - No Treatment|Administrative reasons|1|||
48757702|NCT00195676|156960831|FG000|Period W (Withdrawal) - No Treatment|Other reasons|18|||
48757703|NCT00195676|156960831|FG000|Period R - Retreatment 16 Weeks|Adverse Event|4|||
48757704|NCT00195676|156960831|FG000|Period R - Retreatment 16 Weeks|Lack of Efficacy|5|||
48757705|NCT00195676|156960831|FG000|Period R - Retreatment 16 Weeks|Lost to Follow-up|11|||
48757706|NCT00195676|156960831|FG000|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9|||
48867891|NCT00385697|157353105|FG004|Open-label Segment 1|Withdrawal by Subject|0|||
48867892|NCT00385697|157353101|FG000|Open-label Segment 1|Lost to Follow-up|1|||
48867893|NCT00385697|157353102|FG001|Open-label Segment 1|Lost to Follow-up|0|||
48867894|NCT00385697|157353103|FG002|Open-label Segment 1|Lost to Follow-up|0|||
48867895|NCT00385697|157353104|FG003|Open-label Segment 1|Lost to Follow-up|0|||
48867896|NCT00385697|157353105|FG004|Open-label Segment 1|Lost to Follow-up|0|||
48867897|NCT00385697|157353101|FG000|Double-blind Segment 2|Adverse Event|0|||
48867898|NCT00385697|157353102|FG001|Double-blind Segment 2|Adverse Event|3|||
48867899|NCT00385697|157353103|FG002|Double-blind Segment 2|Adverse Event|1|||
48867900|NCT00385697|157353104|FG003|Double-blind Segment 2|Adverse Event|0|||
48867901|NCT00385697|157353105|FG004|Double-blind Segment 2|Adverse Event|0|||
48867902|NCT00385697|157353101|FG000|Double-blind Segment 2|Lost to Follow-up|0|||
48867903|NCT00385697|157353102|FG001|Double-blind Segment 2|Lost to Follow-up|11|||
48867904|NCT00385697|157353103|FG002|Double-blind Segment 2|Lost to Follow-up|5|||
48867905|NCT00385697|157353104|FG003|Double-blind Segment 2|Lost to Follow-up|2|||
48867906|NCT00385697|157353105|FG004|Double-blind Segment 2|Lost to Follow-up|5|||
48867907|NCT00385697|157353101|FG000|Double-blind Segment 2|Withdrawal by Subject|0|||
48867908|NCT00385697|157353102|FG001|Double-blind Segment 2|Withdrawal by Subject|10|||
48867909|NCT00385697|157353103|FG002|Double-blind Segment 2|Withdrawal by Subject|6|||
48867910|NCT00385697|157353104|FG003|Double-blind Segment 2|Withdrawal by Subject|7|||
48867911|NCT00385697|157353105|FG004|Double-blind Segment 2|Withdrawal by Subject|2|||
48867912|NCT00385697|157353101|FG000|Double-blind Segment 2|Other|0|||
48867913|NCT00385697|157353102|FG001|Double-blind Segment 2|Other|2|||
48867914|NCT00385697|157353103|FG002|Double-blind Segment 2|Other|0|||
48867915|NCT00385697|157353104|FG003|Double-blind Segment 2|Other|0|||
48867916|NCT00385697|157353105|FG004|Double-blind Segment 2|Other|0|||
48867917|NCT00745121|157353108|FG000|Overall Study|Death|3|||
48867918|NCT00745121|157353109|FG001|Overall Study|Death|0|||
48867919|NCT00745121|157353108|FG000|Overall Study|Adverse Event|1|||
48867920|NCT00745121|157353109|FG001|Overall Study|Adverse Event|0|||
48867921|NCT00745121|157353108|FG000|Overall Study|Lost to Follow-up|1|||
48867922|NCT00745121|157353109|FG001|Overall Study|Lost to Follow-up|0|||
48867923|NCT00745121|157353108|FG000|Overall Study|Withdrawal by Subject|4|||
48867924|NCT00745121|157353109|FG001|Overall Study|Withdrawal by Subject|2|||
48867925|NCT00510783|157353122|FG000|Overall Study|Lost to Follow-up|29|||
48867926|NCT00510783|157353123|FG001|Overall Study|Lost to Follow-up|25|||
48867927|NCT00510783|157353122|FG000|Overall Study|Withdrawal by Subject|2|||
48867928|NCT00510783|157353123|FG001|Overall Study|Withdrawal by Subject|3|||
48867929|NCT00510783|157353122|FG000|Overall Study|Protocol Violation|0|||
48867930|NCT00510783|157353123|FG001|Overall Study|Protocol Violation|1|||
48867931|NCT00819013|157353126|FG000|Overall Study|Not meeting continuing study eligibility|2|||
48867932|NCT00819013|157353127|FG001|Overall Study|Not meeting continuing study eligibility|1|||
48867933|NCT00819013|157353128|FG002|Overall Study|Not meeting continuing study eligibility|2|||
48867934|NCT00819013|157353129|FG003|Overall Study|Not meeting continuing study eligibility|1|||
48867935|NCT00819013|157353126|FG000|Overall Study|Adverse Event|0|||
48867936|NCT00819013|157353127|FG001|Overall Study|Adverse Event|0|||
48867937|NCT00819013|157353128|FG002|Overall Study|Adverse Event|1|||
48867938|NCT00819013|157353129|FG003|Overall Study|Adverse Event|0|||
48867939|NCT00819013|157353126|FG000|Overall Study|Withdrawal by Subject|1|||
48867940|NCT00819013|157353127|FG001|Overall Study|Withdrawal by Subject|0|||
48867941|NCT00819013|157353128|FG002|Overall Study|Withdrawal by Subject|1|||
48867942|NCT00819013|157353129|FG003|Overall Study|Withdrawal by Subject|0|||
48867943|NCT00819013|157353126|FG000|Overall Study|Lost to Follow-up|0|||
48867944|NCT00819013|157353127|FG001|Overall Study|Lost to Follow-up|0|||
48867945|NCT00819013|157353128|FG002|Overall Study|Lost to Follow-up|1|||
48867946|NCT00819013|157353129|FG003|Overall Study|Lost to Follow-up|2|||
48867947|NCT00819013|157353126|FG000|Overall Study|Death|0|||
48757707|NCT00195676|156960831|FG000|Period R - Retreatment 16 Weeks|Other reasons|6|||
48757708|NCT03447990|156960832|FG000|Overall Study|Withdrawal by Subject|0|||
48757709|NCT03447990|156960833|FG001|Overall Study|Withdrawal by Subject|0|||
48757710|NCT03447990|156960834|FG002|Overall Study|Withdrawal by Subject|0|||
48757711|NCT03447990|156960835|FG003|Overall Study|Withdrawal by Subject|0|||
48757712|NCT03447990|156960836|FG004|Overall Study|Withdrawal by Subject|0|||
48757713|NCT03447990|156960837|FG005|Overall Study|Withdrawal by Subject|0|||
48757714|NCT03447990|156960838|FG006|Overall Study|Withdrawal by Subject|1|||
48757715|NCT00535223|156960840|FG000|Overall Study|Withdrawal by Subject|4|||
48757716|NCT00535223|156960841|FG001|Overall Study|Withdrawal by Subject|1|||
48757717|NCT00616655|156960842|FG000|Overall Study|Adverse Event|10|||
48757718|NCT00616655|156960843|FG001|Overall Study|Adverse Event|7|||
48757719|NCT00616655|156960844|FG002|Overall Study|Adverse Event|12|||
48757720|NCT00616655|156960842|FG000|Overall Study|Lack of Efficacy|5|||
48757721|NCT00616655|156960843|FG001|Overall Study|Lack of Efficacy|5|||
48757722|NCT00616655|156960844|FG002|Overall Study|Lack of Efficacy|5|||
48757723|NCT00616655|156960842|FG000|Overall Study|Lost to Follow-up|3|||
48757724|NCT00616655|156960843|FG001|Overall Study|Lost to Follow-up|12|||
48757725|NCT00616655|156960844|FG002|Overall Study|Lost to Follow-up|10|||
48757726|NCT00616655|156960842|FG000|Overall Study|Protocol Violation|2|||
48757727|NCT00616655|156960843|FG001|Overall Study|Protocol Violation|4|||
48757728|NCT00616655|156960844|FG002|Overall Study|Protocol Violation|3|||
48757729|NCT00616655|156960842|FG000|Overall Study|Withdrawal by Subject|9|||
48757730|NCT00616655|156960843|FG001|Overall Study|Withdrawal by Subject|7|||
48867948|NCT00819013|157353127|FG001|Overall Study|Death|0|||
48867949|NCT00819013|157353128|FG002|Overall Study|Death|0|||
48867950|NCT00819013|157353129|FG003|Overall Study|Death|1|||
48867951|NCT02442349|157353130|FG000|Overall Study|Death|95|||
48665549|NCT00160199|156628529|FG000|Overall Study|Protocol Violation|8|||
48665550|NCT00160199|156628530|FG001|Overall Study|Protocol Violation|8|||
48665551|NCT00434759|156628531|FG000|Overall Study|Lack of Efficacy|5|||
48665552|NCT00434759|156628532|FG001|Overall Study|Lack of Efficacy|4|||
48665553|NCT00434759|156628531|FG000|Overall Study|Withdrawal by Subject|17|||
48665554|NCT00434759|156628532|FG001|Overall Study|Withdrawal by Subject|1|||
48665555|NCT00434759|156628531|FG000|Overall Study|family affairs|2|||
48665556|NCT00434759|156628532|FG001|Overall Study|family affairs|0|||
48665557|NCT00875056|156628534|FG000|Overall Study|Adverse Event|6|||
48665558|NCT00875056|156628535|FG001|Overall Study|Adverse Event|1|||
48665559|NCT00875056|156628536|FG002|Overall Study|Adverse Event|2|||
48665560|NCT00875056|156628534|FG000|Overall Study|Progressive Disease|14|||
48665561|NCT00875056|156628535|FG001|Overall Study|Progressive Disease|8|||
48665562|NCT00875056|156628536|FG002|Overall Study|Progressive Disease|3|||
48665563|NCT00875056|156628534|FG000|Overall Study|Withdrawal by Subject|3|||
48665564|NCT00875056|156628535|FG001|Overall Study|Withdrawal by Subject|0|||
48665565|NCT00875056|156628536|FG002|Overall Study|Withdrawal by Subject|1|||
48665566|NCT01300819|156628537|FG000|Overall Study|Adverse Event|9|||
48665567|NCT01300819|156628538|FG001|Overall Study|Adverse Event|27|||
48665568|NCT01300819|156628537|FG000|Overall Study|Lack of Efficacy|2|||
48665569|NCT01300819|156628538|FG001|Overall Study|Lack of Efficacy|1|||
48665570|NCT01300819|156628537|FG000|Overall Study|Withdrawal by Subject|10|||
48665571|NCT01300819|156628538|FG001|Overall Study|Withdrawal by Subject|12|||
48665572|NCT01300819|156628537|FG000|Overall Study|Patient was 1 month late for Visit 10|0|||
48665573|NCT01300819|156628538|FG001|Overall Study|Patient was 1 month late for Visit 10|1|||
48665574|NCT01300819|156628537|FG000|Overall Study|Refusal to down titrate study drug|0|||
48665575|NCT01300819|156628538|FG001|Overall Study|Refusal to down titrate study drug|1|||
48757731|NCT00616655|156960844|FG002|Overall Study|Withdrawal by Subject|11|||
48757732|NCT00616655|156960842|FG000|Overall Study|Does not meet in/ex criteria|0|||
48867952|NCT02442349|157353130|FG000|Overall Study|Withdrawal by Subject|27|||
48867953|NCT02442349|157353130|FG000|Overall Study|poor compliance after treatment discontinuation|2|||
48867954|NCT02442349|157353130|FG000|Overall Study|Lost to Follow-up|1|||
48867955|NCT02553460|157353131|FG000|Overall Study|Death|3|||
48867956|NCT02553460|157353131|FG000|Overall Study|Withdrawal by Subject|1|||
48867957|NCT02553460|157353131|FG000|Overall Study|Development of unacceptable toxicity during treatment|1|||
48867958|NCT02553460|157353131|FG000|Overall Study|Relapse or Transplant|14|||
48867959|NCT02553460|157353131|FG000|Overall Study|No response to treatment|2|||
48867960|NCT02553460|157353131|FG000|Overall Study|CAR T cells|2|||
48867961|NCT01544309|157353132|FG000|Overall Study|Withdrawal by Subject|12|||
48867962|NCT01544309|157353133|FG001|Overall Study|Withdrawal by Subject|7|||
48867963|NCT01544309|157353132|FG000|Overall Study|Protocol Violation|2|||
48665576|NCT01300819|156628537|FG000|Overall Study|Administrative reason|0|||
48665577|NCT01300819|156628538|FG001|Overall Study|Administrative reason|1|||
48757733|NCT00616655|156960843|FG001|Overall Study|Does not meet in/ex criteria|0|||
48757734|NCT00616655|156960844|FG002|Overall Study|Does not meet in/ex criteria|2|||
48757735|NCT00616655|156960842|FG000|Overall Study|Other|6|||
48757736|NCT00616655|156960843|FG001|Overall Study|Other|6|||
48757737|NCT00616655|156960844|FG002|Overall Study|Other|5|||
48757738|NCT03761147|156960847|FG000|Overall Study|Withdrawal by Subject|6|||
48665578|NCT01300819|156628537|FG000|Overall Study|Safety follow up not done by mistake|0|||
48665579|NCT01300819|156628538|FG001|Overall Study|Safety follow up not done by mistake|1|||
48665580|NCT01300819|156628537|FG000|Overall Study|Follow up call was not done|1|||
48665581|NCT01300819|156628538|FG001|Overall Study|Follow up call was not done|0|||
48665582|NCT00554099|156628541|FG000|Treatment Period (12 Weeks)|Adverse Event|3|||
48665583|NCT00554099|156628542|FG001|Treatment Period (12 Weeks)|Adverse Event|5|||
48665584|NCT00554099|156628543|FG002|Treatment Period (12 Weeks)|Adverse Event|1|||
48665585|NCT00554099|156628541|FG000|Treatment Period (12 Weeks)|Physician Decision|3|||
48665586|NCT00554099|156628542|FG001|Treatment Period (12 Weeks)|Physician Decision|0|||
48665587|NCT00554099|156628543|FG002|Treatment Period (12 Weeks)|Physician Decision|0|||
48665588|NCT00554099|156628541|FG000|Treatment Period (12 Weeks)|Lost to Follow-up|1|||
48665589|NCT00554099|156628542|FG001|Treatment Period (12 Weeks)|Lost to Follow-up|0|||
48665590|NCT00554099|156628543|FG002|Treatment Period (12 Weeks)|Lost to Follow-up|2|||
48665591|NCT00554099|156628541|FG000|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1|||
48665592|NCT00554099|156628542|FG001|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2|||
48665593|NCT00554099|156628543|FG002|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0|||
48665594|NCT00554099|156628541|FG000|Treatment Period (12 Weeks)|Protocol Violation|0|||
48665595|NCT00554099|156628542|FG001|Treatment Period (12 Weeks)|Protocol Violation|0|||
48665596|NCT00554099|156628543|FG002|Treatment Period (12 Weeks)|Protocol Violation|2|||
48665597|NCT00554099|156628541|FG000|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
48665598|NCT00554099|156628542|FG001|Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
48665599|NCT00554099|156628543|FG002|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
48967086|NCT00764478|157707140|FG001|Overall Study|Protocol Violation|1|||
48967087|NCT00764478|157707141|FG002|Overall Study|Protocol Violation|1|||
48967088|NCT03571256|157707142|FG000|Overall Study|Adverse Event|3|||
48967089|NCT03571256|157707143|FG001|Overall Study|Adverse Event|0|||
48967090|NCT03571256|157707144|FG002|Overall Study|Adverse Event|1|||
48967091|NCT03571256|157707142|FG000|Overall Study|Withdrawal by Subject|3|||
48967092|NCT03571256|157707143|FG001|Overall Study|Withdrawal by Subject|1|||
48967093|NCT03571256|157707144|FG002|Overall Study|Withdrawal by Subject|1|||
48665600|NCT00554099|156628541|FG000|Non-Treatment Phase (9 Months)|Lost to Follow-up|1|||
48665601|NCT00554099|156628542|FG001|Non-Treatment Phase (9 Months)|Lost to Follow-up|2|||
48665602|NCT00554099|156628543|FG002|Non-Treatment Phase (9 Months)|Lost to Follow-up|0|||
48665603|NCT00554099|156628541|FG000|Non-Treatment Phase (9 Months)|Relapse|2|||
48665604|NCT00554099|156628542|FG001|Non-Treatment Phase (9 Months)|Relapse|1|||
48665605|NCT00554099|156628543|FG002|Non-Treatment Phase (9 Months)|Relapse|1|||
48665606|NCT00554099|156628541|FG000|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4|||
48665607|NCT00554099|156628542|FG001|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
48665608|NCT00554099|156628543|FG002|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
48665609|NCT02075632|156628547|FG000|Overall Study|Adverse Event|1|||
48665610|NCT02075632|156628548|FG001|Overall Study|Adverse Event|1|||
48665611|NCT02075632|156628547|FG000|Overall Study|Lost to Follow-up|0|||
48665612|NCT02075632|156628548|FG001|Overall Study|Lost to Follow-up|3|||
48665613|NCT02075632|156628547|FG000|Overall Study|Withdrawal by Subject|0|||
48665614|NCT02075632|156628548|FG001|Overall Study|Withdrawal by Subject|1|||
48665615|NCT00791557|156628549|FG000|Overall Study|Adverse Event|1|||
48665616|NCT02573246|156628552|FG000|Overall Study|Lost to Follow-up|2|||
48665617|NCT02573246|156628553|FG001|Overall Study|Lost to Follow-up|0|||
48967094|NCT03571256|157707142|FG000|Overall Study|Other than specified|0|||
48665618|NCT02573246|156628554|FG002|Overall Study|Lost to Follow-up|0|||
48665619|NCT02573246|156628555|FG003|Overall Study|Lost to Follow-up|0|||
48665620|NCT02573246|156628556|FG004|Overall Study|Lost to Follow-up|1|||
48665621|NCT02573246|156628552|FG000|Overall Study|Withdrawal by Subject|0|||
48665622|NCT02573246|156628553|FG001|Overall Study|Withdrawal by Subject|0|||
48665623|NCT02573246|156628554|FG002|Overall Study|Withdrawal by Subject|0|||
48665624|NCT02573246|156628555|FG003|Overall Study|Withdrawal by Subject|0|||
48665625|NCT02573246|156628556|FG004|Overall Study|Withdrawal by Subject|1|||
48665626|NCT02573246|156628552|FG000|Overall Study|Physician Decision|1|||
48665627|NCT02573246|156628553|FG001|Overall Study|Physician Decision|1|||
48665628|NCT02573246|156628554|FG002|Overall Study|Physician Decision|3|||
48665629|NCT02573246|156628555|FG003|Overall Study|Physician Decision|2|||
48757739|NCT03761147|156960848|FG001|Overall Study|Withdrawal by Subject|1|||
48757740|NCT03761147|156960847|FG000|Overall Study|Adverse Event|1|||
48967095|NCT03571256|157707143|FG001|Overall Study|Other than specified|1|||
48967096|NCT03571256|157707144|FG002|Overall Study|Other than specified|1|||
48967097|NCT03571256|157707142|FG000|Overall Study|Protocol Violation|0|||
48967098|NCT03571256|157707143|FG001|Overall Study|Protocol Violation|1|||
48967099|NCT03571256|157707144|FG002|Overall Study|Protocol Violation|1|||
48967100|NCT02247401|157707147|FG000|Overall Study|Adverse Event|1|||
48665630|NCT02573246|156628556|FG004|Overall Study|Physician Decision|2|||
48665631|NCT03002623|156628557|FG000|Overall Study|Lost to Follow-up|1|||
48967101|NCT02247401|157707148|FG001|Overall Study|Adverse Event|0|||
48967102|NCT02247401|157707149|FG002|Overall Study|Adverse Event|0|||
48967103|NCT02247401|157707147|FG000|Overall Study|Withdrawal by Subject|4|||
49015462|NCT01393990|157893776|FG006|Overall Study|Progressive Disease|1|||
48665632|NCT03002623|156628558|FG001|Overall Study|Lost to Follow-up|0|||
48665633|NCT03002623|156628557|FG000|Overall Study|Physician Decision|1|||
48665634|NCT03002623|156628558|FG001|Overall Study|Physician Decision|1|||
48665635|NCT00657371|156628563|FG000|Overall Study|Poor bowel preparation|15|||
48757741|NCT03761147|156960848|FG001|Overall Study|Adverse Event|3|||
48757742|NCT03630120|156960849|FG000|Overall Study|Disease progression|0|||
48757743|NCT03630120|156960850|FG001|Overall Study|Disease progression|1|||
48757744|NCT03630120|156960851|FG002|Overall Study|Disease progression|1|||
48757745|NCT03630120|156960852|FG003|Overall Study|Disease progression|1|||
48757746|NCT01826487|156960853|FG000|Overall Study|Adverse Event|1|||
48757747|NCT01826487|156960854|FG001|Overall Study|Adverse Event|1|||
48757748|NCT01826487|156960853|FG000|Overall Study|Lost to Follow-up|1|||
48757749|NCT01826487|156960854|FG001|Overall Study|Lost to Follow-up|0|||
48757750|NCT01826487|156960853|FG000|Overall Study|Withdrawal by Subject|1|||
48757751|NCT01826487|156960854|FG001|Overall Study|Withdrawal by Subject|3|||
48757752|NCT01826487|156960853|FG000|Overall Study|Protocol Violation|1|||
48757753|NCT01826487|156960854|FG001|Overall Study|Protocol Violation|1|||
48757754|NCT01408030|156960855|FG000|Treatment Phase (on Drug)|Lost to Follow-up|1|||
48757755|NCT01408030|156960856|FG001|Treatment Phase (on Drug)|Lost to Follow-up|0|||
48757756|NCT01408030|156960857|FG002|Treatment Phase (on Drug)|Lost to Follow-up|1|||
48757757|NCT01408030|156960858|FG003|Treatment Phase (on Drug)|Lost to Follow-up|0|||
48757758|NCT01408030|156960855|FG000|Treatment Phase (on Drug)|Lack of Efficacy|2|||
48757759|NCT01408030|156960856|FG001|Treatment Phase (on Drug)|Lack of Efficacy|6|||
48757760|NCT01408030|156960857|FG002|Treatment Phase (on Drug)|Lack of Efficacy|0|||
48757761|NCT01408030|156960858|FG003|Treatment Phase (on Drug)|Lack of Efficacy|3|||
48757762|NCT01408030|156960855|FG000|Treatment Phase (on Drug)|Protocol Violation|0|||
48757763|NCT01408030|156960856|FG001|Treatment Phase (on Drug)|Protocol Violation|1|||
48757764|NCT01408030|156960857|FG002|Treatment Phase (on Drug)|Protocol Violation|0|||
48757765|NCT01408030|156960858|FG003|Treatment Phase (on Drug)|Protocol Violation|0|||
48757766|NCT01408030|156960855|FG000|Observation Phase (Off Drug)|Lost to Follow-up|0|||
48757767|NCT01408030|156960856|FG001|Observation Phase (Off Drug)|Lost to Follow-up|2|||
48757768|NCT01408030|156960857|FG002|Observation Phase (Off Drug)|Lost to Follow-up|2|||
48757769|NCT01408030|156960858|FG003|Observation Phase (Off Drug)|Lost to Follow-up|0|||
48757770|NCT01408030|156960855|FG000|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
48757771|NCT01408030|156960856|FG001|Observation Phase (Off Drug)|Withdrawal by Subject|2|||
48757772|NCT01408030|156960857|FG002|Observation Phase (Off Drug)|Withdrawal by Subject|1|||
48757773|NCT01408030|156960858|FG003|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
48757774|NCT01408030|156960855|FG000|Observation Phase (Off Drug)|Physician Decision|0|||
48757775|NCT01408030|156960856|FG001|Observation Phase (Off Drug)|Physician Decision|1|||
48757776|NCT01408030|156960857|FG002|Observation Phase (Off Drug)|Physician Decision|2|||
48757777|NCT01408030|156960858|FG003|Observation Phase (Off Drug)|Physician Decision|0|||
48757778|NCT01408030|156960855|FG000|Observation Phase (Off Drug)|Other|1|||
48757779|NCT01408030|156960856|FG001|Observation Phase (Off Drug)|Other|1|||
48757780|NCT01408030|156960857|FG002|Observation Phase (Off Drug)|Other|1|||
48757781|NCT01408030|156960858|FG003|Observation Phase (Off Drug)|Other|1|||
48757782|NCT00423150|156960860|FG000|Overall Study|Adverse Event|11|||
48757783|NCT00423150|156960860|FG000|Overall Study|Progression of disease being studied|69|||
48757784|NCT00423150|156960860|FG000|Overall Study|Withdrawal by Subject|1|||
48757785|NCT00423150|156960860|FG000|Overall Study|Non-compliance with protocol|1|||
48867964|NCT01544309|157353133|FG001|Overall Study|Protocol Violation|1|||
48867965|NCT01544309|157353132|FG000|Overall Study|Physician Decision|4|||
48867966|NCT01544309|157353133|FG001|Overall Study|Physician Decision|1|||
48867967|NCT01544309|157353132|FG000|Overall Study|Not performed pre-dose examination|1|||
48867968|NCT01544309|157353133|FG001|Overall Study|Not performed pre-dose examination|2|||
48867969|NCT01544309|157353132|FG000|Overall Study|Administered prohibit prior medication|1|||
48867970|NCT01544309|157353133|FG001|Overall Study|Administered prohibit prior medication|0|||
48867971|NCT04137367|157353140|FG000|Overall Study|Lost to Follow-up|8|||
48967104|NCT02247401|157707148|FG001|Overall Study|Withdrawal by Subject|1|||
48665636|NCT00657371|156628563|FG000|Overall Study|Unable to intubate the cecum|5|||
48665637|NCT00657371|156628563|FG000|Overall Study|Protocol Violation|2|||
48665638|NCT00657371|156628563|FG000|Overall Study|Device- related reasons|13|||
48665639|NCT00657371|156628563|FG000|Overall Study|Pre-existing medical condition|4|||
48665640|NCT04342689|156628564|FG000|Overall Study|Withdrawal by Subject|32|||
48665641|NCT04342689|156628565|FG001|Overall Study|Withdrawal by Subject|33|||
48665642|NCT04342689|156628564|FG000|Overall Study|Lost to Follow-up|10|||
48867972|NCT04137367|157353141|FG001|Overall Study|Lost to Follow-up|6|||
48967105|NCT02247401|157707149|FG002|Overall Study|Withdrawal by Subject|1|||
48665643|NCT04342689|156628565|FG001|Overall Study|Lost to Follow-up|12|||
48665644|NCT00844805|156628566|FG000|Treatment Phase|Adverse Event|5|||
48665645|NCT00844805|156628567|FG001|Treatment Phase|Adverse Event|1|||
48665646|NCT00844805|156628568|FG002|Treatment Phase|Adverse Event|0|||
48665647|NCT00844805|156628569|FG003|Treatment Phase|Adverse Event|0|||
48757786|NCT00423150|156960860|FG000|Overall Study|Administrative|4|||
48867973|NCT04137367|157353142|FG002|Overall Study|Lost to Follow-up|4|||
48665648|NCT00844805|156628566|FG000|Treatment Phase|Withdrawal by Subject|3|||
48665649|NCT00844805|156628567|FG001|Treatment Phase|Withdrawal by Subject|4|||
48665650|NCT00844805|156628568|FG002|Treatment Phase|Withdrawal by Subject|0|||
48665651|NCT00844805|156628569|FG003|Treatment Phase|Withdrawal by Subject|0|||
48665652|NCT00844805|156628566|FG000|Treatment Phase|Noncompliance With Protocol|1|||
48665653|NCT00844805|156628567|FG001|Treatment Phase|Noncompliance With Protocol|0|||
48665654|NCT00844805|156628568|FG002|Treatment Phase|Noncompliance With Protocol|0|||
48665655|NCT00844805|156628569|FG003|Treatment Phase|Noncompliance With Protocol|0|||
48665656|NCT00844805|156628566|FG000|Treatment Phase|Did Not Meet Protocol Eligibility|1|||
48665657|NCT00844805|156628567|FG001|Treatment Phase|Did Not Meet Protocol Eligibility|2|||
48665658|NCT00844805|156628568|FG002|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
48665659|NCT00844805|156628569|FG003|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
48665660|NCT00844805|156628566|FG000|Follow-Up Phase|Adverse Event|0|||
48665661|NCT00844805|156628567|FG001|Follow-Up Phase|Adverse Event|0|||
48665662|NCT00844805|156628568|FG002|Follow-Up Phase|Adverse Event|1|||
48665663|NCT00844805|156628569|FG003|Follow-Up Phase|Adverse Event|0|||
48665664|NCT00844805|156628566|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
48665665|NCT00844805|156628567|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
48665666|NCT00844805|156628568|FG002|Follow-Up Phase|Withdrawal by Subject|6|||
48757787|NCT03204305|156960862|FG000|Overall Study|Lost to Follow-up|6|||
48757788|NCT03204305|156960863|FG001|Overall Study|Lost to Follow-up|4|||
48757789|NCT03204305|156960864|FG002|Overall Study|Lost to Follow-up|0|||
48757790|NCT03204305|156960865|FG003|Overall Study|Lost to Follow-up|0|||
48665667|NCT00844805|156628569|FG003|Follow-Up Phase|Withdrawal by Subject|3|||
48665668|NCT00844805|156628566|FG000|Follow-Up Phase|Noncompliance With Protocol|0|||
48665669|NCT00844805|156628567|FG001|Follow-Up Phase|Noncompliance With Protocol|0|||
48757791|NCT03204305|156960862|FG000|Overall Study|Physician Decision|1|||
48757792|NCT03204305|156960863|FG001|Overall Study|Physician Decision|0|||
48757793|NCT03204305|156960864|FG002|Overall Study|Physician Decision|0|||
48757794|NCT03204305|156960865|FG003|Overall Study|Physician Decision|0|||
48757795|NCT03204305|156960862|FG000|Overall Study|failure to place arterial line|2|||
48867974|NCT02714257|157353143|FG000|Overall Study|Withdrawal by Subject|6|||
48665670|NCT00844805|156628568|FG002|Follow-Up Phase|Noncompliance With Protocol|0|||
48665671|NCT00844805|156628569|FG003|Follow-Up Phase|Noncompliance With Protocol|1|||
48665672|NCT00844805|156628566|FG000|Follow-Up Phase|Relapse/Recurrence|0|||
48665673|NCT00844805|156628567|FG001|Follow-Up Phase|Relapse/Recurrence|0|||
48665674|NCT00844805|156628568|FG002|Follow-Up Phase|Relapse/Recurrence|2|||
48665675|NCT00844805|156628569|FG003|Follow-Up Phase|Relapse/Recurrence|4|||
48665676|NCT00844805|156628566|FG000|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
48665677|NCT00844805|156628567|FG001|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
48665678|NCT00844805|156628568|FG002|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
48665679|NCT00844805|156628569|FG003|Follow-Up Phase|Did Not Meet Protocol Eligibility|1|||
48665680|NCT01167907|156628576|FG000|Overall Study|Protocol Violation|1|||
48665681|NCT01167907|156628577|FG001|Overall Study|Protocol Violation|0|||
48665682|NCT01167907|156628576|FG000|Overall Study|saphenous catheter dislodged before comp|1|||
48665683|NCT01167907|156628577|FG001|Overall Study|saphenous catheter dislodged before comp|1|||
48757796|NCT03204305|156960863|FG001|Overall Study|failure to place arterial line|1|||
48757797|NCT03204305|156960864|FG002|Overall Study|failure to place arterial line|0|||
48757798|NCT03204305|156960865|FG003|Overall Study|failure to place arterial line|0|||
48867975|NCT02714257|157353144|FG001|Overall Study|Withdrawal by Subject|11|||
48867976|NCT02714257|157353143|FG000|Overall Study|Death|3|||
48867977|NCT02714257|157353144|FG001|Overall Study|Death|4|||
48867978|NCT02714257|157353143|FG000|Overall Study|Lost to Follow-up|1|||
48867979|NCT02714257|157353144|FG001|Overall Study|Lost to Follow-up|6|||
48867980|NCT04206384|157353146|FG000|Overall Study|Withdrawal by Subject|8|||
48867981|NCT04206384|157353146|FG000|Overall Study|Adverse Event|2|||
48867982|NCT04159805|157353149|FG000|Overall Study|Withdrawal by Subject|0|||
48867983|NCT04159805|157353150|FG001|Overall Study|Withdrawal by Subject|2|||
48867984|NCT04159805|157353151|FG002|Overall Study|Withdrawal by Subject|2|||
48867985|NCT02998918|157353152|FG000|Overall Study|Withdrawal by Subject|1|||
48867986|NCT02998918|157353153|FG001|Overall Study|Withdrawal by Subject|0|||
48867987|NCT01679613|157353156|FG000|Overall Study|other than stated above|0|||
48867988|NCT01679613|157353157|FG001|Overall Study|other than stated above|1|||
48867989|NCT01679613|157353158|FG002|Overall Study|other than stated above|2|||
48867990|NCT01679613|157353159|FG003|Overall Study|other than stated above|2|||
48867991|NCT00439647|157353848|FG000|Overall Study|Withdrawal by Subject|25|||
48867992|NCT00439647|157353849|FG001|Overall Study|Withdrawal by Subject|22|||
48867993|NCT00439647|157353848|FG000|Overall Study|Death|15|||
48867994|NCT00439647|157353849|FG001|Overall Study|Death|18|||
48867995|NCT00439647|157353848|FG000|Overall Study|Adverse Event|11|||
48867996|NCT00439647|157353849|FG001|Overall Study|Adverse Event|11|||
48867997|NCT00439647|157353848|FG000|Overall Study|Lost to Follow-up|4|||
48867998|NCT00439647|157353849|FG001|Overall Study|Lost to Follow-up|12|||
48867999|NCT00439647|157353848|FG000|Overall Study|Protocol Violation|3|||
48868000|NCT00439647|157353849|FG001|Overall Study|Protocol Violation|4|||
48665684|NCT00857948|156628578|FG000|Overall Study|Withdrawal by Subject|2|||
48665685|NCT00857948|156628579|FG001|Overall Study|Withdrawal by Subject|0|||
48665686|NCT00857948|156628580|FG002|Overall Study|Withdrawal by Subject|0|||
48665687|NCT00857948|156628581|FG003|Overall Study|Withdrawal by Subject|0|||
48665688|NCT00857948|156628578|FG000|Overall Study|Protocol Violation|1|||
48665689|NCT00857948|156628579|FG001|Overall Study|Protocol Violation|0|||
48665690|NCT00857948|156628580|FG002|Overall Study|Protocol Violation|1|||
48665691|NCT00857948|156628581|FG003|Overall Study|Protocol Violation|0|||
48665692|NCT03077698|156628585|FG000|Progestin Monotherapy|Stable Disease|8|||
48665693|NCT03077698|156628586|FG001|Progestin Monotherapy|Stable Disease|0|||
48665694|NCT03077698|156628585|FG000|Progestin Monotherapy|Adverse Event|1|||
48665695|NCT03077698|156628586|FG001|Progestin Monotherapy|Adverse Event|0|||
48665696|NCT03077698|156628585|FG000|Progestin Monotherapy|Death|1|||
48665697|NCT03077698|156628586|FG001|Progestin Monotherapy|Death|0|||
48665698|NCT03077698|156628585|FG000|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|0|||
48665699|NCT03077698|156628586|FG001|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|2|||
48665700|NCT03077698|156628585|FG000|Sodium Cridanimod & Progestin Therapy|Disease Progression|6|||
48665701|NCT03077698|156628586|FG001|Sodium Cridanimod & Progestin Therapy|Disease Progression|5|||
48665702|NCT03077698|156628585|FG000|Sodium Cridanimod & Progestin Therapy|Adverse Event|0|||
48665703|NCT03077698|156628586|FG001|Sodium Cridanimod & Progestin Therapy|Adverse Event|2|||
48665704|NCT03077698|156628585|FG000|Safety Follow Up|Withdrawal by Subject|2|||
48665705|NCT03077698|156628586|FG001|Safety Follow Up|Withdrawal by Subject|1|||
48665706|NCT03077698|156628585|FG000|Safety Follow Up|Transfer of care to hospice|1|||
48665707|NCT03077698|156628586|FG001|Safety Follow Up|Transfer of care to hospice|0|||
48665708|NCT04135859|156628590|FG000|Overall Study|Withdrawal by Subject|1|||
48665709|NCT04135859|156628591|FG001|Overall Study|Withdrawal by Subject|0|||
48665710|NCT04135859|156628590|FG000|Overall Study|Withdrawal due to screening failure|1|||
48665711|NCT04135859|156628591|FG001|Overall Study|Withdrawal due to screening failure|2|||
48665712|NCT04135859|156628590|FG000|Overall Study|Did not complete stress test|3|||
48665713|NCT04135859|156628591|FG001|Overall Study|Did not complete stress test|3|||
48665714|NCT04135859|156628590|FG000|Overall Study|Did not wear accelerometer and did not complete stress test|0|||
48665715|NCT04135859|156628591|FG001|Overall Study|Did not wear accelerometer and did not complete stress test|2|||
48665716|NCT00613080|156628592|FG000|Overall Study|Ineligible / no protocol treatment|11|||
48665717|NCT01066780|156628593|FG000|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
48665718|NCT01066780|156628594|FG001|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
48665719|NCT01241760|156628597|FG000|Overall Study|Adverse Event|1|||
48665720|NCT01241760|156628598|FG001|Overall Study|Adverse Event|0|||
48665721|NCT01241760|156628597|FG000|Overall Study|Lost to Follow-up|18|||
48665722|NCT01241760|156628598|FG001|Overall Study|Lost to Follow-up|22|||
48665723|NCT01241760|156628597|FG000|Overall Study|Withdrawal by Subject|13|||
48665724|NCT01241760|156628598|FG001|Overall Study|Withdrawal by Subject|13|||
48665725|NCT01241760|156628597|FG000|Overall Study|Switch To Commercially Available Medicat|1|||
48665726|NCT01241760|156628598|FG001|Overall Study|Switch To Commercially Available Medicat|4|||
48665727|NCT01241760|156628597|FG000|Overall Study|Other|1|||
48665728|NCT01241760|156628598|FG001|Overall Study|Other|1|||
48665729|NCT03697993|156628599|FG000|Overall Study|Became Ineligible after Enrollment|1|||
48665730|NCT03697993|156628600|FG001|Overall Study|Became Ineligible after Enrollment|3|||
48665731|NCT03697993|156628599|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
48665732|NCT03697993|156628600|FG001|Overall Study|Enrolled but Treatment not Administered|1|||
48665733|NCT03697993|156628599|FG000|Overall Study|Lost to Follow-up|3|||
48665734|NCT03697993|156628600|FG001|Overall Study|Lost to Follow-up|0|||
48665735|NCT03697993|156628599|FG000|Overall Study|Physician Decision|4|||
48665736|NCT03697993|156628600|FG001|Overall Study|Physician Decision|0|||
48665737|NCT03697993|156628599|FG000|Overall Study|Initial Urine Culture Negative|0|||
48665738|NCT03697993|156628600|FG001|Overall Study|Initial Urine Culture Negative|1|||
48665739|NCT02279498|156628613|FG000|Overall Study|Adverse Event|3|||
48665740|NCT02279498|156628614|FG001|Overall Study|Adverse Event|0|||
48665741|NCT02279498|156628613|FG000|Overall Study|Lack of Efficacy|4|||
48665742|NCT02279498|156628614|FG001|Overall Study|Lack of Efficacy|0|||
48665743|NCT02279498|156628613|FG000|Overall Study|Lost to Follow-up|0|||
48665744|NCT02279498|156628614|FG001|Overall Study|Lost to Follow-up|1|||
48665745|NCT02279498|156628613|FG000|Overall Study|Withdrawal by Subject|9|||
48665746|NCT02279498|156628614|FG001|Overall Study|Withdrawal by Subject|2|||
48665747|NCT02279498|156628613|FG000|Overall Study|Undefined|2|||
48665748|NCT02279498|156628614|FG001|Overall Study|Undefined|1|||
48665749|NCT04284813|156628615|FG000|Overall Study|Withdrawal by Subject|1|||
48665750|NCT02525094|156628616|FG000|Overall Study|Lost to Follow-up|2|||
48665751|NCT02525094|156628617|FG001|Overall Study|Lost to Follow-up|1|||
48665752|NCT02525094|156628616|FG000|Overall Study|Withdrawal by Subject|5|||
48868001|NCT00439647|157353848|FG000|Overall Study|Lack of Efficacy|0|||
48665753|NCT02525094|156628617|FG001|Overall Study|Withdrawal by Subject|6|||
48665754|NCT02525094|156628616|FG000|Overall Study|Not Treated|1|||
48665755|NCT02525094|156628617|FG001|Overall Study|Not Treated|1|||
48665756|NCT01591863|156628618|FG000|Overall Study|Adverse Event|3|||
48868002|NCT00439647|157353849|FG001|Overall Study|Lack of Efficacy|4|||
48967106|NCT02247401|157707147|FG000|Overall Study|Lost to Follow-up|1|||
48967107|NCT02247401|157707148|FG001|Overall Study|Lost to Follow-up|1|||
48967108|NCT02247401|157707149|FG002|Overall Study|Lost to Follow-up|1|||
48967109|NCT03498287|157707150|FG000|Overall Study|Withdrawal by Subject|3|||
48967110|NCT03498287|157707151|FG001|Overall Study|Withdrawal by Subject|0|||
48967111|NCT03498287|157707150|FG000|Overall Study|Protocol Violation|0|||
48967112|NCT03498287|157707151|FG001|Overall Study|Protocol Violation|4|||
48967113|NCT03498287|157707150|FG000|Overall Study|Adverse Event|0|||
48967114|NCT03498287|157707151|FG001|Overall Study|Adverse Event|1|||
48967115|NCT01244191|157707154|FG000|Overall Study|Progressive disease|295|||
48967116|NCT01244191|157707155|FG001|Overall Study|Progressive disease|350|||
48665757|NCT01591863|156628618|FG000|Overall Study|Withdrawal by Subject|1|||
48665758|NCT01591863|156628618|FG000|Overall Study|recurrence|9|||
48665759|NCT01591863|156628618|FG000|Overall Study|Lack of Efficacy|1|||
48665760|NCT00969436|156628620|FG000|Overall Study|Protocol Violation|1|||
48665761|NCT00969436|156628621|FG001|Overall Study|Protocol Violation|3|||
48665762|NCT00969436|156628622|FG002|Overall Study|Protocol Violation|0|||
48665763|NCT00969436|156628620|FG000|Overall Study|Migrated/moved from study area|12|||
48665764|NCT00969436|156628621|FG001|Overall Study|Migrated/moved from study area|10|||
48665765|NCT00969436|156628622|FG002|Overall Study|Migrated/moved from study area|2|||
48665766|NCT00969436|156628620|FG000|Overall Study|Father - serious health problem|0|||
48665767|NCT00969436|156628621|FG001|Overall Study|Father - serious health problem|0|||
48665768|NCT00969436|156628622|FG002|Overall Study|Father - serious health problem|1|||
48665769|NCT00969436|156628620|FG000|Overall Study|Parents personal problem|0|||
48665770|NCT00969436|156628621|FG001|Overall Study|Parents personal problem|0|||
48665771|NCT00969436|156628622|FG002|Overall Study|Parents personal problem|1|||
48665772|NCT00969436|156628620|FG000|Overall Study|Subject eliminated (other vaccine)|1|||
48665773|NCT00969436|156628621|FG001|Overall Study|Subject eliminated (other vaccine)|0|||
48665774|NCT00969436|156628622|FG002|Overall Study|Subject eliminated (other vaccine)|0|||
48665775|NCT00969436|156628620|FG000|Overall Study|Withdrawal by Subject|3|||
48665776|NCT00969436|156628621|FG001|Overall Study|Withdrawal by Subject|0|||
48665777|NCT00969436|156628622|FG002|Overall Study|Withdrawal by Subject|2|||
48665778|NCT00969436|156628620|FG000|Overall Study|Lost to Follow-up|8|||
48665779|NCT00969436|156628621|FG001|Overall Study|Lost to Follow-up|8|||
48665780|NCT00969436|156628622|FG002|Overall Study|Lost to Follow-up|5|||
48665781|NCT00831701|156628625|FG000|Overall Study|Withdrawal by Subject|2|||
48665782|NCT00831701|156628626|FG001|Overall Study|Withdrawal by Subject|0|||
48665783|NCT00831701|156628625|FG000|Overall Study|Stone expulsion before first medication|2|||
48665784|NCT00831701|156628626|FG001|Overall Study|Stone expulsion before first medication|2|||
48665785|NCT00831701|156628625|FG000|Overall Study|Lost to Follow-up|1|||
48665786|NCT00831701|156628626|FG001|Overall Study|Lost to Follow-up|3|||
48665787|NCT00262847|156630056|FG000|Overall Study|Disease Progression|309|||
48665788|NCT00262847|156630057|FG001|Overall Study|Disease Progression|274|||
48665789|NCT00262847|156630058|FG002|Overall Study|Disease Progression|195|||
48665790|NCT00262847|156630056|FG000|Overall Study|Patient Refusal|41|||
48665791|NCT00262847|156630057|FG001|Overall Study|Patient Refusal|52|||
48665792|NCT00262847|156630058|FG002|Overall Study|Patient Refusal|47|||
48665793|NCT00262847|156630056|FG000|Overall Study|Adverse Event|74|||
48665794|NCT00262847|156630057|FG001|Overall Study|Adverse Event|88|||
48665795|NCT00262847|156630058|FG002|Overall Study|Adverse Event|108|||
48665796|NCT00262847|156630056|FG000|Overall Study|Death|8|||
48665797|NCT00262847|156630057|FG001|Overall Study|Death|8|||
48665798|NCT00262847|156630058|FG002|Overall Study|Death|11|||
48665799|NCT00262847|156630056|FG000|Overall Study|Concomitant disease|3|||
48665800|NCT00262847|156630057|FG001|Overall Study|Concomitant disease|2|||
48665801|NCT00262847|156630058|FG002|Overall Study|Concomitant disease|4|||
48665802|NCT00262847|156630056|FG000|Overall Study|Other Reasons|79|||
48665803|NCT00262847|156630057|FG001|Overall Study|Other Reasons|88|||
48665804|NCT00262847|156630058|FG002|Overall Study|Other Reasons|27|||
48665805|NCT00262847|156630056|FG000|Overall Study|Did not receive study treatment|4|||
48665806|NCT00262847|156630057|FG001|Overall Study|Did not receive study treatment|1|||
48665807|NCT00262847|156630058|FG002|Overall Study|Did not receive study treatment|4|||
48665808|NCT02091284|156630059|FG000|Overall Study|Withdrawal by Subject|2|||
48665809|NCT02091284|156630060|FG001|Overall Study|Withdrawal by Subject|1|||
48665810|NCT02091284|156630059|FG000|Overall Study|unreliable data|1|||
48665811|NCT02091284|156630060|FG001|Overall Study|unreliable data|0|||
48665812|NCT03627065|156630067|FG000|Overall Study|Study Terminated by sponsor|1|||
48665813|NCT03627065|156630067|FG000|Overall Study|Withdrawal by Subject|2|||
48665814|NCT02804750|156630068|FG000|Period 1|Adverse Event|0|||
48665815|NCT02804750|156630069|FG001|Period 1|Adverse Event|2|||
48665816|NCT02804750|156630068|FG000|Period 1|Withdrawal by Subject|0|||
48665817|NCT02804750|156630069|FG001|Period 1|Withdrawal by Subject|1|||
48665818|NCT02804750|156630068|FG000|Period 2|Adverse Event|1|||
48665819|NCT02804750|156630069|FG001|Period 2|Adverse Event|0|||
48665820|NCT02804750|156630068|FG000|Period 3|Adverse Event|0|||
48665821|NCT02804750|156630069|FG001|Period 3|Adverse Event|2|||
48665822|NCT02804750|156630068|FG000|Period 4|Adverse Event|0|||
48665823|NCT02804750|156630069|FG001|Period 4|Adverse Event|5|||
48665824|NCT03602885|156630070|FG000|Overall Study|Lost to Follow-up|3|||
48757799|NCT03204305|156960862|FG000|Overall Study|Withdrawal by Subject|2|||
48757800|NCT03204305|156960863|FG001|Overall Study|Withdrawal by Subject|0|||
48757801|NCT03204305|156960864|FG002|Overall Study|Withdrawal by Subject|0|||
48757802|NCT03204305|156960865|FG003|Overall Study|Withdrawal by Subject|0|||
48757803|NCT00455429|156960866|FG000|Overall Study|Study Terminated by Sponsor|0|||
48757804|NCT00455429|156960867|FG001|Overall Study|Study Terminated by Sponsor|0|||
48757805|NCT00455429|156960868|FG002|Overall Study|Study Terminated by Sponsor|0|||
48757806|NCT00455429|156960869|FG003|Overall Study|Study Terminated by Sponsor|3|||
48757807|NCT00455429|156960866|FG000|Overall Study|Lost to Follow-up|1|||
48757808|NCT00455429|156960867|FG001|Overall Study|Lost to Follow-up|0|||
48757809|NCT00455429|156960868|FG002|Overall Study|Lost to Follow-up|0|||
48757810|NCT00455429|156960869|FG003|Overall Study|Lost to Follow-up|3|||
48757811|NCT00455429|156960866|FG000|Overall Study|Withdrawal by Subject|0|||
48665825|NCT03602885|156630071|FG001|Overall Study|Lost to Follow-up|0|||
48665826|NCT02046070|156630072|FG000|Overall Study|Progressive Disease|18|||
48665827|NCT02046070|156630073|FG001|Overall Study|Progressive Disease|11|||
48665828|NCT02046070|156630074|FG002|Overall Study|Progressive Disease|40|||
48665829|NCT02046070|156630072|FG000|Overall Study|Adverse Event|8|||
48665830|NCT02046070|156630073|FG001|Overall Study|Adverse Event|10|||
48665831|NCT02046070|156630074|FG002|Overall Study|Adverse Event|17|||
48665832|NCT02046070|156630072|FG000|Overall Study|Withdrawal by Subject|1|||
48665833|NCT02046070|156630073|FG001|Overall Study|Withdrawal by Subject|2|||
48665834|NCT02046070|156630074|FG002|Overall Study|Withdrawal by Subject|6|||
48665835|NCT02046070|156630072|FG000|Overall Study|Study Terminated by Sponsor|1|||
48665836|NCT02046070|156630073|FG001|Overall Study|Study Terminated by Sponsor|1|||
48665837|NCT02046070|156630074|FG002|Overall Study|Study Terminated by Sponsor|1|||
48665838|NCT02046070|156630072|FG000|Overall Study|Reason not Specified|4|||
48665839|NCT02046070|156630073|FG001|Overall Study|Reason not Specified|4|||
48665840|NCT02046070|156630074|FG002|Overall Study|Reason not Specified|6|||
48665841|NCT01974752|156630078|FG000|Overall Study|Death|33|||
48665842|NCT01974752|156630079|FG001|Overall Study|Death|11|||
48665843|NCT01974752|156630078|FG000|Overall Study|Lost to Follow-up|2|||
48665844|NCT01974752|156630079|FG001|Overall Study|Lost to Follow-up|0|||
48665845|NCT01974752|156630078|FG000|Overall Study|Withdrawal by Subject|2|||
48665846|NCT01974752|156630079|FG001|Overall Study|Withdrawal by Subject|3|||
48665847|NCT01974752|156630078|FG000|Overall Study|Other Eligibility Criteria|0|||
48665848|NCT01974752|156630079|FG001|Overall Study|Other Eligibility Criteria|1|||
48665849|NCT00330928|156630080|FG000|Overall Study|Lost to Follow-up|6|||
48757812|NCT00455429|156960867|FG001|Overall Study|Withdrawal by Subject|1|||
48757813|NCT00455429|156960868|FG002|Overall Study|Withdrawal by Subject|1|||
48757814|NCT00455429|156960869|FG003|Overall Study|Withdrawal by Subject|0|||
48757815|NCT00455429|156960866|FG000|Overall Study|Lack of Efficacy|0|||
48757816|NCT00455429|156960867|FG001|Overall Study|Lack of Efficacy|1|||
48757817|NCT00455429|156960868|FG002|Overall Study|Lack of Efficacy|0|||
48757818|NCT00455429|156960869|FG003|Overall Study|Lack of Efficacy|1|||
48757819|NCT00455429|156960866|FG000|Overall Study|Adverse Event|0|||
48757820|NCT00455429|156960867|FG001|Overall Study|Adverse Event|1|||
48757821|NCT00455429|156960868|FG002|Overall Study|Adverse Event|0|||
48967117|NCT01244191|157707154|FG000|Overall Study|Clinical disease progression|54|||
48967118|NCT01244191|157707155|FG001|Overall Study|Clinical disease progression|36|||
48967119|NCT01244191|157707154|FG000|Overall Study|Adverse Event|65|||
48967120|NCT01244191|157707155|FG001|Overall Study|Adverse Event|48|||
48967121|NCT01244191|157707154|FG000|Overall Study|Death|22|||
48967122|NCT01244191|157707155|FG001|Overall Study|Death|29|||
48967123|NCT01244191|157707154|FG000|Overall Study|Lost to Follow-up|0|||
48967124|NCT01244191|157707155|FG001|Overall Study|Lost to Follow-up|2|||
48967125|NCT01244191|157707154|FG000|Overall Study|Protocol Violation|1|||
48967126|NCT01244191|157707155|FG001|Overall Study|Protocol Violation|2|||
48967127|NCT01244191|157707154|FG000|Overall Study|Withdrawal by Subject|31|||
48967128|NCT01244191|157707155|FG001|Overall Study|Withdrawal by Subject|23|||
48665850|NCT00330928|156630080|FG000|Overall Study|Physician Decision|9|||
48665851|NCT00330928|156630080|FG000|Overall Study|Death|1|||
48665852|NCT00330928|156630080|FG000|Overall Study|IVUS could not be performed.|1|||
48665853|NCT01998893|156630081|FG000|Overall Study|Adverse Event|2|||
48757822|NCT00455429|156960869|FG003|Overall Study|Adverse Event|3|||
48757823|NCT00455429|156960866|FG000|Overall Study|Randomly assigned but not treated|0|||
48757824|NCT00455429|156960867|FG001|Overall Study|Randomly assigned but not treated|0|||
48967129|NCT01244191|157707154|FG000|Overall Study|'Missing' or 'Terminated by sponsor'|12|||
48967130|NCT01244191|157707155|FG001|Overall Study|'Missing' or 'Terminated by sponsor'|8|||
48967131|NCT04142216|157707157|FG000|Overall Study|Hospitalization|0|||
48967132|NCT04142216|157707158|FG001|Overall Study|Hospitalization|2|||
48967133|NCT04142216|157707157|FG000|Overall Study|Death|3|||
48967134|NCT04142216|157707158|FG001|Overall Study|Death|1|||
48967135|NCT04142216|157707157|FG000|Overall Study|Referral to another hemodialysis unit|3|||
48665854|NCT01998893|156630081|FG000|Overall Study|Death|1|||
48665855|NCT01998893|156630081|FG000|Overall Study|Lost to Follow-up|8|||
48665856|NCT01998893|156630081|FG000|Overall Study|Physician Decision|2|||
48665857|NCT01998893|156630081|FG000|Overall Study|Protocol Violation|2|||
48967136|NCT04142216|157707158|FG001|Overall Study|Referral to another hemodialysis unit|2|||
48967137|NCT04142216|157707157|FG000|Overall Study|Use of clove|0|||
48967138|NCT04142216|157707158|FG001|Overall Study|Use of clove|1|||
48967139|NCT01117012|157707159|FG000|Overall Study|Adverse Event|0|||
48967140|NCT01117012|157707160|FG001|Overall Study|Adverse Event|1|||
48967141|NCT01117012|157707159|FG000|Overall Study|Death|1|||
48967142|NCT01117012|157707160|FG001|Overall Study|Death|1|||
48967143|NCT01117012|157707159|FG000|Overall Study|Withdrawal by Subject|3|||
48967144|NCT01117012|157707160|FG001|Overall Study|Withdrawal by Subject|0|||
48967145|NCT01117012|157707159|FG000|Overall Study|Undefined|4|||
48967146|NCT01117012|157707160|FG001|Overall Study|Undefined|3|||
48967147|NCT02726113|157707168|FG000|Total Enrollment|Physician Decision|0|||
48665858|NCT01998893|156630081|FG000|Overall Study|Withdrawal by Subject|1|||
48665859|NCT01998893|156630081|FG000|Overall Study|Transformation to high-grade lymphoma|1|||
48665860|NCT04676867|156630087|FG000|Overall Study|Screen failure|0|||
48665861|NCT04676867|156630088|FG001|Overall Study|Screen failure|0|||
48665862|NCT04676867|156630089|FG002|Overall Study|Screen failure|6|||
48665863|NCT04676867|156630090|FG003|Overall Study|Screen failure|2|||
48665864|NCT04676867|156630087|FG000|Overall Study|Death|0|||
48665865|NCT04676867|156630088|FG001|Overall Study|Death|0|||
48665866|NCT04676867|156630089|FG002|Overall Study|Death|1|||
48665867|NCT04676867|156630090|FG003|Overall Study|Death|0|||
48665868|NCT04676867|156630087|FG000|Overall Study|Withdrawal by Subject|2|||
48665869|NCT04676867|156630088|FG001|Overall Study|Withdrawal by Subject|2|||
48665870|NCT04676867|156630089|FG002|Overall Study|Withdrawal by Subject|4|||
48665871|NCT04676867|156630090|FG003|Overall Study|Withdrawal by Subject|4|||
48665872|NCT04676867|156630087|FG000|Overall Study|Lost to Follow-up|1|||
48665873|NCT04676867|156630088|FG001|Overall Study|Lost to Follow-up|0|||
48967148|NCT02726113|157707169|FG001|Total Enrollment|Physician Decision|1|||
48967149|NCT02726113|157707168|FG000|Total Enrollment|Protocol Violation|1|||
48967150|NCT02726113|157707169|FG001|Total Enrollment|Protocol Violation|0|||
48967151|NCT02726113|157707168|FG000|Total Enrollment|Withdrawal by Subject|2|||
48967152|NCT02726113|157707169|FG001|Total Enrollment|Withdrawal by Subject|1|||
48967153|NCT02726113|157707168|FG000|Total Enrollment|Insurance non-coverage for surgery|1|||
48967154|NCT02726113|157707169|FG001|Total Enrollment|Insurance non-coverage for surgery|1|||
48967155|NCT02726113|157707168|FG000|Genomic Analysis|Protocol Violation|1|||
48967156|NCT02726113|157707169|FG001|Genomic Analysis|Protocol Violation|0|||
48967157|NCT02726113|157707168|FG000|Genomic Analysis|Withdrawal by Subject|2|||
48967158|NCT02726113|157707169|FG001|Genomic Analysis|Withdrawal by Subject|1|||
48967159|NCT02726113|157707168|FG000|Genomic Analysis|Insurance non-coverage for surgery|1|||
48967160|NCT02726113|157707169|FG001|Genomic Analysis|Insurance non-coverage for surgery|1|||
48665874|NCT04676867|156630089|FG002|Overall Study|Lost to Follow-up|0|||
48665875|NCT04676867|156630090|FG003|Overall Study|Lost to Follow-up|0|||
48665876|NCT02231762|156630100|FG000|Combination Phase|Adverse Event|10|||
48665877|NCT02231762|156630101|FG001|Combination Phase|Adverse Event|0|||
48665878|NCT02231762|156630102|FG002|Combination Phase|Adverse Event|0|||
48665879|NCT02231762|156630103|FG003|Combination Phase|Adverse Event|0|||
48665880|NCT02231762|156630100|FG000|Combination Phase|Withdrawal by Subject|2|||
48665881|NCT02231762|156630101|FG001|Combination Phase|Withdrawal by Subject|0|||
48665882|NCT02231762|156630102|FG002|Combination Phase|Withdrawal by Subject|0|||
48665883|NCT02231762|156630103|FG003|Combination Phase|Withdrawal by Subject|0|||
48967161|NCT01763866|157707170|FG000|Overall Study|Withdrawal by Subject|2|||
48967162|NCT01763866|157707171|FG001|Overall Study|Withdrawal by Subject|1|||
48967163|NCT01763866|157707172|FG002|Overall Study|Withdrawal by Subject|4|||
48967164|NCT01763866|157707173|FG003|Overall Study|Withdrawal by Subject|0|||
48967165|NCT01763866|157707174|FG004|Overall Study|Withdrawal by Subject|0|||
48665884|NCT02231762|156630100|FG000|Combination Phase|Disease Progression|6|||
48665885|NCT02231762|156630101|FG001|Combination Phase|Disease Progression|0|||
48967166|NCT01763866|157707175|FG005|Overall Study|Withdrawal by Subject|3|||
48967167|NCT01763866|157707176|FG006|Overall Study|Withdrawal by Subject|4|||
48967168|NCT01763866|157707177|FG007|Overall Study|Withdrawal by Subject|0|||
48967169|NCT01763866|157707178|FG008|Overall Study|Withdrawal by Subject|1|||
48967170|NCT01763866|157707179|FG009|Overall Study|Withdrawal by Subject|1|||
48967171|NCT01763866|157707180|FG010|Overall Study|Withdrawal by Subject|2|||
48967172|NCT01763866|157707181|FG011|Overall Study|Withdrawal by Subject|2|||
48967173|NCT01763866|157707182|FG012|Overall Study|Withdrawal by Subject|2|||
48967174|NCT01763866|157707183|FG013|Overall Study|Withdrawal by Subject|0|||
48967175|NCT01763866|157707184|FG014|Overall Study|Withdrawal by Subject|6|||
48967176|NCT01763866|157707185|FG015|Overall Study|Withdrawal by Subject|3|||
48967177|NCT01763866|157707186|FG016|Overall Study|Withdrawal by Subject|0|||
48665886|NCT02231762|156630102|FG002|Combination Phase|Disease Progression|0|||
48665887|NCT02231762|156630103|FG003|Combination Phase|Disease Progression|0|||
48665888|NCT02231762|156630100|FG000|Combination Phase|Did not meet inclusion criteria|1|||
48665889|NCT02231762|156630101|FG001|Combination Phase|Did not meet inclusion criteria|0|||
48665890|NCT02231762|156630102|FG002|Combination Phase|Did not meet inclusion criteria|0|||
48665891|NCT02231762|156630103|FG003|Combination Phase|Did not meet inclusion criteria|0|||
48757825|NCT00455429|156960868|FG002|Overall Study|Randomly assigned but not treated|0|||
48757826|NCT00455429|156960869|FG003|Overall Study|Randomly assigned but not treated|2|||
48868003|NCT02250183|157353850|FG000|Overall Study|Withdrawal by Subject|2|||
48868004|NCT02250183|157353850|FG000|Overall Study|Adverse Event|5|||
48868005|NCT02250183|157353850|FG000|Overall Study|Lost to Follow-up|1|||
48868006|NCT03746483|157353851|FG000|Overall Study|Adverse Event|0|||
48868007|NCT03746483|157353852|FG001|Overall Study|Adverse Event|1|||
48868008|NCT03746483|157353851|FG000|Overall Study|Lack of Efficacy|3|||
48868009|NCT03746483|157353852|FG001|Overall Study|Lack of Efficacy|2|||
48868010|NCT03746483|157353851|FG000|Overall Study|Lost to Follow-up|1|||
48868011|NCT03746483|157353852|FG001|Overall Study|Lost to Follow-up|0|||
48868012|NCT03746483|157353851|FG000|Overall Study|Protocol Violation|2|||
48868013|NCT03746483|157353852|FG001|Overall Study|Protocol Violation|0|||
48757827|NCT00455429|156960866|FG000|Overall Study|Personal Reason|1|||
48757828|NCT00455429|156960867|FG001|Overall Study|Personal Reason|0|||
48868014|NCT01951261|157353853|FG000|Overall Study|Death|1|||
48868015|NCT01951261|157353854|FG001|Overall Study|Death|0|||
48868016|NCT01951261|157353853|FG000|Overall Study|Lost to Follow-up|4|||
48868017|NCT01951261|157353854|FG001|Overall Study|Lost to Follow-up|3|||
48868018|NCT01951261|157353853|FG000|Overall Study|Protocol Violation|4|||
48868019|NCT01951261|157353854|FG001|Overall Study|Protocol Violation|3|||
48868020|NCT01924806|157353855|FG000|Overall Study|Physician Decision|2|||
48868021|NCT01924806|157353856|FG001|Overall Study|Physician Decision|1|||
48868022|NCT00578318|157353862|FG000|Overall Study|Lost to Follow-up|2|||
48868023|NCT00578318|157353863|FG001|Overall Study|Lost to Follow-up|0|||
48868024|NCT00578318|157353862|FG000|Overall Study|Physician Decision|1|||
48868025|NCT00578318|157353863|FG001|Overall Study|Physician Decision|0|||
48868026|NCT00475735|157353864|FG000|Treatment Period 1|Adverse Event|2|||
48868027|NCT00475735|157353865|FG001|Treatment Period 1|Adverse Event|0|||
48868028|NCT00475735|157353866|FG002|Treatment Period 1|Adverse Event|0|||
48868029|NCT00475735|157353867|FG003|Treatment Period 1|Adverse Event|0|||
48868030|NCT00475735|157353868|FG004|Treatment Period 1|Adverse Event|0|||
48868031|NCT00475735|157353869|FG005|Treatment Period 1|Adverse Event|0|||
48868032|NCT00475735|157353864|FG000|Treatment Period 1|Lack of Efficacy|1|||
48868033|NCT00475735|157353865|FG001|Treatment Period 1|Lack of Efficacy|0|||
48868034|NCT00475735|157353866|FG002|Treatment Period 1|Lack of Efficacy|0|||
48868035|NCT00475735|157353867|FG003|Treatment Period 1|Lack of Efficacy|0|||
48868036|NCT00475735|157353868|FG004|Treatment Period 1|Lack of Efficacy|0|||
48868037|NCT00475735|157353869|FG005|Treatment Period 1|Lack of Efficacy|0|||
48868038|NCT00475735|157353864|FG000|Treatment Period 1|Lost to Follow-up|0|||
48868039|NCT00475735|157353865|FG001|Treatment Period 1|Lost to Follow-up|0|||
48868040|NCT00475735|157353866|FG002|Treatment Period 1|Lost to Follow-up|0|||
48868041|NCT00475735|157353867|FG003|Treatment Period 1|Lost to Follow-up|0|||
48868042|NCT00475735|157353868|FG004|Treatment Period 1|Lost to Follow-up|0|||
48868043|NCT00475735|157353869|FG005|Treatment Period 1|Lost to Follow-up|1|||
48868044|NCT00475735|157353864|FG000|Treatment Period 1|Protocol Violation|0|||
48868045|NCT00475735|157353865|FG001|Treatment Period 1|Protocol Violation|0|||
48868046|NCT00475735|157353866|FG002|Treatment Period 1|Protocol Violation|0|||
48868047|NCT00475735|157353867|FG003|Treatment Period 1|Protocol Violation|1|||
48757829|NCT00455429|156960868|FG002|Overall Study|Personal Reason|0|||
48757830|NCT00455429|156960869|FG003|Overall Study|Personal Reason|0|||
48757831|NCT00455429|156960866|FG000|Overall Study|Non-compliance|0|||
48757832|NCT00455429|156960867|FG001|Overall Study|Non-compliance|0|||
48757833|NCT00455429|156960868|FG002|Overall Study|Non-compliance|0|||
48757834|NCT00455429|156960869|FG003|Overall Study|Non-compliance|1|||
48757835|NCT00455429|156960866|FG000|Overall Study|Other|0|||
48757836|NCT00455429|156960867|FG001|Overall Study|Other|2|||
48757837|NCT00455429|156960868|FG002|Overall Study|Other|0|||
48757838|NCT00455429|156960869|FG003|Overall Study|Other|1|||
48757839|NCT01603459|156960872|FG000|Overall Study|Adverse Event|5|||
48757840|NCT01603459|156960872|FG000|Overall Study|Withdrawal by Subject|5|||
48757841|NCT01603459|156960872|FG000|Overall Study|Lost to Follow-up|3|||
48757842|NCT01603459|156960872|FG000|Overall Study|Predefined discontinuation criteria|3|||
48868048|NCT00475735|157353868|FG004|Treatment Period 1|Protocol Violation|0|||
48868049|NCT00475735|157353869|FG005|Treatment Period 1|Protocol Violation|0|||
48967178|NCT01763866|157707187|FG017|Overall Study|Withdrawal by Subject|1|||
48868050|NCT00475735|157353864|FG000|Treatment Period 1|Withdrawal by Subject|1|||
48868051|NCT00475735|157353865|FG001|Treatment Period 1|Withdrawal by Subject|1|||
48868052|NCT00475735|157353866|FG002|Treatment Period 1|Withdrawal by Subject|0|||
48868053|NCT00475735|157353867|FG003|Treatment Period 1|Withdrawal by Subject|0|||
48757843|NCT01603459|156960872|FG000|Overall Study|Non-compliance|1|||
48757844|NCT01603459|156960872|FG000|Overall Study|Administrative reason|1|||
48868054|NCT00475735|157353868|FG004|Treatment Period 1|Withdrawal by Subject|0|||
48868055|NCT00475735|157353869|FG005|Treatment Period 1|Withdrawal by Subject|0|||
48868056|NCT00475735|157353864|FG000|Treatment Period 1|DC due to AE but continuing|0|||
48868057|NCT00475735|157353865|FG001|Treatment Period 1|DC due to AE but continuing|0|||
49015463|NCT01393990|157893777|FG007|Overall Study|Progressive Disease|1|||
48757845|NCT02335099|156960873|FG000|Treatment|Withdrawal by Subject|1|||
48757846|NCT02335099|156960874|FG001|Treatment|Withdrawal by Subject|3|||
48967179|NCT01763866|157707188|FG018|Overall Study|Withdrawal by Subject|1|||
48967180|NCT01763866|157707189|FG019|Overall Study|Withdrawal by Subject|1|||
48967181|NCT01763866|157707190|FG020|Overall Study|Withdrawal by Subject|2|||
48967182|NCT01763866|157707191|FG021|Overall Study|Withdrawal by Subject|1|||
48967183|NCT01763866|157707192|FG022|Overall Study|Withdrawal by Subject|2|||
48967184|NCT01763866|157707193|FG023|Overall Study|Withdrawal by Subject|1|||
48967185|NCT01763866|157707170|FG000|Overall Study|Decision by sponsor|0|||
48967186|NCT01763866|157707171|FG001|Overall Study|Decision by sponsor|0|||
48967187|NCT01763866|157707172|FG002|Overall Study|Decision by sponsor|1|||
48967188|NCT01763866|157707173|FG003|Overall Study|Decision by sponsor|0|||
48967189|NCT01763866|157707174|FG004|Overall Study|Decision by sponsor|2|||
48967190|NCT01763866|157707175|FG005|Overall Study|Decision by sponsor|0|||
48967191|NCT01763866|157707176|FG006|Overall Study|Decision by sponsor|2|||
48967192|NCT01763866|157707177|FG007|Overall Study|Decision by sponsor|0|||
48967193|NCT01763866|157707178|FG008|Overall Study|Decision by sponsor|2|||
48967194|NCT01763866|157707179|FG009|Overall Study|Decision by sponsor|0|||
48967195|NCT01763866|157707180|FG010|Overall Study|Decision by sponsor|6|||
48967196|NCT01763866|157707181|FG011|Overall Study|Decision by sponsor|0|||
48967197|NCT01763866|157707182|FG012|Overall Study|Decision by sponsor|1|||
48967198|NCT01763866|157707183|FG013|Overall Study|Decision by sponsor|0|||
48967199|NCT01763866|157707184|FG014|Overall Study|Decision by sponsor|5|||
48967200|NCT01763866|157707185|FG015|Overall Study|Decision by sponsor|0|||
48967201|NCT01763866|157707186|FG016|Overall Study|Decision by sponsor|0|||
48967202|NCT01763866|157707187|FG017|Overall Study|Decision by sponsor|0|||
48967203|NCT01763866|157707188|FG018|Overall Study|Decision by sponsor|4|||
48967204|NCT01763866|157707189|FG019|Overall Study|Decision by sponsor|0|||
48967205|NCT01763866|157707190|FG020|Overall Study|Decision by sponsor|2|||
48967206|NCT01763866|157707191|FG021|Overall Study|Decision by sponsor|0|||
48967207|NCT01763866|157707192|FG022|Overall Study|Decision by sponsor|1|||
48967208|NCT01763866|157707193|FG023|Overall Study|Decision by sponsor|0|||
48967209|NCT01763866|157707170|FG000|Overall Study|Lost to Follow-up|0|||
48967210|NCT01763866|157707171|FG001|Overall Study|Lost to Follow-up|0|||
48967211|NCT01763866|157707172|FG002|Overall Study|Lost to Follow-up|0|||
48967212|NCT01763866|157707173|FG003|Overall Study|Lost to Follow-up|0|||
48967213|NCT01763866|157707174|FG004|Overall Study|Lost to Follow-up|0|||
48967214|NCT01763866|157707175|FG005|Overall Study|Lost to Follow-up|0|||
48967215|NCT01763866|157707176|FG006|Overall Study|Lost to Follow-up|1|||
48967216|NCT01763866|157707177|FG007|Overall Study|Lost to Follow-up|0|||
48967217|NCT01763866|157707178|FG008|Overall Study|Lost to Follow-up|0|||
48967218|NCT01763866|157707179|FG009|Overall Study|Lost to Follow-up|0|||
48967219|NCT01763866|157707180|FG010|Overall Study|Lost to Follow-up|0|||
48665892|NCT02231762|156630100|FG000|Combination Phase|Protocol Violation|1|||
48665893|NCT02231762|156630101|FG001|Combination Phase|Protocol Violation|0|||
48665894|NCT02231762|156630102|FG002|Combination Phase|Protocol Violation|0|||
48665895|NCT02231762|156630103|FG003|Combination Phase|Protocol Violation|0|||
48665896|NCT02231762|156630100|FG000|Maintenance Phase|Disease progression|0|||
48665897|NCT02231762|156630101|FG001|Maintenance Phase|Disease progression|3|||
48665898|NCT02231762|156630102|FG002|Maintenance Phase|Disease progression|4|||
48665899|NCT02231762|156630103|FG003|Maintenance Phase|Disease progression|3|||
48665900|NCT02231762|156630100|FG000|Maintenance Phase|Adverse Event|0|||
48665901|NCT02231762|156630101|FG001|Maintenance Phase|Adverse Event|0|||
48665902|NCT02231762|156630102|FG002|Maintenance Phase|Adverse Event|1|||
48665903|NCT02231762|156630103|FG003|Maintenance Phase|Adverse Event|2|||
48665904|NCT03987932|156630107|FG000|Overall Study|Lost to Follow-up|2|||
48665905|NCT03987932|156630108|FG001|Overall Study|Lost to Follow-up|1|||
48967220|NCT01763866|157707181|FG011|Overall Study|Lost to Follow-up|0|||
48967221|NCT01763866|157707182|FG012|Overall Study|Lost to Follow-up|1|||
48967222|NCT01763866|157707183|FG013|Overall Study|Lost to Follow-up|0|||
48967223|NCT01763866|157707184|FG014|Overall Study|Lost to Follow-up|1|||
48967224|NCT01763866|157707185|FG015|Overall Study|Lost to Follow-up|0|||
48967225|NCT01763866|157707186|FG016|Overall Study|Lost to Follow-up|0|||
48967226|NCT01763866|157707187|FG017|Overall Study|Lost to Follow-up|0|||
48967227|NCT01763866|157707188|FG018|Overall Study|Lost to Follow-up|1|||
48967228|NCT01763866|157707189|FG019|Overall Study|Lost to Follow-up|1|||
48967229|NCT01763866|157707190|FG020|Overall Study|Lost to Follow-up|0|||
48967230|NCT01763866|157707191|FG021|Overall Study|Lost to Follow-up|0|||
48967231|NCT01763866|157707192|FG022|Overall Study|Lost to Follow-up|0|||
48967232|NCT01763866|157707193|FG023|Overall Study|Lost to Follow-up|1|||
49015464|NCT01393990|157893778|FG008|Overall Study|Progressive Disease|3|||
48665906|NCT03987932|156630109|FG002|Overall Study|Lost to Follow-up|1|||
48665907|NCT03987932|156630107|FG000|Overall Study|Non-study related elective surgery|0|||
48665908|NCT03987932|156630108|FG001|Overall Study|Non-study related elective surgery|0|||
48665909|NCT03987932|156630109|FG002|Overall Study|Non-study related elective surgery|1|||
48967233|NCT01763866|157707170|FG000|Overall Study|Death|0|||
48967234|NCT01763866|157707171|FG001|Overall Study|Death|0|||
48967235|NCT01763866|157707172|FG002|Overall Study|Death|0|||
48967236|NCT01763866|157707173|FG003|Overall Study|Death|0|||
48967237|NCT01763866|157707174|FG004|Overall Study|Death|0|||
48967238|NCT01763866|157707175|FG005|Overall Study|Death|0|||
48967239|NCT01763866|157707176|FG006|Overall Study|Death|0|||
48967240|NCT01763866|157707177|FG007|Overall Study|Death|0|||
48967241|NCT01763866|157707178|FG008|Overall Study|Death|0|||
48967242|NCT01763866|157707179|FG009|Overall Study|Death|0|||
48967243|NCT01763866|157707180|FG010|Overall Study|Death|0|||
48967244|NCT01763866|157707181|FG011|Overall Study|Death|0|||
48967245|NCT01763866|157707182|FG012|Overall Study|Death|0|||
48967246|NCT01763866|157707183|FG013|Overall Study|Death|0|||
48665910|NCT03093974|156630112|FG000|Overall Study|Withdrawal by Subject|32|||
48665911|NCT03093974|156630113|FG001|Overall Study|Withdrawal by Subject|27|||
48665912|NCT03093974|156630112|FG000|Overall Study|Adverse Event|17|||
48665913|NCT03093974|156630113|FG001|Overall Study|Adverse Event|24|||
48665914|NCT03093974|156630112|FG000|Overall Study|Death|0|||
48665915|NCT03093974|156630113|FG001|Overall Study|Death|1|||
48665916|NCT03093974|156630112|FG000|Overall Study|Non-Compliance with Study Drug|1|||
48665917|NCT03093974|156630113|FG001|Overall Study|Non-Compliance with Study Drug|0|||
48665918|NCT03093974|156630112|FG000|Overall Study|Protocol-Specified withdrawal criterion met|3|||
48665919|NCT03093974|156630113|FG001|Overall Study|Protocol-Specified withdrawal criterion met|16|||
48665920|NCT03093974|156630112|FG000|Overall Study|Lost to Follow-up|0|||
48665921|NCT03093974|156630113|FG001|Overall Study|Lost to Follow-up|1|||
48665922|NCT03093974|156630112|FG000|Overall Study|Other|1|||
48665923|NCT03093974|156630113|FG001|Overall Study|Other|2|||
48665924|NCT00810901|156630117|FG000|Overall Study|Lost to Follow-up|88|||
48665925|NCT00810901|156630118|FG001|Overall Study|Lost to Follow-up|58|||
48665926|NCT00343915|156630121|FG000|Primary Study|Withdrawal by Subject|1|||
48665927|NCT00343915|156630122|FG001|Primary Study|Withdrawal by Subject|0|||
48665928|NCT00343915|156630121|FG000|Primary Study|Lost to Follow-up|2|||
48665929|NCT00343915|156630122|FG001|Primary Study|Lost to Follow-up|3|||
48665930|NCT00343915|156630121|FG000|Primary Study|Other|1|||
48665931|NCT00343915|156630122|FG001|Primary Study|Other|0|||
48665932|NCT01667562|156630123|FG000|Diagnostic Phase|Started Erlotinib in Treatment Period|30|||
48665933|NCT01667562|156630124|FG001|Diagnostic Phase|Started Erlotinib in Treatment Period|0|||
48665934|NCT01667562|156630123|FG000|Erlotinib Phase|Lost to Follow-up|0|||
48665935|NCT01667562|156630124|FG001|Erlotinib Phase|Lost to Follow-up|1|||
48665936|NCT01667562|156630123|FG000|Erlotinib Phase|Adverse Event|0|||
48757847|NCT02335099|156960873|FG000|Treatment|Lost to Follow-up|2|||
48757848|NCT02335099|156960874|FG001|Treatment|Lost to Follow-up|0|||
48757849|NCT02335099|156960873|FG000|Treatment|Death|1|||
48757850|NCT02335099|156960874|FG001|Treatment|Death|0|||
48757851|NCT02335099|156960873|FG000|Treatment|Adverse Event|1|||
48757852|NCT02335099|156960874|FG001|Treatment|Adverse Event|2|||
48757853|NCT02335099|156960873|FG000|Follow-up|Death|0|||
48757854|NCT02335099|156960874|FG001|Follow-up|Death|1|||
48757855|NCT00075582|156960875|FG000|Overall Study|Adverse Event|3|||
48757856|NCT00075582|156960876|FG001|Overall Study|Adverse Event|1|||
48757857|NCT00075582|156960875|FG000|Overall Study|Lack of Efficacy|4|||
48757858|NCT00075582|156960876|FG001|Overall Study|Lack of Efficacy|8|||
48757859|NCT00075582|156960875|FG000|Overall Study|Physician Decision|5|||
48757860|NCT00075582|156960876|FG001|Overall Study|Physician Decision|8|||
48757861|NCT00075582|156960875|FG000|Overall Study|Withdrawal by Subject|2|||
48757862|NCT00075582|156960876|FG001|Overall Study|Withdrawal by Subject|2|||
48757863|NCT00075582|156960875|FG000|Overall Study|Ineligible for study|36|||
48757864|NCT00075582|156960876|FG001|Overall Study|Ineligible for study|16|||
48757865|NCT02154581|156960877|FG000|Overall Study|Lost to Follow-up|7|||
48757866|NCT02154581|156960878|FG001|Overall Study|Lost to Follow-up|8|||
48757867|NCT01641692|156960879|FG000|Treatment Period 1|Adverse Event|1|||
48757868|NCT01641692|156960880|FG001|Treatment Period 1|Adverse Event|0|||
48757869|NCT01641692|156960881|FG002|Treatment Period 1|Adverse Event|0|||
48757870|NCT01641692|156960882|FG003|Treatment Period 1|Adverse Event|0|||
48757871|NCT01641692|156960883|FG004|Treatment Period 1|Adverse Event|0|||
48757872|NCT01641692|156960884|FG005|Treatment Period 1|Adverse Event|0|||
48757873|NCT01641692|156960885|FG006|Treatment Period 1|Adverse Event|0|||
48757874|NCT01641692|156960886|FG007|Treatment Period 1|Adverse Event|0|||
48757875|NCT01641692|156960879|FG000|Treatment Period 1|Lack of Efficacy|0|||
48757876|NCT01641692|156960880|FG001|Treatment Period 1|Lack of Efficacy|0|||
48757877|NCT01641692|156960881|FG002|Treatment Period 1|Lack of Efficacy|0|||
48757878|NCT01641692|156960882|FG003|Treatment Period 1|Lack of Efficacy|0|||
48757879|NCT01641692|156960883|FG004|Treatment Period 1|Lack of Efficacy|0|||
48757880|NCT01641692|156960884|FG005|Treatment Period 1|Lack of Efficacy|0|||
48757881|NCT01641692|156960885|FG006|Treatment Period 1|Lack of Efficacy|0|||
48665937|NCT01667562|156630124|FG001|Erlotinib Phase|Adverse Event|1|||
48665938|NCT01667562|156630123|FG000|Erlotinib Phase|Switch to Commercial Drug|0|||
48665939|NCT01667562|156630124|FG001|Erlotinib Phase|Switch to Commercial Drug|1|||
48665940|NCT01853072|156630126|FG000|Overall Study|Adverse event prior to treatment|0|||
48665941|NCT01853072|156630127|FG001|Overall Study|Adverse event prior to treatment|1|||
48665942|NCT01853072|156630126|FG000|Overall Study|Adverse Event|0|||
48757882|NCT01641692|156960886|FG007|Treatment Period 1|Lack of Efficacy|1|||
48757883|NCT01641692|156960879|FG000|Treatment Period 1|Protocol Violation|1|||
48757884|NCT01641692|156960880|FG001|Treatment Period 1|Protocol Violation|0|||
48967247|NCT01763866|157707184|FG014|Overall Study|Death|0|||
48967248|NCT01763866|157707185|FG015|Overall Study|Death|0|||
48665943|NCT01853072|156630127|FG001|Overall Study|Adverse Event|3|||
48665944|NCT01853072|156630126|FG000|Overall Study|Death|1|||
48868058|NCT00475735|157353866|FG002|Treatment Period 1|DC due to AE but continuing|0|||
48868059|NCT00475735|157353867|FG003|Treatment Period 1|DC due to AE but continuing|1|||
48868060|NCT00475735|157353868|FG004|Treatment Period 1|DC due to AE but continuing|2|||
48868061|NCT00475735|157353869|FG005|Treatment Period 1|DC due to AE but continuing|2|||
48868062|NCT00475735|157353864|FG000|Treatment Period 1|DC due to no efficacy but Continuing|0|||
48868063|NCT00475735|157353865|FG001|Treatment Period 1|DC due to no efficacy but Continuing|1|||
48868064|NCT00475735|157353866|FG002|Treatment Period 1|DC due to no efficacy but Continuing|0|||
48868065|NCT00475735|157353867|FG003|Treatment Period 1|DC due to no efficacy but Continuing|0|||
48868066|NCT00475735|157353868|FG004|Treatment Period 1|DC due to no efficacy but Continuing|0|||
48868067|NCT00475735|157353869|FG005|Treatment Period 1|DC due to no efficacy but Continuing|0|||
48868068|NCT00475735|157353864|FG000|Treatment Washout|Lost to Follow-up|0|||
48868069|NCT00475735|157353865|FG001|Treatment Washout|Lost to Follow-up|1|||
48868070|NCT00475735|157353866|FG002|Treatment Washout|Lost to Follow-up|0|||
48868071|NCT00475735|157353867|FG003|Treatment Washout|Lost to Follow-up|0|||
48868072|NCT00475735|157353868|FG004|Treatment Washout|Lost to Follow-up|0|||
48868073|NCT00475735|157353869|FG005|Treatment Washout|Lost to Follow-up|0|||
48868074|NCT00475735|157353864|FG000|Treatment Washout|Protocol Violation|0|||
48868075|NCT00475735|157353865|FG001|Treatment Washout|Protocol Violation|1|||
48868076|NCT00475735|157353866|FG002|Treatment Washout|Protocol Violation|0|||
48868077|NCT00475735|157353867|FG003|Treatment Washout|Protocol Violation|0|||
48868078|NCT00475735|157353868|FG004|Treatment Washout|Protocol Violation|0|||
48868079|NCT00475735|157353869|FG005|Treatment Washout|Protocol Violation|0|||
48868080|NCT00475735|157353864|FG000|Treatment Period 2|Adverse Event|0|||
48868081|NCT00475735|157353865|FG001|Treatment Period 2|Adverse Event|1|||
48868082|NCT00475735|157353866|FG002|Treatment Period 2|Adverse Event|0|||
48967249|NCT01763866|157707186|FG016|Overall Study|Death|1|||
48967250|NCT01763866|157707187|FG017|Overall Study|Death|0|||
48967251|NCT01763866|157707188|FG018|Overall Study|Death|0|||
48967252|NCT01763866|157707189|FG019|Overall Study|Death|0|||
48967253|NCT01763866|157707190|FG020|Overall Study|Death|0|||
48967254|NCT01763866|157707191|FG021|Overall Study|Death|0|||
48967255|NCT01763866|157707192|FG022|Overall Study|Death|0|||
48868083|NCT00475735|157353867|FG003|Treatment Period 2|Adverse Event|2|||
48967256|NCT01763866|157707193|FG023|Overall Study|Death|0|||
48967257|NCT01164865|157707198|FG000|Overall Study|Lost to Follow-up|2|||
48967258|NCT01164865|157707199|FG001|Overall Study|Lost to Follow-up|1|||
48967259|NCT02581982|157707202|FG000|Overall Study|Lack of Efficacy|12|||
48967260|NCT02581982|157707202|FG000|Overall Study|Adverse Event|3|||
48665945|NCT01853072|156630127|FG001|Overall Study|Death|4|||
48665946|NCT01853072|156630126|FG000|Overall Study|Lost to Follow-up|0|||
48665947|NCT01853072|156630127|FG001|Overall Study|Lost to Follow-up|3|||
48665948|NCT01853072|156630126|FG000|Overall Study|Non-compliance with study drug|0|||
48665949|NCT01853072|156630127|FG001|Overall Study|Non-compliance with study drug|1|||
48665950|NCT01853072|156630126|FG000|Overall Study|Physician Decision|1|||
48665951|NCT01853072|156630127|FG001|Overall Study|Physician Decision|1|||
48665952|NCT01853072|156630126|FG000|Overall Study|Withdrawal by Subject|1|||
48665953|NCT01853072|156630127|FG001|Overall Study|Withdrawal by Subject|2|||
48665954|NCT01853072|156630126|FG000|Overall Study|Reason not specified|9|||
48665955|NCT01853072|156630127|FG001|Overall Study|Reason not specified|6|||
48665956|NCT01527383|156630128|FG000|Overall Study|Adverse Event|5|||
48665957|NCT01527383|156630129|FG001|Overall Study|Adverse Event|0|||
48665958|NCT01527383|156630128|FG000|Overall Study|Lost to Follow-up|3|||
48665959|NCT01527383|156630129|FG001|Overall Study|Lost to Follow-up|0|||
48665960|NCT01527383|156630128|FG000|Overall Study|Physician Decision|2|||
48665961|NCT01527383|156630129|FG001|Overall Study|Physician Decision|0|||
48665962|NCT01527383|156630128|FG000|Overall Study|Pregnancy|1|||
48665963|NCT01527383|156630129|FG001|Overall Study|Pregnancy|0|||
48665964|NCT01527383|156630128|FG000|Overall Study|Protocol Violation|1|||
48665965|NCT01527383|156630129|FG001|Overall Study|Protocol Violation|0|||
48665966|NCT01527383|156630128|FG000|Overall Study|Screen failure|1|||
48665967|NCT01527383|156630129|FG001|Overall Study|Screen failure|0|||
48665968|NCT01527383|156630128|FG000|Overall Study|Participant moved|0|||
48665969|NCT01527383|156630129|FG001|Overall Study|Participant moved|1|||
48665970|NCT01527383|156630128|FG000|Overall Study|Withdrawal by Subject|2|||
48665971|NCT01527383|156630129|FG001|Overall Study|Withdrawal by Subject|3|||
48665972|NCT01304329|156630130|FG000|Third Intervention (3 Days)|Adverse Event|0|||
48665973|NCT01304329|156630131|FG001|Third Intervention (3 Days)|Adverse Event|1|||
48665974|NCT01304329|156630132|FG002|Third Intervention (3 Days)|Adverse Event|0|||
48665975|NCT01304329|156630133|FG003|Third Intervention (3 Days)|Adverse Event|0|||
48967261|NCT02581982|157707202|FG000|Overall Study|Physician Decision|1|||
48967262|NCT00599027|157707203|FG000|Overall Study|Withdrawal by Subject|1|||
49015465|NCT01393990|157893779|FG009|Overall Study|Progressive Disease|1|||
48665976|NCT01304329|156630134|FG004|Third Intervention (3 Days)|Adverse Event|0|||
48665977|NCT01304329|156630135|FG005|Third Intervention (3 Days)|Adverse Event|0|||
48665978|NCT01444027|156630137|FG000|Overall Study|Withdrawal by Subject|4|||
48665979|NCT01444027|156630138|FG001|Overall Study|Withdrawal by Subject|10|||
48868084|NCT00475735|157353868|FG004|Treatment Period 2|Adverse Event|0|||
48868085|NCT00475735|157353869|FG005|Treatment Period 2|Adverse Event|0|||
48868086|NCT00475735|157353864|FG000|Treatment Period 2|Lack of Efficacy|0|||
48868087|NCT00475735|157353865|FG001|Treatment Period 2|Lack of Efficacy|0|||
48868088|NCT00475735|157353866|FG002|Treatment Period 2|Lack of Efficacy|0|||
48868089|NCT00475735|157353867|FG003|Treatment Period 2|Lack of Efficacy|0|||
48868090|NCT00475735|157353868|FG004|Treatment Period 2|Lack of Efficacy|0|||
48868091|NCT00475735|157353869|FG005|Treatment Period 2|Lack of Efficacy|1|||
48868092|NCT00475735|157353864|FG000|Treatment Period 2|Withdrawal by Subject|0|||
48868093|NCT00475735|157353865|FG001|Treatment Period 2|Withdrawal by Subject|0|||
48868094|NCT00475735|157353866|FG002|Treatment Period 2|Withdrawal by Subject|0|||
48868095|NCT00475735|157353867|FG003|Treatment Period 2|Withdrawal by Subject|0|||
48868096|NCT00475735|157353868|FG004|Treatment Period 2|Withdrawal by Subject|1|||
48868097|NCT00475735|157353869|FG005|Treatment Period 2|Withdrawal by Subject|0|||
48868098|NCT03132753|157353872|FG000|Baseline - 6 Month Follow-Up|Lost to Follow-up|27|||
48868099|NCT03132753|157353873|FG001|Baseline - 6 Month Follow-Up|Lost to Follow-up|32|||
48868100|NCT03132753|157353872|FG000|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6|||
48868101|NCT03132753|157353873|FG001|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2|||
48868102|NCT01747629|157353878|FG000|Overall Study|Adverse Event|1|||
48868103|NCT01747629|157353879|FG001|Overall Study|Adverse Event|2|||
48868104|NCT01747629|157353878|FG000|Overall Study|Withdrawal by Subject|2|||
48868105|NCT01747629|157353879|FG001|Overall Study|Withdrawal by Subject|2|||
48868106|NCT01747629|157353878|FG000|Overall Study|Noncompliance|1|||
48868107|NCT01747629|157353879|FG001|Overall Study|Noncompliance|1|||
48868108|NCT01747629|157353878|FG000|Overall Study|Inclusion criteria not met|1|||
48868109|NCT01747629|157353879|FG001|Overall Study|Inclusion criteria not met|0|||
48665980|NCT01444027|156630139|FG002|Overall Study|Withdrawal by Subject|24|||
48665981|NCT01444027|156630137|FG000|Overall Study|Lost to Follow-up|26|||
48665982|NCT01444027|156630138|FG001|Overall Study|Lost to Follow-up|20|||
48665983|NCT01444027|156630139|FG002|Overall Study|Lost to Follow-up|14|||
48665984|NCT00657150|156630140|FG000|Overall Study|Adverse Event|19|||
48665985|NCT00657150|156630141|FG001|Overall Study|Adverse Event|10|||
48665986|NCT00657150|156630140|FG000|Overall Study|Non-compliant with protocol|5|||
48665987|NCT00657150|156630141|FG001|Overall Study|Non-compliant with protocol|9|||
48665988|NCT00657150|156630140|FG000|Overall Study|Lost to Follow-up|2|||
48665989|NCT00657150|156630141|FG001|Overall Study|Lost to Follow-up|0|||
48665990|NCT00657150|156630140|FG000|Overall Study|Withdrawal by Subject|51|||
48665991|NCT00657150|156630141|FG001|Overall Study|Withdrawal by Subject|36|||
48665992|NCT00657150|156630140|FG000|Overall Study|Other|38|||
48665993|NCT00657150|156630141|FG001|Overall Study|Other|38|||
48665994|NCT00657150|156630140|FG000|Treatment|Adverse Event|60|||
48665995|NCT00657150|156630141|FG001|Treatment|Adverse Event|53|||
48665996|NCT00657150|156630140|FG000|Treatment|Non-compliant with protocol|10|||
48665997|NCT00657150|156630141|FG001|Treatment|Non-compliant with protocol|9|||
48665998|NCT00657150|156630140|FG000|Treatment|Lost to Follow-up|1|||
48665999|NCT00657150|156630141|FG001|Treatment|Lost to Follow-up|0|||
48666000|NCT00657150|156630140|FG000|Treatment|Withdrawal by Subject|23|||
48666001|NCT00657150|156630141|FG001|Treatment|Withdrawal by Subject|20|||
48666002|NCT00657150|156630140|FG000|Treatment|Other|13|||
48666003|NCT00657150|156630141|FG001|Treatment|Other|15|||
48666004|NCT00432744|156630142|FG000|Months 0-6|Withdrawal by Subject|4|||
48666005|NCT00432744|156630143|FG001|Months 0-6|Withdrawal by Subject|4|||
48666006|NCT00432744|156630142|FG000|Months 0-6|Too disabled to score|1|||
48666007|NCT00432744|156630143|FG001|Months 0-6|Too disabled to score|0|||
48666008|NCT00432744|156630142|FG000|Months 7 - 12|Withdrawal by Subject|1|||
48666009|NCT00432744|156630143|FG001|Months 7 - 12|Withdrawal by Subject|0|||
48666010|NCT00432744|156630142|FG000|Months 7 - 12|Too disabled to score|0|||
48666011|NCT00432744|156630143|FG001|Months 7 - 12|Too disabled to score|1|||
48666012|NCT00468845|156630144|FG000|Overall Study|Adverse Event|9|||
48666013|NCT00468845|156630145|FG001|Overall Study|Adverse Event|14|||
48666014|NCT00468845|156630146|FG002|Overall Study|Adverse Event|11|||
48666015|NCT00468845|156630144|FG000|Overall Study|Lost to Follow-up|2|||
48666016|NCT00468845|156630145|FG001|Overall Study|Lost to Follow-up|1|||
48666017|NCT00468845|156630146|FG002|Overall Study|Lost to Follow-up|2|||
48666018|NCT00468845|156630144|FG000|Overall Study|Other|4|||
48666019|NCT00468845|156630145|FG001|Overall Study|Other|9|||
48666020|NCT00468845|156630146|FG002|Overall Study|Other|5|||
48666021|NCT00468845|156630144|FG000|Overall Study|No longer willing to participate|5|||
48666022|NCT00468845|156630145|FG001|Overall Study|No longer willing to participate|6|||
48666023|NCT00468845|156630146|FG002|Overall Study|No longer willing to participate|10|||
48666024|NCT00468845|156630144|FG000|Overall Study|Randomized, not treated|1|||
48666025|NCT00468845|156630145|FG001|Overall Study|Randomized, not treated|4|||
48666026|NCT00468845|156630146|FG002|Overall Study|Randomized, not treated|2|||
48666027|NCT02513823|156630148|FG000|Overall Study|Lost to Follow-up|4|||
48666028|NCT02513823|156630148|FG000|Overall Study|Physician Decision|1|||
48666029|NCT00740714|156630149|FG000|Overall Study|Withdrawal by Subject|17|||
48666030|NCT00740714|156630150|FG001|Overall Study|Withdrawal by Subject|19|||
48666031|NCT00740714|156630151|FG002|Overall Study|Withdrawal by Subject|29|||
48868110|NCT01747629|157353878|FG000|Overall Study|Not treated|1|||
48868111|NCT01747629|157353879|FG001|Overall Study|Not treated|0|||
48666032|NCT03344640|156630152|FG000|Overall Study|Adverse Event|1|||
48666033|NCT03344640|156630153|FG001|Overall Study|Adverse Event|0|||
48666034|NCT03344640|156630152|FG000|Overall Study|Physician Decision|1|||
48666035|NCT03344640|156630153|FG001|Overall Study|Physician Decision|1|||
48666036|NCT03344640|156630152|FG000|Overall Study|Withdrawal by Subject|1|||
48666037|NCT03344640|156630153|FG001|Overall Study|Withdrawal by Subject|2|||
48666038|NCT03344640|156630152|FG000|Follow-up Epoch|Withdrawal by Subject|0|||
48666039|NCT03344640|156630153|FG001|Follow-up Epoch|Withdrawal by Subject|2|||
48666040|NCT00259298|156630154|FG000|Overall Study|Withdrawal by Subject|1|||
48666041|NCT00259298|156630154|FG000|Overall Study|Physician Decision|2|||
48666042|NCT01400243|156630155|FG000|Overall Study|Protocol Violation|8|||
48666043|NCT01400243|156630156|FG001|Overall Study|Protocol Violation|11|||
48666044|NCT00815191|156630158|FG000|Overall Study|Protocol Violation|1|||
48666045|NCT00815191|156630159|FG001|Overall Study|Protocol Violation|1|||
48666046|NCT02226549|156630160|FG000|Overall Study|Randomized but Never Treated|1|||
48666047|NCT02226549|156630161|FG001|Overall Study|Randomized but Never Treated|0|||
48666048|NCT02226549|156630160|FG000|Overall Study|Lost to Follow-up|0|||
48666049|NCT02226549|156630161|FG001|Overall Study|Lost to Follow-up|1|||
48666050|NCT04316741|156630163|FG000|Baseline Enrollment|Lost to Follow-up|1|||
48666051|NCT04316741|156630164|FG001|Baseline Enrollment|Lost to Follow-up|1|||
48666052|NCT04316741|156630163|FG000|Immediate Post-Test|Lost to Follow-up|5|||
48666053|NCT04316741|156630164|FG001|Immediate Post-Test|Lost to Follow-up|1|||
48666054|NCT04316741|156630163|FG000|1-month Post-test|Lost to Follow-up|7|||
48666055|NCT04316741|156630164|FG001|1-month Post-test|Lost to Follow-up|2|||
48666056|NCT04316741|156630163|FG000|3-month Follow-up|Lost to Follow-up|10|||
48666057|NCT04316741|156630164|FG001|3-month Follow-up|Lost to Follow-up|2|||
48666058|NCT02356887|156630173|FG000|Overall Study|poor compliance|2|||
48666059|NCT01839656|156630177|FG000|Overall Study|Withdrawal by Subject|1|||
48666060|NCT01839656|156630178|FG001|Overall Study|Withdrawal by Subject|1|||
48666061|NCT01839656|156630177|FG000|Overall Study|Adverse event, serious fatal|1|||
48666062|NCT01839656|156630178|FG001|Overall Study|Adverse event, serious fatal|4|||
48757885|NCT01641692|156960881|FG002|Treatment Period 1|Protocol Violation|0|||
48757886|NCT01641692|156960882|FG003|Treatment Period 1|Protocol Violation|0|||
48757887|NCT01641692|156960883|FG004|Treatment Period 1|Protocol Violation|2|||
48757888|NCT01641692|156960884|FG005|Treatment Period 1|Protocol Violation|0|||
48757889|NCT01641692|156960885|FG006|Treatment Period 1|Protocol Violation|0|||
48757890|NCT01641692|156960886|FG007|Treatment Period 1|Protocol Violation|0|||
48757891|NCT01641692|156960879|FG000|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
48757892|NCT01641692|156960880|FG001|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
48757893|NCT01641692|156960881|FG002|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
48757894|NCT01641692|156960882|FG003|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
48757895|NCT01641692|156960883|FG004|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
48757896|NCT01641692|156960884|FG005|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
48757897|NCT01641692|156960885|FG006|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
48757898|NCT01641692|156960886|FG007|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
48757899|NCT01641692|156960879|FG000|Treatment Period 1|Lost to Follow-up|0|||
48757900|NCT01641692|156960880|FG001|Treatment Period 1|Lost to Follow-up|0|||
48757901|NCT01641692|156960881|FG002|Treatment Period 1|Lost to Follow-up|1|||
48757902|NCT01641692|156960882|FG003|Treatment Period 1|Lost to Follow-up|0|||
48757903|NCT01641692|156960883|FG004|Treatment Period 1|Lost to Follow-up|0|||
48757904|NCT01641692|156960884|FG005|Treatment Period 1|Lost to Follow-up|0|||
48757905|NCT01641692|156960885|FG006|Treatment Period 1|Lost to Follow-up|0|||
48757906|NCT01641692|156960886|FG007|Treatment Period 1|Lost to Follow-up|0|||
48757907|NCT01641692|156960879|FG000|Treatment Period 1|Physician Decision|0|||
48757908|NCT01641692|156960880|FG001|Treatment Period 1|Physician Decision|0|||
48757909|NCT01641692|156960881|FG002|Treatment Period 1|Physician Decision|0|||
48757910|NCT01641692|156960882|FG003|Treatment Period 1|Physician Decision|0|||
48757911|NCT01641692|156960883|FG004|Treatment Period 1|Physician Decision|1|||
48757912|NCT01641692|156960884|FG005|Treatment Period 1|Physician Decision|0|||
48757913|NCT01641692|156960885|FG006|Treatment Period 1|Physician Decision|0|||
48757914|NCT01641692|156960886|FG007|Treatment Period 1|Physician Decision|0|||
48868112|NCT01747629|157353878|FG000|Overall Study|Other|2|||
48757915|NCT01641692|156960879|FG000|Treatment Period 1|Withdrawal by Subject|0|||
48757916|NCT01641692|156960880|FG001|Treatment Period 1|Withdrawal by Subject|0|||
48757917|NCT01641692|156960881|FG002|Treatment Period 1|Withdrawal by Subject|0|||
48757918|NCT01641692|156960882|FG003|Treatment Period 1|Withdrawal by Subject|0|||
48666063|NCT01839656|156630177|FG000|Overall Study|Early study closure|0|||
48666064|NCT01839656|156630178|FG001|Overall Study|Early study closure|11|||
48868113|NCT01747629|157353879|FG001|Overall Study|Other|1|||
48666065|NCT01839656|156630177|FG000|Overall Study|Adverse Event|1|||
48666066|NCT01839656|156630178|FG001|Overall Study|Adverse Event|0|||
48868114|NCT03045302|157353880|FG000|Overall Study|Pre-treatment adverse event|1|||
48868115|NCT01395914|157353881|FG000|Overall Study|Unrelated to study drug AE|6|||
49015466|NCT01393990|157893780|FG010|Overall Study|Progressive Disease|0|||
48666067|NCT02535416|156630181|FG000|Overall Study|Family bereavement overseas|1|||
48666068|NCT02535416|156630182|FG001|Overall Study|Family bereavement overseas|0|||
48967263|NCT00599027|157707204|FG001|Overall Study|Withdrawal by Subject|1|||
48967264|NCT00599027|157707203|FG000|Overall Study|Adverse Event|0|||
48967265|NCT00599027|157707204|FG001|Overall Study|Adverse Event|1|||
48967266|NCT00599027|157707203|FG000|Overall Study|Treatment Failure|0|||
48967267|NCT00599027|157707204|FG001|Overall Study|Treatment Failure|1|||
48967268|NCT05425719|157707205|FG000|Overall Study|Lost to Follow-up|4|||
48967269|NCT05425719|157707206|FG001|Overall Study|Lost to Follow-up|0|||
48967270|NCT05425719|157707205|FG000|Overall Study|Withdrew consent|1|||
48967271|NCT05425719|157707206|FG001|Overall Study|Withdrew consent|1|||
48967272|NCT00131664|157707207|FG000|First Period (First 6 Months)|Lost to Follow-up|7|||
48967273|NCT00131664|157707208|FG001|First Period (First 6 Months)|Lost to Follow-up|3|||
48967274|NCT00131664|157707209|FG002|First Period (First 6 Months)|Lost to Follow-up|3|||
48967275|NCT00131664|157707210|FG003|First Period (First 6 Months)|Lost to Follow-up|0|||
48967276|NCT00131664|157707211|FG004|First Period (First 6 Months)|Lost to Follow-up|0|||
48967277|NCT00131664|157707212|FG005|First Period (First 6 Months)|Lost to Follow-up|0|||
48967278|NCT00131664|157707207|FG000|First Period (First 6 Months)|Death|0|||
48967279|NCT00131664|157707208|FG001|First Period (First 6 Months)|Death|1|||
48967280|NCT00131664|157707209|FG002|First Period (First 6 Months)|Death|0|||
48967281|NCT00131664|157707210|FG003|First Period (First 6 Months)|Death|0|||
48967282|NCT00131664|157707211|FG004|First Period (First 6 Months)|Death|0|||
48967283|NCT00131664|157707212|FG005|First Period (First 6 Months)|Death|0|||
48967284|NCT00131664|157707207|FG000|First Period (First 6 Months)|Protocol Violation|2|||
48967285|NCT00131664|157707208|FG001|First Period (First 6 Months)|Protocol Violation|2|||
48967286|NCT00131664|157707209|FG002|First Period (First 6 Months)|Protocol Violation|1|||
48967287|NCT00131664|157707210|FG003|First Period (First 6 Months)|Protocol Violation|0|||
48666069|NCT02535416|156630183|FG002|Overall Study|Family bereavement overseas|0|||
48666070|NCT02535416|156630184|FG003|Overall Study|Family bereavement overseas|0|||
48666071|NCT02535416|156630185|FG004|Overall Study|Family bereavement overseas|0|||
48666072|NCT02535416|156630186|FG005|Overall Study|Family bereavement overseas|0|||
48666073|NCT02535416|156630187|FG006|Overall Study|Family bereavement overseas|0|||
48666074|NCT02535416|156630188|FG007|Overall Study|Family bereavement overseas|0|||
48666075|NCT02535416|156630189|FG008|Overall Study|Family bereavement overseas|0|||
48666076|NCT02920957|156630190|FG000|First Intervention : 1 Month|Withdrawal by Subject|2|||
48666077|NCT02920957|156630191|FG001|First Intervention : 1 Month|Withdrawal by Subject|0|||
48666078|NCT02920957|156630190|FG000|First Intervention : 1 Month|Lost to Follow-up|1|||
48666079|NCT02920957|156630191|FG001|First Intervention : 1 Month|Lost to Follow-up|0|||
48666080|NCT02920957|156630190|FG000|First Intervention : 1 Month|Adverse Event|1|||
48666081|NCT02920957|156630191|FG001|First Intervention : 1 Month|Adverse Event|0|||
48666082|NCT02920957|156630190|FG000|Second Intervention: 1 Month|Lost to Follow-up|0|||
48666083|NCT02920957|156630191|FG001|Second Intervention: 1 Month|Lost to Follow-up|1|||
48666084|NCT01711866|156630196|FG000|Overall Study|Noncompliant|3|||
48666085|NCT01711866|156630196|FG000|Overall Study|Withdrawal by Subject|3|||
48666086|NCT01711866|156630196|FG000|Overall Study|Adverse Event|2|||
48666087|NCT02290938|156630197|FG000|Overall Study|Lost to Follow-up|14|||
48666088|NCT02290938|156630198|FG001|Overall Study|Lost to Follow-up|43|||
48666089|NCT02558400|156630199|FG000|Overall Study|Adverse Event|47|||
48666090|NCT02558400|156630200|FG001|Overall Study|Adverse Event|53|||
48666091|NCT02558400|156630201|FG002|Overall Study|Adverse Event|4|||
48666092|NCT02558400|156630199|FG000|Overall Study|Withdrawal by Subject|13|||
48666093|NCT02558400|156630200|FG001|Overall Study|Withdrawal by Subject|9|||
48666094|NCT02558400|156630201|FG002|Overall Study|Withdrawal by Subject|8|||
48666095|NCT02558400|156630199|FG000|Overall Study|Non-Compliant|0|||
48666096|NCT02558400|156630200|FG001|Overall Study|Non-Compliant|1|||
48666097|NCT02558400|156630201|FG002|Overall Study|Non-Compliant|3|||
48666098|NCT02558400|156630199|FG000|Overall Study|Lost to Follow-up|5|||
48666099|NCT02558400|156630200|FG001|Overall Study|Lost to Follow-up|5|||
48666100|NCT02558400|156630201|FG002|Overall Study|Lost to Follow-up|4|||
48666101|NCT02558400|156630199|FG000|Overall Study|Lack of Efficacy|0|||
48666102|NCT02558400|156630200|FG001|Overall Study|Lack of Efficacy|13|||
48666103|NCT02558400|156630201|FG002|Overall Study|Lack of Efficacy|1|||
48757919|NCT01641692|156960883|FG004|Treatment Period 1|Withdrawal by Subject|0|||
48757920|NCT01641692|156960884|FG005|Treatment Period 1|Withdrawal by Subject|2|||
48967288|NCT00131664|157707211|FG004|First Period (First 6 Months)|Protocol Violation|0|||
48967289|NCT00131664|157707212|FG005|First Period (First 6 Months)|Protocol Violation|0|||
48967290|NCT00131664|157707207|FG000|First Period (First 6 Months)|Withdrawal by Subject|4|||
48666104|NCT02558400|156630199|FG000|Overall Study|Disallowed Concurrent Medication|6|||
48666105|NCT02558400|156630200|FG001|Overall Study|Disallowed Concurrent Medication|7|||
48666106|NCT02558400|156630201|FG002|Overall Study|Disallowed Concurrent Medication|5|||
48757921|NCT01641692|156960885|FG006|Treatment Period 1|Withdrawal by Subject|0|||
48757922|NCT01641692|156960886|FG007|Treatment Period 1|Withdrawal by Subject|1|||
48666107|NCT02558400|156630199|FG000|Overall Study|Physician Decision|2|||
48666108|NCT02558400|156630200|FG001|Overall Study|Physician Decision|2|||
48666109|NCT02558400|156630201|FG002|Overall Study|Physician Decision|0|||
48666110|NCT02558400|156630199|FG000|Overall Study|Protocol Violation|6|||
48666111|NCT02558400|156630200|FG001|Overall Study|Protocol Violation|3|||
48666112|NCT02558400|156630201|FG002|Overall Study|Protocol Violation|8|||
48666113|NCT02558400|156630199|FG000|Overall Study|Death|0|||
48666114|NCT02558400|156630200|FG001|Overall Study|Death|1|||
48666115|NCT02558400|156630201|FG002|Overall Study|Death|0|||
48666116|NCT02558400|156630199|FG000|Overall Study|Ineligible for the study|0|||
48666117|NCT02558400|156630200|FG001|Overall Study|Ineligible for the study|2|||
48666118|NCT02558400|156630201|FG002|Overall Study|Ineligible for the study|0|||
48666119|NCT00456599|156630202|FG000|Overall Study|Non-compliance|1|||
48666120|NCT00456599|156630202|FG000|Overall Study|Withdrawal by Subject|2|||
48666121|NCT03187834|156632348|FG000|Overall Study|Lost to Follow-up|0|||
48967291|NCT00131664|157707208|FG001|First Period (First 6 Months)|Withdrawal by Subject|6|||
48967292|NCT00131664|157707209|FG002|First Period (First 6 Months)|Withdrawal by Subject|2|||
48967293|NCT00131664|157707210|FG003|First Period (First 6 Months)|Withdrawal by Subject|0|||
48967294|NCT00131664|157707211|FG004|First Period (First 6 Months)|Withdrawal by Subject|0|||
48967295|NCT00131664|157707212|FG005|First Period (First 6 Months)|Withdrawal by Subject|0|||
48967296|NCT00131664|157707207|FG000|First Period (First 6 Months)|Adverse Event|9|||
48967297|NCT00131664|157707208|FG001|First Period (First 6 Months)|Adverse Event|4|||
48967298|NCT00131664|157707209|FG002|First Period (First 6 Months)|Adverse Event|5|||
48967299|NCT00131664|157707210|FG003|First Period (First 6 Months)|Adverse Event|0|||
48967300|NCT00131664|157707211|FG004|First Period (First 6 Months)|Adverse Event|0|||
48967301|NCT00131664|157707212|FG005|First Period (First 6 Months)|Adverse Event|0|||
48967302|NCT00131664|157707207|FG000|First Period (First 6 Months)|Clinically significant lab abnormalities|1|||
48967303|NCT00131664|157707208|FG001|First Period (First 6 Months)|Clinically significant lab abnormalities|2|||
48967304|NCT00131664|157707209|FG002|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
48967305|NCT00131664|157707210|FG003|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
48967306|NCT00131664|157707211|FG004|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
48967307|NCT00131664|157707212|FG005|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
48967308|NCT00131664|157707207|FG000|First Period (First 6 Months)|Administrative reasons|2|||
48967309|NCT00131664|157707208|FG001|First Period (First 6 Months)|Administrative reasons|0|||
48967310|NCT00131664|157707209|FG002|First Period (First 6 Months)|Administrative reasons|5|||
48967311|NCT00131664|157707210|FG003|First Period (First 6 Months)|Administrative reasons|0|||
48967312|NCT00131664|157707211|FG004|First Period (First 6 Months)|Administrative reasons|0|||
48967313|NCT00131664|157707212|FG005|First Period (First 6 Months)|Administrative reasons|0|||
48967314|NCT00131664|157707207|FG000|Second Period (Additional Drug Added)|Lost to Follow-up|3|||
48967315|NCT00131664|157707208|FG001|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
48666122|NCT03187834|156632349|FG001|Overall Study|Lost to Follow-up|1|||
48666123|NCT03187834|156632350|FG002|Overall Study|Lost to Follow-up|2|||
48666124|NCT03187834|156632351|FG003|Overall Study|Lost to Follow-up|2|||
48666125|NCT03187834|156632348|FG000|Overall Study|Had invalid anthropometric measurements|5|||
48666126|NCT03187834|156632349|FG001|Overall Study|Had invalid anthropometric measurements|3|||
48666127|NCT03187834|156632350|FG002|Overall Study|Had invalid anthropometric measurements|4|||
48666128|NCT03187834|156632351|FG003|Overall Study|Had invalid anthropometric measurements|2|||
48666129|NCT00316693|156632352|FG000|Overall Study|Adverse Event|6|||
48666130|NCT00316693|156632353|FG001|Overall Study|Adverse Event|1|||
48666131|NCT00316693|156632352|FG000|Overall Study|Protocol Violation|1|||
48666132|NCT00316693|156632353|FG001|Overall Study|Protocol Violation|0|||
48666133|NCT00316693|156632352|FG000|Overall Study|Withdrawal by Subject|6|||
48666134|NCT00316693|156632353|FG001|Overall Study|Withdrawal by Subject|6|||
48666135|NCT00316693|156632352|FG000|Overall Study|Lost to Follow-up|26|||
48666136|NCT00316693|156632353|FG001|Overall Study|Lost to Follow-up|34|||
48666137|NCT00316693|156632352|FG000|Overall Study|Other|38|||
48666138|NCT00316693|156632353|FG001|Overall Study|Other|44|||
48666139|NCT00240110|156632354|FG000|Overall Study|Lost to Follow-up|6|||
48666140|NCT00240110|156632355|FG001|Overall Study|Lost to Follow-up|7|||
48666141|NCT02982018|156632356|FG000|Overall Study|Incorrect Lens Dispensed|1|||
48666142|NCT02982018|156632357|FG001|Overall Study|Incorrect Lens Dispensed|0|||
48666143|NCT02982018|156632356|FG000|Overall Study|Protocol Violation|1|||
48666144|NCT02982018|156632357|FG001|Overall Study|Protocol Violation|1|||
48666145|NCT02982018|156632356|FG000|Overall Study|Adverse Event|1|||
48666146|NCT02982018|156632357|FG001|Overall Study|Adverse Event|1|||
48666147|NCT02982018|156632356|FG000|Overall Study|Lens Discomfort|2|||
48666148|NCT02982018|156632357|FG001|Overall Study|Lens Discomfort|0|||
48666149|NCT02982018|156632356|FG000|Overall Study|Withdrawal by Subject|0|||
48666150|NCT02982018|156632357|FG001|Overall Study|Withdrawal by Subject|1|||
48666151|NCT00583791|156632358|FG000|Overall Study|Other|67|||
48666152|NCT00583791|156632358|FG000|Overall Study|Death|6|||
48666153|NCT03899064|156632359|FG000|Overall Study|Lost to Follow-up|1|||
48666154|NCT03899064|156632359|FG000|Overall Study|Protocol Violation|2|||
48666155|NCT03899064|156632359|FG000|Overall Study|Withdrawal by Subject|2|||
48666156|NCT03899064|156632359|FG000|Overall Study|Other|2|||
48967316|NCT00131664|157707209|FG002|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
48967317|NCT00131664|157707210|FG003|Second Period (Additional Drug Added)|Lost to Follow-up|1|||
48967318|NCT00131664|157707211|FG004|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
48967319|NCT00131664|157707212|FG005|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
48967320|NCT00131664|157707207|FG000|Second Period (Additional Drug Added)|Protocol Violation|0|||
48967321|NCT00131664|157707208|FG001|Second Period (Additional Drug Added)|Protocol Violation|1|||
48967322|NCT00131664|157707209|FG002|Second Period (Additional Drug Added)|Protocol Violation|1|||
48967323|NCT00131664|157707210|FG003|Second Period (Additional Drug Added)|Protocol Violation|0|||
48967324|NCT00131664|157707211|FG004|Second Period (Additional Drug Added)|Protocol Violation|0|||
48967325|NCT00131664|157707212|FG005|Second Period (Additional Drug Added)|Protocol Violation|0|||
48967326|NCT00131664|157707207|FG000|Second Period (Additional Drug Added)|Withdrawal by Subject|2|||
48967327|NCT00131664|157707208|FG001|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
48967328|NCT00131664|157707209|FG002|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
48967329|NCT00131664|157707210|FG003|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
48967330|NCT00131664|157707211|FG004|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
48967331|NCT00131664|157707212|FG005|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
48967332|NCT00131664|157707207|FG000|Second Period (Additional Drug Added)|Adverse Event|0|||
48967333|NCT00131664|157707208|FG001|Second Period (Additional Drug Added)|Adverse Event|1|||
48967334|NCT00131664|157707209|FG002|Second Period (Additional Drug Added)|Adverse Event|0|||
48967335|NCT00131664|157707210|FG003|Second Period (Additional Drug Added)|Adverse Event|0|||
48967336|NCT00131664|157707211|FG004|Second Period (Additional Drug Added)|Adverse Event|0|||
48967337|NCT00131664|157707212|FG005|Second Period (Additional Drug Added)|Adverse Event|1|||
48967338|NCT00131664|157707207|FG000|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
48967339|NCT00131664|157707208|FG001|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
48967340|NCT00131664|157707209|FG002|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
48967341|NCT00131664|157707210|FG003|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1|||
48967342|NCT00131664|157707211|FG004|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
48967343|NCT00131664|157707212|FG005|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
48967344|NCT00131664|157707207|FG000|Second Period (Additional Drug Added)|Administrative reasons|4|||
48967345|NCT00131664|157707208|FG001|Second Period (Additional Drug Added)|Administrative reasons|2|||
48967346|NCT00131664|157707209|FG002|Second Period (Additional Drug Added)|Administrative reasons|0|||
48967347|NCT00131664|157707210|FG003|Second Period (Additional Drug Added)|Administrative reasons|0|||
48967348|NCT00131664|157707211|FG004|Second Period (Additional Drug Added)|Administrative reasons|1|||
48967349|NCT00131664|157707212|FG005|Second Period (Additional Drug Added)|Administrative reasons|0|||
48967350|NCT01315847|157707214|FG000|Part I, Period 1|Reached maximum number of arterial lines|3|||
48967351|NCT01315847|157707215|FG001|Part I, Period 1|Reached maximum number of arterial lines|0|||
48967352|NCT01315847|157707214|FG000|Part III, Period 1|[11C]MK-4232 synthesis failure|0|||
48967353|NCT01315847|157707215|FG001|Part III, Period 1|[11C]MK-4232 synthesis failure|1|||
48967354|NCT03162055|157708548|FG000|Overall Study|Adverse Event|6|||
48967355|NCT03162055|157708549|FG001|Overall Study|Adverse Event|5|||
48967356|NCT03162055|157708548|FG000|Overall Study|Death|3|||
48967357|NCT03162055|157708549|FG001|Overall Study|Death|3|||
48967358|NCT03162055|157708548|FG000|Overall Study|Lost to Follow-up|0|||
48967359|NCT03162055|157708549|FG001|Overall Study|Lost to Follow-up|1|||
48967360|NCT03162055|157708548|FG000|Overall Study|Study-specific withdrawal criteria|22|||
48967361|NCT03162055|157708549|FG001|Overall Study|Study-specific withdrawal criteria|14|||
48967362|NCT03162055|157708548|FG000|Overall Study|Withdrawal by Subject|17|||
48967363|NCT03162055|157708549|FG001|Overall Study|Withdrawal by Subject|2|||
48967364|NCT03162055|157708548|FG000|Overall Study|Did not receive treatment|2|||
48967365|NCT03162055|157708549|FG001|Overall Study|Did not receive treatment|0|||
48666157|NCT01606787|156632362|FG000|Overall Study|Withdrawal by Subject|4|||
48666158|NCT01606787|156632363|FG001|Overall Study|Withdrawal by Subject|5|||
48666159|NCT01606787|156632362|FG000|Overall Study|Surgery canceled|0|||
48666160|NCT01606787|156632363|FG001|Overall Study|Surgery canceled|2|||
48666161|NCT02080260|156632364|FG000|Overall Study|Death|18|||
48666162|NCT02080260|156632364|FG000|Overall Study|Withdrawal by Subject|1|||
48967366|NCT03162055|157708548|FG000|Overall Study|Incorrect randomization|4|||
48967367|NCT03162055|157708549|FG001|Overall Study|Incorrect randomization|3|||
48967368|NCT03162055|157708548|FG000|Overall Study|Other|8|||
48967369|NCT03162055|157708549|FG001|Overall Study|Other|15|||
48967370|NCT02585999|157708557|FG000|Overall Study|Lost to Follow-up|1|||
48967371|NCT02585999|157708557|FG000|Overall Study|Protocol Violation|1|||
48967372|NCT01207388|157708558|FG000|Overall Study|Death|67|||
48967373|NCT01207388|157708558|FG000|Overall Study|Withdrawal by Subject|1|||
48967374|NCT00363051|157708559|FG000|Overall Study|Adminstrative problems|1|||
48967375|NCT00363051|157708560|FG001|Overall Study|Adminstrative problems|1|||
48967376|NCT00363051|157708559|FG000|Overall Study|Adverse Event|21|||
48666163|NCT02650128|156632367|FG000|Overall Study|Death|2|||
48666164|NCT01231321|156632372|FG000|Overall Study|Adverse Event|3|||
48666165|NCT01231321|156632372|FG000|Overall Study|Lack of Efficacy|2|||
48666166|NCT00908115|156632373|FG000|Overall Study|Other|14|||
48666167|NCT02654236|156632374|FG000|Overall Study|Withdrawal by Subject|0|||
48666168|NCT02654236|156632375|FG001|Overall Study|Withdrawal by Subject|0|||
48666169|NCT02654236|156632376|FG002|Overall Study|Withdrawal by Subject|2|||
48666170|NCT00798317|156632377|FG000|Overall Study|Physician Decision|0|||
48666171|NCT00798317|156632378|FG001|Overall Study|Physician Decision|1|||
48666172|NCT00798317|156632377|FG000|Overall Study|Withdrawal by Subject|5|||
48666173|NCT00798317|156632378|FG001|Overall Study|Withdrawal by Subject|4|||
48666174|NCT00798317|156632377|FG000|Overall Study|Lost to Follow-up|2|||
48666175|NCT00798317|156632378|FG001|Overall Study|Lost to Follow-up|2|||
48666176|NCT00798317|156632377|FG000|Overall Study|Adverse Event|2|||
48666177|NCT00798317|156632378|FG001|Overall Study|Adverse Event|0|||
48666178|NCT00798317|156632377|FG000|Overall Study|Death|1|||
48666179|NCT00798317|156632378|FG001|Overall Study|Death|0|||
48666180|NCT00416715|156632381|FG000|Overall Study|Not evaluable for joint aches|7|||
48666181|NCT00416715|156632381|FG000|Overall Study|Vitamin D levels not evaluable|8|||
48666182|NCT01930890|156632382|FG000|Overall Study|Study Termination|14|||
48666183|NCT01930890|156632383|FG001|Overall Study|Study Termination|28|||
48666184|NCT01930890|156632384|FG002|Overall Study|Study Termination|13|||
48666185|NCT01930890|156632385|FG003|Overall Study|Study Termination|25|||
48666186|NCT01930890|156632382|FG000|Overall Study|Death|0|||
48666187|NCT01930890|156632383|FG001|Overall Study|Death|0|||
48666188|NCT01930890|156632384|FG002|Overall Study|Death|0|||
48967377|NCT00363051|157708560|FG001|Overall Study|Adverse Event|12|||
48967378|NCT00363051|157708559|FG000|Overall Study|New Cancer Therapy|2|||
48967379|NCT00363051|157708560|FG001|Overall Study|New Cancer Therapy|1|||
48967380|NCT00363051|157708559|FG000|Overall Study|Withdrawal by Subject|11|||
48967381|NCT00363051|157708560|FG001|Overall Study|Withdrawal by Subject|3|||
48967382|NCT00363051|157708559|FG000|Overall Study|Lost to Follow-up|0|||
48967383|NCT00363051|157708560|FG001|Overall Study|Lost to Follow-up|1|||
48967384|NCT00363051|157708559|FG000|Overall Study|Protocol Violation|0|||
48967385|NCT00363051|157708560|FG001|Overall Study|Protocol Violation|2|||
48967386|NCT00363051|157708559|FG000|Overall Study|Death|3|||
48967387|NCT00363051|157708560|FG001|Overall Study|Death|2|||
48967388|NCT01925612|157708561|FG000|Overall Study|Progressive Disease|1|||
48967389|NCT01925612|157708562|FG001|Overall Study|Progressive Disease|1|||
48967390|NCT01925612|157708563|FG002|Overall Study|Progressive Disease|1|||
48967391|NCT01925612|157708564|FG003|Overall Study|Progressive Disease|0|||
48967392|NCT01925612|157708565|FG004|Overall Study|Progressive Disease|0|||
48967393|NCT01925612|157708561|FG000|Overall Study|Adverse Event|3|||
48967394|NCT01925612|157708562|FG001|Overall Study|Adverse Event|3|||
48967395|NCT01925612|157708563|FG002|Overall Study|Adverse Event|0|||
48967396|NCT01925612|157708564|FG003|Overall Study|Adverse Event|1|||
48967397|NCT01925612|157708565|FG004|Overall Study|Adverse Event|2|||
48967398|NCT00433446|157708568|FG000|Overall Study|Adverse Event|4|||
48967399|NCT00433446|157708568|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
48967400|NCT00433446|157708568|FG000|Overall Study|Progression|44|||
48967401|NCT00433446|157708568|FG000|Overall Study|Other - Not Protocol specified|3|||
48967402|NCT00433446|157708568|FG000|Overall Study|Ineligible|9|||
48666189|NCT01930890|156632385|FG003|Overall Study|Death|1|||
48666190|NCT01930890|156632382|FG000|Overall Study|Investigator Decision|0|||
48967403|NCT03017846|157708569|FG000|Overall Study|Lost to Follow-up|3|||
48967404|NCT03017846|157708569|FG000|Overall Study|Adverse Event|2|||
48967405|NCT00089479|157708570|FG000|Overall Study|Death|108|||
48967406|NCT00089479|157708571|FG001|Overall Study|Death|75|||
48967407|NCT00089479|157708570|FG000|Overall Study|Withdrawal by Subject|86|||
48967408|NCT00089479|157708571|FG001|Overall Study|Withdrawal by Subject|107|||
48967409|NCT00089479|157708570|FG000|Overall Study|Lost to Follow-up|137|||
48666191|NCT01930890|156632383|FG001|Overall Study|Investigator Decision|1|||
48666192|NCT01930890|156632384|FG002|Overall Study|Investigator Decision|0|||
48666193|NCT01930890|156632385|FG003|Overall Study|Investigator Decision|0|||
48666194|NCT01930890|156632382|FG000|Overall Study|Consent Withdrawn|0|||
48666195|NCT01930890|156632383|FG001|Overall Study|Consent Withdrawn|3|||
48666196|NCT01930890|156632384|FG002|Overall Study|Consent Withdrawn|0|||
48666197|NCT01930890|156632385|FG003|Overall Study|Consent Withdrawn|1|||
48666198|NCT01930890|156632382|FG000|Overall Study|Adverse Event|0|||
48666199|NCT01930890|156632383|FG001|Overall Study|Adverse Event|1|||
48666200|NCT01930890|156632384|FG002|Overall Study|Adverse Event|0|||
48666201|NCT01930890|156632385|FG003|Overall Study|Adverse Event|0|||
48666202|NCT04035564|156632386|FG000|Overall Study|Protocol Violation|1|||
48666203|NCT04035564|156632387|FG001|Overall Study|Protocol Violation|2|||
48666204|NCT04035564|156632386|FG000|Overall Study|No laboratory available|2|||
48666205|NCT04035564|156632387|FG001|Overall Study|No laboratory available|2|||
48666206|NCT04035564|156632386|FG000|Overall Study|Guardian declined consent|1|||
48666207|NCT04035564|156632387|FG001|Overall Study|Guardian declined consent|2|||
48666208|NCT03421743|156632400|FG000|Overall Study|Lack of Efficacy|1|||
48666209|NCT03421743|156632401|FG001|Overall Study|Lack of Efficacy|0|||
48666210|NCT03421743|156632400|FG000|Overall Study|Adverse Event|2|||
48967410|NCT00089479|157708571|FG001|Overall Study|Lost to Follow-up|107|||
48757923|NCT01641692|156960879|FG000|Washout Period 1 (12-14 Days)|Adverse Event|2|||
48757924|NCT01641692|156960880|FG001|Washout Period 1 (12-14 Days)|Adverse Event|0|||
48757925|NCT01641692|156960881|FG002|Washout Period 1 (12-14 Days)|Adverse Event|0|||
48967411|NCT04724733|157708572|FG000|Overall Study|Lost to Follow-up|1|||
48967412|NCT04724733|157708573|FG001|Overall Study|Lost to Follow-up|1|||
48967413|NCT04724733|157708574|FG002|Overall Study|Lost to Follow-up|1|||
48967414|NCT04929613|157708575|FG000|Overall Study|Withdrawal by Subject|12|||
48967415|NCT00091026|157708576|FG000|Overall Study|Patient deemed non eligible-never receiv|1|||
48967416|NCT00091026|157708577|FG001|Overall Study|Patient deemed non eligible-never receiv|0|||
48666211|NCT03421743|156632401|FG001|Overall Study|Adverse Event|1|||
48666212|NCT03421743|156632400|FG000|Overall Study|Withdrawal by Subject|0|||
48666213|NCT03421743|156632401|FG001|Overall Study|Withdrawal by Subject|1|||
48666214|NCT00431951|156632402|FG000|Overall Study|Inability to follow study procedures|1|||
48666215|NCT00431951|156632403|FG001|Overall Study|Inability to follow study procedures|0|||
48666216|NCT00431951|156632404|FG002|Overall Study|Inability to follow study procedures|1|||
48666217|NCT00431951|156632405|FG003|Overall Study|Inability to follow study procedures|2|||
48666218|NCT00431951|156632402|FG000|Overall Study|Lost to Follow-up|0|||
48666219|NCT00431951|156632403|FG001|Overall Study|Lost to Follow-up|1|||
48666220|NCT00431951|156632404|FG002|Overall Study|Lost to Follow-up|0|||
48666221|NCT00431951|156632405|FG003|Overall Study|Lost to Follow-up|0|||
48666222|NCT00431951|156632402|FG000|Overall Study|Withdrawal by Subject|0|||
48666223|NCT00431951|156632403|FG001|Overall Study|Withdrawal by Subject|1|||
48666224|NCT00431951|156632404|FG002|Overall Study|Withdrawal by Subject|0|||
48666225|NCT00431951|156632405|FG003|Overall Study|Withdrawal by Subject|0|||
48666226|NCT00431951|156632402|FG000|Overall Study|Adverse Event|0|||
48666227|NCT00431951|156632403|FG001|Overall Study|Adverse Event|0|||
48666228|NCT00431951|156632404|FG002|Overall Study|Adverse Event|1|||
48666229|NCT00431951|156632405|FG003|Overall Study|Adverse Event|0|||
48967417|NCT00091026|157708576|FG000|Overall Study|Patient withdrew and never received trea|0|||
48666230|NCT00700102|156632409|FG000|Overall Study|Died|394|||
48666231|NCT00700102|156632410|FG001|Overall Study|Died|385|||
48666232|NCT00700102|156632409|FG000|Overall Study|Lost to Follow-up|8|||
48666233|NCT00700102|156632410|FG001|Overall Study|Lost to Follow-up|10|||
48666234|NCT01299571|156632411|FG000|Overall Study|Protocol Violation|107|||
48666235|NCT02525939|156632412|FG000|Overall Study|Lost to Follow-up|27|||
48666236|NCT02525939|156632413|FG001|Overall Study|Lost to Follow-up|24|||
48666237|NCT02525939|156632412|FG000|Overall Study|Physician Decision|0|||
48666238|NCT02525939|156632413|FG001|Overall Study|Physician Decision|1|||
48666239|NCT02525939|156632412|FG000|Overall Study|Withdrawal by Subject|24|||
48666240|NCT02525939|156632413|FG001|Overall Study|Withdrawal by Subject|39|||
48666241|NCT02525939|156632412|FG000|Overall Study|Death|180|||
48666242|NCT02525939|156632413|FG001|Overall Study|Death|179|||
48666243|NCT05590000|156632414|FG000|Overall Study|The patient was indicated for peripheral nerve stimulation|1|||
48666244|NCT00762996|156632415|FG000|Period One|Protocol Violation|0|||
48666245|NCT00762996|156632416|FG001|Period One|Protocol Violation|0|||
48666246|NCT00762996|156632417|FG002|Period One|Protocol Violation|1|||
48666247|NCT00762996|156632418|FG003|Period One|Protocol Violation|0|||
48666248|NCT00762996|156632415|FG000|Period One|ineligible|0|||
48666249|NCT00762996|156632416|FG001|Period One|ineligible|0|||
48666250|NCT00762996|156632417|FG002|Period One|ineligible|1|||
48666251|NCT00762996|156632418|FG003|Period One|ineligible|1|||
48666252|NCT00762996|156632415|FG000|Period One|Adverse Event|0|||
48666253|NCT00762996|156632416|FG001|Period One|Adverse Event|0|||
48666254|NCT00762996|156632417|FG002|Period One|Adverse Event|1|||
48666255|NCT00762996|156632418|FG003|Period One|Adverse Event|0|||
48666256|NCT00762996|156632415|FG000|Period One|Withdrawal by Subject|0|||
48666257|NCT00762996|156632416|FG001|Period One|Withdrawal by Subject|0|||
48666258|NCT00762996|156632417|FG002|Period One|Withdrawal by Subject|1|||
48666259|NCT00762996|156632418|FG003|Period One|Withdrawal by Subject|0|||
48666260|NCT04063787|156632419|FG000|Overall Study|Inadequate Doppler data|4|||
48666261|NCT04063787|156632419|FG000|Overall Study|Lost to Follow-up|2|||
48666262|NCT04063787|156632419|FG000|Overall Study|Death|3|||
48757926|NCT01641692|156960882|FG003|Washout Period 1 (12-14 Days)|Adverse Event|0|||
48967418|NCT00091026|157708577|FG001|Overall Study|Patient withdrew and never received trea|2|||
48967419|NCT00091026|157708576|FG000|Overall Study|Unknown-never received treatment|0|||
48967420|NCT00091026|157708577|FG001|Overall Study|Unknown-never received treatment|1|||
48967421|NCT00565058|157708578|FG000|Overall Study|Adverse Event|1|||
48967422|NCT00565058|157708579|FG001|Overall Study|Adverse Event|0|||
48666263|NCT00849875|156632421|FG000|Overall Study|Death|28|||
48666264|NCT00849875|156632421|FG000|Overall Study|Ongoing (unknown completion status)|11|||
48666265|NCT00849875|156632421|FG000|Overall Study|Others|6|||
48666266|NCT00849875|156632421|FG000|Overall Study|Lost to Follow-up|2|||
48666267|NCT00086502|156632422|FG000|Overall Study|Adverse Event|11|||
48666268|NCT00086502|156632423|FG001|Overall Study|Adverse Event|2|||
48666269|NCT00086502|156632422|FG000|Overall Study|Lack of Efficacy|0|||
48666270|NCT00086502|156632423|FG001|Overall Study|Lack of Efficacy|2|||
48666271|NCT00086502|156632422|FG000|Overall Study|Lost to Follow-up|3|||
48666272|NCT00086502|156632423|FG001|Overall Study|Lost to Follow-up|1|||
48666273|NCT00086502|156632422|FG000|Overall Study|Physician Decision|1|||
48666274|NCT00086502|156632423|FG001|Overall Study|Physician Decision|1|||
48757927|NCT01641692|156960883|FG004|Washout Period 1 (12-14 Days)|Adverse Event|0|||
48757928|NCT01641692|156960884|FG005|Washout Period 1 (12-14 Days)|Adverse Event|0|||
48757929|NCT01641692|156960885|FG006|Washout Period 1 (12-14 Days)|Adverse Event|0|||
48757930|NCT01641692|156960886|FG007|Washout Period 1 (12-14 Days)|Adverse Event|0|||
48757931|NCT01641692|156960879|FG000|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
48757932|NCT01641692|156960880|FG001|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
48757933|NCT01641692|156960881|FG002|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
48757934|NCT01641692|156960882|FG003|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
48757935|NCT01641692|156960883|FG004|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
48757936|NCT01641692|156960884|FG005|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
48757937|NCT01641692|156960885|FG006|Washout Period 1 (12-14 Days)|Protocol Violation|1|||
48757938|NCT01641692|156960886|FG007|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
48757939|NCT01641692|156960879|FG000|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
48757940|NCT01641692|156960880|FG001|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
48757941|NCT01641692|156960881|FG002|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
48757942|NCT01641692|156960882|FG003|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
48757943|NCT01641692|156960883|FG004|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
48757944|NCT01641692|156960884|FG005|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
48666275|NCT00086502|156632422|FG000|Overall Study|Pregnancy|0|||
48666276|NCT00086502|156632423|FG001|Overall Study|Pregnancy|1|||
48666277|NCT00086502|156632422|FG000|Overall Study|Protocol Violation|3|||
48666278|NCT00086502|156632423|FG001|Overall Study|Protocol Violation|3|||
48666279|NCT00086502|156632422|FG000|Overall Study|Withdrawal by Subject|5|||
48666280|NCT00086502|156632423|FG001|Overall Study|Withdrawal by Subject|6|||
48666281|NCT00086502|156632422|FG000|Overall Study|Patient Moved|1|||
48666282|NCT00086502|156632423|FG001|Overall Study|Patient Moved|1|||
48666283|NCT00086502|156632422|FG000|Overall Study|Protocol Discontinuation Criteria|1|||
48666284|NCT00086502|156632423|FG001|Overall Study|Protocol Discontinuation Criteria|3|||
48666285|NCT00086502|156632422|FG000|Overall Study|Patient Accidentally Unblinded|1|||
48666286|NCT00086502|156632423|FG001|Overall Study|Patient Accidentally Unblinded|0|||
48666287|NCT01842581|156632425|FG000|Overall Study|Adverse Event|6|||
48666288|NCT01842581|156632426|FG001|Overall Study|Adverse Event|4|||
48666289|NCT01842581|156632425|FG000|Overall Study|HE breakthrough|26|||
48666290|NCT01842581|156632426|FG001|Overall Study|HE breakthrough|13|||
48666291|NCT01842581|156632425|FG000|Overall Study|Liver transplant|2|||
48666292|NCT01842581|156632426|FG001|Overall Study|Liver transplant|0|||
48666293|NCT01842581|156632425|FG000|Overall Study|Lost to Follow-up|2|||
48666294|NCT01842581|156632426|FG001|Overall Study|Lost to Follow-up|5|||
48757945|NCT01641692|156960885|FG006|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
48757946|NCT01641692|156960886|FG007|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
48757947|NCT01641692|156960879|FG000|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
48757948|NCT01641692|156960880|FG001|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
48757949|NCT01641692|156960881|FG002|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
48868116|NCT01395914|157353882|FG001|Overall Study|Unrelated to study drug AE|1|||
48868117|NCT01395914|157353881|FG000|Overall Study|Death|23|||
48868118|NCT01395914|157353882|FG001|Overall Study|Death|17|||
48868119|NCT01395914|157353881|FG000|Overall Study|Other|9|||
48868120|NCT01395914|157353882|FG001|Overall Study|Other|3|||
48868121|NCT01395914|157353881|FG000|Overall Study|Withdrawal by patient|27|||
48868122|NCT01395914|157353882|FG001|Overall Study|Withdrawal by patient|14|||
48868123|NCT01395914|157353881|FG000|Overall Study|Study drug-related AE|1|||
48868124|NCT01395914|157353882|FG001|Overall Study|Study drug-related AE|0|||
48868125|NCT01395914|157353881|FG000|Overall Study|Lost to Follow-up|6|||
48868126|NCT01395914|157353882|FG001|Overall Study|Lost to Follow-up|2|||
48868127|NCT04414397|157353883|FG000|Control Period|Withdrawal by Subject|2|||
48868128|NCT04414397|157353884|FG001|Control Period|Withdrawal by Subject|2|||
48868129|NCT04414397|157353883|FG000|Control Period|Lost to Follow-up|0|||
48868130|NCT04414397|157353884|FG001|Control Period|Lost to Follow-up|4|||
48868131|NCT04414397|157353883|FG000|Control Period|Protocol deviation|0|||
48868132|NCT04414397|157353884|FG001|Control Period|Protocol deviation|1|||
48868133|NCT04414397|157353883|FG000|Post-Control Period|Withdrawal by Subject|3|||
48868134|NCT04414397|157353884|FG001|Post-Control Period|Withdrawal by Subject|6|||
48868135|NCT04414397|157353883|FG000|Post-Control Period|Lost to Follow-up|4|||
48868136|NCT04414397|157353884|FG001|Post-Control Period|Lost to Follow-up|9|||
48868137|NCT04414397|157353883|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
48868138|NCT04414397|157353884|FG001|Maintenance Treatment Period|Withdrawal by Subject|2|||
48868139|NCT04414397|157353883|FG000|Maintenance Treatment Period|Lost to Follow-up|0|||
48868140|NCT04414397|157353884|FG001|Maintenance Treatment Period|Lost to Follow-up|3|||
48868141|NCT01920178|157353885|FG000|Overall Study|Lost to Follow-up|2|||
48868142|NCT01920178|157353886|FG001|Overall Study|Lost to Follow-up|1|||
48868143|NCT01020747|157353888|FG000|Overall Study|Withdrawal by Subject|1|||
48868144|NCT03028012|157353889|FG000|Overall Study|Lost to Follow-up|2|||
48967423|NCT00304915|157708580|FG000|Overall Study|Lost to Follow-up|11|||
48967424|NCT00304915|157708581|FG001|Overall Study|Lost to Follow-up|11|||
48967425|NCT00304915|157708580|FG000|Overall Study|Death|4|||
48967426|NCT00304915|157708581|FG001|Overall Study|Death|5|||
48967427|NCT00304915|157708580|FG000|Overall Study|Withdrawal by Subject|3|||
48967428|NCT00304915|157708581|FG001|Overall Study|Withdrawal by Subject|0|||
48967429|NCT01819506|157708582|FG000|Overall Study|Physician Decision|5|||
48967430|NCT01819506|157708583|FG001|Overall Study|Physician Decision|2|||
48967431|NCT01819506|157708582|FG000|Overall Study|Withdrawal by Subject|3|||
48967432|NCT01819506|157708583|FG001|Overall Study|Withdrawal by Subject|3|||
48967433|NCT00426556|157708590|FG000|Phase I - Core Phase|Disease Progression|0|||
48967434|NCT00426556|157708591|FG001|Phase I - Core Phase|Disease Progression|6|||
48967435|NCT00426556|157708592|FG002|Phase I - Core Phase|Disease Progression|2|||
48967436|NCT00426556|157708593|FG003|Phase I - Core Phase|Disease Progression|0|||
48967437|NCT00426556|157708590|FG000|Phase I - Core Phase|Adverse Event|1|||
48967438|NCT00426556|157708591|FG001|Phase I - Core Phase|Adverse Event|3|||
48967439|NCT00426556|157708592|FG002|Phase I - Core Phase|Adverse Event|1|||
48967440|NCT00426556|157708593|FG003|Phase I - Core Phase|Adverse Event|0|||
48967441|NCT00426556|157708590|FG000|Phase I - Core Phase|Death|0|||
48967442|NCT00426556|157708591|FG001|Phase I - Core Phase|Death|1|||
48967443|NCT00426556|157708592|FG002|Phase I - Core Phase|Death|0|||
48967444|NCT00426556|157708593|FG003|Phase I - Core Phase|Death|0|||
48967445|NCT00426556|157708590|FG000|Phase I - Extension Phase|Adverse Event|0|||
48967446|NCT00426556|157708591|FG001|Phase I - Extension Phase|Adverse Event|1|||
48666295|NCT01842581|156632425|FG000|Overall Study|Withdrawal by Subject|5|||
48666296|NCT01842581|156632426|FG001|Overall Study|Withdrawal by Subject|7|||
48666297|NCT01842581|156632425|FG000|Overall Study|Other than specified|3|||
48666298|NCT01842581|156632426|FG001|Overall Study|Other than specified|1|||
48666299|NCT01995552|156632427|FG000|Overall Study|Protocol Violation|1|||
48666300|NCT01995552|156632427|FG000|Overall Study|Lack of Efficacy|15|||
48666301|NCT01995552|156632427|FG000|Overall Study|Death|1|||
48666302|NCT02068118|156632430|FG000|18-month Comparative Study Period|Death|90|||
48666303|NCT02068118|156632431|FG001|18-month Comparative Study Period|Death|97|||
48666304|NCT02068118|156632430|FG000|18-month Comparative Study Period|Withdrawal by Subject|23|||
48666305|NCT02068118|156632431|FG001|18-month Comparative Study Period|Withdrawal by Subject|52|||
48666306|NCT02068118|156632430|FG000|18-month Comparative Study Period|Lost to Follow-up|6|||
48666307|NCT02068118|156632431|FG001|18-month Comparative Study Period|Lost to Follow-up|7|||
48666308|NCT02068118|156632430|FG000|18-month Comparative Study Period|Heart transplant|9|||
48666309|NCT02068118|156632431|FG001|18-month Comparative Study Period|Heart transplant|15|||
48666310|NCT02068118|156632430|FG000|18-month Comparative Study Period|Inclusion in another protocol|0|||
48666311|NCT02068118|156632431|FG001|18-month Comparative Study Period|Inclusion in another protocol|2|||
48666312|NCT02068118|156632430|FG000|18-month Comparative Study Period|Hemiplegia|0|||
48666313|NCT02068118|156632431|FG001|18-month Comparative Study Period|Hemiplegia|1|||
48666314|NCT02068118|156632430|FG000|18-month Comparative Study Period|Alzheimer's disease|0|||
48666315|NCT02068118|156632431|FG001|18-month Comparative Study Period|Alzheimer's disease|1|||
48666316|NCT02068118|156632430|FG000|18-month Comparative Study Period|Move|0|||
48666317|NCT02068118|156632431|FG001|18-month Comparative Study Period|Move|1|||
48666318|NCT02068118|156632430|FG000|18-month Comparative Study Period|Hearing loss|0|||
48666319|NCT02068118|156632431|FG001|18-month Comparative Study Period|Hearing loss|1|||
48666320|NCT02068118|156632430|FG000|Extension Period|Death|0|||
48666321|NCT02068118|156632431|FG001|Extension Period|Death|2|||
48666322|NCT02068118|156632430|FG000|Extension Period|Withdrawal by Subject|1|||
48666323|NCT02068118|156632431|FG001|Extension Period|Withdrawal by Subject|0|||
48666324|NCT02068118|156632430|FG000|Extension Period|Heart transplant|1|||
48666325|NCT02068118|156632431|FG001|Extension Period|Heart transplant|0|||
48666326|NCT02068118|156632430|FG000|Extension Period|Wrong device use|0|||
48666327|NCT02068118|156632431|FG001|Extension Period|Wrong device use|1|||
48666328|NCT00624780|156632432|FG000|Treatment Optimization (Up to Week 12)|Adverse Event|7|||
48666329|NCT00624780|156632433|FG001|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
48666330|NCT00624780|156632434|FG002|Treatment Optimization (Up to Week 12)|Adverse Event|15|||
48666331|NCT00624780|156632435|FG003|Treatment Optimization (Up to Week 12)|Adverse Event|3|||
48666332|NCT00624780|156632436|FG004|Treatment Optimization (Up to Week 12)|Adverse Event|9|||
48666333|NCT00624780|156632437|FG005|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
48666334|NCT00624780|156632432|FG000|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
48666335|NCT00624780|156632433|FG001|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2|||
48666336|NCT00624780|156632434|FG002|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10|||
48666337|NCT00624780|156632435|FG003|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
48666338|NCT00624780|156632436|FG004|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9|||
48666339|NCT00624780|156632437|FG005|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1|||
48967447|NCT00426556|157708592|FG002|Phase I - Extension Phase|Adverse Event|1|||
48666340|NCT00624780|156632432|FG000|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
48967448|NCT00426556|157708593|FG003|Phase I - Extension Phase|Adverse Event|0|||
48967449|NCT00426556|157708590|FG000|Phase I - Extension Phase|Disease Progression|5|||
48868145|NCT03028012|157353890|FG001|Overall Study|Lost to Follow-up|3|||
48666341|NCT00624780|156632433|FG001|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
48666342|NCT00624780|156632434|FG002|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
48666343|NCT00624780|156632435|FG003|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
48666344|NCT00624780|156632436|FG004|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
48666345|NCT00624780|156632437|FG005|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
48666346|NCT00624780|156632432|FG000|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
48666347|NCT00624780|156632433|FG001|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2|||
48666348|NCT00624780|156632434|FG002|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7|||
48666349|NCT00624780|156632435|FG003|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
48666350|NCT00624780|156632436|FG004|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
48666351|NCT00624780|156632437|FG005|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
48666352|NCT00624780|156632432|FG000|Treatment Optimization (Up to Week 12)|Other|10|||
48666353|NCT00624780|156632433|FG001|Treatment Optimization (Up to Week 12)|Other|4|||
48666354|NCT00624780|156632434|FG002|Treatment Optimization (Up to Week 12)|Other|8|||
48666355|NCT00624780|156632435|FG003|Treatment Optimization (Up to Week 12)|Other|2|||
48666356|NCT00624780|156632436|FG004|Treatment Optimization (Up to Week 12)|Other|9|||
48666357|NCT00624780|156632437|FG005|Treatment Optimization (Up to Week 12)|Other|0|||
48666358|NCT00624780|156632432|FG000|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
48666359|NCT00624780|156632433|FG001|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4|||
48666360|NCT00624780|156632434|FG002|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
48666361|NCT00624780|156632435|FG003|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2|||
48666362|NCT00624780|156632436|FG004|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3|||
48666363|NCT00624780|156632437|FG005|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1|||
48666364|NCT00624780|156632432|FG000|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
48666365|NCT00624780|156632433|FG001|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1|||
48666366|NCT00624780|156632434|FG002|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
48666367|NCT00624780|156632435|FG003|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
48666368|NCT00624780|156632436|FG004|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
48666369|NCT00624780|156632437|FG005|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
48666370|NCT00624780|156632432|FG000|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
48666371|NCT00624780|156632433|FG001|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
48666372|NCT00624780|156632434|FG002|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
48666373|NCT00624780|156632435|FG003|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
48666374|NCT00624780|156632436|FG004|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
48666375|NCT00624780|156632437|FG005|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
48666376|NCT00624780|156632432|FG000|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
48666377|NCT00624780|156632433|FG001|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
48666378|NCT00624780|156632434|FG002|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
48666379|NCT00624780|156632435|FG003|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
48666380|NCT00624780|156632436|FG004|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
48666381|NCT00624780|156632437|FG005|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
48666382|NCT00624780|156632432|FG000|Fixed Dosing (Week 13 to Week 24)|Other|5|||
48666383|NCT00624780|156632433|FG001|Fixed Dosing (Week 13 to Week 24)|Other|3|||
48666384|NCT00624780|156632434|FG002|Fixed Dosing (Week 13 to Week 24)|Other|4|||
48666385|NCT00624780|156632435|FG003|Fixed Dosing (Week 13 to Week 24)|Other|1|||
48666386|NCT00624780|156632436|FG004|Fixed Dosing (Week 13 to Week 24)|Other|4|||
48666387|NCT00624780|156632437|FG005|Fixed Dosing (Week 13 to Week 24)|Other|3|||
48666388|NCT00624780|156632432|FG000|Treatment Discontinuation (Week 25)|Adverse Event|1|||
48666389|NCT00624780|156632433|FG001|Treatment Discontinuation (Week 25)|Adverse Event|0|||
48666390|NCT00624780|156632434|FG002|Treatment Discontinuation (Week 25)|Adverse Event|2|||
48666391|NCT00624780|156632435|FG003|Treatment Discontinuation (Week 25)|Adverse Event|1|||
48666392|NCT00624780|156632436|FG004|Treatment Discontinuation (Week 25)|Adverse Event|0|||
48666393|NCT00624780|156632437|FG005|Treatment Discontinuation (Week 25)|Adverse Event|1|||
48666394|NCT00624780|156632432|FG000|Treatment Discontinuation (Week 25)|Lack of Efficacy|1|||
48666395|NCT00624780|156632433|FG001|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
48666396|NCT00624780|156632434|FG002|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
48666397|NCT00624780|156632435|FG003|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
48666398|NCT00624780|156632436|FG004|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
48666399|NCT00624780|156632437|FG005|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
48666400|NCT00624780|156632432|FG000|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
48666401|NCT00624780|156632433|FG001|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
48666402|NCT00624780|156632434|FG002|Treatment Discontinuation (Week 25)|Lost to Follow-up|1|||
48666403|NCT00624780|156632435|FG003|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
48666404|NCT00624780|156632436|FG004|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
48666405|NCT00624780|156632437|FG005|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
48666406|NCT00624780|156632432|FG000|Follow-up (Week 26)|Death|0|||
48666407|NCT00624780|156632433|FG001|Follow-up (Week 26)|Death|0|||
48868146|NCT03028012|157353891|FG002|Overall Study|Lost to Follow-up|3|||
48868147|NCT03209973|157353898|FG000|Overall Study|Withdrawal by Subject|7|||
48868148|NCT03209973|157353898|FG000|Overall Study|Lost to Follow-up|2|||
48868149|NCT03209973|157353898|FG000|Overall Study|Death|8|||
48868150|NCT03209973|157353898|FG000|Overall Study|Transferred to Long Term Extension (LTE) study|32|||
48868151|NCT03209973|157353898|FG000|Overall Study|Sponsor Decision|18|||
48868152|NCT03209973|157353898|FG000|Overall Study|Participant Withdrew Due to Higher Risk than Benefit of Treatment|1|||
48868153|NCT03209973|157353898|FG000|Overall Study|Participant Refused to Return to Treatment|2|||
48868154|NCT04778397|157353901|FG000|Overall Study|Death|59|||
48868155|NCT04778397|157353902|FG001|Overall Study|Death|54|||
48967450|NCT00426556|157708591|FG001|Phase I - Extension Phase|Disease Progression|5|||
48967451|NCT00426556|157708592|FG002|Phase I - Extension Phase|Disease Progression|6|||
48967452|NCT00426556|157708593|FG003|Phase I - Extension Phase|Disease Progression|0|||
48868156|NCT04778397|157353903|FG002|Overall Study|Death|11|||
48967453|NCT00426556|157708590|FG000|Phase II - Core Phase|Withdrawal by Subject|0|||
48967454|NCT00426556|157708591|FG001|Phase II - Core Phase|Withdrawal by Subject|0|||
48967455|NCT00426556|157708592|FG002|Phase II - Core Phase|Withdrawal by Subject|0|||
48967456|NCT00426556|157708593|FG003|Phase II - Core Phase|Withdrawal by Subject|3|||
48967457|NCT00426556|157708590|FG000|Phase II - Core Phase|Disease Progression|0|||
48967458|NCT00426556|157708591|FG001|Phase II - Core Phase|Disease Progression|0|||
48666408|NCT00624780|156632434|FG002|Follow-up (Week 26)|Death|1|||
48666409|NCT00624780|156632435|FG003|Follow-up (Week 26)|Death|0|||
48666410|NCT00624780|156632436|FG004|Follow-up (Week 26)|Death|0|||
48666411|NCT00624780|156632437|FG005|Follow-up (Week 26)|Death|0|||
48666412|NCT00624780|156632432|FG000|Follow-up (Week 26)|Adverse Event|0|||
48666413|NCT00624780|156632433|FG001|Follow-up (Week 26)|Adverse Event|0|||
48666414|NCT00624780|156632434|FG002|Follow-up (Week 26)|Adverse Event|0|||
48666415|NCT00624780|156632435|FG003|Follow-up (Week 26)|Adverse Event|0|||
48666416|NCT00624780|156632436|FG004|Follow-up (Week 26)|Adverse Event|1|||
48666417|NCT00624780|156632437|FG005|Follow-up (Week 26)|Adverse Event|0|||
48666418|NCT00624780|156632432|FG000|Follow-up (Week 26)|Lost to Follow-up|0|||
48666419|NCT00624780|156632433|FG001|Follow-up (Week 26)|Lost to Follow-up|0|||
48666420|NCT00624780|156632434|FG002|Follow-up (Week 26)|Lost to Follow-up|1|||
48666421|NCT00624780|156632435|FG003|Follow-up (Week 26)|Lost to Follow-up|0|||
48868157|NCT04778397|157353904|FG003|Overall Study|Death|9|||
48868158|NCT04778397|157353901|FG000|Overall Study|Study Terminated by Sponsor|34|||
48868159|NCT04778397|157353902|FG001|Overall Study|Study Terminated by Sponsor|42|||
48868160|NCT04778397|157353903|FG002|Overall Study|Study Terminated by Sponsor|15|||
48967459|NCT00426556|157708592|FG002|Phase II - Core Phase|Disease Progression|0|||
48967460|NCT00426556|157708593|FG003|Phase II - Core Phase|Disease Progression|16|||
48967461|NCT00426556|157708590|FG000|Phase II - Core Phase|Adverse Event|0|||
48967462|NCT00426556|157708591|FG001|Phase II - Core Phase|Adverse Event|0|||
48967463|NCT00426556|157708592|FG002|Phase II - Core Phase|Adverse Event|0|||
48967464|NCT00426556|157708593|FG003|Phase II - Core Phase|Adverse Event|8|||
48967465|NCT00426556|157708590|FG000|Phase II - Extension Phase|Disease Progression|0|||
48967466|NCT00426556|157708591|FG001|Phase II - Extension Phase|Disease Progression|0|||
48967467|NCT00426556|157708592|FG002|Phase II - Extension Phase|Disease Progression|0|||
48967468|NCT00426556|157708593|FG003|Phase II - Extension Phase|Disease Progression|21|||
48967469|NCT00426556|157708590|FG000|Phase II - Extension Phase|Adverse Event|0|||
48967470|NCT00426556|157708591|FG001|Phase II - Extension Phase|Adverse Event|0|||
48967471|NCT00426556|157708592|FG002|Phase II - Extension Phase|Adverse Event|0|||
48967472|NCT00426556|157708593|FG003|Phase II - Extension Phase|Adverse Event|2|||
48666422|NCT00624780|156632436|FG004|Follow-up (Week 26)|Lost to Follow-up|1|||
48666423|NCT00624780|156632437|FG005|Follow-up (Week 26)|Lost to Follow-up|0|||
48666424|NCT00624780|156632432|FG000|Follow-up (Week 26)|Withdrawal by Subject|1|||
48666425|NCT00624780|156632433|FG001|Follow-up (Week 26)|Withdrawal by Subject|0|||
48666426|NCT00624780|156632434|FG002|Follow-up (Week 26)|Withdrawal by Subject|0|||
48666427|NCT00624780|156632435|FG003|Follow-up (Week 26)|Withdrawal by Subject|0|||
48666428|NCT00624780|156632436|FG004|Follow-up (Week 26)|Withdrawal by Subject|0|||
48666429|NCT00624780|156632437|FG005|Follow-up (Week 26)|Withdrawal by Subject|0|||
48666430|NCT00624780|156632432|FG000|Follow-up (Week 26)|Other|1|||
48666431|NCT00624780|156632433|FG001|Follow-up (Week 26)|Other|1|||
48666432|NCT00624780|156632434|FG002|Follow-up (Week 26)|Other|0|||
48666433|NCT00624780|156632435|FG003|Follow-up (Week 26)|Other|0|||
48666434|NCT00624780|156632436|FG004|Follow-up (Week 26)|Other|0|||
48666435|NCT00624780|156632437|FG005|Follow-up (Week 26)|Other|0|||
48757950|NCT01641692|156960882|FG003|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
48967473|NCT01803711|157708594|FG000|Overall Study|Adverse Event|1|||
48666436|NCT03757130|156632442|FG000|Overall Study|Lost to Follow-up|0|||
48666437|NCT03757130|156632443|FG001|Overall Study|Lost to Follow-up|0|||
48868161|NCT04778397|157353904|FG003|Overall Study|Study Terminated by Sponsor|12|||
48868162|NCT04778397|157353901|FG000|Overall Study|Withdrew Consent|5|||
48868163|NCT04778397|157353902|FG001|Overall Study|Withdrew Consent|4|||
48868164|NCT04778397|157353903|FG002|Overall Study|Withdrew Consent|1|||
48967474|NCT01803711|157708595|FG001|Overall Study|Adverse Event|1|||
48666438|NCT03757130|156632444|FG002|Overall Study|Lost to Follow-up|0|||
48666439|NCT03757130|156632445|FG003|Overall Study|Lost to Follow-up|1|||
48757951|NCT01641692|156960883|FG004|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
48666440|NCT03757130|156632446|FG004|Overall Study|Lost to Follow-up|0|||
48666441|NCT03757130|156632447|FG005|Overall Study|Lost to Follow-up|0|||
48666442|NCT03757130|156632448|FG006|Overall Study|Lost to Follow-up|0|||
48666443|NCT03757130|156632449|FG007|Overall Study|Lost to Follow-up|1|||
48666444|NCT03757130|156632442|FG000|Overall Study|Withdrawal by Subject|0|||
48666445|NCT03757130|156632443|FG001|Overall Study|Withdrawal by Subject|0|||
48757952|NCT01641692|156960884|FG005|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
48757953|NCT01641692|156960885|FG006|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
48757954|NCT01641692|156960886|FG007|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
48757955|NCT01641692|156960879|FG000|Treatment Period 2|Lack of Efficacy|1|||
48757956|NCT01641692|156960880|FG001|Treatment Period 2|Lack of Efficacy|0|||
48757957|NCT01641692|156960881|FG002|Treatment Period 2|Lack of Efficacy|0|||
48757958|NCT01641692|156960882|FG003|Treatment Period 2|Lack of Efficacy|0|||
48757959|NCT01641692|156960883|FG004|Treatment Period 2|Lack of Efficacy|0|||
48666446|NCT03757130|156632444|FG002|Overall Study|Withdrawal by Subject|0|||
48666447|NCT03757130|156632445|FG003|Overall Study|Withdrawal by Subject|0|||
48666448|NCT03757130|156632446|FG004|Overall Study|Withdrawal by Subject|0|||
48666449|NCT03757130|156632447|FG005|Overall Study|Withdrawal by Subject|0|||
48666450|NCT03757130|156632448|FG006|Overall Study|Withdrawal by Subject|1|||
48666451|NCT03757130|156632449|FG007|Overall Study|Withdrawal by Subject|0|||
48666452|NCT02360293|156632450|FG000|Overall Study|Lost to Follow-up|73|||
48666453|NCT02360293|156632451|FG001|Overall Study|Lost to Follow-up|95|||
48666454|NCT02360293|156632450|FG000|Overall Study|Withdrawal by Subject|2|||
48666455|NCT02360293|156632451|FG001|Overall Study|Withdrawal by Subject|1|||
48666456|NCT02360293|156632450|FG000|Overall Study|Excluded|1|||
48666457|NCT02360293|156632451|FG001|Overall Study|Excluded|0|||
48666458|NCT00475865|156632452|FG000|Overall Study|Adverse Event|0|||
48666459|NCT00475865|156632453|FG001|Overall Study|Adverse Event|3|||
48666460|NCT00475865|156632454|FG002|Overall Study|Adverse Event|4|||
48666461|NCT00475865|156632452|FG000|Overall Study|Lack of Efficacy|1|||
48666462|NCT00475865|156632453|FG001|Overall Study|Lack of Efficacy|0|||
48666463|NCT00475865|156632454|FG002|Overall Study|Lack of Efficacy|0|||
48666464|NCT00475865|156632452|FG000|Overall Study|Progressive disease|0|||
48666465|NCT00475865|156632453|FG001|Overall Study|Progressive disease|1|||
48666466|NCT00475865|156632454|FG002|Overall Study|Progressive disease|2|||
48666467|NCT00475865|156632452|FG000|Overall Study|Participant did not wish to continue|1|||
48666468|NCT00475865|156632453|FG001|Overall Study|Participant did not wish to continue|0|||
48666469|NCT00475865|156632454|FG002|Overall Study|Participant did not wish to continue|0|||
48666470|NCT00475865|156632452|FG000|Overall Study|Other than above|0|||
48666471|NCT00475865|156632453|FG001|Overall Study|Other than above|1|||
48666472|NCT00475865|156632454|FG002|Overall Study|Other than above|0|||
48666473|NCT00612508|156632455|FG000|Overall Study|Withdrawal by Subject|3|||
48666474|NCT00612508|156632456|FG001|Overall Study|Withdrawal by Subject|4|||
48666475|NCT02008357|156632457|FG000|Double-blind (Placebo Controlled) Period|Adverse Event|29|||
48666476|NCT02008357|156632458|FG001|Double-blind (Placebo Controlled) Period|Adverse Event|35|||
48666477|NCT02008357|156632457|FG000|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|101|||
48666478|NCT02008357|156632458|FG001|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|88|||
48666479|NCT02008357|156632457|FG000|Double-blind (Placebo Controlled) Period|Death|6|||
48666480|NCT02008357|156632458|FG001|Double-blind (Placebo Controlled) Period|Death|5|||
48666481|NCT02008357|156632457|FG000|Double-blind (Placebo Controlled) Period|Lack of Efficacy|3|||
48666482|NCT02008357|156632458|FG001|Double-blind (Placebo Controlled) Period|Lack of Efficacy|4|||
48666483|NCT02008357|156632457|FG000|Double-blind (Placebo Controlled) Period|Lost to Follow-up|3|||
48666484|NCT02008357|156632458|FG001|Double-blind (Placebo Controlled) Period|Lost to Follow-up|6|||
48757960|NCT01641692|156960884|FG005|Treatment Period 2|Lack of Efficacy|0|||
48757961|NCT01641692|156960885|FG006|Treatment Period 2|Lack of Efficacy|0|||
48757962|NCT01641692|156960886|FG007|Treatment Period 2|Lack of Efficacy|0|||
48757963|NCT01641692|156960879|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
48757964|NCT01641692|156960880|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
48757965|NCT01641692|156960881|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
48757966|NCT01641692|156960882|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
48868165|NCT04778397|157353904|FG003|Overall Study|Withdrew Consent|1|||
48666485|NCT02008357|156632457|FG000|Double-blind (Placebo Controlled) Period|Coordinating Center Request|1|||
48666486|NCT02008357|156632458|FG001|Double-blind (Placebo Controlled) Period|Coordinating Center Request|0|||
48666487|NCT02008357|156632457|FG000|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|6|||
48666488|NCT02008357|156632458|FG001|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|3|||
48868166|NCT04778397|157353901|FG000|Overall Study|Reason Not Specified|1|||
48868167|NCT04778397|157353902|FG001|Overall Study|Reason Not Specified|3|||
48868168|NCT04778397|157353903|FG002|Overall Study|Reason Not Specified|0|||
48868169|NCT04778397|157353904|FG003|Overall Study|Reason Not Specified|2|||
48868170|NCT04778397|157353901|FG000|Overall Study|Lost to Follow-up|2|||
48868171|NCT04778397|157353902|FG001|Overall Study|Lost to Follow-up|1|||
48666489|NCT02008357|156632457|FG000|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
48666490|NCT02008357|156632458|FG001|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
48666491|NCT02008357|156632457|FG000|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
48666492|NCT02008357|156632458|FG001|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
48666493|NCT02008357|156632457|FG000|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|2|||
48666494|NCT02008357|156632458|FG001|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|0|||
48666495|NCT02008357|156632457|FG000|Double-blind (Placebo Controlled) Period|Safety Risk|2|||
48666496|NCT02008357|156632458|FG001|Double-blind (Placebo Controlled) Period|Safety Risk|6|||
48666497|NCT02008357|156632457|FG000|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|0|||
48666498|NCT02008357|156632458|FG001|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|1|||
48666499|NCT02008357|156632457|FG000|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
48666500|NCT02008357|156632458|FG001|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
48666501|NCT02008357|156632457|FG000|Double-blind (Placebo Controlled) Period|Starting New Trial|2|||
48666502|NCT02008357|156632458|FG001|Double-blind (Placebo Controlled) Period|Starting New Trial|0|||
48666503|NCT02008357|156632457|FG000|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|3|||
48666504|NCT02008357|156632458|FG001|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|1|||
48666505|NCT02008357|156632457|FG000|Double-blind (Placebo Controlled) Period|Family Issues|1|||
48967475|NCT00305604|157708596|FG000|Overall Study|Adverse Event|6|||
48666506|NCT02008357|156632458|FG001|Double-blind (Placebo Controlled) Period|Family Issues|1|||
48666507|NCT02008357|156632457|FG000|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|4|||
48666508|NCT02008357|156632458|FG001|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|2|||
48666509|NCT02008357|156632457|FG000|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|0|||
48666510|NCT02008357|156632458|FG001|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|3|||
48666511|NCT02008357|156632457|FG000|Double-blind (Placebo Controlled) Period|Personal Reason|0|||
48666512|NCT02008357|156632458|FG001|Double-blind (Placebo Controlled) Period|Personal Reason|1|||
48666513|NCT02008357|156632457|FG000|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|3|||
48666514|NCT02008357|156632458|FG001|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|0|||
48666515|NCT02008357|156632457|FG000|Double-blind (Placebo Controlled) Period|Site Closure|0|||
48666516|NCT02008357|156632458|FG001|Double-blind (Placebo Controlled) Period|Site Closure|1|||
48666517|NCT02008357|156632457|FG000|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|0|||
48666518|NCT02008357|156632458|FG001|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|1|||
48666519|NCT02008357|156632457|FG000|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|1|||
48666520|NCT02008357|156632458|FG001|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|2|||
48666521|NCT02008357|156632457|FG000|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|0|||
48666522|NCT02008357|156632458|FG001|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|1|||
48666523|NCT02008357|156632457|FG000|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|0|||
48666524|NCT02008357|156632458|FG001|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|1|||
48967476|NCT00305604|157708597|FG001|Overall Study|Adverse Event|3|||
48967477|NCT00305604|157708596|FG000|Overall Study|Lack of Efficacy|11|||
48967478|NCT00305604|157708597|FG001|Overall Study|Lack of Efficacy|18|||
48967479|NCT00305604|157708596|FG000|Overall Study|Lost to Follow-up|0|||
48967480|NCT00305604|157708597|FG001|Overall Study|Lost to Follow-up|4|||
48967481|NCT00305604|157708596|FG000|Overall Study|Protocol Violation|2|||
48967482|NCT00305604|157708597|FG001|Overall Study|Protocol Violation|1|||
48967483|NCT00305604|157708596|FG000|Overall Study|Withdrawal by Subject|12|||
48967484|NCT00305604|157708597|FG001|Overall Study|Withdrawal by Subject|21|||
48967485|NCT00305604|157708596|FG000|Overall Study|Patient moved|1|||
48967486|NCT00305604|157708597|FG001|Overall Study|Patient moved|0|||
48967487|NCT02146248|157708598|FG000|Overall Study|Withdrawal by Subject|2|||
48967488|NCT01578785|157708604|FG000|Overall Study|Withdrawal by Subject|0|||
48967489|NCT01578785|157708605|FG001|Overall Study|Withdrawal by Subject|1|||
48967490|NCT01578785|157708604|FG000|Overall Study|Study terminated by sponsor|59|||
48967491|NCT01578785|157708605|FG001|Overall Study|Study terminated by sponsor|118|||
48967492|NCT00844285|157708606|FG000|Overall Study|Other|0|||
48967493|NCT00844285|157708607|FG001|Overall Study|Other|1|||
48967494|NCT00844285|157708608|FG002|Overall Study|Other|0|||
48967495|NCT00844285|157708606|FG000|Overall Study|Other than specified|95|||
48967496|NCT00844285|157708607|FG001|Overall Study|Other than specified|129|||
48967497|NCT00844285|157708608|FG002|Overall Study|Other than specified|12|||
48967498|NCT00844285|157708606|FG000|Overall Study|Site closure|256|||
48967499|NCT00844285|157708607|FG001|Overall Study|Site closure|450|||
48967500|NCT00844285|157708608|FG002|Overall Study|Site closure|50|||
48967501|NCT00844285|157708606|FG000|Overall Study|Follow-up < 8 years|16|||
48967502|NCT00844285|157708607|FG001|Overall Study|Follow-up < 8 years|23|||
48967503|NCT00844285|157708608|FG002|Overall Study|Follow-up < 8 years|4|||
48666525|NCT02008357|156632457|FG000|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|1|||
48666526|NCT02008357|156632458|FG001|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|0|||
48666527|NCT02008357|156632457|FG000|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|0|||
48757967|NCT01641692|156960883|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
48757968|NCT01641692|156960884|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
48757969|NCT01641692|156960885|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
48757970|NCT01641692|156960886|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
48757971|NCT01641692|156960879|FG000|Treatment Period 2|Lost to Follow-up|0|||
48757972|NCT01641692|156960880|FG001|Treatment Period 2|Lost to Follow-up|0|||
48757973|NCT01641692|156960881|FG002|Treatment Period 2|Lost to Follow-up|0|||
48757974|NCT01641692|156960882|FG003|Treatment Period 2|Lost to Follow-up|0|||
48757975|NCT01641692|156960883|FG004|Treatment Period 2|Lost to Follow-up|0|||
48757976|NCT01641692|156960884|FG005|Treatment Period 2|Lost to Follow-up|1|||
48757977|NCT01641692|156960885|FG006|Treatment Period 2|Lost to Follow-up|0|||
48757978|NCT01641692|156960886|FG007|Treatment Period 2|Lost to Follow-up|0|||
48757979|NCT01641692|156960879|FG000|Treatment Period 2|Withdrawal by Subject|1|||
48757980|NCT01641692|156960880|FG001|Treatment Period 2|Withdrawal by Subject|0|||
48757981|NCT01641692|156960881|FG002|Treatment Period 2|Withdrawal by Subject|0|||
48666528|NCT02008357|156632458|FG001|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|1|||
48666529|NCT02008357|156632457|FG000|Open-label Extension Period|Adverse Event|8|||
48666530|NCT02008357|156632458|FG001|Open-label Extension Period|Adverse Event|7|||
48666531|NCT02008357|156632457|FG000|Open-label Extension Period|Death|7|||
48666532|NCT02008357|156632458|FG001|Open-label Extension Period|Death|4|||
48666533|NCT02008357|156632457|FG000|Open-label Extension Period|Lack of Efficacy|9|||
48666534|NCT02008357|156632458|FG001|Open-label Extension Period|Lack of Efficacy|5|||
48666535|NCT02008357|156632457|FG000|Open-label Extension Period|Lost to Follow-up|2|||
48757982|NCT01641692|156960882|FG003|Treatment Period 2|Withdrawal by Subject|0|||
48757983|NCT01641692|156960883|FG004|Treatment Period 2|Withdrawal by Subject|0|||
48868172|NCT04778397|157353903|FG002|Overall Study|Lost to Follow-up|0|||
48868173|NCT04778397|157353904|FG003|Overall Study|Lost to Follow-up|1|||
48868174|NCT01024036|157353905|FG000|Blinded Treatment|Adverse Event|1|||
48868175|NCT01024036|157353906|FG001|Blinded Treatment|Adverse Event|1|||
48868176|NCT01024036|157353905|FG000|Blinded Treatment|Lack of Efficacy|16|||
48868177|NCT01024036|157353906|FG001|Blinded Treatment|Lack of Efficacy|14|||
48868178|NCT01024036|157353905|FG000|Blinded Treatment|Physician Decision|1|||
48868179|NCT01024036|157353906|FG001|Blinded Treatment|Physician Decision|0|||
48967504|NCT00844285|157708606|FG000|Overall Study|Protocol Violation|26|||
48666536|NCT02008357|156632458|FG001|Open-label Extension Period|Lost to Follow-up|2|||
48666537|NCT02008357|156632457|FG000|Open-label Extension Period|Withdrawal by Subject|27|||
48666538|NCT02008357|156632458|FG001|Open-label Extension Period|Withdrawal by Subject|32|||
48666539|NCT02008357|156632457|FG000|Open-label Extension Period|Study Terminated By Sponsor|300|||
48757984|NCT01641692|156960884|FG005|Treatment Period 2|Withdrawal by Subject|1|||
48757985|NCT01641692|156960885|FG006|Treatment Period 2|Withdrawal by Subject|0|||
48757986|NCT01641692|156960886|FG007|Treatment Period 2|Withdrawal by Subject|1|||
48757987|NCT01641692|156960879|FG000|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
48757988|NCT01641692|156960880|FG001|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
48868180|NCT01024036|157353905|FG000|Blinded Treatment|Death|0|||
48868181|NCT01024036|157353906|FG001|Blinded Treatment|Death|2|||
48967505|NCT00844285|157708607|FG001|Overall Study|Protocol Violation|28|||
48967506|NCT00844285|157708608|FG002|Overall Study|Protocol Violation|54|||
48967507|NCT00844285|157708606|FG000|Overall Study|Death|22|||
48967508|NCT00844285|157708607|FG001|Overall Study|Death|21|||
48967509|NCT00844285|157708608|FG002|Overall Study|Death|8|||
48967510|NCT00844285|157708606|FG000|Overall Study|Withdrew Consent|344|||
48967511|NCT00844285|157708607|FG001|Overall Study|Withdrew Consent|466|||
48967512|NCT00844285|157708608|FG002|Overall Study|Withdrew Consent|70|||
48967513|NCT00844285|157708606|FG000|Overall Study|Lost to Follow-up|330|||
48967514|NCT00844285|157708607|FG001|Overall Study|Lost to Follow-up|486|||
48967515|NCT00844285|157708608|FG002|Overall Study|Lost to Follow-up|74|||
48967516|NCT00192036|157708615|FG000|Overall Study|Protocol Violation|3|||
48967517|NCT00192036|157708615|FG000|Overall Study|Adverse Event|6|||
48967518|NCT00192036|157708615|FG000|Overall Study|Patient/Physician Perception|1|||
48967519|NCT00192036|157708615|FG000|Overall Study|Objective Tumor Progression|4|||
48967520|NCT00192036|157708615|FG000|Overall Study|Clinical Disease Progression|1|||
48967521|NCT00192036|157708615|FG000|Overall Study|Death|1|||
48967522|NCT00192036|157708615|FG000|Overall Study|Unknown or Not Specified|5|||
48967523|NCT03371732|157708616|FG000|Overall Study|Withdrawal by Subject|9|||
48967524|NCT03371732|157708617|FG001|Overall Study|Withdrawal by Subject|3|||
48967525|NCT03371732|157708616|FG000|Overall Study|Refusal to continue|3|||
48967526|NCT03371732|157708617|FG001|Overall Study|Refusal to continue|4|||
48967527|NCT04682353|157708618|FG000|Overall Study|Lost to Follow-up|0|||
48868182|NCT01024036|157353905|FG000|Blinded Treatment|Withdrawal by Subject|4|||
48868183|NCT01024036|157353906|FG001|Blinded Treatment|Withdrawal by Subject|3|||
48967528|NCT04682353|157708619|FG001|Overall Study|Lost to Follow-up|1|||
48666540|NCT02008357|156632458|FG001|Open-label Extension Period|Study Terminated By Sponsor|313|||
48666541|NCT02008357|156632457|FG000|Open-label Extension Period|Safety Risk|2|||
48666542|NCT02008357|156632458|FG001|Open-label Extension Period|Safety Risk|1|||
48666543|NCT02008357|156632457|FG000|Open-label Extension Period|Non-Compliance|0|||
48666544|NCT02008357|156632458|FG001|Open-label Extension Period|Non-Compliance|1|||
48666545|NCT02008357|156632457|FG000|Open-label Extension Period|Investigator Recommendation|0|||
48666546|NCT02008357|156632458|FG001|Open-label Extension Period|Investigator Recommendation|1|||
48666547|NCT02008357|156632457|FG000|Open-label Extension Period|Covid-19 Pandemic Disruption|0|||
48666548|NCT02008357|156632458|FG001|Open-label Extension Period|Covid-19 Pandemic Disruption|1|||
48666549|NCT02008357|156632457|FG000|Open-label Extension Period|Coordinating Center Request|2|||
48666550|NCT02008357|156632458|FG001|Open-label Extension Period|Coordinating Center Request|4|||
48666551|NCT02008357|156632457|FG000|Open-label Extension Period|No Longer Wishes to Participate|1|||
48666552|NCT02008357|156632458|FG001|Open-label Extension Period|No Longer Wishes to Participate|1|||
48666553|NCT02008357|156632457|FG000|Open-label Extension Period|Study Ended|20|||
48666554|NCT02008357|156632458|FG001|Open-label Extension Period|Study Ended|25|||
48666555|NCT02008357|156632457|FG000|Open-label Extension Period|Personal Reasons|0|||
48666556|NCT02008357|156632458|FG001|Open-label Extension Period|Personal Reasons|1|||
48666557|NCT02008357|156632457|FG000|Open-label Extension Period|Discontinued Study Due to Health Issues|0|||
48666558|NCT02008357|156632458|FG001|Open-label Extension Period|Discontinued Study Due to Health Issues|2|||
48666559|NCT02008357|156632457|FG000|Open-label Extension Period|Travel Issues/Limitations|2|||
48666560|NCT02008357|156632458|FG001|Open-label Extension Period|Travel Issues/Limitations|0|||
48666561|NCT02008357|156632457|FG000|Open-label Extension Period|Other|2|||
48666562|NCT02008357|156632458|FG001|Open-label Extension Period|Other|0|||
48666563|NCT02365285|156632459|FG000|Overall Study|Physician Decision|0|||
48666564|NCT02365285|156632460|FG001|Overall Study|Physician Decision|1|||
48666565|NCT02365285|156632461|FG002|Overall Study|Physician Decision|1|||
48666566|NCT02365285|156632462|FG003|Overall Study|Physician Decision|0|||
48666567|NCT02365285|156632459|FG000|Overall Study|Adverse Event|0|||
48666568|NCT02365285|156632460|FG001|Overall Study|Adverse Event|0|||
48666569|NCT02365285|156632461|FG002|Overall Study|Adverse Event|0|||
48666570|NCT02365285|156632462|FG003|Overall Study|Adverse Event|2|||
48666571|NCT00490022|156632464|FG000|Overall Study|Adverse Event|0|||
48757989|NCT01641692|156960881|FG002|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
48757990|NCT01641692|156960882|FG003|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
48757991|NCT01641692|156960883|FG004|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
48757992|NCT01641692|156960884|FG005|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
48757993|NCT01641692|156960885|FG006|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
48757994|NCT01641692|156960886|FG007|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
48757995|NCT01641692|156960879|FG000|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
48757996|NCT01641692|156960880|FG001|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
48757997|NCT01641692|156960881|FG002|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
48757998|NCT01641692|156960882|FG003|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
48757999|NCT01641692|156960883|FG004|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
48758000|NCT01641692|156960884|FG005|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
48758001|NCT01641692|156960885|FG006|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
48758002|NCT01641692|156960886|FG007|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
48758003|NCT01641692|156960879|FG000|Treatment Period 3|Adverse Event|0|||
48758004|NCT01641692|156960880|FG001|Treatment Period 3|Adverse Event|0|||
48758005|NCT01641692|156960881|FG002|Treatment Period 3|Adverse Event|0|||
48758006|NCT01641692|156960882|FG003|Treatment Period 3|Adverse Event|0|||
48758007|NCT01641692|156960883|FG004|Treatment Period 3|Adverse Event|0|||
48758008|NCT01641692|156960884|FG005|Treatment Period 3|Adverse Event|0|||
48758009|NCT01641692|156960885|FG006|Treatment Period 3|Adverse Event|1|||
48758010|NCT01641692|156960886|FG007|Treatment Period 3|Adverse Event|0|||
48758011|NCT01641692|156960879|FG000|Treatment Period 3|Protocol Violation|0|||
48758012|NCT01641692|156960880|FG001|Treatment Period 3|Protocol Violation|0|||
48758013|NCT01641692|156960881|FG002|Treatment Period 3|Protocol Violation|1|||
48758014|NCT01641692|156960882|FG003|Treatment Period 3|Protocol Violation|0|||
48758015|NCT01641692|156960883|FG004|Treatment Period 3|Protocol Violation|0|||
48758016|NCT01641692|156960884|FG005|Treatment Period 3|Protocol Violation|0|||
48758017|NCT01641692|156960885|FG006|Treatment Period 3|Protocol Violation|0|||
48758018|NCT01641692|156960886|FG007|Treatment Period 3|Protocol Violation|0|||
48758019|NCT01641692|156960879|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
48758020|NCT01641692|156960880|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
48758021|NCT01641692|156960881|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
48758022|NCT01641692|156960882|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
48758023|NCT01641692|156960883|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
48758024|NCT01641692|156960884|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
48758025|NCT01641692|156960885|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
48758026|NCT01641692|156960886|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
48967529|NCT04682353|157708620|FG002|Overall Study|Lost to Follow-up|0|||
48967530|NCT04682353|157708621|FG003|Overall Study|Lost to Follow-up|1|||
48967531|NCT04682353|157708618|FG000|Overall Study|Personal reasons|0|||
48967532|NCT04682353|157708619|FG001|Overall Study|Personal reasons|1|||
48967533|NCT04682353|157708620|FG002|Overall Study|Personal reasons|0|||
48967534|NCT04682353|157708621|FG003|Overall Study|Personal reasons|0|||
48967535|NCT00475540|157708622|FG000|36 Months|Lost to Follow-up|4|||
48666572|NCT00490022|156632465|FG001|Overall Study|Adverse Event|2|||
48666573|NCT00490022|156632464|FG000|Overall Study|Withdrawal by Subject|1|||
48666574|NCT00490022|156632465|FG001|Overall Study|Withdrawal by Subject|0|||
48666575|NCT00490022|156632464|FG000|Overall Study|Subject failed to disclose concommitant|0|||
48666576|NCT00490022|156632465|FG001|Overall Study|Subject failed to disclose concommitant|1|||
48666577|NCT02124772|156632466|FG000|Overall Study|Lack of Efficacy|2|||
48666578|NCT02124772|156632467|FG001|Overall Study|Lack of Efficacy|0|||
48666579|NCT02124772|156632468|FG002|Overall Study|Lack of Efficacy|0|||
48666580|NCT02124772|156632469|FG003|Overall Study|Lack of Efficacy|1|||
48666581|NCT02124772|156632470|FG004|Overall Study|Lack of Efficacy|2|||
48666582|NCT02124772|156632471|FG005|Overall Study|Lack of Efficacy|3|||
48666583|NCT02124772|156632472|FG006|Overall Study|Lack of Efficacy|0|||
48666584|NCT02124772|156632473|FG007|Overall Study|Lack of Efficacy|2|||
48666585|NCT02124772|156632474|FG008|Overall Study|Lack of Efficacy|0|||
48666586|NCT02124772|156632475|FG009|Overall Study|Lack of Efficacy|1|||
48666587|NCT02124772|156632476|FG010|Overall Study|Lack of Efficacy|0|||
48666588|NCT02124772|156632477|FG011|Overall Study|Lack of Efficacy|0|||
48666589|NCT02124772|156632478|FG012|Overall Study|Lack of Efficacy|1|||
48666590|NCT02124772|156632466|FG000|Overall Study|Adverse Event|1|||
48666591|NCT02124772|156632467|FG001|Overall Study|Adverse Event|4|||
48666592|NCT02124772|156632468|FG002|Overall Study|Adverse Event|1|||
48666593|NCT02124772|156632469|FG003|Overall Study|Adverse Event|5|||
48666594|NCT02124772|156632470|FG004|Overall Study|Adverse Event|2|||
48666595|NCT02124772|156632471|FG005|Overall Study|Adverse Event|1|||
48666596|NCT02124772|156632472|FG006|Overall Study|Adverse Event|1|||
48666597|NCT02124772|156632473|FG007|Overall Study|Adverse Event|5|||
48666598|NCT02124772|156632474|FG008|Overall Study|Adverse Event|0|||
48666599|NCT02124772|156632475|FG009|Overall Study|Adverse Event|3|||
48666600|NCT02124772|156632476|FG010|Overall Study|Adverse Event|1|||
48666601|NCT02124772|156632477|FG011|Overall Study|Adverse Event|3|||
48666602|NCT02124772|156632478|FG012|Overall Study|Adverse Event|1|||
48666603|NCT02124772|156632466|FG000|Overall Study|Withdrawal consent|0|||
48666604|NCT02124772|156632467|FG001|Overall Study|Withdrawal consent|1|||
48666605|NCT02124772|156632468|FG002|Overall Study|Withdrawal consent|1|||
48666606|NCT02124772|156632469|FG003|Overall Study|Withdrawal consent|1|||
48666607|NCT02124772|156632470|FG004|Overall Study|Withdrawal consent|0|||
48666608|NCT02124772|156632471|FG005|Overall Study|Withdrawal consent|1|||
48666609|NCT02124772|156632472|FG006|Overall Study|Withdrawal consent|1|||
48967536|NCT00475540|157708623|FG001|36 Months|Lost to Follow-up|4|||
48967537|NCT00475540|157708622|FG000|36 Months|Death|1|||
48967538|NCT00475540|157708623|FG001|36 Months|Death|2|||
48967539|NCT00475540|157708622|FG000|36 Months|Censored due to reoperation|3|||
48967540|NCT00475540|157708623|FG001|36 Months|Censored due to reoperation|0|||
48666610|NCT02124772|156632473|FG007|Overall Study|Withdrawal consent|0|||
48666611|NCT02124772|156632474|FG008|Overall Study|Withdrawal consent|0|||
48666612|NCT02124772|156632475|FG009|Overall Study|Withdrawal consent|1|||
48666613|NCT02124772|156632476|FG010|Overall Study|Withdrawal consent|0|||
48666614|NCT02124772|156632477|FG011|Overall Study|Withdrawal consent|1|||
48666615|NCT02124772|156632478|FG012|Overall Study|Withdrawal consent|0|||
48666616|NCT02124772|156632466|FG000|Overall Study|Investigator discretion|0|||
48666617|NCT02124772|156632467|FG001|Overall Study|Investigator discretion|2|||
48666618|NCT02124772|156632468|FG002|Overall Study|Investigator discretion|2|||
48666619|NCT02124772|156632469|FG003|Overall Study|Investigator discretion|1|||
48666620|NCT02124772|156632470|FG004|Overall Study|Investigator discretion|1|||
48666621|NCT02124772|156632471|FG005|Overall Study|Investigator discretion|0|||
48967541|NCT00377429|157708624|FG000|Overall Study|Withdrawal by Subject|5|||
48666622|NCT02124772|156632472|FG006|Overall Study|Investigator discretion|1|||
48666623|NCT02124772|156632473|FG007|Overall Study|Investigator discretion|0|||
48666624|NCT02124772|156632474|FG008|Overall Study|Investigator discretion|0|||
48666625|NCT02124772|156632475|FG009|Overall Study|Investigator discretion|1|||
48666626|NCT02124772|156632476|FG010|Overall Study|Investigator discretion|0|||
48666627|NCT02124772|156632477|FG011|Overall Study|Investigator discretion|1|||
48967542|NCT00377429|157708624|FG000|Overall Study|Adverse Event|8|||
48967543|NCT00377429|157708624|FG000|Overall Study|Physician Decision|1|||
49015467|NCT01393990|157893781|FG011|Overall Study|Progressive Disease|0|||
48666628|NCT02124772|156632478|FG012|Overall Study|Investigator discretion|0|||
48666629|NCT02124772|156632466|FG000|Overall Study|Progressive disease|0|||
48666630|NCT02124772|156632467|FG001|Overall Study|Progressive disease|0|||
48666631|NCT02124772|156632468|FG002|Overall Study|Progressive disease|0|||
48666632|NCT02124772|156632469|FG003|Overall Study|Progressive disease|0|||
48666633|NCT02124772|156632470|FG004|Overall Study|Progressive disease|0|||
48666634|NCT02124772|156632471|FG005|Overall Study|Progressive disease|0|||
48666635|NCT02124772|156632472|FG006|Overall Study|Progressive disease|1|||
48666636|NCT02124772|156632473|FG007|Overall Study|Progressive disease|1|||
48666637|NCT02124772|156632474|FG008|Overall Study|Progressive disease|0|||
48666638|NCT02124772|156632475|FG009|Overall Study|Progressive disease|0|||
48666639|NCT02124772|156632476|FG010|Overall Study|Progressive disease|0|||
48666640|NCT02124772|156632477|FG011|Overall Study|Progressive disease|0|||
48666641|NCT02124772|156632478|FG012|Overall Study|Progressive disease|0|||
48868184|NCT01024036|157353905|FG000|Unblinded Treatment|Adverse Event|0|||
48868185|NCT01024036|157353906|FG001|Unblinded Treatment|Adverse Event|1|||
48868186|NCT01024036|157353905|FG000|Unblinded Treatment|Lack of Efficacy|0|||
48868187|NCT01024036|157353906|FG001|Unblinded Treatment|Lack of Efficacy|2|||
48868188|NCT01024036|157353905|FG000|Follow-Up Period|Lost to Follow-up|1|||
48868189|NCT01024036|157353906|FG001|Follow-Up Period|Lost to Follow-up|1|||
48868190|NCT01024036|157353905|FG000|Follow-Up Period|Withdrawal by Subject|0|||
48868191|NCT01024036|157353906|FG001|Follow-Up Period|Withdrawal by Subject|1|||
48868192|NCT01024036|157353905|FG000|Follow-Up Period|Adverse Event|4|||
48868193|NCT01024036|157353906|FG001|Follow-Up Period|Adverse Event|1|||
48868194|NCT03512288|157353907|FG000|Overall Study|Adverse Event|1|||
48666642|NCT02124772|156632466|FG000|Overall Study|Other|0|||
48666643|NCT02124772|156632467|FG001|Overall Study|Other|7|||
48758027|NCT01641692|156960879|FG000|Treatment Period 3|Lost to Follow-up|0|||
48758028|NCT01641692|156960880|FG001|Treatment Period 3|Lost to Follow-up|1|||
48758029|NCT01641692|156960881|FG002|Treatment Period 3|Lost to Follow-up|0|||
48758030|NCT01641692|156960882|FG003|Treatment Period 3|Lost to Follow-up|0|||
48758031|NCT01641692|156960883|FG004|Treatment Period 3|Lost to Follow-up|0|||
48758032|NCT01641692|156960884|FG005|Treatment Period 3|Lost to Follow-up|0|||
48868195|NCT03512288|157353908|FG001|Overall Study|Adverse Event|0|||
48868196|NCT03512288|157353907|FG000|Overall Study|Lost to Follow-up|12|||
48868197|NCT03512288|157353908|FG001|Overall Study|Lost to Follow-up|15|||
48666644|NCT02124772|156632468|FG002|Overall Study|Other|2|||
48666645|NCT02124772|156632469|FG003|Overall Study|Other|5|||
48666646|NCT02124772|156632470|FG004|Overall Study|Other|4|||
48666647|NCT02124772|156632471|FG005|Overall Study|Other|3|||
48666648|NCT02124772|156632472|FG006|Overall Study|Other|4|||
48666649|NCT02124772|156632473|FG007|Overall Study|Other|1|||
48666650|NCT02124772|156632474|FG008|Overall Study|Other|1|||
48666651|NCT02124772|156632475|FG009|Overall Study|Other|1|||
48666652|NCT02124772|156632476|FG010|Overall Study|Other|1|||
48758033|NCT01641692|156960885|FG006|Treatment Period 3|Lost to Follow-up|0|||
48758034|NCT01641692|156960886|FG007|Treatment Period 3|Lost to Follow-up|0|||
48758035|NCT01641692|156960879|FG000|Washout Period 3 or Follow-up|Protocol Violation|0|||
48758036|NCT01641692|156960880|FG001|Washout Period 3 or Follow-up|Protocol Violation|0|||
48758037|NCT01641692|156960881|FG002|Washout Period 3 or Follow-up|Protocol Violation|0|||
48758038|NCT01641692|156960882|FG003|Washout Period 3 or Follow-up|Protocol Violation|0|||
48758039|NCT01641692|156960883|FG004|Washout Period 3 or Follow-up|Protocol Violation|0|||
48758040|NCT01641692|156960884|FG005|Washout Period 3 or Follow-up|Protocol Violation|1|||
48758041|NCT01641692|156960885|FG006|Washout Period 3 or Follow-up|Protocol Violation|0|||
48758042|NCT01641692|156960886|FG007|Washout Period 3 or Follow-up|Protocol Violation|0|||
48758043|NCT01641692|156960879|FG000|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
48758044|NCT01641692|156960880|FG001|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
48758045|NCT01641692|156960881|FG002|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
48967544|NCT00377429|157708624|FG000|Overall Study|Patient non-compliance|1|||
48967545|NCT00476996|157708629|FG000|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12|||
48967546|NCT00476996|157708630|FG001|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
48967547|NCT00476996|157708631|FG002|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
48967548|NCT00476996|157708632|FG003|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0|||
48967549|NCT00476996|157708629|FG000|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1|||
48758046|NCT01641692|156960882|FG003|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
48758047|NCT01641692|156960883|FG004|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
48758048|NCT01641692|156960884|FG005|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
48758049|NCT01641692|156960885|FG006|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
48758050|NCT01641692|156960886|FG007|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
48758051|NCT01166178|156960887|FG000|Overall Study|Withdrawal by Subject|1|||
48758052|NCT01166178|156960888|FG001|Overall Study|Withdrawal by Subject|0|||
48758053|NCT01166178|156960887|FG000|Overall Study|Study was terminated|20|||
48666653|NCT02124772|156632477|FG011|Overall Study|Other|1|||
48666654|NCT02124772|156632478|FG012|Overall Study|Other|0|||
48666655|NCT02636946|156632479|FG000|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|0|||
48758054|NCT01166178|156960888|FG001|Overall Study|Study was terminated|8|||
48758055|NCT00679263|156960891|FG000|Visit 2/Dose 1|Adverse Event|1|||
48868198|NCT03512288|157353907|FG000|Overall Study|Physician Decision|0|||
48868199|NCT03512288|157353908|FG001|Overall Study|Physician Decision|2|||
48868200|NCT03512288|157353907|FG000|Overall Study|Protocol Violation|6|||
49015468|NCT01393990|157893782|FG012|Overall Study|Progressive Disease|0|||
48666656|NCT02636946|156632480|FG001|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|1|||
48666657|NCT02636946|156632479|FG000|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
48868201|NCT03512288|157353908|FG001|Overall Study|Protocol Violation|4|||
48868202|NCT03512288|157353907|FG000|Overall Study|Medication error without associated adverse event|1|||
48868203|NCT03512288|157353908|FG001|Overall Study|Medication error without associated adverse event|0|||
48868204|NCT03512288|157353907|FG000|Overall Study|No longer met eligibility criteria|5|||
48868205|NCT03512288|157353908|FG001|Overall Study|No longer met eligibility criteria|2|||
48868206|NCT03512288|157353907|FG000|Overall Study|Withdrawal by parent/guardian|14|||
48868207|NCT03512288|157353908|FG001|Overall Study|Withdrawal by parent/guardian|18|||
48868208|NCT03512288|157353907|FG000|Overall Study|Other|1|||
48868209|NCT03512288|157353908|FG001|Overall Study|Other|1|||
48868210|NCT03512288|157353907|FG000|Overall Study|Randomized but not treated|1|||
48868211|NCT03512288|157353908|FG001|Overall Study|Randomized but not treated|1|||
48868212|NCT01208870|157353910|FG000|Overall Study|Lost to Follow-up|2|||
48868213|NCT01208870|157353911|FG001|Overall Study|Lost to Follow-up|8|||
48868214|NCT05172232|157353917|FG000|Overall Study|Lost to Follow-up|3|||
48868215|NCT00727259|157353918|FG000|Overall Study|Not all questionnaires completed|1055|||
48868216|NCT01207492|157353921|FG000|Overall Study|Still on study|1|||
48868217|NCT01207492|157353921|FG000|Overall Study|Withdrawal by Subject|9|||
48868218|NCT01207492|157353921|FG000|Overall Study|Physician Decision|1|||
48868219|NCT01207492|157353921|FG000|Overall Study|Progressive disease|3|||
48868220|NCT01207492|157353921|FG000|Overall Study|Toxicity|1|||
48868221|NCT01772147|157355478|FG000|Overall Study|Adverse Event|13|||
48868222|NCT01772147|157355479|FG001|Overall Study|Adverse Event|10|||
48868223|NCT01772147|157355480|FG002|Overall Study|Adverse Event|6|||
48868224|NCT01772147|157355478|FG000|Overall Study|Withdrew Consent|7|||
48868225|NCT01772147|157355479|FG001|Overall Study|Withdrew Consent|8|||
48868226|NCT01772147|157355480|FG002|Overall Study|Withdrew Consent|4|||
48868227|NCT01772147|157355478|FG000|Overall Study|Lost to Follow-up|1|||
48868228|NCT01772147|157355479|FG001|Overall Study|Lost to Follow-up|0|||
48868229|NCT01772147|157355480|FG002|Overall Study|Lost to Follow-up|1|||
48868230|NCT01772147|157355478|FG000|Overall Study|Protocol Deviation|2|||
48868231|NCT01772147|157355479|FG001|Overall Study|Protocol Deviation|1|||
48868232|NCT01772147|157355480|FG002|Overall Study|Protocol Deviation|1|||
48868233|NCT01772147|157355478|FG000|Overall Study|Lack of Efficacy|8|||
49015469|NCT01393990|157893783|FG013|Overall Study|Progressive Disease|1|||
48666658|NCT02636946|156632480|FG001|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
48666659|NCT02636946|156632479|FG000|Cycle 1 (Day 1 to Week 15)|Protocol Violation|0|||
48666660|NCT02636946|156632480|FG001|Cycle 1 (Day 1 to Week 15)|Protocol Violation|1|||
48666661|NCT02636946|156632479|FG000|Cycle 1 (Day 1 to Week 15)|Reason not Specified|0|||
48666662|NCT02636946|156632480|FG001|Cycle 1 (Day 1 to Week 15)|Reason not Specified|1|||
48666663|NCT02636946|156632479|FG000|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
48666664|NCT02636946|156632480|FG001|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|2|||
48666665|NCT02636946|156632479|FG000|Cycle 2 (Week 16 to Week 31)|Adverse Event|2|||
48666666|NCT02636946|156632480|FG001|Cycle 2 (Week 16 to Week 31)|Adverse Event|1|||
48666667|NCT02358044|156632483|FG000|Overall Study|Adverse Event|0|||
48666668|NCT02358044|156632484|FG001|Overall Study|Adverse Event|1|||
48666669|NCT02358044|156632483|FG000|Overall Study|Lost to Follow-up|2|||
48666670|NCT02358044|156632484|FG001|Overall Study|Lost to Follow-up|1|||
48758056|NCT00679263|156960892|FG001|Visit 2/Dose 1|Adverse Event|0|||
48758057|NCT00679263|156960893|FG002|Visit 2/Dose 1|Adverse Event|0|||
48666671|NCT02358044|156632483|FG000|Overall Study|Physician Decision|0|||
48666672|NCT02358044|156632484|FG001|Overall Study|Physician Decision|1|||
48666673|NCT02358044|156632483|FG000|Overall Study|Withdrawal by Subject|0|||
48758058|NCT00679263|156960891|FG000|Visit 2/Dose 1|subject not compliance|1|||
48758059|NCT00679263|156960892|FG001|Visit 2/Dose 1|subject not compliance|1|||
48758060|NCT00679263|156960893|FG002|Visit 2/Dose 1|subject not compliance|0|||
48758061|NCT03144674|156960894|FG000|Overall Study|Participants Still Ongoing in the Study|1|||
48758062|NCT03144674|156960895|FG001|Overall Study|Participants Still Ongoing in the Study|4|||
48758063|NCT03144674|156960896|FG002|Overall Study|Participants Still Ongoing in the Study|24|||
48758064|NCT03144674|156960897|FG003|Overall Study|Participants Still Ongoing in the Study|54|||
48758065|NCT03144674|156960894|FG000|Overall Study|Death|3|||
48758066|NCT03144674|156960895|FG001|Overall Study|Death|1|||
48868234|NCT01772147|157355479|FG001|Overall Study|Lack of Efficacy|6|||
48868235|NCT01772147|157355480|FG002|Overall Study|Lack of Efficacy|6|||
48868236|NCT01002547|157355481|FG000|Overall Study|Withdrawal by Subject|4|||
48868237|NCT01002547|157355482|FG001|Overall Study|Withdrawal by Subject|0|||
48666674|NCT02358044|156632484|FG001|Overall Study|Withdrawal by Subject|4|||
48868238|NCT01002547|157355483|FG002|Overall Study|Withdrawal by Subject|5|||
48868239|NCT01002547|157355481|FG000|Overall Study|Lost to Follow-up|2|||
48868240|NCT01002547|157355482|FG001|Overall Study|Lost to Follow-up|1|||
48758067|NCT03144674|156960896|FG002|Overall Study|Death|1|||
48758068|NCT03144674|156960897|FG003|Overall Study|Death|10|||
48758069|NCT03144674|156960894|FG000|Overall Study|Lost to Follow-up|0|||
48868241|NCT01002547|157355483|FG002|Overall Study|Lost to Follow-up|1|||
48868242|NCT01002547|157355481|FG000|Overall Study|Physician Decision|1|||
48868243|NCT01002547|157355482|FG001|Overall Study|Physician Decision|0|||
48868244|NCT01002547|157355483|FG002|Overall Study|Physician Decision|0|||
48666675|NCT01636713|156632485|FG000|Overall Study|Adverse Event|16|||
48666676|NCT01636713|156632486|FG001|Overall Study|Adverse Event|16|||
48666677|NCT01636713|156632487|FG002|Overall Study|Adverse Event|7|||
48666678|NCT01636713|156632485|FG000|Overall Study|Lack of Efficacy|6|||
48666679|NCT01636713|156632486|FG001|Overall Study|Lack of Efficacy|6|||
48666680|NCT01636713|156632487|FG002|Overall Study|Lack of Efficacy|2|||
48666681|NCT01636713|156632485|FG000|Overall Study|Protocol Violation|3|||
48666682|NCT01636713|156632486|FG001|Overall Study|Protocol Violation|0|||
48666683|NCT01636713|156632487|FG002|Overall Study|Protocol Violation|1|||
48666684|NCT01636713|156632485|FG000|Overall Study|Lost to Follow-up|0|||
48666685|NCT01636713|156632486|FG001|Overall Study|Lost to Follow-up|0|||
48666686|NCT01636713|156632487|FG002|Overall Study|Lost to Follow-up|1|||
48666687|NCT01636713|156632485|FG000|Overall Study|Withdrawal by Subject|5|||
48666688|NCT01636713|156632486|FG001|Overall Study|Withdrawal by Subject|4|||
48666689|NCT01636713|156632487|FG002|Overall Study|Withdrawal by Subject|8|||
48666690|NCT01636713|156632485|FG000|Overall Study|Met Protocol-defined Stopping Criteria|2|||
48666691|NCT01636713|156632486|FG001|Overall Study|Met Protocol-defined Stopping Criteria|2|||
48666692|NCT01636713|156632487|FG002|Overall Study|Met Protocol-defined Stopping Criteria|4|||
48666693|NCT03780959|156632488|FG000|Part 1|Adverse Event|1|||
48666694|NCT03780959|156632489|FG001|Part 1|Adverse Event|0|||
48666695|NCT03780959|156632490|FG002|Part 1|Adverse Event|0|||
48666696|NCT03780959|156632488|FG000|Part 1|Withdrawal by Subject|1|||
48666697|NCT03780959|156632489|FG001|Part 1|Withdrawal by Subject|0|||
48758070|NCT03144674|156960895|FG001|Overall Study|Lost to Follow-up|1|||
48758071|NCT03144674|156960896|FG002|Overall Study|Lost to Follow-up|1|||
48758072|NCT03144674|156960897|FG003|Overall Study|Lost to Follow-up|1|||
48758073|NCT03144674|156960894|FG000|Overall Study|Withdrawal by Participant|0|||
48758074|NCT03144674|156960895|FG001|Overall Study|Withdrawal by Participant|0|||
48666698|NCT03780959|156632490|FG002|Part 1|Withdrawal by Subject|0|||
48666699|NCT03780959|156632488|FG000|Part 1|Withdrawal by Parent/Guardian|1|||
48666700|NCT03780959|156632489|FG001|Part 1|Withdrawal by Parent/Guardian|0|||
48666701|NCT03780959|156632490|FG002|Part 1|Withdrawal by Parent/Guardian|0|||
48666702|NCT03780959|156632488|FG000|Part 1|Response Status|2|||
48666703|NCT03780959|156632489|FG001|Part 1|Response Status|0|||
48666704|NCT03780959|156632490|FG002|Part 1|Response Status|0|||
48666705|NCT03780959|156632488|FG000|Part 2|Withdrawal by Parent/Guardian|0|||
48666706|NCT03780959|156632489|FG001|Part 2|Withdrawal by Parent/Guardian|1|||
48666707|NCT03780959|156632490|FG002|Part 2|Withdrawal by Parent/Guardian|0|||
48666708|NCT03780959|156632488|FG000|Part 2|Response Status|0|||
48758075|NCT03144674|156960896|FG002|Overall Study|Withdrawal by Participant|0|||
48758076|NCT03144674|156960897|FG003|Overall Study|Withdrawal by Participant|3|||
48758077|NCT03144674|156960894|FG000|Overall Study|Reason not Specified|0|||
48758078|NCT03144674|156960895|FG001|Overall Study|Reason not Specified|0|||
48868245|NCT01002547|157355481|FG000|Overall Study|Death|0|||
48868246|NCT01002547|157355482|FG001|Overall Study|Death|2|||
48868247|NCT01002547|157355483|FG002|Overall Study|Death|2|||
48666709|NCT03780959|156632489|FG001|Part 2|Response Status|18|||
48666710|NCT03780959|156632490|FG002|Part 2|Response Status|6|||
48666711|NCT04493684|156632491|FG000|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
48666712|NCT04493684|156632492|FG001|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
48666713|NCT04493684|156632493|FG002|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
48666714|NCT04493684|156632494|FG003|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
48758079|NCT03144674|156960896|FG002|Overall Study|Reason not Specified|2|||
48758080|NCT03144674|156960897|FG003|Overall Study|Reason not Specified|4|||
48758081|NCT02075658|156960898|FG000|Overall Study|Physician Decision|2|||
48758082|NCT02075658|156960899|FG001|Overall Study|Physician Decision|2|||
48758083|NCT02946047|156960909|FG000|Overall Study|Adverse Event|1|||
48868248|NCT01002547|157355481|FG000|Overall Study|Adverse Event|1|||
48868249|NCT01002547|157355482|FG001|Overall Study|Adverse Event|0|||
48868250|NCT01002547|157355483|FG002|Overall Study|Adverse Event|0|||
48868251|NCT02859558|157355487|FG000|Step 1|Not Eligible|0|||
48758084|NCT02946047|156960910|FG001|Overall Study|Adverse Event|0|||
48868252|NCT02859558|157355488|FG001|Step 1|Not Eligible|0|||
48868253|NCT02859558|157355489|FG002|Step 1|Not Eligible|0|||
48868254|NCT02859558|157355490|FG003|Step 1|Not Eligible|0|||
48868255|NCT02859558|157355491|FG004|Step 1|Not Eligible|3|||
48868256|NCT02859558|157355487|FG000|Step 1|Lost to Follow-up|1|||
48868257|NCT02859558|157355488|FG001|Step 1|Lost to Follow-up|3|||
48868258|NCT02859558|157355489|FG002|Step 1|Lost to Follow-up|3|||
48868259|NCT02859558|157355490|FG003|Step 1|Lost to Follow-up|0|||
48868260|NCT02859558|157355491|FG004|Step 1|Lost to Follow-up|0|||
48868261|NCT02859558|157355487|FG000|Step 1|Did Not Return to Clinic|2|||
48868262|NCT02859558|157355488|FG001|Step 1|Did Not Return to Clinic|3|||
48868263|NCT02859558|157355489|FG002|Step 1|Did Not Return to Clinic|4|||
48666715|NCT04493684|156632495|FG004|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
48666716|NCT04493684|156632496|FG005|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
48758085|NCT02946047|156960911|FG002|Overall Study|Adverse Event|0|||
48868264|NCT02859558|157355490|FG003|Step 1|Did Not Return to Clinic|0|||
48868265|NCT02859558|157355491|FG004|Step 1|Did Not Return to Clinic|0|||
48868266|NCT02859558|157355487|FG000|Step 1|Moved|0|||
48967550|NCT00476996|157708630|FG001|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3|||
48666717|NCT04493684|156632497|FG006|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
48666718|NCT04493684|156632498|FG007|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
48666719|NCT04493684|156632499|FG008|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
48666720|NCT04493684|156632500|FG009|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
48666721|NCT04493684|156632501|FG010|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
48666722|NCT04493684|156632502|FG011|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
48666723|NCT04493684|156632503|FG012|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
48666724|NCT04493684|156632504|FG013|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
48666725|NCT04493684|156632505|FG014|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
48666726|NCT04493684|156632506|FG015|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
48666727|NCT04493684|156632507|FG016|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
48666728|NCT04493684|156632491|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|1|||
48666729|NCT04493684|156632492|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
48666730|NCT04493684|156632493|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
48758086|NCT02946047|156960912|FG003|Overall Study|Adverse Event|0|||
48758087|NCT01894581|156960913|FG000|Overall Study|Withdrawal by Subject|2|||
48758088|NCT01894581|156960914|FG001|Overall Study|Withdrawal by Subject|3|||
48758089|NCT01894581|156960913|FG000|Overall Study|Screen Failure|3|||
48758090|NCT01894581|156960914|FG001|Overall Study|Screen Failure|4|||
48758091|NCT01502423|156960915|FG000|Overall Study|Withdrawal by Subject|0|||
48758092|NCT01502423|156960916|FG001|Overall Study|Withdrawal by Subject|1|||
48758093|NCT03045081|156962689|FG000|Overall Study|Withdrawal by Subject|6|||
48758094|NCT03045081|156962690|FG001|Overall Study|Withdrawal by Subject|11|||
48758095|NCT02699554|156962691|FG000|Overall Study|Lost to Follow-up|9|||
48758096|NCT00100815|156962697|FG000|Overall Study|Progression|24|||
48758097|NCT00100815|156962697|FG000|Overall Study|Adverse Event|18|||
48758098|NCT00100815|156962697|FG000|Overall Study|Death|4|||
48868267|NCT02859558|157355488|FG001|Step 1|Moved|1|||
48868268|NCT02859558|157355489|FG002|Step 1|Moved|1|||
48868269|NCT02859558|157355490|FG003|Step 1|Moved|0|||
48868270|NCT02859558|157355491|FG004|Step 1|Moved|0|||
48868271|NCT02859558|157355487|FG000|Step 1|Withdrawal By Participant|1|||
48868272|NCT02859558|157355488|FG001|Step 1|Withdrawal By Participant|2|||
48868273|NCT02859558|157355489|FG002|Step 1|Withdrawal By Participant|1|||
48868274|NCT02859558|157355490|FG003|Step 1|Withdrawal By Participant|0|||
48868275|NCT02859558|157355491|FG004|Step 1|Withdrawal By Participant|0|||
48868276|NCT02859558|157355487|FG000|Step 1|Had to Interrupt antiretroviral (ARV)|1|||
48868277|NCT02859558|157355488|FG001|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
48868278|NCT02859558|157355489|FG002|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
48868279|NCT02859558|157355490|FG003|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
48868280|NCT02859558|157355491|FG004|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
48868281|NCT02859558|157355487|FG000|Step 1|Incarceration|0|||
48868282|NCT02859558|157355488|FG001|Step 1|Incarceration|1|||
48868283|NCT02859558|157355489|FG002|Step 1|Incarceration|0|||
48868284|NCT02859558|157355490|FG003|Step 1|Incarceration|0|||
48868285|NCT02859558|157355491|FG004|Step 1|Incarceration|0|||
48868286|NCT02859558|157355487|FG000|Step 1|Non-Adherence to Study Drug|2|||
48868287|NCT02859558|157355488|FG001|Step 1|Non-Adherence to Study Drug|0|||
48868288|NCT02859558|157355489|FG002|Step 1|Non-Adherence to Study Drug|1|||
48868289|NCT02859558|157355490|FG003|Step 1|Non-Adherence to Study Drug|0|||
48868290|NCT02859558|157355491|FG004|Step 1|Non-Adherence to Study Drug|0|||
48868291|NCT02859558|157355487|FG000|Step 1|Non-Adherence to Study Requirements|3|||
48868292|NCT02859558|157355488|FG001|Step 1|Non-Adherence to Study Requirements|1|||
48868293|NCT02859558|157355489|FG002|Step 1|Non-Adherence to Study Requirements|0|||
48868294|NCT02859558|157355490|FG003|Step 1|Non-Adherence to Study Requirements|0|||
48868295|NCT02859558|157355491|FG004|Step 1|Non-Adherence to Study Requirements|0|||
48868296|NCT02859558|157355487|FG000|Step 1|Virologic Failure|2|||
48868297|NCT02859558|157355488|FG001|Step 1|Virologic Failure|1|||
48868298|NCT02859558|157355489|FG002|Step 1|Virologic Failure|1|||
48868299|NCT02859558|157355490|FG003|Step 1|Virologic Failure|0|||
48868300|NCT02859558|157355491|FG004|Step 1|Virologic Failure|0|||
48868301|NCT02859558|157355487|FG000|Step 2|Active On Study|23|||
48868302|NCT02859558|157355488|FG001|Step 2|Active On Study|38|||
48868303|NCT02859558|157355489|FG002|Step 2|Active On Study|20|||
48868304|NCT02859558|157355490|FG003|Step 2|Active On Study|0|||
48868305|NCT02859558|157355491|FG004|Step 2|Active On Study|0|||
48868306|NCT02859558|157355487|FG000|Step 2|Did Not Return to Clinic|2|||
48868307|NCT02859558|157355488|FG001|Step 2|Did Not Return to Clinic|0|||
48868308|NCT02859558|157355489|FG002|Step 2|Did Not Return to Clinic|0|||
48868309|NCT02859558|157355490|FG003|Step 2|Did Not Return to Clinic|0|||
48868310|NCT02859558|157355491|FG004|Step 2|Did Not Return to Clinic|0|||
48868311|NCT02859558|157355487|FG000|Step 2|Unexpected Closure of Site|0|||
48868312|NCT02859558|157355488|FG001|Step 2|Unexpected Closure of Site|1|||
48868313|NCT02859558|157355489|FG002|Step 2|Unexpected Closure of Site|1|||
48868314|NCT02859558|157355490|FG003|Step 2|Unexpected Closure of Site|0|||
48868315|NCT02859558|157355491|FG004|Step 2|Unexpected Closure of Site|0|||
48666731|NCT04493684|156632494|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
48666732|NCT04493684|156632495|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
48666733|NCT04493684|156632496|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
48666734|NCT04493684|156632497|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
48666735|NCT04493684|156632498|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
48666736|NCT04493684|156632499|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
48666737|NCT04493684|156632500|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
48666738|NCT04493684|156632501|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
48666739|NCT04493684|156632502|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
48666740|NCT04493684|156632503|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
48666741|NCT04493684|156632504|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
48666742|NCT04493684|156632505|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
48666743|NCT04493684|156632506|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
48666744|NCT04493684|156632507|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
48666745|NCT04493684|156632491|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
48666746|NCT04493684|156632492|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
48666747|NCT04493684|156632493|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
48666748|NCT04493684|156632494|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
48666749|NCT04493684|156632495|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
48666750|NCT04493684|156632496|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
48666751|NCT04493684|156632497|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|1|||
48666752|NCT04493684|156632498|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
48666753|NCT04493684|156632499|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
48666754|NCT04493684|156632500|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
48666755|NCT04493684|156632501|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
48666756|NCT04493684|156632502|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
48666757|NCT04493684|156632503|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
48666758|NCT04493684|156632504|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
48666759|NCT04493684|156632505|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
48666760|NCT04493684|156632506|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
48666761|NCT04493684|156632507|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
48666762|NCT04493684|156632491|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|1|||
48666763|NCT04493684|156632492|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
48666764|NCT04493684|156632493|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
48666765|NCT04493684|156632494|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
48666766|NCT04493684|156632495|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
48666767|NCT04493684|156632496|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
48666768|NCT04493684|156632497|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
48666769|NCT04493684|156632498|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
48666770|NCT04493684|156632499|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
48666771|NCT04493684|156632500|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
48666772|NCT04493684|156632501|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
48666773|NCT04493684|156632502|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
48666774|NCT04493684|156632503|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
48666775|NCT04493684|156632504|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
48666776|NCT04493684|156632505|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
48666777|NCT04493684|156632506|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
48666778|NCT04493684|156632507|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
48666779|NCT04493684|156632491|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
48666780|NCT04493684|156632492|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
48666781|NCT04493684|156632493|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
48666782|NCT04493684|156632494|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
48666783|NCT04493684|156632495|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
48666784|NCT04493684|156632496|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|1|||
48666785|NCT04493684|156632497|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
48666786|NCT04493684|156632498|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
48666787|NCT04493684|156632499|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
48666788|NCT04493684|156632500|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
48666789|NCT04493684|156632501|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
48666790|NCT04493684|156632502|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
48868316|NCT00925288|157355492|FG000|Overall Study|Lost to Follow-up|9|||
48868317|NCT00925288|157355493|FG001|Overall Study|Lost to Follow-up|7|||
48868318|NCT00434577|157355496|FG000|Months 0-3|Serious Adverse Event|0|||
48868319|NCT00434577|157355497|FG001|Months 0-3|Serious Adverse Event|0|||
48868320|NCT00434577|157355498|FG002|Months 0-3|Serious Adverse Event|1|||
48868321|NCT00434577|157355499|FG003|Months 0-3|Serious Adverse Event|0|||
48868322|NCT00434577|157355500|FG004|Months 0-3|Serious Adverse Event|0|||
48868323|NCT00434577|157355496|FG000|Months 0-3|Adverse Event|0|||
48868324|NCT00434577|157355497|FG001|Months 0-3|Adverse Event|1|||
48868325|NCT00434577|157355498|FG002|Months 0-3|Adverse Event|1|||
48868326|NCT00434577|157355499|FG003|Months 0-3|Adverse Event|0|||
48868327|NCT00434577|157355500|FG004|Months 0-3|Adverse Event|0|||
48868328|NCT00434577|157355496|FG000|Months 0-3|Lost to Follow-up|0|||
48868329|NCT00434577|157355497|FG001|Months 0-3|Lost to Follow-up|0|||
48868330|NCT00434577|157355498|FG002|Months 0-3|Lost to Follow-up|0|||
48868331|NCT00434577|157355499|FG003|Months 0-3|Lost to Follow-up|0|||
48868332|NCT00434577|157355500|FG004|Months 0-3|Lost to Follow-up|2|||
48666791|NCT04493684|156632503|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
48666792|NCT04493684|156632504|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
48666793|NCT04493684|156632505|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
48666794|NCT04493684|156632506|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
48666795|NCT04493684|156632507|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
48666796|NCT04493684|156632491|FG000|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
48666797|NCT04493684|156632492|FG001|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
48666798|NCT04493684|156632493|FG002|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
48868333|NCT00434577|157355496|FG000|Months 0-3|Protocol Violation|1|||
48868334|NCT00434577|157355497|FG001|Months 0-3|Protocol Violation|0|||
48868335|NCT00434577|157355498|FG002|Months 0-3|Protocol Violation|1|||
48868336|NCT00434577|157355499|FG003|Months 0-3|Protocol Violation|0|||
48868337|NCT00434577|157355500|FG004|Months 0-3|Protocol Violation|0|||
48868338|NCT00434577|157355496|FG000|Months 0-3|Withdrawal by Subject|2|||
48868339|NCT00434577|157355497|FG001|Months 0-3|Withdrawal by Subject|1|||
48868340|NCT00434577|157355498|FG002|Months 0-3|Withdrawal by Subject|1|||
48868341|NCT00434577|157355499|FG003|Months 0-3|Withdrawal by Subject|1|||
48967551|NCT00476996|157708631|FG002|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
48967552|NCT00476996|157708632|FG003|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
48967553|NCT00476996|157708629|FG000|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24|||
48967554|NCT00476996|157708630|FG001|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20|||
48967555|NCT00476996|157708631|FG002|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21|||
48967556|NCT00476996|157708632|FG003|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0|||
48967557|NCT00476996|157708629|FG000|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
48967558|NCT00476996|157708630|FG001|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2|||
48967559|NCT00476996|157708631|FG002|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
48967560|NCT00476996|157708632|FG003|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
48967561|NCT00476996|157708629|FG000|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
48967562|NCT00476996|157708630|FG001|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4|||
48967563|NCT00476996|157708631|FG002|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3|||
48967564|NCT00476996|157708632|FG003|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
48967565|NCT00476996|157708629|FG000|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22|||
48967566|NCT00476996|157708630|FG001|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5|||
48967567|NCT00476996|157708631|FG002|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6|||
48967568|NCT00476996|157708632|FG003|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0|||
48967569|NCT00476996|157708629|FG000|Blinded Treatment Phase (up to Week 48)|Death|2|||
48967570|NCT00476996|157708630|FG001|Blinded Treatment Phase (up to Week 48)|Death|1|||
48967571|NCT00476996|157708631|FG002|Blinded Treatment Phase (up to Week 48)|Death|1|||
48967572|NCT00476996|157708632|FG003|Blinded Treatment Phase (up to Week 48)|Death|0|||
48967573|NCT00476996|157708629|FG000|Blinded Treatment Phase (up to Week 48)|Adverse Event|11|||
48967574|NCT00476996|157708630|FG001|Blinded Treatment Phase (up to Week 48)|Adverse Event|13|||
48967575|NCT00476996|157708631|FG002|Blinded Treatment Phase (up to Week 48)|Adverse Event|7|||
48967576|NCT00476996|157708632|FG003|Blinded Treatment Phase (up to Week 48)|Adverse Event|0|||
48967577|NCT00476996|157708629|FG000|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
48666799|NCT04493684|156632494|FG003|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
48666800|NCT04493684|156632495|FG004|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
48666801|NCT04493684|156632496|FG005|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
48666802|NCT04493684|156632497|FG006|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
48666803|NCT04493684|156632498|FG007|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
48666804|NCT04493684|156632499|FG008|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
48666805|NCT04493684|156632500|FG009|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
48868342|NCT00434577|157355500|FG004|Months 0-3|Withdrawal by Subject|1|||
48868343|NCT01967719|157355501|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
48868344|NCT01967719|157355502|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
48666806|NCT04493684|156632501|FG010|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
48758099|NCT00100815|156962697|FG000|Overall Study|Other|3|||
48758100|NCT02877082|156962698|FG000|Overall Study|Trial was closed early|5|||
48758101|NCT00849381|156962699|FG000|Overall Study|Adverse Event|1|||
48758102|NCT00849381|156962699|FG000|Overall Study|Lost to Follow-up|129|||
48758103|NCT00849381|156962699|FG000|Overall Study|Protocol Violation|5|||
48758104|NCT00849381|156962699|FG000|Overall Study|Withdrawal by Subject|6|||
48758105|NCT00849381|156962699|FG000|Overall Study|Other|4|||
48758106|NCT03970733|156962700|FG000|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
48758107|NCT03970733|156962701|FG001|Main Study Phase (18 Months)|Withdrawal by Subject|7|||
48758108|NCT03970733|156962702|FG002|Main Study Phase (18 Months)|Withdrawal by Subject|2|||
48758109|NCT03970733|156962703|FG003|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
48758110|NCT03970733|156962704|FG004|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
48967578|NCT00476996|157708630|FG001|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
48967579|NCT00476996|157708631|FG002|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
48967580|NCT00476996|157708632|FG003|OLE Phase (From Week 48)|Withdrawal by Subject|50|||
48967581|NCT00476996|157708629|FG000|OLE Phase (From Week 48)|Adverse Event|0|||
48967582|NCT00476996|157708630|FG001|OLE Phase (From Week 48)|Adverse Event|0|||
48666807|NCT04493684|156632502|FG011|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|1|||
48666808|NCT04493684|156632503|FG012|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
48666809|NCT04493684|156632504|FG013|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
48666810|NCT04493684|156632505|FG014|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
48666811|NCT04493684|156632506|FG015|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
48666812|NCT04493684|156632507|FG016|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
48666813|NCT04493684|156632491|FG000|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
48666814|NCT04493684|156632492|FG001|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
48666815|NCT04493684|156632493|FG002|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
48666816|NCT04493684|156632494|FG003|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
48666817|NCT04493684|156632495|FG004|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
48666818|NCT04493684|156632496|FG005|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
48666819|NCT04493684|156632497|FG006|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
48666820|NCT04493684|156632498|FG007|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
48666821|NCT04493684|156632499|FG008|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
48666822|NCT04493684|156632500|FG009|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
48666823|NCT04493684|156632501|FG010|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
48666824|NCT04493684|156632502|FG011|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
48666825|NCT04493684|156632503|FG012|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
48666826|NCT04493684|156632504|FG013|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
48666827|NCT04493684|156632505|FG014|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
48666828|NCT04493684|156632506|FG015|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|1|||
48666829|NCT04493684|156632507|FG016|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
48666830|NCT04493684|156632491|FG000|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
48666831|NCT04493684|156632492|FG001|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
48666832|NCT04493684|156632493|FG002|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
48666833|NCT04493684|156632494|FG003|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
48666834|NCT04493684|156632495|FG004|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
48666835|NCT04493684|156632496|FG005|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
48666836|NCT04493684|156632497|FG006|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
48666837|NCT04493684|156632498|FG007|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
48666838|NCT04493684|156632499|FG008|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
48666839|NCT04493684|156632500|FG009|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
48666840|NCT04493684|156632501|FG010|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
48666841|NCT04493684|156632502|FG011|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
48666842|NCT04493684|156632503|FG012|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
48666843|NCT04493684|156632504|FG013|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
48758111|NCT03970733|156962700|FG000|Main Study Phase (18 Months)|Moved from study area|2|||
48758112|NCT03970733|156962701|FG001|Main Study Phase (18 Months)|Moved from study area|1|||
48758113|NCT03970733|156962702|FG002|Main Study Phase (18 Months)|Moved from study area|0|||
48967583|NCT00476996|157708631|FG002|OLE Phase (From Week 48)|Adverse Event|0|||
48666844|NCT04493684|156632505|FG014|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
48666845|NCT04493684|156632506|FG015|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|1|||
48666846|NCT04493684|156632507|FG016|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
48666847|NCT03691779|156632517|FG000|Part B (24 Weeks)|Adverse Event|0|||
48666848|NCT03691779|156632518|FG001|Part B (24 Weeks)|Adverse Event|1|||
48758114|NCT03970733|156962703|FG003|Main Study Phase (18 Months)|Moved from study area|0|||
48758115|NCT03970733|156962704|FG004|Main Study Phase (18 Months)|Moved from study area|0|||
48758116|NCT03970733|156962700|FG000|Main Study Phase (18 Months)|Lost to Follow-up|5|||
48758117|NCT03970733|156962701|FG001|Main Study Phase (18 Months)|Lost to Follow-up|5|||
48758118|NCT03970733|156962702|FG002|Main Study Phase (18 Months)|Lost to Follow-up|3|||
48758119|NCT03970733|156962703|FG003|Main Study Phase (18 Months)|Lost to Follow-up|0|||
48758120|NCT03970733|156962704|FG004|Main Study Phase (18 Months)|Lost to Follow-up|0|||
48758121|NCT03970733|156962700|FG000|Main Study Phase (18 Months)|Other|1|||
48758122|NCT03970733|156962701|FG001|Main Study Phase (18 Months)|Other|1|||
48758123|NCT03970733|156962702|FG002|Main Study Phase (18 Months)|Other|0|||
48758124|NCT03970733|156962703|FG003|Main Study Phase (18 Months)|Other|0|||
48758125|NCT03970733|156962704|FG004|Main Study Phase (18 Months)|Other|0|||
48758126|NCT03970733|156962700|FG000|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
48758127|NCT03970733|156962701|FG001|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
48758128|NCT03970733|156962702|FG002|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
48758129|NCT03970733|156962703|FG003|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
48758130|NCT03970733|156962704|FG004|Booster Phase (Approx. 12 Months)|Lost to Follow-up|1|||
48758131|NCT00723892|156962707|FG000|Overall Study|Participant not tracked|33|||
48758132|NCT00723892|156962708|FG001|Overall Study|Participant not tracked|35|||
48758133|NCT00723892|156962707|FG000|Overall Study|Virological criterion|24|||
48758134|NCT00723892|156962708|FG001|Overall Study|Virological criterion|9|||
48758135|NCT00723892|156962707|FG000|Overall Study|Withdrawal by Subject|6|||
48758136|NCT00723892|156962708|FG001|Overall Study|Withdrawal by Subject|9|||
48758137|NCT00723892|156962707|FG000|Overall Study|End planned|11|||
48758138|NCT00723892|156962708|FG001|Overall Study|End planned|7|||
48758139|NCT00723892|156962707|FG000|Overall Study|Bad tolerance|5|||
48758140|NCT00723892|156962708|FG001|Overall Study|Bad tolerance|5|||
48758141|NCT00723892|156962707|FG000|Overall Study|Multiple reasons|17|||
48758142|NCT00723892|156962708|FG001|Overall Study|Multiple reasons|12|||
48967584|NCT00476996|157708632|FG003|OLE Phase (From Week 48)|Adverse Event|8|||
48967585|NCT00476996|157708629|FG000|OLE Phase (From Week 48)|Death|0|||
48666849|NCT03691779|156632517|FG000|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0|||
48666850|NCT03691779|156632518|FG001|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1|||
48666851|NCT00203021|156634072|FG000|Overall Study|Death|4|||
48666852|NCT00203021|156634073|FG001|Overall Study|Death|1|||
48666853|NCT00203021|156634072|FG000|Overall Study|Adverse Event|10|||
48666854|NCT00203021|156634073|FG001|Overall Study|Adverse Event|5|||
48666855|NCT00203021|156634072|FG000|Overall Study|Withdrawal by Subject|45|||
48666856|NCT00203021|156634073|FG001|Overall Study|Withdrawal by Subject|48|||
48666857|NCT00203021|156634072|FG000|Overall Study|Lost to Follow-up|9|||
48666858|NCT00203021|156634073|FG001|Overall Study|Lost to Follow-up|7|||
48666859|NCT00203021|156634072|FG000|Overall Study|Other than specified|11|||
48666860|NCT00203021|156634073|FG001|Overall Study|Other than specified|16|||
48666861|NCT00996801|156634075|FG000|Overall Study|Adverse Event|6|||
48666862|NCT00996801|156634076|FG001|Overall Study|Adverse Event|4|||
48666863|NCT00996801|156634077|FG002|Overall Study|Adverse Event|12|||
48666864|NCT00996801|156634078|FG003|Overall Study|Adverse Event|17|||
48666865|NCT00996801|156634079|FG004|Overall Study|Adverse Event|31|||
48666866|NCT00996801|156634080|FG005|Overall Study|Adverse Event|3|||
48666867|NCT00996801|156634075|FG000|Overall Study|Lack of Efficacy|3|||
48666868|NCT00996801|156634076|FG001|Overall Study|Lack of Efficacy|0|||
48666869|NCT00996801|156634077|FG002|Overall Study|Lack of Efficacy|1|||
48666870|NCT00996801|156634078|FG003|Overall Study|Lack of Efficacy|3|||
48666871|NCT00996801|156634079|FG004|Overall Study|Lack of Efficacy|0|||
48666872|NCT00996801|156634080|FG005|Overall Study|Lack of Efficacy|1|||
48666873|NCT00996801|156634075|FG000|Overall Study|Lost to Follow-up|0|||
48666874|NCT00996801|156634076|FG001|Overall Study|Lost to Follow-up|0|||
48666875|NCT00996801|156634077|FG002|Overall Study|Lost to Follow-up|0|||
48967586|NCT00476996|157708630|FG001|OLE Phase (From Week 48)|Death|0|||
48967587|NCT00476996|157708631|FG002|OLE Phase (From Week 48)|Death|0|||
48967588|NCT00476996|157708632|FG003|OLE Phase (From Week 48)|Death|7|||
48666876|NCT00996801|156634078|FG003|Overall Study|Lost to Follow-up|3|||
48758143|NCT00723892|156962707|FG000|Overall Study|Other|6|||
48758144|NCT00723892|156962708|FG001|Overall Study|Other|3|||
48758145|NCT00723892|156962707|FG000|Overall Study|Study end|1|||
48758146|NCT00723892|156962708|FG001|Overall Study|Study end|3|||
48967589|NCT00476996|157708629|FG000|OLE Phase (From Week 48)|Lack of Efficacy|0|||
48967590|NCT00476996|157708630|FG001|OLE Phase (From Week 48)|Lack of Efficacy|0|||
48967591|NCT00476996|157708631|FG002|OLE Phase (From Week 48)|Lack of Efficacy|0|||
48967592|NCT00476996|157708632|FG003|OLE Phase (From Week 48)|Lack of Efficacy|13|||
48967593|NCT00476996|157708629|FG000|OLE Phase (From Week 48)|Lost to Follow-up|0|||
48666877|NCT00996801|156634079|FG004|Overall Study|Lost to Follow-up|3|||
48758147|NCT00723892|156962707|FG000|Overall Study|Weight loss|1|||
48758148|NCT00723892|156962708|FG001|Overall Study|Weight loss|3|||
48758149|NCT00723892|156962707|FG000|Overall Study|Alcohol abuse|0|||
48967594|NCT00476996|157708630|FG001|OLE Phase (From Week 48)|Lost to Follow-up|0|||
48666878|NCT00996801|156634080|FG005|Overall Study|Lost to Follow-up|2|||
48666879|NCT00996801|156634075|FG000|Overall Study|Physician Decision|0|||
48666880|NCT00996801|156634076|FG001|Overall Study|Physician Decision|0|||
48666881|NCT00996801|156634077|FG002|Overall Study|Physician Decision|0|||
48666882|NCT00996801|156634078|FG003|Overall Study|Physician Decision|1|||
48666883|NCT00996801|156634079|FG004|Overall Study|Physician Decision|0|||
48666884|NCT00996801|156634080|FG005|Overall Study|Physician Decision|0|||
48666885|NCT00996801|156634075|FG000|Overall Study|Progressive Disease|0|||
48666886|NCT00996801|156634076|FG001|Overall Study|Progressive Disease|1|||
48666887|NCT00996801|156634077|FG002|Overall Study|Progressive Disease|0|||
48666888|NCT00996801|156634078|FG003|Overall Study|Progressive Disease|0|||
48666889|NCT00996801|156634079|FG004|Overall Study|Progressive Disease|0|||
48666890|NCT00996801|156634080|FG005|Overall Study|Progressive Disease|0|||
48666891|NCT00996801|156634075|FG000|Overall Study|Protocol Violation|3|||
48666892|NCT00996801|156634076|FG001|Overall Study|Protocol Violation|4|||
48666893|NCT00996801|156634077|FG002|Overall Study|Protocol Violation|1|||
48666894|NCT00996801|156634078|FG003|Overall Study|Protocol Violation|2|||
48666895|NCT00996801|156634079|FG004|Overall Study|Protocol Violation|3|||
48666896|NCT00996801|156634080|FG005|Overall Study|Protocol Violation|4|||
48666897|NCT00996801|156634075|FG000|Overall Study|Study Terminated by Sponsor|0|||
48666898|NCT00996801|156634076|FG001|Overall Study|Study Terminated by Sponsor|1|||
48666899|NCT00996801|156634077|FG002|Overall Study|Study Terminated by Sponsor|0|||
48666900|NCT00996801|156634078|FG003|Overall Study|Study Terminated by Sponsor|0|||
48666901|NCT00996801|156634079|FG004|Overall Study|Study Terminated by Sponsor|46|||
48666902|NCT00996801|156634080|FG005|Overall Study|Study Terminated by Sponsor|0|||
48666903|NCT00996801|156634075|FG000|Overall Study|Withdrawal by Subject|8|||
48666904|NCT00996801|156634076|FG001|Overall Study|Withdrawal by Subject|6|||
48666905|NCT00996801|156634077|FG002|Overall Study|Withdrawal by Subject|9|||
48666906|NCT00996801|156634078|FG003|Overall Study|Withdrawal by Subject|5|||
48666907|NCT00996801|156634079|FG004|Overall Study|Withdrawal by Subject|5|||
48666908|NCT00996801|156634080|FG005|Overall Study|Withdrawal by Subject|9|||
48666909|NCT01688739|156634081|FG000|Overall Study|Administrative Decision|1|||
48666910|NCT01688739|156634082|FG001|Overall Study|Administrative Decision|0|||
48666911|NCT01688739|156634083|FG002|Overall Study|Administrative Decision|0|||
48666912|NCT01688739|156634084|FG003|Overall Study|Administrative Decision|0|||
48666913|NCT01688739|156634085|FG004|Overall Study|Administrative Decision|0|||
48666914|NCT01688739|156634086|FG005|Overall Study|Administrative Decision|0|||
48666915|NCT01688739|156634087|FG006|Overall Study|Administrative Decision|0|||
48666916|NCT01688739|156634088|FG007|Overall Study|Administrative Decision|0|||
48666917|NCT01688739|156634089|FG008|Overall Study|Administrative Decision|0|||
48666918|NCT01688739|156634090|FG009|Overall Study|Administrative Decision|0|||
48666919|NCT00289198|156634091|FG000|Overall Study|Adverse Event|0|||
48666920|NCT00289198|156634092|FG001|Overall Study|Adverse Event|2|||
48666921|NCT00289198|156634091|FG000|Overall Study|Protocol Violation|2|||
48666922|NCT00289198|156634092|FG001|Overall Study|Protocol Violation|1|||
48666923|NCT00289198|156634091|FG000|Overall Study|Withdrawal by Subject|4|||
48666924|NCT00289198|156634092|FG001|Overall Study|Withdrawal by Subject|1|||
48666925|NCT00289198|156634091|FG000|Overall Study|Lack of Efficacy|2|||
48666926|NCT00289198|156634092|FG001|Overall Study|Lack of Efficacy|0|||
48666927|NCT00289198|156634091|FG000|Overall Study|Other: Low compliance|0|||
48666928|NCT00289198|156634092|FG001|Overall Study|Other: Low compliance|1|||
48666929|NCT00289198|156634091|FG000|Overall Study|Other: Physician's decision|0|||
48666930|NCT00289198|156634092|FG001|Overall Study|Other: Physician's decision|1|||
48666931|NCT00289198|156634091|FG000|Overall Study|Other: Unable to attend on schedule|2|||
48967595|NCT00476996|157708631|FG002|OLE Phase (From Week 48)|Lost to Follow-up|0|||
48967596|NCT00476996|157708632|FG003|OLE Phase (From Week 48)|Lost to Follow-up|4|||
48967597|NCT00476996|157708629|FG000|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
48666932|NCT00289198|156634092|FG001|Overall Study|Other: Unable to attend on schedule|1|||
48666933|NCT00289198|156634091|FG000|Overall Study|Other: Miscalculation of the visit date|21|||
48666934|NCT00289198|156634092|FG001|Overall Study|Other: Miscalculation of the visit date|22|||
48666935|NCT00289198|156634091|FG000|Overall Study|Other: Impossible to come on visit|0|||
48666936|NCT00289198|156634092|FG001|Overall Study|Other: Impossible to come on visit|1|||
48666937|NCT01655381|156634095|FG000|Overall Study|Investigator Decision|1|||
48666938|NCT01655381|156634095|FG000|Overall Study|Moved to Another City|1|||
48666939|NCT01655381|156634095|FG000|Overall Study|Insufficient Treatment Response|1|||
48666940|NCT00046930|156634096|FG000|Overall Study|Ineligible|12|||
48666941|NCT00046930|156634097|FG001|Overall Study|Ineligible|4|||
48666942|NCT02119156|156634098|FG000|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
48666943|NCT02119156|156634099|FG001|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
48666944|NCT02119156|156634100|FG002|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1|||
48666945|NCT02119156|156634098|FG000|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4|||
48666946|NCT02119156|156634099|FG001|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
48666947|NCT02119156|156634100|FG002|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
48666948|NCT02119156|156634098|FG000|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1|||
48967598|NCT00476996|157708630|FG001|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
49015470|NCT01393990|157893784|FG014|Overall Study|Progressive Disease|6|||
48666949|NCT02119156|156634099|FG001|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2|||
48758150|NCT00723892|156962708|FG001|Overall Study|Alcohol abuse|1|||
48758151|NCT00723892|156962707|FG000|Overall Study|Intercurrent infection|2|||
48758152|NCT00723892|156962708|FG001|Overall Study|Intercurrent infection|0|||
48967599|NCT00476996|157708631|FG002|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
48666950|NCT02119156|156634100|FG002|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0|||
48666951|NCT02119156|156634098|FG000|Treatment Phase (Up to 52 Weeks)|Physician Decision|1|||
48666952|NCT02119156|156634099|FG001|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
48666953|NCT02119156|156634100|FG002|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
48666954|NCT02119156|156634098|FG000|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0|||
48666955|NCT02119156|156634099|FG001|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10|||
48666956|NCT02119156|156634100|FG002|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7|||
48666957|NCT02469415|156634101|FG000|Overall Study|Withdrawal by Subject|1|||
48666958|NCT02469415|156634101|FG000|Overall Study|Investigational agent placed on hold|2|||
48666959|NCT03554772|156634104|FG000|Overall Study|Lost to Follow-up|0|||
48666960|NCT03554772|156634105|FG001|Overall Study|Lost to Follow-up|0|||
48666961|NCT03554772|156634106|FG002|Overall Study|Lost to Follow-up|0|||
48666962|NCT03554772|156634107|FG003|Overall Study|Lost to Follow-up|2|||
48666963|NCT01994863|156634108|FG000|Period 1|Adverse Event|4|||
48666964|NCT01994863|156634109|FG001|Period 1|Adverse Event|0|||
48666965|NCT01994863|156634108|FG000|Period 1|Withdrawal by Subject|1|||
48666966|NCT01994863|156634109|FG001|Period 1|Withdrawal by Subject|0|||
48666967|NCT01994863|156634108|FG000|Period 1|Trial stopped by sponsor|1|||
48666968|NCT01994863|156634109|FG001|Period 1|Trial stopped by sponsor|3|||
48666969|NCT01994863|156634108|FG000|Period 1|Lack of Efficacy|1|||
48666970|NCT01994863|156634109|FG001|Period 1|Lack of Efficacy|0|||
48666971|NCT01994863|156634108|FG000|Period 2|Adverse Event|0|||
48666972|NCT01994863|156634109|FG001|Period 2|Adverse Event|1|||
48666973|NCT01994863|156634108|FG000|Period 2|Lack of Efficacy|0|||
48666974|NCT01994863|156634109|FG001|Period 2|Lack of Efficacy|2|||
48666975|NCT01994863|156634108|FG000|Period 2|Withdrawal by Subject|1|||
48666976|NCT01994863|156634109|FG001|Period 2|Withdrawal by Subject|1|||
48666977|NCT05136898|156634110|FG000|Overall Study|Adverse Event|2|||
48666978|NCT01009346|156634115|FG000|Overall Study|Adverse Event|4|||
48666979|NCT03271047|156634118|FG000|Phase 1b: Dose Finding Period|Death|8|||
48666980|NCT03271047|156634119|FG001|Phase 1b: Dose Finding Period|Death|8|||
48666981|NCT03271047|156634120|FG002|Phase 1b: Dose Finding Period|Death|0|||
48666982|NCT03271047|156634121|FG003|Phase 1b: Dose Finding Period|Death|0|||
48666983|NCT03271047|156634118|FG000|Phase 1b: Dose Finding Period|Lost to Follow-up|1|||
48666984|NCT03271047|156634119|FG001|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
48666985|NCT03271047|156634120|FG002|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
48666986|NCT03271047|156634121|FG003|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
48666987|NCT03271047|156634118|FG000|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
48666988|NCT03271047|156634119|FG001|Phase 1b: Dose Finding Period|Withdrawal by Subject|2|||
48666989|NCT03271047|156634120|FG002|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
48666990|NCT03271047|156634121|FG003|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
48666991|NCT03271047|156634118|FG000|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
48666992|NCT03271047|156634119|FG001|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
48666993|NCT03271047|156634120|FG002|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
48666994|NCT03271047|156634121|FG003|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
48666995|NCT03271047|156634118|FG000|Randomized Phase 2 Period|Other|0|||
48666996|NCT03271047|156634119|FG001|Randomized Phase 2 Period|Other|0|||
48666997|NCT03271047|156634120|FG002|Randomized Phase 2 Period|Other|0|||
48666998|NCT03271047|156634121|FG003|Randomized Phase 2 Period|Other|1|||
48666999|NCT03271047|156634118|FG000|Randomized Phase 2 Period|Death|0|||
48667000|NCT03271047|156634119|FG001|Randomized Phase 2 Period|Death|0|||
48667001|NCT03271047|156634120|FG002|Randomized Phase 2 Period|Death|20|||
48667002|NCT03271047|156634121|FG003|Randomized Phase 2 Period|Death|21|||
48667003|NCT03271047|156634118|FG000|Randomized Phase 2 Period|Lost to Follow-up|0|||
48667004|NCT03271047|156634119|FG001|Randomized Phase 2 Period|Lost to Follow-up|0|||
48967600|NCT00476996|157708632|FG003|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4|||
48967601|NCT00476996|157708629|FG000|OLE Phase (From Week 48)|Early termination of the study|0|||
48967602|NCT00476996|157708630|FG001|OLE Phase (From Week 48)|Early termination of the study|0|||
48967603|NCT00476996|157708631|FG002|OLE Phase (From Week 48)|Early termination of the study|0|||
48967604|NCT00476996|157708632|FG003|OLE Phase (From Week 48)|Early termination of the study|578|||
48967605|NCT01586806|157708635|FG000|Overall Study|Protocol Violation|0|||
48967606|NCT01586806|157708636|FG001|Overall Study|Protocol Violation|1|||
48967607|NCT01586806|157708637|FG002|Overall Study|Protocol Violation|0|||
48967608|NCT01586806|157708635|FG000|Overall Study|Withdrawal by Subject|1|||
48967609|NCT01586806|157708636|FG001|Overall Study|Withdrawal by Subject|0|||
48967610|NCT01586806|157708637|FG002|Overall Study|Withdrawal by Subject|0|||
48667005|NCT03271047|156634120|FG002|Randomized Phase 2 Period|Lost to Follow-up|2|||
48758153|NCT00723892|156962707|FG000|Overall Study|Drug addiction|1|||
48758154|NCT00723892|156962708|FG001|Overall Study|Drug addiction|0|||
49015471|NCT01393990|157893785|FG015|Overall Study|Progressive Disease|1|||
48868345|NCT01967719|157355503|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
48868346|NCT01967719|157355504|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
48868347|NCT01967719|157355501|FG000|Second Intervention (Day 3)|Withdrawal by Subject|0|||
48868348|NCT01967719|157355502|FG001|Second Intervention (Day 3)|Withdrawal by Subject|1|||
48868349|NCT01967719|157355503|FG002|Second Intervention (Day 3)|Withdrawal by Subject|0|||
48667006|NCT03271047|156634121|FG003|Randomized Phase 2 Period|Lost to Follow-up|1|||
48667007|NCT03271047|156634118|FG000|Randomized Phase 2 Period|Withdrawal by Subject|0|||
48667008|NCT03271047|156634119|FG001|Randomized Phase 2 Period|Withdrawal by Subject|0|||
48667009|NCT03271047|156634120|FG002|Randomized Phase 2 Period|Withdrawal by Subject|5|||
48667010|NCT03271047|156634121|FG003|Randomized Phase 2 Period|Withdrawal by Subject|0|||
48667011|NCT03271047|156634118|FG000|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
48667012|NCT03271047|156634119|FG001|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
48667013|NCT03271047|156634120|FG002|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
48667014|NCT03271047|156634121|FG003|Randomized Phase 2 Period|Completed follow-up per protocol|4|||
48667015|NCT01100528|156634122|FG000|Overall Study|Death|1|||
48667016|NCT01100528|156634122|FG000|Overall Study|Withdrawal by Subject|2|||
48667017|NCT03374202|156634123|FG000|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|1|||
48667018|NCT03374202|156634124|FG001|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|2|||
48667019|NCT03374202|156634125|FG002|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|4|||
48667020|NCT03374202|156634123|FG000|Five Year Long Term Follow Up|Death|0|||
48667021|NCT03374202|156634124|FG001|Five Year Long Term Follow Up|Death|1|||
48667022|NCT03374202|156634125|FG002|Five Year Long Term Follow Up|Death|0|||
48667023|NCT05291936|156634126|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
48667024|NCT05291936|156634127|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
48667025|NCT05291936|156634126|FG000|Period 1|Withdrew Consent during study|1|||
48667026|NCT05291936|156634127|FG001|Period 1|Withdrew Consent during study|0|||
48667027|NCT05291936|156634126|FG000|Period 2|Adverse Event|0|||
48667028|NCT05291936|156634127|FG001|Period 2|Adverse Event|1|||
48667029|NCT05291936|156634126|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
48667030|NCT05291936|156634127|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
48667031|NCT00693472|156634131|FG000|Part 1|Adverse Event|1|||
48667032|NCT00693472|156634132|FG001|Part 1|Adverse Event|1|||
48667033|NCT00693472|156634133|FG002|Part 1|Adverse Event|0|||
48667034|NCT00693472|156634134|FG003|Part 1|Adverse Event|0|||
48667035|NCT00693472|156634131|FG000|Part 1|Lost to Follow-up|0|||
48667036|NCT00693472|156634132|FG001|Part 1|Lost to Follow-up|1|||
48667037|NCT00693472|156634133|FG002|Part 1|Lost to Follow-up|0|||
48667038|NCT00693472|156634134|FG003|Part 1|Lost to Follow-up|0|||
48667039|NCT00693472|156634131|FG000|Part 1|Withdrew - reason unrelated to treatment|5|||
48667040|NCT00693472|156634132|FG001|Part 1|Withdrew - reason unrelated to treatment|2|||
48667041|NCT00693472|156634133|FG002|Part 1|Withdrew - reason unrelated to treatment|0|||
48667042|NCT00693472|156634134|FG003|Part 1|Withdrew - reason unrelated to treatment|0|||
48667043|NCT00693472|156634131|FG000|Part 2|Adverse Event|0|||
48667044|NCT00693472|156634132|FG001|Part 2|Adverse Event|0|||
48667045|NCT00693472|156634133|FG002|Part 2|Adverse Event|1|||
48667046|NCT00693472|156634134|FG003|Part 2|Adverse Event|0|||
48667047|NCT00693472|156634131|FG000|Part 2|Withdrew - reason unrelated to treatment|0|||
48667048|NCT00693472|156634132|FG001|Part 2|Withdrew - reason unrelated to treatment|0|||
48868350|NCT01967719|157355504|FG003|Second Intervention (Day 3)|Withdrawal by Subject|0|||
48868351|NCT02329223|157355505|FG000|Overall Study|Withdrawal by Subject|1|||
48868352|NCT02329223|157355506|FG001|Overall Study|Withdrawal by Subject|2|||
48868353|NCT02329223|157355507|FG002|Overall Study|Withdrawal by Subject|5|||
48868354|NCT02329223|157355505|FG000|Overall Study|Physician Decision|0|||
48868355|NCT02329223|157355506|FG001|Overall Study|Physician Decision|0|||
48868356|NCT02329223|157355507|FG002|Overall Study|Physician Decision|1|||
48868357|NCT02329223|157355505|FG000|Overall Study|Adverse Event|0|||
48868358|NCT02329223|157355506|FG001|Overall Study|Adverse Event|1|||
48868359|NCT02329223|157355507|FG002|Overall Study|Adverse Event|0|||
48868360|NCT01232569|157355508|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
48868361|NCT01232569|157355509|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
48868362|NCT01232569|157355510|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
48868363|NCT01232569|157355511|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
48868364|NCT01232569|157355508|FG000|Double-blind Treatment Period|Escape|2|||
48868365|NCT01232569|157355509|FG001|Double-blind Treatment Period|Escape|2|||
48868366|NCT01232569|157355510|FG002|Double-blind Treatment Period|Escape|0|||
48868367|NCT01232569|157355511|FG003|Double-blind Treatment Period|Escape|0|||
48868368|NCT01232569|157355508|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
48868369|NCT01232569|157355509|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
48868370|NCT01232569|157355510|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
48868371|NCT01232569|157355511|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
48868372|NCT01232569|157355508|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
48868373|NCT01232569|157355509|FG001|Double-blind Treatment Period|Lack of Efficacy|2|||
48868374|NCT01232569|157355510|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
48667049|NCT00693472|156634133|FG002|Part 2|Withdrew - reason unrelated to treatment|1|||
48667050|NCT00693472|156634134|FG003|Part 2|Withdrew - reason unrelated to treatment|2|||
48667051|NCT01038713|156634135|FG000|Overall Study|Patient to hospice|1|||
48667052|NCT01038713|156634136|FG001|Overall Study|Patient to hospice|1|||
48667053|NCT01038713|156634137|FG002|Overall Study|Patient to hospice|1|||
48667054|NCT01038713|156634135|FG000|Overall Study|Lost to Follow-up|3|||
48667055|NCT01038713|156634136|FG001|Overall Study|Lost to Follow-up|0|||
48667056|NCT01038713|156634137|FG002|Overall Study|Lost to Follow-up|0|||
48667057|NCT01038713|156634135|FG000|Overall Study|Neuroendocrine Tumor|0|||
48667058|NCT01038713|156634136|FG001|Overall Study|Neuroendocrine Tumor|1|||
48667059|NCT01038713|156634137|FG002|Overall Study|Neuroendocrine Tumor|0|||
48967611|NCT01586806|157708635|FG000|Overall Study|Lost to Follow-up|2|||
48967612|NCT01586806|157708636|FG001|Overall Study|Lost to Follow-up|3|||
48967613|NCT01586806|157708637|FG002|Overall Study|Lost to Follow-up|2|||
48967614|NCT01230749|157708638|FG000|Overall Study|Adverse Event|0|||
48758155|NCT03060447|156962709|FG000|Overall Study|Withdrawal by Subject|2|||
48758156|NCT03060447|156962710|FG001|Overall Study|Withdrawal by Subject|0|||
48967615|NCT01230749|157708639|FG001|Overall Study|Adverse Event|0|||
48967616|NCT01230749|157708640|FG002|Overall Study|Adverse Event|0|||
48667060|NCT01038713|156634135|FG000|Overall Study|died from PEP|0|||
48667061|NCT01038713|156634136|FG001|Overall Study|died from PEP|1|||
48667062|NCT01038713|156634137|FG002|Overall Study|died from PEP|0|||
48667063|NCT01038713|156634135|FG000|Overall Study|Autoimmune Pancreatitis|1|||
48667064|NCT01038713|156634136|FG001|Overall Study|Autoimmune Pancreatitis|0|||
48667065|NCT01038713|156634137|FG002|Overall Study|Autoimmune Pancreatitis|0|||
48667066|NCT00461305|156634140|FG000|Treatment|Adverse Event|26|||
48667067|NCT00461305|156634141|FG001|Treatment|Adverse Event|3|||
48667068|NCT00461305|156634140|FG000|Treatment|Lost to Follow-up|4|||
48667069|NCT00461305|156634141|FG001|Treatment|Lost to Follow-up|2|||
48667070|NCT00461305|156634140|FG000|Treatment|Protocol Violation|13|||
48667071|NCT00461305|156634141|FG001|Treatment|Protocol Violation|2|||
48667072|NCT00461305|156634140|FG000|Treatment|Withdrawal by Subject|48|||
48667073|NCT00461305|156634141|FG001|Treatment|Withdrawal by Subject|2|||
48667074|NCT00461305|156634140|FG000|Treatment|Never dispensed|5|||
48667075|NCT00461305|156634141|FG001|Treatment|Never dispensed|0|||
48667076|NCT00461305|156634140|FG000|Treatment|Study drug not taken|1|||
48667077|NCT00461305|156634141|FG001|Treatment|Study drug not taken|0|||
48667078|NCT00461305|156634140|FG000|Treatment|Partially missing diary|2|||
48667079|NCT00461305|156634141|FG001|Treatment|Partially missing diary|0|||
48667080|NCT00461305|156634140|FG000|Treatment|Other (missing drug etc)|2|||
48667081|NCT00461305|156634141|FG001|Treatment|Other (missing drug etc)|0|||
48667082|NCT00461305|156634140|FG000|Continued Treatment|Adverse Event|26|||
48667083|NCT00461305|156634141|FG001|Continued Treatment|Adverse Event|0|||
48667084|NCT00461305|156634140|FG000|Continued Treatment|Lost to Follow-up|4|||
48667085|NCT00461305|156634141|FG001|Continued Treatment|Lost to Follow-up|0|||
48667086|NCT00461305|156634140|FG000|Continued Treatment|Protocol Violation|13|||
48667087|NCT00461305|156634141|FG001|Continued Treatment|Protocol Violation|0|||
48667088|NCT00461305|156634140|FG000|Continued Treatment|Withdrawal by Subject|48|||
48667089|NCT00461305|156634141|FG001|Continued Treatment|Withdrawal by Subject|0|||
48758157|NCT01870583|156962711|FG000|Overall Study|Protocol Violation|0|||
48758158|NCT01870583|156962712|FG001|Overall Study|Protocol Violation|5|||
48758159|NCT01870583|156962713|FG002|Overall Study|Protocol Violation|3|||
48758160|NCT01870583|156962711|FG000|Overall Study|Lost to Follow-up|11|||
48758161|NCT01870583|156962712|FG001|Overall Study|Lost to Follow-up|13|||
48758162|NCT01870583|156962713|FG002|Overall Study|Lost to Follow-up|5|||
48758163|NCT01770379|156962718|FG000|Overall Study|Technical issues|1|||
48758164|NCT01770379|156962719|FG001|Overall Study|Technical issues|0|||
48758165|NCT01770379|156962720|FG002|Overall Study|Technical issues|0|||
48758166|NCT01770379|156962718|FG000|Overall Study|Withdrawal by Subject|7|||
48758167|NCT01770379|156962719|FG001|Overall Study|Withdrawal by Subject|10|||
48758168|NCT01770379|156962720|FG002|Overall Study|Withdrawal by Subject|7|||
48758169|NCT01770379|156962718|FG000|Overall Study|study terminated by sponsor|22|||
48758170|NCT01770379|156962719|FG001|Overall Study|study terminated by sponsor|23|||
48758171|NCT01770379|156962720|FG002|Overall Study|study terminated by sponsor|22|||
48868375|NCT01232569|157355511|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
48758172|NCT01770379|156962718|FG000|Overall Study|Protocol Violation|0|||
48758173|NCT01770379|156962719|FG001|Overall Study|Protocol Violation|1|||
48868376|NCT01232569|157355508|FG000|Double-blind Treatment Period|Physician Decision|1|||
48868377|NCT01232569|157355509|FG001|Double-blind Treatment Period|Physician Decision|0|||
48868378|NCT01232569|157355510|FG002|Double-blind Treatment Period|Physician Decision|0|||
48868379|NCT01232569|157355511|FG003|Double-blind Treatment Period|Physician Decision|0|||
48868380|NCT01232569|157355508|FG000|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9|||
48868381|NCT01232569|157355509|FG001|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3|||
48868382|NCT01232569|157355510|FG002|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
48967617|NCT01230749|157708641|FG003|Overall Study|Adverse Event|1|||
48667090|NCT00461305|156634140|FG000|Continued Treatment|Partially missing diary|2|||
48758174|NCT01770379|156962720|FG002|Overall Study|Protocol Violation|1|||
48967618|NCT01230749|157708638|FG000|Overall Study|Physician Decision|0|||
48758175|NCT01770379|156962718|FG000|Overall Study|Physician Decision|0|||
48758176|NCT01770379|156962719|FG001|Overall Study|Physician Decision|1|||
48758177|NCT01770379|156962720|FG002|Overall Study|Physician Decision|2|||
48758178|NCT01770379|156962718|FG000|Overall Study|Lost to Follow-up|0|||
48758179|NCT01770379|156962719|FG001|Overall Study|Lost to Follow-up|0|||
48758180|NCT01770379|156962720|FG002|Overall Study|Lost to Follow-up|2|||
48758181|NCT01770379|156962718|FG000|Overall Study|Lack of Efficacy|8|||
48758182|NCT01770379|156962719|FG001|Overall Study|Lack of Efficacy|6|||
48758183|NCT01770379|156962720|FG002|Overall Study|Lack of Efficacy|6|||
48758184|NCT01770379|156962718|FG000|Overall Study|Adverse Event|1|||
48758185|NCT01770379|156962719|FG001|Overall Study|Adverse Event|3|||
48758186|NCT01770379|156962720|FG002|Overall Study|Adverse Event|2|||
48758187|NCT00311623|156962723|FG000|Overall Study|Physician Decision|0|||
48758188|NCT00311623|156962724|FG001|Overall Study|Physician Decision|0|||
48758189|NCT00311623|156962725|FG002|Overall Study|Physician Decision|2|||
48758190|NCT01912287|156962726|FG000|Overall Study|Ineligible|1|||
48758191|NCT01912287|156962727|FG001|Overall Study|Ineligible|0|||
48758192|NCT01912287|156962728|FG002|Overall Study|Ineligible|1|||
48758193|NCT01912287|156962726|FG000|Overall Study|No-show|0|||
48758194|NCT01912287|156962727|FG001|Overall Study|No-show|0|||
48758195|NCT01912287|156962728|FG002|Overall Study|No-show|1|||
48758196|NCT01912287|156962726|FG000|Overall Study|Dissatisfaction with assigned treatment|4|||
48758197|NCT01912287|156962727|FG001|Overall Study|Dissatisfaction with assigned treatment|2|||
48758198|NCT01912287|156962728|FG002|Overall Study|Dissatisfaction with assigned treatment|1|||
48758199|NCT01912287|156962726|FG000|Overall Study|Felt treatment no longer needed|0|||
48758200|NCT01912287|156962727|FG001|Overall Study|Felt treatment no longer needed|1|||
48758201|NCT01912287|156962728|FG002|Overall Study|Felt treatment no longer needed|0|||
48758202|NCT01912287|156962726|FG000|Overall Study|Life circumstances|4|||
48758203|NCT01912287|156962727|FG001|Overall Study|Life circumstances|2|||
48758204|NCT01912287|156962728|FG002|Overall Study|Life circumstances|0|||
48967619|NCT01230749|157708639|FG001|Overall Study|Physician Decision|0|||
48967620|NCT01230749|157708640|FG002|Overall Study|Physician Decision|1|||
48667091|NCT00461305|156634141|FG001|Continued Treatment|Partially missing diary|0|||
48667092|NCT00461305|156634140|FG000|Continued Treatment|Other (missing drug etc)|2|||
48667093|NCT00461305|156634141|FG001|Continued Treatment|Other (missing drug etc)|0|||
48667094|NCT01048866|156634142|FG000|Overall Study|Adverse Event|1|||
48667095|NCT01048866|156634143|FG001|Overall Study|Adverse Event|0|||
48667096|NCT01048866|156634142|FG000|Overall Study|Protocol Violation|1|||
48667097|NCT01048866|156634143|FG001|Overall Study|Protocol Violation|0|||
48667098|NCT01048866|156634142|FG000|Overall Study|Physician Decision|1|||
48667099|NCT01048866|156634143|FG001|Overall Study|Physician Decision|0|||
48667100|NCT01048866|156634142|FG000|Overall Study|Withdrawal by Subject|0|||
48667101|NCT01048866|156634143|FG001|Overall Study|Withdrawal by Subject|2|||
48667102|NCT01048866|156634142|FG000|Overall Study|Lost to Follow-up|0|||
48667103|NCT01048866|156634143|FG001|Overall Study|Lost to Follow-up|2|||
48667104|NCT01048866|156634142|FG000|Overall Study|Other|1|||
48667105|NCT01048866|156634143|FG001|Overall Study|Other|1|||
48667106|NCT00907296|156634146|FG000|Overall Study|Ineligibility Determined|1|||
48667107|NCT00907296|156634147|FG001|Overall Study|Ineligibility Determined|0|||
48667108|NCT00907296|156634148|FG002|Overall Study|Ineligibility Determined|0|||
48667109|NCT00907296|156634149|FG003|Overall Study|Ineligibility Determined|1|||
48667110|NCT00907296|156634150|FG004|Overall Study|Ineligibility Determined|0|||
48667111|NCT00907296|156634151|FG005|Overall Study|Ineligibility Determined|0|||
48667112|NCT00907296|156634152|FG006|Overall Study|Ineligibility Determined|0|||
48667113|NCT00907296|156634153|FG007|Overall Study|Ineligibility Determined|1|||
48667114|NCT00907296|156634154|FG008|Overall Study|Ineligibility Determined|0|||
48667115|NCT00907296|156634155|FG009|Overall Study|Ineligibility Determined|0|||
48667116|NCT00907296|156634146|FG000|Overall Study|Protocol Deviation|0|||
48667117|NCT00907296|156634147|FG001|Overall Study|Protocol Deviation|1|||
48758205|NCT01912287|156962726|FG000|Overall Study|Lost Interest|1|||
48758206|NCT01912287|156962727|FG001|Overall Study|Lost Interest|0|||
48758207|NCT01912287|156962728|FG002|Overall Study|Lost Interest|0|||
48758208|NCT01912287|156962726|FG000|Overall Study|Uknown reason - subject drop out|5|||
48758209|NCT01912287|156962727|FG001|Overall Study|Uknown reason - subject drop out|7|||
48967621|NCT01230749|157708641|FG003|Overall Study|Physician Decision|0|||
48967622|NCT01230749|157708638|FG000|Overall Study|Withdrawal by Subject|0|||
48967623|NCT01230749|157708639|FG001|Overall Study|Withdrawal by Subject|1|||
48667118|NCT00907296|156634148|FG002|Overall Study|Protocol Deviation|0|||
48667119|NCT00907296|156634149|FG003|Overall Study|Protocol Deviation|0|||
48667120|NCT00907296|156634150|FG004|Overall Study|Protocol Deviation|0|||
48667121|NCT00907296|156634151|FG005|Overall Study|Protocol Deviation|0|||
48667122|NCT00907296|156634152|FG006|Overall Study|Protocol Deviation|0|||
48758210|NCT01912287|156962728|FG002|Overall Study|Uknown reason - subject drop out|3|||
48758211|NCT01912287|156962726|FG000|Overall Study|Missed Assesment|1|||
48758212|NCT01912287|156962727|FG001|Overall Study|Missed Assesment|1|||
48758213|NCT01912287|156962728|FG002|Overall Study|Missed Assesment|1|||
48758214|NCT01912287|156962726|FG000|Overall Study|Scheduling/change in availability|17|||
48758215|NCT01912287|156962727|FG001|Overall Study|Scheduling/change in availability|10|||
48758216|NCT01912287|156962728|FG002|Overall Study|Scheduling/change in availability|8|||
48758217|NCT03103919|156962729|FG000|Overall Study|Adverse Event|2|||
48758218|NCT03103919|156962730|FG001|Overall Study|Adverse Event|2|||
48758219|NCT04984993|156962731|FG000|Overall Study|Withdrawal by Subject|8|||
48758220|NCT04984993|156962732|FG001|Overall Study|Withdrawal by Subject|2|||
48758221|NCT04984993|156962731|FG000|Overall Study|Lost to Follow-up|2|||
48758222|NCT04984993|156962732|FG001|Overall Study|Lost to Follow-up|2|||
48758223|NCT04984993|156962731|FG000|Overall Study|Both patients moved to another country|4|||
48758224|NCT04984993|156962732|FG001|Overall Study|Both patients moved to another country|0|||
48758225|NCT04577118|156962735|FG000|Overall Study|Withdrawal by Subject|4|||
48758226|NCT02710045|156962737|FG000|Overall Study|Death|1|||
48758227|NCT02710045|156962738|FG001|Overall Study|Death|2|||
48758228|NCT02710045|156962739|FG002|Overall Study|Death|0|||
48758229|NCT02710045|156962737|FG000|Overall Study|Withdrawal by Subject|6|||
48758230|NCT02710045|156962738|FG001|Overall Study|Withdrawal by Subject|6|||
48758231|NCT02710045|156962739|FG002|Overall Study|Withdrawal by Subject|2|||
48758232|NCT02710045|156962737|FG000|Overall Study|Protocol Violation|1|||
48758233|NCT02710045|156962738|FG001|Overall Study|Protocol Violation|2|||
48758234|NCT02710045|156962739|FG002|Overall Study|Protocol Violation|3|||
48758235|NCT02710045|156962737|FG000|Overall Study|Lost to Follow-up|3|||
48667123|NCT00907296|156634153|FG007|Overall Study|Protocol Deviation|0|||
48667124|NCT00907296|156634154|FG008|Overall Study|Protocol Deviation|0|||
48667125|NCT00907296|156634155|FG009|Overall Study|Protocol Deviation|0|||
48667126|NCT00907296|156634146|FG000|Overall Study|Noncompliance|1|||
48667127|NCT00907296|156634147|FG001|Overall Study|Noncompliance|1|||
48667128|NCT00907296|156634148|FG002|Overall Study|Noncompliance|1|||
48667129|NCT00907296|156634149|FG003|Overall Study|Noncompliance|0|||
48667130|NCT00907296|156634150|FG004|Overall Study|Noncompliance|0|||
48758236|NCT02710045|156962738|FG001|Overall Study|Lost to Follow-up|6|||
48758237|NCT02710045|156962739|FG002|Overall Study|Lost to Follow-up|7|||
48758238|NCT02710045|156962737|FG000|Overall Study|Physician Decision|0|||
48758239|NCT02710045|156962738|FG001|Overall Study|Physician Decision|0|||
48758240|NCT02710045|156962739|FG002|Overall Study|Physician Decision|1|||
48758241|NCT02710045|156962737|FG000|Overall Study|Poor Attendance|0|||
48758242|NCT02710045|156962738|FG001|Overall Study|Poor Attendance|1|||
48758243|NCT02710045|156962739|FG002|Overall Study|Poor Attendance|0|||
48758244|NCT01359449|156962740|FG000|Overall Study|Lost to Follow-up|1|||
48758245|NCT01359449|156962741|FG001|Overall Study|Lost to Follow-up|0|||
48758246|NCT01359449|156962740|FG000|Overall Study|Protocol Violation|0|||
48758247|NCT01359449|156962741|FG001|Overall Study|Protocol Violation|2|||
48667131|NCT00907296|156634151|FG005|Overall Study|Noncompliance|1|||
48667132|NCT00907296|156634152|FG006|Overall Study|Noncompliance|0|||
48667133|NCT00907296|156634153|FG007|Overall Study|Noncompliance|2|||
48667134|NCT00907296|156634154|FG008|Overall Study|Noncompliance|0|||
48667135|NCT00907296|156634155|FG009|Overall Study|Noncompliance|0|||
48667136|NCT00907296|156634146|FG000|Overall Study|Adverse Event|2|||
48667137|NCT00907296|156634147|FG001|Overall Study|Adverse Event|0|||
48667138|NCT00907296|156634148|FG002|Overall Study|Adverse Event|0|||
48667139|NCT00907296|156634149|FG003|Overall Study|Adverse Event|0|||
48667140|NCT00907296|156634150|FG004|Overall Study|Adverse Event|0|||
48667141|NCT00907296|156634151|FG005|Overall Study|Adverse Event|0|||
48667142|NCT00907296|156634152|FG006|Overall Study|Adverse Event|1|||
48667143|NCT00907296|156634153|FG007|Overall Study|Adverse Event|0|||
48667144|NCT00907296|156634154|FG008|Overall Study|Adverse Event|0|||
48667145|NCT00907296|156634155|FG009|Overall Study|Adverse Event|1|||
48868383|NCT01232569|157355511|FG003|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
48667146|NCT00907296|156634146|FG000|Overall Study|Withdrawal by Subject|7|||
48667147|NCT00907296|156634147|FG001|Overall Study|Withdrawal by Subject|2|||
48667148|NCT00907296|156634148|FG002|Overall Study|Withdrawal by Subject|1|||
48667149|NCT00907296|156634149|FG003|Overall Study|Withdrawal by Subject|1|||
48758248|NCT01359449|156962740|FG000|Overall Study|Withdrawal by Subject|3|||
48758249|NCT01359449|156962741|FG001|Overall Study|Withdrawal by Subject|2|||
48758250|NCT03178773|156962746|FG000|Overall Study|Death|0|||
48758251|NCT03178773|156962747|FG001|Overall Study|Death|1|||
48758252|NCT03178773|156962746|FG000|Overall Study|Lost to Follow-up|29|||
48758253|NCT03178773|156962747|FG001|Overall Study|Lost to Follow-up|25|||
48758254|NCT03178773|156962746|FG000|Overall Study|Withdrawal by Subject|10|||
48758255|NCT03178773|156962747|FG001|Overall Study|Withdrawal by Subject|14|||
48758256|NCT01382446|156962748|FG000|Overall Study|Withdrawal by Subject|0|||
48758257|NCT01382446|156962749|FG001|Overall Study|Withdrawal by Subject|1|||
48868384|NCT01232569|157355508|FG000|Double-blind Treatment Period|Death|2|||
48868385|NCT01232569|157355509|FG001|Double-blind Treatment Period|Death|0|||
48868386|NCT01232569|157355510|FG002|Double-blind Treatment Period|Death|0|||
48868387|NCT01232569|157355511|FG003|Double-blind Treatment Period|Death|0|||
48868388|NCT00651937|157355512|FG000|Overall Study|Withdrawal by Subject|4|||
48868389|NCT00651937|157355513|FG001|Overall Study|Withdrawal by Subject|1|||
48667150|NCT00907296|156634150|FG004|Overall Study|Withdrawal by Subject|1|||
48667151|NCT00907296|156634151|FG005|Overall Study|Withdrawal by Subject|5|||
48758258|NCT01382446|156962748|FG000|Overall Study|Removal from Mechanical Ventilation|3|||
48967624|NCT01230749|157708640|FG002|Overall Study|Withdrawal by Subject|0|||
48967625|NCT01230749|157708641|FG003|Overall Study|Withdrawal by Subject|0|||
48967626|NCT01230749|157708638|FG000|Overall Study|Fasting glucose more than 270 mg/dL|0|||
48967627|NCT01230749|157708639|FG001|Overall Study|Fasting glucose more than 270 mg/dL|1|||
48967628|NCT01230749|157708640|FG002|Overall Study|Fasting glucose more than 270 mg/dL|1|||
48967629|NCT01230749|157708641|FG003|Overall Study|Fasting glucose more than 270 mg/dL|1|||
48967630|NCT00555906|157708642|FG000|Phase 1|Objective Progression or Relapse|3|||
48967631|NCT00555906|157708643|FG001|Phase 1|Objective Progression or Relapse|5|||
48967632|NCT00555906|157708644|FG002|Phase 1|Objective Progression or Relapse|3|||
48967633|NCT00555906|157708645|FG003|Phase 1|Objective Progression or Relapse|1|||
48967634|NCT00555906|157708646|FG004|Phase 1|Objective Progression or Relapse|0|||
48967635|NCT00555906|157708642|FG000|Phase 1|Global Deterioration of Health Status|0|||
48967636|NCT00555906|157708643|FG001|Phase 1|Global Deterioration of Health Status|1|||
48967637|NCT00555906|157708644|FG002|Phase 1|Global Deterioration of Health Status|1|||
48967638|NCT00555906|157708645|FG003|Phase 1|Global Deterioration of Health Status|1|||
48967639|NCT00555906|157708646|FG004|Phase 1|Global Deterioration of Health Status|0|||
48967640|NCT00555906|157708642|FG000|Phase 1|Adverse Event|0|||
48967641|NCT00555906|157708643|FG001|Phase 1|Adverse Event|0|||
48967642|NCT00555906|157708644|FG002|Phase 1|Adverse Event|3|||
48967643|NCT00555906|157708645|FG003|Phase 1|Adverse Event|2|||
48967644|NCT00555906|157708646|FG004|Phase 1|Adverse Event|0|||
48967645|NCT00555906|157708642|FG000|Phase 1|Withdrawal by Subject|0|||
48967646|NCT00555906|157708643|FG001|Phase 1|Withdrawal by Subject|0|||
48967647|NCT00555906|157708644|FG002|Phase 1|Withdrawal by Subject|0|||
48667152|NCT00907296|156634152|FG006|Overall Study|Withdrawal by Subject|3|||
48667153|NCT00907296|156634153|FG007|Overall Study|Withdrawal by Subject|2|||
48667154|NCT00907296|156634154|FG008|Overall Study|Withdrawal by Subject|4|||
48667155|NCT00907296|156634155|FG009|Overall Study|Withdrawal by Subject|2|||
48667156|NCT00907296|156634146|FG000|Overall Study|Lost to Follow-up|9|||
48667157|NCT00907296|156634147|FG001|Overall Study|Lost to Follow-up|1|||
48667158|NCT00907296|156634148|FG002|Overall Study|Lost to Follow-up|0|||
48667159|NCT00907296|156634149|FG003|Overall Study|Lost to Follow-up|2|||
48667160|NCT00907296|156634150|FG004|Overall Study|Lost to Follow-up|0|||
48667161|NCT00907296|156634151|FG005|Overall Study|Lost to Follow-up|3|||
48667162|NCT00907296|156634152|FG006|Overall Study|Lost to Follow-up|2|||
48667163|NCT00907296|156634153|FG007|Overall Study|Lost to Follow-up|2|||
48667164|NCT00907296|156634154|FG008|Overall Study|Lost to Follow-up|0|||
48667165|NCT00907296|156634155|FG009|Overall Study|Lost to Follow-up|4|||
48667166|NCT02395055|156634156|FG000|Overall Study|Withdrawal by Subject|7|||
48667167|NCT02395055|156634157|FG001|Overall Study|Withdrawal by Subject|3|||
48667168|NCT00707746|156634158|FG000|Treatment Period|Adverse Event|2|||
48667169|NCT00707746|156634159|FG001|Treatment Period|Adverse Event|4|||
48667170|NCT00707746|156634158|FG000|Treatment Period|Ineligibility|0|||
48667171|NCT00707746|156634159|FG001|Treatment Period|Ineligibility|1|||
48667172|NCT02392403|156634160|FG000|Overall Study|Adverse Event|1|||
48667173|NCT02392403|156634160|FG000|Overall Study|Death|1|||
48667174|NCT02392403|156634160|FG000|Overall Study|Withdrawal by Subject|1|||
48667175|NCT01219933|156634162|FG000|Overall Study|Adverse Event|8|||
48667176|NCT01219933|156634162|FG000|Overall Study|No LDA reached|5|||
48667177|NCT01219933|156634162|FG000|Overall Study|No LDA maintained|7|||
48967648|NCT00555906|157708645|FG003|Phase 1|Withdrawal by Subject|1|||
48967649|NCT00555906|157708646|FG004|Phase 1|Withdrawal by Subject|0|||
48967650|NCT00555906|157708642|FG000|Phase 2|Adverse Event|0|||
48967651|NCT00555906|157708643|FG001|Phase 2|Adverse Event|0|||
48967652|NCT00555906|157708644|FG002|Phase 2|Adverse Event|0|||
48967653|NCT00555906|157708645|FG003|Phase 2|Adverse Event|0|||
48967654|NCT00555906|157708646|FG004|Phase 2|Adverse Event|4|||
48967655|NCT00555906|157708642|FG000|Phase 2|Global Deterioration of Health Status|0|||
48967656|NCT00555906|157708643|FG001|Phase 2|Global Deterioration of Health Status|0|||
48967657|NCT00555906|157708644|FG002|Phase 2|Global Deterioration of Health Status|0|||
48667178|NCT01219933|156634162|FG000|Overall Study|Lost to Follow-up|3|||
48667179|NCT01219933|156634162|FG000|Overall Study|GC free|1|||
48758259|NCT01382446|156962749|FG001|Overall Study|Removal from Mechanical Ventilation|3|||
48758260|NCT00483379|156962751|FG000|Treatment Period|Adverse Event|1|||
48967658|NCT00555906|157708645|FG003|Phase 2|Global Deterioration of Health Status|0|||
48967659|NCT00555906|157708646|FG004|Phase 2|Global Deterioration of Health Status|2|||
48967660|NCT00555906|157708642|FG000|Phase 2|Objective Progression or Relapse|0|||
48967661|NCT00555906|157708643|FG001|Phase 2|Objective Progression or Relapse|0|||
48967662|NCT00555906|157708644|FG002|Phase 2|Objective Progression or Relapse|0|||
48967663|NCT00555906|157708645|FG003|Phase 2|Objective Progression or Relapse|0|||
49015472|NCT01393990|157893786|FG016|Overall Study|Progressive Disease|0|||
48667180|NCT01219933|156634162|FG000|Overall Study|Withdrawal by Subject|5|||
48667181|NCT01219933|156634162|FG000|Overall Study|Protocol Violation|8|||
48667182|NCT01219933|156634162|FG000|Overall Study|Lack of Efficacy|1|||
48967664|NCT00555906|157708646|FG004|Phase 2|Objective Progression or Relapse|16|||
48967665|NCT00555906|157708642|FG000|Phase 2|Withdrawal by Subject|0|||
48967666|NCT00555906|157708643|FG001|Phase 2|Withdrawal by Subject|0|||
48967667|NCT00555906|157708644|FG002|Phase 2|Withdrawal by Subject|0|||
48758261|NCT00483379|156962752|FG001|Treatment Period|Adverse Event|0|||
48758262|NCT00483379|156962751|FG000|Treatment Period|Withdrawal by Subject|1|||
48758263|NCT00483379|156962752|FG001|Treatment Period|Withdrawal by Subject|0|||
48758264|NCT00514540|156962753|FG000|First-Line Chemo|Withdrawal by Subject|1|||
48758265|NCT00514540|156962753|FG000|First-Line Chemo|Protocol Violation|7|||
48758266|NCT00514540|156962753|FG000|Second-Line|Physician/Patient Decision|31|||
48758267|NCT00422591|156962754|FG000|Overall Study|Physician Decision|4|||
48758268|NCT00422591|156962754|FG000|Overall Study|Withdrawal by Subject|2|||
48758269|NCT04210310|156962755|FG000|Overall Study|Lost to Follow-up|32|||
48758270|NCT04210310|156962756|FG001|Overall Study|Lost to Follow-up|1|||
48758271|NCT00680745|156962760|FG000|Overall Study|Withdrawal by Subject|8|||
48758272|NCT00680745|156962761|FG001|Overall Study|Withdrawal by Subject|3|||
48758273|NCT00680745|156962762|FG002|Overall Study|Withdrawal by Subject|2|||
48758274|NCT00680745|156962763|FG003|Overall Study|Withdrawal by Subject|8|||
48758275|NCT00680745|156962760|FG000|Overall Study|Lost to Follow-up|0|||
48758276|NCT00680745|156962761|FG001|Overall Study|Lost to Follow-up|1|||
48758277|NCT00680745|156962762|FG002|Overall Study|Lost to Follow-up|1|||
48758278|NCT00680745|156962763|FG003|Overall Study|Lost to Follow-up|0|||
48758279|NCT00680745|156962760|FG000|Overall Study|Death|1|||
48758280|NCT00680745|156962761|FG001|Overall Study|Death|0|||
48758281|NCT00680745|156962762|FG002|Overall Study|Death|1|||
48758282|NCT00680745|156962763|FG003|Overall Study|Death|0|||
48758283|NCT00680745|156962760|FG000|Overall Study|Adverse Event|5|||
48758284|NCT00680745|156962761|FG001|Overall Study|Adverse Event|3|||
48667183|NCT00316888|156634163|FG000|Overall Study|Adverse Event|4|||
48667184|NCT00316888|156634164|FG001|Overall Study|Adverse Event|5|||
48667185|NCT00316888|156634163|FG000|Overall Study|Withdrawal by Subject|2|||
48667186|NCT00316888|156634164|FG001|Overall Study|Withdrawal by Subject|2|||
48667187|NCT00316888|156634163|FG000|Overall Study|Not start protocol therapy|0|||
48667188|NCT00316888|156634164|FG001|Overall Study|Not start protocol therapy|1|||
48667189|NCT05239221|156634165|FG000|Overall Study|Adverse Event|0|||
48667190|NCT05239221|156634166|FG001|Overall Study|Adverse Event|0|||
48667191|NCT05239221|156634167|FG002|Overall Study|Adverse Event|0|||
48667192|NCT05239221|156634168|FG003|Overall Study|Adverse Event|0|||
48667193|NCT05239221|156634169|FG004|Overall Study|Adverse Event|0|||
48667194|NCT05239221|156634170|FG005|Overall Study|Adverse Event|0|||
48667195|NCT05239221|156634171|FG006|Overall Study|Adverse Event|1|||
48667196|NCT05239221|156634172|FG007|Overall Study|Adverse Event|0|||
48667197|NCT05239221|156634173|FG008|Overall Study|Adverse Event|0|||
48667198|NCT05239221|156634174|FG009|Overall Study|Adverse Event|0|||
48667199|NCT05239221|156634175|FG010|Overall Study|Adverse Event|1|||
48667200|NCT05239221|156634176|FG011|Overall Study|Adverse Event|1|||
48667201|NCT05239221|156634177|FG012|Overall Study|Adverse Event|0|||
48758285|NCT00680745|156962762|FG002|Overall Study|Adverse Event|3|||
48758286|NCT00680745|156962763|FG003|Overall Study|Adverse Event|3|||
48758287|NCT00680745|156962760|FG000|Overall Study|Poor/Non-compliance|0|||
48758288|NCT00680745|156962761|FG001|Overall Study|Poor/Non-compliance|3|||
48758289|NCT00680745|156962762|FG002|Overall Study|Poor/Non-compliance|0|||
48758290|NCT00680745|156962763|FG003|Overall Study|Poor/Non-compliance|0|||
48758291|NCT00680745|156962760|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
48758292|NCT00680745|156962761|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
48758293|NCT00680745|156962762|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
48868390|NCT00506922|157355523|FG000|Overall Study|Physician Decision|0|||
48868391|NCT00506922|157355524|FG001|Overall Study|Physician Decision|0|||
48868392|NCT00506922|157355525|FG002|Overall Study|Physician Decision|0|||
48868393|NCT00506922|157355526|FG003|Overall Study|Physician Decision|2|||
48868394|NCT00506922|157355527|FG004|Overall Study|Physician Decision|0|||
48868395|NCT00506922|157355523|FG000|Overall Study|Withdrawal by Subject|0|||
48868396|NCT00506922|157355524|FG001|Overall Study|Withdrawal by Subject|0|||
48868397|NCT00506922|157355525|FG002|Overall Study|Withdrawal by Subject|0|||
48868398|NCT00506922|157355526|FG003|Overall Study|Withdrawal by Subject|0|||
48868399|NCT00506922|157355527|FG004|Overall Study|Withdrawal by Subject|1|||
48868400|NCT04816708|157355528|FG000|Overall Study|Lost to Follow-up|10|||
48868401|NCT04816708|157355529|FG001|Overall Study|Lost to Follow-up|4|||
48868402|NCT03226106|157355531|FG000|Overall Study|Withdrawal by Subject|2|||
48868403|NCT03226106|157355532|FG001|Overall Study|Withdrawal by Subject|0|||
48868404|NCT03226106|157355531|FG000|Overall Study|Adverse Event|1|||
48868405|NCT03226106|157355532|FG001|Overall Study|Adverse Event|0|||
48868406|NCT03226106|157355531|FG000|Overall Study|Lost to Follow-up|2|||
48868407|NCT03226106|157355532|FG001|Overall Study|Lost to Follow-up|0|||
48868408|NCT01084239|157355533|FG000|28-Day Follow-up|Lost to Follow-up|4|||
48868409|NCT01084239|157355534|FG001|28-Day Follow-up|Lost to Follow-up|9|||
48868410|NCT00550771|157355536|FG000|Overall Study|Adverse Event|11|||
48868411|NCT00550771|157355537|FG001|Overall Study|Adverse Event|3|||
48868412|NCT00550771|157355536|FG000|Overall Study|Discontinued for study-related reasons|0|||
48868413|NCT00550771|157355537|FG001|Overall Study|Discontinued for study-related reasons|1|||
48868414|NCT00550771|157355536|FG000|Overall Study|Physician Decision|2|||
48868415|NCT00550771|157355537|FG001|Overall Study|Physician Decision|0|||
48868416|NCT00550771|157355536|FG000|Overall Study|Withdrawal by Subject|0|||
48868417|NCT00550771|157355537|FG001|Overall Study|Withdrawal by Subject|1|||
48868418|NCT00550771|157355536|FG000|Overall Study|Protocol Violation|4|||
48868419|NCT00550771|157355537|FG001|Overall Study|Protocol Violation|5|||
48868420|NCT02229396|157355538|FG000|Overall Study|Adverse Event|6|||
48868421|NCT02229396|157355539|FG001|Overall Study|Adverse Event|12|||
48868422|NCT02229396|157355540|FG002|Overall Study|Adverse Event|12|||
48868423|NCT02229396|157355538|FG000|Overall Study|Death|2|||
48868424|NCT02229396|157355539|FG001|Overall Study|Death|3|||
48868425|NCT02229396|157355540|FG002|Overall Study|Death|1|||
48868426|NCT02229396|157355538|FG000|Overall Study|Lost to Follow-up|14|||
48868427|NCT02229396|157355539|FG001|Overall Study|Lost to Follow-up|14|||
48868428|NCT02229396|157355540|FG002|Overall Study|Lost to Follow-up|21|||
48868429|NCT02229396|157355538|FG000|Overall Study|Protocol Violation|2|||
48868430|NCT02229396|157355539|FG001|Overall Study|Protocol Violation|1|||
48868431|NCT02229396|157355540|FG002|Overall Study|Protocol Violation|0|||
48868432|NCT02229396|157355538|FG000|Overall Study|Patient Incorrectly Randomized|0|||
48868433|NCT02229396|157355539|FG001|Overall Study|Patient Incorrectly Randomized|0|||
48868434|NCT02229396|157355540|FG002|Overall Study|Patient Incorrectly Randomized|1|||
48868435|NCT02229396|157355538|FG000|Overall Study|Other|10|||
48967668|NCT00555906|157708645|FG003|Phase 2|Withdrawal by Subject|0|||
48967669|NCT00555906|157708646|FG004|Phase 2|Withdrawal by Subject|2|||
48967670|NCT00555906|157708642|FG000|Phase 2|Other|0|||
48967671|NCT00555906|157708643|FG001|Phase 2|Other|0|||
48967672|NCT00555906|157708644|FG002|Phase 2|Other|0|||
48967673|NCT00555906|157708645|FG003|Phase 2|Other|0|||
48967674|NCT00555906|157708646|FG004|Phase 2|Other|6|||
48967675|NCT00555906|157708642|FG000|Phase 2|Randomized but not Treated|0|||
48967676|NCT00555906|157708643|FG001|Phase 2|Randomized but not Treated|0|||
48967677|NCT00555906|157708644|FG002|Phase 2|Randomized but not Treated|0|||
48967678|NCT00555906|157708645|FG003|Phase 2|Randomized but not Treated|0|||
48967679|NCT00555906|157708646|FG004|Phase 2|Randomized but not Treated|2|||
48967680|NCT01179347|157710603|FG000|Double-blind Period (12 Weeks)|Adverse Event|2|||
48967681|NCT01179347|157710604|FG001|Double-blind Period (12 Weeks)|Adverse Event|6|||
48967682|NCT01179347|157710603|FG000|Double-blind Period (12 Weeks)|Protocol Violation|2|||
48967683|NCT01179347|157710604|FG001|Double-blind Period (12 Weeks)|Protocol Violation|0|||
48967684|NCT01179347|157710603|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
48967685|NCT01179347|157710604|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
48967686|NCT01179347|157710603|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|1|||
48967687|NCT01179347|157710604|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|2|||
48967688|NCT01179347|157710603|FG000|Double-blind Period (12 Weeks)|Other|2|||
48967689|NCT01179347|157710604|FG001|Double-blind Period (12 Weeks)|Other|4|||
48967690|NCT01179347|157710603|FG000|Open-label Period (12 Weeks)|Adverse Event|5|||
48967691|NCT01179347|157710604|FG001|Open-label Period (12 Weeks)|Adverse Event|9|||
48967692|NCT01179347|157710603|FG000|Open-label Period (12 Weeks)|Lack of Efficacy|0|||
48967693|NCT01179347|157710604|FG001|Open-label Period (12 Weeks)|Lack of Efficacy|2|||
48967694|NCT01179347|157710603|FG000|Open-label Period (12 Weeks)|Lost to Follow-up|1|||
48967695|NCT01179347|157710604|FG001|Open-label Period (12 Weeks)|Lost to Follow-up|0|||
48967696|NCT01179347|157710603|FG000|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
48967697|NCT01179347|157710604|FG001|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
48967698|NCT01179347|157710603|FG000|Open-label Period (12 Weeks)|Protocol Violation|1|||
48967699|NCT01179347|157710604|FG001|Open-label Period (12 Weeks)|Protocol Violation|0|||
48967700|NCT01179347|157710603|FG000|Open-label Period (12 Weeks)|Other|7|||
48967701|NCT01179347|157710604|FG001|Open-label Period (12 Weeks)|Other|4|||
48967702|NCT00719953|157710605|FG000|Overall Study|Adverse Event|4|||
48967703|NCT01116687|157710606|FG000|Overall Study|Withdrawal by Subject|4|||
48967704|NCT01195831|157710607|FG000|Overall Study|Lost to Follow-up|2|||
48967705|NCT01195831|157710608|FG001|Overall Study|Lost to Follow-up|4|||
48967706|NCT01195831|157710607|FG000|Overall Study|Withdrawal by Subject|2|||
48967707|NCT01195831|157710608|FG001|Overall Study|Withdrawal by Subject|2|||
48967708|NCT01195831|157710607|FG000|Overall Study|Adverse Event|4|||
48967709|NCT01195831|157710608|FG001|Overall Study|Adverse Event|2|||
48967710|NCT01195831|157710607|FG000|Overall Study|Protocol Violation|0|||
48967711|NCT01195831|157710608|FG001|Overall Study|Protocol Violation|2|||
48967712|NCT02670915|157710609|FG000|Overall Study|Withdrawal by Subject|0|||
48967713|NCT02670915|157710610|FG001|Overall Study|Withdrawal by Subject|1|||
48967714|NCT02670915|157710611|FG002|Overall Study|Withdrawal by Subject|4|||
48967715|NCT02670915|157710609|FG000|Overall Study|Withdrawal by parent/guardian|4|||
48868436|NCT02229396|157355539|FG001|Overall Study|Other|18|||
48868437|NCT02229396|157355540|FG002|Overall Study|Other|15|||
48967716|NCT02670915|157710610|FG001|Overall Study|Withdrawal by parent/guardian|4|||
48967717|NCT02670915|157710611|FG002|Overall Study|Withdrawal by parent/guardian|1|||
48967718|NCT02670915|157710609|FG000|Overall Study|Unclassified|0|||
48967719|NCT02670915|157710610|FG001|Overall Study|Unclassified|3|||
48967720|NCT02670915|157710611|FG002|Overall Study|Unclassified|0|||
48967721|NCT01337167|157710612|FG000|Infant Series|Adverse Event|1|||
48868438|NCT02229396|157355538|FG000|Overall Study|Withdrawal by Subject|42|||
48967722|NCT01337167|157710613|FG001|Infant Series|Adverse Event|1|||
48967723|NCT01337167|157710612|FG000|Infant Series|Death|1|||
48967724|NCT01337167|157710613|FG001|Infant Series|Death|1|||
48967725|NCT01337167|157710612|FG000|Infant Series|Lost to Follow-up|13|||
48967726|NCT01337167|157710613|FG001|Infant Series|Lost to Follow-up|7|||
48967727|NCT01337167|157710612|FG000|Infant Series|Non-compliance with study drug|2|||
48967728|NCT01337167|157710613|FG001|Infant Series|Non-compliance with study drug|1|||
48967729|NCT01337167|157710612|FG000|Infant Series|Physician Decision|3|||
48967730|NCT01337167|157710613|FG001|Infant Series|Physician Decision|1|||
48967731|NCT01337167|157710612|FG000|Infant Series|Protocol Violation|22|||
48967732|NCT01337167|157710613|FG001|Infant Series|Protocol Violation|9|||
48967733|NCT01337167|157710612|FG000|Infant Series|Withdrawal by Subject|15|||
48967734|NCT01337167|157710613|FG001|Infant Series|Withdrawal by Subject|4|||
48967735|NCT01337167|157710612|FG000|Infant Series|Randomized but not vaccinated|5|||
48967736|NCT01337167|157710613|FG001|Infant Series|Randomized but not vaccinated|3|||
48967737|NCT01337167|157710612|FG000|Interim Period|Lost to Follow-up|51|||
48967738|NCT01337167|157710613|FG001|Interim Period|Lost to Follow-up|23|||
48967739|NCT01337167|157710612|FG000|Interim Period|Non-compliance with study drug|1|||
48967740|NCT01337167|157710613|FG001|Interim Period|Non-compliance with study drug|0|||
48967741|NCT01337167|157710612|FG000|Interim Period|Physician Decision|6|||
48967742|NCT01337167|157710613|FG001|Interim Period|Physician Decision|3|||
48967743|NCT01337167|157710612|FG000|Interim Period|Protocol Violation|5|||
48967744|NCT01337167|157710613|FG001|Interim Period|Protocol Violation|3|||
48967745|NCT01337167|157710612|FG000|Interim Period|Withdrawal by Subject|18|||
48967746|NCT01337167|157710613|FG001|Interim Period|Withdrawal by Subject|10|||
48967747|NCT01337167|157710612|FG000|Interim Period|Other protocol criterion not met|0|||
48967748|NCT01337167|157710613|FG001|Interim Period|Other protocol criterion not met|1|||
48967749|NCT01337167|157710612|FG000|Toddler Vaccinations|Lost to Follow-up|11|||
48967750|NCT01337167|157710613|FG001|Toddler Vaccinations|Lost to Follow-up|12|||
48967751|NCT01337167|157710612|FG000|Toddler Vaccinations|Protocol Violation|0|||
48967752|NCT01337167|157710613|FG001|Toddler Vaccinations|Protocol Violation|1|||
48967753|NCT01337167|157710612|FG000|Toddler Vaccinations|Withdrawal by Subject|3|||
48967754|NCT01337167|157710613|FG001|Toddler Vaccinations|Withdrawal by Subject|0|||
48967755|NCT03833817|157710614|FG000|Overall Study|Withdrawal by Subject|3|||
48967756|NCT03833817|157710615|FG001|Overall Study|Withdrawal by Subject|3|||
48967757|NCT03833817|157710614|FG000|Overall Study|Lost to Follow-up|3|||
48967758|NCT03833817|157710615|FG001|Overall Study|Lost to Follow-up|3|||
48967759|NCT01975246|157710618|FG000|Overall Study|Adverse Event|2|||
48967760|NCT01975246|157710619|FG001|Overall Study|Adverse Event|1|||
48967761|NCT01975246|157710618|FG000|Overall Study|Lack of Efficacy|1|||
48967762|NCT01975246|157710619|FG001|Overall Study|Lack of Efficacy|0|||
48967763|NCT01975246|157710618|FG000|Overall Study|Protocol Violation|1|||
48967764|NCT01975246|157710619|FG001|Overall Study|Protocol Violation|0|||
48967765|NCT01975246|157710618|FG000|Overall Study|Other than stated|0|||
48967766|NCT01975246|157710619|FG001|Overall Study|Other than stated|1|||
48967767|NCT01646398|157710620|FG000|Overall Study|Withdrawal by Subject|1|||
48967768|NCT01646398|157710621|FG001|Overall Study|Withdrawal by Subject|0|||
48967769|NCT01263093|157710622|FG000|Washout|Physician Decision|1|||
48967770|NCT01263093|157710623|FG001|Washout|Physician Decision|0|||
48967771|NCT01263093|157710622|FG000|Period 2|Adverse Event|1|||
48967772|NCT01263093|157710623|FG001|Period 2|Adverse Event|0|||
48967773|NCT02174861|157710628|FG000|Overall Study|Decision by sponsor|8|||
48967774|NCT02174861|157710628|FG000|Overall Study|Withdrawal by Subject|124|||
48967775|NCT02174861|157710628|FG000|Overall Study|Lost to Follow-up|26|||
48967776|NCT00605722|157710629|FG000|Overall Study|Adverse Event|6|||
48967777|NCT00605722|157710629|FG000|Overall Study|Insufficient therapeutic response|44|||
48967778|NCT00605722|157710629|FG000|Overall Study|Failure to return|1|||
48967779|NCT00839423|157710632|FG000|Overall Study|Adverse Event|4|||
48967780|NCT00839423|157710633|FG001|Overall Study|Adverse Event|3|||
48967781|NCT00839423|157710634|FG002|Overall Study|Adverse Event|7|||
48967782|NCT00839423|157710635|FG003|Overall Study|Adverse Event|16|||
48667202|NCT05239221|156634178|FG013|Overall Study|Adverse Event|0|||
48967783|NCT00839423|157710632|FG000|Overall Study|Lack of Efficacy|6|||
48967784|NCT00839423|157710633|FG001|Overall Study|Lack of Efficacy|6|||
48967785|NCT00839423|157710634|FG002|Overall Study|Lack of Efficacy|3|||
48967786|NCT00839423|157710635|FG003|Overall Study|Lack of Efficacy|2|||
48967787|NCT00839423|157710632|FG000|Overall Study|Non-compliance|0|||
48967788|NCT00839423|157710633|FG001|Overall Study|Non-compliance|0|||
48667203|NCT05239221|156634179|FG014|Overall Study|Adverse Event|0|||
48967789|NCT00839423|157710634|FG002|Overall Study|Non-compliance|0|||
48967790|NCT00839423|157710635|FG003|Overall Study|Non-compliance|1|||
48967791|NCT00839423|157710632|FG000|Overall Study|Protocol Violation|0|||
48967792|NCT00839423|157710633|FG001|Overall Study|Protocol Violation|1|||
48967793|NCT00839423|157710634|FG002|Overall Study|Protocol Violation|2|||
48967794|NCT00839423|157710635|FG003|Overall Study|Protocol Violation|0|||
48967795|NCT00839423|157710632|FG000|Overall Study|Withdrawal of consent|4|||
48967796|NCT00839423|157710633|FG001|Overall Study|Withdrawal of consent|0|||
48967797|NCT00839423|157710634|FG002|Overall Study|Withdrawal of consent|4|||
48667204|NCT05239221|156634180|FG015|Overall Study|Adverse Event|0|||
48667205|NCT05239221|156634165|FG000|Overall Study|Withdrawal by Subject|0|||
48667206|NCT05239221|156634166|FG001|Overall Study|Withdrawal by Subject|0|||
48667207|NCT05239221|156634167|FG002|Overall Study|Withdrawal by Subject|0|||
48667208|NCT05239221|156634168|FG003|Overall Study|Withdrawal by Subject|0|||
48667209|NCT05239221|156634169|FG004|Overall Study|Withdrawal by Subject|0|||
48667210|NCT05239221|156634170|FG005|Overall Study|Withdrawal by Subject|0|||
48667211|NCT05239221|156634171|FG006|Overall Study|Withdrawal by Subject|0|||
48667212|NCT05239221|156634172|FG007|Overall Study|Withdrawal by Subject|0|||
48667213|NCT05239221|156634173|FG008|Overall Study|Withdrawal by Subject|0|||
48667214|NCT05239221|156634174|FG009|Overall Study|Withdrawal by Subject|0|||
48667215|NCT05239221|156634175|FG010|Overall Study|Withdrawal by Subject|1|||
48667216|NCT05239221|156634176|FG011|Overall Study|Withdrawal by Subject|0|||
48667217|NCT05239221|156634177|FG012|Overall Study|Withdrawal by Subject|0|||
48667218|NCT05239221|156634178|FG013|Overall Study|Withdrawal by Subject|0|||
48667219|NCT05239221|156634179|FG014|Overall Study|Withdrawal by Subject|0|||
48667220|NCT05239221|156634180|FG015|Overall Study|Withdrawal by Subject|1|||
48667221|NCT00652899|156634181|FG000|Overall Study|Death|1|||
48667222|NCT00652899|156634181|FG000|Overall Study|Treating physician decision|1|||
48967798|NCT00839423|157710635|FG003|Overall Study|Withdrawal of consent|1|||
48967799|NCT00839423|157710632|FG000|Overall Study|Lost to Follow-up|1|||
48967800|NCT00839423|157710633|FG001|Overall Study|Lost to Follow-up|0|||
48967801|NCT00839423|157710634|FG002|Overall Study|Lost to Follow-up|1|||
48967802|NCT00839423|157710635|FG003|Overall Study|Lost to Follow-up|0|||
48967803|NCT00839423|157710632|FG000|Overall Study|Administrative or other reasons|3|||
48967804|NCT00839423|157710633|FG001|Overall Study|Administrative or other reasons|0|||
48967805|NCT00839423|157710634|FG002|Overall Study|Administrative or other reasons|1|||
48967806|NCT00839423|157710635|FG003|Overall Study|Administrative or other reasons|0|||
48967807|NCT00971425|157710636|FG000|Overall Study|Adverse Event|1|||
48967808|NCT00971425|157710637|FG001|Overall Study|Adverse Event|1|||
48967809|NCT00971425|157710636|FG000|Overall Study|Withdrawal by Subject|0|||
48967810|NCT00971425|157710637|FG001|Overall Study|Withdrawal by Subject|1|||
48967811|NCT00120289|157710640|FG000|Overall Study|Death|96|||
48967812|NCT00120289|157710641|FG001|Overall Study|Death|82|||
48967813|NCT00120289|157710640|FG000|Overall Study|Lost to Follow-up|11|||
48967814|NCT00120289|157710641|FG001|Overall Study|Lost to Follow-up|14|||
48967815|NCT00120289|157710640|FG000|Overall Study|Withdrawal by Subject|14|||
48967816|NCT00120289|157710641|FG001|Overall Study|Withdrawal by Subject|13|||
48967817|NCT01711541|157710643|FG000|Overall Study|Cancel prior to treatment|0|||
48967818|NCT01711541|157710644|FG001|Overall Study|Cancel prior to treatment|0|||
48967819|NCT01711541|157710645|FG002|Overall Study|Cancel prior to treatment|0|||
48967820|NCT01711541|157710646|FG003|Overall Study|Cancel prior to treatment|1|||
48967821|NCT01711541|157710647|FG004|Overall Study|Cancel prior to treatment|0|||
48967822|NCT01711541|157710643|FG000|Overall Study|Ineligible|0|||
48967823|NCT01711541|157710644|FG001|Overall Study|Ineligible|1|||
48967824|NCT01711541|157710645|FG002|Overall Study|Ineligible|0|||
48967825|NCT01711541|157710646|FG003|Overall Study|Ineligible|0|||
48967826|NCT01711541|157710647|FG004|Overall Study|Ineligible|0|||
48967827|NCT00877006|157710650|FG000|Treatment Period|Death|2|||
48967828|NCT00877006|157710651|FG001|Treatment Period|Death|1|||
48967829|NCT00877006|157710650|FG000|Treatment Period|Adverse Event|10|||
48967830|NCT00877006|157710651|FG001|Treatment Period|Adverse Event|3|||
48967831|NCT00877006|157710650|FG000|Treatment Period|Withdrawal by Subject|2|||
48967832|NCT00877006|157710651|FG001|Treatment Period|Withdrawal by Subject|3|||
48967833|NCT00877006|157710650|FG000|Treatment Period|Protocol Violation|1|||
48967834|NCT00877006|157710651|FG001|Treatment Period|Protocol Violation|0|||
48967835|NCT00877006|157710650|FG000|Treatment Period|Lost to Follow-up|0|||
48967836|NCT00877006|157710651|FG001|Treatment Period|Lost to Follow-up|1|||
48967837|NCT00877006|157710650|FG000|Treatment Period|Disease Progression|1|||
48967838|NCT00877006|157710651|FG001|Treatment Period|Disease Progression|2|||
48967839|NCT00877006|157710650|FG000|Treatment Period|Started New Treatment Regimen|2|||
48967840|NCT00877006|157710651|FG001|Treatment Period|Started New Treatment Regimen|5|||
48967841|NCT00877006|157710650|FG000|Treatment Period|Other|4|||
48967842|NCT00877006|157710651|FG001|Treatment Period|Other|4|||
48967843|NCT00877006|157710650|FG000|Treatment Period|Randomized but Not Treated|3|||
48667223|NCT03461406|156634182|FG000|Overall Study|Death|1|||
48667224|NCT03461406|156634183|FG001|Overall Study|Death|2|||
48967844|NCT00877006|157710651|FG001|Treatment Period|Randomized but Not Treated|8|||
48967845|NCT00877006|157710650|FG000|Long-Term Follow-up Period|Withdrawal by Subject|12|||
48967846|NCT00877006|157710651|FG001|Long-Term Follow-up Period|Withdrawal by Subject|19|||
48967847|NCT00877006|157710650|FG000|Long-Term Follow-up Period|Lost to Follow-up|8|||
48967848|NCT00877006|157710651|FG001|Long-Term Follow-up Period|Lost to Follow-up|9|||
48967849|NCT00877006|157710650|FG000|Long-Term Follow-up Period|Death|26|||
48967850|NCT00877006|157710651|FG001|Long-Term Follow-up Period|Death|18|||
48667225|NCT03461406|156634182|FG000|Overall Study|Consent Withdrawn by Participant|0|||
48667226|NCT03461406|156634183|FG001|Overall Study|Consent Withdrawn by Participant|1|||
48667227|NCT03461406|156634182|FG000|Overall Study|Screen Failure|3|||
48868439|NCT02229396|157355539|FG001|Overall Study|Withdrawal by Subject|28|||
48868440|NCT02229396|157355540|FG002|Overall Study|Withdrawal by Subject|41|||
48868441|NCT02229396|157355538|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
48868442|NCT02229396|157355539|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
48868443|NCT02229396|157355540|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
48868444|NCT02229396|157355538|FG000|Overall Study|Withdrew; No Record on Termination Page|2|||
48868445|NCT02229396|157355539|FG001|Overall Study|Withdrew; No Record on Termination Page|0|||
48868446|NCT02229396|157355540|FG002|Overall Study|Withdrew; No Record on Termination Page|1|||
48868447|NCT05006417|157355541|FG000|Overall Study|PI terminated study for problems with strength testing equipment|1|||
48868448|NCT03681353|157355544|FG000|Overall Study|Lost to Follow-up|2|||
48868449|NCT03681353|157355544|FG000|Overall Study|Withdrawal by Subject|3|||
48868450|NCT03681353|157355544|FG000|Overall Study|withdrawn by PI|2|||
48868451|NCT00726388|157355545|FG000|Overall Study|Withdrawal by Subject|5|||
48868452|NCT00726388|157355545|FG000|Overall Study|Adverse Event|3|||
48868453|NCT00726388|157355545|FG000|Overall Study|Lost to Follow-up|10|||
48868454|NCT00726388|157355545|FG000|Overall Study|Participants Non-compliant With Study Procedures|5|||
48868455|NCT00726388|157355545|FG000|Overall Study|Other|5|||
48868456|NCT00726388|157355545|FG000|Overall Study|Enrolled, Not Treated|79|||
48868457|NCT01011049|157355548|FG000|Overall Study|Protocol Violation|0|||
48868458|NCT01011049|157355549|FG001|Overall Study|Protocol Violation|0|||
48868459|NCT01011049|157355550|FG002|Overall Study|Protocol Violation|2|||
48868460|NCT01011049|157355551|FG003|Overall Study|Protocol Violation|0|||
48868461|NCT01011049|157355548|FG000|Overall Study|Lost to Follow-up|1|||
48868462|NCT01011049|157355549|FG001|Overall Study|Lost to Follow-up|2|||
48868463|NCT01011049|157355550|FG002|Overall Study|Lost to Follow-up|1|||
48868464|NCT01011049|157355551|FG003|Overall Study|Lost to Follow-up|0|||
48868465|NCT01011049|157355548|FG000|Overall Study|Withdrawal by Subject|0|||
48868466|NCT01011049|157355549|FG001|Overall Study|Withdrawal by Subject|0|||
48868467|NCT01011049|157355550|FG002|Overall Study|Withdrawal by Subject|1|||
48868468|NCT01011049|157355551|FG003|Overall Study|Withdrawal by Subject|0|||
48868469|NCT02435381|157355552|FG000|Overall Study|Lost to Follow-up|2|||
48868470|NCT02435381|157355553|FG001|Overall Study|Lost to Follow-up|1|||
48868471|NCT02396758|157355554|FG000|Overall Study|Withdrawal by Subject|2|||
48868472|NCT02396758|157355555|FG001|Overall Study|Withdrawal by Subject|0|||
48868473|NCT02396758|157355556|FG002|Overall Study|Withdrawal by Subject|0|||
48868474|NCT02396758|157355557|FG003|Overall Study|Withdrawal by Subject|1|||
48868475|NCT02396758|157355554|FG000|Overall Study|Lost to Follow-up|8|||
48868476|NCT02396758|157355555|FG001|Overall Study|Lost to Follow-up|5|||
48868477|NCT02396758|157355556|FG002|Overall Study|Lost to Follow-up|3|||
48868478|NCT02396758|157355557|FG003|Overall Study|Lost to Follow-up|3|||
48868479|NCT02396758|157355554|FG000|Overall Study|Death|1|||
48868480|NCT02396758|157355555|FG001|Overall Study|Death|1|||
48868481|NCT02396758|157355556|FG002|Overall Study|Death|0|||
48868482|NCT02396758|157355557|FG003|Overall Study|Death|1|||
48868483|NCT02396758|157355554|FG000|Overall Study|Randomized but not treated|1|||
48868484|NCT02396758|157355555|FG001|Overall Study|Randomized but not treated|0|||
48868485|NCT02396758|157355556|FG002|Overall Study|Randomized but not treated|1|||
48868486|NCT02396758|157355557|FG003|Overall Study|Randomized but not treated|0|||
48868487|NCT02499835|157355558|FG000|Overall Study|Withdrawal by Subject|1|||
48868488|NCT02499835|157355559|FG001|Overall Study|Withdrawal by Subject|0|||
48868489|NCT02499835|157355560|FG002|Overall Study|Withdrawal by Subject|0|||
48868490|NCT02499835|157355561|FG003|Overall Study|Withdrawal by Subject|1|||
48868491|NCT02499835|157355558|FG000|Overall Study|Physician Decision|0|||
48868492|NCT02499835|157355559|FG001|Overall Study|Physician Decision|3|||
48868493|NCT02499835|157355560|FG002|Overall Study|Physician Decision|18|||
48868494|NCT02499835|157355561|FG003|Overall Study|Physician Decision|7|||
48868495|NCT02499835|157355558|FG000|Overall Study|Adverse Event|0|||
48868496|NCT02499835|157355559|FG001|Overall Study|Adverse Event|0|||
48868497|NCT02499835|157355560|FG002|Overall Study|Adverse Event|0|||
48868498|NCT02499835|157355561|FG003|Overall Study|Adverse Event|1|||
48868499|NCT02499835|157355558|FG000|Overall Study|Disease progression|2|||
48868500|NCT02499835|157355559|FG001|Overall Study|Disease progression|1|||
48868501|NCT02499835|157355560|FG002|Overall Study|Disease progression|0|||
48868502|NCT02499835|157355561|FG003|Overall Study|Disease progression|7|||
48868503|NCT00666835|157355562|FG000|Overall Study|Withdrawal by Subject|5|||
48868504|NCT00666835|157355563|FG001|Overall Study|Withdrawal by Subject|2|||
48868505|NCT00666835|157355562|FG000|Overall Study|Lack of Efficacy|0|||
48868506|NCT00666835|157355563|FG001|Overall Study|Lack of Efficacy|1|||
48868507|NCT00666835|157355562|FG000|Overall Study|Incl./excl. not fulfilled|7|||
48868508|NCT00666835|157355563|FG001|Overall Study|Incl./excl. not fulfilled|2|||
48868509|NCT00666835|157355562|FG000|Overall Study|Adverse Event|7|||
48868510|NCT00666835|157355563|FG001|Overall Study|Adverse Event|6|||
48868511|NCT00666835|157355562|FG000|Overall Study|Protocol Violation|2|||
49015473|NCT01393990|157893787|FG017|Overall Study|Progressive Disease|0|||
48868512|NCT00666835|157355563|FG001|Overall Study|Protocol Violation|0|||
48868513|NCT00666835|157355562|FG000|Overall Study|Death|15|||
48868514|NCT00666835|157355563|FG001|Overall Study|Death|4|||
48868515|NCT00666835|157355562|FG000|Overall Study|Kidney Transplantation (NTX)|10|||
48868516|NCT00666835|157355563|FG001|Overall Study|Kidney Transplantation (NTX)|2|||
48967851|NCT00877006|157710650|FG000|Long-Term Follow-up Period|Other|7|||
48667228|NCT03461406|156634183|FG001|Overall Study|Screen Failure|1|||
48667229|NCT03461406|156634182|FG000|Overall Study|Reason not Specified|1|||
48667230|NCT03461406|156634183|FG001|Overall Study|Reason not Specified|3|||
48667231|NCT03461406|156634182|FG000|Overall Study|Lost to Follow-up|3|||
48667232|NCT03461406|156634183|FG001|Overall Study|Lost to Follow-up|0|||
48667233|NCT02639338|156634184|FG000|Overall Study|Lost to Follow-up|2|||
48667234|NCT02639338|156634185|FG001|Overall Study|Lost to Follow-up|2|||
48667235|NCT02639338|156634184|FG000|Overall Study|Withdrew Consent|1|||
48667236|NCT02639338|156634185|FG001|Overall Study|Withdrew Consent|2|||
48667237|NCT02639338|156634184|FG000|Overall Study|Death|1|||
48667238|NCT02639338|156634185|FG001|Overall Study|Death|0|||
48667239|NCT02639338|156634184|FG000|Overall Study|Randomized but Not Treated|0|||
48667240|NCT02639338|156634185|FG001|Overall Study|Randomized but Not Treated|1|||
48967852|NCT00877006|157710651|FG001|Long-Term Follow-up Period|Other|9|||
48967853|NCT02310906|157710654|FG000|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
48667241|NCT02715726|156634189|FG000|Overall Study|Adverse Event|2|||
48667242|NCT02715726|156634190|FG001|Overall Study|Adverse Event|6|||
48667243|NCT02715726|156634189|FG000|Overall Study|Protocol Violation|1|||
48667244|NCT02715726|156634190|FG001|Overall Study|Protocol Violation|0|||
48667245|NCT02715726|156634189|FG000|Overall Study|Death|2|||
48667246|NCT02715726|156634190|FG001|Overall Study|Death|1|||
48667247|NCT02715726|156634189|FG000|Overall Study|Participant moved|1|||
48758294|NCT00680745|156962763|FG003|Overall Study|Subject No Longer Meets Study Criteria|2|||
48758295|NCT00680745|156962760|FG000|Overall Study|False Treatment|0|||
48758296|NCT00680745|156962761|FG001|Overall Study|False Treatment|1|||
48758297|NCT00680745|156962762|FG002|Overall Study|False Treatment|3|||
48758298|NCT00680745|156962763|FG003|Overall Study|False Treatment|0|||
48667248|NCT02715726|156634190|FG001|Overall Study|Participant moved|3|||
48667249|NCT02715726|156634189|FG000|Overall Study|Other than specified above|11|||
48667250|NCT02715726|156634190|FG001|Overall Study|Other than specified above|15|||
48667251|NCT02715726|156634189|FG000|Overall Study|Randomized but not treated|1|||
48667252|NCT02715726|156634190|FG001|Overall Study|Randomized but not treated|2|||
48758299|NCT01574612|156962764|FG000|Overall Study|Adverse Event|3|||
48758300|NCT01574612|156962764|FG000|Overall Study|non compliant with drug|2|||
48758301|NCT01574612|156962764|FG000|Overall Study|Withdrawal by Subject|1|||
48758302|NCT01574612|156962764|FG000|Overall Study|Lost to Follow-up|2|||
48758303|NCT02604212|156962766|FG000|Overall Study|Study Terminated by Sponsor|2|||
48758304|NCT02604212|156962767|FG001|Overall Study|Study Terminated by Sponsor|1|||
48758305|NCT02604212|156962768|FG002|Overall Study|Study Terminated by Sponsor|3|||
48758306|NCT02604212|156962769|FG003|Overall Study|Study Terminated by Sponsor|3|||
48758307|NCT02604212|156962766|FG000|Overall Study|Withdrawal by Subject|0|||
48758308|NCT02604212|156962767|FG001|Overall Study|Withdrawal by Subject|0|||
48758309|NCT02604212|156962768|FG002|Overall Study|Withdrawal by Subject|1|||
48758310|NCT02604212|156962769|FG003|Overall Study|Withdrawal by Subject|0|||
48758311|NCT01892501|156962774|FG000|Overall Study|Protocol Violation|2|||
48758312|NCT01892501|156962774|FG000|Overall Study|Puncture not carried out|9|||
48758313|NCT01892501|156962774|FG000|Overall Study|Radiological monitoring not carried out|5|||
48758314|NCT01892501|156962774|FG000|Overall Study|Non-contributory histological result|12|||
48758315|NCT04339296|156962778|FG000|Overall Study|Refuse to participate after allocation|1|||
48758316|NCT04339296|156962779|FG001|Overall Study|Refuse to participate after allocation|1|||
48758317|NCT04339296|156962778|FG000|Overall Study|Withdrew after completion of baseline|2|||
48758318|NCT04339296|156962779|FG001|Overall Study|Withdrew after completion of baseline|1|||
48667253|NCT01565941|156634191|FG000|Overall Study|Withdrawn by parent/guardian|3|||
48667254|NCT01565941|156634192|FG001|Overall Study|Withdrawn by parent/guardian|2|||
48758319|NCT04339296|156962778|FG000|Overall Study|Lost to Follow-up|0|||
48868517|NCT00666835|157355562|FG000|Overall Study|Hemoglobulin concentration|4|||
48868518|NCT00666835|157355563|FG001|Overall Study|Hemoglobulin concentration|3|||
48868519|NCT00666835|157355562|FG000|Overall Study|Planned operation|2|||
48868520|NCT00666835|157355563|FG001|Overall Study|Planned operation|0|||
48868521|NCT00666835|157355562|FG000|Overall Study|Physician Decision|1|||
48868522|NCT00666835|157355563|FG001|Overall Study|Physician Decision|2|||
48868523|NCT02986659|157355566|FG000|First Intervention Period|Adverse Event|3|||
48868524|NCT02986659|157355567|FG001|First Intervention Period|Adverse Event|1|||
48868525|NCT02986659|157355566|FG000|First Intervention Period|Lost to Follow-up|1|||
48868526|NCT02986659|157355567|FG001|First Intervention Period|Lost to Follow-up|0|||
48868527|NCT02986659|157355566|FG000|First Intervention Period|Withdrawal by Subject|0|||
48868528|NCT02986659|157355567|FG001|First Intervention Period|Withdrawal by Subject|1|||
48868529|NCT02986659|157355566|FG000|Second Intervention Period|Adverse Event|0|||
48868530|NCT02986659|157355567|FG001|Second Intervention Period|Adverse Event|6|||
48868531|NCT02973477|157355573|FG000|First Intervention|Lost to Follow-up|0|||
48868532|NCT02973477|157355574|FG001|First Intervention|Lost to Follow-up|2|||
48868533|NCT02973477|157355573|FG000|Washout|Withdrawal by Subject|1|||
48868534|NCT02973477|157355574|FG001|Washout|Withdrawal by Subject|0|||
48967854|NCT02310906|157710655|FG001|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
48667255|NCT01565941|156634191|FG000|Overall Study|Randomized; did not receive intevention|8|||
48667256|NCT01565941|156634192|FG001|Overall Study|Randomized; did not receive intevention|2|||
48667257|NCT03541187|156634195|FG000|Overall Study|Lost to Follow-up|2|||
48667258|NCT03541187|156634196|FG001|Overall Study|Lost to Follow-up|6|||
48667259|NCT03541187|156634195|FG000|Overall Study|Pregnancy|0|||
48667260|NCT03541187|156634196|FG001|Overall Study|Pregnancy|1|||
48667261|NCT03541187|156634195|FG000|Overall Study|Withdrawal by Subject|6|||
48667262|NCT03541187|156634196|FG001|Overall Study|Withdrawal by Subject|2|||
48758320|NCT04339296|156962779|FG001|Overall Study|Lost to Follow-up|4|||
48758321|NCT04339296|156962778|FG000|Overall Study|Discontinued intervention|5|||
48758322|NCT04339296|156962779|FG001|Overall Study|Discontinued intervention|3|||
48667263|NCT03541187|156634195|FG000|Overall Study|Moved out of town|1|||
48667264|NCT03541187|156634196|FG001|Overall Study|Moved out of town|0|||
48667265|NCT03541187|156634195|FG000|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
48667266|NCT03541187|156634196|FG001|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
48667267|NCT03541187|156634195|FG000|Overall Study|Did not meet randomization criteria|1|||
48667268|NCT03541187|156634196|FG001|Overall Study|Did not meet randomization criteria|1|||
48667269|NCT03541187|156634195|FG000|Overall Study|Potential inability to tolerate maintenance dose|1|||
48667270|NCT03541187|156634196|FG001|Overall Study|Potential inability to tolerate maintenance dose|0|||
48667271|NCT03541187|156634195|FG000|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|0|||
48758323|NCT03311659|156962780|FG000|Overall Study|Protocol Violation|1|||
48758324|NCT03492216|156962785|FG000|Overall Study|Death|1|||
48758325|NCT03492216|156962786|FG001|Overall Study|Death|0|||
48758326|NCT03492216|156962787|FG002|Overall Study|Death|4|||
48758327|NCT03492216|156962788|FG003|Overall Study|Death|0|||
48758328|NCT03492216|156962785|FG000|Overall Study|Withdrawal by Subject|5|||
48758329|NCT03492216|156962786|FG001|Overall Study|Withdrawal by Subject|3|||
48758330|NCT03492216|156962787|FG002|Overall Study|Withdrawal by Subject|1|||
48758331|NCT03492216|156962788|FG003|Overall Study|Withdrawal by Subject|1|||
48758332|NCT03492216|156962785|FG000|Overall Study|Lost to Follow-up|9|||
48758333|NCT03492216|156962786|FG001|Overall Study|Lost to Follow-up|2|||
48758334|NCT03492216|156962787|FG002|Overall Study|Lost to Follow-up|7|||
48758335|NCT03492216|156962788|FG003|Overall Study|Lost to Follow-up|8|||
48758336|NCT03492216|156962785|FG000|Overall Study|Moved|5|||
48758337|NCT03492216|156962786|FG001|Overall Study|Moved|3|||
48758338|NCT03492216|156962787|FG002|Overall Study|Moved|3|||
48758339|NCT03492216|156962788|FG003|Overall Study|Moved|5|||
48758340|NCT03492216|156962785|FG000|Overall Study|Too ill|0|||
48758341|NCT03492216|156962786|FG001|Overall Study|Too ill|1|||
48758342|NCT03492216|156962787|FG002|Overall Study|Too ill|0|||
48758343|NCT03492216|156962788|FG003|Overall Study|Too ill|0|||
48758344|NCT03492216|156962785|FG000|Overall Study|Incarcerated|0|||
48758345|NCT03492216|156962786|FG001|Overall Study|Incarcerated|0|||
48758346|NCT03492216|156962787|FG002|Overall Study|Incarcerated|2|||
48758347|NCT03492216|156962788|FG003|Overall Study|Incarcerated|0|||
48758348|NCT02810392|156962790|FG000|Overall Study|Subject too ill to continue|1|||
48758349|NCT02810392|156962791|FG001|Overall Study|Subject too ill to continue|0|||
48758350|NCT02810392|156962790|FG000|Overall Study|COVID 19 research restrictions|0|||
48758351|NCT02810392|156962791|FG001|Overall Study|COVID 19 research restrictions|1|||
48758352|NCT00453544|156962792|FG000|Overall Study|Withdrawal by Subject|1|||
48758353|NCT00453544|156962793|FG001|Overall Study|Withdrawal by Subject|0|||
48868535|NCT02973477|157355573|FG000|Second Intervention|Lost to Follow-up|1|||
48868536|NCT02973477|157355574|FG001|Second Intervention|Lost to Follow-up|0|||
48868537|NCT01885936|157355575|FG000|Overall Study|Withdrawal by Subject|1|||
48868538|NCT01885936|157355576|FG001|Overall Study|Withdrawal by Subject|0|||
48868539|NCT02853305|157355577|FG000|Overall Study|Death|287|||
48868540|NCT02853305|157355578|FG001|Overall Study|Death|249|||
48868541|NCT02853305|157355579|FG002|Overall Study|Death|300|||
48868542|NCT02853305|157355577|FG000|Overall Study|Withdrawal by Subject|2|||
48868543|NCT02853305|157355578|FG001|Overall Study|Withdrawal by Subject|8|||
48868544|NCT02853305|157355579|FG002|Overall Study|Withdrawal by Subject|3|||
48868545|NCT02853305|157355577|FG000|Overall Study|Transferred to Extension Study|46|||
48868546|NCT02853305|157355578|FG001|Overall Study|Transferred to Extension Study|30|||
48868547|NCT02853305|157355579|FG002|Overall Study|Transferred to Extension Study|25|||
48868548|NCT02853305|157355577|FG000|Overall Study|Did Not Continue on Extension Study|16|||
48868549|NCT02853305|157355578|FG001|Overall Study|Did Not Continue on Extension Study|20|||
48868550|NCT02853305|157355579|FG002|Overall Study|Did Not Continue on Extension Study|24|||
48868551|NCT01093222|157355583|FG000|Overall Study|Ineligible|6|||
48868552|NCT01093222|157355583|FG000|Overall Study|Adverse Event|7|||
48868553|NCT01093222|157355583|FG000|Overall Study|Progression/relapse|24|||
48868554|NCT01093222|157355583|FG000|Overall Study|Death|2|||
48868555|NCT01093222|157355583|FG000|Overall Study|Not protocol specified|1|||
48868556|NCT01281917|157355586|FG000|Overall Study|Withdrawal by Subject|1|||
48868557|NCT03260894|157355591|FG000|Overall Study|Death|6|||
48868558|NCT03260894|157355592|FG001|Overall Study|Death|8|||
48868559|NCT03260894|157355591|FG000|Overall Study|Withdrawal by Subject|4|||
48967855|NCT02310906|157710656|FG002|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
48967856|NCT02310906|157710657|FG003|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2|||
48967857|NCT02310906|157710654|FG000|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
48967858|NCT02310906|157710655|FG001|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
48967859|NCT02310906|157710656|FG002|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2|||
48967860|NCT02310906|157710657|FG003|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4|||
48967861|NCT02310906|157710654|FG000|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
48967862|NCT02310906|157710655|FG001|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
48967863|NCT02310906|157710656|FG002|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
48967864|NCT02310906|157710657|FG003|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1|||
48967865|NCT02310906|157710654|FG000|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
48967866|NCT02310906|157710655|FG001|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
48967867|NCT02310906|157710656|FG002|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
48967868|NCT02310906|157710657|FG003|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1|||
48967869|NCT03819218|157710658|FG000|Overall Study|Protocol Violation|1|||
48667272|NCT03541187|156634196|FG001|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|1|||
48667273|NCT00973102|156634197|FG000|Overall Study|Protocol Violation|1|||
48667274|NCT00973102|156634198|FG001|Overall Study|Protocol Violation|0|||
48667275|NCT00973102|156634197|FG000|Overall Study|Prisoner|0|||
48667276|NCT00973102|156634198|FG001|Overall Study|Prisoner|1|||
48667277|NCT03099148|156634199|FG000|Wash-out|scheduling conflict|0|||
48667278|NCT03099148|156634200|FG001|Wash-out|scheduling conflict|1|||
48667279|NCT03099148|156634201|FG002|Wash-out|scheduling conflict|0|||
48667280|NCT03099148|156634202|FG003|Wash-out|scheduling conflict|0|||
48667281|NCT03099148|156634199|FG000|Wash-out|Adverse Event|0|||
48667282|NCT03099148|156634200|FG001|Wash-out|Adverse Event|1|||
48667283|NCT03099148|156634201|FG002|Wash-out|Adverse Event|0|||
48667284|NCT03099148|156634202|FG003|Wash-out|Adverse Event|0|||
48667285|NCT03474081|156634208|FG000|Overall Study|Adverse Event|6|||
48667286|NCT03474081|156634209|FG001|Overall Study|Adverse Event|3|||
48667287|NCT03474081|156634208|FG000|Overall Study|Lost to Follow-up|2|||
48967870|NCT02016898|157710660|FG000|Overall Study|Death|1|||
48967871|NCT02016898|157710661|FG001|Overall Study|Death|1|||
48967872|NCT02016898|157710660|FG000|Overall Study|Lost to Follow-up|4|||
48967873|NCT02016898|157710661|FG001|Overall Study|Lost to Follow-up|4|||
48967874|NCT00270998|157710669|FG000|3 Month Follow-up|Adverse Event|1|||
48967875|NCT00270998|157710670|FG001|3 Month Follow-up|Adverse Event|0|||
48967876|NCT00270998|157710671|FG002|3 Month Follow-up|Adverse Event|0|||
48967877|NCT00270998|157710669|FG000|3 Month Follow-up|Lack of Efficacy|1|||
48967878|NCT00270998|157710670|FG001|3 Month Follow-up|Lack of Efficacy|2|||
48967879|NCT00270998|157710671|FG002|3 Month Follow-up|Lack of Efficacy|1|||
48967880|NCT00270998|157710669|FG000|3 Month Follow-up|Withdrawal by Subject|11|||
48967881|NCT00270998|157710670|FG001|3 Month Follow-up|Withdrawal by Subject|14|||
48967882|NCT00270998|157710671|FG002|3 Month Follow-up|Withdrawal by Subject|15|||
48967883|NCT00270998|157710669|FG000|3 Month Follow-up|Pessary did not fit|12|||
48967884|NCT00270998|157710670|FG001|3 Month Follow-up|Pessary did not fit|0|||
48967885|NCT00270998|157710671|FG002|3 Month Follow-up|Pessary did not fit|0|||
48967886|NCT00270998|157710669|FG000|3 Month Follow-up|Personal/family health|1|||
48967887|NCT00270998|157710670|FG001|3 Month Follow-up|Personal/family health|1|||
48967888|NCT00270998|157710671|FG002|3 Month Follow-up|Personal/family health|0|||
48967889|NCT00270998|157710669|FG000|3 Month Follow-up|Received/desired alternate treatment|13|||
48667288|NCT03474081|156634209|FG001|Overall Study|Lost to Follow-up|1|||
48667289|NCT03474081|156634208|FG000|Overall Study|Physician Decision|3|||
48667290|NCT03474081|156634209|FG001|Overall Study|Physician Decision|2|||
48667291|NCT03474081|156634208|FG000|Overall Study|Withdrawal by Subject|5|||
48667292|NCT03474081|156634209|FG001|Overall Study|Withdrawal by Subject|7|||
48667293|NCT03474081|156634208|FG000|Overall Study|Investigator site closed|1|||
48667294|NCT03474081|156634209|FG001|Overall Study|Investigator site closed|0|||
48667295|NCT02210091|156634211|FG000|Overall Study|Physician Decision|0|||
48667296|NCT02210091|156634212|FG001|Overall Study|Physician Decision|1|||
48967890|NCT00270998|157710670|FG001|3 Month Follow-up|Received/desired alternate treatment|5|||
48967891|NCT00270998|157710671|FG002|3 Month Follow-up|Received/desired alternate treatment|2|||
48967892|NCT00270998|157710669|FG000|12 Month Follow-up|Lack of Efficacy|5|||
48967893|NCT00270998|157710670|FG001|12 Month Follow-up|Lack of Efficacy|4|||
48967894|NCT00270998|157710671|FG002|12 Month Follow-up|Lack of Efficacy|3|||
48667297|NCT02210091|156634211|FG000|Overall Study|Withdrawal by Sponsor|0|||
48967895|NCT00270998|157710669|FG000|12 Month Follow-up|Withdrawal by Subject|7|||
48967896|NCT00270998|157710670|FG001|12 Month Follow-up|Withdrawal by Subject|12|||
48967897|NCT00270998|157710671|FG002|12 Month Follow-up|Withdrawal by Subject|16|||
48667298|NCT02210091|156634212|FG001|Overall Study|Withdrawal by Sponsor|1|||
48667299|NCT03159104|156634213|FG000|Overall Study|Violation of inclusion criteria|1|||
48667300|NCT03159104|156634214|FG001|Overall Study|Violation of inclusion criteria|2|||
48667301|NCT01638559|156634215|FG000|Overall Study|Lost to Follow-up|1|||
48667302|NCT01638559|156634215|FG000|Overall Study|Withdrawal by Subject|1|||
48967898|NCT00270998|157710669|FG000|12 Month Follow-up|Pessary did not fit|1|||
48967899|NCT00270998|157710670|FG001|12 Month Follow-up|Pessary did not fit|0|||
48967900|NCT00270998|157710671|FG002|12 Month Follow-up|Pessary did not fit|0|||
48967901|NCT00270998|157710669|FG000|12 Month Follow-up|Personal/family health|0|||
48967902|NCT00270998|157710670|FG001|12 Month Follow-up|Personal/family health|5|||
48967903|NCT00270998|157710671|FG002|12 Month Follow-up|Personal/family health|1|||
48967904|NCT00270998|157710669|FG000|12 Month Follow-up|Received/desired alternate treatment|1|||
48967905|NCT00270998|157710670|FG001|12 Month Follow-up|Received/desired alternate treatment|4|||
48967906|NCT00270998|157710671|FG002|12 Month Follow-up|Received/desired alternate treatment|1|||
48967907|NCT03395223|157710672|FG000|Overall Study|Lost to Follow-up|3|||
48967908|NCT03395223|157710672|FG000|Overall Study|Other|1|||
48967909|NCT02553317|157710673|FG000|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0|||
48967910|NCT02553317|157710674|FG001|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1|||
48967911|NCT02553317|157710673|FG000|Overall Treatment Period + Follow-up|Physician Decision|2|||
48967912|NCT02553317|157710674|FG001|Overall Treatment Period + Follow-up|Physician Decision|4|||
48967913|NCT02553317|157710673|FG000|Overall Treatment Period + Follow-up|Non-compliance with study drug|0|||
48967914|NCT02553317|157710674|FG001|Overall Treatment Period + Follow-up|Non-compliance with study drug|1|||
48967915|NCT02553317|157710673|FG000|Overall Treatment Period + Follow-up|Death|1|||
48667303|NCT01638559|156634215|FG000|Overall Study|Subject declined to travel for biopsy|1|||
48967916|NCT02553317|157710674|FG001|Overall Treatment Period + Follow-up|Death|3|||
48967917|NCT02553317|157710673|FG000|Overall Treatment Period + Follow-up|Adverse Event|6|||
48967918|NCT02553317|157710674|FG001|Overall Treatment Period + Follow-up|Adverse Event|5|||
48967919|NCT02553317|157710673|FG000|Overall Treatment Period + Follow-up|Withdrawal by Subject|4|||
48967920|NCT02553317|157710674|FG001|Overall Treatment Period + Follow-up|Withdrawal by Subject|5|||
48967921|NCT02553317|157710673|FG000|Overall Treatment Period + Follow-up|Lost to Follow-up|0|||
48967922|NCT02553317|157710674|FG001|Overall Treatment Period + Follow-up|Lost to Follow-up|1|||
48667304|NCT01545050|156634219|FG000|Overall Study|Lack of Efficacy|0|||
48667305|NCT01545050|156634220|FG001|Overall Study|Lack of Efficacy|0|||
48667306|NCT01545050|156634221|FG002|Overall Study|Lack of Efficacy|0|||
48667307|NCT01545050|156634222|FG003|Overall Study|Lack of Efficacy|3|||
48667308|NCT01545050|156634223|FG004|Overall Study|Lack of Efficacy|2|||
48667309|NCT01545050|156634219|FG000|Overall Study|Adverse Event|1|||
48667310|NCT01545050|156634220|FG001|Overall Study|Adverse Event|1|||
48667311|NCT01545050|156634221|FG002|Overall Study|Adverse Event|2|||
48667312|NCT01545050|156634222|FG003|Overall Study|Adverse Event|2|||
48667313|NCT01545050|156634223|FG004|Overall Study|Adverse Event|0|||
48967923|NCT02553317|157710673|FG000|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
48967924|NCT02553317|157710674|FG001|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
48967925|NCT02553317|157710673|FG000|Overall Treatment Period + Follow-up|Protocol Violation|0|||
48967926|NCT02553317|157710674|FG001|Overall Treatment Period + Follow-up|Protocol Violation|1|||
48967927|NCT02553317|157710673|FG000|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0|||
48967928|NCT02553317|157710674|FG001|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1|||
48967929|NCT00764946|157710680|FG000|Overall Study|Lack of Efficacy|1|||
48967930|NCT00764946|157710681|FG001|Overall Study|Lack of Efficacy|0|||
48967931|NCT00764946|157710682|FG002|Overall Study|Lack of Efficacy|0|||
48967932|NCT00764946|157710680|FG000|Overall Study|Lost to Follow-up|3|||
48967933|NCT00764946|157710681|FG001|Overall Study|Lost to Follow-up|4|||
48967934|NCT00764946|157710682|FG002|Overall Study|Lost to Follow-up|0|||
48967935|NCT00764946|157710680|FG000|Overall Study|Physician Decision|2|||
48967936|NCT00764946|157710681|FG001|Overall Study|Physician Decision|4|||
48967937|NCT00764946|157710682|FG002|Overall Study|Physician Decision|0|||
48967938|NCT00764946|157710680|FG000|Overall Study|Adverse Event|3|||
48967939|NCT00764946|157710681|FG001|Overall Study|Adverse Event|2|||
48667314|NCT01545050|156634219|FG000|Overall Study|Discontinued study treatment|1|||
48667315|NCT01545050|156634220|FG001|Overall Study|Discontinued study treatment|0|||
48667316|NCT01545050|156634221|FG002|Overall Study|Discontinued study treatment|0|||
48667317|NCT01545050|156634222|FG003|Overall Study|Discontinued study treatment|0|||
48667318|NCT01545050|156634223|FG004|Overall Study|Discontinued study treatment|0|||
48667319|NCT01545050|156634219|FG000|Overall Study|Withdrawal by Subject|1|||
48967940|NCT00764946|157710682|FG002|Overall Study|Adverse Event|1|||
48967941|NCT00764946|157710680|FG000|Overall Study|Withdrawal by Subject|3|||
48667320|NCT01545050|156634220|FG001|Overall Study|Withdrawal by Subject|0|||
48667321|NCT01545050|156634221|FG002|Overall Study|Withdrawal by Subject|0|||
48667322|NCT01545050|156634222|FG003|Overall Study|Withdrawal by Subject|2|||
48967942|NCT00764946|157710681|FG001|Overall Study|Withdrawal by Subject|6|||
48967943|NCT00764946|157710682|FG002|Overall Study|Withdrawal by Subject|2|||
48967944|NCT00764946|157710680|FG000|Overall Study|Never Treated|1|||
48967945|NCT00764946|157710681|FG001|Overall Study|Never Treated|1|||
48967946|NCT00764946|157710682|FG002|Overall Study|Never Treated|1|||
48667323|NCT01545050|156634223|FG004|Overall Study|Withdrawal by Subject|1|||
48667324|NCT01545050|156634219|FG000|Overall Study|Participant no longer meets study criteria|0|||
48667325|NCT01545050|156634220|FG001|Overall Study|Participant no longer meets study criteria|2|||
48967947|NCT01354431|157710683|FG000|Pre-Treatment Period|Not reported|1|||
48967948|NCT01354431|157710684|FG001|Pre-Treatment Period|Not reported|0|||
48967949|NCT01354431|157710685|FG002|Pre-Treatment Period|Not reported|0|||
48758354|NCT00453544|156962794|FG002|Overall Study|Withdrawal by Subject|0|||
48758355|NCT00453544|156962795|FG003|Overall Study|Withdrawal by Subject|0|||
48758356|NCT00453544|156962792|FG000|Overall Study|Primary outcome measure not completed|1|||
48758357|NCT00453544|156962793|FG001|Overall Study|Primary outcome measure not completed|1|||
48758358|NCT00453544|156962794|FG002|Overall Study|Primary outcome measure not completed|0|||
48758359|NCT00453544|156962795|FG003|Overall Study|Primary outcome measure not completed|1|||
48758360|NCT02457910|156962796|FG000|Overall Study|Withdrawal by Subject|0|||
48758361|NCT02457910|156962797|FG001|Overall Study|Withdrawal by Subject|0|||
48758362|NCT02457910|156962798|FG002|Overall Study|Withdrawal by Subject|0|||
48758363|NCT02457910|156962799|FG003|Overall Study|Withdrawal by Subject|0|||
48967950|NCT01354431|157710683|FG000|Treatment Period|Disease Progression|50|||
48967951|NCT01354431|157710684|FG001|Treatment Period|Disease Progression|40|||
48967952|NCT01354431|157710685|FG002|Treatment Period|Disease Progression|44|||
48967953|NCT01354431|157710683|FG000|Treatment Period|Study Drug Toxicity|5|||
48967954|NCT01354431|157710684|FG001|Treatment Period|Study Drug Toxicity|8|||
48967955|NCT01354431|157710685|FG002|Treatment Period|Study Drug Toxicity|4|||
48967956|NCT01354431|157710683|FG000|Treatment Period|Death|0|||
48967957|NCT01354431|157710684|FG001|Treatment Period|Death|1|||
48967958|NCT01354431|157710685|FG002|Treatment Period|Death|0|||
48967959|NCT01354431|157710683|FG000|Treatment Period|AE unrelated to study drug|1|||
48967960|NCT01354431|157710684|FG001|Treatment Period|AE unrelated to study drug|2|||
48967961|NCT01354431|157710685|FG002|Treatment Period|AE unrelated to study drug|5|||
48967962|NCT01354431|157710683|FG000|Treatment Period|Participant request to discontinue|2|||
48967963|NCT01354431|157710684|FG001|Treatment Period|Participant request to discontinue|2|||
48967964|NCT01354431|157710685|FG002|Treatment Period|Participant request to discontinue|1|||
48967965|NCT01354431|157710683|FG000|Treatment Period|Participant withdrew consent|0|||
48967966|NCT01354431|157710684|FG001|Treatment Period|Participant withdrew consent|1|||
48967967|NCT01354431|157710685|FG002|Treatment Period|Participant withdrew consent|0|||
48967968|NCT01354431|157710683|FG000|Treatment Period|Participant no longer meeting study criteria|1|||
48967969|NCT01354431|157710684|FG001|Treatment Period|Participant no longer meeting study criteria|0|||
48967970|NCT01354431|157710685|FG002|Treatment Period|Participant no longer meeting study criteria|0|||
48967971|NCT01033487|157710686|FG000|Fourth Intervention Period|Adverse Event|0|||
48967972|NCT01033487|157710687|FG001|Fourth Intervention Period|Adverse Event|0|||
48967973|NCT01033487|157710688|FG002|Fourth Intervention Period|Adverse Event|0|||
48967974|NCT01033487|157710689|FG003|Fourth Intervention Period|Adverse Event|0|||
48967975|NCT01033487|157710690|FG004|Fourth Intervention Period|Adverse Event|0|||
48967976|NCT01033487|157710691|FG005|Fourth Intervention Period|Adverse Event|0|||
48967977|NCT01033487|157710692|FG006|Fourth Intervention Period|Adverse Event|0|||
48967978|NCT01033487|157710693|FG007|Fourth Intervention Period|Adverse Event|0|||
48967979|NCT01033487|157710694|FG008|Fourth Intervention Period|Adverse Event|1|||
48967980|NCT01033487|157710695|FG009|Fourth Intervention Period|Adverse Event|0|||
48967981|NCT02193828|157710697|FG000|Overall Study|Withdrawal by Subject|0|||
48967982|NCT02193828|157710698|FG001|Overall Study|Withdrawal by Subject|0|||
48967983|NCT02193828|157710699|FG002|Overall Study|Withdrawal by Subject|1|||
48967984|NCT02193828|157710700|FG003|Overall Study|Withdrawal by Subject|1|||
48967985|NCT02802878|157710701|FG000|Overall Study|Withdrawal by Subject|3|||
48967986|NCT02802878|157710702|FG001|Overall Study|Withdrawal by Subject|3|||
48967987|NCT02802878|157710701|FG000|Overall Study|Protocol Violation|1|||
48967988|NCT02802878|157710702|FG001|Overall Study|Protocol Violation|0|||
48967989|NCT01769469|157710703|FG000|Overall Study|Consent Withdrawn|5|||
48967990|NCT01769469|157710703|FG000|Overall Study|Moved Out Of Area|3|||
48967991|NCT01769469|157710703|FG000|Overall Study|Lost to Follow-up|17|||
48967992|NCT01769469|157710703|FG000|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7|||
48967993|NCT01769469|157710703|FG000|Overall Study|Subject Confirmed HIV Positive|3|||
48967994|NCT00729326|157710704|FG000|Overall Study|Lost to Follow-up|2|||
48967995|NCT00729326|157710705|FG001|Overall Study|Lost to Follow-up|0|||
48967996|NCT00729326|157710704|FG000|Overall Study|Physician Decision|0|||
48967997|NCT00729326|157710705|FG001|Overall Study|Physician Decision|1|||
48967998|NCT00729326|157710704|FG000|Overall Study|Protocol Violation|3|||
48758364|NCT02457910|156962800|FG004|Overall Study|Withdrawal by Subject|0|||
48967999|NCT00729326|157710705|FG001|Overall Study|Protocol Violation|2|||
48968000|NCT00729326|157710704|FG000|Overall Study|Subject Decision|4|||
48968001|NCT00729326|157710705|FG001|Overall Study|Subject Decision|4|||
48968002|NCT00729326|157710704|FG000|Overall Study|Sponsor Decision|1|||
48968003|NCT00729326|157710705|FG001|Overall Study|Sponsor Decision|2|||
48968004|NCT01235728|157710707|FG000|Overall Study|Protocol Violation|0|||
48968005|NCT01235728|157710708|FG001|Overall Study|Protocol Violation|0|||
48968006|NCT01235728|157710709|FG002|Overall Study|Protocol Violation|0|||
48968007|NCT01235728|157710710|FG003|Overall Study|Protocol Violation|1|||
48968008|NCT01235728|157710711|FG004|Overall Study|Protocol Violation|0|||
48968009|NCT01235728|157710712|FG005|Overall Study|Protocol Violation|0|||
48968010|NCT01235728|157710713|FG006|Overall Study|Protocol Violation|0|||
48968011|NCT01235728|157710714|FG007|Overall Study|Protocol Violation|0|||
48968012|NCT00862654|157710715|FG000|Overall Study|Lack of Efficacy|1|||
48968013|NCT00862654|157710716|FG001|Overall Study|Lack of Efficacy|0|||
48667326|NCT01545050|156634221|FG002|Overall Study|Participant no longer meets study criteria|0|||
48667327|NCT01545050|156634222|FG003|Overall Study|Participant no longer meets study criteria|0|||
48667328|NCT01545050|156634223|FG004|Overall Study|Participant no longer meets study criteria|1|||
48667329|NCT01545050|156634219|FG000|Overall Study|Administrative reason by sponsor|4|||
48667330|NCT01545050|156634220|FG001|Overall Study|Administrative reason by sponsor|2|||
48667331|NCT01545050|156634221|FG002|Overall Study|Administrative reason by sponsor|3|||
48667332|NCT01545050|156634222|FG003|Overall Study|Administrative reason by sponsor|5|||
48667333|NCT01545050|156634223|FG004|Overall Study|Administrative reason by sponsor|5|||
48667334|NCT02540291|156634224|FG000|Overall Study|Death|7|||
48667335|NCT02540291|156634225|FG001|Overall Study|Death|7|||
48667336|NCT02540291|156634226|FG002|Overall Study|Death|5|||
48667337|NCT02540291|156634227|FG003|Overall Study|Death|7|||
48667338|NCT02540291|156634224|FG000|Overall Study|Lost to Follow-up|0|||
48667339|NCT02540291|156634225|FG001|Overall Study|Lost to Follow-up|0|||
48667340|NCT02540291|156634226|FG002|Overall Study|Lost to Follow-up|1|||
48667341|NCT02540291|156634227|FG003|Overall Study|Lost to Follow-up|0|||
48667342|NCT02540291|156634224|FG000|Overall Study|Withdrawal Of Consent|0|||
48667343|NCT02540291|156634225|FG001|Overall Study|Withdrawal Of Consent|1|||
48667344|NCT02540291|156634226|FG002|Overall Study|Withdrawal Of Consent|0|||
48667345|NCT02540291|156634227|FG003|Overall Study|Withdrawal Of Consent|0|||
48667346|NCT02540291|156634224|FG000|Overall Study|Study Terminated By Sponsor|1|||
48667347|NCT02540291|156634225|FG001|Overall Study|Study Terminated By Sponsor|0|||
48667348|NCT02540291|156634226|FG002|Overall Study|Study Terminated By Sponsor|0|||
48667349|NCT02540291|156634227|FG003|Overall Study|Study Terminated By Sponsor|0|||
48667350|NCT02540291|156634224|FG000|Overall Study|Other|0|||
48667351|NCT02540291|156634225|FG001|Overall Study|Other|0|||
48667352|NCT02540291|156634226|FG002|Overall Study|Other|1|||
48667353|NCT02540291|156634227|FG003|Overall Study|Other|0|||
48667354|NCT00279812|156634228|FG000|Overall Study|Protocol Violation|1|||
48667355|NCT00279812|156634229|FG001|Overall Study|Protocol Violation|1|||
48667356|NCT00279812|156634230|FG002|Overall Study|Protocol Violation|0|||
48667357|NCT00279812|156634231|FG003|Overall Study|Protocol Violation|0|||
48667358|NCT00279812|156634232|FG004|Overall Study|Protocol Violation|1|||
48667359|NCT00279812|156634233|FG005|Overall Study|Protocol Violation|0|||
48968014|NCT00862654|157710717|FG002|Overall Study|Lack of Efficacy|1|||
48968015|NCT00862654|157710718|FG003|Overall Study|Lack of Efficacy|0|||
48968016|NCT00862654|157710715|FG000|Overall Study|Lost to Follow-up|1|||
48968017|NCT00862654|157710716|FG001|Overall Study|Lost to Follow-up|2|||
48968018|NCT00862654|157710717|FG002|Overall Study|Lost to Follow-up|1|||
48968019|NCT00862654|157710718|FG003|Overall Study|Lost to Follow-up|3|||
48968020|NCT00862654|157710715|FG000|Overall Study|Adverse Event|0|||
48968021|NCT00862654|157710716|FG001|Overall Study|Adverse Event|1|||
48968022|NCT00862654|157710717|FG002|Overall Study|Adverse Event|1|||
48667360|NCT00279812|156634228|FG000|Overall Study|Withdrawal by Subject|0|||
48667361|NCT00279812|156634229|FG001|Overall Study|Withdrawal by Subject|4|||
48667362|NCT00279812|156634230|FG002|Overall Study|Withdrawal by Subject|2|||
48667363|NCT00279812|156634231|FG003|Overall Study|Withdrawal by Subject|0|||
48667364|NCT00279812|156634232|FG004|Overall Study|Withdrawal by Subject|0|||
48667365|NCT00279812|156634233|FG005|Overall Study|Withdrawal by Subject|0|||
48667366|NCT00279812|156634228|FG000|Overall Study|Adverse Event|0|||
48667367|NCT00279812|156634229|FG001|Overall Study|Adverse Event|1|||
48667368|NCT00279812|156634230|FG002|Overall Study|Adverse Event|1|||
48667369|NCT00279812|156634231|FG003|Overall Study|Adverse Event|0|||
48667370|NCT00279812|156634232|FG004|Overall Study|Adverse Event|2|||
48968023|NCT00862654|157710718|FG003|Overall Study|Adverse Event|0|||
48968024|NCT00862654|157710715|FG000|Overall Study|Pregnancy|1|||
48667371|NCT00279812|156634233|FG005|Overall Study|Adverse Event|1|||
48667372|NCT01350115|156635467|FG000|Long Term Follow-Up (All Patients)|Lost to Follow-up|0|||
48667373|NCT01350115|156635468|FG001|Long Term Follow-Up (All Patients)|Lost to Follow-up|1|||
48667374|NCT01350115|156635467|FG000|Long Term Follow-Up (All Patients)|Adverse Event|0|||
48667375|NCT01350115|156635468|FG001|Long Term Follow-Up (All Patients)|Adverse Event|1|||
48667376|NCT01350115|156635467|FG000|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1|||
48667377|NCT01350115|156635468|FG001|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0|||
48667378|NCT02210832|156635470|FG000|Overall Study|Pregnancy termination .|3|||
48667379|NCT02210832|156635471|FG001|Overall Study|Pregnancy termination .|4|||
48667380|NCT02210832|156635472|FG002|Overall Study|Pregnancy termination .|1|||
48667381|NCT02210832|156635470|FG000|Overall Study|Lost to Follow-up|26|||
48667382|NCT02210832|156635471|FG001|Overall Study|Lost to Follow-up|32|||
48667383|NCT02210832|156635472|FG002|Overall Study|Lost to Follow-up|17|||
48667384|NCT01596335|156635473|FG000|Overall Study|exacerbation of primary disease|5|||
48667385|NCT01596335|156635474|FG001|Overall Study|exacerbation of primary disease|9|||
48667386|NCT04524455|156635475|FG000|Overall Study|Death|3|||
48667387|NCT04524455|156635476|FG001|Overall Study|Death|3|||
48667388|NCT04524455|156635475|FG000|Overall Study|Decision by Sponsor|0|||
48758365|NCT02457910|156962801|FG005|Overall Study|Withdrawal by Subject|1|||
48758366|NCT02457910|156962796|FG000|Overall Study|Adverse Event|0|||
48758367|NCT02457910|156962797|FG001|Overall Study|Adverse Event|2|||
48758368|NCT02457910|156962798|FG002|Overall Study|Adverse Event|1|||
48758369|NCT02457910|156962799|FG003|Overall Study|Adverse Event|1|||
48758370|NCT02457910|156962800|FG004|Overall Study|Adverse Event|1|||
48758371|NCT02457910|156962801|FG005|Overall Study|Adverse Event|3|||
48758372|NCT02457910|156962796|FG000|Overall Study|Disease progression|3|||
48758373|NCT02457910|156962797|FG001|Overall Study|Disease progression|3|||
48758374|NCT02457910|156962798|FG002|Overall Study|Disease progression|1|||
48667389|NCT04524455|156635476|FG001|Overall Study|Decision by Sponsor|2|||
48667390|NCT04524455|156635475|FG000|Overall Study|Withdrawal of Consent From Study|1|||
48667391|NCT04524455|156635476|FG001|Overall Study|Withdrawal of Consent From Study|0|||
48667392|NCT04524455|156635475|FG000|Overall Study|Lost to Follow-up|0|||
48667393|NCT04524455|156635476|FG001|Overall Study|Lost to Follow-up|1|||
48667394|NCT01519674|156635492|FG000|Overall Study|Adverse Event|3|||
48667395|NCT01519674|156635493|FG001|Overall Study|Adverse Event|3|||
48667396|NCT01519674|156635494|FG002|Overall Study|Adverse Event|0|||
48667397|NCT01519674|156635492|FG000|Overall Study|Lack of Efficacy|1|||
48667398|NCT01519674|156635493|FG001|Overall Study|Lack of Efficacy|1|||
48667399|NCT01519674|156635494|FG002|Overall Study|Lack of Efficacy|1|||
48667400|NCT01519674|156635492|FG000|Overall Study|Protocol Violation|0|||
48667401|NCT01519674|156635493|FG001|Overall Study|Protocol Violation|3|||
48667402|NCT01519674|156635494|FG002|Overall Study|Protocol Violation|1|||
48667403|NCT01519674|156635492|FG000|Overall Study|Withdrawal Criteria|7|||
48667404|NCT01519674|156635493|FG001|Overall Study|Withdrawal Criteria|2|||
48667405|NCT01519674|156635494|FG002|Overall Study|Withdrawal Criteria|7|||
48667406|NCT01519674|156635492|FG000|Overall Study|Unsclassified|10|||
48667407|NCT01519674|156635493|FG001|Overall Study|Unsclassified|4|||
48667408|NCT01519674|156635494|FG002|Overall Study|Unsclassified|3|||
48667409|NCT01610596|156635495|FG000|Overall Study|Lost to Follow-up|0|||
48667410|NCT01610596|156635496|FG001|Overall Study|Lost to Follow-up|1|||
48667411|NCT02317809|156635497|FG000|First Intervention Period (8 Days)|Protocol Non-Compliance|2|||
48667412|NCT02317809|156635498|FG001|First Intervention Period (8 Days)|Protocol Non-Compliance|0|||
48667413|NCT02317809|156635497|FG000|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1|||
48667414|NCT02317809|156635498|FG001|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0|||
48667415|NCT01114360|156635499|FG000|Intervention 1 (4 Weeks)|Physician Decision|0|||
48667416|NCT01114360|156635500|FG001|Intervention 1 (4 Weeks)|Physician Decision|1|||
48667417|NCT01646203|156635501|FG000|Overall Study|Adverse Event|2|||
48667418|NCT01646203|156635502|FG001|Overall Study|Adverse Event|0|||
48758375|NCT02457910|156962799|FG003|Overall Study|Disease progression|1|||
48758376|NCT02457910|156962800|FG004|Overall Study|Disease progression|4|||
48758377|NCT02457910|156962801|FG005|Overall Study|Disease progression|6|||
48758378|NCT02457910|156962796|FG000|Overall Study|Other complicating illness|0|||
48667419|NCT01646203|156635503|FG002|Overall Study|Adverse Event|1|||
48667420|NCT01646203|156635501|FG000|Overall Study|Withdrawal by Subject|0|||
48667421|NCT01646203|156635502|FG001|Overall Study|Withdrawal by Subject|1|||
48667422|NCT01646203|156635503|FG002|Overall Study|Withdrawal by Subject|0|||
48667423|NCT01646203|156635501|FG000|Overall Study|Physician's Decision|0|||
48667424|NCT01646203|156635502|FG001|Overall Study|Physician's Decision|1|||
48667425|NCT01646203|156635503|FG002|Overall Study|Physician's Decision|0|||
48667426|NCT03458702|156635504|FG000|Study Condition A (Yoga or Rest)|Lost to Follow-up|4|||
48667427|NCT03458702|156635505|FG001|Study Condition A (Yoga or Rest)|Lost to Follow-up|6|||
48667428|NCT03458702|156635504|FG000|Study Condition B (Yoga or Rest)|Lost to Follow-up|4|||
48667429|NCT03458702|156635505|FG001|Study Condition B (Yoga or Rest)|Lost to Follow-up|2|||
48667430|NCT02120365|156635510|FG000|Overall Study|Withdrawal by Subject|0|||
48667431|NCT02120365|156635511|FG001|Overall Study|Withdrawal by Subject|0|||
48667432|NCT02120365|156635512|FG002|Overall Study|Withdrawal by Subject|2|||
48667433|NCT02120365|156635513|FG003|Overall Study|Withdrawal by Subject|4|||
48667434|NCT02120365|156635514|FG004|Overall Study|Withdrawal by Subject|0|||
48667435|NCT02120365|156635515|FG005|Overall Study|Withdrawal by Subject|2|||
48667436|NCT02410824|156635517|FG000|First Intervention (One Week)|Headache|0|||
48667437|NCT02410824|156635518|FG001|First Intervention (One Week)|Headache|1|||
48667438|NCT01920152|156635519|FG000|Overall Study|Withdrawal by Subject|1|||
48667439|NCT01920152|156635520|FG001|Overall Study|Withdrawal by Subject|2|||
48667440|NCT00746733|156635521|FG000|Second Intervention|Adverse Event|1|||
48667441|NCT00746733|156635522|FG001|Second Intervention|Adverse Event|0|||
48667442|NCT00746733|156635521|FG000|Third Intervention|Withdrawal by Subject|1|||
48667443|NCT00746733|156635522|FG001|Third Intervention|Withdrawal by Subject|1|||
48667444|NCT01287195|156635523|FG000|Overall Study|Withdrawal by Subject|2|||
48758379|NCT02457910|156962797|FG001|Overall Study|Other complicating illness|0|||
48758380|NCT02457910|156962798|FG002|Overall Study|Other complicating illness|0|||
48758381|NCT02457910|156962799|FG003|Overall Study|Other complicating illness|0|||
48758382|NCT02457910|156962800|FG004|Overall Study|Other complicating illness|0|||
48758383|NCT02457910|156962801|FG005|Overall Study|Other complicating illness|1|||
49015474|NCT01393990|157893770|FG000|Overall Study|Death|0|||
48758384|NCT02457910|156962796|FG000|Overall Study|Death|0|||
48758385|NCT02457910|156962797|FG001|Overall Study|Death|0|||
48758386|NCT02457910|156962798|FG002|Overall Study|Death|1|||
48758387|NCT02457910|156962799|FG003|Overall Study|Death|0|||
48758388|NCT02457910|156962800|FG004|Overall Study|Death|0|||
48758389|NCT02457910|156962801|FG005|Overall Study|Death|0|||
48758390|NCT00362115|156962802|FG000|Overall Study|Adverse Event|0|||
48758391|NCT00362115|156962803|FG001|Overall Study|Adverse Event|1|||
48758392|NCT00362115|156962804|FG002|Overall Study|Adverse Event|1|||
48758393|NCT00362115|156962805|FG003|Overall Study|Adverse Event|1|||
48758394|NCT00362115|156962806|FG004|Overall Study|Adverse Event|2|||
48667445|NCT01319721|156635527|FG000|Overall Study|Lost to Follow-up|1|||
48667446|NCT01319721|156635528|FG001|Overall Study|Lost to Follow-up|6|||
48667447|NCT00334282|156635529|FG000|Overall Study|Lost to Follow-up|11|||
48667448|NCT00334282|156635530|FG001|Overall Study|Lost to Follow-up|5|||
48667449|NCT00334282|156635529|FG000|Overall Study|Withdrawal by Subject|17|||
48667450|NCT00334282|156635530|FG001|Overall Study|Withdrawal by Subject|3|||
48667451|NCT00334282|156635529|FG000|Overall Study|Death|194|||
48667452|NCT00334282|156635530|FG001|Overall Study|Death|100|||
48667453|NCT00837876|156635531|FG000|Overall Study|Death|2|||
48667454|NCT00837876|156635531|FG000|Overall Study|Adverse Event|7|||
48667455|NCT00837876|156635531|FG000|Overall Study|Physician Decision|1|||
48667456|NCT00837876|156635531|FG000|Overall Study|Withdrawal by Subject|3|||
48667457|NCT00837876|156635531|FG000|Overall Study|disease progression|24|||
48667458|NCT01116427|156635532|FG000|Core Phase|Adverse Event|0|||
48667459|NCT01116427|156635533|FG001|Core Phase|Adverse Event|1|||
48667460|NCT01116427|156635532|FG000|Core Phase|Lost to Follow-up|1|||
48667461|NCT01116427|156635533|FG001|Core Phase|Lost to Follow-up|0|||
48667462|NCT01116427|156635532|FG000|Core Phase|Withdrawal by Subject|3|||
48667463|NCT01116427|156635533|FG001|Core Phase|Withdrawal by Subject|0|||
48667464|NCT01116427|156635532|FG000|Core Phase|Worsening Multiple Sclerosis|1|||
48667465|NCT01116427|156635533|FG001|Core Phase|Worsening Multiple Sclerosis|0|||
48667466|NCT01116427|156635532|FG000|Extension Phase|Adverse Event|1|||
48667467|NCT01116427|156635533|FG001|Extension Phase|Adverse Event|1|||
48667468|NCT01116427|156635532|FG000|Extension Phase|Lost to Follow-up|2|||
48667469|NCT01116427|156635533|FG001|Extension Phase|Lost to Follow-up|0|||
48667470|NCT01116427|156635532|FG000|Extension Phase|Withdrawal by Subject|5|||
48667471|NCT01116427|156635533|FG001|Extension Phase|Withdrawal by Subject|1|||
48667472|NCT01116427|156635532|FG000|Extension Phase|Not using appropriate birth control|1|||
48667473|NCT01116427|156635533|FG001|Extension Phase|Not using appropriate birth control|0|||
48667474|NCT00453973|156635534|FG000|Overall Study|Adverse Event|4|||
48667475|NCT00453973|156635535|FG001|Overall Study|Adverse Event|9|||
48667476|NCT00453973|156635534|FG000|Overall Study|Withdrawal by Subject|7|||
48667477|NCT00453973|156635535|FG001|Overall Study|Withdrawal by Subject|6|||
48667478|NCT00453973|156635534|FG000|Overall Study|PI Decision|0|||
48667479|NCT00453973|156635535|FG001|Overall Study|PI Decision|2|||
48667480|NCT00453973|156635534|FG000|Overall Study|Relocation|1|||
48667481|NCT00453973|156635535|FG001|Overall Study|Relocation|0|||
48667482|NCT00453973|156635534|FG000|Overall Study|Renal transplant|1|||
48667483|NCT00453973|156635535|FG001|Overall Study|Renal transplant|1|||
48667484|NCT00453973|156635534|FG000|Overall Study|Site closed by sponsor|3|||
48667485|NCT00453973|156635535|FG001|Overall Study|Site closed by sponsor|0|||
48667486|NCT00453973|156635534|FG000|Overall Study|Sponsor Decision to Terminate Study|35|||
48667487|NCT00453973|156635535|FG001|Overall Study|Sponsor Decision to Terminate Study|30|||
48667488|NCT01969500|156635536|FG000|Overall Study|Death|0|||
48667489|NCT01969500|156635537|FG001|Overall Study|Death|1|||
48667490|NCT01969500|156635536|FG000|Overall Study|extended hospitalization|1|||
48667491|NCT01969500|156635537|FG001|Overall Study|extended hospitalization|1|||
48667492|NCT01439126|156635540|FG000|Overall Study|Adverse Event|2|||
48667493|NCT01439126|156635541|FG001|Overall Study|Adverse Event|0|||
48667494|NCT01439126|156635540|FG000|Overall Study|Withdrawal by Subject|5|||
48667495|NCT01439126|156635541|FG001|Overall Study|Withdrawal by Subject|21|||
48667496|NCT01439126|156635540|FG000|Overall Study|Protocol Violation|6|||
48667497|NCT01439126|156635541|FG001|Overall Study|Protocol Violation|4|||
48667498|NCT01439126|156635540|FG000|Overall Study|Lost to Follow-up|6|||
48667499|NCT01439126|156635541|FG001|Overall Study|Lost to Follow-up|3|||
48758395|NCT00362115|156962807|FG005|Overall Study|Adverse Event|2|||
48758396|NCT00362115|156962808|FG006|Overall Study|Adverse Event|1|||
48758397|NCT00362115|156962802|FG000|Overall Study|Protocol Violation|0|||
49015475|NCT01393990|157893771|FG001|Overall Study|Death|0|||
48667500|NCT01439126|156635540|FG000|Overall Study|Other-Use of prohibited treatment|0|||
48667501|NCT01439126|156635541|FG001|Overall Study|Other-Use of prohibited treatment|2|||
48667502|NCT01439126|156635540|FG000|Overall Study|Other-Miscellaneous|12|||
48667503|NCT01439126|156635541|FG001|Overall Study|Other-Miscellaneous|12|||
48667504|NCT02576860|156635549|FG000|Overall Study|Adverse Event|6|||
48667505|NCT02576860|156635550|FG001|Overall Study|Adverse Event|6|||
48667506|NCT02576860|156635549|FG000|Overall Study|Lost to Follow-up|5|||
48667507|NCT02576860|156635550|FG001|Overall Study|Lost to Follow-up|7|||
48667508|NCT02576860|156635549|FG000|Overall Study|Physician Decision|0|||
48758398|NCT00362115|156962803|FG001|Overall Study|Protocol Violation|0|||
48667509|NCT02576860|156635550|FG001|Overall Study|Physician Decision|1|||
48667510|NCT02576860|156635549|FG000|Overall Study|Protocol Violation|0|||
48667511|NCT02576860|156635550|FG001|Overall Study|Protocol Violation|2|||
48667512|NCT02576860|156635549|FG000|Overall Study|Withdrawal by Subject|13|||
48667513|NCT02576860|156635550|FG001|Overall Study|Withdrawal by Subject|8|||
48667514|NCT02576860|156635549|FG000|Overall Study|Disallowed medication|1|||
48667515|NCT02576860|156635550|FG001|Overall Study|Disallowed medication|0|||
48667516|NCT00780273|156635551|FG000|Overall Study|Death|1|||
48667517|NCT00780273|156635551|FG000|Overall Study|Lost to Follow-up|1|||
48667518|NCT02827500|156635552|FG000|Overall Study|Death|7|||
48667519|NCT02827500|156635553|FG001|Overall Study|Death|3|||
48667520|NCT02827500|156635552|FG000|Overall Study|Lost to Follow-up|1|||
48667521|NCT02827500|156635553|FG001|Overall Study|Lost to Follow-up|1|||
48667522|NCT02827500|156635552|FG000|Overall Study|Withdrawal by Subject|3|||
48667523|NCT02827500|156635553|FG001|Overall Study|Withdrawal by Subject|1|||
48667524|NCT02827500|156635552|FG000|Overall Study|Missing primary endpoint data|3|||
48667525|NCT02827500|156635553|FG001|Overall Study|Missing primary endpoint data|1|||
48667526|NCT02827500|156635552|FG000|Overall Study|Other|5|||
48667527|NCT02827500|156635553|FG001|Overall Study|Other|1|||
48667528|NCT03689244|156635554|FG000|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|7|||
48667529|NCT03689244|156635555|FG001|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|8|||
48667530|NCT03689244|156635556|FG002|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
48667531|NCT03689244|156635557|FG003|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
48667532|NCT03689244|156635554|FG000|Double Blind Period (Up to 27.7 Months)|Other|1|||
48667533|NCT03689244|156635555|FG001|Double Blind Period (Up to 27.7 Months)|Other|1|||
48667534|NCT03689244|156635556|FG002|Double Blind Period (Up to 27.7 Months)|Other|0|||
48667535|NCT03689244|156635557|FG003|Double Blind Period (Up to 27.7 Months)|Other|0|||
48667536|NCT03689244|156635554|FG000|Double Blind Period (Up to 27.7 Months)|Sponsor decision|44|||
48667537|NCT03689244|156635555|FG001|Double Blind Period (Up to 27.7 Months)|Sponsor decision|47|||
48667538|NCT03689244|156635556|FG002|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
48667539|NCT03689244|156635557|FG003|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
48667540|NCT03689244|156635554|FG000|Double Blind Period (Up to 27.7 Months)|Death|1|||
48667541|NCT03689244|156635555|FG001|Double Blind Period (Up to 27.7 Months)|Death|0|||
48667542|NCT03689244|156635556|FG002|Double Blind Period (Up to 27.7 Months)|Death|0|||
48667543|NCT03689244|156635557|FG003|Double Blind Period (Up to 27.7 Months)|Death|0|||
48667544|NCT03689244|156635554|FG000|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
48667545|NCT03689244|156635555|FG001|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
48667546|NCT03689244|156635556|FG002|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
48667547|NCT03689244|156635557|FG003|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
48667548|NCT03689244|156635554|FG000|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
48667549|NCT03689244|156635555|FG001|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
48667550|NCT03689244|156635556|FG002|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|1|||
48667551|NCT03689244|156635557|FG003|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
48667552|NCT03689244|156635554|FG000|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
48667553|NCT03689244|156635555|FG001|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
48667554|NCT03689244|156635556|FG002|Open Label Period (Up to 20.8 Months)|Physician Decision|1|||
48667555|NCT03689244|156635557|FG003|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
48667556|NCT03689244|156635554|FG000|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
48667557|NCT03689244|156635555|FG001|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
48667558|NCT03689244|156635556|FG002|Open Label Period (Up to 20.8 Months)|Sponsor Decision|7|||
48667559|NCT03689244|156635557|FG003|Open Label Period (Up to 20.8 Months)|Sponsor Decision|6|||
48667560|NCT01541917|156635558|FG000|Overall Study|Lost to Follow-up|2|||
48667561|NCT01541917|156635559|FG001|Overall Study|Lost to Follow-up|2|||
48667562|NCT01541917|156635558|FG000|Overall Study|Withdrawal by Subject|13|||
48667563|NCT01541917|156635559|FG001|Overall Study|Withdrawal by Subject|7|||
48667564|NCT03263780|156635560|FG000|Overall Study|Withdrawal by Subject|3|||
48667565|NCT03263780|156635560|FG000|Overall Study|Ineligible (incomplete post-HIFU)|7|||
48667566|NCT01739803|156635561|FG000|Overall Study|Lost to Follow-up|9|||
48667567|NCT01739803|156635562|FG001|Overall Study|Lost to Follow-up|6|||
48667568|NCT03426631|156635565|FG000|Overall Study|Lost to Follow-up|0|||
48667569|NCT03426631|156635566|FG001|Overall Study|Lost to Follow-up|1|||
48667570|NCT02698371|156635591|FG000|All Participants Flow|Lost to Follow-up|3|||
48667571|NCT02698371|156635591|FG000|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3|||
48667572|NCT02698371|156635591|FG000|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3|||
48667573|NCT02698371|156635591|FG000|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3|||
48667574|NCT02698371|156635591|FG000|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3|||
48667575|NCT02698371|156635591|FG000|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3|||
48667576|NCT02698371|156635591|FG000|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2|||
48667577|NCT00267150|156635592|FG000|Overall Study|Adverse Event|1|||
48667578|NCT01561963|156635595|FG000|Overall Study|Adverse Event|1|||
48667579|NCT00424190|156635597|FG000|Overall Study|Withdrew consent|3|||
48758399|NCT00362115|156962804|FG002|Overall Study|Protocol Violation|0|||
48758400|NCT00362115|156962805|FG003|Overall Study|Protocol Violation|0|||
48758401|NCT00362115|156962806|FG004|Overall Study|Protocol Violation|0|||
48758402|NCT00362115|156962807|FG005|Overall Study|Protocol Violation|1|||
48758403|NCT00362115|156962808|FG006|Overall Study|Protocol Violation|0|||
48758404|NCT00362115|156962802|FG000|Overall Study|Lost to Follow-up|0|||
48758405|NCT00362115|156962803|FG001|Overall Study|Lost to Follow-up|1|||
48758406|NCT00362115|156962804|FG002|Overall Study|Lost to Follow-up|0|||
48667580|NCT00424190|156635598|FG001|Overall Study|Withdrew consent|4|||
48667581|NCT00424190|156635597|FG000|Overall Study|Death|3|||
48667582|NCT00424190|156635598|FG001|Overall Study|Death|0|||
48667583|NCT00424190|156635597|FG000|Overall Study|Noncompliance|1|||
48667584|NCT00424190|156635598|FG001|Overall Study|Noncompliance|2|||
48667585|NCT00424190|156635597|FG000|Overall Study|Request of sponsor or investigator|0|||
48667586|NCT00424190|156635598|FG001|Overall Study|Request of sponsor or investigator|2|||
48667587|NCT00424190|156635597|FG000|Overall Study|Diagnosis of osteomyelitis|0|||
48667588|NCT00424190|156635598|FG001|Overall Study|Diagnosis of osteomyelitis|1|||
48667589|NCT00424190|156635597|FG000|Overall Study|Other|15|||
48667590|NCT00424190|156635598|FG001|Overall Study|Other|21|||
48667591|NCT02598128|156635602|FG000|Period A: Days -7 to -1|Adverse Event|1|||
48667592|NCT02598128|156635603|FG001|Period A: Days -7 to -1|Adverse Event|0|||
48667593|NCT02598128|156635604|FG002|Period A: Days -7 to -1|Adverse Event|0|||
48667594|NCT02598128|156635605|FG003|Period A: Days -7 to -1|Adverse Event|0|||
48667595|NCT01595581|156635610|FG000|Overall Study|Withdrawal by Subject|1|||
48667596|NCT01595581|156635611|FG001|Overall Study|Withdrawal by Subject|0|||
48667597|NCT02383433|156635612|FG000|Overall Study|Disease progression|2|||
48667598|NCT01278407|156637431|FG000|Confirmatory Phase|Adverse Event|5|||
48667599|NCT01278407|156637432|FG001|Confirmatory Phase|Adverse Event|10|||
48667600|NCT01278407|156637433|FG002|Confirmatory Phase|Adverse Event|1|||
48758407|NCT00362115|156962805|FG003|Overall Study|Lost to Follow-up|0|||
48758408|NCT00362115|156962806|FG004|Overall Study|Lost to Follow-up|2|||
48758409|NCT00362115|156962807|FG005|Overall Study|Lost to Follow-up|0|||
48758410|NCT00362115|156962808|FG006|Overall Study|Lost to Follow-up|1|||
48758411|NCT00362115|156962802|FG000|Overall Study|Withdrawal by Subject|1|||
48758412|NCT00362115|156962803|FG001|Overall Study|Withdrawal by Subject|3|||
48758413|NCT00362115|156962804|FG002|Overall Study|Withdrawal by Subject|1|||
48758414|NCT00362115|156962805|FG003|Overall Study|Withdrawal by Subject|0|||
48758415|NCT00362115|156962806|FG004|Overall Study|Withdrawal by Subject|1|||
48758416|NCT00362115|156962807|FG005|Overall Study|Withdrawal by Subject|3|||
48758417|NCT00362115|156962808|FG006|Overall Study|Withdrawal by Subject|4|||
48758418|NCT00362115|156962802|FG000|Overall Study|Lack of Efficacy|1|||
48758419|NCT00362115|156962803|FG001|Overall Study|Lack of Efficacy|0|||
48758420|NCT00362115|156962804|FG002|Overall Study|Lack of Efficacy|5|||
48758421|NCT00362115|156962805|FG003|Overall Study|Lack of Efficacy|2|||
48758422|NCT00362115|156962806|FG004|Overall Study|Lack of Efficacy|2|||
48758423|NCT00362115|156962807|FG005|Overall Study|Lack of Efficacy|0|||
48667601|NCT01278407|156637434|FG003|Confirmatory Phase|Adverse Event|0|||
48667602|NCT01278407|156637435|FG004|Confirmatory Phase|Adverse Event|0|||
48667603|NCT01278407|156637431|FG000|Confirmatory Phase|Participant's Choice|3|||
48667604|NCT01278407|156637432|FG001|Confirmatory Phase|Participant's Choice|5|||
48667605|NCT01278407|156637433|FG002|Confirmatory Phase|Participant's Choice|3|||
48667606|NCT01278407|156637434|FG003|Confirmatory Phase|Participant's Choice|0|||
48667607|NCT01278407|156637435|FG004|Confirmatory Phase|Participant's Choice|0|||
48667608|NCT01278407|156637431|FG000|Confirmatory Phase|Other|1|||
48667609|NCT01278407|156637432|FG001|Confirmatory Phase|Other|1|||
48667610|NCT01278407|156637433|FG002|Confirmatory Phase|Other|2|||
48667611|NCT01278407|156637434|FG003|Confirmatory Phase|Other|0|||
48667612|NCT01278407|156637435|FG004|Confirmatory Phase|Other|0|||
48667613|NCT01278407|156637431|FG000|Extension Phase|Adverse Event|0|||
48667614|NCT01278407|156637432|FG001|Extension Phase|Adverse Event|0|||
48667615|NCT01278407|156637433|FG002|Extension Phase|Adverse Event|0|||
48667616|NCT01278407|156637434|FG003|Extension Phase|Adverse Event|7|||
48667617|NCT01278407|156637435|FG004|Extension Phase|Adverse Event|16|||
48667618|NCT01278407|156637431|FG000|Extension Phase|Participant's Choice|0|||
48667619|NCT01278407|156637432|FG001|Extension Phase|Participant's Choice|0|||
48667620|NCT01278407|156637433|FG002|Extension Phase|Participant's Choice|0|||
48667621|NCT01278407|156637434|FG003|Extension Phase|Participant's Choice|4|||
48758424|NCT00362115|156962808|FG006|Overall Study|Lack of Efficacy|3|||
48758425|NCT00362115|156962802|FG000|Overall Study|Physician Decision|0|||
48758426|NCT00362115|156962803|FG001|Overall Study|Physician Decision|0|||
48758427|NCT00362115|156962804|FG002|Overall Study|Physician Decision|0|||
48758428|NCT00362115|156962805|FG003|Overall Study|Physician Decision|0|||
48758429|NCT00362115|156962806|FG004|Overall Study|Physician Decision|0|||
48968025|NCT00862654|157710716|FG001|Overall Study|Pregnancy|1|||
48667622|NCT01278407|156637435|FG004|Extension Phase|Participant's Choice|11|||
48667623|NCT01278407|156637431|FG000|Extension Phase|Other|0|||
48667624|NCT01278407|156637432|FG001|Extension Phase|Other|0|||
48667625|NCT01278407|156637433|FG002|Extension Phase|Other|0|||
48758430|NCT00362115|156962807|FG005|Overall Study|Physician Decision|0|||
48758431|NCT00362115|156962808|FG006|Overall Study|Physician Decision|3|||
48667626|NCT01278407|156637434|FG003|Extension Phase|Other|1|||
48667627|NCT01278407|156637435|FG004|Extension Phase|Other|3|||
48667628|NCT02753127|156637442|FG000|Overall Study|Lost to Follow-up|13|||
48758432|NCT00362115|156962802|FG000|Overall Study|Other|0|||
48758433|NCT00362115|156962803|FG001|Overall Study|Other|1|||
48758434|NCT00362115|156962804|FG002|Overall Study|Other|0|||
48758435|NCT00362115|156962805|FG003|Overall Study|Other|1|||
48758436|NCT00362115|156962806|FG004|Overall Study|Other|0|||
48758437|NCT00362115|156962807|FG005|Overall Study|Other|1|||
48758438|NCT00362115|156962808|FG006|Overall Study|Other|0|||
48968026|NCT00862654|157710717|FG002|Overall Study|Pregnancy|0|||
48968027|NCT00862654|157710718|FG003|Overall Study|Pregnancy|0|||
48667629|NCT02753127|156637443|FG001|Overall Study|Lost to Follow-up|11|||
48667630|NCT02753127|156637442|FG000|Overall Study|Withdrawal by Subject|37|||
48667631|NCT02753127|156637443|FG001|Overall Study|Withdrawal by Subject|47|||
48667632|NCT02753127|156637442|FG000|Overall Study|Other|3|||
48667633|NCT02753127|156637443|FG001|Overall Study|Other|8|||
48667634|NCT02753127|156637442|FG000|Overall Study|Hospice|0|||
48667635|NCT02753127|156637443|FG001|Overall Study|Hospice|2|||
48667636|NCT02351349|156637444|FG000|Overall Study|Withdrawal by Subject|2|||
48667637|NCT02351349|156637445|FG001|Overall Study|Withdrawal by Subject|3|||
48667638|NCT02981524|156637446|FG000|Overall Study|Progressive Disease|14|||
48667639|NCT02981524|156637446|FG000|Overall Study|Death (unrelated)|1|||
48667640|NCT02981524|156637446|FG000|Overall Study|Treatment Related Toxicity|1|||
48667641|NCT02981524|156637446|FG000|Overall Study|Withdrawal by Subject|1|||
48667642|NCT00186537|156637450|FG000|Overall Study|Withdrawal by Subject|4|||
48667643|NCT00186537|156637451|FG001|Overall Study|Withdrawal by Subject|0|||
48667644|NCT00186537|156637452|FG002|Overall Study|Withdrawal by Subject|3|||
48667645|NCT00186537|156637450|FG000|Overall Study|ALT > 1.5 x ULN|3|||
48667646|NCT00186537|156637451|FG001|Overall Study|ALT > 1.5 x ULN|0|||
48667647|NCT00186537|156637452|FG002|Overall Study|ALT > 1.5 x ULN|0|||
48667648|NCT03684304|156637453|FG000|Overall Study|Lost to Follow-up|19|||
48667649|NCT03684304|156637454|FG001|Overall Study|Lost to Follow-up|17|||
48667650|NCT00385723|156637456|FG000|Overall Study|Lost to Follow-up|1|||
48667651|NCT00385723|156637457|FG001|Overall Study|Lost to Follow-up|1|||
48667652|NCT00385723|156637458|FG002|Overall Study|Lost to Follow-up|0|||
48667653|NCT00385723|156637456|FG000|Overall Study|Withdrawal by Subject|1|||
48667654|NCT00385723|156637457|FG001|Overall Study|Withdrawal by Subject|0|||
48667655|NCT00385723|156637458|FG002|Overall Study|Withdrawal by Subject|2|||
48667656|NCT01484834|156637459|FG000|Overall Study|Lost to Follow-up|5|||
48667657|NCT01484834|156637460|FG001|Overall Study|Lost to Follow-up|8|||
48667658|NCT01484834|156637461|FG002|Overall Study|Lost to Follow-up|1|||
48667659|NCT01484834|156637462|FG003|Overall Study|Lost to Follow-up|4|||
48667660|NCT03455829|156637463|FG000|Overall Study|Death|2|||
48667661|NCT03455829|156637464|FG001|Overall Study|Death|3|||
48667662|NCT03455829|156637465|FG002|Overall Study|Death|2|||
48667663|NCT03455829|156637466|FG003|Overall Study|Death|4|||
48667664|NCT03455829|156637467|FG004|Overall Study|Death|2|||
48758439|NCT01387347|156962809|FG000|Overall Study|Lost to Follow-up|2|||
48667665|NCT03455829|156637463|FG000|Overall Study|Study terminated and patients did not have progressive disease or died|5|||
48667666|NCT03455829|156637464|FG001|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
48667667|NCT03455829|156637465|FG002|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
48667668|NCT03455829|156637466|FG003|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
48667669|NCT03455829|156637467|FG004|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
48667670|NCT03455829|156637463|FG000|Overall Study|Disease progression|0|||
48667671|NCT03455829|156637464|FG001|Overall Study|Disease progression|0|||
48667672|NCT03455829|156637465|FG002|Overall Study|Disease progression|0|||
48667673|NCT03455829|156637466|FG003|Overall Study|Disease progression|1|||
48667674|NCT03455829|156637467|FG004|Overall Study|Disease progression|1|||
48667675|NCT00673881|156637468|FG000|Overall Study|Withdrawal by Subject|1|||
48667676|NCT01719003|156637469|FG000|Overall Study|Non compliant with protocol|1|||
48758440|NCT01387347|156962810|FG001|Overall Study|Lost to Follow-up|1|||
48968028|NCT00862654|157710715|FG000|Overall Study|Withdrawal by Subject|2|||
48667677|NCT01719003|156637470|FG001|Overall Study|Non compliant with protocol|1|||
48667678|NCT01719003|156637471|FG002|Overall Study|Non compliant with protocol|0|||
48667679|NCT01719003|156637472|FG003|Overall Study|Non compliant with protocol|1|||
48667680|NCT01719003|156637473|FG004|Overall Study|Non compliant with protocol|2|||
48667681|NCT01719003|156637474|FG005|Overall Study|Non compliant with protocol|1|||
48758441|NCT03605303|156962814|FG000|Period 1|Study Terminated|2|||
48968029|NCT00862654|157710716|FG001|Overall Study|Withdrawal by Subject|2|||
48968030|NCT00862654|157710717|FG002|Overall Study|Withdrawal by Subject|2|||
48667682|NCT01719003|156637475|FG006|Overall Study|Non compliant with protocol|2|||
48667683|NCT01719003|156637476|FG007|Overall Study|Non compliant with protocol|3|||
48667684|NCT01719003|156637477|FG008|Overall Study|Non compliant with protocol|0|||
48667685|NCT01719003|156637469|FG000|Overall Study|Adverse Event|6|||
48667686|NCT01719003|156637470|FG001|Overall Study|Adverse Event|5|||
48667687|NCT01719003|156637471|FG002|Overall Study|Adverse Event|4|||
48758442|NCT03605303|156962815|FG001|Period 1|Study Terminated|1|||
48758443|NCT02153112|156962816|FG000|Overall Study|Adverse Event|0|||
48758444|NCT02153112|156962817|FG001|Overall Study|Adverse Event|0|||
48758445|NCT02153112|156962818|FG002|Overall Study|Adverse Event|1|||
48758446|NCT02153112|156962819|FG003|Overall Study|Adverse Event|0|||
48758447|NCT02153112|156962820|FG004|Overall Study|Adverse Event|0|||
48758448|NCT02153112|156962821|FG005|Overall Study|Adverse Event|0|||
48758449|NCT02153112|156962822|FG006|Overall Study|Adverse Event|0|||
48758450|NCT02153112|156962823|FG007|Overall Study|Adverse Event|0|||
48758451|NCT02153112|156962824|FG008|Overall Study|Adverse Event|0|||
48758452|NCT02153112|156962825|FG009|Overall Study|Adverse Event|0|||
48758453|NCT02153112|156962816|FG000|Overall Study|Lost to Follow-up|1|||
48758454|NCT02153112|156962817|FG001|Overall Study|Lost to Follow-up|1|||
48758455|NCT02153112|156962818|FG002|Overall Study|Lost to Follow-up|0|||
48758456|NCT02153112|156962819|FG003|Overall Study|Lost to Follow-up|0|||
48758457|NCT02153112|156962820|FG004|Overall Study|Lost to Follow-up|2|||
48968031|NCT00862654|157710718|FG003|Overall Study|Withdrawal by Subject|3|||
48968032|NCT00862654|157710715|FG000|Overall Study|Subject mistake|0|||
48968033|NCT00862654|157710716|FG001|Overall Study|Subject mistake|1|||
48968034|NCT00862654|157710717|FG002|Overall Study|Subject mistake|0|||
48968035|NCT00862654|157710718|FG003|Overall Study|Subject mistake|0|||
48968036|NCT00862654|157710715|FG000|Overall Study|Familly constraint|0|||
48968037|NCT00862654|157710716|FG001|Overall Study|Familly constraint|1|||
48968038|NCT00862654|157710717|FG002|Overall Study|Familly constraint|0|||
48968039|NCT00862654|157710718|FG003|Overall Study|Familly constraint|0|||
48968040|NCT00862654|157710715|FG000|Overall Study|Never used study drugs|1|||
48968041|NCT00862654|157710716|FG001|Overall Study|Never used study drugs|0|||
48968042|NCT00862654|157710717|FG002|Overall Study|Never used study drugs|0|||
48968043|NCT00862654|157710718|FG003|Overall Study|Never used study drugs|0|||
48968044|NCT00862654|157710715|FG000|Overall Study|Included after end of inclusions|0|||
48968045|NCT00862654|157710716|FG001|Overall Study|Included after end of inclusions|0|||
48968046|NCT00862654|157710717|FG002|Overall Study|Included after end of inclusions|1|||
48968047|NCT00862654|157710718|FG003|Overall Study|Included after end of inclusions|0|||
48968048|NCT03219567|157710731|FG000|Overall Study|Withdrawal by Subject|0|||
48968049|NCT03219567|157710732|FG001|Overall Study|Withdrawal by Subject|1|||
48968050|NCT02394795|157710733|FG000|Overall Study|Adverse Event|92|||
48968051|NCT02394795|157710734|FG001|Overall Study|Adverse Event|70|||
48667688|NCT01719003|156637472|FG003|Overall Study|Adverse Event|3|||
48667689|NCT01719003|156637473|FG004|Overall Study|Adverse Event|4|||
48667690|NCT01719003|156637474|FG005|Overall Study|Adverse Event|3|||
48667691|NCT01719003|156637475|FG006|Overall Study|Adverse Event|6|||
48667692|NCT01719003|156637476|FG007|Overall Study|Adverse Event|5|||
48667693|NCT01719003|156637477|FG008|Overall Study|Adverse Event|0|||
48667694|NCT01719003|156637469|FG000|Overall Study|Lost to Follow-up|0|||
48667695|NCT01719003|156637470|FG001|Overall Study|Lost to Follow-up|6|||
48667696|NCT01719003|156637471|FG002|Overall Study|Lost to Follow-up|7|||
48667697|NCT01719003|156637472|FG003|Overall Study|Lost to Follow-up|2|||
48667698|NCT01719003|156637473|FG004|Overall Study|Lost to Follow-up|3|||
48667699|NCT01719003|156637474|FG005|Overall Study|Lost to Follow-up|4|||
48667700|NCT01719003|156637475|FG006|Overall Study|Lost to Follow-up|3|||
48667701|NCT01719003|156637476|FG007|Overall Study|Lost to Follow-up|2|||
48758458|NCT02153112|156962821|FG005|Overall Study|Lost to Follow-up|1|||
48758459|NCT02153112|156962822|FG006|Overall Study|Lost to Follow-up|1|||
48758460|NCT02153112|156962823|FG007|Overall Study|Lost to Follow-up|0|||
48758461|NCT02153112|156962824|FG008|Overall Study|Lost to Follow-up|1|||
48968052|NCT02394795|157710733|FG000|Overall Study|Lost to Follow-up|0|||
48968053|NCT02394795|157710734|FG001|Overall Study|Lost to Follow-up|1|||
48968054|NCT02394795|157710733|FG000|Overall Study|Withdrawal by Subject|17|||
48968055|NCT02394795|157710734|FG001|Overall Study|Withdrawal by Subject|26|||
48968056|NCT02394795|157710733|FG000|Overall Study|Lack of Efficacy|181|||
48968057|NCT02394795|157710734|FG001|Overall Study|Lack of Efficacy|211|||
48968058|NCT02394795|157710733|FG000|Overall Study|Death|4|||
48968059|NCT02394795|157710734|FG001|Overall Study|Death|5|||
48968060|NCT02394795|157710733|FG000|Overall Study|Physician Decision|109|||
48667702|NCT01719003|156637477|FG008|Overall Study|Lost to Follow-up|2|||
48968061|NCT02394795|157710734|FG001|Overall Study|Physician Decision|93|||
48968062|NCT02146833|157710735|FG000|Overall Study|Death|10|||
48968063|NCT02146833|157710735|FG000|Overall Study|No longer consented to study treatment|1|||
48667703|NCT01719003|156637469|FG000|Overall Study|Refusal to continue, not due to AE|2|||
48667704|NCT01719003|156637470|FG001|Overall Study|Refusal to continue, not due to AE|5|||
48758462|NCT02153112|156962825|FG009|Overall Study|Lost to Follow-up|1|||
48758463|NCT02153112|156962816|FG000|Overall Study|Withdrawal by Subject|3|||
48758464|NCT02153112|156962817|FG001|Overall Study|Withdrawal by Subject|1|||
48968064|NCT00617656|157710736|FG000|Overall Study|Inclusion error|4|||
48968065|NCT00617656|157710737|FG001|Overall Study|Inclusion error|4|||
48968066|NCT00617656|157710738|FG002|Overall Study|Inclusion error|0|||
48968067|NCT00617656|157710739|FG003|Overall Study|Inclusion error|0|||
48667705|NCT01719003|156637471|FG002|Overall Study|Refusal to continue, not due to AE|4|||
48968068|NCT00617656|157710736|FG000|Overall Study|Missing data|44|||
48968069|NCT00617656|157710737|FG001|Overall Study|Missing data|30|||
48968070|NCT00617656|157710738|FG002|Overall Study|Missing data|13|||
48968071|NCT00617656|157710739|FG003|Overall Study|Missing data|6|||
48968072|NCT00617656|157710736|FG000|Overall Study|Withdrawal by Subject|0|||
48667706|NCT01719003|156637472|FG003|Overall Study|Refusal to continue, not due to AE|4|||
48667707|NCT01719003|156637473|FG004|Overall Study|Refusal to continue, not due to AE|4|||
48667708|NCT01719003|156637474|FG005|Overall Study|Refusal to continue, not due to AE|3|||
48667709|NCT01719003|156637475|FG006|Overall Study|Refusal to continue, not due to AE|8|||
48667710|NCT01719003|156637476|FG007|Overall Study|Refusal to continue, not due to AE|7|||
48667711|NCT01719003|156637477|FG008|Overall Study|Refusal to continue, not due to AE|1|||
48667712|NCT01719003|156637469|FG000|Overall Study|Reason other than those specified|0|||
48667713|NCT01719003|156637470|FG001|Overall Study|Reason other than those specified|0|||
48667714|NCT01719003|156637471|FG002|Overall Study|Reason other than those specified|2|||
48667715|NCT01719003|156637472|FG003|Overall Study|Reason other than those specified|3|||
48667716|NCT01719003|156637473|FG004|Overall Study|Reason other than those specified|4|||
48667717|NCT01719003|156637474|FG005|Overall Study|Reason other than those specified|1|||
48667718|NCT01719003|156637475|FG006|Overall Study|Reason other than those specified|0|||
48667719|NCT01719003|156637476|FG007|Overall Study|Reason other than those specified|3|||
48667720|NCT01719003|156637477|FG008|Overall Study|Reason other than those specified|1|||
48667721|NCT01719003|156637469|FG000|Overall Study|Lack of Efficacy|0|||
48667722|NCT01719003|156637470|FG001|Overall Study|Lack of Efficacy|0|||
48667723|NCT01719003|156637471|FG002|Overall Study|Lack of Efficacy|0|||
48667724|NCT01719003|156637472|FG003|Overall Study|Lack of Efficacy|0|||
48667725|NCT01719003|156637473|FG004|Overall Study|Lack of Efficacy|0|||
48667726|NCT01719003|156637474|FG005|Overall Study|Lack of Efficacy|0|||
48667727|NCT01719003|156637475|FG006|Overall Study|Lack of Efficacy|1|||
48667728|NCT01719003|156637476|FG007|Overall Study|Lack of Efficacy|0|||
48667729|NCT01719003|156637477|FG008|Overall Study|Lack of Efficacy|0|||
48667730|NCT03283150|156637482|FG000|Overall Study|Withdrawal by Subject|6|||
48667731|NCT03283150|156637483|FG001|Overall Study|Withdrawal by Subject|0|||
48667732|NCT03283150|156637484|FG002|Overall Study|Withdrawal by Subject|0|||
48667733|NCT01143896|156637485|FG000|Overall Study|Did not complete Baseline Interview|5|||
48667734|NCT01143896|156637486|FG001|Overall Study|Did not complete Baseline Interview|4|||
48667735|NCT01143896|156637485|FG000|Overall Study|Lost to Follow-up|18|||
48667736|NCT01143896|156637486|FG001|Overall Study|Lost to Follow-up|13|||
48667737|NCT01143896|156637485|FG000|Overall Study|Withdrawal by Subject|13|||
48667738|NCT01143896|156637486|FG001|Overall Study|Withdrawal by Subject|5|||
48667739|NCT01143896|156637485|FG000|Overall Study|Death|6|||
48667740|NCT01143896|156637486|FG001|Overall Study|Death|3|||
48667741|NCT02084238|156637489|FG000|Overall Study|Lost to Follow-up|2|||
48758465|NCT02153112|156962818|FG002|Overall Study|Withdrawal by Subject|2|||
48868560|NCT03260894|157355592|FG001|Overall Study|Withdrawal by Subject|11|||
48868561|NCT03260894|157355591|FG000|Overall Study|On-going at clinical cut off date|36|||
48868562|NCT03260894|157355592|FG001|Overall Study|On-going at clinical cut off date|31|||
48868563|NCT02864147|157355593|FG000|Overall Study|Withdrawal by Subject|3|||
48868564|NCT02864147|157355594|FG001|Overall Study|Withdrawal by Subject|2|||
48868565|NCT02864147|157355595|FG002|Overall Study|Withdrawal by Subject|1|||
48868566|NCT02864147|157355593|FG000|Overall Study|Lost to Follow-up|0|||
48868567|NCT02864147|157355594|FG001|Overall Study|Lost to Follow-up|4|||
48868568|NCT02864147|157355595|FG002|Overall Study|Lost to Follow-up|0|||
48868569|NCT02864147|157355593|FG000|Overall Study|Adverse Event|0|||
48868570|NCT02864147|157355594|FG001|Overall Study|Adverse Event|1|||
48868571|NCT02864147|157355595|FG002|Overall Study|Adverse Event|0|||
48868572|NCT02864147|157355593|FG000|Overall Study|Pregnancy|4|||
48868573|NCT02864147|157355594|FG001|Overall Study|Pregnancy|0|||
48868574|NCT02864147|157355595|FG002|Overall Study|Pregnancy|0|||
48868575|NCT02864147|157355593|FG000|Overall Study|Physician Decision|0|||
48868576|NCT02864147|157355594|FG001|Overall Study|Physician Decision|0|||
48868577|NCT02864147|157355595|FG002|Overall Study|Physician Decision|1|||
48868578|NCT02864147|157355593|FG000|Overall Study|Opted for excisional procedures|0|||
48868579|NCT02864147|157355594|FG001|Overall Study|Opted for excisional procedures|0|||
48868580|NCT02864147|157355595|FG002|Overall Study|Opted for excisional procedures|3|||
48868581|NCT00312845|157355596|FG000|Overall Study|Adverse Event|19|||
48868582|NCT00312845|157355597|FG001|Overall Study|Adverse Event|5|||
48868583|NCT00312845|157355596|FG000|Overall Study|Death|2|||
48868584|NCT00312845|157355597|FG001|Overall Study|Death|2|||
48868585|NCT00312845|157355596|FG000|Overall Study|Withdrawal by Subject|14|||
48868586|NCT00312845|157355597|FG001|Overall Study|Withdrawal by Subject|6|||
48868587|NCT00312845|157355596|FG000|Overall Study|Disease Progression|56|||
48868588|NCT00312845|157355597|FG001|Overall Study|Disease Progression|77|||
48868589|NCT00312845|157355596|FG000|Overall Study|Lost to Follow-up|2|||
48868590|NCT00312845|157355597|FG001|Overall Study|Lost to Follow-up|0|||
48868591|NCT00312845|157355596|FG000|Overall Study|Other|6|||
48868592|NCT00312845|157355597|FG001|Overall Study|Other|5|||
48868593|NCT01221948|157355598|FG000|Overall Study|Physician Decision|5|||
48868594|NCT01221948|157355598|FG000|Overall Study|Withdrawal by Subject|2|||
48968073|NCT00617656|157710737|FG001|Overall Study|Withdrawal by Subject|2|||
48667742|NCT04375397|156637492|FG000|Overall Study|Death|1|||
48667743|NCT04375397|156637493|FG001|Overall Study|Death|1|||
48667744|NCT04375397|156637492|FG000|Overall Study|Withdrew consent|2|||
48667745|NCT04375397|156637493|FG001|Overall Study|Withdrew consent|0|||
48667746|NCT04375397|156637492|FG000|Overall Study|Lost to Follow-up|6|||
48667747|NCT04375397|156637493|FG001|Overall Study|Lost to Follow-up|4|||
48667748|NCT04375397|156637492|FG000|Overall Study|Other, not specified|0|||
48667749|NCT04375397|156637493|FG001|Overall Study|Other, not specified|1|||
48667750|NCT03412604|156637494|FG000|Overall Study|Withdrawal by Subject|1|||
48667751|NCT05545644|156637496|FG000|Overall Study|Lost to Follow-up|4|||
48667752|NCT05545644|156637497|FG001|Overall Study|Lost to Follow-up|3|||
48667753|NCT03242252|156637498|FG000|Overall Study|At the Participant's own Request|18|||
48667754|NCT03242252|156637499|FG001|Overall Study|At the Participant's own Request|10|||
48667755|NCT03242252|156637500|FG002|Overall Study|At the Participant's own Request|15|||
48667756|NCT03242252|156637498|FG000|Overall Study|Adverse Event|8|||
48667757|NCT03242252|156637499|FG001|Overall Study|Adverse Event|6|||
48667758|NCT03242252|156637500|FG002|Overall Study|Adverse Event|9|||
48667759|NCT03242252|156637498|FG000|Overall Study|Poor Compliance to Protocol|0|||
48667760|NCT03242252|156637499|FG001|Overall Study|Poor Compliance to Protocol|2|||
48667761|NCT03242252|156637500|FG002|Overall Study|Poor Compliance to Protocol|3|||
48667762|NCT03242252|156637498|FG000|Overall Study|Study Terminated by Sponsor|1|||
48758466|NCT02153112|156962819|FG003|Overall Study|Withdrawal by Subject|2|||
48758467|NCT02153112|156962820|FG004|Overall Study|Withdrawal by Subject|1|||
48868595|NCT01221948|157355598|FG000|Overall Study|not disclosed|2|||
48667763|NCT03242252|156637499|FG001|Overall Study|Study Terminated by Sponsor|0|||
48667764|NCT03242252|156637500|FG002|Overall Study|Study Terminated by Sponsor|0|||
48667765|NCT03242252|156637498|FG000|Overall Study|Reason not Specified|4|||
48667766|NCT03242252|156637499|FG001|Overall Study|Reason not Specified|4|||
48667767|NCT03242252|156637500|FG002|Overall Study|Reason not Specified|1|||
48667768|NCT03242252|156637498|FG000|Overall Study|Lost to Follow-up|5|||
48667769|NCT03242252|156637499|FG001|Overall Study|Lost to Follow-up|1|||
48667770|NCT03242252|156637500|FG002|Overall Study|Lost to Follow-up|4|||
48667771|NCT00993499|156637507|FG000|Run-in Period (8 Days)|Adverse Event|0|||
48667772|NCT00993499|156637508|FG001|Run-in Period (8 Days)|Adverse Event|1|||
48667773|NCT00993499|156637509|FG002|Run-in Period (8 Days)|Adverse Event|0|||
48667774|NCT00993499|156637510|FG003|Run-in Period (8 Days)|Adverse Event|0|||
48667775|NCT00993499|156637511|FG004|Run-in Period (8 Days)|Adverse Event|0|||
48667776|NCT00993499|156637512|FG005|Run-in Period (8 Days)|Adverse Event|0|||
48667777|NCT00993499|156637507|FG000|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1|||
48667778|NCT00993499|156637508|FG001|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
48667779|NCT00993499|156637509|FG002|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
48667780|NCT00993499|156637510|FG003|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
48667781|NCT00993499|156637511|FG004|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
48667782|NCT00993499|156637512|FG005|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
48667783|NCT00993499|156637507|FG000|Run-in Period (8 Days)|Consent withdrawn|0|||
48667784|NCT00993499|156637508|FG001|Run-in Period (8 Days)|Consent withdrawn|1|||
48667785|NCT00993499|156637509|FG002|Run-in Period (8 Days)|Consent withdrawn|0|||
48667786|NCT00993499|156637510|FG003|Run-in Period (8 Days)|Consent withdrawn|0|||
48667787|NCT00993499|156637511|FG004|Run-in Period (8 Days)|Consent withdrawn|0|||
48667788|NCT00993499|156637512|FG005|Run-in Period (8 Days)|Consent withdrawn|0|||
48667789|NCT00993499|156637507|FG000|Run-in Period (8 Days)|Progressive disease|0|||
48667790|NCT00993499|156637508|FG001|Run-in Period (8 Days)|Progressive disease|1|||
48667791|NCT00993499|156637509|FG002|Run-in Period (8 Days)|Progressive disease|1|||
48667792|NCT00993499|156637510|FG003|Run-in Period (8 Days)|Progressive disease|0|||
48667793|NCT00993499|156637511|FG004|Run-in Period (8 Days)|Progressive disease|0|||
48667794|NCT00993499|156637512|FG005|Run-in Period (8 Days)|Progressive disease|0|||
48667795|NCT00993499|156637507|FG000|Discontinued Before Starting Course 3|Progressive Disease|2|||
48667796|NCT00993499|156637508|FG001|Discontinued Before Starting Course 3|Progressive Disease|2|||
48667797|NCT00993499|156637509|FG002|Discontinued Before Starting Course 3|Progressive Disease|0|||
48667798|NCT00993499|156637510|FG003|Discontinued Before Starting Course 3|Progressive Disease|0|||
48667799|NCT00993499|156637511|FG004|Discontinued Before Starting Course 3|Progressive Disease|0|||
48667800|NCT00993499|156637512|FG005|Discontinued Before Starting Course 3|Progressive Disease|0|||
48667801|NCT00993499|156637507|FG000|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
48667802|NCT00993499|156637508|FG001|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
48667803|NCT00993499|156637509|FG002|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
48868596|NCT01221948|157355598|FG000|Overall Study|Death|1|||
48868597|NCT01221948|157355598|FG000|Overall Study|Protocol Violation|4|||
48868598|NCT02865135|157355599|FG000|Overall Study|Death|0|||
48868599|NCT02865135|157355600|FG001|Overall Study|Death|1|||
48868600|NCT02865135|157355601|FG002|Overall Study|Death|0|||
48868601|NCT02865135|157355599|FG000|Overall Study|Progression|6|||
48868602|NCT02865135|157355600|FG001|Overall Study|Progression|2|||
48868603|NCT02865135|157355601|FG002|Overall Study|Progression|2|||
48868604|NCT02212197|157355602|FG000|Overall Study|Need for radiotherapy|1|||
48868605|NCT02212197|157355603|FG001|Overall Study|Need for radiotherapy|0|||
48758468|NCT02153112|156962821|FG005|Overall Study|Withdrawal by Subject|1|||
48758469|NCT02153112|156962822|FG006|Overall Study|Withdrawal by Subject|7|||
48758470|NCT02153112|156962823|FG007|Overall Study|Withdrawal by Subject|2|||
48758471|NCT02153112|156962824|FG008|Overall Study|Withdrawal by Subject|13|||
48758472|NCT02153112|156962825|FG009|Overall Study|Withdrawal by Subject|12|||
48758473|NCT02153112|156962816|FG000|Overall Study|Reason not Specified|0|||
48758474|NCT02153112|156962817|FG001|Overall Study|Reason not Specified|0|||
48758475|NCT02153112|156962818|FG002|Overall Study|Reason not Specified|0|||
48758476|NCT02153112|156962819|FG003|Overall Study|Reason not Specified|0|||
48758477|NCT02153112|156962820|FG004|Overall Study|Reason not Specified|0|||
48758478|NCT02153112|156962821|FG005|Overall Study|Reason not Specified|0|||
48758479|NCT02153112|156962822|FG006|Overall Study|Reason not Specified|0|||
48758480|NCT02153112|156962823|FG007|Overall Study|Reason not Specified|0|||
48758481|NCT02153112|156962824|FG008|Overall Study|Reason not Specified|1|||
48758482|NCT02153112|156962825|FG009|Overall Study|Reason not Specified|1|||
48758483|NCT00309842|156962826|FG000|Overall Study|Lost to Follow-up|1|||
48758484|NCT00561080|156962827|FG000|Vaccination Period (up to Month 4)|Adverse Event|0|||
48758485|NCT00561080|156962828|FG001|Vaccination Period (up to Month 4)|Adverse Event|4|||
48758486|NCT00561080|156962829|FG002|Vaccination Period (up to Month 4)|Adverse Event|6|||
48758487|NCT00561080|156962827|FG000|Vaccination Period (up to Month 4)|Definitive Contra-indication|0|||
48758488|NCT00561080|156962828|FG001|Vaccination Period (up to Month 4)|Definitive Contra-indication|2|||
48758489|NCT00561080|156962829|FG002|Vaccination Period (up to Month 4)|Definitive Contra-indication|3|||
48758490|NCT00561080|156962827|FG000|Vaccination Period (up to Month 4)|Protocol Violation|0|||
48758491|NCT00561080|156962828|FG001|Vaccination Period (up to Month 4)|Protocol Violation|1|||
48758492|NCT00561080|156962829|FG002|Vaccination Period (up to Month 4)|Protocol Violation|3|||
48758493|NCT00561080|156962827|FG000|Vaccination Period (up to Month 4)|Withdrawal by Subject|3|||
48758494|NCT00561080|156962828|FG001|Vaccination Period (up to Month 4)|Withdrawal by Subject|16|||
48758495|NCT00561080|156962829|FG002|Vaccination Period (up to Month 4)|Withdrawal by Subject|13|||
48968074|NCT00617656|157710738|FG002|Overall Study|Withdrawal by Subject|0|||
48968075|NCT00617656|157710739|FG003|Overall Study|Withdrawal by Subject|0|||
48968076|NCT02483078|157710740|FG000|Part 1 One-week Randomized|Lost to Follow-up|0|||
48968077|NCT02483078|157710741|FG001|Part 1 One-week Randomized|Lost to Follow-up|1|||
48968078|NCT02483078|157710740|FG000|Part 2 Open Label Treatment Period|Non-medical|0|||
48968079|NCT02483078|157710741|FG001|Part 2 Open Label Treatment Period|Non-medical|1|||
48968080|NCT02483078|157710740|FG000|Part 2 Open Label Treatment Period|Withdrawal by Subject|0|||
48968081|NCT02483078|157710741|FG001|Part 2 Open Label Treatment Period|Withdrawal by Subject|1|||
48968082|NCT02483078|157710740|FG000|Part 2 Open Label Treatment Period|Subject non compliant|0|||
48968083|NCT02483078|157710741|FG001|Part 2 Open Label Treatment Period|Subject non compliant|1|||
48968084|NCT02483078|157710740|FG000|Part 2 Open Label Treatment Period|Lost to Follow-up|0|||
48968085|NCT02483078|157710741|FG001|Part 2 Open Label Treatment Period|Lost to Follow-up|1|||
48968086|NCT02483078|157710740|FG000|Part 2 Open Label Treatment Period|Adverse Event|0|||
48968087|NCT02483078|157710741|FG001|Part 2 Open Label Treatment Period|Adverse Event|1|||
48968088|NCT00795509|157710742|FG000|Overall Study|Protocol Violation|31|||
48968089|NCT02849626|157710747|FG000|Core Phase (up to 23 Weeks)|Adverse Event|11|||
48968090|NCT02849626|157710748|FG001|Core Phase (up to 23 Weeks)|Adverse Event|3|||
48968091|NCT02849626|157710749|FG002|Core Phase (up to 23 Weeks)|Adverse Event|0|||
48968092|NCT02849626|157710750|FG003|Core Phase (up to 23 Weeks)|Adverse Event|0|||
48968093|NCT02849626|157710747|FG000|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7|||
48968094|NCT02849626|157710748|FG001|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2|||
48968095|NCT02849626|157710749|FG002|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
48968096|NCT02849626|157710750|FG003|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
48968097|NCT02849626|157710747|FG000|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6|||
48968098|NCT02849626|157710748|FG001|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2|||
48968099|NCT02849626|157710749|FG002|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
48968100|NCT02849626|157710750|FG003|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
48968101|NCT02849626|157710747|FG000|Core Phase (up to 23 Weeks)|Non-specified|3|||
48968102|NCT02849626|157710748|FG001|Core Phase (up to 23 Weeks)|Non-specified|0|||
48758496|NCT00561080|156962827|FG000|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
48758497|NCT00561080|156962828|FG001|Vaccination Period (up to Month 4)|Lost to Follow-up|1|||
48968103|NCT02849626|157710749|FG002|Core Phase (up to 23 Weeks)|Non-specified|0|||
48968104|NCT02849626|157710750|FG003|Core Phase (up to 23 Weeks)|Non-specified|0|||
48968105|NCT02849626|157710747|FG000|Extension Phase A (up to 29 Weeks)|Adverse Event|3|||
48968106|NCT02849626|157710748|FG001|Extension Phase A (up to 29 Weeks)|Adverse Event|2|||
48968107|NCT02849626|157710749|FG002|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
48968108|NCT02849626|157710750|FG003|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
48968109|NCT02849626|157710747|FG000|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4|||
48968110|NCT02849626|157710748|FG001|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
48968111|NCT02849626|157710749|FG002|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
48758498|NCT00561080|156962829|FG002|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
48968112|NCT02849626|157710750|FG003|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
48968113|NCT02849626|157710747|FG000|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|3|||
48968114|NCT02849626|157710748|FG001|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|1|||
48968115|NCT02849626|157710749|FG002|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
48968116|NCT02849626|157710750|FG003|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
48968117|NCT02849626|157710747|FG000|Extension Phase A (up to 29 Weeks)|Non-specified|1|||
48968118|NCT02849626|157710748|FG001|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
48968119|NCT02849626|157710749|FG002|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
48968120|NCT02849626|157710750|FG003|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
48968121|NCT02849626|157710747|FG000|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
48968122|NCT02849626|157710748|FG001|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
48968123|NCT02849626|157710749|FG002|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|3|||
48968124|NCT02849626|157710750|FG003|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
48968125|NCT02849626|157710747|FG000|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
48968126|NCT02849626|157710748|FG001|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
48968127|NCT02849626|157710749|FG002|Extension Phase B (up to 89 Weeks)|Participant choice|1|||
48968128|NCT02849626|157710750|FG003|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
48968129|NCT02849626|157710747|FG000|Extension Phase B (up to 89 Weeks)|Other|0|||
48968130|NCT02849626|157710748|FG001|Extension Phase B (up to 89 Weeks)|Other|0|||
48968131|NCT02849626|157710749|FG002|Extension Phase B (up to 89 Weeks)|Other|1|||
48968132|NCT02849626|157710750|FG003|Extension Phase B (up to 89 Weeks)|Other|0|||
48968133|NCT00889681|157710751|FG000|Overall Study|Not meeting qualification Criteria|2|||
48968134|NCT00889681|157710751|FG000|Overall Study|Insurance disapproval|1|||
48968135|NCT00631540|157710752|FG000|Overall Study|Withdrawal by Subject|5|||
48968136|NCT00631540|157710752|FG000|Overall Study|Death|4|||
48968137|NCT00631540|157710752|FG000|Overall Study|Lost to Follow-up|2|||
48968138|NCT00631540|157710752|FG000|Overall Study|Core Lab Data Unavailable|3|||
48968139|NCT00593840|157710753|FG000|Overall Study|Withdrawal by Subject|1|||
48968140|NCT00871572|157710754|FG000|Overall Study|Adverse Event|0|||
48968141|NCT00871572|157710755|FG001|Overall Study|Adverse Event|2|||
48968142|NCT00871572|157710756|FG002|Overall Study|Adverse Event|0|||
48968143|NCT00871572|157710757|FG003|Overall Study|Adverse Event|3|||
48968144|NCT00871572|157710754|FG000|Overall Study|Investigator Decision|0|||
48968145|NCT00871572|157710755|FG001|Overall Study|Investigator Decision|1|||
48968146|NCT00871572|157710756|FG002|Overall Study|Investigator Decision|0|||
48968147|NCT00871572|157710757|FG003|Overall Study|Investigator Decision|1|||
48968148|NCT00871572|157710754|FG000|Overall Study|Lost to Follow-up|0|||
48968149|NCT00871572|157710755|FG001|Overall Study|Lost to Follow-up|1|||
48968150|NCT00871572|157710756|FG002|Overall Study|Lost to Follow-up|0|||
48968151|NCT00871572|157710757|FG003|Overall Study|Lost to Follow-up|1|||
48968152|NCT00871572|157710754|FG000|Overall Study|Protocol Violation|0|||
48968153|NCT00871572|157710755|FG001|Overall Study|Protocol Violation|0|||
48968154|NCT00871572|157710756|FG002|Overall Study|Protocol Violation|1|||
48968155|NCT00871572|157710757|FG003|Overall Study|Protocol Violation|1|||
48968156|NCT00871572|157710754|FG000|Overall Study|Sponsor Decision|1|||
48968157|NCT00871572|157710755|FG001|Overall Study|Sponsor Decision|0|||
48968158|NCT00871572|157710756|FG002|Overall Study|Sponsor Decision|0|||
48968159|NCT00871572|157710757|FG003|Overall Study|Sponsor Decision|0|||
48968160|NCT00871572|157710754|FG000|Overall Study|Withdrawal by Subject|1|||
48968161|NCT00871572|157710755|FG001|Overall Study|Withdrawal by Subject|2|||
48868606|NCT02212197|157355604|FG002|Overall Study|Need for radiotherapy|0|||
48868607|NCT03015181|157355605|FG000|Overall Study|Enrolled, but product never administered|1|||
48868608|NCT03015181|157355606|FG001|Overall Study|Enrolled, but product never administered|0|||
48868609|NCT03015181|157355607|FG002|Overall Study|Enrolled, but product never administered|0|||
48868610|NCT03015181|157355608|FG003|Overall Study|Enrolled, but product never administered|0|||
48868611|NCT03015181|157355609|FG004|Overall Study|Enrolled, but product never administered|0|||
48868612|NCT03015181|157355610|FG005|Overall Study|Enrolled, but product never administered|0|||
48868613|NCT03015181|157355611|FG006|Overall Study|Enrolled, but product never administered|0|||
48968162|NCT00871572|157710756|FG002|Overall Study|Withdrawal by Subject|3|||
48968163|NCT00871572|157710757|FG003|Overall Study|Withdrawal by Subject|1|||
48868614|NCT03015181|157355605|FG000|Overall Study|Withdrawal by Subject|0|||
48868615|NCT03015181|157355606|FG001|Overall Study|Withdrawal by Subject|0|||
48868616|NCT03015181|157355607|FG002|Overall Study|Withdrawal by Subject|0|||
48968164|NCT01185704|157710758|FG000|Overall Study|Randomized but not treated|3|||
48968165|NCT01185704|157710759|FG001|Overall Study|Randomized but not treated|3|||
48968166|NCT01185704|157710758|FG000|Overall Study|Lack of ovarian response|5|||
48968167|NCT01185704|157710759|FG001|Overall Study|Lack of ovarian response|1|||
48968168|NCT01185704|157710758|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|5|||
48968169|NCT01185704|157710759|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
48968170|NCT01185704|157710758|FG000|Overall Study|Ectopic pregnancy|0|||
48868617|NCT03015181|157355608|FG003|Overall Study|Withdrawal by Subject|0|||
48968171|NCT01185704|157710759|FG001|Overall Study|Ectopic pregnancy|1|||
48968172|NCT01654523|157710761|FG000|Overall Study|Withdrawal by Subject|1|||
49015476|NCT01393990|157893772|FG002|Overall Study|Death|0|||
48758499|NCT00561080|156962827|FG000|Vaccination Period (up to Month 4)|Other|0|||
48758500|NCT00561080|156962828|FG001|Vaccination Period (up to Month 4)|Other|2|||
48758501|NCT00561080|156962829|FG002|Vaccination Period (up to Month 4)|Other|1|||
48758502|NCT00561080|156962827|FG000|12-month Post Last Dose Follow-up|Adverse Event|3|||
48758503|NCT00561080|156962828|FG001|12-month Post Last Dose Follow-up|Adverse Event|3|||
48758504|NCT00561080|156962829|FG002|12-month Post Last Dose Follow-up|Adverse Event|1|||
48758505|NCT00561080|156962827|FG000|12-month Post Last Dose Follow-up|Protocol Violation|0|||
48758506|NCT00561080|156962828|FG001|12-month Post Last Dose Follow-up|Protocol Violation|0|||
48758507|NCT00561080|156962829|FG002|12-month Post Last Dose Follow-up|Protocol Violation|4|||
48758508|NCT00561080|156962827|FG000|12-month Post Last Dose Follow-up|Withdrawal by Subject|2|||
48758509|NCT00561080|156962828|FG001|12-month Post Last Dose Follow-up|Withdrawal by Subject|6|||
48758510|NCT00561080|156962829|FG002|12-month Post Last Dose Follow-up|Withdrawal by Subject|5|||
48758511|NCT00561080|156962827|FG000|12-month Post Last Dose Follow-up|Lost to Follow-up|2|||
48758512|NCT00561080|156962828|FG001|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
48758513|NCT00561080|156962829|FG002|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
48758514|NCT03519347|156962834|FG000|Interventional Crossover Period 1|Death|0|||
48758515|NCT03519347|156962835|FG001|Interventional Crossover Period 1|Death|0|||
48758516|NCT03519347|156962836|FG002|Interventional Crossover Period 1|Death|0|||
48758517|NCT03519347|156962837|FG003|Interventional Crossover Period 1|Death|1|||
48758518|NCT00982488|156964571|FG000|Overall Study|Administrative reason by sponsor|81|||
48758519|NCT00982488|156964572|FG001|Overall Study|Administrative reason by sponsor|3|||
48758520|NCT00982488|156964573|FG002|Overall Study|Administrative reason by sponsor|11|||
48758521|NCT00982488|156964574|FG003|Overall Study|Administrative reason by sponsor|0|||
48758522|NCT00982488|156964575|FG004|Overall Study|Administrative reason by sponsor|0|||
48758523|NCT00982488|156964571|FG000|Overall Study|Adverse event unrelated to study drug|5|||
48758524|NCT00982488|156964572|FG001|Overall Study|Adverse event unrelated to study drug|1|||
48758525|NCT00982488|156964573|FG002|Overall Study|Adverse event unrelated to study drug|0|||
48758526|NCT00982488|156964574|FG003|Overall Study|Adverse event unrelated to study drug|0|||
48758527|NCT00982488|156964575|FG004|Overall Study|Adverse event unrelated to study drug|0|||
48758528|NCT00982488|156964571|FG000|Overall Study|Death|11|||
48758529|NCT00982488|156964572|FG001|Overall Study|Death|0|||
48758530|NCT00982488|156964573|FG002|Overall Study|Death|2|||
48758531|NCT00982488|156964574|FG003|Overall Study|Death|0|||
48758532|NCT00982488|156964575|FG004|Overall Study|Death|0|||
48758533|NCT00982488|156964571|FG000|Overall Study|Disease progression|30|||
48758534|NCT00982488|156964572|FG001|Overall Study|Disease progression|5|||
48758535|NCT00982488|156964573|FG002|Overall Study|Disease progression|10|||
48758536|NCT00982488|156964574|FG003|Overall Study|Disease progression|1|||
48758537|NCT00982488|156964575|FG004|Overall Study|Disease progression|1|||
48758538|NCT00982488|156964571|FG000|Overall Study|Lost to Follow-up|1|||
48758539|NCT00982488|156964572|FG001|Overall Study|Lost to Follow-up|0|||
48758540|NCT00982488|156964573|FG002|Overall Study|Lost to Follow-up|0|||
48758541|NCT00982488|156964574|FG003|Overall Study|Lost to Follow-up|0|||
48758542|NCT00982488|156964575|FG004|Overall Study|Lost to Follow-up|0|||
48758543|NCT00982488|156964571|FG000|Overall Study|Maximum clinical benefit|1|||
48758544|NCT00982488|156964572|FG001|Overall Study|Maximum clinical benefit|1|||
48758545|NCT00982488|156964573|FG002|Overall Study|Maximum clinical benefit|1|||
48758546|NCT00982488|156964574|FG003|Overall Study|Maximum clinical benefit|0|||
48758547|NCT00982488|156964575|FG004|Overall Study|Maximum clinical benefit|0|||
48758548|NCT00982488|156964571|FG000|Overall Study|Other|15|||
48758549|NCT00982488|156964572|FG001|Overall Study|Other|1|||
48758550|NCT00982488|156964573|FG002|Overall Study|Other|3|||
48758551|NCT00982488|156964574|FG003|Overall Study|Other|1|||
48758552|NCT00982488|156964575|FG004|Overall Study|Other|0|||
48758553|NCT00982488|156964571|FG000|Overall Study|Poor compliance/noncompliance|0|||
48758554|NCT00982488|156964572|FG001|Overall Study|Poor compliance/noncompliance|1|||
48758555|NCT00982488|156964573|FG002|Overall Study|Poor compliance/noncompliance|0|||
48758556|NCT00982488|156964574|FG003|Overall Study|Poor compliance/noncompliance|0|||
48758557|NCT00982488|156964575|FG004|Overall Study|Poor compliance/noncompliance|0|||
48758558|NCT00982488|156964571|FG000|Overall Study|Stem cell transplant|2|||
48758559|NCT00982488|156964572|FG001|Overall Study|Stem cell transplant|0|||
48758560|NCT00982488|156964573|FG002|Overall Study|Stem cell transplant|0|||
48758561|NCT00982488|156964574|FG003|Overall Study|Stem cell transplant|1|||
48758562|NCT00982488|156964575|FG004|Overall Study|Stem cell transplant|0|||
48758563|NCT00982488|156964571|FG000|Overall Study|Study drug toxicity|34|||
48758564|NCT00982488|156964572|FG001|Overall Study|Study drug toxicity|1|||
48758565|NCT00982488|156964573|FG002|Overall Study|Study drug toxicity|6|||
48758566|NCT00982488|156964574|FG003|Overall Study|Study drug toxicity|0|||
48758567|NCT00982488|156964575|FG004|Overall Study|Study drug toxicity|0|||
48758568|NCT00982488|156964571|FG000|Overall Study|Withdrawal by Subject|5|||
48758569|NCT00982488|156964572|FG001|Overall Study|Withdrawal by Subject|1|||
48758570|NCT00982488|156964573|FG002|Overall Study|Withdrawal by Subject|1|||
48758571|NCT00982488|156964574|FG003|Overall Study|Withdrawal by Subject|0|||
48758572|NCT00982488|156964575|FG004|Overall Study|Withdrawal by Subject|0|||
48758573|NCT00463346|156964576|FG000|Overall Study|Withdrawal by Subject|3|||
48868618|NCT03015181|157355609|FG004|Overall Study|Withdrawal by Subject|0|||
48868619|NCT03015181|157355610|FG005|Overall Study|Withdrawal by Subject|1|||
48868620|NCT03015181|157355611|FG006|Overall Study|Withdrawal by Subject|0|||
48868621|NCT03015181|157355605|FG000|Overall Study|Physician Decision|0|||
48667804|NCT00993499|156637510|FG003|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
48667805|NCT00993499|156637511|FG004|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
48667806|NCT00993499|156637512|FG005|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
48667807|NCT00993499|156637507|FG000|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
48667808|NCT00993499|156637508|FG001|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
48667809|NCT00993499|156637509|FG002|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
48667810|NCT00993499|156637510|FG003|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
48667811|NCT00993499|156637511|FG004|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
48667812|NCT00993499|156637512|FG005|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
48667813|NCT00993499|156637507|FG000|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
48667814|NCT00993499|156637508|FG001|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
48667815|NCT00993499|156637509|FG002|Discontinued Before Starting Course 3|Non compliance with the protocol|2|||
48667816|NCT00993499|156637510|FG003|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
48667817|NCT00993499|156637511|FG004|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
48667818|NCT00993499|156637512|FG005|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
48667819|NCT00993499|156637507|FG000|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
48667820|NCT00993499|156637508|FG001|Discontinued After Starting Course 3|Withdrawal by Subject|1|||
48667821|NCT00993499|156637509|FG002|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
48667822|NCT00993499|156637510|FG003|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
48868622|NCT03015181|157355606|FG001|Overall Study|Physician Decision|0|||
48667823|NCT00993499|156637511|FG004|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
48667824|NCT00993499|156637512|FG005|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
48667825|NCT00993499|156637507|FG000|Discontinued After Starting Course 3|Progressive Disease|6|||
48667826|NCT00993499|156637508|FG001|Discontinued After Starting Course 3|Progressive Disease|4|||
48667827|NCT00993499|156637509|FG002|Discontinued After Starting Course 3|Progressive Disease|3|||
48667828|NCT00993499|156637510|FG003|Discontinued After Starting Course 3|Progressive Disease|1|||
48667829|NCT00993499|156637511|FG004|Discontinued After Starting Course 3|Progressive Disease|3|||
48868623|NCT03015181|157355607|FG002|Overall Study|Physician Decision|0|||
48868624|NCT03015181|157355608|FG003|Overall Study|Physician Decision|0|||
48868625|NCT03015181|157355609|FG004|Overall Study|Physician Decision|0|||
48868626|NCT03015181|157355610|FG005|Overall Study|Physician Decision|0|||
48868627|NCT03015181|157355611|FG006|Overall Study|Physician Decision|1|||
48868628|NCT01077622|157355612|FG000|Overall Study|Physician Decision|2|||
48868629|NCT01077622|157355612|FG000|Overall Study|Withdrawal by Subject|1|||
48868630|NCT02551692|157355615|FG000|Overall Study|Lost to Follow-up|0|||
48868631|NCT02551692|157355616|FG001|Overall Study|Lost to Follow-up|1|||
48868632|NCT02551692|157355617|FG002|Overall Study|Lost to Follow-up|4|||
48868633|NCT02551692|157355615|FG000|Overall Study|Withdrawal by Subject|1|||
48868634|NCT02551692|157355616|FG001|Overall Study|Withdrawal by Subject|0|||
48868635|NCT02551692|157355617|FG002|Overall Study|Withdrawal by Subject|1|||
48868636|NCT03900715|157355618|FG000|Overall Study|Protocol Deviation|1|||
48868637|NCT03900715|157355618|FG000|Overall Study|Lack of Efficacy|1|||
48868638|NCT03900715|157355618|FG000|Overall Study|Progressive Disease|6|||
48868639|NCT03900715|157355618|FG000|Overall Study|Adverse Event|2|||
48868640|NCT03900715|157355618|FG000|Overall Study|Other reasons|11|||
48868641|NCT01123642|157356906|FG000|Overall Study|Lost to Follow-up|23|||
48868642|NCT01123642|157356906|FG000|Overall Study|Withdrawal by Subject|9|||
48868643|NCT01123642|157356906|FG000|Overall Study|ineligible at baseline assessment|36|||
48868644|NCT00088452|157356907|FG000|Overall Study|Did not receive intervention|1|||
48868645|NCT00088452|157356908|FG001|Overall Study|Did not receive intervention|0|||
48667830|NCT00993499|156637512|FG005|Discontinued After Starting Course 3|Progressive Disease|3|||
48667831|NCT00993499|156637507|FG000|Discontinued After Starting Course 3|DLT|1|||
48667832|NCT00993499|156637508|FG001|Discontinued After Starting Course 3|DLT|0|||
48667833|NCT00993499|156637509|FG002|Discontinued After Starting Course 3|DLT|2|||
48667834|NCT00993499|156637510|FG003|Discontinued After Starting Course 3|DLT|1|||
48667835|NCT00993499|156637511|FG004|Discontinued After Starting Course 3|DLT|0|||
48667836|NCT00993499|156637512|FG005|Discontinued After Starting Course 3|DLT|0|||
48667837|NCT00993499|156637507|FG000|Discontinued After Starting Course 3|Other adverse event|1|||
48667838|NCT00993499|156637508|FG001|Discontinued After Starting Course 3|Other adverse event|0|||
48868646|NCT00088452|157356909|FG002|Overall Study|Did not receive intervention|1|||
48868647|NCT00143598|157356911|FG000|Overall Study|Lost to Follow-up|23|||
48868648|NCT00143598|157356912|FG001|Overall Study|Lost to Follow-up|21|||
48868649|NCT00143598|157356911|FG000|Overall Study|Withdrawal by Subject|33|||
48868650|NCT00143598|157356912|FG001|Overall Study|Withdrawal by Subject|37|||
48868651|NCT00143598|157356911|FG000|Overall Study|Death|36|||
48868652|NCT00143598|157356912|FG001|Overall Study|Death|36|||
48667839|NCT00993499|156637509|FG002|Discontinued After Starting Course 3|Other adverse event|1|||
48667840|NCT00993499|156637510|FG003|Discontinued After Starting Course 3|Other adverse event|0|||
48667841|NCT00993499|156637511|FG004|Discontinued After Starting Course 3|Other adverse event|0|||
48667842|NCT00993499|156637512|FG005|Discontinued After Starting Course 3|Other adverse event|0|||
48667843|NCT02759315|156637513|FG000|Overall Study|Adverse Event|0|||
48667844|NCT02759315|156637514|FG001|Overall Study|Adverse Event|0|||
48667845|NCT02759315|156637515|FG002|Overall Study|Adverse Event|0|||
48667846|NCT02759315|156637516|FG003|Overall Study|Adverse Event|1|||
48667847|NCT02759315|156637517|FG004|Overall Study|Adverse Event|0|||
48667848|NCT02759315|156637513|FG000|Overall Study|Death|0|||
48667849|NCT02759315|156637514|FG001|Overall Study|Death|0|||
48667850|NCT02759315|156637515|FG002|Overall Study|Death|1|||
48667851|NCT02759315|156637516|FG003|Overall Study|Death|0|||
48667852|NCT02759315|156637517|FG004|Overall Study|Death|0|||
48667853|NCT02759315|156637513|FG000|Overall Study|Lost to Follow-up|2|||
48667854|NCT02759315|156637514|FG001|Overall Study|Lost to Follow-up|0|||
48667855|NCT02759315|156637515|FG002|Overall Study|Lost to Follow-up|4|||
48667856|NCT02759315|156637516|FG003|Overall Study|Lost to Follow-up|0|||
48667857|NCT02759315|156637517|FG004|Overall Study|Lost to Follow-up|0|||
48667858|NCT02759315|156637513|FG000|Overall Study|Protocol Violation|0|||
48667859|NCT02759315|156637514|FG001|Overall Study|Protocol Violation|1|||
48667860|NCT02759315|156637515|FG002|Overall Study|Protocol Violation|0|||
48667861|NCT02759315|156637516|FG003|Overall Study|Protocol Violation|0|||
48667862|NCT02759315|156637517|FG004|Overall Study|Protocol Violation|0|||
48868653|NCT01589523|157356914|FG000|Overall Study|Withdrawal by Subject|1|||
48868654|NCT01145417|157356924|FG000|Overall Study|Death|1|||
48868655|NCT01145417|157356925|FG001|Overall Study|Death|0|||
48868656|NCT01145417|157356924|FG000|Overall Study|Lost to Follow-up|2|||
48868657|NCT01145417|157356925|FG001|Overall Study|Lost to Follow-up|1|||
48868658|NCT01145417|157356924|FG000|Overall Study|Withdrawal by Subject|1|||
48868659|NCT01145417|157356925|FG001|Overall Study|Withdrawal by Subject|2|||
48868660|NCT01145417|157356924|FG000|Overall Study|Pregnancy|1|||
48868661|NCT01145417|157356925|FG001|Overall Study|Pregnancy|0|||
48868662|NCT01145417|157356924|FG000|Overall Study|Adverse Event|0|||
48868663|NCT01145417|157356925|FG001|Overall Study|Adverse Event|1|||
48868664|NCT01145417|157356924|FG000|Overall Study|Study terminated by sponsor|35|||
48868665|NCT01145417|157356925|FG001|Overall Study|Study terminated by sponsor|43|||
48868666|NCT01145417|157356924|FG000|Overall Study|Other|1|||
48868667|NCT01145417|157356925|FG001|Overall Study|Other|0|||
48868668|NCT01191697|157356928|FG000|Overall Study|Death|1|||
48868669|NCT01191697|157356928|FG000|Overall Study|Physician Decision|2|||
48868670|NCT01191697|157356928|FG000|Overall Study|Pursue chemoradiation|2|||
48868671|NCT01191697|157356928|FG000|Overall Study|Break from chemotherapy|2|||
48868672|NCT01191697|157356928|FG000|Overall Study|Withdrawal by Subject|1|||
48868673|NCT01191697|157356928|FG000|Overall Study|Surveillance|1|||
48868674|NCT01191697|157356928|FG000|Overall Study|Adverse Event|2|||
48868675|NCT01191697|157356928|FG000|Overall Study|Subject never received treatment and wasn't analyzed.|1|||
48868676|NCT01191697|157356928|FG000|Overall Study|Not completed but analyzed|25|||
48868677|NCT05060237|157356930|FG000|Overall Study|Withdrawal by Subject|4|||
48868678|NCT05060237|157356930|FG000|Overall Study|Screening failure|8|||
48868679|NCT00265096|157356937|FG000|Overall Study|Adverse Event|14|||
48667863|NCT02759315|156637513|FG000|Overall Study|Study terminated prior to completion|2|||
48667864|NCT02759315|156637514|FG001|Overall Study|Study terminated prior to completion|0|||
48667865|NCT02759315|156637515|FG002|Overall Study|Study terminated prior to completion|5|||
48667866|NCT02759315|156637516|FG003|Overall Study|Study terminated prior to completion|0|||
48667867|NCT02759315|156637517|FG004|Overall Study|Study terminated prior to completion|1|||
48667868|NCT00870194|156637523|FG000|Overall Study|Adverse Event|10|||
48667869|NCT00870194|156637524|FG001|Overall Study|Adverse Event|5|||
48667870|NCT00870194|156637523|FG000|Overall Study|Lack of Efficacy|0|||
48667871|NCT00870194|156637524|FG001|Overall Study|Lack of Efficacy|1|||
48667872|NCT00870194|156637523|FG000|Overall Study|Lost to Follow-up|2|||
48667873|NCT00870194|156637524|FG001|Overall Study|Lost to Follow-up|0|||
48667874|NCT00870194|156637523|FG000|Overall Study|Physician Decision|3|||
48667875|NCT00870194|156637524|FG001|Overall Study|Physician Decision|1|||
48667876|NCT00870194|156637523|FG000|Overall Study|Protocol Violation|3|||
48667877|NCT00870194|156637524|FG001|Overall Study|Protocol Violation|3|||
48667878|NCT00870194|156637523|FG000|Overall Study|Entry Criteria Not Met|1|||
48868680|NCT00265096|157356938|FG001|Overall Study|Adverse Event|18|||
48868681|NCT00265096|157356939|FG002|Overall Study|Adverse Event|18|||
48868682|NCT00265096|157356937|FG000|Overall Study|Lost to Follow-up|2|||
48868683|NCT00265096|157356938|FG001|Overall Study|Lost to Follow-up|5|||
48667879|NCT00870194|156637524|FG001|Overall Study|Entry Criteria Not Met|2|||
48667880|NCT00870194|156637523|FG000|Overall Study|Subject Decision|7|||
48667881|NCT00870194|156637524|FG001|Overall Study|Subject Decision|2|||
48868684|NCT00265096|157356939|FG002|Overall Study|Lost to Follow-up|3|||
48868685|NCT00265096|157356937|FG000|Overall Study|Death|0|||
48868686|NCT00265096|157356938|FG001|Overall Study|Death|1|||
48868687|NCT00265096|157356939|FG002|Overall Study|Death|2|||
48868688|NCT00265096|157356937|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
48968173|NCT01313208|157710762|FG000|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3|||
48968174|NCT01313208|157710763|FG001|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2|||
48968175|NCT01313208|157710762|FG000|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1|||
48968176|NCT01313208|157710763|FG001|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2|||
48968177|NCT01313208|157710762|FG000|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0|||
48968178|NCT01313208|157710763|FG001|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1|||
48667882|NCT00162266|156637525|FG000|Double-Blind Period|Adverse Event|5|||
48667883|NCT00162266|156637526|FG001|Double-Blind Period|Adverse Event|9|||
48667884|NCT00162266|156637527|FG002|Double-Blind Period|Adverse Event|11|||
48667885|NCT00162266|156637528|FG003|Double-Blind Period|Adverse Event|0|||
48667886|NCT00162266|156637525|FG000|Double-Blind Period|Death|0|||
48868689|NCT00265096|157356938|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
48868690|NCT00265096|157356939|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
48868691|NCT00265096|157356937|FG000|Overall Study|Other|11|||
48868692|NCT00265096|157356938|FG001|Overall Study|Other|19|||
48868693|NCT00265096|157356939|FG002|Overall Study|Other|10|||
48868694|NCT03022045|157356940|FG000|Overall Study|Adverse Event|0|||
48868695|NCT03022045|157356941|FG001|Overall Study|Adverse Event|1|||
48868696|NCT03022045|157356940|FG000|Overall Study|Withdrawal by Subject|1|||
48868697|NCT03022045|157356941|FG001|Overall Study|Withdrawal by Subject|1|||
48868698|NCT03972137|157356942|FG000|Overall Study|Lost to Follow-up|2|||
48868699|NCT03972137|157356942|FG000|Overall Study|Withdrawal by Subject|4|||
48868700|NCT03220776|157356943|FG000|Overall Study|Claustrophobia|0|||
48868701|NCT03220776|157356944|FG001|Overall Study|Claustrophobia|1|||
48868702|NCT03220776|157356945|FG002|Overall Study|Claustrophobia|1|||
48868703|NCT03220776|157356946|FG003|Overall Study|Claustrophobia|0|||
48868704|NCT03220776|157356947|FG004|Overall Study|Claustrophobia|1|||
48868705|NCT03220776|157356948|FG005|Overall Study|Claustrophobia|0|||
48868706|NCT03220776|157356943|FG000|Overall Study|MRI Equipment Failure|1|||
48868707|NCT03220776|157356944|FG001|Overall Study|MRI Equipment Failure|0|||
48868708|NCT03220776|157356945|FG002|Overall Study|MRI Equipment Failure|0|||
48868709|NCT03220776|157356946|FG003|Overall Study|MRI Equipment Failure|0|||
48868710|NCT03220776|157356947|FG004|Overall Study|MRI Equipment Failure|0|||
48868711|NCT03220776|157356948|FG005|Overall Study|MRI Equipment Failure|0|||
48968179|NCT01313208|157710762|FG000|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1|||
48968180|NCT01313208|157710763|FG001|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0|||
48968181|NCT01313208|157710762|FG000|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1|||
48968182|NCT01313208|157710763|FG001|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0|||
48667887|NCT00162266|156637526|FG001|Double-Blind Period|Death|1|||
48667888|NCT00162266|156637527|FG002|Double-Blind Period|Death|0|||
48667889|NCT00162266|156637528|FG003|Double-Blind Period|Death|0|||
48667890|NCT00162266|156637525|FG000|Double-Blind Period|Lost to Follow-up|1|||
48667891|NCT00162266|156637526|FG001|Double-Blind Period|Lost to Follow-up|2|||
48667892|NCT00162266|156637527|FG002|Double-Blind Period|Lost to Follow-up|0|||
48667893|NCT00162266|156637528|FG003|Double-Blind Period|Lost to Follow-up|0|||
48667894|NCT00162266|156637525|FG000|Double-Blind Period|Other Reason|1|||
48667895|NCT00162266|156637526|FG001|Double-Blind Period|Other Reason|0|||
48667896|NCT00162266|156637527|FG002|Double-Blind Period|Other Reason|1|||
48667897|NCT00162266|156637528|FG003|Double-Blind Period|Other Reason|0|||
48667898|NCT00162266|156637525|FG000|Double-Blind Period|Lack of Efficacy|13|||
48667899|NCT00162266|156637526|FG001|Double-Blind Period|Lack of Efficacy|17|||
48667900|NCT00162266|156637527|FG002|Double-Blind Period|Lack of Efficacy|30|||
48667901|NCT00162266|156637528|FG003|Double-Blind Period|Lack of Efficacy|0|||
48667902|NCT00162266|156637525|FG000|Double-Blind Period|Withdrawal by Subject|5|||
48667903|NCT00162266|156637526|FG001|Double-Blind Period|Withdrawal by Subject|2|||
48667904|NCT00162266|156637527|FG002|Double-Blind Period|Withdrawal by Subject|6|||
48667905|NCT00162266|156637528|FG003|Double-Blind Period|Withdrawal by Subject|0|||
48667906|NCT00162266|156637525|FG000|Open-Label Period|Death|0|||
48968183|NCT01313208|157710762|FG000|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3|||
48968184|NCT01313208|157710763|FG001|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1|||
48968185|NCT01313208|157710762|FG000|Open-label Phase (Weeks 13 - 24)|Noncompliance|0|||
48968186|NCT01313208|157710763|FG001|Open-label Phase (Weeks 13 - 24)|Noncompliance|2|||
48968187|NCT01313208|157710762|FG000|Open-label Phase (Weeks 13 - 24)|Adverse Event|1|||
48968188|NCT01313208|157710763|FG001|Open-label Phase (Weeks 13 - 24)|Adverse Event|0|||
48968189|NCT01313208|157710762|FG000|Open-label Phase (Weeks 13 - 24)|Other|2|||
48968190|NCT01313208|157710763|FG001|Open-label Phase (Weeks 13 - 24)|Other|0|||
48968191|NCT02939599|157710767|FG000|Overall Study|Adverse Event|1|||
48968192|NCT02939599|157710768|FG001|Overall Study|Adverse Event|0|||
48868712|NCT03220776|157356943|FG000|Overall Study|Inclimate Weather|0|||
48667907|NCT00162266|156637526|FG001|Open-Label Period|Death|0|||
48667908|NCT00162266|156637527|FG002|Open-Label Period|Death|0|||
48667909|NCT00162266|156637528|FG003|Open-Label Period|Death|7|||
48868713|NCT03220776|157356944|FG001|Overall Study|Inclimate Weather|0|||
48868714|NCT03220776|157356945|FG002|Overall Study|Inclimate Weather|0|||
48868715|NCT03220776|157356946|FG003|Overall Study|Inclimate Weather|0|||
48868716|NCT03220776|157356947|FG004|Overall Study|Inclimate Weather|0|||
48667910|NCT00162266|156637525|FG000|Open-Label Period|Adverse Event|0|||
48667911|NCT00162266|156637526|FG001|Open-Label Period|Adverse Event|0|||
48667912|NCT00162266|156637527|FG002|Open-Label Period|Adverse Event|0|||
48667913|NCT00162266|156637528|FG003|Open-Label Period|Adverse Event|46|||
48667914|NCT00162266|156637525|FG000|Open-Label Period|Lack of Efficacy|0|||
48667915|NCT00162266|156637526|FG001|Open-Label Period|Lack of Efficacy|0|||
48667916|NCT00162266|156637527|FG002|Open-Label Period|Lack of Efficacy|0|||
48667917|NCT00162266|156637528|FG003|Open-Label Period|Lack of Efficacy|26|||
48667918|NCT00162266|156637525|FG000|Open-Label Period|Lost to Follow-up|0|||
48667919|NCT00162266|156637526|FG001|Open-Label Period|Lost to Follow-up|0|||
48667920|NCT00162266|156637527|FG002|Open-Label Period|Lost to Follow-up|0|||
48667921|NCT00162266|156637528|FG003|Open-Label Period|Lost to Follow-up|3|||
48667922|NCT00162266|156637525|FG000|Open-Label Period|Withdrawal by Subject|0|||
48667923|NCT00162266|156637526|FG001|Open-Label Period|Withdrawal by Subject|0|||
48667924|NCT00162266|156637527|FG002|Open-Label Period|Withdrawal by Subject|0|||
48667925|NCT00162266|156637528|FG003|Open-Label Period|Withdrawal by Subject|31|||
48667926|NCT00162266|156637525|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
48667927|NCT00162266|156637526|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
48667928|NCT00162266|156637527|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
48667929|NCT00162266|156637528|FG003|Open-Label Period|Administrative Reason By Sponsor|9|||
48667930|NCT00162266|156637525|FG000|Open-Label Period|Other Reasons|0|||
48667931|NCT00162266|156637526|FG001|Open-Label Period|Other Reasons|0|||
48667932|NCT00162266|156637527|FG002|Open-Label Period|Other Reasons|0|||
48667933|NCT00162266|156637528|FG003|Open-Label Period|Other Reasons|15|||
48667934|NCT01754194|156637531|FG000|Overall Study|Lost to Follow-up|39|||
48667935|NCT01754194|156637532|FG001|Overall Study|Lost to Follow-up|14|||
48667936|NCT01754194|156637531|FG000|Overall Study|Withdrawal by Subject|4|||
48667937|NCT01754194|156637532|FG001|Overall Study|Withdrawal by Subject|5|||
48667938|NCT01754194|156637531|FG000|Overall Study|Other|9|||
48667939|NCT01754194|156637532|FG001|Overall Study|Other|8|||
48667940|NCT01896271|156637533|FG000|Overall Study|Physician Decision|10|||
48667941|NCT02322190|156637534|FG000|Overall Study|Death on study|1|||
48667942|NCT02322190|156637535|FG001|Overall Study|Death on study|0|||
48667943|NCT02776033|156637539|FG000|Overall Study|Withdrawal by Subject|0|||
48667944|NCT02776033|156637540|FG001|Overall Study|Withdrawal by Subject|0|||
48667945|NCT02776033|156637541|FG002|Overall Study|Withdrawal by Subject|2|||
48667946|NCT02776033|156637539|FG000|Overall Study|Physician Decision|2|||
48667947|NCT02776033|156637540|FG001|Overall Study|Physician Decision|0|||
48667948|NCT02776033|156637541|FG002|Overall Study|Physician Decision|0|||
48667949|NCT02776033|156637539|FG000|Overall Study|Lost to Follow-up|1|||
48667950|NCT02776033|156637540|FG001|Overall Study|Lost to Follow-up|0|||
48667951|NCT02776033|156637541|FG002|Overall Study|Lost to Follow-up|0|||
48667952|NCT02776033|156637539|FG000|Overall Study|Adverse Event|1|||
48667953|NCT02776033|156637540|FG001|Overall Study|Adverse Event|2|||
48667954|NCT02776033|156637541|FG002|Overall Study|Adverse Event|0|||
48667955|NCT03149003|156637542|FG000|Overall Study|Randomized but not treated|0|||
48667956|NCT03149003|156637543|FG001|Overall Study|Randomized but not treated|1|||
48667957|NCT03149003|156637544|FG002|Overall Study|Randomized but not treated|18|||
48667958|NCT01685983|156637545|FG000|Overall Study|Adverse Event|7|||
48667959|NCT01685983|156637545|FG000|Overall Study|Death|1|||
48667960|NCT01685983|156637545|FG000|Overall Study|Withdrawal by Subject|19|||
48667961|NCT01685983|156637545|FG000|Overall Study|Protocol Violation|2|||
48667962|NCT01685983|156637545|FG000|Overall Study|Physician Decision|13|||
48667963|NCT01685983|156637545|FG000|Overall Study|Other|7|||
48667964|NCT01685983|156637545|FG000|Overall Study|Progressive Disease|32|||
48667965|NCT01685983|156637545|FG000|Overall Study|Noncompliance with Study Drug|1|||
48667966|NCT00582738|156637547|FG000|Overall Study|Administrative Problems|7|||
48667967|NCT00582738|156637548|FG001|Overall Study|Administrative Problems|8|||
48667968|NCT00582738|156637547|FG000|Overall Study|Adverse Event|0|||
48667969|NCT00582738|156637548|FG001|Overall Study|Adverse Event|5|||
48667970|NCT00582738|156637547|FG000|Overall Study|Graft Lost|0|||
48667971|NCT00582738|156637548|FG001|Overall Study|Graft Lost|1|||
48667972|NCT00582738|156637547|FG000|Overall Study|Other|1|||
48667973|NCT00582738|156637548|FG001|Overall Study|Other|0|||
48667974|NCT00582738|156637547|FG000|Overall Study|Protocol Violation|1|||
48667975|NCT00582738|156637548|FG001|Overall Study|Protocol Violation|1|||
48667976|NCT00582738|156637547|FG000|Overall Study|Withdrawal by Subject|0|||
48667977|NCT00582738|156637548|FG001|Overall Study|Withdrawal by Subject|3|||
48667978|NCT04047420|156637549|FG000|Enrollment (Pre-dose) Period|Refused Participation|2|||
48667979|NCT04047420|156637549|FG000|Washout Period|Refused Participation|2|||
48667980|NCT02012686|156637553|FG000|Overall Study|muscle contraction|0|||
48667981|NCT02012686|156637554|FG001|Overall Study|muscle contraction|1|||
48868717|NCT03220776|157356948|FG005|Overall Study|Inclimate Weather|1|||
48868718|NCT03220776|157356943|FG000|Overall Study|Physician Decision|0|||
48868719|NCT03220776|157356944|FG001|Overall Study|Physician Decision|0|||
48868720|NCT03220776|157356945|FG002|Overall Study|Physician Decision|0|||
48868721|NCT03220776|157356946|FG003|Overall Study|Physician Decision|1|||
48868722|NCT03220776|157356947|FG004|Overall Study|Physician Decision|0|||
48667982|NCT02012686|156637553|FG000|Overall Study|electrocardiography monitoring noise|0|||
48667983|NCT02012686|156637554|FG001|Overall Study|electrocardiography monitoring noise|1|||
48667984|NCT04912895|156637555|FG000|Overall Study|Unable to provide specimen|2|||
48667985|NCT04912895|156637556|FG001|Overall Study|Unable to provide specimen|0|||
48667986|NCT04912895|156637557|FG002|Overall Study|Unable to provide specimen|0|||
48667987|NCT01703065|156637558|FG000|Overall Study|Lack of Efficacy|1|||
48758574|NCT00463346|156964577|FG001|Overall Study|Withdrawal by Subject|3|||
48758575|NCT00488345|156964587|FG000|Overall Study|Adverse Event|0|||
48758576|NCT00488345|156964588|FG001|Overall Study|Adverse Event|1|||
48758577|NCT00488345|156964589|FG002|Overall Study|Adverse Event|1|||
48758578|NCT00488345|156964587|FG000|Overall Study|Unable to administer antibiotics at home|0|||
48758579|NCT00488345|156964588|FG001|Overall Study|Unable to administer antibiotics at home|1|||
48758580|NCT00488345|156964589|FG002|Overall Study|Unable to administer antibiotics at home|0|||
48758581|NCT00488345|156964587|FG000|Overall Study|Institutional Review Board review|0|||
48758582|NCT00488345|156964588|FG001|Overall Study|Institutional Review Board review|0|||
48758583|NCT00488345|156964589|FG002|Overall Study|Institutional Review Board review|1|||
48758584|NCT00488345|156964587|FG000|Overall Study|Surgical team recommendation|0|||
48758585|NCT00488345|156964588|FG001|Overall Study|Surgical team recommendation|1|||
48758586|NCT00488345|156964589|FG002|Overall Study|Surgical team recommendation|0|||
48758587|NCT00488345|156964587|FG000|Overall Study|Parent/legal guardian request|0|||
48758588|NCT00488345|156964588|FG001|Overall Study|Parent/legal guardian request|1|||
48868723|NCT03220776|157356948|FG005|Overall Study|Physician Decision|0|||
48968193|NCT02939599|157710767|FG000|Overall Study|Study Terminated By Sponsor|2|||
48968194|NCT02939599|157710768|FG001|Overall Study|Study Terminated By Sponsor|2|||
48968195|NCT01957787|157710773|FG000|Overall Study|Death|18|||
48968196|NCT01957787|157710773|FG000|Overall Study|Lost to Follow-up|3|||
48968197|NCT01957787|157710773|FG000|Overall Study|Withdrawal by Subject|3|||
48968198|NCT01957787|157710773|FG000|Overall Study|Entered Hospice or Similar Program|2|||
48968199|NCT01957787|157710773|FG000|Overall Study|Index Tumor(s) Resected|2|||
48968200|NCT01957787|157710773|FG000|Overall Study|Index Tumor was Primary Lung Cancer|2|||
48968201|NCT01957787|157710773|FG000|Overall Study|Local therapy, not cryoablation|6|||
48968202|NCT04354155|157710774|FG000|Overall Study|Withdrawal by Subject|1|||
48968203|NCT04354155|157710774|FG000|Overall Study|Did not meet criteria for study intervention|1|||
48968204|NCT01686958|157710775|FG000|Overall Study|Withdrawal by Subject|1|||
48968205|NCT01283997|157712483|FG000|Overall Study|Physician Decision|8|||
48968206|NCT01283997|157712484|FG001|Overall Study|Physician Decision|10|||
48667988|NCT01703065|156637559|FG001|Overall Study|Lack of Efficacy|0|||
48667989|NCT03262116|156637560|FG000|Overall Study|Physician Decision|0|||
48667990|NCT03262116|156637561|FG001|Overall Study|Physician Decision|2|||
48667991|NCT03262116|156637562|FG002|Overall Study|Physician Decision|1|||
48667992|NCT03262116|156637563|FG003|Overall Study|Physician Decision|1|||
48667993|NCT03262116|156637564|FG004|Overall Study|Physician Decision|1|||
48667994|NCT03262116|156637565|FG005|Overall Study|Physician Decision|2|||
48667995|NCT03022981|156637568|FG000|Overall Study|Adverse Event|0|||
48667996|NCT03022981|156637569|FG001|Overall Study|Adverse Event|1|||
48667997|NCT03022981|156637570|FG002|Overall Study|Adverse Event|0|||
48667998|NCT03022981|156637568|FG000|Overall Study|Investigator's Discretion|0|||
48667999|NCT03022981|156637569|FG001|Overall Study|Investigator's Discretion|1|||
48668000|NCT03022981|156637570|FG002|Overall Study|Investigator's Discretion|2|||
48668001|NCT03022981|156637568|FG000|Overall Study|Lost to Follow-up|6|||
48668002|NCT03022981|156637569|FG001|Overall Study|Lost to Follow-up|2|||
48758589|NCT00488345|156964589|FG002|Overall Study|Parent/legal guardian request|1|||
48758590|NCT03182829|156964591|FG000|Overall Study|Protocol Violation|12|||
48758591|NCT03182829|156964592|FG001|Overall Study|Protocol Violation|12|||
48758592|NCT03182829|156964591|FG000|Overall Study|Other|4|||
48868724|NCT03220776|157356943|FG000|Overall Study|Potential presence of non-MRI safe metal in body|0|||
48868725|NCT03220776|157356944|FG001|Overall Study|Potential presence of non-MRI safe metal in body|0|||
48868726|NCT03220776|157356945|FG002|Overall Study|Potential presence of non-MRI safe metal in body|0|||
48868727|NCT03220776|157356946|FG003|Overall Study|Potential presence of non-MRI safe metal in body|1|||
48868728|NCT03220776|157356947|FG004|Overall Study|Potential presence of non-MRI safe metal in body|0|||
48868729|NCT03220776|157356948|FG005|Overall Study|Potential presence of non-MRI safe metal in body|0|||
48868730|NCT03220776|157356943|FG000|Overall Study|Protocol Violation|0|||
48868731|NCT03220776|157356944|FG001|Overall Study|Protocol Violation|0|||
48868732|NCT03220776|157356945|FG002|Overall Study|Protocol Violation|0|||
48868733|NCT03220776|157356946|FG003|Overall Study|Protocol Violation|2|||
48868734|NCT03220776|157356947|FG004|Overall Study|Protocol Violation|0|||
48868735|NCT03220776|157356948|FG005|Overall Study|Protocol Violation|1|||
48868736|NCT03220776|157356943|FG000|Overall Study|Withdrawal by Subject|1|||
48868737|NCT03220776|157356944|FG001|Overall Study|Withdrawal by Subject|0|||
48868738|NCT03220776|157356945|FG002|Overall Study|Withdrawal by Subject|0|||
48868739|NCT03220776|157356946|FG003|Overall Study|Withdrawal by Subject|0|||
48668003|NCT03022981|156637570|FG002|Overall Study|Lost to Follow-up|1|||
48668004|NCT03022981|156637568|FG000|Overall Study|Non-Compliance With Study Drug|0|||
48668005|NCT03022981|156637569|FG001|Overall Study|Non-Compliance With Study Drug|0|||
48758593|NCT03182829|156964592|FG001|Overall Study|Other|3|||
48758594|NCT00254540|156964593|FG000|Overall Study|Adverse Event|6|||
48758595|NCT00254540|156964594|FG001|Overall Study|Adverse Event|7|||
48758596|NCT00254540|156964593|FG000|Overall Study|Lack of Efficacy|13|||
48758597|NCT00254540|156964594|FG001|Overall Study|Lack of Efficacy|13|||
48758598|NCT00254540|156964593|FG000|Overall Study|Death|0|||
48758599|NCT00254540|156964594|FG001|Overall Study|Death|1|||
48758600|NCT00254540|156964593|FG000|Overall Study|Laboratory Test Abnormality|0|||
48758601|NCT00254540|156964594|FG001|Overall Study|Laboratory Test Abnormality|1|||
48758602|NCT00249444|156964595|FG000|Overall Study|Lost to Follow-up|2|||
48758603|NCT00249444|156964596|FG001|Overall Study|Lost to Follow-up|2|||
48758604|NCT00249444|156964595|FG000|Overall Study|non-compliant|9|||
48758605|NCT00249444|156964596|FG001|Overall Study|non-compliant|11|||
48758606|NCT00249444|156964595|FG000|Overall Study|Adverse Event|1|||
48758607|NCT00249444|156964596|FG001|Overall Study|Adverse Event|1|||
48758608|NCT00249444|156964595|FG000|Overall Study|life event|0|||
48758609|NCT00249444|156964596|FG001|Overall Study|life event|1|||
48758610|NCT00412854|156964599|FG000|Overall Study|Withdrawn due to adverse events|1|||
48758611|NCT00412854|156964600|FG001|Overall Study|Withdrawn due to adverse events|5|||
48758612|NCT00412854|156964599|FG000|Overall Study|Withdrawn for other reasons|13|||
48758613|NCT00412854|156964600|FG001|Overall Study|Withdrawn for other reasons|11|||
48668006|NCT03022981|156637570|FG002|Overall Study|Non-Compliance With Study Drug|2|||
48668007|NCT03022981|156637568|FG000|Overall Study|Withdrew Assent By Parent/Guardian|0|||
48668008|NCT03022981|156637569|FG001|Overall Study|Withdrew Assent By Parent/Guardian|0|||
48668009|NCT03022981|156637570|FG002|Overall Study|Withdrew Assent By Parent/Guardian|1|||
48668010|NCT00654004|156637574|FG000|Overall Study|Lost to Follow-up|1|||
48668011|NCT00654004|156637575|FG001|Overall Study|Lost to Follow-up|0|||
48668012|NCT01378429|156637576|FG000|Overall Study|Noncompliance with study drug|1|||
48668013|NCT01378429|156637577|FG001|Overall Study|Noncompliance with study drug|0|||
48668014|NCT02241187|156637578|FG000|Overall Study|Protocol closed due to lack of accrual.|2|||
48668015|NCT01490294|156637579|FG000|Overall Study|Prematurely discontinuation|4|||
48668016|NCT01490294|156637580|FG001|Overall Study|Prematurely discontinuation|0|||
48668017|NCT01490294|156637581|FG002|Overall Study|Prematurely discontinuation|1|||
48668018|NCT01490294|156637582|FG003|Overall Study|Prematurely discontinuation|1|||
48668019|NCT01490294|156637579|FG000|Overall Study|Adverse Event|1|||
48668020|NCT01490294|156637580|FG001|Overall Study|Adverse Event|0|||
48668021|NCT01490294|156637581|FG002|Overall Study|Adverse Event|0|||
48668022|NCT01490294|156637582|FG003|Overall Study|Adverse Event|0|||
48668023|NCT02404649|156637592|FG000|Overall Study|Adverse Event|1|||
48668024|NCT02404649|156637593|FG001|Overall Study|Adverse Event|2|||
48668025|NCT00330668|156637594|FG000|BID Dosing Period|Adverse Event|1|||
48668026|NCT00330668|156637594|FG000|BID Dosing Period|Lost to Follow-up|7|||
48668027|NCT00330668|156637594|FG000|BID Dosing Period|Non-Compliance|5|||
48668028|NCT00330668|156637594|FG000|BID Dosing Period|Withdrawal by Subject|19|||
48668029|NCT00330668|156637594|FG000|BID Dosing Period|Sponsor's decision|1|||
48668030|NCT00330668|156637594|FG000|BID Dosing Period|Other|3|||
48668031|NCT00330668|156637594|FG000|QD Dosing Period|Sponsor decision to terminate study|74|||
48668032|NCT00330668|156637594|FG000|QD Dosing Period|Other|1|||
48668033|NCT00330668|156637594|FG000|QD Dosing Period|Withdrawal by Subject|1|||
48668034|NCT00330668|156637594|FG000|QD Dosing Period|Lost to Follow-up|2|||
48692757|NCT01469221|156724592|FG002|Double Blind Phase|Protocol Violation|0|||
48692758|NCT01469221|156724590|FG000|Double Blind Phase|Physician Decision|1|||
48692759|NCT01469221|156724591|FG001|Double Blind Phase|Physician Decision|1|||
48692760|NCT01469221|156724592|FG002|Double Blind Phase|Physician Decision|0|||
48692761|NCT01469221|156724590|FG000|Double Blind Phase|Sponsor Terminate Study|12|||
48692762|NCT01469221|156724591|FG001|Double Blind Phase|Sponsor Terminate Study|16|||
48692763|NCT01469221|156724592|FG002|Double Blind Phase|Sponsor Terminate Study|0|||
48692764|NCT03988608|156724593|FG000|Overall Study|Adverse Event|1|||
48692765|NCT03988608|156724593|FG000|Overall Study|Lost to Follow-up|1|||
48692766|NCT03988608|156724593|FG000|Overall Study|Withdrawal by Subject|3|||
48692767|NCT03988608|156724593|FG000|Overall Study|Death|1|||
48692768|NCT02140047|156724594|FG000|Overall Study|Withdrawal by parent/guardian|1|||
48758614|NCT01710033|156964601|FG000|Stage 2|Adverse Event|0|||
48758615|NCT01710033|156964602|FG001|Stage 2|Adverse Event|0|||
48758616|NCT01710033|156964603|FG002|Stage 2|Adverse Event|0|||
48868740|NCT03220776|157356947|FG004|Overall Study|Withdrawal by Subject|0|||
48692769|NCT02140047|156724595|FG001|Overall Study|Withdrawal by parent/guardian|1|||
48692770|NCT02140047|156724596|FG002|Overall Study|Withdrawal by parent/guardian|0|||
48758617|NCT01710033|156964604|FG003|Stage 2|Adverse Event|0|||
48758618|NCT01710033|156964605|FG004|Stage 2|Adverse Event|1|||
48758619|NCT02085785|156964608|FG000|Overall Study|Withdrawal by Subject|2|||
48758620|NCT02085785|156964609|FG001|Overall Study|Withdrawal by Subject|1|||
48758621|NCT02085785|156964608|FG000|Overall Study|Lost to Follow-up|0|||
48692771|NCT00333775|156724599|FG000|Overall Study|Death|144|||
48692772|NCT00333775|156724600|FG001|Overall Study|Death|149|||
48692773|NCT00333775|156724601|FG002|Overall Study|Death|143|||
48692774|NCT00333775|156724599|FG000|Overall Study|In Follow-up When Study Stopped|87|||
48758622|NCT02085785|156964609|FG001|Overall Study|Lost to Follow-up|1|||
48758623|NCT02772081|156964610|FG000|Overall Study|Physician Decision|1|||
48758624|NCT02772081|156964611|FG001|Overall Study|Physician Decision|1|||
48758625|NCT02772081|156964610|FG000|Overall Study|Death|1|||
48758626|NCT02772081|156964611|FG001|Overall Study|Death|1|||
48758627|NCT00469092|156964615|FG000|Overall Study|Adverse Event|5|||
48758628|NCT00469092|156964616|FG001|Overall Study|Adverse Event|4|||
48758629|NCT00469092|156964615|FG000|Overall Study|Lack of Efficacy|1|||
48758630|NCT00469092|156964616|FG001|Overall Study|Lack of Efficacy|0|||
48758631|NCT00469092|156964615|FG000|Overall Study|Lost to Follow-up|1|||
48758632|NCT00469092|156964616|FG001|Overall Study|Lost to Follow-up|2|||
48758633|NCT00469092|156964615|FG000|Overall Study|Protocol Violation|3|||
48758634|NCT00469092|156964616|FG001|Overall Study|Protocol Violation|3|||
48758635|NCT00469092|156964615|FG000|Overall Study|Withdrawal by Subject|4|||
48758636|NCT00469092|156964616|FG001|Overall Study|Withdrawal by Subject|4|||
48758637|NCT00469092|156964615|FG000|Overall Study|Withdrawal Criteria|3|||
48758638|NCT00469092|156964616|FG001|Overall Study|Withdrawal Criteria|4|||
48758639|NCT00469092|156964615|FG000|Overall Study|Incorrectly Randomised|4|||
48758640|NCT00469092|156964616|FG001|Overall Study|Incorrectly Randomised|3|||
48758641|NCT00469092|156964615|FG000|Overall Study|Contraindication metformin/glimepiride|1|||
48758642|NCT00469092|156964616|FG001|Overall Study|Contraindication metformin/glimepiride|0|||
48758643|NCT00469092|156964615|FG000|Overall Study|Use of lipid lowering drug|1|||
48758644|NCT00469092|156964616|FG001|Overall Study|Use of lipid lowering drug|0|||
48758645|NCT00469092|156964615|FG000|Overall Study|Hypoglycaemic Episodes|1|||
48758646|NCT00469092|156964616|FG001|Overall Study|Hypoglycaemic Episodes|1|||
48758647|NCT00469092|156964615|FG000|Overall Study|Abnormal lab value|1|||
48758648|NCT00469092|156964616|FG001|Overall Study|Abnormal lab value|0|||
48758649|NCT00469092|156964615|FG000|Overall Study|Use of Corticosteroid|1|||
48758650|NCT00469092|156964616|FG001|Overall Study|Use of Corticosteroid|0|||
48758651|NCT02024867|156964617|FG000|Overall Study|Protocol Violation|3|||
48968207|NCT01283997|157712483|FG000|Overall Study|Withdrawal by Subject|3|||
48968208|NCT01283997|157712484|FG001|Overall Study|Withdrawal by Subject|2|||
48968209|NCT01283997|157712483|FG000|Overall Study|Physically unable to continue|0|||
48968210|NCT01283997|157712484|FG001|Overall Study|Physically unable to continue|1|||
48758652|NCT02024867|156964618|FG001|Overall Study|Protocol Violation|3|||
48758653|NCT02024867|156964617|FG000|Overall Study|Lost to Follow-up|6|||
48758654|NCT02024867|156964618|FG001|Overall Study|Lost to Follow-up|4|||
48758655|NCT02063854|156964619|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
48968211|NCT01283997|157712483|FG000|Overall Study|Progressive disease|1|||
48968212|NCT01283997|157712484|FG001|Overall Study|Progressive disease|0|||
48968213|NCT01283997|157712483|FG000|Overall Study|Other|4|||
48968214|NCT01283997|157712484|FG001|Overall Study|Other|4|||
48968215|NCT02862548|157712488|FG000|Randomized Phase (Up to Week 48)|Death|0|||
48668035|NCT00387647|156639045|FG000|Overall Study|Death|18|||
48758656|NCT02063854|156964620|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
48758657|NCT02063854|156964621|FG002|Overall Study|Pretreatment Event/Adverse Event|13|||
48758658|NCT02063854|156964622|FG003|Overall Study|Pretreatment Event/Adverse Event|8|||
48758659|NCT02063854|156964623|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
48758660|NCT02063854|156964624|FG005|Overall Study|Pretreatment Event/Adverse Event|18|||
48758661|NCT02063854|156964625|FG006|Overall Study|Pretreatment Event/Adverse Event|4|||
48758662|NCT02063854|156964619|FG000|Overall Study|Major Protocol Deviation|0|||
48968216|NCT02862548|157712489|FG001|Randomized Phase (Up to Week 48)|Death|1|||
48968217|NCT02862548|157712488|FG000|OLE Phase (Week 49 to Week 192)|Death|2|||
48968218|NCT02862548|157712489|FG001|OLE Phase (Week 49 to Week 192)|Death|0|||
48968219|NCT02862548|157712488|FG000|OLE Phase (Week 49 to Week 192)|Adverse Event|1|||
48968220|NCT02862548|157712489|FG001|OLE Phase (Week 49 to Week 192)|Adverse Event|0|||
48668036|NCT04030247|156639046|FG000|Overall Study|Withdrawal by Subject|4|||
48668037|NCT04030247|156639046|FG000|Overall Study|Lost to Follow-up|13|||
48668038|NCT00840060|156639047|FG000|Overall Study|Withdrawal by Subject|1|||
48668039|NCT00840060|156639048|FG001|Overall Study|Withdrawal by Subject|0|||
48668040|NCT00840060|156639047|FG000|Overall Study|Change in emotional/behavioral status|0|||
48668041|NCT00840060|156639048|FG001|Overall Study|Change in emotional/behavioral status|1|||
48668042|NCT01263015|156639049|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|13|||
48668043|NCT01263015|156639050|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|48|||
48668044|NCT01263015|156639049|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18|||
48758663|NCT02063854|156964620|FG001|Overall Study|Major Protocol Deviation|0|||
48758664|NCT02063854|156964621|FG002|Overall Study|Major Protocol Deviation|3|||
48758665|NCT02063854|156964622|FG003|Overall Study|Major Protocol Deviation|0|||
48668045|NCT01263015|156639050|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14|||
48758666|NCT02063854|156964623|FG004|Overall Study|Major Protocol Deviation|0|||
48758667|NCT02063854|156964624|FG005|Overall Study|Major Protocol Deviation|0|||
48758668|NCT02063854|156964625|FG006|Overall Study|Major Protocol Deviation|0|||
48758669|NCT02063854|156964619|FG000|Overall Study|Voluntary Withdrawal|2|||
48758670|NCT02063854|156964620|FG001|Overall Study|Voluntary Withdrawal|0|||
48758671|NCT02063854|156964621|FG002|Overall Study|Voluntary Withdrawal|8|||
48668046|NCT01263015|156639049|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14|||
48758672|NCT02063854|156964622|FG003|Overall Study|Voluntary Withdrawal|1|||
48758673|NCT02063854|156964623|FG004|Overall Study|Voluntary Withdrawal|3|||
48758674|NCT02063854|156964624|FG005|Overall Study|Voluntary Withdrawal|6|||
48758675|NCT02063854|156964625|FG006|Overall Study|Voluntary Withdrawal|1|||
48758676|NCT02063854|156964619|FG000|Overall Study|Surgical Dental Work Performed/Planned|5|||
48758677|NCT02063854|156964620|FG001|Overall Study|Surgical Dental Work Performed/Planned|2|||
48968221|NCT02862548|157712488|FG000|OLE Phase (Week 49 to Week 192)|Withdrew Consent|0|||
48968222|NCT02862548|157712489|FG001|OLE Phase (Week 49 to Week 192)|Withdrew Consent|1|||
48968223|NCT00880763|157712490|FG000|Extension Period (Part 2)|Adverse Event|0|||
48758678|NCT02063854|156964621|FG002|Overall Study|Surgical Dental Work Performed/Planned|6|||
48758679|NCT02063854|156964622|FG003|Overall Study|Surgical Dental Work Performed/Planned|1|||
48758680|NCT02063854|156964623|FG004|Overall Study|Surgical Dental Work Performed/Planned|1|||
48758681|NCT02063854|156964624|FG005|Overall Study|Surgical Dental Work Performed/Planned|6|||
48758682|NCT02063854|156964625|FG006|Overall Study|Surgical Dental Work Performed/Planned|1|||
48758683|NCT02063854|156964619|FG000|Overall Study|Reason Not Specified|1|||
48758684|NCT02063854|156964620|FG001|Overall Study|Reason Not Specified|0|||
48758685|NCT02063854|156964621|FG002|Overall Study|Reason Not Specified|0|||
48758686|NCT02063854|156964622|FG003|Overall Study|Reason Not Specified|0|||
48758687|NCT02063854|156964623|FG004|Overall Study|Reason Not Specified|0|||
48758688|NCT02063854|156964624|FG005|Overall Study|Reason Not Specified|0|||
48758689|NCT02063854|156964625|FG006|Overall Study|Reason Not Specified|0|||
48758690|NCT02063854|156964619|FG000|Overall Study|Did Not Receive Study Drug|0|||
48758691|NCT02063854|156964620|FG001|Overall Study|Did Not Receive Study Drug|0|||
48758692|NCT02063854|156964621|FG002|Overall Study|Did Not Receive Study Drug|0|||
48758693|NCT02063854|156964622|FG003|Overall Study|Did Not Receive Study Drug|0|||
48758694|NCT02063854|156964623|FG004|Overall Study|Did Not Receive Study Drug|0|||
48758695|NCT02063854|156964624|FG005|Overall Study|Did Not Receive Study Drug|1|||
48758696|NCT02063854|156964625|FG006|Overall Study|Did Not Receive Study Drug|0|||
48758697|NCT02436356|156964626|FG000|Overall Study|Excluded by MRI Screening|0|||
48758698|NCT02436356|156964627|FG001|Overall Study|Excluded by MRI Screening|0|||
48758699|NCT02436356|156964628|FG002|Overall Study|Excluded by MRI Screening|2|||
48758700|NCT02436356|156964626|FG000|Overall Study|Lost to Follow-up|0|||
48758701|NCT02436356|156964627|FG001|Overall Study|Lost to Follow-up|1|||
48758702|NCT02436356|156964628|FG002|Overall Study|Lost to Follow-up|0|||
48758703|NCT02436356|156964626|FG000|Overall Study|Surgical Approach (Dorsal not volar)|1|||
48758704|NCT02436356|156964627|FG001|Overall Study|Surgical Approach (Dorsal not volar)|0|||
48758705|NCT02436356|156964628|FG002|Overall Study|Surgical Approach (Dorsal not volar)|0|||
48758706|NCT02436356|156964626|FG000|Overall Study|Excluded due to other medical conditions|3|||
48758707|NCT02436356|156964627|FG001|Overall Study|Excluded due to other medical conditions|0|||
48758708|NCT02436356|156964628|FG002|Overall Study|Excluded due to other medical conditions|0|||
48758709|NCT02436356|156964626|FG000|Overall Study|Withdrawal by Subject|1|||
48758710|NCT02436356|156964627|FG001|Overall Study|Withdrawal by Subject|0|||
48758711|NCT02436356|156964628|FG002|Overall Study|Withdrawal by Subject|0|||
48758712|NCT01462084|156964629|FG000|Overall Study|Withdrawal by Subject|1|||
48758713|NCT01462084|156964630|FG001|Overall Study|Withdrawal by Subject|0|||
48758714|NCT01462084|156964629|FG000|Overall Study|Protocol Violation|1|||
48758715|NCT01462084|156964630|FG001|Overall Study|Protocol Violation|1|||
48758716|NCT02611778|156964631|FG000|Overall Study|Withdrawal by Subject|2|||
48758717|NCT02611778|156964632|FG001|Overall Study|Withdrawal by Subject|8|||
48758718|NCT02611778|156964631|FG000|Overall Study|Adverse Event|1|||
48758719|NCT02611778|156964632|FG001|Overall Study|Adverse Event|2|||
48758720|NCT02611778|156964631|FG000|Overall Study|Death|2|||
48758721|NCT02611778|156964632|FG001|Overall Study|Death|1|||
48758722|NCT02611778|156964631|FG000|Overall Study|Protocol Violation|1|||
48758723|NCT02611778|156964632|FG001|Overall Study|Protocol Violation|0|||
48758724|NCT02611778|156964631|FG000|Overall Study|Lost to Follow-up|3|||
48758725|NCT02611778|156964632|FG001|Overall Study|Lost to Follow-up|1|||
48758726|NCT02611778|156964631|FG000|Overall Study|Need for alternative treatment|1|||
48758727|NCT02611778|156964632|FG001|Overall Study|Need for alternative treatment|0|||
48758728|NCT02611778|156964631|FG000|Overall Study|Other Reason|2|||
48758729|NCT02611778|156964632|FG001|Overall Study|Other Reason|1|||
48758730|NCT00810407|156964633|FG000|Overall Study|Protocol Violation|3|||
48758731|NCT00810407|156964633|FG000|Overall Study|No Visit After First Day of Treatment|3|||
48758732|NCT02864251|156964637|FG000|Pre-Treatment|Adverse Event Unrelated to Study drug|1|||
48868741|NCT03220776|157356948|FG005|Overall Study|Withdrawal by Subject|0|||
48868742|NCT03226353|157356949|FG000|Overall Study|Withdrawal by Subject|1|||
48868743|NCT03226353|157356949|FG000|Overall Study|Screen Failure|5|||
48868744|NCT00498433|157356950|FG000|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2|||
48868745|NCT00498433|157356951|FG001|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
48868746|NCT00498433|157356952|FG002|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
48868747|NCT00498433|157356950|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2|||
48868748|NCT00498433|157356951|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
48968224|NCT00880763|157712491|FG001|Extension Period (Part 2)|Adverse Event|0|||
48758733|NCT02864251|156964638|FG001|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
48758734|NCT02864251|156964639|FG002|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
48758735|NCT02864251|156964637|FG000|Pre-Treatment|Withdrawal by Participant|0|||
48758736|NCT02864251|156964638|FG001|Pre-Treatment|Withdrawal by Participant|0|||
48758737|NCT02864251|156964639|FG002|Pre-Treatment|Withdrawal by Participant|4|||
48758738|NCT02864251|156964637|FG000|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
48758739|NCT02864251|156964638|FG001|Pre-Treatment|Participant no Longer Meets Study Criteria|1|||
48758740|NCT02864251|156964639|FG002|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
48758741|NCT02864251|156964637|FG000|Pre-Treatment|Other Reasons|0|||
48758742|NCT02864251|156964638|FG001|Pre-Treatment|Other Reasons|1|||
48758743|NCT02864251|156964639|FG002|Pre-Treatment|Other Reasons|1|||
48758744|NCT02864251|156964637|FG000|Treatment|Disease Progression|109|||
48758745|NCT02864251|156964638|FG001|Treatment|Disease Progression|52|||
48758746|NCT02864251|156964639|FG002|Treatment|Disease Progression|101|||
48758747|NCT02864251|156964637|FG000|Treatment|Study Drug Toxicity|9|||
48758748|NCT02864251|156964638|FG001|Treatment|Study Drug Toxicity|4|||
48758749|NCT02864251|156964639|FG002|Treatment|Study Drug Toxicity|10|||
48758750|NCT02864251|156964637|FG000|Treatment|Death|0|||
48758751|NCT02864251|156964638|FG001|Treatment|Death|2|||
48758752|NCT02864251|156964639|FG002|Treatment|Death|3|||
48758753|NCT02864251|156964637|FG000|Treatment|Adverse Event Unrelated to Study Drug|1|||
48668047|NCT01263015|156639050|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12|||
48668048|NCT01263015|156639049|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17|||
48668049|NCT01263015|156639050|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18|||
48668050|NCT01263015|156639049|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9|||
48668051|NCT01263015|156639050|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15|||
48668052|NCT01263015|156639049|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|1|||
48668053|NCT01263015|156639050|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|2|||
48668054|NCT01263015|156639049|FG000|Open-label Phase: 48 Weeks Duration|Adverse Event|3|||
48668055|NCT01263015|156639050|FG001|Open-label Phase: 48 Weeks Duration|Adverse Event|10|||
48668056|NCT01263015|156639049|FG000|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7|||
48668057|NCT01263015|156639050|FG001|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2|||
48668058|NCT01263015|156639049|FG000|Open-label Phase: 48 Weeks Duration|Protocol Violation|3|||
48668059|NCT01263015|156639050|FG001|Open-label Phase: 48 Weeks Duration|Protocol Violation|2|||
48668060|NCT01263015|156639049|FG000|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
48668061|NCT01263015|156639050|FG001|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
48668062|NCT01263015|156639049|FG000|Open-label Phase: 48 Weeks Duration|Physician Decision|0|||
48668063|NCT01263015|156639050|FG001|Open-label Phase: 48 Weeks Duration|Physician Decision|2|||
48668064|NCT01263015|156639049|FG000|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3|||
48668065|NCT01263015|156639050|FG001|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7|||
48668066|NCT03131596|156639051|FG000|Overall Study|Protocol Violation|3|||
48668067|NCT03131596|156639052|FG001|Overall Study|Protocol Violation|3|||
48668068|NCT03131596|156639051|FG000|Overall Study|Lost to Follow-up|3|||
48668069|NCT03131596|156639052|FG001|Overall Study|Lost to Follow-up|0|||
48668070|NCT00509093|156639055|FG000|Overall Study|Adverse Event|10|||
48668071|NCT00509093|156639055|FG000|Overall Study|Disease Progression|9|||
48668072|NCT00509093|156639055|FG000|Overall Study|Transformed into MDS|1|||
48668073|NCT00509093|156639055|FG000|Overall Study|Withdrawal by Subject|3|||
48668074|NCT00509093|156639055|FG000|Overall Study|Physician Decision|1|||
48668075|NCT03204890|156639059|FG000|Overall Study|Withdrawal by Subject|1|||
48668076|NCT01176565|156639060|FG000|Overall Study|Lost to Follow-up|12|||
48668077|NCT01176565|156639061|FG001|Overall Study|Lost to Follow-up|16|||
48668078|NCT01176565|156639060|FG000|Overall Study|Withdrawal by Subject|7|||
48668079|NCT01176565|156639061|FG001|Overall Study|Withdrawal by Subject|1|||
48668080|NCT01176565|156639060|FG000|Overall Study|Not Analyzed (any other reason)|1|||
48668081|NCT01176565|156639061|FG001|Overall Study|Not Analyzed (any other reason)|2|||
48668082|NCT03369431|156639063|FG000|Overall Study|Lost to Follow-up|1|||
48668083|NCT03369431|156639064|FG001|Overall Study|Lost to Follow-up|3|||
48668084|NCT03369431|156639063|FG000|Overall Study|Withdrawal by Subject|2|||
48668085|NCT03369431|156639064|FG001|Overall Study|Withdrawal by Subject|3|||
48668086|NCT03369431|156639063|FG000|Overall Study|Protocol Violation|1|||
48668087|NCT03369431|156639064|FG001|Overall Study|Protocol Violation|1|||
48668088|NCT02212678|156639065|FG000|Overall Study|Adverse Event|1|||
48668089|NCT01635764|156639066|FG000|Overall Study|Adverse Event|46|||
48668090|NCT01635764|156639066|FG000|Overall Study|Lack of Efficacy|76|||
48668091|NCT01635764|156639066|FG000|Overall Study|Exceed Protocol-specified Interventions|2|||
48758754|NCT02864251|156964638|FG001|Treatment|Adverse Event Unrelated to Study Drug|1|||
48758755|NCT02864251|156964639|FG002|Treatment|Adverse Event Unrelated to Study Drug|6|||
48758756|NCT02864251|156964637|FG000|Treatment|Participant Requested to Discontinue Study Treatment|8|||
48968225|NCT00880763|157712492|FG002|Extension Period (Part 2)|Adverse Event|1|||
48668092|NCT01635764|156639066|FG000|Overall Study|Protocol Deviation|1|||
48668093|NCT01635764|156639066|FG000|Overall Study|Withdrew Consent|67|||
48668094|NCT01635764|156639066|FG000|Overall Study|Lost to Follow-up|53|||
48968226|NCT00880763|157712493|FG003|Extension Period (Part 2)|Adverse Event|1|||
48968227|NCT00880763|157712490|FG000|Extension Period (Part 2)|Withdrawal by Subject|0|||
48968228|NCT00880763|157712491|FG001|Extension Period (Part 2)|Withdrawal by Subject|2|||
48968229|NCT00880763|157712492|FG002|Extension Period (Part 2)|Withdrawal by Subject|1|||
48968230|NCT00880763|157712493|FG003|Extension Period (Part 2)|Withdrawal by Subject|1|||
48968231|NCT00880763|157712490|FG000|Extension Period (Part 2)|Physician Decision|0|||
48968232|NCT00880763|157712491|FG001|Extension Period (Part 2)|Physician Decision|1|||
48968233|NCT00880763|157712492|FG002|Extension Period (Part 2)|Physician Decision|1|||
48968234|NCT00880763|157712493|FG003|Extension Period (Part 2)|Physician Decision|0|||
48968235|NCT00880763|157712490|FG000|Extension Period (Part 2)|Lack of Efficacy|0|||
48968236|NCT00880763|157712491|FG001|Extension Period (Part 2)|Lack of Efficacy|0|||
48968237|NCT00880763|157712492|FG002|Extension Period (Part 2)|Lack of Efficacy|0|||
48668095|NCT01635764|156639066|FG000|Overall Study|Other|28|||
48968238|NCT00880763|157712493|FG003|Extension Period (Part 2)|Lack of Efficacy|1|||
48968239|NCT01993615|157712494|FG000|Overall Study|Death|1|||
48968240|NCT01993615|157712495|FG001|Overall Study|Death|0|||
48968241|NCT01617655|157712496|FG000|Overall Study|Adverse Event|2|||
48968242|NCT01617655|157712497|FG001|Overall Study|Adverse Event|3|||
48968243|NCT01617655|157712496|FG000|Overall Study|Poor compliance to protocol|1|||
48968244|NCT01617655|157712497|FG001|Overall Study|Poor compliance to protocol|4|||
48968245|NCT01617655|157712496|FG000|Overall Study|Participants moved|0|||
48968246|NCT01617655|157712497|FG001|Overall Study|Participants moved|4|||
48968247|NCT01617655|157712496|FG000|Overall Study|Consent withdrawn by participant|1|||
48968248|NCT01617655|157712497|FG001|Overall Study|Consent withdrawn by participant|1|||
48968249|NCT01617655|157712496|FG000|Overall Study|Last visit outside protocol visit window|1|||
48968250|NCT01617655|157712497|FG001|Overall Study|Last visit outside protocol visit window|10|||
48968251|NCT01617655|157712496|FG000|Overall Study|Site closure|3|||
48968252|NCT01617655|157712497|FG001|Overall Study|Site closure|5|||
48968253|NCT01617655|157712496|FG000|Overall Study|Other than specified above|1|||
48968254|NCT01617655|157712497|FG001|Overall Study|Other than specified above|2|||
48968255|NCT01175213|157712498|FG000|IGSC, 10%/rHuPH20|Withdrawal by Subject|4|||
48968256|NCT01175213|157712499|FG001|IGSC, 10%/rHuPH20|Withdrawal by Subject|0|||
48968257|NCT01175213|157712498|FG000|IGSC, 10%/rHuPH20|Death|1|||
48968258|NCT01175213|157712499|FG001|IGSC, 10%/rHuPH20|Death|0|||
48968259|NCT01175213|157712498|FG000|IGSC, 10%/rHuPH20|bone marrow transplant|1|||
48968260|NCT01175213|157712499|FG001|IGSC, 10%/rHuPH20|bone marrow transplant|0|||
48968261|NCT01175213|157712498|FG000|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6|||
48968262|NCT01175213|157712499|FG001|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0|||
48968263|NCT01175213|157712498|FG000|IGSC, 10%/rHuPH20|site elected to exit study|3|||
48968264|NCT01175213|157712499|FG001|IGSC, 10%/rHuPH20|site elected to exit study|0|||
48968265|NCT01175213|157712498|FG000|Safety Follow-up|Adverse Event|1|||
48968266|NCT01175213|157712499|FG001|Safety Follow-up|Adverse Event|0|||
48968267|NCT01245764|157712502|FG000|Study Phase A|Other|3|||
48968268|NCT01245764|157712503|FG001|Study Phase A|Other|2|||
48968269|NCT01245764|157712504|FG002|Study Phase A|Other|3|||
48668096|NCT00933244|156639067|FG000|Overall Study|Withdrawal by Subject|5|||
48668097|NCT00933244|156639068|FG001|Overall Study|Withdrawal by Subject|1|||
48668098|NCT00933244|156639069|FG002|Overall Study|Withdrawal by Subject|3|||
48968270|NCT01245764|157712505|FG003|Study Phase A|Other|1|||
48968271|NCT01245764|157712502|FG000|Study Phase A|Protocol Violation|6|||
48968272|NCT01245764|157712503|FG001|Study Phase A|Protocol Violation|3|||
48968273|NCT01245764|157712504|FG002|Study Phase A|Protocol Violation|2|||
48968274|NCT01245764|157712505|FG003|Study Phase A|Protocol Violation|2|||
48968275|NCT01245764|157712502|FG000|Study Phase A|Lost to Follow-up|0|||
48968276|NCT01245764|157712503|FG001|Study Phase A|Lost to Follow-up|0|||
48968277|NCT01245764|157712504|FG002|Study Phase A|Lost to Follow-up|5|||
48968278|NCT01245764|157712505|FG003|Study Phase A|Lost to Follow-up|0|||
48968279|NCT01357980|157712510|FG000|Overall Study|Lack of Efficacy|0|||
48968280|NCT01357980|157712511|FG001|Overall Study|Lack of Efficacy|1|||
48968281|NCT01357980|157712512|FG002|Overall Study|Lack of Efficacy|0|||
48968282|NCT01357980|157712513|FG003|Overall Study|Lack of Efficacy|0|||
48668099|NCT02258529|156639070|FG000|Overall Study|Study Terminated by Sponsor|9|||
48668100|NCT02258529|156639070|FG000|Overall Study|Adverse Event|1|||
48668101|NCT01318070|156639072|FG000|Overall Study|Adverse Event|1|||
48968283|NCT01357980|157712510|FG000|Overall Study|Consent withdrawn|0|||
48968284|NCT01357980|157712511|FG001|Overall Study|Consent withdrawn|0|||
48968285|NCT01357980|157712512|FG002|Overall Study|Consent withdrawn|1|||
48968286|NCT01357980|157712513|FG003|Overall Study|Consent withdrawn|0|||
48968287|NCT00387348|157712514|FG000|Overall Study|Death|1|||
48968288|NCT00387348|157712515|FG001|Overall Study|Death|1|||
48968289|NCT00387348|157712516|FG002|Overall Study|Death|0|||
48968290|NCT00387348|157712514|FG000|Overall Study|Physician Decision|1|||
48968291|NCT00387348|157712515|FG001|Overall Study|Physician Decision|0|||
48968292|NCT00387348|157712516|FG002|Overall Study|Physician Decision|1|||
48968293|NCT00387348|157712514|FG000|Overall Study|Withdrawal by Subject|0|||
48968294|NCT00387348|157712515|FG001|Overall Study|Withdrawal by Subject|2|||
48968295|NCT00387348|157712516|FG002|Overall Study|Withdrawal by Subject|2|||
48968296|NCT00387348|157712514|FG000|Overall Study|Adverse Event|1|||
48968297|NCT00387348|157712515|FG001|Overall Study|Adverse Event|0|||
48758757|NCT02864251|156964638|FG001|Treatment|Participant Requested to Discontinue Study Treatment|0|||
48758758|NCT02864251|156964639|FG002|Treatment|Participant Requested to Discontinue Study Treatment|5|||
48758759|NCT02864251|156964637|FG000|Treatment|Withdrawal by Participant|8|||
48758760|NCT02864251|156964638|FG001|Treatment|Withdrawal by Participant|5|||
48758761|NCT02864251|156964639|FG002|Treatment|Withdrawal by Participant|13|||
48758762|NCT02864251|156964637|FG000|Treatment|Maximum Clinical Benefit|1|||
48758763|NCT02864251|156964638|FG001|Treatment|Maximum Clinical Benefit|0|||
48758764|NCT02864251|156964639|FG002|Treatment|Maximum Clinical Benefit|1|||
48758765|NCT02864251|156964637|FG000|Treatment|Participant no Longer Meets Study Criteria|0|||
48758766|NCT02864251|156964638|FG001|Treatment|Participant no Longer Meets Study Criteria|1|||
48758767|NCT02864251|156964639|FG002|Treatment|Participant no Longer Meets Study Criteria|0|||
48758768|NCT02864251|156964637|FG000|Treatment|Other Reasons|1|||
48758769|NCT02864251|156964638|FG001|Treatment|Other Reasons|1|||
48758770|NCT02864251|156964639|FG002|Treatment|Other Reasons|4|||
48758771|NCT02864251|156964637|FG000|Treatment|Administrative Reason by Sponsor|1|||
48758772|NCT02864251|156964638|FG001|Treatment|Administrative Reason by Sponsor|0|||
48668102|NCT01318070|156639073|FG001|Overall Study|Adverse Event|1|||
48668103|NCT01318070|156639074|FG002|Overall Study|Adverse Event|5|||
48668104|NCT01318070|156639072|FG000|Overall Study|Withdrawal by Subject|0|||
48668105|NCT01318070|156639073|FG001|Overall Study|Withdrawal by Subject|1|||
48668106|NCT01318070|156639074|FG002|Overall Study|Withdrawal by Subject|1|||
48668107|NCT01318070|156639072|FG000|Overall Study|Lack of Efficacy|0|||
48668108|NCT01318070|156639073|FG001|Overall Study|Lack of Efficacy|0|||
48668109|NCT01318070|156639074|FG002|Overall Study|Lack of Efficacy|1|||
48668110|NCT01318070|156639072|FG000|Overall Study|Principal Investigator Discretion|1|||
48668111|NCT01318070|156639073|FG001|Overall Study|Principal Investigator Discretion|0|||
48668112|NCT01318070|156639074|FG002|Overall Study|Principal Investigator Discretion|0|||
48668113|NCT00391391|156639075|FG000|Overall Study|Adverse Event|0|||
48758773|NCT02864251|156964639|FG002|Treatment|Administrative Reason by Sponsor|0|||
48758774|NCT00276159|156964641|FG000|Overall Study|Did not receive all 24 doses of 852A|6|||
48758775|NCT02617511|156964650|FG000|Overall Study|Withdrawal by Subject|1|||
48968298|NCT00387348|157712516|FG002|Overall Study|Adverse Event|1|||
48668114|NCT00391391|156639076|FG001|Overall Study|Adverse Event|0|||
48668115|NCT00391391|156639077|FG002|Overall Study|Adverse Event|0|||
48758776|NCT02617511|156964651|FG001|Overall Study|Withdrawal by Subject|0|||
48758777|NCT00171223|156964652|FG000|Overall Study|Adverse Event (Non-fatal)|6|||
48758778|NCT00171223|156964653|FG001|Overall Study|Adverse Event (Non-fatal)|5|||
48758779|NCT00171223|156964654|FG002|Overall Study|Adverse Event (Non-fatal)|19|||
48758780|NCT00171223|156964652|FG000|Overall Study|Abnormal Laboratory Value (s)|4|||
48758781|NCT00171223|156964653|FG001|Overall Study|Abnormal Laboratory Value (s)|2|||
48758782|NCT00171223|156964654|FG002|Overall Study|Abnormal Laboratory Value (s)|3|||
48758783|NCT00171223|156964652|FG000|Overall Study|Abnormal Procedure|1|||
48758784|NCT00171223|156964653|FG001|Overall Study|Abnormal Procedure|0|||
48758785|NCT00171223|156964654|FG002|Overall Study|Abnormal Procedure|0|||
48758786|NCT00171223|156964652|FG000|Overall Study|Unsatisfactory Therapeutic Effect|57|||
48758787|NCT00171223|156964653|FG001|Overall Study|Unsatisfactory Therapeutic Effect|43|||
48758788|NCT00171223|156964654|FG002|Overall Study|Unsatisfactory Therapeutic Effect|52|||
48758789|NCT00171223|156964652|FG000|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
48758790|NCT00171223|156964653|FG001|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4|||
48758791|NCT00171223|156964654|FG002|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
48758792|NCT00171223|156964652|FG000|Overall Study|Protocol Violation|2|||
48758793|NCT00171223|156964653|FG001|Overall Study|Protocol Violation|2|||
48758794|NCT00171223|156964654|FG002|Overall Study|Protocol Violation|3|||
48868749|NCT00498433|157356952|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
48868750|NCT00498433|157356950|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15|||
48868751|NCT00498433|157356951|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
48868752|NCT00498433|157356952|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
48868753|NCT00498433|157356950|FG000|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1|||
48868754|NCT00498433|157356951|FG001|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
48868755|NCT00498433|157356952|FG002|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
48868756|NCT00744796|157356954|FG000|Post-Operative 6-9 Months|Lost to Follow-up|12|||
48868757|NCT02581189|157356955|FG000|Overall Study|Failure to return|36|||
48868758|NCT02581189|157356955|FG000|Overall Study|Withdrew consent|5|||
48868759|NCT02581189|157356955|FG000|Overall Study|Death|3|||
48868760|NCT02581189|157356955|FG000|Overall Study|Insufficient virological response|2|||
48868761|NCT02581189|157356955|FG000|Overall Study|Other, not specified|7|||
48868762|NCT05372913|157356956|FG000|Overall Study|Withdrawal by Subject|0|||
48868763|NCT05372913|157356957|FG001|Overall Study|Withdrawal by Subject|2|||
48968299|NCT00505752|157712517|FG000|Overall Study|Adverse Event|1|||
48968300|NCT00505752|157712518|FG001|Overall Study|Adverse Event|0|||
48758795|NCT00171223|156964652|FG000|Overall Study|Participant Withdrew Consent|12|||
48758796|NCT00171223|156964653|FG001|Overall Study|Participant Withdrew Consent|21|||
48968301|NCT00505752|157712519|FG002|Overall Study|Adverse Event|1|||
48758797|NCT00171223|156964654|FG002|Overall Study|Participant Withdrew Consent|15|||
48758798|NCT00171223|156964652|FG000|Overall Study|Lost to Follow-up|5|||
48758799|NCT00171223|156964653|FG001|Overall Study|Lost to Follow-up|2|||
48758800|NCT00171223|156964654|FG002|Overall Study|Lost to Follow-up|3|||
48758801|NCT00171223|156964652|FG000|Overall Study|Administrative Problems|4|||
48758802|NCT00171223|156964653|FG001|Overall Study|Administrative Problems|7|||
48758803|NCT00171223|156964654|FG002|Overall Study|Administrative Problems|6|||
48758804|NCT00171223|156964652|FG000|Overall Study|Adverse Event (Serious Fatal)|6|||
48758805|NCT00171223|156964653|FG001|Overall Study|Adverse Event (Serious Fatal)|8|||
48758806|NCT00171223|156964654|FG002|Overall Study|Adverse Event (Serious Fatal)|9|||
48758807|NCT00171223|156964652|FG000|Overall Study|Not Specified (No Data Collected After Cut-off)|41|||
48758808|NCT00171223|156964653|FG001|Overall Study|Not Specified (No Data Collected After Cut-off)|47|||
48758809|NCT00171223|156964654|FG002|Overall Study|Not Specified (No Data Collected After Cut-off)|58|||
48758810|NCT02188589|156964660|FG000|Overall Study|Withdrawal by Subject|5|||
48758811|NCT00894322|156964661|FG000|Overall Study|Withdrawal by Subject|1|||
48758812|NCT00894322|156964662|FG001|Overall Study|Withdrawal by Subject|0|||
48758813|NCT00894322|156964663|FG002|Overall Study|Withdrawal by Subject|0|||
48758814|NCT01519960|156964669|FG000|Overall Study|Withdrawal from the study|26|||
48758815|NCT01519960|156964670|FG001|Overall Study|Withdrawal from the study|22|||
48758816|NCT01519960|156964671|FG002|Overall Study|Withdrawal from the study|5|||
48758817|NCT02951156|156964672|FG000|Overall Study|Death|3|||
48758818|NCT02951156|156964673|FG001|Overall Study|Death|8|||
48758819|NCT02951156|156964674|FG002|Overall Study|Death|5|||
48758820|NCT02951156|156964672|FG000|Overall Study|Progressive disease|1|||
48758821|NCT02951156|156964673|FG001|Overall Study|Progressive disease|0|||
48758822|NCT02951156|156964674|FG002|Overall Study|Progressive disease|1|||
48758823|NCT02951156|156964672|FG000|Overall Study|Withdrawal by Subject|0|||
48758824|NCT02951156|156964673|FG001|Overall Study|Withdrawal by Subject|0|||
48758825|NCT02951156|156964674|FG002|Overall Study|Withdrawal by Subject|1|||
48758826|NCT02951156|156964672|FG000|Overall Study|Study terminated by sponsor|0|||
48758827|NCT02951156|156964673|FG001|Overall Study|Study terminated by sponsor|0|||
48758828|NCT02951156|156964674|FG002|Overall Study|Study terminated by sponsor|1|||
48758829|NCT02951156|156964672|FG000|Overall Study|Other|5|||
48758830|NCT02951156|156964673|FG001|Overall Study|Other|1|||
48758831|NCT02951156|156964674|FG002|Overall Study|Other|2|||
48758832|NCT00378209|156964677|FG000|Overall Study|Progressive disease|11|||
48758833|NCT00378209|156964677|FG000|Overall Study|Adverse Event|3|||
48758834|NCT00378209|156964677|FG000|Overall Study|Initiation of non-protocol therapy|3|||
48758835|NCT00378209|156964677|FG000|Overall Study|Physician Decision|3|||
48758836|NCT00378209|156964677|FG000|Overall Study|Death|1|||
48758837|NCT00378209|156964677|FG000|Overall Study|Treatment delay|1|||
48668116|NCT00391391|156639078|FG003|Overall Study|Adverse Event|1|||
48668117|NCT00391391|156639075|FG000|Overall Study|Lost to Follow-up|1|||
48758838|NCT00744627|156964678|FG000|Overall Study|Adverse Event|6|||
48758839|NCT00744627|156964679|FG001|Overall Study|Adverse Event|9|||
48758840|NCT00744627|156964678|FG000|Overall Study|Lack of Efficacy|7|||
48758841|NCT00744627|156964679|FG001|Overall Study|Lack of Efficacy|3|||
48668118|NCT00391391|156639076|FG001|Overall Study|Lost to Follow-up|3|||
48668119|NCT00391391|156639077|FG002|Overall Study|Lost to Follow-up|7|||
48668120|NCT00391391|156639078|FG003|Overall Study|Lost to Follow-up|4|||
48668121|NCT00391391|156639075|FG000|Overall Study|Protocol Violation|2|||
48668122|NCT00391391|156639076|FG001|Overall Study|Protocol Violation|3|||
48668123|NCT00391391|156639077|FG002|Overall Study|Protocol Violation|6|||
48668124|NCT00391391|156639078|FG003|Overall Study|Protocol Violation|7|||
48668125|NCT00391391|156639075|FG000|Overall Study|Withdrawal by Subject|6|||
48668126|NCT00391391|156639076|FG001|Overall Study|Withdrawal by Subject|4|||
48668127|NCT00391391|156639077|FG002|Overall Study|Withdrawal by Subject|10|||
48668128|NCT00391391|156639078|FG003|Overall Study|Withdrawal by Subject|7|||
48668129|NCT01533922|156639079|FG000|Overall Study|Adverse Event|5|||
48668130|NCT01533922|156639080|FG001|Overall Study|Adverse Event|8|||
48668131|NCT01533922|156639081|FG002|Overall Study|Adverse Event|6|||
48758842|NCT00744627|156964678|FG000|Overall Study|Noncompliance|0|||
48668132|NCT01533922|156639082|FG003|Overall Study|Adverse Event|3|||
48668133|NCT01533922|156639083|FG004|Overall Study|Adverse Event|4|||
48668134|NCT01533922|156639079|FG000|Overall Study|Lack of Efficacy|0|||
48668135|NCT01533922|156639080|FG001|Overall Study|Lack of Efficacy|0|||
48668136|NCT01533922|156639081|FG002|Overall Study|Lack of Efficacy|1|||
48758843|NCT00744627|156964679|FG001|Overall Study|Noncompliance|1|||
48758844|NCT00744627|156964678|FG000|Overall Study|Protocol Deviations|0|||
48668137|NCT01533922|156639082|FG003|Overall Study|Lack of Efficacy|0|||
48668138|NCT01533922|156639083|FG004|Overall Study|Lack of Efficacy|0|||
48668139|NCT01533922|156639079|FG000|Overall Study|Protocol Violation|0|||
48668140|NCT01533922|156639080|FG001|Overall Study|Protocol Violation|3|||
48668141|NCT01533922|156639081|FG002|Overall Study|Protocol Violation|0|||
48758845|NCT00744627|156964679|FG001|Overall Study|Protocol Deviations|2|||
48758846|NCT00744627|156964678|FG000|Overall Study|Voluntary Withdrawal|9|||
48758847|NCT00744627|156964679|FG001|Overall Study|Voluntary Withdrawal|6|||
48758848|NCT00744627|156964678|FG000|Overall Study|Lost to Follow-up|2|||
48758849|NCT00744627|156964679|FG001|Overall Study|Lost to Follow-up|1|||
48758850|NCT00744627|156964678|FG000|Overall Study|Other|1|||
48758851|NCT00744627|156964679|FG001|Overall Study|Other|0|||
48758852|NCT00768300|156964680|FG000|Overall Study|Randomized but not treated|1|||
48758853|NCT00768300|156964681|FG001|Overall Study|Randomized but not treated|1|||
48758854|NCT00768300|156964680|FG000|Overall Study|Adverse Event|10|||
48758855|NCT00768300|156964681|FG001|Overall Study|Adverse Event|2|||
48758856|NCT00768300|156964680|FG000|Overall Study|Protocol Violation|6|||
48758857|NCT00768300|156964681|FG001|Overall Study|Protocol Violation|1|||
48758858|NCT00768300|156964680|FG000|Overall Study|Withdrawal by Subject|13|||
48758859|NCT00768300|156964681|FG001|Overall Study|Withdrawal by Subject|7|||
48758860|NCT00768300|156964680|FG000|Overall Study|Physician Decision|2|||
48758861|NCT00768300|156964681|FG001|Overall Study|Physician Decision|3|||
48758862|NCT00768300|156964680|FG000|Overall Study|Study discontinued by Sponsor|271|||
48758863|NCT00768300|156964681|FG001|Overall Study|Study discontinued by Sponsor|140|||
48758864|NCT00768300|156964680|FG000|Overall Study|Death|21|||
48758865|NCT00768300|156964681|FG001|Overall Study|Death|5|||
48758866|NCT00768300|156964680|FG000|Overall Study|Subject moved to pursue lung transplant|1|||
48758867|NCT00768300|156964681|FG001|Overall Study|Subject moved to pursue lung transplant|1|||
48758868|NCT00768300|156964680|FG000|Overall Study|Screen failure following randomization|1|||
48758869|NCT00768300|156964681|FG001|Overall Study|Screen failure following randomization|0|||
48758870|NCT00768300|156964680|FG000|Overall Study|Received lung transplant|1|||
48758871|NCT00768300|156964681|FG001|Overall Study|Received lung transplant|1|||
48868764|NCT05372913|157356956|FG000|Overall Study|Protocol Violation|2|||
48668142|NCT01533922|156639082|FG003|Overall Study|Protocol Violation|0|||
48668143|NCT01533922|156639083|FG004|Overall Study|Protocol Violation|1|||
48668144|NCT01533922|156639079|FG000|Overall Study|Withdrawal by Subject|3|||
48668145|NCT01533922|156639080|FG001|Overall Study|Withdrawal by Subject|1|||
48668146|NCT01533922|156639081|FG002|Overall Study|Withdrawal by Subject|2|||
48668147|NCT01533922|156639082|FG003|Overall Study|Withdrawal by Subject|2|||
48668148|NCT01533922|156639083|FG004|Overall Study|Withdrawal by Subject|1|||
48668149|NCT01533922|156639079|FG000|Overall Study|Other reason not defined above|2|||
48668150|NCT01533922|156639080|FG001|Overall Study|Other reason not defined above|0|||
48668151|NCT01533922|156639081|FG002|Overall Study|Other reason not defined above|1|||
48668152|NCT01533922|156639082|FG003|Overall Study|Other reason not defined above|0|||
48668153|NCT01533922|156639083|FG004|Overall Study|Other reason not defined above|0|||
48668154|NCT00930969|156639084|FG000|Overall Study|Death|5|||
48668155|NCT00930969|156639084|FG000|Overall Study|Lost to Follow-up|1|||
48668156|NCT00930969|156639084|FG000|Overall Study|Physician Decision|13|||
48668157|NCT00930969|156639084|FG000|Overall Study|Withdrawal by Subject|19|||
48668158|NCT02876328|156639085|FG000|Overall Study|Death|2|||
48668159|NCT02876328|156639086|FG001|Overall Study|Death|1|||
48668160|NCT02876328|156639087|FG002|Overall Study|Death|3|||
48668161|NCT02876328|156639088|FG003|Overall Study|Death|0|||
48668162|NCT02876328|156639089|FG004|Overall Study|Death|0|||
48668163|NCT02876328|156639090|FG005|Overall Study|Death|0|||
48668164|NCT02876328|156639091|FG006|Overall Study|Death|1|||
48758872|NCT00768300|156964680|FG000|Overall Study|Lost to Follow-up|0|||
48758873|NCT00768300|156964681|FG001|Overall Study|Lost to Follow-up|1|||
48758874|NCT00768300|156964680|FG000|Overall Study|Began prohibited concomitant medication|0|||
48758875|NCT00768300|156964681|FG001|Overall Study|Began prohibited concomitant medication|1|||
48758876|NCT00768300|156964680|FG000|Overall Study|Treated but never dosed with Study drug|1|||
48868765|NCT05372913|157356957|FG001|Overall Study|Protocol Violation|2|||
48868766|NCT05372913|157356956|FG000|Overall Study|Adverse Event|0|||
48868767|NCT05372913|157356957|FG001|Overall Study|Adverse Event|1|||
48868768|NCT03193216|157356958|FG000|Overall Study|Lost to Follow-up|1|||
48868769|NCT03193216|157356959|FG001|Overall Study|Lost to Follow-up|0|||
48868770|NCT03193216|157356958|FG000|Overall Study|Withdrawal by Subject|5|||
48868771|NCT03193216|157356959|FG001|Overall Study|Withdrawal by Subject|0|||
48868772|NCT03193216|157356958|FG000|Overall Study|Physician Decision|4|||
48868773|NCT03193216|157356959|FG001|Overall Study|Physician Decision|0|||
48868774|NCT03275402|157356960|FG000|Overall Study|Death|17|||
48868775|NCT03275402|157356960|FG000|Overall Study|Study terminated by sponsor|21|||
48868776|NCT03275402|157356960|FG000|Overall Study|Withdrawal by Subject|1|||
48868777|NCT05135156|157356961|FG000|Overall Study|Lost to Follow-up|0|||
48868778|NCT05135156|157356962|FG001|Overall Study|Lost to Follow-up|0|||
48868779|NCT05135156|157356963|FG002|Overall Study|Lost to Follow-up|2|||
48868780|NCT01797705|157356964|FG000|Overall Study|Equipment anomalies during sleep studies|4|||
48868781|NCT01797705|157356964|FG000|Overall Study|Withdrawal by Subject|1|||
48868782|NCT02512861|157356968|FG000|Overall Study|Protocol Violation|3|||
48868783|NCT02512861|157356969|FG001|Overall Study|Protocol Violation|7|||
48868784|NCT02512861|157356968|FG000|Overall Study|Physician Decision|3|||
48868785|NCT02512861|157356969|FG001|Overall Study|Physician Decision|1|||
48668165|NCT02876328|156639092|FG007|Overall Study|Death|3|||
48668166|NCT02876328|156639093|FG008|Overall Study|Death|0|||
48668167|NCT02876328|156639094|FG009|Overall Study|Death|1|||
48668168|NCT02876328|156639095|FG010|Overall Study|Death|1|||
48668169|NCT02876328|156639096|FG011|Overall Study|Death|0|||
48668170|NCT02876328|156639097|FG012|Overall Study|Death|0|||
48668171|NCT02876328|156639098|FG013|Overall Study|Death|0|||
48668172|NCT02876328|156639099|FG014|Overall Study|Death|0|||
48668173|NCT02876328|156639100|FG015|Overall Study|Death|0|||
48758877|NCT00768300|156964681|FG001|Overall Study|Treated but never dosed with Study drug|0|||
48758878|NCT00768300|156964680|FG000|Overall Study|Missing data|1|||
48758879|NCT00768300|156964681|FG001|Overall Study|Missing data|0|||
48758880|NCT01374087|156964690|FG000|Overall Study|Adverse Event|1|||
48758881|NCT01374087|156964691|FG001|Overall Study|Adverse Event|0|||
48758882|NCT01374087|156964690|FG000|Overall Study|Disease progression|2|||
48758883|NCT01374087|156964691|FG001|Overall Study|Disease progression|2|||
48758884|NCT01374087|156964690|FG000|Overall Study|Study discontinued|13|||
48758885|NCT01374087|156964691|FG001|Overall Study|Study discontinued|13|||
48758886|NCT00624052|156964697|FG000|Overall Study|Adverse Event|7|||
48758887|NCT00624052|156964698|FG001|Overall Study|Adverse Event|6|||
48758888|NCT00624052|156964699|FG002|Overall Study|Adverse Event|0|||
48758889|NCT00624052|156964700|FG003|Overall Study|Adverse Event|3|||
48758890|NCT00624052|156964697|FG000|Overall Study|Lack of Efficacy|1|||
48758891|NCT00624052|156964698|FG001|Overall Study|Lack of Efficacy|1|||
48668174|NCT02876328|156639101|FG016|Overall Study|Death|1|||
48668175|NCT02876328|156639102|FG017|Overall Study|Death|1|||
48668176|NCT02876328|156639103|FG018|Overall Study|Death|0|||
48668177|NCT02876328|156639104|FG019|Overall Study|Death|0|||
48668178|NCT02876328|156639105|FG020|Overall Study|Death|0|||
48668179|NCT02876328|156639106|FG021|Overall Study|Death|1|||
48668180|NCT02876328|156639107|FG022|Overall Study|Death|0|||
48668181|NCT02876328|156639108|FG023|Overall Study|Death|0|||
48668182|NCT02876328|156639085|FG000|Overall Study|Withdrawal by Subject|0|||
48668183|NCT02876328|156639086|FG001|Overall Study|Withdrawal by Subject|2|||
48668184|NCT02876328|156639087|FG002|Overall Study|Withdrawal by Subject|3|||
48668185|NCT02876328|156639088|FG003|Overall Study|Withdrawal by Subject|3|||
48668186|NCT02876328|156639089|FG004|Overall Study|Withdrawal by Subject|0|||
48668187|NCT02876328|156639090|FG005|Overall Study|Withdrawal by Subject|1|||
48668188|NCT02876328|156639091|FG006|Overall Study|Withdrawal by Subject|0|||
48668189|NCT02876328|156639092|FG007|Overall Study|Withdrawal by Subject|1|||
48668190|NCT02876328|156639093|FG008|Overall Study|Withdrawal by Subject|1|||
48668191|NCT02876328|156639094|FG009|Overall Study|Withdrawal by Subject|2|||
48668192|NCT02876328|156639095|FG010|Overall Study|Withdrawal by Subject|0|||
48668193|NCT02876328|156639096|FG011|Overall Study|Withdrawal by Subject|0|||
48668194|NCT02876328|156639097|FG012|Overall Study|Withdrawal by Subject|0|||
48668195|NCT02876328|156639098|FG013|Overall Study|Withdrawal by Subject|0|||
48668196|NCT02876328|156639099|FG014|Overall Study|Withdrawal by Subject|0|||
48668197|NCT02876328|156639100|FG015|Overall Study|Withdrawal by Subject|0|||
48668198|NCT02876328|156639101|FG016|Overall Study|Withdrawal by Subject|1|||
48668199|NCT02876328|156639102|FG017|Overall Study|Withdrawal by Subject|3|||
48668200|NCT02876328|156639103|FG018|Overall Study|Withdrawal by Subject|0|||
48668201|NCT02876328|156639104|FG019|Overall Study|Withdrawal by Subject|0|||
48668202|NCT02876328|156639105|FG020|Overall Study|Withdrawal by Subject|1|||
48668203|NCT02876328|156639106|FG021|Overall Study|Withdrawal by Subject|0|||
48668204|NCT02876328|156639107|FG022|Overall Study|Withdrawal by Subject|0|||
48668205|NCT02876328|156639108|FG023|Overall Study|Withdrawal by Subject|0|||
48668206|NCT02876328|156639085|FG000|Overall Study|Missed 12 Month Visit|15|||
48668207|NCT02876328|156639086|FG001|Overall Study|Missed 12 Month Visit|10|||
48668208|NCT02876328|156639087|FG002|Overall Study|Missed 12 Month Visit|11|||
48668209|NCT02876328|156639088|FG003|Overall Study|Missed 12 Month Visit|6|||
48668210|NCT02876328|156639089|FG004|Overall Study|Missed 12 Month Visit|10|||
48758892|NCT00624052|156964699|FG002|Overall Study|Lack of Efficacy|0|||
48758893|NCT00624052|156964700|FG003|Overall Study|Lack of Efficacy|0|||
48668211|NCT02876328|156639090|FG005|Overall Study|Missed 12 Month Visit|14|||
48668212|NCT02876328|156639091|FG006|Overall Study|Missed 12 Month Visit|3|||
48668213|NCT02876328|156639092|FG007|Overall Study|Missed 12 Month Visit|8|||
48668214|NCT02876328|156639093|FG008|Overall Study|Missed 12 Month Visit|9|||
48668215|NCT02876328|156639094|FG009|Overall Study|Missed 12 Month Visit|5|||
48668216|NCT02876328|156639095|FG010|Overall Study|Missed 12 Month Visit|4|||
48668217|NCT02876328|156639096|FG011|Overall Study|Missed 12 Month Visit|1|||
48668218|NCT02876328|156639097|FG012|Overall Study|Missed 12 Month Visit|5|||
48668219|NCT02876328|156639098|FG013|Overall Study|Missed 12 Month Visit|4|||
48668220|NCT02876328|156639099|FG014|Overall Study|Missed 12 Month Visit|4|||
48668221|NCT02876328|156639100|FG015|Overall Study|Missed 12 Month Visit|4|||
48668222|NCT02876328|156639101|FG016|Overall Study|Missed 12 Month Visit|3|||
48968302|NCT00505752|157712520|FG003|Overall Study|Adverse Event|0|||
48668223|NCT02876328|156639102|FG017|Overall Study|Missed 12 Month Visit|6|||
48668224|NCT02876328|156639103|FG018|Overall Study|Missed 12 Month Visit|2|||
48668225|NCT02876328|156639104|FG019|Overall Study|Missed 12 Month Visit|2|||
48758894|NCT00624052|156964697|FG000|Overall Study|Lost to Follow-up|2|||
48758895|NCT00624052|156964698|FG001|Overall Study|Lost to Follow-up|3|||
48758896|NCT00624052|156964699|FG002|Overall Study|Lost to Follow-up|1|||
48668226|NCT02876328|156639105|FG020|Overall Study|Missed 12 Month Visit|11|||
48758897|NCT00624052|156964700|FG003|Overall Study|Lost to Follow-up|0|||
48758898|NCT00624052|156964697|FG000|Overall Study|Non compliant with the protocol|2|||
48758899|NCT00624052|156964698|FG001|Overall Study|Non compliant with the protocol|1|||
48758900|NCT00624052|156964699|FG002|Overall Study|Non compliant with the protocol|1|||
48758901|NCT00624052|156964700|FG003|Overall Study|Non compliant with the protocol|1|||
48758902|NCT00624052|156964697|FG000|Overall Study|Consent withdrawn|3|||
48758903|NCT00624052|156964698|FG001|Overall Study|Consent withdrawn|1|||
48758904|NCT00624052|156964699|FG002|Overall Study|Consent withdrawn|1|||
48758905|NCT00624052|156964700|FG003|Overall Study|Consent withdrawn|0|||
48758906|NCT00624052|156964697|FG000|Overall Study|Changed job/ran out if meds|0|||
48758907|NCT00624052|156964698|FG001|Overall Study|Changed job/ran out if meds|2|||
48758908|NCT00624052|156964699|FG002|Overall Study|Changed job/ran out if meds|0|||
48758909|NCT00624052|156964700|FG003|Overall Study|Changed job/ran out if meds|0|||
48758910|NCT00946712|156964701|FG000|Overall Study|Adverse Event|118|||
48968303|NCT00505752|157712517|FG000|Overall Study|Lost to Follow-up|1|||
48968304|NCT00505752|157712518|FG001|Overall Study|Lost to Follow-up|0|||
48668227|NCT02876328|156639106|FG021|Overall Study|Missed 12 Month Visit|7|||
48668228|NCT02876328|156639107|FG022|Overall Study|Missed 12 Month Visit|1|||
48668229|NCT02876328|156639108|FG023|Overall Study|Missed 12 Month Visit|0|||
48668230|NCT02712424|156639109|FG000|Overall Study|Lost to Follow-up|34|||
48668231|NCT02712424|156639110|FG001|Overall Study|Lost to Follow-up|32|||
48668232|NCT01443130|156639111|FG000|Overall Study|Lost to Follow-up|44|||
48668233|NCT01443130|156639112|FG001|Overall Study|Lost to Follow-up|42|||
48668234|NCT01443130|156639113|FG002|Overall Study|Lost to Follow-up|50|||
48668235|NCT01443130|156639114|FG003|Overall Study|Lost to Follow-up|23|||
48668236|NCT01443130|156639115|FG004|Overall Study|Lost to Follow-up|25|||
48668237|NCT01443130|156639116|FG005|Overall Study|Lost to Follow-up|21|||
48668238|NCT01443130|156639111|FG000|Overall Study|Death|0|||
48668239|NCT01443130|156639112|FG001|Overall Study|Death|1|||
48668240|NCT01443130|156639113|FG002|Overall Study|Death|0|||
48668241|NCT01443130|156639114|FG003|Overall Study|Death|7|||
48668242|NCT01443130|156639115|FG004|Overall Study|Death|10|||
48668243|NCT01443130|156639116|FG005|Overall Study|Death|8|||
48668244|NCT01443130|156639111|FG000|Overall Study|Adverse Event|2|||
48668245|NCT01443130|156639112|FG001|Overall Study|Adverse Event|1|||
48668246|NCT01443130|156639113|FG002|Overall Study|Adverse Event|1|||
48668247|NCT01443130|156639114|FG003|Overall Study|Adverse Event|0|||
48668248|NCT01443130|156639115|FG004|Overall Study|Adverse Event|0|||
48668249|NCT01443130|156639116|FG005|Overall Study|Adverse Event|0|||
48668250|NCT01443130|156639111|FG000|Overall Study|Protocol Violation|2|||
48668251|NCT01443130|156639112|FG001|Overall Study|Protocol Violation|1|||
48668252|NCT01443130|156639113|FG002|Overall Study|Protocol Violation|3|||
48668253|NCT01443130|156639114|FG003|Overall Study|Protocol Violation|2|||
48668254|NCT01443130|156639115|FG004|Overall Study|Protocol Violation|2|||
48668255|NCT01443130|156639116|FG005|Overall Study|Protocol Violation|3|||
48668256|NCT01443130|156639111|FG000|Overall Study|Withdrawal by Subject|15|||
48668257|NCT01443130|156639112|FG001|Overall Study|Withdrawal by Subject|14|||
48668258|NCT01443130|156639113|FG002|Overall Study|Withdrawal by Subject|12|||
48668259|NCT01443130|156639114|FG003|Overall Study|Withdrawal by Subject|7|||
48668260|NCT01443130|156639115|FG004|Overall Study|Withdrawal by Subject|7|||
48668261|NCT01443130|156639116|FG005|Overall Study|Withdrawal by Subject|2|||
48968305|NCT00505752|157712519|FG002|Overall Study|Lost to Follow-up|0|||
48968306|NCT00505752|157712520|FG003|Overall Study|Lost to Follow-up|0|||
48968307|NCT00505752|157712517|FG000|Overall Study|Lack of ovarian response|1|||
48968308|NCT00505752|157712518|FG001|Overall Study|Lack of ovarian response|3|||
48968309|NCT00505752|157712519|FG002|Overall Study|Lack of ovarian response|0|||
48968310|NCT00505752|157712520|FG003|Overall Study|Lack of ovarian response|0|||
48968311|NCT00505752|157712517|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
48968312|NCT00505752|157712518|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
48668262|NCT01443130|156639111|FG000|Overall Study|Death of Subject's Infant|5|||
48668263|NCT01443130|156639112|FG001|Overall Study|Death of Subject's Infant|10|||
48668264|NCT01443130|156639113|FG002|Overall Study|Death of Subject's Infant|11|||
48968313|NCT00505752|157712519|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
48668265|NCT01443130|156639114|FG003|Overall Study|Death of Subject's Infant|0|||
48668266|NCT01443130|156639115|FG004|Overall Study|Death of Subject's Infant|0|||
48668267|NCT01443130|156639116|FG005|Overall Study|Death of Subject's Infant|0|||
48668268|NCT00364533|156639117|FG000|Overall Study|Adverse Event|8|||
48668269|NCT00364533|156639118|FG001|Overall Study|Adverse Event|7|||
48668270|NCT00364533|156639119|FG002|Overall Study|Adverse Event|15|||
48668271|NCT00364533|156639120|FG003|Overall Study|Adverse Event|5|||
48668272|NCT00364533|156639121|FG004|Overall Study|Adverse Event|2|||
48668273|NCT00364533|156639117|FG000|Overall Study|Withdrawal by Subject|4|||
48668274|NCT00364533|156639118|FG001|Overall Study|Withdrawal by Subject|8|||
48668275|NCT00364533|156639119|FG002|Overall Study|Withdrawal by Subject|6|||
48668276|NCT00364533|156639120|FG003|Overall Study|Withdrawal by Subject|6|||
48668277|NCT00364533|156639121|FG004|Overall Study|Withdrawal by Subject|6|||
48758911|NCT00946712|156964702|FG001|Overall Study|Adverse Event|124|||
48758912|NCT00946712|156964701|FG000|Overall Study|Disease progression|308|||
48668278|NCT00364533|156639117|FG000|Overall Study|Lack of Efficacy|22|||
48668279|NCT00364533|156639118|FG001|Overall Study|Lack of Efficacy|22|||
48868786|NCT02512861|157356968|FG000|Overall Study|Withdrawal by Subject|0|||
48668280|NCT00364533|156639119|FG002|Overall Study|Lack of Efficacy|21|||
48668281|NCT00364533|156639120|FG003|Overall Study|Lack of Efficacy|17|||
48668282|NCT00364533|156639121|FG004|Overall Study|Lack of Efficacy|42|||
48668283|NCT00364533|156639117|FG000|Overall Study|Subject discharged from hospital|4|||
48668284|NCT00364533|156639118|FG001|Overall Study|Subject discharged from hospital|1|||
48668285|NCT00364533|156639119|FG002|Overall Study|Subject discharged from hospital|2|||
48668286|NCT00364533|156639120|FG003|Overall Study|Subject discharged from hospital|3|||
48668287|NCT00364533|156639121|FG004|Overall Study|Subject discharged from hospital|1|||
48668288|NCT00364533|156639117|FG000|Overall Study|Variations in drug compliance|2|||
48758913|NCT00946712|156964702|FG001|Overall Study|Disease progression|404|||
48758914|NCT00946712|156964701|FG000|Overall Study|Death|21|||
48758915|NCT00946712|156964702|FG001|Overall Study|Death|22|||
48758916|NCT00946712|156964701|FG000|Overall Study|No treatment given|25|||
48758917|NCT00946712|156964702|FG001|Overall Study|No treatment given|29|||
48758918|NCT00946712|156964701|FG000|Overall Study|Other reasons|61|||
48758919|NCT00946712|156964702|FG001|Overall Study|Other reasons|73|||
48758920|NCT00946712|156964701|FG000|Overall Study|On Treatment|0|||
48758921|NCT00946712|156964702|FG001|Overall Study|On Treatment|4|||
48758922|NCT00946712|156964701|FG000|Overall Study|Ineligible|14|||
48758923|NCT00946712|156964702|FG001|Overall Study|Ineligible|6|||
48758924|NCT00853723|156964703|FG000|Overall Study|Adverse Event|3|||
48758925|NCT00853723|156964704|FG001|Overall Study|Adverse Event|4|||
48758926|NCT00853723|156964705|FG002|Overall Study|Adverse Event|1|||
48758927|NCT00853723|156964703|FG000|Overall Study|Withdrawal by Subject|2|||
48758928|NCT00853723|156964704|FG001|Overall Study|Withdrawal by Subject|1|||
48758929|NCT00853723|156964705|FG002|Overall Study|Withdrawal by Subject|0|||
48758930|NCT00853723|156964703|FG000|Overall Study|Protocol Violation|1|||
48758931|NCT00853723|156964704|FG001|Overall Study|Protocol Violation|2|||
48758932|NCT00853723|156964705|FG002|Overall Study|Protocol Violation|1|||
48758933|NCT05778786|156964706|FG000|Period 1|COVID-19 Related|3|||
48758934|NCT05778786|156964707|FG001|Period 1|COVID-19 Related|3|||
48758935|NCT05778786|156964706|FG000|Period 1|Withdrew Consent during Study|1|||
48758936|NCT05778786|156964707|FG001|Period 1|Withdrew Consent during Study|0|||
48758937|NCT05778786|156964706|FG000|Period 2|Unsatisfactory Lens Fitting due to Study Lens|0|||
48758938|NCT05778786|156964707|FG001|Period 2|Unsatisfactory Lens Fitting due to Study Lens|1|||
48758939|NCT05778786|156964706|FG000|Period 2|Other: Incorrect Study Lens Dispensed|0|||
48758940|NCT05778786|156964707|FG001|Period 2|Other: Incorrect Study Lens Dispensed|1|||
48758941|NCT01173718|156964708|FG000|Overall Study|Death|17|||
48758942|NCT01173718|156964708|FG000|Overall Study|Abandonment of study graft|27|||
48758943|NCT02406651|156964709|FG000|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3|||
48758944|NCT03158051|156964716|FG000|Overall Study|Lost to Follow-up|41|||
48868787|NCT02512861|157356969|FG001|Overall Study|Withdrawal by Subject|1|||
48868788|NCT00922441|157356972|FG000|Overall Study|Protocol Violation|0|||
48868789|NCT00922441|157356973|FG001|Overall Study|Protocol Violation|0|||
48868790|NCT00922441|157356974|FG002|Overall Study|Protocol Violation|2|||
48868791|NCT00922441|157356972|FG000|Overall Study|Withdrawal by Subject|0|||
48868792|NCT00922441|157356973|FG001|Overall Study|Withdrawal by Subject|0|||
48868793|NCT00922441|157356974|FG002|Overall Study|Withdrawal by Subject|1|||
48868794|NCT00797511|157356976|FG000|Overall Study|Withdrawal by Subject|1|||
48868795|NCT01388478|157356977|FG000|Overall Study|Adverse Event|4|||
48868796|NCT01388478|157356977|FG000|Overall Study|Withdrawal by Subject|1|||
48868797|NCT02621047|157356978|FG000|Overall Study|Adverse Event|0|||
48868798|NCT02621047|157356979|FG001|Overall Study|Adverse Event|0|||
48868799|NCT02621047|157356980|FG002|Overall Study|Adverse Event|1|||
48868800|NCT01990664|157356981|FG000|Overall Study|Lost to Follow-up|2|||
48868801|NCT01990664|157356982|FG001|Overall Study|Lost to Follow-up|6|||
48868802|NCT01990664|157356981|FG000|Overall Study|Withdrawal by Subject|2|||
48868803|NCT01990664|157356982|FG001|Overall Study|Withdrawal by Subject|3|||
48868804|NCT01990664|157356981|FG000|Overall Study|Protocol Violation|1|||
48868805|NCT01990664|157356982|FG001|Overall Study|Protocol Violation|0|||
48868806|NCT01990664|157356981|FG000|Overall Study|Lens Discomfort|1|||
48868807|NCT01990664|157356982|FG001|Overall Study|Lens Discomfort|1|||
48868808|NCT01990664|157356981|FG000|Overall Study|Lens Handling Difficulties|1|||
48868809|NCT01990664|157356982|FG001|Overall Study|Lens Handling Difficulties|0|||
48868810|NCT01990664|157356981|FG000|Overall Study|Unsatisfactory Visual Response|0|||
48868811|NCT01990664|157356982|FG001|Overall Study|Unsatisfactory Visual Response|1|||
48868812|NCT02381652|157356989|FG000|Overall Study|Withdrawal by Subject|0|||
48868813|NCT02381652|157356990|FG001|Overall Study|Withdrawal by Subject|0|||
48868814|NCT02381652|157356991|FG002|Overall Study|Withdrawal by Subject|1|||
48868815|NCT05012397|157356992|FG000|Overall Study|Death|10|||
48758945|NCT03158051|156964717|FG001|Overall Study|Lost to Follow-up|47|||
48758946|NCT03158051|156964716|FG000|Overall Study|Physician Decision|6|||
48758947|NCT03158051|156964717|FG001|Overall Study|Physician Decision|7|||
48758948|NCT03158051|156964716|FG000|Overall Study|Withdrawal by Subject|24|||
48968314|NCT00505752|157712520|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
48968315|NCT00505752|157712517|FG000|Overall Study|No oocytes retrieved|0|||
48968316|NCT00505752|157712518|FG001|Overall Study|No oocytes retrieved|2|||
48968317|NCT00505752|157712519|FG002|Overall Study|No oocytes retrieved|0|||
48968318|NCT00505752|157712520|FG003|Overall Study|No oocytes retrieved|1|||
48968319|NCT00505752|157712517|FG000|Overall Study|No Fertilization|1|||
48968320|NCT00505752|157712518|FG001|Overall Study|No Fertilization|1|||
48968321|NCT00505752|157712519|FG002|Overall Study|No Fertilization|2|||
48968322|NCT00505752|157712520|FG003|Overall Study|No Fertilization|1|||
48968323|NCT00505752|157712517|FG000|Overall Study|All embryos/blastocysts discarded|0|||
48968324|NCT00505752|157712518|FG001|Overall Study|All embryos/blastocysts discarded|0|||
48968325|NCT00505752|157712519|FG002|Overall Study|All embryos/blastocysts discarded|1|||
48968326|NCT00505752|157712520|FG003|Overall Study|All embryos/blastocysts discarded|1|||
48968327|NCT00505752|157712517|FG000|Overall Study|Other|1|||
48968328|NCT00505752|157712518|FG001|Overall Study|Other|2|||
48968329|NCT00505752|157712519|FG002|Overall Study|Other|1|||
48968330|NCT00505752|157712520|FG003|Overall Study|Other|2|||
48968331|NCT01624506|157712523|FG000|Overall Study|Lost to Follow-up|29|||
48968332|NCT01624506|157712524|FG001|Overall Study|Lost to Follow-up|15|||
48968333|NCT01624506|157712523|FG000|Overall Study|Withdrawal by Subject|9|||
48968334|NCT01624506|157712524|FG001|Overall Study|Withdrawal by Subject|2|||
48968335|NCT01624506|157712523|FG000|Overall Study|Death|1|||
48968336|NCT01624506|157712524|FG001|Overall Study|Death|0|||
48968337|NCT01624506|157712523|FG000|Overall Study|LINX explants|23|||
48968338|NCT01624506|157712524|FG001|Overall Study|LINX explants|0|||
48968339|NCT01624506|157712523|FG000|Overall Study|Adverse Event|3|||
48968340|NCT01624506|157712524|FG001|Overall Study|Adverse Event|0|||
48968341|NCT01149343|157712525|FG000|Overall Study|Withdrawal by Subject|1|||
48968342|NCT01149343|157712526|FG001|Overall Study|Withdrawal by Subject|1|||
48968343|NCT01149343|157712527|FG002|Overall Study|Withdrawal by Subject|1|||
48968344|NCT01149343|157712528|FG003|Overall Study|Withdrawal by Subject|5|||
48968345|NCT01149343|157712525|FG000|Overall Study|Death|10|||
48968346|NCT01149343|157712526|FG001|Overall Study|Death|13|||
48968347|NCT01149343|157712527|FG002|Overall Study|Death|18|||
48968348|NCT01149343|157712528|FG003|Overall Study|Death|18|||
48968349|NCT01149343|157712525|FG000|Overall Study|Lost to Follow-up|1|||
48968350|NCT01149343|157712526|FG001|Overall Study|Lost to Follow-up|0|||
48968351|NCT01149343|157712527|FG002|Overall Study|Lost to Follow-up|0|||
48968352|NCT01149343|157712528|FG003|Overall Study|Lost to Follow-up|1|||
48968353|NCT01149343|157712525|FG000|Overall Study|Other|8|||
48968354|NCT01149343|157712526|FG001|Overall Study|Other|10|||
48968355|NCT01149343|157712527|FG002|Overall Study|Other|2|||
48968356|NCT01149343|157712528|FG003|Overall Study|Other|14|||
48968357|NCT01149343|157712525|FG000|Overall Study|Sponsor study termination|0|||
48968358|NCT01149343|157712526|FG001|Overall Study|Sponsor study termination|0|||
48968359|NCT01149343|157712527|FG002|Overall Study|Sponsor study termination|0|||
48968360|NCT01149343|157712528|FG003|Overall Study|Sponsor study termination|2|||
48968361|NCT01149343|157712525|FG000|Overall Study|Recurrence / Progressive disease|0|||
48968362|NCT01149343|157712526|FG001|Overall Study|Recurrence / Progressive disease|0|||
48968363|NCT01149343|157712527|FG002|Overall Study|Recurrence / Progressive disease|1|||
48968364|NCT01149343|157712528|FG003|Overall Study|Recurrence / Progressive disease|0|||
48968365|NCT03943446|157712529|FG000|Overall Study|Lost to Follow-up|0|||
48968366|NCT03943446|157712530|FG001|Overall Study|Lost to Follow-up|0|||
48968367|NCT03943446|157712531|FG002|Overall Study|Lost to Follow-up|1|||
48968368|NCT03943446|157712529|FG000|Overall Study|Withdrawal by Subject|1|||
48968369|NCT03943446|157712530|FG001|Overall Study|Withdrawal by Subject|1|||
48968370|NCT03943446|157712531|FG002|Overall Study|Withdrawal by Subject|2|||
48968371|NCT03943446|157712529|FG000|Overall Study|Study Terminated by Sponsor|1|||
48968372|NCT03943446|157712530|FG001|Overall Study|Study Terminated by Sponsor|2|||
48758949|NCT03158051|156964717|FG001|Overall Study|Withdrawal by Subject|15|||
48968373|NCT03943446|157712531|FG002|Overall Study|Study Terminated by Sponsor|1|||
48968374|NCT03943446|157712529|FG000|Overall Study|Reason not Specified|5|||
48968375|NCT03943446|157712530|FG001|Overall Study|Reason not Specified|1|||
48758950|NCT03158051|156964716|FG000|Overall Study|Death|0|||
48758951|NCT03158051|156964717|FG001|Overall Study|Death|1|||
48758952|NCT02892760|156966295|FG000|Overall Study|Withdrawal by Subject|3|||
48758953|NCT02673489|156966296|FG000|Treatment Period|Lost to Follow-up|3|||
48758954|NCT02673489|156966297|FG001|Treatment Period|Lost to Follow-up|0|||
48758955|NCT02673489|156966296|FG000|Treatment Period|Participant request to discontinue|1|||
48758956|NCT02673489|156966297|FG001|Treatment Period|Participant request to discontinue|1|||
48968376|NCT03943446|157712531|FG002|Overall Study|Reason not Specified|3|||
48968377|NCT02119026|157712532|FG000|1st-line Treatment|Adverse Event|9|||
48968378|NCT02119026|157712533|FG001|1st-line Treatment|Adverse Event|14|||
48968379|NCT02119026|157712532|FG000|1st-line Treatment|Physician Decision|3|||
48968380|NCT02119026|157712533|FG001|1st-line Treatment|Physician Decision|8|||
48968381|NCT02119026|157712532|FG000|1st-line Treatment|Withdrawal by Subject|4|||
48758957|NCT02673489|156966296|FG000|Treatment Period|Participant moved to another province|1|||
48968382|NCT02119026|157712533|FG001|1st-line Treatment|Withdrawal by Subject|10|||
48868816|NCT05012397|157356992|FG000|Overall Study|Physician Decision|9|||
48868817|NCT05012397|157356992|FG000|Overall Study|Withdrawal by Subject|5|||
48868818|NCT05012397|157356992|FG000|Overall Study|Lost to Follow-up|2|||
48868819|NCT00920699|157356993|FG000|Overall Study|Withdrawal by Subject|2|||
48868820|NCT00920699|157356994|FG001|Overall Study|Withdrawal by Subject|0|||
48868821|NCT00920699|157356995|FG002|Overall Study|Withdrawal by Subject|2|||
48868822|NCT00920699|157356993|FG000|Overall Study|no longer met eligibility|0|||
48868823|NCT00920699|157356994|FG001|Overall Study|no longer met eligibility|1|||
48868824|NCT00920699|157356995|FG002|Overall Study|no longer met eligibility|0|||
48868825|NCT00920699|157356993|FG000|Overall Study|Lost to Follow-up|0|||
48868826|NCT00920699|157356994|FG001|Overall Study|Lost to Follow-up|0|||
48868827|NCT00920699|157356995|FG002|Overall Study|Lost to Follow-up|2|||
48868828|NCT00297778|157356999|FG000|Overall Study|Adverse Event|16|||
48868829|NCT00297778|157357000|FG001|Overall Study|Adverse Event|10|||
48868830|NCT00297778|157356999|FG000|Overall Study|Withdrawal by Subject|1|||
48868831|NCT00297778|157357000|FG001|Overall Study|Withdrawal by Subject|5|||
48868832|NCT00297778|157356999|FG000|Overall Study|Lack of Efficacy|2|||
48868833|NCT00297778|157357000|FG001|Overall Study|Lack of Efficacy|1|||
48868834|NCT00297778|157356999|FG000|Overall Study|Non-compliant with trial protocol|0|||
48868835|NCT00297778|157357000|FG001|Overall Study|Non-compliant with trial protocol|3|||
48868836|NCT00297778|157356999|FG000|Overall Study|Other|0|||
48868837|NCT00297778|157357000|FG001|Overall Study|Other|1|||
48868838|NCT02996097|157357008|FG000|Overall Study|Lost to Follow-up|11|||
48868839|NCT02996097|157357009|FG001|Overall Study|Lost to Follow-up|11|||
48868840|NCT01820637|157357010|FG000|Overall Study|Death|2|||
48868841|NCT01820637|157357010|FG000|Overall Study|Withdrawal by Subject|1|||
48868842|NCT00583115|157357011|FG000|Overall Study|Death|1|||
48868843|NCT04358068|157357012|FG000|Overall Study|Did not initiate study treatment|2|||
48868844|NCT04358068|157357013|FG001|Overall Study|Did not initiate study treatment|2|||
48868845|NCT00576823|157357017|FG000|12-week Efficacy Phase|Parent's schedule issue|1|||
48868846|NCT00576823|157357018|FG001|12-week Efficacy Phase|Parent's schedule issue|0|||
48758958|NCT02673489|156966297|FG001|Treatment Period|Participant moved to another province|0|||
48868847|NCT00576823|157357019|FG002|12-week Efficacy Phase|Parent's schedule issue|0|||
48868848|NCT00576823|157357017|FG000|40-week Safety Extension Phase|Lack of Efficacy|1|||
48868849|NCT00576823|157357018|FG001|40-week Safety Extension Phase|Lack of Efficacy|0|||
48968383|NCT02119026|157712532|FG000|1st-line Treatment|Patient condition or compliance|6|||
48968384|NCT02119026|157712533|FG001|1st-line Treatment|Patient condition or compliance|4|||
48968385|NCT02119026|157712532|FG000|1st-line Treatment|Surgery of metastases|2|||
48968386|NCT02119026|157712533|FG001|1st-line Treatment|Surgery of metastases|1|||
48968387|NCT02119026|157712532|FG000|1st-line Treatment|Death|2|||
48968388|NCT02119026|157712533|FG001|1st-line Treatment|Death|1|||
48968389|NCT02119026|157712532|FG000|2nd-line Treatment|Lost to Follow-up|2|||
48968390|NCT02119026|157712533|FG001|2nd-line Treatment|Lost to Follow-up|0|||
48968391|NCT02119026|157712532|FG000|2nd-line Treatment|Withdrawal by Subject|3|||
48968392|NCT02119026|157712533|FG001|2nd-line Treatment|Withdrawal by Subject|1|||
48968393|NCT02119026|157712532|FG000|2nd-line Treatment|Adverse Event|4|||
48968394|NCT02119026|157712533|FG001|2nd-line Treatment|Adverse Event|1|||
48968395|NCT00340834|157712537|FG000|Core Phase of Study|Adverse Event|26|||
48968396|NCT00340834|157712538|FG001|Core Phase of Study|Adverse Event|9|||
48868850|NCT00576823|157357019|FG002|40-week Safety Extension Phase|Lack of Efficacy|0|||
48868851|NCT01209286|157357020|FG000|Overall Study|Adverse Event|4|||
48868852|NCT01209286|157357021|FG001|Overall Study|Adverse Event|3|||
48868853|NCT01209286|157357022|FG002|Overall Study|Adverse Event|1|||
48868854|NCT01209286|157357020|FG000|Overall Study|Hematological Relapse After Remission|0|||
48868855|NCT01209286|157357021|FG001|Overall Study|Hematological Relapse After Remission|1|||
48968397|NCT00340834|157712539|FG002|Core Phase of Study|Adverse Event|9|||
48758959|NCT02673489|156966296|FG000|Treatment Period|Participant was incarcerated|0|||
48758960|NCT02673489|156966297|FG001|Treatment Period|Participant was incarcerated|1|||
48758961|NCT02673489|156966296|FG000|Treatment Period|Adverse Event|0|||
48758962|NCT02673489|156966297|FG001|Treatment Period|Adverse Event|1|||
48758963|NCT02673489|156966296|FG000|Follow Up Period|Unable to return for week 24 follow-up|0|||
48758964|NCT02673489|156966297|FG001|Follow Up Period|Unable to return for week 24 follow-up|1|||
48758965|NCT02673489|156966296|FG000|Follow Up Period|Unable to return for follow-up|0|||
48758966|NCT02673489|156966297|FG001|Follow Up Period|Unable to return for follow-up|1|||
48758967|NCT00773292|156966298|FG000|Treatment 48 Weeks|Adverse Event|1|||
48758968|NCT00773292|156966298|FG000|Treatment 48 Weeks|Lack of Efficacy|1|||
48758969|NCT00202644|156966301|FG000|Overall Study|Adverse Event|12|||
48758970|NCT00202644|156966302|FG001|Overall Study|Adverse Event|13|||
48758971|NCT00202644|156966301|FG000|Overall Study|Withdrawal by Subject|8|||
48758972|NCT00202644|156966302|FG001|Overall Study|Withdrawal by Subject|6|||
48758973|NCT00202644|156966301|FG000|Overall Study|Lack of Efficacy|6|||
48758974|NCT00202644|156966302|FG001|Overall Study|Lack of Efficacy|6|||
48758975|NCT00202644|156966301|FG000|Overall Study|Lost to Follow-up|0|||
48758976|NCT00202644|156966302|FG001|Overall Study|Lost to Follow-up|1|||
48758977|NCT00202644|156966301|FG000|Overall Study|Other|9|||
48758978|NCT00202644|156966302|FG001|Overall Study|Other|1|||
48668289|NCT00364533|156639118|FG001|Overall Study|Variations in drug compliance|1|||
48668290|NCT00364533|156639119|FG002|Overall Study|Variations in drug compliance|1|||
48668291|NCT00364533|156639120|FG003|Overall Study|Variations in drug compliance|0|||
48668292|NCT00364533|156639121|FG004|Overall Study|Variations in drug compliance|0|||
48668293|NCT00364533|156639117|FG000|Overall Study|Non-compliance|1|||
48668294|NCT00364533|156639118|FG001|Overall Study|Non-compliance|0|||
48758979|NCT02057198|156966303|FG000|Overall Study|Death|0|||
48758980|NCT02057198|156966304|FG001|Overall Study|Death|0|||
48968398|NCT00340834|157712540|FG003|Core Phase of Study|Adverse Event|0|||
48968399|NCT00340834|157712541|FG004|Core Phase of Study|Adverse Event|0|||
48968400|NCT00340834|157712537|FG000|Core Phase of Study|Withdrawal by Subject|11|||
48968401|NCT00340834|157712538|FG001|Core Phase of Study|Withdrawal by Subject|9|||
48968402|NCT00340834|157712539|FG002|Core Phase of Study|Withdrawal by Subject|16|||
48968403|NCT00340834|157712540|FG003|Core Phase of Study|Withdrawal by Subject|0|||
48968404|NCT00340834|157712541|FG004|Core Phase of Study|Withdrawal by Subject|0|||
48968405|NCT00340834|157712537|FG000|Core Phase of Study|Administrative Problems|6|||
48968406|NCT00340834|157712538|FG001|Core Phase of Study|Administrative Problems|2|||
48968407|NCT00340834|157712539|FG002|Core Phase of Study|Administrative Problems|7|||
48968408|NCT00340834|157712540|FG003|Core Phase of Study|Administrative Problems|0|||
48968409|NCT00340834|157712541|FG004|Core Phase of Study|Administrative Problems|0|||
48968410|NCT00340834|157712537|FG000|Core Phase of Study|Lack of Efficacy|3|||
48968411|NCT00340834|157712538|FG001|Core Phase of Study|Lack of Efficacy|3|||
48968412|NCT00340834|157712539|FG002|Core Phase of Study|Lack of Efficacy|7|||
48968413|NCT00340834|157712540|FG003|Core Phase of Study|Lack of Efficacy|0|||
48968414|NCT00340834|157712541|FG004|Core Phase of Study|Lack of Efficacy|0|||
48968415|NCT00340834|157712537|FG000|Core Phase of Study|Abnormal laboratory value(s)|4|||
48968416|NCT00340834|157712538|FG001|Core Phase of Study|Abnormal laboratory value(s)|6|||
48968417|NCT00340834|157712539|FG002|Core Phase of Study|Abnormal laboratory value(s)|1|||
48968418|NCT00340834|157712540|FG003|Core Phase of Study|Abnormal laboratory value(s)|0|||
48968419|NCT00340834|157712541|FG004|Core Phase of Study|Abnormal laboratory value(s)|0|||
48968420|NCT00340834|157712537|FG000|Core Phase of Study|Abnormal test procedure result(s)|4|||
49015477|NCT01393990|157893773|FG003|Overall Study|Death|0|||
48668295|NCT00364533|156639119|FG002|Overall Study|Non-compliance|0|||
48668296|NCT00364533|156639120|FG003|Overall Study|Non-compliance|0|||
48758981|NCT02057198|156966305|FG002|Overall Study|Death|1|||
48758982|NCT02057198|156966303|FG000|Overall Study|Discharged early; lost to followup|0|||
48758983|NCT02057198|156966304|FG001|Overall Study|Discharged early; lost to followup|1|||
48758984|NCT02057198|156966305|FG002|Overall Study|Discharged early; lost to followup|0|||
48758985|NCT00350636|156966306|FG000|Overall Study|Adverse Event|19|||
48758986|NCT00350636|156966307|FG001|Overall Study|Adverse Event|13|||
48758987|NCT00350636|156966306|FG000|Overall Study|Protocol Violation|1|||
48758988|NCT00350636|156966307|FG001|Overall Study|Protocol Violation|3|||
48758989|NCT00350636|156966306|FG000|Overall Study|Withdrawal by Subject|13|||
48758990|NCT00350636|156966307|FG001|Overall Study|Withdrawal by Subject|17|||
48758991|NCT00350636|156966306|FG000|Overall Study|Lost to Follow-up|9|||
48758992|NCT00350636|156966307|FG001|Overall Study|Lost to Follow-up|8|||
48758993|NCT00350636|156966306|FG000|Overall Study|Physician Decision|0|||
48758994|NCT00350636|156966307|FG001|Overall Study|Physician Decision|2|||
48758995|NCT00350636|156966306|FG000|Overall Study|Other|1|||
48758996|NCT00350636|156966307|FG001|Overall Study|Other|2|||
48758997|NCT02750592|156966308|FG000|Overall Study|Adverse Event|3|||
48758998|NCT02750592|156966308|FG000|Overall Study|Lack of Efficacy|2|||
48758999|NCT00453921|156966314|FG000|Overall Study|Withdrawal by Subject|1|||
48759000|NCT00453921|156966315|FG001|Overall Study|Withdrawal by Subject|1|||
48759001|NCT00453921|156966316|FG002|Overall Study|Withdrawal by Subject|1|||
48759002|NCT00453921|156966317|FG003|Overall Study|Withdrawal by Subject|1|||
48759003|NCT00453921|156966314|FG000|Overall Study|Lost to Follow-up|0|||
48759004|NCT00453921|156966315|FG001|Overall Study|Lost to Follow-up|0|||
48759005|NCT00453921|156966316|FG002|Overall Study|Lost to Follow-up|1|||
48759006|NCT00453921|156966317|FG003|Overall Study|Lost to Follow-up|0|||
48759007|NCT00303498|156966318|FG000|Run-In-Phase (10 Weeks)|Adverse Event|5|||
48759008|NCT00303498|156966319|FG001|Run-In-Phase (10 Weeks)|Adverse Event|1|||
48759009|NCT00303498|156966318|FG000|Run-In-Phase (10 Weeks)|Physician Decision|0|||
48759010|NCT00303498|156966319|FG001|Run-In-Phase (10 Weeks)|Physician Decision|1|||
48668297|NCT00364533|156639121|FG004|Overall Study|Non-compliance|0|||
48668298|NCT00364533|156639117|FG000|Overall Study|Protocol Violation|1|||
48668299|NCT00364533|156639118|FG001|Overall Study|Protocol Violation|1|||
48668300|NCT00364533|156639119|FG002|Overall Study|Protocol Violation|0|||
48668301|NCT00364533|156639120|FG003|Overall Study|Protocol Violation|0|||
48668302|NCT00364533|156639121|FG004|Overall Study|Protocol Violation|0|||
48668303|NCT03157583|156639122|FG000|Overall Study|Other (did not meet study criteria)|1|||
48668304|NCT01814670|156639123|FG000|Overall Study|Protocol Violation|12|||
48668305|NCT01943552|156639128|FG000|Overall Study|Adverse Event|3|||
48668306|NCT01943552|156639129|FG001|Overall Study|Adverse Event|2|||
48668307|NCT01943552|156639128|FG000|Overall Study|Withdrawal by Subject|6|||
48668308|NCT01943552|156639129|FG001|Overall Study|Withdrawal by Subject|6|||
48868856|NCT01209286|157357022|FG002|Overall Study|Hematological Relapse After Remission|1|||
48868857|NCT01209286|157357020|FG000|Overall Study|Remission Not Achieved in 2 Cycles|1|||
48868858|NCT01209286|157357021|FG001|Overall Study|Remission Not Achieved in 2 Cycles|3|||
48868859|NCT01209286|157357022|FG002|Overall Study|Remission Not Achieved in 2 Cycles|1|||
48868860|NCT01209286|157357020|FG000|Overall Study|Physician Decision|0|||
48868861|NCT01209286|157357021|FG001|Overall Study|Physician Decision|2|||
48868862|NCT01209286|157357022|FG002|Overall Study|Physician Decision|0|||
48868863|NCT01209286|157357020|FG000|Overall Study|Other|0|||
48868864|NCT01209286|157357021|FG001|Overall Study|Other|1|||
48868865|NCT01209286|157357022|FG002|Overall Study|Other|0|||
48868866|NCT01260142|157357025|FG000|Treatment Period 1|Study on hold|1|||
48868867|NCT01260142|157357026|FG001|Treatment Period 1|Study on hold|1|||
48868868|NCT01260142|157357027|FG002|Treatment Period 1|Study on hold|0|||
48868869|NCT01260142|157357028|FG003|Treatment Period 1|Study on hold|0|||
48868870|NCT01260142|157357029|FG004|Treatment Period 1|Study on hold|1|||
48868871|NCT01260142|157357030|FG005|Treatment Period 1|Study on hold|2|||
48868872|NCT01260142|157357025|FG000|Treatment Period 1|Unexplained elevated sys. BP|0|||
48868873|NCT01260142|157357026|FG001|Treatment Period 1|Unexplained elevated sys. BP|0|||
48868874|NCT01260142|157357027|FG002|Treatment Period 1|Unexplained elevated sys. BP|0|||
48868875|NCT01260142|157357028|FG003|Treatment Period 1|Unexplained elevated sys. BP|0|||
48868876|NCT01260142|157357029|FG004|Treatment Period 1|Unexplained elevated sys. BP|1|||
48868877|NCT01260142|157357030|FG005|Treatment Period 1|Unexplained elevated sys. BP|0|||
48868878|NCT01260142|157357025|FG000|Treatment Period 1|Withdrawal by Subject|0|||
48868879|NCT01260142|157357026|FG001|Treatment Period 1|Withdrawal by Subject|0|||
48868880|NCT01260142|157357027|FG002|Treatment Period 1|Withdrawal by Subject|0|||
48868881|NCT01260142|157357028|FG003|Treatment Period 1|Withdrawal by Subject|0|||
48868882|NCT01260142|157357029|FG004|Treatment Period 1|Withdrawal by Subject|0|||
48868883|NCT01260142|157357030|FG005|Treatment Period 1|Withdrawal by Subject|1|||
48868884|NCT04479761|157357031|FG000|Overall Study|could not perform the balance tasks|1|||
48868885|NCT04479761|157357032|FG001|Overall Study|could not perform the balance tasks|0|||
48868886|NCT04479761|157357033|FG002|Overall Study|could not perform the balance tasks|0|||
48868887|NCT04479761|157357031|FG000|Overall Study|Adverse Event|1|||
48868888|NCT04479761|157357032|FG001|Overall Study|Adverse Event|0|||
48759011|NCT00303498|156966318|FG000|Run-In-Phase (10 Weeks)|Withdrawal by Subject|5|||
48759012|NCT00303498|156966319|FG001|Run-In-Phase (10 Weeks)|Withdrawal by Subject|0|||
48759013|NCT00303498|156966318|FG000|Run-In-Phase (10 Weeks)|Sponsor Decision|6|||
48759014|NCT00303498|156966319|FG001|Run-In-Phase (10 Weeks)|Sponsor Decision|3|||
48759015|NCT00303498|156966318|FG000|Run-In-Phase (10 Weeks)|Other|4|||
48759016|NCT00303498|156966319|FG001|Run-In-Phase (10 Weeks)|Other|1|||
48759017|NCT00303498|156966318|FG000|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|3|||
48759018|NCT00303498|156966319|FG001|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|2|||
48759019|NCT00303498|156966318|FG000|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|1|||
48759020|NCT00303498|156966319|FG001|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|0|||
48759021|NCT00303498|156966318|FG000|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|1|||
48759022|NCT00303498|156966319|FG001|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|0|||
48759023|NCT00303498|156966318|FG000|Maintenance Phase (24 Weeks)|Death|1|||
48759024|NCT00303498|156966319|FG001|Maintenance Phase (24 Weeks)|Death|0|||
48759025|NCT00303498|156966318|FG000|Maintenance Phase (24 Weeks)|Adverse Event|2|||
48759026|NCT00303498|156966319|FG001|Maintenance Phase (24 Weeks)|Adverse Event|1|||
48759027|NCT00303498|156966318|FG000|Maintenance Phase (24 Weeks)|Physician Decision|1|||
48759028|NCT00303498|156966319|FG001|Maintenance Phase (24 Weeks)|Physician Decision|0|||
48759029|NCT00303498|156966318|FG000|Maintenance Phase (24 Weeks)|Withdrawal by Subject|3|||
48759030|NCT00303498|156966319|FG001|Maintenance Phase (24 Weeks)|Withdrawal by Subject|4|||
48759031|NCT00303498|156966318|FG000|Maintenance Phase (24 Weeks)|Sponsor Decision|4|||
48759032|NCT00303498|156966319|FG001|Maintenance Phase (24 Weeks)|Sponsor Decision|0|||
48759033|NCT00303498|156966318|FG000|Maintenance Phase (24 Weeks)|Other|1|||
48759034|NCT00303498|156966319|FG001|Maintenance Phase (24 Weeks)|Other|0|||
48759035|NCT00303498|156966318|FG000|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|1|||
48759036|NCT00303498|156966319|FG001|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|2|||
48868889|NCT04479761|157357033|FG002|Overall Study|Adverse Event|0|||
48868890|NCT04479761|157357031|FG000|Overall Study|one control did not meet screening criteria|0|||
48868891|NCT04479761|157357032|FG001|Overall Study|one control did not meet screening criteria|0|||
48868892|NCT04479761|157357033|FG002|Overall Study|one control did not meet screening criteria|1|||
48868893|NCT04479761|157357031|FG000|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
48868894|NCT04479761|157357032|FG001|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|3|||
48868895|NCT04479761|157357033|FG002|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
48759037|NCT00303498|156966318|FG000|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|0|||
48868896|NCT00514813|157357036|FG000|Overall Study|Study terminated|14|||
48868897|NCT00514813|157357037|FG001|Overall Study|Study terminated|74|||
48868898|NCT00514813|157357038|FG002|Overall Study|Study terminated|40|||
48668309|NCT01943552|156639128|FG000|Overall Study|Other Reasons|16|||
48668310|NCT01943552|156639129|FG001|Overall Study|Other Reasons|17|||
48668311|NCT00117793|156639130|FG000|Overall Study|Withdrawal by Subject|12|||
48668312|NCT01475162|156639131|FG000|Overall Study|Physician Decision|1|||
48668313|NCT01475162|156639131|FG000|Overall Study|Death|10|||
48668314|NCT01475162|156639131|FG000|Overall Study|Study closed for safety|3|||
48668315|NCT02565810|156639133|FG000|Overall Study|Withdrawal by Subject|1|||
48668316|NCT01827332|156639136|FG000|Overall Study|Lost to Follow-up|2|||
48668317|NCT01827332|156639137|FG001|Overall Study|Lost to Follow-up|1|||
48668318|NCT00490139|156639138|FG000|Overall Study|Death|106|||
48668319|NCT00490139|156639139|FG001|Overall Study|Death|119|||
48668320|NCT00490139|156639140|FG002|Overall Study|Death|168|||
48668321|NCT00490139|156639141|FG003|Overall Study|Death|135|||
48668322|NCT00490139|156639138|FG000|Overall Study|Lost to Follow-up|56|||
48668323|NCT00490139|156639139|FG001|Overall Study|Lost to Follow-up|46|||
48668324|NCT00490139|156639140|FG002|Overall Study|Lost to Follow-up|58|||
48668325|NCT00490139|156639141|FG003|Overall Study|Lost to Follow-up|56|||
48668326|NCT00490139|156639138|FG000|Overall Study|Participant Withdrew Consent|146|||
48668327|NCT00490139|156639139|FG001|Overall Study|Participant Withdrew Consent|110|||
48668328|NCT00490139|156639140|FG002|Overall Study|Participant Withdrew Consent|208|||
48668329|NCT00490139|156639141|FG003|Overall Study|Participant Withdrew Consent|116|||
48668330|NCT02049138|156639144|FG000|Overall Study|Adverse Event|46|||
48668331|NCT02049138|156639145|FG001|Overall Study|Adverse Event|25|||
48668332|NCT02049138|156639146|FG002|Overall Study|Adverse Event|1|||
48668333|NCT02049138|156639144|FG000|Overall Study|Withdrawal by Subject|57|||
48668334|NCT02049138|156639145|FG001|Overall Study|Withdrawal by Subject|21|||
48668335|NCT02049138|156639146|FG002|Overall Study|Withdrawal by Subject|5|||
48759038|NCT00303498|156966319|FG001|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|1|||
48759039|NCT01394523|156966320|FG000|Overall Study|Unable to place block|1|||
48759040|NCT01394523|156966321|FG001|Overall Study|Unable to place block|0|||
48759041|NCT01394523|156966322|FG002|Overall Study|Unable to place block|0|||
48759042|NCT04741074|156966323|FG000|Overall Study|Withdrawal by Subject|1|||
48759043|NCT04741074|156966324|FG001|Overall Study|Withdrawal by Subject|1|||
48759044|NCT04741074|156966323|FG000|Overall Study|Study terminated prematurely|1|||
48759045|NCT04741074|156966324|FG001|Overall Study|Study terminated prematurely|0|||
48759046|NCT02632552|156966325|FG000|Overall Study|Lost to Follow-up|14|||
48759047|NCT02632552|156966326|FG001|Overall Study|Lost to Follow-up|8|||
48759048|NCT02632552|156966325|FG000|Overall Study|Withdrawal by Subject|2|||
48759049|NCT02632552|156966326|FG001|Overall Study|Withdrawal by Subject|0|||
48759050|NCT02632552|156966325|FG000|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|7|||
48759051|NCT02632552|156966326|FG001|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|2|||
48759052|NCT03538158|156966334|FG000|Overall Study|Lost to Follow-up|13|||
48759053|NCT03538158|156966335|FG001|Overall Study|Lost to Follow-up|7|||
48759054|NCT03538158|156966334|FG000|Overall Study|Withdrawal by Subject|2|||
48759055|NCT03538158|156966335|FG001|Overall Study|Withdrawal by Subject|1|||
48759056|NCT00405587|156966336|FG000|Overall Study|Death|0|||
48759057|NCT00405587|156966337|FG001|Overall Study|Death|0|||
48759058|NCT00405587|156966338|FG002|Overall Study|Death|0|||
48759059|NCT00405587|156966339|FG003|Overall Study|Death|1|||
48759060|NCT00405587|156966336|FG000|Overall Study|Disease Progression|22|||
48759061|NCT00405587|156966337|FG001|Overall Study|Disease Progression|23|||
48759062|NCT00405587|156966338|FG002|Overall Study|Disease Progression|21|||
48759063|NCT00405587|156966339|FG003|Overall Study|Disease Progression|17|||
48759064|NCT00405587|156966336|FG000|Overall Study|Physician Decision|3|||
48759065|NCT00405587|156966337|FG001|Overall Study|Physician Decision|2|||
48759066|NCT00405587|156966338|FG002|Overall Study|Physician Decision|0|||
48759067|NCT00405587|156966339|FG003|Overall Study|Physician Decision|0|||
48759068|NCT00405587|156966336|FG000|Overall Study|Adverse Event|1|||
48759069|NCT00405587|156966337|FG001|Overall Study|Adverse Event|0|||
48759070|NCT00405587|156966338|FG002|Overall Study|Adverse Event|0|||
48759071|NCT00405587|156966339|FG003|Overall Study|Adverse Event|0|||
48759072|NCT00405587|156966336|FG000|Overall Study|Lost to Follow-up|0|||
48759073|NCT00405587|156966337|FG001|Overall Study|Lost to Follow-up|1|||
48759074|NCT00405587|156966338|FG002|Overall Study|Lost to Follow-up|1|||
48759075|NCT00405587|156966339|FG003|Overall Study|Lost to Follow-up|0|||
48759076|NCT00405587|156966336|FG000|Overall Study|Radiation induced necrosis|0|||
48759077|NCT00405587|156966337|FG001|Overall Study|Radiation induced necrosis|1|||
48759078|NCT00405587|156966338|FG002|Overall Study|Radiation induced necrosis|0|||
48759079|NCT00405587|156966339|FG003|Overall Study|Radiation induced necrosis|0|||
48759080|NCT00405587|156966336|FG000|Overall Study|Withdrawal by Subject|0|||
48759081|NCT00405587|156966337|FG001|Overall Study|Withdrawal by Subject|0|||
48759082|NCT00405587|156966338|FG002|Overall Study|Withdrawal by Subject|0|||
48759083|NCT00405587|156966339|FG003|Overall Study|Withdrawal by Subject|2|||
48759084|NCT00405587|156966336|FG000|Overall Study|Participant not dosed|0|||
48759085|NCT00405587|156966337|FG001|Overall Study|Participant not dosed|1|||
48759086|NCT00405587|156966338|FG002|Overall Study|Participant not dosed|0|||
48668336|NCT02049138|156639144|FG000|Overall Study|Lost to Follow-up|18|||
48868899|NCT00514813|157357039|FG003|Overall Study|Study terminated|2|||
48868900|NCT00514813|157357036|FG000|Overall Study|Adverse Event|0|||
48868901|NCT00514813|157357037|FG001|Overall Study|Adverse Event|2|||
48868902|NCT00514813|157357038|FG002|Overall Study|Adverse Event|2|||
48668337|NCT02049138|156639145|FG001|Overall Study|Lost to Follow-up|5|||
48668338|NCT02049138|156639146|FG002|Overall Study|Lost to Follow-up|1|||
48668339|NCT02049138|156639144|FG000|Overall Study|Lack of Efficacy|10|||
48759087|NCT00405587|156966339|FG003|Overall Study|Participant not dosed|0|||
48759088|NCT00507442|156966340|FG000|Overall Study|Adverse Event|8|||
48759089|NCT00507442|156966341|FG001|Overall Study|Adverse Event|11|||
48759090|NCT00507442|156966342|FG002|Overall Study|Adverse Event|4|||
48759091|NCT00507442|156966343|FG003|Overall Study|Adverse Event|1|||
48759092|NCT00507442|156966340|FG000|Overall Study|Protocol Violation|0|||
48759093|NCT00507442|156966341|FG001|Overall Study|Protocol Violation|1|||
48759094|NCT00507442|156966342|FG002|Overall Study|Protocol Violation|0|||
48759095|NCT00507442|156966343|FG003|Overall Study|Protocol Violation|0|||
48759096|NCT00507442|156966340|FG000|Overall Study|Lost to Follow-up|0|||
48759097|NCT00507442|156966341|FG001|Overall Study|Lost to Follow-up|0|||
48759098|NCT00507442|156966342|FG002|Overall Study|Lost to Follow-up|1|||
48759099|NCT00507442|156966343|FG003|Overall Study|Lost to Follow-up|0|||
48668340|NCT02049138|156639145|FG001|Overall Study|Lack of Efficacy|26|||
48668341|NCT02049138|156639146|FG002|Overall Study|Lack of Efficacy|1|||
48668342|NCT02049138|156639144|FG000|Overall Study|Non-Compliance|15|||
48668343|NCT02049138|156639145|FG001|Overall Study|Non-Compliance|6|||
48668344|NCT02049138|156639146|FG002|Overall Study|Non-Compliance|0|||
48668345|NCT02049138|156639144|FG000|Overall Study|Required Alternative / Prohibited Therapy|1|||
48668346|NCT02049138|156639145|FG001|Overall Study|Required Alternative / Prohibited Therapy|1|||
48668347|NCT02049138|156639146|FG002|Overall Study|Required Alternative / Prohibited Therapy|0|||
48668348|NCT02049138|156639144|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|1|||
48668349|NCT02049138|156639145|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
48668350|NCT02049138|156639146|FG002|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
48668351|NCT02049138|156639144|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
48668352|NCT02049138|156639145|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
48668353|NCT02049138|156639146|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
48759100|NCT00507442|156966340|FG000|Overall Study|Physician Decision|0|||
48759101|NCT00507442|156966341|FG001|Overall Study|Physician Decision|2|||
48759102|NCT00507442|156966342|FG002|Overall Study|Physician Decision|4|||
48868903|NCT00514813|157357039|FG003|Overall Study|Adverse Event|0|||
48868904|NCT00514813|157357036|FG000|Overall Study|Protocol Violation|1|||
48868905|NCT00514813|157357037|FG001|Overall Study|Protocol Violation|0|||
48868906|NCT00514813|157357038|FG002|Overall Study|Protocol Violation|0|||
48868907|NCT00514813|157357039|FG003|Overall Study|Protocol Violation|0|||
48868908|NCT00514813|157357036|FG000|Overall Study|Withdrawal by Subject|0|||
48868909|NCT00514813|157357037|FG001|Overall Study|Withdrawal by Subject|1|||
48868910|NCT00514813|157357038|FG002|Overall Study|Withdrawal by Subject|0|||
48868911|NCT00514813|157357039|FG003|Overall Study|Withdrawal by Subject|0|||
48868912|NCT00514813|157357036|FG000|Overall Study|Lack of Efficacy|0|||
48868913|NCT00514813|157357037|FG001|Overall Study|Lack of Efficacy|1|||
48868914|NCT00514813|157357038|FG002|Overall Study|Lack of Efficacy|0|||
48868915|NCT00514813|157357039|FG003|Overall Study|Lack of Efficacy|0|||
48868916|NCT00514813|157357036|FG000|Overall Study|Kidney transplant|0|||
48868917|NCT00514813|157357037|FG001|Overall Study|Kidney transplant|6|||
48868918|NCT00514813|157357038|FG002|Overall Study|Kidney transplant|2|||
48868919|NCT00514813|157357039|FG003|Overall Study|Kidney transplant|0|||
48868920|NCT00514813|157357036|FG000|Overall Study|Death|0|||
48868921|NCT00514813|157357037|FG001|Overall Study|Death|2|||
48868922|NCT00514813|157357038|FG002|Overall Study|Death|3|||
48868923|NCT00514813|157357039|FG003|Overall Study|Death|2|||
48868924|NCT02979613|157357040|FG000|Double-Blind Phase|Withdrew Consent|2|||
48868925|NCT02979613|157357041|FG001|Double-Blind Phase|Withdrew Consent|4|||
48868926|NCT02979613|157357040|FG000|Double-Blind Phase|Pregnancy|2|||
48868927|NCT02979613|157357041|FG001|Double-Blind Phase|Pregnancy|2|||
48868928|NCT02979613|157357040|FG000|Double-Blind Phase|Adverse Event|2|||
48868929|NCT02979613|157357041|FG001|Double-Blind Phase|Adverse Event|0|||
48868930|NCT02979613|157357040|FG000|Double-Blind Phase|Lost to Follow-up|1|||
48668354|NCT02049138|156639144|FG000|Overall Study|Other|15|||
48668355|NCT02049138|156639145|FG001|Overall Study|Other|13|||
48668356|NCT02049138|156639146|FG002|Overall Study|Other|0|||
48759103|NCT00507442|156966343|FG003|Overall Study|Physician Decision|1|||
48759104|NCT00507442|156966340|FG000|Overall Study|Progressive Disease|2|||
48759105|NCT00507442|156966341|FG001|Overall Study|Progressive Disease|4|||
48759106|NCT00507442|156966342|FG002|Overall Study|Progressive Disease|2|||
48868931|NCT02979613|157357041|FG001|Double-Blind Phase|Lost to Follow-up|1|||
48868932|NCT02979613|157357040|FG000|Double-Blind Phase|Protocol Violation|1|||
48868933|NCT02979613|157357041|FG001|Double-Blind Phase|Protocol Violation|1|||
48868934|NCT02979613|157357040|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
48868935|NCT02979613|157357041|FG001|Double-Blind Phase|Randomized but Never Treated|0|||
48868936|NCT02979613|157357040|FG000|Open-Label Extension (OLE) Phase|Withdrew Consent|2|||
48968421|NCT00340834|157712538|FG001|Core Phase of Study|Abnormal test procedure result(s)|3|||
48968422|NCT00340834|157712539|FG002|Core Phase of Study|Abnormal test procedure result(s)|3|||
48968423|NCT00340834|157712540|FG003|Core Phase of Study|Abnormal test procedure result(s)|0|||
48968424|NCT00340834|157712541|FG004|Core Phase of Study|Abnormal test procedure result(s)|0|||
48968425|NCT00340834|157712537|FG000|Core Phase of Study|Lost to Follow-up|1|||
48968426|NCT00340834|157712538|FG001|Core Phase of Study|Lost to Follow-up|1|||
48968427|NCT00340834|157712539|FG002|Core Phase of Study|Lost to Follow-up|4|||
48968428|NCT00340834|157712540|FG003|Core Phase of Study|Lost to Follow-up|0|||
48968429|NCT00340834|157712541|FG004|Core Phase of Study|Lost to Follow-up|0|||
48968430|NCT00340834|157712537|FG000|Core Phase of Study|Death|2|||
48968431|NCT00340834|157712538|FG001|Core Phase of Study|Death|0|||
48968432|NCT00340834|157712539|FG002|Core Phase of Study|Death|0|||
48968433|NCT00340834|157712540|FG003|Core Phase of Study|Death|0|||
48968434|NCT00340834|157712541|FG004|Core Phase of Study|Death|0|||
48968435|NCT00340834|157712537|FG000|Core Phase of Study|Protocol Violation|0|||
48968436|NCT00340834|157712538|FG001|Core Phase of Study|Protocol Violation|0|||
48968437|NCT00340834|157712539|FG002|Core Phase of Study|Protocol Violation|2|||
48968438|NCT00340834|157712540|FG003|Core Phase of Study|Protocol Violation|0|||
48968439|NCT00340834|157712541|FG004|Core Phase of Study|Protocol Violation|0|||
48968440|NCT00340834|157712537|FG000|Extension Phase of Study|Subject did not receive study drug|0|||
48968441|NCT00340834|157712538|FG001|Extension Phase of Study|Subject did not receive study drug|1|||
48968442|NCT00340834|157712539|FG002|Extension Phase of Study|Subject did not receive study drug|0|||
48968443|NCT00340834|157712540|FG003|Extension Phase of Study|Subject did not receive study drug|2|||
48968444|NCT00340834|157712541|FG004|Extension Phase of Study|Subject did not receive study drug|0|||
48668357|NCT02049138|156639144|FG000|Overall Study|Missing|0|||
48668358|NCT02049138|156639145|FG001|Overall Study|Missing|1|||
48968445|NCT00340834|157712537|FG000|Extension Phase of Study|Subject withdrew consent|26|||
48968446|NCT00340834|157712538|FG001|Extension Phase of Study|Subject withdrew consent|31|||
48968447|NCT00340834|157712539|FG002|Extension Phase of Study|Subject withdrew consent|0|||
48968448|NCT00340834|157712540|FG003|Extension Phase of Study|Subject withdrew consent|12|||
48668359|NCT02049138|156639146|FG002|Overall Study|Missing|0|||
48668360|NCT02428413|156639147|FG000|Overall Study|Device to measure WAG malfunctioned|3|||
48668361|NCT02428413|156639148|FG001|Overall Study|Device to measure WAG malfunctioned|5|||
48668362|NCT02428413|156639147|FG000|Overall Study|Protocol Violation|1|||
48668363|NCT02428413|156639148|FG001|Overall Study|Protocol Violation|2|||
48668364|NCT02428413|156639147|FG000|Overall Study|Case Cancelled|2|||
48668365|NCT02428413|156639148|FG001|Overall Study|Case Cancelled|0|||
48668366|NCT02428413|156639147|FG000|Overall Study|Missed Cases|1|||
48668367|NCT02428413|156639148|FG001|Overall Study|Missed Cases|2|||
48668368|NCT02428413|156639147|FG000|Overall Study|Nurse Refusal|1|||
48668369|NCT02428413|156639148|FG001|Overall Study|Nurse Refusal|0|||
48668370|NCT00661388|156639149|FG000|Overall Study|Adverse Event|14|||
48668371|NCT00661388|156639149|FG000|Overall Study|Protocol Violation|7|||
48668372|NCT00661388|156639149|FG000|Overall Study|Renal transplantation|1|||
48668373|NCT00661388|156639149|FG000|Overall Study|Dialysis initiation|1|||
48668374|NCT00661388|156639149|FG000|Overall Study|Administrative reasons|1|||
48668375|NCT00413374|156639150|FG000|Overall Study|Ineligible due to screening criteria.|3|||
48668376|NCT00413374|156639151|FG001|Overall Study|Ineligible due to screening criteria.|0|||
48668377|NCT00413374|156639150|FG000|Overall Study|Adverse Event|1|||
48668378|NCT00413374|156639151|FG001|Overall Study|Adverse Event|0|||
48668379|NCT00413374|156639150|FG000|Overall Study|Lost to Follow-up|1|||
48668380|NCT00413374|156639151|FG001|Overall Study|Lost to Follow-up|0|||
48668381|NCT00413374|156639150|FG000|Overall Study|Surgery|1|||
48668382|NCT00413374|156639151|FG001|Overall Study|Surgery|0|||
48668383|NCT00552760|156639152|FG000|Overall Study|Adverse Event|3|||
48668384|NCT00552760|156639153|FG001|Overall Study|Adverse Event|5|||
48668385|NCT00552760|156639152|FG000|Overall Study|Relapsed- Depressed Event|10|||
48668386|NCT00552760|156639153|FG001|Overall Study|Relapsed- Depressed Event|16|||
48668387|NCT00552760|156639152|FG000|Overall Study|Relapse- Manic Event|3|||
48668388|NCT00552760|156639153|FG001|Overall Study|Relapse- Manic Event|3|||
48668389|NCT00552760|156639152|FG000|Overall Study|Relapsed- Mixed Event|3|||
48668390|NCT00552760|156639153|FG001|Overall Study|Relapsed- Mixed Event|5|||
48668391|NCT00552760|156639152|FG000|Overall Study|Protocol Violation|0|||
48668392|NCT00552760|156639153|FG001|Overall Study|Protocol Violation|1|||
48668393|NCT00552760|156639152|FG000|Overall Study|Lost to Follow-up|1|||
48668394|NCT00552760|156639153|FG001|Overall Study|Lost to Follow-up|1|||
48668395|NCT00552760|156639152|FG000|Overall Study|Non-compliance|1|||
48668396|NCT00552760|156639153|FG001|Overall Study|Non-compliance|1|||
48668397|NCT00552760|156639152|FG000|Overall Study|Medical Condition|1|||
48668398|NCT00552760|156639153|FG001|Overall Study|Medical Condition|1|||
48668399|NCT00552760|156639152|FG000|Overall Study|Withdrawal by Subject|3|||
48668400|NCT00552760|156639153|FG001|Overall Study|Withdrawal by Subject|0|||
48968449|NCT00340834|157712541|FG004|Extension Phase of Study|Subject withdrew consent|15|||
48968450|NCT00340834|157712537|FG000|Extension Phase of Study|Adverse Event|21|||
48668401|NCT00552760|156639152|FG000|Overall Study|Medication Change|1|||
48668402|NCT00552760|156639153|FG001|Overall Study|Medication Change|0|||
48868937|NCT02979613|157357041|FG001|Open-Label Extension (OLE) Phase|Withdrew Consent|4|||
48868938|NCT02979613|157357040|FG000|Open-Label Extension (OLE) Phase|Adverse Event|1|||
48868939|NCT02979613|157357041|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
48868940|NCT02979613|157357040|FG000|Open-Label Extension (OLE) Phase|Death|0|||
48868941|NCT02979613|157357041|FG001|Open-Label Extension (OLE) Phase|Death|1|||
48868942|NCT02979613|157357040|FG000|Open-Label Extension (OLE) Phase|Investigator's Discretion|0|||
48868943|NCT02979613|157357041|FG001|Open-Label Extension (OLE) Phase|Investigator's Discretion|1|||
48868944|NCT01201915|157357042|FG000|Overall Study|Adverse Event|2|||
48868945|NCT01201915|157357043|FG001|Overall Study|Adverse Event|1|||
48868946|NCT01201915|157357044|FG002|Overall Study|Adverse Event|1|||
48868947|NCT01201915|157357042|FG000|Overall Study|Lost to Follow-up|0|||
48868948|NCT01201915|157357043|FG001|Overall Study|Lost to Follow-up|4|||
48868949|NCT01201915|157357044|FG002|Overall Study|Lost to Follow-up|0|||
48868950|NCT01201915|157357042|FG000|Overall Study|Physician Decision|3|||
48868951|NCT01201915|157357043|FG001|Overall Study|Physician Decision|0|||
48868952|NCT01201915|157357044|FG002|Overall Study|Physician Decision|0|||
48868953|NCT01201915|157357042|FG000|Overall Study|Subject Decision|3|||
48968451|NCT00340834|157712538|FG001|Extension Phase of Study|Adverse Event|22|||
48968452|NCT00340834|157712539|FG002|Extension Phase of Study|Adverse Event|0|||
48968453|NCT00340834|157712540|FG003|Extension Phase of Study|Adverse Event|19|||
48968454|NCT00340834|157712541|FG004|Extension Phase of Study|Adverse Event|7|||
48968455|NCT00340834|157712537|FG000|Extension Phase of Study|Abnormal laboratory value(s)|14|||
48968456|NCT00340834|157712538|FG001|Extension Phase of Study|Abnormal laboratory value(s)|13|||
48968457|NCT00340834|157712539|FG002|Extension Phase of Study|Abnormal laboratory value(s)|0|||
48868954|NCT01201915|157357043|FG001|Overall Study|Subject Decision|3|||
48868955|NCT01201915|157357044|FG002|Overall Study|Subject Decision|5|||
48868956|NCT01201915|157357042|FG000|Overall Study|Target Lesion Progression|0|||
48868957|NCT01201915|157357043|FG001|Overall Study|Target Lesion Progression|3|||
48868958|NCT01201915|157357044|FG002|Overall Study|Target Lesion Progression|0|||
48868959|NCT00635570|157358875|FG000|Overall Study|Lost to Follow-up|8|||
48868960|NCT00635570|157358876|FG001|Overall Study|Lost to Follow-up|8|||
48868961|NCT00635570|157358875|FG000|Overall Study|Withdrawal by Subject|1|||
48868962|NCT00635570|157358876|FG001|Overall Study|Withdrawal by Subject|1|||
48868963|NCT00635570|157358875|FG000|Overall Study|Adverse Event|2|||
48868964|NCT00635570|157358876|FG001|Overall Study|Adverse Event|0|||
48868965|NCT00635570|157358875|FG000|Overall Study|Physician Decision|1|||
48868966|NCT00635570|157358876|FG001|Overall Study|Physician Decision|0|||
48868967|NCT00635570|157358875|FG000|Overall Study|Did not complete survey|2|||
48868968|NCT00635570|157358876|FG001|Overall Study|Did not complete survey|1|||
48668403|NCT00199888|156639154|FG000|Overall Study|Lost to Follow-up|1|||
48668404|NCT05219669|156639157|FG000|Period 1 (1 Day)|Withdrawal by Subject|0|||
48668405|NCT05219669|156639158|FG001|Period 1 (1 Day)|Withdrawal by Subject|0|||
48668406|NCT05219669|156639159|FG002|Period 1 (1 Day)|Withdrawal by Subject|1|||
48668407|NCT05219669|156639160|FG003|Period 1 (1 Day)|Withdrawal by Subject|0|||
48668408|NCT05219669|156639161|FG004|Period 1 (1 Day)|Withdrawal by Subject|0|||
48668409|NCT05219669|156639162|FG005|Period 1 (1 Day)|Withdrawal by Subject|0|||
48668410|NCT03134183|156639163|FG000|Overall Study|Withdrawal by Subject|1|||
48668411|NCT03134183|156639164|FG001|Overall Study|Withdrawal by Subject|1|||
48668412|NCT02177838|156639165|FG000|Overall Study|Withdrawal by Subject|1|||
48668413|NCT02177838|156639165|FG000|Overall Study|Physician Decision|1|||
48668414|NCT02177838|156639165|FG000|Overall Study|Death|1|||
48668415|NCT02621073|156639166|FG000|Overall Study|Lost to Follow-up|0|||
48668416|NCT02621073|156639167|FG001|Overall Study|Lost to Follow-up|1|||
48668417|NCT02621073|156639166|FG000|Overall Study|Physician Decision|3|||
48668418|NCT02621073|156639167|FG001|Overall Study|Physician Decision|2|||
48668419|NCT00495755|156639168|FG000|Overall Study|Adverse Event|3|||
48668420|NCT00454649|156639171|FG000|Overall Study|Lack of Efficacy|2|||
48668421|NCT00454649|156639172|FG001|Overall Study|Lack of Efficacy|2|||
48668422|NCT00454649|156639173|FG002|Overall Study|Lack of Efficacy|10|||
48668423|NCT00454649|156639174|FG003|Overall Study|Lack of Efficacy|3|||
48668424|NCT00454649|156639175|FG004|Overall Study|Lack of Efficacy|0|||
48668425|NCT00454649|156639176|FG005|Overall Study|Lack of Efficacy|4|||
48668426|NCT00454649|156639177|FG006|Overall Study|Lack of Efficacy|5|||
48668427|NCT00454649|156639178|FG007|Overall Study|Lack of Efficacy|13|||
48668428|NCT00454649|156639179|FG008|Overall Study|Lack of Efficacy|10|||
48668429|NCT00454649|156639180|FG009|Overall Study|Lack of Efficacy|2|||
48868969|NCT00635570|157358875|FG000|Overall Study|Early termination(No sexual activity)|1|||
48868970|NCT00635570|157358876|FG001|Overall Study|Early termination(No sexual activity)|1|||
48868971|NCT02176356|157358877|FG000|Overall Study|Screen Failure|14|||
48868972|NCT02176356|157358877|FG000|Overall Study|Lost to Follow-up|4|||
48668430|NCT00454649|156639171|FG000|Overall Study|Adverse Event|0|||
48668431|NCT00454649|156639172|FG001|Overall Study|Adverse Event|1|||
48668432|NCT00454649|156639173|FG002|Overall Study|Adverse Event|3|||
48868973|NCT02176356|157358877|FG000|Overall Study|Personal Reasons|3|||
48868974|NCT02176356|157358877|FG000|Overall Study|Other Miscellaneous Reasons|2|||
48868975|NCT02675998|157358881|FG000|8-Week Treatment Period|Adverse Event|6|||
48868976|NCT02675998|157358882|FG001|8-Week Treatment Period|Adverse Event|5|||
48759107|NCT00507442|156966343|FG003|Overall Study|Progressive Disease|0|||
48759108|NCT00507442|156966340|FG000|Overall Study|Withdrawal by Subject|4|||
48759109|NCT00507442|156966341|FG001|Overall Study|Withdrawal by Subject|4|||
48759110|NCT00507442|156966342|FG002|Overall Study|Withdrawal by Subject|2|||
48759111|NCT00507442|156966343|FG003|Overall Study|Withdrawal by Subject|1|||
48759112|NCT00507442|156966340|FG000|Overall Study|Other|2|||
48759113|NCT00507442|156966341|FG001|Overall Study|Other|5|||
48759114|NCT00507442|156966342|FG002|Overall Study|Other|2|||
48759115|NCT00507442|156966343|FG003|Overall Study|Other|2|||
48759116|NCT00695396|156966344|FG000|Overall Study|Study Closed Prematurely|5|||
48759117|NCT00695396|156966345|FG001|Overall Study|Study Closed Prematurely|6|||
48868977|NCT02675998|157358883|FG002|8-Week Treatment Period|Adverse Event|6|||
48868978|NCT02675998|157358884|FG003|8-Week Treatment Period|Adverse Event|0|||
48668433|NCT00454649|156639174|FG003|Overall Study|Adverse Event|0|||
48668434|NCT00454649|156639175|FG004|Overall Study|Adverse Event|1|||
48668435|NCT00454649|156639176|FG005|Overall Study|Adverse Event|2|||
48668436|NCT00454649|156639177|FG006|Overall Study|Adverse Event|3|||
48668437|NCT00454649|156639178|FG007|Overall Study|Adverse Event|4|||
48668438|NCT00454649|156639179|FG008|Overall Study|Adverse Event|6|||
48668439|NCT00454649|156639180|FG009|Overall Study|Adverse Event|2|||
48668440|NCT00454649|156639171|FG000|Overall Study|Lost to Follow-up|0|||
48668441|NCT00454649|156639172|FG001|Overall Study|Lost to Follow-up|0|||
48668442|NCT00454649|156639173|FG002|Overall Study|Lost to Follow-up|1|||
48668443|NCT00454649|156639174|FG003|Overall Study|Lost to Follow-up|0|||
48668444|NCT00454649|156639175|FG004|Overall Study|Lost to Follow-up|0|||
48668445|NCT00454649|156639176|FG005|Overall Study|Lost to Follow-up|0|||
48668446|NCT00454649|156639177|FG006|Overall Study|Lost to Follow-up|1|||
48668447|NCT00454649|156639178|FG007|Overall Study|Lost to Follow-up|0|||
48668448|NCT00454649|156639179|FG008|Overall Study|Lost to Follow-up|0|||
48668449|NCT00454649|156639180|FG009|Overall Study|Lost to Follow-up|0|||
48668450|NCT00454649|156639171|FG000|Overall Study|Other|1|||
48668451|NCT00454649|156639172|FG001|Overall Study|Other|1|||
48668452|NCT00454649|156639173|FG002|Overall Study|Other|5|||
48668453|NCT00454649|156639174|FG003|Overall Study|Other|3|||
48668454|NCT00454649|156639175|FG004|Overall Study|Other|0|||
48668455|NCT00454649|156639176|FG005|Overall Study|Other|0|||
48668456|NCT00454649|156639177|FG006|Overall Study|Other|0|||
48668457|NCT00454649|156639178|FG007|Overall Study|Other|0|||
48668458|NCT00454649|156639179|FG008|Overall Study|Other|3|||
48668459|NCT00454649|156639180|FG009|Overall Study|Other|1|||
48668460|NCT00454649|156639171|FG000|Overall Study|Withdrawal by Subject|0|||
48668461|NCT00454649|156639172|FG001|Overall Study|Withdrawal by Subject|0|||
48668462|NCT00454649|156639173|FG002|Overall Study|Withdrawal by Subject|0|||
48668463|NCT00454649|156639174|FG003|Overall Study|Withdrawal by Subject|0|||
48668464|NCT00454649|156639175|FG004|Overall Study|Withdrawal by Subject|0|||
48668465|NCT00454649|156639176|FG005|Overall Study|Withdrawal by Subject|1|||
48668466|NCT00454649|156639177|FG006|Overall Study|Withdrawal by Subject|0|||
48668467|NCT00454649|156639178|FG007|Overall Study|Withdrawal by Subject|2|||
48668468|NCT00454649|156639179|FG008|Overall Study|Withdrawal by Subject|1|||
48668469|NCT00454649|156639180|FG009|Overall Study|Withdrawal by Subject|0|||
48668470|NCT02745535|156639182|FG000|Overall Study|Death|1|||
48668471|NCT02745535|156639182|FG000|Overall Study|Adverse Event|3|||
48868979|NCT02675998|157358881|FG000|8-Week Treatment Period|Withdrawal by Subject|3|||
48868980|NCT02675998|157358882|FG001|8-Week Treatment Period|Withdrawal by Subject|3|||
48868981|NCT02675998|157358883|FG002|8-Week Treatment Period|Withdrawal by Subject|3|||
48868982|NCT02675998|157358884|FG003|8-Week Treatment Period|Withdrawal by Subject|0|||
48868983|NCT02675998|157358881|FG000|8-Week Treatment Period|Lack of Efficacy|2|||
48668472|NCT02745535|156639182|FG000|Overall Study|Lost to Follow-up|2|||
48668473|NCT00459537|156639185|FG000|Overall Study|Adverse Event|1|||
48668474|NCT00459537|156639186|FG001|Overall Study|Adverse Event|6|||
48668475|NCT00459537|156639185|FG000|Overall Study|Lack of Efficacy|10|||
48668476|NCT00459537|156639186|FG001|Overall Study|Lack of Efficacy|11|||
48759118|NCT00695396|156966346|FG002|Overall Study|Study Closed Prematurely|8|||
48759119|NCT00695396|156966344|FG000|Overall Study|Withdrawal by Subject|2|||
48759120|NCT00695396|156966345|FG001|Overall Study|Withdrawal by Subject|2|||
48759121|NCT00695396|156966346|FG002|Overall Study|Withdrawal by Subject|0|||
48759122|NCT01086540|156966347|FG000|Overall Study|Death|3|||
48868984|NCT02675998|157358882|FG001|8-Week Treatment Period|Lack of Efficacy|5|||
48668477|NCT00459537|156639185|FG000|Overall Study|Withdrawal by Subject|20|||
48668478|NCT00459537|156639186|FG001|Overall Study|Withdrawal by Subject|26|||
48668479|NCT00459537|156639185|FG000|Overall Study|Lost to Follow-up|27|||
48668480|NCT00459537|156639186|FG001|Overall Study|Lost to Follow-up|30|||
48668481|NCT00459537|156639185|FG000|Overall Study|Administrative problems|3|||
48668482|NCT00459537|156639186|FG001|Overall Study|Administrative problems|0|||
48668483|NCT00459537|156639185|FG000|Overall Study|Protocol Violation|4|||
48668484|NCT00459537|156639186|FG001|Overall Study|Protocol Violation|3|||
48668485|NCT00459537|156639185|FG000|Overall Study|Missing|1|||
48668486|NCT00459537|156639186|FG001|Overall Study|Missing|0|||
48668487|NCT00637572|156639189|FG000|Overall Study|Adverse Event|1|||
48759123|NCT01086540|156966348|FG001|Overall Study|Death|1|||
48668488|NCT00637572|156639190|FG001|Overall Study|Adverse Event|2|||
48668489|NCT00637572|156639189|FG000|Overall Study|Death|0|||
48668490|NCT00637572|156639190|FG001|Overall Study|Death|1|||
48668491|NCT00637572|156639189|FG000|Overall Study|Lost to Follow-up|0|||
48668492|NCT00637572|156639190|FG001|Overall Study|Lost to Follow-up|1|||
48668493|NCT00637572|156639189|FG000|Overall Study|Physician Decision|1|||
48668494|NCT00637572|156639190|FG001|Overall Study|Physician Decision|1|||
48668495|NCT00637572|156639189|FG000|Overall Study|Withdrawal by Subject|0|||
48668496|NCT00637572|156639190|FG001|Overall Study|Withdrawal by Subject|2|||
48668497|NCT00637572|156639189|FG000|Overall Study|Illicit Drug Use|1|||
48668498|NCT00637572|156639190|FG001|Overall Study|Illicit Drug Use|0|||
48668499|NCT00896649|156639191|FG000|Overall Study|Physician Decision|1|||
48668500|NCT00896649|156639191|FG000|Overall Study|Pregnancy|1|||
48668501|NCT00896649|156639191|FG000|Overall Study|missing documentation|1|||
48668502|NCT00896649|156639191|FG000|Overall Study|technical difficulties|2|||
48668503|NCT04033068|156639192|FG000|Overall Study|Withdrawal by Subject|0|||
48668504|NCT04033068|156639193|FG001|Overall Study|Withdrawal by Subject|0|||
48668505|NCT04033068|156639194|FG002|Overall Study|Withdrawal by Subject|1|||
48668506|NCT04033068|156639195|FG003|Overall Study|Withdrawal by Subject|0|||
48668507|NCT04033068|156639192|FG000|Overall Study|Lost to Follow-up|0|||
48668508|NCT04033068|156639193|FG001|Overall Study|Lost to Follow-up|1|||
48668509|NCT04033068|156639194|FG002|Overall Study|Lost to Follow-up|0|||
48668510|NCT04033068|156639195|FG003|Overall Study|Lost to Follow-up|0|||
48668511|NCT04033068|156639192|FG000|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
48668512|NCT04033068|156639193|FG001|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
48668513|NCT04033068|156639194|FG002|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
48668514|NCT04033068|156639195|FG003|Overall Study|Inclusion / exclusion criteria not fulfilled|1|||
48668515|NCT01075984|156639196|FG000|Treatment Phase|Adverse Event|0|||
48668516|NCT01075984|156639197|FG001|Treatment Phase|Adverse Event|1|||
48668517|NCT01075984|156639198|FG002|Treatment Phase|Adverse Event|3|||
48668518|NCT01075984|156639199|FG003|Treatment Phase|Adverse Event|7|||
48668519|NCT01075984|156639200|FG004|Treatment Phase|Adverse Event|35|||
48668520|NCT01075984|156639196|FG000|Treatment Phase|Protocol Violation|0|||
48668521|NCT01075984|156639197|FG001|Treatment Phase|Protocol Violation|0|||
48668522|NCT01075984|156639198|FG002|Treatment Phase|Protocol Violation|1|||
48668523|NCT01075984|156639199|FG003|Treatment Phase|Protocol Violation|0|||
48668524|NCT01075984|156639200|FG004|Treatment Phase|Protocol Violation|3|||
48668525|NCT01075984|156639196|FG000|Treatment Phase|Withdrawal by Subject|0|||
48668526|NCT01075984|156639197|FG001|Treatment Phase|Withdrawal by Subject|0|||
48668527|NCT01075984|156639198|FG002|Treatment Phase|Withdrawal by Subject|2|||
48668528|NCT01075984|156639199|FG003|Treatment Phase|Withdrawal by Subject|0|||
48668529|NCT01075984|156639200|FG004|Treatment Phase|Withdrawal by Subject|15|||
48668530|NCT01075984|156639196|FG000|Treatment Phase|Treatment Failure|0|||
48668531|NCT01075984|156639197|FG001|Treatment Phase|Treatment Failure|0|||
48668532|NCT01075984|156639198|FG002|Treatment Phase|Treatment Failure|1|||
48668533|NCT01075984|156639199|FG003|Treatment Phase|Treatment Failure|0|||
48668534|NCT01075984|156639200|FG004|Treatment Phase|Treatment Failure|5|||
48668535|NCT01075984|156639196|FG000|Treatment Phase|Progression of disease|0|||
48668536|NCT01075984|156639197|FG001|Treatment Phase|Progression of disease|0|||
48668537|NCT01075984|156639198|FG002|Treatment Phase|Progression of disease|0|||
48668538|NCT01075984|156639199|FG003|Treatment Phase|Progression of disease|0|||
48868985|NCT02675998|157358883|FG002|8-Week Treatment Period|Lack of Efficacy|3|||
48868986|NCT02675998|157358884|FG003|8-Week Treatment Period|Lack of Efficacy|0|||
48868987|NCT02675998|157358881|FG000|8-Week Treatment Period|Physician Decision|1|||
48868988|NCT02675998|157358882|FG001|8-Week Treatment Period|Physician Decision|0|||
48868989|NCT02675998|157358883|FG002|8-Week Treatment Period|Physician Decision|2|||
48868990|NCT02675998|157358884|FG003|8-Week Treatment Period|Physician Decision|0|||
48868991|NCT02675998|157358881|FG000|8-Week Treatment Period|GI side Effects|1|||
48868992|NCT02675998|157358882|FG001|8-Week Treatment Period|GI side Effects|4|||
48668539|NCT01075984|156639200|FG004|Treatment Phase|Progression of disease|2|||
48668540|NCT01075984|156639196|FG000|Follow-up Phase|Protocol Violation|0|||
48868993|NCT02675998|157358883|FG002|8-Week Treatment Period|GI side Effects|2|||
48868994|NCT02675998|157358884|FG003|8-Week Treatment Period|GI side Effects|0|||
48868995|NCT02675998|157358881|FG000|8-Week Treatment Period|Protocol Violation|1|||
48668541|NCT01075984|156639197|FG001|Follow-up Phase|Protocol Violation|0|||
48668542|NCT01075984|156639198|FG002|Follow-up Phase|Protocol Violation|1|||
48668543|NCT01075984|156639199|FG003|Follow-up Phase|Protocol Violation|0|||
48668544|NCT01075984|156639200|FG004|Follow-up Phase|Protocol Violation|3|||
48868996|NCT02675998|157358882|FG001|8-Week Treatment Period|Protocol Violation|1|||
48668545|NCT01075984|156639196|FG000|Follow-up Phase|Adverse Event|0|||
48668546|NCT01075984|156639197|FG001|Follow-up Phase|Adverse Event|0|||
48668547|NCT01075984|156639198|FG002|Follow-up Phase|Adverse Event|0|||
48668548|NCT01075984|156639199|FG003|Follow-up Phase|Adverse Event|2|||
48668549|NCT01075984|156639200|FG004|Follow-up Phase|Adverse Event|27|||
48668550|NCT01075984|156639196|FG000|Follow-up Phase|Administrative|0|||
48668551|NCT01075984|156639197|FG001|Follow-up Phase|Administrative|0|||
48668552|NCT01075984|156639198|FG002|Follow-up Phase|Administrative|0|||
48668553|NCT01075984|156639199|FG003|Follow-up Phase|Administrative|0|||
48668554|NCT01075984|156639200|FG004|Follow-up Phase|Administrative|1|||
48668555|NCT01075984|156639196|FG000|Follow-up Phase|Withdrawal by Subject|0|||
48668556|NCT01075984|156639197|FG001|Follow-up Phase|Withdrawal by Subject|0|||
48668557|NCT01075984|156639198|FG002|Follow-up Phase|Withdrawal by Subject|0|||
48668558|NCT01075984|156639199|FG003|Follow-up Phase|Withdrawal by Subject|0|||
48668559|NCT01075984|156639200|FG004|Follow-up Phase|Withdrawal by Subject|10|||
48668560|NCT01075984|156639196|FG000|Follow-up Phase|Progression of disease|0|||
48668561|NCT01075984|156639197|FG001|Follow-up Phase|Progression of disease|0|||
48668562|NCT01075984|156639198|FG002|Follow-up Phase|Progression of disease|0|||
48668563|NCT01075984|156639199|FG003|Follow-up Phase|Progression of disease|0|||
48668564|NCT01075984|156639200|FG004|Follow-up Phase|Progression of disease|2|||
48668565|NCT01075984|156639196|FG000|Follow-up Phase|Treatment failure|0|||
48668566|NCT01075984|156639197|FG001|Follow-up Phase|Treatment failure|0|||
48668567|NCT01075984|156639198|FG002|Follow-up Phase|Treatment failure|0|||
48668568|NCT01075984|156639199|FG003|Follow-up Phase|Treatment failure|0|||
48668569|NCT01075984|156639200|FG004|Follow-up Phase|Treatment failure|4|||
48668570|NCT04232215|156639207|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
48868997|NCT02675998|157358883|FG002|8-Week Treatment Period|Protocol Violation|1|||
48668571|NCT04232215|156639208|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
48868998|NCT02675998|157358884|FG003|8-Week Treatment Period|Protocol Violation|0|||
48868999|NCT02675998|157358881|FG000|8-Week Treatment Period|Other|3|||
48869000|NCT02675998|157358882|FG001|8-Week Treatment Period|Other|1|||
48668572|NCT02440789|156639212|FG000|Overall Study|Withdrawal by Subject|3|||
48668573|NCT02440789|156639212|FG000|Overall Study|Not willing to adhere to reqs|1|||
48668574|NCT01806064|156641329|FG000|Overall Study|Randomized Not Enrolled|0|||
48668575|NCT01806064|156641330|FG001|Overall Study|Randomized Not Enrolled|0|||
48668576|NCT01806064|156641331|FG002|Overall Study|Randomized Not Enrolled|0|||
48668577|NCT01806064|156641332|FG003|Overall Study|Randomized Not Enrolled|1|||
48668578|NCT01806064|156641333|FG004|Overall Study|Randomized Not Enrolled|2|||
48668579|NCT02559414|156641335|FG000|Overall Study|Lost to Follow-up|0|||
48869001|NCT02675998|157358883|FG002|8-Week Treatment Period|Other|2|||
48869002|NCT02675998|157358884|FG003|8-Week Treatment Period|Other|0|||
48869003|NCT02675998|157358881|FG000|4-Week Randomized Withdrawal Period|Lack of Efficacy|0|||
48869004|NCT02675998|157358882|FG001|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
48869005|NCT02675998|157358883|FG002|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
48668580|NCT02559414|156641336|FG001|Overall Study|Lost to Follow-up|1|||
48668581|NCT02559414|156641337|FG002|Overall Study|Lost to Follow-up|0|||
48668582|NCT02559414|156641335|FG000|Overall Study|Withdrawal by Subject|1|||
48668583|NCT02559414|156641336|FG001|Overall Study|Withdrawal by Subject|0|||
48668584|NCT02559414|156641337|FG002|Overall Study|Withdrawal by Subject|1|||
48668585|NCT02559414|156641335|FG000|Overall Study|Other|0|||
48668586|NCT02559414|156641336|FG001|Overall Study|Other|1|||
48668587|NCT02559414|156641337|FG002|Overall Study|Other|1|||
48668588|NCT00440310|156641345|FG000|Overall Study|Lost to Follow-up|4|||
48668589|NCT00440310|156641346|FG001|Overall Study|Lost to Follow-up|5|||
48668590|NCT00440310|156641345|FG000|Overall Study|Protocol Violation|0|||
48668591|NCT00440310|156641346|FG001|Overall Study|Protocol Violation|1|||
48668592|NCT00440310|156641345|FG000|Overall Study|Withdrawal by Subject|15|||
48668593|NCT00440310|156641346|FG001|Overall Study|Withdrawal by Subject|14|||
48668594|NCT00440310|156641345|FG000|Overall Study|No Reply at EOS|7|||
48869006|NCT02675998|157358884|FG003|4-Week Randomized Withdrawal Period|Lack of Efficacy|3|||
48869007|NCT02675998|157358881|FG000|4-Week Randomized Withdrawal Period|Adverse Event|0|||
48869008|NCT02675998|157358882|FG001|4-Week Randomized Withdrawal Period|Adverse Event|0|||
48869009|NCT02675998|157358883|FG002|4-Week Randomized Withdrawal Period|Adverse Event|1|||
48869010|NCT02675998|157358884|FG003|4-Week Randomized Withdrawal Period|Adverse Event|3|||
48869011|NCT02675998|157358881|FG000|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
48869012|NCT02675998|157358882|FG001|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
48869013|NCT02675998|157358883|FG002|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
48869014|NCT02675998|157358884|FG003|4-Week Randomized Withdrawal Period|Protocol Violation|1|||
48668595|NCT00440310|156641346|FG001|Overall Study|No Reply at EOS|7|||
48668596|NCT00440310|156641345|FG000|Overall Study|Other|1|||
48668597|NCT00440310|156641346|FG001|Overall Study|Other|0|||
48869015|NCT02675998|157358881|FG000|4-Week Randomized Withdrawal Period|Physician Decision|1|||
48869016|NCT02675998|157358882|FG001|4-Week Randomized Withdrawal Period|Physician Decision|0|||
48668598|NCT00440310|156641345|FG000|Overall Study|Status Unknown|1|||
49015478|NCT01393990|157893774|FG004|Overall Study|Death|1|||
48668599|NCT00440310|156641346|FG001|Overall Study|Status Unknown|3|||
48668600|NCT00680368|156641347|FG000|Overall Study|not supervised, not eligible|15|||
48668601|NCT01300351|156641348|FG000|Overall Study|Did not receive treatment|2|||
48668602|NCT01300351|156641349|FG001|Overall Study|Did not receive treatment|0|||
48668603|NCT01300351|156641348|FG000|Overall Study|Ongoing treatment at data cut-off|27|||
48668604|NCT01300351|156641349|FG001|Overall Study|Ongoing treatment at data cut-off|23|||
48869017|NCT02675998|157358883|FG002|4-Week Randomized Withdrawal Period|Physician Decision|0|||
48869018|NCT02675998|157358884|FG003|4-Week Randomized Withdrawal Period|Physician Decision|0|||
48869019|NCT02675998|157358881|FG000|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
48869020|NCT02675998|157358882|FG001|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
48869021|NCT02675998|157358883|FG002|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
48668605|NCT01300351|156641348|FG000|Overall Study|Lost to Follow-up|0|||
48668606|NCT01300351|156641349|FG001|Overall Study|Lost to Follow-up|1|||
48668607|NCT01300351|156641348|FG000|Overall Study|Adverse Event|0|||
48668608|NCT01300351|156641349|FG001|Overall Study|Adverse Event|4|||
48668609|NCT01300351|156641348|FG000|Overall Study|Withdrawal by Subject|7|||
48668610|NCT01300351|156641349|FG001|Overall Study|Withdrawal by Subject|10|||
48668611|NCT02677844|156641350|FG000|Period 3|Withdrawal by Subject|0|||
48668612|NCT02677844|156641351|FG001|Period 3|Withdrawal by Subject|0|||
48668613|NCT02677844|156641352|FG002|Period 3|Withdrawal by Subject|0|||
48869022|NCT02675998|157358884|FG003|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1|||
48668614|NCT02677844|156641353|FG003|Period 3|Withdrawal by Subject|1|||
48668615|NCT02677844|156641354|FG004|Period 3|Withdrawal by Subject|0|||
48668616|NCT02677844|156641355|FG005|Period 3|Withdrawal by Subject|0|||
48668617|NCT02677844|156641356|FG006|Period 3|Withdrawal by Subject|0|||
48668618|NCT02230683|156641357|FG000|Overall Study|Adverse Event|1|||
48668619|NCT00096018|156641359|FG000|Overall Study|Became Ineligible (not treated)|0|||
48668620|NCT00096018|156641360|FG001|Overall Study|Became Ineligible (not treated)|3|||
48668621|NCT00096018|156641359|FG000|Overall Study|Miscellaneous (not treated)|0|||
48668622|NCT00096018|156641360|FG001|Overall Study|Miscellaneous (not treated)|2|||
48668623|NCT00096018|156641359|FG000|Overall Study|Adverse Event|0|||
48668624|NCT00096018|156641360|FG001|Overall Study|Adverse Event|5|||
48668625|NCT00096018|156641359|FG000|Overall Study|Death|0|||
48668626|NCT00096018|156641360|FG001|Overall Study|Death|1|||
48668627|NCT00096018|156641359|FG000|Overall Study|Withdrawal by Subject|0|||
48668628|NCT00096018|156641360|FG001|Overall Study|Withdrawal by Subject|2|||
48668629|NCT00096018|156641359|FG000|Overall Study|Miscellaneous|2|||
48668630|NCT00096018|156641360|FG001|Overall Study|Miscellaneous|1|||
48668631|NCT02266875|156641361|FG000|Overall Study|Withdrawal by Subject|9|||
48668632|NCT02266875|156641362|FG001|Overall Study|Withdrawal by Subject|0|||
48668633|NCT02266875|156641361|FG000|Overall Study|Lost to Follow-up|2|||
48668634|NCT02266875|156641362|FG001|Overall Study|Lost to Follow-up|0|||
48668635|NCT01554514|156641365|FG000|Overall Study|1 patient ineligible with congenital TTP|1|||
48668636|NCT01554514|156641365|FG000|Overall Study|Physician Decision|1|||
48668637|NCT01030874|156641366|FG000|Overall Study|Withdrawal by Subject|1|||
48668638|NCT01030874|156641367|FG001|Overall Study|Withdrawal by Subject|0|||
48668639|NCT01030874|156641366|FG000|Overall Study|Discharged in first 2 weeks|17|||
48668640|NCT01030874|156641367|FG001|Overall Study|Discharged in first 2 weeks|16|||
48668641|NCT02299076|156641368|FG000|Overall Study|Fraudulent Entries|20|||
48668642|NCT02299076|156641369|FG001|Overall Study|Fraudulent Entries|14|||
48668643|NCT00549770|156641370|FG000|Overall Study|Protocol deviation|1|||
48668644|NCT00549770|156641371|FG001|Overall Study|Protocol deviation|1|||
48668645|NCT00549770|156641372|FG002|Overall Study|Protocol deviation|1|||
48668646|NCT00549770|156641373|FG003|Overall Study|Protocol deviation|2|||
48668647|NCT00549770|156641374|FG004|Overall Study|Protocol deviation|2|||
48668648|NCT00549770|156641375|FG005|Overall Study|Protocol deviation|2|||
48668649|NCT00549770|156641376|FG006|Overall Study|Protocol deviation|1|||
48668650|NCT00549770|156641377|FG007|Overall Study|Protocol deviation|2|||
48668651|NCT00549770|156641370|FG000|Overall Study|Administrative problems|0|||
48668652|NCT00549770|156641371|FG001|Overall Study|Administrative problems|1|||
48668653|NCT00549770|156641372|FG002|Overall Study|Administrative problems|0|||
48869023|NCT01703845|157358885|FG000|Overall Study|Adverse Event|1|||
48668654|NCT00549770|156641373|FG003|Overall Study|Administrative problems|0|||
48668655|NCT00549770|156641374|FG004|Overall Study|Administrative problems|0|||
48668656|NCT00549770|156641375|FG005|Overall Study|Administrative problems|0|||
48668657|NCT00549770|156641376|FG006|Overall Study|Administrative problems|0|||
48668658|NCT00549770|156641377|FG007|Overall Study|Administrative problems|1|||
48668659|NCT00549770|156641370|FG000|Overall Study|Lost to Follow-up|0|||
48668660|NCT00549770|156641371|FG001|Overall Study|Lost to Follow-up|0|||
48869024|NCT01703845|157358886|FG001|Overall Study|Adverse Event|0|||
48668661|NCT00549770|156641372|FG002|Overall Study|Lost to Follow-up|2|||
48668662|NCT00549770|156641373|FG003|Overall Study|Lost to Follow-up|2|||
48668663|NCT00549770|156641374|FG004|Overall Study|Lost to Follow-up|3|||
48668664|NCT00549770|156641375|FG005|Overall Study|Lost to Follow-up|2|||
48668665|NCT00549770|156641376|FG006|Overall Study|Lost to Follow-up|0|||
48668666|NCT00549770|156641377|FG007|Overall Study|Lost to Follow-up|0|||
48668667|NCT00549770|156641370|FG000|Overall Study|Withdrawal by Subject|4|||
48668668|NCT00549770|156641371|FG001|Overall Study|Withdrawal by Subject|6|||
48668669|NCT00549770|156641372|FG002|Overall Study|Withdrawal by Subject|4|||
48668670|NCT00549770|156641373|FG003|Overall Study|Withdrawal by Subject|5|||
48668671|NCT00549770|156641374|FG004|Overall Study|Withdrawal by Subject|6|||
48668672|NCT00549770|156641375|FG005|Overall Study|Withdrawal by Subject|6|||
48668673|NCT00549770|156641376|FG006|Overall Study|Withdrawal by Subject|4|||
48668674|NCT00549770|156641377|FG007|Overall Study|Withdrawal by Subject|9|||
48668675|NCT00549770|156641370|FG000|Overall Study|Lack of Efficacy|1|||
48668676|NCT00549770|156641371|FG001|Overall Study|Lack of Efficacy|0|||
48668677|NCT00549770|156641372|FG002|Overall Study|Lack of Efficacy|2|||
48668678|NCT00549770|156641373|FG003|Overall Study|Lack of Efficacy|3|||
48668679|NCT00549770|156641374|FG004|Overall Study|Lack of Efficacy|5|||
48668680|NCT00549770|156641375|FG005|Overall Study|Lack of Efficacy|1|||
48668681|NCT00549770|156641376|FG006|Overall Study|Lack of Efficacy|3|||
48668682|NCT00549770|156641377|FG007|Overall Study|Lack of Efficacy|8|||
48668683|NCT00549770|156641370|FG000|Overall Study|Abnormal test procedure results|0|||
48668684|NCT00549770|156641371|FG001|Overall Study|Abnormal test procedure results|0|||
48668685|NCT00549770|156641372|FG002|Overall Study|Abnormal test procedure results|0|||
48668686|NCT00549770|156641373|FG003|Overall Study|Abnormal test procedure results|2|||
48668687|NCT00549770|156641374|FG004|Overall Study|Abnormal test procedure results|0|||
48668688|NCT00549770|156641375|FG005|Overall Study|Abnormal test procedure results|1|||
48668689|NCT00549770|156641376|FG006|Overall Study|Abnormal test procedure results|1|||
48668690|NCT00549770|156641377|FG007|Overall Study|Abnormal test procedure results|1|||
48668691|NCT00549770|156641370|FG000|Overall Study|Abnormal laboratory values|0|||
48668692|NCT00549770|156641371|FG001|Overall Study|Abnormal laboratory values|0|||
48668693|NCT00549770|156641372|FG002|Overall Study|Abnormal laboratory values|0|||
48668694|NCT00549770|156641373|FG003|Overall Study|Abnormal laboratory values|0|||
48668695|NCT00549770|156641374|FG004|Overall Study|Abnormal laboratory values|0|||
48668696|NCT00549770|156641375|FG005|Overall Study|Abnormal laboratory values|1|||
48668697|NCT00549770|156641376|FG006|Overall Study|Abnormal laboratory values|0|||
48668698|NCT00549770|156641377|FG007|Overall Study|Abnormal laboratory values|0|||
48668699|NCT00549770|156641370|FG000|Overall Study|Adverse Event|1|||
48668700|NCT00549770|156641371|FG001|Overall Study|Adverse Event|3|||
48668701|NCT00549770|156641372|FG002|Overall Study|Adverse Event|1|||
48668702|NCT00549770|156641373|FG003|Overall Study|Adverse Event|2|||
48668703|NCT00549770|156641374|FG004|Overall Study|Adverse Event|1|||
48668704|NCT00549770|156641375|FG005|Overall Study|Adverse Event|0|||
48759124|NCT01086540|156966347|FG000|Overall Study|Physician Decision|2|||
48759125|NCT01086540|156966348|FG001|Overall Study|Physician Decision|1|||
48759126|NCT01086540|156966347|FG000|Overall Study|Addition of new therapy for PAH|1|||
48759127|NCT01086540|156966348|FG001|Overall Study|Addition of new therapy for PAH|0|||
48759128|NCT00333866|156966351|FG000|Overall Study|Adverse Event|23|||
48759129|NCT00333866|156966352|FG001|Overall Study|Adverse Event|37|||
48759130|NCT00333866|156966353|FG002|Overall Study|Adverse Event|38|||
48759131|NCT00333866|156966354|FG003|Overall Study|Adverse Event|47|||
48759132|NCT00333866|156966351|FG000|Overall Study|Other|3|||
48759133|NCT00333866|156966352|FG001|Overall Study|Other|2|||
48759134|NCT00333866|156966353|FG002|Overall Study|Other|2|||
48759135|NCT00333866|156966354|FG003|Overall Study|Other|2|||
48759136|NCT00333866|156966351|FG000|Overall Study|Lack of Efficacy|8|||
48759137|NCT00333866|156966352|FG001|Overall Study|Lack of Efficacy|6|||
48759138|NCT00333866|156966353|FG002|Overall Study|Lack of Efficacy|3|||
48759139|NCT00333866|156966354|FG003|Overall Study|Lack of Efficacy|5|||
48759140|NCT00333866|156966351|FG000|Overall Study|Lost to Follow-up|1|||
48759141|NCT00333866|156966352|FG001|Overall Study|Lost to Follow-up|2|||
48759142|NCT00333866|156966353|FG002|Overall Study|Lost to Follow-up|2|||
48759143|NCT00333866|156966354|FG003|Overall Study|Lost to Follow-up|2|||
48759144|NCT00333866|156966351|FG000|Overall Study|Withdrawal by Subject|8|||
48759145|NCT00333866|156966352|FG001|Overall Study|Withdrawal by Subject|14|||
48759146|NCT00333866|156966353|FG002|Overall Study|Withdrawal by Subject|4|||
48759147|NCT00333866|156966354|FG003|Overall Study|Withdrawal by Subject|9|||
48759148|NCT00333866|156966351|FG000|Overall Study|Randomized but not Treated|5|||
48759149|NCT00333866|156966352|FG001|Overall Study|Randomized but not Treated|3|||
48759150|NCT00333866|156966353|FG002|Overall Study|Randomized but not Treated|2|||
48668705|NCT00549770|156641376|FG006|Overall Study|Adverse Event|5|||
48668706|NCT00549770|156641377|FG007|Overall Study|Adverse Event|4|||
48668707|NCT00357656|156641382|FG000|Overall Study|Other, No surgery performed|0|||
48668708|NCT00357656|156641383|FG001|Overall Study|Other, No surgery performed|3|||
48668709|NCT00685373|156641386|FG000|Overall Study|Adverse Event|3|||
48668710|NCT00685373|156641386|FG000|Overall Study|Withdrawal by Subject|5|||
48668711|NCT00685373|156641386|FG000|Overall Study|Lack of Efficacy|3|||
48668712|NCT00685373|156641386|FG000|Overall Study|Condition no longer requires study drug|1|||
48668713|NCT00685373|156641386|FG000|Overall Study|Lost to Follow-up|2|||
48759151|NCT00333866|156966354|FG003|Overall Study|Randomized but not Treated|1|||
48759152|NCT02956486|156966355|FG000|Core Phase|Adverse Event|51|||
48759153|NCT02956486|156966356|FG001|Core Phase|Adverse Event|88|||
48759154|NCT02956486|156966357|FG002|Core Phase|Adverse Event|0|||
48759155|NCT02956486|156966355|FG000|Core Phase|Lost to Follow-up|8|||
48668714|NCT00685373|156641386|FG000|Overall Study|Protocol Violation|1|||
48668715|NCT02758301|156641387|FG000|Overall Study|Death|12|||
48668716|NCT02758301|156641388|FG001|Overall Study|Death|0|||
48668717|NCT02758301|156641387|FG000|Overall Study|Physician Decision|10|||
48759156|NCT02956486|156966356|FG001|Core Phase|Lost to Follow-up|6|||
48759157|NCT02956486|156966357|FG002|Core Phase|Lost to Follow-up|0|||
48759158|NCT02956486|156966355|FG000|Core Phase|Inadequate therapeutic effect|4|||
48668718|NCT02758301|156641388|FG001|Overall Study|Physician Decision|1|||
48668719|NCT02758301|156641387|FG000|Overall Study|Withdrawal by Subject|5|||
48668720|NCT02758301|156641388|FG001|Overall Study|Withdrawal by Subject|6|||
48869025|NCT01703845|157358885|FG000|Overall Study|Protocol Violation|1|||
48869026|NCT01703845|157358886|FG001|Overall Study|Protocol Violation|0|||
48869027|NCT01703845|157358885|FG000|Overall Study|other than stated above|1|||
48869028|NCT01703845|157358886|FG001|Overall Study|other than stated above|0|||
48869029|NCT00848393|157358887|FG000|Overall Study|Protocol Violation|0|||
48869030|NCT00848393|157358888|FG001|Overall Study|Protocol Violation|0|||
48869031|NCT00848393|157358889|FG002|Overall Study|Protocol Violation|1|||
48869032|NCT00848393|157358887|FG000|Overall Study|surgical complications unrelated to stud|0|||
48869033|NCT00848393|157358888|FG001|Overall Study|surgical complications unrelated to stud|0|||
48869034|NCT00848393|157358889|FG002|Overall Study|surgical complications unrelated to stud|2|||
48869035|NCT01194271|157358894|FG000|Overall Study|Withdrawal by Subject|1|||
48869036|NCT01194271|157358894|FG000|Overall Study|Ineligible, Screen Failure|1|||
48869037|NCT01194271|157358894|FG000|Overall Study|Death|1|||
48869038|NCT00443898|157358899|FG000|Overall Study|Adverse Event|0|||
48869039|NCT00443898|157358900|FG001|Overall Study|Adverse Event|0|||
48869040|NCT00443898|157358901|FG002|Overall Study|Adverse Event|1|||
48869041|NCT00443898|157358902|FG003|Overall Study|Adverse Event|1|||
48869042|NCT00443898|157358899|FG000|Overall Study|Lack of Efficacy|2|||
48869043|NCT00443898|157358900|FG001|Overall Study|Lack of Efficacy|3|||
48869044|NCT00443898|157358901|FG002|Overall Study|Lack of Efficacy|3|||
48869045|NCT00443898|157358902|FG003|Overall Study|Lack of Efficacy|1|||
48869046|NCT00443898|157358899|FG000|Overall Study|Protocol Violation|1|||
48869047|NCT00443898|157358900|FG001|Overall Study|Protocol Violation|1|||
48869048|NCT00443898|157358901|FG002|Overall Study|Protocol Violation|1|||
48869049|NCT00443898|157358902|FG003|Overall Study|Protocol Violation|0|||
48869050|NCT00443898|157358899|FG000|Overall Study|Withdrawal by Subject|11|||
48869051|NCT00443898|157358900|FG001|Overall Study|Withdrawal by Subject|10|||
48869052|NCT00443898|157358901|FG002|Overall Study|Withdrawal by Subject|10|||
48869053|NCT00443898|157358902|FG003|Overall Study|Withdrawal by Subject|6|||
48869054|NCT00443898|157358899|FG000|Overall Study|Lost to Follow-up|10|||
48869055|NCT00443898|157358900|FG001|Overall Study|Lost to Follow-up|10|||
48869056|NCT00443898|157358901|FG002|Overall Study|Lost to Follow-up|14|||
48869057|NCT00443898|157358902|FG003|Overall Study|Lost to Follow-up|10|||
48869058|NCT00443898|157358899|FG000|Overall Study|Death|0|||
48869059|NCT00443898|157358900|FG001|Overall Study|Death|1|||
48869060|NCT00443898|157358901|FG002|Overall Study|Death|0|||
48869061|NCT00443898|157358902|FG003|Overall Study|Death|0|||
48869062|NCT00644332|157358905|FG000|Overall Study|Adverse Event|11|||
48869063|NCT00644332|157358905|FG000|Overall Study|Withdrawal by Subject|6|||
48869064|NCT00644332|157358905|FG000|Overall Study|Completion Status Unknown|2|||
48869065|NCT00644332|157358905|FG000|Overall Study|Did Not Meet Eligibility Requirements|1|||
48869066|NCT00644332|157358905|FG000|Overall Study|Could Not Attend Scheduled Visits|1|||
48869067|NCT02705625|157358906|FG000|Overall Study|Protocol Violation|1|||
48869068|NCT02705625|157358907|FG001|Overall Study|Protocol Violation|0|||
48869069|NCT02705625|157358908|FG002|Overall Study|Protocol Violation|0|||
48869070|NCT02705625|157358906|FG000|Overall Study|Adverse Event|6|||
48869071|NCT02705625|157358907|FG001|Overall Study|Adverse Event|5|||
48869072|NCT02705625|157358908|FG002|Overall Study|Adverse Event|2|||
48869073|NCT02705625|157358906|FG000|Overall Study|Death|0|||
48869074|NCT02705625|157358907|FG001|Overall Study|Death|0|||
48968458|NCT00340834|157712540|FG003|Extension Phase of Study|Abnormal laboratory value(s)|13|||
48968459|NCT00340834|157712541|FG004|Extension Phase of Study|Abnormal laboratory value(s)|4|||
48968460|NCT00340834|157712537|FG000|Extension Phase of Study|Unsatisfactory therapeutic effect|13|||
48968461|NCT00340834|157712538|FG001|Extension Phase of Study|Unsatisfactory therapeutic effect|7|||
48968462|NCT00340834|157712539|FG002|Extension Phase of Study|Unsatisfactory therapeutic effect|0|||
48968463|NCT00340834|157712540|FG003|Extension Phase of Study|Unsatisfactory therapeutic effect|4|||
48668721|NCT02758301|156641387|FG000|Overall Study|Lost to Follow-up|7|||
48668722|NCT02758301|156641388|FG001|Overall Study|Lost to Follow-up|0|||
48668723|NCT02758301|156641387|FG000|Overall Study|Protocol Violation|0|||
48668724|NCT02758301|156641388|FG001|Overall Study|Protocol Violation|1|||
48668725|NCT01302054|156641389|FG000|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4|||
48968464|NCT00340834|157712541|FG004|Extension Phase of Study|Unsatisfactory therapeutic effect|9|||
48968465|NCT00340834|157712537|FG000|Extension Phase of Study|Lost to Follow-up|1|||
48968466|NCT00340834|157712538|FG001|Extension Phase of Study|Lost to Follow-up|1|||
48968467|NCT00340834|157712539|FG002|Extension Phase of Study|Lost to Follow-up|0|||
48968468|NCT00340834|157712540|FG003|Extension Phase of Study|Lost to Follow-up|2|||
48869075|NCT02705625|157358908|FG002|Overall Study|Death|1|||
48869076|NCT02705625|157358906|FG000|Overall Study|Withdrawal by Subject|1|||
48869077|NCT02705625|157358907|FG001|Overall Study|Withdrawal by Subject|4|||
48869078|NCT02705625|157358908|FG002|Overall Study|Withdrawal by Subject|5|||
48869079|NCT02705625|157358906|FG000|Overall Study|Lost to Follow-up|0|||
48869080|NCT02705625|157358907|FG001|Overall Study|Lost to Follow-up|0|||
48869081|NCT02705625|157358908|FG002|Overall Study|Lost to Follow-up|1|||
48668726|NCT01302054|156641390|FG001|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
48668727|NCT01302054|156641391|FG002|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
48668728|NCT01302054|156641389|FG000|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17|||
48668729|NCT01302054|156641390|FG001|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
48668730|NCT01302054|156641391|FG002|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
48668731|NCT01302054|156641389|FG000|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16|||
48668732|NCT01302054|156641390|FG001|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
48668733|NCT01302054|156641391|FG002|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
48668734|NCT01302054|156641389|FG000|Tolterodine Open-Label Run-In Phase|Protocol Violation|8|||
48668735|NCT01302054|156641390|FG001|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
48668736|NCT01302054|156641391|FG002|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
48668737|NCT01302054|156641389|FG000|Tolterodine Open-Label Run-In Phase|Adverse Event|13|||
48668738|NCT01302054|156641390|FG001|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
48668739|NCT01302054|156641391|FG002|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
48759159|NCT02956486|156966356|FG001|Core Phase|Inadequate therapeutic effect|5|||
48759160|NCT02956486|156966357|FG002|Core Phase|Inadequate therapeutic effect|0|||
48759161|NCT02956486|156966355|FG000|Core Phase|Withdrawal by Subject|101|||
48759162|NCT02956486|156966356|FG001|Core Phase|Withdrawal by Subject|104|||
48759163|NCT02956486|156966357|FG002|Core Phase|Withdrawal by Subject|0|||
48759164|NCT02956486|156966355|FG000|Core Phase|Study terminated by sponsor|888|||
48668740|NCT01302054|156641389|FG000|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314|||
48668741|NCT01302054|156641390|FG001|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
48668742|NCT01302054|156641391|FG002|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
48668743|NCT01302054|156641389|FG000|Tolterodine Open-Label Run-In Phase|Other|7|||
48668744|NCT01302054|156641390|FG001|Tolterodine Open-Label Run-In Phase|Other|0|||
48668745|NCT01302054|156641391|FG002|Tolterodine Open-Label Run-In Phase|Other|0|||
48668746|NCT01302054|156641389|FG000|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2|||
48668747|NCT01302054|156641390|FG001|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
48668748|NCT01302054|156641391|FG002|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
48668749|NCT01302054|156641389|FG000|Double-Blind Treatment Phase|Lack of Efficacy|0|||
48668750|NCT01302054|156641390|FG001|Double-Blind Treatment Phase|Lack of Efficacy|2|||
48668751|NCT01302054|156641391|FG002|Double-Blind Treatment Phase|Lack of Efficacy|4|||
48668752|NCT01302054|156641389|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
48668753|NCT01302054|156641390|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
48668754|NCT01302054|156641391|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
48668755|NCT01302054|156641389|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
48668756|NCT01302054|156641390|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|6|||
48668757|NCT01302054|156641391|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|14|||
48668758|NCT01302054|156641389|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
48668759|NCT01302054|156641390|FG001|Double-Blind Treatment Phase|Protocol Violation|3|||
48668760|NCT01302054|156641391|FG002|Double-Blind Treatment Phase|Protocol Violation|6|||
48668761|NCT01302054|156641389|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
48668762|NCT01302054|156641390|FG001|Double-Blind Treatment Phase|Adverse Event|10|||
48668763|NCT01302054|156641391|FG002|Double-Blind Treatment Phase|Adverse Event|10|||
48668764|NCT01302054|156641389|FG000|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
48668765|NCT01302054|156641390|FG001|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
48759165|NCT02956486|156966356|FG001|Core Phase|Study terminated by sponsor|848|||
48759166|NCT02956486|156966357|FG002|Core Phase|Study terminated by sponsor|0|||
48759167|NCT02956486|156966355|FG000|Core Phase|Other|27|||
48759168|NCT02956486|156966356|FG001|Core Phase|Other|18|||
48759169|NCT02956486|156966357|FG002|Core Phase|Other|0|||
48759170|NCT02956486|156966355|FG000|Core Phase|Not treated|0|||
48759171|NCT02956486|156966356|FG001|Core Phase|Not treated|3|||
48668766|NCT01302054|156641391|FG002|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2|||
48668767|NCT01302054|156641389|FG000|Double-Blind Treatment Phase|Other|0|||
48668768|NCT01302054|156641390|FG001|Double-Blind Treatment Phase|Other|4|||
48668769|NCT01302054|156641391|FG002|Double-Blind Treatment Phase|Other|9|||
48869082|NCT02705625|157358906|FG000|Overall Study|Non-compliance|0|||
48869083|NCT02705625|157358907|FG001|Overall Study|Non-compliance|1|||
48869084|NCT02705625|157358908|FG002|Overall Study|Non-compliance|1|||
48668770|NCT02713867|156641392|FG000|Randomization|Other Reason|2|||
48759172|NCT02956486|156966357|FG002|Core Phase|Not treated|0|||
48759173|NCT02956486|156966355|FG000|Extension Phase|Adverse Event|0|||
48759174|NCT02956486|156966356|FG001|Extension Phase|Adverse Event|0|||
48759175|NCT02956486|156966357|FG002|Extension Phase|Adverse Event|2|||
48869085|NCT02705625|157358906|FG000|Overall Study|Overdosing|0|||
48869086|NCT02705625|157358907|FG001|Overall Study|Overdosing|0|||
48869087|NCT02705625|157358908|FG002|Overall Study|Overdosing|1|||
48869088|NCT00510198|157358909|FG000|Overall Study|Withdrawal by Subject|5|||
48869089|NCT00510198|157358910|FG001|Overall Study|Withdrawal by Subject|4|||
48869090|NCT00329550|157358911|FG000|Overall Study|Adverse Event|3|||
48869091|NCT00329550|157358912|FG001|Overall Study|Adverse Event|4|||
48869092|NCT00329550|157358913|FG002|Overall Study|Adverse Event|2|||
48869093|NCT00329550|157358911|FG000|Overall Study|Withdrawal of Consent|1|||
48869094|NCT00329550|157358912|FG001|Overall Study|Withdrawal of Consent|0|||
48869095|NCT00329550|157358913|FG002|Overall Study|Withdrawal of Consent|1|||
48869096|NCT00329550|157358911|FG000|Overall Study|Due to Relocation|0|||
48869097|NCT00329550|157358912|FG001|Overall Study|Due to Relocation|0|||
48869098|NCT00329550|157358913|FG002|Overall Study|Due to Relocation|1|||
48869099|NCT02158247|157358919|FG000|Overall Study|Invisible vocal cords|5|||
48869100|NCT02973802|157358929|FG000|Overall Study|Lost to Follow-up|1|||
48869101|NCT02973802|157358929|FG000|Overall Study|Withdrawal by Subject|1|||
48869102|NCT03357471|157358930|FG000|Overall Study|Adverse Event|1|||
48869103|NCT03357471|157358931|FG001|Overall Study|Adverse Event|0|||
48869104|NCT03357471|157358930|FG000|Overall Study|Lost to Follow-up|1|||
48869105|NCT03357471|157358931|FG001|Overall Study|Lost to Follow-up|0|||
48869106|NCT03730662|157358934|FG000|Treatment Period (52 Weeks)|Adverse Event|3|||
48869107|NCT03730662|157358935|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
48869108|NCT03730662|157358936|FG002|Treatment Period (52 Weeks)|Adverse Event|0|||
48668771|NCT02713867|156641393|FG001|Randomization|Other Reason|1|||
48668772|NCT02713867|156641392|FG000|Randomization|Participant Withdrew consent|0|||
48668773|NCT02713867|156641393|FG001|Randomization|Participant Withdrew consent|2|||
48668774|NCT02713867|156641392|FG000|Treatment Period|Other Reasons|22|||
48668775|NCT02713867|156641393|FG001|Treatment Period|Other Reasons|28|||
48668776|NCT02713867|156641392|FG000|Treatment Period|Administrative reason by sponsor|21|||
48668777|NCT02713867|156641393|FG001|Treatment Period|Administrative reason by sponsor|16|||
48668778|NCT02713867|156641392|FG000|Treatment Period|No longer meets study criteria|2|||
48668779|NCT02713867|156641393|FG001|Treatment Period|No longer meets study criteria|1|||
48668780|NCT02713867|156641392|FG000|Treatment Period|Poor/Non Compliance|1|||
48668781|NCT02713867|156641393|FG001|Treatment Period|Poor/Non Compliance|0|||
48668782|NCT02713867|156641392|FG000|Treatment Period|Maximum Clinical Benefit|5|||
48668783|NCT02713867|156641393|FG001|Treatment Period|Maximum Clinical Benefit|6|||
48668784|NCT02713867|156641392|FG000|Treatment Period|Withdrew consent|3|||
48668785|NCT02713867|156641393|FG001|Treatment Period|Withdrew consent|6|||
48668786|NCT02713867|156641392|FG000|Treatment Period|Requested to Discontinue|8|||
48668787|NCT02713867|156641393|FG001|Treatment Period|Requested to Discontinue|8|||
48668788|NCT02713867|156641392|FG000|Treatment Period|AE unrelated to Study Drug|11|||
48668789|NCT02713867|156641393|FG001|Treatment Period|AE unrelated to Study Drug|10|||
48668790|NCT02713867|156641392|FG000|Treatment Period|Death|7|||
48668791|NCT02713867|156641393|FG001|Treatment Period|Death|3|||
48668792|NCT02713867|156641392|FG000|Treatment Period|Study Drug Toxicity|16|||
48668793|NCT02713867|156641393|FG001|Treatment Period|Study Drug Toxicity|19|||
48668794|NCT02713867|156641392|FG000|Treatment Period|Disease Progression|82|||
48668795|NCT02713867|156641393|FG001|Treatment Period|Disease Progression|83|||
48668796|NCT02855944|156641396|FG000|Period 1: Treatment|Ongoing|14|||
48668797|NCT02855944|156641397|FG001|Period 1: Treatment|Ongoing|0|||
48668798|NCT02855944|156641396|FG000|Period 1: Treatment|Discontinued prior to starting study drug|1|||
48668799|NCT02855944|156641397|FG001|Period 1: Treatment|Discontinued prior to starting study drug|3|||
48668800|NCT02855944|156641396|FG000|Period 2: Crossover to Rucaparib|Ongoing|0|||
48668801|NCT02855944|156641397|FG001|Period 2: Crossover to Rucaparib|Ongoing|5|||
48668802|NCT02250664|156641398|FG000|Overall Study|Lost to Follow-up|18|||
48668803|NCT02250664|156641399|FG001|Overall Study|Lost to Follow-up|28|||
48668804|NCT02250664|156641400|FG002|Overall Study|Lost to Follow-up|33|||
48668805|NCT02250664|156641398|FG000|Overall Study|Personal Reasons|7|||
48668806|NCT02250664|156641399|FG001|Overall Study|Personal Reasons|8|||
48668807|NCT02250664|156641400|FG002|Overall Study|Personal Reasons|14|||
48668808|NCT02250664|156641398|FG000|Overall Study|Adverse Event|6|||
48668809|NCT02250664|156641399|FG001|Overall Study|Adverse Event|3|||
48668810|NCT02250664|156641400|FG002|Overall Study|Adverse Event|8|||
48668811|NCT02250664|156641398|FG000|Overall Study|Incarcerated|2|||
48668812|NCT02250664|156641399|FG001|Overall Study|Incarcerated|1|||
48668813|NCT02250664|156641400|FG002|Overall Study|Incarcerated|2|||
48869109|NCT03730662|157358937|FG003|Treatment Period (52 Weeks)|Adverse Event|3|||
48668814|NCT02250664|156641398|FG000|Overall Study|Withdrawal by Subject|0|||
48668815|NCT02250664|156641399|FG001|Overall Study|Withdrawal by Subject|1|||
48869110|NCT03730662|157358934|FG000|Treatment Period (52 Weeks)|Screen Failure|0|||
48869111|NCT03730662|157358935|FG001|Treatment Period (52 Weeks)|Screen Failure|1|||
48869112|NCT03730662|157358936|FG002|Treatment Period (52 Weeks)|Screen Failure|0|||
48869113|NCT03730662|157358937|FG003|Treatment Period (52 Weeks)|Screen Failure|0|||
48869114|NCT03730662|157358934|FG000|Treatment Period (52 Weeks)|Death|6|||
48869115|NCT03730662|157358935|FG001|Treatment Period (52 Weeks)|Death|2|||
48869116|NCT03730662|157358936|FG002|Treatment Period (52 Weeks)|Death|2|||
48869117|NCT03730662|157358937|FG003|Treatment Period (52 Weeks)|Death|9|||
48869118|NCT03730662|157358934|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|4|||
48668816|NCT02250664|156641400|FG002|Overall Study|Withdrawal by Subject|2|||
48668817|NCT02250664|156641398|FG000|Overall Study|Death|0|||
48668818|NCT02250664|156641399|FG001|Overall Study|Death|1|||
48869119|NCT03730662|157358935|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
48869120|NCT03730662|157358936|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
48869121|NCT03730662|157358937|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|11|||
48869122|NCT03730662|157358934|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
48869123|NCT03730662|157358935|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
48869124|NCT03730662|157358936|FG002|Treatment Period (52 Weeks)|Physician Decision|0|||
48869125|NCT03730662|157358937|FG003|Treatment Period (52 Weeks)|Physician Decision|3|||
48869126|NCT03730662|157358934|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
48869127|NCT03730662|157358935|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
48869128|NCT03730662|157358936|FG002|Treatment Period (52 Weeks)|Protocol Violation|0|||
48869129|NCT03730662|157358937|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
48869130|NCT03730662|157358934|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
48869131|NCT03730662|157358935|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
48869132|NCT03730662|157358936|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
48869133|NCT03730662|157358937|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|23|||
48869134|NCT03730662|157358934|FG000|Treatment Period (52 Weeks)|Personal Reason|2|||
48668819|NCT02250664|156641400|FG002|Overall Study|Death|1|||
48668820|NCT02250664|156641398|FG000|Overall Study|Physician Decision|1|||
48668821|NCT02250664|156641399|FG001|Overall Study|Physician Decision|3|||
48668822|NCT02250664|156641400|FG002|Overall Study|Physician Decision|1|||
48869135|NCT03730662|157358935|FG001|Treatment Period (52 Weeks)|Personal Reason|2|||
48869136|NCT03730662|157358936|FG002|Treatment Period (52 Weeks)|Personal Reason|0|||
48869137|NCT03730662|157358937|FG003|Treatment Period (52 Weeks)|Personal Reason|2|||
48869138|NCT03730662|157358934|FG000|Variable Treatment Period|Adverse Event|1|||
48869139|NCT03730662|157358935|FG001|Variable Treatment Period|Adverse Event|2|||
48869140|NCT03730662|157358936|FG002|Variable Treatment Period|Adverse Event|0|||
48869141|NCT03730662|157358937|FG003|Variable Treatment Period|Adverse Event|7|||
48869142|NCT03730662|157358934|FG000|Variable Treatment Period|Death|9|||
48869143|NCT03730662|157358935|FG001|Variable Treatment Period|Death|0|||
48869144|NCT03730662|157358936|FG002|Variable Treatment Period|Death|6|||
48869145|NCT03730662|157358937|FG003|Variable Treatment Period|Death|26|||
48668823|NCT02250664|156641398|FG000|Overall Study|Protocol Violation|1|||
48668824|NCT02250664|156641399|FG001|Overall Study|Protocol Violation|0|||
48668825|NCT02250664|156641400|FG002|Overall Study|Protocol Violation|1|||
48668826|NCT02250664|156641398|FG000|Overall Study|Reason unknown|1|||
48668827|NCT02250664|156641399|FG001|Overall Study|Reason unknown|0|||
48668828|NCT02250664|156641400|FG002|Overall Study|Reason unknown|0|||
48668829|NCT01369680|156641401|FG000|Overall Study|Lost to Follow-up|0|||
48668830|NCT01369680|156641402|FG001|Overall Study|Lost to Follow-up|0|||
48668831|NCT01369680|156641403|FG002|Overall Study|Lost to Follow-up|1|||
48668832|NCT01369680|156641404|FG003|Overall Study|Lost to Follow-up|2|||
48668833|NCT02391961|156641405|FG000|First Intervention (4 Weeks)|Adverse Event|2|||
48668834|NCT02391961|156641406|FG001|First Intervention (4 Weeks)|Adverse Event|0|||
48869146|NCT03730662|157358934|FG000|Variable Treatment Period|Lost to Follow-up|2|||
48869147|NCT03730662|157358935|FG001|Variable Treatment Period|Lost to Follow-up|1|||
48869148|NCT03730662|157358936|FG002|Variable Treatment Period|Lost to Follow-up|4|||
48869149|NCT03730662|157358937|FG003|Variable Treatment Period|Lost to Follow-up|11|||
48869150|NCT03730662|157358934|FG000|Variable Treatment Period|Personal Reason|0|||
48869151|NCT03730662|157358935|FG001|Variable Treatment Period|Personal Reason|2|||
48869152|NCT03730662|157358936|FG002|Variable Treatment Period|Personal Reason|1|||
48869153|NCT03730662|157358937|FG003|Variable Treatment Period|Personal Reason|6|||
48869154|NCT03730662|157358934|FG000|Variable Treatment Period|Physician Decision|0|||
48869155|NCT03730662|157358935|FG001|Variable Treatment Period|Physician Decision|0|||
48869156|NCT03730662|157358936|FG002|Variable Treatment Period|Physician Decision|0|||
48869157|NCT03730662|157358937|FG003|Variable Treatment Period|Physician Decision|3|||
48869158|NCT03730662|157358934|FG000|Variable Treatment Period|Protocol Violation|0|||
48869159|NCT03730662|157358935|FG001|Variable Treatment Period|Protocol Violation|1|||
48869160|NCT03730662|157358936|FG002|Variable Treatment Period|Protocol Violation|1|||
48869161|NCT03730662|157358937|FG003|Variable Treatment Period|Protocol Violation|1|||
48869162|NCT03730662|157358934|FG000|Variable Treatment Period|Withdrawal by Subject|2|||
48869163|NCT03730662|157358935|FG001|Variable Treatment Period|Withdrawal by Subject|1|||
48869164|NCT03730662|157358936|FG002|Variable Treatment Period|Withdrawal by Subject|4|||
48869165|NCT03730662|157358937|FG003|Variable Treatment Period|Withdrawal by Subject|17|||
48869166|NCT03168425|157358942|FG000|Overall Study|Lost to Follow-up|5|||
48869167|NCT03168425|157358943|FG001|Overall Study|Lost to Follow-up|8|||
48869168|NCT03168425|157358942|FG000|Overall Study|unable to confirm post op opioids|2|||
48869169|NCT03168425|157358943|FG001|Overall Study|unable to confirm post op opioids|3|||
48869170|NCT04491006|157358944|FG000|Overall Study|Adverse Event|0|||
48668835|NCT02391961|156641405|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
48869171|NCT04491006|157358945|FG001|Overall Study|Adverse Event|3|||
48869172|NCT04491006|157358946|FG002|Overall Study|Adverse Event|5|||
48869173|NCT04491006|157358944|FG000|Overall Study|Withdrawal by Subject|1|||
48869174|NCT04491006|157358945|FG001|Overall Study|Withdrawal by Subject|0|||
48869175|NCT04491006|157358946|FG002|Overall Study|Withdrawal by Subject|2|||
48869176|NCT02166047|157358947|FG000|Overall Study|Withdrawal by Participant|0|||
48668836|NCT02391961|156641406|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
48869177|NCT02166047|157358948|FG001|Overall Study|Withdrawal by Participant|1|||
48869178|NCT02166047|157358949|FG002|Overall Study|Withdrawal by Participant|2|||
48869179|NCT02166047|157358950|FG003|Overall Study|Withdrawal by Participant|0|||
48869180|NCT02166047|157358951|FG004|Overall Study|Withdrawal by Participant|0|||
48869181|NCT02166047|157358952|FG005|Overall Study|Withdrawal by Participant|0|||
48869182|NCT02166047|157358953|FG006|Overall Study|Withdrawal by Participant|1|||
48668837|NCT02391961|156641405|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
48668838|NCT02391961|156641406|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
48668839|NCT00514020|156641407|FG000|Overall Study|Adverse Event|6|||
48668840|NCT00514020|156641407|FG000|Overall Study|Withdrawal by Subject|3|||
48668841|NCT00514020|156641407|FG000|Overall Study|Physician Decision|1|||
48668842|NCT00514020|156641407|FG000|Overall Study|disease progression|9|||
48869183|NCT02166047|157358954|FG007|Overall Study|Withdrawal by Participant|0|||
48668843|NCT00514020|156641407|FG000|Overall Study|other complicating disease|2|||
48668844|NCT00514020|156641407|FG000|Overall Study|patient went to radiation treatment|1|||
48668845|NCT00514020|156641407|FG000|Overall Study|"patients moved to the no tx group"|6|||
48668846|NCT02308488|156641411|FG000|Overall Study|Withdrawal by Subject|2|||
48668847|NCT02723175|156641412|FG000|Overall Study|Lost to 1 Month Follow Up|3|||
48668848|NCT02723175|156641413|FG001|Overall Study|Lost to 1 Month Follow Up|2|||
48668849|NCT02723175|156641412|FG000|Overall Study|Lost to 3 Month Follow Up|1|||
48668850|NCT02723175|156641413|FG001|Overall Study|Lost to 3 Month Follow Up|1|||
48668851|NCT02914561|156641418|FG000|Induction Study (Day 1 to Week 10)|Adverse Event|15|||
48668852|NCT02914561|156641419|FG001|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
48668853|NCT02914561|156641420|FG002|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
48668854|NCT02914561|156641421|FG003|Induction Study (Day 1 to Week 10)|Adverse Event|24|||
48668855|NCT02914561|156641422|FG004|Induction Study (Day 1 to Week 10)|Adverse Event|31|||
48668856|NCT02914561|156641423|FG005|Induction Study (Day 1 to Week 10)|Adverse Event|19|||
48668857|NCT02914561|156641424|FG006|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
48668858|NCT02914561|156641425|FG007|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
48668859|NCT02914561|156641426|FG008|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
48668860|NCT02914561|156641427|FG009|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
48668861|NCT02914561|156641428|FG010|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
48668862|NCT02914561|156641418|FG000|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|1|||
48668863|NCT02914561|156641419|FG001|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|9|||
48668864|NCT02914561|156641420|FG002|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|6|||
48668865|NCT02914561|156641421|FG003|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
48668866|NCT02914561|156641422|FG004|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|7|||
48668867|NCT02914561|156641423|FG005|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|12|||
48869184|NCT02166047|157358955|FG008|Overall Study|Withdrawal by Participant|0|||
48869185|NCT02166047|157358956|FG009|Overall Study|Withdrawal by Participant|0|||
48869186|NCT02166047|157358957|FG010|Overall Study|Withdrawal by Participant|0|||
48869187|NCT02166047|157358958|FG011|Overall Study|Withdrawal by Participant|0|||
48869188|NCT02166047|157358947|FG000|Overall Study|Adverse Event|0|||
48869189|NCT02166047|157358948|FG001|Overall Study|Adverse Event|0|||
48869190|NCT02166047|157358949|FG002|Overall Study|Adverse Event|0|||
48668868|NCT02914561|156641424|FG006|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
48869191|NCT02166047|157358950|FG003|Overall Study|Adverse Event|0|||
48869192|NCT02166047|157358951|FG004|Overall Study|Adverse Event|1|||
48869193|NCT02166047|157358952|FG005|Overall Study|Adverse Event|0|||
48869194|NCT02166047|157358953|FG006|Overall Study|Adverse Event|1|||
48869195|NCT02166047|157358954|FG007|Overall Study|Adverse Event|0|||
48869196|NCT02166047|157358955|FG008|Overall Study|Adverse Event|0|||
48869197|NCT02166047|157358956|FG009|Overall Study|Adverse Event|0|||
48869198|NCT02166047|157358957|FG010|Overall Study|Adverse Event|2|||
48869199|NCT02166047|157358958|FG011|Overall Study|Adverse Event|0|||
48869200|NCT01049984|157358966|FG000|Overall Study|Withdrawal by Subject|1|||
48869201|NCT01049984|157358967|FG001|Overall Study|Withdrawal by Subject|5|||
48869202|NCT01049984|157358966|FG000|Overall Study|Protocol Violation|3|||
48869203|NCT01049984|157358967|FG001|Overall Study|Protocol Violation|4|||
48869204|NCT01049984|157358966|FG000|Overall Study|Lost to Follow-up|2|||
48869205|NCT01049984|157358967|FG001|Overall Study|Lost to Follow-up|1|||
48869206|NCT01049984|157358966|FG000|Overall Study|Adverse Event|13|||
48869207|NCT01049984|157358967|FG001|Overall Study|Adverse Event|7|||
48869208|NCT01049984|157358966|FG000|Overall Study|Treatment failure|0|||
48869209|NCT01049984|157358967|FG001|Overall Study|Treatment failure|2|||
48869210|NCT02254681|157358968|FG000|Overall Study|Lack of Efficacy|6|||
48869211|NCT03461211|157358974|FG000|Overall Study|Adverse Event|1|||
48869212|NCT03461211|157358975|FG001|Overall Study|Adverse Event|1|||
48869213|NCT03461211|157358974|FG000|Overall Study|Lack of Efficacy|0|||
48869214|NCT03461211|157358975|FG001|Overall Study|Lack of Efficacy|1|||
48668869|NCT02914561|156641425|FG007|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
48668870|NCT02914561|156641426|FG008|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
48869215|NCT03807700|157358976|FG000|Overall Study|Withdrawal by Subject|2|||
48869216|NCT03807700|157358977|FG001|Overall Study|Withdrawal by Subject|1|||
48869217|NCT00053352|157358980|FG000|Overall Study|Lost to Follow-up|0|||
48759176|NCT02956486|156966355|FG000|Extension Phase|Study terminated by sponsor|0|||
48759177|NCT02956486|156966356|FG001|Extension Phase|Study terminated by sponsor|0|||
48759178|NCT02956486|156966357|FG002|Extension Phase|Study terminated by sponsor|16|||
48759179|NCT02956486|156966355|FG000|Extension Phase|Not Treated|0|||
48759180|NCT02956486|156966356|FG001|Extension Phase|Not Treated|0|||
48759181|NCT02956486|156966357|FG002|Extension Phase|Not Treated|1|||
48759182|NCT00720057|156966358|FG000|Overall Study|Lost to Follow-up|0|||
48759183|NCT00720057|156966359|FG001|Overall Study|Lost to Follow-up|2|||
48759184|NCT00720057|156966358|FG000|Overall Study|Protocol Violation|1|||
48759185|NCT00720057|156966359|FG001|Overall Study|Protocol Violation|0|||
48759186|NCT00720057|156966358|FG000|Overall Study|Withdrawal by Subject|0|||
48759187|NCT00720057|156966359|FG001|Overall Study|Withdrawal by Subject|1|||
48759188|NCT02062879|156966372|FG000|Overall Study|Withdrawal by Subject|4|||
48759189|NCT02062879|156966373|FG001|Overall Study|Withdrawal by Subject|1|||
48759190|NCT00322842|156966374|FG000|Overall Study|Withdrawal by Subject|0|||
48759191|NCT00322842|156966375|FG001|Overall Study|Withdrawal by Subject|1|||
48759192|NCT00322842|156966374|FG000|Overall Study|Lost to Follow-up|0|||
48759193|NCT00322842|156966375|FG001|Overall Study|Lost to Follow-up|1|||
48759194|NCT00322842|156966374|FG000|Overall Study|Refused transplant|1|||
48869218|NCT00053352|157358981|FG001|Overall Study|Lost to Follow-up|1|||
48869219|NCT00053352|157358980|FG000|Overall Study|Physician Decision|11|||
48869220|NCT00053352|157358981|FG001|Overall Study|Physician Decision|1|||
48869221|NCT00053352|157358980|FG000|Overall Study|Withdrawal by Subject|1|||
48869222|NCT00053352|157358981|FG001|Overall Study|Withdrawal by Subject|0|||
48869223|NCT00053352|157358980|FG000|Overall Study|Ineligible|8|||
48869224|NCT00053352|157358981|FG001|Overall Study|Ineligible|8|||
48869225|NCT00053352|157358980|FG000|Overall Study|Disease at new site|1|||
48869226|NCT00053352|157358981|FG001|Overall Study|Disease at new site|0|||
48869227|NCT02316847|157358983|FG000|Overall Study|Adverse Event|0|||
48869228|NCT02316847|157358984|FG001|Overall Study|Adverse Event|3|||
48869229|NCT02316847|157358983|FG000|Overall Study|Lost to Follow-up|0|||
48869230|NCT02316847|157358984|FG001|Overall Study|Lost to Follow-up|2|||
48869231|NCT02316847|157358983|FG000|Overall Study|Physician Decision|0|||
48869232|NCT02316847|157358984|FG001|Overall Study|Physician Decision|1|||
48869233|NCT02316847|157358983|FG000|Overall Study|Pregnancy|0|||
48869234|NCT02316847|157358984|FG001|Overall Study|Pregnancy|1|||
48869235|NCT02316847|157358983|FG000|Overall Study|Withdrawal by Subject|2|||
48968469|NCT00340834|157712541|FG004|Extension Phase of Study|Lost to Follow-up|3|||
48759195|NCT00322842|156966375|FG001|Overall Study|Refused transplant|0|||
48869236|NCT02316847|157358984|FG001|Overall Study|Withdrawal by Subject|9|||
48869237|NCT02316847|157358983|FG000|Overall Study|Noncompliance with study drug|0|||
48869238|NCT02316847|157358984|FG001|Overall Study|Noncompliance with study drug|3|||
48869239|NCT02316847|157358983|FG000|Overall Study|Withdrawn due to termination by Sponsor|7|||
48869240|NCT02316847|157358984|FG001|Overall Study|Withdrawn due to termination by Sponsor|67|||
48869241|NCT01370018|157358985|FG000|Overall Study|Did not meet criteria for analysis|1|||
48869242|NCT01525641|157358986|FG000|Overall Study|Case report form not collected|25|||
48869243|NCT01525641|157358986|FG000|Overall Study|No visit since the first visit|16|||
48869244|NCT01525641|157358986|FG000|Overall Study|Adverse Event|73|||
48869245|NCT01525641|157358986|FG000|Overall Study|Lack of Efficacy|24|||
48869246|NCT01525641|157358986|FG000|Overall Study|Improvement|5|||
48869247|NCT01525641|157358986|FG000|Overall Study|Lost to follow-up (relocation)|1|||
48869248|NCT01525641|157358986|FG000|Overall Study|Lost to follow-up (Unknown reason)|10|||
48869249|NCT01525641|157358986|FG000|Overall Study|Lost to follow-up (Changing hospital)|19|||
48869250|NCT01525641|157358986|FG000|Overall Study|Other than stated above|7|||
48869251|NCT02236598|157358994|FG000|Overall Study|Adverse Event|0|||
48869252|NCT02236598|157358995|FG001|Overall Study|Adverse Event|1|||
48869253|NCT02236598|157358994|FG000|Overall Study|Withdrawal by Subject|0|||
48869254|NCT02236598|157358995|FG001|Overall Study|Withdrawal by Subject|1|||
48869255|NCT03175198|157359003|FG000|Overall Study|Adverse Event|480|||
48869256|NCT03175198|157359003|FG000|Overall Study|No actual visit|120|||
48869257|NCT03175198|157359003|FG000|Overall Study|Registration rule not followed|4|||
48869258|NCT03175198|157359003|FG000|Overall Study|Patients received Prazaxa treatment before|5|||
48869259|NCT03175198|157359003|FG000|Overall Study|Other personal reason|509|||
48869260|NCT03175198|157359003|FG000|Overall Study|To take a contraindication/careful administration drug|8|||
48869261|NCT03175198|157359003|FG000|Overall Study|Lost to follow-up (changing hospital)|373|||
48869262|NCT03175198|157359003|FG000|Overall Study|Lost to follow-up (unknown reason)|146|||
48869263|NCT03175198|157359003|FG000|Overall Study|To conduct invasive treatment of operation|53|||
48869264|NCT03175198|157359003|FG000|Overall Study|Improvement of nonvalvular atrial fibrillation|629|||
48869265|NCT02201771|157359004|FG000|Overall Study|Death|3|||
48869266|NCT02201771|157359005|FG001|Overall Study|Death|2|||
48869267|NCT02201771|157359006|FG002|Overall Study|Death|0|||
48869268|NCT02201771|157359004|FG000|Overall Study|Protocol Violation|10|||
48869269|NCT02201771|157359005|FG001|Overall Study|Protocol Violation|8|||
48869270|NCT02201771|157359006|FG002|Overall Study|Protocol Violation|10|||
48869271|NCT01678898|157359008|FG000|PB-102-F01|Adverse Event|0|||
48759196|NCT00322842|156966374|FG000|Overall Study|Death|1|||
48759197|NCT00322842|156966375|FG001|Overall Study|Death|0|||
48869272|NCT01678898|157359009|FG001|PB-102-F01|Adverse Event|1|||
48869273|NCT01678898|157359010|FG002|PB-102-F01|Adverse Event|0|||
48869274|NCT01678898|157359008|FG000|PB-102-F01|Physician Decision|0|||
48869275|NCT01678898|157359009|FG001|PB-102-F01|Physician Decision|1|||
48869276|NCT01678898|157359010|FG002|PB-102-F01|Physician Decision|0|||
48869277|NCT00640042|157359011|FG000|Enrollment|Did not receive study drug|83|||
48869278|NCT04043806|157359012|FG000|Overall Study|Commercial drug is available for participants|13|||
48869279|NCT04043806|157359012|FG000|Overall Study|Physician Decision|2|||
48869280|NCT04043806|157359012|FG000|Overall Study|Other|12|||
48869281|NCT04043806|157359012|FG000|Overall Study|Adverse Event|2|||
48869282|NCT04043806|157359012|FG000|Overall Study|Lost to Follow-up|6|||
48869283|NCT04043806|157359012|FG000|Overall Study|Other non-compliance|2|||
48869284|NCT04043806|157359012|FG000|Overall Study|Withdrawal of Consent (not due to AE)|8|||
48869285|NCT04043806|157359012|FG000|Overall Study|Never Dosed|1|||
48869286|NCT02604342|157359016|FG000|Overall Study|Death|32|||
48869287|NCT02604342|157359017|FG001|Overall Study|Death|16|||
48869288|NCT02604342|157359016|FG000|Overall Study|Progression of disease|1|||
48869289|NCT02604342|157359017|FG001|Overall Study|Progression of disease|0|||
48869290|NCT02604342|157359016|FG000|Overall Study|Withdrawal by Subject|5|||
48869291|NCT02604342|157359017|FG001|Overall Study|Withdrawal by Subject|6|||
48869292|NCT02604342|157359016|FG000|Overall Study|Other|1|||
48869293|NCT02604342|157359017|FG001|Overall Study|Other|0|||
48869294|NCT02604342|157359016|FG000|Overall Study|Study Termination by Sponsor|1|||
48869295|NCT02604342|157359017|FG001|Overall Study|Study Termination by Sponsor|0|||
48869296|NCT02604342|157359016|FG000|Overall Study|Lost to Follow-up|1|||
48869297|NCT02604342|157359017|FG001|Overall Study|Lost to Follow-up|1|||
48869298|NCT02604342|157359016|FG000|Overall Study|Physician Decision|2|||
48869299|NCT02604342|157359017|FG001|Overall Study|Physician Decision|0|||
48869300|NCT02261285|157359018|FG000|Overall Study|Disease progression|0|||
48869301|NCT02261285|157359019|FG001|Overall Study|Disease progression|0|||
48869302|NCT02261285|157359020|FG002|Overall Study|Disease progression|1|||
48869303|NCT01560585|157359023|FG000|Overall Study|Physician Decision|3|||
48869304|NCT01363297|157359026|FG000|Overall Study|Other|0|||
48869305|NCT01363297|157359027|FG001|Overall Study|Other|0|||
48869306|NCT01363297|157359028|FG002|Overall Study|Other|0|||
48869307|NCT01363297|157359029|FG003|Overall Study|Other|0|||
48869308|NCT01363297|157359030|FG004|Overall Study|Other|1|||
48869309|NCT01363297|157359026|FG000|Overall Study|Death|3|||
48869310|NCT01363297|157359027|FG001|Overall Study|Death|6|||
48869311|NCT01363297|157359028|FG002|Overall Study|Death|6|||
48869312|NCT01363297|157359029|FG003|Overall Study|Death|10|||
48869313|NCT01363297|157359030|FG004|Overall Study|Death|30|||
48869314|NCT01705145|157359033|FG000|Part B|Adverse Event|1|||
48869315|NCT01203956|157359034|FG000|Second Two-week Period|Non-compliant: no evaluable results|5|||
48869316|NCT01203956|157359035|FG001|Second Two-week Period|Non-compliant: no evaluable results|6|||
48869317|NCT02269917|157359036|FG000|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|25|||
48869318|NCT02269917|157359037|FG001|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|7|||
48869319|NCT02269917|157359038|FG002|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|0|||
48869320|NCT02269917|157359036|FG000|BL to EOE-Test and BL to Switch-Control|Other|19|||
48869321|NCT02269917|157359037|FG001|BL to EOE-Test and BL to Switch-Control|Other|4|||
48869322|NCT02269917|157359038|FG002|BL to EOE-Test and BL to Switch-Control|Other|0|||
48869323|NCT02269917|157359036|FG000|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|32|||
48869324|NCT02269917|157359037|FG001|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|10|||
48869325|NCT02269917|157359038|FG002|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|0|||
48869326|NCT02269917|157359036|FG000|BL to EOE-Test and BL to Switch-Control|Adverse Event|24|||
48869327|NCT02269917|157359037|FG001|BL to EOE-Test and BL to Switch-Control|Adverse Event|4|||
48869328|NCT02269917|157359038|FG002|BL to EOE-Test and BL to Switch-Control|Adverse Event|0|||
48869329|NCT02269917|157359036|FG000|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|4|||
48869330|NCT02269917|157359037|FG001|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
48869331|NCT02269917|157359038|FG002|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
48869332|NCT02269917|157359036|FG000|BL to EOE-Test and BL to Switch-Control|Physician Decision|4|||
48869333|NCT02269917|157359037|FG001|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
48869334|NCT02269917|157359038|FG002|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
48869335|NCT02269917|157359036|FG000|BL to EOE-Test and BL to Switch-Control|Protocol Violation|2|||
48869336|NCT02269917|157359037|FG001|BL to EOE-Test and BL to Switch-Control|Protocol Violation|1|||
48869337|NCT02269917|157359038|FG002|BL to EOE-Test and BL to Switch-Control|Protocol Violation|0|||
48869338|NCT02269917|157359036|FG000|BL to EOE-Test and BL to Switch-Control|Death|4|||
48869339|NCT02269917|157359037|FG001|BL to EOE-Test and BL to Switch-Control|Death|0|||
48869340|NCT02269917|157359038|FG002|BL to EOE-Test and BL to Switch-Control|Death|0|||
48869341|NCT02269917|157359036|FG000|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|3|||
48869342|NCT02269917|157359037|FG001|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|5|||
48869343|NCT02269917|157359038|FG002|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|0|||
48869344|NCT02269917|157359036|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
48668871|NCT02914561|156641427|FG009|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
48668872|NCT02914561|156641428|FG010|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
48668873|NCT02914561|156641418|FG000|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
48668874|NCT02914561|156641419|FG001|Induction Study (Day 1 to Week 10)|Protocol Violation|4|||
48668875|NCT02914561|156641420|FG002|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
48668876|NCT02914561|156641421|FG003|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
48668877|NCT02914561|156641422|FG004|Induction Study (Day 1 to Week 10)|Protocol Violation|3|||
48668878|NCT02914561|156641423|FG005|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
48668879|NCT02914561|156641424|FG006|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
48668880|NCT02914561|156641425|FG007|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
48668881|NCT02914561|156641426|FG008|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
48869345|NCT02269917|157359037|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
48869346|NCT02269917|157359038|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
48869347|NCT02269917|157359036|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
48869348|NCT02269917|157359037|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
48869349|NCT02269917|157359038|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|10|||
48869350|NCT02269917|157359036|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
48869351|NCT02269917|157359037|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
48869352|NCT02269917|157359038|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|11|||
48869353|NCT02269917|157359036|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
48869354|NCT02269917|157359037|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
48869355|NCT02269917|157359038|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
48869356|NCT02269917|157359036|FG000|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
48869357|NCT02269917|157359037|FG001|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
48869358|NCT02269917|157359038|FG002|Switch to D/C/F/TAF (Until EOE)|Pregnancy|2|||
48869359|NCT02269917|157359036|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
48869360|NCT02269917|157359037|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
48869361|NCT02269917|157359038|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|5|||
48869362|NCT02269917|157359036|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
48869363|NCT02269917|157359037|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
48869364|NCT02269917|157359038|FG002|Switch to D/C/F/TAF (Until EOE)|Other|8|||
48869365|NCT02383927|157359039|FG000|Overall Study|Disease Progression|8|||
48869366|NCT02383927|157359040|FG001|Overall Study|Disease Progression|8|||
48869367|NCT02383927|157359041|FG002|Overall Study|Disease Progression|15|||
48869368|NCT02383927|157359042|FG003|Overall Study|Disease Progression|4|||
48869369|NCT02383927|157359039|FG000|Overall Study|Physician Decision|0|||
48869370|NCT02383927|157359040|FG001|Overall Study|Physician Decision|0|||
48869371|NCT02383927|157359041|FG002|Overall Study|Physician Decision|2|||
48869372|NCT02383927|157359042|FG003|Overall Study|Physician Decision|0|||
48869373|NCT02383927|157359039|FG000|Overall Study|Termination by Symptomatic Deterioration|0|||
48869374|NCT02383927|157359040|FG001|Overall Study|Termination by Symptomatic Deterioration|0|||
48869375|NCT02383927|157359041|FG002|Overall Study|Termination by Symptomatic Deterioration|6|||
48869376|NCT02383927|157359042|FG003|Overall Study|Termination by Symptomatic Deterioration|0|||
48869377|NCT02383927|157359039|FG000|Overall Study|Adverse Event|4|||
48869378|NCT02383927|157359040|FG001|Overall Study|Adverse Event|1|||
48869379|NCT02383927|157359041|FG002|Overall Study|Adverse Event|3|||
48869380|NCT02383927|157359042|FG003|Overall Study|Adverse Event|5|||
48869381|NCT02383927|157359039|FG000|Overall Study|Miscellaneous|1|||
48869382|NCT02383927|157359040|FG001|Overall Study|Miscellaneous|0|||
48869383|NCT02383927|157359041|FG002|Overall Study|Miscellaneous|0|||
48869384|NCT02383927|157359042|FG003|Overall Study|Miscellaneous|1|||
48869385|NCT02383927|157359039|FG000|Overall Study|Withdrawal by Subject|0|||
48869386|NCT02383927|157359040|FG001|Overall Study|Withdrawal by Subject|1|||
48869387|NCT02383927|157359041|FG002|Overall Study|Withdrawal by Subject|4|||
48869388|NCT02383927|157359042|FG003|Overall Study|Withdrawal by Subject|0|||
48869389|NCT01184859|157360565|FG000|Period 1: Single Dose|Insufficient urine production|0|||
48869390|NCT01184859|157360566|FG001|Period 1: Single Dose|Insufficient urine production|1|||
48869391|NCT01184859|157360567|FG002|Period 1: Single Dose|Insufficient urine production|0|||
48869392|NCT01184859|157360568|FG003|Period 1: Single Dose|Insufficient urine production|0|||
48869393|NCT01184859|157360569|FG004|Period 1: Single Dose|Insufficient urine production|0|||
48869394|NCT01184859|157360565|FG000|Period 1: Single Dose|Protocol Violation|0|||
48869395|NCT01184859|157360566|FG001|Period 1: Single Dose|Protocol Violation|1|||
48869396|NCT01184859|157360567|FG002|Period 1: Single Dose|Protocol Violation|0|||
48869397|NCT01184859|157360568|FG003|Period 1: Single Dose|Protocol Violation|0|||
48869398|NCT01184859|157360569|FG004|Period 1: Single Dose|Protocol Violation|0|||
48869399|NCT01184859|157360565|FG000|Period 1: Single Dose|Adverse Event|0|||
48869400|NCT01184859|157360566|FG001|Period 1: Single Dose|Adverse Event|0|||
48869401|NCT01184859|157360567|FG002|Period 1: Single Dose|Adverse Event|0|||
48869402|NCT01184859|157360568|FG003|Period 1: Single Dose|Adverse Event|0|||
48869403|NCT01184859|157360569|FG004|Period 1: Single Dose|Adverse Event|1|||
48869404|NCT01184859|157360565|FG000|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
48869405|NCT01184859|157360566|FG001|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
48869406|NCT01184859|157360567|FG002|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
48869407|NCT01184859|157360568|FG003|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
48869408|NCT01184859|157360569|FG004|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1|||
48869409|NCT01184859|157360565|FG000|Period 2: Daily Dose for 28 Days|Adverse Event|1|||
48869410|NCT01184859|157360566|FG001|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
48869411|NCT01184859|157360567|FG002|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
48869412|NCT01184859|157360568|FG003|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
48869413|NCT01184859|157360569|FG004|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
48869414|NCT00796614|157360573|FG000|Overall Study|Adverse Event|1|||
48869415|NCT00796614|157360574|FG001|Overall Study|Adverse Event|2|||
48869416|NCT00796614|157360575|FG002|Overall Study|Adverse Event|0|||
48869417|NCT00796614|157360576|FG003|Overall Study|Adverse Event|0|||
48869418|NCT00796614|157360573|FG000|Overall Study|Protocol Violation|0|||
48869419|NCT00796614|157360574|FG001|Overall Study|Protocol Violation|0|||
48869420|NCT00796614|157360575|FG002|Overall Study|Protocol Violation|2|||
48869421|NCT00796614|157360576|FG003|Overall Study|Protocol Violation|0|||
48869422|NCT00796614|157360573|FG000|Overall Study|Lost to Follow-up|2|||
48869423|NCT00796614|157360574|FG001|Overall Study|Lost to Follow-up|2|||
48759198|NCT01412021|156966376|FG000|Overall Study|Case Report Forms Not Retrieved|7|||
48759199|NCT01412021|156966376|FG000|Overall Study|Treatment Prior to Approval|3|||
48759200|NCT01412021|156966376|FG000|Overall Study|Transferred to Other Hospital|9|||
48759201|NCT02221284|156966377|FG000|Overall Study|Case Report Forms Uncollected|56|||
48759202|NCT02221284|156966377|FG000|Overall Study|Protocol Deviation|5|||
48759203|NCT01466387|156966378|FG000|Overall Study|Adverse Event|0|||
48759204|NCT01466387|156966379|FG001|Overall Study|Adverse Event|0|||
48759205|NCT01466387|156966380|FG002|Overall Study|Adverse Event|1|||
48759206|NCT01466387|156966381|FG003|Overall Study|Adverse Event|1|||
48759207|NCT01466387|156966382|FG004|Overall Study|Adverse Event|0|||
48759208|NCT01466387|156966383|FG005|Overall Study|Adverse Event|0|||
48759209|NCT01466387|156966378|FG000|Overall Study|Lost to Follow-up|0|||
48759210|NCT01466387|156966379|FG001|Overall Study|Lost to Follow-up|0|||
48759211|NCT01466387|156966380|FG002|Overall Study|Lost to Follow-up|0|||
48869424|NCT00796614|157360575|FG002|Overall Study|Lost to Follow-up|1|||
48869425|NCT00796614|157360576|FG003|Overall Study|Lost to Follow-up|0|||
48869426|NCT00796614|157360573|FG000|Overall Study|Withdrawal by Subject|1|||
48869427|NCT00796614|157360574|FG001|Overall Study|Withdrawal by Subject|0|||
48869428|NCT00796614|157360575|FG002|Overall Study|Withdrawal by Subject|0|||
48869429|NCT00796614|157360576|FG003|Overall Study|Withdrawal by Subject|1|||
48869430|NCT00796614|157360573|FG000|Overall Study|Other than stated|1|||
48869431|NCT00796614|157360574|FG001|Overall Study|Other than stated|0|||
48869432|NCT00796614|157360575|FG002|Overall Study|Other than stated|0|||
48869433|NCT00796614|157360576|FG003|Overall Study|Other than stated|0|||
48869434|NCT00509821|157360577|FG000|Study Period 1 (Induction)|Death|0|||
48869435|NCT00509821|157360578|FG001|Study Period 1 (Induction)|Death|1|||
48869436|NCT00509821|157360577|FG000|Study Period 1 (Induction)|Adverse Event|0|||
48869437|NCT00509821|157360578|FG001|Study Period 1 (Induction)|Adverse Event|2|||
48869438|NCT00509821|157360577|FG000|Study Period 1 (Induction)|Progressive Disease|0|||
48869439|NCT00509821|157360578|FG001|Study Period 1 (Induction)|Progressive Disease|1|||
48869440|NCT00560313|157360579|FG000|Overall Study|Adverse Events or Death|2|||
48869441|NCT00560313|157360579|FG000|Overall Study|Withdrawal by Subject|2|||
48869442|NCT00560313|157360579|FG000|Overall Study|Lost to Follow-up|1|||
48869443|NCT00560313|157360579|FG000|Overall Study|Protocol Violation|1|||
48869444|NCT03449134|157360580|FG000|52-Week Treatment Period|Death|2|||
48869445|NCT03449134|157360581|FG001|52-Week Treatment Period|Death|1|||
48869446|NCT03449134|157360582|FG002|52-Week Treatment Period|Death|0|||
48869447|NCT03449134|157360580|FG000|52-Week Treatment Period|Lost to Follow-up|2|||
48869448|NCT03449134|157360581|FG001|52-Week Treatment Period|Lost to Follow-up|1|||
48869449|NCT03449134|157360582|FG002|52-Week Treatment Period|Lost to Follow-up|1|||
48869450|NCT03449134|157360580|FG000|52-Week Treatment Period|Physician Decision|2|||
48869451|NCT03449134|157360581|FG001|52-Week Treatment Period|Physician Decision|3|||
48869452|NCT03449134|157360582|FG002|52-Week Treatment Period|Physician Decision|3|||
48869453|NCT03449134|157360580|FG000|52-Week Treatment Period|Screen Failure|1|||
48869454|NCT03449134|157360581|FG001|52-Week Treatment Period|Screen Failure|0|||
48869455|NCT03449134|157360582|FG002|52-Week Treatment Period|Screen Failure|1|||
48869456|NCT03449134|157360580|FG000|52-Week Treatment Period|Withdrawal by Subject|37|||
48869457|NCT03449134|157360581|FG001|52-Week Treatment Period|Withdrawal by Subject|39|||
48869458|NCT03449134|157360582|FG002|52-Week Treatment Period|Withdrawal by Subject|55|||
48759212|NCT01466387|156966381|FG003|Overall Study|Lost to Follow-up|0|||
48759213|NCT01466387|156966382|FG004|Overall Study|Lost to Follow-up|0|||
48759214|NCT01466387|156966383|FG005|Overall Study|Lost to Follow-up|1|||
48759215|NCT01466387|156966378|FG000|Overall Study|Protocol Violation|1|||
48759216|NCT01466387|156966379|FG001|Overall Study|Protocol Violation|0|||
48869459|NCT03449134|157360580|FG000|52-Week Treatment Period|Site Closure|1|||
48869460|NCT03449134|157360581|FG001|52-Week Treatment Period|Site Closure|0|||
48869461|NCT03449134|157360582|FG002|52-Week Treatment Period|Site Closure|0|||
48869462|NCT02514577|157360585|FG000|Overall Study|Lost to Follow-up|6|||
48869463|NCT02514577|157360586|FG001|Overall Study|Lost to Follow-up|6|||
48869464|NCT02514577|157360585|FG000|Overall Study|Protocol Violation|1|||
48869465|NCT02514577|157360586|FG001|Overall Study|Protocol Violation|0|||
48759217|NCT01466387|156966380|FG002|Overall Study|Protocol Violation|0|||
48869466|NCT02514577|157360585|FG000|Overall Study|Withdrawal by Subject|6|||
48869467|NCT02514577|157360586|FG001|Overall Study|Withdrawal by Subject|6|||
48869468|NCT02514577|157360585|FG000|Overall Study|Adverse Event|1|||
48869469|NCT02514577|157360586|FG001|Overall Study|Adverse Event|1|||
48869470|NCT01960348|157360587|FG000|Overall Study|Adverse event, not serious|2|||
48869471|NCT01960348|157360588|FG001|Overall Study|Adverse event, not serious|2|||
48869472|NCT01960348|157360587|FG000|Overall Study|Adverse event, serious fatal|6|||
48869473|NCT01960348|157360588|FG001|Overall Study|Adverse event, serious fatal|5|||
48759218|NCT01466387|156966381|FG003|Overall Study|Protocol Violation|1|||
48759219|NCT01466387|156966382|FG004|Overall Study|Protocol Violation|0|||
48869474|NCT01960348|157360587|FG000|Overall Study|Adverse event, serious non-fatal|0|||
48869475|NCT01960348|157360588|FG001|Overall Study|Adverse event, serious non-fatal|3|||
48869476|NCT01960348|157360587|FG000|Overall Study|Withdrawal by Subject|1|||
48869477|NCT01960348|157360588|FG001|Overall Study|Withdrawal by Subject|11|||
48869478|NCT01960348|157360587|FG000|Overall Study|Physician Decision|0|||
48869479|NCT01960348|157360588|FG001|Overall Study|Physician Decision|1|||
48869480|NCT01960348|157360587|FG000|Overall Study|Protocol Violation|1|||
48869481|NCT01960348|157360588|FG001|Overall Study|Protocol Violation|0|||
48869482|NCT04357964|157360589|FG000|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|5|||
48869483|NCT04357964|157360590|FG001|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|0|||
48869484|NCT04357964|157360589|FG000|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|13|||
48869485|NCT04357964|157360590|FG001|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|0|||
48869486|NCT04357964|157360589|FG000|Overall Study|Adipose sample was insufficient quality|0|||
48869487|NCT04357964|157360590|FG001|Overall Study|Adipose sample was insufficient quality|1|||
48869488|NCT00766142|157360591|FG000|Overall Study|Protocol Violation|4|||
48869489|NCT00349622|157360594|FG000|Overall Study|Death|168|||
48869490|NCT00349622|157360595|FG001|Overall Study|Death|86|||
48759220|NCT01466387|156966383|FG005|Overall Study|Protocol Violation|0|||
48759221|NCT01675128|156966384|FG000|Overall Study|Disease progression on study|1|||
48759222|NCT01675128|156966385|FG001|Overall Study|Disease progression on study|1|||
48759223|NCT01675128|156966386|FG002|Overall Study|Disease progression on study|1|||
48759224|NCT01675128|156966384|FG000|Overall Study|Refused further treatment|1|||
48869491|NCT00349622|157360594|FG000|Overall Study|Lost to Follow-up|5|||
48869492|NCT00349622|157360595|FG001|Overall Study|Lost to Follow-up|1|||
48869493|NCT00349622|157360594|FG000|Overall Study|Withdrawal by Subject|5|||
48869494|NCT00349622|157360595|FG001|Overall Study|Withdrawal by Subject|9|||
48869495|NCT02151643|157360596|FG000|Overall Study|Adverse Event|2|||
48869496|NCT02151643|157360597|FG001|Overall Study|Adverse Event|0|||
48869497|NCT02151643|157360598|FG002|Overall Study|Adverse Event|1|||
48869498|NCT02151643|157360599|FG003|Overall Study|Adverse Event|4|||
48869499|NCT02151643|157360600|FG004|Overall Study|Adverse Event|0|||
48869500|NCT02151643|157360596|FG000|Overall Study|Withdrawal by Subject|0|||
48869501|NCT02151643|157360597|FG001|Overall Study|Withdrawal by Subject|1|||
48869502|NCT02151643|157360598|FG002|Overall Study|Withdrawal by Subject|1|||
48869503|NCT02151643|157360599|FG003|Overall Study|Withdrawal by Subject|1|||
48869504|NCT02151643|157360600|FG004|Overall Study|Withdrawal by Subject|1|||
48759225|NCT01675128|156966385|FG001|Overall Study|Refused further treatment|0|||
48869505|NCT02151643|157360596|FG000|Overall Study|Hyperphosphataemia|1|||
48869506|NCT02151643|157360597|FG001|Overall Study|Hyperphosphataemia|0|||
48869507|NCT02151643|157360598|FG002|Overall Study|Hyperphosphataemia|0|||
48869508|NCT02151643|157360599|FG003|Overall Study|Hyperphosphataemia|0|||
48759226|NCT01675128|156966386|FG002|Overall Study|Refused further treatment|0|||
48759227|NCT01675128|156966384|FG000|Overall Study|Pulmonary complication; off study|0|||
48759228|NCT01675128|156966385|FG001|Overall Study|Pulmonary complication; off study|1|||
48759229|NCT01675128|156966386|FG002|Overall Study|Pulmonary complication; off study|0|||
48869509|NCT02151643|157360600|FG004|Overall Study|Hyperphosphataemia|1|||
48869510|NCT02151643|157360596|FG000|Overall Study|High Ferritin levels|3|||
48869511|NCT02151643|157360597|FG001|Overall Study|High Ferritin levels|3|||
48869512|NCT02151643|157360598|FG002|Overall Study|High Ferritin levels|2|||
48869513|NCT02151643|157360599|FG003|Overall Study|High Ferritin levels|2|||
48869514|NCT02151643|157360600|FG004|Overall Study|High Ferritin levels|1|||
48869515|NCT00460564|157360603|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
48869516|NCT00460564|157360604|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|1|||
48759230|NCT00945009|156966387|FG000|Overall Study|Lack of Efficacy|10|||
48759231|NCT00945009|156966388|FG001|Overall Study|Lack of Efficacy|0|||
48869517|NCT00460564|157360605|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
48869518|NCT00460564|157360606|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
48869519|NCT00460564|157360607|FG004|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
48869520|NCT00460564|157360608|FG005|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
48869521|NCT00460564|157360609|FG006|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
48759232|NCT00945009|156966389|FG002|Overall Study|Lack of Efficacy|0|||
48759233|NCT00945009|156966387|FG000|Overall Study|Physician Decision|21|||
48759234|NCT00945009|156966388|FG001|Overall Study|Physician Decision|4|||
48759235|NCT00945009|156966389|FG002|Overall Study|Physician Decision|3|||
48759236|NCT00945009|156966387|FG000|Overall Study|Protocol Violation|6|||
48759237|NCT00945009|156966388|FG001|Overall Study|Protocol Violation|1|||
48759238|NCT00945009|156966389|FG002|Overall Study|Protocol Violation|0|||
48759239|NCT00945009|156966387|FG000|Overall Study|Withdrawal by Subject|1|||
48759240|NCT00945009|156966388|FG001|Overall Study|Withdrawal by Subject|0|||
48759241|NCT00945009|156966389|FG002|Overall Study|Withdrawal by Subject|0|||
48759242|NCT00945009|156966387|FG000|Overall Study|Ineligible|6|||
48759243|NCT00945009|156966388|FG001|Overall Study|Ineligible|1|||
48759244|NCT00945009|156966389|FG002|Overall Study|Ineligible|0|||
48759245|NCT00945009|156966387|FG000|Overall Study|Inevaluable|0|||
48759246|NCT00945009|156966388|FG001|Overall Study|Inevaluable|1|||
48759247|NCT00945009|156966389|FG002|Overall Study|Inevaluable|0|||
48759248|NCT00945009|156966387|FG000|Overall Study|Refusal of further protocol|1|||
48759249|NCT00945009|156966388|FG001|Overall Study|Refusal of further protocol|0|||
48759250|NCT00945009|156966389|FG002|Overall Study|Refusal of further protocol|0|||
48759251|NCT00832585|156966390|FG000|Overall Study|Withdrawal by Subject|1|||
48759252|NCT00832585|156966390|FG000|Overall Study|Lost to Follow-up|1|||
48759253|NCT03560531|156966391|FG000|Overall Study|Death|4|||
48759254|NCT03560531|156966392|FG001|Overall Study|Death|1|||
48759255|NCT03560531|156966393|FG002|Overall Study|Death|1|||
48759256|NCT03560531|156966394|FG003|Overall Study|Death|2|||
48759257|NCT03560531|156966395|FG004|Overall Study|Death|6|||
48759258|NCT03560531|156966396|FG005|Overall Study|Death|1|||
48759259|NCT03560531|156966397|FG006|Overall Study|Death|4|||
48759260|NCT03560531|156966398|FG007|Overall Study|Death|8|||
48759261|NCT03560531|156966399|FG008|Overall Study|Death|1|||
48759262|NCT03560531|156966400|FG009|Overall Study|Death|3|||
48759263|NCT03560531|156966401|FG010|Overall Study|Death|2|||
48759264|NCT03560531|156966402|FG011|Overall Study|Death|0|||
48759265|NCT03560531|156966403|FG012|Overall Study|Death|4|||
48759266|NCT03560531|156966404|FG013|Overall Study|Death|1|||
48759267|NCT03560531|156966391|FG000|Overall Study|Lost to Follow-up|1|||
48759268|NCT03560531|156966392|FG001|Overall Study|Lost to Follow-up|1|||
48759269|NCT03560531|156966393|FG002|Overall Study|Lost to Follow-up|0|||
48759270|NCT03560531|156966394|FG003|Overall Study|Lost to Follow-up|0|||
48759271|NCT03560531|156966395|FG004|Overall Study|Lost to Follow-up|0|||
48759272|NCT03560531|156966396|FG005|Overall Study|Lost to Follow-up|0|||
48759273|NCT03560531|156966397|FG006|Overall Study|Lost to Follow-up|1|||
48759274|NCT03560531|156966398|FG007|Overall Study|Lost to Follow-up|0|||
48759275|NCT03560531|156966399|FG008|Overall Study|Lost to Follow-up|0|||
48759276|NCT03560531|156966400|FG009|Overall Study|Lost to Follow-up|0|||
48759277|NCT03560531|156966401|FG010|Overall Study|Lost to Follow-up|0|||
48759278|NCT03560531|156966402|FG011|Overall Study|Lost to Follow-up|0|||
48759279|NCT03560531|156966403|FG012|Overall Study|Lost to Follow-up|0|||
48759280|NCT03560531|156966404|FG013|Overall Study|Lost to Follow-up|0|||
48759281|NCT03560531|156966391|FG000|Overall Study|Withdrawal by Subject|1|||
48759282|NCT03560531|156966392|FG001|Overall Study|Withdrawal by Subject|0|||
48759283|NCT03560531|156966393|FG002|Overall Study|Withdrawal by Subject|0|||
48759284|NCT03560531|156966394|FG003|Overall Study|Withdrawal by Subject|0|||
48759285|NCT03560531|156966395|FG004|Overall Study|Withdrawal by Subject|0|||
48759286|NCT03560531|156966396|FG005|Overall Study|Withdrawal by Subject|0|||
48869522|NCT00460564|157360610|FG007|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
48869523|NCT00460564|157360603|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1|||
48869524|NCT00460564|157360604|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
48869525|NCT00460564|157360605|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
48869526|NCT00460564|157360606|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
48869527|NCT00460564|157360607|FG004|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
48869528|NCT00460564|157360608|FG005|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
48869529|NCT00460564|157360609|FG006|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
48869530|NCT00460564|157360610|FG007|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
48869531|NCT00460564|157360603|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
48869532|NCT00460564|157360604|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
48869533|NCT00460564|157360605|FG002|Open-Label Phase (36 Weeks)|Adverse Event|0|||
48869534|NCT00460564|157360606|FG003|Open-Label Phase (36 Weeks)|Adverse Event|0|||
49015479|NCT01393990|157893775|FG005|Overall Study|Death|0|||
48759287|NCT03560531|156966397|FG006|Overall Study|Withdrawal by Subject|0|||
48759288|NCT03560531|156966398|FG007|Overall Study|Withdrawal by Subject|3|||
48759289|NCT03560531|156966399|FG008|Overall Study|Withdrawal by Subject|2|||
48759290|NCT03560531|156966400|FG009|Overall Study|Withdrawal by Subject|0|||
48759291|NCT03560531|156966401|FG010|Overall Study|Withdrawal by Subject|0|||
48759292|NCT03560531|156966402|FG011|Overall Study|Withdrawal by Subject|0|||
48759293|NCT03560531|156966403|FG012|Overall Study|Withdrawal by Subject|2|||
48759294|NCT03560531|156966404|FG013|Overall Study|Withdrawal by Subject|0|||
48759295|NCT03560531|156966391|FG000|Overall Study|Study end per-protocol|1|||
48759296|NCT03560531|156966392|FG001|Overall Study|Study end per-protocol|1|||
48869535|NCT00460564|157360607|FG004|Open-Label Phase (36 Weeks)|Adverse Event|3|||
48869536|NCT00460564|157360608|FG005|Open-Label Phase (36 Weeks)|Adverse Event|5|||
48869537|NCT00460564|157360609|FG006|Open-Label Phase (36 Weeks)|Adverse Event|2|||
48869538|NCT00460564|157360610|FG007|Open-Label Phase (36 Weeks)|Adverse Event|0|||
48869539|NCT00460564|157360603|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
48869540|NCT00460564|157360604|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
48869541|NCT00460564|157360605|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
48869542|NCT00460564|157360606|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
48869543|NCT00460564|157360607|FG004|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5|||
48869544|NCT00460564|157360608|FG005|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1|||
48869545|NCT00460564|157360609|FG006|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
48869546|NCT00460564|157360610|FG007|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
48869547|NCT00460564|157360603|FG000|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
48869548|NCT00460564|157360604|FG001|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
48869549|NCT00460564|157360605|FG002|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
48869550|NCT00460564|157360606|FG003|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
48869551|NCT00460564|157360607|FG004|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1|||
48869552|NCT00460564|157360608|FG005|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
48869553|NCT00460564|157360609|FG006|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
48869554|NCT00460564|157360610|FG007|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
48869555|NCT01990313|157360613|FG000|Overall Study|Lost to Follow-up|1|||
48869556|NCT03511378|157360614|FG000|Overall Study|Withdrawal by Subject|2|||
48869557|NCT03511378|157360615|FG001|Overall Study|Withdrawal by Subject|2|||
48869558|NCT03511378|157360614|FG000|Overall Study|Patient not coming or schedule visit|1|||
48869559|NCT03511378|157360615|FG001|Overall Study|Patient not coming or schedule visit|0|||
48869560|NCT00730847|157360616|FG000|Overall Study|Adverse Event|1|||
48869561|NCT00730847|157360616|FG000|Overall Study|Protocol Violation|2|||
48869562|NCT00730847|157360616|FG000|Overall Study|Withdrawal by Subject|16|||
48869563|NCT00730847|157360616|FG000|Overall Study|Lost to Follow-up|67|||
48869564|NCT00730847|157360616|FG000|Overall Study|Unknown completion status|21|||
48869565|NCT00730847|157360616|FG000|Overall Study|Other|24|||
48869566|NCT02330562|157360624|FG000|Overall Study|Adverse Event|0|||
48869567|NCT02330562|157360625|FG001|Overall Study|Adverse Event|0|||
48869568|NCT02330562|157360626|FG002|Overall Study|Adverse Event|3|||
48869569|NCT02330562|157360627|FG003|Overall Study|Adverse Event|0|||
48869570|NCT02330562|157360628|FG004|Overall Study|Adverse Event|3|||
48869571|NCT02330562|157360629|FG005|Overall Study|Adverse Event|1|||
48869572|NCT02330562|157360630|FG006|Overall Study|Adverse Event|0|||
48869573|NCT02330562|157360631|FG007|Overall Study|Adverse Event|0|||
48869574|NCT02330562|157360632|FG008|Overall Study|Adverse Event|0|||
48869575|NCT02330562|157360633|FG009|Overall Study|Adverse Event|1|||
48869576|NCT02330562|157360634|FG010|Overall Study|Adverse Event|1|||
48869577|NCT02330562|157360624|FG000|Overall Study|Participant decision|1|||
48869578|NCT02330562|157360625|FG001|Overall Study|Participant decision|0|||
48869579|NCT02330562|157360626|FG002|Overall Study|Participant decision|4|||
48869580|NCT02330562|157360627|FG003|Overall Study|Participant decision|1|||
48869581|NCT02330562|157360628|FG004|Overall Study|Participant decision|5|||
48869582|NCT02330562|157360629|FG005|Overall Study|Participant decision|2|||
48869583|NCT02330562|157360630|FG006|Overall Study|Participant decision|0|||
48869584|NCT02330562|157360631|FG007|Overall Study|Participant decision|0|||
48869585|NCT02330562|157360632|FG008|Overall Study|Participant decision|0|||
48869586|NCT02330562|157360633|FG009|Overall Study|Participant decision|3|||
48869587|NCT02330562|157360634|FG010|Overall Study|Participant decision|0|||
48869588|NCT02330562|157360624|FG000|Overall Study|Disease progression|5|||
48869589|NCT02330562|157360625|FG001|Overall Study|Disease progression|3|||
48869590|NCT02330562|157360626|FG002|Overall Study|Disease progression|20|||
48869591|NCT02330562|157360627|FG003|Overall Study|Disease progression|28|||
48869592|NCT02330562|157360628|FG004|Overall Study|Disease progression|23|||
48869593|NCT02330562|157360629|FG005|Overall Study|Disease progression|7|||
48869594|NCT02330562|157360630|FG006|Overall Study|Disease progression|1|||
48869595|NCT02330562|157360631|FG007|Overall Study|Disease progression|1|||
48869596|NCT02330562|157360632|FG008|Overall Study|Disease progression|1|||
48869597|NCT02330562|157360633|FG009|Overall Study|Disease progression|0|||
48869598|NCT02330562|157360634|FG010|Overall Study|Disease progression|5|||
48869599|NCT02330562|157360624|FG000|Overall Study|Other reasons|0|||
48869600|NCT02330562|157360625|FG001|Overall Study|Other reasons|0|||
48869601|NCT02330562|157360626|FG002|Overall Study|Other reasons|0|||
48869602|NCT02330562|157360627|FG003|Overall Study|Other reasons|1|||
48869603|NCT02330562|157360628|FG004|Overall Study|Other reasons|0|||
48869604|NCT02330562|157360629|FG005|Overall Study|Other reasons|0|||
48869605|NCT02330562|157360630|FG006|Overall Study|Other reasons|0|||
48869606|NCT02330562|157360631|FG007|Overall Study|Other reasons|0|||
48869607|NCT02330562|157360632|FG008|Overall Study|Other reasons|0|||
48869608|NCT02330562|157360633|FG009|Overall Study|Other reasons|0|||
48869609|NCT02330562|157360634|FG010|Overall Study|Other reasons|0|||
48759297|NCT03560531|156966393|FG002|Overall Study|Study end per-protocol|2|||
48759298|NCT03560531|156966394|FG003|Overall Study|Study end per-protocol|0|||
48759299|NCT03560531|156966395|FG004|Overall Study|Study end per-protocol|1|||
48759300|NCT03560531|156966396|FG005|Overall Study|Study end per-protocol|0|||
48759301|NCT03560531|156966397|FG006|Overall Study|Study end per-protocol|0|||
48759302|NCT03560531|156966398|FG007|Overall Study|Study end per-protocol|0|||
48759303|NCT03560531|156966399|FG008|Overall Study|Study end per-protocol|0|||
48759304|NCT03560531|156966400|FG009|Overall Study|Study end per-protocol|0|||
48759305|NCT03560531|156966401|FG010|Overall Study|Study end per-protocol|0|||
48759306|NCT03560531|156966402|FG011|Overall Study|Study end per-protocol|0|||
48759307|NCT03560531|156966403|FG012|Overall Study|Study end per-protocol|0|||
48759308|NCT03560531|156966404|FG013|Overall Study|Study end per-protocol|0|||
48759309|NCT03560531|156966391|FG000|Overall Study|Early study termination by sponsor|9|||
48759310|NCT03560531|156966392|FG001|Overall Study|Early study termination by sponsor|0|||
48759311|NCT03560531|156966393|FG002|Overall Study|Early study termination by sponsor|0|||
48759312|NCT03560531|156966394|FG003|Overall Study|Early study termination by sponsor|4|||
48759313|NCT03560531|156966395|FG004|Overall Study|Early study termination by sponsor|8|||
48759314|NCT03560531|156966396|FG005|Overall Study|Early study termination by sponsor|2|||
48759315|NCT03560531|156966397|FG006|Overall Study|Early study termination by sponsor|5|||
48759316|NCT03560531|156966398|FG007|Overall Study|Early study termination by sponsor|64|||
48759317|NCT03560531|156966399|FG008|Overall Study|Early study termination by sponsor|7|||
48759318|NCT03560531|156966400|FG009|Overall Study|Early study termination by sponsor|2|||
48759319|NCT03560531|156966401|FG010|Overall Study|Early study termination by sponsor|16|||
48869610|NCT02330562|157360624|FG000|Overall Study|Withdrawal by Subject|0|||
48869611|NCT02330562|157360625|FG001|Overall Study|Withdrawal by Subject|0|||
48869612|NCT02330562|157360626|FG002|Overall Study|Withdrawal by Subject|0|||
48869613|NCT02330562|157360627|FG003|Overall Study|Withdrawal by Subject|0|||
48869614|NCT02330562|157360628|FG004|Overall Study|Withdrawal by Subject|0|||
48869615|NCT02330562|157360629|FG005|Overall Study|Withdrawal by Subject|0|||
48869616|NCT02330562|157360630|FG006|Overall Study|Withdrawal by Subject|0|||
48869617|NCT02330562|157360631|FG007|Overall Study|Withdrawal by Subject|0|||
48869618|NCT02330562|157360632|FG008|Overall Study|Withdrawal by Subject|0|||
48869619|NCT02330562|157360633|FG009|Overall Study|Withdrawal by Subject|1|||
48869620|NCT02330562|157360634|FG010|Overall Study|Withdrawal by Subject|0|||
48869621|NCT03294941|157360635|FG000|Overall Study|Withdrawal by Subject|0|||
48869622|NCT03294941|157360636|FG001|Overall Study|Withdrawal by Subject|2|||
48869623|NCT00520403|157360637|FG000|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6|||
48869624|NCT00520403|157360637|FG000|Bevacizumab + IFN/Vinblastine|Adverse Event|4|||
48759320|NCT03560531|156966402|FG011|Overall Study|Early study termination by sponsor|2|||
48759321|NCT03560531|156966403|FG012|Overall Study|Early study termination by sponsor|6|||
48759322|NCT03560531|156966404|FG013|Overall Study|Early study termination by sponsor|2|||
48759323|NCT01474876|156966410|FG000|Overall Study|Adverse Event|11|||
48759324|NCT01474876|156966411|FG001|Overall Study|Adverse Event|5|||
48759325|NCT01474876|156966412|FG002|Overall Study|Adverse Event|0|||
48759326|NCT01474876|156966410|FG000|Overall Study|Serious Adverse Event|2|||
48759327|NCT01474876|156966411|FG001|Overall Study|Serious Adverse Event|3|||
48759328|NCT01474876|156966412|FG002|Overall Study|Serious Adverse Event|0|||
48759329|NCT01474876|156966410|FG000|Overall Study|Lost to Follow-up|5|||
48759330|NCT01474876|156966411|FG001|Overall Study|Lost to Follow-up|4|||
48759331|NCT01474876|156966412|FG002|Overall Study|Lost to Follow-up|0|||
48759332|NCT01474876|156966410|FG000|Overall Study|Investigator's decision|28|||
48759333|NCT01474876|156966411|FG001|Overall Study|Investigator's decision|6|||
48759334|NCT01474876|156966412|FG002|Overall Study|Investigator's decision|0|||
48759335|NCT01474876|156966410|FG000|Overall Study|Patient's request|19|||
48759336|NCT01474876|156966411|FG001|Overall Study|Patient's request|5|||
48759337|NCT01474876|156966412|FG002|Overall Study|Patient's request|0|||
48759338|NCT01474876|156966410|FG000|Overall Study|Investigator's decision and pt request|1|||
48759339|NCT01474876|156966411|FG001|Overall Study|Investigator's decision and pt request|0|||
48869625|NCT00520403|157360637|FG000|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4|||
48869626|NCT00520403|157360637|FG000|Bevacizumab + IFN/Vinblastine|Death|2|||
48869627|NCT00520403|157360637|FG000|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1|||
48869628|NCT00520403|157360637|FG000|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1|||
48759340|NCT01474876|156966412|FG002|Overall Study|Investigator's decision and pt request|0|||
48759341|NCT03839212|156966415|FG000|Overall Study|COVID-19 related suspension of research activities.|4|||
48869629|NCT00520403|157360637|FG000|Bevacizumab Monotherapy|Radiological progression of cancer|1|||
48869630|NCT00520403|157360637|FG000|Bevacizumab Monotherapy|Symptomatic progression of cancer|1|||
48869631|NCT00875615|157360638|FG000|Overall Study|Withdrawal by Subject|1|||
48869632|NCT00405912|157360639|FG000|Overall Study|Withdrawal by Subject|12|||
49015480|NCT01393990|157893776|FG006|Overall Study|Death|0|||
48759342|NCT01765153|156966420|FG000|Training Phase 1|Format of intervention differed|1|||
48759343|NCT01765153|156966421|FG001|Training Phase 1|Format of intervention differed|0|||
48759344|NCT01765153|156966420|FG000|Training Phase 1|Poor participation in intervention|0|||
49015481|NCT01393990|157893777|FG007|Overall Study|Death|0|||
48759345|NCT01765153|156966421|FG001|Training Phase 1|Poor participation in intervention|1|||
48759346|NCT01765153|156966420|FG000|Rest Phase 1|Withdrawal by Subject|0|||
48759347|NCT01765153|156966421|FG001|Rest Phase 1|Withdrawal by Subject|1|||
48759348|NCT01765153|156966420|FG000|Training Phase 2|Withdrawal by Subject|0|||
48759349|NCT01765153|156966421|FG001|Training Phase 2|Withdrawal by Subject|1|||
48759350|NCT01765153|156966420|FG000|Rest Phase 2|Lost to Follow-up|2|||
48759351|NCT01765153|156966421|FG001|Rest Phase 2|Lost to Follow-up|1|||
48759352|NCT02005250|156966422|FG000|Overall Study|Lost to Follow-up|15|||
48759353|NCT02005250|156966423|FG001|Overall Study|Lost to Follow-up|5|||
48759354|NCT02588833|156966424|FG000|Part 1|Withdrawal by Subject|1|||
48759355|NCT02588833|156966425|FG001|Part 1|Withdrawal by Subject|0|||
48759356|NCT02588833|156966424|FG000|Part 2A|Physician Decision|0|||
48759357|NCT02588833|156966425|FG001|Part 2A|Physician Decision|1|||
48759358|NCT02588833|156966424|FG000|Part 2A|Withdrawal by Subject|0|||
48759359|NCT02588833|156966425|FG001|Part 2A|Withdrawal by Subject|1|||
48869633|NCT00405912|157360640|FG001|Overall Study|Withdrawal by Subject|11|||
48869634|NCT00405912|157360641|FG002|Overall Study|Withdrawal by Subject|12|||
48869635|NCT00405912|157360639|FG000|Overall Study|Lost to Follow-up|4|||
48869636|NCT00405912|157360640|FG001|Overall Study|Lost to Follow-up|8|||
48869637|NCT00405912|157360641|FG002|Overall Study|Lost to Follow-up|4|||
48869638|NCT01797562|157360642|FG000|Overall Study|Protocol Violation|5|||
48869639|NCT00632931|157360643|FG000|Part 1, Period 1|Protocol Violation|1|||
48869640|NCT00632931|157360644|FG001|Part 1, Period 1|Protocol Violation|0|||
48869641|NCT00632931|157360645|FG002|Part 1, Period 1|Protocol Violation|0|||
48869642|NCT00632931|157360643|FG000|Part 1, Period 1|Withdrawal by Subject|1|||
48869643|NCT00632931|157360644|FG001|Part 1, Period 1|Withdrawal by Subject|0|||
48869644|NCT00632931|157360645|FG002|Part 1, Period 1|Withdrawal by Subject|0|||
48869645|NCT00632931|157360643|FG000|Part 2|Adverse Event|0|||
48869646|NCT00632931|157360644|FG001|Part 2|Adverse Event|0|||
48869647|NCT00632931|157360645|FG002|Part 2|Adverse Event|3|||
48869648|NCT00632931|157360643|FG000|Part 2|Death|0|||
48869649|NCT00632931|157360644|FG001|Part 2|Death|0|||
48869650|NCT00632931|157360645|FG002|Part 2|Death|1|||
48869651|NCT00632931|157360643|FG000|Part 2|Lack of Efficacy|0|||
48869652|NCT00632931|157360644|FG001|Part 2|Lack of Efficacy|0|||
48869653|NCT00632931|157360645|FG002|Part 2|Lack of Efficacy|17|||
48869654|NCT00632931|157360643|FG000|Part 2|Withdrawal by Subject|0|||
48869655|NCT00632931|157360644|FG001|Part 2|Withdrawal by Subject|0|||
48869656|NCT00632931|157360645|FG002|Part 2|Withdrawal by Subject|3|||
48869657|NCT01751165|157360646|FG000|Overall Study|Adverse event, serious fatal|1|||
48869658|NCT01751165|157360647|FG001|Overall Study|Adverse event, serious fatal|0|||
48869659|NCT01751165|157360648|FG002|Overall Study|Adverse event, serious fatal|1|||
49015482|NCT01393990|157893778|FG008|Overall Study|Death|0|||
48668882|NCT02914561|156641427|FG009|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
48668883|NCT02914561|156641428|FG010|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
48668884|NCT02914561|156641418|FG000|Induction Study (Day 1 to Week 10)|Physician Decision|1|||
48668885|NCT02914561|156641419|FG001|Induction Study (Day 1 to Week 10)|Physician Decision|5|||
48668886|NCT02914561|156641420|FG002|Induction Study (Day 1 to Week 10)|Physician Decision|2|||
48668887|NCT02914561|156641421|FG003|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
48668888|NCT02914561|156641422|FG004|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
48668889|NCT02914561|156641423|FG005|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
48668890|NCT02914561|156641424|FG006|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
48668891|NCT02914561|156641425|FG007|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
48668892|NCT02914561|156641426|FG008|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
48668893|NCT02914561|156641427|FG009|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
48668894|NCT02914561|156641428|FG010|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
48668895|NCT02914561|156641418|FG000|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
48668896|NCT02914561|156641419|FG001|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
48668897|NCT02914561|156641420|FG002|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
48668898|NCT02914561|156641421|FG003|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
48668899|NCT02914561|156641422|FG004|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
48668900|NCT02914561|156641423|FG005|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
48668901|NCT02914561|156641424|FG006|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
48668902|NCT02914561|156641425|FG007|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
48668903|NCT02914561|156641426|FG008|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
48668904|NCT02914561|156641427|FG009|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
48668905|NCT02914561|156641428|FG010|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
48668906|NCT02914561|156641418|FG000|Induction Study (Day 1 to Week 10)|Pregnancy|1|||
48759360|NCT02588833|156966424|FG000|Part 2B|Adverse Event|0|||
48869660|NCT01751165|157360646|FG000|Overall Study|Withdrawal by Subject|0|||
48869661|NCT01751165|157360647|FG001|Overall Study|Withdrawal by Subject|0|||
48869662|NCT01751165|157360648|FG002|Overall Study|Withdrawal by Subject|1|||
48869663|NCT01751165|157360646|FG000|Overall Study|Serious adverse event|0|||
49015483|NCT01393990|157893779|FG009|Overall Study|Death|0|||
48759361|NCT02588833|156966425|FG001|Part 2B|Adverse Event|1|||
48759362|NCT02588833|156966424|FG000|Part 2C|Adverse Event|0|||
48759363|NCT02588833|156966425|FG001|Part 2C|Adverse Event|1|||
48759364|NCT02588833|156966424|FG000|Part 2C|Withdrawal by Subject|0|||
48759365|NCT02588833|156966425|FG001|Part 2C|Withdrawal by Subject|1|||
48759366|NCT02588833|156966424|FG000|Part 3 (Safety Follow-up)|Other|0|||
48759367|NCT02588833|156966425|FG001|Part 3 (Safety Follow-up)|Other|2|||
48759368|NCT01077804|156966427|FG000|Overall Study|Unreachable|102|||
48759369|NCT01077804|156966427|FG000|Overall Study|Refused to continue|79|||
48759370|NCT01077804|156966427|FG000|Overall Study|Other|18|||
48759371|NCT02921776|156966428|FG000|Overall Study|patient deterioration, fatigue|2|||
48759372|NCT02921776|156966429|FG001|Overall Study|patient deterioration, fatigue|6|||
48759373|NCT02921776|156966430|FG002|Overall Study|patient deterioration, fatigue|0|||
48668907|NCT02914561|156641419|FG001|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
48668908|NCT02914561|156641420|FG002|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
48759374|NCT02921776|156966431|FG003|Overall Study|patient deterioration, fatigue|0|||
48759375|NCT02921776|156966432|FG004|Overall Study|patient deterioration, fatigue|0|||
48759376|NCT02921776|156966433|FG005|Overall Study|patient deterioration, fatigue|0|||
48759377|NCT02921776|156966434|FG006|Overall Study|patient deterioration, fatigue|0|||
48759378|NCT02921776|156966435|FG007|Overall Study|patient deterioration, fatigue|0|||
48759379|NCT02921776|156966428|FG000|Overall Study|Withdrawal by Subject|0|||
48759380|NCT02921776|156966429|FG001|Overall Study|Withdrawal by Subject|2|||
48759381|NCT02921776|156966430|FG002|Overall Study|Withdrawal by Subject|0|||
48759382|NCT02921776|156966431|FG003|Overall Study|Withdrawal by Subject|1|||
48759383|NCT02921776|156966432|FG004|Overall Study|Withdrawal by Subject|1|||
48759384|NCT02921776|156966433|FG005|Overall Study|Withdrawal by Subject|0|||
48759385|NCT02921776|156966434|FG006|Overall Study|Withdrawal by Subject|8|||
48759386|NCT02921776|156966435|FG007|Overall Study|Withdrawal by Subject|1|||
48759387|NCT02921776|156966428|FG000|Overall Study|Death|0|||
48759388|NCT02921776|156966429|FG001|Overall Study|Death|0|||
48759389|NCT02921776|156966430|FG002|Overall Study|Death|0|||
48759390|NCT02921776|156966431|FG003|Overall Study|Death|2|||
48759391|NCT02921776|156966432|FG004|Overall Study|Death|0|||
48759392|NCT02921776|156966433|FG005|Overall Study|Death|0|||
48759393|NCT02921776|156966434|FG006|Overall Study|Death|0|||
48759394|NCT02921776|156966435|FG007|Overall Study|Death|0|||
48759395|NCT02921776|156966428|FG000|Overall Study|extubation or early discharge|0|||
48759396|NCT02921776|156966429|FG001|Overall Study|extubation or early discharge|0|||
48759397|NCT02921776|156966430|FG002|Overall Study|extubation or early discharge|0|||
48759398|NCT02921776|156966431|FG003|Overall Study|extubation or early discharge|5|||
48869664|NCT01751165|157360647|FG001|Overall Study|Serious adverse event|2|||
48869665|NCT01751165|157360648|FG002|Overall Study|Serious adverse event|0|||
48869666|NCT01751165|157360646|FG000|Overall Study|Lost to Follow-up|1|||
48869667|NCT01751165|157360647|FG001|Overall Study|Lost to Follow-up|1|||
49015484|NCT01393990|157893780|FG010|Overall Study|Death|0|||
48668909|NCT02914561|156641421|FG003|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
48668910|NCT02914561|156641422|FG004|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
48668911|NCT02914561|156641423|FG005|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
48668912|NCT02914561|156641424|FG006|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
48668913|NCT02914561|156641425|FG007|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
48668914|NCT02914561|156641426|FG008|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
48668915|NCT02914561|156641427|FG009|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
48668916|NCT02914561|156641428|FG010|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
48668917|NCT02914561|156641418|FG000|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
48668918|NCT02914561|156641419|FG001|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
48668919|NCT02914561|156641420|FG002|Induction Study (Day 1 to Week 10)|Lost to Follow-up|1|||
48668920|NCT02914561|156641421|FG003|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
48668921|NCT02914561|156641422|FG004|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
48668922|NCT02914561|156641423|FG005|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
48668923|NCT02914561|156641424|FG006|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
48668924|NCT02914561|156641425|FG007|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
48668925|NCT02914561|156641426|FG008|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
48668926|NCT02914561|156641427|FG009|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
48668927|NCT02914561|156641428|FG010|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
48668928|NCT02914561|156641418|FG000|Induction Study (Day 1 to Week 10)|Randomized but not treated|1|||
48668929|NCT02914561|156641419|FG001|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
48668930|NCT02914561|156641420|FG002|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
48668931|NCT02914561|156641421|FG003|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
48668932|NCT02914561|156641422|FG004|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
48668933|NCT02914561|156641423|FG005|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
48668934|NCT02914561|156641424|FG006|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
48668935|NCT02914561|156641425|FG007|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
48869668|NCT01751165|157360648|FG002|Overall Study|Lost to Follow-up|1|||
48869669|NCT00833898|157360649|FG000|Overall Study|Withdrawal by Subject|33|||
48869670|NCT00833898|157360650|FG001|Overall Study|Withdrawal by Subject|27|||
48869671|NCT00833898|157360649|FG000|Overall Study|Lost to Follow-up|7|||
48869672|NCT00833898|157360650|FG001|Overall Study|Lost to Follow-up|7|||
48869673|NCT00833898|157360649|FG000|Overall Study|Patient did not receive transplant|0|||
48869674|NCT00833898|157360650|FG001|Overall Study|Patient did not receive transplant|2|||
48869675|NCT00917462|157360653|FG000|Overall Study|Clinical Deterioration|1|||
48869676|NCT01780545|157360654|FG000|Overall Study|Withdrawal by Subject|3|||
48869677|NCT01780545|157360655|FG001|Overall Study|Withdrawal by Subject|1|||
48968470|NCT00340834|157712537|FG000|Extension Phase of Study|Subject no longer requires study drug|4|||
48968471|NCT00340834|157712538|FG001|Extension Phase of Study|Subject no longer requires study drug|0|||
48968472|NCT00340834|157712539|FG002|Extension Phase of Study|Subject no longer requires study drug|0|||
48968473|NCT00340834|157712540|FG003|Extension Phase of Study|Subject no longer requires study drug|0|||
48968474|NCT00340834|157712541|FG004|Extension Phase of Study|Subject no longer requires study drug|2|||
48968475|NCT00340834|157712537|FG000|Extension Phase of Study|Administrative problems|3|||
48968476|NCT00340834|157712538|FG001|Extension Phase of Study|Administrative problems|0|||
48968477|NCT00340834|157712539|FG002|Extension Phase of Study|Administrative problems|0|||
48968478|NCT00340834|157712540|FG003|Extension Phase of Study|Administrative problems|1|||
48968479|NCT00340834|157712541|FG004|Extension Phase of Study|Administrative problems|1|||
48968480|NCT00340834|157712537|FG000|Extension Phase of Study|Abnormal test procedure result(s)|0|||
48968481|NCT00340834|157712538|FG001|Extension Phase of Study|Abnormal test procedure result(s)|1|||
48968482|NCT00340834|157712539|FG002|Extension Phase of Study|Abnormal test procedure result(s)|0|||
48869678|NCT01780545|157360654|FG000|Overall Study|Lost to Follow-up|1|||
48869679|NCT01780545|157360655|FG001|Overall Study|Lost to Follow-up|1|||
48869680|NCT03214250|157360661|FG000|Overall Study|Death|5|||
48869681|NCT03214250|157360662|FG001|Overall Study|Death|5|||
48869682|NCT03214250|157360663|FG002|Overall Study|Death|7|||
48869683|NCT03214250|157360664|FG003|Overall Study|Death|4|||
48869684|NCT03214250|157360665|FG004|Overall Study|Death|23|||
48869685|NCT03214250|157360666|FG005|Overall Study|Death|23|||
48869686|NCT03214250|157360667|FG006|Overall Study|Death|24|||
48869687|NCT03214250|157360661|FG000|Overall Study|Lost to Follow-up|0|||
48869688|NCT03214250|157360662|FG001|Overall Study|Lost to Follow-up|0|||
48869689|NCT03214250|157360663|FG002|Overall Study|Lost to Follow-up|0|||
48869690|NCT03214250|157360664|FG003|Overall Study|Lost to Follow-up|1|||
48869691|NCT03214250|157360665|FG004|Overall Study|Lost to Follow-up|1|||
48869692|NCT03214250|157360666|FG005|Overall Study|Lost to Follow-up|2|||
48869693|NCT03214250|157360667|FG006|Overall Study|Lost to Follow-up|0|||
48869694|NCT03214250|157360661|FG000|Overall Study|Other|0|||
48869695|NCT03214250|157360662|FG001|Overall Study|Other|0|||
48869696|NCT03214250|157360663|FG002|Overall Study|Other|0|||
48869697|NCT03214250|157360664|FG003|Overall Study|Other|0|||
48869698|NCT03214250|157360665|FG004|Overall Study|Other|1|||
48869699|NCT03214250|157360666|FG005|Overall Study|Other|1|||
48869700|NCT03214250|157360667|FG006|Overall Study|Other|2|||
48869701|NCT03214250|157360661|FG000|Overall Study|Remains on Study|2|||
48869702|NCT03214250|157360662|FG001|Overall Study|Remains on Study|2|||
48869703|NCT03214250|157360663|FG002|Overall Study|Remains on Study|0|||
48869704|NCT03214250|157360664|FG003|Overall Study|Remains on Study|1|||
48869705|NCT03214250|157360665|FG004|Overall Study|Remains on Study|7|||
48869706|NCT03214250|157360666|FG005|Overall Study|Remains on Study|5|||
48869707|NCT03214250|157360667|FG006|Overall Study|Remains on Study|3|||
48869708|NCT03214250|157360661|FG000|Overall Study|Withdrawal by Subject|0|||
48869709|NCT03214250|157360662|FG001|Overall Study|Withdrawal by Subject|0|||
48869710|NCT03214250|157360663|FG002|Overall Study|Withdrawal by Subject|1|||
48869711|NCT03214250|157360664|FG003|Overall Study|Withdrawal by Subject|2|||
48869712|NCT03214250|157360665|FG004|Overall Study|Withdrawal by Subject|5|||
48869713|NCT03214250|157360666|FG005|Overall Study|Withdrawal by Subject|0|||
48869714|NCT03214250|157360667|FG006|Overall Study|Withdrawal by Subject|2|||
48869715|NCT03036150|157360668|FG000|Overall Study|Withdrawal by Subject|8|||
48869716|NCT03036150|157360669|FG001|Overall Study|Withdrawal by Subject|3|||
48869717|NCT03036150|157360668|FG000|Overall Study|Lost to Follow-up|2|||
48869718|NCT03036150|157360669|FG001|Overall Study|Lost to Follow-up|2|||
48869719|NCT01037413|157360670|FG000|Part A: Skin Testing|Adverse Event|1|||
48869720|NCT01037413|157360671|FG001|Part A: Skin Testing|Adverse Event|0|||
48968483|NCT00340834|157712540|FG003|Extension Phase of Study|Abnormal test procedure result(s)|0|||
48968484|NCT00340834|157712541|FG004|Extension Phase of Study|Abnormal test procedure result(s)|2|||
48869721|NCT01037413|157360670|FG000|Part A: Skin Testing|Protocol Violation|1|||
48869722|NCT01037413|157360671|FG001|Part A: Skin Testing|Protocol Violation|0|||
48869723|NCT01037413|157360670|FG000|Part B: Scar Revision|Withdrawal by Subject|0|||
48869724|NCT01037413|157360671|FG001|Part B: Scar Revision|Withdrawal by Subject|1|||
48869725|NCT01037413|157360670|FG000|Part B: Scar Revision|Assigned But Not Treated|0|||
48869726|NCT01037413|157360671|FG001|Part B: Scar Revision|Assigned But Not Treated|1|||
48869727|NCT02172950|157360672|FG000|Overall Study|Physician Decision|3|||
48869728|NCT02172950|157360673|FG001|Overall Study|Physician Decision|3|||
48869729|NCT02172950|157360672|FG000|Overall Study|Lack of Efficacy|1|||
48968485|NCT00340834|157712537|FG000|Extension Phase of Study|Protocol Violation|3|||
48968486|NCT00340834|157712538|FG001|Extension Phase of Study|Protocol Violation|0|||
48968487|NCT00340834|157712539|FG002|Extension Phase of Study|Protocol Violation|0|||
48968488|NCT00340834|157712540|FG003|Extension Phase of Study|Protocol Violation|0|||
48968489|NCT00340834|157712541|FG004|Extension Phase of Study|Protocol Violation|0|||
48968490|NCT00340834|157712537|FG000|Extension Phase of Study|Death|0|||
48968491|NCT00340834|157712538|FG001|Extension Phase of Study|Death|0|||
48968492|NCT00340834|157712539|FG002|Extension Phase of Study|Death|0|||
48968493|NCT00340834|157712540|FG003|Extension Phase of Study|Death|0|||
48968494|NCT00340834|157712541|FG004|Extension Phase of Study|Death|1|||
48968495|NCT00571688|157712542|FG000|Overall Study|Lost to Follow-up|3|||
48968496|NCT00571688|157712543|FG001|Overall Study|Lost to Follow-up|6|||
48968497|NCT00571688|157712542|FG000|Overall Study|subject did not tolerate Consta|1|||
48968498|NCT00571688|157712543|FG001|Overall Study|subject did not tolerate Consta|0|||
48668936|NCT02914561|156641426|FG008|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
48668937|NCT02914561|156641427|FG009|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
48668938|NCT02914561|156641428|FG010|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
48668939|NCT02914561|156641418|FG000|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
48668940|NCT02914561|156641419|FG001|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
48668941|NCT02914561|156641420|FG002|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
48668942|NCT02914561|156641421|FG003|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
48668943|NCT02914561|156641422|FG004|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
48668944|NCT02914561|156641423|FG005|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
48668945|NCT02914561|156641424|FG006|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|31|||
48668946|NCT02914561|156641425|FG007|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|32|||
48668947|NCT02914561|156641426|FG008|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|40|||
48668948|NCT02914561|156641427|FG009|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|25|||
48668949|NCT02914561|156641428|FG010|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|43|||
48668950|NCT02914561|156641418|FG000|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
48668951|NCT02914561|156641419|FG001|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
48668952|NCT02914561|156641420|FG002|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
48668953|NCT02914561|156641421|FG003|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
48668954|NCT02914561|156641422|FG004|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
48668955|NCT02914561|156641423|FG005|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
48668956|NCT02914561|156641424|FG006|Maintenance Study (Weeks 11 to 58)|Adverse Event|9|||
48668957|NCT02914561|156641425|FG007|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
48668958|NCT02914561|156641426|FG008|Maintenance Study (Weeks 11 to 58)|Adverse Event|11|||
48668959|NCT02914561|156641427|FG009|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
48668960|NCT02914561|156641428|FG010|Maintenance Study (Weeks 11 to 58)|Adverse Event|12|||
48668961|NCT02914561|156641418|FG000|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
48668962|NCT02914561|156641419|FG001|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
48668963|NCT02914561|156641420|FG002|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
48668964|NCT02914561|156641421|FG003|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
48668965|NCT02914561|156641422|FG004|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
48668966|NCT02914561|156641423|FG005|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
48668967|NCT02914561|156641424|FG006|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|5|||
48668968|NCT02914561|156641425|FG007|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
48668969|NCT02914561|156641426|FG008|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|2|||
48668970|NCT02914561|156641427|FG009|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
48668971|NCT02914561|156641428|FG010|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|9|||
48668972|NCT02914561|156641418|FG000|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
48668973|NCT02914561|156641419|FG001|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
48668974|NCT02914561|156641420|FG002|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
48668975|NCT02914561|156641421|FG003|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
48668976|NCT02914561|156641422|FG004|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
48668977|NCT02914561|156641423|FG005|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
48668978|NCT02914561|156641424|FG006|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
48668979|NCT02914561|156641425|FG007|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
48668980|NCT02914561|156641426|FG008|Maintenance Study (Weeks 11 to 58)|Protocol Violation|2|||
48668981|NCT02914561|156641427|FG009|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
48668982|NCT02914561|156641428|FG010|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
48668983|NCT02914561|156641418|FG000|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
48668984|NCT02914561|156641419|FG001|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
48668985|NCT02914561|156641420|FG002|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
48668986|NCT02914561|156641421|FG003|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
48668987|NCT02914561|156641422|FG004|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
48968499|NCT00571688|157712542|FG000|Overall Study|subject moved out of the area|1|||
48869730|NCT02172950|157360673|FG001|Overall Study|Lack of Efficacy|0|||
48869731|NCT02172950|157360672|FG000|Overall Study|Adverse Event|4|||
48869732|NCT02172950|157360673|FG001|Overall Study|Adverse Event|1|||
48968500|NCT00571688|157712543|FG001|Overall Study|subject moved out of the area|0|||
48968501|NCT01194869|157712544|FG000|Overall Study|Disease Progression|2|||
48968502|NCT01194869|157712544|FG000|Overall Study|Toxicity|2|||
48869733|NCT02172950|157360672|FG000|Overall Study|Withdrawal by Subject|10|||
48869734|NCT02172950|157360673|FG001|Overall Study|Withdrawal by Subject|0|||
48869735|NCT02172950|157360672|FG000|Overall Study|Protocol Violation|1|||
48869736|NCT02172950|157360673|FG001|Overall Study|Protocol Violation|0|||
48869737|NCT02172950|157360672|FG000|Overall Study|Lost to Follow-up|1|||
48869738|NCT02172950|157360673|FG001|Overall Study|Lost to Follow-up|0|||
48869739|NCT02172950|157360672|FG000|Overall Study|Death|1|||
48869740|NCT02172950|157360673|FG001|Overall Study|Death|0|||
48869741|NCT02172950|157360672|FG000|Overall Study|Patient traveling|1|||
48869742|NCT02172950|157360673|FG001|Overall Study|Patient traveling|0|||
48869743|NCT02172950|157360672|FG000|Overall Study|Patient went to other country|1|||
48869744|NCT02172950|157360673|FG001|Overall Study|Patient went to other country|0|||
48869745|NCT02172950|157360672|FG000|Overall Study|Patient relocated overseas|1|||
48869746|NCT02172950|157360673|FG001|Overall Study|Patient relocated overseas|1|||
48668988|NCT02914561|156641423|FG005|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
48668989|NCT02914561|156641424|FG006|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
48668990|NCT02914561|156641425|FG007|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
48668991|NCT02914561|156641426|FG008|Maintenance Study (Weeks 11 to 58)|Physician Decision|2|||
48869747|NCT02172950|157360672|FG000|Overall Study|Patient moving|1|||
48869748|NCT02172950|157360673|FG001|Overall Study|Patient moving|0|||
48869749|NCT00931918|157360674|FG000|Overall Study|Adverse Event|4|||
48869750|NCT00931918|157360675|FG001|Overall Study|Adverse Event|6|||
48869751|NCT00931918|157360674|FG000|Overall Study|Progressive Disease|2|||
48869752|NCT00931918|157360675|FG001|Overall Study|Progressive Disease|1|||
48869753|NCT00931918|157360674|FG000|Overall Study|Symptomatic Deterioration|1|||
48869754|NCT00931918|157360675|FG001|Overall Study|Symptomatic Deterioration|0|||
48869755|NCT00931918|157360674|FG000|Overall Study|Withdrawal by Patient|3|||
48869756|NCT00931918|157360675|FG001|Overall Study|Withdrawal by Patient|4|||
48869757|NCT00931918|157360674|FG000|Overall Study|Other Reason not Specified|4|||
48869758|NCT00931918|157360675|FG001|Overall Study|Other Reason not Specified|4|||
48869759|NCT00931918|157360674|FG000|Overall Study|Did not receive study drug|3|||
48869760|NCT00931918|157360675|FG001|Overall Study|Did not receive study drug|2|||
48869761|NCT00496626|157360676|FG000|Overall Study|Lost to Follow-up|0|||
48869762|NCT00496626|157360677|FG001|Overall Study|Lost to Follow-up|1|||
48869763|NCT00496626|157360676|FG000|Overall Study|Protocol Violation|1|||
48869764|NCT00496626|157360677|FG001|Overall Study|Protocol Violation|0|||
48869765|NCT00496626|157360676|FG000|Overall Study|Withdrawal by Subject|5|||
48869766|NCT00496626|157360677|FG001|Overall Study|Withdrawal by Subject|4|||
48869767|NCT00496626|157360676|FG000|Overall Study|Relocated|0|||
48869768|NCT00496626|157360677|FG001|Overall Study|Relocated|1|||
48869769|NCT03772041|157360682|FG000|Overall Study|Adverse Event|8|||
48869770|NCT03772041|157360683|FG001|Overall Study|Adverse Event|3|||
48869771|NCT03772041|157360682|FG000|Overall Study|Withdrawal by Subject|0|||
48869772|NCT03772041|157360683|FG001|Overall Study|Withdrawal by Subject|2|||
48869773|NCT03772041|157360682|FG000|Overall Study|Protocol Violation|4|||
48869774|NCT03772041|157360683|FG001|Overall Study|Protocol Violation|2|||
48869775|NCT03772041|157360682|FG000|Overall Study|Physician Decision|2|||
48869776|NCT03772041|157360683|FG001|Overall Study|Physician Decision|3|||
48668992|NCT02914561|156641427|FG009|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
48668993|NCT02914561|156641428|FG010|Maintenance Study (Weeks 11 to 58)|Physician Decision|3|||
48668994|NCT02914561|156641418|FG000|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
48668995|NCT02914561|156641419|FG001|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
48668996|NCT02914561|156641420|FG002|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
48668997|NCT02914561|156641421|FG003|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
48668998|NCT02914561|156641422|FG004|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
48668999|NCT02914561|156641423|FG005|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
48669000|NCT02914561|156641424|FG006|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|3|||
48669001|NCT02914561|156641425|FG007|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
48669002|NCT02914561|156641426|FG008|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|1|||
48869777|NCT02204319|157360684|FG000|Overall Study|Pregnancy|1|||
48869778|NCT02204319|157360684|FG000|Overall Study|Withdrawal by Subject|2|||
48869779|NCT02959177|157360685|FG000|Double-Blind Treatment Phase|Adverse Event|5|||
48869780|NCT02959177|157360686|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
48869781|NCT02959177|157360687|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
48869782|NCT02959177|157360685|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
48869783|NCT02959177|157360686|FG001|Double-Blind Treatment Phase|Physician Decision|0|||
48869784|NCT02959177|157360687|FG002|Double-Blind Treatment Phase|Physician Decision|0|||
48869785|NCT02959177|157360685|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
48669003|NCT02914561|156641427|FG009|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
48669004|NCT02914561|156641428|FG010|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
48669005|NCT02914561|156641418|FG000|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
48669006|NCT02914561|156641419|FG001|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
48669007|NCT02914561|156641420|FG002|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
48669008|NCT02914561|156641421|FG003|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
48669009|NCT02914561|156641422|FG004|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
48669010|NCT02914561|156641423|FG005|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
48669011|NCT02914561|156641424|FG006|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
48669012|NCT02914561|156641425|FG007|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
48669013|NCT02914561|156641426|FG008|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|1|||
48669014|NCT02914561|156641427|FG009|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
48759399|NCT02921776|156966432|FG004|Overall Study|extubation or early discharge|5|||
48759400|NCT02921776|156966433|FG005|Overall Study|extubation or early discharge|0|||
48759401|NCT02921776|156966434|FG006|Overall Study|extubation or early discharge|0|||
48759402|NCT02921776|156966435|FG007|Overall Study|extubation or early discharge|0|||
48759403|NCT02921776|156966428|FG000|Overall Study|Lost to Follow-up|0|||
48759404|NCT02921776|156966429|FG001|Overall Study|Lost to Follow-up|0|||
48759405|NCT02921776|156966430|FG002|Overall Study|Lost to Follow-up|0|||
48759406|NCT02921776|156966431|FG003|Overall Study|Lost to Follow-up|0|||
48759407|NCT02921776|156966432|FG004|Overall Study|Lost to Follow-up|0|||
48759408|NCT02921776|156966433|FG005|Overall Study|Lost to Follow-up|2|||
48759409|NCT02921776|156966434|FG006|Overall Study|Lost to Follow-up|3|||
48759410|NCT02921776|156966435|FG007|Overall Study|Lost to Follow-up|6|||
48759411|NCT00567892|156966436|FG000|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
48759412|NCT00567892|156966437|FG001|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
48759413|NCT00567892|156966438|FG002|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
48759414|NCT00567892|156966439|FG003|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4|||
48759415|NCT00567892|156966436|FG000|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
48759416|NCT00567892|156966437|FG001|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
48759417|NCT00567892|156966438|FG002|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
48759418|NCT00567892|156966439|FG003|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
48759419|NCT02762266|156967926|FG000|Overall Study|Physician Decision|2|||
48759420|NCT02762266|156967927|FG001|Overall Study|Physician Decision|0|||
48759421|NCT01404325|156967930|FG000|Overall Study|Lost to Follow-up|1|||
48759422|NCT01404325|156967931|FG001|Overall Study|Lost to Follow-up|0|||
48759423|NCT01404325|156967930|FG000|Overall Study|Death|2|||
48759424|NCT01404325|156967931|FG001|Overall Study|Death|0|||
48759425|NCT01404325|156967930|FG000|Overall Study|Graft loss/Retransplantation|1|||
48759426|NCT01404325|156967931|FG001|Overall Study|Graft loss/Retransplantation|0|||
48759427|NCT01404325|156967930|FG000|Overall Study|non-specified reason|0|||
48759428|NCT01404325|156967931|FG001|Overall Study|non-specified reason|2|||
48759429|NCT00623727|156967932|FG000|Double Blind (DB)|Adverse Event|1|||
48759430|NCT00623727|156967933|FG001|Double Blind (DB)|Adverse Event|3|||
48759431|NCT00623727|156967932|FG000|Double Blind (DB)|Physician Decision|0|||
48669015|NCT02914561|156641428|FG010|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
48669016|NCT02914561|156641418|FG000|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
48669017|NCT02914561|156641419|FG001|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
48759432|NCT00623727|156967933|FG001|Double Blind (DB)|Physician Decision|1|||
48869786|NCT02959177|157360686|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
48869787|NCT02959177|157360687|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
48869788|NCT02959177|157360685|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
48759433|NCT00623727|156967932|FG000|Double Blind (DB)|Withdrawal by Subject|8|||
48869789|NCT02959177|157360686|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
48869790|NCT02959177|157360687|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
48869791|NCT02959177|157360685|FG000|Follow-up Post Treatment Phase|Lost to Follow-up|1|||
48869792|NCT02959177|157360686|FG001|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
48869793|NCT02959177|157360687|FG002|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
48869794|NCT02959177|157360685|FG000|Follow-up Post Treatment Phase|Adverse Event|0|||
48869795|NCT02959177|157360686|FG001|Follow-up Post Treatment Phase|Adverse Event|1|||
48869796|NCT02959177|157360687|FG002|Follow-up Post Treatment Phase|Adverse Event|0|||
48869797|NCT02959177|157360685|FG000|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
48869798|NCT02959177|157360686|FG001|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
48869799|NCT02959177|157360687|FG002|Follow-up Post Treatment Phase|Withdrawal by Subject|2|||
48869800|NCT00591409|157360688|FG000|Overall Study|Not Treated|0|||
48869801|NCT00591409|157360689|FG001|Overall Study|Not Treated|0|||
48869802|NCT00591409|157360690|FG002|Overall Study|Not Treated|0|||
48759434|NCT00623727|156967933|FG001|Double Blind (DB)|Withdrawal by Subject|2|||
48759435|NCT00623727|156967932|FG000|Double Blind (DB)|Lack of Efficacy|2|||
48869803|NCT00591409|157360691|FG003|Overall Study|Not Treated|0|||
48869804|NCT00591409|157360692|FG004|Overall Study|Not Treated|1|||
48669018|NCT02914561|156641420|FG002|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
48669019|NCT02914561|156641421|FG003|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
48669020|NCT02914561|156641422|FG004|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
48669021|NCT02914561|156641423|FG005|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
48669022|NCT02914561|156641424|FG006|Maintenance Study (Weeks 11 to 58)|Pregnancy|1|||
48669023|NCT02914561|156641425|FG007|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
48669024|NCT02914561|156641426|FG008|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
48669025|NCT02914561|156641427|FG009|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
48669026|NCT02914561|156641428|FG010|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
48669027|NCT02914561|156641418|FG000|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
48669028|NCT02914561|156641419|FG001|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
48669029|NCT02914561|156641420|FG002|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
48669030|NCT02914561|156641421|FG003|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
48669031|NCT02914561|156641422|FG004|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
48669032|NCT02914561|156641423|FG005|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
48669033|NCT02914561|156641424|FG006|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
48669034|NCT02914561|156641425|FG007|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
48669035|NCT02914561|156641426|FG008|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
48669036|NCT02914561|156641427|FG009|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
48669037|NCT02914561|156641428|FG010|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
48669038|NCT01300455|156641429|FG000|Washout|Withdrawal by Subject|1|||
48669039|NCT01300455|156641430|FG001|Washout|Withdrawal by Subject|0|||
48669040|NCT02528357|156641433|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
48669041|NCT02528357|156641434|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1|||
48669042|NCT02528357|156641435|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
48669043|NCT02528357|156641436|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
48669044|NCT02528357|156641437|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
48669045|NCT02528357|156641438|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
48669046|NCT02528357|156641439|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
48669047|NCT02528357|156641440|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
48669048|NCT02528357|156641441|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
48669049|NCT02528357|156641442|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
48669050|NCT02528357|156641443|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
48669051|NCT02528357|156641444|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
48669052|NCT02528357|156641445|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
48669053|NCT02528357|156641446|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
48669054|NCT02528357|156641447|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
48669055|NCT02528357|156641448|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
48669056|NCT02528357|156641449|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
48669057|NCT02528357|156641450|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
48669058|NCT02528357|156641451|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
48669059|NCT02528357|156641433|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
48669060|NCT02528357|156641434|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
48669061|NCT02528357|156641435|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
48669062|NCT02528357|156641436|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
48669063|NCT02528357|156641437|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
48669064|NCT02528357|156641438|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2|||
48669065|NCT02528357|156641439|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
48669066|NCT02528357|156641440|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
48869805|NCT00591409|157360693|FG005|Overall Study|Not Treated|0|||
48869806|NCT00591409|157360694|FG006|Overall Study|Not Treated|0|||
48869807|NCT00591409|157360695|FG007|Overall Study|Not Treated|0|||
48869808|NCT00591409|157360696|FG008|Overall Study|Not Treated|0|||
48869809|NCT00591409|157360697|FG009|Overall Study|Not Treated|1|||
48869810|NCT01898442|157360701|FG000|Overall Study|Hemolysis/technical problems|1|||
48869811|NCT01898442|157360702|FG001|Overall Study|Hemolysis/technical problems|2|||
48869812|NCT01898442|157360703|FG002|Overall Study|Hemolysis/technical problems|2|||
48869813|NCT01898442|157360701|FG000|Overall Study|Patient vomited pills|0|||
48869814|NCT01898442|157360702|FG001|Overall Study|Patient vomited pills|0|||
48869815|NCT01898442|157360703|FG002|Overall Study|Patient vomited pills|1|||
48869816|NCT01713998|157360704|FG000|Overall Study|Lost to Follow-up|2|||
48869817|NCT01713998|157360705|FG001|Overall Study|Lost to Follow-up|0|||
48869818|NCT01713998|157360706|FG002|Overall Study|Lost to Follow-up|2|||
48869819|NCT01713998|157360704|FG000|Overall Study|Withdrawal by Subject|1|||
48869820|NCT01713998|157360705|FG001|Overall Study|Withdrawal by Subject|0|||
48869821|NCT01713998|157360706|FG002|Overall Study|Withdrawal by Subject|0|||
48869822|NCT03811834|157360709|FG000|Period 1 ( 7 Days)|Adverse Event|1|||
48869823|NCT02143063|157360710|FG000|Overall Study|Lost to Follow-up|16|||
48869824|NCT02143063|157360711|FG001|Overall Study|Lost to Follow-up|28|||
48869825|NCT02143063|157360712|FG002|Overall Study|Lost to Follow-up|29|||
48869826|NCT02143063|157360710|FG000|Overall Study|Withdrawal by Subject|0|||
48869827|NCT02143063|157360711|FG001|Overall Study|Withdrawal by Subject|1|||
48869828|NCT02143063|157360712|FG002|Overall Study|Withdrawal by Subject|0|||
48869829|NCT02143063|157360710|FG000|Overall Study|Death|0|||
48869830|NCT02143063|157360711|FG001|Overall Study|Death|1|||
48869831|NCT02143063|157360712|FG002|Overall Study|Death|1|||
48869832|NCT03188536|157360716|FG000|Overall Study|No relapse/refractoriness(last 6 months)|5|||
48869833|NCT03188536|157360716|FG000|Overall Study|Not participated/met inclusion criteria|1|||
48869834|NCT03638258|157360717|FG000|Overall Study|Adverse Event|1|||
48869835|NCT03638258|157360718|FG001|Overall Study|Adverse Event|0|||
48869836|NCT03638258|157360719|FG002|Overall Study|Adverse Event|2|||
48869837|NCT03638258|157360717|FG000|Overall Study|Lost to Follow-up|2|||
48869838|NCT03638258|157360718|FG001|Overall Study|Lost to Follow-up|4|||
48869839|NCT03638258|157360719|FG002|Overall Study|Lost to Follow-up|5|||
48869840|NCT03638258|157360717|FG000|Overall Study|Pregnancy|0|||
48869841|NCT03638258|157360718|FG001|Overall Study|Pregnancy|0|||
48869842|NCT03638258|157360719|FG002|Overall Study|Pregnancy|1|||
48869843|NCT03638258|157360717|FG000|Overall Study|Protocol Violation|0|||
48869844|NCT03638258|157360718|FG001|Overall Study|Protocol Violation|0|||
48869845|NCT03638258|157360719|FG002|Overall Study|Protocol Violation|1|||
48869846|NCT03638258|157360717|FG000|Overall Study|Withdrawal by Subject|4|||
48869847|NCT03638258|157360718|FG001|Overall Study|Withdrawal by Subject|5|||
48869848|NCT03638258|157360719|FG002|Overall Study|Withdrawal by Subject|12|||
48869849|NCT03638258|157360717|FG000|Overall Study|Lack of Efficacy|0|||
48869850|NCT03638258|157360718|FG001|Overall Study|Lack of Efficacy|0|||
48869851|NCT03638258|157360719|FG002|Overall Study|Lack of Efficacy|2|||
48869852|NCT02168478|157360721|FG000|Overall Study|Withdrawal by Subject|1|||
48869853|NCT02168478|157360721|FG000|Overall Study|Did Not Consent to Participation|2|||
48869854|NCT02168478|157360721|FG000|Overall Study|Did Not Meet Exclusionary Criteria|1|||
48869855|NCT01157377|157360722|FG000|Overall Study|Lost to Follow-up|0|||
48869856|NCT01157377|157360723|FG001|Overall Study|Lost to Follow-up|0|||
48869857|NCT01157377|157360724|FG002|Overall Study|Lost to Follow-up|1|||
48869858|NCT01157377|157360725|FG003|Overall Study|Lost to Follow-up|0|||
48869859|NCT01157377|157360726|FG004|Overall Study|Lost to Follow-up|1|||
48869860|NCT01157377|157360727|FG005|Overall Study|Lost to Follow-up|1|||
48869861|NCT01157377|157360728|FG006|Overall Study|Lost to Follow-up|0|||
48869862|NCT01157377|157360722|FG000|Overall Study|Personal Reasons|2|||
48869863|NCT01157377|157360723|FG001|Overall Study|Personal Reasons|1|||
48869864|NCT01157377|157360724|FG002|Overall Study|Personal Reasons|0|||
48869865|NCT01157377|157360725|FG003|Overall Study|Personal Reasons|1|||
48669067|NCT02528357|156641441|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
48869866|NCT01157377|157360726|FG004|Overall Study|Personal Reasons|0|||
48869867|NCT01157377|157360727|FG005|Overall Study|Personal Reasons|0|||
48869868|NCT01157377|157360728|FG006|Overall Study|Personal Reasons|0|||
48869869|NCT01157377|157360722|FG000|Overall Study|Protocol Violation|0|||
48869870|NCT01157377|157360723|FG001|Overall Study|Protocol Violation|0|||
48869871|NCT01157377|157360724|FG002|Overall Study|Protocol Violation|0|||
48869872|NCT01157377|157360725|FG003|Overall Study|Protocol Violation|0|||
48869873|NCT01157377|157360726|FG004|Overall Study|Protocol Violation|0|||
48869874|NCT01157377|157360727|FG005|Overall Study|Protocol Violation|1|||
48869875|NCT01157377|157360728|FG006|Overall Study|Protocol Violation|0|||
48869876|NCT01157377|157360722|FG000|Overall Study|Lack of Efficacy|0|||
48869877|NCT01157377|157360723|FG001|Overall Study|Lack of Efficacy|0|||
48869878|NCT01157377|157360724|FG002|Overall Study|Lack of Efficacy|0|||
48869879|NCT01157377|157360725|FG003|Overall Study|Lack of Efficacy|0|||
48869880|NCT01157377|157360726|FG004|Overall Study|Lack of Efficacy|0|||
48869881|NCT01157377|157360727|FG005|Overall Study|Lack of Efficacy|0|||
48869882|NCT01157377|157360728|FG006|Overall Study|Lack of Efficacy|1|||
48869883|NCT01157377|157360722|FG000|Overall Study|Other Miscellaneous Reasons|0|||
48869884|NCT01157377|157360723|FG001|Overall Study|Other Miscellaneous Reasons|2|||
48869885|NCT01157377|157360724|FG002|Overall Study|Other Miscellaneous Reasons|0|||
48869886|NCT01157377|157360725|FG003|Overall Study|Other Miscellaneous Reasons|0|||
48869887|NCT01157377|157360726|FG004|Overall Study|Other Miscellaneous Reasons|1|||
48869888|NCT01157377|157360727|FG005|Overall Study|Other Miscellaneous Reasons|1|||
48869889|NCT01157377|157360728|FG006|Overall Study|Other Miscellaneous Reasons|1|||
48869890|NCT00372255|157360729|FG000|Overall Study|Withdrawn for other reasons|2|||
48869891|NCT00372255|157360730|FG001|Overall Study|Withdrawn for other reasons|1|||
48869892|NCT03605368|157360735|FG000|Overall Study|Lost to Follow-up|2|||
48869893|NCT03605368|157360736|FG001|Overall Study|Lost to Follow-up|1|||
48869894|NCT03605368|157360737|FG002|Overall Study|Lost to Follow-up|3|||
48869895|NCT03605368|157360738|FG003|Overall Study|Lost to Follow-up|2|||
48869896|NCT03605368|157360735|FG000|Overall Study|Withdrawal by Subject|0|||
48869897|NCT03605368|157360736|FG001|Overall Study|Withdrawal by Subject|0|||
48869898|NCT03605368|157360737|FG002|Overall Study|Withdrawal by Subject|4|||
48968503|NCT01453998|157712547|FG000|After Protocol Amendment 2.|Withdrawal by Subject|1|||
48869899|NCT03605368|157360738|FG003|Overall Study|Withdrawal by Subject|3|||
48669068|NCT02528357|156641442|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
48669069|NCT02528357|156641443|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
48669070|NCT02528357|156641444|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
48869900|NCT02016690|157360739|FG000|Overall Study|Excluded from SAS: Enrollment violation|2|||
48869901|NCT02016690|157360739|FG000|Overall Study|Excluded from SAS: Duplication|2|||
48869902|NCT02016690|157360739|FG000|Overall Study|Excluded from SAS: Early treatment|2|||
48869903|NCT02016690|157360739|FG000|Overall Study|Excluded from SAS: Ineligible for study|2|||
48869904|NCT02016690|157360739|FG000|Overall Study|Did not meet inclusion criteria|13|||
48869905|NCT02016690|157360739|FG000|Overall Study|Hospitalized for RSV at study start|3|||
48869906|NCT01726517|157360742|FG000|Overall Study|Withdrawal by Subject|0|||
48869907|NCT01726517|157360743|FG001|Overall Study|Withdrawal by Subject|0|||
48869908|NCT01726517|157360744|FG002|Overall Study|Withdrawal by Subject|1|||
48869909|NCT01726517|157360745|FG003|Overall Study|Withdrawal by Subject|0|||
48869910|NCT01726517|157360746|FG004|Overall Study|Withdrawal by Subject|0|||
48869911|NCT00552513|157362588|FG000|Overall Study|Lost to Follow-up|5|||
48869912|NCT00552513|157362589|FG001|Overall Study|Lost to Follow-up|1|||
48869913|NCT01580995|157362596|FG000|Overall Study|Lost to Follow-up|2|||
48869914|NCT01580995|157362597|FG001|Overall Study|Lost to Follow-up|2|||
48869915|NCT02517528|157362598|FG000|Overall Study|Withdrawal by Subject|1|||
48869916|NCT03440047|157362601|FG000|Overall Study|Withdrawal by Subject|2|||
48869917|NCT00043186|157362608|FG000|Overall Study|Physician Decision|0|||
48869918|NCT00043186|157362609|FG001|Overall Study|Physician Decision|0|||
48869919|NCT00043186|157362610|FG002|Overall Study|Physician Decision|3|||
48869920|NCT00043186|157362611|FG003|Overall Study|Physician Decision|0|||
48869921|NCT00043186|157362612|FG004|Overall Study|Physician Decision|1|||
48869922|NCT00043186|157362613|FG005|Overall Study|Physician Decision|0|||
48869923|NCT00043186|157362614|FG006|Overall Study|Physician Decision|0|||
48869924|NCT00043186|157362615|FG007|Overall Study|Physician Decision|1|||
48869925|NCT00043186|157362616|FG008|Overall Study|Physician Decision|1|||
48869926|NCT00043186|157362608|FG000|Overall Study|Adverse Event|2|||
48869927|NCT00043186|157362609|FG001|Overall Study|Adverse Event|2|||
48869928|NCT00043186|157362610|FG002|Overall Study|Adverse Event|2|||
48869929|NCT00043186|157362611|FG003|Overall Study|Adverse Event|3|||
48869930|NCT00043186|157362612|FG004|Overall Study|Adverse Event|2|||
48869931|NCT00043186|157362613|FG005|Overall Study|Adverse Event|1|||
48869932|NCT00043186|157362614|FG006|Overall Study|Adverse Event|2|||
48869933|NCT00043186|157362615|FG007|Overall Study|Adverse Event|1|||
48869934|NCT00043186|157362616|FG008|Overall Study|Adverse Event|3|||
48869935|NCT00043186|157362608|FG000|Overall Study|Withdrawal by Subject|11|||
48869936|NCT00043186|157362609|FG001|Overall Study|Withdrawal by Subject|8|||
48869937|NCT00043186|157362610|FG002|Overall Study|Withdrawal by Subject|11|||
48869938|NCT00043186|157362611|FG003|Overall Study|Withdrawal by Subject|13|||
48869939|NCT00043186|157362612|FG004|Overall Study|Withdrawal by Subject|14|||
48869940|NCT00043186|157362613|FG005|Overall Study|Withdrawal by Subject|6|||
48869941|NCT00043186|157362614|FG006|Overall Study|Withdrawal by Subject|12|||
48869942|NCT00043186|157362615|FG007|Overall Study|Withdrawal by Subject|9|||
48869943|NCT00043186|157362616|FG008|Overall Study|Withdrawal by Subject|10|||
48869944|NCT00043186|157362608|FG000|Overall Study|Death|0|||
48869945|NCT00043186|157362609|FG001|Overall Study|Death|0|||
48869946|NCT00043186|157362610|FG002|Overall Study|Death|1|||
48869947|NCT00043186|157362611|FG003|Overall Study|Death|0|||
48869948|NCT00043186|157362612|FG004|Overall Study|Death|0|||
48869949|NCT00043186|157362613|FG005|Overall Study|Death|0|||
48869950|NCT00043186|157362614|FG006|Overall Study|Death|2|||
48869951|NCT00043186|157362615|FG007|Overall Study|Death|0|||
48869952|NCT00043186|157362616|FG008|Overall Study|Death|0|||
48869953|NCT00043186|157362608|FG000|Overall Study|Disease progression|1|||
48869954|NCT00043186|157362609|FG001|Overall Study|Disease progression|0|||
48869955|NCT00043186|157362610|FG002|Overall Study|Disease progression|0|||
48869956|NCT00043186|157362611|FG003|Overall Study|Disease progression|3|||
48869957|NCT00043186|157362612|FG004|Overall Study|Disease progression|0|||
48869958|NCT00043186|157362613|FG005|Overall Study|Disease progression|0|||
48869959|NCT00043186|157362614|FG006|Overall Study|Disease progression|0|||
48869960|NCT00043186|157362615|FG007|Overall Study|Disease progression|4|||
48869961|NCT00043186|157362616|FG008|Overall Study|Disease progression|0|||
48869962|NCT00043186|157362608|FG000|Overall Study|Ineligibility determined|0|||
48869963|NCT00043186|157362609|FG001|Overall Study|Ineligibility determined|0|||
48869964|NCT00043186|157362610|FG002|Overall Study|Ineligibility determined|0|||
48869965|NCT00043186|157362611|FG003|Overall Study|Ineligibility determined|0|||
48869966|NCT00043186|157362612|FG004|Overall Study|Ineligibility determined|0|||
48869967|NCT00043186|157362613|FG005|Overall Study|Ineligibility determined|0|||
48869968|NCT00043186|157362614|FG006|Overall Study|Ineligibility determined|0|||
48869969|NCT00043186|157362615|FG007|Overall Study|Ineligibility determined|0|||
48869970|NCT00043186|157362616|FG008|Overall Study|Ineligibility determined|1|||
48869971|NCT00043186|157362608|FG000|Overall Study|Lost to Follow-up|3|||
48869972|NCT00043186|157362609|FG001|Overall Study|Lost to Follow-up|5|||
48869973|NCT00043186|157362610|FG002|Overall Study|Lost to Follow-up|1|||
48869974|NCT00043186|157362611|FG003|Overall Study|Lost to Follow-up|1|||
48669071|NCT02528357|156641445|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
48669072|NCT02528357|156641446|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
48669073|NCT02528357|156641447|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
48669074|NCT02528357|156641448|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
48669075|NCT02528357|156641449|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
48669076|NCT02528357|156641450|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
48669077|NCT02528357|156641451|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
48669078|NCT02528357|156641433|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
48669079|NCT02528357|156641434|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
48669080|NCT02528357|156641435|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
48669081|NCT02528357|156641436|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
48669082|NCT02528357|156641437|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3|||
48669083|NCT02528357|156641438|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
48669084|NCT02528357|156641439|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
48669085|NCT02528357|156641440|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1|||
48669086|NCT02528357|156641441|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
48669087|NCT02528357|156641442|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
48669088|NCT02528357|156641443|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
48669089|NCT02528357|156641444|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
48669090|NCT02528357|156641445|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
48669091|NCT02528357|156641446|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
48669092|NCT02528357|156641447|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
48669093|NCT02528357|156641448|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
48669094|NCT02528357|156641449|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
48669095|NCT02528357|156641450|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
48669096|NCT02528357|156641451|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
48669097|NCT02528357|156641433|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669098|NCT02528357|156641434|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669099|NCT02528357|156641435|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669100|NCT02528357|156641436|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669101|NCT02528357|156641437|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
48669102|NCT02528357|156641438|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669103|NCT02528357|156641439|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669104|NCT02528357|156641440|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669105|NCT02528357|156641441|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669106|NCT02528357|156641442|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669107|NCT02528357|156641443|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669108|NCT02528357|156641444|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669109|NCT02528357|156641445|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669110|NCT02528357|156641446|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669111|NCT02528357|156641447|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669112|NCT02528357|156641448|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669113|NCT02528357|156641449|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669114|NCT02528357|156641450|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669115|NCT02528357|156641451|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669116|NCT02528357|156641433|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
48669117|NCT02528357|156641434|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
48669118|NCT02528357|156641435|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
48669119|NCT02528357|156641436|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
48669120|NCT02528357|156641437|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
48759436|NCT00623727|156967933|FG001|Double Blind (DB)|Lack of Efficacy|2|||
48759437|NCT00623727|156967932|FG000|Double Blind (DB)|Termination of the double-blind period|22|||
48759438|NCT00623727|156967933|FG001|Double Blind (DB)|Termination of the double-blind period|21|||
48759439|NCT00623727|156967932|FG000|Double Blind (DB)|Lost to Follow-up|1|||
48759440|NCT00623727|156967933|FG001|Double Blind (DB)|Lost to Follow-up|1|||
48759441|NCT00623727|156967932|FG000|Double Blind (DB)|Protocol Violation|2|||
48759442|NCT00623727|156967933|FG001|Double Blind (DB)|Protocol Violation|2|||
48759443|NCT00623727|156967932|FG000|Open Label Follow-up|Withdrawal by Subject|0|||
48669121|NCT02528357|156641438|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
48669122|NCT02528357|156641439|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
48669123|NCT02528357|156641440|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
48669124|NCT02528357|156641441|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
48669125|NCT02528357|156641442|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
48669126|NCT02528357|156641443|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
48669127|NCT02528357|156641444|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
48669128|NCT02528357|156641445|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
48669129|NCT02528357|156641446|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1|||
48669130|NCT02528357|156641447|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5|||
48669131|NCT02528357|156641448|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
48669132|NCT02528357|156641449|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
48669133|NCT02528357|156641450|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
48669134|NCT02528357|156641451|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
48669135|NCT02528357|156641433|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
48669136|NCT02528357|156641434|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
48669137|NCT02528357|156641435|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
48669138|NCT02528357|156641436|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
48669139|NCT02528357|156641437|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
48669140|NCT02528357|156641438|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
48669141|NCT02528357|156641439|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
48669142|NCT02528357|156641440|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
48669143|NCT02528357|156641441|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
48669144|NCT02528357|156641442|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
48669145|NCT02528357|156641443|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
48669146|NCT02528357|156641444|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
48669147|NCT02528357|156641445|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
48669148|NCT02528357|156641446|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1|||
48669149|NCT02528357|156641447|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
48669150|NCT02528357|156641448|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
48669151|NCT02528357|156641449|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
48669152|NCT02528357|156641450|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
48669153|NCT02528357|156641451|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
48669154|NCT02528357|156641433|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
48669155|NCT02528357|156641434|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
48669156|NCT02528357|156641435|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
48669157|NCT02528357|156641436|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
48669158|NCT02528357|156641437|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
48669159|NCT02528357|156641438|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
48669160|NCT02528357|156641439|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
48669161|NCT02528357|156641440|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
48669162|NCT02528357|156641441|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
48669163|NCT02528357|156641442|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
48669164|NCT02528357|156641443|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
48669165|NCT02528357|156641444|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
48669166|NCT02528357|156641445|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
48669167|NCT02528357|156641446|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
48669168|NCT02528357|156641447|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
48669169|NCT02528357|156641448|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
48669170|NCT02528357|156641449|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
48669171|NCT02528357|156641450|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
48669172|NCT02528357|156641451|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
48669173|NCT02528357|156641433|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669174|NCT02528357|156641434|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669175|NCT02528357|156641435|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669176|NCT02528357|156641436|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669177|NCT02528357|156641437|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669178|NCT02528357|156641438|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669179|NCT02528357|156641439|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48692775|NCT00333775|156724600|FG001|Overall Study|In Follow-up When Study Stopped|92|||
48669180|NCT02528357|156641440|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669181|NCT02528357|156641441|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
48669182|NCT02528357|156641442|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
48669183|NCT02528357|156641443|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669184|NCT02528357|156641444|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
48669185|NCT02528357|156641445|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
48669186|NCT02528357|156641446|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
48669187|NCT02528357|156641447|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
48669188|NCT02528357|156641448|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669189|NCT02528357|156641449|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669190|NCT02528357|156641450|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669191|NCT02528357|156641451|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669192|NCT02528357|156641433|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
48669193|NCT02528357|156641434|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
48669194|NCT02528357|156641435|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
48669195|NCT02528357|156641436|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
48669196|NCT02528357|156641437|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
48669197|NCT02528357|156641438|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
48669198|NCT02528357|156641439|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
48669199|NCT02528357|156641440|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
48669200|NCT02528357|156641441|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
48669201|NCT02528357|156641442|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
48669202|NCT02528357|156641443|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
48669203|NCT02528357|156641444|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
48669204|NCT02528357|156641445|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
48669205|NCT02528357|156641446|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
48669206|NCT02528357|156641447|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
48669207|NCT02528357|156641448|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
48669208|NCT02528357|156641449|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2|||
48669209|NCT02528357|156641450|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
48669210|NCT02528357|156641451|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
48669211|NCT02528357|156641433|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669212|NCT02528357|156641434|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669213|NCT02528357|156641435|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669214|NCT02528357|156641436|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669215|NCT02528357|156641437|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669216|NCT02528357|156641438|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669217|NCT02528357|156641439|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669218|NCT02528357|156641440|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669219|NCT02528357|156641441|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669220|NCT02528357|156641442|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669221|NCT02528357|156641443|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669222|NCT02528357|156641444|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669223|NCT02528357|156641445|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669224|NCT02528357|156641446|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669225|NCT02528357|156641447|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669226|NCT02528357|156641448|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669227|NCT02528357|156641449|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
48692776|NCT00333775|156724601|FG002|Overall Study|In Follow-up When Study Stopped|96|||
48692777|NCT00333775|156724599|FG000|Overall Study|Lost to Follow-up|10|||
48692778|NCT00333775|156724600|FG001|Overall Study|Lost to Follow-up|7|||
48692779|NCT00333775|156724601|FG002|Overall Study|Lost to Follow-up|8|||
48692780|NCT03110315|156724603|FG000|Overall Study|Withdrawal by Subject|1|||
48692781|NCT03110315|156724604|FG001|Overall Study|Withdrawal by Subject|0|||
48692782|NCT01188772|156724610|FG000|Overall Study|Randomized but Not Treated|0|||
48692783|NCT01188772|156724611|FG001|Overall Study|Randomized but Not Treated|1|||
48869975|NCT00043186|157362612|FG004|Overall Study|Lost to Follow-up|1|||
48869976|NCT00043186|157362613|FG005|Overall Study|Lost to Follow-up|1|||
48869977|NCT00043186|157362614|FG006|Overall Study|Lost to Follow-up|1|||
48869978|NCT00043186|157362615|FG007|Overall Study|Lost to Follow-up|1|||
48869979|NCT00043186|157362616|FG008|Overall Study|Lost to Follow-up|2|||
48869980|NCT00043186|157362608|FG000|Overall Study|Noncompliance|0|||
48869981|NCT00043186|157362609|FG001|Overall Study|Noncompliance|0|||
48869982|NCT00043186|157362610|FG002|Overall Study|Noncompliance|1|||
48869983|NCT00043186|157362611|FG003|Overall Study|Noncompliance|1|||
48869984|NCT00043186|157362612|FG004|Overall Study|Noncompliance|0|||
48869985|NCT00043186|157362613|FG005|Overall Study|Noncompliance|0|||
48869986|NCT00043186|157362614|FG006|Overall Study|Noncompliance|0|||
48869987|NCT00043186|157362615|FG007|Overall Study|Noncompliance|0|||
48869988|NCT00043186|157362616|FG008|Overall Study|Noncompliance|0|||
48869989|NCT00043186|157362608|FG000|Overall Study|Other|0|||
48869990|NCT00043186|157362609|FG001|Overall Study|Other|0|||
48669228|NCT02528357|156641450|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
48669229|NCT02528357|156641451|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
48869991|NCT00043186|157362610|FG002|Overall Study|Other|1|||
48869992|NCT00043186|157362611|FG003|Overall Study|Other|1|||
48669230|NCT01455220|156641456|FG000|Overall Study|screen fail|30|||
48669231|NCT02438813|156641459|FG000|Overall Study|Patient Decision|59|||
48669232|NCT02438813|156641459|FG000|Overall Study|Patient Lost to Follow-Up|137|||
48669233|NCT02438813|156641459|FG000|Overall Study|Study Ended by Sponsor|80|||
48669234|NCT02438813|156641459|FG000|Overall Study|Patients Not Treated/No EOT Visit|249|||
48869993|NCT00043186|157362612|FG004|Overall Study|Other|0|||
48869994|NCT00043186|157362613|FG005|Overall Study|Other|0|||
48869995|NCT00043186|157362614|FG006|Overall Study|Other|0|||
48869996|NCT00043186|157362615|FG007|Overall Study|Other|0|||
48869997|NCT00043186|157362616|FG008|Overall Study|Other|0|||
48869998|NCT02396953|157362617|FG000|Overall Study|Withdrawal by Subject|0|||
48869999|NCT02396953|157362618|FG001|Overall Study|Withdrawal by Subject|0|||
48870000|NCT02396953|157362619|FG002|Overall Study|Withdrawal by Subject|1|||
48870001|NCT02396953|157362617|FG000|Overall Study|Insulin like Growth Factor-1 increased|3|||
48870002|NCT02396953|157362618|FG001|Overall Study|Insulin like Growth Factor-1 increased|2|||
48669235|NCT01672866|156641464|FG000|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40|||
48870003|NCT02396953|157362619|FG002|Overall Study|Insulin like Growth Factor-1 increased|2|||
48870004|NCT02396953|157362617|FG000|Overall Study|Personal Reasons|1|||
48870005|NCT02396953|157362618|FG001|Overall Study|Personal Reasons|1|||
48870006|NCT02396953|157362619|FG002|Overall Study|Personal Reasons|0|||
48870007|NCT00488319|157362620|FG000|Overall Study|Adverse Event|1|||
48870008|NCT00488319|157362621|FG001|Overall Study|Adverse Event|2|||
48870009|NCT00488319|157362622|FG002|Overall Study|Adverse Event|23|||
48870010|NCT00488319|157362620|FG000|Overall Study|Lack of Efficacy|6|||
48870011|NCT00488319|157362621|FG001|Overall Study|Lack of Efficacy|12|||
48870012|NCT00488319|157362622|FG002|Overall Study|Lack of Efficacy|27|||
48870013|NCT00488319|157362620|FG000|Overall Study|Lost to Follow-up|3|||
48870014|NCT00488319|157362621|FG001|Overall Study|Lost to Follow-up|5|||
48870015|NCT00488319|157362622|FG002|Overall Study|Lost to Follow-up|16|||
48870016|NCT00488319|157362620|FG000|Overall Study|Withdrawal by Subject|5|||
48870017|NCT00488319|157362621|FG001|Overall Study|Withdrawal by Subject|20|||
48870018|NCT00488319|157362622|FG002|Overall Study|Withdrawal by Subject|44|||
48870019|NCT00488319|157362620|FG000|Overall Study|Other reasons for withdrawal|0|||
48870020|NCT00488319|157362621|FG001|Overall Study|Other reasons for withdrawal|4|||
48870021|NCT00488319|157362622|FG002|Overall Study|Other reasons for withdrawal|12|||
48870022|NCT00706914|157362623|FG000|Overall Study|Lack of Efficacy|0|||
48669236|NCT01672866|156641465|FG001|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42|||
48669237|NCT01672866|156641466|FG002|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35|||
48669238|NCT01672866|156641464|FG000|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9|||
48669239|NCT01672866|156641465|FG001|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8|||
48669240|NCT01672866|156641466|FG002|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12|||
48669241|NCT01672866|156641464|FG000|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
48669242|NCT01672866|156641465|FG001|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
48669243|NCT01672866|156641466|FG002|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5|||
48669244|NCT01672866|156641464|FG000|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
48669245|NCT01672866|156641465|FG001|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
48669246|NCT01672866|156641466|FG002|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
48870023|NCT00706914|157362624|FG001|Overall Study|Lack of Efficacy|1|||
48870024|NCT00706914|157362625|FG002|Overall Study|Lack of Efficacy|0|||
48870025|NCT00706914|157362623|FG000|Overall Study|Lost to Follow-up|1|||
48870026|NCT00706914|157362624|FG001|Overall Study|Lost to Follow-up|0|||
48870027|NCT00706914|157362625|FG002|Overall Study|Lost to Follow-up|0|||
48870028|NCT00706914|157362623|FG000|Overall Study|Adverse Event|2|||
48870029|NCT00706914|157362624|FG001|Overall Study|Adverse Event|2|||
48870030|NCT00706914|157362625|FG002|Overall Study|Adverse Event|0|||
48870031|NCT00706914|157362623|FG000|Overall Study|Protocol Violation|3|||
48759444|NCT00623727|156967933|FG001|Open Label Follow-up|Withdrawal by Subject|1|||
48759445|NCT00623727|156967932|FG000|Open Label Follow-up|Study termination|0|||
48759446|NCT00623727|156967933|FG001|Open Label Follow-up|Study termination|6|||
48759447|NCT00623727|156967932|FG000|Open Label Follow-up|Participant convenience|0|||
48759448|NCT00623727|156967933|FG001|Open Label Follow-up|Participant convenience|1|||
48759449|NCT01199289|156967934|FG000|Overall Study|Ineligibility determined|2|||
48759450|NCT01199289|156967935|FG001|Overall Study|Ineligibility determined|1|||
48759451|NCT01199289|156967936|FG002|Overall Study|Ineligibility determined|0|||
48759452|NCT01199289|156967937|FG003|Overall Study|Ineligibility determined|0|||
48759453|NCT01199289|156967934|FG000|Overall Study|Protocol Violation|1|||
48759454|NCT01199289|156967935|FG001|Overall Study|Protocol Violation|0|||
48759455|NCT01199289|156967936|FG002|Overall Study|Protocol Violation|0|||
48759456|NCT01199289|156967937|FG003|Overall Study|Protocol Violation|1|||
48759457|NCT01199289|156967934|FG000|Overall Study|Noncompliance|1|||
48759458|NCT01199289|156967935|FG001|Overall Study|Noncompliance|0|||
48759459|NCT01199289|156967936|FG002|Overall Study|Noncompliance|2|||
48759460|NCT01199289|156967937|FG003|Overall Study|Noncompliance|0|||
48759461|NCT01199289|156967934|FG000|Overall Study|Adverse Event|0|||
48759462|NCT01199289|156967935|FG001|Overall Study|Adverse Event|3|||
48759463|NCT01199289|156967936|FG002|Overall Study|Adverse Event|1|||
48759464|NCT01199289|156967937|FG003|Overall Study|Adverse Event|4|||
48759465|NCT01199289|156967934|FG000|Overall Study|Full consent withdrawn|2|||
48759466|NCT01199289|156967935|FG001|Overall Study|Full consent withdrawn|2|||
48759467|NCT01199289|156967936|FG002|Overall Study|Full consent withdrawn|2|||
48759468|NCT01199289|156967937|FG003|Overall Study|Full consent withdrawn|3|||
48759469|NCT01199289|156967934|FG000|Overall Study|Administrative decision|0|||
48870032|NCT00706914|157362624|FG001|Overall Study|Protocol Violation|1|||
48759470|NCT01199289|156967935|FG001|Overall Study|Administrative decision|0|||
48759471|NCT01199289|156967936|FG002|Overall Study|Administrative decision|0|||
48759472|NCT01199289|156967937|FG003|Overall Study|Administrative decision|1|||
48759473|NCT01199289|156967934|FG000|Overall Study|Lost to Follow-up|0|||
48759474|NCT01199289|156967935|FG001|Overall Study|Lost to Follow-up|0|||
48759475|NCT01199289|156967936|FG002|Overall Study|Lost to Follow-up|0|||
48759476|NCT01199289|156967937|FG003|Overall Study|Lost to Follow-up|1|||
48759477|NCT01199289|156967934|FG000|Overall Study|Protocol-specified criteria|3|||
48759478|NCT01199289|156967935|FG001|Overall Study|Protocol-specified criteria|0|||
48759479|NCT01199289|156967936|FG002|Overall Study|Protocol-specified criteria|0|||
48759480|NCT01199289|156967937|FG003|Overall Study|Protocol-specified criteria|1|||
48759481|NCT01199289|156967934|FG000|Overall Study|Pregnancy|0|||
48759482|NCT01199289|156967935|FG001|Overall Study|Pregnancy|1|||
48759483|NCT01199289|156967936|FG002|Overall Study|Pregnancy|0|||
48759484|NCT01199289|156967937|FG003|Overall Study|Pregnancy|1|||
48759485|NCT02636868|156967938|FG000|Overall Study|Death|0|||
48759486|NCT02636868|156967939|FG001|Overall Study|Death|1|||
48759487|NCT02636868|156967940|FG002|Overall Study|Death|2|||
48759488|NCT02141282|156967941|FG000|Overall Study|Adverse event, not related to progression|8|||
48759489|NCT02141282|156967942|FG001|Overall Study|Adverse event, not related to progression|1|||
48759490|NCT02141282|156967943|FG002|Overall Study|Adverse event, not related to progression|3|||
48759491|NCT02141282|156967944|FG003|Overall Study|Adverse event, not related to progression|1|||
48759492|NCT02141282|156967941|FG000|Overall Study|Adverse event, related to progression|1|||
48759493|NCT02141282|156967942|FG001|Overall Study|Adverse event, related to progression|0|||
48759494|NCT02141282|156967943|FG002|Overall Study|Adverse event, related to progression|2|||
48759495|NCT02141282|156967944|FG003|Overall Study|Adverse event, related to progression|0|||
48759496|NCT02141282|156967941|FG000|Overall Study|COVID-19 infection|1|||
48759497|NCT02141282|156967942|FG001|Overall Study|COVID-19 infection|0|||
48759498|NCT02141282|156967943|FG002|Overall Study|COVID-19 infection|0|||
48759499|NCT02141282|156967944|FG003|Overall Study|COVID-19 infection|0|||
48870033|NCT00706914|157362625|FG002|Overall Study|Protocol Violation|1|||
48759500|NCT02141282|156967941|FG000|Overall Study|Lost to Follow-up|0|||
48759501|NCT02141282|156967942|FG001|Overall Study|Lost to Follow-up|0|||
48759502|NCT02141282|156967943|FG002|Overall Study|Lost to Follow-up|4|||
48759503|NCT02141282|156967944|FG003|Overall Study|Lost to Follow-up|2|||
48759504|NCT02141282|156967941|FG000|Overall Study|Other, not specified|14|||
48759505|NCT02141282|156967942|FG001|Overall Study|Other, not specified|11|||
48759506|NCT02141282|156967943|FG002|Overall Study|Other, not specified|23|||
48759507|NCT02141282|156967944|FG003|Overall Study|Other, not specified|9|||
48759508|NCT02141282|156967941|FG000|Overall Study|Progressive disease, Richter's|4|||
48870034|NCT01059526|157362630|FG000|Overall Study|Patient enrolled but not treated|20|||
48870035|NCT01059526|157362631|FG001|Overall Study|Patient enrolled but not treated|17|||
48870036|NCT01059526|157362630|FG000|Overall Study|Adverse Event|2|||
48870037|NCT01059526|157362631|FG001|Overall Study|Adverse Event|2|||
48870038|NCT01059526|157362630|FG000|Overall Study|Protocol Violation|0|||
48759509|NCT02141282|156967942|FG001|Overall Study|Progressive disease, Richter's|1|||
48759510|NCT02141282|156967943|FG002|Overall Study|Progressive disease, Richter's|1|||
48759511|NCT02141282|156967944|FG003|Overall Study|Progressive disease, Richter's|1|||
48759512|NCT02141282|156967941|FG000|Overall Study|Progressive disease per protocol|12|||
48759513|NCT02141282|156967942|FG001|Overall Study|Progressive disease per protocol|7|||
48759514|NCT02141282|156967943|FG002|Overall Study|Progressive disease per protocol|9|||
48759515|NCT02141282|156967944|FG003|Overall Study|Progressive disease per protocol|2|||
48759516|NCT02141282|156967941|FG000|Overall Study|Stem cell transplant|1|||
48669247|NCT01672866|156641464|FG000|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
48669248|NCT01672866|156641465|FG001|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
48669249|NCT01672866|156641466|FG002|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2|||
48669250|NCT01672866|156641464|FG000|Blinded Phase (up to 240 Weeks)|Protocol Violation|2|||
48669251|NCT01672866|156641465|FG001|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
48759517|NCT02141282|156967942|FG001|Overall Study|Stem cell transplant|0|||
48759518|NCT02141282|156967943|FG002|Overall Study|Stem cell transplant|1|||
48759519|NCT02141282|156967944|FG003|Overall Study|Stem cell transplant|0|||
48759520|NCT02141282|156967941|FG000|Overall Study|Study terminated by Sponsor|0|||
48759521|NCT02141282|156967942|FG001|Overall Study|Study terminated by Sponsor|1|||
48759522|NCT02141282|156967943|FG002|Overall Study|Study terminated by Sponsor|0|||
48759523|NCT02141282|156967944|FG003|Overall Study|Study terminated by Sponsor|0|||
48759524|NCT02141282|156967941|FG000|Overall Study|Subject non-compliance|0|||
48759525|NCT02141282|156967942|FG001|Overall Study|Subject non-compliance|0|||
48759526|NCT02141282|156967943|FG002|Overall Study|Subject non-compliance|1|||
48759527|NCT02141282|156967944|FG003|Overall Study|Subject non-compliance|0|||
48759528|NCT02141282|156967941|FG000|Overall Study|Withdrew consent|2|||
48759529|NCT02141282|156967942|FG001|Overall Study|Withdrew consent|0|||
48759530|NCT02141282|156967943|FG002|Overall Study|Withdrew consent|4|||
48759531|NCT02141282|156967944|FG003|Overall Study|Withdrew consent|0|||
48759532|NCT03312933|156967945|FG000|Overall Study|Protocol Violation|15|||
48759533|NCT03312933|156967945|FG000|Overall Study|Lost to Follow-up|36|||
48759534|NCT03312933|156967945|FG000|Overall Study|Withdrawal by Subject|3|||
48759535|NCT02068443|156967946|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
48759536|NCT02068443|156967947|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
48759537|NCT02068443|156967948|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
48759538|NCT02068443|156967946|FG000|Overall Study|Voluntary Withdrawal|4|||
48759539|NCT02068443|156967947|FG001|Overall Study|Voluntary Withdrawal|0|||
48759540|NCT02068443|156967948|FG002|Overall Study|Voluntary Withdrawal|1|||
48759541|NCT02068443|156967946|FG000|Overall Study|Lack of Efficacy|2|||
48759542|NCT02068443|156967947|FG001|Overall Study|Lack of Efficacy|1|||
48759543|NCT02068443|156967948|FG002|Overall Study|Lack of Efficacy|0|||
48759544|NCT02068443|156967946|FG000|Overall Study|Other Reason Not Specified|1|||
48759545|NCT02068443|156967947|FG001|Overall Study|Other Reason Not Specified|0|||
48759546|NCT02068443|156967948|FG002|Overall Study|Other Reason Not Specified|0|||
48759547|NCT01986855|156967949|FG000|Overall Study|Adverse Event|1|||
48759548|NCT01986855|156967950|FG001|Overall Study|Adverse Event|0|||
48759549|NCT01986855|156967951|FG002|Overall Study|Adverse Event|0|||
48870039|NCT01059526|157362631|FG001|Overall Study|Protocol Violation|1|||
48870040|NCT01059526|157362630|FG000|Overall Study|Withdrawal by Subject|3|||
48870041|NCT01059526|157362631|FG001|Overall Study|Withdrawal by Subject|1|||
48870042|NCT01059526|157362630|FG000|Overall Study|Lost to Follow-up|4|||
48870043|NCT01059526|157362631|FG001|Overall Study|Lost to Follow-up|1|||
48870044|NCT01059526|157362630|FG000|Overall Study|Patient found to be dermatographic|1|||
48669252|NCT01672866|156641466|FG002|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
48669253|NCT01672866|156641464|FG000|Blinded Phase (up to 240 Weeks)|Death|0|||
48669254|NCT01672866|156641465|FG001|Blinded Phase (up to 240 Weeks)|Death|0|||
48669255|NCT01672866|156641466|FG002|Blinded Phase (up to 240 Weeks)|Death|1|||
48669256|NCT01672866|156641464|FG000|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3|||
48669257|NCT01672866|156641465|FG001|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
48669258|NCT01672866|156641466|FG002|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
48669259|NCT01672866|156641464|FG000|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11|||
48759550|NCT01986855|156967949|FG000|Overall Study|Death|3|||
48759551|NCT01986855|156967950|FG001|Overall Study|Death|4|||
48759552|NCT01986855|156967951|FG002|Overall Study|Death|4|||
48759553|NCT01986855|156967949|FG000|Overall Study|Lost to Follow-up|2|||
48759554|NCT01986855|156967950|FG001|Overall Study|Lost to Follow-up|1|||
48759555|NCT01986855|156967951|FG002|Overall Study|Lost to Follow-up|0|||
48759556|NCT01986855|156967949|FG000|Overall Study|Screen Failure|0|||
48759557|NCT01986855|156967950|FG001|Overall Study|Screen Failure|1|||
48759558|NCT01986855|156967951|FG002|Overall Study|Screen Failure|0|||
48759559|NCT01986855|156967949|FG000|Overall Study|Participant Moved|0|||
48870045|NCT01059526|157362631|FG001|Overall Study|Patient found to be dermatographic|0|||
48870046|NCT00523549|157362635|FG000|Overall Study|Adverse Event|6|||
48870047|NCT00523549|157362636|FG001|Overall Study|Adverse Event|3|||
48870048|NCT00523549|157362635|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
48870049|NCT00523549|157362636|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
48870050|NCT00523549|157362635|FG000|Overall Study|Protocol Deviation|3|||
48870051|NCT00523549|157362636|FG001|Overall Study|Protocol Deviation|1|||
48759560|NCT01986855|156967950|FG001|Overall Study|Participant Moved|0|||
48759561|NCT01986855|156967951|FG002|Overall Study|Participant Moved|2|||
48669260|NCT01672866|156641465|FG001|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15|||
48669261|NCT01672866|156641466|FG002|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16|||
48669262|NCT01672866|156641464|FG000|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8|||
48669263|NCT01672866|156641465|FG001|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
48669264|NCT01672866|156641466|FG002|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
48669265|NCT01672866|156641464|FG000|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
48669266|NCT01672866|156641465|FG001|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0|||
48669267|NCT01672866|156641466|FG002|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
48669268|NCT01672866|156641464|FG000|Open-Label Phase (up to 240 Weeks)|Death|1|||
48669269|NCT01672866|156641465|FG001|Open-Label Phase (up to 240 Weeks)|Death|0|||
48669270|NCT01672866|156641466|FG002|Open-Label Phase (up to 240 Weeks)|Death|0|||
48669271|NCT01672866|156641464|FG000|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1|||
48669272|NCT01672866|156641465|FG001|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
48669273|NCT01672866|156641466|FG002|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
48669274|NCT01459913|156641467|FG000|Overall Study|Adverse Event|0|||
48669275|NCT01459913|156641468|FG001|Overall Study|Adverse Event|0|||
48669276|NCT01459913|156641469|FG002|Overall Study|Adverse Event|0|||
48870052|NCT00523549|157362635|FG000|Overall Study|Patient withdrew consent|7|||
48870053|NCT00523549|157362636|FG001|Overall Study|Patient withdrew consent|6|||
48870054|NCT00523549|157362635|FG000|Overall Study|Lost to Follow-up|3|||
48870055|NCT00523549|157362636|FG001|Overall Study|Lost to Follow-up|5|||
48870056|NCT03463577|157362637|FG000|Overall Study|Lost to Follow-up|238|||
48870057|NCT03463577|157362638|FG001|Overall Study|Lost to Follow-up|435|||
48669277|NCT01459913|156641470|FG003|Overall Study|Adverse Event|3|||
48669278|NCT01459913|156641467|FG000|Overall Study|Withdrawal by Subject|4|||
48669279|NCT01459913|156641468|FG001|Overall Study|Withdrawal by Subject|0|||
48669280|NCT01459913|156641469|FG002|Overall Study|Withdrawal by Subject|0|||
48669281|NCT01459913|156641470|FG003|Overall Study|Withdrawal by Subject|5|||
48669282|NCT01459913|156641467|FG000|Overall Study|Lost to Follow-up|7|||
48669283|NCT01459913|156641468|FG001|Overall Study|Lost to Follow-up|4|||
48669284|NCT01459913|156641469|FG002|Overall Study|Lost to Follow-up|1|||
48669285|NCT01459913|156641470|FG003|Overall Study|Lost to Follow-up|8|||
48669286|NCT01459913|156641467|FG000|Overall Study|Death|0|||
48669287|NCT01459913|156641468|FG001|Overall Study|Death|0|||
48669288|NCT01459913|156641469|FG002|Overall Study|Death|0|||
48669289|NCT01459913|156641470|FG003|Overall Study|Death|1|||
48669290|NCT01459913|156641467|FG000|Overall Study|Non- Compliance|0|||
48669291|NCT01459913|156641468|FG001|Overall Study|Non- Compliance|0|||
48669292|NCT01459913|156641469|FG002|Overall Study|Non- Compliance|0|||
48669293|NCT01459913|156641470|FG003|Overall Study|Non- Compliance|3|||
48669294|NCT01459913|156641467|FG000|Overall Study|Physician Decision|0|||
48669295|NCT01459913|156641468|FG001|Overall Study|Physician Decision|1|||
48669296|NCT01459913|156641469|FG002|Overall Study|Physician Decision|0|||
48669297|NCT01459913|156641470|FG003|Overall Study|Physician Decision|0|||
48669298|NCT01459913|156641467|FG000|Overall Study|Study Terminated by Sponsor|30|||
48669299|NCT01459913|156641468|FG001|Overall Study|Study Terminated by Sponsor|15|||
48669300|NCT01459913|156641469|FG002|Overall Study|Study Terminated by Sponsor|9|||
48669301|NCT01459913|156641470|FG003|Overall Study|Study Terminated by Sponsor|11|||
48669302|NCT01459913|156641467|FG000|Overall Study|Other|0|||
48669303|NCT01459913|156641468|FG001|Overall Study|Other|0|||
48669304|NCT01459913|156641469|FG002|Overall Study|Other|3|||
48669305|NCT01459913|156641470|FG003|Overall Study|Other|1|||
48669306|NCT01459913|156641467|FG000|Overall Study|Did Not Meet Inclusion Criteria|0|||
48669307|NCT01459913|156641468|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
48669308|NCT01459913|156641469|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
48669309|NCT01459913|156641470|FG003|Overall Study|Did Not Meet Inclusion Criteria|1|||
48669310|NCT01389323|156641471|FG000|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41|||
48669311|NCT01389323|156641471|FG000|Treatment Period (up to 48 Weeks)|Adverse Event|24|||
48669312|NCT01389323|156641471|FG000|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6|||
48669313|NCT01389323|156641471|FG000|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7|||
48669314|NCT01389323|156641471|FG000|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10|||
48669315|NCT01389323|156641471|FG000|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5|||
48870058|NCT03463577|157362639|FG002|Overall Study|Lost to Follow-up|0|||
48669316|NCT01389323|156641471|FG000|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2|||
48669317|NCT01389323|156641471|FG000|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10|||
48669318|NCT01389323|156641471|FG000|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22|||
48669319|NCT01389323|156641471|FG000|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2|||
48669320|NCT01389323|156641471|FG000|Follow-up Period (up to 48 Weeks)|Other|3|||
48669321|NCT01064687|156641474|FG000|Overall Study|Adverse Event|9|||
48870059|NCT03463577|157362640|FG003|Overall Study|Lost to Follow-up|0|||
48870060|NCT03463577|157362641|FG004|Overall Study|Lost to Follow-up|0|||
48669322|NCT01064687|156641475|FG001|Overall Study|Adverse Event|4|||
48669323|NCT01064687|156641476|FG002|Overall Study|Adverse Event|10|||
48669324|NCT01064687|156641477|FG003|Overall Study|Adverse Event|3|||
48669325|NCT01064687|156641474|FG000|Overall Study|Death|1|||
48669326|NCT01064687|156641475|FG001|Overall Study|Death|1|||
48669327|NCT01064687|156641476|FG002|Overall Study|Death|0|||
48669328|NCT01064687|156641477|FG003|Overall Study|Death|0|||
48669329|NCT01064687|156641474|FG000|Overall Study|Entry Criteria Not Met|3|||
48669330|NCT01064687|156641475|FG001|Overall Study|Entry Criteria Not Met|0|||
48669331|NCT01064687|156641476|FG002|Overall Study|Entry Criteria Not Met|0|||
48669332|NCT01064687|156641477|FG003|Overall Study|Entry Criteria Not Met|0|||
48669333|NCT01064687|156641474|FG000|Overall Study|Lack of Efficacy|1|||
48759562|NCT01986855|156967949|FG000|Overall Study|Withdrawal by Subject|7|||
48759563|NCT01986855|156967950|FG001|Overall Study|Withdrawal by Subject|8|||
48759564|NCT01986855|156967951|FG002|Overall Study|Withdrawal by Subject|5|||
48759565|NCT00664742|156967952|FG000|Overall Study|Withdrawn due to adverse events|3|||
48759566|NCT00664742|156967952|FG000|Overall Study|Withdrawal by Subject|31|||
48759567|NCT00664742|156967952|FG000|Overall Study|Lost to Follow-up|92|||
48669334|NCT01064687|156641475|FG001|Overall Study|Lack of Efficacy|0|||
48669335|NCT01064687|156641476|FG002|Overall Study|Lack of Efficacy|2|||
48669336|NCT01064687|156641477|FG003|Overall Study|Lack of Efficacy|3|||
48669337|NCT01064687|156641474|FG000|Overall Study|Lost to Follow-up|7|||
48669338|NCT01064687|156641475|FG001|Overall Study|Lost to Follow-up|10|||
48669339|NCT01064687|156641476|FG002|Overall Study|Lost to Follow-up|13|||
48669340|NCT01064687|156641477|FG003|Overall Study|Lost to Follow-up|5|||
48669341|NCT01064687|156641474|FG000|Overall Study|Physician Decision|2|||
48669342|NCT01064687|156641475|FG001|Overall Study|Physician Decision|2|||
48669343|NCT01064687|156641476|FG002|Overall Study|Physician Decision|0|||
48759568|NCT03745937|156967953|FG000|Overall Study|Withdrawal by Subject|0|||
48759569|NCT03745937|156967954|FG001|Overall Study|Withdrawal by Subject|0|||
48759570|NCT03745937|156967955|FG002|Overall Study|Withdrawal by Subject|0|||
48759571|NCT03745937|156967956|FG003|Overall Study|Withdrawal by Subject|1|||
48759572|NCT03745937|156967953|FG000|Overall Study|Not-specifed|0|||
48759573|NCT03745937|156967954|FG001|Overall Study|Not-specifed|1|||
48759574|NCT03745937|156967955|FG002|Overall Study|Not-specifed|0|||
48759575|NCT03745937|156967956|FG003|Overall Study|Not-specifed|1|||
48759576|NCT00156533|156967960|FG000|Overall Study|Withdrawn - Medication Expiration|0|||
48759577|NCT00156533|156967961|FG001|Overall Study|Withdrawn - Medication Expiration|2|||
48759578|NCT00156533|156967962|FG002|Overall Study|Withdrawn - Medication Expiration|1|||
48759579|NCT00156533|156967963|FG003|Overall Study|Withdrawn - Medication Expiration|0|||
48759580|NCT00156533|156967960|FG000|Overall Study|Withdrawal by Subject|1|||
48759581|NCT00156533|156967961|FG001|Overall Study|Withdrawal by Subject|0|||
48759582|NCT00156533|156967962|FG002|Overall Study|Withdrawal by Subject|0|||
48669344|NCT01064687|156641477|FG003|Overall Study|Physician Decision|0|||
48669345|NCT01064687|156641474|FG000|Overall Study|Protocol Violation|1|||
48669346|NCT01064687|156641475|FG001|Overall Study|Protocol Violation|1|||
48669347|NCT01064687|156641476|FG002|Overall Study|Protocol Violation|0|||
48669348|NCT01064687|156641477|FG003|Overall Study|Protocol Violation|1|||
48669349|NCT01064687|156641474|FG000|Overall Study|Sponsor Decision|0|||
48669350|NCT01064687|156641475|FG001|Overall Study|Sponsor Decision|0|||
48669351|NCT01064687|156641476|FG002|Overall Study|Sponsor Decision|3|||
48870061|NCT03463577|157362642|FG005|Overall Study|Lost to Follow-up|0|||
48870062|NCT03463577|157362637|FG000|Overall Study|With unknown pregnancy outcome|0|||
48870063|NCT03463577|157362638|FG001|Overall Study|With unknown pregnancy outcome|5|||
48669352|NCT01064687|156641477|FG003|Overall Study|Sponsor Decision|0|||
48669353|NCT01064687|156641474|FG000|Overall Study|Withdrawal by Subject|9|||
48669354|NCT01064687|156641475|FG001|Overall Study|Withdrawal by Subject|7|||
48669355|NCT01064687|156641476|FG002|Overall Study|Withdrawal by Subject|12|||
48669356|NCT01064687|156641477|FG003|Overall Study|Withdrawal by Subject|5|||
48759583|NCT00156533|156967963|FG003|Overall Study|Withdrawal by Subject|1|||
48759584|NCT00156533|156967960|FG000|Overall Study|Failed Screening|1|||
48870064|NCT03463577|157362639|FG002|Overall Study|With unknown pregnancy outcome|0|||
48870065|NCT03463577|157362640|FG003|Overall Study|With unknown pregnancy outcome|0|||
48870066|NCT03463577|157362641|FG004|Overall Study|With unknown pregnancy outcome|0|||
48870067|NCT03463577|157362642|FG005|Overall Study|With unknown pregnancy outcome|0|||
48870068|NCT03463577|157362637|FG000|Overall Study|Maternal death|2|||
48669357|NCT01064687|156641474|FG000|Overall Study|Treatment Noncompliance|1|||
48669358|NCT01064687|156641475|FG001|Overall Study|Treatment Noncompliance|1|||
48669359|NCT01064687|156641476|FG002|Overall Study|Treatment Noncompliance|1|||
48669360|NCT01064687|156641477|FG003|Overall Study|Treatment Noncompliance|0|||
48669361|NCT00619489|156641478|FG000|Overall Study|Adverse Event|0|||
48669362|NCT00619489|156641479|FG001|Overall Study|Adverse Event|7|||
48669363|NCT00619489|156641478|FG000|Overall Study|Withdrawal by Subject|1|||
48669364|NCT00619489|156641479|FG001|Overall Study|Withdrawal by Subject|1|||
48759585|NCT00156533|156967961|FG001|Overall Study|Failed Screening|0|||
48759586|NCT00156533|156967962|FG002|Overall Study|Failed Screening|1|||
48759587|NCT00156533|156967963|FG003|Overall Study|Failed Screening|1|||
48759588|NCT00082355|156967964|FG000|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1|||
48669365|NCT00619489|156641478|FG000|Overall Study|Lack of Efficacy|0|||
48669366|NCT00619489|156641479|FG001|Overall Study|Lack of Efficacy|11|||
48669367|NCT00619489|156641478|FG000|Overall Study|Rolled over to Study C13008 (NCT00790933|22|||
48669368|NCT00619489|156641479|FG001|Overall Study|Rolled over to Study C13008 (NCT00790933|15|||
48669369|NCT02966015|156641480|FG000|Inclusion Visit|did not answer questionnaire|8|||
48669370|NCT02966015|156641481|FG001|Inclusion Visit|did not answer questionnaire|3|||
48669371|NCT00845065|156641483|FG000|Overall Study|Adverse Event|3|||
48669372|NCT00845065|156641484|FG001|Overall Study|Adverse Event|23|||
48669373|NCT00845065|156641483|FG000|Overall Study|Lack of Efficacy|43|||
48669374|NCT00845065|156641484|FG001|Overall Study|Lack of Efficacy|21|||
48669375|NCT00845065|156641483|FG000|Overall Study|Non-Medical Reasons|1|||
48669376|NCT00845065|156641484|FG001|Overall Study|Non-Medical Reasons|11|||
48669377|NCT01977690|156641485|FG000|Overall Study|Withdrawal by Subject|0|||
48669378|NCT01977690|156641486|FG001|Overall Study|Withdrawal by Subject|4|||
48669379|NCT02644356|156641489|FG000|Overall Study|Withdrawal by Subject|2|||
48669380|NCT01291277|156641490|FG000|Overall Study|Death|2|||
48669381|NCT01291277|156641491|FG001|Overall Study|Death|2|||
48669382|NCT01291277|156641490|FG000|Overall Study|Lost to Follow-up|3|||
48669383|NCT01291277|156641491|FG001|Overall Study|Lost to Follow-up|1|||
48669384|NCT01831817|156641492|FG000|Overall Study|Lost to Follow-up|1|||
48669385|NCT01831817|156641493|FG001|Overall Study|Lost to Follow-up|0|||
48669386|NCT01831817|156641494|FG002|Overall Study|Lost to Follow-up|0|||
48759589|NCT00082355|156967964|FG000|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1|||
48759590|NCT00082355|156967964|FG000|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28|||
48759591|NCT01254227|156967965|FG000|Overall Study|Withdrawal by Subject|6|||
48759592|NCT01254227|156967965|FG000|Overall Study|Lost to Follow-up|6|||
48759593|NCT01254227|156967965|FG000|Overall Study|Adverse Event|5|||
48759594|NCT01254227|156967965|FG000|Overall Study|Abnormal test procedure result|5|||
48759595|NCT01254227|156967965|FG000|Overall Study|Administrative problems|2|||
48759596|NCT01254227|156967965|FG000|Overall Study|Death|1|||
48759597|NCT01254227|156967965|FG000|Overall Study|Protocol deviation|1|||
48759598|NCT01485640|156967966|FG000|Overall Study|Adverse Event|10|||
48759599|NCT01485640|156967966|FG000|Overall Study|Lack of Efficacy|2|||
48759600|NCT01485640|156967966|FG000|Overall Study|Protocol Violation|1|||
48759601|NCT01485640|156967966|FG000|Overall Study|Withdrawal by Subject|14|||
48759602|NCT01485640|156967966|FG000|Overall Study|Terminated by Sponsor|95|||
48759603|NCT03020407|156967967|FG000|Overall Study|Withdrawal by Subject|2|||
48759604|NCT03020407|156967968|FG001|Overall Study|Withdrawal by Subject|1|||
48759605|NCT03020407|156967967|FG000|Overall Study|Lost to Follow-up|2|||
48759606|NCT03020407|156967968|FG001|Overall Study|Lost to Follow-up|3|||
48759607|NCT03020407|156967967|FG000|Overall Study|Protocol Violation|0|||
48759608|NCT03020407|156967968|FG001|Overall Study|Protocol Violation|1|||
48759609|NCT00708643|156967969|FG000|Overall Study|Adverse Event|0|||
48759610|NCT00708643|156967970|FG001|Overall Study|Adverse Event|1|||
48759611|NCT00887354|156967972|FG000|Treatment Phase (Week 0 to Week 26)|Death|0|||
48759612|NCT00887354|156967973|FG001|Treatment Phase (Week 0 to Week 26)|Death|1|||
48759613|NCT00887354|156967972|FG000|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
48759614|NCT00887354|156967973|FG001|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
48759615|NCT00887354|156967972|FG000|Treatment Phase (Week 0 to Week 26)|Physician Decision|2|||
48759616|NCT00887354|156967973|FG001|Treatment Phase (Week 0 to Week 26)|Physician Decision|1|||
48759617|NCT00887354|156967972|FG000|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14|||
48759618|NCT00887354|156967973|FG001|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8|||
48759619|NCT00887354|156967972|FG000|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
48759620|NCT00887354|156967973|FG001|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
48759621|NCT00887354|156967972|FG000|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2|||
48759622|NCT00887354|156967973|FG001|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1|||
48759623|NCT00887354|156967972|FG000|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
48759624|NCT00887354|156967973|FG001|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
48759625|NCT00887354|156967972|FG000|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1|||
48759626|NCT00887354|156967973|FG001|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2|||
48759627|NCT00887354|156967972|FG000|Treatment Phase (Week 0 to Week 26)|No efficacy data|20|||
48759628|NCT00887354|156967973|FG001|Treatment Phase (Week 0 to Week 26)|No efficacy data|25|||
48759629|NCT00887354|156967972|FG000|Treatment Phase (Week 0 to Week 26)|Not Treated|5|||
48759630|NCT00887354|156967973|FG001|Treatment Phase (Week 0 to Week 26)|Not Treated|3|||
48759631|NCT00887354|156967972|FG000|Open Label Phase (Week 26 to Week 78)|Death|0|||
48759632|NCT00887354|156967973|FG001|Open Label Phase (Week 26 to Week 78)|Death|2|||
48759633|NCT00887354|156967972|FG000|Open Label Phase (Week 26 to Week 78)|Physician Decision|0|||
48759634|NCT00887354|156967973|FG001|Open Label Phase (Week 26 to Week 78)|Physician Decision|1|||
48759635|NCT00887354|156967972|FG000|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1|||
48669387|NCT01831817|156641495|FG003|Overall Study|Lost to Follow-up|0|||
48669388|NCT01831817|156641492|FG000|Overall Study|Withdrawl of Consent|3|||
48669389|NCT01831817|156641493|FG001|Overall Study|Withdrawl of Consent|0|||
48669390|NCT01831817|156641494|FG002|Overall Study|Withdrawl of Consent|0|||
48669391|NCT01831817|156641495|FG003|Overall Study|Withdrawl of Consent|0|||
48669392|NCT03684694|156641504|FG000|Phase 1|Withdrawal by Subject|1|||
48669393|NCT03684694|156641505|FG001|Phase 1|Withdrawal by Subject|0|||
48669394|NCT03684694|156641506|FG002|Phase 1|Withdrawal by Subject|0|||
48669395|NCT03684694|156641507|FG003|Phase 1|Withdrawal by Subject|0|||
48669396|NCT03684694|156641508|FG004|Phase 1|Withdrawal by Subject|0|||
48669397|NCT03684694|156641509|FG005|Phase 1|Withdrawal by Subject|0|||
48669398|NCT03684694|156641504|FG000|Phase 1|Investigator/Sponsor Decision|12|||
48669399|NCT03684694|156641505|FG001|Phase 1|Investigator/Sponsor Decision|2|||
48669400|NCT03684694|156641506|FG002|Phase 1|Investigator/Sponsor Decision|1|||
48669401|NCT03684694|156641507|FG003|Phase 1|Investigator/Sponsor Decision|0|||
48669402|NCT03684694|156641508|FG004|Phase 1|Investigator/Sponsor Decision|0|||
48669403|NCT03684694|156641509|FG005|Phase 1|Investigator/Sponsor Decision|0|||
48669404|NCT03684694|156641504|FG000|Phase 1|Death|24|||
48669405|NCT03684694|156641505|FG001|Phase 1|Death|0|||
48669406|NCT03684694|156641506|FG002|Phase 1|Death|3|||
48669407|NCT03684694|156641507|FG003|Phase 1|Death|0|||
48669408|NCT03684694|156641508|FG004|Phase 1|Death|0|||
48669409|NCT03684694|156641509|FG005|Phase 1|Death|0|||
48669410|NCT03684694|156641504|FG000|Phase 1|Lost to Follow-up|0|||
48669411|NCT03684694|156641505|FG001|Phase 1|Lost to Follow-up|0|||
48669412|NCT03684694|156641506|FG002|Phase 1|Lost to Follow-up|1|||
48669413|NCT03684694|156641507|FG003|Phase 1|Lost to Follow-up|0|||
48669414|NCT03684694|156641508|FG004|Phase 1|Lost to Follow-up|0|||
48669415|NCT03684694|156641509|FG005|Phase 1|Lost to Follow-up|0|||
48669416|NCT03684694|156641504|FG000|Phase 1|Miscellaneous|0|||
48759636|NCT00887354|156967973|FG001|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2|||
48759637|NCT00887354|156967972|FG000|Open Label Phase (Week 26 to Week 78)|Adverse Event|1|||
48759638|NCT00887354|156967973|FG001|Open Label Phase (Week 26 to Week 78)|Adverse Event|0|||
48759639|NCT00887354|156967972|FG000|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
48759640|NCT00887354|156967973|FG001|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
48759641|NCT00665353|156967976|FG000|Study Step 1|Adverse Event|1|||
48759642|NCT00665353|156967976|FG000|Study Step 1|Withdrawal by Subject|2|||
48759643|NCT00665353|156967976|FG000|Study Step 2|Lost to Follow-up|2|||
48759644|NCT00665353|156967976|FG000|Study Step 2|Lack of Efficacy|12|||
48759645|NCT01012622|156967977|FG000|Overall Study|Withdrawal by Subject|6|||
48759646|NCT01012622|156967977|FG000|Overall Study|Lost to Follow-up|5|||
48759647|NCT01012622|156967977|FG000|Overall Study|Adverse Event|7|||
48759648|NCT01012622|156967977|FG000|Overall Study|non-compliance with the drug|9|||
48759649|NCT01012622|156967977|FG000|Overall Study|Other|1|||
48759650|NCT01012622|156967977|FG000|Overall Study|screening failure|1|||
48759651|NCT01012622|156967977|FG000|Overall Study|withdrawal of consent by a parent|2|||
48759652|NCT04532099|156967978|FG000|First Wear Period (30 Days)|Withdrawal by Subject|1|||
48759653|NCT04532099|156967979|FG001|First Wear Period (30 Days)|Withdrawal by Subject|0|||
48759654|NCT04532099|156967980|FG002|First Wear Period (30 Days)|Withdrawal by Subject|0|||
48759655|NCT03724812|156967981|FG000|Overall Study|Missed Visit|1|||
48759656|NCT03724812|156967981|FG000|Overall Study|Death|2|||
48759657|NCT03724812|156967981|FG000|Overall Study|Withdrawal by Subject|1|||
48759658|NCT04461015|156967987|FG000|Overall Study|IV access lost during the study|0|||
48759659|NCT04461015|156967988|FG001|Overall Study|IV access lost during the study|1|||
48870069|NCT03463577|157362638|FG001|Overall Study|Maternal death|0|||
48870070|NCT03463577|157362639|FG002|Overall Study|Maternal death|0|||
48870071|NCT03463577|157362640|FG003|Overall Study|Maternal death|0|||
48870072|NCT03463577|157362641|FG004|Overall Study|Maternal death|0|||
48870073|NCT03463577|157362642|FG005|Overall Study|Maternal death|0|||
48870074|NCT03463577|157362637|FG000|Overall Study|Neonatal death|0|||
48870075|NCT03463577|157362638|FG001|Overall Study|Neonatal death|0|||
48870076|NCT03463577|157362639|FG002|Overall Study|Neonatal death|0|||
48870077|NCT03463577|157362640|FG003|Overall Study|Neonatal death|15|||
48870078|NCT03463577|157362641|FG004|Overall Study|Neonatal death|17|||
48870079|NCT03463577|157362642|FG005|Overall Study|Neonatal death|0|||
48870080|NCT00843115|157362645|FG000|Overall Study|Death|4|||
48870081|NCT00843115|157362645|FG000|Overall Study|Adverse Event|30|||
48870082|NCT00843115|157362645|FG000|Overall Study|Lost to Follow-up|4|||
48870083|NCT00843115|157362645|FG000|Overall Study|Withdrawal by Subject|17|||
48870084|NCT00843115|157362645|FG000|Overall Study|Family wanted meds stopped|1|||
48870085|NCT00843115|157362645|FG000|Overall Study|Family does not want continuation|1|||
48870086|NCT00843115|157362645|FG000|Overall Study|Patient forgot to take meds|1|||
48870087|NCT00843115|157362645|FG000|Overall Study|Does not meet entrance criteria|1|||
48870088|NCT00843115|157362645|FG000|Overall Study|Physician Decision|1|||
48870089|NCT00843115|157362645|FG000|Overall Study|Family discontinued meds|1|||
48870090|NCT00843115|157362645|FG000|Overall Study|patient took for 2 days then stopped|1|||
48870091|NCT00843115|157362645|FG000|Overall Study|patient never took the medication|1|||
48870092|NCT00843115|157362645|FG000|Overall Study|hospitalized due to deterioration|1|||
48669417|NCT03684694|156641505|FG001|Phase 1|Miscellaneous|1|||
48669418|NCT03684694|156641506|FG002|Phase 1|Miscellaneous|0|||
48669419|NCT03684694|156641507|FG003|Phase 1|Miscellaneous|0|||
48669420|NCT03684694|156641508|FG004|Phase 1|Miscellaneous|0|||
48669421|NCT03684694|156641509|FG005|Phase 1|Miscellaneous|0|||
48669422|NCT03684694|156641504|FG000|Phase 2|Withdrawal by Subject|0|||
48669423|NCT03684694|156641505|FG001|Phase 2|Withdrawal by Subject|0|||
48669424|NCT03684694|156641506|FG002|Phase 2|Withdrawal by Subject|0|||
48669425|NCT03684694|156641507|FG003|Phase 2|Withdrawal by Subject|0|||
48669426|NCT03684694|156641508|FG004|Phase 2|Withdrawal by Subject|0|||
48669427|NCT03684694|156641509|FG005|Phase 2|Withdrawal by Subject|1|||
48669428|NCT03684694|156641504|FG000|Phase 2|Investigator/Sponsor Decision|0|||
48669429|NCT03684694|156641505|FG001|Phase 2|Investigator/Sponsor Decision|0|||
48669430|NCT03684694|156641506|FG002|Phase 2|Investigator/Sponsor Decision|0|||
48669431|NCT03684694|156641507|FG003|Phase 2|Investigator/Sponsor Decision|17|||
48669432|NCT03684694|156641508|FG004|Phase 2|Investigator/Sponsor Decision|16|||
48669433|NCT03684694|156641509|FG005|Phase 2|Investigator/Sponsor Decision|6|||
48669434|NCT03684694|156641504|FG000|Phase 2|Death|0|||
48759660|NCT04461015|156967987|FG000|Overall Study|Withdrawal by Subject|0|||
48759661|NCT04461015|156967988|FG001|Overall Study|Withdrawal by Subject|1|||
48759662|NCT02150954|156967989|FG000|Overall Study|Protocol Violation|1|||
48759663|NCT02150954|156967990|FG001|Overall Study|Protocol Violation|0|||
48759664|NCT02631850|156967991|FG000|Treatment Period|Lost to Follow-up|0|||
48759665|NCT02631850|156967992|FG001|Treatment Period|Lost to Follow-up|1|||
48759666|NCT02631850|156967993|FG002|Treatment Period|Lost to Follow-up|0|||
48759667|NCT02631850|156967994|FG003|Treatment Period|Lost to Follow-up|0|||
48759668|NCT02631850|156967991|FG000|Treatment Period|Protocol Violation|1|||
48759669|NCT02631850|156967992|FG001|Treatment Period|Protocol Violation|0|||
48759670|NCT02631850|156967993|FG002|Treatment Period|Protocol Violation|0|||
48759671|NCT02631850|156967994|FG003|Treatment Period|Protocol Violation|0|||
48759672|NCT02631850|156967991|FG000|Treatment Period|Withdrawal by Subject|0|||
48759673|NCT02631850|156967992|FG001|Treatment Period|Withdrawal by Subject|5|||
48759674|NCT02631850|156967993|FG002|Treatment Period|Withdrawal by Subject|2|||
48759675|NCT02631850|156967994|FG003|Treatment Period|Withdrawal by Subject|2|||
48759676|NCT02631850|156967991|FG000|Treatment Period|Adverse Event|1|||
48759677|NCT02631850|156967992|FG001|Treatment Period|Adverse Event|0|||
48759678|NCT02631850|156967993|FG002|Treatment Period|Adverse Event|2|||
48759679|NCT02631850|156967994|FG003|Treatment Period|Adverse Event|3|||
48759680|NCT02631850|156967991|FG000|Treatment Period|Family medical issue|1|||
48759681|NCT02631850|156967992|FG001|Treatment Period|Family medical issue|0|||
48759682|NCT02631850|156967993|FG002|Treatment Period|Family medical issue|0|||
48759683|NCT02631850|156967994|FG003|Treatment Period|Family medical issue|0|||
48759684|NCT02631850|156967991|FG000|6 Month Follow up|Lost to Follow-up|5|||
48759685|NCT02631850|156967992|FG001|6 Month Follow up|Lost to Follow-up|8|||
48759686|NCT02631850|156967993|FG002|6 Month Follow up|Lost to Follow-up|3|||
48759687|NCT02631850|156967994|FG003|6 Month Follow up|Lost to Follow-up|5|||
48759688|NCT02631850|156967991|FG000|6 Month Follow up|Withdrawal by Subject|1|||
48759689|NCT02631850|156967992|FG001|6 Month Follow up|Withdrawal by Subject|0|||
48759690|NCT02631850|156967993|FG002|6 Month Follow up|Withdrawal by Subject|0|||
48759691|NCT02631850|156967994|FG003|6 Month Follow up|Withdrawal by Subject|2|||
48759692|NCT02631850|156967991|FG000|6 Month Follow up|Adverse Event|1|||
48759693|NCT02631850|156967992|FG001|6 Month Follow up|Adverse Event|4|||
48759694|NCT02631850|156967993|FG002|6 Month Follow up|Adverse Event|1|||
48759695|NCT02631850|156967994|FG003|6 Month Follow up|Adverse Event|3|||
48759696|NCT02631850|156967991|FG000|6 Month Follow up|moved out of state, transportation issues, family medical issue|0|||
48870093|NCT00843115|157362645|FG000|Overall Study|week 12 not done|1|||
48870094|NCT00843115|157362645|FG000|Overall Study|Syndrome De Glissement|1|||
48870095|NCT00292981|157362646|FG000|Overall Study|Adverse Event|1|||
48870096|NCT00292981|157362646|FG000|Overall Study|Lost to Follow-up|13|||
48870097|NCT00292981|157362646|FG000|Overall Study|Withdrawal by Subject|22|||
48870098|NCT00292981|157362646|FG000|Overall Study|Other|3|||
48870099|NCT01172639|157362647|FG000|Overall Study|Death|1|||
48870100|NCT01172639|157362648|FG001|Overall Study|Death|1|||
48870101|NCT01172639|157362649|FG002|Overall Study|Death|0|||
48870102|NCT01172639|157362650|FG003|Overall Study|Death|0|||
48870103|NCT01172639|157362651|FG004|Overall Study|Death|0|||
48870104|NCT01172639|157362647|FG000|Overall Study|Lost to Follow-up|9|||
48870105|NCT01172639|157362648|FG001|Overall Study|Lost to Follow-up|7|||
48870106|NCT01172639|157362649|FG002|Overall Study|Lost to Follow-up|11|||
48870107|NCT01172639|157362650|FG003|Overall Study|Lost to Follow-up|6|||
48870108|NCT01172639|157362651|FG004|Overall Study|Lost to Follow-up|6|||
48870109|NCT01172639|157362647|FG000|Overall Study|Withdrawal by Subject|3|||
48870110|NCT01172639|157362648|FG001|Overall Study|Withdrawal by Subject|3|||
48870111|NCT01172639|157362649|FG002|Overall Study|Withdrawal by Subject|5|||
48870112|NCT01172639|157362650|FG003|Overall Study|Withdrawal by Subject|5|||
48759697|NCT02631850|156967992|FG001|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
48759698|NCT02631850|156967993|FG002|6 Month Follow up|moved out of state, transportation issues, family medical issue|2|||
48759699|NCT02631850|156967994|FG003|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
48759700|NCT03287804|156967995|FG000|Overall Study|Death|1|||
48870113|NCT01172639|157362651|FG004|Overall Study|Withdrawal by Subject|0|||
48870114|NCT00225277|157362654|FG000|Overall Study|Adverse Event|30|||
48669435|NCT03684694|156641505|FG001|Phase 2|Death|0|||
48669436|NCT03684694|156641506|FG002|Phase 2|Death|0|||
48669437|NCT03684694|156641507|FG003|Phase 2|Death|28|||
48870115|NCT00225277|157362655|FG001|Overall Study|Adverse Event|34|||
48870116|NCT00225277|157362654|FG000|Overall Study|Lack of Efficacy|4|||
48870117|NCT00225277|157362655|FG001|Overall Study|Lack of Efficacy|1|||
48870118|NCT00225277|157362654|FG000|Overall Study|Lost to Follow-up|4|||
48870119|NCT00225277|157362655|FG001|Overall Study|Lost to Follow-up|6|||
48870120|NCT00225277|157362654|FG000|Overall Study|Physician Decision|6|||
48870121|NCT00225277|157362655|FG001|Overall Study|Physician Decision|8|||
48870122|NCT00225277|157362654|FG000|Overall Study|Protocol Violation|6|||
48870123|NCT00225277|157362655|FG001|Overall Study|Protocol Violation|3|||
48870124|NCT00225277|157362654|FG000|Overall Study|Withdrawal by Subject|40|||
48870125|NCT00225277|157362655|FG001|Overall Study|Withdrawal by Subject|34|||
48870126|NCT00225277|157362654|FG000|Overall Study|Other|7|||
48870127|NCT00225277|157362655|FG001|Overall Study|Other|9|||
48870128|NCT03371485|157362656|FG000|Main Trial (6 AST-VAC2 Vaccinations)|Participant died before receiving AST-VAC2.|1|||
48870129|NCT03371485|157362656|FG000|2-year Follow-up|Death|5|||
48870130|NCT01264887|157362667|FG000|Overall Study|Adverse Event|5|||
48870131|NCT01264887|157362667|FG000|Overall Study|Death|7|||
48870132|NCT01264887|157362667|FG000|Overall Study|Lack of Efficacy|5|||
48870133|NCT01264887|157362667|FG000|Overall Study|Physician Decision|4|||
48870134|NCT01264887|157362667|FG000|Overall Study|Withdrawal by Subject|6|||
48870135|NCT01264887|157362667|FG000|Overall Study|Sponsor Decision Administrative Reasons|2|||
48870136|NCT01264887|157362667|FG000|Overall Study|Other|2|||
48870137|NCT04531813|157362668|FG000|Overall Study|Protocol Violation|1|||
48870138|NCT04531813|157362668|FG000|Overall Study|Withdrawal by Subject|1|||
48870139|NCT00118703|157362671|FG000|Overall Study|Protocol Violation|1|||
48870140|NCT00118703|157362672|FG001|Overall Study|Protocol Violation|0|||
48870141|NCT00118703|157362671|FG000|Overall Study|Adverse Event|1|||
48870142|NCT00118703|157362672|FG001|Overall Study|Adverse Event|1|||
48870143|NCT00118703|157362671|FG000|Overall Study|Participant took two different treatment|0|||
49015485|NCT01393990|157893781|FG011|Overall Study|Death|0|||
48669438|NCT03684694|156641508|FG004|Phase 2|Death|14|||
48669439|NCT03684694|156641509|FG005|Phase 2|Death|3|||
48669440|NCT03684694|156641504|FG000|Phase 2|Lost to Follow-up|0|||
48669441|NCT03684694|156641505|FG001|Phase 2|Lost to Follow-up|0|||
48669442|NCT03684694|156641506|FG002|Phase 2|Lost to Follow-up|0|||
48669443|NCT03684694|156641507|FG003|Phase 2|Lost to Follow-up|1|||
48669444|NCT03684694|156641508|FG004|Phase 2|Lost to Follow-up|0|||
48669445|NCT03684694|156641509|FG005|Phase 2|Lost to Follow-up|0|||
48669446|NCT03684694|156641504|FG000|Phase 2|Miscellaneous|0|||
48669447|NCT03684694|156641505|FG001|Phase 2|Miscellaneous|0|||
48669448|NCT03684694|156641506|FG002|Phase 2|Miscellaneous|0|||
48669449|NCT03684694|156641507|FG003|Phase 2|Miscellaneous|3|||
48669450|NCT03684694|156641508|FG004|Phase 2|Miscellaneous|0|||
48669451|NCT03684694|156641509|FG005|Phase 2|Miscellaneous|0|||
48669452|NCT03529110|156643160|FG000|Overall Study|Progressive Disease|66|||
48669453|NCT03529110|156643161|FG001|Overall Study|Progressive Disease|158|||
48669454|NCT03529110|156643160|FG000|Overall Study|Clinical Progression|4|||
48669455|NCT03529110|156643161|FG001|Overall Study|Clinical Progression|12|||
48669456|NCT03529110|156643160|FG000|Overall Study|Adverse Event|35|||
48669457|NCT03529110|156643161|FG001|Overall Study|Adverse Event|17|||
48669458|NCT03529110|156643160|FG000|Overall Study|Withdrawal by Subject (from treatment only)|13|||
48669459|NCT03529110|156643161|FG001|Overall Study|Withdrawal by Subject (from treatment only)|11|||
48669460|NCT03529110|156643160|FG000|Overall Study|Lack of Efficacy|3|||
48669461|NCT03529110|156643161|FG001|Overall Study|Lack of Efficacy|3|||
48669462|NCT03529110|156643160|FG000|Overall Study|Physician Decision|2|||
48669463|NCT03529110|156643161|FG001|Overall Study|Physician Decision|8|||
48669464|NCT03529110|156643160|FG000|Overall Study|Miscellaneous|2|||
48669465|NCT03529110|156643161|FG001|Overall Study|Miscellaneous|5|||
48669466|NCT02191605|156643162|FG000|Overall Study|Lost to Follow-up|9|||
48669467|NCT02191605|156643163|FG001|Overall Study|Lost to Follow-up|4|||
48669468|NCT02191605|156643164|FG002|Overall Study|Lost to Follow-up|7|||
48669469|NCT02191605|156643165|FG003|Overall Study|Lost to Follow-up|3|||
48669470|NCT02191605|156643166|FG004|Overall Study|Lost to Follow-up|4|||
48669471|NCT03323736|156643171|FG000|Overall Study|Screen Failure|14|||
48669472|NCT03323736|156643172|FG001|Overall Study|Screen Failure|9|||
48669473|NCT03323736|156643173|FG002|Overall Study|Screen Failure|1|||
48669474|NCT03323736|156643171|FG000|Overall Study|Withdrawal Before Treatment|3|||
48669475|NCT03323736|156643172|FG001|Overall Study|Withdrawal Before Treatment|1|||
48669476|NCT03323736|156643173|FG002|Overall Study|Withdrawal Before Treatment|1|||
48669477|NCT03323736|156643171|FG000|Overall Study|Iontophoresis fill/no iontophoresis|2|||
48669478|NCT03323736|156643172|FG001|Overall Study|Iontophoresis fill/no iontophoresis|2|||
48669479|NCT03323736|156643173|FG002|Overall Study|Iontophoresis fill/no iontophoresis|0|||
48669480|NCT02017522|156643174|FG000|Overall Study|Withdrawal by Subject|1|||
48669481|NCT02455076|156643175|FG000|Inpatient|Withdrawal by Subject|1|||
48669482|NCT02455076|156643176|FG001|Inpatient|Withdrawal by Subject|0|||
48669483|NCT02455076|156643177|FG002|Inpatient|Withdrawal by Subject|0|||
48669484|NCT02455076|156643178|FG003|Inpatient|Withdrawal by Subject|0|||
48669485|NCT02455076|156643179|FG004|Inpatient|Withdrawal by Subject|0|||
48669486|NCT02455076|156643175|FG000|Inpatient|Discharged <24 h after admission|0|||
48870144|NCT00118703|157362672|FG001|Overall Study|Participant took two different treatment|1|||
48870145|NCT00118703|157362671|FG000|Overall Study|Withdrawal by Subject|2|||
48870146|NCT00118703|157362672|FG001|Overall Study|Withdrawal by Subject|5|||
48870147|NCT00118703|157362671|FG000|Overall Study|Lost to Follow-up|1|||
48870148|NCT00118703|157362672|FG001|Overall Study|Lost to Follow-up|2|||
48870149|NCT05523219|157362673|FG000|Overall Study|Wrong inclusion|1|||
48870150|NCT05523219|157362673|FG000|Overall Study|Lost to Follow-up|7|||
48870151|NCT00130728|157362674|FG000|Overall Study|Death|258|||
48870152|NCT00130728|157362675|FG001|Overall Study|Death|258|||
48870153|NCT00130728|157362674|FG000|Overall Study|Lost to Follow-up|4|||
48870154|NCT00130728|157362675|FG001|Overall Study|Lost to Follow-up|0|||
48870155|NCT00130728|157362674|FG000|Overall Study|Withdrawal by Subject|0|||
48870156|NCT00130728|157362675|FG001|Overall Study|Withdrawal by Subject|2|||
48870157|NCT01919398|157362683|FG000|Overall Study|Progressive Disease|0|||
48870158|NCT01919398|157362684|FG001|Overall Study|Progressive Disease|0|||
48870159|NCT01919398|157362685|FG002|Overall Study|Progressive Disease|4|||
48870160|NCT04522778|157362686|FG000|Overall Study|Patient did not want to wear the device|1|||
48870161|NCT04522778|157362687|FG001|Overall Study|Patient did not want to wear the device|0|||
48870162|NCT04522778|157362686|FG000|Overall Study|Lost to Follow-up|0|||
48870163|NCT04522778|157362687|FG001|Overall Study|Lost to Follow-up|1|||
48870164|NCT04052997|157362688|FG000|Overall Study|Withdrawal by Subject|17|||
48870165|NCT04052997|157362688|FG000|Overall Study|Physician Decision|50|||
48870166|NCT04052997|157362688|FG000|Overall Study|Death|43|||
48870167|NCT04052997|157362688|FG000|Overall Study|Lost to Follow-up|5|||
48870168|NCT04052997|157362688|FG000|Overall Study|Progression of Disease|1|||
48870169|NCT04750577|157362689|FG000|Overall Study|Adverse Event|2|||
48870170|NCT04750577|157362690|FG001|Overall Study|Adverse Event|10|||
48870171|NCT04750577|157362691|FG002|Overall Study|Adverse Event|8|||
48870172|NCT04750577|157362692|FG003|Overall Study|Adverse Event|1|||
48870173|NCT04750577|157362689|FG000|Overall Study|Change of residence|0|||
48870174|NCT04750577|157362690|FG001|Overall Study|Change of residence|0|||
48870175|NCT04750577|157362691|FG002|Overall Study|Change of residence|1|||
48870176|NCT04750577|157362692|FG003|Overall Study|Change of residence|0|||
48870177|NCT04750577|157362689|FG000|Overall Study|Burden of study procedures|0|||
48870178|NCT04750577|157362690|FG001|Overall Study|Burden of study procedures|2|||
48870179|NCT04750577|157362691|FG002|Overall Study|Burden of study procedures|2|||
48870180|NCT04750577|157362692|FG003|Overall Study|Burden of study procedures|0|||
48870181|NCT04750577|157362689|FG000|Overall Study|Prematurely discontinued|0|||
48870182|NCT04750577|157362690|FG001|Overall Study|Prematurely discontinued|0|||
48870183|NCT04750577|157362691|FG002|Overall Study|Prematurely discontinued|0|||
48870184|NCT04750577|157362692|FG003|Overall Study|Prematurely discontinued|2|||
48870185|NCT04750577|157362689|FG000|Overall Study|Protocol deviation|1|||
48870186|NCT04750577|157362690|FG001|Overall Study|Protocol deviation|1|||
48870187|NCT04750577|157362691|FG002|Overall Study|Protocol deviation|1|||
48870188|NCT04750577|157362692|FG003|Overall Study|Protocol deviation|1|||
48870189|NCT04750577|157362689|FG000|Overall Study|Other than listed|3|||
48870190|NCT04750577|157362690|FG001|Overall Study|Other than listed|2|||
48870191|NCT04750577|157362691|FG002|Overall Study|Other than listed|2|||
48870192|NCT04750577|157362692|FG003|Overall Study|Other than listed|1|||
48870193|NCT04750577|157362689|FG000|Overall Study|Not treated|0|||
48870194|NCT04750577|157362690|FG001|Overall Study|Not treated|0|||
48870195|NCT04750577|157362691|FG002|Overall Study|Not treated|0|||
48870196|NCT04750577|157362692|FG003|Overall Study|Not treated|2|||
48870197|NCT00361842|157362693|FG000|Overall Study|Withdrawal by Subject|2|||
48870198|NCT00361842|157362694|FG001|Overall Study|Withdrawal by Subject|3|||
48870199|NCT00361842|157362693|FG000|Overall Study|Death|2|||
48870200|NCT00361842|157362694|FG001|Overall Study|Death|1|||
48870201|NCT00361842|157362693|FG000|Overall Study|Disease progression|19|||
48870202|NCT00361842|157362694|FG001|Overall Study|Disease progression|20|||
48870203|NCT00361842|157362693|FG000|Overall Study|Adverse Event|2|||
48870204|NCT00361842|157362694|FG001|Overall Study|Adverse Event|3|||
48870205|NCT00361842|157362693|FG000|Overall Study|Occurrence of unacceptable toxicity|1|||
48870206|NCT00361842|157362694|FG001|Overall Study|Occurrence of unacceptable toxicity|5|||
48870207|NCT00361842|157362693|FG000|Overall Study|Other|1|||
48870208|NCT00361842|157362694|FG001|Overall Study|Other|0|||
48870209|NCT00361842|157362693|FG000|Overall Study|Other|0|||
48870210|NCT00361842|157362694|FG001|Overall Study|Other|2|||
48870211|NCT04814992|157362695|FG000|Overall Study|Withdrawal by Subject|6|||
48870212|NCT04814992|157362696|FG001|Overall Study|Withdrawal by Subject|3|||
48669487|NCT02455076|156643176|FG001|Inpatient|Discharged <24 h after admission|1|||
48669488|NCT02455076|156643177|FG002|Inpatient|Discharged <24 h after admission|0|||
48669489|NCT02455076|156643178|FG003|Inpatient|Discharged <24 h after admission|0|||
48669490|NCT02455076|156643179|FG004|Inpatient|Discharged <24 h after admission|0|||
48669491|NCT02455076|156643175|FG000|Inpatient|Adverse Event|3|||
48669492|NCT02455076|156643176|FG001|Inpatient|Adverse Event|0|||
48669493|NCT02455076|156643177|FG002|Inpatient|Adverse Event|0|||
48870213|NCT04814992|157362695|FG000|Overall Study|Lost to Follow-up|1|||
48669494|NCT02455076|156643178|FG003|Inpatient|Adverse Event|0|||
48669495|NCT02455076|156643179|FG004|Inpatient|Adverse Event|0|||
48870214|NCT04814992|157362696|FG001|Overall Study|Lost to Follow-up|4|||
48870215|NCT01078584|157362697|FG000|Overall Study|Final Status Unknown|1073|||
48870216|NCT01078584|157362697|FG000|Overall Study|Lost to Follow-up|670|||
48870217|NCT01078584|157362697|FG000|Overall Study|Non-serious Adverse Event|577|||
48870218|NCT01078584|157362697|FG000|Overall Study|Withdrawal of Consent|244|||
48870219|NCT01078584|157362697|FG000|Overall Study|Physician Withdrew from Study|90|||
48870220|NCT01078584|157362697|FG000|Overall Study|Non-compliance|67|||
48870221|NCT01078584|157362697|FG000|Overall Study|Blood Pressure Controlled|49|||
48870222|NCT01078584|157362697|FG000|Overall Study|Physician Switched Medication|26|||
48870223|NCT01078584|157362697|FG000|Overall Study|Physician Discontinued Patient|12|||
48870224|NCT01078584|157362697|FG000|Overall Study|Lack of Efficacy|98|||
48870225|NCT01078584|157362697|FG000|Overall Study|Protocol Violation|75|||
48669496|NCT02455076|156643175|FG000|Outpatient|Adverse Event|0|||
48669497|NCT02455076|156643176|FG001|Outpatient|Adverse Event|0|||
48669498|NCT02455076|156643177|FG002|Outpatient|Adverse Event|0|||
48669499|NCT02455076|156643178|FG003|Outpatient|Adverse Event|5|||
48669500|NCT02455076|156643179|FG004|Outpatient|Adverse Event|0|||
48669501|NCT02455076|156643175|FG000|Outpatient|Lost to Follow-up|0|||
48669502|NCT02455076|156643176|FG001|Outpatient|Lost to Follow-up|0|||
48669503|NCT02455076|156643177|FG002|Outpatient|Lost to Follow-up|0|||
48669504|NCT02455076|156643178|FG003|Outpatient|Lost to Follow-up|1|||
48669505|NCT02455076|156643179|FG004|Outpatient|Lost to Follow-up|12|||
48669506|NCT03002311|156643180|FG000|Overall Study|Lost to Follow-up|13|||
48669507|NCT03002311|156643181|FG001|Overall Study|Lost to Follow-up|26|||
48669508|NCT03002311|156643180|FG000|Overall Study|Referral provider called to schedule app|3|||
48669509|NCT03002311|156643181|FG001|Overall Study|Referral provider called to schedule app|3|||
48669510|NCT03002311|156643180|FG000|Overall Study|Physician Decision|3|||
48669511|NCT03002311|156643181|FG001|Overall Study|Physician Decision|1|||
48669512|NCT00940485|156643182|FG000|Overall Study|HBeAb positive at Baseline|3|||
48669513|NCT00940485|156643183|FG001|Overall Study|HBeAb positive at Baseline|2|||
48669514|NCT00940485|156643182|FG000|Overall Study|Lost to Follow-up|2|||
48669515|NCT00940485|156643183|FG001|Overall Study|Lost to Follow-up|3|||
48669516|NCT00940485|156643182|FG000|Overall Study|Adverse Event|8|||
48669517|NCT00940485|156643183|FG001|Overall Study|Adverse Event|0|||
48669518|NCT00940485|156643182|FG000|Overall Study|Withdrawal by Subject|1|||
48669519|NCT00940485|156643183|FG001|Overall Study|Withdrawal by Subject|1|||
48669520|NCT00940485|156643182|FG000|Overall Study|Others|1|||
48669521|NCT00940485|156643183|FG001|Overall Study|Others|1|||
48669522|NCT00286221|156643188|FG000|Overall Study|Protocol Violation|2|||
48669523|NCT00286221|156643189|FG001|Overall Study|Protocol Violation|1|||
48669524|NCT00286221|156643190|FG002|Overall Study|Protocol Violation|6|||
48669525|NCT00286221|156643191|FG003|Overall Study|Protocol Violation|4|||
48669526|NCT00286221|156643188|FG000|Overall Study|Unanticipated Neurosurgical Complication|6|||
48669527|NCT00286221|156643189|FG001|Overall Study|Unanticipated Neurosurgical Complication|3|||
48669528|NCT00286221|156643190|FG002|Overall Study|Unanticipated Neurosurgical Complication|3|||
48669529|NCT00286221|156643191|FG003|Overall Study|Unanticipated Neurosurgical Complication|2|||
48669530|NCT00286221|156643188|FG000|Overall Study|Inability to trigger PCA|2|||
48669531|NCT00286221|156643189|FG001|Overall Study|Inability to trigger PCA|0|||
48669532|NCT00286221|156643190|FG002|Overall Study|Inability to trigger PCA|0|||
48669533|NCT00286221|156643191|FG003|Overall Study|Inability to trigger PCA|0|||
48669534|NCT00286221|156643188|FG000|Overall Study|Unrecognized exclusion criteria met|0|||
48669535|NCT00286221|156643189|FG001|Overall Study|Unrecognized exclusion criteria met|1|||
48669536|NCT00286221|156643190|FG002|Overall Study|Unrecognized exclusion criteria met|0|||
48669537|NCT00286221|156643191|FG003|Overall Study|Unrecognized exclusion criteria met|0|||
48669538|NCT02648217|156643192|FG000|Overall Study|Adverse Event|0|||
48669539|NCT02648217|156643193|FG001|Overall Study|Adverse Event|1|||
48669540|NCT02648217|156643192|FG000|Overall Study|Lost to Follow-up|1|||
48669541|NCT02648217|156643193|FG001|Overall Study|Lost to Follow-up|1|||
48669542|NCT02648217|156643192|FG000|Overall Study|Withdrawal by Subject|4|||
48669543|NCT02648217|156643193|FG001|Overall Study|Withdrawal by Subject|3|||
48669544|NCT02648217|156643192|FG000|Overall Study|Unclassified|5|||
48669545|NCT02648217|156643193|FG001|Overall Study|Unclassified|0|||
48669546|NCT00548717|156643194|FG000|Overall Study|Death|5|||
48669547|NCT00548717|156643195|FG001|Overall Study|Death|2|||
48669548|NCT00548717|156643194|FG000|Overall Study|Relapse|3|||
48669549|NCT00548717|156643195|FG001|Overall Study|Relapse|0|||
48669550|NCT00548717|156643194|FG000|Overall Study|Alternative treatment for GVHD|1|||
48669551|NCT00548717|156643195|FG001|Overall Study|Alternative treatment for GVHD|0|||
48669552|NCT02642965|156643196|FG000|Overall Study|Lack of Efficacy|4|||
48669553|NCT02642965|156643196|FG000|Overall Study|Physician Decision|9|||
48669554|NCT02809053|156643197|FG000|Overall Study|Death|0|||
48669555|NCT02809053|156643198|FG001|Overall Study|Death|1|||
48669556|NCT02809053|156643197|FG000|Overall Study|Lost to Follow-up|3|||
48669557|NCT02809053|156643198|FG001|Overall Study|Lost to Follow-up|1|||
48669558|NCT02809053|156643197|FG000|Overall Study|Withdrawal by Subject|2|||
48669559|NCT02809053|156643198|FG001|Overall Study|Withdrawal by Subject|3|||
48669560|NCT02809053|156643197|FG000|Overall Study|Disease Progression|2|||
48669561|NCT02809053|156643198|FG001|Overall Study|Disease Progression|1|||
48870226|NCT01078584|157362697|FG000|Overall Study|Serious Adverse Event|27|||
48870227|NCT01078584|157362697|FG000|Overall Study|Multiple Reasons|2|||
48870228|NCT01121185|157362700|FG000|Overall Study|Not infused|0|||
48870229|NCT01121185|157362701|FG001|Overall Study|Not infused|1|||
48870230|NCT01121185|157362700|FG000|Overall Study|Not transplanted|1|||
48870231|NCT01121185|157362701|FG001|Overall Study|Not transplanted|0|||
48870232|NCT01091519|157362706|FG000|Overall Study|Adverse Event|12|||
48870233|NCT01091519|157362707|FG001|Overall Study|Adverse Event|16|||
48870234|NCT01091519|157362706|FG000|Overall Study|Death|1|||
48870235|NCT01091519|157362707|FG001|Overall Study|Death|0|||
48870236|NCT01091519|157362706|FG000|Overall Study|Lack of Efficacy|16|||
48870237|NCT01091519|157362707|FG001|Overall Study|Lack of Efficacy|19|||
48870238|NCT01091519|157362706|FG000|Overall Study|Lost to Follow-up|14|||
48870239|NCT01091519|157362707|FG001|Overall Study|Lost to Follow-up|24|||
48870240|NCT01091519|157362706|FG000|Overall Study|Withdrawal by Subject|2|||
48870241|NCT01091519|157362707|FG001|Overall Study|Withdrawal by Subject|2|||
48870242|NCT01091519|157362706|FG000|Overall Study|Other|6|||
48870243|NCT01091519|157362707|FG001|Overall Study|Other|8|||
48870244|NCT01091519|157362706|FG000|Overall Study|Randomized not treated|4|||
48870245|NCT01091519|157362707|FG001|Overall Study|Randomized not treated|4|||
48870246|NCT00496834|157362710|FG000|Overall Study|Withdrawal by Subject|4|||
48870247|NCT00496834|157362711|FG001|Overall Study|Withdrawal by Subject|6|||
48870248|NCT00496834|157362710|FG000|Overall Study|Contraindicated medication administered|0|||
48870249|NCT00496834|157362711|FG001|Overall Study|Contraindicated medication administered|1|||
48870250|NCT00496834|157362710|FG000|Overall Study|Inclusion/exclusion criteria not met|3|||
48870251|NCT00496834|157362711|FG001|Overall Study|Inclusion/exclusion criteria not met|2|||
48870252|NCT00496834|157362710|FG000|Overall Study|Adverse Event|5|||
48870253|NCT00496834|157362711|FG001|Overall Study|Adverse Event|3|||
48870254|NCT00496834|157362710|FG000|Overall Study|IP administration violation|2|||
48870255|NCT00496834|157362711|FG001|Overall Study|IP administration violation|0|||
48870256|NCT00496834|157362710|FG000|Overall Study|Lost to Follow-up|2|||
48870257|NCT00496834|157362711|FG001|Overall Study|Lost to Follow-up|0|||
48870258|NCT00496834|157362710|FG000|Overall Study|Blood Pressure control failure|2|||
48870259|NCT00496834|157362711|FG001|Overall Study|Blood Pressure control failure|1|||
48870260|NCT02647645|157362712|FG000|Overall Study|Lost to Follow-up|2|||
48870261|NCT02647645|157362713|FG001|Overall Study|Lost to Follow-up|1|||
48870262|NCT01494298|157362716|FG000|Overall Study|Protocol Violation|2|||
48870263|NCT01494298|157362717|FG001|Overall Study|Protocol Violation|8|||
48870264|NCT01180790|157362718|FG000|Overall Study|Adverse Event|1|||
48870265|NCT01180790|157362719|FG001|Overall Study|Adverse Event|1|||
48870266|NCT01180790|157362720|FG002|Overall Study|Adverse Event|2|||
48870267|NCT01180790|157362721|FG003|Overall Study|Adverse Event|0|||
48870268|NCT01180790|157362722|FG004|Overall Study|Adverse Event|1|||
48870269|NCT01180790|157362723|FG005|Overall Study|Adverse Event|3|||
48870270|NCT01180790|157362724|FG006|Overall Study|Adverse Event|0|||
48870271|NCT01180790|157362718|FG000|Overall Study|Withdrawal by Subject|3|||
48870272|NCT01180790|157362719|FG001|Overall Study|Withdrawal by Subject|0|||
48870273|NCT01180790|157362720|FG002|Overall Study|Withdrawal by Subject|5|||
48870274|NCT01180790|157362721|FG003|Overall Study|Withdrawal by Subject|0|||
48870275|NCT01180790|157362722|FG004|Overall Study|Withdrawal by Subject|2|||
48870276|NCT01180790|157362723|FG005|Overall Study|Withdrawal by Subject|1|||
48870277|NCT01180790|157362724|FG006|Overall Study|Withdrawal by Subject|0|||
48870278|NCT01180790|157362718|FG000|Overall Study|Lost to Follow-up|3|||
48870279|NCT01180790|157362719|FG001|Overall Study|Lost to Follow-up|1|||
48870280|NCT01180790|157362720|FG002|Overall Study|Lost to Follow-up|0|||
48870281|NCT01180790|157362721|FG003|Overall Study|Lost to Follow-up|2|||
48870282|NCT01180790|157362722|FG004|Overall Study|Lost to Follow-up|1|||
48870283|NCT01180790|157362723|FG005|Overall Study|Lost to Follow-up|0|||
48870284|NCT01180790|157362724|FG006|Overall Study|Lost to Follow-up|1|||
48870285|NCT01180790|157362718|FG000|Overall Study|Physician Decision|1|||
48870286|NCT01180790|157362719|FG001|Overall Study|Physician Decision|0|||
48870287|NCT01180790|157362720|FG002|Overall Study|Physician Decision|0|||
48870288|NCT01180790|157362721|FG003|Overall Study|Physician Decision|1|||
48870289|NCT01180790|157362722|FG004|Overall Study|Physician Decision|0|||
48870290|NCT01180790|157362723|FG005|Overall Study|Physician Decision|0|||
48870291|NCT01180790|157362724|FG006|Overall Study|Physician Decision|0|||
48669562|NCT02445573|156643201|FG000|Overall Study|Withdrawal by Subject|1|||
48870292|NCT01180790|157362718|FG000|Overall Study|Lack of Efficacy|1|||
48870293|NCT01180790|157362719|FG001|Overall Study|Lack of Efficacy|2|||
48870294|NCT01180790|157362720|FG002|Overall Study|Lack of Efficacy|5|||
48870295|NCT01180790|157362721|FG003|Overall Study|Lack of Efficacy|6|||
48669563|NCT02445573|156643202|FG001|Overall Study|Withdrawal by Subject|1|||
48870296|NCT01180790|157362722|FG004|Overall Study|Lack of Efficacy|1|||
48870297|NCT01180790|157362723|FG005|Overall Study|Lack of Efficacy|3|||
48669564|NCT02445573|156643201|FG000|Overall Study|Lost to Follow-up|0|||
48870298|NCT01180790|157362724|FG006|Overall Study|Lack of Efficacy|0|||
48870299|NCT01180790|157362718|FG000|Overall Study|compliance|0|||
48870300|NCT01180790|157362719|FG001|Overall Study|compliance|1|||
48669565|NCT02445573|156643202|FG001|Overall Study|Lost to Follow-up|1|||
48669566|NCT00290498|156643203|FG000|Overall Study|Death|2|||
48669567|NCT00290498|156643204|FG001|Overall Study|Death|0|||
48669568|NCT00290498|156643203|FG000|Overall Study|Physician Decision|1|||
48669569|NCT00290498|156643204|FG001|Overall Study|Physician Decision|0|||
48669570|NCT00290498|156643203|FG000|Overall Study|Withdrawal by Subject|1|||
48669571|NCT00290498|156643204|FG001|Overall Study|Withdrawal by Subject|0|||
48759701|NCT03287804|156967995|FG000|Overall Study|Physician Decision|2|||
48759702|NCT03287804|156967995|FG000|Overall Study|Progressive disease|8|||
48759703|NCT01046682|156967997|FG000|Overall Study|Adverse Event|2|||
48759704|NCT01046682|156967998|FG001|Overall Study|Adverse Event|0|||
48759705|NCT00326950|156967999|FG000|Overall Study|Progressive Disease|1|||
48759706|NCT00949325|156968008|FG000|Overall Study|Adverse Event|0|||
48759707|NCT00949325|156968009|FG001|Overall Study|Adverse Event|2|||
48870301|NCT01180790|157362720|FG002|Overall Study|compliance|0|||
48870302|NCT01180790|157362721|FG003|Overall Study|compliance|0|||
48870303|NCT01180790|157362722|FG004|Overall Study|compliance|0|||
48759708|NCT00949325|156968010|FG002|Overall Study|Adverse Event|0|||
48759709|NCT00451321|156968011|FG000|Overall Study|Lost to Follow-up|3|||
48759710|NCT00451321|156968012|FG001|Overall Study|Lost to Follow-up|3|||
48759711|NCT00451321|156968013|FG002|Overall Study|Lost to Follow-up|1|||
48759712|NCT00451321|156968014|FG003|Overall Study|Lost to Follow-up|3|||
48759713|NCT00451321|156968015|FG004|Overall Study|Lost to Follow-up|0|||
48759714|NCT00451321|156968016|FG005|Overall Study|Lost to Follow-up|1|||
48759715|NCT00451321|156968017|FG006|Overall Study|Lost to Follow-up|0|||
48759716|NCT00451321|156968018|FG007|Overall Study|Lost to Follow-up|0|||
48759717|NCT00451321|156968011|FG000|Overall Study|Withdrawal by Subject|3|||
48870304|NCT01180790|157362723|FG005|Overall Study|compliance|0|||
48870305|NCT01180790|157362724|FG006|Overall Study|compliance|0|||
48870306|NCT01180790|157362718|FG000|Overall Study|Severe coronary atherosclerosis (death)|0|||
48870307|NCT01180790|157362719|FG001|Overall Study|Severe coronary atherosclerosis (death)|0|||
48870308|NCT01180790|157362720|FG002|Overall Study|Severe coronary atherosclerosis (death)|1|||
48870309|NCT01180790|157362721|FG003|Overall Study|Severe coronary atherosclerosis (death)|0|||
48870310|NCT01180790|157362722|FG004|Overall Study|Severe coronary atherosclerosis (death)|0|||
48870311|NCT01180790|157362723|FG005|Overall Study|Severe coronary atherosclerosis (death)|0|||
48870312|NCT01180790|157362724|FG006|Overall Study|Severe coronary atherosclerosis (death)|0|||
48870313|NCT01251887|157362726|FG000|Overall Study|Scheduling conflict|1|||
48870314|NCT01251887|157362727|FG001|Overall Study|Scheduling conflict|2|||
48870315|NCT01251887|157362728|FG002|Overall Study|Scheduling conflict|2|||
48870316|NCT01251887|157362726|FG000|Overall Study|Physician Decision|0|||
48870317|NCT01251887|157362727|FG001|Overall Study|Physician Decision|1|||
48870318|NCT01251887|157362728|FG002|Overall Study|Physician Decision|0|||
48669572|NCT00290498|156643203|FG000|Overall Study|Ineligible|3|||
48669573|NCT00290498|156643204|FG001|Overall Study|Ineligible|0|||
48669574|NCT00290498|156643203|FG000|Overall Study|Non-Compliance|1|||
48669575|NCT00290498|156643204|FG001|Overall Study|Non-Compliance|0|||
48669576|NCT01716104|156643207|FG000|Overall Study|Do not meet inclusion criteria|6|||
48669577|NCT01716104|156643208|FG001|Overall Study|Do not meet inclusion criteria|7|||
48669578|NCT00635089|156643213|FG000|Overall Study|Adverse Event|7|||
48669579|NCT00635089|156643213|FG000|Overall Study|Lack of Efficacy|28|||
48669580|NCT00635089|156643213|FG000|Overall Study|Protocol Deviation|4|||
48669581|NCT00635089|156643213|FG000|Overall Study|Lost to Follow-up|8|||
48669582|NCT00635089|156643213|FG000|Overall Study|Other|31|||
48669583|NCT00975143|156643218|FG000|Overall Study|Adverse Event|19|||
48669584|NCT00975143|156643219|FG001|Overall Study|Adverse Event|15|||
48669585|NCT00975143|156643218|FG000|Overall Study|Withdrawal by Subject|15|||
48669586|NCT00975143|156643219|FG001|Overall Study|Withdrawal by Subject|15|||
48669587|NCT00975143|156643218|FG000|Overall Study|Lost to Follow-up|20|||
48669588|NCT00975143|156643219|FG001|Overall Study|Lost to Follow-up|16|||
48669589|NCT00975143|156643218|FG000|Overall Study|Non-compliance|5|||
48669590|NCT00975143|156643219|FG001|Overall Study|Non-compliance|8|||
48669591|NCT00975143|156643218|FG000|Overall Study|Physician Decision|1|||
48759718|NCT00451321|156968012|FG001|Overall Study|Withdrawal by Subject|1|||
48759719|NCT00451321|156968013|FG002|Overall Study|Withdrawal by Subject|0|||
48759720|NCT00451321|156968014|FG003|Overall Study|Withdrawal by Subject|4|||
48870319|NCT01831726|157362731|FG000|Overall Study|Adverse Event|16|||
48870320|NCT01831726|157362731|FG000|Overall Study|Death|7|||
48870321|NCT01831726|157362731|FG000|Overall Study|Disease Progression|49|||
48870322|NCT01831726|157362731|FG000|Overall Study|Physician Decision|1|||
48669592|NCT00975143|156643219|FG001|Overall Study|Physician Decision|2|||
48669593|NCT00975143|156643218|FG000|Overall Study|Details not available|10|||
48669594|NCT00975143|156643219|FG001|Overall Study|Details not available|4|||
48669595|NCT01283542|156643220|FG000|Main Phase|Acute or progressive vision loss|1|||
48669596|NCT01283542|156643220|FG000|Main Phase|Uncontrolled diabetes mellitus|1|||
48669597|NCT01283542|156643220|FG000|Main Phase|abnormal laboratory values|5|||
48669598|NCT01283542|156643220|FG000|Extension Phase|Physician Decision|1|||
48669599|NCT01283542|156643220|FG000|Extension Phase|Adverse Event|1|||
48669600|NCT01283542|156643220|FG000|Extension Phase|Administrative problems|1|||
48669601|NCT05059977|156643221|FG000|Overall Study|Withdrawal by Subject|0|||
48669602|NCT05059977|156643222|FG001|Overall Study|Withdrawal by Subject|0|||
48669603|NCT05059977|156643223|FG002|Overall Study|Withdrawal by Subject|1|||
48669604|NCT00121641|156643229|FG000|24-week Short-term Treatment Period|Lack of Efficacy|15|||
48669605|NCT00121641|156643230|FG001|24-week Short-term Treatment Period|Lack of Efficacy|21|||
48669606|NCT00121641|156643231|FG002|24-week Short-term Treatment Period|Lack of Efficacy|14|||
48669607|NCT00121641|156643232|FG003|24-week Short-term Treatment Period|Lack of Efficacy|25|||
48669608|NCT00121641|156643233|FG004|24-week Short-term Treatment Period|Lack of Efficacy|30|||
48669609|NCT00121641|156643229|FG000|24-week Short-term Treatment Period|Subject Withdrew Consent|9|||
48759721|NCT00451321|156968015|FG004|Overall Study|Withdrawal by Subject|0|||
48759722|NCT00451321|156968016|FG005|Overall Study|Withdrawal by Subject|0|||
48759723|NCT00451321|156968017|FG006|Overall Study|Withdrawal by Subject|0|||
48759724|NCT00451321|156968018|FG007|Overall Study|Withdrawal by Subject|0|||
48759725|NCT00451321|156968011|FG000|Overall Study|Study closed/terminated|1|||
48759726|NCT00451321|156968012|FG001|Overall Study|Study closed/terminated|1|||
48759727|NCT00451321|156968013|FG002|Overall Study|Study closed/terminated|17|||
48759728|NCT00451321|156968014|FG003|Overall Study|Study closed/terminated|5|||
48759729|NCT00451321|156968015|FG004|Overall Study|Study closed/terminated|7|||
48759730|NCT00451321|156968016|FG005|Overall Study|Study closed/terminated|7|||
48759731|NCT00451321|156968017|FG006|Overall Study|Study closed/terminated|5|||
48759732|NCT00451321|156968018|FG007|Overall Study|Study closed/terminated|3|||
48759733|NCT00451321|156968011|FG000|Overall Study|Sponsor decision to amend protocol|0|||
48759734|NCT00451321|156968012|FG001|Overall Study|Sponsor decision to amend protocol|0|||
48759735|NCT00451321|156968013|FG002|Overall Study|Sponsor decision to amend protocol|0|||
48759736|NCT00451321|156968014|FG003|Overall Study|Sponsor decision to amend protocol|0|||
48759737|NCT00451321|156968015|FG004|Overall Study|Sponsor decision to amend protocol|0|||
48759738|NCT00451321|156968016|FG005|Overall Study|Sponsor decision to amend protocol|1|||
48759739|NCT00451321|156968017|FG006|Overall Study|Sponsor decision to amend protocol|1|||
48759740|NCT00451321|156968018|FG007|Overall Study|Sponsor decision to amend protocol|3|||
48759741|NCT02064166|156968019|FG000|Overall Study|Adverse Event|1|||
48759742|NCT02064166|156968020|FG001|Overall Study|Adverse Event|0|||
48759743|NCT00993291|156968021|FG000|Overall Study|Withdrawal by Subject|1|||
48759744|NCT00149747|156968022|FG000|Overall Study|Death|1|||
48759745|NCT00149747|156968023|FG001|Overall Study|Death|0|||
48759746|NCT00149747|156968022|FG000|Overall Study|Withdrawal by Subject|3|||
48759747|NCT00149747|156968023|FG001|Overall Study|Withdrawal by Subject|3|||
48759748|NCT00271609|156968024|FG000|Overall Study|Adverse Event|11|||
48759749|NCT00271609|156968025|FG001|Overall Study|Adverse Event|3|||
48759750|NCT00271609|156968024|FG000|Overall Study|Withdrawal by Subject|2|||
48759751|NCT00271609|156968025|FG001|Overall Study|Withdrawal by Subject|0|||
48759752|NCT03051607|156968026|FG000|Overall Study|Adverse Event|66|||
48759753|NCT02039674|156968027|FG000|Overall Study|Adverse Event|0|||
48759754|NCT02039674|156968028|FG001|Overall Study|Adverse Event|0|||
48759755|NCT02039674|156968029|FG002|Overall Study|Adverse Event|0|||
48759756|NCT02039674|156968030|FG003|Overall Study|Adverse Event|1|||
48759757|NCT02039674|156968031|FG004|Overall Study|Adverse Event|0|||
48759758|NCT02039674|156968032|FG005|Overall Study|Adverse Event|0|||
48759759|NCT02039674|156968033|FG006|Overall Study|Adverse Event|0|||
48759760|NCT02039674|156968034|FG007|Overall Study|Adverse Event|0|||
48759761|NCT02039674|156968035|FG008|Overall Study|Adverse Event|2|||
48759762|NCT02039674|156968036|FG009|Overall Study|Adverse Event|1|||
48759763|NCT02039674|156968037|FG010|Overall Study|Adverse Event|0|||
48759764|NCT02039674|156968038|FG011|Overall Study|Adverse Event|2|||
48759765|NCT02039674|156968039|FG012|Overall Study|Adverse Event|3|||
48759766|NCT02039674|156968040|FG013|Overall Study|Adverse Event|1|||
48759767|NCT02039674|156968027|FG000|Overall Study|Death|2|||
48759768|NCT02039674|156968028|FG001|Overall Study|Death|0|||
48759769|NCT02039674|156968029|FG002|Overall Study|Death|2|||
48759770|NCT02039674|156968030|FG003|Overall Study|Death|3|||
48759771|NCT02039674|156968031|FG004|Overall Study|Death|0|||
48759772|NCT02039674|156968032|FG005|Overall Study|Death|0|||
48759773|NCT02039674|156968033|FG006|Overall Study|Death|1|||
48759774|NCT02039674|156968034|FG007|Overall Study|Death|0|||
48759775|NCT02039674|156968035|FG008|Overall Study|Death|2|||
48759776|NCT02039674|156968036|FG009|Overall Study|Death|0|||
48759777|NCT02039674|156968037|FG010|Overall Study|Death|1|||
48759778|NCT02039674|156968038|FG011|Overall Study|Death|3|||
48759779|NCT02039674|156968039|FG012|Overall Study|Death|2|||
48759780|NCT02039674|156968040|FG013|Overall Study|Death|8|||
48759781|NCT02039674|156968027|FG000|Overall Study|Excluded Medication|1|||
48759782|NCT02039674|156968028|FG001|Overall Study|Excluded Medication|1|||
48759783|NCT02039674|156968029|FG002|Overall Study|Excluded Medication|0|||
48759784|NCT02039674|156968030|FG003|Overall Study|Excluded Medication|1|||
48759785|NCT02039674|156968031|FG004|Overall Study|Excluded Medication|0|||
48759786|NCT02039674|156968032|FG005|Overall Study|Excluded Medication|1|||
48759787|NCT02039674|156968033|FG006|Overall Study|Excluded Medication|0|||
48759788|NCT02039674|156968034|FG007|Overall Study|Excluded Medication|0|||
48759789|NCT02039674|156968035|FG008|Overall Study|Excluded Medication|2|||
48669610|NCT00121641|156643230|FG001|24-week Short-term Treatment Period|Subject Withdrew Consent|11|||
48759790|NCT02039674|156968036|FG009|Overall Study|Excluded Medication|3|||
48870323|NCT01831726|157362731|FG000|Overall Study|Subject/guardian decision|7|||
48870324|NCT01393613|157362732|FG000|Overall Study|Adverse Event|11|||
48870325|NCT01393613|157362733|FG001|Overall Study|Adverse Event|11|||
48870326|NCT01393613|157362734|FG002|Overall Study|Adverse Event|13|||
48870327|NCT01393613|157362735|FG003|Overall Study|Adverse Event|22|||
48870328|NCT01393613|157362732|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
48870329|NCT01393613|157362733|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
48870330|NCT01393613|157362734|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
48870331|NCT01393613|157362735|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
48870332|NCT01393613|157362732|FG000|Overall Study|Physician Decision|2|||
48759791|NCT02039674|156968037|FG010|Overall Study|Excluded Medication|5|||
48759792|NCT02039674|156968038|FG011|Overall Study|Excluded Medication|6|||
48870333|NCT01393613|157362733|FG001|Overall Study|Physician Decision|0|||
48870334|NCT01393613|157362734|FG002|Overall Study|Physician Decision|0|||
48870335|NCT01393613|157362735|FG003|Overall Study|Physician Decision|1|||
48759793|NCT02039674|156968039|FG012|Overall Study|Excluded Medication|8|||
48759794|NCT02039674|156968040|FG013|Overall Study|Excluded Medication|3|||
48870336|NCT01393613|157362732|FG000|Overall Study|Withdrawal by Subject|15|||
48870337|NCT01393613|157362733|FG001|Overall Study|Withdrawal by Subject|25|||
48870338|NCT01393613|157362734|FG002|Overall Study|Withdrawal by Subject|23|||
48759795|NCT02039674|156968027|FG000|Overall Study|Lost to Follow-up|0|||
48759796|NCT02039674|156968028|FG001|Overall Study|Lost to Follow-up|0|||
48870339|NCT01393613|157362735|FG003|Overall Study|Withdrawal by Subject|21|||
48870340|NCT01393613|157362732|FG000|Overall Study|Protocol Deviation|2|||
48870341|NCT01393613|157362733|FG001|Overall Study|Protocol Deviation|1|||
48870342|NCT01393613|157362734|FG002|Overall Study|Protocol Deviation|0|||
48870343|NCT01393613|157362735|FG003|Overall Study|Protocol Deviation|0|||
48870344|NCT01393613|157362732|FG000|Overall Study|Lack of Efficacy|9|||
48870345|NCT01393613|157362733|FG001|Overall Study|Lack of Efficacy|20|||
48759797|NCT02039674|156968029|FG002|Overall Study|Lost to Follow-up|0|||
48759798|NCT02039674|156968030|FG003|Overall Study|Lost to Follow-up|0|||
48759799|NCT02039674|156968031|FG004|Overall Study|Lost to Follow-up|1|||
48759800|NCT02039674|156968032|FG005|Overall Study|Lost to Follow-up|1|||
48870346|NCT01393613|157362734|FG002|Overall Study|Lack of Efficacy|16|||
48870347|NCT01393613|157362735|FG003|Overall Study|Lack of Efficacy|21|||
48870348|NCT03821064|157362736|FG000|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1|||
48870349|NCT00474383|157362737|FG000|Main Study|Adverse Event|11|||
48870350|NCT00474383|157362738|FG001|Main Study|Adverse Event|0|||
48870351|NCT00474383|157362737|FG000|Main Study|Symptomatic Deterioration|1|||
48669611|NCT00121641|156643231|FG002|24-week Short-term Treatment Period|Subject Withdrew Consent|5|||
48669612|NCT00121641|156643232|FG003|24-week Short-term Treatment Period|Subject Withdrew Consent|10|||
48669613|NCT00121641|156643233|FG004|24-week Short-term Treatment Period|Subject Withdrew Consent|3|||
48669614|NCT00121641|156643229|FG000|24-week Short-term Treatment Period|Adverse Event|3|||
48669615|NCT00121641|156643230|FG001|24-week Short-term Treatment Period|Adverse Event|3|||
48669616|NCT00121641|156643231|FG002|24-week Short-term Treatment Period|Adverse Event|4|||
48669617|NCT00121641|156643232|FG003|24-week Short-term Treatment Period|Adverse Event|0|||
48669618|NCT00121641|156643233|FG004|24-week Short-term Treatment Period|Adverse Event|2|||
48759801|NCT02039674|156968033|FG006|Overall Study|Lost to Follow-up|0|||
48870352|NCT00474383|157362738|FG001|Main Study|Symptomatic Deterioration|0|||
48669619|NCT00121641|156643229|FG000|24-week Short-term Treatment Period|Lost to Follow-up|0|||
48669620|NCT00121641|156643230|FG001|24-week Short-term Treatment Period|Lost to Follow-up|2|||
48669621|NCT00121641|156643231|FG002|24-week Short-term Treatment Period|Lost to Follow-up|3|||
48759802|NCT02039674|156968034|FG007|Overall Study|Lost to Follow-up|0|||
48759803|NCT02039674|156968035|FG008|Overall Study|Lost to Follow-up|0|||
48759804|NCT02039674|156968036|FG009|Overall Study|Lost to Follow-up|0|||
48759805|NCT02039674|156968037|FG010|Overall Study|Lost to Follow-up|0|||
48870353|NCT00474383|157362737|FG000|Main Study|Progressive Disease|23|||
48870354|NCT00474383|157362738|FG001|Main Study|Progressive Disease|0|||
48870355|NCT00474383|157362737|FG000|Main Study|Other|1|||
48870356|NCT00474383|157362738|FG001|Main Study|Other|0|||
48870357|NCT00474383|157362737|FG000|Between Main Study and Extension|Did Not Enter Extension Phase|6|||
48870358|NCT00474383|157362738|FG001|Between Main Study and Extension|Did Not Enter Extension Phase|0|||
48870359|NCT00474383|157362737|FG000|Extension|Progressive Disease|0|||
48870360|NCT00474383|157362738|FG001|Extension|Progressive Disease|5|||
48870361|NCT02598934|157362741|FG000|Overall Study|Adverse Event|11|||
48870362|NCT02598934|157362742|FG001|Overall Study|Adverse Event|13|||
48870363|NCT02598934|157362741|FG000|Overall Study|Failure to Return|3|||
48870364|NCT02598934|157362742|FG001|Overall Study|Failure to Return|3|||
48870365|NCT02598934|157362741|FG000|Overall Study|Withdrawal by Subject|2|||
48870366|NCT02598934|157362742|FG001|Overall Study|Withdrawal by Subject|3|||
48870367|NCT02598934|157362741|FG000|Overall Study|Administrative|2|||
48669622|NCT00121641|156643232|FG003|24-week Short-term Treatment Period|Lost to Follow-up|4|||
48669623|NCT00121641|156643233|FG004|24-week Short-term Treatment Period|Lost to Follow-up|4|||
48759806|NCT02039674|156968038|FG011|Overall Study|Lost to Follow-up|2|||
48759807|NCT02039674|156968039|FG012|Overall Study|Lost to Follow-up|2|||
48759808|NCT02039674|156968040|FG013|Overall Study|Lost to Follow-up|1|||
48870368|NCT02598934|157362742|FG001|Overall Study|Administrative|1|||
48669624|NCT00121641|156643229|FG000|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
48669625|NCT00121641|156643230|FG001|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
48669626|NCT00121641|156643231|FG002|24-week Short-term Treatment Period|Poor / Non-compliance|3|||
48669627|NCT00121641|156643232|FG003|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
48669628|NCT00121641|156643233|FG004|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
48669629|NCT00121641|156643229|FG000|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
48669630|NCT00121641|156643230|FG001|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
48669631|NCT00121641|156643231|FG002|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
48669632|NCT00121641|156643232|FG003|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
48669633|NCT00121641|156643233|FG004|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
48669634|NCT00121641|156643229|FG000|24-week Short-term Treatment Period|Other Reason|1|||
48669635|NCT00121641|156643230|FG001|24-week Short-term Treatment Period|Other Reason|0|||
48669636|NCT00121641|156643231|FG002|24-week Short-term Treatment Period|Other Reason|0|||
48669637|NCT00121641|156643232|FG003|24-week Short-term Treatment Period|Other Reason|0|||
48669638|NCT00121641|156643233|FG004|24-week Short-term Treatment Period|Other Reason|0|||
48669639|NCT00121641|156643229|FG000|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
48759809|NCT02039674|156968027|FG000|Overall Study|Physician Decision|0|||
48759810|NCT02039674|156968028|FG001|Overall Study|Physician Decision|0|||
48759811|NCT02039674|156968029|FG002|Overall Study|Physician Decision|0|||
48759812|NCT02039674|156968030|FG003|Overall Study|Physician Decision|0|||
48759813|NCT02039674|156968031|FG004|Overall Study|Physician Decision|0|||
48759814|NCT02039674|156968032|FG005|Overall Study|Physician Decision|0|||
48759815|NCT02039674|156968033|FG006|Overall Study|Physician Decision|0|||
48759816|NCT02039674|156968034|FG007|Overall Study|Physician Decision|0|||
48759817|NCT02039674|156968035|FG008|Overall Study|Physician Decision|0|||
48759818|NCT02039674|156968036|FG009|Overall Study|Physician Decision|0|||
48759819|NCT02039674|156968037|FG010|Overall Study|Physician Decision|0|||
48759820|NCT02039674|156968038|FG011|Overall Study|Physician Decision|1|||
48759821|NCT02039674|156968039|FG012|Overall Study|Physician Decision|1|||
48759822|NCT02039674|156968040|FG013|Overall Study|Physician Decision|0|||
48759823|NCT02039674|156968027|FG000|Overall Study|Progressive Disease|8|||
48759824|NCT02039674|156968028|FG001|Overall Study|Progressive Disease|8|||
48759825|NCT02039674|156968029|FG002|Overall Study|Progressive Disease|6|||
48759826|NCT02039674|156968030|FG003|Overall Study|Progressive Disease|7|||
48759827|NCT02039674|156968031|FG004|Overall Study|Progressive Disease|9|||
48759828|NCT02039674|156968032|FG005|Overall Study|Progressive Disease|10|||
48759829|NCT02039674|156968033|FG006|Overall Study|Progressive Disease|1|||
48759830|NCT02039674|156968034|FG007|Overall Study|Progressive Disease|3|||
48759831|NCT02039674|156968035|FG008|Overall Study|Progressive Disease|6|||
48759832|NCT02039674|156968036|FG009|Overall Study|Progressive Disease|4|||
48759833|NCT02039674|156968037|FG010|Overall Study|Progressive Disease|0|||
48759834|NCT02039674|156968038|FG011|Overall Study|Progressive Disease|34|||
48759835|NCT02039674|156968039|FG012|Overall Study|Progressive Disease|34|||
48759836|NCT02039674|156968040|FG013|Overall Study|Progressive Disease|18|||
48759837|NCT02039674|156968027|FG000|Overall Study|Withdrawal by Subject|1|||
48759838|NCT02039674|156968028|FG001|Overall Study|Withdrawal by Subject|2|||
48759839|NCT02039674|156968029|FG002|Overall Study|Withdrawal by Subject|3|||
48759840|NCT02039674|156968030|FG003|Overall Study|Withdrawal by Subject|0|||
48759841|NCT02039674|156968031|FG004|Overall Study|Withdrawal by Subject|1|||
48759842|NCT02039674|156968032|FG005|Overall Study|Withdrawal by Subject|0|||
48759843|NCT02039674|156968033|FG006|Overall Study|Withdrawal by Subject|0|||
48759844|NCT02039674|156968034|FG007|Overall Study|Withdrawal by Subject|0|||
48759845|NCT02039674|156968035|FG008|Overall Study|Withdrawal by Subject|0|||
48759846|NCT02039674|156968036|FG009|Overall Study|Withdrawal by Subject|1|||
48759847|NCT02039674|156968037|FG010|Overall Study|Withdrawal by Subject|1|||
48759848|NCT02039674|156968038|FG011|Overall Study|Withdrawal by Subject|4|||
48759849|NCT02039674|156968039|FG012|Overall Study|Withdrawal by Subject|6|||
48759850|NCT02039674|156968040|FG013|Overall Study|Withdrawal by Subject|2|||
48759851|NCT02039674|156968027|FG000|Overall Study|Clinical Progression|0|||
48759852|NCT02039674|156968028|FG001|Overall Study|Clinical Progression|0|||
48759853|NCT02039674|156968029|FG002|Overall Study|Clinical Progression|0|||
48759854|NCT02039674|156968030|FG003|Overall Study|Clinical Progression|0|||
48759855|NCT02039674|156968031|FG004|Overall Study|Clinical Progression|0|||
48759856|NCT02039674|156968032|FG005|Overall Study|Clinical Progression|0|||
48759857|NCT02039674|156968033|FG006|Overall Study|Clinical Progression|1|||
48759858|NCT02039674|156968034|FG007|Overall Study|Clinical Progression|0|||
48759859|NCT02039674|156968035|FG008|Overall Study|Clinical Progression|0|||
48870369|NCT02598934|157362741|FG000|Overall Study|Protocol Violation|1|||
48669640|NCT00121641|156643230|FG001|48-month Short Term + Long Term Period|Lack of Efficacy|27|||
48669641|NCT00121641|156643231|FG002|48-month Short Term + Long Term Period|Lack of Efficacy|21|||
48669642|NCT00121641|156643232|FG003|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
48669643|NCT00121641|156643233|FG004|48-month Short Term + Long Term Period|Lack of Efficacy|25|||
48759860|NCT02039674|156968036|FG009|Overall Study|Clinical Progression|0|||
48870370|NCT02598934|157362742|FG001|Overall Study|Protocol Violation|2|||
48870371|NCT03918447|157362743|FG000|Overall Study|Death|1|||
48870372|NCT03918447|157362744|FG001|Overall Study|Death|0|||
48870373|NCT03918447|157362743|FG000|Overall Study|Lost to Follow-up|13|||
48870374|NCT03918447|157362744|FG001|Overall Study|Lost to Follow-up|6|||
48870375|NCT03918447|157362743|FG000|Overall Study|Withdrawal by Subject|19|||
48870376|NCT03918447|157362744|FG001|Overall Study|Withdrawal by Subject|17|||
48870377|NCT03918447|157362743|FG000|Overall Study|Study Terminated by Sponsor|195|||
48870378|NCT03918447|157362744|FG001|Overall Study|Study Terminated by Sponsor|197|||
48870379|NCT03918447|157362743|FG000|Overall Study|Reason not Specified|0|||
48870380|NCT03918447|157362744|FG001|Overall Study|Reason not Specified|1|||
48870381|NCT02394925|157362745|FG000|Overall Study|Adverse Event|1|||
48870382|NCT02394925|157362745|FG000|Overall Study|Lens Discomfort|3|||
48870383|NCT02394925|157362745|FG000|Overall Study|Lens handling difficulities|5|||
48870384|NCT02394925|157362745|FG000|Overall Study|Lost to Follow-up|9|||
48870385|NCT02394925|157362745|FG000|Overall Study|Protocol Violation|5|||
48870386|NCT02394925|157362745|FG000|Overall Study|No longer meet eligibility criteria|1|||
48870387|NCT02394925|157362745|FG000|Overall Study|Unsatisfactory Visual Response|5|||
48870388|NCT05896696|157362751|FG000|Overall Study|Screening Failure|7|||
48870389|NCT05896696|157362751|FG000|Overall Study|Withdrawal by Subject|2|||
48870390|NCT03098797|157364252|FG000|Part 2 Open Label Extension|Adverse Event|2|||
48870391|NCT03098797|157364253|FG001|Part 2 Open Label Extension|Adverse Event|0|||
48870392|NCT00740597|157364255|FG000|Overall Study|insurance would not cover treatment|1|||
48870393|NCT00332488|157364256|FG000|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8|||
48870394|NCT00332488|157364257|FG001|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2|||
48870395|NCT00332488|157364258|FG002|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6|||
48870396|NCT00332488|157364256|FG000|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13|||
48870397|NCT00332488|157364257|FG001|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2|||
48870398|NCT00332488|157364258|FG002|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10|||
48870399|NCT00332488|157364256|FG000|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21|||
48870400|NCT00332488|157364257|FG001|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10|||
48870401|NCT00332488|157364258|FG002|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20|||
48870402|NCT00332488|157364256|FG000|Initial Treatment Phase (Weeks 0 - 12)|Various|4|||
48870403|NCT00332488|157364257|FG001|Initial Treatment Phase (Weeks 0 - 12)|Various|0|||
48870404|NCT00332488|157364258|FG002|Initial Treatment Phase (Weeks 0 - 12)|Various|20|||
48870405|NCT00332488|157364256|FG000|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1|||
48870406|NCT00332488|157364257|FG001|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3|||
48870407|NCT00332488|157364258|FG002|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0|||
48870408|NCT00332488|157364256|FG000|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3|||
48870409|NCT00332488|157364257|FG001|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1|||
48870410|NCT00332488|157364258|FG002|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0|||
48870411|NCT00332488|157364256|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
48870412|NCT00332488|157364257|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
48870413|NCT00332488|157364258|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3|||
48870414|NCT00332488|157364256|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
48870415|NCT00332488|157364257|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
48870416|NCT00332488|157364258|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1|||
48870417|NCT00332488|157364256|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
48870418|NCT00332488|157364257|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
48669644|NCT00121641|156643229|FG000|48-month Short Term + Long Term Period|Subject Withdrew Consent|25|||
48669645|NCT00121641|156643230|FG001|48-month Short Term + Long Term Period|Subject Withdrew Consent|28|||
48669646|NCT00121641|156643231|FG002|48-month Short Term + Long Term Period|Subject Withdrew Consent|17|||
48669647|NCT00121641|156643232|FG003|48-month Short Term + Long Term Period|Subject Withdrew Consent|24|||
48669648|NCT00121641|156643233|FG004|48-month Short Term + Long Term Period|Subject Withdrew Consent|10|||
48669649|NCT00121641|156643229|FG000|48-month Short Term + Long Term Period|Adverse Event|9|||
48669650|NCT00121641|156643230|FG001|48-month Short Term + Long Term Period|Adverse Event|10|||
48669651|NCT00121641|156643231|FG002|48-month Short Term + Long Term Period|Adverse Event|10|||
48669652|NCT00121641|156643232|FG003|48-month Short Term + Long Term Period|Adverse Event|5|||
48759861|NCT02039674|156968037|FG010|Overall Study|Clinical Progression|0|||
48870419|NCT00332488|157364258|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3|||
48870420|NCT00332488|157364256|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
48870421|NCT00332488|157364257|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
48870422|NCT00332488|157364258|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1|||
48669653|NCT00121641|156643233|FG004|48-month Short Term + Long Term Period|Adverse Event|5|||
48669654|NCT00121641|156643229|FG000|48-month Short Term + Long Term Period|Lost to Follow-up|9|||
48669655|NCT00121641|156643230|FG001|48-month Short Term + Long Term Period|Lost to Follow-up|7|||
48669656|NCT00121641|156643231|FG002|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
48669657|NCT00121641|156643232|FG003|48-month Short Term + Long Term Period|Lost to Follow-up|11|||
48759862|NCT02039674|156968038|FG011|Overall Study|Clinical Progression|0|||
48759863|NCT02039674|156968039|FG012|Overall Study|Clinical Progression|1|||
48759864|NCT02039674|156968040|FG013|Overall Study|Clinical Progression|0|||
48759865|NCT02039674|156968027|FG000|Overall Study|Sponsor Decision|1|||
48759866|NCT02039674|156968028|FG001|Overall Study|Sponsor Decision|1|||
48759867|NCT02039674|156968029|FG002|Overall Study|Sponsor Decision|1|||
48759868|NCT02039674|156968030|FG003|Overall Study|Sponsor Decision|1|||
48759869|NCT02039674|156968031|FG004|Overall Study|Sponsor Decision|1|||
48759870|NCT02039674|156968032|FG005|Overall Study|Sponsor Decision|0|||
48759871|NCT02039674|156968033|FG006|Overall Study|Sponsor Decision|0|||
48759872|NCT02039674|156968034|FG007|Overall Study|Sponsor Decision|0|||
48669658|NCT00121641|156643233|FG004|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
48669659|NCT00121641|156643229|FG000|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
48669660|NCT00121641|156643230|FG001|48-month Short Term + Long Term Period|Poor / Non-compliance|1|||
48669661|NCT00121641|156643231|FG002|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
48669662|NCT00121641|156643232|FG003|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
48669663|NCT00121641|156643233|FG004|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
48759873|NCT02039674|156968035|FG008|Overall Study|Sponsor Decision|0|||
48759874|NCT02039674|156968036|FG009|Overall Study|Sponsor Decision|3|||
48759875|NCT02039674|156968037|FG010|Overall Study|Sponsor Decision|0|||
48669664|NCT00121641|156643229|FG000|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
48759876|NCT02039674|156968038|FG011|Overall Study|Sponsor Decision|8|||
48759877|NCT02039674|156968039|FG012|Overall Study|Sponsor Decision|5|||
48759878|NCT02039674|156968040|FG013|Overall Study|Sponsor Decision|0|||
48759879|NCT02039674|156968027|FG000|Overall Study|Other|0|||
48759880|NCT02039674|156968028|FG001|Overall Study|Other|0|||
48759881|NCT02039674|156968029|FG002|Overall Study|Other|0|||
48759882|NCT02039674|156968030|FG003|Overall Study|Other|0|||
48759883|NCT02039674|156968031|FG004|Overall Study|Other|0|||
48759884|NCT02039674|156968032|FG005|Overall Study|Other|0|||
48759885|NCT02039674|156968033|FG006|Overall Study|Other|0|||
48759886|NCT02039674|156968034|FG007|Overall Study|Other|0|||
48759887|NCT02039674|156968035|FG008|Overall Study|Other|0|||
48759888|NCT02039674|156968036|FG009|Overall Study|Other|0|||
48759889|NCT02039674|156968037|FG010|Overall Study|Other|0|||
48759890|NCT02039674|156968038|FG011|Overall Study|Other|0|||
48759891|NCT02039674|156968039|FG012|Overall Study|Other|1|||
48759892|NCT02039674|156968040|FG013|Overall Study|Other|0|||
48759893|NCT02136576|156968047|FG000|Overall Study|Lost to Follow-up|2|||
48759894|NCT02136576|156968048|FG001|Overall Study|Lost to Follow-up|0|||
48759895|NCT02136576|156968049|FG002|Overall Study|Lost to Follow-up|0|||
48759896|NCT01092182|156968058|FG000|Overall Study|Death|0|||
48759897|NCT01092182|156968059|FG001|Overall Study|Death|5|||
48759898|NCT01092182|156968060|FG002|Overall Study|Death|3|||
48759899|NCT01092182|156968058|FG000|Overall Study|participant safety|1|||
48759900|NCT01092182|156968059|FG001|Overall Study|participant safety|2|||
48759901|NCT01092182|156968060|FG002|Overall Study|participant safety|0|||
48759902|NCT01092182|156968058|FG000|Overall Study|Physician Decision|0|||
48759903|NCT01092182|156968059|FG001|Overall Study|Physician Decision|6|||
48759904|NCT01092182|156968060|FG002|Overall Study|Physician Decision|0|||
48759905|NCT01092182|156968058|FG000|Overall Study|Did not meet criteria|0|||
48759906|NCT01092182|156968059|FG001|Overall Study|Did not meet criteria|0|||
48759907|NCT01092182|156968060|FG002|Overall Study|Did not meet criteria|25|||
48759908|NCT01092182|156968058|FG000|Overall Study|Non-compliance|0|||
48759909|NCT01092182|156968059|FG001|Overall Study|Non-compliance|3|||
48759910|NCT01092182|156968060|FG002|Overall Study|Non-compliance|0|||
48759911|NCT01092182|156968058|FG000|Overall Study|Participant refused follow-up|0|||
48759912|NCT01092182|156968059|FG001|Overall Study|Participant refused follow-up|2|||
48759913|NCT01092182|156968060|FG002|Overall Study|Participant refused follow-up|0|||
48759914|NCT01951157|156968061|FG000|Overall Study|Progressive Disease|12|||
48759915|NCT01951157|156968062|FG001|Overall Study|Progressive Disease|13|||
48759916|NCT01951157|156968063|FG002|Overall Study|Progressive Disease|10|||
48870423|NCT00332488|157364256|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
48870424|NCT00332488|157364257|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
48870425|NCT00332488|157364258|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8|||
48870426|NCT00332488|157364256|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
48870427|NCT00332488|157364257|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
48759917|NCT01951157|156968061|FG000|Overall Study|Treatment-unrelated AE|1|||
48759918|NCT01951157|156968062|FG001|Overall Study|Treatment-unrelated AE|0|||
48669665|NCT00121641|156643230|FG001|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3|||
48669666|NCT00121641|156643231|FG002|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
48669667|NCT00121641|156643232|FG003|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
48759919|NCT01951157|156968063|FG002|Overall Study|Treatment-unrelated AE|3|||
48759920|NCT01951157|156968061|FG000|Overall Study|Study Termination|0|||
48759921|NCT01951157|156968062|FG001|Overall Study|Study Termination|0|||
48759922|NCT01951157|156968063|FG002|Overall Study|Study Termination|1|||
48759923|NCT01951157|156968061|FG000|Overall Study|Physician Decision|5|||
48759924|NCT01951157|156968062|FG001|Overall Study|Physician Decision|3|||
48759925|NCT01951157|156968063|FG002|Overall Study|Physician Decision|2|||
48759926|NCT01951157|156968061|FG000|Overall Study|Non-treatmentrelated death|2|||
48759927|NCT01951157|156968062|FG001|Overall Study|Non-treatmentrelated death|2|||
48759928|NCT01951157|156968063|FG002|Overall Study|Non-treatmentrelated death|2|||
48759929|NCT01951157|156968061|FG000|Overall Study|No treated|0|||
48759930|NCT01951157|156968062|FG001|Overall Study|No treated|1|||
48759931|NCT01951157|156968063|FG002|Overall Study|No treated|0|||
48759932|NCT01951157|156968061|FG000|Overall Study|Treatment-related AE|2|||
48759933|NCT01951157|156968062|FG001|Overall Study|Treatment-related AE|0|||
48759934|NCT01951157|156968063|FG002|Overall Study|Treatment-related AE|4|||
48759935|NCT01951157|156968061|FG000|Overall Study|Consent withdrawn by subject|0|||
48759936|NCT01951157|156968062|FG001|Overall Study|Consent withdrawn by subject|1|||
48759937|NCT01951157|156968063|FG002|Overall Study|Consent withdrawn by subject|3|||
48870428|NCT00332488|157364258|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Various|5|||
48870429|NCT01845649|157364265|FG000|Overall Study|Adverse Event|7|||
48870430|NCT01845649|157364266|FG001|Overall Study|Adverse Event|10|||
48870431|NCT01845649|157364265|FG000|Overall Study|Lack of Efficacy|1|||
48870432|NCT01845649|157364266|FG001|Overall Study|Lack of Efficacy|1|||
48870433|NCT01845649|157364265|FG000|Overall Study|Lost to Follow-up|2|||
48870434|NCT01845649|157364266|FG001|Overall Study|Lost to Follow-up|2|||
48870435|NCT01845649|157364265|FG000|Overall Study|Withdrew Consent|12|||
48870436|NCT01845649|157364266|FG001|Overall Study|Withdrew Consent|4|||
48870437|NCT01845649|157364265|FG000|Overall Study|Protocol Deviation|7|||
48870438|NCT01845649|157364266|FG001|Overall Study|Protocol Deviation|4|||
48870439|NCT01845649|157364265|FG000|Overall Study|Reason not Specified|2|||
48759938|NCT01951157|156968061|FG000|Overall Study|Treatment-related death|0|||
48759939|NCT01951157|156968062|FG001|Overall Study|Treatment-related death|2|||
48759940|NCT01951157|156968063|FG002|Overall Study|Treatment-related death|0|||
48870440|NCT01845649|157364266|FG001|Overall Study|Reason not Specified|1|||
48870441|NCT00508274|157364267|FG000|Overall Study|Adverse Event|5|||
48870442|NCT00508274|157364267|FG000|Overall Study|Death|7|||
48870443|NCT00508274|157364267|FG000|Overall Study|Disease progression|32|||
48870444|NCT00508274|157364267|FG000|Overall Study|Withdrawal by Subject|1|||
48870445|NCT00508274|157364267|FG000|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2|||
48870446|NCT00508274|157364267|FG000|Overall Study|Missing|3|||
48870447|NCT01746108|157364269|FG000|Overall Study|Migrated /moved from study area|0|||
48669668|NCT00121641|156643233|FG004|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
48669669|NCT00121641|156643229|FG000|48-month Short Term + Long Term Period|Pregnancy|0|||
48669670|NCT00121641|156643230|FG001|48-month Short Term + Long Term Period|Pregnancy|1|||
48669671|NCT00121641|156643231|FG002|48-month Short Term + Long Term Period|Pregnancy|0|||
48669672|NCT00121641|156643232|FG003|48-month Short Term + Long Term Period|Pregnancy|1|||
48669673|NCT00121641|156643233|FG004|48-month Short Term + Long Term Period|Pregnancy|0|||
48669674|NCT00121641|156643229|FG000|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
48669675|NCT00121641|156643230|FG001|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2|||
48669676|NCT00121641|156643231|FG002|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
48669677|NCT00121641|156643232|FG003|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
48669678|NCT00121641|156643233|FG004|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
48669679|NCT00121641|156643229|FG000|48-month Short Term + Long Term Period|Death|0|||
48669680|NCT00121641|156643230|FG001|48-month Short Term + Long Term Period|Death|0|||
48669681|NCT00121641|156643231|FG002|48-month Short Term + Long Term Period|Death|0|||
48669682|NCT00121641|156643232|FG003|48-month Short Term + Long Term Period|Death|1|||
48669683|NCT00121641|156643233|FG004|48-month Short Term + Long Term Period|Death|0|||
48669684|NCT00121641|156643229|FG000|48-month Short Term + Long Term Period|Missing|0|||
48669685|NCT00121641|156643230|FG001|48-month Short Term + Long Term Period|Missing|0|||
48669686|NCT00121641|156643231|FG002|48-month Short Term + Long Term Period|Missing|1|||
48669687|NCT00121641|156643232|FG003|48-month Short Term + Long Term Period|Missing|0|||
48759941|NCT01712854|156968064|FG000|Overall Study|Physician Decision|1|||
48759942|NCT00238121|156968067|FG000|Overall Study|Withdrawal by Subject|1|||
48759943|NCT00238121|156968068|FG001|Overall Study|Withdrawal by Subject|1|||
48759944|NCT00238121|156968067|FG000|Overall Study|Adverse Event|2|||
48759945|NCT00238121|156968068|FG001|Overall Study|Adverse Event|1|||
48669688|NCT00121641|156643233|FG004|48-month Short Term + Long Term Period|Missing|0|||
48669689|NCT00121641|156643229|FG000|48-month Short Term + Long Term Period|Other Reason|5|||
48669690|NCT00121641|156643230|FG001|48-month Short Term + Long Term Period|Other Reason|3|||
48669691|NCT00121641|156643231|FG002|48-month Short Term + Long Term Period|Other Reason|2|||
48759946|NCT02587065|156968069|FG000|Overall Study|Adverse Event|14|||
48759947|NCT02587065|156968069|FG000|Overall Study|Withdrawal of Informed Consent (IC)|5|||
48870448|NCT01746108|157364270|FG001|Overall Study|Migrated /moved from study area|1|||
48870449|NCT01746108|157364271|FG002|Overall Study|Migrated /moved from study area|0|||
48870450|NCT01746108|157364269|FG000|Overall Study|Adverse event, non-fatal|0|||
48870451|NCT01746108|157364270|FG001|Overall Study|Adverse event, non-fatal|1|||
48759948|NCT02587065|156968069|FG000|Overall Study|Non-adherence to the Protocol|3|||
48759949|NCT02587065|156968069|FG000|Overall Study|Discontinuation of Study Medication|2|||
48759950|NCT02587065|156968069|FG000|Overall Study|Reason not Specified|3|||
48759951|NCT02447081|156968072|FG000|Overall Study|Death|161|||
48759952|NCT02447081|156968072|FG000|Overall Study|Lost to Follow-up|36|||
48759953|NCT02447081|156968072|FG000|Overall Study|Visit not completed|17|||
48759954|NCT02447081|156968072|FG000|Overall Study|unsuccessful implant procedure|10|||
48759955|NCT02867709|156968073|FG000|Treatment Period|Adverse Event|1|||
48759956|NCT02867709|156968074|FG001|Treatment Period|Adverse Event|1|||
48759957|NCT02867709|156968075|FG002|Treatment Period|Adverse Event|2|||
48759958|NCT02867709|156968073|FG000|Treatment Period|Withdrawal of Consent|7|||
48759959|NCT02867709|156968074|FG001|Treatment Period|Withdrawal of Consent|9|||
48759960|NCT02867709|156968075|FG002|Treatment Period|Withdrawal of Consent|8|||
48759961|NCT02867709|156968073|FG000|Treatment Period|Lost to Follow-up|17|||
48759962|NCT02867709|156968074|FG001|Treatment Period|Lost to Follow-up|20|||
48759963|NCT02867709|156968075|FG002|Treatment Period|Lost to Follow-up|20|||
48759964|NCT02867709|156968073|FG000|Treatment Period|Lack of Qualifying Event|42|||
48759965|NCT02867709|156968074|FG001|Treatment Period|Lack of Qualifying Event|55|||
48759966|NCT02867709|156968075|FG002|Treatment Period|Lack of Qualifying Event|42|||
48759967|NCT02867709|156968073|FG000|Treatment Period|Protocol Violation|3|||
48759968|NCT02867709|156968074|FG001|Treatment Period|Protocol Violation|2|||
48759969|NCT02867709|156968075|FG002|Treatment Period|Protocol Violation|3|||
48759970|NCT02867709|156968073|FG000|Safety Follow-up Period|Withdrawal of Consent|1|||
48759971|NCT02867709|156968074|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
48759972|NCT02867709|156968075|FG002|Safety Follow-up Period|Withdrawal of Consent|6|||
48759973|NCT02867709|156968073|FG000|Safety Follow-up Period|Lost to Follow-up|10|||
48759974|NCT02867709|156968074|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
48759975|NCT02867709|156968075|FG002|Safety Follow-up Period|Lost to Follow-up|7|||
48759976|NCT02867709|156968073|FG000|Safety Follow-up Period|Pregnancy|0|||
48759977|NCT02867709|156968074|FG001|Safety Follow-up Period|Pregnancy|1|||
48759978|NCT02867709|156968075|FG002|Safety Follow-up Period|Pregnancy|0|||
48759979|NCT02867709|156968073|FG000|Safety Follow-up Period|Protocol Violation|0|||
48759980|NCT02867709|156968074|FG001|Safety Follow-up Period|Protocol Violation|1|||
48759981|NCT02867709|156968075|FG002|Safety Follow-up Period|Protocol Violation|1|||
48759982|NCT01848756|156968076|FG000|Overall Study|Adverse Event|1|||
48759983|NCT01848756|156968076|FG000|Overall Study|Withdrawal by Subject|1|||
48759984|NCT01848756|156968076|FG000|Overall Study|Enrolled in Error|1|||
48759985|NCT01042236|156970018|FG000|Treatment Period 1|Adverse Event|0|||
48759986|NCT01042236|156970019|FG001|Treatment Period 1|Adverse Event|1|||
48759987|NCT01042236|156970020|FG002|Treatment Period 1|Adverse Event|0|||
48759988|NCT01042236|156970021|FG003|Treatment Period 1|Adverse Event|0|||
48759989|NCT01042236|156970022|FG004|Treatment Period 1|Adverse Event|1|||
48759990|NCT01042236|156970023|FG005|Treatment Period 1|Adverse Event|0|||
48759991|NCT01042236|156970018|FG000|Treatment Period 3|Adverse Event|0|||
48759992|NCT01042236|156970019|FG001|Treatment Period 3|Adverse Event|0|||
48759993|NCT01042236|156970020|FG002|Treatment Period 3|Adverse Event|0|||
48759994|NCT01042236|156970021|FG003|Treatment Period 3|Adverse Event|1|||
48759995|NCT01042236|156970022|FG004|Treatment Period 3|Adverse Event|0|||
48759996|NCT01042236|156970023|FG005|Treatment Period 3|Adverse Event|0|||
48759997|NCT01042236|156970018|FG000|Treatment Period 3|Protocol Violation|0|||
48759998|NCT01042236|156970019|FG001|Treatment Period 3|Protocol Violation|0|||
48759999|NCT01042236|156970020|FG002|Treatment Period 3|Protocol Violation|0|||
48760000|NCT01042236|156970021|FG003|Treatment Period 3|Protocol Violation|1|||
48760001|NCT01042236|156970022|FG004|Treatment Period 3|Protocol Violation|0|||
48760002|NCT01042236|156970023|FG005|Treatment Period 3|Protocol Violation|0|||
48760003|NCT02981342|156970027|FG000|Overall Study|Adverse Event|0|||
48760004|NCT02981342|156970028|FG001|Overall Study|Adverse Event|0|||
48760005|NCT02981342|156970029|FG002|Overall Study|Adverse Event|0|||
48760006|NCT02981342|156970030|FG003|Overall Study|Adverse Event|1|||
48760007|NCT02981342|156970027|FG000|Overall Study|Death|0|||
48669692|NCT00121641|156643232|FG003|48-month Short Term + Long Term Period|Other Reason|0|||
48669693|NCT00121641|156643233|FG004|48-month Short Term + Long Term Period|Other Reason|1|||
48669694|NCT02096263|156643236|FG000|Overall Study|Adverse Event|1|||
48669695|NCT02096263|156643237|FG001|Overall Study|Adverse Event|0|||
48669696|NCT02096263|156643238|FG002|Overall Study|Adverse Event|1|||
48870452|NCT01746108|157364271|FG002|Overall Study|Adverse event, non-fatal|0|||
48870453|NCT01746108|157364269|FG000|Overall Study|Withdrawal by Subject|0|||
48669697|NCT02096263|156643236|FG000|Overall Study|Lost to Follow-up|14|||
48669698|NCT02096263|156643237|FG001|Overall Study|Lost to Follow-up|18|||
48870454|NCT01746108|157364270|FG001|Overall Study|Withdrawal by Subject|1|||
48870455|NCT01746108|157364271|FG002|Overall Study|Withdrawal by Subject|0|||
48870456|NCT01746108|157364269|FG000|Overall Study|Lost to Follow-up|0|||
48669699|NCT02096263|156643238|FG002|Overall Study|Lost to Follow-up|15|||
48760008|NCT02981342|156970028|FG001|Overall Study|Death|9|||
48760009|NCT02981342|156970029|FG002|Overall Study|Death|9|||
48760010|NCT02981342|156970030|FG003|Overall Study|Death|4|||
48870457|NCT01746108|157364270|FG001|Overall Study|Lost to Follow-up|1|||
48870458|NCT01746108|157364271|FG002|Overall Study|Lost to Follow-up|0|||
48760011|NCT02981342|156970027|FG000|Overall Study|Withdrawal by Subject|0|||
48760012|NCT02981342|156970028|FG001|Overall Study|Withdrawal by Subject|0|||
48760013|NCT02981342|156970029|FG002|Overall Study|Withdrawal by Subject|3|||
48760014|NCT02981342|156970030|FG003|Overall Study|Withdrawal by Subject|1|||
48760015|NCT02981342|156970027|FG000|Overall Study|Study closed by sponsor|0|||
48760016|NCT02981342|156970028|FG001|Overall Study|Study closed by sponsor|0|||
48760017|NCT02981342|156970029|FG002|Overall Study|Study closed by sponsor|1|||
48760018|NCT02981342|156970030|FG003|Overall Study|Study closed by sponsor|1|||
48760019|NCT02981342|156970027|FG000|Overall Study|Randomized, Never Treated|0|||
48760020|NCT02981342|156970028|FG001|Overall Study|Randomized, Never Treated|1|||
48760021|NCT02981342|156970029|FG002|Overall Study|Randomized, Never Treated|0|||
48760022|NCT02981342|156970030|FG003|Overall Study|Randomized, Never Treated|7|||
48760023|NCT02981342|156970027|FG000|Overall Study|Lost to Follow-up|0|||
48760024|NCT02981342|156970028|FG001|Overall Study|Lost to Follow-up|1|||
48760025|NCT02981342|156970029|FG002|Overall Study|Lost to Follow-up|0|||
48760026|NCT02981342|156970030|FG003|Overall Study|Lost to Follow-up|0|||
48760027|NCT01372501|156970031|FG000|Overall Study|Adverse Event|4|||
48760028|NCT01372501|156970031|FG000|Overall Study|Device migration|1|||
48760029|NCT00462761|156970032|FG000|Overall Study|Adverse Event|6|||
48760030|NCT00462761|156970032|FG000|Overall Study|Withdrawal by Subject|9|||
48760031|NCT00462761|156970032|FG000|Overall Study|Physician Decision|5|||
48760032|NCT00462761|156970032|FG000|Overall Study|Disease progression|43|||
48760033|NCT00462761|156970032|FG000|Overall Study|Death|12|||
48760034|NCT00462761|156970032|FG000|Overall Study|Other|1|||
48760035|NCT01365507|156970033|FG000|Overall Study|Withdrawal Criteria|8|||
48760036|NCT01365507|156970034|FG001|Overall Study|Withdrawal Criteria|5|||
48760037|NCT01365507|156970033|FG000|Overall Study|Unclassified|1|||
48760038|NCT01365507|156970034|FG001|Overall Study|Unclassified|4|||
48760039|NCT01466348|156970037|FG000|Period I - First Intervention|Withdrawal by Subject|0|||
48760040|NCT01466348|156970038|FG001|Period I - First Intervention|Withdrawal by Subject|1|||
48760041|NCT02489344|156970039|FG000|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1|||
48760042|NCT02489344|156970039|FG000|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1|||
48760043|NCT02489344|156970039|FG000|LTS14116 (Extension Study): 31 Months|Adverse Event|1|||
48760044|NCT02489344|156970039|FG000|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2|||
48760045|NCT01139450|156970050|FG000|Overall Study|Withdrawal by Subject|7|||
48760046|NCT01139450|156970051|FG001|Overall Study|Withdrawal by Subject|10|||
48760047|NCT01139450|156970052|FG002|Overall Study|Withdrawal by Subject|13|||
48760048|NCT01139450|156970050|FG000|Overall Study|Lack of Efficacy|3|||
48760049|NCT01139450|156970051|FG001|Overall Study|Lack of Efficacy|1|||
48760050|NCT01139450|156970052|FG002|Overall Study|Lack of Efficacy|8|||
48760051|NCT01139450|156970050|FG000|Overall Study|Protocol Violation|6|||
48760052|NCT01139450|156970051|FG001|Overall Study|Protocol Violation|5|||
48760053|NCT01139450|156970052|FG002|Overall Study|Protocol Violation|2|||
48669700|NCT02096263|156643236|FG000|Overall Study|Other|7|||
48669701|NCT02096263|156643237|FG001|Overall Study|Other|9|||
48669702|NCT02096263|156643238|FG002|Overall Study|Other|6|||
48669703|NCT02096263|156643236|FG000|Overall Study|Sponsor study termination|0|||
48669704|NCT02096263|156643237|FG001|Overall Study|Sponsor study termination|0|||
48669705|NCT02096263|156643238|FG002|Overall Study|Sponsor study termination|1|||
48669706|NCT02096263|156643236|FG000|Overall Study|Protocol Violation|7|||
48669707|NCT02096263|156643237|FG001|Overall Study|Protocol Violation|2|||
48669708|NCT02096263|156643238|FG002|Overall Study|Protocol Violation|8|||
48669709|NCT02096263|156643236|FG000|Overall Study|Withdrawal by Subject|5|||
48669710|NCT02096263|156643237|FG001|Overall Study|Withdrawal by Subject|7|||
48669711|NCT02096263|156643238|FG002|Overall Study|Withdrawal by Subject|8|||
48669712|NCT03322423|156643239|FG000|Period 1|Subject no longer eligible|0|||
48669713|NCT03322423|156643240|FG001|Period 1|Subject no longer eligible|1|||
48669714|NCT03322423|156643239|FG000|Period 1|Withdrawal by Subject|0|||
48669715|NCT03322423|156643240|FG001|Period 1|Withdrawal by Subject|1|||
48669716|NCT03322423|156643239|FG000|Period 1|Incorrect Lens Dispensed|1|||
48760054|NCT01139450|156970050|FG000|Overall Study|Lost to Follow-up|9|||
48760055|NCT01139450|156970051|FG001|Overall Study|Lost to Follow-up|7|||
48760056|NCT01139450|156970052|FG002|Overall Study|Lost to Follow-up|11|||
48760057|NCT01139450|156970050|FG000|Overall Study|Administrative|0|||
48760058|NCT01139450|156970051|FG001|Overall Study|Administrative|0|||
48760059|NCT01139450|156970052|FG002|Overall Study|Administrative|1|||
48760060|NCT01139450|156970050|FG000|Overall Study|Adverse Event|2|||
48669717|NCT03322423|156643240|FG001|Period 1|Incorrect Lens Dispensed|0|||
48669718|NCT03322423|156643239|FG000|Period 1|Unsatisfactory Lens Fitting|1|||
48669719|NCT03322423|156643240|FG001|Period 1|Unsatisfactory Lens Fitting|0|||
48760061|NCT01139450|156970051|FG001|Overall Study|Adverse Event|2|||
48760062|NCT01139450|156970052|FG002|Overall Study|Adverse Event|3|||
48760063|NCT00605475|156970058|FG000|Overall Study|Abnormal Laboratory Values|0|||
48760064|NCT00605475|156970059|FG001|Overall Study|Abnormal Laboratory Values|0|||
48760065|NCT00605475|156970060|FG002|Overall Study|Abnormal Laboratory Values|0|||
48669720|NCT03322423|156643239|FG000|Period 2|Dispensed incorrect lens in left eye|0|||
48669721|NCT03322423|156643240|FG001|Period 2|Dispensed incorrect lens in left eye|1|||
48870459|NCT01874665|157364277|FG000|Overall Study|Adverse Event|6|||
48870460|NCT01874665|157364278|FG001|Overall Study|Adverse Event|2|||
48870461|NCT01874665|157364277|FG000|Overall Study|Withdrawal by Subject|4|||
48870462|NCT01874665|157364278|FG001|Overall Study|Withdrawal by Subject|1|||
48870463|NCT01874665|157364277|FG000|Overall Study|Physician Decision|3|||
48870464|NCT01874665|157364278|FG001|Overall Study|Physician Decision|0|||
48870465|NCT01874665|157364277|FG000|Overall Study|Clinical Progressive Disease|4|||
48870466|NCT01874665|157364278|FG001|Overall Study|Clinical Progressive Disease|3|||
48870467|NCT01874665|157364277|FG000|Overall Study|Study Terminated by Sponsor|0|||
48870468|NCT01874665|157364278|FG001|Overall Study|Study Terminated by Sponsor|2|||
48870469|NCT01874665|157364277|FG000|Overall Study|Documented Progressive Disease|11|||
48870470|NCT01874665|157364278|FG001|Overall Study|Documented Progressive Disease|7|||
48870471|NCT01874665|157364277|FG000|Overall Study|Other|2|||
48870472|NCT01874665|157364278|FG001|Overall Study|Other|0|||
48870473|NCT04582669|157364279|FG000|Overall Study|Subject missed appointment(s).|1|||
48870474|NCT04582669|157364280|FG001|Overall Study|Subject missed appointment(s).|0|||
48870475|NCT04582669|157364281|FG002|Overall Study|Subject missed appointment(s).|1|||
48870476|NCT04582669|157364282|FG003|Overall Study|Subject missed appointment(s).|2|||
48870477|NCT04582669|157364279|FG000|Overall Study|Protocol Violation|0|||
48870478|NCT04582669|157364280|FG001|Overall Study|Protocol Violation|1|||
48870479|NCT04582669|157364281|FG002|Overall Study|Protocol Violation|1|||
48870480|NCT04582669|157364282|FG003|Overall Study|Protocol Violation|0|||
48870481|NCT01274559|157364283|FG000|Overall Study|Adverse Event|57|||
48870482|NCT01274559|157364284|FG001|Overall Study|Adverse Event|13|||
48870483|NCT01274559|157364283|FG000|Overall Study|Death|1|||
48870484|NCT01274559|157364284|FG001|Overall Study|Death|1|||
48870485|NCT01274559|157364283|FG000|Overall Study|Lost to Follow-up|3|||
48870486|NCT01274559|157364284|FG001|Overall Study|Lost to Follow-up|3|||
48669722|NCT03322423|156643239|FG000|Period 2|Protocol Violation|1|||
48669723|NCT03322423|156643240|FG001|Period 2|Protocol Violation|0|||
48669724|NCT03322423|156643239|FG000|Period 2|Subject not eligible for Pytergiumectomy|0|||
48669725|NCT03322423|156643240|FG001|Period 2|Subject not eligible for Pytergiumectomy|1|||
48669726|NCT01264770|156643241|FG000|Overall Study|Not reported|0|||
48669727|NCT01264770|156643242|FG001|Overall Study|Not reported|0|||
48669728|NCT01264770|156643243|FG002|Overall Study|Not reported|1|||
48669729|NCT01264770|156643244|FG003|Overall Study|Not reported|0|||
48669730|NCT01264770|156643245|FG004|Overall Study|Not reported|0|||
48669731|NCT01264770|156643246|FG005|Overall Study|Not reported|0|||
48669732|NCT01264770|156643241|FG000|Overall Study|e.g., change in circumstances|8|||
48669733|NCT01264770|156643242|FG001|Overall Study|e.g., change in circumstances|3|||
48669734|NCT01264770|156643243|FG002|Overall Study|e.g., change in circumstances|3|||
48669735|NCT01264770|156643244|FG003|Overall Study|e.g., change in circumstances|3|||
48669736|NCT01264770|156643245|FG004|Overall Study|e.g., change in circumstances|4|||
48669737|NCT01264770|156643246|FG005|Overall Study|e.g., change in circumstances|4|||
48669738|NCT01264770|156643241|FG000|Overall Study|Severe non-compliance to protocol|0|||
48669739|NCT01264770|156643242|FG001|Overall Study|Severe non-compliance to protocol|0|||
48669740|NCT01264770|156643243|FG002|Overall Study|Severe non-compliance to protocol|1|||
48669741|NCT01264770|156643244|FG003|Overall Study|Severe non-compliance to protocol|1|||
48669742|NCT01264770|156643245|FG004|Overall Study|Severe non-compliance to protocol|0|||
48669743|NCT01264770|156643246|FG005|Overall Study|Severe non-compliance to protocol|0|||
48669744|NCT01264770|156643241|FG000|Overall Study|Lack of therapeutic response|1|||
48669745|NCT01264770|156643242|FG001|Overall Study|Lack of therapeutic response|0|||
48669746|NCT01264770|156643243|FG002|Overall Study|Lack of therapeutic response|2|||
48669747|NCT01264770|156643244|FG003|Overall Study|Lack of therapeutic response|1|||
48669748|NCT01264770|156643245|FG004|Overall Study|Lack of therapeutic response|1|||
48669749|NCT01264770|156643246|FG005|Overall Study|Lack of therapeutic response|0|||
48669750|NCT01264770|156643241|FG000|Overall Study|Dev. of study specific discont. criteria|2|||
48669751|NCT01264770|156643242|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
48669752|NCT01264770|156643243|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
48669753|NCT01264770|156643244|FG003|Overall Study|Dev. of study specific discont. criteria|0|||
48669754|NCT01264770|156643245|FG004|Overall Study|Dev. of study specific discont. criteria|1|||
48669755|NCT01264770|156643246|FG005|Overall Study|Dev. of study specific discont. criteria|1|||
48669756|NCT01264770|156643241|FG000|Overall Study|Lost to Follow-up|0|||
48669757|NCT01264770|156643242|FG001|Overall Study|Lost to Follow-up|0|||
48669758|NCT01264770|156643243|FG002|Overall Study|Lost to Follow-up|1|||
48669759|NCT01264770|156643244|FG003|Overall Study|Lost to Follow-up|1|||
48669760|NCT01264770|156643245|FG004|Overall Study|Lost to Follow-up|0|||
48870487|NCT01274559|157364283|FG000|Overall Study|Non-compliance with Study Drug|2|||
48870488|NCT01274559|157364284|FG001|Overall Study|Non-compliance with Study Drug|4|||
48870489|NCT01274559|157364283|FG000|Overall Study|Physician Decision|2|||
48669761|NCT01264770|156643246|FG005|Overall Study|Lost to Follow-up|0|||
48870490|NCT01274559|157364284|FG001|Overall Study|Physician Decision|1|||
48870491|NCT01274559|157364283|FG000|Overall Study|Protocol Violation|28|||
48870492|NCT01274559|157364284|FG001|Overall Study|Protocol Violation|23|||
48870493|NCT01274559|157364283|FG000|Overall Study|Study Terminated by Sponsor|79|||
48669762|NCT01264770|156643241|FG000|Overall Study|Adverse Event|7|||
48669763|NCT01264770|156643242|FG001|Overall Study|Adverse Event|7|||
48669764|NCT01264770|156643243|FG002|Overall Study|Adverse Event|8|||
48669765|NCT01264770|156643244|FG003|Overall Study|Adverse Event|0|||
48669766|NCT01264770|156643245|FG004|Overall Study|Adverse Event|2|||
48669767|NCT01264770|156643246|FG005|Overall Study|Adverse Event|1|||
48669768|NCT01985360|156643249|FG000|Overall Study|Withdrawal by Subject|4|||
48669769|NCT01985360|156643250|FG001|Overall Study|Withdrawal by Subject|0|||
48669770|NCT01985360|156643249|FG000|Overall Study|Lost to Follow-up|5|||
48669771|NCT01985360|156643250|FG001|Overall Study|Lost to Follow-up|3|||
48669772|NCT02976103|156643251|FG000|Overall Study|Withdrawal by Subject|1|||
48669773|NCT02976103|156643252|FG001|Overall Study|Withdrawal by Subject|0|||
48669774|NCT02976103|156643251|FG000|Overall Study|Lost to Follow-up|12|||
48669775|NCT02976103|156643252|FG001|Overall Study|Lost to Follow-up|8|||
48669776|NCT02683668|156643256|FG000|Period 2|Withdrawal by Subject|0|||
48669777|NCT02683668|156643257|FG001|Period 2|Withdrawal by Subject|1|||
48669778|NCT02683668|156643258|FG002|Period 2|Withdrawal by Subject|0|||
48669779|NCT02544373|156643261|FG000|Overall Study|Lost to Follow-up|5|||
48669780|NCT02544373|156643262|FG001|Overall Study|Lost to Follow-up|3|||
48669781|NCT02544373|156643261|FG000|Overall Study|Withdrawal by Subject|8|||
48669782|NCT02544373|156643262|FG001|Overall Study|Withdrawal by Subject|2|||
48669783|NCT02117349|156643263|FG000|Overall Study|Withdrawal by Subject|1|||
48669784|NCT02117349|156643264|FG001|Overall Study|Withdrawal by Subject|0|||
48669785|NCT02117349|156643263|FG000|Overall Study|Lost to Follow-up|1|||
48669786|NCT02117349|156643264|FG001|Overall Study|Lost to Follow-up|1|||
48669787|NCT02117349|156643263|FG000|Overall Study|Death|1|||
48669788|NCT02117349|156643264|FG001|Overall Study|Death|0|||
48669789|NCT02265796|156643265|FG000|Overall Study|Death|1|||
48669790|NCT02265796|156643266|FG001|Overall Study|Death|0|||
48669791|NCT02265796|156643265|FG000|Overall Study|started on excluded medication|1|||
48669792|NCT02265796|156643266|FG001|Overall Study|started on excluded medication|0|||
48669793|NCT02265796|156643265|FG000|Overall Study|Withdrawal by Subject|1|||
48870494|NCT01274559|157364284|FG001|Overall Study|Study Terminated by Sponsor|87|||
48870495|NCT01274559|157364283|FG000|Overall Study|Withdrawal by Subject|25|||
48870496|NCT01274559|157364284|FG001|Overall Study|Withdrawal by Subject|13|||
48870497|NCT02971228|157364286|FG000|Overall Study|Withdrawal by Subject|1|||
48870498|NCT02971228|157364287|FG001|Overall Study|Withdrawal by Subject|1|||
48870499|NCT02971228|157364288|FG002|Overall Study|Withdrawal by Subject|0|||
48870500|NCT02971228|157364289|FG003|Overall Study|Withdrawal by Subject|0|||
48870501|NCT02971228|157364290|FG004|Overall Study|Withdrawal by Subject|0|||
48870502|NCT02971228|157364286|FG000|Overall Study|Logistical challenges|0|||
48870503|NCT02971228|157364287|FG001|Overall Study|Logistical challenges|1|||
48870504|NCT02971228|157364288|FG002|Overall Study|Logistical challenges|0|||
48870505|NCT02971228|157364289|FG003|Overall Study|Logistical challenges|0|||
48870506|NCT02971228|157364290|FG004|Overall Study|Logistical challenges|0|||
48870507|NCT01664923|157364291|FG000|Period1:Double Blind Phase-29 Months|Death|8|||
48870508|NCT01664923|157364292|FG001|Period1:Double Blind Phase-29 Months|Death|6|||
48870509|NCT01664923|157364291|FG000|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0|||
48870510|NCT01664923|157364292|FG001|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1|||
48870511|NCT01664923|157364291|FG000|Period1:Double Blind Phase-29 Months|Protocol Violation|2|||
48870512|NCT01664923|157364292|FG001|Period1:Double Blind Phase-29 Months|Protocol Violation|0|||
48870513|NCT01664923|157364291|FG000|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12|||
48669794|NCT02265796|156643266|FG001|Overall Study|Withdrawal by Subject|1|||
48669795|NCT04023682|156643268|FG000|Overall Study|Clinical schedules did not allow continued participation|6|||
48669796|NCT00897390|156643271|FG000|Overall Study|Adverse Event|2|||
48669797|NCT00897390|156643271|FG000|Overall Study|No Longer Met Study Criteria|1|||
48669798|NCT00897390|156643271|FG000|Overall Study|Personal Reasons|1|||
48669799|NCT00897390|156643271|FG000|Overall Study|Did not Return for the Clinic Visit|2|||
48669800|NCT00958217|156643277|FG000|Overall Study|Death|2|||
48669801|NCT00958217|156643278|FG001|Overall Study|Death|1|||
48669802|NCT00958217|156643277|FG000|Overall Study|Withdrawal by Subject|4|||
48669803|NCT00958217|156643278|FG001|Overall Study|Withdrawal by Subject|3|||
48669804|NCT00958217|156643277|FG000|Overall Study|Lost to Follow-up|17|||
48669805|NCT00958217|156643278|FG001|Overall Study|Lost to Follow-up|19|||
48669806|NCT00958217|156643277|FG000|Overall Study|Moved out of area|1|||
48669807|NCT00958217|156643278|FG001|Overall Study|Moved out of area|1|||
48669808|NCT00958217|156643277|FG000|Overall Study|Inpatient hospitalization|0|||
48669809|NCT00958217|156643278|FG001|Overall Study|Inpatient hospitalization|1|||
48669810|NCT04349033|156643280|FG000|Overall Study|Lost to Follow-up|3|||
48669811|NCT04349033|156643281|FG001|Overall Study|Lost to Follow-up|1|||
48669812|NCT04349033|156643282|FG002|Overall Study|Lost to Follow-up|1|||
48669813|NCT00324233|156643288|FG000|First Period|unable to insert catheter|1|||
48870514|NCT01664923|157364292|FG001|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8|||
48870515|NCT01664923|157364291|FG000|Period1:Double Blind Phase-29 Months|Disease Progression|65|||
48669814|NCT00324233|156643289|FG001|First Period|unable to insert catheter|0|||
48669815|NCT00324233|156643288|FG000|Second Period|unable to insert catheter|1|||
48669816|NCT00324233|156643289|FG001|Second Period|unable to insert catheter|1|||
48669817|NCT00324233|156643288|FG000|Second Period|Protocol Violation|4|||
48669818|NCT00324233|156643289|FG001|Second Period|Protocol Violation|6|||
48669819|NCT01972789|156643290|FG000|Overall Study|Adverse Event|11|||
48669820|NCT01972789|156643291|FG001|Overall Study|Adverse Event|4|||
48669821|NCT01972789|156643290|FG000|Overall Study|Subject withdrew consent|14|||
48669822|NCT01972789|156643291|FG001|Overall Study|Subject withdrew consent|12|||
48669823|NCT01972789|156643290|FG000|Overall Study|Lost to Follow-up|4|||
48669824|NCT01972789|156643291|FG001|Overall Study|Lost to Follow-up|7|||
48669825|NCT01972789|156643290|FG000|Overall Study|Death|7|||
48669826|NCT01972789|156643291|FG001|Overall Study|Death|5|||
48669827|NCT01972789|156643290|FG000|Overall Study|Protocol deviation|1|||
48669828|NCT01972789|156643291|FG001|Overall Study|Protocol deviation|0|||
48669829|NCT01972789|156643290|FG000|Overall Study|Physician Decision|3|||
48669830|NCT01972789|156643291|FG001|Overall Study|Physician Decision|2|||
48669831|NCT02198235|156643292|FG000|Overall Study|Lost to Follow-up|3|||
48669832|NCT02198235|156643293|FG001|Overall Study|Lost to Follow-up|2|||
48669833|NCT02198235|156643294|FG002|Overall Study|Lost to Follow-up|2|||
48669834|NCT03442296|156643296|FG000|3 Month Follow-up|Death|3|||
48669835|NCT03442296|156643297|FG001|3 Month Follow-up|Death|1|||
48669836|NCT03442296|156643296|FG000|3 Month Follow-up|Lost to Follow-up|1|||
48669837|NCT03442296|156643297|FG001|3 Month Follow-up|Lost to Follow-up|1|||
48669838|NCT03442296|156643296|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
48669839|NCT03442296|156643297|FG001|3 Month Follow-up|Withdrawal by Subject|0|||
48669840|NCT03442296|156643296|FG000|3 Month Follow-up|Obtained Hearing Aids|0|||
48669841|NCT03442296|156643297|FG001|3 Month Follow-up|Obtained Hearing Aids|1|||
48669842|NCT03442296|156643296|FG000|12 Month Follow-up|Incomplete measurement|1|||
48669843|NCT03442296|156643297|FG001|12 Month Follow-up|Incomplete measurement|1|||
48669844|NCT00718770|156643298|FG000|Overall Study|Adverse Event|1|||
48669845|NCT00718770|156643298|FG000|Overall Study|Lack of Efficacy|1|||
48669846|NCT00718770|156643298|FG000|Overall Study|Lack of Efficacy|1|||
48669847|NCT00718770|156643298|FG000|Overall Study|Adverse Event|1|||
48669848|NCT00718770|156643298|FG000|Overall Study|Lack of Efficacy|1|||
48669849|NCT00718770|156643298|FG000|Overall Study|Adverse Event|1|||
48669850|NCT00718770|156643298|FG000|Overall Study|Lack of Efficacy|1|||
48669851|NCT00718770|156643298|FG000|Overall Study|Adverse Event|1|||
48669852|NCT00042666|156643299|FG000|Overall Study|Adverse Event|2|||
48669853|NCT00042666|156643299|FG000|Overall Study|Death|4|||
48669854|NCT00042666|156643299|FG000|Overall Study|Protocol Violation|1|||
48669855|NCT00042666|156643299|FG000|Overall Study|Participant/Physician Perception|1|||
48669856|NCT00042666|156643299|FG000|Overall Study|Progressive Disease|41|||
48669857|NCT00042666|156643299|FG000|Overall Study|Other|1|||
48669858|NCT00042666|156643299|FG000|Overall Study|Other|4|||
48669859|NCT02516228|156643302|FG000|Overall Study|Lost to Follow-up|1|||
48669860|NCT02516228|156643302|FG000|Overall Study|Withdrawal by Subject|1|||
48669861|NCT02516228|156643302|FG000|Overall Study|Physician Decision|1|||
48669862|NCT00727558|156643305|FG000|Overall Study|Lens issue|0|||
48669863|NCT00727558|156643306|FG001|Overall Study|Lens issue|1|||
48669864|NCT00727558|156643305|FG000|Overall Study|Adverse Event|0|||
48669865|NCT00727558|156643306|FG001|Overall Study|Adverse Event|1|||
48669866|NCT00727558|156643305|FG000|Overall Study|Subject unable to return for follow-up|1|||
48669867|NCT00727558|156643306|FG001|Overall Study|Subject unable to return for follow-up|1|||
48669868|NCT00727558|156643305|FG000|Overall Study|Lost to Follow-up|1|||
48669869|NCT00727558|156643306|FG001|Overall Study|Lost to Follow-up|0|||
48669870|NCT02478255|156643311|FG000|Overall Study|Physician Decision|6|||
48669871|NCT02478255|156643312|FG001|Overall Study|Physician Decision|0|||
48669872|NCT02478255|156643311|FG000|Overall Study|Withdrawal by Subject|2|||
48669873|NCT02478255|156643312|FG001|Overall Study|Withdrawal by Subject|0|||
48870516|NCT01664923|157364292|FG001|Period1:Double Blind Phase-29 Months|Disease Progression|132|||
48870517|NCT01664923|157364291|FG000|Period1:Double Blind Phase-29 Months|Adverse Event|14|||
48669874|NCT00664326|156644710|FG000|Overall Study|Adverse Event|14|||
48669875|NCT00664326|156644710|FG000|Overall Study|Noncompliance with study medication|3|||
48669876|NCT00664326|156644710|FG000|Overall Study|Withdrawal by Subject|1|||
48669877|NCT00664326|156644710|FG000|Overall Study|Physician Decision|1|||
48669878|NCT00664326|156644710|FG000|Overall Study|Other Reasons|3|||
48669879|NCT00664326|156644710|FG000|Overall Study|Death|2|||
48669880|NCT00664326|156644710|FG000|Overall Study|Disease Progression/Recurrence/Relapse|24|||
48669881|NCT05079477|156644711|FG000|Overall Study|Lost to Follow-up|2|||
48669882|NCT05079477|156644712|FG001|Overall Study|Lost to Follow-up|0|||
48669883|NCT05079477|156644711|FG000|Overall Study|Withdrawal by Subject|1|||
48669884|NCT05079477|156644712|FG001|Overall Study|Withdrawal by Subject|0|||
48669885|NCT05079477|156644711|FG000|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
48669886|NCT05079477|156644712|FG001|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
48669887|NCT05079477|156644711|FG000|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|0|||
48669888|NCT05079477|156644712|FG001|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|2|||
48669889|NCT04732949|156644713|FG000|Overall Study|Withdrawal by Subject|23|||
48870518|NCT01664923|157364292|FG001|Period1:Double Blind Phase-29 Months|Adverse Event|9|||
48870519|NCT01664923|157364291|FG000|Period1:Double Blind Phase-29 Months|Other|3|||
48870520|NCT01664923|157364292|FG001|Period1:Double Blind Phase-29 Months|Other|4|||
48870521|NCT01664923|157364291|FG000|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1|||
48870522|NCT01664923|157364292|FG001|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0|||
48870523|NCT01664923|157364291|FG000|Period 2: Open-label Phase-36 Months|Death|3|||
48870524|NCT01664923|157364292|FG001|Period 2: Open-label Phase-36 Months|Death|1|||
48870525|NCT01664923|157364291|FG000|Period 2: Open-label Phase-36 Months|On Treatment|1|||
48870526|NCT01664923|157364292|FG001|Period 2: Open-label Phase-36 Months|On Treatment|1|||
48870527|NCT01664923|157364291|FG000|Period 2: Open-label Phase-36 Months|Disease progression|28|||
48870528|NCT01664923|157364292|FG001|Period 2: Open-label Phase-36 Months|Disease progression|9|||
48870529|NCT01664923|157364291|FG000|Period 2: Open-label Phase-36 Months|Other|3|||
48870530|NCT01664923|157364292|FG001|Period 2: Open-label Phase-36 Months|Other|1|||
48870531|NCT01664923|157364291|FG000|Period 2: Open-label Phase-36 Months|Adverse Event|4|||
48870532|NCT01664923|157364292|FG001|Period 2: Open-label Phase-36 Months|Adverse Event|7|||
48870533|NCT01664923|157364291|FG000|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2|||
48870534|NCT01664923|157364292|FG001|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4|||
48870535|NCT04270747|157364293|FG000|Through Week 16|Adverse Event|1|||
48669890|NCT04732949|156644714|FG001|Overall Study|Withdrawal by Subject|27|||
48669891|NCT04732949|156644713|FG000|Overall Study|Protocol Violation|0|||
48669892|NCT04732949|156644714|FG001|Overall Study|Protocol Violation|1|||
48669893|NCT04732949|156644713|FG000|Overall Study|Non-compliance|0|||
48870536|NCT04270747|157364294|FG001|Through Week 16|Adverse Event|2|||
48870537|NCT04270747|157364295|FG002|Through Week 16|Adverse Event|0|||
48870538|NCT04270747|157364293|FG000|Through Week 16|Death|0|||
48870539|NCT04270747|157364294|FG001|Through Week 16|Death|2|||
48870540|NCT04270747|157364295|FG002|Through Week 16|Death|0|||
48870541|NCT04270747|157364293|FG000|Through Week 16|Consent Withdrawn|3|||
48870542|NCT04270747|157364294|FG001|Through Week 16|Consent Withdrawn|3|||
48870543|NCT04270747|157364295|FG002|Through Week 16|Consent Withdrawn|0|||
48870544|NCT04270747|157364293|FG000|Through Week 16|Physician Decision|1|||
48870545|NCT04270747|157364294|FG001|Through Week 16|Physician Decision|1|||
48870546|NCT04270747|157364295|FG002|Through Week 16|Physician Decision|0|||
48870547|NCT04270747|157364293|FG000|Through Week 16|Lost to Follow-up|2|||
48870548|NCT04270747|157364294|FG001|Through Week 16|Lost to Follow-up|0|||
48870549|NCT04270747|157364295|FG002|Through Week 16|Lost to Follow-up|0|||
48870550|NCT04270747|157364293|FG000|Through Week 16|Protocol Violation|1|||
48870551|NCT04270747|157364294|FG001|Through Week 16|Protocol Violation|2|||
48870552|NCT04270747|157364295|FG002|Through Week 16|Protocol Violation|0|||
48870553|NCT04270747|157364293|FG000|Through Week 16|Protocol Specified Criteria|6|||
48870554|NCT04270747|157364294|FG001|Through Week 16|Protocol Specified Criteria|7|||
48870555|NCT04270747|157364295|FG002|Through Week 16|Protocol Specified Criteria|0|||
48870556|NCT04270747|157364293|FG000|Through Week 16|Miscellaneous|1|||
48870557|NCT04270747|157364294|FG001|Through Week 16|Miscellaneous|1|||
48870558|NCT04270747|157364295|FG002|Through Week 16|Miscellaneous|0|||
48870559|NCT04270747|157364293|FG000|Post Week 16|Adverse Event|7|||
48870560|NCT04270747|157364294|FG001|Post Week 16|Adverse Event|5|||
48870561|NCT04270747|157364295|FG002|Post Week 16|Adverse Event|1|||
48870562|NCT04270747|157364293|FG000|Post Week 16|Death|2|||
48669894|NCT04732949|156644714|FG001|Overall Study|Non-compliance|2|||
48669895|NCT04732949|156644713|FG000|Overall Study|Physician Decision|2|||
48669896|NCT04732949|156644714|FG001|Overall Study|Physician Decision|1|||
48669897|NCT04732949|156644713|FG000|Overall Study|Serious adverse event (Fatal)|16|||
48669898|NCT04732949|156644714|FG001|Overall Study|Serious adverse event (Fatal)|18|||
48760066|NCT00605475|156970061|FG003|Overall Study|Abnormal Laboratory Values|0|||
48760067|NCT00605475|156970062|FG004|Overall Study|Abnormal Laboratory Values|0|||
48760068|NCT00605475|156970063|FG005|Overall Study|Abnormal Laboratory Values|0|||
48760069|NCT00605475|156970064|FG006|Overall Study|Abnormal Laboratory Values|0|||
48760070|NCT00605475|156970065|FG007|Overall Study|Abnormal Laboratory Values|0|||
48760071|NCT00605475|156970066|FG008|Overall Study|Abnormal Laboratory Values|1|||
48760072|NCT00605475|156970067|FG009|Overall Study|Abnormal Laboratory Values|0|||
48870563|NCT04270747|157364294|FG001|Post Week 16|Death|0|||
48870564|NCT04270747|157364295|FG002|Post Week 16|Death|2|||
48870565|NCT04270747|157364293|FG000|Post Week 16|Consent Withdrawn|4|||
48870566|NCT04270747|157364294|FG001|Post Week 16|Consent Withdrawn|3|||
48870567|NCT04270747|157364295|FG002|Post Week 16|Consent Withdrawn|6|||
48870568|NCT04270747|157364293|FG000|Post Week 16|Physician Decision|3|||
48870569|NCT04270747|157364294|FG001|Post Week 16|Physician Decision|1|||
48870570|NCT04270747|157364295|FG002|Post Week 16|Physician Decision|1|||
48870571|NCT04270747|157364293|FG000|Post Week 16|Lost to Follow-up|2|||
48870572|NCT04270747|157364294|FG001|Post Week 16|Lost to Follow-up|1|||
48870573|NCT04270747|157364295|FG002|Post Week 16|Lost to Follow-up|0|||
48669899|NCT04732949|156644713|FG000|Overall Study|Serious adverse event (Non fatal)|2|||
48870574|NCT04270747|157364293|FG000|Post Week 16|Requirement for Alternative Therapy|1|||
48870575|NCT04270747|157364294|FG001|Post Week 16|Requirement for Alternative Therapy|0|||
49015486|NCT01393990|157893782|FG012|Overall Study|Death|0|||
48760073|NCT00605475|156970058|FG000|Overall Study|Administrative problems|0|||
48760074|NCT00605475|156970059|FG001|Overall Study|Administrative problems|0|||
48760075|NCT00605475|156970060|FG002|Overall Study|Administrative problems|0|||
48760076|NCT00605475|156970061|FG003|Overall Study|Administrative problems|0|||
48760077|NCT00605475|156970062|FG004|Overall Study|Administrative problems|0|||
48760078|NCT00605475|156970063|FG005|Overall Study|Administrative problems|0|||
48760079|NCT00605475|156970064|FG006|Overall Study|Administrative problems|1|||
48760080|NCT00605475|156970065|FG007|Overall Study|Administrative problems|0|||
48760081|NCT00605475|156970066|FG008|Overall Study|Administrative problems|0|||
48760082|NCT00605475|156970067|FG009|Overall Study|Administrative problems|0|||
48760083|NCT00605475|156970058|FG000|Overall Study|Lost to Follow-up|0|||
48870576|NCT04270747|157364295|FG002|Post Week 16|Requirement for Alternative Therapy|0|||
48870577|NCT04270747|157364293|FG000|Post Week 16|Requirement for Alternative Dosing Schedule|2|||
48870578|NCT04270747|157364294|FG001|Post Week 16|Requirement for Alternative Dosing Schedule|1|||
48669900|NCT04732949|156644714|FG001|Overall Study|Serious adverse event (Non fatal)|1|||
48669901|NCT04732949|156644713|FG000|Overall Study|Non-serious adverse event|1|||
48669902|NCT04732949|156644714|FG001|Overall Study|Non-serious adverse event|3|||
48669903|NCT04732949|156644713|FG000|Overall Study|Lost to Follow-up|26|||
48669904|NCT04732949|156644714|FG001|Overall Study|Lost to Follow-up|27|||
48669905|NCT04732949|156644713|FG000|Overall Study|Other|6|||
48669906|NCT04732949|156644714|FG001|Overall Study|Other|3|||
48669907|NCT02771626|156644716|FG000|Overall Study|Adverse Event|1|||
48669908|NCT02771626|156644717|FG001|Overall Study|Adverse Event|5|||
48669909|NCT02771626|156644718|FG002|Overall Study|Adverse Event|3|||
48669910|NCT02771626|156644719|FG003|Overall Study|Adverse Event|0|||
48669911|NCT02771626|156644720|FG004|Overall Study|Adverse Event|1|||
48669912|NCT02771626|156644721|FG005|Overall Study|Adverse Event|1|||
48669913|NCT02771626|156644716|FG000|Overall Study|Radiologic Disease Progression|6|||
48669914|NCT02771626|156644717|FG001|Overall Study|Radiologic Disease Progression|13|||
48669915|NCT02771626|156644718|FG002|Overall Study|Radiologic Disease Progression|10|||
48669916|NCT02771626|156644719|FG003|Overall Study|Radiologic Disease Progression|7|||
48669917|NCT02771626|156644720|FG004|Overall Study|Radiologic Disease Progression|28|||
48669918|NCT02771626|156644721|FG005|Overall Study|Radiologic Disease Progression|15|||
48669919|NCT02771626|156644716|FG000|Overall Study|Symptomatic Deterioration|0|||
48669920|NCT02771626|156644717|FG001|Overall Study|Symptomatic Deterioration|4|||
48669921|NCT02771626|156644718|FG002|Overall Study|Symptomatic Deterioration|2|||
48669922|NCT02771626|156644719|FG003|Overall Study|Symptomatic Deterioration|0|||
48669923|NCT02771626|156644720|FG004|Overall Study|Symptomatic Deterioration|5|||
48760084|NCT00605475|156970059|FG001|Overall Study|Lost to Follow-up|0|||
48760085|NCT00605475|156970060|FG002|Overall Study|Lost to Follow-up|0|||
48760086|NCT00605475|156970061|FG003|Overall Study|Lost to Follow-up|0|||
48760087|NCT00605475|156970062|FG004|Overall Study|Lost to Follow-up|0|||
48870579|NCT04270747|157364295|FG002|Post Week 16|Requirement for Alternative Dosing Schedule|0|||
48870580|NCT04270747|157364293|FG000|Post Week 16|Miscellaneous|1|||
48870581|NCT04270747|157364294|FG001|Post Week 16|Miscellaneous|0|||
48870582|NCT04270747|157364295|FG002|Post Week 16|Miscellaneous|1|||
48870583|NCT02482935|157364296|FG000|Period 1|Withdrawal by Subject|1|||
48870584|NCT02482935|157364297|FG001|Period 1|Withdrawal by Subject|0|||
48870585|NCT00827775|157364300|FG000|Overall Study|Withdrawal by Subject|0|||
48870586|NCT00827775|157364301|FG001|Overall Study|Withdrawal by Subject|5|||
48870587|NCT03891641|157364302|FG000|Overall Study|Study Stoppage Due to COVID-19|2|||
48870588|NCT03891641|157364303|FG001|Overall Study|Study Stoppage Due to COVID-19|2|||
48870589|NCT02777242|157364305|FG000|Overall Study|Other|2|||
48870590|NCT02777242|157364305|FG000|Overall Study|Lost to Follow-up|1|||
48870591|NCT02777242|157364305|FG000|Overall Study|Multiple|1|||
48870592|NCT02777242|157364305|FG000|Overall Study|Sponsor's request|1|||
48870593|NCT02777242|157364305|FG000|Overall Study|Withdrawal by Subject|1|||
48870594|NCT00255944|157364308|FG000|Overall Study|Lost to Follow-up|797|||
48870595|NCT00255944|157364309|FG001|Overall Study|Lost to Follow-up|834|||
48870596|NCT01129115|157364310|FG000|Overall Study|Adverse Event|1|||
48870597|NCT01129115|157364311|FG001|Overall Study|Adverse Event|2|||
48870598|NCT01129115|157364312|FG002|Overall Study|Adverse Event|3|||
48870599|NCT01129115|157364313|FG003|Overall Study|Adverse Event|3|||
48870600|NCT01129115|157364310|FG000|Overall Study|Withdrawal by Subject|1|||
48870601|NCT01129115|157364311|FG001|Overall Study|Withdrawal by Subject|3|||
48870602|NCT01129115|157364312|FG002|Overall Study|Withdrawal by Subject|1|||
48870603|NCT01129115|157364313|FG003|Overall Study|Withdrawal by Subject|4|||
48870604|NCT01129115|157364310|FG000|Overall Study|Protocol Violation|0|||
48870605|NCT01129115|157364311|FG001|Overall Study|Protocol Violation|2|||
48669924|NCT02771626|156644721|FG005|Overall Study|Symptomatic Deterioration|2|||
48669925|NCT02771626|156644716|FG000|Overall Study|Participant Request|0|||
48669926|NCT02771626|156644717|FG001|Overall Study|Participant Request|1|||
48669927|NCT02771626|156644718|FG002|Overall Study|Participant Request|0|||
48669928|NCT02771626|156644719|FG003|Overall Study|Participant Request|2|||
48870606|NCT01129115|157364312|FG002|Overall Study|Protocol Violation|2|||
48870607|NCT01129115|157364313|FG003|Overall Study|Protocol Violation|2|||
48669929|NCT02771626|156644720|FG004|Overall Study|Participant Request|0|||
48870608|NCT02212301|157364314|FG000|Period 1|Lost to Follow-up|0|||
48870609|NCT02212301|157364315|FG001|Period 1|Lost to Follow-up|1|||
48669930|NCT02771626|156644721|FG005|Overall Study|Participant Request|1|||
48669931|NCT02771626|156644716|FG000|Overall Study|Investigator Decision|0|||
48669932|NCT02771626|156644717|FG001|Overall Study|Investigator Decision|1|||
48669933|NCT02771626|156644718|FG002|Overall Study|Investigator Decision|0|||
48669934|NCT02771626|156644719|FG003|Overall Study|Investigator Decision|0|||
48669935|NCT02771626|156644720|FG004|Overall Study|Investigator Decision|1|||
48669936|NCT02771626|156644721|FG005|Overall Study|Investigator Decision|0|||
48669937|NCT02771626|156644716|FG000|Overall Study|Study Termination by Sponsor|0|||
48669938|NCT02771626|156644717|FG001|Overall Study|Study Termination by Sponsor|2|||
48669939|NCT02771626|156644718|FG002|Overall Study|Study Termination by Sponsor|1|||
48669940|NCT02771626|156644719|FG003|Overall Study|Study Termination by Sponsor|0|||
48669941|NCT02771626|156644720|FG004|Overall Study|Study Termination by Sponsor|1|||
48870610|NCT03927222|157364316|FG000|Overall Study|Progression|3|||
48870611|NCT03927222|157364316|FG000|Overall Study|CMV testing results inconclusive|1|||
48870612|NCT03927222|157364316|FG000|Overall Study|Unable to generate enough vaccines|1|||
48669942|NCT02771626|156644721|FG005|Overall Study|Study Termination by Sponsor|0|||
48669943|NCT02771626|156644716|FG000|Overall Study|Informed Consent Withdrawn|0|||
48669944|NCT02771626|156644717|FG001|Overall Study|Informed Consent Withdrawn|0|||
48669945|NCT02771626|156644718|FG002|Overall Study|Informed Consent Withdrawn|1|||
48669946|NCT02771626|156644719|FG003|Overall Study|Informed Consent Withdrawn|0|||
48669947|NCT02771626|156644720|FG004|Overall Study|Informed Consent Withdrawn|1|||
48669948|NCT02771626|156644721|FG005|Overall Study|Informed Consent Withdrawn|1|||
48669949|NCT02771626|156644716|FG000|Overall Study|Other, Not Specified|1|||
48669950|NCT02771626|156644717|FG001|Overall Study|Other, Not Specified|0|||
48669951|NCT02771626|156644718|FG002|Overall Study|Other, Not Specified|0|||
48669952|NCT02771626|156644719|FG003|Overall Study|Other, Not Specified|0|||
48669953|NCT02771626|156644720|FG004|Overall Study|Other, Not Specified|0|||
48669954|NCT02771626|156644721|FG005|Overall Study|Other, Not Specified|1|||
48669955|NCT04094584|156644722|FG000|Overall Study|No interest in study|88|||
48669956|NCT04094584|156644722|FG000|Overall Study|Unwilling to undergo screening tests|36|||
48669957|NCT04094584|156644722|FG000|Overall Study|Liver disease (enzymes >5 times upper limit of cirrhosis)|8|||
48669958|NCT04094584|156644722|FG000|Overall Study|Opioid use|7|||
48669959|NCT04094584|156644722|FG000|Overall Study|Need for major surgery in study period|4|||
48669960|NCT04094584|156644722|FG000|Overall Study|eligible but declined enrollment|4|||
48692784|NCT01188772|156724612|FG002|Overall Study|Randomized but Not Treated|0|||
48870613|NCT03927222|157364316|FG000|Overall Study|Early study termination|1|||
48870614|NCT01747837|157364317|FG000|Overall Study|Lost to Follow-up|5|||
48870615|NCT01747837|157364318|FG001|Overall Study|Lost to Follow-up|2|||
48870616|NCT01747837|157364317|FG000|Overall Study|Death|4|||
48870617|NCT01747837|157364318|FG001|Overall Study|Death|4|||
48870618|NCT00817336|157364320|FG000|Overall Study|Withdrawal by Subject|1|||
48870619|NCT00817336|157364321|FG001|Overall Study|Withdrawal by Subject|1|||
48870620|NCT02299427|157364322|FG000|Overall Study|Withdrawal by Subject|1|||
48870621|NCT02299427|157364323|FG001|Overall Study|Withdrawal by Subject|0|||
48870622|NCT02299427|157364322|FG000|Overall Study|Lost to Follow-up|1|||
48870623|NCT02299427|157364323|FG001|Overall Study|Lost to Follow-up|3|||
48870624|NCT02299427|157364322|FG000|Overall Study|not adherent to dog website use|21|||
48692785|NCT01188772|156724613|FG003|Overall Study|Randomized but Not Treated|0|||
48692786|NCT01188772|156724610|FG000|Overall Study|Adverse Event|0|||
48692787|NCT01188772|156724611|FG001|Overall Study|Adverse Event|1|||
48692788|NCT01188772|156724612|FG002|Overall Study|Adverse Event|2|||
48692789|NCT01188772|156724613|FG003|Overall Study|Adverse Event|0|||
48692790|NCT01188772|156724610|FG000|Overall Study|Lost to Follow-up|4|||
48692791|NCT01188772|156724611|FG001|Overall Study|Lost to Follow-up|1|||
48692792|NCT01188772|156724612|FG002|Overall Study|Lost to Follow-up|1|||
48692793|NCT01188772|156724613|FG003|Overall Study|Lost to Follow-up|1|||
48692794|NCT01188772|156724610|FG000|Overall Study|Non-responder|0|||
48692795|NCT01188772|156724611|FG001|Overall Study|Non-responder|0|||
48692796|NCT01188772|156724612|FG002|Overall Study|Non-responder|3|||
48692797|NCT01188772|156724613|FG003|Overall Study|Non-responder|0|||
48692798|NCT01188772|156724610|FG000|Overall Study|Physician Decision|0|||
48692799|NCT01188772|156724611|FG001|Overall Study|Physician Decision|0|||
48692800|NCT01188772|156724612|FG002|Overall Study|Physician Decision|1|||
48692801|NCT01188772|156724613|FG003|Overall Study|Physician Decision|0|||
48692802|NCT01188772|156724610|FG000|Overall Study|Terminated by Sponsor|0|||
48692803|NCT01188772|156724611|FG001|Overall Study|Terminated by Sponsor|0|||
48692804|NCT01188772|156724612|FG002|Overall Study|Terminated by Sponsor|1|||
48692805|NCT01188772|156724613|FG003|Overall Study|Terminated by Sponsor|0|||
48692806|NCT01188772|156724610|FG000|Overall Study|Treatment Failure|0|||
48692807|NCT01188772|156724611|FG001|Overall Study|Treatment Failure|0|||
48692808|NCT01188772|156724612|FG002|Overall Study|Treatment Failure|1|||
48692809|NCT01188772|156724613|FG003|Overall Study|Treatment Failure|0|||
48692810|NCT01188772|156724610|FG000|Overall Study|Virologic Failure|1|||
48692811|NCT01188772|156724611|FG001|Overall Study|Virologic Failure|0|||
48870625|NCT02299427|157364323|FG001|Overall Study|not adherent to dog website use|0|||
48870626|NCT00511797|157364331|FG000|Overall Study|Adverse Event|1|||
48870627|NCT00511797|157364332|FG001|Overall Study|Adverse Event|2|||
48870628|NCT00511797|157364333|FG002|Overall Study|Adverse Event|2|||
48870629|NCT00511797|157364334|FG003|Overall Study|Adverse Event|2|||
48870630|NCT00511797|157364331|FG000|Overall Study|Lost to Follow-up|1|||
48870631|NCT00511797|157364332|FG001|Overall Study|Lost to Follow-up|0|||
48870632|NCT00511797|157364333|FG002|Overall Study|Lost to Follow-up|0|||
48870633|NCT00511797|157364334|FG003|Overall Study|Lost to Follow-up|1|||
48870634|NCT00511797|157364331|FG000|Overall Study|Pregnancy|0|||
48870635|NCT00511797|157364332|FG001|Overall Study|Pregnancy|0|||
48760088|NCT00605475|156970063|FG005|Overall Study|Lost to Follow-up|0|||
48760089|NCT00605475|156970064|FG006|Overall Study|Lost to Follow-up|0|||
48760090|NCT00605475|156970065|FG007|Overall Study|Lost to Follow-up|0|||
48760091|NCT00605475|156970066|FG008|Overall Study|Lost to Follow-up|1|||
48760092|NCT00605475|156970067|FG009|Overall Study|Lost to Follow-up|1|||
48760093|NCT00605475|156970058|FG000|Overall Study|Protocol Violation|0|||
48760094|NCT00605475|156970059|FG001|Overall Study|Protocol Violation|0|||
48760095|NCT00605475|156970060|FG002|Overall Study|Protocol Violation|0|||
48760096|NCT00605475|156970061|FG003|Overall Study|Protocol Violation|0|||
48760097|NCT00605475|156970062|FG004|Overall Study|Protocol Violation|1|||
48760098|NCT00605475|156970063|FG005|Overall Study|Protocol Violation|0|||
48760099|NCT00605475|156970064|FG006|Overall Study|Protocol Violation|0|||
48760100|NCT00605475|156970065|FG007|Overall Study|Protocol Violation|0|||
48760101|NCT00605475|156970066|FG008|Overall Study|Protocol Violation|0|||
48760102|NCT00605475|156970067|FG009|Overall Study|Protocol Violation|0|||
48760103|NCT00605475|156970058|FG000|Overall Study|Withdrawal by Subject|0|||
48870636|NCT00511797|157364333|FG002|Overall Study|Pregnancy|0|||
48870637|NCT00511797|157364334|FG003|Overall Study|Pregnancy|1|||
48870638|NCT00511797|157364331|FG000|Overall Study|Protocol Violation|0|||
48870639|NCT00511797|157364332|FG001|Overall Study|Protocol Violation|2|||
48870640|NCT00511797|157364333|FG002|Overall Study|Protocol Violation|2|||
48870641|NCT00511797|157364334|FG003|Overall Study|Protocol Violation|3|||
48669961|NCT04094584|156644722|FG000|Overall Study|Chose to stop injections after week 4 but continued case management and provided complete data|2|||
48760104|NCT00605475|156970059|FG001|Overall Study|Withdrawal by Subject|0|||
48669962|NCT04094584|156644722|FG000|Overall Study|Missed study visits resulting. in incomplete data but sufficient for a pre-post comparison|2|||
48669963|NCT04094584|156644722|FG000|Overall Study|Lost to Follow-up|3|||
48669964|NCT04094584|156644722|FG000|Overall Study|Withdrawal by Subject|2|||
48669965|NCT00300365|156644723|FG000|Overall Study|Lost to Follow-up|1|||
48669966|NCT00300365|156644724|FG001|Overall Study|Lost to Follow-up|0|||
48669967|NCT00300365|156644723|FG000|Overall Study|Physician Decision|2|||
48669968|NCT00300365|156644724|FG001|Overall Study|Physician Decision|0|||
48669969|NCT00300365|156644723|FG000|Overall Study|Withdrawal by Subject|1|||
48669970|NCT00300365|156644724|FG001|Overall Study|Withdrawal by Subject|0|||
48669971|NCT00300365|156644723|FG000|Overall Study|Adverse Event|0|||
48669972|NCT00300365|156644724|FG001|Overall Study|Adverse Event|2|||
48669973|NCT02717130|156644725|FG000|Overall Study|Withdrawal by Subject|1|||
48760105|NCT00605475|156970060|FG002|Overall Study|Withdrawal by Subject|0|||
48760106|NCT00605475|156970061|FG003|Overall Study|Withdrawal by Subject|0|||
48760107|NCT00605475|156970062|FG004|Overall Study|Withdrawal by Subject|0|||
48760108|NCT00605475|156970063|FG005|Overall Study|Withdrawal by Subject|2|||
48760109|NCT00605475|156970064|FG006|Overall Study|Withdrawal by Subject|0|||
48760110|NCT00605475|156970065|FG007|Overall Study|Withdrawal by Subject|0|||
48760111|NCT00605475|156970066|FG008|Overall Study|Withdrawal by Subject|0|||
48760112|NCT00605475|156970067|FG009|Overall Study|Withdrawal by Subject|1|||
48760113|NCT02357901|156970071|FG000|Run-In Period (Days -14 to Day -1)|Run-In failures|161|||
48760114|NCT02357901|156970072|FG001|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
48760115|NCT02357901|156970073|FG002|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
48870642|NCT00511797|157364331|FG000|Overall Study|Withdrawal by Subject|3|||
48870643|NCT00511797|157364332|FG001|Overall Study|Withdrawal by Subject|3|||
48870644|NCT00511797|157364333|FG002|Overall Study|Withdrawal by Subject|4|||
48669974|NCT02717130|156644725|FG000|Overall Study|Adverse Event|1|||
48760116|NCT02357901|156970074|FG003|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
48870645|NCT00511797|157364334|FG003|Overall Study|Withdrawal by Subject|2|||
48870646|NCT00511797|157364331|FG000|Overall Study|Never dispensed|1|||
48760117|NCT02357901|156970071|FG000|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0|||
48870647|NCT00511797|157364332|FG001|Overall Study|Never dispensed|0|||
48870648|NCT00511797|157364333|FG002|Overall Study|Never dispensed|1|||
48760118|NCT02357901|156970072|FG001|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26|||
48760119|NCT02357901|156970073|FG002|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23|||
48760120|NCT02357901|156970074|FG003|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12|||
48760121|NCT02357901|156970071|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
48870649|NCT00511797|157364334|FG003|Overall Study|Never dispensed|3|||
48870650|NCT00511797|157364331|FG000|Overall Study|Study drug not taken|0|||
48870651|NCT00511797|157364332|FG001|Overall Study|Study drug not taken|1|||
48669975|NCT02717130|156644725|FG000|Overall Study|Physician Decision|1|||
48669976|NCT02717130|156644725|FG000|Overall Study|Study Closure|4|||
48669977|NCT00530920|156644728|FG000|Overall Study|Randomized but not treated|0|||
48669978|NCT00530920|156644729|FG001|Overall Study|Randomized but not treated|2|||
48669979|NCT00530920|156644730|FG002|Overall Study|Randomized but not treated|0|||
48669980|NCT00530920|156644728|FG000|Overall Study|Adverse Event|0|||
48669981|NCT00530920|156644729|FG001|Overall Study|Adverse Event|0|||
48669982|NCT00530920|156644730|FG002|Overall Study|Adverse Event|3|||
48669983|NCT00530920|156644728|FG000|Overall Study|Withdrawal by Subject|0|||
48669984|NCT00530920|156644729|FG001|Overall Study|Withdrawal by Subject|0|||
48669985|NCT00530920|156644730|FG002|Overall Study|Withdrawal by Subject|1|||
48669986|NCT03688555|156644731|FG000|Treatment Period|Adverse Event|0|||
48669987|NCT03688555|156644732|FG001|Treatment Period|Adverse Event|0|||
48669988|NCT03688555|156644733|FG002|Treatment Period|Adverse Event|1|||
48669989|NCT02900170|156644735|FG000|Overall Study|Lost to Follow-up|8|||
48669990|NCT01600053|156644738|FG000|Overall Study|Adverse Event|2|||
48669991|NCT01600053|156644738|FG000|Overall Study|trial will not meet the interim endpoint|9|||
48669992|NCT01177969|156644741|FG000|Overall Study|Protocol Violation|2|||
48669993|NCT01177969|156644742|FG001|Overall Study|Protocol Violation|1|||
48669994|NCT01177969|156644741|FG000|Overall Study|Withdrawal by Subject|1|||
48669995|NCT01177969|156644742|FG001|Overall Study|Withdrawal by Subject|2|||
48669996|NCT02421601|156644743|FG000|Overall Study|Adverse Event|4|||
48669997|NCT02421601|156644743|FG000|Overall Study|Lack of Efficacy|5|||
48669998|NCT02421601|156644743|FG000|Overall Study|Physician Decision|1|||
48669999|NCT02421601|156644743|FG000|Overall Study|Withdrawal by Subject|31|||
48670000|NCT02421601|156644743|FG000|Overall Study|Others|41|||
48870652|NCT00511797|157364333|FG002|Overall Study|Study drug not taken|0|||
48870653|NCT00511797|157364334|FG003|Overall Study|Study drug not taken|1|||
48870654|NCT00511797|157364331|FG000|Overall Study|Partially missing diary|0|||
48870655|NCT00511797|157364332|FG001|Overall Study|Partially missing diary|0|||
48870656|NCT00511797|157364333|FG002|Overall Study|Partially missing diary|1|||
48870657|NCT00511797|157364334|FG003|Overall Study|Partially missing diary|0|||
48870658|NCT00511797|157364331|FG000|Overall Study|Other (moving etc)|1|||
48870659|NCT00511797|157364332|FG001|Overall Study|Other (moving etc)|0|||
48870660|NCT00511797|157364333|FG002|Overall Study|Other (moving etc)|1|||
48870661|NCT00511797|157364334|FG003|Overall Study|Other (moving etc)|2|||
48870662|NCT02287883|157364339|FG000|Overall Study|Death|8|||
48870663|NCT02287883|157364340|FG001|Overall Study|Death|7|||
48870664|NCT02287883|157364339|FG000|Overall Study|No longer eligible|222|||
48870665|NCT02287883|157364340|FG001|Overall Study|No longer eligible|182|||
48870666|NCT02287883|157364339|FG000|Overall Study|Non-response to survey|229|||
48870667|NCT02287883|157364340|FG001|Overall Study|Non-response to survey|237|||
48870668|NCT00802438|157364349|FG000|Overall Study|Screen Failure|20|||
48870669|NCT00802438|157364349|FG000|Overall Study|Withdrawal by Subject|7|||
48870670|NCT00802438|157364349|FG000|Overall Study|Physician Decision|1|||
48870671|NCT00679549|157364350|FG000|Overall Study|dropout|2|||
48870672|NCT00679549|157364351|FG001|Overall Study|dropout|4|||
48870673|NCT00679549|157364350|FG000|Overall Study|missing outcome echocardiograms|4|||
48870674|NCT00679549|157364351|FG001|Overall Study|missing outcome echocardiograms|5|||
48870675|NCT03280108|157364353|FG000|Overall Study|Lost to Follow-up|2|||
48870676|NCT03280108|157364354|FG001|Overall Study|Lost to Follow-up|0|||
48870677|NCT01978236|157364355|FG000|Overall Study|Discontinued due to study close|2|||
48870678|NCT00125853|157364357|FG000|Wash-out (4 Weeks)|Lost to Follow-up|3|||
48870679|NCT00125853|157364358|FG001|Wash-out (4 Weeks)|Lost to Follow-up|7|||
48870680|NCT04353817|157364359|FG000|Overall Study|Adverse Event|0|||
48870681|NCT04353817|157364360|FG001|Overall Study|Adverse Event|1|||
48870682|NCT02101268|157364361|FG000|Randomized Treatment Phase|Subject Decision|8|||
48870683|NCT02101268|157364362|FG001|Randomized Treatment Phase|Subject Decision|4|||
48870684|NCT02101268|157364363|FG002|Randomized Treatment Phase|Subject Decision|0|||
48870685|NCT02101268|157364364|FG003|Randomized Treatment Phase|Subject Decision|0|||
48670001|NCT00581360|156644745|FG000|Overall Study|Withdrawal by Subject|1|||
48670002|NCT00257660|156644747|FG000|Overall Study|Lack of Efficacy|5|||
48870686|NCT02101268|157364361|FG000|Randomized Treatment Phase|Physician Decision|4|||
48870687|NCT02101268|157364362|FG001|Randomized Treatment Phase|Physician Decision|1|||
48870688|NCT02101268|157364363|FG002|Randomized Treatment Phase|Physician Decision|0|||
48870689|NCT02101268|157364364|FG003|Randomized Treatment Phase|Physician Decision|0|||
48870690|NCT02101268|157364361|FG000|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
48870691|NCT02101268|157364362|FG001|Randomized Treatment Phase|Symptomatic Spleen Growth|1|||
48670003|NCT00257660|156644748|FG001|Overall Study|Lack of Efficacy|23|||
48670004|NCT00257660|156644747|FG000|Overall Study|Withdrawal by Subject|2|||
48870692|NCT02101268|157364363|FG002|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
48870693|NCT02101268|157364364|FG003|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
48870694|NCT02101268|157364361|FG000|Randomized Treatment Phase|Adverse Event|6|||
48870695|NCT02101268|157364362|FG001|Randomized Treatment Phase|Adverse Event|0|||
48870696|NCT02101268|157364363|FG002|Randomized Treatment Phase|Adverse Event|0|||
48670005|NCT00257660|156644748|FG001|Overall Study|Withdrawal by Subject|0|||
48670006|NCT00257660|156644747|FG000|Overall Study|Lost to Follow-up|1|||
48670007|NCT00257660|156644748|FG001|Overall Study|Lost to Follow-up|0|||
48870697|NCT02101268|157364364|FG003|Randomized Treatment Phase|Adverse Event|0|||
48870698|NCT02101268|157364361|FG000|Randomized Treatment Phase|Death|5|||
48870699|NCT02101268|157364362|FG001|Randomized Treatment Phase|Death|4|||
48870700|NCT02101268|157364363|FG002|Randomized Treatment Phase|Death|0|||
48870701|NCT02101268|157364364|FG003|Randomized Treatment Phase|Death|0|||
48870702|NCT02101268|157364361|FG000|Randomized Treatment Phase|Disease Progression|4|||
48870703|NCT02101268|157364362|FG001|Randomized Treatment Phase|Disease Progression|1|||
48870704|NCT02101268|157364363|FG002|Randomized Treatment Phase|Disease Progression|0|||
48870705|NCT02101268|157364364|FG003|Randomized Treatment Phase|Disease Progression|0|||
48870706|NCT02101268|157364361|FG000|Extended Treatment Phase|Subject Decision|0|||
48870707|NCT02101268|157364362|FG001|Extended Treatment Phase|Subject Decision|0|||
48870708|NCT02101268|157364363|FG002|Extended Treatment Phase|Subject Decision|3|||
48870709|NCT02101268|157364364|FG003|Extended Treatment Phase|Subject Decision|2|||
48870710|NCT02101268|157364361|FG000|Extended Treatment Phase|Physician Decision|0|||
48670008|NCT00257660|156644747|FG000|Overall Study|PI & Subject Schedule Conflicts|1|||
48670009|NCT00257660|156644748|FG001|Overall Study|PI & Subject Schedule Conflicts|0|||
48670010|NCT00257660|156644747|FG000|Overall Study|No longer wanted to do blood draws|1|||
48670011|NCT00257660|156644748|FG001|Overall Study|No longer wanted to do blood draws|0|||
48670012|NCT00491608|156644749|FG000|Overall Study|Death|2|||
48670013|NCT00491608|156644749|FG000|Overall Study|Withdrawal by Subject|1|||
48670014|NCT02925741|156644750|FG000|Overall Study|Withdrawal by Subject|11|||
48670015|NCT02925741|156644751|FG001|Overall Study|Withdrawal by Subject|0|||
48670016|NCT00025155|156644752|FG000|Overall Study|Ineligible: Wrong primary cancer site|1|||
48670017|NCT00025155|156644752|FG000|Overall Study|Ineligible: Second primary cancer site|1|||
48670018|NCT05086510|156644755|FG000|Overall Study|Lost to Follow-up|0|||
48670019|NCT05086510|156644756|FG001|Overall Study|Lost to Follow-up|2|||
48670020|NCT05086510|156644755|FG000|Overall Study|Death|0|||
48670021|NCT05086510|156644756|FG001|Overall Study|Death|2|||
48670022|NCT00587847|156644762|FG000|Overall Study|Lack of Efficacy|5|||
48670023|NCT00587847|156644762|FG000|Overall Study|Adverse Event|2|||
48670024|NCT00343382|156644763|FG000|Overall Study|Adverse Event|2|||
48670025|NCT00343382|156644764|FG001|Overall Study|Adverse Event|10|||
48670026|NCT00343382|156644765|FG002|Overall Study|Adverse Event|7|||
48670027|NCT00343382|156644763|FG000|Overall Study|Withdrawal by Subject|1|||
48670028|NCT00343382|156644764|FG001|Overall Study|Withdrawal by Subject|2|||
48670029|NCT00343382|156644765|FG002|Overall Study|Withdrawal by Subject|6|||
48670030|NCT00343382|156644763|FG000|Overall Study|Other Reason Not Specified|1|||
48670031|NCT00343382|156644764|FG001|Overall Study|Other Reason Not Specified|2|||
48670032|NCT00343382|156644765|FG002|Overall Study|Other Reason Not Specified|4|||
48670033|NCT04032080|156644766|FG000|Overall Study|Death|6|||
48670034|NCT04881747|156644767|FG000|Period 2 Washout|Adverse Event|1|||
48670035|NCT04881747|156644768|FG001|Period 2 Washout|Adverse Event|0|||
48670036|NCT04881747|156644769|FG002|Period 2 Washout|Adverse Event|0|||
48670037|NCT04881747|156644770|FG003|Period 2 Washout|Adverse Event|0|||
48670038|NCT04881747|156644771|FG004|Period 2 Washout|Adverse Event|1|||
48670039|NCT04881747|156644772|FG005|Period 2 Washout|Adverse Event|0|||
48670040|NCT04881747|156644767|FG000|Period 2 Washout|Withdrawal by Subject|1|||
48670041|NCT04881747|156644768|FG001|Period 2 Washout|Withdrawal by Subject|0|||
48670042|NCT04881747|156644769|FG002|Period 2 Washout|Withdrawal by Subject|0|||
48670043|NCT04881747|156644770|FG003|Period 2 Washout|Withdrawal by Subject|1|||
48670044|NCT04881747|156644771|FG004|Period 2 Washout|Withdrawal by Subject|0|||
48670045|NCT04881747|156644772|FG005|Period 2 Washout|Withdrawal by Subject|0|||
48670046|NCT03332160|156644773|FG000|Overall Study|Withdrawal by Subject|1|||
48670047|NCT03332160|156644774|FG001|Overall Study|Withdrawal by Subject|1|||
48670048|NCT03332160|156644773|FG000|Overall Study|Adverse Event|0|||
48670049|NCT03332160|156644774|FG001|Overall Study|Adverse Event|1|||
48670050|NCT03332160|156644773|FG000|Overall Study|Developed Exclusion Criteria|0|||
48670051|NCT03332160|156644774|FG001|Overall Study|Developed Exclusion Criteria|1|||
48670052|NCT03332160|156644773|FG000|Overall Study|Non-adherence to treatment|0|||
48670053|NCT03332160|156644774|FG001|Overall Study|Non-adherence to treatment|2|||
48670054|NCT00409344|156644775|FG000|Overall Study|no enrollment|0|||
48670055|NCT00409344|156644776|FG001|Overall Study|no enrollment|0|||
48870711|NCT02101268|157364362|FG001|Extended Treatment Phase|Physician Decision|0|||
48870712|NCT02101268|157364363|FG002|Extended Treatment Phase|Physician Decision|5|||
48870713|NCT02101268|157364364|FG003|Extended Treatment Phase|Physician Decision|2|||
48870714|NCT02101268|157364361|FG000|Extended Treatment Phase|Adverse Event|0|||
48870715|NCT02101268|157364362|FG001|Extended Treatment Phase|Adverse Event|0|||
48670056|NCT00351273|156644778|FG000|Overall Study|Lost to Follow-up|1|||
48670057|NCT00351273|156644779|FG001|Overall Study|Lost to Follow-up|2|||
48670058|NCT00351273|156644780|FG002|Overall Study|Lost to Follow-up|5|||
48670059|NCT03869333|156644783|FG000|Overall Study|Lost to Follow-up|1|||
48670060|NCT03869333|156644784|FG001|Overall Study|Lost to Follow-up|0|||
48870716|NCT02101268|157364363|FG002|Extended Treatment Phase|Adverse Event|14|||
48870717|NCT02101268|157364364|FG003|Extended Treatment Phase|Adverse Event|18|||
48870718|NCT02101268|157364361|FG000|Extended Treatment Phase|Death|0|||
48870719|NCT02101268|157364362|FG001|Extended Treatment Phase|Death|0|||
48870720|NCT02101268|157364363|FG002|Extended Treatment Phase|Death|5|||
48870721|NCT02101268|157364364|FG003|Extended Treatment Phase|Death|1|||
48870722|NCT02101268|157364361|FG000|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
48870723|NCT02101268|157364362|FG001|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
48870724|NCT02101268|157364363|FG002|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|15|||
48870725|NCT02101268|157364364|FG003|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|7|||
48870726|NCT02101268|157364361|FG000|Extended Treatment Phase|Disease Progression|0|||
48870727|NCT02101268|157364362|FG001|Extended Treatment Phase|Disease Progression|0|||
48870728|NCT02101268|157364363|FG002|Extended Treatment Phase|Disease Progression|13|||
48870729|NCT02101268|157364364|FG003|Extended Treatment Phase|Disease Progression|6|||
48870730|NCT02101268|157364361|FG000|Extended Treatment Phase|Lack of Efficacy|0|||
48870731|NCT02101268|157364362|FG001|Extended Treatment Phase|Lack of Efficacy|0|||
49015487|NCT01393990|157893783|FG013|Overall Study|Death|1|||
48670061|NCT03869333|156644785|FG002|Overall Study|Lost to Follow-up|0|||
48670062|NCT03869333|156644786|FG003|Overall Study|Lost to Follow-up|0|||
48670063|NCT03869333|156644783|FG000|Overall Study|Pregnancy|1|||
48870732|NCT02101268|157364363|FG002|Extended Treatment Phase|Lack of Efficacy|9|||
48870733|NCT02101268|157364364|FG003|Extended Treatment Phase|Lack of Efficacy|4|||
48870734|NCT00740870|157364367|FG000|Overall Study|Not Catheterized|4|||
48870735|NCT00740870|157364367|FG000|Overall Study|Further testing contraindicated implant|17|||
48870736|NCT01193218|157364368|FG000|0-12 Weeks|Adverse Event|6|||
48870737|NCT01193218|157364369|FG001|0-12 Weeks|Adverse Event|0|||
48870738|NCT01193218|157364370|FG002|0-12 Weeks|Adverse Event|1|||
48870739|NCT01193218|157364371|FG003|0-12 Weeks|Adverse Event|0|||
48870740|NCT01193218|157364372|FG004|0-12 Weeks|Adverse Event|0|||
48870741|NCT01193218|157364373|FG005|0-12 Weeks|Adverse Event|2|||
48870742|NCT01193218|157364374|FG006|0-12 Weeks|Adverse Event|2|||
48870743|NCT01193218|157364375|FG007|0-12 Weeks|Adverse Event|0|||
48870744|NCT01193218|157364368|FG000|0-12 Weeks|Protocol Violation|0|||
48870745|NCT01193218|157364369|FG001|0-12 Weeks|Protocol Violation|0|||
48870746|NCT01193218|157364370|FG002|0-12 Weeks|Protocol Violation|0|||
48870747|NCT01193218|157364371|FG003|0-12 Weeks|Protocol Violation|0|||
48870748|NCT01193218|157364372|FG004|0-12 Weeks|Protocol Violation|1|||
48870749|NCT01193218|157364373|FG005|0-12 Weeks|Protocol Violation|1|||
48870750|NCT01193218|157364374|FG006|0-12 Weeks|Protocol Violation|0|||
48870751|NCT01193218|157364375|FG007|0-12 Weeks|Protocol Violation|0|||
48870752|NCT01193218|157364368|FG000|0-12 Weeks|Withdrawal by Subject|3|||
48870753|NCT01193218|157364369|FG001|0-12 Weeks|Withdrawal by Subject|0|||
48870754|NCT01193218|157364370|FG002|0-12 Weeks|Withdrawal by Subject|2|||
48870755|NCT01193218|157364371|FG003|0-12 Weeks|Withdrawal by Subject|0|||
48870756|NCT01193218|157364372|FG004|0-12 Weeks|Withdrawal by Subject|0|||
48870757|NCT01193218|157364373|FG005|0-12 Weeks|Withdrawal by Subject|0|||
48870758|NCT01193218|157364374|FG006|0-12 Weeks|Withdrawal by Subject|1|||
48870759|NCT01193218|157364375|FG007|0-12 Weeks|Withdrawal by Subject|0|||
48870760|NCT01193218|157364368|FG000|12-52 Weeks|Adverse Event|1|||
48870761|NCT01193218|157364369|FG001|12-52 Weeks|Adverse Event|0|||
48870762|NCT01193218|157364370|FG002|12-52 Weeks|Adverse Event|1|||
48760122|NCT02357901|156970072|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20|||
48870763|NCT01193218|157364371|FG003|12-52 Weeks|Adverse Event|2|||
48870764|NCT01193218|157364372|FG004|12-52 Weeks|Adverse Event|3|||
48870765|NCT01193218|157364373|FG005|12-52 Weeks|Adverse Event|3|||
48870766|NCT01193218|157364374|FG006|12-52 Weeks|Adverse Event|1|||
48670064|NCT03869333|156644784|FG001|Overall Study|Pregnancy|0|||
48670065|NCT03869333|156644785|FG002|Overall Study|Pregnancy|0|||
48670066|NCT03869333|156644786|FG003|Overall Study|Pregnancy|0|||
48760123|NCT02357901|156970073|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21|||
48760124|NCT02357901|156970074|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18|||
48760125|NCT02357901|156970071|FG000|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0|||
48760126|NCT02357901|156970072|FG001|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3|||
48760127|NCT02357901|156970073|FG002|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5|||
48760128|NCT02357901|156970074|FG003|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18|||
48760129|NCT02357901|156970071|FG000|Treatment Period (Day 1 to Week 24)|Adverse Event|0|||
48760130|NCT02357901|156970072|FG001|Treatment Period (Day 1 to Week 24)|Adverse Event|6|||
48760131|NCT02357901|156970073|FG002|Treatment Period (Day 1 to Week 24)|Adverse Event|10|||
48760132|NCT02357901|156970074|FG003|Treatment Period (Day 1 to Week 24)|Adverse Event|2|||
48870767|NCT01193218|157364375|FG007|12-52 Weeks|Adverse Event|2|||
48870768|NCT01193218|157364368|FG000|12-52 Weeks|Lack of Efficacy|0|||
48870769|NCT01193218|157364369|FG001|12-52 Weeks|Lack of Efficacy|0|||
48870770|NCT01193218|157364370|FG002|12-52 Weeks|Lack of Efficacy|0|||
48870771|NCT01193218|157364371|FG003|12-52 Weeks|Lack of Efficacy|0|||
48870772|NCT01193218|157364372|FG004|12-52 Weeks|Lack of Efficacy|0|||
48870773|NCT01193218|157364373|FG005|12-52 Weeks|Lack of Efficacy|0|||
48870774|NCT01193218|157364374|FG006|12-52 Weeks|Lack of Efficacy|1|||
48870775|NCT01193218|157364375|FG007|12-52 Weeks|Lack of Efficacy|0|||
48870776|NCT01193218|157364368|FG000|12-52 Weeks|Withdrawal by Subject|3|||
48870777|NCT01193218|157364369|FG001|12-52 Weeks|Withdrawal by Subject|0|||
48870778|NCT01193218|157364370|FG002|12-52 Weeks|Withdrawal by Subject|3|||
48968504|NCT01453998|157712548|FG001|After Protocol Amendment 2.|Withdrawal by Subject|0|||
48670067|NCT03869333|156644783|FG000|Overall Study|Physician Decision|0|||
48670068|NCT03869333|156644784|FG001|Overall Study|Physician Decision|1|||
48670069|NCT03869333|156644785|FG002|Overall Study|Physician Decision|0|||
48670070|NCT03869333|156644786|FG003|Overall Study|Physician Decision|0|||
48670071|NCT04208087|156644789|FG000|Overall Study|Adverse Event|1|||
48670072|NCT04208087|156644790|FG001|Overall Study|Adverse Event|0|||
48670073|NCT04208087|156644791|FG002|Overall Study|Adverse Event|0|||
48670074|NCT04208087|156644792|FG003|Overall Study|Adverse Event|0|||
48670075|NCT04208087|156644793|FG004|Overall Study|Adverse Event|0|||
48670076|NCT04208087|156644789|FG000|Overall Study|Withdrawal by Subject|0|||
48670077|NCT04208087|156644790|FG001|Overall Study|Withdrawal by Subject|0|||
48870779|NCT01193218|157364371|FG003|12-52 Weeks|Withdrawal by Subject|0|||
48870780|NCT01193218|157364372|FG004|12-52 Weeks|Withdrawal by Subject|0|||
48870781|NCT01193218|157364373|FG005|12-52 Weeks|Withdrawal by Subject|2|||
48870782|NCT01193218|157364374|FG006|12-52 Weeks|Withdrawal by Subject|1|||
48870783|NCT01193218|157364375|FG007|12-52 Weeks|Withdrawal by Subject|2|||
48870784|NCT01193218|157364368|FG000|12-52 Weeks|Other reason than above|1|||
48760133|NCT02357901|156970071|FG000|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
48760134|NCT02357901|156970072|FG001|Treatment Period (Day 1 to Week 24)|Protocol Violation|2|||
48760135|NCT02357901|156970073|FG002|Treatment Period (Day 1 to Week 24)|Protocol Violation|5|||
48760136|NCT02357901|156970074|FG003|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
48760137|NCT02357901|156970071|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0|||
48760138|NCT02357901|156970072|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
48760139|NCT02357901|156970073|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
48760140|NCT02357901|156970074|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3|||
48760141|NCT02357901|156970071|FG000|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
48760142|NCT02357901|156970072|FG001|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
48760143|NCT02357901|156970073|FG002|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
48760144|NCT02357901|156970074|FG003|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
48760145|NCT02357901|156970071|FG000|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
48760146|NCT02357901|156970072|FG001|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1|||
48760147|NCT02357901|156970073|FG002|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
48760148|NCT02357901|156970074|FG003|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3|||
48760149|NCT02357901|156970071|FG000|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
48760150|NCT02357901|156970072|FG001|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
48760151|NCT02357901|156970073|FG002|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
48760152|NCT02357901|156970074|FG003|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
48760153|NCT02357901|156970071|FG000|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0|||
48760154|NCT02357901|156970072|FG001|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17|||
48760155|NCT02357901|156970073|FG002|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6|||
48760156|NCT02357901|156970074|FG003|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7|||
48760157|NCT00413192|156970082|FG000|Overall Study|Disease progression|26|||
48760158|NCT00413192|156970083|FG001|Overall Study|Disease progression|31|||
48760159|NCT00413192|156970084|FG002|Overall Study|Disease progression|16|||
48760160|NCT00413192|156970085|FG003|Overall Study|Disease progression|25|||
48760161|NCT00413192|156970082|FG000|Overall Study|Toxicity|3|||
48760162|NCT00413192|156970083|FG001|Overall Study|Toxicity|2|||
48760163|NCT00413192|156970084|FG002|Overall Study|Toxicity|2|||
48760164|NCT00413192|156970085|FG003|Overall Study|Toxicity|2|||
48760165|NCT00413192|156970082|FG000|Overall Study|Withdrawal by Subject|3|||
48760166|NCT00413192|156970083|FG001|Overall Study|Withdrawal by Subject|5|||
48760167|NCT00413192|156970084|FG002|Overall Study|Withdrawal by Subject|0|||
48760168|NCT00413192|156970085|FG003|Overall Study|Withdrawal by Subject|1|||
48760169|NCT00413192|156970082|FG000|Overall Study|Intercurrent illness|0|||
48760170|NCT00413192|156970083|FG001|Overall Study|Intercurrent illness|0|||
48760171|NCT00413192|156970084|FG002|Overall Study|Intercurrent illness|0|||
48760172|NCT00413192|156970085|FG003|Overall Study|Intercurrent illness|1|||
48760173|NCT00413192|156970082|FG000|Overall Study|Intercurrent death|0|||
48760174|NCT00413192|156970083|FG001|Overall Study|Intercurrent death|1|||
48760175|NCT00413192|156970084|FG002|Overall Study|Intercurrent death|0|||
48760176|NCT00413192|156970085|FG003|Overall Study|Intercurrent death|0|||
48760177|NCT00413192|156970082|FG000|Overall Study|Other|5|||
48760178|NCT00413192|156970083|FG001|Overall Study|Other|1|||
48760179|NCT00413192|156970084|FG002|Overall Study|Other|1|||
48760180|NCT00413192|156970085|FG003|Overall Study|Other|2|||
48760181|NCT00413192|156970082|FG000|Overall Study|Not treated|0|||
48760182|NCT00413192|156970083|FG001|Overall Study|Not treated|0|||
48760183|NCT00413192|156970084|FG002|Overall Study|Not treated|0|||
48760184|NCT00413192|156970085|FG003|Overall Study|Not treated|1|||
48760185|NCT00278954|156970090|FG000|Overall Study|Adverse Event|3|||
48760186|NCT00278954|156970090|FG000|Overall Study|Lost to Follow-up|1|||
48760187|NCT00278954|156970090|FG000|Overall Study|Withdrawal by Subject|1|||
48760188|NCT01454570|156970095|FG000|Overall Study|Withdrawal by Subject|2|||
48760189|NCT01454570|156970095|FG000|Overall Study|Screen Failure|7|||
48760190|NCT00772707|156970096|FG000|Overall Study|Withdrawn|3|||
48760191|NCT00885755|156970098|FG000|Part I: Trastuzumab+Taxane|Adverse Event|1|||
48760192|NCT00885755|156970099|FG001|Part I: Trastuzumab+Taxane|Adverse Event|0|||
48760193|NCT00885755|156970100|FG002|Part I: Trastuzumab+Taxane|Adverse Event|0|||
48760194|NCT00885755|156970098|FG000|Part I: Trastuzumab+Taxane|Unknown Reason|16|||
48760195|NCT00885755|156970099|FG001|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
48760196|NCT00885755|156970100|FG002|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
48760197|NCT00885755|156970098|FG000|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1|||
48760198|NCT00885755|156970099|FG001|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
48760199|NCT00885755|156970100|FG002|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
48760200|NCT00885755|156970098|FG000|Part I: Trastuzumab+Taxane|Death|0|||
48760201|NCT00885755|156970099|FG001|Part I: Trastuzumab+Taxane|Death|0|||
48760202|NCT00885755|156970100|FG002|Part I: Trastuzumab+Taxane|Death|1|||
48760203|NCT00885755|156970098|FG000|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5|||
48870785|NCT01193218|157364369|FG001|12-52 Weeks|Other reason than above|0|||
48870786|NCT01193218|157364370|FG002|12-52 Weeks|Other reason than above|0|||
48870787|NCT01193218|157364371|FG003|12-52 Weeks|Other reason than above|1|||
48870788|NCT01193218|157364372|FG004|12-52 Weeks|Other reason than above|1|||
48870789|NCT01193218|157364373|FG005|12-52 Weeks|Other reason than above|0|||
48870790|NCT01193218|157364374|FG006|12-52 Weeks|Other reason than above|0|||
48870791|NCT01193218|157364375|FG007|12-52 Weeks|Other reason than above|0|||
48870792|NCT00239681|157364376|FG000|Overall Study|Adverse Event|100|||
48870793|NCT00239681|157364377|FG001|Overall Study|Adverse Event|99|||
48870794|NCT00239681|157364376|FG000|Overall Study|Withdrawal by Subject|458|||
48870795|NCT00239681|157364377|FG001|Overall Study|Withdrawal by Subject|489|||
48870796|NCT00239681|157364376|FG000|Overall Study|Lost to Follow-up|28|||
48870797|NCT00239681|157364377|FG001|Overall Study|Lost to Follow-up|22|||
48870798|NCT00239681|157364376|FG000|Overall Study|Protocol Violation|4|||
48870799|NCT00239681|157364377|FG001|Overall Study|Protocol Violation|4|||
48870800|NCT00239681|157364376|FG000|Overall Study|Physician Decision|13|||
48870801|NCT00239681|157364377|FG001|Overall Study|Physician Decision|17|||
48870802|NCT00239681|157364376|FG000|Overall Study|No information chacked on CaseReportForm|90|||
48870803|NCT00239681|157364377|FG001|Overall Study|No information chacked on CaseReportForm|84|||
48870804|NCT00363649|157364384|FG000|Overall Study|Withdrawal by Subject|1|||
48870805|NCT00363649|157364385|FG001|Overall Study|Withdrawal by Subject|1|||
48870806|NCT00363649|157364384|FG000|Overall Study|Adverse Event|6|||
48870807|NCT00363649|157364385|FG001|Overall Study|Adverse Event|0|||
48870808|NCT00002597|157364386|FG000|Overall Study|Protocol Violation|19|||
48870809|NCT00002597|157364387|FG001|Overall Study|Protocol Violation|17|||
48870810|NCT00002597|157364386|FG000|Overall Study|Withdrawal by Subject|7|||
48870811|NCT00002597|157364387|FG001|Overall Study|Withdrawal by Subject|6|||
48870812|NCT02109107|157364391|FG000|Overall Study|Lost to Follow-up|2|||
48870813|NCT01702519|157364392|FG000|Washout Period|Lost to Follow-up|1|||
48870814|NCT01702519|157364393|FG001|Washout Period|Lost to Follow-up|0|||
48870815|NCT01702519|157364392|FG000|Washout Period|Withdrawal by Subject|0|||
48870816|NCT01702519|157364393|FG001|Washout Period|Withdrawal by Subject|2|||
48870817|NCT03738397|157364394|FG000|Overall Study|Adverse Event|3|||
48670078|NCT04208087|156644791|FG002|Overall Study|Withdrawal by Subject|1|||
48670079|NCT04208087|156644792|FG003|Overall Study|Withdrawal by Subject|0|||
48760204|NCT00885755|156970099|FG001|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
48760205|NCT00885755|156970100|FG002|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
48760206|NCT01266460|156970101|FG000|Overall Study|Adverse Event|3|||
48760207|NCT01266460|156970101|FG000|Overall Study|Withdrawal by Subject|5|||
48760208|NCT01266460|156970101|FG000|Overall Study|Disease Progression|18|||
48760209|NCT01266460|156970101|FG000|Overall Study|Not otherwise specified|8|||
48760210|NCT01589445|156970102|FG000|001 (Pioglitazone) -3 Months|Protocol Violation|1|||
48760211|NCT01589445|156970102|FG000|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1|||
48760212|NCT01589445|156970102|FG000|001 (Pioglitazone) -3 Months|Lost to Follow-up|2|||
48760213|NCT01589445|156970102|FG000|001 (Pioglitazone) -3 Months|Lack of Efficacy|1|||
48760214|NCT01589445|156970102|FG000|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2|||
48760215|NCT01589445|156970102|FG000|002 (Metformin)-3 Months|Lack of Efficacy|1|||
48760216|NCT01589445|156970102|FG000|002 (Metformin)-3 Months|Lost to Follow-up|2|||
48760217|NCT01589445|156970102|FG000|002 (Metformin)-3 Months|Protocol Violation|2|||
48760218|NCT01589445|156970102|FG000|002 (Metformin)-3 Months|Adverse Event|2|||
48760219|NCT01589445|156970102|FG000|002 (Metformin)-3 Months|Husbands of female patients refrained|2|||
48760220|NCT01050257|156970117|FG000|Overall Study|Adverse Event|4|||
48760221|NCT01050257|156970118|FG001|Overall Study|Adverse Event|4|||
48760222|NCT01050257|156970119|FG002|Overall Study|Adverse Event|2|||
48760223|NCT01050257|156970117|FG000|Overall Study|Admin/Other (did not switch to oral)|6|||
48870818|NCT03738397|157364395|FG001|Overall Study|Adverse Event|7|||
48870819|NCT03738397|157364394|FG000|Overall Study|Withdrawal by Subject|8|||
48670080|NCT04208087|156644793|FG004|Overall Study|Withdrawal by Subject|0|||
48670081|NCT04208087|156644789|FG000|Overall Study|Other|0|||
48670082|NCT04208087|156644790|FG001|Overall Study|Other|0|||
48670083|NCT04208087|156644791|FG002|Overall Study|Other|0|||
48670084|NCT04208087|156644792|FG003|Overall Study|Other|0|||
48670085|NCT04208087|156644793|FG004|Overall Study|Other|1|||
48670086|NCT01198509|156644794|FG000|Overall Study|Withdrawal by Subject|1|||
48760224|NCT01050257|156970118|FG001|Overall Study|Admin/Other (did not switch to oral)|2|||
48870820|NCT03738397|157364395|FG001|Overall Study|Withdrawal by Subject|11|||
48870821|NCT03738397|157364394|FG000|Overall Study|Lost to Follow-up|7|||
48870822|NCT03738397|157364395|FG001|Overall Study|Lost to Follow-up|5|||
48870823|NCT03738397|157364394|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
48670087|NCT01198509|156644795|FG001|Overall Study|Withdrawal by Subject|0|||
48870824|NCT03738397|157364395|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
48870825|NCT03738397|157364394|FG000|Overall Study|Other|4|||
48870826|NCT03738397|157364395|FG001|Overall Study|Other|6|||
48670088|NCT01198509|156644796|FG002|Overall Study|Withdrawal by Subject|0|||
48870827|NCT00904722|157364396|FG000|Overall Study|Physician Decision|1|||
48870828|NCT00069277|157364398|FG000|Overall Study|Adverse Event|3|||
48760225|NCT01050257|156970119|FG002|Overall Study|Admin/Other (did not switch to oral)|2|||
48760226|NCT01050257|156970117|FG000|Overall Study|Withdrawal by Subject|0|||
48760227|NCT01050257|156970118|FG001|Overall Study|Withdrawal by Subject|3|||
48760228|NCT01050257|156970119|FG002|Overall Study|Withdrawal by Subject|0|||
48760229|NCT01050257|156970117|FG000|Overall Study|No reason specified|0|||
48760230|NCT01050257|156970118|FG001|Overall Study|No reason specified|0|||
48760231|NCT01050257|156970119|FG002|Overall Study|No reason specified|2|||
48760232|NCT01050257|156970117|FG000|Overall Study|Refused treatment/ Did not Cooperate|1|||
48760233|NCT01050257|156970118|FG001|Overall Study|Refused treatment/ Did not Cooperate|1|||
48760234|NCT01050257|156970119|FG002|Overall Study|Refused treatment/ Did not Cooperate|0|||
48760235|NCT01050257|156970117|FG000|Overall Study|Violation criteria|0|||
48760236|NCT01050257|156970118|FG001|Overall Study|Violation criteria|1|||
48760237|NCT01050257|156970119|FG002|Overall Study|Violation criteria|0|||
48760238|NCT01050257|156970117|FG000|Overall Study|Failure to return|0|||
48760239|NCT01050257|156970118|FG001|Overall Study|Failure to return|2|||
48670089|NCT01198509|156644797|FG003|Overall Study|Withdrawal by Subject|0|||
48670090|NCT01198509|156644798|FG004|Overall Study|Withdrawal by Subject|0|||
48670091|NCT01198509|156644799|FG005|Overall Study|Withdrawal by Subject|0|||
48670092|NCT02228096|156644805|FG000|Overall Study|Study terminated by Sponsor|24|||
48670093|NCT02228096|156644805|FG000|Overall Study|Lack of Efficacy|18|||
48670094|NCT02228096|156644805|FG000|Overall Study|Death|12|||
48670095|NCT02228096|156644805|FG000|Overall Study|Physician Decision|3|||
48670096|NCT02228096|156644805|FG000|Overall Study|Subject/guardian decision|2|||
48670097|NCT02228096|156644805|FG000|Overall Study|New therapy for study indication|1|||
48670098|NCT02228096|156644805|FG000|Overall Study|Enrolled, not infused|11|||
48670099|NCT01969721|156644807|FG000|Overall Study|Adverse Event|3|||
48670100|NCT01969721|156644808|FG001|Overall Study|Adverse Event|8|||
48670101|NCT01969721|156644809|FG002|Overall Study|Adverse Event|3|||
48670102|NCT01969721|156644810|FG003|Overall Study|Adverse Event|2|||
48670103|NCT01969721|156644807|FG000|Overall Study|Lack of Efficacy|0|||
48670104|NCT01969721|156644808|FG001|Overall Study|Lack of Efficacy|0|||
48670105|NCT01969721|156644809|FG002|Overall Study|Lack of Efficacy|1|||
48670106|NCT01969721|156644810|FG003|Overall Study|Lack of Efficacy|0|||
48670107|NCT01969721|156644807|FG000|Overall Study|Non compliant with protocol|1|||
48670108|NCT01969721|156644808|FG001|Overall Study|Non compliant with protocol|1|||
48670109|NCT01969721|156644809|FG002|Overall Study|Non compliant with protocol|0|||
48670110|NCT01969721|156644810|FG003|Overall Study|Non compliant with protocol|2|||
48670111|NCT01969721|156644807|FG000|Overall Study|Other not defined above|0|||
48670112|NCT01969721|156644808|FG001|Overall Study|Other not defined above|2|||
48670113|NCT01969721|156644809|FG002|Overall Study|Other not defined above|0|||
48670114|NCT01969721|156644810|FG003|Overall Study|Other not defined above|0|||
48670115|NCT01969721|156644807|FG000|Overall Study|Discontinued during washout periods.|0|||
48670116|NCT01969721|156644808|FG001|Overall Study|Discontinued during washout periods.|1|||
48670117|NCT01969721|156644809|FG002|Overall Study|Discontinued during washout periods.|1|||
48670118|NCT01969721|156644810|FG003|Overall Study|Discontinued during washout periods.|2|||
48670119|NCT00558272|156644811|FG000|Overall Study|Adverse Event|10|||
48670120|NCT00558272|156644812|FG001|Overall Study|Adverse Event|0|||
48670121|NCT00558272|156644811|FG000|Overall Study|Death|1|||
48670122|NCT00558272|156644812|FG001|Overall Study|Death|0|||
48670123|NCT00558272|156644811|FG000|Overall Study|Dev. of study specific discon. criteria|1|||
48670124|NCT00558272|156644812|FG001|Overall Study|Dev. of study specific discon. criteria|0|||
48670125|NCT00558272|156644811|FG000|Overall Study|AZ study team decision|0|||
48670126|NCT00558272|156644812|FG001|Overall Study|AZ study team decision|1|||
48670127|NCT00558272|156644811|FG000|Overall Study|Incorrectly enrolled|1|||
48670128|NCT00558272|156644812|FG001|Overall Study|Incorrectly enrolled|0|||
48670129|NCT00558272|156644811|FG000|Overall Study|Withdrawal by Subject|0|||
48670130|NCT00558272|156644812|FG001|Overall Study|Withdrawal by Subject|1|||
48670131|NCT00952614|156644813|FG000|Overall Study|Death|3|||
48670132|NCT00952614|156644813|FG000|Overall Study|Lost to Follow-up|3|||
48670133|NCT00952614|156644813|FG000|Overall Study|other reason|1|||
48670134|NCT00849108|156644817|FG000|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1|||
48760240|NCT01050257|156970119|FG002|Overall Study|Failure to return|0|||
48670135|NCT00849108|156644818|FG001|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0|||
48670136|NCT00849108|156644817|FG000|Cohort 2 Efficacy|Adverse Event|0|||
48670137|NCT00849108|156644818|FG001|Cohort 2 Efficacy|Adverse Event|1|||
48670138|NCT00849108|156644817|FG000|Cohort 2 Efficacy|Other|0|||
48670139|NCT00849108|156644818|FG001|Cohort 2 Efficacy|Other|9|||
48670140|NCT02963701|156644819|FG000|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1|||
48670141|NCT02963701|156644820|FG001|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0|||
48760241|NCT01050257|156970117|FG000|Overall Study|Death|0|||
48760242|NCT01050257|156970118|FG001|Overall Study|Death|0|||
48760243|NCT01050257|156970119|FG002|Overall Study|Death|1|||
48760244|NCT00278109|156970121|FG000|Overall Study|Adverse Event|3|||
48670142|NCT03480009|156644821|FG000|Overall Study|Lost to Follow-up|4|||
48670143|NCT03480009|156644822|FG001|Overall Study|Lost to Follow-up|5|||
48670144|NCT03480009|156644823|FG002|Overall Study|Lost to Follow-up|4|||
48670145|NCT03480009|156644824|FG003|Overall Study|Lost to Follow-up|0|||
48670146|NCT04496453|156644826|FG000|Overall Study|Lost to Follow-up|6|||
48670147|NCT02456857|156644831|FG000|Overall Study|Disease Progression|4|||
48670148|NCT01220180|156644832|FG000|Overall Study|Lost to Follow-up|76|||
48670149|NCT01220180|156644832|FG000|Overall Study|Other|72|||
48670150|NCT01220180|156644832|FG000|Overall Study|Adverse Event|35|||
48670151|NCT01220180|156644832|FG000|Overall Study|Lack of Efficacy|22|||
48670152|NCT01220180|156644832|FG000|Overall Study|Death|1|||
48670153|NCT01220180|156644832|FG000|Overall Study|Randomized but not treated|1|||
48670154|NCT02262754|156644835|FG000|Overall Study|Adverse Event|3|||
48670155|NCT02262754|156644836|FG001|Overall Study|Adverse Event|4|||
48670156|NCT02262754|156644837|FG002|Overall Study|Adverse Event|0|||
48670157|NCT02262754|156644835|FG000|Overall Study|Lack of Efficacy|2|||
48670158|NCT02262754|156644836|FG001|Overall Study|Lack of Efficacy|0|||
48670159|NCT02262754|156644837|FG002|Overall Study|Lack of Efficacy|1|||
48670160|NCT02262754|156644835|FG000|Overall Study|Lost to Follow-up|0|||
48670161|NCT02262754|156644836|FG001|Overall Study|Lost to Follow-up|0|||
48670162|NCT02262754|156644837|FG002|Overall Study|Lost to Follow-up|1|||
48670163|NCT02262754|156644835|FG000|Overall Study|No longer meets eligibility criteria|0|||
48670164|NCT02262754|156644836|FG001|Overall Study|No longer meets eligibility criteria|1|||
48670165|NCT02262754|156644837|FG002|Overall Study|No longer meets eligibility criteria|0|||
48670166|NCT02262754|156644835|FG000|Overall Study|Study terminated by sponsor|5|||
48670167|NCT02262754|156644836|FG001|Overall Study|Study terminated by sponsor|4|||
48670168|NCT02262754|156644837|FG002|Overall Study|Study terminated by sponsor|4|||
48670169|NCT02262754|156644835|FG000|Overall Study|Protocol Violation|1|||
48670170|NCT02262754|156644836|FG001|Overall Study|Protocol Violation|0|||
48670171|NCT02262754|156644837|FG002|Overall Study|Protocol Violation|0|||
48670172|NCT02262754|156644835|FG000|Overall Study|Withdrawal by Subject|1|||
48670173|NCT02262754|156644836|FG001|Overall Study|Withdrawal by Subject|0|||
48670174|NCT02262754|156644837|FG002|Overall Study|Withdrawal by Subject|1|||
48670175|NCT02262754|156644835|FG000|Overall Study|Other|4|||
48670176|NCT02262754|156644836|FG001|Overall Study|Other|0|||
48670177|NCT02262754|156644837|FG002|Overall Study|Other|2|||
48670178|NCT05327361|156644838|FG000|Overall Study|Lost to Follow-up|4|||
48670179|NCT03281304|156644839|FG000|Treatment Phase (up to 42 Months)|Adverse Event|10|||
48670180|NCT03281304|156644840|FG001|Treatment Phase (up to 42 Months)|Adverse Event|10|||
48670181|NCT03281304|156644839|FG000|Treatment Phase (up to 42 Months)|Lack of Efficacy|3|||
48670182|NCT03281304|156644840|FG001|Treatment Phase (up to 42 Months)|Lack of Efficacy|2|||
48670183|NCT03281304|156644839|FG000|Treatment Phase (up to 42 Months)|Pregnancy|1|||
48670184|NCT03281304|156644840|FG001|Treatment Phase (up to 42 Months)|Pregnancy|0|||
48670185|NCT03281304|156644839|FG000|Treatment Phase (up to 42 Months)|Withdrawal by Subject|5|||
48670186|NCT03281304|156644840|FG001|Treatment Phase (up to 42 Months)|Withdrawal by Subject|12|||
48670187|NCT03281304|156644839|FG000|Treatment Phase (up to 42 Months)|Death|0|||
48670188|NCT03281304|156644840|FG001|Treatment Phase (up to 42 Months)|Death|1|||
48670189|NCT03281304|156644839|FG000|Treatment Phase (up to 42 Months)|Study terminated by sponsor|15|||
48670190|NCT03281304|156644840|FG001|Treatment Phase (up to 42 Months)|Study terminated by sponsor|16|||
48670191|NCT03281304|156644839|FG000|Treatment Phase (up to 42 Months)|Other|0|||
48670192|NCT03281304|156644840|FG001|Treatment Phase (up to 42 Months)|Other|2|||
48670193|NCT03281304|156644839|FG000|Follow-up Phase (up to 4 Weeks)|Other|2|||
48760245|NCT00278109|156970121|FG000|Overall Study|social circumstances|1|||
48760246|NCT00613015|156970123|FG000|Overall Study|Lost to Follow-up|0|||
48760247|NCT00613015|156970124|FG001|Overall Study|Lost to Follow-up|1|||
48760248|NCT00613015|156970125|FG002|Overall Study|Lost to Follow-up|3|||
48760249|NCT00613015|156970126|FG003|Overall Study|Lost to Follow-up|3|||
48760250|NCT00613015|156970127|FG004|Overall Study|Lost to Follow-up|2|||
48760251|NCT00613015|156970128|FG005|Overall Study|Lost to Follow-up|3|||
48760252|NCT02205333|156970129|FG000|Overall Study|Death|5|||
48760253|NCT02205333|156970130|FG001|Overall Study|Death|6|||
48760254|NCT02205333|156970131|FG002|Overall Study|Death|2|||
48760255|NCT02205333|156970132|FG003|Overall Study|Death|6|||
48760256|NCT02205333|156970133|FG004|Overall Study|Death|5|||
48760257|NCT02205333|156970134|FG005|Overall Study|Death|3|||
48760258|NCT02205333|156970135|FG006|Overall Study|Death|3|||
48760259|NCT02205333|156970136|FG007|Overall Study|Death|2|||
48760260|NCT02205333|156970137|FG008|Overall Study|Death|0|||
48760261|NCT02205333|156970129|FG000|Overall Study|Withdrawal by Subject|1|||
48760262|NCT02205333|156970130|FG001|Overall Study|Withdrawal by Subject|0|||
48760263|NCT02205333|156970131|FG002|Overall Study|Withdrawal by Subject|0|||
48760264|NCT02205333|156970132|FG003|Overall Study|Withdrawal by Subject|1|||
48760265|NCT02205333|156970133|FG004|Overall Study|Withdrawal by Subject|0|||
48760266|NCT02205333|156970134|FG005|Overall Study|Withdrawal by Subject|0|||
48760267|NCT02205333|156970135|FG006|Overall Study|Withdrawal by Subject|2|||
48760268|NCT02205333|156970136|FG007|Overall Study|Withdrawal by Subject|0|||
48760269|NCT02205333|156970137|FG008|Overall Study|Withdrawal by Subject|0|||
48760270|NCT00454987|156970138|FG000|Booster Period (NCT00258700)|Adverse Event|1|||
48760271|NCT00454987|156970139|FG001|Booster Period (NCT00258700)|Adverse Event|0|||
48760272|NCT00454987|156970140|FG002|Booster Period (NCT00258700)|Adverse Event|0|||
48670194|NCT03281304|156644840|FG001|Follow-up Phase (up to 4 Weeks)|Other|1|||
48670195|NCT00626405|156644841|FG000|Overall Study|Deemed Ineligible|1|||
48670196|NCT00626405|156644842|FG001|Overall Study|Deemed Ineligible|0|||
48670197|NCT00626405|156644841|FG000|Overall Study|Withdrawal by Subject|0|||
48670198|NCT00626405|156644842|FG001|Overall Study|Withdrawal by Subject|1|||
48670199|NCT04046250|156644843|FG000|Overall Study|Death|0|||
48670200|NCT04046250|156644844|FG001|Overall Study|Death|1|||
48670201|NCT04046250|156644843|FG000|Overall Study|Withdrawal by Subject|3|||
48670202|NCT04046250|156644844|FG001|Overall Study|Withdrawal by Subject|3|||
48670203|NCT00566254|156644849|FG000|Overall Study|Adverse Event|3|||
48670204|NCT00566254|156644850|FG001|Overall Study|Adverse Event|1|||
48670205|NCT00566254|156644849|FG000|Overall Study|Protocol Violation|1|||
48670206|NCT00566254|156644850|FG001|Overall Study|Protocol Violation|3|||
48670207|NCT00566254|156644849|FG000|Overall Study|Withdrawal by Subject|1|||
48670208|NCT00566254|156644850|FG001|Overall Study|Withdrawal by Subject|2|||
48670209|NCT00566254|156644849|FG000|Overall Study|Lack of Efficacy|5|||
48670210|NCT00566254|156644850|FG001|Overall Study|Lack of Efficacy|6|||
48670211|NCT00566254|156644849|FG000|Overall Study|Other|0|||
48670212|NCT00566254|156644850|FG001|Overall Study|Other|2|||
48670213|NCT00758589|156646444|FG000|Overall Study|Adverse Event|3|||
48670214|NCT00758589|156646445|FG001|Overall Study|Adverse Event|2|||
48670215|NCT00758589|156646446|FG002|Overall Study|Adverse Event|5|||
48670216|NCT00758589|156646447|FG003|Overall Study|Adverse Event|4|||
48670217|NCT00758589|156646444|FG000|Overall Study|Withdrawal by Subject|0|||
48870829|NCT00069277|157364398|FG000|Overall Study|Withdrawal by Subject|1|||
48870830|NCT00069277|157364398|FG000|Overall Study|Progressive Disease|15|||
48870831|NCT00069277|157364398|FG000|Overall Study|Physician Decision|2|||
48870832|NCT02956278|157365721|FG000|Overall Study|Withdrawal by Subject|6|||
48670218|NCT00758589|156646445|FG001|Overall Study|Withdrawal by Subject|1|||
48670219|NCT00758589|156646446|FG002|Overall Study|Withdrawal by Subject|1|||
48870833|NCT02956278|157365722|FG001|Overall Study|Withdrawal by Subject|2|||
48870834|NCT02956278|157365723|FG002|Overall Study|Withdrawal by Subject|0|||
48870835|NCT00961896|157365740|FG000|Overall Study|Abnormal laboratory value|0|||
48870836|NCT00961896|157365741|FG001|Overall Study|Abnormal laboratory value|0|||
48870837|NCT00961896|157365742|FG002|Overall Study|Abnormal laboratory value|1|||
48870838|NCT00695136|157365743|FG000|Overall Study|Withdrawal by Subject|1|||
48870839|NCT00695136|157365743|FG000|Overall Study|unrelated adverse event|1|||
48870840|NCT00275301|157365744|FG000|Overall Study|Adverse Event|5|||
48870841|NCT01644188|157365745|FG000|Overall Study|Adverse Event|44|||
48670220|NCT00758589|156646447|FG003|Overall Study|Withdrawal by Subject|1|||
48670221|NCT00758589|156646444|FG000|Overall Study|Palm stopped to work|0|||
48670222|NCT00758589|156646445|FG001|Overall Study|Palm stopped to work|0|||
48670223|NCT00758589|156646446|FG002|Overall Study|Palm stopped to work|0|||
48670224|NCT00758589|156646447|FG003|Overall Study|Palm stopped to work|1|||
48670225|NCT01825941|156646448|FG000|Overall Study|Lost to Follow-up|4|||
48670226|NCT01825941|156646449|FG001|Overall Study|Lost to Follow-up|1|||
48670227|NCT03966885|156646450|FG000|Overall Study|Death|1|||
48670228|NCT03966885|156646451|FG001|Overall Study|Death|0|||
48670229|NCT03966885|156646450|FG000|Overall Study|Lost to Follow-up|1|||
48670230|NCT03966885|156646451|FG001|Overall Study|Lost to Follow-up|2|||
48670231|NCT03966885|156646450|FG000|Overall Study|Not post-assessed. Study ended early due to COVID-19|20|||
48670232|NCT03966885|156646451|FG001|Overall Study|Not post-assessed. Study ended early due to COVID-19|16|||
48670233|NCT03966885|156646450|FG000|Overall Study|Moved from study area.|0|||
48670234|NCT03966885|156646451|FG001|Overall Study|Moved from study area.|2|||
48670235|NCT02032407|156646452|FG000|Overall Study|Lost to Follow-up|2|||
48670236|NCT02032407|156646452|FG000|Overall Study|Pregnancy|1|||
48670237|NCT02032407|156646452|FG000|Overall Study|Other Miscellaneous Reasons|2|||
48670238|NCT00734071|156646454|FG000|Overall Study|Adverse Event|4|||
48670239|NCT00734071|156646455|FG001|Overall Study|Adverse Event|3|||
48670240|NCT00734071|156646454|FG000|Overall Study|Lack of Efficacy|3|||
48670241|NCT00734071|156646455|FG001|Overall Study|Lack of Efficacy|1|||
48670242|NCT00734071|156646454|FG000|Overall Study|Noncompliance|2|||
48670243|NCT00734071|156646455|FG001|Overall Study|Noncompliance|2|||
48670244|NCT00734071|156646454|FG000|Overall Study|Protocol Deviations|3|||
48670245|NCT00734071|156646455|FG001|Overall Study|Protocol Deviations|4|||
48870842|NCT01644188|157365746|FG001|Overall Study|Adverse Event|20|||
48870843|NCT01644188|157365745|FG000|Overall Study|Poor compliance to protocol|26|||
48870844|NCT01644188|157365746|FG001|Overall Study|Poor compliance to protocol|14|||
48870845|NCT01644188|157365745|FG000|Overall Study|Physician Decision|1|||
48670246|NCT00734071|156646454|FG000|Overall Study|Voluntary Withdrawal|9|||
48670247|NCT00734071|156646455|FG001|Overall Study|Voluntary Withdrawal|7|||
48870846|NCT01644188|157365746|FG001|Overall Study|Physician Decision|3|||
49015488|NCT01393990|157893784|FG014|Overall Study|Death|1|||
48670248|NCT00734071|156646454|FG000|Overall Study|Lost to Follow-up|16|||
48670249|NCT00734071|156646455|FG001|Overall Study|Lost to Follow-up|8|||
48670250|NCT00734071|156646454|FG000|Overall Study|Other|1|||
48670251|NCT00734071|156646455|FG001|Overall Study|Other|2|||
48670252|NCT00541346|156646456|FG000|Follow-up|Adverse Event|1|||
48692812|NCT01188772|156724612|FG002|Overall Study|Virologic Failure|0|||
48670253|NCT03559699|156646457|FG000|Overall Study|Withdrawal by Subject|6|||
48670254|NCT03559699|156646457|FG000|Overall Study|Lost to Follow-up|1|||
48870847|NCT01644188|157365745|FG000|Overall Study|Participant moved|7|||
48870848|NCT01644188|157365746|FG001|Overall Study|Participant moved|2|||
48870849|NCT01644188|157365745|FG000|Overall Study|Related to auto-injector administration|2|||
48870850|NCT01644188|157365746|FG001|Overall Study|Related to auto-injector administration|2|||
48870851|NCT01644188|157365745|FG000|Overall Study|Consent withdrawn by participant|14|||
48870852|NCT01644188|157365746|FG001|Overall Study|Consent withdrawn by participant|7|||
48870853|NCT01644188|157365745|FG000|Overall Study|Selection criteria finally not met|2|||
48870854|NCT01644188|157365746|FG001|Overall Study|Selection criteria finally not met|0|||
48870855|NCT01644188|157365745|FG000|Overall Study|Lost to Follow-up|1|||
48870856|NCT01644188|157365746|FG001|Overall Study|Lost to Follow-up|0|||
48870857|NCT01644188|157365745|FG000|Overall Study|Death|4|||
48870858|NCT01644188|157365746|FG001|Overall Study|Death|3|||
48870859|NCT01644188|157365745|FG000|Overall Study|Last visit outside protocol visit window|14|||
48870860|NCT01644188|157365746|FG001|Overall Study|Last visit outside protocol visit window|16|||
48870861|NCT01644188|157365745|FG000|Overall Study|Site closure|1|||
48870862|NCT01644188|157365746|FG001|Overall Study|Site closure|1|||
48870863|NCT01644188|157365745|FG000|Overall Study|Other than specified above|6|||
48870864|NCT01644188|157365746|FG001|Overall Study|Other than specified above|7|||
48870865|NCT00526097|157365749|FG000|Overall Study|Adverse Event|6|||
48870866|NCT00526097|157365750|FG001|Overall Study|Adverse Event|44|||
48870867|NCT00526097|157365749|FG000|Overall Study|Protocol Violation|4|||
48870868|NCT00526097|157365750|FG001|Overall Study|Protocol Violation|10|||
48670255|NCT00471887|156646458|FG000|Overall Study|Adverse Event|9|||
48670256|NCT01062061|156646467|FG000|Overall Study|Enrolled more than once|2|||
48670257|NCT01062061|156646467|FG000|Overall Study|Investigated before study start|13|||
48670258|NCT01062061|156646467|FG000|Overall Study|Outside chief indications|10|||
48670259|NCT01062061|156646467|FG000|Overall Study|Failed to meet inclusion criteria|2|||
48670260|NCT00771615|156646470|FG000|Overall Study|Withdrawal by Subject|0|||
48670261|NCT00771615|156646471|FG001|Overall Study|Withdrawal by Subject|1|||
48670262|NCT00771615|156646472|FG002|Overall Study|Withdrawal by Subject|0|||
48670263|NCT00771615|156646473|FG003|Overall Study|Withdrawal by Subject|0|||
48670264|NCT00771615|156646474|FG004|Overall Study|Withdrawal by Subject|0|||
48670265|NCT00771615|156646475|FG005|Overall Study|Withdrawal by Subject|0|||
48670266|NCT00771615|156646476|FG006|Overall Study|Withdrawal by Subject|0|||
48670267|NCT00771615|156646477|FG007|Overall Study|Withdrawal by Subject|1|||
48670268|NCT00771615|156646478|FG008|Overall Study|Withdrawal by Subject|0|||
48670269|NCT00771615|156646470|FG000|Overall Study|Lost to Follow-up|1|||
48670270|NCT00771615|156646471|FG001|Overall Study|Lost to Follow-up|1|||
48670271|NCT00771615|156646472|FG002|Overall Study|Lost to Follow-up|1|||
48670272|NCT00771615|156646473|FG003|Overall Study|Lost to Follow-up|1|||
48670273|NCT00771615|156646474|FG004|Overall Study|Lost to Follow-up|0|||
48670274|NCT00771615|156646475|FG005|Overall Study|Lost to Follow-up|1|||
48670275|NCT00771615|156646476|FG006|Overall Study|Lost to Follow-up|1|||
48670276|NCT00771615|156646477|FG007|Overall Study|Lost to Follow-up|0|||
48670277|NCT00771615|156646478|FG008|Overall Study|Lost to Follow-up|0|||
48670278|NCT00689793|156646479|FG000|Overall Study|Lost to Follow-up|4|||
48670279|NCT00689793|156646480|FG001|Overall Study|Lost to Follow-up|5|||
48670280|NCT03779503|156646482|FG000|First Intervention|Adverse Event|0|||
48670281|NCT03779503|156646483|FG001|First Intervention|Adverse Event|1|||
48670282|NCT03779503|156646482|FG000|First Intervention|Withdrawal by Subject|1|||
48670283|NCT03779503|156646483|FG001|First Intervention|Withdrawal by Subject|0|||
48670284|NCT02066415|156646484|FG000|Overall Study|Decision by Sponsor|5|||
48670285|NCT02066415|156646485|FG001|Overall Study|Decision by Sponsor|4|||
48670286|NCT02066415|156646486|FG002|Overall Study|Decision by Sponsor|2|||
48670287|NCT02066415|156646484|FG000|Overall Study|Withdrawal by Subject|9|||
48670288|NCT02066415|156646485|FG001|Overall Study|Withdrawal by Subject|1|||
48760273|NCT00454987|156970138|FG000|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
48760274|NCT00454987|156970139|FG001|Booster Period (NCT00258700)|Withdrawal by Subject|1|||
48760275|NCT00454987|156970140|FG002|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
48760276|NCT00454987|156970138|FG000|Booster Period (NCT00258700)|Lost to Follow-up|1|||
48760277|NCT00454987|156970139|FG001|Booster Period (NCT00258700)|Lost to Follow-up|0|||
48760278|NCT00454987|156970140|FG002|Booster Period (NCT00258700)|Lost to Follow-up|0|||
48760279|NCT01476696|156970141|FG000|Overall Study|Sponsor decision|2|||
48760280|NCT01476696|156970142|FG001|Overall Study|Sponsor decision|1|||
48870869|NCT00526097|157365749|FG000|Overall Study|Withdrawal by Subject|3|||
48870870|NCT00526097|157365750|FG001|Overall Study|Withdrawal by Subject|1|||
48968505|NCT01453998|157712549|FG002|After Protocol Amendment 2.|Withdrawal by Subject|0|||
48670289|NCT02066415|156646486|FG002|Overall Study|Withdrawal by Subject|4|||
48670290|NCT02066415|156646484|FG000|Overall Study|Lost to Follow-up|7|||
48670291|NCT02066415|156646485|FG001|Overall Study|Lost to Follow-up|2|||
48670292|NCT02066415|156646486|FG002|Overall Study|Lost to Follow-up|2|||
48670293|NCT02634606|156646488|FG000|Overall Study|unable to obtain the drug at start|13|||
48670294|NCT04957758|156646493|FG000|Overall Study|Adverse Event|1|||
48670295|NCT04957758|156646494|FG001|Overall Study|Adverse Event|0|||
48670296|NCT04957758|156646493|FG000|Overall Study|Lost to Follow-up|0|||
48670297|NCT04957758|156646494|FG001|Overall Study|Lost to Follow-up|2|||
48670298|NCT04957758|156646493|FG000|Overall Study|Withdrawal by Subject|4|||
48670299|NCT04957758|156646494|FG001|Overall Study|Withdrawal by Subject|2|||
48670300|NCT04957758|156646493|FG000|Overall Study|Protocol Violation|0|||
48670301|NCT04957758|156646494|FG001|Overall Study|Protocol Violation|1|||
48670302|NCT02066129|156646497|FG000|Overall Study|Lost to Follow-up|13|||
48670303|NCT02066129|156646498|FG001|Overall Study|Lost to Follow-up|12|||
48670304|NCT02066129|156646497|FG000|Overall Study|Withdrawal by Subject|7|||
48670305|NCT02066129|156646498|FG001|Overall Study|Withdrawal by Subject|10|||
48670306|NCT02066129|156646497|FG000|Overall Study|Lack of Efficacy|8|||
48870871|NCT00526097|157365749|FG000|Overall Study|Other|2|||
48670307|NCT02066129|156646498|FG001|Overall Study|Lack of Efficacy|10|||
48670308|NCT02066129|156646497|FG000|Overall Study|Physician Decision|1|||
48670309|NCT02066129|156646498|FG001|Overall Study|Physician Decision|1|||
48670310|NCT00847015|156646502|FG000|Overall Study|Withdrawal by Subject|1|||
48670311|NCT00847015|156646502|FG000|Overall Study|declined any surgery|1|||
48670312|NCT00847015|156646502|FG000|Overall Study|partial cystectomy vs radical cystectomy|1|||
48670313|NCT03230292|156646505|FG000|Overall Study|Adverse Event|1|||
48670314|NCT03230292|156646505|FG000|Overall Study|Protocol Violation|1|||
48670315|NCT03230292|156646505|FG000|Overall Study|Lost to Follow-up|1|||
48670316|NCT03230292|156646505|FG000|Overall Study|Withdrawal by Subject|3|||
48670317|NCT00908037|156646508|FG000|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
48670318|NCT00908037|156646509|FG001|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
48670319|NCT00908037|156646510|FG002|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
48670320|NCT00908037|156646511|FG003|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
48670321|NCT00908037|156646512|FG004|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
48670322|NCT00908037|156646513|FG005|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
48670323|NCT00908037|156646514|FG006|Part 2 (7 Week Randomized Period)|Protocol Violation|3|||
48670324|NCT00908037|156646515|FG007|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
48670325|NCT00908037|156646516|FG008|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
48670326|NCT00908037|156646517|FG009|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
48670327|NCT00908037|156646518|FG010|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
48670328|NCT00908037|156646519|FG011|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
48670329|NCT00908037|156646508|FG000|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
48670330|NCT00908037|156646509|FG001|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
48670331|NCT00908037|156646510|FG002|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
48670332|NCT00908037|156646511|FG003|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
48670333|NCT00908037|156646512|FG004|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2|||
48670334|NCT00908037|156646513|FG005|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
48670335|NCT00908037|156646514|FG006|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
48670336|NCT00908037|156646515|FG007|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
48670337|NCT00908037|156646516|FG008|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4|||
48670338|NCT00908037|156646517|FG009|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
48670339|NCT00908037|156646518|FG010|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
48670340|NCT00908037|156646519|FG011|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
48670341|NCT00908037|156646508|FG000|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
48670342|NCT00908037|156646509|FG001|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
48670343|NCT00908037|156646510|FG002|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
48670344|NCT00908037|156646511|FG003|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
48670345|NCT00908037|156646512|FG004|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
48670346|NCT00908037|156646513|FG005|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
48670347|NCT00908037|156646514|FG006|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
48670348|NCT00908037|156646515|FG007|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
48670349|NCT00908037|156646516|FG008|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
48670350|NCT00908037|156646517|FG009|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
48670351|NCT00908037|156646518|FG010|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
48670352|NCT00908037|156646519|FG011|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
48670353|NCT00908037|156646508|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
48670354|NCT00908037|156646509|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
48670355|NCT00908037|156646510|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
48670356|NCT00908037|156646511|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
48670357|NCT00908037|156646512|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
48670358|NCT00908037|156646513|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
48670359|NCT00908037|156646514|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
48670360|NCT00908037|156646515|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
48870872|NCT00526097|157365750|FG001|Overall Study|Other|1|||
48870873|NCT04140266|157365751|FG000|Overall Study|Physician Decision|2|||
48870874|NCT04140266|157365752|FG001|Overall Study|Physician Decision|0|||
48670361|NCT00908037|156646516|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
48670362|NCT00908037|156646517|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
48670363|NCT00908037|156646518|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
48670364|NCT00908037|156646519|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1|||
48670365|NCT00908037|156646508|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
48670366|NCT00908037|156646509|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
48670367|NCT00908037|156646510|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
48670368|NCT00908037|156646511|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
48670369|NCT00908037|156646512|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
48670370|NCT00908037|156646513|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
48670371|NCT00908037|156646514|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
48670372|NCT00908037|156646515|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
48760281|NCT01476696|156970143|FG002|Overall Study|Sponsor decision|0|||
48760282|NCT01476696|156970141|FG000|Overall Study|Withdrawal by Subject|1|||
48760283|NCT01476696|156970142|FG001|Overall Study|Withdrawal by Subject|0|||
48760284|NCT01476696|156970143|FG002|Overall Study|Withdrawal by Subject|0|||
48760285|NCT01179477|156970146|FG000|Overall Study|Death|542|||
48760286|NCT01179477|156970146|FG000|Overall Study|Unsuccessful implant|80|||
48760287|NCT01179477|156970146|FG000|Overall Study|Non-death withdrawal|438|||
48760288|NCT01179477|156970146|FG000|Overall Study|Did not complete final visit|27|||
48760289|NCT00071760|156970148|FG000|Overall Study|Adverse Event|2|||
48760290|NCT00071760|156970149|FG001|Overall Study|Adverse Event|1|||
48760291|NCT00071760|156970148|FG000|Overall Study|Lost to Follow-up|0|||
48760292|NCT00071760|156970149|FG001|Overall Study|Lost to Follow-up|3|||
48760293|NCT00071760|156970148|FG000|Overall Study|Protocol Violation|1|||
48760294|NCT00071760|156970149|FG001|Overall Study|Protocol Violation|0|||
48760295|NCT00071760|156970148|FG000|Overall Study|Withdrawal by Subject|0|||
48760296|NCT00071760|156970149|FG001|Overall Study|Withdrawal by Subject|1|||
48870875|NCT04140266|157365751|FG000|Overall Study|Withdrawal by Subject|4|||
48670373|NCT00908037|156646516|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
48670374|NCT00908037|156646517|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1|||
48670375|NCT00908037|156646518|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
48670376|NCT00908037|156646519|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2|||
48670377|NCT00908037|156646508|FG000|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
48670378|NCT00908037|156646509|FG001|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
48670379|NCT00908037|156646510|FG002|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
48670380|NCT00908037|156646511|FG003|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
48670381|NCT00908037|156646512|FG004|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
48670382|NCT00908037|156646513|FG005|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
48760297|NCT00071760|156970148|FG000|Overall Study|Insufficient Viral Load Response|1|||
48760298|NCT00071760|156970149|FG001|Overall Study|Insufficient Viral Load Response|1|||
48760299|NCT00071760|156970148|FG000|Overall Study|Lack of availability of RTV|1|||
48760300|NCT00071760|156970149|FG001|Overall Study|Lack of availability of RTV|0|||
48760301|NCT00071760|156970148|FG000|Overall Study|Physician Decision|2|||
48760302|NCT00071760|156970149|FG001|Overall Study|Physician Decision|1|||
48760303|NCT00071760|156970148|FG000|Overall Study|Relocation|0|||
48760304|NCT00071760|156970149|FG001|Overall Study|Relocation|1|||
48760305|NCT01994629|156970155|FG000|Overall Study|Withdrawal by Subject|1|||
48870876|NCT04140266|157365752|FG001|Overall Study|Withdrawal by Subject|2|||
48870877|NCT00721214|157365753|FG000|Overall Study|Chose another center for transplant|1|||
48870878|NCT00721214|157365753|FG000|Overall Study|Death|3|||
48870879|NCT03022578|157365754|FG000|Overall Study|Adverse Event|1|||
48870880|NCT03022578|157365754|FG000|Overall Study|Lack of Efficacy|2|||
48870881|NCT03022578|157365754|FG000|Overall Study|Withdrawal by Subject|1|||
48870882|NCT03924947|157365757|FG000|Part 1: Double Blind Period 1|Other, Not Specified|0|||
48870883|NCT03924947|157365758|FG001|Part 1: Double Blind Period 1|Other, Not Specified|0|||
48870884|NCT03924947|157365759|FG002|Part 1: Double Blind Period 1|Other, Not Specified|1|||
48870885|NCT03924947|157365760|FG003|Part 1: Double Blind Period 1|Other, Not Specified|0|||
48870886|NCT03924947|157365761|FG004|Part 1: Double Blind Period 1|Other, Not Specified|0|||
48870887|NCT03924947|157365762|FG005|Part 1: Double Blind Period 1|Other, Not Specified|0|||
48760306|NCT01994629|156970156|FG001|Overall Study|Withdrawal by Subject|0|||
48760307|NCT01994629|156970155|FG000|Overall Study|Lost to Follow-up|0|||
48760308|NCT01994629|156970156|FG001|Overall Study|Lost to Follow-up|3|||
48760309|NCT04120974|156970157|FG000|Overall Study|Death|1|||
48760310|NCT04120974|156970157|FG000|Overall Study|Physician Decision|1|||
48870888|NCT04150341|157365763|FG000|Overall Study|Physician Decision|0|||
48870889|NCT04150341|157365764|FG001|Overall Study|Physician Decision|0|||
48870890|NCT04150341|157365765|FG002|Overall Study|Physician Decision|1|||
48670383|NCT00908037|156646514|FG006|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
48760311|NCT04120974|156970157|FG000|Overall Study|Lost to Follow-up|6|||
48870891|NCT04150341|157365766|FG003|Overall Study|Physician Decision|0|||
48870892|NCT04150341|157365767|FG004|Overall Study|Physician Decision|0|||
48670384|NCT00908037|156646515|FG007|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
48670385|NCT00908037|156646516|FG008|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
48670386|NCT00908037|156646517|FG009|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1|||
48670387|NCT00908037|156646518|FG010|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
48670388|NCT00908037|156646519|FG011|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
48670389|NCT00908037|156646508|FG000|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
48670390|NCT00908037|156646509|FG001|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
48670391|NCT00908037|156646510|FG002|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
48670392|NCT00908037|156646511|FG003|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
48670393|NCT00908037|156646512|FG004|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
48670394|NCT00908037|156646513|FG005|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
48670395|NCT00908037|156646514|FG006|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
48670396|NCT00908037|156646515|FG007|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
48670397|NCT00908037|156646516|FG008|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
48670398|NCT00908037|156646517|FG009|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
48670399|NCT00908037|156646518|FG010|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2|||
48870893|NCT04150341|157365768|FG005|Overall Study|Physician Decision|0|||
48870894|NCT04150341|157365763|FG000|Overall Study|Adverse Event|0|||
48870895|NCT04150341|157365764|FG001|Overall Study|Adverse Event|0|||
48870896|NCT04150341|157365765|FG002|Overall Study|Adverse Event|0|||
48870897|NCT04150341|157365766|FG003|Overall Study|Adverse Event|0|||
48870898|NCT04150341|157365767|FG004|Overall Study|Adverse Event|1|||
48670400|NCT00908037|156646519|FG011|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
48670401|NCT00908037|156646508|FG000|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
48670402|NCT00908037|156646509|FG001|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
48670403|NCT00908037|156646510|FG002|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
48670404|NCT00908037|156646511|FG003|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
48670405|NCT00908037|156646512|FG004|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
48670406|NCT00908037|156646513|FG005|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
48670407|NCT00908037|156646514|FG006|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
48670408|NCT00908037|156646515|FG007|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
48670409|NCT00908037|156646516|FG008|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
48670410|NCT00908037|156646517|FG009|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1|||
48760312|NCT03424265|156970158|FG000|Overall Study|screening failure|1|||
48760313|NCT03424265|156970159|FG001|Overall Study|screening failure|0|||
48760314|NCT03424265|156970158|FG000|Overall Study|Withdrawal by Subject|0|||
48760315|NCT03424265|156970159|FG001|Overall Study|Withdrawal by Subject|2|||
48760316|NCT03089606|156970160|FG000|Overall Study|Progression after Cycle 1|1|||
48760317|NCT00335972|156970161|FG000|Overall Study|not given treatments|0|||
48760318|NCT00335972|156970162|FG001|Overall Study|not given treatments|3|||
48760319|NCT01846611|156970163|FG000|Overall Study|Lost to Follow-up|4|||
48760320|NCT01846611|156970164|FG001|Overall Study|Lost to Follow-up|6|||
48760321|NCT01846611|156970163|FG000|Overall Study|Withdrawal by Subject|15|||
48760322|NCT01846611|156970164|FG001|Overall Study|Withdrawal by Subject|19|||
48760323|NCT01846611|156970163|FG000|Overall Study|Other|19|||
48760324|NCT01846611|156970164|FG001|Overall Study|Other|18|||
48760325|NCT01505868|156970166|FG000|Overall Study|Withdrawal by Subject|1|||
48760326|NCT01505868|156970167|FG001|Overall Study|Withdrawal by Subject|0|||
48760327|NCT01505868|156970168|FG002|Overall Study|Withdrawal by Subject|0|||
48760328|NCT01505868|156970169|FG003|Overall Study|Withdrawal by Subject|0|||
48760329|NCT01505868|156970170|FG004|Overall Study|Withdrawal by Subject|0|||
48760330|NCT03341533|156970175|FG000|Overall Study|Withdrawal by Subject|1|||
48870899|NCT04150341|157365768|FG005|Overall Study|Adverse Event|0|||
48870900|NCT00702650|157365769|FG000|Overall Study|Withdrawal by Subject|9|||
48870901|NCT00702650|157365769|FG000|Overall Study|Non-Compliance of Study Drug|3|||
48870902|NCT00702650|157365769|FG000|Overall Study|Lost to Follow-up|2|||
48870903|NCT00702650|157365769|FG000|Overall Study|Non-Compliance with Site Directives|1|||
48870904|NCT00702650|157365769|FG000|Overall Study|Sponsor Request|1|||
48870905|NCT00702650|157365769|FG000|Overall Study|Screening Testosterone Levels >300 ng/dL|1|||
48870906|NCT00702650|157365769|FG000|Overall Study|Adverse Event|3|||
48870907|NCT00899379|157365771|FG000|Overall Study|Adverse Event|2|||
48870908|NCT00899379|157365772|FG001|Overall Study|Adverse Event|2|||
48870909|NCT00899379|157365773|FG002|Overall Study|Adverse Event|1|||
48870910|NCT00899379|157365774|FG003|Overall Study|Adverse Event|1|||
48870911|NCT00899379|157365775|FG004|Overall Study|Adverse Event|2|||
48870912|NCT00899379|157365771|FG000|Overall Study|Lack of Efficacy|0|||
48870913|NCT00899379|157365772|FG001|Overall Study|Lack of Efficacy|4|||
48870914|NCT00899379|157365773|FG002|Overall Study|Lack of Efficacy|3|||
48870915|NCT00899379|157365774|FG003|Overall Study|Lack of Efficacy|0|||
48870916|NCT00899379|157365775|FG004|Overall Study|Lack of Efficacy|1|||
48870917|NCT00899379|157365771|FG000|Overall Study|Lost to Follow-up|9|||
48870918|NCT00899379|157365772|FG001|Overall Study|Lost to Follow-up|3|||
48760331|NCT03341533|156970176|FG001|Overall Study|Withdrawal by Subject|1|||
48760332|NCT03341533|156970175|FG000|Overall Study|Not eligible after randomization|2|||
48760333|NCT03341533|156970176|FG001|Overall Study|Not eligible after randomization|1|||
48760334|NCT02882854|156970177|FG000|Overall Study|Lost to Follow-up|1|||
48760335|NCT02882854|156970178|FG001|Overall Study|Lost to Follow-up|2|||
48870919|NCT00899379|157365773|FG002|Overall Study|Lost to Follow-up|0|||
48670411|NCT00908037|156646518|FG010|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
48670412|NCT00908037|156646519|FG011|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
48670413|NCT00908037|156646508|FG000|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
48670414|NCT00908037|156646509|FG001|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
48670415|NCT00908037|156646510|FG002|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
48670416|NCT00908037|156646511|FG003|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
48670417|NCT00908037|156646512|FG004|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
48670418|NCT00908037|156646513|FG005|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
48670419|NCT00908037|156646514|FG006|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
48670420|NCT00908037|156646515|FG007|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
48670421|NCT00908037|156646516|FG008|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
48670422|NCT00908037|156646517|FG009|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
48670423|NCT00908037|156646518|FG010|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2|||
48670424|NCT00908037|156646519|FG011|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
48670425|NCT01147900|156646520|FG000|At Year 10|Lost to Follow-up|0|||
48670426|NCT01147900|156646521|FG001|At Year 10|Lost to Follow-up|1|||
48670427|NCT01147900|156646522|FG002|At Year 10|Lost to Follow-up|0|||
48670428|NCT03443427|156646523|FG000|Overall Study|Adverse Event|2|||
48670429|NCT03443427|156646524|FG001|Overall Study|Adverse Event|3|||
48670430|NCT03443427|156646523|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
48670431|NCT03443427|156646524|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
48670432|NCT03443427|156646523|FG000|Overall Study|Other|4|||
48670433|NCT03443427|156646524|FG001|Overall Study|Other|6|||
48670434|NCT01732913|156646529|FG000|Overall Study|Study Terminated by Sponsor|105|||
48670435|NCT01732913|156646530|FG001|Overall Study|Study Terminated by Sponsor|55|||
48670436|NCT01732913|156646529|FG000|Overall Study|Withdrawal by Subject|27|||
48670437|NCT01732913|156646530|FG001|Overall Study|Withdrawal by Subject|4|||
48670438|NCT01732913|156646529|FG000|Overall Study|Physician Decision|14|||
48670439|NCT01732913|156646530|FG001|Overall Study|Physician Decision|7|||
48670440|NCT01732913|156646529|FG000|Overall Study|Other|7|||
48670441|NCT01732913|156646530|FG001|Overall Study|Other|1|||
48670442|NCT01732913|156646529|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|3|||
48670443|NCT01732913|156646530|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|2|||
48670444|NCT01792518|156646531|FG000|Overall Study|Adverse Event|3|||
48670445|NCT01792518|156646532|FG001|Overall Study|Adverse Event|4|||
48670446|NCT01792518|156646531|FG000|Overall Study|Protocol Violation|0|||
48670447|NCT01792518|156646532|FG001|Overall Study|Protocol Violation|1|||
48670448|NCT01792518|156646531|FG000|Overall Study|Lost to Follow-up|3|||
48670449|NCT01792518|156646532|FG001|Overall Study|Lost to Follow-up|1|||
48670450|NCT01792518|156646531|FG000|Overall Study|Withdrawal by Subject|2|||
48670451|NCT01792518|156646532|FG001|Overall Study|Withdrawal by Subject|0|||
48670452|NCT01792518|156646531|FG000|Overall Study|Other Reason|0|||
48670453|NCT01792518|156646532|FG001|Overall Study|Other Reason|1|||
48670454|NCT03233438|156646535|FG000|Overall Study|Lost to Follow-up|4|||
48670455|NCT03233438|156646536|FG001|Overall Study|Lost to Follow-up|9|||
48670456|NCT03233438|156646535|FG000|Overall Study|Withdrawal by Subject|2|||
48670457|NCT03233438|156646536|FG001|Overall Study|Withdrawal by Subject|1|||
48670458|NCT03233438|156646535|FG000|Overall Study|No recording of dalbavancin|0|||
48670459|NCT03233438|156646536|FG001|Overall Study|No recording of dalbavancin|1|||
48670460|NCT02613169|156646539|FG000|Overall Study|Withdrawal by Subject|4|||
48670461|NCT02613169|156646540|FG001|Overall Study|Withdrawal by Subject|1|||
48760336|NCT02882854|156970177|FG000|Overall Study|Physician Decision|0|||
48760337|NCT02882854|156970178|FG001|Overall Study|Physician Decision|1|||
48760338|NCT02197806|156970181|FG000|Overall Study|Adverse Event|0|||
48760339|NCT02197806|156970182|FG001|Overall Study|Adverse Event|1|||
48870920|NCT00899379|157365774|FG003|Overall Study|Lost to Follow-up|6|||
48870921|NCT00899379|157365775|FG004|Overall Study|Lost to Follow-up|2|||
48670462|NCT02613169|156646539|FG000|Overall Study|Lost to Follow-up|0|||
48670463|NCT02613169|156646540|FG001|Overall Study|Lost to Follow-up|5|||
48670464|NCT02613169|156646539|FG000|Overall Study|HIV|0|||
48670465|NCT02613169|156646540|FG001|Overall Study|HIV|2|||
48670466|NCT02613169|156646539|FG000|Overall Study|No TB infection endpoint|14|||
48670467|NCT02613169|156646540|FG001|Overall Study|No TB infection endpoint|9|||
48670468|NCT02337725|156646542|FG000|Overall Study|Pretreatment Event/AE before Treatment|0|||
48670469|NCT02337725|156646543|FG001|Overall Study|Pretreatment Event/AE before Treatment|1|||
48760340|NCT02197806|156970183|FG002|Overall Study|Adverse Event|0|||
48870922|NCT00899379|157365771|FG000|Overall Study|Protocol Violation|0|||
48870923|NCT00899379|157365772|FG001|Overall Study|Protocol Violation|0|||
48870924|NCT00899379|157365773|FG002|Overall Study|Protocol Violation|1|||
48870925|NCT00899379|157365774|FG003|Overall Study|Protocol Violation|1|||
48870926|NCT00899379|157365775|FG004|Overall Study|Protocol Violation|0|||
48870927|NCT00899379|157365771|FG000|Overall Study|Withdrawal by Subject|2|||
48870928|NCT00899379|157365772|FG001|Overall Study|Withdrawal by Subject|4|||
48870929|NCT00899379|157365773|FG002|Overall Study|Withdrawal by Subject|2|||
48870930|NCT00899379|157365774|FG003|Overall Study|Withdrawal by Subject|3|||
48870931|NCT00899379|157365775|FG004|Overall Study|Withdrawal by Subject|6|||
48870932|NCT00899379|157365771|FG000|Overall Study|Pregnancy|0|||
48870933|NCT00899379|157365772|FG001|Overall Study|Pregnancy|0|||
48870934|NCT00899379|157365773|FG002|Overall Study|Pregnancy|1|||
48870935|NCT00899379|157365774|FG003|Overall Study|Pregnancy|0|||
48870936|NCT00899379|157365775|FG004|Overall Study|Pregnancy|1|||
48870937|NCT00899379|157365771|FG000|Overall Study|Patient Uncooperative|0|||
48870938|NCT00899379|157365772|FG001|Overall Study|Patient Uncooperative|1|||
48870939|NCT00899379|157365773|FG002|Overall Study|Patient Uncooperative|0|||
48870940|NCT00899379|157365774|FG003|Overall Study|Patient Uncooperative|1|||
48760341|NCT02197806|156970184|FG003|Overall Study|Adverse Event|1|||
48760342|NCT03774433|156970191|FG000|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14|||
48760343|NCT01288287|156970198|FG000|Overall Study|Lost to Follow-up|8|||
48760344|NCT01288287|156970198|FG000|Overall Study|Withdrawal by Subject|4|||
48760345|NCT01288287|156970198|FG000|Overall Study|Lack of Efficacy|13|||
48760346|NCT01288287|156970198|FG000|Overall Study|Other Reason|13|||
48870941|NCT00899379|157365775|FG004|Overall Study|Patient Uncooperative|2|||
48870942|NCT00899379|157365771|FG000|Overall Study|Abnormal Baseline ECG|0|||
48870943|NCT00899379|157365772|FG001|Overall Study|Abnormal Baseline ECG|0|||
48870944|NCT00899379|157365773|FG002|Overall Study|Abnormal Baseline ECG|0|||
48870945|NCT00899379|157365774|FG003|Overall Study|Abnormal Baseline ECG|1|||
48870946|NCT00899379|157365775|FG004|Overall Study|Abnormal Baseline ECG|0|||
48870947|NCT00899379|157365771|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
48870948|NCT00899379|157365772|FG001|Overall Study|No Longer Met Inc/Exc Criteria|1|||
48870949|NCT00899379|157365773|FG002|Overall Study|No Longer Met Inc/Exc Criteria|1|||
48870950|NCT00899379|157365774|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
48870951|NCT00899379|157365775|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
48670470|NCT02337725|156646542|FG000|Overall Study|Pretreatment Event/AE in Treatment|8|||
48760347|NCT01288287|156970198|FG000|Overall Study|Unknown Reason|1|||
48760348|NCT01288287|156970198|FG000|Overall Study|Unknown Status|7|||
48760349|NCT01581307|156970199|FG000|Overall Study|Withdrawal by Subject|1|||
48760350|NCT00878709|156970200|FG000|Overall Study|Withdrawal by Subject|197|||
48760351|NCT00878709|156970201|FG001|Overall Study|Withdrawal by Subject|120|||
48760352|NCT00878709|156970200|FG000|Overall Study|Lost to Follow-up|35|||
48760353|NCT00878709|156970201|FG001|Overall Study|Lost to Follow-up|33|||
48760354|NCT00878709|156970200|FG000|Overall Study|Other Reasons|93|||
48670471|NCT02337725|156646543|FG001|Overall Study|Pretreatment Event/AE in Treatment|3|||
48670472|NCT02337725|156646542|FG000|Overall Study|Major Protocol Deviation|0|||
48670473|NCT02337725|156646543|FG001|Overall Study|Major Protocol Deviation|1|||
48670474|NCT02337725|156646542|FG000|Overall Study|Voluntary Withdrawal|14|||
48670475|NCT02337725|156646543|FG001|Overall Study|Voluntary Withdrawal|3|||
48670476|NCT02337725|156646542|FG000|Overall Study|Lack of Efficacy|4|||
48670477|NCT02337725|156646543|FG001|Overall Study|Lack of Efficacy|0|||
48670478|NCT00084656|156646544|FG000|Overall Study|Other reasons|0|||
48670479|NCT00084656|156646545|FG001|Overall Study|Other reasons|12|||
48670480|NCT00084656|156646546|FG002|Overall Study|Other reasons|11|||
48670481|NCT00084656|156646544|FG000|Overall Study|Withdrawal by Subject|15|||
48760355|NCT00878709|156970201|FG001|Overall Study|Other Reasons|84|||
48760356|NCT02268786|156970202|FG000|Overall Study|No Euploid Embryos available|42|||
48870952|NCT00899379|157365771|FG000|Overall Study|Not Completed/Entered Extn|5|||
48870953|NCT00899379|157365772|FG001|Overall Study|Not Completed/Entered Extn|1|||
48870954|NCT00899379|157365773|FG002|Overall Study|Not Completed/Entered Extn|6|||
48870955|NCT00899379|157365774|FG003|Overall Study|Not Completed/Entered Extn|4|||
48870956|NCT00899379|157365775|FG004|Overall Study|Not Completed/Entered Extn|3|||
48870957|NCT00899379|157365771|FG000|Overall Study|Study Terminated|3|||
48670482|NCT00084656|156646545|FG001|Overall Study|Withdrawal by Subject|4|||
48760357|NCT02268786|156970203|FG001|Overall Study|No Euploid Embryos available|0|||
48870958|NCT00899379|157365772|FG001|Overall Study|Study Terminated|0|||
48870959|NCT00899379|157365773|FG002|Overall Study|Study Terminated|3|||
48870960|NCT00899379|157365774|FG003|Overall Study|Study Terminated|3|||
48870961|NCT00899379|157365775|FG004|Overall Study|Study Terminated|1|||
48870962|NCT00899379|157365771|FG000|Overall Study|Lost to Follow-up|3|||
48870963|NCT00899379|157365772|FG001|Overall Study|Lost to Follow-up|1|||
48870964|NCT00899379|157365773|FG002|Overall Study|Lost to Follow-up|0|||
48670483|NCT00084656|156646546|FG002|Overall Study|Withdrawal by Subject|4|||
48760358|NCT02268786|156970202|FG000|Overall Study|Withdrawal by Subject|7|||
48870965|NCT00899379|157365774|FG003|Overall Study|Lost to Follow-up|2|||
48870966|NCT00899379|157365775|FG004|Overall Study|Lost to Follow-up|5|||
48670484|NCT00084656|156646544|FG000|Overall Study|Disease relapse|0|||
48670485|NCT00084656|156646545|FG001|Overall Study|Disease relapse|9|||
48670486|NCT00084656|156646546|FG002|Overall Study|Disease relapse|10|||
48670487|NCT00084656|156646544|FG000|Overall Study|Disease progression|9|||
48670488|NCT00084656|156646545|FG001|Overall Study|Disease progression|0|||
48670489|NCT00084656|156646546|FG002|Overall Study|Disease progression|0|||
48670490|NCT00084656|156646544|FG000|Overall Study|Lost to Follow-up|1|||
48670491|NCT00084656|156646545|FG001|Overall Study|Lost to Follow-up|0|||
48670492|NCT00084656|156646546|FG002|Overall Study|Lost to Follow-up|1|||
48670493|NCT02772978|156646547|FG000|Overall Study|Withdrawal by Subject|1|||
48670494|NCT02772978|156646548|FG001|Overall Study|Withdrawal by Subject|1|||
48670495|NCT00576576|156646552|FG000|Overall Study|Lost to Follow-up|6|||
48670496|NCT00576576|156646552|FG000|Overall Study|Protocol Violation|1|||
48670497|NCT03135210|156646553|FG000|Overall Study|Death|0|||
48670498|NCT03135210|156646554|FG001|Overall Study|Death|1|||
48670499|NCT01751776|156646555|FG000|Overall Study|Adverse Event|0|||
48670500|NCT01751776|156646556|FG001|Overall Study|Adverse Event|0|||
48670501|NCT01751776|156646557|FG002|Overall Study|Adverse Event|0|||
48670502|NCT01751776|156646558|FG003|Overall Study|Adverse Event|0|||
48670503|NCT01751776|156646559|FG004|Overall Study|Adverse Event|0|||
48670504|NCT01751776|156646560|FG005|Overall Study|Adverse Event|0|||
48670505|NCT01751776|156646561|FG006|Overall Study|Adverse Event|4|||
48670506|NCT01751776|156646562|FG007|Overall Study|Adverse Event|2|||
48670507|NCT01751776|156646555|FG000|Overall Study|Consent withdrawn|0|||
48670508|NCT01751776|156646556|FG001|Overall Study|Consent withdrawn|0|||
48670509|NCT01751776|156646557|FG002|Overall Study|Consent withdrawn|0|||
48670510|NCT01751776|156646558|FG003|Overall Study|Consent withdrawn|0|||
48670511|NCT01751776|156646559|FG004|Overall Study|Consent withdrawn|0|||
48670512|NCT01751776|156646560|FG005|Overall Study|Consent withdrawn|0|||
48670513|NCT01751776|156646561|FG006|Overall Study|Consent withdrawn|0|||
48670514|NCT01751776|156646562|FG007|Overall Study|Consent withdrawn|1|||
48670515|NCT01751776|156646555|FG000|Overall Study|Other reason not specified above|0|||
48670516|NCT01751776|156646556|FG001|Overall Study|Other reason not specified above|0|||
48670517|NCT01751776|156646557|FG002|Overall Study|Other reason not specified above|0|||
48670518|NCT01751776|156646558|FG003|Overall Study|Other reason not specified above|0|||
48670519|NCT01751776|156646559|FG004|Overall Study|Other reason not specified above|0|||
48670520|NCT01751776|156646560|FG005|Overall Study|Other reason not specified above|0|||
48670521|NCT01751776|156646561|FG006|Overall Study|Other reason not specified above|0|||
48670522|NCT01751776|156646562|FG007|Overall Study|Other reason not specified above|1|||
48670523|NCT00160654|156646563|FG000|Overall Study|Adverse Event|14|||
48670524|NCT00160654|156646563|FG000|Overall Study|Lack of Efficacy|4|||
48670525|NCT00160654|156646563|FG000|Overall Study|Lost to Follow-up|2|||
48670526|NCT00160654|156646563|FG000|Overall Study|Intake of expired drug|7|||
48670527|NCT00160654|156646563|FG000|Overall Study|Psychological trauma|1|||
48670528|NCT00160654|156646563|FG000|Overall Study|Sponsor decision|1|||
48670529|NCT00160654|156646563|FG000|Overall Study|Patient met exclusion criteria|1|||
48670530|NCT00160654|156646563|FG000|Overall Study|Patient decision|1|||
48670531|NCT00160654|156646563|FG000|Overall Study|Poor compliance, dilantin toxicity|1|||
48670532|NCT00160654|156646563|FG000|Overall Study|Met exclusion criteria|1|||
48670533|NCT00590577|156646564|FG000|Overall Study|Lack of Efficacy|31|||
48670534|NCT00590577|156646565|FG001|Overall Study|Lack of Efficacy|28|||
48670535|NCT00590577|156646566|FG002|Overall Study|Lack of Efficacy|23|||
48670536|NCT00590577|156646567|FG003|Overall Study|Lack of Efficacy|45|||
48670537|NCT00590577|156646564|FG000|Overall Study|Withdrawal by Subject|23|||
48670538|NCT00590577|156646565|FG001|Overall Study|Withdrawal by Subject|28|||
48670539|NCT00590577|156646566|FG002|Overall Study|Withdrawal by Subject|30|||
48670540|NCT00590577|156646567|FG003|Overall Study|Withdrawal by Subject|26|||
48670541|NCT00590577|156646564|FG000|Overall Study|Adverse Event|10|||
48670542|NCT00590577|156646565|FG001|Overall Study|Adverse Event|10|||
48670543|NCT00590577|156646566|FG002|Overall Study|Adverse Event|13|||
48670544|NCT00590577|156646567|FG003|Overall Study|Adverse Event|11|||
48670545|NCT00590577|156646564|FG000|Overall Study|Lost to Follow-up|12|||
48670546|NCT00590577|156646565|FG001|Overall Study|Lost to Follow-up|6|||
48670547|NCT00590577|156646566|FG002|Overall Study|Lost to Follow-up|6|||
48670548|NCT00590577|156646567|FG003|Overall Study|Lost to Follow-up|9|||
48670549|NCT00590577|156646564|FG000|Overall Study|Pregnancy|0|||
48760359|NCT02268786|156970203|FG001|Overall Study|Withdrawal by Subject|14|||
48760360|NCT02268786|156970202|FG000|Overall Study|Thaw Failure|6|||
48760361|NCT02268786|156970203|FG001|Overall Study|Thaw Failure|4|||
48760362|NCT02268786|156970202|FG000|Overall Study|Protocol Violation|1|||
48760363|NCT02268786|156970203|FG001|Overall Study|Protocol Violation|0|||
48760364|NCT04251221|156970204|FG000|Overall Study|Arterial Line Failure, unable to proceed with PET scan|2|||
48760365|NCT04251221|156970205|FG001|Overall Study|Arterial Line Failure, unable to proceed with PET scan|0|||
48760366|NCT02068222|156970209|FG000|Overall Study|Lost to Follow-up|1|||
48760367|NCT00531232|156972205|FG000|Overall Study|Investigator decision|0|||
48760368|NCT00531232|156972206|FG001|Overall Study|Investigator decision|0|||
48760369|NCT00531232|156972207|FG002|Overall Study|Investigator decision|4|||
48760370|NCT00531232|156972205|FG000|Overall Study|Participants refused further treatment|0|||
48870967|NCT00899379|157365771|FG000|Overall Study|Withdrawal by Subject|4|||
48870968|NCT00899379|157365772|FG001|Overall Study|Withdrawal by Subject|7|||
48870969|NCT00899379|157365773|FG002|Overall Study|Withdrawal by Subject|4|||
48870970|NCT00899379|157365774|FG003|Overall Study|Withdrawal by Subject|7|||
48870971|NCT00899379|157365775|FG004|Overall Study|Withdrawal by Subject|2|||
48870972|NCT00899379|157365771|FG000|Overall Study|Pregnancy|1|||
48870973|NCT00899379|157365772|FG001|Overall Study|Pregnancy|0|||
48870974|NCT00899379|157365773|FG002|Overall Study|Pregnancy|0|||
48760371|NCT00531232|156972206|FG001|Overall Study|Participants refused further treatment|1|||
48760372|NCT00531232|156972207|FG002|Overall Study|Participants refused further treatment|2|||
48760373|NCT00531232|156972205|FG000|Overall Study|Adverse events (AEs)|1|||
48760374|NCT00531232|156972206|FG001|Overall Study|Adverse events (AEs)|2|||
48760375|NCT00531232|156972207|FG002|Overall Study|Adverse events (AEs)|2|||
48760376|NCT00531232|156972205|FG000|Overall Study|Treatment failure|1|||
48760377|NCT00531232|156972206|FG001|Overall Study|Treatment failure|3|||
48760378|NCT00531232|156972207|FG002|Overall Study|Treatment failure|7|||
48760379|NCT00531232|156972205|FG000|Overall Study|Disease recurrence|0|||
48760380|NCT00531232|156972206|FG001|Overall Study|Disease recurrence|0|||
48760381|NCT00531232|156972207|FG002|Overall Study|Disease recurrence|1|||
48760382|NCT00531232|156972205|FG000|Overall Study|Deceased|2|||
48760383|NCT00531232|156972206|FG001|Overall Study|Deceased|2|||
48760384|NCT00531232|156972207|FG002|Overall Study|Deceased|2|||
48760385|NCT00531232|156972205|FG000|Overall Study|Withdrawal by Subject|0|||
48760386|NCT00531232|156972206|FG001|Overall Study|Withdrawal by Subject|1|||
48760387|NCT00531232|156972207|FG002|Overall Study|Withdrawal by Subject|2|||
48760388|NCT00531232|156972205|FG000|Overall Study|Other|0|||
48870975|NCT00899379|157365774|FG003|Overall Study|Pregnancy|0|||
48870976|NCT00899379|157365775|FG004|Overall Study|Pregnancy|0|||
48670550|NCT00590577|156646565|FG001|Overall Study|Pregnancy|1|||
48670551|NCT00590577|156646566|FG002|Overall Study|Pregnancy|0|||
48670552|NCT00590577|156646567|FG003|Overall Study|Pregnancy|0|||
48670553|NCT00590577|156646564|FG000|Overall Study|Various reasons|1|||
48670554|NCT00590577|156646565|FG001|Overall Study|Various reasons|3|||
48670555|NCT00590577|156646566|FG002|Overall Study|Various reasons|1|||
48670556|NCT00590577|156646567|FG003|Overall Study|Various reasons|2|||
48670557|NCT02477553|156646572|FG000|Overall Study|Screening up-to-date|12|||
48670558|NCT02477553|156646573|FG001|Overall Study|Screening up-to-date|13|||
48670559|NCT02477553|156646572|FG000|Overall Study|No MD visit|1|||
48670560|NCT02477553|156646573|FG001|Overall Study|No MD visit|1|||
48670561|NCT02477553|156646572|FG000|Overall Study|Workup consistent w/CRC|1|||
48670562|NCT02477553|156646573|FG001|Overall Study|Workup consistent w/CRC|1|||
48670563|NCT02477553|156646572|FG000|Overall Study|Technical issues with intervention|2|||
48670564|NCT02477553|156646573|FG001|Overall Study|Technical issues with intervention|0|||
48670565|NCT02477553|156646572|FG000|Overall Study|Elevated risk for CRC|2|||
48670566|NCT02477553|156646573|FG001|Overall Study|Elevated risk for CRC|2|||
48670567|NCT02477553|156646572|FG000|Overall Study|MD advised against screening|1|||
48670568|NCT02477553|156646573|FG001|Overall Study|MD advised against screening|3|||
48670569|NCT02477553|156646572|FG000|Overall Study|patient deceased|1|||
48670570|NCT02477553|156646573|FG001|Overall Study|patient deceased|0|||
48670571|NCT01345682|156646574|FG000|Overall Study|Progressive disease per RECIST|226|||
48670572|NCT01345682|156646575|FG001|Overall Study|Progressive disease per RECIST|93|||
48670573|NCT01345682|156646574|FG000|Overall Study|Worsening of underlying cancer disease|23|||
48670574|NCT01345682|156646575|FG001|Overall Study|Worsening of underlying cancer disease|12|||
48670575|NCT01345682|156646574|FG000|Overall Study|Adverse Event|51|||
48670576|NCT01345682|156646575|FG001|Overall Study|Adverse Event|41|||
48670577|NCT01345682|156646574|FG000|Overall Study|Non-compliance with protocol|0|||
48670578|NCT01345682|156646575|FG001|Overall Study|Non-compliance with protocol|1|||
48670579|NCT01345682|156646574|FG000|Overall Study|Lost to Follow-up|0|||
48670580|NCT01345682|156646575|FG001|Overall Study|Lost to Follow-up|1|||
48670581|NCT01345682|156646574|FG000|Overall Study|Refused to continue trial medication|16|||
48670582|NCT01345682|156646575|FG001|Overall Study|Refused to continue trial medication|9|||
48670583|NCT01345682|156646574|FG000|Overall Study|Not treated|2|||
48670584|NCT01345682|156646575|FG001|Overall Study|Not treated|1|||
48760389|NCT00531232|156972206|FG001|Overall Study|Other|0|||
48870977|NCT00899379|157365771|FG000|Overall Study|Patient Uncooperative|0|||
48870978|NCT00899379|157365772|FG001|Overall Study|Patient Uncooperative|0|||
48870979|NCT00899379|157365773|FG002|Overall Study|Patient Uncooperative|0|||
49015489|NCT01393990|157893785|FG015|Overall Study|Death|0|||
48670585|NCT01345682|156646574|FG000|Overall Study|Reason other than those specified above|4|||
48670586|NCT01345682|156646575|FG001|Overall Study|Reason other than those specified above|3|||
48670587|NCT05098509|156646576|FG000|Overall Study|Withdrawal by Subject|0|||
48670588|NCT05098509|156646577|FG001|Overall Study|Withdrawal by Subject|0|||
48670589|NCT05098509|156646578|FG002|Overall Study|Withdrawal by Subject|1|||
48670590|NCT05098509|156646579|FG003|Overall Study|Withdrawal by Subject|0|||
48760390|NCT00531232|156972207|FG002|Overall Study|Other|5|||
48760391|NCT00939809|156972208|FG000|Overall Study|Adverse Event|2|||
48760392|NCT00939809|156972208|FG000|Overall Study|Death|1|||
48760393|NCT04779489|156972209|FG000|Overall Study|Physician Decision|1|||
48670591|NCT05098509|156646576|FG000|Overall Study|Early study termination|1|||
48670592|NCT05098509|156646577|FG001|Overall Study|Early study termination|1|||
48670593|NCT05098509|156646578|FG002|Overall Study|Early study termination|1|||
48670594|NCT05098509|156646579|FG003|Overall Study|Early study termination|0|||
48670595|NCT00483002|156646586|FG000|Overall Study|Adverse Event|68|||
48670596|NCT00483002|156646586|FG000|Overall Study|Lack of Efficacy|555|||
48670597|NCT00483002|156646586|FG000|Overall Study|Lost to Follow-up|962|||
48670598|NCT00483002|156646586|FG000|Overall Study|Other|2|||
48670599|NCT00483002|156646586|FG000|Overall Study|Other|967|||
48670600|NCT03834220|156646593|FG000|Overall Study|Adverse Event|1|||
48670601|NCT03834220|156646594|FG001|Overall Study|Adverse Event|0|||
48670602|NCT03834220|156646595|FG002|Overall Study|Adverse Event|0|||
48670603|NCT03834220|156646593|FG000|Overall Study|Death|8|||
48670604|NCT03834220|156646594|FG001|Overall Study|Death|1|||
48670605|NCT03834220|156646595|FG002|Overall Study|Death|17|||
48670606|NCT03834220|156646593|FG000|Overall Study|Reason not Specified|9|||
48670607|NCT03834220|156646594|FG001|Overall Study|Reason not Specified|0|||
48670608|NCT03834220|156646595|FG002|Overall Study|Reason not Specified|6|||
48670609|NCT03834220|156646593|FG000|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|10|||
48670610|NCT03834220|156646594|FG001|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|1|||
48670611|NCT03834220|156646595|FG002|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|4|||
48670612|NCT03834220|156646593|FG000|Overall Study|Withdrawal of Consent|2|||
48670613|NCT03834220|156646594|FG001|Overall Study|Withdrawal of Consent|2|||
48670614|NCT03834220|156646595|FG002|Overall Study|Withdrawal of Consent|2|||
48670615|NCT00527332|156646603|FG000|Overall Study|Protocol Violation|4|||
48670616|NCT00527332|156646604|FG001|Overall Study|Protocol Violation|8|||
48670617|NCT00527332|156646603|FG000|Overall Study|Withdrew consent|5|||
48670618|NCT00527332|156646604|FG001|Overall Study|Withdrew consent|1|||
48670619|NCT02666105|156646605|FG000|Overall Study|Death|1|||
48670620|NCT00852241|156646607|FG000|Overall Study|Physician Decision|18|||
48670621|NCT03369236|156646608|FG000|Double-blind Treatment Period|Accidental unblinding|0|||
48670622|NCT03369236|156646609|FG001|Double-blind Treatment Period|Accidental unblinding|1|||
48670623|NCT03369236|156646608|FG000|Open-label Extension Period|Lack of Efficacy|2|||
48670624|NCT03369236|156646609|FG001|Open-label Extension Period|Lack of Efficacy|1|||
48670625|NCT03369236|156646608|FG000|Open-label Extension Period|Adverse Event|0|||
48670626|NCT03369236|156646609|FG001|Open-label Extension Period|Adverse Event|1|||
48670627|NCT03369236|156646608|FG000|Open-label Extension Period|Sponsor decision to close study|3|||
48670628|NCT03369236|156646609|FG001|Open-label Extension Period|Sponsor decision to close study|4|||
48670629|NCT05320393|156648214|FG000|Overall Study|Withdrawal by Subject|1|||
48760394|NCT00503308|156972212|FG000|Overall Study|Protocol Violation|2|||
48760395|NCT00503308|156972213|FG001|Overall Study|Protocol Violation|1|||
48760396|NCT03232281|156972214|FG000|Overall Study|Adverse Event|1|||
48760397|NCT03232281|156972215|FG001|Overall Study|Adverse Event|1|||
48670630|NCT05320393|156648215|FG001|Overall Study|Withdrawal by Subject|0|||
48670631|NCT05320393|156648216|FG002|Overall Study|Withdrawal by Subject|2|||
48760398|NCT03232281|156972214|FG000|Overall Study|Withdrawal by Subject|5|||
48760399|NCT03232281|156972215|FG001|Overall Study|Withdrawal by Subject|4|||
48760400|NCT03232281|156972214|FG000|Overall Study|Protocol Deviation|1|||
48760401|NCT03232281|156972215|FG001|Overall Study|Protocol Deviation|1|||
48760402|NCT02522286|156972217|FG000|Overall Study|Withdrawal by Subject|3|||
48760403|NCT02522286|156972218|FG001|Overall Study|Withdrawal by Subject|0|||
48760404|NCT02522286|156972219|FG002|Overall Study|Withdrawal by Subject|0|||
48760405|NCT02522286|156972220|FG003|Overall Study|Withdrawal by Subject|3|||
48760406|NCT01132482|156972225|FG000|Overall Study|Adverse Event|1|||
48760407|NCT01132482|156972226|FG001|Overall Study|Adverse Event|0|||
48760408|NCT02189473|156972227|FG000|Overall Study|Death|22|||
48760409|NCT02189473|156972228|FG001|Overall Study|Death|23|||
48760410|NCT02189473|156972227|FG000|Overall Study|Lost to Follow-up|1|||
48760411|NCT02189473|156972228|FG001|Overall Study|Lost to Follow-up|2|||
48760412|NCT01998737|156972229|FG000|Overall Study|Corrupted database|23|||
48760413|NCT01998737|156972230|FG001|Overall Study|Corrupted database|0|||
48760414|NCT01955161|156972231|FG000|Overall Study|Withdrawal before treatment|2|||
48760415|NCT01955161|156972232|FG001|Overall Study|Withdrawal before treatment|0|||
48760416|NCT01955161|156972233|FG002|Overall Study|Withdrawal before treatment|1|||
48760417|NCT01955161|156972231|FG000|Overall Study|Adverse Event|10|||
48760418|NCT01955161|156972232|FG001|Overall Study|Adverse Event|14|||
48760419|NCT01955161|156972233|FG002|Overall Study|Adverse Event|15|||
48760420|NCT01955161|156972231|FG000|Overall Study|Death|1|||
48670632|NCT05320393|156648214|FG000|Overall Study|Lost to Follow-up|1|||
48670633|NCT05320393|156648215|FG001|Overall Study|Lost to Follow-up|2|||
48670634|NCT05320393|156648216|FG002|Overall Study|Lost to Follow-up|1|||
48670635|NCT05320393|156648214|FG000|Overall Study|Moved; too much driving|0|||
48670636|NCT05320393|156648215|FG001|Overall Study|Moved; too much driving|0|||
48760421|NCT01955161|156972232|FG001|Overall Study|Death|1|||
48760422|NCT01955161|156972233|FG002|Overall Study|Death|3|||
48760423|NCT01955161|156972231|FG000|Overall Study|Withdrawal by Subject|9|||
48760424|NCT01955161|156972232|FG001|Overall Study|Withdrawal by Subject|8|||
48760425|NCT01955161|156972233|FG002|Overall Study|Withdrawal by Subject|12|||
48760426|NCT01955161|156972231|FG000|Overall Study|Protocol Violation|2|||
48760427|NCT01955161|156972232|FG001|Overall Study|Protocol Violation|0|||
48760428|NCT01955161|156972233|FG002|Overall Study|Protocol Violation|0|||
48760429|NCT01955161|156972231|FG000|Overall Study|Other reason: physician decision|0|||
48760430|NCT01955161|156972232|FG001|Overall Study|Other reason: physician decision|1|||
48760431|NCT01955161|156972233|FG002|Overall Study|Other reason: physician decision|1|||
48760432|NCT01955161|156972231|FG000|Overall Study|Other reason: disallowed medication|1|||
48760433|NCT01955161|156972232|FG001|Overall Study|Other reason: disallowed medication|0|||
48760434|NCT01955161|156972233|FG002|Overall Study|Other reason: disallowed medication|1|||
48760435|NCT01955161|156972231|FG000|Overall Study|Other reason: caregiver unavailable|1|||
48760436|NCT01955161|156972232|FG001|Overall Study|Other reason: caregiver unavailable|0|||
48760437|NCT01955161|156972233|FG002|Overall Study|Other reason: caregiver unavailable|0|||
48760438|NCT01955161|156972231|FG000|Overall Study|Other reason: moved to nursing home|0|||
48760439|NCT01955161|156972232|FG001|Overall Study|Other reason: moved to nursing home|1|||
48760440|NCT01955161|156972233|FG002|Overall Study|Other reason: moved to nursing home|0|||
48760441|NCT01955161|156972231|FG000|Overall Study|Other reason: insufficient compliance|0|||
48760442|NCT01955161|156972232|FG001|Overall Study|Other reason: insufficient compliance|0|||
48760443|NCT01955161|156972233|FG002|Overall Study|Other reason: insufficient compliance|1|||
48760444|NCT01955161|156972231|FG000|Overall Study|Other reason: primary biliary cirrhosis|1|||
48760445|NCT01955161|156972232|FG001|Overall Study|Other reason: primary biliary cirrhosis|0|||
48760446|NCT01955161|156972233|FG002|Overall Study|Other reason: primary biliary cirrhosis|0|||
48760447|NCT01955161|156972231|FG000|Overall Study|Other reason: patient's will|0|||
48760448|NCT01955161|156972232|FG001|Overall Study|Other reason: patient's will|0|||
48760449|NCT01955161|156972233|FG002|Overall Study|Other reason: patient's will|1|||
48760450|NCT01614990|156972234|FG000|Overall Study|Protocol Violation|1|||
48760451|NCT01614990|156972235|FG001|Overall Study|Protocol Violation|1|||
48760452|NCT01172847|156972236|FG000|Overall Study|Withdrawal by Subject|3|||
48760453|NCT03720470|156972237|FG000|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
48760454|NCT03720470|156972238|FG001|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
48760455|NCT03720470|156972239|FG002|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
48760456|NCT03720470|156972240|FG003|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
48760457|NCT03720470|156972241|FG004|Treatment Period: First Part 16 Weeks|Adverse Event|8|||
48760458|NCT03720470|156972242|FG005|Treatment Period: First Part 16 Weeks|Adverse Event|6|||
48760459|NCT03720470|156972237|FG000|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
48760460|NCT03720470|156972238|FG001|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
48760461|NCT03720470|156972239|FG002|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
48760462|NCT03720470|156972240|FG003|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
48760463|NCT03720470|156972241|FG004|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
48760464|NCT03720470|156972242|FG005|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
48760465|NCT03720470|156972237|FG000|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
48760466|NCT03720470|156972238|FG001|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
48760467|NCT03720470|156972239|FG002|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
48760468|NCT03720470|156972240|FG003|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
48760469|NCT03720470|156972241|FG004|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
48760470|NCT03720470|156972242|FG005|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
48760471|NCT03720470|156972237|FG000|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
48760472|NCT03720470|156972238|FG001|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
48760473|NCT03720470|156972239|FG002|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
48760474|NCT03720470|156972240|FG003|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
48760475|NCT03720470|156972241|FG004|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
48760476|NCT03720470|156972242|FG005|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
48760477|NCT03720470|156972237|FG000|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
48760478|NCT03720470|156972238|FG001|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
48760479|NCT03720470|156972239|FG002|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
48760480|NCT03720470|156972240|FG003|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
48760481|NCT03720470|156972241|FG004|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
48760482|NCT03720470|156972242|FG005|Treatment Period: First Part 16 Weeks|Protocol deviation|1|||
48760483|NCT03720470|156972237|FG000|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5|||
48760484|NCT03720470|156972238|FG001|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
48760485|NCT03720470|156972239|FG002|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
48760486|NCT03720470|156972240|FG003|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9|||
48760487|NCT03720470|156972241|FG004|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3|||
48760488|NCT03720470|156972242|FG005|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6|||
48760489|NCT03720470|156972237|FG000|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
48760490|NCT03720470|156972238|FG001|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
48870980|NCT00899379|157365774|FG003|Overall Study|Patient Uncooperative|1|||
48870981|NCT00899379|157365775|FG004|Overall Study|Patient Uncooperative|0|||
48870982|NCT00899379|157365771|FG000|Overall Study|Abnormal Prestudy Labs|0|||
48870983|NCT00899379|157365772|FG001|Overall Study|Abnormal Prestudy Labs|0|||
48870984|NCT00899379|157365773|FG002|Overall Study|Abnormal Prestudy Labs|0|||
48870985|NCT00899379|157365774|FG003|Overall Study|Abnormal Prestudy Labs|0|||
48670637|NCT05320393|156648216|FG002|Overall Study|Moved; too much driving|2|||
48670638|NCT05320393|156648214|FG000|Overall Study|Did not receive treatment|0|||
48670639|NCT05320393|156648215|FG001|Overall Study|Did not receive treatment|0|||
48670640|NCT05320393|156648216|FG002|Overall Study|Did not receive treatment|1|||
48670641|NCT04969198|156648217|FG000|Overall Study|Withdrawal by Subject|20|||
48670642|NCT04969198|156648217|FG000|Overall Study|Withdrawn by PI for Participant Non-Compliance|16|||
48670643|NCT04969198|156648217|FG000|Overall Study|Lost to Follow-up|20|||
48670644|NCT01272869|156648218|FG000|Period 2 (14 Days)|Adverse Event|1|||
48670645|NCT01272869|156648219|FG001|Period 2 (14 Days)|Adverse Event|0|||
48670646|NCT00490776|156648220|FG000|Overall Study|Withdrawal by Subject|1|||
48670647|NCT00490776|156648220|FG000|Overall Study|Administrative Problems|1|||
48670648|NCT00490776|156648220|FG000|Overall Study|Death|1|||
48670649|NCT00490776|156648220|FG000|Overall Study|New Cancer Therapy|1|||
48670650|NCT00490776|156648220|FG000|Overall Study|Disease Progression|5|||
48670651|NCT00308074|156648221|FG000|Overall Study|Withdrawal by Subject|1|||
48670652|NCT01424566|156648222|FG000|Single-blind Treatment|Adverse Event|71|||
48670653|NCT01424566|156648223|FG001|Single-blind Treatment|Adverse Event|0|||
48670654|NCT01424566|156648224|FG002|Single-blind Treatment|Adverse Event|0|||
48670655|NCT01424566|156648222|FG000|Single-blind Treatment|Withdrawal by Subject|16|||
48670656|NCT01424566|156648223|FG001|Single-blind Treatment|Withdrawal by Subject|0|||
48670657|NCT01424566|156648224|FG002|Single-blind Treatment|Withdrawal by Subject|0|||
48670658|NCT01424566|156648222|FG000|Single-blind Treatment|Withdrawal by Investigator|2|||
48670659|NCT01424566|156648223|FG001|Single-blind Treatment|Withdrawal by Investigator|0|||
48670660|NCT01424566|156648224|FG002|Single-blind Treatment|Withdrawal by Investigator|0|||
48670661|NCT01424566|156648222|FG000|Single-blind Treatment|Did Not Meet Inclusion Criteria|108|||
48670662|NCT01424566|156648223|FG001|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
48670663|NCT01424566|156648224|FG002|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
48670664|NCT01424566|156648222|FG000|Single-blind Treatment|Met Exclusion Criteria|1|||
48670665|NCT01424566|156648223|FG001|Single-blind Treatment|Met Exclusion Criteria|0|||
48670666|NCT01424566|156648224|FG002|Single-blind Treatment|Met Exclusion Criteria|0|||
48670667|NCT01424566|156648222|FG000|Single-blind Treatment|Did Not Administer Any Study Drug|2|||
48670668|NCT01424566|156648223|FG001|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
48670669|NCT01424566|156648224|FG002|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
48670670|NCT01424566|156648222|FG000|Double-blind Treatment|Adverse Event|0|||
48670671|NCT01424566|156648223|FG001|Double-blind Treatment|Adverse Event|21|||
48670672|NCT01424566|156648224|FG002|Double-blind Treatment|Adverse Event|13|||
48670673|NCT01424566|156648222|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
48670674|NCT01424566|156648223|FG001|Double-blind Treatment|Withdrawal by Subject|2|||
48670675|NCT01424566|156648224|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
48670676|NCT01424566|156648222|FG000|Double-blind Treatment|Withdrawal by Investigator|0|||
48670677|NCT01424566|156648223|FG001|Double-blind Treatment|Withdrawal by Investigator|1|||
48670678|NCT01424566|156648224|FG002|Double-blind Treatment|Withdrawal by Investigator|1|||
48670679|NCT01424566|156648222|FG000|Double-blind Treatment|Lack of Efficacy|0|||
48670680|NCT01424566|156648223|FG001|Double-blind Treatment|Lack of Efficacy|1|||
48670681|NCT01424566|156648224|FG002|Double-blind Treatment|Lack of Efficacy|1|||
48670682|NCT03883113|156648225|FG000|Overall Study|Physician Decision|4|||
48670683|NCT03883113|156648226|FG001|Overall Study|Physician Decision|2|||
48670684|NCT03883113|156648225|FG000|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9|||
48670685|NCT03883113|156648226|FG001|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7|||
48670686|NCT03883113|156648225|FG000|Overall Study|Pregnancy|1|||
48670687|NCT03883113|156648226|FG001|Overall Study|Pregnancy|0|||
48670688|NCT03883113|156648225|FG000|Overall Study|Adverse Event|0|||
48670689|NCT03883113|156648226|FG001|Overall Study|Adverse Event|1|||
48670690|NCT03883113|156648225|FG000|Overall Study|Withdrawal by Subject|1|||
48670691|NCT03883113|156648226|FG001|Overall Study|Withdrawal by Subject|2|||
48670692|NCT03883113|156648225|FG000|Overall Study|Lost to Follow-up|1|||
48670693|NCT03883113|156648226|FG001|Overall Study|Lost to Follow-up|0|||
48670694|NCT03689712|156648227|FG000|Overall Study|Adverse Event|1|||
48670695|NCT03689712|156648228|FG001|Overall Study|Adverse Event|0|||
48670696|NCT03689712|156648227|FG000|Overall Study|Death|20|||
48670697|NCT03689712|156648228|FG001|Overall Study|Death|10|||
48670698|NCT03689712|156648227|FG000|Overall Study|Lost to Follow-up|6|||
48670699|NCT03689712|156648228|FG001|Overall Study|Lost to Follow-up|6|||
48670700|NCT03689712|156648227|FG000|Overall Study|Other|1|||
48670701|NCT03689712|156648228|FG001|Overall Study|Other|0|||
48670702|NCT03689712|156648227|FG000|Overall Study|Patient Non-Compliance|0|||
48670703|NCT03689712|156648228|FG001|Overall Study|Patient Non-Compliance|1|||
48670704|NCT03689712|156648227|FG000|Overall Study|Withdrawal by Subject|20|||
48670705|NCT03689712|156648228|FG001|Overall Study|Withdrawal by Subject|4|||
48692813|NCT01188772|156724613|FG003|Overall Study|Virologic Failure|0|||
48760491|NCT03720470|156972239|FG002|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
48760492|NCT03720470|156972240|FG003|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
48760493|NCT03720470|156972241|FG004|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
48760494|NCT03720470|156972242|FG005|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
48760495|NCT03720470|156972237|FG000|Treatment Period: First Part 16 Weeks|Other|1|||
48760496|NCT03720470|156972238|FG001|Treatment Period: First Part 16 Weeks|Other|0|||
48760497|NCT03720470|156972239|FG002|Treatment Period: First Part 16 Weeks|Other|0|||
48760498|NCT03720470|156972240|FG003|Treatment Period: First Part 16 Weeks|Other|1|||
48760499|NCT03720470|156972241|FG004|Treatment Period: First Part 16 Weeks|Other|2|||
48760500|NCT03720470|156972242|FG005|Treatment Period: First Part 16 Weeks|Other|2|||
48760501|NCT03720470|156972237|FG000|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
48760502|NCT03720470|156972238|FG001|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
48760503|NCT03720470|156972239|FG002|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
48760504|NCT03720470|156972240|FG003|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
48760505|NCT03720470|156972241|FG004|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
48760506|NCT03720470|156972242|FG005|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1|||
48760507|NCT03720470|156972237|FG000|Treatment Period: Final 4 Weeks|Adverse Event|0|||
48760508|NCT03720470|156972238|FG001|Treatment Period: Final 4 Weeks|Adverse Event|0|||
48760509|NCT03720470|156972239|FG002|Treatment Period: Final 4 Weeks|Adverse Event|0|||
48760510|NCT03720470|156972240|FG003|Treatment Period: Final 4 Weeks|Adverse Event|2|||
48870986|NCT00899379|157365775|FG004|Overall Study|Abnormal Prestudy Labs|2|||
48870987|NCT00899379|157365771|FG000|Overall Study|Abnormal Baseline ECG|0|||
48870988|NCT00899379|157365772|FG001|Overall Study|Abnormal Baseline ECG|0|||
48870989|NCT00899379|157365773|FG002|Overall Study|Abnormal Baseline ECG|1|||
48870990|NCT00899379|157365774|FG003|Overall Study|Abnormal Baseline ECG|1|||
48870991|NCT00899379|157365775|FG004|Overall Study|Abnormal Baseline ECG|0|||
48870992|NCT00899379|157365771|FG000|Overall Study|No Attack Pretreatment|3|||
48870993|NCT00899379|157365772|FG001|Overall Study|No Attack Pretreatment|5|||
48870994|NCT00899379|157365773|FG002|Overall Study|No Attack Pretreatment|5|||
48870995|NCT00899379|157365774|FG003|Overall Study|No Attack Pretreatment|6|||
48870996|NCT00899379|157365775|FG004|Overall Study|No Attack Pretreatment|4|||
48870997|NCT00899379|157365771|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
48870998|NCT00899379|157365772|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
48870999|NCT00899379|157365773|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
48871000|NCT00899379|157365774|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
48871001|NCT00899379|157365775|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
48871002|NCT00899379|157365771|FG000|Overall Study|Inc/Exc Criteria Not Met|0|||
48871003|NCT00899379|157365772|FG001|Overall Study|Inc/Exc Criteria Not Met|0|||
48871004|NCT00899379|157365773|FG002|Overall Study|Inc/Exc Criteria Not Met|1|||
48871005|NCT00899379|157365774|FG003|Overall Study|Inc/Exc Criteria Not Met|0|||
48871006|NCT00899379|157365775|FG004|Overall Study|Inc/Exc Criteria Not Met|0|||
48871007|NCT01649297|157365777|FG000|Overall Study|Adverse Event|5|||
48871008|NCT01649297|157365778|FG001|Overall Study|Adverse Event|5|||
48871009|NCT01649297|157365779|FG002|Overall Study|Adverse Event|4|||
48871010|NCT01649297|157365780|FG003|Overall Study|Adverse Event|13|||
48871011|NCT01649297|157365781|FG004|Overall Study|Adverse Event|1|||
48871012|NCT01649297|157365777|FG000|Overall Study|Lack of Efficacy|0|||
48871013|NCT01649297|157365778|FG001|Overall Study|Lack of Efficacy|0|||
48871014|NCT01649297|157365779|FG002|Overall Study|Lack of Efficacy|0|||
48871015|NCT01649297|157365780|FG003|Overall Study|Lack of Efficacy|0|||
48871016|NCT01649297|157365781|FG004|Overall Study|Lack of Efficacy|1|||
48871017|NCT01649297|157365777|FG000|Overall Study|Non compliant with Protocol|1|||
48871018|NCT01649297|157365778|FG001|Overall Study|Non compliant with Protocol|0|||
48871019|NCT01649297|157365779|FG002|Overall Study|Non compliant with Protocol|3|||
48871020|NCT01649297|157365780|FG003|Overall Study|Non compliant with Protocol|2|||
48871021|NCT01649297|157365781|FG004|Overall Study|Non compliant with Protocol|1|||
48871022|NCT01649297|157365777|FG000|Overall Study|Lost to Follow-up|1|||
48871023|NCT01649297|157365778|FG001|Overall Study|Lost to Follow-up|1|||
48871024|NCT01649297|157365779|FG002|Overall Study|Lost to Follow-up|4|||
48871025|NCT01649297|157365780|FG003|Overall Study|Lost to Follow-up|3|||
48871026|NCT01649297|157365781|FG004|Overall Study|Lost to Follow-up|0|||
48871027|NCT01649297|157365777|FG000|Overall Study|Patient withdrawal (not due to AE)|3|||
48871028|NCT01649297|157365778|FG001|Overall Study|Patient withdrawal (not due to AE)|6|||
48871029|NCT01649297|157365779|FG002|Overall Study|Patient withdrawal (not due to AE)|4|||
48871030|NCT01649297|157365780|FG003|Overall Study|Patient withdrawal (not due to AE)|1|||
48871031|NCT01649297|157365781|FG004|Overall Study|Patient withdrawal (not due to AE)|1|||
48871032|NCT01649297|157365777|FG000|Overall Study|For other reason|4|||
48871033|NCT01649297|157365778|FG001|Overall Study|For other reason|1|||
48871034|NCT01649297|157365779|FG002|Overall Study|For other reason|2|||
48871035|NCT01649297|157365780|FG003|Overall Study|For other reason|0|||
48871036|NCT01649297|157365781|FG004|Overall Study|For other reason|0|||
48871037|NCT00463580|157365782|FG000|Overall Study|Lost to Follow-up|1|||
48871038|NCT00463580|157365783|FG001|Overall Study|Lost to Follow-up|0|||
48871039|NCT00463580|157365782|FG000|Overall Study|Schedule conflict|2|||
48871040|NCT00463580|157365783|FG001|Overall Study|Schedule conflict|0|||
48871041|NCT00463580|157365782|FG000|Overall Study|Medical/psychiatric complications|0|||
48871042|NCT00463580|157365783|FG001|Overall Study|Medical/psychiatric complications|2|||
48871043|NCT00858247|157365784|FG000|Baseline Assessment|Withdrawal by Subject|1|||
48871044|NCT00858247|157365785|FG001|Baseline Assessment|Withdrawal by Subject|1|||
48871045|NCT00858247|157365784|FG000|Baseline Assessment|Poor IV access|1|||
48871046|NCT00858247|157365785|FG001|Baseline Assessment|Poor IV access|0|||
48871047|NCT00858247|157365784|FG000|Baseline Assessment|Protocol Violation|0|||
48871048|NCT00858247|157365785|FG001|Baseline Assessment|Protocol Violation|1|||
48871049|NCT00858247|157365784|FG000|Week 12 Follow-up|Withdrawal by Subject|0|||
48871050|NCT00858247|157365785|FG001|Week 12 Follow-up|Withdrawal by Subject|1|||
48871051|NCT00337285|157365788|FG000|Overall Study|Withdrawal by Subject|42|||
48871052|NCT00337285|157365788|FG000|Overall Study|Lost to Follow-up|41|||
48871053|NCT00337285|157365788|FG000|Overall Study|Adverse Event|28|||
48871054|NCT00337285|157365788|FG000|Overall Study|Protocol Violation|27|||
48871055|NCT00337285|157365788|FG000|Overall Study|Lack of Efficacy|11|||
48871056|NCT00337285|157365788|FG000|Overall Study|Death|1|||
48871057|NCT00337285|157365788|FG000|Overall Study|Physician Decision|1|||
48871058|NCT00337285|157365788|FG000|Overall Study|Lack of protocol compliance|7|||
48871059|NCT00553605|157365789|FG000|Overall Study|Did not meet entrance criteria|1|||
48871060|NCT00553605|157365790|FG001|Overall Study|Did not meet entrance criteria|3|||
48871061|NCT00553605|157365789|FG000|Overall Study|Did not receive full dose|1|||
48871062|NCT00553605|157365790|FG001|Overall Study|Did not receive full dose|0|||
48871063|NCT00553605|157365789|FG000|Overall Study|Randomized but not treated|2|||
48871064|NCT00553605|157365790|FG001|Overall Study|Randomized but not treated|0|||
48871065|NCT04545476|157365795|FG000|Overall Study|Lost to Follow-up|1|||
48871066|NCT04545476|157365796|FG001|Overall Study|Lost to Follow-up|1|||
48871067|NCT04545476|157365797|FG002|Overall Study|Lost to Follow-up|0|||
48871068|NCT04545476|157365798|FG003|Overall Study|Lost to Follow-up|0|||
48871069|NCT01435798|157365801|FG000|Overall Study|Withdrawal by Subject|1|||
48871070|NCT02427958|157365802|FG000|Overall Study|Pretreatment Event (PTE) or AE|3|||
48871071|NCT02427958|157365802|FG000|Overall Study|Lost to Follow-up|6|||
48871072|NCT02427958|157365802|FG000|Overall Study|Withdrawal by Subject|14|||
48871073|NCT02427958|157365802|FG000|Overall Study|Lack of Efficacy|1|||
48871074|NCT01530087|157365803|FG000|Overall Study|Physician Decision|2|||
48871075|NCT01182181|157365804|FG000|First Intervention|Adverse Event|1|||
48871076|NCT01182181|157365805|FG001|First Intervention|Adverse Event|0|||
48871077|NCT01182181|157365804|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
48871078|NCT01182181|157365805|FG001|Washout of 21 Days|Withdrawal by Subject|1|||
48871079|NCT00866918|157365806|FG000|Overall Study|Death|1|||
48871080|NCT00866918|157365807|FG001|Overall Study|Death|5|||
48871081|NCT00866918|157365806|FG000|Overall Study|Lack of Efficacy|1|||
48871082|NCT00866918|157365807|FG001|Overall Study|Lack of Efficacy|1|||
48871083|NCT00866918|157365806|FG000|Overall Study|Physician Decision|10|||
48871084|NCT00866918|157365807|FG001|Overall Study|Physician Decision|2|||
48871085|NCT00866918|157365806|FG000|Overall Study|Ineligible|2|||
48871086|NCT00866918|157365807|FG001|Overall Study|Ineligible|4|||
48871087|NCT00866918|157365806|FG000|Overall Study|Inevaluable- RQPCR negative at diagnosi|1|||
48871088|NCT00866918|157365807|FG001|Overall Study|Inevaluable- RQPCR negative at diagnosi|0|||
48871089|NCT00866918|157365806|FG000|Overall Study|Secondary malignancy|1|||
48871090|NCT00866918|157365807|FG001|Overall Study|Secondary malignancy|0|||
48871091|NCT01121913|157365808|FG000|First Intervention Period|Adverse Event|0|||
48871092|NCT01121913|157365809|FG001|First Intervention Period|Adverse Event|0|||
48871093|NCT01121913|157365810|FG002|First Intervention Period|Adverse Event|1|||
48871094|NCT01121913|157365811|FG003|First Intervention Period|Adverse Event|0|||
48871095|NCT01121913|157365808|FG000|First Washout Period|Withdrawal by Subject|1|||
48871096|NCT01121913|157365809|FG001|First Washout Period|Withdrawal by Subject|0|||
48871097|NCT01121913|157365810|FG002|First Washout Period|Withdrawal by Subject|0|||
48670706|NCT03689712|156648227|FG000|Overall Study|Patients Continuing in Long Term Follow Up|88|||
48871098|NCT01121913|157365811|FG003|First Washout Period|Withdrawal by Subject|0|||
48871099|NCT01121913|157365808|FG000|Second Intervention Period|Adverse Event|0|||
48871100|NCT01121913|157365809|FG001|Second Intervention Period|Adverse Event|0|||
48871101|NCT01121913|157365810|FG002|Second Intervention Period|Adverse Event|1|||
48871102|NCT01121913|157365811|FG003|Second Intervention Period|Adverse Event|0|||
48871103|NCT01121913|157365808|FG000|Second Washout Period|Withdrawal by Subject|0|||
48871104|NCT01121913|157365809|FG001|Second Washout Period|Withdrawal by Subject|0|||
48871105|NCT01121913|157365810|FG002|Second Washout Period|Withdrawal by Subject|1|||
48871106|NCT01121913|157365811|FG003|Second Washout Period|Withdrawal by Subject|0|||
48871107|NCT01121913|157365808|FG000|Third Washout Period|Adverse Event|1|||
48871108|NCT01121913|157365809|FG001|Third Washout Period|Adverse Event|0|||
48871109|NCT01121913|157365810|FG002|Third Washout Period|Adverse Event|0|||
48871110|NCT01121913|157365811|FG003|Third Washout Period|Adverse Event|0|||
48871111|NCT03974100|157365812|FG000|TP1 - Day 1 to Week 52|Adverse Event|1|||
48871112|NCT03974100|157365813|FG001|TP1 - Day 1 to Week 52|Adverse Event|3|||
48871113|NCT03974100|157365814|FG002|TP1 - Day 1 to Week 52|Adverse Event|0|||
48871114|NCT03974100|157365815|FG003|TP1 - Day 1 to Week 52|Adverse Event|0|||
48871115|NCT03974100|157365816|FG004|TP1 - Day 1 to Week 52|Adverse Event|0|||
48871116|NCT03974100|157365812|FG000|TP1 - Day 1 to Week 52|Death|1|||
48871117|NCT03974100|157365813|FG001|TP1 - Day 1 to Week 52|Death|0|||
48871118|NCT03974100|157365814|FG002|TP1 - Day 1 to Week 52|Death|0|||
48871119|NCT03974100|157365815|FG003|TP1 - Day 1 to Week 52|Death|0|||
48871120|NCT03974100|157365816|FG004|TP1 - Day 1 to Week 52|Death|0|||
48871121|NCT03974100|157365812|FG000|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
48871122|NCT03974100|157365813|FG001|TP1 - Day 1 to Week 52|Lost to Follow-up|1|||
48871123|NCT03974100|157365814|FG002|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
48871124|NCT03974100|157365815|FG003|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
48871125|NCT03974100|157365816|FG004|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
48871126|NCT03974100|157365812|FG000|TP1 - Day 1 to Week 52|Physician Decision|0|||
48871127|NCT03974100|157365813|FG001|TP1 - Day 1 to Week 52|Physician Decision|2|||
48871128|NCT03974100|157365814|FG002|TP1 - Day 1 to Week 52|Physician Decision|0|||
48760511|NCT03720470|156972241|FG004|Treatment Period: Final 4 Weeks|Adverse Event|1|||
48760512|NCT03720470|156972242|FG005|Treatment Period: Final 4 Weeks|Adverse Event|1|||
48760513|NCT03720470|156972237|FG000|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
48760514|NCT03720470|156972238|FG001|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
48760515|NCT03720470|156972239|FG002|Treatment Period: Final 4 Weeks|Lack of Efficacy|1|||
48760516|NCT03720470|156972240|FG003|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
48760517|NCT03720470|156972241|FG004|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
48760518|NCT03720470|156972242|FG005|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
48760519|NCT03720470|156972237|FG000|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
48760520|NCT03720470|156972238|FG001|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
48760521|NCT03720470|156972239|FG002|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
48760522|NCT03720470|156972240|FG003|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
48760523|NCT03720470|156972241|FG004|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
48760524|NCT03720470|156972242|FG005|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
48760525|NCT03720470|156972237|FG000|Treatment Period: Final 4 Weeks|Pregnancy|0|||
48871129|NCT03974100|157365815|FG003|TP1 - Day 1 to Week 52|Physician Decision|0|||
48871130|NCT03974100|157365816|FG004|TP1 - Day 1 to Week 52|Physician Decision|0|||
48871131|NCT03974100|157365812|FG000|TP1 - Day 1 to Week 52|Subject decision|8|||
48871132|NCT03974100|157365813|FG001|TP1 - Day 1 to Week 52|Subject decision|9|||
48871133|NCT03974100|157365814|FG002|TP1 - Day 1 to Week 52|Subject decision|0|||
48871134|NCT03974100|157365815|FG003|TP1 - Day 1 to Week 52|Subject decision|0|||
48871135|NCT03974100|157365816|FG004|TP1 - Day 1 to Week 52|Subject decision|0|||
48871136|NCT03974100|157365812|FG000|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
48871137|NCT03974100|157365813|FG001|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
48871138|NCT03974100|157365814|FG002|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
48871139|NCT03974100|157365815|FG003|TP2- Week 52 to Week 78|Lost to Follow-up|1|||
48871140|NCT03974100|157365816|FG004|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
48871141|NCT03974100|157365812|FG000|TP2- Week 52 to Week 78|Subject decision|0|||
48871142|NCT03974100|157365813|FG001|TP2- Week 52 to Week 78|Subject decision|0|||
48670707|NCT03689712|156648228|FG001|Overall Study|Patients Continuing in Long Term Follow Up|71|||
48670708|NCT03689712|156648227|FG000|Overall Study|Randomized but not Treated|13|||
48670709|NCT03689712|156648228|FG001|Overall Study|Randomized but not Treated|7|||
48670710|NCT03689712|156648227|FG000|Overall Study|Subject Dosing Suspended due to Product Issue|16|||
48670711|NCT03689712|156648228|FG001|Overall Study|Subject Dosing Suspended due to Product Issue|12|||
48670712|NCT03266172|156648234|FG000|Part A: Period 1(2 Days)|Withdrawal by Subject|1|||
48670713|NCT03266172|156648235|FG001|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
48670714|NCT03266172|156648236|FG002|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
48670715|NCT03266172|156648234|FG000|Part A: Washout Period (7 Days)|Adverse Event|1|||
48670716|NCT03266172|156648235|FG001|Part A: Washout Period (7 Days)|Adverse Event|0|||
48670717|NCT03266172|156648236|FG002|Part A: Washout Period (7 Days)|Adverse Event|0|||
48670718|NCT03266172|156648234|FG000|Part A: Washout Period (7 Days)|Withdrawal by Subject|1|||
48670719|NCT03266172|156648235|FG001|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
48670720|NCT03266172|156648236|FG002|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
48670721|NCT03266172|156648234|FG000|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
48670722|NCT03266172|156648235|FG001|Part B: Washout (7 Days)|Withdrawal by Subject|2|||
48670723|NCT03266172|156648236|FG002|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
48670724|NCT03266172|156648234|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
48670725|NCT03266172|156648235|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
48670726|NCT03266172|156648236|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
48670727|NCT03266172|156648234|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
48760526|NCT03720470|156972238|FG001|Treatment Period: Final 4 Weeks|Pregnancy|0|||
48871143|NCT03974100|157365814|FG002|TP2- Week 52 to Week 78|Subject decision|0|||
48871144|NCT03974100|157365815|FG003|TP2- Week 52 to Week 78|Subject decision|1|||
48871145|NCT03974100|157365816|FG004|TP2- Week 52 to Week 78|Subject decision|0|||
48871146|NCT01704547|157365817|FG000|Overall Study|Physician Decision|4|||
48871147|NCT01704547|157365817|FG000|Overall Study|Withdrawal by Subject|1|||
48670728|NCT03266172|156648235|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
48670729|NCT03266172|156648236|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
48670730|NCT00864851|156648237|FG000|Overall Study|Withdrawal by Subject|0|||
48670731|NCT00864851|156648238|FG001|Overall Study|Withdrawal by Subject|1|||
48670732|NCT00864851|156648239|FG002|Overall Study|Withdrawal by Subject|0|||
48670733|NCT00864851|156648237|FG000|Overall Study|Physician Decision|1|||
48670734|NCT00864851|156648238|FG001|Overall Study|Physician Decision|0|||
48670735|NCT00864851|156648239|FG002|Overall Study|Physician Decision|0|||
48670736|NCT00864851|156648237|FG000|Overall Study|Death|1|||
48670737|NCT00864851|156648238|FG001|Overall Study|Death|0|||
48670738|NCT00864851|156648239|FG002|Overall Study|Death|0|||
48670739|NCT00864851|156648237|FG000|Overall Study|Patient uncooperative|1|||
48670740|NCT00864851|156648238|FG001|Overall Study|Patient uncooperative|0|||
48670741|NCT00864851|156648239|FG002|Overall Study|Patient uncooperative|0|||
48670742|NCT00413010|156648240|FG000|Overall Study|Adverse Event|8|||
48670743|NCT00413010|156648241|FG001|Overall Study|Adverse Event|4|||
48670744|NCT00413010|156648240|FG000|Overall Study|Laboratory abnormality|0|||
48670745|NCT00413010|156648241|FG001|Overall Study|Laboratory abnormality|2|||
48670746|NCT00413010|156648240|FG000|Overall Study|Lack of Efficacy|0|||
48670747|NCT00413010|156648241|FG001|Overall Study|Lack of Efficacy|3|||
48670748|NCT00413010|156648240|FG000|Overall Study|Lost to Follow-up|3|||
48670749|NCT00413010|156648241|FG001|Overall Study|Lost to Follow-up|0|||
48670750|NCT00413010|156648240|FG000|Overall Study|Withdrawal by Subject|7|||
48670751|NCT00413010|156648241|FG001|Overall Study|Withdrawal by Subject|2|||
48670752|NCT00413010|156648240|FG000|Overall Study|Due to termination of the study|54|||
48670753|NCT00413010|156648241|FG001|Overall Study|Due to termination of the study|52|||
48670754|NCT00443781|156648242|FG000|Overall Study|Lost to Follow-up|10|||
48670755|NCT00443781|156648242|FG000|Overall Study|Physician Decision|2|||
48670756|NCT00443781|156648242|FG000|Overall Study|Protocol Violation|1|||
48670757|NCT00443781|156648242|FG000|Overall Study|Withdrawal by Subject|6|||
48670758|NCT00443781|156648242|FG000|Overall Study|Unable to comply with study follow up|2|||
48670759|NCT00443781|156648242|FG000|Overall Study|Investigator terminated participation|1|||
48670760|NCT00443781|156648242|FG000|Overall Study|Insurance not covered|2|||
48670761|NCT00443781|156648242|FG000|Overall Study|PD/FAD not done|1|||
48670762|NCT00430937|156648243|FG000|Overall Study|Adverse Event|3|||
48670763|NCT00430937|156648244|FG001|Overall Study|Adverse Event|8|||
48670764|NCT00430937|156648243|FG000|Overall Study|Death|0|||
48670765|NCT00430937|156648244|FG001|Overall Study|Death|1|||
48670766|NCT00430937|156648243|FG000|Overall Study|Lost to Follow-up|6|||
48670767|NCT00430937|156648244|FG001|Overall Study|Lost to Follow-up|6|||
48670768|NCT00430937|156648243|FG000|Overall Study|Withdrawal by Subject|5|||
48670769|NCT00430937|156648244|FG001|Overall Study|Withdrawal by Subject|2|||
48670770|NCT00430937|156648243|FG000|Overall Study|Protocol Violation|3|||
48670771|NCT00430937|156648244|FG001|Overall Study|Protocol Violation|2|||
48670772|NCT00430937|156648243|FG000|Overall Study|Lack of Efficacy|6|||
48670773|NCT00430937|156648244|FG001|Overall Study|Lack of Efficacy|5|||
48670774|NCT00430937|156648243|FG000|Overall Study|Inappropriate enrollment|2|||
48670775|NCT00430937|156648244|FG001|Overall Study|Inappropriate enrollment|1|||
48670776|NCT00430937|156648243|FG000|Overall Study|Administrative reasons|1|||
48670777|NCT00430937|156648244|FG001|Overall Study|Administrative reasons|0|||
48670778|NCT00430937|156648243|FG000|Overall Study|Protocol discontinuation criteria met|1|||
48670779|NCT00430937|156648244|FG001|Overall Study|Protocol discontinuation criteria met|2|||
48670780|NCT00430937|156648243|FG000|Overall Study|Unable to classify|0|||
48670781|NCT00430937|156648244|FG001|Overall Study|Unable to classify|1|||
48670782|NCT01659255|156648245|FG000|Overall Study|Adverse Event|0|||
48670783|NCT01659255|156648246|FG001|Overall Study|Adverse Event|0|||
48670784|NCT01659255|156648247|FG002|Overall Study|Adverse Event|0|||
48670785|NCT01659255|156648248|FG003|Overall Study|Adverse Event|0|||
48670786|NCT01659255|156648249|FG004|Overall Study|Adverse Event|0|||
48670787|NCT01659255|156648250|FG005|Overall Study|Adverse Event|1|||
48670788|NCT01659255|156648251|FG006|Overall Study|Adverse Event|1|||
48670789|NCT01659255|156648252|FG007|Overall Study|Adverse Event|0|||
48670790|NCT01659255|156648253|FG008|Overall Study|Adverse Event|0|||
48670791|NCT01659255|156648254|FG009|Overall Study|Adverse Event|1|||
48670792|NCT01659255|156648255|FG010|Overall Study|Adverse Event|0|||
48670793|NCT01659255|156648256|FG011|Overall Study|Adverse Event|1|||
48670794|NCT01659255|156648257|FG012|Overall Study|Adverse Event|0|||
48670795|NCT01659255|156648258|FG013|Overall Study|Adverse Event|2|||
48670796|NCT01659255|156648259|FG014|Overall Study|Adverse Event|0|||
48670797|NCT01659255|156648260|FG015|Overall Study|Adverse Event|1|||
48670798|NCT01659255|156648261|FG016|Overall Study|Adverse Event|0|||
48670799|NCT01659255|156648245|FG000|Overall Study|Death|0|||
48670800|NCT01659255|156648246|FG001|Overall Study|Death|1|||
48968506|NCT03495453|157712559|FG000|Overall Study|Withdrawal by Subject|0|||
48670801|NCT01659255|156648247|FG002|Overall Study|Death|0|||
48670802|NCT01659255|156648248|FG003|Overall Study|Death|0|||
48670803|NCT01659255|156648249|FG004|Overall Study|Death|0|||
48670804|NCT01659255|156648250|FG005|Overall Study|Death|0|||
48670805|NCT01659255|156648251|FG006|Overall Study|Death|0|||
48871148|NCT02413593|157365818|FG000|Overall Study|Lost to Follow-up|3|||
48871149|NCT02413593|157365818|FG000|Overall Study|Adverse Event|1|||
48871150|NCT02564718|157365819|FG000|Overall Study|Withdrew from treatment|0|||
48871151|NCT02564718|157365820|FG001|Overall Study|Withdrew from treatment|1|||
48871152|NCT00001941|157365821|FG000|Overall Study|not treated- rapidly progressing disease|0|||
48871153|NCT00001941|157365822|FG001|Overall Study|not treated- rapidly progressing disease|0|||
48871154|NCT00001941|157365823|FG002|Overall Study|not treated- rapidly progressing disease|0|||
48871155|NCT00001941|157365824|FG003|Overall Study|not treated- rapidly progressing disease|0|||
48871156|NCT00001941|157365825|FG004|Overall Study|not treated- rapidly progressing disease|1|||
48871157|NCT03723915|157365826|FG000|Screening|Failed to meet screening requirements.|2|||
48871158|NCT03723915|157365826|FG000|On Treatment|Failed to meet treatment requirements|2|||
48871159|NCT00874497|157365827|FG000|Overall Study|Lost to Follow-up|2|||
48871160|NCT00874497|157365828|FG001|Overall Study|Lost to Follow-up|4|||
48871161|NCT00874497|157365827|FG000|Overall Study|Adverse Event|9|||
48871162|NCT00874497|157365828|FG001|Overall Study|Adverse Event|4|||
48871163|NCT00874497|157365827|FG000|Overall Study|Sponsor Discontinued Trial|7|||
48871164|NCT00874497|157365828|FG001|Overall Study|Sponsor Discontinued Trial|3|||
48871165|NCT00874497|157365827|FG000|Overall Study|Met Withdrawal Criteria|4|||
48871166|NCT00874497|157365828|FG001|Overall Study|Met Withdrawal Criteria|2|||
48871167|NCT00874497|157365827|FG000|Overall Study|Physician Decision|1|||
48871168|NCT00874497|157365828|FG001|Overall Study|Physician Decision|1|||
48871169|NCT00874497|157365827|FG000|Overall Study|Withdrawal by Subject|5|||
48871170|NCT00874497|157365828|FG001|Overall Study|Withdrawal by Subject|4|||
48871171|NCT03269695|157365829|FG000|Overall Study|Adverse Event|2|||
48871172|NCT03269695|157365830|FG001|Overall Study|Adverse Event|1|||
48871173|NCT03269695|157365829|FG000|Overall Study|Lack of Efficacy|0|||
48871174|NCT03269695|157365830|FG001|Overall Study|Lack of Efficacy|1|||
48871175|NCT03269695|157365829|FG000|Overall Study|Withdrawal by Subject|0|||
48871176|NCT03269695|157365830|FG001|Overall Study|Withdrawal by Subject|1|||
48871177|NCT00264498|157365831|FG000|Randomized Treatment|Death|0|||
48871178|NCT00264498|157365832|FG001|Randomized Treatment|Death|3|||
48871179|NCT00264498|157365831|FG000|Randomized Treatment|Withdrawal by Subject|0|||
48871180|NCT00264498|157365832|FG001|Randomized Treatment|Withdrawal by Subject|1|||
48871181|NCT00264498|157365831|FG000|Randomized Treatment|Objective disease Progression|13|||
48871182|NCT00264498|157365832|FG001|Randomized Treatment|Objective disease Progression|14|||
48871183|NCT00264498|157365831|FG000|Randomized Treatment|Physician Decision|1|||
48871184|NCT00264498|157365832|FG001|Randomized Treatment|Physician Decision|0|||
48871185|NCT00264498|157365831|FG000|Randomized Treatment|Incorrectly randomized|1|||
48871186|NCT00264498|157365832|FG001|Randomized Treatment|Incorrectly randomized|0|||
48871187|NCT00264498|157365831|FG000|Randomized Treatment|Study Closure|1|||
48871188|NCT00264498|157365832|FG001|Randomized Treatment|Study Closure|0|||
48871189|NCT00264498|157365831|FG000|Randomized Treatment|Protocol Violation|1|||
48871190|NCT00264498|157365832|FG001|Randomized Treatment|Protocol Violation|0|||
48871191|NCT00264498|157365831|FG000|Crossover Treatment|Death|1|||
48871192|NCT00264498|157365832|FG001|Crossover Treatment|Death|3|||
48871193|NCT00264498|157365831|FG000|Crossover Treatment|Objective disease progression|4|||
48871194|NCT00264498|157365832|FG001|Crossover Treatment|Objective disease progression|5|||
48871195|NCT00264498|157365831|FG000|Crossover Treatment|Study closure|0|||
48871196|NCT00264498|157365832|FG001|Crossover Treatment|Study closure|1|||
48871197|NCT00264498|157365831|FG000|Crossover Treatment|Withdrawal by Subject|1|||
48871198|NCT00264498|157365832|FG001|Crossover Treatment|Withdrawal by Subject|0|||
48871199|NCT01222078|157365838|FG000|Overall Study|Early termination of the study|1|||
48871200|NCT02230306|157365839|FG000|Overall Study|Did not receive study treatment|1|||
48871201|NCT01225159|157365840|FG000|Overall Study|Change operation|1|||
48871202|NCT01225159|157365841|FG001|Overall Study|Change operation|0|||
48871203|NCT02037256|157365851|FG000|Overall Study|Protocol Violation|0|||
48871204|NCT02037256|157365852|FG001|Overall Study|Protocol Violation|1|||
48871205|NCT02037256|157365851|FG000|Overall Study|Withdrawn prior to Velcade|0|||
48871206|NCT02037256|157365852|FG001|Overall Study|Withdrawn prior to Velcade|2|||
48871207|NCT04599907|157365853|FG000|Overall Study|Withdrawal by Subject|1|||
48871208|NCT04599907|157365854|FG001|Overall Study|Withdrawal by Subject|7|||
48871209|NCT04599907|157365855|FG002|Overall Study|Withdrawal by Subject|6|||
48871210|NCT04599907|157365853|FG000|Overall Study|Lost to Follow-up|0|||
48871211|NCT04599907|157365854|FG001|Overall Study|Lost to Follow-up|1|||
48871212|NCT04599907|157365855|FG002|Overall Study|Lost to Follow-up|0|||
48871213|NCT02633397|157365856|FG000|Overall Study|Adverse Event|8|||
48871214|NCT02633397|157365857|FG001|Overall Study|Adverse Event|8|||
48871215|NCT02633397|157365856|FG000|Overall Study|Study Burden|4|||
48871216|NCT02633397|157365857|FG001|Overall Study|Study Burden|1|||
48968507|NCT03495453|157712560|FG001|Overall Study|Withdrawal by Subject|1|||
48968508|NCT00085917|157712561|FG000|Overall Study|Adverse Event|4|||
48871217|NCT02633397|157365856|FG000|Overall Study|Treatment interruption|2|||
48871218|NCT02633397|157365857|FG001|Overall Study|Treatment interruption|5|||
48871219|NCT02633397|157365856|FG000|Overall Study|Death|2|||
48871220|NCT02633397|157365857|FG001|Overall Study|Death|2|||
48871221|NCT02633397|157365856|FG000|Overall Study|Physician Decision|0|||
48968509|NCT00085917|157712562|FG001|Overall Study|Adverse Event|3|||
48968510|NCT00209170|157712563|FG000|Overall Study|Adverse Event|0|||
48968511|NCT00209170|157712564|FG001|Overall Study|Adverse Event|1|||
48968512|NCT00209170|157712563|FG000|Overall Study|Withdrawal by Subject|2|||
48968513|NCT00209170|157712564|FG001|Overall Study|Withdrawal by Subject|1|||
48968514|NCT00209170|157712563|FG000|Overall Study|Lack of Efficacy|0|||
48968515|NCT00209170|157712564|FG001|Overall Study|Lack of Efficacy|1|||
48968516|NCT02022033|157712565|FG000|Overall Study|Physician Decision|1|||
48968517|NCT02806947|157712566|FG000|Overall Study|Withdrawal by Subject|5|||
48968518|NCT02806947|157712567|FG001|Overall Study|Withdrawal by Subject|1|||
48968519|NCT00865189|157712568|FG000|Overall Study|Other|1|||
48968520|NCT00865189|157712569|FG001|Overall Study|Other|2|||
48968521|NCT00865189|157712568|FG000|Overall Study|Death|4|||
48968522|NCT00865189|157712569|FG001|Overall Study|Death|11|||
48968523|NCT00865189|157712568|FG000|Overall Study|Lost to Follow-up|6|||
48968524|NCT00865189|157712569|FG001|Overall Study|Lost to Follow-up|6|||
48968525|NCT00865189|157712568|FG000|Overall Study|Withdrawal by Subject|1|||
48968526|NCT00865189|157712569|FG001|Overall Study|Withdrawal by Subject|0|||
48968527|NCT02029638|157712577|FG000|Overall Study|Death|0|||
48968528|NCT02029638|157712578|FG001|Overall Study|Death|0|||
48968529|NCT02029638|157712579|FG002|Overall Study|Death|1|||
48968530|NCT02029638|157712577|FG000|Overall Study|Decision by Study Sponsor or Regulatory|2|||
48968531|NCT02029638|157712578|FG001|Overall Study|Decision by Study Sponsor or Regulatory|0|||
48968532|NCT02029638|157712579|FG002|Overall Study|Decision by Study Sponsor or Regulatory|0|||
48968533|NCT04176445|157712586|FG000|Overall Study|Adverse Event|0|||
48968534|NCT04176445|157712587|FG001|Overall Study|Adverse Event|1|||
48968535|NCT04176445|157712586|FG000|Overall Study|change plans weaning after first intervention|0|||
48968536|NCT04176445|157712587|FG001|Overall Study|change plans weaning after first intervention|1|||
48968537|NCT00187889|157712588|FG000|Overall Study|Withdrawal by Subject|6|||
48968538|NCT00187889|157712589|FG001|Overall Study|Withdrawal by Subject|4|||
48968539|NCT04046341|157712590|FG000|Overall Study|Lost to Follow-up|2|||
48968540|NCT04046341|157712590|FG000|Overall Study|Withdrawal by Subject|1|||
48968541|NCT02887859|157712597|FG000|Overall Study|Ongoing|6|||
48968542|NCT02887859|157712597|FG000|Overall Study|Adverse Event|7|||
48968543|NCT02887859|157712597|FG000|Overall Study|Death|1|||
48968544|NCT02887859|157712597|FG000|Overall Study|Physician Decision|1|||
48968545|NCT04377672|157712602|FG000|Overall Study|Participants was withdrawn from study due to false positive COVID-19 test|1|||
48968546|NCT03954444|157712603|FG000|Overall Study|Withdrawal by Subject|5|||
48968547|NCT03954444|157712604|FG001|Overall Study|Withdrawal by Subject|5|||
48968548|NCT03954444|157712605|FG002|Overall Study|Withdrawal by Subject|5|||
48968549|NCT03954444|157712603|FG000|Overall Study|Adverse Event|1|||
48968550|NCT03954444|157712604|FG001|Overall Study|Adverse Event|3|||
48968551|NCT03954444|157712605|FG002|Overall Study|Adverse Event|2|||
48968552|NCT03954444|157712603|FG000|Overall Study|Protocol Violation|0|||
48968553|NCT03954444|157712604|FG001|Overall Study|Protocol Violation|3|||
48968554|NCT03954444|157712605|FG002|Overall Study|Protocol Violation|5|||
48968555|NCT03954444|157712603|FG000|Overall Study|Use of prohibited therapy|1|||
48968556|NCT03954444|157712604|FG001|Overall Study|Use of prohibited therapy|1|||
48670806|NCT01659255|156648252|FG007|Overall Study|Death|1|||
48670807|NCT01659255|156648253|FG008|Overall Study|Death|1|||
48670808|NCT01659255|156648254|FG009|Overall Study|Death|0|||
48670809|NCT01659255|156648255|FG010|Overall Study|Death|0|||
48968557|NCT03954444|157712605|FG002|Overall Study|Use of prohibited therapy|2|||
48968558|NCT03954444|157712603|FG000|Overall Study|Lost to Follow-up|1|||
48968559|NCT03954444|157712604|FG001|Overall Study|Lost to Follow-up|0|||
48968560|NCT03954444|157712605|FG002|Overall Study|Lost to Follow-up|1|||
49015490|NCT01393990|157893786|FG016|Overall Study|Death|0|||
48670810|NCT01659255|156648256|FG011|Overall Study|Death|0|||
48670811|NCT01659255|156648257|FG012|Overall Study|Death|1|||
48670812|NCT01659255|156648258|FG013|Overall Study|Death|1|||
48670813|NCT01659255|156648259|FG014|Overall Study|Death|2|||
48670814|NCT01659255|156648260|FG015|Overall Study|Death|1|||
48670815|NCT01659255|156648261|FG016|Overall Study|Death|0|||
48670816|NCT01659255|156648245|FG000|Overall Study|Progressive Disease|2|||
48670817|NCT01659255|156648246|FG001|Overall Study|Progressive Disease|0|||
48670818|NCT01659255|156648247|FG002|Overall Study|Progressive Disease|0|||
48670819|NCT01659255|156648248|FG003|Overall Study|Progressive Disease|0|||
48670820|NCT01659255|156648249|FG004|Overall Study|Progressive Disease|0|||
48670821|NCT01659255|156648250|FG005|Overall Study|Progressive Disease|0|||
48670822|NCT01659255|156648251|FG006|Overall Study|Progressive Disease|0|||
48670823|NCT01659255|156648252|FG007|Overall Study|Progressive Disease|1|||
48670824|NCT01659255|156648253|FG008|Overall Study|Progressive Disease|0|||
48670825|NCT01659255|156648254|FG009|Overall Study|Progressive Disease|2|||
48670826|NCT01659255|156648255|FG010|Overall Study|Progressive Disease|2|||
48670827|NCT01659255|156648256|FG011|Overall Study|Progressive Disease|3|||
48670828|NCT01659255|156648257|FG012|Overall Study|Progressive Disease|5|||
48670829|NCT01659255|156648258|FG013|Overall Study|Progressive Disease|13|||
48670830|NCT01659255|156648259|FG014|Overall Study|Progressive Disease|6|||
48670831|NCT01659255|156648260|FG015|Overall Study|Progressive Disease|2|||
48670832|NCT01659255|156648261|FG016|Overall Study|Progressive Disease|3|||
48968561|NCT03954444|157712603|FG000|Overall Study|Non-compliant with study drug application|2|||
48968562|NCT03954444|157712604|FG001|Overall Study|Non-compliant with study drug application|2|||
48968563|NCT03954444|157712605|FG002|Overall Study|Non-compliant with study drug application|0|||
48968564|NCT03954444|157712603|FG000|Overall Study|Administrative reasons|0|||
48968565|NCT03954444|157712604|FG001|Overall Study|Administrative reasons|0|||
48968566|NCT03954444|157712605|FG002|Overall Study|Administrative reasons|1|||
48968567|NCT03954444|157712603|FG000|Overall Study|Miscellaneous|3|||
48968568|NCT03954444|157712604|FG001|Overall Study|Miscellaneous|2|||
48968569|NCT03954444|157712605|FG002|Overall Study|Miscellaneous|1|||
48968570|NCT02447458|157712612|FG000|Overall Study|Other|0|||
48968571|NCT02447458|157712613|FG001|Overall Study|Other|0|||
48968572|NCT02447458|157712614|FG002|Overall Study|Other|1|||
48968573|NCT02447458|157712615|FG003|Overall Study|Other|0|||
48968574|NCT02447458|157712616|FG004|Overall Study|Other|0|||
48968575|NCT02447458|157712617|FG005|Overall Study|Other|0|||
48968576|NCT00405652|157712618|FG000|Overall Study|Adverse Event|4|||
48968577|NCT02853032|157712619|FG000|Overall Study|Adverse Event|4|||
48968578|NCT02853032|157712620|FG001|Overall Study|Adverse Event|0|||
48871222|NCT02633397|157365857|FG001|Overall Study|Physician Decision|1|||
48871223|NCT03494985|157365858|FG000|Overall Study|Adverse Event|3|||
48871224|NCT03494985|157365859|FG001|Overall Study|Adverse Event|2|||
48871225|NCT03494985|157365860|FG002|Overall Study|Adverse Event|3|||
48871226|NCT03494985|157365861|FG003|Overall Study|Adverse Event|0|||
48871227|NCT03494985|157365858|FG000|Overall Study|Other (Withdrawal of consent)|2|||
48871228|NCT03494985|157365859|FG001|Overall Study|Other (Withdrawal of consent)|3|||
48871229|NCT03494985|157365860|FG002|Overall Study|Other (Withdrawal of consent)|2|||
48871230|NCT03494985|157365861|FG003|Overall Study|Other (Withdrawal of consent)|5|||
48871231|NCT03494985|157365858|FG000|Overall Study|Other (Not specified)|0|||
48871232|NCT03494985|157365859|FG001|Overall Study|Other (Not specified)|1|||
48968579|NCT02853032|157712619|FG000|Overall Study|Withdrawal by Subject|3|||
48968580|NCT02853032|157712620|FG001|Overall Study|Withdrawal by Subject|1|||
48968581|NCT02853032|157712619|FG000|Overall Study|Requested to withdraw from all treatment|2|||
48968582|NCT02853032|157712620|FG001|Overall Study|Requested to withdraw from all treatment|2|||
48968583|NCT03726333|157712629|FG000|Overall Study|Progressive Disease|0|||
48968584|NCT03726333|157712630|FG001|Overall Study|Progressive Disease|0|||
48968585|NCT03726333|157712631|FG002|Overall Study|Progressive Disease|1|||
48968586|NCT03726333|157712632|FG003|Overall Study|Progressive Disease|0|||
48968587|NCT03726333|157712633|FG004|Overall Study|Progressive Disease|0|||
48968588|NCT02565615|157712634|FG000|Overall Study|Death|0|||
48968589|NCT02565615|157712635|FG001|Overall Study|Death|1|||
48968590|NCT02565615|157712636|FG002|Overall Study|Death|0|||
48968591|NCT02565615|157712637|FG003|Overall Study|Death|0|||
48968592|NCT02565615|157712638|FG004|Overall Study|Death|4|||
48968593|NCT02565615|157712634|FG000|Overall Study|Not willing to participate in study|2|||
48968594|NCT02565615|157712635|FG001|Overall Study|Not willing to participate in study|21|||
48968595|NCT02565615|157712636|FG002|Overall Study|Not willing to participate in study|0|||
48968596|NCT02565615|157712637|FG003|Overall Study|Not willing to participate in study|1|||
48968597|NCT02565615|157712638|FG004|Overall Study|Not willing to participate in study|169|||
48968598|NCT02565615|157712634|FG000|Overall Study|Lost to Follow-up|0|||
48968599|NCT02565615|157712635|FG001|Overall Study|Lost to Follow-up|4|||
48968600|NCT02565615|157712636|FG002|Overall Study|Lost to Follow-up|0|||
48968601|NCT02565615|157712637|FG003|Overall Study|Lost to Follow-up|1|||
48968602|NCT02565615|157712638|FG004|Overall Study|Lost to Follow-up|765|||
48968603|NCT02565615|157712634|FG000|Overall Study|Not meeting eligibility criteria|0|||
48968604|NCT02565615|157712635|FG001|Overall Study|Not meeting eligibility criteria|7|||
48968605|NCT02565615|157712636|FG002|Overall Study|Not meeting eligibility criteria|0|||
48968606|NCT02565615|157712637|FG003|Overall Study|Not meeting eligibility criteria|0|||
48670833|NCT01659255|156648245|FG000|Overall Study|Withdrew Consent|0|||
48670834|NCT01659255|156648246|FG001|Overall Study|Withdrew Consent|0|||
48670835|NCT01659255|156648247|FG002|Overall Study|Withdrew Consent|0|||
48670836|NCT01659255|156648248|FG003|Overall Study|Withdrew Consent|0|||
48968607|NCT02565615|157712638|FG004|Overall Study|Not meeting eligibility criteria|25|||
48968608|NCT02565615|157712634|FG000|Overall Study|Reason not defined|0|||
48968609|NCT02565615|157712635|FG001|Overall Study|Reason not defined|2|||
48968610|NCT02565615|157712636|FG002|Overall Study|Reason not defined|0|||
48968611|NCT02565615|157712637|FG003|Overall Study|Reason not defined|1|||
48670837|NCT01659255|156648249|FG004|Overall Study|Withdrew Consent|0|||
48670838|NCT01659255|156648250|FG005|Overall Study|Withdrew Consent|0|||
48968612|NCT02565615|157712638|FG004|Overall Study|Reason not defined|62|||
48670839|NCT01659255|156648251|FG006|Overall Study|Withdrew Consent|0|||
48968613|NCT02565615|157712634|FG000|Overall Study|Adverse Event|1|||
48968614|NCT02565615|157712635|FG001|Overall Study|Adverse Event|1|||
48968615|NCT02565615|157712636|FG002|Overall Study|Adverse Event|0|||
48670840|NCT01659255|156648252|FG007|Overall Study|Withdrew Consent|0|||
48968616|NCT02565615|157712637|FG003|Overall Study|Adverse Event|0|||
48968617|NCT02565615|157712638|FG004|Overall Study|Adverse Event|9|||
48968618|NCT02565615|157712634|FG000|Overall Study|Untreated|0|||
48968619|NCT02565615|157712635|FG001|Overall Study|Untreated|0|||
48968620|NCT02565615|157712636|FG002|Overall Study|Untreated|0|||
48968621|NCT02565615|157712637|FG003|Overall Study|Untreated|0|||
48968622|NCT02565615|157712638|FG004|Overall Study|Untreated|567|||
48968623|NCT00788697|157712639|FG000|Overall Study|No study drug administered|12|||
48968624|NCT00788697|157712639|FG000|Overall Study|Training Patients|74|||
48968625|NCT00788697|157712639|FG000|Overall Study|no truth standard procedure available|5|||
48968626|NCT00788697|157712639|FG000|Overall Study|Technically inadequate truth standard|1|||
48968627|NCT00788697|157712639|FG000|Overall Study|Indeterminate diagnosis from truth stand|17|||
48968628|NCT01419080|157712640|FG000|Overall Study|Withdrawal by Subject|75|||
48968629|NCT01419080|157712640|FG000|Overall Study|Death|30|||
48968630|NCT01419080|157712640|FG000|Overall Study|Lost to Follow-up|23|||
48968631|NCT01419080|157712640|FG000|Overall Study|Too Ill|3|||
48968632|NCT01998880|157712641|FG000|Overall Study|Adverse Events or Intercurrent Illness|16|||
48968633|NCT01998880|157712642|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
48968634|NCT01998880|157712641|FG000|Overall Study|Disease Progression|1|||
48968635|NCT01998880|157712642|FG001|Overall Study|Disease Progression|8|||
48968636|NCT01998880|157712641|FG000|Overall Study|Withdrew Consent|2|||
48968637|NCT01998880|157712642|FG001|Overall Study|Withdrew Consent|1|||
48968638|NCT01998880|157712641|FG000|Overall Study|Death|3|||
48968639|NCT01998880|157712642|FG001|Overall Study|Death|6|||
48968640|NCT01998880|157712641|FG000|Overall Study|Insufficient Therapeutic Response|1|||
48968641|NCT01998880|157712642|FG001|Overall Study|Insufficient Therapeutic Response|5|||
48670841|NCT01659255|156648253|FG008|Overall Study|Withdrew Consent|0|||
48670842|NCT01659255|156648254|FG009|Overall Study|Withdrew Consent|0|||
48670843|NCT01659255|156648255|FG010|Overall Study|Withdrew Consent|1|||
48670844|NCT01659255|156648256|FG011|Overall Study|Withdrew Consent|0|||
48670845|NCT01659255|156648257|FG012|Overall Study|Withdrew Consent|0|||
48670846|NCT01659255|156648258|FG013|Overall Study|Withdrew Consent|1|||
48670847|NCT01659255|156648259|FG014|Overall Study|Withdrew Consent|0|||
48670848|NCT01659255|156648260|FG015|Overall Study|Withdrew Consent|0|||
48670849|NCT01659255|156648261|FG016|Overall Study|Withdrew Consent|0|||
48670850|NCT01659255|156648245|FG000|Overall Study|Investigator Decision|0|||
48670851|NCT01659255|156648246|FG001|Overall Study|Investigator Decision|0|||
48670852|NCT01659255|156648247|FG002|Overall Study|Investigator Decision|0|||
48670853|NCT01659255|156648248|FG003|Overall Study|Investigator Decision|0|||
48670854|NCT01659255|156648249|FG004|Overall Study|Investigator Decision|0|||
48670855|NCT01659255|156648250|FG005|Overall Study|Investigator Decision|0|||
48670856|NCT01659255|156648251|FG006|Overall Study|Investigator Decision|0|||
48670857|NCT01659255|156648252|FG007|Overall Study|Investigator Decision|0|||
48670858|NCT01659255|156648253|FG008|Overall Study|Investigator Decision|0|||
48670859|NCT01659255|156648254|FG009|Overall Study|Investigator Decision|0|||
48670860|NCT01659255|156648255|FG010|Overall Study|Investigator Decision|0|||
48670861|NCT01659255|156648256|FG011|Overall Study|Investigator Decision|0|||
48670862|NCT01659255|156648257|FG012|Overall Study|Investigator Decision|1|||
48670863|NCT01659255|156648258|FG013|Overall Study|Investigator Decision|1|||
48760527|NCT03720470|156972239|FG002|Treatment Period: Final 4 Weeks|Pregnancy|0|||
48968642|NCT01998880|157712641|FG000|Overall Study|Administrative/Other|1|||
48968643|NCT01998880|157712642|FG001|Overall Study|Administrative/Other|1|||
48968644|NCT01998880|157712641|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
48968645|NCT01998880|157712642|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
48968646|NCT01998880|157712641|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
48670864|NCT01659255|156648259|FG014|Overall Study|Investigator Decision|0|||
48760528|NCT03720470|156972240|FG003|Treatment Period: Final 4 Weeks|Pregnancy|0|||
48760529|NCT03720470|156972241|FG004|Treatment Period: Final 4 Weeks|Pregnancy|0|||
48760530|NCT03720470|156972242|FG005|Treatment Period: Final 4 Weeks|Pregnancy|1|||
48760531|NCT03720470|156972237|FG000|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
48760532|NCT03720470|156972238|FG001|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
48760533|NCT03720470|156972239|FG002|Treatment Period: Final 4 Weeks|Protocol Deviation|1|||
48760534|NCT03720470|156972240|FG003|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
48760535|NCT03720470|156972241|FG004|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
48760536|NCT03720470|156972242|FG005|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
48760537|NCT03720470|156972237|FG000|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
48760538|NCT03720470|156972238|FG001|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1|||
48760539|NCT03720470|156972239|FG002|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
48760540|NCT03720470|156972240|FG003|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
48968647|NCT01998880|157712642|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
48968648|NCT01998880|157712641|FG000|Overall Study|Did Not Receive Treatment|3|||
48968649|NCT01998880|157712642|FG001|Overall Study|Did Not Receive Treatment|2|||
48670865|NCT01659255|156648260|FG015|Overall Study|Investigator Decision|0|||
48670866|NCT01659255|156648261|FG016|Overall Study|Investigator Decision|0|||
48670867|NCT01659255|156648245|FG000|Overall Study|Sponsor's Decision|0|||
48670868|NCT01659255|156648246|FG001|Overall Study|Sponsor's Decision|0|||
48670869|NCT01659255|156648247|FG002|Overall Study|Sponsor's Decision|0|||
48968650|NCT00453180|157714599|FG000|Overall Study|Lost to Follow-up|2|||
48968651|NCT00453180|157714600|FG001|Overall Study|Lost to Follow-up|1|||
48760541|NCT03720470|156972241|FG004|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
48760542|NCT03720470|156972242|FG005|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
48760543|NCT03720470|156972237|FG000|Treatment Period: Final 4 Weeks|Other|0|||
48760544|NCT03720470|156972238|FG001|Treatment Period: Final 4 Weeks|Other|1|||
48760545|NCT03720470|156972239|FG002|Treatment Period: Final 4 Weeks|Other|0|||
48760546|NCT03720470|156972240|FG003|Treatment Period: Final 4 Weeks|Other|2|||
48760547|NCT03720470|156972241|FG004|Treatment Period: Final 4 Weeks|Other|1|||
48760548|NCT03720470|156972242|FG005|Treatment Period: Final 4 Weeks|Other|0|||
48760549|NCT01163279|156972244|FG000|Overall Study|Withdrawal by Subject|2|||
48760550|NCT01163279|156972245|FG001|Overall Study|Withdrawal by Subject|0|||
48760551|NCT02411292|156972246|FG000|Overall Study|Discharged before 3rd enoxaparin dose|16|||
48760552|NCT02411292|156972246|FG000|Overall Study|Death|2|||
48760553|NCT02411292|156972246|FG000|Overall Study|Lost to Follow-up|3|||
48760554|NCT02784821|156972247|FG000|Overall Study|Death|0|||
48968652|NCT00453180|157714599|FG000|Overall Study|Adverse Event|1|||
48968653|NCT00453180|157714600|FG001|Overall Study|Adverse Event|2|||
48968654|NCT01747811|157714601|FG000|Overall Study|Lack of Efficacy|2|||
48968655|NCT01747811|157714602|FG001|Overall Study|Lack of Efficacy|4|||
48968656|NCT00949910|157714604|FG000|Overall Study|Progressive Disease|3750|||
48968657|NCT00949910|157714604|FG000|Overall Study|Symptomatic Deterioration|1088|||
48968658|NCT00949910|157714604|FG000|Overall Study|Lost to Follow-up|100|||
48968659|NCT00949910|157714604|FG000|Overall Study|Study Drug-Related Adverse Event|315|||
48968660|NCT00949910|157714604|FG000|Overall Study|Participant Refusal|390|||
48968661|NCT00949910|157714604|FG000|Overall Study|Death Due to Malignant Disease|456|||
48968662|NCT00949910|157714604|FG000|Overall Study|Death Due to Progression/Deterioration|4|||
48968663|NCT00949910|157714604|FG000|Overall Study|Death Due to Adverse Event|115|||
48968664|NCT00949910|157714604|FG000|Overall Study|Death Due to Toxicity|3|||
48968665|NCT00949910|157714604|FG000|Overall Study|Death from Unknown Cause|5|||
48968666|NCT00949910|157714604|FG000|Overall Study|Unspecified Progression/Deterioration|13|||
48968667|NCT00949910|157714604|FG000|Overall Study|Switched to Compassionate/Other Use|174|||
48968668|NCT00949910|157714604|FG000|Overall Study|Switched to Commercial Treatment|4|||
48968669|NCT00949910|157714604|FG000|Overall Study|Violation of Eligibility|23|||
48968670|NCT00949910|157714604|FG000|Overall Study|Logistical Reasons|13|||
48968671|NCT00949910|157714604|FG000|Overall Study|Non-Compliance|10|||
48670870|NCT01659255|156648248|FG003|Overall Study|Sponsor's Decision|0|||
48968672|NCT00949910|157714604|FG000|Overall Study|Prolonged Dosing Interruption|4|||
48968673|NCT00949910|157714604|FG000|Overall Study|Adverse Event|83|||
48968674|NCT00949910|157714604|FG000|Overall Study|Serious Adverse Event|6|||
48968675|NCT00949910|157714604|FG000|Overall Study|Physician/Participant Decision|7|||
48968676|NCT00949910|157714604|FG000|Overall Study|Other|4|||
48968677|NCT00949910|157714604|FG000|Overall Study|No Data|9|||
48670871|NCT01659255|156648249|FG004|Overall Study|Sponsor's Decision|0|||
48670872|NCT01659255|156648250|FG005|Overall Study|Sponsor's Decision|0|||
48670873|NCT01659255|156648251|FG006|Overall Study|Sponsor's Decision|1|||
48670874|NCT01659255|156648252|FG007|Overall Study|Sponsor's Decision|0|||
48670875|NCT01659255|156648253|FG008|Overall Study|Sponsor's Decision|0|||
48670876|NCT01659255|156648254|FG009|Overall Study|Sponsor's Decision|0|||
48670877|NCT01659255|156648255|FG010|Overall Study|Sponsor's Decision|0|||
48670878|NCT01659255|156648256|FG011|Overall Study|Sponsor's Decision|0|||
48670879|NCT01659255|156648257|FG012|Overall Study|Sponsor's Decision|0|||
48670880|NCT01659255|156648258|FG013|Overall Study|Sponsor's Decision|0|||
48670881|NCT01659255|156648259|FG014|Overall Study|Sponsor's Decision|0|||
48670882|NCT01659255|156648260|FG015|Overall Study|Sponsor's Decision|0|||
48670883|NCT01659255|156648261|FG016|Overall Study|Sponsor's Decision|0|||
48670884|NCT01659255|156648245|FG000|Overall Study|Completed Treatment Per Protocol at the Time|0|||
48670885|NCT01659255|156648246|FG001|Overall Study|Completed Treatment Per Protocol at the Time|0|||
48670886|NCT01659255|156648247|FG002|Overall Study|Completed Treatment Per Protocol at the Time|0|||
48670887|NCT01659255|156648248|FG003|Overall Study|Completed Treatment Per Protocol at the Time|0|||
48670888|NCT01659255|156648249|FG004|Overall Study|Completed Treatment Per Protocol at the Time|0|||
48670889|NCT01659255|156648250|FG005|Overall Study|Completed Treatment Per Protocol at the Time|0|||
48670890|NCT01659255|156648251|FG006|Overall Study|Completed Treatment Per Protocol at the Time|0|||
48670891|NCT01659255|156648252|FG007|Overall Study|Completed Treatment Per Protocol at the Time|0|||
48670892|NCT01659255|156648253|FG008|Overall Study|Completed Treatment Per Protocol at the Time|0|||
48670893|NCT01659255|156648254|FG009|Overall Study|Completed Treatment Per Protocol at the Time|0|||
48670894|NCT01659255|156648255|FG010|Overall Study|Completed Treatment Per Protocol at the Time|0|||
48670895|NCT01659255|156648256|FG011|Overall Study|Completed Treatment Per Protocol at the Time|0|||
48670896|NCT01659255|156648257|FG012|Overall Study|Completed Treatment Per Protocol at the Time|0|||
48670897|NCT01659255|156648258|FG013|Overall Study|Completed Treatment Per Protocol at the Time|0|||
48670898|NCT01659255|156648259|FG014|Overall Study|Completed Treatment Per Protocol at the Time|0|||
48670899|NCT01659255|156648260|FG015|Overall Study|Completed Treatment Per Protocol at the Time|1|||
48760555|NCT02784821|156972248|FG001|Overall Study|Death|5|||
48760556|NCT02784821|156972249|FG002|Overall Study|Death|4|||
48760557|NCT02784821|156972250|FG003|Overall Study|Death|5|||
48670900|NCT01659255|156648261|FG016|Overall Study|Completed Treatment Per Protocol at the Time|0|||
48670901|NCT01659255|156648245|FG000|Overall Study|Participant Went on to Have an Allograft|0|||
48670902|NCT01659255|156648246|FG001|Overall Study|Participant Went on to Have an Allograft|0|||
48670903|NCT01659255|156648247|FG002|Overall Study|Participant Went on to Have an Allograft|0|||
48670904|NCT01659255|156648248|FG003|Overall Study|Participant Went on to Have an Allograft|0|||
48670905|NCT01659255|156648249|FG004|Overall Study|Participant Went on to Have an Allograft|0|||
48670906|NCT01659255|156648250|FG005|Overall Study|Participant Went on to Have an Allograft|0|||
48670907|NCT01659255|156648251|FG006|Overall Study|Participant Went on to Have an Allograft|0|||
48670908|NCT01659255|156648252|FG007|Overall Study|Participant Went on to Have an Allograft|0|||
48670909|NCT01659255|156648253|FG008|Overall Study|Participant Went on to Have an Allograft|0|||
48670910|NCT01659255|156648254|FG009|Overall Study|Participant Went on to Have an Allograft|0|||
48670911|NCT01659255|156648255|FG010|Overall Study|Participant Went on to Have an Allograft|0|||
48670912|NCT01659255|156648256|FG011|Overall Study|Participant Went on to Have an Allograft|0|||
48670913|NCT01659255|156648257|FG012|Overall Study|Participant Went on to Have an Allograft|1|||
48670914|NCT01659255|156648258|FG013|Overall Study|Participant Went on to Have an Allograft|0|||
48670915|NCT01659255|156648259|FG014|Overall Study|Participant Went on to Have an Allograft|0|||
48670916|NCT01659255|156648260|FG015|Overall Study|Participant Went on to Have an Allograft|0|||
48670917|NCT01659255|156648261|FG016|Overall Study|Participant Went on to Have an Allograft|0|||
48670918|NCT02006069|156648262|FG000|Overall Study|MPP other programming|239|||
48670919|NCT02006069|156648263|FG001|Overall Study|MPP other programming|0|||
48670920|NCT02006069|156648262|FG000|Overall Study|RV only pacing|0|||
48670921|NCT02006069|156648263|FG001|Overall Study|RV only pacing|3|||
48670922|NCT02989805|156648264|FG000|Overall Study|invalid consent|6|||
48670923|NCT02989805|156648265|FG001|Overall Study|invalid consent|4|||
48670924|NCT02760810|156648273|FG000|Overall Study|Protocol Violation|1|||
48670925|NCT01581619|156648274|FG000|Overall Study|Withdrawal by Subject|1|||
48670926|NCT01581619|156648274|FG000|Overall Study|Lost to Follow-up|1|||
48670927|NCT01639755|156648275|FG000|Overall Study|Study Ongoing|15|||
48670928|NCT01639755|156648275|FG000|Overall Study|Patient had device explantation|4|||
48670929|NCT03847909|156648277|FG000|Overall Study|Withdrawal by Subject|1|||
48670930|NCT03847909|156648278|FG001|Overall Study|Withdrawal by Subject|1|||
48670931|NCT03629912|156648279|FG000|Overall Study|Lost to Follow-up|19|||
48670932|NCT03629912|156648280|FG001|Overall Study|Lost to Follow-up|7|||
48670933|NCT03629912|156648281|FG002|Overall Study|Lost to Follow-up|5|||
48670934|NCT03629912|156648282|FG003|Overall Study|Lost to Follow-up|1|||
48670935|NCT03629912|156648279|FG000|Overall Study|Withdrawal by Subject|6|||
48670936|NCT03629912|156648280|FG001|Overall Study|Withdrawal by Subject|0|||
48670937|NCT03629912|156648281|FG002|Overall Study|Withdrawal by Subject|1|||
48670938|NCT03629912|156648282|FG003|Overall Study|Withdrawal by Subject|2|||
48670939|NCT03629912|156648279|FG000|Overall Study|Illness or Injury Unrelated to Research Study|3|||
48670940|NCT03629912|156648280|FG001|Overall Study|Illness or Injury Unrelated to Research Study|6|||
48670941|NCT03629912|156648281|FG002|Overall Study|Illness or Injury Unrelated to Research Study|3|||
48670942|NCT03629912|156648282|FG003|Overall Study|Illness or Injury Unrelated to Research Study|1|||
48760558|NCT02794103|156972251|FG000|Overall Study|Loss to follow up due to high sedation|3|||
48760559|NCT01881230|156972269|FG000|Overall Study|Death|2|||
48760560|NCT01881230|156972270|FG001|Overall Study|Death|0|||
48760561|NCT01881230|156972271|FG002|Overall Study|Death|1|||
48760562|NCT01881230|156972269|FG000|Overall Study|Adverse Event|9|||
48760563|NCT01881230|156972270|FG001|Overall Study|Adverse Event|13|||
48760564|NCT01881230|156972271|FG002|Overall Study|Adverse Event|12|||
48760565|NCT01881230|156972269|FG000|Overall Study|Progressive Disease|31|||
48760566|NCT01881230|156972270|FG001|Overall Study|Progressive Disease|35|||
48760567|NCT01881230|156972271|FG002|Overall Study|Progressive Disease|36|||
48760568|NCT01881230|156972269|FG000|Overall Study|Symptomatic Deterioration|3|||
48760569|NCT01881230|156972270|FG001|Overall Study|Symptomatic Deterioration|3|||
48760570|NCT01881230|156972271|FG002|Overall Study|Symptomatic Deterioration|1|||
48760571|NCT01881230|156972269|FG000|Overall Study|Withdrawal by Subject|6|||
48760572|NCT01881230|156972270|FG001|Overall Study|Withdrawal by Subject|4|||
48760573|NCT01881230|156972271|FG002|Overall Study|Withdrawal by Subject|6|||
48760574|NCT01881230|156972269|FG000|Overall Study|Physician Decision|4|||
48670943|NCT03629912|156648279|FG000|Overall Study|Death|1|||
48670944|NCT03629912|156648280|FG001|Overall Study|Death|0|||
48670945|NCT03629912|156648281|FG002|Overall Study|Death|0|||
48760575|NCT01881230|156972270|FG001|Overall Study|Physician Decision|3|||
48670946|NCT03629912|156648282|FG003|Overall Study|Death|0|||
48670947|NCT00869401|156648283|FG000|Overall Study|Withdrawal by Subject|0|||
48670948|NCT00869401|156648284|FG001|Overall Study|Withdrawal by Subject|0|||
48760576|NCT01881230|156972271|FG002|Overall Study|Physician Decision|6|||
48670949|NCT00869401|156648285|FG002|Overall Study|Withdrawal by Subject|0|||
48670950|NCT00869401|156648286|FG003|Overall Study|Withdrawal by Subject|5|||
48760577|NCT01881230|156972269|FG000|Overall Study|Non-Compliance with Study Drug|1|||
48968678|NCT03097614|157714615|FG000|Overall Study|Adverse Event|3|||
48760578|NCT01881230|156972270|FG001|Overall Study|Non-Compliance with Study Drug|2|||
48760579|NCT01881230|156972271|FG002|Overall Study|Non-Compliance with Study Drug|0|||
48968679|NCT01830816|157714619|FG000|Overall Study|Progressive Disease|12|||
48968680|NCT01830816|157714620|FG001|Overall Study|Progressive Disease|7|||
48968681|NCT01830816|157714621|FG002|Overall Study|Progressive Disease|7|||
48968682|NCT01830816|157714619|FG000|Overall Study|Adverse Event|3|||
48968683|NCT01830816|157714620|FG001|Overall Study|Adverse Event|4|||
48968684|NCT01830816|157714621|FG002|Overall Study|Adverse Event|0|||
48968685|NCT01830816|157714619|FG000|Overall Study|Study Terminated by Sponsor|1|||
48968686|NCT01830816|157714620|FG001|Overall Study|Study Terminated by Sponsor|1|||
48968687|NCT01830816|157714621|FG002|Overall Study|Study Terminated by Sponsor|0|||
48968688|NCT01830816|157714619|FG000|Overall Study|Withdrawal by Subject|1|||
48968689|NCT01830816|157714620|FG001|Overall Study|Withdrawal by Subject|1|||
48968690|NCT01830816|157714621|FG002|Overall Study|Withdrawal by Subject|0|||
48968691|NCT01830816|157714619|FG000|Overall Study|Lost to Follow-up|0|||
48968692|NCT01830816|157714620|FG001|Overall Study|Lost to Follow-up|1|||
48968693|NCT01830816|157714621|FG002|Overall Study|Lost to Follow-up|0|||
48968694|NCT01830816|157714619|FG000|Overall Study|Symptomatic Deterioration|1|||
48968695|NCT01830816|157714620|FG001|Overall Study|Symptomatic Deterioration|0|||
48968696|NCT01830816|157714621|FG002|Overall Study|Symptomatic Deterioration|0|||
48968697|NCT01830816|157714619|FG000|Overall Study|Reason not Specified|2|||
48968698|NCT01830816|157714620|FG001|Overall Study|Reason not Specified|0|||
48968699|NCT01830816|157714621|FG002|Overall Study|Reason not Specified|0|||
48968700|NCT03172481|157714622|FG000|Double-blind|Withdrawal by Subject|1|||
48968701|NCT03172481|157714623|FG001|Double-blind|Withdrawal by Subject|0|||
48968702|NCT01281189|157714637|FG000|Overall Study|Adverse Event|7|||
48968703|NCT01281189|157714638|FG001|Overall Study|Adverse Event|9|||
48968704|NCT01281189|157714637|FG000|Overall Study|Lost to Follow-up|6|||
48968705|NCT01281189|157714638|FG001|Overall Study|Lost to Follow-up|4|||
48968706|NCT01281189|157714637|FG000|Overall Study|Withdrawal by Subject|21|||
48968707|NCT01281189|157714638|FG001|Overall Study|Withdrawal by Subject|24|||
48968708|NCT01281189|157714637|FG000|Overall Study|Physician Decision|2|||
48968709|NCT01281189|157714638|FG001|Overall Study|Physician Decision|3|||
48968710|NCT01281189|157714637|FG000|Overall Study|Death|103|||
48968711|NCT01281189|157714638|FG001|Overall Study|Death|91|||
48968712|NCT01281189|157714637|FG000|Overall Study|Other|8|||
48968713|NCT01281189|157714638|FG001|Overall Study|Other|12|||
48968714|NCT01563107|157714639|FG000|Overall Study|Physician Decision|0|||
48968715|NCT01563107|157714640|FG001|Overall Study|Physician Decision|1|||
48968716|NCT01563107|157714641|FG002|Overall Study|Physician Decision|1|||
48968717|NCT01563107|157714642|FG003|Overall Study|Physician Decision|3|||
48968718|NCT01563107|157714639|FG000|Overall Study|Withdrawal by Subject|1|||
48968719|NCT01563107|157714640|FG001|Overall Study|Withdrawal by Subject|2|||
48968720|NCT01563107|157714641|FG002|Overall Study|Withdrawal by Subject|1|||
48968721|NCT01563107|157714642|FG003|Overall Study|Withdrawal by Subject|2|||
48968722|NCT01019252|157714647|FG000|Initial CBT for ADHD vs. Wait List|Time constraints|2|||
48968723|NCT01019252|157714648|FG001|Initial CBT for ADHD vs. Wait List|Time constraints|0|||
48968724|NCT01019252|157714647|FG000|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1|||
48968725|NCT01019252|157714648|FG001|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0|||
48968726|NCT01019252|157714647|FG000|Wait List Cross-over to CBT for ADHD|Time constraints|0|||
48968727|NCT01019252|157714648|FG001|Wait List Cross-over to CBT for ADHD|Time constraints|2|||
48968728|NCT01019252|157714647|FG000|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0|||
48968729|NCT01019252|157714648|FG001|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5|||
48968730|NCT02514772|157714649|FG000|Overall Study|Adverse Event|1|||
48968731|NCT02514772|157714650|FG001|Overall Study|Adverse Event|0|||
48968732|NCT02514772|157714649|FG000|Overall Study|Death|0|||
48968733|NCT02514772|157714650|FG001|Overall Study|Death|1|||
48968734|NCT02514772|157714649|FG000|Overall Study|Withdrawal by Subject|2|||
48968735|NCT02514772|157714650|FG001|Overall Study|Withdrawal by Subject|1|||
48968736|NCT03024255|157714651|FG000|Overall Study|Adverse Event|1|||
48968737|NCT03024255|157714652|FG001|Overall Study|Adverse Event|4|||
48968738|NCT03024255|157714653|FG002|Overall Study|Adverse Event|8|||
48968739|NCT03024255|157714654|FG003|Overall Study|Adverse Event|0|||
48968740|NCT03024255|157714651|FG000|Overall Study|Withdrawal by Subject|3|||
48968741|NCT03024255|157714652|FG001|Overall Study|Withdrawal by Subject|1|||
48968742|NCT03024255|157714653|FG002|Overall Study|Withdrawal by Subject|0|||
48968743|NCT03024255|157714654|FG003|Overall Study|Withdrawal by Subject|3|||
48968744|NCT03024255|157714651|FG000|Overall Study|Protocol Violation|0|||
48968745|NCT03024255|157714652|FG001|Overall Study|Protocol Violation|0|||
48968746|NCT03024255|157714653|FG002|Overall Study|Protocol Violation|2|||
48968747|NCT03024255|157714654|FG003|Overall Study|Protocol Violation|0|||
48968748|NCT03024255|157714651|FG000|Overall Study|Lost to Follow-up|1|||
48968749|NCT03024255|157714652|FG001|Overall Study|Lost to Follow-up|2|||
48968750|NCT03024255|157714653|FG002|Overall Study|Lost to Follow-up|1|||
48968751|NCT03024255|157714654|FG003|Overall Study|Lost to Follow-up|1|||
48670951|NCT00869401|156648287|FG004|Overall Study|Withdrawal by Subject|3|||
48968752|NCT03024255|157714651|FG000|Overall Study|Lack of Efficacy|1|||
48968753|NCT03024255|157714652|FG001|Overall Study|Lack of Efficacy|0|||
48968754|NCT03024255|157714653|FG002|Overall Study|Lack of Efficacy|0|||
48968755|NCT03024255|157714654|FG003|Overall Study|Lack of Efficacy|0|||
48968756|NCT03024255|157714651|FG000|Overall Study|Protocol Noncompliance|1|||
48968757|NCT03024255|157714652|FG001|Overall Study|Protocol Noncompliance|1|||
48968758|NCT03024255|157714653|FG002|Overall Study|Protocol Noncompliance|0|||
48968759|NCT03024255|157714654|FG003|Overall Study|Protocol Noncompliance|1|||
48968760|NCT02685995|157714655|FG000|Overall Study|Insertion of immediately puncturable graft.|1|||
48968761|NCT02685995|157714656|FG001|Overall Study|Insertion of immediately puncturable graft.|1|||
48968762|NCT03625141|157714657|FG000|Overall Study|Adverse Event|0|||
48968763|NCT03625141|157714658|FG001|Overall Study|Adverse Event|2|||
48968764|NCT03625141|157714657|FG000|Overall Study|Study Terminated By Sponsor|1|||
48968765|NCT03625141|157714658|FG001|Overall Study|Study Terminated By Sponsor|13|||
48968766|NCT03625141|157714657|FG000|Overall Study|Withdrawal by Subject|3|||
48968767|NCT03625141|157714658|FG001|Overall Study|Withdrawal by Subject|0|||
48968768|NCT03625141|157714657|FG000|Overall Study|Withdrawal Of Consent|0|||
48968769|NCT03625141|157714658|FG001|Overall Study|Withdrawal Of Consent|1|||
48968770|NCT03625141|157714657|FG000|Overall Study|Death|11|||
48968771|NCT03625141|157714658|FG001|Overall Study|Death|47|||
48968772|NCT03625141|157714657|FG000|Overall Study|Progressive Disease|0|||
48968773|NCT03625141|157714658|FG001|Overall Study|Progressive Disease|2|||
48968774|NCT01188096|157714659|FG000|Overall Study|progression of disease|4|||
48968775|NCT01188096|157714659|FG000|Overall Study|Withdrawal by Subject|2|||
48968776|NCT02680587|157714663|FG000|Overall Study|Withdrawal by Subject|1|||
48968777|NCT02680587|157714664|FG001|Overall Study|Withdrawal by Subject|0|||
48968778|NCT04209530|157714665|FG000|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4|||
48968779|NCT04209530|157714666|FG001|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2|||
48968780|NCT04209530|157714665|FG000|Overall Study|Withdrawal by Subject|0|||
48968781|NCT04209530|157714666|FG001|Overall Study|Withdrawal by Subject|1|||
48968782|NCT01188538|157714667|FG000|Overall Study|Lost to Follow-up|0|||
48968783|NCT01188538|157714668|FG001|Overall Study|Lost to Follow-up|1|||
48968784|NCT04154943|157714669|FG000|Overall Study|Study Ongoing|68|||
48968785|NCT04154943|157714669|FG000|Overall Study|Lost to Follow-up|1|||
48968786|NCT04154943|157714669|FG000|Overall Study|Decision by the Investigator|1|||
48968787|NCT04154943|157714669|FG000|Overall Study|Death|5|||
48968788|NCT04154943|157714669|FG000|Overall Study|Withdrawal by Subject|4|||
48968789|NCT00118911|157714670|FG000|Overall Study|Withdrawal by Subject|2|||
48968790|NCT00118911|157714671|FG001|Overall Study|Withdrawal by Subject|5|||
48968791|NCT02980692|157714672|FG000|Double Blind Placebo Controlled Period|Adverse Event|1|||
48968792|NCT02980692|157714673|FG001|Double Blind Placebo Controlled Period|Adverse Event|2|||
48968793|NCT02980692|157714674|FG002|Double Blind Placebo Controlled Period|Adverse Event|1|||
48968794|NCT02980692|157714675|FG003|Double Blind Placebo Controlled Period|Adverse Event|2|||
48968795|NCT02980692|157714676|FG004|Double Blind Placebo Controlled Period|Adverse Event|0|||
48968796|NCT02980692|157714672|FG000|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
48968797|NCT02980692|157714673|FG001|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
48968798|NCT02980692|157714674|FG002|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
48968799|NCT02980692|157714675|FG003|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
48968800|NCT02980692|157714676|FG004|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
48968801|NCT02980692|157714672|FG000|Double Blind Placebo Controlled Period|Investigator Decision|0|||
48968802|NCT02980692|157714673|FG001|Double Blind Placebo Controlled Period|Investigator Decision|0|||
48968803|NCT02980692|157714674|FG002|Double Blind Placebo Controlled Period|Investigator Decision|0|||
48968804|NCT02980692|157714675|FG003|Double Blind Placebo Controlled Period|Investigator Decision|2|||
48968805|NCT02980692|157714676|FG004|Double Blind Placebo Controlled Period|Investigator Decision|0|||
48968806|NCT02980692|157714672|FG000|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
48968807|NCT02980692|157714673|FG001|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
48968808|NCT02980692|157714674|FG002|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
48968809|NCT02980692|157714675|FG003|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
48968810|NCT02980692|157714676|FG004|Double Blind Placebo Controlled Period|Withdrawal by Subject|4|||
48968811|NCT02980692|157714672|FG000|Double Blind Placebo Controlled Period|Protocol Violation|2|||
48968812|NCT02980692|157714673|FG001|Double Blind Placebo Controlled Period|Protocol Violation|0|||
48968813|NCT02980692|157714674|FG002|Double Blind Placebo Controlled Period|Protocol Violation|1|||
48968814|NCT02980692|157714675|FG003|Double Blind Placebo Controlled Period|Protocol Violation|0|||
48968815|NCT02980692|157714676|FG004|Double Blind Placebo Controlled Period|Protocol Violation|0|||
48670952|NCT02175368|156648288|FG000|Overall Study|Lost to Follow-up|1|||
48670953|NCT00903331|156648289|FG000|Overall Study|Death|4|||
48670954|NCT00903331|156648290|FG001|Overall Study|Death|8|||
48670955|NCT00903331|156648289|FG000|Overall Study|Withdrawal of consent|1|||
48968816|NCT02980692|157714672|FG000|Double Blind Placebo Controlled Period|Other|1|||
48968817|NCT02980692|157714673|FG001|Double Blind Placebo Controlled Period|Other|0|||
48968818|NCT02980692|157714674|FG002|Double Blind Placebo Controlled Period|Other|0|||
49015491|NCT01393990|157893787|FG017|Overall Study|Death|0|||
48670956|NCT00903331|156648290|FG001|Overall Study|Withdrawal of consent|8|||
48968819|NCT02980692|157714675|FG003|Double Blind Placebo Controlled Period|Other|0|||
48968820|NCT02980692|157714676|FG004|Double Blind Placebo Controlled Period|Other|1|||
48968821|NCT02980692|157714672|FG000|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|9|||
48968822|NCT02980692|157714673|FG001|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|12|||
48968823|NCT02980692|157714674|FG002|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|13|||
48968824|NCT02980692|157714675|FG003|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
48968825|NCT02980692|157714676|FG004|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
48968826|NCT02980692|157714672|FG000|Double-blind Follow-up Period|Adverse Event|0|||
48968827|NCT02980692|157714673|FG001|Double-blind Follow-up Period|Adverse Event|0|||
48968828|NCT02980692|157714674|FG002|Double-blind Follow-up Period|Adverse Event|0|||
48968829|NCT02980692|157714675|FG003|Double-blind Follow-up Period|Adverse Event|1|||
48968830|NCT02980692|157714676|FG004|Double-blind Follow-up Period|Adverse Event|1|||
48968831|NCT02980692|157714672|FG000|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
48968832|NCT02980692|157714673|FG001|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|2|||
48968833|NCT02980692|157714674|FG002|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|1|||
48968834|NCT02980692|157714675|FG003|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
48968835|NCT02980692|157714676|FG004|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
48968836|NCT02980692|157714672|FG000|Double-blind Follow-up Period|Lost to Follow-up|0|||
48968837|NCT02980692|157714673|FG001|Double-blind Follow-up Period|Lost to Follow-up|0|||
48968838|NCT02980692|157714674|FG002|Double-blind Follow-up Period|Lost to Follow-up|1|||
48968839|NCT02980692|157714675|FG003|Double-blind Follow-up Period|Lost to Follow-up|0|||
48968840|NCT02980692|157714676|FG004|Double-blind Follow-up Period|Lost to Follow-up|0|||
48968841|NCT02980692|157714672|FG000|Double-blind Follow-up Period|Pregnancy|0|||
48968842|NCT02980692|157714673|FG001|Double-blind Follow-up Period|Pregnancy|0|||
48968843|NCT02980692|157714674|FG002|Double-blind Follow-up Period|Pregnancy|1|||
48968844|NCT02980692|157714675|FG003|Double-blind Follow-up Period|Pregnancy|1|||
48968845|NCT02980692|157714676|FG004|Double-blind Follow-up Period|Pregnancy|0|||
48968846|NCT02980692|157714672|FG000|Double-blind Follow-up Period|Withdrawal by Subject|0|||
48968847|NCT02980692|157714673|FG001|Double-blind Follow-up Period|Withdrawal by Subject|1|||
48968848|NCT02980692|157714674|FG002|Double-blind Follow-up Period|Withdrawal by Subject|0|||
48968849|NCT02980692|157714675|FG003|Double-blind Follow-up Period|Withdrawal by Subject|1|||
48968850|NCT02980692|157714676|FG004|Double-blind Follow-up Period|Withdrawal by Subject|1|||
48968851|NCT02980692|157714672|FG000|Double-blind Follow-up Period|Other|0|||
48968852|NCT02980692|157714673|FG001|Double-blind Follow-up Period|Other|0|||
48968853|NCT02980692|157714674|FG002|Double-blind Follow-up Period|Other|1|||
48968854|NCT02980692|157714675|FG003|Double-blind Follow-up Period|Other|1|||
48968855|NCT02980692|157714676|FG004|Double-blind Follow-up Period|Other|3|||
48968856|NCT00792701|157714677|FG000|Overall Study|Adverse Event|0|||
48670957|NCT00903331|156648289|FG000|Overall Study|Lung transplant|0|||
48670958|NCT00903331|156648290|FG001|Overall Study|Lung transplant|2|||
48670959|NCT00249613|156648291|FG000|12 Month Follow-up|Death|1|||
48670960|NCT00249613|156648292|FG001|12 Month Follow-up|Death|1|||
48670961|NCT00249613|156648291|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
48670962|NCT00249613|156648292|FG001|12 Month Follow-up|Withdrawal by Subject|6|||
48670963|NCT00249613|156648291|FG000|12 Month Follow-up|Lost to Follow-up|10|||
48670964|NCT00249613|156648292|FG001|12 Month Follow-up|Lost to Follow-up|8|||
48670965|NCT02437084|156648293|FG000|Overall Study|Withdrawal by Subject|2|||
48670966|NCT02437084|156648293|FG000|Overall Study|Physician Decision|1|||
48670967|NCT00884832|156648294|FG000|Overall Study|Withdrawal by Subject|0|||
48670968|NCT00884832|156648295|FG001|Overall Study|Withdrawal by Subject|1|||
48670969|NCT01571453|156648296|FG000|Overall Study|Adverse Event|14|||
48670970|NCT01571453|156648297|FG001|Overall Study|Adverse Event|32|||
48670971|NCT01571453|156648296|FG000|Overall Study|Lack of Efficacy|8|||
48670972|NCT01571453|156648297|FG001|Overall Study|Lack of Efficacy|3|||
48670973|NCT01571453|156648296|FG000|Overall Study|Non-compliance|2|||
48670974|NCT01571453|156648297|FG001|Overall Study|Non-compliance|4|||
48670975|NCT01571453|156648296|FG000|Overall Study|Protocol Violation|1|||
48670976|NCT01571453|156648297|FG001|Overall Study|Protocol Violation|5|||
48670977|NCT01571453|156648296|FG000|Overall Study|Withdrawal of consent|5|||
48670978|NCT01571453|156648297|FG001|Overall Study|Withdrawal of consent|13|||
48968857|NCT00792701|157714678|FG001|Overall Study|Adverse Event|22|||
48968858|NCT00792701|157714677|FG000|Overall Study|Ineligible|1|||
48968859|NCT00792701|157714678|FG001|Overall Study|Ineligible|3|||
48968860|NCT00792701|157714677|FG000|Overall Study|Withdrawal by Subject|1|||
48968861|NCT00792701|157714678|FG001|Overall Study|Withdrawal by Subject|19|||
48968862|NCT00792701|157714677|FG000|Overall Study|Not protocol specified|17|||
48968863|NCT00792701|157714678|FG001|Overall Study|Not protocol specified|0|||
48968864|NCT01153841|157714681|FG000|Overall Study|Adverse Event|1|||
48968865|NCT01153841|157714682|FG001|Overall Study|Adverse Event|0|||
48968866|NCT01153841|157714681|FG000|Overall Study|Withdrawal by Subject|1|||
48968867|NCT01153841|157714682|FG001|Overall Study|Withdrawal by Subject|0|||
48968868|NCT01153841|157714681|FG000|Overall Study|Protocol Violation|2|||
48968869|NCT01153841|157714682|FG001|Overall Study|Protocol Violation|0|||
48968870|NCT01153841|157714681|FG000|Overall Study|Lost to Follow-up|2|||
48968871|NCT01153841|157714682|FG001|Overall Study|Lost to Follow-up|0|||
48968872|NCT00691093|157714685|FG000|Overall Study|Adverse Event|1|||
48968873|NCT00691093|157714685|FG000|Overall Study|Lost to Follow-up|1|||
48968874|NCT00691093|157714685|FG000|Overall Study|Lack of Efficacy|1|||
48968875|NCT00691093|157714685|FG000|Overall Study|Ongoing at Date of Cut-Off|4|||
48968876|NCT01335698|157714695|FG000|Treatment Stage 1|Lack of Efficacy|3|||
48968877|NCT01335698|157714696|FG001|Treatment Stage 1|Lack of Efficacy|1|||
48968878|NCT01335698|157714697|FG002|Treatment Stage 1|Lack of Efficacy|3|||
48968879|NCT01335698|157714698|FG003|Treatment Stage 1|Lack of Efficacy|3|||
48968880|NCT01335698|157714699|FG004|Treatment Stage 1|Lack of Efficacy|1|||
48968881|NCT01335698|157714695|FG000|Treatment Stage 1|Adverse Event|1|||
48968882|NCT01335698|157714696|FG001|Treatment Stage 1|Adverse Event|2|||
48968883|NCT01335698|157714697|FG002|Treatment Stage 1|Adverse Event|2|||
48968884|NCT01335698|157714698|FG003|Treatment Stage 1|Adverse Event|1|||
48968885|NCT01335698|157714699|FG004|Treatment Stage 1|Adverse Event|1|||
48968886|NCT01335698|157714695|FG000|Treatment Stage 1|Withdrawal by Subject|1|||
48968887|NCT01335698|157714696|FG001|Treatment Stage 1|Withdrawal by Subject|2|||
48968888|NCT01335698|157714697|FG002|Treatment Stage 1|Withdrawal by Subject|0|||
48968889|NCT01335698|157714698|FG003|Treatment Stage 1|Withdrawal by Subject|1|||
48968890|NCT01335698|157714699|FG004|Treatment Stage 1|Withdrawal by Subject|0|||
48968891|NCT01335698|157714695|FG000|Treatment Stage 1|Lost to Follow-up|1|||
48968892|NCT01335698|157714696|FG001|Treatment Stage 1|Lost to Follow-up|1|||
48968893|NCT01335698|157714697|FG002|Treatment Stage 1|Lost to Follow-up|0|||
48968894|NCT01335698|157714698|FG003|Treatment Stage 1|Lost to Follow-up|0|||
48968895|NCT01335698|157714699|FG004|Treatment Stage 1|Lost to Follow-up|0|||
48968896|NCT01335698|157714695|FG000|Treatment Stage 1|Poor compliance/noncompliance|0|||
48968897|NCT01335698|157714696|FG001|Treatment Stage 1|Poor compliance/noncompliance|1|||
48968898|NCT01335698|157714697|FG002|Treatment Stage 1|Poor compliance/noncompliance|0|||
48968899|NCT01335698|157714698|FG003|Treatment Stage 1|Poor compliance/noncompliance|2|||
48968900|NCT01335698|157714699|FG004|Treatment Stage 1|Poor compliance/noncompliance|0|||
48968901|NCT01335698|157714695|FG000|Treatment Stage 1|No longer meets study criteria|1|||
48968902|NCT01335698|157714696|FG001|Treatment Stage 1|No longer meets study criteria|1|||
48968903|NCT01335698|157714697|FG002|Treatment Stage 1|No longer meets study criteria|0|||
48968904|NCT01335698|157714698|FG003|Treatment Stage 1|No longer meets study criteria|1|||
48968905|NCT01335698|157714699|FG004|Treatment Stage 1|No longer meets study criteria|0|||
48968906|NCT01335698|157714695|FG000|Treatment Stage 1|Other|1|||
48968907|NCT01335698|157714696|FG001|Treatment Stage 1|Other|0|||
48968908|NCT01335698|157714697|FG002|Treatment Stage 1|Other|0|||
48968909|NCT01335698|157714698|FG003|Treatment Stage 1|Other|1|||
48968910|NCT01335698|157714699|FG004|Treatment Stage 1|Other|0|||
48968911|NCT01335698|157714695|FG000|Treatment Stage 2|Lack of Efficacy|2|||
48968912|NCT01335698|157714696|FG001|Treatment Stage 2|Lack of Efficacy|1|||
48968913|NCT01335698|157714697|FG002|Treatment Stage 2|Lack of Efficacy|3|||
48968914|NCT01335698|157714698|FG003|Treatment Stage 2|Lack of Efficacy|1|||
48968915|NCT01335698|157714699|FG004|Treatment Stage 2|Lack of Efficacy|0|||
48968916|NCT01335698|157714695|FG000|Treatment Stage 2|Adverse Event|2|||
48968917|NCT01335698|157714696|FG001|Treatment Stage 2|Adverse Event|0|||
48968918|NCT01335698|157714697|FG002|Treatment Stage 2|Adverse Event|0|||
48968919|NCT01335698|157714698|FG003|Treatment Stage 2|Adverse Event|3|||
48968920|NCT01335698|157714699|FG004|Treatment Stage 2|Adverse Event|0|||
48968921|NCT01335698|157714695|FG000|Treatment Stage 2|Withdrawal by Subject|3|||
48968922|NCT01335698|157714696|FG001|Treatment Stage 2|Withdrawal by Subject|1|||
48968923|NCT01335698|157714697|FG002|Treatment Stage 2|Withdrawal by Subject|1|||
48968924|NCT01335698|157714698|FG003|Treatment Stage 2|Withdrawal by Subject|0|||
48968925|NCT01335698|157714699|FG004|Treatment Stage 2|Withdrawal by Subject|0|||
48968926|NCT01335698|157714695|FG000|Treatment Stage 2|Poor compliance/noncompliance|1|||
48968927|NCT01335698|157714696|FG001|Treatment Stage 2|Poor compliance/noncompliance|0|||
48968928|NCT01335698|157714697|FG002|Treatment Stage 2|Poor compliance/noncompliance|1|||
48968929|NCT01335698|157714698|FG003|Treatment Stage 2|Poor compliance/noncompliance|3|||
48968930|NCT01335698|157714699|FG004|Treatment Stage 2|Poor compliance/noncompliance|1|||
48968931|NCT01335698|157714695|FG000|Treatment Stage 2|Lost to Follow-up|1|||
48968932|NCT01335698|157714696|FG001|Treatment Stage 2|Lost to Follow-up|0|||
48968933|NCT01335698|157714697|FG002|Treatment Stage 2|Lost to Follow-up|0|||
48968934|NCT01335698|157714698|FG003|Treatment Stage 2|Lost to Follow-up|0|||
48968935|NCT01335698|157714699|FG004|Treatment Stage 2|Lost to Follow-up|0|||
48968936|NCT01335698|157714695|FG000|Treatment Stage 2|Capsules received at state hospital|1|||
48968937|NCT01335698|157714696|FG001|Treatment Stage 2|Capsules received at state hospital|0|||
48968938|NCT01335698|157714697|FG002|Treatment Stage 2|Capsules received at state hospital|0|||
48968939|NCT01335698|157714698|FG003|Treatment Stage 2|Capsules received at state hospital|0|||
48760580|NCT01881230|156972269|FG000|Overall Study|Given Commercially Available Drug|0|||
48760581|NCT01881230|156972270|FG001|Overall Study|Given Commercially Available Drug|0|||
48760582|NCT01881230|156972271|FG002|Overall Study|Given Commercially Available Drug|2|||
48760583|NCT01881230|156972269|FG000|Overall Study|Protocol Violation|1|||
48760584|NCT01881230|156972270|FG001|Overall Study|Protocol Violation|1|||
48760585|NCT01881230|156972271|FG002|Overall Study|Protocol Violation|0|||
48760586|NCT01881230|156972269|FG000|Overall Study|Miscellaneous|3|||
48760587|NCT01881230|156972270|FG001|Overall Study|Miscellaneous|3|||
48760588|NCT01881230|156972271|FG002|Overall Study|Miscellaneous|0|||
48760589|NCT01881230|156972269|FG000|Overall Study|Untreated: Other|0|||
48968940|NCT01335698|157714699|FG004|Treatment Stage 2|Capsules received at state hospital|0|||
48968941|NCT01335698|157714695|FG000|Treatment Stage 2|Subject no longer meets study criteria|0|||
48968942|NCT01335698|157714696|FG001|Treatment Stage 2|Subject no longer meets study criteria|0|||
48968943|NCT01335698|157714697|FG002|Treatment Stage 2|Subject no longer meets study criteria|0|||
48968944|NCT01335698|157714698|FG003|Treatment Stage 2|Subject no longer meets study criteria|1|||
48968945|NCT01335698|157714699|FG004|Treatment Stage 2|Subject no longer meets study criteria|0|||
48968946|NCT01335698|157714695|FG000|Treatment Stage 2|Switched to another formulation|1|||
48968947|NCT01335698|157714696|FG001|Treatment Stage 2|Switched to another formulation|1|||
48968948|NCT01335698|157714697|FG002|Treatment Stage 2|Switched to another formulation|0|||
48968949|NCT01335698|157714698|FG003|Treatment Stage 2|Switched to another formulation|0|||
48968950|NCT01335698|157714699|FG004|Treatment Stage 2|Switched to another formulation|0|||
48968951|NCT01838590|157714700|FG000|Overall Study|Lack of Efficacy|12|||
48968952|NCT01838590|157714701|FG001|Overall Study|Lack of Efficacy|4|||
48968953|NCT01838590|157714700|FG000|Overall Study|Lost to Follow-up|0|||
48968954|NCT01838590|157714701|FG001|Overall Study|Lost to Follow-up|1|||
48968955|NCT02133742|157714704|FG000|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2|||
48968956|NCT02133742|157714704|FG000|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31|||
48760590|NCT01881230|156972270|FG001|Overall Study|Untreated: Other|0|||
48760591|NCT01881230|156972271|FG002|Overall Study|Untreated: Other|1|||
48760592|NCT01881230|156972269|FG000|Overall Study|Untreated: Death|0|||
48760593|NCT01881230|156972270|FG001|Overall Study|Untreated: Death|0|||
48760594|NCT01881230|156972271|FG002|Overall Study|Untreated: Death|1|||
48760595|NCT01881230|156972269|FG000|Overall Study|Untreated: Withdrawal Before Study Start|1|||
48760596|NCT01881230|156972270|FG001|Overall Study|Untreated: Withdrawal Before Study Start|0|||
48760597|NCT01881230|156972271|FG002|Overall Study|Untreated: Withdrawal Before Study Start|0|||
48760598|NCT02232425|156972272|FG000|Overall Study|Lost to Follow-up|6|||
48760599|NCT02232425|156972273|FG001|Overall Study|Lost to Follow-up|2|||
48760600|NCT02232425|156972272|FG000|Overall Study|Adverse Event|2|||
48760601|NCT02232425|156972273|FG001|Overall Study|Adverse Event|0|||
48760602|NCT02232425|156972272|FG000|Overall Study|Withdrawal by Subject|5|||
48760603|NCT02232425|156972273|FG001|Overall Study|Withdrawal by Subject|6|||
48760604|NCT02232425|156972272|FG000|Overall Study|Lack of Efficacy|1|||
48760605|NCT02232425|156972273|FG001|Overall Study|Lack of Efficacy|0|||
48760606|NCT02917031|156972274|FG000|Overall Study|Reason not specified|7|||
48760607|NCT02917031|156972275|FG001|Overall Study|Reason not specified|5|||
48760608|NCT02917031|156972276|FG002|Overall Study|Reason not specified|6|||
48760609|NCT02917031|156972274|FG000|Overall Study|Development of study-specific withdrawal criteria|1|||
48760610|NCT02917031|156972275|FG001|Overall Study|Development of study-specific withdrawal criteria|1|||
48760611|NCT02917031|156972276|FG002|Overall Study|Development of study-specific withdrawal criteria|0|||
48760612|NCT02917031|156972274|FG000|Overall Study|Withdrawal by Subject|3|||
48760613|NCT02917031|156972275|FG001|Overall Study|Withdrawal by Subject|3|||
48760614|NCT02917031|156972276|FG002|Overall Study|Withdrawal by Subject|0|||
48968957|NCT02133742|157714704|FG000|Period 2:Dose Expansion Phase (1344days)|Death|13|||
48968958|NCT02133742|157714704|FG000|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5|||
48968959|NCT02133742|157714704|FG000|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1|||
48670979|NCT01571453|156648296|FG000|Overall Study|Lost to Follow-up|4|||
48670980|NCT01571453|156648297|FG001|Overall Study|Lost to Follow-up|2|||
48670981|NCT01571453|156648296|FG000|Overall Study|Administrative or other reason(s)|4|||
48670982|NCT01571453|156648297|FG001|Overall Study|Administrative or other reason(s)|3|||
48670983|NCT02453555|156648298|FG000|24-week Double-blind Treatment Period|Adverse Event|2|||
48670984|NCT02453555|156648299|FG001|24-week Double-blind Treatment Period|Adverse Event|0|||
48670985|NCT02453555|156648300|FG002|24-week Double-blind Treatment Period|Adverse Event|0|||
48670986|NCT02453555|156648301|FG003|24-week Double-blind Treatment Period|Adverse Event|0|||
48670987|NCT02453555|156648302|FG004|24-week Double-blind Treatment Period|Adverse Event|0|||
48760615|NCT02917031|156972274|FG000|Overall Study|Physician Decision|1|||
48760616|NCT02917031|156972275|FG001|Overall Study|Physician Decision|0|||
48760617|NCT02917031|156972276|FG002|Overall Study|Physician Decision|0|||
48760618|NCT02917031|156972274|FG000|Overall Study|Adverse Event|4|||
48760619|NCT02917031|156972275|FG001|Overall Study|Adverse Event|1|||
48968960|NCT00435994|157714705|FG000|Overall Study|Lost to Follow-up|7|||
48968961|NCT00435994|157714706|FG001|Overall Study|Lost to Follow-up|0|||
48968962|NCT00435994|157714707|FG002|Overall Study|Lost to Follow-up|0|||
48760620|NCT02917031|156972276|FG002|Overall Study|Adverse Event|5|||
48968963|NCT03505749|157714708|FG000|Overall Study|Lost to Follow-up|7|||
48968964|NCT03505749|157714709|FG001|Overall Study|Lost to Follow-up|11|||
48968965|NCT03505749|157714708|FG000|Overall Study|Withdrawal by Subject|6|||
48968966|NCT03505749|157714709|FG001|Overall Study|Withdrawal by Subject|0|||
48968967|NCT03505749|157714708|FG000|Overall Study|Discharged from treatment|3|||
48968968|NCT03505749|157714709|FG001|Overall Study|Discharged from treatment|6|||
48968969|NCT01151540|157714710|FG000|Overall Study|Other|2|||
48968970|NCT01151540|157714710|FG000|Overall Study|Adverse event, non-fatal|4|||
48968971|NCT01151540|157714710|FG000|Overall Study|Withdrawal by Subject|7|||
48968972|NCT03479216|157714711|FG000|Overall Study|Withdrawal by Subject|3|||
48968973|NCT03479216|157714712|FG001|Overall Study|Withdrawal by Subject|2|||
48968974|NCT03479216|157714711|FG000|Overall Study|Physician Decision|2|||
48968975|NCT03479216|157714712|FG001|Overall Study|Physician Decision|3|||
48968976|NCT03846219|157714719|FG000|Overall Study|Withdrawal by Subject|3|||
48968977|NCT03846219|157714720|FG001|Overall Study|Withdrawal by Subject|2|||
48968978|NCT03846219|157714721|FG002|Overall Study|Withdrawal by Subject|2|||
48968979|NCT03846219|157714719|FG000|Overall Study|Fulfilled hepatoxicity-related stopping rules|0|||
48968980|NCT03846219|157714720|FG001|Overall Study|Fulfilled hepatoxicity-related stopping rules|2|||
48968981|NCT03846219|157714721|FG002|Overall Study|Fulfilled hepatoxicity-related stopping rules|1|||
48968982|NCT03846219|157714719|FG000|Overall Study|Physician Decision|0|||
48968983|NCT03846219|157714720|FG001|Overall Study|Physician Decision|0|||
48968984|NCT03846219|157714721|FG002|Overall Study|Physician Decision|2|||
48968985|NCT02472795|157714722|FG000|Overall Study|Adverse Event|0|||
48968986|NCT02472795|157714723|FG001|Overall Study|Adverse Event|1|||
48968987|NCT02472795|157714724|FG002|Overall Study|Adverse Event|0|||
48968988|NCT02472795|157714725|FG003|Overall Study|Adverse Event|0|||
48968989|NCT02472795|157714726|FG004|Overall Study|Adverse Event|2|||
48968990|NCT02472795|157714722|FG000|Overall Study|Withdrawal by Subject|0|||
48968991|NCT02472795|157714723|FG001|Overall Study|Withdrawal by Subject|0|||
48968992|NCT02472795|157714724|FG002|Overall Study|Withdrawal by Subject|0|||
48968993|NCT02472795|157714725|FG003|Overall Study|Withdrawal by Subject|0|||
48968994|NCT02472795|157714726|FG004|Overall Study|Withdrawal by Subject|1|||
48968995|NCT05109702|157714727|FG000|Treatment Period (8 Weeks)|Adverse Event|0|||
48968996|NCT05109702|157714728|FG001|Treatment Period (8 Weeks)|Adverse Event|5|||
48968997|NCT05109702|157714729|FG002|Treatment Period (8 Weeks)|Adverse Event|2|||
48968998|NCT05109702|157714727|FG000|Treatment Period (8 Weeks)|Protocol Violation|0|||
48968999|NCT05109702|157714728|FG001|Treatment Period (8 Weeks)|Protocol Violation|0|||
48969000|NCT05109702|157714729|FG002|Treatment Period (8 Weeks)|Protocol Violation|1|||
48969001|NCT05109702|157714727|FG000|Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
48969002|NCT05109702|157714728|FG001|Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
48969003|NCT05109702|157714729|FG002|Treatment Period (8 Weeks)|Withdrawal by Subject|3|||
48969004|NCT05109702|157714727|FG000|Treatment Period (8 Weeks)|Administrative reasons|0|||
48969005|NCT05109702|157714728|FG001|Treatment Period (8 Weeks)|Administrative reasons|1|||
48969006|NCT05109702|157714729|FG002|Treatment Period (8 Weeks)|Administrative reasons|1|||
48969007|NCT05109702|157714727|FG000|Treatment Period (8 Weeks)|Other than specified|0|||
48969008|NCT05109702|157714728|FG001|Treatment Period (8 Weeks)|Other than specified|3|||
48969009|NCT05109702|157714729|FG002|Treatment Period (8 Weeks)|Other than specified|1|||
48969010|NCT03094832|157714730|FG000|Overall Study|Lost to Follow-up|0|||
48969011|NCT03094832|157714731|FG001|Overall Study|Lost to Follow-up|0|||
48969012|NCT03094832|157714732|FG002|Overall Study|Lost to Follow-up|0|||
48969013|NCT03094832|157714733|FG003|Overall Study|Lost to Follow-up|1|||
48969014|NCT03094832|157714734|FG004|Overall Study|Lost to Follow-up|1|||
48969015|NCT03094832|157714730|FG000|Overall Study|Death|1|||
48969016|NCT03094832|157714731|FG001|Overall Study|Death|0|||
48969017|NCT03094832|157714732|FG002|Overall Study|Death|0|||
48670988|NCT02453555|156648303|FG005|24-week Double-blind Treatment Period|Adverse Event|0|||
48670989|NCT02453555|156648298|FG000|24-week Double-blind Treatment Period|Lost to Follow-up|1|||
48670990|NCT02453555|156648299|FG001|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
48670991|NCT02453555|156648300|FG002|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
48969018|NCT03094832|157714733|FG003|Overall Study|Death|0|||
48670992|NCT02453555|156648301|FG003|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
48670993|NCT02453555|156648302|FG004|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
48670994|NCT02453555|156648303|FG005|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
48670995|NCT02453555|156648298|FG000|24-week Double-blind Treatment Period|Withdrawal by Subject|2|||
48969019|NCT03094832|157714734|FG004|Overall Study|Death|0|||
48969020|NCT03094832|157714730|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
48969021|NCT03094832|157714731|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
48969022|NCT03094832|157714732|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
48969023|NCT03094832|157714733|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
48969024|NCT03094832|157714734|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
48969025|NCT03094832|157714730|FG000|Overall Study|Other|13|||
48969026|NCT03094832|157714731|FG001|Overall Study|Other|20|||
48969027|NCT03094832|157714732|FG002|Overall Study|Other|1|||
48969028|NCT03094832|157714733|FG003|Overall Study|Other|7|||
48969029|NCT03094832|157714734|FG004|Overall Study|Other|1|||
48670996|NCT02453555|156648299|FG001|24-week Double-blind Treatment Period|Withdrawal by Subject|4|||
48670997|NCT02453555|156648300|FG002|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
48670998|NCT02453555|156648301|FG003|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
48670999|NCT02453555|156648302|FG004|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
48671000|NCT02453555|156648303|FG005|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
48671001|NCT02453555|156648298|FG000|24-week Double-blind Treatment Period|Other than specified above|0|||
48671002|NCT02453555|156648299|FG001|24-week Double-blind Treatment Period|Other than specified above|3|||
48671003|NCT02453555|156648300|FG002|24-week Double-blind Treatment Period|Other than specified above|0|||
48671004|NCT02453555|156648301|FG003|24-week Double-blind Treatment Period|Other than specified above|0|||
48671005|NCT02453555|156648302|FG004|24-week Double-blind Treatment Period|Other than specified above|0|||
48671006|NCT02453555|156648303|FG005|24-week Double-blind Treatment Period|Other than specified above|0|||
48671007|NCT02453555|156648298|FG000|Extension Period|Adverse Event|0|||
48671008|NCT02453555|156648299|FG001|Extension Period|Adverse Event|0|||
48671009|NCT02453555|156648300|FG002|Extension Period|Adverse Event|1|||
48671010|NCT02453555|156648301|FG003|Extension Period|Adverse Event|2|||
48671011|NCT02453555|156648302|FG004|Extension Period|Adverse Event|1|||
48671012|NCT02453555|156648303|FG005|Extension Period|Adverse Event|1|||
48671013|NCT02453555|156648298|FG000|Extension Period|Protocol Violation|0|||
48671014|NCT02453555|156648299|FG001|Extension Period|Protocol Violation|0|||
48671015|NCT02453555|156648300|FG002|Extension Period|Protocol Violation|1|||
48671016|NCT02453555|156648301|FG003|Extension Period|Protocol Violation|0|||
48671017|NCT02453555|156648302|FG004|Extension Period|Protocol Violation|0|||
48671018|NCT02453555|156648303|FG005|Extension Period|Protocol Violation|0|||
48671019|NCT02453555|156648298|FG000|Extension Period|Withdrawal by Subject|0|||
48671020|NCT02453555|156648299|FG001|Extension Period|Withdrawal by Subject|0|||
48671021|NCT02453555|156648300|FG002|Extension Period|Withdrawal by Subject|1|||
48671022|NCT02453555|156648301|FG003|Extension Period|Withdrawal by Subject|0|||
48671023|NCT02453555|156648302|FG004|Extension Period|Withdrawal by Subject|0|||
48671024|NCT02453555|156648303|FG005|Extension Period|Withdrawal by Subject|0|||
48671025|NCT00444067|156648308|FG000|Overall Study|Lost to Follow-up|0|||
48671026|NCT00444067|156648309|FG001|Overall Study|Lost to Follow-up|1|||
48671027|NCT00500760|156648314|FG000|Overall Study|Death|32|||
48671028|NCT00500760|156648315|FG001|Overall Study|Death|15|||
48671029|NCT00500760|156648314|FG000|Overall Study|Withdrawal by Subject|5|||
48671030|NCT00500760|156648315|FG001|Overall Study|Withdrawal by Subject|7|||
48671031|NCT00500760|156648314|FG000|Overall Study|Administrative decision|2|||
48671032|NCT00500760|156648315|FG001|Overall Study|Administrative decision|0|||
48671033|NCT00500760|156648314|FG000|Overall Study|Lost to Follow-up|3|||
48671034|NCT00500760|156648315|FG001|Overall Study|Lost to Follow-up|0|||
48671035|NCT00500760|156648314|FG000|Overall Study|Other|1|||
48671036|NCT00500760|156648315|FG001|Overall Study|Other|2|||
48671037|NCT00710385|156648317|FG000|Overall Study|Did not qualify|1|||
48671038|NCT00710385|156648317|FG000|Overall Study|Withdrawal by Subject|1|||
48671039|NCT00710385|156648317|FG000|Overall Study|Undisclosed back pain|1|||
48671040|NCT00710385|156648317|FG000|Overall Study|Physician Decision|1|||
48671041|NCT00710385|156648317|FG000|Overall Study|Undisclosed excessive methadone use|1|||
48671042|NCT00129961|156648318|FG000|Overall Study|Adverse Event|1|||
48671043|NCT00129961|156648319|FG001|Overall Study|Adverse Event|0|||
48671044|NCT00129961|156648318|FG000|Overall Study|Death|1|||
48671045|NCT00129961|156648319|FG001|Overall Study|Death|1|||
48671046|NCT00129961|156648318|FG000|Overall Study|Withdrawal by Sponsor|14|||
48671047|NCT00129961|156648319|FG001|Overall Study|Withdrawal by Sponsor|20|||
48671048|NCT00129961|156648318|FG000|Overall Study|Physician Decision|1|||
48671049|NCT00129961|156648319|FG001|Overall Study|Physician Decision|0|||
48671050|NCT00129961|156648318|FG000|Overall Study|Withdrawal by Subject|2|||
48671051|NCT00129961|156648319|FG001|Overall Study|Withdrawal by Subject|1|||
48671052|NCT00129961|156648318|FG000|Overall Study|Missing Record|0|||
48671053|NCT00129961|156648319|FG001|Overall Study|Missing Record|1|||
48671054|NCT01600092|156648320|FG000|Overall Study|Adverse Event|2|||
48671055|NCT01600092|156648321|FG001|Overall Study|Adverse Event|0|||
48671056|NCT01600092|156648320|FG000|Overall Study|Lost to Follow-up|4|||
48671057|NCT01600092|156648321|FG001|Overall Study|Lost to Follow-up|6|||
48671058|NCT01600092|156648320|FG000|Overall Study|Withdrawal by parent/guardian|8|||
48671059|NCT01600092|156648321|FG001|Overall Study|Withdrawal by parent/guardian|6|||
48671060|NCT01600092|156648320|FG000|Overall Study|Physician Decision|1|||
48671061|NCT01600092|156648321|FG001|Overall Study|Physician Decision|1|||
48671062|NCT01600092|156648320|FG000|Overall Study|Randomized but not vaccinated|3|||
48671063|NCT01600092|156648321|FG001|Overall Study|Randomized but not vaccinated|3|||
48671064|NCT04598269|156648322|FG000|Overall Study|Adverse Event|0|||
48671065|NCT04598269|156648323|FG001|Overall Study|Adverse Event|3|||
48671066|NCT04598269|156648322|FG000|Overall Study|Withdrawal by Subject|1|||
48671067|NCT04598269|156648323|FG001|Overall Study|Withdrawal by Subject|4|||
48671068|NCT04598269|156648322|FG000|Overall Study|Lost to Follow-up|1|||
48671069|NCT04598269|156648323|FG001|Overall Study|Lost to Follow-up|0|||
48671070|NCT04598269|156648322|FG000|Overall Study|Not Treated|2|||
48671071|NCT04598269|156648323|FG001|Overall Study|Not Treated|0|||
48671072|NCT03550404|156648324|FG000|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|3|||
48671073|NCT03550404|156648325|FG001|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
48671074|NCT03550404|156648326|FG002|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
48671075|NCT03550404|156648324|FG000|Phase 2|Vacated position|1|||
48671076|NCT03550404|156648325|FG001|Phase 2|Vacated position|0|||
48671077|NCT03550404|156648326|FG002|Phase 2|Vacated position|0|||
48671078|NCT02925728|156648327|FG000|Overall Study|Death|3|||
48671079|NCT02925728|156648328|FG001|Overall Study|Death|5|||
48671080|NCT02925728|156648327|FG000|Overall Study|Physician Decision|1|||
48671081|NCT02925728|156648328|FG001|Overall Study|Physician Decision|0|||
48671082|NCT02925728|156648327|FG000|Overall Study|Withdrawal by Subject|1|||
48671083|NCT02925728|156648328|FG001|Overall Study|Withdrawal by Subject|0|||
48671084|NCT02102399|156648329|FG000|Overall Study|Withdrawal by Subject|6|||
48671085|NCT02102399|156648330|FG001|Overall Study|Withdrawal by Subject|4|||
48671086|NCT03652675|156648331|FG000|Overall Study|Lost to Follow-up|4|||
48671087|NCT03652675|156648332|FG001|Overall Study|Lost to Follow-up|4|||
48671088|NCT00086411|156648333|FG000|Overall Study|Lost to Follow-up|11|||
48671089|NCT00086411|156648334|FG001|Overall Study|Lost to Follow-up|11|||
48671090|NCT00086411|156648335|FG002|Overall Study|Lost to Follow-up|13|||
48671091|NCT00086411|156648336|FG003|Overall Study|Lost to Follow-up|12|||
48671092|NCT01704456|156648337|FG000|Overall Study|Lost to Follow-up|8|||
48671093|NCT01704456|156648338|FG001|Overall Study|Lost to Follow-up|14|||
48671094|NCT03596450|156648339|FG000|Overall Study|Death|9|||
48671095|NCT03596450|156648340|FG001|Overall Study|Death|9|||
48671096|NCT03596450|156648339|FG000|Overall Study|Protocol Violation|18|||
48671097|NCT03596450|156648340|FG001|Overall Study|Protocol Violation|26|||
48671098|NCT03596450|156648339|FG000|Overall Study|Lost to Follow-up|50|||
48871233|NCT03494985|157365860|FG002|Overall Study|Other (Not specified)|1|||
48969030|NCT02322411|157714735|FG000|Overall Study|Lost to Follow-up|4|||
48671099|NCT03596450|156648340|FG001|Overall Study|Lost to Follow-up|56|||
48671100|NCT03596450|156648339|FG000|Overall Study|Adverse Event|14|||
48671101|NCT03596450|156648340|FG001|Overall Study|Adverse Event|7|||
48671102|NCT03596450|156648339|FG000|Overall Study|Withdrawal by Subject|38|||
48671103|NCT03596450|156648340|FG001|Overall Study|Withdrawal by Subject|36|||
48671104|NCT03596450|156648339|FG000|Overall Study|Accidentally Randomized|2|||
48671105|NCT03596450|156648340|FG001|Overall Study|Accidentally Randomized|0|||
48671106|NCT03596450|156648339|FG000|Overall Study|Other reasons|48|||
48671107|NCT03596450|156648340|FG001|Overall Study|Other reasons|53|||
48671108|NCT03596450|156648339|FG000|Overall Study|Pregnancy|2|||
48671109|NCT03596450|156648340|FG001|Overall Study|Pregnancy|0|||
48671110|NCT00447122|156648341|FG000|Overall Study|worsening medical condition -came off|0|||
48671111|NCT00447122|156648342|FG001|Overall Study|worsening medical condition -came off|1|||
48671112|NCT00447122|156648343|FG002|Overall Study|worsening medical condition -came off|0|||
48671113|NCT00447122|156648344|FG003|Overall Study|worsening medical condition -came off|0|||
48671114|NCT00915551|156648345|FG000|Overall Study|Withdrawal by Subject|0|||
48671115|NCT00915551|156648346|FG001|Overall Study|Withdrawal by Subject|1|||
48671116|NCT01274429|156648349|FG000|Overall Study|Study closed do to lack of funding|5|||
48671117|NCT00830180|156648350|FG000|Overall Study|Adverse Event|6|||
48671118|NCT00830180|156648350|FG000|Overall Study|Death|11|||
48671119|NCT00830180|156648350|FG000|Overall Study|Insufficient clinical response|1|||
48671120|NCT00830180|156648350|FG000|Overall Study|Withdrawal by Subject|5|||
48671121|NCT00830180|156648350|FG000|Overall Study|Progressive disease|2|||
48671122|NCT00830180|156648350|FG000|Overall Study|Other - Unspecified|1|||
48671123|NCT00629798|156648351|FG000|Overall Study|Not Treated|4|||
48871234|NCT03494985|157365861|FG003|Overall Study|Other (Not specified)|0|||
48871235|NCT02154347|157365862|FG000|Double-blind Period|Adverse Event|1|||
48871236|NCT02154347|157365863|FG001|Double-blind Period|Adverse Event|2|||
48871237|NCT02154347|157365862|FG000|Double-blind Period|Lack of Efficacy|1|||
48871238|NCT02154347|157365863|FG001|Double-blind Period|Lack of Efficacy|0|||
48871239|NCT02154347|157365862|FG000|Double-blind Period|Physician Decision|0|||
48871240|NCT02154347|157365863|FG001|Double-blind Period|Physician Decision|1|||
48871241|NCT02154347|157365862|FG000|Double-blind Period|Withdrawal by Subject|1|||
48871242|NCT02154347|157365863|FG001|Double-blind Period|Withdrawal by Subject|1|||
48871243|NCT02154347|157365862|FG000|Open-label Period|Adverse Event|3|||
48871244|NCT02154347|157365863|FG001|Open-label Period|Adverse Event|4|||
48871245|NCT02154347|157365862|FG000|Open-label Period|Lack of Efficacy|4|||
48871246|NCT02154347|157365863|FG001|Open-label Period|Lack of Efficacy|19|||
48871247|NCT02154347|157365862|FG000|Open-label Period|Protocol Violation|0|||
48871248|NCT02154347|157365863|FG001|Open-label Period|Protocol Violation|1|||
48871249|NCT02154347|157365862|FG000|Open-label Period|Withdrawal by Subject|0|||
48871250|NCT02154347|157365863|FG001|Open-label Period|Withdrawal by Subject|1|||
48969031|NCT02322411|157714736|FG001|Overall Study|Lost to Follow-up|7|||
48871251|NCT04811339|157365865|FG000|Overall Study|lack of transportation not wanting to return|4|||
48871252|NCT04811339|157365866|FG001|Overall Study|lack of transportation not wanting to return|8|||
48671124|NCT04384523|156648352|FG000|Overall Study|Lost to Follow-up|0|||
48671125|NCT04384523|156648353|FG001|Overall Study|Lost to Follow-up|0|||
48969032|NCT02322411|157714735|FG000|Overall Study|Withdrawal by Subject|1|||
48969033|NCT02322411|157714736|FG001|Overall Study|Withdrawal by Subject|0|||
48969034|NCT01392378|157714737|FG000|Infant Series|Adverse Event|0|||
48969035|NCT01392378|157714738|FG001|Infant Series|Adverse Event|0|||
48969036|NCT01392378|157714739|FG002|Infant Series|Adverse Event|0|||
48969037|NCT01392378|157714740|FG003|Infant Series|Adverse Event|1|||
48671126|NCT04384523|156648354|FG002|Overall Study|Lost to Follow-up|0|||
48671127|NCT04384523|156648355|FG003|Overall Study|Lost to Follow-up|0|||
48671128|NCT04384523|156648356|FG004|Overall Study|Lost to Follow-up|0|||
48671129|NCT04384523|156648357|FG005|Overall Study|Lost to Follow-up|1|||
48671130|NCT04384523|156648352|FG000|Overall Study|Protocol Violation|0|||
48671131|NCT04384523|156648353|FG001|Overall Study|Protocol Violation|1|||
48671132|NCT04384523|156648354|FG002|Overall Study|Protocol Violation|0|||
48760621|NCT02917031|156972274|FG000|Overall Study|Death|2|||
48760622|NCT02917031|156972275|FG001|Overall Study|Death|3|||
48760623|NCT02917031|156972276|FG002|Overall Study|Death|4|||
48760624|NCT01465022|156972277|FG000|Overall Study|Lost to Follow-up|15|||
48760625|NCT01465022|156972278|FG001|Overall Study|Lost to Follow-up|14|||
48760626|NCT01465022|156972279|FG002|Overall Study|Lost to Follow-up|0|||
48671133|NCT04384523|156648355|FG003|Overall Study|Protocol Violation|0|||
48671134|NCT04384523|156648356|FG004|Overall Study|Protocol Violation|0|||
48671135|NCT04384523|156648357|FG005|Overall Study|Protocol Violation|0|||
48671136|NCT04384523|156648352|FG000|Overall Study|Withdrawal by Subject|1|||
48671137|NCT04384523|156648353|FG001|Overall Study|Withdrawal by Subject|0|||
48671138|NCT04384523|156648354|FG002|Overall Study|Withdrawal by Subject|0|||
48671139|NCT04384523|156648355|FG003|Overall Study|Withdrawal by Subject|0|||
48671140|NCT04384523|156648356|FG004|Overall Study|Withdrawal by Subject|0|||
48671141|NCT04384523|156648357|FG005|Overall Study|Withdrawal by Subject|0|||
48671142|NCT02554981|156648362|FG000|Overall Study|Adverse Event|1|||
48671143|NCT02554981|156648362|FG000|Overall Study|Administrative Reasons|1|||
48671144|NCT02554981|156648362|FG000|Overall Study|Other Miscellaneous Reasons|3|||
48671145|NCT01174173|156648363|FG000|Overall Study|drug-drug interaction|1|||
48671146|NCT03597061|156648364|FG000|Overall Study|Lost to Follow-up|1|||
48671147|NCT03597061|156648365|FG001|Overall Study|Lost to Follow-up|0|||
48671148|NCT03597061|156648364|FG000|Overall Study|Protocol Violation|0|||
48760627|NCT01465022|156972277|FG000|Overall Study|Breastfeeding discontinuation before 8 w|8|||
48760628|NCT01465022|156972278|FG001|Overall Study|Breastfeeding discontinuation before 8 w|9|||
48760629|NCT01465022|156972279|FG002|Overall Study|Breastfeeding discontinuation before 8 w|0|||
48760630|NCT01465022|156972277|FG000|Overall Study|Not Randomized|0|||
48760631|NCT01465022|156972278|FG001|Overall Study|Not Randomized|0|||
48760632|NCT01465022|156972279|FG002|Overall Study|Not Randomized|70|||
48760633|NCT01327300|156972280|FG000|Washout (3 Weeks)|Withdrawal by Subject|1|||
48760634|NCT01327300|156972281|FG001|Washout (3 Weeks)|Withdrawal by Subject|0|||
48760635|NCT03739112|156972282|FG000|Overall Study|Adverse Event|2|||
48760636|NCT03739112|156972283|FG001|Overall Study|Adverse Event|2|||
48760637|NCT03739112|156972282|FG000|Overall Study|Withdrawal by Subject|38|||
48760638|NCT03739112|156972283|FG001|Overall Study|Withdrawal by Subject|19|||
48760639|NCT03739112|156972282|FG000|Overall Study|Lost to Follow-up|31|||
48760640|NCT03739112|156972283|FG001|Overall Study|Lost to Follow-up|33|||
48760641|NCT03739112|156972282|FG000|Overall Study|Protocol Deviation|12|||
48760642|NCT03739112|156972283|FG001|Overall Study|Protocol Deviation|9|||
48760643|NCT03739112|156972282|FG000|Overall Study|Physician Decision|1|||
48760644|NCT03739112|156972283|FG001|Overall Study|Physician Decision|0|||
48760645|NCT03739112|156972282|FG000|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|12|||
48760646|NCT03739112|156972283|FG001|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|16|||
48760647|NCT03739112|156972282|FG000|Overall Study|Site went on hold|65|||
48760648|NCT03739112|156972283|FG001|Overall Study|Site went on hold|67|||
48760649|NCT03739112|156972282|FG000|Overall Study|Other than specified|8|||
48760650|NCT03739112|156972283|FG001|Overall Study|Other than specified|5|||
48760651|NCT03739112|156972282|FG000|Overall Study|Randomized but not vaccinated|31|||
48760652|NCT03739112|156972283|FG001|Overall Study|Randomized but not vaccinated|25|||
48760653|NCT02618434|156972286|FG000|Overall Study|Withdrawal by Subject|0|||
48760654|NCT02618434|156972287|FG001|Overall Study|Withdrawal by Subject|2|||
48760655|NCT02618434|156972288|FG002|Overall Study|Withdrawal by Subject|3|||
48760656|NCT02618434|156972286|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
48760657|NCT02618434|156972287|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
48760658|NCT02618434|156972288|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
48760659|NCT02618434|156972286|FG000|Overall Study|Lost to Follow-up|3|||
48760660|NCT02618434|156972287|FG001|Overall Study|Lost to Follow-up|1|||
48760661|NCT02618434|156972288|FG002|Overall Study|Lost to Follow-up|3|||
48760662|NCT02618434|156972286|FG000|Overall Study|Adverse Event|1|||
48760663|NCT02618434|156972287|FG001|Overall Study|Adverse Event|0|||
48760664|NCT02618434|156972288|FG002|Overall Study|Adverse Event|12|||
48969038|NCT01392378|157714741|FG004|Infant Series|Adverse Event|0|||
48969039|NCT01392378|157714737|FG000|Infant Series|Lost to Follow-up|0|||
48969040|NCT01392378|157714738|FG001|Infant Series|Lost to Follow-up|0|||
48671149|NCT03597061|156648365|FG001|Overall Study|Protocol Violation|1|||
48671150|NCT02160145|156648366|FG000|Prerandomization Single-blind Period|Placebo run-in failure|23|||
48969041|NCT01392378|157714739|FG002|Infant Series|Lost to Follow-up|0|||
48969042|NCT01392378|157714740|FG003|Infant Series|Lost to Follow-up|1|||
48969043|NCT01392378|157714741|FG004|Infant Series|Lost to Follow-up|0|||
48969044|NCT01392378|157714737|FG000|Infant Series|Protocol Violation|0|||
48969045|NCT01392378|157714738|FG001|Infant Series|Protocol Violation|1|||
48969046|NCT01392378|157714739|FG002|Infant Series|Protocol Violation|0|||
48969047|NCT01392378|157714740|FG003|Infant Series|Protocol Violation|0|||
48969048|NCT01392378|157714741|FG004|Infant Series|Protocol Violation|0|||
48969049|NCT01392378|157714737|FG000|Infant Series|Withdrawal by Parent|4|||
48969050|NCT01392378|157714738|FG001|Infant Series|Withdrawal by Parent|1|||
48760665|NCT02618434|156972286|FG000|Overall Study|Physician Decision|0|||
48760666|NCT02618434|156972287|FG001|Overall Study|Physician Decision|1|||
48760667|NCT02618434|156972288|FG002|Overall Study|Physician Decision|0|||
48760668|NCT02618434|156972286|FG000|Overall Study|Protocol Violation|0|||
48760669|NCT02618434|156972287|FG001|Overall Study|Protocol Violation|0|||
48760670|NCT02618434|156972288|FG002|Overall Study|Protocol Violation|1|||
48760671|NCT02618434|156972286|FG000|Overall Study|Other, Multiple categories|1|||
48760672|NCT02618434|156972287|FG001|Overall Study|Other, Multiple categories|1|||
48760673|NCT02618434|156972288|FG002|Overall Study|Other, Multiple categories|1|||
48760674|NCT00644969|156972294|FG000|Treatment Phase|Randomized, not treated|1|||
48760675|NCT00644969|156972295|FG001|Treatment Phase|Randomized, not treated|0|||
48969051|NCT01392378|157714739|FG002|Infant Series|Withdrawal by Parent|0|||
48671151|NCT02160145|156648367|FG001|Prerandomization Single-blind Period|Placebo run-in failure|0|||
48969052|NCT01392378|157714740|FG003|Infant Series|Withdrawal by Parent|0|||
48969053|NCT01392378|157714741|FG004|Infant Series|Withdrawal by Parent|0|||
48969054|NCT01392378|157714737|FG000|After Infant Series|Lost to Follow-up|0|||
48969055|NCT01392378|157714738|FG001|After Infant Series|Lost to Follow-up|0|||
48969056|NCT01392378|157714739|FG002|After Infant Series|Lost to Follow-up|1|||
48969057|NCT01392378|157714740|FG003|After Infant Series|Lost to Follow-up|0|||
48969058|NCT01392378|157714741|FG004|After Infant Series|Lost to Follow-up|0|||
48969059|NCT01392378|157714737|FG000|After Infant Series|Withdrawal by Parent|0|||
48969060|NCT01392378|157714738|FG001|After Infant Series|Withdrawal by Parent|1|||
48969061|NCT01392378|157714739|FG002|After Infant Series|Withdrawal by Parent|1|||
48969062|NCT01392378|157714740|FG003|After Infant Series|Withdrawal by Parent|0|||
48969063|NCT01392378|157714741|FG004|After Infant Series|Withdrawal by Parent|1|||
48969064|NCT01392378|157714737|FG000|Toddler Dose|Lost to Follow-up|0|||
48969065|NCT01392378|157714738|FG001|Toddler Dose|Lost to Follow-up|0|||
48969066|NCT01392378|157714739|FG002|Toddler Dose|Lost to Follow-up|0|||
48969067|NCT01392378|157714740|FG003|Toddler Dose|Lost to Follow-up|1|||
48969068|NCT01392378|157714741|FG004|Toddler Dose|Lost to Follow-up|0|||
48969069|NCT01392378|157714737|FG000|Toddler Dose|Withdrawal by Parent|0|||
48969070|NCT01392378|157714738|FG001|Toddler Dose|Withdrawal by Parent|1|||
48969071|NCT01392378|157714739|FG002|Toddler Dose|Withdrawal by Parent|0|||
48969072|NCT01392378|157714740|FG003|Toddler Dose|Withdrawal by Parent|1|||
48969073|NCT01392378|157714741|FG004|Toddler Dose|Withdrawal by Parent|1|||
48671152|NCT02160145|156648368|FG002|Prerandomization Single-blind Period|Placebo run-in failure|0|||
48671153|NCT02160145|156648366|FG000|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126|||
48671154|NCT02160145|156648367|FG001|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
48671155|NCT02160145|156648368|FG002|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
48671156|NCT02160145|156648366|FG000|Randomized Double-blind Period|Subject decision|0|||
48671157|NCT02160145|156648367|FG001|Randomized Double-blind Period|Subject decision|21|||
48671158|NCT02160145|156648368|FG002|Randomized Double-blind Period|Subject decision|20|||
48671159|NCT02160145|156648366|FG000|Randomized Double-blind Period|Lost to Follow-up|0|||
48671160|NCT02160145|156648367|FG001|Randomized Double-blind Period|Lost to Follow-up|1|||
48671161|NCT02160145|156648368|FG002|Randomized Double-blind Period|Lost to Follow-up|3|||
48671162|NCT02160145|156648366|FG000|Randomized Double-blind Period|Physician Decision|0|||
48671163|NCT02160145|156648367|FG001|Randomized Double-blind Period|Physician Decision|7|||
48671164|NCT02160145|156648368|FG002|Randomized Double-blind Period|Physician Decision|5|||
48671165|NCT00375518|156648369|FG000|Overall Study|Withdrawal by Subject|2|||
48671166|NCT00375518|156648370|FG001|Overall Study|Withdrawal by Subject|10|||
48671167|NCT00375518|156648369|FG000|Overall Study|Patient Not Treated|6|||
48671168|NCT00375518|156648370|FG001|Overall Study|Patient Not Treated|6|||
48671169|NCT00375518|156648369|FG000|Overall Study|Death|0|||
48671170|NCT00375518|156648370|FG001|Overall Study|Death|1|||
48671171|NCT03755661|156648373|FG000|Overall Study|Lost to Follow-up|1|||
48760676|NCT00644969|156972294|FG000|Treatment Phase|Adverse Event|3|||
48760677|NCT00644969|156972295|FG001|Treatment Phase|Adverse Event|0|||
48969074|NCT02810951|157714753|FG000|Overall Study|Adverse Event|1|||
48969075|NCT03627494|157714754|FG000|Part A Washout 2 (7 Days)|Adverse Event|1|||
48969076|NCT03627494|157714755|FG001|Part A Washout 2 (7 Days)|Adverse Event|0|||
48969077|NCT03627494|157714756|FG002|Part A Washout 2 (7 Days)|Adverse Event|1|||
48969078|NCT03627494|157714757|FG003|Part A Washout 2 (7 Days)|Adverse Event|0|||
48969079|NCT03627494|157714758|FG004|Part A Washout 2 (7 Days)|Adverse Event|0|||
48969080|NCT03627494|157714759|FG005|Part A Washout 2 (7 Days)|Adverse Event|0|||
48969081|NCT03627494|157714760|FG006|Part A Washout 2 (7 Days)|Adverse Event|0|||
48969082|NCT03627494|157714761|FG007|Part A Washout 2 (7 Days)|Adverse Event|0|||
48969083|NCT03627494|157714762|FG008|Part A Washout 2 (7 Days)|Adverse Event|0|||
48969084|NCT03627494|157714763|FG009|Part A Washout 2 (7 Days)|Adverse Event|0|||
48969085|NCT03627494|157714764|FG010|Part A Washout 2 (7 Days)|Adverse Event|0|||
48969086|NCT03627494|157714765|FG011|Part A Washout 2 (7 Days)|Adverse Event|0|||
48969087|NCT03627494|157714754|FG000|Part B (Maximum of 34 Days)|Adverse Event|0|||
48969088|NCT03627494|157714755|FG001|Part B (Maximum of 34 Days)|Adverse Event|0|||
48969089|NCT03627494|157714756|FG002|Part B (Maximum of 34 Days)|Adverse Event|0|||
48969090|NCT03627494|157714757|FG003|Part B (Maximum of 34 Days)|Adverse Event|0|||
48969091|NCT03627494|157714758|FG004|Part B (Maximum of 34 Days)|Adverse Event|0|||
48969092|NCT03627494|157714759|FG005|Part B (Maximum of 34 Days)|Adverse Event|0|||
48671172|NCT03755661|156648374|FG001|Overall Study|Lost to Follow-up|0|||
48671173|NCT01264419|156648375|FG000|Overall Study|Lost to Follow-up|3|||
48671174|NCT03959982|156650472|FG000|Overall Study|Withdrawal by Subject|1|||
48671175|NCT03959982|156650473|FG001|Overall Study|Withdrawal by Subject|0|||
48671176|NCT03959982|156650472|FG000|Overall Study|Physician Decision|2|||
48671177|NCT03959982|156650473|FG001|Overall Study|Physician Decision|0|||
48671178|NCT03959982|156650472|FG000|Overall Study|Lost to Follow-up|1|||
48671179|NCT03959982|156650473|FG001|Overall Study|Lost to Follow-up|0|||
48969093|NCT03627494|157714760|FG006|Part B (Maximum of 34 Days)|Adverse Event|0|||
49015492|NCT01393990|157893770|FG000|Overall Study|Withdrawal by Subject|0|||
48671180|NCT01309269|156650474|FG000|Overall Study|Adverse Event|56|||
48671181|NCT01309269|156650474|FG000|Overall Study|Withdrawal by Subject|25|||
48671182|NCT01309269|156650474|FG000|Overall Study|Lack of Acceptance|15|||
48671183|NCT01309269|156650474|FG000|Overall Study|Other Erythropoiesis-stimulating Agents|119|||
48671184|NCT01309269|156650474|FG000|Overall Study|Kidney Transplant|25|||
48671185|NCT01309269|156650474|FG000|Overall Study|Administrative Problems|141|||
48671186|NCT01309269|156650474|FG000|Overall Study|Other|256|||
48671187|NCT01309269|156650474|FG000|Overall Study|Other|1|||
48671188|NCT01309269|156650474|FG000|Overall Study|Study Completion Data Not Recorded|95|||
48671189|NCT01309269|156650474|FG000|Overall Study|Enrolled but not Treated|107|||
48671190|NCT00528996|156650475|FG000|Overall Study|Other reasons than listing|6|||
48671191|NCT00528996|156650476|FG001|Overall Study|Other reasons than listing|7|||
48671192|NCT00528996|156650477|FG002|Overall Study|Other reasons than listing|14|||
48671193|NCT00528996|156650478|FG003|Overall Study|Other reasons than listing|11|||
48671194|NCT00528996|156650479|FG004|Overall Study|Other reasons than listing|5|||
48671195|NCT00528996|156650475|FG000|Overall Study|Refused continue medication|16|||
48671196|NCT00528996|156650476|FG001|Overall Study|Refused continue medication|0|||
48671197|NCT00528996|156650477|FG002|Overall Study|Refused continue medication|3|||
48671198|NCT00528996|156650478|FG003|Overall Study|Refused continue medication|3|||
48671199|NCT00528996|156650479|FG004|Overall Study|Refused continue medication|6|||
48671200|NCT00528996|156650475|FG000|Overall Study|Lost to Follow-up|2|||
48671201|NCT00528996|156650476|FG001|Overall Study|Lost to Follow-up|0|||
48671202|NCT00528996|156650477|FG002|Overall Study|Lost to Follow-up|4|||
48671203|NCT00528996|156650478|FG003|Overall Study|Lost to Follow-up|1|||
48671204|NCT00528996|156650479|FG004|Overall Study|Lost to Follow-up|3|||
48671205|NCT00528996|156650475|FG000|Overall Study|Protocol Violation|1|||
48671206|NCT00528996|156650476|FG001|Overall Study|Protocol Violation|2|||
48671207|NCT00528996|156650477|FG002|Overall Study|Protocol Violation|3|||
48671208|NCT00528996|156650478|FG003|Overall Study|Protocol Violation|3|||
48671209|NCT00528996|156650479|FG004|Overall Study|Protocol Violation|2|||
48671210|NCT00528996|156650475|FG000|Overall Study|Lack of Efficacy|7|||
48671211|NCT00528996|156650476|FG001|Overall Study|Lack of Efficacy|2|||
48671212|NCT00528996|156650477|FG002|Overall Study|Lack of Efficacy|1|||
48671213|NCT00528996|156650478|FG003|Overall Study|Lack of Efficacy|3|||
48671214|NCT00528996|156650479|FG004|Overall Study|Lack of Efficacy|3|||
48671215|NCT00528996|156650475|FG000|Overall Study|Adverse Event|32|||
48671216|NCT00528996|156650476|FG001|Overall Study|Adverse Event|13|||
48671217|NCT00528996|156650477|FG002|Overall Study|Adverse Event|18|||
48671218|NCT00528996|156650478|FG003|Overall Study|Adverse Event|29|||
48671219|NCT00528996|156650479|FG004|Overall Study|Adverse Event|18|||
48671220|NCT00837759|156650480|FG000|Overall Study|Protocol Violation|3|||
48671221|NCT00837759|156650480|FG000|Overall Study|Lost to Follow-up|1|||
48671222|NCT02081599|156650481|FG000|Period 1：Double-blind Period|Adverse Event|3|||
48671223|NCT02081599|156650482|FG001|Period 1：Double-blind Period|Adverse Event|0|||
48671224|NCT02081599|156650481|FG000|Period 1：Double-blind Period|Lack of Efficacy|2|||
48671225|NCT02081599|156650482|FG001|Period 1：Double-blind Period|Lack of Efficacy|1|||
48671226|NCT02081599|156650481|FG000|Period 1：Double-blind Period|Physician Decision|1|||
48671227|NCT02081599|156650482|FG001|Period 1：Double-blind Period|Physician Decision|0|||
48671228|NCT02081599|156650481|FG000|Period 1：Double-blind Period|Protocol Violation|0|||
48671229|NCT02081599|156650482|FG001|Period 1：Double-blind Period|Protocol Violation|1|||
48671230|NCT02081599|156650481|FG000|Period 1：Double-blind Period|Withdrawal by Subject|1|||
48671231|NCT02081599|156650482|FG001|Period 1：Double-blind Period|Withdrawal by Subject|0|||
48671232|NCT02081599|156650481|FG000|Period 1：Double-blind Period|stopping criteria|1|||
48671233|NCT02081599|156650482|FG001|Period 1：Double-blind Period|stopping criteria|0|||
48671234|NCT02081599|156650481|FG000|Period 2：Open-label Period|Adverse Event|1|||
48671235|NCT02081599|156650482|FG001|Period 2：Open-label Period|Adverse Event|0|||
48671236|NCT02081599|156650481|FG000|Period 2：Open-label Period|Lack of Efficacy|2|||
48671237|NCT02081599|156650482|FG001|Period 2：Open-label Period|Lack of Efficacy|4|||
48671238|NCT02081599|156650481|FG000|Period 2：Open-label Period|Physician Decision|1|||
48671239|NCT02081599|156650482|FG001|Period 2：Open-label Period|Physician Decision|0|||
48671240|NCT02081599|156650481|FG000|Period 2：Open-label Period|Withdrawal by Subject|2|||
48671241|NCT02081599|156650482|FG001|Period 2：Open-label Period|Withdrawal by Subject|0|||
48671242|NCT01103063|156650483|FG000|Overall Study|Adverse Event|3|||
48671243|NCT01103063|156650484|FG001|Overall Study|Adverse Event|1|||
48671244|NCT01103063|156650483|FG000|Overall Study|Lost to Follow-up|68|||
48671245|NCT01103063|156650484|FG001|Overall Study|Lost to Follow-up|51|||
48671246|NCT01103063|156650483|FG000|Overall Study|Withdrawal by Subject|60|||
48671247|NCT01103063|156650484|FG001|Overall Study|Withdrawal by Subject|15|||
48671248|NCT01103063|156650483|FG000|Overall Study|Other|16|||
48671249|NCT01103063|156650484|FG001|Overall Study|Other|11|||
48871253|NCT04811339|157365867|FG002|Overall Study|lack of transportation not wanting to return|0|||
48871254|NCT04811339|157365865|FG000|Overall Study|Adverse Event|3|||
48871255|NCT04811339|157365866|FG001|Overall Study|Adverse Event|0|||
48871256|NCT04811339|157365867|FG002|Overall Study|Adverse Event|0|||
48871257|NCT04811339|157365865|FG000|Overall Study|Lost to Follow-up|1|||
48871258|NCT04811339|157365866|FG001|Overall Study|Lost to Follow-up|0|||
48871259|NCT04811339|157365867|FG002|Overall Study|Lost to Follow-up|0|||
48871260|NCT04811339|157365865|FG000|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|1|||
48871261|NCT04811339|157365866|FG001|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
48871262|NCT04811339|157365867|FG002|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
48871263|NCT04811339|157365865|FG000|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
48871264|NCT04811339|157365866|FG001|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|6|||
48871265|NCT04811339|157365867|FG002|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
48871266|NCT04811339|157365865|FG000|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
48871267|NCT04811339|157365866|FG001|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|4|||
48871268|NCT04811339|157365867|FG002|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
48871269|NCT04811339|157365865|FG000|Overall Study|Withdrawal by Subject|0|||
48871270|NCT04811339|157365866|FG001|Overall Study|Withdrawal by Subject|3|||
48871271|NCT04811339|157365867|FG002|Overall Study|Withdrawal by Subject|0|||
48871272|NCT04811339|157365865|FG000|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
48871273|NCT04811339|157365866|FG001|Overall Study|Transferred to ICU for non-COVID-19 related problem|1|||
48871274|NCT04811339|157365867|FG002|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
48871275|NCT04811339|157365865|FG000|Overall Study|Early on Nurse/Physician communication issue|0|||
48871276|NCT04811339|157365866|FG001|Overall Study|Early on Nurse/Physician communication issue|3|||
48871277|NCT04811339|157365867|FG002|Overall Study|Early on Nurse/Physician communication issue|0|||
48871278|NCT00092521|157367445|FG000|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6|||
48871279|NCT00092521|157367446|FG001|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
48871280|NCT00092521|157367447|FG002|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7|||
48871281|NCT00092521|157367448|FG003|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
48871282|NCT00092521|157367445|FG000|Vaccination (Day 1 Through Month 7)|Adverse Event|1|||
48871283|NCT00092521|157367446|FG001|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
48871284|NCT00092521|157367447|FG002|Vaccination (Day 1 Through Month 7)|Adverse Event|7|||
48871285|NCT00092521|157367448|FG003|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
48871286|NCT00092521|157367445|FG000|Vaccination (Day 1 Through Month 7)|Death|0|||
48871287|NCT00092521|157367446|FG001|Vaccination (Day 1 Through Month 7)|Death|0|||
48871288|NCT00092521|157367447|FG002|Vaccination (Day 1 Through Month 7)|Death|1|||
48871289|NCT00092521|157367448|FG003|Vaccination (Day 1 Through Month 7)|Death|0|||
48871290|NCT00092521|157367445|FG000|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51|||
48871291|NCT00092521|157367446|FG001|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6|||
48871292|NCT00092521|157367447|FG002|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44|||
48871293|NCT00092521|157367448|FG003|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0|||
48871294|NCT00092521|157367445|FG000|Vaccination (Day 1 Through Month 7)|Pregnancy|5|||
48871295|NCT00092521|157367446|FG001|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
48871296|NCT00092521|157367447|FG002|Vaccination (Day 1 Through Month 7)|Pregnancy|7|||
48871297|NCT00092521|157367448|FG003|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
48871298|NCT00092521|157367445|FG000|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59|||
48871299|NCT00092521|157367446|FG001|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7|||
48871300|NCT00092521|157367447|FG002|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62|||
48671250|NCT01103063|156650483|FG000|Overall Study|Protocol Violation|1|||
48671251|NCT01103063|156650484|FG001|Overall Study|Protocol Violation|0|||
48671252|NCT01103063|156650483|FG000|Overall Study|Study terminated by Sponsor|326|||
48671253|NCT01103063|156650484|FG001|Overall Study|Study terminated by Sponsor|342|||
48671254|NCT01103063|156650483|FG000|Overall Study|Death|3|||
48671255|NCT01103063|156650484|FG001|Overall Study|Death|1|||
48671256|NCT03320330|156650485|FG000|Overall Study|Lack of Efficacy|5|||
48969094|NCT03627494|157714761|FG007|Part B (Maximum of 34 Days)|Adverse Event|0|||
48969095|NCT03627494|157714762|FG008|Part B (Maximum of 34 Days)|Adverse Event|2|||
48969096|NCT03627494|157714763|FG009|Part B (Maximum of 34 Days)|Adverse Event|0|||
48969097|NCT03627494|157714764|FG010|Part B (Maximum of 34 Days)|Adverse Event|0|||
48969098|NCT03627494|157714765|FG011|Part B (Maximum of 34 Days)|Adverse Event|0|||
48969099|NCT03627494|157714754|FG000|Part C Washout 1 (7 Days)|Adverse Event|0|||
48969100|NCT03627494|157714755|FG001|Part C Washout 1 (7 Days)|Adverse Event|0|||
48969101|NCT03627494|157714756|FG002|Part C Washout 1 (7 Days)|Adverse Event|0|||
48969102|NCT03627494|157714757|FG003|Part C Washout 1 (7 Days)|Adverse Event|0|||
48969103|NCT03627494|157714758|FG004|Part C Washout 1 (7 Days)|Adverse Event|0|||
48969104|NCT03627494|157714759|FG005|Part C Washout 1 (7 Days)|Adverse Event|0|||
48969105|NCT03627494|157714760|FG006|Part C Washout 1 (7 Days)|Adverse Event|0|||
48969106|NCT03627494|157714761|FG007|Part C Washout 1 (7 Days)|Adverse Event|0|||
48969107|NCT03627494|157714762|FG008|Part C Washout 1 (7 Days)|Adverse Event|0|||
48969108|NCT03627494|157714763|FG009|Part C Washout 1 (7 Days)|Adverse Event|0|||
48969109|NCT03627494|157714764|FG010|Part C Washout 1 (7 Days)|Adverse Event|1|||
48969110|NCT03627494|157714765|FG011|Part C Washout 1 (7 Days)|Adverse Event|1|||
48969111|NCT03199638|157714767|FG000|Overall Study|inability to drink glutamine during regularly|0|||
48969112|NCT03199638|157714768|FG001|Overall Study|inability to drink glutamine during regularly|2|||
48969113|NCT01412060|157714769|FG000|Open-label Run-in Period (RIP)|Adverse Event|86|||
48969114|NCT01412060|157714770|FG001|Open-label Run-in Period (RIP)|Adverse Event|0|||
48969115|NCT01412060|157714771|FG002|Open-label Run-in Period (RIP)|Adverse Event|0|||
48969116|NCT01412060|157714769|FG000|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66|||
48969117|NCT01412060|157714770|FG001|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
48969118|NCT01412060|157714771|FG002|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
48969119|NCT01412060|157714769|FG000|Open-label Run-in Period (RIP)|Protocol Violation|27|||
48969120|NCT01412060|157714770|FG001|Open-label Run-in Period (RIP)|Protocol Violation|0|||
48969121|NCT01412060|157714771|FG002|Open-label Run-in Period (RIP)|Protocol Violation|0|||
48969122|NCT01412060|157714769|FG000|Open-label Run-in Period (RIP)|Withdrawal of Consent|117|||
48969123|NCT01412060|157714770|FG001|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
48969124|NCT01412060|157714771|FG002|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
48969125|NCT01412060|157714769|FG000|Open-label Run-in Period (RIP)|Lost to Follow-up|32|||
48969126|NCT01412060|157714770|FG001|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
48969127|NCT01412060|157714771|FG002|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
48969128|NCT01412060|157714769|FG000|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19|||
48969129|NCT01412060|157714770|FG001|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
48969130|NCT01412060|157714771|FG002|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
48969131|NCT01412060|157714769|FG000|Period Between RIP and SP|Adverse Event|4|||
48969132|NCT01412060|157714770|FG001|Period Between RIP and SP|Adverse Event|0|||
48969133|NCT01412060|157714771|FG002|Period Between RIP and SP|Adverse Event|0|||
48969134|NCT01412060|157714769|FG000|Period Between RIP and SP|Insufficient Therapeutic Response|19|||
48969135|NCT01412060|157714770|FG001|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
48969136|NCT01412060|157714771|FG002|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
48969137|NCT01412060|157714769|FG000|Period Between RIP and SP|Protocol Violation|2|||
48969138|NCT01412060|157714770|FG001|Period Between RIP and SP|Protocol Violation|0|||
48969139|NCT01412060|157714771|FG002|Period Between RIP and SP|Protocol Violation|0|||
48969140|NCT01412060|157714769|FG000|Period Between RIP and SP|Withdrawal of Consent|1|||
48969141|NCT01412060|157714770|FG001|Period Between RIP and SP|Withdrawal of Consent|0|||
48969142|NCT01412060|157714771|FG002|Period Between RIP and SP|Withdrawal of Consent|0|||
48969143|NCT01412060|157714769|FG000|Period Between RIP and SP|Lost to Follow-up|5|||
48969144|NCT01412060|157714770|FG001|Period Between RIP and SP|Lost to Follow-up|0|||
48969145|NCT01412060|157714771|FG002|Period Between RIP and SP|Lost to Follow-up|0|||
48969146|NCT01412060|157714769|FG000|Period Between RIP and SP|Other Miscellaneous Reasons|23|||
48969147|NCT01412060|157714770|FG001|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
48969148|NCT01412060|157714771|FG002|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
48969149|NCT01412060|157714769|FG000|Open-label Stabilization Period (SP)|Adverse Event|9|||
48969150|NCT01412060|157714770|FG001|Open-label Stabilization Period (SP)|Adverse Event|0|||
48969151|NCT01412060|157714771|FG002|Open-label Stabilization Period (SP)|Adverse Event|0|||
48969152|NCT01412060|157714769|FG000|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9|||
48969153|NCT01412060|157714770|FG001|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
48969154|NCT01412060|157714771|FG002|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
48969155|NCT01412060|157714769|FG000|Open-label Stabilization Period (SP)|Protocol Violation|14|||
48969156|NCT01412060|157714770|FG001|Open-label Stabilization Period (SP)|Protocol Violation|0|||
48969157|NCT01412060|157714771|FG002|Open-label Stabilization Period (SP)|Protocol Violation|0|||
48969158|NCT01412060|157714769|FG000|Open-label Stabilization Period (SP)|Withdrawal of Consent|40|||
48969159|NCT01412060|157714770|FG001|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
48969160|NCT01412060|157714771|FG002|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
48969161|NCT01412060|157714769|FG000|Open-label Stabilization Period (SP)|Lost to Follow-up|9|||
48871301|NCT00092521|157367448|FG003|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0|||
48871302|NCT00092521|157367445|FG000|Vaccination (Day 1 Through Month 7)|Moved|14|||
48871303|NCT00092521|157367446|FG001|Vaccination (Day 1 Through Month 7)|Moved|1|||
48871304|NCT00092521|157367447|FG002|Vaccination (Day 1 Through Month 7)|Moved|18|||
48871305|NCT00092521|157367448|FG003|Vaccination (Day 1 Through Month 7)|Moved|0|||
48871306|NCT00092521|157367445|FG000|Vaccination (Day 1 Through Month 7)|Unblinded|2|||
48871307|NCT00092521|157367446|FG001|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
48871308|NCT00092521|157367447|FG002|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
48871309|NCT00092521|157367448|FG003|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
48871310|NCT00092521|157367445|FG000|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2|||
48871311|NCT00092521|157367446|FG001|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
48871312|NCT00092521|157367447|FG002|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
48871313|NCT00092521|157367448|FG003|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
48871314|NCT00092521|157367445|FG000|Follow-Up (After Month 7)|Subjects Continuing|34|||
48871315|NCT00092521|157367446|FG001|Follow-Up (After Month 7)|Subjects Continuing|4|||
48871316|NCT00092521|157367447|FG002|Follow-Up (After Month 7)|Subjects Continuing|35|||
48871317|NCT00092521|157367448|FG003|Follow-Up (After Month 7)|Subjects Continuing|0|||
48871318|NCT00092521|157367445|FG000|Follow-Up (After Month 7)|Subjects in Extension|13|||
48871319|NCT00092521|157367446|FG001|Follow-Up (After Month 7)|Subjects in Extension|109|||
48871320|NCT00092521|157367447|FG002|Follow-Up (After Month 7)|Subjects in Extension|412|||
48871321|NCT00092521|157367448|FG003|Follow-Up (After Month 7)|Subjects in Extension|0|||
48871322|NCT00092521|157367445|FG000|Follow-Up (After Month 7)|Adverse Event|1|||
48871323|NCT00092521|157367446|FG001|Follow-Up (After Month 7)|Adverse Event|0|||
48871324|NCT00092521|157367447|FG002|Follow-Up (After Month 7)|Adverse Event|0|||
48871325|NCT00092521|157367448|FG003|Follow-Up (After Month 7)|Adverse Event|0|||
48871326|NCT00092521|157367445|FG000|Follow-Up (After Month 7)|Death|2|||
48871327|NCT00092521|157367446|FG001|Follow-Up (After Month 7)|Death|0|||
48871328|NCT00092521|157367447|FG002|Follow-Up (After Month 7)|Death|1|||
48871329|NCT00092521|157367448|FG003|Follow-Up (After Month 7)|Death|0|||
48871330|NCT00092521|157367445|FG000|Follow-Up (After Month 7)|Lost to Follow-up|113|||
48871331|NCT00092521|157367446|FG001|Follow-Up (After Month 7)|Lost to Follow-up|14|||
48871332|NCT00092521|157367447|FG002|Follow-Up (After Month 7)|Lost to Follow-up|108|||
48871333|NCT00092521|157367448|FG003|Follow-Up (After Month 7)|Lost to Follow-up|0|||
48871334|NCT00092521|157367445|FG000|Follow-Up (After Month 7)|Protocol Violation|1|||
48871335|NCT00092521|157367446|FG001|Follow-Up (After Month 7)|Protocol Violation|1|||
48871336|NCT00092521|157367447|FG002|Follow-Up (After Month 7)|Protocol Violation|5|||
48871337|NCT00092521|157367448|FG003|Follow-Up (After Month 7)|Protocol Violation|0|||
48871338|NCT00092521|157367445|FG000|Follow-Up (After Month 7)|Withdrawal by Subject|40|||
48871339|NCT00092521|157367446|FG001|Follow-Up (After Month 7)|Withdrawal by Subject|6|||
48871340|NCT00092521|157367447|FG002|Follow-Up (After Month 7)|Withdrawal by Subject|51|||
48871341|NCT00092521|157367448|FG003|Follow-Up (After Month 7)|Withdrawal by Subject|0|||
48871342|NCT00092521|157367445|FG000|Follow-Up (After Month 7)|Moved|32|||
48871343|NCT00092521|157367446|FG001|Follow-Up (After Month 7)|Moved|2|||
48871344|NCT00092521|157367447|FG002|Follow-Up (After Month 7)|Moved|28|||
48871345|NCT00092521|157367448|FG003|Follow-Up (After Month 7)|Moved|0|||
48871346|NCT00092521|157367445|FG000|Follow-Up (After Month 7)|Site Terminated|3|||
48871347|NCT00092521|157367446|FG001|Follow-Up (After Month 7)|Site Terminated|0|||
48871348|NCT00092521|157367447|FG002|Follow-Up (After Month 7)|Site Terminated|3|||
48871349|NCT00092521|157367448|FG003|Follow-Up (After Month 7)|Site Terminated|0|||
48871350|NCT00092521|157367445|FG000|Follow-Up (After Month 7)|Travel|2|||
48871351|NCT00092521|157367446|FG001|Follow-Up (After Month 7)|Travel|0|||
48871352|NCT00092521|157367447|FG002|Follow-Up (After Month 7)|Travel|0|||
48871353|NCT00092521|157367448|FG003|Follow-Up (After Month 7)|Travel|0|||
48871354|NCT00092521|157367445|FG000|Follow-Up (After Month 7)|Visits Compressed|5|||
48871355|NCT00092521|157367446|FG001|Follow-Up (After Month 7)|Visits Compressed|0|||
48871356|NCT00092521|157367447|FG002|Follow-Up (After Month 7)|Visits Compressed|5|||
48871357|NCT00092521|157367448|FG003|Follow-Up (After Month 7)|Visits Compressed|0|||
48871358|NCT00092521|157367445|FG000|Extension Study (Group 4)|Excluded ineligible for extension|0|||
48969162|NCT01412060|157714770|FG001|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
48969163|NCT01412060|157714771|FG002|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
48871359|NCT00092521|157367446|FG001|Extension Study (Group 4)|Excluded ineligible for extension|0|||
48871360|NCT00092521|157367447|FG002|Extension Study (Group 4)|Excluded ineligible for extension|0|||
48871361|NCT00092521|157367448|FG003|Extension Study (Group 4)|Excluded ineligible for extension|23|||
48871362|NCT00092521|157367445|FG000|Extension Study (Group 4)|Adverse Event|0|||
48871363|NCT00092521|157367446|FG001|Extension Study (Group 4)|Adverse Event|0|||
48871364|NCT00092521|157367447|FG002|Extension Study (Group 4)|Adverse Event|0|||
48871365|NCT00092521|157367448|FG003|Extension Study (Group 4)|Adverse Event|2|||
48871366|NCT00092521|157367445|FG000|Extension Study (Group 4)|Lost to Follow-up|0|||
48871367|NCT00092521|157367446|FG001|Extension Study (Group 4)|Lost to Follow-up|0|||
48871368|NCT00092521|157367447|FG002|Extension Study (Group 4)|Lost to Follow-up|0|||
48969164|NCT01412060|157714769|FG000|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19|||
48969165|NCT01412060|157714770|FG001|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
48969166|NCT01412060|157714771|FG002|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
48969167|NCT01412060|157714769|FG000|Period Between SP and DBP|Protocol Violation|2|||
48969168|NCT01412060|157714770|FG001|Period Between SP and DBP|Protocol Violation|0|||
48969169|NCT01412060|157714771|FG002|Period Between SP and DBP|Protocol Violation|0|||
48969170|NCT01412060|157714769|FG000|Period Between SP and DBP|Withdrawal of Consent|2|||
48969171|NCT01412060|157714770|FG001|Period Between SP and DBP|Withdrawal of Consent|0|||
48969172|NCT01412060|157714771|FG002|Period Between SP and DBP|Withdrawal of Consent|0|||
48969173|NCT01412060|157714769|FG000|Period Between SP and DBP|Lost to Follow-up|1|||
48969174|NCT01412060|157714770|FG001|Period Between SP and DBP|Lost to Follow-up|0|||
48969175|NCT01412060|157714771|FG002|Period Between SP and DBP|Lost to Follow-up|0|||
48969176|NCT01412060|157714769|FG000|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4|||
48969177|NCT01412060|157714770|FG001|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
48969178|NCT01412060|157714771|FG002|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
48969179|NCT01412060|157714769|FG000|Period Between SP and DBP|Other Miscellaneous Reasons|55|||
48969180|NCT01412060|157714770|FG001|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
48969181|NCT01412060|157714771|FG002|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
48969182|NCT01412060|157714769|FG000|Double-blind Treatment Phase (DBP)|Adverse Event|0|||
48969183|NCT01412060|157714770|FG001|Double-blind Treatment Phase (DBP)|Adverse Event|5|||
48969184|NCT01412060|157714771|FG002|Double-blind Treatment Phase (DBP)|Adverse Event|6|||
48969185|NCT01412060|157714769|FG000|Double-blind Treatment Phase (DBP)|Protocol Violation|0|||
48969186|NCT01412060|157714770|FG001|Double-blind Treatment Phase (DBP)|Protocol Violation|4|||
48969187|NCT01412060|157714771|FG002|Double-blind Treatment Phase (DBP)|Protocol Violation|5|||
48969188|NCT01412060|157714769|FG000|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0|||
48969189|NCT01412060|157714770|FG001|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10|||
48969190|NCT01412060|157714771|FG002|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15|||
48969191|NCT01412060|157714769|FG000|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0|||
48969192|NCT01412060|157714770|FG001|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6|||
48969193|NCT01412060|157714771|FG002|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5|||
48969194|NCT01412060|157714769|FG000|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0|||
48969195|NCT01412060|157714770|FG001|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11|||
48969196|NCT01412060|157714771|FG002|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27|||
48969197|NCT01412060|157714769|FG000|Double-blind Treatment Phase (DBP)|Relapse|0|||
48671257|NCT03320330|156650486|FG001|Overall Study|Lack of Efficacy|5|||
48671258|NCT03320330|156650487|FG002|Overall Study|Lack of Efficacy|14|||
48671259|NCT03320330|156650485|FG000|Overall Study|Physician Decision|1|||
48671260|NCT03320330|156650486|FG001|Overall Study|Physician Decision|0|||
48671261|NCT03320330|156650487|FG002|Overall Study|Physician Decision|0|||
48671262|NCT00031460|156650488|FG000|Overall Study|Lost to Follow-up|0|||
48671263|NCT00031460|156650489|FG001|Overall Study|Lost to Follow-up|1|||
48969198|NCT01412060|157714770|FG001|Double-blind Treatment Phase (DBP)|Relapse|47|||
48969199|NCT01412060|157714771|FG002|Double-blind Treatment Phase (DBP)|Relapse|25|||
48969200|NCT00709124|157714772|FG000|Overall Study|Death|3|||
48969201|NCT00709124|157714773|FG001|Overall Study|Death|1|||
48969202|NCT00709124|157714772|FG000|Overall Study|encephalopathy; can't do assessment|1|||
48969203|NCT00709124|157714773|FG001|Overall Study|encephalopathy; can't do assessment|0|||
48969204|NCT00373490|157714775|FG000|Overall Study|Adverse Event|0|||
48969205|NCT00373490|157714776|FG001|Overall Study|Adverse Event|1|||
48969206|NCT00373490|157714775|FG000|Overall Study|Lack of Efficacy|9|||
48969207|NCT00373490|157714776|FG001|Overall Study|Lack of Efficacy|4|||
48969208|NCT00373490|157714775|FG000|Overall Study|Withdrawal by Subject|0|||
48969209|NCT00373490|157714776|FG001|Overall Study|Withdrawal by Subject|1|||
48969210|NCT02148211|157714777|FG000|Overall Study|Lost to Follow-up|352|||
48969211|NCT02017899|157717101|FG000|Overall Study|Withdrawal by Subject|0|||
48969212|NCT02017899|157717102|FG001|Overall Study|Withdrawal by Subject|0|||
48969213|NCT02017899|157717103|FG002|Overall Study|Withdrawal by Subject|0|||
48969214|NCT02017899|157717104|FG003|Overall Study|Withdrawal by Subject|1|||
48969215|NCT02017899|157717105|FG004|Overall Study|Withdrawal by Subject|1|||
48969216|NCT02017899|157717106|FG005|Overall Study|Withdrawal by Subject|0|||
48671264|NCT00031460|156650488|FG000|Overall Study|Withdrawal by Subject|1|||
48671265|NCT00031460|156650489|FG001|Overall Study|Withdrawal by Subject|1|||
48671266|NCT00031460|156650488|FG000|Overall Study|Non-Compliant|1|||
48969217|NCT00369967|157717108|FG000|Overall Study|Lost to Follow-up|23|||
48969218|NCT00369967|157717109|FG001|Overall Study|Lost to Follow-up|12|||
48969219|NCT00804843|157717113|FG000|Overall Study|Protocol Violation|1|||
48969220|NCT00804843|157717114|FG001|Overall Study|Protocol Violation|0|||
48969221|NCT00804843|157717113|FG000|Overall Study|Adverse Event|8|||
48969222|NCT00804843|157717114|FG001|Overall Study|Adverse Event|5|||
48969223|NCT00804843|157717113|FG000|Overall Study|Withdrawal by Subject|1|||
48671267|NCT00031460|156650489|FG001|Overall Study|Non-Compliant|1|||
48671268|NCT00031460|156650488|FG000|Overall Study|Death|0|||
48671269|NCT00031460|156650489|FG001|Overall Study|Death|1|||
48969224|NCT00804843|157717114|FG001|Overall Study|Withdrawal by Subject|2|||
48969225|NCT00884221|157717115|FG000|Overall Study|Withdrawal by Subject|0|||
48969226|NCT00884221|157717116|FG001|Overall Study|Withdrawal by Subject|3|||
48969227|NCT00884221|157717115|FG000|Overall Study|Adverse Event|6|||
48969228|NCT00884221|157717116|FG001|Overall Study|Adverse Event|3|||
48969229|NCT00884221|157717115|FG000|Overall Study|Protocol Violation|16|||
48969230|NCT00884221|157717116|FG001|Overall Study|Protocol Violation|13|||
48969231|NCT00884221|157717115|FG000|Overall Study|Cancellation of Cycle and Other Reason|12|||
48969232|NCT00884221|157717116|FG001|Overall Study|Cancellation of Cycle and Other Reason|13|||
48969233|NCT01824693|157717117|FG000|Overall Study|Death|0|||
48969234|NCT01824693|157717118|FG001|Overall Study|Death|1|||
48969235|NCT01824693|157717119|FG002|Overall Study|Death|0|||
48969236|NCT01824693|157717117|FG000|Overall Study|Physician Decision|1|||
48969237|NCT01824693|157717118|FG001|Overall Study|Physician Decision|1|||
48969238|NCT01824693|157717119|FG002|Overall Study|Physician Decision|1|||
48969239|NCT01824693|157717117|FG000|Overall Study|Withdrawal by Subject|0|||
48969240|NCT01824693|157717118|FG001|Overall Study|Withdrawal by Subject|0|||
48969241|NCT01824693|157717119|FG002|Overall Study|Withdrawal by Subject|1|||
48969242|NCT01824693|157717117|FG000|Overall Study|Progressive Disease|0|||
48969243|NCT01824693|157717118|FG001|Overall Study|Progressive Disease|5|||
48969244|NCT01824693|157717119|FG002|Overall Study|Progressive Disease|0|||
48969245|NCT01824693|157717117|FG000|Overall Study|Ineligible|0|||
48969246|NCT01824693|157717118|FG001|Overall Study|Ineligible|0|||
48969247|NCT01824693|157717119|FG002|Overall Study|Ineligible|3|||
48969248|NCT01824693|157717117|FG000|Overall Study|No Transplant Planned|0|||
48969249|NCT01824693|157717118|FG001|Overall Study|No Transplant Planned|0|||
48969250|NCT01824693|157717119|FG002|Overall Study|No Transplant Planned|10|||
48969251|NCT00003476|157717120|FG000|Overall Study|Not evaluable|1|||
48969252|NCT02667457|157717121|FG000|Overall Study|Withdrawal by Subject|1|||
48969253|NCT02667457|157717122|FG001|Overall Study|Withdrawal by Subject|0|||
48969254|NCT02667457|157717121|FG000|Overall Study|Other Reason|0|||
48969255|NCT02667457|157717122|FG001|Overall Study|Other Reason|2|||
48969256|NCT02475850|157717125|FG000|Overall Study|Death|155|||
48969257|NCT02475850|157717126|FG001|Overall Study|Death|141|||
48969258|NCT02475850|157717125|FG000|Overall Study|Lost to Follow-up|217|||
48969259|NCT02475850|157717126|FG001|Overall Study|Lost to Follow-up|188|||
48969260|NCT02475850|157717125|FG000|Overall Study|Withdrawal by Subject|221|||
48969261|NCT02475850|157717126|FG001|Overall Study|Withdrawal by Subject|155|||
48969262|NCT00781963|157717132|FG000|Overall Study|Death|3|||
48969263|NCT00781963|157717133|FG001|Overall Study|Death|0|||
48969264|NCT00781963|157717132|FG000|Overall Study|Lost to Follow-up|2|||
48969265|NCT00781963|157717133|FG001|Overall Study|Lost to Follow-up|1|||
48969266|NCT00781963|157717132|FG000|Overall Study|Withdrawal by Subject|3|||
48671270|NCT00031460|156650488|FG000|Overall Study|Reactivation of Disease|5|||
48671271|NCT00031460|156650489|FG001|Overall Study|Reactivation of Disease|9|||
48671272|NCT00031460|156650488|FG000|Overall Study|Disruption of blinded drug supply|2|||
48671273|NCT00031460|156650489|FG001|Overall Study|Disruption of blinded drug supply|0|||
48671274|NCT00031460|156650488|FG000|Overall Study|Confirmed unevaluable|0|||
48671275|NCT00031460|156650489|FG001|Overall Study|Confirmed unevaluable|1|||
48671276|NCT02198794|156650490|FG000|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79|||
48671277|NCT02198794|156650491|FG001|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
48671278|NCT02198794|156650492|FG002|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
48671279|NCT02198794|156650493|FG003|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
48671280|NCT02198794|156650490|FG000|Part A: Open-Label (158 Weeks)|Adverse Event|33|||
48671281|NCT02198794|156650491|FG001|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
48671282|NCT02198794|156650492|FG002|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
48760678|NCT00644969|156972294|FG000|Treatment Phase|Withdrawal by Subject|4|||
48969267|NCT00781963|157717133|FG001|Overall Study|Withdrawal by Subject|1|||
48671283|NCT02198794|156650493|FG003|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
48760679|NCT00644969|156972295|FG001|Treatment Phase|Withdrawal by Subject|0|||
48760680|NCT00644969|156972294|FG000|Treatment Phase|Lost to Follow-up|2|||
48760681|NCT00644969|156972295|FG001|Treatment Phase|Lost to Follow-up|2|||
48760682|NCT00644969|156972294|FG000|Treatment Phase|Other|4|||
48760683|NCT00644969|156972295|FG001|Treatment Phase|Other|1|||
48760684|NCT00644969|156972294|FG000|Post Treatment Phase|Death|1|||
48760685|NCT00644969|156972295|FG001|Post Treatment Phase|Death|0|||
48760686|NCT00644969|156972294|FG000|Post Treatment Phase|Withdrawal by Subject|4|||
48760687|NCT00644969|156972295|FG001|Post Treatment Phase|Withdrawal by Subject|2|||
48760688|NCT00644969|156972294|FG000|Post Treatment Phase|Lost to Follow-up|4|||
48969268|NCT00781963|157717132|FG000|Overall Study|Refused follow-up|9|||
48969269|NCT00781963|157717133|FG001|Overall Study|Refused follow-up|0|||
48969270|NCT03297216|157717134|FG000|Overall Study|Death|0|||
48969271|NCT03297216|157717135|FG001|Overall Study|Death|1|||
48969272|NCT03297216|157717134|FG000|Overall Study|Miscarriage|0|||
48969273|NCT03297216|157717135|FG001|Overall Study|Miscarriage|2|||
48760689|NCT00644969|156972295|FG001|Post Treatment Phase|Lost to Follow-up|1|||
48969274|NCT03297216|157717134|FG000|Overall Study|Lost to Follow-up|3|||
48969275|NCT03297216|157717135|FG001|Overall Study|Lost to Follow-up|2|||
48671284|NCT02198794|156650490|FG000|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24|||
48671285|NCT02198794|156650491|FG001|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
48671286|NCT02198794|156650492|FG002|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
48671287|NCT02198794|156650493|FG003|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
48671288|NCT02198794|156650490|FG000|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9|||
48671289|NCT02198794|156650491|FG001|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
48671290|NCT02198794|156650492|FG002|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
48671291|NCT02198794|156650493|FG003|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
48671292|NCT02198794|156650490|FG000|Part A: Open-Label (158 Weeks)|Death|8|||
48671293|NCT02198794|156650491|FG001|Part A: Open-Label (158 Weeks)|Death|0|||
48671294|NCT02198794|156650492|FG002|Part A: Open-Label (158 Weeks)|Death|0|||
48671295|NCT02198794|156650493|FG003|Part A: Open-Label (158 Weeks)|Death|0|||
48671296|NCT02198794|156650490|FG000|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3|||
48671297|NCT02198794|156650491|FG001|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
48671298|NCT02198794|156650492|FG002|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
48760690|NCT00644969|156972294|FG000|Post Treatment Phase|Other|1|||
48760691|NCT00644969|156972295|FG001|Post Treatment Phase|Other|0|||
48760692|NCT00697515|156972296|FG000|Dose Optimization Period|Adverse Event|4|||
48760693|NCT00697515|156972297|FG001|Dose Optimization Period|Adverse Event|0|||
48760694|NCT00697515|156972296|FG000|Dose Optimization Period|Withdrawal by Subject|5|||
48760695|NCT00697515|156972297|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
48760696|NCT00697515|156972296|FG000|Dose Optimization Period|Lost to Follow-up|2|||
48760697|NCT00697515|156972297|FG001|Dose Optimization Period|Lost to Follow-up|0|||
48760698|NCT00697515|156972296|FG000|Dose Optimization Period|sponsor request|2|||
48760699|NCT00697515|156972297|FG001|Dose Optimization Period|sponsor request|0|||
48760700|NCT00697515|156972296|FG000|Dose Optimization Period|called to active duty|1|||
48760701|NCT00697515|156972297|FG001|Dose Optimization Period|called to active duty|0|||
48760702|NCT00697515|156972296|FG000|Dose Optimization Period|elevated QTc|1|||
48760703|NCT00697515|156972297|FG001|Dose Optimization Period|elevated QTc|0|||
48760704|NCT00697515|156972296|FG000|First Intervention (Crossover Period)|Natural disaster|8|||
48760705|NCT00697515|156972297|FG001|First Intervention (Crossover Period)|Natural disaster|9|||
48871369|NCT00092521|157367448|FG003|Extension Study (Group 4)|Lost to Follow-up|87|||
48871370|NCT00092521|157367445|FG000|Extension Study (Group 4)|Pregnancy|0|||
48871371|NCT00092521|157367446|FG001|Extension Study (Group 4)|Pregnancy|0|||
48871372|NCT00092521|157367447|FG002|Extension Study (Group 4)|Pregnancy|0|||
48871373|NCT00092521|157367448|FG003|Extension Study (Group 4)|Pregnancy|4|||
48871374|NCT00092521|157367445|FG000|Extension Study (Group 4)|Protocol Violation|0|||
48871375|NCT00092521|157367446|FG001|Extension Study (Group 4)|Protocol Violation|0|||
48871376|NCT00092521|157367447|FG002|Extension Study (Group 4)|Protocol Violation|0|||
48871377|NCT00092521|157367448|FG003|Extension Study (Group 4)|Protocol Violation|2|||
48871378|NCT00092521|157367445|FG000|Extension Study (Group 4)|Withdrawal by Subject|0|||
48871379|NCT00092521|157367446|FG001|Extension Study (Group 4)|Withdrawal by Subject|0|||
48871380|NCT00092521|157367447|FG002|Extension Study (Group 4)|Withdrawal by Subject|0|||
48871381|NCT00092521|157367448|FG003|Extension Study (Group 4)|Withdrawal by Subject|46|||
48871382|NCT00092521|157367445|FG000|Extension Study (Group 4)|Moved|0|||
48871383|NCT00092521|157367446|FG001|Extension Study (Group 4)|Moved|0|||
48871384|NCT00092521|157367447|FG002|Extension Study (Group 4)|Moved|0|||
48871385|NCT00092521|157367448|FG003|Extension Study (Group 4)|Moved|16|||
48871386|NCT00092521|157367445|FG000|Extension Study (Group 4)|Site Terminated|0|||
48871387|NCT00092521|157367446|FG001|Extension Study (Group 4)|Site Terminated|0|||
48871388|NCT00092521|157367447|FG002|Extension Study (Group 4)|Site Terminated|0|||
48871389|NCT00092521|157367448|FG003|Extension Study (Group 4)|Site Terminated|4|||
48871390|NCT00092521|157367445|FG000|Extension Study (Group 4)|Unable/unwilling to return|0|||
48871391|NCT00092521|157367446|FG001|Extension Study (Group 4)|Unable/unwilling to return|0|||
48871392|NCT00092521|157367447|FG002|Extension Study (Group 4)|Unable/unwilling to return|0|||
48871393|NCT00092521|157367448|FG003|Extension Study (Group 4)|Unable/unwilling to return|25|||
48871394|NCT02720185|157367449|FG000|Overall Study|Lost to Follow-up|1|||
48871395|NCT03475056|157367450|FG000|Overall Study|Lost to Follow-up|0|||
48871396|NCT03475056|157367451|FG001|Overall Study|Lost to Follow-up|1|||
48871397|NCT03475056|157367450|FG000|Overall Study|Moved from Area|0|||
48871398|NCT03475056|157367451|FG001|Overall Study|Moved from Area|2|||
48871399|NCT00195442|157367453|FG000|Overall Study|Less than expected therapeutic effect|38|||
48871400|NCT00195442|157367453|FG000|Overall Study|Lost to Follow-up|27|||
48871401|NCT00195442|157367453|FG000|Overall Study|Switch to other Factor VIII preparation|23|||
48871402|NCT00195442|157367453|FG000|Overall Study|Intermittent product shortage|21|||
48871403|NCT00195442|157367453|FG000|Overall Study|Death|7|||
48871404|NCT00195442|157367453|FG000|Overall Study|No reason specified|4|||
48871405|NCT00195442|157367453|FG000|Overall Study|Poor cooperation|2|||
48871406|NCT00195442|157367453|FG000|Overall Study|Other|14|||
48871407|NCT01202409|157367458|FG000|Overall Study|Adverse Event|1|||
48871408|NCT01202409|157367458|FG000|Overall Study|Ineligible - KRAS mutants|7|||
48871409|NCT00468858|157367462|FG000|Overall Study|Adverse Event|0|||
48871410|NCT00468858|157367463|FG001|Overall Study|Adverse Event|1|||
48671299|NCT02198794|156650493|FG003|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
48671300|NCT02198794|156650490|FG000|Part A: Open-Label (158 Weeks)|Other than specified|5|||
48671301|NCT02198794|156650491|FG001|Part A: Open-Label (158 Weeks)|Other than specified|0|||
48671302|NCT02198794|156650492|FG002|Part A: Open-Label (158 Weeks)|Other than specified|0|||
48671303|NCT02198794|156650493|FG003|Part A: Open-Label (158 Weeks)|Other than specified|0|||
48671304|NCT02198794|156650490|FG000|Part A: Open-Label (158 Weeks)|Study terminated|1|||
48671305|NCT02198794|156650491|FG001|Part A: Open-Label (158 Weeks)|Study terminated|0|||
48671306|NCT02198794|156650492|FG002|Part A: Open-Label (158 Weeks)|Study terminated|0|||
48671307|NCT02198794|156650493|FG003|Part A: Open-Label (158 Weeks)|Study terminated|0|||
48671308|NCT02198794|156650490|FG000|Part A: Open-Label (158 Weeks)|Protocol deviation|1|||
48969276|NCT00603733|157717136|FG000|Active Phase ITT|Adverse Event|8|||
48969277|NCT00603733|157717137|FG001|Active Phase ITT|Adverse Event|7|||
48969278|NCT00603733|157717136|FG000|Active Phase ITT|Withdrawal by Subject|0|||
48969279|NCT00603733|157717137|FG001|Active Phase ITT|Withdrawal by Subject|3|||
48969280|NCT00603733|157717136|FG000|Active Phase ITT|Lost to Follow-up|0|||
48969281|NCT00603733|157717137|FG001|Active Phase ITT|Lost to Follow-up|1|||
48969282|NCT00603733|157717136|FG000|Active Phase ITT|Did not meet inclusion/exclusion|1|||
48969283|NCT00603733|157717137|FG001|Active Phase ITT|Did not meet inclusion/exclusion|3|||
48969284|NCT00603733|157717136|FG000|Active Phase ITT|Lack of Efficacy|1|||
48969285|NCT00603733|157717137|FG001|Active Phase ITT|Lack of Efficacy|2|||
48969286|NCT00603733|157717136|FG000|Active Phase ITT|Subject moved, site closed|1|||
48969287|NCT00603733|157717137|FG001|Active Phase ITT|Subject moved, site closed|1|||
48969288|NCT00603733|157717136|FG000|Run-In Phase - 4 Weeks|Adverse Event|2|||
48969289|NCT00603733|157717137|FG001|Run-In Phase - 4 Weeks|Adverse Event|1|||
48969290|NCT00603733|157717136|FG000|Run-In Phase - 4 Weeks|Withdrawal by Subject|4|||
48969291|NCT00603733|157717137|FG001|Run-In Phase - 4 Weeks|Withdrawal by Subject|1|||
48969292|NCT00603733|157717136|FG000|Run-In Phase - 4 Weeks|Lost to Follow-up|1|||
48969293|NCT00603733|157717137|FG001|Run-In Phase - 4 Weeks|Lost to Follow-up|0|||
48969294|NCT00603733|157717136|FG000|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5|||
48969295|NCT00603733|157717137|FG001|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10|||
48969296|NCT00603733|157717136|FG000|Run-In Phase - 4 Weeks|Lack of Efficacy|2|||
48969297|NCT00603733|157717137|FG001|Run-In Phase - 4 Weeks|Lack of Efficacy|1|||
48969298|NCT00603733|157717136|FG000|Maintenance Phase ITT|Adverse Event|3|||
48969299|NCT00603733|157717137|FG001|Maintenance Phase ITT|Adverse Event|6|||
48969300|NCT00603733|157717136|FG000|Maintenance Phase ITT|Withdrawal by Subject|1|||
48969301|NCT00603733|157717137|FG001|Maintenance Phase ITT|Withdrawal by Subject|0|||
48969302|NCT00603733|157717136|FG000|Maintenance Phase ITT|Protocol Violation|1|||
48969303|NCT00603733|157717137|FG001|Maintenance Phase ITT|Protocol Violation|1|||
48969304|NCT00603733|157717136|FG000|Maintenance Phase ITT|Lost to Follow-up|0|||
48969305|NCT00603733|157717137|FG001|Maintenance Phase ITT|Lost to Follow-up|1|||
48969306|NCT00603733|157717136|FG000|Maintenance Phase ITT|Lack of Efficacy|2|||
48969307|NCT00603733|157717137|FG001|Maintenance Phase ITT|Lack of Efficacy|2|||
48969308|NCT00603733|157717136|FG000|Maintenance Phase ITT|Physician Decision|0|||
48969309|NCT00603733|157717137|FG001|Maintenance Phase ITT|Physician Decision|1|||
48671309|NCT02198794|156650491|FG001|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
48671310|NCT02198794|156650492|FG002|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
48969310|NCT00603733|157717136|FG000|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3|||
48969311|NCT00603733|157717137|FG001|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5|||
48969312|NCT02064205|157717138|FG000|Overall Study|Withdrawal by Subject|1|||
48969313|NCT03057951|157717139|FG000|Overall Study|Adverse Event|553|||
48969314|NCT03057951|157717140|FG001|Overall Study|Adverse Event|575|||
48969315|NCT03057951|157717139|FG000|Overall Study|Protocol Violation|30|||
48969316|NCT03057951|157717140|FG001|Overall Study|Protocol Violation|24|||
48969317|NCT03057951|157717139|FG000|Overall Study|Lost to Follow-up|6|||
48969318|NCT03057951|157717140|FG001|Overall Study|Lost to Follow-up|16|||
48969319|NCT03057951|157717139|FG000|Overall Study|Patient refusal to continue, not due to AE|304|||
48969320|NCT03057951|157717140|FG001|Overall Study|Patient refusal to continue, not due to AE|284|||
48969321|NCT03057951|157717139|FG000|Overall Study|Study drug stopped, reason missing|6|||
48671311|NCT02198794|156650493|FG003|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
48671312|NCT02198794|156650490|FG000|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142|||
48671313|NCT02198794|156650491|FG001|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
48671314|NCT02198794|156650492|FG002|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
48671315|NCT02198794|156650493|FG003|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
48671316|NCT02198794|156650490|FG000|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
48671317|NCT02198794|156650491|FG001|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3|||
48760706|NCT00697515|156972296|FG000|First Intervention (Crossover Period)|Adverse Event|0|||
48969322|NCT03057951|157717140|FG001|Overall Study|Study drug stopped, reason missing|1|||
48969323|NCT03057951|157717139|FG000|Overall Study|Medical advice|6|||
48969324|NCT03057951|157717140|FG001|Overall Study|Medical advice|2|||
48969325|NCT03057951|157717139|FG000|Overall Study|Due to Covid-19 Pandemic|2|||
48969326|NCT03057951|157717140|FG001|Overall Study|Due to Covid-19 Pandemic|8|||
48969327|NCT03057951|157717139|FG000|Overall Study|Investigator decision|2|||
48969328|NCT03057951|157717140|FG001|Overall Study|Investigator decision|0|||
48969329|NCT03057951|157717139|FG000|Overall Study|Patient decision|5|||
48969330|NCT03057951|157717140|FG001|Overall Study|Patient decision|2|||
48969331|NCT03057951|157717139|FG000|Overall Study|Not attending study visits|3|||
48969332|NCT03057951|157717140|FG001|Overall Study|Not attending study visits|0|||
48969333|NCT03057951|157717139|FG000|Overall Study|Patient moved away|3|||
48969334|NCT03057951|157717140|FG001|Overall Study|Patient moved away|4|||
48969335|NCT03057951|157717139|FG000|Overall Study|Other reason than stated above|23|||
48969336|NCT03057951|157717140|FG001|Overall Study|Other reason than stated above|29|||
48969337|NCT03057951|157717139|FG000|Overall Study|Not treated|2|||
48969338|NCT03057951|157717140|FG001|Overall Study|Not treated|1|||
48969339|NCT03434418|157717144|FG000|Overall Study|Disease Progression|11|||
48969340|NCT03434418|157717144|FG000|Overall Study|Adverse Event|2|||
48969341|NCT03434418|157717144|FG000|Overall Study|Physician Decision|1|||
48969342|NCT03434418|157717144|FG000|Overall Study|Decline in Performance Status (PS)|1|||
48969343|NCT00225147|157717155|FG000|Open-label Phase|Lost to Follow-up|0|||
48969344|NCT00225147|157717156|FG001|Open-label Phase|Lost to Follow-up|0|||
48969345|NCT00225147|157717157|FG002|Open-label Phase|Lost to Follow-up|0|||
48969346|NCT00225147|157717158|FG003|Open-label Phase|Lost to Follow-up|4|||
48969347|NCT00225147|157717155|FG000|Open-label Phase|Withdrawal by Subject|0|||
48969348|NCT00225147|157717156|FG001|Open-label Phase|Withdrawal by Subject|0|||
48969349|NCT00225147|157717157|FG002|Open-label Phase|Withdrawal by Subject|0|||
48969350|NCT00225147|157717158|FG003|Open-label Phase|Withdrawal by Subject|6|||
48969351|NCT04019795|157717159|FG000|Overall Study|Withdrawal by Subject|1|||
48969352|NCT04019795|157717160|FG001|Overall Study|Withdrawal by Subject|2|||
48969353|NCT04019795|157717161|FG002|Overall Study|Withdrawal by Subject|2|||
48969354|NCT04019795|157717162|FG003|Overall Study|Withdrawal by Subject|1|||
48969355|NCT04019795|157717159|FG000|Overall Study|Lost to Follow-up|0|||
48969356|NCT04019795|157717160|FG001|Overall Study|Lost to Follow-up|1|||
48969357|NCT04019795|157717161|FG002|Overall Study|Lost to Follow-up|1|||
48969358|NCT04019795|157717162|FG003|Overall Study|Lost to Follow-up|2|||
48969359|NCT04019795|157717159|FG000|Overall Study|Treatment non-compliance|3|||
48969360|NCT04019795|157717160|FG001|Overall Study|Treatment non-compliance|1|||
48969361|NCT04019795|157717161|FG002|Overall Study|Treatment non-compliance|2|||
48969362|NCT04019795|157717162|FG003|Overall Study|Treatment non-compliance|0|||
48969363|NCT04019795|157717159|FG000|Overall Study|Physician Decision|0|||
48969364|NCT04019795|157717160|FG001|Overall Study|Physician Decision|0|||
48969365|NCT04019795|157717161|FG002|Overall Study|Physician Decision|1|||
48969366|NCT04019795|157717162|FG003|Overall Study|Physician Decision|0|||
48969367|NCT04019795|157717159|FG000|Overall Study|Adverse Event|1|||
48969368|NCT04019795|157717160|FG001|Overall Study|Adverse Event|0|||
48969369|NCT04019795|157717161|FG002|Overall Study|Adverse Event|0|||
48969370|NCT04019795|157717162|FG003|Overall Study|Adverse Event|0|||
48969371|NCT04671342|157717163|FG000|Consented and Screened (Visit 1)|Screen Failure|3|||
48969372|NCT04671342|157717163|FG000|Consented and Screened (Visit 1)|Lost to Follow-up|4|||
48969373|NCT04671342|157717163|FG000|Consented and Screened (Visit 1)|Withdrawal by Subject|1|||
48969374|NCT04671342|157717163|FG000|Consented and Screened (Visit 1)|Withdrawn by sponsor due to recruitment consideration (CSA patients)|39|||
48969375|NCT04671342|157717163|FG000|Completed Visit 2 With Evaluable Data|Unusable device data|58|||
48969376|NCT04671342|157717163|FG000|Completed Visit 2 With Evaluable Data|Unusable PSG data|1|||
48969377|NCT02273037|157717166|FG000|Overall Study|Lost to Follow-up|1|||
48969378|NCT02273037|157717167|FG001|Overall Study|Lost to Follow-up|0|||
48969379|NCT02273037|157717166|FG000|Overall Study|Delivered before monitoring initiated|1|||
48969380|NCT02273037|157717167|FG001|Overall Study|Delivered before monitoring initiated|3|||
48969381|NCT02273037|157717166|FG000|Overall Study|Breech delivery|2|||
48969382|NCT02273037|157717167|FG001|Overall Study|Breech delivery|3|||
48969383|NCT02273037|157717166|FG000|Overall Study|Multiple delivery|2|||
48969384|NCT02273037|157717167|FG001|Overall Study|Multiple delivery|2|||
48969385|NCT02273037|157717166|FG000|Overall Study|Other complication|2|||
48969386|NCT02273037|157717167|FG001|Overall Study|Other complication|0|||
48969387|NCT02899377|157717171|FG000|Overall Study|Adverse Event|1|||
48969388|NCT02899377|157717172|FG001|Overall Study|Adverse Event|0|||
48969389|NCT00851253|157717173|FG000|Overall Study|Disease Progression|1|||
48969390|NCT00851253|157717174|FG001|Overall Study|Disease Progression|0|||
48969391|NCT01231607|157717175|FG000|Overall Study|Adverse Event|0|||
48671318|NCT02198794|156650492|FG002|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1|||
48671319|NCT02198794|156650493|FG003|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
48671320|NCT02198794|156650490|FG000|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
48671321|NCT02198794|156650491|FG001|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
48671322|NCT02198794|156650492|FG002|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
48671323|NCT02198794|156650493|FG003|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
48969392|NCT01231607|157717176|FG001|Overall Study|Adverse Event|8|||
48969393|NCT01231607|157717177|FG002|Overall Study|Adverse Event|4|||
48969394|NCT01231607|157717178|FG003|Overall Study|Adverse Event|4|||
48969395|NCT01231607|157717179|FG004|Overall Study|Adverse Event|5|||
48969396|NCT01231607|157717175|FG000|Overall Study|Lost to Follow-up|13|||
48969397|NCT01231607|157717176|FG001|Overall Study|Lost to Follow-up|11|||
48671324|NCT02198794|156650490|FG000|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
48671325|NCT02198794|156650491|FG001|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
48671326|NCT02198794|156650492|FG002|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
48671327|NCT02198794|156650493|FG003|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|3|||
48671328|NCT02198794|156650490|FG000|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
48671329|NCT02198794|156650491|FG001|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
48671330|NCT02198794|156650492|FG002|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
48969398|NCT01231607|157717177|FG002|Overall Study|Lost to Follow-up|10|||
48969399|NCT01231607|157717178|FG003|Overall Study|Lost to Follow-up|10|||
48969400|NCT01231607|157717179|FG004|Overall Study|Lost to Follow-up|4|||
48969401|NCT01231607|157717175|FG000|Overall Study|Physician Decision|4|||
48969402|NCT01231607|157717176|FG001|Overall Study|Physician Decision|4|||
48969403|NCT01231607|157717177|FG002|Overall Study|Physician Decision|3|||
48969404|NCT01231607|157717178|FG003|Overall Study|Physician Decision|5|||
48969405|NCT01231607|157717179|FG004|Overall Study|Physician Decision|4|||
48969406|NCT01231607|157717175|FG000|Overall Study|Protocol Violation|3|||
48969407|NCT01231607|157717176|FG001|Overall Study|Protocol Violation|2|||
48969408|NCT01231607|157717177|FG002|Overall Study|Protocol Violation|0|||
48969409|NCT01231607|157717178|FG003|Overall Study|Protocol Violation|2|||
48671331|NCT02198794|156650493|FG003|Part C: Safety Assessment (52 Weeks)|Adverse Event|2|||
48671332|NCT02198794|156650490|FG000|Part C: Safety Assessment (52 Weeks)|Death|0|||
48671333|NCT02198794|156650491|FG001|Part C: Safety Assessment (52 Weeks)|Death|0|||
48671334|NCT02198794|156650492|FG002|Part C: Safety Assessment (52 Weeks)|Death|0|||
48671335|NCT02198794|156650493|FG003|Part C: Safety Assessment (52 Weeks)|Death|2|||
48671336|NCT02905006|156650496|FG000|Overall Study|Adverse Event|1|||
48671337|NCT02905006|156650497|FG001|Overall Study|Adverse Event|1|||
48671338|NCT02905006|156650498|FG002|Overall Study|Adverse Event|1|||
48671339|NCT02905006|156650499|FG003|Overall Study|Adverse Event|1|||
48671340|NCT02905006|156650500|FG004|Overall Study|Adverse Event|0|||
48671341|NCT02905006|156650501|FG005|Overall Study|Adverse Event|1|||
48671342|NCT02905006|156650496|FG000|Overall Study|Lack of Efficacy|1|||
48671343|NCT02905006|156650497|FG001|Overall Study|Lack of Efficacy|0|||
48671344|NCT02905006|156650498|FG002|Overall Study|Lack of Efficacy|0|||
48671345|NCT02905006|156650499|FG003|Overall Study|Lack of Efficacy|0|||
48671346|NCT02905006|156650500|FG004|Overall Study|Lack of Efficacy|0|||
48671347|NCT02905006|156650501|FG005|Overall Study|Lack of Efficacy|0|||
48671348|NCT02905006|156650496|FG000|Overall Study|Protocol Violation|2|||
48671349|NCT02905006|156650497|FG001|Overall Study|Protocol Violation|0|||
48671350|NCT02905006|156650498|FG002|Overall Study|Protocol Violation|0|||
48671351|NCT02905006|156650499|FG003|Overall Study|Protocol Violation|0|||
48671352|NCT02905006|156650500|FG004|Overall Study|Protocol Violation|0|||
48671353|NCT02905006|156650501|FG005|Overall Study|Protocol Violation|0|||
48671354|NCT02905006|156650496|FG000|Overall Study|Lost to Follow-up|0|||
48671355|NCT02905006|156650497|FG001|Overall Study|Lost to Follow-up|0|||
48671356|NCT02905006|156650498|FG002|Overall Study|Lost to Follow-up|0|||
48671357|NCT02905006|156650499|FG003|Overall Study|Lost to Follow-up|1|||
48871411|NCT00468858|157367464|FG002|Overall Study|Adverse Event|0|||
48871412|NCT00468858|157367462|FG000|Overall Study|Withdrawal by Subject|7|||
48871413|NCT00468858|157367463|FG001|Overall Study|Withdrawal by Subject|4|||
48871414|NCT00468858|157367464|FG002|Overall Study|Withdrawal by Subject|5|||
48871415|NCT00468858|157367462|FG000|Overall Study|Relocation|1|||
48871416|NCT00468858|157367463|FG001|Overall Study|Relocation|3|||
48871417|NCT00468858|157367464|FG002|Overall Study|Relocation|3|||
48871418|NCT00468858|157367462|FG000|Overall Study|Lost to Follow-up|1|||
48871419|NCT00468858|157367463|FG001|Overall Study|Lost to Follow-up|2|||
48871420|NCT00468858|157367464|FG002|Overall Study|Lost to Follow-up|5|||
48871421|NCT00468858|157367462|FG000|Overall Study|Other|0|||
48871422|NCT00468858|157367463|FG001|Overall Study|Other|0|||
48871423|NCT00468858|157367464|FG002|Overall Study|Other|1|||
48871424|NCT00853229|157367468|FG000|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
48871425|NCT00853229|157367469|FG001|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
48871426|NCT03187353|157367474|FG000|First Intervention (6 Weeks)|Adverse Event|3|||
48871427|NCT03187353|157367475|FG001|First Intervention (6 Weeks)|Adverse Event|2|||
48871428|NCT03187353|157367474|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
48871429|NCT03187353|157367475|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
48871430|NCT03187353|157367474|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
48871431|NCT03187353|157367475|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
48871432|NCT03187353|157367474|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
48871433|NCT03187353|157367475|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
48871434|NCT03187353|157367474|FG000|Washout (2 Weeks)|Adverse Event|2|||
48871435|NCT03187353|157367475|FG001|Washout (2 Weeks)|Adverse Event|0|||
48871436|NCT03187353|157367474|FG000|Second Intervention (6 Weeks)|Adverse Event|1|||
48871437|NCT03187353|157367475|FG001|Second Intervention (6 Weeks)|Adverse Event|0|||
48871438|NCT02215954|157367476|FG000|Overall Study|Adverse Event|0|||
48969410|NCT01231607|157717179|FG004|Overall Study|Protocol Violation|2|||
48969411|NCT01231607|157717175|FG000|Overall Study|Withdrawal by Subject|9|||
48671358|NCT02905006|156650500|FG004|Overall Study|Lost to Follow-up|1|||
48671359|NCT02905006|156650501|FG005|Overall Study|Lost to Follow-up|0|||
48671360|NCT02905006|156650496|FG000|Overall Study|Withdrawal by Subject|0|||
48671361|NCT02905006|156650497|FG001|Overall Study|Withdrawal by Subject|0|||
48671362|NCT02905006|156650498|FG002|Overall Study|Withdrawal by Subject|1|||
48671363|NCT02905006|156650499|FG003|Overall Study|Withdrawal by Subject|1|||
48671364|NCT02905006|156650500|FG004|Overall Study|Withdrawal by Subject|0|||
48671365|NCT02905006|156650501|FG005|Overall Study|Withdrawal by Subject|1|||
48671366|NCT02905006|156650496|FG000|Overall Study|Screening exclusion criteria met|1|||
48671367|NCT02905006|156650497|FG001|Overall Study|Screening exclusion criteria met|0|||
48671368|NCT02905006|156650498|FG002|Overall Study|Screening exclusion criteria met|0|||
48671369|NCT02905006|156650499|FG003|Overall Study|Screening exclusion criteria met|0|||
48671370|NCT02905006|156650500|FG004|Overall Study|Screening exclusion criteria met|0|||
48671371|NCT02905006|156650501|FG005|Overall Study|Screening exclusion criteria met|0|||
48671372|NCT02905006|156650496|FG000|Overall Study|Lab withdrawal criterion met|0|||
48671373|NCT02905006|156650497|FG001|Overall Study|Lab withdrawal criterion met|1|||
48671374|NCT02905006|156650498|FG002|Overall Study|Lab withdrawal criterion met|2|||
48671375|NCT02905006|156650499|FG003|Overall Study|Lab withdrawal criterion met|2|||
48671376|NCT02905006|156650500|FG004|Overall Study|Lab withdrawal criterion met|2|||
48671377|NCT02905006|156650501|FG005|Overall Study|Lab withdrawal criterion met|1|||
48671378|NCT02905006|156650496|FG000|Overall Study|Positive for Tuberculosis|0|||
48671379|NCT02905006|156650497|FG001|Overall Study|Positive for Tuberculosis|1|||
48671380|NCT02905006|156650498|FG002|Overall Study|Positive for Tuberculosis|0|||
48671381|NCT02905006|156650499|FG003|Overall Study|Positive for Tuberculosis|0|||
48671382|NCT02905006|156650500|FG004|Overall Study|Positive for Tuberculosis|0|||
48671383|NCT02905006|156650501|FG005|Overall Study|Positive for Tuberculosis|0|||
48671384|NCT02905006|156650496|FG000|Overall Study|Subject positive for Hep B|0|||
48671385|NCT02905006|156650497|FG001|Overall Study|Subject positive for Hep B|0|||
48671386|NCT02905006|156650498|FG002|Overall Study|Subject positive for Hep B|1|||
48671387|NCT02905006|156650499|FG003|Overall Study|Subject positive for Hep B|0|||
48671388|NCT02905006|156650500|FG004|Overall Study|Subject positive for Hep B|0|||
48671389|NCT02905006|156650501|FG005|Overall Study|Subject positive for Hep B|0|||
48671390|NCT02905006|156650496|FG000|Overall Study|Patient moved abroad|0|||
48760707|NCT00697515|156972297|FG001|First Intervention (Crossover Period)|Adverse Event|2|||
48760708|NCT00697515|156972296|FG000|First Intervention (Crossover Period)|Withdrawal by Subject|2|||
48760709|NCT00697515|156972297|FG001|First Intervention (Crossover Period)|Withdrawal by Subject|1|||
48760710|NCT00697515|156972296|FG000|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
48760711|NCT00697515|156972297|FG001|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
48760712|NCT02389998|156972298|FG000|Overall Study|car accident|1|||
48760713|NCT02389998|156972299|FG001|Overall Study|car accident|0|||
48760714|NCT03045887|156972300|FG000|Part A,Washout Period 1(4 Weeks)|Physician Decision|3|||
48760715|NCT03045887|156972301|FG001|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
48760716|NCT03045887|156972302|FG002|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
48760717|NCT03045887|156972303|FG003|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
48760718|NCT03045887|156972304|FG004|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
48760719|NCT03045887|156972305|FG005|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
48760720|NCT03045887|156972306|FG006|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
48760721|NCT03045887|156972307|FG007|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
48760722|NCT03045887|156972308|FG008|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
48760723|NCT03045887|156972309|FG009|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
48760724|NCT03045887|156972300|FG000|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
48760725|NCT03045887|156972301|FG001|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
48871439|NCT02215954|157367477|FG001|Overall Study|Adverse Event|0|||
48871440|NCT02215954|157367478|FG002|Overall Study|Adverse Event|1|||
48871441|NCT02215954|157367476|FG000|Overall Study|Withdrawal by Subject|0|||
48871442|NCT02215954|157367477|FG001|Overall Study|Withdrawal by Subject|0|||
48871443|NCT02215954|157367478|FG002|Overall Study|Withdrawal by Subject|2|||
48871444|NCT02215954|157367476|FG000|Overall Study|Not exposed|1|||
48871445|NCT02215954|157367477|FG001|Overall Study|Not exposed|1|||
48871446|NCT02215954|157367478|FG002|Overall Study|Not exposed|3|||
48871447|NCT01167192|157367479|FG000|Overall Study|Adverse Event|1|||
48871448|NCT01167192|157367479|FG000|Overall Study|Death|1|||
48871449|NCT01167192|157367479|FG000|Overall Study|Withdrawal by Subject|1|||
48871450|NCT01167192|157367479|FG000|Overall Study|Insurance denial|1|||
48871451|NCT03414047|157367480|FG000|Overall Study|Adverse Event|0|||
48871452|NCT03414047|157367481|FG001|Overall Study|Adverse Event|0|||
48871453|NCT03414047|157367482|FG002|Overall Study|Adverse Event|1|||
48871454|NCT03414047|157367483|FG003|Overall Study|Adverse Event|1|||
48871455|NCT03414047|157367480|FG000|Overall Study|Physician Decision|1|||
48871456|NCT03414047|157367481|FG001|Overall Study|Physician Decision|0|||
48871457|NCT03414047|157367482|FG002|Overall Study|Physician Decision|0|||
48871458|NCT03414047|157367483|FG003|Overall Study|Physician Decision|1|||
48871459|NCT03414047|157367480|FG000|Overall Study|Withdrawal by Subject|1|||
48871460|NCT03414047|157367481|FG001|Overall Study|Withdrawal by Subject|0|||
48871461|NCT03414047|157367482|FG002|Overall Study|Withdrawal by Subject|2|||
48871462|NCT03414047|157367483|FG003|Overall Study|Withdrawal by Subject|0|||
48871463|NCT01187407|157367496|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29|||
48871464|NCT01187407|157367497|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
48871465|NCT01187407|157367498|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
48871466|NCT01187407|157367499|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
48871467|NCT01187407|157367500|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
48871468|NCT01187407|157367496|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4|||
48871469|NCT01187407|157367497|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
48871470|NCT01187407|157367498|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
48871471|NCT01187407|157367499|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
48871472|NCT01187407|157367500|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
48871473|NCT01187407|157367496|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9|||
48871474|NCT01187407|157367497|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
48871475|NCT01187407|157367498|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
48871476|NCT01187407|157367499|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
48871477|NCT01187407|157367500|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
48871478|NCT01187407|157367496|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
48871479|NCT01187407|157367497|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
48871480|NCT01187407|157367498|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
48871481|NCT01187407|157367499|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
48671391|NCT02905006|156650497|FG001|Overall Study|Patient moved abroad|0|||
48671392|NCT02905006|156650498|FG002|Overall Study|Patient moved abroad|0|||
48671393|NCT02905006|156650499|FG003|Overall Study|Patient moved abroad|1|||
48671394|NCT02905006|156650500|FG004|Overall Study|Patient moved abroad|0|||
48871482|NCT01187407|157367500|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
48871483|NCT01187407|157367496|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13|||
48671395|NCT02905006|156650501|FG005|Overall Study|Patient moved abroad|0|||
48671396|NCT02905006|156650496|FG000|Overall Study|Patient randomized by mistake|0|||
48671397|NCT02905006|156650497|FG001|Overall Study|Patient randomized by mistake|0|||
48671398|NCT02905006|156650498|FG002|Overall Study|Patient randomized by mistake|0|||
48671399|NCT02905006|156650499|FG003|Overall Study|Patient randomized by mistake|0|||
48671400|NCT02905006|156650500|FG004|Overall Study|Patient randomized by mistake|0|||
48671401|NCT02905006|156650501|FG005|Overall Study|Patient randomized by mistake|1|||
48671402|NCT01939366|156650502|FG000|Overall Study|Adverse Event|8|||
48671403|NCT01939366|156650503|FG001|Overall Study|Adverse Event|17|||
48671404|NCT01939366|156650504|FG002|Overall Study|Adverse Event|30|||
48871484|NCT01187407|157367497|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
48871485|NCT01187407|157367498|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
48871486|NCT01187407|157367499|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
48871487|NCT01187407|157367500|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
48871488|NCT01187407|157367496|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29|||
48871489|NCT01187407|157367497|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
48871490|NCT01187407|157367498|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
48871491|NCT01187407|157367499|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
48871492|NCT01187407|157367500|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
48871493|NCT01187407|157367496|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4|||
48871494|NCT01187407|157367497|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
48871495|NCT01187407|157367498|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
48871496|NCT01187407|157367499|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
48871497|NCT01187407|157367500|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
48871498|NCT01187407|157367496|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
48871499|NCT01187407|157367497|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
48871500|NCT01187407|157367498|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6|||
48871501|NCT01187407|157367499|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5|||
48871502|NCT01187407|157367500|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12|||
48969412|NCT01231607|157717176|FG001|Overall Study|Withdrawal by Subject|9|||
48671405|NCT01939366|156650505|FG003|Overall Study|Adverse Event|8|||
48671406|NCT01939366|156650506|FG004|Overall Study|Adverse Event|5|||
48671407|NCT01939366|156650502|FG000|Overall Study|Lack of Efficacy|2|||
48671408|NCT01939366|156650503|FG001|Overall Study|Lack of Efficacy|1|||
48671409|NCT01939366|156650504|FG002|Overall Study|Lack of Efficacy|1|||
48871503|NCT01187407|157367496|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
48969413|NCT01231607|157717177|FG002|Overall Study|Withdrawal by Subject|14|||
48969414|NCT01231607|157717178|FG003|Overall Study|Withdrawal by Subject|17|||
48671410|NCT01939366|156650505|FG003|Overall Study|Lack of Efficacy|1|||
48671411|NCT01939366|156650506|FG004|Overall Study|Lack of Efficacy|3|||
48671412|NCT01939366|156650502|FG000|Overall Study|Lost to Follow-up|1|||
48671413|NCT01939366|156650503|FG001|Overall Study|Lost to Follow-up|1|||
48969415|NCT01231607|157717179|FG004|Overall Study|Withdrawal by Subject|9|||
48969416|NCT02197897|157717180|FG000|Overall Study|not eligible|1|||
48969417|NCT02062398|157717181|FG000|Overall Study|Implant removal|1|||
48969418|NCT02227849|157717188|FG000|Overall Study|Adverse Event|4|||
48969419|NCT02227849|157717188|FG000|Overall Study|Physician Decision|1|||
48969420|NCT02227849|157717188|FG000|Overall Study|Withdrawal by Subject|3|||
48969421|NCT02151682|157717189|FG000|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
48969422|NCT02151682|157717190|FG001|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2|||
48969423|NCT02151682|157717191|FG002|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
48969424|NCT02151682|157717192|FG003|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
48671414|NCT01939366|156650504|FG002|Overall Study|Lost to Follow-up|0|||
48671415|NCT01939366|156650505|FG003|Overall Study|Lost to Follow-up|0|||
48671416|NCT01939366|156650506|FG004|Overall Study|Lost to Follow-up|0|||
48671417|NCT01939366|156650502|FG000|Overall Study|Withdrawal by Subject|1|||
48671418|NCT01939366|156650503|FG001|Overall Study|Withdrawal by Subject|0|||
48671419|NCT01939366|156650504|FG002|Overall Study|Withdrawal by Subject|2|||
48671420|NCT01939366|156650505|FG003|Overall Study|Withdrawal by Subject|2|||
48671421|NCT01939366|156650506|FG004|Overall Study|Withdrawal by Subject|3|||
48671422|NCT01939366|156650502|FG000|Overall Study|Inclusion criteria not met|0|||
48671423|NCT01939366|156650503|FG001|Overall Study|Inclusion criteria not met|1|||
48671424|NCT01939366|156650504|FG002|Overall Study|Inclusion criteria not met|1|||
48671425|NCT01939366|156650505|FG003|Overall Study|Inclusion criteria not met|0|||
48671426|NCT01939366|156650506|FG004|Overall Study|Inclusion criteria not met|1|||
48671427|NCT01939366|156650502|FG000|Overall Study|Other|0|||
48671428|NCT01939366|156650503|FG001|Overall Study|Other|0|||
48671429|NCT01939366|156650504|FG002|Overall Study|Other|2|||
48671430|NCT01939366|156650505|FG003|Overall Study|Other|2|||
48671431|NCT01939366|156650506|FG004|Overall Study|Other|1|||
48671432|NCT01939366|156650502|FG000|Overall Study|Protocol Violation|0|||
48671433|NCT01939366|156650503|FG001|Overall Study|Protocol Violation|0|||
48671434|NCT01939366|156650504|FG002|Overall Study|Protocol Violation|0|||
48671435|NCT01939366|156650505|FG003|Overall Study|Protocol Violation|1|||
48671436|NCT01939366|156650506|FG004|Overall Study|Protocol Violation|0|||
48671437|NCT01939366|156650502|FG000|Overall Study|Sponsor decision|0|||
48671438|NCT01939366|156650503|FG001|Overall Study|Sponsor decision|0|||
48671439|NCT01939366|156650504|FG002|Overall Study|Sponsor decision|0|||
48871504|NCT01187407|157367497|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3|||
48871505|NCT01187407|157367498|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
48871506|NCT01187407|157367499|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5|||
48871507|NCT01187407|157367500|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13|||
48871508|NCT01187407|157367496|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
48871509|NCT01187407|157367497|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
48871510|NCT01187407|157367498|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
48871511|NCT01187407|157367499|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
48871512|NCT01187407|157367500|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
48871513|NCT01187407|157367496|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
48871514|NCT01187407|157367497|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
48871515|NCT01187407|157367498|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
48871516|NCT01187407|157367499|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
48871517|NCT01187407|157367500|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
48871518|NCT01187407|157367496|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
48871519|NCT01187407|157367497|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6|||
48871520|NCT01187407|157367498|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
48871521|NCT01187407|157367499|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3|||
48871522|NCT01187407|157367500|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10|||
48871523|NCT01187407|157367496|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
48871524|NCT01187407|157367497|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
48871525|NCT01187407|157367498|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
48871526|NCT01187407|157367499|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11|||
48871527|NCT01187407|157367500|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22|||
48871528|NCT01187407|157367496|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
48871529|NCT01187407|157367497|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
48871530|NCT01187407|157367498|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
48871531|NCT01187407|157367499|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
48871532|NCT01187407|157367500|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
48871533|NCT04035577|157367501|FG000|Overall Study|Lost to Follow-up|1|||
48871534|NCT04035577|157367501|FG000|Overall Study|Withdrawal by Subject|1|||
48871535|NCT00505414|157367502|FG000|Titration Phase|Adverse Event|0|||
48969425|NCT02151682|157717193|FG004|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
48671440|NCT01939366|156650505|FG003|Overall Study|Sponsor decision|0|||
48671441|NCT01939366|156650506|FG004|Overall Study|Sponsor decision|2|||
48969426|NCT02151682|157717194|FG005|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
48969427|NCT02151682|157717189|FG000|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
48969428|NCT02151682|157717190|FG001|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1|||
48969429|NCT02151682|157717191|FG002|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
48969430|NCT02151682|157717192|FG003|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
48969431|NCT02151682|157717193|FG004|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
48969432|NCT02151682|157717194|FG005|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
48969433|NCT02151682|157717189|FG000|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
48969434|NCT02151682|157717190|FG001|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1|||
48969435|NCT02151682|157717191|FG002|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
48969436|NCT02151682|157717192|FG003|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
48969437|NCT02151682|157717193|FG004|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
48969438|NCT02151682|157717194|FG005|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
48969439|NCT02151682|157717189|FG000|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
48969440|NCT02151682|157717190|FG001|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
48969441|NCT02151682|157717191|FG002|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
48969442|NCT02151682|157717192|FG003|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
48871536|NCT00505414|157367503|FG001|Titration Phase|Adverse Event|0|||
48871537|NCT00505414|157367504|FG002|Titration Phase|Adverse Event|0|||
48871538|NCT00505414|157367505|FG003|Titration Phase|Adverse Event|8|||
48871539|NCT00505414|157367506|FG004|Titration Phase|Adverse Event|3|||
48871540|NCT00505414|157367502|FG000|Titration Phase|Death|0|||
48871541|NCT00505414|157367503|FG001|Titration Phase|Death|0|||
48969443|NCT02151682|157717193|FG004|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
48969444|NCT02151682|157717194|FG005|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
48969445|NCT02151682|157717189|FG000|Part 1: 14 Days Morphine or Tapentadol|Missing|1|||
48969446|NCT02151682|157717190|FG001|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
48969447|NCT02151682|157717191|FG002|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
48969448|NCT02151682|157717192|FG003|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
48969449|NCT02151682|157717193|FG004|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
48969450|NCT02151682|157717194|FG005|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
48969451|NCT02151682|157717189|FG000|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
48969452|NCT02151682|157717190|FG001|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
48969453|NCT02151682|157717191|FG002|Part 2: Tapent. Extension or Observation|Adverse Event|3|||
48969454|NCT02151682|157717192|FG003|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
48969455|NCT02151682|157717193|FG004|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
48969456|NCT02151682|157717194|FG005|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
48969457|NCT02151682|157717189|FG000|Part 2: Tapent. Extension or Observation|Death|0|||
48969458|NCT02151682|157717190|FG001|Part 2: Tapent. Extension or Observation|Death|0|||
48969459|NCT02151682|157717191|FG002|Part 2: Tapent. Extension or Observation|Death|0|||
48969460|NCT02151682|157717192|FG003|Part 2: Tapent. Extension or Observation|Death|2|||
48969461|NCT02151682|157717193|FG004|Part 2: Tapent. Extension or Observation|Death|0|||
48969462|NCT02151682|157717194|FG005|Part 2: Tapent. Extension or Observation|Death|0|||
48969463|NCT02151682|157717189|FG000|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
48969464|NCT02151682|157717190|FG001|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
48969465|NCT02151682|157717191|FG002|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
48969466|NCT02151682|157717192|FG003|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
48969467|NCT02151682|157717193|FG004|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
48969468|NCT02151682|157717194|FG005|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
48871542|NCT00505414|157367504|FG002|Titration Phase|Death|0|||
48969469|NCT02151682|157717189|FG000|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
48969470|NCT02151682|157717190|FG001|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
48969471|NCT02151682|157717191|FG002|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3|||
48969472|NCT02151682|157717192|FG003|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
48969473|NCT02151682|157717193|FG004|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
48671442|NCT01939366|156650502|FG000|Overall Study|GCP non-compliance at site|2|||
48671443|NCT01939366|156650503|FG001|Overall Study|GCP non-compliance at site|3|||
48671444|NCT01939366|156650504|FG002|Overall Study|GCP non-compliance at site|2|||
48671445|NCT01939366|156650505|FG003|Overall Study|GCP non-compliance at site|3|||
48671446|NCT01939366|156650506|FG004|Overall Study|GCP non-compliance at site|3|||
48671447|NCT02853435|156650507|FG000|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
48671448|NCT02853435|156650508|FG001|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
48871543|NCT00505414|157367505|FG003|Titration Phase|Death|2|||
48871544|NCT00505414|157367506|FG004|Titration Phase|Death|0|||
48969474|NCT02151682|157717194|FG005|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
48969475|NCT02151682|157717189|FG000|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
48671449|NCT02853435|156650509|FG002|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
48871545|NCT00505414|157367502|FG000|Titration Phase|Lack of Efficacy|0|||
48969476|NCT02151682|157717190|FG001|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
48969477|NCT02151682|157717191|FG002|Part 2: Tapent. Extension or Observation|Protocol Violation|1|||
48969478|NCT02151682|157717192|FG003|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
48969479|NCT02151682|157717193|FG004|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
48969480|NCT02151682|157717194|FG005|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
48969481|NCT02151682|157717189|FG000|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
48969482|NCT02151682|157717190|FG001|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
48969483|NCT02151682|157717191|FG002|Part 2: Tapent. Extension or Observation|No need for opioid|13|||
48969484|NCT02151682|157717192|FG003|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
48969485|NCT02151682|157717193|FG004|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
48969486|NCT02151682|157717194|FG005|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
48969487|NCT02151682|157717189|FG000|Part 2: Tapent. Extension or Observation|Missing|0|||
48969488|NCT02151682|157717190|FG001|Part 2: Tapent. Extension or Observation|Missing|0|||
48969489|NCT02151682|157717191|FG002|Part 2: Tapent. Extension or Observation|Missing|0|||
48969490|NCT02151682|157717192|FG003|Part 2: Tapent. Extension or Observation|Missing|1|||
48969491|NCT02151682|157717193|FG004|Part 2: Tapent. Extension or Observation|Missing|0|||
48969492|NCT02151682|157717194|FG005|Part 2: Tapent. Extension or Observation|Missing|0|||
48969493|NCT02151682|157717189|FG000|Part 2: Tapent. Extension or Observation|Various other|0|||
48969494|NCT02151682|157717190|FG001|Part 2: Tapent. Extension or Observation|Various other|0|||
48969495|NCT02151682|157717191|FG002|Part 2: Tapent. Extension or Observation|Various other|6|||
48969496|NCT02151682|157717192|FG003|Part 2: Tapent. Extension or Observation|Various other|0|||
48969497|NCT02151682|157717193|FG004|Part 2: Tapent. Extension or Observation|Various other|0|||
48969498|NCT02151682|157717194|FG005|Part 2: Tapent. Extension or Observation|Various other|0|||
48969499|NCT02151682|157717189|FG000|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
48969500|NCT02151682|157717190|FG001|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
48969501|NCT02151682|157717191|FG002|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1|||
48969502|NCT02151682|157717192|FG003|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
48969503|NCT02151682|157717193|FG004|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
48969504|NCT02151682|157717194|FG005|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
48871546|NCT00505414|157367503|FG001|Titration Phase|Lack of Efficacy|0|||
48871547|NCT00505414|157367504|FG002|Titration Phase|Lack of Efficacy|0|||
48871548|NCT00505414|157367505|FG003|Titration Phase|Lack of Efficacy|10|||
48871549|NCT00505414|157367506|FG004|Titration Phase|Lack of Efficacy|1|||
48871550|NCT00505414|157367502|FG000|Titration Phase|Protocol Violation|0|||
48871551|NCT00505414|157367503|FG001|Titration Phase|Protocol Violation|0|||
48871552|NCT00505414|157367504|FG002|Titration Phase|Protocol Violation|0|||
48871553|NCT00505414|157367505|FG003|Titration Phase|Protocol Violation|0|||
48871554|NCT00505414|157367506|FG004|Titration Phase|Protocol Violation|1|||
48871555|NCT00505414|157367502|FG000|Titration Phase|Withdrawal by Subject|0|||
48871556|NCT00505414|157367503|FG001|Titration Phase|Withdrawal by Subject|0|||
48871557|NCT00505414|157367504|FG002|Titration Phase|Withdrawal by Subject|0|||
48871558|NCT00505414|157367505|FG003|Titration Phase|Withdrawal by Subject|3|||
48871559|NCT00505414|157367506|FG004|Titration Phase|Withdrawal by Subject|4|||
48871560|NCT00505414|157367502|FG000|Titration Phase|Underlying disease and therapy required|0|||
48871561|NCT00505414|157367503|FG001|Titration Phase|Underlying disease and therapy required|0|||
48871562|NCT00505414|157367504|FG002|Titration Phase|Underlying disease and therapy required|0|||
48871563|NCT00505414|157367505|FG003|Titration Phase|Underlying disease and therapy required|7|||
48871564|NCT00505414|157367506|FG004|Titration Phase|Underlying disease and therapy required|3|||
48871565|NCT00505414|157367502|FG000|Maintenance Phase|Adverse Event|2|||
48871566|NCT00505414|157367503|FG001|Maintenance Phase|Adverse Event|2|||
48871567|NCT00505414|157367504|FG002|Maintenance Phase|Adverse Event|3|||
48969505|NCT02151682|157717189|FG000|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
48969506|NCT02151682|157717190|FG001|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
48969507|NCT02151682|157717191|FG002|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
48671450|NCT02853435|156650510|FG003|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
48671451|NCT02853435|156650511|FG004|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1|||
48671452|NCT02853435|156650512|FG005|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
48671453|NCT03199391|156650513|FG000|Overall Study|Death|1|||
48671454|NCT03199391|156650513|FG000|Overall Study|Lost to Follow-up|3|||
48671455|NCT03199391|156650513|FG000|Overall Study|Adverse Event|2|||
48671456|NCT03199391|156650513|FG000|Overall Study|Withdrawal by Subject|10|||
48671457|NCT01267175|156650515|FG000|Overall Study|Withdrawal by Subject|1|||
48671458|NCT01267175|156650515|FG000|Overall Study|Lost to Follow-up|1|||
48671459|NCT01966445|156650516|FG000|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
48671460|NCT01966445|156650517|FG001|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
48671461|NCT01966445|156650518|FG002|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
48871568|NCT00505414|157367505|FG003|Maintenance Phase|Adverse Event|0|||
48871569|NCT00505414|157367506|FG004|Maintenance Phase|Adverse Event|0|||
48969508|NCT02151682|157717192|FG003|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
48969509|NCT02151682|157717193|FG004|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
48969510|NCT02151682|157717194|FG005|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1|||
48969511|NCT02151682|157717189|FG000|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
48969512|NCT02151682|157717190|FG001|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
48969513|NCT02151682|157717191|FG002|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
48969514|NCT02151682|157717192|FG003|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
48969515|NCT02151682|157717193|FG004|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
48969516|NCT02151682|157717194|FG005|Part 2: Observ. Aft. Tapent. Extension|Death|1|||
48871570|NCT00505414|157367502|FG000|Maintenance Phase|Death|2|||
48871571|NCT00505414|157367503|FG001|Maintenance Phase|Death|0|||
48871572|NCT00505414|157367504|FG002|Maintenance Phase|Death|1|||
48871573|NCT00505414|157367505|FG003|Maintenance Phase|Death|0|||
48871574|NCT00505414|157367506|FG004|Maintenance Phase|Death|0|||
48871575|NCT00505414|157367502|FG000|Maintenance Phase|Lack of Efficacy|2|||
48871576|NCT00505414|157367503|FG001|Maintenance Phase|Lack of Efficacy|1|||
48871577|NCT00505414|157367504|FG002|Maintenance Phase|Lack of Efficacy|1|||
48871578|NCT00505414|157367505|FG003|Maintenance Phase|Lack of Efficacy|0|||
48871579|NCT00505414|157367506|FG004|Maintenance Phase|Lack of Efficacy|0|||
48871580|NCT00505414|157367502|FG000|Maintenance Phase|Withdrawal by Subject|0|||
48871581|NCT00505414|157367503|FG001|Maintenance Phase|Withdrawal by Subject|0|||
48871582|NCT00505414|157367504|FG002|Maintenance Phase|Withdrawal by Subject|1|||
48871583|NCT00505414|157367505|FG003|Maintenance Phase|Withdrawal by Subject|0|||
48871584|NCT00505414|157367506|FG004|Maintenance Phase|Withdrawal by Subject|0|||
48871585|NCT00505414|157367502|FG000|Maintenance Phase|underlying disease and therapy required|0|||
48871586|NCT00505414|157367503|FG001|Maintenance Phase|underlying disease and therapy required|2|||
48871587|NCT00505414|157367504|FG002|Maintenance Phase|underlying disease and therapy required|2|||
48871588|NCT00505414|157367505|FG003|Maintenance Phase|underlying disease and therapy required|0|||
48871589|NCT00505414|157367506|FG004|Maintenance Phase|underlying disease and therapy required|0|||
48871590|NCT00857233|157367507|FG000|Overall Study|Adverse Event|24|||
48871591|NCT00857233|157367507|FG000|Overall Study|Lack of Efficacy|1|||
48871592|NCT00857233|157367507|FG000|Overall Study|Non-compliance|1|||
48871593|NCT00857233|157367507|FG000|Overall Study|Withdrawal of Consent|9|||
48871594|NCT00857233|157367507|FG000|Overall Study|Lost to Follow-up|4|||
48871595|NCT00857233|157367507|FG000|Overall Study|Nursing Home Placement|14|||
48871596|NCT00857233|157367507|FG000|Overall Study|Other Reasons|2|||
48871597|NCT01560871|157367508|FG000|Overall Study|transportation issues|2|||
48871598|NCT01560871|157367509|FG001|Overall Study|transportation issues|1|||
48871599|NCT01560871|157367508|FG000|Overall Study|relocation|1|||
48871600|NCT01560871|157367509|FG001|Overall Study|relocation|0|||
48871601|NCT01560871|157367508|FG000|Overall Study|readmission to a hospital|2|||
48871602|NCT01560871|157367509|FG001|Overall Study|readmission to a hospital|1|||
48871603|NCT01560871|157367508|FG000|Overall Study|Lost to Follow-up|1|||
48871604|NCT01560871|157367509|FG001|Overall Study|Lost to Follow-up|0|||
48871605|NCT00634920|157367510|FG000|Period 1 - Pre-Randomization|Adverse Event|0|||
48871606|NCT00634920|157367511|FG001|Period 1 - Pre-Randomization|Adverse Event|0|||
48871607|NCT00634920|157367512|FG002|Period 1 - Pre-Randomization|Adverse Event|36|||
48871608|NCT00634920|157367510|FG000|Period 1 - Pre-Randomization|Wound healing problems|0|||
48871609|NCT00634920|157367511|FG001|Period 1 - Pre-Randomization|Wound healing problems|0|||
48871610|NCT00634920|157367512|FG002|Period 1 - Pre-Randomization|Wound healing problems|16|||
48871611|NCT00634920|157367510|FG000|Period 1 - Pre-Randomization|Rejections|0|||
48871612|NCT00634920|157367511|FG001|Period 1 - Pre-Randomization|Rejections|0|||
48871613|NCT00634920|157367512|FG002|Period 1 - Pre-Randomization|Rejections|55|||
48871614|NCT00634920|157367510|FG000|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
48871615|NCT00634920|157367511|FG001|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
48871616|NCT00634920|157367512|FG002|Period 1 - Pre-Randomization|Withdrawal by Subject|21|||
48871617|NCT00634920|157367510|FG000|Period 1 - Pre-Randomization|Non-Compliance|0|||
48871618|NCT00634920|157367511|FG001|Period 1 - Pre-Randomization|Non-Compliance|0|||
48871619|NCT00634920|157367512|FG002|Period 1 - Pre-Randomization|Non-Compliance|3|||
48871620|NCT00634920|157367510|FG000|Period 1 - Pre-Randomization|Other issues|0|||
48871621|NCT00634920|157367511|FG001|Period 1 - Pre-Randomization|Other issues|0|||
48871622|NCT00634920|157367512|FG002|Period 1 - Pre-Randomization|Other issues|6|||
48871623|NCT00634920|157367510|FG000|Period 2 - Post-Randomization|Adverse Event|37|||
48969517|NCT02151682|157717189|FG000|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
48871624|NCT00634920|157367511|FG001|Period 2 - Post-Randomization|Adverse Event|9|||
48871625|NCT00634920|157367512|FG002|Period 2 - Post-Randomization|Adverse Event|0|||
48871626|NCT00634920|157367510|FG000|Period 2 - Post-Randomization|Rejection|11|||
48871627|NCT00634920|157367511|FG001|Period 2 - Post-Randomization|Rejection|5|||
48969518|NCT02151682|157717190|FG001|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
48871628|NCT00634920|157367512|FG002|Period 2 - Post-Randomization|Rejection|0|||
49015493|NCT01393990|157893771|FG001|Overall Study|Withdrawal by Subject|0|||
48871629|NCT00634920|157367510|FG000|Period 2 - Post-Randomization|Death|2|||
48871630|NCT00634920|157367511|FG001|Period 2 - Post-Randomization|Death|5|||
48969519|NCT02151682|157717191|FG002|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
48969520|NCT02151682|157717192|FG003|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
48969521|NCT02151682|157717193|FG004|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
48969522|NCT02151682|157717194|FG005|Part 2: Observ. Aft. Tapent. Extension|Missing|3|||
48969523|NCT02151682|157717189|FG000|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
48871631|NCT00634920|157367512|FG002|Period 2 - Post-Randomization|Death|0|||
48871632|NCT00634920|157367510|FG000|Period 2 - Post-Randomization|consent withdrawal, non compliance|9|||
48871633|NCT00634920|157367511|FG001|Period 2 - Post-Randomization|consent withdrawal, non compliance|13|||
48871634|NCT00634920|157367512|FG002|Period 2 - Post-Randomization|consent withdrawal, non compliance|0|||
48871635|NCT00634920|157367510|FG000|Period 2 - Post-Randomization|Patients did not receive study drug|2|||
48871636|NCT00634920|157367511|FG001|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
48871637|NCT00634920|157367512|FG002|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
48871638|NCT00004445|157367513|FG000|Overall Study|Physician Decision|2|||
48871639|NCT00004445|157367513|FG000|Overall Study|Withdrawal by Subject|1|||
48871640|NCT00436956|157367516|FG000|Overall Study|Not evaluable|1|||
48871641|NCT00436956|157367517|FG001|Overall Study|Not evaluable|0|||
48871642|NCT00607997|157367518|FG000|Overall Study|Lack of Efficacy|6|||
48871643|NCT00607997|157367519|FG001|Overall Study|Lack of Efficacy|20|||
48871644|NCT00607997|157367520|FG002|Overall Study|Lack of Efficacy|14|||
48871645|NCT00607997|157367521|FG003|Overall Study|Lack of Efficacy|10|||
48871646|NCT00607997|157367518|FG000|Overall Study|Death|8|||
48871647|NCT00607997|157367519|FG001|Overall Study|Death|5|||
48871648|NCT00607997|157367520|FG002|Overall Study|Death|2|||
48871649|NCT00607997|157367521|FG003|Overall Study|Death|5|||
48871650|NCT00607997|157367518|FG000|Overall Study|Adverse Event|3|||
48871651|NCT00607997|157367519|FG001|Overall Study|Adverse Event|1|||
48871652|NCT00607997|157367520|FG002|Overall Study|Adverse Event|2|||
48871653|NCT00607997|157367521|FG003|Overall Study|Adverse Event|0|||
48871654|NCT00607997|157367518|FG000|Overall Study|Physician Decision|4|||
48871655|NCT00607997|157367519|FG001|Overall Study|Physician Decision|1|||
48871656|NCT00607997|157367520|FG002|Overall Study|Physician Decision|0|||
48871657|NCT00607997|157367521|FG003|Overall Study|Physician Decision|0|||
48871658|NCT00607997|157367518|FG000|Overall Study|Relapse, recurrent illness|4|||
48871659|NCT00607997|157367519|FG001|Overall Study|Relapse, recurrent illness|0|||
48871660|NCT00607997|157367520|FG002|Overall Study|Relapse, recurrent illness|2|||
48871661|NCT00607997|157367521|FG003|Overall Study|Relapse, recurrent illness|0|||
48871662|NCT00607997|157367518|FG000|Overall Study|Other without explanation|2|||
48871663|NCT00607997|157367519|FG001|Overall Study|Other without explanation|0|||
48871664|NCT00607997|157367520|FG002|Overall Study|Other without explanation|4|||
48871665|NCT00607997|157367521|FG003|Overall Study|Other without explanation|1|||
48871666|NCT00623363|157367522|FG000|Overall Study|Adverse Event|2|||
48871667|NCT00623363|157367523|FG001|Overall Study|Adverse Event|2|||
48871668|NCT04706793|157367524|FG000|Treatment|Disease worsening|10|||
48871669|NCT04706793|157367525|FG001|Treatment|Disease worsening|10|||
48871670|NCT04706793|157367524|FG000|Follow-up|Lack of Efficacy|1|||
48871671|NCT04706793|157367525|FG001|Follow-up|Lack of Efficacy|0|||
48871672|NCT04706793|157367524|FG000|Follow-up|Disease worsening|8|||
48871673|NCT04706793|157367525|FG001|Follow-up|Disease worsening|10|||
48871674|NCT04706793|157367524|FG000|Follow-up|Adverse Event|1|||
48871675|NCT04706793|157367525|FG001|Follow-up|Adverse Event|0|||
48871676|NCT00839332|157367526|FG000|Phase 1|Disease Progression|38|||
48871677|NCT00839332|157367527|FG001|Phase 1|Disease Progression|0|||
48871678|NCT00839332|157367528|FG002|Phase 1|Disease Progression|0|||
48871679|NCT00839332|157367526|FG000|Phase 1|Adverse Event|6|||
48871680|NCT00839332|157367527|FG001|Phase 1|Adverse Event|0|||
48871681|NCT00839332|157367528|FG002|Phase 1|Adverse Event|0|||
48871682|NCT00839332|157367526|FG000|Phase 1|Withdrawal by Subject|4|||
48871683|NCT00839332|157367527|FG001|Phase 1|Withdrawal by Subject|0|||
48871684|NCT00839332|157367528|FG002|Phase 1|Withdrawal by Subject|0|||
48871685|NCT00839332|157367526|FG000|Phase 1|Physician Decision|2|||
48871686|NCT00839332|157367527|FG001|Phase 1|Physician Decision|0|||
48871687|NCT00839332|157367528|FG002|Phase 1|Physician Decision|0|||
48969524|NCT02151682|157717190|FG001|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
48671462|NCT01966445|156650519|FG003|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2|||
48671463|NCT01966445|156650520|FG004|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
48671464|NCT01966445|156650521|FG005|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1|||
48671465|NCT01966445|156650522|FG006|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
48671466|NCT01966445|156650516|FG000|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
48671467|NCT01966445|156650517|FG001|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
48671468|NCT01966445|156650518|FG002|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
48671469|NCT01966445|156650519|FG003|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
48671470|NCT01966445|156650520|FG004|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
48671471|NCT01966445|156650521|FG005|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
48871688|NCT00839332|157367526|FG000|Phase 2|Protocol Violation|0|||
48871689|NCT00839332|157367527|FG001|Phase 2|Protocol Violation|1|||
48871690|NCT00839332|157367528|FG002|Phase 2|Protocol Violation|0|||
48871691|NCT00839332|157367526|FG000|Phase 2|Disease Progression|0|||
48871692|NCT00839332|157367527|FG001|Phase 2|Disease Progression|46|||
48871693|NCT00839332|157367528|FG002|Phase 2|Disease Progression|21|||
48969525|NCT02151682|157717191|FG002|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
48969526|NCT02151682|157717192|FG003|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
48969527|NCT02151682|157717193|FG004|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
48969528|NCT02151682|157717194|FG005|Part 2: Observ. Aft. Tapent. Extension|Various other|2|||
48969529|NCT01213264|157717195|FG000|Overall Study|Adverse Event|1|||
48969530|NCT01213264|157717196|FG001|Overall Study|Adverse Event|0|||
48969531|NCT01213264|157717197|FG002|Overall Study|Adverse Event|0|||
48969532|NCT01213264|157717195|FG000|Overall Study|Lost to Follow-up|1|||
48671472|NCT01966445|156650522|FG006|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
48671473|NCT01966445|156650516|FG000|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
48671474|NCT01966445|156650517|FG001|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
48871694|NCT00839332|157367526|FG000|Phase 2|Adverse Event|0|||
48871695|NCT00839332|157367527|FG001|Phase 2|Adverse Event|8|||
48671475|NCT01966445|156650518|FG002|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
48671476|NCT01966445|156650519|FG003|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
48671477|NCT01966445|156650520|FG004|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2|||
48671478|NCT01966445|156650521|FG005|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
48671479|NCT01966445|156650522|FG006|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
48671480|NCT01966445|156650516|FG000|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
48760726|NCT03045887|156972302|FG002|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
48871696|NCT00839332|157367528|FG002|Phase 2|Adverse Event|6|||
48871697|NCT00839332|157367526|FG000|Phase 2|Death|0|||
48871698|NCT00839332|157367527|FG001|Phase 2|Death|4|||
48871699|NCT00839332|157367528|FG002|Phase 2|Death|2|||
48871700|NCT00839332|157367526|FG000|Phase 2|Withdrawal by Subject|0|||
48871701|NCT00839332|157367527|FG001|Phase 2|Withdrawal by Subject|5|||
48871702|NCT00839332|157367528|FG002|Phase 2|Withdrawal by Subject|8|||
48871703|NCT00839332|157367526|FG000|Phase 2|Physician Decision|0|||
48871704|NCT00839332|157367527|FG001|Phase 2|Physician Decision|4|||
48871705|NCT00839332|157367528|FG002|Phase 2|Physician Decision|1|||
48871706|NCT00839332|157367526|FG000|Phase 2|Lost to Follow-up|0|||
48871707|NCT00839332|157367527|FG001|Phase 2|Lost to Follow-up|0|||
48871708|NCT00839332|157367528|FG002|Phase 2|Lost to Follow-up|1|||
48871709|NCT01930214|157367529|FG000|Overall Study|Death|4|||
48871710|NCT01930214|157367530|FG001|Overall Study|Death|4|||
48969533|NCT01213264|157717196|FG001|Overall Study|Lost to Follow-up|2|||
48969534|NCT01213264|157717197|FG002|Overall Study|Lost to Follow-up|6|||
48969535|NCT01359046|157717198|FG000|Overall Study|Did not receive allocated intervention|6|||
48969536|NCT01359046|157717199|FG001|Overall Study|Did not receive allocated intervention|6|||
48969537|NCT01359046|157717198|FG000|Overall Study|Physician Decision|1|||
48969538|NCT01359046|157717199|FG001|Overall Study|Physician Decision|11|||
48969539|NCT00290589|157717200|FG000|Overall Study|Lost to Follow-up|2|||
48969540|NCT00290589|157717201|FG001|Overall Study|Lost to Follow-up|2|||
48969541|NCT01896856|157717209|FG000|Overall Study|Transportation issues / Non-compliance|0|||
48969542|NCT01896856|157717210|FG001|Overall Study|Transportation issues / Non-compliance|0|||
48969543|NCT01896856|157717211|FG002|Overall Study|Transportation issues / Non-compliance|1|||
48969544|NCT01896856|157717212|FG003|Overall Study|Transportation issues / Non-compliance|0|||
48969545|NCT01896856|157717213|FG004|Overall Study|Transportation issues / Non-compliance|0|||
48969546|NCT01896856|157717214|FG005|Overall Study|Transportation issues / Non-compliance|0|||
48969547|NCT02378883|157717215|FG000|Enrollment|Subject did not meet Inclusion criteria|6|||
48969548|NCT02378883|157717215|FG000|Enrollment|Attempt to use Apollo was not performed|3|||
48969549|NCT02378883|157717215|FG000|30 Day Follow-Up|Withdrawal by Subject|1|||
48969550|NCT02378883|157717215|FG000|30 Day Follow-Up|Physician Decision|2|||
48969551|NCT02378883|157717215|FG000|30 Day Follow-Up|Missed Visit|2|||
48969552|NCT02378883|157717215|FG000|30 Day Follow-Up|Death|1|||
48969553|NCT02378883|157717215|FG000|12 Months Follow-Up|Lost to Follow-up|3|||
48969554|NCT02378883|157717215|FG000|12 Months Follow-Up|Death|2|||
48969555|NCT00776555|157717216|FG000|Overall Study|Study terminated|3|||
48969556|NCT00776555|157717217|FG001|Overall Study|Study terminated|0|||
48969557|NCT00416312|157717220|FG000|Overall Study|tumors not visible on imaging|2|||
48969558|NCT02248857|157717221|FG000|3 Month|Withdrawal by Subject|9|||
48969559|NCT02248857|157717222|FG001|3 Month|Withdrawal by Subject|3|||
48871711|NCT01930214|157367531|FG002|Overall Study|Death|11|||
48969560|NCT02248857|157717223|FG002|3 Month|Withdrawal by Subject|4|||
48969561|NCT02248857|157717221|FG000|3 Month|Unable to reach for 3 month|35|||
48969562|NCT02248857|157717222|FG001|3 Month|Unable to reach for 3 month|29|||
49015494|NCT01393990|157893772|FG002|Overall Study|Withdrawal by Subject|0|||
48871712|NCT01930214|157367529|FG000|Overall Study|Lost to Follow-up|12|||
48871713|NCT01930214|157367530|FG001|Overall Study|Lost to Follow-up|13|||
48871714|NCT01930214|157367531|FG002|Overall Study|Lost to Follow-up|12|||
48871715|NCT01930214|157367529|FG000|Overall Study|Voluntary withdrawal of infomed consent|2|||
48969563|NCT02248857|157717223|FG002|3 Month|Unable to reach for 3 month|26|||
48969564|NCT02248857|157717221|FG000|3 Month|Partially completed, unable to finish|2|||
48969565|NCT02248857|157717222|FG001|3 Month|Partially completed, unable to finish|2|||
48969566|NCT02248857|157717223|FG002|3 Month|Partially completed, unable to finish|1|||
48969567|NCT02248857|157717221|FG000|6 Month|Lost to Follow-up|27|||
48969568|NCT02248857|157717222|FG001|6 Month|Lost to Follow-up|26|||
48969569|NCT02248857|157717223|FG002|6 Month|Lost to Follow-up|15|||
48969570|NCT02248857|157717221|FG000|6 Month|Partially completed, unable to finish|0|||
48671481|NCT01966445|156650517|FG001|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
48671482|NCT01966445|156650518|FG002|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
48671483|NCT01966445|156650519|FG003|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
48671484|NCT01966445|156650520|FG004|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
48671485|NCT01966445|156650521|FG005|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
48671486|NCT01966445|156650522|FG006|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3|||
48671487|NCT01966445|156650516|FG000|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
48671488|NCT01966445|156650517|FG001|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
48671489|NCT01966445|156650518|FG002|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
48671490|NCT01966445|156650519|FG003|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
48671491|NCT01966445|156650520|FG004|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
48671492|NCT01966445|156650521|FG005|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
48671493|NCT01966445|156650522|FG006|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2|||
48671494|NCT01141478|156650526|FG000|Overall Study|Withdrawal by Subject|1|||
48671495|NCT01141478|156650527|FG001|Overall Study|Withdrawal by Subject|1|||
48671496|NCT00902174|156650528|FG000|Overall Study|Adverse Event|27|||
48671497|NCT00902174|156650529|FG001|Overall Study|Adverse Event|7|||
48671498|NCT00902174|156650528|FG000|Overall Study|Lack of Efficacy|1|||
48671499|NCT00902174|156650529|FG001|Overall Study|Lack of Efficacy|5|||
48671500|NCT00902174|156650528|FG000|Overall Study|Death|2|||
48671501|NCT00902174|156650529|FG001|Overall Study|Death|2|||
48671502|NCT00902174|156650528|FG000|Overall Study|Withdrawal by Subject|2|||
48671503|NCT00902174|156650529|FG001|Overall Study|Withdrawal by Subject|1|||
48671504|NCT00902174|156650528|FG000|Overall Study|Abnormal labs|1|||
48671505|NCT00902174|156650529|FG001|Overall Study|Abnormal labs|1|||
48671506|NCT00902174|156650528|FG000|Overall Study|Protocol Violation|1|||
48671507|NCT00902174|156650529|FG001|Overall Study|Protocol Violation|1|||
48671508|NCT00902174|156650528|FG000|Overall Study|Administration problem|0|||
48671509|NCT00902174|156650529|FG001|Overall Study|Administration problem|1|||
48671510|NCT03006887|156650533|FG000|Overall Study|Adverse Event|1|||
48671511|NCT00462748|156650534|FG000|Overall Study|Adverse Event|7|||
48671512|NCT00462748|156650535|FG001|Overall Study|Adverse Event|5|||
48671513|NCT00462748|156650536|FG002|Overall Study|Adverse Event|9|||
48671514|NCT00462748|156650534|FG000|Overall Study|Protocol Violation|0|||
48671515|NCT00462748|156650535|FG001|Overall Study|Protocol Violation|2|||
48671516|NCT00462748|156650536|FG002|Overall Study|Protocol Violation|1|||
48671517|NCT00462748|156650534|FG000|Overall Study|Withdrew consent|3|||
48671518|NCT00462748|156650535|FG001|Overall Study|Withdrew consent|3|||
48671519|NCT00462748|156650536|FG002|Overall Study|Withdrew consent|0|||
48671520|NCT00462748|156650534|FG000|Overall Study|Lost to Follow-up|1|||
48671521|NCT00462748|156650535|FG001|Overall Study|Lost to Follow-up|1|||
48671522|NCT00462748|156650536|FG002|Overall Study|Lost to Follow-up|1|||
48671523|NCT00462748|156650534|FG000|Overall Study|Discontinued after 41 days Rx|1|||
48671524|NCT00462748|156650535|FG001|Overall Study|Discontinued after 41 days Rx|0|||
48671525|NCT00462748|156650536|FG002|Overall Study|Discontinued after 41 days Rx|0|||
48671526|NCT01818492|156650537|FG000|Overall Study|Adverse Event|2|||
48671527|NCT01818492|156650537|FG000|Overall Study|Death|3|||
48760727|NCT03045887|156972303|FG003|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1|||
48760728|NCT03045887|156972304|FG004|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
48760729|NCT03045887|156972305|FG005|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
48760730|NCT03045887|156972306|FG006|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
48760731|NCT03045887|156972307|FG007|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
48760732|NCT03045887|156972308|FG008|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
48760733|NCT03045887|156972309|FG009|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
48760734|NCT03045887|156972300|FG000|Part A, Period 2 (1 Day)|Adverse Event|1|||
48760735|NCT03045887|156972301|FG001|Part A, Period 2 (1 Day)|Adverse Event|0|||
48760736|NCT03045887|156972302|FG002|Part A, Period 2 (1 Day)|Adverse Event|0|||
48760737|NCT03045887|156972303|FG003|Part A, Period 2 (1 Day)|Adverse Event|0|||
48760738|NCT03045887|156972304|FG004|Part A, Period 2 (1 Day)|Adverse Event|0|||
48671528|NCT01818492|156650537|FG000|Overall Study|Withdrawal by Subject|1|||
48760739|NCT03045887|156972305|FG005|Part A, Period 2 (1 Day)|Adverse Event|0|||
48969571|NCT02248857|157717222|FG001|6 Month|Partially completed, unable to finish|1|||
48671529|NCT01818492|156650537|FG000|Overall Study|Additional therapy when not allowed PP|4|||
48671530|NCT00082381|156650538|FG000|Overall Study|Adverse Event|27|||
48671531|NCT00082381|156650539|FG001|Overall Study|Adverse Event|2|||
48671532|NCT00082381|156650538|FG000|Overall Study|Lost to Follow-up|5|||
48671533|NCT00082381|156650539|FG001|Overall Study|Lost to Follow-up|7|||
48671534|NCT00082381|156650538|FG000|Overall Study|Patient Decision|8|||
48671535|NCT00082381|156650539|FG001|Overall Study|Patient Decision|4|||
48671536|NCT00082381|156650538|FG000|Overall Study|Physician Decision|1|||
48671537|NCT00082381|156650539|FG001|Overall Study|Physician Decision|2|||
48671538|NCT00082381|156650538|FG000|Overall Study|Protocol Violation|10|||
48671539|NCT00082381|156650539|FG001|Overall Study|Protocol Violation|11|||
48671540|NCT00082381|156650538|FG000|Overall Study|Loss of Glucose Control|4|||
48671541|NCT00082381|156650539|FG001|Overall Study|Loss of Glucose Control|0|||
48671542|NCT04109976|156650540|FG000|Overall Study|Withdrawal by Subject|1|||
48671543|NCT04109976|156650541|FG001|Overall Study|Withdrawal by Subject|0|||
48671544|NCT01438177|156650542|FG000|Overall Study|Withdrawal by Subject|1|||
48671545|NCT01438177|156650542|FG000|Overall Study|Initiation of new therapy|1|||
48671546|NCT00619099|156650545|FG000|Overall Study|Progressive Disease|7|||
48671547|NCT00619099|156650546|FG001|Overall Study|Progressive Disease|5|||
48671548|NCT00619099|156650545|FG000|Overall Study|Allogeneic Bone Marrow Transplantation|2|||
48671549|NCT00619099|156650546|FG001|Overall Study|Allogeneic Bone Marrow Transplantation|1|||
48671550|NCT00619099|156650545|FG000|Overall Study|Adverse Event|4|||
48671551|NCT00619099|156650546|FG001|Overall Study|Adverse Event|3|||
48671552|NCT00619099|156650545|FG000|Overall Study|Emergence of Clinically Significant Lab|1|||
48671553|NCT00619099|156650546|FG001|Overall Study|Emergence of Clinically Significant Lab|2|||
48671554|NCT00619099|156650545|FG000|Overall Study|Withdrawal by Subject|10|||
48671555|NCT00619099|156650546|FG001|Overall Study|Withdrawal by Subject|2|||
48671556|NCT00619099|156650545|FG000|Overall Study|Physician Decision|9|||
48671557|NCT00619099|156650546|FG001|Overall Study|Physician Decision|6|||
48671558|NCT00885482|156650547|FG000|Overall Study|Pregnancy|1|||
48671559|NCT00885482|156650547|FG000|Overall Study|Lack of Efficacy|1|||
48671560|NCT00885482|156650547|FG000|Overall Study|Death|1|||
48671561|NCT00885482|156650547|FG000|Overall Study|low Therapeutic drug monitoring (TDM)|1|||
48671562|NCT00129467|156650548|FG000|Received Intervention|Death|1|||
48671563|NCT00129467|156650549|FG001|Received Intervention|Death|1|||
48671564|NCT00129467|156650548|FG000|Received Intervention|Cardiac SAE (hypertension)|1|||
48671565|NCT00129467|156650549|FG001|Received Intervention|Cardiac SAE (hypertension)|1|||
48671566|NCT00129467|156650548|FG000|Received Intervention|Delirium|2|||
48671567|NCT00129467|156650549|FG001|Received Intervention|Delirium|0|||
48671568|NCT00129467|156650548|FG000|Received Intervention|Withdrawal by Subject|1|||
48671569|NCT00129467|156650549|FG001|Received Intervention|Withdrawal by Subject|0|||
48671570|NCT00129467|156650548|FG000|Received Intervention|Nausea|1|||
48671571|NCT00129467|156650549|FG001|Received Intervention|Nausea|0|||
48671572|NCT00129467|156650548|FG000|Received Intervention|Intolerance to citalopram|0|||
48671573|NCT00129467|156650549|FG001|Received Intervention|Intolerance to citalopram|1|||
48671574|NCT00129467|156650548|FG000|Received Intervention|Dizzyness, fatigue|0|||
48671575|NCT00129467|156650549|FG001|Received Intervention|Dizzyness, fatigue|1|||
48671576|NCT00129467|156650548|FG000|Open Label for SSRI+Methylphenidate Arm|Death|1|||
48671577|NCT00129467|156650549|FG001|Open Label for SSRI+Methylphenidate Arm|Death|0|||
48671578|NCT00129467|156650548|FG000|Open Label for SSRI+Methylphenidate Arm|Delirium|1|||
48671579|NCT00129467|156650549|FG001|Open Label for SSRI+Methylphenidate Arm|Delirium|0|||
48671580|NCT00694304|156650550|FG000|Overall Study|Adverse Event|42|||
48671581|NCT00694304|156650550|FG000|Overall Study|Lack of Efficacy|35|||
48671582|NCT00694304|156650550|FG000|Overall Study|Non-compliance With Study Product|16|||
48671583|NCT00694304|156650550|FG000|Overall Study|Protocol Violation|6|||
48671584|NCT00694304|156650550|FG000|Overall Study|Withdrawal of Consent|61|||
48671585|NCT00694304|156650550|FG000|Overall Study|Lost to Follow-up|15|||
48969572|NCT02248857|157717223|FG002|6 Month|Partially completed, unable to finish|0|||
48969573|NCT02248857|157717221|FG000|6 Month|Withdrawal by Subject|0|||
48969574|NCT02248857|157717222|FG001|6 Month|Withdrawal by Subject|2|||
48969575|NCT02248857|157717223|FG002|6 Month|Withdrawal by Subject|2|||
48969576|NCT02248857|157717221|FG000|6 Month|Death|1|||
48671586|NCT00694304|156650550|FG000|Overall Study|Administrative or Other Reasons|32|||
48671587|NCT00778895|156650551|FG000|Active Phase|Adverse Event|3|||
48671588|NCT00778895|156650552|FG001|Active Phase|Adverse Event|1|||
48671589|NCT00778895|156650553|FG002|Active Phase|Adverse Event|0|||
48671590|NCT00778895|156650551|FG000|Active Phase|Withdrawal by Subject|1|||
48671591|NCT00778895|156650552|FG001|Active Phase|Withdrawal by Subject|4|||
48671592|NCT00778895|156650553|FG002|Active Phase|Withdrawal by Subject|0|||
48760740|NCT03045887|156972306|FG006|Part A, Period 2 (1 Day)|Adverse Event|0|||
48969577|NCT02248857|157717222|FG001|6 Month|Death|0|||
48969578|NCT02248857|157717223|FG002|6 Month|Death|0|||
48969579|NCT03700736|157717227|FG000|Overall Study|Pregnancy|1|||
48671593|NCT00778895|156650551|FG000|Active Phase|Lost to Follow-up|1|||
48671594|NCT00778895|156650552|FG001|Active Phase|Lost to Follow-up|1|||
48671595|NCT00778895|156650553|FG002|Active Phase|Lost to Follow-up|0|||
48671596|NCT00778895|156650551|FG000|Active Phase|Other|2|||
48760741|NCT03045887|156972307|FG007|Part A, Period 2 (1 Day)|Adverse Event|0|||
48969580|NCT03700736|157717228|FG001|Overall Study|Pregnancy|1|||
48969581|NCT03700736|157717227|FG000|Overall Study|Withdrawal by Subject|2|||
48671597|NCT00778895|156650552|FG001|Active Phase|Other|0|||
48671598|NCT00778895|156650553|FG002|Active Phase|Other|0|||
48671599|NCT00778895|156650551|FG000|ESFU Phase|Adverse Event|2|||
48671600|NCT00778895|156650552|FG001|ESFU Phase|Adverse Event|1|||
48671601|NCT00778895|156650553|FG002|ESFU Phase|Adverse Event|0|||
48671602|NCT00778895|156650551|FG000|ESFU Phase|Withdrawal by Subject|1|||
48671603|NCT00778895|156650552|FG001|ESFU Phase|Withdrawal by Subject|4|||
48671604|NCT00778895|156650553|FG002|ESFU Phase|Withdrawal by Subject|0|||
48671605|NCT00778895|156650551|FG000|ESFU Phase|Lost to Follow-up|6|||
48671606|NCT00778895|156650552|FG001|ESFU Phase|Lost to Follow-up|7|||
48671607|NCT00778895|156650553|FG002|ESFU Phase|Lost to Follow-up|2|||
48671608|NCT00778895|156650551|FG000|ESFU Phase|Other|2|||
48671609|NCT00778895|156650552|FG001|ESFU Phase|Other|0|||
48671610|NCT00778895|156650553|FG002|ESFU Phase|Other|0|||
48671611|NCT01927055|156650557|FG000|Open-label|Adverse Event|6|||
48671612|NCT01927055|156650558|FG001|Open-label|Adverse Event|0|||
48671613|NCT01927055|156650559|FG002|Open-label|Adverse Event|0|||
48760742|NCT03045887|156972308|FG008|Part A, Period 2 (1 Day)|Adverse Event|0|||
48760743|NCT03045887|156972309|FG009|Part A, Period 2 (1 Day)|Adverse Event|0|||
48969582|NCT03700736|157717228|FG001|Overall Study|Withdrawal by Subject|6|||
48969583|NCT01255306|157717229|FG000|Overall Study|Physician Decision|1|||
48969584|NCT01255306|157717230|FG001|Overall Study|Physician Decision|1|||
48969585|NCT01575899|157717233|FG000|Overall Study|Lost to Follow-up|3|||
48969586|NCT01575899|157717234|FG001|Overall Study|Lost to Follow-up|4|||
48969587|NCT01575899|157717235|FG002|Overall Study|Lost to Follow-up|2|||
48969588|NCT01575899|157717233|FG000|Overall Study|Protocol Violation|2|||
48671614|NCT01927055|156650557|FG000|Open-label|Withdrawal by Subject|1|||
48671615|NCT01927055|156650558|FG001|Open-label|Withdrawal by Subject|0|||
48671616|NCT01927055|156650559|FG002|Open-label|Withdrawal by Subject|0|||
48671617|NCT01927055|156650557|FG000|Open-label|Study Stopped|4|||
48671618|NCT01927055|156650558|FG001|Open-label|Study Stopped|0|||
48671619|NCT01927055|156650559|FG002|Open-label|Study Stopped|0|||
48671620|NCT01927055|156650557|FG000|Open-label|Supine Hypertension|4|||
48671621|NCT01927055|156650558|FG001|Open-label|Supine Hypertension|0|||
48671622|NCT01927055|156650559|FG002|Open-label|Supine Hypertension|0|||
48671623|NCT01927055|156650557|FG000|Open-label|Difficulty attending study visits|1|||
48671624|NCT01927055|156650558|FG001|Open-label|Difficulty attending study visits|0|||
48671625|NCT01927055|156650559|FG002|Open-label|Difficulty attending study visits|0|||
48671626|NCT01927055|156650557|FG000|Double-Blind|Adverse Event|0|||
48671627|NCT01927055|156650558|FG001|Double-Blind|Adverse Event|1|||
48671628|NCT01927055|156650559|FG002|Double-Blind|Adverse Event|1|||
48671629|NCT01927055|156650557|FG000|Double-Blind|Protocol Violation|0|||
48671630|NCT01927055|156650558|FG001|Double-Blind|Protocol Violation|0|||
48671631|NCT01927055|156650559|FG002|Double-Blind|Protocol Violation|1|||
48671632|NCT01927055|156650557|FG000|Double-Blind|Withdrawal by Subject|0|||
48671633|NCT01927055|156650558|FG001|Double-Blind|Withdrawal by Subject|2|||
48671634|NCT01927055|156650559|FG002|Double-Blind|Withdrawal by Subject|3|||
48671635|NCT01927055|156650557|FG000|Double-Blind|Study Stopped|0|||
48671636|NCT01927055|156650558|FG001|Double-Blind|Study Stopped|7|||
48671637|NCT01927055|156650559|FG002|Double-Blind|Study Stopped|7|||
48671638|NCT01927055|156650557|FG000|Double-Blind|Supine Hypertension|0|||
48671639|NCT01927055|156650558|FG001|Double-Blind|Supine Hypertension|0|||
48671640|NCT01927055|156650559|FG002|Double-Blind|Supine Hypertension|1|||
48671641|NCT01927055|156650557|FG000|Double-Blind|Extended Vacation|0|||
48671642|NCT01927055|156650558|FG001|Double-Blind|Extended Vacation|1|||
48671643|NCT01927055|156650559|FG002|Double-Blind|Extended Vacation|0|||
48760744|NCT03045887|156972300|FG000|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
48969589|NCT01575899|157717234|FG001|Overall Study|Protocol Violation|1|||
48969590|NCT01575899|157717235|FG002|Overall Study|Protocol Violation|0|||
48969591|NCT02671461|157717236|FG000|Treatment|Adverse Event|0|||
48671644|NCT01424228|156650560|FG000|Overall Study|Withdrawal by Subject|27|||
48671645|NCT01424228|156650561|FG001|Overall Study|Withdrawal by Subject|11|||
48969592|NCT02671461|157717237|FG001|Treatment|Adverse Event|0|||
48969593|NCT02671461|157717238|FG002|Treatment|Adverse Event|1|||
48969594|NCT02671461|157717236|FG000|Treatment|Administrative Reason by Sponsor|1|||
48969595|NCT02671461|157717237|FG001|Treatment|Administrative Reason by Sponsor|3|||
48671646|NCT01424228|156650560|FG000|Overall Study|Adverse Event|10|||
48969596|NCT02671461|157717238|FG002|Treatment|Administrative Reason by Sponsor|4|||
48969597|NCT02671461|157717236|FG000|Treatment|Randomized, not treated|1|||
48671647|NCT01424228|156650561|FG001|Overall Study|Adverse Event|14|||
48671648|NCT01424228|156650560|FG000|Overall Study|Sponsor's decision|9|||
48671649|NCT01424228|156650561|FG001|Overall Study|Sponsor's decision|12|||
48671650|NCT01424228|156650560|FG000|Overall Study|Lack of Efficacy|5|||
48671651|NCT01424228|156650561|FG001|Overall Study|Lack of Efficacy|7|||
48671652|NCT01424228|156650560|FG000|Overall Study|inclusion/exclusion criteria not met|2|||
48671653|NCT01424228|156650561|FG001|Overall Study|inclusion/exclusion criteria not met|2|||
48671654|NCT01424228|156650560|FG000|Overall Study|Non-compliance|2|||
48671655|NCT01424228|156650561|FG001|Overall Study|Non-compliance|0|||
48671656|NCT01424228|156650560|FG000|Overall Study|Worsening of symptoms|1|||
48671657|NCT01424228|156650561|FG001|Overall Study|Worsening of symptoms|0|||
48671658|NCT01424228|156650560|FG000|Overall Study|Unplanned journey|0|||
48671659|NCT01424228|156650561|FG001|Overall Study|Unplanned journey|1|||
48671660|NCT00499746|156650568|FG000|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7|||
48671661|NCT00499746|156650568|FG000|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3|||
48671662|NCT00499746|156650568|FG000|Phase 1(6-9 One Day Sessions)|Investigator decision|1|||
48671663|NCT00499746|156650568|FG000|Phase 1(6-9 One Day Sessions)|Unable to determine|1|||
48671664|NCT02273960|156650569|FG000|Short Term Period|Lost to Follow-up|1|||
48671665|NCT02273960|156650570|FG001|Short Term Period|Lost to Follow-up|0|||
48671666|NCT02273960|156650571|FG002|Short Term Period|Lost to Follow-up|0|||
48671667|NCT02273960|156650572|FG003|Short Term Period|Lost to Follow-up|0|||
48671668|NCT02273960|156650569|FG000|Short Term Period|Lack of Efficacy|0|||
48671669|NCT02273960|156650570|FG001|Short Term Period|Lack of Efficacy|0|||
48671670|NCT02273960|156650571|FG002|Short Term Period|Lack of Efficacy|0|||
48671671|NCT02273960|156650572|FG003|Short Term Period|Lack of Efficacy|1|||
48671672|NCT02273960|156650569|FG000|Short Term Period|ST complete, not entering LTE|4|||
48671673|NCT02273960|156650570|FG001|Short Term Period|ST complete, not entering LTE|6|||
48671674|NCT02273960|156650571|FG002|Short Term Period|ST complete, not entering LTE|4|||
48671675|NCT02273960|156650572|FG003|Short Term Period|ST complete, not entering LTE|5|||
48671676|NCT02273960|156650569|FG000|Long Term Extension|Death|0|||
48671677|NCT02273960|156650570|FG001|Long Term Extension|Death|0|||
48671678|NCT02273960|156650571|FG002|Long Term Extension|Death|0|||
48671679|NCT02273960|156650572|FG003|Long Term Extension|Death|1|||
48671680|NCT01624090|156650573|FG000|Overall Study|DLT, taken off therapy|0|||
48671681|NCT01624090|156650574|FG001|Overall Study|DLT, taken off therapy|1|||
48671682|NCT01624090|156650575|FG002|Overall Study|DLT, taken off therapy|0|||
48671683|NCT01624090|156650576|FG003|Overall Study|DLT, taken off therapy|0|||
48671684|NCT01624090|156650573|FG000|Overall Study|Withdrew prior to treatment|0|||
48671685|NCT01624090|156650574|FG001|Overall Study|Withdrew prior to treatment|1|||
48671686|NCT01624090|156650575|FG002|Overall Study|Withdrew prior to treatment|0|||
48671687|NCT01624090|156650576|FG003|Overall Study|Withdrew prior to treatment|0|||
48671688|NCT01624090|156650573|FG000|Overall Study|Died on study|0|||
48671689|NCT01624090|156650574|FG001|Overall Study|Died on study|0|||
48671690|NCT01624090|156650575|FG002|Overall Study|Died on study|2|||
48671691|NCT01624090|156650576|FG003|Overall Study|Died on study|0|||
48671692|NCT01624090|156650573|FG000|Overall Study|Did not complete 1 crse of therapy|0|||
48671693|NCT01624090|156650574|FG001|Overall Study|Did not complete 1 crse of therapy|0|||
48671694|NCT01624090|156650575|FG002|Overall Study|Did not complete 1 crse of therapy|2|||
48671695|NCT01624090|156650576|FG003|Overall Study|Did not complete 1 crse of therapy|0|||
48671696|NCT01624090|156650573|FG000|Overall Study|Dose escalated|0|||
48671697|NCT01624090|156650574|FG001|Overall Study|Dose escalated|0|||
48671698|NCT01624090|156650575|FG002|Overall Study|Dose escalated|3|||
48671699|NCT01624090|156650576|FG003|Overall Study|Dose escalated|0|||
48671700|NCT00772109|156650577|FG000|Overall Study|Serious adverse event|1|||
48760745|NCT03045887|156972301|FG001|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
48969598|NCT02671461|157717237|FG001|Treatment|Randomized, not treated|0|||
48969599|NCT02671461|157717238|FG002|Treatment|Randomized, not treated|0|||
48969600|NCT02671461|157717236|FG000|Follow-up|Withdrawal by Subject|1|||
48969601|NCT02671461|157717237|FG001|Follow-up|Withdrawal by Subject|0|||
48969602|NCT02671461|157717238|FG002|Follow-up|Withdrawal by Subject|0|||
48969603|NCT02671461|157717236|FG000|Follow-up|Lost to Follow-up|0|||
48969604|NCT02671461|157717237|FG001|Follow-up|Lost to Follow-up|0|||
48671701|NCT00772109|156650578|FG001|Overall Study|Serious adverse event|0|||
48671702|NCT00772109|156650579|FG002|Overall Study|Serious adverse event|1|||
48760746|NCT03045887|156972302|FG002|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
48671703|NCT00772109|156650580|FG003|Overall Study|Serious adverse event|0|||
48671704|NCT00772109|156650577|FG000|Overall Study|Protocol Violation|5|||
48671705|NCT00772109|156650578|FG001|Overall Study|Protocol Violation|8|||
48760747|NCT03045887|156972303|FG003|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
48760748|NCT03045887|156972304|FG004|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
48760749|NCT03045887|156972305|FG005|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
48760750|NCT03045887|156972306|FG006|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
48760751|NCT03045887|156972307|FG007|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
48760752|NCT03045887|156972308|FG008|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
48760753|NCT03045887|156972309|FG009|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
48969605|NCT02671461|157717238|FG002|Follow-up|Lost to Follow-up|1|||
48671706|NCT00772109|156650579|FG002|Overall Study|Protocol Violation|7|||
48671707|NCT00772109|156650580|FG003|Overall Study|Protocol Violation|6|||
48969606|NCT02671461|157717236|FG000|Follow-up|Administrative Reason by Sponsor|0|||
48969607|NCT02671461|157717237|FG001|Follow-up|Administrative Reason by Sponsor|1|||
48969608|NCT02671461|157717238|FG002|Follow-up|Administrative Reason by Sponsor|0|||
48969609|NCT02261883|157717239|FG000|Overall Study|Death|3|||
48671708|NCT00772109|156650577|FG000|Overall Study|Lost to Follow-up|7|||
48671709|NCT00772109|156650578|FG001|Overall Study|Lost to Follow-up|3|||
48671710|NCT00772109|156650579|FG002|Overall Study|Lost to Follow-up|5|||
48671711|NCT00772109|156650580|FG003|Overall Study|Lost to Follow-up|9|||
48969610|NCT02261883|157717240|FG001|Overall Study|Death|2|||
48969611|NCT02261883|157717239|FG000|Overall Study|Physician Decision|1|||
48969612|NCT02261883|157717240|FG001|Overall Study|Physician Decision|0|||
48969613|NCT02261883|157717239|FG000|Overall Study|Protocol Violation|1|||
48969614|NCT02261883|157717240|FG001|Overall Study|Protocol Violation|0|||
48969615|NCT02261883|157717239|FG000|Overall Study|Withdrawal by Subject|0|||
48969616|NCT02261883|157717240|FG001|Overall Study|Withdrawal by Subject|1|||
48969617|NCT02261883|157717239|FG000|Overall Study|Required ECMO Prior to Study Drug Administration|1|||
48969618|NCT02261883|157717240|FG001|Overall Study|Required ECMO Prior to Study Drug Administration|0|||
48969619|NCT03097029|157717243|FG000|Overall Study|Withdrawal by Subject|1|||
48969620|NCT01626989|157717244|FG000|Screening Period|Screen Failure|15|||
48969621|NCT01626989|157717245|FG001|Screening Period|Screen Failure|0|||
48969622|NCT01626989|157717246|FG002|Screening Period|Screen Failure|0|||
48969623|NCT01626989|157717244|FG000|Screening Period|Withdrawal by Subject|2|||
48969624|NCT01626989|157717245|FG001|Screening Period|Withdrawal by Subject|0|||
48969625|NCT01626989|157717246|FG002|Screening Period|Withdrawal by Subject|0|||
48969626|NCT02807844|157717247|FG000|Overall Study|Physician Decision|0|||
48969627|NCT02807844|157717248|FG001|Overall Study|Physician Decision|0|||
48969628|NCT02807844|157717249|FG002|Overall Study|Physician Decision|0|||
48969629|NCT02807844|157717250|FG003|Overall Study|Physician Decision|0|||
48969630|NCT02807844|157717251|FG004|Overall Study|Physician Decision|0|||
48969631|NCT02807844|157717252|FG005|Overall Study|Physician Decision|0|||
48969632|NCT02807844|157717253|FG006|Overall Study|Physician Decision|3|||
48969633|NCT02807844|157717254|FG007|Overall Study|Physician Decision|0|||
48671712|NCT00772109|156650577|FG000|Overall Study|Withdrawal by Subject|8|||
48671713|NCT00772109|156650578|FG001|Overall Study|Withdrawal by Subject|8|||
48671714|NCT00772109|156650579|FG002|Overall Study|Withdrawal by Subject|6|||
48671715|NCT00772109|156650580|FG003|Overall Study|Withdrawal by Subject|16|||
48671716|NCT00752726|156650581|FG000|Overall Study|Lost to Follow-up|2|||
48671717|NCT00752726|156650582|FG001|Overall Study|Lost to Follow-up|1|||
48671718|NCT00752726|156650581|FG000|Overall Study|Adverse Event|3|||
48671719|NCT00752726|156650582|FG001|Overall Study|Adverse Event|0|||
48671720|NCT00752726|156650581|FG000|Overall Study|Withdrawal by Subject|5|||
48671721|NCT00752726|156650582|FG001|Overall Study|Withdrawal by Subject|10|||
48671722|NCT00752726|156650581|FG000|Overall Study|Other Reason|1|||
48671723|NCT00752726|156650582|FG001|Overall Study|Other Reason|2|||
48671724|NCT01403116|156650583|FG000|Overall Study|Adverse Event|7|||
48671725|NCT01403116|156650584|FG001|Overall Study|Adverse Event|4|||
48671726|NCT01403116|156650583|FG000|Overall Study|Lost to Follow-up|7|||
48671727|NCT01403116|156650584|FG001|Overall Study|Lost to Follow-up|5|||
48671728|NCT01403116|156650583|FG000|Overall Study|Withdrawal by Subject|12|||
48671729|NCT01403116|156650584|FG001|Overall Study|Withdrawal by Subject|15|||
48671730|NCT01403116|156650583|FG000|Overall Study|Non-compliance of study drug|3|||
48671731|NCT01403116|156650584|FG001|Overall Study|Non-compliance of study drug|0|||
48671732|NCT01403116|156650583|FG000|Overall Study|Protocol Violation|0|||
48671733|NCT01403116|156650584|FG001|Overall Study|Protocol Violation|1|||
48671734|NCT01403116|156650583|FG000|Overall Study|undisclosed Hx of Prostate Ca|1|||
48671735|NCT01403116|156650584|FG001|Overall Study|undisclosed Hx of Prostate Ca|0|||
48671736|NCT01403116|156650583|FG000|Overall Study|Hct >54%|2|||
48671737|NCT01403116|156650584|FG001|Overall Study|Hct >54%|0|||
48671738|NCT01403116|156650583|FG000|Overall Study|unable to keep appointments|0|||
48671739|NCT01403116|156650584|FG001|Overall Study|unable to keep appointments|2|||
48671740|NCT01895309|156650585|FG000|Overall Study|Adverse Event|13|||
48671741|NCT01895309|156650586|FG001|Overall Study|Adverse Event|17|||
48671742|NCT01895309|156650585|FG000|Overall Study|Protocol Violation|1|||
48671743|NCT01895309|156650586|FG001|Overall Study|Protocol Violation|0|||
48671744|NCT01895309|156650585|FG000|Overall Study|Lack of Efficacy|1|||
48671745|NCT01895309|156650586|FG001|Overall Study|Lack of Efficacy|3|||
48671746|NCT01895309|156650585|FG000|Overall Study|Lost to Follow-up|1|||
48671747|NCT01895309|156650586|FG001|Overall Study|Lost to Follow-up|3|||
48671748|NCT01895309|156650585|FG000|Overall Study|Physician Decision|15|||
48671749|NCT01895309|156650586|FG001|Overall Study|Physician Decision|10|||
48671750|NCT01895309|156650585|FG000|Overall Study|Withdrawal by Subject|9|||
48671751|NCT01895309|156650586|FG001|Overall Study|Withdrawal by Subject|18|||
48671752|NCT01457846|156650587|FG000|Overall Study|Death before treatment|1|||
48671753|NCT01457846|156650588|FG001|Overall Study|Death before treatment|2|||
48671754|NCT01457846|156650587|FG000|Overall Study|Did not receive treatment|0|||
48671755|NCT01457846|156650588|FG001|Overall Study|Did not receive treatment|1|||
48969634|NCT02807844|157717255|FG008|Overall Study|Physician Decision|1|||
48969635|NCT02807844|157717256|FG009|Overall Study|Physician Decision|2|||
48969636|NCT02807844|157717247|FG000|Overall Study|Death|0|||
48969637|NCT02807844|157717248|FG001|Overall Study|Death|0|||
48969638|NCT02807844|157717249|FG002|Overall Study|Death|2|||
48969639|NCT02807844|157717250|FG003|Overall Study|Death|4|||
48671756|NCT01457846|156650587|FG000|Overall Study|Death|27|||
48671757|NCT01457846|156650588|FG001|Overall Study|Death|16|||
48671758|NCT01457846|156650587|FG000|Overall Study|Unclassified reason for not completed|11|||
48969640|NCT02807844|157717251|FG004|Overall Study|Death|1|||
48969641|NCT02807844|157717252|FG005|Overall Study|Death|2|||
48969642|NCT02807844|157717253|FG006|Overall Study|Death|1|||
48969643|NCT02807844|157717254|FG007|Overall Study|Death|2|||
48969644|NCT02807844|157717255|FG008|Overall Study|Death|0|||
48969645|NCT02807844|157717256|FG009|Overall Study|Death|1|||
48969646|NCT02807844|157717247|FG000|Overall Study|Withdrawal by Subject|0|||
48969647|NCT02807844|157717248|FG001|Overall Study|Withdrawal by Subject|0|||
48969648|NCT02807844|157717249|FG002|Overall Study|Withdrawal by Subject|2|||
48969649|NCT02807844|157717250|FG003|Overall Study|Withdrawal by Subject|1|||
48969650|NCT02807844|157717251|FG004|Overall Study|Withdrawal by Subject|1|||
48969651|NCT02807844|157717252|FG005|Overall Study|Withdrawal by Subject|0|||
48969652|NCT02807844|157717253|FG006|Overall Study|Withdrawal by Subject|1|||
48969653|NCT02807844|157717254|FG007|Overall Study|Withdrawal by Subject|0|||
48969654|NCT02807844|157717255|FG008|Overall Study|Withdrawal by Subject|0|||
48969655|NCT02807844|157717256|FG009|Overall Study|Withdrawal by Subject|0|||
48969656|NCT02807844|157717247|FG000|Overall Study|Progressive disease|5|||
48969657|NCT02807844|157717248|FG001|Overall Study|Progressive disease|12|||
48969658|NCT02807844|157717249|FG002|Overall Study|Progressive disease|8|||
48969659|NCT02807844|157717250|FG003|Overall Study|Progressive disease|8|||
48969660|NCT02807844|157717251|FG004|Overall Study|Progressive disease|3|||
48969661|NCT02807844|157717252|FG005|Overall Study|Progressive disease|8|||
48671759|NCT01457846|156650588|FG001|Overall Study|Unclassified reason for not completed|10|||
48671760|NCT01457846|156650587|FG000|Overall Study|Withdrawal by Subject|1|||
48671761|NCT01457846|156650588|FG001|Overall Study|Withdrawal by Subject|1|||
48671762|NCT01457846|156650587|FG000|Overall Study|Lost to Follow-up|1|||
48671763|NCT01457846|156650588|FG001|Overall Study|Lost to Follow-up|0|||
48671764|NCT02726022|156650591|FG000|Overall Study|Adverse Event|14|||
48671765|NCT02726022|156650591|FG000|Overall Study|Treatment Failure|8|||
48671766|NCT02726022|156650591|FG000|Overall Study|Poor Compliance|13|||
48671767|NCT02726022|156650591|FG000|Overall Study|Treatment Failure and Poor Compliance|1|||
48671768|NCT00760838|156650592|FG000|Overall Study|Adverse Event|1|||
48671769|NCT00760838|156650593|FG001|Overall Study|Adverse Event|1|||
48671770|NCT00760838|156650592|FG000|Overall Study|Lack of Efficacy|1|||
48671771|NCT00760838|156650593|FG001|Overall Study|Lack of Efficacy|0|||
48671772|NCT00760838|156650592|FG000|Overall Study|Lost to Follow-up|2|||
48671773|NCT00760838|156650593|FG001|Overall Study|Lost to Follow-up|0|||
48671774|NCT00760838|156650592|FG000|Overall Study|Withdrawal by Subject|1|||
48671775|NCT00760838|156650593|FG001|Overall Study|Withdrawal by Subject|1|||
48671776|NCT02039856|156650594|FG000|Overall Study|Death|5|||
48671777|NCT02039856|156650595|FG001|Overall Study|Death|3|||
48671778|NCT02039856|156650594|FG000|Overall Study|Partial survey completion|61|||
48671779|NCT02039856|156650595|FG001|Overall Study|Partial survey completion|26|||
48671780|NCT02039856|156650594|FG000|Overall Study|Lost to Follow-up|388|||
48671781|NCT02039856|156650595|FG001|Overall Study|Lost to Follow-up|206|||
48671782|NCT02039856|156650594|FG000|Overall Study|Withdrawal by Subject|1573|||
48671783|NCT02039856|156650595|FG001|Overall Study|Withdrawal by Subject|618|||
48671784|NCT02607228|156650596|FG000|Overall Study|Progressive Disease|4|||
48671785|NCT02607228|156650597|FG001|Overall Study|Progressive Disease|3|||
48671786|NCT02607228|156650598|FG002|Overall Study|Progressive Disease|1|||
48671787|NCT02607228|156650599|FG003|Overall Study|Progressive Disease|5|||
48671788|NCT02607228|156650600|FG004|Overall Study|Progressive Disease|4|||
48671789|NCT02607228|156650601|FG005|Overall Study|Progressive Disease|3|||
48671790|NCT02607228|156650602|FG006|Overall Study|Progressive Disease|1|||
48671791|NCT02607228|156650596|FG000|Overall Study|Adverse Event|1|||
48671792|NCT02607228|156650597|FG001|Overall Study|Adverse Event|0|||
48671793|NCT02607228|156650598|FG002|Overall Study|Adverse Event|1|||
48671794|NCT02607228|156650599|FG003|Overall Study|Adverse Event|0|||
48671795|NCT02607228|156650600|FG004|Overall Study|Adverse Event|1|||
48671796|NCT02607228|156650601|FG005|Overall Study|Adverse Event|1|||
48671797|NCT02607228|156650602|FG006|Overall Study|Adverse Event|1|||
48671798|NCT02607228|156650596|FG000|Overall Study|Investigator's Discretion|0|||
48671799|NCT02607228|156650597|FG001|Overall Study|Investigator's Discretion|0|||
48671800|NCT02607228|156650598|FG002|Overall Study|Investigator's Discretion|1|||
48671801|NCT02607228|156650599|FG003|Overall Study|Investigator's Discretion|0|||
48969662|NCT02807844|157717253|FG006|Overall Study|Progressive disease|14|||
48969663|NCT02807844|157717254|FG007|Overall Study|Progressive disease|17|||
48969664|NCT02807844|157717255|FG008|Overall Study|Progressive disease|19|||
48969665|NCT02807844|157717256|FG009|Overall Study|Progressive disease|15|||
48969666|NCT02807844|157717247|FG000|Overall Study|Adverse Event|1|||
48671802|NCT02607228|156650600|FG004|Overall Study|Investigator's Discretion|0|||
48671803|NCT02607228|156650601|FG005|Overall Study|Investigator's Discretion|1|||
48671804|NCT02607228|156650602|FG006|Overall Study|Investigator's Discretion|0|||
48671805|NCT02607228|156650596|FG000|Overall Study|Withdrew Consent|0|||
48671806|NCT02607228|156650597|FG001|Overall Study|Withdrew Consent|1|||
48671807|NCT02607228|156650598|FG002|Overall Study|Withdrew Consent|0|||
48671808|NCT02607228|156650599|FG003|Overall Study|Withdrew Consent|0|||
48671809|NCT02607228|156650600|FG004|Overall Study|Withdrew Consent|0|||
48671810|NCT02607228|156650601|FG005|Overall Study|Withdrew Consent|1|||
48671811|NCT02607228|156650602|FG006|Overall Study|Withdrew Consent|0|||
48969667|NCT02807844|157717248|FG001|Overall Study|Adverse Event|0|||
48671812|NCT02607228|156650596|FG000|Overall Study|Study Terminated by Sponsor|0|||
48671813|NCT02607228|156650597|FG001|Overall Study|Study Terminated by Sponsor|0|||
48671814|NCT02607228|156650598|FG002|Overall Study|Study Terminated by Sponsor|0|||
48671815|NCT02607228|156650599|FG003|Overall Study|Study Terminated by Sponsor|1|||
48671816|NCT02607228|156650600|FG004|Overall Study|Study Terminated by Sponsor|0|||
48671817|NCT02607228|156650601|FG005|Overall Study|Study Terminated by Sponsor|0|||
48671818|NCT02607228|156650602|FG006|Overall Study|Study Terminated by Sponsor|0|||
48671819|NCT03235089|156650603|FG000|Overall Study|Lost to Follow-up|1|||
48671820|NCT03235089|156650604|FG001|Overall Study|Lost to Follow-up|1|||
48671821|NCT03235089|156650603|FG000|Overall Study|Physician Decision|2|||
48671822|NCT03235089|156650604|FG001|Overall Study|Physician Decision|2|||
48671823|NCT03238924|156650605|FG000|Overall Study|Withdrawal by Subject|2|||
48671824|NCT03238924|156650606|FG001|Overall Study|Withdrawal by Subject|2|||
48671825|NCT01455194|156650607|FG000|Overall Study|Screen Failure|20|||
48671826|NCT01455194|156650608|FG001|Overall Study|Screen Failure|0|||
48671827|NCT01455194|156650609|FG002|Overall Study|Screen Failure|0|||
48671828|NCT01455194|156650610|FG003|Overall Study|Screen Failure|0|||
48671829|NCT01455194|156650607|FG000|Overall Study|Randomisation Failure|90|||
48671830|NCT01455194|156650608|FG001|Overall Study|Randomisation Failure|0|||
48671831|NCT01455194|156650609|FG002|Overall Study|Randomisation Failure|0|||
48671832|NCT01455194|156650610|FG003|Overall Study|Randomisation Failure|0|||
48671833|NCT01455194|156650607|FG000|Overall Study|Deterioration in asthma|12|||
48671834|NCT01455194|156650608|FG001|Overall Study|Deterioration in asthma|6|||
48671835|NCT01455194|156650609|FG002|Overall Study|Deterioration in asthma|14|||
48671836|NCT01455194|156650610|FG003|Overall Study|Deterioration in asthma|9|||
48969668|NCT02807844|157717249|FG002|Overall Study|Adverse Event|0|||
48671837|NCT01455194|156650607|FG000|Overall Study|Adverse Event|1|||
48671838|NCT01455194|156650608|FG001|Overall Study|Adverse Event|1|||
48671839|NCT01455194|156650609|FG002|Overall Study|Adverse Event|1|||
48671840|NCT01455194|156650610|FG003|Overall Study|Adverse Event|3|||
48671841|NCT01455194|156650607|FG000|Overall Study|Withdrawal by Subject|21|||
48671842|NCT01455194|156650608|FG001|Overall Study|Withdrawal by Subject|16|||
48671843|NCT01455194|156650609|FG002|Overall Study|Withdrawal by Subject|12|||
48671844|NCT01455194|156650610|FG003|Overall Study|Withdrawal by Subject|9|||
48671845|NCT01455194|156650607|FG000|Overall Study|Lost to Follow-up|2|||
48671846|NCT01455194|156650608|FG001|Overall Study|Lost to Follow-up|0|||
48671847|NCT01455194|156650609|FG002|Overall Study|Lost to Follow-up|1|||
48671848|NCT01455194|156650610|FG003|Overall Study|Lost to Follow-up|1|||
48671849|NCT01455194|156650607|FG000|Overall Study|Pregnancy|0|||
48671850|NCT01455194|156650608|FG001|Overall Study|Pregnancy|1|||
48671851|NCT01455194|156650609|FG002|Overall Study|Pregnancy|1|||
48671852|NCT01455194|156650610|FG003|Overall Study|Pregnancy|0|||
48671853|NCT01455194|156650607|FG000|Overall Study|Discontinuation criterion fulfilled|3|||
48671854|NCT01455194|156650608|FG001|Overall Study|Discontinuation criterion fulfilled|2|||
48671855|NCT01455194|156650609|FG002|Overall Study|Discontinuation criterion fulfilled|0|||
48671856|NCT01455194|156650610|FG003|Overall Study|Discontinuation criterion fulfilled|2|||
48671857|NCT01455194|156650607|FG000|Overall Study|Miscellaneous|4|||
48671858|NCT01455194|156650608|FG001|Overall Study|Miscellaneous|5|||
48671859|NCT01455194|156650609|FG002|Overall Study|Miscellaneous|1|||
48671860|NCT01455194|156650610|FG003|Overall Study|Miscellaneous|4|||
48671861|NCT03916484|156650611|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
48671862|NCT03916484|156650612|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|1|||
48671863|NCT03916484|156650613|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
48671864|NCT03916484|156650614|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
48671865|NCT03916484|156650611|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
48671866|NCT03916484|156650612|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|11|||
48671867|NCT03916484|156650613|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|4|||
48671868|NCT03916484|156650614|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
48671869|NCT04407234|156650617|FG000|Overall Study|Adverse Event|3|||
48671870|NCT04407234|156650618|FG001|Overall Study|Adverse Event|3|||
48671871|NCT01879072|156650619|FG000|Overall Study|Withdrawal by Subject|121|||
48671872|NCT01879072|156650619|FG000|Overall Study|Not Transplanted|30|||
48969669|NCT02807844|157717250|FG003|Overall Study|Adverse Event|0|||
48671873|NCT02277119|156650620|FG000|Overall Study|Lack of Efficacy|1|||
48671874|NCT02277119|156650621|FG001|Overall Study|Lack of Efficacy|1|||
48671875|NCT02277119|156650622|FG002|Overall Study|Lack of Efficacy|1|||
48671876|NCT02277119|156650620|FG000|Overall Study|Protocol Violation|2|||
48671877|NCT02277119|156650621|FG001|Overall Study|Protocol Violation|3|||
48671878|NCT02277119|156650622|FG002|Overall Study|Protocol Violation|7|||
48671879|NCT02461745|156650623|FG000|Overall Study|Lack of Efficacy|9|||
48671880|NCT02461745|156650624|FG001|Overall Study|Lack of Efficacy|1|||
48671881|NCT02461745|156650623|FG000|Overall Study|Lost to Follow-up|2|||
48671882|NCT02461745|156650624|FG001|Overall Study|Lost to Follow-up|2|||
48671883|NCT02461745|156650623|FG000|Overall Study|Withdrawal by Subject|3|||
48671884|NCT02461745|156650624|FG001|Overall Study|Withdrawal by Subject|1|||
48671885|NCT03848949|156650625|FG000|Overall Study|Lost to Follow-up|5|||
48671886|NCT03848949|156650626|FG001|Overall Study|Lost to Follow-up|7|||
48671887|NCT00118430|156650629|FG000|Overall Study|Withdrawal by Subject|6|||
48671888|NCT00118430|156650630|FG001|Overall Study|Withdrawal by Subject|2|||
48671889|NCT00118430|156650631|FG002|Overall Study|Withdrawal by Subject|0|||
48671890|NCT00118430|156650629|FG000|Overall Study|Lost to Follow-up|15|||
48671891|NCT00118430|156650630|FG001|Overall Study|Lost to Follow-up|22|||
48671892|NCT00118430|156650631|FG002|Overall Study|Lost to Follow-up|28|||
48671893|NCT01306656|156651726|FG000|Overall Study|Lost to Follow-up|1|||
48671894|NCT01306656|156651727|FG001|Overall Study|Lost to Follow-up|0|||
48671895|NCT01282294|156651731|FG000|Overall Study|Lost to Follow-up|14|||
48671896|NCT01282294|156651731|FG000|Overall Study|Screening failure|1|||
48671897|NCT01282294|156651731|FG000|Overall Study|Adverse Event|1|||
48969670|NCT02807844|157717251|FG004|Overall Study|Adverse Event|1|||
48969671|NCT02807844|157717252|FG005|Overall Study|Adverse Event|1|||
48969672|NCT02807844|157717253|FG006|Overall Study|Adverse Event|1|||
48969673|NCT02807844|157717254|FG007|Overall Study|Adverse Event|1|||
48969674|NCT02807844|157717255|FG008|Overall Study|Adverse Event|1|||
48969675|NCT02807844|157717256|FG009|Overall Study|Adverse Event|2|||
48969676|NCT02031432|157717264|FG000|Overall Study|Protocol Violation|1|||
48969677|NCT02031432|157717264|FG000|Overall Study|Lack of Efficacy|5|||
48969678|NCT02031432|157717264|FG000|Overall Study|Cancer Progression|2|||
48969679|NCT02031432|157717264|FG000|Overall Study|Withdrawn as forbidden meds required|1|||
48969680|NCT02031432|157717264|FG000|Overall Study|Adverse Event|8|||
48969681|NCT02031432|157717264|FG000|Overall Study|Withdrawal by Subject|5|||
48969682|NCT02031432|157717264|FG000|Overall Study|Lost to Follow-up|1|||
48969683|NCT02031432|157717264|FG000|Overall Study|Inclusion/Exclusion criteria not met|5|||
48671898|NCT01282294|156651731|FG000|Overall Study|Patient non-compliance|2|||
48671899|NCT01282294|156651731|FG000|Overall Study|Physician Decision|1|||
48671900|NCT00701805|156651732|FG000|Overall Study|Withdrawal by Subject|3|||
48671901|NCT00701805|156651733|FG001|Overall Study|Withdrawal by Subject|1|||
48671902|NCT00701805|156651734|FG002|Overall Study|Withdrawal by Subject|4|||
48671903|NCT00701805|156651735|FG003|Overall Study|Withdrawal by Subject|3|||
48671904|NCT00701805|156651732|FG000|Overall Study|Adverse Event|0|||
48671905|NCT00701805|156651733|FG001|Overall Study|Adverse Event|1|||
48671906|NCT00701805|156651734|FG002|Overall Study|Adverse Event|1|||
48671907|NCT00701805|156651735|FG003|Overall Study|Adverse Event|0|||
48671908|NCT00701805|156651732|FG000|Overall Study|Missed 7 consecutive doses|0|||
48671909|NCT00701805|156651733|FG001|Overall Study|Missed 7 consecutive doses|1|||
48671910|NCT00701805|156651734|FG002|Overall Study|Missed 7 consecutive doses|0|||
48671911|NCT00701805|156651735|FG003|Overall Study|Missed 7 consecutive doses|0|||
48671912|NCT00701805|156651732|FG000|Overall Study|Admitted to hospital for 2 weeks|0|||
48671913|NCT00701805|156651733|FG001|Overall Study|Admitted to hospital for 2 weeks|0|||
48671914|NCT00701805|156651734|FG002|Overall Study|Admitted to hospital for 2 weeks|1|||
48671915|NCT00701805|156651735|FG003|Overall Study|Admitted to hospital for 2 weeks|0|||
48671916|NCT00701805|156651732|FG000|Overall Study|Physician decision, change of therapy|0|||
48671917|NCT00701805|156651733|FG001|Overall Study|Physician decision, change of therapy|0|||
48671918|NCT00701805|156651734|FG002|Overall Study|Physician decision, change of therapy|0|||
48671919|NCT00701805|156651735|FG003|Overall Study|Physician decision, change of therapy|1|||
48671920|NCT00701805|156651732|FG000|Overall Study|Difficult to travel to dialysis site|0|||
48671921|NCT00701805|156651733|FG001|Overall Study|Difficult to travel to dialysis site|0|||
48671922|NCT00701805|156651734|FG002|Overall Study|Difficult to travel to dialysis site|1|||
48969684|NCT02031432|157717264|FG000|Overall Study|Death|10|||
48671923|NCT00701805|156651735|FG003|Overall Study|Difficult to travel to dialysis site|0|||
48671924|NCT00701805|156651732|FG000|Overall Study|Resumption criteria were not met|0|||
48671925|NCT00701805|156651733|FG001|Overall Study|Resumption criteria were not met|1|||
48671926|NCT00701805|156651734|FG002|Overall Study|Resumption criteria were not met|0|||
48671927|NCT00701805|156651735|FG003|Overall Study|Resumption criteria were not met|0|||
48671928|NCT03769311|156651737|FG000|Overall Study|Withdrawal by Subject|1|||
48671929|NCT00881504|156651738|FG000|Overall Study|Withdrawal by Subject|1|||
48671930|NCT00007020|156651739|FG000|Overall Study|Death|16|||
48671931|NCT00007020|156651739|FG000|Overall Study|Lost to Follow-up|13|||
48671932|NCT00007020|156651739|FG000|Overall Study|Pt withdrawn (worsening cholestasis)|1|||
48671933|NCT00007020|156651739|FG000|Overall Study|Pt withdrawn (liver transplant)|4|||
48671934|NCT00007020|156651739|FG000|Overall Study|Pt cared for by outside physician|4|||
48671935|NCT00007020|156651739|FG000|Overall Study|No evidence of treatment|6|||
48671936|NCT01571232|156651740|FG000|Overall Study|Lost to Follow-up|0|||
48671937|NCT01571232|156651741|FG001|Overall Study|Lost to Follow-up|1|||
48969685|NCT00004732|157717266|FG000|Overall Study|Withdrawal by Subject|36|||
48969686|NCT00004732|157717267|FG001|Overall Study|Withdrawal by Subject|64|||
48969687|NCT00004732|157717266|FG000|Overall Study|Lost to Follow-up|33|||
48969688|NCT00004732|157717267|FG001|Overall Study|Lost to Follow-up|47|||
48671938|NCT01571232|156651740|FG000|Overall Study|Withdrawal by Subject|1|||
48671939|NCT01571232|156651741|FG001|Overall Study|Withdrawal by Subject|0|||
48671940|NCT01751139|156651742|FG000|Overall Study|Other|135|||
48671941|NCT01751139|156651742|FG000|Overall Study|Sponsor study termination|1609|||
48969689|NCT01250756|157717268|FG000|Infant Series|Withdrawal by Subject|4|||
48671942|NCT01751139|156651742|FG000|Overall Study|Lost to Follow-up|240|||
48671943|NCT01751139|156651742|FG000|Overall Study|Withdrawal by Subject|251|||
48671944|NCT01751139|156651742|FG000|Overall Study|Adverse Event|1|||
48671945|NCT01751139|156651742|FG000|Overall Study|Death|31|||
48671946|NCT01266317|156651743|FG000|Overall Study|Withdrawal by Subject|2|||
48671947|NCT01867086|156651744|FG000|Overall Study|Disease Progression|1|||
48671948|NCT01657760|156651747|FG000|Overall Study|Withdrawal by Subject|0|||
48671949|NCT01657760|156651748|FG001|Overall Study|Withdrawal by Subject|0|||
48760754|NCT03045887|156972300|FG000|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
48760755|NCT03045887|156972301|FG001|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
48760756|NCT03045887|156972302|FG002|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
48760757|NCT03045887|156972303|FG003|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1|||
48969690|NCT01250756|157717269|FG001|Infant Series|Withdrawal by Subject|5|||
48969691|NCT01250756|157717268|FG000|Infant Series|Randomized, Not Vaccinated|2|||
48969692|NCT01250756|157717269|FG001|Infant Series|Randomized, Not Vaccinated|2|||
48969693|NCT01250756|157717268|FG000|Infant Series|Other|22|||
48969694|NCT01250756|157717269|FG001|Infant Series|Other|0|||
48969695|NCT01250756|157717268|FG000|After Infant Series|Adverse Event|5|||
48969696|NCT01250756|157717269|FG001|After Infant Series|Adverse Event|2|||
48969697|NCT01250756|157717268|FG000|After Infant Series|Withdrawal by Subject|4|||
48969698|NCT01250756|157717269|FG001|After Infant Series|Withdrawal by Subject|1|||
48969699|NCT01250756|157717268|FG000|After Infant Series|Other|2|||
48969700|NCT01250756|157717269|FG001|After Infant Series|Other|1|||
48969701|NCT01250756|157717268|FG000|Toddler Dose|Adverse Event|0|||
48969702|NCT01250756|157717269|FG001|Toddler Dose|Adverse Event|1|||
48969703|NCT01250756|157717268|FG000|After Toddler Dose|Adverse Event|0|||
48969704|NCT01250756|157717269|FG001|After Toddler Dose|Adverse Event|1|||
48969705|NCT00753688|157717270|FG000|Overall Study|Death|102|||
48969706|NCT00753688|157717271|FG001|Overall Study|Death|203|||
48969707|NCT00753688|157717270|FG000|Overall Study|Missing|4|||
48969708|NCT00753688|157717271|FG001|Overall Study|Missing|9|||
48969709|NCT00753688|157717270|FG000|Overall Study|Participant Withdrew Consent|2|||
48969710|NCT00753688|157717271|FG001|Overall Study|Participant Withdrew Consent|2|||
48969711|NCT00753688|157717270|FG000|Overall Study|Ongoing - in Follow-up|15|||
48969712|NCT00753688|157717271|FG001|Overall Study|Ongoing - in Follow-up|31|||
48969713|NCT00753688|157717270|FG000|Overall Study|Adverse Event|0|||
48969714|NCT00753688|157717271|FG001|Overall Study|Adverse Event|1|||
48969715|NCT00108953|157717272|FG000|Follow-up|Death|18|||
48969716|NCT00108953|157717273|FG001|Follow-up|Death|26|||
48969717|NCT00108953|157717272|FG000|Follow-up|Lost to Follow-up|1|||
48969718|NCT00108953|157717273|FG001|Follow-up|Lost to Follow-up|1|||
48969719|NCT00108953|157717272|FG000|Follow-up|Study terminated by sponsor|10|||
48969720|NCT00108953|157717273|FG001|Follow-up|Study terminated by sponsor|6|||
48969721|NCT04294095|157717280|FG000|Overall Study|Adverse Event|1|||
48969722|NCT04294095|157717281|FG001|Overall Study|Adverse Event|0|||
48969723|NCT02674685|157717284|FG000|Overall Study|Withdrawal by Subject|4|||
48969724|NCT04126031|157717287|FG000|Part A|Withdrawal by Subject|0|||
48969725|NCT04126031|157717288|FG001|Part A|Withdrawal by Subject|0|||
48969726|NCT04126031|157717289|FG002|Part A|Withdrawal by Subject|1|||
48969727|NCT04126031|157717290|FG003|Part A|Withdrawal by Subject|0|||
48969728|NCT04126031|157717291|FG004|Part A|Withdrawal by Subject|0|||
48969729|NCT04126031|157717292|FG005|Part A|Withdrawal by Subject|0|||
48671950|NCT01657760|156651749|FG002|Overall Study|Withdrawal by Subject|0|||
48671951|NCT01657760|156651750|FG003|Overall Study|Withdrawal by Subject|1|||
48671952|NCT01657760|156651747|FG000|Overall Study|Physician Decision|1|||
48671953|NCT01657760|156651748|FG001|Overall Study|Physician Decision|1|||
48671954|NCT01657760|156651749|FG002|Overall Study|Physician Decision|1|||
48671955|NCT01657760|156651750|FG003|Overall Study|Physician Decision|2|||
48671956|NCT02704689|156651753|FG000|Overall Study|Physician Decision|1|||
48671957|NCT02704689|156651753|FG000|Overall Study|Study device not implanted|2|||
48760758|NCT03045887|156972304|FG004|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
48969730|NCT04126031|157717287|FG000|Part A|Other|1|||
48969731|NCT04126031|157717288|FG001|Part A|Other|0|||
48969732|NCT04126031|157717289|FG002|Part A|Other|0|||
48969733|NCT04126031|157717290|FG003|Part A|Other|0|||
48969734|NCT04126031|157717291|FG004|Part A|Other|0|||
48969735|NCT04126031|157717292|FG005|Part A|Other|0|||
48969736|NCT04126031|157717287|FG000|Part B|Adverse Event|0|||
48969737|NCT04126031|157717288|FG001|Part B|Adverse Event|0|||
48969738|NCT04126031|157717289|FG002|Part B|Adverse Event|0|||
48969739|NCT04126031|157717290|FG003|Part B|Adverse Event|0|||
48969740|NCT04126031|157717291|FG004|Part B|Adverse Event|0|||
48671958|NCT03908476|156651759|FG000|Overall Study|Death|3|||
48671959|NCT03908476|156651760|FG001|Overall Study|Death|0|||
48671960|NCT03908476|156651759|FG000|Overall Study|Lost to Follow-up|3|||
48671961|NCT03908476|156651760|FG001|Overall Study|Lost to Follow-up|1|||
48671962|NCT03908476|156651759|FG000|Overall Study|Withdrawal by Subject|7|||
48671963|NCT03908476|156651760|FG001|Overall Study|Withdrawal by Subject|1|||
48969741|NCT04126031|157717292|FG005|Part B|Adverse Event|2|||
48969742|NCT04126031|157717287|FG000|Part B|Pre-existing hypertransaminasemia|0|||
48969743|NCT04126031|157717288|FG001|Part B|Pre-existing hypertransaminasemia|0|||
48671964|NCT03908476|156651759|FG000|Overall Study|Physician Decision|2|||
48671965|NCT03908476|156651760|FG001|Overall Study|Physician Decision|0|||
48671966|NCT03908476|156651759|FG000|Overall Study|System Explanted and not Replaced|4|||
48671967|NCT03908476|156651760|FG001|Overall Study|System Explanted and not Replaced|0|||
48671968|NCT03908476|156651759|FG000|Overall Study|Intrathecal Pump|1|||
48671969|NCT03908476|156651760|FG001|Overall Study|Intrathecal Pump|0|||
48671970|NCT03908476|156651759|FG000|Overall Study|Patient Has Requested an Explant of the Device|1|||
48671971|NCT03908476|156651760|FG001|Overall Study|Patient Has Requested an Explant of the Device|0|||
48671972|NCT02936284|156651766|FG000|Overall Study|Withdrawal by Subject|3|||
48671973|NCT02936284|156651767|FG001|Overall Study|Withdrawal by Subject|1|||
48671974|NCT02936284|156651766|FG000|Overall Study|Lost to Follow-up|7|||
48671975|NCT02936284|156651767|FG001|Overall Study|Lost to Follow-up|8|||
48671976|NCT00799591|156651768|FG000|Overall Study|De-escalation of doses|20|||
48671977|NCT00799591|156651768|FG000|Overall Study|Death|14|||
48671978|NCT00799591|156651768|FG000|Overall Study|Technical failure|12|||
48671979|NCT00799591|156651768|FG000|Overall Study|Resistant germ|11|||
48671980|NCT00799591|156651768|FG000|Overall Study|New infection|4|||
48671981|NCT00799591|156651768|FG000|Overall Study|Resistance germ and technical failure|2|||
48671982|NCT00799591|156651768|FG000|Overall Study|Persistance of fever undetermined origin|1|||
48671983|NCT00799591|156651768|FG000|Overall Study|Antibiotic changed, no apparent reason|1|||
48671984|NCT00799591|156651768|FG000|Overall Study|Infectious origin not probable|1|||
48671985|NCT03194438|156651771|FG000|Overall Study|Withdrawal by Subject|2|||
48671986|NCT01146288|156651775|FG000|First Intervention(1 Day)|Adverse Event|0|||
48671987|NCT01146288|156651776|FG001|First Intervention(1 Day)|Adverse Event|1|||
48871716|NCT01930214|157367530|FG001|Overall Study|Voluntary withdrawal of infomed consent|4|||
48671988|NCT00483041|156651780|FG000|Overall Study|ABNORMAL LAB DATA AT SCREENING|0|||
48671989|NCT00483041|156651781|FG001|Overall Study|ABNORMAL LAB DATA AT SCREENING|1|||
48671990|NCT01110382|156651783|FG000|Overall Study|Withdrawal by Subject|0|||
48671991|NCT01110382|156651784|FG001|Overall Study|Withdrawal by Subject|1|||
48671992|NCT01110382|156651783|FG000|Overall Study|Protocol Violation|0|||
48671993|NCT01110382|156651784|FG001|Overall Study|Protocol Violation|1|||
48671994|NCT03743064|156651793|FG000|Overall Study|Adverse Event|7|||
48671995|NCT03743064|156651794|FG001|Overall Study|Adverse Event|9|||
48671996|NCT03743064|156651793|FG000|Overall Study|Death|25|||
48671997|NCT03743064|156651794|FG001|Overall Study|Death|28|||
48671998|NCT03743064|156651793|FG000|Overall Study|Lost to Follow-up|3|||
48671999|NCT03743064|156651794|FG001|Overall Study|Lost to Follow-up|6|||
48672000|NCT03743064|156651793|FG000|Overall Study|Withdrawal by Subject|28|||
48672001|NCT03743064|156651794|FG001|Overall Study|Withdrawal by Subject|25|||
48672002|NCT03743064|156651793|FG000|Overall Study|Physician Decision|2|||
48672003|NCT03743064|156651794|FG001|Overall Study|Physician Decision|4|||
48672004|NCT03743064|156651793|FG000|Overall Study|"Reported as Other in Clinical Study Report"|6|||
48672005|NCT03743064|156651794|FG001|Overall Study|"Reported as Other in Clinical Study Report"|2|||
48871717|NCT01930214|157367531|FG002|Overall Study|Voluntary withdrawal of infomed consent|2|||
48871718|NCT01930214|157367529|FG000|Overall Study|Physician Decision|2|||
48871719|NCT01930214|157367530|FG001|Overall Study|Physician Decision|0|||
48871720|NCT01930214|157367531|FG002|Overall Study|Physician Decision|0|||
48871721|NCT02062645|157367532|FG000|Overall Study|Adverse Event|2|||
48871722|NCT02062645|157367532|FG000|Overall Study|Protocol Violation|8|||
48871723|NCT02062645|157367532|FG000|Overall Study|Lost to Follow-up|5|||
48871724|NCT03589300|157367533|FG000|Overall Study|Adverse Event|2|||
48871725|NCT03589300|157367533|FG000|Overall Study|Death|4|||
48871726|NCT03589300|157367533|FG000|Overall Study|Lost to Follow-up|12|||
48871727|NCT03589300|157367533|FG000|Overall Study|Withdrawal by Subject|5|||
48871728|NCT04947436|157367534|FG000|Overall Study|Lost to Follow-up|3|||
48871729|NCT04947436|157367535|FG001|Overall Study|Lost to Follow-up|7|||
48871730|NCT04947436|157367536|FG002|Overall Study|Lost to Follow-up|5|||
48871731|NCT04947436|157367534|FG000|Overall Study|Death|1|||
48871732|NCT04947436|157367535|FG001|Overall Study|Death|1|||
48871733|NCT04947436|157367536|FG002|Overall Study|Death|1|||
48871734|NCT00087555|157367540|FG000|Overall Study|Adverse Event|3|||
48871735|NCT00087555|157367541|FG001|Overall Study|Adverse Event|6|||
48871736|NCT00087555|157367542|FG002|Overall Study|Adverse Event|14|||
48871737|NCT00087555|157367540|FG000|Overall Study|Lost to Follow-up|0|||
48871738|NCT00087555|157367541|FG001|Overall Study|Lost to Follow-up|1|||
48871739|NCT00087555|157367542|FG002|Overall Study|Lost to Follow-up|1|||
48871740|NCT00087555|157367540|FG000|Overall Study|Non - Compliance|1|||
48871741|NCT00087555|157367541|FG001|Overall Study|Non - Compliance|0|||
48871742|NCT00087555|157367542|FG002|Overall Study|Non - Compliance|0|||
48871743|NCT00087555|157367540|FG000|Overall Study|Protocol Violation|0|||
48672006|NCT01423916|156651797|FG000|Overall Study|Adverse Event|5|||
48672007|NCT01423916|156651798|FG001|Overall Study|Adverse Event|9|||
48672008|NCT01423916|156651799|FG002|Overall Study|Adverse Event|2|||
48672009|NCT01423916|156651797|FG000|Overall Study|Met Withdrawal Criteria|1|||
48672010|NCT01423916|156651798|FG001|Overall Study|Met Withdrawal Criteria|1|||
48871744|NCT00087555|157367541|FG001|Overall Study|Protocol Violation|0|||
48871745|NCT00087555|157367542|FG002|Overall Study|Protocol Violation|2|||
48672011|NCT01423916|156651799|FG002|Overall Study|Met Withdrawal Criteria|1|||
48672012|NCT01423916|156651797|FG000|Overall Study|Physician Decision|1|||
48672013|NCT01423916|156651798|FG001|Overall Study|Physician Decision|0|||
48672014|NCT01423916|156651799|FG002|Overall Study|Physician Decision|1|||
48672015|NCT01423916|156651797|FG000|Overall Study|Withdrawal by Subject|3|||
48672016|NCT01423916|156651798|FG001|Overall Study|Withdrawal by Subject|10|||
48672017|NCT01423916|156651799|FG002|Overall Study|Withdrawal by Subject|3|||
48672018|NCT01423916|156651797|FG000|Overall Study|Protocol Deviation|1|||
48672019|NCT01423916|156651798|FG001|Overall Study|Protocol Deviation|0|||
48672020|NCT01423916|156651799|FG002|Overall Study|Protocol Deviation|0|||
48672021|NCT02553538|156651802|FG000|Overall Study|Could Not Reach by Telephone|133|||
48672022|NCT02553538|156651803|FG001|Overall Study|Could Not Reach by Telephone|0|||
48672023|NCT02553538|156651802|FG000|Overall Study|Died or Left Network|54|||
48672024|NCT02553538|156651803|FG001|Overall Study|Died or Left Network|56|||
48672025|NCT03316950|156651806|FG000|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|1|||
48672026|NCT03316950|156651807|FG001|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|2|||
48672027|NCT03316950|156651808|FG002|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|3|||
48672028|NCT03316950|156651809|FG003|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|0|||
48672029|NCT03316950|156651806|FG000|Initial Intervention (1 to 3 Months)|Physician Decision|2|||
48672030|NCT03316950|156651807|FG001|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
48672031|NCT03316950|156651808|FG002|Initial Intervention (1 to 3 Months)|Physician Decision|1|||
48672032|NCT03316950|156651809|FG003|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
48672033|NCT03316950|156651806|FG000|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
48672034|NCT03316950|156651807|FG001|Initial Intervention (1 to 3 Months)|Lost to Follow-up|2|||
48672035|NCT03316950|156651808|FG002|Initial Intervention (1 to 3 Months)|Lost to Follow-up|5|||
48672036|NCT03316950|156651809|FG003|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
48672037|NCT01406015|156651810|FG000|Overall Study|Withdrawal by Subject|3|||
48672038|NCT01406015|156651811|FG001|Overall Study|Withdrawal by Subject|3|||
48672039|NCT00576472|156651821|FG000|MPH In-Lab Phase|Declined participation in medication pha|0|||
48672040|NCT00576472|156651822|FG001|MPH In-Lab Phase|Declined participation in medication pha|0|||
48672041|NCT00576472|156651823|FG002|MPH In-Lab Phase|Declined participation in medication pha|0|||
48672042|NCT00576472|156651824|FG003|MPH In-Lab Phase|Declined participation in medication pha|75|||
48672043|NCT00576472|156651825|FG004|MPH In-Lab Phase|Declined participation in medication pha|0|||
48672044|NCT00576472|156651826|FG005|MPH In-Lab Phase|Declined participation in medication pha|0|||
48672045|NCT00576472|156651827|FG006|MPH In-Lab Phase|Declined participation in medication pha|0|||
48672046|NCT00576472|156651828|FG007|MPH In-Lab Phase|Declined participation in medication pha|0|||
48672047|NCT00576472|156651829|FG008|MPH In-Lab Phase|Declined participation in medication pha|0|||
48672048|NCT00576472|156651830|FG009|MPH In-Lab Phase|Declined participation in medication pha|0|||
48672049|NCT00576472|156651831|FG010|MPH In-Lab Phase|Declined participation in medication pha|0|||
48672050|NCT00576472|156651832|FG011|MPH In-Lab Phase|Declined participation in medication pha|0|||
48672051|NCT00576472|156651833|FG012|MPH In-Lab Phase|Declined participation in medication pha|0|||
48672052|NCT00576472|156651834|FG013|MPH In-Lab Phase|Declined participation in medication pha|0|||
48672053|NCT00576472|156651835|FG014|MPH In-Lab Phase|Declined participation in medication pha|0|||
48672054|NCT00576472|156651821|FG000|MPH In-Lab Phase|Lost to Follow-up|0|||
48672055|NCT00576472|156651822|FG001|MPH In-Lab Phase|Lost to Follow-up|0|||
48672056|NCT00576472|156651823|FG002|MPH In-Lab Phase|Lost to Follow-up|0|||
48871746|NCT00087555|157367540|FG000|Overall Study|Screen Failure|1|||
48871747|NCT00087555|157367541|FG001|Overall Study|Screen Failure|1|||
48871748|NCT00087555|157367542|FG002|Overall Study|Screen Failure|0|||
48871749|NCT00087555|157367540|FG000|Overall Study|Pregnancy|0|||
48871750|NCT00087555|157367541|FG001|Overall Study|Pregnancy|1|||
48871751|NCT00087555|157367542|FG002|Overall Study|Pregnancy|1|||
48871752|NCT00087555|157367540|FG000|Overall Study|Withdrawal by Subject|3|||
48871753|NCT00087555|157367541|FG001|Overall Study|Withdrawal by Subject|2|||
48871754|NCT00087555|157367542|FG002|Overall Study|Withdrawal by Subject|1|||
48871755|NCT00087555|157367540|FG000|Overall Study|Lack of Efficacy|2|||
48871756|NCT00087555|157367541|FG001|Overall Study|Lack of Efficacy|0|||
48871757|NCT00087555|157367542|FG002|Overall Study|Lack of Efficacy|1|||
48871758|NCT00087555|157367540|FG000|Overall Study|Non Compliance|0|||
48871759|NCT00087555|157367541|FG001|Overall Study|Non Compliance|0|||
48871760|NCT00087555|157367542|FG002|Overall Study|Non Compliance|1|||
48871761|NCT00087555|157367540|FG000|Overall Study|Chronic Migraine Headaches (Med History)|1|||
48871762|NCT00087555|157367541|FG001|Overall Study|Chronic Migraine Headaches (Med History)|0|||
48871763|NCT00087555|157367542|FG002|Overall Study|Chronic Migraine Headaches (Med History)|0|||
48871764|NCT00087555|157367540|FG000|Overall Study|Patient wanted to go back on Med|1|||
48871765|NCT00087555|157367541|FG001|Overall Study|Patient wanted to go back on Med|0|||
48871766|NCT00087555|157367542|FG002|Overall Study|Patient wanted to go back on Med|0|||
48871767|NCT02024750|157367543|FG000|Overall Study|Withdrawal by Subject|2|||
48871768|NCT02024750|157367544|FG001|Overall Study|Withdrawal by Subject|1|||
48871769|NCT03772613|157367545|FG000|Overall Study|Lost to Follow-up|0|||
48871770|NCT03772613|157367546|FG001|Overall Study|Lost to Follow-up|1|||
48871771|NCT03772613|157367547|FG002|Overall Study|Lost to Follow-up|1|||
48672057|NCT00576472|156651824|FG003|MPH In-Lab Phase|Lost to Follow-up|1|||
48672058|NCT00576472|156651825|FG004|MPH In-Lab Phase|Lost to Follow-up|0|||
48672059|NCT00576472|156651826|FG005|MPH In-Lab Phase|Lost to Follow-up|0|||
48672060|NCT00576472|156651827|FG006|MPH In-Lab Phase|Lost to Follow-up|0|||
48672061|NCT00576472|156651828|FG007|MPH In-Lab Phase|Lost to Follow-up|0|||
48672062|NCT00576472|156651829|FG008|MPH In-Lab Phase|Lost to Follow-up|0|||
48672063|NCT00576472|156651830|FG009|MPH In-Lab Phase|Lost to Follow-up|0|||
48672064|NCT00576472|156651831|FG010|MPH In-Lab Phase|Lost to Follow-up|0|||
48672065|NCT00576472|156651832|FG011|MPH In-Lab Phase|Lost to Follow-up|0|||
48672066|NCT00576472|156651833|FG012|MPH In-Lab Phase|Lost to Follow-up|0|||
48672067|NCT00576472|156651834|FG013|MPH In-Lab Phase|Lost to Follow-up|0|||
48672068|NCT00576472|156651835|FG014|MPH In-Lab Phase|Lost to Follow-up|0|||
48672069|NCT00576472|156651821|FG000|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
48672070|NCT00576472|156651822|FG001|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
48672071|NCT00576472|156651823|FG002|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
48672072|NCT00576472|156651824|FG003|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4|||
48672073|NCT00576472|156651825|FG004|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
48672074|NCT00576472|156651826|FG005|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
48672075|NCT00576472|156651827|FG006|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
48672076|NCT00576472|156651828|FG007|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
48672077|NCT00576472|156651829|FG008|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
48672078|NCT00576472|156651830|FG009|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
48672079|NCT00576472|156651831|FG010|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
48672080|NCT00576472|156651832|FG011|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
48672081|NCT00576472|156651833|FG012|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
48672082|NCT00576472|156651834|FG013|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
48672083|NCT00576472|156651835|FG014|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
48672084|NCT00576472|156651821|FG000|MPH In-Lab Phase|No attention/academic problems|0|||
48672085|NCT00576472|156651822|FG001|MPH In-Lab Phase|No attention/academic problems|0|||
48672086|NCT00576472|156651823|FG002|MPH In-Lab Phase|No attention/academic problems|0|||
48672087|NCT00576472|156651824|FG003|MPH In-Lab Phase|No attention/academic problems|245|||
48672088|NCT00576472|156651825|FG004|MPH In-Lab Phase|No attention/academic problems|0|||
48760759|NCT03045887|156972305|FG005|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
48871772|NCT01349036|157367549|FG000|Overall Study|Disease progression|13|||
48871773|NCT01349036|157367550|FG001|Overall Study|Disease progression|22|||
48871774|NCT01349036|157367549|FG000|Overall Study|Other|1|||
48760760|NCT03045887|156972306|FG006|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
48760761|NCT03045887|156972307|FG007|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
48760762|NCT03045887|156972308|FG008|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
48871775|NCT01349036|157367550|FG001|Overall Study|Other|0|||
48871776|NCT01349036|157367549|FG000|Overall Study|Withdrawal by Subject|0|||
48871777|NCT01349036|157367550|FG001|Overall Study|Withdrawal by Subject|2|||
48871778|NCT01182207|157367551|FG000|First Intervention|Positive Hepatitis Results|0|||
48871779|NCT01182207|157367552|FG001|First Intervention|Positive Hepatitis Results|1|||
48871780|NCT01182207|157367551|FG000|Second Intervention|Emeses within 1 hour of dosing|1|||
48871781|NCT01182207|157367552|FG001|Second Intervention|Emeses within 1 hour of dosing|0|||
48871782|NCT03796208|157367553|FG000|Overall Study|Withdrawal by Subject|3|||
48871783|NCT03796208|157367554|FG001|Overall Study|Withdrawal by Subject|0|||
48871784|NCT03796208|157367553|FG000|Overall Study|Loss of pregnancy|1|||
48871785|NCT03796208|157367554|FG001|Overall Study|Loss of pregnancy|1|||
48969744|NCT04126031|157717289|FG002|Part B|Pre-existing hypertransaminasemia|0|||
48969745|NCT04126031|157717290|FG003|Part B|Pre-existing hypertransaminasemia|0|||
48969746|NCT04126031|157717291|FG004|Part B|Pre-existing hypertransaminasemia|1|||
48760763|NCT03045887|156972309|FG009|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
48760764|NCT01290666|156972310|FG000|Overall Study|Lost to Follow-up|11|||
48760765|NCT01290666|156972310|FG000|Overall Study|Withdrawal by Subject|23|||
48760766|NCT01290666|156972310|FG000|Overall Study|Early Termination of Study|4|||
48760767|NCT00464568|156972311|FG000|Overall Study|Adverse Event|2|||
48760768|NCT03318315|156972317|FG000|Overall Study|Lost to Follow-up|3|||
48760769|NCT03318315|156972318|FG001|Overall Study|Lost to Follow-up|2|||
48969747|NCT04126031|157717292|FG005|Part B|Pre-existing hypertransaminasemia|0|||
48672089|NCT00576472|156651826|FG005|MPH In-Lab Phase|No attention/academic problems|0|||
48672090|NCT00576472|156651827|FG006|MPH In-Lab Phase|No attention/academic problems|0|||
48672091|NCT00576472|156651828|FG007|MPH In-Lab Phase|No attention/academic problems|0|||
48672092|NCT00576472|156651829|FG008|MPH In-Lab Phase|No attention/academic problems|0|||
48672093|NCT00576472|156651830|FG009|MPH In-Lab Phase|No attention/academic problems|0|||
48760770|NCT03318315|156972319|FG002|Overall Study|Lost to Follow-up|1|||
48760771|NCT03318315|156972317|FG000|Overall Study|Protocol Violation|1|||
48871786|NCT03796208|157367553|FG000|Overall Study|Changed prenatal clinics|0|||
48871787|NCT03796208|157367554|FG001|Overall Study|Changed prenatal clinics|5|||
48871788|NCT03796208|157367553|FG000|Overall Study|Lost to Follow-up|20|||
48871789|NCT03796208|157367554|FG001|Overall Study|Lost to Follow-up|16|||
48969748|NCT02713789|157717294|FG000|Overall Study|Lost to Follow-up|0|||
48969749|NCT02713789|157717295|FG001|Overall Study|Lost to Follow-up|1|||
48969750|NCT02713789|157717296|FG002|Overall Study|Lost to Follow-up|1|||
48871790|NCT01087814|157367555|FG000|First Intervention (5 Days)|Withdrawal by Subject|3|||
48871791|NCT01087814|157367556|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
48871792|NCT01087814|157367555|FG000|Second Intervention (5 Days)|Physician Decision|1|||
48871793|NCT01087814|157367556|FG001|Second Intervention (5 Days)|Physician Decision|0|||
48871794|NCT01891890|157367557|FG000|Overall Study|Lost to Follow-up|0|||
48871795|NCT01891890|157367558|FG001|Overall Study|Lost to Follow-up|0|||
48871796|NCT01891890|157367559|FG002|Overall Study|Lost to Follow-up|1|||
48871797|NCT01891890|157367557|FG000|Overall Study|Study ended before endpoint reached|7|||
48871798|NCT01891890|157367558|FG001|Overall Study|Study ended before endpoint reached|3|||
48871799|NCT01891890|157367559|FG002|Overall Study|Study ended before endpoint reached|6|||
48871800|NCT00661713|157367560|FG000|Overall Study|Death|1|||
48871801|NCT00661713|157367561|FG001|Overall Study|Death|0|||
48871802|NCT00661713|157367562|FG002|Overall Study|Death|0|||
48871803|NCT00661713|157367563|FG003|Overall Study|Death|0|||
48871804|NCT00661713|157367564|FG004|Overall Study|Death|1|||
48871805|NCT00661713|157367565|FG005|Overall Study|Death|0|||
48871806|NCT00661713|157367566|FG006|Overall Study|Death|0|||
48871807|NCT00661713|157367567|FG007|Overall Study|Death|0|||
48871808|NCT00661713|157367560|FG000|Overall Study|Unable to Classify|1|||
48871809|NCT00661713|157367561|FG001|Overall Study|Unable to Classify|0|||
48871810|NCT00661713|157367562|FG002|Overall Study|Unable to Classify|0|||
48871811|NCT00661713|157367563|FG003|Overall Study|Unable to Classify|0|||
48871812|NCT00661713|157367564|FG004|Overall Study|Unable to Classify|0|||
48871813|NCT00661713|157367565|FG005|Overall Study|Unable to Classify|0|||
48871814|NCT00661713|157367566|FG006|Overall Study|Unable to Classify|0|||
48871815|NCT00661713|157367567|FG007|Overall Study|Unable to Classify|0|||
48871816|NCT00661713|157367560|FG000|Overall Study|Protocol Violation|1|||
48871817|NCT00661713|157367561|FG001|Overall Study|Protocol Violation|6|||
48871818|NCT00661713|157367562|FG002|Overall Study|Protocol Violation|3|||
48871819|NCT00661713|157367563|FG003|Overall Study|Protocol Violation|3|||
48871820|NCT00661713|157367564|FG004|Overall Study|Protocol Violation|0|||
48871821|NCT00661713|157367565|FG005|Overall Study|Protocol Violation|2|||
48871822|NCT00661713|157367566|FG006|Overall Study|Protocol Violation|2|||
48871823|NCT00661713|157367567|FG007|Overall Study|Protocol Violation|1|||
48871824|NCT00661713|157367560|FG000|Overall Study|Withdrawal by Subject|11|||
48871825|NCT00661713|157367561|FG001|Overall Study|Withdrawal by Subject|25|||
48871826|NCT00661713|157367562|FG002|Overall Study|Withdrawal by Subject|12|||
48871827|NCT00661713|157367563|FG003|Overall Study|Withdrawal by Subject|21|||
48871828|NCT00661713|157367564|FG004|Overall Study|Withdrawal by Subject|12|||
48871829|NCT00661713|157367565|FG005|Overall Study|Withdrawal by Subject|26|||
48871830|NCT00661713|157367566|FG006|Overall Study|Withdrawal by Subject|45|||
48871831|NCT00661713|157367567|FG007|Overall Study|Withdrawal by Subject|9|||
48871832|NCT00661713|157367560|FG000|Overall Study|Lost to Follow-up|2|||
48871833|NCT00661713|157367561|FG001|Overall Study|Lost to Follow-up|7|||
48871834|NCT00661713|157367562|FG002|Overall Study|Lost to Follow-up|2|||
48871835|NCT00661713|157367563|FG003|Overall Study|Lost to Follow-up|2|||
48871836|NCT00661713|157367564|FG004|Overall Study|Lost to Follow-up|5|||
48871837|NCT00661713|157367565|FG005|Overall Study|Lost to Follow-up|7|||
48871838|NCT00661713|157367566|FG006|Overall Study|Lost to Follow-up|14|||
48871839|NCT00661713|157367567|FG007|Overall Study|Lost to Follow-up|1|||
48871840|NCT00661713|157367560|FG000|Overall Study|Administrative Reason|0|||
48871841|NCT00661713|157367561|FG001|Overall Study|Administrative Reason|1|||
48871842|NCT00661713|157367562|FG002|Overall Study|Administrative Reason|0|||
48871843|NCT00661713|157367563|FG003|Overall Study|Administrative Reason|2|||
48871844|NCT00661713|157367564|FG004|Overall Study|Administrative Reason|2|||
48871845|NCT00661713|157367565|FG005|Overall Study|Administrative Reason|2|||
48871846|NCT00661713|157367566|FG006|Overall Study|Administrative Reason|1|||
48871847|NCT00661713|157367567|FG007|Overall Study|Administrative Reason|0|||
48871848|NCT00661713|157367560|FG000|Overall Study|Adverse Event|0|||
48871849|NCT00661713|157367561|FG001|Overall Study|Adverse Event|0|||
48871850|NCT00661713|157367562|FG002|Overall Study|Adverse Event|0|||
48871851|NCT00661713|157367563|FG003|Overall Study|Adverse Event|0|||
48969751|NCT01410799|157717297|FG000|Overall Study|PI decision|13|||
48969752|NCT02999100|157717299|FG000|Part 1 (up to 15 Days)|Adverse Event|0|||
48871852|NCT00661713|157367564|FG004|Overall Study|Adverse Event|0|||
48871853|NCT00661713|157367565|FG005|Overall Study|Adverse Event|0|||
48871854|NCT00661713|157367566|FG006|Overall Study|Adverse Event|1|||
48871855|NCT00661713|157367567|FG007|Overall Study|Adverse Event|0|||
48871856|NCT00661713|157367560|FG000|Overall Study|Inappropriate Enrollment|0|||
48871857|NCT00661713|157367561|FG001|Overall Study|Inappropriate Enrollment|0|||
48871858|NCT00661713|157367562|FG002|Overall Study|Inappropriate Enrollment|0|||
48871859|NCT00661713|157367563|FG003|Overall Study|Inappropriate Enrollment|0|||
48871860|NCT00661713|157367564|FG004|Overall Study|Inappropriate Enrollment|0|||
48871861|NCT00661713|157367565|FG005|Overall Study|Inappropriate Enrollment|0|||
48871862|NCT00661713|157367566|FG006|Overall Study|Inappropriate Enrollment|1|||
48969753|NCT02999100|157717300|FG001|Part 1 (up to 15 Days)|Adverse Event|1|||
48969754|NCT02999100|157717301|FG002|Part 1 (up to 15 Days)|Adverse Event|0|||
48969755|NCT02999100|157717302|FG003|Part 1 (up to 15 Days)|Adverse Event|0|||
48969756|NCT02999100|157717303|FG004|Part 1 (up to 15 Days)|Adverse Event|0|||
48969757|NCT02999100|157717304|FG005|Part 1 (up to 15 Days)|Adverse Event|0|||
48969758|NCT02999100|157717299|FG000|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
48969759|NCT02999100|157717300|FG001|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
48969760|NCT02999100|157717301|FG002|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
48969761|NCT02999100|157717302|FG003|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
48969762|NCT02999100|157717303|FG004|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
48969763|NCT02999100|157717304|FG005|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1|||
48969764|NCT02999100|157717299|FG000|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
48969765|NCT02999100|157717300|FG001|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
48969766|NCT02999100|157717301|FG002|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1|||
48969767|NCT02999100|157717302|FG003|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
48969768|NCT02999100|157717303|FG004|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
48969769|NCT02999100|157717304|FG005|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
48969770|NCT00367432|157717305|FG000|First Period (16 Weeks)|Adverse Event|6|||
48969771|NCT00367432|157717306|FG001|First Period (16 Weeks)|Adverse Event|0|||
48969772|NCT00367432|157717305|FG000|First Period (16 Weeks)|Lack of Efficacy|24|||
48969773|NCT00367432|157717306|FG001|First Period (16 Weeks)|Lack of Efficacy|0|||
48969774|NCT00367432|157717305|FG000|First Period (16 Weeks)|Withdrawal by Subject|6|||
48969775|NCT00367432|157717306|FG001|First Period (16 Weeks)|Withdrawal by Subject|0|||
48969776|NCT00367432|157717305|FG000|First Period (16 Weeks)|Other Reason|2|||
48969777|NCT00367432|157717306|FG001|First Period (16 Weeks)|Other Reason|0|||
48969778|NCT00367432|157717305|FG000|Second Period (up to 54 Months)|Adverse Event|14|||
48969779|NCT00367432|157717306|FG001|Second Period (up to 54 Months)|Adverse Event|3|||
48969780|NCT00367432|157717305|FG000|Second Period (up to 54 Months)|Lack of Efficacy|59|||
48969781|NCT00367432|157717306|FG001|Second Period (up to 54 Months)|Lack of Efficacy|5|||
48969782|NCT00367432|157717305|FG000|Second Period (up to 54 Months)|Lost to Follow-up|0|||
48969783|NCT00367432|157717306|FG001|Second Period (up to 54 Months)|Lost to Follow-up|1|||
48969784|NCT00367432|157717305|FG000|Second Period (up to 54 Months)|Withdrawal by Subject|8|||
48969785|NCT00367432|157717306|FG001|Second Period (up to 54 Months)|Withdrawal by Subject|5|||
48969786|NCT00367432|157717305|FG000|Second Period (up to 54 Months)|Other Reason|6|||
48969787|NCT00367432|157717306|FG001|Second Period (up to 54 Months)|Other Reason|2|||
48969788|NCT00676208|157717308|FG000|Overall Study|Lost to Follow-up|0|||
48969789|NCT00676208|157717309|FG001|Overall Study|Lost to Follow-up|2|||
48969790|NCT00676208|157717308|FG000|Overall Study|Incomplete data|2|||
48969791|NCT00676208|157717309|FG001|Overall Study|Incomplete data|4|||
48969792|NCT00719862|157717310|FG000|Overall Study|Adverse Event|1|||
48969793|NCT00719862|157717311|FG001|Overall Study|Adverse Event|2|||
48969794|NCT00719862|157717310|FG000|Overall Study|Lack of Efficacy|3|||
48969795|NCT00719862|157717311|FG001|Overall Study|Lack of Efficacy|0|||
48969796|NCT00719862|157717310|FG000|Overall Study|Non-Compliance|1|||
48969797|NCT00719862|157717311|FG001|Overall Study|Non-Compliance|0|||
48969798|NCT00719862|157717310|FG000|Overall Study|Withdrawal by Subject|1|||
48969799|NCT00719862|157717311|FG001|Overall Study|Withdrawal by Subject|0|||
48969800|NCT00719862|157717310|FG000|Overall Study|Lost to Follow-up|0|||
48969801|NCT00719862|157717311|FG001|Overall Study|Lost to Follow-up|1|||
48969802|NCT00719862|157717310|FG000|Overall Study|Other|2|||
48969803|NCT00719862|157717311|FG001|Overall Study|Other|3|||
48969804|NCT02091921|157717313|FG000|Overall Study|Adverse Event|3|||
48969805|NCT01296698|157717314|FG000|Overall Study|Adverse Event|1|||
48969806|NCT01296698|157717315|FG001|Overall Study|Adverse Event|0|||
48969807|NCT01296698|157717314|FG000|Overall Study|Death|1|||
48969808|NCT01296698|157717315|FG001|Overall Study|Death|0|||
48969809|NCT01296698|157717314|FG000|Overall Study|Lost to Follow-up|19|||
48969810|NCT01296698|157717315|FG001|Overall Study|Lost to Follow-up|1|||
48672094|NCT00576472|156651831|FG010|MPH In-Lab Phase|No attention/academic problems|0|||
48672095|NCT00576472|156651832|FG011|MPH In-Lab Phase|No attention/academic problems|0|||
48672096|NCT00576472|156651833|FG012|MPH In-Lab Phase|No attention/academic problems|0|||
48672097|NCT00576472|156651834|FG013|MPH In-Lab Phase|No attention/academic problems|0|||
48672098|NCT00576472|156651835|FG014|MPH In-Lab Phase|No attention/academic problems|0|||
48672099|NCT00576472|156651821|FG000|MPH In-Lab Phase|Psychiatric exclusion|0|||
48672100|NCT00576472|156651822|FG001|MPH In-Lab Phase|Psychiatric exclusion|0|||
48672101|NCT00576472|156651823|FG002|MPH In-Lab Phase|Psychiatric exclusion|0|||
48672102|NCT00576472|156651824|FG003|MPH In-Lab Phase|Psychiatric exclusion|10|||
48672103|NCT00576472|156651825|FG004|MPH In-Lab Phase|Psychiatric exclusion|0|||
48969811|NCT01296698|157717314|FG000|Overall Study|Withdrawal by Subject|12|||
48969812|NCT01296698|157717315|FG001|Overall Study|Withdrawal by Subject|0|||
48969813|NCT01296698|157717314|FG000|Overall Study|Difficulty Contacting Subject|2|||
48672104|NCT00576472|156651826|FG005|MPH In-Lab Phase|Psychiatric exclusion|0|||
48672105|NCT00576472|156651827|FG006|MPH In-Lab Phase|Psychiatric exclusion|0|||
48672106|NCT00576472|156651828|FG007|MPH In-Lab Phase|Psychiatric exclusion|0|||
48672107|NCT00576472|156651829|FG008|MPH In-Lab Phase|Psychiatric exclusion|0|||
48969814|NCT01296698|157717315|FG001|Overall Study|Difficulty Contacting Subject|0|||
48969815|NCT01296698|157717314|FG000|Overall Study|Study Terminated by Sponsor|209|||
48871863|NCT00661713|157367567|FG007|Overall Study|Inappropriate Enrollment|0|||
48871864|NCT01215032|157367572|FG000|Overall Study|Adverse Event|3|||
48871865|NCT01215032|157367572|FG000|Overall Study|Lack of Efficacy|17|||
48871866|NCT01125566|157367573|FG000|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182|||
48871867|NCT01125566|157367574|FG001|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119|||
48871868|NCT01125566|157367575|FG002|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0|||
48871869|NCT01125566|157367573|FG000|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
48871870|NCT01125566|157367574|FG001|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
48871871|NCT01125566|157367575|FG002|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0|||
48871872|NCT01125566|157367573|FG000|Patients Before the Switch (26Apr2013)|Adverse Event|25|||
48871873|NCT01125566|157367574|FG001|Patients Before the Switch (26Apr2013)|Adverse Event|5|||
48871874|NCT01125566|157367575|FG002|Patients Before the Switch (26Apr2013)|Adverse Event|0|||
48871875|NCT01125566|157367573|FG000|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
48871876|NCT01125566|157367574|FG001|Patients Before the Switch (26Apr2013)|Protocol Violation|2|||
48871877|NCT01125566|157367575|FG002|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
48871878|NCT01125566|157367573|FG000|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24|||
48871879|NCT01125566|157367574|FG001|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23|||
48871880|NCT01125566|157367575|FG002|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0|||
48871881|NCT01125566|157367573|FG000|Patients Before the Switch (26Apr2013)|Not treated|2|||
48871882|NCT01125566|157367574|FG001|Patients Before the Switch (26Apr2013)|Not treated|0|||
48871883|NCT01125566|157367575|FG002|Patients Before the Switch (26Apr2013)|Not treated|0|||
48871884|NCT01125566|157367573|FG000|Patients Before the Switch (26Apr2013)|Other than listed above|25|||
48871885|NCT01125566|157367574|FG001|Patients Before the Switch (26Apr2013)|Other than listed above|13|||
48871886|NCT01125566|157367575|FG002|Patients Before the Switch (26Apr2013)|Other than listed above|0|||
48871887|NCT01125566|157367573|FG000|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
48871888|NCT01125566|157367574|FG001|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
48871889|NCT01125566|157367575|FG002|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0|||
48871890|NCT01125566|157367573|FG000|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
48871891|NCT01125566|157367574|FG001|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
48871892|NCT01125566|157367575|FG002|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59|||
48871893|NCT01125566|157367573|FG000|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
48871894|NCT01125566|157367574|FG001|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
48871895|NCT01125566|157367575|FG002|Patients Who Switched From AV to TV|Refused to continue taking medication|7|||
48871896|NCT01125566|157367573|FG000|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
48871897|NCT01125566|157367574|FG001|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
48969816|NCT01296698|157717315|FG001|Overall Study|Study Terminated by Sponsor|12|||
48969817|NCT02198651|157719093|FG000|Lead-in Period|Withdrew consent|13|||
48969818|NCT02198651|157719094|FG001|Lead-in Period|Withdrew consent|0|||
48871898|NCT01125566|157367575|FG002|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3|||
48871899|NCT01125566|157367573|FG000|Patients Who Switched From AV to TV|Other than listed above|0|||
48871900|NCT01125566|157367574|FG001|Patients Who Switched From AV to TV|Other than listed above|0|||
48871901|NCT01125566|157367575|FG002|Patients Who Switched From AV to TV|Other than listed above|4|||
48871902|NCT02725008|157367576|FG000|Overall Study|Lost to Follow-up|7|||
48871903|NCT02725008|157367577|FG001|Overall Study|Lost to Follow-up|9|||
48871904|NCT02725008|157367576|FG000|Overall Study|Withdrawal by Subject|2|||
48871905|NCT02725008|157367577|FG001|Overall Study|Withdrawal by Subject|2|||
48871906|NCT02725008|157367576|FG000|Overall Study|Admitted to hospital|0|||
48871907|NCT02725008|157367577|FG001|Overall Study|Admitted to hospital|1|||
48871908|NCT02970305|157367582|FG000|Overall Study|Adverse Event|10|||
48871909|NCT02970305|157367583|FG001|Overall Study|Adverse Event|6|||
48871910|NCT02970305|157367582|FG000|Overall Study|Lack of Efficacy|1|||
48871911|NCT02970305|157367583|FG001|Overall Study|Lack of Efficacy|1|||
48871912|NCT02970305|157367582|FG000|Overall Study|Noncompliance with study drug|2|||
48871913|NCT02970305|157367583|FG001|Overall Study|Noncompliance with study drug|4|||
48871914|NCT02970305|157367582|FG000|Overall Study|Protocol Violation|2|||
48871915|NCT02970305|157367583|FG001|Overall Study|Protocol Violation|2|||
48871916|NCT02970305|157367582|FG000|Overall Study|Withdrawal by Subject|12|||
48871917|NCT02970305|157367583|FG001|Overall Study|Withdrawal by Subject|11|||
48871918|NCT02970305|157367582|FG000|Overall Study|Not further specified|1|||
48871919|NCT02970305|157367583|FG001|Overall Study|Not further specified|2|||
48871920|NCT02970305|157367582|FG000|Overall Study|Lost to Follow-up|1|||
48871921|NCT02970305|157367583|FG001|Overall Study|Lost to Follow-up|2|||
48871922|NCT00983892|157367584|FG000|Overall Study|Withdrawal by Subject|10|||
48969819|NCT02198651|157719095|FG002|Lead-in Period|Withdrew consent|0|||
48969820|NCT02198651|157719096|FG003|Lead-in Period|Withdrew consent|0|||
48969821|NCT02198651|157719097|FG004|Lead-in Period|Withdrew consent|0|||
48969822|NCT02198651|157719093|FG000|Lead-in Period|Adverse Event|2|||
48969823|NCT02198651|157719094|FG001|Lead-in Period|Adverse Event|0|||
48969824|NCT02198651|157719095|FG002|Lead-in Period|Adverse Event|0|||
48969825|NCT02198651|157719096|FG003|Lead-in Period|Adverse Event|0|||
48969826|NCT02198651|157719097|FG004|Lead-in Period|Adverse Event|0|||
48969827|NCT02198651|157719093|FG000|Lead-in Period|Other, not specified|22|||
48969828|NCT02198651|157719094|FG001|Lead-in Period|Other, not specified|0|||
48969829|NCT02198651|157719095|FG002|Lead-in Period|Other, not specified|0|||
48969830|NCT02198651|157719096|FG003|Lead-in Period|Other, not specified|0|||
48969831|NCT02198651|157719097|FG004|Lead-in Period|Other, not specified|0|||
48969832|NCT02198651|157719093|FG000|Double-blind Period|Withdrew consent|0|||
48969833|NCT02198651|157719094|FG001|Double-blind Period|Withdrew consent|4|||
48969834|NCT02198651|157719095|FG002|Double-blind Period|Withdrew consent|0|||
48969835|NCT02198651|157719096|FG003|Double-blind Period|Withdrew consent|0|||
48969836|NCT02198651|157719097|FG004|Double-blind Period|Withdrew consent|0|||
48969837|NCT02198651|157719093|FG000|Double-blind Period|Adverse Event|0|||
48969838|NCT02198651|157719094|FG001|Double-blind Period|Adverse Event|1|||
48969839|NCT02198651|157719095|FG002|Double-blind Period|Adverse Event|0|||
48969840|NCT02198651|157719096|FG003|Double-blind Period|Adverse Event|0|||
48969841|NCT02198651|157719097|FG004|Double-blind Period|Adverse Event|0|||
48969842|NCT02198651|157719093|FG000|Double-blind Period|Other, not specified|0|||
48969843|NCT02198651|157719094|FG001|Double-blind Period|Other, not specified|4|||
48969844|NCT02198651|157719095|FG002|Double-blind Period|Other, not specified|1|||
48969845|NCT02198651|157719096|FG003|Double-blind Period|Other, not specified|0|||
48969846|NCT02198651|157719097|FG004|Double-blind Period|Other, not specified|0|||
48969847|NCT02198651|157719093|FG000|Open-label Rescue Period|Withdrew consent|0|||
48969848|NCT02198651|157719094|FG001|Open-label Rescue Period|Withdrew consent|0|||
48969849|NCT02198651|157719095|FG002|Open-label Rescue Period|Withdrew consent|0|||
48969850|NCT02198651|157719096|FG003|Open-label Rescue Period|Withdrew consent|2|||
48969851|NCT02198651|157719097|FG004|Open-label Rescue Period|Withdrew consent|0|||
48969852|NCT02198651|157719093|FG000|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
48969853|NCT02198651|157719094|FG001|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
48969854|NCT02198651|157719095|FG002|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
48969855|NCT02198651|157719096|FG003|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1|||
48969856|NCT02198651|157719097|FG004|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
48969857|NCT01146951|157719098|FG000|Overall Study|Adverse Event|4|||
48969858|NCT01146951|157719099|FG001|Overall Study|Adverse Event|1|||
48969859|NCT02126670|157719107|FG000|Overall Study|Withdrawal by Subject|1|||
48969860|NCT02126670|157719108|FG001|Overall Study|Withdrawal by Subject|0|||
48969861|NCT02126670|157719109|FG002|Overall Study|Withdrawal by Subject|0|||
48969862|NCT02126670|157719110|FG003|Overall Study|Withdrawal by Subject|1|||
48969863|NCT02700919|157719111|FG000|Overall Study|Physician Decision|1|||
48969864|NCT02700919|157719112|FG001|Overall Study|Physician Decision|0|||
48969865|NCT02700919|157719113|FG002|Overall Study|Physician Decision|0|||
48969866|NCT02700919|157719111|FG000|Overall Study|Protocol Violation|1|||
48969867|NCT02700919|157719112|FG001|Overall Study|Protocol Violation|0|||
48969868|NCT02700919|157719113|FG002|Overall Study|Protocol Violation|0|||
48969869|NCT02700919|157719111|FG000|Overall Study|Adverse Event|1|||
48672108|NCT00576472|156651830|FG009|MPH In-Lab Phase|Psychiatric exclusion|0|||
48672109|NCT00576472|156651831|FG010|MPH In-Lab Phase|Psychiatric exclusion|0|||
48672110|NCT00576472|156651832|FG011|MPH In-Lab Phase|Psychiatric exclusion|0|||
48672111|NCT00576472|156651833|FG012|MPH In-Lab Phase|Psychiatric exclusion|0|||
48969870|NCT02700919|157719112|FG001|Overall Study|Adverse Event|3|||
48969871|NCT02700919|157719113|FG002|Overall Study|Adverse Event|1|||
48969872|NCT02700919|157719111|FG000|Overall Study|Withdrawal by Subject|5|||
48969873|NCT02700919|157719112|FG001|Overall Study|Withdrawal by Subject|8|||
48969874|NCT02700919|157719113|FG002|Overall Study|Withdrawal by Subject|2|||
48969875|NCT02700919|157719111|FG000|Overall Study|Lost to Follow-up|2|||
48672112|NCT00576472|156651834|FG013|MPH In-Lab Phase|Psychiatric exclusion|0|||
48672113|NCT00576472|156651835|FG014|MPH In-Lab Phase|Psychiatric exclusion|0|||
48672114|NCT00576472|156651821|FG000|MPH Cross Over Phase|Withdrawal by Subject|0|||
48672115|NCT00576472|156651822|FG001|MPH Cross Over Phase|Withdrawal by Subject|0|||
48969876|NCT02700919|157719112|FG001|Overall Study|Lost to Follow-up|0|||
48969877|NCT02700919|157719113|FG002|Overall Study|Lost to Follow-up|0|||
48969878|NCT02700919|157719111|FG000|Overall Study|Other|2|||
48969879|NCT02700919|157719112|FG001|Overall Study|Other|1|||
48969880|NCT02700919|157719113|FG002|Overall Study|Other|1|||
48969881|NCT04507776|157719118|FG000|Overall Study|Participants did not meet the entrance criteria|201|||
48969882|NCT00830115|157719122|FG000|Overall Study|Adverse Event|2|||
48969883|NCT00830115|157719122|FG000|Overall Study|Improvement/recovery|1|||
48969884|NCT02501902|157719123|FG000|Overall Study|Subject Refused Further Follow-up|0|||
48969885|NCT02501902|157719124|FG001|Overall Study|Subject Refused Further Follow-up|0|||
48672116|NCT00576472|156651823|FG002|MPH Cross Over Phase|Withdrawal by Subject|0|||
48672117|NCT00576472|156651824|FG003|MPH Cross Over Phase|Withdrawal by Subject|0|||
48969886|NCT02501902|157719125|FG002|Overall Study|Subject Refused Further Follow-up|0|||
48969887|NCT02501902|157719126|FG003|Overall Study|Subject Refused Further Follow-up|0|||
48672118|NCT00576472|156651825|FG004|MPH Cross Over Phase|Withdrawal by Subject|0|||
48672119|NCT00576472|156651826|FG005|MPH Cross Over Phase|Withdrawal by Subject|0|||
48672120|NCT00576472|156651827|FG006|MPH Cross Over Phase|Withdrawal by Subject|6|||
48672121|NCT00576472|156651828|FG007|MPH Cross Over Phase|Withdrawal by Subject|0|||
48672122|NCT00576472|156651829|FG008|MPH Cross Over Phase|Withdrawal by Subject|0|||
48672123|NCT00576472|156651830|FG009|MPH Cross Over Phase|Withdrawal by Subject|0|||
48672124|NCT00576472|156651831|FG010|MPH Cross Over Phase|Withdrawal by Subject|0|||
48672125|NCT00576472|156651832|FG011|MPH Cross Over Phase|Withdrawal by Subject|0|||
48672126|NCT00576472|156651833|FG012|MPH Cross Over Phase|Withdrawal by Subject|0|||
48672127|NCT00576472|156651834|FG013|MPH Cross Over Phase|Withdrawal by Subject|0|||
48672128|NCT00576472|156651835|FG014|MPH Cross Over Phase|Withdrawal by Subject|0|||
48672129|NCT00576472|156651821|FG000|MPH Cross Over Phase|Ineligible due to disease|0|||
48672130|NCT00576472|156651822|FG001|MPH Cross Over Phase|Ineligible due to disease|0|||
48672131|NCT00576472|156651823|FG002|MPH Cross Over Phase|Ineligible due to disease|0|||
48672132|NCT00576472|156651824|FG003|MPH Cross Over Phase|Ineligible due to disease|0|||
48672133|NCT00576472|156651825|FG004|MPH Cross Over Phase|Ineligible due to disease|0|||
48672134|NCT00576472|156651826|FG005|MPH Cross Over Phase|Ineligible due to disease|0|||
48672135|NCT00576472|156651827|FG006|MPH Cross Over Phase|Ineligible due to disease|2|||
48672136|NCT00576472|156651828|FG007|MPH Cross Over Phase|Ineligible due to disease|0|||
48871923|NCT00983892|157367585|FG001|Overall Study|Withdrawal by Subject|12|||
48871924|NCT02175745|157367586|FG000|Overall Study|Not Eligible|1|||
48871925|NCT01665599|157367592|FG000|Overall Study|Adverse Event|1|||
48871926|NCT01665599|157367592|FG000|Overall Study|Consent Withdrawn|1|||
48871927|NCT01665599|157367592|FG000|Overall Study|Investigator/Sponsor decision|1|||
48871928|NCT01665599|157367592|FG000|Overall Study|Death|1|||
48871929|NCT01665599|157367592|FG000|Overall Study|Lost to Follow-up|2|||
48871930|NCT01665599|157367592|FG000|Overall Study|Participant Left for More Than 3 Months|1|||
48871931|NCT01665599|157367592|FG000|Overall Study|Could Not Continue Due to Time Constrain|1|||
48871932|NCT01837797|157367593|FG000|Period 1|Adverse Event|9|||
48871933|NCT01837797|157367594|FG001|Period 1|Adverse Event|0|||
48871934|NCT01837797|157367595|FG002|Period 1|Adverse Event|0|||
48871935|NCT01837797|157367596|FG003|Period 1|Adverse Event|0|||
48871936|NCT01837797|157367597|FG004|Period 1|Adverse Event|0|||
48871937|NCT01837797|157367593|FG000|Period 1|Withdrawal by Subject|6|||
48871938|NCT01837797|157367594|FG001|Period 1|Withdrawal by Subject|0|||
48871939|NCT01837797|157367595|FG002|Period 1|Withdrawal by Subject|0|||
48871940|NCT01837797|157367596|FG003|Period 1|Withdrawal by Subject|0|||
48871941|NCT01837797|157367597|FG004|Period 1|Withdrawal by Subject|0|||
48871942|NCT01837797|157367593|FG000|Period 1|Administrative reasons|76|||
48871943|NCT01837797|157367594|FG001|Period 1|Administrative reasons|0|||
48871944|NCT01837797|157367595|FG002|Period 1|Administrative reasons|0|||
48871945|NCT01837797|157367596|FG003|Period 1|Administrative reasons|0|||
48871946|NCT01837797|157367597|FG004|Period 1|Administrative reasons|0|||
48871947|NCT01837797|157367593|FG000|Period 1|Withdrawal of consent before treatment|1|||
48871948|NCT01837797|157367594|FG001|Period 1|Withdrawal of consent before treatment|0|||
48871949|NCT01837797|157367595|FG002|Period 1|Withdrawal of consent before treatment|0|||
48871950|NCT01837797|157367596|FG003|Period 1|Withdrawal of consent before treatment|0|||
48871951|NCT01837797|157367597|FG004|Period 1|Withdrawal of consent before treatment|0|||
48871952|NCT01837797|157367593|FG000|Period 1|Other|10|||
48871953|NCT01837797|157367594|FG001|Period 1|Other|0|||
48871954|NCT01837797|157367595|FG002|Period 1|Other|0|||
48871955|NCT01837797|157367596|FG003|Period 1|Other|0|||
48871956|NCT01837797|157367597|FG004|Period 1|Other|0|||
48871957|NCT01837797|157367593|FG000|Period 2|Administrative or other reasons|0|||
48871958|NCT01837797|157367594|FG001|Period 2|Administrative or other reasons|5|||
48871959|NCT01837797|157367595|FG002|Period 2|Administrative or other reasons|2|||
48871960|NCT01837797|157367596|FG003|Period 2|Administrative or other reasons|4|||
48871961|NCT01837797|157367597|FG004|Period 2|Administrative or other reasons|0|||
48871962|NCT01837797|157367593|FG000|Period 2|Adverse Event|0|||
48871963|NCT01837797|157367594|FG001|Period 2|Adverse Event|0|||
48871964|NCT01837797|157367595|FG002|Period 2|Adverse Event|0|||
48871965|NCT01837797|157367596|FG003|Period 2|Adverse Event|1|||
48871966|NCT01837797|157367597|FG004|Period 2|Adverse Event|0|||
48871967|NCT01837797|157367593|FG000|Period 3|Adverse Event|0|||
48871968|NCT01837797|157367594|FG001|Period 3|Adverse Event|0|||
48871969|NCT01837797|157367595|FG002|Period 3|Adverse Event|0|||
48871970|NCT01837797|157367596|FG003|Period 3|Adverse Event|0|||
48871971|NCT01837797|157367597|FG004|Period 3|Adverse Event|1|||
48871972|NCT01837797|157367593|FG000|Period 3|Administrative reasons|0|||
48969888|NCT02501902|157719127|FG004|Overall Study|Subject Refused Further Follow-up|0|||
48871973|NCT01837797|157367594|FG001|Period 3|Administrative reasons|0|||
48871974|NCT01837797|157367595|FG002|Period 3|Administrative reasons|0|||
48871975|NCT01837797|157367596|FG003|Period 3|Administrative reasons|0|||
48871976|NCT01837797|157367597|FG004|Period 3|Administrative reasons|20|||
48871977|NCT01837797|157367593|FG000|Period 3|Other|0|||
48871978|NCT01837797|157367594|FG001|Period 3|Other|0|||
48871979|NCT01837797|157367595|FG002|Period 3|Other|0|||
48871980|NCT01837797|157367596|FG003|Period 3|Other|0|||
48672137|NCT00576472|156651829|FG008|MPH Cross Over Phase|Ineligible due to disease|0|||
48672138|NCT00576472|156651830|FG009|MPH Cross Over Phase|Ineligible due to disease|0|||
48672139|NCT00576472|156651831|FG010|MPH Cross Over Phase|Ineligible due to disease|0|||
48672140|NCT00576472|156651832|FG011|MPH Cross Over Phase|Ineligible due to disease|0|||
48871981|NCT01837797|157367597|FG004|Period 3|Other|2|||
48871982|NCT00988117|157367598|FG000|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1|||
48871983|NCT00988117|157367598|FG000|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2|||
48871984|NCT01220856|157367599|FG000|Overall Study|graft loss|3|||
48871985|NCT01220856|157367600|FG001|Overall Study|graft loss|3|||
48871986|NCT01220856|157367599|FG000|Overall Study|Lost to Follow-up|1|||
48871987|NCT01220856|157367600|FG001|Overall Study|Lost to Follow-up|0|||
48871988|NCT02257918|157367601|FG000|Overall Study|Lost to Follow-up|4|||
48871989|NCT02257918|157367602|FG001|Overall Study|Lost to Follow-up|1|||
48871990|NCT02257918|157367603|FG002|Overall Study|Lost to Follow-up|0|||
48871991|NCT02257918|157367601|FG000|Overall Study|Withdrawal by Subject|0|||
48871992|NCT02257918|157367602|FG001|Overall Study|Withdrawal by Subject|0|||
48871993|NCT02257918|157367603|FG002|Overall Study|Withdrawal by Subject|1|||
48871994|NCT02257918|157367601|FG000|Overall Study|Pregnancy|0|||
48871995|NCT02257918|157367602|FG001|Overall Study|Pregnancy|0|||
48871996|NCT02257918|157367603|FG002|Overall Study|Pregnancy|1|||
48672141|NCT00576472|156651833|FG012|MPH Cross Over Phase|Ineligible due to disease|0|||
48871997|NCT00691678|157367606|FG000|Overall Study|Adverse Event|5|||
48871998|NCT00691678|157367606|FG000|Overall Study|life events, pain|11|||
48871999|NCT01878383|157369638|FG000|Overall Study|Lost to Follow-up|0|||
48872000|NCT01878383|157369639|FG001|Overall Study|Lost to Follow-up|1499|||
48872001|NCT03464383|157369640|FG000|Overall Study|Lost to Follow-up|1|||
48872002|NCT03464383|157369641|FG001|Overall Study|Lost to Follow-up|0|||
48872003|NCT03464383|157369642|FG002|Overall Study|Lost to Follow-up|0|||
48872004|NCT03464383|157369640|FG000|Overall Study|Withdrawal by Subject|0|||
48872005|NCT03464383|157369641|FG001|Overall Study|Withdrawal by Subject|1|||
48872006|NCT03464383|157369642|FG002|Overall Study|Withdrawal by Subject|0|||
48872007|NCT00381888|157369643|FG000|Overall Study|Death|1|||
48872008|NCT00381888|157369643|FG000|Overall Study|Withdrawal by Subject|1|||
48872009|NCT00381888|157369643|FG000|Overall Study|Physician Decision|1|||
48872010|NCT00381888|157369643|FG000|Overall Study|Protocol Violation|9|||
48872011|NCT00381888|157369643|FG000|Overall Study|Had laparoscopic surgery|2|||
48872012|NCT00381888|157369643|FG000|Overall Study|Surgery was cancelled|2|||
48872013|NCT00381888|157369643|FG000|Overall Study|Adverse Event|1|||
48872014|NCT00746785|157369644|FG000|Overall Study|Lost to Follow-up|29|||
48872015|NCT00746785|157369645|FG001|Overall Study|Lost to Follow-up|25|||
48872016|NCT00746785|157369646|FG002|Overall Study|Lost to Follow-up|27|||
48872017|NCT01231464|157369647|FG000|Overall Study|Adverse Event|0|||
48872018|NCT01231464|157369648|FG001|Overall Study|Adverse Event|1|||
48872019|NCT01231464|157369647|FG000|Overall Study|Protocol Violation|1|||
48872020|NCT01231464|157369648|FG001|Overall Study|Protocol Violation|2|||
48872021|NCT01231464|157369647|FG000|Overall Study|Lost to Follow-up|1|||
48872022|NCT01231464|157369648|FG001|Overall Study|Lost to Follow-up|2|||
48872023|NCT01231464|157369647|FG000|Overall Study|Withdrawal by Subject|3|||
48872024|NCT01231464|157369648|FG001|Overall Study|Withdrawal by Subject|2|||
48872025|NCT00605566|157369649|FG000|Overall Study|Adverse Event|1|||
48872026|NCT00605566|157369649|FG000|Overall Study|Clinical deterioration|1|||
48872027|NCT00605566|157369649|FG000|Overall Study|Poor compliance in run-in period|1|||
48872028|NCT00951171|157369650|FG000|Overall Study|Adverse Event|2|||
48872029|NCT00951171|157369651|FG001|Overall Study|Adverse Event|0|||
48872030|NCT00957996|157369652|FG000|Overall Study|Death|4|||
48872031|NCT00957996|157369653|FG001|Overall Study|Death|10|||
48872032|NCT00957996|157369652|FG000|Overall Study|Lost to Follow-up|4|||
48872033|NCT00957996|157369653|FG001|Overall Study|Lost to Follow-up|7|||
48872034|NCT00957996|157369652|FG000|Overall Study|Withdrawal by Subject|9|||
48872035|NCT00957996|157369653|FG001|Overall Study|Withdrawal by Subject|2|||
48872036|NCT00957996|157369652|FG000|Overall Study|Adverse Event|2|||
48872037|NCT00957996|157369653|FG001|Overall Study|Adverse Event|1|||
48872038|NCT00957996|157369652|FG000|Overall Study|Physician Decision|1|||
48872039|NCT00957996|157369653|FG001|Overall Study|Physician Decision|1|||
48872040|NCT00957996|157369652|FG000|Overall Study|Influenza-related complication|0|||
48872041|NCT00957996|157369653|FG001|Overall Study|Influenza-related complication|1|||
48872042|NCT00957996|157369652|FG000|Overall Study|Missing|1|||
48872043|NCT00957996|157369653|FG001|Overall Study|Missing|0|||
48872044|NCT00957996|157369652|FG000|Overall Study|Noncompliance; Protocol Deviations|5|||
48872045|NCT00957996|157369653|FG001|Overall Study|Noncompliance; Protocol Deviations|6|||
48872046|NCT00792259|157369654|FG000|Overall Study|Poor Quality Scans|1|||
48872047|NCT00792259|157369655|FG001|Overall Study|Poor Quality Scans|0|||
48872048|NCT00792259|157369656|FG002|Overall Study|Poor Quality Scans|0|||
48872049|NCT00371462|157369657|FG000|Overall Study|Withdrawal by Subject|1|||
48872050|NCT00371462|157369658|FG001|Overall Study|Withdrawal by Subject|0|||
48872051|NCT00371462|157369657|FG000|Overall Study|Other|7|||
48872052|NCT00371462|157369658|FG001|Overall Study|Other|8|||
48672142|NCT00576472|156651834|FG013|MPH Cross Over Phase|Ineligible due to disease|0|||
48672143|NCT00576472|156651835|FG014|MPH Cross Over Phase|Ineligible due to disease|0|||
48672144|NCT00576472|156651821|FG000|MPH Cross Over Phase|Physician Decision|0|||
48672145|NCT00576472|156651822|FG001|MPH Cross Over Phase|Physician Decision|0|||
48672146|NCT00576472|156651823|FG002|MPH Cross Over Phase|Physician Decision|0|||
48672147|NCT00576472|156651824|FG003|MPH Cross Over Phase|Physician Decision|0|||
48672148|NCT00576472|156651825|FG004|MPH Cross Over Phase|Physician Decision|0|||
48969889|NCT02501902|157719128|FG005|Overall Study|Subject Refused Further Follow-up|0|||
48672149|NCT00576472|156651826|FG005|MPH Cross Over Phase|Physician Decision|0|||
48872053|NCT00113269|157369662|FG000|Overall Study|Not transplanted, donor issues|4|||
48872054|NCT00113269|157369663|FG001|Overall Study|Not transplanted, donor issues|0|||
48872055|NCT00113269|157369664|FG002|Overall Study|Not transplanted, donor issues|2|||
48872056|NCT00113269|157369665|FG003|Overall Study|Not transplanted, donor issues|2|||
48872057|NCT00113269|157369662|FG000|Overall Study|Not transplanted, recipient issues|2|||
48872058|NCT00113269|157369663|FG001|Overall Study|Not transplanted, recipient issues|1|||
48872059|NCT00113269|157369664|FG002|Overall Study|Not transplanted, recipient issues|7|||
48872060|NCT00113269|157369665|FG003|Overall Study|Not transplanted, recipient issues|4|||
48872061|NCT00113269|157369662|FG000|Overall Study|Early graft loss, technical|0|||
48872062|NCT00113269|157369663|FG001|Overall Study|Early graft loss, technical|0|||
48872063|NCT00113269|157369664|FG002|Overall Study|Early graft loss, technical|2|||
48872064|NCT00113269|157369665|FG003|Overall Study|Early graft loss, technical|0|||
48872065|NCT00113269|157369662|FG000|Overall Study|Death in operating room|0|||
48872066|NCT00113269|157369663|FG001|Overall Study|Death in operating room|0|||
48872067|NCT00113269|157369664|FG002|Overall Study|Death in operating room|0|||
48872068|NCT00113269|157369665|FG003|Overall Study|Death in operating room|1|||
48872069|NCT00113269|157369662|FG000|Overall Study|Did not meet eligibility - pre-treatment|0|||
48872070|NCT00113269|157369663|FG001|Overall Study|Did not meet eligibility - pre-treatment|0|||
48872071|NCT00113269|157369664|FG002|Overall Study|Did not meet eligibility - pre-treatment|0|||
48872072|NCT00113269|157369665|FG003|Overall Study|Did not meet eligibility - pre-treatment|2|||
48872073|NCT00113269|157369662|FG000|Overall Study|Adverse Event|2|||
48872074|NCT00113269|157369663|FG001|Overall Study|Adverse Event|7|||
48872075|NCT00113269|157369664|FG002|Overall Study|Adverse Event|11|||
48872076|NCT00113269|157369665|FG003|Overall Study|Adverse Event|7|||
48872077|NCT00113269|157369662|FG000|Overall Study|Withdrawal by Subject|4|||
48872078|NCT00113269|157369663|FG001|Overall Study|Withdrawal by Subject|3|||
48872079|NCT00113269|157369664|FG002|Overall Study|Withdrawal by Subject|4|||
48872080|NCT00113269|157369665|FG003|Overall Study|Withdrawal by Subject|2|||
48872081|NCT00113269|157369662|FG000|Overall Study|Graft loss|6|||
48872082|NCT00113269|157369663|FG001|Overall Study|Graft loss|6|||
48872083|NCT00113269|157369664|FG002|Overall Study|Graft loss|4|||
48872084|NCT00113269|157369665|FG003|Overall Study|Graft loss|9|||
48872085|NCT00113269|157369662|FG000|Overall Study|Protocol Violation|1|||
48672150|NCT00576472|156651827|FG006|MPH Cross Over Phase|Physician Decision|4|||
48672151|NCT00576472|156651828|FG007|MPH Cross Over Phase|Physician Decision|0|||
48672152|NCT00576472|156651829|FG008|MPH Cross Over Phase|Physician Decision|0|||
48672153|NCT00576472|156651830|FG009|MPH Cross Over Phase|Physician Decision|0|||
48672154|NCT00576472|156651831|FG010|MPH Cross Over Phase|Physician Decision|0|||
48672155|NCT00576472|156651832|FG011|MPH Cross Over Phase|Physician Decision|0|||
48672156|NCT00576472|156651833|FG012|MPH Cross Over Phase|Physician Decision|0|||
48672157|NCT00576472|156651834|FG013|MPH Cross Over Phase|Physician Decision|0|||
48672158|NCT00576472|156651835|FG014|MPH Cross Over Phase|Physician Decision|0|||
48672159|NCT00576472|156651821|FG000|MPH Cross Over Phase|Did not complete cross over phase|0|||
48672160|NCT00576472|156651822|FG001|MPH Cross Over Phase|Did not complete cross over phase|0|||
48672161|NCT00576472|156651823|FG002|MPH Cross Over Phase|Did not complete cross over phase|0|||
48672162|NCT00576472|156651824|FG003|MPH Cross Over Phase|Did not complete cross over phase|0|||
48672163|NCT00576472|156651825|FG004|MPH Cross Over Phase|Did not complete cross over phase|0|||
48672164|NCT00576472|156651826|FG005|MPH Cross Over Phase|Did not complete cross over phase|0|||
48672165|NCT00576472|156651827|FG006|MPH Cross Over Phase|Did not complete cross over phase|0|||
48872086|NCT00113269|157369663|FG001|Overall Study|Protocol Violation|0|||
48872087|NCT00113269|157369664|FG002|Overall Study|Protocol Violation|4|||
48969890|NCT02501902|157719129|FG006|Overall Study|Subject Refused Further Follow-up|0|||
48969891|NCT02501902|157719130|FG007|Overall Study|Subject Refused Further Follow-up|1|||
48672166|NCT00576472|156651828|FG007|MPH Cross Over Phase|Did not complete cross over phase|0|||
48672167|NCT00576472|156651829|FG008|MPH Cross Over Phase|Did not complete cross over phase|2|||
48672168|NCT00576472|156651830|FG009|MPH Cross Over Phase|Did not complete cross over phase|0|||
48672169|NCT00576472|156651831|FG010|MPH Cross Over Phase|Did not complete cross over phase|1|||
48672170|NCT00576472|156651832|FG011|MPH Cross Over Phase|Did not complete cross over phase|1|||
48672171|NCT00576472|156651833|FG012|MPH Cross Over Phase|Did not complete cross over phase|0|||
48672172|NCT00576472|156651834|FG013|MPH Cross Over Phase|Did not complete cross over phase|0|||
48672173|NCT00576472|156651835|FG014|MPH Cross Over Phase|Did not complete cross over phase|0|||
48872088|NCT00113269|157369665|FG003|Overall Study|Protocol Violation|2|||
48872089|NCT00113269|157369662|FG000|Overall Study|Lost to Follow-up|2|||
48969892|NCT02501902|157719123|FG000|Overall Study|Study Terminated by Sponsor|0|||
48969893|NCT02501902|157719124|FG001|Overall Study|Study Terminated by Sponsor|3|||
48969894|NCT02501902|157719125|FG002|Overall Study|Study Terminated by Sponsor|0|||
48969895|NCT02501902|157719126|FG003|Overall Study|Study Terminated by Sponsor|1|||
48969896|NCT02501902|157719127|FG004|Overall Study|Study Terminated by Sponsor|1|||
48969897|NCT02501902|157719128|FG005|Overall Study|Study Terminated by Sponsor|0|||
48969898|NCT02501902|157719129|FG006|Overall Study|Study Terminated by Sponsor|2|||
48969899|NCT02501902|157719130|FG007|Overall Study|Study Terminated by Sponsor|4|||
48969900|NCT02501902|157719123|FG000|Overall Study|Death|3|||
48969901|NCT02501902|157719124|FG001|Overall Study|Death|4|||
48969902|NCT02501902|157719125|FG002|Overall Study|Death|4|||
48969903|NCT02501902|157719126|FG003|Overall Study|Death|10|||
48672174|NCT00576472|156651821|FG000|MPH Home Maintenance Phase|Did not meet response criteria|0|||
48672175|NCT00576472|156651822|FG001|MPH Home Maintenance Phase|Did not meet response criteria|0|||
48672176|NCT00576472|156651823|FG002|MPH Home Maintenance Phase|Did not meet response criteria|0|||
48672177|NCT00576472|156651824|FG003|MPH Home Maintenance Phase|Did not meet response criteria|0|||
48672178|NCT00576472|156651825|FG004|MPH Home Maintenance Phase|Did not meet response criteria|0|||
48672179|NCT00576472|156651826|FG005|MPH Home Maintenance Phase|Did not meet response criteria|0|||
48672180|NCT00576472|156651827|FG006|MPH Home Maintenance Phase|Did not meet response criteria|0|||
48672181|NCT00576472|156651828|FG007|MPH Home Maintenance Phase|Did not meet response criteria|0|||
48672182|NCT00576472|156651829|FG008|MPH Home Maintenance Phase|Did not meet response criteria|0|||
48672183|NCT00576472|156651830|FG009|MPH Home Maintenance Phase|Did not meet response criteria|0|||
48672184|NCT00576472|156651831|FG010|MPH Home Maintenance Phase|Did not meet response criteria|0|||
48672185|NCT00576472|156651832|FG011|MPH Home Maintenance Phase|Did not meet response criteria|0|||
48672186|NCT00576472|156651833|FG012|MPH Home Maintenance Phase|Did not meet response criteria|0|||
48672187|NCT00576472|156651834|FG013|MPH Home Maintenance Phase|Did not meet response criteria|16|||
48672188|NCT00576472|156651835|FG014|MPH Home Maintenance Phase|Did not meet response criteria|0|||
48672189|NCT00576472|156651821|FG000|MPH Home Maintenance Phase|Declined to participate|0|||
48672190|NCT00576472|156651822|FG001|MPH Home Maintenance Phase|Declined to participate|0|||
48672191|NCT00576472|156651823|FG002|MPH Home Maintenance Phase|Declined to participate|0|||
48672192|NCT00576472|156651824|FG003|MPH Home Maintenance Phase|Declined to participate|0|||
48672193|NCT00576472|156651825|FG004|MPH Home Maintenance Phase|Declined to participate|0|||
48672194|NCT00576472|156651826|FG005|MPH Home Maintenance Phase|Declined to participate|0|||
48672195|NCT00576472|156651827|FG006|MPH Home Maintenance Phase|Declined to participate|0|||
48672196|NCT00576472|156651828|FG007|MPH Home Maintenance Phase|Declined to participate|0|||
48672197|NCT00576472|156651829|FG008|MPH Home Maintenance Phase|Declined to participate|0|||
48672198|NCT00576472|156651830|FG009|MPH Home Maintenance Phase|Declined to participate|0|||
48672199|NCT00576472|156651831|FG010|MPH Home Maintenance Phase|Declined to participate|0|||
48672200|NCT00576472|156651832|FG011|MPH Home Maintenance Phase|Declined to participate|0|||
48672201|NCT00576472|156651833|FG012|MPH Home Maintenance Phase|Declined to participate|0|||
48672202|NCT00576472|156651834|FG013|MPH Home Maintenance Phase|Declined to participate|7|||
48672203|NCT00576472|156651835|FG014|MPH Home Maintenance Phase|Declined to participate|0|||
48872090|NCT00113269|157369663|FG001|Overall Study|Lost to Follow-up|3|||
48672204|NCT00576472|156651821|FG000|MPH Home Maintenance Phase|Insufficient data|0|||
48672205|NCT00576472|156651822|FG001|MPH Home Maintenance Phase|Insufficient data|0|||
48672206|NCT00576472|156651823|FG002|MPH Home Maintenance Phase|Insufficient data|0|||
48672207|NCT00576472|156651824|FG003|MPH Home Maintenance Phase|Insufficient data|0|||
48672208|NCT00576472|156651825|FG004|MPH Home Maintenance Phase|Insufficient data|0|||
48872091|NCT00113269|157369664|FG002|Overall Study|Lost to Follow-up|6|||
48872092|NCT00113269|157369665|FG003|Overall Study|Lost to Follow-up|3|||
48872093|NCT00113269|157369662|FG000|Overall Study|Sponsor elected to discontinue patient|1|||
48872094|NCT00113269|157369663|FG001|Overall Study|Sponsor elected to discontinue patient|0|||
48872095|NCT00113269|157369664|FG002|Overall Study|Sponsor elected to discontinue patient|0|||
48872096|NCT00113269|157369665|FG003|Overall Study|Sponsor elected to discontinue patient|1|||
48872097|NCT00113269|157369662|FG000|Overall Study|Discontinued due to rejection|0|||
48872098|NCT00113269|157369663|FG001|Overall Study|Discontinued due to rejection|0|||
48872099|NCT00113269|157369664|FG002|Overall Study|Discontinued due to rejection|1|||
48872100|NCT00113269|157369665|FG003|Overall Study|Discontinued due to rejection|0|||
48872101|NCT00113269|157369662|FG000|Overall Study|Moved|0|||
48872102|NCT00113269|157369663|FG001|Overall Study|Moved|1|||
48872103|NCT00113269|157369664|FG002|Overall Study|Moved|0|||
48872104|NCT00113269|157369665|FG003|Overall Study|Moved|3|||
48872105|NCT00113269|157369662|FG000|Overall Study|Received pancreas transplant|0|||
48872106|NCT00113269|157369663|FG001|Overall Study|Received pancreas transplant|0|||
48872107|NCT00113269|157369664|FG002|Overall Study|Received pancreas transplant|0|||
48872108|NCT00113269|157369665|FG003|Overall Study|Received pancreas transplant|2|||
48872109|NCT00113269|157369662|FG000|Overall Study|Withdrew consent, Prednisone initiated|0|||
48872110|NCT00113269|157369663|FG001|Overall Study|Withdrew consent, Prednisone initiated|0|||
48872111|NCT00113269|157369664|FG002|Overall Study|Withdrew consent, Prednisone initiated|0|||
48872112|NCT00113269|157369665|FG003|Overall Study|Withdrew consent, Prednisone initiated|1|||
48969904|NCT02501902|157719127|FG004|Overall Study|Death|10|||
48969905|NCT02501902|157719128|FG005|Overall Study|Death|11|||
48969906|NCT02501902|157719129|FG006|Overall Study|Death|7|||
48969907|NCT02501902|157719130|FG007|Overall Study|Death|15|||
48969908|NCT02384395|157719131|FG000|Overall Study|Physician Decision|4|||
48969909|NCT02384395|157719131|FG000|Overall Study|Withdrawal by Subject|3|||
48969910|NCT02384395|157719131|FG000|Overall Study|Lost to Follow-up|3|||
48969911|NCT02513771|157719132|FG000|Overall Study|Lost to Follow-up|1|||
48672209|NCT00576472|156651826|FG005|MPH Home Maintenance Phase|Insufficient data|0|||
48672210|NCT00576472|156651827|FG006|MPH Home Maintenance Phase|Insufficient data|0|||
48672211|NCT00576472|156651828|FG007|MPH Home Maintenance Phase|Insufficient data|0|||
48672212|NCT00576472|156651829|FG008|MPH Home Maintenance Phase|Insufficient data|0|||
48672213|NCT00576472|156651830|FG009|MPH Home Maintenance Phase|Insufficient data|0|||
48672214|NCT00576472|156651831|FG010|MPH Home Maintenance Phase|Insufficient data|0|||
48672215|NCT00576472|156651832|FG011|MPH Home Maintenance Phase|Insufficient data|0|||
48672216|NCT00576472|156651833|FG012|MPH Home Maintenance Phase|Insufficient data|0|||
48672217|NCT00576472|156651834|FG013|MPH Home Maintenance Phase|Insufficient data|4|||
48672218|NCT00576472|156651835|FG014|MPH Home Maintenance Phase|Insufficient data|0|||
48672219|NCT00576472|156651821|FG000|MPH Home Maintenance Phase|Side effects|0|||
48672220|NCT00576472|156651822|FG001|MPH Home Maintenance Phase|Side effects|0|||
48672221|NCT00576472|156651823|FG002|MPH Home Maintenance Phase|Side effects|0|||
48672222|NCT00576472|156651824|FG003|MPH Home Maintenance Phase|Side effects|0|||
48672223|NCT00576472|156651825|FG004|MPH Home Maintenance Phase|Side effects|0|||
48672224|NCT00576472|156651826|FG005|MPH Home Maintenance Phase|Side effects|0|||
48672225|NCT00576472|156651827|FG006|MPH Home Maintenance Phase|Side effects|0|||
48672226|NCT00576472|156651828|FG007|MPH Home Maintenance Phase|Side effects|0|||
48672227|NCT00576472|156651829|FG008|MPH Home Maintenance Phase|Side effects|0|||
48672228|NCT00576472|156651830|FG009|MPH Home Maintenance Phase|Side effects|0|||
48672229|NCT00576472|156651831|FG010|MPH Home Maintenance Phase|Side effects|0|||
48672230|NCT00576472|156651832|FG011|MPH Home Maintenance Phase|Side effects|0|||
48672231|NCT00576472|156651833|FG012|MPH Home Maintenance Phase|Side effects|0|||
48672232|NCT00576472|156651834|FG013|MPH Home Maintenance Phase|Side effects|0|||
48672233|NCT00576472|156651835|FG014|MPH Home Maintenance Phase|Side effects|8|||
48672234|NCT00576472|156651821|FG000|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
48672235|NCT00576472|156651822|FG001|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
48672236|NCT00576472|156651823|FG002|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
48672237|NCT00576472|156651824|FG003|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
48672238|NCT00576472|156651825|FG004|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
48672239|NCT00576472|156651826|FG005|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
48672240|NCT00576472|156651827|FG006|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
48672241|NCT00576472|156651828|FG007|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
48672242|NCT00576472|156651829|FG008|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
48672243|NCT00576472|156651830|FG009|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
48672244|NCT00576472|156651831|FG010|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
48672245|NCT00576472|156651832|FG011|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
48672246|NCT00576472|156651833|FG012|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
48672247|NCT00576472|156651834|FG013|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
48672248|NCT00576472|156651835|FG014|MPH Home Maintenance Phase|Withdrawal by Subject|6|||
48672249|NCT00576472|156651821|FG000|MPH Home Maintenance Phase|Medical reasons|0|||
48672250|NCT00576472|156651822|FG001|MPH Home Maintenance Phase|Medical reasons|0|||
48672251|NCT00576472|156651823|FG002|MPH Home Maintenance Phase|Medical reasons|0|||
48672252|NCT00576472|156651824|FG003|MPH Home Maintenance Phase|Medical reasons|0|||
48672253|NCT00576472|156651825|FG004|MPH Home Maintenance Phase|Medical reasons|0|||
48672254|NCT00576472|156651826|FG005|MPH Home Maintenance Phase|Medical reasons|0|||
48672255|NCT00576472|156651827|FG006|MPH Home Maintenance Phase|Medical reasons|0|||
48672256|NCT00576472|156651828|FG007|MPH Home Maintenance Phase|Medical reasons|0|||
48672257|NCT00576472|156651829|FG008|MPH Home Maintenance Phase|Medical reasons|0|||
48672258|NCT00576472|156651830|FG009|MPH Home Maintenance Phase|Medical reasons|0|||
48672259|NCT00576472|156651831|FG010|MPH Home Maintenance Phase|Medical reasons|0|||
48672260|NCT00576472|156651832|FG011|MPH Home Maintenance Phase|Medical reasons|0|||
48672261|NCT00576472|156651833|FG012|MPH Home Maintenance Phase|Medical reasons|0|||
48672262|NCT00576472|156651834|FG013|MPH Home Maintenance Phase|Medical reasons|0|||
48672263|NCT00576472|156651835|FG014|MPH Home Maintenance Phase|Medical reasons|6|||
48672264|NCT00576472|156651821|FG000|MPH Home Maintenance Phase|Lost to Follow-up|0|||
48969912|NCT02513771|157719133|FG001|Overall Study|Lost to Follow-up|1|||
48969913|NCT02513771|157719132|FG000|Overall Study|Not being able to get to clinic|1|||
48672265|NCT00576472|156651822|FG001|MPH Home Maintenance Phase|Lost to Follow-up|0|||
48672266|NCT00576472|156651823|FG002|MPH Home Maintenance Phase|Lost to Follow-up|0|||
48672267|NCT00576472|156651824|FG003|MPH Home Maintenance Phase|Lost to Follow-up|0|||
48672268|NCT00576472|156651825|FG004|MPH Home Maintenance Phase|Lost to Follow-up|0|||
48672269|NCT00576472|156651826|FG005|MPH Home Maintenance Phase|Lost to Follow-up|0|||
48672270|NCT00576472|156651827|FG006|MPH Home Maintenance Phase|Lost to Follow-up|0|||
48760772|NCT03318315|156972318|FG001|Overall Study|Protocol Violation|1|||
48969914|NCT02513771|157719133|FG001|Overall Study|Not being able to get to clinic|0|||
48969915|NCT01705587|157719134|FG000|Overall Study|Withdrawal by Subject|0|||
48969916|NCT01705587|157719135|FG001|Overall Study|Withdrawal by Subject|1|||
48969917|NCT01280266|157719136|FG000|First Intervention (Week 1-4)|Adverse Event|1|||
48969918|NCT01280266|157719137|FG001|First Intervention (Week 1-4)|Adverse Event|0|||
48969919|NCT01280266|157719136|FG000|First Intervention (Week 1-4)|Withdrawal by Subject|0|||
48969920|NCT01280266|157719137|FG001|First Intervention (Week 1-4)|Withdrawal by Subject|2|||
48969921|NCT02137837|157719138|FG000|Overall Study|Adverse Event|0|||
48969922|NCT02137837|157719139|FG001|Overall Study|Adverse Event|2|||
48969923|NCT02137837|157719140|FG002|Overall Study|Adverse Event|1|||
48969924|NCT02137837|157719138|FG000|Overall Study|Refusal unrelated to adverse event|2|||
48969925|NCT02137837|157719139|FG001|Overall Study|Refusal unrelated to adverse event|2|||
48969926|NCT02137837|157719140|FG002|Overall Study|Refusal unrelated to adverse event|1|||
48969927|NCT02137837|157719138|FG000|Overall Study|Progression/relapse|9|||
48969928|NCT02137837|157719139|FG001|Overall Study|Progression/relapse|7|||
48969929|NCT02137837|157719140|FG002|Overall Study|Progression/relapse|7|||
48969930|NCT02137837|157719138|FG000|Overall Study|Not protocol specified|2|||
48969931|NCT02137837|157719139|FG001|Overall Study|Not protocol specified|1|||
48969932|NCT02137837|157719140|FG002|Overall Study|Not protocol specified|3|||
48969933|NCT00109772|157719145|FG000|Double-blind Treatment|Adverse Event|14|||
48969934|NCT00109772|157719146|FG001|Double-blind Treatment|Adverse Event|5|||
48969935|NCT00109772|157719145|FG000|Double-blind Treatment|Lack of Efficacy|1|||
48969936|NCT00109772|157719146|FG001|Double-blind Treatment|Lack of Efficacy|0|||
48969937|NCT00109772|157719145|FG000|Double-blind Treatment|Withdrawal by Subject|2|||
48969938|NCT00109772|157719146|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
48969939|NCT00109772|157719145|FG000|Double-blind Treatment|Lost to Follow-up|2|||
48672271|NCT00576472|156651828|FG007|MPH Home Maintenance Phase|Lost to Follow-up|0|||
48672272|NCT00576472|156651829|FG008|MPH Home Maintenance Phase|Lost to Follow-up|0|||
48672273|NCT00576472|156651830|FG009|MPH Home Maintenance Phase|Lost to Follow-up|0|||
48672274|NCT00576472|156651831|FG010|MPH Home Maintenance Phase|Lost to Follow-up|0|||
48672275|NCT00576472|156651832|FG011|MPH Home Maintenance Phase|Lost to Follow-up|0|||
48672276|NCT00576472|156651833|FG012|MPH Home Maintenance Phase|Lost to Follow-up|0|||
48672277|NCT00576472|156651834|FG013|MPH Home Maintenance Phase|Lost to Follow-up|0|||
48672278|NCT00576472|156651835|FG014|MPH Home Maintenance Phase|Lost to Follow-up|3|||
48672279|NCT00599638|156651836|FG000|First Intervention Period (2 Weeks)|Adverse Event|1|||
48672280|NCT00599638|156651837|FG001|First Intervention Period (2 Weeks)|Adverse Event|0|||
48672281|NCT00599638|156651838|FG002|First Intervention Period (2 Weeks)|Adverse Event|3|||
48672282|NCT00599638|156651839|FG003|First Intervention Period (2 Weeks)|Adverse Event|2|||
48672283|NCT00599638|156651836|FG000|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
48672284|NCT00599638|156651837|FG001|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
48672285|NCT00599638|156651838|FG002|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
48672286|NCT00599638|156651839|FG003|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
48672287|NCT00599638|156651836|FG000|First Intervention Period (2 Weeks)|Protocol Violation|0|||
48672288|NCT00599638|156651837|FG001|First Intervention Period (2 Weeks)|Protocol Violation|1|||
48672289|NCT00599638|156651838|FG002|First Intervention Period (2 Weeks)|Protocol Violation|0|||
48672290|NCT00599638|156651839|FG003|First Intervention Period (2 Weeks)|Protocol Violation|1|||
48672291|NCT00599638|156651836|FG000|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
48672292|NCT00599638|156651837|FG001|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
48672293|NCT00599638|156651838|FG002|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
48672294|NCT00599638|156651839|FG003|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
48672295|NCT00599638|156651836|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
48672296|NCT00599638|156651837|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
48672297|NCT00599638|156651838|FG002|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
48672298|NCT00599638|156651839|FG003|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
48672299|NCT00599638|156651836|FG000|Washout Period (2 Weeks)|Adverse Event|0|||
48672300|NCT00599638|156651837|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
48672301|NCT00599638|156651838|FG002|Washout Period (2 Weeks)|Adverse Event|0|||
48672302|NCT00599638|156651839|FG003|Washout Period (2 Weeks)|Adverse Event|1|||
48672303|NCT00599638|156651836|FG000|Washout Period (2 Weeks)|Lost to Follow-up|0|||
48872113|NCT00113269|157369662|FG000|Overall Study|Did not meet eligibility criteria|1|||
48872114|NCT00113269|157369663|FG001|Overall Study|Did not meet eligibility criteria|0|||
48872115|NCT00113269|157369664|FG002|Overall Study|Did not meet eligibility criteria|0|||
48872116|NCT00113269|157369665|FG003|Overall Study|Did not meet eligibility criteria|1|||
48872117|NCT00113269|157369662|FG000|Overall Study|Unable to return for follow up|2|||
48872118|NCT00113269|157369663|FG001|Overall Study|Unable to return for follow up|1|||
48872119|NCT00113269|157369664|FG002|Overall Study|Unable to return for follow up|0|||
48872120|NCT00113269|157369665|FG003|Overall Study|Unable to return for follow up|0|||
48872121|NCT02210208|157369666|FG000|Period A (Graft Site)|Withdrawal by Subject|1|||
48872122|NCT02210208|157369666|FG000|Period A (Graft Site)|Physician decided not to graft at OR|1|||
48969940|NCT00109772|157719146|FG001|Double-blind Treatment|Lost to Follow-up|3|||
48872123|NCT02210208|157369666|FG000|Period B (Donor Site)|7 subjects healed at or before Day 14|7|||
48872124|NCT01171183|157369667|FG000|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
48872125|NCT01171183|157369668|FG001|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
48872126|NCT01171183|157369667|FG000|Residential Facility (Weeks 1-2)|Protocol Violation|0|||
48872127|NCT01171183|157369668|FG001|Residential Facility (Weeks 1-2)|Protocol Violation|1|||
48872128|NCT01171183|157369667|FG000|Residential Facility (Weeks 1-2)|BP outside of study parameters|0|||
48872129|NCT01171183|157369668|FG001|Residential Facility (Weeks 1-2)|BP outside of study parameters|3|||
48872130|NCT01171183|157369667|FG000|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
48872131|NCT01171183|157369668|FG001|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
48872132|NCT01171183|157369667|FG000|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7|||
48872133|NCT01171183|157369668|FG001|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3|||
48872134|NCT01171183|157369667|FG000|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1|||
48872135|NCT01171183|157369668|FG001|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0|||
48672304|NCT00599638|156651837|FG001|Washout Period (2 Weeks)|Lost to Follow-up|0|||
48672305|NCT00599638|156651838|FG002|Washout Period (2 Weeks)|Lost to Follow-up|0|||
48672306|NCT00599638|156651839|FG003|Washout Period (2 Weeks)|Lost to Follow-up|1|||
48672307|NCT00599638|156651836|FG000|Washout Period (2 Weeks)|Protocol Violation|0|||
48672308|NCT00599638|156651837|FG001|Washout Period (2 Weeks)|Protocol Violation|1|||
48672309|NCT00599638|156651838|FG002|Washout Period (2 Weeks)|Protocol Violation|0|||
48672310|NCT00599638|156651839|FG003|Washout Period (2 Weeks)|Protocol Violation|0|||
48872136|NCT01101334|157369669|FG000|Overall Study|Adverse Event|9|||
48872137|NCT01101334|157369670|FG001|Overall Study|Adverse Event|4|||
48872138|NCT01101334|157369669|FG000|Overall Study|Death|7|||
48872139|NCT01101334|157369670|FG001|Overall Study|Death|1|||
48872140|NCT01101334|157369669|FG000|Overall Study|Withdrawal by Subject|4|||
48872141|NCT01101334|157369670|FG001|Overall Study|Withdrawal by Subject|3|||
48872142|NCT01101334|157369669|FG000|Overall Study|Withdrawal by Sponsor|1|||
48872143|NCT01101334|157369670|FG001|Overall Study|Withdrawal by Sponsor|1|||
48872144|NCT01101334|157369669|FG000|Overall Study|Progressive Disease|22|||
48872145|NCT01101334|157369670|FG001|Overall Study|Progressive Disease|35|||
48872146|NCT01101334|157369669|FG000|Overall Study|Other|2|||
48872147|NCT01101334|157369670|FG001|Overall Study|Other|1|||
48872148|NCT03864341|157369675|FG000|Overall Study|Withdrawal by Subject|1|||
48872149|NCT01066936|157369676|FG000|Overall Study|Death|2|||
48872150|NCT01066936|157369676|FG000|Overall Study|Device revised/removed|1|||
48872151|NCT01066936|157369676|FG000|Overall Study|Lost to Follow-up|3|||
48872152|NCT01066936|157369676|FG000|Overall Study|Withdrawal by Subject|4|||
48872153|NCT01904136|157369677|FG000|Overall Study|Physician Decision|0|||
48872154|NCT01904136|157369678|FG001|Overall Study|Physician Decision|0|||
48872155|NCT01904136|157369679|FG002|Overall Study|Physician Decision|0|||
48872156|NCT01904136|157369680|FG003|Overall Study|Physician Decision|0|||
48872157|NCT01904136|157369681|FG004|Overall Study|Physician Decision|0|||
48872158|NCT01904136|157369682|FG005|Overall Study|Physician Decision|1|||
48872159|NCT01904136|157369683|FG006|Overall Study|Physician Decision|0|||
48872160|NCT01904136|157369684|FG007|Overall Study|Physician Decision|0|||
48872161|NCT01904136|157369685|FG008|Overall Study|Physician Decision|0|||
48872162|NCT02507687|157369691|FG000|Overall Study|Adverse Event|3|||
48872163|NCT02507687|157369692|FG001|Overall Study|Adverse Event|2|||
48872164|NCT02507687|157369693|FG002|Overall Study|Adverse Event|2|||
48872165|NCT02507687|157369694|FG003|Overall Study|Adverse Event|2|||
48872166|NCT02507687|157369691|FG000|Overall Study|Withdrawal by Subject|1|||
48872167|NCT02507687|157369692|FG001|Overall Study|Withdrawal by Subject|4|||
48872168|NCT02507687|157369693|FG002|Overall Study|Withdrawal by Subject|6|||
48672311|NCT00599638|156651836|FG000|Second Intervention Period (2 Weeks)|Protocol Violation|1|||
48872169|NCT02507687|157369694|FG003|Overall Study|Withdrawal by Subject|6|||
48872170|NCT02507687|157369691|FG000|Overall Study|Protocol Violation|1|||
48872171|NCT02507687|157369692|FG001|Overall Study|Protocol Violation|0|||
48872172|NCT02507687|157369693|FG002|Overall Study|Protocol Violation|2|||
48872173|NCT02507687|157369694|FG003|Overall Study|Protocol Violation|0|||
48872174|NCT02507687|157369691|FG000|Overall Study|Lost to Follow-up|0|||
48872175|NCT02507687|157369692|FG001|Overall Study|Lost to Follow-up|0|||
48872176|NCT02507687|157369693|FG002|Overall Study|Lost to Follow-up|2|||
48969941|NCT00109772|157719145|FG000|Double-blind Treatment|Protocol Violation|0|||
48969942|NCT00109772|157719146|FG001|Double-blind Treatment|Protocol Violation|1|||
48872177|NCT02507687|157369694|FG003|Overall Study|Lost to Follow-up|1|||
48969943|NCT00109772|157719145|FG000|Double-blind Treatment|Other|0|||
48969944|NCT00109772|157719146|FG001|Double-blind Treatment|Other|4|||
48969945|NCT00109772|157719145|FG000|Double-blind Treatment|Withdrew prior to treatment|3|||
48760773|NCT03318315|156972319|FG002|Overall Study|Protocol Violation|1|||
48872178|NCT02507687|157369691|FG000|Overall Study|Screen Failure|0|||
48872179|NCT02507687|157369692|FG001|Overall Study|Screen Failure|0|||
48872180|NCT02507687|157369693|FG002|Overall Study|Screen Failure|1|||
48872181|NCT02507687|157369694|FG003|Overall Study|Screen Failure|0|||
48872182|NCT02507687|157369691|FG000|Overall Study|Other, Not Specified|0|||
48872183|NCT02507687|157369692|FG001|Overall Study|Other, Not Specified|0|||
48672312|NCT00599638|156651837|FG001|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
48672313|NCT00599638|156651838|FG002|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
48672314|NCT00599638|156651839|FG003|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
48672315|NCT05026853|156651840|FG000|Overall Study|Cancelled appointment|1|||
48672316|NCT05026853|156651841|FG001|Overall Study|Cancelled appointment|0|||
48672317|NCT05026853|156651840|FG000|Overall Study|Excluded due to technical difficulties with generating scorecard|8|||
48672318|NCT05026853|156651841|FG001|Overall Study|Excluded due to technical difficulties with generating scorecard|0|||
48672319|NCT05026853|156651840|FG000|Overall Study|Did not complete 12-week survey|16|||
48672320|NCT05026853|156651841|FG001|Overall Study|Did not complete 12-week survey|16|||
48672321|NCT02895945|156651842|FG000|Overall Study|Physician Decision|2|||
48672322|NCT02895945|156651843|FG001|Overall Study|Physician Decision|1|||
48969946|NCT00109772|157719146|FG001|Double-blind Treatment|Withdrew prior to treatment|1|||
48672323|NCT03429543|156651844|FG000|Overall Study|Adverse Event|1|||
48672324|NCT03429543|156651845|FG001|Overall Study|Adverse Event|1|||
48672325|NCT03429543|156651846|FG002|Overall Study|Adverse Event|0|||
48672326|NCT03429543|156651847|FG003|Overall Study|Adverse Event|0|||
48672327|NCT03429543|156651848|FG004|Overall Study|Adverse Event|0|||
48672328|NCT03429543|156651849|FG005|Overall Study|Adverse Event|2|||
48672329|NCT03429543|156651850|FG006|Overall Study|Adverse Event|0|||
48672330|NCT03429543|156651844|FG000|Overall Study|Lost to Follow-up|1|||
48672331|NCT03429543|156651845|FG001|Overall Study|Lost to Follow-up|0|||
48672332|NCT03429543|156651846|FG002|Overall Study|Lost to Follow-up|0|||
48672333|NCT03429543|156651847|FG003|Overall Study|Lost to Follow-up|0|||
48672334|NCT03429543|156651848|FG004|Overall Study|Lost to Follow-up|1|||
48672335|NCT03429543|156651849|FG005|Overall Study|Lost to Follow-up|0|||
48672336|NCT03429543|156651850|FG006|Overall Study|Lost to Follow-up|0|||
48672337|NCT03429543|156651844|FG000|Overall Study|Withdrawal by Subject|5|||
48969947|NCT00109772|157719145|FG000|Open-label Extension|Adverse Event|10|||
48672338|NCT03429543|156651845|FG001|Overall Study|Withdrawal by Subject|0|||
48672339|NCT03429543|156651846|FG002|Overall Study|Withdrawal by Subject|1|||
48672340|NCT03429543|156651847|FG003|Overall Study|Withdrawal by Subject|2|||
48672341|NCT03429543|156651848|FG004|Overall Study|Withdrawal by Subject|6|||
48672342|NCT03429543|156651849|FG005|Overall Study|Withdrawal by Subject|3|||
48672343|NCT03429543|156651850|FG006|Overall Study|Withdrawal by Subject|1|||
48672344|NCT03429543|156651844|FG000|Overall Study|Other reason than listed|0|||
48672345|NCT03429543|156651845|FG001|Overall Study|Other reason than listed|1|||
48672346|NCT03429543|156651846|FG002|Overall Study|Other reason than listed|0|||
48672347|NCT03429543|156651847|FG003|Overall Study|Other reason than listed|0|||
48672348|NCT03429543|156651848|FG004|Overall Study|Other reason than listed|4|||
48672349|NCT03429543|156651849|FG005|Overall Study|Other reason than listed|4|||
48672350|NCT03429543|156651850|FG006|Overall Study|Other reason than listed|0|||
48672351|NCT03429543|156651844|FG000|Overall Study|Not treated|0|||
48672352|NCT03429543|156651845|FG001|Overall Study|Not treated|0|||
48672353|NCT03429543|156651846|FG002|Overall Study|Not treated|0|||
48672354|NCT03429543|156651847|FG003|Overall Study|Not treated|0|||
48672355|NCT03429543|156651848|FG004|Overall Study|Not treated|1|||
48672356|NCT03429543|156651849|FG005|Overall Study|Not treated|0|||
48672357|NCT03429543|156651850|FG006|Overall Study|Not treated|0|||
48672358|NCT02345330|156651852|FG000|Overall Study|Death|1|||
48672359|NCT02345330|156651852|FG000|Overall Study|Progressive Disease|2|||
48672360|NCT03688100|156651853|FG000|Overall Study|Lost to Follow-up|21|||
48672361|NCT03688100|156651854|FG001|Overall Study|Lost to Follow-up|15|||
48672362|NCT03688100|156651855|FG002|Overall Study|Lost to Follow-up|15|||
48672363|NCT03688100|156651856|FG003|Overall Study|Lost to Follow-up|18|||
48672364|NCT03688100|156651853|FG000|Overall Study|Withdrawal by Subject|19|||
48672365|NCT03688100|156651854|FG001|Overall Study|Withdrawal by Subject|16|||
48672366|NCT03688100|156651855|FG002|Overall Study|Withdrawal by Subject|0|||
48672367|NCT03688100|156651856|FG003|Overall Study|Withdrawal by Subject|0|||
48672368|NCT03688100|156651853|FG000|Overall Study|Death|36|||
48672369|NCT03688100|156651854|FG001|Overall Study|Death|27|||
48672370|NCT03688100|156651855|FG002|Overall Study|Death|0|||
48672371|NCT03688100|156651856|FG003|Overall Study|Death|0|||
48672372|NCT00094107|156651859|FG000|Overall Study|Lack of Efficacy|23|||
48672373|NCT00094107|156651859|FG000|Overall Study|Death|5|||
48672374|NCT00094107|156651859|FG000|Overall Study|Adverse Event|3|||
48672375|NCT00094107|156651859|FG000|Overall Study|Withdrawal due to Disease Progression|1|||
48672376|NCT00372697|156653483|FG000|Overall Study|Protocol Violation|1|||
48969948|NCT00109772|157719146|FG001|Open-label Extension|Adverse Event|19|||
48969949|NCT00109772|157719145|FG000|Open-label Extension|Lack of Efficacy|19|||
48672377|NCT00372697|156653484|FG001|Overall Study|Protocol Violation|1|||
48672378|NCT02271945|156653486|FG000|Overall Study|Death|3|||
48672379|NCT02271945|156653487|FG001|Overall Study|Death|3|||
48672380|NCT02271945|156653486|FG000|Overall Study|Withdrawal by Subject|1|||
48672381|NCT02271945|156653487|FG001|Overall Study|Withdrawal by Subject|1|||
48672382|NCT02271945|156653486|FG000|Overall Study|Other|1|||
48969950|NCT00109772|157719146|FG001|Open-label Extension|Lack of Efficacy|11|||
48672383|NCT02271945|156653487|FG001|Overall Study|Other|1|||
48672384|NCT00454181|156653489|FG000|Overall Study|Adverse Event|1|||
48672385|NCT00454181|156653490|FG001|Overall Study|Adverse Event|1|||
48672386|NCT00454181|156653489|FG000|Overall Study|Lost to Follow-up|11|||
48672387|NCT00454181|156653490|FG001|Overall Study|Lost to Follow-up|1|||
48672388|NCT00454181|156653489|FG000|Overall Study|Protocol Violation|1|||
48672389|NCT00454181|156653490|FG001|Overall Study|Protocol Violation|1|||
48672390|NCT00454181|156653489|FG000|Overall Study|Withdrawal by Subject|2|||
48672391|NCT00454181|156653490|FG001|Overall Study|Withdrawal by Subject|0|||
48672392|NCT00109577|156653491|FG000|Overall Study|Withdrawal by Subject|3|||
48672393|NCT00109577|156653492|FG001|Overall Study|Withdrawal by Subject|3|||
48672394|NCT01026220|156653493|FG000|Induction|Death|1|||
48672395|NCT01026220|156653494|FG001|Induction|Death|0|||
48672396|NCT01026220|156653495|FG002|Induction|Death|0|||
48672397|NCT01026220|156653493|FG000|Induction|Lack of Efficacy|2|||
48672398|NCT01026220|156653494|FG001|Induction|Lack of Efficacy|0|||
48672399|NCT01026220|156653495|FG002|Induction|Lack of Efficacy|0|||
48672400|NCT01026220|156653493|FG000|Induction|Physician Decision|12|||
48672401|NCT01026220|156653494|FG001|Induction|Physician Decision|0|||
48672402|NCT01026220|156653495|FG002|Induction|Physician Decision|0|||
48672403|NCT01026220|156653493|FG000|Induction|Withdrawal by Subject|9|||
48672404|NCT01026220|156653494|FG001|Induction|Withdrawal by Subject|0|||
48672405|NCT01026220|156653495|FG002|Induction|Withdrawal by Subject|0|||
48672406|NCT01026220|156653493|FG000|Induction|Ineligible|1|||
48672407|NCT01026220|156653494|FG001|Induction|Ineligible|0|||
48672408|NCT01026220|156653495|FG002|Induction|Ineligible|0|||
48672409|NCT01026220|156653493|FG000|Consolidation Maintenance|Death|0|||
48672410|NCT01026220|156653494|FG001|Consolidation Maintenance|Death|1|||
48672411|NCT01026220|156653495|FG002|Consolidation Maintenance|Death|0|||
48672412|NCT01026220|156653493|FG000|Consolidation Maintenance|Lack of Efficacy|0|||
48672413|NCT01026220|156653494|FG001|Consolidation Maintenance|Lack of Efficacy|1|||
48672414|NCT01026220|156653495|FG002|Consolidation Maintenance|Lack of Efficacy|1|||
48672415|NCT01026220|156653493|FG000|Consolidation Maintenance|Physician Decision|0|||
48672416|NCT01026220|156653494|FG001|Consolidation Maintenance|Physician Decision|2|||
48672417|NCT01026220|156653495|FG002|Consolidation Maintenance|Physician Decision|7|||
48672418|NCT01026220|156653493|FG000|Consolidation Maintenance|Withdrawal by Subject|0|||
48672419|NCT01026220|156653494|FG001|Consolidation Maintenance|Withdrawal by Subject|2|||
48672420|NCT01026220|156653495|FG002|Consolidation Maintenance|Withdrawal by Subject|6|||
48672421|NCT00521222|156653497|FG000|Overall Study|Lost to Follow-up|0|||
48672422|NCT00521222|156653498|FG001|Overall Study|Lost to Follow-up|0|||
48672423|NCT00521222|156653499|FG002|Overall Study|Lost to Follow-up|1|||
48672424|NCT00521222|156653500|FG003|Overall Study|Lost to Follow-up|1|||
48672425|NCT00521222|156653497|FG000|Overall Study|Withdrawal by Subject|0|||
48672426|NCT00521222|156653498|FG001|Overall Study|Withdrawal by Subject|0|||
48672427|NCT00521222|156653499|FG002|Overall Study|Withdrawal by Subject|2|||
48672428|NCT00521222|156653500|FG003|Overall Study|Withdrawal by Subject|0|||
48672429|NCT00521222|156653497|FG000|Overall Study|Physician Decision|0|||
48672430|NCT00521222|156653498|FG001|Overall Study|Physician Decision|1|||
48672431|NCT00521222|156653499|FG002|Overall Study|Physician Decision|0|||
48672432|NCT00521222|156653500|FG003|Overall Study|Physician Decision|1|||
48672433|NCT02879578|156653508|FG000|Overall Study|Adverse Event|1|||
48672434|NCT02879578|156653509|FG001|Overall Study|Adverse Event|2|||
48672435|NCT02879578|156653510|FG002|Overall Study|Adverse Event|14|||
48672436|NCT02879578|156653508|FG000|Overall Study|Protocol Violation|0|||
48672437|NCT02879578|156653509|FG001|Overall Study|Protocol Violation|1|||
48672438|NCT02879578|156653510|FG002|Overall Study|Protocol Violation|1|||
48969951|NCT00109772|157719145|FG000|Open-label Extension|Withdrawal by Subject|9|||
48969952|NCT00109772|157719146|FG001|Open-label Extension|Withdrawal by Subject|6|||
48969953|NCT00109772|157719145|FG000|Open-label Extension|Lost to Follow-up|1|||
48969954|NCT00109772|157719146|FG001|Open-label Extension|Lost to Follow-up|0|||
48969955|NCT00109772|157719145|FG000|Open-label Extension|Death|0|||
48969956|NCT00109772|157719146|FG001|Open-label Extension|Death|1|||
48969957|NCT00109772|157719145|FG000|Open-label Extension|Protocol Violation|2|||
48969958|NCT00109772|157719146|FG001|Open-label Extension|Protocol Violation|2|||
48672439|NCT02879578|156653508|FG000|Overall Study|Withdrawal by Subject|8|||
48672440|NCT02879578|156653509|FG001|Overall Study|Withdrawal by Subject|6|||
48672441|NCT02879578|156653510|FG002|Overall Study|Withdrawal by Subject|9|||
48672442|NCT02879578|156653508|FG000|Overall Study|Lost to Follow-up|1|||
48672443|NCT02879578|156653509|FG001|Overall Study|Lost to Follow-up|0|||
48672444|NCT02879578|156653510|FG002|Overall Study|Lost to Follow-up|4|||
48672445|NCT02879578|156653508|FG000|Overall Study|Physician Decision|0|||
48969959|NCT00109772|157719145|FG000|Open-label Extension|Other|4|||
48969960|NCT00109772|157719146|FG001|Open-label Extension|Other|10|||
48969961|NCT01989754|157719147|FG000|Overall Study|Withdrawal by Subject|10|||
48672446|NCT02879578|156653509|FG001|Overall Study|Physician Decision|0|||
48672447|NCT02879578|156653510|FG002|Overall Study|Physician Decision|4|||
48672448|NCT01183468|156653511|FG000|Overall Study|Lost to Follow-up|2|||
48672449|NCT01183468|156653512|FG001|Overall Study|Lost to Follow-up|1|||
48672450|NCT01183468|156653513|FG002|Overall Study|Lost to Follow-up|0|||
48672451|NCT01183468|156653514|FG003|Overall Study|Lost to Follow-up|0|||
48969962|NCT01989754|157719148|FG001|Overall Study|Withdrawal by Subject|14|||
48969963|NCT01989754|157719147|FG000|Overall Study|Lost to Follow-up|28|||
48969964|NCT01989754|157719148|FG001|Overall Study|Lost to Follow-up|20|||
48969965|NCT01989754|157719147|FG000|Overall Study|Closed Site|1|||
48969966|NCT01989754|157719148|FG001|Overall Study|Closed Site|1|||
48969967|NCT01306032|157719150|FG000|First Intervention|Adverse Event|1|||
48969968|NCT01306032|157719151|FG001|First Intervention|Adverse Event|0|||
48969969|NCT01306032|157719152|FG002|First Intervention|Adverse Event|1|||
48969970|NCT01306032|157719153|FG003|First Intervention|Adverse Event|0|||
48969971|NCT01306032|157719154|FG004|First Intervention|Adverse Event|0|||
48969972|NCT01306032|157719155|FG005|First Intervention|Adverse Event|1|||
48969973|NCT01306032|157719150|FG000|First Intervention|Withdrawal by Subject|0|||
48969974|NCT01306032|157719151|FG001|First Intervention|Withdrawal by Subject|2|||
48969975|NCT01306032|157719152|FG002|First Intervention|Withdrawal by Subject|0|||
48672452|NCT01183468|156653511|FG000|Overall Study|Physician Decision|1|||
48672453|NCT01183468|156653512|FG001|Overall Study|Physician Decision|0|||
48760774|NCT03318315|156972317|FG000|Overall Study|Withdrawal by Subject|0|||
48760775|NCT03318315|156972318|FG001|Overall Study|Withdrawal by Subject|0|||
48760776|NCT03318315|156972319|FG002|Overall Study|Withdrawal by Subject|2|||
48760777|NCT02968563|156972320|FG000|Overall Study|Adverse Event|0|||
48760778|NCT02968563|156972321|FG001|Overall Study|Adverse Event|6|||
48760779|NCT02968563|156972320|FG000|Overall Study|Death|1|||
48672454|NCT01183468|156653513|FG002|Overall Study|Physician Decision|0|||
48672455|NCT01183468|156653514|FG003|Overall Study|Physician Decision|0|||
48672456|NCT01183468|156653511|FG000|Overall Study|Withdrawal by Subject|0|||
48672457|NCT01183468|156653512|FG001|Overall Study|Withdrawal by Subject|1|||
48672458|NCT01183468|156653513|FG002|Overall Study|Withdrawal by Subject|0|||
48672459|NCT01183468|156653514|FG003|Overall Study|Withdrawal by Subject|0|||
48672460|NCT00671437|156653515|FG000|Overall Study|Progressive disease before C1 week 8|8|||
48672461|NCT00671437|156653515|FG000|Overall Study|Cutaneous SCC of head and neck|3|||
48672462|NCT00671437|156653515|FG000|Overall Study|Adverse Event|3|||
48760780|NCT02968563|156972321|FG001|Overall Study|Death|1|||
48872184|NCT02507687|157369693|FG002|Overall Study|Other, Not Specified|2|||
48872185|NCT02507687|157369694|FG003|Overall Study|Other, Not Specified|4|||
48872186|NCT00853372|157369695|FG000|Overall Study|Death|30|||
48872187|NCT00853372|157369696|FG001|Overall Study|Death|26|||
48872188|NCT00853372|157369695|FG000|Overall Study|Lost to Follow-up|1|||
48872189|NCT00853372|157369696|FG001|Overall Study|Lost to Follow-up|2|||
48872190|NCT00853372|157369695|FG000|Overall Study|Full Consent Withdrawn|1|||
48872191|NCT00853372|157369696|FG001|Overall Study|Full Consent Withdrawn|1|||
48872192|NCT01821729|157369697|FG000|Overall Study|Withdrawal by Subject|1|||
48872193|NCT02916706|157369699|FG000|Overall Study|Adverse Event|0|||
48872194|NCT02916706|157369700|FG001|Overall Study|Adverse Event|1|||
48872195|NCT02916706|157369699|FG000|Overall Study|Lost to Follow-up|0|||
48872196|NCT02916706|157369700|FG001|Overall Study|Lost to Follow-up|1|||
48872197|NCT02916706|157369699|FG000|Overall Study|Physician Decision|1|||
48872198|NCT02916706|157369700|FG001|Overall Study|Physician Decision|0|||
48872199|NCT02916706|157369699|FG000|Overall Study|Protocol Violation|3|||
48872200|NCT02916706|157369700|FG001|Overall Study|Protocol Violation|1|||
48872201|NCT02916706|157369699|FG000|Overall Study|Withdrawal by Subject|6|||
48872202|NCT02916706|157369700|FG001|Overall Study|Withdrawal by Subject|9|||
48872203|NCT02916706|157369699|FG000|Overall Study|Other|5|||
48872204|NCT02916706|157369700|FG001|Overall Study|Other|19|||
48872205|NCT01093599|157369701|FG000|Overall Study|Lost to Follow-up|32|||
48872206|NCT01093599|157369702|FG001|Overall Study|Lost to Follow-up|46|||
48872207|NCT03296566|157369703|FG000|Overall Study|Lost to Follow-up|19|||
48872208|NCT03296566|157369704|FG001|Overall Study|Lost to Follow-up|46|||
48872209|NCT03296566|157369703|FG000|Overall Study|Withdrawal by Subject|0|||
48872210|NCT03296566|157369704|FG001|Overall Study|Withdrawal by Subject|3|||
48672463|NCT00671437|156653515|FG000|Overall Study|Ineligible post-hoc|1|||
48672464|NCT01440881|156653516|FG000|Overall Study|Death|0|||
48760781|NCT02968563|156972320|FG000|Overall Study|Lost to Follow-up|0|||
48760782|NCT02968563|156972321|FG001|Overall Study|Lost to Follow-up|1|||
48760783|NCT02369341|156972322|FG000|Overall Study|Migrated/moved from study area|1|||
48760784|NCT02369341|156972323|FG001|Overall Study|Migrated/moved from study area|0|||
48760785|NCT01996826|156972324|FG000|Overall Study|Lost to Follow-up|6|||
48760786|NCT01996826|156972325|FG001|Overall Study|Lost to Follow-up|2|||
48872211|NCT00487552|157369707|FG000|Overall Study|Unsuccessful magnet placements|3|||
48672465|NCT01440881|156653517|FG001|Overall Study|Death|1|||
48760787|NCT01996826|156972324|FG000|Overall Study|Physician Decision|1|||
48760788|NCT01996826|156972325|FG001|Overall Study|Physician Decision|1|||
48872212|NCT00487552|157369707|FG000|Overall Study|Death due to progressive malignancy|2|||
48672466|NCT03927404|156653518|FG000|Overall Study|Withdrawal by Subject|1|||
48872213|NCT00487552|157369707|FG000|Overall Study|Stent not placed|1|||
48872214|NCT02412111|157369708|FG000|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1|||
48872215|NCT02412111|157369709|FG001|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
48969976|NCT01306032|157719153|FG003|First Intervention|Withdrawal by Subject|1|||
48872216|NCT02412111|157369710|FG002|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
48969977|NCT01306032|157719154|FG004|First Intervention|Withdrawal by Subject|0|||
48672467|NCT04311463|156653519|FG000|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
48672468|NCT04311463|156653520|FG001|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|0|||
48672469|NCT04311463|156653519|FG000|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
48969978|NCT01306032|157719155|FG005|First Intervention|Withdrawal by Subject|0|||
48969979|NCT01306032|157719150|FG000|First Intervention|Death|0|||
48969980|NCT01306032|157719151|FG001|First Intervention|Death|0|||
48969981|NCT01306032|157719152|FG002|First Intervention|Death|1|||
48969982|NCT01306032|157719153|FG003|First Intervention|Death|0|||
48969983|NCT01306032|157719154|FG004|First Intervention|Death|0|||
48969984|NCT01306032|157719155|FG005|First Intervention|Death|0|||
48969985|NCT01306032|157719150|FG000|First Intervention|Ineligible|0|||
48969986|NCT01306032|157719151|FG001|First Intervention|Ineligible|0|||
48969987|NCT01306032|157719152|FG002|First Intervention|Ineligible|0|||
48969988|NCT01306032|157719153|FG003|First Intervention|Ineligible|0|||
48969989|NCT01306032|157719154|FG004|First Intervention|Ineligible|0|||
48969990|NCT01306032|157719155|FG005|First Intervention|Ineligible|1|||
48969991|NCT01306032|157719150|FG000|First Intervention|Progressive disease|0|||
48969992|NCT01306032|157719151|FG001|First Intervention|Progressive disease|0|||
48969993|NCT01306032|157719152|FG002|First Intervention|Progressive disease|0|||
48969994|NCT01306032|157719153|FG003|First Intervention|Progressive disease|0|||
48969995|NCT01306032|157719154|FG004|First Intervention|Progressive disease|2|||
48969996|NCT01306032|157719155|FG005|First Intervention|Progressive disease|0|||
48969997|NCT01306032|157719150|FG000|Disease Progression/Crossover|Withdrawal by Subject|0|||
48969998|NCT01306032|157719151|FG001|Disease Progression/Crossover|Withdrawal by Subject|0|||
48969999|NCT01306032|157719152|FG002|Disease Progression/Crossover|Withdrawal by Subject|0|||
48970000|NCT01306032|157719153|FG003|Disease Progression/Crossover|Withdrawal by Subject|1|||
48970001|NCT01306032|157719154|FG004|Disease Progression/Crossover|Withdrawal by Subject|0|||
48970002|NCT01306032|157719155|FG005|Disease Progression/Crossover|Withdrawal by Subject|0|||
48970003|NCT01306032|157719150|FG000|Disease Progression/Crossover|other/symptomatic progression|0|||
48970004|NCT01306032|157719151|FG001|Disease Progression/Crossover|other/symptomatic progression|2|||
48970005|NCT01306032|157719152|FG002|Disease Progression/Crossover|other/symptomatic progression|0|||
48970006|NCT01306032|157719153|FG003|Disease Progression/Crossover|other/symptomatic progression|2|||
48672470|NCT04311463|156653520|FG001|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
48672471|NCT04311463|156653519|FG000|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|2|||
48672472|NCT04311463|156653520|FG001|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
48672473|NCT01229449|156653523|FG000|Overall Study|Withdrawal by Subject|0|||
48672474|NCT01229449|156653524|FG001|Overall Study|Withdrawal by Subject|3|||
48672475|NCT01229449|156653525|FG002|Overall Study|Withdrawal by Subject|0|||
48672476|NCT01229449|156653526|FG003|Overall Study|Withdrawal by Subject|1|||
48672477|NCT01229449|156653527|FG004|Overall Study|Withdrawal by Subject|1|||
48672478|NCT01229449|156653523|FG000|Overall Study|Lost to Follow-up|1|||
48672479|NCT01229449|156653524|FG001|Overall Study|Lost to Follow-up|1|||
48970007|NCT01306032|157719154|FG004|Disease Progression/Crossover|other/symptomatic progression|0|||
48970008|NCT01306032|157719155|FG005|Disease Progression/Crossover|other/symptomatic progression|0|||
48970009|NCT05441540|157719156|FG000|Overall Study|Withdrawal by Subject|2|||
48970010|NCT00168064|157719157|FG000|Overall Study|Adverse Event|26|||
48672480|NCT01229449|156653525|FG002|Overall Study|Lost to Follow-up|1|||
48672481|NCT01229449|156653526|FG003|Overall Study|Lost to Follow-up|0|||
48672482|NCT01229449|156653527|FG004|Overall Study|Lost to Follow-up|0|||
48672483|NCT01229449|156653523|FG000|Overall Study|Physician Decision|0|||
48672484|NCT01229449|156653524|FG001|Overall Study|Physician Decision|0|||
48672485|NCT01229449|156653525|FG002|Overall Study|Physician Decision|1|||
48672486|NCT01229449|156653526|FG003|Overall Study|Physician Decision|0|||
48672487|NCT01229449|156653527|FG004|Overall Study|Physician Decision|0|||
48672488|NCT00737633|156653528|FG000|Overall Study|Study terminated by sponsor|44|||
48672489|NCT00737633|156653529|FG001|Overall Study|Study terminated by sponsor|55|||
48672490|NCT00737633|156653528|FG000|Overall Study|Lost to Follow-up|0|||
48672491|NCT00737633|156653529|FG001|Overall Study|Lost to Follow-up|1|||
48760789|NCT03164928|156972328|FG000|Overall Study|Lost to Follow-up|1|||
48760790|NCT03164928|156972329|FG001|Overall Study|Lost to Follow-up|0|||
48760791|NCT02092662|156972332|FG000|Overall Study|Lost to Follow-up|13|||
48760792|NCT02092662|156972333|FG001|Overall Study|Lost to Follow-up|0|||
48970011|NCT00168064|157719158|FG001|Overall Study|Adverse Event|22|||
48970012|NCT00168064|157719157|FG000|Overall Study|Withdrawal by Subject|3|||
48970013|NCT00168064|157719158|FG001|Overall Study|Withdrawal by Subject|4|||
48760793|NCT02532647|156972334|FG000|Overall Study|Did not receive trial medication|1|||
48970014|NCT00168064|157719157|FG000|Overall Study|Lack of Efficacy|4|||
48970015|NCT00168064|157719158|FG001|Overall Study|Lack of Efficacy|4|||
48970016|NCT00168064|157719157|FG000|Overall Study|Lost to Follow-up|4|||
48970017|NCT00168064|157719158|FG001|Overall Study|Lost to Follow-up|3|||
48970018|NCT00168064|157719157|FG000|Overall Study|Non-compliance|2|||
48970019|NCT00168064|157719158|FG001|Overall Study|Non-compliance|3|||
48970020|NCT00168064|157719157|FG000|Overall Study|Concurrent Illness|4|||
48970021|NCT00168064|157719158|FG001|Overall Study|Concurrent Illness|3|||
48672492|NCT00737633|156653528|FG000|Overall Study|protocol non-compliance|0|||
48672493|NCT00737633|156653529|FG001|Overall Study|protocol non-compliance|1|||
48672494|NCT01147848|156653530|FG000|Run-in Period|Screen Failure|623|||
48672495|NCT01147848|156653531|FG001|Run-in Period|Screen Failure|0|||
48672496|NCT01147848|156653532|FG002|Run-in Period|Screen Failure|0|||
48672497|NCT01147848|156653530|FG000|Run-in Period|Run-in Failure|135|||
48672498|NCT01147848|156653531|FG001|Run-in Period|Run-in Failure|0|||
48672499|NCT01147848|156653532|FG002|Run-in Period|Run-in Failure|0|||
48970022|NCT00168064|157719157|FG000|Overall Study|Subject's Best interest|2|||
48970023|NCT00168064|157719158|FG001|Overall Study|Subject's Best interest|2|||
48970024|NCT00168064|157719157|FG000|Overall Study|Various|4|||
48970025|NCT00168064|157719158|FG001|Overall Study|Various|3|||
48970026|NCT00830804|157719161|FG000|Overall Study|Lost to Follow-up|4|||
48970027|NCT00830804|157719161|FG000|Overall Study|Death|1|||
48970028|NCT00830804|157719161|FG000|Overall Study|Unable to get to clinic|7|||
48970029|NCT00830804|157719161|FG000|Overall Study|Consent withdrawn|2|||
48970030|NCT00830804|157719161|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
48970031|NCT01357889|157719162|FG000|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2|||
48970032|NCT01357889|157719163|FG001|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1|||
48970033|NCT01357889|157719162|FG000|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
48970034|NCT01357889|157719163|FG001|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
48970035|NCT01357889|157719162|FG000|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1|||
48970036|NCT01357889|157719163|FG001|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0|||
48970037|NCT01357889|157719162|FG000|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
48970038|NCT01357889|157719163|FG001|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
48970039|NCT01357889|157719162|FG000|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0|||
48970040|NCT01357889|157719163|FG001|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2|||
48970041|NCT01357889|157719162|FG000|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0|||
48970042|NCT01357889|157719163|FG001|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2|||
48970043|NCT01357889|157719162|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5|||
48970044|NCT01357889|157719163|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2|||
48970045|NCT01357889|157719162|FG000|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2|||
48970046|NCT01357889|157719163|FG001|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1|||
48970047|NCT01357889|157719162|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
48970048|NCT01357889|157719163|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
48970049|NCT01357889|157719162|FG000|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1|||
48970050|NCT01357889|157719163|FG001|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0|||
48970051|NCT01357889|157719162|FG000|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0|||
48970052|NCT01357889|157719163|FG001|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4|||
48970053|NCT01357889|157719162|FG000|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1|||
48970054|NCT01357889|157719163|FG001|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0|||
48970055|NCT01357889|157719162|FG000|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1|||
48970056|NCT01357889|157719163|FG001|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0|||
48970057|NCT04685499|157719164|FG000|Overall Study|Study Terminated Early|1|||
48970058|NCT03332303|157719165|FG000|Overall Study|Participant did not dose|1|||
48970059|NCT03332303|157719166|FG001|Overall Study|Participant did not dose|2|||
48970060|NCT03332303|157719167|FG002|Overall Study|Participant did not dose|0|||
48970061|NCT03332303|157719165|FG000|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
48970062|NCT03332303|157719166|FG001|Overall Study|Participant did not have at least one post-randomization evaluation|1|||
48970063|NCT03332303|157719167|FG002|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
48970064|NCT03332303|157719165|FG000|Overall Study|Participant developed concurrent vaginal infection/illness|4|||
48970065|NCT03332303|157719166|FG001|Overall Study|Participant developed concurrent vaginal infection/illness|1|||
48970066|NCT03332303|157719167|FG002|Overall Study|Participant developed concurrent vaginal infection/illness|0|||
48970067|NCT03332303|157719165|FG000|Overall Study|Participant did not administer 75-125% of intended dose|0|||
48970068|NCT03332303|157719166|FG001|Overall Study|Participant did not administer 75-125% of intended dose|3|||
48970069|NCT03332303|157719167|FG002|Overall Study|Participant did not administer 75-125% of intended dose|0|||
48970070|NCT03332303|157719165|FG000|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
48672500|NCT01147848|156653530|FG000|Randomized Phase|Adverse Event|0|||
48672501|NCT01147848|156653531|FG001|Randomized Phase|Adverse Event|6|||
48672502|NCT01147848|156653532|FG002|Randomized Phase|Adverse Event|8|||
48672503|NCT01147848|156653530|FG000|Randomized Phase|Lack of Efficacy|0|||
48970071|NCT03332303|157719166|FG001|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
48970072|NCT03332303|157719167|FG002|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|3|||
48970073|NCT03332303|157719165|FG000|Overall Study|Participant did not meet all inclusion/exclusion criteria|4|||
48970074|NCT03332303|157719166|FG001|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
48672504|NCT01147848|156653531|FG001|Randomized Phase|Lack of Efficacy|20|||
48672505|NCT01147848|156653532|FG002|Randomized Phase|Lack of Efficacy|11|||
48672506|NCT01147848|156653530|FG000|Randomized Phase|Protocol Violation|0|||
48872217|NCT02412111|157369708|FG000|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2|||
48872218|NCT02412111|157369709|FG001|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
48872219|NCT02412111|157369710|FG002|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
48872220|NCT02412111|157369708|FG000|Active Comparator Period (8 Weeks)|Adverse Event|0|||
48872221|NCT02412111|157369709|FG001|Active Comparator Period (8 Weeks)|Adverse Event|0|||
48872222|NCT02412111|157369710|FG002|Active Comparator Period (8 Weeks)|Adverse Event|2|||
48872223|NCT02412111|157369708|FG000|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
48872224|NCT02412111|157369709|FG001|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
48872225|NCT02412111|157369710|FG002|Active Comparator Period (8 Weeks)|Participants refused further dosing|1|||
48872226|NCT02412111|157369708|FG000|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
48872227|NCT02412111|157369709|FG001|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
48672507|NCT01147848|156653531|FG001|Randomized Phase|Protocol Violation|7|||
48672508|NCT01147848|156653532|FG002|Randomized Phase|Protocol Violation|10|||
48672509|NCT01147848|156653530|FG000|Randomized Phase|Lost to Follow-up|0|||
48672510|NCT01147848|156653531|FG001|Randomized Phase|Lost to Follow-up|5|||
48672511|NCT01147848|156653532|FG002|Randomized Phase|Lost to Follow-up|7|||
48672512|NCT01147848|156653530|FG000|Randomized Phase|Physician Decision|0|||
48872228|NCT02412111|157369710|FG002|Active Comparator Period (8 Weeks)|Lost to Follow-up|1|||
48872229|NCT02412111|157369708|FG000|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
48872230|NCT02412111|157369709|FG001|Active Comparator Period (8 Weeks)|Other non-compliance|1|||
48872231|NCT02412111|157369710|FG002|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
48872232|NCT02412111|157369708|FG000|Active Comparator Period (8 Weeks)|Other|0|||
48872233|NCT02412111|157369709|FG001|Active Comparator Period (8 Weeks)|Other|0|||
48872234|NCT02412111|157369710|FG002|Active Comparator Period (8 Weeks)|Other|2|||
48872235|NCT00630552|157369711|FG000|Overall Study|Adverse Event|0|||
48672513|NCT01147848|156653531|FG001|Randomized Phase|Physician Decision|0|||
48672514|NCT01147848|156653532|FG002|Randomized Phase|Physician Decision|1|||
48672515|NCT01147848|156653530|FG000|Randomized Phase|Withdrawal by Subject|0|||
48672516|NCT01147848|156653531|FG001|Randomized Phase|Withdrawal by Subject|7|||
48672517|NCT01147848|156653532|FG002|Randomized Phase|Withdrawal by Subject|9|||
48872236|NCT00630552|157369712|FG001|Overall Study|Adverse Event|1|||
48872237|NCT00630552|157369713|FG002|Overall Study|Adverse Event|5|||
48872238|NCT00630552|157369714|FG003|Overall Study|Adverse Event|4|||
48872239|NCT00630552|157369715|FG004|Overall Study|Adverse Event|2|||
48872240|NCT00630552|157369711|FG000|Overall Study|Disease progression|5|||
48872241|NCT00630552|157369712|FG001|Overall Study|Disease progression|6|||
48872242|NCT00630552|157369713|FG002|Overall Study|Disease progression|27|||
48872243|NCT00630552|157369714|FG003|Overall Study|Disease progression|22|||
48872244|NCT00630552|157369715|FG004|Overall Study|Disease progression|31|||
48872245|NCT00630552|157369711|FG000|Overall Study|Never received IP|0|||
48872246|NCT00630552|157369712|FG001|Overall Study|Never received IP|0|||
48872247|NCT00630552|157369713|FG002|Overall Study|Never received IP|0|||
48872248|NCT00630552|157369714|FG003|Overall Study|Never received IP|2|||
48872249|NCT00630552|157369715|FG004|Overall Study|Never received IP|2|||
48872250|NCT00630552|157369711|FG000|Overall Study|Ineligibility determined|0|||
48872251|NCT00630552|157369712|FG001|Overall Study|Ineligibility determined|0|||
48872252|NCT00630552|157369713|FG002|Overall Study|Ineligibility determined|0|||
48872253|NCT00630552|157369714|FG003|Overall Study|Ineligibility determined|0|||
48872254|NCT00630552|157369715|FG004|Overall Study|Ineligibility determined|1|||
48872255|NCT00630552|157369711|FG000|Overall Study|Protocol Violation|0|||
48872256|NCT00630552|157369712|FG001|Overall Study|Protocol Violation|0|||
48872257|NCT00630552|157369713|FG002|Overall Study|Protocol Violation|0|||
48872258|NCT00630552|157369714|FG003|Overall Study|Protocol Violation|1|||
48872259|NCT00630552|157369715|FG004|Overall Study|Protocol Violation|0|||
48872260|NCT00630552|157369711|FG000|Overall Study|Physician Decision|0|||
48872261|NCT00630552|157369712|FG001|Overall Study|Physician Decision|0|||
48872262|NCT00630552|157369713|FG002|Overall Study|Physician Decision|0|||
48872263|NCT00630552|157369714|FG003|Overall Study|Physician Decision|0|||
48872264|NCT00630552|157369715|FG004|Overall Study|Physician Decision|1|||
48872265|NCT00630552|157369711|FG000|Overall Study|Death|0|||
48872266|NCT00630552|157369712|FG001|Overall Study|Death|0|||
48872267|NCT00630552|157369713|FG002|Overall Study|Death|1|||
48872268|NCT00630552|157369714|FG003|Overall Study|Death|2|||
48872269|NCT00630552|157369715|FG004|Overall Study|Death|2|||
48872270|NCT00630552|157369711|FG000|Overall Study|Withdrawal by Subject|0|||
48672518|NCT02986854|156653535|FG000|Overall Study|Withdrawal by Subject|0|||
48672519|NCT02986854|156653536|FG001|Overall Study|Withdrawal by Subject|1|||
48872271|NCT00630552|157369712|FG001|Overall Study|Withdrawal by Subject|0|||
48872272|NCT00630552|157369713|FG002|Overall Study|Withdrawal by Subject|0|||
48872273|NCT00630552|157369714|FG003|Overall Study|Withdrawal by Subject|1|||
48872274|NCT00630552|157369715|FG004|Overall Study|Withdrawal by Subject|0|||
48872275|NCT00630552|157369711|FG000|Overall Study|Other|0|||
48872276|NCT00630552|157369712|FG001|Overall Study|Other|0|||
48672520|NCT02986854|156653537|FG002|Overall Study|Withdrawal by Subject|1|||
48672521|NCT02986854|156653535|FG000|Overall Study|Lost to Follow-up|3|||
48672522|NCT02986854|156653536|FG001|Overall Study|Lost to Follow-up|11|||
48970075|NCT03332303|157719167|FG002|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
48970076|NCT03332303|157719165|FG000|Overall Study|Participant had a significant protocol deviation|0|||
48970077|NCT03332303|157719166|FG001|Overall Study|Participant had a significant protocol deviation|1|||
48970078|NCT03332303|157719167|FG002|Overall Study|Participant had a significant protocol deviation|0|||
48970079|NCT01688635|157719175|FG000|Washout 1|Withdrawal by Subject|1|||
48672523|NCT02986854|156653537|FG002|Overall Study|Lost to Follow-up|2|||
48672524|NCT02014584|156653538|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
48672525|NCT02014584|156653539|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
48672526|NCT02014584|156653540|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
48672527|NCT02014584|156653541|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
48672528|NCT02014584|156653542|FG004|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
48672529|NCT02014584|156653543|FG005|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
48672530|NCT02014584|156653538|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2|||
48672531|NCT02014584|156653539|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5|||
48672532|NCT02014584|156653540|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
48672533|NCT02014584|156653541|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
48672534|NCT02014584|156653542|FG004|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
48672535|NCT02014584|156653543|FG005|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
48672536|NCT02014584|156653538|FG000|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
48672537|NCT02014584|156653539|FG001|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
48672538|NCT02014584|156653540|FG002|Open-Label Period (24 Weeks)|Lost to Follow-up|2|||
48672539|NCT02014584|156653541|FG003|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
48672540|NCT02014584|156653542|FG004|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
48672541|NCT02014584|156653543|FG005|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
48672542|NCT02014584|156653538|FG000|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
48672543|NCT02014584|156653539|FG001|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
48672544|NCT02014584|156653540|FG002|Open-Label Period (24 Weeks)|Withdrawal by Subject|3|||
48672545|NCT02014584|156653541|FG003|Open-Label Period (24 Weeks)|Withdrawal by Subject|1|||
48672546|NCT02014584|156653542|FG004|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
48672547|NCT02014584|156653543|FG005|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
48672548|NCT02014584|156653538|FG000|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
48672549|NCT02014584|156653539|FG001|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
48672550|NCT02014584|156653540|FG002|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
48672551|NCT02014584|156653541|FG003|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
48672552|NCT02014584|156653542|FG004|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1|||
48672553|NCT02014584|156653543|FG005|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
48672554|NCT00666965|156653545|FG000|Overall Study|Adverse Event|0|||
48970080|NCT01688635|157719176|FG001|Washout 1|Withdrawal by Subject|0|||
48970081|NCT01688635|157719175|FG000|Washout 1|Adverse Event|0|||
48672555|NCT00666965|156653546|FG001|Overall Study|Adverse Event|2|||
48672556|NCT00666965|156653547|FG002|Overall Study|Adverse Event|1|||
48672557|NCT00666965|156653548|FG003|Overall Study|Adverse Event|9|||
48672558|NCT00666965|156653545|FG000|Overall Study|Lack of Efficacy|1|||
48672559|NCT00666965|156653546|FG001|Overall Study|Lack of Efficacy|1|||
48672560|NCT00666965|156653547|FG002|Overall Study|Lack of Efficacy|0|||
48970082|NCT01688635|157719176|FG001|Washout 1|Adverse Event|1|||
48970083|NCT01688635|157719175|FG000|Washout 1|Physician Decision|0|||
48672561|NCT00666965|156653548|FG003|Overall Study|Lack of Efficacy|0|||
48672562|NCT00666965|156653545|FG000|Overall Study|Protocol Violation|0|||
48760794|NCT02532647|156972335|FG001|Overall Study|Did not receive trial medication|0|||
48760795|NCT02532647|156972336|FG002|Overall Study|Did not receive trial medication|1|||
48760796|NCT00536107|156972337|FG000|Overall Study|Death|5|||
48760797|NCT00536107|156972338|FG001|Overall Study|Death|1|||
48760798|NCT00536107|156972337|FG000|Overall Study|Incorrect enrolment|1|||
48760799|NCT00536107|156972338|FG001|Overall Study|Incorrect enrolment|0|||
48760800|NCT00536107|156972337|FG000|Overall Study|Withdrawal by Subject|0|||
48760801|NCT00536107|156972338|FG001|Overall Study|Withdrawal by Subject|1|||
48760802|NCT00536107|156972337|FG000|Overall Study|Study Termination|2|||
48760803|NCT00536107|156972338|FG001|Overall Study|Study Termination|4|||
48760804|NCT03897179|156972339|FG000|Overall Study|Withdrawal by Subject|1|||
48760805|NCT01480076|156972340|FG000|Overall Study|Run-in Failure|52|||
48760806|NCT01480076|156972340|FG000|Overall Study|Adverse Event|39|||
48760807|NCT01480076|156972340|FG000|Overall Study|Death|2|||
48970084|NCT01688635|157719176|FG001|Washout 1|Physician Decision|1|||
48672563|NCT00666965|156653546|FG001|Overall Study|Protocol Violation|0|||
48672564|NCT00666965|156653547|FG002|Overall Study|Protocol Violation|0|||
48672565|NCT00666965|156653548|FG003|Overall Study|Protocol Violation|2|||
48672566|NCT00666965|156653545|FG000|Overall Study|Discontinuation criteria|2|||
48672567|NCT00666965|156653546|FG001|Overall Study|Discontinuation criteria|1|||
48672568|NCT00666965|156653547|FG002|Overall Study|Discontinuation criteria|1|||
48760808|NCT01480076|156972340|FG000|Overall Study|Disease Progression|5|||
48970085|NCT01688635|157719175|FG000|Washout 2|Physician Decision|1|||
48970086|NCT01688635|157719176|FG001|Washout 2|Physician Decision|0|||
48970087|NCT01688635|157719175|FG000|Washout 2|Withdrawal by Subject|1|||
48970088|NCT01688635|157719176|FG001|Washout 2|Withdrawal by Subject|0|||
48970089|NCT01688635|157719175|FG000|Washout 2|Sponsor Decision|1|||
48970090|NCT01688635|157719176|FG001|Washout 2|Sponsor Decision|2|||
48970091|NCT01688635|157719175|FG000|Washout 3|Withdrawal by Subject|1|||
48970092|NCT01688635|157719176|FG001|Washout 3|Withdrawal by Subject|0|||
48970093|NCT01181778|157719178|FG000|Overall Study|Physician Decision|48|||
48970094|NCT01602549|157719179|FG000|Overall Study|Protocol Violation|0|||
48970095|NCT01602549|157719180|FG001|Overall Study|Protocol Violation|1|||
48970096|NCT01602549|157719179|FG000|Overall Study|Withdrawal by Subject|1|||
48970097|NCT01602549|157719180|FG001|Overall Study|Withdrawal by Subject|0|||
48970098|NCT01601470|157719181|FG000|Period 2 - LCZ696|Physician Decision|1|||
48970099|NCT02661464|157719182|FG000|Overall Study|Lost to Follow-up|28|||
48970100|NCT02661464|157719183|FG001|Overall Study|Lost to Follow-up|0|||
48970101|NCT02661464|157719184|FG002|Overall Study|Lost to Follow-up|0|||
48970102|NCT02661464|157719185|FG003|Overall Study|Lost to Follow-up|0|||
48970103|NCT02661464|157719182|FG000|Overall Study|Withdrawal by Subject|3|||
48970104|NCT02661464|157719183|FG001|Overall Study|Withdrawal by Subject|1|||
48970105|NCT02661464|157719184|FG002|Overall Study|Withdrawal by Subject|0|||
48970106|NCT02661464|157719185|FG003|Overall Study|Withdrawal by Subject|0|||
48970107|NCT02661464|157719182|FG000|Overall Study|Participants terminated prematurely|288|||
48970108|NCT02661464|157719183|FG001|Overall Study|Participants terminated prematurely|52|||
48970109|NCT02661464|157719184|FG002|Overall Study|Participants terminated prematurely|1|||
48970110|NCT02661464|157719185|FG003|Overall Study|Participants terminated prematurely|1|||
48970111|NCT02661464|157719182|FG000|Overall Study|Participants who had no post-baseline visits.|3|||
48970112|NCT02661464|157719183|FG001|Overall Study|Participants who had no post-baseline visits.|4|||
48970113|NCT02661464|157719184|FG002|Overall Study|Participants who had no post-baseline visits.|0|||
48970114|NCT02661464|157719185|FG003|Overall Study|Participants who had no post-baseline visits.|0|||
48970115|NCT00903370|157719186|FG000|Overall Study|Death|13|||
48970116|NCT00903370|157719187|FG001|Overall Study|Death|10|||
48970117|NCT00903370|157719186|FG000|Overall Study|Withdrawal by Subject|9|||
48970118|NCT00903370|157719187|FG001|Overall Study|Withdrawal by Subject|6|||
48970119|NCT00903370|157719186|FG000|Overall Study|Lost to Follow-up|6|||
48970120|NCT00903370|157719187|FG001|Overall Study|Lost to Follow-up|8|||
48970121|NCT01125293|157719188|FG000|Overall Study|Disease Progression|1|||
48970122|NCT01125293|157719189|FG001|Overall Study|Disease Progression|3|||
48970123|NCT01125293|157719190|FG002|Overall Study|Disease Progression|4|||
48970124|NCT01125293|157719191|FG003|Overall Study|Disease Progression|3|||
48970125|NCT01125293|157719192|FG004|Overall Study|Disease Progression|5|||
48970126|NCT01125293|157719193|FG005|Overall Study|Disease Progression|12|||
48970127|NCT01125293|157719188|FG000|Overall Study|Adverse Event|1|||
48970128|NCT01125293|157719189|FG001|Overall Study|Adverse Event|0|||
48970129|NCT01125293|157719190|FG002|Overall Study|Adverse Event|0|||
48970130|NCT01125293|157719191|FG003|Overall Study|Adverse Event|0|||
48970131|NCT01125293|157719192|FG004|Overall Study|Adverse Event|2|||
48970132|NCT01125293|157719193|FG005|Overall Study|Adverse Event|8|||
48970133|NCT01125293|157719188|FG000|Overall Study|Symptomatic Deterioration|1|||
48970134|NCT01125293|157719189|FG001|Overall Study|Symptomatic Deterioration|0|||
48970135|NCT01125293|157719190|FG002|Overall Study|Symptomatic Deterioration|0|||
48970136|NCT01125293|157719191|FG003|Overall Study|Symptomatic Deterioration|0|||
48970137|NCT01125293|157719192|FG004|Overall Study|Symptomatic Deterioration|0|||
48970138|NCT01125293|157719193|FG005|Overall Study|Symptomatic Deterioration|0|||
48970139|NCT01125293|157719188|FG000|Overall Study|Death|0|||
48970140|NCT01125293|157719189|FG001|Overall Study|Death|0|||
48672569|NCT00666965|156653548|FG003|Overall Study|Discontinuation criteria|2|||
48672570|NCT00666965|156653545|FG000|Overall Study|Withdrawal by Subject|0|||
48970141|NCT01125293|157719190|FG002|Overall Study|Death|0|||
48970142|NCT01125293|157719191|FG003|Overall Study|Death|0|||
48970143|NCT01125293|157719192|FG004|Overall Study|Death|1|||
48970144|NCT01125293|157719193|FG005|Overall Study|Death|0|||
48970145|NCT01125293|157719188|FG000|Overall Study|Withdrawal by Subject|0|||
48970146|NCT01125293|157719189|FG001|Overall Study|Withdrawal by Subject|0|||
48970147|NCT01125293|157719190|FG002|Overall Study|Withdrawal by Subject|0|||
48970148|NCT01125293|157719191|FG003|Overall Study|Withdrawal by Subject|0|||
48970149|NCT01125293|157719192|FG004|Overall Study|Withdrawal by Subject|2|||
48970150|NCT01125293|157719193|FG005|Overall Study|Withdrawal by Subject|1|||
48970151|NCT01125293|157719188|FG000|Overall Study|Physician Decision|0|||
48970152|NCT01125293|157719189|FG001|Overall Study|Physician Decision|0|||
48970153|NCT01125293|157719190|FG002|Overall Study|Physician Decision|0|||
48970154|NCT01125293|157719191|FG003|Overall Study|Physician Decision|0|||
48970155|NCT01125293|157719192|FG004|Overall Study|Physician Decision|0|||
48970156|NCT01125293|157719193|FG005|Overall Study|Physician Decision|2|||
48970157|NCT00014911|157719194|FG000|Overall Study|Adverse Event|1|||
48672571|NCT00666965|156653546|FG001|Overall Study|Withdrawal by Subject|0|||
48970158|NCT00014911|157719194|FG000|Overall Study|Lost to Follow-up|1|||
48970159|NCT00014911|157719194|FG000|Overall Study|Withdrawal by Subject|6|||
48672572|NCT00666965|156653547|FG002|Overall Study|Withdrawal by Subject|0|||
48672573|NCT00666965|156653548|FG003|Overall Study|Withdrawal by Subject|2|||
48672574|NCT01555125|156653559|FG000|Induction Period|Lost to Follow-up|0|||
48672575|NCT01555125|156653560|FG001|Induction Period|Lost to Follow-up|2|||
48672576|NCT01555125|156653561|FG002|Induction Period|Lost to Follow-up|0|||
48672577|NCT01555125|156653562|FG003|Induction Period|Lost to Follow-up|0|||
48672578|NCT01555125|156653563|FG004|Induction Period|Lost to Follow-up|0|||
48672579|NCT01555125|156653559|FG000|Induction Period|Adverse Event|0|||
48672580|NCT01555125|156653560|FG001|Induction Period|Adverse Event|1|||
48672581|NCT01555125|156653561|FG002|Induction Period|Adverse Event|0|||
48672582|NCT01555125|156653562|FG003|Induction Period|Adverse Event|0|||
48672583|NCT01555125|156653563|FG004|Induction Period|Adverse Event|1|||
48672584|NCT01555125|156653559|FG000|Induction Period|Subject / guardian decision|0|||
48672585|NCT01555125|156653560|FG001|Induction Period|Subject / guardian decision|0|||
48872277|NCT00630552|157369713|FG002|Overall Study|Other|4|||
48872278|NCT00630552|157369714|FG003|Overall Study|Other|2|||
48872279|NCT00630552|157369715|FG004|Overall Study|Other|0|||
48672586|NCT01555125|156653561|FG002|Induction Period|Subject / guardian decision|0|||
48672587|NCT01555125|156653562|FG003|Induction Period|Subject / guardian decision|0|||
48672588|NCT01555125|156653563|FG004|Induction Period|Subject / guardian decision|2|||
48672589|NCT01555125|156653559|FG000|Induction Period|Death|1|||
48672590|NCT01555125|156653560|FG001|Induction Period|Death|0|||
48672591|NCT01555125|156653561|FG002|Induction Period|Death|0|||
48672592|NCT01555125|156653562|FG003|Induction Period|Death|0|||
48672593|NCT01555125|156653563|FG004|Induction Period|Death|0|||
48672594|NCT01555125|156653559|FG000|Maintenance Period|Adverse Event|1|||
48672595|NCT01555125|156653560|FG001|Maintenance Period|Adverse Event|1|||
48672596|NCT01555125|156653561|FG002|Maintenance Period|Adverse Event|0|||
48672597|NCT01555125|156653562|FG003|Maintenance Period|Adverse Event|0|||
48672598|NCT01555125|156653563|FG004|Maintenance Period|Adverse Event|0|||
48672599|NCT01555125|156653559|FG000|Maintenance Period|Subject / guardian decision|1|||
48672600|NCT01555125|156653560|FG001|Maintenance Period|Subject / guardian decision|2|||
48672601|NCT01555125|156653561|FG002|Maintenance Period|Subject / guardian decision|0|||
48672602|NCT01555125|156653562|FG003|Maintenance Period|Subject / guardian decision|0|||
48672603|NCT01555125|156653563|FG004|Maintenance Period|Subject / guardian decision|0|||
48672604|NCT01555125|156653559|FG000|Maintenance Period|Lost to Follow-up|2|||
48672605|NCT01555125|156653560|FG001|Maintenance Period|Lost to Follow-up|0|||
48672606|NCT01555125|156653561|FG002|Maintenance Period|Lost to Follow-up|0|||
48672607|NCT01555125|156653562|FG003|Maintenance Period|Lost to Follow-up|1|||
48672608|NCT01555125|156653563|FG004|Maintenance Period|Lost to Follow-up|0|||
48672609|NCT01555125|156653559|FG000|Maintenance Period|Lack of Efficacy|6|||
48672610|NCT01555125|156653560|FG001|Maintenance Period|Lack of Efficacy|1|||
48672611|NCT01555125|156653561|FG002|Maintenance Period|Lack of Efficacy|3|||
48672612|NCT01555125|156653562|FG003|Maintenance Period|Lack of Efficacy|0|||
48672613|NCT01555125|156653563|FG004|Maintenance Period|Lack of Efficacy|0|||
48672614|NCT01555125|156653559|FG000|Maintenance Period|Physician Decision|0|||
48672615|NCT01555125|156653560|FG001|Maintenance Period|Physician Decision|0|||
48672616|NCT01555125|156653561|FG002|Maintenance Period|Physician Decision|1|||
48672617|NCT01555125|156653562|FG003|Maintenance Period|Physician Decision|0|||
48672618|NCT01555125|156653563|FG004|Maintenance Period|Physician Decision|0|||
48672619|NCT01555125|156653559|FG000|Maintenance Period|Death|0|||
48672620|NCT01555125|156653560|FG001|Maintenance Period|Death|0|||
48672621|NCT01555125|156653561|FG002|Maintenance Period|Death|0|||
48672622|NCT01555125|156653562|FG003|Maintenance Period|Death|1|||
48672623|NCT01555125|156653563|FG004|Maintenance Period|Death|0|||
48672624|NCT01555125|156653559|FG000|Extension|Adverse Event|1|||
48672625|NCT01555125|156653560|FG001|Extension|Adverse Event|2|||
48672626|NCT01555125|156653561|FG002|Extension|Adverse Event|1|||
48672627|NCT01555125|156653562|FG003|Extension|Adverse Event|1|||
48672628|NCT01555125|156653563|FG004|Extension|Adverse Event|0|||
48872280|NCT01951378|157369716|FG000|Overall Study|Study Terminated-Not completed|23|||
48672629|NCT01555125|156653559|FG000|Extension|Protocol deviation|1|||
48872281|NCT01951378|157369717|FG001|Overall Study|Study Terminated-Not completed|17|||
48672630|NCT01555125|156653560|FG001|Extension|Protocol deviation|0|||
48872282|NCT03305809|157369719|FG000|Overall Study|Adverse Event|2|||
48672631|NCT01555125|156653561|FG002|Extension|Protocol deviation|0|||
48672632|NCT01555125|156653562|FG003|Extension|Protocol deviation|0|||
48672633|NCT01555125|156653563|FG004|Extension|Protocol deviation|0|||
48672634|NCT01555125|156653559|FG000|Extension|Lack of Efficacy|7|||
48672635|NCT01555125|156653560|FG001|Extension|Lack of Efficacy|6|||
48672636|NCT01555125|156653561|FG002|Extension|Lack of Efficacy|3|||
48672637|NCT01555125|156653562|FG003|Extension|Lack of Efficacy|0|||
48672638|NCT01555125|156653563|FG004|Extension|Lack of Efficacy|0|||
48672639|NCT01555125|156653559|FG000|Extension|Lost to Follow-up|2|||
48672640|NCT01555125|156653560|FG001|Extension|Lost to Follow-up|1|||
48672641|NCT01555125|156653561|FG002|Extension|Lost to Follow-up|2|||
48672642|NCT01555125|156653562|FG003|Extension|Lost to Follow-up|0|||
48672643|NCT01555125|156653563|FG004|Extension|Lost to Follow-up|0|||
48672644|NCT01555125|156653559|FG000|Extension|Study terminated by sponsor|32|||
48970160|NCT00014911|157719194|FG000|Overall Study|Unknown Reasons|2|||
48970161|NCT00014911|157719194|FG000|Overall Study|Immunosuppression-related Side Effects|1|||
48970162|NCT04992546|157719195|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
48970163|NCT04992546|157719195|FG000|Double-Blinded Treatment Period|Doses missed due to Covid-19 pandemic circumstances at the site|1|||
48970164|NCT04992546|157719195|FG000|Open-Label Treatment Period|Adverse Event|3|||
48970165|NCT04992546|157719195|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
48970166|NCT03210220|157719196|FG000|Overall Study|Physician Decision|1|||
48970167|NCT03210220|157719197|FG001|Overall Study|Physician Decision|0|||
48970168|NCT01184846|157719198|FG000|Overall Study|Adverse Event|2|||
48970169|NCT01184846|157719198|FG000|Overall Study|Insufficient response|1|||
48970170|NCT01946412|157719199|FG000|Overall Study|Adverse Event|1|||
48970171|NCT01946412|157719199|FG000|Overall Study|Non-Compliance|1|||
48970172|NCT01946412|157719199|FG000|Overall Study|Continued with commercial Kalydeco|2|||
48970173|NCT01946412|157719199|FG000|Overall Study|Difficulty in swallowing|1|||
48970174|NCT02224638|157719200|FG000|Overall Study|Adverse Event|1|||
48970175|NCT02224638|157719201|FG001|Overall Study|Adverse Event|1|||
48970176|NCT03148756|157719202|FG000|Overall Study|Study Terminated|0|||
48970177|NCT03148756|157719203|FG001|Overall Study|Study Terminated|1|||
48970178|NCT01924299|157719206|FG000|Period 2|Withdrawal by Subject|1|||
48970179|NCT01924299|157719207|FG001|Period 2|Withdrawal by Subject|0|||
48970180|NCT01924299|157719206|FG000|Period 2|Adverse Event|0|||
48970181|NCT01924299|157719207|FG001|Period 2|Adverse Event|1|||
48970182|NCT01532570|157719208|FG000|Overall Study|Lack of Efficacy|1|||
48970183|NCT01532570|157719209|FG001|Overall Study|Lack of Efficacy|0|||
48970184|NCT01532570|157719210|FG002|Overall Study|Lack of Efficacy|0|||
48970185|NCT01532570|157719211|FG003|Overall Study|Lack of Efficacy|0|||
48970186|NCT01532570|157719208|FG000|Overall Study|Withdrawal by Subject|0|||
48970187|NCT01532570|157719209|FG001|Overall Study|Withdrawal by Subject|1|||
48970188|NCT01532570|157719210|FG002|Overall Study|Withdrawal by Subject|0|||
48970189|NCT01532570|157719211|FG003|Overall Study|Withdrawal by Subject|0|||
48970190|NCT02177175|157719212|FG000|Overall Study|stopped trastuzumab so was taken off study|1|||
48970191|NCT02177175|157719213|FG001|Overall Study|stopped trastuzumab so was taken off study|0|||
48970192|NCT03820726|157719214|FG000|Overall Study|Other than listed|23|||
48970193|NCT03820726|157719214|FG000|Overall Study|Withdrawal by Subject|37|||
48970194|NCT03820726|157719214|FG000|Overall Study|Lost to Follow-up|3|||
48970195|NCT03820726|157719214|FG000|Overall Study|Protocol deviation|1|||
48970196|NCT03820726|157719214|FG000|Overall Study|Adverse Event|146|||
48970197|NCT03820726|157719214|FG000|Overall Study|Not treated|1|||
48970198|NCT00345540|157719220|FG000|Overall Study|Withdrawal by Subject|1|||
48970199|NCT01406652|157719221|FG000|Overall Study|Lost-to-follow-up|3|||
48970200|NCT01406652|157719222|FG001|Overall Study|Lost-to-follow-up|4|||
48970201|NCT01406652|157719221|FG000|Overall Study|Withdrawal by Subject|2|||
48970202|NCT01406652|157719222|FG001|Overall Study|Withdrawal by Subject|2|||
48970203|NCT01406652|157719221|FG000|Overall Study|Insufficient follow-up|5|||
48970204|NCT01406652|157719222|FG001|Overall Study|Insufficient follow-up|4|||
48970205|NCT01406652|157719221|FG000|Overall Study|Infection not sure|10|||
48970206|NCT01406652|157719222|FG001|Overall Study|Infection not sure|10|||
48970207|NCT00659126|157719224|FG000|Overall Study|Adverse Event|2|||
48970208|NCT00659126|157719225|FG001|Overall Study|Adverse Event|2|||
48970209|NCT00659126|157719224|FG000|Overall Study|Screen failure|1|||
48970210|NCT00659126|157719225|FG001|Overall Study|Screen failure|1|||
48970211|NCT00659126|157719224|FG000|Overall Study|Technical problems with MRI|0|||
48970212|NCT00659126|157719225|FG001|Overall Study|Technical problems with MRI|1|||
48970213|NCT04095442|157720833|FG000|Overall Study|Lost to Follow-up|0|||
48970214|NCT04095442|157720834|FG001|Overall Study|Lost to Follow-up|1|||
48970215|NCT04095442|157720833|FG000|Overall Study|Screen failure|1|||
48970216|NCT04095442|157720834|FG001|Overall Study|Screen failure|0|||
48970217|NCT03363919|157720835|FG000|Overall Study|Withdrawal by subject - did not receive allocated intervention|0|||
48970218|NCT03363919|157720836|FG001|Overall Study|Withdrawal by subject - did not receive allocated intervention|1|||
48970219|NCT03363919|157720835|FG000|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|1|||
48970220|NCT03363919|157720836|FG001|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|4|||
48970221|NCT00424346|157720839|FG000|Core Study|Adverse Event|5|||
48970222|NCT00424346|157720840|FG001|Core Study|Adverse Event|3|||
48970223|NCT00424346|157720841|FG002|Core Study|Adverse Event|1|||
48970224|NCT00424346|157720842|FG003|Core Study|Adverse Event|1|||
48970225|NCT00424346|157720839|FG000|Core Study|Abnormal Laboratory Values|0|||
48970226|NCT00424346|157720840|FG001|Core Study|Abnormal Laboratory Values|1|||
48970227|NCT00424346|157720841|FG002|Core Study|Abnormal Laboratory Values|0|||
48970228|NCT00424346|157720842|FG003|Core Study|Abnormal Laboratory Values|0|||
48970229|NCT00424346|157720839|FG000|Core Study|Lack of Efficacy|1|||
48970230|NCT00424346|157720840|FG001|Core Study|Lack of Efficacy|3|||
48970231|NCT00424346|157720841|FG002|Core Study|Lack of Efficacy|0|||
48970232|NCT00424346|157720842|FG003|Core Study|Lack of Efficacy|4|||
48970233|NCT00424346|157720839|FG000|Core Study|Withdrawal by Subject|1|||
48970234|NCT00424346|157720840|FG001|Core Study|Withdrawal by Subject|0|||
48970235|NCT00424346|157720841|FG002|Core Study|Withdrawal by Subject|0|||
48970236|NCT00424346|157720842|FG003|Core Study|Withdrawal by Subject|2|||
48970237|NCT00424346|157720839|FG000|Core Study|Lost to Follow-up|1|||
48970238|NCT00424346|157720840|FG001|Core Study|Lost to Follow-up|1|||
48970239|NCT00424346|157720841|FG002|Core Study|Lost to Follow-up|0|||
48970240|NCT00424346|157720842|FG003|Core Study|Lost to Follow-up|0|||
48970241|NCT00424346|157720839|FG000|Core Study|Administrative Problems|1|||
48970242|NCT00424346|157720840|FG001|Core Study|Administrative Problems|0|||
48970243|NCT00424346|157720841|FG002|Core Study|Administrative Problems|1|||
48970244|NCT00424346|157720842|FG003|Core Study|Administrative Problems|0|||
48970245|NCT00424346|157720839|FG000|Core Study|Protocol Violation|0|||
48970246|NCT00424346|157720840|FG001|Core Study|Protocol Violation|0|||
48970247|NCT00424346|157720841|FG002|Core Study|Protocol Violation|2|||
48970248|NCT00424346|157720842|FG003|Core Study|Protocol Violation|0|||
48970249|NCT00424346|157720839|FG000|Extension Phase|Adverse Event|0|||
48970250|NCT00424346|157720840|FG001|Extension Phase|Adverse Event|9|||
48970251|NCT00424346|157720841|FG002|Extension Phase|Adverse Event|5|||
48970252|NCT00424346|157720842|FG003|Extension Phase|Adverse Event|4|||
48970253|NCT00424346|157720839|FG000|Extension Phase|Lack of Efficacy|0|||
48970254|NCT00424346|157720840|FG001|Extension Phase|Lack of Efficacy|16|||
48970255|NCT00424346|157720841|FG002|Extension Phase|Lack of Efficacy|14|||
48970256|NCT00424346|157720842|FG003|Extension Phase|Lack of Efficacy|11|||
48970257|NCT00424346|157720839|FG000|Extension Phase|Withdrawal by Subject|0|||
48970258|NCT00424346|157720840|FG001|Extension Phase|Withdrawal by Subject|5|||
48970259|NCT00424346|157720841|FG002|Extension Phase|Withdrawal by Subject|3|||
48970260|NCT00424346|157720842|FG003|Extension Phase|Withdrawal by Subject|4|||
48970261|NCT00424346|157720839|FG000|Extension Phase|Lost to Follow-up|0|||
48970262|NCT00424346|157720840|FG001|Extension Phase|Lost to Follow-up|2|||
48970263|NCT00424346|157720841|FG002|Extension Phase|Lost to Follow-up|0|||
48970264|NCT00424346|157720842|FG003|Extension Phase|Lost to Follow-up|0|||
48970265|NCT00424346|157720839|FG000|Extension Phase|Administrative Problems|0|||
48970266|NCT00424346|157720840|FG001|Extension Phase|Administrative Problems|69|||
48970267|NCT00424346|157720841|FG002|Extension Phase|Administrative Problems|32|||
48970268|NCT00424346|157720842|FG003|Extension Phase|Administrative Problems|35|||
48970269|NCT00424346|157720839|FG000|Extension Phase|Death|0|||
48970270|NCT00424346|157720840|FG001|Extension Phase|Death|0|||
48970271|NCT00424346|157720841|FG002|Extension Phase|Death|0|||
48970272|NCT00424346|157720842|FG003|Extension Phase|Death|1|||
48970273|NCT00424346|157720839|FG000|Extension Phase|Protocol Violation|0|||
48970274|NCT00424346|157720840|FG001|Extension Phase|Protocol Violation|1|||
48970275|NCT00424346|157720841|FG002|Extension Phase|Protocol Violation|1|||
48760809|NCT01480076|156972340|FG000|Overall Study|Non-compliance With Study Protocol|15|||
48970276|NCT00424346|157720842|FG003|Extension Phase|Protocol Violation|0|||
48970277|NCT01002742|157720845|FG000|Overall Study|Determined to be ineligible|0|||
48672645|NCT01555125|156653560|FG001|Extension|Study terminated by sponsor|33|||
48672646|NCT01555125|156653561|FG002|Extension|Study terminated by sponsor|16|||
48760810|NCT01480076|156972340|FG000|Overall Study|Withdrawal by Subject|105|||
48760811|NCT01480076|156972340|FG000|Overall Study|Lost to Follow-up|7|||
48760812|NCT01480076|156972340|FG000|Overall Study|Investigator Decision|13|||
48760813|NCT01480076|156972340|FG000|Overall Study|Other|52|||
48970278|NCT01002742|157720846|FG001|Overall Study|Determined to be ineligible|1|||
48970279|NCT03927911|157720847|FG000|Overall Study|problems with eDiary|0|||
48970280|NCT03927911|157720848|FG001|Overall Study|problems with eDiary|1|||
48970281|NCT03927911|157720849|FG002|Overall Study|problems with eDiary|0|||
48970282|NCT03927911|157720850|FG003|Overall Study|problems with eDiary|1|||
48970283|NCT03927911|157720851|FG004|Overall Study|problems with eDiary|0|||
48672647|NCT01555125|156653562|FG003|Extension|Study terminated by sponsor|20|||
48672648|NCT01555125|156653563|FG004|Extension|Study terminated by sponsor|0|||
48672649|NCT01555125|156653559|FG000|Extension|Subject/guardian decision|1|||
48672650|NCT01555125|156653560|FG001|Extension|Subject/guardian decision|9|||
48672651|NCT01555125|156653561|FG002|Extension|Subject/guardian decision|1|||
48672652|NCT01555125|156653562|FG003|Extension|Subject/guardian decision|0|||
48672653|NCT01555125|156653563|FG004|Extension|Subject/guardian decision|0|||
48672654|NCT01555125|156653559|FG000|Extension|Technical Problems|1|||
48672655|NCT01555125|156653560|FG001|Extension|Technical Problems|0|||
48672656|NCT01555125|156653561|FG002|Extension|Technical Problems|0|||
48672657|NCT01555125|156653562|FG003|Extension|Technical Problems|1|||
48672658|NCT01555125|156653563|FG004|Extension|Technical Problems|0|||
48672659|NCT01555125|156653559|FG000|Follow-Up Period|Lost to Follow-up|1|||
48672660|NCT01555125|156653560|FG001|Follow-Up Period|Lost to Follow-up|0|||
48970284|NCT03927911|157720852|FG005|Overall Study|problems with eDiary|4|||
48970285|NCT03927911|157720847|FG000|Overall Study|Adverse Event|0|||
48672661|NCT01555125|156653561|FG002|Follow-Up Period|Lost to Follow-up|0|||
48672662|NCT01555125|156653562|FG003|Follow-Up Period|Lost to Follow-up|0|||
48672663|NCT01555125|156653563|FG004|Follow-Up Period|Lost to Follow-up|0|||
48672664|NCT01555125|156653559|FG000|Follow-Up Period|Subject / guardian decision|3|||
48672665|NCT01555125|156653560|FG001|Follow-Up Period|Subject / guardian decision|1|||
48970286|NCT03927911|157720848|FG001|Overall Study|Adverse Event|0|||
48970287|NCT03927911|157720849|FG002|Overall Study|Adverse Event|0|||
48672666|NCT01555125|156653561|FG002|Follow-Up Period|Subject / guardian decision|1|||
48672667|NCT01555125|156653562|FG003|Follow-Up Period|Subject / guardian decision|1|||
48672668|NCT01555125|156653563|FG004|Follow-Up Period|Subject / guardian decision|0|||
48672669|NCT04268745|156653566|FG000|Overall Study|Lost to Follow-up|2|||
48672670|NCT04268745|156653567|FG001|Overall Study|Lost to Follow-up|3|||
48672671|NCT04268745|156653566|FG000|Overall Study|Withdrawal by Subject|4|||
48672672|NCT04268745|156653567|FG001|Overall Study|Withdrawal by Subject|2|||
48672673|NCT04268745|156653566|FG000|Overall Study|Death in the family|1|||
48672674|NCT04268745|156653567|FG001|Overall Study|Death in the family|0|||
48672675|NCT04058886|156653568|FG000|Overall Study|Withdrawal by Subject|4|||
48672676|NCT04058886|156653568|FG000|Overall Study|Inadequate deafness interpreter service|1|||
48672677|NCT01371305|156653569|FG000|Overall Study|Adverse Event|0|||
48672678|NCT01371305|156653570|FG001|Overall Study|Adverse Event|0|||
48672679|NCT01371305|156653571|FG002|Overall Study|Adverse Event|0|||
48672680|NCT01371305|156653572|FG003|Overall Study|Adverse Event|2|||
48672681|NCT01371305|156653573|FG004|Overall Study|Adverse Event|1|||
48672682|NCT01371305|156653574|FG005|Overall Study|Adverse Event|0|||
48672683|NCT01371305|156653569|FG000|Overall Study|Study terminated by sponsor|0|||
48672684|NCT01371305|156653570|FG001|Overall Study|Study terminated by sponsor|0|||
48672685|NCT01371305|156653571|FG002|Overall Study|Study terminated by sponsor|0|||
48672686|NCT01371305|156653572|FG003|Overall Study|Study terminated by sponsor|0|||
48672687|NCT01371305|156653573|FG004|Overall Study|Study terminated by sponsor|3|||
48672688|NCT01371305|156653574|FG005|Overall Study|Study terminated by sponsor|1|||
48872283|NCT03305809|157369720|FG001|Overall Study|Adverse Event|2|||
48872284|NCT03305809|157369721|FG002|Overall Study|Adverse Event|6|||
48872285|NCT03305809|157369722|FG003|Overall Study|Adverse Event|6|||
48672689|NCT01371305|156653569|FG000|Overall Study|Subject request|0|||
48672690|NCT01371305|156653570|FG001|Overall Study|Subject request|0|||
48672691|NCT01371305|156653571|FG002|Overall Study|Subject request|0|||
48672692|NCT01371305|156653572|FG003|Overall Study|Subject request|0|||
48872286|NCT03305809|157369719|FG000|Overall Study|Death|0|||
48872287|NCT03305809|157369720|FG001|Overall Study|Death|0|||
48872288|NCT03305809|157369721|FG002|Overall Study|Death|1|||
48872289|NCT03305809|157369722|FG003|Overall Study|Death|1|||
48872290|NCT03305809|157369719|FG000|Overall Study|Lost to Follow-up|1|||
48872291|NCT03305809|157369720|FG001|Overall Study|Lost to Follow-up|2|||
48872292|NCT03305809|157369721|FG002|Overall Study|Lost to Follow-up|0|||
48872293|NCT03305809|157369722|FG003|Overall Study|Lost to Follow-up|0|||
48672693|NCT01371305|156653573|FG004|Overall Study|Subject request|0|||
48672694|NCT01371305|156653574|FG005|Overall Study|Subject request|1|||
48760814|NCT00704535|156972341|FG000|Overall Study|Adverse Event|2|||
48760815|NCT00704535|156972341|FG000|Overall Study|Death|2|||
48760816|NCT00704535|156972341|FG000|Overall Study|Lost to Follow-up|8|||
48760817|NCT00704535|156972341|FG000|Overall Study|Protocol Violation|10|||
48760818|NCT00704535|156972341|FG000|Overall Study|Completed status not on Case Report Form|124|||
48872294|NCT03305809|157369719|FG000|Overall Study|Sponsor Decision|1|||
48872295|NCT03305809|157369720|FG001|Overall Study|Sponsor Decision|0|||
48872296|NCT03305809|157369721|FG002|Overall Study|Sponsor Decision|1|||
48872297|NCT03305809|157369722|FG003|Overall Study|Sponsor Decision|8|||
48872298|NCT03305809|157369719|FG000|Overall Study|Physician Decision|0|||
48872299|NCT03305809|157369720|FG001|Overall Study|Physician Decision|0|||
48872300|NCT03305809|157369721|FG002|Overall Study|Physician Decision|2|||
48872301|NCT03305809|157369722|FG003|Overall Study|Physician Decision|4|||
48872302|NCT03305809|157369719|FG000|Overall Study|Progressive Disease|0|||
48760819|NCT00371254|156972344|FG000|Overall Study|Disease progression|13|||
48760820|NCT00371254|156972345|FG001|Overall Study|Disease progression|13|||
48760821|NCT00371254|156972344|FG000|Overall Study|Study drug toxicity|3|||
48760822|NCT00371254|156972345|FG001|Overall Study|Study drug toxicity|5|||
48760823|NCT00371254|156972344|FG000|Overall Study|Subject request|5|||
48760824|NCT00371254|156972345|FG001|Overall Study|Subject request|0|||
48760825|NCT00371254|156972344|FG000|Overall Study|Investigator Decision|2|||
48872303|NCT03305809|157369720|FG001|Overall Study|Progressive Disease|0|||
48970288|NCT03927911|157720850|FG003|Overall Study|Adverse Event|0|||
48970289|NCT03927911|157720851|FG004|Overall Study|Adverse Event|0|||
48970290|NCT03927911|157720852|FG005|Overall Study|Adverse Event|1|||
48970291|NCT03927911|157720847|FG000|Overall Study|not treated -study terminated by sponsor|0|||
48672695|NCT02999633|156653576|FG000|Overall Study|Adverse Event|2|||
48672696|NCT02999633|156653576|FG000|Overall Study|Progressive disease|12|||
48672697|NCT01092663|156653589|FG000|Overall Study|Withdrawal by Subject|3|||
48672698|NCT01092663|156653590|FG001|Overall Study|Withdrawal by Subject|2|||
48672699|NCT01092663|156653589|FG000|Overall Study|Glucose >300mg/dL|1|||
48672700|NCT01092663|156653590|FG001|Overall Study|Glucose >300mg/dL|0|||
48872304|NCT03305809|157369721|FG002|Overall Study|Progressive Disease|1|||
48872305|NCT03305809|157369722|FG003|Overall Study|Progressive Disease|0|||
48872306|NCT03305809|157369719|FG000|Overall Study|Protocol Violation|1|||
48872307|NCT03305809|157369720|FG001|Overall Study|Protocol Violation|0|||
48872308|NCT03305809|157369721|FG002|Overall Study|Protocol Violation|2|||
48760826|NCT00371254|156972345|FG001|Overall Study|Investigator Decision|0|||
48872309|NCT03305809|157369722|FG003|Overall Study|Protocol Violation|3|||
48970292|NCT03927911|157720848|FG001|Overall Study|not treated -study terminated by sponsor|1|||
48970293|NCT03927911|157720849|FG002|Overall Study|not treated -study terminated by sponsor|0|||
48970294|NCT03927911|157720850|FG003|Overall Study|not treated -study terminated by sponsor|0|||
48970295|NCT03927911|157720851|FG004|Overall Study|not treated -study terminated by sponsor|0|||
48970296|NCT03927911|157720852|FG005|Overall Study|not treated -study terminated by sponsor|0|||
48970297|NCT03927911|157720847|FG000|Overall Study|Surgery cancelled|0|||
48970298|NCT03927911|157720848|FG001|Overall Study|Surgery cancelled|0|||
48970299|NCT03927911|157720849|FG002|Overall Study|Surgery cancelled|0|||
48970300|NCT03927911|157720850|FG003|Overall Study|Surgery cancelled|1|||
48970301|NCT03927911|157720851|FG004|Overall Study|Surgery cancelled|0|||
48970302|NCT03927911|157720852|FG005|Overall Study|Surgery cancelled|1|||
48970303|NCT03927911|157720847|FG000|Overall Study|Protocol Violation|0|||
48970304|NCT03927911|157720848|FG001|Overall Study|Protocol Violation|0|||
48970305|NCT03927911|157720849|FG002|Overall Study|Protocol Violation|0|||
48970306|NCT03927911|157720850|FG003|Overall Study|Protocol Violation|0|||
48970307|NCT03927911|157720851|FG004|Overall Study|Protocol Violation|0|||
48970308|NCT03927911|157720852|FG005|Overall Study|Protocol Violation|1|||
48970309|NCT02150213|157720859|FG000|Overall Study|Lost to Follow-up|1|||
48970310|NCT02150213|157720859|FG000|Overall Study|Withdrawal by Subject|1|||
48970311|NCT01779648|157720860|FG000|Overall Study|Protocol Violation|1|||
48672701|NCT01092663|156653589|FG000|Overall Study|High fasting triglyceride|2|||
48672702|NCT01092663|156653590|FG001|Overall Study|High fasting triglyceride|0|||
48672703|NCT01092663|156653589|FG000|Overall Study|Adverse Event|1|||
48672704|NCT01092663|156653590|FG001|Overall Study|Adverse Event|1|||
48672705|NCT01092663|156653589|FG000|Overall Study|Protocol Violation|0|||
48672706|NCT01092663|156653590|FG001|Overall Study|Protocol Violation|1|||
48672707|NCT03908970|156653591|FG000|Overall Study|Adverse Event|7|||
48672708|NCT03908970|156653592|FG001|Overall Study|Adverse Event|21|||
48672709|NCT03908970|156653591|FG000|Overall Study|Physician Decision|1|||
48672710|NCT03908970|156653592|FG001|Overall Study|Physician Decision|4|||
48672711|NCT03908970|156653591|FG000|Overall Study|Withdrawal by Subject|9|||
48672712|NCT03908970|156653592|FG001|Overall Study|Withdrawal by Subject|22|||
48672713|NCT03565237|156653593|FG000|Overall Study|Non-compliance of Investigational Product|1|||
48672714|NCT03565237|156653593|FG000|Overall Study|Physician Decision|1|||
48672715|NCT01140061|156653594|FG000|Part I|Adverse Event|1|||
48672716|NCT01140061|156653595|FG001|Part I|Adverse Event|0|||
48672717|NCT01140061|156653596|FG002|Part I|Adverse Event|0|||
48672718|NCT01140061|156653597|FG003|Part I|Adverse Event|0|||
48672719|NCT01140061|156653598|FG004|Part I|Adverse Event|0|||
48672720|NCT01140061|156653599|FG005|Part I|Adverse Event|0|||
48760827|NCT00371254|156972344|FG000|Overall Study|Adverse event unrelated to study drug|0|||
48760828|NCT00371254|156972345|FG001|Overall Study|Adverse event unrelated to study drug|1|||
48760829|NCT00371254|156972344|FG000|Overall Study|Lost to Follow-up|0|||
48760830|NCT00371254|156972345|FG001|Overall Study|Lost to Follow-up|1|||
48760831|NCT00371254|156972344|FG000|Overall Study|Withdrawal by Subject|0|||
48760832|NCT00371254|156972345|FG001|Overall Study|Withdrawal by Subject|1|||
48760833|NCT01324388|156972346|FG000|Part 1 of Study|Adverse Event|2|||
48760834|NCT01324388|156972347|FG001|Part 1 of Study|Adverse Event|0|||
48760835|NCT01324388|156972348|FG002|Part 1 of Study|Adverse Event|0|||
48872310|NCT03305809|157369719|FG000|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
48872311|NCT03305809|157369720|FG001|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
48872312|NCT03305809|157369721|FG002|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
48872313|NCT03305809|157369722|FG003|Overall Study|Withdrawal due to Assessment Committee Decision|2|||
48872314|NCT03305809|157369719|FG000|Overall Study|Withdrawal by Subject|2|||
48872315|NCT03305809|157369720|FG001|Overall Study|Withdrawal by Subject|4|||
48872316|NCT03305809|157369721|FG002|Overall Study|Withdrawal by Subject|5|||
48872317|NCT03305809|157369722|FG003|Overall Study|Withdrawal by Subject|2|||
48872318|NCT03305809|157369719|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
48872319|NCT03305809|157369720|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
48872320|NCT03305809|157369721|FG002|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
48872321|NCT03305809|157369722|FG003|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
48872322|NCT01402063|157369725|FG000|Overall Study|Withdrawal by Subject|3|||
48872323|NCT01402063|157369726|FG001|Overall Study|Withdrawal by Subject|3|||
48872324|NCT01774019|157369734|FG000|Overall Study|No longer meets protocol criteria|2|||
48872325|NCT01774019|157369735|FG001|Overall Study|No longer meets protocol criteria|0|||
48872326|NCT01774019|157369734|FG000|Overall Study|Withdrawal by Subject|1|||
48872327|NCT01774019|157369735|FG001|Overall Study|Withdrawal by Subject|0|||
48872328|NCT01774019|157369734|FG000|Overall Study|Surgery delayed > 120 days|1|||
48872329|NCT01774019|157369735|FG001|Overall Study|Surgery delayed > 120 days|0|||
48872330|NCT01774019|157369734|FG000|Overall Study|Patient refused surgery|1|||
48872331|NCT01774019|157369735|FG001|Overall Study|Patient refused surgery|1|||
48872332|NCT01774019|157369734|FG000|Overall Study|Unable to implant study device|1|||
48970312|NCT01779648|157720861|FG001|Overall Study|Protocol Violation|0|||
48672721|NCT01140061|156653600|FG006|Part I|Adverse Event|0|||
48672722|NCT01140061|156653601|FG007|Part I|Adverse Event|0|||
48672723|NCT01140061|156653602|FG008|Part I|Adverse Event|0|||
48672724|NCT01140061|156653603|FG009|Part I|Adverse Event|0|||
48672725|NCT01140061|156653594|FG000|Extension|Laboratory Adverse Event|0|||
48672726|NCT01140061|156653595|FG001|Extension|Laboratory Adverse Event|0|||
48672727|NCT01140061|156653596|FG002|Extension|Laboratory Adverse Event|0|||
48672728|NCT01140061|156653597|FG003|Extension|Laboratory Adverse Event|0|||
48672729|NCT01140061|156653598|FG004|Extension|Laboratory Adverse Event|0|||
48672730|NCT01140061|156653599|FG005|Extension|Laboratory Adverse Event|0|||
48672731|NCT01140061|156653600|FG006|Extension|Laboratory Adverse Event|0|||
48672732|NCT01140061|156653601|FG007|Extension|Laboratory Adverse Event|0|||
48672733|NCT01140061|156653602|FG008|Extension|Laboratory Adverse Event|0|||
48672734|NCT01140061|156653603|FG009|Extension|Laboratory Adverse Event|1|||
48672735|NCT04006392|156653607|FG000|Overall Study|Lost to Follow-up|0|||
48672736|NCT04006392|156653608|FG001|Overall Study|Lost to Follow-up|1|||
48672737|NCT01067469|156653610|FG000|Overall Study|Withdrawal by Subject|0|||
48672738|NCT01067469|156653611|FG001|Overall Study|Withdrawal by Subject|1|||
48672739|NCT01067469|156653610|FG000|Overall Study|Disease Progression|0|||
48672740|NCT01067469|156653611|FG001|Overall Study|Disease Progression|1|||
48672741|NCT01959243|156653612|FG000|Overall Study|Investigator Decision|3|||
48672742|NCT01959243|156653613|FG001|Overall Study|Investigator Decision|0|||
48672743|NCT01959243|156653612|FG000|Overall Study|Adverse Event|5|||
48672744|NCT01959243|156653613|FG001|Overall Study|Adverse Event|2|||
48672745|NCT01959243|156653612|FG000|Overall Study|Administrative reasons|2|||
48672746|NCT01959243|156653613|FG001|Overall Study|Administrative reasons|1|||
48672747|NCT01959243|156653612|FG000|Overall Study|Lost to Follow-up|3|||
48672748|NCT01959243|156653613|FG001|Overall Study|Lost to Follow-up|1|||
48672749|NCT00428844|156653614|FG000|Completed Study Drug Treatment|Adverse Event|2|||
48672750|NCT00428844|156653615|FG001|Completed Study Drug Treatment|Adverse Event|4|||
48672751|NCT00428844|156653616|FG002|Completed Study Drug Treatment|Adverse Event|4|||
48672752|NCT00428844|156653614|FG000|Completed Study Drug Treatment|Protocol Violation|0|||
48672753|NCT00428844|156653615|FG001|Completed Study Drug Treatment|Protocol Violation|1|||
48672754|NCT00428844|156653616|FG002|Completed Study Drug Treatment|Protocol Violation|1|||
48672755|NCT00428844|156653614|FG000|Completed Study Drug Treatment|Withdrawal by Subject|0|||
48672756|NCT00428844|156653615|FG001|Completed Study Drug Treatment|Withdrawal by Subject|1|||
48672757|NCT00428844|156653616|FG002|Completed Study Drug Treatment|Withdrawal by Subject|1|||
48672758|NCT00428844|156653614|FG000|Completed Study Drug Treatment|Randomized Not Treated|0|||
48672759|NCT00428844|156653615|FG001|Completed Study Drug Treatment|Randomized Not Treated|0|||
48672760|NCT00428844|156653616|FG002|Completed Study Drug Treatment|Randomized Not Treated|1|||
48672761|NCT00428844|156653614|FG000|Completed Test of Cure (TOC) Visit|Adverse Event|0|||
48672762|NCT00428844|156653615|FG001|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
48672763|NCT00428844|156653616|FG002|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
48672764|NCT00428844|156653614|FG000|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
48672765|NCT00428844|156653615|FG001|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
48672766|NCT00428844|156653616|FG002|Completed Test of Cure (TOC) Visit|Protocol Violation|1|||
48672767|NCT00428844|156653614|FG000|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1|||
48672768|NCT00428844|156653615|FG001|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
48672769|NCT00428844|156653616|FG002|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
48672770|NCT00428844|156653614|FG000|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2|||
48672771|NCT00428844|156653615|FG001|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
48672772|NCT00428844|156653616|FG002|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
48672773|NCT00428844|156653614|FG000|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
48672774|NCT00428844|156653615|FG001|Completed Test of Cure (TOC) Visit|Microbiologic failure|1|||
48672775|NCT00428844|156653616|FG002|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
48672776|NCT04576897|156653617|FG000|Overall Study|37 scans were determined by the sponsor to be invalid.|37|||
48672777|NCT03824587|156653618|FG000|Run-in Period|Screen Failure|0|||
48672778|NCT03824587|156653619|FG001|Run-in Period|Screen Failure|275|||
48672779|NCT03824587|156653618|FG000|Treatment Period|Adverse Event|4|||
48672780|NCT03824587|156653619|FG001|Treatment Period|Adverse Event|1|||
48760836|NCT01324388|156972349|FG003|Part 1 of Study|Adverse Event|0|||
48760837|NCT01324388|156972346|FG000|Part 1 of Study|Protocol Violation|1|||
48970313|NCT02267278|157720864|FG000|Overall Study|Proceeded to transplantation (allo-HCT)|1|||
48970314|NCT02267278|157720864|FG000|Overall Study|transformation to acute leukemia (AML)|1|||
48970315|NCT02267278|157720864|FG000|Overall Study|Developed new cancer diagnoses|2|||
48970316|NCT02267278|157720864|FG000|Overall Study|prescribed prohibited medication|1|||
48970317|NCT00291499|157720871|FG000|Overall Study|Adverse Event|3|||
48672781|NCT03824587|156653618|FG000|Treatment Period|Withdrawal by Subject|0|||
48672782|NCT03824587|156653619|FG001|Treatment Period|Withdrawal by Subject|1|||
48672783|NCT03824587|156653618|FG000|Treatment Period|Kidney Transplant|1|||
48672784|NCT03824587|156653619|FG001|Treatment Period|Kidney Transplant|1|||
48672785|NCT02126839|156653620|FG000|Overall Study|Adverse Event|0|||
48672786|NCT02126839|156653621|FG001|Overall Study|Adverse Event|1|||
48672787|NCT02126839|156653620|FG000|Overall Study|Withdrawal by Subject|1|||
48760838|NCT01324388|156972347|FG001|Part 1 of Study|Protocol Violation|2|||
48970318|NCT00291499|157720872|FG001|Overall Study|Adverse Event|8|||
48970319|NCT00291499|157720871|FG000|Overall Study|Change to other therapy|2|||
48970320|NCT00291499|157720872|FG001|Overall Study|Change to other therapy|1|||
48970321|NCT00291499|157720871|FG000|Overall Study|Intercurrent illness|1|||
48760839|NCT01324388|156972348|FG002|Part 1 of Study|Protocol Violation|0|||
48970322|NCT00291499|157720872|FG001|Overall Study|Intercurrent illness|0|||
48760840|NCT01324388|156972349|FG003|Part 1 of Study|Protocol Violation|0|||
48760841|NCT01324388|156972346|FG000|Part 1 of Study|Physician Decision|1|||
48760842|NCT01324388|156972347|FG001|Part 1 of Study|Physician Decision|0|||
48760843|NCT01324388|156972348|FG002|Part 1 of Study|Physician Decision|0|||
48760844|NCT01324388|156972349|FG003|Part 1 of Study|Physician Decision|0|||
48760845|NCT01324388|156972346|FG000|Part 2 of Study: First Intervention|Protocol Violation|0|||
48760846|NCT01324388|156972347|FG001|Part 2 of Study: First Intervention|Protocol Violation|0|||
48760847|NCT01324388|156972348|FG002|Part 2 of Study: First Intervention|Protocol Violation|0|||
48760848|NCT01324388|156972349|FG003|Part 2 of Study: First Intervention|Protocol Violation|1|||
48760849|NCT01324388|156972346|FG000|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
48760850|NCT01324388|156972347|FG001|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
48760851|NCT01324388|156972348|FG002|Part 2 of Study: Second Intervention|Withdrawal by Subject|1|||
48760852|NCT01324388|156972349|FG003|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
48760853|NCT01405963|156972350|FG000|Overall Study|Moved Away|2|||
48760854|NCT01405963|156972351|FG001|Overall Study|Moved Away|0|||
48760855|NCT01405963|156972350|FG000|Overall Study|Adverse Event|0|||
48760856|NCT01405963|156972351|FG001|Overall Study|Adverse Event|1|||
48760857|NCT01405963|156972350|FG000|Overall Study|Lost to Follow-up|0|||
48760858|NCT01405963|156972351|FG001|Overall Study|Lost to Follow-up|1|||
48760859|NCT01187043|156972352|FG000|Overall Study|Adverse Event|0|||
48760860|NCT01187043|156972353|FG001|Overall Study|Adverse Event|0|||
48760861|NCT01187043|156972354|FG002|Overall Study|Adverse Event|0|||
48760862|NCT01187043|156972355|FG003|Overall Study|Adverse Event|0|||
48760863|NCT01187043|156972356|FG004|Overall Study|Adverse Event|1|||
48760864|NCT01187043|156972352|FG000|Overall Study|Unable to make scheduled visits|1|||
48760865|NCT01187043|156972353|FG001|Overall Study|Unable to make scheduled visits|0|||
48760866|NCT01187043|156972354|FG002|Overall Study|Unable to make scheduled visits|4|||
48760867|NCT01187043|156972355|FG003|Overall Study|Unable to make scheduled visits|0|||
48760868|NCT01187043|156972356|FG004|Overall Study|Unable to make scheduled visits|1|||
48760869|NCT02802592|156972360|FG000|Overall Study|Study terminated due to loss of funding|4|||
48760870|NCT00108160|156972361|FG000|Overall Study|Lost to Follow-up|25|||
48760871|NCT00108160|156972362|FG001|Overall Study|Lost to Follow-up|12|||
48760872|NCT00108160|156972361|FG000|Overall Study|Death|1|||
48760873|NCT00108160|156972362|FG001|Overall Study|Death|2|||
48760874|NCT00108160|156972361|FG000|Overall Study|Withdrawal by Subject|4|||
48760875|NCT00108160|156972362|FG001|Overall Study|Withdrawal by Subject|2|||
48760876|NCT00108160|156972361|FG000|Overall Study|Protocol Violation|9|||
48760877|NCT00108160|156972362|FG001|Overall Study|Protocol Violation|5|||
48760878|NCT02081079|156972363|FG000|Overall Study|Lack of Efficacy|3|||
48760879|NCT02081079|156972364|FG001|Overall Study|Lack of Efficacy|2|||
48760880|NCT02081079|156972363|FG000|Overall Study|Lost to Follow-up|1|||
48760881|NCT02081079|156972364|FG001|Overall Study|Lost to Follow-up|0|||
48760882|NCT02225743|156972365|FG000|Overall Study|Withdrawal by Subject|18|||
48760883|NCT00484939|156972372|FG000|Overall Study|Death|9|||
48760884|NCT00484939|156972373|FG001|Overall Study|Death|13|||
48760885|NCT00484939|156972372|FG000|Overall Study|Adverse Event|22|||
48760886|NCT00484939|156972373|FG001|Overall Study|Adverse Event|12|||
48760887|NCT00484939|156972372|FG000|Overall Study|Patient Withdrew Consent|19|||
48760888|NCT00484939|156972373|FG001|Overall Study|Patient Withdrew Consent|10|||
48760889|NCT00484939|156972372|FG000|Overall Study|Protocol Violation|3|||
48760890|NCT00484939|156972373|FG001|Overall Study|Protocol Violation|3|||
48760891|NCT00484939|156972372|FG000|Overall Study|Lost to Follow-up|0|||
48760892|NCT00484939|156972373|FG001|Overall Study|Lost to Follow-up|3|||
48760893|NCT00484939|156972372|FG000|Overall Study|Discretion of Investigator or Sponsor|7|||
48760894|NCT00484939|156972373|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
48760895|NCT00484939|156972372|FG000|Overall Study|Disease progression|67|||
48760896|NCT00484939|156972373|FG001|Overall Study|Disease progression|88|||
48760897|NCT00484939|156972372|FG000|Overall Study|Screen Failure|2|||
48760898|NCT00484939|156972373|FG001|Overall Study|Screen Failure|2|||
48760899|NCT00484939|156972372|FG000|Overall Study|Reason Not Specified|11|||
48760900|NCT00484939|156972373|FG001|Overall Study|Reason Not Specified|6|||
48760901|NCT00101907|156972376|FG000|Overall Study|Adverse Event|1|||
48760902|NCT00101907|156972377|FG001|Overall Study|Adverse Event|0|||
48760903|NCT00101907|156972378|FG002|Overall Study|Adverse Event|0|||
48760904|NCT00101907|156972379|FG003|Overall Study|Adverse Event|0|||
48760905|NCT00101907|156972380|FG004|Overall Study|Adverse Event|0|||
48760906|NCT00101907|156972381|FG005|Overall Study|Adverse Event|0|||
48760907|NCT00101907|156972376|FG000|Overall Study|Death|0|||
48760908|NCT00101907|156972377|FG001|Overall Study|Death|1|||
48970323|NCT00291499|157720871|FG000|Overall Study|Protocol Violation|2|||
48970324|NCT00291499|157720872|FG001|Overall Study|Protocol Violation|2|||
48672788|NCT02126839|156653621|FG001|Overall Study|Withdrawal by Subject|0|||
48672789|NCT02126839|156653620|FG000|Overall Study|Withdrawal by parent/guardian|1|||
48760909|NCT00101907|156972378|FG002|Overall Study|Death|0|||
48672790|NCT02126839|156653621|FG001|Overall Study|Withdrawal by parent/guardian|0|||
48672791|NCT02126839|156653620|FG000|Overall Study|Protocol Violation|2|||
48970325|NCT00291499|157720871|FG000|Overall Study|Other reasons|1|||
48970326|NCT00291499|157720872|FG001|Overall Study|Other reasons|4|||
48970327|NCT04325906|157720873|FG000|Overall Study|Withdrawal by Subject|2|||
48970328|NCT04325906|157720874|FG001|Overall Study|Withdrawal by Subject|0|||
48970329|NCT00618995|157720875|FG000|Period 1|Adverse Event|0|||
48970330|NCT00618995|157720876|FG001|Period 1|Adverse Event|0|||
48970331|NCT00618995|157720877|FG002|Period 1|Adverse Event|1|||
48970332|NCT00618995|157720878|FG003|Period 1|Adverse Event|0|||
48970333|NCT00618995|157720875|FG000|Period 1|Protocol Violation|0|||
48970334|NCT00618995|157720876|FG001|Period 1|Protocol Violation|1|||
48970335|NCT00618995|157720877|FG002|Period 1|Protocol Violation|1|||
48970336|NCT00618995|157720878|FG003|Period 1|Protocol Violation|0|||
48970337|NCT00618995|157720875|FG000|Period 2|Protocol Violation|0|||
48970338|NCT00618995|157720876|FG001|Period 2|Protocol Violation|0|||
48970339|NCT00618995|157720877|FG002|Period 2|Protocol Violation|1|||
48970340|NCT00618995|157720878|FG003|Period 2|Protocol Violation|0|||
48970341|NCT00618995|157720875|FG000|Period 4|Adverse Event|1|||
48970342|NCT00618995|157720876|FG001|Period 4|Adverse Event|0|||
48970343|NCT00618995|157720877|FG002|Period 4|Adverse Event|0|||
48970344|NCT00618995|157720878|FG003|Period 4|Adverse Event|0|||
48970345|NCT00282568|157720881|FG000|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2|||
48970346|NCT00282568|157720881|FG000|Pharmacokinetic Treatment Period|Enrolled erroneously|1|||
48970347|NCT00282568|157720881|FG000|Extended Treatment Period|Adverse Event|17|||
48970348|NCT00282568|157720881|FG000|Extended Treatment Period|Non-compliance|4|||
48970349|NCT00282568|157720881|FG000|Extended Treatment Period|Physician Decision|1|||
48760910|NCT00101907|156972379|FG003|Overall Study|Death|0|||
48970350|NCT00282568|157720881|FG000|Extended Treatment Period|Lost to Follow-up|2|||
48970351|NCT00830960|157720884|FG000|Overall Study|Death|5|||
48970352|NCT00830960|157720885|FG001|Overall Study|Death|4|||
48970353|NCT00830960|157720886|FG002|Overall Study|Death|3|||
48970354|NCT00830960|157720887|FG003|Overall Study|Death|2|||
48970355|NCT00830960|157720888|FG004|Overall Study|Death|6|||
48970356|NCT00830960|157720889|FG005|Overall Study|Death|1|||
48970357|NCT00830960|157720884|FG000|Overall Study|Lost to Follow-up|1|||
48970358|NCT00830960|157720885|FG001|Overall Study|Lost to Follow-up|1|||
48970359|NCT00830960|157720886|FG002|Overall Study|Lost to Follow-up|1|||
48970360|NCT00830960|157720887|FG003|Overall Study|Lost to Follow-up|0|||
48970361|NCT00830960|157720888|FG004|Overall Study|Lost to Follow-up|0|||
48672792|NCT02126839|156653621|FG001|Overall Study|Protocol Violation|3|||
48672793|NCT02126839|156653620|FG000|Overall Study|Sponsor request|0|||
48672794|NCT02126839|156653621|FG001|Overall Study|Sponsor request|1|||
48672795|NCT02126839|156653620|FG000|Overall Study|Lost to Follow-up|1|||
48672796|NCT02126839|156653621|FG001|Overall Study|Lost to Follow-up|4|||
48672797|NCT02126839|156653620|FG000|Overall Study|Other|5|||
48672798|NCT02126839|156653621|FG001|Overall Study|Other|5|||
48672799|NCT00812565|156653622|FG000|Overall Study|Did Not Receive Study Medication|1|||
48672800|NCT00812565|156653623|FG001|Overall Study|Did Not Receive Study Medication|1|||
48672801|NCT00812565|156653624|FG002|Overall Study|Did Not Receive Study Medication|0|||
48672802|NCT00812565|156653625|FG003|Overall Study|Did Not Receive Study Medication|0|||
48672803|NCT00812565|156653626|FG004|Overall Study|Did Not Receive Study Medication|0|||
48672804|NCT00812565|156653627|FG005|Overall Study|Did Not Receive Study Medication|0|||
48672805|NCT00812565|156653628|FG006|Overall Study|Did Not Receive Study Medication|0|||
48672806|NCT00812565|156653629|FG007|Overall Study|Did Not Receive Study Medication|0|||
48672807|NCT00812565|156653622|FG000|Overall Study|Adverse Event|0|||
48672808|NCT00812565|156653623|FG001|Overall Study|Adverse Event|0|||
48672809|NCT00812565|156653624|FG002|Overall Study|Adverse Event|0|||
48760911|NCT00101907|156972380|FG004|Overall Study|Death|3|||
48760912|NCT00101907|156972381|FG005|Overall Study|Death|0|||
48970362|NCT00830960|157720889|FG005|Overall Study|Lost to Follow-up|1|||
48760913|NCT00101907|156972376|FG000|Overall Study|Physician Decision|0|||
48970363|NCT00830960|157720884|FG000|Overall Study|Withdrawal by Subject|19|||
48970364|NCT00830960|157720885|FG001|Overall Study|Withdrawal by Subject|19|||
48970365|NCT00830960|157720886|FG002|Overall Study|Withdrawal by Subject|18|||
48970366|NCT00830960|157720887|FG003|Overall Study|Withdrawal by Subject|23|||
48970367|NCT00830960|157720888|FG004|Overall Study|Withdrawal by Subject|16|||
48970368|NCT00830960|157720889|FG005|Overall Study|Withdrawal by Subject|21|||
48970369|NCT00830960|157720884|FG000|Overall Study|Sponsor Decision|1|||
48672810|NCT00812565|156653625|FG003|Overall Study|Adverse Event|2|||
48672811|NCT00812565|156653626|FG004|Overall Study|Adverse Event|0|||
48672812|NCT00812565|156653627|FG005|Overall Study|Adverse Event|0|||
48760914|NCT00101907|156972377|FG001|Overall Study|Physician Decision|0|||
48970370|NCT00830960|157720885|FG001|Overall Study|Sponsor Decision|2|||
48970371|NCT00830960|157720886|FG002|Overall Study|Sponsor Decision|3|||
48970372|NCT00830960|157720887|FG003|Overall Study|Sponsor Decision|4|||
48872333|NCT01774019|157369735|FG001|Overall Study|Unable to implant study device|0|||
48872334|NCT01774019|157369734|FG000|Overall Study|Lost to Follow-up|0|||
48872335|NCT01774019|157369735|FG001|Overall Study|Lost to Follow-up|3|||
48872336|NCT01004185|157369736|FG000|Overall Study|Adverse Event|1|||
48872337|NCT01004185|157369737|FG001|Overall Study|Adverse Event|1|||
48872338|NCT01004185|157369736|FG000|Overall Study|Lost to Follow-up|0|||
48872339|NCT01004185|157369737|FG001|Overall Study|Lost to Follow-up|1|||
48872340|NCT01004185|157369736|FG000|Overall Study|Lack of Efficacy|2|||
48872341|NCT01004185|157369737|FG001|Overall Study|Lack of Efficacy|1|||
48872342|NCT01004185|157369736|FG000|Overall Study|Sponsor Terminated Study|4|||
48872343|NCT01004185|157369737|FG001|Overall Study|Sponsor Terminated Study|5|||
48872344|NCT01004185|157369736|FG000|Overall Study|Withdrawal by Subject|2|||
48872345|NCT01004185|157369737|FG001|Overall Study|Withdrawal by Subject|1|||
48872346|NCT03481556|157369741|FG000|Overall Study|Adverse Event|1|||
48872347|NCT03481556|157369742|FG001|Overall Study|Adverse Event|0|||
48872348|NCT03481556|157369743|FG002|Overall Study|Adverse Event|0|||
48872349|NCT03481556|157369744|FG003|Overall Study|Adverse Event|0|||
48872350|NCT03481556|157369741|FG000|Overall Study|Death|4|||
48872351|NCT03481556|157369742|FG001|Overall Study|Death|2|||
48872352|NCT03481556|157369743|FG002|Overall Study|Death|3|||
48872353|NCT03481556|157369744|FG003|Overall Study|Death|16|||
48872354|NCT03481556|157369741|FG000|Overall Study|Study Terminated by Sponsor|10|||
48872355|NCT03481556|157369742|FG001|Overall Study|Study Terminated by Sponsor|5|||
48872356|NCT03481556|157369743|FG002|Overall Study|Study Terminated by Sponsor|2|||
48872357|NCT03481556|157369744|FG003|Overall Study|Study Terminated by Sponsor|9|||
48970373|NCT00830960|157720888|FG004|Overall Study|Sponsor Decision|5|||
48970374|NCT00830960|157720889|FG005|Overall Study|Sponsor Decision|7|||
48760915|NCT00101907|156972378|FG002|Overall Study|Physician Decision|0|||
48760916|NCT00101907|156972379|FG003|Overall Study|Physician Decision|1|||
48760917|NCT00101907|156972380|FG004|Overall Study|Physician Decision|1|||
48760918|NCT00101907|156972381|FG005|Overall Study|Physician Decision|0|||
48760919|NCT00101907|156972376|FG000|Overall Study|Withdrawal by Subject|1|||
48760920|NCT00101907|156972377|FG001|Overall Study|Withdrawal by Subject|0|||
48760921|NCT00101907|156972378|FG002|Overall Study|Withdrawal by Subject|1|||
48760922|NCT00101907|156972379|FG003|Overall Study|Withdrawal by Subject|0|||
48760923|NCT00101907|156972380|FG004|Overall Study|Withdrawal by Subject|1|||
48760924|NCT00101907|156972381|FG005|Overall Study|Withdrawal by Subject|0|||
48760925|NCT00994240|156972382|FG000|Overall Study|Lost to Follow-up|3|||
48760926|NCT00994240|156972383|FG001|Overall Study|Lost to Follow-up|2|||
48760927|NCT00994240|156972382|FG000|Overall Study|Withdrawal by Subject|1|||
48760928|NCT00994240|156972383|FG001|Overall Study|Withdrawal by Subject|0|||
48760929|NCT00994240|156972382|FG000|Overall Study|study termination|2|||
48760930|NCT00994240|156972383|FG001|Overall Study|study termination|3|||
48760931|NCT00651755|156972384|FG000|Cycle 1 (First 21 Days)|Withdrawal by Subject|1|||
48760932|NCT00651755|156972385|FG001|Cycle 1 (First 21 Days)|Withdrawal by Subject|0|||
48760933|NCT00651755|156972384|FG000|Cycle 2 (Second 21 Days)|Not Evaluable|0|||
48760934|NCT00651755|156972385|FG001|Cycle 2 (Second 21 Days)|Not Evaluable|1|||
48760935|NCT03245008|156972388|FG000|Overall Study|Adverse Event|15|||
48760936|NCT03245008|156972389|FG001|Overall Study|Adverse Event|18|||
48760937|NCT03245008|156972390|FG002|Overall Study|Adverse Event|15|||
48760938|NCT03245008|156972391|FG003|Overall Study|Adverse Event|0|||
48760939|NCT03245008|156972392|FG004|Overall Study|Adverse Event|1|||
48760940|NCT03245008|156972388|FG000|Overall Study|Lack of Efficacy|0|||
48760941|NCT03245008|156972389|FG001|Overall Study|Lack of Efficacy|1|||
48760942|NCT03245008|156972390|FG002|Overall Study|Lack of Efficacy|0|||
48760943|NCT03245008|156972391|FG003|Overall Study|Lack of Efficacy|0|||
48760944|NCT03245008|156972392|FG004|Overall Study|Lack of Efficacy|0|||
48872358|NCT00619983|157369745|FG000|Test Drug Alone|Withdrawal by Subject|1|||
48872359|NCT00619983|157369746|FG001|Test Drug Alone|Withdrawal by Subject|0|||
48872360|NCT00619983|157369747|FG002|Test Drug Alone|Withdrawal by Subject|0|||
48872361|NCT00619983|157369748|FG003|Test Drug Alone|Withdrawal by Subject|1|||
48872362|NCT00619983|157369745|FG000|Test Drug Alone|Failure of daily diary device|1|||
48872363|NCT00619983|157369746|FG001|Test Drug Alone|Failure of daily diary device|1|||
48872364|NCT00619983|157369747|FG002|Test Drug Alone|Failure of daily diary device|2|||
48760945|NCT03245008|156972388|FG000|Overall Study|Lost to Follow-up|4|||
48760946|NCT03245008|156972389|FG001|Overall Study|Lost to Follow-up|1|||
48760947|NCT03245008|156972390|FG002|Overall Study|Lost to Follow-up|0|||
48872365|NCT00619983|157369748|FG003|Test Drug Alone|Failure of daily diary device|2|||
48872366|NCT01316887|157369749|FG000|Overall Study|Adverse Event|13|||
48872367|NCT01316887|157369750|FG001|Overall Study|Adverse Event|21|||
48872368|NCT01316887|157369751|FG002|Overall Study|Adverse Event|17|||
48872369|NCT01316887|157369749|FG000|Overall Study|Lack of Efficacy|9|||
48872370|NCT01316887|157369750|FG001|Overall Study|Lack of Efficacy|3|||
48872371|NCT01316887|157369751|FG002|Overall Study|Lack of Efficacy|1|||
48872372|NCT01316887|157369749|FG000|Overall Study|Protocol Violation|2|||
48760948|NCT03245008|156972391|FG003|Overall Study|Lost to Follow-up|0|||
48872373|NCT01316887|157369750|FG001|Overall Study|Protocol Violation|6|||
48970375|NCT00830960|157720884|FG000|Overall Study|No study drug received|7|||
48672813|NCT00812565|156653628|FG006|Overall Study|Adverse Event|0|||
48672814|NCT00812565|156653629|FG007|Overall Study|Adverse Event|1|||
48672815|NCT00812565|156653622|FG000|Overall Study|Did Not Come to Study Visit|1|||
48672816|NCT00812565|156653623|FG001|Overall Study|Did Not Come to Study Visit|0|||
48970376|NCT00830960|157720885|FG001|Overall Study|No study drug received|2|||
48970377|NCT00830960|157720886|FG002|Overall Study|No study drug received|4|||
48970378|NCT00830960|157720887|FG003|Overall Study|No study drug received|3|||
48970379|NCT00830960|157720888|FG004|Overall Study|No study drug received|5|||
48970380|NCT00830960|157720889|FG005|Overall Study|No study drug received|7|||
48970381|NCT03074149|157720890|FG000|Overall Study|Reason unknown|22|||
48970382|NCT03074149|157720891|FG001|Overall Study|Reason unknown|35|||
48970383|NCT03074149|157720890|FG000|Overall Study|Death|10|||
48970384|NCT03074149|157720891|FG001|Overall Study|Death|45|||
48970385|NCT01376245|157720893|FG000|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66|||
48970386|NCT01376245|157720894|FG001|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
48970387|NCT01376245|157720895|FG002|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
48970388|NCT01376245|157720896|FG003|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
48970389|NCT01376245|157720897|FG004|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
48970390|NCT01376245|157720893|FG000|2-wk Single-blind Placebo Run-in Period|Adverse Event|4|||
48970391|NCT01376245|157720894|FG001|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
48970392|NCT01376245|157720895|FG002|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
48970393|NCT01376245|157720896|FG003|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
48970394|NCT01376245|157720897|FG004|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
48970395|NCT01376245|157720893|FG000|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1|||
48970396|NCT01376245|157720894|FG001|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
48970397|NCT01376245|157720895|FG002|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
48970398|NCT01376245|157720896|FG003|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
48970399|NCT01376245|157720897|FG004|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
48970400|NCT01376245|157720893|FG000|2-wk Single-blind Placebo Run-in Period|Physician Decision|2|||
48970401|NCT01376245|157720894|FG001|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
48970402|NCT01376245|157720895|FG002|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
48970403|NCT01376245|157720896|FG003|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
48970404|NCT01376245|157720897|FG004|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
48970405|NCT01376245|157720893|FG000|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28|||
48970406|NCT01376245|157720894|FG001|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
48970407|NCT01376245|157720895|FG002|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
48970408|NCT01376245|157720896|FG003|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
48970409|NCT01376245|157720897|FG004|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
48970410|NCT01376245|157720893|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
48970411|NCT01376245|157720894|FG001|24-week, Double-blind Treatment Period|Adverse Event|16|||
48970412|NCT01376245|157720895|FG002|24-week, Double-blind Treatment Period|Adverse Event|7|||
48970413|NCT01376245|157720896|FG003|24-week, Double-blind Treatment Period|Adverse Event|8|||
48970414|NCT01376245|157720897|FG004|24-week, Double-blind Treatment Period|Adverse Event|18|||
48970415|NCT01376245|157720893|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy|0|||
48970416|NCT01376245|157720894|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
48970417|NCT01376245|157720895|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy|5|||
48970418|NCT01376245|157720896|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
48970419|NCT01376245|157720897|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy|3|||
48970420|NCT01376245|157720893|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
48970421|NCT01376245|157720894|FG001|24-week, Double-blind Treatment Period|Protocol Violation|2|||
48970422|NCT01376245|157720895|FG002|24-week, Double-blind Treatment Period|Protocol Violation|0|||
48970423|NCT01376245|157720896|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
48970424|NCT01376245|157720897|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
48970425|NCT01376245|157720893|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
48970426|NCT01376245|157720894|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2|||
48970427|NCT01376245|157720895|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3|||
48970428|NCT01376245|157720896|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1|||
48970429|NCT01376245|157720897|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
48970430|NCT01376245|157720893|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
48970431|NCT01376245|157720894|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
48970432|NCT01376245|157720895|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
48970433|NCT01376245|157720896|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
48672817|NCT00812565|156653624|FG002|Overall Study|Did Not Come to Study Visit|0|||
48672818|NCT00812565|156653625|FG003|Overall Study|Did Not Come to Study Visit|0|||
48672819|NCT00812565|156653626|FG004|Overall Study|Did Not Come to Study Visit|0|||
48672820|NCT00812565|156653627|FG005|Overall Study|Did Not Come to Study Visit|0|||
48672821|NCT00812565|156653628|FG006|Overall Study|Did Not Come to Study Visit|0|||
48672822|NCT00812565|156653629|FG007|Overall Study|Did Not Come to Study Visit|0|||
48672823|NCT00812565|156653622|FG000|Overall Study|Withdrawal of Consent|1|||
48672824|NCT00812565|156653623|FG001|Overall Study|Withdrawal of Consent|0|||
48672825|NCT00812565|156653624|FG002|Overall Study|Withdrawal of Consent|0|||
48672826|NCT00812565|156653625|FG003|Overall Study|Withdrawal of Consent|0|||
48672827|NCT00812565|156653626|FG004|Overall Study|Withdrawal of Consent|1|||
48872374|NCT01316887|157369751|FG002|Overall Study|Protocol Violation|6|||
48872375|NCT01316887|157369749|FG000|Overall Study|Protocol-defined Stopping Criteria|8|||
48872376|NCT01316887|157369750|FG001|Overall Study|Protocol-defined Stopping Criteria|37|||
48872377|NCT01316887|157369751|FG002|Overall Study|Protocol-defined Stopping Criteria|36|||
48872378|NCT01316887|157369749|FG000|Overall Study|Study Closed/Terminated|2|||
48872379|NCT01316887|157369750|FG001|Overall Study|Study Closed/Terminated|4|||
48872380|NCT01316887|157369751|FG002|Overall Study|Study Closed/Terminated|3|||
48872381|NCT01316887|157369749|FG000|Overall Study|Lost to Follow-up|1|||
48872382|NCT01316887|157369750|FG001|Overall Study|Lost to Follow-up|7|||
48872383|NCT01316887|157369751|FG002|Overall Study|Lost to Follow-up|5|||
48872384|NCT01316887|157369749|FG000|Overall Study|Withdrawal by Subject|8|||
48872385|NCT01316887|157369750|FG001|Overall Study|Withdrawal by Subject|16|||
48872386|NCT01316887|157369751|FG002|Overall Study|Withdrawal by Subject|15|||
48872387|NCT00809341|157369752|FG000|Overall Study|Physician Decision|0|||
48872388|NCT00809341|157369753|FG001|Overall Study|Physician Decision|1|||
48872389|NCT02447432|157369756|FG000|Epoch 001|Adverse Event|1|||
48872390|NCT02447432|157369757|FG001|Epoch 001|Adverse Event|1|||
48872391|NCT02447432|157369756|FG000|Epoch 001|Withdrawal by Subject|0|||
48872392|NCT02447432|157369757|FG001|Epoch 001|Withdrawal by Subject|4|||
48872393|NCT02447432|157369756|FG000|Epoch 001|Migrated/moved from study area|3|||
48872394|NCT02447432|157369757|FG001|Epoch 001|Migrated/moved from study area|5|||
48872395|NCT02447432|157369756|FG000|Epoch 001|Lost to Follow-up|1|||
48872396|NCT02447432|157369757|FG001|Epoch 001|Lost to Follow-up|3|||
48872397|NCT03245619|157369760|FG000|Part A (Up to Day 22)|Physician Decision|4|||
48872398|NCT03245619|157369761|FG001|Part A (Up to Day 22)|Physician Decision|6|||
48872399|NCT03245619|157369762|FG002|Part A (Up to Day 22)|Physician Decision|6|||
48872400|NCT03245619|157369763|FG003|Part A (Up to Day 22)|Physician Decision|0|||
48872401|NCT03245619|157369764|FG004|Part A (Up to Day 22)|Physician Decision|0|||
48872402|NCT03245619|157369765|FG005|Part A (Up to Day 22)|Physician Decision|0|||
48872403|NCT03245619|157369766|FG006|Part A (Up to Day 22)|Physician Decision|0|||
48872404|NCT03245619|157369767|FG007|Part A (Up to Day 22)|Physician Decision|0|||
48872405|NCT03245619|157369768|FG008|Part A (Up to Day 22)|Physician Decision|0|||
48872406|NCT03245619|157369769|FG009|Part A (Up to Day 22)|Physician Decision|0|||
48872407|NCT03245619|157369770|FG010|Part A (Up to Day 22)|Physician Decision|0|||
48872408|NCT03245619|157369771|FG011|Part A (Up to Day 22)|Physician Decision|0|||
48872409|NCT03245619|157369772|FG012|Part A (Up to Day 22)|Physician Decision|0|||
48872410|NCT03245619|157369773|FG013|Part A (Up to Day 22)|Physician Decision|0|||
48872411|NCT03245619|157369774|FG014|Part A (Up to Day 22)|Physician Decision|0|||
48872412|NCT03245619|157369775|FG015|Part A (Up to Day 22)|Physician Decision|0|||
48872413|NCT03245619|157369776|FG016|Part A (Up to Day 22)|Physician Decision|0|||
48872414|NCT01340300|157369777|FG000|Overall Study|Lost to Follow-up|3|||
48872415|NCT01340300|157369778|FG001|Overall Study|Lost to Follow-up|0|||
48872416|NCT01340300|157369779|FG002|Overall Study|Lost to Follow-up|5|||
48872417|NCT01340300|157369780|FG003|Overall Study|Lost to Follow-up|10|||
48872418|NCT01340300|157369777|FG000|Overall Study|Withdrawal by Subject|5|||
48872419|NCT01340300|157369778|FG001|Overall Study|Withdrawal by Subject|6|||
48872420|NCT01340300|157369779|FG002|Overall Study|Withdrawal by Subject|6|||
48872421|NCT01340300|157369780|FG003|Overall Study|Withdrawal by Subject|3|||
48872422|NCT01340300|157369777|FG000|Overall Study|Adverse Event|1|||
48872423|NCT01340300|157369778|FG001|Overall Study|Adverse Event|0|||
48872424|NCT01340300|157369779|FG002|Overall Study|Adverse Event|4|||
48872425|NCT01340300|157369780|FG003|Overall Study|Adverse Event|0|||
48872426|NCT01340300|157369777|FG000|Overall Study|Physician Decision|0|||
48872427|NCT01340300|157369778|FG001|Overall Study|Physician Decision|1|||
48872428|NCT01340300|157369779|FG002|Overall Study|Physician Decision|0|||
48872429|NCT01340300|157369780|FG003|Overall Study|Physician Decision|0|||
48872430|NCT01340300|157369777|FG000|Overall Study|Unrelated sickness|0|||
48872431|NCT01340300|157369778|FG001|Overall Study|Unrelated sickness|2|||
48872432|NCT01340300|157369779|FG002|Overall Study|Unrelated sickness|0|||
48872433|NCT01340300|157369780|FG003|Overall Study|Unrelated sickness|1|||
48872434|NCT03544229|157369781|FG000|Overall Study|Adverse Event|1|||
48872435|NCT03544229|157369782|FG001|Overall Study|Adverse Event|0|||
48872436|NCT03544229|157369783|FG002|Overall Study|Adverse Event|1|||
48872437|NCT03544229|157369784|FG003|Overall Study|Adverse Event|0|||
48872438|NCT03544229|157369781|FG000|Overall Study|Protocol Deviation|0|||
48872439|NCT03544229|157369782|FG001|Overall Study|Protocol Deviation|0|||
48872440|NCT03544229|157369783|FG002|Overall Study|Protocol Deviation|1|||
48872441|NCT03544229|157369784|FG003|Overall Study|Protocol Deviation|0|||
48872442|NCT03544229|157369781|FG000|Overall Study|Lost to Follow-up|3|||
48872443|NCT03544229|157369782|FG001|Overall Study|Lost to Follow-up|0|||
48760949|NCT03245008|156972392|FG004|Overall Study|Lost to Follow-up|1|||
48872444|NCT03544229|157369783|FG002|Overall Study|Lost to Follow-up|0|||
48872445|NCT03544229|157369784|FG003|Overall Study|Lost to Follow-up|2|||
48872446|NCT03544229|157369781|FG000|Overall Study|Voluntary Withdrawal|2|||
48872447|NCT03544229|157369782|FG001|Overall Study|Voluntary Withdrawal|1|||
48872448|NCT03544229|157369783|FG002|Overall Study|Voluntary Withdrawal|3|||
48872449|NCT03544229|157369784|FG003|Overall Study|Voluntary Withdrawal|0|||
48872450|NCT03544229|157369781|FG000|Overall Study|Lack of Efficacy|0|||
48872451|NCT03544229|157369782|FG001|Overall Study|Lack of Efficacy|1|||
48872452|NCT03544229|157369783|FG002|Overall Study|Lack of Efficacy|0|||
48872453|NCT03544229|157369784|FG003|Overall Study|Lack of Efficacy|0|||
48872454|NCT01836198|157369788|FG000|Part A, Period 2|Protocol Violation|0|||
48872455|NCT01836198|157369789|FG001|Part A, Period 2|Protocol Violation|1|||
48872456|NCT01836198|157369790|FG002|Part A, Period 2|Protocol Violation|0|||
48872457|NCT00217022|157369797|FG000|Overall Study|Withdrawal by Subject|1|||
48872458|NCT00217022|157369798|FG001|Overall Study|Withdrawal by Subject|1|||
48872459|NCT00409409|157369799|FG000|Overall Study|Adverse Event|7|||
48872460|NCT00409409|157369800|FG001|Overall Study|Adverse Event|2|||
48872461|NCT00409409|157369799|FG000|Overall Study|Withdrawal by Subject|1|||
48872462|NCT00409409|157369800|FG001|Overall Study|Withdrawal by Subject|1|||
48872463|NCT00409409|157369799|FG000|Overall Study|Any other reason not above-mentioned|0|||
48872464|NCT00409409|157369800|FG001|Overall Study|Any other reason not above-mentioned|1|||
48872465|NCT00591591|157369801|FG000|Overall Study|Withdrawal by Subject|1|||
48872466|NCT00591591|157369802|FG001|Overall Study|Withdrawal by Subject|37|||
48872467|NCT00591591|157369801|FG000|Overall Study|Lack of Efficacy|10|||
48872468|NCT00591591|157369802|FG001|Overall Study|Lack of Efficacy|2|||
48872469|NCT01880437|157369806|FG000|Overall Study|Death|12|||
48872470|NCT01880437|157369807|FG001|Overall Study|Death|4|||
48872471|NCT01880437|157369808|FG002|Overall Study|Death|17|||
48760950|NCT03245008|156972388|FG000|Overall Study|Physician Decision|1|||
48760951|NCT03245008|156972389|FG001|Overall Study|Physician Decision|3|||
48760952|NCT03245008|156972390|FG002|Overall Study|Physician Decision|4|||
48760953|NCT03245008|156972391|FG003|Overall Study|Physician Decision|0|||
48760954|NCT03245008|156972392|FG004|Overall Study|Physician Decision|0|||
48760955|NCT03245008|156972388|FG000|Overall Study|Protocol Violation|0|||
48760956|NCT03245008|156972389|FG001|Overall Study|Protocol Violation|1|||
48760957|NCT03245008|156972390|FG002|Overall Study|Protocol Violation|0|||
48760958|NCT03245008|156972391|FG003|Overall Study|Protocol Violation|0|||
48760959|NCT03245008|156972392|FG004|Overall Study|Protocol Violation|0|||
48760960|NCT03245008|156972388|FG000|Overall Study|Withdrawal by Subject|20|||
48760961|NCT03245008|156972389|FG001|Overall Study|Withdrawal by Subject|19|||
48760962|NCT03245008|156972390|FG002|Overall Study|Withdrawal by Subject|11|||
48760963|NCT03245008|156972391|FG003|Overall Study|Withdrawal by Subject|0|||
48760964|NCT03245008|156972392|FG004|Overall Study|Withdrawal by Subject|0|||
48760965|NCT03245008|156972388|FG000|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
48760966|NCT03245008|156972389|FG001|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
48760967|NCT03245008|156972390|FG002|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
48760968|NCT03245008|156972391|FG003|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
48760969|NCT03245008|156972392|FG004|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
48760970|NCT03245008|156972388|FG000|Overall Study|Failure to meet randomization criteria|0|||
48760971|NCT03245008|156972389|FG001|Overall Study|Failure to meet randomization criteria|1|||
48760972|NCT03245008|156972390|FG002|Overall Study|Failure to meet randomization criteria|0|||
48760973|NCT03245008|156972391|FG003|Overall Study|Failure to meet randomization criteria|1|||
48760974|NCT03245008|156972392|FG004|Overall Study|Failure to meet randomization criteria|0|||
48760975|NCT03204981|156973957|FG000|Overall Study|Physician Decision|2|||
48760976|NCT03204981|156973957|FG000|Overall Study|Screen failures (no inducible VT or PVCs)|4|||
48760977|NCT00951665|156973958|FG000|Phase 1b|Adverse Event|2|||
48760978|NCT00951665|156973959|FG001|Phase 1b|Adverse Event|1|||
48760979|NCT00951665|156973960|FG002|Phase 1b|Adverse Event|0|||
48872472|NCT01880437|157369806|FG000|Overall Study|Study terminated by Sponsor|3|||
48872473|NCT01880437|157369807|FG001|Overall Study|Study terminated by Sponsor|0|||
48872474|NCT01880437|157369808|FG002|Overall Study|Study terminated by Sponsor|2|||
48872475|NCT00510146|157369811|FG000|Double-Blind Treatment|Adverse Event|30|||
48760980|NCT00951665|156973961|FG003|Phase 1b|Adverse Event|1|||
48760981|NCT00951665|156973962|FG004|Phase 1b|Adverse Event|0|||
48760982|NCT00951665|156973963|FG005|Phase 1b|Adverse Event|0|||
48760983|NCT00951665|156973958|FG000|Phase 1b|Death|1|||
48760984|NCT00951665|156973959|FG001|Phase 1b|Death|0|||
48760985|NCT00951665|156973960|FG002|Phase 1b|Death|2|||
48872476|NCT00510146|157369812|FG001|Double-Blind Treatment|Adverse Event|13|||
48872477|NCT00510146|157369811|FG000|Double-Blind Treatment|Lack of Efficacy|6|||
48872478|NCT00510146|157369812|FG001|Double-Blind Treatment|Lack of Efficacy|13|||
48872479|NCT00510146|157369811|FG000|Double-Blind Treatment|Lost to Follow-up|3|||
48872480|NCT00510146|157369812|FG001|Double-Blind Treatment|Lost to Follow-up|7|||
48872481|NCT00510146|157369811|FG000|Double-Blind Treatment|Physician Decision|6|||
48872482|NCT00510146|157369812|FG001|Double-Blind Treatment|Physician Decision|0|||
48970434|NCT01376245|157720897|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
48970435|NCT01376245|157720893|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
48970436|NCT01376245|157720894|FG001|24-week, Double-blind Treatment Period|Physician Decision|0|||
48970437|NCT01376245|157720895|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
48970438|NCT01376245|157720896|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
48970439|NCT01376245|157720897|FG004|24-week, Double-blind Treatment Period|Physician Decision|0|||
48970440|NCT01376245|157720893|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
48970441|NCT01376245|157720894|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
48970442|NCT01376245|157720895|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
48970443|NCT01376245|157720896|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
48970444|NCT01376245|157720897|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
48970445|NCT00961116|157720898|FG000|Washout Period of 7 Days|Adverse Event|1|||
48970446|NCT00961116|157720899|FG001|Washout Period of 7 Days|Adverse Event|1|||
48970447|NCT00961116|157720898|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
48970448|NCT00961116|157720899|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
48970449|NCT00961116|157720898|FG000|Washout Period of 7 Days|Protocol Violation|0|||
48970450|NCT00961116|157720899|FG001|Washout Period of 7 Days|Protocol Violation|1|||
48970451|NCT00050960|157720900|FG000|Overall Study|Progressive Disease|137|||
48970452|NCT00050960|157720901|FG001|Overall Study|Progressive Disease|93|||
48970453|NCT00050960|157720900|FG000|Overall Study|Stable Disease|19|||
48970454|NCT00050960|157720901|FG001|Overall Study|Stable Disease|48|||
48970455|NCT00050960|157720900|FG000|Overall Study|Partial Response|14|||
48970456|NCT00050960|157720901|FG001|Overall Study|Partial Response|19|||
48970457|NCT00050960|157720900|FG000|Overall Study|Complete Response|0|||
48970458|NCT00050960|157720901|FG001|Overall Study|Complete Response|2|||
48970459|NCT00050960|157720900|FG000|Overall Study|Adverse Event|62|||
48970460|NCT00050960|157720901|FG001|Overall Study|Adverse Event|61|||
48970461|NCT00050960|157720900|FG000|Overall Study|Lost to Follow-up|0|||
48970462|NCT00050960|157720901|FG001|Overall Study|Lost to Follow-up|1|||
48970463|NCT00050960|157720900|FG000|Overall Study|Withdrawal by Subject|23|||
48970464|NCT00050960|157720901|FG001|Overall Study|Withdrawal by Subject|18|||
48970465|NCT00050960|157720900|FG000|Overall Study|Administrative|31|||
48970466|NCT00050960|157720901|FG001|Overall Study|Administrative|46|||
48970467|NCT00050960|157720900|FG000|Overall Study|Non-compliance|3|||
48970468|NCT00050960|157720901|FG001|Overall Study|Non-compliance|1|||
48970469|NCT00050960|157720900|FG000|Overall Study|Death|13|||
48970470|NCT00050960|157720901|FG001|Overall Study|Death|15|||
48970471|NCT02727660|157720902|FG000|Overall Study|Lack of Efficacy|40|||
48970472|NCT02727660|157720903|FG001|Overall Study|Lack of Efficacy|40|||
48970473|NCT02727660|157720904|FG002|Overall Study|Lack of Efficacy|70|||
48970474|NCT02727660|157720902|FG000|Overall Study|Adverse Event|28|||
48970475|NCT02727660|157720903|FG001|Overall Study|Adverse Event|21|||
48970476|NCT02727660|157720904|FG002|Overall Study|Adverse Event|32|||
48970477|NCT02727660|157720902|FG000|Overall Study|Withdrawal by Subject|26|||
48970478|NCT02727660|157720903|FG001|Overall Study|Withdrawal by Subject|25|||
48970479|NCT02727660|157720904|FG002|Overall Study|Withdrawal by Subject|30|||
48970480|NCT02727660|157720902|FG000|Overall Study|Physician Decision|3|||
48970481|NCT02727660|157720903|FG001|Overall Study|Physician Decision|8|||
48970482|NCT02727660|157720904|FG002|Overall Study|Physician Decision|14|||
48970483|NCT02727660|157720902|FG000|Overall Study|Lost to Follow-up|5|||
48970484|NCT02727660|157720903|FG001|Overall Study|Lost to Follow-up|9|||
48970485|NCT02727660|157720904|FG002|Overall Study|Lost to Follow-up|8|||
48970486|NCT02727660|157720902|FG000|Overall Study|Protocol Violation|7|||
48672828|NCT00812565|156653627|FG005|Overall Study|Withdrawal of Consent|0|||
48672829|NCT00812565|156653628|FG006|Overall Study|Withdrawal of Consent|0|||
48672830|NCT00812565|156653629|FG007|Overall Study|Withdrawal of Consent|0|||
48672831|NCT00812565|156653622|FG000|Overall Study|Reason Not Specified|0|||
48672832|NCT00812565|156653623|FG001|Overall Study|Reason Not Specified|0|||
48672833|NCT00812565|156653624|FG002|Overall Study|Reason Not Specified|0|||
48970487|NCT02727660|157720903|FG001|Overall Study|Protocol Violation|5|||
48970488|NCT02727660|157720904|FG002|Overall Study|Protocol Violation|5|||
48970489|NCT02727660|157720902|FG000|Overall Study|Protocol Specified Disc. Criteria|5|||
48672834|NCT00812565|156653625|FG003|Overall Study|Reason Not Specified|0|||
48970490|NCT02727660|157720903|FG001|Overall Study|Protocol Specified Disc. Criteria|5|||
48970491|NCT02727660|157720904|FG002|Overall Study|Protocol Specified Disc. Criteria|2|||
48970492|NCT02727660|157720902|FG000|Overall Study|Administrative Reasons|2|||
48760986|NCT00951665|156973961|FG003|Phase 1b|Death|0|||
48970493|NCT02727660|157720903|FG001|Overall Study|Administrative Reasons|3|||
48970494|NCT02727660|157720904|FG002|Overall Study|Administrative Reasons|4|||
48970495|NCT03379376|157720905|FG000|Overall Study|Lost to Follow-up|2|||
48970496|NCT03379376|157720905|FG000|Overall Study|Did not wish to complete follow up|1|||
48970497|NCT03379376|157720905|FG000|Overall Study|Overwhelmed, didn't want to continue|1|||
48672835|NCT00812565|156653626|FG004|Overall Study|Reason Not Specified|0|||
48672836|NCT00812565|156653627|FG005|Overall Study|Reason Not Specified|1|||
48672837|NCT00812565|156653628|FG006|Overall Study|Reason Not Specified|0|||
48970498|NCT03379376|157720905|FG000|Overall Study|Death|1|||
48970499|NCT01928082|157720908|FG000|Overall Study|Study terminated.|1|||
48970500|NCT03549117|157720912|FG000|Overall Study|Withdrawal by Subject|1|||
48970501|NCT03549117|157720913|FG001|Overall Study|Withdrawal by Subject|0|||
48970502|NCT00293241|157720914|FG000|Overall Study|Lost to Follow-up|9|||
48970503|NCT00293241|157720915|FG001|Overall Study|Lost to Follow-up|16|||
48970504|NCT00293241|157720914|FG000|Overall Study|Physician Decision|23|||
48970505|NCT00293241|157720915|FG001|Overall Study|Physician Decision|17|||
48970506|NCT00293241|157720914|FG000|Overall Study|Withdrawal by Subject|4|||
48970507|NCT00293241|157720915|FG001|Overall Study|Withdrawal by Subject|8|||
48970508|NCT03803202|157720916|FG000|Overall Study|Other|0|||
48970509|NCT03803202|157720917|FG001|Overall Study|Other|1|||
48970510|NCT03803202|157720918|FG002|Overall Study|Other|0|||
48970511|NCT03803202|157720919|FG003|Overall Study|Other|0|||
48970512|NCT03803202|157720920|FG004|Overall Study|Other|0|||
48970513|NCT03803202|157720921|FG005|Overall Study|Other|0|||
48970514|NCT03803202|157720922|FG006|Overall Study|Other|0|||
48970515|NCT03803202|157720923|FG007|Overall Study|Other|0|||
48970516|NCT03803202|157720924|FG008|Overall Study|Other|0|||
48970517|NCT03803202|157720916|FG000|Overall Study|Death|0|||
48970518|NCT03803202|157720917|FG001|Overall Study|Death|0|||
48970519|NCT03803202|157720918|FG002|Overall Study|Death|0|||
48970520|NCT03803202|157720919|FG003|Overall Study|Death|0|||
48970521|NCT03803202|157720920|FG004|Overall Study|Death|0|||
48970522|NCT03803202|157720921|FG005|Overall Study|Death|1|||
48672838|NCT00812565|156653629|FG007|Overall Study|Reason Not Specified|0|||
48672839|NCT02328027|156653632|FG000|Overall Study|Withdrawal by Subject|0|||
48970523|NCT03803202|157720922|FG006|Overall Study|Death|0|||
48970524|NCT03803202|157720923|FG007|Overall Study|Death|0|||
48970525|NCT03803202|157720924|FG008|Overall Study|Death|0|||
48970526|NCT03803202|157720916|FG000|Overall Study|Withdrawal by Subject|0|||
48970527|NCT03803202|157720917|FG001|Overall Study|Withdrawal by Subject|0|||
48970528|NCT03803202|157720918|FG002|Overall Study|Withdrawal by Subject|1|||
48970529|NCT03803202|157720919|FG003|Overall Study|Withdrawal by Subject|0|||
48970530|NCT03803202|157720920|FG004|Overall Study|Withdrawal by Subject|0|||
48970531|NCT03803202|157720921|FG005|Overall Study|Withdrawal by Subject|0|||
48970532|NCT03803202|157720922|FG006|Overall Study|Withdrawal by Subject|0|||
48970533|NCT03803202|157720923|FG007|Overall Study|Withdrawal by Subject|1|||
48970534|NCT03803202|157720924|FG008|Overall Study|Withdrawal by Subject|0|||
48970535|NCT03803202|157720916|FG000|Overall Study|Lost to Follow-up|0|||
48970536|NCT03803202|157720917|FG001|Overall Study|Lost to Follow-up|0|||
48970537|NCT03803202|157720918|FG002|Overall Study|Lost to Follow-up|0|||
48970538|NCT03803202|157720919|FG003|Overall Study|Lost to Follow-up|1|||
48970539|NCT03803202|157720920|FG004|Overall Study|Lost to Follow-up|1|||
48970540|NCT03803202|157720921|FG005|Overall Study|Lost to Follow-up|0|||
48970541|NCT03803202|157720922|FG006|Overall Study|Lost to Follow-up|1|||
48970542|NCT03803202|157720923|FG007|Overall Study|Lost to Follow-up|0|||
48970543|NCT03803202|157720924|FG008|Overall Study|Lost to Follow-up|0|||
48970544|NCT03595384|157720925|FG000|Overall Study|Other time commitments|8|||
48970545|NCT03595384|157720925|FG000|Overall Study|Changes to session time|7|||
48970546|NCT03595384|157720925|FG000|Overall Study|Relocation out of country|1|||
48970547|NCT01203787|157720926|FG000|Overall Study|Death|12|||
48970548|NCT01203787|157720927|FG001|Overall Study|Death|10|||
48970549|NCT01203787|157720926|FG000|Overall Study|Withdrawal by Subject|6|||
48970550|NCT01203787|157720927|FG001|Overall Study|Withdrawal by Subject|2|||
48970551|NCT01203787|157720926|FG000|Overall Study|Lost to Follow-up|2|||
48970552|NCT01203787|157720927|FG001|Overall Study|Lost to Follow-up|0|||
48970553|NCT01203787|157720926|FG000|Overall Study|Adverse Event|11|||
48970554|NCT01203787|157720927|FG001|Overall Study|Adverse Event|15|||
48970555|NCT01576406|157720928|FG000|Overall Study|Lost to Follow-up|1|||
48970556|NCT01576406|157720929|FG001|Overall Study|Lost to Follow-up|2|||
48970557|NCT01576406|157720930|FG002|Overall Study|Lost to Follow-up|0|||
48672840|NCT02328027|156653633|FG001|Overall Study|Withdrawal by Subject|1|||
48672841|NCT01736618|156653634|FG000|Overall Study|Death|294|||
48970558|NCT01576406|157720931|FG003|Overall Study|Lost to Follow-up|0|||
48672842|NCT01736618|156653634|FG000|Overall Study|Lost to Follow-up|193|||
48672843|NCT01736618|156653634|FG000|Overall Study|Withdrawal by Subject|54|||
48672844|NCT01736618|156653634|FG000|Overall Study|Subject unable to be followed at study location|223|||
48672845|NCT01736618|156653634|FG000|Overall Study|Physician Decision|33|||
48760987|NCT00951665|156973962|FG004|Phase 1b|Death|0|||
48970559|NCT01576406|157720932|FG004|Overall Study|Lost to Follow-up|0|||
48970560|NCT01576406|157720933|FG005|Overall Study|Lost to Follow-up|0|||
48970561|NCT01576406|157720928|FG000|Overall Study|Death|3|||
49015495|NCT01393990|157893773|FG003|Overall Study|Withdrawal by Subject|0|||
48970562|NCT01576406|157720929|FG001|Overall Study|Death|4|||
48970563|NCT01576406|157720930|FG002|Overall Study|Death|8|||
48970564|NCT01576406|157720931|FG003|Overall Study|Death|5|||
48970565|NCT01576406|157720932|FG004|Overall Study|Death|7|||
48970566|NCT01576406|157720933|FG005|Overall Study|Death|9|||
48970567|NCT01576406|157720928|FG000|Overall Study|Non-clinical trial supply of Crizotinib|0|||
48970568|NCT01576406|157720929|FG001|Overall Study|Non-clinical trial supply of Crizotinib|0|||
48970569|NCT01576406|157720930|FG002|Overall Study|Non-clinical trial supply of Crizotinib|1|||
48970570|NCT01576406|157720931|FG003|Overall Study|Non-clinical trial supply of Crizotinib|1|||
48970571|NCT01576406|157720932|FG004|Overall Study|Non-clinical trial supply of Crizotinib|0|||
48970572|NCT01576406|157720933|FG005|Overall Study|Non-clinical trial supply of Crizotinib|0|||
48970573|NCT01576406|157720928|FG000|Overall Study|Withdrawal the consent|2|||
48970574|NCT01576406|157720929|FG001|Overall Study|Withdrawal the consent|2|||
48970575|NCT01576406|157720930|FG002|Overall Study|Withdrawal the consent|5|||
48970576|NCT01576406|157720931|FG003|Overall Study|Withdrawal the consent|1|||
48970577|NCT01576406|157720932|FG004|Overall Study|Withdrawal the consent|1|||
48970578|NCT01576406|157720933|FG005|Overall Study|Withdrawal the consent|3|||
48672846|NCT01736618|156653634|FG000|Overall Study|Transplant or removal of target organ|19|||
48672847|NCT01736618|156653634|FG000|Overall Study|Change in indication or condition|78|||
48672848|NCT01736618|156653634|FG000|Overall Study|Study device explant|103|||
48672849|NCT01736618|156653634|FG000|Overall Study|Unable to complete implant|2|||
48672850|NCT01748825|156653635|FG000|Dose Escalation|Refused further treatment|2|||
48970579|NCT01576406|157720928|FG000|Overall Study|Other|0|||
48970580|NCT01576406|157720929|FG001|Overall Study|Other|0|||
48970581|NCT01576406|157720930|FG002|Overall Study|Other|2|||
48970582|NCT01576406|157720931|FG003|Overall Study|Other|2|||
48970583|NCT01576406|157720932|FG004|Overall Study|Other|0|||
48970584|NCT01576406|157720933|FG005|Overall Study|Other|0|||
48672851|NCT01748825|156653636|FG001|Dose Escalation|Refused further treatment|2|||
48672852|NCT01748825|156653637|FG002|Dose Escalation|Refused further treatment|0|||
48672853|NCT01748825|156653638|FG003|Dose Escalation|Refused further treatment|0|||
48672854|NCT01748825|156653639|FG004|Dose Escalation|Refused further treatment|1|||
48672855|NCT01748825|156653640|FG005|Dose Escalation|Refused further treatment|2|||
48672856|NCT01748825|156653641|FG006|Dose Escalation|Refused further treatment|0|||
48970585|NCT04199793|157720940|FG000|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
48970586|NCT04199793|157720941|FG001|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
48970587|NCT04199793|157720940|FG000|Overall Study|Withdrawal by Subject|1|||
48970588|NCT04199793|157720941|FG001|Overall Study|Withdrawal by Subject|1|||
48970589|NCT01815580|157720942|FG000|Overall Study|Lost to Follow-up|4|||
48970590|NCT01815580|157720943|FG001|Overall Study|Lost to Follow-up|7|||
48970591|NCT01815580|157720942|FG000|Overall Study|Withdrawal by Subject|3|||
48672857|NCT01748825|156653642|FG007|Dose Escalation|Refused further treatment|0|||
48672858|NCT01748825|156653643|FG008|Dose Escalation|Refused further treatment|0|||
48672859|NCT01748825|156653644|FG009|Dose Escalation|Refused further treatment|0|||
48970592|NCT01815580|157720943|FG001|Overall Study|Withdrawal by Subject|4|||
48970593|NCT01815580|157720942|FG000|Overall Study|Excluded from analysis|5|||
48970594|NCT01815580|157720943|FG001|Overall Study|Excluded from analysis|4|||
48970595|NCT00425100|157720947|FG000|Overall Study|Adverse Event|36|||
48970596|NCT00425100|157720947|FG000|Overall Study|Lack of Efficacy|4|||
48970597|NCT00425100|157720947|FG000|Overall Study|Lost to Follow-up|2|||
48672860|NCT01748825|156653635|FG000|Dose Escalation|Switched to alternative treatment|0|||
48672861|NCT01748825|156653636|FG001|Dose Escalation|Switched to alternative treatment|0|||
48672862|NCT01748825|156653637|FG002|Dose Escalation|Switched to alternative treatment|0|||
48672863|NCT01748825|156653638|FG003|Dose Escalation|Switched to alternative treatment|1|||
48672864|NCT01748825|156653639|FG004|Dose Escalation|Switched to alternative treatment|0|||
48672865|NCT01748825|156653640|FG005|Dose Escalation|Switched to alternative treatment|0|||
48672866|NCT01748825|156653641|FG006|Dose Escalation|Switched to alternative treatment|0|||
48672867|NCT01748825|156653642|FG007|Dose Escalation|Switched to alternative treatment|0|||
48672868|NCT01748825|156653643|FG008|Dose Escalation|Switched to alternative treatment|0|||
48672869|NCT01748825|156653644|FG009|Dose Escalation|Switched to alternative treatment|0|||
48672870|NCT01748825|156653635|FG000|Dose Escalation|Adverse Event|0|||
48672871|NCT01748825|156653636|FG001|Dose Escalation|Adverse Event|0|||
48672872|NCT01748825|156653637|FG002|Dose Escalation|Adverse Event|0|||
48672873|NCT01748825|156653638|FG003|Dose Escalation|Adverse Event|0|||
48672874|NCT01748825|156653639|FG004|Dose Escalation|Adverse Event|0|||
48672875|NCT01748825|156653640|FG005|Dose Escalation|Adverse Event|0|||
48672876|NCT01748825|156653641|FG006|Dose Escalation|Adverse Event|1|||
48672877|NCT01748825|156653642|FG007|Dose Escalation|Adverse Event|0|||
48672878|NCT01748825|156653643|FG008|Dose Escalation|Adverse Event|0|||
48672879|NCT01748825|156653644|FG009|Dose Escalation|Adverse Event|0|||
48672880|NCT01748825|156653635|FG000|Dose Expansion|Refused further treatment|0|||
48672881|NCT01748825|156653636|FG001|Dose Expansion|Refused further treatment|0|||
48672882|NCT01748825|156653637|FG002|Dose Expansion|Refused further treatment|0|||
48672883|NCT01748825|156653638|FG003|Dose Expansion|Refused further treatment|0|||
48672884|NCT01748825|156653639|FG004|Dose Expansion|Refused further treatment|0|||
48672885|NCT01748825|156653640|FG005|Dose Expansion|Refused further treatment|0|||
48672886|NCT01748825|156653641|FG006|Dose Expansion|Refused further treatment|0|||
48672887|NCT01748825|156653642|FG007|Dose Expansion|Refused further treatment|0|||
48672888|NCT01748825|156653643|FG008|Dose Expansion|Refused further treatment|1|||
48970598|NCT00425100|157720947|FG000|Overall Study|Protocol Violation|4|||
48970599|NCT00425100|157720947|FG000|Overall Study|Withdrawal by Subject|7|||
48970600|NCT00888615|157720948|FG000|Overall Study|No treatment|2|||
48872483|NCT00510146|157369811|FG000|Double-Blind Treatment|Protocol Violation|1|||
48872484|NCT00510146|157369812|FG001|Double-Blind Treatment|Protocol Violation|2|||
48872485|NCT00510146|157369811|FG000|Double-Blind Treatment|Withdrawal by Subject|27|||
48872486|NCT00510146|157369812|FG001|Double-Blind Treatment|Withdrawal by Subject|13|||
48872487|NCT00510146|157369811|FG000|Double-Blind Treatment|Clinical Relapse|0|||
48970601|NCT00861380|157720951|FG000|Overall Study|Withdrawal Information not recorded|8427|||
48672889|NCT01748825|156653644|FG009|Dose Expansion|Refused further treatment|1|||
48672890|NCT01748825|156653635|FG000|Dose Expansion|Switched to alternative treatment|0|||
48672891|NCT01748825|156653636|FG001|Dose Expansion|Switched to alternative treatment|0|||
48672892|NCT01748825|156653637|FG002|Dose Expansion|Switched to alternative treatment|0|||
48672893|NCT01748825|156653638|FG003|Dose Expansion|Switched to alternative treatment|0|||
48672894|NCT01748825|156653639|FG004|Dose Expansion|Switched to alternative treatment|0|||
48672895|NCT01748825|156653640|FG005|Dose Expansion|Switched to alternative treatment|0|||
48672896|NCT01748825|156653641|FG006|Dose Expansion|Switched to alternative treatment|0|||
48672897|NCT01748825|156653642|FG007|Dose Expansion|Switched to alternative treatment|0|||
48672898|NCT01748825|156653643|FG008|Dose Expansion|Switched to alternative treatment|0|||
48672899|NCT01748825|156653644|FG009|Dose Expansion|Switched to alternative treatment|1|||
48672900|NCT01748825|156653635|FG000|Dose Expansion|Adverse Event|0|||
48672901|NCT01748825|156653636|FG001|Dose Expansion|Adverse Event|0|||
48672902|NCT01748825|156653637|FG002|Dose Expansion|Adverse Event|0|||
48672903|NCT01748825|156653638|FG003|Dose Expansion|Adverse Event|0|||
48672904|NCT01748825|156653639|FG004|Dose Expansion|Adverse Event|0|||
48672905|NCT01748825|156653640|FG005|Dose Expansion|Adverse Event|0|||
48672906|NCT01748825|156653641|FG006|Dose Expansion|Adverse Event|0|||
48672907|NCT01748825|156653642|FG007|Dose Expansion|Adverse Event|0|||
48672908|NCT01748825|156653643|FG008|Dose Expansion|Adverse Event|0|||
48672909|NCT01748825|156653644|FG009|Dose Expansion|Adverse Event|3|||
48872488|NCT00510146|157369812|FG001|Double-Blind Treatment|Clinical Relapse|1|||
48872489|NCT00510146|157369811|FG000|Double-Blind Treatment|Entry Criteria Not Met|3|||
48872490|NCT00510146|157369812|FG001|Double-Blind Treatment|Entry Criteria Not Met|0|||
48872491|NCT00510146|157369811|FG000|Open-Label Treatment|Adverse Event|22|||
48872492|NCT00510146|157369812|FG001|Open-Label Treatment|Adverse Event|8|||
48872493|NCT00510146|157369811|FG000|Open-Label Treatment|Death|1|||
48872494|NCT00510146|157369812|FG001|Open-Label Treatment|Death|1|||
48872495|NCT00510146|157369811|FG000|Open-Label Treatment|Lack of Efficacy|4|||
48872496|NCT00510146|157369812|FG001|Open-Label Treatment|Lack of Efficacy|0|||
48872497|NCT00510146|157369811|FG000|Open-Label Treatment|Lost to Follow-up|10|||
48872498|NCT00510146|157369812|FG001|Open-Label Treatment|Lost to Follow-up|1|||
48872499|NCT00510146|157369811|FG000|Open-Label Treatment|Physician Decision|3|||
48872500|NCT00510146|157369812|FG001|Open-Label Treatment|Physician Decision|1|||
48872501|NCT00510146|157369811|FG000|Open-Label Treatment|Protocol Violation|4|||
48872502|NCT00510146|157369812|FG001|Open-Label Treatment|Protocol Violation|2|||
48872503|NCT00510146|157369811|FG000|Open-Label Treatment|Withdrawal by Subject|24|||
48872504|NCT00510146|157369812|FG001|Open-Label Treatment|Withdrawal by Subject|12|||
48872505|NCT00510146|157369811|FG000|Open-Label Treatment|Clinical Relapse|1|||
48872506|NCT00510146|157369812|FG001|Open-Label Treatment|Clinical Relapse|1|||
48872507|NCT00510146|157369811|FG000|Open-Label Treatment|Sponsor Decision|2|||
48872508|NCT00510146|157369812|FG001|Open-Label Treatment|Sponsor Decision|0|||
48872509|NCT01200485|157369813|FG000|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1|||
48872510|NCT01200485|157369814|FG001|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
48872511|NCT01200485|157369815|FG002|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
48872512|NCT01200485|157369813|FG000|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2|||
48872513|NCT01200485|157369814|FG001|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
48872514|NCT01200485|157369815|FG002|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
48872515|NCT01438840|157369818|FG000|Core Study|Adverse Event|0|||
48872516|NCT01438840|157369819|FG001|Core Study|Adverse Event|3|||
48872517|NCT01438840|157369820|FG002|Core Study|Adverse Event|0|||
48872518|NCT01438840|157369818|FG000|Core Study|Lack of Efficacy|15|||
48872519|NCT01438840|157369819|FG001|Core Study|Lack of Efficacy|7|||
48872520|NCT01438840|157369820|FG002|Core Study|Lack of Efficacy|0|||
48872521|NCT01438840|157369818|FG000|Core Study|Withdrawal of consent|1|||
48872522|NCT01438840|157369819|FG001|Core Study|Withdrawal of consent|0|||
48872523|NCT01438840|157369820|FG002|Core Study|Withdrawal of consent|0|||
48872524|NCT01438840|157369818|FG000|Extension Phase|Adverse Event|0|||
48872525|NCT01438840|157369819|FG001|Extension Phase|Adverse Event|0|||
48872526|NCT01438840|157369820|FG002|Extension Phase|Adverse Event|3|||
48872527|NCT01438840|157369818|FG000|Extension Phase|Lost to Follow-up|0|||
48872528|NCT01438840|157369819|FG001|Extension Phase|Lost to Follow-up|0|||
48872529|NCT01438840|157369820|FG002|Extension Phase|Lost to Follow-up|1|||
48872530|NCT01438840|157369818|FG000|Extension Phase|Withdrawal by Subject|0|||
48872531|NCT01438840|157369819|FG001|Extension Phase|Withdrawal by Subject|0|||
48672910|NCT01748825|156653635|FG000|Dose Expansion|Physician Decision|0|||
48872532|NCT01438840|157369820|FG002|Extension Phase|Withdrawal by Subject|3|||
48872533|NCT01438840|157369818|FG000|Extension Phase|Lack of Efficacy|0|||
48970602|NCT00861380|157720952|FG001|Overall Study|Withdrawal Information not recorded|9112|||
48970603|NCT00861380|157720953|FG002|Overall Study|Withdrawal Information not recorded|8872|||
48970604|NCT00861380|157720954|FG003|Overall Study|Withdrawal Information not recorded|3689|||
48970605|NCT00861380|157720955|FG004|Overall Study|Withdrawal Information not recorded|1812|||
48970606|NCT00861380|157720956|FG005|Overall Study|Withdrawal Information not recorded|6249|||
48970607|NCT00861380|157720957|FG006|Overall Study|Withdrawal Information not recorded|3020|||
48970608|NCT00628758|157720961|FG000|Overall Study|Adverse Event|2|||
48970609|NCT00628758|157720962|FG001|Overall Study|Adverse Event|3|||
48970610|NCT00628758|157720961|FG000|Overall Study|Withdrawal by Subject|6|||
48970611|NCT00628758|157720962|FG001|Overall Study|Withdrawal by Subject|3|||
48970612|NCT00628758|157720961|FG000|Overall Study|Death|1|||
48970613|NCT00628758|157720962|FG001|Overall Study|Death|0|||
48970614|NCT00628758|157720961|FG000|Overall Study|Protocol Violation|5|||
48970615|NCT00628758|157720962|FG001|Overall Study|Protocol Violation|1|||
48970616|NCT00628758|157720961|FG000|Overall Study|Lost to Follow-up|25|||
48970617|NCT00628758|157720962|FG001|Overall Study|Lost to Follow-up|31|||
48970618|NCT00628758|157720961|FG000|Overall Study|Pregnancy|2|||
48970619|NCT00628758|157720962|FG001|Overall Study|Pregnancy|2|||
48970620|NCT00628758|157720961|FG000|Overall Study|Investigator Moved|3|||
48970621|NCT00628758|157720962|FG001|Overall Study|Investigator Moved|0|||
48970622|NCT00628758|157720961|FG000|Overall Study|Treatment Failure|0|||
48970623|NCT00628758|157720962|FG001|Overall Study|Treatment Failure|2|||
48970624|NCT02228564|157720963|FG000|Overall Study|Withdrawal by Subject|10|||
48970625|NCT02228564|157720963|FG000|Overall Study|Death|11|||
48970626|NCT02228564|157720963|FG000|Overall Study|Physician Decision|5|||
48970627|NCT02228564|157720963|FG000|Overall Study|Lost to Follow-up|17|||
48970628|NCT02228564|157720963|FG000|Overall Study|Other|6|||
48970629|NCT00065442|157720964|FG000|Overall Study|Lost to Follow-up|1|||
48970630|NCT00065442|157720965|FG001|Overall Study|Lost to Follow-up|1|||
48970631|NCT00065442|157720964|FG000|Overall Study|Death|121|||
48970632|NCT00065442|157720965|FG001|Overall Study|Death|210|||
48970633|NCT00065442|157720964|FG000|Overall Study|Withdrawal by Subject|3|||
48970634|NCT00065442|157720965|FG001|Overall Study|Withdrawal by Subject|9|||
48970635|NCT00562640|157722407|FG000|Overall Study|Death|0|||
48970636|NCT00562640|157722408|FG001|Overall Study|Death|1|||
48970637|NCT00562640|157722409|FG002|Overall Study|Death|1|||
48970638|NCT00562640|157722410|FG003|Overall Study|Death|0|||
48872534|NCT01438840|157369819|FG001|Extension Phase|Lack of Efficacy|0|||
48872535|NCT01438840|157369820|FG002|Extension Phase|Lack of Efficacy|2|||
48872536|NCT01438840|157369818|FG000|Extension Phase|Other|0|||
48872537|NCT01438840|157369819|FG001|Extension Phase|Other|0|||
48872538|NCT01438840|157369820|FG002|Extension Phase|Other|1|||
48872539|NCT03569475|157369823|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
48872540|NCT03569475|157369824|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|2|||
48872541|NCT03569475|157369825|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|5|||
48872542|NCT03569475|157369823|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
48872543|NCT03569475|157369824|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
48872544|NCT03569475|157369825|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
48872545|NCT03569475|157369823|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|7|||
48872546|NCT03569475|157369824|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|10|||
48872547|NCT03569475|157369825|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|9|||
48872548|NCT03569475|157369823|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
48872549|NCT03569475|157369824|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
48872550|NCT03569475|157369825|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|6|||
48872551|NCT03569475|157369823|FG000|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
48872552|NCT03569475|157369824|FG001|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
48872553|NCT03569475|157369825|FG002|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
48872554|NCT03569475|157369823|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
48872555|NCT03569475|157369824|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
48872556|NCT03569475|157369825|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
48872557|NCT03569475|157369823|FG000|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
48872558|NCT03569475|157369824|FG001|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
48872559|NCT03569475|157369825|FG002|Double-blind Treatment Period (8 Weeks)|Reason not Specified|2|||
48872560|NCT03569475|157369823|FG000|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|0|||
48872561|NCT03569475|157369824|FG001|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
48970639|NCT02658968|157722411|FG000|Received Rituximab|Adverse Event|0|||
48970640|NCT02658968|157722412|FG001|Received Rituximab|Adverse Event|0|||
48970641|NCT02658968|157722413|FG002|Received Rituximab|Adverse Event|0|||
48970642|NCT02658968|157722414|FG003|Received Rituximab|Adverse Event|0|||
48970643|NCT02658968|157722415|FG004|Received Rituximab|Adverse Event|1|||
48970644|NCT02658968|157722411|FG000|Received Rituximab|Progressive disease|0|||
48970645|NCT02658968|157722412|FG001|Received Rituximab|Progressive disease|0|||
48970646|NCT02658968|157722413|FG002|Received Rituximab|Progressive disease|0|||
48970647|NCT02658968|157722414|FG003|Received Rituximab|Progressive disease|0|||
48970648|NCT02658968|157722415|FG004|Received Rituximab|Progressive disease|1|||
48872562|NCT03569475|157369825|FG002|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
48872563|NCT03569475|157369823|FG000|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|0|||
48872564|NCT03569475|157369824|FG001|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
48872565|NCT03569475|157369825|FG002|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
48872566|NCT04969224|157369826|FG000|Overall Study|Adverse Event|1|||
48872567|NCT04969224|157369826|FG000|Overall Study|Enrolled but never dosed|1|||
48872568|NCT02506881|157369827|FG000|First Intervention (Day 1)|Protocol Violation|0|||
48872569|NCT02506881|157369828|FG001|First Intervention (Day 1)|Protocol Violation|0|||
48872570|NCT02506881|157369829|FG002|First Intervention (Day 1)|Protocol Violation|1|||
48872571|NCT02506881|157369830|FG003|First Intervention (Day 1)|Protocol Violation|0|||
48872572|NCT02506881|157369827|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
48872573|NCT02506881|157369828|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
48872574|NCT02506881|157369829|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
48872575|NCT02506881|157369830|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
48872576|NCT02506881|157369827|FG000|First Intervention (Day 1)|Violation of blood storage conditions|0|||
48872577|NCT02506881|157369828|FG001|First Intervention (Day 1)|Violation of blood storage conditions|0|||
48872578|NCT02506881|157369829|FG002|First Intervention (Day 1)|Violation of blood storage conditions|12|||
48872579|NCT02506881|157369830|FG003|First Intervention (Day 1)|Violation of blood storage conditions|12|||
48872580|NCT02918292|157369836|FG000|Study Enrollment Prior to Transplant|Death|1|||
48872581|NCT02918292|157369836|FG000|Study Follow up After Transplant|Death|6|||
48872582|NCT00519285|157369837|FG000|Overall Study|Adverse Event|127|||
48872583|NCT00519285|157369838|FG001|Overall Study|Adverse Event|266|||
48872584|NCT00519285|157369837|FG000|Overall Study|Disease progression|334|||
48872585|NCT00519285|157369838|FG001|Overall Study|Disease progression|186|||
48872586|NCT00519285|157369837|FG000|Overall Study|Physician Decision|75|||
48872587|NCT00519285|157369838|FG001|Overall Study|Physician Decision|47|||
48872588|NCT00519285|157369837|FG000|Overall Study|Participant's request|53|||
48872589|NCT00519285|157369838|FG001|Overall Study|Participant's request|84|||
48872590|NCT00519285|157369837|FG000|Overall Study|Consent withdrawn|4|||
48872591|NCT00519285|157369838|FG001|Overall Study|Consent withdrawn|5|||
48872592|NCT00519285|157369837|FG000|Overall Study|Poor compliance to protocol|5|||
48872593|NCT00519285|157369838|FG001|Overall Study|Poor compliance to protocol|7|||
48872594|NCT00519285|157369837|FG000|Overall Study|Reason unspecified|5|||
48872595|NCT00519285|157369838|FG001|Overall Study|Reason unspecified|8|||
48872596|NCT00519285|157369837|FG000|Overall Study|Not treated|8|||
48872597|NCT00519285|157369838|FG001|Overall Study|Not treated|7|||
48872598|NCT00519285|157369837|FG000|Overall Study|Treatment ongoing|1|||
48872599|NCT00519285|157369838|FG001|Overall Study|Treatment ongoing|2|||
48872600|NCT00808899|157369839|FG000|Overall Study|Death|1|||
48872601|NCT00808899|157369839|FG000|Overall Study|Physician Decision|3|||
48872602|NCT03774875|157369840|FG000|Placebo-controlled Period (Week 1-16)|Adverse Event|8|||
48872603|NCT03774875|157369841|FG001|Placebo-controlled Period (Week 1-16)|Adverse Event|16|||
48872604|NCT03774875|157369840|FG000|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|2|||
48872605|NCT03774875|157369841|FG001|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|4|||
48872606|NCT03774875|157369840|FG000|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|12|||
48872607|NCT03774875|157369841|FG001|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|10|||
48872608|NCT03774875|157369840|FG000|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|0|||
48872609|NCT03774875|157369841|FG001|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|2|||
48872610|NCT03774875|157369840|FG000|Placebo-controlled Period (Week 1-16)|Protocol Deviation|0|||
48872611|NCT03774875|157369841|FG001|Placebo-controlled Period (Week 1-16)|Protocol Deviation|1|||
48872612|NCT03774875|157369840|FG000|Placebo-controlled Period (Week 1-16)|Reason Unknown|1|||
48872613|NCT03774875|157369841|FG001|Placebo-controlled Period (Week 1-16)|Reason Unknown|0|||
48872614|NCT03774875|157369840|FG000|Apremilast Extension Period (Week 16-52)|Adverse Event|6|||
48872615|NCT03774875|157369841|FG001|Apremilast Extension Period (Week 16-52)|Adverse Event|9|||
48872616|NCT03774875|157369840|FG000|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|2|||
48872617|NCT03774875|157369841|FG001|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|11|||
48872618|NCT03774875|157369840|FG000|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|7|||
48872619|NCT03774875|157369841|FG001|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|20|||
48872620|NCT03774875|157369840|FG000|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|0|||
48872621|NCT03774875|157369841|FG001|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|2|||
48872622|NCT03774875|157369840|FG000|Apremilast Extension Period (Week 16-52)|Other|1|||
48872623|NCT03774875|157369841|FG001|Apremilast Extension Period (Week 16-52)|Other|1|||
48872624|NCT03774875|157369840|FG000|Apremilast Extension Period (Week 16-52)|Protocol Deviation|0|||
48872625|NCT03774875|157369841|FG001|Apremilast Extension Period (Week 16-52)|Protocol Deviation|1|||
48872626|NCT03774875|157369840|FG000|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|0|||
48872627|NCT03774875|157369841|FG001|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|3|||
48872628|NCT03561597|157369844|FG000|Overall Study|Lost to Follow-up|20|||
48872629|NCT00573651|157369849|FG000|Overall Study|Lost to Follow-up|3|||
48872630|NCT00573651|157369849|FG000|Overall Study|Withdrawal by Subject|1|||
48872631|NCT02972242|157371748|FG000|Overall Study|Withdrawal by Subject|1|||
48970649|NCT02658968|157722411|FG000|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|2|||
48970650|NCT02658968|157722412|FG001|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
48970651|NCT02658968|157722413|FG002|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
48970652|NCT02658968|157722414|FG003|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
48970653|NCT02658968|157722415|FG004|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
48970654|NCT02658968|157722411|FG000|Received Lilotomab and Betalutin|Progressive disease|1|||
48970655|NCT02658968|157722412|FG001|Received Lilotomab and Betalutin|Progressive disease|0|||
48970656|NCT02658968|157722413|FG002|Received Lilotomab and Betalutin|Progressive disease|0|||
48970657|NCT02658968|157722414|FG003|Received Lilotomab and Betalutin|Progressive disease|0|||
48970658|NCT02658968|157722415|FG004|Received Lilotomab and Betalutin|Progressive disease|0|||
48970659|NCT02658968|157722411|FG000|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
48970660|NCT02658968|157722412|FG001|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
48970661|NCT02658968|157722413|FG002|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
48970662|NCT02658968|157722414|FG003|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
48970663|NCT02658968|157722415|FG004|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
48970664|NCT02658968|157722411|FG000|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
48970665|NCT02658968|157722412|FG001|Received Lilotomab and Betalutin|Lost to Follow-up|1|||
48970666|NCT02658968|157722413|FG002|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
48970667|NCT02658968|157722414|FG003|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
48970668|NCT02658968|157722415|FG004|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
48970669|NCT02658968|157722411|FG000|Received Lilotomab and Betalutin|Adverse Event|0|||
48970670|NCT02658968|157722412|FG001|Received Lilotomab and Betalutin|Adverse Event|0|||
48970671|NCT02658968|157722413|FG002|Received Lilotomab and Betalutin|Adverse Event|0|||
48970672|NCT02658968|157722414|FG003|Received Lilotomab and Betalutin|Adverse Event|1|||
48970673|NCT02658968|157722415|FG004|Received Lilotomab and Betalutin|Adverse Event|0|||
48970674|NCT00696436|157722420|FG000|Overall Study|Adverse Event|7|||
48970675|NCT00696436|157722421|FG001|Overall Study|Adverse Event|9|||
48970676|NCT00696436|157722422|FG002|Overall Study|Adverse Event|8|||
48970677|NCT00696436|157722423|FG003|Overall Study|Adverse Event|6|||
48970678|NCT00696436|157722424|FG004|Overall Study|Adverse Event|4|||
48970679|NCT00696436|157722420|FG000|Overall Study|Protocol Violation|3|||
48970680|NCT00696436|157722421|FG001|Overall Study|Protocol Violation|2|||
48970681|NCT00696436|157722422|FG002|Overall Study|Protocol Violation|2|||
48970682|NCT00696436|157722423|FG003|Overall Study|Protocol Violation|0|||
48970683|NCT00696436|157722424|FG004|Overall Study|Protocol Violation|1|||
48970684|NCT00696436|157722420|FG000|Overall Study|Lost to Follow-up|1|||
48970685|NCT00696436|157722421|FG001|Overall Study|Lost to Follow-up|6|||
48970686|NCT00696436|157722422|FG002|Overall Study|Lost to Follow-up|2|||
48970687|NCT00696436|157722423|FG003|Overall Study|Lost to Follow-up|4|||
48970688|NCT00696436|157722424|FG004|Overall Study|Lost to Follow-up|3|||
48970689|NCT00696436|157722420|FG000|Overall Study|Withdrawal by Subject|4|||
48970690|NCT00696436|157722421|FG001|Overall Study|Withdrawal by Subject|11|||
48970691|NCT00696436|157722422|FG002|Overall Study|Withdrawal by Subject|5|||
48970692|NCT00696436|157722423|FG003|Overall Study|Withdrawal by Subject|7|||
48970693|NCT00696436|157722424|FG004|Overall Study|Withdrawal by Subject|1|||
48970694|NCT00696436|157722420|FG000|Overall Study|Lack of Efficacy|3|||
48970695|NCT00696436|157722421|FG001|Overall Study|Lack of Efficacy|1|||
48970696|NCT00696436|157722422|FG002|Overall Study|Lack of Efficacy|5|||
48970697|NCT00696436|157722423|FG003|Overall Study|Lack of Efficacy|2|||
48970698|NCT00696436|157722424|FG004|Overall Study|Lack of Efficacy|4|||
48970699|NCT00696436|157722420|FG000|Overall Study|Participant Unavailability|2|||
48970700|NCT00696436|157722421|FG001|Overall Study|Participant Unavailability|0|||
48970701|NCT00696436|157722422|FG002|Overall Study|Participant Unavailability|2|||
48970702|NCT00696436|157722423|FG003|Overall Study|Participant Unavailability|1|||
48970703|NCT00696436|157722424|FG004|Overall Study|Participant Unavailability|0|||
48970704|NCT00696436|157722420|FG000|Overall Study|Administrative Error|2|||
48970705|NCT00696436|157722421|FG001|Overall Study|Administrative Error|0|||
48970706|NCT00696436|157722422|FG002|Overall Study|Administrative Error|2|||
48970707|NCT00696436|157722423|FG003|Overall Study|Administrative Error|0|||
48970708|NCT00696436|157722424|FG004|Overall Study|Administrative Error|0|||
48970709|NCT00696436|157722420|FG000|Overall Study|Participant Non-compliance|0|||
48970710|NCT00696436|157722421|FG001|Overall Study|Participant Non-compliance|0|||
48970711|NCT00696436|157722422|FG002|Overall Study|Participant Non-compliance|1|||
48970712|NCT00696436|157722423|FG003|Overall Study|Participant Non-compliance|2|||
48970713|NCT00696436|157722424|FG004|Overall Study|Participant Non-compliance|0|||
48970714|NCT00696436|157722420|FG000|Overall Study|Administrative Decision|1|||
48970715|NCT00696436|157722421|FG001|Overall Study|Administrative Decision|0|||
48970716|NCT00696436|157722422|FG002|Overall Study|Administrative Decision|0|||
48970717|NCT00696436|157722423|FG003|Overall Study|Administrative Decision|0|||
48970718|NCT00696436|157722424|FG004|Overall Study|Administrative Decision|0|||
48970719|NCT00696436|157722420|FG000|Overall Study|Missing|0|||
48970720|NCT00696436|157722421|FG001|Overall Study|Missing|1|||
48970721|NCT00696436|157722422|FG002|Overall Study|Missing|1|||
48970722|NCT00696436|157722423|FG003|Overall Study|Missing|0|||
48970723|NCT00696436|157722424|FG004|Overall Study|Missing|0|||
48970724|NCT01297309|157722427|FG000|Overall Study|Eligibility failure|2|||
48970725|NCT01297309|157722427|FG000|Overall Study|Screen failure|2|||
48970726|NCT01297309|157722427|FG000|Overall Study|Withdrawal by Subject|5|||
48970727|NCT01297309|157722427|FG000|Overall Study|Adverse Event|1|||
48970728|NCT01297309|157722427|FG000|Overall Study|Investigator Decision|2|||
48970729|NCT01297309|157722427|FG000|Overall Study|Death|1|||
48970730|NCT01297309|157722427|FG000|Overall Study|Participant not entering extensionperiod|1|||
48970731|NCT02533401|157722429|FG000|Overall Study|Adverse Event/Intercurrent Disease|3|||
48970732|NCT02533401|157722429|FG000|Overall Study|Death|5|||
48970733|NCT02533401|157722429|FG000|Overall Study|Insufficient Response/Progressed Disease|1|||
48970734|NCT02533401|157722429|FG000|Overall Study|Lost to Follow-up|1|||
48970735|NCT02533401|157722429|FG000|Overall Study|Violation of Selection Criteria|1|||
48970736|NCT01143714|157722430|FG000|Overall Study|Adverse Event|4|||
48970737|NCT01143714|157722431|FG001|Overall Study|Adverse Event|2|||
48970738|NCT01143714|157722430|FG000|Overall Study|Withdrawal by Subject|1|||
48970739|NCT01143714|157722431|FG001|Overall Study|Withdrawal by Subject|0|||
48970740|NCT01143714|157722430|FG000|Overall Study|Subject non-compliance|0|||
48970741|NCT01143714|157722431|FG001|Overall Study|Subject non-compliance|1|||
48970742|NCT01143714|157722430|FG000|Overall Study|wound closed = deemed healed|1|||
48970743|NCT01143714|157722431|FG001|Overall Study|wound closed = deemed healed|0|||
48970744|NCT01143714|157722430|FG000|Overall Study|wound size increased|1|||
48970745|NCT01143714|157722431|FG001|Overall Study|wound size increased|0|||
48970746|NCT05552859|157722432|FG000|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
48970747|NCT05552859|157722433|FG001|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
48970748|NCT02141217|157722436|FG000|Overall Study|Adverse Event|1|||
48970749|NCT02141217|157722437|FG001|Overall Study|Adverse Event|2|||
48970750|NCT02141217|157722436|FG000|Overall Study|Protocol Violation|1|||
48970751|NCT02141217|157722437|FG001|Overall Study|Protocol Violation|4|||
48970752|NCT02141217|157722436|FG000|Overall Study|Withdrawal by Subject|6|||
48970753|NCT02141217|157722437|FG001|Overall Study|Withdrawal by Subject|0|||
48970754|NCT02141217|157722436|FG000|Overall Study|Lost to Follow-up|1|||
48970755|NCT02141217|157722437|FG001|Overall Study|Lost to Follow-up|1|||
48970756|NCT02141217|157722436|FG000|Overall Study|Physician Decision|1|||
48970757|NCT02141217|157722437|FG001|Overall Study|Physician Decision|0|||
48970758|NCT02141217|157722436|FG000|Overall Study|Surgical Intervention|1|||
48970759|NCT02141217|157722437|FG001|Overall Study|Surgical Intervention|1|||
48970760|NCT00810810|157722438|FG000|Overall Study|Withdrawal by Subject|0|||
48970761|NCT00810810|157722439|FG001|Overall Study|Withdrawal by Subject|8|||
48970762|NCT00810810|157722440|FG002|Overall Study|Withdrawal by Subject|10|||
48970763|NCT00810810|157722441|FG003|Overall Study|Withdrawal by Subject|8|||
48970764|NCT00810810|157722438|FG000|Overall Study|Physician Decision|0|||
48970765|NCT00810810|157722439|FG001|Overall Study|Physician Decision|3|||
48970766|NCT00810810|157722440|FG002|Overall Study|Physician Decision|1|||
48970767|NCT00810810|157722441|FG003|Overall Study|Physician Decision|5|||
48970768|NCT02563925|157722444|FG000|Overall Study|Withdrawal by Subject|2|||
48970769|NCT00425113|157722450|FG000|Overall Study|uncontrolled diabetes mellitus|1|||
48970770|NCT00425113|157722451|FG001|Overall Study|uncontrolled diabetes mellitus|0|||
48970771|NCT00425113|157722450|FG000|Overall Study|diagnosis of abdominal TB|0|||
48970772|NCT00425113|157722451|FG001|Overall Study|diagnosis of abdominal TB|1|||
48970773|NCT00425113|157722450|FG000|Overall Study|missing study drug more than 14 days|0|||
48970774|NCT00425113|157722451|FG001|Overall Study|missing study drug more than 14 days|1|||
48970775|NCT00425113|157722450|FG000|Overall Study|Withdrawal by Subject|1|||
48970776|NCT00425113|157722451|FG001|Overall Study|Withdrawal by Subject|0|||
48970777|NCT01342952|157722454|FG000|Overall Study|Adverse Event|0|||
48970778|NCT01342952|157722455|FG001|Overall Study|Adverse Event|5|||
48970779|NCT01342952|157722456|FG002|Overall Study|Adverse Event|1|||
48970780|NCT01342952|157722457|FG003|Overall Study|Adverse Event|0|||
48970781|NCT01342952|157722454|FG000|Overall Study|Lost to Follow-up|0|||
48970782|NCT01342952|157722455|FG001|Overall Study|Lost to Follow-up|2|||
48970783|NCT01342952|157722456|FG002|Overall Study|Lost to Follow-up|0|||
48970784|NCT01342952|157722457|FG003|Overall Study|Lost to Follow-up|0|||
48970785|NCT01342952|157722454|FG000|Overall Study|Withdrawal by Subject|1|||
48970786|NCT01342952|157722455|FG001|Overall Study|Withdrawal by Subject|1|||
48970787|NCT01342952|157722456|FG002|Overall Study|Withdrawal by Subject|0|||
48970788|NCT01342952|157722457|FG003|Overall Study|Withdrawal by Subject|0|||
48970789|NCT01342952|157722454|FG000|Overall Study|Physician Decision|3|||
48970790|NCT01342952|157722455|FG001|Overall Study|Physician Decision|3|||
48970791|NCT01342952|157722456|FG002|Overall Study|Physician Decision|1|||
48970792|NCT01342952|157722457|FG003|Overall Study|Physician Decision|0|||
48970793|NCT03228394|157722458|FG000|Overall Study|Lost to Follow-up|0|||
49015496|NCT01393990|157893774|FG004|Overall Study|Withdrawal by Subject|0|||
48970794|NCT03228394|157722459|FG001|Overall Study|Lost to Follow-up|0|||
48970795|NCT03228394|157722460|FG002|Overall Study|Lost to Follow-up|1|||
48970796|NCT03228394|157722461|FG003|Overall Study|Lost to Follow-up|1|||
48970797|NCT03228394|157722462|FG004|Overall Study|Lost to Follow-up|0|||
48970798|NCT03228394|157722463|FG005|Overall Study|Lost to Follow-up|0|||
48970799|NCT03228394|157722464|FG006|Overall Study|Lost to Follow-up|2|||
48970800|NCT03228394|157722465|FG007|Overall Study|Lost to Follow-up|0|||
48970801|NCT03228394|157722458|FG000|Overall Study|Withdrawal by Subject|0|||
48970802|NCT03228394|157722459|FG001|Overall Study|Withdrawal by Subject|0|||
48970803|NCT03228394|157722460|FG002|Overall Study|Withdrawal by Subject|1|||
48970804|NCT03228394|157722461|FG003|Overall Study|Withdrawal by Subject|0|||
48970805|NCT03228394|157722462|FG004|Overall Study|Withdrawal by Subject|0|||
48970806|NCT03228394|157722463|FG005|Overall Study|Withdrawal by Subject|0|||
48970807|NCT03228394|157722464|FG006|Overall Study|Withdrawal by Subject|1|||
48970808|NCT03228394|157722465|FG007|Overall Study|Withdrawal by Subject|3|||
48970809|NCT03228394|157722458|FG000|Overall Study|Protocol Violation|0|||
48970810|NCT03228394|157722459|FG001|Overall Study|Protocol Violation|0|||
48970811|NCT03228394|157722460|FG002|Overall Study|Protocol Violation|0|||
48970812|NCT03228394|157722461|FG003|Overall Study|Protocol Violation|1|||
48970813|NCT03228394|157722462|FG004|Overall Study|Protocol Violation|0|||
48970814|NCT03228394|157722463|FG005|Overall Study|Protocol Violation|0|||
48970815|NCT03228394|157722464|FG006|Overall Study|Protocol Violation|0|||
48970816|NCT03228394|157722465|FG007|Overall Study|Protocol Violation|0|||
48970817|NCT03228394|157722458|FG000|Overall Study|Physician Decision|0|||
48970818|NCT03228394|157722459|FG001|Overall Study|Physician Decision|0|||
48970819|NCT03228394|157722460|FG002|Overall Study|Physician Decision|0|||
48970820|NCT03228394|157722461|FG003|Overall Study|Physician Decision|0|||
48970821|NCT03228394|157722462|FG004|Overall Study|Physician Decision|0|||
48970822|NCT03228394|157722463|FG005|Overall Study|Physician Decision|0|||
48970823|NCT03228394|157722464|FG006|Overall Study|Physician Decision|1|||
48970824|NCT03228394|157722465|FG007|Overall Study|Physician Decision|0|||
48970825|NCT03228394|157722458|FG000|Overall Study|Noncompliance|0|||
48970826|NCT03228394|157722459|FG001|Overall Study|Noncompliance|0|||
48970827|NCT03228394|157722460|FG002|Overall Study|Noncompliance|0|||
48970828|NCT03228394|157722461|FG003|Overall Study|Noncompliance|0|||
48970829|NCT03228394|157722462|FG004|Overall Study|Noncompliance|0|||
48970830|NCT03228394|157722463|FG005|Overall Study|Noncompliance|0|||
48970831|NCT03228394|157722464|FG006|Overall Study|Noncompliance|1|||
48970832|NCT03228394|157722465|FG007|Overall Study|Noncompliance|0|||
48970833|NCT00879437|157722466|FG000|Overall Study|Protocol Violation|0|||
48970834|NCT00879437|157722467|FG001|Overall Study|Protocol Violation|1|||
48672911|NCT01748825|156653636|FG001|Dose Expansion|Physician Decision|0|||
48672912|NCT01748825|156653637|FG002|Dose Expansion|Physician Decision|0|||
48672913|NCT01748825|156653638|FG003|Dose Expansion|Physician Decision|0|||
48672914|NCT01748825|156653639|FG004|Dose Expansion|Physician Decision|0|||
48672915|NCT01748825|156653640|FG005|Dose Expansion|Physician Decision|0|||
48672916|NCT01748825|156653641|FG006|Dose Expansion|Physician Decision|0|||
48672917|NCT01748825|156653642|FG007|Dose Expansion|Physician Decision|0|||
48672918|NCT01748825|156653643|FG008|Dose Expansion|Physician Decision|1|||
48672919|NCT01748825|156653644|FG009|Dose Expansion|Physician Decision|0|||
48672920|NCT02123576|156653647|FG000|Overall Study|Adverse Event|1|||
48672921|NCT02123576|156653648|FG001|Overall Study|Adverse Event|0|||
48672922|NCT00547521|156653649|FG000|Short Term Study (4 Months)|Adverse Event|1|||
48672923|NCT00547521|156653650|FG001|Short Term Study (4 Months)|Adverse Event|0|||
48672924|NCT00547521|156653649|FG000|Short Term Study (4 Months)|Lack of Efficacy|0|||
48672925|NCT00547521|156653650|FG001|Short Term Study (4 Months)|Lack of Efficacy|2|||
48672926|NCT00547521|156653649|FG000|Short Term Study (4 Months)|Withdrawal of consent|0|||
48672927|NCT00547521|156653650|FG001|Short Term Study (4 Months)|Withdrawal of consent|1|||
48672928|NCT00547521|156653649|FG000|Short Term Study (4 Months)|primary endpoint evaluation not complete|0|||
48672929|NCT00547521|156653650|FG001|Short Term Study (4 Months)|primary endpoint evaluation not complete|1|||
48672930|NCT00547521|156653649|FG000|Long Term Extension (LTE) Study|Lack of Efficacy|0|||
48672931|NCT00547521|156653650|FG001|Long Term Extension (LTE) Study|Lack of Efficacy|14|||
48672932|NCT00547521|156653649|FG000|Long Term Extension (LTE) Study|Adverse Event|0|||
48672933|NCT00547521|156653650|FG001|Long Term Extension (LTE) Study|Adverse Event|9|||
48970835|NCT00879437|157722466|FG000|Overall Study|Death|1|||
48970836|NCT00879437|157722467|FG001|Overall Study|Death|0|||
48970837|NCT05159362|157722468|FG000|Field Testing (4 Weeks)|Withdrawal by Subject|1|||
48970838|NCT05159362|157722469|FG001|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
48970839|NCT05159362|157722470|FG002|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
48970840|NCT01170221|157722471|FG000|Overall Study|Lost to Follow-up|22|||
48970841|NCT01170221|157722472|FG001|Overall Study|Lost to Follow-up|21|||
48672934|NCT00547521|156653649|FG000|Long Term Extension (LTE) Study|Lost to Follow-up|0|||
48970842|NCT01170221|157722471|FG000|Overall Study|Withdrawal by Subject|9|||
48970843|NCT01170221|157722472|FG001|Overall Study|Withdrawal by Subject|7|||
48970844|NCT01170221|157722471|FG000|Overall Study|Subject completed only screening and LFU|1|||
49015497|NCT01393990|157893775|FG005|Overall Study|Withdrawal by Subject|0|||
48970845|NCT01170221|157722472|FG001|Overall Study|Subject completed only screening and LFU|0|||
48970846|NCT01170221|157722471|FG000|Overall Study|Randomized but not treated|1|||
48970847|NCT01170221|157722472|FG001|Overall Study|Randomized but not treated|0|||
48970848|NCT02693691|157722473|FG000|Primary Endpoint Analysis (First 12M)|Death|30|||
48970849|NCT02693691|157722473|FG000|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12|||
48970850|NCT02693691|157722473|FG000|Primary Endpoint Analysis (First 12M)|Physician Decision|7|||
48970851|NCT02693691|157722473|FG000|Primary Endpoint Analysis (First 12M)|Adverse Event|1|||
48970852|NCT02693691|157722473|FG000|Extended Follow-Up (Until Last pt 12M)|Death|12|||
48970853|NCT02693691|157722473|FG000|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11|||
48970854|NCT02693691|157722473|FG000|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1|||
48970855|NCT03970824|157722474|FG000|Overall Study|Withdrawal by Subject|1|||
48970856|NCT03970824|157722475|FG001|Overall Study|Withdrawal by Subject|1|||
48970857|NCT03970824|157722476|FG002|Overall Study|Withdrawal by Subject|3|||
48970858|NCT03970824|157722474|FG000|Overall Study|Lost to Follow-up|0|||
48970859|NCT03970824|157722475|FG001|Overall Study|Lost to Follow-up|2|||
48970860|NCT03970824|157722476|FG002|Overall Study|Lost to Follow-up|1|||
48970861|NCT03970824|157722474|FG000|Overall Study|Adverse Event|1|||
48970862|NCT03970824|157722475|FG001|Overall Study|Adverse Event|0|||
48970863|NCT03970824|157722476|FG002|Overall Study|Adverse Event|0|||
48970864|NCT01153893|157722477|FG000|Overall Study|Adverse Event|1|||
48970865|NCT01153893|157722478|FG001|Overall Study|Adverse Event|0|||
48970866|NCT01040845|157722479|FG000|Overall Study|Withdrawal by Subject|1|||
48970867|NCT01040845|157722480|FG001|Overall Study|Withdrawal by Subject|1|||
48970868|NCT01040845|157722479|FG000|Overall Study|Physician Decision|1|||
48672935|NCT00547521|156653650|FG001|Long Term Extension (LTE) Study|Lost to Follow-up|3|||
48672936|NCT00547521|156653649|FG000|Long Term Extension (LTE) Study|Withdrawal by Subject|0|||
48672937|NCT00547521|156653650|FG001|Long Term Extension (LTE) Study|Withdrawal by Subject|2|||
48970869|NCT01040845|157722480|FG001|Overall Study|Physician Decision|0|||
48970870|NCT03407170|157722485|FG000|Overall Study|Adverse Event|1|||
48970871|NCT01248364|157722489|FG000|Overall Study|Adverse Event|0|||
48970872|NCT01248364|157722490|FG001|Overall Study|Adverse Event|1|||
48970873|NCT01248364|157722491|FG002|Overall Study|Adverse Event|0|||
48970874|NCT01248364|157722492|FG003|Overall Study|Adverse Event|0|||
48970875|NCT05567393|157722496|FG000|Overall Study|Voluntary Withdrawal|0|||
48970876|NCT05567393|157722497|FG001|Overall Study|Voluntary Withdrawal|0|||
48970877|NCT05567393|157722498|FG002|Overall Study|Voluntary Withdrawal|0|||
48970878|NCT05567393|157722499|FG003|Overall Study|Voluntary Withdrawal|0|||
48970879|NCT05567393|157722500|FG004|Overall Study|Voluntary Withdrawal|0|||
48970880|NCT05567393|157722501|FG005|Overall Study|Voluntary Withdrawal|0|||
48970881|NCT05567393|157722502|FG006|Overall Study|Voluntary Withdrawal|0|||
48970882|NCT05567393|157722503|FG007|Overall Study|Voluntary Withdrawal|0|||
48970883|NCT05567393|157722504|FG008|Overall Study|Voluntary Withdrawal|0|||
48970884|NCT05567393|157722505|FG009|Overall Study|Voluntary Withdrawal|0|||
48970885|NCT05567393|157722506|FG010|Overall Study|Voluntary Withdrawal|0|||
48970886|NCT05567393|157722507|FG011|Overall Study|Voluntary Withdrawal|0|||
48970887|NCT05567393|157722508|FG012|Overall Study|Voluntary Withdrawal|0|||
48970888|NCT05567393|157722509|FG013|Overall Study|Voluntary Withdrawal|1|||
48970889|NCT05567393|157722510|FG014|Overall Study|Voluntary Withdrawal|0|||
48970890|NCT05567393|157722511|FG015|Overall Study|Voluntary Withdrawal|0|||
48970891|NCT05567393|157722512|FG016|Overall Study|Voluntary Withdrawal|0|||
48970892|NCT05567393|157722513|FG017|Overall Study|Voluntary Withdrawal|0|||
48970893|NCT01270958|157722516|FG000|Overall Study|Lost to Follow-up|2|||
48970894|NCT01270958|157722516|FG000|Overall Study|Did not meet inclusion criteria for age|2|||
48970895|NCT05563714|157722519|FG000|Overall Study|Death|2|||
48970896|NCT05563714|157722520|FG001|Overall Study|Death|2|||
48970897|NCT05563714|157722521|FG002|Overall Study|Death|0|||
48970898|NCT05563714|157722522|FG003|Overall Study|Death|0|||
48970899|NCT05563714|157722519|FG000|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|4|||
48970900|NCT05563714|157722520|FG001|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|3|||
48970901|NCT05563714|157722521|FG002|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
48970902|NCT05563714|157722522|FG003|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
48970903|NCT05563714|157722519|FG000|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|1|||
48970904|NCT05563714|157722520|FG001|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|2|||
48970905|NCT05563714|157722521|FG002|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
48970906|NCT05563714|157722522|FG003|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
48970907|NCT05563714|157722519|FG000|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
48672938|NCT00547521|156653649|FG000|Long Term Extension (LTE) Study|Other|0|||
48970908|NCT05563714|157722520|FG001|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|1|||
48970909|NCT05563714|157722521|FG002|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
48970910|NCT05563714|157722522|FG003|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
48970911|NCT05563714|157722519|FG000|Overall Study|Lost to Follow-up|22|||
48970912|NCT05563714|157722520|FG001|Overall Study|Lost to Follow-up|19|||
48970913|NCT05563714|157722521|FG002|Overall Study|Lost to Follow-up|0|||
48970914|NCT05563714|157722522|FG003|Overall Study|Lost to Follow-up|0|||
48970915|NCT00141037|157722523|FG000|Overall Study|Physician Decision|1|||
48970916|NCT00141037|157722524|FG001|Overall Study|Physician Decision|2|||
48970917|NCT00141037|157722523|FG000|Overall Study|Lost to Follow-up|3|||
48970918|NCT00141037|157722524|FG001|Overall Study|Lost to Follow-up|1|||
48970919|NCT00141037|157722523|FG000|Overall Study|Protocol Violation|0|||
48970920|NCT00141037|157722524|FG001|Overall Study|Protocol Violation|2|||
48970921|NCT00141037|157722523|FG000|Overall Study|Withdrawal by Subject|2|||
48970922|NCT00141037|157722524|FG001|Overall Study|Withdrawal by Subject|1|||
48970923|NCT00141037|157722523|FG000|Overall Study|Other|0|||
48970924|NCT00141037|157722524|FG001|Overall Study|Other|1|||
48970925|NCT00141037|157722523|FG000|Overall Study|Moved from area|1|||
48970926|NCT00141037|157722524|FG001|Overall Study|Moved from area|7|||
48970927|NCT00141037|157722523|FG000|Overall Study|Graft Failure|3|||
48970928|NCT00141037|157722524|FG001|Overall Study|Graft Failure|4|||
48970929|NCT00260429|157722525|FG000|Overall Study|failure to follow appointments|1|||
48970930|NCT00260429|157722526|FG001|Overall Study|failure to follow appointments|0|||
48970931|NCT00260429|157722525|FG000|Overall Study|scheduled hand surgery|1|||
48970932|NCT00260429|157722526|FG001|Overall Study|scheduled hand surgery|0|||
48970933|NCT04179786|157722527|FG000|Overall Study|Withdrawal by Subject|8|||
48970934|NCT00970268|157722530|FG000|Overall Study|Withdrawal by Subject|12|||
48970935|NCT00970268|157722531|FG001|Overall Study|Withdrawal by Subject|19|||
48970936|NCT00970268|157722530|FG000|Overall Study|Adverse Event|15|||
48970937|NCT00970268|157722531|FG001|Overall Study|Adverse Event|12|||
48970938|NCT00970268|157722530|FG000|Overall Study|Lack of Efficacy|3|||
48970939|NCT00970268|157722531|FG001|Overall Study|Lack of Efficacy|6|||
48970940|NCT00970268|157722530|FG000|Overall Study|Protocol Violation|4|||
48970941|NCT00970268|157722531|FG001|Overall Study|Protocol Violation|7|||
48970942|NCT00970268|157722530|FG000|Overall Study|Other Reason|3|||
48970943|NCT00970268|157722531|FG001|Overall Study|Other Reason|1|||
48970944|NCT00970268|157722530|FG000|Overall Study|COPD Exacerbation|4|||
48970945|NCT00970268|157722531|FG001|Overall Study|COPD Exacerbation|2|||
48970946|NCT00970268|157722530|FG000|Overall Study|Lost to Follow-up|1|||
48970947|NCT00970268|157722531|FG001|Overall Study|Lost to Follow-up|2|||
48970948|NCT00970268|157722530|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
48970949|NCT00970268|157722531|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
48970950|NCT01938001|157722532|FG000|Pre-Treatment|Adverse Event unrelated to Study Drug|1|||
48970951|NCT01938001|157722533|FG001|Pre-Treatment|Adverse Event unrelated to Study Drug|0|||
48970952|NCT01938001|157722532|FG000|Pre-Treatment|Death|1|||
48970953|NCT01938001|157722533|FG001|Pre-Treatment|Death|0|||
48970954|NCT01938001|157722532|FG000|Treatment|Death|2|||
48970955|NCT01938001|157722533|FG001|Treatment|Death|0|||
48970956|NCT01938001|157722532|FG000|Treatment|Adverse Event|14|||
48970957|NCT01938001|157722533|FG001|Treatment|Adverse Event|8|||
48970958|NCT01938001|157722532|FG000|Treatment|Progressive Disease|21|||
48970959|NCT01938001|157722533|FG001|Treatment|Progressive Disease|54|||
48970960|NCT01938001|157722532|FG000|Treatment|Withdrawal by Subject|13|||
48970961|NCT01938001|157722533|FG001|Treatment|Withdrawal by Subject|7|||
48970962|NCT01938001|157722532|FG000|Treatment|Other reasons|2|||
48970963|NCT01938001|157722533|FG001|Treatment|Other reasons|1|||
48970964|NCT03032510|157722534|FG000|Overall Study|Adverse Event|5|||
48970965|NCT03032510|157722535|FG001|Overall Study|Adverse Event|2|||
48970966|NCT03032510|157722534|FG000|Overall Study|Lost to Follow-up|8|||
48970967|NCT03032510|157722535|FG001|Overall Study|Lost to Follow-up|7|||
48970968|NCT03032510|157722534|FG000|Overall Study|Withdrawal by Subject|8|||
48672939|NCT00547521|156653650|FG001|Long Term Extension (LTE) Study|Other|2|||
48672940|NCT00547521|156653649|FG000|Long Term Extension (LTE) Study|Poor/Non-Compliance|0|||
48672941|NCT00547521|156653650|FG001|Long Term Extension (LTE) Study|Poor/Non-Compliance|1|||
48672942|NCT03149029|156654977|FG000|Overall Study|Adverse Event|2|||
48672943|NCT03149029|156654978|FG001|Overall Study|Adverse Event|0|||
48970969|NCT03032510|157722535|FG001|Overall Study|Withdrawal by Subject|7|||
48970970|NCT03032510|157722534|FG000|Overall Study|Subject noncompliance|4|||
48970971|NCT03032510|157722535|FG001|Overall Study|Subject noncompliance|2|||
48970972|NCT03032510|157722534|FG000|Overall Study|Physician Decision|2|||
48970973|NCT03032510|157722535|FG001|Overall Study|Physician Decision|0|||
48970974|NCT03310580|157722542|FG000|Overall Study|Adverse Event|0|||
48970975|NCT03310580|157722543|FG001|Overall Study|Adverse Event|1|||
48970976|NCT03310580|157722544|FG002|Overall Study|Adverse Event|0|||
48970977|NCT02633046|157722546|FG000|Overall Study|Adverse Event|8|||
48970978|NCT02633046|157722546|FG000|Overall Study|Physician Decision|7|||
48970979|NCT02633046|157722546|FG000|Overall Study|Withdrawal by Subject|8|||
48970980|NCT02633046|157722546|FG000|Overall Study|Increased proteinuria|2|||
48970981|NCT02633046|157722546|FG000|Overall Study|Participant decided not to continue with open label extension|1|||
48970982|NCT02633046|157722546|FG000|Overall Study|Mutual decision patient and physician|1|||
48970983|NCT02427100|157722551|FG000|Overall Study|Lost to Follow-up|0|||
48672944|NCT03344172|156654980|FG000|Overall Study|Received <1 dose of treatment|1|||
48970984|NCT02427100|157722552|FG001|Overall Study|Lost to Follow-up|2|||
48970985|NCT05263921|157724386|FG000|Overall Study|Other: family emergency.|0|||
48970986|NCT05263921|157724387|FG001|Overall Study|Other: family emergency.|0|||
48970987|NCT05263921|157724388|FG002|Overall Study|Other: family emergency.|1|||
48970988|NCT05263921|157724389|FG003|Overall Study|Other: family emergency.|0|||
48970989|NCT02499575|157724390|FG000|Overall Study|Protocol Violation|0|||
48970990|NCT02499575|157724391|FG001|Overall Study|Protocol Violation|1|||
48970991|NCT03287869|157724392|FG000|Overall Study|Adverse Event|14|||
48970992|NCT03287869|157724393|FG001|Overall Study|Adverse Event|12|||
48970993|NCT03287869|157724392|FG000|Overall Study|Lack of Efficacy|1|||
48970994|NCT03287869|157724393|FG001|Overall Study|Lack of Efficacy|0|||
48970995|NCT03287869|157724392|FG000|Overall Study|Lost to Follow-up|13|||
48970996|NCT03287869|157724393|FG001|Overall Study|Lost to Follow-up|19|||
48970997|NCT03287869|157724392|FG000|Overall Study|Non-Compliance With Study Drug|5|||
48970998|NCT03287869|157724393|FG001|Overall Study|Non-Compliance With Study Drug|9|||
48760988|NCT00951665|156973963|FG005|Phase 1b|Death|0|||
48760989|NCT00951665|156973958|FG000|Phase 1b|Physician Decision|4|||
48760990|NCT00951665|156973959|FG001|Phase 1b|Physician Decision|0|||
48760991|NCT00951665|156973960|FG002|Phase 1b|Physician Decision|1|||
48760992|NCT00951665|156973961|FG003|Phase 1b|Physician Decision|0|||
48760993|NCT00951665|156973962|FG004|Phase 1b|Physician Decision|0|||
48970999|NCT03287869|157724392|FG000|Overall Study|Progressive Disease|1|||
48971000|NCT03287869|157724393|FG001|Overall Study|Progressive Disease|0|||
48760994|NCT00951665|156973963|FG005|Phase 1b|Physician Decision|0|||
48760995|NCT00951665|156973958|FG000|Phase 1b|Withdrawal by Subject|0|||
48872632|NCT02972242|157371749|FG001|Overall Study|Withdrawal by Subject|0|||
48872633|NCT02826798|157371752|FG000|Overall Study|Withdrawal by Subject|0|||
48872634|NCT02826798|157371753|FG001|Overall Study|Withdrawal by Subject|1|||
48872635|NCT02826798|157371754|FG002|Overall Study|Withdrawal by Subject|0|||
48872636|NCT02826798|157371755|FG003|Overall Study|Withdrawal by Subject|1|||
48872637|NCT02826798|157371756|FG004|Overall Study|Withdrawal by Subject|0|||
48971001|NCT03287869|157724392|FG000|Overall Study|Protocol Deviation|2|||
48971002|NCT03287869|157724393|FG001|Overall Study|Protocol Deviation|1|||
48971003|NCT03287869|157724392|FG000|Overall Study|Withdrawal by Subject|36|||
48971004|NCT03287869|157724393|FG001|Overall Study|Withdrawal by Subject|43|||
48971005|NCT03287869|157724392|FG000|Overall Study|Early Closure of the Site|0|||
48971006|NCT03287869|157724393|FG001|Overall Study|Early Closure of the Site|1|||
48971007|NCT03287869|157724392|FG000|Overall Study|Physician Decision|5|||
48971008|NCT03287869|157724393|FG001|Overall Study|Physician Decision|5|||
48971009|NCT03287869|157724392|FG000|Overall Study|Reason not Specified|6|||
48971010|NCT03287869|157724393|FG001|Overall Study|Reason not Specified|3|||
48971011|NCT03488238|157724394|FG000|Overall Study|Equipment malfunction|1|||
48971012|NCT03488238|157724394|FG000|Overall Study|Adverse Event|1|||
48672945|NCT03344172|156654981|FG001|Overall Study|Received <1 dose of treatment|0|||
48672946|NCT00931801|156654982|FG000|Overall Study|Adverse Event|0|||
48672947|NCT00931801|156654983|FG001|Overall Study|Adverse Event|0|||
48672948|NCT00931801|156654984|FG002|Overall Study|Adverse Event|1|||
48672949|NCT00931801|156654982|FG000|Overall Study|Lost to Follow-up|0|||
48672950|NCT00931801|156654983|FG001|Overall Study|Lost to Follow-up|1|||
48672951|NCT00931801|156654984|FG002|Overall Study|Lost to Follow-up|0|||
48672952|NCT00931801|156654982|FG000|Overall Study|Withdrawal by Subject|1|||
48672953|NCT00931801|156654983|FG001|Overall Study|Withdrawal by Subject|0|||
48672954|NCT00931801|156654984|FG002|Overall Study|Withdrawal by Subject|0|||
48672955|NCT00931801|156654982|FG000|Overall Study|Confirmed Virologic Failure|0|||
48672956|NCT00931801|156654983|FG001|Overall Study|Confirmed Virologic Failure|0|||
48672957|NCT00931801|156654984|FG002|Overall Study|Confirmed Virologic Failure|3|||
48672958|NCT00708734|156654985|FG000|Overall Study|scheduling conflict|2|||
48672959|NCT00708734|156654985|FG000|Overall Study|moved|1|||
48672960|NCT00708734|156654985|FG000|Overall Study|leg injury|1|||
48672961|NCT00708734|156654985|FG000|Overall Study|knee replacement|1|||
48672962|NCT00708734|156654985|FG000|Overall Study|vertigo|1|||
48872638|NCT01268098|157371757|FG000|Overall Study|Adverse Event|1|||
48872639|NCT01268098|157371758|FG001|Overall Study|Adverse Event|0|||
48872640|NCT01722045|157371759|FG000|Overall Study|Adverse Event|8|||
48872641|NCT01722045|157371759|FG000|Overall Study|Death|3|||
48872642|NCT01722045|157371759|FG000|Overall Study|Withdrawal by Subject|8|||
48872643|NCT01722045|157371759|FG000|Overall Study|Lost to Follow-up|4|||
48872644|NCT01722045|157371759|FG000|Overall Study|Protocol Deviation|1|||
48872645|NCT01722045|157371759|FG000|Overall Study|Physician Decision|3|||
48872646|NCT01722045|157371759|FG000|Overall Study|Relocation (did not wish to transfer)|1|||
48872647|NCT02561078|157371764|FG000|Overall Study|Adverse Event|5|||
48872648|NCT02561078|157371765|FG001|Overall Study|Adverse Event|2|||
48872649|NCT02561078|157371764|FG000|Overall Study|Death|2|||
48872650|NCT02561078|157371765|FG001|Overall Study|Death|1|||
48872651|NCT02561078|157371764|FG000|Overall Study|Lost to Follow-up|2|||
48971013|NCT02282982|157724397|FG000|Overall Study|Lost to Follow-up|15|||
48971014|NCT02282982|157724397|FG000|Overall Study|Withdrew consent|2|||
48672963|NCT00708734|156654985|FG000|Overall Study|leg fracture|1|||
48872652|NCT02561078|157371765|FG001|Overall Study|Lost to Follow-up|6|||
48971015|NCT02282982|157724397|FG000|Overall Study|Death|4|||
48971016|NCT02282982|157724397|FG000|Overall Study|Lack of product|156|||
48971017|NCT02282982|157724397|FG000|Overall Study|Palivizumab is ended|11|||
48971018|NCT02282982|157724397|FG000|Overall Study|Other, not specified|18|||
48971019|NCT03039738|157724398|FG000|Overall Study|Incomplete data sets|54|||
48971020|NCT03039738|157724399|FG001|Overall Study|Incomplete data sets|0|||
48971021|NCT02670928|157724400|FG000|Overall Study|Adverse Event|3|||
48971022|NCT02670928|157724401|FG001|Overall Study|Adverse Event|1|||
48971023|NCT02670928|157724400|FG000|Overall Study|Withdrawal by Subject|4|||
48971024|NCT02670928|157724401|FG001|Overall Study|Withdrawal by Subject|0|||
48971025|NCT02670928|157724400|FG000|Overall Study|Lost to Follow-up|1|||
48971026|NCT02670928|157724401|FG001|Overall Study|Lost to Follow-up|0|||
48971027|NCT02670928|157724400|FG000|Overall Study|Miss 3 classes in a row in first 12 wks|2|||
48971028|NCT02670928|157724401|FG001|Overall Study|Miss 3 classes in a row in first 12 wks|0|||
48971029|NCT04681729|157724402|FG000|Overall Study|Lack of Efficacy|2|||
48971030|NCT04681729|157724403|FG001|Overall Study|Lack of Efficacy|2|||
48971031|NCT04681729|157724402|FG000|Overall Study|Withdrawal by Subject|8|||
48971032|NCT04681729|157724403|FG001|Overall Study|Withdrawal by Subject|9|||
48971033|NCT02678312|157724404|FG000|Part 1 Open Label Epoch- Period 1|Adverse Event|1|||
48971034|NCT02678312|157724405|FG001|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
48971035|NCT02678312|157724406|FG002|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
48971036|NCT02678312|157724407|FG003|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
48971037|NCT02678312|157724408|FG004|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
48971038|NCT02678312|157724404|FG000|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|1|||
48971039|NCT02678312|157724405|FG001|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
48971040|NCT02678312|157724406|FG002|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
48971041|NCT02678312|157724407|FG003|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
48971042|NCT02678312|157724408|FG004|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
48971043|NCT02678312|157724404|FG000|Part 1 Open Label Epoch- Period 1|Physician Decision|1|||
48971044|NCT02678312|157724405|FG001|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
48971045|NCT02678312|157724406|FG002|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
48971046|NCT02678312|157724407|FG003|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
48971047|NCT02678312|157724408|FG004|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
48971048|NCT02678312|157724404|FG000|Part 2 Double Blind Epoch|Adverse Event|0|||
48971049|NCT02678312|157724405|FG001|Part 2 Double Blind Epoch|Adverse Event|0|||
48971050|NCT02678312|157724406|FG002|Part 2 Double Blind Epoch|Adverse Event|0|||
48971051|NCT02678312|157724407|FG003|Part 2 Double Blind Epoch|Adverse Event|1|||
48971052|NCT02678312|157724408|FG004|Part 2 Double Blind Epoch|Adverse Event|2|||
48971053|NCT02678312|157724404|FG000|Part 2 Double Blind Epoch|Death|0|||
48971054|NCT02678312|157724405|FG001|Part 2 Double Blind Epoch|Death|0|||
48971055|NCT02678312|157724406|FG002|Part 2 Double Blind Epoch|Death|0|||
48971056|NCT02678312|157724407|FG003|Part 2 Double Blind Epoch|Death|8|||
48971057|NCT02678312|157724408|FG004|Part 2 Double Blind Epoch|Death|12|||
48971058|NCT02678312|157724404|FG000|Part 2 Double Blind Epoch|Technical Problems|0|||
48971059|NCT02678312|157724405|FG001|Part 2 Double Blind Epoch|Technical Problems|0|||
48971060|NCT02678312|157724406|FG002|Part 2 Double Blind Epoch|Technical Problems|0|||
48971061|NCT02678312|157724407|FG003|Part 2 Double Blind Epoch|Technical Problems|4|||
48971062|NCT02678312|157724408|FG004|Part 2 Double Blind Epoch|Technical Problems|2|||
48971063|NCT02678312|157724404|FG000|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
48971064|NCT02678312|157724405|FG001|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
48971065|NCT02678312|157724406|FG002|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
48971066|NCT02678312|157724407|FG003|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
48971067|NCT02678312|157724408|FG004|Part 2 Double Blind Epoch|Lost to Follow-up|2|||
48971068|NCT02678312|157724404|FG000|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
48971069|NCT02678312|157724405|FG001|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
48971070|NCT02678312|157724406|FG002|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
48971071|NCT02678312|157724407|FG003|Part 2 Double Blind Epoch|Subject/guardian Decision|5|||
48971072|NCT02678312|157724408|FG004|Part 2 Double Blind Epoch|Subject/guardian Decision|6|||
48971073|NCT00912340|157724409|FG000|Overall Study|Adverse Event|2|||
48971074|NCT00912340|157724410|FG001|Overall Study|Adverse Event|4|||
48971075|NCT00912340|157724411|FG002|Overall Study|Adverse Event|0|||
48971076|NCT00912340|157724409|FG000|Overall Study|Protocol revised to remove arm|0|||
48971077|NCT00912340|157724410|FG001|Overall Study|Protocol revised to remove arm|0|||
48971078|NCT00912340|157724411|FG002|Overall Study|Protocol revised to remove arm|4|||
48971079|NCT01517412|157724416|FG000|Overall Study|Adverse Event|10|||
48971080|NCT01517412|157724417|FG001|Overall Study|Adverse Event|11|||
48971081|NCT01517412|157724416|FG000|Overall Study|Lack of Efficacy|10|||
48971082|NCT01517412|157724417|FG001|Overall Study|Lack of Efficacy|5|||
48971083|NCT01517412|157724416|FG000|Overall Study|Poor compliance to protocol|8|||
48971084|NCT01517412|157724417|FG001|Overall Study|Poor compliance to protocol|3|||
48971085|NCT01517412|157724416|FG000|Overall Study|Other than specified above|8|||
48971086|NCT01517412|157724417|FG001|Overall Study|Other than specified above|5|||
48971087|NCT02591238|157724418|FG000|Overall Study|Pregnancy|1|||
48672964|NCT00895661|156654990|FG000|Overall Study|Death|1|||
48672965|NCT00895661|156654990|FG000|Overall Study|reason unknown|2|||
48672966|NCT02211313|156654991|FG000|Overall Study|Treatment Failure|5|||
48672967|NCT02211313|156654992|FG001|Overall Study|Treatment Failure|2|||
48672968|NCT02211313|156654991|FG000|Overall Study|No Follow up Questionnaires|1|||
48672969|NCT02211313|156654992|FG001|Overall Study|No Follow up Questionnaires|1|||
48872653|NCT02561078|157371764|FG000|Overall Study|Non-Compliance with Study Drug|6|||
48872654|NCT02561078|157371765|FG001|Overall Study|Non-Compliance with Study Drug|3|||
48872655|NCT02561078|157371764|FG000|Overall Study|Physician Decision|2|||
48872656|NCT02561078|157371765|FG001|Overall Study|Physician Decision|3|||
48872657|NCT02561078|157371764|FG000|Overall Study|Withdrawal by Subject|13|||
48872658|NCT02561078|157371765|FG001|Overall Study|Withdrawal by Subject|10|||
48872659|NCT01947517|157371766|FG000|Overall Study|Withdrawal by Subject|1|||
48872660|NCT01947517|157371767|FG001|Overall Study|Withdrawal by Subject|1|||
48872661|NCT02418845|157371771|FG000|Overall Study|Lost to Follow-up|7|||
48872662|NCT02418845|157371772|FG001|Overall Study|Lost to Follow-up|2|||
48872663|NCT02418845|157371771|FG000|Overall Study|Lack of Efficacy|0|||
48872664|NCT02418845|157371772|FG001|Overall Study|Lack of Efficacy|3|||
48872665|NCT02418845|157371771|FG000|Overall Study|Physician Decision|5|||
48872666|NCT02418845|157371772|FG001|Overall Study|Physician Decision|5|||
48872667|NCT02418845|157371771|FG000|Overall Study|Protocol Violation|1|||
48872668|NCT02418845|157371772|FG001|Overall Study|Protocol Violation|0|||
48872669|NCT02418845|157371771|FG000|Overall Study|Withdrawal by Subject|3|||
48872670|NCT02418845|157371772|FG001|Overall Study|Withdrawal by Subject|2|||
48872671|NCT03119688|157371773|FG000|Overall Study|Adverse Event|4|||
48872672|NCT01243411|157371774|FG000|Overall Study|Withdrawal by Subject|18|||
48872673|NCT01243411|157371774|FG000|Overall Study|Lost to Follow-up|10|||
48872674|NCT01243411|157371774|FG000|Overall Study|Adverse Event|5|||
48872675|NCT01243411|157371774|FG000|Overall Study|Other|8|||
48872676|NCT02624869|157371775|FG000|Overall Study|Lost to Follow-up|0|||
48872677|NCT02624869|157371776|FG001|Overall Study|Lost to Follow-up|0|||
48872678|NCT02624869|157371777|FG002|Overall Study|Lost to Follow-up|1|||
48872679|NCT02624869|157371775|FG000|Overall Study|Withdrawal by Subject|1|||
48872680|NCT02624869|157371776|FG001|Overall Study|Withdrawal by Subject|3|||
48872681|NCT02624869|157371777|FG002|Overall Study|Withdrawal by Subject|1|||
48872682|NCT00494026|157371778|FG000|Overall Study|Sponsor Decision|4|||
48872683|NCT00477464|157371779|FG000|Overall Study|Lost to Follow-up|1|||
48872684|NCT00477464|157371779|FG000|Overall Study|Death|36|||
48872685|NCT00477464|157371779|FG000|Overall Study|Completion of protocol-defined follow-up|14|||
48872686|NCT00863798|157371780|FG000|Overall Study|Adverse Event|5|||
48872687|NCT00863798|157371781|FG001|Overall Study|Adverse Event|2|||
48872688|NCT00863798|157371782|FG002|Overall Study|Adverse Event|4|||
48872689|NCT00863798|157371780|FG000|Overall Study|Participant failed to return|2|||
48872690|NCT00863798|157371781|FG001|Overall Study|Participant failed to return|1|||
48872691|NCT00863798|157371782|FG002|Overall Study|Participant failed to return|0|||
48872692|NCT00863798|157371780|FG000|Overall Study|Investigator request|1|||
48872693|NCT00863798|157371781|FG001|Overall Study|Investigator request|2|||
48872694|NCT00863798|157371782|FG002|Overall Study|Investigator request|1|||
48872695|NCT00863798|157371780|FG000|Overall Study|Lack of Efficacy|4|||
48872696|NCT00863798|157371781|FG001|Overall Study|Lack of Efficacy|3|||
48872697|NCT00863798|157371782|FG002|Overall Study|Lack of Efficacy|6|||
48872698|NCT00863798|157371780|FG000|Overall Study|Lost to Follow-up|6|||
48872699|NCT00863798|157371781|FG001|Overall Study|Lost to Follow-up|9|||
48872700|NCT00863798|157371782|FG002|Overall Study|Lost to Follow-up|5|||
48872701|NCT00863798|157371780|FG000|Overall Study|Other|2|||
48672970|NCT01641822|156654995|FG000|Run-in Phase|Noncompliance with study drug|1|||
48872702|NCT00863798|157371781|FG001|Overall Study|Other|3|||
48872703|NCT00863798|157371782|FG002|Overall Study|Other|1|||
48672971|NCT01641822|156654996|FG001|Run-in Phase|Noncompliance with study drug|0|||
48872704|NCT00863798|157371780|FG000|Overall Study|Protocol Violation|0|||
48872705|NCT00863798|157371781|FG001|Overall Study|Protocol Violation|1|||
48872706|NCT00863798|157371782|FG002|Overall Study|Protocol Violation|1|||
48872707|NCT00863798|157371780|FG000|Overall Study|Withdrawal by Subject|8|||
48872708|NCT00863798|157371781|FG001|Overall Study|Withdrawal by Subject|7|||
48872709|NCT00863798|157371782|FG002|Overall Study|Withdrawal by Subject|4|||
48872710|NCT00863798|157371780|FG000|Overall Study|Randomized not treated|4|||
48872711|NCT00863798|157371781|FG001|Overall Study|Randomized not treated|2|||
48971088|NCT02591238|157724419|FG001|Overall Study|Pregnancy|0|||
48672972|NCT01641822|156654997|FG002|Run-in Phase|Noncompliance with study drug|0|||
48872712|NCT00863798|157371782|FG002|Overall Study|Randomized not treated|3|||
48872713|NCT00816556|157371783|FG000|Overall Study|Adverse Event|1|||
48872714|NCT00816556|157371784|FG001|Overall Study|Adverse Event|1|||
48872715|NCT00816556|157371785|FG002|Overall Study|Adverse Event|1|||
48872716|NCT00816556|157371783|FG000|Overall Study|Withdrawal by Subject|1|||
48872717|NCT00816556|157371784|FG001|Overall Study|Withdrawal by Subject|1|||
48872718|NCT00816556|157371785|FG002|Overall Study|Withdrawal by Subject|1|||
48872719|NCT00816556|157371783|FG000|Overall Study|Lost to Follow-up|0|||
48872720|NCT00816556|157371784|FG001|Overall Study|Lost to Follow-up|0|||
48971089|NCT02591238|157724420|FG002|Overall Study|Pregnancy|0|||
48971090|NCT02591238|157724421|FG003|Overall Study|Pregnancy|0|||
48971091|NCT02591238|157724418|FG000|Overall Study|Withdrawal by Subject|0|||
48971092|NCT02591238|157724419|FG001|Overall Study|Withdrawal by Subject|0|||
48971093|NCT02591238|157724420|FG002|Overall Study|Withdrawal by Subject|0|||
48971094|NCT02591238|157724421|FG003|Overall Study|Withdrawal by Subject|1|||
48971095|NCT02591238|157724418|FG000|Overall Study|influenza|0|||
48971096|NCT02591238|157724419|FG001|Overall Study|influenza|0|||
48971097|NCT02591238|157724420|FG002|Overall Study|influenza|0|||
48971098|NCT02591238|157724421|FG003|Overall Study|influenza|1|||
48971099|NCT02591238|157724418|FG000|Overall Study|personal circumstances|0|||
48971100|NCT02591238|157724419|FG001|Overall Study|personal circumstances|0|||
48971101|NCT02591238|157724420|FG002|Overall Study|personal circumstances|0|||
48971102|NCT02591238|157724421|FG003|Overall Study|personal circumstances|1|||
48971103|NCT02591238|157724418|FG000|Overall Study|personal circumstances|0|||
48971104|NCT02591238|157724419|FG001|Overall Study|personal circumstances|1|||
48971105|NCT02591238|157724420|FG002|Overall Study|personal circumstances|0|||
48971106|NCT02591238|157724421|FG003|Overall Study|personal circumstances|0|||
48971107|NCT00656084|157724422|FG000|Overall Study|Adverse Event|4|||
48971108|NCT00656084|157724422|FG000|Overall Study|Withdrawal by Subject|1|||
48971109|NCT00656084|157724422|FG000|Overall Study|Patient Request|1|||
48971110|NCT00656084|157724422|FG000|Overall Study|Investigator Request|1|||
48971111|NCT02759562|157724425|FG000|Open-Label Treatment Period|Withdrew Consent|1|||
48971112|NCT02759562|157724426|FG001|Open-Label Treatment Period|Withdrew Consent|0|||
48971113|NCT02759562|157724425|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
48971114|NCT02759562|157724426|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
48971115|NCT00728936|157724427|FG000|Overall Study|Withdrawal by Subject|0|||
48971116|NCT00728936|157724428|FG001|Overall Study|Withdrawal by Subject|0|||
48971117|NCT00728936|157724429|FG002|Overall Study|Withdrawal by Subject|0|||
48971118|NCT00728936|157724430|FG003|Overall Study|Withdrawal by Subject|0|||
48971119|NCT00728936|157724431|FG004|Overall Study|Withdrawal by Subject|0|||
48971120|NCT00728936|157724432|FG005|Overall Study|Withdrawal by Subject|1|||
48971121|NCT00728936|157724433|FG006|Overall Study|Withdrawal by Subject|0|||
48971122|NCT00132314|157724434|FG000|Overall Study|Lost to Follow-up|70|||
48971123|NCT00132314|157724435|FG001|Overall Study|Lost to Follow-up|62|||
48971124|NCT00132314|157724434|FG000|Overall Study|Lacked SSN|1|||
48971125|NCT00132314|157724435|FG001|Overall Study|Lacked SSN|3|||
48971126|NCT00132314|157724434|FG000|Overall Study|Refused intervention at baseline|2|||
48971127|NCT00132314|157724435|FG001|Overall Study|Refused intervention at baseline|7|||
48971128|NCT00415519|157724437|FG000|Overall Study|Adverse Event|1|||
48971129|NCT00415519|157724438|FG001|Overall Study|Adverse Event|0|||
48971130|NCT00415519|157724437|FG000|Overall Study|Withdrawal by Subject|2|||
48971131|NCT00415519|157724438|FG001|Overall Study|Withdrawal by Subject|0|||
48971132|NCT00415519|157724437|FG000|Overall Study|Patient's convenience|1|||
48971133|NCT00415519|157724438|FG001|Overall Study|Patient's convenience|0|||
48971134|NCT01797445|157724441|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
48971135|NCT01797445|157724442|FG001|Double-Blind Phase|Randomized but Not Treated|2|||
48971136|NCT01797445|157724441|FG000|Double-Blind Phase|Adverse Event|3|||
48971137|NCT01797445|157724442|FG001|Double-Blind Phase|Adverse Event|0|||
48760996|NCT00951665|156973959|FG001|Phase 1b|Withdrawal by Subject|1|||
48760997|NCT00951665|156973960|FG002|Phase 1b|Withdrawal by Subject|0|||
48971138|NCT01797445|157724441|FG000|Double-Blind Phase|Death|5|||
48971139|NCT01797445|157724442|FG001|Double-Blind Phase|Death|4|||
48760998|NCT00951665|156973961|FG003|Phase 1b|Withdrawal by Subject|0|||
48971140|NCT01797445|157724441|FG000|Double-Blind Phase|Pregnancy|0|||
48971141|NCT01797445|157724442|FG001|Double-Blind Phase|Pregnancy|1|||
48760999|NCT00951665|156973962|FG004|Phase 1b|Withdrawal by Subject|0|||
48971142|NCT01797445|157724441|FG000|Double-Blind Phase|Lack of Efficacy|1|||
48761000|NCT00951665|156973963|FG005|Phase 1b|Withdrawal by Subject|0|||
48971143|NCT01797445|157724442|FG001|Double-Blind Phase|Lack of Efficacy|2|||
48872721|NCT00816556|157371785|FG002|Overall Study|Lost to Follow-up|1|||
48872722|NCT01309243|157371786|FG000|Randomized Phase Through Week 96|Randomized but not treated|6|||
48872723|NCT01309243|157371787|FG001|Randomized Phase Through Week 96|Randomized but not treated|7|||
48872724|NCT01309243|157371786|FG000|Randomized Phase Through Week 96|Adverse Event|12|||
48872725|NCT01309243|157371787|FG001|Randomized Phase Through Week 96|Adverse Event|43|||
48872726|NCT01309243|157371786|FG000|Randomized Phase Through Week 96|Death|0|||
48872727|NCT01309243|157371787|FG001|Randomized Phase Through Week 96|Death|1|||
48872728|NCT01309243|157371786|FG000|Randomized Phase Through Week 96|Pregnancy|2|||
48872729|NCT01309243|157371787|FG001|Randomized Phase Through Week 96|Pregnancy|0|||
48872730|NCT01309243|157371786|FG000|Randomized Phase Through Week 96|Lack of Efficacy|16|||
48872731|NCT01309243|157371787|FG001|Randomized Phase Through Week 96|Lack of Efficacy|4|||
48872732|NCT01309243|157371786|FG000|Randomized Phase Through Week 96|Investigators Discretion|3|||
48971144|NCT01797445|157724441|FG000|Double-Blind Phase|Investigator's Discretion|15|||
48971145|NCT01797445|157724442|FG001|Double-Blind Phase|Investigator's Discretion|17|||
48971146|NCT01797445|157724441|FG000|Double-Blind Phase|Noncompliance with Study Drug|5|||
48971147|NCT01797445|157724442|FG001|Double-Blind Phase|Noncompliance with Study Drug|1|||
48971148|NCT01797445|157724441|FG000|Double-Blind Phase|Protocol Violation|0|||
48971149|NCT01797445|157724442|FG001|Double-Blind Phase|Protocol Violation|1|||
48672973|NCT01641822|156654995|FG000|Run-in Phase|Adverse Event|3|||
48672974|NCT01641822|156654996|FG001|Run-in Phase|Adverse Event|0|||
48672975|NCT01641822|156654997|FG002|Run-in Phase|Adverse Event|0|||
48672976|NCT01641822|156654995|FG000|Run-in Phase|Withdrew consent|1|||
48672977|NCT01641822|156654996|FG001|Run-in Phase|Withdrew consent|0|||
48672978|NCT01641822|156654997|FG002|Run-in Phase|Withdrew consent|0|||
48672979|NCT01641822|156654995|FG000|Run-in Phase|Protocol-specified criteria for withdraw|9|||
48672980|NCT01641822|156654996|FG001|Run-in Phase|Protocol-specified criteria for withdraw|0|||
48672981|NCT01641822|156654997|FG002|Run-in Phase|Protocol-specified criteria for withdraw|0|||
48872733|NCT01309243|157371787|FG001|Randomized Phase Through Week 96|Investigators Discretion|6|||
48872734|NCT01309243|157371786|FG000|Randomized Phase Through Week 96|Withdrew Consent|12|||
48872735|NCT01309243|157371787|FG001|Randomized Phase Through Week 96|Withdrew Consent|18|||
48971150|NCT01797445|157724441|FG000|Double-Blind Phase|Withdrew Consent|20|||
48971151|NCT01797445|157724442|FG001|Double-Blind Phase|Withdrew Consent|35|||
48971152|NCT01797445|157724441|FG000|Double-Blind Phase|Lost to Follow-up|34|||
48971153|NCT01797445|157724442|FG001|Double-Blind Phase|Lost to Follow-up|26|||
48971154|NCT01797445|157724441|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
48971155|NCT01797445|157724442|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
48971156|NCT01373918|157724443|FG000|Overall Study|Physician Decision|0|||
48971157|NCT01373918|157724444|FG001|Overall Study|Physician Decision|1|||
48971158|NCT03004976|157724445|FG000|Overall Study|Lost to Follow-up|7|||
48971159|NCT03004976|157724446|FG001|Overall Study|Lost to Follow-up|5|||
48971160|NCT03004976|157724445|FG000|Overall Study|Physician Decision|1|||
48971161|NCT03004976|157724446|FG001|Overall Study|Physician Decision|0|||
48971162|NCT03004976|157724445|FG000|Overall Study|Withdrawal by Subject|1|||
48971163|NCT03004976|157724446|FG001|Overall Study|Withdrawal by Subject|0|||
48971164|NCT03004976|157724445|FG000|Overall Study|Death|4|||
48971165|NCT03004976|157724446|FG001|Overall Study|Death|1|||
48971166|NCT01807949|157724452|FG000|Overall Study|Adverse Event|1|||
48971167|NCT01807949|157724453|FG001|Overall Study|Adverse Event|2|||
48971168|NCT01807949|157724454|FG002|Overall Study|Adverse Event|2|||
48971169|NCT01807949|157724452|FG000|Overall Study|Withdrawal by Subject|1|||
48971170|NCT01807949|157724453|FG001|Overall Study|Withdrawal by Subject|2|||
48971171|NCT01807949|157724454|FG002|Overall Study|Withdrawal by Subject|2|||
48971172|NCT01807949|157724452|FG000|Overall Study|Non-Compliance|0|||
48971173|NCT01807949|157724453|FG001|Overall Study|Non-Compliance|0|||
48971174|NCT01807949|157724454|FG002|Overall Study|Non-Compliance|1|||
48971175|NCT01807949|157724452|FG000|Overall Study|Undefined|0|||
48971176|NCT01807949|157724453|FG001|Overall Study|Undefined|1|||
48971177|NCT01807949|157724454|FG002|Overall Study|Undefined|2|||
48971178|NCT01807949|157724452|FG000|Overall Study|Randomized But Not Treated|0|||
48971179|NCT01807949|157724453|FG001|Overall Study|Randomized But Not Treated|2|||
48971180|NCT01807949|157724454|FG002|Overall Study|Randomized But Not Treated|2|||
48971181|NCT00407550|157724455|FG000|Overall Study|Adverse Event|0|||
48971182|NCT00407550|157724456|FG001|Overall Study|Adverse Event|1|||
48971183|NCT00407550|157724455|FG000|Overall Study|Withdrawal by Subject|0|||
48971184|NCT00407550|157724456|FG001|Overall Study|Withdrawal by Subject|2|||
48971185|NCT00407550|157724455|FG000|Overall Study|Death|1|||
48971186|NCT00407550|157724456|FG001|Overall Study|Death|0|||
48971187|NCT00407550|157724455|FG000|Overall Study|Insurance or Other medical condition|2|||
48971188|NCT00407550|157724456|FG001|Overall Study|Insurance or Other medical condition|1|||
48971189|NCT00724815|157724457|FG000|Overall Study|Randomized, not treated|31|||
48971190|NCT00724815|157724458|FG001|Overall Study|Randomized, not treated|30|||
48672982|NCT01641822|156654995|FG000|Comparative Phase|Noncompliance with study drug|0|||
48971191|NCT00724815|157724457|FG000|Overall Study|Adverse Event|5|||
48672983|NCT01641822|156654996|FG001|Comparative Phase|Noncompliance with study drug|1|||
48672984|NCT01641822|156654997|FG002|Comparative Phase|Noncompliance with study drug|0|||
48672985|NCT01641822|156654995|FG000|Comparative Phase|Investigator's discretion|0|||
48672986|NCT01641822|156654996|FG001|Comparative Phase|Investigator's discretion|0|||
48672987|NCT01641822|156654997|FG002|Comparative Phase|Investigator's discretion|1|||
48672988|NCT01641822|156654995|FG000|Comparative Phase|Pregnancy|0|||
48672989|NCT01641822|156654996|FG001|Comparative Phase|Pregnancy|0|||
48672990|NCT01641822|156654997|FG002|Comparative Phase|Pregnancy|1|||
48672991|NCT01641822|156654995|FG000|Comparative Phase|Adverse event, serious fatal|0|||
48672992|NCT01641822|156654996|FG001|Comparative Phase|Adverse event, serious fatal|1|||
48672993|NCT01641822|156654997|FG002|Comparative Phase|Adverse event, serious fatal|0|||
48672994|NCT01641822|156654995|FG000|Comparative Phase|Withdrew consent|0|||
48672995|NCT01641822|156654996|FG001|Comparative Phase|Withdrew consent|3|||
48672996|NCT01641822|156654997|FG002|Comparative Phase|Withdrew consent|7|||
48672997|NCT01641822|156654995|FG000|Comparative Phase|Protocol-specified criteria for withdraw|0|||
48672998|NCT01641822|156654996|FG001|Comparative Phase|Protocol-specified criteria for withdraw|1|||
48672999|NCT01641822|156654997|FG002|Comparative Phase|Protocol-specified criteria for withdraw|1|||
48673000|NCT00454584|156654998|FG000|Controlled Period|Adverse Event|5|||
48673001|NCT00454584|156654999|FG001|Controlled Period|Adverse Event|2|||
48673002|NCT00454584|156655000|FG002|Controlled Period|Adverse Event|1|||
48673003|NCT00454584|156655001|FG003|Controlled Period|Adverse Event|0|||
48673004|NCT00454584|156655002|FG004|Controlled Period|Adverse Event|0|||
48673005|NCT00454584|156655003|FG005|Controlled Period|Adverse Event|0|||
48673006|NCT00454584|156654998|FG000|Controlled Period|Lost to Follow-up|1|||
48673007|NCT00454584|156654999|FG001|Controlled Period|Lost to Follow-up|2|||
48673008|NCT00454584|156655000|FG002|Controlled Period|Lost to Follow-up|2|||
48872736|NCT01309243|157371786|FG000|Randomized Phase Through Week 96|Lost to Follow-up|23|||
48872737|NCT01309243|157371787|FG001|Randomized Phase Through Week 96|Lost to Follow-up|22|||
48872738|NCT01309243|157371786|FG000|Randomized Phase Through Week 96|Subject Non-Compliance|9|||
48872739|NCT01309243|157371787|FG001|Randomized Phase Through Week 96|Subject Non-Compliance|7|||
48872740|NCT01309243|157371786|FG000|Randomized Phase Through Week 96|Protocol Violation|1|||
48971192|NCT00724815|157724458|FG001|Overall Study|Adverse Event|3|||
48971193|NCT00724815|157724457|FG000|Overall Study|Lost to Follow-up|4|||
48971194|NCT00724815|157724458|FG001|Overall Study|Lost to Follow-up|1|||
48971195|NCT00724815|157724457|FG000|Overall Study|Other Various|3|||
48971196|NCT00724815|157724458|FG001|Overall Study|Other Various|5|||
48971197|NCT02759861|157724465|FG000|Overall Study|Death|1|||
48971198|NCT00813917|157724468|FG000|Overall Study|Adverse Event|0|||
48673009|NCT00454584|156655001|FG003|Controlled Period|Lost to Follow-up|0|||
48673010|NCT00454584|156655002|FG004|Controlled Period|Lost to Follow-up|0|||
48673011|NCT00454584|156655003|FG005|Controlled Period|Lost to Follow-up|0|||
48673012|NCT00454584|156654998|FG000|Controlled Period|Other|5|||
48971199|NCT00813917|157724469|FG001|Overall Study|Adverse Event|1|||
48971200|NCT00813917|157724468|FG000|Overall Study|Withdrawal by Subject|3|||
48971201|NCT00813917|157724469|FG001|Overall Study|Withdrawal by Subject|4|||
48971202|NCT00813917|157724468|FG000|Overall Study|Lost to Follow-up|3|||
48971203|NCT00813917|157724469|FG001|Overall Study|Lost to Follow-up|1|||
48971204|NCT01522443|157724472|FG000|Overall Study|No longer receiving clinical benefit|36|||
48971205|NCT01522443|157724473|FG001|Overall Study|No longer receiving clinical benefit|28|||
48971206|NCT01522443|157724472|FG000|Overall Study|Adverse Event|10|||
48971207|NCT01522443|157724473|FG001|Overall Study|Adverse Event|15|||
48971208|NCT01522443|157724472|FG000|Overall Study|Withdrawal by Subject|5|||
48971209|NCT01522443|157724473|FG001|Overall Study|Withdrawal by Subject|8|||
48971210|NCT01522443|157724472|FG000|Overall Study|No study treatment given|1|||
48971211|NCT01522443|157724473|FG001|Overall Study|No study treatment given|1|||
48971212|NCT01522443|157724472|FG000|Overall Study|Other|1|||
48971213|NCT01522443|157724473|FG001|Overall Study|Other|3|||
48971214|NCT01369225|157724474|FG000|Overall Study|Withdrawal by Subject|1|||
48971215|NCT01369225|157724475|FG001|Overall Study|Withdrawal by Subject|0|||
48971216|NCT01369225|157724476|FG002|Overall Study|Withdrawal by Subject|2|||
48971217|NCT01369225|157724477|FG003|Overall Study|Withdrawal by Subject|1|||
48673013|NCT00454584|156654999|FG001|Controlled Period|Other|4|||
48872741|NCT01309243|157371787|FG001|Randomized Phase Through Week 96|Protocol Violation|1|||
48872742|NCT01309243|157371786|FG000|Extension Phase|Lost to Follow-up|6|||
48971218|NCT01369225|157724478|FG004|Overall Study|Withdrawal by Subject|0|||
48971219|NCT01369225|157724479|FG005|Overall Study|Withdrawal by Subject|0|||
48872743|NCT01309243|157371787|FG001|Extension Phase|Lost to Follow-up|0|||
48872744|NCT03927690|157371788|FG000|Overall Study|Withdrawal by Subject|3|||
48971220|NCT01369225|157724474|FG000|Overall Study|Does Not Meet Entrance Criteria|0|||
48971221|NCT01369225|157724475|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
48971222|NCT01369225|157724476|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
48971223|NCT01369225|157724477|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
48971224|NCT01369225|157724478|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
48673014|NCT00454584|156655000|FG002|Controlled Period|Other|2|||
48673015|NCT00454584|156655001|FG003|Controlled Period|Other|0|||
48673016|NCT00454584|156655002|FG004|Controlled Period|Other|0|||
48971225|NCT01369225|157724479|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
48971226|NCT01369225|157724474|FG000|Overall Study|Other|1|||
48971227|NCT01369225|157724475|FG001|Overall Study|Other|0|||
48971228|NCT01369225|157724476|FG002|Overall Study|Other|0|||
48971229|NCT01369225|157724477|FG003|Overall Study|Other|0|||
48971230|NCT01369225|157724478|FG004|Overall Study|Other|1|||
48971231|NCT01369225|157724479|FG005|Overall Study|Other|0|||
48971232|NCT01369225|157724474|FG000|Overall Study|Adverse Event|0|||
48971233|NCT01369225|157724475|FG001|Overall Study|Adverse Event|0|||
48971234|NCT01369225|157724476|FG002|Overall Study|Adverse Event|0|||
48971235|NCT01369225|157724477|FG003|Overall Study|Adverse Event|1|||
48971236|NCT01369225|157724478|FG004|Overall Study|Adverse Event|1|||
48971237|NCT01369225|157724479|FG005|Overall Study|Adverse Event|0|||
48971238|NCT00990249|157724492|FG000|Overall Study|Disease Progression|8|||
48971239|NCT00990249|157724492|FG000|Overall Study|Non-Compliance|1|||
48971240|NCT00990249|157724492|FG000|Overall Study|Death|2|||
48761001|NCT00951665|156973958|FG000|Phase 1b|Disease Progression|13|||
48761002|NCT00951665|156973959|FG001|Phase 1b|Disease Progression|2|||
48971241|NCT00990249|157724492|FG000|Overall Study|Not treated|2|||
48971242|NCT00973622|157724493|FG000|Overall Study|did not attend MRI|14|||
48971243|NCT00973622|157724494|FG001|Overall Study|did not attend MRI|3|||
48971244|NCT00973622|157724493|FG000|Overall Study|did not pass MRI screen|6|||
48971245|NCT00973622|157724494|FG001|Overall Study|did not pass MRI screen|0|||
48971246|NCT00973622|157724493|FG000|Overall Study|did not complete rTMS sessions|11|||
48971247|NCT00973622|157724494|FG001|Overall Study|did not complete rTMS sessions|2|||
48971248|NCT03673956|157724495|FG000|Overall Study|Lost to Follow-up|1|||
48971249|NCT03673956|157724496|FG001|Overall Study|Lost to Follow-up|0|||
48971250|NCT03673956|157724497|FG002|Overall Study|Lost to Follow-up|0|||
48971251|NCT03673956|157724498|FG003|Overall Study|Lost to Follow-up|0|||
48971252|NCT03673956|157724495|FG000|Overall Study|Did not use the prescribed topical antibiotics as directed|1|||
48971253|NCT03673956|157724496|FG001|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
48971254|NCT03673956|157724497|FG002|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
48971255|NCT03673956|157724498|FG003|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
48971256|NCT03037307|157724499|FG000|Period 1|Did Not Meet Study Criteria|0|||
48971257|NCT03037307|157724500|FG001|Period 1|Did Not Meet Study Criteria|0|||
48971258|NCT03037307|157724501|FG002|Period 1|Did Not Meet Study Criteria|0|||
48971259|NCT03037307|157724502|FG003|Period 1|Did Not Meet Study Criteria|1|||
48971260|NCT03037307|157724503|FG004|Period 1|Did Not Meet Study Criteria|0|||
48971261|NCT03037307|157724504|FG005|Period 1|Did Not Meet Study Criteria|0|||
48971262|NCT03814005|157724505|FG000|Part B: Day 8 to Day 343|Adverse Event|2|||
48971263|NCT03814005|157724506|FG001|Part B: Day 8 to Day 343|Adverse Event|0|||
48971264|NCT03814005|157724507|FG002|Part B: Day 8 to Day 343|Adverse Event|0|||
48971265|NCT03814005|157724505|FG000|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
48971266|NCT03814005|157724506|FG001|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
48971267|NCT03814005|157724507|FG002|Part B: Day 8 to Day 343|Withdrawal by Subject|3|||
48971268|NCT03814005|157724505|FG000|Part B: Day 8 to Day 343|Progressive Disease|4|||
48971269|NCT03814005|157724506|FG001|Part B: Day 8 to Day 343|Progressive Disease|2|||
48971270|NCT03814005|157724507|FG002|Part B: Day 8 to Day 343|Progressive Disease|0|||
48971271|NCT03814005|157724505|FG000|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|2|||
48971272|NCT03814005|157724506|FG001|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
48971273|NCT03814005|157724507|FG002|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
48971274|NCT03814005|157724505|FG000|Part B: Day 8 to Day 343|Symptomatic Deterioration|1|||
48971275|NCT03814005|157724506|FG001|Part B: Day 8 to Day 343|Symptomatic Deterioration|2|||
48971276|NCT03814005|157724507|FG002|Part B: Day 8 to Day 343|Symptomatic Deterioration|0|||
48971277|NCT03814005|157724505|FG000|Part B: Day 8 to Day 343|Reason not Specified|1|||
48971278|NCT03814005|157724506|FG001|Part B: Day 8 to Day 343|Reason not Specified|0|||
48971279|NCT03814005|157724507|FG002|Part B: Day 8 to Day 343|Reason not Specified|0|||
48971280|NCT01504971|157724509|FG000|Overall Study|Physician Decision|13|||
48971281|NCT03483116|157724510|FG000|Overall Study|Adverse Event|0|||
48971282|NCT03483116|157724511|FG001|Overall Study|Adverse Event|1|||
48971283|NCT03483116|157724512|FG002|Overall Study|Adverse Event|0|||
48971284|NCT03483116|157724513|FG003|Overall Study|Adverse Event|1|||
48761003|NCT00951665|156973960|FG002|Phase 1b|Disease Progression|14|||
48761004|NCT00951665|156973961|FG003|Phase 1b|Disease Progression|0|||
48971285|NCT03483116|157724510|FG000|Overall Study|Protocol Violation|1|||
48971286|NCT03483116|157724511|FG001|Overall Study|Protocol Violation|0|||
48971287|NCT03483116|157724512|FG002|Overall Study|Protocol Violation|0|||
48971288|NCT03483116|157724513|FG003|Overall Study|Protocol Violation|7|||
48971289|NCT03483116|157724510|FG000|Overall Study|Lost to Follow-up|9|||
48971290|NCT03483116|157724511|FG001|Overall Study|Lost to Follow-up|4|||
48971291|NCT03483116|157724512|FG002|Overall Study|Lost to Follow-up|9|||
48971292|NCT03483116|157724513|FG003|Overall Study|Lost to Follow-up|5|||
48971293|NCT03483116|157724510|FG000|Overall Study|Death|1|||
48971294|NCT03483116|157724511|FG001|Overall Study|Death|0|||
48971295|NCT03483116|157724512|FG002|Overall Study|Death|2|||
48971296|NCT03483116|157724513|FG003|Overall Study|Death|1|||
48971297|NCT03483116|157724510|FG000|Overall Study|Withdrawal by Subject|14|||
48971298|NCT03483116|157724511|FG001|Overall Study|Withdrawal by Subject|16|||
48971299|NCT03483116|157724512|FG002|Overall Study|Withdrawal by Subject|14|||
48971300|NCT03483116|157724513|FG003|Overall Study|Withdrawal by Subject|16|||
48971301|NCT03483116|157724510|FG000|Overall Study|Unknown other reason|3|||
48971302|NCT03483116|157724511|FG001|Overall Study|Unknown other reason|2|||
48971303|NCT03483116|157724512|FG002|Overall Study|Unknown other reason|1|||
48971304|NCT03483116|157724513|FG003|Overall Study|Unknown other reason|1|||
48971305|NCT02156804|157724514|FG000|Overall Study|Withdrawal by Subject|1|||
48971306|NCT04581863|157724516|FG000|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|17|||
48971307|NCT04581863|157724517|FG001|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|31|||
48971308|NCT00268463|157724518|FG000|Overall Study|study terminated due to low accrual|10|||
48971309|NCT00268463|157724519|FG001|Overall Study|study terminated due to low accrual|12|||
48971310|NCT00225212|157724520|FG000|Overall Study|Disease progression|2|||
48971311|NCT00225212|157724520|FG000|Overall Study|Death|1|||
48971312|NCT00225212|157724520|FG000|Overall Study|Adverse Event|2|||
48971313|NCT00225212|157724520|FG000|Overall Study|Intercurrent illness|1|||
48971314|NCT03370913|157724521|FG000|Overall Study|Death|1|||
48971315|NCT03370913|157724521|FG000|Overall Study|Lost to Follow-up|1|||
48971316|NCT02443805|157724522|FG000|Overall Study|Adverse Event|100|||
48971317|NCT02443805|157724523|FG001|Overall Study|Adverse Event|18|||
48971318|NCT02443805|157724522|FG000|Overall Study|Withdrawal by Subject|73|||
48971319|NCT02443805|157724523|FG001|Overall Study|Withdrawal by Subject|74|||
48971320|NCT02443805|157724522|FG000|Overall Study|Lost to Follow-up|19|||
48971321|NCT02443805|157724523|FG001|Overall Study|Lost to Follow-up|14|||
48971322|NCT02443805|157724522|FG000|Overall Study|Pregnancy|6|||
48971323|NCT02443805|157724523|FG001|Overall Study|Pregnancy|5|||
48971324|NCT02443805|157724522|FG000|Overall Study|Protocol Violation|2|||
48971325|NCT02443805|157724523|FG001|Overall Study|Protocol Violation|4|||
48971326|NCT02443805|157724522|FG000|Overall Study|Lack of Efficacy|1|||
48971327|NCT02443805|157724523|FG001|Overall Study|Lack of Efficacy|1|||
48971328|NCT02443805|157724522|FG000|Overall Study|Non-compliance with study drug|6|||
48971329|NCT02443805|157724523|FG001|Overall Study|Non-compliance with study drug|4|||
48971330|NCT02443805|157724522|FG000|Overall Study|Withdrawal by parent/guardian|3|||
48971331|NCT02443805|157724523|FG001|Overall Study|Withdrawal by parent/guardian|5|||
48971332|NCT02443805|157724522|FG000|Overall Study|Any other reason not above-mentioned|3|||
48971333|NCT02443805|157724523|FG001|Overall Study|Any other reason not above-mentioned|2|||
48971334|NCT04362813|157724524|FG000|Overall Study|Death|12|||
48971335|NCT04362813|157724525|FG001|Overall Study|Death|16|||
48971336|NCT04362813|157724524|FG000|Overall Study|Withdrawal by Subject|3|||
48971337|NCT04362813|157724525|FG001|Overall Study|Withdrawal by Subject|1|||
48971338|NCT04362813|157724524|FG000|Overall Study|Protocol Violation|0|||
48971339|NCT04362813|157724525|FG001|Overall Study|Protocol Violation|3|||
48971340|NCT04362813|157724524|FG000|Overall Study|Lost to Follow-up|1|||
48971341|NCT04362813|157724525|FG001|Overall Study|Lost to Follow-up|1|||
48971342|NCT04362813|157724524|FG000|Overall Study|Enrolled but did not receive treatment|2|||
48971343|NCT04362813|157724525|FG001|Overall Study|Enrolled but did not receive treatment|4|||
48971344|NCT00389441|157724526|FG000|Overall Study|Adverse Event|7|||
48971345|NCT00389441|157724526|FG000|Overall Study|Death|4|||
48971346|NCT00389441|157724526|FG000|Overall Study|Lost to Follow-up|2|||
48971347|NCT00389441|157724526|FG000|Overall Study|Withdrawal by Subject|4|||
48971348|NCT00389441|157724526|FG000|Overall Study|Physician Decision|1|||
48971349|NCT00389441|157724526|FG000|Overall Study|Protocol Violation|1|||
48971350|NCT00389441|157724526|FG000|Overall Study|Global deterioration of health status|4|||
48971351|NCT00389441|157724526|FG000|Overall Study|Objective progression or relapse|26|||
48971352|NCT00389441|157724526|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|2|||
48971353|NCT00389441|157724526|FG000|Overall Study|Clinical progression|1|||
48971354|NCT01732107|157724527|FG000|Overall Study|Adverse Event|2|||
48971355|NCT01732107|157724527|FG000|Overall Study|Disease Progression|8|||
48971356|NCT01732107|157724527|FG000|Overall Study|Physician Decision|1|||
48971357|NCT01732107|157724527|FG000|Overall Study|Withdrawal by Subject|2|||
48971358|NCT01162304|157724529|FG000|Overall Study|Beck scale to high|11|||
48971359|NCT01851863|157724530|FG000|Overall Study|Did not receive study medication|2|||
48971360|NCT01851863|157724531|FG001|Overall Study|Did not receive study medication|5|||
48971361|NCT01851863|157724532|FG002|Overall Study|Did not receive study medication|3|||
48971362|NCT01851863|157724533|FG003|Overall Study|Did not receive study medication|0|||
48971363|NCT01851863|157724530|FG000|Overall Study|Lost to Follow-up|3|||
48971364|NCT01851863|157724531|FG001|Overall Study|Lost to Follow-up|4|||
48971365|NCT01851863|157724532|FG002|Overall Study|Lost to Follow-up|2|||
48971366|NCT01851863|157724533|FG003|Overall Study|Lost to Follow-up|3|||
48971367|NCT01587274|157724534|FG000|Overall Study|Lost to Follow-up|4|||
48971368|NCT01587274|157724535|FG001|Overall Study|Lost to Follow-up|5|||
48971369|NCT01587274|157724536|FG002|Overall Study|Lost to Follow-up|3|||
48971370|NCT01963780|157724537|FG000|Overall Study|Death|7|||
48971371|NCT00637377|157724541|FG000|Overall Study|Adverse Event|2|||
48971372|NCT00637377|157724542|FG001|Overall Study|Adverse Event|6|||
48971373|NCT00637377|157724543|FG002|Overall Study|Adverse Event|8|||
48971374|NCT00637377|157724544|FG003|Overall Study|Adverse Event|9|||
48971375|NCT00637377|157724541|FG000|Overall Study|Death|1|||
48971376|NCT00637377|157724542|FG001|Overall Study|Death|3|||
48971377|NCT00637377|157724543|FG002|Overall Study|Death|2|||
48971378|NCT00637377|157724544|FG003|Overall Study|Death|1|||
48971379|NCT00637377|157724541|FG000|Overall Study|Lack of Efficacy|0|||
48971380|NCT00637377|157724542|FG001|Overall Study|Lack of Efficacy|0|||
48971381|NCT00637377|157724543|FG002|Overall Study|Lack of Efficacy|1|||
48971382|NCT00637377|157724544|FG003|Overall Study|Lack of Efficacy|1|||
48971383|NCT00637377|157724541|FG000|Overall Study|Lost to Follow-up|4|||
48971384|NCT00637377|157724542|FG001|Overall Study|Lost to Follow-up|1|||
48971385|NCT00637377|157724543|FG002|Overall Study|Lost to Follow-up|2|||
48971386|NCT00637377|157724544|FG003|Overall Study|Lost to Follow-up|2|||
48971387|NCT00637377|157724541|FG000|Overall Study|Protocol Violation|2|||
48971388|NCT00637377|157724542|FG001|Overall Study|Protocol Violation|1|||
48971389|NCT00637377|157724543|FG002|Overall Study|Protocol Violation|1|||
48971390|NCT00637377|157724544|FG003|Overall Study|Protocol Violation|0|||
48971391|NCT00637377|157724541|FG000|Overall Study|Withdrawal by Subject|11|||
48971392|NCT00637377|157724542|FG001|Overall Study|Withdrawal by Subject|15|||
48971393|NCT00637377|157724543|FG002|Overall Study|Withdrawal by Subject|13|||
48971394|NCT00637377|157724544|FG003|Overall Study|Withdrawal by Subject|11|||
48971395|NCT00637377|157724541|FG000|Overall Study|Other (no further information available)|7|||
48971396|NCT00637377|157724542|FG001|Overall Study|Other (no further information available)|6|||
48971397|NCT00637377|157724543|FG002|Overall Study|Other (no further information available)|10|||
48971398|NCT00637377|157724544|FG003|Overall Study|Other (no further information available)|5|||
48971399|NCT02142504|157724545|FG000|Overall Study|Protocol Violation|2|||
48971400|NCT02142504|157724546|FG001|Overall Study|Protocol Violation|1|||
48971401|NCT02142504|157724547|FG002|Overall Study|Protocol Violation|2|||
48971402|NCT02142504|157724545|FG000|Overall Study|Adverse Event|2|||
48971403|NCT02142504|157724546|FG001|Overall Study|Adverse Event|3|||
48971404|NCT02142504|157724547|FG002|Overall Study|Adverse Event|4|||
48971405|NCT02142504|157724545|FG000|Overall Study|Lost to Follow-up|12|||
48971406|NCT02142504|157724546|FG001|Overall Study|Lost to Follow-up|19|||
48971407|NCT02142504|157724547|FG002|Overall Study|Lost to Follow-up|17|||
48971408|NCT02142504|157724545|FG000|Overall Study|Withdrawal by Subject|7|||
48971409|NCT02142504|157724546|FG001|Overall Study|Withdrawal by Subject|9|||
48971410|NCT02142504|157724547|FG002|Overall Study|Withdrawal by Subject|11|||
48971411|NCT02142504|157724545|FG000|Overall Study|Pregnancy|4|||
48971412|NCT02142504|157724546|FG001|Overall Study|Pregnancy|4|||
48971413|NCT02142504|157724547|FG002|Overall Study|Pregnancy|2|||
48971414|NCT02142504|157724545|FG000|Overall Study|Physician Decision|0|||
48971415|NCT02142504|157724546|FG001|Overall Study|Physician Decision|1|||
48971416|NCT02142504|157724547|FG002|Overall Study|Physician Decision|3|||
48971417|NCT02142504|157724545|FG000|Overall Study|Reason Not Specified|4|||
48971418|NCT02142504|157724546|FG001|Overall Study|Reason Not Specified|5|||
48971419|NCT02142504|157724547|FG002|Overall Study|Reason Not Specified|4|||
48971420|NCT02925312|157724548|FG000|Overall Study|Lost to Follow-up|25|||
48971421|NCT02925312|157724549|FG001|Overall Study|Lost to Follow-up|0|||
48673017|NCT00454584|156655003|FG005|Controlled Period|Other|0|||
48971422|NCT02925312|157724548|FG000|Overall Study|Adverse Event|2|||
48971423|NCT02925312|157724549|FG001|Overall Study|Adverse Event|0|||
48971424|NCT02120352|157724552|FG000|Induction Period (20 Weeks)|Adverse Event|3|||
48971425|NCT02120352|157724553|FG001|Induction Period (20 Weeks)|Adverse Event|0|||
48971426|NCT02120352|157724554|FG002|Induction Period (20 Weeks)|Adverse Event|0|||
48971427|NCT02120352|157724555|FG003|Induction Period (20 Weeks)|Adverse Event|0|||
48971428|NCT02120352|157724556|FG004|Induction Period (20 Weeks)|Adverse Event|0|||
48971429|NCT02120352|157724557|FG005|Induction Period (20 Weeks)|Adverse Event|0|||
48971430|NCT02120352|157724558|FG006|Induction Period (20 Weeks)|Adverse Event|0|||
48971431|NCT02120352|157724552|FG000|Induction Period (20 Weeks)|Lack of Efficacy|5|||
48971432|NCT02120352|157724553|FG001|Induction Period (20 Weeks)|Lack of Efficacy|0|||
48673018|NCT00454584|156654998|FG000|After Controlled Period|Adverse Event|0|||
48673019|NCT00454584|156654999|FG001|After Controlled Period|Adverse Event|0|||
48673020|NCT00454584|156655000|FG002|After Controlled Period|Adverse Event|0|||
48971433|NCT02120352|157724554|FG002|Induction Period (20 Weeks)|Lack of Efficacy|0|||
48971434|NCT02120352|157724555|FG003|Induction Period (20 Weeks)|Lack of Efficacy|0|||
48971435|NCT02120352|157724556|FG004|Induction Period (20 Weeks)|Lack of Efficacy|0|||
48971436|NCT02120352|157724557|FG005|Induction Period (20 Weeks)|Lack of Efficacy|0|||
48971437|NCT02120352|157724558|FG006|Induction Period (20 Weeks)|Lack of Efficacy|0|||
48971438|NCT02120352|157724552|FG000|Induction Period (20 Weeks)|Protocol Violation|2|||
48971439|NCT02120352|157724553|FG001|Induction Period (20 Weeks)|Protocol Violation|0|||
48971440|NCT02120352|157724554|FG002|Induction Period (20 Weeks)|Protocol Violation|0|||
48971441|NCT02120352|157724555|FG003|Induction Period (20 Weeks)|Protocol Violation|0|||
48971442|NCT02120352|157724556|FG004|Induction Period (20 Weeks)|Protocol Violation|0|||
48971443|NCT02120352|157724557|FG005|Induction Period (20 Weeks)|Protocol Violation|0|||
48971444|NCT02120352|157724558|FG006|Induction Period (20 Weeks)|Protocol Violation|0|||
48673021|NCT00454584|156655001|FG003|After Controlled Period|Adverse Event|9|||
48971445|NCT02120352|157724552|FG000|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3|||
48971446|NCT02120352|157724553|FG001|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
48971447|NCT02120352|157724554|FG002|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
48971448|NCT02120352|157724555|FG003|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
48872745|NCT03927690|157371789|FG001|Overall Study|Withdrawal by Subject|1|||
48872746|NCT03927690|157371790|FG002|Overall Study|Withdrawal by Subject|1|||
48872747|NCT03927690|157371788|FG000|Overall Study|Adverse Event|1|||
48872748|NCT03927690|157371789|FG001|Overall Study|Adverse Event|0|||
48872749|NCT03927690|157371790|FG002|Overall Study|Adverse Event|0|||
48872750|NCT03927690|157371788|FG000|Overall Study|Death|1|||
48872751|NCT03927690|157371789|FG001|Overall Study|Death|0|||
48872752|NCT03927690|157371790|FG002|Overall Study|Death|0|||
48872753|NCT03927690|157371788|FG000|Overall Study|Lost to Follow-up|2|||
48872754|NCT03927690|157371789|FG001|Overall Study|Lost to Follow-up|2|||
48872755|NCT03927690|157371790|FG002|Overall Study|Lost to Follow-up|1|||
48872756|NCT01850823|157371791|FG000|Overall Study|Early Visit Window|0|||
48872757|NCT01850823|157371792|FG001|Overall Study|Early Visit Window|1|||
48872758|NCT01850823|157371793|FG002|Overall Study|Early Visit Window|4|||
48872759|NCT01850823|157371791|FG000|Overall Study|Enrolled in Error|0|||
48872760|NCT01850823|157371792|FG001|Overall Study|Enrolled in Error|1|||
48872761|NCT01850823|157371793|FG002|Overall Study|Enrolled in Error|2|||
48872762|NCT01850823|157371791|FG000|Overall Study|Lack of Efficacy|1|||
48872763|NCT01850823|157371792|FG001|Overall Study|Lack of Efficacy|0|||
48872764|NCT01850823|157371793|FG002|Overall Study|Lack of Efficacy|0|||
48872765|NCT01850823|157371791|FG000|Overall Study|Lost to Follow-up|0|||
48872766|NCT01850823|157371792|FG001|Overall Study|Lost to Follow-up|0|||
48872767|NCT01850823|157371793|FG002|Overall Study|Lost to Follow-up|1|||
48872768|NCT01850823|157371791|FG000|Overall Study|Restricted Medication|0|||
48872769|NCT01850823|157371792|FG001|Overall Study|Restricted Medication|0|||
48872770|NCT01850823|157371793|FG002|Overall Study|Restricted Medication|2|||
48872771|NCT01850823|157371791|FG000|Overall Study|Significant worstening of SAR|0|||
48872772|NCT01850823|157371792|FG001|Overall Study|Significant worstening of SAR|1|||
48872773|NCT01850823|157371793|FG002|Overall Study|Significant worstening of SAR|0|||
48872774|NCT01850823|157371791|FG000|Overall Study|Withdrawal by Subject|2|||
48872775|NCT01850823|157371792|FG001|Overall Study|Withdrawal by Subject|0|||
48872776|NCT01850823|157371793|FG002|Overall Study|Withdrawal by Subject|1|||
48872777|NCT00805285|157371798|FG000|Overall Study|Lack of Efficacy|1|||
48872778|NCT00551135|157371799|FG000|Overall Study|Adverse Event|1|||
48872779|NCT00551135|157371800|FG001|Overall Study|Adverse Event|0|||
48872780|NCT00551135|157371801|FG002|Overall Study|Adverse Event|1|||
48872781|NCT00551135|157371802|FG003|Overall Study|Adverse Event|1|||
48872782|NCT00551135|157371799|FG000|Overall Study|Lost to Follow-up|0|||
48872783|NCT00551135|157371800|FG001|Overall Study|Lost to Follow-up|0|||
48872784|NCT00551135|157371801|FG002|Overall Study|Lost to Follow-up|0|||
48872785|NCT00551135|157371802|FG003|Overall Study|Lost to Follow-up|1|||
48872786|NCT00551135|157371799|FG000|Overall Study|Other|3|||
48872787|NCT00551135|157371800|FG001|Overall Study|Other|2|||
48872788|NCT00551135|157371801|FG002|Overall Study|Other|1|||
48872789|NCT00551135|157371802|FG003|Overall Study|Other|2|||
48872790|NCT00551135|157371799|FG000|Overall Study|Withdrawal by Subject|1|||
48872791|NCT00551135|157371800|FG001|Overall Study|Withdrawal by Subject|0|||
48872792|NCT00551135|157371801|FG002|Overall Study|Withdrawal by Subject|3|||
48872793|NCT00551135|157371802|FG003|Overall Study|Withdrawal by Subject|1|||
48872794|NCT00548847|157371803|FG000|Overall Study|Disease progression|7|||
48872795|NCT01588366|157371806|FG000|Overall Study|Adverse Event|0|||
48872796|NCT01588366|157371807|FG001|Overall Study|Adverse Event|1|||
48872797|NCT01588366|157371808|FG002|Overall Study|Adverse Event|0|||
48872798|NCT01588366|157371809|FG003|Overall Study|Adverse Event|1|||
48872799|NCT01588366|157371810|FG004|Overall Study|Adverse Event|0|||
48872800|NCT01588366|157371811|FG005|Overall Study|Adverse Event|2|||
48872801|NCT00677092|157371812|FG000|Overall Study|Adverse Event|1|||
48872802|NCT00677092|157371812|FG000|Overall Study|Lost to Follow-up|1|||
48872803|NCT00677092|157371812|FG000|Overall Study|Withdrawal by Subject|3|||
48872804|NCT00677092|157371812|FG000|Overall Study|Death Prior to Receiving Treatment|1|||
48872805|NCT00585975|157371813|FG000|Overall Study|Withdrawal by Subject|3|||
48872806|NCT00585975|157371814|FG001|Overall Study|Withdrawal by Subject|3|||
48872807|NCT00585975|157371813|FG000|Overall Study|Lost to Follow-up|2|||
48872808|NCT00585975|157371814|FG001|Overall Study|Lost to Follow-up|1|||
48872809|NCT00585975|157371813|FG000|Overall Study|Enrollment met/over-enrolled|10|||
48872810|NCT00585975|157371814|FG001|Overall Study|Enrollment met/over-enrolled|9|||
48872811|NCT02716298|157371817|FG000|First Intervention (1 Month)|Lens discomfort|1|||
48872812|NCT02716298|157371818|FG001|First Intervention (1 Month)|Lens discomfort|1|||
48872813|NCT02246218|157371822|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
48872814|NCT02246218|157371823|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
48872815|NCT02246218|157371822|FG000|Overall Study|Stopping Rule: Liver Transplant|2|||
48872816|NCT02246218|157371823|FG001|Overall Study|Stopping Rule: Liver Transplant|4|||
48872817|NCT02246218|157371822|FG000|Overall Study|Adverse Event|1|||
48673022|NCT00454584|156655002|FG004|After Controlled Period|Adverse Event|3|||
48673023|NCT00454584|156655003|FG005|After Controlled Period|Adverse Event|9|||
48673024|NCT00454584|156654998|FG000|After Controlled Period|Lack of Efficacy|0|||
48673025|NCT00454584|156654999|FG001|After Controlled Period|Lack of Efficacy|0|||
48673026|NCT00454584|156655000|FG002|After Controlled Period|Lack of Efficacy|0|||
48673027|NCT00454584|156655001|FG003|After Controlled Period|Lack of Efficacy|1|||
48673028|NCT00454584|156655002|FG004|After Controlled Period|Lack of Efficacy|0|||
48673029|NCT00454584|156655003|FG005|After Controlled Period|Lack of Efficacy|0|||
48872818|NCT02246218|157371823|FG001|Overall Study|Adverse Event|1|||
48872819|NCT02246218|157371822|FG000|Overall Study|Lost to Follow-up|1|||
48872820|NCT02246218|157371823|FG001|Overall Study|Lost to Follow-up|0|||
48872821|NCT01321723|157371824|FG000|Overall Study|Adverse Event|3|||
48872822|NCT01321723|157371825|FG001|Overall Study|Adverse Event|5|||
48872823|NCT01321723|157371826|FG002|Overall Study|Adverse Event|2|||
48872824|NCT01321723|157371824|FG000|Overall Study|Withdrawal by Subject|2|||
48872825|NCT01321723|157371825|FG001|Overall Study|Withdrawal by Subject|0|||
48872826|NCT01321723|157371826|FG002|Overall Study|Withdrawal by Subject|2|||
48872827|NCT03318783|157371834|FG000|Overall Study|Withdrawal by Subject|0|||
48872828|NCT03318783|157371835|FG001|Overall Study|Withdrawal by Subject|1|||
48872829|NCT03318783|157371834|FG000|Overall Study|Death|0|||
48872830|NCT03318783|157371835|FG001|Overall Study|Death|1|||
48872831|NCT00545571|157371836|FG000|Overall Study|Administrative Reasons|1|||
48872832|NCT00545571|157371836|FG000|Overall Study|Adverse Event|2|||
48872833|NCT00545571|157371836|FG000|Overall Study|Death|5|||
48872834|NCT00545571|157371836|FG000|Overall Study|Lack of Efficacy|1|||
48872835|NCT00545571|157371836|FG000|Overall Study|Protocol Violation|2|||
48872836|NCT00545571|157371836|FG000|Overall Study|Refused Treatment|1|||
48872837|NCT00545571|157371836|FG000|Overall Study|Screen Failure|16|||
48872838|NCT00545571|157371836|FG000|Overall Study|Transfusion|12|||
48872839|NCT00545571|157371836|FG000|Overall Study|Early Termination of Study|24|||
48872840|NCT00545571|157371836|FG000|Overall Study|Kidney Transplantation|3|||
48872841|NCT01721746|157371838|FG000|Pre-Treatment|Participant request to discontinue Study treatment|0|||
48872842|NCT01721746|157371839|FG001|Pre-Treatment|Participant request to discontinue Study treatment|13|||
48872843|NCT01721746|157371838|FG000|Pre-Treatment|Withdrawal by Subject|1|||
48872844|NCT01721746|157371839|FG001|Pre-Treatment|Withdrawal by Subject|16|||
48872845|NCT01721746|157371838|FG000|Pre-Treatment|Poor/Non-compliance|1|||
48872846|NCT01721746|157371839|FG001|Pre-Treatment|Poor/Non-compliance|0|||
48872847|NCT01721746|157371838|FG000|Pre-Treatment|Participant no longer met study criteria|2|||
48872848|NCT01721746|157371839|FG001|Pre-Treatment|Participant no longer met study criteria|2|||
48872849|NCT01721746|157371838|FG000|Treatment|Disease Progression|192|||
48872850|NCT01721746|157371839|FG001|Treatment|Disease Progression|74|||
48872851|NCT01721746|157371838|FG000|Treatment|Study Drug Toxicity|19|||
48872852|NCT01721746|157371839|FG001|Treatment|Study Drug Toxicity|11|||
48872853|NCT01721746|157371838|FG000|Treatment|Adverse Event unrelated to Study Drug|6|||
48872854|NCT01721746|157371839|FG001|Treatment|Adverse Event unrelated to Study Drug|3|||
48872855|NCT01721746|157371838|FG000|Treatment|Participant request to discontinue Study treatment|26|||
48872856|NCT01721746|157371839|FG001|Treatment|Participant request to discontinue Study treatment|7|||
48872857|NCT01721746|157371838|FG000|Treatment|Participant withdrew consent|4|||
48872858|NCT01721746|157371839|FG001|Treatment|Participant withdrew consent|2|||
48872859|NCT01721746|157371838|FG000|Treatment|Maximum Clinical Benefit|9|||
48872860|NCT01721746|157371839|FG001|Treatment|Maximum Clinical Benefit|3|||
48872861|NCT01721746|157371838|FG000|Treatment|Poor/Non-compliance|2|||
48872862|NCT01721746|157371839|FG001|Treatment|Poor/Non-compliance|0|||
48872863|NCT01721746|157371838|FG000|Treatment|Participant no longer met Study criteria|4|||
48872864|NCT01721746|157371839|FG001|Treatment|Participant no longer met Study criteria|0|||
48872865|NCT01721746|157371838|FG000|Treatment|Other reasons|6|||
48872866|NCT01721746|157371839|FG001|Treatment|Other reasons|2|||
48872867|NCT02049515|157371840|FG000|Overall Study|Adverse Event|46|||
48872868|NCT02049515|157371841|FG001|Overall Study|Adverse Event|2|||
48872869|NCT02049515|157371840|FG000|Overall Study|Protocol-specified Disease Progression|23|||
48872870|NCT02049515|157371841|FG001|Overall Study|Protocol-specified Disease Progression|2|||
48872871|NCT02049515|157371840|FG000|Overall Study|Death|6|||
48872872|NCT02049515|157371841|FG001|Overall Study|Death|0|||
48872873|NCT02049515|157371840|FG000|Overall Study|Physician Decision|5|||
48872874|NCT02049515|157371841|FG001|Overall Study|Physician Decision|1|||
48872875|NCT02049515|157371840|FG000|Overall Study|Withdrawal by Subject|3|||
48872876|NCT02049515|157371841|FG001|Overall Study|Withdrawal by Subject|0|||
48872877|NCT02049515|157371840|FG000|Overall Study|Termination of the Study by Sponsor|2|||
48872878|NCT02049515|157371841|FG001|Overall Study|Termination of the Study by Sponsor|0|||
48872879|NCT02049515|157371840|FG000|Overall Study|Protocol Violation|1|||
48872880|NCT02049515|157371841|FG001|Overall Study|Protocol Violation|1|||
48872881|NCT02049515|157371840|FG000|Overall Study|Clinical Deterioration|1|||
48872882|NCT02049515|157371841|FG001|Overall Study|Clinical Deterioration|0|||
48872883|NCT02049515|157371840|FG000|Overall Study|Need Treatment for Metastatic Melanoma|1|||
48872884|NCT02049515|157371841|FG001|Overall Study|Need Treatment for Metastatic Melanoma|0|||
48673030|NCT00454584|156654998|FG000|After Controlled Period|Lost to Follow-up|0|||
48971449|NCT02120352|157724556|FG004|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
48971450|NCT02120352|157724557|FG005|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
48971451|NCT02120352|157724558|FG006|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
48971452|NCT02120352|157724552|FG000|Induction Period (20 Weeks)|Lost to Follow-up|2|||
48971453|NCT02120352|157724553|FG001|Induction Period (20 Weeks)|Lost to Follow-up|0|||
48971454|NCT02120352|157724554|FG002|Induction Period (20 Weeks)|Lost to Follow-up|0|||
48971455|NCT02120352|157724555|FG003|Induction Period (20 Weeks)|Lost to Follow-up|0|||
48971456|NCT02120352|157724556|FG004|Induction Period (20 Weeks)|Lost to Follow-up|0|||
48971457|NCT02120352|157724557|FG005|Induction Period (20 Weeks)|Lost to Follow-up|0|||
48971458|NCT02120352|157724558|FG006|Induction Period (20 Weeks)|Lost to Follow-up|0|||
48971459|NCT02120352|157724552|FG000|Induction Period (20 Weeks)|Withdrawal by Subject|5|||
48971460|NCT02120352|157724553|FG001|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
48971461|NCT02120352|157724554|FG002|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
48971462|NCT02120352|157724555|FG003|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
48971463|NCT02120352|157724556|FG004|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
48971464|NCT02120352|157724557|FG005|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
48971465|NCT02120352|157724558|FG006|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
48971466|NCT02120352|157724552|FG000|Induction Period (20 Weeks)|Physician Decision|1|||
48971467|NCT02120352|157724553|FG001|Induction Period (20 Weeks)|Physician Decision|0|||
48971468|NCT02120352|157724554|FG002|Induction Period (20 Weeks)|Physician Decision|0|||
48971469|NCT02120352|157724555|FG003|Induction Period (20 Weeks)|Physician Decision|0|||
48971470|NCT02120352|157724556|FG004|Induction Period (20 Weeks)|Physician Decision|0|||
48971471|NCT02120352|157724557|FG005|Induction Period (20 Weeks)|Physician Decision|0|||
48971472|NCT02120352|157724558|FG006|Induction Period (20 Weeks)|Physician Decision|0|||
48971473|NCT02120352|157724552|FG000|Maintenance Period (Up to Week 96)|Adverse Event|0|||
48971474|NCT02120352|157724553|FG001|Maintenance Period (Up to Week 96)|Adverse Event|1|||
48971475|NCT02120352|157724554|FG002|Maintenance Period (Up to Week 96)|Adverse Event|8|||
48971476|NCT02120352|157724555|FG003|Maintenance Period (Up to Week 96)|Adverse Event|1|||
48971477|NCT02120352|157724556|FG004|Maintenance Period (Up to Week 96)|Adverse Event|0|||
48971478|NCT02120352|157724557|FG005|Maintenance Period (Up to Week 96)|Adverse Event|0|||
48971479|NCT02120352|157724558|FG006|Maintenance Period (Up to Week 96)|Adverse Event|0|||
48971480|NCT02120352|157724552|FG000|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
48971481|NCT02120352|157724553|FG001|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
48971482|NCT02120352|157724554|FG002|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
48971483|NCT02120352|157724555|FG003|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
48971484|NCT02120352|157724556|FG004|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
48971485|NCT02120352|157724557|FG005|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
48971486|NCT02120352|157724558|FG006|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
48971487|NCT02120352|157724552|FG000|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
48971488|NCT02120352|157724553|FG001|Maintenance Period (Up to Week 96)|Protocol Violation|1|||
48971489|NCT02120352|157724554|FG002|Maintenance Period (Up to Week 96)|Protocol Violation|2|||
48971490|NCT02120352|157724555|FG003|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
48971491|NCT02120352|157724556|FG004|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
48971492|NCT02120352|157724557|FG005|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
48971493|NCT02120352|157724558|FG006|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
48971494|NCT02120352|157724552|FG000|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
48971495|NCT02120352|157724553|FG001|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
48971496|NCT02120352|157724554|FG002|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
48971497|NCT02120352|157724555|FG003|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
48971498|NCT02120352|157724556|FG004|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
48971499|NCT02120352|157724557|FG005|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
48971500|NCT02120352|157724558|FG006|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
48971501|NCT02120352|157724552|FG000|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
48971502|NCT02120352|157724553|FG001|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
48971503|NCT02120352|157724554|FG002|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
48971504|NCT02120352|157724555|FG003|Maintenance Period (Up to Week 96)|Lost to Follow-up|1|||
48673031|NCT00454584|156654999|FG001|After Controlled Period|Lost to Follow-up|0|||
48971505|NCT02120352|157724556|FG004|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
48673032|NCT00454584|156655000|FG002|After Controlled Period|Lost to Follow-up|0|||
48673033|NCT00454584|156655001|FG003|After Controlled Period|Lost to Follow-up|2|||
48673034|NCT00454584|156655002|FG004|After Controlled Period|Lost to Follow-up|4|||
48673035|NCT00454584|156655003|FG005|After Controlled Period|Lost to Follow-up|6|||
48673036|NCT00454584|156654998|FG000|After Controlled Period|Other|0|||
48673037|NCT00454584|156654999|FG001|After Controlled Period|Other|0|||
48971506|NCT02120352|157724557|FG005|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
48971507|NCT02120352|157724558|FG006|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
48673038|NCT00454584|156655000|FG002|After Controlled Period|Other|0|||
48673039|NCT00454584|156655001|FG003|After Controlled Period|Other|1|||
48673040|NCT00454584|156655002|FG004|After Controlled Period|Other|0|||
48673041|NCT00454584|156655003|FG005|After Controlled Period|Other|0|||
48673042|NCT00454584|156654998|FG000|After Controlled Period|Other|0|||
48673043|NCT00454584|156654999|FG001|After Controlled Period|Other|0|||
48673044|NCT00454584|156655000|FG002|After Controlled Period|Other|0|||
48673045|NCT00454584|156655001|FG003|After Controlled Period|Other|13|||
48673046|NCT00454584|156655002|FG004|After Controlled Period|Other|5|||
48673047|NCT00454584|156655003|FG005|After Controlled Period|Other|17|||
48673048|NCT04268173|156655007|FG000|Overall Study|Lost to Follow-up|75|||
48673049|NCT04268173|156655008|FG001|Overall Study|Lost to Follow-up|108|||
48673050|NCT01353911|156655009|FG000|Overall Study|Lost to Follow-up|2|||
48673051|NCT01353911|156655010|FG001|Overall Study|Lost to Follow-up|6|||
48673052|NCT01353911|156655011|FG002|Overall Study|Lost to Follow-up|4|||
48673053|NCT01353911|156655012|FG003|Overall Study|Lost to Follow-up|0|||
48673054|NCT01353911|156655013|FG004|Overall Study|Lost to Follow-up|4|||
48673055|NCT01353911|156655014|FG005|Overall Study|Lost to Follow-up|4|||
48872885|NCT02049515|157371840|FG000|Overall Study|Treatment Interruption >42 Days|1|||
48872886|NCT02049515|157371841|FG001|Overall Study|Treatment Interruption >42 Days|0|||
48872887|NCT02049515|157371840|FG000|Overall Study|Suspected and Unconfirmed Disease Progression|1|||
48872888|NCT02049515|157371841|FG001|Overall Study|Suspected and Unconfirmed Disease Progression|0|||
48872889|NCT02138253|157371845|FG000|Overall Study|Adverse Event|3|||
48872890|NCT02138253|157371846|FG001|Overall Study|Adverse Event|3|||
48872891|NCT02138253|157371845|FG000|Overall Study|Lost to Follow-up|2|||
48872892|NCT02138253|157371846|FG001|Overall Study|Lost to Follow-up|1|||
48872893|NCT02138253|157371845|FG000|Overall Study|Physician Decision|2|||
48872894|NCT02138253|157371846|FG001|Overall Study|Physician Decision|0|||
48872895|NCT02138253|157371845|FG000|Overall Study|Non compliance|1|||
48872896|NCT02138253|157371846|FG001|Overall Study|Non compliance|0|||
48872897|NCT02138253|157371845|FG000|Overall Study|Withdrawal by Subject|1|||
48872898|NCT02138253|157371846|FG001|Overall Study|Withdrawal by Subject|0|||
48872899|NCT00468130|157371850|FG000|Overall Study|Adverse Event|2|||
48872900|NCT00468130|157371851|FG001|Overall Study|Adverse Event|1|||
48872901|NCT00468130|157371850|FG000|Overall Study|Withdrawal by Subject|0|||
48872902|NCT00468130|157371851|FG001|Overall Study|Withdrawal by Subject|1|||
48872903|NCT01006889|157371852|FG000|Overall Study|Withdrawal by Subject|3|||
48872904|NCT01841112|157371853|FG000|Single Dose Segment (Day 1)|Not Treated|1|||
48872905|NCT01841112|157371854|FG001|Single Dose Segment (Day 1)|Not Treated|1|||
48872906|NCT01841112|157371855|FG002|Single Dose Segment (Day 1)|Not Treated|1|||
48872907|NCT01841112|157371856|FG003|Single Dose Segment (Day 1)|Not Treated|0|||
48971508|NCT02120352|157724552|FG000|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
48971509|NCT02120352|157724553|FG001|Maintenance Period (Up to Week 96)|Withdrawal by Subject|1|||
48971510|NCT02120352|157724554|FG002|Maintenance Period (Up to Week 96)|Withdrawal by Subject|3|||
48971511|NCT02120352|157724555|FG003|Maintenance Period (Up to Week 96)|Withdrawal by Subject|5|||
48971512|NCT02120352|157724556|FG004|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
48971513|NCT02120352|157724557|FG005|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
48971514|NCT02120352|157724558|FG006|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
48971515|NCT02120352|157724552|FG000|Maintenance Period (Up to Week 96)|Physician Decision|0|||
48971516|NCT02120352|157724553|FG001|Maintenance Period (Up to Week 96)|Physician Decision|1|||
48971517|NCT02120352|157724554|FG002|Maintenance Period (Up to Week 96)|Physician Decision|0|||
48971518|NCT02120352|157724555|FG003|Maintenance Period (Up to Week 96)|Physician Decision|0|||
48971519|NCT02120352|157724556|FG004|Maintenance Period (Up to Week 96)|Physician Decision|0|||
48971520|NCT02120352|157724557|FG005|Maintenance Period (Up to Week 96)|Physician Decision|0|||
48971521|NCT02120352|157724558|FG006|Maintenance Period (Up to Week 96)|Physician Decision|0|||
48971522|NCT02120352|157724552|FG000|Extension Period (Week 97 to Study End)|Adverse Event|0|||
48971523|NCT02120352|157724553|FG001|Extension Period (Week 97 to Study End)|Adverse Event|3|||
48971524|NCT02120352|157724554|FG002|Extension Period (Week 97 to Study End)|Adverse Event|11|||
48971525|NCT02120352|157724555|FG003|Extension Period (Week 97 to Study End)|Adverse Event|0|||
48971526|NCT02120352|157724556|FG004|Extension Period (Week 97 to Study End)|Adverse Event|2|||
48971527|NCT02120352|157724557|FG005|Extension Period (Week 97 to Study End)|Adverse Event|1|||
48971528|NCT02120352|157724558|FG006|Extension Period (Week 97 to Study End)|Adverse Event|0|||
48971529|NCT02120352|157724552|FG000|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
48971530|NCT02120352|157724553|FG001|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
48971531|NCT02120352|157724554|FG002|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
48971532|NCT02120352|157724555|FG003|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
48971533|NCT02120352|157724556|FG004|Extension Period (Week 97 to Study End)|Lack of Efficacy|1|||
48971534|NCT02120352|157724557|FG005|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
48673056|NCT01353911|156655015|FG006|Overall Study|Lost to Follow-up|3|||
48673057|NCT01353911|156655016|FG007|Overall Study|Lost to Follow-up|6|||
48673058|NCT01353911|156655009|FG000|Overall Study|Withdrawal by Subject|2|||
48761005|NCT00951665|156973962|FG004|Phase 1b|Disease Progression|0|||
48872908|NCT01841112|157371857|FG004|Single Dose Segment (Day 1)|Not Treated|0|||
48872909|NCT00723125|157371862|FG000|Overall Study|Met Dx|1|||
48971535|NCT02120352|157724558|FG006|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
48971536|NCT02120352|157724552|FG000|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
48971537|NCT02120352|157724553|FG001|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
48971538|NCT02120352|157724554|FG002|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
48971539|NCT02120352|157724555|FG003|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
48971540|NCT02120352|157724556|FG004|Extension Period (Week 97 to Study End)|Protocol Violation|2|||
48971541|NCT02120352|157724557|FG005|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
48971542|NCT02120352|157724558|FG006|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
48971543|NCT02120352|157724552|FG000|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
48971544|NCT02120352|157724553|FG001|Extension Period (Week 97 to Study End)|Withdrawal by Subject|7|||
48971545|NCT02120352|157724554|FG002|Extension Period (Week 97 to Study End)|Withdrawal by Subject|9|||
48971546|NCT02120352|157724555|FG003|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
48971547|NCT02120352|157724556|FG004|Extension Period (Week 97 to Study End)|Withdrawal by Subject|2|||
48971548|NCT02120352|157724557|FG005|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
48971549|NCT02120352|157724558|FG006|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
48971550|NCT02120352|157724552|FG000|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
48971551|NCT02120352|157724553|FG001|Extension Period (Week 97 to Study End)|Lost to Follow-up|2|||
48971552|NCT02120352|157724554|FG002|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
48971553|NCT02120352|157724555|FG003|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
48971554|NCT02120352|157724556|FG004|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
48971555|NCT02120352|157724557|FG005|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
48971556|NCT02120352|157724558|FG006|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
48971557|NCT02120352|157724552|FG000|Extension Period (Week 97 to Study End)|Physician Decision|0|||
48971558|NCT02120352|157724553|FG001|Extension Period (Week 97 to Study End)|Physician Decision|2|||
48971559|NCT02120352|157724554|FG002|Extension Period (Week 97 to Study End)|Physician Decision|2|||
48971560|NCT02120352|157724555|FG003|Extension Period (Week 97 to Study End)|Physician Decision|0|||
48971561|NCT02120352|157724556|FG004|Extension Period (Week 97 to Study End)|Physician Decision|0|||
48971562|NCT02120352|157724557|FG005|Extension Period (Week 97 to Study End)|Physician Decision|0|||
48971563|NCT02120352|157724558|FG006|Extension Period (Week 97 to Study End)|Physician Decision|0|||
48971564|NCT02120352|157724552|FG000|Extension Period (Week 97 to Study End)|Site closed|0|||
48971565|NCT02120352|157724553|FG001|Extension Period (Week 97 to Study End)|Site closed|0|||
48971566|NCT02120352|157724554|FG002|Extension Period (Week 97 to Study End)|Site closed|1|||
48971567|NCT02120352|157724555|FG003|Extension Period (Week 97 to Study End)|Site closed|0|||
48971568|NCT02120352|157724556|FG004|Extension Period (Week 97 to Study End)|Site closed|0|||
48971569|NCT02120352|157724557|FG005|Extension Period (Week 97 to Study End)|Site closed|1|||
48971570|NCT02120352|157724558|FG006|Extension Period (Week 97 to Study End)|Site closed|0|||
48971571|NCT02120352|157724552|FG000|Long-Term Follow-up Period (52 Weeks)|Other|0|||
48971572|NCT02120352|157724553|FG001|Long-Term Follow-up Period (52 Weeks)|Other|0|||
48971573|NCT02120352|157724554|FG002|Long-Term Follow-up Period (52 Weeks)|Other|0|||
48673059|NCT01353911|156655010|FG001|Overall Study|Withdrawal by Subject|3|||
48673060|NCT01353911|156655011|FG002|Overall Study|Withdrawal by Subject|4|||
48673061|NCT01353911|156655012|FG003|Overall Study|Withdrawal by Subject|2|||
48673062|NCT01353911|156655013|FG004|Overall Study|Withdrawal by Subject|2|||
48673063|NCT01353911|156655014|FG005|Overall Study|Withdrawal by Subject|3|||
48673064|NCT01353911|156655015|FG006|Overall Study|Withdrawal by Subject|3|||
48673065|NCT01353911|156655016|FG007|Overall Study|Withdrawal by Subject|9|||
48673066|NCT01353911|156655009|FG000|Overall Study|Status Not Recorded|4|||
48673067|NCT01353911|156655010|FG001|Overall Study|Status Not Recorded|0|||
48673068|NCT01353911|156655011|FG002|Overall Study|Status Not Recorded|1|||
48673069|NCT01353911|156655012|FG003|Overall Study|Status Not Recorded|0|||
48673070|NCT01353911|156655013|FG004|Overall Study|Status Not Recorded|0|||
48673071|NCT01353911|156655014|FG005|Overall Study|Status Not Recorded|0|||
48673072|NCT01353911|156655015|FG006|Overall Study|Status Not Recorded|0|||
48673073|NCT01353911|156655016|FG007|Overall Study|Status Not Recorded|0|||
48673074|NCT01729208|156655017|FG000|Baseline|Physician Decision|5|||
48673075|NCT01729208|156655018|FG001|Baseline|Physician Decision|4|||
48673076|NCT01729208|156655017|FG000|12 Months Follow-up|Withdrawal by Subject|4|||
48673077|NCT01729208|156655018|FG001|12 Months Follow-up|Withdrawal by Subject|7|||
48673078|NCT01729208|156655017|FG000|12 Months Follow-up|Lost to Follow-up|3|||
48971574|NCT02120352|157724555|FG003|Long-Term Follow-up Period (52 Weeks)|Other|0|||
48673079|NCT01729208|156655018|FG001|12 Months Follow-up|Lost to Follow-up|3|||
48673080|NCT01729208|156655017|FG000|24 Months Follow-up|Lost to Follow-up|3|||
48673081|NCT01729208|156655018|FG001|24 Months Follow-up|Lost to Follow-up|0|||
48673082|NCT01729208|156655017|FG000|36 Months Follow-up|Physician Decision|1|||
48761006|NCT00951665|156973963|FG005|Phase 1b|Disease Progression|0|||
48761007|NCT00951665|156973958|FG000|Phase 1b|Protocol Violation|2|||
48673083|NCT01729208|156655018|FG001|36 Months Follow-up|Physician Decision|0|||
48761008|NCT00951665|156973959|FG001|Phase 1b|Protocol Violation|0|||
48971575|NCT02120352|157724556|FG004|Long-Term Follow-up Period (52 Weeks)|Other|0|||
48971576|NCT02120352|157724557|FG005|Long-Term Follow-up Period (52 Weeks)|Other|0|||
48971577|NCT02120352|157724558|FG006|Long-Term Follow-up Period (52 Weeks)|Other|6|||
48971578|NCT01610206|157724561|FG000|Overall Study|Adverse Event|10|||
48971579|NCT01610206|157724562|FG001|Overall Study|Adverse Event|30|||
48971580|NCT00967226|157726272|FG000|Overall Study|Adverse Event|0|||
48971581|NCT00967226|157726273|FG001|Overall Study|Adverse Event|5|||
48971582|NCT00967226|157726272|FG000|Overall Study|Protocol Violation|2|||
48971583|NCT00967226|157726273|FG001|Overall Study|Protocol Violation|0|||
48971584|NCT00967226|157726272|FG000|Overall Study|Physician Decision|0|||
48971585|NCT00967226|157726273|FG001|Overall Study|Physician Decision|1|||
48971586|NCT03947255|157726274|FG000|Overall Study|Study Closure by Sponsor|2|||
48971587|NCT03947255|157726275|FG001|Overall Study|Study Closure by Sponsor|2|||
48971588|NCT03947255|157726274|FG000|Overall Study|Withdrawal by Subject|2|||
48971589|NCT03947255|157726275|FG001|Overall Study|Withdrawal by Subject|2|||
48971590|NCT03947255|157726274|FG000|Overall Study|Lost to Follow-up|2|||
48673084|NCT01729208|156655017|FG000|36 Months Follow-up|Withdrawal by Subject|2|||
48673085|NCT01729208|156655018|FG001|36 Months Follow-up|Withdrawal by Subject|4|||
48673086|NCT03995355|156655021|FG000|Overall Study|Adverse Event|1|||
48673087|NCT03995355|156655022|FG001|Overall Study|Adverse Event|0|||
48673088|NCT03995355|156655021|FG000|Overall Study|Withdrawal by Subject|1|||
48673089|NCT03995355|156655022|FG001|Overall Study|Withdrawal by Subject|0|||
48673090|NCT03995355|156655021|FG000|Overall Study|Scheduling Issues|0|||
48673091|NCT03995355|156655022|FG001|Overall Study|Scheduling Issues|1|||
48673092|NCT00494507|156655025|FG000|Double-Blind Phase|Adverse Event|2|||
48673093|NCT00494507|156655026|FG001|Double-Blind Phase|Adverse Event|0|||
48673094|NCT00494507|156655027|FG002|Double-Blind Phase|Adverse Event|1|||
48673095|NCT00494507|156655028|FG003|Double-Blind Phase|Adverse Event|0|||
48673096|NCT00494507|156655025|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
48673097|NCT00494507|156655026|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
48971591|NCT03947255|157726275|FG001|Overall Study|Lost to Follow-up|0|||
48971592|NCT03947255|157726274|FG000|Overall Study|Death|0|||
48971593|NCT03947255|157726275|FG001|Overall Study|Death|2|||
48971594|NCT03073213|157726276|FG000|Multiple Dose Period|Protocol Violation|0|||
48971595|NCT03073213|157726277|FG001|Multiple Dose Period|Protocol Violation|0|||
48971596|NCT03073213|157726278|FG002|Multiple Dose Period|Protocol Violation|1|||
48971597|NCT01253187|157726282|FG000|Period 2|Withdrawal by Subject|0|||
48971598|NCT01253187|157726283|FG001|Period 2|Withdrawal by Subject|0|||
48971599|NCT01253187|157726284|FG002|Period 2|Withdrawal by Subject|0|||
48971600|NCT01253187|157726285|FG003|Period 2|Withdrawal by Subject|0|||
48971601|NCT01253187|157726286|FG004|Period 2|Withdrawal by Subject|1|||
48971602|NCT01253187|157726287|FG005|Period 2|Withdrawal by Subject|0|||
48971603|NCT01253187|157726282|FG000|Period 3|Pregnancy|1|||
48971604|NCT01253187|157726283|FG001|Period 3|Pregnancy|0|||
48971605|NCT01253187|157726284|FG002|Period 3|Pregnancy|0|||
48971606|NCT01253187|157726285|FG003|Period 3|Pregnancy|0|||
48971607|NCT01253187|157726286|FG004|Period 3|Pregnancy|0|||
48971608|NCT01253187|157726287|FG005|Period 3|Pregnancy|0|||
48971609|NCT01253187|157726282|FG000|Period 3|difficulty with blood sampling|0|||
48971610|NCT01253187|157726283|FG001|Period 3|difficulty with blood sampling|1|||
48971611|NCT01253187|157726284|FG002|Period 3|difficulty with blood sampling|0|||
48971612|NCT01253187|157726285|FG003|Period 3|difficulty with blood sampling|0|||
48971613|NCT01253187|157726286|FG004|Period 3|difficulty with blood sampling|0|||
48971614|NCT01253187|157726287|FG005|Period 3|difficulty with blood sampling|0|||
48971615|NCT01253187|157726282|FG000|Period 3|non-compliance|0|||
48971616|NCT01253187|157726283|FG001|Period 3|non-compliance|0|||
48971617|NCT01253187|157726284|FG002|Period 3|non-compliance|0|||
48971618|NCT01253187|157726285|FG003|Period 3|non-compliance|0|||
48971619|NCT01253187|157726286|FG004|Period 3|non-compliance|1|||
48673098|NCT00494507|156655027|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
48673099|NCT00494507|156655028|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
48673100|NCT00494507|156655025|FG000|Double-Blind Phase|Subject Non-compliance|0|||
48673101|NCT00494507|156655026|FG001|Double-Blind Phase|Subject Non-compliance|0|||
48673102|NCT00494507|156655027|FG002|Double-Blind Phase|Subject Non-compliance|1|||
48971620|NCT01253187|157726287|FG005|Period 3|non-compliance|0|||
48971621|NCT01293006|157726288|FG000|Period 2|Lost to Follow-up|1|||
48971622|NCT01293006|157726289|FG001|Period 2|Lost to Follow-up|0|||
48673103|NCT00494507|156655028|FG003|Double-Blind Phase|Subject Non-compliance|0|||
48971623|NCT01293006|157726290|FG002|Period 2|Lost to Follow-up|0|||
48673104|NCT00494507|156655025|FG000|Double-Blind Phase|Negative DNA test|0|||
48673105|NCT00494507|156655026|FG001|Double-Blind Phase|Negative DNA test|0|||
48971624|NCT01293006|157726291|FG003|Period 2|Lost to Follow-up|0|||
48971625|NCT02528253|157726292|FG000|Overall Study|Adverse Event|3|||
48971626|NCT02528253|157726293|FG001|Overall Study|Adverse Event|4|||
48971627|NCT02528253|157726294|FG002|Overall Study|Adverse Event|4|||
48971628|NCT02528253|157726295|FG003|Overall Study|Adverse Event|8|||
48971629|NCT02528253|157726296|FG004|Overall Study|Adverse Event|18|||
48971630|NCT02528253|157726292|FG000|Overall Study|Death|2|||
48971631|NCT02528253|157726293|FG001|Overall Study|Death|2|||
48971632|NCT02528253|157726294|FG002|Overall Study|Death|1|||
48673106|NCT00494507|156655027|FG002|Double-Blind Phase|Negative DNA test|0|||
48673107|NCT00494507|156655028|FG003|Double-Blind Phase|Negative DNA test|1|||
48673108|NCT00494507|156655025|FG000|Open-Label Phase|Adverse Event|0|||
48673109|NCT00494507|156655026|FG001|Open-Label Phase|Adverse Event|1|||
48673110|NCT00494507|156655027|FG002|Open-Label Phase|Adverse Event|5|||
48673111|NCT00494507|156655028|FG003|Open-Label Phase|Adverse Event|3|||
48673112|NCT00494507|156655025|FG000|Open-Label Phase|Worsening Disease|0|||
48673113|NCT00494507|156655026|FG001|Open-Label Phase|Worsening Disease|0|||
48673114|NCT00494507|156655027|FG002|Open-Label Phase|Worsening Disease|0|||
48673115|NCT00494507|156655028|FG003|Open-Label Phase|Worsening Disease|2|||
48673116|NCT00924404|156655029|FG000|Overall Study|Lost to Follow-up|6|||
48673117|NCT00924404|156655030|FG001|Overall Study|Lost to Follow-up|4|||
48673118|NCT00295932|156655035|FG000|Overall Study|Not Treated|0|||
48673119|NCT00295932|156655036|FG001|Overall Study|Not Treated|0|||
48673120|NCT00295932|156655037|FG002|Overall Study|Not Treated|0|||
48673121|NCT00295932|156655038|FG003|Overall Study|Not Treated|0|||
48673122|NCT00295932|156655039|FG004|Overall Study|Not Treated|0|||
48673123|NCT00295932|156655040|FG005|Overall Study|Not Treated|0|||
48673124|NCT00295932|156655041|FG006|Overall Study|Not Treated|0|||
48673125|NCT00295932|156655042|FG007|Overall Study|Not Treated|0|||
48673126|NCT00295932|156655043|FG008|Overall Study|Not Treated|0|||
48673127|NCT00295932|156655044|FG009|Overall Study|Not Treated|0|||
48673128|NCT00295932|156655045|FG010|Overall Study|Not Treated|1|||
48673129|NCT03729245|156655046|FG000|Overall Study|Lost to Follow-up|5|||
48673130|NCT03729245|156655047|FG001|Overall Study|Lost to Follow-up|6|||
48673131|NCT03729245|156655046|FG000|Overall Study|Withdrawal by Subject|16|||
48673132|NCT03729245|156655047|FG001|Overall Study|Withdrawal by Subject|19|||
48673133|NCT03729245|156655046|FG000|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|1|||
48673134|NCT03729245|156655047|FG001|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|0|||
48673135|NCT04891107|156655048|FG000|Overall Study|Physician Decision|1|||
48673136|NCT04891107|156655048|FG000|Overall Study|Withdrawal by Subject|1|||
48673137|NCT04891107|156655048|FG000|Overall Study|Screen failure after consent|1|||
48673138|NCT02540993|156655049|FG000|Overall Study|Lost to Follow-up|5|||
48673139|NCT02540993|156655050|FG001|Overall Study|Lost to Follow-up|3|||
48673140|NCT02540993|156655049|FG000|Overall Study|Withdrawal by Subject|4|||
48673141|NCT02540993|156655050|FG001|Overall Study|Withdrawal by Subject|6|||
48673142|NCT02540993|156655049|FG000|Overall Study|GCP violations|33|||
48673143|NCT02540993|156655050|FG001|Overall Study|GCP violations|27|||
48673144|NCT00079677|156655051|FG000|Overall Study|Adverse Event|5|||
48673145|NCT00079677|156655052|FG001|Overall Study|Adverse Event|6|||
48673146|NCT00079677|156655051|FG000|Overall Study|Lack of Efficacy|1|||
48673147|NCT00079677|156655052|FG001|Overall Study|Lack of Efficacy|0|||
48673148|NCT00079677|156655051|FG000|Overall Study|Lost to Follow-up|2|||
48673149|NCT00079677|156655052|FG001|Overall Study|Lost to Follow-up|2|||
48673150|NCT00079677|156655051|FG000|Overall Study|Physician Decision|3|||
48673151|NCT00079677|156655052|FG001|Overall Study|Physician Decision|0|||
48673152|NCT00079677|156655051|FG000|Overall Study|Protocol Violation|2|||
48673153|NCT00079677|156655052|FG001|Overall Study|Protocol Violation|3|||
48673154|NCT00079677|156655051|FG000|Overall Study|Withdrawal by Subject|5|||
48673155|NCT00079677|156655052|FG001|Overall Study|Withdrawal by Subject|3|||
48673156|NCT00079677|156655051|FG000|Overall Study|Miscellaneous|2|||
48673157|NCT00079677|156655052|FG001|Overall Study|Miscellaneous|0|||
48673158|NCT00989781|156655056|FG000|Ovarian Response to hCG|Lost to Follow-up|3|||
48673159|NCT00989781|156655057|FG001|Ovarian Response to hCG|Lost to Follow-up|2|||
48673160|NCT01270256|156655058|FG000|Overall Study|Withdrawal by Subject|1|||
48673161|NCT01270256|156655059|FG001|Overall Study|Withdrawal by Subject|0|||
48673162|NCT01012323|156655062|FG000|Overall Study|Investigator Judgment|1|||
48673163|NCT00932165|156655063|FG000|Overall Study|Lost to Follow-up|1|||
48673164|NCT02726945|156655064|FG000|Overall Study|Withdrawal by Subject|0|||
48673165|NCT02726945|156655065|FG001|Overall Study|Withdrawal by Subject|0|||
48673166|NCT02726945|156655066|FG002|Overall Study|Withdrawal by Subject|1|||
48673167|NCT02726945|156655064|FG000|Overall Study|Elected to have total knee replacement|0|||
48673168|NCT02726945|156655065|FG001|Overall Study|Elected to have total knee replacement|1|||
48673169|NCT02726945|156655066|FG002|Overall Study|Elected to have total knee replacement|0|||
48673170|NCT00293020|156655070|FG000|Overall Study|Withdrawal by Subject|34|||
48673171|NCT00293020|156655070|FG000|Overall Study|Adverse Event|30|||
48673172|NCT00293020|156655070|FG000|Overall Study|Death|32|||
48673173|NCT00293020|156655070|FG000|Overall Study|Lack of Efficacy|12|||
48761009|NCT00951665|156973960|FG002|Phase 1b|Protocol Violation|0|||
48971633|NCT02528253|157726295|FG003|Overall Study|Death|0|||
48971634|NCT02528253|157726296|FG004|Overall Study|Death|1|||
48971635|NCT02528253|157726292|FG000|Overall Study|Insufficient clinical response|7|||
48971636|NCT02528253|157726293|FG001|Overall Study|Insufficient clinical response|10|||
48971637|NCT02528253|157726294|FG002|Overall Study|Insufficient clinical response|13|||
48673174|NCT00293020|156655070|FG000|Overall Study|Lost to Follow-up|4|||
48673175|NCT00293020|156655070|FG000|Overall Study|Protocol Violation|6|||
48673176|NCT00293020|156655070|FG000|Overall Study|Physician Decision|21|||
48673177|NCT00293020|156655070|FG000|Overall Study|Other Reason|22|||
48673178|NCT00293020|156655070|FG000|Overall Study|No dose taken|1|||
48673179|NCT02540265|156655073|FG000|Overall Study|Lost to Follow-up|0|||
48673180|NCT02540265|156655074|FG001|Overall Study|Lost to Follow-up|0|||
48673181|NCT02540265|156655075|FG002|Overall Study|Lost to Follow-up|1|||
48673182|NCT02951429|156655077|FG000|Overall Study|Adverse Event|3|||
48673183|NCT02951429|156655078|FG001|Overall Study|Adverse Event|7|||
48673184|NCT02951429|156655077|FG000|Overall Study|Death|28|||
48673185|NCT02951429|156655078|FG001|Overall Study|Death|36|||
48673186|NCT02951429|156655077|FG000|Overall Study|Lack of Efficacy|0|||
48673187|NCT02951429|156655078|FG001|Overall Study|Lack of Efficacy|1|||
48673188|NCT02951429|156655077|FG000|Overall Study|Lost to Follow-up|0|||
48673189|NCT02951429|156655078|FG001|Overall Study|Lost to Follow-up|1|||
48673190|NCT02951429|156655077|FG000|Overall Study|Lung Transplantation|9|||
48971638|NCT02528253|157726295|FG003|Overall Study|Insufficient clinical response|12|||
48971639|NCT02528253|157726296|FG004|Overall Study|Insufficient clinical response|16|||
48971640|NCT02528253|157726292|FG000|Overall Study|Lost to Follow-up|16|||
48971641|NCT02528253|157726293|FG001|Overall Study|Lost to Follow-up|9|||
48971642|NCT02528253|157726294|FG002|Overall Study|Lost to Follow-up|31|||
48971643|NCT02528253|157726295|FG003|Overall Study|Lost to Follow-up|16|||
48971644|NCT02528253|157726296|FG004|Overall Study|Lost to Follow-up|34|||
48971645|NCT02528253|157726292|FG000|Overall Study|Other|21|||
48971646|NCT02528253|157726293|FG001|Overall Study|Other|22|||
48673191|NCT02951429|156655078|FG001|Overall Study|Lung Transplantation|6|||
48673192|NCT02951429|156655077|FG000|Overall Study|Other|1|||
48673193|NCT02951429|156655078|FG001|Overall Study|Other|3|||
48673194|NCT02951429|156655077|FG000|Overall Study|Progressive Disease|1|||
48673195|NCT02951429|156655078|FG001|Overall Study|Progressive Disease|1|||
48673196|NCT02951429|156655077|FG000|Overall Study|Withdrawal by Subject|7|||
48673197|NCT02951429|156655078|FG001|Overall Study|Withdrawal by Subject|11|||
48673198|NCT02951429|156655077|FG000|Overall Study|Participant ongoing in the study|23|||
48673199|NCT02951429|156655078|FG001|Overall Study|Participant ongoing in the study|17|||
48673200|NCT03101085|156655079|FG000|Overall Study|Lost to Follow-up|0|||
48971647|NCT02528253|157726294|FG002|Overall Study|Other|58|||
48971648|NCT02528253|157726295|FG003|Overall Study|Other|52|||
48971649|NCT02528253|157726296|FG004|Overall Study|Other|76|||
48971650|NCT02528253|157726292|FG000|Overall Study|Withdrawal by Subject|25|||
48971651|NCT02528253|157726293|FG001|Overall Study|Withdrawal by Subject|20|||
48971652|NCT02528253|157726294|FG002|Overall Study|Withdrawal by Subject|29|||
48971653|NCT02528253|157726295|FG003|Overall Study|Withdrawal by Subject|48|||
48971654|NCT02528253|157726296|FG004|Overall Study|Withdrawal by Subject|73|||
48971655|NCT02528253|157726292|FG000|Overall Study|Protocol Violation|1|||
48971656|NCT02528253|157726293|FG001|Overall Study|Protocol Violation|2|||
48971657|NCT02528253|157726294|FG002|Overall Study|Protocol Violation|4|||
48971658|NCT02528253|157726295|FG003|Overall Study|Protocol Violation|0|||
48971659|NCT02528253|157726296|FG004|Overall Study|Protocol Violation|4|||
48971660|NCT02528253|157726292|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
48971661|NCT02528253|157726293|FG001|Overall Study|Withdrawn Due to Pregnancy|1|||
48971662|NCT02528253|157726294|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
48971663|NCT02528253|157726295|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
48971664|NCT02528253|157726296|FG004|Overall Study|Withdrawn Due to Pregnancy|1|||
48971665|NCT03628599|157726297|FG000|Overall Study|Adverse Event|0|||
48971666|NCT03628599|157726298|FG001|Overall Study|Adverse Event|1|||
48971667|NCT02966353|157726299|FG000|Overall Study|Withdrawal by Subject|7|||
48971668|NCT02966353|157726299|FG000|Overall Study|Adverse Event|4|||
48971669|NCT02966353|157726299|FG000|Overall Study|Death|4|||
48971670|NCT02966353|157726299|FG000|Overall Study|Physician Decision|3|||
48971671|NCT02966353|157726299|FG000|Overall Study|Progressive disease|2|||
48971672|NCT02966353|157726299|FG000|Overall Study|Protocol deviation|2|||
48971673|NCT00438464|157726300|FG000|Overall Study|Terminated Early|14|||
48971674|NCT00438464|157726301|FG001|Overall Study|Terminated Early|5|||
48971675|NCT00438464|157726300|FG000|Overall Study|Incomplete data submission|0|||
48971676|NCT00438464|157726301|FG001|Overall Study|Incomplete data submission|2|||
48673201|NCT03101085|156655080|FG001|Overall Study|Lost to Follow-up|1|||
48673202|NCT00498355|156655086|FG000|Overall Study|Lost to Follow-up|1|||
48971677|NCT02905825|157726307|FG000|Overall Study|Protocol Violation|11|||
48971678|NCT02905825|157726307|FG000|Overall Study|Device Malfunction|1|||
48971679|NCT01175590|157726311|FG000|Overall Study|Lost to Follow-up|1|||
48971680|NCT01175590|157726312|FG001|Overall Study|Lost to Follow-up|0|||
48673203|NCT02161757|156655089|FG000|Randomised Through Start Treatment|Did not receive treatment|3|||
48761010|NCT00951665|156973961|FG003|Phase 1b|Protocol Violation|0|||
48971681|NCT01175590|157726311|FG000|Overall Study|Withdrawal by Subject|0|||
48971682|NCT01175590|157726312|FG001|Overall Study|Withdrawal by Subject|2|||
48971683|NCT01175590|157726311|FG000|Overall Study|Adverse Event|4|||
48971684|NCT01175590|157726312|FG001|Overall Study|Adverse Event|0|||
48971685|NCT01175590|157726311|FG000|Overall Study|Physician Decision|1|||
48971686|NCT01175590|157726312|FG001|Overall Study|Physician Decision|4|||
48673204|NCT02161757|156655090|FG001|Randomised Through Start Treatment|Did not receive treatment|2|||
48673205|NCT02161757|156655091|FG002|Randomised Through Start Treatment|Did not receive treatment|0|||
48971687|NCT01175590|157726311|FG000|Overall Study|Lack of Efficacy|1|||
48673206|NCT02161757|156655089|FG000|Treatment Through Study Completion|Adverse Event|1|||
48673207|NCT02161757|156655090|FG001|Treatment Through Study Completion|Adverse Event|1|||
48673208|NCT02161757|156655091|FG002|Treatment Through Study Completion|Adverse Event|0|||
48673209|NCT02161757|156655089|FG000|Treatment Through Study Completion|Protocol Violation|0|||
48673210|NCT02161757|156655090|FG001|Treatment Through Study Completion|Protocol Violation|1|||
48673211|NCT02161757|156655091|FG002|Treatment Through Study Completion|Protocol Violation|2|||
48673212|NCT02161757|156655089|FG000|Treatment Through Study Completion|Withdrawal by Subject|27|||
48673213|NCT02161757|156655090|FG001|Treatment Through Study Completion|Withdrawal by Subject|19|||
48673214|NCT02161757|156655091|FG002|Treatment Through Study Completion|Withdrawal by Subject|20|||
48673215|NCT02161757|156655089|FG000|Treatment Through Study Completion|Lost to Follow-up|7|||
48673216|NCT02161757|156655090|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
48971688|NCT01175590|157726312|FG001|Overall Study|Lack of Efficacy|1|||
48971689|NCT01175590|157726311|FG000|Overall Study|Residual Bacterial Conjunctivitis|1|||
48971690|NCT01175590|157726312|FG001|Overall Study|Residual Bacterial Conjunctivitis|0|||
48971691|NCT01175590|157726311|FG000|Overall Study|Treated not as randomized|3|||
48673217|NCT02161757|156655091|FG002|Treatment Through Study Completion|Lost to Follow-up|4|||
48673218|NCT02161757|156655089|FG000|Treatment Through Study Completion|Other|20|||
48673219|NCT02161757|156655090|FG001|Treatment Through Study Completion|Other|19|||
48673220|NCT02161757|156655091|FG002|Treatment Through Study Completion|Other|12|||
48761011|NCT00951665|156973962|FG004|Phase 1b|Protocol Violation|0|||
48761012|NCT00951665|156973963|FG005|Phase 1b|Protocol Violation|0|||
48761013|NCT00951665|156973958|FG000|Phase 2a|Adverse Event|0|||
48761014|NCT00951665|156973959|FG001|Phase 2a|Adverse Event|0|||
48971692|NCT01175590|157726312|FG001|Overall Study|Treated not as randomized|2|||
48971693|NCT01175590|157726311|FG000|Overall Study|Herpes Simplex Dermatitis|1|||
48971694|NCT01175590|157726312|FG001|Overall Study|Herpes Simplex Dermatitis|0|||
48971695|NCT01175590|157726311|FG000|Overall Study|Protocol Violation|0|||
48971696|NCT01175590|157726312|FG001|Overall Study|Protocol Violation|1|||
48673221|NCT02161757|156655089|FG000|Treatment Through Study Completion|Death|2|||
48673222|NCT02161757|156655090|FG001|Treatment Through Study Completion|Death|1|||
48761015|NCT00951665|156973960|FG002|Phase 2a|Adverse Event|0|||
48761016|NCT00951665|156973961|FG003|Phase 2a|Adverse Event|0|||
48761017|NCT00951665|156973962|FG004|Phase 2a|Adverse Event|2|||
48761018|NCT00951665|156973963|FG005|Phase 2a|Adverse Event|0|||
48761019|NCT00951665|156973958|FG000|Phase 2a|Death|0|||
48761020|NCT00951665|156973959|FG001|Phase 2a|Death|0|||
48761021|NCT00951665|156973960|FG002|Phase 2a|Death|0|||
48761022|NCT00951665|156973961|FG003|Phase 2a|Death|0|||
48761023|NCT00951665|156973962|FG004|Phase 2a|Death|1|||
48761024|NCT00951665|156973963|FG005|Phase 2a|Death|1|||
48761025|NCT00951665|156973958|FG000|Phase 2a|Lost to Follow-up|0|||
48761026|NCT00951665|156973959|FG001|Phase 2a|Lost to Follow-up|0|||
48761027|NCT00951665|156973960|FG002|Phase 2a|Lost to Follow-up|0|||
48761028|NCT00951665|156973961|FG003|Phase 2a|Lost to Follow-up|0|||
48761029|NCT00951665|156973962|FG004|Phase 2a|Lost to Follow-up|1|||
48761030|NCT00951665|156973963|FG005|Phase 2a|Lost to Follow-up|0|||
48761031|NCT00951665|156973958|FG000|Phase 2a|Physician Decision|0|||
48761032|NCT00951665|156973959|FG001|Phase 2a|Physician Decision|0|||
48761033|NCT00951665|156973960|FG002|Phase 2a|Physician Decision|0|||
48761034|NCT00951665|156973961|FG003|Phase 2a|Physician Decision|0|||
48761035|NCT00951665|156973962|FG004|Phase 2a|Physician Decision|0|||
48761036|NCT00951665|156973963|FG005|Phase 2a|Physician Decision|1|||
48761037|NCT00951665|156973958|FG000|Phase 2a|Withdrawal by Subject|0|||
48761038|NCT00951665|156973959|FG001|Phase 2a|Withdrawal by Subject|0|||
48761039|NCT00951665|156973960|FG002|Phase 2a|Withdrawal by Subject|0|||
48761040|NCT00951665|156973961|FG003|Phase 2a|Withdrawal by Subject|0|||
48761041|NCT00951665|156973962|FG004|Phase 2a|Withdrawal by Subject|2|||
48761042|NCT00951665|156973963|FG005|Phase 2a|Withdrawal by Subject|0|||
48761043|NCT00951665|156973958|FG000|Phase 2a|Disease Progression|0|||
48761044|NCT00951665|156973959|FG001|Phase 2a|Disease Progression|0|||
48761045|NCT00951665|156973960|FG002|Phase 2a|Disease Progression|0|||
48761046|NCT00951665|156973961|FG003|Phase 2a|Disease Progression|0|||
48761047|NCT00951665|156973962|FG004|Phase 2a|Disease Progression|6|||
48761048|NCT00951665|156973963|FG005|Phase 2a|Disease Progression|5|||
48761049|NCT02723084|156973964|FG000|Overall Study|Withdrawal by Subject|1|||
48761050|NCT02723084|156973965|FG001|Overall Study|Withdrawal by Subject|1|||
48761051|NCT02723084|156973964|FG000|Overall Study|Lost to Follow-up|3|||
48761052|NCT02723084|156973965|FG001|Overall Study|Lost to Follow-up|0|||
48761053|NCT00312494|156973968|FG000|Overall Study|Randomized; not treated with study drug|9|||
48761054|NCT00312494|156973969|FG001|Overall Study|Randomized; not treated with study drug|10|||
48761055|NCT00312494|156973970|FG002|Overall Study|Randomized; not treated with study drug|5|||
48971697|NCT00092677|157726313|FG000|Overall Study|Lost to Follow-up|0|||
48971698|NCT00092677|157726314|FG001|Overall Study|Lost to Follow-up|2|||
48761056|NCT00312494|156973968|FG000|Overall Study|Adverse Event|33|||
48761057|NCT00312494|156973969|FG001|Overall Study|Adverse Event|15|||
48761058|NCT00312494|156973970|FG002|Overall Study|Adverse Event|11|||
48761059|NCT00312494|156973968|FG000|Overall Study|Lack of Efficacy|4|||
48761060|NCT00312494|156973969|FG001|Overall Study|Lack of Efficacy|6|||
48872910|NCT00723125|157371863|FG001|Overall Study|Met Dx|0|||
48673223|NCT02161757|156655091|FG002|Treatment Through Study Completion|Death|1|||
48673224|NCT03664765|156655092|FG000|Overall Study|Withdrawal by Subject|4|||
48673225|NCT03664765|156655093|FG001|Overall Study|Withdrawal by Subject|1|||
48673226|NCT03664765|156655092|FG000|Overall Study|Lost to Follow-up|0|||
48673227|NCT03664765|156655093|FG001|Overall Study|Lost to Follow-up|1|||
48673228|NCT01153698|156655094|FG000|Overall Study|Adverse Event|12|||
48673229|NCT01153698|156655094|FG000|Overall Study|Lost to Follow-up|4|||
48673230|NCT01153698|156655094|FG000|Overall Study|Withdrawal by Subject|2|||
48673231|NCT01153698|156655094|FG000|Overall Study|Switch to other anticoagulants|4|||
48673232|NCT01153698|156655094|FG000|Overall Study|Other|2|||
48761061|NCT00312494|156973970|FG002|Overall Study|Lack of Efficacy|8|||
48761062|NCT00312494|156973968|FG000|Overall Study|Laboratory abnormality|1|||
48761063|NCT00312494|156973969|FG001|Overall Study|Laboratory abnormality|0|||
48761064|NCT00312494|156973970|FG002|Overall Study|Laboratory abnormality|0|||
48761065|NCT00312494|156973968|FG000|Overall Study|Lost to Follow-up|8|||
48761066|NCT00312494|156973969|FG001|Overall Study|Lost to Follow-up|8|||
48761067|NCT00312494|156973970|FG002|Overall Study|Lost to Follow-up|8|||
48761068|NCT00312494|156973968|FG000|Overall Study|Withdrawal by Subject|6|||
48761069|NCT00312494|156973969|FG001|Overall Study|Withdrawal by Subject|9|||
48761070|NCT00312494|156973970|FG002|Overall Study|Withdrawal by Subject|10|||
48761071|NCT00312494|156973968|FG000|Overall Study|Other|10|||
48761072|NCT00312494|156973969|FG001|Overall Study|Other|10|||
48761073|NCT00312494|156973970|FG002|Overall Study|Other|1|||
48761074|NCT05024058|156973971|FG000|Treatment|Study terminated by sponsor|5|||
48761075|NCT05024058|156973972|FG001|Treatment|Study terminated by sponsor|6|||
48761076|NCT05024058|156973973|FG002|Treatment|Study terminated by sponsor|4|||
48761077|NCT05024058|156973974|FG003|Treatment|Study terminated by sponsor|2|||
48761078|NCT05024058|156973975|FG004|Treatment|Study terminated by sponsor|3|||
48761079|NCT05024058|156973976|FG005|Treatment|Study terminated by sponsor|3|||
48761080|NCT05024058|156973977|FG006|Treatment|Study terminated by sponsor|1|||
48761081|NCT05024058|156973978|FG007|Treatment|Study terminated by sponsor|3|||
48761082|NCT05024058|156973979|FG008|Treatment|Study terminated by sponsor|6|||
48761083|NCT05024058|156973980|FG009|Treatment|Study terminated by sponsor|6|||
48761084|NCT05024058|156973971|FG000|Follow-up|Withdrawal by Subject|1|||
48761085|NCT05024058|156973972|FG001|Follow-up|Withdrawal by Subject|0|||
48761086|NCT05024058|156973973|FG002|Follow-up|Withdrawal by Subject|1|||
48761087|NCT05024058|156973974|FG003|Follow-up|Withdrawal by Subject|0|||
48761088|NCT05024058|156973975|FG004|Follow-up|Withdrawal by Subject|0|||
48761089|NCT05024058|156973976|FG005|Follow-up|Withdrawal by Subject|0|||
48761090|NCT05024058|156973977|FG006|Follow-up|Withdrawal by Subject|0|||
48761091|NCT05024058|156973978|FG007|Follow-up|Withdrawal by Subject|1|||
48761092|NCT05024058|156973979|FG008|Follow-up|Withdrawal by Subject|0|||
48761093|NCT05024058|156973980|FG009|Follow-up|Withdrawal by Subject|1|||
48761094|NCT00520975|156973981|FG000|Overall Study|Disease progression|31|||
48761095|NCT00520975|156973982|FG001|Overall Study|Disease progression|23|||
48761096|NCT00520975|156973981|FG000|Overall Study|Adverse Event|7|||
48761097|NCT00520975|156973982|FG001|Overall Study|Adverse Event|10|||
48761098|NCT00520975|156973981|FG000|Overall Study|Death|0|||
48761099|NCT00520975|156973982|FG001|Overall Study|Death|2|||
48761100|NCT00520975|156973981|FG000|Overall Study|Withdrawal by Subject|3|||
48761101|NCT00520975|156973982|FG001|Overall Study|Withdrawal by Subject|5|||
48761102|NCT00520975|156973981|FG000|Overall Study|Other therapy|2|||
48761103|NCT00520975|156973982|FG001|Overall Study|Other therapy|4|||
48761104|NCT00520975|156973981|FG000|Overall Study|Other reasons|4|||
48761105|NCT00520975|156973982|FG001|Overall Study|Other reasons|2|||
48761106|NCT00520975|156973981|FG000|Overall Study|Not start protocol therapy|1|||
48761107|NCT00520975|156973982|FG001|Overall Study|Not start protocol therapy|2|||
48761108|NCT01528072|156973985|FG000|Overall Study|Withdrawal by Subject|5|||
48761109|NCT01528072|156973985|FG000|Overall Study|Physician Decision|1|||
48761110|NCT01528072|156973985|FG000|Overall Study|Determined not eligible by AEAC|1|||
48761111|NCT01528072|156973985|FG000|Overall Study|Missed Visit|2|||
48761112|NCT01528072|156973985|FG000|Overall Study|Lost to Follow-up|5|||
48761113|NCT01528072|156973985|FG000|Overall Study|Explanted|2|||
48761114|NCT01528072|156973985|FG000|Overall Study|Site Closure|4|||
48761115|NCT01528072|156973985|FG000|Overall Study|Death|2|||
48761116|NCT01528072|156973985|FG000|Overall Study|Early Termination of Study|52|||
48761117|NCT02436759|156973986|FG000|Overall Study|Adverse Event|3|||
48761118|NCT02436759|156973987|FG001|Overall Study|Adverse Event|0|||
48761119|NCT02436759|156973986|FG000|Overall Study|Protocol Violation|1|||
48761120|NCT02436759|156973987|FG001|Overall Study|Protocol Violation|0|||
48761121|NCT02436759|156973986|FG000|Overall Study|Withdrawal by Subject|0|||
48761122|NCT02436759|156973987|FG001|Overall Study|Withdrawal by Subject|1|||
48761123|NCT05089682|156973992|FG000|Overall Study|Withdrawal by Subject|2|||
48761124|NCT01275833|156973993|FG000|Overall Study|Study terminated|1|||
48761125|NCT01275833|156973994|FG001|Overall Study|Study terminated|1|||
48673233|NCT01153698|156655094|FG000|Overall Study|Not treated with Pradaxa|5|||
48673234|NCT04583956|156655095|FG000|Overall Study|Death|9|||
48761126|NCT02246673|156974003|FG000|Overall Study|Sponsor Decision|1|||
48971699|NCT00092677|157726313|FG000|Overall Study|Adminstrative|5|||
48971700|NCT00092677|157726314|FG001|Overall Study|Adminstrative|9|||
48971701|NCT01601704|157726315|FG000|Overall Study|Randomized but not dispensed study med|1|||
48971702|NCT01601704|157726316|FG001|Overall Study|Randomized but not dispensed study med|4|||
48971703|NCT01090102|157726317|FG000|First 12 Weeks|Withdrawal by Subject|1|||
48971704|NCT01090102|157726318|FG001|First 12 Weeks|Withdrawal by Subject|1|||
48971705|NCT01090102|157726317|FG000|First 12 Weeks|Adverse Event|2|||
48971706|NCT01090102|157726318|FG001|First 12 Weeks|Adverse Event|0|||
48971707|NCT01090102|157726317|FG000|First 12 Weeks|Death|1|||
48971708|NCT01090102|157726318|FG001|First 12 Weeks|Death|1|||
48971709|NCT01090102|157726317|FG000|Second 12 Weeks|Withdrawal by Subject|0|||
48971710|NCT01090102|157726318|FG001|Second 12 Weeks|Withdrawal by Subject|1|||
48971711|NCT03805971|157726320|FG000|Overall Study|Withdrawal by Subject|1|||
48971712|NCT03805971|157726320|FG000|Overall Study|Protocol Violation|2|||
48971713|NCT03351478|157726321|FG000|Overall Study|At the subject's own request|11|||
48971714|NCT03351478|157726322|FG001|Overall Study|At the subject's own request|12|||
48971715|NCT03351478|157726323|FG002|Overall Study|At the subject's own request|5|||
48971716|NCT03351478|157726321|FG000|Overall Study|Adverse Event|1|||
48971717|NCT03351478|157726322|FG001|Overall Study|Adverse Event|2|||
48971718|NCT03351478|157726323|FG002|Overall Study|Adverse Event|1|||
48971719|NCT03351478|157726321|FG000|Overall Study|Poor compliance to protocol|1|||
48971720|NCT03351478|157726322|FG001|Overall Study|Poor compliance to protocol|0|||
48971721|NCT03351478|157726323|FG002|Overall Study|Poor compliance to protocol|0|||
48971722|NCT03351478|157726321|FG000|Overall Study|Reason not Specified|1|||
48971723|NCT03351478|157726322|FG001|Overall Study|Reason not Specified|3|||
48971724|NCT03351478|157726323|FG002|Overall Study|Reason not Specified|0|||
48971725|NCT03351478|157726321|FG000|Overall Study|Lost to Follow-up|0|||
48971726|NCT03351478|157726322|FG001|Overall Study|Lost to Follow-up|0|||
48971727|NCT03351478|157726323|FG002|Overall Study|Lost to Follow-up|1|||
48971728|NCT03485222|157726328|FG000|Overall Study|Death|0|||
48971729|NCT03485222|157726329|FG001|Overall Study|Death|1|||
48971730|NCT03485222|157726328|FG000|Overall Study|Lost to Follow-up|2|||
48971731|NCT03485222|157726329|FG001|Overall Study|Lost to Follow-up|1|||
48971732|NCT03911869|157726332|FG000|Safety Lead-in Phase|Death|7|||
48971733|NCT03911869|157726333|FG001|Safety Lead-in Phase|Death|0|||
48971734|NCT03911869|157726334|FG002|Safety Lead-in Phase|Death|0|||
48971735|NCT03911869|157726332|FG000|Safety Lead-in Phase|Study termination by sponsor|2|||
48971736|NCT03911869|157726333|FG001|Safety Lead-in Phase|Study termination by sponsor|0|||
48971737|NCT03911869|157726334|FG002|Safety Lead-in Phase|Study termination by sponsor|0|||
48971738|NCT03911869|157726332|FG000|Safety Lead-in Phase|Other|1|||
48971739|NCT03911869|157726333|FG001|Safety Lead-in Phase|Other|0|||
48971740|NCT03911869|157726334|FG002|Safety Lead-in Phase|Other|0|||
48673235|NCT04583956|156655096|FG001|Overall Study|Death|11|||
48673236|NCT04583956|156655095|FG000|Overall Study|Lost to Follow-up|7|||
48673237|NCT04583956|156655096|FG001|Overall Study|Lost to Follow-up|9|||
48673238|NCT04583956|156655095|FG000|Overall Study|Protocol Violation|2|||
48673239|NCT04583956|156655096|FG001|Overall Study|Protocol Violation|0|||
48673240|NCT04583956|156655095|FG000|Overall Study|Withdrawal by Subject|0|||
48673241|NCT04583956|156655096|FG001|Overall Study|Withdrawal by Subject|2|||
48673242|NCT04583956|156655095|FG000|Overall Study|Randomized but not dosed|2|||
48673243|NCT04583956|156655096|FG001|Overall Study|Randomized but not dosed|3|||
48673244|NCT04583956|156655095|FG000|Overall Study|Withdrawal of consent before product administration|1|||
48673245|NCT04583956|156655096|FG001|Overall Study|Withdrawal of consent before product administration|0|||
48673246|NCT02332291|156655097|FG000|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3|||
48971741|NCT03911869|157726332|FG000|Phase 2|Death|0|||
48971742|NCT03911869|157726333|FG001|Phase 2|Death|3|||
48673247|NCT02332291|156655098|FG001|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5|||
48971743|NCT03911869|157726334|FG002|Phase 2|Death|0|||
48971744|NCT00688545|157726335|FG000|Overall Study|Lost to Follow-up|1|||
48971745|NCT00688545|157726336|FG001|Overall Study|Lost to Follow-up|4|||
48971746|NCT00688545|157726335|FG000|Overall Study|Insurance/cost of drug|0|||
48673248|NCT02332291|156655097|FG000|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0|||
48673249|NCT02332291|156655098|FG001|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4|||
48673250|NCT02332291|156655097|FG000|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1|||
48673251|NCT02332291|156655098|FG001|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0|||
48673252|NCT02332291|156655097|FG000|Phase 2: Open-Label Bupropion|Adverse Event|2|||
48971747|NCT00688545|157726336|FG001|Overall Study|Insurance/cost of drug|1|||
48971748|NCT00688545|157726335|FG000|Overall Study|Withdrawal by Subject|2|||
48971749|NCT00688545|157726336|FG001|Overall Study|Withdrawal by Subject|3|||
48971750|NCT00688545|157726335|FG000|Overall Study|Unspecified, unrelated to AE/Toxicity|2|||
48971751|NCT00688545|157726336|FG001|Overall Study|Unspecified, unrelated to AE/Toxicity|7|||
48971752|NCT04295356|157726337|FG000|Overall Study|Physician Decision|1|||
48971753|NCT04295356|157726338|FG001|Overall Study|Physician Decision|0|||
48761127|NCT02246673|156974004|FG001|Overall Study|Sponsor Decision|0|||
48971754|NCT04295356|157726337|FG000|Overall Study|Lost to Follow-up|0|||
48971755|NCT04295356|157726338|FG001|Overall Study|Lost to Follow-up|3|||
48971756|NCT04295356|157726337|FG000|Overall Study|Protocol Violation|0|||
48971757|NCT04295356|157726338|FG001|Overall Study|Protocol Violation|1|||
48971758|NCT00469209|157726341|FG000|Overall Study|Adverse Event|1|||
48971759|NCT00469209|157726342|FG001|Overall Study|Adverse Event|0|||
48971760|NCT00469209|157726343|FG002|Overall Study|Adverse Event|1|||
48971761|NCT01457924|157726346|FG000|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
48971762|NCT01457924|157726347|FG001|Treatment Phase (Weeks 0-24)|Adverse Event|4|||
48971763|NCT01457924|157726348|FG002|Treatment Phase (Weeks 0-24)|Adverse Event|1|||
48971764|NCT01457924|157726349|FG003|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
48971765|NCT01457924|157726350|FG004|Treatment Phase (Weeks 0-24)|Adverse Event|2|||
48971766|NCT01457924|157726346|FG000|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
48971767|NCT01457924|157726347|FG001|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
48971768|NCT01457924|157726348|FG002|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
48971769|NCT01457924|157726349|FG003|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
48971770|NCT01457924|157726350|FG004|Treatment Phase (Weeks 0-24)|Physician Decision|1|||
48971771|NCT01457924|157726346|FG000|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1|||
48971772|NCT01457924|157726347|FG001|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
48971773|NCT01457924|157726348|FG002|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
48971774|NCT01457924|157726349|FG003|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
48971775|NCT01457924|157726350|FG004|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
48971776|NCT01457924|157726346|FG000|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
48971777|NCT01457924|157726347|FG001|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
48971778|NCT01457924|157726348|FG002|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
48971779|NCT01457924|157726349|FG003|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
48971780|NCT01457924|157726350|FG004|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
48971781|NCT01457924|157726346|FG000|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
48971782|NCT01457924|157726347|FG001|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
48971783|NCT01457924|157726348|FG002|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
48971784|NCT01457924|157726349|FG003|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
48971785|NCT01457924|157726350|FG004|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
48971786|NCT01457924|157726346|FG000|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
48971787|NCT01457924|157726347|FG001|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
48971788|NCT01457924|157726348|FG002|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
48971789|NCT01457924|157726349|FG003|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
48971790|NCT01457924|157726350|FG004|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2|||
48971791|NCT01457924|157726346|FG000|FUP (Weeks 24-48)|Adverse Event|0|||
48971792|NCT01457924|157726347|FG001|FUP (Weeks 24-48)|Adverse Event|0|||
48971793|NCT01457924|157726348|FG002|FUP (Weeks 24-48)|Adverse Event|1|||
48971794|NCT01457924|157726349|FG003|FUP (Weeks 24-48)|Adverse Event|0|||
48971795|NCT01457924|157726350|FG004|FUP (Weeks 24-48)|Adverse Event|0|||
48971796|NCT01457924|157726346|FG000|FUP (Weeks 24-48)|Physician Decision|1|||
48971797|NCT01457924|157726347|FG001|FUP (Weeks 24-48)|Physician Decision|0|||
48971798|NCT01457924|157726348|FG002|FUP (Weeks 24-48)|Physician Decision|1|||
48971799|NCT01457924|157726349|FG003|FUP (Weeks 24-48)|Physician Decision|0|||
48971800|NCT01457924|157726350|FG004|FUP (Weeks 24-48)|Physician Decision|0|||
48971801|NCT01457924|157726346|FG000|FUP (Weeks 24-48)|Lost to Follow-up|0|||
48971802|NCT01457924|157726347|FG001|FUP (Weeks 24-48)|Lost to Follow-up|0|||
48971803|NCT01457924|157726348|FG002|FUP (Weeks 24-48)|Lost to Follow-up|0|||
48971804|NCT01457924|157726349|FG003|FUP (Weeks 24-48)|Lost to Follow-up|1|||
48971805|NCT01457924|157726350|FG004|FUP (Weeks 24-48)|Lost to Follow-up|0|||
48971806|NCT01457924|157726346|FG000|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
48971807|NCT01457924|157726347|FG001|FUP (Weeks 24-48)|Withdrawal by Subject|1|||
48971808|NCT01457924|157726348|FG002|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
48971809|NCT01457924|157726349|FG003|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
48971810|NCT01457924|157726350|FG004|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
48971811|NCT01457924|157726346|FG000|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
48971812|NCT01457924|157726347|FG001|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
48971813|NCT01457924|157726348|FG002|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
48971814|NCT01457924|157726349|FG003|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
48971815|NCT01457924|157726350|FG004|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
48971816|NCT01457924|157726346|FG000|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
48971817|NCT01457924|157726347|FG001|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4|||
48971818|NCT01457924|157726348|FG002|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2|||
48673253|NCT02332291|156655098|FG001|Phase 2: Open-Label Bupropion|Adverse Event|7|||
48971819|NCT01457924|157726349|FG003|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
48971820|NCT01457924|157726350|FG004|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5|||
48971821|NCT01457924|157726346|FG000|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
48673254|NCT02332291|156655097|FG000|Phase 2: Open-Label Bupropion|Worsening Depression|0|||
48673255|NCT02332291|156655098|FG001|Phase 2: Open-Label Bupropion|Worsening Depression|1|||
48971822|NCT01457924|157726347|FG001|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0|||
48971823|NCT01457924|157726348|FG002|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
48971824|NCT01457924|157726349|FG003|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2|||
48971825|NCT01457924|157726350|FG004|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
48971826|NCT03235726|157726351|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
48971827|NCT03235726|157726352|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
48971828|NCT03235726|157726353|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
48971829|NCT03235726|157726354|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
48971830|NCT03235726|157726355|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1|||
48971831|NCT03235726|157726356|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
48971832|NCT03235726|157726357|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
48971833|NCT03235726|157726358|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
48971834|NCT03235726|157726359|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
48971835|NCT03235726|157726360|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
48971836|NCT03235726|157726351|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
48971837|NCT03235726|157726352|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
48971838|NCT03235726|157726353|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
48971839|NCT03235726|157726354|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
48971840|NCT03235726|157726355|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1|||
48971841|NCT03235726|157726356|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
48971842|NCT03235726|157726357|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
48971843|NCT03235726|157726358|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
48971844|NCT03235726|157726359|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
48971845|NCT03235726|157726360|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
48971846|NCT01438307|157726361|FG000|Overall Study|Death|1|||
48971847|NCT01438307|157726362|FG001|Overall Study|Death|1|||
48971848|NCT01467661|157726364|FG000|Overall Study|Adverse Event|16|||
48971849|NCT01467661|157726364|FG000|Overall Study|Withdrawal by Subject|1|||
48971850|NCT01467661|157726364|FG000|Overall Study|Lack of Efficacy|3|||
48971851|NCT01467661|157726364|FG000|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1|||
48673256|NCT02332291|156655097|FG000|Phase 2: Open-Label Bupropion|Lost to Follow-up|1|||
48673257|NCT02332291|156655098|FG001|Phase 2: Open-Label Bupropion|Lost to Follow-up|0|||
48673258|NCT01983774|156655099|FG000|Overall Study|Lung Transplant|0|||
48673259|NCT01983774|156655100|FG001|Overall Study|Lung Transplant|1|||
48673260|NCT01983774|156655099|FG000|Overall Study|Lost to Follow-up|1|||
48673261|NCT01983774|156655100|FG001|Overall Study|Lost to Follow-up|0|||
48673262|NCT01990859|156655105|FG000|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5|||
48673263|NCT01990859|156655105|FG000|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17|||
48971852|NCT04397796|157726365|FG000|Overall Study|Death|3|||
48971853|NCT04397796|157726366|FG001|Overall Study|Death|1|||
48971854|NCT00510068|157726369|FG000|Double-blind Period|Disease progression|98|||
48971855|NCT00510068|157726370|FG001|Double-blind Period|Disease progression|169|||
48971856|NCT00510068|157726369|FG000|Double-blind Period|Final primary analysis|52|||
48971857|NCT00510068|157726370|FG001|Double-blind Period|Final primary analysis|18|||
48971858|NCT00510068|157726369|FG000|Double-blind Period|Adverse Event|37|||
48971859|NCT00510068|157726370|FG001|Double-blind Period|Adverse Event|7|||
48971860|NCT00510068|157726369|FG000|Double-blind Period|Withdrawal by Subject|8|||
48971861|NCT00510068|157726370|FG001|Double-blind Period|Withdrawal by Subject|6|||
48971862|NCT00510068|157726369|FG000|Double-blind Period|Death|4|||
48971863|NCT00510068|157726370|FG001|Double-blind Period|Death|3|||
48971864|NCT00510068|157726369|FG000|Double-blind Period|Abnormal test result (s)|1|||
48971865|NCT00510068|157726370|FG001|Double-blind Period|Abnormal test result (s)|0|||
48673264|NCT01439373|156655109|FG000|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0|||
48673265|NCT01439373|156655110|FG001|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1|||
48673266|NCT01439373|156655109|FG000|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2|||
48673267|NCT01439373|156655110|FG001|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0|||
48761128|NCT02246673|156974005|FG002|Overall Study|Sponsor Decision|0|||
48761129|NCT02246673|156974006|FG003|Overall Study|Sponsor Decision|0|||
48971866|NCT00510068|157726369|FG000|Double-blind Period|Lost to Follow-up|1|||
48971867|NCT00510068|157726370|FG001|Double-blind Period|Lost to Follow-up|0|||
48971868|NCT00510068|157726369|FG000|Double-blind Period|Protocol Violation|6|||
48971869|NCT00510068|157726370|FG001|Double-blind Period|Protocol Violation|0|||
48761130|NCT02246673|156974007|FG004|Overall Study|Sponsor Decision|0|||
48971870|NCT00510068|157726369|FG000|Open-label Period|Disease Progression|124|||
48971871|NCT00510068|157726370|FG001|Open-label Period|Disease Progression|0|||
48971872|NCT00510068|157726369|FG000|Open-label Period|Adverse Event|46|||
48673268|NCT02708355|156655111|FG000|Overall Study|Adverse Event|1|||
48673269|NCT02708355|156655112|FG001|Overall Study|Adverse Event|0|||
48971873|NCT00510068|157726370|FG001|Open-label Period|Adverse Event|0|||
48673270|NCT02708355|156655113|FG002|Overall Study|Adverse Event|0|||
48971874|NCT00510068|157726369|FG000|Open-label Period|Withdrawal by Subject|21|||
48971875|NCT00510068|157726370|FG001|Open-label Period|Withdrawal by Subject|0|||
48971876|NCT00510068|157726369|FG000|Open-label Period|Administrative problems|17|||
48971877|NCT00510068|157726370|FG001|Open-label Period|Administrative problems|0|||
48971878|NCT00510068|157726369|FG000|Open-label Period|Death|7|||
48971879|NCT00510068|157726370|FG001|Open-label Period|Death|0|||
48971880|NCT00510068|157726369|FG000|Open-label Period|New cancer therapy|7|||
48971881|NCT00510068|157726370|FG001|Open-label Period|New cancer therapy|0|||
48971882|NCT00510068|157726369|FG000|Open-label Period|Protocol Violation|2|||
48971883|NCT00510068|157726370|FG001|Open-label Period|Protocol Violation|0|||
48971884|NCT00510068|157726369|FG000|Open-label Period|Abnormal laboratory value (s)|1|||
48971885|NCT00510068|157726370|FG001|Open-label Period|Abnormal laboratory value (s)|0|||
48971886|NCT00105560|157726372|FG000|Overall Study|Lost to Follow-up|1|||
48971887|NCT01192204|157726376|FG000|Overall Study|could not keep recall appointments|1|||
48971888|NCT01192204|157726377|FG001|Overall Study|could not keep recall appointments|0|||
48673271|NCT02725866|156655114|FG000|Overall Study|Failure to return|6|||
48673272|NCT02725866|156655114|FG000|Overall Study|Withdrew consent|3|||
48673273|NCT02725866|156655114|FG000|Overall Study|Insufficient virological response|1|||
48673274|NCT02725866|156655114|FG000|Overall Study|Other, not specified|4|||
48673275|NCT02593318|156655115|FG000|Overall Study|Withdrawal by Subject|1|||
48673276|NCT02593318|156655116|FG001|Overall Study|Withdrawal by Subject|1|||
48673277|NCT01078168|156655118|FG000|Overall Study|Physician Decision|0|||
48673278|NCT01078168|156655119|FG001|Overall Study|Physician Decision|1|||
48673279|NCT00986362|156655120|FG000|Overall Study|Death|2|||
48673280|NCT00986362|156655121|FG001|Overall Study|Death|0|||
48971889|NCT01998399|157726379|FG000|Overall Study|Lost to Follow-up|1|||
48971890|NCT01998399|157726380|FG001|Overall Study|Lost to Follow-up|3|||
48971891|NCT01998399|157726379|FG000|Overall Study|Death|4|||
48971892|NCT01998399|157726380|FG001|Overall Study|Death|2|||
48971893|NCT01998399|157726379|FG000|Overall Study|Study stopped before dosing completed|3|||
48971894|NCT01998399|157726380|FG001|Overall Study|Study stopped before dosing completed|3|||
48971895|NCT01998399|157726379|FG000|Overall Study|Withdrawal by Subject|0|||
48971896|NCT01998399|157726380|FG001|Overall Study|Withdrawal by Subject|1|||
48971897|NCT00617591|157726381|FG000|Overall Study|Withdrew consent during Induction|4|||
48971898|NCT00617591|157726381|FG000|Overall Study|Withdrew consent during Maintenance|6|||
48971899|NCT04114539|157726383|FG000|Overall Study|Adverse Event|14|||
48971900|NCT04114539|157726383|FG000|Overall Study|Lost to Follow-up|2|||
48971901|NCT04114539|157726383|FG000|Overall Study|Non-compliance with Protocol|2|||
48971902|NCT04114539|157726383|FG000|Overall Study|Non-compliance with Study Drug|1|||
48971903|NCT04114539|157726383|FG000|Overall Study|Withdrawal by Parent/Caregiver|8|||
48971904|NCT04114539|157726383|FG000|Overall Study|Withdrew consent|10|||
48971905|NCT04114539|157726383|FG000|Overall Study|Others not specified|5|||
48971906|NCT04114539|157726383|FG000|Overall Study|Investigator Decision|2|||
48971907|NCT00376246|157726384|FG000|First Intervention (2 Weeks)|Adverse Event|2|||
48971908|NCT00376246|157726385|FG001|First Intervention (2 Weeks)|Adverse Event|0|||
48971909|NCT00376246|157726384|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
48971910|NCT00376246|157726385|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
48971911|NCT00376246|157726384|FG000|First Intervention (2 Weeks)|Lost to Follow-up|1|||
48971912|NCT00376246|157726385|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
48971913|NCT03404518|157726388|FG000|Overall Study|Lost to Follow-up|28|||
48971914|NCT03404518|157726389|FG001|Overall Study|Lost to Follow-up|30|||
48971915|NCT03404518|157726388|FG000|Overall Study|Protocol Violation|13|||
48971916|NCT03404518|157726389|FG001|Overall Study|Protocol Violation|6|||
48971917|NCT04285853|157726398|FG000|Overall Study|Withdrawal by Subject|1|||
48971918|NCT04285853|157726399|FG001|Overall Study|Withdrawal by Subject|0|||
48971919|NCT04285853|157726398|FG000|Overall Study|Lost to Follow-up|9|||
48971920|NCT04285853|157726399|FG001|Overall Study|Lost to Follow-up|5|||
48971921|NCT03205982|157726400|FG000|Overall Study|Lost to Follow-up|20|||
48971922|NCT03205982|157726401|FG001|Overall Study|Lost to Follow-up|19|||
48673281|NCT00986362|156655120|FG000|Overall Study|Lost to Follow-up|0|||
48673282|NCT00986362|156655121|FG001|Overall Study|Lost to Follow-up|1|||
48673283|NCT03172130|156657189|FG000|Overall Study|Failure to tolerate CPAP/Sham CPAP|3|||
48673284|NCT03172130|156657190|FG001|Overall Study|Failure to tolerate CPAP/Sham CPAP|1|||
48673285|NCT03667690|156657191|FG000|Overall Study|Adverse Event|0|||
48673286|NCT03667690|156657192|FG001|Overall Study|Adverse Event|3|||
48673287|NCT03667690|156657191|FG000|Overall Study|Death|22|||
48673288|NCT03667690|156657192|FG001|Overall Study|Death|21|||
48673289|NCT03667690|156657191|FG000|Overall Study|Lost to Follow-up|4|||
48673290|NCT03667690|156657192|FG001|Overall Study|Lost to Follow-up|5|||
48673291|NCT03667690|156657191|FG000|Overall Study|Withdrawal by Subject|7|||
48673292|NCT03667690|156657192|FG001|Overall Study|Withdrawal by Subject|8|||
48673293|NCT03667690|156657191|FG000|Overall Study|Subject could not return for additional investigational product|1|||
48673294|NCT03667690|156657192|FG001|Overall Study|Subject could not return for additional investigational product|0|||
48673295|NCT03667690|156657191|FG000|Overall Study|Subject discharged to hospice care|2|||
48673296|NCT03667690|156657192|FG001|Overall Study|Subject discharged to hospice care|0|||
48971923|NCT03205982|157726400|FG000|Overall Study|Withdrawal by Subject|4|||
48971924|NCT03205982|157726401|FG001|Overall Study|Withdrawal by Subject|3|||
48971925|NCT03205982|157726400|FG000|Overall Study|Withdrawal by PI|0|||
48971926|NCT03205982|157726401|FG001|Overall Study|Withdrawal by PI|1|||
48971927|NCT01072448|157726402|FG000|Overall Study|Adverse Event|9|||
48971928|NCT01072448|157726403|FG001|Overall Study|Adverse Event|10|||
48971929|NCT01072448|157726402|FG000|Overall Study|Subject withdrew consent|4|||
48971930|NCT01072448|157726403|FG001|Overall Study|Subject withdrew consent|9|||
48971931|NCT01072448|157726402|FG000|Overall Study|Protocol deviation|3|||
48971932|NCT01072448|157726403|FG001|Overall Study|Protocol deviation|4|||
48971933|NCT01072448|157726402|FG000|Overall Study|Abnormal test procedure result(s)|1|||
48971934|NCT01072448|157726403|FG001|Overall Study|Abnormal test procedure result(s)|0|||
48971935|NCT01072448|157726402|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
48971936|NCT01072448|157726403|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
48971937|NCT01072448|157726402|FG000|Overall Study|Lost to Follow-up|1|||
48971938|NCT01072448|157726403|FG001|Overall Study|Lost to Follow-up|1|||
48971939|NCT01072448|157726402|FG000|Overall Study|Abnormal laboratory value(s)|0|||
48971940|NCT01072448|157726403|FG001|Overall Study|Abnormal laboratory value(s)|1|||
48971941|NCT01072448|157726402|FG000|Overall Study|Death|0|||
48971942|NCT01072448|157726403|FG001|Overall Study|Death|2|||
48971943|NCT01496274|157726404|FG000|Overall Study|Protocol Violation|0|||
48971944|NCT01496274|157726405|FG001|Overall Study|Protocol Violation|1|||
48971945|NCT01496274|157726404|FG000|Overall Study|Adverse Event|1|||
48971946|NCT01496274|157726405|FG001|Overall Study|Adverse Event|1|||
48971947|NCT01496274|157726404|FG000|Overall Study|Withdrawal by Subject|2|||
48971948|NCT01496274|157726405|FG001|Overall Study|Withdrawal by Subject|0|||
48971949|NCT01496274|157726404|FG000|Overall Study|Lost to Follow-up|0|||
48971950|NCT01496274|157726405|FG001|Overall Study|Lost to Follow-up|3|||
48971951|NCT00436982|157727768|FG000|Overall Study|Withdrawal by Subject|3|||
48971952|NCT00436982|157727769|FG001|Overall Study|Withdrawal by Subject|1|||
48971953|NCT00436982|157727768|FG000|Overall Study|Did not receive allocated intervention|0|||
48971954|NCT00436982|157727769|FG001|Overall Study|Did not receive allocated intervention|1|||
48971955|NCT00436982|157727768|FG000|Overall Study|no RSA data|1|||
48971956|NCT00436982|157727769|FG001|Overall Study|no RSA data|2|||
48971957|NCT00953225|157727770|FG000|Overall Study|Withdrawal by Subject|2|||
48971958|NCT00953225|157727771|FG001|Overall Study|Withdrawal by Subject|0|||
48971959|NCT02088541|157727774|FG000|Overall Study|Adverse Event|3|||
48971960|NCT02088541|157727775|FG001|Overall Study|Adverse Event|0|||
48971961|NCT02088541|157727776|FG002|Overall Study|Adverse Event|3|||
48971962|NCT02088541|157727777|FG003|Overall Study|Adverse Event|3|||
48971963|NCT02088541|157727778|FG004|Overall Study|Adverse Event|0|||
48971964|NCT02088541|157727774|FG000|Overall Study|Death|51|||
48971965|NCT02088541|157727775|FG001|Overall Study|Death|21|||
48971966|NCT02088541|157727776|FG002|Overall Study|Death|85|||
48971967|NCT02088541|157727777|FG003|Overall Study|Death|28|||
48971968|NCT02088541|157727778|FG004|Overall Study|Death|38|||
48971969|NCT02088541|157727774|FG000|Overall Study|Lost to Follow-up|2|||
48971970|NCT02088541|157727775|FG001|Overall Study|Lost to Follow-up|0|||
48971971|NCT02088541|157727776|FG002|Overall Study|Lost to Follow-up|1|||
48971972|NCT02088541|157727777|FG003|Overall Study|Lost to Follow-up|0|||
48971973|NCT02088541|157727778|FG004|Overall Study|Lost to Follow-up|0|||
48971974|NCT02088541|157727774|FG000|Overall Study|Physician Decision|2|||
48971975|NCT02088541|157727775|FG001|Overall Study|Physician Decision|1|||
48971976|NCT02088541|157727776|FG002|Overall Study|Physician Decision|2|||
48971977|NCT02088541|157727777|FG003|Overall Study|Physician Decision|0|||
48971978|NCT02088541|157727778|FG004|Overall Study|Physician Decision|2|||
48971979|NCT02088541|157727774|FG000|Overall Study|Disease progression|7|||
48971980|NCT02088541|157727775|FG001|Overall Study|Disease progression|1|||
48971981|NCT02088541|157727776|FG002|Overall Study|Disease progression|2|||
48971982|NCT02088541|157727777|FG003|Overall Study|Disease progression|3|||
48971983|NCT02088541|157727778|FG004|Overall Study|Disease progression|1|||
48971984|NCT02088541|157727774|FG000|Overall Study|Study terminated by sponsor|1|||
48971985|NCT02088541|157727775|FG001|Overall Study|Study terminated by sponsor|1|||
48971986|NCT02088541|157727776|FG002|Overall Study|Study terminated by sponsor|12|||
48971987|NCT02088541|157727777|FG003|Overall Study|Study terminated by sponsor|2|||
48971988|NCT02088541|157727778|FG004|Overall Study|Study terminated by sponsor|6|||
48971989|NCT02088541|157727774|FG000|Overall Study|Withdrawal by Subject|3|||
48971990|NCT02088541|157727775|FG001|Overall Study|Withdrawal by Subject|2|||
48971991|NCT02088541|157727776|FG002|Overall Study|Withdrawal by Subject|9|||
48971992|NCT02088541|157727777|FG003|Overall Study|Withdrawal by Subject|7|||
48971993|NCT02088541|157727778|FG004|Overall Study|Withdrawal by Subject|10|||
48971994|NCT02088541|157727774|FG000|Overall Study|Other|2|||
48971995|NCT02088541|157727775|FG001|Overall Study|Other|1|||
48971996|NCT02088541|157727776|FG002|Overall Study|Other|3|||
48971997|NCT02088541|157727777|FG003|Overall Study|Other|1|||
48971998|NCT02088541|157727778|FG004|Overall Study|Other|1|||
48971999|NCT05742841|157727779|FG000|Overall Study|Withdrawal by Subject|1|||
48972000|NCT05742841|157727779|FG000|Overall Study|Lost to Follow-up|1|||
48972001|NCT00801892|157727780|FG000|Main Study Period|Withdrawal by Subject|0|||
48972002|NCT00801892|157727781|FG001|Main Study Period|Withdrawal by Subject|1|||
48972003|NCT00801892|157727780|FG000|Sham Crossover Period|Lost to Follow-up|0|||
48972004|NCT00801892|157727781|FG001|Sham Crossover Period|Lost to Follow-up|2|||
48972005|NCT03472040|157727782|FG000|Overall Study|Physician Decision|0|||
48972006|NCT03472040|157727783|FG001|Overall Study|Physician Decision|3|||
48972007|NCT03472040|157727782|FG000|Overall Study|Withdrawal by Subject|10|||
48972008|NCT03472040|157727783|FG001|Overall Study|Withdrawal by Subject|23|||
48972009|NCT03472040|157727782|FG000|Overall Study|Perceived Lack of Efficacy|29|||
48972010|NCT03472040|157727783|FG001|Overall Study|Perceived Lack of Efficacy|30|||
48972011|NCT03472040|157727782|FG000|Overall Study|Lab Abnormality or Adverse Event (AE)|7|||
48972012|NCT03472040|157727783|FG001|Overall Study|Lab Abnormality or Adverse Event (AE)|25|||
48972013|NCT03472040|157727782|FG000|Overall Study|Intercurrent Illness/Medical Condition|2|||
48972014|NCT03472040|157727783|FG001|Overall Study|Intercurrent Illness/Medical Condition|3|||
48972015|NCT03472040|157727782|FG000|Overall Study|Other - Not Otherwise Specified (NOS)|4|||
48673297|NCT03667690|156657191|FG000|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|1|||
48673298|NCT03667690|156657192|FG001|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|0|||
48673299|NCT03667690|156657191|FG000|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|2|||
48673300|NCT03667690|156657192|FG001|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|1|||
48673301|NCT03667690|156657191|FG000|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
48673302|NCT03667690|156657192|FG001|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
48673303|NCT03667690|156657191|FG000|Overall Study|Subject was dropped due to exclusion criterion number 9|1|||
48673304|NCT03667690|156657192|FG001|Overall Study|Subject was dropped due to exclusion criterion number 9|0|||
48761131|NCT02246673|156974003|FG000|Overall Study|Withdrawal by Subject|0|||
48761132|NCT02246673|156974004|FG001|Overall Study|Withdrawal by Subject|0|||
48872911|NCT00723125|157371862|FG000|Overall Study|Withdrawal by Subject|15|||
48872912|NCT00723125|157371863|FG001|Overall Study|Withdrawal by Subject|6|||
48872913|NCT00723125|157371862|FG000|Overall Study|Adverse Event|2|||
48872914|NCT00723125|157371863|FG001|Overall Study|Adverse Event|0|||
48872915|NCT00878553|157371864|FG000|Sleep Study|Withdrawal by Subject|2|||
48872916|NCT00878553|157371865|FG001|Sleep Study|Withdrawal by Subject|0|||
48872917|NCT00878553|157371866|FG002|Sleep Study|Withdrawal by Subject|0|||
48872918|NCT00878553|157371867|FG003|Sleep Study|Withdrawal by Subject|0|||
48872919|NCT00878553|157371868|FG004|Sleep Study|Withdrawal by Subject|0|||
48872920|NCT00878553|157371864|FG000|Sleep Study|Lost to Follow-up|1|||
48872921|NCT00878553|157371865|FG001|Sleep Study|Lost to Follow-up|0|||
48872922|NCT00878553|157371866|FG002|Sleep Study|Lost to Follow-up|0|||
48872923|NCT00878553|157371867|FG003|Sleep Study|Lost to Follow-up|0|||
48872924|NCT00878553|157371868|FG004|Sleep Study|Lost to Follow-up|0|||
48872925|NCT00878553|157371864|FG000|Sleep Study|car accident|1|||
48872926|NCT00878553|157371865|FG001|Sleep Study|car accident|0|||
48872927|NCT00878553|157371866|FG002|Sleep Study|car accident|0|||
48872928|NCT00878553|157371867|FG003|Sleep Study|car accident|0|||
48872929|NCT00878553|157371868|FG004|Sleep Study|car accident|0|||
48872930|NCT00878553|157371864|FG000|Sleep Study|family emergency|1|||
48872931|NCT00878553|157371865|FG001|Sleep Study|family emergency|0|||
48872932|NCT00878553|157371866|FG002|Sleep Study|family emergency|0|||
48872933|NCT00878553|157371867|FG003|Sleep Study|family emergency|0|||
48872934|NCT00878553|157371868|FG004|Sleep Study|family emergency|0|||
48872935|NCT00878553|157371864|FG000|PK Study|Withdrawal by Subject|0|||
48872936|NCT00878553|157371865|FG001|PK Study|Withdrawal by Subject|0|||
48872937|NCT00878553|157371866|FG002|PK Study|Withdrawal by Subject|0|||
48872938|NCT00878553|157371867|FG003|PK Study|Withdrawal by Subject|1|||
48872939|NCT00878553|157371868|FG004|PK Study|Withdrawal by Subject|0|||
48872940|NCT02725528|157371873|FG000|Overall Study|Lost to Follow-up|1|||
48872941|NCT02725528|157371874|FG001|Overall Study|Lost to Follow-up|4|||
48872942|NCT02725528|157371873|FG000|Overall Study|Withdrawal by Subject|0|||
48872943|NCT02725528|157371874|FG001|Overall Study|Withdrawal by Subject|1|||
48872944|NCT04354168|157371875|FG000|Overall Study|Lost to Follow-up|22|||
48872945|NCT00025662|157371876|FG000|Overall Study|Withdrawal by Subject|2|||
48872946|NCT00025662|157371876|FG000|Overall Study|Technical failure of manipulation|1|||
48872947|NCT02132117|157371877|FG000|Overall Study|Adverse Event|6|||
48872948|NCT02132117|157371878|FG001|Overall Study|Adverse Event|1|||
48872949|NCT02132117|157371877|FG000|Overall Study|Lost to Follow-up|2|||
48872950|NCT02132117|157371878|FG001|Overall Study|Lost to Follow-up|2|||
48872951|NCT02132117|157371877|FG000|Overall Study|Personal Reasons|1|||
48872952|NCT02132117|157371878|FG001|Overall Study|Personal Reasons|2|||
48872953|NCT02132117|157371877|FG000|Overall Study|Other Miscellaneous Reasons|2|||
48872954|NCT02132117|157371878|FG001|Overall Study|Other Miscellaneous Reasons|0|||
48872955|NCT02630706|157371880|FG000|Overall Study|Adverse Event|2|||
48872956|NCT02630706|157371881|FG001|Overall Study|Adverse Event|1|||
48872957|NCT02630706|157371882|FG002|Overall Study|Adverse Event|1|||
48972016|NCT03472040|157727783|FG001|Overall Study|Other - Not Otherwise Specified (NOS)|19|||
48972017|NCT03472040|157727782|FG000|Overall Study|Subject Non-compliance|2|||
48972018|NCT03472040|157727783|FG001|Overall Study|Subject Non-compliance|5|||
48673305|NCT03667690|156657191|FG000|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|0|||
48673306|NCT03667690|156657192|FG001|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|1|||
48673307|NCT03647267|156657196|FG000|Overall Study|Lost to Follow-up|1|||
48673308|NCT03647267|156657197|FG001|Overall Study|Lost to Follow-up|0|||
48673309|NCT01041287|156657198|FG000|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
48673310|NCT01041287|156657199|FG001|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
48673311|NCT01041287|156657198|FG000|Treatment Period 2 (3 Months)|Adverse Event|0|||
48673312|NCT01041287|156657199|FG001|Treatment Period 2 (3 Months)|Adverse Event|2|||
48673313|NCT04544683|156657207|FG000|Overall Study|Lost to Follow-up|2|||
48673314|NCT04544683|156657207|FG000|Overall Study|Underwent cervical spine surgery|6|||
48673315|NCT03459365|156657214|FG000|Overall Study|Withdrawal by Subject|6|||
48761133|NCT02246673|156974005|FG002|Overall Study|Withdrawal by Subject|0|||
48761134|NCT02246673|156974006|FG003|Overall Study|Withdrawal by Subject|0|||
48761135|NCT02246673|156974007|FG004|Overall Study|Withdrawal by Subject|1|||
48761136|NCT02246673|156974003|FG000|Overall Study|Lost to Follow-up|0|||
48761137|NCT02246673|156974004|FG001|Overall Study|Lost to Follow-up|0|||
48761138|NCT02246673|156974005|FG002|Overall Study|Lost to Follow-up|0|||
48761139|NCT02246673|156974006|FG003|Overall Study|Lost to Follow-up|1|||
48761140|NCT02246673|156974007|FG004|Overall Study|Lost to Follow-up|0|||
48761141|NCT02246673|156974003|FG000|Overall Study|Protocol Violation|0|||
48761142|NCT02246673|156974004|FG001|Overall Study|Protocol Violation|0|||
48872958|NCT02630706|157371880|FG000|Overall Study|Lost to Follow-up|0|||
48872959|NCT02630706|157371881|FG001|Overall Study|Lost to Follow-up|1|||
48872960|NCT02630706|157371882|FG002|Overall Study|Lost to Follow-up|2|||
48872961|NCT02630706|157371880|FG000|Overall Study|Physician Decision|1|||
48872962|NCT02630706|157371881|FG001|Overall Study|Physician Decision|1|||
48872963|NCT02630706|157371882|FG002|Overall Study|Physician Decision|0|||
48872964|NCT02630706|157371880|FG000|Overall Study|Pregnancy|0|||
48872965|NCT02630706|157371881|FG001|Overall Study|Pregnancy|1|||
48872966|NCT02630706|157371882|FG002|Overall Study|Pregnancy|0|||
48872967|NCT02630706|157371880|FG000|Overall Study|Withdrawal by Subject|4|||
48872968|NCT02630706|157371881|FG001|Overall Study|Withdrawal by Subject|5|||
48872969|NCT02630706|157371882|FG002|Overall Study|Withdrawal by Subject|7|||
48872970|NCT00582114|157371884|FG000|Overall Study|Death|4|||
48872971|NCT00582114|157371885|FG001|Overall Study|Death|4|||
48872972|NCT00582114|157371884|FG000|Overall Study|Kidney Transplant|3|||
48872973|NCT00582114|157371885|FG001|Overall Study|Kidney Transplant|1|||
48872974|NCT00582114|157371884|FG000|Overall Study|Lost to Follow-up|7|||
48872975|NCT00582114|157371885|FG001|Overall Study|Lost to Follow-up|6|||
48872976|NCT00582114|157371884|FG000|Overall Study|Withdrawal by Subject|8|||
48872977|NCT00582114|157371885|FG001|Overall Study|Withdrawal by Subject|16|||
48872978|NCT00582114|157371884|FG000|Overall Study|Adverse Event|1|||
48872979|NCT00582114|157371885|FG001|Overall Study|Adverse Event|1|||
48872980|NCT00582114|157371884|FG000|Overall Study|Physician Decision|0|||
48872981|NCT00582114|157371885|FG001|Overall Study|Physician Decision|6|||
48872982|NCT00582114|157371884|FG000|Overall Study|Stopped by data safety monitoring board|19|||
48872983|NCT00582114|157371885|FG001|Overall Study|Stopped by data safety monitoring board|20|||
48872984|NCT01062971|157371886|FG000|Overall Study|Protocol Violation|1|||
48872985|NCT01062971|157371887|FG001|Overall Study|Protocol Violation|3|||
48872986|NCT01062971|157371886|FG000|Overall Study|Lost to Follow-up|3|||
48872987|NCT01062971|157371887|FG001|Overall Study|Lost to Follow-up|4|||
48872988|NCT01161628|157371888|FG000|Overall Study|Death|6|||
48872989|NCT01161628|157371888|FG000|Overall Study|Lack of Efficacy|2|||
48872990|NCT01018732|157371889|FG000|Overall Study|Lost to Follow-up|0|||
48872991|NCT01018732|157371890|FG001|Overall Study|Lost to Follow-up|0|||
48872992|NCT01018732|157371891|FG002|Overall Study|Lost to Follow-up|3|||
48872993|NCT01018732|157371889|FG000|Overall Study|Protocol Violation|1|||
48872994|NCT01018732|157371890|FG001|Overall Study|Protocol Violation|1|||
48872995|NCT01018732|157371891|FG002|Overall Study|Protocol Violation|0|||
48872996|NCT01018732|157371889|FG000|Overall Study|Inappropriate Enrollment|0|||
48872997|NCT01018732|157371890|FG001|Overall Study|Inappropriate Enrollment|1|||
48872998|NCT01018732|157371891|FG002|Overall Study|Inappropriate Enrollment|0|||
48872999|NCT01018732|157371889|FG000|Overall Study|Unable to Classify|0|||
48873000|NCT01018732|157371890|FG001|Overall Study|Unable to Classify|0|||
48873001|NCT01018732|157371891|FG002|Overall Study|Unable to Classify|1|||
48873002|NCT03765164|157371892|FG000|Pre-intervention|Withdrawal by Subject|5|||
48873003|NCT03765164|157371893|FG001|Pre-intervention|Withdrawal by Subject|6|||
48873004|NCT02781311|157371894|FG000|Overall Study|Adverse Event|2|||
48873005|NCT02781311|157371895|FG001|Overall Study|Adverse Event|6|||
48873006|NCT02781311|157371896|FG002|Overall Study|Adverse Event|1|||
48873007|NCT02781311|157371894|FG000|Overall Study|Withdrawal of Consent|11|||
48873008|NCT02781311|157371895|FG001|Overall Study|Withdrawal of Consent|12|||
48761143|NCT02246673|156974005|FG002|Overall Study|Protocol Violation|0|||
48761144|NCT02246673|156974006|FG003|Overall Study|Protocol Violation|1|||
48873009|NCT02781311|157371896|FG002|Overall Study|Withdrawal of Consent|2|||
48873010|NCT02781311|157371894|FG000|Overall Study|Lost to Follow-up|11|||
48873011|NCT02781311|157371895|FG001|Overall Study|Lost to Follow-up|8|||
48972019|NCT03472040|157727782|FG000|Overall Study|Discontinuation due to Rash|0|||
48972020|NCT03472040|157727783|FG001|Overall Study|Discontinuation due to Rash|1|||
48972021|NCT03472040|157727782|FG000|Overall Study|Subsequent Ineligibility|0|||
48972022|NCT03472040|157727783|FG001|Overall Study|Subsequent Ineligibility|2|||
48972023|NCT03472040|157727782|FG000|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|46|||
48972024|NCT03472040|157727783|FG001|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|175|||
48972025|NCT03276572|157727792|FG000|Overall Study|In follow-up|0|||
48972026|NCT03276572|157727793|FG001|Overall Study|In follow-up|0|||
48972027|NCT03276572|157727794|FG002|Overall Study|In follow-up|0|||
48972028|NCT03276572|157727795|FG003|Overall Study|In follow-up|0|||
48972029|NCT03276572|157727796|FG004|Overall Study|In follow-up|0|||
48972030|NCT03276572|157727797|FG005|Overall Study|In follow-up|1|||
48972031|NCT03276572|157727798|FG006|Overall Study|In follow-up|1|||
48972032|NCT03276572|157727792|FG000|Overall Study|Lost to Follow-up|0|||
48972033|NCT03276572|157727793|FG001|Overall Study|Lost to Follow-up|0|||
48972034|NCT03276572|157727794|FG002|Overall Study|Lost to Follow-up|0|||
48972035|NCT03276572|157727795|FG003|Overall Study|Lost to Follow-up|0|||
48972036|NCT03276572|157727796|FG004|Overall Study|Lost to Follow-up|0|||
48972037|NCT03276572|157727797|FG005|Overall Study|Lost to Follow-up|0|||
48972038|NCT03276572|157727798|FG006|Overall Study|Lost to Follow-up|1|||
48972039|NCT03657810|157727799|FG000|Overall Study|Adverse Event|0|||
48972040|NCT03657810|157727800|FG001|Overall Study|Adverse Event|1|||
48972041|NCT03657810|157727801|FG002|Overall Study|Adverse Event|0|||
48972042|NCT03657810|157727799|FG000|Overall Study|Lack of Efficacy|4|||
48972043|NCT03657810|157727800|FG001|Overall Study|Lack of Efficacy|1|||
48972044|NCT03657810|157727801|FG002|Overall Study|Lack of Efficacy|3|||
48673316|NCT03459365|156657214|FG000|Overall Study|Protocol Violation|8|||
48673317|NCT01543776|156657217|FG000|Overall Study|Withdrawal by Subject|2|||
48972045|NCT03657810|157727799|FG000|Overall Study|Protocol Violation|1|||
48972046|NCT03657810|157727800|FG001|Overall Study|Protocol Violation|0|||
48972047|NCT03657810|157727801|FG002|Overall Study|Protocol Violation|0|||
48972048|NCT03657810|157727799|FG000|Overall Study|Lost to Follow-up|0|||
48972049|NCT03657810|157727800|FG001|Overall Study|Lost to Follow-up|1|||
48972050|NCT03657810|157727801|FG002|Overall Study|Lost to Follow-up|0|||
48972051|NCT03657810|157727799|FG000|Overall Study|Not provided|0|||
48972052|NCT03657810|157727800|FG001|Overall Study|Not provided|1|||
48972053|NCT03657810|157727801|FG002|Overall Study|Not provided|0|||
48972054|NCT03175562|157727802|FG000|Overall Study|Adverse Event|1|||
48972055|NCT03175562|157727802|FG000|Overall Study|Lost to Follow-up|3|||
48972056|NCT03175562|157727802|FG000|Overall Study|Withdrawal by Subject|7|||
48972057|NCT03175562|157727802|FG000|Overall Study|Other (Not Specified)|5|||
48972058|NCT01878097|157727805|FG000|Baseline|Surveys not fully completed|2497|||
48972059|NCT01878097|157727806|FG001|Baseline|Surveys not fully completed|1800|||
48972060|NCT01878097|157727805|FG000|Implementation Year 1|Surveys not fully completed|3202|||
48972061|NCT01878097|157727806|FG001|Implementation Year 1|Surveys not fully completed|2549|||
48972062|NCT01878097|157727805|FG000|Implementation Year 2|Surveys not fully completed|3281|||
48972063|NCT01878097|157727806|FG001|Implementation Year 2|Surveys not fully completed|2841|||
48972064|NCT01878097|157727805|FG000|Implementation Year 3|Surveys not fully completed|3494|||
48972065|NCT01878097|157727806|FG001|Implementation Year 3|Surveys not fully completed|2980|||
48972066|NCT01878097|157727805|FG000|Implementation Year 4|Surveys not fully completed|3604|||
48972067|NCT01878097|157727806|FG001|Implementation Year 4|Surveys not fully completed|3007|||
48972068|NCT01590212|157727807|FG000|Overall Study|Withdrawal by Subject|2|||
48972069|NCT01590212|157727808|FG001|Overall Study|Withdrawal by Subject|2|||
48972070|NCT01590212|157727809|FG002|Overall Study|Withdrawal by Subject|2|||
48972071|NCT01590212|157727807|FG000|Overall Study|Lost to Follow-up|1|||
48972072|NCT01590212|157727808|FG001|Overall Study|Lost to Follow-up|2|||
48972073|NCT01590212|157727809|FG002|Overall Study|Lost to Follow-up|3|||
48972074|NCT00150345|157727812|FG000|Overall Study|Death|5|||
48972075|NCT00150345|157727813|FG001|Overall Study|Death|2|||
48972076|NCT00150345|157727812|FG000|Overall Study|Adverse Event|8|||
48673318|NCT01543776|156657218|FG001|Overall Study|Withdrawal by Subject|2|||
48673319|NCT00707954|156657219|FG000|Overall Study|Physician Decision|0|||
48972077|NCT00150345|157727813|FG001|Overall Study|Adverse Event|6|||
48972078|NCT00150345|157727812|FG000|Overall Study|Lack of Efficacy|5|||
48972079|NCT00150345|157727813|FG001|Overall Study|Lack of Efficacy|4|||
48972080|NCT00150345|157727812|FG000|Overall Study|Withdrawal by Subject|3|||
48972081|NCT00150345|157727813|FG001|Overall Study|Withdrawal by Subject|4|||
48972082|NCT00150345|157727812|FG000|Overall Study|Laboratory abnormality|1|||
48972083|NCT00150345|157727813|FG001|Overall Study|Laboratory abnormality|2|||
48972084|NCT00150345|157727812|FG000|Overall Study|Other|12|||
48972085|NCT00150345|157727813|FG001|Overall Study|Other|14|||
48972086|NCT01392742|157727814|FG000|Overall Study|Premature study termination|42|||
48972087|NCT01392742|157727814|FG000|Overall Study|Failure to return|35|||
48972088|NCT01392742|157727814|FG000|Overall Study|No treatment/no cooperation/withdrew|12|||
48972089|NCT01392742|157727814|FG000|Overall Study|Lost to Follow-up|34|||
48972090|NCT01392742|157727814|FG000|Overall Study|Insufficient therapeutic response (ITR)|30|||
48972091|NCT01392742|157727814|FG000|Overall Study|ITR and Protocol deviation|1|||
48972092|NCT01392742|157727814|FG000|Overall Study|Adverse event/intercurrent illness|17|||
48972093|NCT01392742|157727814|FG000|Overall Study|Protocol Violation|14|||
48972094|NCT01392742|157727814|FG000|Overall Study|Other|3|||
48972095|NCT01392742|157727814|FG000|Overall Study|Missing information|13|||
48972096|NCT01599806|157727820|FG000|Overall Study|Lost to Follow-up|20|||
48673320|NCT00707954|156657220|FG001|Overall Study|Physician Decision|0|||
48673321|NCT00707954|156657221|FG002|Overall Study|Physician Decision|0|||
48673322|NCT00707954|156657222|FG003|Overall Study|Physician Decision|0|||
48673323|NCT00707954|156657223|FG004|Overall Study|Physician Decision|1|||
48972097|NCT01599806|157727821|FG001|Overall Study|Lost to Follow-up|20|||
48972098|NCT01599806|157727820|FG000|Overall Study|Withdrawal by Subject|12|||
48972099|NCT01599806|157727821|FG001|Overall Study|Withdrawal by Subject|12|||
48972100|NCT01599806|157727820|FG000|Overall Study|Other Eligibility criteria|11|||
48972101|NCT01599806|157727821|FG001|Overall Study|Other Eligibility criteria|9|||
48972102|NCT03934541|157727823|FG000|Overall Study|Study Terminated by Sponsor|0|||
48972103|NCT03934541|157727824|FG001|Overall Study|Study Terminated by Sponsor|1|||
48972104|NCT03934541|157727825|FG002|Overall Study|Study Terminated by Sponsor|0|||
48972105|NCT03934541|157727826|FG003|Overall Study|Study Terminated by Sponsor|0|||
48972106|NCT04702984|157727829|FG000|Overall Study|Adverse Event Unrelated to the Study Device|1|||
48972107|NCT00841672|157727830|FG000|Overall Study|Adverse Event|7|||
48972108|NCT00841672|157727831|FG001|Overall Study|Adverse Event|16|||
48972109|NCT00841672|157727830|FG000|Overall Study|Abnormal test procedure result(s)|0|||
48972110|NCT00841672|157727831|FG001|Overall Study|Abnormal test procedure result(s)|1|||
48972111|NCT00841672|157727830|FG000|Overall Study|Subject withdrew consent|2|||
48972112|NCT00841672|157727831|FG001|Overall Study|Subject withdrew consent|4|||
48972113|NCT00841672|157727830|FG000|Overall Study|Lost to Follow-up|1|||
48972114|NCT00841672|157727831|FG001|Overall Study|Lost to Follow-up|1|||
48972115|NCT00841672|157727830|FG000|Overall Study|Administrative problems|9|||
48972116|NCT00841672|157727831|FG001|Overall Study|Administrative problems|9|||
48972117|NCT00841672|157727830|FG000|Overall Study|Misrandomized|1|||
48972118|NCT00841672|157727831|FG001|Overall Study|Misrandomized|0|||
48972119|NCT00841672|157727830|FG000|Overall Study|Protocol Deviation|0|||
48972120|NCT00841672|157727831|FG001|Overall Study|Protocol Deviation|1|||
48972121|NCT00166517|157727834|FG000|Overall Study|Lost to Follow-up|1|||
48972122|NCT00166517|157727835|FG001|Overall Study|Lost to Follow-up|0|||
48972123|NCT00166517|157727834|FG000|Overall Study|Protocol Violation|4|||
48972124|NCT00166517|157727835|FG001|Overall Study|Protocol Violation|1|||
48972125|NCT00166517|157727834|FG000|Overall Study|Withdrawal by Subject|0|||
48972126|NCT00166517|157727835|FG001|Overall Study|Withdrawal by Subject|1|||
48972127|NCT01455415|157727839|FG000|Period 1|Adverse Event (AE) Related to Study Drug|9|||
48673324|NCT00528801|156657224|FG000|Overall Study|Withdrawal by Subject|1|||
48673325|NCT00528801|156657225|FG001|Overall Study|Withdrawal by Subject|1|||
48673326|NCT00528801|156657224|FG000|Overall Study|Protocol Violation|11|||
48673327|NCT00528801|156657225|FG001|Overall Study|Protocol Violation|5|||
48673328|NCT00528801|156657224|FG000|Overall Study|Lost to Follow-up|15|||
48673329|NCT00528801|156657225|FG001|Overall Study|Lost to Follow-up|4|||
48673330|NCT00528801|156657224|FG000|Overall Study|Administrative Reasons|0|||
48673331|NCT00528801|156657225|FG001|Overall Study|Administrative Reasons|1|||
48673332|NCT03626545|156657228|FG000|Overall Study|Progressive disease|3|||
48673333|NCT03626545|156657229|FG001|Overall Study|Progressive disease|82|||
48673334|NCT03626545|156657230|FG002|Overall Study|Progressive disease|85|||
48673335|NCT03626545|156657228|FG000|Overall Study|Adverse Event|3|||
48673336|NCT03626545|156657229|FG001|Overall Study|Adverse Event|13|||
48673337|NCT03626545|156657230|FG002|Overall Study|Adverse Event|10|||
48673338|NCT03626545|156657228|FG000|Overall Study|Physician Decision|1|||
48673339|NCT03626545|156657229|FG001|Overall Study|Physician Decision|18|||
48673340|NCT03626545|156657230|FG002|Overall Study|Physician Decision|14|||
48673341|NCT03626545|156657228|FG000|Overall Study|Subject Decision|0|||
48972128|NCT01455415|157727840|FG001|Period 1|Adverse Event (AE) Related to Study Drug|6|||
48972129|NCT01455415|157727839|FG000|Period 1|Lost To Follow-up Related to Study Drug|3|||
48972130|NCT01455415|157727840|FG001|Period 1|Lost To Follow-up Related to Study Drug|3|||
48972131|NCT01455415|157727839|FG000|Period 1|Drug Error not Associated to AE|0|||
48673342|NCT03626545|156657229|FG001|Overall Study|Subject Decision|5|||
48761145|NCT02246673|156974007|FG004|Overall Study|Protocol Violation|0|||
48761146|NCT02250443|156974011|FG000|Overall Study|Administrative problems|7|||
48972132|NCT01455415|157727840|FG001|Period 1|Drug Error not Associated to AE|1|||
48972133|NCT01455415|157727839|FG000|Period 1|AE Not Related to Study Drug|2|||
48972134|NCT01455415|157727840|FG001|Period 1|AE Not Related to Study Drug|6|||
48761147|NCT02250443|156974011|FG000|Overall Study|Adverse Event|3|||
48761148|NCT02337907|156974013|FG000|Overall Study|Other than listed|1|||
48673343|NCT03626545|156657230|FG002|Overall Study|Subject Decision|5|||
48673344|NCT03626545|156657228|FG000|Overall Study|Death|1|||
48673345|NCT03626545|156657229|FG001|Overall Study|Death|1|||
48972135|NCT01455415|157727839|FG000|Period 1|Withdrawal by Subject|4|||
48673346|NCT03626545|156657230|FG002|Overall Study|Death|1|||
48673347|NCT03626545|156657228|FG000|Overall Study|Protocol Deviation|0|||
48673348|NCT03626545|156657229|FG001|Overall Study|Protocol Deviation|1|||
48673349|NCT03626545|156657230|FG002|Overall Study|Protocol Deviation|1|||
48972136|NCT01455415|157727840|FG001|Period 1|Withdrawal by Subject|5|||
48972137|NCT01455415|157727839|FG000|Period 1|Unspecified Reason|1|||
48972138|NCT01455415|157727840|FG001|Period 1|Unspecified Reason|1|||
48972139|NCT01455415|157727839|FG000|Period 1|Protocol Violation|0|||
48972140|NCT01455415|157727840|FG001|Period 1|Protocol Violation|2|||
48972141|NCT01455415|157727839|FG000|Washout|AE Related to Study Drug|2|||
48972142|NCT01455415|157727840|FG001|Washout|AE Related to Study Drug|0|||
48972143|NCT01455415|157727839|FG000|Washout|Lost to Follow-up|1|||
48972144|NCT01455415|157727840|FG001|Washout|Lost to Follow-up|0|||
48972145|NCT01455415|157727839|FG000|Washout|Drug Error not Associated to AE|2|||
48972146|NCT01455415|157727840|FG001|Washout|Drug Error not Associated to AE|1|||
48972147|NCT01455415|157727839|FG000|Washout|AE Not Related to Study Drug|2|||
48972148|NCT01455415|157727840|FG001|Washout|AE Not Related to Study Drug|3|||
48972149|NCT01455415|157727839|FG000|Washout|Unspecified Reason|1|||
48972150|NCT01455415|157727840|FG001|Washout|Unspecified Reason|2|||
48972151|NCT01455415|157727839|FG000|Washout|Protocol Violation|0|||
48972152|NCT01455415|157727840|FG001|Washout|Protocol Violation|1|||
48972153|NCT01455415|157727839|FG000|Period 2|AE Related to Study Drug|1|||
48972154|NCT01455415|157727840|FG001|Period 2|AE Related to Study Drug|2|||
48972155|NCT01455415|157727839|FG000|Period 2|Lost to Follow-up|2|||
48972156|NCT01455415|157727840|FG001|Period 2|Lost to Follow-up|1|||
48972157|NCT01455415|157727839|FG000|Period 2|AE Not Related to Study Drug|2|||
48972158|NCT01455415|157727840|FG001|Period 2|AE Not Related to Study Drug|1|||
48972159|NCT01455415|157727839|FG000|Period 2|Lack of Efficacy|2|||
48972160|NCT01455415|157727840|FG001|Period 2|Lack of Efficacy|0|||
48972161|NCT01455415|157727839|FG000|Period 2|Withdrawal by Subject|2|||
48972162|NCT01455415|157727840|FG001|Period 2|Withdrawal by Subject|3|||
48972163|NCT01455415|157727839|FG000|Period 2|Unspecified Reason|2|||
48972164|NCT01455415|157727840|FG001|Period 2|Unspecified Reason|3|||
48972165|NCT01455415|157727839|FG000|Period 2|Protocol Violation|2|||
48972166|NCT01455415|157727840|FG001|Period 2|Protocol Violation|0|||
48972167|NCT01455415|157727839|FG000|Follow-up|AE Related to Study Drug|0|||
48972168|NCT01455415|157727840|FG001|Follow-up|AE Related to Study Drug|1|||
48972169|NCT01455415|157727839|FG000|Follow-up|Lack of Efficacy|0|||
48972170|NCT01455415|157727840|FG001|Follow-up|Lack of Efficacy|1|||
48972171|NCT01455415|157727839|FG000|Follow-up|Withdrawal by Subject|2|||
48972172|NCT01455415|157727840|FG001|Follow-up|Withdrawal by Subject|0|||
48972173|NCT01455415|157727839|FG000|Follow-up|Unspecified Reason|1|||
48972174|NCT01455415|157727840|FG001|Follow-up|Unspecified Reason|0|||
48972175|NCT03094611|157727845|FG000|Overall Study|Lack of Efficacy|1|||
48972176|NCT03094611|157727845|FG000|Overall Study|Stem Cell Transplant|1|||
48972177|NCT00842361|157727846|FG000|Overall Study|Protocol Violation|1|||
48972178|NCT00842361|157727847|FG001|Overall Study|Protocol Violation|0|||
48972179|NCT00842361|157727846|FG000|Overall Study|Unclassified|0|||
48972180|NCT00842361|157727847|FG001|Overall Study|Unclassified|2|||
48972181|NCT02186561|157727848|FG000|Enrollment|Did Not Meet Inclusion Criteria|46|||
48972182|NCT02186561|157727848|FG000|Enrollment|Enrollment Cap Reached|5|||
48972183|NCT02186561|157727848|FG000|Enrollment|Insurance Denial|2|||
48972184|NCT02186561|157727848|FG000|Enrollment|Withdrawal by Subject|2|||
48972185|NCT02186561|157727848|FG000|Enrollment|Investigator Withdrew Consent|1|||
48972186|NCT02186561|157727848|FG000|30-Day Post Index Procedure Visit|Death|1|||
48673350|NCT03626545|156657228|FG000|Overall Study|Guardian Decision|0|||
48673351|NCT03626545|156657229|FG001|Overall Study|Guardian Decision|0|||
48673352|NCT03626545|156657230|FG002|Overall Study|Guardian Decision|1|||
48673353|NCT00679172|156657231|FG000|Overall Study|Non-compliance|1|||
48673354|NCT00679172|156657232|FG001|Overall Study|Non-compliance|1|||
48673355|NCT00679172|156657233|FG002|Overall Study|Non-compliance|0|||
48673356|NCT00679172|156657234|FG003|Overall Study|Non-compliance|1|||
48673357|NCT00679172|156657235|FG004|Overall Study|Non-compliance|0|||
48673358|NCT00679172|156657231|FG000|Overall Study|Other not specified|0|||
48673359|NCT00679172|156657232|FG001|Overall Study|Other not specified|0|||
48673360|NCT00679172|156657233|FG002|Overall Study|Other not specified|1|||
48673361|NCT00679172|156657234|FG003|Overall Study|Other not specified|0|||
48673362|NCT00679172|156657235|FG004|Overall Study|Other not specified|0|||
48673363|NCT00387725|156657250|FG000|Overall Study|Adverse Event|0|||
48673364|NCT00387725|156657251|FG001|Overall Study|Adverse Event|0|||
48673365|NCT00387725|156657252|FG002|Overall Study|Adverse Event|0|||
48761149|NCT02337907|156974014|FG001|Overall Study|Other than listed|0|||
48972187|NCT02186561|157727848|FG000|1- Year Post Index Procedure Visit|Death|1|||
48673366|NCT00387725|156657253|FG003|Overall Study|Adverse Event|1|||
48673367|NCT00387725|156657250|FG000|Overall Study|Protocol Violation|0|||
48673368|NCT00387725|156657251|FG001|Overall Study|Protocol Violation|1|||
48972188|NCT02186561|157727848|FG000|1- Year Post Index Procedure Visit|Missed|1|||
48673369|NCT00387725|156657252|FG002|Overall Study|Protocol Violation|0|||
48673370|NCT00387725|156657253|FG003|Overall Study|Protocol Violation|0|||
48673371|NCT00387725|156657250|FG000|Overall Study|Withdrawal by Subject|1|||
48761150|NCT02337907|156974015|FG002|Overall Study|Other than listed|0|||
48972189|NCT00587301|157727849|FG000|Overall Study|Screen Failure|9|||
48972190|NCT00587301|157727849|FG000|Overall Study|Lost to Follow-up|22|||
48972191|NCT00587301|157727849|FG000|Overall Study|Withdrawal by Subject|7|||
48673372|NCT00387725|156657251|FG001|Overall Study|Withdrawal by Subject|0|||
48972192|NCT00587301|157727849|FG000|Overall Study|Protocol Violation|7|||
48972193|NCT02758613|157727854|FG000|Treatment|Physician and Sponsor Decision|1|||
48972194|NCT02758613|157727855|FG001|Treatment|Physician and Sponsor Decision|0|||
48972195|NCT02758613|157727856|FG002|Treatment|Physician and Sponsor Decision|0|||
48972196|NCT02758613|157727857|FG003|Treatment|Physician and Sponsor Decision|0|||
48972197|NCT02758613|157727854|FG000|Treatment|Withdrawal by Subject|1|||
48972198|NCT02758613|157727855|FG001|Treatment|Withdrawal by Subject|0|||
48972199|NCT02758613|157727856|FG002|Treatment|Withdrawal by Subject|1|||
48972200|NCT02758613|157727857|FG003|Treatment|Withdrawal by Subject|0|||
48972201|NCT01400139|157727859|FG000|HYD Core Study|Adverse Event|210|||
48972202|NCT01400139|157727859|FG000|HYD Core Study|Lack of Efficacy|59|||
48972203|NCT01400139|157727859|FG000|HYD Core Study|Withdrawal by Subject|114|||
48972204|NCT01400139|157727859|FG000|HYD Core Study|Lost to Follow-up|39|||
48972205|NCT01400139|157727859|FG000|HYD Core Study|Confirmed or suspected diversion|20|||
48972206|NCT01400139|157727859|FG000|HYD Core Study|Administrative|56|||
48972207|NCT01400139|157727859|FG000|HYD Core Study|Did not qualify for Maintenance Period|14|||
48972208|NCT01400139|157727859|FG000|HYD Extension Period|Adverse Event|8|||
48972209|NCT01400139|157727859|FG000|HYD Extension Period|Withdrawal by Subject|5|||
48972210|NCT01400139|157727859|FG000|HYD Extension Period|Administrative|10|||
48972211|NCT00418717|157727863|FG000|Treatment Period A - Weeks 1-4|Protocol Violation|1|||
48972212|NCT00418717|157727863|FG000|Treatment Period B - Weeks 5-12|Adverse Event|2|||
48972213|NCT00351819|157727864|FG000|Overall Study|Lost to Follow-up|4|||
48972214|NCT00351819|157727865|FG001|Overall Study|Lost to Follow-up|4|||
48972215|NCT00351819|157727864|FG000|Overall Study|Withdrawal by Subject|0|||
48972216|NCT00351819|157727865|FG001|Overall Study|Withdrawal by Subject|4|||
48972217|NCT00351819|157727864|FG000|Overall Study|Elevated PSA|1|||
48972218|NCT00351819|157727865|FG001|Overall Study|Elevated PSA|1|||
48972219|NCT00351819|157727864|FG000|Overall Study|Traumatic ankle fracture|1|||
48972220|NCT00351819|157727865|FG001|Overall Study|Traumatic ankle fracture|0|||
48972221|NCT00351819|157727864|FG000|Overall Study|Unprofessional behavior|1|||
48972222|NCT00351819|157727865|FG001|Overall Study|Unprofessional behavior|0|||
48972223|NCT00351819|157727864|FG000|Overall Study|Non-compliance|0|||
48972224|NCT00351819|157727865|FG001|Overall Study|Non-compliance|1|||
48972225|NCT00351819|157727864|FG000|Overall Study|Incarcerated|0|||
48972226|NCT00351819|157727865|FG001|Overall Study|Incarcerated|1|||
48972227|NCT00351819|157727864|FG000|Overall Study|Enrolled in another trial|0|||
48972228|NCT00351819|157727865|FG001|Overall Study|Enrolled in another trial|1|||
48972229|NCT00249795|157727868|FG000|Overall Study|Not treated|16|||
48972230|NCT00249795|157727869|FG001|Overall Study|Not treated|14|||
48972231|NCT00249795|157727868|FG000|Overall Study|Symptomatic hypotension|127|||
48972232|NCT00249795|157727869|FG001|Overall Study|Symptomatic hypotension|64|||
48972233|NCT00249795|157727868|FG000|Overall Study|Other Serious Adverse Event|84|||
48972234|NCT00249795|157727869|FG001|Overall Study|Other Serious Adverse Event|93|||
48972235|NCT00249795|157727868|FG000|Overall Study|Qualifying condition not present|26|||
48972236|NCT00249795|157727869|FG001|Overall Study|Qualifying condition not present|29|||
48972237|NCT00249795|157727868|FG000|Overall Study|Withdrawal by Subject|678|||
48972238|NCT00249795|157727869|FG001|Overall Study|Withdrawal by Subject|742|||
48972239|NCT00249795|157727868|FG000|Overall Study|Thromboembolic / outcome event|39|||
48972240|NCT00249795|157727869|FG001|Overall Study|Thromboembolic / outcome event|45|||
48972241|NCT00249795|157727868|FG000|Overall Study|Oral anticoagulant required|2|||
48972242|NCT00249795|157727869|FG001|Overall Study|Oral anticoagulant required|0|||
48972243|NCT00249795|157727868|FG000|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7|||
48972244|NCT00249795|157727869|FG001|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3|||
48972245|NCT00249795|157727868|FG000|Overall Study|Non-compliance|71|||
48972246|NCT00249795|157727869|FG001|Overall Study|Non-compliance|69|||
48972247|NCT00249795|157727868|FG000|Overall Study|Study drug intolerance|3|||
48972248|NCT00249795|157727869|FG001|Overall Study|Study drug intolerance|3|||
48972249|NCT00249795|157727868|FG000|Overall Study|Other adverse events (non-serious)|188|||
48673373|NCT00387725|156657252|FG002|Overall Study|Withdrawal by Subject|1|||
48673374|NCT00387725|156657253|FG003|Overall Study|Withdrawal by Subject|0|||
48972250|NCT00249795|157727869|FG001|Overall Study|Other adverse events (non-serious)|159|||
48972251|NCT00249795|157727868|FG000|Overall Study|Physician withdrew consent|71|||
48972252|NCT00249795|157727869|FG001|Overall Study|Physician withdrew consent|63|||
48972253|NCT00249795|157727868|FG000|Overall Study|Surgery / procedure|4|||
48972254|NCT00249795|157727869|FG001|Overall Study|Surgery / procedure|5|||
48972255|NCT00249795|157727868|FG000|Overall Study|Angiotensin II receptor blocker required|35|||
48673375|NCT00387725|156657250|FG000|Overall Study|Parent/legal guardian request|0|||
48673376|NCT00387725|156657251|FG001|Overall Study|Parent/legal guardian request|0|||
48673377|NCT00387725|156657252|FG002|Overall Study|Parent/legal guardian request|1|||
48673378|NCT00387725|156657253|FG003|Overall Study|Parent/legal guardian request|1|||
48673379|NCT01918332|156657254|FG000|Overall Study|Adverse Event|0|||
48972256|NCT00249795|157727869|FG001|Overall Study|Angiotensin II receptor blocker required|58|||
48972257|NCT00249795|157727868|FG000|Overall Study|Lightheadedness / dizziness|15|||
48972258|NCT00249795|157727869|FG001|Overall Study|Lightheadedness / dizziness|11|||
48972259|NCT00249795|157727868|FG000|Overall Study|Hypotension (non-symptomatic)|5|||
48972260|NCT00249795|157727869|FG001|Overall Study|Hypotension (non-symptomatic)|5|||
48972261|NCT00249795|157727868|FG000|Overall Study|Other contraindicated medication|1|||
48972262|NCT00249795|157727869|FG001|Overall Study|Other contraindicated medication|1|||
48972263|NCT00249795|157727868|FG000|Overall Study|Event related to cardiac condition|17|||
48972264|NCT00249795|157727869|FG001|Overall Study|Event related to cardiac condition|16|||
48972265|NCT00249795|157727868|FG000|Overall Study|Patient not wish to continue after May08|4|||
48972266|NCT00249795|157727869|FG001|Overall Study|Patient not wish to continue after May08|6|||
48972267|NCT00249795|157727868|FG000|Overall Study|Site not agree to continue after May08|1|||
48972268|NCT00249795|157727869|FG001|Overall Study|Site not agree to continue after May08|1|||
48972269|NCT00249795|157727868|FG000|Overall Study|Lost to Follow-up|0|||
48972270|NCT00249795|157727869|FG001|Overall Study|Lost to Follow-up|2|||
48972271|NCT00249795|157727868|FG000|Overall Study|Missing|0|||
48972272|NCT00249795|157727869|FG001|Overall Study|Missing|1|||
48972273|NCT00615914|157727870|FG000|Overall Study|Adverse Event|274|||
48972274|NCT00615914|157727870|FG000|Overall Study|Death|20|||
48972275|NCT00615914|157727870|FG000|Overall Study|Lack of Efficacy|59|||
48972276|NCT00615914|157727870|FG000|Overall Study|Lost to Follow-up|187|||
48972277|NCT00615914|157727870|FG000|Overall Study|Withdrawal by Subject|16|||
48972278|NCT00615914|157727870|FG000|Overall Study|Physician Decision|4|||
48972279|NCT00615914|157727870|FG000|Overall Study|No data was collected.|65|||
48972280|NCT00615914|157727870|FG000|Overall Study|No treatment|2|||
48972281|NCT00615914|157727870|FG000|Overall Study|Irregularly enrolled patients|10|||
48972282|NCT00089999|157727872|FG000|Overall Study|Adverse Event|4|||
48972283|NCT00089999|157727873|FG001|Overall Study|Adverse Event|7|||
48972284|NCT00089999|157727872|FG000|Overall Study|Withdrawal by Subject|0|||
48972285|NCT00089999|157727873|FG001|Overall Study|Withdrawal by Subject|4|||
48972286|NCT00089999|157727872|FG000|Overall Study|Lost to Follow-up|2|||
48972287|NCT00089999|157727873|FG001|Overall Study|Lost to Follow-up|1|||
48972288|NCT00089999|157727872|FG000|Overall Study|Radiological Progression of Cancer|52|||
48972289|NCT00089999|157727873|FG001|Overall Study|Radiological Progression of Cancer|44|||
48972290|NCT00089999|157727872|FG000|Overall Study|Symptomatic Progression of Cancer|2|||
48972291|NCT00089999|157727873|FG001|Overall Study|Symptomatic Progression of Cancer|5|||
48673380|NCT01918332|156657255|FG001|Overall Study|Adverse Event|0|||
48673381|NCT01918332|156657256|FG002|Overall Study|Adverse Event|0|||
48673382|NCT01918332|156657257|FG003|Overall Study|Adverse Event|1|||
48972292|NCT00089999|157727872|FG000|Overall Study|Death|3|||
48972293|NCT00089999|157727873|FG001|Overall Study|Death|3|||
48972294|NCT00089999|157727872|FG000|Overall Study|Poor General Condition|1|||
48972295|NCT00089999|157727873|FG001|Overall Study|Poor General Condition|0|||
48972296|NCT00089999|157727872|FG000|Overall Study|Clinical Progression|1|||
48972297|NCT00089999|157727873|FG001|Overall Study|Clinical Progression|2|||
48972298|NCT00089999|157727872|FG000|Overall Study|Physician Decision|2|||
48972299|NCT00089999|157727873|FG001|Overall Study|Physician Decision|2|||
48972300|NCT00089999|157727872|FG000|Overall Study|Patient Underwent Surgery|2|||
48972301|NCT00089999|157727873|FG001|Overall Study|Patient Underwent Surgery|0|||
48972302|NCT00089999|157727872|FG000|Overall Study|Skin Nodule Over Right Mastectomy|0|||
48972303|NCT00089999|157727873|FG001|Overall Study|Skin Nodule Over Right Mastectomy|1|||
48972304|NCT00996593|157727876|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7|||
48972305|NCT00996593|157727876|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3|||
48972306|NCT00996593|157727876|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|22|||
48972307|NCT00996593|157727876|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
48972308|NCT00996593|157727876|FG000|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6|||
48972309|NCT00996593|157727876|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3|||
48972310|NCT00996593|157727876|FG000|Dosimetric and Therapeutic Treatment|Non-compliance|1|||
48972311|NCT00996593|157727876|FG000|Long-Term Follow-Up|Withdrawal by Subject|2|||
48972312|NCT00996593|157727876|FG000|Long-Term Follow-Up|Site Closed|1|||
48972313|NCT00719537|157727879|FG000|Overall Study|Withdrawal by Subject|1|||
48972314|NCT00719537|157727880|FG001|Overall Study|Withdrawal by Subject|0|||
48972315|NCT00719537|157727879|FG000|Overall Study|Lost to Follow-up|0|||
48972316|NCT00719537|157727880|FG001|Overall Study|Lost to Follow-up|1|||
48972317|NCT02460978|157727881|FG000|Overall Study|Adverse Event|17|||
48972318|NCT02460978|157727882|FG001|Overall Study|Adverse Event|11|||
48972319|NCT02460978|157727883|FG002|Overall Study|Adverse Event|11|||
48972320|NCT02460978|157727881|FG000|Overall Study|Withdrawal by Subject|5|||
48972321|NCT02460978|157727882|FG001|Overall Study|Withdrawal by Subject|5|||
48972322|NCT02460978|157727883|FG002|Overall Study|Withdrawal by Subject|14|||
48673383|NCT01918332|156657254|FG000|Overall Study|Withdrawal by Subject|2|||
48673384|NCT01918332|156657255|FG001|Overall Study|Withdrawal by Subject|3|||
48673385|NCT01918332|156657256|FG002|Overall Study|Withdrawal by Subject|2|||
48673386|NCT01918332|156657257|FG003|Overall Study|Withdrawal by Subject|3|||
48972323|NCT02460978|157727881|FG000|Overall Study|Lost to Follow-up|2|||
48972324|NCT02460978|157727882|FG001|Overall Study|Lost to Follow-up|3|||
48673387|NCT01918332|156657254|FG000|Overall Study|Protocol Violation|6|||
48673388|NCT01918332|156657255|FG001|Overall Study|Protocol Violation|2|||
48972325|NCT02460978|157727883|FG002|Overall Study|Lost to Follow-up|1|||
48972326|NCT02460978|157727881|FG000|Overall Study|Protocol Violation|1|||
48972327|NCT02460978|157727882|FG001|Overall Study|Protocol Violation|1|||
48873012|NCT02781311|157371896|FG002|Overall Study|Lost to Follow-up|1|||
48873013|NCT02781311|157371894|FG000|Overall Study|Non-Compliance with Study Drug|2|||
48873014|NCT02781311|157371895|FG001|Overall Study|Non-Compliance with Study Drug|0|||
48873015|NCT02781311|157371896|FG002|Overall Study|Non-Compliance with Study Drug|0|||
48873016|NCT02394665|157371897|FG000|Overall Study|Physician Decision|1|||
48873017|NCT02394665|157371898|FG001|Overall Study|Physician Decision|0|||
48873018|NCT02394665|157371899|FG002|Overall Study|Physician Decision|0|||
48972328|NCT02460978|157727883|FG002|Overall Study|Protocol Violation|1|||
48972329|NCT02460978|157727881|FG000|Overall Study|Discontinued due to DKA/hypoglycemia|2|||
48972330|NCT02460978|157727882|FG001|Overall Study|Discontinued due to DKA/hypoglycemia|5|||
48972331|NCT02460978|157727883|FG002|Overall Study|Discontinued due to DKA/hypoglycemia|4|||
48972332|NCT02460978|157727881|FG000|Overall Study|Pregnancy|0|||
48972333|NCT02460978|157727882|FG001|Overall Study|Pregnancy|0|||
48972334|NCT02460978|157727883|FG002|Overall Study|Pregnancy|2|||
48972335|NCT00045630|157727884|FG000|Overall Study|Adverse Event|1|||
48972336|NCT00045630|157727884|FG000|Overall Study|Refusal unrelated to adverse event|1|||
48972337|NCT00045630|157727884|FG000|Overall Study|Progression/relapse|1|||
48972338|NCT00045630|157727884|FG000|Overall Study|Death|1|||
48972339|NCT00045630|157727884|FG000|Overall Study|Ineligible|2|||
48972340|NCT00994162|157727885|FG000|Overall Study|Withdrawal by Subject|1|||
48972341|NCT00994162|157727885|FG000|Overall Study|Lost to Follow-up|2|||
48972342|NCT00994162|157727885|FG000|Overall Study|Product Complaint|1|||
48972343|NCT00994162|157727885|FG000|Overall Study|Poor Compliance|5|||
48972344|NCT00994162|157727885|FG000|Overall Study|Lack of Response|3|||
48972345|NCT00994162|157727885|FG000|Overall Study|Discharged from Hospital|4|||
48972346|NCT00994162|157727885|FG000|Overall Study|Death|2|||
48972347|NCT00994162|157727885|FG000|Overall Study|Care Transferred to Another Physician|2|||
48972348|NCT00994162|157727885|FG000|Overall Study|Discontinued and Changed to Iodoflex|1|||
48972349|NCT00994162|157727885|FG000|Overall Study|Physician Decision|2|||
48972350|NCT00994162|157727885|FG000|Overall Study|Surrounding Wound Erythematous|1|||
48972351|NCT00994162|157727885|FG000|Overall Study|Machine Losing Vaccum|1|||
48972352|NCT00994162|157727885|FG000|Overall Study|Patient Lived Too Far Away|1|||
48972353|NCT00994162|157727885|FG000|Overall Study|Above Knee Amputation|1|||
48972354|NCT00994162|157727885|FG000|Overall Study|Reason Not Reported By Site|1|||
48972355|NCT01142193|157727886|FG000|Overall Study|Adverse Event|12|||
48972356|NCT01142193|157727887|FG001|Overall Study|Adverse Event|4|||
48673389|NCT01918332|156657256|FG002|Overall Study|Protocol Violation|6|||
48673390|NCT01918332|156657257|FG003|Overall Study|Protocol Violation|3|||
48673391|NCT01918332|156657254|FG000|Overall Study|lipid result by central lab did not meet|0|||
48673392|NCT01918332|156657255|FG001|Overall Study|lipid result by central lab did not meet|0|||
48873019|NCT00815919|157371900|FG000|Overall Study|Unrelated Fungal Infection|1|||
48972357|NCT01142193|157727886|FG000|Overall Study|Lack of Efficacy|2|||
48972358|NCT01142193|157727887|FG001|Overall Study|Lack of Efficacy|1|||
48972359|NCT01142193|157727886|FG000|Overall Study|Physician Decision|1|||
48673393|NCT01918332|156657256|FG002|Overall Study|lipid result by central lab did not meet|1|||
48673394|NCT01918332|156657257|FG003|Overall Study|lipid result by central lab did not meet|0|||
48673395|NCT02408523|156657258|FG000|Overall Study|Adverse Event|4|||
48673396|NCT02408523|156657259|FG001|Overall Study|Adverse Event|10|||
48673397|NCT02408523|156657258|FG000|Overall Study|Lack of Efficacy|0|||
48673398|NCT02408523|156657259|FG001|Overall Study|Lack of Efficacy|1|||
48673399|NCT02408523|156657258|FG000|Overall Study|Protocol Violation|1|||
48673400|NCT02408523|156657259|FG001|Overall Study|Protocol Violation|2|||
48673401|NCT02408523|156657258|FG000|Overall Study|Lost to Follow-up|2|||
48673402|NCT02408523|156657259|FG001|Overall Study|Lost to Follow-up|3|||
48673403|NCT02408523|156657258|FG000|Overall Study|Withdrawal by Subject|3|||
48673404|NCT02408523|156657259|FG001|Overall Study|Withdrawal by Subject|1|||
48673405|NCT02408523|156657258|FG000|Overall Study|Sponsor request|1|||
48673406|NCT02408523|156657259|FG001|Overall Study|Sponsor request|0|||
48673407|NCT02408523|156657258|FG000|Overall Study|Did not satisfy extension conditions|0|||
48673408|NCT02408523|156657259|FG001|Overall Study|Did not satisfy extension conditions|1|||
48673409|NCT01549873|156657260|FG000|Overall Study|Physician Decision|0|||
48673410|NCT01549873|156657261|FG001|Overall Study|Physician Decision|1|||
48673411|NCT02943915|156657262|FG000|Overall Study|Withdrawal by Subject|2|||
48673412|NCT02943915|156657263|FG001|Overall Study|Withdrawal by Subject|1|||
48673413|NCT02943915|156657264|FG002|Overall Study|Withdrawal by Subject|0|||
48673414|NCT02943915|156657265|FG003|Overall Study|Withdrawal by Subject|0|||
48673415|NCT02943915|156657262|FG000|Overall Study|Lost to Follow-up|3|||
48673416|NCT02943915|156657263|FG001|Overall Study|Lost to Follow-up|1|||
48972360|NCT01142193|157727887|FG001|Overall Study|Physician Decision|1|||
48972361|NCT01142193|157727886|FG000|Overall Study|Withdrawal by Subject|4|||
48972362|NCT01142193|157727887|FG001|Overall Study|Withdrawal by Subject|3|||
48972363|NCT01142193|157727886|FG000|Overall Study|Protocol Discontinuation Criterion Met|1|||
48972364|NCT01142193|157727887|FG001|Overall Study|Protocol Discontinuation Criterion Met|0|||
48972365|NCT01142193|157727886|FG000|Overall Study|Other|1|||
48972366|NCT01142193|157727887|FG001|Overall Study|Other|2|||
48972367|NCT03549429|157727891|FG000|Overall Study|Protocol Violation|5|||
48972368|NCT03549429|157727892|FG001|Overall Study|Protocol Violation|3|||
48972369|NCT00924729|157727893|FG000|Overall Study|insufficient volume for analysis|1|||
48972370|NCT00924729|157727894|FG001|Overall Study|insufficient volume for analysis|0|||
48972371|NCT00924729|157727893|FG000|Overall Study|Protocol Violation|1|||
48972372|NCT00924729|157727894|FG001|Overall Study|Protocol Violation|0|||
48972373|NCT00493467|157727897|FG000|Overall Study|Death|1|||
48972374|NCT00282867|157727898|FG000|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
48972375|NCT00282867|157727899|FG001|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
48972376|NCT00282867|157727900|FG002|Overall Study|d/c prior to prim outcome, 3 m f/u done|0|||
48972377|NCT00802867|157727901|FG000|Overall Study|Lost to Follow-up|6|||
48972378|NCT00802867|157727901|FG000|Overall Study|Protocol Violation|6|||
48972379|NCT00802867|157727901|FG000|Overall Study|Withdrawal by Subject|1|||
48972380|NCT00588523|157727902|FG000|Overall Study|Not treated|3|||
48972381|NCT01015820|157727903|FG000|Overall Study|Suboptimal measurements|1|||
48972382|NCT01015820|157727904|FG001|Overall Study|Suboptimal measurements|0|||
48972383|NCT00701441|157727905|FG000|Overall Study|failure in cpap compliance|0|||
48972384|NCT00701441|157727906|FG001|Overall Study|failure in cpap compliance|4|||
48972385|NCT00669032|157727909|FG000|Overall Study|Lost to Follow-up|6|||
48972386|NCT00669032|157727910|FG001|Overall Study|Lost to Follow-up|5|||
48972387|NCT00669032|157727909|FG000|Overall Study|Lack of Efficacy|8|||
48972388|NCT00669032|157727910|FG001|Overall Study|Lack of Efficacy|19|||
48972389|NCT00669032|157727909|FG000|Overall Study|Withdrawal by Subject|12|||
48972390|NCT00669032|157727910|FG001|Overall Study|Withdrawal by Subject|13|||
48972391|NCT00669032|157727909|FG000|Overall Study|Adverse Event|12|||
48972392|NCT00669032|157727910|FG001|Overall Study|Adverse Event|16|||
48972393|NCT00669032|157727909|FG000|Overall Study|Physician Decision|1|||
48972394|NCT00669032|157727910|FG001|Overall Study|Physician Decision|1|||
48972395|NCT00669032|157727909|FG000|Overall Study|No fulfilment of the selection criteria|5|||
48972396|NCT00669032|157727910|FG001|Overall Study|No fulfilment of the selection criteria|5|||
48972397|NCT02420795|157729641|FG000|Overall Study|Withdrawal by Subject|1|||
48972398|NCT02420795|157729642|FG001|Overall Study|Withdrawal by Subject|0|||
48972399|NCT02420795|157729643|FG002|Overall Study|Withdrawal by Subject|0|||
48972400|NCT02420795|157729641|FG000|Overall Study|Adverse Event|1|||
48972401|NCT02420795|157729642|FG001|Overall Study|Adverse Event|0|||
48972402|NCT02420795|157729643|FG002|Overall Study|Adverse Event|0|||
48673417|NCT02943915|156657264|FG002|Overall Study|Lost to Follow-up|0|||
48972403|NCT02420795|157729641|FG000|Overall Study|Progressive disease|2|||
48972404|NCT02420795|157729642|FG001|Overall Study|Progressive disease|2|||
48972405|NCT02420795|157729643|FG002|Overall Study|Progressive disease|4|||
48972406|NCT02420795|157729641|FG000|Overall Study|Death|0|||
48972407|NCT02420795|157729642|FG001|Overall Study|Death|0|||
48972408|NCT02420795|157729643|FG002|Overall Study|Death|1|||
48972409|NCT01827319|157729644|FG000|Overall Study|Lost to Follow-up|3|||
48972410|NCT01494987|157729646|FG000|Overall Study|Adverse Event|6|||
48972411|NCT01494987|157729647|FG001|Overall Study|Adverse Event|5|||
48972412|NCT01494987|157729646|FG000|Overall Study|Hyperglycemia|6|||
48972413|NCT01494987|157729647|FG001|Overall Study|Hyperglycemia|4|||
48972414|NCT01494987|157729646|FG000|Overall Study|Investigator's Discretion|1|||
48972415|NCT01494987|157729647|FG001|Overall Study|Investigator's Discretion|2|||
48972416|NCT01494987|157729646|FG000|Overall Study|Lost to Follow-up|1|||
48972417|NCT01494987|157729647|FG001|Overall Study|Lost to Follow-up|1|||
48972418|NCT01494987|157729646|FG000|Overall Study|Protocol Violation|3|||
48972419|NCT01494987|157729647|FG001|Overall Study|Protocol Violation|3|||
48972420|NCT01494987|157729646|FG000|Overall Study|Subject Non-Compliance|9|||
48972421|NCT01494987|157729647|FG001|Overall Study|Subject Non-Compliance|10|||
48972422|NCT01494987|157729646|FG000|Overall Study|Subject Withdrew Consent|2|||
48972423|NCT01494987|157729647|FG001|Overall Study|Subject Withdrew Consent|3|||
48972424|NCT00510484|157729656|FG000|Wash-out Period|Adverse Event|0|||
48972425|NCT00510484|157729657|FG001|Wash-out Period|Adverse Event|1|||
48972426|NCT00712933|157729661|FG000|Overall Study|Adverse Event|69|||
48972427|NCT00712933|157729661|FG000|Overall Study|Lack of Efficacy|6|||
48972428|NCT00712933|157729661|FG000|Overall Study|Lost to Follow-up|22|||
48972429|NCT00712933|157729661|FG000|Overall Study|Non-compliance with study drug|13|||
48972430|NCT00712933|157729661|FG000|Overall Study|Other Pregnancy|37|||
48673418|NCT02943915|156657265|FG003|Overall Study|Lost to Follow-up|0|||
48673419|NCT02943915|156657262|FG000|Overall Study|excluded|0|||
48972431|NCT00712933|157729661|FG000|Overall Study|Sponsor decision|14|||
48972432|NCT00712933|157729661|FG000|Overall Study|Withdrew consent|4|||
48972433|NCT00712933|157729661|FG000|Overall Study|Hip replacement surgery|1|||
48972434|NCT00712933|157729661|FG000|Overall Study|Involved in Clinical research|3|||
48972435|NCT00712933|157729661|FG000|Overall Study|Participant hospitalized|1|||
48972436|NCT00712933|157729661|FG000|Overall Study|Participant travelled overseas|2|||
48972437|NCT00712933|157729661|FG000|Overall Study|Death of patient|1|||
48972438|NCT00712933|157729661|FG000|Overall Study|Other Physician decision|1|||
48972439|NCT00712933|157729661|FG000|Overall Study|Not committed to contraception|1|||
48972440|NCT00712933|157729661|FG000|Overall Study|Participant received medication|1|||
48972441|NCT00712933|157729661|FG000|Overall Study|Physician Decision|36|||
48972442|NCT00712933|157729661|FG000|Overall Study|Protocol Violation|4|||
48972443|NCT00712933|157729661|FG000|Overall Study|Withdrawal by Subject|151|||
48972444|NCT00443846|157729662|FG000|Overall Study|Withdrawn due to intercurrent disease|1|||
48972445|NCT00443846|157729663|FG001|Overall Study|Withdrawn due to intercurrent disease|0|||
48972446|NCT00443846|157729662|FG000|Overall Study|Not vaccinated, no blood sample drawn|1|||
48972447|NCT00443846|157729663|FG001|Overall Study|Not vaccinated, no blood sample drawn|0|||
48972448|NCT00443846|157729662|FG000|Overall Study|Adverse Event|0|||
48673420|NCT02943915|156657263|FG001|Overall Study|excluded|1|||
48673421|NCT02943915|156657264|FG002|Overall Study|excluded|0|||
48673422|NCT02943915|156657265|FG003|Overall Study|excluded|0|||
48673423|NCT02252965|156657268|FG000|Overall Study|Adverse Event|9|||
48673424|NCT02252965|156657269|FG001|Overall Study|Adverse Event|14|||
48673425|NCT02252965|156657268|FG000|Overall Study|Lost to Follow-up|16|||
48673426|NCT02252965|156657269|FG001|Overall Study|Lost to Follow-up|8|||
48673427|NCT02252965|156657268|FG000|Overall Study|Protocol Violation|4|||
48673428|NCT02252965|156657269|FG001|Overall Study|Protocol Violation|5|||
48673429|NCT02252965|156657268|FG000|Overall Study|Lack of Efficacy|0|||
48673430|NCT02252965|156657269|FG001|Overall Study|Lack of Efficacy|2|||
48673431|NCT02252965|156657268|FG000|Overall Study|Withdrawal by Subject|7|||
48673432|NCT02252965|156657269|FG001|Overall Study|Withdrawal by Subject|9|||
48673433|NCT02252965|156657268|FG000|Overall Study|Other|4|||
48673434|NCT02252965|156657269|FG001|Overall Study|Other|5|||
48673435|NCT01068769|156657274|FG000|Overall Study|Ineligible|1|||
48673436|NCT01276223|156657276|FG000|Overall Study|Adverse Event|7|||
48673437|NCT01276223|156657277|FG001|Overall Study|Adverse Event|4|||
48673438|NCT01276223|156657278|FG002|Overall Study|Adverse Event|1|||
48673439|NCT01276223|156657276|FG000|Overall Study|Lost to Follow-up|0|||
48673440|NCT01276223|156657277|FG001|Overall Study|Lost to Follow-up|0|||
48673441|NCT01276223|156657278|FG002|Overall Study|Lost to Follow-up|1|||
48673442|NCT01276223|156657276|FG000|Overall Study|Other|0|||
48673443|NCT01276223|156657277|FG001|Overall Study|Other|0|||
48673444|NCT01276223|156657278|FG002|Overall Study|Other|1|||
48673445|NCT01276223|156657276|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|3|||
48673446|NCT01276223|156657277|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
48673447|NCT01276223|156657278|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
48673448|NCT01276223|156657276|FG000|Overall Study|Protocol Violation|1|||
48673449|NCT01276223|156657277|FG001|Overall Study|Protocol Violation|0|||
48673450|NCT01276223|156657278|FG002|Overall Study|Protocol Violation|0|||
48673451|NCT02702414|156657279|FG000|Overall Study|Death|96|||
48673452|NCT02702414|156657280|FG001|Overall Study|Death|42|||
48673453|NCT02702414|156657279|FG000|Overall Study|Lost to Follow-up|0|||
48673454|NCT02702414|156657280|FG001|Overall Study|Lost to Follow-up|1|||
48972449|NCT00443846|157729663|FG001|Overall Study|Adverse Event|1|||
48972450|NCT00443846|157729662|FG000|Overall Study|Personal reason|8|||
48972451|NCT00443846|157729663|FG001|Overall Study|Personal reason|3|||
48972452|NCT00443846|157729662|FG000|Overall Study|Lost to Follow-up|1|||
48972453|NCT00443846|157729663|FG001|Overall Study|Lost to Follow-up|2|||
48972454|NCT01329341|157729664|FG000|Overall Study|Withdrawal by Subject|44|||
48972455|NCT02988219|157729667|FG000|Overall Study|Lack of Efficacy|1|||
48972456|NCT02988219|157729668|FG001|Overall Study|Lack of Efficacy|1|||
48972457|NCT02988219|157729667|FG000|Overall Study|Withdrawal by Subject|0|||
48972458|NCT02988219|157729668|FG001|Overall Study|Withdrawal by Subject|2|||
48673455|NCT02702414|156657279|FG000|Overall Study|Withdrawal by Subject|0|||
48673456|NCT02702414|156657280|FG001|Overall Study|Withdrawal by Subject|1|||
48673457|NCT02702414|156657279|FG000|Overall Study|Protocol Violation|1|||
48673458|NCT02702414|156657280|FG001|Overall Study|Protocol Violation|0|||
48673459|NCT02702414|156657279|FG000|Overall Study|Sponsor Decision|8|||
48673460|NCT02702414|156657280|FG001|Overall Study|Sponsor Decision|7|||
48673461|NCT00802893|156657284|FG000|Overall Study|study terminated|3|||
48673462|NCT02868229|156657285|FG000|Overall Study|Adverse Event|1|||
48673463|NCT02868229|156657286|FG001|Overall Study|Adverse Event|0|||
48673464|NCT02868229|156657287|FG002|Overall Study|Adverse Event|0|||
48972459|NCT00105183|157729671|FG000|Overall Study|Death|19|||
48972460|NCT00105183|157729672|FG001|Overall Study|Death|13|||
48673465|NCT02868229|156657288|FG003|Overall Study|Adverse Event|1|||
48673466|NCT02868229|156657285|FG000|Overall Study|Death|0|||
48673467|NCT02868229|156657286|FG001|Overall Study|Death|0|||
48673468|NCT02868229|156657287|FG002|Overall Study|Death|1|||
48673469|NCT02868229|156657288|FG003|Overall Study|Death|1|||
48673470|NCT02868229|156657285|FG000|Overall Study|Missed dose|0|||
48673471|NCT02868229|156657286|FG001|Overall Study|Missed dose|0|||
48673472|NCT02868229|156657287|FG002|Overall Study|Missed dose|0|||
48673473|NCT02868229|156657288|FG003|Overall Study|Missed dose|3|||
48673474|NCT01113580|156657289|FG000|Overall Study|Protocol Violation|1|||
48673475|NCT01113580|156657290|FG001|Overall Study|Protocol Violation|0|||
48673476|NCT00320424|156657291|FG000|Overall Study|Adverse Event|3|||
48673477|NCT00320424|156657291|FG000|Overall Study|Other|3|||
48673478|NCT02337634|156657296|FG000|Overall Study|Protocol Violation|3|||
48673479|NCT02337634|156657297|FG001|Overall Study|Protocol Violation|1|||
48972461|NCT00105183|157729673|FG002|Overall Study|Death|15|||
48761151|NCT02337907|156974016|FG003|Overall Study|Other than listed|1|||
48761152|NCT02337907|156974017|FG004|Overall Study|Other than listed|1|||
48761153|NCT02337907|156974018|FG005|Overall Study|Other than listed|0|||
48761154|NCT02337907|156974013|FG000|Overall Study|Withdrawal by Subject|2|||
48761155|NCT02337907|156974014|FG001|Overall Study|Withdrawal by Subject|3|||
48761156|NCT02337907|156974015|FG002|Overall Study|Withdrawal by Subject|0|||
48761157|NCT02337907|156974016|FG003|Overall Study|Withdrawal by Subject|2|||
48761158|NCT02337907|156974017|FG004|Overall Study|Withdrawal by Subject|5|||
48761159|NCT02337907|156974018|FG005|Overall Study|Withdrawal by Subject|0|||
48761160|NCT02337907|156974013|FG000|Overall Study|Lost to Follow-up|0|||
48873020|NCT00815919|157371900|FG000|Overall Study|AML Relapse|1|||
48673480|NCT02337634|156657296|FG000|Overall Study|Lost to Follow-up|1|||
48673481|NCT02337634|156657297|FG001|Overall Study|Lost to Follow-up|0|||
48673482|NCT03422536|156657300|FG000|Randomized|Physician Decision|1|||
48673483|NCT03422536|156657301|FG001|Randomized|Physician Decision|1|||
48673484|NCT03422536|156657300|FG000|Allocation - Received Intervention|Disease progression|19|||
48673485|NCT03422536|156657301|FG001|Allocation - Received Intervention|Disease progression|25|||
48673486|NCT03422536|156657300|FG000|Allocation - Received Intervention|Death|1|||
48673487|NCT03422536|156657301|FG001|Allocation - Received Intervention|Death|3|||
48673488|NCT03422536|156657300|FG000|Allocation - Received Intervention|Adverse Event|1|||
48673489|NCT03422536|156657301|FG001|Allocation - Received Intervention|Adverse Event|0|||
48673490|NCT03422536|156657300|FG000|Allocation - Received Intervention|Physician Decision|1|||
48673491|NCT03422536|156657301|FG001|Allocation - Received Intervention|Physician Decision|1|||
48673492|NCT03422536|156657300|FG000|Allocation - Received Intervention|Withdrawal by Subject|3|||
48673493|NCT03422536|156657301|FG001|Allocation - Received Intervention|Withdrawal by Subject|2|||
48673494|NCT03422536|156657300|FG000|Allocation - Received Intervention|Lost to Follow-up|1|||
48673495|NCT03422536|156657301|FG001|Allocation - Received Intervention|Lost to Follow-up|0|||
48673496|NCT01818284|156657302|FG000|Overall Study|Not eligible due to White Blood Counts|4|||
48673497|NCT01818284|156657303|FG001|Overall Study|Not eligible due to White Blood Counts|4|||
48673498|NCT01818284|156657302|FG000|Overall Study|Death|0|||
48673499|NCT01818284|156657303|FG001|Overall Study|Death|2|||
48673500|NCT00527319|156657305|FG000|Overall Study|Withdrawal by Subject|5|||
48673501|NCT00527319|156657306|FG001|Overall Study|Withdrawal by Subject|0|||
48673502|NCT00527319|156657307|FG002|Overall Study|Withdrawal by Subject|1|||
48673503|NCT00527319|156657305|FG000|Overall Study|Lost to Follow-up|1|||
48673504|NCT00527319|156657306|FG001|Overall Study|Lost to Follow-up|0|||
48673505|NCT00527319|156657307|FG002|Overall Study|Lost to Follow-up|0|||
48673506|NCT00527319|156657305|FG000|Overall Study|Death|0|||
48673507|NCT00527319|156657306|FG001|Overall Study|Death|3|||
48673508|NCT00527319|156657307|FG002|Overall Study|Death|1|||
48673509|NCT00527319|156657305|FG000|Overall Study|Intercurrent Medical Illness|0|||
48673510|NCT00527319|156657306|FG001|Overall Study|Intercurrent Medical Illness|1|||
48673511|NCT00527319|156657307|FG002|Overall Study|Intercurrent Medical Illness|3|||
48673512|NCT00527319|156657305|FG000|Overall Study|Adverse Event|0|||
48673513|NCT00527319|156657306|FG001|Overall Study|Adverse Event|0|||
48673514|NCT00527319|156657307|FG002|Overall Study|Adverse Event|1|||
48673515|NCT02690649|156657308|FG000|Overall Study|Withdrawal by Subject|1|||
48673516|NCT02690649|156657309|FG001|Overall Study|Withdrawal by Subject|1|||
48673517|NCT02690649|156657308|FG000|Overall Study|Protocol Violation|0|||
48673518|NCT02690649|156657309|FG001|Overall Study|Protocol Violation|3|||
48673519|NCT02335424|156657310|FG000|Overall Study|Withdrawal by Subject|19|||
48673520|NCT02335424|156657310|FG000|Overall Study|Adverse Event|25|||
48673521|NCT02335424|156657310|FG000|Overall Study|Death|273|||
48673522|NCT02335424|156657310|FG000|Overall Study|Lost to Follow-up|3|||
48673523|NCT02335424|156657310|FG000|Overall Study|Physician Decision|13|||
48673524|NCT02335424|156657310|FG000|Overall Study|Participation in study terminated by Sponsor|39|||
48673525|NCT02335424|156657310|FG000|Overall Study|Protocol Violation|1|||
48673526|NCT02335424|156657310|FG000|Overall Study|Screen failure|1|||
48673527|NCT02294734|156657311|FG000|Overall Study|Adverse Event|5|||
48673528|NCT02294734|156657312|FG001|Overall Study|Adverse Event|5|||
48673529|NCT02294734|156657311|FG000|Overall Study|Met Protocol Defined Stopping Criteria|1|||
48673530|NCT02294734|156657312|FG001|Overall Study|Met Protocol Defined Stopping Criteria|0|||
48673531|NCT02294734|156657311|FG000|Overall Study|Lost to Follow-up|2|||
48673532|NCT02294734|156657312|FG001|Overall Study|Lost to Follow-up|0|||
48673533|NCT02294734|156657311|FG000|Overall Study|Physician Decision|2|||
48673534|NCT02294734|156657312|FG001|Overall Study|Physician Decision|1|||
48673535|NCT02294734|156657311|FG000|Overall Study|Withdrawal by Subject|4|||
48673536|NCT02294734|156657312|FG001|Overall Study|Withdrawal by Subject|2|||
48673537|NCT01422824|156657313|FG000|Overall Study|Case record form not evaluated|1|||
48673538|NCT01422824|156657313|FG000|Overall Study|Lost to Follow-up|37|||
48673539|NCT00551291|156657315|FG000|Overall Study|Physician Decision|1|||
48673540|NCT01375608|156657317|FG000|Overall Study|Withdrawal by Subject|2|||
48673541|NCT04405245|156657318|FG000|Overall Study|Adverse Event|0|||
48673542|NCT04405245|156657319|FG001|Overall Study|Adverse Event|1|||
48673543|NCT04405245|156657320|FG002|Overall Study|Adverse Event|0|||
48761161|NCT02337907|156974014|FG001|Overall Study|Lost to Follow-up|0|||
48761162|NCT02337907|156974015|FG002|Overall Study|Lost to Follow-up|0|||
48761163|NCT02337907|156974016|FG003|Overall Study|Lost to Follow-up|0|||
48761164|NCT02337907|156974017|FG004|Overall Study|Lost to Follow-up|0|||
48761165|NCT02337907|156974018|FG005|Overall Study|Lost to Follow-up|1|||
48761166|NCT02337907|156974013|FG000|Overall Study|Adverse Event|1|||
48761167|NCT02337907|156974014|FG001|Overall Study|Adverse Event|1|||
48761168|NCT02337907|156974015|FG002|Overall Study|Adverse Event|1|||
48761169|NCT02337907|156974016|FG003|Overall Study|Adverse Event|1|||
48761170|NCT02337907|156974017|FG004|Overall Study|Adverse Event|4|||
48761171|NCT02337907|156974018|FG005|Overall Study|Adverse Event|0|||
48761172|NCT02141997|156974019|FG000|Overall Study|Adverse Event|0|||
48761173|NCT02141997|156974020|FG001|Overall Study|Adverse Event|2|||
48761174|NCT02141997|156974021|FG002|Overall Study|Adverse Event|0|||
48761175|NCT02141997|156974022|FG003|Overall Study|Adverse Event|1|||
48761176|NCT02141997|156974019|FG000|Overall Study|Participant noncompliance|1|||
48761177|NCT02141997|156974020|FG001|Overall Study|Participant noncompliance|0|||
48761178|NCT02141997|156974021|FG002|Overall Study|Participant noncompliance|0|||
48761179|NCT02141997|156974022|FG003|Overall Study|Participant noncompliance|0|||
48761180|NCT02141997|156974019|FG000|Overall Study|Withdrew consent|1|||
48761181|NCT02141997|156974020|FG001|Overall Study|Withdrew consent|0|||
48761182|NCT02141997|156974021|FG002|Overall Study|Withdrew consent|3|||
48761183|NCT02141997|156974022|FG003|Overall Study|Withdrew consent|0|||
48761184|NCT02141997|156974019|FG000|Overall Study|Other|1|||
48761185|NCT02141997|156974020|FG001|Overall Study|Other|4|||
48873021|NCT00815919|157371900|FG000|Overall Study|Lack of Efficacy|2|||
48873022|NCT00546078|157371901|FG000|Overall Study|Lost to Follow-up|1|||
48873023|NCT00546078|157371902|FG001|Overall Study|Lost to Follow-up|3|||
48873024|NCT00546078|157371901|FG000|Overall Study|Withdrawal by Subject|2|||
48873025|NCT00546078|157371902|FG001|Overall Study|Withdrawal by Subject|3|||
48873026|NCT00546078|157371901|FG000|Overall Study|Other reason|1|||
48873027|NCT00546078|157371902|FG001|Overall Study|Other reason|1|||
48873028|NCT00604188|157371903|FG000|Overall Study|Adverse Event|1|||
48873029|NCT00604188|157371904|FG001|Overall Study|Adverse Event|4|||
48873030|NCT00604188|157371903|FG000|Overall Study|Lost to Follow-up|17|||
48873031|NCT00604188|157371904|FG001|Overall Study|Lost to Follow-up|15|||
48873032|NCT00604188|157371903|FG000|Overall Study|Withdrawal by Subject|5|||
48873033|NCT00604188|157371904|FG001|Overall Study|Withdrawal by Subject|1|||
48873034|NCT00604188|157371903|FG000|Overall Study|Non-compliance with protocol|4|||
48873035|NCT00604188|157371904|FG001|Overall Study|Non-compliance with protocol|4|||
48873036|NCT00604188|157371903|FG000|Overall Study|Did not receive study drug|0|||
48873037|NCT00604188|157371904|FG001|Overall Study|Did not receive study drug|1|||
48873038|NCT01431950|157371906|FG000|Overall Study|Study Site Closed/Terminated|7|||
48873039|NCT01431950|157371907|FG001|Overall Study|Study Site Closed/Terminated|3|||
48873040|NCT01431950|157371906|FG000|Overall Study|Withdrawal by Subject|4|||
48873041|NCT01431950|157371907|FG001|Overall Study|Withdrawal by Subject|3|||
48873042|NCT01431950|157371906|FG000|Overall Study|Protocol Violation|2|||
48873043|NCT01431950|157371907|FG001|Overall Study|Protocol Violation|3|||
48873044|NCT01431950|157371906|FG000|Overall Study|Adverse Event|2|||
48873045|NCT01431950|157371907|FG001|Overall Study|Adverse Event|2|||
48873046|NCT01431950|157371906|FG000|Overall Study|Physician Decision|2|||
48873047|NCT01431950|157371907|FG001|Overall Study|Physician Decision|1|||
48873048|NCT01431950|157371906|FG000|Overall Study|Lack of Efficacy|2|||
48873049|NCT01431950|157371907|FG001|Overall Study|Lack of Efficacy|1|||
48873050|NCT01431950|157371906|FG000|Overall Study|Lost to Follow-up|0|||
48873051|NCT01431950|157371907|FG001|Overall Study|Lost to Follow-up|1|||
48873052|NCT01431950|157371906|FG000|Overall Study|Met Protocol-defined Stopping Criteria|0|||
48873053|NCT01431950|157371907|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
48873054|NCT02101983|157371908|FG000|Overall Study|Physician Decision|1|||
48873055|NCT02101983|157371909|FG001|Overall Study|Physician Decision|0|||
48873056|NCT02592707|157371914|FG000|Overall Study|Consent Withdrawn|0|||
48873057|NCT02592707|157371915|FG001|Overall Study|Consent Withdrawn|1|||
48873058|NCT02592707|157371916|FG002|Overall Study|Consent Withdrawn|2|||
48873059|NCT02592707|157371917|FG003|Overall Study|Consent Withdrawn|0|||
48873060|NCT02592707|157371914|FG000|Overall Study|Death|1|||
48873061|NCT02592707|157371915|FG001|Overall Study|Death|0|||
48873062|NCT02592707|157371916|FG002|Overall Study|Death|0|||
48873063|NCT02592707|157371917|FG003|Overall Study|Death|0|||
48873064|NCT02592707|157371914|FG000|Overall Study|Progressive Disease|4|||
48873065|NCT02592707|157371915|FG001|Overall Study|Progressive Disease|4|||
48873066|NCT02592707|157371916|FG002|Overall Study|Progressive Disease|3|||
48873067|NCT02592707|157371917|FG003|Overall Study|Progressive Disease|3|||
48873068|NCT02592707|157371914|FG000|Overall Study|Other|0|||
48873069|NCT02592707|157371915|FG001|Overall Study|Other|0|||
48873070|NCT02592707|157371916|FG002|Overall Study|Other|1|||
48873071|NCT02592707|157371917|FG003|Overall Study|Other|2|||
48873072|NCT02592707|157371914|FG000|Overall Study|Never entered LTFU period|1|||
48873073|NCT02592707|157371915|FG001|Overall Study|Never entered LTFU period|0|||
48873074|NCT02592707|157371916|FG002|Overall Study|Never entered LTFU period|0|||
48873075|NCT02592707|157371917|FG003|Overall Study|Never entered LTFU period|2|||
48873076|NCT04124471|157371918|FG000|Overall Study|screen failure|1|||
48972462|NCT00105183|157729671|FG000|Overall Study|Withdrawal by Subject|1|||
48972463|NCT00105183|157729672|FG001|Overall Study|Withdrawal by Subject|1|||
48972464|NCT00105183|157729673|FG002|Overall Study|Withdrawal by Subject|4|||
48972465|NCT00105183|157729671|FG000|Overall Study|Physician Decision|1|||
48972466|NCT00105183|157729672|FG001|Overall Study|Physician Decision|2|||
48972467|NCT00105183|157729673|FG002|Overall Study|Physician Decision|3|||
48972468|NCT00105183|157729671|FG000|Overall Study|Lost to Follow-up|0|||
48972469|NCT00105183|157729672|FG001|Overall Study|Lost to Follow-up|1|||
48972470|NCT00105183|157729673|FG002|Overall Study|Lost to Follow-up|1|||
48972471|NCT00105183|157729671|FG000|Overall Study|Other reason|1|||
48972472|NCT00105183|157729672|FG001|Overall Study|Other reason|2|||
48972473|NCT00105183|157729673|FG002|Overall Study|Other reason|0|||
48972474|NCT00555568|157729675|FG000|Overall Study|Lost to Follow-up|26|||
48972475|NCT00555568|157729676|FG001|Overall Study|Lost to Follow-up|16|||
48673544|NCT03836677|156657321|FG000|Period 1|Adverse Event|0|||
48673545|NCT03836677|156657322|FG001|Period 1|Adverse Event|1|||
48673546|NCT03836677|156657321|FG000|Period 2|Severe non-compliance to protocol|1|||
48673547|NCT03836677|156657322|FG001|Period 2|Severe non-compliance to protocol|0|||
48673548|NCT01504204|156657329|FG000|Overall Study|Lost to Follow-up|1|||
48673549|NCT01504204|156657330|FG001|Overall Study|Lost to Follow-up|1|||
48673550|NCT03689855|156657334|FG000|Overall Study|Adverse Event|3|||
48673551|NCT03689855|156657334|FG000|Overall Study|Withdrawal by Subject|1|||
48673552|NCT03178669|156657341|FG000|Overall Study|Adverse Event|4|||
48673553|NCT03178669|156657342|FG001|Overall Study|Adverse Event|1|||
48673554|NCT03178669|156657343|FG002|Overall Study|Adverse Event|4|||
48873077|NCT00719212|157373270|FG000|Overall Study|Death|41|||
48873078|NCT00719212|157373270|FG000|Overall Study|Lost to Follow-up|2|||
48873079|NCT00719212|157373270|FG000|Overall Study|Withdrawal by Subject|1|||
48873080|NCT00197106|157373271|FG000|4-Week Run-In Period|Did not meet entry criteria|99|||
48873081|NCT00197106|157373272|FG001|4-Week Run-In Period|Did not meet entry criteria|0|||
48873082|NCT00197106|157373273|FG002|4-Week Run-In Period|Did not meet entry criteria|0|||
48873083|NCT00197106|157373271|FG000|Overall Treatment Period|Lack of Efficacy|0|||
48873084|NCT00197106|157373272|FG001|Overall Treatment Period|Lack of Efficacy|1|||
48873085|NCT00197106|157373273|FG002|Overall Treatment Period|Lack of Efficacy|0|||
48873086|NCT00197106|157373271|FG000|Overall Treatment Period|Lost to Follow-up|0|||
48873087|NCT00197106|157373272|FG001|Overall Treatment Period|Lost to Follow-up|0|||
48873088|NCT00197106|157373273|FG002|Overall Treatment Period|Lost to Follow-up|2|||
48873089|NCT00197106|157373271|FG000|Overall Treatment Period|Protocol Violation|0|||
48873090|NCT00197106|157373272|FG001|Overall Treatment Period|Protocol Violation|0|||
48873091|NCT00197106|157373273|FG002|Overall Treatment Period|Protocol Violation|2|||
48873092|NCT00197106|157373271|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
48873093|NCT00197106|157373272|FG001|Overall Treatment Period|Withdrawal by Subject|0|||
48873094|NCT00197106|157373273|FG002|Overall Treatment Period|Withdrawal by Subject|2|||
48873095|NCT01755546|157373276|FG000|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1|||
48873096|NCT01755546|157373276|FG000|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3|||
48873097|NCT01755546|157373276|FG000|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1|||
48873098|NCT01755546|157373276|FG000|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5|||
48873099|NCT01755546|157373276|FG000|Titration Phase|Adverse Event|11|||
48873100|NCT01755546|157373276|FG000|Titration Phase|Lack of Efficacy|18|||
48873101|NCT01755546|157373276|FG000|Titration Phase|Protocol Violation|9|||
48873102|NCT01755546|157373276|FG000|Titration Phase|Lost to Follow-up|2|||
48873103|NCT01755546|157373276|FG000|Titration Phase|Other and Continuing|22|||
48873104|NCT01755546|157373276|FG000|Titration Phase|Withdrawal by Subject|8|||
48972476|NCT00555568|157729677|FG002|Overall Study|Lost to Follow-up|16|||
48972477|NCT03862495|157729685|FG000|Overall Study|Lost to Follow-up|37|||
48972478|NCT03862495|157729686|FG001|Overall Study|Lost to Follow-up|35|||
48972479|NCT01156532|157729691|FG000|Overall Study|Family Reasons|1|||
48972480|NCT01156532|157729691|FG000|Overall Study|Lost to Follow-up|1|||
48972481|NCT01135017|157729699|FG000|Overall Study|Adverse Event|3|||
48972482|NCT01135017|157729700|FG001|Overall Study|Adverse Event|8|||
48972483|NCT01135017|157729699|FG000|Overall Study|Other than above|3|||
48972484|NCT01135017|157729700|FG001|Overall Study|Other than above|4|||
48972485|NCT01148693|157729703|FG000|Overall Study|Attempts for cannulation were failed|13|||
48873105|NCT01755546|157373276|FG000|Long Term Treatment|Adverse Event|12|||
48972486|NCT01148693|157729704|FG001|Overall Study|Attempts for cannulation were failed|10|||
48972487|NCT00050622|157729705|FG000|Overall Study|Adverse Event|1|||
48972488|NCT03841526|157729706|FG000|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
48972489|NCT03841526|157729707|FG001|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
48972490|NCT03841526|157729708|FG002|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
48673555|NCT03178669|156657344|FG003|Overall Study|Adverse Event|2|||
48673556|NCT03178669|156657345|FG004|Overall Study|Adverse Event|2|||
48673557|NCT03178669|156657341|FG000|Overall Study|Lack of Efficacy|0|||
48972491|NCT03841526|157729709|FG003|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
48673558|NCT03178669|156657342|FG001|Overall Study|Lack of Efficacy|0|||
48873106|NCT01755546|157373276|FG000|Long Term Treatment|Lack of Efficacy|6|||
48972492|NCT03841526|157729710|FG004|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
48673559|NCT03178669|156657343|FG002|Overall Study|Lack of Efficacy|2|||
48972493|NCT03841526|157729711|FG005|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
48972494|NCT03841526|157729706|FG000|CRC Phase: Second Treatment|Adverse Event|0|||
48972495|NCT03841526|157729707|FG001|CRC Phase: Second Treatment|Adverse Event|0|||
48673560|NCT03178669|156657344|FG003|Overall Study|Lack of Efficacy|0|||
48673561|NCT03178669|156657345|FG004|Overall Study|Lack of Efficacy|1|||
48673562|NCT03178669|156657341|FG000|Overall Study|Physician Decision|0|||
48673563|NCT03178669|156657342|FG001|Overall Study|Physician Decision|0|||
48673564|NCT03178669|156657343|FG002|Overall Study|Physician Decision|0|||
48673565|NCT03178669|156657344|FG003|Overall Study|Physician Decision|0|||
48673566|NCT03178669|156657345|FG004|Overall Study|Physician Decision|1|||
48673567|NCT03178669|156657341|FG000|Overall Study|Withdrawal by Subject|1|||
48673568|NCT03178669|156657342|FG001|Overall Study|Withdrawal by Subject|0|||
48673569|NCT03178669|156657343|FG002|Overall Study|Withdrawal by Subject|1|||
48673570|NCT03178669|156657344|FG003|Overall Study|Withdrawal by Subject|1|||
48673571|NCT03178669|156657345|FG004|Overall Study|Withdrawal by Subject|0|||
48673572|NCT03178669|156657341|FG000|Overall Study|Lost to Follow-up|0|||
48673573|NCT03178669|156657342|FG001|Overall Study|Lost to Follow-up|0|||
48673574|NCT03178669|156657343|FG002|Overall Study|Lost to Follow-up|0|||
48673575|NCT03178669|156657344|FG003|Overall Study|Lost to Follow-up|1|||
48673576|NCT03178669|156657345|FG004|Overall Study|Lost to Follow-up|0|||
48673577|NCT00084487|156657347|FG000|Overall Study|Death|1|||
48673578|NCT01532869|156657348|FG000|Blinded-Treatment Period (Up to Week 24)|Death|0|||
48673579|NCT01532869|156657349|FG001|Blinded-Treatment Period (Up to Week 24)|Death|1|||
48673580|NCT01532869|156657348|FG000|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2|||
48673581|NCT01532869|156657349|FG001|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3|||
48673582|NCT01532869|156657348|FG000|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0|||
48673583|NCT01532869|156657349|FG001|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1|||
48673584|NCT01532869|156657348|FG000|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1|||
48673585|NCT01532869|156657349|FG001|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0|||
48673586|NCT01532869|156657348|FG000|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
48673587|NCT01532869|156657349|FG001|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
48673588|NCT01532869|156657348|FG000|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4|||
48673589|NCT01532869|156657349|FG001|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2|||
48673590|NCT01532869|156657348|FG000|Blinded-Treatment Period (Up to Week 48)|Death|0|||
48972496|NCT03841526|157729708|FG002|CRC Phase: Second Treatment|Adverse Event|0|||
48972497|NCT03841526|157729709|FG003|CRC Phase: Second Treatment|Adverse Event|1|||
48972498|NCT03841526|157729710|FG004|CRC Phase: Second Treatment|Adverse Event|0|||
48972499|NCT03841526|157729711|FG005|CRC Phase: Second Treatment|Adverse Event|0|||
48972500|NCT03841526|157729706|FG000|Outpatient Phase Treatment|Physician Decision|0|||
48972501|NCT03841526|157729707|FG001|Outpatient Phase Treatment|Physician Decision|1|||
48972502|NCT03841526|157729708|FG002|Outpatient Phase Treatment|Physician Decision|0|||
48972503|NCT03841526|157729709|FG003|Outpatient Phase Treatment|Physician Decision|0|||
48972504|NCT03841526|157729710|FG004|Outpatient Phase Treatment|Physician Decision|0|||
48972505|NCT03841526|157729711|FG005|Outpatient Phase Treatment|Physician Decision|0|||
48972506|NCT03841526|157729706|FG000|Outpatient Phase Treatment|Withdrawal by Subject|0|||
48972507|NCT03841526|157729707|FG001|Outpatient Phase Treatment|Withdrawal by Subject|0|||
48972508|NCT03841526|157729708|FG002|Outpatient Phase Treatment|Withdrawal by Subject|1|||
48972509|NCT03841526|157729709|FG003|Outpatient Phase Treatment|Withdrawal by Subject|0|||
48972510|NCT03841526|157729710|FG004|Outpatient Phase Treatment|Withdrawal by Subject|0|||
48972511|NCT03841526|157729711|FG005|Outpatient Phase Treatment|Withdrawal by Subject|1|||
48972512|NCT03000686|157729713|FG000|Part 1, Period 1 (1 Day)|Adverse Event|0|||
48972513|NCT03000686|157729714|FG001|Part 1, Period 1 (1 Day)|Adverse Event|1|||
48972514|NCT03000686|157729715|FG002|Part 1, Period 1 (1 Day)|Adverse Event|0|||
48972515|NCT03000686|157729716|FG003|Part 1, Period 1 (1 Day)|Adverse Event|0|||
48972516|NCT03371251|157729718|FG000|Overall Study|Withdrawal by Subject|1|||
48972517|NCT03371251|157729719|FG001|Overall Study|Withdrawal by Subject|0|||
48972518|NCT03371251|157729720|FG002|Overall Study|Withdrawal by Subject|1|||
48972519|NCT03371251|157729721|FG003|Overall Study|Withdrawal by Subject|0|||
48972520|NCT03371251|157729722|FG004|Overall Study|Withdrawal by Subject|2|||
48972521|NCT03371251|157729723|FG005|Overall Study|Withdrawal by Subject|2|||
48972522|NCT03371251|157729718|FG000|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|1|||
48972523|NCT03371251|157729719|FG001|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
48972524|NCT03371251|157729720|FG002|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
48972525|NCT03371251|157729721|FG003|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
48972526|NCT03371251|157729722|FG004|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|2|||
49015498|NCT01393990|157893776|FG006|Overall Study|Withdrawal by Subject|0|||
48673591|NCT01532869|156657349|FG001|Blinded-Treatment Period (Up to Week 48)|Death|3|||
48673592|NCT01532869|156657348|FG000|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4|||
48761186|NCT02141997|156974021|FG002|Overall Study|Other|0|||
48761187|NCT02141997|156974022|FG003|Overall Study|Other|0|||
48972527|NCT03371251|157729723|FG005|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|3|||
48972528|NCT03371251|157729718|FG000|Overall Study|Adverse Event|0|||
48972529|NCT03371251|157729719|FG001|Overall Study|Adverse Event|0|||
48972530|NCT03371251|157729720|FG002|Overall Study|Adverse Event|0|||
48972531|NCT03371251|157729721|FG003|Overall Study|Adverse Event|0|||
48972532|NCT03371251|157729722|FG004|Overall Study|Adverse Event|1|||
48972533|NCT03371251|157729723|FG005|Overall Study|Adverse Event|0|||
48972534|NCT03371251|157729718|FG000|Overall Study|Decision by Sponsor|0|||
48972535|NCT03371251|157729719|FG001|Overall Study|Decision by Sponsor|0|||
48972536|NCT03371251|157729720|FG002|Overall Study|Decision by Sponsor|0|||
48972537|NCT03371251|157729721|FG003|Overall Study|Decision by Sponsor|0|||
48972538|NCT03371251|157729722|FG004|Overall Study|Decision by Sponsor|2|||
48972539|NCT03371251|157729723|FG005|Overall Study|Decision by Sponsor|0|||
48673593|NCT01532869|156657349|FG001|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5|||
48673594|NCT01532869|156657348|FG000|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0|||
48673595|NCT01532869|156657349|FG001|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1|||
48673596|NCT01532869|156657348|FG000|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1|||
48673597|NCT01532869|156657349|FG001|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0|||
48673598|NCT01532869|156657348|FG000|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0|||
48673599|NCT01532869|156657349|FG001|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1|||
48673600|NCT01532869|156657348|FG000|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5|||
48673601|NCT01532869|156657349|FG001|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3|||
48673602|NCT01532869|156657348|FG000|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1|||
48673603|NCT01532869|156657349|FG001|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0|||
48673604|NCT01532869|156657348|FG000|Open-label Period (Week 48 to Week 96)|Adverse Event|4|||
48673605|NCT01532869|156657349|FG001|Open-label Period (Week 48 to Week 96)|Adverse Event|1|||
48673606|NCT01532869|156657348|FG000|Open-label Period (Week 48 to Week 96)|Non-compliance|1|||
48673607|NCT01532869|156657349|FG001|Open-label Period (Week 48 to Week 96)|Non-compliance|0|||
48673608|NCT01532869|156657348|FG000|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
48673609|NCT01532869|156657349|FG001|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
48761188|NCT01592344|156974025|FG000|Overall Study|Adverse Event|1|||
48761189|NCT01592344|156974026|FG001|Overall Study|Adverse Event|1|||
48761190|NCT01592344|156974025|FG000|Overall Study|Lack of Efficacy|1|||
48761191|NCT01592344|156974026|FG001|Overall Study|Lack of Efficacy|0|||
48761192|NCT01592344|156974025|FG000|Overall Study|not available at primary outcome visit|2|||
48761193|NCT01592344|156974026|FG001|Overall Study|not available at primary outcome visit|4|||
48761194|NCT02016482|156974027|FG000|Period A|Adverse Event|3|||
48873107|NCT01755546|157373276|FG000|Long Term Treatment|Protocol Violation|10|||
48873108|NCT01755546|157373276|FG000|Long Term Treatment|Withdrawal by Subject|35|||
48873109|NCT01755546|157373276|FG000|Long Term Treatment|Lost to Follow-up|17|||
48873110|NCT01755546|157373276|FG000|Long Term Treatment|other and ongoing|41|||
48873111|NCT02166476|157373280|FG000|Overall Study|Withdrawal by Subject|5|||
48873112|NCT02166476|157373281|FG001|Overall Study|Withdrawal by Subject|7|||
48873113|NCT02166476|157373280|FG000|Overall Study|Adverse Event|3|||
48873114|NCT02166476|157373281|FG001|Overall Study|Adverse Event|3|||
48873115|NCT02166476|157373280|FG000|Overall Study|Lost to Follow-up|5|||
48873116|NCT02166476|157373281|FG001|Overall Study|Lost to Follow-up|10|||
48873117|NCT02166476|157373280|FG000|Overall Study|Physician Decision|1|||
48873118|NCT02166476|157373281|FG001|Overall Study|Physician Decision|0|||
48873119|NCT02166476|157373280|FG000|Overall Study|Unable to Come for Visit|0|||
48873120|NCT02166476|157373281|FG001|Overall Study|Unable to Come for Visit|3|||
48873121|NCT04333147|157373282|FG000|Overall Study|Adverse Event|43|||
48873122|NCT04333147|157373283|FG001|Overall Study|Adverse Event|40|||
48873123|NCT04333147|157373282|FG000|Overall Study|Lack of Efficacy|49|||
48873124|NCT04333147|157373283|FG001|Overall Study|Lack of Efficacy|48|||
48873125|NCT04333147|157373282|FG000|Overall Study|Lost to Follow-up|19|||
48873126|NCT04333147|157373283|FG001|Overall Study|Lost to Follow-up|16|||
48873127|NCT04333147|157373282|FG000|Overall Study|Physician Decision|17|||
48873128|NCT04333147|157373283|FG001|Overall Study|Physician Decision|20|||
48972540|NCT00294684|157729726|FG000|Overall Study|Lost to Follow-up|5|||
48972541|NCT00294684|157729727|FG001|Overall Study|Lost to Follow-up|8|||
48972542|NCT01001234|157729729|FG000|Overall Study|Withdrawal by Subject|2|||
48972543|NCT01001234|157729730|FG001|Overall Study|Withdrawal by Subject|0|||
48673610|NCT01532869|156657348|FG000|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
48673611|NCT01532869|156657349|FG001|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
48673612|NCT01009086|156657351|FG000|Overall Study|Lack of Efficacy|16|||
48761195|NCT02016482|156974028|FG001|Period A|Adverse Event|5|||
48761196|NCT02016482|156974027|FG000|Period A|Withdrawal by Subject|3|||
48873129|NCT04333147|157373282|FG000|Overall Study|Withdrawal by Subject|65|||
48972544|NCT01001234|157729731|FG002|Overall Study|Withdrawal by Subject|3|||
48972545|NCT01001234|157729732|FG003|Overall Study|Withdrawal by Subject|0|||
48972546|NCT01001234|157729733|FG004|Overall Study|Withdrawal by Subject|0|||
48873130|NCT04333147|157373283|FG001|Overall Study|Withdrawal by Subject|68|||
48873131|NCT04333147|157373282|FG000|Overall Study|INVESTIGATOR SITE CLOSED|6|||
48761197|NCT02016482|156974028|FG001|Period A|Withdrawal by Subject|4|||
48972547|NCT01001234|157729729|FG000|Overall Study|Protocol Violation|34|||
48972548|NCT01001234|157729730|FG001|Overall Study|Protocol Violation|3|||
48972549|NCT01001234|157729731|FG002|Overall Study|Protocol Violation|19|||
48972550|NCT01001234|157729732|FG003|Overall Study|Protocol Violation|18|||
48972551|NCT01001234|157729733|FG004|Overall Study|Protocol Violation|0|||
48972552|NCT01001234|157729729|FG000|Overall Study|Lost to Follow-up|0|||
48972553|NCT01001234|157729730|FG001|Overall Study|Lost to Follow-up|0|||
48972554|NCT01001234|157729731|FG002|Overall Study|Lost to Follow-up|1|||
48761198|NCT02016482|156974027|FG000|Period A|Lost to Follow-up|3|||
48761199|NCT02016482|156974028|FG001|Period A|Lost to Follow-up|3|||
48761200|NCT02016482|156974027|FG000|Period A|Lack of Efficacy|2|||
48761201|NCT02016482|156974028|FG001|Period A|Lack of Efficacy|1|||
48761202|NCT02016482|156974027|FG000|Period A|Other|3|||
48761203|NCT02016482|156974028|FG001|Period A|Other|0|||
48761204|NCT02016482|156974027|FG000|Period A|Protocol Violation|0|||
48761205|NCT02016482|156974028|FG001|Period A|Protocol Violation|1|||
48761206|NCT02016482|156974027|FG000|Period A|Required Alternative/Prohibited Therapy|0|||
48761207|NCT02016482|156974028|FG001|Period A|Required Alternative/Prohibited Therapy|1|||
48761208|NCT02016482|156974027|FG000|Period B|Withdrawal by Subject|1|||
48761209|NCT02016482|156974028|FG001|Period B|Withdrawal by Subject|1|||
48761210|NCT02016482|156974027|FG000|Period B|Lost to Follow-up|2|||
48761211|NCT02016482|156974028|FG001|Period B|Lost to Follow-up|0|||
48761212|NCT02016482|156974027|FG000|Period B|Lack of Efficacy|6|||
48761213|NCT02016482|156974028|FG001|Period B|Lack of Efficacy|4|||
48761214|NCT02016482|156974027|FG000|Period B|Other|4|||
48761215|NCT02016482|156974028|FG001|Period B|Other|0|||
48761216|NCT02016482|156974027|FG000|Period B|Required Alternative/Prohibited Therapy|0|||
48761217|NCT02016482|156974028|FG001|Period B|Required Alternative/Prohibited Therapy|2|||
48761218|NCT00791518|156974032|FG000|Overall Study|Protocol Violation|93|||
48761219|NCT00751348|156974033|FG000|Overall Study|Withdrawal by Subject|5|||
48761220|NCT00751348|156974034|FG001|Overall Study|Withdrawal by Subject|2|||
48761221|NCT00751348|156974033|FG000|Overall Study|Migration from study area|1|||
48761222|NCT00751348|156974034|FG001|Overall Study|Migration from study area|0|||
48761223|NCT00006478|156974040|FG000|Overall Study|Vaccine could not be produced|1|||
48761224|NCT00006478|156974040|FG000|Overall Study|Physician Decision|6|||
48761225|NCT03054870|156974047|FG000|Day of Ventilation Imaging|Protocol Violation|4|||
48761226|NCT03054870|156974047|FG000|Day of Ventilation Imaging|Lost to Follow-up|1|||
48761227|NCT01176266|156974050|FG000|Overall Study|Death|6|||
48761228|NCT01176266|156974050|FG000|Overall Study|Withdrawal by Subject|3|||
48761229|NCT00728130|156974051|FG000|Overall Study|Withdrawal by Subject|1|||
48761230|NCT00728130|156974051|FG000|Overall Study|Paperwork not completed in time|1|||
48761231|NCT00728130|156974051|FG000|Overall Study|Physician Decision|1|||
48761232|NCT01154218|156974054|FG000|Third Intervention Period|Adverse Event|0|||
48761233|NCT01154218|156974055|FG001|Third Intervention Period|Adverse Event|1|||
48761234|NCT01154218|156974056|FG002|Third Intervention Period|Adverse Event|0|||
48761235|NCT01154218|156974057|FG003|Third Intervention Period|Adverse Event|0|||
48761236|NCT01154218|156974054|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
48761237|NCT01154218|156974055|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
48761238|NCT01154218|156974056|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
48761239|NCT01154218|156974057|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
48761240|NCT01154218|156974054|FG000|Fourth Intervention Period|Withdrawal by Subject|1|||
48761241|NCT01154218|156974055|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
48761242|NCT01154218|156974056|FG002|Fourth Intervention Period|Withdrawal by Subject|0|||
48761243|NCT01154218|156974057|FG003|Fourth Intervention Period|Withdrawal by Subject|0|||
48761244|NCT01265849|156974058|FG000|Overall Study|Randomized//Treatment not initiated|1|||
48873132|NCT04333147|157373283|FG001|Overall Study|INVESTIGATOR SITE CLOSED|2|||
48761245|NCT01265849|156974059|FG001|Overall Study|Randomized//Treatment not initiated|4|||
48761246|NCT01265849|156974060|FG002|Overall Study|Randomized//Treatment not initiated|0|||
48761247|NCT01265849|156974058|FG000|Overall Study|Physician Decision|1|||
48761248|NCT01265849|156974059|FG001|Overall Study|Physician Decision|2|||
48873133|NCT04333147|157373282|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|6|||
48873134|NCT04333147|157373283|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|9|||
48873135|NCT04333147|157373282|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|1251|||
48873136|NCT04333147|157373283|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1256|||
48873137|NCT03062449|157373284|FG000|Overall Study|Withdrawal by Subject|7|||
48873138|NCT03062449|157373285|FG001|Overall Study|Withdrawal by Subject|1|||
48873139|NCT00983905|157373286|FG000|Theophylline Alone|Adverse Event|1|||
48873140|NCT00983905|157373286|FG000|Colchicine Alone|Adverse Event|2|||
48873141|NCT01114139|157373287|FG000|Overall Study|Adverse Event|3|||
48873142|NCT01114139|157373288|FG001|Overall Study|Adverse Event|2|||
48873143|NCT01114139|157373287|FG000|Overall Study|Lost to Follow-up|15|||
48873144|NCT01114139|157373288|FG001|Overall Study|Lost to Follow-up|3|||
48873145|NCT01114139|157373287|FG000|Overall Study|Withdrawal by Subject|17|||
48761249|NCT01265849|156974060|FG002|Overall Study|Physician Decision|0|||
48761250|NCT01265849|156974058|FG000|Overall Study|Lost to Follow-up|18|||
48972555|NCT01001234|157729732|FG003|Overall Study|Lost to Follow-up|2|||
48673613|NCT01009086|156657352|FG001|Overall Study|Lack of Efficacy|15|||
48972556|NCT01001234|157729733|FG004|Overall Study|Lost to Follow-up|0|||
48972557|NCT01001234|157729729|FG000|Overall Study|Physician Decision|1|||
48972558|NCT01001234|157729730|FG001|Overall Study|Physician Decision|0|||
48972559|NCT01001234|157729731|FG002|Overall Study|Physician Decision|0|||
48972560|NCT01001234|157729732|FG003|Overall Study|Physician Decision|0|||
48972561|NCT01001234|157729733|FG004|Overall Study|Physician Decision|0|||
48972562|NCT01001234|157729729|FG000|Overall Study|Not Treated: Adverse Event|1|||
48972563|NCT01001234|157729730|FG001|Overall Study|Not Treated: Adverse Event|0|||
48972564|NCT01001234|157729731|FG002|Overall Study|Not Treated: Adverse Event|0|||
48972565|NCT01001234|157729732|FG003|Overall Study|Not Treated: Adverse Event|0|||
48972566|NCT01001234|157729733|FG004|Overall Study|Not Treated: Adverse Event|0|||
48972567|NCT01001234|157729729|FG000|Overall Study|Not Treated: Withdrawal by Subject|23|||
48972568|NCT01001234|157729730|FG001|Overall Study|Not Treated: Withdrawal by Subject|2|||
48972569|NCT01001234|157729731|FG002|Overall Study|Not Treated: Withdrawal by Subject|2|||
48972570|NCT01001234|157729732|FG003|Overall Study|Not Treated: Withdrawal by Subject|0|||
48972571|NCT01001234|157729733|FG004|Overall Study|Not Treated: Withdrawal by Subject|0|||
48972572|NCT01001234|157729729|FG000|Overall Study|Not Treated: Protocol Violation|3|||
48972573|NCT01001234|157729730|FG001|Overall Study|Not Treated: Protocol Violation|0|||
48972574|NCT01001234|157729731|FG002|Overall Study|Not Treated: Protocol Violation|0|||
48972575|NCT01001234|157729732|FG003|Overall Study|Not Treated: Protocol Violation|0|||
48972576|NCT01001234|157729733|FG004|Overall Study|Not Treated: Protocol Violation|0|||
48972577|NCT01001234|157729729|FG000|Overall Study|Not Treated: Lost to Follow-up|53|||
48972578|NCT01001234|157729730|FG001|Overall Study|Not Treated: Lost to Follow-up|4|||
48972579|NCT01001234|157729731|FG002|Overall Study|Not Treated: Lost to Follow-up|7|||
48972580|NCT01001234|157729732|FG003|Overall Study|Not Treated: Lost to Follow-up|5|||
48972581|NCT01001234|157729733|FG004|Overall Study|Not Treated: Lost to Follow-up|0|||
48972582|NCT01001234|157729729|FG000|Overall Study|Not Treated: Pregnancy|3|||
48972583|NCT01001234|157729730|FG001|Overall Study|Not Treated: Pregnancy|0|||
48972584|NCT01001234|157729731|FG002|Overall Study|Not Treated: Pregnancy|0|||
48972585|NCT01001234|157729732|FG003|Overall Study|Not Treated: Pregnancy|0|||
48972586|NCT01001234|157729733|FG004|Overall Study|Not Treated: Pregnancy|0|||
48972587|NCT01001234|157729729|FG000|Overall Study|Not Treated: Physician Decision|37|||
48972588|NCT01001234|157729730|FG001|Overall Study|Not Treated: Physician Decision|4|||
48972589|NCT01001234|157729731|FG002|Overall Study|Not Treated: Physician Decision|0|||
48972590|NCT01001234|157729732|FG003|Overall Study|Not Treated: Physician Decision|0|||
48972591|NCT01001234|157729733|FG004|Overall Study|Not Treated: Physician Decision|0|||
48972592|NCT01001234|157729729|FG000|Overall Study|Not Treated: Lack of Qualifying Event|248|||
48972593|NCT01001234|157729730|FG001|Overall Study|Not Treated: Lack of Qualifying Event|13|||
48972594|NCT01001234|157729731|FG002|Overall Study|Not Treated: Lack of Qualifying Event|0|||
48972595|NCT01001234|157729732|FG003|Overall Study|Not Treated: Lack of Qualifying Event|0|||
48972596|NCT01001234|157729733|FG004|Overall Study|Not Treated: Lack of Qualifying Event|0|||
48972597|NCT01167153|157729736|FG000|Overall Study|Non-effective therapy|1|||
48972598|NCT01167153|157729737|FG001|Overall Study|Non-effective therapy|4|||
48972599|NCT01167153|157729736|FG000|Overall Study|AE including clinical laboratory AE|2|||
48972600|NCT01167153|157729737|FG001|Overall Study|AE including clinical laboratory AE|8|||
48972601|NCT01167153|157729736|FG000|Overall Study|Hypotension|1|||
48972602|NCT01167153|157729737|FG001|Overall Study|Hypotension|0|||
48972603|NCT01167153|157729736|FG000|Overall Study|Lost to Follow-up|7|||
48972604|NCT01167153|157729737|FG001|Overall Study|Lost to Follow-up|9|||
48972605|NCT01167153|157729736|FG000|Overall Study|Non-compliance to concomitant medication|0|||
48972606|NCT01167153|157729737|FG001|Overall Study|Non-compliance to concomitant medication|2|||
48972607|NCT01167153|157729736|FG000|Overall Study|Investigator initiation withdrawal,Other|1|||
48972608|NCT01167153|157729737|FG001|Overall Study|Investigator initiation withdrawal,Other|1|||
48972609|NCT01167153|157729736|FG000|Overall Study|Withdrawal consent|1|||
48972610|NCT01167153|157729737|FG001|Overall Study|Withdrawal consent|1|||
48972611|NCT01167153|157729736|FG000|Overall Study|Subject initiation withdrawal, Other|5|||
48972612|NCT01167153|157729737|FG001|Overall Study|Subject initiation withdrawal, Other|8|||
48972613|NCT04449276|157729740|FG000|Overall Study|Adverse Event|1|||
48972614|NCT04449276|157729741|FG001|Overall Study|Adverse Event|2|||
48972615|NCT04449276|157729742|FG002|Overall Study|Adverse Event|0|||
48972616|NCT04449276|157729743|FG003|Overall Study|Adverse Event|0|||
48972617|NCT04449276|157729744|FG004|Overall Study|Adverse Event|2|||
48972618|NCT04449276|157729745|FG005|Overall Study|Adverse Event|0|||
48972619|NCT04449276|157729746|FG006|Overall Study|Adverse Event|0|||
48972620|NCT04449276|157729747|FG007|Overall Study|Adverse Event|1|||
48972621|NCT04449276|157729740|FG000|Overall Study|Withdrawal by Subject|2|||
48972622|NCT04449276|157729741|FG001|Overall Study|Withdrawal by Subject|0|||
48673614|NCT01009086|156657353|FG002|Overall Study|Lack of Efficacy|9|||
48972623|NCT04449276|157729742|FG002|Overall Study|Withdrawal by Subject|0|||
48972624|NCT04449276|157729743|FG003|Overall Study|Withdrawal by Subject|1|||
48972625|NCT04449276|157729744|FG004|Overall Study|Withdrawal by Subject|0|||
48972626|NCT04449276|157729745|FG005|Overall Study|Withdrawal by Subject|0|||
48972627|NCT04449276|157729746|FG006|Overall Study|Withdrawal by Subject|0|||
48972628|NCT04449276|157729747|FG007|Overall Study|Withdrawal by Subject|0|||
48972629|NCT04449276|157729740|FG000|Overall Study|Other|0|||
48972630|NCT04449276|157729741|FG001|Overall Study|Other|2|||
48972631|NCT04449276|157729742|FG002|Overall Study|Other|3|||
48972632|NCT04449276|157729743|FG003|Overall Study|Other|2|||
48972633|NCT04449276|157729744|FG004|Overall Study|Other|0|||
48972634|NCT04449276|157729745|FG005|Overall Study|Other|0|||
48972635|NCT04449276|157729746|FG006|Overall Study|Other|0|||
48972636|NCT04449276|157729747|FG007|Overall Study|Other|1|||
48972637|NCT01061567|157729748|FG000|Overall Study|Adverse Event|32|||
48972638|NCT01061567|157729748|FG000|Overall Study|Death|2|||
48972639|NCT01061567|157729748|FG000|Overall Study|Lack of Efficacy|3|||
48972640|NCT01061567|157729748|FG000|Overall Study|Lost to Follow-up|24|||
48972641|NCT01061567|157729748|FG000|Overall Study|Protocol Violation|1|||
48972642|NCT01061567|157729748|FG000|Overall Study|Withdrawal by Subject|11|||
48972643|NCT01061567|157729748|FG000|Overall Study|Other reason than stated above|3|||
48972644|NCT00563368|157729749|FG000|Overall Study|Lost to Follow-up|14|||
48972645|NCT00563368|157729750|FG001|Overall Study|Lost to Follow-up|14|||
48972646|NCT00563368|157729751|FG002|Overall Study|Lost to Follow-up|12|||
48972647|NCT00563368|157729752|FG003|Overall Study|Lost to Follow-up|6|||
48972648|NCT00563368|157729753|FG004|Overall Study|Lost to Follow-up|9|||
48972649|NCT00563368|157729754|FG005|Overall Study|Lost to Follow-up|8|||
48972650|NCT00563368|157729755|FG006|Overall Study|Lost to Follow-up|9|||
48972651|NCT00563368|157729749|FG000|Overall Study|Adverse Event|3|||
48972652|NCT00563368|157729750|FG001|Overall Study|Adverse Event|4|||
48972653|NCT00563368|157729751|FG002|Overall Study|Adverse Event|5|||
48972654|NCT00563368|157729752|FG003|Overall Study|Adverse Event|9|||
48972655|NCT00563368|157729753|FG004|Overall Study|Adverse Event|6|||
48972656|NCT00563368|157729754|FG005|Overall Study|Adverse Event|10|||
48972657|NCT00563368|157729755|FG006|Overall Study|Adverse Event|17|||
48972658|NCT00563368|157729749|FG000|Overall Study|Withdrawal by Subject|11|||
48972659|NCT00563368|157729750|FG001|Overall Study|Withdrawal by Subject|6|||
48972660|NCT00563368|157729751|FG002|Overall Study|Withdrawal by Subject|5|||
48972661|NCT00563368|157729752|FG003|Overall Study|Withdrawal by Subject|7|||
48972662|NCT00563368|157729753|FG004|Overall Study|Withdrawal by Subject|8|||
48972663|NCT00563368|157729754|FG005|Overall Study|Withdrawal by Subject|5|||
48972664|NCT00563368|157729755|FG006|Overall Study|Withdrawal by Subject|4|||
48972665|NCT00563368|157729749|FG000|Overall Study|protocol non-compliance|1|||
48972666|NCT00563368|157729750|FG001|Overall Study|protocol non-compliance|1|||
48972667|NCT00563368|157729751|FG002|Overall Study|protocol non-compliance|2|||
48972668|NCT00563368|157729752|FG003|Overall Study|protocol non-compliance|1|||
48972669|NCT00563368|157729753|FG004|Overall Study|protocol non-compliance|0|||
48972670|NCT00563368|157729754|FG005|Overall Study|protocol non-compliance|1|||
48972671|NCT00563368|157729755|FG006|Overall Study|protocol non-compliance|3|||
48972672|NCT00563368|157729749|FG000|Overall Study|Pregnancy|1|||
48972673|NCT00563368|157729750|FG001|Overall Study|Pregnancy|0|||
48972674|NCT00563368|157729751|FG002|Overall Study|Pregnancy|1|||
48972675|NCT00563368|157729752|FG003|Overall Study|Pregnancy|2|||
48972676|NCT00563368|157729753|FG004|Overall Study|Pregnancy|1|||
48972677|NCT00563368|157729754|FG005|Overall Study|Pregnancy|2|||
48972678|NCT00563368|157729755|FG006|Overall Study|Pregnancy|0|||
48972679|NCT00563368|157729749|FG000|Overall Study|requirement for restricted medication|0|||
48972680|NCT00563368|157729750|FG001|Overall Study|requirement for restricted medication|0|||
48972681|NCT00563368|157729751|FG002|Overall Study|requirement for restricted medication|2|||
48972682|NCT00563368|157729752|FG003|Overall Study|requirement for restricted medication|0|||
48972683|NCT00563368|157729753|FG004|Overall Study|requirement for restricted medication|0|||
48972684|NCT00563368|157729754|FG005|Overall Study|requirement for restricted medication|0|||
48972685|NCT00563368|157729755|FG006|Overall Study|requirement for restricted medication|0|||
48673615|NCT01009086|156657351|FG000|Overall Study|Lost to Follow-up|4|||
48972686|NCT00563368|157729749|FG000|Overall Study|Other|5|||
48972687|NCT00563368|157729750|FG001|Overall Study|Other|5|||
48972688|NCT00563368|157729751|FG002|Overall Study|Other|3|||
48972689|NCT00563368|157729752|FG003|Overall Study|Other|4|||
48673616|NCT01009086|156657352|FG001|Overall Study|Lost to Follow-up|5|||
48673617|NCT01009086|156657353|FG002|Overall Study|Lost to Follow-up|3|||
48972690|NCT00563368|157729753|FG004|Overall Study|Other|4|||
48972691|NCT00563368|157729754|FG005|Overall Study|Other|4|||
48972692|NCT00563368|157729755|FG006|Overall Study|Other|0|||
48972693|NCT01831804|157729756|FG000|Overall Study|Adverse Event|0|||
48972694|NCT01831804|157729757|FG001|Overall Study|Adverse Event|0|||
48972695|NCT01831804|157729758|FG002|Overall Study|Adverse Event|0|||
48972696|NCT01831804|157729759|FG003|Overall Study|Adverse Event|0|||
48972697|NCT01831804|157729760|FG004|Overall Study|Adverse Event|0|||
48972698|NCT01831804|157729761|FG005|Overall Study|Adverse Event|0|||
48972699|NCT01831804|157729762|FG006|Overall Study|Adverse Event|1|||
48972700|NCT01831804|157729763|FG007|Overall Study|Adverse Event|0|||
48972701|NCT01831804|157729764|FG008|Overall Study|Adverse Event|1|||
48972702|NCT01831804|157729756|FG000|Overall Study|Protocol Violation|0|||
48972703|NCT01831804|157729757|FG001|Overall Study|Protocol Violation|0|||
48972704|NCT01831804|157729758|FG002|Overall Study|Protocol Violation|2|||
48972705|NCT01831804|157729759|FG003|Overall Study|Protocol Violation|0|||
48972706|NCT01831804|157729760|FG004|Overall Study|Protocol Violation|0|||
48972707|NCT01831804|157729761|FG005|Overall Study|Protocol Violation|0|||
48972708|NCT01831804|157729762|FG006|Overall Study|Protocol Violation|0|||
48972709|NCT01831804|157729763|FG007|Overall Study|Protocol Violation|0|||
48972710|NCT01831804|157729764|FG008|Overall Study|Protocol Violation|0|||
48972711|NCT01831804|157729756|FG000|Overall Study|Protocol defined stopping criteria|1|||
48972712|NCT01831804|157729757|FG001|Overall Study|Protocol defined stopping criteria|1|||
48972713|NCT01831804|157729758|FG002|Overall Study|Protocol defined stopping criteria|3|||
48972714|NCT01831804|157729759|FG003|Overall Study|Protocol defined stopping criteria|0|||
48972715|NCT01831804|157729760|FG004|Overall Study|Protocol defined stopping criteria|1|||
48972716|NCT01831804|157729761|FG005|Overall Study|Protocol defined stopping criteria|0|||
48972717|NCT01831804|157729762|FG006|Overall Study|Protocol defined stopping criteria|0|||
48673618|NCT01009086|156657351|FG000|Overall Study|Adverse Event|12|||
48673619|NCT01009086|156657352|FG001|Overall Study|Adverse Event|11|||
48673620|NCT01009086|156657353|FG002|Overall Study|Adverse Event|8|||
48673621|NCT01009086|156657351|FG000|Overall Study|Withdrawal by Subject|9|||
48673622|NCT01009086|156657352|FG001|Overall Study|Withdrawal by Subject|11|||
48673623|NCT01009086|156657353|FG002|Overall Study|Withdrawal by Subject|13|||
48673624|NCT01009086|156657351|FG000|Overall Study|Other|3|||
48673625|NCT01009086|156657352|FG001|Overall Study|Other|5|||
48673626|NCT01009086|156657353|FG002|Overall Study|Other|1|||
48673627|NCT03040986|156657354|FG000|Overall Study|Hospice|1|||
48673628|NCT03040986|156657355|FG001|Overall Study|Hospice|0|||
48673629|NCT03040986|156657354|FG000|Overall Study|Adverse Event|2|||
48673630|NCT03040986|156657355|FG001|Overall Study|Adverse Event|1|||
48673631|NCT03040986|156657354|FG000|Overall Study|Disease progression on study|3|||
48673632|NCT03040986|156657355|FG001|Overall Study|Disease progression on study|1|||
48673633|NCT01793883|156657357|FG000|Overall Study|Withdrawal by Subject|3|||
48673634|NCT01793883|156657358|FG001|Overall Study|Withdrawal by Subject|7|||
48673635|NCT01793883|156657359|FG002|Overall Study|Withdrawal by Subject|3|||
48673636|NCT01793883|156657357|FG000|Overall Study|Subject noncompliance|0|||
48673637|NCT01793883|156657358|FG001|Overall Study|Subject noncompliance|1|||
48673638|NCT01793883|156657359|FG002|Overall Study|Subject noncompliance|1|||
48673639|NCT01793883|156657357|FG000|Overall Study|Lost to Follow-up|5|||
48673640|NCT01793883|156657358|FG001|Overall Study|Lost to Follow-up|1|||
48673641|NCT01793883|156657359|FG002|Overall Study|Lost to Follow-up|3|||
48673642|NCT01793883|156657357|FG000|Overall Study|Randomized in error|1|||
48673643|NCT01793883|156657358|FG001|Overall Study|Randomized in error|0|||
48673644|NCT01793883|156657359|FG002|Overall Study|Randomized in error|0|||
48673645|NCT01793883|156657357|FG000|Overall Study|Unable to complete spriometry|1|||
48673646|NCT01793883|156657358|FG001|Overall Study|Unable to complete spriometry|0|||
48673647|NCT01793883|156657359|FG002|Overall Study|Unable to complete spriometry|0|||
48673648|NCT01793883|156657357|FG000|Overall Study|Unable to complete measurements|1|||
48673649|NCT01793883|156657358|FG001|Overall Study|Unable to complete measurements|0|||
48673650|NCT01793883|156657359|FG002|Overall Study|Unable to complete measurements|0|||
48673651|NCT01793883|156657357|FG000|Overall Study|Met exclusion criteria|1|||
48673652|NCT01793883|156657358|FG001|Overall Study|Met exclusion criteria|0|||
48673653|NCT01793883|156657359|FG002|Overall Study|Met exclusion criteria|0|||
48673654|NCT01793883|156657357|FG000|Overall Study|Dosing error|0|||
48673655|NCT01793883|156657358|FG001|Overall Study|Dosing error|1|||
48673656|NCT01793883|156657359|FG002|Overall Study|Dosing error|0|||
48673657|NCT01793883|156657357|FG000|Overall Study|Respiratory distress during spirometry|0|||
48673658|NCT01793883|156657358|FG001|Overall Study|Respiratory distress during spirometry|0|||
48673659|NCT01793883|156657359|FG002|Overall Study|Respiratory distress during spirometry|1|||
48673660|NCT00761527|156657367|FG000|Overall Study|Adverse Event|3|||
48673661|NCT00761527|156657367|FG000|Overall Study|Poor Compliance|8|||
48673662|NCT00761527|156657367|FG000|Overall Study|Lost to Follow-up|9|||
48673663|NCT00761527|156657367|FG000|Overall Study|Unknown reason|2|||
48673664|NCT01431963|156657368|FG000|Overall Study|Adverse Event|18|||
48673665|NCT01431963|156657368|FG000|Overall Study|Lack of Efficacy|7|||
48673666|NCT01431963|156657368|FG000|Overall Study|Protocol Violation|1|||
48673667|NCT01431963|156657368|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
48673668|NCT01431963|156657368|FG000|Overall Study|Physician Decision|4|||
48673669|NCT01431963|156657368|FG000|Overall Study|Withdrawal by Subject|3|||
48673670|NCT00620113|156657369|FG000|Overall Study|Adverse Event|3|||
48673671|NCT00620113|156657370|FG001|Overall Study|Adverse Event|2|||
48673672|NCT00620113|156657371|FG002|Overall Study|Adverse Event|2|||
48673673|NCT00620113|156657372|FG003|Overall Study|Adverse Event|1|||
48673674|NCT00620113|156657369|FG000|Overall Study|Lack of Efficacy|2|||
48673675|NCT00620113|156657370|FG001|Overall Study|Lack of Efficacy|3|||
48673676|NCT00620113|156657371|FG002|Overall Study|Lack of Efficacy|0|||
48673677|NCT00620113|156657372|FG003|Overall Study|Lack of Efficacy|2|||
48673678|NCT00620113|156657369|FG000|Overall Study|Physician Decision|1|||
48673679|NCT00620113|156657370|FG001|Overall Study|Physician Decision|0|||
48673680|NCT00620113|156657371|FG002|Overall Study|Physician Decision|0|||
48673681|NCT00620113|156657372|FG003|Overall Study|Physician Decision|2|||
48673682|NCT00620113|156657369|FG000|Overall Study|Protocol Violation|2|||
48673683|NCT00620113|156657370|FG001|Overall Study|Protocol Violation|1|||
48673684|NCT00620113|156657371|FG002|Overall Study|Protocol Violation|0|||
48673685|NCT00620113|156657372|FG003|Overall Study|Protocol Violation|0|||
48673686|NCT00620113|156657369|FG000|Overall Study|Withdrawal by Subject|5|||
48673687|NCT00620113|156657370|FG001|Overall Study|Withdrawal by Subject|1|||
48673688|NCT00620113|156657371|FG002|Overall Study|Withdrawal by Subject|3|||
48673689|NCT00620113|156657372|FG003|Overall Study|Withdrawal by Subject|5|||
48873146|NCT01114139|157373288|FG001|Overall Study|Withdrawal by Subject|6|||
48873147|NCT01114139|157373287|FG000|Overall Study|Other-Missed 1 visit|1|||
48873148|NCT01114139|157373288|FG001|Overall Study|Other-Missed 1 visit|0|||
48873149|NCT01114139|157373287|FG000|Overall Study|Other-Protocol Violation|1|||
48873150|NCT01114139|157373288|FG001|Overall Study|Other-Protocol Violation|0|||
48873151|NCT01114139|157373287|FG000|Overall Study|Other-Out of window for study drug dose|1|||
48873152|NCT01114139|157373288|FG001|Overall Study|Other-Out of window for study drug dose|0|||
48873153|NCT01114139|157373287|FG000|Overall Study|Other-Participant falsified records|0|||
48873154|NCT01114139|157373288|FG001|Overall Study|Other-Participant falsified records|1|||
48873155|NCT01114139|157373287|FG000|Overall Study|Other-Participant went on hospice|0|||
48873156|NCT01114139|157373288|FG001|Overall Study|Other-Participant went on hospice|1|||
48873157|NCT01114139|157373287|FG000|Overall Study|Other-Physician changed treatment|1|||
48873158|NCT01114139|157373288|FG001|Overall Study|Other-Physician changed treatment|0|||
48873159|NCT01114139|157373287|FG000|Overall Study|Other-Withdrew prior to receiving dose|1|||
48873160|NCT01114139|157373288|FG001|Overall Study|Other-Withdrew prior to receiving dose|3|||
48873161|NCT00280683|157373289|FG000|Overall Study|Withdrawal by Subject|1|||
48873162|NCT00280683|157373290|FG001|Overall Study|Withdrawal by Subject|2|||
48873163|NCT00280683|157373289|FG000|Overall Study|Adverse Event|1|||
48873164|NCT00280683|157373290|FG001|Overall Study|Adverse Event|1|||
48873165|NCT01169636|157373291|FG000|Overall Study|Adverse Event|0|||
48873166|NCT01169636|157373292|FG001|Overall Study|Adverse Event|0|||
48873167|NCT01169636|157373293|FG002|Overall Study|Adverse Event|1|||
48873168|NCT01169636|157373294|FG003|Overall Study|Adverse Event|1|||
48873169|NCT01169636|157373295|FG004|Overall Study|Adverse Event|0|||
48873170|NCT01169636|157373291|FG000|Overall Study|Screen failure|0|||
48873171|NCT01169636|157373292|FG001|Overall Study|Screen failure|0|||
48873172|NCT01169636|157373293|FG002|Overall Study|Screen failure|2|||
48873173|NCT01169636|157373294|FG003|Overall Study|Screen failure|0|||
48873174|NCT01169636|157373295|FG004|Overall Study|Screen failure|0|||
48873175|NCT01169636|157373291|FG000|Overall Study|Withdrawal by Subject|0|||
48873176|NCT01169636|157373292|FG001|Overall Study|Withdrawal by Subject|0|||
48873177|NCT01169636|157373293|FG002|Overall Study|Withdrawal by Subject|0|||
48873178|NCT01169636|157373294|FG003|Overall Study|Withdrawal by Subject|0|||
48873179|NCT01169636|157373295|FG004|Overall Study|Withdrawal by Subject|3|||
48873180|NCT02466243|157373296|FG000|Part B Open-label Treatment Period|Adverse Event|1|||
48873181|NCT02466243|157373297|FG001|Part B Open-label Treatment Period|Adverse Event|0|||
48873182|NCT02466243|157373296|FG000|Part B Open-label Treatment Period|Withdrawal by Subject|0|||
48873183|NCT02466243|157373297|FG001|Part B Open-label Treatment Period|Withdrawal by Subject|2|||
48873184|NCT02466243|157373296|FG000|Part B Open-label Treatment Period|Sponsor Decision|8|||
48873185|NCT02466243|157373297|FG001|Part B Open-label Treatment Period|Sponsor Decision|6|||
48873186|NCT02466243|157373296|FG000|Part B Open-label Treatment Period|Missing|2|||
48873187|NCT02466243|157373297|FG001|Part B Open-label Treatment Period|Missing|2|||
48873188|NCT00784147|157373298|FG000|Overall Study|Lost to Follow-up|2|||
48873189|NCT00784147|157373299|FG001|Overall Study|Lost to Follow-up|4|||
48873190|NCT00784147|157373298|FG000|Overall Study|Withdrawal by Subject|1|||
48873191|NCT00784147|157373299|FG001|Overall Study|Withdrawal by Subject|3|||
48873192|NCT00784147|157373298|FG000|Overall Study|Physician Decision|2|||
48873193|NCT00784147|157373299|FG001|Overall Study|Physician Decision|1|||
48873194|NCT00784147|157373298|FG000|Overall Study|Protocol Violation|1|||
48873195|NCT00784147|157373299|FG001|Overall Study|Protocol Violation|1|||
48873196|NCT00784147|157373298|FG000|Overall Study|Death|2|||
48873197|NCT00784147|157373299|FG001|Overall Study|Death|0|||
48873198|NCT01379703|157373304|FG000|Study Start Through 9 Months|Lost to Follow-up|2|||
48873199|NCT01379703|157373305|FG001|Study Start Through 9 Months|Lost to Follow-up|61|||
48873200|NCT01379703|157373306|FG002|Study Start Through 9 Months|Lost to Follow-up|104|||
48873201|NCT01379703|157373304|FG000|Study Start Through 9 Months|Adverse Event|0|||
48673690|NCT00619307|156657374|FG000|Overall Study|Adverse Event|0|||
48673691|NCT00619307|156657375|FG001|Overall Study|Adverse Event|1|||
48873202|NCT01379703|157373305|FG001|Study Start Through 9 Months|Adverse Event|14|||
48873203|NCT01379703|157373306|FG002|Study Start Through 9 Months|Adverse Event|10|||
48873204|NCT01379703|157373304|FG000|Study Start Through 9 Months|Withdrawal by Subject|0|||
48873205|NCT01379703|157373305|FG001|Study Start Through 9 Months|Withdrawal by Subject|6|||
48873206|NCT01379703|157373306|FG002|Study Start Through 9 Months|Withdrawal by Subject|1|||
48873207|NCT01379703|157373304|FG000|Study Start Through 9 Months|Treatment Failure|0|||
48873208|NCT01379703|157373305|FG001|Study Start Through 9 Months|Treatment Failure|2|||
48972718|NCT01831804|157729763|FG007|Overall Study|Protocol defined stopping criteria|0|||
48972719|NCT01831804|157729764|FG008|Overall Study|Protocol defined stopping criteria|0|||
48972720|NCT01831804|157729756|FG000|Overall Study|Lost to Follow-up|0|||
48972721|NCT01831804|157729757|FG001|Overall Study|Lost to Follow-up|0|||
48972722|NCT01831804|157729758|FG002|Overall Study|Lost to Follow-up|1|||
48972723|NCT01831804|157729759|FG003|Overall Study|Lost to Follow-up|0|||
48972724|NCT01831804|157729760|FG004|Overall Study|Lost to Follow-up|0|||
48673692|NCT00619307|156657374|FG000|Overall Study|Lost to Follow-up|0|||
48673693|NCT00619307|156657375|FG001|Overall Study|Lost to Follow-up|1|||
48673694|NCT00619307|156657374|FG000|Overall Study|Protocol Violation|3|||
48673695|NCT00619307|156657375|FG001|Overall Study|Protocol Violation|0|||
48673696|NCT00619307|156657374|FG000|Overall Study|Withdrew consent|1|||
48673697|NCT00619307|156657375|FG001|Overall Study|Withdrew consent|0|||
48673698|NCT00619307|156657374|FG000|Overall Study|Severe migraine|0|||
48673699|NCT00619307|156657375|FG001|Overall Study|Severe migraine|1|||
48673700|NCT00619307|156657374|FG000|Overall Study|MS attack plus steroids|0|||
48673701|NCT00619307|156657375|FG001|Overall Study|MS attack plus steroids|1|||
48673702|NCT00965419|156657376|FG000|Open Label Treatment for Responders|Adverse Event|33|||
48673703|NCT00965419|156657376|FG000|Open Label Treatment for Responders|Entry Criteria Not Met|1|||
48673704|NCT00965419|156657376|FG000|Open Label Treatment for Responders|Protocol Violation|21|||
48673705|NCT00965419|156657376|FG000|Open Label Treatment for Responders|Withdrawal by Subject|27|||
48673706|NCT00965419|156657376|FG000|Open Label Treatment for Responders|Physician Decision|6|||
48673707|NCT00965419|156657376|FG000|Open Label Treatment for Responders|Sponsor Decision|5|||
48673708|NCT00965419|156657376|FG000|Open Label Treatment for Responders|Parent/Caregiver Decision|41|||
48673709|NCT00965419|156657376|FG000|Open Label Treatment for Responders|Lack of Efficacy|67|||
48673710|NCT00965419|156657376|FG000|Open Label Treatment for Responders|Lost to Follow-up|46|||
48673711|NCT00965419|156657376|FG000|Follow-up Phase|Adverse Event|9|||
48673712|NCT00965419|156657376|FG000|Follow-up Phase|Protocol Violation|4|||
48673713|NCT00965419|156657376|FG000|Follow-up Phase|Withdrawal by Subject|8|||
48673714|NCT00965419|156657376|FG000|Follow-up Phase|Physician Decision|4|||
48673715|NCT00965419|156657376|FG000|Follow-up Phase|Parent/Caregiver Decision|9|||
48673716|NCT00965419|156657376|FG000|Follow-up Phase|Lack of Efficacy|28|||
48673717|NCT00151372|156659501|FG000|Overall Study|Death|12|||
48673718|NCT00151372|156659502|FG001|Overall Study|Death|11|||
48673719|NCT00151372|156659501|FG000|Overall Study|Lost to Follow-up|5|||
48673720|NCT00151372|156659502|FG001|Overall Study|Lost to Follow-up|5|||
48673721|NCT00151372|156659501|FG000|Overall Study|Too sick medically to continue|5|||
48673722|NCT00151372|156659502|FG001|Overall Study|Too sick medically to continue|6|||
48673723|NCT00151372|156659501|FG000|Overall Study|Withdrawal by Subject|7|||
48761251|NCT01265849|156974059|FG001|Overall Study|Lost to Follow-up|15|||
48761252|NCT01265849|156974060|FG002|Overall Study|Lost to Follow-up|5|||
48673724|NCT00151372|156659502|FG001|Overall Study|Withdrawal by Subject|7|||
48673725|NCT00924508|156659503|FG000|Overall Study|Withdrawal by Subject|3|||
48673726|NCT02429791|156659504|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|6|||
48673727|NCT02429791|156659505|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|2|||
48673728|NCT02429791|156659504|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
48673729|NCT02429791|156659505|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|2|||
48673730|NCT02429791|156659504|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
48673731|NCT02429791|156659505|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
48673732|NCT02429791|156659504|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
48673733|NCT02429791|156659505|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2|||
48673734|NCT02429791|156659504|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|1|||
48673735|NCT02429791|156659505|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|4|||
48673736|NCT02429791|156659504|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3|||
48673737|NCT02429791|156659505|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
48673738|NCT02429791|156659504|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11|||
48673739|NCT02429791|156659505|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12|||
48673740|NCT02429791|156659504|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
48673741|NCT02429791|156659505|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4|||
48673742|NCT02429791|156659504|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4|||
48673743|NCT02429791|156659505|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
48673744|NCT02429791|156659504|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0|||
48673745|NCT02429791|156659505|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1|||
48673746|NCT02429791|156659504|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
48673747|NCT02429791|156659505|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
48673748|NCT02429791|156659504|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7|||
48673749|NCT02429791|156659505|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5|||
48673750|NCT02429791|156659504|FG000|Continuation Phase(Week 148 to Week 411)|Adverse Event|3|||
48673751|NCT02429791|156659505|FG001|Continuation Phase(Week 148 to Week 411)|Adverse Event|1|||
48761253|NCT01265849|156974058|FG000|Overall Study|Not otherwise specified|1|||
48972725|NCT01831804|157729761|FG005|Overall Study|Lost to Follow-up|0|||
48673752|NCT02429791|156659504|FG000|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|1|||
48673753|NCT02429791|156659505|FG001|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|0|||
48673754|NCT02429791|156659504|FG000|Continuation Phase(Week 148 to Week 411)|Protocol Violation|1|||
48673755|NCT02429791|156659505|FG001|Continuation Phase(Week 148 to Week 411)|Protocol Violation|0|||
48761254|NCT01265849|156974059|FG001|Overall Study|Not otherwise specified|6|||
48673756|NCT02429791|156659504|FG000|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
48673757|NCT02429791|156659505|FG001|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
48673758|NCT02429791|156659504|FG000|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
48673759|NCT02429791|156659505|FG001|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
48673760|NCT02429791|156659504|FG000|Continuation Phase(Week 148 to Week 411)|Investigator discretion|0|||
48673761|NCT02429791|156659505|FG001|Continuation Phase(Week 148 to Week 411)|Investigator discretion|2|||
48673762|NCT00859937|156659508|FG000|Overall Study|Protocol Violation|1|||
48673763|NCT00859937|156659509|FG001|Overall Study|Protocol Violation|0|||
48673764|NCT03203291|156659510|FG000|Overall Study|Withdrawal by Subject|1|||
48673765|NCT03180307|156659512|FG000|Overall Study|Lost to Follow-up|2|||
48673766|NCT03180307|156659513|FG001|Overall Study|Lost to Follow-up|0|||
48673767|NCT03180307|156659512|FG000|Overall Study|Death|1|||
48673768|NCT03180307|156659513|FG001|Overall Study|Death|0|||
48673769|NCT03180307|156659512|FG000|Overall Study|Majority of which were disease too extensive and camera not used|3|||
48673770|NCT03180307|156659513|FG001|Overall Study|Majority of which were disease too extensive and camera not used|0|||
48673771|NCT01563172|156659514|FG000|Overall Study|Adverse Event|5|||
48673772|NCT01563172|156659514|FG000|Overall Study|Lost to Follow-up|2|||
48673773|NCT01563172|156659514|FG000|Overall Study|Other (Protocol deviation)|5|||
48673774|NCT01563172|156659514|FG000|Overall Study|Other (Not specified)|1|||
48673775|NCT01620528|156659515|FG000|Treatment Period|Did Not Receive Study Drug|0|||
48673776|NCT01620528|156659516|FG001|Treatment Period|Did Not Receive Study Drug|0|||
48673777|NCT01620528|156659517|FG002|Treatment Period|Did Not Receive Study Drug|1|||
48761255|NCT01265849|156974060|FG002|Overall Study|Not otherwise specified|1|||
48761256|NCT01265849|156974058|FG000|Overall Study|Withdrawal by Subject|25|||
48673778|NCT01620528|156659515|FG000|Treatment Period|Withdrawal by Subject|35|||
48673779|NCT01620528|156659516|FG001|Treatment Period|Withdrawal by Subject|21|||
48673780|NCT01620528|156659517|FG002|Treatment Period|Withdrawal by Subject|16|||
48673781|NCT01620528|156659515|FG000|Treatment Period|Adverse Event|17|||
48673782|NCT01620528|156659516|FG001|Treatment Period|Adverse Event|13|||
48673783|NCT01620528|156659517|FG002|Treatment Period|Adverse Event|21|||
48673784|NCT01620528|156659515|FG000|Treatment Period|Lost to Follow-up|16|||
48673785|NCT01620528|156659516|FG001|Treatment Period|Lost to Follow-up|8|||
48673786|NCT01620528|156659517|FG002|Treatment Period|Lost to Follow-up|14|||
48673787|NCT01620528|156659515|FG000|Treatment Period|Other|9|||
48673788|NCT01620528|156659516|FG001|Treatment Period|Other|5|||
48673789|NCT01620528|156659517|FG002|Treatment Period|Other|7|||
48673790|NCT01620528|156659515|FG000|Treatment Period|Subject Noncompliant|11|||
48673791|NCT01620528|156659516|FG001|Treatment Period|Subject Noncompliant|2|||
48673792|NCT01620528|156659517|FG002|Treatment Period|Subject Noncompliant|2|||
48673793|NCT01620528|156659515|FG000|Treatment Period|Pregnancy|7|||
48673794|NCT01620528|156659516|FG001|Treatment Period|Pregnancy|2|||
48673795|NCT01620528|156659517|FG002|Treatment Period|Pregnancy|2|||
48673796|NCT01620528|156659515|FG000|Treatment Period|Surgery/Invasive Intervention|5|||
48761257|NCT01265849|156974059|FG001|Overall Study|Withdrawal by Subject|34|||
48761258|NCT01265849|156974060|FG002|Overall Study|Withdrawal by Subject|13|||
48761259|NCT03255382|156974061|FG000|Overall Study|Adverse Event|3|||
48873209|NCT01379703|157373306|FG002|Study Start Through 9 Months|Treatment Failure|2|||
48873210|NCT01379703|157373304|FG000|Study Start Through 9 Months|Patient Noncompliance|0|||
48873211|NCT01379703|157373305|FG001|Study Start Through 9 Months|Patient Noncompliance|0|||
48873212|NCT01379703|157373306|FG002|Study Start Through 9 Months|Patient Noncompliance|1|||
48873213|NCT01379703|157373304|FG000|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
48873214|NCT01379703|157373305|FG001|Study Start Through 9 Months|Tuberculosis/TB treatment|4|||
48873215|NCT01379703|157373306|FG002|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
48873216|NCT01379703|157373304|FG000|Study Start Through 9 Months|Medication not available|0|||
48873217|NCT01379703|157373305|FG001|Study Start Through 9 Months|Medication not available|2|||
48873218|NCT01379703|157373306|FG002|Study Start Through 9 Months|Medication not available|1|||
48873219|NCT01379703|157373304|FG000|Study Start Through 9 Months|Poor general condition|0|||
48873220|NCT01379703|157373305|FG001|Study Start Through 9 Months|Poor general condition|1|||
48873221|NCT01379703|157373306|FG002|Study Start Through 9 Months|Poor general condition|0|||
48873222|NCT01379703|157373304|FG000|Study Start Through 9 Months|Increased triglycerides|0|||
48873223|NCT01379703|157373305|FG001|Study Start Through 9 Months|Increased triglycerides|1|||
48873224|NCT01379703|157373306|FG002|Study Start Through 9 Months|Increased triglycerides|0|||
48873225|NCT01379703|157373304|FG000|Study Start Through 9 Months|Reason unknown|2|||
48873226|NCT01379703|157373305|FG001|Study Start Through 9 Months|Reason unknown|31|||
48873227|NCT01379703|157373306|FG002|Study Start Through 9 Months|Reason unknown|24|||
48873228|NCT01379703|157373304|FG000|9 Months Through 18 Months|Lost to Follow-up|0|||
48673797|NCT01620528|156659516|FG001|Treatment Period|Surgery/Invasive Intervention|1|||
48673798|NCT01620528|156659517|FG002|Treatment Period|Surgery/Invasive Intervention|3|||
48673799|NCT01620528|156659515|FG000|Treatment Period|Exclusionary Medication Received|0|||
48673800|NCT01620528|156659516|FG001|Treatment Period|Exclusionary Medication Received|1|||
48673801|NCT01620528|156659517|FG002|Treatment Period|Exclusionary Medication Received|0|||
48673802|NCT01620528|156659515|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
48673803|NCT01620528|156659516|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
48673804|NCT01620528|156659517|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
48673805|NCT01620528|156659515|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
48673806|NCT01620528|156659516|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
48673807|NCT01620528|156659517|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
48673808|NCT01620528|156659515|FG000|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0|||
48673809|NCT01620528|156659516|FG001|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
48673810|NCT01620528|156659517|FG002|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
48673811|NCT01620528|156659515|FG000|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8|||
48673812|NCT01620528|156659516|FG001|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3|||
48673813|NCT01620528|156659517|FG002|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4|||
48673814|NCT01620528|156659515|FG000|Post-Treatment Follow-Up Period|Other|6|||
48673815|NCT01620528|156659516|FG001|Post-Treatment Follow-Up Period|Other|4|||
48673816|NCT01620528|156659517|FG002|Post-Treatment Follow-Up Period|Other|2|||
48673833|NCT05392803|156659530|FG000|Overall Study|Lost to Follow-up|0|||
48673834|NCT05392803|156659531|FG001|Overall Study|Lost to Follow-up|2|||
48673835|NCT04294147|156659532|FG000|Overall Study|Protocol Violation|2|||
48673836|NCT04294147|156659533|FG001|Overall Study|Protocol Violation|0|||
48673837|NCT01772576|156659534|FG000|Overall Study|Death|15|||
48673838|NCT01772576|156659534|FG000|Overall Study|Protocol Violation|1|||
48673839|NCT01772576|156659534|FG000|Overall Study|Lost to Follow-up|3|||
48673840|NCT01772576|156659534|FG000|Overall Study|Study device not used|3|||
48673841|NCT01772576|156659534|FG000|Overall Study|Adverse Event|6|||
48673842|NCT01772576|156659534|FG000|Overall Study|Withdrawal by Subject|6|||
48673843|NCT00923845|156659537|FG000|Induction Therapy|Poor performance status|0|||
48673844|NCT00923845|156659538|FG001|Induction Therapy|Poor performance status|2|||
48673845|NCT00559988|156659539|FG000|Overall Study|Death|147|||
48673846|NCT00559988|156659540|FG001|Overall Study|Death|140|||
48673847|NCT00559988|156659539|FG000|Overall Study|Withdrawal by Subject|152|||
48673848|NCT00559988|156659540|FG001|Overall Study|Withdrawal by Subject|139|||
48673849|NCT00559988|156659539|FG000|Overall Study|Lost to Follow-up|42|||
48673850|NCT00559988|156659540|FG001|Overall Study|Lost to Follow-up|56|||
48673851|NCT00559988|156659539|FG000|Overall Study|ICD device explanted|10|||
48673852|NCT00559988|156659540|FG001|Overall Study|ICD device explanted|17|||
48673853|NCT02891382|156659541|FG000|Overall Study|Lost to Follow-up|3|||
48761260|NCT03255382|156974062|FG001|Overall Study|Adverse Event|0|||
48761261|NCT03255382|156974061|FG000|Overall Study|Lost to Follow-up|2|||
48761262|NCT03255382|156974062|FG001|Overall Study|Lost to Follow-up|0|||
48761263|NCT03255382|156974061|FG000|Overall Study|Withdrawal by Subject|2|||
48761264|NCT03255382|156974062|FG001|Overall Study|Withdrawal by Subject|0|||
48761265|NCT03255382|156974061|FG000|Overall Study|Other|6|||
48761266|NCT03255382|156974062|FG001|Overall Study|Other|0|||
48761267|NCT01522365|156974064|FG000|Overall Study|Withdrawal by Subject|1|||
48761268|NCT01522365|156974065|FG001|Overall Study|Withdrawal by Subject|1|||
48761269|NCT01522365|156974064|FG000|Overall Study|Lost to Follow-up|1|||
48761270|NCT01522365|156974065|FG001|Overall Study|Lost to Follow-up|1|||
48972726|NCT01831804|157729762|FG006|Overall Study|Lost to Follow-up|0|||
48673854|NCT02891382|156659542|FG001|Overall Study|Lost to Follow-up|4|||
48673855|NCT02891382|156659543|FG002|Overall Study|Lost to Follow-up|5|||
48673856|NCT02891382|156659544|FG003|Overall Study|Lost to Follow-up|3|||
48673857|NCT02891382|156659545|FG004|Overall Study|Lost to Follow-up|4|||
48673858|NCT00504894|156659546|FG000|Overall Study|fMRI technical problems|1|||
48761271|NCT00673179|156974066|FG000|Overall Study|Toxicity/Complications|3|||
48972727|NCT01831804|157729763|FG007|Overall Study|Lost to Follow-up|0|||
48972728|NCT01831804|157729764|FG008|Overall Study|Lost to Follow-up|1|||
48972729|NCT01831804|157729756|FG000|Overall Study|Investigator discretion|0|||
48972730|NCT01831804|157729757|FG001|Overall Study|Investigator discretion|0|||
48972731|NCT01831804|157729758|FG002|Overall Study|Investigator discretion|0|||
48972732|NCT01831804|157729759|FG003|Overall Study|Investigator discretion|0|||
48972733|NCT01831804|157729760|FG004|Overall Study|Investigator discretion|1|||
48972734|NCT01831804|157729761|FG005|Overall Study|Investigator discretion|0|||
48972735|NCT01831804|157729762|FG006|Overall Study|Investigator discretion|0|||
48972736|NCT01831804|157729763|FG007|Overall Study|Investigator discretion|1|||
48972737|NCT01831804|157729764|FG008|Overall Study|Investigator discretion|0|||
48972738|NCT01831804|157729756|FG000|Overall Study|Withdrew Consent|0|||
48972739|NCT01831804|157729757|FG001|Overall Study|Withdrew Consent|1|||
48972740|NCT01831804|157729758|FG002|Overall Study|Withdrew Consent|0|||
48972741|NCT01831804|157729759|FG003|Overall Study|Withdrew Consent|0|||
48972742|NCT01831804|157729760|FG004|Overall Study|Withdrew Consent|0|||
48972743|NCT01831804|157729761|FG005|Overall Study|Withdrew Consent|0|||
48972744|NCT01831804|157729762|FG006|Overall Study|Withdrew Consent|0|||
48972745|NCT01831804|157729763|FG007|Overall Study|Withdrew Consent|2|||
48972746|NCT01831804|157729764|FG008|Overall Study|Withdrew Consent|0|||
48972747|NCT01459068|157729765|FG000|Overall Study|Withdrawal by Subject|8|||
48972748|NCT01459068|157729766|FG001|Overall Study|Withdrawal by Subject|18|||
48972749|NCT01459068|157729765|FG000|Overall Study|Lost to Follow-up|31|||
48972750|NCT01459068|157729766|FG001|Overall Study|Lost to Follow-up|15|||
48972751|NCT01459068|157729765|FG000|Overall Study|Death|0|||
48972752|NCT01459068|157729766|FG001|Overall Study|Death|1|||
48972753|NCT01614795|157729773|FG000|Overall Study|Adverse Event|0|||
48972754|NCT01614795|157729774|FG001|Overall Study|Adverse Event|0|||
48972755|NCT01614795|157729775|FG002|Overall Study|Adverse Event|1|||
48972756|NCT01614795|157729776|FG003|Overall Study|Adverse Event|1|||
48972757|NCT01614795|157729773|FG000|Overall Study|Lack of Efficacy|10|||
48972758|NCT01614795|157729774|FG001|Overall Study|Lack of Efficacy|10|||
48972759|NCT01614795|157729775|FG002|Overall Study|Lack of Efficacy|9|||
48972760|NCT01614795|157729776|FG003|Overall Study|Lack of Efficacy|8|||
48972761|NCT01614795|157729773|FG000|Overall Study|Physician Decision|1|||
48972762|NCT01614795|157729774|FG001|Overall Study|Physician Decision|0|||
48972763|NCT01614795|157729775|FG002|Overall Study|Physician Decision|1|||
48972764|NCT01614795|157729776|FG003|Overall Study|Physician Decision|1|||
48972765|NCT01614795|157729773|FG000|Overall Study|Withdrawal by Subject|0|||
48972766|NCT01614795|157729774|FG001|Overall Study|Withdrawal by Subject|1|||
48972767|NCT01614795|157729775|FG002|Overall Study|Withdrawal by Subject|0|||
48972768|NCT01614795|157729776|FG003|Overall Study|Withdrawal by Subject|2|||
48972769|NCT01614795|157729773|FG000|Overall Study|Ineligible|0|||
48972770|NCT01614795|157729774|FG001|Overall Study|Ineligible|1|||
48972771|NCT01614795|157729775|FG002|Overall Study|Ineligible|0|||
48972772|NCT01614795|157729776|FG003|Overall Study|Ineligible|0|||
48972773|NCT00196196|157729777|FG000|Overall Study|Withdrawal by Subject|2|||
48972774|NCT00196196|157729777|FG000|Overall Study|Did not have required condition (hydroce|5|||
48972775|NCT02023112|157729778|FG000|Overall Study|Withdrawal by Subject|2|||
48972776|NCT02023112|157729779|FG001|Overall Study|Withdrawal by Subject|1|||
48972777|NCT01425749|157729780|FG000|Overall Study|progression of melanoma|0|||
48972778|NCT01425749|157729781|FG001|Overall Study|progression of melanoma|1|||
48972779|NCT02910219|157729782|FG000|Overall Study|Withdrawal by Subject|1|||
48972780|NCT02910219|157729783|FG001|Overall Study|Withdrawal by Subject|1|||
48972781|NCT01293084|157729784|FG000|Overall Study|Physician Decision|3|||
48972782|NCT01293084|157729784|FG000|Overall Study|Withdrawal by Subject|2|||
48972783|NCT00422903|157729785|FG000|Overall Study|Disease Progression|3|||
48972784|NCT00422903|157729786|FG001|Overall Study|Disease Progression|1|||
48972785|NCT00422903|157729785|FG000|Overall Study|Adverse Event|0|||
48972786|NCT00422903|157729786|FG001|Overall Study|Adverse Event|2|||
48972787|NCT00422903|157729785|FG000|Overall Study|Informed Consent Withdrawn|1|||
48972788|NCT00422903|157729786|FG001|Overall Study|Informed Consent Withdrawn|2|||
48972789|NCT02096042|157729789|FG000|Overall Study|Disease Progression|1|||
48673859|NCT00504894|156659547|FG001|Overall Study|fMRI technical problems|1|||
48673860|NCT00504894|156659548|FG002|Overall Study|fMRI technical problems|0|||
48673861|NCT00504894|156659546|FG000|Overall Study|Withdrawal by Subject|0|||
48673862|NCT00504894|156659547|FG001|Overall Study|Withdrawal by Subject|1|||
48673863|NCT00504894|156659548|FG002|Overall Study|Withdrawal by Subject|0|||
48673864|NCT00504894|156659546|FG000|Overall Study|Infusion technical problems|0|||
48673865|NCT00504894|156659547|FG001|Overall Study|Infusion technical problems|1|||
48972790|NCT02096042|157729790|FG001|Overall Study|Disease Progression|0|||
48972791|NCT02096042|157729791|FG002|Overall Study|Disease Progression|0|||
48972792|NCT02983799|157729792|FG000|Overall Study|Withdrawn from study before data cut-off|28|||
48972793|NCT02983799|157729793|FG001|Overall Study|Withdrawn from study before data cut-off|12|||
48972794|NCT02983799|157729794|FG002|Overall Study|Withdrawn from study before data cut-off|23|||
48972795|NCT02983799|157729795|FG003|Overall Study|Withdrawn from study before data cut-off|25|||
48972796|NCT02983799|157729796|FG004|Overall Study|Withdrawn from study before data cut-off|1|||
48673866|NCT00504894|156659548|FG002|Overall Study|Infusion technical problems|0|||
48972797|NCT02983799|157729792|FG000|Overall Study|Death|20|||
48972798|NCT02983799|157729793|FG001|Overall Study|Death|5|||
48972799|NCT02983799|157729794|FG002|Overall Study|Death|23|||
48972800|NCT02983799|157729795|FG003|Overall Study|Death|47|||
48972801|NCT02983799|157729796|FG004|Overall Study|Death|7|||
48972802|NCT02983799|157729792|FG000|Overall Study|Withdrawal by Subject|1|||
48972803|NCT02983799|157729793|FG001|Overall Study|Withdrawal by Subject|0|||
48972804|NCT02983799|157729794|FG002|Overall Study|Withdrawal by Subject|3|||
48972805|NCT02983799|157729795|FG003|Overall Study|Withdrawal by Subject|4|||
48972806|NCT02983799|157729796|FG004|Overall Study|Withdrawal by Subject|1|||
48972807|NCT02983799|157729792|FG000|Overall Study|Protocol Violation|0|||
48972808|NCT02983799|157729793|FG001|Overall Study|Protocol Violation|1|||
48972809|NCT02983799|157729794|FG002|Overall Study|Protocol Violation|0|||
48972810|NCT02983799|157729795|FG003|Overall Study|Protocol Violation|0|||
48972811|NCT02983799|157729796|FG004|Overall Study|Protocol Violation|1|||
48972812|NCT02983799|157729792|FG000|Overall Study|Lost to Follow-up|1|||
48972813|NCT02983799|157729793|FG001|Overall Study|Lost to Follow-up|0|||
48972814|NCT02983799|157729794|FG002|Overall Study|Lost to Follow-up|1|||
48972815|NCT02983799|157729795|FG003|Overall Study|Lost to Follow-up|0|||
48673867|NCT00504894|156659546|FG000|Overall Study|poor subject data|2|||
48673868|NCT00504894|156659547|FG001|Overall Study|poor subject data|0|||
48673869|NCT00504894|156659548|FG002|Overall Study|poor subject data|0|||
48673870|NCT03244826|156659550|FG000|Overall Study|Withdrawal by Subject|2|||
48673871|NCT03244826|156659551|FG001|Overall Study|Withdrawal by Subject|0|||
48673872|NCT03244826|156659550|FG000|Overall Study|Transplant delayed or withdrawn|12|||
48673873|NCT03244826|156659551|FG001|Overall Study|Transplant delayed or withdrawn|10|||
48673874|NCT02673684|156659554|FG000|Overall Study|Study not completed d/t loss of funding|9|||
48673875|NCT02673684|156659555|FG001|Overall Study|Study not completed d/t loss of funding|8|||
48673876|NCT02678923|156659556|FG000|Overall Study|Protocol Deviation (Not Dosed)|1|||
48673877|NCT02678923|156659557|FG001|Overall Study|Protocol Deviation (Not Dosed)|3|||
48673878|NCT02678923|156659556|FG000|Overall Study|Withdrawal by Subject|3|||
48673879|NCT02678923|156659557|FG001|Overall Study|Withdrawal by Subject|2|||
48673880|NCT02678923|156659556|FG000|Overall Study|Lost to Follow-up|1|||
48673881|NCT02678923|156659557|FG001|Overall Study|Lost to Follow-up|0|||
48673882|NCT02678923|156659556|FG000|Overall Study|Did Not Return for Study Visits|1|||
48673883|NCT02678923|156659557|FG001|Overall Study|Did Not Return for Study Visits|0|||
48673884|NCT04356040|156659558|FG000|Overall Study|Death|2|||
48673885|NCT04356040|156659559|FG001|Overall Study|Death|0|||
48673886|NCT04356040|156659558|FG000|Overall Study|Lost to Follow-up|1|||
48972816|NCT02983799|157729796|FG004|Overall Study|Lost to Follow-up|0|||
48972817|NCT00651313|157729804|FG000|Overall Study|Adverse Event|0|||
48972818|NCT00651313|157729805|FG001|Overall Study|Adverse Event|1|||
48972819|NCT00651313|157729804|FG000|Overall Study|Withdrawal by Subject|3|||
48972820|NCT00651313|157729805|FG001|Overall Study|Withdrawal by Subject|1|||
48673887|NCT04356040|156659559|FG001|Overall Study|Lost to Follow-up|0|||
48673888|NCT04356040|156659558|FG000|Overall Study|Physician Decision|0|||
48673889|NCT04356040|156659559|FG001|Overall Study|Physician Decision|1|||
48673890|NCT04356040|156659558|FG000|Overall Study|Withdrawal by Subject|13|||
48673891|NCT04356040|156659559|FG001|Overall Study|Withdrawal by Subject|1|||
48673892|NCT04356040|156659558|FG000|Overall Study|Enrollment Pause|10|||
48673893|NCT04356040|156659559|FG001|Overall Study|Enrollment Pause|0|||
48673894|NCT04356040|156659558|FG000|Overall Study|Did not meet Inclusion/Exclusion criteria|7|||
48673895|NCT04356040|156659559|FG001|Overall Study|Did not meet Inclusion/Exclusion criteria|0|||
48972821|NCT00651313|157729804|FG000|Overall Study|Lost to Follow-up|1|||
48972822|NCT00651313|157729805|FG001|Overall Study|Lost to Follow-up|1|||
48972823|NCT00651313|157729804|FG000|Overall Study|Adminstrative Discontinuation|2|||
48972824|NCT00651313|157729805|FG001|Overall Study|Adminstrative Discontinuation|3|||
48972825|NCT00981747|157729806|FG000|Losartan|Withdrawal by Subject|1|||
48972826|NCT00981747|157729806|FG000|Losartan|Death|1|||
48972827|NCT00981747|157729806|FG000|Placebo Oral Tablet|Withdrawal by Subject|1|||
48972828|NCT03034057|157729811|FG000|Overall Study|Withdrawal by Subject|10|||
48972829|NCT03034057|157729811|FG000|Overall Study|Protocol Violation|1|||
48673896|NCT04356040|156659558|FG000|Overall Study|Procedure aborted prior to device insertion into the vasculature|1|||
48673897|NCT04356040|156659559|FG001|Overall Study|Procedure aborted prior to device insertion into the vasculature|0|||
48673898|NCT04356040|156659558|FG000|Overall Study|PI left institution|3|||
48673899|NCT04356040|156659559|FG001|Overall Study|PI left institution|0|||
48673900|NCT02828020|156659560|FG000|Treatment Period|Adverse Event|3|||
48673901|NCT02828020|156659561|FG001|Treatment Period|Adverse Event|1|||
48673902|NCT02828020|156659562|FG002|Treatment Period|Adverse Event|1|||
48972830|NCT03034057|157729811|FG000|Overall Study|Not defined|2|||
48972831|NCT03034057|157729811|FG000|Overall Study|Lost to Follow-up|19|||
48972832|NCT03034057|157729811|FG000|Overall Study|Adverse Event|22|||
48972833|NCT03034057|157729811|FG000|Overall Study|Medication error without associated AE|1|||
48972834|NCT01814826|157729812|FG000|Overall Study|Other|3|||
48972835|NCT01814826|157729813|FG001|Overall Study|Other|5|||
48972836|NCT01814826|157729814|FG002|Overall Study|Other|0|||
48972837|NCT01814826|157729812|FG000|Overall Study|Death|29|||
48972838|NCT01814826|157729813|FG001|Overall Study|Death|24|||
48972839|NCT01814826|157729814|FG002|Overall Study|Death|3|||
48972840|NCT01313078|157729816|FG000|Overall Study|Death|1|||
48972841|NCT01313078|157729816|FG000|Overall Study|Discontinued study drug|1|||
48972842|NCT01313078|157729816|FG000|Overall Study|Withdrawal by Subject|1|||
48972843|NCT04209400|157729819|FG000|Overall Study|Withdrawal by Subject|0|||
48673903|NCT02828020|156659560|FG000|Treatment Period|Withdrawal of Consent|10|||
48972844|NCT04209400|157729820|FG001|Overall Study|Withdrawal by Subject|1|||
48972845|NCT02843178|157731785|FG000|Overall Study|Lost to Follow-up|8|||
48972846|NCT02843178|157731786|FG001|Overall Study|Lost to Follow-up|8|||
48972847|NCT02843178|157731787|FG002|Overall Study|Lost to Follow-up|6|||
48972848|NCT02843178|157731788|FG003|Overall Study|Lost to Follow-up|3|||
48972849|NCT02843178|157731785|FG000|Overall Study|Withdrawal by Subject|0|||
48972850|NCT02843178|157731786|FG001|Overall Study|Withdrawal by Subject|0|||
48972851|NCT02843178|157731787|FG002|Overall Study|Withdrawal by Subject|1|||
48972852|NCT02843178|157731788|FG003|Overall Study|Withdrawal by Subject|1|||
48972853|NCT01742091|157731792|FG000|Overall Study|Adverse Event|0|||
48972854|NCT01742091|157731793|FG001|Overall Study|Adverse Event|0|||
48972855|NCT01742091|157731794|FG002|Overall Study|Adverse Event|0|||
48972856|NCT01742091|157731795|FG003|Overall Study|Adverse Event|0|||
48972857|NCT01742091|157731796|FG004|Overall Study|Adverse Event|1|||
48972858|NCT01742091|157731797|FG005|Overall Study|Adverse Event|0|||
48972859|NCT01742091|157731792|FG000|Overall Study|Physician Decision|0|||
48972860|NCT01742091|157731793|FG001|Overall Study|Physician Decision|0|||
48972861|NCT01742091|157731794|FG002|Overall Study|Physician Decision|0|||
48972862|NCT01742091|157731795|FG003|Overall Study|Physician Decision|0|||
48972863|NCT01742091|157731796|FG004|Overall Study|Physician Decision|0|||
48972864|NCT01742091|157731797|FG005|Overall Study|Physician Decision|1|||
48972865|NCT01742091|157731792|FG000|Overall Study|Withdrawal by Subject|0|||
48972866|NCT01742091|157731793|FG001|Overall Study|Withdrawal by Subject|0|||
48972867|NCT01742091|157731794|FG002|Overall Study|Withdrawal by Subject|0|||
48972868|NCT01742091|157731795|FG003|Overall Study|Withdrawal by Subject|1|||
48972869|NCT01742091|157731796|FG004|Overall Study|Withdrawal by Subject|0|||
48972870|NCT01742091|157731797|FG005|Overall Study|Withdrawal by Subject|0|||
48972871|NCT01742091|157731792|FG000|Overall Study|Lost to Follow-up|0|||
48972872|NCT01742091|157731793|FG001|Overall Study|Lost to Follow-up|0|||
48972873|NCT01742091|157731794|FG002|Overall Study|Lost to Follow-up|0|||
48972874|NCT01742091|157731795|FG003|Overall Study|Lost to Follow-up|0|||
48972875|NCT01742091|157731796|FG004|Overall Study|Lost to Follow-up|0|||
48972876|NCT01742091|157731797|FG005|Overall Study|Lost to Follow-up|1|||
48972877|NCT00640146|157731798|FG000|Overall Study|Adverse Event|2|||
48972878|NCT00640146|157731799|FG001|Overall Study|Adverse Event|0|||
48972879|NCT00640146|157731798|FG000|Overall Study|Lost to Follow-up|0|||
48972880|NCT00640146|157731799|FG001|Overall Study|Lost to Follow-up|1|||
48972881|NCT00640146|157731798|FG000|Overall Study|Lack of Efficacy|0|||
48972882|NCT00640146|157731799|FG001|Overall Study|Lack of Efficacy|1|||
48972883|NCT00640146|157731798|FG000|Overall Study|Withdrawal by Subject|1|||
48972884|NCT00640146|157731799|FG001|Overall Study|Withdrawal by Subject|1|||
48972885|NCT00640146|157731798|FG000|Overall Study|Randomized but not treated|1|||
48972886|NCT00640146|157731799|FG001|Overall Study|Randomized but not treated|3|||
48972887|NCT00525785|157731803|FG000|Overall Study|Withdrawal by Subject|1|||
48972888|NCT00525785|157731803|FG000|Overall Study|Lack of Efficacy|1|||
48972889|NCT00525785|157731803|FG000|Overall Study|Physician Decision|1|||
48972890|NCT02455388|157731804|FG000|Overall Study|Protocol Violation|1|||
48972891|NCT02455388|157731805|FG001|Overall Study|Protocol Violation|0|||
48972892|NCT02455388|157731806|FG002|Overall Study|Protocol Violation|4|||
48972893|NCT02455388|157731804|FG000|Overall Study|Withdrawal by Subject|0|||
48972894|NCT02455388|157731805|FG001|Overall Study|Withdrawal by Subject|0|||
48972895|NCT02455388|157731806|FG002|Overall Study|Withdrawal by Subject|7|||
48972896|NCT03170258|157731812|FG000|Overall Study|Physician Decision|4|||
48972897|NCT03170258|157731813|FG001|Overall Study|Physician Decision|0|||
48972898|NCT03170258|157731812|FG000|Overall Study|Equipment issues|1|||
48673904|NCT02828020|156659561|FG001|Treatment Period|Withdrawal of Consent|14|||
48673905|NCT02828020|156659562|FG002|Treatment Period|Withdrawal of Consent|9|||
48673906|NCT02828020|156659560|FG000|Treatment Period|Lost to Follow-up|21|||
48673907|NCT02828020|156659561|FG001|Treatment Period|Lost to Follow-up|24|||
48673908|NCT02828020|156659562|FG002|Treatment Period|Lost to Follow-up|18|||
48673909|NCT02828020|156659560|FG000|Treatment Period|Lack of Qualifying Event|44|||
48673910|NCT02828020|156659561|FG001|Treatment Period|Lack of Qualifying Event|53|||
48673911|NCT02828020|156659562|FG002|Treatment Period|Lack of Qualifying Event|43|||
48972899|NCT03170258|157731813|FG001|Overall Study|Equipment issues|0|||
48972900|NCT03170258|157731812|FG000|Overall Study|Medication|1|||
48972901|NCT03170258|157731813|FG001|Overall Study|Medication|0|||
48972902|NCT03170258|157731812|FG000|Overall Study|Sleep issues|1|||
48972903|NCT03170258|157731813|FG001|Overall Study|Sleep issues|0|||
48972904|NCT04839393|157731834|FG000|Overall Study|Adverse Event|0|||
48972905|NCT04839393|157731835|FG001|Overall Study|Adverse Event|0|||
48972906|NCT04839393|157731836|FG002|Overall Study|Adverse Event|2|||
48972907|NCT04839393|157731834|FG000|Overall Study|Withdrawal by participant|0|||
48673912|NCT02828020|156659560|FG000|Treatment Period|Pregnancy|0|||
48873229|NCT01379703|157373305|FG001|9 Months Through 18 Months|Lost to Follow-up|178|||
48873230|NCT01379703|157373306|FG002|9 Months Through 18 Months|Lost to Follow-up|0|||
48873231|NCT01379703|157373304|FG000|9 Months Through 18 Months|Withdrawal by Subject|0|||
48873232|NCT01379703|157373305|FG001|9 Months Through 18 Months|Withdrawal by Subject|11|||
48873233|NCT01379703|157373306|FG002|9 Months Through 18 Months|Withdrawal by Subject|0|||
48873234|NCT01379703|157373304|FG000|9 Months Through 18 Months|Adverse Event|0|||
48873235|NCT01379703|157373305|FG001|9 Months Through 18 Months|Adverse Event|6|||
48873236|NCT01379703|157373306|FG002|9 Months Through 18 Months|Adverse Event|0|||
48873237|NCT01379703|157373304|FG000|9 Months Through 18 Months|Treatment failure|0|||
48873238|NCT01379703|157373305|FG001|9 Months Through 18 Months|Treatment failure|5|||
48873239|NCT01379703|157373306|FG002|9 Months Through 18 Months|Treatment failure|0|||
48873240|NCT01379703|157373304|FG000|9 Months Through 18 Months|Patient Noncompliance|0|||
48873241|NCT01379703|157373305|FG001|9 Months Through 18 Months|Patient Noncompliance|4|||
48873242|NCT01379703|157373306|FG002|9 Months Through 18 Months|Patient Noncompliance|0|||
48873243|NCT01379703|157373304|FG000|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
48873244|NCT01379703|157373305|FG001|9 Months Through 18 Months|Tuberculosis/TB treatment|2|||
48873245|NCT01379703|157373306|FG002|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
48873246|NCT01379703|157373304|FG000|9 Months Through 18 Months|Fatigue|0|||
48873247|NCT01379703|157373305|FG001|9 Months Through 18 Months|Fatigue|1|||
48873248|NCT01379703|157373306|FG002|9 Months Through 18 Months|Fatigue|0|||
48873249|NCT01379703|157373304|FG000|9 Months Through 18 Months|Reason Unknown|0|||
48873250|NCT01379703|157373305|FG001|9 Months Through 18 Months|Reason Unknown|23|||
48873251|NCT01379703|157373306|FG002|9 Months Through 18 Months|Reason Unknown|0|||
48873252|NCT00427778|157373309|FG000|First Intervention (4 Weeks)|no longer interested|1|||
48873253|NCT00427778|157373310|FG001|First Intervention (4 Weeks)|no longer interested|0|||
48873254|NCT00427778|157373309|FG000|First Intervention (4 Weeks)|Not successfully fitted with ring|2|||
48873255|NCT00427778|157373310|FG001|First Intervention (4 Weeks)|Not successfully fitted with ring|0|||
48873256|NCT00427778|157373309|FG000|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0|||
48873257|NCT00427778|157373310|FG001|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1|||
48873258|NCT00427778|157373309|FG000|First Intervention (4 Weeks)|anxious about using ring|1|||
48873259|NCT00427778|157373310|FG001|First Intervention (4 Weeks)|anxious about using ring|0|||
48873260|NCT01101997|157373311|FG000|Overall Study|Withdrawal by Subject|2|||
48873261|NCT02741713|157373312|FG000|Overall Study|Surgery type changed intra-operatively|2|||
48873262|NCT02741713|157373313|FG001|Overall Study|Surgery type changed intra-operatively|1|||
48873263|NCT00594178|157373314|FG000|Overall Study|Physician Decision|5|||
48873264|NCT02599688|157373315|FG000|Overall Study|Lack of Efficacy|1|||
48873265|NCT02599688|157373315|FG000|Overall Study|Withdrawal by Subject|1|||
48873266|NCT02599688|157373315|FG000|Overall Study|Termination by Sponsor|2|||
48873267|NCT00704171|157373325|FG000|Overall Study|Withdrawal by Subject|1|||
48873268|NCT00704171|157373326|FG001|Overall Study|Withdrawal by Subject|0|||
48873269|NCT00350298|157373329|FG000|Overall Study|Death|7|||
48873270|NCT00350298|157373330|FG001|Overall Study|Death|8|||
48873271|NCT00350298|157373329|FG000|Overall Study|Lost to Follow-up|1|||
48873272|NCT00350298|157373330|FG001|Overall Study|Lost to Follow-up|2|||
48873273|NCT00350298|157373329|FG000|Overall Study|Withdrawal by Subject|1|||
48873274|NCT00350298|157373330|FG001|Overall Study|Withdrawal by Subject|3|||
48873275|NCT02171130|157373331|FG000|Overall Study|Death|1|||
48873276|NCT02171130|157373331|FG000|Overall Study|Discontinued; Clinical Material Issue|16|||
48873277|NCT02171130|157373331|FG000|Overall Study|Discontinued; Site Termination|5|||
48873278|NCT02171130|157373331|FG000|Overall Study|Withdrawal by Subject|3|||
48873279|NCT02171130|157373331|FG000|Overall Study|Physician Decision|1|||
48873280|NCT02171130|157373331|FG000|Overall Study|Lost to Follow-up|1|||
48873281|NCT02171130|157373331|FG000|Overall Study|Met Exclusion Criteria|1|||
48873282|NCT00776659|157373339|FG000|Overall Study|Lost to Follow-up|15|||
48873283|NCT00776659|157373339|FG000|Overall Study|Withdrawal by Subject|10|||
48873284|NCT00776659|157373339|FG000|Overall Study|Study Terminated by Sponsor|1|||
48873285|NCT03082612|157373340|FG000|Overall Study|Lost to Follow-up|2|||
48873286|NCT03082612|157373341|FG001|Overall Study|Lost to Follow-up|0|||
48873287|NCT00129649|157373342|FG000|Overall Study|Withdrawal by Subject|76|||
48873288|NCT00129649|157373343|FG001|Overall Study|Withdrawal by Subject|65|||
48873289|NCT00025506|157373348|FG000|Overall Study|Ineligible: clerical error|1|||
48873290|NCT00025506|157373348|FG000|Overall Study|Ineligible: wrong cell type|5|||
48873291|NCT00025506|157373348|FG000|Overall Study|Ineligible: inadequate pathology|2|||
48873292|NCT00025506|157373348|FG000|Overall Study|Never Treated|2|||
48873293|NCT00713206|157373349|FG000|Overall Study|Lost to Follow-up|4|||
48873294|NCT00713206|157373350|FG001|Overall Study|Lost to Follow-up|4|||
48873295|NCT00713206|157373349|FG000|Overall Study|Death|1|||
48873296|NCT00713206|157373350|FG001|Overall Study|Death|0|||
48873297|NCT02561806|157373351|FG000|Induction Period|Adverse Event|0|||
48873298|NCT02561806|157373352|FG001|Induction Period|Adverse Event|2|||
48873299|NCT02561806|157373351|FG000|Induction Period|Lack of Efficacy|1|||
48873300|NCT02561806|157373352|FG001|Induction Period|Lack of Efficacy|0|||
48873301|NCT02561806|157373351|FG000|Induction Period|Withdrawal by Subject|0|||
48873302|NCT02561806|157373352|FG001|Induction Period|Withdrawal by Subject|2|||
48673913|NCT02828020|156659561|FG001|Treatment Period|Pregnancy|2|||
48673914|NCT02828020|156659562|FG002|Treatment Period|Pregnancy|0|||
48673915|NCT02828020|156659560|FG000|Treatment Period|Protocol Violation|2|||
48673916|NCT02828020|156659561|FG001|Treatment Period|Protocol Violation|4|||
48673917|NCT02828020|156659562|FG002|Treatment Period|Protocol Violation|7|||
48673918|NCT02828020|156659560|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
48673919|NCT02828020|156659561|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
48673920|NCT02828020|156659562|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
48673921|NCT02828020|156659560|FG000|Safety Follow-up Period|Withdrawal of Consent|10|||
48673922|NCT02828020|156659561|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
48673923|NCT02828020|156659562|FG002|Safety Follow-up Period|Withdrawal of Consent|7|||
48673924|NCT02828020|156659560|FG000|Safety Follow-up Period|Lost to Follow-up|9|||
48673925|NCT02828020|156659561|FG001|Safety Follow-up Period|Lost to Follow-up|8|||
48673926|NCT02828020|156659562|FG002|Safety Follow-up Period|Lost to Follow-up|11|||
48673927|NCT02828020|156659560|FG000|Safety Follow-up Period|Protocol Violation|0|||
48673928|NCT02828020|156659561|FG001|Safety Follow-up Period|Protocol Violation|2|||
48673929|NCT02828020|156659562|FG002|Safety Follow-up Period|Protocol Violation|1|||
48673930|NCT02828020|156659560|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|1|||
48673931|NCT02828020|156659561|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
48673932|NCT02828020|156659562|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
48673933|NCT01008904|156659563|FG000|Overall Study|Lost to Follow-up|1|||
48673934|NCT01008904|156659563|FG000|Overall Study|Adverse Event|2|||
48673935|NCT01008904|156659563|FG000|Overall Study|unexpected unrelated surgery|1|||
48673936|NCT00788710|156659564|FG000|Overall Study|Adverse Event|1|||
48673937|NCT00788710|156659565|FG001|Overall Study|Adverse Event|3|||
48673938|NCT00788710|156659566|FG002|Overall Study|Adverse Event|4|||
48673939|NCT00788710|156659564|FG000|Overall Study|Lack of Efficacy|0|||
48673940|NCT00788710|156659565|FG001|Overall Study|Lack of Efficacy|0|||
48873303|NCT02561806|157373351|FG000|Induction Period|Site staff became unblinded|1|||
48873304|NCT02561806|157373352|FG001|Induction Period|Site staff became unblinded|0|||
48873305|NCT02561806|157373351|FG000|Induction Period|Randomized but not treated|0|||
48873306|NCT02561806|157373352|FG001|Induction Period|Randomized but not treated|1|||
48873307|NCT02561806|157373351|FG000|Maintenance Period|Adverse Event|2|||
48873308|NCT02561806|157373352|FG001|Maintenance Period|Adverse Event|1|||
48873309|NCT02561806|157373351|FG000|Maintenance Period|Lack of Efficacy|3|||
48873310|NCT02561806|157373352|FG001|Maintenance Period|Lack of Efficacy|1|||
48873311|NCT02561806|157373351|FG000|Maintenance Period|Lost to Follow-up|2|||
48873312|NCT02561806|157373352|FG001|Maintenance Period|Lost to Follow-up|2|||
48873313|NCT02561806|157373351|FG000|Maintenance Period|Protocol Violation|1|||
48873314|NCT02561806|157373352|FG001|Maintenance Period|Protocol Violation|0|||
48873315|NCT02561806|157373351|FG000|Maintenance Period|Withdrawal by Subject|5|||
48873316|NCT02561806|157373352|FG001|Maintenance Period|Withdrawal by Subject|3|||
48873317|NCT02561806|157373351|FG000|Maintenance Period|Site staff became unblinded|0|||
48873318|NCT02561806|157373352|FG001|Maintenance Period|Site staff became unblinded|1|||
48873319|NCT02561806|157373351|FG000|Post-Treatment Follow-up|Lost to Follow-up|1|||
48873320|NCT02561806|157373352|FG001|Post-Treatment Follow-up|Lost to Follow-up|1|||
48873321|NCT02561806|157373351|FG000|Post-Treatment Follow-up|Withdrawal by Subject|1|||
48873322|NCT02561806|157373352|FG001|Post-Treatment Follow-up|Withdrawal by Subject|0|||
48873323|NCT04081389|157373353|FG000|Overall Study|Withdrawal by Subject|0|||
48873324|NCT04081389|157373354|FG001|Overall Study|Withdrawal by Subject|0|||
48873325|NCT04081389|157373355|FG002|Overall Study|Withdrawal by Subject|1|||
48873326|NCT04081389|157373356|FG003|Overall Study|Withdrawal by Subject|0|||
48873327|NCT02460562|157373357|FG000|Overall Study|Lost to Follow-up|15|||
48873328|NCT02460562|157373358|FG001|Overall Study|Lost to Follow-up|16|||
48873329|NCT02725567|157373359|FG000|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|0|||
48873330|NCT02725567|157373360|FG001|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|1|||
48873331|NCT02725567|157373359|FG000|Part B + A/B ( Up to 24 Weeks)|Physician Decision|0|||
48873332|NCT02725567|157373360|FG001|Part B + A/B ( Up to 24 Weeks)|Physician Decision|1|||
48873333|NCT02725567|157373359|FG000|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|0|||
48873334|NCT02725567|157373360|FG001|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|1|||
48873335|NCT01585298|157373361|FG000|Overall Study|Study completion was not documented.|1|||
48873336|NCT01585298|157373361|FG000|Overall Study|Protocol deviation|1|||
48873337|NCT01585298|157373361|FG000|Overall Study|Administrative problems|4|||
48873338|NCT01585298|157373361|FG000|Overall Study|Lost to Follow-up|2|||
48873339|NCT01585298|157373361|FG000|Overall Study|Withdrawal by Subject|4|||
48873340|NCT01585298|157373361|FG000|Overall Study|Abnormal test procedure results|1|||
48873341|NCT01585298|157373361|FG000|Overall Study|Adverse Event|24|||
48873342|NCT02108652|157373363|FG000|Overall Study|Death|253|||
48673941|NCT00788710|156659566|FG002|Overall Study|Lack of Efficacy|1|||
48673942|NCT00788710|156659564|FG000|Overall Study|Lost to Follow-up|0|||
48673943|NCT00788710|156659565|FG001|Overall Study|Lost to Follow-up|1|||
48673944|NCT00788710|156659566|FG002|Overall Study|Lost to Follow-up|0|||
48673945|NCT00788710|156659564|FG000|Overall Study|Physician Decision|2|||
48673946|NCT00788710|156659565|FG001|Overall Study|Physician Decision|1|||
48972908|NCT04839393|157731835|FG001|Overall Study|Withdrawal by participant|0|||
48972909|NCT04839393|157731836|FG002|Overall Study|Withdrawal by participant|1|||
48972910|NCT00762268|157731839|FG000|Overall Study|Withdrawal by Subject|3|||
48972911|NCT00762268|157731840|FG001|Overall Study|Withdrawal by Subject|3|||
48972912|NCT01001572|157731841|FG000|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32|||
48972913|NCT01001572|157731842|FG001|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
48972914|NCT01001572|157731843|FG002|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
48972915|NCT01001572|157731841|FG000|Single-Blind Valsartan 160 mg|Adverse Event|11|||
48972916|NCT01001572|157731842|FG001|Single-Blind Valsartan 160 mg|Adverse Event|0|||
48972917|NCT01001572|157731843|FG002|Single-Blind Valsartan 160 mg|Adverse Event|0|||
48972918|NCT01001572|157731841|FG000|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96|||
48972919|NCT01001572|157731842|FG001|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
48972920|NCT01001572|157731843|FG002|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
48972921|NCT01001572|157731841|FG000|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7|||
48972922|NCT01001572|157731842|FG001|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
48972923|NCT01001572|157731843|FG002|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
48972924|NCT01001572|157731841|FG000|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1|||
48972925|NCT01001572|157731842|FG001|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
48972926|NCT01001572|157731843|FG002|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
48972927|NCT01001572|157731841|FG000|Single-Blind Valsartan 160 mg|Lost to Follow-up|4|||
48972928|NCT01001572|157731842|FG001|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
48972929|NCT01001572|157731843|FG002|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
48972930|NCT01001572|157731841|FG000|Single-Blind Valsartan 160 mg|Administrative problems|82|||
48972931|NCT01001572|157731842|FG001|Single-Blind Valsartan 160 mg|Administrative problems|0|||
48972932|NCT01001572|157731843|FG002|Single-Blind Valsartan 160 mg|Administrative problems|0|||
48972933|NCT01001572|157731841|FG000|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45|||
48972934|NCT01001572|157731842|FG001|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
48972935|NCT01001572|157731843|FG002|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
48972936|NCT01001572|157731841|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
48972937|NCT01001572|157731842|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
48972938|NCT01001572|157731843|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
48972939|NCT01001572|157731841|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
48972940|NCT01001572|157731842|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|8|||
48972941|NCT01001572|157731843|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
48972942|NCT01001572|157731841|FG000|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
48972943|NCT01001572|157731842|FG001|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
48972944|NCT01001572|157731843|FG002|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1|||
48972945|NCT01001572|157731841|FG000|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
48972946|NCT01001572|157731842|FG001|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
48972947|NCT01001572|157731843|FG002|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1|||
48972948|NCT01001572|157731841|FG000|Double-Blind Treatment Phase|Protocol deviation|0|||
48972949|NCT01001572|157731842|FG001|Double-Blind Treatment Phase|Protocol deviation|0|||
48972950|NCT01001572|157731843|FG002|Double-Blind Treatment Phase|Protocol deviation|1|||
48972951|NCT01001572|157731841|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
48972952|NCT01001572|157731842|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
48972953|NCT01001572|157731843|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
48972954|NCT01094808|157731845|FG000|Overall Study|Withdrawal by Subject|1|||
48972955|NCT01094808|157731846|FG001|Overall Study|Withdrawal by Subject|1|||
48673947|NCT00788710|156659566|FG002|Overall Study|Physician Decision|0|||
48972956|NCT01094808|157731847|FG002|Overall Study|Withdrawal by Subject|0|||
48673948|NCT00788710|156659564|FG000|Overall Study|Protocol Violation|0|||
48673949|NCT00788710|156659565|FG001|Overall Study|Protocol Violation|1|||
48673950|NCT00788710|156659566|FG002|Overall Study|Protocol Violation|1|||
48673951|NCT00788710|156659564|FG000|Overall Study|Withdrawal by Subject|2|||
48673952|NCT00788710|156659565|FG001|Overall Study|Withdrawal by Subject|2|||
48673953|NCT00788710|156659566|FG002|Overall Study|Withdrawal by Subject|0|||
48673954|NCT01183065|156659567|FG000|Overall Study|Patient no longer fits eligibility crite|1|||
48673955|NCT01008449|156659569|FG000|Overall Study|Lost to Follow-up|29|||
48673956|NCT01008449|156659570|FG001|Overall Study|Lost to Follow-up|19|||
48673957|NCT01717326|156659571|FG000|Overall Study|Death|0|||
48673958|NCT01717326|156659572|FG001|Overall Study|Death|0|||
48673959|NCT01717326|156659573|FG002|Overall Study|Death|0|||
48673960|NCT01717326|156659574|FG003|Overall Study|Death|0|||
48673961|NCT01717326|156659575|FG004|Overall Study|Death|0|||
48673962|NCT01717326|156659576|FG005|Overall Study|Death|0|||
48673963|NCT01717326|156659577|FG006|Overall Study|Death|0|||
48673964|NCT01717326|156659578|FG007|Overall Study|Death|0|||
48673965|NCT01717326|156659579|FG008|Overall Study|Death|0|||
48673966|NCT01717326|156659580|FG009|Overall Study|Death|0|||
48673967|NCT01717326|156659581|FG010|Overall Study|Death|1|||
48673968|NCT01717326|156659582|FG011|Overall Study|Death|0|||
48673969|NCT01717326|156659583|FG012|Overall Study|Death|0|||
48673970|NCT01717326|156659584|FG013|Overall Study|Death|0|||
48673971|NCT01717326|156659585|FG014|Overall Study|Death|0|||
48673972|NCT01717326|156659586|FG015|Overall Study|Death|0|||
48673973|NCT01717326|156659587|FG016|Overall Study|Death|0|||
48673974|NCT01717326|156659588|FG017|Overall Study|Death|0|||
48673975|NCT01717326|156659589|FG018|Overall Study|Death|0|||
48673976|NCT01717326|156659590|FG019|Overall Study|Death|0|||
48673977|NCT01717326|156659571|FG000|Overall Study|Lost to Follow-up|3|||
48673978|NCT01717326|156659572|FG001|Overall Study|Lost to Follow-up|0|||
48673979|NCT01717326|156659573|FG002|Overall Study|Lost to Follow-up|0|||
48673980|NCT01717326|156659574|FG003|Overall Study|Lost to Follow-up|2|||
48673981|NCT01717326|156659575|FG004|Overall Study|Lost to Follow-up|1|||
48673982|NCT01717326|156659576|FG005|Overall Study|Lost to Follow-up|0|||
48673983|NCT01717326|156659577|FG006|Overall Study|Lost to Follow-up|1|||
48673984|NCT01717326|156659578|FG007|Overall Study|Lost to Follow-up|0|||
48673985|NCT01717326|156659579|FG008|Overall Study|Lost to Follow-up|0|||
48673986|NCT01717326|156659580|FG009|Overall Study|Lost to Follow-up|0|||
48673987|NCT01717326|156659581|FG010|Overall Study|Lost to Follow-up|1|||
48673988|NCT01717326|156659582|FG011|Overall Study|Lost to Follow-up|0|||
48673989|NCT01717326|156659583|FG012|Overall Study|Lost to Follow-up|0|||
48673990|NCT01717326|156659584|FG013|Overall Study|Lost to Follow-up|0|||
48673991|NCT01717326|156659585|FG014|Overall Study|Lost to Follow-up|0|||
48673992|NCT01717326|156659586|FG015|Overall Study|Lost to Follow-up|2|||
48673993|NCT01717326|156659587|FG016|Overall Study|Lost to Follow-up|1|||
48673994|NCT01717326|156659588|FG017|Overall Study|Lost to Follow-up|0|||
48673995|NCT01717326|156659589|FG018|Overall Study|Lost to Follow-up|2|||
48673996|NCT01717326|156659590|FG019|Overall Study|Lost to Follow-up|3|||
48673997|NCT01717326|156659571|FG000|Overall Study|Physician Decision|0|||
48673998|NCT01717326|156659572|FG001|Overall Study|Physician Decision|0|||
48673999|NCT01717326|156659573|FG002|Overall Study|Physician Decision|0|||
48674000|NCT01717326|156659574|FG003|Overall Study|Physician Decision|0|||
48674001|NCT01717326|156659575|FG004|Overall Study|Physician Decision|0|||
48674002|NCT01717326|156659576|FG005|Overall Study|Physician Decision|0|||
48674003|NCT01717326|156659577|FG006|Overall Study|Physician Decision|0|||
48674004|NCT01717326|156659578|FG007|Overall Study|Physician Decision|0|||
48674005|NCT01717326|156659579|FG008|Overall Study|Physician Decision|0|||
48674006|NCT01717326|156659580|FG009|Overall Study|Physician Decision|1|||
48674007|NCT01717326|156659581|FG010|Overall Study|Physician Decision|0|||
48674008|NCT01717326|156659582|FG011|Overall Study|Physician Decision|0|||
48674009|NCT01717326|156659583|FG012|Overall Study|Physician Decision|0|||
48674010|NCT01717326|156659584|FG013|Overall Study|Physician Decision|0|||
48674011|NCT01717326|156659585|FG014|Overall Study|Physician Decision|0|||
48674012|NCT01717326|156659586|FG015|Overall Study|Physician Decision|0|||
48674013|NCT01717326|156659587|FG016|Overall Study|Physician Decision|0|||
48674014|NCT01717326|156659588|FG017|Overall Study|Physician Decision|0|||
48674015|NCT01717326|156659589|FG018|Overall Study|Physician Decision|0|||
48674016|NCT01717326|156659590|FG019|Overall Study|Physician Decision|0|||
48674017|NCT01717326|156659571|FG000|Overall Study|Protocol Violation|0|||
48674018|NCT01717326|156659572|FG001|Overall Study|Protocol Violation|0|||
48674019|NCT01717326|156659573|FG002|Overall Study|Protocol Violation|0|||
48674020|NCT01717326|156659574|FG003|Overall Study|Protocol Violation|0|||
48674021|NCT01717326|156659575|FG004|Overall Study|Protocol Violation|1|||
48674022|NCT01717326|156659576|FG005|Overall Study|Protocol Violation|0|||
48674023|NCT01717326|156659577|FG006|Overall Study|Protocol Violation|0|||
48674024|NCT01717326|156659578|FG007|Overall Study|Protocol Violation|0|||
48674025|NCT01717326|156659579|FG008|Overall Study|Protocol Violation|0|||
48674026|NCT01717326|156659580|FG009|Overall Study|Protocol Violation|0|||
48674027|NCT01717326|156659581|FG010|Overall Study|Protocol Violation|0|||
48674028|NCT01717326|156659582|FG011|Overall Study|Protocol Violation|0|||
48674029|NCT01717326|156659583|FG012|Overall Study|Protocol Violation|0|||
48674030|NCT01717326|156659584|FG013|Overall Study|Protocol Violation|0|||
48674031|NCT01717326|156659585|FG014|Overall Study|Protocol Violation|0|||
48674032|NCT01717326|156659586|FG015|Overall Study|Protocol Violation|0|||
48674033|NCT01717326|156659587|FG016|Overall Study|Protocol Violation|0|||
48674034|NCT01717326|156659588|FG017|Overall Study|Protocol Violation|0|||
48674035|NCT01717326|156659589|FG018|Overall Study|Protocol Violation|0|||
48674036|NCT01717326|156659590|FG019|Overall Study|Protocol Violation|0|||
48674037|NCT01717326|156659571|FG000|Overall Study|Withdrawal by Subject|0|||
48674038|NCT01717326|156659572|FG001|Overall Study|Withdrawal by Subject|1|||
48674039|NCT01717326|156659573|FG002|Overall Study|Withdrawal by Subject|0|||
48674040|NCT01717326|156659574|FG003|Overall Study|Withdrawal by Subject|0|||
48674041|NCT01717326|156659575|FG004|Overall Study|Withdrawal by Subject|0|||
48674042|NCT01717326|156659576|FG005|Overall Study|Withdrawal by Subject|0|||
48674043|NCT01717326|156659577|FG006|Overall Study|Withdrawal by Subject|0|||
48674044|NCT01717326|156659578|FG007|Overall Study|Withdrawal by Subject|0|||
48674045|NCT01717326|156659579|FG008|Overall Study|Withdrawal by Subject|0|||
48674046|NCT01717326|156659580|FG009|Overall Study|Withdrawal by Subject|1|||
48674047|NCT01717326|156659581|FG010|Overall Study|Withdrawal by Subject|0|||
48674048|NCT01717326|156659582|FG011|Overall Study|Withdrawal by Subject|0|||
48674049|NCT01717326|156659583|FG012|Overall Study|Withdrawal by Subject|1|||
48674050|NCT01717326|156659584|FG013|Overall Study|Withdrawal by Subject|0|||
48674051|NCT01717326|156659585|FG014|Overall Study|Withdrawal by Subject|0|||
48674052|NCT01717326|156659586|FG015|Overall Study|Withdrawal by Subject|1|||
48674053|NCT01717326|156659587|FG016|Overall Study|Withdrawal by Subject|0|||
49015499|NCT01393990|157893777|FG007|Overall Study|Withdrawal by Subject|0|||
48674054|NCT01717326|156659588|FG017|Overall Study|Withdrawal by Subject|0|||
48674055|NCT01717326|156659589|FG018|Overall Study|Withdrawal by Subject|2|||
48674056|NCT01717326|156659590|FG019|Overall Study|Withdrawal by Subject|3|||
48674057|NCT01123707|156659591|FG000|Overall Study|Lost to Follow-up|3|||
48674058|NCT01123707|156659592|FG001|Overall Study|Lost to Follow-up|1|||
48674059|NCT01123707|156659593|FG002|Overall Study|Lost to Follow-up|3|||
48674060|NCT01123707|156659594|FG003|Overall Study|Lost to Follow-up|2|||
48674061|NCT01123707|156659591|FG000|Overall Study|Adverse Event|5|||
48674062|NCT01123707|156659592|FG001|Overall Study|Adverse Event|7|||
48674063|NCT01123707|156659593|FG002|Overall Study|Adverse Event|5|||
48674064|NCT01123707|156659594|FG003|Overall Study|Adverse Event|3|||
48674065|NCT01123707|156659591|FG000|Overall Study|Sponsor Discontinued Study|30|||
48674066|NCT01123707|156659592|FG001|Overall Study|Sponsor Discontinued Study|24|||
48761272|NCT00673179|156974067|FG001|Overall Study|Toxicity/Complications|0|||
48761273|NCT00281684|156974070|FG000|Overall Study|Lost to Follow-up|0|||
48761274|NCT00281684|156974071|FG001|Overall Study|Lost to Follow-up|0|||
48761275|NCT00281684|156974072|FG002|Overall Study|Lost to Follow-up|1|||
48761276|NCT00281684|156974073|FG003|Overall Study|Lost to Follow-up|0|||
48761277|NCT00281684|156974070|FG000|Overall Study|Withdrawal by Subject|1|||
48761278|NCT00281684|156974071|FG001|Overall Study|Withdrawal by Subject|0|||
48761279|NCT00281684|156974072|FG002|Overall Study|Withdrawal by Subject|0|||
48761280|NCT00281684|156974073|FG003|Overall Study|Withdrawal by Subject|0|||
48761281|NCT01536379|156975597|FG000|Overall Study|Adverse Event|1|||
48761282|NCT01536379|156975598|FG001|Overall Study|Adverse Event|2|||
48761283|NCT01536379|156975597|FG000|Overall Study|Withdrawal by Subject|1|||
48761284|NCT01536379|156975598|FG001|Overall Study|Withdrawal by Subject|1|||
48761285|NCT02081690|156975599|FG000|Overall Study|Death|3|||
48761286|NCT02081690|156975599|FG000|Overall Study|Physician Decision|3|||
48761287|NCT02081690|156975599|FG000|Overall Study|Withdrawal by Subject|1|||
48761288|NCT01852942|156975606|FG000|Overall Study|Physician Decision|1|||
48761289|NCT01852942|156975607|FG001|Overall Study|Physician Decision|0|||
48761290|NCT01852942|156975606|FG000|Overall Study|Death|1|||
48761291|NCT01852942|156975607|FG001|Overall Study|Death|1|||
48761292|NCT01852942|156975606|FG000|Overall Study|Withdrawal by Subject|2|||
48761293|NCT01852942|156975607|FG001|Overall Study|Withdrawal by Subject|3|||
48761294|NCT01852942|156975606|FG000|Overall Study|Lost to Follow-up|1|||
48761295|NCT01852942|156975607|FG001|Overall Study|Lost to Follow-up|2|||
48761296|NCT03025542|156975609|FG000|Overall Study|Adverse Event|0|||
48761297|NCT03025542|156975610|FG001|Overall Study|Adverse Event|2|||
48761298|NCT03025542|156975609|FG000|Overall Study|Lost to Follow-up|1|||
48761299|NCT03025542|156975610|FG001|Overall Study|Lost to Follow-up|0|||
48761300|NCT03025542|156975609|FG000|Overall Study|Withdrawal by Subject|1|||
48761301|NCT03025542|156975610|FG001|Overall Study|Withdrawal by Subject|0|||
48761302|NCT00415909|156975611|FG000|Overall Study|Withdrawal by Subject|2|||
48674067|NCT01123707|156659593|FG002|Overall Study|Sponsor Discontinued Study|25|||
48761303|NCT00415909|156975611|FG000|Overall Study|Death|1|||
48761304|NCT00702403|156975612|FG000|From Consent to Engraftment|Progressive leukemia|6|||
48761305|NCT00702403|156975612|FG000|From Consent to Engraftment|Critically ill|2|||
48674068|NCT01123707|156659594|FG003|Overall Study|Sponsor Discontinued Study|40|||
48761306|NCT00702403|156975612|FG000|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2|||
48761307|NCT00702403|156975612|FG000|From Consent to Engraftment|Myocardial infarction|1|||
48761308|NCT00702403|156975612|FG000|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4|||
48873343|NCT02108652|157373363|FG000|Overall Study|Lost to Follow-up|2|||
48873344|NCT02108652|157373363|FG000|Overall Study|Withdrawal by Subject|16|||
48873345|NCT02108652|157373363|FG000|Overall Study|Study Terminated By Sponsor|31|||
48873346|NCT02108652|157373363|FG000|Overall Study|Non-Compliance|1|||
48873347|NCT02108652|157373363|FG000|Overall Study|Physician Decision|6|||
48873348|NCT02108652|157373363|FG000|Overall Study|Progression Of Disease|1|||
48873349|NCT03845075|157373366|FG000|Part 1 - DB|Withdrawal by Subject|1|||
48873350|NCT03845075|157373367|FG001|Part 1 - DB|Withdrawal by Subject|1|||
48873351|NCT03845075|157373368|FG002|Part 1 - DB|Withdrawal by Subject|0|||
48873352|NCT03845075|157373369|FG003|Part 1 - DB|Withdrawal by Subject|0|||
48873353|NCT03845075|157373366|FG000|Part 1 - DB|Adverse Event|0|||
48873354|NCT03845075|157373367|FG001|Part 1 - DB|Adverse Event|1|||
48873355|NCT03845075|157373368|FG002|Part 1 - DB|Adverse Event|0|||
48873356|NCT03845075|157373369|FG003|Part 1 - DB|Adverse Event|0|||
48873357|NCT03845075|157373366|FG000|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|1|||
48873358|NCT03845075|157373367|FG001|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
48873359|NCT03845075|157373368|FG002|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
48873360|NCT03845075|157373369|FG003|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
48972957|NCT01444898|157731848|FG000|Overall Study|Withdrawal by Subject|1|||
48972958|NCT01181141|157731849|FG000|Overall Study|Adverse Event|2|||
48972959|NCT01181141|157731850|FG001|Overall Study|Adverse Event|1|||
48972960|NCT01181141|157731849|FG000|Overall Study|Lack of Efficacy|1|||
48972961|NCT01181141|157731850|FG001|Overall Study|Lack of Efficacy|0|||
48972962|NCT01181141|157731849|FG000|Overall Study|Lost to Follow-up|1|||
48972963|NCT01181141|157731850|FG001|Overall Study|Lost to Follow-up|1|||
48972964|NCT01181141|157731849|FG000|Overall Study|Physician Decision|2|||
48972965|NCT01181141|157731850|FG001|Overall Study|Physician Decision|0|||
48972966|NCT01181141|157731849|FG000|Overall Study|Protocol Violation|3|||
48972967|NCT01181141|157731850|FG001|Overall Study|Protocol Violation|1|||
48972968|NCT01181141|157731849|FG000|Overall Study|Withdrawal by Subject|3|||
48972969|NCT01181141|157731850|FG001|Overall Study|Withdrawal by Subject|1|||
48972970|NCT02001688|157731854|FG000|Overall Study|Withdrawal by Subject|0|||
48972971|NCT02001688|157731855|FG001|Overall Study|Withdrawal by Subject|0|||
48972972|NCT02001688|157731856|FG002|Overall Study|Withdrawal by Subject|1|||
48972973|NCT02001688|157731854|FG000|Overall Study|Adverse Event|0|||
48972974|NCT02001688|157731855|FG001|Overall Study|Adverse Event|1|||
48972975|NCT02001688|157731856|FG002|Overall Study|Adverse Event|0|||
48972976|NCT01628393|157731857|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|1|||
48972977|NCT01628393|157731858|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
48972978|NCT01628393|157731859|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
48972979|NCT01628393|157731860|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
48972980|NCT01628393|157731861|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
48972981|NCT01628393|157731857|FG000|Placebo-controlled Treatment Period|Protocol Violation|0|||
48972982|NCT01628393|157731858|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
48972983|NCT01628393|157731859|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
48972984|NCT01628393|157731860|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
48972985|NCT01628393|157731861|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
48972986|NCT01628393|157731857|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
48972987|NCT01628393|157731858|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
48972988|NCT01628393|157731859|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
48972989|NCT01628393|157731860|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
48972990|NCT01628393|157731861|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
48972991|NCT01628393|157731857|FG000|Blinded Active Extension Period|Adverse Event|0|||
48972992|NCT01628393|157731858|FG001|Blinded Active Extension Period|Adverse Event|1|||
48972993|NCT01628393|157731859|FG002|Blinded Active Extension Period|Adverse Event|0|||
48972994|NCT01628393|157731860|FG003|Blinded Active Extension Period|Adverse Event|2|||
48972995|NCT01628393|157731861|FG004|Blinded Active Extension Period|Adverse Event|2|||
48972996|NCT01628393|157731857|FG000|Blinded Active Extension Period|Lack of Efficacy|0|||
48972997|NCT01628393|157731858|FG001|Blinded Active Extension Period|Lack of Efficacy|0|||
48972998|NCT01628393|157731859|FG002|Blinded Active Extension Period|Lack of Efficacy|2|||
48972999|NCT01628393|157731860|FG003|Blinded Active Extension Period|Lack of Efficacy|0|||
48973000|NCT01628393|157731861|FG004|Blinded Active Extension Period|Lack of Efficacy|2|||
48973001|NCT01628393|157731857|FG000|Blinded Active Extension Period|Physician Decision|0|||
48973002|NCT01628393|157731858|FG001|Blinded Active Extension Period|Physician Decision|3|||
48973003|NCT01628393|157731859|FG002|Blinded Active Extension Period|Physician Decision|0|||
48973004|NCT01628393|157731860|FG003|Blinded Active Extension Period|Physician Decision|1|||
48973005|NCT01628393|157731861|FG004|Blinded Active Extension Period|Physician Decision|0|||
48973006|NCT01628393|157731857|FG000|Blinded Active Extension Period|Protocol Violation|0|||
48973007|NCT01628393|157731858|FG001|Blinded Active Extension Period|Protocol Violation|0|||
48973008|NCT01628393|157731859|FG002|Blinded Active Extension Period|Protocol Violation|2|||
49015500|NCT01393990|157893778|FG008|Overall Study|Withdrawal by Subject|0|||
48674069|NCT01123707|156659591|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
48674070|NCT01123707|156659592|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
48674071|NCT01123707|156659593|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
48674072|NCT01123707|156659594|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
48674073|NCT01123707|156659591|FG000|Overall Study|Investigator Withdrew Participant|0|||
48674074|NCT01123707|156659592|FG001|Overall Study|Investigator Withdrew Participant|1|||
48674075|NCT01123707|156659593|FG002|Overall Study|Investigator Withdrew Participant|1|||
48674076|NCT01123707|156659594|FG003|Overall Study|Investigator Withdrew Participant|1|||
48674077|NCT01123707|156659591|FG000|Overall Study|Subject Withdrew Consent|4|||
48674078|NCT01123707|156659592|FG001|Overall Study|Subject Withdrew Consent|5|||
48674079|NCT01123707|156659593|FG002|Overall Study|Subject Withdrew Consent|1|||
48674080|NCT01123707|156659594|FG003|Overall Study|Subject Withdrew Consent|2|||
48674081|NCT01123707|156659591|FG000|Overall Study|Lack of Efficacy|1|||
48674082|NCT01123707|156659592|FG001|Overall Study|Lack of Efficacy|2|||
48674083|NCT01123707|156659593|FG002|Overall Study|Lack of Efficacy|1|||
48674084|NCT01123707|156659594|FG003|Overall Study|Lack of Efficacy|0|||
48674085|NCT01123707|156659591|FG000|Overall Study|Subject Met Exclusion Criteria|0|||
48973009|NCT01628393|157731860|FG003|Blinded Active Extension Period|Protocol Violation|1|||
48873361|NCT00690378|157373370|FG000|Overall Study|Adverse Event|1|||
48873362|NCT00690378|157373371|FG001|Overall Study|Adverse Event|0|||
48873363|NCT00690378|157373370|FG000|Overall Study|Withdrawal by Subject|2|||
48873364|NCT00690378|157373371|FG001|Overall Study|Withdrawal by Subject|0|||
48873365|NCT00690378|157373370|FG000|Overall Study|Protocol Violation|1|||
48873366|NCT00690378|157373371|FG001|Overall Study|Protocol Violation|0|||
48873367|NCT00690378|157373370|FG000|Overall Study|Lost to Follow-up|2|||
48761309|NCT00702403|156975612|FG000|From Consent to Engraftment|Miscellaneous (unanticipated) other|2|||
48761310|NCT00702403|156975612|FG000|From Engraftment to Study Completion|Failed pre-1st dose criteria|11|||
48761311|NCT00702403|156975612|FG000|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4|||
48761312|NCT00702403|156975612|FG000|From Engraftment to Study Completion|Non-compliance|2|||
48761313|NCT00702403|156975612|FG000|From Engraftment to Study Completion|Adenocarcinoma|1|||
48761314|NCT00702403|156975612|FG000|From Engraftment to Study Completion|Liver GVHD|1|||
48761315|NCT00702403|156975612|FG000|From Engraftment to Study Completion|Suicide|1|||
48761316|NCT00702403|156975612|FG000|From Engraftment to Study Completion|Acute respiratory distress syndrome|1|||
48761317|NCT00702403|156975612|FG000|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1|||
48761318|NCT00702403|156975612|FG000|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5|||
48761319|NCT00380978|156975614|FG000|Overall Study|Refused allocated intervention|0|||
48761320|NCT00380978|156975615|FG001|Overall Study|Refused allocated intervention|6|||
48761321|NCT00380978|156975614|FG000|Overall Study|Wrong study envelope|0|||
48761322|NCT00380978|156975615|FG001|Overall Study|Wrong study envelope|2|||
48761323|NCT00380978|156975614|FG000|Overall Study|Allocation prior to analgesia request|1|||
48761324|NCT00380978|156975615|FG001|Overall Study|Allocation prior to analgesia request|2|||
48761325|NCT00380978|156975614|FG000|Overall Study|Parous patient|1|||
48761326|NCT00380978|156975615|FG001|Overall Study|Parous patient|0|||
48761327|NCT00225251|156975616|FG000|Overall Study|Withdrawal by Subject|1|||
48761328|NCT00225251|156975617|FG001|Overall Study|Withdrawal by Subject|1|||
48761329|NCT01287897|156975618|FG000|Overall Study|Adverse Event|5|||
48761330|NCT01287897|156975619|FG001|Overall Study|Adverse Event|3|||
48761331|NCT01287897|156975620|FG002|Overall Study|Adverse Event|6|||
48761332|NCT01287897|156975621|FG003|Overall Study|Adverse Event|4|||
48761333|NCT01287897|156975618|FG000|Overall Study|Lack of Efficacy|2|||
48761334|NCT01287897|156975619|FG001|Overall Study|Lack of Efficacy|0|||
48761335|NCT01287897|156975620|FG002|Overall Study|Lack of Efficacy|0|||
48761336|NCT01287897|156975621|FG003|Overall Study|Lack of Efficacy|0|||
48761337|NCT01287897|156975618|FG000|Overall Study|Protocol Violation|1|||
48761338|NCT01287897|156975619|FG001|Overall Study|Protocol Violation|1|||
48761339|NCT01287897|156975620|FG002|Overall Study|Protocol Violation|0|||
48761340|NCT01287897|156975621|FG003|Overall Study|Protocol Violation|1|||
48761341|NCT01287897|156975618|FG000|Overall Study|Lost to Follow-up|0|||
48761342|NCT01287897|156975619|FG001|Overall Study|Lost to Follow-up|0|||
48761343|NCT01287897|156975620|FG002|Overall Study|Lost to Follow-up|2|||
48761344|NCT01287897|156975621|FG003|Overall Study|Lost to Follow-up|0|||
48761345|NCT01287897|156975618|FG000|Overall Study|Withdrawal by Subject|1|||
48761346|NCT01287897|156975619|FG001|Overall Study|Withdrawal by Subject|5|||
48761347|NCT01287897|156975620|FG002|Overall Study|Withdrawal by Subject|3|||
48761348|NCT01287897|156975621|FG003|Overall Study|Withdrawal by Subject|2|||
48761349|NCT01287897|156975618|FG000|Overall Study|Not consented properly|0|||
48761350|NCT01287897|156975619|FG001|Overall Study|Not consented properly|1|||
48761351|NCT01287897|156975620|FG002|Overall Study|Not consented properly|0|||
48761352|NCT01287897|156975621|FG003|Overall Study|Not consented properly|0|||
48761353|NCT01287897|156975618|FG000|Overall Study|Not meeting entrance criteria|1|||
48761354|NCT01287897|156975619|FG001|Overall Study|Not meeting entrance criteria|1|||
48761355|NCT01287897|156975620|FG002|Overall Study|Not meeting entrance criteria|0|||
48761356|NCT01287897|156975621|FG003|Overall Study|Not meeting entrance criteria|0|||
48761357|NCT01287897|156975618|FG000|Overall Study|Other|1|||
48761358|NCT01287897|156975619|FG001|Overall Study|Other|0|||
48761359|NCT01287897|156975620|FG002|Overall Study|Other|1|||
48761360|NCT01287897|156975621|FG003|Overall Study|Other|0|||
48873368|NCT00690378|157373371|FG001|Overall Study|Lost to Follow-up|3|||
48873369|NCT00690378|157373370|FG000|Overall Study|Did not meet inc/exc criteria|13|||
48873370|NCT00690378|157373371|FG001|Overall Study|Did not meet inc/exc criteria|11|||
48873371|NCT00690378|157373370|FG000|Overall Study|Social problem|1|||
48873372|NCT00690378|157373371|FG001|Overall Study|Social problem|0|||
48873373|NCT00935259|157373372|FG000|Period 1|Administrative (scheduling conflict)|1|||
48873374|NCT00935259|157373373|FG001|Period 1|Administrative (scheduling conflict)|1|||
48873375|NCT00537329|157373374|FG000|Overall Study|Death|10|||
48761361|NCT01499667|156975626|FG000|Overall Study|administrative problems|4|||
48761362|NCT01499667|156975627|FG001|Overall Study|administrative problems|5|||
48761363|NCT01499667|156975628|FG002|Overall Study|administrative problems|5|||
48761364|NCT01499667|156975626|FG000|Overall Study|Protocol Violation|1|||
48761365|NCT01499667|156975627|FG001|Overall Study|Protocol Violation|3|||
48873376|NCT00537329|157373374|FG000|Overall Study|Adverse Event|3|||
48761366|NCT01499667|156975628|FG002|Overall Study|Protocol Violation|2|||
48761367|NCT01499667|156975626|FG000|Overall Study|Adverse Event|0|||
48674086|NCT01123707|156659592|FG001|Overall Study|Subject Met Exclusion Criteria|0|||
48674087|NCT01123707|156659593|FG002|Overall Study|Subject Met Exclusion Criteria|2|||
48674088|NCT01123707|156659594|FG003|Overall Study|Subject Met Exclusion Criteria|1|||
48674089|NCT02687581|156659596|FG000|Overall Study|Withdrawal by Subject|1|||
48674090|NCT02687581|156659597|FG001|Overall Study|Withdrawal by Subject|0|||
48674091|NCT02687581|156659598|FG002|Overall Study|Withdrawal by Subject|0|||
48674092|NCT02687581|156659599|FG003|Overall Study|Withdrawal by Subject|1|||
48674093|NCT02687581|156659596|FG000|Overall Study|Lost to Follow-up|2|||
48674094|NCT02687581|156659597|FG001|Overall Study|Lost to Follow-up|2|||
48674095|NCT02687581|156659598|FG002|Overall Study|Lost to Follow-up|0|||
48973010|NCT01628393|157731861|FG004|Blinded Active Extension Period|Protocol Violation|0|||
48973011|NCT01628393|157731857|FG000|Blinded Active Extension Period|Withdrawal by Subject|0|||
48973012|NCT01628393|157731858|FG001|Blinded Active Extension Period|Withdrawal by Subject|6|||
48973013|NCT01628393|157731859|FG002|Blinded Active Extension Period|Withdrawal by Subject|2|||
48973014|NCT01628393|157731860|FG003|Blinded Active Extension Period|Withdrawal by Subject|0|||
48973015|NCT01628393|157731861|FG004|Blinded Active Extension Period|Withdrawal by Subject|2|||
48973016|NCT01548417|157731867|FG000|Overall Study|Withdrawal by Subject|0|||
48973017|NCT01548417|157731868|FG001|Overall Study|Withdrawal by Subject|2|||
48973018|NCT03168555|157731869|FG000|Visit 1 (Pro-operative)|intercurrent disease, drop-out before visit 1|1|||
48973019|NCT03168555|157731869|FG000|Visit 2 (Post-operative)|Lost to Follow-up|1|||
48973020|NCT03168555|157731869|FG000|Visit 2 (Post-operative)|Adverse Event|1|||
48973021|NCT03168555|157731869|FG000|Visit 2 (Post-operative)|Withdrawal by Subject|2|||
48973022|NCT04423757|157731872|FG000|Overall Study|Adverse Event|2|||
48973023|NCT04423757|157731873|FG001|Overall Study|Adverse Event|0|||
48973024|NCT04423757|157731872|FG000|Overall Study|Not treated|1|||
48973025|NCT04423757|157731873|FG001|Overall Study|Not treated|1|||
48973026|NCT01000025|157731874|FG000|Overall Study|Adverse Event|43|||
48973027|NCT01000025|157731875|FG001|Overall Study|Adverse Event|2|||
48973028|NCT01000025|157731874|FG000|Overall Study|Withdrawal by Subject|13|||
48973029|NCT01000025|157731875|FG001|Overall Study|Withdrawal by Subject|8|||
48973030|NCT01000025|157731874|FG000|Overall Study|Death|23|||
48973031|NCT01000025|157731875|FG001|Overall Study|Death|13|||
48973032|NCT01000025|157731874|FG000|Overall Study|Lack of Efficacy|363|||
48973033|NCT01000025|157731875|FG001|Overall Study|Lack of Efficacy|208|||
48973034|NCT01000025|157731874|FG000|Overall Study|Intercurrent Illness|26|||
48973035|NCT01000025|157731875|FG001|Overall Study|Intercurrent Illness|7|||
48973036|NCT02571972|157731876|FG000|Overall Study|Protocol Violation|2|||
48973037|NCT02571972|157731876|FG000|Overall Study|Withdrawal by Subject|2|||
48973038|NCT02917629|157731877|FG000|Overall Study|Withdrawal by Subject|0|||
48973039|NCT02917629|157731878|FG001|Overall Study|Withdrawal by Subject|1|||
48973040|NCT00701103|157731882|FG000|Overall Study|Adverse Event|0|||
48973041|NCT00701103|157731883|FG001|Overall Study|Adverse Event|0|||
48973042|NCT00701103|157731884|FG002|Overall Study|Adverse Event|1|||
48674096|NCT02687581|156659599|FG003|Overall Study|Lost to Follow-up|0|||
48674097|NCT02687581|156659596|FG000|Overall Study|the device is too small for the patient.|1|||
48973043|NCT00701103|157731885|FG003|Overall Study|Adverse Event|1|||
48973044|NCT00701103|157731886|FG004|Overall Study|Adverse Event|0|||
48973045|NCT00701103|157731887|FG005|Overall Study|Adverse Event|1|||
48973046|NCT00701103|157731888|FG006|Overall Study|Adverse Event|1|||
48973047|NCT00701103|157731889|FG007|Overall Study|Adverse Event|0|||
48973048|NCT00701103|157731890|FG008|Overall Study|Adverse Event|0|||
48973049|NCT00701103|157731891|FG009|Overall Study|Adverse Event|2|||
48973050|NCT00701103|157731892|FG010|Overall Study|Adverse Event|0|||
48973051|NCT00701103|157731882|FG000|Overall Study|Progressive Disease|5|||
48973052|NCT00701103|157731883|FG001|Overall Study|Progressive Disease|2|||
48973053|NCT00701103|157731884|FG002|Overall Study|Progressive Disease|6|||
48973054|NCT00701103|157731885|FG003|Overall Study|Progressive Disease|5|||
48973055|NCT00701103|157731886|FG004|Overall Study|Progressive Disease|6|||
48973056|NCT00701103|157731887|FG005|Overall Study|Progressive Disease|5|||
48973057|NCT00701103|157731888|FG006|Overall Study|Progressive Disease|7|||
48973058|NCT00701103|157731889|FG007|Overall Study|Progressive Disease|7|||
48973059|NCT00701103|157731890|FG008|Overall Study|Progressive Disease|8|||
48973060|NCT00701103|157731891|FG009|Overall Study|Progressive Disease|8|||
48973061|NCT00701103|157731892|FG010|Overall Study|Progressive Disease|11|||
48973062|NCT00701103|157731882|FG000|Overall Study|Withdrawal by Subject|0|||
48973063|NCT00701103|157731883|FG001|Overall Study|Withdrawal by Subject|1|||
48973064|NCT00701103|157731884|FG002|Overall Study|Withdrawal by Subject|1|||
48973065|NCT00701103|157731885|FG003|Overall Study|Withdrawal by Subject|0|||
48973066|NCT00701103|157731886|FG004|Overall Study|Withdrawal by Subject|0|||
48973067|NCT00701103|157731887|FG005|Overall Study|Withdrawal by Subject|0|||
48674098|NCT02687581|156659597|FG001|Overall Study|the device is too small for the patient.|0|||
48973068|NCT00701103|157731888|FG006|Overall Study|Withdrawal by Subject|0|||
48973069|NCT00701103|157731889|FG007|Overall Study|Withdrawal by Subject|0|||
48973070|NCT00701103|157731890|FG008|Overall Study|Withdrawal by Subject|0|||
48674099|NCT02687581|156659598|FG002|Overall Study|the device is too small for the patient.|0|||
48973071|NCT00701103|157731891|FG009|Overall Study|Withdrawal by Subject|0|||
48973072|NCT00701103|157731892|FG010|Overall Study|Withdrawal by Subject|0|||
48973073|NCT00701103|157731882|FG000|Overall Study|Other|0|||
48973074|NCT00701103|157731883|FG001|Overall Study|Other|0|||
48973075|NCT00701103|157731884|FG002|Overall Study|Other|0|||
48973076|NCT00701103|157731885|FG003|Overall Study|Other|0|||
48973077|NCT00701103|157731886|FG004|Overall Study|Other|0|||
48973078|NCT00701103|157731887|FG005|Overall Study|Other|0|||
48973079|NCT00701103|157731888|FG006|Overall Study|Other|0|||
48973080|NCT00701103|157731889|FG007|Overall Study|Other|0|||
48973081|NCT00701103|157731890|FG008|Overall Study|Other|1|||
48973082|NCT00701103|157731891|FG009|Overall Study|Other|1|||
48973083|NCT00701103|157731892|FG010|Overall Study|Other|0|||
48973084|NCT03339401|157731895|FG000|Overall Study|Death|2|||
48973085|NCT03339401|157731896|FG001|Overall Study|Death|1|||
48973086|NCT03339401|157731895|FG000|Overall Study|Withdrawal by Subject|2|||
48973087|NCT03339401|157731896|FG001|Overall Study|Withdrawal by Subject|0|||
48973088|NCT03339401|157731895|FG000|Overall Study|Study terminated|4|||
48973089|NCT03339401|157731896|FG001|Overall Study|Study terminated|3|||
48973090|NCT03339401|157731895|FG000|Overall Study|Investigator Decision|1|||
48973091|NCT03339401|157731896|FG001|Overall Study|Investigator Decision|0|||
48973092|NCT00718523|157731897|FG000|Overall Study|Withdrawal by Subject|5|||
48973093|NCT00718523|157731898|FG001|Overall Study|Withdrawal by Subject|7|||
48973094|NCT00718523|157731897|FG000|Overall Study|Death|13|||
48973095|NCT00718523|157731898|FG001|Overall Study|Death|17|||
48973096|NCT02762708|157731901|FG000|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
48973097|NCT02762708|157731902|FG001|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|2|||
48973098|NCT02762708|157731903|FG002|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
48973099|NCT02762708|157731904|FG003|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
48973100|NCT03271307|157731905|FG000|Overall Study|Lost to Follow-up|0|||
48973101|NCT03271307|157731906|FG001|Overall Study|Lost to Follow-up|0|||
48973102|NCT03271307|157731907|FG002|Overall Study|Lost to Follow-up|0|||
48973103|NCT03271307|157731908|FG003|Overall Study|Lost to Follow-up|28|||
48973104|NCT03271307|157731909|FG004|Overall Study|Lost to Follow-up|91|||
48973105|NCT01929707|157731910|FG000|Intervention Period 1|Lost to Follow-up|0|||
48973106|NCT01929707|157731911|FG001|Intervention Period 1|Lost to Follow-up|0|||
48973107|NCT01929707|157731912|FG002|Intervention Period 1|Lost to Follow-up|0|||
48973108|NCT01929707|157731913|FG003|Intervention Period 1|Lost to Follow-up|1|||
48973109|NCT01929707|157731914|FG004|Intervention Period 1|Lost to Follow-up|0|||
48973110|NCT01929707|157731915|FG005|Intervention Period 1|Lost to Follow-up|0|||
48973111|NCT01929707|157731916|FG006|Intervention Period 1|Lost to Follow-up|0|||
48973112|NCT01929707|157731917|FG007|Intervention Period 1|Lost to Follow-up|0|||
48973113|NCT01929707|157731910|FG000|Intervention Period 1|Withdrawal by Subject|0|||
48973114|NCT01929707|157731911|FG001|Intervention Period 1|Withdrawal by Subject|0|||
48973115|NCT01929707|157731912|FG002|Intervention Period 1|Withdrawal by Subject|0|||
48973116|NCT01929707|157731913|FG003|Intervention Period 1|Withdrawal by Subject|2|||
48973117|NCT01929707|157731914|FG004|Intervention Period 1|Withdrawal by Subject|0|||
48973118|NCT01929707|157731915|FG005|Intervention Period 1|Withdrawal by Subject|0|||
48973119|NCT01929707|157731916|FG006|Intervention Period 1|Withdrawal by Subject|0|||
48973120|NCT01929707|157731917|FG007|Intervention Period 1|Withdrawal by Subject|0|||
48973121|NCT01929707|157731910|FG000|Intervention Period 2|Withdrawal by Subject|0|||
48973122|NCT01929707|157731911|FG001|Intervention Period 2|Withdrawal by Subject|0|||
48973123|NCT01929707|157731912|FG002|Intervention Period 2|Withdrawal by Subject|0|||
48973124|NCT01929707|157731913|FG003|Intervention Period 2|Withdrawal by Subject|0|||
48973125|NCT01929707|157731914|FG004|Intervention Period 2|Withdrawal by Subject|0|||
48674100|NCT02687581|156659599|FG003|Overall Study|the device is too small for the patient.|0|||
48973126|NCT01929707|157731915|FG005|Intervention Period 2|Withdrawal by Subject|2|||
48973127|NCT01929707|157731916|FG006|Intervention Period 2|Withdrawal by Subject|0|||
48973128|NCT01929707|157731917|FG007|Intervention Period 2|Withdrawal by Subject|0|||
48973129|NCT00910728|157731922|FG000|Overall Study|Lack of Efficacy|2|||
48973130|NCT00910728|157731923|FG001|Overall Study|Lack of Efficacy|3|||
48973131|NCT00910728|157731924|FG002|Overall Study|Lack of Efficacy|1|||
48973132|NCT00910728|157731925|FG003|Overall Study|Lack of Efficacy|2|||
48973133|NCT00910728|157731926|FG004|Overall Study|Lack of Efficacy|1|||
48674101|NCT02305238|156659602|FG000|Overall Study|Death|2|||
48973134|NCT00910728|157731927|FG005|Overall Study|Lack of Efficacy|0|||
48973135|NCT00910728|157731928|FG006|Overall Study|Lack of Efficacy|2|||
48973136|NCT00910728|157731929|FG007|Overall Study|Lack of Efficacy|2|||
48973137|NCT00910728|157731930|FG008|Overall Study|Lack of Efficacy|2|||
48973138|NCT00910728|157731922|FG000|Overall Study|Withdrawal by Subject|0|||
48973139|NCT00910728|157731923|FG001|Overall Study|Withdrawal by Subject|0|||
48973140|NCT00910728|157731924|FG002|Overall Study|Withdrawal by Subject|0|||
48973141|NCT00910728|157731925|FG003|Overall Study|Withdrawal by Subject|0|||
48973142|NCT00910728|157731926|FG004|Overall Study|Withdrawal by Subject|3|||
48973143|NCT00910728|157731927|FG005|Overall Study|Withdrawal by Subject|1|||
48973144|NCT00910728|157731928|FG006|Overall Study|Withdrawal by Subject|2|||
48973145|NCT00910728|157731929|FG007|Overall Study|Withdrawal by Subject|0|||
48873377|NCT00537329|157373374|FG000|Overall Study|Lack of Efficacy|2|||
48873378|NCT00537329|157373374|FG000|Overall Study|Lost to Follow-up|6|||
48873379|NCT00537329|157373374|FG000|Overall Study|Withdrawal by Subject|4|||
48873380|NCT00537329|157373374|FG000|Overall Study|Other|1|||
48873381|NCT01242371|157373375|FG000|Overall Study|Withdrawal by Subject|2|||
48873382|NCT01242371|157373376|FG001|Overall Study|Withdrawal by Subject|2|||
48873383|NCT01242371|157373375|FG000|Overall Study|Protocol Violation|0|||
48873384|NCT01242371|157373376|FG001|Overall Study|Protocol Violation|3|||
48873385|NCT00778921|157373377|FG000|Overall Study|Adverse Event|9|||
48873386|NCT00778921|157373378|FG001|Overall Study|Adverse Event|10|||
48873387|NCT00778921|157373379|FG002|Overall Study|Adverse Event|14|||
48873388|NCT00778921|157373377|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
48873389|NCT00778921|157373378|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
48873390|NCT00778921|157373379|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
48873391|NCT00778921|157373377|FG000|Overall Study|Abnormal Test Procedure Result(s)|0|||
48873392|NCT00778921|157373378|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
48873393|NCT00778921|157373379|FG002|Overall Study|Abnormal Test Procedure Result(s)|2|||
48873394|NCT00778921|157373377|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
48873395|NCT00778921|157373378|FG001|Overall Study|Unsatisfactory therapeutic response|1|||
48873396|NCT00778921|157373379|FG002|Overall Study|Unsatisfactory therapeutic response|1|||
48761368|NCT01499667|156975627|FG001|Overall Study|Adverse Event|2|||
48761369|NCT01499667|156975628|FG002|Overall Study|Adverse Event|2|||
48761370|NCT01499667|156975626|FG000|Overall Study|Withdrawal by Subject|2|||
48761371|NCT01499667|156975627|FG001|Overall Study|Withdrawal by Subject|1|||
48761372|NCT01499667|156975628|FG002|Overall Study|Withdrawal by Subject|1|||
48761373|NCT01499667|156975626|FG000|Overall Study|Lack of Efficacy|2|||
48761374|NCT01499667|156975627|FG001|Overall Study|Lack of Efficacy|0|||
48761375|NCT01499667|156975628|FG002|Overall Study|Lack of Efficacy|0|||
48761376|NCT00759863|156975629|FG000|Overall Study|Death, moved, or lost contact|20|||
48761377|NCT00759863|156975630|FG001|Overall Study|Death, moved, or lost contact|18|||
48761378|NCT01729754|156975631|FG000|Part 1|Adverse Event|2|||
48761379|NCT01729754|156975632|FG001|Part 1|Adverse Event|0|||
48761380|NCT01729754|156975633|FG002|Part 1|Adverse Event|0|||
48761381|NCT01729754|156975634|FG003|Part 1|Adverse Event|1|||
48761382|NCT01729754|156975635|FG004|Part 1|Adverse Event|0|||
48761383|NCT01729754|156975636|FG005|Part 1|Adverse Event|0|||
48761384|NCT01729754|156975637|FG006|Part 1|Adverse Event|2|||
48761385|NCT01729754|156975638|FG007|Part 1|Adverse Event|0|||
48761386|NCT01729754|156975639|FG008|Part 1|Adverse Event|0|||
48761387|NCT01729754|156975640|FG009|Part 1|Adverse Event|5|||
48761388|NCT01729754|156975631|FG000|Part 1|Lack of Efficacy|1|||
48761389|NCT01729754|156975632|FG001|Part 1|Lack of Efficacy|0|||
48761390|NCT01729754|156975633|FG002|Part 1|Lack of Efficacy|0|||
48761391|NCT01729754|156975634|FG003|Part 1|Lack of Efficacy|0|||
48761392|NCT01729754|156975635|FG004|Part 1|Lack of Efficacy|0|||
48761393|NCT01729754|156975636|FG005|Part 1|Lack of Efficacy|0|||
48761394|NCT01729754|156975637|FG006|Part 1|Lack of Efficacy|2|||
48761395|NCT01729754|156975638|FG007|Part 1|Lack of Efficacy|0|||
48761396|NCT01729754|156975639|FG008|Part 1|Lack of Efficacy|0|||
48761397|NCT01729754|156975640|FG009|Part 1|Lack of Efficacy|0|||
48761398|NCT01729754|156975631|FG000|Part 1|Lost to Follow-up|1|||
48761399|NCT01729754|156975632|FG001|Part 1|Lost to Follow-up|0|||
48761400|NCT01729754|156975633|FG002|Part 1|Lost to Follow-up|0|||
48761401|NCT01729754|156975634|FG003|Part 1|Lost to Follow-up|2|||
48761402|NCT01729754|156975635|FG004|Part 1|Lost to Follow-up|0|||
48761403|NCT01729754|156975636|FG005|Part 1|Lost to Follow-up|0|||
48761404|NCT01729754|156975637|FG006|Part 1|Lost to Follow-up|3|||
48761405|NCT01729754|156975638|FG007|Part 1|Lost to Follow-up|0|||
48761406|NCT01729754|156975639|FG008|Part 1|Lost to Follow-up|0|||
48761407|NCT01729754|156975640|FG009|Part 1|Lost to Follow-up|3|||
48761408|NCT01729754|156975631|FG000|Part 1|Non-compliance with Study Drug|1|||
48761409|NCT01729754|156975632|FG001|Part 1|Non-compliance with Study Drug|0|||
48761410|NCT01729754|156975633|FG002|Part 1|Non-compliance with Study Drug|0|||
48761411|NCT01729754|156975634|FG003|Part 1|Non-compliance with Study Drug|0|||
48761412|NCT01729754|156975635|FG004|Part 1|Non-compliance with Study Drug|0|||
48761413|NCT01729754|156975636|FG005|Part 1|Non-compliance with Study Drug|0|||
48761414|NCT01729754|156975637|FG006|Part 1|Non-compliance with Study Drug|0|||
48761415|NCT01729754|156975638|FG007|Part 1|Non-compliance with Study Drug|0|||
48761416|NCT01729754|156975639|FG008|Part 1|Non-compliance with Study Drug|0|||
48761417|NCT01729754|156975640|FG009|Part 1|Non-compliance with Study Drug|0|||
48761418|NCT01729754|156975631|FG000|Part 1|Physician Decision|0|||
48761419|NCT01729754|156975632|FG001|Part 1|Physician Decision|0|||
48761420|NCT01729754|156975633|FG002|Part 1|Physician Decision|0|||
48761421|NCT01729754|156975634|FG003|Part 1|Physician Decision|0|||
48761422|NCT01729754|156975635|FG004|Part 1|Physician Decision|0|||
48761423|NCT01729754|156975636|FG005|Part 1|Physician Decision|0|||
48761424|NCT01729754|156975637|FG006|Part 1|Physician Decision|0|||
48761425|NCT01729754|156975638|FG007|Part 1|Physician Decision|0|||
48761426|NCT01729754|156975639|FG008|Part 1|Physician Decision|0|||
48761427|NCT01729754|156975640|FG009|Part 1|Physician Decision|4|||
48761428|NCT01729754|156975631|FG000|Part 1|Pregnancy|0|||
48973146|NCT00910728|157731930|FG008|Overall Study|Withdrawal by Subject|0|||
48973147|NCT00910728|157731922|FG000|Overall Study|(not specified)|2|||
48973148|NCT00910728|157731923|FG001|Overall Study|(not specified)|0|||
48973149|NCT00910728|157731924|FG002|Overall Study|(not specified)|1|||
48973150|NCT00910728|157731925|FG003|Overall Study|(not specified)|0|||
48973151|NCT00910728|157731926|FG004|Overall Study|(not specified)|1|||
48973152|NCT00910728|157731927|FG005|Overall Study|(not specified)|0|||
48973153|NCT00910728|157731928|FG006|Overall Study|(not specified)|0|||
48973154|NCT00910728|157731929|FG007|Overall Study|(not specified)|0|||
48973155|NCT00910728|157731930|FG008|Overall Study|(not specified)|0|||
48973156|NCT00910728|157731922|FG000|Overall Study|Adverse Event|2|||
48973157|NCT00910728|157731923|FG001|Overall Study|Adverse Event|0|||
48973158|NCT00910728|157731924|FG002|Overall Study|Adverse Event|1|||
48973159|NCT00910728|157731925|FG003|Overall Study|Adverse Event|1|||
48973160|NCT00910728|157731926|FG004|Overall Study|Adverse Event|0|||
48973161|NCT00910728|157731927|FG005|Overall Study|Adverse Event|0|||
48973162|NCT00910728|157731928|FG006|Overall Study|Adverse Event|2|||
48973163|NCT00910728|157731929|FG007|Overall Study|Adverse Event|1|||
48973164|NCT00910728|157731930|FG008|Overall Study|Adverse Event|1|||
48973165|NCT03365947|157731931|FG000|Overall Study|Lost to Follow-up|0|||
48973166|NCT03365947|157731932|FG001|Overall Study|Lost to Follow-up|0|||
48973167|NCT03365947|157731933|FG002|Overall Study|Lost to Follow-up|0|||
48973168|NCT03365947|157731934|FG003|Overall Study|Lost to Follow-up|0|||
48973169|NCT03365947|157731935|FG004|Overall Study|Lost to Follow-up|0|||
48973170|NCT03365947|157731936|FG005|Overall Study|Lost to Follow-up|1|||
48973171|NCT03365947|157731937|FG006|Overall Study|Lost to Follow-up|0|||
48973172|NCT03365947|157731938|FG007|Overall Study|Lost to Follow-up|0|||
48973173|NCT03365947|157731939|FG008|Overall Study|Lost to Follow-up|0|||
48674102|NCT02305238|156659603|FG001|Overall Study|Death|1|||
48674103|NCT02305238|156659604|FG002|Overall Study|Death|0|||
48674104|NCT02305238|156659602|FG000|Overall Study|Progressive disease|4|||
48674105|NCT02305238|156659603|FG001|Overall Study|Progressive disease|4|||
48674106|NCT02305238|156659604|FG002|Overall Study|Progressive disease|0|||
48674107|NCT02305238|156659602|FG000|Overall Study|Logistical difficulties|1|||
48674108|NCT02305238|156659603|FG001|Overall Study|Logistical difficulties|3|||
48674109|NCT02305238|156659604|FG002|Overall Study|Logistical difficulties|0|||
48674110|NCT02305238|156659602|FG000|Overall Study|Protocol Violation|0|||
48674111|NCT02305238|156659603|FG001|Overall Study|Protocol Violation|3|||
48674112|NCT02305238|156659604|FG002|Overall Study|Protocol Violation|0|||
48674113|NCT02305238|156659602|FG000|Overall Study|Physician Decision|2|||
48674114|NCT02305238|156659603|FG001|Overall Study|Physician Decision|1|||
48674115|NCT02305238|156659604|FG002|Overall Study|Physician Decision|0|||
48674116|NCT02305238|156659602|FG000|Overall Study|Adverse Event|4|||
48674117|NCT02305238|156659603|FG001|Overall Study|Adverse Event|2|||
48674118|NCT02305238|156659604|FG002|Overall Study|Adverse Event|0|||
48674119|NCT02305238|156659602|FG000|Overall Study|Withdrawal by Subject|3|||
48674120|NCT02305238|156659603|FG001|Overall Study|Withdrawal by Subject|4|||
48674121|NCT02305238|156659604|FG002|Overall Study|Withdrawal by Subject|0|||
48674122|NCT02305238|156659602|FG000|Overall Study|Randomized failure|0|||
48674123|NCT02305238|156659603|FG001|Overall Study|Randomized failure|0|||
48674124|NCT02305238|156659604|FG002|Overall Study|Randomized failure|8|||
48674125|NCT02305238|156659602|FG000|Overall Study|Required procedure failed|0|||
48674126|NCT02305238|156659603|FG001|Overall Study|Required procedure failed|1|||
48674127|NCT02305238|156659604|FG002|Overall Study|Required procedure failed|0|||
48674128|NCT01019369|156659605|FG000|Overall Study|Lost to Follow-up|10|||
48674129|NCT01019369|156659606|FG001|Overall Study|Lost to Follow-up|6|||
48674130|NCT01019369|156659605|FG000|Overall Study|Withdrawal by Subject|0|||
48674131|NCT01019369|156659606|FG001|Overall Study|Withdrawal by Subject|1|||
48674132|NCT00488826|156659607|FG000|Overall Study|Withdrawal by Subject|40|||
48674133|NCT00488826|156659608|FG001|Overall Study|Withdrawal by Subject|35|||
48674134|NCT00488826|156659609|FG002|Overall Study|Withdrawal by Subject|19|||
48674135|NCT00488826|156659607|FG000|Overall Study|Protocol Violation|0|||
48674136|NCT00488826|156659608|FG001|Overall Study|Protocol Violation|0|||
48674137|NCT00488826|156659609|FG002|Overall Study|Protocol Violation|2|||
48674138|NCT00488826|156659607|FG000|Overall Study|Adverse Event|9|||
48674139|NCT00488826|156659608|FG001|Overall Study|Adverse Event|15|||
48674140|NCT00488826|156659609|FG002|Overall Study|Adverse Event|4|||
48674141|NCT00488826|156659607|FG000|Overall Study|Lost to Follow-up|5|||
48674142|NCT00488826|156659608|FG001|Overall Study|Lost to Follow-up|1|||
48674143|NCT00488826|156659609|FG002|Overall Study|Lost to Follow-up|0|||
48674144|NCT00488826|156659607|FG000|Overall Study|Protocol Deviations|2|||
48674145|NCT00488826|156659608|FG001|Overall Study|Protocol Deviations|1|||
48674146|NCT00488826|156659609|FG002|Overall Study|Protocol Deviations|1|||
48674147|NCT01990612|156659610|FG000|Overall Study|Lost to Follow-up|2|||
48674148|NCT01990612|156659611|FG001|Overall Study|Lost to Follow-up|1|||
48674149|NCT01990612|156659610|FG000|Overall Study|Withdrawal by Subject|5|||
48674150|NCT01990612|156659611|FG001|Overall Study|Withdrawal by Subject|2|||
48973174|NCT03365947|157731940|FG009|Overall Study|Lost to Follow-up|0|||
48973175|NCT03365947|157731941|FG010|Overall Study|Lost to Follow-up|0|||
48973176|NCT03365947|157731942|FG011|Overall Study|Lost to Follow-up|0|||
48674151|NCT03043651|156659617|FG000|Overall Study|Death|1|||
48674152|NCT03043651|156659617|FG000|Overall Study|Progressive Disease|2|||
48674153|NCT03043651|156659617|FG000|Overall Study|Adverse Event|2|||
48674154|NCT03043651|156659617|FG000|Overall Study|Withdrawal by Subject|4|||
48674155|NCT03043651|156659617|FG000|Overall Study|Study Terminated by Sponsor|39|||
48674156|NCT02428205|156659618|FG000|Overall Study|Lack of Efficacy|1|||
48674157|NCT02428205|156659619|FG001|Overall Study|Lack of Efficacy|0|||
48674158|NCT02428205|156659618|FG000|Overall Study|Lost to Follow-up|1|||
48674159|NCT02428205|156659619|FG001|Overall Study|Lost to Follow-up|1|||
48674160|NCT02428205|156659618|FG000|Overall Study|Worse behavior|0|||
48674161|NCT02428205|156659619|FG001|Overall Study|Worse behavior|1|||
48674162|NCT01630889|156659620|FG000|Overall Study|Death|2|||
48674163|NCT01630889|156659620|FG000|Overall Study|Withdrawal by Subject|1|||
48674164|NCT01630889|156659620|FG000|Overall Study|Other than Specified|2|||
48674165|NCT01630889|156659620|FG000|Overall Study|Lost to Follow-up|4|||
48674166|NCT01630889|156659620|FG000|Overall Study|Other|1|||
48674167|NCT02974842|156659621|FG000|Overall Study|Withdrawal by Subject|4|||
48674168|NCT02974842|156659621|FG000|Overall Study|Screen failures|4|||
48674169|NCT02980133|156659622|FG000|Overall Study|Other than specified|1|||
48674170|NCT02980133|156659623|FG001|Overall Study|Other than specified|1|||
48674171|NCT02980133|156659624|FG002|Overall Study|Other than specified|2|||
48674172|NCT02980133|156659625|FG003|Overall Study|Other than specified|2|||
48674173|NCT02980133|156659622|FG000|Overall Study|Lost to Follow-up|0|||
48674174|NCT02980133|156659623|FG001|Overall Study|Lost to Follow-up|0|||
48674175|NCT02980133|156659624|FG002|Overall Study|Lost to Follow-up|1|||
48674176|NCT02980133|156659625|FG003|Overall Study|Lost to Follow-up|3|||
48674177|NCT02980133|156659622|FG000|Overall Study|Protocol Violation|0|||
48674178|NCT02980133|156659623|FG001|Overall Study|Protocol Violation|1|||
48674179|NCT02980133|156659624|FG002|Overall Study|Protocol Violation|0|||
48674180|NCT02980133|156659625|FG003|Overall Study|Protocol Violation|0|||
48674181|NCT02980133|156659622|FG000|Overall Study|Withdrawal by parent/guardian|6|||
48674182|NCT02980133|156659623|FG001|Overall Study|Withdrawal by parent/guardian|3|||
48674183|NCT02980133|156659624|FG002|Overall Study|Withdrawal by parent/guardian|3|||
48674184|NCT02980133|156659625|FG003|Overall Study|Withdrawal by parent/guardian|1|||
48674185|NCT02980133|156659622|FG000|Overall Study|Withdrawal by Subject|0|||
48674186|NCT02980133|156659623|FG001|Overall Study|Withdrawal by Subject|0|||
48674187|NCT02980133|156659624|FG002|Overall Study|Withdrawal by Subject|1|||
48674188|NCT02980133|156659625|FG003|Overall Study|Withdrawal by Subject|0|||
48674189|NCT03208088|156659628|FG000|Period 2|Withdrawal by Subject|0|||
48674190|NCT03208088|156659629|FG001|Period 2|Withdrawal by Subject|0|||
48674191|NCT03208088|156659630|FG002|Period 2|Withdrawal by Subject|0|||
48674192|NCT03208088|156659631|FG003|Period 2|Withdrawal by Subject|0|||
48674193|NCT03208088|156659632|FG004|Period 2|Withdrawal by Subject|0|||
48674194|NCT03208088|156659633|FG005|Period 2|Withdrawal by Subject|0|||
48674195|NCT03208088|156659634|FG006|Period 2|Withdrawal by Subject|0|||
48674196|NCT03208088|156659635|FG007|Period 2|Withdrawal by Subject|0|||
48674197|NCT03208088|156659636|FG008|Period 2|Withdrawal by Subject|1|||
48674198|NCT03208088|156659637|FG009|Period 2|Withdrawal by Subject|0|||
48674199|NCT03208088|156659628|FG000|Period 3|Unsatisfactory Test Article|0|||
48674200|NCT03208088|156659629|FG001|Period 3|Unsatisfactory Test Article|0|||
48674201|NCT03208088|156659630|FG002|Period 3|Unsatisfactory Test Article|0|||
48674202|NCT03208088|156659631|FG003|Period 3|Unsatisfactory Test Article|1|||
48674203|NCT03208088|156659632|FG004|Period 3|Unsatisfactory Test Article|0|||
48674204|NCT03208088|156659633|FG005|Period 3|Unsatisfactory Test Article|0|||
48674205|NCT03208088|156659634|FG006|Period 3|Unsatisfactory Test Article|0|||
48674206|NCT03208088|156659635|FG007|Period 3|Unsatisfactory Test Article|0|||
48674207|NCT03208088|156659636|FG008|Period 3|Unsatisfactory Test Article|0|||
48674208|NCT03208088|156659637|FG009|Period 3|Unsatisfactory Test Article|0|||
48674209|NCT03208088|156659628|FG000|Period 4|Unsatisfactory Test Article|0|||
48674210|NCT03208088|156659629|FG001|Period 4|Unsatisfactory Test Article|0|||
48674211|NCT03208088|156659630|FG002|Period 4|Unsatisfactory Test Article|0|||
48674212|NCT03208088|156659631|FG003|Period 4|Unsatisfactory Test Article|1|||
48761429|NCT01729754|156975632|FG001|Part 1|Pregnancy|0|||
48674213|NCT03208088|156659632|FG004|Period 4|Unsatisfactory Test Article|0|||
48674214|NCT03208088|156659633|FG005|Period 4|Unsatisfactory Test Article|0|||
48674215|NCT03208088|156659634|FG006|Period 4|Unsatisfactory Test Article|0|||
48674216|NCT03208088|156659635|FG007|Period 4|Unsatisfactory Test Article|0|||
48674217|NCT03208088|156659636|FG008|Period 4|Unsatisfactory Test Article|0|||
48674218|NCT03208088|156659637|FG009|Period 4|Unsatisfactory Test Article|0|||
48674219|NCT01068158|156659638|FG000|Overall Study|Withdrawal by Subject|1|||
48674220|NCT01068158|156659639|FG001|Overall Study|Withdrawal by Subject|2|||
48674221|NCT01068158|156659638|FG000|Overall Study|Lost to Follow-up|7|||
48674222|NCT01068158|156659639|FG001|Overall Study|Lost to Follow-up|0|||
48674223|NCT01068158|156659638|FG000|Overall Study|Protocol Violation|0|||
48674224|NCT01068158|156659639|FG001|Overall Study|Protocol Violation|2|||
48674225|NCT00172042|156659641|FG000|Overall Study|Adverse Event|27|||
48674226|NCT00172042|156659642|FG001|Overall Study|Adverse Event|13|||
48674227|NCT00172042|156659641|FG000|Overall Study|Abnormal laboratory value(s)|5|||
48674228|NCT00172042|156659642|FG001|Overall Study|Abnormal laboratory value(s)|1|||
48674229|NCT00172042|156659641|FG000|Overall Study|Abnormal test procedure(s)|0|||
48674230|NCT00172042|156659642|FG001|Overall Study|Abnormal test procedure(s)|3|||
48674231|NCT00172042|156659641|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
48674232|NCT00172042|156659642|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
48674233|NCT00172042|156659641|FG000|Overall Study|Patient no longer requires study drug|10|||
48674234|NCT00172042|156659642|FG001|Overall Study|Patient no longer requires study drug|8|||
48973177|NCT03365947|157731943|FG012|Overall Study|Lost to Follow-up|0|||
48973178|NCT03365947|157731944|FG013|Overall Study|Lost to Follow-up|0|||
48973179|NCT03365947|157731945|FG014|Overall Study|Lost to Follow-up|0|||
48973180|NCT03365947|157731946|FG015|Overall Study|Lost to Follow-up|0|||
48973181|NCT03365947|157731947|FG016|Overall Study|Lost to Follow-up|0|||
48674235|NCT00172042|156659641|FG000|Overall Study|Protocol Violation|8|||
48674236|NCT00172042|156659642|FG001|Overall Study|Protocol Violation|7|||
48674237|NCT00172042|156659641|FG000|Overall Study|Withdrawal by Subject|37|||
48674238|NCT00172042|156659642|FG001|Overall Study|Withdrawal by Subject|25|||
48674239|NCT00172042|156659641|FG000|Overall Study|Lost to Follow-up|3|||
48674240|NCT00172042|156659642|FG001|Overall Study|Lost to Follow-up|5|||
48674241|NCT00172042|156659641|FG000|Overall Study|Administrative problems|13|||
48674242|NCT00172042|156659642|FG001|Overall Study|Administrative problems|10|||
48674243|NCT00172042|156659641|FG000|Overall Study|Death|42|||
48674244|NCT00172042|156659642|FG001|Overall Study|Death|42|||
48674245|NCT03170193|156659643|FG000|Overall Study|Withdrawal by Subject|0|||
48674246|NCT03170193|156659644|FG001|Overall Study|Withdrawal by Subject|0|||
48674247|NCT03170193|156659645|FG002|Overall Study|Withdrawal by Subject|0|||
48674248|NCT03170193|156659646|FG003|Overall Study|Withdrawal by Subject|1|||
48674249|NCT03170193|156659647|FG004|Overall Study|Withdrawal by Subject|0|||
48674250|NCT03170193|156659648|FG005|Overall Study|Withdrawal by Subject|0|||
48674251|NCT03170193|156659649|FG006|Overall Study|Withdrawal by Subject|0|||
48674252|NCT03170193|156659643|FG000|Overall Study|Lost to Follow-up|1|||
48674253|NCT03170193|156659644|FG001|Overall Study|Lost to Follow-up|1|||
48973182|NCT03365947|157731948|FG017|Overall Study|Lost to Follow-up|0|||
48973183|NCT03365947|157731949|FG018|Overall Study|Lost to Follow-up|0|||
48973184|NCT01225172|157731954|FG000|Overall Study|Subject decision to stop|1|||
48973185|NCT01225172|157731955|FG001|Overall Study|Subject decision to stop|0|||
48973186|NCT01225172|157731954|FG000|Overall Study|Subject request to discontinue treatment|3|||
48973187|NCT01225172|157731955|FG001|Overall Study|Subject request to discontinue treatment|1|||
48973188|NCT01225172|157731954|FG000|Overall Study|Subject no longer meets study criteria|1|||
48973189|NCT01225172|157731955|FG001|Overall Study|Subject no longer meets study criteria|0|||
48973190|NCT01225172|157731954|FG000|Overall Study|Withdrawal by Subject|1|||
48973191|NCT01225172|157731955|FG001|Overall Study|Withdrawal by Subject|0|||
48973192|NCT02290340|157731956|FG000|Overall Study|Lost to Follow-up|0|||
48973193|NCT02290340|157731957|FG001|Overall Study|Lost to Follow-up|0|||
48973194|NCT02290340|157731958|FG002|Overall Study|Lost to Follow-up|0|||
48973195|NCT02290340|157731959|FG003|Overall Study|Lost to Follow-up|1|||
48973196|NCT02290340|157731956|FG000|Overall Study|Withdrawal by Subject|1|||
48973197|NCT02290340|157731957|FG001|Overall Study|Withdrawal by Subject|0|||
48973198|NCT02290340|157731958|FG002|Overall Study|Withdrawal by Subject|0|||
48973199|NCT02290340|157731959|FG003|Overall Study|Withdrawal by Subject|0|||
48674254|NCT03170193|156659645|FG002|Overall Study|Lost to Follow-up|0|||
48973200|NCT02290340|157731956|FG000|Overall Study|Other|1|||
48973201|NCT02290340|157731957|FG001|Overall Study|Other|0|||
48973202|NCT02290340|157731958|FG002|Overall Study|Other|0|||
48674255|NCT03170193|156659646|FG003|Overall Study|Lost to Follow-up|0|||
48674256|NCT03170193|156659647|FG004|Overall Study|Lost to Follow-up|0|||
48674257|NCT03170193|156659648|FG005|Overall Study|Lost to Follow-up|0|||
48674258|NCT03170193|156659649|FG006|Overall Study|Lost to Follow-up|0|||
48674259|NCT00238238|156659654|FG000|Overall Study|Withdrawal by Subject|0|||
48674260|NCT00238238|156659655|FG001|Overall Study|Withdrawal by Subject|3|||
48674261|NCT00238238|156659656|FG002|Overall Study|Withdrawal by Subject|0|||
48973203|NCT02290340|157731959|FG003|Overall Study|Other|1|||
48973204|NCT00179517|157731960|FG000|Overall Study|Withdrawal by Subject|2|||
48973205|NCT00179517|157731961|FG001|Overall Study|Withdrawal by Subject|1|||
48973206|NCT00023712|157731967|FG000|Overall Study|Not platinum sensitive|1|||
48973207|NCT00023712|157731968|FG001|Overall Study|Not platinum sensitive|0|||
48973208|NCT00023712|157731967|FG000|Overall Study|Never treated|1|||
48973209|NCT00023712|157731968|FG001|Overall Study|Never treated|1|||
48674262|NCT03052816|156659658|FG000|Overall Study|Withdrawal by Subject|1|||
48674263|NCT03052816|156659659|FG001|Overall Study|Withdrawal by Subject|0|||
48674264|NCT03052816|156659658|FG000|Overall Study|Desired opioids|2|||
48674265|NCT03052816|156659659|FG001|Overall Study|Desired opioids|0|||
48674266|NCT00895453|156659660|FG000|Overall Study|Lost to Follow-up|25|||
48674267|NCT00895453|156659661|FG001|Overall Study|Lost to Follow-up|25|||
48674268|NCT00895453|156659662|FG002|Overall Study|Lost to Follow-up|23|||
48973210|NCT01042938|157731969|FG000|Overall Study|Withdrawal by Subject|1|||
48973211|NCT01042938|157731970|FG001|Overall Study|Withdrawal by Subject|1|||
48973212|NCT01042938|157731969|FG000|Overall Study|Protocol Violation|1|||
48674269|NCT04699461|156659663|FG000|Overall Study|Withdrawal by Subject|1|||
48674270|NCT04699461|156659664|FG001|Overall Study|Withdrawal by Subject|0|||
48674271|NCT04699461|156659663|FG000|Overall Study|Study termination by sponsor|2|||
48674272|NCT04699461|156659664|FG001|Overall Study|Study termination by sponsor|1|||
48674273|NCT04699461|156659663|FG000|Overall Study|Death|1|||
48674274|NCT04699461|156659664|FG001|Overall Study|Death|0|||
48674275|NCT04699461|156659663|FG000|Overall Study|Radiographic progression|0|||
48674276|NCT04699461|156659664|FG001|Overall Study|Radiographic progression|1|||
48674277|NCT04167137|156659667|FG000|Overall Study|Disease progression|1|||
48674278|NCT04167137|156659668|FG001|Overall Study|Disease progression|1|||
48674279|NCT04167137|156659669|FG002|Overall Study|Disease progression|3|||
48674280|NCT04167137|156659670|FG003|Overall Study|Disease progression|3|||
48674281|NCT04167137|156659671|FG004|Overall Study|Disease progression|2|||
48674282|NCT04167137|156659672|FG005|Overall Study|Disease progression|3|||
48674283|NCT04167137|156659673|FG006|Overall Study|Disease progression|2|||
48674284|NCT04167137|156659674|FG007|Overall Study|Disease progression|2|||
48674285|NCT04167137|156659667|FG000|Overall Study|Withdrawal by Subject|1|||
48674286|NCT04167137|156659668|FG001|Overall Study|Withdrawal by Subject|0|||
48674287|NCT04167137|156659669|FG002|Overall Study|Withdrawal by Subject|0|||
48674288|NCT04167137|156659670|FG003|Overall Study|Withdrawal by Subject|1|||
48674289|NCT04167137|156659671|FG004|Overall Study|Withdrawal by Subject|0|||
48674290|NCT04167137|156659672|FG005|Overall Study|Withdrawal by Subject|2|||
48674291|NCT04167137|156659673|FG006|Overall Study|Withdrawal by Subject|1|||
48674292|NCT04167137|156659674|FG007|Overall Study|Withdrawal by Subject|0|||
48674293|NCT04167137|156659667|FG000|Overall Study|Adverse Event|0|||
48674294|NCT04167137|156659668|FG001|Overall Study|Adverse Event|0|||
48674295|NCT04167137|156659669|FG002|Overall Study|Adverse Event|0|||
48674296|NCT04167137|156659670|FG003|Overall Study|Adverse Event|0|||
48674297|NCT04167137|156659671|FG004|Overall Study|Adverse Event|0|||
48674298|NCT04167137|156659672|FG005|Overall Study|Adverse Event|1|||
48674299|NCT04167137|156659673|FG006|Overall Study|Adverse Event|0|||
48674300|NCT04167137|156659674|FG007|Overall Study|Adverse Event|1|||
48674301|NCT04167137|156659667|FG000|Overall Study|Physician Decision|0|||
48674302|NCT04167137|156659668|FG001|Overall Study|Physician Decision|0|||
48674303|NCT04167137|156659669|FG002|Overall Study|Physician Decision|0|||
48674304|NCT04167137|156659670|FG003|Overall Study|Physician Decision|1|||
48674305|NCT04167137|156659671|FG004|Overall Study|Physician Decision|0|||
48674306|NCT04167137|156659672|FG005|Overall Study|Physician Decision|0|||
48674307|NCT04167137|156659673|FG006|Overall Study|Physician Decision|1|||
48674308|NCT04167137|156659674|FG007|Overall Study|Physician Decision|0|||
48674309|NCT04167137|156659667|FG000|Overall Study|Death|0|||
48674310|NCT04167137|156659668|FG001|Overall Study|Death|1|||
48674311|NCT04167137|156659669|FG002|Overall Study|Death|0|||
48674312|NCT04167137|156659670|FG003|Overall Study|Death|0|||
48674313|NCT04167137|156659671|FG004|Overall Study|Death|0|||
48674314|NCT04167137|156659672|FG005|Overall Study|Death|0|||
48674315|NCT04167137|156659673|FG006|Overall Study|Death|0|||
48761430|NCT01729754|156975633|FG002|Part 1|Pregnancy|0|||
48761431|NCT01729754|156975634|FG003|Part 1|Pregnancy|1|||
48761432|NCT01729754|156975635|FG004|Part 1|Pregnancy|0|||
48761433|NCT01729754|156975636|FG005|Part 1|Pregnancy|0|||
48761434|NCT01729754|156975637|FG006|Part 1|Pregnancy|0|||
48761435|NCT01729754|156975638|FG007|Part 1|Pregnancy|0|||
48674316|NCT04167137|156659674|FG007|Overall Study|Death|0|||
48674317|NCT04167137|156659667|FG000|Overall Study|Study terminated by Sponsor|0|||
48674318|NCT04167137|156659668|FG001|Overall Study|Study terminated by Sponsor|0|||
48674319|NCT04167137|156659669|FG002|Overall Study|Study terminated by Sponsor|0|||
48674320|NCT04167137|156659670|FG003|Overall Study|Study terminated by Sponsor|0|||
48674321|NCT04167137|156659671|FG004|Overall Study|Study terminated by Sponsor|0|||
48674322|NCT04167137|156659672|FG005|Overall Study|Study terminated by Sponsor|0|||
48674323|NCT04167137|156659673|FG006|Overall Study|Study terminated by Sponsor|0|||
48761436|NCT01729754|156975639|FG008|Part 1|Pregnancy|0|||
48761437|NCT01729754|156975640|FG009|Part 1|Pregnancy|1|||
48761438|NCT01729754|156975631|FG000|Part 1|Progressive Disease|0|||
48761439|NCT01729754|156975632|FG001|Part 1|Progressive Disease|0|||
48674324|NCT04167137|156659674|FG007|Overall Study|Study terminated by Sponsor|1|||
48674325|NCT00211887|156659675|FG000|Overall Study|Adverse Event|8|||
48674326|NCT00211887|156659676|FG001|Overall Study|Adverse Event|4|||
48674327|NCT00211887|156659677|FG002|Overall Study|Adverse Event|6|||
48674328|NCT00211887|156659675|FG000|Overall Study|Death|1|||
48674329|NCT00211887|156659676|FG001|Overall Study|Death|1|||
48674330|NCT00211887|156659677|FG002|Overall Study|Death|1|||
48674331|NCT00211887|156659675|FG000|Overall Study|Lost to Follow-up|28|||
48674332|NCT00211887|156659676|FG001|Overall Study|Lost to Follow-up|13|||
48674333|NCT00211887|156659677|FG002|Overall Study|Lost to Follow-up|9|||
48674334|NCT00211887|156659675|FG000|Overall Study|Non-medical reason|31|||
48674335|NCT00211887|156659676|FG001|Overall Study|Non-medical reason|14|||
48674336|NCT00211887|156659677|FG002|Overall Study|Non-medical reason|8|||
48761440|NCT01729754|156975633|FG002|Part 1|Progressive Disease|0|||
48761441|NCT01729754|156975634|FG003|Part 1|Progressive Disease|0|||
48761442|NCT01729754|156975635|FG004|Part 1|Progressive Disease|0|||
48761443|NCT01729754|156975636|FG005|Part 1|Progressive Disease|0|||
48973213|NCT01042938|157731970|FG001|Overall Study|Protocol Violation|1|||
48973214|NCT01042938|157731969|FG000|Overall Study|Ineligible: RTOG study conflict|1|||
48973215|NCT01042938|157731970|FG001|Overall Study|Ineligible: RTOG study conflict|0|||
48973216|NCT01822223|157731973|FG000|Overall Study|Death|0|||
48973217|NCT01822223|157731974|FG001|Overall Study|Death|1|||
48973218|NCT02679781|157731975|FG000|Overall Study|Lost to Follow-up|1|||
48973219|NCT02679781|157731976|FG001|Overall Study|Lost to Follow-up|2|||
48973220|NCT02679781|157731975|FG000|Overall Study|low cooperation, referral to treatment under general anesthesia|6|||
48674337|NCT00211887|156659675|FG000|Overall Study|Other medical reason|15|||
48674338|NCT00211887|156659676|FG001|Overall Study|Other medical reason|11|||
48674339|NCT00211887|156659677|FG002|Overall Study|Other medical reason|7|||
48674340|NCT00211887|156659675|FG000|Overall Study|Side effects|19|||
48674341|NCT00211887|156659676|FG001|Overall Study|Side effects|13|||
48674342|NCT00211887|156659677|FG002|Overall Study|Side effects|5|||
48674343|NCT00687531|156659678|FG000|Overall Study|Did not meet protocol eligibility|104|||
48674344|NCT00687531|156659678|FG000|Overall Study|Adverse Event|5|||
48674345|NCT00687531|156659678|FG000|Overall Study|Lost to Follow-up|26|||
48674346|NCT00856297|156659679|FG000|Overall Study|Unable to classify|2|||
48674347|NCT00856297|156659680|FG001|Overall Study|Unable to classify|0|||
48674348|NCT00856297|156659681|FG002|Overall Study|Unable to classify|0|||
48674349|NCT00856297|156659682|FG003|Overall Study|Unable to classify|0|||
48674350|NCT00856297|156659683|FG004|Overall Study|Unable to classify|0|||
48674351|NCT03890367|156659687|FG000|Overall Study|Withdrawal by parent/guardian|1|||
48674352|NCT03890367|156659688|FG001|Overall Study|Withdrawal by parent/guardian|3|||
48674353|NCT03890367|156659689|FG002|Overall Study|Withdrawal by parent/guardian|0|||
48674354|NCT03890367|156659687|FG000|Overall Study|Protocol deviation|2|||
48674355|NCT03890367|156659688|FG001|Overall Study|Protocol deviation|2|||
48674356|NCT03890367|156659689|FG002|Overall Study|Protocol deviation|1|||
48674357|NCT03890367|156659687|FG000|Overall Study|Lost to Follow-up|1|||
48674358|NCT03890367|156659688|FG001|Overall Study|Lost to Follow-up|1|||
48674359|NCT03890367|156659689|FG002|Overall Study|Lost to Follow-up|0|||
48674360|NCT03857542|156659690|FG000|Overall Study|Adverse Event|1|||
48674361|NCT03857542|156659691|FG001|Overall Study|Adverse Event|3|||
48674362|NCT03857542|156659690|FG000|Overall Study|Withdrawal by Subject|2|||
48674363|NCT03857542|156659691|FG001|Overall Study|Withdrawal by Subject|1|||
48674364|NCT03857542|156659690|FG000|Overall Study|Lost to Follow-up|2|||
48674365|NCT03857542|156659691|FG001|Overall Study|Lost to Follow-up|1|||
48674366|NCT03857542|156659690|FG000|Overall Study|Reason not Specified|1|||
48674367|NCT03857542|156659691|FG001|Overall Study|Reason not Specified|0|||
48674368|NCT02593825|156661466|FG000|Intervention|Lost to Follow-up|10|||
48674369|NCT02593825|156661467|FG001|Intervention|Lost to Follow-up|12|||
48674370|NCT03654885|156661468|FG000|Overall Study|Randomized, Not Treated: Consent Withdrawn|5|||
48674371|NCT03654885|156661469|FG001|Overall Study|Randomized, Not Treated: Consent Withdrawn|3|||
48674372|NCT03654885|156661468|FG000|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|0|||
48674373|NCT03654885|156661469|FG001|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|3|||
48674374|NCT03654885|156661468|FG000|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|7|||
48674375|NCT03654885|156661469|FG001|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|1|||
48674376|NCT03654885|156661468|FG000|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|7|||
48674377|NCT03654885|156661469|FG001|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|1|||
48674378|NCT03654885|156661468|FG000|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|1|||
48674379|NCT03654885|156661469|FG001|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|0|||
48674380|NCT03654885|156661468|FG000|Overall Study|Adverse Event in Study Eye|3|||
48674381|NCT03654885|156661469|FG001|Overall Study|Adverse Event in Study Eye|0|||
48674382|NCT03654885|156661468|FG000|Overall Study|Consent Withdrawn|1|||
48674383|NCT03654885|156661469|FG001|Overall Study|Consent Withdrawn|0|||
48674384|NCT03654885|156661468|FG000|Overall Study|Death|3|||
48674385|NCT03654885|156661469|FG001|Overall Study|Death|1|||
48674386|NCT03654885|156661468|FG000|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|0|||
48674387|NCT03654885|156661469|FG001|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|1|||
48973221|NCT02679781|157731976|FG001|Overall Study|low cooperation, referral to treatment under general anesthesia|1|||
48674388|NCT03654885|156661468|FG000|Overall Study|Lost to Follow-up|3|||
48674389|NCT03654885|156661469|FG001|Overall Study|Lost to Follow-up|3|||
48973222|NCT00437203|157731977|FG000|Overall Study|Death|0|||
48674390|NCT04736628|156661470|FG000|Overall Study|Not treated|0|||
48674391|NCT04736628|156661471|FG001|Overall Study|Not treated|0|||
48674392|NCT04736628|156661472|FG002|Overall Study|Not treated|0|||
48674393|NCT04736628|156661473|FG003|Overall Study|Not treated|2|||
48674394|NCT04736628|156661470|FG000|Overall Study|Other reason than listed|1|||
48674395|NCT04736628|156661471|FG001|Overall Study|Other reason than listed|2|||
48674396|NCT04736628|156661472|FG002|Overall Study|Other reason than listed|2|||
48973223|NCT00437203|157731978|FG001|Overall Study|Death|0|||
48674397|NCT04736628|156661473|FG003|Overall Study|Other reason than listed|3|||
48674398|NCT04736628|156661470|FG000|Overall Study|Protocol deviation|0|||
48674399|NCT04736628|156661471|FG001|Overall Study|Protocol deviation|0|||
48674400|NCT04736628|156661472|FG002|Overall Study|Protocol deviation|0|||
48674401|NCT04736628|156661473|FG003|Overall Study|Protocol deviation|1|||
48674402|NCT04736628|156661470|FG000|Overall Study|Burden of study procedures|1|||
48674403|NCT04736628|156661471|FG001|Overall Study|Burden of study procedures|0|||
48674404|NCT04736628|156661472|FG002|Overall Study|Burden of study procedures|0|||
48674405|NCT04736628|156661473|FG003|Overall Study|Burden of study procedures|1|||
48674406|NCT04736628|156661470|FG000|Overall Study|Change of residence|0|||
48674407|NCT04736628|156661471|FG001|Overall Study|Change of residence|1|||
48674408|NCT04736628|156661472|FG002|Overall Study|Change of residence|0|||
48674409|NCT04736628|156661473|FG003|Overall Study|Change of residence|0|||
48674410|NCT04736628|156661470|FG000|Overall Study|Perceived lack of efficacy|1|||
48674411|NCT04736628|156661471|FG001|Overall Study|Perceived lack of efficacy|0|||
48674412|NCT04736628|156661472|FG002|Overall Study|Perceived lack of efficacy|0|||
48674413|NCT04736628|156661473|FG003|Overall Study|Perceived lack of efficacy|1|||
48674414|NCT04736628|156661470|FG000|Overall Study|Adverse Event|3|||
48674415|NCT04736628|156661471|FG001|Overall Study|Adverse Event|2|||
48674416|NCT04736628|156661472|FG002|Overall Study|Adverse Event|4|||
48674417|NCT04736628|156661473|FG003|Overall Study|Adverse Event|3|||
48674418|NCT00820222|156661479|FG000|Overall Study|Lost to Follow-up|10|||
48674419|NCT00820222|156661480|FG001|Overall Study|Lost to Follow-up|9|||
48674420|NCT00820222|156661479|FG000|Overall Study|Withdrawal by Subject|19|||
48674421|NCT00820222|156661480|FG001|Overall Study|Withdrawal by Subject|21|||
48674422|NCT00820222|156661479|FG000|Overall Study|Physician Decision|93|||
48674423|NCT00820222|156661480|FG001|Overall Study|Physician Decision|88|||
48674424|NCT00820222|156661479|FG000|Overall Study|Sponsor Terminated Study|43|||
48674425|NCT00820222|156661480|FG001|Overall Study|Sponsor Terminated Study|65|||
48674426|NCT00820222|156661479|FG000|Overall Study|Unkown|11|||
48674427|NCT00820222|156661480|FG001|Overall Study|Unkown|7|||
48674428|NCT01789606|156661482|FG000|Overall Study|Participant not Purchased the Product|0|||
48674429|NCT01789606|156661483|FG001|Overall Study|Participant not Purchased the Product|20|||
48674430|NCT01789606|156661482|FG000|Overall Study|Withdrawal by Subject|0|||
48674431|NCT01789606|156661483|FG001|Overall Study|Withdrawal by Subject|1|||
48674432|NCT01789606|156661482|FG000|Overall Study|Ineligible|6|||
48674433|NCT01789606|156661483|FG001|Overall Study|Ineligible|2|||
48674434|NCT01789606|156661482|FG000|Overall Study|Administrative Reasons|17|||
48674435|NCT01789606|156661483|FG001|Overall Study|Administrative Reasons|6|||
48674436|NCT01789606|156661482|FG000|Overall Study|No Study Medication Taken|0|||
48674437|NCT01789606|156661483|FG001|Overall Study|No Study Medication Taken|1|||
48674438|NCT01789606|156661482|FG000|Overall Study|Protocol Violation|0|||
48674439|NCT01789606|156661483|FG001|Overall Study|Protocol Violation|55|||
48674440|NCT01789606|156661482|FG000|Overall Study|Adverse Event|0|||
48674441|NCT01789606|156661483|FG001|Overall Study|Adverse Event|3|||
48674442|NCT01789606|156661482|FG000|Overall Study|Lost to Follow-up|0|||
48674443|NCT01789606|156661483|FG001|Overall Study|Lost to Follow-up|14|||
48674444|NCT01789606|156661482|FG000|Overall Study|Ineligible or not Willing to Continue|0|||
48674445|NCT01789606|156661483|FG001|Overall Study|Ineligible or not Willing to Continue|348|||
48674446|NCT00095173|156661484|FG000|Open-Label Lead-In Phase (Period A)|Adverse Event|1|||
48674447|NCT00095173|156661485|FG001|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
48674448|NCT00095173|156661486|FG002|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
48674449|NCT00095173|156661487|FG003|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
48674450|NCT00095173|156661488|FG004|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
48674451|NCT00095173|156661489|FG005|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
48674452|NCT00095173|156661484|FG000|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17|||
48674453|NCT00095173|156661485|FG001|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
48674454|NCT00095173|156661486|FG002|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
48674455|NCT00095173|156661487|FG003|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
48674456|NCT00095173|156661488|FG004|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
48674457|NCT00095173|156661489|FG005|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
48674458|NCT00095173|156661484|FG000|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1|||
48674459|NCT00095173|156661485|FG001|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
48674460|NCT00095173|156661486|FG002|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
48674461|NCT00095173|156661487|FG003|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
48674462|NCT00095173|156661488|FG004|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
48674463|NCT00095173|156661489|FG005|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
48674464|NCT00095173|156661484|FG000|Open-Label Lead-In Phase (Period A)|Other|1|||
48674465|NCT00095173|156661485|FG001|Open-Label Lead-In Phase (Period A)|Other|0|||
48674466|NCT00095173|156661486|FG002|Open-Label Lead-In Phase (Period A)|Other|0|||
48674467|NCT00095173|156661487|FG003|Open-Label Lead-In Phase (Period A)|Other|0|||
48674468|NCT00095173|156661488|FG004|Open-Label Lead-In Phase (Period A)|Other|0|||
48674469|NCT00095173|156661489|FG005|Open-Label Lead-In Phase (Period A)|Other|0|||
48674470|NCT00095173|156661484|FG000|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
48674471|NCT00095173|156661485|FG001|Double-Blind Phase (Period B)|Lack of Efficacy|10|||
48674472|NCT00095173|156661486|FG002|Double-Blind Phase (Period B)|Lack of Efficacy|31|||
48873397|NCT00778921|157373377|FG000|Overall Study|Patient No Longer Requires Study Drug|0|||
48873398|NCT00778921|157373378|FG001|Overall Study|Patient No Longer Requires Study Drug|1|||
48873399|NCT00778921|157373379|FG002|Overall Study|Patient No Longer Requires Study Drug|0|||
48873400|NCT00778921|157373377|FG000|Overall Study|Patient withdrew request|3|||
48873401|NCT00778921|157373378|FG001|Overall Study|Patient withdrew request|1|||
48873402|NCT00778921|157373379|FG002|Overall Study|Patient withdrew request|6|||
48873403|NCT00778921|157373377|FG000|Overall Study|Lost to Follow-up|0|||
48873404|NCT00778921|157373378|FG001|Overall Study|Lost to Follow-up|2|||
48873405|NCT00778921|157373379|FG002|Overall Study|Lost to Follow-up|1|||
48873406|NCT00778921|157373377|FG000|Overall Study|Administrative Problems|1|||
48873407|NCT00778921|157373378|FG001|Overall Study|Administrative Problems|2|||
48873408|NCT00778921|157373379|FG002|Overall Study|Administrative Problems|0|||
48873409|NCT00778921|157373377|FG000|Overall Study|Protocol Violation|3|||
48873410|NCT00778921|157373378|FG001|Overall Study|Protocol Violation|0|||
48873411|NCT00778921|157373379|FG002|Overall Study|Protocol Violation|2|||
48873412|NCT00778921|157373377|FG000|Overall Study|Not treated|0|||
48873413|NCT00778921|157373378|FG001|Overall Study|Not treated|2|||
48873414|NCT00778921|157373379|FG002|Overall Study|Not treated|2|||
48873415|NCT00461123|157373380|FG000|Overall Study|Adverse Event|1|||
48873416|NCT00461123|157373381|FG001|Overall Study|Adverse Event|0|||
48873417|NCT00461123|157373380|FG000|Overall Study|Lost to Follow-up|1|||
48873418|NCT00461123|157373381|FG001|Overall Study|Lost to Follow-up|1|||
48873419|NCT00461123|157373380|FG000|Overall Study|Protocol Violation|3|||
48873420|NCT00461123|157373381|FG001|Overall Study|Protocol Violation|2|||
48873421|NCT00461123|157373380|FG000|Overall Study|Withdrawal by Subject|1|||
48873422|NCT00461123|157373381|FG001|Overall Study|Withdrawal by Subject|3|||
48873423|NCT02353871|157373382|FG000|Overall Study|Protocol deviation|0|||
48674473|NCT00095173|156661487|FG003|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
48674474|NCT00095173|156661488|FG004|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
48674475|NCT00095173|156661489|FG005|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
48674476|NCT00095173|156661484|FG000|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
48873424|NCT02353871|157373383|FG001|Overall Study|Protocol deviation|1|||
48873425|NCT02353871|157373382|FG000|Overall Study|Consent withdrawn|1|||
48873426|NCT02353871|157373383|FG001|Overall Study|Consent withdrawn|8|||
48873427|NCT02353871|157373382|FG000|Overall Study|Lost to Follow-up|2|||
48873428|NCT02353871|157373383|FG001|Overall Study|Lost to Follow-up|0|||
48873429|NCT01482429|157373386|FG000|Care Usual|Protocol Violation|0|||
48973224|NCT00437203|157731979|FG002|Overall Study|Death|1|||
48973225|NCT00437203|157731980|FG003|Overall Study|Death|0|||
48973226|NCT00437203|157731981|FG004|Overall Study|Death|0|||
48674477|NCT00095173|156661485|FG001|Double-Blind Phase (Period B)|Withdrawal by Subject|1|||
48674478|NCT00095173|156661486|FG002|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
48674479|NCT00095173|156661487|FG003|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
48674480|NCT00095173|156661488|FG004|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
48674481|NCT00095173|156661489|FG005|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
48674482|NCT00095173|156661484|FG000|Open-Label Extension Phase (Period C)|Death|0|||
48674483|NCT00095173|156661485|FG001|Open-Label Extension Phase (Period C)|Death|0|||
48674484|NCT00095173|156661486|FG002|Open-Label Extension Phase (Period C)|Death|0|||
48674485|NCT00095173|156661487|FG003|Open-Label Extension Phase (Period C)|Death|0|||
48674486|NCT00095173|156661488|FG004|Open-Label Extension Phase (Period C)|Death|0|||
48674487|NCT00095173|156661489|FG005|Open-Label Extension Phase (Period C)|Death|1|||
48674488|NCT00095173|156661484|FG000|Open-Label Extension Phase (Period C)|Adverse Event|0|||
48674489|NCT00095173|156661485|FG001|Open-Label Extension Phase (Period C)|Adverse Event|0|||
48674490|NCT00095173|156661486|FG002|Open-Label Extension Phase (Period C)|Adverse Event|0|||
48674491|NCT00095173|156661487|FG003|Open-Label Extension Phase (Period C)|Adverse Event|1|||
48674492|NCT00095173|156661488|FG004|Open-Label Extension Phase (Period C)|Adverse Event|2|||
48674493|NCT00095173|156661489|FG005|Open-Label Extension Phase (Period C)|Adverse Event|3|||
48674494|NCT00095173|156661484|FG000|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
48674495|NCT00095173|156661485|FG001|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
48674496|NCT00095173|156661486|FG002|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
48674497|NCT00095173|156661487|FG003|Open-Label Extension Phase (Period C)|Lack of Efficacy|11|||
48674498|NCT00095173|156661488|FG004|Open-Label Extension Phase (Period C)|Lack of Efficacy|5|||
48674499|NCT00095173|156661489|FG005|Open-Label Extension Phase (Period C)|Lack of Efficacy|8|||
48761444|NCT01729754|156975637|FG006|Part 1|Progressive Disease|0|||
48873430|NCT01482429|157373387|FG001|Care Usual|Protocol Violation|172|||
48873431|NCT01482429|157373386|FG000|Care Usual|Lost to Follow-up|0|||
48873432|NCT01482429|157373387|FG001|Care Usual|Lost to Follow-up|1|||
48873433|NCT01482429|157373386|FG000|Protocol|Protocol Violation|275|||
48873434|NCT01482429|157373387|FG001|Protocol|Protocol Violation|0|||
48873435|NCT02650466|157373388|FG000|Overall Study|Physician Decision|1|||
48873436|NCT02650466|157373388|FG000|Overall Study|Withdrawal by Subject|5|||
48873437|NCT02650466|157373388|FG000|Overall Study|Lost to Follow-up|1|||
48873438|NCT02484547|157373389|FG000|Placebo-Controlled Period|Adverse Event|10|||
48973227|NCT00437203|157731982|FG005|Overall Study|Death|0|||
48973228|NCT00437203|157731983|FG006|Overall Study|Death|0|||
48973229|NCT00437203|157731984|FG007|Overall Study|Death|1|||
48973230|NCT00437203|157731985|FG008|Overall Study|Death|0|||
48973231|NCT00437203|157731986|FG009|Overall Study|Death|1|||
48973232|NCT00437203|157731977|FG000|Overall Study|Adverse Event|1|||
48973233|NCT00437203|157731978|FG001|Overall Study|Adverse Event|1|||
48973234|NCT00437203|157731979|FG002|Overall Study|Adverse Event|0|||
48973235|NCT00437203|157731980|FG003|Overall Study|Adverse Event|0|||
48973236|NCT00437203|157731981|FG004|Overall Study|Adverse Event|0|||
48973237|NCT00437203|157731982|FG005|Overall Study|Adverse Event|0|||
48973238|NCT00437203|157731983|FG006|Overall Study|Adverse Event|0|||
48973239|NCT00437203|157731984|FG007|Overall Study|Adverse Event|1|||
48973240|NCT00437203|157731985|FG008|Overall Study|Adverse Event|0|||
48973241|NCT00437203|157731986|FG009|Overall Study|Adverse Event|1|||
48973242|NCT00437203|157731977|FG000|Overall Study|Study terminated by sponsor|0|||
48973243|NCT00437203|157731978|FG001|Overall Study|Study terminated by sponsor|0|||
48973244|NCT00437203|157731979|FG002|Overall Study|Study terminated by sponsor|0|||
48973245|NCT00437203|157731980|FG003|Overall Study|Study terminated by sponsor|0|||
48674500|NCT00095173|156661484|FG000|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
48674501|NCT00095173|156661485|FG001|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
48973246|NCT00437203|157731981|FG004|Overall Study|Study terminated by sponsor|0|||
48973247|NCT00437203|157731982|FG005|Overall Study|Study terminated by sponsor|0|||
48761445|NCT01729754|156975638|FG007|Part 1|Progressive Disease|0|||
48761446|NCT01729754|156975639|FG008|Part 1|Progressive Disease|0|||
48761447|NCT01729754|156975640|FG009|Part 1|Progressive Disease|1|||
48761448|NCT01729754|156975631|FG000|Part 1|Protocol Violation|2|||
48761449|NCT01729754|156975632|FG001|Part 1|Protocol Violation|0|||
48761450|NCT01729754|156975633|FG002|Part 1|Protocol Violation|0|||
48761451|NCT01729754|156975634|FG003|Part 1|Protocol Violation|1|||
48973248|NCT00437203|157731983|FG006|Overall Study|Study terminated by sponsor|0|||
48973249|NCT00437203|157731984|FG007|Overall Study|Study terminated by sponsor|0|||
48674502|NCT00095173|156661486|FG002|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
48674503|NCT00095173|156661487|FG003|Open-Label Extension Phase (Period C)|Lost to Follow-up|2|||
48674504|NCT00095173|156661488|FG004|Open-Label Extension Phase (Period C)|Lost to Follow-up|5|||
48761452|NCT01729754|156975635|FG004|Part 1|Protocol Violation|0|||
48761453|NCT01729754|156975636|FG005|Part 1|Protocol Violation|0|||
48761454|NCT01729754|156975637|FG006|Part 1|Protocol Violation|1|||
48873439|NCT02484547|157373390|FG001|Placebo-Controlled Period|Adverse Event|13|||
48873440|NCT02484547|157373391|FG002|Placebo-Controlled Period|Adverse Event|20|||
48873441|NCT02484547|157373392|FG003|Placebo-Controlled Period|Adverse Event|0|||
48873442|NCT02484547|157373393|FG004|Placebo-Controlled Period|Adverse Event|0|||
48873443|NCT02484547|157373394|FG005|Placebo-Controlled Period|Adverse Event|0|||
48873444|NCT02484547|157373395|FG006|Placebo-Controlled Period|Adverse Event|0|||
48873445|NCT02484547|157373389|FG000|Placebo-Controlled Period|Change of Treatment|0|||
48873446|NCT02484547|157373390|FG001|Placebo-Controlled Period|Change of Treatment|0|||
48873447|NCT02484547|157373391|FG002|Placebo-Controlled Period|Change of Treatment|1|||
48873448|NCT02484547|157373392|FG003|Placebo-Controlled Period|Change of Treatment|0|||
48873449|NCT02484547|157373393|FG004|Placebo-Controlled Period|Change of Treatment|0|||
48873450|NCT02484547|157373394|FG005|Placebo-Controlled Period|Change of Treatment|0|||
48873451|NCT02484547|157373395|FG006|Placebo-Controlled Period|Change of Treatment|0|||
48873452|NCT02484547|157373389|FG000|Placebo-Controlled Period|Consent Withdrawn|15|||
48873453|NCT02484547|157373390|FG001|Placebo-Controlled Period|Consent Withdrawn|32|||
48873454|NCT02484547|157373391|FG002|Placebo-Controlled Period|Consent Withdrawn|26|||
48873455|NCT02484547|157373392|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
48873456|NCT02484547|157373393|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
48873457|NCT02484547|157373394|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
48873458|NCT02484547|157373395|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
48674505|NCT00095173|156661489|FG005|Open-Label Extension Phase (Period C)|Lost to Follow-up|6|||
48674506|NCT00095173|156661484|FG000|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
48873459|NCT02484547|157373389|FG000|Placebo-Controlled Period|Death|5|||
48873460|NCT02484547|157373390|FG001|Placebo-Controlled Period|Death|0|||
48973250|NCT00437203|157731985|FG008|Overall Study|Study terminated by sponsor|1|||
48973251|NCT00437203|157731986|FG009|Overall Study|Study terminated by sponsor|0|||
48973252|NCT00437203|157731977|FG000|Overall Study|Objective progression or relapse|5|||
48973253|NCT00437203|157731978|FG001|Overall Study|Objective progression or relapse|6|||
48973254|NCT00437203|157731979|FG002|Overall Study|Objective progression or relapse|2|||
48674507|NCT00095173|156661485|FG001|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
48674508|NCT00095173|156661486|FG002|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
48873461|NCT02484547|157373391|FG002|Placebo-Controlled Period|Death|6|||
48873462|NCT02484547|157373392|FG003|Placebo-Controlled Period|Death|0|||
48873463|NCT02484547|157373393|FG004|Placebo-Controlled Period|Death|0|||
48873464|NCT02484547|157373394|FG005|Placebo-Controlled Period|Death|0|||
48873465|NCT02484547|157373395|FG006|Placebo-Controlled Period|Death|0|||
48973255|NCT00437203|157731980|FG003|Overall Study|Objective progression or relapse|3|||
48761455|NCT01729754|156975638|FG007|Part 1|Protocol Violation|0|||
48761456|NCT01729754|156975639|FG008|Part 1|Protocol Violation|0|||
48761457|NCT01729754|156975640|FG009|Part 1|Protocol Violation|0|||
48761458|NCT01729754|156975631|FG000|Part 1|Withdrawal by Subject|5|||
48761459|NCT01729754|156975632|FG001|Part 1|Withdrawal by Subject|0|||
48761460|NCT01729754|156975633|FG002|Part 1|Withdrawal by Subject|0|||
48761461|NCT01729754|156975634|FG003|Part 1|Withdrawal by Subject|7|||
48761462|NCT01729754|156975635|FG004|Part 1|Withdrawal by Subject|0|||
48761463|NCT01729754|156975636|FG005|Part 1|Withdrawal by Subject|0|||
48761464|NCT01729754|156975637|FG006|Part 1|Withdrawal by Subject|5|||
48761465|NCT01729754|156975638|FG007|Part 1|Withdrawal by Subject|0|||
48761466|NCT01729754|156975639|FG008|Part 1|Withdrawal by Subject|0|||
48761467|NCT01729754|156975640|FG009|Part 1|Withdrawal by Subject|6|||
48761468|NCT01729754|156975631|FG000|Part 1|Other Protocol Specified Criteria|2|||
48873466|NCT02484547|157373389|FG000|Placebo-Controlled Period|Disease Progression|2|||
48674509|NCT00095173|156661487|FG003|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4|||
48674510|NCT00095173|156661488|FG004|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6|||
48674511|NCT00095173|156661489|FG005|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
48674512|NCT00095173|156661484|FG000|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
48674513|NCT00095173|156661485|FG001|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
48674514|NCT00095173|156661486|FG002|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
48674515|NCT00095173|156661487|FG003|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
48674516|NCT00095173|156661488|FG004|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
48674517|NCT00095173|156661489|FG005|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
48674518|NCT00095173|156661484|FG000|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
48674519|NCT00095173|156661485|FG001|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
48674520|NCT00095173|156661486|FG002|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
48674521|NCT00095173|156661487|FG003|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
48674522|NCT00095173|156661488|FG004|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
48674523|NCT00095173|156661489|FG005|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
48674524|NCT00095173|156661484|FG000|Open-Label Extension Phase (Period C)|Pregnancy|0|||
48674525|NCT00095173|156661485|FG001|Open-Label Extension Phase (Period C)|Pregnancy|0|||
48674526|NCT00095173|156661486|FG002|Open-Label Extension Phase (Period C)|Pregnancy|0|||
48674527|NCT00095173|156661487|FG003|Open-Label Extension Phase (Period C)|Pregnancy|1|||
48674528|NCT00095173|156661488|FG004|Open-Label Extension Phase (Period C)|Pregnancy|2|||
48674529|NCT00095173|156661489|FG005|Open-Label Extension Phase (Period C)|Pregnancy|3|||
48674530|NCT00095173|156661484|FG000|Open-Label Extension Phase (Period C)|Other|0|||
48674531|NCT00095173|156661485|FG001|Open-Label Extension Phase (Period C)|Other|0|||
48674532|NCT00095173|156661486|FG002|Open-Label Extension Phase (Period C)|Other|0|||
48674533|NCT00095173|156661487|FG003|Open-Label Extension Phase (Period C)|Other|4|||
48674534|NCT00095173|156661488|FG004|Open-Label Extension Phase (Period C)|Other|6|||
48761469|NCT01729754|156975632|FG001|Part 1|Other Protocol Specified Criteria|0|||
48761470|NCT01729754|156975633|FG002|Part 1|Other Protocol Specified Criteria|0|||
48761471|NCT01729754|156975634|FG003|Part 1|Other Protocol Specified Criteria|0|||
48761472|NCT01729754|156975635|FG004|Part 1|Other Protocol Specified Criteria|0|||
48761473|NCT01729754|156975636|FG005|Part 1|Other Protocol Specified Criteria|0|||
48873467|NCT02484547|157373390|FG001|Placebo-Controlled Period|Disease Progression|0|||
48873468|NCT02484547|157373391|FG002|Placebo-Controlled Period|Disease Progression|1|||
48873469|NCT02484547|157373392|FG003|Placebo-Controlled Period|Disease Progression|0|||
48873470|NCT02484547|157373393|FG004|Placebo-Controlled Period|Disease Progression|0|||
48873471|NCT02484547|157373394|FG005|Placebo-Controlled Period|Disease Progression|0|||
48873472|NCT02484547|157373395|FG006|Placebo-Controlled Period|Disease Progression|0|||
48873473|NCT02484547|157373389|FG000|Placebo-Controlled Period|Investigator Decision|2|||
48873474|NCT02484547|157373390|FG001|Placebo-Controlled Period|Investigator Decision|2|||
48873475|NCT02484547|157373391|FG002|Placebo-Controlled Period|Investigator Decision|5|||
48873476|NCT02484547|157373392|FG003|Placebo-Controlled Period|Investigator Decision|0|||
48873477|NCT02484547|157373393|FG004|Placebo-Controlled Period|Investigator Decision|0|||
48873478|NCT02484547|157373394|FG005|Placebo-Controlled Period|Investigator Decision|0|||
48873479|NCT02484547|157373395|FG006|Placebo-Controlled Period|Investigator Decision|0|||
48873480|NCT02484547|157373389|FG000|Placebo-Controlled Period|Lost to Follow-up|3|||
48873481|NCT02484547|157373390|FG001|Placebo-Controlled Period|Lost to Follow-up|1|||
48873482|NCT02484547|157373391|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
48873483|NCT02484547|157373392|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
48873484|NCT02484547|157373393|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
48873485|NCT02484547|157373394|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
48873486|NCT02484547|157373395|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
48873487|NCT02484547|157373389|FG000|Placebo-Controlled Period|Relocation|1|||
48873488|NCT02484547|157373390|FG001|Placebo-Controlled Period|Relocation|1|||
48873489|NCT02484547|157373391|FG002|Placebo-Controlled Period|Relocation|1|||
48873490|NCT02484547|157373392|FG003|Placebo-Controlled Period|Relocation|0|||
48873491|NCT02484547|157373393|FG004|Placebo-Controlled Period|Relocation|0|||
48873492|NCT02484547|157373394|FG005|Placebo-Controlled Period|Relocation|0|||
48973256|NCT00437203|157731981|FG004|Overall Study|Objective progression or relapse|3|||
48973257|NCT00437203|157731982|FG005|Overall Study|Objective progression or relapse|3|||
48973258|NCT00437203|157731983|FG006|Overall Study|Objective progression or relapse|6|||
48973259|NCT00437203|157731984|FG007|Overall Study|Objective progression or relapse|1|||
48973260|NCT00437203|157731985|FG008|Overall Study|Objective progression or relapse|2|||
48973261|NCT00437203|157731986|FG009|Overall Study|Objective progression or relapse|2|||
48973262|NCT00437203|157731977|FG000|Overall Study|Other|0|||
48973263|NCT00437203|157731978|FG001|Overall Study|Other|1|||
48973264|NCT00437203|157731979|FG002|Overall Study|Other|0|||
48973265|NCT00437203|157731980|FG003|Overall Study|Other|0|||
48973266|NCT00437203|157731981|FG004|Overall Study|Other|0|||
48973267|NCT00437203|157731982|FG005|Overall Study|Other|0|||
48973268|NCT00437203|157731983|FG006|Overall Study|Other|1|||
48973269|NCT00437203|157731984|FG007|Overall Study|Other|0|||
48973270|NCT00437203|157731985|FG008|Overall Study|Other|0|||
48973271|NCT00437203|157731986|FG009|Overall Study|Other|0|||
48973272|NCT03136484|157731987|FG000|Overall Study|Withdrawal by Subject|19|||
48973273|NCT03136484|157731988|FG001|Overall Study|Withdrawal by Subject|14|||
48973274|NCT03136484|157731987|FG000|Overall Study|Lost to Follow-up|7|||
48973275|NCT03136484|157731988|FG001|Overall Study|Lost to Follow-up|8|||
48973276|NCT03136484|157731987|FG000|Overall Study|Death|1|||
48973277|NCT03136484|157731988|FG001|Overall Study|Death|0|||
48973278|NCT02999191|157731996|FG000|Wash-out Period 1 [21 Days]|Adverse Event|0|||
48973279|NCT02999191|157731997|FG001|Wash-out Period 1 [21 Days]|Adverse Event|1|||
48973280|NCT02999191|157731998|FG002|Wash-out Period 1 [21 Days]|Adverse Event|0|||
48973281|NCT00646113|157733897|FG000|Overall Study|Lost to Follow-up|5|||
48973282|NCT00646113|157733897|FG000|Overall Study|Adverse Event|3|||
48973283|NCT02109744|157733900|FG000|Overall Study|Death|1|||
48973284|NCT02109744|157733901|FG001|Overall Study|Death|1|||
48973285|NCT02109744|157733900|FG000|Overall Study|no marrow exam|1|||
48973286|NCT02109744|157733901|FG001|Overall Study|no marrow exam|0|||
48973287|NCT03326869|157733902|FG000|Overall Study|Study data has been lost to natural disa|1|||
48973288|NCT03326869|157733903|FG001|Overall Study|Study data has been lost to natural disa|1|||
48973289|NCT03750240|157733905|FG000|Overall Study|Technical Difficulties|2|||
48973290|NCT01316939|157733908|FG000|Overall Study|Study closed/terminated|26|||
48973291|NCT01316939|157733909|FG001|Overall Study|Study closed/terminated|25|||
48761474|NCT01729754|156975637|FG006|Part 1|Other Protocol Specified Criteria|1|||
48761475|NCT01729754|156975638|FG007|Part 1|Other Protocol Specified Criteria|0|||
48761476|NCT01729754|156975639|FG008|Part 1|Other Protocol Specified Criteria|0|||
48761477|NCT01729754|156975640|FG009|Part 1|Other Protocol Specified Criteria|4|||
48761478|NCT01729754|156975631|FG000|Part 2|Adverse Event|2|||
48761479|NCT01729754|156975632|FG001|Part 2|Adverse Event|0|||
48761480|NCT01729754|156975633|FG002|Part 2|Adverse Event|0|||
48873493|NCT02484547|157373395|FG006|Placebo-Controlled Period|Relocation|0|||
48973292|NCT01316939|157733910|FG002|Overall Study|Study closed/terminated|23|||
48674535|NCT00095173|156661489|FG005|Open-Label Extension Phase (Period C)|Other|8|||
48674536|NCT01105377|156661492|FG000|Overall Study|Withdrawal by Subject|0|||
48674537|NCT01105377|156661493|FG001|Overall Study|Withdrawal by Subject|1|||
48674538|NCT03157037|156661497|FG000|Overall Study|Death|1|||
48674539|NCT00383162|156661498|FG000|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3|||
48674540|NCT00383162|156661499|FG001|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4|||
48674541|NCT00383162|156661498|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|8|||
48674542|NCT00383162|156661499|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
48761481|NCT01729754|156975634|FG003|Part 2|Adverse Event|0|||
48761482|NCT01729754|156975635|FG004|Part 2|Adverse Event|0|||
48761483|NCT01729754|156975636|FG005|Part 2|Adverse Event|0|||
48761484|NCT01729754|156975637|FG006|Part 2|Adverse Event|0|||
48761485|NCT01729754|156975638|FG007|Part 2|Adverse Event|0|||
48873494|NCT02484547|157373389|FG000|Placebo-Controlled Period|Study Visit Burden|2|||
48873495|NCT02484547|157373390|FG001|Placebo-Controlled Period|Study Visit Burden|8|||
48873496|NCT02484547|157373391|FG002|Placebo-Controlled Period|Study Visit Burden|5|||
48873497|NCT02484547|157373392|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
48873498|NCT02484547|157373393|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
48873499|NCT02484547|157373394|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
48873500|NCT02484547|157373395|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
48873501|NCT02484547|157373389|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4|||
48873502|NCT02484547|157373390|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
48873503|NCT02484547|157373391|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
48873504|NCT02484547|157373392|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
48873505|NCT02484547|157373393|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
48873506|NCT02484547|157373394|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
48873507|NCT02484547|157373395|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
48973293|NCT01316939|157733908|FG000|Overall Study|Lack of Efficacy|24|||
48973294|NCT01316939|157733909|FG001|Overall Study|Lack of Efficacy|25|||
48973295|NCT01316939|157733910|FG002|Overall Study|Lack of Efficacy|25|||
48973296|NCT01316939|157733908|FG000|Overall Study|Adverse Event|9|||
48973297|NCT01316939|157733909|FG001|Overall Study|Adverse Event|12|||
48973298|NCT01316939|157733910|FG002|Overall Study|Adverse Event|11|||
48973299|NCT01316939|157733908|FG000|Overall Study|Withdrawal by Subject|1|||
48973300|NCT01316939|157733909|FG001|Overall Study|Withdrawal by Subject|3|||
48973301|NCT01316939|157733910|FG002|Overall Study|Withdrawal by Subject|6|||
48973302|NCT01316939|157733908|FG000|Overall Study|Physician Decision|2|||
48973303|NCT01316939|157733909|FG001|Overall Study|Physician Decision|2|||
48973304|NCT01316939|157733910|FG002|Overall Study|Physician Decision|1|||
48973305|NCT01316939|157733908|FG000|Overall Study|Lost to Follow-up|0|||
48973306|NCT01316939|157733909|FG001|Overall Study|Lost to Follow-up|0|||
48973307|NCT01316939|157733910|FG002|Overall Study|Lost to Follow-up|2|||
48973308|NCT01316939|157733908|FG000|Overall Study|Met Liver chemistry stopping criteria|1|||
48973309|NCT01316939|157733909|FG001|Overall Study|Met Liver chemistry stopping criteria|0|||
48973310|NCT01316939|157733910|FG002|Overall Study|Met Liver chemistry stopping criteria|1|||
48973311|NCT01316939|157733908|FG000|Overall Study|Protocol Violation|0|||
48973312|NCT01316939|157733909|FG001|Overall Study|Protocol Violation|1|||
48973313|NCT01316939|157733910|FG002|Overall Study|Protocol Violation|0|||
48973314|NCT02254551|157733911|FG000|Dose Escalation|Physician Decision|1|||
48973315|NCT02254551|157733911|FG000|Dose Escalation|Dose-limiting toxicity|2|||
48973316|NCT00010803|157733913|FG000|Overall Study|Withdrawal by Subject|97|||
48973317|NCT00010803|157733914|FG001|Overall Study|Withdrawal by Subject|98|||
48973318|NCT01595438|157733918|FG000|Overall Study|Lost to Follow-up|20|||
48873508|NCT02484547|157373389|FG000|Placebo-Controlled Period|Reason not Specified|216|||
48873509|NCT02484547|157373390|FG001|Placebo-Controlled Period|Reason not Specified|194|||
48873510|NCT02484547|157373391|FG002|Placebo-Controlled Period|Reason not Specified|183|||
48873511|NCT02484547|157373392|FG003|Placebo-Controlled Period|Reason not Specified|0|||
48873512|NCT02484547|157373393|FG004|Placebo-Controlled Period|Reason not Specified|0|||
48873513|NCT02484547|157373394|FG005|Placebo-Controlled Period|Reason not Specified|0|||
48873514|NCT02484547|157373395|FG006|Placebo-Controlled Period|Reason not Specified|0|||
48873515|NCT02484547|157373389|FG000|Long-Term Extension Period|Adverse Event|0|||
48873516|NCT02484547|157373390|FG001|Long-Term Extension Period|Adverse Event|0|||
48873517|NCT02484547|157373391|FG002|Long-Term Extension Period|Adverse Event|0|||
48873518|NCT02484547|157373392|FG003|Long-Term Extension Period|Adverse Event|0|||
48873519|NCT02484547|157373393|FG004|Long-Term Extension Period|Adverse Event|1|||
48873520|NCT02484547|157373394|FG005|Long-Term Extension Period|Adverse Event|3|||
48873521|NCT02484547|157373395|FG006|Long-Term Extension Period|Adverse Event|2|||
48873522|NCT02484547|157373389|FG000|Long-Term Extension Period|Death|0|||
48873523|NCT02484547|157373390|FG001|Long-Term Extension Period|Death|0|||
48873524|NCT02484547|157373391|FG002|Long-Term Extension Period|Death|0|||
48873525|NCT02484547|157373392|FG003|Long-Term Extension Period|Death|0|||
48873526|NCT02484547|157373393|FG004|Long-Term Extension Period|Death|0|||
48873527|NCT02484547|157373394|FG005|Long-Term Extension Period|Death|3|||
48873528|NCT02484547|157373395|FG006|Long-Term Extension Period|Death|0|||
48873529|NCT02484547|157373389|FG000|Long-Term Extension Period|Disease Progression|0|||
48873530|NCT02484547|157373390|FG001|Long-Term Extension Period|Disease Progression|0|||
48973319|NCT01595438|157733919|FG001|Overall Study|Lost to Follow-up|20|||
48973320|NCT01595438|157733918|FG000|Overall Study|Withdrawal by Subject|12|||
48973321|NCT01595438|157733919|FG001|Overall Study|Withdrawal by Subject|12|||
48973322|NCT01595438|157733918|FG000|Overall Study|Other Eligibility criteria|11|||
48973323|NCT01595438|157733919|FG001|Overall Study|Other Eligibility criteria|9|||
48973324|NCT01106391|157733932|FG000|Overall Study|Death|12|||
48973325|NCT01106391|157733932|FG000|Overall Study|Withdrawal by Subject|7|||
48973326|NCT00561340|157733933|FG000|Overall Study|refused to drink pediasure|6|||
48973327|NCT00561340|157733934|FG001|Overall Study|refused to drink pediasure|0|||
48973328|NCT00391807|157733935|FG000|Overall Study|Did not receive study medication|23|||
48973329|NCT00391807|157733935|FG000|Overall Study|Adverse Event|177|||
48973330|NCT00391807|157733935|FG000|Overall Study|Pregnancy|25|||
48973331|NCT00391807|157733935|FG000|Overall Study|Lost to Follow-up|227|||
48973332|NCT00391807|157733935|FG000|Overall Study|Withdrawal by Subject|147|||
48973333|NCT00391807|157733935|FG000|Overall Study|Protocol Violation|20|||
48873531|NCT02484547|157373391|FG002|Long-Term Extension Period|Disease Progression|0|||
48873532|NCT02484547|157373392|FG003|Long-Term Extension Period|Disease Progression|0|||
48873533|NCT02484547|157373393|FG004|Long-Term Extension Period|Disease Progression|2|||
48873534|NCT02484547|157373394|FG005|Long-Term Extension Period|Disease Progression|4|||
48873535|NCT02484547|157373395|FG006|Long-Term Extension Period|Disease Progression|0|||
48873536|NCT02484547|157373389|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
48873537|NCT02484547|157373390|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
48873538|NCT02484547|157373391|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
48873539|NCT02484547|157373392|FG003|Long-Term Extension Period|Lost to Follow-up|1|||
48873540|NCT02484547|157373393|FG004|Long-Term Extension Period|Lost to Follow-up|1|||
48873541|NCT02484547|157373394|FG005|Long-Term Extension Period|Lost to Follow-up|2|||
48873542|NCT02484547|157373395|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
48973334|NCT00391807|157733935|FG000|Overall Study|Various|96|||
48973335|NCT00047008|157733936|FG000|Overall Study|Withdrawn consent|2|||
48973336|NCT00047008|157733937|FG001|Overall Study|Withdrawn consent|3|||
48973337|NCT00047008|157733936|FG000|Overall Study|Ineligible|9|||
48973338|NCT00047008|157733937|FG001|Overall Study|Ineligible|8|||
48973339|NCT03725293|157733939|FG000|Overall Study|Physician Decision|9|||
48674543|NCT00383162|156661498|FG000|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4|||
48674544|NCT00383162|156661499|FG001|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2|||
48674545|NCT00383162|156661498|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2|||
48674546|NCT00383162|156661499|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0|||
48674547|NCT00383162|156661498|FG000|Migraine Attack 1 (Period 1)|Non-compliant|3|||
48674548|NCT00383162|156661499|FG001|Migraine Attack 1 (Period 1)|Non-compliant|0|||
48674549|NCT00383162|156661498|FG000|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1|||
48674550|NCT00383162|156661499|FG001|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3|||
48674551|NCT00383162|156661498|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
48674552|NCT00383162|156661499|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
48674553|NCT00383162|156661498|FG000|Migraine Attack 2 (Period 2)|Adverse Event|1|||
48674554|NCT00383162|156661499|FG001|Migraine Attack 2 (Period 2)|Adverse Event|0|||
48674555|NCT00383162|156661498|FG000|Migraine Attack 2 (Period 2)|Unknown reason|0|||
48674556|NCT00383162|156661499|FG001|Migraine Attack 2 (Period 2)|Unknown reason|3|||
48674557|NCT00235716|156661500|FG000|Overall Study|Death|26|||
48674558|NCT00235716|156661501|FG001|Overall Study|Death|39|||
48674559|NCT00235716|156661502|FG002|Overall Study|Death|32|||
48674560|NCT00235716|156661503|FG003|Overall Study|Death|31|||
48674561|NCT00235716|156661500|FG000|Overall Study|Withdrawal by Subject|23|||
48674562|NCT00235716|156661501|FG001|Overall Study|Withdrawal by Subject|19|||
48674563|NCT00235716|156661502|FG002|Overall Study|Withdrawal by Subject|17|||
48674564|NCT00235716|156661503|FG003|Overall Study|Withdrawal by Subject|18|||
48674565|NCT00235716|156661500|FG000|Overall Study|Lost to Follow-up|12|||
48674566|NCT00235716|156661501|FG001|Overall Study|Lost to Follow-up|7|||
48674567|NCT00235716|156661502|FG002|Overall Study|Lost to Follow-up|14|||
48674568|NCT00235716|156661503|FG003|Overall Study|Lost to Follow-up|10|||
48674569|NCT00235716|156661500|FG000|Overall Study|Adverse Event|1|||
48674570|NCT00235716|156661501|FG001|Overall Study|Adverse Event|1|||
48674571|NCT00235716|156661502|FG002|Overall Study|Adverse Event|1|||
48674572|NCT00235716|156661503|FG003|Overall Study|Adverse Event|0|||
48674573|NCT00235716|156661500|FG000|Overall Study|Physician Decision|0|||
48973340|NCT03725293|157733940|FG001|Overall Study|Physician Decision|6|||
48973341|NCT03725293|157733939|FG000|Overall Study|alternative vascular access needs|1|||
48973342|NCT03725293|157733940|FG001|Overall Study|alternative vascular access needs|2|||
48973343|NCT03725293|157733939|FG000|Overall Study|venous anatomy screen failures|2|||
48973344|NCT03725293|157733940|FG001|Overall Study|venous anatomy screen failures|1|||
48973345|NCT03447821|157733946|FG000|Overall Study|Withdrawal by Subject|1|||
48973346|NCT03447821|157733947|FG001|Overall Study|Withdrawal by Subject|1|||
48973347|NCT03447821|157733948|FG002|Overall Study|Withdrawal by Subject|0|||
48973348|NCT03447821|157733946|FG000|Overall Study|Lost to Follow-up|0|||
48973349|NCT03447821|157733947|FG001|Overall Study|Lost to Follow-up|0|||
48973350|NCT03447821|157733948|FG002|Overall Study|Lost to Follow-up|1|||
48973351|NCT02023268|157733950|FG000|Overall Study|Lack of Efficacy|0|||
48973352|NCT02023268|157733951|FG001|Overall Study|Lack of Efficacy|1|||
48973353|NCT02023268|157733950|FG000|Overall Study|Adverse Event|0|||
48973354|NCT02023268|157733951|FG001|Overall Study|Adverse Event|2|||
48973355|NCT02023268|157733950|FG000|Overall Study|Withdrawal by Subject|0|||
48973356|NCT02023268|157733951|FG001|Overall Study|Withdrawal by Subject|1|||
48973357|NCT01611298|157733960|FG000|Overall Study|Relapsed|2|||
48973358|NCT00928512|157733961|FG000|Overall Study|Adverse Event|4|||
48973359|NCT00928512|157733962|FG001|Overall Study|Adverse Event|3|||
48973360|NCT00928512|157733963|FG002|Overall Study|Adverse Event|2|||
48973361|NCT00928512|157733964|FG003|Overall Study|Adverse Event|8|||
48973362|NCT00928512|157733965|FG004|Overall Study|Adverse Event|6|||
48973363|NCT00928512|157733961|FG000|Overall Study|Lack of Efficacy|2|||
48973364|NCT00928512|157733962|FG001|Overall Study|Lack of Efficacy|0|||
48973365|NCT00928512|157733963|FG002|Overall Study|Lack of Efficacy|4|||
48674574|NCT00235716|156661501|FG001|Overall Study|Physician Decision|1|||
48674575|NCT00235716|156661502|FG002|Overall Study|Physician Decision|1|||
48674576|NCT00235716|156661503|FG003|Overall Study|Physician Decision|3|||
48973366|NCT00928512|157733964|FG003|Overall Study|Lack of Efficacy|7|||
48973367|NCT00928512|157733965|FG004|Overall Study|Lack of Efficacy|3|||
48973368|NCT00928512|157733961|FG000|Overall Study|Protocol Violation|0|||
48973369|NCT00928512|157733962|FG001|Overall Study|Protocol Violation|1|||
48973370|NCT00928512|157733963|FG002|Overall Study|Protocol Violation|0|||
48973371|NCT00928512|157733964|FG003|Overall Study|Protocol Violation|1|||
48973372|NCT00928512|157733965|FG004|Overall Study|Protocol Violation|3|||
48973373|NCT00928512|157733961|FG000|Overall Study|Withdrawal by Subject|3|||
48973374|NCT00928512|157733962|FG001|Overall Study|Withdrawal by Subject|0|||
48973375|NCT00928512|157733963|FG002|Overall Study|Withdrawal by Subject|3|||
48973376|NCT00928512|157733964|FG003|Overall Study|Withdrawal by Subject|4|||
48674577|NCT02249182|156661504|FG000|Treatment Phase|Lost to Follow-up|4|||
48674578|NCT02249182|156661505|FG001|Treatment Phase|Lost to Follow-up|0|||
48674579|NCT02249182|156661506|FG002|Treatment Phase|Lost to Follow-up|0|||
48973377|NCT00928512|157733965|FG004|Overall Study|Withdrawal by Subject|0|||
48973378|NCT00928512|157733961|FG000|Overall Study|Lost to Follow-up|1|||
48973379|NCT00928512|157733962|FG001|Overall Study|Lost to Follow-up|1|||
48973380|NCT00928512|157733963|FG002|Overall Study|Lost to Follow-up|2|||
48674580|NCT02249182|156661507|FG003|Treatment Phase|Lost to Follow-up|0|||
48973381|NCT00928512|157733964|FG003|Overall Study|Lost to Follow-up|1|||
48973382|NCT00928512|157733965|FG004|Overall Study|Lost to Follow-up|3|||
48973383|NCT00928512|157733961|FG000|Overall Study|Administrative Problems|0|||
48973384|NCT00928512|157733962|FG001|Overall Study|Administrative Problems|1|||
48973385|NCT00928512|157733963|FG002|Overall Study|Administrative Problems|0|||
48973386|NCT00928512|157733964|FG003|Overall Study|Administrative Problems|0|||
48973387|NCT00928512|157733965|FG004|Overall Study|Administrative Problems|0|||
48973388|NCT01095666|157733966|FG000|Overall Study|Lack of Efficacy|0|||
48973389|NCT01095666|157733967|FG001|Overall Study|Lack of Efficacy|0|||
48973390|NCT01095666|157733968|FG002|Overall Study|Lack of Efficacy|1|||
48973391|NCT01095666|157733966|FG000|Overall Study|Adverse Event|2|||
48973392|NCT01095666|157733967|FG001|Overall Study|Adverse Event|1|||
48973393|NCT01095666|157733968|FG002|Overall Study|Adverse Event|3|||
48973394|NCT01095666|157733966|FG000|Overall Study|Lost to Follow-up|2|||
48973395|NCT01095666|157733967|FG001|Overall Study|Lost to Follow-up|2|||
48973396|NCT01095666|157733968|FG002|Overall Study|Lost to Follow-up|0|||
48973397|NCT01095666|157733966|FG000|Overall Study|Withdrawal by Subject|6|||
48973398|NCT01095666|157733967|FG001|Overall Study|Withdrawal by Subject|6|||
48973399|NCT01095666|157733968|FG002|Overall Study|Withdrawal by Subject|1|||
48973400|NCT01095666|157733966|FG000|Overall Study|Non-compliance, not met criteria etc.|7|||
48973401|NCT01095666|157733967|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
48973402|NCT01095666|157733968|FG002|Overall Study|Non-compliance, not met criteria etc.|2|||
48973403|NCT01975675|157733969|FG000|Overall Study|Death|0|||
48973404|NCT01975675|157733970|FG001|Overall Study|Death|1|||
48973405|NCT01975675|157733971|FG002|Overall Study|Death|0|||
48973406|NCT01975675|157733972|FG003|Overall Study|Death|0|||
48973407|NCT02709109|157733973|FG000|Treatment Period 1 (28 Days)|Adverse Event|3|||
48973408|NCT02709109|157733974|FG001|Treatment Period 1 (28 Days)|Adverse Event|3|||
48973409|NCT02709109|157733975|FG002|Treatment Period 1 (28 Days)|Adverse Event|1|||
48973410|NCT02709109|157733976|FG003|Treatment Period 1 (28 Days)|Adverse Event|0|||
48973411|NCT02709109|157733973|FG000|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
48973412|NCT02709109|157733974|FG001|Treatment Period 1 (28 Days)|Participant refused further dosing|2|||
48973413|NCT02709109|157733975|FG002|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
48973414|NCT02709109|157733976|FG003|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
48973415|NCT02709109|157733973|FG000|Treatment Period 1 (28 Days)|Non-compliance with study drug|1|||
48973416|NCT02709109|157733974|FG001|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
48973417|NCT02709109|157733975|FG002|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
48973418|NCT02709109|157733976|FG003|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
48973419|NCT02709109|157733973|FG000|Washout Period (28 Days)|Other|2|||
48973420|NCT02709109|157733974|FG001|Washout Period (28 Days)|Other|2|||
48973421|NCT02709109|157733975|FG002|Washout Period (28 Days)|Other|3|||
48973422|NCT02709109|157733976|FG003|Washout Period (28 Days)|Other|0|||
48973423|NCT02709109|157733973|FG000|Treatment Period 2 (28 Days)|Adverse Event|2|||
48973424|NCT02709109|157733974|FG001|Treatment Period 2 (28 Days)|Adverse Event|3|||
48973425|NCT02709109|157733975|FG002|Treatment Period 2 (28 Days)|Adverse Event|0|||
48973426|NCT02709109|157733976|FG003|Treatment Period 2 (28 Days)|Adverse Event|0|||
48973427|NCT02709109|157733973|FG000|Treatment Period 2 (28 Days)|Other non-compliance|0|||
48973428|NCT02709109|157733974|FG001|Treatment Period 2 (28 Days)|Other non-compliance|1|||
48973429|NCT02709109|157733975|FG002|Treatment Period 2 (28 Days)|Other non-compliance|1|||
48973430|NCT02709109|157733976|FG003|Treatment Period 2 (28 Days)|Other non-compliance|0|||
48973431|NCT02709109|157733973|FG000|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
48973432|NCT02709109|157733974|FG001|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
48973433|NCT02709109|157733975|FG002|Treatment Period 2 (28 Days)|Requires prohibited medication|1|||
48973434|NCT02709109|157733976|FG003|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
48973435|NCT02709109|157733973|FG000|Treatment Period 2 (28 Days)|Other|0|||
48973436|NCT02709109|157733974|FG001|Treatment Period 2 (28 Days)|Other|0|||
48674581|NCT02249182|156661508|FG004|Treatment Phase|Lost to Follow-up|0|||
48674582|NCT01299116|156661511|FG000|Overall Study|Lost to Follow-up|65|||
48674583|NCT01299116|156661512|FG001|Overall Study|Lost to Follow-up|9|||
48674584|NCT01299116|156661513|FG002|Overall Study|Lost to Follow-up|11|||
48674585|NCT01620944|156661514|FG000|Overall Study|Early termination of Study|2|||
48973437|NCT02709109|157733975|FG002|Treatment Period 2 (28 Days)|Other|1|||
48973438|NCT02709109|157733976|FG003|Treatment Period 2 (28 Days)|Other|0|||
48973439|NCT01468701|157733978|FG000|Overall Study|Not eligible|91|||
48973440|NCT01468701|157733979|FG001|Overall Study|Not eligible|140|||
48973441|NCT01468701|157733980|FG002|Overall Study|Not eligible|29|||
48973442|NCT01468701|157733981|FG003|Overall Study|Not eligible|12|||
48674586|NCT01620944|156661515|FG001|Overall Study|Early termination of Study|1|||
48674587|NCT01364389|156661521|FG000|Overall Study|Withdrawal by Subject|0|||
48674588|NCT01364389|156661522|FG001|Overall Study|Withdrawal by Subject|1|||
48674589|NCT01364389|156661523|FG002|Overall Study|Withdrawal by Subject|0|||
48674590|NCT01364389|156661521|FG000|Overall Study|Protocol deviation|0|||
48674591|NCT01364389|156661522|FG001|Overall Study|Protocol deviation|0|||
48674592|NCT01364389|156661523|FG002|Overall Study|Protocol deviation|1|||
48674593|NCT01364389|156661521|FG000|Overall Study|Administrative problems|1|||
48674594|NCT01364389|156661522|FG001|Overall Study|Administrative problems|0|||
48674595|NCT01364389|156661523|FG002|Overall Study|Administrative problems|0|||
48674596|NCT01364389|156661521|FG000|Overall Study|Adverse Event|1|||
48674597|NCT01364389|156661522|FG001|Overall Study|Adverse Event|0|||
48674598|NCT01364389|156661523|FG002|Overall Study|Adverse Event|0|||
48973443|NCT01468701|157733982|FG004|Overall Study|Not eligible|22|||
48973444|NCT01468701|157733983|FG005|Overall Study|Not eligible|2|||
48973445|NCT01468701|157733984|FG006|Overall Study|Not eligible|39|||
48973446|NCT01468701|157733985|FG007|Overall Study|Not eligible|1|||
48973447|NCT01468701|157733986|FG008|Overall Study|Not eligible|40|||
48973448|NCT01468701|157733987|FG009|Overall Study|Not eligible|126|||
48973449|NCT01468701|157733988|FG010|Overall Study|Not eligible|39|||
48973450|NCT01468701|157733989|FG011|Overall Study|Not eligible|33|||
48973451|NCT01468701|157733990|FG012|Overall Study|Not eligible|1|||
48973452|NCT01468701|157733991|FG013|Overall Study|Not eligible|19|||
48973453|NCT01468701|157733992|FG014|Overall Study|Not eligible|1|||
48973454|NCT01468701|157733993|FG015|Overall Study|Not eligible|32|||
48973455|NCT01468701|157733994|FG016|Overall Study|Not eligible|0|||
48973456|NCT01468701|157733978|FG000|Overall Study|Lost to Follow-up|306|||
48973457|NCT01468701|157733979|FG001|Overall Study|Lost to Follow-up|0|||
48973458|NCT01468701|157733980|FG002|Overall Study|Lost to Follow-up|0|||
48973459|NCT01468701|157733981|FG003|Overall Study|Lost to Follow-up|0|||
48973460|NCT01468701|157733982|FG004|Overall Study|Lost to Follow-up|0|||
48973461|NCT01468701|157733983|FG005|Overall Study|Lost to Follow-up|0|||
48973462|NCT01468701|157733984|FG006|Overall Study|Lost to Follow-up|0|||
48973463|NCT01468701|157733985|FG007|Overall Study|Lost to Follow-up|0|||
48973464|NCT01468701|157733986|FG008|Overall Study|Lost to Follow-up|215|||
48973465|NCT01468701|157733987|FG009|Overall Study|Lost to Follow-up|309|||
48973466|NCT01468701|157733988|FG010|Overall Study|Lost to Follow-up|224|||
48973467|NCT01468701|157733989|FG011|Overall Study|Lost to Follow-up|212|||
48973468|NCT01468701|157733990|FG012|Overall Study|Lost to Follow-up|11|||
48973469|NCT01468701|157733991|FG013|Overall Study|Lost to Follow-up|164|||
48973470|NCT01468701|157733992|FG014|Overall Study|Lost to Follow-up|17|||
48973471|NCT01468701|157733993|FG015|Overall Study|Lost to Follow-up|127|||
48973472|NCT01468701|157733994|FG016|Overall Study|Lost to Follow-up|1|||
48973473|NCT01468701|157733978|FG000|Overall Study|Withdrawal by Subject|165|||
48973474|NCT01468701|157733979|FG001|Overall Study|Withdrawal by Subject|0|||
48973475|NCT01468701|157733980|FG002|Overall Study|Withdrawal by Subject|0|||
48973476|NCT01468701|157733981|FG003|Overall Study|Withdrawal by Subject|0|||
48973477|NCT01468701|157733982|FG004|Overall Study|Withdrawal by Subject|0|||
48973478|NCT01468701|157733983|FG005|Overall Study|Withdrawal by Subject|0|||
48973479|NCT01468701|157733984|FG006|Overall Study|Withdrawal by Subject|0|||
48973480|NCT01468701|157733985|FG007|Overall Study|Withdrawal by Subject|0|||
48973481|NCT01468701|157733986|FG008|Overall Study|Withdrawal by Subject|83|||
48973482|NCT01468701|157733987|FG009|Overall Study|Withdrawal by Subject|88|||
48973483|NCT01468701|157733988|FG010|Overall Study|Withdrawal by Subject|100|||
48973484|NCT01468701|157733989|FG011|Overall Study|Withdrawal by Subject|114|||
48973485|NCT01468701|157733990|FG012|Overall Study|Withdrawal by Subject|9|||
48973486|NCT01468701|157733991|FG013|Overall Study|Withdrawal by Subject|47|||
48973487|NCT01468701|157733992|FG014|Overall Study|Withdrawal by Subject|6|||
48973488|NCT01468701|157733993|FG015|Overall Study|Withdrawal by Subject|31|||
48973489|NCT01468701|157733994|FG016|Overall Study|Withdrawal by Subject|0|||
48973490|NCT01468701|157733978|FG000|Overall Study|Other reasons than listed|437|||
48973491|NCT01468701|157733979|FG001|Overall Study|Other reasons than listed|0|||
48973492|NCT01468701|157733980|FG002|Overall Study|Other reasons than listed|0|||
48973493|NCT01468701|157733981|FG003|Overall Study|Other reasons than listed|0|||
48973494|NCT01468701|157733982|FG004|Overall Study|Other reasons than listed|0|||
48973495|NCT01468701|157733983|FG005|Overall Study|Other reasons than listed|0|||
48973496|NCT01468701|157733984|FG006|Overall Study|Other reasons than listed|0|||
48674599|NCT03216746|156661524|FG000|Overall Study|Lost to Follow-up|6|||
48973497|NCT01468701|157733985|FG007|Overall Study|Other reasons than listed|0|||
48973498|NCT01468701|157733986|FG008|Overall Study|Other reasons than listed|318|||
48973499|NCT01468701|157733987|FG009|Overall Study|Other reasons than listed|658|||
48973500|NCT01468701|157733988|FG010|Overall Study|Other reasons than listed|433|||
48973501|NCT01468701|157733989|FG011|Overall Study|Other reasons than listed|504|||
48674600|NCT03216746|156661525|FG001|Overall Study|Lost to Follow-up|8|||
48973502|NCT01468701|157733990|FG012|Overall Study|Other reasons than listed|28|||
48973503|NCT01468701|157733991|FG013|Overall Study|Other reasons than listed|239|||
49015501|NCT01393990|157893779|FG009|Overall Study|Withdrawal by Subject|0|||
48674601|NCT03216746|156661526|FG002|Overall Study|Lost to Follow-up|5|||
48674602|NCT03216746|156661527|FG003|Overall Study|Lost to Follow-up|6|||
48973504|NCT01468701|157733992|FG014|Overall Study|Other reasons than listed|39|||
48973505|NCT01468701|157733993|FG015|Overall Study|Other reasons than listed|172|||
48973506|NCT01468701|157733994|FG016|Overall Study|Other reasons than listed|0|||
48973507|NCT01468701|157733978|FG000|Overall Study|No end of study case report form|0|||
48973508|NCT01468701|157733979|FG001|Overall Study|No end of study case report form|0|||
48973509|NCT01468701|157733980|FG002|Overall Study|No end of study case report form|0|||
48973510|NCT01468701|157733981|FG003|Overall Study|No end of study case report form|0|||
48973511|NCT01468701|157733982|FG004|Overall Study|No end of study case report form|0|||
48973512|NCT01468701|157733983|FG005|Overall Study|No end of study case report form|0|||
48973513|NCT01468701|157733984|FG006|Overall Study|No end of study case report form|0|||
48973514|NCT01468701|157733985|FG007|Overall Study|No end of study case report form|0|||
48973515|NCT01468701|157733986|FG008|Overall Study|No end of study case report form|4|||
48973516|NCT01468701|157733987|FG009|Overall Study|No end of study case report form|1|||
48973517|NCT01468701|157733988|FG010|Overall Study|No end of study case report form|2|||
48973518|NCT01468701|157733989|FG011|Overall Study|No end of study case report form|3|||
48973519|NCT01468701|157733990|FG012|Overall Study|No end of study case report form|0|||
48973520|NCT01468701|157733991|FG013|Overall Study|No end of study case report form|1|||
48973521|NCT01468701|157733992|FG014|Overall Study|No end of study case report form|0|||
48973522|NCT01468701|157733993|FG015|Overall Study|No end of study case report form|0|||
48973523|NCT01468701|157733994|FG016|Overall Study|No end of study case report form|0|||
48973524|NCT01468701|157733978|FG000|Overall Study|Not being followed up|0|||
48973525|NCT01468701|157733979|FG001|Overall Study|Not being followed up|4963|||
48973526|NCT01468701|157733980|FG002|Overall Study|Not being followed up|1755|||
48973527|NCT01468701|157733981|FG003|Overall Study|Not being followed up|703|||
48674603|NCT00835341|156661528|FG000|Overall Study|Lost to Follow-up|3|||
48674604|NCT00835341|156661529|FG001|Overall Study|Lost to Follow-up|12|||
48674605|NCT01114438|156661530|FG000|Overall Study|Adverse Event|10|||
48674606|NCT01114438|156661530|FG000|Overall Study|concomitant medication|1|||
48674607|NCT01114438|156661530|FG000|Overall Study|Physician Decision|1|||
48674608|NCT01114438|156661530|FG000|Overall Study|Withdrawal by Subject|2|||
48674609|NCT00991406|156661545|FG000|Overall Study|One participant did not respond to FES.|1|||
48674610|NCT01746173|156661546|FG000|Overall Study|Disease Progression|2|||
48674611|NCT02596945|156661548|FG000|Overall Study|No documentation of study drug dosing|3|||
48973528|NCT01468701|157733982|FG004|Overall Study|Not being followed up|1714|||
48973529|NCT01468701|157733983|FG005|Overall Study|Not being followed up|126|||
48973530|NCT01468701|157733984|FG006|Overall Study|Not being followed up|1170|||
48973531|NCT01468701|157733985|FG007|Overall Study|Not being followed up|4|||
48973532|NCT01468701|157733986|FG008|Overall Study|Not being followed up|0|||
48973533|NCT01468701|157733987|FG009|Overall Study|Not being followed up|0|||
48973534|NCT01468701|157733988|FG010|Overall Study|Not being followed up|0|||
48973535|NCT01468701|157733989|FG011|Overall Study|Not being followed up|0|||
48973536|NCT01468701|157733990|FG012|Overall Study|Not being followed up|0|||
48973537|NCT01468701|157733991|FG013|Overall Study|Not being followed up|0|||
48973538|NCT01468701|157733992|FG014|Overall Study|Not being followed up|0|||
48973539|NCT01468701|157733993|FG015|Overall Study|Not being followed up|0|||
48973540|NCT01468701|157733994|FG016|Overall Study|Not being followed up|0|||
48973541|NCT01068717|157733996|FG000|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1|||
48674612|NCT02596945|156661548|FG000|Overall Study|Other|32|||
48674613|NCT02596945|156661548|FG000|Overall Study|Change to hemodialysis|15|||
48674614|NCT02596945|156661548|FG000|Overall Study|Other Erythropoietin stimulating agent|4|||
48674615|NCT02596945|156661548|FG000|Overall Study|Withdrawal by Subject|1|||
48674616|NCT02596945|156661548|FG000|Overall Study|Missing|1|||
48674617|NCT00411632|156661549|FG000|Overall Study|Death|1|||
48674618|NCT01007838|156661550|FG000|Overall Study|Withdrawal by Subject|1|||
48674619|NCT01007838|156661551|FG001|Overall Study|Withdrawal by Subject|0|||
48674620|NCT01007838|156661552|FG002|Overall Study|Withdrawal by Subject|0|||
48674621|NCT01007838|156661553|FG003|Overall Study|Withdrawal by Subject|0|||
48674622|NCT01007838|156661550|FG000|Overall Study|Physician Decision|1|||
48674623|NCT01007838|156661551|FG001|Overall Study|Physician Decision|0|||
48674624|NCT01007838|156661552|FG002|Overall Study|Physician Decision|0|||
48674625|NCT01007838|156661553|FG003|Overall Study|Physician Decision|0|||
48674626|NCT01007838|156661550|FG000|Overall Study|Started home haemodialysis|1|||
48674627|NCT01007838|156661551|FG001|Overall Study|Started home haemodialysis|0|||
48674628|NCT01007838|156661552|FG002|Overall Study|Started home haemodialysis|0|||
48674629|NCT01007838|156661553|FG003|Overall Study|Started home haemodialysis|0|||
48674630|NCT00455143|156661556|FG000|Overall Study|Physician Decision|1|||
48761486|NCT01729754|156975639|FG008|Part 2|Adverse Event|1|||
48973542|NCT01068717|157733997|FG001|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
48973543|NCT01068717|157733998|FG002|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
48973544|NCT01068717|157733999|FG003|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
48674631|NCT00455143|156661556|FG000|Overall Study|Withdrawal by Subject|1|||
48674632|NCT00455143|156661556|FG000|Overall Study|Staff was not avail to follow patient|2|||
48674633|NCT00455143|156661556|FG000|Overall Study|No longer met Inclusion Criteria|1|||
48674634|NCT00455143|156661556|FG000|Overall Study|Surgical time, staff not available|1|||
48674635|NCT00408434|156661561|FG000|Overall Study|Adverse Event|0|||
48973545|NCT01449955|157734004|FG000|Overall Study|Withdrawal by Subject|1|||
48973546|NCT01449955|157734005|FG001|Overall Study|Withdrawal by Subject|2|||
48973547|NCT03997760|157734015|FG000|Overall Study|Protocol Deviation|0|||
48973548|NCT03997760|157734016|FG001|Overall Study|Protocol Deviation|1|||
48973549|NCT03997760|157734017|FG002|Overall Study|Protocol Deviation|0|||
48973550|NCT03997760|157734018|FG003|Overall Study|Protocol Deviation|0|||
48973551|NCT00251589|157734019|FG000|Overall Study|Adverse Event|5|||
48973552|NCT00251589|157734020|FG001|Overall Study|Adverse Event|1|||
48973553|NCT00251589|157734021|FG002|Overall Study|Adverse Event|2|||
48973554|NCT00251589|157734022|FG003|Overall Study|Adverse Event|1|||
48973555|NCT00251589|157734019|FG000|Overall Study|Withdrawal by Subject|1|||
48973556|NCT00251589|157734020|FG001|Overall Study|Withdrawal by Subject|1|||
48973557|NCT00251589|157734021|FG002|Overall Study|Withdrawal by Subject|0|||
48973558|NCT00251589|157734022|FG003|Overall Study|Withdrawal by Subject|0|||
48973559|NCT00251589|157734019|FG000|Overall Study|Discontinued due to progressive disease|9|||
48973560|NCT00251589|157734020|FG001|Overall Study|Discontinued due to progressive disease|1|||
48973561|NCT00251589|157734021|FG002|Overall Study|Discontinued due to progressive disease|0|||
48973562|NCT00251589|157734022|FG003|Overall Study|Discontinued due to progressive disease|1|||
48973563|NCT00856986|157734023|FG000|Run-in Period, Weeks -12-0|Adverse Event|0|||
48973564|NCT00856986|157734024|FG001|Run-in Period, Weeks -12-0|Adverse Event|0|||
48973565|NCT00856986|157734025|FG002|Run-in Period, Weeks -12-0|Adverse Event|0|||
48973566|NCT00856986|157734026|FG003|Run-in Period, Weeks -12-0|Adverse Event|92|||
48973567|NCT00856986|157734027|FG004|Run-in Period, Weeks -12-0|Adverse Event|0|||
48973568|NCT00856986|157734023|FG000|Run-in Period, Weeks -12-0|Protocol Violation|0|||
48973569|NCT00856986|157734024|FG001|Run-in Period, Weeks -12-0|Protocol Violation|0|||
48973570|NCT00856986|157734025|FG002|Run-in Period, Weeks -12-0|Protocol Violation|0|||
48973571|NCT00856986|157734026|FG003|Run-in Period, Weeks -12-0|Protocol Violation|24|||
48973572|NCT00856986|157734027|FG004|Run-in Period, Weeks -12-0|Protocol Violation|0|||
48973573|NCT00856986|157734023|FG000|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
48973574|NCT00856986|157734024|FG001|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
48973575|NCT00856986|157734025|FG002|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
48973576|NCT00856986|157734026|FG003|Run-in Period, Weeks -12-0|Withdrawal Criteria|10|||
48973577|NCT00856986|157734027|FG004|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
48973578|NCT00856986|157734023|FG000|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
48973579|NCT00856986|157734024|FG001|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
48973580|NCT00856986|157734025|FG002|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
48973581|NCT00856986|157734026|FG003|Run-in Period, Weeks -12-0|Lost to Follow-up|11|||
48973582|NCT00856986|157734027|FG004|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
48973583|NCT00856986|157734023|FG000|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
48973584|NCT00856986|157734024|FG001|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
48973585|NCT00856986|157734025|FG002|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
48973586|NCT00856986|157734026|FG003|Run-in Period, Weeks -12-0|Lack of Efficacy|6|||
48973587|NCT00856986|157734027|FG004|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
48973588|NCT00856986|157734023|FG000|Run-in Period, Weeks -12-0|Unclassified|0|||
48973589|NCT00856986|157734024|FG001|Run-in Period, Weeks -12-0|Unclassified|0|||
48973590|NCT00856986|157734025|FG002|Run-in Period, Weeks -12-0|Unclassified|0|||
48973591|NCT00856986|157734026|FG003|Run-in Period, Weeks -12-0|Unclassified|24|||
48973592|NCT00856986|157734027|FG004|Run-in Period, Weeks -12-0|Unclassified|0|||
48973593|NCT00856986|157734023|FG000|Main Period, Weeks 0-26|Adverse Event|6|||
48973594|NCT00856986|157734024|FG001|Main Period, Weeks 0-26|Adverse Event|4|||
48674636|NCT00408434|156661562|FG001|Overall Study|Adverse Event|0|||
48674637|NCT00408434|156661563|FG002|Overall Study|Adverse Event|1|||
48674638|NCT00408434|156661564|FG003|Overall Study|Adverse Event|0|||
48973595|NCT00856986|157734025|FG002|Main Period, Weeks 0-26|Adverse Event|9|||
48973596|NCT00856986|157734026|FG003|Main Period, Weeks 0-26|Adverse Event|0|||
48973597|NCT00856986|157734027|FG004|Main Period, Weeks 0-26|Adverse Event|0|||
48973598|NCT00856986|157734023|FG000|Main Period, Weeks 0-26|Protocol Violation|4|||
48973599|NCT00856986|157734024|FG001|Main Period, Weeks 0-26|Protocol Violation|5|||
48973600|NCT00856986|157734025|FG002|Main Period, Weeks 0-26|Protocol Violation|7|||
48973601|NCT00856986|157734026|FG003|Main Period, Weeks 0-26|Protocol Violation|0|||
48973602|NCT00856986|157734027|FG004|Main Period, Weeks 0-26|Protocol Violation|0|||
48973603|NCT00856986|157734023|FG000|Main Period, Weeks 0-26|Withdrawal Criteria|11|||
48973604|NCT00856986|157734024|FG001|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
48973605|NCT00856986|157734025|FG002|Main Period, Weeks 0-26|Withdrawal Criteria|3|||
48973606|NCT00856986|157734026|FG003|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
48973607|NCT00856986|157734027|FG004|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
48973608|NCT00856986|157734023|FG000|Main Period, Weeks 0-26|Lost to Follow-up|1|||
48973609|NCT00856986|157734024|FG001|Main Period, Weeks 0-26|Lost to Follow-up|1|||
48973610|NCT00856986|157734025|FG002|Main Period, Weeks 0-26|Lost to Follow-up|2|||
48674639|NCT00408434|156661565|FG004|Overall Study|Adverse Event|0|||
48973611|NCT00856986|157734026|FG003|Main Period, Weeks 0-26|Lost to Follow-up|0|||
48973612|NCT00856986|157734027|FG004|Main Period, Weeks 0-26|Lost to Follow-up|0|||
48973613|NCT00856986|157734023|FG000|Main Period, Weeks 0-26|Lack of Efficacy|5|||
48873543|NCT02484547|157373389|FG000|Long-Term Extension Period|Loss of Capacity|0|||
48873544|NCT02484547|157373390|FG001|Long-Term Extension Period|Loss of Capacity|0|||
48873545|NCT02484547|157373391|FG002|Long-Term Extension Period|Loss of Capacity|0|||
48873546|NCT02484547|157373392|FG003|Long-Term Extension Period|Loss of Capacity|0|||
48873547|NCT02484547|157373393|FG004|Long-Term Extension Period|Loss of Capacity|1|||
48873548|NCT02484547|157373394|FG005|Long-Term Extension Period|Loss of Capacity|0|||
48873549|NCT02484547|157373395|FG006|Long-Term Extension Period|Loss of Capacity|0|||
48873550|NCT02484547|157373389|FG000|Long-Term Extension Period|Change of Treatment|0|||
48873551|NCT02484547|157373390|FG001|Long-Term Extension Period|Change of Treatment|0|||
48873552|NCT02484547|157373391|FG002|Long-Term Extension Period|Change of Treatment|0|||
48873553|NCT02484547|157373392|FG003|Long-Term Extension Period|Change of Treatment|0|||
48873554|NCT02484547|157373393|FG004|Long-Term Extension Period|Change of Treatment|0|||
48873555|NCT02484547|157373394|FG005|Long-Term Extension Period|Change of Treatment|0|||
48873556|NCT02484547|157373395|FG006|Long-Term Extension Period|Change of Treatment|1|||
48873557|NCT02484547|157373389|FG000|Long-Term Extension Period|Consent Withdrawn|0|||
48873558|NCT02484547|157373390|FG001|Long-Term Extension Period|Consent Withdrawn|0|||
48873559|NCT02484547|157373391|FG002|Long-Term Extension Period|Consent Withdrawn|0|||
48873560|NCT02484547|157373392|FG003|Long-Term Extension Period|Consent Withdrawn|6|||
48873561|NCT02484547|157373393|FG004|Long-Term Extension Period|Consent Withdrawn|7|||
48873562|NCT02484547|157373394|FG005|Long-Term Extension Period|Consent Withdrawn|13|||
48873563|NCT02484547|157373395|FG006|Long-Term Extension Period|Consent Withdrawn|17|||
48873564|NCT02484547|157373389|FG000|Long-Term Extension Period|Investigator Decision|0|||
48873565|NCT02484547|157373390|FG001|Long-Term Extension Period|Investigator Decision|0|||
48873566|NCT02484547|157373391|FG002|Long-Term Extension Period|Investigator Decision|0|||
48873567|NCT02484547|157373392|FG003|Long-Term Extension Period|Investigator Decision|2|||
48873568|NCT02484547|157373393|FG004|Long-Term Extension Period|Investigator Decision|1|||
48873569|NCT02484547|157373394|FG005|Long-Term Extension Period|Investigator Decision|0|||
48873570|NCT02484547|157373395|FG006|Long-Term Extension Period|Investigator Decision|1|||
48873571|NCT02484547|157373389|FG000|Long-Term Extension Period|Relocation|0|||
48873572|NCT02484547|157373390|FG001|Long-Term Extension Period|Relocation|0|||
48873573|NCT02484547|157373391|FG002|Long-Term Extension Period|Relocation|0|||
48873574|NCT02484547|157373392|FG003|Long-Term Extension Period|Relocation|1|||
48873575|NCT02484547|157373393|FG004|Long-Term Extension Period|Relocation|1|||
48873576|NCT02484547|157373394|FG005|Long-Term Extension Period|Relocation|0|||
48873577|NCT02484547|157373395|FG006|Long-Term Extension Period|Relocation|0|||
48873578|NCT02484547|157373389|FG000|Long-Term Extension Period|Study Visit Burden|0|||
48873579|NCT02484547|157373390|FG001|Long-Term Extension Period|Study Visit Burden|0|||
48873580|NCT02484547|157373391|FG002|Long-Term Extension Period|Study Visit Burden|0|||
48873581|NCT02484547|157373392|FG003|Long-Term Extension Period|Study Visit Burden|2|||
48873582|NCT02484547|157373393|FG004|Long-Term Extension Period|Study Visit Burden|0|||
48873583|NCT02484547|157373394|FG005|Long-Term Extension Period|Study Visit Burden|0|||
48873584|NCT02484547|157373395|FG006|Long-Term Extension Period|Study Visit Burden|3|||
48873585|NCT02484547|157373389|FG000|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
48873586|NCT02484547|157373390|FG001|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
48873587|NCT02484547|157373391|FG002|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
48873588|NCT02484547|157373392|FG003|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
48873589|NCT02484547|157373393|FG004|Long-Term Extension Period|Withdrawal by Parent/Guardian|1|||
48873590|NCT02484547|157373394|FG005|Long-Term Extension Period|Withdrawal by Parent/Guardian|3|||
48873591|NCT02484547|157373395|FG006|Long-Term Extension Period|Withdrawal by Parent/Guardian|2|||
48873592|NCT02484547|157373389|FG000|Long-Term Extension Period|Reason not Specified|0|||
48873593|NCT02484547|157373390|FG001|Long-Term Extension Period|Reason not Specified|0|||
48873594|NCT02484547|157373391|FG002|Long-Term Extension Period|Reason not Specified|0|||
48873595|NCT02484547|157373392|FG003|Long-Term Extension Period|Reason not Specified|119|||
48873596|NCT02484547|157373393|FG004|Long-Term Extension Period|Reason not Specified|117|||
48873597|NCT02484547|157373394|FG005|Long-Term Extension Period|Reason not Specified|223|||
48873598|NCT02484547|157373395|FG006|Long-Term Extension Period|Reason not Specified|231|||
48973614|NCT00856986|157734024|FG001|Main Period, Weeks 0-26|Lack of Efficacy|2|||
48973615|NCT00856986|157734025|FG002|Main Period, Weeks 0-26|Lack of Efficacy|0|||
48973616|NCT00856986|157734026|FG003|Main Period, Weeks 0-26|Lack of Efficacy|0|||
48973617|NCT00856986|157734027|FG004|Main Period, Weeks 0-26|Lack of Efficacy|0|||
48973618|NCT00856986|157734023|FG000|Main Period, Weeks 0-26|Unclassified|7|||
48973619|NCT00856986|157734024|FG001|Main Period, Weeks 0-26|Unclassified|6|||
48873599|NCT04680637|157373396|FG000|Overall Study|Lost to Follow-up|0|||
48873600|NCT04680637|157373397|FG001|Overall Study|Lost to Follow-up|1|||
48873601|NCT04680637|157373398|FG002|Overall Study|Lost to Follow-up|0|||
48873602|NCT04680637|157373399|FG003|Overall Study|Lost to Follow-up|1|||
48873603|NCT04680637|157373396|FG000|Overall Study|Death|1|||
48873604|NCT04680637|157373397|FG001|Overall Study|Death|0|||
48873605|NCT04680637|157373398|FG002|Overall Study|Death|0|||
48873606|NCT04680637|157373399|FG003|Overall Study|Death|0|||
48873607|NCT04680637|157373396|FG000|Overall Study|Withdrawal by Subject|7|||
48873608|NCT04680637|157373397|FG001|Overall Study|Withdrawal by Subject|10|||
48973620|NCT00856986|157734025|FG002|Main Period, Weeks 0-26|Unclassified|7|||
48973621|NCT00856986|157734026|FG003|Main Period, Weeks 0-26|Unclassified|0|||
48973622|NCT00856986|157734027|FG004|Main Period, Weeks 0-26|Unclassified|0|||
48674640|NCT00408434|156661566|FG005|Overall Study|Adverse Event|0|||
48674641|NCT00408434|156661567|FG006|Overall Study|Adverse Event|0|||
48674642|NCT00408434|156661561|FG000|Overall Study|Progressive disease|6|||
48674643|NCT00408434|156661562|FG001|Overall Study|Progressive disease|3|||
48674644|NCT00408434|156661563|FG002|Overall Study|Progressive disease|4|||
48674645|NCT00408434|156661564|FG003|Overall Study|Progressive disease|3|||
48674646|NCT00408434|156661565|FG004|Overall Study|Progressive disease|3|||
48674647|NCT00408434|156661566|FG005|Overall Study|Progressive disease|1|||
48973623|NCT00856986|157734023|FG000|Extension Period, Weeks 26-52|Adverse Event|3|||
48973624|NCT00856986|157734024|FG001|Extension Period, Weeks 26-52|Adverse Event|3|||
48973625|NCT00856986|157734025|FG002|Extension Period, Weeks 26-52|Adverse Event|10|||
48674648|NCT00408434|156661567|FG006|Overall Study|Progressive disease|4|||
48674649|NCT00408434|156661561|FG000|Overall Study|Other|0|||
48674650|NCT00408434|156661562|FG001|Overall Study|Other|0|||
48674651|NCT00408434|156661563|FG002|Overall Study|Other|1|||
48674652|NCT00408434|156661564|FG003|Overall Study|Other|0|||
48674653|NCT00408434|156661565|FG004|Overall Study|Other|2|||
48674654|NCT00408434|156661566|FG005|Overall Study|Other|1|||
48674655|NCT00408434|156661567|FG006|Overall Study|Other|0|||
48674656|NCT00408434|156661561|FG000|Overall Study|Terminated by Investigator|0|||
48674657|NCT00408434|156661562|FG001|Overall Study|Terminated by Investigator|0|||
48674658|NCT00408434|156661563|FG002|Overall Study|Terminated by Investigator|0|||
48674659|NCT00408434|156661564|FG003|Overall Study|Terminated by Investigator|0|||
48674660|NCT00408434|156661565|FG004|Overall Study|Terminated by Investigator|1|||
48674661|NCT00408434|156661566|FG005|Overall Study|Terminated by Investigator|1|||
48973626|NCT00856986|157734026|FG003|Extension Period, Weeks 26-52|Adverse Event|0|||
48973627|NCT00856986|157734027|FG004|Extension Period, Weeks 26-52|Adverse Event|0|||
48973628|NCT00856986|157734023|FG000|Extension Period, Weeks 26-52|Protocol Violation|6|||
48973629|NCT00856986|157734024|FG001|Extension Period, Weeks 26-52|Protocol Violation|2|||
48973630|NCT00856986|157734025|FG002|Extension Period, Weeks 26-52|Protocol Violation|5|||
48973631|NCT00856986|157734026|FG003|Extension Period, Weeks 26-52|Protocol Violation|0|||
48973632|NCT00856986|157734027|FG004|Extension Period, Weeks 26-52|Protocol Violation|0|||
48973633|NCT00856986|157734023|FG000|Extension Period, Weeks 26-52|Withdrawal Criteria|2|||
48973634|NCT00856986|157734024|FG001|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
48973635|NCT00856986|157734025|FG002|Extension Period, Weeks 26-52|Withdrawal Criteria|8|||
48973636|NCT00856986|157734026|FG003|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
48973637|NCT00856986|157734027|FG004|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
48973638|NCT00856986|157734023|FG000|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
48973639|NCT00856986|157734024|FG001|Extension Period, Weeks 26-52|Lost to Follow-up|5|||
48973640|NCT00856986|157734025|FG002|Extension Period, Weeks 26-52|Lost to Follow-up|2|||
48973641|NCT00856986|157734026|FG003|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
48973642|NCT00856986|157734027|FG004|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
48973643|NCT00856986|157734023|FG000|Extension Period, Weeks 26-52|Lack of Efficacy|4|||
48973644|NCT00856986|157734024|FG001|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
48973645|NCT00856986|157734025|FG002|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
48973646|NCT00856986|157734026|FG003|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
48973647|NCT00856986|157734027|FG004|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
48973648|NCT00856986|157734023|FG000|Extension Period, Weeks 26-52|Unclassified|4|||
48973649|NCT00856986|157734024|FG001|Extension Period, Weeks 26-52|Unclassified|2|||
48674662|NCT00408434|156661567|FG006|Overall Study|Terminated by Investigator|0|||
48674663|NCT03068767|156661578|FG000|Overall Study|Lost to Follow-up|7|||
48973650|NCT00856986|157734025|FG002|Extension Period, Weeks 26-52|Unclassified|11|||
48973651|NCT00856986|157734026|FG003|Extension Period, Weeks 26-52|Unclassified|0|||
48973652|NCT00856986|157734027|FG004|Extension Period, Weeks 26-52|Unclassified|0|||
48973653|NCT04018612|157734028|FG000|Overall Study|Withdrawal by Subject|1|||
48973654|NCT04018612|157734029|FG001|Overall Study|Withdrawal by Subject|0|||
48973655|NCT04018612|157734030|FG002|Overall Study|Withdrawal by Subject|1|||
48973656|NCT02650895|157734033|FG000|Overall Study|Withdrawal by Subject|0|||
48973657|NCT02650895|157734034|FG001|Overall Study|Withdrawal by Subject|1|||
48973658|NCT02650895|157734035|FG002|Overall Study|Withdrawal by Subject|0|||
48973659|NCT02650895|157734036|FG003|Overall Study|Withdrawal by Subject|0|||
48973660|NCT02650895|157734037|FG004|Overall Study|Withdrawal by Subject|0|||
48973661|NCT02650895|157734038|FG005|Overall Study|Withdrawal by Subject|0|||
48674664|NCT03068767|156661579|FG001|Overall Study|Lost to Follow-up|3|||
48674665|NCT03068767|156661578|FG000|Overall Study|Protocol Violation|3|||
48674666|NCT03068767|156661579|FG001|Overall Study|Protocol Violation|0|||
48674667|NCT00186901|156661580|FG000|Overall Study|Pregnancy|6|||
48674668|NCT00186901|156661581|FG001|Overall Study|Pregnancy|3|||
48674669|NCT00186901|156661582|FG002|Overall Study|Pregnancy|0|||
48674670|NCT00186901|156661580|FG000|Overall Study|Lost to Follow-up|6|||
48674671|NCT00186901|156661581|FG001|Overall Study|Lost to Follow-up|3|||
48973662|NCT00361218|157734039|FG000|Overall Study|Lost to Follow-up|11|||
48973663|NCT00361218|157734039|FG000|Overall Study|Personal Reasons|7|||
48973664|NCT00361218|157734039|FG000|Overall Study|terminated / withdrawn due to toxicity /|5|||
48973665|NCT02671760|157734040|FG000|Overall Study|Lost to Follow-up|0|||
48973666|NCT02671760|157734041|FG001|Overall Study|Lost to Follow-up|1|||
48973667|NCT02671760|157734042|FG002|Overall Study|Lost to Follow-up|0|||
48973668|NCT00565812|157734044|FG000|Overall Study|Death|2|||
48973669|NCT00565812|157734045|FG001|Overall Study|Death|1|||
48973670|NCT00565812|157734046|FG002|Overall Study|Death|3|||
48973671|NCT00565812|157734044|FG000|Overall Study|Did not Meet Entrance Criteria|1|||
48973672|NCT00565812|157734045|FG001|Overall Study|Did not Meet Entrance Criteria|0|||
48973673|NCT00565812|157734046|FG002|Overall Study|Did not Meet Entrance Criteria|1|||
48973674|NCT00565812|157734044|FG000|Overall Study|Lost to Follow-up|10|||
48973675|NCT00565812|157734045|FG001|Overall Study|Lost to Follow-up|8|||
48973676|NCT00565812|157734046|FG002|Overall Study|Lost to Follow-up|8|||
48973677|NCT00565812|157734044|FG000|Overall Study|Withdrawal by Subject|58|||
48973678|NCT00565812|157734045|FG001|Overall Study|Withdrawal by Subject|47|||
48973679|NCT00565812|157734046|FG002|Overall Study|Withdrawal by Subject|48|||
48973680|NCT00565812|157734044|FG000|Overall Study|Work Schedule|5|||
48973681|NCT00565812|157734045|FG001|Overall Study|Work Schedule|3|||
48973682|NCT00565812|157734046|FG002|Overall Study|Work Schedule|1|||
48973683|NCT00565812|157734044|FG000|Overall Study|Protocol Violation|2|||
48973684|NCT00565812|157734045|FG001|Overall Study|Protocol Violation|6|||
48973685|NCT00565812|157734046|FG002|Overall Study|Protocol Violation|4|||
48973686|NCT00565812|157734044|FG000|Overall Study|Adverse Event|41|||
48973687|NCT00565812|157734045|FG001|Overall Study|Adverse Event|54|||
48973688|NCT00565812|157734046|FG002|Overall Study|Adverse Event|40|||
48973689|NCT00565812|157734044|FG000|Overall Study|Jury Duty|1|||
48973690|NCT00565812|157734045|FG001|Overall Study|Jury Duty|0|||
48973691|NCT00565812|157734046|FG002|Overall Study|Jury Duty|0|||
48674672|NCT00186901|156661582|FG002|Overall Study|Lost to Follow-up|0|||
48674673|NCT00186901|156661580|FG000|Overall Study|Bone Mineral Density dropped > 5%|9|||
48674674|NCT00186901|156661581|FG001|Overall Study|Bone Mineral Density dropped > 5%|7|||
48674675|NCT00186901|156661582|FG002|Overall Study|Bone Mineral Density dropped > 5%|0|||
48674676|NCT00186901|156661580|FG000|Overall Study|ALL relapse or second malignancy|1|||
48674677|NCT00186901|156661581|FG001|Overall Study|ALL relapse or second malignancy|2|||
48674678|NCT00186901|156661582|FG002|Overall Study|ALL relapse or second malignancy|0|||
48674679|NCT00186901|156661580|FG000|Overall Study|Withdrawal by Subject|4|||
48674680|NCT00186901|156661581|FG001|Overall Study|Withdrawal by Subject|5|||
48674681|NCT00186901|156661582|FG002|Overall Study|Withdrawal by Subject|0|||
48674682|NCT00186901|156661580|FG000|Overall Study|Open label|3|||
48674683|NCT00186901|156661581|FG001|Overall Study|Open label|2|||
48674684|NCT00186901|156661582|FG002|Overall Study|Open label|0|||
48674685|NCT00186901|156661580|FG000|Overall Study|Limited adherence to study requirements|20|||
48674686|NCT00186901|156661581|FG001|Overall Study|Limited adherence to study requirements|23|||
48674687|NCT00186901|156661582|FG002|Overall Study|Limited adherence to study requirements|0|||
48674688|NCT00186901|156661580|FG000|Overall Study|Bone Mineral Density > 0|0|||
48973692|NCT00565812|157734044|FG000|Overall Study|Relocated Out of Area|5|||
48973693|NCT00565812|157734045|FG001|Overall Study|Relocated Out of Area|8|||
48973694|NCT00565812|157734046|FG002|Overall Study|Relocated Out of Area|9|||
48973695|NCT00565812|157734044|FG000|Overall Study|Sponsor Decision|1|||
48973696|NCT00565812|157734045|FG001|Overall Study|Sponsor Decision|5|||
48973697|NCT00565812|157734046|FG002|Overall Study|Sponsor Decision|1|||
48674689|NCT00186901|156661581|FG001|Overall Study|Bone Mineral Density > 0|0|||
48674690|NCT00186901|156661582|FG002|Overall Study|Bone Mineral Density > 0|149|||
48674691|NCT00999518|156661583|FG000|Overall Study|Adverse Event|1|||
48674692|NCT00999518|156661584|FG001|Overall Study|Adverse Event|6|||
48674693|NCT00999518|156661585|FG002|Overall Study|Adverse Event|3|||
48674694|NCT00999518|156661586|FG003|Overall Study|Adverse Event|1|||
48674695|NCT00999518|156661587|FG004|Overall Study|Adverse Event|2|||
48674696|NCT00999518|156661583|FG000|Overall Study|Lack of Efficacy|2|||
48674697|NCT00999518|156661584|FG001|Overall Study|Lack of Efficacy|0|||
48674698|NCT00999518|156661585|FG002|Overall Study|Lack of Efficacy|0|||
48674699|NCT00999518|156661586|FG003|Overall Study|Lack of Efficacy|2|||
48674700|NCT00999518|156661587|FG004|Overall Study|Lack of Efficacy|2|||
48674701|NCT00999518|156661583|FG000|Overall Study|Lost to Follow-up|0|||
48973698|NCT00565812|157734044|FG000|Overall Study|Domestic Reasons|7|||
48973699|NCT00565812|157734045|FG001|Overall Study|Domestic Reasons|1|||
48973700|NCT00565812|157734046|FG002|Overall Study|Domestic Reasons|3|||
48973701|NCT00565812|157734044|FG000|Overall Study|Research Site Closure|6|||
48674702|NCT00999518|156661584|FG001|Overall Study|Lost to Follow-up|0|||
48674703|NCT00999518|156661585|FG002|Overall Study|Lost to Follow-up|0|||
48674704|NCT00999518|156661586|FG003|Overall Study|Lost to Follow-up|4|||
48973702|NCT00565812|157734045|FG001|Overall Study|Research Site Closure|1|||
48973703|NCT00565812|157734046|FG002|Overall Study|Research Site Closure|8|||
48973704|NCT00565812|157734044|FG000|Overall Study|Surgical Intervention|0|||
48674705|NCT00999518|156661587|FG004|Overall Study|Lost to Follow-up|1|||
48674706|NCT00999518|156661583|FG000|Overall Study|Did not meet entrance criteria|0|||
48674707|NCT00999518|156661584|FG001|Overall Study|Did not meet entrance criteria|0|||
48761487|NCT01729754|156975640|FG009|Part 2|Adverse Event|2|||
48973705|NCT00565812|157734045|FG001|Overall Study|Surgical Intervention|1|||
48973706|NCT00565812|157734046|FG002|Overall Study|Surgical Intervention|2|||
48973707|NCT00565812|157734044|FG000|Overall Study|Low Compliance|1|||
48973708|NCT00565812|157734045|FG001|Overall Study|Low Compliance|0|||
48973709|NCT00565812|157734046|FG002|Overall Study|Low Compliance|1|||
48973710|NCT00565812|157734044|FG000|Overall Study|Follow-up Visit Not Completed|2|||
48973711|NCT00565812|157734045|FG001|Overall Study|Follow-up Visit Not Completed|0|||
48674708|NCT00999518|156661585|FG002|Overall Study|Did not meet entrance criteria|0|||
48674709|NCT00999518|156661586|FG003|Overall Study|Did not meet entrance criteria|0|||
48674710|NCT00999518|156661587|FG004|Overall Study|Did not meet entrance criteria|1|||
48674711|NCT00999518|156661583|FG000|Overall Study|Study terminated by sponsor|10|||
48674712|NCT00999518|156661584|FG001|Overall Study|Study terminated by sponsor|6|||
48674713|NCT00999518|156661585|FG002|Overall Study|Study terminated by sponsor|5|||
48761488|NCT01729754|156975631|FG000|Part 2|Lack of Efficacy|0|||
48973712|NCT00565812|157734046|FG002|Overall Study|Follow-up Visit Not Completed|1|||
48973713|NCT00565812|157734044|FG000|Overall Study|Physician Decision|2|||
48973714|NCT00565812|157734045|FG001|Overall Study|Physician Decision|0|||
48973715|NCT00565812|157734046|FG002|Overall Study|Physician Decision|0|||
48973716|NCT01802515|157734051|FG000|Overall Study|Withdrawal by Subject|3|||
48973717|NCT01802515|157734052|FG001|Overall Study|Withdrawal by Subject|0|||
48761489|NCT01729754|156975632|FG001|Part 2|Lack of Efficacy|0|||
48761490|NCT01729754|156975633|FG002|Part 2|Lack of Efficacy|0|||
48761491|NCT01729754|156975634|FG003|Part 2|Lack of Efficacy|0|||
48761492|NCT01729754|156975635|FG004|Part 2|Lack of Efficacy|0|||
48761493|NCT01729754|156975636|FG005|Part 2|Lack of Efficacy|0|||
48973718|NCT01802515|157734053|FG002|Overall Study|Withdrawal by Subject|0|||
48973719|NCT02738580|157734056|FG000|Overall Study|Adverse Event|1|||
48674714|NCT00999518|156661586|FG003|Overall Study|Study terminated by sponsor|5|||
48674715|NCT00999518|156661587|FG004|Overall Study|Study terminated by sponsor|9|||
48674716|NCT00999518|156661583|FG000|Overall Study|Pregnancy|0|||
48674717|NCT00999518|156661584|FG001|Overall Study|Pregnancy|0|||
48761494|NCT01729754|156975637|FG006|Part 2|Lack of Efficacy|0|||
48761495|NCT01729754|156975638|FG007|Part 2|Lack of Efficacy|0|||
48761496|NCT01729754|156975639|FG008|Part 2|Lack of Efficacy|2|||
48761497|NCT01729754|156975640|FG009|Part 2|Lack of Efficacy|2|||
48761498|NCT01729754|156975631|FG000|Part 2|Lost to Follow-up|0|||
48761499|NCT01729754|156975632|FG001|Part 2|Lost to Follow-up|0|||
48761500|NCT01729754|156975633|FG002|Part 2|Lost to Follow-up|0|||
48761501|NCT01729754|156975634|FG003|Part 2|Lost to Follow-up|2|||
48761502|NCT01729754|156975635|FG004|Part 2|Lost to Follow-up|0|||
48761503|NCT01729754|156975636|FG005|Part 2|Lost to Follow-up|0|||
48761504|NCT01729754|156975637|FG006|Part 2|Lost to Follow-up|0|||
48761505|NCT01729754|156975638|FG007|Part 2|Lost to Follow-up|1|||
48761506|NCT01729754|156975639|FG008|Part 2|Lost to Follow-up|0|||
48761507|NCT01729754|156975640|FG009|Part 2|Lost to Follow-up|2|||
48761508|NCT01729754|156975631|FG000|Part 2|Non-Compliance with Study Drug|0|||
48761509|NCT01729754|156975632|FG001|Part 2|Non-Compliance with Study Drug|0|||
48761510|NCT01729754|156975633|FG002|Part 2|Non-Compliance with Study Drug|0|||
48761511|NCT01729754|156975634|FG003|Part 2|Non-Compliance with Study Drug|0|||
48761512|NCT01729754|156975635|FG004|Part 2|Non-Compliance with Study Drug|0|||
48761513|NCT01729754|156975636|FG005|Part 2|Non-Compliance with Study Drug|0|||
48761514|NCT01729754|156975637|FG006|Part 2|Non-Compliance with Study Drug|0|||
48761515|NCT01729754|156975638|FG007|Part 2|Non-Compliance with Study Drug|0|||
48761516|NCT01729754|156975639|FG008|Part 2|Non-Compliance with Study Drug|0|||
48761517|NCT01729754|156975640|FG009|Part 2|Non-Compliance with Study Drug|1|||
48761518|NCT01729754|156975631|FG000|Part 2|Pregnancy|0|||
48761519|NCT01729754|156975632|FG001|Part 2|Pregnancy|0|||
48761520|NCT01729754|156975633|FG002|Part 2|Pregnancy|0|||
48761521|NCT01729754|156975634|FG003|Part 2|Pregnancy|1|||
48761522|NCT01729754|156975635|FG004|Part 2|Pregnancy|0|||
48761523|NCT01729754|156975636|FG005|Part 2|Pregnancy|0|||
48761524|NCT01729754|156975637|FG006|Part 2|Pregnancy|0|||
48761525|NCT01729754|156975638|FG007|Part 2|Pregnancy|0|||
48761526|NCT01729754|156975639|FG008|Part 2|Pregnancy|0|||
48761527|NCT01729754|156975640|FG009|Part 2|Pregnancy|1|||
48761528|NCT01729754|156975631|FG000|Part 2|Withdrawal by Subject|3|||
48761529|NCT01729754|156975632|FG001|Part 2|Withdrawal by Subject|0|||
48761530|NCT01729754|156975633|FG002|Part 2|Withdrawal by Subject|0|||
48761531|NCT01729754|156975634|FG003|Part 2|Withdrawal by Subject|2|||
48761532|NCT01729754|156975635|FG004|Part 2|Withdrawal by Subject|0|||
48761533|NCT01729754|156975636|FG005|Part 2|Withdrawal by Subject|0|||
48761534|NCT01729754|156975637|FG006|Part 2|Withdrawal by Subject|0|||
48761535|NCT01729754|156975638|FG007|Part 2|Withdrawal by Subject|1|||
48761536|NCT01729754|156975639|FG008|Part 2|Withdrawal by Subject|1|||
48761537|NCT01729754|156975640|FG009|Part 2|Withdrawal by Subject|4|||
48761538|NCT01729754|156975631|FG000|Part 2|Other Protocol Specified Criteria|1|||
48761539|NCT01729754|156975632|FG001|Part 2|Other Protocol Specified Criteria|0|||
48761540|NCT01729754|156975633|FG002|Part 2|Other Protocol Specified Criteria|0|||
48761541|NCT01729754|156975634|FG003|Part 2|Other Protocol Specified Criteria|0|||
48761542|NCT01729754|156975635|FG004|Part 2|Other Protocol Specified Criteria|0|||
48761543|NCT01729754|156975636|FG005|Part 2|Other Protocol Specified Criteria|0|||
48973720|NCT02738580|157734057|FG001|Overall Study|Adverse Event|0|||
48973721|NCT02738580|157734056|FG000|Overall Study|Lack of Efficacy|3|||
48973722|NCT02738580|157734057|FG001|Overall Study|Lack of Efficacy|2|||
48973723|NCT02738580|157734056|FG000|Overall Study|Withdrawal by Subject|0|||
48973724|NCT02738580|157734057|FG001|Overall Study|Withdrawal by Subject|1|||
48973725|NCT02738580|157734056|FG000|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0|||
48973726|NCT02738580|157734057|FG001|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1|||
48973727|NCT01041404|157734058|FG000|Overall Study|Adverse Event|45|||
48973728|NCT01041404|157734059|FG001|Overall Study|Adverse Event|35|||
48973729|NCT01041404|157734058|FG000|Overall Study|Lack of Efficacy|200|||
48973730|NCT01041404|157734059|FG001|Overall Study|Lack of Efficacy|210|||
48973731|NCT01041404|157734058|FG000|Overall Study|Violation of Selection Criteria|0|||
48973732|NCT01041404|157734059|FG001|Overall Study|Violation of Selection Criteria|1|||
48973733|NCT01041404|157734058|FG000|Overall Study|Protocol Violation|4|||
48973734|NCT01041404|157734059|FG001|Overall Study|Protocol Violation|0|||
48973735|NCT01041404|157734058|FG000|Overall Study|Withdrawal by Subject|29|||
48973736|NCT01041404|157734059|FG001|Overall Study|Withdrawal by Subject|23|||
48973737|NCT01041404|157734058|FG000|Overall Study|Failure to Return|1|||
48973738|NCT01041404|157734059|FG001|Overall Study|Failure to Return|2|||
48973739|NCT01041404|157734058|FG000|Overall Study|Other|11|||
48973740|NCT01041404|157734059|FG001|Overall Study|Other|23|||
48973741|NCT00423592|157734060|FG000|Overall Study|Adverse Event (through Week 12)|2|||
48674718|NCT00999518|156661585|FG002|Overall Study|Pregnancy|1|||
48674719|NCT00999518|156661586|FG003|Overall Study|Pregnancy|0|||
48674720|NCT00999518|156661587|FG004|Overall Study|Pregnancy|0|||
48674721|NCT00999518|156661583|FG000|Overall Study|Protocol Violation|0|||
48674722|NCT00999518|156661584|FG001|Overall Study|Protocol Violation|1|||
48674723|NCT00999518|156661585|FG002|Overall Study|Protocol Violation|0|||
48674724|NCT00999518|156661586|FG003|Overall Study|Protocol Violation|0|||
48674725|NCT00999518|156661587|FG004|Overall Study|Protocol Violation|2|||
48674726|NCT00999518|156661583|FG000|Overall Study|Withdrawal by Subject|5|||
48674727|NCT00999518|156661584|FG001|Overall Study|Withdrawal by Subject|4|||
48674728|NCT00999518|156661585|FG002|Overall Study|Withdrawal by Subject|10|||
48674729|NCT00999518|156661586|FG003|Overall Study|Withdrawal by Subject|6|||
48674730|NCT00999518|156661587|FG004|Overall Study|Withdrawal by Subject|1|||
48674731|NCT00999518|156661583|FG000|Overall Study|Other|5|||
48674732|NCT00999518|156661584|FG001|Overall Study|Other|7|||
48674733|NCT00999518|156661585|FG002|Overall Study|Other|1|||
48674734|NCT00999518|156661586|FG003|Overall Study|Other|4|||
48674735|NCT00999518|156661587|FG004|Overall Study|Other|5|||
48674736|NCT00999518|156661583|FG000|Overall Study|Randomized but not Treated|1|||
48674737|NCT00999518|156661584|FG001|Overall Study|Randomized but not Treated|1|||
48674738|NCT00999518|156661585|FG002|Overall Study|Randomized but not Treated|2|||
48674739|NCT00999518|156661586|FG003|Overall Study|Randomized but not Treated|0|||
48674740|NCT00999518|156661587|FG004|Overall Study|Randomized but not Treated|1|||
48674741|NCT03304873|156661589|FG000|Overall Study|Lost to Follow-up|1|||
48674742|NCT03304873|156661590|FG001|Overall Study|Lost to Follow-up|8|||
48674743|NCT00400569|156661593|FG000|Overall Study|Death|1|||
48674744|NCT02921087|156661594|FG000|Overall Study|Withdrawal by Subject|0|||
48674745|NCT02921087|156661595|FG001|Overall Study|Withdrawal by Subject|1|||
48674746|NCT02697435|156661602|FG000|Overall Study|Withdrawal by Subject|1|||
48674747|NCT02697435|156661603|FG001|Overall Study|Withdrawal by Subject|0|||
48674748|NCT02697435|156661602|FG000|Overall Study|Physician Decision|0|||
48674749|NCT02697435|156661603|FG001|Overall Study|Physician Decision|4|||
48674750|NCT04230213|156661604|FG000|TP1: Week 0 (Day 1) to Week 10|Other|8|||
48674751|NCT04230213|156661605|FG001|TP1: Week 0 (Day 1) to Week 10|Other|0|||
48674752|NCT04230213|156661606|FG002|TP1: Week 0 (Day 1) to Week 10|Other|0|||
48674753|NCT04230213|156661604|FG000|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|7|||
48674754|NCT04230213|156661605|FG001|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
48674755|NCT04230213|156661606|FG002|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
48674756|NCT04230213|156661604|FG000|TP1: Week 0 (Day 1) to Week 10|Physician Decision|3|||
48674757|NCT04230213|156661605|FG001|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
48674758|NCT04230213|156661606|FG002|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
48674759|NCT04230213|156661604|FG000|TP2: Week 10 to Week 16|Other|0|||
48674760|NCT04230213|156661605|FG001|TP2: Week 10 to Week 16|Other|2|||
48674761|NCT04230213|156661606|FG002|TP2: Week 10 to Week 16|Other|1|||
48674762|NCT04230213|156661604|FG000|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
48674763|NCT04230213|156661605|FG001|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
48674764|NCT04230213|156661606|FG002|TP2: Week 10 to Week 16|Withdrawal by Subject|2|||
48674765|NCT04230213|156661604|FG000|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
48973742|NCT00423592|157734060|FG000|Overall Study|Adverse Event (post Week 12)|5|||
48973743|NCT01176240|157734061|FG000|Study 306A|Lack of Efficacy|2|||
48973744|NCT01176240|157734062|FG001|Study 306A|Lack of Efficacy|1|||
48973745|NCT01176240|157734061|FG000|Study 306A|Protocol Violation|0|||
48973746|NCT01176240|157734062|FG001|Study 306A|Protocol Violation|1|||
48674766|NCT04230213|156661605|FG001|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
48674767|NCT04230213|156661606|FG002|TP3: Week 16 to Week 22|Lost to Follow-up|1|||
48973747|NCT01176240|157734061|FG000|Study 306A|Withdrawal by Subject|0|||
48973748|NCT01176240|157734062|FG001|Study 306A|Withdrawal by Subject|1|||
48973749|NCT01176240|157734061|FG000|Study 306A|Stop due to diverse problems|1|||
48973750|NCT01176240|157734062|FG001|Study 306A|Stop due to diverse problems|0|||
48973751|NCT01176240|157734061|FG000|Study 306B|Lack of Efficacy|5|||
48973752|NCT01176240|157734062|FG001|Study 306B|Lack of Efficacy|3|||
48973753|NCT01176240|157734061|FG000|Study 306B|Adverse Event|10|||
48973754|NCT01176240|157734062|FG001|Study 306B|Adverse Event|5|||
48973755|NCT01176240|157734061|FG000|Study 306B|Protocol Violation|2|||
48973756|NCT01176240|157734062|FG001|Study 306B|Protocol Violation|3|||
48973757|NCT01176240|157734061|FG000|Study 306B|Withdrawal by Subject|4|||
48973758|NCT01176240|157734062|FG001|Study 306B|Withdrawal by Subject|1|||
48973759|NCT01176240|157734061|FG000|Study 306B|Physician Decision|2|||
48973760|NCT01176240|157734062|FG001|Study 306B|Physician Decision|1|||
48973761|NCT01176240|157734061|FG000|Study 306B|Supine Hypertension|1|||
48973762|NCT01176240|157734062|FG001|Study 306B|Supine Hypertension|2|||
48973763|NCT01176240|157734061|FG000|Study 306B|Lost to Follow-up|0|||
48973764|NCT01176240|157734062|FG001|Study 306B|Lost to Follow-up|1|||
48973765|NCT01176240|157734061|FG000|Study 306B|withdrew prior to dosing|2|||
48973766|NCT01176240|157734062|FG001|Study 306B|withdrew prior to dosing|1|||
48973767|NCT01993667|157734063|FG000|Overall Study|Insufficient data to analyze|16|||
48973768|NCT01993667|157734064|FG001|Overall Study|Insufficient data to analyze|16|||
48973769|NCT01993667|157734063|FG000|Overall Study|Insufficient altitude reached|3|||
48973770|NCT01993667|157734064|FG001|Overall Study|Insufficient altitude reached|1|||
48973771|NCT01993667|157734063|FG000|Overall Study|Lost to Follow-up|2|||
48973772|NCT01993667|157734064|FG001|Overall Study|Lost to Follow-up|2|||
48973773|NCT00571519|157735712|FG000|Overall Study|Subject withdrew consent|0|||
48973774|NCT00571519|157735713|FG001|Overall Study|Subject withdrew consent|1|||
48973775|NCT00571519|157735714|FG002|Overall Study|Subject withdrew consent|0|||
48973776|NCT00571519|157735715|FG003|Overall Study|Subject withdrew consent|2|||
48973777|NCT00571519|157735716|FG004|Overall Study|Subject withdrew consent|1|||
48973778|NCT00571519|157735717|FG005|Overall Study|Subject withdrew consent|1|||
48973779|NCT00571519|157735718|FG006|Overall Study|Subject withdrew consent|2|||
48973780|NCT00571519|157735712|FG000|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
48674768|NCT04230213|156661604|FG000|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
48674769|NCT04230213|156661605|FG001|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
48674770|NCT04230213|156661606|FG002|TP3: Week 16 to Week 22|Withdrawal by Subject|2|||
48674771|NCT04230213|156661604|FG000|TP3: Week 16 to Week 22|Physician Decision|0|||
48674772|NCT04230213|156661605|FG001|TP3: Week 16 to Week 22|Physician Decision|0|||
48674773|NCT04230213|156661606|FG002|TP3: Week 16 to Week 22|Physician Decision|1|||
48674774|NCT04230213|156661604|FG000|TP3: Week 16 to Week 22|Other|0|||
48674775|NCT04230213|156661605|FG001|TP3: Week 16 to Week 22|Other|1|||
48674776|NCT04230213|156661606|FG002|TP3: Week 16 to Week 22|Other|3|||
48674777|NCT04230213|156661604|FG000|TP4: Week 22 to Week 32|Other|0|||
48674778|NCT04230213|156661605|FG001|TP4: Week 22 to Week 32|Other|5|||
48674779|NCT04230213|156661606|FG002|TP4: Week 22 to Week 32|Other|5|||
48674780|NCT04230213|156661604|FG000|TP4: Week 22 to Week 32|Withdrawal by Subject|0|||
48674781|NCT04230213|156661605|FG001|TP4: Week 22 to Week 32|Withdrawal by Subject|1|||
48674782|NCT04230213|156661606|FG002|TP4: Week 22 to Week 32|Withdrawal by Subject|2|||
48674783|NCT04230213|156661604|FG000|TP4: Week 22 to Week 32|Physician Decision|0|||
48674784|NCT04230213|156661605|FG001|TP4: Week 22 to Week 32|Physician Decision|2|||
48674785|NCT04230213|156661606|FG002|TP4: Week 22 to Week 32|Physician Decision|1|||
48674786|NCT04230213|156661604|FG000|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
48674787|NCT04230213|156661605|FG001|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
48674788|NCT04230213|156661606|FG002|Follow up: Week 32 to Week 36|Withdrawal by Subject|1|||
48674789|NCT04230213|156661604|FG000|Follow up: Week 32 to Week 36|Other|0|||
48674790|NCT04230213|156661605|FG001|Follow up: Week 32 to Week 36|Other|1|||
48674791|NCT04230213|156661606|FG002|Follow up: Week 32 to Week 36|Other|1|||
48674792|NCT02353728|156661607|FG000|Overall Study|Subject non-compliance|1|||
48674793|NCT02301624|156661611|FG000|Blind Induction Phase|Withdrawal by Subject|1|||
48674794|NCT02301624|156661612|FG001|Blind Induction Phase|Withdrawal by Subject|0|||
48674795|NCT02301624|156661611|FG000|Open-label Maintenance Phase|Withdrawal by Subject|4|||
48674796|NCT02301624|156661612|FG001|Open-label Maintenance Phase|Withdrawal by Subject|8|||
48973781|NCT00571519|157735713|FG001|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
48674797|NCT02301624|156661611|FG000|Open-label Maintenance Phase|Adverse Event|2|||
48674798|NCT02301624|156661612|FG001|Open-label Maintenance Phase|Adverse Event|5|||
48674799|NCT02301624|156661611|FG000|Open-label Maintenance Phase|Physician Decision|3|||
48674800|NCT02301624|156661612|FG001|Open-label Maintenance Phase|Physician Decision|3|||
48674801|NCT02301624|156661611|FG000|Open-label Maintenance Phase|Death|2|||
48973782|NCT00571519|157735714|FG002|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
48973783|NCT00571519|157735715|FG003|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
48973784|NCT00571519|157735716|FG004|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
48973785|NCT00571519|157735717|FG005|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
48973786|NCT00571519|157735718|FG006|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
48973787|NCT00571519|157735712|FG000|Overall Study|Therapeutic failure/lack of efficacy|0|||
48973788|NCT00571519|157735713|FG001|Overall Study|Therapeutic failure/lack of efficacy|1|||
48973789|NCT00571519|157735714|FG002|Overall Study|Therapeutic failure/lack of efficacy|0|||
48973790|NCT00571519|157735715|FG003|Overall Study|Therapeutic failure/lack of efficacy|0|||
48973791|NCT00571519|157735716|FG004|Overall Study|Therapeutic failure/lack of efficacy|0|||
48973792|NCT00571519|157735717|FG005|Overall Study|Therapeutic failure/lack of efficacy|0|||
48973793|NCT00571519|157735718|FG006|Overall Study|Therapeutic failure/lack of efficacy|0|||
48973794|NCT00571519|157735712|FG000|Overall Study|Termination of study by Sponsor|2|||
48973795|NCT00571519|157735713|FG001|Overall Study|Termination of study by Sponsor|7|||
48973796|NCT00571519|157735714|FG002|Overall Study|Termination of study by Sponsor|10|||
48973797|NCT00571519|157735715|FG003|Overall Study|Termination of study by Sponsor|24|||
48973798|NCT00571519|157735716|FG004|Overall Study|Termination of study by Sponsor|8|||
48973799|NCT00571519|157735717|FG005|Overall Study|Termination of study by Sponsor|9|||
48973800|NCT00571519|157735718|FG006|Overall Study|Termination of study by Sponsor|22|||
48973801|NCT00571519|157735712|FG000|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
48973802|NCT00571519|157735713|FG001|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
48973803|NCT00571519|157735714|FG002|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1|||
48973804|NCT00571519|157735715|FG003|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
48973805|NCT00571519|157735716|FG004|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
48973806|NCT00571519|157735717|FG005|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
48973807|NCT00571519|157735718|FG006|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
48973808|NCT00355134|157735719|FG000|Core Phase|Withdrawal by Subject|35|||
48973809|NCT00355134|157735720|FG001|Core Phase|Withdrawal by Subject|24|||
48973810|NCT00355134|157735721|FG002|Core Phase|Withdrawal by Subject|35|||
48973811|NCT00355134|157735722|FG003|Core Phase|Withdrawal by Subject|0|||
48973812|NCT00355134|157735723|FG004|Core Phase|Withdrawal by Subject|0|||
48973813|NCT00355134|157735719|FG000|Core Phase|Adverse Event|28|||
48973814|NCT00355134|157735720|FG001|Core Phase|Adverse Event|22|||
48973815|NCT00355134|157735721|FG002|Core Phase|Adverse Event|16|||
48973816|NCT00355134|157735722|FG003|Core Phase|Adverse Event|0|||
48973817|NCT00355134|157735723|FG004|Core Phase|Adverse Event|0|||
48973818|NCT00355134|157735719|FG000|Core Phase|Lost to Follow-up|17|||
48973819|NCT00355134|157735720|FG001|Core Phase|Lost to Follow-up|13|||
48973820|NCT00355134|157735721|FG002|Core Phase|Lost to Follow-up|21|||
48973821|NCT00355134|157735722|FG003|Core Phase|Lost to Follow-up|0|||
48973822|NCT00355134|157735723|FG004|Core Phase|Lost to Follow-up|0|||
48973823|NCT00355134|157735719|FG000|Core Phase|Abnormal laboratory value(s)|19|||
48973824|NCT00355134|157735720|FG001|Core Phase|Abnormal laboratory value(s)|14|||
48973825|NCT00355134|157735721|FG002|Core Phase|Abnormal laboratory value(s)|2|||
48973826|NCT00355134|157735722|FG003|Core Phase|Abnormal laboratory value(s)|0|||
48973827|NCT00355134|157735723|FG004|Core Phase|Abnormal laboratory value(s)|0|||
48973828|NCT00355134|157735719|FG000|Core Phase|Unsatisfactory therapeutic effect|10|||
48973829|NCT00355134|157735720|FG001|Core Phase|Unsatisfactory therapeutic effect|6|||
48973830|NCT00355134|157735721|FG002|Core Phase|Unsatisfactory therapeutic effect|17|||
48973831|NCT00355134|157735722|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
48973832|NCT00355134|157735723|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
48973833|NCT00355134|157735719|FG000|Core Phase|Administrative problems|5|||
48973834|NCT00355134|157735720|FG001|Core Phase|Administrative problems|3|||
48973835|NCT00355134|157735721|FG002|Core Phase|Administrative problems|5|||
48973836|NCT00355134|157735722|FG003|Core Phase|Administrative problems|0|||
48973837|NCT00355134|157735723|FG004|Core Phase|Administrative problems|0|||
48973838|NCT00355134|157735719|FG000|Core Phase|Protocol Violation|3|||
48761544|NCT01729754|156975637|FG006|Part 2|Other Protocol Specified Criteria|0|||
48761545|NCT01729754|156975638|FG007|Part 2|Other Protocol Specified Criteria|1|||
48761546|NCT01729754|156975639|FG008|Part 2|Other Protocol Specified Criteria|0|||
48761547|NCT01729754|156975640|FG009|Part 2|Other Protocol Specified Criteria|0|||
48761548|NCT01729754|156975631|FG000|Part 3|Adverse Event|0|||
48761549|NCT01729754|156975632|FG001|Part 3|Adverse Event|0|||
48761550|NCT01729754|156975633|FG002|Part 3|Adverse Event|1|||
48761551|NCT01729754|156975634|FG003|Part 3|Adverse Event|0|||
48761552|NCT01729754|156975635|FG004|Part 3|Adverse Event|0|||
48973839|NCT00355134|157735720|FG001|Core Phase|Protocol Violation|2|||
48973840|NCT00355134|157735721|FG002|Core Phase|Protocol Violation|2|||
48973841|NCT00355134|157735722|FG003|Core Phase|Protocol Violation|0|||
48973842|NCT00355134|157735723|FG004|Core Phase|Protocol Violation|0|||
48973843|NCT00355134|157735719|FG000|Core Phase|Abnormal test procedure result(s)|1|||
48973844|NCT00355134|157735720|FG001|Core Phase|Abnormal test procedure result(s)|2|||
49015502|NCT01393990|157893780|FG010|Overall Study|Withdrawal by Subject|0|||
48761553|NCT01729754|156975636|FG005|Part 3|Adverse Event|5|||
48761554|NCT01729754|156975637|FG006|Part 3|Adverse Event|0|||
48761555|NCT01729754|156975638|FG007|Part 3|Adverse Event|0|||
48761556|NCT01729754|156975639|FG008|Part 3|Adverse Event|0|||
48761557|NCT01729754|156975640|FG009|Part 3|Adverse Event|3|||
48761558|NCT01729754|156975631|FG000|Part 3|Death|0|||
48761559|NCT01729754|156975632|FG001|Part 3|Death|0|||
48761560|NCT01729754|156975633|FG002|Part 3|Death|0|||
48761561|NCT01729754|156975634|FG003|Part 3|Death|0|||
48761562|NCT01729754|156975635|FG004|Part 3|Death|0|||
48761563|NCT01729754|156975636|FG005|Part 3|Death|2|||
48761564|NCT01729754|156975637|FG006|Part 3|Death|0|||
48761565|NCT01729754|156975638|FG007|Part 3|Death|0|||
48761566|NCT01729754|156975639|FG008|Part 3|Death|0|||
48761567|NCT01729754|156975640|FG009|Part 3|Death|0|||
48761568|NCT01729754|156975631|FG000|Part 3|Lack of Efficacy|0|||
48761569|NCT01729754|156975632|FG001|Part 3|Lack of Efficacy|0|||
48761570|NCT01729754|156975633|FG002|Part 3|Lack of Efficacy|0|||
48761571|NCT01729754|156975634|FG003|Part 3|Lack of Efficacy|0|||
48761572|NCT01729754|156975635|FG004|Part 3|Lack of Efficacy|2|||
48761573|NCT01729754|156975636|FG005|Part 3|Lack of Efficacy|0|||
48761574|NCT01729754|156975637|FG006|Part 3|Lack of Efficacy|0|||
48761575|NCT01729754|156975638|FG007|Part 3|Lack of Efficacy|0|||
48761576|NCT01729754|156975639|FG008|Part 3|Lack of Efficacy|0|||
48761577|NCT01729754|156975640|FG009|Part 3|Lack of Efficacy|4|||
48761578|NCT01729754|156975631|FG000|Part 3|Lost to Follow-up|0|||
48761579|NCT01729754|156975632|FG001|Part 3|Lost to Follow-up|1|||
48761580|NCT01729754|156975633|FG002|Part 3|Lost to Follow-up|2|||
48761581|NCT01729754|156975634|FG003|Part 3|Lost to Follow-up|0|||
48761582|NCT01729754|156975635|FG004|Part 3|Lost to Follow-up|0|||
48761583|NCT01729754|156975636|FG005|Part 3|Lost to Follow-up|3|||
48761584|NCT01729754|156975637|FG006|Part 3|Lost to Follow-up|0|||
48761585|NCT01729754|156975638|FG007|Part 3|Lost to Follow-up|0|||
48761586|NCT01729754|156975639|FG008|Part 3|Lost to Follow-up|1|||
48761587|NCT01729754|156975640|FG009|Part 3|Lost to Follow-up|0|||
48761588|NCT01729754|156975631|FG000|Part 3|Physician Decision|0|||
48761589|NCT01729754|156975632|FG001|Part 3|Physician Decision|0|||
48761590|NCT01729754|156975633|FG002|Part 3|Physician Decision|1|||
48761591|NCT01729754|156975634|FG003|Part 3|Physician Decision|0|||
48761592|NCT01729754|156975635|FG004|Part 3|Physician Decision|0|||
48761593|NCT01729754|156975636|FG005|Part 3|Physician Decision|0|||
48761594|NCT01729754|156975637|FG006|Part 3|Physician Decision|0|||
48761595|NCT01729754|156975638|FG007|Part 3|Physician Decision|0|||
48973845|NCT00355134|157735721|FG002|Core Phase|Abnormal test procedure result(s)|1|||
48973846|NCT00355134|157735722|FG003|Core Phase|Abnormal test procedure result(s)|0|||
48973847|NCT00355134|157735723|FG004|Core Phase|Abnormal test procedure result(s)|0|||
48973848|NCT00355134|157735719|FG000|Core Phase|Condition no longer requires study drug|1|||
48973849|NCT00355134|157735720|FG001|Core Phase|Condition no longer requires study drug|0|||
48973850|NCT00355134|157735721|FG002|Core Phase|Condition no longer requires study drug|1|||
48973851|NCT00355134|157735722|FG003|Core Phase|Condition no longer requires study drug|0|||
48973852|NCT00355134|157735723|FG004|Core Phase|Condition no longer requires study drug|0|||
48973853|NCT00355134|157735719|FG000|Extension Phase|Withdrawal by Subject|7|||
48973854|NCT00355134|157735720|FG001|Extension Phase|Withdrawal by Subject|11|||
48973855|NCT00355134|157735721|FG002|Extension Phase|Withdrawal by Subject|0|||
48973856|NCT00355134|157735722|FG003|Extension Phase|Withdrawal by Subject|7|||
48973857|NCT00355134|157735723|FG004|Extension Phase|Withdrawal by Subject|5|||
48973858|NCT00355134|157735719|FG000|Extension Phase|Adverse Event|13|||
48973859|NCT00355134|157735720|FG001|Extension Phase|Adverse Event|9|||
48973860|NCT00355134|157735721|FG002|Extension Phase|Adverse Event|0|||
48973861|NCT00355134|157735722|FG003|Extension Phase|Adverse Event|3|||
48973862|NCT00355134|157735723|FG004|Extension Phase|Adverse Event|5|||
48973863|NCT00355134|157735719|FG000|Extension Phase|Lost to Follow-up|2|||
48973864|NCT00355134|157735720|FG001|Extension Phase|Lost to Follow-up|6|||
48973865|NCT00355134|157735721|FG002|Extension Phase|Lost to Follow-up|0|||
48973866|NCT00355134|157735722|FG003|Extension Phase|Lost to Follow-up|2|||
48973867|NCT00355134|157735723|FG004|Extension Phase|Lost to Follow-up|4|||
48973868|NCT00355134|157735719|FG000|Extension Phase|Abnormal laboratory value(s)|4|||
48973869|NCT00355134|157735720|FG001|Extension Phase|Abnormal laboratory value(s)|2|||
48761596|NCT01729754|156975639|FG008|Part 3|Physician Decision|0|||
48761597|NCT01729754|156975640|FG009|Part 3|Physician Decision|0|||
48761598|NCT01729754|156975631|FG000|Part 3|Withdrawal by Subject|0|||
48761599|NCT01729754|156975632|FG001|Part 3|Withdrawal by Subject|4|||
48761600|NCT01729754|156975633|FG002|Part 3|Withdrawal by Subject|1|||
48761601|NCT01729754|156975634|FG003|Part 3|Withdrawal by Subject|0|||
48973870|NCT00355134|157735721|FG002|Extension Phase|Abnormal laboratory value(s)|0|||
48973871|NCT00355134|157735722|FG003|Extension Phase|Abnormal laboratory value(s)|2|||
48761602|NCT01729754|156975635|FG004|Part 3|Withdrawal by Subject|2|||
48761603|NCT01729754|156975636|FG005|Part 3|Withdrawal by Subject|1|||
48761604|NCT01729754|156975637|FG006|Part 3|Withdrawal by Subject|0|||
48761605|NCT01729754|156975638|FG007|Part 3|Withdrawal by Subject|2|||
48761606|NCT01729754|156975639|FG008|Part 3|Withdrawal by Subject|0|||
48761607|NCT01729754|156975640|FG009|Part 3|Withdrawal by Subject|0|||
48761608|NCT01729754|156975631|FG000|Part 3|Other Protocol Specified Criteria|0|||
48761609|NCT01729754|156975632|FG001|Part 3|Other Protocol Specified Criteria|0|||
48761610|NCT01729754|156975633|FG002|Part 3|Other Protocol Specified Criteria|0|||
48973872|NCT00355134|157735723|FG004|Extension Phase|Abnormal laboratory value(s)|2|||
48973873|NCT00355134|157735719|FG000|Extension Phase|Administrative problems|2|||
48973874|NCT00355134|157735720|FG001|Extension Phase|Administrative problems|4|||
48973875|NCT00355134|157735721|FG002|Extension Phase|Administrative problems|0|||
48973876|NCT00355134|157735722|FG003|Extension Phase|Administrative problems|1|||
48973877|NCT00355134|157735723|FG004|Extension Phase|Administrative problems|1|||
48973878|NCT00355134|157735719|FG000|Extension Phase|Unsatisfactory therapeutic effect|3|||
48973879|NCT00355134|157735720|FG001|Extension Phase|Unsatisfactory therapeutic effect|4|||
48674802|NCT02301624|156661612|FG001|Open-label Maintenance Phase|Death|1|||
48674803|NCT02301624|156661611|FG000|Open-label Maintenance Phase|Participant felt no change in condition|1|||
48674804|NCT02301624|156661612|FG001|Open-label Maintenance Phase|Participant felt no change in condition|0|||
48674805|NCT00895310|156661613|FG000|Overall Study|Withdrawal by Subject|1|||
48674806|NCT00659230|156661616|FG000|Overall Study|Lost to Follow-up|2|||
48973880|NCT00355134|157735721|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
48973881|NCT00355134|157735722|FG003|Extension Phase|Unsatisfactory therapeutic effect|0|||
48973882|NCT00355134|157735723|FG004|Extension Phase|Unsatisfactory therapeutic effect|1|||
48973883|NCT00355134|157735719|FG000|Extension Phase|Abnormal test procedure result(s)|0|||
48973884|NCT00355134|157735720|FG001|Extension Phase|Abnormal test procedure result(s)|1|||
48973885|NCT00355134|157735721|FG002|Extension Phase|Abnormal test procedure result(s)|0|||
48973886|NCT00355134|157735722|FG003|Extension Phase|Abnormal test procedure result(s)|0|||
48973887|NCT00355134|157735723|FG004|Extension Phase|Abnormal test procedure result(s)|1|||
48973888|NCT00355134|157735719|FG000|Extension Phase|Protocol Violation|0|||
48973889|NCT00355134|157735720|FG001|Extension Phase|Protocol Violation|0|||
48973890|NCT00355134|157735721|FG002|Extension Phase|Protocol Violation|0|||
48973891|NCT00355134|157735722|FG003|Extension Phase|Protocol Violation|1|||
48973892|NCT00355134|157735723|FG004|Extension Phase|Protocol Violation|0|||
48973893|NCT01451398|157735724|FG000|Overall Study|Adverse Event|7|||
48973894|NCT01451398|157735725|FG001|Overall Study|Adverse Event|9|||
48973895|NCT01451398|157735724|FG000|Overall Study|Protocol Violation|1|||
48973896|NCT01451398|157735725|FG001|Overall Study|Protocol Violation|2|||
48973897|NCT01451398|157735724|FG000|Overall Study|Physician Decision|1|||
48973898|NCT01451398|157735725|FG001|Overall Study|Physician Decision|1|||
48973899|NCT01451398|157735724|FG000|Overall Study|Withdrawal by Subject|10|||
48973900|NCT01451398|157735725|FG001|Overall Study|Withdrawal by Subject|14|||
48973901|NCT01451398|157735724|FG000|Overall Study|Lost to Follow-up|6|||
48973902|NCT01451398|157735725|FG001|Overall Study|Lost to Follow-up|4|||
48973903|NCT01451398|157735724|FG000|Overall Study|Non-compliance with study drug|1|||
48973904|NCT01451398|157735725|FG001|Overall Study|Non-compliance with study drug|3|||
48973905|NCT01451398|157735724|FG000|Overall Study|Non-compliance with protocol|1|||
48973906|NCT01451398|157735725|FG001|Overall Study|Non-compliance with protocol|1|||
48973907|NCT01451398|157735724|FG000|Overall Study|Moved out of country|0|||
48973908|NCT01451398|157735725|FG001|Overall Study|Moved out of country|1|||
48973909|NCT01451398|157735724|FG000|Overall Study|Adverse Event + Elevated Fasting Glucose|0|||
48973910|NCT01451398|157735725|FG001|Overall Study|Adverse Event + Elevated Fasting Glucose|1|||
48973911|NCT01451398|157735724|FG000|Overall Study|Lack of Efficacy|0|||
48973912|NCT01451398|157735725|FG001|Overall Study|Lack of Efficacy|1|||
48973913|NCT04058158|157735726|FG000|Period 1|Death|1|||
48973914|NCT04058158|157735727|FG001|Period 1|Death|0|||
48973915|NCT04058158|157735726|FG000|Period 1|Adverse Event|1|||
48973916|NCT04058158|157735727|FG001|Period 1|Adverse Event|1|||
48973917|NCT04058158|157735726|FG000|Period 1|Pregnancy|0|||
48973918|NCT04058158|157735727|FG001|Period 1|Pregnancy|1|||
48973919|NCT02009930|157735732|FG000|Overall Study|withdrawn|5|||
48973920|NCT01136746|157735733|FG000|Overall Study|Lost to Follow-up|0|||
48973921|NCT01136746|157735734|FG001|Overall Study|Lost to Follow-up|2|||
48973922|NCT01136746|157735733|FG000|Overall Study|Protocol Violation|2|||
48973923|NCT01136746|157735734|FG001|Overall Study|Protocol Violation|1|||
48973924|NCT01136746|157735733|FG000|Overall Study|Death|1|||
48973925|NCT01136746|157735734|FG001|Overall Study|Death|0|||
48973926|NCT03907969|157735735|FG000|Monotherapy Part A|Withdrawal by Subject|0|||
48973927|NCT03907969|157735736|FG001|Monotherapy Part A|Withdrawal by Subject|0|||
48674807|NCT00659230|156661617|FG001|Overall Study|Lost to Follow-up|5|||
48973928|NCT03907969|157735737|FG002|Monotherapy Part A|Withdrawal by Subject|0|||
48973929|NCT03907969|157735738|FG003|Monotherapy Part A|Withdrawal by Subject|0|||
48973930|NCT03907969|157735739|FG004|Monotherapy Part A|Withdrawal by Subject|1|||
48973931|NCT03907969|157735740|FG005|Monotherapy Part A|Withdrawal by Subject|1|||
48973932|NCT03907969|157735741|FG006|Monotherapy Part A|Withdrawal by Subject|0|||
48973933|NCT03907969|157735742|FG007|Monotherapy Part A|Withdrawal by Subject|0|||
48973934|NCT03907969|157735743|FG008|Monotherapy Part A|Withdrawal by Subject|0|||
48973935|NCT03907969|157735744|FG009|Monotherapy Part A|Withdrawal by Subject|0|||
48973936|NCT03907969|157735745|FG010|Monotherapy Part A|Withdrawal by Subject|0|||
48973937|NCT03907969|157735735|FG000|Monotherapy Part A|Progressive Disease|0|||
48973938|NCT03907969|157735736|FG001|Monotherapy Part A|Progressive Disease|1|||
48973939|NCT03907969|157735737|FG002|Monotherapy Part A|Progressive Disease|0|||
48973940|NCT03907969|157735738|FG003|Monotherapy Part A|Progressive Disease|0|||
48973941|NCT03907969|157735739|FG004|Monotherapy Part A|Progressive Disease|0|||
48973942|NCT03907969|157735740|FG005|Monotherapy Part A|Progressive Disease|1|||
48674808|NCT00659230|156661616|FG000|Overall Study|Lost source documentation|5|||
48674809|NCT00659230|156661617|FG001|Overall Study|Lost source documentation|4|||
48674810|NCT00659230|156661616|FG000|Overall Study|Did not return post-randomization|2|||
48674811|NCT00659230|156661617|FG001|Overall Study|Did not return post-randomization|3|||
48674812|NCT00861471|156661618|FG000|Overall Study|Withdrawal by Subject|1|||
48674813|NCT00861471|156661618|FG000|Overall Study|Adverse Event|2|||
48674814|NCT00861471|156661618|FG000|Overall Study|Lack of Efficacy|3|||
48674815|NCT00861471|156661618|FG000|Overall Study|treatment for lumbar laminectomy|1|||
48674816|NCT00861471|156661618|FG000|Overall Study|Physician Decision|2|||
48674817|NCT00269633|156661621|FG000|Overall Study|Withdrawal by Subject|1|||
48674818|NCT00269633|156661622|FG001|Overall Study|Withdrawal by Subject|0|||
48761611|NCT01729754|156975634|FG003|Part 3|Other Protocol Specified Criteria|0|||
48761612|NCT01729754|156975635|FG004|Part 3|Other Protocol Specified Criteria|0|||
48761613|NCT01729754|156975636|FG005|Part 3|Other Protocol Specified Criteria|2|||
48761614|NCT01729754|156975637|FG006|Part 3|Other Protocol Specified Criteria|0|||
48761615|NCT01729754|156975638|FG007|Part 3|Other Protocol Specified Criteria|1|||
48761616|NCT01729754|156975639|FG008|Part 3|Other Protocol Specified Criteria|0|||
48761617|NCT01729754|156975640|FG009|Part 3|Other Protocol Specified Criteria|0|||
48761618|NCT00605813|156975643|FG000|Overall Study|Protocol Violation|25|||
48761619|NCT03683758|156975647|FG000|Overall Study|Non-study commitment conflict|1|||
48761620|NCT03683758|156975648|FG001|Overall Study|Non-study commitment conflict|3|||
48761621|NCT03683758|156975647|FG000|Overall Study|Illness preventing participation|1|||
48761622|NCT03683758|156975648|FG001|Overall Study|Illness preventing participation|0|||
48761623|NCT03683758|156975647|FG000|Overall Study|Adverse Event|1|||
48761624|NCT03683758|156975648|FG001|Overall Study|Adverse Event|0|||
48761625|NCT00174915|156975651|FG000|Overall Study|Lost to Follow-up|19|||
48761626|NCT00174915|156975652|FG001|Overall Study|Lost to Follow-up|17|||
48761627|NCT00174915|156975653|FG002|Overall Study|Lost to Follow-up|9|||
48761628|NCT00174915|156975654|FG003|Overall Study|Lost to Follow-up|17|||
48761629|NCT00174915|156975655|FG004|Overall Study|Lost to Follow-up|10|||
48761630|NCT00174915|156975651|FG000|Overall Study|Adverse Event|18|||
48761631|NCT00174915|156975652|FG001|Overall Study|Adverse Event|16|||
48761632|NCT00174915|156975653|FG002|Overall Study|Adverse Event|11|||
48761633|NCT00174915|156975654|FG003|Overall Study|Adverse Event|18|||
48761634|NCT00174915|156975655|FG004|Overall Study|Adverse Event|5|||
48761635|NCT00174915|156975651|FG000|Overall Study|Personal Reason(s)|16|||
48761636|NCT00174915|156975652|FG001|Overall Study|Personal Reason(s)|16|||
48761637|NCT00174915|156975653|FG002|Overall Study|Personal Reason(s)|9|||
48761638|NCT00174915|156975654|FG003|Overall Study|Personal Reason(s)|9|||
48761639|NCT00174915|156975655|FG004|Overall Study|Personal Reason(s)|9|||
48761640|NCT00174915|156975651|FG000|Overall Study|Other|15|||
48761641|NCT00174915|156975652|FG001|Overall Study|Other|8|||
48761642|NCT00174915|156975653|FG002|Overall Study|Other|6|||
48761643|NCT00174915|156975654|FG003|Overall Study|Other|5|||
48761644|NCT00174915|156975655|FG004|Overall Study|Other|3|||
48761645|NCT00174915|156975651|FG000|Overall Study|Gout Flare|13|||
48761646|NCT00174915|156975652|FG001|Overall Study|Gout Flare|6|||
48761647|NCT00174915|156975653|FG002|Overall Study|Gout Flare|8|||
48761648|NCT00174915|156975654|FG003|Overall Study|Gout Flare|1|||
48761649|NCT00174915|156975655|FG004|Overall Study|Gout Flare|0|||
48761650|NCT00174915|156975651|FG000|Overall Study|Protocol Violation|6|||
48973943|NCT03907969|157735741|FG006|Monotherapy Part A|Progressive Disease|2|||
48973944|NCT03907969|157735742|FG007|Monotherapy Part A|Progressive Disease|0|||
48973945|NCT03907969|157735743|FG008|Monotherapy Part A|Progressive Disease|0|||
48973946|NCT03907969|157735744|FG009|Monotherapy Part A|Progressive Disease|0|||
48973947|NCT03907969|157735745|FG010|Monotherapy Part A|Progressive Disease|0|||
48973948|NCT03907969|157735735|FG000|Monotherapy Part A|Death|0|||
48973949|NCT03907969|157735736|FG001|Monotherapy Part A|Death|0|||
48973950|NCT03907969|157735737|FG002|Monotherapy Part A|Death|1|||
48973951|NCT03907969|157735738|FG003|Monotherapy Part A|Death|1|||
48973952|NCT03907969|157735739|FG004|Monotherapy Part A|Death|0|||
48973953|NCT03907969|157735740|FG005|Monotherapy Part A|Death|1|||
48973954|NCT03907969|157735741|FG006|Monotherapy Part A|Death|0|||
48761651|NCT00174915|156975652|FG001|Overall Study|Protocol Violation|3|||
48761652|NCT00174915|156975653|FG002|Overall Study|Protocol Violation|3|||
48761653|NCT00174915|156975654|FG003|Overall Study|Protocol Violation|6|||
48761654|NCT00174915|156975655|FG004|Overall Study|Protocol Violation|3|||
48973955|NCT03907969|157735742|FG007|Monotherapy Part A|Death|0|||
48674819|NCT03887221|156661623|FG000|Overall Study|Protocol Violation|1|||
48674820|NCT03887221|156661624|FG001|Overall Study|Protocol Violation|0|||
48761655|NCT00174915|156975651|FG000|Overall Study|Therapeutic Failure|6|||
48761656|NCT00174915|156975652|FG001|Overall Study|Therapeutic Failure|3|||
48973956|NCT03907969|157735743|FG008|Monotherapy Part A|Death|0|||
48973957|NCT03907969|157735744|FG009|Monotherapy Part A|Death|0|||
48674821|NCT00445770|156661625|FG000|Overall Study|Adverse Event|9|||
48761657|NCT00174915|156975653|FG002|Overall Study|Therapeutic Failure|2|||
48761658|NCT00174915|156975654|FG003|Overall Study|Therapeutic Failure|1|||
48761659|NCT00174915|156975655|FG004|Overall Study|Therapeutic Failure|3|||
48761660|NCT04127786|156975656|FG000|Primary Series|Adverse Event|1|||
48761661|NCT04127786|156975657|FG001|Primary Series|Adverse Event|0|||
48674822|NCT00445770|156661626|FG001|Overall Study|Adverse Event|15|||
48674823|NCT00445770|156661627|FG002|Overall Study|Adverse Event|19|||
48873609|NCT04680637|157373398|FG002|Overall Study|Withdrawal by Subject|17|||
48873610|NCT04680637|157373399|FG003|Overall Study|Withdrawal by Subject|15|||
48973958|NCT03907969|157735745|FG010|Monotherapy Part A|Death|0|||
48973959|NCT03907969|157735735|FG000|Combination Therapy Part A|Adverse Event|0|||
48973960|NCT03907969|157735736|FG001|Combination Therapy Part A|Adverse Event|0|||
48973961|NCT03907969|157735737|FG002|Combination Therapy Part A|Adverse Event|0|||
48973962|NCT03907969|157735738|FG003|Combination Therapy Part A|Adverse Event|0|||
48973963|NCT03907969|157735739|FG004|Combination Therapy Part A|Adverse Event|0|||
48973964|NCT03907969|157735740|FG005|Combination Therapy Part A|Adverse Event|0|||
48973965|NCT03907969|157735741|FG006|Combination Therapy Part A|Adverse Event|0|||
48973966|NCT03907969|157735742|FG007|Combination Therapy Part A|Adverse Event|0|||
48973967|NCT03907969|157735743|FG008|Combination Therapy Part A|Adverse Event|0|||
48973968|NCT03907969|157735744|FG009|Combination Therapy Part A|Adverse Event|1|||
48973969|NCT03907969|157735745|FG010|Combination Therapy Part A|Adverse Event|1|||
48973970|NCT03907969|157735735|FG000|Combination Therapy Part A|Progressive disease|0|||
48674824|NCT00445770|156661625|FG000|Overall Study|Lack of Efficacy|38|||
48873611|NCT04680637|157373396|FG000|Overall Study|Decision by Sponsor|21|||
48873612|NCT04680637|157373397|FG001|Overall Study|Decision by Sponsor|15|||
48873613|NCT04680637|157373398|FG002|Overall Study|Decision by Sponsor|7|||
48873614|NCT04680637|157373399|FG003|Overall Study|Decision by Sponsor|32|||
48873615|NCT00344032|157373400|FG000|Overall Study|Adverse Event|0|||
48873616|NCT00344032|157373401|FG001|Overall Study|Adverse Event|1|||
48873617|NCT00344032|157373400|FG000|Overall Study|Withdrawal by Subject|6|||
48873618|NCT00344032|157373401|FG001|Overall Study|Withdrawal by Subject|2|||
48873619|NCT00344032|157373400|FG000|Overall Study|Lost to Follow-up|4|||
48873620|NCT00344032|157373401|FG001|Overall Study|Lost to Follow-up|6|||
48873621|NCT00344032|157373400|FG000|Overall Study|Physician Decision|4|||
48873622|NCT00344032|157373401|FG001|Overall Study|Physician Decision|1|||
48873623|NCT02202109|157375086|FG000|Overall Study|Lost to Follow-up|88|||
48873624|NCT02202109|157375087|FG001|Overall Study|Lost to Follow-up|87|||
48873625|NCT02202109|157375086|FG000|Overall Study|Withdrawal by Subject|2|||
48873626|NCT02202109|157375087|FG001|Overall Study|Withdrawal by Subject|0|||
48873627|NCT02806505|157375091|FG000|Overall Study|Adverse event/intercurrent illness|1|||
48873628|NCT02806505|157375092|FG001|Overall Study|Adverse event/intercurrent illness|3|||
48873629|NCT02806505|157375091|FG000|Overall Study|Death|4|||
48873630|NCT02806505|157375092|FG001|Overall Study|Death|0|||
48873631|NCT02806505|157375091|FG000|Overall Study|Did not cooperate/refused treatment|3|||
48873632|NCT02806505|157375092|FG001|Overall Study|Did not cooperate/refused treatment|3|||
48873633|NCT02806505|157375091|FG000|Overall Study|Failure to return|0|||
48873634|NCT02806505|157375092|FG001|Overall Study|Failure to return|1|||
48873635|NCT02806505|157375091|FG000|Overall Study|Insufficient therapeutic response|2|||
48873636|NCT02806505|157375092|FG001|Overall Study|Insufficient therapeutic response|4|||
48873637|NCT01181609|157375097|FG000|Overall Study|Adverse Event|1|||
48873638|NCT01181609|157375097|FG000|Overall Study|Withdrawal by Subject|1|||
48873639|NCT01181609|157375097|FG000|Overall Study|Lost to Follow-up|1|||
48873640|NCT01181609|157375097|FG000|Overall Study|Death|50|||
48873641|NCT01333111|157375103|FG000|Overall Study|patient undergoing major surgery|0|||
48873642|NCT01333111|157375104|FG001|Overall Study|patient undergoing major surgery|2|||
48873643|NCT01333111|157375105|FG002|Overall Study|patient undergoing major surgery|0|||
48873644|NCT01333111|157375103|FG000|Overall Study|personal reasons|0|||
48873645|NCT01333111|157375104|FG001|Overall Study|personal reasons|0|||
48873646|NCT01333111|157375105|FG002|Overall Study|personal reasons|1|||
48873647|NCT01333111|157375103|FG000|Overall Study|unclassified|1|||
48873648|NCT01333111|157375104|FG001|Overall Study|unclassified|0|||
48873649|NCT01333111|157375105|FG002|Overall Study|unclassified|0|||
48873650|NCT01333111|157375103|FG000|Overall Study|withdrawal criteria|0|||
48873651|NCT01333111|157375104|FG001|Overall Study|withdrawal criteria|1|||
48873652|NCT01333111|157375105|FG002|Overall Study|withdrawal criteria|0|||
48873653|NCT01333111|157375103|FG000|Overall Study|Non-compliance|1|||
48873654|NCT01333111|157375104|FG001|Overall Study|Non-compliance|0|||
48873655|NCT01333111|157375105|FG002|Overall Study|Non-compliance|0|||
48973971|NCT03907969|157735736|FG001|Combination Therapy Part A|Progressive disease|0|||
48973972|NCT03907969|157735737|FG002|Combination Therapy Part A|Progressive disease|0|||
48973973|NCT03907969|157735738|FG003|Combination Therapy Part A|Progressive disease|0|||
48674825|NCT00445770|156661626|FG001|Overall Study|Lack of Efficacy|13|||
48873656|NCT01333111|157375103|FG000|Overall Study|Ineffective therapy|0|||
48873657|NCT01333111|157375104|FG001|Overall Study|Ineffective therapy|0|||
48873658|NCT01333111|157375105|FG002|Overall Study|Ineffective therapy|1|||
48873659|NCT02161406|157375106|FG000|Overall Study|Death|2|||
48873660|NCT02161406|157375107|FG001|Overall Study|Death|1|||
48873661|NCT02161406|157375106|FG000|Overall Study|Lost to Follow-up|2|||
48973974|NCT03907969|157735739|FG004|Combination Therapy Part A|Progressive disease|0|||
48873662|NCT02161406|157375107|FG001|Overall Study|Lost to Follow-up|1|||
48873663|NCT02161406|157375106|FG000|Overall Study|Withdrawal by Subject|2|||
48873664|NCT02161406|157375107|FG001|Overall Study|Withdrawal by Subject|4|||
48873665|NCT02161406|157375106|FG000|Overall Study|investigator withdrew subject|3|||
48973975|NCT03907969|157735740|FG005|Combination Therapy Part A|Progressive disease|0|||
48973976|NCT03907969|157735741|FG006|Combination Therapy Part A|Progressive disease|0|||
48973977|NCT03907969|157735742|FG007|Combination Therapy Part A|Progressive disease|1|||
48973978|NCT03907969|157735743|FG008|Combination Therapy Part A|Progressive disease|0|||
48973979|NCT03907969|157735744|FG009|Combination Therapy Part A|Progressive disease|2|||
48973980|NCT03907969|157735745|FG010|Combination Therapy Part A|Progressive disease|3|||
48973981|NCT03907969|157735735|FG000|Combination Therapy Part A|Death|0|||
48973982|NCT03907969|157735736|FG001|Combination Therapy Part A|Death|0|||
48761662|NCT04127786|156975658|FG002|Primary Series|Adverse Event|0|||
48761663|NCT04127786|156975659|FG003|Primary Series|Adverse Event|1|||
48761664|NCT04127786|156975660|FG004|Primary Series|Adverse Event|0|||
48761665|NCT04127786|156975661|FG005|Primary Series|Adverse Event|1|||
48761666|NCT04127786|156975656|FG000|Primary Series|Protocol Violation|5|||
48973983|NCT03907969|157735737|FG002|Combination Therapy Part A|Death|0|||
48973984|NCT03907969|157735738|FG003|Combination Therapy Part A|Death|0|||
48973985|NCT03907969|157735739|FG004|Combination Therapy Part A|Death|0|||
48973986|NCT03907969|157735740|FG005|Combination Therapy Part A|Death|0|||
48973987|NCT03907969|157735741|FG006|Combination Therapy Part A|Death|0|||
48973988|NCT03907969|157735742|FG007|Combination Therapy Part A|Death|0|||
48973989|NCT03907969|157735743|FG008|Combination Therapy Part A|Death|1|||
48973990|NCT03907969|157735744|FG009|Combination Therapy Part A|Death|0|||
48674826|NCT00445770|156661627|FG002|Overall Study|Lack of Efficacy|6|||
48674827|NCT00445770|156661625|FG000|Overall Study|Lost to Follow-up|0|||
48674828|NCT00445770|156661626|FG001|Overall Study|Lost to Follow-up|2|||
48674829|NCT00445770|156661627|FG002|Overall Study|Lost to Follow-up|0|||
48674830|NCT00445770|156661625|FG000|Overall Study|Other|6|||
48674831|NCT00445770|156661626|FG001|Overall Study|Other|5|||
48674832|NCT00445770|156661627|FG002|Overall Study|Other|6|||
48674833|NCT04412707|156661628|FG000|Cycle 1|Death|0|||
48674834|NCT04412707|156661629|FG001|Cycle 1|Death|3|||
48674835|NCT04412707|156661628|FG000|Cycle 1|Disease progression|1|||
48674836|NCT04412707|156661629|FG001|Cycle 1|Disease progression|2|||
48674837|NCT04412707|156661628|FG000|Cycle 2|Death|0|||
48674838|NCT04412707|156661629|FG001|Cycle 2|Death|1|||
48761667|NCT04127786|156975657|FG001|Primary Series|Protocol Violation|3|||
48761668|NCT04127786|156975658|FG002|Primary Series|Protocol Violation|4|||
48873666|NCT02161406|157375107|FG001|Overall Study|investigator withdrew subject|1|||
48973991|NCT03907969|157735745|FG010|Combination Therapy Part A|Death|1|||
48973992|NCT03907969|157735735|FG000|Combination Therapy Part A|Withdrawal by Subject|0|||
48973993|NCT03907969|157735736|FG001|Combination Therapy Part A|Withdrawal by Subject|0|||
48973994|NCT03907969|157735737|FG002|Combination Therapy Part A|Withdrawal by Subject|0|||
48674839|NCT04412707|156661628|FG000|Cycle 2|Disease progression|3|||
48674840|NCT04412707|156661629|FG001|Cycle 2|Disease progression|0|||
48674841|NCT04412707|156661628|FG000|Cycle 3 to End of Study (EOS)|Death|1|||
48674842|NCT04412707|156661629|FG001|Cycle 3 to End of Study (EOS)|Death|3|||
48674843|NCT04412707|156661628|FG000|Cycle 3 to End of Study (EOS)|Disease progression|4|||
48674844|NCT04412707|156661629|FG001|Cycle 3 to End of Study (EOS)|Disease progression|2|||
48674845|NCT04412707|156661628|FG000|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|4|||
48674846|NCT04412707|156661629|FG001|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|2|||
48761669|NCT04127786|156975659|FG003|Primary Series|Protocol Violation|3|||
48761670|NCT04127786|156975660|FG004|Primary Series|Protocol Violation|2|||
48761671|NCT04127786|156975661|FG005|Primary Series|Protocol Violation|0|||
48873667|NCT02161406|157375106|FG000|Overall Study|Lack of Efficacy|1|||
48873668|NCT02161406|157375107|FG001|Overall Study|Lack of Efficacy|1|||
48873669|NCT02161406|157375106|FG000|Overall Study|relocation|0|||
48873670|NCT02161406|157375107|FG001|Overall Study|relocation|1|||
48873671|NCT03458728|157375110|FG000|Overall Study|Adverse Event|1|||
48873672|NCT03458728|157375111|FG001|Overall Study|Adverse Event|0|||
48873673|NCT03458728|157375110|FG000|Overall Study|Physician Decision|1|||
48873674|NCT03458728|157375111|FG001|Overall Study|Physician Decision|0|||
48873675|NCT03458728|157375110|FG000|Overall Study|Progressive disease - clinical assessment|1|||
48873676|NCT03458728|157375111|FG001|Overall Study|Progressive disease - clinical assessment|0|||
48873677|NCT03458728|157375110|FG000|Overall Study|Progressive disease - radiological progression|21|||
48873678|NCT03458728|157375111|FG001|Overall Study|Progressive disease - radiological progression|6|||
48873679|NCT03458728|157375110|FG000|Overall Study|Withdrawal by Subject|0|||
48873680|NCT03458728|157375111|FG001|Overall Study|Withdrawal by Subject|1|||
48873681|NCT00381797|157375115|FG000|Overall Study|Withdrawal by Subject|1|||
48873682|NCT00381797|157375116|FG001|Overall Study|Withdrawal by Subject|1|||
48873683|NCT00381797|157375117|FG002|Overall Study|Withdrawal by Subject|0|||
48674847|NCT04412707|156661628|FG000|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|1|||
48674848|NCT04412707|156661629|FG001|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|0|||
48674849|NCT02927938|156661630|FG000|Overall Study|Death|0|||
48674850|NCT02927938|156661631|FG001|Overall Study|Death|1|||
48674851|NCT02927938|156661632|FG002|Overall Study|Death|0|||
48674852|NCT02927938|156661633|FG003|Overall Study|Death|4|||
48761672|NCT04127786|156975656|FG000|Primary Series|Withdrawal by Subject|0|||
48873684|NCT00381797|157375118|FG003|Overall Study|Withdrawal by Subject|0|||
48873685|NCT00381797|157375119|FG004|Overall Study|Withdrawal by Subject|2|||
48973995|NCT03907969|157735738|FG003|Combination Therapy Part A|Withdrawal by Subject|0|||
48973996|NCT03907969|157735739|FG004|Combination Therapy Part A|Withdrawal by Subject|0|||
48973997|NCT03907969|157735740|FG005|Combination Therapy Part A|Withdrawal by Subject|0|||
48973998|NCT03907969|157735741|FG006|Combination Therapy Part A|Withdrawal by Subject|0|||
48674853|NCT02927938|156661630|FG000|Overall Study|Early Study Termination|1|||
48973999|NCT03907969|157735742|FG007|Combination Therapy Part A|Withdrawal by Subject|0|||
48974000|NCT03907969|157735743|FG008|Combination Therapy Part A|Withdrawal by Subject|0|||
48974001|NCT03907969|157735744|FG009|Combination Therapy Part A|Withdrawal by Subject|1|||
48974002|NCT03907969|157735745|FG010|Combination Therapy Part A|Withdrawal by Subject|0|||
48974003|NCT03907969|157735735|FG000|Combination Therapy Part A|Other than specified main reasons|0|||
48974004|NCT03907969|157735736|FG001|Combination Therapy Part A|Other than specified main reasons|0|||
48974005|NCT03907969|157735737|FG002|Combination Therapy Part A|Other than specified main reasons|0|||
48974006|NCT03907969|157735738|FG003|Combination Therapy Part A|Other than specified main reasons|0|||
48974007|NCT03907969|157735739|FG004|Combination Therapy Part A|Other than specified main reasons|0|||
48974008|NCT03907969|157735740|FG005|Combination Therapy Part A|Other than specified main reasons|0|||
48974009|NCT03907969|157735741|FG006|Combination Therapy Part A|Other than specified main reasons|0|||
48974010|NCT03907969|157735742|FG007|Combination Therapy Part A|Other than specified main reasons|0|||
48974011|NCT03907969|157735743|FG008|Combination Therapy Part A|Other than specified main reasons|1|||
48974012|NCT03907969|157735744|FG009|Combination Therapy Part A|Other than specified main reasons|0|||
48974013|NCT03907969|157735745|FG010|Combination Therapy Part A|Other than specified main reasons|0|||
48974014|NCT03907969|157735735|FG000|Combination Therapy Part A|Physician Decision|0|||
48974015|NCT03907969|157735736|FG001|Combination Therapy Part A|Physician Decision|0|||
48974016|NCT03907969|157735737|FG002|Combination Therapy Part A|Physician Decision|0|||
48974017|NCT03907969|157735738|FG003|Combination Therapy Part A|Physician Decision|0|||
48974018|NCT03907969|157735739|FG004|Combination Therapy Part A|Physician Decision|0|||
48974019|NCT03907969|157735740|FG005|Combination Therapy Part A|Physician Decision|0|||
48974020|NCT03907969|157735741|FG006|Combination Therapy Part A|Physician Decision|0|||
48974021|NCT03907969|157735742|FG007|Combination Therapy Part A|Physician Decision|1|||
48974022|NCT03907969|157735743|FG008|Combination Therapy Part A|Physician Decision|0|||
48974023|NCT03907969|157735744|FG009|Combination Therapy Part A|Physician Decision|0|||
48974024|NCT03907969|157735745|FG010|Combination Therapy Part A|Physician Decision|1|||
48974025|NCT02580240|157735750|FG000|Overall Study|Physician Decision|2|||
48974026|NCT02580240|157735751|FG001|Overall Study|Physician Decision|0|||
48974027|NCT00607919|157735752|FG000|Acute Phase|Adverse Event|9|||
48974028|NCT00607919|157735753|FG001|Acute Phase|Adverse Event|2|||
48974029|NCT00607919|157735752|FG000|Acute Phase|Entry Criteria Not Met|1|||
48974030|NCT00607919|157735753|FG001|Acute Phase|Entry Criteria Not Met|1|||
48974031|NCT00607919|157735752|FG000|Acute Phase|Lack of Efficacy|1|||
48974032|NCT00607919|157735753|FG001|Acute Phase|Lack of Efficacy|2|||
48974033|NCT00607919|157735752|FG000|Acute Phase|Lost to Follow-up|9|||
48974034|NCT00607919|157735753|FG001|Acute Phase|Lost to Follow-up|3|||
48974035|NCT00607919|157735752|FG000|Acute Phase|Parent/Caregiver Decision|6|||
48974036|NCT00607919|157735753|FG001|Acute Phase|Parent/Caregiver Decision|4|||
48974037|NCT00607919|157735752|FG000|Acute Phase|Protocol Violation|5|||
48974038|NCT00607919|157735753|FG001|Acute Phase|Protocol Violation|1|||
48974039|NCT00607919|157735752|FG000|Acute Phase|Withdrawal by Subject|3|||
48974040|NCT00607919|157735753|FG001|Acute Phase|Withdrawal by Subject|3|||
48974041|NCT00607919|157735752|FG000|Open-Label Phase|Adverse Event|1|||
48974042|NCT00607919|157735753|FG001|Open-Label Phase|Adverse Event|5|||
48974043|NCT00607919|157735752|FG000|Open-Label Phase|Lost to Follow-up|4|||
48974044|NCT00607919|157735753|FG001|Open-Label Phase|Lost to Follow-up|1|||
48974045|NCT00607919|157735752|FG000|Open-Label Phase|Protocol Violation|2|||
48974046|NCT00607919|157735753|FG001|Open-Label Phase|Protocol Violation|2|||
48974047|NCT00607919|157735752|FG000|Open-Label Phase|Withdrawal by Subject|2|||
48974048|NCT00607919|157735753|FG001|Open-Label Phase|Withdrawal by Subject|2|||
48974049|NCT00607919|157735752|FG000|Open-Label Phase|Parent/Caregiver Decision|1|||
48974050|NCT00607919|157735753|FG001|Open-Label Phase|Parent/Caregiver Decision|2|||
48974051|NCT02786836|157735754|FG000|Overall Study|Death|1|||
48974052|NCT02786836|157735754|FG000|Overall Study|Lack of Efficacy|2|||
48974053|NCT02786836|157735754|FG000|Overall Study|Protocol Violation|3|||
48974054|NCT02786836|157735754|FG000|Overall Study|Withdrawal by Subject|3|||
48974055|NCT02786836|157735754|FG000|Overall Study|Liver Transplantation|2|||
48974056|NCT02786836|157735754|FG000|Overall Study|Device or Pharmacy Issues|3|||
48974057|NCT02057068|157735755|FG000|Overall Study|Withdrawal by Subject|2|||
48974058|NCT02057068|157735756|FG001|Overall Study|Withdrawal by Subject|2|||
48674854|NCT02927938|156661631|FG001|Overall Study|Early Study Termination|5|||
48674855|NCT02927938|156661632|FG002|Overall Study|Early Study Termination|4|||
48674856|NCT02927938|156661633|FG003|Overall Study|Early Study Termination|3|||
48674857|NCT02834247|156661637|FG000|Dose Escalation Phase|Study Terminated by Sponsor|1|||
48674858|NCT02834247|156661638|FG001|Dose Escalation Phase|Study Terminated by Sponsor|2|||
48674859|NCT02834247|156661639|FG002|Dose Escalation Phase|Study Terminated by Sponsor|0|||
48674860|NCT02834247|156661640|FG003|Dose Escalation Phase|Study Terminated by Sponsor|0|||
48674861|NCT02834247|156661637|FG000|Dose Escalation Phase|Death|5|||
48674862|NCT02834247|156661638|FG001|Dose Escalation Phase|Death|6|||
48674863|NCT02834247|156661639|FG002|Dose Escalation Phase|Death|5|||
48674864|NCT02834247|156661640|FG003|Dose Escalation Phase|Death|0|||
48674865|NCT02834247|156661637|FG000|Dose Escalation Phase|Lost to Follow-up|0|||
48674866|NCT02834247|156661638|FG001|Dose Escalation Phase|Lost to Follow-up|1|||
48674867|NCT02834247|156661639|FG002|Dose Escalation Phase|Lost to Follow-up|0|||
48674868|NCT02834247|156661640|FG003|Dose Escalation Phase|Lost to Follow-up|0|||
48674869|NCT02834247|156661637|FG000|Dose Escalation Phase|Withdrawal by Subject|2|||
48674870|NCT02834247|156661638|FG001|Dose Escalation Phase|Withdrawal by Subject|2|||
48674871|NCT02834247|156661639|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
48674872|NCT02834247|156661640|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
48674873|NCT02834247|156661637|FG000|Dose Expansion Phase|Study Terminated by Sponsor|0|||
48674874|NCT02834247|156661638|FG001|Dose Expansion Phase|Study Terminated by Sponsor|0|||
48674875|NCT02834247|156661639|FG002|Dose Expansion Phase|Study Terminated by Sponsor|0|||
48674876|NCT02834247|156661640|FG003|Dose Expansion Phase|Study Terminated by Sponsor|7|||
48674877|NCT02834247|156661637|FG000|Dose Expansion Phase|Death|0|||
48674878|NCT02834247|156661638|FG001|Dose Expansion Phase|Death|0|||
48674879|NCT02834247|156661639|FG002|Dose Expansion Phase|Death|0|||
48674880|NCT02834247|156661640|FG003|Dose Expansion Phase|Death|8|||
48674881|NCT02834247|156661637|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
48674882|NCT02834247|156661638|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
48674883|NCT02834247|156661639|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
48674884|NCT02834247|156661640|FG003|Dose Expansion Phase|Lost to Follow-up|1|||
48674885|NCT02834247|156661637|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
48674886|NCT02834247|156661638|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
48674887|NCT02834247|156661639|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
48674888|NCT02834247|156661640|FG003|Dose Expansion Phase|Withdrawal by Subject|1|||
48674889|NCT01073930|156663364|FG000|Overall Study|Withdrawal by Subject|3|||
48674890|NCT01073930|156663365|FG001|Overall Study|Withdrawal by Subject|2|||
48674891|NCT01073930|156663364|FG000|Overall Study|Lost to Follow-up|0|||
48674892|NCT01073930|156663365|FG001|Overall Study|Lost to Follow-up|1|||
48674893|NCT01073930|156663364|FG000|Overall Study|Adverse Event|0|||
48674894|NCT01073930|156663365|FG001|Overall Study|Adverse Event|1|||
48674895|NCT01073930|156663364|FG000|Overall Study|Noncompliance with study drug|0|||
48674896|NCT01073930|156663365|FG001|Overall Study|Noncompliance with study drug|1|||
48761673|NCT04127786|156975657|FG001|Primary Series|Withdrawal by Subject|0|||
48761674|NCT04127786|156975658|FG002|Primary Series|Withdrawal by Subject|0|||
48761675|NCT04127786|156975659|FG003|Primary Series|Withdrawal by Subject|1|||
48761676|NCT04127786|156975660|FG004|Primary Series|Withdrawal by Subject|0|||
48761677|NCT04127786|156975661|FG005|Primary Series|Withdrawal by Subject|0|||
48761678|NCT04127786|156975656|FG000|Primary Series|Withdrawal by Parent/Guardian|2|||
48761679|NCT04127786|156975657|FG001|Primary Series|Withdrawal by Parent/Guardian|1|||
48761680|NCT04127786|156975658|FG002|Primary Series|Withdrawal by Parent/Guardian|0|||
48761681|NCT04127786|156975659|FG003|Primary Series|Withdrawal by Parent/Guardian|0|||
48761682|NCT04127786|156975660|FG004|Primary Series|Withdrawal by Parent/Guardian|0|||
48761683|NCT04127786|156975661|FG005|Primary Series|Withdrawal by Parent/Guardian|0|||
48761684|NCT04127786|156975656|FG000|Booster Phase|Withdrawal by Subject|2|||
48761685|NCT04127786|156975657|FG001|Booster Phase|Withdrawal by Subject|0|||
48761686|NCT04127786|156975658|FG002|Booster Phase|Withdrawal by Subject|0|||
48761687|NCT04127786|156975659|FG003|Booster Phase|Withdrawal by Subject|0|||
48761688|NCT04127786|156975660|FG004|Booster Phase|Withdrawal by Subject|0|||
48761689|NCT04127786|156975661|FG005|Booster Phase|Withdrawal by Subject|0|||
48761690|NCT02255500|156975662|FG000|Overall Study|Withdrawal by Subject|1|||
48761691|NCT02255500|156975663|FG001|Overall Study|Withdrawal by Subject|0|||
48761692|NCT00460031|156975664|FG000|Overall Study|Adverse Event|5|||
48761693|NCT00460031|156975664|FG000|Overall Study|Withdrawal by Subject|5|||
48761694|NCT00460031|156975664|FG000|Overall Study|Death|1|||
48761695|NCT04254978|156975666|FG000|Initial Treatment Period (ITP)|Withdrawal by Subject|3|||
48761696|NCT04254978|156975666|FG000|Initial Treatment Period (ITP)|Adverse Event|5|||
48761697|NCT04254978|156975666|FG000|Initial Treatment Period (ITP)|Lack of Efficacy|1|||
48761698|NCT04254978|156975666|FG000|Additional Treatment Period (ATP)|Withdrawal by Subject|3|||
48873686|NCT00381797|157375115|FG000|Overall Study|Ineligible|0|||
48873687|NCT00381797|157375116|FG001|Overall Study|Ineligible|0|||
48674897|NCT01073930|156663364|FG000|Overall Study|Inadequate prep; unable to do procedure|0|||
48674898|NCT01073930|156663365|FG001|Overall Study|Inadequate prep; unable to do procedure|1|||
48761699|NCT04254978|156975666|FG000|Additional Treatment Period (ATP)|Physician Decision|1|||
48761700|NCT04254978|156975666|FG000|Additional Treatment Period (ATP)|Adverse Event|7|||
48761701|NCT02520011|156975667|FG000|Overall Study|Adverse Event|0|||
48761702|NCT02520011|156975668|FG001|Overall Study|Adverse Event|1|||
48873688|NCT00381797|157375117|FG002|Overall Study|Ineligible|0|||
48873689|NCT00381797|157375118|FG003|Overall Study|Ineligible|1|||
48674899|NCT01209078|156663366|FG000|Overall Study|Adverse Event|5|||
48674900|NCT01209078|156663367|FG001|Overall Study|Adverse Event|0|||
48873690|NCT00381797|157375119|FG004|Overall Study|Ineligible|0|||
48873691|NCT01222533|157375122|FG000|Overall Study|Adverse Event|5|||
48873692|NCT01222533|157375122|FG000|Overall Study|Withdrawal by Subject|5|||
48873693|NCT01222533|157375122|FG000|Overall Study|Other|4|||
48873694|NCT03418493|157375123|FG000|Overall Study|Adverse Event|1|||
48873695|NCT03418493|157375124|FG001|Overall Study|Adverse Event|0|||
48873696|NCT03418493|157375125|FG002|Overall Study|Adverse Event|0|||
48873697|NCT03418493|157375126|FG003|Overall Study|Adverse Event|0|||
48873698|NCT03418493|157375127|FG004|Overall Study|Adverse Event|0|||
48873699|NCT03418493|157375128|FG005|Overall Study|Adverse Event|0|||
48873700|NCT03418493|157375129|FG006|Overall Study|Adverse Event|0|||
48873701|NCT03418493|157375130|FG007|Overall Study|Adverse Event|0|||
48873702|NCT03418493|157375131|FG008|Overall Study|Adverse Event|0|||
48873703|NCT03418493|157375132|FG009|Overall Study|Adverse Event|0|||
48873704|NCT03418493|157375133|FG010|Overall Study|Adverse Event|0|||
48873705|NCT03418493|157375123|FG000|Overall Study|Protocol Violation|0|||
48873706|NCT03418493|157375124|FG001|Overall Study|Protocol Violation|0|||
48873707|NCT03418493|157375125|FG002|Overall Study|Protocol Violation|0|||
48873708|NCT03418493|157375126|FG003|Overall Study|Protocol Violation|0|||
48873709|NCT03418493|157375127|FG004|Overall Study|Protocol Violation|0|||
48873710|NCT03418493|157375128|FG005|Overall Study|Protocol Violation|0|||
48873711|NCT03418493|157375129|FG006|Overall Study|Protocol Violation|0|||
48873712|NCT03418493|157375130|FG007|Overall Study|Protocol Violation|0|||
48873713|NCT03418493|157375131|FG008|Overall Study|Protocol Violation|0|||
48873714|NCT03418493|157375132|FG009|Overall Study|Protocol Violation|1|||
48873715|NCT03418493|157375133|FG010|Overall Study|Protocol Violation|0|||
48873716|NCT02637856|157375137|FG000|Main Study (Baseline to Week 100)|Adverse Event|9|||
48873717|NCT02637856|157375138|FG001|Main Study (Baseline to Week 100)|Adverse Event|0|||
48873718|NCT02637856|157375137|FG000|Main Study (Baseline to Week 100)|Lost to Follow-up|5|||
48873719|NCT02637856|157375138|FG001|Main Study (Baseline to Week 100)|Lost to Follow-up|0|||
48873720|NCT02637856|157375137|FG000|Main Study (Baseline to Week 100)|Physician Decision|2|||
48873721|NCT02637856|157375138|FG001|Main Study (Baseline to Week 100)|Physician Decision|0|||
48873722|NCT02637856|157375137|FG000|Main Study (Baseline to Week 100)|Pregnancy|7|||
48873723|NCT02637856|157375138|FG001|Main Study (Baseline to Week 100)|Pregnancy|0|||
48873724|NCT02637856|157375137|FG000|Main Study (Baseline to Week 100)|Withdrawal by Subject|20|||
48873725|NCT02637856|157375138|FG001|Main Study (Baseline to Week 100)|Withdrawal by Subject|0|||
48873726|NCT02637856|157375137|FG000|Main Study (Baseline to Week 100)|Protocol Deviation|2|||
48873727|NCT02637856|157375138|FG001|Main Study (Baseline to Week 100)|Protocol Deviation|0|||
48873728|NCT02637856|157375137|FG000|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164|||
48873729|NCT02637856|157375138|FG001|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0|||
48873730|NCT02637856|157375137|FG000|Main Study (Baseline to Week 100)|Failed Drug Test|1|||
48873731|NCT02637856|157375138|FG001|Main Study (Baseline to Week 100)|Failed Drug Test|0|||
48873732|NCT02637856|157375137|FG000|Main Study (Baseline to Week 100)|Incarceration|1|||
48873733|NCT02637856|157375138|FG001|Main Study (Baseline to Week 100)|Incarceration|0|||
48873734|NCT02637856|157375137|FG000|Main Study (Baseline to Week 100)|Pregnancy Attempts|2|||
48873735|NCT02637856|157375138|FG001|Main Study (Baseline to Week 100)|Pregnancy Attempts|0|||
48873736|NCT02637856|157375137|FG000|Main Study (Baseline to Week 100)|Site Closing|6|||
48873737|NCT02637856|157375138|FG001|Main Study (Baseline to Week 100)|Site Closing|0|||
48873738|NCT02637856|157375137|FG000|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0|||
48873739|NCT02637856|157375138|FG001|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1|||
48873740|NCT02637856|157375137|FG000|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0|||
48873741|NCT02637856|157375138|FG001|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3|||
48873742|NCT01057251|157375139|FG000|Overall Study|Did not meet InclusionExclusion criteria|4|||
48873743|NCT01057251|157375140|FG001|Overall Study|Did not meet InclusionExclusion criteria|2|||
48873744|NCT01057251|157375139|FG000|Overall Study|Adverse Event|4|||
48974059|NCT02057068|157735755|FG000|Overall Study|Caregiver (CG) Health|0|||
48974060|NCT02057068|157735756|FG001|Overall Study|Caregiver (CG) Health|2|||
48674901|NCT01209078|156663366|FG000|Overall Study|Lost to Follow-up|4|||
48674902|NCT01209078|156663367|FG001|Overall Study|Lost to Follow-up|0|||
48674903|NCT01209078|156663366|FG000|Overall Study|Physician Decision|5|||
48674904|NCT01209078|156663367|FG001|Overall Study|Physician Decision|2|||
48674905|NCT01209078|156663366|FG000|Overall Study|Withdrawal by Subject|2|||
48674906|NCT01209078|156663367|FG001|Overall Study|Withdrawal by Subject|1|||
48674907|NCT01912339|156663368|FG000|Blinded (0 to 3 Months)|Declined to participate|1|||
48873745|NCT01057251|157375140|FG001|Overall Study|Adverse Event|2|||
48873746|NCT01057251|157375139|FG000|Overall Study|Lack of Efficacy|2|||
48873747|NCT01057251|157375140|FG001|Overall Study|Lack of Efficacy|11|||
48873748|NCT01057251|157375139|FG000|Overall Study|Protocol Violation|6|||
48873749|NCT01057251|157375140|FG001|Overall Study|Protocol Violation|2|||
48873750|NCT01057251|157375139|FG000|Overall Study|Withdrawal by Subject|4|||
48873751|NCT01057251|157375140|FG001|Overall Study|Withdrawal by Subject|5|||
48873752|NCT01057251|157375139|FG000|Overall Study|Lost to Follow-up|7|||
48873753|NCT01057251|157375140|FG001|Overall Study|Lost to Follow-up|6|||
48974061|NCT02057068|157735755|FG000|Overall Study|Carepartner (CP) Health|4|||
48674908|NCT01912339|156663369|FG001|Blinded (0 to 3 Months)|Declined to participate|0|||
48674909|NCT01912339|156663370|FG002|Blinded (0 to 3 Months)|Declined to participate|0|||
48674910|NCT01912339|156663368|FG000|Blinded (0 to 3 Months)|Open Prostatectomy|1|||
48974062|NCT02057068|157735756|FG001|Overall Study|Carepartner (CP) Health|2|||
48974063|NCT02057068|157735755|FG000|Overall Study|Lost to Follow-up|2|||
48674911|NCT01912339|156663369|FG001|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
48974064|NCT02057068|157735756|FG001|Overall Study|Lost to Follow-up|2|||
48974065|NCT04685538|157735757|FG000|Overall Study|Adverse Event|0|||
48974066|NCT04685538|157735758|FG001|Overall Study|Adverse Event|1|||
48974067|NCT04685538|157735757|FG000|Overall Study|Lost to Follow-up|0|||
48974068|NCT04685538|157735758|FG001|Overall Study|Lost to Follow-up|2|||
48974069|NCT02920450|157735759|FG000|Overall Study|Death|1|||
48974070|NCT02920450|157735760|FG001|Overall Study|Death|0|||
48974071|NCT02920450|157735761|FG002|Overall Study|Death|0|||
48974072|NCT02920450|157735762|FG003|Overall Study|Death|0|||
48974073|NCT02920450|157735759|FG000|Overall Study|Withdrawal by Subject|1|||
48974074|NCT02920450|157735760|FG001|Overall Study|Withdrawal by Subject|0|||
48974075|NCT02920450|157735761|FG002|Overall Study|Withdrawal by Subject|0|||
48974076|NCT02920450|157735762|FG003|Overall Study|Withdrawal by Subject|0|||
48974077|NCT01484561|157735763|FG000|Overall Study|Lack of Efficacy|3|||
48974078|NCT01484561|157735764|FG001|Overall Study|Lack of Efficacy|1|||
48974079|NCT01484561|157735763|FG000|Overall Study|Lost to Follow-up|1|||
48974080|NCT01484561|157735764|FG001|Overall Study|Lost to Follow-up|0|||
48974081|NCT01484561|157735763|FG000|Overall Study|Withdrawal by Subject|3|||
48974082|NCT01484561|157735764|FG001|Overall Study|Withdrawal by Subject|0|||
48974083|NCT01484561|157735763|FG000|Overall Study|Other|1|||
48974084|NCT01484561|157735764|FG001|Overall Study|Other|1|||
48974085|NCT01484561|157735763|FG000|Overall Study|Adverse Event|1|||
48674912|NCT01912339|156663370|FG002|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
48674913|NCT01912339|156663368|FG000|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1|||
48674914|NCT01912339|156663369|FG001|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
48974086|NCT01484561|157735764|FG001|Overall Study|Adverse Event|4|||
48974087|NCT00432562|157735765|FG000|Overall Study|Death|3|||
48974088|NCT00432562|157735766|FG001|Overall Study|Death|0|||
48974089|NCT00114218|157735767|FG000|Overall Study|Wrong Cell Type|2|||
48974090|NCT00114218|157735767|FG000|Overall Study|Wrong Primary|1|||
48974091|NCT00114218|157735767|FG000|Overall Study|Never Treated|1|||
48974092|NCT00968708|157735768|FG000|Overall Study|Adverse Event|169|||
48974093|NCT00968708|157735769|FG001|Overall Study|Adverse Event|150|||
48974094|NCT00968708|157735768|FG000|Overall Study|Major Protocol Deviation|0|||
48974095|NCT00968708|157735769|FG001|Overall Study|Major Protocol Deviation|1|||
48974096|NCT00968708|157735768|FG000|Overall Study|Lost to Follow-up|19|||
48974097|NCT00968708|157735769|FG001|Overall Study|Lost to Follow-up|11|||
48974098|NCT00968708|157735768|FG000|Overall Study|Voluntary Withdrawal|104|||
48974099|NCT00968708|157735769|FG001|Overall Study|Voluntary Withdrawal|101|||
48974100|NCT00968708|157735768|FG000|Overall Study|Investigator Discretion|0|||
48974101|NCT00968708|157735769|FG001|Overall Study|Investigator Discretion|1|||
48974102|NCT00968708|157735768|FG000|Overall Study|Other|26|||
48974103|NCT00968708|157735769|FG001|Overall Study|Other|34|||
48674915|NCT01912339|156663370|FG002|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
48674916|NCT01912339|156663368|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5|||
48674917|NCT01912339|156663369|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
48674918|NCT01912339|156663370|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
48674919|NCT01912339|156663368|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5|||
48674920|NCT01912339|156663369|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
48674921|NCT01912339|156663370|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
48674922|NCT01912339|156663368|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1|||
48674923|NCT01912339|156663369|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0|||
48674924|NCT01912339|156663370|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3|||
48674925|NCT01912339|156663368|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1|||
48674926|NCT01912339|156663369|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
48674927|NCT01912339|156663370|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
48674928|NCT01912339|156663368|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1|||
48974104|NCT01981109|157735773|FG000|Overall Study|Death|36|||
48974105|NCT01981109|157735773|FG000|Overall Study|Withdrawal by Subject|40|||
48974106|NCT01981109|157735773|FG000|Overall Study|Lost to Follow-up|9|||
48974107|NCT01981109|157735773|FG000|Overall Study|No Discontinuation Documentation|37|||
48974108|NCT01981109|157735773|FG000|Overall Study|Study Termination|100|||
48974109|NCT01981109|157735773|FG000|Overall Study|No data available|2|||
48974110|NCT03639987|157735781|FG000|Overall Study|Study terminated by sponsor|26|||
48974111|NCT03639987|157735782|FG001|Overall Study|Study terminated by sponsor|25|||
48974112|NCT03639987|157735781|FG000|Overall Study|Lost to Follow-up|0|||
48974113|NCT03639987|157735782|FG001|Overall Study|Lost to Follow-up|1|||
48674929|NCT01912339|156663369|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
48674930|NCT01912339|156663370|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
48974114|NCT00431496|157735785|FG000|Overall Study|Adverse Event|3|||
48974115|NCT00431496|157735785|FG000|Overall Study|Lost to Follow-up|1|||
48974116|NCT00431496|157735785|FG000|Overall Study|Withdrawal by Subject|2|||
48974117|NCT00431496|157735785|FG000|Overall Study|Protocol-specified criteria|5|||
48974118|NCT01079195|157735786|FG000|Overall Study|No Documentation of Tarka Therapy|739|||
48974119|NCT01079195|157735786|FG000|Overall Study|No Documentation Available|437|||
48974120|NCT01079195|157735786|FG000|Overall Study|Adverse Event|157|||
48974121|NCT01079195|157735786|FG000|Overall Study|Reason Unknown|39|||
48974122|NCT01079195|157735786|FG000|Overall Study|Withdrawal by Subject|18|||
48974123|NCT01079195|157735786|FG000|Overall Study|Financial Reasons|15|||
48974124|NCT01079195|157735786|FG000|Overall Study|Lack of Effectiveness|12|||
48974125|NCT01079195|157735786|FG000|Overall Study|Physician Decision|4|||
48974126|NCT01079195|157735786|FG000|Overall Study|Improved Status of Participant|4|||
48974127|NCT01079195|157735786|FG000|Overall Study|No Follow-up Documentation Available|4|||
48974128|NCT01079195|157735786|FG000|Overall Study|Non-compliance|2|||
48974129|NCT01915095|157735787|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
48974130|NCT01915095|157735788|FG001|Overall Study|Some subjects were unable to commit to the training study.|0|||
48974131|NCT01915095|157735789|FG002|Overall Study|Some subjects were unable to commit to the training study.|0|||
48974132|NCT01915095|157735790|FG003|Overall Study|Some subjects were unable to commit to the training study.|4|||
48974133|NCT01915095|157735791|FG004|Overall Study|Some subjects were unable to commit to the training study.|6|||
48974134|NCT00807014|157735792|FG000|Overall Study|Participant Considered Disease Cured|13|||
48974135|NCT00807014|157735793|FG001|Overall Study|Participant Considered Disease Cured|2|||
48974136|NCT00807014|157735792|FG000|Overall Study|Participant Considered Disease Not Cured|2|||
48974137|NCT00807014|157735793|FG001|Overall Study|Participant Considered Disease Not Cured|7|||
48974138|NCT00807014|157735792|FG000|Overall Study|Protocol Violation|2|||
48974139|NCT00807014|157735793|FG001|Overall Study|Protocol Violation|8|||
48974140|NCT00807014|157735792|FG000|Overall Study|Adverse Event|0|||
48974141|NCT00807014|157735793|FG001|Overall Study|Adverse Event|2|||
48974142|NCT00807014|157735792|FG000|Overall Study|Lost to Follow-up|9|||
48974143|NCT00807014|157735793|FG001|Overall Study|Lost to Follow-up|7|||
48974144|NCT00807014|157735792|FG000|Overall Study|Recovery|1|||
48974145|NCT00807014|157735793|FG001|Overall Study|Recovery|0|||
48674931|NCT01912339|156663368|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
48674932|NCT01912339|156663369|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
48674933|NCT01912339|156663370|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1|||
48674934|NCT01912339|156663368|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
48674935|NCT01912339|156663369|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
48674936|NCT01912339|156663370|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1|||
48761703|NCT02520011|156975669|FG002|Overall Study|Adverse Event|2|||
48974146|NCT00807014|157735792|FG000|Overall Study|Missed Visit 2 Due to Personal Reasons|0|||
48974147|NCT00807014|157735793|FG001|Overall Study|Missed Visit 2 Due to Personal Reasons|1|||
48974148|NCT02067533|157735800|FG000|Overall Study|Lost to Follow-up|4|||
48974149|NCT02067533|157735801|FG001|Overall Study|Lost to Follow-up|2|||
48974150|NCT01947894|157735803|FG000|Overall Study|Other|3|||
48974151|NCT01947894|157735804|FG001|Overall Study|Other|4|||
48974152|NCT01947894|157735805|FG002|Overall Study|Other|3|||
48974153|NCT01947894|157735803|FG000|Overall Study|Withdrawal by Subject|12|||
48974154|NCT01947894|157735804|FG001|Overall Study|Withdrawal by Subject|4|||
48974155|NCT01947894|157735805|FG002|Overall Study|Withdrawal by Subject|1|||
48974156|NCT01947894|157735803|FG000|Overall Study|Death|12|||
48974157|NCT01947894|157735804|FG001|Overall Study|Death|1|||
48761704|NCT02520011|156975667|FG000|Overall Study|Death|0|||
48761705|NCT02520011|156975668|FG001|Overall Study|Death|8|||
48761706|NCT02520011|156975669|FG002|Overall Study|Death|1|||
48761707|NCT02520011|156975667|FG000|Overall Study|Lack of Efficacy|4|||
48761708|NCT02520011|156975668|FG001|Overall Study|Lack of Efficacy|26|||
48761709|NCT02520011|156975669|FG002|Overall Study|Lack of Efficacy|4|||
48761710|NCT02520011|156975667|FG000|Overall Study|Physician Decision|0|||
48761711|NCT02520011|156975668|FG001|Overall Study|Physician Decision|2|||
48761712|NCT02520011|156975669|FG002|Overall Study|Physician Decision|0|||
48761713|NCT02520011|156975667|FG000|Overall Study|Withdrawal by Subject|1|||
48761714|NCT02520011|156975668|FG001|Overall Study|Withdrawal by Subject|3|||
48761715|NCT02520011|156975669|FG002|Overall Study|Withdrawal by Subject|0|||
48761716|NCT02520011|156975667|FG000|Overall Study|Protocol Deviation|0|||
48761717|NCT02520011|156975668|FG001|Overall Study|Protocol Deviation|1|||
48974158|NCT01947894|157735805|FG002|Overall Study|Death|0|||
48974159|NCT01947894|157735803|FG000|Overall Study|Physician Decision|2|||
48974160|NCT01947894|157735804|FG001|Overall Study|Physician Decision|0|||
48974161|NCT01947894|157735805|FG002|Overall Study|Physician Decision|0|||
48974162|NCT01947894|157735803|FG000|Overall Study|Adverse Event|5|||
48974163|NCT01947894|157735804|FG001|Overall Study|Adverse Event|1|||
48674937|NCT01912339|156663368|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
48761718|NCT02520011|156975669|FG002|Overall Study|Protocol Deviation|0|||
48761719|NCT02520011|156975667|FG000|Overall Study|Patient went to hospice|0|||
48761720|NCT02520011|156975668|FG001|Overall Study|Patient went to hospice|1|||
48974164|NCT01947894|157735805|FG002|Overall Study|Adverse Event|0|||
48761721|NCT02520011|156975669|FG002|Overall Study|Patient went to hospice|0|||
48761722|NCT02520011|156975667|FG000|Overall Study|Progressive disease following response|0|||
48761723|NCT02520011|156975668|FG001|Overall Study|Progressive disease following response|4|||
48761724|NCT02520011|156975669|FG002|Overall Study|Progressive disease following response|2|||
48761725|NCT02066467|156975671|FG000|Overall Study|Did not undergo implant procedure|24|||
48761726|NCT02066467|156975671|FG000|Overall Study|Attempted to implant withoput success|43|||
48761727|NCT02066467|156975671|FG000|Overall Study|Consent ineligible|1|||
48761728|NCT02066467|156975671|FG000|Overall Study|Death|54|||
48761729|NCT02066467|156975671|FG000|Overall Study|Lost to Follow-up|51|||
48761730|NCT02066467|156975671|FG000|Overall Study|Adverse Event|20|||
48761731|NCT02066467|156975671|FG000|Overall Study|Withdrawal by Subject|16|||
48761732|NCT02066467|156975671|FG000|Overall Study|Physician Decision|2|||
48761733|NCT02066467|156975671|FG000|Overall Study|Not defined|4|||
48761734|NCT00491387|156975673|FG000|Overall Study|study terminated|20|||
48761735|NCT04267133|156975674|FG000|Overall Study|Withdrawal by Subject|1|||
48761736|NCT04267133|156975674|FG000|Overall Study|Adverse Event|4|||
48761737|NCT02419742|156975677|FG000|Overall Study|Adverse Event|2|||
48761738|NCT02419742|156975678|FG001|Overall Study|Adverse Event|0|||
48761739|NCT02419742|156975677|FG000|Overall Study|Disease Progression|0|||
48761740|NCT02419742|156975678|FG001|Overall Study|Disease Progression|1|||
48761741|NCT02419742|156975677|FG000|Overall Study|Withdrew Consent|2|||
48674938|NCT01912339|156663369|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
48674939|NCT01912339|156663370|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1|||
48674940|NCT01912339|156663368|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
48674941|NCT01912339|156663369|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
48674942|NCT01912339|156663370|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1|||
48674943|NCT01912339|156663368|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120|||
48674944|NCT01912339|156663369|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0|||
48674945|NCT01912339|156663370|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46|||
48674946|NCT03221842|156663375|FG000|Period 1 (Open-label)|Adverse Event|4|||
48674947|NCT03221842|156663376|FG001|Period 1 (Open-label)|Adverse Event|0|||
48674948|NCT03221842|156663375|FG000|Period 1 (Open-label)|Physician Decision|2|||
48674949|NCT03221842|156663376|FG001|Period 1 (Open-label)|Physician Decision|0|||
48674950|NCT03221842|156663375|FG000|Period 1 (Open-label)|Lost to Follow-up|1|||
48674951|NCT03221842|156663376|FG001|Period 1 (Open-label)|Lost to Follow-up|0|||
48674952|NCT03221842|156663375|FG000|Period 1 (Open-label)|Terminated by sponsor|1|||
48674953|NCT03221842|156663376|FG001|Period 1 (Open-label)|Terminated by sponsor|0|||
48761742|NCT02419742|156975678|FG001|Overall Study|Withdrew Consent|1|||
48761743|NCT02419742|156975677|FG000|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|1|||
48761744|NCT02419742|156975678|FG001|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|0|||
48761745|NCT01514760|156975682|FG000|Overall Study|Lost to Follow-up|2|||
48761746|NCT02574247|156975683|FG000|Overall Study|Withdrawal by Subject|1|||
48761747|NCT02574247|156975684|FG001|Overall Study|Withdrawal by Subject|0|||
48761748|NCT02574247|156975685|FG002|Overall Study|Withdrawal by Subject|0|||
48761749|NCT02574247|156975683|FG000|Overall Study|Did not meet inclusion criteria|4|||
48761750|NCT02574247|156975684|FG001|Overall Study|Did not meet inclusion criteria|3|||
48761751|NCT02574247|156975685|FG002|Overall Study|Did not meet inclusion criteria|5|||
48761752|NCT02420691|156975687|FG000|Overall Study|Adverse Event|3|||
48761753|NCT02420691|156975687|FG000|Overall Study|Withdrawal by Subject|3|||
48761754|NCT00003901|156975688|FG000|Overall Study|Adverse Event|1|||
48761755|NCT00003901|156975688|FG000|Overall Study|Withdrawal by Subject|1|||
48761756|NCT00003901|156975688|FG000|Overall Study|Ineligible|6|||
48761757|NCT00003901|156975688|FG000|Overall Study|CT Scan not within protocol requirement|2|||
48761758|NCT00003901|156975688|FG000|Overall Study|Chest X-Ray not done prior registration|1|||
48761759|NCT00003901|156975688|FG000|Overall Study|Medical problems|6|||
48761760|NCT02503332|156975689|FG000|Overall Study|Adverse Event|17|||
48761761|NCT02503332|156975690|FG001|Overall Study|Adverse Event|5|||
48761762|NCT02503332|156975691|FG002|Overall Study|Adverse Event|3|||
48761763|NCT02503332|156975692|FG003|Overall Study|Adverse Event|1|||
48761764|NCT02503332|156975689|FG000|Overall Study|Investigator's Decision|5|||
48761765|NCT02503332|156975690|FG001|Overall Study|Investigator's Decision|1|||
48974165|NCT01947894|157735803|FG000|Overall Study|Switched to other growth hormone brand|53|||
48974166|NCT01947894|157735804|FG001|Overall Study|Switched to other growth hormone brand|8|||
48974167|NCT01947894|157735805|FG002|Overall Study|Switched to other growth hormone brand|23|||
48974168|NCT01302691|157735818|FG000|Overall Study|Adverse Event|2|||
48761766|NCT02503332|156975691|FG002|Overall Study|Investigator's Decision|0|||
48761767|NCT02503332|156975692|FG003|Overall Study|Investigator's Decision|0|||
48761768|NCT02503332|156975689|FG000|Overall Study|Sponsor's Decision|1|||
48761769|NCT02503332|156975690|FG001|Overall Study|Sponsor's Decision|0|||
48761770|NCT02503332|156975691|FG002|Overall Study|Sponsor's Decision|0|||
48974169|NCT01302691|157735819|FG001|Overall Study|Adverse Event|0|||
48761771|NCT02503332|156975692|FG003|Overall Study|Sponsor's Decision|1|||
48761772|NCT02503332|156975689|FG000|Overall Study|Subject Request|6|||
48974170|NCT01302691|157735818|FG000|Overall Study|Death|0|||
48974171|NCT01302691|157735819|FG001|Overall Study|Death|1|||
48974172|NCT01302691|157735818|FG000|Overall Study|Lost to Follow-up|1|||
48974173|NCT01302691|157735819|FG001|Overall Study|Lost to Follow-up|0|||
48974174|NCT01302691|157735818|FG000|Overall Study|Blood Pressure/Potassium Criteria Met|6|||
48974175|NCT01302691|157735819|FG001|Overall Study|Blood Pressure/Potassium Criteria Met|4|||
48974176|NCT01302691|157735818|FG000|Overall Study|Physician Decision|0|||
48974177|NCT01302691|157735819|FG001|Overall Study|Physician Decision|1|||
48974178|NCT01302691|157735818|FG000|Overall Study|Protocol Violation|1|||
48974179|NCT01302691|157735819|FG001|Overall Study|Protocol Violation|0|||
48974180|NCT00643448|157735820|FG000|Overall Study|Lack of Efficacy|2|||
48974181|NCT00643448|157735821|FG001|Overall Study|Lack of Efficacy|0|||
48974182|NCT00643448|157735822|FG002|Overall Study|Lack of Efficacy|4|||
48974183|NCT00643448|157735820|FG000|Overall Study|Adverse Event|2|||
48974184|NCT00643448|157735821|FG001|Overall Study|Adverse Event|2|||
48974185|NCT00643448|157735822|FG002|Overall Study|Adverse Event|2|||
48974186|NCT00643448|157735820|FG000|Overall Study|QTcF>550 ms|0|||
48974187|NCT00643448|157735821|FG001|Overall Study|QTcF>550 ms|3|||
48974188|NCT00643448|157735822|FG002|Overall Study|QTcF>550 ms|0|||
48974189|NCT03693404|157735823|FG000|Overall Study|Withdrawal by Subject|1|||
48974190|NCT03693404|157735824|FG001|Overall Study|Withdrawal by Subject|0|||
48974191|NCT03693404|157735823|FG000|Overall Study|Lost to Follow-up|0|||
48974192|NCT03693404|157735824|FG001|Overall Study|Lost to Follow-up|5|||
48974193|NCT03693404|157735823|FG000|Overall Study|Excluded from Analysis|0|||
48974194|NCT03693404|157735824|FG001|Overall Study|Excluded from Analysis|1|||
48974195|NCT02079519|157735825|FG000|Overall Study|Disease Progression|9|||
48974196|NCT02079519|157735825|FG000|Overall Study|Adverse Event|1|||
48974197|NCT02566109|157735826|FG000|Overall Study|Withdrawal by Subject|1|||
48974198|NCT03209362|157735827|FG000|Overall Study|Adverse Event|0|||
48974199|NCT03209362|157735828|FG001|Overall Study|Adverse Event|1|||
48974200|NCT03209362|157735827|FG000|Overall Study|Lost to Follow-up|0|||
48974201|NCT03209362|157735828|FG001|Overall Study|Lost to Follow-up|1|||
48974202|NCT03209362|157735827|FG000|Overall Study|Withdrawal by Subject|2|||
48974203|NCT03209362|157735828|FG001|Overall Study|Withdrawal by Subject|0|||
48974204|NCT03209362|157735827|FG000|Overall Study|Other|0|||
48974205|NCT03209362|157735828|FG001|Overall Study|Other|1|||
48974206|NCT00422669|157735829|FG000|Overall Study|The study was terminated early.|98|||
48974207|NCT00422669|157735830|FG001|Overall Study|The study was terminated early.|100|||
48974208|NCT00422669|157735831|FG002|Overall Study|The study was terminated early.|7|||
48974209|NCT02517268|157735834|FG000|Overall Study|Withdrawal by Subject|1|||
48974210|NCT02517268|157735835|FG001|Overall Study|Withdrawal by Subject|0|||
48974211|NCT00064077|157735836|FG000|Overall Study|Improper prior treatment|1|||
48974212|NCT00064077|157735837|FG001|Overall Study|Improper prior treatment|0|||
48974213|NCT00064077|157735838|FG002|Overall Study|Improper prior treatment|0|||
48974214|NCT00064077|157735839|FG003|Overall Study|Improper prior treatment|0|||
48974215|NCT00064077|157735836|FG000|Overall Study|Poor risk|2|||
48974216|NCT00064077|157735837|FG001|Overall Study|Poor risk|0|||
48974217|NCT00064077|157735838|FG002|Overall Study|Poor risk|1|||
48974218|NCT00064077|157735839|FG003|Overall Study|Poor risk|1|||
48674954|NCT03221842|156663375|FG000|Period 1 (Open-label)|Other|2|||
48674955|NCT03221842|156663376|FG001|Period 1 (Open-label)|Other|0|||
48674956|NCT03221842|156663375|FG000|Period 2 (Randomized, Blinded)|Death|0|||
48674957|NCT03221842|156663376|FG001|Period 2 (Randomized, Blinded)|Death|1|||
48674958|NCT03221842|156663375|FG000|Period 2 (Randomized, Blinded)|Lack of Efficacy|1|||
48674959|NCT03221842|156663376|FG001|Period 2 (Randomized, Blinded)|Lack of Efficacy|0|||
48674960|NCT01286077|156663377|FG000|Overall Study|Adverse Event|2|||
48674961|NCT01286077|156663378|FG001|Overall Study|Adverse Event|0|||
48674962|NCT01286077|156663377|FG000|Overall Study|Death|1|||
48674963|NCT01286077|156663378|FG001|Overall Study|Death|0|||
48674964|NCT01286077|156663377|FG000|Overall Study|Protocol Violation|1|||
48674965|NCT01286077|156663378|FG001|Overall Study|Protocol Violation|1|||
48674966|NCT01286077|156663377|FG000|Overall Study|Withdrawal by Subject|0|||
48674967|NCT01286077|156663378|FG001|Overall Study|Withdrawal by Subject|2|||
48974219|NCT00064077|157735836|FG000|Overall Study|Pathology|10|||
48974220|NCT00064077|157735837|FG001|Overall Study|Pathology|7|||
48974221|NCT00064077|157735838|FG002|Overall Study|Pathology|3|||
48974222|NCT00064077|157735839|FG003|Overall Study|Pathology|4|||
48974223|NCT00064077|157735836|FG000|Overall Study|No surgery|0|||
48974224|NCT00064077|157735837|FG001|Overall Study|No surgery|0|||
48974225|NCT00064077|157735838|FG002|Overall Study|No surgery|1|||
48974226|NCT00064077|157735839|FG003|Overall Study|No surgery|0|||
48974227|NCT00064077|157735836|FG000|Overall Study|No tumor|0|||
48674968|NCT01286077|156663377|FG000|Overall Study|Intercurrent illness|1|||
48674969|NCT01286077|156663378|FG001|Overall Study|Intercurrent illness|0|||
48674970|NCT01286077|156663377|FG000|Overall Study|Non-compliance|1|||
48674971|NCT01286077|156663378|FG001|Overall Study|Non-compliance|0|||
48974228|NCT00064077|157735837|FG001|Overall Study|No tumor|0|||
48974229|NCT00064077|157735838|FG002|Overall Study|No tumor|1|||
48974230|NCT00064077|157735839|FG003|Overall Study|No tumor|0|||
48974231|NCT00064077|157735836|FG000|Overall Study|Other reasons|2|||
48974232|NCT00064077|157735837|FG001|Overall Study|Other reasons|2|||
48974233|NCT00064077|157735838|FG002|Overall Study|Other reasons|1|||
48974234|NCT00064077|157735839|FG003|Overall Study|Other reasons|2|||
48974235|NCT03446612|157735841|FG000|Overall Study|Protocol defined stopping criteria|0|||
48974236|NCT03446612|157735842|FG001|Overall Study|Protocol defined stopping criteria|1|||
48974237|NCT01448707|157735845|FG000|Overall Study|Adverse Event|3|||
48974238|NCT01448707|157735846|FG001|Overall Study|Adverse Event|1|||
48974239|NCT01448707|157735845|FG000|Overall Study|Lost to Follow-up|2|||
48974240|NCT01448707|157735846|FG001|Overall Study|Lost to Follow-up|6|||
48674972|NCT01286077|156663377|FG000|Overall Study|The subject starts with alternative MMY|0|||
48873754|NCT01057251|157375139|FG000|Overall Study|Other Reason|1|||
48873755|NCT01057251|157375140|FG001|Overall Study|Other Reason|1|||
48873756|NCT04544865|157375141|FG000|Overall Study|Death|0|||
48873757|NCT04544865|157375142|FG001|Overall Study|Death|2|||
48873758|NCT04544865|157375141|FG000|Overall Study|Lost to Follow-up|11|||
48873759|NCT04544865|157375142|FG001|Overall Study|Lost to Follow-up|7|||
48873760|NCT04544865|157375141|FG000|Overall Study|Withdrawal by Subject|0|||
48873761|NCT04544865|157375142|FG001|Overall Study|Withdrawal by Subject|1|||
48873762|NCT04544865|157375141|FG000|Overall Study|Other|0|||
48873763|NCT04544865|157375142|FG001|Overall Study|Other|1|||
48873764|NCT00988533|157375143|FG000|Overall Study|Lost to Follow-up|3|||
48873765|NCT01772823|157375146|FG000|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1|||
48873766|NCT01772823|157375147|FG001|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0|||
48873767|NCT01772823|157375146|FG000|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
48873768|NCT01772823|157375147|FG001|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
48873769|NCT01772823|157375146|FG000|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1|||
48873770|NCT01772823|157375147|FG001|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0|||
48873771|NCT01772823|157375146|FG000|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2|||
48873772|NCT01772823|157375147|FG001|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1|||
48873773|NCT01772823|157375146|FG000|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6|||
48873774|NCT01772823|157375147|FG001|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0|||
48873775|NCT01772823|157375146|FG000|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1|||
48873776|NCT01772823|157375147|FG001|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0|||
48873777|NCT01772823|157375146|FG000|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15|||
48873778|NCT01772823|157375147|FG001|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13|||
48873779|NCT01772823|157375146|FG000|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6|||
48873780|NCT01772823|157375147|FG001|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1|||
48873781|NCT01772823|157375146|FG000|Treatment Phase (Week 0- Week 48)|Moved out of area|4|||
48873782|NCT01772823|157375147|FG001|Treatment Phase (Week 0- Week 48)|Moved out of area|3|||
48873783|NCT01772823|157375146|FG000|Treatment Phase (Week 0- Week 48)|Incarcerated|1|||
48873784|NCT01772823|157375147|FG001|Treatment Phase (Week 0- Week 48)|Incarcerated|0|||
48873785|NCT01772823|157375146|FG000|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1|||
48873786|NCT01772823|157375147|FG001|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0|||
48873787|NCT01772823|157375146|FG000|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
48873788|NCT01772823|157375147|FG001|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
48873789|NCT01772823|157375146|FG000|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6|||
48873790|NCT01772823|157375147|FG001|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5|||
48873791|NCT01772823|157375146|FG000|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1|||
48873792|NCT01772823|157375147|FG001|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2|||
48873793|NCT01772823|157375146|FG000|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
48873794|NCT01772823|157375147|FG001|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
48873795|NCT01772823|157375146|FG000|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1|||
48873796|NCT01772823|157375147|FG001|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0|||
48873797|NCT00611715|157375152|FG000|Overall Study|Disease Progression|24|||
48873798|NCT00611715|157375153|FG001|Overall Study|Disease Progression|4|||
48873799|NCT00611715|157375152|FG000|Overall Study|Withdrawal by Subject|5|||
48873800|NCT00611715|157375153|FG001|Overall Study|Withdrawal by Subject|1|||
48873801|NCT00611715|157375152|FG000|Overall Study|Adverse Event|9|||
48873802|NCT00611715|157375153|FG001|Overall Study|Adverse Event|1|||
48873803|NCT00611715|157375152|FG000|Overall Study|Death|1|||
48873804|NCT00611715|157375153|FG001|Overall Study|Death|0|||
48873805|NCT00611715|157375152|FG000|Overall Study|two patients are still on treatment|2|||
48873806|NCT00611715|157375153|FG001|Overall Study|two patients are still on treatment|0|||
48873807|NCT02669407|157375154|FG000|Overall Study|Physician Decision|3|||
48873808|NCT00727415|157375155|FG000|Phase I|Dose Limiting Toxicity|2|||
48873809|NCT02647788|157375157|FG000|Overall Study|Lost to Follow-up|13|||
48873810|NCT02647788|157375158|FG001|Overall Study|Lost to Follow-up|11|||
48873811|NCT02647788|157375157|FG000|Overall Study|Did not want opiate|0|||
48974241|NCT01448707|157735845|FG000|Overall Study|Withdrawal by Subject|6|||
48974242|NCT01448707|157735846|FG001|Overall Study|Withdrawal by Subject|7|||
48974243|NCT01448707|157735845|FG000|Overall Study|Other|7|||
48974244|NCT01448707|157735846|FG001|Overall Study|Other|4|||
48974245|NCT00653328|157735848|FG000|Overall Study|Withdrawal by Subject|1|||
48974246|NCT00653328|157735848|FG000|Overall Study|Adverse Event|2|||
48974247|NCT00653328|157735848|FG000|Overall Study|Disease progression|10|||
48974248|NCT00653328|157735848|FG000|Overall Study|Drug manufacturer no longing making drug|2|||
48974249|NCT01809197|157735855|FG000|Overall Study|Lost to Follow-up|4|||
48974250|NCT01809197|157735856|FG001|Overall Study|Lost to Follow-up|2|||
48974251|NCT01809197|157735855|FG000|Overall Study|Adverse Event|2|||
48974252|NCT01809197|157735856|FG001|Overall Study|Adverse Event|3|||
48974253|NCT01809197|157735855|FG000|Overall Study|Failed slit lamp exam|1|||
48974254|NCT01809197|157735856|FG001|Overall Study|Failed slit lamp exam|0|||
48974255|NCT01809197|157735855|FG000|Overall Study|Non-Compliance|1|||
48974256|NCT01809197|157735856|FG001|Overall Study|Non-Compliance|1|||
48974257|NCT01809197|157735855|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
48974258|NCT01809197|157735856|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
48974259|NCT01809197|157735855|FG000|Overall Study|Withdrawal by Subject|1|||
48974260|NCT01809197|157735856|FG001|Overall Study|Withdrawal by Subject|1|||
48974261|NCT01809197|157735855|FG000|Overall Study|Product not available|0|||
48974262|NCT01809197|157735856|FG001|Overall Study|Product not available|1|||
48974263|NCT04968353|157735857|FG000|Overall Study|Non-compliance|1|||
48974264|NCT04968353|157735858|FG001|Overall Study|Non-compliance|0|||
48974265|NCT04968353|157735859|FG002|Overall Study|Non-compliance|2|||
48974266|NCT04968353|157735860|FG003|Overall Study|Non-compliance|0|||
48974267|NCT00255034|157737965|FG000|Overall Study|Withdrawal by Subject|15|||
48974268|NCT00255034|157737966|FG001|Overall Study|Withdrawal by Subject|38|||
48974269|NCT03788967|157737967|FG000|Overall Study|Lost to Follow-up|14|||
48974270|NCT03788967|157737968|FG001|Overall Study|Lost to Follow-up|10|||
48974271|NCT03788967|157737967|FG000|Overall Study|Participant Non-Compliance/Uncooperativeness|3|||
48974272|NCT03788967|157737968|FG001|Overall Study|Participant Non-Compliance/Uncooperativeness|6|||
48974273|NCT03788967|157737967|FG000|Overall Study|Participant Withdrawal of Consent|13|||
48974274|NCT03788967|157737968|FG001|Overall Study|Participant Withdrawal of Consent|5|||
48974275|NCT03788967|157737967|FG000|Overall Study|Adverse Event|1|||
48974276|NCT03788967|157737968|FG001|Overall Study|Adverse Event|1|||
48974277|NCT03788967|157737967|FG000|Overall Study|COVID-19|1|||
48974278|NCT03788967|157737968|FG001|Overall Study|COVID-19|2|||
48974279|NCT01412151|157737972|FG000|Week 0 - 306 - Treatment Period|Death|1|||
48974280|NCT01412151|157737972|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1|||
48974281|NCT01412151|157737972|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3|||
48761773|NCT02503332|156975690|FG001|Overall Study|Subject Request|5|||
48873812|NCT02647788|157375158|FG001|Overall Study|Did not want opiate|1|||
48873813|NCT02647788|157375157|FG000|Overall Study|Withdrawal by Subject|1|||
48873814|NCT02647788|157375158|FG001|Overall Study|Withdrawal by Subject|0|||
48873815|NCT02647788|157375157|FG000|Overall Study|Felt itchy with assigned medication|1|||
48873816|NCT02647788|157375158|FG001|Overall Study|Felt itchy with assigned medication|0|||
48873817|NCT02647788|157375157|FG000|Overall Study|Felt nauseous with assigned medication|1|||
48873818|NCT02647788|157375158|FG001|Overall Study|Felt nauseous with assigned medication|1|||
48873819|NCT01657877|157375159|FG000|Overall Study|Withdrawal by Subject|4|||
48873820|NCT01657877|157375159|FG000|Overall Study|Protocol Violation|6|||
48873821|NCT01657877|157375159|FG000|Overall Study|Adverse Event|2|||
48873822|NCT01657877|157375159|FG000|Overall Study|Other Reason|2|||
48873823|NCT05043883|157375162|FG000|Overall Study|Minimum required measurements could not be taken|4|||
48873824|NCT00644878|157375163|FG000|Overall Study|Adverse Event|2|||
48873825|NCT00644878|157375163|FG000|Overall Study|Abnormal laboratory value|3|||
48873826|NCT00644878|157375163|FG000|Overall Study|Protocol deviation|2|||
48873827|NCT00644878|157375163|FG000|Overall Study|Treatment duration completed as per protocol|11|||
48873828|NCT01278615|157375166|FG000|Overall Study|Withdrawal by Subject|2|||
48873829|NCT00905359|157375167|FG000|Overall Study|Lost to Follow-up|17|||
48873830|NCT00905359|157375168|FG001|Overall Study|Lost to Follow-up|10|||
48873831|NCT00905359|157375167|FG000|Overall Study|Death|2|||
48873832|NCT00905359|157375168|FG001|Overall Study|Death|0|||
48873833|NCT00905359|157375167|FG000|Overall Study|Withdrawal consent|5|||
48873834|NCT00905359|157375168|FG001|Overall Study|Withdrawal consent|6|||
48873835|NCT00338949|157375169|FG000|Subject Screening|Screen failures|11|||
48873836|NCT00338949|157375170|FG001|Subject Screening|Screen failures|11|||
48974282|NCT01412151|157737972|FG000|Week 306 - 310 - Washout Period|Withdrawal by Subject|2|||
48974283|NCT02687711|157737973|FG000|Overall Study|Adverse Event|89|||
48974284|NCT02687711|157737973|FG000|Overall Study|Lack of Efficacy|70|||
48974285|NCT02687711|157737973|FG000|Overall Study|Lost to Follow-up|20|||
48974286|NCT02687711|157737973|FG000|Overall Study|Consent withdrawn|15|||
48974287|NCT02687711|157737973|FG000|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1|||
48974288|NCT02687711|157737973|FG000|Overall Study|Too expensive|4|||
48974289|NCT02687711|157737973|FG000|Overall Study|Participant moved abroad|1|||
48674973|NCT01286077|156663378|FG001|Overall Study|The subject starts with alternative MMY|3|||
48674974|NCT01286077|156663377|FG000|Overall Study|Patient's decision to stop treatment|3|||
48674975|NCT01286077|156663378|FG001|Overall Study|Patient's decision to stop treatment|0|||
48674976|NCT01286077|156663377|FG000|Overall Study|Progression of disease|0|||
48674977|NCT01286077|156663378|FG001|Overall Study|Progression of disease|1|||
48674978|NCT01286077|156663377|FG000|Overall Study|refill medication not received in time|1|||
48674979|NCT01286077|156663378|FG001|Overall Study|refill medication not received in time|0|||
48674980|NCT00434642|156663379|FG000|Blinded Treatment Phase|Adverse Event|12|||
48674981|NCT00434642|156663380|FG001|Blinded Treatment Phase|Adverse Event|58|||
48674982|NCT00434642|156663379|FG000|Blinded Treatment Phase|Clinical Disease Progression|4|||
48674983|NCT00434642|156663380|FG001|Blinded Treatment Phase|Clinical Disease Progression|5|||
48674984|NCT00434642|156663379|FG000|Blinded Treatment Phase|Disease Progression Per RECIST|168|||
48674985|NCT00434642|156663380|FG001|Blinded Treatment Phase|Disease Progression Per RECIST|109|||
48674986|NCT00434642|156663379|FG000|Blinded Treatment Phase|Physician Decision|19|||
48674987|NCT00434642|156663380|FG001|Blinded Treatment Phase|Physician Decision|27|||
48674988|NCT00434642|156663379|FG000|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3|||
48761774|NCT02503332|156975691|FG002|Overall Study|Subject Request|2|||
48761775|NCT02503332|156975692|FG003|Overall Study|Subject Request|1|||
48974290|NCT02687711|157737973|FG000|Overall Study|Progression of other medical condition (dementia, pneumonia)|1|||
48974291|NCT02687711|157737973|FG000|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1|||
48974292|NCT02687711|157737973|FG000|Overall Study|Disliked taste|1|||
48974293|NCT02687711|157737973|FG000|Overall Study|Low mood|1|||
48974294|NCT02687711|157737973|FG000|Overall Study|Side effects|1|||
48974295|NCT02687711|157737973|FG000|Overall Study|Change of Hospital|1|||
48974296|NCT02687711|157737973|FG000|Overall Study|Liver Encephalopathy|1|||
48974297|NCT02687711|157737973|FG000|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1|||
48974298|NCT02687711|157737973|FG000|Overall Study|Withdrawn due to intake interruption|1|||
48974299|NCT02687711|157737973|FG000|Overall Study|Stopped in preparation for epilepsy surgery|1|||
48974300|NCT02687711|157737973|FG000|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1|||
48974301|NCT02687711|157737973|FG000|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1|||
48974302|NCT03621189|157737974|FG000|Overall Study|Withdrawal by Subject|0|||
48974303|NCT03621189|157737975|FG001|Overall Study|Withdrawal by Subject|3|||
48974304|NCT03621189|157737974|FG000|Overall Study|Physician Decision|0|||
48974305|NCT03621189|157737975|FG001|Overall Study|Physician Decision|2|||
48974306|NCT02215616|157737976|FG000|Overall Study|Sponsor requested to stop study drug|0|||
48974307|NCT02215616|157737977|FG001|Overall Study|Sponsor requested to stop study drug|0|||
48974308|NCT02215616|157737978|FG002|Overall Study|Sponsor requested to stop study drug|1|||
48974309|NCT02215616|157737979|FG003|Overall Study|Sponsor requested to stop study drug|4|||
48974310|NCT02215616|157737976|FG000|Overall Study|Death|1|||
48974311|NCT02215616|157737977|FG001|Overall Study|Death|0|||
48974312|NCT02215616|157737978|FG002|Overall Study|Death|0|||
48974313|NCT02215616|157737979|FG003|Overall Study|Death|0|||
48974314|NCT02215616|157737976|FG000|Overall Study|Adverse Event|7|||
48974315|NCT02215616|157737977|FG001|Overall Study|Adverse Event|4|||
48974316|NCT02215616|157737978|FG002|Overall Study|Adverse Event|9|||
48974317|NCT02215616|157737979|FG003|Overall Study|Adverse Event|2|||
48974318|NCT02215616|157737976|FG000|Overall Study|Withdrawal by Subject|1|||
48974319|NCT02215616|157737977|FG001|Overall Study|Withdrawal by Subject|8|||
48974320|NCT02215616|157737978|FG002|Overall Study|Withdrawal by Subject|2|||
48974321|NCT02215616|157737979|FG003|Overall Study|Withdrawal by Subject|5|||
48974322|NCT02215616|157737976|FG000|Overall Study|Non-compliance|0|||
48974323|NCT02215616|157737977|FG001|Overall Study|Non-compliance|2|||
48974324|NCT02215616|157737978|FG002|Overall Study|Non-compliance|1|||
48974325|NCT02215616|157737979|FG003|Overall Study|Non-compliance|0|||
48974326|NCT02215616|157737976|FG000|Overall Study|Protocol Violation|0|||
48974327|NCT02215616|157737977|FG001|Overall Study|Protocol Violation|2|||
48974328|NCT02215616|157737978|FG002|Overall Study|Protocol Violation|0|||
48974329|NCT02215616|157737979|FG003|Overall Study|Protocol Violation|0|||
48974330|NCT02215616|157737976|FG000|Overall Study|Lost to Follow-up|1|||
48974331|NCT02215616|157737977|FG001|Overall Study|Lost to Follow-up|1|||
48974332|NCT02215616|157737978|FG002|Overall Study|Lost to Follow-up|0|||
48974333|NCT02215616|157737979|FG003|Overall Study|Lost to Follow-up|1|||
48974334|NCT02215616|157737976|FG000|Overall Study|Other than specified|1|||
48974335|NCT02215616|157737977|FG001|Overall Study|Other than specified|0|||
48974336|NCT02215616|157737978|FG002|Overall Study|Other than specified|1|||
48974337|NCT02215616|157737979|FG003|Overall Study|Other than specified|1|||
48974338|NCT04847141|157737980|FG000|Overall Study|Adverse Event|1|||
48974339|NCT04847141|157737981|FG001|Overall Study|Adverse Event|0|||
48974340|NCT04847141|157737982|FG002|Overall Study|Adverse Event|1|||
48974341|NCT04847141|157737980|FG000|Overall Study|Withdrawal by Subject|2|||
48974342|NCT04847141|157737981|FG001|Overall Study|Withdrawal by Subject|4|||
48974343|NCT04847141|157737982|FG002|Overall Study|Withdrawal by Subject|3|||
48761776|NCT02503332|156975689|FG000|Overall Study|Death|0|||
48974344|NCT04847141|157737980|FG000|Overall Study|Lost to Follow-up|7|||
48974345|NCT04847141|157737981|FG001|Overall Study|Lost to Follow-up|5|||
48974346|NCT04847141|157737982|FG002|Overall Study|Lost to Follow-up|7|||
48974347|NCT04847141|157737980|FG000|Overall Study|Reason not Specified|0|||
48974348|NCT04847141|157737981|FG001|Overall Study|Reason not Specified|1|||
48974349|NCT04847141|157737982|FG002|Overall Study|Reason not Specified|0|||
48974350|NCT01634113|157737983|FG000|Overall Study|Not treated|0|||
48674989|NCT00434642|156663380|FG001|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0|||
48974351|NCT01634113|157737984|FG001|Overall Study|Not treated|0|||
48974352|NCT01634113|157737985|FG002|Overall Study|Not treated|1|||
48974353|NCT02848313|157737988|FG000|Overall Study|Adverse Event|1|||
48974354|NCT02848313|157737989|FG001|Overall Study|Adverse Event|2|||
48974355|NCT02848313|157737988|FG000|Overall Study|Lack of Efficacy|0|||
48974356|NCT02848313|157737989|FG001|Overall Study|Lack of Efficacy|1|||
48974357|NCT02848313|157737988|FG000|Overall Study|Withdrawal by Subject|1|||
48974358|NCT02848313|157737989|FG001|Overall Study|Withdrawal by Subject|1|||
48974359|NCT02848313|157737988|FG000|Overall Study|Lost to follow up|1|||
48974360|NCT02848313|157737989|FG001|Overall Study|Lost to follow up|0|||
48974361|NCT00212758|157737992|FG000|Standard Therapy of GH (12 Months)|Adverse Event|1|||
48974362|NCT00212758|157737993|FG001|Standard Therapy of GH (12 Months)|Adverse Event|0|||
48974363|NCT00212758|157737992|FG000|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
48974364|NCT00212758|157737993|FG001|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
48974365|NCT02707601|157737994|FG000|Overall Study|Death|0|||
48974366|NCT02707601|157737995|FG001|Overall Study|Death|1|||
48974367|NCT02707601|157737994|FG000|Overall Study|Lack of Efficacy|0|||
48974368|NCT02707601|157737995|FG001|Overall Study|Lack of Efficacy|1|||
48974369|NCT02707601|157737994|FG000|Overall Study|Investigator's Discretion|1|||
48974370|NCT02707601|157737995|FG001|Overall Study|Investigator's Discretion|0|||
48974371|NCT02707601|157737994|FG000|Overall Study|Withdrew Consent|0|||
48974372|NCT02707601|157737995|FG001|Overall Study|Withdrew Consent|1|||
48974373|NCT02707601|157737994|FG000|Overall Study|Lost to Follow-up|1|||
48974374|NCT02707601|157737995|FG001|Overall Study|Lost to Follow-up|1|||
48974375|NCT02707601|157737994|FG000|Overall Study|Participants Randomized but Not Treated|2|||
48974376|NCT02707601|157737995|FG001|Overall Study|Participants Randomized but Not Treated|0|||
48974377|NCT00666536|157737996|FG000|Overall Study|Adverse Event|9|||
48974378|NCT00666536|157737997|FG001|Overall Study|Adverse Event|19|||
48974379|NCT00666536|157737996|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
48974380|NCT00666536|157737997|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
48974381|NCT00666536|157737996|FG000|Overall Study|Protocol deviation(s)|8|||
48974382|NCT00666536|157737997|FG001|Overall Study|Protocol deviation(s)|6|||
48974383|NCT00666536|157737996|FG000|Overall Study|Withdrawal by Subject|10|||
48974384|NCT00666536|157737997|FG001|Overall Study|Withdrawal by Subject|9|||
48974385|NCT00666536|157737996|FG000|Overall Study|Lost to Follow-up|4|||
48974386|NCT00666536|157737997|FG001|Overall Study|Lost to Follow-up|3|||
48974387|NCT01415908|157737998|FG000|Overall Study|Withdrawal by Subject|1|||
48974388|NCT01415908|157737999|FG001|Overall Study|Withdrawal by Subject|0|||
48974389|NCT01527110|157738000|FG000|Overall Study|Adverse Event|1|||
48974390|NCT01387074|157738001|FG000|Overall Study|Lost to Follow-up|7|||
48974391|NCT01387074|157738001|FG000|Overall Study|Lack of Efficacy|1|||
48974392|NCT01224106|157738002|FG000|Double-Blind Treatment Phase|Death|3|||
48974393|NCT01224106|157738003|FG001|Double-Blind Treatment Phase|Death|0|||
48974394|NCT01224106|157738004|FG002|Double-Blind Treatment Phase|Death|0|||
48974395|NCT01224106|157738005|FG003|Double-Blind Treatment Phase|Death|0|||
48974396|NCT01224106|157738006|FG004|Double-Blind Treatment Phase|Death|0|||
48974397|NCT01224106|157738002|FG000|Double-Blind Treatment Phase|Physician Decision|6|||
48974398|NCT01224106|157738003|FG001|Double-Blind Treatment Phase|Physician Decision|5|||
48974399|NCT01224106|157738004|FG002|Double-Blind Treatment Phase|Physician Decision|4|||
48974400|NCT01224106|157738005|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
48974401|NCT01224106|157738006|FG004|Double-Blind Treatment Phase|Physician Decision|0|||
48974402|NCT01224106|157738002|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
48974403|NCT01224106|157738003|FG001|Double-Blind Treatment Phase|Adverse Event|5|||
48974404|NCT01224106|157738004|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
48674990|NCT00434642|156663379|FG000|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32|||
48674991|NCT00434642|156663380|FG001|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29|||
48674992|NCT00434642|156663379|FG000|Blinded Treatment Phase|Did not Receive Treatment|4|||
48674993|NCT00434642|156663380|FG001|Blinded Treatment Phase|Did not Receive Treatment|1|||
48674994|NCT00434642|156663379|FG000|Open-label Treatment Phase|Adverse Event|0|||
48974405|NCT01224106|157738005|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
48974406|NCT01224106|157738006|FG004|Double-Blind Treatment Phase|Adverse Event|0|||
48974407|NCT01224106|157738002|FG000|Double-Blind Treatment Phase|Other|0|||
48974408|NCT01224106|157738003|FG001|Double-Blind Treatment Phase|Other|0|||
48974409|NCT01224106|157738004|FG002|Double-Blind Treatment Phase|Other|1|||
48974410|NCT01224106|157738005|FG003|Double-Blind Treatment Phase|Other|0|||
48974411|NCT01224106|157738006|FG004|Double-Blind Treatment Phase|Other|0|||
48974412|NCT01224106|157738002|FG000|Double-Blind Treatment Phase|Participant/legal guardian decision|7|||
48974413|NCT01224106|157738003|FG001|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
48974414|NCT01224106|157738004|FG002|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
48974415|NCT01224106|157738005|FG003|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
48974416|NCT01224106|157738006|FG004|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
48974417|NCT01224106|157738002|FG000|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|62|||
48974418|NCT01224106|157738003|FG001|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|68|||
48974419|NCT01224106|157738004|FG002|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|63|||
48974420|NCT01224106|157738005|FG003|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
48974421|NCT01224106|157738006|FG004|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
48974422|NCT01224106|157738002|FG000|Double-Blind Treatment Phase|Lost to Follow-up|1|||
48974423|NCT01224106|157738003|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
48974424|NCT01224106|157738004|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
48974425|NCT01224106|157738005|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
48974426|NCT01224106|157738006|FG004|Double-Blind Treatment Phase|Lost to Follow-up|0|||
48974427|NCT01224106|157738002|FG000|Open-Label Extension (OLE) Phase|Death|0|||
48974428|NCT01224106|157738003|FG001|Open-Label Extension (OLE) Phase|Death|0|||
48974429|NCT01224106|157738004|FG002|Open-Label Extension (OLE) Phase|Death|0|||
48974430|NCT01224106|157738005|FG003|Open-Label Extension (OLE) Phase|Death|1|||
48974431|NCT01224106|157738006|FG004|Open-Label Extension (OLE) Phase|Death|3|||
48974432|NCT01224106|157738002|FG000|Open-Label Extension (OLE) Phase|Adverse Event|0|||
48974433|NCT01224106|157738003|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
48974434|NCT01224106|157738004|FG002|Open-Label Extension (OLE) Phase|Adverse Event|0|||
48974435|NCT01224106|157738005|FG003|Open-Label Extension (OLE) Phase|Adverse Event|2|||
48974436|NCT01224106|157738006|FG004|Open-Label Extension (OLE) Phase|Adverse Event|6|||
48974437|NCT01224106|157738002|FG000|Open-Label Extension (OLE) Phase|Physician Decision|0|||
48974438|NCT01224106|157738003|FG001|Open-Label Extension (OLE) Phase|Physician Decision|0|||
48974439|NCT01224106|157738004|FG002|Open-Label Extension (OLE) Phase|Physician Decision|0|||
48974440|NCT01224106|157738005|FG003|Open-Label Extension (OLE) Phase|Physician Decision|2|||
48974441|NCT01224106|157738006|FG004|Open-Label Extension (OLE) Phase|Physician Decision|7|||
48974442|NCT01224106|157738002|FG000|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
48674995|NCT00434642|156663380|FG001|Open-label Treatment Phase|Adverse Event|5|||
48674996|NCT00434642|156663379|FG000|Open-label Treatment Phase|Disease Progression Per RECIST|0|||
48674997|NCT00434642|156663380|FG001|Open-label Treatment Phase|Disease Progression Per RECIST|6|||
48974443|NCT01224106|157738003|FG001|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
48974444|NCT01224106|157738004|FG002|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
48974445|NCT01224106|157738005|FG003|Open-Label Extension (OLE) Phase|Withdrawal by Subject|6|||
48974446|NCT01224106|157738006|FG004|Open-Label Extension (OLE) Phase|Withdrawal by Subject|15|||
48974447|NCT01224106|157738002|FG000|Open-Label Extension (OLE) Phase|Other|0|||
48974448|NCT01224106|157738003|FG001|Open-Label Extension (OLE) Phase|Other|0|||
48974449|NCT01224106|157738004|FG002|Open-Label Extension (OLE) Phase|Other|0|||
48974450|NCT01224106|157738005|FG003|Open-Label Extension (OLE) Phase|Other|5|||
48974451|NCT01224106|157738006|FG004|Open-Label Extension (OLE) Phase|Other|3|||
48974452|NCT01156363|157738007|FG000|Overall Study|Adverse Event|6|||
48974453|NCT01156363|157738007|FG000|Overall Study|Insufficient Therapeutic Response|5|||
48974454|NCT01156363|157738007|FG000|Overall Study|Failure to Return|1|||
48974455|NCT01156363|157738007|FG000|Overall Study|Refused Treatment|4|||
48974456|NCT01156363|157738007|FG000|Overall Study|Other|6|||
48974457|NCT02773368|157738008|FG000|Overall Study|Lost to Follow-up|4|||
48974458|NCT02773368|157738009|FG001|Overall Study|Lost to Follow-up|1|||
48974459|NCT02773368|157738008|FG000|Overall Study|Withdrawal by Subject|5|||
48974460|NCT02773368|157738009|FG001|Overall Study|Withdrawal by Subject|1|||
48974461|NCT02773368|157738008|FG000|Overall Study|Unclassified|1|||
48974462|NCT02773368|157738009|FG001|Overall Study|Unclassified|1|||
48974463|NCT02773368|157738008|FG000|Overall Study|Missing|0|||
48974464|NCT02773368|157738009|FG001|Overall Study|Missing|1|||
48974465|NCT02255760|157738013|FG000|Overall Study|Lost to Follow-up|0|||
48974466|NCT02255760|157738014|FG001|Overall Study|Lost to Follow-up|1|||
48974467|NCT02255760|157738015|FG002|Overall Study|Lost to Follow-up|0|||
48974468|NCT02255760|157738016|FG003|Overall Study|Lost to Follow-up|0|||
48974469|NCT02255760|157738017|FG004|Overall Study|Lost to Follow-up|0|||
48974470|NCT00618813|157738018|FG000|Overall Study|Lack of Efficacy|1|||
48974471|NCT00618813|157738018|FG000|Overall Study|Physician Decision|2|||
48974472|NCT00618813|157738018|FG000|Overall Study|Withdrawal by Subject|1|||
48674998|NCT00527982|156663381|FG000|Overall Study|Physician Decision|1|||
48974473|NCT01194414|157738019|FG000|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11|||
48674999|NCT00527982|156663382|FG001|Overall Study|Physician Decision|0|||
48675000|NCT04541628|156663391|FG000|Overall Study|Study Terminated|1|||
48675001|NCT04541628|156663392|FG001|Overall Study|Study Terminated|1|||
48675002|NCT04541628|156663393|FG002|Overall Study|Study Terminated|1|||
48675003|NCT01192412|156663394|FG000|Overall Study|Lost to Follow-up|2|||
48675004|NCT01192412|156663395|FG001|Overall Study|Lost to Follow-up|1|||
48675005|NCT01192412|156663394|FG000|Overall Study|Withdrawal by Subject|2|||
48974474|NCT01194414|157738020|FG001|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8|||
48974475|NCT01194414|157738021|FG002|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
48974476|NCT01194414|157738022|FG003|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
48974477|NCT01194414|157738019|FG000|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9|||
48974478|NCT01194414|157738020|FG001|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5|||
48974479|NCT01194414|157738021|FG002|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
48974480|NCT01194414|157738022|FG003|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
48974481|NCT01194414|157738019|FG000|24 Weeks Double Blind Period|Protocol Violation|5|||
48974482|NCT01194414|157738020|FG001|24 Weeks Double Blind Period|Protocol Violation|3|||
48974483|NCT01194414|157738021|FG002|24 Weeks Double Blind Period|Protocol Violation|0|||
48974484|NCT01194414|157738022|FG003|24 Weeks Double Blind Period|Protocol Violation|0|||
48974485|NCT01194414|157738019|FG000|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
48974486|NCT01194414|157738020|FG001|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5|||
48974487|NCT01194414|157738021|FG002|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
48974488|NCT01194414|157738022|FG003|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
48974489|NCT01194414|157738019|FG000|24 Weeks Double Blind Period|Pregnancy|2|||
48974490|NCT01194414|157738020|FG001|24 Weeks Double Blind Period|Pregnancy|2|||
48974491|NCT01194414|157738021|FG002|24 Weeks Double Blind Period|Pregnancy|0|||
48974492|NCT01194414|157738022|FG003|24 Weeks Double Blind Period|Pregnancy|0|||
48974493|NCT01194414|157738019|FG000|24 Weeks Double Blind Period|Lost to Follow-up|2|||
48675006|NCT01192412|156663395|FG001|Overall Study|Withdrawal by Subject|1|||
48675007|NCT02421588|156663398|FG000|Overall Study|Non-treatment-related AE|8|||
48675008|NCT02421588|156663399|FG001|Overall Study|Non-treatment-related AE|8|||
48675009|NCT02421588|156663398|FG000|Overall Study|Progressive disease|152|||
48675010|NCT02421588|156663399|FG001|Overall Study|Progressive disease|135|||
48675011|NCT02421588|156663398|FG000|Overall Study|Death|11|||
48675012|NCT02421588|156663399|FG001|Overall Study|Death|3|||
48675013|NCT02421588|156663398|FG000|Overall Study|Physician Decision|8|||
48675014|NCT02421588|156663399|FG001|Overall Study|Physician Decision|17|||
48675015|NCT02421588|156663398|FG000|Overall Study|Other reason not specified|3|||
48974494|NCT01194414|157738020|FG001|24 Weeks Double Blind Period|Lost to Follow-up|1|||
48974495|NCT01194414|157738021|FG002|24 Weeks Double Blind Period|Lost to Follow-up|0|||
48974496|NCT01194414|157738022|FG003|24 Weeks Double Blind Period|Lost to Follow-up|0|||
48974497|NCT01194414|157738019|FG000|24 Weeks Double Blind Period|Other|0|||
48974498|NCT01194414|157738020|FG001|24 Weeks Double Blind Period|Other|1|||
48974499|NCT01194414|157738021|FG002|24 Weeks Double Blind Period|Other|0|||
48974500|NCT01194414|157738022|FG003|24 Weeks Double Blind Period|Other|0|||
48974501|NCT01194414|157738019|FG000|24 Weeks Double Blind Period|Adverse Event|28|||
48974502|NCT01194414|157738020|FG001|24 Weeks Double Blind Period|Adverse Event|40|||
48974503|NCT01194414|157738021|FG002|24 Weeks Double Blind Period|Adverse Event|0|||
48974504|NCT01194414|157738022|FG003|24 Weeks Double Blind Period|Adverse Event|0|||
48974505|NCT01194414|157738019|FG000|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2|||
48974506|NCT01194414|157738020|FG001|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1|||
48974507|NCT01194414|157738021|FG002|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
48974508|NCT01194414|157738022|FG003|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
48974509|NCT01194414|157738019|FG000|24 Weeks Double Blind Period|Death|0|||
48974510|NCT01194414|157738020|FG001|24 Weeks Double Blind Period|Death|1|||
48974511|NCT01194414|157738021|FG002|24 Weeks Double Blind Period|Death|0|||
48974512|NCT01194414|157738022|FG003|24 Weeks Double Blind Period|Death|0|||
48974513|NCT01194414|157738019|FG000|72 Weeks Open Label Extension|Randomized but not Treated|3|||
48974514|NCT01194414|157738020|FG001|72 Weeks Open Label Extension|Randomized but not Treated|5|||
48974515|NCT01194414|157738021|FG002|72 Weeks Open Label Extension|Randomized but not Treated|0|||
48974516|NCT01194414|157738022|FG003|72 Weeks Open Label Extension|Randomized but not Treated|0|||
48974517|NCT01194414|157738019|FG000|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20|||
48974518|NCT01194414|157738020|FG001|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14|||
48974519|NCT01194414|157738021|FG002|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1|||
48974520|NCT01194414|157738022|FG003|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6|||
48974521|NCT01194414|157738019|FG000|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9|||
48974522|NCT01194414|157738020|FG001|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11|||
48974523|NCT01194414|157738021|FG002|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2|||
48974524|NCT01194414|157738022|FG003|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3|||
48974525|NCT01194414|157738019|FG000|72 Weeks Open Label Extension|Lost to Follow-up|4|||
48974526|NCT01194414|157738020|FG001|72 Weeks Open Label Extension|Lost to Follow-up|3|||
48974527|NCT01194414|157738021|FG002|72 Weeks Open Label Extension|Lost to Follow-up|2|||
48974528|NCT01194414|157738022|FG003|72 Weeks Open Label Extension|Lost to Follow-up|1|||
48974529|NCT01194414|157738019|FG000|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3|||
48675016|NCT02421588|156663399|FG001|Overall Study|Other reason not specified|1|||
48675017|NCT02421588|156663398|FG000|Overall Study|Symptomatic deterioration|13|||
48761777|NCT02503332|156975690|FG001|Overall Study|Death|2|||
48761778|NCT02503332|156975691|FG002|Overall Study|Death|2|||
48974530|NCT01194414|157738020|FG001|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5|||
48974531|NCT01194414|157738021|FG002|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
48974532|NCT01194414|157738022|FG003|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
48974533|NCT01194414|157738019|FG000|72 Weeks Open Label Extension|Pregnancy|1|||
48974534|NCT01194414|157738020|FG001|72 Weeks Open Label Extension|Pregnancy|3|||
48974535|NCT01194414|157738021|FG002|72 Weeks Open Label Extension|Pregnancy|1|||
48974536|NCT01194414|157738022|FG003|72 Weeks Open Label Extension|Pregnancy|1|||
48974537|NCT01194414|157738019|FG000|72 Weeks Open Label Extension|Other|2|||
48974538|NCT01194414|157738020|FG001|72 Weeks Open Label Extension|Other|1|||
48974539|NCT01194414|157738021|FG002|72 Weeks Open Label Extension|Other|0|||
48974540|NCT01194414|157738022|FG003|72 Weeks Open Label Extension|Other|0|||
48974541|NCT01194414|157738019|FG000|72 Weeks Open Label Extension|Protocol Violation|0|||
48974542|NCT01194414|157738020|FG001|72 Weeks Open Label Extension|Protocol Violation|0|||
48974543|NCT01194414|157738021|FG002|72 Weeks Open Label Extension|Protocol Violation|0|||
48974544|NCT01194414|157738022|FG003|72 Weeks Open Label Extension|Protocol Violation|1|||
48974545|NCT01194414|157738019|FG000|72 Weeks Open Label Extension|Adverse Event|35|||
48974546|NCT01194414|157738020|FG001|72 Weeks Open Label Extension|Adverse Event|21|||
48675018|NCT02421588|156663399|FG001|Overall Study|Symptomatic deterioration|19|||
48675019|NCT02421588|156663398|FG000|Overall Study|Treatment-related AE|10|||
48675020|NCT02421588|156663399|FG001|Overall Study|Treatment-related AE|14|||
48675021|NCT02421588|156663398|FG000|Overall Study|Withdrawal by Subject|14|||
48675022|NCT02421588|156663399|FG001|Overall Study|Withdrawal by Subject|16|||
48675023|NCT02421588|156663398|FG000|Overall Study|Not treated|2|||
48675024|NCT02421588|156663399|FG001|Overall Study|Not treated|8|||
48675025|NCT00296140|156663400|FG000|Overall Study|Lost to Follow-up|1|||
48675026|NCT00296140|156663401|FG001|Overall Study|Lost to Follow-up|0|||
48675027|NCT00296140|156663400|FG000|Overall Study|Withdrawal by Subject|1|||
48675028|NCT00296140|156663401|FG001|Overall Study|Withdrawal by Subject|0|||
48675029|NCT00296140|156663400|FG000|Overall Study|Discharge to Nursing Home|1|||
48675030|NCT00296140|156663401|FG001|Overall Study|Discharge to Nursing Home|0|||
48675031|NCT04369950|156663402|FG000|Overall Study|Protocol Violation|2|||
48675032|NCT04369950|156663403|FG001|Overall Study|Protocol Violation|2|||
48675033|NCT00773747|156663404|FG000|Overall Study|Lack of Efficacy|112|||
48675034|NCT00773747|156663405|FG001|Overall Study|Lack of Efficacy|144|||
48675035|NCT00773747|156663404|FG000|Overall Study|Physician Decision|26|||
48675036|NCT00773747|156663405|FG001|Overall Study|Physician Decision|18|||
48675037|NCT00773747|156663404|FG000|Overall Study|Lost to Follow-up|0|||
48675038|NCT00773747|156663405|FG001|Overall Study|Lost to Follow-up|1|||
48675039|NCT00773747|156663404|FG000|Overall Study|Protocol Violation|2|||
48675040|NCT00773747|156663405|FG001|Overall Study|Protocol Violation|2|||
48675041|NCT00773747|156663404|FG000|Overall Study|Withdrawal by Subject|89|||
48675042|NCT00773747|156663405|FG001|Overall Study|Withdrawal by Subject|61|||
48675043|NCT00773747|156663404|FG000|Overall Study|Adverse Event|61|||
48675044|NCT00773747|156663405|FG001|Overall Study|Adverse Event|62|||
48675045|NCT00773747|156663404|FG000|Overall Study|Death|5|||
48675046|NCT00773747|156663405|FG001|Overall Study|Death|8|||
48675047|NCT00773747|156663404|FG000|Overall Study|Not Treated|2|||
48675048|NCT00773747|156663405|FG001|Overall Study|Not Treated|0|||
48675049|NCT02540668|156663406|FG000|Period 2 - LY3314814 and Warfarin|Physician Decision|0|||
48675050|NCT02540668|156663407|FG001|Period 2 - LY3314814 and Warfarin|Physician Decision|1|||
48675051|NCT03270891|156663408|FG000|Overall Study|Lost to Follow-up|3|||
48675052|NCT03270891|156663409|FG001|Overall Study|Lost to Follow-up|6|||
48675053|NCT03270891|156663410|FG002|Overall Study|Lost to Follow-up|0|||
48675054|NCT03270891|156663408|FG000|Overall Study|Withdrawal by Subject|1|||
48675055|NCT03270891|156663409|FG001|Overall Study|Withdrawal by Subject|0|||
48761779|NCT02503332|156975692|FG003|Overall Study|Death|0|||
48974547|NCT01194414|157738021|FG002|72 Weeks Open Label Extension|Adverse Event|2|||
48974548|NCT01194414|157738022|FG003|72 Weeks Open Label Extension|Adverse Event|12|||
48974549|NCT01194414|157738019|FG000|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
48974550|NCT01194414|157738020|FG001|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
48974551|NCT01194414|157738021|FG002|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
49015503|NCT01393990|157893781|FG011|Overall Study|Withdrawal by Subject|0|||
48675056|NCT03270891|156663410|FG002|Overall Study|Withdrawal by Subject|0|||
48675057|NCT03270891|156663408|FG000|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
48675058|NCT03270891|156663409|FG001|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
48675059|NCT03270891|156663410|FG002|Overall Study|For Physician arm only; those physicians who did not have patients who participated|7|||
48675060|NCT04302545|156663411|FG000|Overall Study|Lost to Follow-up|3|||
48675061|NCT04302545|156663412|FG001|Overall Study|Lost to Follow-up|4|||
48675062|NCT02516592|156663415|FG000|Overall Study|Patient withdrew consent|5|||
48675063|NCT02516592|156663416|FG001|Overall Study|Patient withdrew consent|2|||
48675064|NCT02516592|156663415|FG000|Overall Study|Protocol deviation|4|||
48761780|NCT02503332|156975689|FG000|Overall Study|Other|5|||
48675065|NCT02516592|156663416|FG001|Overall Study|Protocol deviation|4|||
48675066|NCT02516592|156663415|FG000|Overall Study|Lost to Follow-up|2|||
48675067|NCT02516592|156663416|FG001|Overall Study|Lost to Follow-up|3|||
48675068|NCT02516592|156663415|FG000|Overall Study|Patient/guardian decision|2|||
48675069|NCT02516592|156663416|FG001|Overall Study|Patient/guardian decision|1|||
48675070|NCT02516592|156663415|FG000|Overall Study|Adverse Event|1|||
48675071|NCT02516592|156663416|FG001|Overall Study|Adverse Event|2|||
48675072|NCT02516592|156663415|FG000|Overall Study|Abnormal test procedure result|1|||
48761781|NCT02503332|156975690|FG001|Overall Study|Other|6|||
48761782|NCT02503332|156975691|FG002|Overall Study|Other|1|||
48761783|NCT02503332|156975692|FG003|Overall Study|Other|1|||
48761784|NCT02424383|156975693|FG000|Overall Study|Withdrawal by Subject|32|||
48761785|NCT02424383|156975693|FG000|Overall Study|Death|170|||
48761786|NCT02424383|156975693|FG000|Overall Study|Sponsor's decision|3|||
48974552|NCT01194414|157738022|FG003|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
48974553|NCT01194414|157738019|FG000|72 Weeks Open Label Extension|Death|1|||
48974554|NCT01194414|157738020|FG001|72 Weeks Open Label Extension|Death|2|||
48974555|NCT01194414|157738021|FG002|72 Weeks Open Label Extension|Death|0|||
48974556|NCT01194414|157738022|FG003|72 Weeks Open Label Extension|Death|2|||
48974557|NCT01112982|157738037|FG000|Overall Study|Withdrawal by Subject|1|||
48974558|NCT01112982|157738037|FG000|Overall Study|exceeded weight limit to complete MRI|1|||
48974559|NCT00291187|157738038|FG000|Overall Study|Protocol Violation- No Drug Administered|0|||
48974560|NCT00291187|157738039|FG001|Overall Study|Protocol Violation- No Drug Administered|0|||
48974561|NCT00291187|157738040|FG002|Overall Study|Protocol Violation- No Drug Administered|1|||
48974562|NCT00291187|157738041|FG003|Overall Study|Protocol Violation- No Drug Administered|0|||
48974563|NCT02260388|157738042|FG000|Overall Study|Lost to Follow-up|2|||
48974564|NCT02260388|157738043|FG001|Overall Study|Lost to Follow-up|8|||
48974565|NCT02260388|157738044|FG002|Overall Study|Lost to Follow-up|3|||
48974566|NCT02260388|157738045|FG003|Overall Study|Lost to Follow-up|4|||
48974567|NCT04445688|157738046|FG000|Washout (One Week)|Adverse Event|2|||
48974568|NCT04445688|157738046|FG000|Washout (One Week)|Withdrawal by Subject|1|||
48974569|NCT02266004|157738047|FG000|Overall Study|unrelated adverse event|1|||
48974570|NCT02266004|157738047|FG000|Overall Study|Physician Decision|1|||
48974571|NCT00126672|157738049|FG000|Overall Study|Adverse Event|4|||
48974572|NCT00126672|157738049|FG000|Overall Study|Lost to Follow-up|4|||
48974573|NCT02076334|157738054|FG000|Overall Study|Protocol Violation|1|||
48974574|NCT02076334|157738055|FG001|Overall Study|Protocol Violation|0|||
48974575|NCT02076334|157738056|FG002|Overall Study|Protocol Violation|0|||
48974576|NCT02076334|157738057|FG003|Overall Study|Protocol Violation|0|||
48974577|NCT02076334|157738054|FG000|Overall Study|Lost to Follow-up|0|||
48974578|NCT02076334|157738055|FG001|Overall Study|Lost to Follow-up|1|||
48974579|NCT02076334|157738056|FG002|Overall Study|Lost to Follow-up|1|||
48974580|NCT02076334|157738057|FG003|Overall Study|Lost to Follow-up|0|||
48974581|NCT02076334|157738054|FG000|Overall Study|muscle soreness|0|||
48974582|NCT02076334|157738055|FG001|Overall Study|muscle soreness|0|||
48974583|NCT02076334|157738056|FG002|Overall Study|muscle soreness|0|||
48974584|NCT02076334|157738057|FG003|Overall Study|muscle soreness|1|||
48974585|NCT04153929|157738058|FG000|Overall Study|Other than listed|2|||
48974586|NCT04153929|157738059|FG001|Overall Study|Other than listed|2|||
48974587|NCT04153929|157738060|FG002|Overall Study|Other than listed|0|||
48974588|NCT04153929|157738061|FG003|Overall Study|Other than listed|1|||
48974589|NCT04153929|157738062|FG004|Overall Study|Other than listed|0|||
48974590|NCT04153929|157738063|FG005|Overall Study|Other than listed|2|||
48974591|NCT04153929|157738064|FG006|Overall Study|Other than listed|2|||
48974592|NCT04153929|157738065|FG007|Overall Study|Other than listed|1|||
48974593|NCT04153929|157738058|FG000|Overall Study|Lost to Follow-up|2|||
48974594|NCT04153929|157738059|FG001|Overall Study|Lost to Follow-up|1|||
48974595|NCT04153929|157738060|FG002|Overall Study|Lost to Follow-up|0|||
48974596|NCT04153929|157738061|FG003|Overall Study|Lost to Follow-up|1|||
48974597|NCT04153929|157738062|FG004|Overall Study|Lost to Follow-up|1|||
48974598|NCT04153929|157738063|FG005|Overall Study|Lost to Follow-up|0|||
48974599|NCT04153929|157738064|FG006|Overall Study|Lost to Follow-up|0|||
48974600|NCT04153929|157738065|FG007|Overall Study|Lost to Follow-up|0|||
48974601|NCT04153929|157738058|FG000|Overall Study|Withdrawal by Subject|3|||
48974602|NCT04153929|157738059|FG001|Overall Study|Withdrawal by Subject|1|||
48974603|NCT04153929|157738060|FG002|Overall Study|Withdrawal by Subject|0|||
48974604|NCT04153929|157738061|FG003|Overall Study|Withdrawal by Subject|3|||
48974605|NCT04153929|157738062|FG004|Overall Study|Withdrawal by Subject|1|||
48974606|NCT04153929|157738063|FG005|Overall Study|Withdrawal by Subject|0|||
48974607|NCT04153929|157738064|FG006|Overall Study|Withdrawal by Subject|1|||
48974608|NCT04153929|157738065|FG007|Overall Study|Withdrawal by Subject|0|||
48974609|NCT04153929|157738058|FG000|Overall Study|Protocol Violation|0|||
48974610|NCT04153929|157738059|FG001|Overall Study|Protocol Violation|0|||
48974611|NCT04153929|157738060|FG002|Overall Study|Protocol Violation|0|||
48675073|NCT02516592|156663416|FG001|Overall Study|Abnormal test procedure result|0|||
48675074|NCT02516592|156663415|FG000|Overall Study|Death|1|||
48761787|NCT02424383|156975693|FG000|Overall Study|Investigator's decision|44|||
48761788|NCT02424383|156975693|FG000|Overall Study|Lost to Follow-up|81|||
48675075|NCT02516592|156663416|FG001|Overall Study|Death|1|||
48675076|NCT00098306|156663417|FG000|Double Blind|Randomized, not treated|9|||
48675077|NCT00098306|156663418|FG001|Double Blind|Randomized, not treated|5|||
48675078|NCT00098306|156663419|FG002|Double Blind|Randomized, not treated|2|||
48675079|NCT00098306|156663420|FG003|Double Blind|Randomized, not treated|0|||
48675080|NCT00098306|156663421|FG004|Double Blind|Randomized, not treated|0|||
48675081|NCT00098306|156663422|FG005|Double Blind|Randomized, not treated|0|||
48675082|NCT00098306|156663423|FG006|Double Blind|Randomized, not treated|0|||
48675083|NCT00098306|156663417|FG000|Double Blind|Ongoing at cut-off date|151|||
48675084|NCT00098306|156663418|FG001|Double Blind|Ongoing at cut-off date|166|||
48675085|NCT00098306|156663419|FG002|Double Blind|Ongoing at cut-off date|72|||
48675086|NCT00098306|156663420|FG003|Double Blind|Ongoing at cut-off date|0|||
48675087|NCT00098306|156663421|FG004|Double Blind|Ongoing at cut-off date|0|||
48675088|NCT00098306|156663422|FG005|Double Blind|Ongoing at cut-off date|0|||
48761789|NCT02424383|156975693|FG000|Overall Study|Other|7|||
48761790|NCT02424383|156975693|FG000|Overall Study|Ineligible for Major Protocol Deviation|39|||
48761791|NCT02625090|156975706|FG000|Overall Study|Participant wants to be pregnant|2|||
48974612|NCT04153929|157738061|FG003|Overall Study|Protocol Violation|0|||
48974613|NCT04153929|157738062|FG004|Overall Study|Protocol Violation|0|||
48974614|NCT04153929|157738063|FG005|Overall Study|Protocol Violation|0|||
48974615|NCT04153929|157738064|FG006|Overall Study|Protocol Violation|1|||
48675089|NCT00098306|156663423|FG006|Double Blind|Ongoing at cut-off date|0|||
48675090|NCT00098306|156663417|FG000|Double Blind|Adverse Event|11|||
48675091|NCT00098306|156663418|FG001|Double Blind|Adverse Event|10|||
48675092|NCT00098306|156663419|FG002|Double Blind|Adverse Event|6|||
48675093|NCT00098306|156663420|FG003|Double Blind|Adverse Event|0|||
48675094|NCT00098306|156663421|FG004|Double Blind|Adverse Event|0|||
48675095|NCT00098306|156663422|FG005|Double Blind|Adverse Event|0|||
48675096|NCT00098306|156663423|FG006|Double Blind|Adverse Event|0|||
48974616|NCT04153929|157738065|FG007|Overall Study|Protocol Violation|2|||
48974617|NCT04153929|157738058|FG000|Overall Study|Adverse Event|3|||
48974618|NCT04153929|157738059|FG001|Overall Study|Adverse Event|5|||
48974619|NCT04153929|157738060|FG002|Overall Study|Adverse Event|5|||
48974620|NCT04153929|157738061|FG003|Overall Study|Adverse Event|11|||
48974621|NCT04153929|157738062|FG004|Overall Study|Adverse Event|15|||
48974622|NCT04153929|157738063|FG005|Overall Study|Adverse Event|4|||
48974623|NCT04153929|157738064|FG006|Overall Study|Adverse Event|8|||
48974624|NCT04153929|157738065|FG007|Overall Study|Adverse Event|2|||
48974625|NCT04153929|157738058|FG000|Overall Study|Not treated|1|||
48974626|NCT04153929|157738059|FG001|Overall Study|Not treated|0|||
48974627|NCT04153929|157738060|FG002|Overall Study|Not treated|0|||
48974628|NCT04153929|157738061|FG003|Overall Study|Not treated|0|||
48974629|NCT04153929|157738062|FG004|Overall Study|Not treated|0|||
48974630|NCT04153929|157738063|FG005|Overall Study|Not treated|0|||
48974631|NCT04153929|157738064|FG006|Overall Study|Not treated|1|||
48974632|NCT04153929|157738065|FG007|Overall Study|Not treated|0|||
48974633|NCT00753623|157738066|FG000|Phase I (14 Days)|Withdrawal by Subject|1|||
48974634|NCT00753623|157738067|FG001|Phase I (14 Days)|Withdrawal by Subject|1|||
48974635|NCT00753623|157738066|FG000|Phase I (14 Days)|Physician Decision|1|||
48974636|NCT00753623|157738067|FG001|Phase I (14 Days)|Physician Decision|2|||
48974637|NCT00753623|157738066|FG000|Phase I (14 Days)|Adverse Event|0|||
48974638|NCT00753623|157738067|FG001|Phase I (14 Days)|Adverse Event|1|||
48974639|NCT00753623|157738066|FG000|Washout (7 Days)|Physician Decision|1|||
48974640|NCT00753623|157738067|FG001|Washout (7 Days)|Physician Decision|0|||
48974641|NCT00753623|157738066|FG000|Phase II (14 Days)|Physician Decision|0|||
48974642|NCT00753623|157738067|FG001|Phase II (14 Days)|Physician Decision|1|||
48974643|NCT04083794|157738068|FG000|Overall Study|Lost to Follow-up|9|||
48974644|NCT03383614|157738069|FG000|Overall Study|Withdrawal by Subject|0|||
48974645|NCT03383614|157738070|FG001|Overall Study|Withdrawal by Subject|1|||
48974646|NCT03383614|157738071|FG002|Overall Study|Withdrawal by Subject|0|||
48675097|NCT00098306|156663417|FG000|Double Blind|Lack of Efficacy|43|||
48761792|NCT02625090|156975706|FG000|Overall Study|For the Promoter|1|||
48974647|NCT03383614|157738072|FG003|Overall Study|Withdrawal by Subject|0|||
48974648|NCT01749800|157738073|FG000|Overall Study|not meeting inclusion criteria|3|||
48974649|NCT01749800|157738074|FG001|Overall Study|not meeting inclusion criteria|0|||
48974650|NCT01749800|157738075|FG002|Overall Study|not meeting inclusion criteria|0|||
48974651|NCT01749800|157738073|FG000|Overall Study|Withdrawal by Subject|0|||
48974652|NCT01749800|157738074|FG001|Overall Study|Withdrawal by Subject|1|||
48974653|NCT01749800|157738075|FG002|Overall Study|Withdrawal by Subject|0|||
48974654|NCT00814307|157738077|FG000|Overall Study|Randomized but not treated|1|||
48974655|NCT00814307|157738078|FG001|Overall Study|Randomized but not treated|0|||
48974656|NCT00814307|157738079|FG002|Overall Study|Randomized but not treated|0|||
48675098|NCT00098306|156663418|FG001|Double Blind|Lack of Efficacy|34|||
48675099|NCT00098306|156663419|FG002|Double Blind|Lack of Efficacy|17|||
48675100|NCT00098306|156663420|FG003|Double Blind|Lack of Efficacy|0|||
48675101|NCT00098306|156663421|FG004|Double Blind|Lack of Efficacy|0|||
48675102|NCT00098306|156663422|FG005|Double Blind|Lack of Efficacy|0|||
48761793|NCT02625090|156975706|FG000|Overall Study|Sponsor's Decision|9|||
48974657|NCT00814307|157738080|FG003|Overall Study|Randomized but not treated|0|||
48974658|NCT00814307|157738077|FG000|Overall Study|Adverse Event|3|||
48974659|NCT00814307|157738078|FG001|Overall Study|Adverse Event|9|||
48974660|NCT00814307|157738079|FG002|Overall Study|Adverse Event|3|||
48974661|NCT00814307|157738080|FG003|Overall Study|Adverse Event|2|||
48974662|NCT00814307|157738077|FG000|Overall Study|Lack of Efficacy|1|||
48974663|NCT00814307|157738078|FG001|Overall Study|Lack of Efficacy|1|||
48974664|NCT00814307|157738079|FG002|Overall Study|Lack of Efficacy|3|||
48974665|NCT00814307|157738080|FG003|Overall Study|Lack of Efficacy|4|||
48974666|NCT00814307|157738077|FG000|Overall Study|Other|1|||
48974667|NCT00814307|157738078|FG001|Overall Study|Other|2|||
48974668|NCT00814307|157738079|FG002|Overall Study|Other|0|||
48974669|NCT00814307|157738080|FG003|Overall Study|Other|1|||
48974670|NCT00814307|157738077|FG000|Overall Study|Protocol Violation|2|||
48974671|NCT00814307|157738078|FG001|Overall Study|Protocol Violation|8|||
48974672|NCT00814307|157738079|FG002|Overall Study|Protocol Violation|1|||
48974673|NCT00814307|157738080|FG003|Overall Study|Protocol Violation|1|||
48974674|NCT00814307|157738077|FG000|Overall Study|Withdrawal by Subject|4|||
48974675|NCT00814307|157738078|FG001|Overall Study|Withdrawal by Subject|6|||
48974676|NCT00814307|157738079|FG002|Overall Study|Withdrawal by Subject|0|||
48974677|NCT00814307|157738080|FG003|Overall Study|Withdrawal by Subject|2|||
48974678|NCT00814307|157738077|FG000|Overall Study|Death|0|||
48974679|NCT00814307|157738078|FG001|Overall Study|Death|1|||
48974680|NCT00814307|157738079|FG002|Overall Study|Death|0|||
48974681|NCT00814307|157738080|FG003|Overall Study|Death|0|||
48974682|NCT01906476|157738086|FG000|Overall Study|Lost to Follow-up|17|||
48974683|NCT01906476|157738087|FG001|Overall Study|Lost to Follow-up|16|||
48974684|NCT02177812|157738092|FG000|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
48974685|NCT02177812|157738093|FG001|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
48974686|NCT02177812|157738094|FG002|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
48974687|NCT02177812|157738095|FG003|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
48974688|NCT02177812|157738096|FG004|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
48974689|NCT02177812|157738097|FG005|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
48974690|NCT02177812|157738098|FG006|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2|||
48974691|NCT02177812|157738099|FG007|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
48974692|NCT02177812|157738100|FG008|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
48974693|NCT02177812|157738092|FG000|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
48974694|NCT02177812|157738093|FG001|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
48974695|NCT02177812|157738094|FG002|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
48974696|NCT02177812|157738095|FG003|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
48974697|NCT02177812|157738096|FG004|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
48974698|NCT02177812|157738097|FG005|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
48974699|NCT02177812|157738098|FG006|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
48974700|NCT02177812|157738099|FG007|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
48974701|NCT02177812|157738100|FG008|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
48974702|NCT02177812|157738092|FG000|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
48974703|NCT02177812|157738093|FG001|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
48974704|NCT02177812|157738094|FG002|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
48974705|NCT02177812|157738095|FG003|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
48974706|NCT02177812|157738096|FG004|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
48974707|NCT02177812|157738097|FG005|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
48974708|NCT02177812|157738098|FG006|Part 1 (Median of 4 Weeks)|Adverse Event|6|||
48974709|NCT02177812|157738099|FG007|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
48974710|NCT02177812|157738100|FG008|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
48974711|NCT01931150|157738101|FG000|Overall Study|Withdrawal by Subject|1|||
48974712|NCT01931150|157738102|FG001|Overall Study|Withdrawal by Subject|2|||
48974713|NCT00845845|157738106|FG000|Overall Study|Lost to Follow-up|0|||
48974714|NCT00845845|157738107|FG001|Overall Study|Lost to Follow-up|4|||
48974715|NCT01685203|157738110|FG000|Overall Study|Lost to Follow-up|3|||
48974716|NCT01685203|157738111|FG001|Overall Study|Lost to Follow-up|3|||
48974717|NCT01685203|157738112|FG002|Overall Study|Lost to Follow-up|0|||
48974718|NCT01685203|157738113|FG003|Overall Study|Lost to Follow-up|1|||
48974719|NCT01685203|157738114|FG004|Overall Study|Lost to Follow-up|0|||
48974720|NCT01685203|157738115|FG005|Overall Study|Lost to Follow-up|0|||
49015504|NCT01393990|157893782|FG012|Overall Study|Withdrawal by Subject|0|||
48675103|NCT00098306|156663423|FG006|Double Blind|Lack of Efficacy|0|||
48675104|NCT00098306|156663417|FG000|Double Blind|Death|1|||
48675105|NCT00098306|156663418|FG001|Double Blind|Death|4|||
48675106|NCT00098306|156663419|FG002|Double Blind|Death|1|||
48675107|NCT00098306|156663420|FG003|Double Blind|Death|0|||
48974721|NCT01685203|157738116|FG006|Overall Study|Lost to Follow-up|0|||
48974722|NCT01685203|157738110|FG000|Overall Study|Adverse Event|0|||
48974723|NCT01685203|157738111|FG001|Overall Study|Adverse Event|0|||
48974724|NCT01685203|157738112|FG002|Overall Study|Adverse Event|0|||
48974725|NCT01685203|157738113|FG003|Overall Study|Adverse Event|0|||
48974726|NCT01685203|157738114|FG004|Overall Study|Adverse Event|0|||
48974727|NCT01685203|157738115|FG005|Overall Study|Adverse Event|2|||
48974728|NCT01685203|157738116|FG006|Overall Study|Adverse Event|0|||
48974729|NCT01685203|157738110|FG000|Overall Study|Adverse event and withdrew consent|1|||
48974730|NCT01685203|157738111|FG001|Overall Study|Adverse event and withdrew consent|0|||
48974731|NCT01685203|157738112|FG002|Overall Study|Adverse event and withdrew consent|0|||
48974732|NCT01685203|157738113|FG003|Overall Study|Adverse event and withdrew consent|0|||
48974733|NCT01685203|157738114|FG004|Overall Study|Adverse event and withdrew consent|0|||
48974734|NCT01685203|157738115|FG005|Overall Study|Adverse event and withdrew consent|0|||
48974735|NCT01685203|157738116|FG006|Overall Study|Adverse event and withdrew consent|0|||
48974736|NCT01685203|157738110|FG000|Overall Study|Patient's decision|0|||
48974737|NCT01685203|157738111|FG001|Overall Study|Patient's decision|0|||
48974738|NCT01685203|157738112|FG002|Overall Study|Patient's decision|0|||
48974739|NCT01685203|157738113|FG003|Overall Study|Patient's decision|0|||
48974740|NCT01685203|157738114|FG004|Overall Study|Patient's decision|0|||
48974741|NCT01685203|157738115|FG005|Overall Study|Patient's decision|1|||
48974742|NCT01685203|157738116|FG006|Overall Study|Patient's decision|0|||
48974743|NCT00383708|157738120|FG000|Enrolment Through Start Treatment|Withdrawal by Subject|1|||
48974744|NCT00383708|157738120|FG000|Enrolment Through Start Treatment|Did not meet entry criteria|32|||
48974745|NCT00383708|157738120|FG000|Run-in Period|Protocol Violation|4|||
48974746|NCT00383708|157738120|FG000|Run-in Period|Adverse Event|2|||
48974747|NCT00383708|157738120|FG000|Run-in Period|Claustrophobia|1|||
48974748|NCT00383708|157738120|FG000|Co-administration Period|Adverse Event|5|||
48974749|NCT00318370|157738121|FG000|Period 1|Lack of Efficacy|5|||
48974750|NCT00318370|157738122|FG001|Period 1|Lack of Efficacy|0|||
48974751|NCT00318370|157738123|FG002|Period 1|Lack of Efficacy|0|||
48974752|NCT00318370|157738121|FG000|Period 1|Physician Decision|1|||
48974753|NCT00318370|157738122|FG001|Period 1|Physician Decision|0|||
48974754|NCT00318370|157738123|FG002|Period 1|Physician Decision|0|||
48974755|NCT00318370|157738121|FG000|Period 1|Withdrawal by Subject|1|||
48974756|NCT00318370|157738122|FG001|Period 1|Withdrawal by Subject|0|||
48974757|NCT00318370|157738123|FG002|Period 1|Withdrawal by Subject|0|||
48974758|NCT00318370|157738121|FG000|Period 2|Adverse Event|0|||
48974759|NCT00318370|157738122|FG001|Period 2|Adverse Event|3|||
48974760|NCT00318370|157738123|FG002|Period 2|Adverse Event|0|||
48974761|NCT00318370|157738121|FG000|Period 2|Lack of Efficacy|0|||
48974762|NCT00318370|157738122|FG001|Period 2|Lack of Efficacy|5|||
48974763|NCT00318370|157738123|FG002|Period 2|Lack of Efficacy|0|||
48974764|NCT00318370|157738121|FG000|Period 2|Physician Decision|0|||
48974765|NCT00318370|157738122|FG001|Period 2|Physician Decision|1|||
48974766|NCT00318370|157738123|FG002|Period 2|Physician Decision|0|||
48974767|NCT00318370|157738121|FG000|Period 2|Withdrawal by Subject|0|||
48974768|NCT00318370|157738122|FG001|Period 2|Withdrawal by Subject|1|||
48974769|NCT00318370|157738123|FG002|Period 2|Withdrawal by Subject|0|||
48974770|NCT00318370|157738121|FG000|Period 2|Other|0|||
48974771|NCT00318370|157738122|FG001|Period 2|Other|1|||
48974772|NCT00318370|157738123|FG002|Period 2|Other|0|||
48974773|NCT00318370|157738121|FG000|Period 3|Adverse Event|0|||
48974774|NCT00318370|157738122|FG001|Period 3|Adverse Event|0|||
48974775|NCT00318370|157738123|FG002|Period 3|Adverse Event|1|||
48974776|NCT00318370|157738121|FG000|Period 3|Lack of Efficacy|0|||
48974777|NCT00318370|157738122|FG001|Period 3|Lack of Efficacy|0|||
48974778|NCT00318370|157738123|FG002|Period 3|Lack of Efficacy|24|||
48974779|NCT00318370|157738121|FG000|Period 3|Death|0|||
48974780|NCT00318370|157738122|FG001|Period 3|Death|0|||
48974781|NCT00318370|157738123|FG002|Period 3|Death|1|||
48974782|NCT00318370|157738121|FG000|Period 3|Physician Decision|0|||
48974783|NCT00318370|157738122|FG001|Period 3|Physician Decision|0|||
48974784|NCT00318370|157738123|FG002|Period 3|Physician Decision|1|||
48974785|NCT00318370|157738121|FG000|Period 3|Withdrawal by Subject|0|||
48974786|NCT00318370|157738122|FG001|Period 3|Withdrawal by Subject|0|||
48974787|NCT00318370|157738123|FG002|Period 3|Withdrawal by Subject|3|||
48974788|NCT00318370|157738121|FG000|Period 3|Other|0|||
48974789|NCT00318370|157738122|FG001|Period 3|Other|0|||
48974790|NCT00318370|157738123|FG002|Period 3|Other|3|||
48974791|NCT01750840|157738128|FG000|Overall Study|Lost to Follow-up|4|||
48974792|NCT01437267|157738129|FG000|Overall Study|Withdrawal by Subject|0|||
48974793|NCT01437267|157738130|FG001|Overall Study|Withdrawal by Subject|0|||
48974794|NCT01437267|157738131|FG002|Overall Study|Withdrawal by Subject|0|||
48974795|NCT01437267|157738132|FG003|Overall Study|Withdrawal by Subject|1|||
48974796|NCT01437267|157738133|FG004|Overall Study|Withdrawal by Subject|0|||
48974797|NCT01437267|157738134|FG005|Overall Study|Withdrawal by Subject|0|||
48974798|NCT01437267|157738129|FG000|Overall Study|Protocol Violation|0|||
48974799|NCT01437267|157738130|FG001|Overall Study|Protocol Violation|1|||
48974800|NCT01437267|157738131|FG002|Overall Study|Protocol Violation|0|||
48974801|NCT01437267|157738132|FG003|Overall Study|Protocol Violation|0|||
48974802|NCT01437267|157738133|FG004|Overall Study|Protocol Violation|0|||
48974803|NCT01437267|157738134|FG005|Overall Study|Protocol Violation|0|||
48974804|NCT00479167|157738135|FG000|Overall Study|Withdrawal by Subject|1|||
48974805|NCT01997281|157738140|FG000|Overall Study|Withdrawal by Subject|1|||
48974806|NCT01997281|157738141|FG001|Overall Study|Withdrawal by Subject|0|||
48974807|NCT00333970|157738147|FG000|Overall Study|Withdrawal by Subject|13|||
48974808|NCT00333970|157738148|FG001|Overall Study|Withdrawal by Subject|7|||
48974809|NCT01570309|157738149|FG000|Overall Study|Withdrawal by Subject|3|||
48974810|NCT01570309|157738150|FG001|Overall Study|Withdrawal by Subject|3|||
48974811|NCT01770145|157740073|FG000|Baseline|Adverse Event|20|||
48974812|NCT01770145|157740073|FG000|Baseline|Withdrawal by Subject|1|||
48974813|NCT01770145|157740073|FG000|Baseline|Lost to Follow-up|1|||
48974814|NCT01770145|157740073|FG000|Baseline|Unable to define optimal dose|4|||
48974815|NCT01770145|157740073|FG000|Treatment|Adverse Event|3|||
48974816|NCT01770145|157740073|FG000|Treatment|Withdrawal by Subject|1|||
48974817|NCT03706040|157740074|FG000|Period A (Week 0 to Week 16)|Adverse Event|3|||
48974818|NCT03706040|157740075|FG001|Period A (Week 0 to Week 16)|Adverse Event|2|||
48974819|NCT03706040|157740076|FG002|Period A (Week 0 to Week 16)|Adverse Event|1|||
48974820|NCT03706040|157740077|FG003|Period A (Week 0 to Week 16)|Adverse Event|0|||
48974821|NCT03706040|157740078|FG004|Period A (Week 0 to Week 16)|Adverse Event|0|||
48974822|NCT03706040|157740079|FG005|Period A (Week 0 to Week 16)|Adverse Event|0|||
48974823|NCT03706040|157740080|FG006|Period A (Week 0 to Week 16)|Adverse Event|0|||
48974824|NCT03706040|157740074|FG000|Period A (Week 0 to Week 16)|Withdrew Consent|3|||
48974825|NCT03706040|157740075|FG001|Period A (Week 0 to Week 16)|Withdrew Consent|5|||
48974826|NCT03706040|157740076|FG002|Period A (Week 0 to Week 16)|Withdrew Consent|4|||
48974827|NCT03706040|157740077|FG003|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
48974828|NCT03706040|157740078|FG004|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
48974829|NCT03706040|157740079|FG005|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
48974830|NCT03706040|157740080|FG006|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
48974831|NCT03706040|157740074|FG000|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
48974832|NCT03706040|157740075|FG001|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
48974833|NCT03706040|157740076|FG002|Period A (Week 0 to Week 16)|Lost to Follow-up|4|||
48974834|NCT03706040|157740077|FG003|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
48974835|NCT03706040|157740078|FG004|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
48675108|NCT00098306|156663421|FG004|Double Blind|Death|0|||
48675109|NCT00098306|156663422|FG005|Double Blind|Death|0|||
48675110|NCT00098306|156663423|FG006|Double Blind|Death|0|||
48675111|NCT00098306|156663417|FG000|Double Blind|Participant defaulted|19|||
48675112|NCT00098306|156663418|FG001|Double Blind|Participant defaulted|18|||
48675113|NCT00098306|156663419|FG002|Double Blind|Participant defaulted|11|||
48675114|NCT00098306|156663420|FG003|Double Blind|Participant defaulted|0|||
48675115|NCT00098306|156663421|FG004|Double Blind|Participant defaulted|0|||
48675116|NCT00098306|156663422|FG005|Double Blind|Participant defaulted|0|||
48675117|NCT00098306|156663423|FG006|Double Blind|Participant defaulted|0|||
48675118|NCT00098306|156663417|FG000|Double Blind|Un-specified|7|||
48675119|NCT00098306|156663418|FG001|Double Blind|Un-specified|3|||
48675120|NCT00098306|156663419|FG002|Double Blind|Un-specified|11|||
48675121|NCT00098306|156663420|FG003|Double Blind|Un-specified|0|||
48675122|NCT00098306|156663421|FG004|Double Blind|Un-specified|0|||
48675123|NCT00098306|156663422|FG005|Double Blind|Un-specified|0|||
48675124|NCT00098306|156663423|FG006|Double Blind|Un-specified|0|||
48675125|NCT00098306|156663417|FG000|Open Label|Lack of Efficacy|0|||
48675126|NCT00098306|156663418|FG001|Open Label|Lack of Efficacy|0|||
48675127|NCT00098306|156663419|FG002|Open Label|Lack of Efficacy|0|||
48675128|NCT00098306|156663420|FG003|Open Label|Lack of Efficacy|13|||
48675129|NCT00098306|156663421|FG004|Open Label|Lack of Efficacy|0|||
48675130|NCT00098306|156663422|FG005|Open Label|Lack of Efficacy|0|||
48675131|NCT00098306|156663423|FG006|Open Label|Lack of Efficacy|0|||
48675132|NCT00098306|156663417|FG000|Open Label|Adverse Event|0|||
48675133|NCT00098306|156663418|FG001|Open Label|Adverse Event|0|||
48675134|NCT00098306|156663419|FG002|Open Label|Adverse Event|0|||
48761794|NCT02625090|156975706|FG000|Overall Study|Somnolence|1|||
48761795|NCT02625090|156975706|FG000|Overall Study|Study terminated by Sponsor|7|||
48974836|NCT03706040|157740079|FG005|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
48974837|NCT03706040|157740080|FG006|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
48974838|NCT03706040|157740074|FG000|Period A (Week 0 to Week 16)|Other|2|||
48974839|NCT03706040|157740075|FG001|Period A (Week 0 to Week 16)|Other|0|||
48974840|NCT03706040|157740076|FG002|Period A (Week 0 to Week 16)|Other|2|||
48974841|NCT03706040|157740077|FG003|Period A (Week 0 to Week 16)|Other|0|||
48974842|NCT03706040|157740078|FG004|Period A (Week 0 to Week 16)|Other|0|||
48974843|NCT03706040|157740079|FG005|Period A (Week 0 to Week 16)|Other|0|||
48974844|NCT03706040|157740080|FG006|Period A (Week 0 to Week 16)|Other|0|||
48974845|NCT03706040|157740074|FG000|Period B (Week 16 to Week 52)|Adverse Event|0|||
48974846|NCT03706040|157740075|FG001|Period B (Week 16 to Week 52)|Adverse Event|0|||
48974847|NCT03706040|157740076|FG002|Period B (Week 16 to Week 52)|Adverse Event|0|||
48974848|NCT03706040|157740077|FG003|Period B (Week 16 to Week 52)|Adverse Event|1|||
48675135|NCT00098306|156663420|FG003|Open Label|Adverse Event|2|||
48675136|NCT00098306|156663421|FG004|Open Label|Adverse Event|0|||
48974849|NCT03706040|157740078|FG004|Period B (Week 16 to Week 52)|Adverse Event|2|||
48675137|NCT00098306|156663422|FG005|Open Label|Adverse Event|0|||
48675138|NCT00098306|156663423|FG006|Open Label|Adverse Event|0|||
48675139|NCT00098306|156663417|FG000|Open Label|Death|0|||
48675140|NCT00098306|156663418|FG001|Open Label|Death|0|||
48675141|NCT00098306|156663419|FG002|Open Label|Death|0|||
48675142|NCT00098306|156663420|FG003|Open Label|Death|4|||
48761796|NCT02625090|156975706|FG000|Overall Study|Negative Benefit/Risk|1|||
48974850|NCT03706040|157740079|FG005|Period B (Week 16 to Week 52)|Adverse Event|3|||
48974851|NCT03706040|157740080|FG006|Period B (Week 16 to Week 52)|Adverse Event|0|||
48974852|NCT03706040|157740074|FG000|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
48974853|NCT03706040|157740075|FG001|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
48974854|NCT03706040|157740076|FG002|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
48974855|NCT03706040|157740077|FG003|Period B (Week 16 to Week 52)|Withdrew Consent|3|||
48974856|NCT03706040|157740078|FG004|Period B (Week 16 to Week 52)|Withdrew Consent|2|||
48974857|NCT03706040|157740079|FG005|Period B (Week 16 to Week 52)|Withdrew Consent|1|||
48974858|NCT03706040|157740080|FG006|Period B (Week 16 to Week 52)|Withdrew Consent|10|||
48974859|NCT03706040|157740074|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
48974860|NCT03706040|157740075|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
48974861|NCT03706040|157740076|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
48974862|NCT03706040|157740077|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
48974863|NCT03706040|157740078|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
48675143|NCT00098306|156663421|FG004|Open Label|Death|0|||
48675144|NCT00098306|156663422|FG005|Open Label|Death|0|||
48675145|NCT00098306|156663423|FG006|Open Label|Death|0|||
48675146|NCT00098306|156663417|FG000|Open Label|Participant defaulted|0|||
48675147|NCT00098306|156663418|FG001|Open Label|Participant defaulted|0|||
48675148|NCT00098306|156663419|FG002|Open Label|Participant defaulted|0|||
48974864|NCT03706040|157740079|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
48974865|NCT03706040|157740080|FG006|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
48974866|NCT03706040|157740074|FG000|Period B (Week 16 to Week 52)|Other|0|||
48974867|NCT03706040|157740075|FG001|Period B (Week 16 to Week 52)|Other|0|||
48974868|NCT03706040|157740076|FG002|Period B (Week 16 to Week 52)|Other|0|||
48974869|NCT03706040|157740077|FG003|Period B (Week 16 to Week 52)|Other|4|||
48675149|NCT00098306|156663420|FG003|Open Label|Participant defaulted|24|||
48675150|NCT00098306|156663421|FG004|Open Label|Participant defaulted|0|||
48675151|NCT00098306|156663422|FG005|Open Label|Participant defaulted|0|||
48675152|NCT00098306|156663423|FG006|Open Label|Participant defaulted|0|||
48675153|NCT00098306|156663417|FG000|Open Label|Un-specified|0|||
48675154|NCT00098306|156663418|FG001|Open Label|Un-specified|0|||
48974870|NCT03706040|157740078|FG004|Period B (Week 16 to Week 52)|Other|5|||
48974871|NCT03706040|157740079|FG005|Period B (Week 16 to Week 52)|Other|23|||
48974872|NCT03706040|157740080|FG006|Period B (Week 16 to Week 52)|Other|17|||
48974873|NCT00927758|157740081|FG000|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
48974874|NCT00927758|157740082|FG001|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
48675155|NCT00098306|156663419|FG002|Open Label|Un-specified|0|||
48675156|NCT00098306|156663420|FG003|Open Label|Un-specified|15|||
48675157|NCT00098306|156663421|FG004|Open Label|Un-specified|0|||
48675158|NCT00098306|156663422|FG005|Open Label|Un-specified|0|||
48675159|NCT00098306|156663423|FG006|Open Label|Un-specified|0|||
48675160|NCT00098306|156663417|FG000|Open Label|Ongoing at cut-off date|0|||
48675161|NCT00098306|156663418|FG001|Open Label|Ongoing at cut-off date|0|||
48675162|NCT00098306|156663419|FG002|Open Label|Ongoing at cut-off date|0|||
48675163|NCT00098306|156663420|FG003|Open Label|Ongoing at cut-off date|269|||
48675164|NCT00098306|156663421|FG004|Open Label|Ongoing at cut-off date|62|||
48675165|NCT00098306|156663422|FG005|Open Label|Ongoing at cut-off date|0|||
48675166|NCT00098306|156663423|FG006|Open Label|Ongoing at cut-off date|0|||
48675167|NCT00098306|156663417|FG000|Observational Phase|Death|0|||
48675168|NCT00098306|156663418|FG001|Observational Phase|Death|0|||
48675169|NCT00098306|156663419|FG002|Observational Phase|Death|0|||
48675170|NCT00098306|156663420|FG003|Observational Phase|Death|0|||
48675171|NCT00098306|156663421|FG004|Observational Phase|Death|0|||
48675172|NCT00098306|156663422|FG005|Observational Phase|Death|5|||
48675173|NCT00098306|156663423|FG006|Observational Phase|Death|4|||
48675174|NCT00098306|156663417|FG000|Observational Phase|Participant defaulted|0|||
48675175|NCT00098306|156663418|FG001|Observational Phase|Participant defaulted|0|||
48675176|NCT00098306|156663419|FG002|Observational Phase|Participant defaulted|0|||
48675177|NCT00098306|156663420|FG003|Observational Phase|Participant defaulted|0|||
48974875|NCT00927758|157740083|FG002|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
48974876|NCT00927758|157740084|FG003|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
48675178|NCT00098306|156663421|FG004|Observational Phase|Participant defaulted|0|||
48974877|NCT00927758|157740085|FG004|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
48974878|NCT00927758|157740086|FG005|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
48974879|NCT00927758|157740081|FG000|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
48675179|NCT00098306|156663422|FG005|Observational Phase|Participant defaulted|34|||
48675180|NCT00098306|156663423|FG006|Observational Phase|Participant defaulted|18|||
48675181|NCT00098306|156663417|FG000|Observational Phase|Un-specified|0|||
48675182|NCT00098306|156663418|FG001|Observational Phase|Un-specified|0|||
48675183|NCT00098306|156663419|FG002|Observational Phase|Un-specified|0|||
48675184|NCT00098306|156663420|FG003|Observational Phase|Un-specified|0|||
48675185|NCT00098306|156663421|FG004|Observational Phase|Un-specified|0|||
48675186|NCT00098306|156663422|FG005|Observational Phase|Un-specified|7|||
48675187|NCT00098306|156663423|FG006|Observational Phase|Un-specified|4|||
48761797|NCT02625090|156975706|FG000|Overall Study|Protocol Deviation|2|||
48675188|NCT01374178|156663426|FG000|Washout Period of at Least 7 Days|Withdrawal by Subject|1|||
48675189|NCT01374178|156663427|FG001|Washout Period of at Least 7 Days|Withdrawal by Subject|0|||
48675190|NCT01374178|156663426|FG000|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2|||
48675191|NCT01374178|156663427|FG001|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0|||
48675192|NCT01079936|156663430|FG000|Phase I: MTD|First Remission Status|2|||
48675193|NCT01079936|156663431|FG001|Phase I: MTD|First Remission Status|0|||
48675194|NCT01079936|156663432|FG002|Phase I: MTD|First Remission Status|0|||
48675195|NCT01079936|156663433|FG003|Phase I: MTD|First Remission Status|0|||
48675196|NCT01079936|156663434|FG004|Phase I: MTD|First Remission Status|0|||
48675197|NCT01079936|156663430|FG000|Phase I: MTD|No Stem Cell Transplantation|2|||
48675198|NCT01079936|156663431|FG001|Phase I: MTD|No Stem Cell Transplantation|0|||
48675199|NCT01079936|156663432|FG002|Phase I: MTD|No Stem Cell Transplantation|0|||
48675200|NCT01079936|156663433|FG003|Phase I: MTD|No Stem Cell Transplantation|0|||
48675201|NCT01079936|156663434|FG004|Phase I: MTD|No Stem Cell Transplantation|0|||
48675202|NCT01079936|156663430|FG000|Phase II|Adverse Event|0|||
48675203|NCT01079936|156663431|FG001|Phase II|Adverse Event|0|||
48675204|NCT01079936|156663432|FG002|Phase II|Adverse Event|1|||
48675205|NCT01079936|156663433|FG003|Phase II|Adverse Event|0|||
48675206|NCT01079936|156663434|FG004|Phase II|Adverse Event|0|||
48675207|NCT01079936|156663430|FG000|Phase II|Insurance Issue|0|||
48675208|NCT01079936|156663431|FG001|Phase II|Insurance Issue|0|||
48675209|NCT01079936|156663432|FG002|Phase II|Insurance Issue|0|||
48675210|NCT01079936|156663433|FG003|Phase II|Insurance Issue|0|||
48675211|NCT01079936|156663434|FG004|Phase II|Insurance Issue|1|||
48761798|NCT02625090|156975706|FG000|Overall Study|Lack of Efficacy|16|||
48761799|NCT02625090|156975706|FG000|Overall Study|Adverse Event|3|||
48675212|NCT00395850|156663441|FG000|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6|||
48675213|NCT00395850|156663442|FG001|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
48675214|NCT00395850|156663443|FG002|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
48675215|NCT00395850|156663444|FG003|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
48675216|NCT00395850|156663441|FG000|Pre-randomization Baseline/Induction|Withdrawal by Subject|4|||
48675217|NCT00395850|156663442|FG001|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
48675218|NCT00395850|156663443|FG002|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
48675219|NCT00395850|156663444|FG003|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
48675220|NCT00395850|156663441|FG000|Pre-randomization Baseline/Induction|Inconsistent attendance|1|||
48675221|NCT00395850|156663442|FG001|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
48675222|NCT00395850|156663443|FG002|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
48675223|NCT00395850|156663444|FG003|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
48675224|NCT00395850|156663441|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
48675225|NCT00395850|156663442|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
48675226|NCT00395850|156663443|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6|||
48675227|NCT00395850|156663444|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4|||
48675228|NCT00395850|156663441|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1|||
48675229|NCT00395850|156663442|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
48675230|NCT00395850|156663443|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
48675231|NCT00395850|156663444|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
48675232|NCT00395850|156663441|FG000|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1|||
48675233|NCT00395850|156663442|FG001|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
48675234|NCT00395850|156663443|FG002|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
48675235|NCT00395850|156663444|FG003|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
48675236|NCT00395850|156663441|FG000|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1|||
48675237|NCT00395850|156663442|FG001|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
48675238|NCT00395850|156663443|FG002|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
48761800|NCT00857220|156975707|FG000|Overall Study|Adverse Event|35|||
48761801|NCT00857220|156975707|FG000|Overall Study|Death|1|||
48761802|NCT00857220|156975707|FG000|Overall Study|Lack of Efficacy|11|||
48761803|NCT00857220|156975707|FG000|Overall Study|Lost to Follow-up|30|||
48761804|NCT00857220|156975707|FG000|Overall Study|Physician Decision|4|||
48761805|NCT00857220|156975707|FG000|Overall Study|Protocol Violation|16|||
48761806|NCT00857220|156975707|FG000|Overall Study|Withdrawal by Subject|67|||
48761807|NCT00857220|156975707|FG000|Overall Study|Clinical Hold|6|||
48761808|NCT00857220|156975707|FG000|Overall Study|Site Closed|5|||
48761809|NCT00857220|156975707|FG000|Overall Study|Miscellaneous|8|||
48761810|NCT01505608|156975709|FG000|Phase I|Lack of Efficacy|0|||
48761811|NCT01505608|156975710|FG001|Phase I|Lack of Efficacy|4|||
48761812|NCT01505608|156975709|FG000|Phase I|Adverse Event|0|||
48675239|NCT00395850|156663444|FG003|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
48675240|NCT01753401|156663445|FG000|Double-blind Period (8 Weeks)|Adverse Event|0|||
48761813|NCT01505608|156975710|FG001|Phase I|Adverse Event|1|||
48761814|NCT01505608|156975709|FG000|Phase I|Withdrawal by Subject|0|||
48761815|NCT01505608|156975710|FG001|Phase I|Withdrawal by Subject|1|||
48675241|NCT01753401|156663446|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
48675242|NCT01753401|156663447|FG002|Double-blind Period (8 Weeks)|Adverse Event|0|||
48675243|NCT01753401|156663448|FG003|Double-blind Period (8 Weeks)|Adverse Event|0|||
48675244|NCT01753401|156663445|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
48675245|NCT01753401|156663446|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
48675246|NCT01753401|156663447|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
48675247|NCT01753401|156663448|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
48675248|NCT01753401|156663445|FG000|Double-blind Period (8 Weeks)|Protocol Violation|0|||
48675249|NCT01753401|156663446|FG001|Double-blind Period (8 Weeks)|Protocol Violation|1|||
48675250|NCT01753401|156663447|FG002|Double-blind Period (8 Weeks)|Protocol Violation|0|||
48675251|NCT01753401|156663448|FG003|Double-blind Period (8 Weeks)|Protocol Violation|0|||
48675252|NCT01753401|156663445|FG000|Open Label Period (44 Weeks)|Adverse Event|0|||
48675253|NCT01753401|156663446|FG001|Open Label Period (44 Weeks)|Adverse Event|0|||
48675254|NCT01753401|156663447|FG002|Open Label Period (44 Weeks)|Adverse Event|3|||
48675255|NCT01753401|156663448|FG003|Open Label Period (44 Weeks)|Adverse Event|4|||
48675256|NCT01753401|156663445|FG000|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
48675257|NCT01753401|156663446|FG001|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
48675258|NCT01753401|156663447|FG002|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
48675259|NCT01753401|156663448|FG003|Open Label Period (44 Weeks)|Withdrawal by Subject|2|||
48675260|NCT01753401|156663445|FG000|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
48675261|NCT01753401|156663446|FG001|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
48974880|NCT00927758|157740082|FG001|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
48675262|NCT01753401|156663447|FG002|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
48974881|NCT00927758|157740083|FG002|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
48974882|NCT00927758|157740084|FG003|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
48974883|NCT00927758|157740085|FG004|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
48974884|NCT00927758|157740086|FG005|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
48974885|NCT00324740|157740087|FG000|Overall Study|Withdrawal by Subject|1|||
48974886|NCT00324740|157740088|FG001|Overall Study|Withdrawal by Subject|0|||
48974887|NCT00324740|157740089|FG002|Overall Study|Withdrawal by Subject|1|||
48974888|NCT00439725|157740091|FG000|Treatment Period|Withdrawal by Subject|22|||
48974889|NCT00439725|157740092|FG001|Treatment Period|Withdrawal by Subject|19|||
48974890|NCT00439725|157740091|FG000|Treatment Period|Study terminated by sponsor|156|||
48974891|NCT00439725|157740092|FG001|Treatment Period|Study terminated by sponsor|148|||
48974892|NCT00439725|157740091|FG000|Treatment Period|Site closed by investigator|1|||
48974893|NCT00439725|157740092|FG001|Treatment Period|Site closed by investigator|2|||
48974894|NCT00439725|157740091|FG000|Treatment Period|Adverse Event|39|||
48974895|NCT00439725|157740092|FG001|Treatment Period|Adverse Event|18|||
48974896|NCT00439725|157740091|FG000|Treatment Period|Physician Decision|1|||
48974897|NCT00439725|157740092|FG001|Treatment Period|Physician Decision|1|||
48974898|NCT00439725|157740091|FG000|Treatment Period|Protocol Violation|2|||
48974899|NCT00439725|157740092|FG001|Treatment Period|Protocol Violation|1|||
48974900|NCT00439725|157740091|FG000|Treatment Period|Clinical endpoint reached|6|||
48974901|NCT00439725|157740092|FG001|Treatment Period|Clinical endpoint reached|50|||
48974902|NCT00439725|157740091|FG000|Treatment Period|Technical problems|1|||
48974903|NCT00439725|157740092|FG001|Treatment Period|Technical problems|0|||
48974904|NCT00439725|157740091|FG000|Treatment Period|Lost to Follow-up|1|||
48974905|NCT00439725|157740092|FG001|Treatment Period|Lost to Follow-up|1|||
48974906|NCT00439725|157740091|FG000|Treatment Period|Participant convenience|1|||
48974907|NCT00439725|157740092|FG001|Treatment Period|Participant convenience|0|||
48974908|NCT00439725|157740091|FG000|Treatment Period|Protocol driven decision point|1|||
48974909|NCT00439725|157740092|FG001|Treatment Period|Protocol driven decision point|1|||
48974910|NCT00439725|157740091|FG000|Treatment Period|Death|1|||
48974911|NCT00439725|157740092|FG001|Treatment Period|Death|1|||
48761816|NCT01505608|156975709|FG000|Phase II|Lack of Efficacy|2|||
48761817|NCT01505608|156975710|FG001|Phase II|Lack of Efficacy|1|||
48761818|NCT01505608|156975709|FG000|Phase II|Protocol Violation|0|||
48761819|NCT01505608|156975710|FG001|Phase II|Protocol Violation|1|||
48761820|NCT03165110|156975714|FG000|Overall Study|Anroid phone software incompatibility|1|||
48761821|NCT02726074|156975715|FG000|Overall Study|Withdrawal by Subject|4|||
48761822|NCT02726074|156975715|FG000|Overall Study|Adverse Event|14|||
48761823|NCT02726074|156975715|FG000|Overall Study|Protocol Violation|3|||
48761824|NCT02726074|156975715|FG000|Overall Study|Lost to Follow-up|2|||
48974912|NCT00439725|157740091|FG000|Treatment Period|Participant did not receive treatment|4|||
48974913|NCT00439725|157740092|FG001|Treatment Period|Participant did not receive treatment|4|||
48974914|NCT00439725|157740091|FG000|Observational Period|Withdrawal by Subject|2|||
48974915|NCT00439725|157740092|FG001|Observational Period|Withdrawal by Subject|2|||
48974916|NCT00439725|157740091|FG000|Observational Period|Lost to Follow-up|0|||
48974917|NCT00439725|157740092|FG001|Observational Period|Lost to Follow-up|1|||
48974918|NCT00439725|157740091|FG000|Observational Period|Death|0|||
48675263|NCT01753401|156663448|FG003|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
48974919|NCT00439725|157740092|FG001|Observational Period|Death|2|||
48974920|NCT00439725|157740091|FG000|Observational Period|Study termination by sponsor|1|||
48974921|NCT00439725|157740092|FG001|Observational Period|Study termination by sponsor|1|||
48974922|NCT00439725|157740091|FG000|Observational Period|Clinical endpoint reached|3|||
48974923|NCT00439725|157740092|FG001|Observational Period|Clinical endpoint reached|1|||
48974924|NCT00439725|157740091|FG000|Observational Period|Technical problems|1|||
48974925|NCT00439725|157740092|FG001|Observational Period|Technical problems|0|||
48974926|NCT00439725|157740091|FG000|Observational Period|Participant convenience|1|||
48974927|NCT00439725|157740092|FG001|Observational Period|Participant convenience|0|||
48974928|NCT03077243|157740093|FG000|Overall Study|Death|1|||
48974929|NCT03077243|157740094|FG001|Overall Study|Death|2|||
48974930|NCT03077243|157740095|FG002|Overall Study|Death|0|||
48974931|NCT03077243|157740096|FG003|Overall Study|Death|0|||
48974932|NCT03077243|157740093|FG000|Overall Study|Withdrawal by Subject|1|||
48974933|NCT03077243|157740094|FG001|Overall Study|Withdrawal by Subject|3|||
48974934|NCT03077243|157740095|FG002|Overall Study|Withdrawal by Subject|0|||
48974935|NCT03077243|157740096|FG003|Overall Study|Withdrawal by Subject|0|||
48974936|NCT03077243|157740093|FG000|Overall Study|Physician Decision|1|||
48974937|NCT03077243|157740094|FG001|Overall Study|Physician Decision|0|||
48974938|NCT03077243|157740095|FG002|Overall Study|Physician Decision|0|||
48974939|NCT03077243|157740096|FG003|Overall Study|Physician Decision|0|||
48974940|NCT03077243|157740093|FG000|Overall Study|Research at two study sites terminated early|0|||
48974941|NCT03077243|157740094|FG001|Overall Study|Research at two study sites terminated early|0|||
48974942|NCT03077243|157740095|FG002|Overall Study|Research at two study sites terminated early|0|||
48675264|NCT01753401|156663445|FG000|Open Label Period (44 Weeks)|Reason not provided|0|||
48675265|NCT01753401|156663446|FG001|Open Label Period (44 Weeks)|Reason not provided|0|||
48675266|NCT01753401|156663447|FG002|Open Label Period (44 Weeks)|Reason not provided|0|||
48675267|NCT01753401|156663448|FG003|Open Label Period (44 Weeks)|Reason not provided|2|||
48675268|NCT00470418|156663449|FG000|Overall Study|Withdrawal by Subject|1|||
48675269|NCT00470418|156663450|FG001|Overall Study|Withdrawal by Subject|0|||
48675270|NCT00545103|156663451|FG000|Overall Study|Lack of Efficacy|48|||
48974943|NCT03077243|157740096|FG003|Overall Study|Research at two study sites terminated early|69|||
48974944|NCT01432457|157740097|FG000|Overall Study|Adverse Event|7|||
48974945|NCT01432457|157740098|FG001|Overall Study|Adverse Event|10|||
48974946|NCT01432457|157740099|FG002|Overall Study|Adverse Event|16|||
48974947|NCT01432457|157740097|FG000|Overall Study|Lack of Efficacy|2|||
48974948|NCT01432457|157740098|FG001|Overall Study|Lack of Efficacy|1|||
48974949|NCT01432457|157740099|FG002|Overall Study|Lack of Efficacy|1|||
48974950|NCT01432457|157740097|FG000|Overall Study|Lost to Follow-up|11|||
48974951|NCT01432457|157740098|FG001|Overall Study|Lost to Follow-up|15|||
48974952|NCT01432457|157740099|FG002|Overall Study|Lost to Follow-up|20|||
48974953|NCT01432457|157740097|FG000|Overall Study|Protocol Violation|3|||
48974954|NCT01432457|157740098|FG001|Overall Study|Protocol Violation|2|||
48974955|NCT01432457|157740099|FG002|Overall Study|Protocol Violation|6|||
48974956|NCT01432457|157740097|FG000|Overall Study|Withdrawal by Subject|6|||
48974957|NCT01432457|157740098|FG001|Overall Study|Withdrawal by Subject|11|||
48974958|NCT01432457|157740099|FG002|Overall Study|Withdrawal by Subject|9|||
48974959|NCT01432457|157740097|FG000|Overall Study|Reasons not defined|2|||
48974960|NCT01432457|157740098|FG001|Overall Study|Reasons not defined|3|||
48974961|NCT01432457|157740099|FG002|Overall Study|Reasons not defined|4|||
48974962|NCT01432457|157740097|FG000|Overall Study|Did not take study drug|6|||
48974963|NCT01432457|157740098|FG001|Overall Study|Did not take study drug|6|||
48974964|NCT01432457|157740099|FG002|Overall Study|Did not take study drug|3|||
48974965|NCT01544478|157740100|FG000|Overall Study|Adverse Event|1|||
48974966|NCT01544478|157740100|FG000|Overall Study|Death|1|||
48974967|NCT01544478|157740100|FG000|Overall Study|Lost to Follow-up|48|||
48974968|NCT01544478|157740100|FG000|Overall Study|Physician Decision|15|||
48974969|NCT01544478|157740100|FG000|Overall Study|Pregnancy|1|||
48974970|NCT01544478|157740100|FG000|Overall Study|Withdrawal by Subject|52|||
48974971|NCT00094835|157740101|FG000|Overall Study|Physician Decision|1|||
48974972|NCT00094835|157740102|FG001|Overall Study|Physician Decision|0|||
48675271|NCT00545103|156663452|FG001|Overall Study|Lack of Efficacy|45|||
48675272|NCT00545103|156663453|FG002|Overall Study|Lack of Efficacy|31|||
48675273|NCT00545103|156663454|FG003|Overall Study|Lack of Efficacy|27|||
48675274|NCT00545103|156663451|FG000|Overall Study|Withdrawal by Subject|6|||
48675275|NCT00545103|156663452|FG001|Overall Study|Withdrawal by Subject|10|||
48974973|NCT00094835|157740103|FG002|Overall Study|Physician Decision|0|||
48974974|NCT00094835|157740104|FG003|Overall Study|Physician Decision|0|||
48974975|NCT00094835|157740105|FG004|Overall Study|Physician Decision|0|||
48974976|NCT00094835|157740106|FG005|Overall Study|Physician Decision|1|||
48974977|NCT00094835|157740107|FG006|Overall Study|Physician Decision|0|||
48974978|NCT00094835|157740101|FG000|Overall Study|Withdrawal by Subject|0|||
48974979|NCT00094835|157740102|FG001|Overall Study|Withdrawal by Subject|0|||
48675276|NCT00545103|156663453|FG002|Overall Study|Withdrawal by Subject|18|||
48974980|NCT00094835|157740103|FG002|Overall Study|Withdrawal by Subject|0|||
48974981|NCT00094835|157740104|FG003|Overall Study|Withdrawal by Subject|0|||
48974982|NCT00094835|157740105|FG004|Overall Study|Withdrawal by Subject|0|||
48974983|NCT00094835|157740106|FG005|Overall Study|Withdrawal by Subject|0|||
48974984|NCT00094835|157740107|FG006|Overall Study|Withdrawal by Subject|1|||
48974985|NCT00094835|157740101|FG000|Overall Study|Lost to Follow-up|0|||
48974986|NCT00094835|157740102|FG001|Overall Study|Lost to Follow-up|0|||
48974987|NCT00094835|157740103|FG002|Overall Study|Lost to Follow-up|0|||
48974988|NCT00094835|157740104|FG003|Overall Study|Lost to Follow-up|0|||
48974989|NCT00094835|157740105|FG004|Overall Study|Lost to Follow-up|1|||
48974990|NCT00094835|157740106|FG005|Overall Study|Lost to Follow-up|0|||
48974991|NCT00094835|157740107|FG006|Overall Study|Lost to Follow-up|0|||
48974992|NCT00094835|157740101|FG000|Overall Study|Death|1|||
48974993|NCT00094835|157740102|FG001|Overall Study|Death|0|||
48974994|NCT00094835|157740103|FG002|Overall Study|Death|0|||
48974995|NCT00094835|157740104|FG003|Overall Study|Death|0|||
48974996|NCT00094835|157740105|FG004|Overall Study|Death|1|||
48974997|NCT00094835|157740106|FG005|Overall Study|Death|0|||
48974998|NCT00094835|157740107|FG006|Overall Study|Death|0|||
48974999|NCT00094835|157740101|FG000|Overall Study|Non-compliance|1|||
48975000|NCT00094835|157740102|FG001|Overall Study|Non-compliance|2|||
48975001|NCT00094835|157740103|FG002|Overall Study|Non-compliance|2|||
48975002|NCT00094835|157740104|FG003|Overall Study|Non-compliance|0|||
48975003|NCT00094835|157740105|FG004|Overall Study|Non-compliance|2|||
48975004|NCT00094835|157740106|FG005|Overall Study|Non-compliance|2|||
48975005|NCT00094835|157740107|FG006|Overall Study|Non-compliance|1|||
48975006|NCT00094835|157740101|FG000|Overall Study|Other|1|||
48975007|NCT00094835|157740102|FG001|Overall Study|Other|1|||
48975008|NCT00094835|157740103|FG002|Overall Study|Other|1|||
48975009|NCT00094835|157740104|FG003|Overall Study|Other|1|||
48975010|NCT00094835|157740105|FG004|Overall Study|Other|0|||
48975011|NCT00094835|157740106|FG005|Overall Study|Other|0|||
48975012|NCT00094835|157740107|FG006|Overall Study|Other|0|||
48975013|NCT01709708|157740112|FG000|Overall Study|Protocol Violation|1|||
48975014|NCT01709708|157740113|FG001|Overall Study|Protocol Violation|2|||
48975015|NCT04731922|157740116|FG000|Overall Study|Adverse Event|0|||
48975016|NCT04731922|157740117|FG001|Overall Study|Adverse Event|0|||
48975017|NCT04731922|157740118|FG002|Overall Study|Adverse Event|0|||
48975018|NCT04731922|157740119|FG003|Overall Study|Adverse Event|0|||
48975019|NCT04731922|157740120|FG004|Overall Study|Adverse Event|0|||
48975020|NCT04731922|157740121|FG005|Overall Study|Adverse Event|0|||
48975021|NCT04731922|157740122|FG006|Overall Study|Adverse Event|0|||
48975022|NCT04731922|157740123|FG007|Overall Study|Adverse Event|0|||
48975023|NCT04731922|157740124|FG008|Overall Study|Adverse Event|0|||
48975024|NCT04731922|157740125|FG009|Overall Study|Adverse Event|0|||
48975025|NCT04731922|157740126|FG010|Overall Study|Adverse Event|1|||
48975026|NCT04731922|157740127|FG011|Overall Study|Adverse Event|0|||
48975027|NCT04731922|157740128|FG012|Overall Study|Adverse Event|0|||
48975028|NCT04731922|157740129|FG013|Overall Study|Adverse Event|0|||
48975029|NCT04731922|157740130|FG014|Overall Study|Adverse Event|0|||
48975030|NCT04731922|157740131|FG015|Overall Study|Adverse Event|0|||
48975031|NCT04731922|157740132|FG016|Overall Study|Adverse Event|0|||
48975032|NCT04731922|157740116|FG000|Overall Study|Lost to Follow-up|0|||
48975033|NCT04731922|157740117|FG001|Overall Study|Lost to Follow-up|0|||
48975034|NCT04731922|157740118|FG002|Overall Study|Lost to Follow-up|0|||
48975035|NCT04731922|157740119|FG003|Overall Study|Lost to Follow-up|1|||
48975036|NCT04731922|157740120|FG004|Overall Study|Lost to Follow-up|0|||
48975037|NCT04731922|157740121|FG005|Overall Study|Lost to Follow-up|1|||
48975038|NCT04731922|157740122|FG006|Overall Study|Lost to Follow-up|0|||
48761825|NCT02726074|156975715|FG000|Overall Study|Others|3|||
48761826|NCT02140567|156975716|FG000|Overall Study|Problems with recording equipment|6|||
48761827|NCT02036502|156975717|FG000|Part 1:Dose Determination/Escalation|Death|3|||
48761828|NCT02036502|156975718|FG001|Part 1:Dose Determination/Escalation|Death|2|||
48975039|NCT04731922|157740123|FG007|Overall Study|Lost to Follow-up|0|||
48975040|NCT04731922|157740124|FG008|Overall Study|Lost to Follow-up|0|||
48975041|NCT04731922|157740125|FG009|Overall Study|Lost to Follow-up|0|||
48975042|NCT04731922|157740126|FG010|Overall Study|Lost to Follow-up|0|||
48975043|NCT04731922|157740127|FG011|Overall Study|Lost to Follow-up|0|||
48975044|NCT04731922|157740128|FG012|Overall Study|Lost to Follow-up|0|||
48975045|NCT04731922|157740129|FG013|Overall Study|Lost to Follow-up|0|||
48975046|NCT04731922|157740130|FG014|Overall Study|Lost to Follow-up|0|||
48975047|NCT04731922|157740131|FG015|Overall Study|Lost to Follow-up|0|||
48975048|NCT04731922|157740132|FG016|Overall Study|Lost to Follow-up|0|||
48975049|NCT04731922|157740116|FG000|Overall Study|Withdrawal by Subject|1|||
48975050|NCT04731922|157740117|FG001|Overall Study|Withdrawal by Subject|0|||
48975051|NCT04731922|157740118|FG002|Overall Study|Withdrawal by Subject|0|||
48975052|NCT04731922|157740119|FG003|Overall Study|Withdrawal by Subject|0|||
48975053|NCT04731922|157740120|FG004|Overall Study|Withdrawal by Subject|1|||
48975054|NCT04731922|157740121|FG005|Overall Study|Withdrawal by Subject|0|||
48975055|NCT04731922|157740122|FG006|Overall Study|Withdrawal by Subject|1|||
48975056|NCT04731922|157740123|FG007|Overall Study|Withdrawal by Subject|0|||
48975057|NCT04731922|157740124|FG008|Overall Study|Withdrawal by Subject|0|||
48975058|NCT04731922|157740125|FG009|Overall Study|Withdrawal by Subject|0|||
48975059|NCT04731922|157740126|FG010|Overall Study|Withdrawal by Subject|0|||
48975060|NCT04731922|157740127|FG011|Overall Study|Withdrawal by Subject|0|||
48975061|NCT04731922|157740128|FG012|Overall Study|Withdrawal by Subject|0|||
48975062|NCT04731922|157740129|FG013|Overall Study|Withdrawal by Subject|1|||
48975063|NCT04731922|157740130|FG014|Overall Study|Withdrawal by Subject|0|||
48975064|NCT04731922|157740131|FG015|Overall Study|Withdrawal by Subject|0|||
48975065|NCT04731922|157740132|FG016|Overall Study|Withdrawal by Subject|0|||
48975066|NCT04731922|157740116|FG000|Overall Study|Other|0|||
48975067|NCT04731922|157740117|FG001|Overall Study|Other|0|||
48975068|NCT04731922|157740118|FG002|Overall Study|Other|0|||
48975069|NCT04731922|157740119|FG003|Overall Study|Other|0|||
48975070|NCT04731922|157740120|FG004|Overall Study|Other|0|||
48975071|NCT04731922|157740121|FG005|Overall Study|Other|0|||
48975072|NCT04731922|157740122|FG006|Overall Study|Other|1|||
48975073|NCT04731922|157740123|FG007|Overall Study|Other|0|||
48975074|NCT04731922|157740124|FG008|Overall Study|Other|0|||
48975075|NCT04731922|157740125|FG009|Overall Study|Other|0|||
48975076|NCT04731922|157740126|FG010|Overall Study|Other|0|||
48975077|NCT04731922|157740127|FG011|Overall Study|Other|0|||
48975078|NCT04731922|157740128|FG012|Overall Study|Other|0|||
48975079|NCT04731922|157740129|FG013|Overall Study|Other|0|||
48975080|NCT04731922|157740130|FG014|Overall Study|Other|0|||
48975081|NCT04731922|157740131|FG015|Overall Study|Other|0|||
48975082|NCT04731922|157740132|FG016|Overall Study|Other|0|||
48975083|NCT02007252|157740133|FG000|Overall Study|Administrative problems|3|||
48975084|NCT02007252|157740134|FG001|Overall Study|Administrative problems|7|||
48975085|NCT02007252|157740133|FG000|Overall Study|Abnormal laboratory value(s)|1|||
48975086|NCT02007252|157740134|FG001|Overall Study|Abnormal laboratory value(s)|0|||
48975087|NCT02007252|157740133|FG000|Overall Study|Adverse Event|7|||
48975088|NCT02007252|157740134|FG001|Overall Study|Adverse Event|4|||
48975089|NCT00527072|157740135|FG000|Overall Study|Adverse Event|13|||
48975090|NCT00527072|157740135|FG000|Overall Study|Lack of Efficacy|11|||
48975091|NCT00527072|157740135|FG000|Overall Study|Lost to Follow-up|3|||
48975092|NCT00527072|157740135|FG000|Overall Study|Protocol Violation|2|||
48975093|NCT00527072|157740135|FG000|Overall Study|Withdrawal by Subject|7|||
48975094|NCT03417505|157740136|FG000|First Lens Type (30 Days)|Lost to Follow-up|1|||
48975095|NCT03417505|157740137|FG001|First Lens Type (30 Days)|Lost to Follow-up|1|||
48975096|NCT00254163|157740138|FG000|Overall Study|Adverse Event|29|||
48975097|NCT00254163|157740139|FG001|Overall Study|Adverse Event|26|||
48975098|NCT00254163|157740138|FG000|Overall Study|Patient request/withdrew consent|6|||
48975099|NCT00254163|157740139|FG001|Overall Study|Patient request/withdrew consent|4|||
48975100|NCT00254163|157740138|FG000|Overall Study|Investigator request|1|||
48975101|NCT00254163|157740139|FG001|Overall Study|Investigator request|3|||
48975102|NCT00254163|157740138|FG000|Overall Study|Failed entry|1|||
48975103|NCT00254163|157740139|FG001|Overall Study|Failed entry|3|||
48975104|NCT00254163|157740138|FG000|Overall Study|Progressive disease|0|||
48975105|NCT00254163|157740139|FG001|Overall Study|Progressive disease|1|||
48975106|NCT00254163|157740138|FG000|Overall Study|Death|0|||
48975107|NCT00254163|157740139|FG001|Overall Study|Death|1|||
48975108|NCT00254163|157740138|FG000|Overall Study|Other|8|||
48975109|NCT00254163|157740139|FG001|Overall Study|Other|8|||
48975110|NCT01119963|157740140|FG000|Overall Study|Lost to Follow-up|1|||
48975111|NCT01119963|157740141|FG001|Overall Study|Lost to Follow-up|1|||
48975112|NCT02657434|157740142|FG000|Overall Study|Study Terminated By Sponsor|64|||
48975113|NCT02657434|157740143|FG001|Overall Study|Study Terminated By Sponsor|82|||
48975114|NCT02657434|157740142|FG000|Overall Study|Death|189|||
48975115|NCT02657434|157740143|FG001|Overall Study|Death|190|||
48975116|NCT02657434|157740142|FG000|Overall Study|Lost to Follow-up|2|||
48975117|NCT02657434|157740143|FG001|Overall Study|Lost to Follow-up|2|||
48975118|NCT02657434|157740142|FG000|Overall Study|Randomization by Error|2|||
48975119|NCT02657434|157740143|FG001|Overall Study|Randomization by Error|0|||
48975120|NCT02657434|157740142|FG000|Overall Study|Withdrawal by Subject|28|||
48873837|NCT00338949|157375169|FG000|Randomization|Withdrawal by Subject|1|||
48873838|NCT00338949|157375170|FG001|Randomization|Withdrawal by Subject|0|||
48873839|NCT00338949|157375169|FG000|Randomization|Adverse Event|0|||
48975121|NCT02657434|157740143|FG001|Overall Study|Withdrawal by Subject|17|||
48975122|NCT02657434|157740142|FG000|Overall Study|Protocol Violation|1|||
48975123|NCT02657434|157740143|FG001|Overall Study|Protocol Violation|0|||
48975124|NCT02657434|157740142|FG000|Overall Study|Physician Decision|0|||
48873840|NCT00338949|157375170|FG001|Randomization|Adverse Event|5|||
48873841|NCT03000348|157375172|FG000|Overall Study|Adverse Event|1|||
48873842|NCT03000348|157375173|FG001|Overall Study|Adverse Event|1|||
48873843|NCT03000348|157375174|FG002|Overall Study|Adverse Event|1|||
48873844|NCT03000348|157375175|FG003|Overall Study|Adverse Event|1|||
48975125|NCT02657434|157740143|FG001|Overall Study|Physician Decision|1|||
48873845|NCT03000348|157375176|FG004|Overall Study|Adverse Event|1|||
48975126|NCT00239356|157740146|FG000|Overall Study|Lack of Efficacy|1|||
48975127|NCT00239356|157740147|FG001|Overall Study|Lack of Efficacy|0|||
48873846|NCT03000348|157375177|FG005|Overall Study|Adverse Event|1|||
48873847|NCT03000348|157375172|FG000|Overall Study|Lost to Follow-up|0|||
48975128|NCT00239356|157740146|FG000|Overall Study|Adverse Event|6|||
48975129|NCT00239356|157740147|FG001|Overall Study|Adverse Event|0|||
48975130|NCT00239356|157740146|FG000|Overall Study|Withdrawal by Subject|15|||
48675277|NCT00545103|156663454|FG003|Overall Study|Withdrawal by Subject|22|||
48675278|NCT00545103|156663451|FG000|Overall Study|Adverse Event|11|||
48975131|NCT00239356|157740147|FG001|Overall Study|Withdrawal by Subject|6|||
48975132|NCT00239356|157740146|FG000|Overall Study|Lost to Follow-up|3|||
48975133|NCT00239356|157740147|FG001|Overall Study|Lost to Follow-up|0|||
48975134|NCT00239356|157740146|FG000|Overall Study|poor/non-compliance|2|||
48975135|NCT00239356|157740147|FG001|Overall Study|poor/non-compliance|0|||
48975136|NCT00239356|157740146|FG000|Overall Study|Pregnancy|1|||
48975137|NCT00239356|157740147|FG001|Overall Study|Pregnancy|0|||
48975138|NCT00239356|157740146|FG000|Overall Study|Administrative reason|0|||
48975139|NCT00239356|157740147|FG001|Overall Study|Administrative reason|1|||
48975140|NCT00239356|157740146|FG000|Overall Study|Drug available on market|11|||
48975141|NCT00239356|157740147|FG001|Overall Study|Drug available on market|2|||
48975142|NCT04897594|157740151|FG000|Overall Study|Lost to Follow-up|0|||
48975143|NCT04897594|157740152|FG001|Overall Study|Lost to Follow-up|1|||
48975144|NCT04897594|157740153|FG002|Overall Study|Lost to Follow-up|1|||
48975145|NCT04897594|157740151|FG000|Overall Study|Sponsor Decision|0|||
48975146|NCT04897594|157740152|FG001|Overall Study|Sponsor Decision|0|||
48975147|NCT04897594|157740153|FG002|Overall Study|Sponsor Decision|1|||
48975148|NCT04897594|157740151|FG000|Overall Study|Withdrawal by Subject|1|||
48975149|NCT04897594|157740152|FG001|Overall Study|Withdrawal by Subject|0|||
48975150|NCT04897594|157740153|FG002|Overall Study|Withdrawal by Subject|1|||
48975151|NCT02911519|157740156|FG000|Overall Study|Lost to Follow-up|2|||
48975152|NCT02911519|157740157|FG001|Overall Study|Lost to Follow-up|2|||
48975153|NCT02911519|157740156|FG000|Overall Study|Death|0|||
48975154|NCT02911519|157740157|FG001|Overall Study|Death|2|||
48975155|NCT03892707|157740158|FG000|Overall Study|Screen failure|6|||
48975156|NCT03892707|157740159|FG001|Overall Study|Screen failure|0|||
48975157|NCT03892707|157740158|FG000|Overall Study|Pain resolution|0|||
48975158|NCT03892707|157740159|FG001|Overall Study|Pain resolution|4|||
48975159|NCT03892707|157740158|FG000|Overall Study|Withdrawal by Subject|0|||
48975160|NCT03892707|157740159|FG001|Overall Study|Withdrawal by Subject|1|||
48975161|NCT03892707|157740158|FG000|Overall Study|Other (long business trip)|0|||
48975162|NCT03892707|157740159|FG001|Overall Study|Other (long business trip)|1|||
48975163|NCT00810043|157740160|FG000|Overall Study|Withdrawal by Subject|1|||
48975164|NCT00810043|157740161|FG001|Overall Study|Withdrawal by Subject|0|||
48975165|NCT00810043|157740162|FG002|Overall Study|Withdrawal by Subject|2|||
48975166|NCT00810043|157740160|FG000|Overall Study|Lost to Follow-up|1|||
48975167|NCT00810043|157740161|FG001|Overall Study|Lost to Follow-up|0|||
48975168|NCT00810043|157740162|FG002|Overall Study|Lost to Follow-up|0|||
48975169|NCT00810043|157740160|FG000|Overall Study|Physician Decision|0|||
48975170|NCT00810043|157740161|FG001|Overall Study|Physician Decision|0|||
48975171|NCT00810043|157740162|FG002|Overall Study|Physician Decision|2|||
48975172|NCT00810043|157740160|FG000|Overall Study|Death|2|||
48975173|NCT00810043|157740161|FG001|Overall Study|Death|0|||
48975174|NCT00810043|157740162|FG002|Overall Study|Death|0|||
48975175|NCT00810043|157740160|FG000|Overall Study|Unrelated medical problem|0|||
48975176|NCT00810043|157740161|FG001|Overall Study|Unrelated medical problem|1|||
48975177|NCT00810043|157740162|FG002|Overall Study|Unrelated medical problem|0|||
48975178|NCT00810043|157740160|FG000|Overall Study|Non-medical problem|0|||
48975179|NCT00810043|157740161|FG001|Overall Study|Non-medical problem|0|||
48975180|NCT00810043|157740162|FG002|Overall Study|Non-medical problem|1|||
48975181|NCT00810043|157740160|FG000|Overall Study|No longer met enrollment criteria|0|||
48975182|NCT00810043|157740161|FG001|Overall Study|No longer met enrollment criteria|0|||
48975183|NCT00810043|157740162|FG002|Overall Study|No longer met enrollment criteria|3|||
48975184|NCT01665768|157740163|FG000|Overall Study|Adverse Event|3|||
48975185|NCT01665768|157740163|FG000|Overall Study|Lack of Efficacy|19|||
48975186|NCT01665768|157740163|FG000|Overall Study|Withdrawal by Subject|1|||
48975187|NCT03051217|157740164|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|2|||
48975188|NCT03051217|157740165|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
48975189|NCT03051217|157740166|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
48975190|NCT03051217|157740167|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
48975191|NCT03051217|157740168|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
48975192|NCT03051217|157740169|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
48675279|NCT00545103|156663452|FG001|Overall Study|Adverse Event|12|||
48675280|NCT00545103|156663453|FG002|Overall Study|Adverse Event|17|||
48675281|NCT00545103|156663454|FG003|Overall Study|Adverse Event|10|||
48675282|NCT00545103|156663451|FG000|Overall Study|Lost to Follow-up|4|||
48975193|NCT03051217|157740170|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
48975194|NCT03051217|157740164|FG000|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
48675283|NCT00545103|156663452|FG001|Overall Study|Lost to Follow-up|6|||
48975195|NCT03051217|157740165|FG001|Initial Period (Week 0 to Week 16)|Protocol Violation|1|||
48975196|NCT03051217|157740166|FG002|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
48975197|NCT03051217|157740167|FG003|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
48975198|NCT03051217|157740168|FG004|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
48975199|NCT03051217|157740169|FG005|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
48975200|NCT03051217|157740170|FG006|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
48675284|NCT00545103|156663453|FG002|Overall Study|Lost to Follow-up|3|||
48675285|NCT00545103|156663454|FG003|Overall Study|Lost to Follow-up|4|||
48675286|NCT00545103|156663451|FG000|Overall Study|Protocol Violation|1|||
48675287|NCT00545103|156663452|FG001|Overall Study|Protocol Violation|2|||
48675288|NCT00545103|156663453|FG002|Overall Study|Protocol Violation|3|||
48675289|NCT00545103|156663454|FG003|Overall Study|Protocol Violation|0|||
48675290|NCT00545103|156663451|FG000|Overall Study|Suspected recurrence of diverticulitis|1|||
48975201|NCT03051217|157740164|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
48975202|NCT03051217|157740165|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
48975203|NCT03051217|157740166|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
48975204|NCT03051217|157740167|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
48975205|NCT03051217|157740168|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
48975206|NCT03051217|157740169|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
48975207|NCT03051217|157740170|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
48975208|NCT03051217|157740164|FG000|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
48975209|NCT03051217|157740165|FG001|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
48975210|NCT03051217|157740166|FG002|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
48975211|NCT03051217|157740167|FG003|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
48975212|NCT03051217|157740168|FG004|Maintenance Period (Week 16 to Week 52)|Adverse Event|2|||
48975213|NCT03051217|157740169|FG005|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
48975214|NCT03051217|157740170|FG006|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
48975215|NCT03051217|157740164|FG000|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
48975216|NCT03051217|157740165|FG001|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
48975217|NCT03051217|157740166|FG002|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
48975218|NCT03051217|157740167|FG003|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1|||
48975219|NCT03051217|157740168|FG004|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
48975220|NCT03051217|157740169|FG005|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
48975221|NCT03051217|157740170|FG006|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
48975222|NCT03051217|157740164|FG000|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
48975223|NCT03051217|157740165|FG001|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
48975224|NCT03051217|157740166|FG002|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
48975225|NCT03051217|157740167|FG003|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1|||
48975226|NCT03051217|157740168|FG004|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
48975227|NCT03051217|157740169|FG005|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
48975228|NCT03051217|157740170|FG006|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
48975229|NCT03051217|157740164|FG000|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
48975230|NCT03051217|157740165|FG001|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
48975231|NCT03051217|157740166|FG002|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
48975232|NCT03051217|157740167|FG003|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
48975233|NCT03051217|157740168|FG004|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1|||
48975234|NCT03051217|157740169|FG005|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
48975235|NCT03051217|157740170|FG006|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
48975236|NCT03051217|157740164|FG000|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
48975237|NCT03051217|157740165|FG001|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
48975238|NCT03051217|157740166|FG002|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
48675291|NCT00545103|156663452|FG001|Overall Study|Suspected recurrence of diverticulitis|0|||
48675292|NCT00545103|156663453|FG002|Overall Study|Suspected recurrence of diverticulitis|0|||
48675293|NCT00545103|156663454|FG003|Overall Study|Suspected recurrence of diverticulitis|3|||
48675294|NCT00545103|156663451|FG000|Overall Study|Difficult to open package|0|||
48675295|NCT00545103|156663452|FG001|Overall Study|Difficult to open package|0|||
48675296|NCT00545103|156663453|FG002|Overall Study|Difficult to open package|0|||
48675297|NCT00545103|156663454|FG003|Overall Study|Difficult to open package|1|||
48675298|NCT00545103|156663451|FG000|Overall Study|Investigational product not taken|1|||
48675299|NCT00545103|156663452|FG001|Overall Study|Investigational product not taken|0|||
48675300|NCT00545103|156663453|FG002|Overall Study|Investigational product not taken|0|||
48675301|NCT00545103|156663454|FG003|Overall Study|Investigational product not taken|1|||
48675302|NCT00545103|156663451|FG000|Overall Study|Wish to start a family|0|||
48675303|NCT00545103|156663452|FG001|Overall Study|Wish to start a family|0|||
48675304|NCT00545103|156663453|FG002|Overall Study|Wish to start a family|0|||
48675305|NCT00545103|156663454|FG003|Overall Study|Wish to start a family|1|||
48675306|NCT00545103|156663451|FG000|Overall Study|Diverticulitis crisis|0|||
48675307|NCT00545103|156663452|FG001|Overall Study|Diverticulitis crisis|0|||
48675308|NCT00545103|156663453|FG002|Overall Study|Diverticulitis crisis|0|||
48675309|NCT00545103|156663454|FG003|Overall Study|Diverticulitis crisis|1|||
48675310|NCT00545103|156663451|FG000|Overall Study|Personal reasons|1|||
48675311|NCT00545103|156663452|FG001|Overall Study|Personal reasons|0|||
48675312|NCT00545103|156663453|FG002|Overall Study|Personal reasons|0|||
48975239|NCT03051217|157740167|FG003|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
48975240|NCT03051217|157740168|FG004|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
48975241|NCT03051217|157740169|FG005|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1|||
48975242|NCT03051217|157740170|FG006|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
48975243|NCT00641706|157740171|FG000|Overall Study|Adverse Event|2|||
48975244|NCT00641706|157740172|FG001|Overall Study|Adverse Event|1|||
48975245|NCT00641706|157740171|FG000|Overall Study|Withdrawal by Subject|6|||
48975246|NCT00641706|157740172|FG001|Overall Study|Withdrawal by Subject|1|||
48975247|NCT00641706|157740171|FG000|Overall Study|Clinical Decline|1|||
48975248|NCT00641706|157740172|FG001|Overall Study|Clinical Decline|0|||
48975249|NCT00641706|157740171|FG000|Overall Study|Lead Investigator Decision|0|||
48975250|NCT00641706|157740172|FG001|Overall Study|Lead Investigator Decision|1|||
48975251|NCT03135262|157740173|FG000|Overall Study|discontinued due to worsening of pre-existing medical condition|1|||
48975252|NCT03135262|157740174|FG001|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
48975253|NCT03135262|157740175|FG002|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
48975254|NCT03135262|157740176|FG003|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
48975255|NCT03135262|157740177|FG004|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
48975256|NCT03135262|157740173|FG000|Overall Study|Progression of disease|0|||
48975257|NCT03135262|157740174|FG001|Overall Study|Progression of disease|0|||
48975258|NCT03135262|157740175|FG002|Overall Study|Progression of disease|0|||
48975259|NCT03135262|157740176|FG003|Overall Study|Progression of disease|1|||
48975260|NCT03135262|157740177|FG004|Overall Study|Progression of disease|0|||
48975261|NCT03135262|157740173|FG000|Overall Study|Death|6|||
48975262|NCT03135262|157740174|FG001|Overall Study|Death|2|||
48975263|NCT03135262|157740175|FG002|Overall Study|Death|2|||
48975264|NCT03135262|157740176|FG003|Overall Study|Death|2|||
48975265|NCT03135262|157740177|FG004|Overall Study|Death|0|||
48975266|NCT03135262|157740173|FG000|Overall Study|Withdrawal by Subject|0|||
48975267|NCT03135262|157740174|FG001|Overall Study|Withdrawal by Subject|0|||
48675313|NCT00545103|156663454|FG003|Overall Study|Personal reasons|0|||
48975268|NCT03135262|157740175|FG002|Overall Study|Withdrawal by Subject|1|||
48975269|NCT03135262|157740176|FG003|Overall Study|Withdrawal by Subject|0|||
48975270|NCT03135262|157740177|FG004|Overall Study|Withdrawal by Subject|1|||
48975271|NCT03135262|157740173|FG000|Overall Study|Study terminated by sponsor|2|||
48975272|NCT03135262|157740174|FG001|Overall Study|Study terminated by sponsor|4|||
48975273|NCT03135262|157740175|FG002|Overall Study|Study terminated by sponsor|4|||
48975274|NCT03135262|157740176|FG003|Overall Study|Study terminated by sponsor|3|||
48975275|NCT03135262|157740177|FG004|Overall Study|Study terminated by sponsor|0|||
48975276|NCT01989572|157740187|FG000|Overall Study|Lack of Efficacy|35|||
48975277|NCT01989572|157740188|FG001|Overall Study|Lack of Efficacy|48|||
48975278|NCT01989572|157740189|FG002|Overall Study|Lack of Efficacy|48|||
48975279|NCT01989572|157740190|FG003|Overall Study|Lack of Efficacy|43|||
48975280|NCT01989572|157740191|FG004|Overall Study|Lack of Efficacy|71|||
48975281|NCT01989572|157740192|FG005|Overall Study|Lack of Efficacy|79|||
48975282|NCT01989572|157740187|FG000|Overall Study|Adverse Event|2|||
48975283|NCT01989572|157740188|FG001|Overall Study|Adverse Event|1|||
48975284|NCT01989572|157740189|FG002|Overall Study|Adverse Event|3|||
48975285|NCT01989572|157740190|FG003|Overall Study|Adverse Event|0|||
48975286|NCT01989572|157740191|FG004|Overall Study|Adverse Event|3|||
48975287|NCT01989572|157740192|FG005|Overall Study|Adverse Event|0|||
48975288|NCT01989572|157740187|FG000|Overall Study|Death|0|||
48975289|NCT01989572|157740188|FG001|Overall Study|Death|0|||
48975290|NCT01989572|157740189|FG002|Overall Study|Death|0|||
48975291|NCT01989572|157740190|FG003|Overall Study|Death|0|||
48975292|NCT01989572|157740191|FG004|Overall Study|Death|1|||
48975293|NCT01989572|157740192|FG005|Overall Study|Death|0|||
48975294|NCT01989572|157740187|FG000|Overall Study|Withdrawal by Subject|4|||
48975295|NCT01989572|157740188|FG001|Overall Study|Withdrawal by Subject|1|||
48975296|NCT01989572|157740189|FG002|Overall Study|Withdrawal by Subject|5|||
48975297|NCT01989572|157740190|FG003|Overall Study|Withdrawal by Subject|1|||
48975298|NCT01989572|157740191|FG004|Overall Study|Withdrawal by Subject|12|||
48975299|NCT01989572|157740192|FG005|Overall Study|Withdrawal by Subject|4|||
48975300|NCT01989572|157740187|FG000|Overall Study|complicating disease|1|||
48975301|NCT01989572|157740188|FG001|Overall Study|complicating disease|1|||
48975302|NCT01989572|157740189|FG002|Overall Study|complicating disease|2|||
48975303|NCT01989572|157740190|FG003|Overall Study|complicating disease|0|||
48975304|NCT01989572|157740191|FG004|Overall Study|complicating disease|1|||
48975305|NCT01989572|157740192|FG005|Overall Study|complicating disease|0|||
48975306|NCT01989572|157740187|FG000|Overall Study|error|2|||
48975307|NCT01989572|157740188|FG001|Overall Study|error|1|||
48975308|NCT01989572|157740189|FG002|Overall Study|error|1|||
48675314|NCT00545103|156663451|FG000|Overall Study|Subject's decision|1|||
48675315|NCT00545103|156663452|FG001|Overall Study|Subject's decision|0|||
48675316|NCT00545103|156663453|FG002|Overall Study|Subject's decision|0|||
48675317|NCT00545103|156663454|FG003|Overall Study|Subject's decision|0|||
48675318|NCT00545103|156663451|FG000|Overall Study|Noncompliance|0|||
48975309|NCT01989572|157740190|FG003|Overall Study|error|1|||
48975310|NCT01989572|157740191|FG004|Overall Study|error|1|||
48975311|NCT01989572|157740192|FG005|Overall Study|error|1|||
48975312|NCT01989572|157740187|FG000|Overall Study|maximum dose reached|0|||
48975313|NCT01989572|157740188|FG001|Overall Study|maximum dose reached|1|||
48975314|NCT01989572|157740189|FG002|Overall Study|maximum dose reached|0|||
48975315|NCT01989572|157740190|FG003|Overall Study|maximum dose reached|0|||
48975316|NCT01989572|157740191|FG004|Overall Study|maximum dose reached|1|||
48975317|NCT01989572|157740192|FG005|Overall Study|maximum dose reached|0|||
48975318|NCT01989572|157740187|FG000|Overall Study|unknown/not specify|3|||
48975319|NCT01989572|157740188|FG001|Overall Study|unknown/not specify|4|||
48975320|NCT01989572|157740189|FG002|Overall Study|unknown/not specify|1|||
48975321|NCT01989572|157740190|FG003|Overall Study|unknown/not specify|3|||
48975322|NCT01989572|157740191|FG004|Overall Study|unknown/not specify|3|||
48975323|NCT01989572|157740192|FG005|Overall Study|unknown/not specify|5|||
48975324|NCT01989572|157740187|FG000|Overall Study|not start protocol therapy|5|||
48975325|NCT01989572|157740188|FG001|Overall Study|not start protocol therapy|1|||
48975326|NCT01989572|157740189|FG002|Overall Study|not start protocol therapy|2|||
48975327|NCT01989572|157740190|FG003|Overall Study|not start protocol therapy|3|||
48975328|NCT01989572|157740191|FG004|Overall Study|not start protocol therapy|4|||
48975329|NCT01989572|157740192|FG005|Overall Study|not start protocol therapy|18|||
48975330|NCT01989572|157740187|FG000|Overall Study|alternative therapy|3|||
48975331|NCT01989572|157740188|FG001|Overall Study|alternative therapy|0|||
48975332|NCT01989572|157740189|FG002|Overall Study|alternative therapy|0|||
48975333|NCT01989572|157740190|FG003|Overall Study|alternative therapy|0|||
48975334|NCT01989572|157740191|FG004|Overall Study|alternative therapy|1|||
48975335|NCT01989572|157740192|FG005|Overall Study|alternative therapy|3|||
48975336|NCT04583969|157740193|FG000|Overall Study|Death|31|||
48975337|NCT04583969|157740194|FG001|Overall Study|Death|38|||
48975338|NCT04583969|157740193|FG000|Overall Study|Lost to Follow-up|16|||
48975339|NCT04583969|157740194|FG001|Overall Study|Lost to Follow-up|13|||
48975340|NCT04583969|157740193|FG000|Overall Study|Protocol Violation|1|||
48975341|NCT04583969|157740194|FG001|Overall Study|Protocol Violation|0|||
48975342|NCT04583969|157740193|FG000|Overall Study|Withdrawal by Subject|3|||
48975343|NCT04583969|157740194|FG001|Overall Study|Withdrawal by Subject|3|||
48975344|NCT04583969|157740193|FG000|Overall Study|RANDOMIZED BUT NOT DOSED|2|||
48975345|NCT04583969|157740194|FG001|Overall Study|RANDOMIZED BUT NOT DOSED|4|||
48975346|NCT04583969|157740193|FG000|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|1|||
48975347|NCT04583969|157740194|FG001|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|0|||
48975348|NCT04583969|157740193|FG000|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|1|||
48975349|NCT04583969|157740194|FG001|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|0|||
48975350|NCT04583969|157740193|FG000|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
48975351|NCT04583969|157740194|FG001|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
48975352|NCT04583969|157740193|FG000|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|1|||
48975353|NCT04583969|157740194|FG001|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|0|||
48975354|NCT02143141|157740201|FG000|Overall Study|pain scores at 24 hours not collected|1|||
48975355|NCT02143141|157740202|FG001|Overall Study|pain scores at 24 hours not collected|0|||
48975356|NCT00246376|157740203|FG000|Overall Study|Dropped/withdrew during dietary run-in|11|||
48975357|NCT00246376|157740204|FG001|Overall Study|Dropped/withdrew during dietary run-in|5|||
48975358|NCT00246376|157740205|FG002|Overall Study|Dropped/withdrew during dietary run-in|4|||
48975359|NCT00246376|157740206|FG003|Overall Study|Dropped/withdrew during dietary run-in|7|||
48975360|NCT00246376|157740207|FG004|Overall Study|Dropped/withdrew during dietary run-in|3|||
48975361|NCT00246376|157740203|FG000|Overall Study|Adverse Event|2|||
48975362|NCT00246376|157740204|FG001|Overall Study|Adverse Event|3|||
48975363|NCT00246376|157740205|FG002|Overall Study|Adverse Event|1|||
48975364|NCT00246376|157740206|FG003|Overall Study|Adverse Event|3|||
48975365|NCT00246376|157740207|FG004|Overall Study|Adverse Event|1|||
48975366|NCT00246376|157740203|FG000|Overall Study|Lost to Follow-up|2|||
48975367|NCT00246376|157740204|FG001|Overall Study|Lost to Follow-up|11|||
48975368|NCT00246376|157740205|FG002|Overall Study|Lost to Follow-up|11|||
48975369|NCT00246376|157740206|FG003|Overall Study|Lost to Follow-up|16|||
48975370|NCT00246376|157740207|FG004|Overall Study|Lost to Follow-up|13|||
48975371|NCT01057862|157740208|FG000|Overall Study|Withdrawal by Subject|1|||
48975372|NCT01057862|157740209|FG001|Overall Study|Withdrawal by Subject|2|||
48975373|NCT03363165|157740210|FG000|3-month Follow-up|Death|0|||
48975374|NCT03363165|157740211|FG001|3-month Follow-up|Death|1|||
48975375|NCT03363165|157740210|FG000|6-month Follow-up|Death|0|||
48975376|NCT03363165|157740211|FG001|6-month Follow-up|Death|1|||
48975377|NCT03363165|157740210|FG000|6-month Follow-up|Withdrawal by Subject|1|||
48975378|NCT03363165|157740211|FG001|6-month Follow-up|Withdrawal by Subject|1|||
48975379|NCT03363165|157740210|FG000|12-month Follow-up|Death|1|||
48975380|NCT03363165|157740211|FG001|12-month Follow-up|Death|1|||
48975381|NCT03363165|157740210|FG000|12-month Follow-up|Withdrawal by Subject|1|||
48975382|NCT03363165|157740211|FG001|12-month Follow-up|Withdrawal by Subject|1|||
48975383|NCT01585168|157740213|FG000|Overall Study|Lost to Follow-up|3|||
48975384|NCT01585168|157740214|FG001|Overall Study|Lost to Follow-up|1|||
48975385|NCT01585168|157740215|FG002|Overall Study|Lost to Follow-up|1|||
48975386|NCT01585168|157740216|FG003|Overall Study|Lost to Follow-up|1|||
48975387|NCT01855945|157740217|FG000|Overall Study|Adverse Event|0|||
48975388|NCT01855945|157740218|FG001|Overall Study|Adverse Event|0|||
48975389|NCT01855945|157740219|FG002|Overall Study|Adverse Event|0|||
48975390|NCT01855945|157740220|FG003|Overall Study|Adverse Event|0|||
48975391|NCT01855945|157740221|FG004|Overall Study|Adverse Event|0|||
48975392|NCT01855945|157740222|FG005|Overall Study|Adverse Event|0|||
48975393|NCT01855945|157740223|FG006|Overall Study|Adverse Event|1|||
48975394|NCT01855945|157740224|FG007|Overall Study|Adverse Event|0|||
48975395|NCT01855945|157740225|FG008|Overall Study|Adverse Event|0|||
48975396|NCT01855945|157740226|FG009|Overall Study|Adverse Event|0|||
48975397|NCT01855945|157740227|FG010|Overall Study|Adverse Event|0|||
48975398|NCT01855945|157740228|FG011|Overall Study|Adverse Event|0|||
48975399|NCT01855945|157740217|FG000|Overall Study|Death|0|||
48975400|NCT01855945|157740218|FG001|Overall Study|Death|0|||
48975401|NCT01855945|157740219|FG002|Overall Study|Death|0|||
48975402|NCT01855945|157740220|FG003|Overall Study|Death|0|||
48975403|NCT01855945|157740221|FG004|Overall Study|Death|0|||
48975404|NCT01855945|157740222|FG005|Overall Study|Death|0|||
48975405|NCT01855945|157740223|FG006|Overall Study|Death|2|||
48975406|NCT01855945|157740224|FG007|Overall Study|Death|0|||
48975407|NCT01855945|157740225|FG008|Overall Study|Death|0|||
48975408|NCT01855945|157740226|FG009|Overall Study|Death|0|||
48975409|NCT01855945|157740227|FG010|Overall Study|Death|0|||
48975410|NCT01855945|157740228|FG011|Overall Study|Death|0|||
48975411|NCT01855945|157740217|FG000|Overall Study|Lost to Follow-up|11|||
48975412|NCT01855945|157740218|FG001|Overall Study|Lost to Follow-up|10|||
48975413|NCT01855945|157740219|FG002|Overall Study|Lost to Follow-up|7|||
48975414|NCT01855945|157740220|FG003|Overall Study|Lost to Follow-up|3|||
48975415|NCT01855945|157740221|FG004|Overall Study|Lost to Follow-up|0|||
48975416|NCT01855945|157740222|FG005|Overall Study|Lost to Follow-up|3|||
48975417|NCT01855945|157740223|FG006|Overall Study|Lost to Follow-up|4|||
48975418|NCT01855945|157740224|FG007|Overall Study|Lost to Follow-up|7|||
48975419|NCT01855945|157740225|FG008|Overall Study|Lost to Follow-up|2|||
48975420|NCT01855945|157740226|FG009|Overall Study|Lost to Follow-up|0|||
48975421|NCT01855945|157740227|FG010|Overall Study|Lost to Follow-up|0|||
48975422|NCT01855945|157740228|FG011|Overall Study|Lost to Follow-up|2|||
48975423|NCT01855945|157740217|FG000|Overall Study|Other - Unclassified|1|||
48975424|NCT01855945|157740218|FG001|Overall Study|Other - Unclassified|1|||
48975425|NCT01855945|157740219|FG002|Overall Study|Other - Unclassified|1|||
48975426|NCT01855945|157740220|FG003|Overall Study|Other - Unclassified|0|||
48975427|NCT01855945|157740221|FG004|Overall Study|Other - Unclassified|0|||
48975428|NCT01855945|157740222|FG005|Overall Study|Other - Unclassified|0|||
48975429|NCT01855945|157740223|FG006|Overall Study|Other - Unclassified|2|||
48975430|NCT01855945|157740224|FG007|Overall Study|Other - Unclassified|1|||
48975431|NCT01855945|157740225|FG008|Overall Study|Other - Unclassified|0|||
48675319|NCT00545103|156663452|FG001|Overall Study|Noncompliance|1|||
48675320|NCT00545103|156663453|FG002|Overall Study|Noncompliance|0|||
48675321|NCT00545103|156663454|FG003|Overall Study|Noncompliance|0|||
48675322|NCT00545103|156663451|FG000|Overall Study|Investigator decision|0|||
48675323|NCT00545103|156663452|FG001|Overall Study|Investigator decision|0|||
48675324|NCT00545103|156663453|FG002|Overall Study|Investigator decision|1|||
48675325|NCT00545103|156663454|FG003|Overall Study|Investigator decision|0|||
48975432|NCT01855945|157740226|FG009|Overall Study|Other - Unclassified|0|||
48975433|NCT01855945|157740227|FG010|Overall Study|Other - Unclassified|1|||
48975434|NCT01855945|157740228|FG011|Overall Study|Other - Unclassified|0|||
48975435|NCT01855945|157740217|FG000|Overall Study|Withdrawal by Subject|4|||
48975436|NCT01855945|157740218|FG001|Overall Study|Withdrawal by Subject|0|||
48975437|NCT01855945|157740219|FG002|Overall Study|Withdrawal by Subject|4|||
48975438|NCT01855945|157740220|FG003|Overall Study|Withdrawal by Subject|1|||
48975439|NCT01855945|157740221|FG004|Overall Study|Withdrawal by Subject|1|||
48975440|NCT01855945|157740222|FG005|Overall Study|Withdrawal by Subject|0|||
48975441|NCT01855945|157740223|FG006|Overall Study|Withdrawal by Subject|1|||
48975442|NCT01855945|157740224|FG007|Overall Study|Withdrawal by Subject|0|||
48975443|NCT01855945|157740225|FG008|Overall Study|Withdrawal by Subject|0|||
48975444|NCT01855945|157740226|FG009|Overall Study|Withdrawal by Subject|2|||
48975445|NCT01855945|157740227|FG010|Overall Study|Withdrawal by Subject|4|||
48975446|NCT01855945|157740228|FG011|Overall Study|Withdrawal by Subject|1|||
48975447|NCT03146403|157740229|FG000|Overall Study|Withdrawal by Subject|0|||
48975448|NCT03146403|157740230|FG001|Overall Study|Withdrawal by Subject|3|||
48975449|NCT03146403|157740229|FG000|Overall Study|Lost to Follow-up|2|||
48975450|NCT03146403|157740230|FG001|Overall Study|Lost to Follow-up|0|||
48975451|NCT00770224|157740232|FG000|Step 1: Induction|Adverse Event|3|||
48975452|NCT00770224|157740233|FG001|Step 1: Induction|Adverse Event|0|||
48975453|NCT00770224|157740232|FG000|Step 1: Induction|Refusal unrelated to adverse event|6|||
48975454|NCT00770224|157740233|FG001|Step 1: Induction|Refusal unrelated to adverse event|0|||
48675326|NCT00545103|156663451|FG000|Overall Study|Subject moved|0|||
48975455|NCT00770224|157740232|FG000|Step 1: Induction|Other reason not protocol specified|2|||
48675327|NCT00545103|156663452|FG001|Overall Study|Subject moved|1|||
48675328|NCT00545103|156663453|FG002|Overall Study|Subject moved|0|||
48675329|NCT00545103|156663454|FG003|Overall Study|Subject moved|0|||
48675330|NCT00545103|156663451|FG000|Overall Study|Use of prohibited medication|0|||
48675331|NCT00545103|156663452|FG001|Overall Study|Use of prohibited medication|0|||
48675332|NCT00545103|156663453|FG002|Overall Study|Use of prohibited medication|1|||
48975456|NCT00770224|157740233|FG001|Step 1: Induction|Other reason not protocol specified|0|||
48975457|NCT00770224|157740232|FG000|Step 1: Induction|Ineligible|2|||
48975458|NCT00770224|157740233|FG001|Step 1: Induction|Ineligible|0|||
48975459|NCT00770224|157740232|FG000|Step 1: Induction|No protocol treatment given|1|||
48975460|NCT00770224|157740233|FG001|Step 1: Induction|No protocol treatment given|0|||
48975461|NCT00770224|157740232|FG000|Step 2: Maintenance|Adverse Event|0|||
48975462|NCT00770224|157740233|FG001|Step 2: Maintenance|Adverse Event|10|||
48975463|NCT00770224|157740232|FG000|Step 2: Maintenance|Refusal unrelated to adverse event|0|||
48975464|NCT00770224|157740233|FG001|Step 2: Maintenance|Refusal unrelated to adverse event|8|||
48975465|NCT00770224|157740232|FG000|Step 2: Maintenance|Progression/relapse|0|||
48975466|NCT00770224|157740233|FG001|Step 2: Maintenance|Progression/relapse|1|||
48975467|NCT00770224|157740232|FG000|Step 2: Maintenance|Death|0|||
48975468|NCT00770224|157740233|FG001|Step 2: Maintenance|Death|2|||
48975469|NCT00770224|157740232|FG000|Step 2: Maintenance|Other reason not protocol specified|0|||
48975470|NCT00770224|157740233|FG001|Step 2: Maintenance|Other reason not protocol specified|7|||
48975471|NCT00770224|157740232|FG000|Step 2: Maintenance|Ineligible|0|||
48975472|NCT00770224|157740233|FG001|Step 2: Maintenance|Ineligible|2|||
48975473|NCT04186663|157740238|FG000|Overall Study|Lost to Follow-up|1|||
48975474|NCT04186663|157740238|FG000|Overall Study|Unable to complete blood draw|3|||
48975475|NCT02033850|157740241|FG000|Overall Study|Death|1|||
48975476|NCT02033850|157740242|FG001|Overall Study|Death|0|||
48975477|NCT02033850|157740241|FG000|Overall Study|unrelated medical reason|1|||
48975478|NCT02033850|157740242|FG001|Overall Study|unrelated medical reason|1|||
48975479|NCT01202760|157740245|FG000|Overall Study|Entry Criteria Not Met|0|||
48975480|NCT01202760|157740246|FG001|Overall Study|Entry Criteria Not Met|3|||
48975481|NCT01202760|157740247|FG002|Overall Study|Entry Criteria Not Met|1|||
48975482|NCT01202760|157740245|FG000|Overall Study|Adverse Event|11|||
48975483|NCT01202760|157740246|FG001|Overall Study|Adverse Event|9|||
48975484|NCT01202760|157740247|FG002|Overall Study|Adverse Event|10|||
48975485|NCT01202760|157740245|FG000|Overall Study|Death|2|||
48975486|NCT01202760|157740246|FG001|Overall Study|Death|1|||
48975487|NCT01202760|157740247|FG002|Overall Study|Death|0|||
48975488|NCT01202760|157740245|FG000|Overall Study|Lack of Efficacy|6|||
48975489|NCT01202760|157740246|FG001|Overall Study|Lack of Efficacy|8|||
48975490|NCT01202760|157740247|FG002|Overall Study|Lack of Efficacy|7|||
48975491|NCT01202760|157740245|FG000|Overall Study|Lost to Follow-up|0|||
48975492|NCT01202760|157740246|FG001|Overall Study|Lost to Follow-up|2|||
48975493|NCT01202760|157740247|FG002|Overall Study|Lost to Follow-up|1|||
48975494|NCT01202760|157740245|FG000|Overall Study|Parent / Caregiver Decision|0|||
48975495|NCT01202760|157740246|FG001|Overall Study|Parent / Caregiver Decision|1|||
48975496|NCT01202760|157740247|FG002|Overall Study|Parent / Caregiver Decision|0|||
48975497|NCT01202760|157740245|FG000|Overall Study|Withdrawal by Subject|17|||
48975498|NCT01202760|157740246|FG001|Overall Study|Withdrawal by Subject|18|||
48975499|NCT01202760|157740247|FG002|Overall Study|Withdrawal by Subject|14|||
48975500|NCT01202760|157740245|FG000|Overall Study|Physician Decision|0|||
48975501|NCT01202760|157740246|FG001|Overall Study|Physician Decision|1|||
48975502|NCT01202760|157740247|FG002|Overall Study|Physician Decision|0|||
48975503|NCT01202760|157740245|FG000|Overall Study|Protocol Violation|7|||
48975504|NCT01202760|157740246|FG001|Overall Study|Protocol Violation|5|||
48975505|NCT01202760|157740247|FG002|Overall Study|Protocol Violation|2|||
48975506|NCT01202760|157740245|FG000|Overall Study|Sponsor Decision|4|||
48975507|NCT01202760|157740246|FG001|Overall Study|Sponsor Decision|4|||
48975508|NCT01202760|157740247|FG002|Overall Study|Sponsor Decision|0|||
48675333|NCT00545103|156663454|FG003|Overall Study|Use of prohibited medication|0|||
48975509|NCT05041062|157740253|FG000|Overall Study|Adverse Event|2|||
48975510|NCT02820038|157740254|FG000|Overall Study|Lost to Follow-up|7|||
48975511|NCT02820038|157740255|FG001|Overall Study|Lost to Follow-up|11|||
48975512|NCT02820038|157740256|FG002|Overall Study|Lost to Follow-up|2|||
48975513|NCT02820038|157740257|FG003|Overall Study|Lost to Follow-up|9|||
48975514|NCT02820038|157740254|FG000|Overall Study|Withdrawal by Subject|3|||
48975515|NCT02820038|157740255|FG001|Overall Study|Withdrawal by Subject|14|||
48975516|NCT02820038|157740256|FG002|Overall Study|Withdrawal by Subject|3|||
48975517|NCT02820038|157740257|FG003|Overall Study|Withdrawal by Subject|13|||
48975518|NCT03215667|157740259|FG000|Overall Study|Physician Decision|4|||
48975519|NCT03934203|157740260|FG000|Overall Study|Adverse Event|0|||
48975520|NCT03934203|157740261|FG001|Overall Study|Adverse Event|0|||
48975521|NCT03934203|157740262|FG002|Overall Study|Adverse Event|1|||
48975522|NCT03934203|157740263|FG003|Overall Study|Adverse Event|0|||
48975523|NCT03934203|157740264|FG004|Overall Study|Adverse Event|1|||
48975524|NCT03934203|157740265|FG005|Overall Study|Adverse Event|0|||
48975525|NCT03934203|157740266|FG006|Overall Study|Adverse Event|2|||
48975526|NCT03934203|157740267|FG007|Overall Study|Adverse Event|0|||
48975527|NCT03934203|157740268|FG008|Overall Study|Adverse Event|0|||
48975528|NCT03934203|157740269|FG009|Overall Study|Adverse Event|0|||
48975529|NCT03934203|157740270|FG010|Overall Study|Adverse Event|0|||
48975530|NCT03934203|157740271|FG011|Overall Study|Adverse Event|0|||
48975531|NCT03934203|157740272|FG012|Overall Study|Adverse Event|0|||
48975532|NCT03934203|157740273|FG013|Overall Study|Adverse Event|1|||
48975533|NCT03934203|157740274|FG014|Overall Study|Adverse Event|0|||
48975534|NCT00412113|157740275|FG000|Overall Study|Adverse Event|11|||
48975535|NCT00412113|157740276|FG001|Overall Study|Adverse Event|15|||
48975536|NCT00412113|157740275|FG000|Overall Study|did not receive treatment|1|||
48975537|NCT00412113|157740276|FG001|Overall Study|did not receive treatment|0|||
48975538|NCT03682055|157742470|FG000|Overall Study|Lack of Efficacy|1|||
48975539|NCT03682055|157742471|FG001|Overall Study|Lack of Efficacy|2|||
48975540|NCT03682055|157742472|FG002|Overall Study|Lack of Efficacy|1|||
48975541|NCT03682055|157742473|FG003|Overall Study|Lack of Efficacy|2|||
48975542|NCT03682055|157742474|FG004|Overall Study|Lack of Efficacy|1|||
48975543|NCT03682055|157742475|FG005|Overall Study|Lack of Efficacy|3|||
48975544|NCT03682055|157742470|FG000|Overall Study|Withdrawal by Subject|0|||
48975545|NCT03682055|157742471|FG001|Overall Study|Withdrawal by Subject|0|||
48975546|NCT03682055|157742472|FG002|Overall Study|Withdrawal by Subject|0|||
48975547|NCT03682055|157742473|FG003|Overall Study|Withdrawal by Subject|0|||
48975548|NCT03682055|157742474|FG004|Overall Study|Withdrawal by Subject|0|||
48975549|NCT03682055|157742475|FG005|Overall Study|Withdrawal by Subject|1|||
48975550|NCT03682055|157742470|FG000|Overall Study|Termination of Study by Sponsor|0|||
48975551|NCT03682055|157742471|FG001|Overall Study|Termination of Study by Sponsor|0|||
48975552|NCT03682055|157742472|FG002|Overall Study|Termination of Study by Sponsor|0|||
48975553|NCT03682055|157742473|FG003|Overall Study|Termination of Study by Sponsor|0|||
48975554|NCT03682055|157742474|FG004|Overall Study|Termination of Study by Sponsor|0|||
48975555|NCT03682055|157742475|FG005|Overall Study|Termination of Study by Sponsor|3|||
48975556|NCT03127852|157742476|FG000|Overall Study|Withdrawal by Subject|4|||
48975557|NCT03127852|157742477|FG001|Overall Study|Withdrawal by Subject|1|||
48975558|NCT03127852|157742476|FG000|Overall Study|Death|1|||
48975559|NCT03127852|157742477|FG001|Overall Study|Death|1|||
48975560|NCT01135394|157742478|FG000|Screening|Lost to Follow-up|2|||
48975561|NCT01135394|157742478|FG000|Screening|Withdrawal by Subject|10|||
48975562|NCT01135394|157742478|FG000|Screening|Screening failure|16|||
48975563|NCT01135394|157742478|FG000|Screening|Physician Decision|5|||
48975564|NCT01135394|157742478|FG000|Baseline Assessment|Withdrawal by Subject|9|||
48975565|NCT01135394|157742478|FG000|Baseline Assessment|Physician Decision|3|||
48975566|NCT01135394|157742478|FG000|Baseline Assessment|Lost to Follow-up|2|||
48975567|NCT01135394|157742478|FG000|Baseline Assessment|Adverse Event|1|||
48975568|NCT01135394|157742478|FG000|Study Treatment|Withdrawal by Subject|1|||
48975569|NCT01135394|157742478|FG000|Study Treatment|Physician Decision|1|||
48975570|NCT01135394|157742478|FG000|Study Treatment|Adverse Event|2|||
48975571|NCT03597503|157742482|FG000|Overall Study|Withdrawal by Subject|0|||
48675334|NCT00545103|156663451|FG000|Overall Study|Does not want to take study drug anymore|1|||
48975572|NCT03597503|157742483|FG001|Overall Study|Withdrawal by Subject|2|||
48975573|NCT03597503|157742482|FG000|Overall Study|Lost to Follow-up|1|||
48975574|NCT03597503|157742483|FG001|Overall Study|Lost to Follow-up|2|||
48975575|NCT03597503|157742482|FG000|Overall Study|Protocol Violation|1|||
48975576|NCT03597503|157742483|FG001|Overall Study|Protocol Violation|0|||
48975577|NCT00323310|157742484|FG000|Overall Study|Withdrawal by Subject|1|||
48975578|NCT00323310|157742484|FG000|Overall Study|a parent refused blood draw|1|||
48975579|NCT00323310|157742484|FG000|Overall Study|did not complete the 24-hr f-up visit|1|||
48975580|NCT03510910|157742485|FG000|Overall Study|Incomplete Survey|2|||
48975581|NCT03510910|157742486|FG001|Overall Study|Incomplete Survey|3|||
48975582|NCT03984812|157742487|FG000|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
48975583|NCT03984812|157742488|FG001|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
48975584|NCT03984812|157742489|FG002|Part 1 (Up to Day 28)|Withdrawal by Subject|1|||
48675335|NCT00545103|156663452|FG001|Overall Study|Does not want to take study drug anymore|0|||
48675336|NCT00545103|156663453|FG002|Overall Study|Does not want to take study drug anymore|1|||
48675337|NCT00545103|156663454|FG003|Overall Study|Does not want to take study drug anymore|0|||
48675338|NCT00545103|156663451|FG000|Overall Study|Subject met endpoint under protocol v. 1|0|||
48675339|NCT00545103|156663452|FG001|Overall Study|Subject met endpoint under protocol v. 1|0|||
48975585|NCT03984812|157742490|FG003|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
48975586|NCT03984812|157742491|FG004|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
48975587|NCT03984812|157742492|FG005|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
48975588|NCT03984812|157742493|FG006|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
48975589|NCT03984812|157742494|FG007|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
48975590|NCT03984812|157742495|FG008|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
48975591|NCT03984812|157742496|FG009|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
48975592|NCT03984812|157742497|FG010|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
48975593|NCT02574481|157742498|FG000|Overall Study|Withdrawal by Subject|29|||
48975594|NCT02574481|157742499|FG001|Overall Study|Withdrawal by Subject|15|||
48975595|NCT02574481|157742500|FG002|Overall Study|Withdrawal by Subject|4|||
48873848|NCT03000348|157375173|FG001|Overall Study|Lost to Follow-up|0|||
48873849|NCT03000348|157375174|FG002|Overall Study|Lost to Follow-up|1|||
48873850|NCT03000348|157375175|FG003|Overall Study|Lost to Follow-up|0|||
48873851|NCT03000348|157375176|FG004|Overall Study|Lost to Follow-up|0|||
48873852|NCT03000348|157375177|FG005|Overall Study|Lost to Follow-up|0|||
48873853|NCT03000348|157375172|FG000|Overall Study|Withdrawal by Subject|0|||
48873854|NCT03000348|157375173|FG001|Overall Study|Withdrawal by Subject|1|||
48873855|NCT03000348|157375174|FG002|Overall Study|Withdrawal by Subject|0|||
48873856|NCT03000348|157375175|FG003|Overall Study|Withdrawal by Subject|0|||
48873857|NCT03000348|157375176|FG004|Overall Study|Withdrawal by Subject|0|||
48873858|NCT03000348|157375177|FG005|Overall Study|Withdrawal by Subject|0|||
48873859|NCT03000348|157375172|FG000|Overall Study|Consent|0|||
48873860|NCT03000348|157375173|FG001|Overall Study|Consent|0|||
48873861|NCT03000348|157375174|FG002|Overall Study|Consent|0|||
48873862|NCT03000348|157375175|FG003|Overall Study|Consent|0|||
48873863|NCT03000348|157375176|FG004|Overall Study|Consent|1|||
48873864|NCT03000348|157375177|FG005|Overall Study|Consent|0|||
48873865|NCT03000348|157375172|FG000|Overall Study|Failure to expectorate sputum|1|||
48873866|NCT03000348|157375173|FG001|Overall Study|Failure to expectorate sputum|0|||
48873867|NCT03000348|157375174|FG002|Overall Study|Failure to expectorate sputum|1|||
48873868|NCT03000348|157375175|FG003|Overall Study|Failure to expectorate sputum|0|||
48873869|NCT03000348|157375176|FG004|Overall Study|Failure to expectorate sputum|1|||
48873870|NCT03000348|157375177|FG005|Overall Study|Failure to expectorate sputum|0|||
48873871|NCT03000348|157375172|FG000|Overall Study|No gram negative|1|||
48873872|NCT03000348|157375173|FG001|Overall Study|No gram negative|2|||
48873873|NCT03000348|157375174|FG002|Overall Study|No gram negative|1|||
48761829|NCT02036502|156975719|FG002|Part 1:Dose Determination/Escalation|Death|0|||
48761830|NCT02036502|156975720|FG003|Part 1:Dose Determination/Escalation|Death|0|||
48761831|NCT02036502|156975721|FG004|Part 1:Dose Determination/Escalation|Death|0|||
48675340|NCT00545103|156663453|FG002|Overall Study|Subject met endpoint under protocol v. 1|1|||
48675341|NCT00545103|156663454|FG003|Overall Study|Subject met endpoint under protocol v. 1|0|||
48675342|NCT00545103|156663451|FG000|Overall Study|Death|0|||
48675343|NCT00545103|156663452|FG001|Overall Study|Death|1|||
48675344|NCT00545103|156663453|FG002|Overall Study|Death|0|||
48675345|NCT00545103|156663454|FG003|Overall Study|Death|0|||
48761832|NCT02036502|156975722|FG005|Part 1:Dose Determination/Escalation|Death|0|||
48761833|NCT02036502|156975723|FG006|Part 1:Dose Determination/Escalation|Death|0|||
48761834|NCT02036502|156975724|FG007|Part 1:Dose Determination/Escalation|Death|0|||
48761835|NCT02036502|156975717|FG000|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3|||
48761836|NCT02036502|156975718|FG001|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
48761837|NCT02036502|156975719|FG002|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
48761838|NCT02036502|156975720|FG003|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
48761839|NCT02036502|156975721|FG004|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
48761840|NCT02036502|156975722|FG005|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
48761841|NCT02036502|156975723|FG006|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
48761842|NCT02036502|156975724|FG007|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
48761843|NCT02036502|156975717|FG000|Part 1:Dose Determination/Escalation|Adverse Event|0|||
48761844|NCT02036502|156975718|FG001|Part 1:Dose Determination/Escalation|Adverse Event|1|||
48761845|NCT02036502|156975719|FG002|Part 1:Dose Determination/Escalation|Adverse Event|0|||
48761846|NCT02036502|156975720|FG003|Part 1:Dose Determination/Escalation|Adverse Event|0|||
48761847|NCT02036502|156975721|FG004|Part 1:Dose Determination/Escalation|Adverse Event|0|||
48761848|NCT02036502|156975722|FG005|Part 1:Dose Determination/Escalation|Adverse Event|0|||
48761849|NCT02036502|156975723|FG006|Part 1:Dose Determination/Escalation|Adverse Event|0|||
48761850|NCT02036502|156975724|FG007|Part 1:Dose Determination/Escalation|Adverse Event|0|||
48761851|NCT02036502|156975717|FG000|Part 1:Dose Determination/Escalation|Not treated|0|||
48761852|NCT02036502|156975718|FG001|Part 1:Dose Determination/Escalation|Not treated|1|||
48761853|NCT02036502|156975719|FG002|Part 1:Dose Determination/Escalation|Not treated|0|||
48761854|NCT02036502|156975720|FG003|Part 1:Dose Determination/Escalation|Not treated|0|||
48761855|NCT02036502|156975721|FG004|Part 1:Dose Determination/Escalation|Not treated|0|||
48761856|NCT02036502|156975722|FG005|Part 1:Dose Determination/Escalation|Not treated|0|||
48873874|NCT03000348|157375175|FG003|Overall Study|No gram negative|1|||
48675346|NCT01953913|156663455|FG000|Overall Study|Disease Progression|349|||
48675347|NCT01953913|156663455|FG000|Overall Study|Worsening of underlying cancer|22|||
48675348|NCT01953913|156663455|FG000|Overall Study|Adverse Event|20|||
48761857|NCT02036502|156975723|FG006|Part 1:Dose Determination/Escalation|Not treated|0|||
48873875|NCT03000348|157375176|FG004|Overall Study|No gram negative|1|||
48873876|NCT03000348|157375177|FG005|Overall Study|No gram negative|1|||
48873877|NCT03000348|157375172|FG000|Overall Study|Patient had no transport|0|||
48873878|NCT03000348|157375173|FG001|Overall Study|Patient had no transport|0|||
48873879|NCT03000348|157375174|FG002|Overall Study|Patient had no transport|0|||
48873880|NCT03000348|157375175|FG003|Overall Study|Patient had no transport|1|||
48675349|NCT01953913|156663455|FG000|Overall Study|Protocol Violation|6|||
48675350|NCT01953913|156663455|FG000|Overall Study|Lost to Follow-up|4|||
48761858|NCT02036502|156975724|FG007|Part 1:Dose Determination/Escalation|Not treated|0|||
48761859|NCT02036502|156975717|FG000|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
48761860|NCT02036502|156975718|FG001|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
48975596|NCT02574481|157742501|FG003|Overall Study|Withdrawal by Subject|1|||
48975597|NCT02574481|157742498|FG000|Overall Study|Adverse Event|5|||
48975598|NCT02574481|157742499|FG001|Overall Study|Adverse Event|1|||
48975599|NCT02574481|157742500|FG002|Overall Study|Adverse Event|1|||
48675351|NCT01953913|156663455|FG000|Overall Study|Withdrawal by Subject|32|||
48675352|NCT01953913|156663455|FG000|Overall Study|Other than listed|108|||
48675353|NCT01953913|156663455|FG000|Overall Study|Not Treated|1|||
48675354|NCT03615066|156663458|FG000|Main Study|Withdrew Consent|0|||
48675355|NCT03615066|156663459|FG001|Main Study|Withdrew Consent|1|||
48675356|NCT03615066|156663460|FG002|Main Study|Withdrew Consent|1|||
48675357|NCT03615066|156663458|FG000|Main Study|Lost to Follow-up|0|||
48675358|NCT03615066|156663459|FG001|Main Study|Lost to Follow-up|0|||
48761861|NCT02036502|156975719|FG002|Part 2:Dose Confirmation|Study Terminated by Sponsor|2|||
48761862|NCT02036502|156975720|FG003|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
48761863|NCT02036502|156975721|FG004|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
48761864|NCT02036502|156975722|FG005|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
48761865|NCT02036502|156975723|FG006|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
48761866|NCT02036502|156975724|FG007|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
48761867|NCT02036502|156975717|FG000|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
48761868|NCT02036502|156975718|FG001|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
48761869|NCT02036502|156975719|FG002|Part 2:Dose Confirmation|Withdrawal by Subject|3|||
48761870|NCT02036502|156975720|FG003|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
48761871|NCT02036502|156975721|FG004|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
48761872|NCT02036502|156975722|FG005|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
48761873|NCT02036502|156975723|FG006|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
48761874|NCT02036502|156975724|FG007|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
48761875|NCT02036502|156975717|FG000|Part 2:Dose Confirmation|Death|0|||
48761876|NCT02036502|156975718|FG001|Part 2:Dose Confirmation|Death|0|||
48761877|NCT02036502|156975719|FG002|Part 2:Dose Confirmation|Death|1|||
48761878|NCT02036502|156975720|FG003|Part 2:Dose Confirmation|Death|0|||
48761879|NCT02036502|156975721|FG004|Part 2:Dose Confirmation|Death|0|||
48761880|NCT02036502|156975722|FG005|Part 2:Dose Confirmation|Death|0|||
48761881|NCT02036502|156975723|FG006|Part 2:Dose Confirmation|Death|0|||
48761882|NCT02036502|156975724|FG007|Part 2:Dose Confirmation|Death|0|||
48761883|NCT02036502|156975717|FG000|Part 2:Dose Confirmation|Not treated|0|||
48761884|NCT02036502|156975718|FG001|Part 2:Dose Confirmation|Not treated|0|||
48761885|NCT02036502|156975719|FG002|Part 2:Dose Confirmation|Not treated|0|||
48761886|NCT02036502|156975720|FG003|Part 2:Dose Confirmation|Not treated|1|||
48761887|NCT02036502|156975721|FG004|Part 2:Dose Confirmation|Not treated|0|||
48761888|NCT02036502|156975722|FG005|Part 2:Dose Confirmation|Not treated|0|||
48761889|NCT02036502|156975723|FG006|Part 2:Dose Confirmation|Not treated|0|||
48761890|NCT02036502|156975724|FG007|Part 2:Dose Confirmation|Not treated|0|||
48761891|NCT02036502|156975717|FG000|Part 3:Dose Expansion|Adverse Event|0|||
48761892|NCT02036502|156975718|FG001|Part 3:Dose Expansion|Adverse Event|0|||
48761893|NCT02036502|156975719|FG002|Part 3:Dose Expansion|Adverse Event|0|||
48761894|NCT02036502|156975720|FG003|Part 3:Dose Expansion|Adverse Event|0|||
48761895|NCT02036502|156975721|FG004|Part 3:Dose Expansion|Adverse Event|0|||
48761896|NCT02036502|156975722|FG005|Part 3:Dose Expansion|Adverse Event|4|||
48761897|NCT02036502|156975723|FG006|Part 3:Dose Expansion|Adverse Event|0|||
48761898|NCT02036502|156975724|FG007|Part 3:Dose Expansion|Adverse Event|2|||
48761899|NCT02036502|156975717|FG000|Part 3:Dose Expansion|Death|0|||
48761900|NCT02036502|156975718|FG001|Part 3:Dose Expansion|Death|0|||
48761901|NCT02036502|156975719|FG002|Part 3:Dose Expansion|Death|0|||
48761902|NCT02036502|156975720|FG003|Part 3:Dose Expansion|Death|0|||
48761903|NCT02036502|156975721|FG004|Part 3:Dose Expansion|Death|0|||
48761904|NCT02036502|156975722|FG005|Part 3:Dose Expansion|Death|24|||
48761905|NCT02036502|156975723|FG006|Part 3:Dose Expansion|Death|0|||
48761906|NCT02036502|156975724|FG007|Part 3:Dose Expansion|Death|3|||
48761907|NCT02036502|156975717|FG000|Part 3:Dose Expansion|Lost to Follow-up|0|||
48761908|NCT02036502|156975718|FG001|Part 3:Dose Expansion|Lost to Follow-up|0|||
48761909|NCT02036502|156975719|FG002|Part 3:Dose Expansion|Lost to Follow-up|0|||
48761910|NCT02036502|156975720|FG003|Part 3:Dose Expansion|Lost to Follow-up|0|||
48761911|NCT02036502|156975721|FG004|Part 3:Dose Expansion|Lost to Follow-up|0|||
48761912|NCT02036502|156975722|FG005|Part 3:Dose Expansion|Lost to Follow-up|0|||
48761913|NCT02036502|156975723|FG006|Part 3:Dose Expansion|Lost to Follow-up|0|||
48761914|NCT02036502|156975724|FG007|Part 3:Dose Expansion|Lost to Follow-up|1|||
48761915|NCT02036502|156975717|FG000|Part 3:Dose Expansion|Physician Decision|0|||
48761916|NCT02036502|156975718|FG001|Part 3:Dose Expansion|Physician Decision|0|||
48975600|NCT02574481|157742501|FG003|Overall Study|Adverse Event|0|||
48975601|NCT02574481|157742498|FG000|Overall Study|Visit Missed|15|||
48675359|NCT03615066|156663460|FG002|Main Study|Lost to Follow-up|1|||
48675360|NCT03615066|156663458|FG000|Treatment-free Follow-up (TFFU) Phase|Adverse Event|1|||
48975602|NCT02574481|157742499|FG001|Overall Study|Visit Missed|7|||
48975603|NCT02574481|157742500|FG002|Overall Study|Visit Missed|5|||
48975604|NCT02574481|157742501|FG003|Overall Study|Visit Missed|0|||
48975605|NCT02574481|157742498|FG000|Overall Study|Other|7|||
48975606|NCT02574481|157742499|FG001|Overall Study|Other|2|||
48975607|NCT02574481|157742500|FG002|Overall Study|Other|0|||
48975608|NCT02574481|157742501|FG003|Overall Study|Other|0|||
48975609|NCT02574481|157742498|FG000|Overall Study|Death|48|||
48975610|NCT02574481|157742499|FG001|Overall Study|Death|26|||
48975611|NCT02574481|157742500|FG002|Overall Study|Death|12|||
48975612|NCT02574481|157742501|FG003|Overall Study|Death|4|||
48975613|NCT02574481|157742498|FG000|Overall Study|Physician Decision|5|||
48975614|NCT02574481|157742499|FG001|Overall Study|Physician Decision|2|||
48975615|NCT02574481|157742500|FG002|Overall Study|Physician Decision|0|||
48975616|NCT02574481|157742501|FG003|Overall Study|Physician Decision|0|||
48975617|NCT02574481|157742498|FG000|Overall Study|Lost to Follow-up|5|||
48975618|NCT02574481|157742499|FG001|Overall Study|Lost to Follow-up|1|||
48975619|NCT02574481|157742500|FG002|Overall Study|Lost to Follow-up|3|||
48975620|NCT02574481|157742501|FG003|Overall Study|Lost to Follow-up|0|||
48975621|NCT01105936|157742505|FG000|Period 1|Adverse Event|0|||
48975622|NCT01105936|157742506|FG001|Period 1|Adverse Event|0|||
48975623|NCT01105936|157742507|FG002|Period 1|Adverse Event|0|||
48975624|NCT01105936|157742508|FG003|Period 1|Adverse Event|1|||
48975625|NCT01105936|157742505|FG000|Period 2|Adverse Event|1|||
48975626|NCT01105936|157742506|FG001|Period 2|Adverse Event|0|||
48975627|NCT01105936|157742507|FG002|Period 2|Adverse Event|0|||
48975628|NCT01105936|157742508|FG003|Period 2|Adverse Event|0|||
48975629|NCT01105936|157742505|FG000|Period 3|Protocol Violation|0|||
48975630|NCT01105936|157742506|FG001|Period 3|Protocol Violation|2|||
48975631|NCT01105936|157742507|FG002|Period 3|Protocol Violation|0|||
48975632|NCT01105936|157742508|FG003|Period 3|Protocol Violation|0|||
48975633|NCT00379236|157742509|FG000|Double-blind|Adverse Event|11|||
48975634|NCT00379236|157742510|FG001|Double-blind|Adverse Event|6|||
48975635|NCT00379236|157742511|FG002|Double-blind|Adverse Event|0|||
48975636|NCT00379236|157742509|FG000|Double-blind|Protocol Violation|3|||
48975637|NCT00379236|157742510|FG001|Double-blind|Protocol Violation|3|||
48975638|NCT00379236|157742511|FG002|Double-blind|Protocol Violation|0|||
48975639|NCT00379236|157742509|FG000|Double-blind|Withdrawal by Subject|12|||
48975640|NCT00379236|157742510|FG001|Double-blind|Withdrawal by Subject|13|||
48975641|NCT00379236|157742511|FG002|Double-blind|Withdrawal by Subject|0|||
48975642|NCT00379236|157742509|FG000|Double-blind|Lost to Follow-up|4|||
48975643|NCT00379236|157742510|FG001|Double-blind|Lost to Follow-up|3|||
48975644|NCT00379236|157742511|FG002|Double-blind|Lost to Follow-up|0|||
48975645|NCT00379236|157742509|FG000|Double-blind|Use of exclusionary medication|1|||
48975646|NCT00379236|157742510|FG001|Double-blind|Use of exclusionary medication|2|||
48975647|NCT00379236|157742511|FG002|Double-blind|Use of exclusionary medication|0|||
48975648|NCT00379236|157742509|FG000|Double-blind|Other|3|||
48975649|NCT00379236|157742510|FG001|Double-blind|Other|7|||
48975650|NCT00379236|157742511|FG002|Double-blind|Other|0|||
48975651|NCT00379236|157742509|FG000|Double-blind|Data could not be retrieved|2|||
48975652|NCT00379236|157742510|FG001|Double-blind|Data could not be retrieved|2|||
48975653|NCT00379236|157742511|FG002|Double-blind|Data could not be retrieved|0|||
48975654|NCT00379236|157742509|FG000|Open-label Extension|Adverse Event|0|||
48975655|NCT00379236|157742510|FG001|Open-label Extension|Adverse Event|0|||
48975656|NCT00379236|157742511|FG002|Open-label Extension|Adverse Event|13|||
48975657|NCT00379236|157742509|FG000|Open-label Extension|Protocol Violation|0|||
48975658|NCT00379236|157742510|FG001|Open-label Extension|Protocol Violation|0|||
48975659|NCT00379236|157742511|FG002|Open-label Extension|Protocol Violation|7|||
48975660|NCT00379236|157742509|FG000|Open-label Extension|Withdrawal by Subject|0|||
48975661|NCT00379236|157742510|FG001|Open-label Extension|Withdrawal by Subject|0|||
48975662|NCT00379236|157742511|FG002|Open-label Extension|Withdrawal by Subject|13|||
48975663|NCT00379236|157742509|FG000|Open-label Extension|Lost to Follow-up|0|||
48975664|NCT00379236|157742510|FG001|Open-label Extension|Lost to Follow-up|0|||
48975665|NCT00379236|157742511|FG002|Open-label Extension|Lost to Follow-up|12|||
48975666|NCT00379236|157742509|FG000|Open-label Extension|Use of exclusionary medication|0|||
48675361|NCT03615066|156663459|FG001|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
48975667|NCT00379236|157742510|FG001|Open-label Extension|Use of exclusionary medication|0|||
48975668|NCT00379236|157742511|FG002|Open-label Extension|Use of exclusionary medication|3|||
48975669|NCT00379236|157742509|FG000|Open-label Extension|Other|0|||
48975670|NCT00379236|157742510|FG001|Open-label Extension|Other|0|||
48975671|NCT00379236|157742511|FG002|Open-label Extension|Other|7|||
48975672|NCT03565991|157742512|FG000|Overall Study|Other|11|||
48975673|NCT03565991|157742513|FG001|Overall Study|Other|0|||
48975674|NCT03565991|157742512|FG000|Overall Study|Global deterioration of health status|14|||
48975675|NCT03565991|157742513|FG001|Overall Study|Global deterioration of health status|4|||
48975676|NCT03565991|157742512|FG000|Overall Study|Withdrawal by Subject|2|||
48975677|NCT03565991|157742513|FG001|Overall Study|Withdrawal by Subject|6|||
48975678|NCT03565991|157742512|FG000|Overall Study|Progressive disease|121|||
48975679|NCT03565991|157742513|FG001|Overall Study|Progressive disease|29|||
48975680|NCT03565991|157742512|FG000|Overall Study|Death|3|||
48975681|NCT03565991|157742513|FG001|Overall Study|Death|0|||
48975682|NCT03565991|157742512|FG000|Overall Study|Adverse Event|7|||
48975683|NCT03565991|157742513|FG001|Overall Study|Adverse Event|2|||
48975684|NCT00520299|157742514|FG000|Overall Study|Withdrawal by Subject|0|||
48975685|NCT00520299|157742515|FG001|Overall Study|Withdrawal by Subject|0|||
48975686|NCT00520299|157742516|FG002|Overall Study|Withdrawal by Subject|2|||
48975687|NCT00520299|157742514|FG000|Overall Study|Progressive disease|0|||
48975688|NCT00520299|157742515|FG001|Overall Study|Progressive disease|3|||
48975689|NCT00520299|157742516|FG002|Overall Study|Progressive disease|4|||
48975690|NCT04624672|157742518|FG000|Overall Study|Early Study Closure|2|||
48975691|NCT04624672|157742519|FG001|Overall Study|Early Study Closure|1|||
48975692|NCT00106249|157742520|FG000|Overall Study|Lost to Follow-up|3|||
48975693|NCT00106249|157742521|FG001|Overall Study|Lost to Follow-up|2|||
48975694|NCT00948428|157742522|FG000|Overall Study|Withdrawal by Subject|6|||
48975695|NCT00948428|157742523|FG001|Overall Study|Withdrawal by Subject|12|||
48975696|NCT00948428|157742524|FG002|Overall Study|Withdrawal by Subject|7|||
48975697|NCT00948428|157742522|FG000|Overall Study|Adverse Event|6|||
48975698|NCT00948428|157742523|FG001|Overall Study|Adverse Event|3|||
48975699|NCT00948428|157742524|FG002|Overall Study|Adverse Event|0|||
48975700|NCT00948428|157742522|FG000|Overall Study|Lost to Follow-up|2|||
48975701|NCT00948428|157742523|FG001|Overall Study|Lost to Follow-up|1|||
48975702|NCT00948428|157742524|FG002|Overall Study|Lost to Follow-up|1|||
48975703|NCT00948428|157742522|FG000|Overall Study|Death|2|||
48975704|NCT00948428|157742523|FG001|Overall Study|Death|0|||
48975705|NCT00948428|157742524|FG002|Overall Study|Death|0|||
48975706|NCT00948428|157742522|FG000|Overall Study|Intercurrent Illness|1|||
48975707|NCT00948428|157742523|FG001|Overall Study|Intercurrent Illness|0|||
48675362|NCT03615066|156663460|FG002|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
48975708|NCT00948428|157742524|FG002|Overall Study|Intercurrent Illness|0|||
48975709|NCT00948428|157742522|FG000|Overall Study|Non-compliance|1|||
48975710|NCT00948428|157742523|FG001|Overall Study|Non-compliance|2|||
48975711|NCT00948428|157742524|FG002|Overall Study|Non-compliance|0|||
48975712|NCT03518034|157742525|FG000|Overall Study|Not Treated|5|||
48975713|NCT03518034|157742526|FG001|Overall Study|Not Treated|1|||
48975714|NCT03518034|157742525|FG000|Overall Study|Withdrawal by Subject|309|||
48975715|NCT03518034|157742526|FG001|Overall Study|Withdrawal by Subject|351|||
48975716|NCT03518034|157742525|FG000|Overall Study|Lost to Follow-up|446|||
48975717|NCT03518034|157742526|FG001|Overall Study|Lost to Follow-up|458|||
48975718|NCT03518034|157742525|FG000|Overall Study|Adverse Event|138|||
48975719|NCT03518034|157742526|FG001|Overall Study|Adverse Event|130|||
48975720|NCT03518034|157742525|FG000|Overall Study|Lack of Efficacy|11|||
48975721|NCT03518034|157742526|FG001|Overall Study|Lack of Efficacy|23|||
48975722|NCT03518034|157742525|FG000|Overall Study|COVID-19 Logistical Restriction|7|||
48975723|NCT03518034|157742526|FG001|Overall Study|COVID-19 Logistical Restriction|3|||
48975724|NCT03518034|157742525|FG000|Overall Study|Serum Testosterone Level >750 ng/dL|5|||
48975725|NCT03518034|157742526|FG001|Overall Study|Serum Testosterone Level >750 ng/dL|0|||
48975726|NCT03518034|157742525|FG000|Overall Study|Other, Not Specified|84|||
48975727|NCT03518034|157742526|FG001|Overall Study|Other, Not Specified|53|||
48975728|NCT03518034|157742525|FG000|Overall Study|Reason Missing|2|||
48975729|NCT03518034|157742526|FG001|Overall Study|Reason Missing|3|||
48975730|NCT04067011|157742529|FG000|Overall Study|Not Treated|8|||
48975731|NCT04067011|157742530|FG001|Overall Study|Not Treated|7|||
48975732|NCT04067011|157742531|FG002|Overall Study|Not Treated|5|||
48975733|NCT04067011|157742529|FG000|Overall Study|Adverse Event|2|||
48975734|NCT04067011|157742530|FG001|Overall Study|Adverse Event|1|||
48975735|NCT04067011|157742531|FG002|Overall Study|Adverse Event|0|||
48975736|NCT04067011|157742529|FG000|Overall Study|Withdrawal by Subject|6|||
48975737|NCT04067011|157742530|FG001|Overall Study|Withdrawal by Subject|2|||
48975738|NCT04067011|157742531|FG002|Overall Study|Withdrawal by Subject|1|||
48975739|NCT04067011|157742529|FG000|Overall Study|Lost to Follow-up|0|||
48975740|NCT04067011|157742530|FG001|Overall Study|Lost to Follow-up|0|||
48975741|NCT04067011|157742531|FG002|Overall Study|Lost to Follow-up|1|||
48975742|NCT04067011|157742529|FG000|Overall Study|Physician Decision|1|||
48975743|NCT04067011|157742530|FG001|Overall Study|Physician Decision|1|||
48975744|NCT04067011|157742531|FG002|Overall Study|Physician Decision|0|||
48975745|NCT04067011|157742529|FG000|Overall Study|Other Reasons|2|||
48975746|NCT04067011|157742530|FG001|Overall Study|Other Reasons|0|||
48975747|NCT04067011|157742531|FG002|Overall Study|Other Reasons|1|||
48975748|NCT04067011|157742529|FG000|Overall Study|Missing|0|||
48975749|NCT04067011|157742530|FG001|Overall Study|Missing|2|||
48975750|NCT04067011|157742531|FG002|Overall Study|Missing|0|||
48975751|NCT00608881|157742532|FG000|Overall Study|Death|22|||
48975752|NCT00608881|157742533|FG001|Overall Study|Death|13|||
48975753|NCT00608881|157742532|FG000|Overall Study|Adverse Event|5|||
48975754|NCT00608881|157742533|FG001|Overall Study|Adverse Event|3|||
48975755|NCT00608881|157742532|FG000|Overall Study|Lost to Follow-up|28|||
48975756|NCT00608881|157742533|FG001|Overall Study|Lost to Follow-up|14|||
48975757|NCT00608881|157742532|FG000|Overall Study|Withdrawal by Subject|18|||
48975758|NCT00608881|157742533|FG001|Overall Study|Withdrawal by Subject|29|||
48675363|NCT03615066|156663458|FG000|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|1|||
48675364|NCT03615066|156663459|FG001|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
48675365|NCT03615066|156663460|FG002|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
48975759|NCT00608881|157742532|FG000|Overall Study|Physician Decision|5|||
48975760|NCT00608881|157742533|FG001|Overall Study|Physician Decision|5|||
48975761|NCT00608881|157742532|FG000|Overall Study|Institutionalized|1|||
48975762|NCT00608881|157742533|FG001|Overall Study|Institutionalized|2|||
48975763|NCT00367341|157742536|FG000|Overall Study|Physician Decision|1|||
48975764|NCT00367341|157742537|FG001|Overall Study|Physician Decision|0|||
48975765|NCT00367341|157742536|FG000|Overall Study|Protocol Violation|1|||
48975766|NCT00367341|157742537|FG001|Overall Study|Protocol Violation|0|||
48975767|NCT00517413|157742538|FG000|Overall Study|Adverse Event|7|||
48975768|NCT00517413|157742538|FG000|Overall Study|Death|13|||
48975769|NCT00517413|157742538|FG000|Overall Study|Protocol Violation|15|||
48975770|NCT00517413|157742538|FG000|Overall Study|Withdrawal by Subject|2|||
48975771|NCT00517413|157742538|FG000|Overall Study|Failure to return|1|||
48975772|NCT00517413|157742538|FG000|Overall Study|Other-Reasons|23|||
48975773|NCT00369278|157742539|FG000|Overall Study|Adverse Event|14|||
48975774|NCT00369278|157742540|FG001|Overall Study|Adverse Event|11|||
48975775|NCT00369278|157742539|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
48975776|NCT00369278|157742540|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
48975777|NCT00369278|157742539|FG000|Overall Study|Protocol Violation|2|||
48975778|NCT00369278|157742540|FG001|Overall Study|Protocol Violation|1|||
48975779|NCT00369278|157742539|FG000|Overall Study|Withdrawal by Subject|2|||
48975780|NCT00369278|157742540|FG001|Overall Study|Withdrawal by Subject|2|||
48975781|NCT00369278|157742539|FG000|Overall Study|Lost to Follow-up|1|||
48975782|NCT00369278|157742540|FG001|Overall Study|Lost to Follow-up|0|||
48975783|NCT00369278|157742539|FG000|Overall Study|Graft loss|1|||
48975784|NCT00369278|157742540|FG001|Overall Study|Graft loss|2|||
48975785|NCT00796003|157742541|FG000|Overall Study|Disease Progression|2|||
48975786|NCT00796003|157742542|FG001|Overall Study|Disease Progression|13|||
48975787|NCT00796003|157742541|FG000|Overall Study|Adverse Event|1|||
48975788|NCT00796003|157742542|FG001|Overall Study|Adverse Event|7|||
48975789|NCT00796003|157742541|FG000|Overall Study|Specified organ function not met|0|||
48975790|NCT00796003|157742542|FG001|Overall Study|Specified organ function not met|1|||
48975791|NCT00796003|157742541|FG000|Overall Study|Physician Decision|0|||
48975792|NCT00796003|157742542|FG001|Overall Study|Physician Decision|4|||
48975793|NCT00796003|157742541|FG000|Overall Study|Withdrawal by Subject|0|||
48975794|NCT00796003|157742542|FG001|Overall Study|Withdrawal by Subject|1|||
48975795|NCT00796003|157742541|FG000|Overall Study|Other|0|||
48975796|NCT00796003|157742542|FG001|Overall Study|Other|1|||
48975797|NCT00796003|157742541|FG000|Overall Study|Participants Not treated|0|||
48975798|NCT00796003|157742542|FG001|Overall Study|Participants Not treated|2|||
48975799|NCT00636441|157742544|FG000|Overall Study|Adverse Event|0|||
48975800|NCT00636441|157742545|FG001|Overall Study|Adverse Event|1|||
48975801|NCT00636441|157742546|FG002|Overall Study|Adverse Event|1|||
48975802|NCT00636441|157742547|FG003|Overall Study|Adverse Event|0|||
48975803|NCT00636441|157742548|FG004|Overall Study|Adverse Event|0|||
48975804|NCT00636441|157742549|FG005|Overall Study|Adverse Event|1|||
48975805|NCT00636441|157742550|FG006|Overall Study|Adverse Event|0|||
48975806|NCT00636441|157742544|FG000|Overall Study|Late, ineligible|0|||
48975807|NCT00636441|157742545|FG001|Overall Study|Late, ineligible|0|||
48975808|NCT00636441|157742546|FG002|Overall Study|Late, ineligible|0|||
48975809|NCT00636441|157742547|FG003|Overall Study|Late, ineligible|0|||
48975810|NCT00636441|157742548|FG004|Overall Study|Late, ineligible|0|||
48975811|NCT00636441|157742549|FG005|Overall Study|Late, ineligible|0|||
48975812|NCT00636441|157742550|FG006|Overall Study|Late, ineligible|1|||
48975813|NCT00636441|157742544|FG000|Overall Study|Screen Failure|0|||
48975814|NCT00636441|157742545|FG001|Overall Study|Screen Failure|0|||
48975815|NCT00636441|157742546|FG002|Overall Study|Screen Failure|0|||
48975816|NCT00636441|157742547|FG003|Overall Study|Screen Failure|0|||
48975817|NCT00636441|157742548|FG004|Overall Study|Screen Failure|0|||
48975818|NCT00636441|157742549|FG005|Overall Study|Screen Failure|0|||
48975819|NCT00636441|157742550|FG006|Overall Study|Screen Failure|17|||
48975820|NCT00615459|157742552|FG000|Period I|Adverse Event|2|||
48975821|NCT00615459|157742553|FG001|Period I|Adverse Event|0|||
48975822|NCT00615459|157742554|FG002|Period I|Adverse Event|1|||
48975823|NCT00615459|157742555|FG003|Period I|Adverse Event|0|||
48975824|NCT00615459|157742552|FG000|Period I|Subject withdrew consent|1|||
48975825|NCT00615459|157742553|FG001|Period I|Subject withdrew consent|0|||
48975826|NCT00615459|157742554|FG002|Period I|Subject withdrew consent|0|||
48975827|NCT00615459|157742555|FG003|Period I|Subject withdrew consent|1|||
48975828|NCT00615459|157742552|FG000|Period I|Abnormal test procedure results|1|||
48975829|NCT00615459|157742553|FG001|Period I|Abnormal test procedure results|1|||
48975830|NCT00615459|157742554|FG002|Period I|Abnormal test procedure results|1|||
48975831|NCT00615459|157742555|FG003|Period I|Abnormal test procedure results|0|||
48975832|NCT00615459|157742552|FG000|Period II|Adverse Event|1|||
48975833|NCT00615459|157742553|FG001|Period II|Adverse Event|0|||
48975834|NCT00615459|157742554|FG002|Period II|Adverse Event|0|||
48975835|NCT00615459|157742555|FG003|Period II|Adverse Event|0|||
48975836|NCT00615459|157742552|FG000|Period II|Lost to Follow-up|0|||
48975837|NCT00615459|157742553|FG001|Period II|Lost to Follow-up|0|||
48975838|NCT00615459|157742554|FG002|Period II|Lost to Follow-up|0|||
48975839|NCT00615459|157742555|FG003|Period II|Lost to Follow-up|1|||
48975840|NCT00615459|157742552|FG000|Period III|Adverse Event|0|||
48975841|NCT00615459|157742553|FG001|Period III|Adverse Event|1|||
48975842|NCT00615459|157742554|FG002|Period III|Adverse Event|0|||
48975843|NCT00615459|157742555|FG003|Period III|Adverse Event|0|||
48975844|NCT00615459|157742552|FG000|Period III|Administrative problems|0|||
48975845|NCT00615459|157742553|FG001|Period III|Administrative problems|1|||
48975846|NCT00615459|157742554|FG002|Period III|Administrative problems|1|||
48975847|NCT00615459|157742555|FG003|Period III|Administrative problems|0|||
48975848|NCT00615459|157742552|FG000|Period III|Unsatisfactory therapeutic effect|0|||
48975849|NCT00615459|157742553|FG001|Period III|Unsatisfactory therapeutic effect|1|||
48975850|NCT00615459|157742554|FG002|Period III|Unsatisfactory therapeutic effect|0|||
48975851|NCT00615459|157742555|FG003|Period III|Unsatisfactory therapeutic effect|0|||
48975852|NCT00918346|157742558|FG000|First Treatment Period (4 Weeks)|Lack of Efficacy|0|||
48975853|NCT00918346|157742559|FG001|First Treatment Period (4 Weeks)|Lack of Efficacy|1|||
48975854|NCT02475629|157742560|FG000|Overall Study|Adverse Event|1|||
48975855|NCT02475629|157742560|FG000|Overall Study|Death|4|||
48975856|NCT02475629|157742560|FG000|Overall Study|Physician Decision|1|||
48975857|NCT02475629|157742560|FG000|Overall Study|Withdrawal by Subject|1|||
48975858|NCT02475629|157742560|FG000|Overall Study|Lost to Follow-up|1|||
48975859|NCT02475629|157742560|FG000|Overall Study|Subject non-compliance|1|||
48975860|NCT01421069|157742561|FG000|Parent Study|drug ineffective+prohibited drug taken|1|||
48975861|NCT01421069|157742561|FG000|Parent Study|Failed to return|3|||
48975862|NCT01421069|157742561|FG000|Parent Study|Withdrawal by Subject|1|||
48975863|NCT01421069|157742561|FG000|Parent Study|Lost to Follow-up|2|||
48975864|NCT01421069|157742561|FG000|Parent Study|Lack of Efficacy|1|||
48975865|NCT01421069|157742561|FG000|Overall Period for Extension Study|Other|2|||
48975866|NCT01421069|157742561|FG000|Overall Period for Extension Study|Medication error without associated adverse event|1|||
48975867|NCT01421069|157742561|FG000|Overall Period for Extension Study|No longer willing to participate|14|||
48975868|NCT01421069|157742561|FG000|Overall Period for Extension Study|Pregnancy|1|||
48975869|NCT01421069|157742561|FG000|Overall Period for Extension Study|Adverse Event|1|||
48975870|NCT01421069|157742561|FG000|Overall Period for Extension Study|Protocol Violation|1|||
48975871|NCT01421069|157742561|FG000|Overall Period for Extension Study|Lost to Follow-up|4|||
48975872|NCT01421069|157742561|FG000|Overall Period for Extension Study|Lack of Efficacy|1|||
48975873|NCT01421069|157742561|FG000|Active Treatment Period|Other|1|||
48975874|NCT01421069|157742561|FG000|Active Treatment Period|No longer willing to participate in study|8|||
48975875|NCT01421069|157742561|FG000|Active Treatment Period|Insufficient clinical response|1|||
48975876|NCT01421069|157742561|FG000|Active Treatment Period|Medication error without associated adverse event|1|||
48975877|NCT01421069|157742561|FG000|Active Treatment Period|Pregnancy|1|||
48975878|NCT01421069|157742561|FG000|Active Treatment Period|Adverse Event|1|||
48975879|NCT01421069|157742561|FG000|Active Treatment Period|Enrolled in withdrawal period|30|||
48975880|NCT01421069|157742561|FG000|Active Treatment Period|Enrolled in observational period|29|||
48975881|NCT01421069|157742561|FG000|2a. Withdrawal Period|No longer willing to participate in study|2|||
48975882|NCT01421069|157742561|FG000|2a. Withdrawal Period|Lost to Follow-up|1|||
48975883|NCT01421069|157742561|FG000|2a. Withdrawal Period|Enrolled in observational period|7|||
48975884|NCT01421069|157742561|FG000|2a. Withdrawal Period|Enrolled in re-treatment period|13|||
48975885|NCT01421069|157742561|FG000|2b. Retreatment Period|Enrolled in observational period|7|||
48975886|NCT01421069|157742561|FG000|2b. Retreatment Period|Protocol Violation|1|||
48975887|NCT01421069|157742561|FG000|Observational Period|Other|1|||
48975888|NCT01421069|157742561|FG000|Observational Period|No longer willing to participate in study|4|||
48975889|NCT01421069|157742561|FG000|Observational Period|Lost to Follow-up|3|||
48975890|NCT03238352|157742562|FG000|Overall Study|Lost to Follow-up|0|||
48975891|NCT03238352|157742563|FG001|Overall Study|Lost to Follow-up|2|||
48675366|NCT03615066|156663458|FG000|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
48975892|NCT03238352|157742564|FG002|Overall Study|Lost to Follow-up|1|||
48975893|NCT03238352|157742562|FG000|Overall Study|Withdrawal by Subject|0|||
48975894|NCT03238352|157742563|FG001|Overall Study|Withdrawal by Subject|1|||
48975895|NCT03238352|157742564|FG002|Overall Study|Withdrawal by Subject|0|||
48975896|NCT02896192|157742569|FG000|Open-Label Period (10 Weeks)|Lack of Efficacy|1|||
48975897|NCT02896192|157742569|FG000|Open-Label Period (10 Weeks)|Protocol Violation|1|||
48975898|NCT02896192|157742569|FG000|Open-Label Period (32 Weeks)|Lost to Follow-up|1|||
48975899|NCT00560794|157742574|FG000|Overall Study|Adverse Event|2|||
48975900|NCT00560794|157742574|FG000|Overall Study|Patient was not Compliant|1|||
48975901|NCT00560794|157742574|FG000|Overall Study|Minimal Residual Disease Relapse|1|||
48975902|NCT00560794|157742574|FG000|Overall Study|Hematological Relapse|1|||
48675367|NCT03615066|156663459|FG001|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|1|||
48675368|NCT03615066|156663460|FG002|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
48675369|NCT02104947|156663462|FG000|Overall Study|Withdrawal by Subject|10|||
48675370|NCT02104947|156663463|FG001|Overall Study|Withdrawal by Subject|3|||
48975903|NCT00560794|157742574|FG000|Overall Study|Received Bone Marrow Transplant|6|||
48975904|NCT01810380|157742575|FG000|Overall Study|Randomised not treated|2|||
48975905|NCT01810380|157742576|FG001|Overall Study|Randomised not treated|1|||
48975906|NCT01810380|157742577|FG002|Overall Study|Randomised not treated|1|||
48975907|NCT01810380|157742575|FG000|Overall Study|Adverse Event|11|||
48975908|NCT01810380|157742576|FG001|Overall Study|Adverse Event|14|||
48975909|NCT01810380|157742577|FG002|Overall Study|Adverse Event|4|||
48975910|NCT01810380|157742575|FG000|Overall Study|Lack of Efficacy|24|||
48975911|NCT01810380|157742576|FG001|Overall Study|Lack of Efficacy|10|||
48975912|NCT01810380|157742577|FG002|Overall Study|Lack of Efficacy|11|||
48975913|NCT01810380|157742575|FG000|Overall Study|Protocol Violation|1|||
48975914|NCT01810380|157742576|FG001|Overall Study|Protocol Violation|0|||
48975915|NCT01810380|157742577|FG002|Overall Study|Protocol Violation|1|||
48975916|NCT01810380|157742575|FG000|Overall Study|Withdrawal by Subject|6|||
48975917|NCT01810380|157742576|FG001|Overall Study|Withdrawal by Subject|0|||
48975918|NCT01810380|157742577|FG002|Overall Study|Withdrawal by Subject|6|||
48975919|NCT01810380|157742575|FG000|Overall Study|Administrative or other reasons|11|||
48975920|NCT01810380|157742576|FG001|Overall Study|Administrative or other reasons|13|||
48975921|NCT01810380|157742577|FG002|Overall Study|Administrative or other reasons|9|||
48975922|NCT00614991|157742578|FG000|Overall Study|Adverse Event|3|||
48975923|NCT00614991|157742579|FG001|Overall Study|Adverse Event|3|||
48975924|NCT00614991|157742580|FG002|Overall Study|Adverse Event|0|||
48975925|NCT00614991|157742581|FG003|Overall Study|Adverse Event|0|||
48975926|NCT00614991|157742582|FG004|Overall Study|Adverse Event|1|||
48675371|NCT02104947|156663462|FG000|Overall Study|Lost to Follow-up|4|||
48675372|NCT02104947|156663463|FG001|Overall Study|Lost to Follow-up|4|||
48675373|NCT02104947|156663462|FG000|Overall Study|Protocol Violation|6|||
48675374|NCT02104947|156663463|FG001|Overall Study|Protocol Violation|8|||
48675375|NCT02104947|156663462|FG000|Overall Study|Adverse Event|57|||
48675376|NCT02104947|156663463|FG001|Overall Study|Adverse Event|38|||
48975927|NCT00614991|157742583|FG005|Overall Study|Adverse Event|0|||
48975928|NCT01190020|157742584|FG000|Overall Study|Adverse Event|2|||
48975929|NCT01190020|157742585|FG001|Overall Study|Adverse Event|0|||
48975930|NCT01190020|157742584|FG000|Overall Study|Lost to Follow-up|2|||
48975931|NCT01190020|157742585|FG001|Overall Study|Lost to Follow-up|0|||
48975932|NCT01190020|157742584|FG000|Overall Study|Withdrawal by Subject|3|||
48975933|NCT01190020|157742585|FG001|Overall Study|Withdrawal by Subject|0|||
48975934|NCT00441480|157742586|FG000|Overall Study|Protocol Violation|1|||
48975935|NCT00441480|157742587|FG001|Overall Study|Protocol Violation|1|||
48975936|NCT00441480|157742586|FG000|Overall Study|Withdrawal by Subject|2|||
48975937|NCT00441480|157742587|FG001|Overall Study|Withdrawal by Subject|3|||
48975938|NCT03689972|157742588|FG000|Part 1 (Day 1 up to Week 72)|Adverse Event|1|||
48975939|NCT03689972|157742589|FG001|Part 1 (Day 1 up to Week 72)|Adverse Event|3|||
48975940|NCT03689972|157742590|FG002|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
48975941|NCT03689972|157742591|FG003|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
48975942|NCT03689972|157742592|FG004|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
48975943|NCT03689972|157742588|FG000|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
48975944|NCT03689972|157742589|FG001|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|2|||
48975945|NCT03689972|157742590|FG002|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
48975946|NCT03689972|157742591|FG003|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
48975947|NCT03689972|157742592|FG004|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
48975948|NCT03689972|157742588|FG000|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
48975949|NCT03689972|157742589|FG001|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|6|||
48975950|NCT03689972|157742590|FG002|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
48675377|NCT02104947|156663462|FG000|Overall Study|Other than stated above|2|||
48675378|NCT02104947|156663463|FG001|Overall Study|Other than stated above|3|||
48675379|NCT01844778|156663464|FG000|Overall Study|Protocol deviation|0|||
48675380|NCT01844778|156663465|FG001|Overall Study|Protocol deviation|1|||
48675381|NCT01844778|156663466|FG002|Overall Study|Protocol deviation|2|||
48675382|NCT01844778|156663464|FG000|Overall Study|Withdrawal by Subject|2|||
48675383|NCT01844778|156663465|FG001|Overall Study|Withdrawal by Subject|0|||
48675384|NCT01844778|156663466|FG002|Overall Study|Withdrawal by Subject|0|||
48675385|NCT01844778|156663464|FG000|Overall Study|Adverse Event|0|||
48675386|NCT01844778|156663465|FG001|Overall Study|Adverse Event|2|||
48675387|NCT01844778|156663466|FG002|Overall Study|Adverse Event|2|||
48675388|NCT00844558|156663470|FG000|Overall Study|Withdrawal by Subject|9|||
48675389|NCT00844558|156663471|FG001|Overall Study|Withdrawal by Subject|2|||
48675390|NCT00844558|156663470|FG000|Overall Study|Death|1|||
48675391|NCT00844558|156663471|FG001|Overall Study|Death|0|||
48675392|NCT00844558|156663470|FG000|Overall Study|Protocol Violation|1|||
48675393|NCT00844558|156663471|FG001|Overall Study|Protocol Violation|1|||
48675394|NCT00844558|156663470|FG000|Overall Study|Lost to Follow-up|0|||
48675395|NCT00844558|156663471|FG001|Overall Study|Lost to Follow-up|1|||
48675396|NCT00844558|156663470|FG000|Overall Study|Physician Decision|1|||
48675397|NCT00844558|156663471|FG001|Overall Study|Physician Decision|0|||
48675398|NCT01300260|156663477|FG000|Period 1 of Study: First Intervention|Adverse Event|0|||
48975951|NCT03689972|157742591|FG003|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
48975952|NCT03689972|157742592|FG004|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
48975953|NCT03689972|157742588|FG000|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|1|||
48975954|NCT03689972|157742589|FG001|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|3|||
48975955|NCT03689972|157742590|FG002|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
48975956|NCT03689972|157742591|FG003|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
48975957|NCT03689972|157742592|FG004|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
48975958|NCT03689972|157742588|FG000|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|14|||
48975959|NCT03689972|157742589|FG001|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|9|||
48975960|NCT03689972|157742590|FG002|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
48975961|NCT03689972|157742591|FG003|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
48975962|NCT03689972|157742592|FG004|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
48975963|NCT03689972|157742588|FG000|Part 1 (Day 1 up to Week 72)|Investigator Decision|9|||
48975964|NCT03689972|157742589|FG001|Part 1 (Day 1 up to Week 72)|Investigator Decision|6|||
48975965|NCT03689972|157742590|FG002|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
48975966|NCT03689972|157742591|FG003|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
48975967|NCT03689972|157742592|FG004|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
48975968|NCT03689972|157742588|FG000|Part 1 (Day 1 up to Week 72)|Pregnancy|5|||
48975969|NCT03689972|157742589|FG001|Part 1 (Day 1 up to Week 72)|Pregnancy|1|||
48975970|NCT03689972|157742590|FG002|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
48975971|NCT03689972|157742591|FG003|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
48975972|NCT03689972|157742592|FG004|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
48975973|NCT03689972|157742588|FG000|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|3|||
48975974|NCT03689972|157742589|FG001|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|2|||
48975975|NCT03689972|157742590|FG002|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
48975976|NCT03689972|157742591|FG003|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
48975977|NCT03689972|157742592|FG004|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
48975978|NCT03689972|157742588|FG000|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
48975979|NCT03689972|157742589|FG001|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
48975980|NCT03689972|157742590|FG002|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
48975981|NCT03689972|157742591|FG003|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
48975982|NCT03689972|157742592|FG004|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
48975983|NCT03689972|157742588|FG000|Part 1 (Day 1 up to Week 72)|Reason not Specified|20|||
48975984|NCT03689972|157742589|FG001|Part 1 (Day 1 up to Week 72)|Reason not Specified|16|||
48975985|NCT03689972|157742590|FG002|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
48975986|NCT03689972|157742591|FG003|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
48975987|NCT03689972|157742592|FG004|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
48975988|NCT03689972|157742588|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
48975989|NCT03689972|157742589|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
48975990|NCT03689972|157742590|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|2|||
48975991|NCT03689972|157742591|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
48975992|NCT03689972|157742592|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
48975993|NCT03689972|157742588|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
48975994|NCT03689972|157742589|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
48975995|NCT03689972|157742590|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|1|||
48975996|NCT03689972|157742591|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
48975997|NCT03689972|157742592|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
48975998|NCT03689972|157742588|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
48975999|NCT03689972|157742589|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
48976000|NCT03689972|157742590|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|2|||
48976001|NCT03689972|157742591|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
48976002|NCT03689972|157742592|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
48675399|NCT01300260|156663478|FG001|Period 1 of Study: First Intervention|Adverse Event|1|||
48675400|NCT01300260|156663477|FG000|Period 1 of Study: First Intervention|Withdrawal by Subject|1|||
48675401|NCT01300260|156663478|FG001|Period 1 of Study: First Intervention|Withdrawal by Subject|0|||
48675402|NCT01300260|156663477|FG000|Period 2 of Study: Second Intervention|Adverse Event|0|||
48675403|NCT01300260|156663478|FG001|Period 2 of Study: Second Intervention|Adverse Event|1|||
48675404|NCT01336023|156663482|FG000|Week 0 to Week 26|Adverse Event|8|||
48675405|NCT01336023|156663483|FG001|Week 0 to Week 26|Adverse Event|10|||
48675406|NCT01336023|156663484|FG002|Week 0 to Week 26|Adverse Event|24|||
48761917|NCT02036502|156975719|FG002|Part 3:Dose Expansion|Physician Decision|0|||
48761918|NCT02036502|156975720|FG003|Part 3:Dose Expansion|Physician Decision|0|||
48761919|NCT02036502|156975721|FG004|Part 3:Dose Expansion|Physician Decision|0|||
48761920|NCT02036502|156975722|FG005|Part 3:Dose Expansion|Physician Decision|1|||
48761921|NCT02036502|156975723|FG006|Part 3:Dose Expansion|Physician Decision|0|||
48976003|NCT03689972|157742588|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
48976004|NCT03689972|157742589|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
48976005|NCT03689972|157742590|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
48976006|NCT03689972|157742591|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
48976007|NCT03689972|157742592|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
48976008|NCT03689972|157742588|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
48976009|NCT03689972|157742589|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
48976010|NCT03689972|157742590|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
48976011|NCT03689972|157742591|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|7|||
48976012|NCT03689972|157742592|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|1|||
48976013|NCT03689972|157742588|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
48976014|NCT03689972|157742589|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
48976015|NCT03689972|157742590|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
48976016|NCT03689972|157742591|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
48976017|NCT03689972|157742592|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
48976018|NCT03689972|157742588|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
48976019|NCT03689972|157742589|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
48976020|NCT03689972|157742590|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
48976021|NCT03689972|157742591|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
48976022|NCT03689972|157742592|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|1|||
48976023|NCT03689972|157742588|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
48976024|NCT03689972|157742589|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
48976025|NCT03689972|157742590|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
48976026|NCT03689972|157742591|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|2|||
48976027|NCT03689972|157742592|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|1|||
48976028|NCT03689972|157742588|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
48976029|NCT03689972|157742589|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
48976030|NCT03689972|157742590|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
48976031|NCT03689972|157742591|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
48976032|NCT03689972|157742592|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|12|||
48976033|NCT04857892|157742593|FG000|Part 1: Period 1 (Day 1)|Adverse Event|1|||
48976034|NCT04857892|157742594|FG001|Part 1: Period 1 (Day 1)|Adverse Event|0|||
48976035|NCT04857892|157742595|FG002|Part 1: Period 1 (Day 1)|Adverse Event|0|||
48976036|NCT04857892|157742596|FG003|Part 1: Period 1 (Day 1)|Adverse Event|0|||
48976037|NCT04857892|157742597|FG004|Part 1: Period 1 (Day 1)|Adverse Event|0|||
48976038|NCT04857892|157742593|FG000|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|2|||
48976039|NCT04857892|157742594|FG001|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
48976040|NCT04857892|157742595|FG002|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
48976041|NCT04857892|157742596|FG003|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
48976042|NCT04857892|157742597|FG004|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
48976043|NCT04857892|157742593|FG000|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
48976044|NCT04857892|157742594|FG001|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
48976045|NCT04857892|157742595|FG002|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
48976046|NCT04857892|157742596|FG003|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
48976047|NCT04857892|157742597|FG004|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|1|||
48976048|NCT00608842|157742598|FG000|Overall Study|Participant's Request|0|||
48976049|NCT00608842|157742599|FG001|Overall Study|Participant's Request|1|||
48976050|NCT00608842|157742600|FG002|Overall Study|Participant's Request|2|||
48976051|NCT00608842|157742601|FG003|Overall Study|Participant's Request|1|||
48976052|NCT00608842|157742598|FG000|Overall Study|Lost to Follow-up|1|||
48976053|NCT00608842|157742599|FG001|Overall Study|Lost to Follow-up|0|||
48976054|NCT00608842|157742600|FG002|Overall Study|Lost to Follow-up|0|||
48976055|NCT00608842|157742601|FG003|Overall Study|Lost to Follow-up|0|||
48976056|NCT02829775|157742602|FG000|Overall Study|Death|1|||
48976057|NCT02829775|157742602|FG000|Overall Study|Withdrawal by Subject|3|||
48976058|NCT02829775|157742602|FG000|Overall Study|Disease remission|1|||
48976059|NCT01249157|157742605|FG000|Overall Study|Withdrawal by Subject|1|||
48976060|NCT03796195|157742606|FG000|Overall Study|Study closed early|1|||
48976061|NCT03799627|157742615|FG000|Overall Study|Adverse Event|1|||
48976062|NCT03799627|157742616|FG001|Overall Study|Adverse Event|2|||
48976063|NCT03799627|157742617|FG002|Overall Study|Adverse Event|0|||
48976064|NCT03799627|157742618|FG003|Overall Study|Adverse Event|0|||
48976065|NCT03799627|157742619|FG004|Overall Study|Adverse Event|2|||
48976066|NCT03799627|157742620|FG005|Overall Study|Adverse Event|5|||
48976067|NCT03799627|157742621|FG006|Overall Study|Adverse Event|0|||
48976068|NCT03799627|157742622|FG007|Overall Study|Adverse Event|2|||
48976069|NCT03799627|157742623|FG008|Overall Study|Adverse Event|0|||
48675407|NCT01336023|156663482|FG000|Week 0 to Week 26|Lack of Efficacy|0|||
48873881|NCT03000348|157375176|FG004|Overall Study|Patient had no transport|0|||
48873882|NCT03000348|157375177|FG005|Overall Study|Patient had no transport|0|||
48873883|NCT03000348|157375172|FG000|Overall Study|Dosing|0|||
48873884|NCT03000348|157375173|FG001|Overall Study|Dosing|0|||
48873885|NCT03000348|157375174|FG002|Overall Study|Dosing|0|||
48873886|NCT03000348|157375175|FG003|Overall Study|Dosing|0|||
48873887|NCT03000348|157375176|FG004|Overall Study|Dosing|1|||
48873888|NCT03000348|157375177|FG005|Overall Study|Dosing|0|||
48873889|NCT03517111|157375178|FG000|Enrolled|Withdrawal by Subject|0|||
48873890|NCT03517111|157375179|FG001|Enrolled|Withdrawal by Subject|1|||
48873891|NCT03517111|157375180|FG002|Enrolled|Withdrawal by Subject|0|||
48873892|NCT03517111|157375178|FG000|T2 Survey (Week 10-12)|Intervention workshops cancelled|83|||
48873893|NCT03517111|157375179|FG001|T2 Survey (Week 10-12)|Intervention workshops cancelled|78|||
48873894|NCT03517111|157375180|FG002|T2 Survey (Week 10-12)|Intervention workshops cancelled|60|||
48873895|NCT03517111|157375178|FG000|T2 Survey (Week 10-12)|Lost to Follow-up|36|||
48873896|NCT03517111|157375179|FG001|T2 Survey (Week 10-12)|Lost to Follow-up|12|||
48873897|NCT03517111|157375180|FG002|T2 Survey (Week 10-12)|Lost to Follow-up|23|||
48873898|NCT03517111|157375178|FG000|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|9|||
48873899|NCT03517111|157375179|FG001|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|3|||
48873900|NCT03517111|157375180|FG002|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|4|||
48873901|NCT03517111|157375178|FG000|T3 Survey (Weeks 24-26)|Lost to Follow-up|27|||
48873902|NCT03517111|157375179|FG001|T3 Survey (Weeks 24-26)|Lost to Follow-up|6|||
48873903|NCT03517111|157375180|FG002|T3 Survey (Weeks 24-26)|Lost to Follow-up|15|||
48873904|NCT00912223|157375181|FG000|Overall Study|Withdrawal by Subject|1|||
48873905|NCT00912223|157375181|FG000|Overall Study|Not transplanted|1|||
48873906|NCT00912223|157375181|FG000|Overall Study|Transformed disease|1|||
48873907|NCT02196077|157375182|FG000|Overall Study|Adverse Event|4|||
48873908|NCT02196077|157375182|FG000|Overall Study|Lack of Efficacy|1|||
48873909|NCT02196077|157375182|FG000|Overall Study|Withdrawal by Subject|14|||
48873910|NCT02196077|157375182|FG000|Overall Study|Physician Decision|1|||
48761922|NCT02036502|156975724|FG007|Part 3:Dose Expansion|Physician Decision|0|||
48761923|NCT02036502|156975717|FG000|Part 3:Dose Expansion|Progressive Disease|0|||
48976070|NCT03799627|157742615|FG000|Overall Study|Physician Decision|2|||
48976071|NCT03799627|157742616|FG001|Overall Study|Physician Decision|2|||
48976072|NCT03799627|157742617|FG002|Overall Study|Physician Decision|0|||
48976073|NCT03799627|157742618|FG003|Overall Study|Physician Decision|0|||
48976074|NCT03799627|157742619|FG004|Overall Study|Physician Decision|2|||
48976075|NCT03799627|157742620|FG005|Overall Study|Physician Decision|2|||
48976076|NCT03799627|157742621|FG006|Overall Study|Physician Decision|0|||
48976077|NCT03799627|157742622|FG007|Overall Study|Physician Decision|0|||
48976078|NCT03799627|157742623|FG008|Overall Study|Physician Decision|0|||
48976079|NCT03799627|157742615|FG000|Overall Study|Withdrawal by Subject|1|||
48976080|NCT03799627|157742616|FG001|Overall Study|Withdrawal by Subject|1|||
48976081|NCT03799627|157742617|FG002|Overall Study|Withdrawal by Subject|0|||
48976082|NCT03799627|157742618|FG003|Overall Study|Withdrawal by Subject|2|||
48976083|NCT03799627|157742619|FG004|Overall Study|Withdrawal by Subject|0|||
48976084|NCT03799627|157742620|FG005|Overall Study|Withdrawal by Subject|3|||
48976085|NCT03799627|157742621|FG006|Overall Study|Withdrawal by Subject|0|||
48976086|NCT03799627|157742622|FG007|Overall Study|Withdrawal by Subject|0|||
48976087|NCT03799627|157742623|FG008|Overall Study|Withdrawal by Subject|0|||
48976088|NCT03799627|157742615|FG000|Overall Study|Lack of Efficacy|0|||
48976089|NCT03799627|157742616|FG001|Overall Study|Lack of Efficacy|0|||
48976090|NCT03799627|157742617|FG002|Overall Study|Lack of Efficacy|0|||
48976091|NCT03799627|157742618|FG003|Overall Study|Lack of Efficacy|1|||
48976092|NCT03799627|157742619|FG004|Overall Study|Lack of Efficacy|0|||
48976093|NCT03799627|157742620|FG005|Overall Study|Lack of Efficacy|0|||
48976094|NCT03799627|157742621|FG006|Overall Study|Lack of Efficacy|0|||
48976095|NCT03799627|157742622|FG007|Overall Study|Lack of Efficacy|0|||
48761924|NCT02036502|156975718|FG001|Part 3:Dose Expansion|Progressive Disease|0|||
48761925|NCT02036502|156975719|FG002|Part 3:Dose Expansion|Progressive Disease|0|||
48761926|NCT02036502|156975720|FG003|Part 3:Dose Expansion|Progressive Disease|0|||
48761927|NCT02036502|156975721|FG004|Part 3:Dose Expansion|Progressive Disease|0|||
48761928|NCT02036502|156975722|FG005|Part 3:Dose Expansion|Progressive Disease|1|||
48873911|NCT02196077|157375182|FG000|Overall Study|Lost to Follow-up|3|||
48873912|NCT02196077|157375182|FG000|Overall Study|Protocol Violation|24|||
48873913|NCT02344173|157375188|FG000|Procedure|Ablation Procedure Not Performed|7|||
48873914|NCT02344173|157375188|FG000|12-month Visit|Death|8|||
48873915|NCT02344173|157375188|FG000|12-month Visit|Withdrawal by Subject|30|||
48873916|NCT02344173|157375188|FG000|12-month Visit|Lost to Follow-up|58|||
48976096|NCT03799627|157742623|FG008|Overall Study|Lack of Efficacy|0|||
48976097|NCT03799627|157742615|FG000|Overall Study|Lost to Follow-up|0|||
48976098|NCT03799627|157742616|FG001|Overall Study|Lost to Follow-up|0|||
48976099|NCT03799627|157742617|FG002|Overall Study|Lost to Follow-up|0|||
48976100|NCT03799627|157742618|FG003|Overall Study|Lost to Follow-up|0|||
48976101|NCT03799627|157742619|FG004|Overall Study|Lost to Follow-up|0|||
48976102|NCT03799627|157742620|FG005|Overall Study|Lost to Follow-up|0|||
48761929|NCT02036502|156975723|FG006|Part 3:Dose Expansion|Progressive Disease|0|||
48976103|NCT03799627|157742621|FG006|Overall Study|Lost to Follow-up|1|||
48675408|NCT01336023|156663483|FG001|Week 0 to Week 26|Lack of Efficacy|1|||
48675409|NCT01336023|156663484|FG002|Week 0 to Week 26|Lack of Efficacy|0|||
48675410|NCT01336023|156663482|FG000|Week 0 to Week 26|Protocol Violation|1|||
48675411|NCT01336023|156663483|FG001|Week 0 to Week 26|Protocol Violation|2|||
48873917|NCT03845023|157375189|FG000|Follow-Up (14 Days)|Lost to Follow-up|1|||
48873918|NCT03845023|157375190|FG001|Follow-Up (14 Days)|Lost to Follow-up|0|||
48873919|NCT03845023|157375191|FG002|Follow-Up (14 Days)|Lost to Follow-up|0|||
48873920|NCT03845023|157375192|FG003|Follow-Up (14 Days)|Lost to Follow-up|0|||
48873921|NCT03845023|157375189|FG000|Follow-Up (14 Days)|Adverse Event|0|||
48873922|NCT03845023|157375190|FG001|Follow-Up (14 Days)|Adverse Event|0|||
48976104|NCT03799627|157742622|FG007|Overall Study|Lost to Follow-up|0|||
48976105|NCT03799627|157742623|FG008|Overall Study|Lost to Follow-up|1|||
48976106|NCT03799627|157742615|FG000|Overall Study|Death|0|||
48976107|NCT03799627|157742616|FG001|Overall Study|Death|0|||
48976108|NCT03799627|157742617|FG002|Overall Study|Death|0|||
48976109|NCT03799627|157742618|FG003|Overall Study|Death|1|||
48976110|NCT03799627|157742619|FG004|Overall Study|Death|0|||
48976111|NCT03799627|157742620|FG005|Overall Study|Death|0|||
48976112|NCT03799627|157742621|FG006|Overall Study|Death|0|||
48976113|NCT03799627|157742622|FG007|Overall Study|Death|0|||
48976114|NCT03799627|157742623|FG008|Overall Study|Death|0|||
48976115|NCT03799627|157742615|FG000|Overall Study|Study Drug Put on Hold|1|||
48976116|NCT03799627|157742616|FG001|Overall Study|Study Drug Put on Hold|0|||
48976117|NCT03799627|157742617|FG002|Overall Study|Study Drug Put on Hold|0|||
48976118|NCT03799627|157742618|FG003|Overall Study|Study Drug Put on Hold|0|||
48976119|NCT03799627|157742619|FG004|Overall Study|Study Drug Put on Hold|0|||
48976120|NCT03799627|157742620|FG005|Overall Study|Study Drug Put on Hold|0|||
48976121|NCT03799627|157742621|FG006|Overall Study|Study Drug Put on Hold|0|||
48976122|NCT03799627|157742622|FG007|Overall Study|Study Drug Put on Hold|0|||
48976123|NCT03799627|157742623|FG008|Overall Study|Study Drug Put on Hold|0|||
48976124|NCT03799627|157742615|FG000|Overall Study|Due to Urgent Safety Measures Letter|1|||
48976125|NCT03799627|157742616|FG001|Overall Study|Due to Urgent Safety Measures Letter|2|||
48976126|NCT03799627|157742617|FG002|Overall Study|Due to Urgent Safety Measures Letter|0|||
48976127|NCT03799627|157742618|FG003|Overall Study|Due to Urgent Safety Measures Letter|2|||
48976128|NCT03799627|157742619|FG004|Overall Study|Due to Urgent Safety Measures Letter|1|||
48976129|NCT03799627|157742620|FG005|Overall Study|Due to Urgent Safety Measures Letter|0|||
48976130|NCT03799627|157742621|FG006|Overall Study|Due to Urgent Safety Measures Letter|0|||
48976131|NCT03799627|157742622|FG007|Overall Study|Due to Urgent Safety Measures Letter|0|||
48976132|NCT03799627|157742623|FG008|Overall Study|Due to Urgent Safety Measures Letter|0|||
48976133|NCT03799627|157742615|FG000|Overall Study|Kidney Transplantation|1|||
48976134|NCT03799627|157742616|FG001|Overall Study|Kidney Transplantation|0|||
48976135|NCT03799627|157742617|FG002|Overall Study|Kidney Transplantation|0|||
48976136|NCT03799627|157742618|FG003|Overall Study|Kidney Transplantation|1|||
48976137|NCT03799627|157742619|FG004|Overall Study|Kidney Transplantation|1|||
48976138|NCT03799627|157742620|FG005|Overall Study|Kidney Transplantation|0|||
48976139|NCT03799627|157742621|FG006|Overall Study|Kidney Transplantation|0|||
48976140|NCT03799627|157742622|FG007|Overall Study|Kidney Transplantation|0|||
48976141|NCT03799627|157742623|FG008|Overall Study|Kidney Transplantation|0|||
48976142|NCT03799627|157742615|FG000|Overall Study|Participant Was on Rescue Epogen|0|||
48976143|NCT03799627|157742616|FG001|Overall Study|Participant Was on Rescue Epogen|1|||
48976144|NCT03799627|157742617|FG002|Overall Study|Participant Was on Rescue Epogen|0|||
48976145|NCT03799627|157742618|FG003|Overall Study|Participant Was on Rescue Epogen|0|||
48976146|NCT03799627|157742619|FG004|Overall Study|Participant Was on Rescue Epogen|0|||
48976147|NCT03799627|157742620|FG005|Overall Study|Participant Was on Rescue Epogen|0|||
48976148|NCT03799627|157742621|FG006|Overall Study|Participant Was on Rescue Epogen|1|||
48675412|NCT01336023|156663484|FG002|Week 0 to Week 26|Protocol Violation|0|||
48873923|NCT03845023|157375191|FG002|Follow-Up (14 Days)|Adverse Event|1|||
48873924|NCT03845023|157375192|FG003|Follow-Up (14 Days)|Adverse Event|1|||
48873925|NCT01185171|157375195|FG000|Induction Chemotherapy|Withdrawal by Subject|1|||
48976149|NCT03799627|157742622|FG007|Overall Study|Participant Was on Rescue Epogen|0|||
48976150|NCT03799627|157742623|FG008|Overall Study|Participant Was on Rescue Epogen|1|||
48976151|NCT03799627|157742615|FG000|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
48976152|NCT03799627|157742616|FG001|Overall Study|Placed on Dose Hold Until End of Treatment|1|||
48976153|NCT03799627|157742617|FG002|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
48976154|NCT03799627|157742618|FG003|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
48976155|NCT03799627|157742619|FG004|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
48976156|NCT03799627|157742620|FG005|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
48976157|NCT03799627|157742621|FG006|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
48976158|NCT03799627|157742622|FG007|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
48976159|NCT03799627|157742623|FG008|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
48976160|NCT03799627|157742615|FG000|Overall Study|Met Exclusion Criteria|0|||
48976161|NCT03799627|157742616|FG001|Overall Study|Met Exclusion Criteria|0|||
48976162|NCT03799627|157742617|FG002|Overall Study|Met Exclusion Criteria|0|||
48976163|NCT03799627|157742618|FG003|Overall Study|Met Exclusion Criteria|1|||
48976164|NCT03799627|157742619|FG004|Overall Study|Met Exclusion Criteria|0|||
48976165|NCT03799627|157742620|FG005|Overall Study|Met Exclusion Criteria|0|||
48976166|NCT03799627|157742621|FG006|Overall Study|Met Exclusion Criteria|0|||
48976167|NCT03799627|157742622|FG007|Overall Study|Met Exclusion Criteria|0|||
48976168|NCT03799627|157742623|FG008|Overall Study|Met Exclusion Criteria|0|||
48976169|NCT03799627|157742615|FG000|Overall Study|Investigational Product Noncompliance|0|||
48976170|NCT03799627|157742616|FG001|Overall Study|Investigational Product Noncompliance|0|||
48976171|NCT03799627|157742617|FG002|Overall Study|Investigational Product Noncompliance|0|||
48976172|NCT03799627|157742618|FG003|Overall Study|Investigational Product Noncompliance|1|||
48976173|NCT03799627|157742619|FG004|Overall Study|Investigational Product Noncompliance|0|||
48976174|NCT03799627|157742620|FG005|Overall Study|Investigational Product Noncompliance|0|||
48976175|NCT03799627|157742621|FG006|Overall Study|Investigational Product Noncompliance|0|||
48976176|NCT03799627|157742622|FG007|Overall Study|Investigational Product Noncompliance|0|||
48976177|NCT03799627|157742623|FG008|Overall Study|Investigational Product Noncompliance|0|||
48976178|NCT03799627|157742615|FG000|Overall Study|Participant Relocation|0|||
48976179|NCT03799627|157742616|FG001|Overall Study|Participant Relocation|0|||
48976180|NCT03799627|157742617|FG002|Overall Study|Participant Relocation|0|||
48976181|NCT03799627|157742618|FG003|Overall Study|Participant Relocation|1|||
48976182|NCT03799627|157742619|FG004|Overall Study|Participant Relocation|0|||
48976183|NCT03799627|157742620|FG005|Overall Study|Participant Relocation|1|||
48976184|NCT03799627|157742621|FG006|Overall Study|Participant Relocation|0|||
48976185|NCT03799627|157742622|FG007|Overall Study|Participant Relocation|0|||
48976186|NCT03799627|157742623|FG008|Overall Study|Participant Relocation|0|||
48976187|NCT03799627|157742615|FG000|Overall Study|Eurofin Issue|0|||
48976188|NCT03799627|157742616|FG001|Overall Study|Eurofin Issue|0|||
48873926|NCT01185171|157375195|FG000|Induction Chemotherapy|Duodenal Ulcer|1|||
48873927|NCT01185171|157375195|FG000|Concurrent Chemo and Radiation Treatment|Death|3|||
48976189|NCT03799627|157742617|FG002|Overall Study|Eurofin Issue|0|||
48976190|NCT03799627|157742618|FG003|Overall Study|Eurofin Issue|0|||
48976191|NCT03799627|157742619|FG004|Overall Study|Eurofin Issue|1|||
48976192|NCT03799627|157742620|FG005|Overall Study|Eurofin Issue|0|||
48976193|NCT03799627|157742621|FG006|Overall Study|Eurofin Issue|0|||
48976194|NCT03799627|157742622|FG007|Overall Study|Eurofin Issue|0|||
48976195|NCT03799627|157742623|FG008|Overall Study|Eurofin Issue|0|||
48976196|NCT03799627|157742615|FG000|Overall Study|Noncompliance with Site Instructions|0|||
48976197|NCT03799627|157742616|FG001|Overall Study|Noncompliance with Site Instructions|0|||
48976198|NCT03799627|157742617|FG002|Overall Study|Noncompliance with Site Instructions|0|||
48976199|NCT03799627|157742618|FG003|Overall Study|Noncompliance with Site Instructions|0|||
48976200|NCT03799627|157742619|FG004|Overall Study|Noncompliance with Site Instructions|1|||
48976201|NCT03799627|157742620|FG005|Overall Study|Noncompliance with Site Instructions|0|||
48873928|NCT01185171|157375195|FG000|Maintenance|Elevated liver transaminases|3|||
48873929|NCT01185171|157375195|FG000|Maintenance|Rush|2|||
48873930|NCT01185171|157375195|FG000|Maintenance|Diarrhea|1|||
48873931|NCT01185171|157375195|FG000|Maintenance|Xerostomia|1|||
48873932|NCT01185171|157375195|FG000|Maintenance|Nausea|1|||
48873933|NCT01185171|157375195|FG000|Maintenance|Comorbid Illness|2|||
48976202|NCT03799627|157742621|FG006|Overall Study|Noncompliance with Site Instructions|0|||
48976203|NCT03799627|157742622|FG007|Overall Study|Noncompliance with Site Instructions|0|||
48976204|NCT03799627|157742623|FG008|Overall Study|Noncompliance with Site Instructions|0|||
48976205|NCT03799627|157742615|FG000|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
48976206|NCT03799627|157742616|FG001|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
48976207|NCT03799627|157742617|FG002|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
48976208|NCT03799627|157742618|FG003|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
48976209|NCT03799627|157742619|FG004|Overall Study|Participant's Last Dose Prior to End of Treatment|1|||
48976210|NCT03799627|157742620|FG005|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
48976211|NCT03799627|157742621|FG006|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
48976212|NCT03799627|157742622|FG007|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
48873934|NCT01185171|157375195|FG000|Maintenance|Withdrawal by Subject|1|||
48976213|NCT03799627|157742623|FG008|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
48873935|NCT01185171|157375195|FG000|Maintenance|Disease Recurrence|1|||
48873936|NCT00715117|157375196|FG000|Overall Study|Crohn's flare and rescue with steroids|0|||
48976214|NCT03799627|157742615|FG000|Overall Study|Changes In Hemoglobin Values|1|||
48976215|NCT03799627|157742616|FG001|Overall Study|Changes In Hemoglobin Values|2|||
48976216|NCT03799627|157742617|FG002|Overall Study|Changes In Hemoglobin Values|1|||
48976217|NCT03799627|157742618|FG003|Overall Study|Changes In Hemoglobin Values|0|||
48976218|NCT03799627|157742619|FG004|Overall Study|Changes In Hemoglobin Values|0|||
48976219|NCT03799627|157742620|FG005|Overall Study|Changes In Hemoglobin Values|2|||
48976220|NCT03799627|157742621|FG006|Overall Study|Changes In Hemoglobin Values|1|||
48976221|NCT03799627|157742622|FG007|Overall Study|Changes In Hemoglobin Values|0|||
48873937|NCT00715117|157375197|FG001|Overall Study|Crohn's flare and rescue with steroids|1|||
48976222|NCT03799627|157742623|FG008|Overall Study|Changes In Hemoglobin Values|1|||
48976223|NCT00062647|157742624|FG000|Overall Study|Death|2|||
48761930|NCT02036502|156975724|FG007|Part 3:Dose Expansion|Progressive Disease|0|||
48761931|NCT02036502|156975717|FG000|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
48761932|NCT02036502|156975718|FG001|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
48761933|NCT02036502|156975719|FG002|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
48761934|NCT02036502|156975720|FG003|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
48761935|NCT02036502|156975721|FG004|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
48761936|NCT02036502|156975722|FG005|Part 3:Dose Expansion|Study Terminated by Sponsor|11|||
48761937|NCT02036502|156975723|FG006|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
48761938|NCT02036502|156975724|FG007|Part 3:Dose Expansion|Study Terminated by Sponsor|2|||
48761939|NCT02036502|156975717|FG000|Part 3:Dose Expansion|Withdrawal by Subject|0|||
48761940|NCT02036502|156975718|FG001|Part 3:Dose Expansion|Withdrawal by Subject|0|||
48761941|NCT02036502|156975719|FG002|Part 3:Dose Expansion|Withdrawal by Subject|0|||
48761942|NCT02036502|156975720|FG003|Part 3:Dose Expansion|Withdrawal by Subject|0|||
48761943|NCT02036502|156975721|FG004|Part 3:Dose Expansion|Withdrawal by Subject|0|||
48761944|NCT02036502|156975722|FG005|Part 3:Dose Expansion|Withdrawal by Subject|4|||
48873938|NCT00365547|157375198|FG000|Overall Study|Insurance did not cover Avastin|1|||
48873939|NCT00365547|157375198|FG000|Overall Study|Screen failure|1|||
48873940|NCT00365547|157375198|FG000|Overall Study|Withdrawal by Subject|1|||
48873941|NCT01503164|157375202|FG000|Overall Study|Withdrawal by Subject|2|||
48873942|NCT01503164|157375203|FG001|Overall Study|Withdrawal by Subject|1|||
48873943|NCT03023423|157375204|FG000|Overall Study|Death|5|||
48873944|NCT03023423|157375205|FG001|Overall Study|Death|12|||
48873945|NCT03023423|157375206|FG002|Overall Study|Death|20|||
48873946|NCT03023423|157375204|FG000|Overall Study|Other|0|||
48873947|NCT03023423|157375205|FG001|Overall Study|Other|2|||
48873948|NCT03023423|157375206|FG002|Overall Study|Other|2|||
48873949|NCT03023423|157375204|FG000|Overall Study|Ongoing|2|||
48873950|NCT03023423|157375205|FG001|Overall Study|Ongoing|32|||
48873951|NCT03023423|157375206|FG002|Overall Study|Ongoing|24|||
48873952|NCT03512197|157375207|FG000|Overall Study|Guardian decision|1|||
48873953|NCT03512197|157375208|FG001|Overall Study|Guardian decision|1|||
48873954|NCT03512197|157375207|FG000|Overall Study|Lack of Efficacy|19|||
48873955|NCT03512197|157375208|FG001|Overall Study|Lack of Efficacy|11|||
48873956|NCT03512197|157375207|FG000|Overall Study|New Therapy for Study Indication|16|||
48873957|NCT03512197|157375208|FG001|Overall Study|New Therapy for Study Indication|16|||
48873958|NCT03512197|157375207|FG000|Overall Study|Physician Decision|60|||
48873959|NCT03512197|157375208|FG001|Overall Study|Physician Decision|60|||
48873960|NCT03512197|157375207|FG000|Overall Study|Protocol Violation|0|||
48873961|NCT03512197|157375208|FG001|Overall Study|Protocol Violation|2|||
48873962|NCT03512197|157375207|FG000|Overall Study|Terminated by Sponsored|46|||
48873963|NCT03512197|157375208|FG001|Overall Study|Terminated by Sponsored|50|||
48873964|NCT03512197|157375207|FG000|Overall Study|Subject Decision|15|||
48873965|NCT03512197|157375208|FG001|Overall Study|Subject Decision|12|||
48873966|NCT03512197|157375207|FG000|Overall Study|Withdrawal of informed consent|20|||
48873967|NCT03512197|157375208|FG001|Overall Study|Withdrawal of informed consent|14|||
48873968|NCT03512197|157375207|FG000|Overall Study|Adverse Event|30|||
48873969|NCT03512197|157375208|FG001|Overall Study|Adverse Event|34|||
48873970|NCT03512197|157375207|FG000|Overall Study|Death|14|||
48873971|NCT03512197|157375208|FG001|Overall Study|Death|9|||
48873972|NCT03512197|157375207|FG000|Overall Study|Failure to meet Continuation Criteria|24|||
48873973|NCT03512197|157375208|FG001|Overall Study|Failure to meet Continuation Criteria|28|||
48873974|NCT03512197|157375207|FG000|Overall Study|Missing|3|||
48873975|NCT03512197|157375208|FG001|Overall Study|Missing|13|||
48873976|NCT01227928|157375209|FG000|Overall Study|Lost to Follow-up|4|||
48873977|NCT01227928|157375210|FG001|Overall Study|Lost to Follow-up|2|||
48873978|NCT01227928|157375209|FG000|Overall Study|Withdrawal by Subject|4|||
48873979|NCT01227928|157375210|FG001|Overall Study|Withdrawal by Subject|3|||
48873980|NCT01227928|157375209|FG000|Overall Study|Death|14|||
48873981|NCT01227928|157375210|FG001|Overall Study|Death|12|||
48873982|NCT00356759|157375213|FG000|Overall Study|Death|5|||
48873983|NCT00356759|157375214|FG001|Overall Study|Death|2|||
48873984|NCT00356759|157375213|FG000|Overall Study|Withdrawal by Subject|2|||
48873985|NCT00356759|157375214|FG001|Overall Study|Withdrawal by Subject|2|||
48873986|NCT00356759|157375213|FG000|Overall Study|Adverse Event|1|||
48976224|NCT00062647|157742625|FG001|Overall Study|Death|2|||
48976225|NCT00062647|157742624|FG000|Overall Study|Adverse Event|1|||
48873987|NCT00356759|157375214|FG001|Overall Study|Adverse Event|3|||
48873988|NCT00356759|157375213|FG000|Overall Study|Lost to Follow-up|1|||
48873989|NCT00356759|157375214|FG001|Overall Study|Lost to Follow-up|1|||
48873990|NCT00356759|157375213|FG000|Overall Study|Intercurrent disease or persistent extre|5|||
48873991|NCT00356759|157375214|FG001|Overall Study|Intercurrent disease or persistent extre|2|||
48873992|NCT00934700|157375218|FG000|Overall Study|missing scan|5|||
48873993|NCT00934700|157375219|FG001|Overall Study|missing scan|9|||
48873994|NCT00934700|157375218|FG000|Overall Study|Death|8|||
48873995|NCT00934700|157375219|FG001|Overall Study|Death|3|||
48873996|NCT05239598|157375223|FG000|Phase II (Open Label)|Lost to Follow-up|1|||
48976226|NCT00062647|157742625|FG001|Overall Study|Adverse Event|1|||
48976227|NCT00062647|157742624|FG000|Overall Study|Withdrawal by Subject|2|||
48976228|NCT00062647|157742625|FG001|Overall Study|Withdrawal by Subject|1|||
48976229|NCT00062647|157742624|FG000|Overall Study|Protocol Violation|1|||
48976230|NCT00062647|157742625|FG001|Overall Study|Protocol Violation|0|||
48976231|NCT00062647|157742624|FG000|Overall Study|Lost to Follow-up|1|||
48976232|NCT00062647|157742625|FG001|Overall Study|Lost to Follow-up|2|||
48976233|NCT00062647|157742624|FG000|Overall Study|Failed continuation criteria|4|||
48976234|NCT00062647|157742625|FG001|Overall Study|Failed continuation criteria|2|||
48976235|NCT00062647|157742624|FG000|Overall Study|Other|4|||
48976236|NCT00062647|157742625|FG001|Overall Study|Other|4|||
48976237|NCT00062647|157742624|FG000|Overall Study|Never received study treatment|1|||
48976238|NCT00062647|157742625|FG001|Overall Study|Never received study treatment|1|||
48976239|NCT04445051|157742626|FG000|Overall Study|Adverse Event|0|||
48976240|NCT04445051|157742627|FG001|Overall Study|Adverse Event|0|||
48976241|NCT04445051|157742628|FG002|Overall Study|Adverse Event|1|||
48976242|NCT04445051|157742629|FG003|Overall Study|Adverse Event|0|||
48976243|NCT04445051|157742630|FG004|Overall Study|Adverse Event|0|||
48976244|NCT04445051|157742631|FG005|Overall Study|Adverse Event|0|||
48976245|NCT01197794|157742632|FG000|Overall Study|Adverse Event|3|||
48976246|NCT01197794|157742633|FG001|Overall Study|Adverse Event|2|||
48976247|NCT01197794|157742634|FG002|Overall Study|Adverse Event|4|||
48976248|NCT01197794|157742635|FG003|Overall Study|Adverse Event|4|||
48976249|NCT01197794|157742636|FG004|Overall Study|Adverse Event|4|||
48976250|NCT01197794|157742637|FG005|Overall Study|Adverse Event|2|||
48976251|NCT01197794|157742638|FG006|Overall Study|Adverse Event|3|||
48976252|NCT01197794|157742632|FG000|Overall Study|Protocol Violation|0|||
48976253|NCT01197794|157742633|FG001|Overall Study|Protocol Violation|0|||
48976254|NCT01197794|157742634|FG002|Overall Study|Protocol Violation|0|||
48976255|NCT01197794|157742635|FG003|Overall Study|Protocol Violation|0|||
48976256|NCT01197794|157742636|FG004|Overall Study|Protocol Violation|2|||
48976257|NCT01197794|157742637|FG005|Overall Study|Protocol Violation|0|||
48976258|NCT01197794|157742638|FG006|Overall Study|Protocol Violation|1|||
48976259|NCT01197794|157742632|FG000|Overall Study|Development of study withdrawal criteria|3|||
48976260|NCT01197794|157742633|FG001|Overall Study|Development of study withdrawal criteria|0|||
48976261|NCT01197794|157742634|FG002|Overall Study|Development of study withdrawal criteria|0|||
48976262|NCT01197794|157742635|FG003|Overall Study|Development of study withdrawal criteria|1|||
48976263|NCT01197794|157742636|FG004|Overall Study|Development of study withdrawal criteria|0|||
48976264|NCT01197794|157742637|FG005|Overall Study|Development of study withdrawal criteria|0|||
48976265|NCT01197794|157742638|FG006|Overall Study|Development of study withdrawal criteria|1|||
48976266|NCT01197794|157742632|FG000|Overall Study|Eligibility criteria not fulfilled|5|||
48976267|NCT01197794|157742633|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
48976268|NCT01197794|157742634|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
48976269|NCT01197794|157742635|FG003|Overall Study|Eligibility criteria not fulfilled|5|||
48976270|NCT01197794|157742636|FG004|Overall Study|Eligibility criteria not fulfilled|5|||
48976271|NCT01197794|157742637|FG005|Overall Study|Eligibility criteria not fulfilled|9|||
48976272|NCT01197794|157742638|FG006|Overall Study|Eligibility criteria not fulfilled|6|||
48976273|NCT01197794|157742632|FG000|Overall Study|Withdrawal by Subject|3|||
48976274|NCT01197794|157742633|FG001|Overall Study|Withdrawal by Subject|3|||
48976275|NCT01197794|157742634|FG002|Overall Study|Withdrawal by Subject|4|||
48976276|NCT01197794|157742635|FG003|Overall Study|Withdrawal by Subject|1|||
48976277|NCT01197794|157742636|FG004|Overall Study|Withdrawal by Subject|1|||
48873997|NCT05239598|157375224|FG001|Phase II (Open Label)|Lost to Follow-up|0|||
48873998|NCT05239598|157375223|FG000|Phase II (Open Label)|Withdrawal by Subject|1|||
48976278|NCT01197794|157742637|FG005|Overall Study|Withdrawal by Subject|5|||
48976279|NCT01197794|157742638|FG006|Overall Study|Withdrawal by Subject|6|||
48976280|NCT01197794|157742632|FG000|Overall Study|Lost to Follow-up|1|||
48976281|NCT01197794|157742633|FG001|Overall Study|Lost to Follow-up|1|||
48976282|NCT01197794|157742634|FG002|Overall Study|Lost to Follow-up|0|||
48976283|NCT01197794|157742635|FG003|Overall Study|Lost to Follow-up|1|||
48976284|NCT01197794|157742636|FG004|Overall Study|Lost to Follow-up|0|||
48976285|NCT01197794|157742637|FG005|Overall Study|Lost to Follow-up|1|||
48976286|NCT01197794|157742638|FG006|Overall Study|Lost to Follow-up|0|||
48976287|NCT01197794|157742632|FG000|Overall Study|Other|1|||
48976288|NCT01197794|157742633|FG001|Overall Study|Other|1|||
48976289|NCT01197794|157742634|FG002|Overall Study|Other|3|||
48976290|NCT01197794|157742635|FG003|Overall Study|Other|0|||
48976291|NCT01197794|157742636|FG004|Overall Study|Other|2|||
48976292|NCT01197794|157742637|FG005|Overall Study|Other|2|||
48976293|NCT01197794|157742638|FG006|Overall Study|Other|4|||
48976294|NCT02392468|157742645|FG000|Overall Study|Adverse Event|0|||
48976295|NCT02392468|157742646|FG001|Overall Study|Adverse Event|1|||
48976296|NCT02392468|157742647|FG002|Overall Study|Adverse Event|0|||
48976297|NCT02392468|157742648|FG003|Overall Study|Adverse Event|0|||
48976298|NCT02392468|157742649|FG004|Overall Study|Adverse Event|0|||
48976299|NCT02392468|157742650|FG005|Overall Study|Adverse Event|1|||
48976300|NCT05166603|157742653|FG000|Overall Study|Withdrawal by Subject|68|||
48976301|NCT05166603|157742654|FG001|Overall Study|Withdrawal by Subject|0|||
48976302|NCT01512108|157744584|FG000|Overall Study|Adverse Event|9|||
48976303|NCT01512108|157744585|FG001|Overall Study|Adverse Event|4|||
48976304|NCT01512108|157744584|FG000|Overall Study|Protocol Violation|1|||
48976305|NCT01512108|157744585|FG001|Overall Study|Protocol Violation|2|||
48976306|NCT01512108|157744584|FG000|Overall Study|Withdrawal Criteria|1|||
48976307|NCT01512108|157744585|FG001|Overall Study|Withdrawal Criteria|0|||
48976308|NCT01512108|157744584|FG000|Overall Study|Unclassified|11|||
48976309|NCT01512108|157744585|FG001|Overall Study|Unclassified|3|||
48976310|NCT02332798|157744588|FG000|Overall Study|Unwilling to Participate in Study|0|||
48976311|NCT02332798|157744589|FG001|Overall Study|Unwilling to Participate in Study|1|||
48976312|NCT02332798|157744590|FG002|Overall Study|Unwilling to Participate in Study|1|||
48976313|NCT02332798|157744588|FG000|Overall Study|Positive Urine Drug Test|0|||
48976314|NCT02332798|157744589|FG001|Overall Study|Positive Urine Drug Test|1|||
48976315|NCT02332798|157744590|FG002|Overall Study|Positive Urine Drug Test|0|||
48976316|NCT02332798|157744588|FG000|Overall Study|Abnormal Laboratory Findings|1|||
48976317|NCT02332798|157744589|FG001|Overall Study|Abnormal Laboratory Findings|0|||
48976318|NCT02332798|157744590|FG002|Overall Study|Abnormal Laboratory Findings|0|||
48976319|NCT02688153|157744591|FG000|Overall Study|Death|7|||
48976320|NCT02688153|157744592|FG001|Overall Study|Death|5|||
48976321|NCT02688153|157744591|FG000|Overall Study|Withdrawal by Subject|4|||
48976322|NCT02688153|157744592|FG001|Overall Study|Withdrawal by Subject|2|||
48976323|NCT02688153|157744591|FG000|Overall Study|Valve Explant|1|||
48976324|NCT02688153|157744592|FG001|Overall Study|Valve Explant|0|||
48976325|NCT02688153|157744591|FG000|Overall Study|Conversion to Commercial Valve|3|||
48976326|NCT02688153|157744592|FG001|Overall Study|Conversion to Commercial Valve|0|||
48976327|NCT02043509|157744595|FG000|Baseline to 1st Follow-up|Lost to Follow-up|61|||
48976328|NCT02043509|157744596|FG001|Baseline to 1st Follow-up|Lost to Follow-up|47|||
48976329|NCT02043509|157744595|FG000|Baseline to 1st Follow-up|Withdrawal by Subject|4|||
48976330|NCT02043509|157744596|FG001|Baseline to 1st Follow-up|Withdrawal by Subject|0|||
48976331|NCT02043509|157744595|FG000|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
48976332|NCT02043509|157744596|FG001|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
48976333|NCT02043509|157744595|FG000|Baseline to 2nd Follow-up|Withdrawal by Subject|7|||
48976334|NCT02043509|157744596|FG001|Baseline to 2nd Follow-up|Withdrawal by Subject|5|||
48976335|NCT00191386|157744597|FG000|Overall Study|Adverse Event|16|||
48976336|NCT00191386|157744597|FG000|Overall Study|Lost to Follow-up|1|||
48976337|NCT00191386|157744597|FG000|Overall Study|Entry Criteria Exclusion|3|||
48976338|NCT00191386|157744597|FG000|Overall Study|Protocol Violation|18|||
48976339|NCT00191386|157744597|FG000|Overall Study|Withdrawal by Subject|96|||
48976340|NCT00191386|157744597|FG000|Overall Study|Physician Decision|11|||
48976341|NCT00191386|157744597|FG000|Overall Study|Lack of Efficacy|15|||
48976342|NCT01673490|157744598|FG000|Overall Study|Lost to Follow-up|1|||
48976343|NCT01673490|157744598|FG000|Overall Study|Adverse Event|3|||
48976344|NCT01673490|157744598|FG000|Overall Study|Withdrawal by Subject|3|||
48976345|NCT04134728|157744599|FG000|Overall Study|Adverse Event|3|||
48976346|NCT04134728|157744600|FG001|Overall Study|Adverse Event|2|||
48976347|NCT04134728|157744601|FG002|Overall Study|Adverse Event|9|||
48976348|NCT04134728|157744602|FG003|Overall Study|Adverse Event|0|||
48976349|NCT04134728|157744603|FG004|Overall Study|Adverse Event|0|||
48976350|NCT04134728|157744604|FG005|Overall Study|Adverse Event|0|||
48976351|NCT04134728|157744599|FG000|Overall Study|Lack of Efficacy|3|||
48976352|NCT04134728|157744600|FG001|Overall Study|Lack of Efficacy|3|||
48976353|NCT04134728|157744601|FG002|Overall Study|Lack of Efficacy|1|||
48675413|NCT01336023|156663482|FG000|Week 0 to Week 26|Withdrawal Criteria|34|||
48675414|NCT01336023|156663483|FG001|Week 0 to Week 26|Withdrawal Criteria|69|||
48675415|NCT01336023|156663484|FG002|Week 0 to Week 26|Withdrawal Criteria|40|||
48675416|NCT01336023|156663482|FG000|Week 0 to Week 26|Unclassified|5|||
48675417|NCT01336023|156663483|FG001|Week 0 to Week 26|Unclassified|16|||
48675418|NCT01336023|156663484|FG002|Week 0 to Week 26|Unclassified|9|||
48675419|NCT01336023|156663482|FG000|Week 27 to 52|Adverse Event|1|||
48675420|NCT01336023|156663483|FG001|Week 27 to 52|Adverse Event|5|||
48675421|NCT01336023|156663484|FG002|Week 27 to 52|Adverse Event|2|||
48675422|NCT01336023|156663482|FG000|Week 27 to 52|Protocol Violation|0|||
48675423|NCT01336023|156663483|FG001|Week 27 to 52|Protocol Violation|2|||
48675424|NCT01336023|156663484|FG002|Week 27 to 52|Protocol Violation|1|||
48675425|NCT01336023|156663482|FG000|Week 27 to 52|Withdrawal Criteria|14|||
48675426|NCT01336023|156663483|FG001|Week 27 to 52|Withdrawal Criteria|19|||
48675427|NCT01336023|156663484|FG002|Week 27 to 52|Withdrawal Criteria|16|||
48976354|NCT04134728|157744602|FG003|Overall Study|Lack of Efficacy|2|||
48976355|NCT04134728|157744603|FG004|Overall Study|Lack of Efficacy|0|||
48976356|NCT04134728|157744604|FG005|Overall Study|Lack of Efficacy|0|||
48976357|NCT04134728|157744599|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
48976358|NCT04134728|157744600|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
48976359|NCT04134728|157744601|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
48976360|NCT04134728|157744602|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
48976361|NCT04134728|157744603|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
48675428|NCT01336023|156663482|FG000|Week 27 to 52|Unclassified|13|||
48976362|NCT04134728|157744604|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
48976363|NCT04134728|157744599|FG000|Overall Study|Protocol Deviation|0|||
48976364|NCT04134728|157744600|FG001|Overall Study|Protocol Deviation|0|||
48976365|NCT04134728|157744601|FG002|Overall Study|Protocol Deviation|1|||
48976366|NCT04134728|157744602|FG003|Overall Study|Protocol Deviation|0|||
48976367|NCT04134728|157744603|FG004|Overall Study|Protocol Deviation|0|||
48976368|NCT04134728|157744604|FG005|Overall Study|Protocol Deviation|0|||
48976369|NCT04134728|157744599|FG000|Overall Study|Informed Consent Withdrawn|3|||
48976370|NCT04134728|157744600|FG001|Overall Study|Informed Consent Withdrawn|6|||
48976371|NCT04134728|157744601|FG002|Overall Study|Informed Consent Withdrawn|8|||
48976372|NCT04134728|157744602|FG003|Overall Study|Informed Consent Withdrawn|1|||
48976373|NCT04134728|157744603|FG004|Overall Study|Informed Consent Withdrawn|1|||
48976374|NCT04134728|157744604|FG005|Overall Study|Informed Consent Withdrawn|0|||
48976375|NCT04134728|157744599|FG000|Overall Study|Physician Decision|2|||
48976376|NCT04134728|157744600|FG001|Overall Study|Physician Decision|0|||
48976377|NCT04134728|157744601|FG002|Overall Study|Physician Decision|0|||
48976378|NCT04134728|157744602|FG003|Overall Study|Physician Decision|0|||
48976379|NCT04134728|157744603|FG004|Overall Study|Physician Decision|0|||
48976380|NCT04134728|157744604|FG005|Overall Study|Physician Decision|0|||
48976381|NCT04134728|157744599|FG000|Overall Study|Lost to Follow-up|1|||
48976382|NCT04134728|157744600|FG001|Overall Study|Lost to Follow-up|2|||
48976383|NCT04134728|157744601|FG002|Overall Study|Lost to Follow-up|1|||
48976384|NCT04134728|157744602|FG003|Overall Study|Lost to Follow-up|0|||
48976385|NCT04134728|157744603|FG004|Overall Study|Lost to Follow-up|0|||
48976386|NCT04134728|157744604|FG005|Overall Study|Lost to Follow-up|1|||
48976387|NCT04134728|157744599|FG000|Overall Study|Investigator Site Closed|0|||
48976388|NCT04134728|157744600|FG001|Overall Study|Investigator Site Closed|1|||
48976389|NCT04134728|157744601|FG002|Overall Study|Investigator Site Closed|1|||
48976390|NCT04134728|157744602|FG003|Overall Study|Investigator Site Closed|0|||
48976391|NCT04134728|157744603|FG004|Overall Study|Investigator Site Closed|0|||
48976392|NCT04134728|157744604|FG005|Overall Study|Investigator Site Closed|0|||
48976393|NCT00446641|157744605|FG000|Overall Study|Withdrawal by Subject|8|||
48976394|NCT00446641|157744606|FG001|Overall Study|Withdrawal by Subject|3|||
48976395|NCT00446641|157744605|FG000|Overall Study|poor compliance|8|||
48976396|NCT00446641|157744606|FG001|Overall Study|poor compliance|6|||
48976397|NCT00446641|157744605|FG000|Overall Study|Lost to Follow-up|1|||
48976398|NCT00446641|157744606|FG001|Overall Study|Lost to Follow-up|1|||
48976399|NCT01826448|157744612|FG000|Overall Study|Adverse Event|1|||
48976400|NCT01826448|157744613|FG001|Overall Study|Adverse Event|3|||
48976401|NCT01826448|157744612|FG000|Overall Study|Disease progression|2|||
48976402|NCT01826448|157744613|FG001|Overall Study|Disease progression|4|||
48976403|NCT01826448|157744612|FG000|Overall Study|Withdrawal by Subject|1|||
48976404|NCT01826448|157744613|FG001|Overall Study|Withdrawal by Subject|0|||
48976405|NCT01826448|157744612|FG000|Overall Study|Physician Decision|0|||
48976406|NCT01826448|157744613|FG001|Overall Study|Physician Decision|1|||
48976407|NCT01826448|157744612|FG000|Overall Study|2 active cancers|0|||
48976408|NCT01826448|157744613|FG001|Overall Study|2 active cancers|1|||
48976409|NCT01352845|157744614|FG000|Overall Study|Lost to Follow-up|313|||
48976410|NCT01352845|157744615|FG001|Overall Study|Lost to Follow-up|92|||
48976411|NCT01352845|157744614|FG000|Overall Study|No Longer Willing to Participate|205|||
48976412|NCT01352845|157744615|FG001|Overall Study|No Longer Willing to Participate|58|||
48976413|NCT01352845|157744614|FG000|Overall Study|Withdrawal by Subject|48|||
48976414|NCT01352845|157744615|FG001|Overall Study|Withdrawal by Subject|16|||
48976415|NCT01352845|157744614|FG000|Overall Study|No Longer Meets Eligibility Criteria|24|||
48976416|NCT01352845|157744615|FG001|Overall Study|No Longer Meets Eligibility Criteria|11|||
48976417|NCT01352845|157744614|FG000|Overall Study|Pregnancy|27|||
48976418|NCT01352845|157744615|FG001|Overall Study|Pregnancy|7|||
48976419|NCT01352845|157744614|FG000|Overall Study|Adverse Event|22|||
48976420|NCT01352845|157744615|FG001|Overall Study|Adverse Event|6|||
48976421|NCT01352845|157744614|FG000|Overall Study|Other|17|||
48976422|NCT01352845|157744615|FG001|Overall Study|Other|7|||
48976423|NCT01352845|157744614|FG000|Overall Study|Protocol Violation|12|||
48976424|NCT01352845|157744615|FG001|Overall Study|Protocol Violation|6|||
48976425|NCT01352845|157744614|FG000|Overall Study|Death|3|||
48976426|NCT01352845|157744615|FG001|Overall Study|Death|0|||
48976427|NCT02204410|157744616|FG000|Overall Study|Lost to Follow-up|5|||
48976428|NCT02204410|157744616|FG000|Overall Study|Physician Decision|2|||
48976429|NCT02204410|157744616|FG000|Overall Study|Protocol Violation|1|||
48976430|NCT02204410|157744616|FG000|Overall Study|Withdrawal by Subject|3|||
48976431|NCT02959970|157744626|FG000|Overall Study|Adverse Event|1|||
48976432|NCT02959970|157744627|FG001|Overall Study|Adverse Event|0|||
48976433|NCT02959970|157744626|FG000|Overall Study|Withdrawal by Subject|0|||
48976434|NCT02959970|157744627|FG001|Overall Study|Withdrawal by Subject|2|||
48976435|NCT02959970|157744626|FG000|Overall Study|Lost to Follow-up|1|||
48976436|NCT02959970|157744627|FG001|Overall Study|Lost to Follow-up|5|||
48976437|NCT02327078|157744628|FG000|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
48976438|NCT02327078|157744629|FG001|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
48976439|NCT02327078|157744630|FG002|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|2|||
48976440|NCT02327078|157744631|FG003|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
48976441|NCT02327078|157744632|FG004|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
48976442|NCT02327078|157744633|FG005|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
48976443|NCT02327078|157744634|FG006|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
48976444|NCT02327078|157744635|FG007|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|11|||
48976445|NCT02327078|157744636|FG008|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|25|||
48976446|NCT02327078|157744628|FG000|Overall Study|Death|2|||
48976447|NCT02327078|157744629|FG001|Overall Study|Death|4|||
48976448|NCT02327078|157744630|FG002|Overall Study|Death|10|||
48976449|NCT02327078|157744631|FG003|Overall Study|Death|6|||
48976450|NCT02327078|157744632|FG004|Overall Study|Death|4|||
48976451|NCT02327078|157744633|FG005|Overall Study|Death|3|||
48976452|NCT02327078|157744634|FG006|Overall Study|Death|2|||
48976453|NCT02327078|157744635|FG007|Overall Study|Death|51|||
48976454|NCT02327078|157744636|FG008|Overall Study|Death|97|||
48976455|NCT02327078|157744628|FG000|Overall Study|Lost to Follow-up|0|||
48976456|NCT02327078|157744629|FG001|Overall Study|Lost to Follow-up|1|||
48976457|NCT02327078|157744630|FG002|Overall Study|Lost to Follow-up|1|||
48976458|NCT02327078|157744631|FG003|Overall Study|Lost to Follow-up|0|||
48976459|NCT02327078|157744632|FG004|Overall Study|Lost to Follow-up|0|||
48976460|NCT02327078|157744633|FG005|Overall Study|Lost to Follow-up|0|||
48976461|NCT02327078|157744634|FG006|Overall Study|Lost to Follow-up|0|||
48976462|NCT02327078|157744635|FG007|Overall Study|Lost to Follow-up|2|||
48976463|NCT02327078|157744636|FG008|Overall Study|Lost to Follow-up|5|||
48976464|NCT02327078|157744628|FG000|Overall Study|Site Terminated by Sponsor|1|||
48976465|NCT02327078|157744629|FG001|Overall Study|Site Terminated by Sponsor|0|||
48976466|NCT02327078|157744630|FG002|Overall Study|Site Terminated by Sponsor|1|||
48976467|NCT02327078|157744631|FG003|Overall Study|Site Terminated by Sponsor|4|||
48976468|NCT02327078|157744632|FG004|Overall Study|Site Terminated by Sponsor|0|||
48976469|NCT02327078|157744633|FG005|Overall Study|Site Terminated by Sponsor|0|||
48976470|NCT02327078|157744634|FG006|Overall Study|Site Terminated by Sponsor|0|||
48976471|NCT02327078|157744635|FG007|Overall Study|Site Terminated by Sponsor|11|||
48976472|NCT02327078|157744636|FG008|Overall Study|Site Terminated by Sponsor|25|||
48976473|NCT02327078|157744628|FG000|Overall Study|Physician Decision|0|||
48976474|NCT02327078|157744629|FG001|Overall Study|Physician Decision|0|||
48976475|NCT02327078|157744630|FG002|Overall Study|Physician Decision|0|||
48976476|NCT02327078|157744631|FG003|Overall Study|Physician Decision|1|||
48976477|NCT02327078|157744632|FG004|Overall Study|Physician Decision|0|||
48976478|NCT02327078|157744633|FG005|Overall Study|Physician Decision|0|||
48976479|NCT02327078|157744634|FG006|Overall Study|Physician Decision|0|||
48976480|NCT02327078|157744635|FG007|Overall Study|Physician Decision|0|||
48976481|NCT02327078|157744636|FG008|Overall Study|Physician Decision|1|||
48976482|NCT02327078|157744628|FG000|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
48976483|NCT02327078|157744629|FG001|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
48976484|NCT02327078|157744630|FG002|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
48976485|NCT02327078|157744631|FG003|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
48976486|NCT02327078|157744632|FG004|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
48976487|NCT02327078|157744633|FG005|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
48675429|NCT01336023|156663483|FG001|Week 27 to 52|Unclassified|18|||
48675430|NCT01336023|156663484|FG002|Week 27 to 52|Unclassified|9|||
48675431|NCT00695864|156663495|FG000|Placebo|Withdrawal by Subject|1|||
48675432|NCT00695864|156663495|FG000|Placebo|Physician Decision|4|||
48675433|NCT01894022|156663498|FG000|Overall Study|Death|1|||
48675434|NCT01894022|156663499|FG001|Overall Study|Death|0|||
48675435|NCT01894022|156663498|FG000|Overall Study|Adverse Event, non-fatal|1|||
48675436|NCT01894022|156663499|FG001|Overall Study|Adverse Event, non-fatal|0|||
48675437|NCT01894022|156663498|FG000|Overall Study|Study Closed/terminated|7|||
48675438|NCT01894022|156663499|FG001|Overall Study|Study Closed/terminated|10|||
48675439|NCT02202538|156663500|FG000|Overall Study|Withdrawal by Subject|5|||
48976488|NCT02327078|157744634|FG006|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
48976489|NCT02327078|157744635|FG007|Overall Study|Completed 100 Day Safety Follow-up Period|3|||
48976490|NCT02327078|157744636|FG008|Overall Study|Completed 100 Day Safety Follow-up Period|11|||
48976491|NCT02327078|157744628|FG000|Overall Study|Reason not Specified|0|||
48976492|NCT02327078|157744629|FG001|Overall Study|Reason not Specified|0|||
48976493|NCT02327078|157744630|FG002|Overall Study|Reason not Specified|0|||
48976494|NCT02327078|157744631|FG003|Overall Study|Reason not Specified|0|||
48976495|NCT02327078|157744632|FG004|Overall Study|Reason not Specified|0|||
48976496|NCT02327078|157744633|FG005|Overall Study|Reason not Specified|0|||
48976497|NCT02327078|157744634|FG006|Overall Study|Reason not Specified|0|||
48976498|NCT02327078|157744635|FG007|Overall Study|Reason not Specified|5|||
48976499|NCT02327078|157744636|FG008|Overall Study|Reason not Specified|12|||
48976500|NCT03250624|157744648|FG000|Overall Study|Lack of Efficacy|1|||
48976501|NCT03250624|157744649|FG001|Overall Study|Lack of Efficacy|4|||
48976502|NCT03250624|157744648|FG000|Overall Study|Adverse Event|0|||
48976503|NCT03250624|157744649|FG001|Overall Study|Adverse Event|1|||
48976504|NCT03250624|157744648|FG000|Overall Study|Other|1|||
48976505|NCT03250624|157744649|FG001|Overall Study|Other|2|||
48976506|NCT02809118|157744653|FG000|Overall Study|Withdrawal by Subject|0|||
48976507|NCT02809118|157744654|FG001|Overall Study|Withdrawal by Subject|1|||
48976508|NCT02809118|157744655|FG002|Overall Study|Withdrawal by Subject|1|||
48675440|NCT02202538|156663500|FG000|Overall Study|Did not meet all inclusion criteria|2|||
48675441|NCT02202538|156663500|FG000|Overall Study|Investigator Decision|1|||
48675442|NCT02651220|156663501|FG000|Overall Study|Adverse Event|1|||
48675443|NCT02651220|156663502|FG001|Overall Study|Adverse Event|5|||
48675444|NCT02651220|156663503|FG002|Overall Study|Adverse Event|1|||
48675445|NCT02651220|156663501|FG000|Overall Study|Lost to Follow-up|8|||
48675446|NCT02651220|156663502|FG001|Overall Study|Lost to Follow-up|14|||
48675447|NCT02651220|156663503|FG002|Overall Study|Lost to Follow-up|14|||
48675448|NCT02651220|156663501|FG000|Overall Study|Non-Compliance with Study Drug|4|||
48873999|NCT05239598|157375224|FG001|Phase II (Open Label)|Withdrawal by Subject|0|||
48874000|NCT02282059|157375225|FG000|Overall Study|Other|15|||
48874001|NCT02282059|157375226|FG001|Overall Study|Other|3|||
48874002|NCT02282059|157375225|FG000|Overall Study|Participant refused further follow-up|8|||
48874003|NCT02282059|157375226|FG001|Overall Study|Participant refused further follow-up|4|||
48976509|NCT01235338|157744656|FG000|Overall Study|Adverse Event|3|||
48675449|NCT02651220|156663502|FG001|Overall Study|Non-Compliance with Study Drug|0|||
48675450|NCT02651220|156663503|FG002|Overall Study|Non-Compliance with Study Drug|1|||
48675451|NCT02651220|156663501|FG000|Overall Study|Pregnancy|1|||
48675452|NCT02651220|156663502|FG001|Overall Study|Pregnancy|0|||
48675453|NCT02651220|156663503|FG002|Overall Study|Pregnancy|1|||
48675454|NCT02651220|156663501|FG000|Overall Study|Protocol Violation|0|||
48675455|NCT02651220|156663502|FG001|Overall Study|Protocol Violation|0|||
48976510|NCT01235338|157744657|FG001|Overall Study|Adverse Event|2|||
48976511|NCT01235338|157744656|FG000|Overall Study|Protocol Violation|1|||
48976512|NCT01235338|157744657|FG001|Overall Study|Protocol Violation|1|||
48976513|NCT01235338|157744656|FG000|Overall Study|Withdrawal by Subject|5|||
48976514|NCT01235338|157744657|FG001|Overall Study|Withdrawal by Subject|0|||
48976515|NCT01235338|157744656|FG000|Overall Study|Exclusion criteria violations|1|||
48976516|NCT01235338|157744657|FG001|Overall Study|Exclusion criteria violations|1|||
48976517|NCT01235338|157744656|FG000|Overall Study|Positive drug screen|0|||
48976518|NCT01235338|157744657|FG001|Overall Study|Positive drug screen|1|||
48976519|NCT01235338|157744656|FG000|Overall Study|Prohibited meds|1|||
48976520|NCT01235338|157744657|FG001|Overall Study|Prohibited meds|0|||
48976521|NCT00093470|157744660|FG000|Overall Study|Disease progression|39|||
48976522|NCT00093470|157744661|FG001|Overall Study|Disease progression|0|||
48976523|NCT00093470|157744660|FG000|Overall Study|Adverse Event|15|||
48976524|NCT00093470|157744661|FG001|Overall Study|Adverse Event|0|||
48976525|NCT00093470|157744660|FG000|Overall Study|Death|2|||
48976526|NCT00093470|157744661|FG001|Overall Study|Death|0|||
48976527|NCT00093470|157744660|FG000|Overall Study|Withdrawal by Subject|8|||
48976528|NCT00093470|157744661|FG001|Overall Study|Withdrawal by Subject|0|||
48976529|NCT00093470|157744660|FG000|Overall Study|Alternative therapy|2|||
48976530|NCT00093470|157744661|FG001|Overall Study|Alternative therapy|0|||
48976531|NCT00093470|157744660|FG000|Overall Study|Other complicating disease|3|||
48976532|NCT00093470|157744661|FG001|Overall Study|Other complicating disease|0|||
48976533|NCT00093470|157744660|FG000|Overall Study|Physician Decision|2|||
48976534|NCT00093470|157744661|FG001|Overall Study|Physician Decision|0|||
48976535|NCT00093470|157744660|FG000|Overall Study|Never started treatment|1|||
48976536|NCT00093470|157744661|FG001|Overall Study|Never started treatment|0|||
48976537|NCT00093470|157744660|FG000|Overall Study|ANC < 1000 on day 1 of cycle 1|1|||
48976538|NCT00093470|157744661|FG001|Overall Study|ANC < 1000 on day 1 of cycle 1|0|||
48976539|NCT00247273|157744662|FG000|Overall Study|Adverse Event|85|||
48675456|NCT02651220|156663503|FG002|Overall Study|Protocol Violation|1|||
48675457|NCT02651220|156663501|FG000|Overall Study|Withdrawal by Subject|5|||
48874004|NCT02282059|157375225|FG000|Overall Study|Lost to Follow-up|19|||
48874005|NCT02282059|157375226|FG001|Overall Study|Lost to Follow-up|3|||
48874006|NCT02282059|157375225|FG000|Overall Study|Death|40|||
48874007|NCT02282059|157375226|FG001|Overall Study|Death|8|||
48874008|NCT01340014|157375227|FG000|Period 1, First 7 Days|Adverse Event|1|||
48874009|NCT01340014|157375228|FG001|Period 1, First 7 Days|Adverse Event|0|||
48976540|NCT00247273|157744663|FG001|Overall Study|Adverse Event|80|||
48976541|NCT00247273|157744662|FG000|Overall Study|Physician Decision|6|||
48976542|NCT00247273|157744663|FG001|Overall Study|Physician Decision|3|||
48976543|NCT00247273|157744662|FG000|Overall Study|Lost to Follow-up|7|||
48976544|NCT00247273|157744663|FG001|Overall Study|Lost to Follow-up|7|||
48976545|NCT00247273|157744662|FG000|Overall Study|Withdrawal by Subject|46|||
48976546|NCT00247273|157744663|FG001|Overall Study|Withdrawal by Subject|47|||
48976547|NCT00247273|157744662|FG000|Overall Study|Did not take any study drug|2|||
48874010|NCT01340014|157375227|FG000|Period 1, First 7 Days|Personal Reasons|1|||
48976548|NCT00247273|157744663|FG001|Overall Study|Did not take any study drug|0|||
48976549|NCT00524043|157744665|FG000|Overall Study|Lack of Efficacy|15|||
48976550|NCT00524043|157744666|FG001|Overall Study|Lack of Efficacy|13|||
48976551|NCT00524043|157744667|FG002|Overall Study|Lack of Efficacy|14|||
48976552|NCT00524043|157744665|FG000|Overall Study|Withdrawal by Subject|5|||
48976553|NCT00524043|157744666|FG001|Overall Study|Withdrawal by Subject|7|||
48976554|NCT00524043|157744667|FG002|Overall Study|Withdrawal by Subject|7|||
48675458|NCT02651220|156663502|FG001|Overall Study|Withdrawal by Subject|6|||
48976555|NCT00524043|157744665|FG000|Overall Study|Adverse Event|5|||
48976556|NCT00524043|157744666|FG001|Overall Study|Adverse Event|2|||
48976557|NCT00524043|157744667|FG002|Overall Study|Adverse Event|7|||
48976558|NCT00524043|157744665|FG000|Overall Study|Lost to Follow-up|3|||
48976559|NCT00524043|157744666|FG001|Overall Study|Lost to Follow-up|5|||
48976560|NCT00524043|157744667|FG002|Overall Study|Lost to Follow-up|3|||
48976561|NCT00524043|157744665|FG000|Overall Study|Various (eg, incarceration)|2|||
48976562|NCT00524043|157744666|FG001|Overall Study|Various (eg, incarceration)|1|||
48976563|NCT00524043|157744667|FG002|Overall Study|Various (eg, incarceration)|0|||
48976564|NCT02244619|157744674|FG000|Overall Study|Did not receive study intervention|8|||
48976565|NCT02244619|157744675|FG001|Overall Study|Did not receive study intervention|21|||
48976566|NCT00445341|157744676|FG000|Overall Study|refused further treatment|1|||
48976567|NCT00445341|157744676|FG000|Overall Study|taken off treatment too early|1|||
48976568|NCT00732641|157744677|FG000|Overall Study|Relapse or Progressive Disease|65|||
48976569|NCT00732641|157744678|FG001|Overall Study|Relapse or Progressive Disease|101|||
48976570|NCT00732641|157744677|FG000|Overall Study|Serious Adverse Events|12|||
48976571|NCT00732641|157744678|FG001|Overall Study|Serious Adverse Events|3|||
48976572|NCT00732641|157744677|FG000|Overall Study|Physician Decision|6|||
48976573|NCT00732641|157744678|FG001|Overall Study|Physician Decision|0|||
48976574|NCT00732641|157744677|FG000|Overall Study|Withdrawal by Subject|4|||
48976575|NCT00732641|157744678|FG001|Overall Study|Withdrawal by Subject|2|||
48976576|NCT00732641|157744677|FG000|Overall Study|Unable to Complete|1|||
48976577|NCT00732641|157744678|FG001|Overall Study|Unable to Complete|1|||
48675459|NCT02651220|156663503|FG002|Overall Study|Withdrawal by Subject|8|||
48976578|NCT00732641|157744677|FG000|Overall Study|Other|18|||
48976579|NCT00732641|157744678|FG001|Overall Study|Other|5|||
48976580|NCT02873208|157744681|FG000|Overall Study|Withdrawal by Subject|36|||
48976581|NCT02873208|157744681|FG000|Overall Study|Lost to Follow-up|22|||
48976582|NCT02873208|157744681|FG000|Overall Study|Adverse Event|15|||
48976583|NCT02873208|157744681|FG000|Overall Study|Non-compliance with study drug|12|||
48976584|NCT02873208|157744681|FG000|Overall Study|Protocol Violation|8|||
48976585|NCT02873208|157744681|FG000|Overall Study|Pregnancy|2|||
48976586|NCT02873208|157744681|FG000|Overall Study|Incarceration|1|||
48976587|NCT02873208|157744681|FG000|Overall Study|Lack of Efficacy|1|||
48976588|NCT02873208|157744681|FG000|Overall Study|Physician Decision|1|||
48976589|NCT00420342|157744682|FG000|Overall Study|Lost to Follow-up|1|||
48976590|NCT00420342|157744683|FG001|Overall Study|Lost to Follow-up|0|||
48976591|NCT00420342|157744684|FG002|Overall Study|Lost to Follow-up|1|||
48976592|NCT00420342|157744682|FG000|Overall Study|Withdrawal by Subject|0|||
48976593|NCT00420342|157744683|FG001|Overall Study|Withdrawal by Subject|2|||
48976594|NCT00420342|157744684|FG002|Overall Study|Withdrawal by Subject|0|||
48976595|NCT00003838|157744691|FG000|Overall Study|Death|0|||
48976596|NCT00003838|157744692|FG001|Overall Study|Death|12|||
48976597|NCT00003838|157744693|FG002|Overall Study|Death|7|||
48976598|NCT00003838|157744691|FG000|Overall Study|Lost to Follow-up|0|||
48976599|NCT00003838|157744692|FG001|Overall Study|Lost to Follow-up|1|||
48976600|NCT00003838|157744693|FG002|Overall Study|Lost to Follow-up|1|||
48976601|NCT00003838|157744691|FG000|Overall Study|Disease Progression|0|||
48976602|NCT00003838|157744692|FG001|Overall Study|Disease Progression|12|||
48976603|NCT00003838|157744693|FG002|Overall Study|Disease Progression|0|||
48976604|NCT00865046|157744694|FG000|Overall Study|Lost to Follow-up|1|||
48976605|NCT00865046|157744695|FG001|Overall Study|Lost to Follow-up|4|||
48976606|NCT00865046|157744696|FG002|Overall Study|Lost to Follow-up|0|||
48976607|NCT00865046|157744694|FG000|Overall Study|Death|0|||
48976608|NCT00865046|157744695|FG001|Overall Study|Death|1|||
48976609|NCT00865046|157744696|FG002|Overall Study|Death|1|||
48976610|NCT00865046|157744694|FG000|Overall Study|Withdrawal by Subject|5|||
48976611|NCT00865046|157744695|FG001|Overall Study|Withdrawal by Subject|0|||
48976612|NCT00865046|157744696|FG002|Overall Study|Withdrawal by Subject|0|||
48976613|NCT01024920|157744699|FG000|Overall Study|Progressive disease|47|||
48976614|NCT01024920|157744700|FG001|Overall Study|Progressive disease|25|||
48976615|NCT01024920|157744699|FG000|Overall Study|Adverse Event|8|||
48976616|NCT01024920|157744700|FG001|Overall Study|Adverse Event|4|||
48976617|NCT01024920|157744699|FG000|Overall Study|Lost to Follow-up|0|||
48976618|NCT01024920|157744700|FG001|Overall Study|Lost to Follow-up|1|||
48976619|NCT01024920|157744699|FG000|Overall Study|Patient refusal to continue|4|||
48976620|NCT01024920|157744700|FG001|Overall Study|Patient refusal to continue|0|||
48976621|NCT01024920|157744699|FG000|Overall Study|Other than listed|5|||
48976622|NCT01024920|157744700|FG001|Overall Study|Other than listed|1|||
48976623|NCT01024920|157744699|FG000|Overall Study|Not treated|3|||
48976624|NCT01024920|157744700|FG001|Overall Study|Not treated|0|||
48976625|NCT01024920|157744699|FG000|Overall Study|Protocol Violation|0|||
48976626|NCT01024920|157744700|FG001|Overall Study|Protocol Violation|1|||
48976627|NCT01688999|157744701|FG000|Overall Study|Withdrawal by Subject|5|||
48976628|NCT01688999|157744702|FG001|Overall Study|Withdrawal by Subject|1|||
48976629|NCT01688999|157744703|FG002|Overall Study|Withdrawal by Subject|1|||
48976630|NCT01688999|157744701|FG000|Overall Study|Adverse Event|2|||
48976631|NCT01688999|157744702|FG001|Overall Study|Adverse Event|0|||
48976632|NCT01688999|157744703|FG002|Overall Study|Adverse Event|2|||
48976633|NCT01688999|157744701|FG000|Overall Study|Ineligible/Not treated|1|||
48976634|NCT01688999|157744702|FG001|Overall Study|Ineligible/Not treated|0|||
48976635|NCT01688999|157744703|FG002|Overall Study|Ineligible/Not treated|0|||
48976636|NCT02708966|157744704|FG000|Overall Study|Lost to Follow-up|2|||
48976637|NCT02708966|157744705|FG001|Overall Study|Lost to Follow-up|2|||
48675460|NCT02651220|156663501|FG000|Overall Study|Miscellaneous|4|||
48675461|NCT02651220|156663502|FG001|Overall Study|Miscellaneous|1|||
48675462|NCT02651220|156663503|FG002|Overall Study|Miscellaneous|2|||
48675463|NCT02651220|156663501|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
48675464|NCT02651220|156663502|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
48675465|NCT02651220|156663503|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
48675466|NCT02220712|156663513|FG000|Overall Study|Adverse Event|1|||
48675467|NCT02220712|156663513|FG000|Overall Study|Withdrawal by Subject|2|||
48675468|NCT02220712|156663513|FG000|Overall Study|Exacerbation of symptoms of an underlying disease|1|||
48675469|NCT01069705|156663514|FG000|Overall Study|Adverse Event|1|||
48675470|NCT01069705|156663514|FG000|Overall Study|Withdrawal by Subject|2|||
48675471|NCT03624127|156663519|FG000|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
48675472|NCT03624127|156663520|FG001|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|1|||
48675473|NCT03624127|156663521|FG002|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
48675474|NCT03624127|156663519|FG000|Treatment Week 0 - Week 16|Adverse Event|5|||
48675475|NCT03624127|156663520|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
48675476|NCT03624127|156663521|FG002|Treatment Week 0 - Week 16|Adverse Event|10|||
48675477|NCT03624127|156663519|FG000|Treatment Week 0 - Week 16|Death|0|||
48675478|NCT03624127|156663520|FG001|Treatment Week 0 - Week 16|Death|1|||
48675479|NCT03624127|156663521|FG002|Treatment Week 0 - Week 16|Death|0|||
48675480|NCT03624127|156663519|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|0|||
48675481|NCT03624127|156663520|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
48675482|NCT03624127|156663521|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
48675483|NCT03624127|156663519|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|7|||
48675484|NCT03624127|156663520|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
48675485|NCT03624127|156663521|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|4|||
48874011|NCT01340014|157375228|FG001|Period 1, First 7 Days|Personal Reasons|0|||
48874012|NCT01340014|157375227|FG000|Period 2, Second 7 Days|Adverse Event|0|||
48874013|NCT01340014|157375228|FG001|Period 2, Second 7 Days|Adverse Event|1|||
48874014|NCT02194829|157375229|FG000|Overall Study|Adverse Event|2|||
48874015|NCT02194829|157375230|FG001|Overall Study|Adverse Event|2|||
48874016|NCT02194829|157375229|FG000|Overall Study|Death|0|||
48874017|NCT02194829|157375230|FG001|Overall Study|Death|1|||
48874018|NCT02194829|157375229|FG000|Overall Study|Disease progression|0|||
48976638|NCT02959190|157744707|FG000|Open Label|Adverse Event|5|||
48976639|NCT02959190|157744708|FG001|Open Label|Adverse Event|7|||
48976640|NCT02959190|157744709|FG002|Open Label|Adverse Event|3|||
48976641|NCT02959190|157744710|FG003|Open Label|Adverse Event|4|||
48976642|NCT02959190|157744707|FG000|Open Label|Pregnancy|0|||
48976643|NCT02959190|157744708|FG001|Open Label|Pregnancy|1|||
48976644|NCT02959190|157744709|FG002|Open Label|Pregnancy|0|||
48976645|NCT02959190|157744710|FG003|Open Label|Pregnancy|0|||
48976646|NCT02959190|157744707|FG000|Open Label|Withdrawal by Subject|2|||
48976647|NCT02959190|157744708|FG001|Open Label|Withdrawal by Subject|8|||
48976648|NCT02959190|157744709|FG002|Open Label|Withdrawal by Subject|0|||
48976649|NCT02959190|157744710|FG003|Open Label|Withdrawal by Subject|0|||
48976650|NCT02959190|157744707|FG000|Open Label|Physician Decision|0|||
48976651|NCT02959190|157744708|FG001|Open Label|Physician Decision|0|||
48976652|NCT02959190|157744709|FG002|Open Label|Physician Decision|1|||
48976653|NCT02959190|157744710|FG003|Open Label|Physician Decision|0|||
48976654|NCT02959190|157744707|FG000|Open Label|Protocol Violation|0|||
48976655|NCT02959190|157744708|FG001|Open Label|Protocol Violation|0|||
48675486|NCT03624127|156663519|FG000|Treatment Week 0 - Week 16|Protocol Violation|1|||
48874019|NCT02194829|157375230|FG001|Overall Study|Disease progression|1|||
48874020|NCT02194829|157375229|FG000|Overall Study|Withdrawal by Subject|0|||
48874021|NCT02194829|157375230|FG001|Overall Study|Withdrawal by Subject|1|||
48874022|NCT02194829|157375229|FG000|Overall Study|Never started protocol therapy|0|||
48976656|NCT02959190|157744709|FG002|Open Label|Protocol Violation|0|||
48976657|NCT02959190|157744710|FG003|Open Label|Protocol Violation|2|||
48976658|NCT02959190|157744707|FG000|Post Treatment Follow Up|Adverse Event|1|||
48976659|NCT02959190|157744708|FG001|Post Treatment Follow Up|Adverse Event|1|||
48976660|NCT02959190|157744709|FG002|Post Treatment Follow Up|Adverse Event|0|||
48976661|NCT02959190|157744710|FG003|Post Treatment Follow Up|Adverse Event|0|||
48976662|NCT02959190|157744707|FG000|Post Treatment Follow Up|Withdrawal by Subject|2|||
48976663|NCT02959190|157744708|FG001|Post Treatment Follow Up|Withdrawal by Subject|0|||
48976664|NCT02959190|157744709|FG002|Post Treatment Follow Up|Withdrawal by Subject|1|||
48976665|NCT02959190|157744710|FG003|Post Treatment Follow Up|Withdrawal by Subject|0|||
48976666|NCT03039790|157744711|FG000|Overall Study|Lost to Follow-up|2|||
48976667|NCT03039790|157744712|FG001|Overall Study|Lost to Follow-up|0|||
48976668|NCT03039790|157744713|FG002|Overall Study|Lost to Follow-up|1|||
48976669|NCT03039790|157744714|FG003|Overall Study|Lost to Follow-up|1|||
48976670|NCT03039790|157744715|FG004|Overall Study|Lost to Follow-up|0|||
48976671|NCT03039790|157744716|FG005|Overall Study|Lost to Follow-up|1|||
48976672|NCT03039790|157744717|FG006|Overall Study|Lost to Follow-up|1|||
48976673|NCT03039790|157744718|FG007|Overall Study|Lost to Follow-up|1|||
48976674|NCT03039790|157744719|FG008|Overall Study|Lost to Follow-up|0|||
48976675|NCT03039790|157744720|FG009|Overall Study|Lost to Follow-up|1|||
48976676|NCT03039790|157744721|FG010|Overall Study|Lost to Follow-up|1|||
48976677|NCT03039790|157744722|FG011|Overall Study|Lost to Follow-up|0|||
48976678|NCT03039790|157744723|FG012|Overall Study|Lost to Follow-up|1|||
48976679|NCT03039790|157744724|FG013|Overall Study|Lost to Follow-up|0|||
48976680|NCT03039790|157744725|FG014|Overall Study|Lost to Follow-up|3|||
48976681|NCT03039790|157744726|FG015|Overall Study|Lost to Follow-up|1|||
48976682|NCT03039790|157744727|FG016|Overall Study|Lost to Follow-up|2|||
48976683|NCT03039790|157744728|FG017|Overall Study|Lost to Follow-up|2|||
48976684|NCT03039790|157744729|FG018|Overall Study|Lost to Follow-up|1|||
48976685|NCT03039790|157744730|FG019|Overall Study|Lost to Follow-up|3|||
48976686|NCT03039790|157744711|FG000|Overall Study|Withdrawal of Consent|1|||
48976687|NCT03039790|157744712|FG001|Overall Study|Withdrawal of Consent|0|||
48976688|NCT03039790|157744713|FG002|Overall Study|Withdrawal of Consent|0|||
48976689|NCT03039790|157744714|FG003|Overall Study|Withdrawal of Consent|1|||
48976690|NCT03039790|157744715|FG004|Overall Study|Withdrawal of Consent|0|||
48976691|NCT03039790|157744716|FG005|Overall Study|Withdrawal of Consent|0|||
48976692|NCT03039790|157744717|FG006|Overall Study|Withdrawal of Consent|0|||
48976693|NCT03039790|157744718|FG007|Overall Study|Withdrawal of Consent|0|||
48976694|NCT03039790|157744719|FG008|Overall Study|Withdrawal of Consent|0|||
48976695|NCT03039790|157744720|FG009|Overall Study|Withdrawal of Consent|1|||
48976696|NCT03039790|157744721|FG010|Overall Study|Withdrawal of Consent|0|||
48976697|NCT03039790|157744722|FG011|Overall Study|Withdrawal of Consent|0|||
48976698|NCT03039790|157744723|FG012|Overall Study|Withdrawal of Consent|2|||
48976699|NCT03039790|157744724|FG013|Overall Study|Withdrawal of Consent|0|||
48976700|NCT03039790|157744725|FG014|Overall Study|Withdrawal of Consent|1|||
48976701|NCT03039790|157744726|FG015|Overall Study|Withdrawal of Consent|5|||
48976702|NCT03039790|157744727|FG016|Overall Study|Withdrawal of Consent|3|||
48976703|NCT03039790|157744728|FG017|Overall Study|Withdrawal of Consent|0|||
48976704|NCT03039790|157744729|FG018|Overall Study|Withdrawal of Consent|2|||
48976705|NCT03039790|157744730|FG019|Overall Study|Withdrawal of Consent|5|||
48976706|NCT03039790|157744711|FG000|Overall Study|Death|0|||
48976707|NCT03039790|157744712|FG001|Overall Study|Death|0|||
48976708|NCT03039790|157744713|FG002|Overall Study|Death|0|||
48976709|NCT03039790|157744714|FG003|Overall Study|Death|0|||
48976710|NCT03039790|157744715|FG004|Overall Study|Death|0|||
48976711|NCT03039790|157744716|FG005|Overall Study|Death|0|||
48976712|NCT03039790|157744717|FG006|Overall Study|Death|0|||
48976713|NCT03039790|157744718|FG007|Overall Study|Death|0|||
48976714|NCT03039790|157744719|FG008|Overall Study|Death|0|||
48976715|NCT03039790|157744720|FG009|Overall Study|Death|0|||
48976716|NCT03039790|157744721|FG010|Overall Study|Death|0|||
48976717|NCT03039790|157744722|FG011|Overall Study|Death|0|||
48976718|NCT03039790|157744723|FG012|Overall Study|Death|0|||
48976719|NCT03039790|157744724|FG013|Overall Study|Death|0|||
48976720|NCT03039790|157744725|FG014|Overall Study|Death|0|||
48976721|NCT03039790|157744726|FG015|Overall Study|Death|1|||
48976722|NCT03039790|157744727|FG016|Overall Study|Death|3|||
48976723|NCT03039790|157744728|FG017|Overall Study|Death|0|||
48976724|NCT03039790|157744729|FG018|Overall Study|Death|2|||
48976725|NCT03039790|157744730|FG019|Overall Study|Death|0|||
48976726|NCT03039790|157744711|FG000|Overall Study|Reason, not Specified|1|||
48976727|NCT03039790|157744712|FG001|Overall Study|Reason, not Specified|0|||
48976728|NCT03039790|157744713|FG002|Overall Study|Reason, not Specified|0|||
48976729|NCT03039790|157744714|FG003|Overall Study|Reason, not Specified|0|||
48976730|NCT03039790|157744715|FG004|Overall Study|Reason, not Specified|0|||
48976731|NCT03039790|157744716|FG005|Overall Study|Reason, not Specified|0|||
48976732|NCT03039790|157744717|FG006|Overall Study|Reason, not Specified|0|||
48976733|NCT03039790|157744718|FG007|Overall Study|Reason, not Specified|0|||
48976734|NCT03039790|157744719|FG008|Overall Study|Reason, not Specified|0|||
48976735|NCT03039790|157744720|FG009|Overall Study|Reason, not Specified|0|||
48976736|NCT03039790|157744721|FG010|Overall Study|Reason, not Specified|0|||
48976737|NCT03039790|157744722|FG011|Overall Study|Reason, not Specified|0|||
48976738|NCT03039790|157744723|FG012|Overall Study|Reason, not Specified|0|||
48976739|NCT03039790|157744724|FG013|Overall Study|Reason, not Specified|0|||
48976740|NCT03039790|157744725|FG014|Overall Study|Reason, not Specified|0|||
48976741|NCT03039790|157744726|FG015|Overall Study|Reason, not Specified|0|||
48976742|NCT03039790|157744727|FG016|Overall Study|Reason, not Specified|2|||
48976743|NCT03039790|157744728|FG017|Overall Study|Reason, not Specified|0|||
48976744|NCT03039790|157744729|FG018|Overall Study|Reason, not Specified|1|||
48976745|NCT03039790|157744730|FG019|Overall Study|Reason, not Specified|0|||
48675487|NCT03624127|156663520|FG001|Treatment Week 0 - Week 16|Protocol Violation|1|||
48675488|NCT03624127|156663521|FG002|Treatment Week 0 - Week 16|Protocol Violation|2|||
48675489|NCT03624127|156663519|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|4|||
48675490|NCT03624127|156663520|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
48675491|NCT03624127|156663521|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
48675492|NCT03624127|156663519|FG000|Treatment Week 0 - Week 16|Other reasons|8|||
48675493|NCT03624127|156663520|FG001|Treatment Week 0 - Week 16|Other reasons|5|||
48675494|NCT03624127|156663521|FG002|Treatment Week 0 - Week 16|Other reasons|3|||
48976746|NCT01390038|157744732|FG000|Overall Study|Death|1|||
48976747|NCT01390038|157744732|FG000|Overall Study|Lost to Follow-up|1|||
48675495|NCT03624127|156663519|FG000|Treatment Week 16 - Week 24|Adverse Event|1|||
48675496|NCT03624127|156663520|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
48675497|NCT03624127|156663521|FG002|Treatment Week 16 - Week 24|Adverse Event|1|||
48675498|NCT03624127|156663519|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|3|||
48675499|NCT03624127|156663520|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
48675500|NCT03624127|156663521|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
48675501|NCT03624127|156663519|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
48675502|NCT03624127|156663520|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
48675503|NCT03624127|156663521|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
48675504|NCT03624127|156663519|FG000|Treatment Week 16 - Week 24|Protocol Violation|1|||
48675505|NCT03624127|156663520|FG001|Treatment Week 16 - Week 24|Protocol Violation|0|||
48675506|NCT03624127|156663521|FG002|Treatment Week 16 - Week 24|Protocol Violation|0|||
48675507|NCT03624127|156663519|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
48675508|NCT03624127|156663520|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
48675509|NCT03624127|156663521|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
48675510|NCT03624127|156663519|FG000|Treatment Week 16 - Week 24|Other reasons|3|||
48675511|NCT03624127|156663520|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
48675512|NCT03624127|156663521|FG002|Treatment Week 16 - Week 24|Other reasons|0|||
48675513|NCT03624127|156663519|FG000|Treatment Week 24 - Week 52|Adverse Event|8|||
48675514|NCT03624127|156663520|FG001|Treatment Week 24 - Week 52|Adverse Event|0|||
48675515|NCT03624127|156663521|FG002|Treatment Week 24 - Week 52|Adverse Event|1|||
48675516|NCT03624127|156663519|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|6|||
48675517|NCT03624127|156663520|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
48675518|NCT03624127|156663521|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
48675519|NCT03624127|156663519|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|5|||
48675520|NCT03624127|156663520|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
48675521|NCT03624127|156663521|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|1|||
48675522|NCT03624127|156663519|FG000|Treatment Week 24 - Week 52|Protocol Violation|2|||
48675523|NCT03624127|156663520|FG001|Treatment Week 24 - Week 52|Protocol Violation|0|||
48675524|NCT03624127|156663521|FG002|Treatment Week 24 - Week 52|Protocol Violation|0|||
48675525|NCT03624127|156663519|FG000|Treatment Week 24 - Week 52|Site terminated by sponsor|2|||
48675526|NCT03624127|156663520|FG001|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
48675527|NCT03624127|156663521|FG002|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
48675528|NCT03624127|156663519|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|10|||
48675529|NCT03624127|156663520|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
48976748|NCT01390038|157744732|FG000|Overall Study|Withdrawal by Subject|4|||
48976749|NCT01390038|157744732|FG000|Overall Study|Simpliciti System Removal|2|||
48976750|NCT02092324|157744743|FG000|Overall Study|Adverse Event|1|||
48976751|NCT02092324|157744743|FG000|Overall Study|Lack of Efficacy|6|||
48976752|NCT02092324|157744743|FG000|Overall Study|Proceed to Transplant|3|||
48976753|NCT02092324|157744743|FG000|Overall Study|Physician Decision|7|||
48675530|NCT03624127|156663521|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
48675531|NCT03624127|156663519|FG000|Treatment Week 24 - Week 52|Other reasons|19|||
48675532|NCT03624127|156663520|FG001|Treatment Week 24 - Week 52|Other reasons|0|||
48675533|NCT03624127|156663521|FG002|Treatment Week 24 - Week 52|Other reasons|2|||
48675534|NCT00330681|156663522|FG000|Overall Study|Adverse Event|3|||
48675535|NCT00330681|156663523|FG001|Overall Study|Adverse Event|6|||
48675536|NCT00330681|156663522|FG000|Overall Study|Protocol Violation|0|||
48675537|NCT00330681|156663523|FG001|Overall Study|Protocol Violation|1|||
48976754|NCT02092324|157744743|FG000|Overall Study|Misdiagnosis|2|||
48976755|NCT03039569|157744748|FG000|Overall Study|Lost to Follow-up|5|||
48976756|NCT03039569|157744749|FG001|Overall Study|Lost to Follow-up|4|||
48976757|NCT00368472|157744750|FG000|Overall Study|Adverse Event|22|||
48976758|NCT00368472|157744750|FG000|Overall Study|Medication non-compliance|4|||
48675538|NCT00330681|156663522|FG000|Overall Study|Withdrawal by Subject|5|||
48675539|NCT00330681|156663523|FG001|Overall Study|Withdrawal by Subject|5|||
48976759|NCT00368472|157744750|FG000|Overall Study|Protocol Violation|2|||
48976760|NCT00368472|157744750|FG000|Overall Study|Request of Investigator or Sponsor|3|||
48976761|NCT00368472|157744750|FG000|Overall Study|Withdrawal by Subject|40|||
48675540|NCT00330681|156663522|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
48675541|NCT00330681|156663523|FG001|Overall Study|Tracheotomy due to worsening of ALS|2|||
48675542|NCT00621140|156663524|FG000|Overall Study|Adverse Event|4|||
48675543|NCT00621140|156663525|FG001|Overall Study|Adverse Event|5|||
48976762|NCT00368472|157744750|FG000|Overall Study|Diary non-compliance|1|||
48675544|NCT00621140|156663524|FG000|Overall Study|Lost to Follow-up|1|||
48675545|NCT00621140|156663525|FG001|Overall Study|Lost to Follow-up|2|||
48976763|NCT00368472|157744750|FG000|Overall Study|Other|32|||
48976764|NCT00368472|157744750|FG000|Overall Study|Missing Final Disposition Date|1|||
48976765|NCT00002981|157744751|FG000|Overall Study|Inevaluable|6|||
48976766|NCT03457636|157744754|FG000|Overall Study|Lost to Follow-up|2|||
48976767|NCT03619837|157744758|FG000|Screening|received organs from HCV-negative donors|47|||
48976768|NCT03619837|157744758|FG000|Screening|died on the wait-list|2|||
48976769|NCT03619837|157744758|FG000|Screening|remained on the wait list|40|||
48976770|NCT03619837|157744758|FG000|Screening|didn't meet eligibility criteria|3|||
48976771|NCT03619837|157744758|FG000|Screening|withdrew consent|2|||
48976772|NCT03619837|157744758|FG000|Screening|never listed for HCV-viremic donor|1|||
48976773|NCT03619837|157744758|FG000|Screening|developed exclusion criteria|2|||
48976774|NCT03619837|157744758|FG000|Screening|excluded by the investigator due to non-compliance|1|||
48976775|NCT04095793|157744759|FG000|Overall Study|Adverse Event|3|||
48976776|NCT04095793|157744759|FG000|Overall Study|Study Terminated by Sponsor|103|||
48976777|NCT04095793|157744759|FG000|Overall Study|Withdrawal by Subject|4|||
48976778|NCT02724111|157744760|FG000|Overall Study|Protocol Violation|2|||
48976779|NCT02724111|157744761|FG001|Overall Study|Protocol Violation|5|||
48976780|NCT02384993|157744762|FG000|Overall Study|Adverse Event|0|||
48976781|NCT02384993|157744763|FG001|Overall Study|Adverse Event|1|||
48976782|NCT00422240|157744769|FG000|Overall Study|Lack of Efficacy|1|||
48976783|NCT00422240|157744770|FG001|Overall Study|Lack of Efficacy|2|||
48976784|NCT00422240|157744771|FG002|Overall Study|Lack of Efficacy|0|||
48976785|NCT00422240|157744772|FG003|Overall Study|Lack of Efficacy|1|||
48976786|NCT00422240|157744769|FG000|Overall Study|Adverse Event|11|||
48976787|NCT00422240|157744770|FG001|Overall Study|Adverse Event|4|||
48976788|NCT00422240|157744771|FG002|Overall Study|Adverse Event|5|||
48976789|NCT00422240|157744772|FG003|Overall Study|Adverse Event|2|||
48976790|NCT00422240|157744769|FG000|Overall Study|Subject request|21|||
48976791|NCT00422240|157744770|FG001|Overall Study|Subject request|17|||
48976792|NCT00422240|157744771|FG002|Overall Study|Subject request|18|||
48976793|NCT00422240|157744772|FG003|Overall Study|Subject request|30|||
48976794|NCT00422240|157744769|FG000|Overall Study|Protocol Violation|0|||
48976795|NCT00422240|157744770|FG001|Overall Study|Protocol Violation|1|||
48976796|NCT00422240|157744771|FG002|Overall Study|Protocol Violation|0|||
48976797|NCT00422240|157744772|FG003|Overall Study|Protocol Violation|1|||
48976798|NCT00422240|157744769|FG000|Overall Study|Lost to Follow-up|31|||
48675546|NCT00621140|156663524|FG000|Overall Study|Withdrawal by Subject|4|||
48675547|NCT00621140|156663525|FG001|Overall Study|Withdrawal by Subject|6|||
48675548|NCT00621140|156663524|FG000|Overall Study|Other incl. lack of efficacy|6|||
48675549|NCT00621140|156663525|FG001|Overall Study|Other incl. lack of efficacy|5|||
48675550|NCT01138501|156663526|FG000|Overall Study|Protocol Violation|2|||
48675551|NCT01138501|156663526|FG000|Overall Study|Withdrawal by Subject|3|||
48675552|NCT00360568|156663527|FG000|Overall Study|Adverse Event|1|||
48675553|NCT00360568|156663528|FG001|Overall Study|Adverse Event|2|||
48675554|NCT00360568|156663527|FG000|Overall Study|Lack of Efficacy|1|||
48761945|NCT02036502|156975723|FG006|Part 3:Dose Expansion|Withdrawal by Subject|1|||
48761946|NCT02036502|156975724|FG007|Part 3:Dose Expansion|Withdrawal by Subject|2|||
48761947|NCT02036502|156975717|FG000|Part 3:Dose Expansion|Not Treated|0|||
48976799|NCT00422240|157744770|FG001|Overall Study|Lost to Follow-up|32|||
48976800|NCT00422240|157744771|FG002|Overall Study|Lost to Follow-up|19|||
48976801|NCT00422240|157744772|FG003|Overall Study|Lost to Follow-up|34|||
48976802|NCT00422240|157744769|FG000|Overall Study|Other|1|||
48976803|NCT00422240|157744770|FG001|Overall Study|Other|0|||
48976804|NCT00422240|157744771|FG002|Overall Study|Other|0|||
48976805|NCT00422240|157744772|FG003|Overall Study|Other|1|||
48976806|NCT00422240|157744769|FG000|Overall Study|Pregnancy|3|||
48976807|NCT00422240|157744770|FG001|Overall Study|Pregnancy|1|||
48761948|NCT02036502|156975718|FG001|Part 3:Dose Expansion|Not Treated|0|||
48874023|NCT02194829|157375230|FG001|Overall Study|Never started protocol therapy|1|||
48976808|NCT00422240|157744771|FG002|Overall Study|Pregnancy|1|||
48976809|NCT00422240|157744772|FG003|Overall Study|Pregnancy|2|||
48976810|NCT00107172|157746234|FG000|Overall Study|Withdrawal by Subject|1|||
48976811|NCT00107172|157746235|FG001|Overall Study|Withdrawal by Subject|0|||
48976812|NCT00107172|157746234|FG000|Overall Study|Death|0|||
48976813|NCT00107172|157746235|FG001|Overall Study|Death|2|||
48976814|NCT00107172|157746234|FG000|Overall Study|Other Reason|4|||
48976815|NCT00107172|157746235|FG001|Overall Study|Other Reason|3|||
48976816|NCT00595868|157746238|FG000|Overall Study|Lost to Follow-up|45|||
48976817|NCT00595868|157746239|FG001|Overall Study|Lost to Follow-up|50|||
48976818|NCT04268303|157746240|FG000|Overall Study|Lost to Follow-up|1|||
48675555|NCT00360568|156663528|FG001|Overall Study|Lack of Efficacy|0|||
48675556|NCT00360568|156663527|FG000|Overall Study|Withdrawal by Subject|0|||
48675557|NCT00360568|156663528|FG001|Overall Study|Withdrawal by Subject|3|||
48675558|NCT03657095|156663529|FG000|Overall Study|Withdrawal by Subject|1|||
48976819|NCT04268303|157746241|FG001|Overall Study|Lost to Follow-up|1|||
48976820|NCT04268303|157746242|FG002|Overall Study|Lost to Follow-up|2|||
48976821|NCT04268303|157746240|FG000|Overall Study|Withdrawal by Subject|0|||
48976822|NCT04268303|157746241|FG001|Overall Study|Withdrawal by Subject|1|||
48675559|NCT03657095|156663530|FG001|Overall Study|Withdrawal by Subject|1|||
48675560|NCT03657095|156663529|FG000|Overall Study|Adverse Event|0|||
48675561|NCT03657095|156663530|FG001|Overall Study|Adverse Event|3|||
48675562|NCT03657095|156663529|FG000|Overall Study|Study Terminated by Sponsor|58|||
48874024|NCT01816685|157376914|FG000|Overall Study|Lost to Follow-up|7|||
48874025|NCT01816685|157376915|FG001|Overall Study|Lost to Follow-up|9|||
48874026|NCT01816685|157376914|FG000|Overall Study|Surgery Cancelled|3|||
48874027|NCT01816685|157376915|FG001|Overall Study|Surgery Cancelled|2|||
48874028|NCT01157351|157376916|FG000|Overall Study|Adverse Event|5|||
48874029|NCT01157351|157376917|FG001|Overall Study|Adverse Event|4|||
48976823|NCT04268303|157746242|FG002|Overall Study|Withdrawal by Subject|1|||
48976824|NCT04268303|157746240|FG000|Overall Study|Adverse Event|2|||
48976825|NCT04268303|157746241|FG001|Overall Study|Adverse Event|0|||
48976826|NCT04268303|157746242|FG002|Overall Study|Adverse Event|0|||
48976827|NCT00859573|157746243|FG000|Overall Study|Withdrawal by Subject|4|||
48976828|NCT00859573|157746244|FG001|Overall Study|Withdrawal by Subject|1|||
48976829|NCT00859573|157746243|FG000|Overall Study|Physician Decision|1|||
48976830|NCT00859573|157746244|FG001|Overall Study|Physician Decision|1|||
48976831|NCT02944513|157746246|FG000|Overall Study|Withdrawal by Subject|4|||
48976832|NCT02944513|157746247|FG001|Overall Study|Withdrawal by Subject|1|||
48976833|NCT00937326|157746253|FG000|Overall Study|Adverse Event|0|||
48976834|NCT00937326|157746254|FG001|Overall Study|Adverse Event|3|||
48976835|NCT00937326|157746255|FG002|Overall Study|Adverse Event|1|||
48976836|NCT00937326|157746256|FG003|Overall Study|Adverse Event|1|||
48976837|NCT00937326|157746257|FG004|Overall Study|Adverse Event|2|||
48976838|NCT00937326|157746253|FG000|Overall Study|Death|0|||
48976839|NCT00937326|157746254|FG001|Overall Study|Death|0|||
48976840|NCT00937326|157746255|FG002|Overall Study|Death|1|||
48976841|NCT00937326|157746256|FG003|Overall Study|Death|0|||
48976842|NCT00937326|157746257|FG004|Overall Study|Death|0|||
48976843|NCT00937326|157746253|FG000|Overall Study|Withdrawal by Subject|3|||
48976844|NCT00937326|157746254|FG001|Overall Study|Withdrawal by Subject|4|||
48976845|NCT00937326|157746255|FG002|Overall Study|Withdrawal by Subject|1|||
48976846|NCT00937326|157746256|FG003|Overall Study|Withdrawal by Subject|4|||
48976847|NCT00937326|157746257|FG004|Overall Study|Withdrawal by Subject|3|||
48976848|NCT00937326|157746253|FG000|Overall Study|Chest X-ray showed a suspicious shadow|0|||
48976849|NCT00937326|157746254|FG001|Overall Study|Chest X-ray showed a suspicious shadow|0|||
48976850|NCT00937326|157746255|FG002|Overall Study|Chest X-ray showed a suspicious shadow|1|||
48976851|NCT00937326|157746256|FG003|Overall Study|Chest X-ray showed a suspicious shadow|0|||
48976852|NCT00937326|157746257|FG004|Overall Study|Chest X-ray showed a suspicious shadow|0|||
48976853|NCT02578992|157746258|FG000|Overall Study|equipment not available or malfunction|3|||
48976854|NCT02578992|157746259|FG001|Overall Study|equipment not available or malfunction|3|||
48976855|NCT03382262|157746260|FG000|Overall Study|Physician Decision|0|||
48976856|NCT03382262|157746261|FG001|Overall Study|Physician Decision|0|||
48976857|NCT03382262|157746262|FG002|Overall Study|Physician Decision|1|||
48976858|NCT03382262|157746263|FG003|Overall Study|Physician Decision|0|||
48976859|NCT03382262|157746260|FG000|Overall Study|Withdrawal by Subject|0|||
48976860|NCT03382262|157746261|FG001|Overall Study|Withdrawal by Subject|0|||
48976861|NCT03382262|157746262|FG002|Overall Study|Withdrawal by Subject|0|||
48976862|NCT03382262|157746263|FG003|Overall Study|Withdrawal by Subject|1|||
48976863|NCT02940860|157746264|FG000|Overall Study|Non-serious AE|1|||
48976864|NCT02940860|157746265|FG001|Overall Study|Non-serious AE|2|||
48976865|NCT02940860|157746264|FG000|Overall Study|Serious AE|7|||
48976866|NCT02940860|157746265|FG001|Overall Study|Serious AE|3|||
48675563|NCT03657095|156663530|FG001|Overall Study|Study Terminated by Sponsor|49|||
48675564|NCT01743040|156663531|FG000|Overall Study|Death|1|||
48675565|NCT01743040|156663531|FG000|Overall Study|Lost to Follow-up|66|||
48675566|NCT01743040|156663531|FG000|Overall Study|Physician Decision|40|||
48874030|NCT01157351|157376916|FG000|Overall Study|Death|1|||
48874031|NCT01157351|157376917|FG001|Overall Study|Death|0|||
48874032|NCT01157351|157376916|FG000|Overall Study|Lost to Follow-up|53|||
48874033|NCT01157351|157376917|FG001|Overall Study|Lost to Follow-up|55|||
48976867|NCT02940860|157746264|FG000|Overall Study|Withdrawal by Subject|19|||
48976868|NCT02940860|157746265|FG001|Overall Study|Withdrawal by Subject|9|||
48976869|NCT02940860|157746264|FG000|Overall Study|Lost to Follow-up|13|||
48976870|NCT02940860|157746265|FG001|Overall Study|Lost to Follow-up|7|||
48976871|NCT02940860|157746264|FG000|Overall Study|Physician Decision|5|||
48976872|NCT02940860|157746265|FG001|Overall Study|Physician Decision|3|||
48976873|NCT02940860|157746264|FG000|Overall Study|Sponsor Decision|0|||
48976874|NCT02940860|157746265|FG001|Overall Study|Sponsor Decision|1|||
48675567|NCT01743040|156663531|FG000|Overall Study|Protocol Violation|1|||
48675568|NCT01743040|156663531|FG000|Overall Study|Withdrawal by Subject|121|||
48874034|NCT01157351|157376916|FG000|Overall Study|Withdrawal by Subject|37|||
48976875|NCT02940860|157746264|FG000|Overall Study|Protocol Violation|0|||
48976876|NCT02940860|157746265|FG001|Overall Study|Protocol Violation|2|||
48976877|NCT02940860|157746264|FG000|Overall Study|Death|3|||
48976878|NCT02940860|157746265|FG001|Overall Study|Death|2|||
48976879|NCT02940860|157746264|FG000|Overall Study|Moved, poor venous access, transport|6|||
48976880|NCT02940860|157746265|FG001|Overall Study|Moved, poor venous access, transport|4|||
48976881|NCT02940860|157746264|FG000|Overall Study|Not treated|2|||
48976882|NCT02940860|157746265|FG001|Overall Study|Not treated|2|||
48976883|NCT03654560|157746271|FG000|Overall Study|Death|3|||
48976884|NCT03654560|157746272|FG001|Overall Study|Death|1|||
48976885|NCT03654560|157746271|FG000|Overall Study|Lost to Follow-up|1|||
48976886|NCT03654560|157746272|FG001|Overall Study|Lost to Follow-up|0|||
48976887|NCT00985738|157746277|FG000|Overall Study|Study closed prematurely|8|||
48976888|NCT00985738|157746278|FG001|Overall Study|Study closed prematurely|8|||
48976889|NCT01843205|157746282|FG000|First Treatment (11 Days)|Withdrawal by Subject|1|||
48976890|NCT01843205|157746283|FG001|First Treatment (11 Days)|Withdrawal by Subject|0|||
48976891|NCT03938636|157746284|FG000|Overall Study|Protocol Violation|0|||
48976892|NCT03938636|157746285|FG001|Overall Study|Protocol Violation|1|||
48976893|NCT03938636|157746286|FG002|Overall Study|Protocol Violation|1|||
48976894|NCT03938636|157746284|FG000|Overall Study|Subject withdrew due to death in family|0|||
48976895|NCT03938636|157746285|FG001|Overall Study|Subject withdrew due to death in family|1|||
48976896|NCT03938636|157746286|FG002|Overall Study|Subject withdrew due to death in family|0|||
48976897|NCT03938636|157746284|FG000|Overall Study|Missed visit|0|||
48976898|NCT03938636|157746285|FG001|Overall Study|Missed visit|1|||
48976899|NCT03938636|157746286|FG002|Overall Study|Missed visit|0|||
48976900|NCT03938636|157746284|FG000|Overall Study|Adverse Event|0|||
48976901|NCT03938636|157746285|FG001|Overall Study|Adverse Event|0|||
48976902|NCT03938636|157746286|FG002|Overall Study|Adverse Event|1|||
48976903|NCT03938636|157746284|FG000|Overall Study|Lost to Follow-up|0|||
48976904|NCT03938636|157746285|FG001|Overall Study|Lost to Follow-up|0|||
48976905|NCT03938636|157746286|FG002|Overall Study|Lost to Follow-up|1|||
48976906|NCT00606177|157746287|FG000|Overall Study|Adverse Event|9|||
48976907|NCT00606177|157746288|FG001|Overall Study|Adverse Event|5|||
48976908|NCT00606177|157746287|FG000|Overall Study|Lack of Efficacy|3|||
48976909|NCT00606177|157746288|FG001|Overall Study|Lack of Efficacy|7|||
48976910|NCT00606177|157746287|FG000|Overall Study|Physician Decision|1|||
48976911|NCT00606177|157746288|FG001|Overall Study|Physician Decision|0|||
48976912|NCT00606177|157746287|FG000|Overall Study|Protocol Violation|1|||
48976913|NCT00606177|157746288|FG001|Overall Study|Protocol Violation|4|||
48976914|NCT00606177|157746287|FG000|Overall Study|Withdrawal by Subject|5|||
48976915|NCT00606177|157746288|FG001|Overall Study|Withdrawal by Subject|6|||
48976916|NCT00606177|157746287|FG000|Overall Study|Progression to depressive phase|6|||
48976917|NCT00606177|157746288|FG001|Overall Study|Progression to depressive phase|1|||
48976918|NCT00606177|157746287|FG000|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
48976919|NCT00606177|157746288|FG001|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
48976920|NCT00606177|157746287|FG000|Overall Study|Change of residence or other commitments|1|||
48976921|NCT00606177|157746288|FG001|Overall Study|Change of residence or other commitments|1|||
48976922|NCT00711412|157746289|FG000|Induction Treatment|Death|2|||
48976923|NCT00711412|157746289|FG000|Induction Treatment|Adverse Event|1|||
48976924|NCT00711412|157746289|FG000|Induction Treatment|Other|1|||
48976925|NCT00711412|157746289|FG000|Evaluated for Combination Treatment|Adverse Event|2|||
48976926|NCT00711412|157746289|FG000|Evaluated for Combination Treatment|Death|1|||
48976927|NCT00711412|157746289|FG000|Evaluated for Combination Treatment|Withdrawal by Subject|1|||
48976928|NCT00711412|157746289|FG000|Evaluated for Combination Treatment|Progressive disease|2|||
48976929|NCT00711412|157746289|FG000|Combination Treatment|Progressive Disease|1|||
48976930|NCT00711412|157746289|FG000|Evaluation for Response and Surgery|Progressive Disease|2|||
48761949|NCT02036502|156975719|FG002|Part 3:Dose Expansion|Not Treated|0|||
48761950|NCT02036502|156975720|FG003|Part 3:Dose Expansion|Not Treated|0|||
48976931|NCT00711412|157746289|FG000|Evaluation for Response and Surgery|Too high risk for surgery|2|||
48976932|NCT00711412|157746289|FG000|Evaluation for Response and Surgery|Withdrawal by Subject|1|||
48976933|NCT00711412|157746289|FG000|Evaluation for Response and Surgery|Death|1|||
48976934|NCT00711412|157746289|FG000|Survival Follow up Until Death|Other|12|||
48976935|NCT00446797|157746290|FG000|Overall Study|Lack of Efficacy|0|||
48976936|NCT00446797|157746291|FG001|Overall Study|Lack of Efficacy|2|||
48976937|NCT00446797|157746290|FG000|Overall Study|Lost to Follow-up|5|||
48976938|NCT00446797|157746291|FG001|Overall Study|Lost to Follow-up|3|||
48761951|NCT02036502|156975721|FG004|Part 3:Dose Expansion|Not Treated|0|||
48976939|NCT00446797|157746290|FG000|Overall Study|Withdrawal by Subject|2|||
48976940|NCT00446797|157746291|FG001|Overall Study|Withdrawal by Subject|2|||
48976941|NCT00446797|157746290|FG000|Overall Study|Protocol Violation|1|||
48976942|NCT00446797|157746291|FG001|Overall Study|Protocol Violation|3|||
48976943|NCT00446797|157746290|FG000|Overall Study|subject entered at another site|0|||
48976944|NCT00446797|157746291|FG001|Overall Study|subject entered at another site|1|||
48976945|NCT00446797|157746290|FG000|Overall Study|did not meet entrance criteria|0|||
48976946|NCT00446797|157746291|FG001|Overall Study|did not meet entrance criteria|1|||
48976947|NCT00441727|157746292|FG000|Overall Study|Protocol Violation|19|||
48976948|NCT00441727|157746293|FG001|Overall Study|Protocol Violation|28|||
48761952|NCT02036502|156975722|FG005|Part 3:Dose Expansion|Not Treated|2|||
48761953|NCT02036502|156975723|FG006|Part 3:Dose Expansion|Not Treated|0|||
48761954|NCT02036502|156975724|FG007|Part 3:Dose Expansion|Not Treated|0|||
48976949|NCT00441727|157746294|FG002|Overall Study|Protocol Violation|32|||
48976950|NCT00441727|157746292|FG000|Overall Study|Adverse Event|26|||
48976951|NCT00441727|157746293|FG001|Overall Study|Adverse Event|33|||
48976952|NCT00441727|157746294|FG002|Overall Study|Adverse Event|28|||
48976953|NCT00441727|157746292|FG000|Overall Study|Lack of Efficacy|7|||
48976954|NCT00441727|157746293|FG001|Overall Study|Lack of Efficacy|8|||
48976955|NCT00441727|157746294|FG002|Overall Study|Lack of Efficacy|48|||
48976956|NCT00441727|157746292|FG000|Overall Study|Withdrawal by Subject|40|||
48976957|NCT00441727|157746293|FG001|Overall Study|Withdrawal by Subject|34|||
48976958|NCT00441727|157746294|FG002|Overall Study|Withdrawal by Subject|47|||
48976959|NCT00441727|157746292|FG000|Overall Study|Lost to Follow-up|5|||
48976960|NCT00441727|157746293|FG001|Overall Study|Lost to Follow-up|6|||
48976961|NCT00441727|157746294|FG002|Overall Study|Lost to Follow-up|5|||
48976962|NCT00441727|157746292|FG000|Overall Study|Safety Reasons|3|||
48976963|NCT00441727|157746293|FG001|Overall Study|Safety Reasons|1|||
48976964|NCT00441727|157746294|FG002|Overall Study|Safety Reasons|3|||
48976965|NCT00441727|157746292|FG000|Overall Study|Various reason specified|6|||
48976966|NCT00441727|157746293|FG001|Overall Study|Various reason specified|8|||
48976967|NCT00441727|157746294|FG002|Overall Study|Various reason specified|5|||
48976968|NCT02147691|157746296|FG000|Overall Study|Withdrawal by Subject|2|||
48976969|NCT02147691|157746297|FG001|Overall Study|Withdrawal by Subject|0|||
48976970|NCT02147691|157746296|FG000|Overall Study|Adverse Event|2|||
48976971|NCT02147691|157746297|FG001|Overall Study|Adverse Event|0|||
48976972|NCT02147691|157746296|FG000|Overall Study|Lost to Follow-up|0|||
48976973|NCT02147691|157746297|FG001|Overall Study|Lost to Follow-up|1|||
48976974|NCT02580591|157746300|FG000|Overall Study|Adverse Event|0|||
48976975|NCT02580591|157746301|FG001|Overall Study|Adverse Event|1|||
48976976|NCT02580591|157746302|FG002|Overall Study|Adverse Event|2|||
48976977|NCT02580591|157746303|FG003|Overall Study|Adverse Event|5|||
48976978|NCT02580591|157746300|FG000|Overall Study|Protocol Violation|3|||
48976979|NCT02580591|157746301|FG001|Overall Study|Protocol Violation|2|||
48976980|NCT02580591|157746302|FG002|Overall Study|Protocol Violation|1|||
48976981|NCT02580591|157746303|FG003|Overall Study|Protocol Violation|1|||
48976982|NCT02580591|157746300|FG000|Overall Study|Lost to Follow-up|5|||
48976983|NCT02580591|157746301|FG001|Overall Study|Lost to Follow-up|3|||
48976984|NCT02580591|157746302|FG002|Overall Study|Lost to Follow-up|3|||
48976985|NCT02580591|157746303|FG003|Overall Study|Lost to Follow-up|1|||
48976986|NCT02580591|157746300|FG000|Overall Study|Withdrawal by Subject|6|||
48976987|NCT02580591|157746301|FG001|Overall Study|Withdrawal by Subject|1|||
48976988|NCT02580591|157746302|FG002|Overall Study|Withdrawal by Subject|2|||
48976989|NCT02580591|157746303|FG003|Overall Study|Withdrawal by Subject|3|||
48976990|NCT02580591|157746300|FG000|Overall Study|Not treated|1|||
48976991|NCT02580591|157746301|FG001|Overall Study|Not treated|1|||
48976992|NCT02580591|157746302|FG002|Overall Study|Not treated|0|||
48976993|NCT02580591|157746303|FG003|Overall Study|Not treated|0|||
48976994|NCT02580591|157746300|FG000|Overall Study|Other than specified|3|||
48976995|NCT02580591|157746301|FG001|Overall Study|Other than specified|2|||
48976996|NCT02580591|157746302|FG002|Overall Study|Other than specified|5|||
48976997|NCT02580591|157746303|FG003|Overall Study|Other than specified|2|||
48976998|NCT00429572|157746307|FG000|Overall Study|Disease progression|1|||
48976999|NCT01712490|157746308|FG000|Overall Study|Ongoing|601|||
48977000|NCT01712490|157746309|FG001|Overall Study|Ongoing|586|||
48977001|NCT01712490|157746308|FG000|Overall Study|Other|11|||
48977002|NCT01712490|157746309|FG001|Overall Study|Other|11|||
48977003|NCT01712490|157746308|FG000|Overall Study|Withdrawal by Subject|36|||
48977004|NCT01712490|157746309|FG001|Overall Study|Withdrawal by Subject|44|||
48977005|NCT01712490|157746308|FG000|Overall Study|Lost to Follow-up|16|||
48675569|NCT01894243|156663532|FG000|Overall Study|Adverse Event|0|||
48675570|NCT01894243|156663533|FG001|Overall Study|Adverse Event|1|||
48977006|NCT01712490|157746309|FG001|Overall Study|Lost to Follow-up|29|||
48977007|NCT02910089|157746311|FG000|Overall Study|Lost insurance eligibility|22|||
48977008|NCT02910089|157746312|FG001|Overall Study|Lost insurance eligibility|16|||
48977009|NCT02623699|157746321|FG000|Part A (Up to 63 Days)|Consent Withdrawn|0|||
48675571|NCT01894243|156663534|FG002|Overall Study|Adverse Event|2|||
48675572|NCT01894243|156663532|FG000|Overall Study|Death|0|||
48675573|NCT01894243|156663533|FG001|Overall Study|Death|0|||
48977010|NCT02623699|157746322|FG001|Part A (Up to 63 Days)|Consent Withdrawn|1|||
48977011|NCT02623699|157746323|FG002|Part A (Up to 63 Days)|Consent Withdrawn|0|||
48977012|NCT02623699|157746324|FG003|Part A (Up to 63 Days)|Consent Withdrawn|0|||
48977013|NCT02623699|157746325|FG004|Part A (Up to 63 Days)|Consent Withdrawn|0|||
48977014|NCT02623699|157746326|FG005|Part A (Up to 63 Days)|Consent Withdrawn|0|||
48675574|NCT01894243|156663534|FG002|Overall Study|Death|3|||
48675575|NCT01894243|156663532|FG000|Overall Study|Lack of Efficacy|3|||
48977015|NCT02623699|157746327|FG006|Part A (Up to 63 Days)|Consent Withdrawn|0|||
48977016|NCT02623699|157746328|FG007|Part A (Up to 63 Days)|Consent Withdrawn|0|||
48977017|NCT02623699|157746329|FG008|Part A (Up to 63 Days)|Consent Withdrawn|0|||
48977018|NCT02623699|157746330|FG009|Part A (Up to 63 Days)|Consent Withdrawn|0|||
48977019|NCT02623699|157746331|FG010|Part A (Up to 63 Days)|Consent Withdrawn|0|||
48977020|NCT02623699|157746332|FG011|Part A (Up to 63 Days)|Consent Withdrawn|0|||
48874035|NCT01157351|157376917|FG001|Overall Study|Withdrawal by Subject|27|||
48874036|NCT01157351|157376916|FG000|Overall Study|Physician Decision|5|||
48874037|NCT01157351|157376917|FG001|Overall Study|Physician Decision|4|||
48874038|NCT01157351|157376916|FG000|Overall Study|Protocol Violation|0|||
48874039|NCT01157351|157376917|FG001|Overall Study|Protocol Violation|1|||
48874040|NCT01157351|157376916|FG000|Overall Study|Other|32|||
48874041|NCT01157351|157376917|FG001|Overall Study|Other|36|||
48874042|NCT01157351|157376916|FG000|Overall Study|Noncompliance with Study Drug|0|||
48874043|NCT01157351|157376917|FG001|Overall Study|Noncompliance with Study Drug|3|||
48874044|NCT01157351|157376916|FG000|Overall Study|Randomized but not Treated|4|||
48874045|NCT01157351|157376917|FG001|Overall Study|Randomized but not Treated|2|||
48874046|NCT01726049|157376921|FG000|Overall Study|Death|1|||
48874047|NCT01726049|157376922|FG001|Overall Study|Death|1|||
48874048|NCT01726049|157376921|FG000|Overall Study|Adverse Event|4|||
48874049|NCT01726049|157376922|FG001|Overall Study|Adverse Event|1|||
48874050|NCT01726049|157376921|FG000|Overall Study|refused second HC|0|||
48874051|NCT01726049|157376922|FG001|Overall Study|refused second HC|2|||
48874052|NCT00664105|157376923|FG000|Overall Study|Death|3|||
48874053|NCT00664105|157376923|FG000|Overall Study|Withdrawal by Subject|5|||
48874054|NCT00664105|157376923|FG000|Overall Study|Adverse Event|9|||
48874055|NCT00664105|157376923|FG000|Overall Study|Disease progression|7|||
48874056|NCT04732871|157376924|FG000|Overall Study|Adverse event (AE) requiring expedited reporting|9|||
48874057|NCT04732871|157376925|FG001|Overall Study|Adverse event (AE) requiring expedited reporting|1|||
48874058|NCT04732871|157376926|FG002|Overall Study|Adverse event (AE) requiring expedited reporting|3|||
48874059|NCT04732871|157376924|FG000|Overall Study|Lost to Follow-up|7|||
48874060|NCT04732871|157376925|FG001|Overall Study|Lost to Follow-up|4|||
48874061|NCT04732871|157376926|FG002|Overall Study|Lost to Follow-up|3|||
48874062|NCT04732871|157376924|FG000|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|26|||
48874063|NCT04732871|157376925|FG001|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|7|||
48874064|NCT04732871|157376926|FG002|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|6|||
48874065|NCT04732871|157376924|FG000|Overall Study|Migrated / moved from the study area|5|||
48874066|NCT04732871|157376925|FG001|Overall Study|Migrated / moved from the study area|0|||
48874067|NCT04732871|157376926|FG002|Overall Study|Migrated / moved from the study area|0|||
48874068|NCT04732871|157376924|FG000|Overall Study|Other|1|||
48874069|NCT04732871|157376925|FG001|Overall Study|Other|0|||
48874070|NCT04732871|157376926|FG002|Overall Study|Other|1|||
48874071|NCT04732871|157376924|FG000|Overall Study|Ongoing|6|||
48874072|NCT04732871|157376925|FG001|Overall Study|Ongoing|0|||
48874073|NCT04732871|157376926|FG002|Overall Study|Ongoing|1|||
48874074|NCT04732871|157376924|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
48874075|NCT04732871|157376925|FG001|Overall Study|Unsolicited non-serious adverse event|0|||
48874076|NCT04732871|157376926|FG002|Overall Study|Unsolicited non-serious adverse event|0|||
48874077|NCT00598871|157376927|FG000|Overall Study|Adverse Event|0|||
48874078|NCT00598871|157376928|FG001|Overall Study|Adverse Event|1|||
48874079|NCT01983462|157376929|FG000|Overall Study|Adverse Event|1|||
48874080|NCT01983462|157376930|FG001|Overall Study|Adverse Event|0|||
48874081|NCT01983462|157376931|FG002|Overall Study|Adverse Event|0|||
48874082|NCT01470599|157376932|FG000|Overall Study|Did not meet entrance criteria|1|||
48874083|NCT01470599|157376933|FG001|Overall Study|Did not meet entrance criteria|0|||
48874084|NCT01470599|157376932|FG000|Overall Study|Lost to Follow-up|2|||
48874085|NCT01470599|157376933|FG001|Overall Study|Lost to Follow-up|1|||
48675576|NCT01894243|156663533|FG001|Overall Study|Lack of Efficacy|3|||
48675577|NCT01894243|156663534|FG002|Overall Study|Lack of Efficacy|1|||
48675578|NCT01894243|156663532|FG000|Overall Study|Condition under investigation worsened|8|||
48675579|NCT01894243|156663533|FG001|Overall Study|Condition under investigation worsened|6|||
48675580|NCT01894243|156663534|FG002|Overall Study|Condition under investigation worsened|2|||
48675581|NCT01894243|156663532|FG000|Overall Study|Subject decision|1|||
48675582|NCT01894243|156663533|FG001|Overall Study|Subject decision|0|||
48675583|NCT01894243|156663534|FG002|Overall Study|Subject decision|0|||
48675584|NCT01894243|156663532|FG000|Overall Study|Other|1|||
48675585|NCT01894243|156663533|FG001|Overall Study|Other|0|||
48675586|NCT01894243|156663534|FG002|Overall Study|Other|0|||
48675587|NCT00828750|156663535|FG000|Overall Study|Lack of Efficacy|3|||
48675588|NCT00828750|156663535|FG000|Overall Study|Normal PC Remained While No Treatment|1|||
48675589|NCT00765063|156665332|FG000|Overall Study|Lack of Efficacy|5|||
48675590|NCT00765063|156665332|FG000|Overall Study|Withdrawal by Subject|1|||
48675591|NCT00765063|156665332|FG000|Overall Study|Other|16|||
48675592|NCT00765063|156665332|FG000|Overall Study|Protocol Violation|6|||
48675593|NCT00765063|156665332|FG000|Overall Study|Adverse Event|4|||
48675594|NCT03416127|156665333|FG000|Overall Study|Withdrawal by Subject|0|||
48675595|NCT03416127|156665334|FG001|Overall Study|Withdrawal by Subject|1|||
48675596|NCT03416127|156665335|FG002|Overall Study|Withdrawal by Subject|1|||
48874086|NCT01470599|157376932|FG000|Overall Study|Withdrawal by Subject|3|||
48874087|NCT01470599|157376933|FG001|Overall Study|Withdrawal by Subject|4|||
48874088|NCT01470599|157376932|FG000|Overall Study|Other|1|||
48874089|NCT01470599|157376933|FG001|Overall Study|Other|0|||
48977021|NCT02623699|157746321|FG000|Part B (Up to 289 Days)|Lost to Follow-up|0|||
48977022|NCT02623699|157746322|FG001|Part B (Up to 289 Days)|Lost to Follow-up|0|||
48977023|NCT02623699|157746323|FG002|Part B (Up to 289 Days)|Lost to Follow-up|0|||
48977024|NCT02623699|157746324|FG003|Part B (Up to 289 Days)|Lost to Follow-up|0|||
48977025|NCT02623699|157746325|FG004|Part B (Up to 289 Days)|Lost to Follow-up|0|||
48977026|NCT02623699|157746326|FG005|Part B (Up to 289 Days)|Lost to Follow-up|0|||
48977027|NCT02623699|157746327|FG006|Part B (Up to 289 Days)|Lost to Follow-up|1|||
48977028|NCT02623699|157746328|FG007|Part B (Up to 289 Days)|Lost to Follow-up|0|||
48977029|NCT02623699|157746329|FG008|Part B (Up to 289 Days)|Lost to Follow-up|0|||
48977030|NCT02623699|157746330|FG009|Part B (Up to 289 Days)|Lost to Follow-up|0|||
48977031|NCT02623699|157746331|FG010|Part B (Up to 289 Days)|Lost to Follow-up|0|||
48977032|NCT02623699|157746332|FG011|Part B (Up to 289 Days)|Lost to Follow-up|0|||
48977033|NCT02623699|157746321|FG000|Part B (Up to 289 Days)|Consent Withdrawn|0|||
48977034|NCT02623699|157746322|FG001|Part B (Up to 289 Days)|Consent Withdrawn|0|||
48977035|NCT02623699|157746323|FG002|Part B (Up to 289 Days)|Consent Withdrawn|0|||
48977036|NCT02623699|157746324|FG003|Part B (Up to 289 Days)|Consent Withdrawn|0|||
48977037|NCT02623699|157746325|FG004|Part B (Up to 289 Days)|Consent Withdrawn|0|||
48977038|NCT02623699|157746326|FG005|Part B (Up to 289 Days)|Consent Withdrawn|1|||
48977039|NCT02623699|157746327|FG006|Part B (Up to 289 Days)|Consent Withdrawn|0|||
48977040|NCT02623699|157746328|FG007|Part B (Up to 289 Days)|Consent Withdrawn|0|||
48977041|NCT02623699|157746329|FG008|Part B (Up to 289 Days)|Consent Withdrawn|0|||
48977042|NCT02623699|157746330|FG009|Part B (Up to 289 Days)|Consent Withdrawn|0|||
48977043|NCT02623699|157746331|FG010|Part B (Up to 289 Days)|Consent Withdrawn|0|||
48977044|NCT02623699|157746332|FG011|Part B (Up to 289 Days)|Consent Withdrawn|0|||
48977045|NCT02623699|157746321|FG000|Part B (Up to 289 Days)|Death|0|||
48977046|NCT02623699|157746322|FG001|Part B (Up to 289 Days)|Death|0|||
48977047|NCT02623699|157746323|FG002|Part B (Up to 289 Days)|Death|0|||
48977048|NCT02623699|157746324|FG003|Part B (Up to 289 Days)|Death|0|||
48977049|NCT02623699|157746325|FG004|Part B (Up to 289 Days)|Death|0|||
48977050|NCT02623699|157746326|FG005|Part B (Up to 289 Days)|Death|1|||
48977051|NCT02623699|157746327|FG006|Part B (Up to 289 Days)|Death|1|||
48977052|NCT02623699|157746328|FG007|Part B (Up to 289 Days)|Death|0|||
48977053|NCT02623699|157746329|FG008|Part B (Up to 289 Days)|Death|1|||
48977054|NCT02623699|157746330|FG009|Part B (Up to 289 Days)|Death|0|||
48977055|NCT02623699|157746331|FG010|Part B (Up to 289 Days)|Death|0|||
48977056|NCT02623699|157746332|FG011|Part B (Up to 289 Days)|Death|0|||
48977057|NCT02623699|157746321|FG000|Part C (Up to 236 Days)|Adverse Event|0|||
48977058|NCT02623699|157746322|FG001|Part C (Up to 236 Days)|Adverse Event|0|||
48977059|NCT02623699|157746323|FG002|Part C (Up to 236 Days)|Adverse Event|0|||
48977060|NCT02623699|157746324|FG003|Part C (Up to 236 Days)|Adverse Event|0|||
48977061|NCT02623699|157746325|FG004|Part C (Up to 236 Days)|Adverse Event|0|||
48977062|NCT02623699|157746326|FG005|Part C (Up to 236 Days)|Adverse Event|0|||
48977063|NCT02623699|157746327|FG006|Part C (Up to 236 Days)|Adverse Event|0|||
48977064|NCT02623699|157746328|FG007|Part C (Up to 236 Days)|Adverse Event|0|||
48977065|NCT02623699|157746329|FG008|Part C (Up to 236 Days)|Adverse Event|0|||
48977066|NCT02623699|157746330|FG009|Part C (Up to 236 Days)|Adverse Event|0|||
48977067|NCT02623699|157746331|FG010|Part C (Up to 236 Days)|Adverse Event|0|||
48977068|NCT02623699|157746332|FG011|Part C (Up to 236 Days)|Adverse Event|2|||
48977069|NCT02623699|157746321|FG000|Part C (Up to 236 Days)|Consent Withdrawn|0|||
48977070|NCT02623699|157746322|FG001|Part C (Up to 236 Days)|Consent Withdrawn|0|||
48977071|NCT02623699|157746323|FG002|Part C (Up to 236 Days)|Consent Withdrawn|0|||
48977072|NCT02623699|157746324|FG003|Part C (Up to 236 Days)|Consent Withdrawn|0|||
48977073|NCT02623699|157746325|FG004|Part C (Up to 236 Days)|Consent Withdrawn|0|||
48977074|NCT02623699|157746326|FG005|Part C (Up to 236 Days)|Consent Withdrawn|0|||
48977075|NCT02623699|157746327|FG006|Part C (Up to 236 Days)|Consent Withdrawn|0|||
48977076|NCT02623699|157746328|FG007|Part C (Up to 236 Days)|Consent Withdrawn|0|||
48977077|NCT02623699|157746329|FG008|Part C (Up to 236 Days)|Consent Withdrawn|0|||
48977078|NCT02623699|157746330|FG009|Part C (Up to 236 Days)|Consent Withdrawn|0|||
48977079|NCT02623699|157746331|FG010|Part C (Up to 236 Days)|Consent Withdrawn|1|||
48977080|NCT02623699|157746332|FG011|Part C (Up to 236 Days)|Consent Withdrawn|2|||
48977081|NCT02623699|157746321|FG000|Part C (Up to 236 Days)|Death|0|||
48977082|NCT02623699|157746322|FG001|Part C (Up to 236 Days)|Death|0|||
48977083|NCT02623699|157746323|FG002|Part C (Up to 236 Days)|Death|0|||
48977084|NCT02623699|157746324|FG003|Part C (Up to 236 Days)|Death|0|||
48977085|NCT02623699|157746325|FG004|Part C (Up to 236 Days)|Death|0|||
48977086|NCT02623699|157746326|FG005|Part C (Up to 236 Days)|Death|0|||
48977087|NCT02623699|157746327|FG006|Part C (Up to 236 Days)|Death|0|||
48977088|NCT02623699|157746328|FG007|Part C (Up to 236 Days)|Death|0|||
48977089|NCT02623699|157746329|FG008|Part C (Up to 236 Days)|Death|0|||
48977090|NCT02623699|157746330|FG009|Part C (Up to 236 Days)|Death|0|||
48977091|NCT02623699|157746331|FG010|Part C (Up to 236 Days)|Death|0|||
48977092|NCT02623699|157746332|FG011|Part C (Up to 236 Days)|Death|1|||
48977093|NCT02623699|157746321|FG000|Part C (Up to 236 Days)|Disease Progression|0|||
48977094|NCT02623699|157746322|FG001|Part C (Up to 236 Days)|Disease Progression|0|||
48977095|NCT02623699|157746323|FG002|Part C (Up to 236 Days)|Disease Progression|0|||
48977096|NCT02623699|157746324|FG003|Part C (Up to 236 Days)|Disease Progression|0|||
48977097|NCT02623699|157746325|FG004|Part C (Up to 236 Days)|Disease Progression|0|||
48977098|NCT02623699|157746326|FG005|Part C (Up to 236 Days)|Disease Progression|0|||
48977099|NCT02623699|157746327|FG006|Part C (Up to 236 Days)|Disease Progression|0|||
48977100|NCT02623699|157746328|FG007|Part C (Up to 236 Days)|Disease Progression|0|||
48977101|NCT02623699|157746329|FG008|Part C (Up to 236 Days)|Disease Progression|0|||
48977102|NCT02623699|157746330|FG009|Part C (Up to 236 Days)|Disease Progression|0|||
48977103|NCT02623699|157746331|FG010|Part C (Up to 236 Days)|Disease Progression|2|||
48977104|NCT02623699|157746332|FG011|Part C (Up to 236 Days)|Disease Progression|3|||
48977105|NCT00899678|157746333|FG000|Induction Period (Weeks 0 to 6)|Adverse Event|6|||
48977106|NCT00899678|157746334|FG001|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
48977107|NCT00899678|157746335|FG002|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
48977108|NCT00899678|157746333|FG000|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17|||
48977109|NCT00899678|157746334|FG001|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
48977110|NCT00899678|157746335|FG002|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
48977111|NCT00899678|157746333|FG000|Induction Period (Weeks 0 to 6)|Protocol Violation|1|||
48977112|NCT00899678|157746334|FG001|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
48977113|NCT00899678|157746335|FG002|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
48977114|NCT00899678|157746333|FG000|Induction Period (Weeks 0 to 6)|Other reason|1|||
48675597|NCT02522325|156665336|FG000|Overall Study|Adverse Event|0|||
48675598|NCT02522325|156665337|FG001|Overall Study|Adverse Event|1|||
48675599|NCT01629953|156665340|FG000|Overall Study|Death|3|||
48675600|NCT01629953|156665341|FG001|Overall Study|Death|1|||
48675601|NCT01629953|156665340|FG000|Overall Study|Lost to Follow-up|10|||
48675602|NCT01629953|156665341|FG001|Overall Study|Lost to Follow-up|14|||
48675603|NCT02783599|156665342|FG000|Overall Study|Progressive disease|23|||
48675604|NCT02783599|156665342|FG000|Overall Study|Surgical Resection|10|||
48675605|NCT02783599|156665342|FG000|Overall Study|Adverse Event|4|||
48675606|NCT02783599|156665342|FG000|Overall Study|Physician Decision|2|||
48675607|NCT02783599|156665342|FG000|Overall Study|Death|1|||
48675608|NCT00615030|156665343|FG000|Period I|Administrative problem|0|||
48675609|NCT00615030|156665344|FG001|Period I|Administrative problem|0|||
48675610|NCT00615030|156665345|FG002|Period I|Administrative problem|0|||
48675611|NCT00615030|156665346|FG003|Period I|Administrative problem|0|||
48675612|NCT00615030|156665347|FG004|Period I|Administrative problem|1|||
48675613|NCT00615030|156665348|FG005|Period I|Administrative problem|0|||
48675614|NCT00615030|156665349|FG006|Period I|Administrative problem|0|||
48761955|NCT03065244|156975726|FG000|Overall Study|Lost to Follow-up|1|||
48761956|NCT03065244|156975727|FG001|Overall Study|Lost to Follow-up|1|||
48761957|NCT03065244|156975726|FG000|Overall Study|Diagnosed with a different disease|1|||
48761958|NCT03065244|156975727|FG001|Overall Study|Diagnosed with a different disease|1|||
48761959|NCT03065244|156975726|FG000|Overall Study|Protocol Violation|0|||
48761960|NCT03065244|156975727|FG001|Overall Study|Protocol Violation|1|||
48761961|NCT03065244|156975726|FG000|Overall Study|Withdrawal by Subject|1|||
48761962|NCT03065244|156975727|FG001|Overall Study|Withdrawal by Subject|1|||
48761963|NCT02291055|156975731|FG000|Overall Study|Death|2|||
48761964|NCT02291055|156975732|FG001|Overall Study|Death|2|||
48761965|NCT02291055|156975733|FG002|Overall Study|Death|5|||
48761966|NCT02291055|156975734|FG003|Overall Study|Death|8|||
48761967|NCT02291055|156975735|FG004|Overall Study|Death|12|||
48761968|NCT02291055|156975731|FG000|Overall Study|Lost to Follow-up|0|||
48761969|NCT02291055|156975732|FG001|Overall Study|Lost to Follow-up|0|||
48761970|NCT02291055|156975733|FG002|Overall Study|Lost to Follow-up|0|||
48761971|NCT02291055|156975734|FG003|Overall Study|Lost to Follow-up|1|||
48761972|NCT02291055|156975735|FG004|Overall Study|Lost to Follow-up|2|||
48761973|NCT02291055|156975731|FG000|Overall Study|Withdrawal by Subject|3|||
48761974|NCT02291055|156975732|FG001|Overall Study|Withdrawal by Subject|1|||
48761975|NCT02291055|156975733|FG002|Overall Study|Withdrawal by Subject|1|||
48761976|NCT02291055|156975734|FG003|Overall Study|Withdrawal by Subject|5|||
48761977|NCT02291055|156975735|FG004|Overall Study|Withdrawal by Subject|10|||
48761978|NCT02291055|156975731|FG000|Overall Study|Progressive Disease|0|||
48761979|NCT02291055|156975732|FG001|Overall Study|Progressive Disease|0|||
48761980|NCT02291055|156975733|FG002|Overall Study|Progressive Disease|1|||
48761981|NCT02291055|156975734|FG003|Overall Study|Progressive Disease|4|||
48761982|NCT02291055|156975735|FG004|Overall Study|Progressive Disease|2|||
48761983|NCT02291055|156975731|FG000|Overall Study|Study Terminated by Sponsor|0|||
48761984|NCT02291055|156975732|FG001|Overall Study|Study Terminated by Sponsor|0|||
48977115|NCT00899678|157746334|FG001|Induction Period (Weeks 0 to 6)|Other reason|0|||
48675615|NCT00615030|156665350|FG007|Period I|Administrative problem|0|||
48675616|NCT00615030|156665351|FG008|Period I|Administrative problem|0|||
48675617|NCT00615030|156665352|FG009|Period I|Administrative problem|0|||
48675618|NCT00615030|156665353|FG010|Period I|Administrative problem|0|||
48761985|NCT02291055|156975733|FG002|Overall Study|Study Terminated by Sponsor|0|||
48761986|NCT02291055|156975734|FG003|Overall Study|Study Terminated by Sponsor|5|||
48761987|NCT02291055|156975735|FG004|Overall Study|Study Terminated by Sponsor|1|||
48761988|NCT02291055|156975731|FG000|Overall Study|Other|0|||
48761989|NCT02291055|156975732|FG001|Overall Study|Other|2|||
48761990|NCT02291055|156975733|FG002|Overall Study|Other|1|||
48761991|NCT02291055|156975734|FG003|Overall Study|Other|4|||
48761992|NCT02291055|156975735|FG004|Overall Study|Other|0|||
48977116|NCT00899678|157746335|FG002|Induction Period (Weeks 0 to 6)|Other reason|0|||
48977117|NCT00899678|157746333|FG000|Maintenance Period (Weeks 8 to 62)|Adverse Event|0|||
48977118|NCT00899678|157746334|FG001|Maintenance Period (Weeks 8 to 62)|Adverse Event|10|||
48977119|NCT00899678|157746335|FG002|Maintenance Period (Weeks 8 to 62)|Adverse Event|5|||
48977120|NCT00899678|157746333|FG000|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0|||
48977121|NCT00899678|157746334|FG001|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11|||
48977122|NCT00899678|157746335|FG002|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18|||
48977123|NCT00899678|157746333|FG000|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0|||
48977124|NCT00899678|157746334|FG001|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
48977125|NCT00899678|157746335|FG002|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
48977126|NCT00899678|157746333|FG000|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0|||
48977127|NCT00899678|157746334|FG001|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1|||
48977128|NCT00899678|157746335|FG002|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2|||
48977129|NCT00899678|157746333|FG000|Maintenance Period (Weeks 8 to 62)|Other reason|0|||
48977130|NCT00899678|157746334|FG001|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
48977131|NCT00899678|157746335|FG002|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
48977132|NCT00033371|157746336|FG000|Overall Study|Adverse Event|1|||
48977133|NCT00033371|157746337|FG001|Overall Study|Adverse Event|5|||
48977134|NCT00033371|157746336|FG000|Overall Study|Lost to Follow-up|2|||
48977135|NCT00033371|157746337|FG001|Overall Study|Lost to Follow-up|1|||
48977136|NCT00033371|157746336|FG000|Overall Study|Withdrawal by Subject|3|||
48977137|NCT00033371|157746337|FG001|Overall Study|Withdrawal by Subject|3|||
48977138|NCT00033371|157746336|FG000|Overall Study|Disease Progression|0|||
48977139|NCT00033371|157746337|FG001|Overall Study|Disease Progression|1|||
48977140|NCT02699125|157746338|FG000|Placebo|Lost to Follow-up|2|||
48977141|NCT02699125|157746339|FG001|Placebo|Lost to Follow-up|0|||
48977142|NCT02699125|157746338|FG000|Placebo|Protocol Violation|1|||
48977143|NCT02699125|157746339|FG001|Placebo|Protocol Violation|0|||
48977144|NCT02699125|157746338|FG000|Placebo|Withdrawal by Subject|0|||
48977145|NCT02699125|157746339|FG001|Placebo|Withdrawal by Subject|4|||
48977146|NCT02699125|157746338|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|7|||
48977147|NCT02699125|157746339|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
48977148|NCT00572728|157746340|FG000|Overall Study|Withdrawal by Subject|10|||
48977149|NCT00572728|157746340|FG000|Overall Study|Ineligible|3|||
48977150|NCT00572728|157746340|FG000|Overall Study|Enrolled under Amendment 4|5|||
48977151|NCT00572728|157746340|FG000|Overall Study|Offstudy due to complicating disease|1|||
48977152|NCT00572728|157746340|FG000|Overall Study|FLT1 not completed|4|||
48977153|NCT00572728|157746340|FG000|Overall Study|First Chemotherapy not initiated|2|||
48977154|NCT00572728|157746340|FG000|Overall Study|FLT2 not completed|5|||
48977155|NCT00572728|157746340|FG000|Overall Study|Second chemotherapy not initiated|1|||
48977156|NCT00572728|157746340|FG000|Overall Study|FLT2 after second chemotherapy initiated|7|||
48977157|NCT00572728|157746340|FG000|Overall Study|Pathology missing|1|||
48977158|NCT03630016|157746345|FG000|Overall Study|Poor Sensor Placement|1|||
48977159|NCT00255008|157746348|FG000|Overall Study|Adverse Event|1|||
48977160|NCT00255008|157746349|FG001|Overall Study|Adverse Event|1|||
48977161|NCT00255008|157746350|FG002|Overall Study|Adverse Event|2|||
48977162|NCT00255008|157746351|FG003|Overall Study|Adverse Event|0|||
48977163|NCT00255008|157746348|FG000|Overall Study|Lost to Follow-up|1|||
48977164|NCT00255008|157746349|FG001|Overall Study|Lost to Follow-up|0|||
48977165|NCT00255008|157746350|FG002|Overall Study|Lost to Follow-up|1|||
48977166|NCT00255008|157746351|FG003|Overall Study|Lost to Follow-up|2|||
48977167|NCT00255008|157746348|FG000|Overall Study|Did not meet viral reduction criteria|4|||
48977168|NCT00255008|157746349|FG001|Overall Study|Did not meet viral reduction criteria|5|||
48977169|NCT00255008|157746350|FG002|Overall Study|Did not meet viral reduction criteria|0|||
48977170|NCT00255008|157746351|FG003|Overall Study|Did not meet viral reduction criteria|1|||
48977171|NCT00255008|157746348|FG000|Overall Study|Withdrew consent|0|||
48977172|NCT00255008|157746349|FG001|Overall Study|Withdrew consent|0|||
48977173|NCT00255008|157746350|FG002|Overall Study|Withdrew consent|2|||
48977174|NCT00255008|157746351|FG003|Overall Study|Withdrew consent|0|||
48977175|NCT00255008|157746348|FG000|Overall Study|Sponsor request|18|||
48977176|NCT00255008|157746349|FG001|Overall Study|Sponsor request|3|||
48977177|NCT00255008|157746350|FG002|Overall Study|Sponsor request|8|||
48977178|NCT00255008|157746351|FG003|Overall Study|Sponsor request|17|||
48761993|NCT01393405|156975736|FG000|Induction Period (week1-16)|Lack of Efficacy|70|||
48761994|NCT01393405|156975737|FG001|Induction Period (week1-16)|Lack of Efficacy|0|||
48761995|NCT01393405|156975738|FG002|Induction Period (week1-16)|Lack of Efficacy|0|||
48761996|NCT01393405|156975736|FG000|Induction Period (week1-16)|Adverse Event|16|||
48761997|NCT01393405|156975737|FG001|Induction Period (week1-16)|Adverse Event|0|||
48874090|NCT01470599|157376932|FG000|Overall Study|Protocol Violation|3|||
48977179|NCT00255008|157746348|FG000|Overall Study|Adverse lab experience|1|||
48977180|NCT00255008|157746349|FG001|Overall Study|Adverse lab experience|0|||
48977181|NCT00255008|157746350|FG002|Overall Study|Adverse lab experience|0|||
48977182|NCT00255008|157746351|FG003|Overall Study|Adverse lab experience|0|||
48761998|NCT01393405|156975738|FG002|Induction Period (week1-16)|Adverse Event|0|||
48977183|NCT00255008|157746348|FG000|Overall Study|Other|7|||
48977184|NCT00255008|157746349|FG001|Overall Study|Other|0|||
48977185|NCT00255008|157746350|FG002|Overall Study|Other|3|||
48977186|NCT00255008|157746351|FG003|Overall Study|Other|2|||
48977187|NCT01833806|157746352|FG000|Overall Study|Alternative treatment|2|||
48977188|NCT01833806|157746352|FG000|Overall Study|Death|5|||
48977189|NCT01833806|157746352|FG000|Overall Study|Physician Decision|1|||
48977190|NCT01833806|157746352|FG000|Overall Study|Lost to Follow-up|1|||
48977191|NCT05083949|157746356|FG000|Period 1|Positive doping for Tetrahydrocannabinol (THC)|2|||
48977192|NCT05083949|157746357|FG001|Period 1|Positive doping for Tetrahydrocannabinol (THC)|1|||
48977193|NCT05083949|157746356|FG000|Period 1|Adverse Event|1|||
48977194|NCT05083949|157746357|FG001|Period 1|Adverse Event|1|||
48977195|NCT05083949|157746356|FG000|Period 2|The patient was not able to eat the full content of the breakfast|1|||
48977196|NCT05083949|157746357|FG001|Period 2|The patient was not able to eat the full content of the breakfast|0|||
48977197|NCT05083949|157746356|FG000|Period 2|Adverse Event|0|||
48977198|NCT05083949|157746357|FG001|Period 2|Adverse Event|2|||
48977199|NCT03128307|157746358|FG000|Overall Study|Lost to Follow-up|29|||
48977200|NCT03128307|157746358|FG000|Overall Study|Withdrawal by Subject|5|||
48977201|NCT03148795|157746361|FG000|Overall Study|Progressive Disease|1|||
48977202|NCT01927068|157746362|FG000|Overall Study|Death|37|||
48977203|NCT01927068|157746363|FG001|Overall Study|Death|3|||
48977204|NCT01927068|157746362|FG000|Overall Study|Withdrawal by Subject|50|||
48977205|NCT01927068|157746363|FG001|Overall Study|Withdrawal by Subject|3|||
48977206|NCT01927068|157746362|FG000|Overall Study|Lost to Follow-up|10|||
48977207|NCT01927068|157746363|FG001|Overall Study|Lost to Follow-up|2|||
48977208|NCT01927068|157746362|FG000|Overall Study|Physician Decision|9|||
48977209|NCT01927068|157746363|FG001|Overall Study|Physician Decision|0|||
48977210|NCT01927068|157746362|FG000|Overall Study|Missed last follow-up visit|2|||
48977211|NCT01927068|157746363|FG001|Overall Study|Missed last follow-up visit|0|||
48977212|NCT01201967|157746364|FG000|Overall Study|Lost to Follow-up|6|||
48977213|NCT01201967|157746365|FG001|Overall Study|Lost to Follow-up|5|||
48977214|NCT00441012|157746366|FG000|Overall Study|Adverse Event|0|||
48977215|NCT00441012|157746367|FG001|Overall Study|Adverse Event|1|||
48977216|NCT00441012|157746366|FG000|Overall Study|Lost to Follow-up|3|||
48977217|NCT00441012|157746367|FG001|Overall Study|Lost to Follow-up|3|||
48977218|NCT00441012|157746366|FG000|Overall Study|Protocol Violation|10|||
48977219|NCT00441012|157746367|FG001|Overall Study|Protocol Violation|9|||
48977220|NCT00441012|157746366|FG000|Overall Study|Withdrawal by Subject|4|||
48977221|NCT00441012|157746367|FG001|Overall Study|Withdrawal by Subject|0|||
48977222|NCT00441012|157746366|FG000|Overall Study|Subject Randomized but Not Vaccinated|1|||
48977223|NCT00441012|157746367|FG001|Overall Study|Subject Randomized but Not Vaccinated|0|||
48977224|NCT00880607|157746368|FG000|Overall Study|Physician Decision|2|||
48977225|NCT00880607|157746369|FG001|Overall Study|Physician Decision|2|||
48977226|NCT00880607|157746368|FG000|Overall Study|Protocol Violation|2|||
48977227|NCT00880607|157746369|FG001|Overall Study|Protocol Violation|1|||
48977228|NCT00880607|157746368|FG000|Overall Study|surgery did not extend past L1 level|3|||
48977229|NCT00880607|157746369|FG001|Overall Study|surgery did not extend past L1 level|0|||
48977230|NCT01300767|157746370|FG000|Overall Study|Discomfort|2|||
48977231|NCT01300767|157746370|FG000|Overall Study|Biomicroscopy|1|||
48977232|NCT01300767|157746370|FG000|Overall Study|Unacceptable fit|1|||
48977233|NCT04021706|157748019|FG000|Overall Study|Adverse Event|2|||
48977234|NCT04021706|157748020|FG001|Overall Study|Adverse Event|0|||
48977235|NCT04021706|157748019|FG000|Overall Study|Withdrawal by Subject|1|||
48977236|NCT04021706|157748020|FG001|Overall Study|Withdrawal by Subject|2|||
48977237|NCT04021706|157748019|FG000|Overall Study|Physician Decision|1|||
48977238|NCT04021706|157748020|FG001|Overall Study|Physician Decision|0|||
48977239|NCT01102140|157748023|FG000|Overall Study|Lost to Follow-up|1|||
48977240|NCT01102140|157748024|FG001|Overall Study|Lost to Follow-up|0|||
48977241|NCT01102140|157748023|FG000|Overall Study|Investigator terminated study|2|||
48977242|NCT01102140|157748024|FG001|Overall Study|Investigator terminated study|2|||
48977243|NCT05406440|157748025|FG000|Overall Study|Lost to Follow-up|0|||
48977244|NCT05406440|157748026|FG001|Overall Study|Lost to Follow-up|0|||
48977245|NCT05406440|157748027|FG002|Overall Study|Lost to Follow-up|0|||
48977246|NCT05406440|157748028|FG003|Overall Study|Lost to Follow-up|0|||
48977247|NCT05406440|157748029|FG004|Overall Study|Lost to Follow-up|2|||
48977248|NCT05406440|157748030|FG005|Overall Study|Lost to Follow-up|0|||
48977249|NCT05406440|157748031|FG006|Overall Study|Lost to Follow-up|0|||
48977250|NCT05406440|157748025|FG000|Overall Study|Physician Decision|0|||
48977251|NCT05406440|157748026|FG001|Overall Study|Physician Decision|0|||
48977252|NCT05406440|157748027|FG002|Overall Study|Physician Decision|0|||
48977253|NCT05406440|157748028|FG003|Overall Study|Physician Decision|0|||
48977254|NCT05406440|157748029|FG004|Overall Study|Physician Decision|1|||
48977255|NCT05406440|157748030|FG005|Overall Study|Physician Decision|0|||
48977256|NCT05406440|157748031|FG006|Overall Study|Physician Decision|0|||
48977257|NCT05406440|157748025|FG000|Overall Study|Withdrawal by Subject|0|||
48977258|NCT05406440|157748026|FG001|Overall Study|Withdrawal by Subject|0|||
48977259|NCT05406440|157748027|FG002|Overall Study|Withdrawal by Subject|0|||
48977260|NCT05406440|157748028|FG003|Overall Study|Withdrawal by Subject|0|||
48977261|NCT05406440|157748029|FG004|Overall Study|Withdrawal by Subject|0|||
48977262|NCT05406440|157748030|FG005|Overall Study|Withdrawal by Subject|2|||
48977263|NCT05406440|157748031|FG006|Overall Study|Withdrawal by Subject|0|||
48977264|NCT04432376|157748033|FG000|Double-blind Treatment Period|Adverse Event|2|||
48977265|NCT04432376|157748034|FG001|Double-blind Treatment Period|Adverse Event|6|||
48977266|NCT04432376|157748035|FG002|Double-blind Treatment Period|Adverse Event|0|||
48977267|NCT04432376|157748033|FG000|Double-blind Treatment Period|Lost to Follow-up|2|||
48977268|NCT04432376|157748034|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
48977269|NCT04432376|157748035|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
48977270|NCT04432376|157748033|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
48977271|NCT04432376|157748034|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
48977272|NCT04432376|157748035|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
48977273|NCT04432376|157748033|FG000|Double-blind Treatment Period|Protocol Violation|0|||
48977274|NCT04432376|157748034|FG001|Double-blind Treatment Period|Protocol Violation|1|||
48977275|NCT04432376|157748035|FG002|Double-blind Treatment Period|Protocol Violation|0|||
48977276|NCT04432376|157748033|FG000|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
48977277|NCT04432376|157748034|FG001|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|1|||
48977278|NCT04432376|157748035|FG002|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
48977279|NCT04914819|157748037|FG000|Overall Study|Pregnancy|3|||
48977280|NCT04914819|157748038|FG001|Overall Study|Pregnancy|1|||
48977281|NCT04914819|157748037|FG000|Overall Study|Discontinued study|4|||
48977282|NCT04914819|157748038|FG001|Overall Study|Discontinued study|1|||
48977283|NCT04914819|157748037|FG000|Overall Study|Lost to Follow-up|7|||
48977284|NCT04914819|157748038|FG001|Overall Study|Lost to Follow-up|0|||
48977285|NCT00790218|157748039|FG000|Overall Study|Death|1|||
48977286|NCT00790218|157748040|FG001|Overall Study|Death|0|||
48977287|NCT00790218|157748041|FG002|Overall Study|Death|0|||
48977288|NCT00086385|157748042|FG000|Overall Study|Death|2|||
48977289|NCT00086385|157748043|FG001|Overall Study|Death|2|||
48977290|NCT00086385|157748044|FG002|Overall Study|Death|1|||
48977291|NCT00086385|157748045|FG003|Overall Study|Death|1|||
48977292|NCT02715804|157748052|FG000|Overall Study|Death|222|||
48977293|NCT02715804|157748053|FG001|Overall Study|Death|106|||
48977294|NCT02715804|157748052|FG000|Overall Study|Withdrawal by Subject|5|||
48977295|NCT02715804|157748053|FG001|Overall Study|Withdrawal by Subject|4|||
48977296|NCT02715804|157748052|FG000|Overall Study|Other than specified|2|||
48977297|NCT02715804|157748053|FG001|Overall Study|Other than specified|3|||
48977298|NCT04038385|157748055|FG000|Overall Study|Completed baseline assessment only|7|||
48977299|NCT04038385|157748056|FG001|Overall Study|Completed baseline assessment only|4|||
48977300|NCT04038385|157748055|FG000|Overall Study|Moved out of area|4|||
48761999|NCT01393405|156975736|FG000|Induction Period (week1-16)|Withdrawal by Subject|9|||
48977301|NCT04038385|157748056|FG001|Overall Study|Moved out of area|2|||
48977302|NCT04038385|157748055|FG000|Overall Study|Discontinued study involvement|6|||
48977303|NCT04038385|157748056|FG001|Overall Study|Discontinued study involvement|1|||
48977304|NCT03424044|157748057|FG000|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
48762000|NCT01393405|156975737|FG001|Induction Period (week1-16)|Withdrawal by Subject|0|||
48977305|NCT03424044|157748058|FG001|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
48977306|NCT03424044|157748059|FG002|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1|||
48977307|NCT03424044|157748060|FG003|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
48977308|NCT03424044|157748061|FG004|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
48977309|NCT03424044|157748062|FG005|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
48977310|NCT03424044|157748063|FG006|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
48977311|NCT03424044|157748064|FG007|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
48977312|NCT03424044|157748065|FG008|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
48977313|NCT03424044|157748057|FG000|First Intervention (76 Hours)|Adverse Event|0|||
48977314|NCT03424044|157748058|FG001|First Intervention (76 Hours)|Adverse Event|0|||
48977315|NCT03424044|157748059|FG002|First Intervention (76 Hours)|Adverse Event|0|||
48977316|NCT03424044|157748060|FG003|First Intervention (76 Hours)|Adverse Event|0|||
48977317|NCT03424044|157748061|FG004|First Intervention (76 Hours)|Adverse Event|1|||
48977318|NCT03424044|157748062|FG005|First Intervention (76 Hours)|Adverse Event|0|||
48977319|NCT03424044|157748063|FG006|First Intervention (76 Hours)|Adverse Event|0|||
48977320|NCT03424044|157748064|FG007|First Intervention (76 Hours)|Adverse Event|0|||
48977321|NCT03424044|157748065|FG008|First Intervention (76 Hours)|Adverse Event|0|||
48762001|NCT01393405|156975738|FG002|Induction Period (week1-16)|Withdrawal by Subject|0|||
48762002|NCT01393405|156975736|FG000|Maintenance Period Week|Lack of Efficacy|0|||
48762003|NCT01393405|156975737|FG001|Maintenance Period Week|Lack of Efficacy|22|||
48762004|NCT01393405|156975738|FG002|Maintenance Period Week|Lack of Efficacy|22|||
48762005|NCT01393405|156975736|FG000|Maintenance Period Week|Adverse Event|0|||
48762006|NCT01393405|156975737|FG001|Maintenance Period Week|Adverse Event|5|||
48977322|NCT03424044|157748057|FG000|First Intervention (76 Hours)|device issues|0|||
48977323|NCT03424044|157748058|FG001|First Intervention (76 Hours)|device issues|0|||
49015505|NCT01393990|157893783|FG013|Overall Study|Withdrawal by Subject|0|||
48977324|NCT03424044|157748059|FG002|First Intervention (76 Hours)|device issues|0|||
48977325|NCT03424044|157748060|FG003|First Intervention (76 Hours)|device issues|0|||
48977326|NCT03424044|157748061|FG004|First Intervention (76 Hours)|device issues|0|||
48977327|NCT03424044|157748062|FG005|First Intervention (76 Hours)|device issues|0|||
48977328|NCT03424044|157748063|FG006|First Intervention (76 Hours)|device issues|1|||
48977329|NCT03424044|157748064|FG007|First Intervention (76 Hours)|device issues|1|||
48977330|NCT03424044|157748065|FG008|First Intervention (76 Hours)|device issues|1|||
48977331|NCT03424044|157748057|FG000|Third Intervention (76 Hours)|Adverse Event|1|||
48977332|NCT03424044|157748058|FG001|Third Intervention (76 Hours)|Adverse Event|0|||
48977333|NCT03424044|157748059|FG002|Third Intervention (76 Hours)|Adverse Event|0|||
48977334|NCT03424044|157748060|FG003|Third Intervention (76 Hours)|Adverse Event|0|||
48977335|NCT03424044|157748061|FG004|Third Intervention (76 Hours)|Adverse Event|0|||
48977336|NCT03424044|157748062|FG005|Third Intervention (76 Hours)|Adverse Event|0|||
48977337|NCT03424044|157748063|FG006|Third Intervention (76 Hours)|Adverse Event|1|||
48762007|NCT01393405|156975738|FG002|Maintenance Period Week|Adverse Event|2|||
48762008|NCT01393405|156975736|FG000|Maintenance Period Week|Withdrawal by Subject|0|||
48762009|NCT01393405|156975737|FG001|Maintenance Period Week|Withdrawal by Subject|1|||
48977338|NCT03424044|157748064|FG007|Third Intervention (76 Hours)|Adverse Event|0|||
48977339|NCT03424044|157748065|FG008|Third Intervention (76 Hours)|Adverse Event|0|||
48977340|NCT03424044|157748057|FG000|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
48977341|NCT03424044|157748058|FG001|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
48977342|NCT03424044|157748059|FG002|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
48977343|NCT03424044|157748060|FG003|Third Intervention (76 Hours)|Withdrawal by Subject|1|||
48977344|NCT03424044|157748061|FG004|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
48977345|NCT03424044|157748062|FG005|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
48977346|NCT03424044|157748063|FG006|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
48977347|NCT03424044|157748064|FG007|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
48977348|NCT03424044|157748065|FG008|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
48977349|NCT00209092|157748069|FG000|Overall Study|Progression of disease|7|||
48977350|NCT00209092|157748070|FG001|Overall Study|Progression of disease|1|||
48977351|NCT00209092|157748069|FG000|Overall Study|Adverse Event|0|||
48977352|NCT00209092|157748070|FG001|Overall Study|Adverse Event|1|||
48977353|NCT00209092|157748069|FG000|Overall Study|Withdrawal by Subject|1|||
48977354|NCT00209092|157748070|FG001|Overall Study|Withdrawal by Subject|0|||
48977355|NCT00509028|157748071|FG000|Overall Study|Adverse Event|2|||
48977356|NCT00509028|157748072|FG001|Overall Study|Adverse Event|0|||
48977357|NCT00509028|157748071|FG000|Overall Study|Withdrawal by Subject|4|||
48977358|NCT00509028|157748072|FG001|Overall Study|Withdrawal by Subject|3|||
48977359|NCT00509028|157748071|FG000|Overall Study|Lost to Follow-up|0|||
48977360|NCT00509028|157748072|FG001|Overall Study|Lost to Follow-up|1|||
48977361|NCT00509028|157748071|FG000|Overall Study|Protocol Violation|4|||
48977362|NCT00509028|157748072|FG001|Overall Study|Protocol Violation|2|||
48977363|NCT00509028|157748071|FG000|Overall Study|Non-compliance|2|||
48977364|NCT00509028|157748072|FG001|Overall Study|Non-compliance|1|||
48977365|NCT02116361|157748074|FG000|Overall Study|Pregnancy|0|||
48977366|NCT02116361|157748075|FG001|Overall Study|Pregnancy|0|||
48977367|NCT02116361|157748076|FG002|Overall Study|Pregnancy|0|||
48977368|NCT02116361|157748077|FG003|Overall Study|Pregnancy|1|||
48977369|NCT02116361|157748074|FG000|Overall Study|Protocol Violation|1|||
48977370|NCT02116361|157748075|FG001|Overall Study|Protocol Violation|0|||
48977371|NCT02116361|157748076|FG002|Overall Study|Protocol Violation|0|||
48977372|NCT02116361|157748077|FG003|Overall Study|Protocol Violation|2|||
48977373|NCT02116361|157748074|FG000|Overall Study|Physician Decision|2|||
48977374|NCT02116361|157748075|FG001|Overall Study|Physician Decision|3|||
48977375|NCT02116361|157748076|FG002|Overall Study|Physician Decision|0|||
48977376|NCT02116361|157748077|FG003|Overall Study|Physician Decision|0|||
48977377|NCT02116361|157748074|FG000|Overall Study|Adverse Event|1|||
48977378|NCT02116361|157748075|FG001|Overall Study|Adverse Event|0|||
48977379|NCT02116361|157748076|FG002|Overall Study|Adverse Event|0|||
48977380|NCT02116361|157748077|FG003|Overall Study|Adverse Event|3|||
48977381|NCT02116361|157748074|FG000|Overall Study|Other Reasons|3|||
48977382|NCT02116361|157748075|FG001|Overall Study|Other Reasons|3|||
48977383|NCT02116361|157748076|FG002|Overall Study|Other Reasons|3|||
48977384|NCT02116361|157748077|FG003|Overall Study|Other Reasons|3|||
48977385|NCT02116361|157748074|FG000|Overall Study|Lack of Efficacy|5|||
48762010|NCT01393405|156975738|FG002|Maintenance Period Week|Withdrawal by Subject|0|||
48762011|NCT01393405|156975736|FG000|Maintenance Period Week|Lost to Follow-up|0|||
48762012|NCT01393405|156975737|FG001|Maintenance Period Week|Lost to Follow-up|1|||
48977386|NCT02116361|157748075|FG001|Overall Study|Lack of Efficacy|7|||
48977387|NCT02116361|157748076|FG002|Overall Study|Lack of Efficacy|4|||
48977388|NCT02116361|157748077|FG003|Overall Study|Lack of Efficacy|3|||
48977389|NCT02116361|157748074|FG000|Overall Study|Lost to Follow-up|4|||
48977390|NCT02116361|157748075|FG001|Overall Study|Lost to Follow-up|5|||
48977391|NCT02116361|157748076|FG002|Overall Study|Lost to Follow-up|7|||
48977392|NCT02116361|157748077|FG003|Overall Study|Lost to Follow-up|5|||
48977393|NCT02116361|157748074|FG000|Overall Study|Personal Reasons|6|||
48675619|NCT00615030|156665354|FG011|Period I|Administrative problem|0|||
48675620|NCT00615030|156665343|FG000|Period I|Protocol deviation|1|||
48675621|NCT00615030|156665344|FG001|Period I|Protocol deviation|0|||
48675622|NCT00615030|156665345|FG002|Period I|Protocol deviation|0|||
48675623|NCT00615030|156665346|FG003|Period I|Protocol deviation|0|||
48675624|NCT00615030|156665347|FG004|Period I|Protocol deviation|0|||
48675625|NCT00615030|156665348|FG005|Period I|Protocol deviation|0|||
48675626|NCT00615030|156665349|FG006|Period I|Protocol deviation|0|||
48675627|NCT00615030|156665350|FG007|Period I|Protocol deviation|0|||
48675628|NCT00615030|156665351|FG008|Period I|Protocol deviation|0|||
48675629|NCT00615030|156665352|FG009|Period I|Protocol deviation|0|||
48675630|NCT00615030|156665353|FG010|Period I|Protocol deviation|0|||
48675631|NCT00615030|156665354|FG011|Period I|Protocol deviation|0|||
48675632|NCT00615030|156665343|FG000|Period I|Subject withdrew consent|0|||
48675633|NCT00615030|156665344|FG001|Period I|Subject withdrew consent|0|||
48675634|NCT00615030|156665345|FG002|Period I|Subject withdrew consent|0|||
48675635|NCT00615030|156665346|FG003|Period I|Subject withdrew consent|0|||
48675636|NCT00615030|156665347|FG004|Period I|Subject withdrew consent|0|||
48675637|NCT00615030|156665348|FG005|Period I|Subject withdrew consent|0|||
48675638|NCT00615030|156665349|FG006|Period I|Subject withdrew consent|0|||
48675639|NCT00615030|156665350|FG007|Period I|Subject withdrew consent|0|||
48675640|NCT00615030|156665351|FG008|Period I|Subject withdrew consent|1|||
48675641|NCT00615030|156665352|FG009|Period I|Subject withdrew consent|0|||
48675642|NCT00615030|156665353|FG010|Period I|Subject withdrew consent|1|||
48675643|NCT00615030|156665354|FG011|Period I|Subject withdrew consent|1|||
48675644|NCT00615030|156665343|FG000|Period I|Abnormal laboratory value(s)|0|||
48675645|NCT00615030|156665344|FG001|Period I|Abnormal laboratory value(s)|0|||
48675646|NCT00615030|156665345|FG002|Period I|Abnormal laboratory value(s)|0|||
48675647|NCT00615030|156665346|FG003|Period I|Abnormal laboratory value(s)|0|||
48675648|NCT00615030|156665347|FG004|Period I|Abnormal laboratory value(s)|0|||
48675649|NCT00615030|156665348|FG005|Period I|Abnormal laboratory value(s)|1|||
48675650|NCT00615030|156665349|FG006|Period I|Abnormal laboratory value(s)|0|||
48675651|NCT00615030|156665350|FG007|Period I|Abnormal laboratory value(s)|0|||
48675652|NCT00615030|156665351|FG008|Period I|Abnormal laboratory value(s)|0|||
48675653|NCT00615030|156665352|FG009|Period I|Abnormal laboratory value(s)|0|||
48675654|NCT00615030|156665353|FG010|Period I|Abnormal laboratory value(s)|0|||
48675655|NCT00615030|156665354|FG011|Period I|Abnormal laboratory value(s)|0|||
48675656|NCT00615030|156665343|FG000|Period II|Adverse Event|0|||
48675657|NCT00615030|156665344|FG001|Period II|Adverse Event|0|||
48675658|NCT00615030|156665345|FG002|Period II|Adverse Event|1|||
48675659|NCT00615030|156665346|FG003|Period II|Adverse Event|0|||
48675660|NCT00615030|156665347|FG004|Period II|Adverse Event|0|||
48675661|NCT00615030|156665348|FG005|Period II|Adverse Event|0|||
48675662|NCT00615030|156665349|FG006|Period II|Adverse Event|0|||
48675663|NCT00615030|156665350|FG007|Period II|Adverse Event|0|||
48675664|NCT00615030|156665351|FG008|Period II|Adverse Event|1|||
48675665|NCT00615030|156665352|FG009|Period II|Adverse Event|0|||
48675666|NCT00615030|156665353|FG010|Period II|Adverse Event|0|||
48675667|NCT00615030|156665354|FG011|Period II|Adverse Event|0|||
48977394|NCT02116361|157748075|FG001|Overall Study|Personal Reasons|6|||
48977395|NCT02116361|157748076|FG002|Overall Study|Personal Reasons|4|||
48977396|NCT02116361|157748077|FG003|Overall Study|Personal Reasons|9|||
48977397|NCT02116361|157748074|FG000|Overall Study|Investigator Decision - Relapse|9|||
48977398|NCT02116361|157748075|FG001|Overall Study|Investigator Decision - Relapse|7|||
48977399|NCT02116361|157748076|FG002|Overall Study|Investigator Decision - Relapse|8|||
48977400|NCT02116361|157748077|FG003|Overall Study|Investigator Decision - Relapse|5|||
48977401|NCT00136357|157748078|FG000|Overall Study|Withdrawal by Subject|3|||
48977402|NCT00136357|157748079|FG001|Overall Study|Withdrawal by Subject|2|||
48675668|NCT00615030|156665343|FG000|Period II|Subject withdrew consent|0|||
48675669|NCT00615030|156665344|FG001|Period II|Subject withdrew consent|0|||
48874091|NCT01470599|157376933|FG001|Overall Study|Protocol Violation|1|||
48977403|NCT02025530|157748080|FG000|Overall Study|No longer met elligibility criteria|5|||
48977404|NCT02025530|157748081|FG001|Overall Study|No longer met elligibility criteria|1|||
48977405|NCT01355497|157748084|FG000|Overall Study|Death|19|||
48675670|NCT00615030|156665345|FG002|Period II|Subject withdrew consent|0|||
48675671|NCT00615030|156665346|FG003|Period II|Subject withdrew consent|1|||
48675672|NCT00615030|156665347|FG004|Period II|Subject withdrew consent|0|||
48675673|NCT00615030|156665348|FG005|Period II|Subject withdrew consent|0|||
48675674|NCT00615030|156665349|FG006|Period II|Subject withdrew consent|1|||
48675675|NCT00615030|156665350|FG007|Period II|Subject withdrew consent|0|||
48675676|NCT00615030|156665351|FG008|Period II|Subject withdrew consent|0|||
48675677|NCT00615030|156665352|FG009|Period II|Subject withdrew consent|0|||
48675678|NCT00615030|156665353|FG010|Period II|Subject withdrew consent|0|||
48675679|NCT00615030|156665354|FG011|Period II|Subject withdrew consent|0|||
48675680|NCT00615030|156665343|FG000|Period III|Administrative problems|1|||
48675681|NCT00615030|156665344|FG001|Period III|Administrative problems|0|||
48675682|NCT00615030|156665345|FG002|Period III|Administrative problems|0|||
48675683|NCT00615030|156665346|FG003|Period III|Administrative problems|1|||
48675684|NCT00615030|156665347|FG004|Period III|Administrative problems|0|||
48977406|NCT01355497|157748085|FG001|Overall Study|Death|18|||
48977407|NCT01355497|157748084|FG000|Overall Study|Lost to Follow-up|3|||
48977408|NCT01355497|157748085|FG001|Overall Study|Lost to Follow-up|0|||
48977409|NCT01355497|157748084|FG000|Overall Study|Protocol Violation|0|||
48977410|NCT01355497|157748085|FG001|Overall Study|Protocol Violation|1|||
48977411|NCT01355497|157748084|FG000|Overall Study|other-not provided|9|||
48977412|NCT01355497|157748085|FG001|Overall Study|other-not provided|4|||
48977413|NCT01355497|157748084|FG000|Overall Study|Withdrawal by Subject|12|||
48977414|NCT01355497|157748085|FG001|Overall Study|Withdrawal by Subject|20|||
48977415|NCT01355497|157748084|FG000|Overall Study|noncompliance|1|||
48977416|NCT01355497|157748085|FG001|Overall Study|noncompliance|2|||
48675685|NCT00615030|156665348|FG005|Period III|Administrative problems|0|||
48675686|NCT00615030|156665349|FG006|Period III|Administrative problems|0|||
48675687|NCT00615030|156665350|FG007|Period III|Administrative problems|0|||
48675688|NCT00615030|156665351|FG008|Period III|Administrative problems|0|||
48675689|NCT00615030|156665352|FG009|Period III|Administrative problems|0|||
48675690|NCT00615030|156665353|FG010|Period III|Administrative problems|0|||
48675691|NCT00615030|156665354|FG011|Period III|Administrative problems|0|||
48675692|NCT00151476|156665355|FG000|FAP Identified Subjects|Protocol Violation|0|||
48675693|NCT00151476|156665356|FG001|FAP Identified Subjects|Protocol Violation|1|||
48675694|NCT00151476|156665355|FG000|FAP Analyzed Subjects|Lost to Follow-up|0|||
48675695|NCT00151476|156665356|FG001|FAP Analyzed Subjects|Lost to Follow-up|2|||
48675696|NCT00151476|156665355|FG000|FAP Analyzed Subjects|Other study participation|0|||
48675697|NCT00151476|156665356|FG001|FAP Analyzed Subjects|Other study participation|1|||
48675698|NCT02708485|156665361|FG000|Overall Study|Withdrawal by Subject|3|||
48675699|NCT02708485|156665362|FG001|Overall Study|Withdrawal by Subject|2|||
48675700|NCT02479139|156665363|FG000|Overall Study|Lost to Follow-up|2|||
48675701|NCT02479139|156665364|FG001|Overall Study|Lost to Follow-up|4|||
48675702|NCT02479139|156665365|FG002|Overall Study|Lost to Follow-up|4|||
48675703|NCT02479139|156665366|FG003|Overall Study|Lost to Follow-up|2|||
48675704|NCT02479139|156665367|FG004|Overall Study|Lost to Follow-up|3|||
48675705|NCT02479139|156665368|FG005|Overall Study|Lost to Follow-up|5|||
48675706|NCT02479139|156665363|FG000|Overall Study|Withdrew Consent|5|||
48675707|NCT02479139|156665364|FG001|Overall Study|Withdrew Consent|6|||
48675708|NCT02479139|156665365|FG002|Overall Study|Withdrew Consent|1|||
48675709|NCT02479139|156665366|FG003|Overall Study|Withdrew Consent|4|||
48675710|NCT02479139|156665367|FG004|Overall Study|Withdrew Consent|1|||
48675711|NCT02479139|156665368|FG005|Overall Study|Withdrew Consent|1|||
48675712|NCT02479139|156665363|FG000|Overall Study|Treatment Failure/Lack of Efficacy|0|||
48675713|NCT02479139|156665364|FG001|Overall Study|Treatment Failure/Lack of Efficacy|0|||
48675714|NCT02479139|156665365|FG002|Overall Study|Treatment Failure/Lack of Efficacy|1|||
48675715|NCT02479139|156665366|FG003|Overall Study|Treatment Failure/Lack of Efficacy|0|||
48675716|NCT02479139|156665367|FG004|Overall Study|Treatment Failure/Lack of Efficacy|0|||
48977417|NCT01355497|157748084|FG000|Overall Study|progressive disease|11|||
48977418|NCT01355497|157748085|FG001|Overall Study|progressive disease|8|||
48977419|NCT01355497|157748084|FG000|Overall Study|Adverse Event|11|||
48977420|NCT01355497|157748085|FG001|Overall Study|Adverse Event|10|||
48977421|NCT00511108|157748086|FG000|Overall Study|Adverse Event|2|||
48977422|NCT00511108|157748087|FG001|Overall Study|Adverse Event|0|||
48977423|NCT00511108|157748088|FG002|Overall Study|Adverse Event|1|||
48977424|NCT00511108|157748089|FG003|Overall Study|Adverse Event|2|||
48977425|NCT00511108|157748086|FG000|Overall Study|Lost to Follow-up|0|||
48977426|NCT00511108|157748087|FG001|Overall Study|Lost to Follow-up|2|||
48977427|NCT00511108|157748088|FG002|Overall Study|Lost to Follow-up|1|||
48977428|NCT00511108|157748089|FG003|Overall Study|Lost to Follow-up|0|||
48977429|NCT00511108|157748086|FG000|Overall Study|Physician Decision|0|||
48977430|NCT00511108|157748087|FG001|Overall Study|Physician Decision|0|||
48977431|NCT00511108|157748088|FG002|Overall Study|Physician Decision|0|||
48977432|NCT00511108|157748089|FG003|Overall Study|Physician Decision|1|||
48675717|NCT02479139|156665368|FG005|Overall Study|Treatment Failure/Lack of Efficacy|0|||
48977433|NCT00511108|157748086|FG000|Overall Study|Withdrawal by Subject|4|||
48977434|NCT00511108|157748087|FG001|Overall Study|Withdrawal by Subject|0|||
48977435|NCT00511108|157748088|FG002|Overall Study|Withdrawal by Subject|3|||
48675718|NCT02479139|156665363|FG000|Overall Study|Other Miscellaneous Reasons|1|||
48675719|NCT02479139|156665364|FG001|Overall Study|Other Miscellaneous Reasons|0|||
48675720|NCT02479139|156665365|FG002|Overall Study|Other Miscellaneous Reasons|1|||
48675721|NCT02479139|156665366|FG003|Overall Study|Other Miscellaneous Reasons|1|||
48675722|NCT02479139|156665367|FG004|Overall Study|Other Miscellaneous Reasons|1|||
48675723|NCT02479139|156665368|FG005|Overall Study|Other Miscellaneous Reasons|0|||
48675724|NCT00764673|156665369|FG000|Overall Study|Death|1|||
48977436|NCT00511108|157748089|FG003|Overall Study|Withdrawal by Subject|2|||
48977437|NCT01678313|157748096|FG000|Completed the 3-month Therapy|Lost to Follow-up|3|||
48977438|NCT01678313|157748097|FG001|Completed the 3-month Therapy|Lost to Follow-up|8|||
48977439|NCT01678313|157748096|FG000|Completed the 3-month Therapy|Physician Decision|3|||
48977440|NCT01678313|157748097|FG001|Completed the 3-month Therapy|Physician Decision|4|||
48977441|NCT01678313|157748096|FG000|PSA >4 ng/dL at 3 Months|PSA≦4|8|||
48977442|NCT01678313|157748097|FG001|PSA >4 ng/dL at 3 Months|PSA≦4|9|||
48977443|NCT01678313|157748096|FG000|Prostate Biopsy at 3 Months|Not received prostate biopsy|11|||
48977444|NCT01678313|157748097|FG001|Prostate Biopsy at 3 Months|Not received prostate biopsy|12|||
48977445|NCT01266070|157748098|FG000|Overall Study|Adverse Event|3|||
48977446|NCT01266070|157748098|FG000|Overall Study|Protocol Violation|1|||
48977447|NCT03006926|157748099|FG000|Overall Study|Adverse Event|0|||
48977448|NCT03006926|157748100|FG001|Overall Study|Adverse Event|27|||
48977449|NCT03006926|157748099|FG000|Overall Study|Withdrawal by Subject|0|||
48977450|NCT03006926|157748100|FG001|Overall Study|Withdrawal by Subject|1|||
48977451|NCT03006926|157748099|FG000|Overall Study|Radiological Disease Progression|0|||
48977452|NCT03006926|157748100|FG001|Overall Study|Radiological Disease Progression|52|||
48977453|NCT03006926|157748099|FG000|Overall Study|Clinical Disease Progression|0|||
48977454|NCT03006926|157748100|FG001|Overall Study|Clinical Disease Progression|10|||
48977455|NCT03006926|157748099|FG000|Overall Study|Other|0|||
48977456|NCT03006926|157748100|FG001|Overall Study|Other|8|||
48977457|NCT02977507|157748103|FG000|Overall Study|Protocol Deviation|1|||
48977458|NCT02977507|157748104|FG001|Overall Study|Protocol Deviation|0|||
48977459|NCT02977507|157748103|FG000|Overall Study|Lost to Follow-up|1|||
48977460|NCT02977507|157748104|FG001|Overall Study|Lost to Follow-up|0|||
48977461|NCT02768103|157748106|FG000|Overall Study|1 participant did not fit in the fMRI|1|||
48977462|NCT00611767|157748131|FG000|Overall Study|Withdrawal by Subject|4|||
48977463|NCT00611767|157748132|FG001|Overall Study|Withdrawal by Subject|1|||
48977464|NCT00611767|157748131|FG000|Overall Study|Thiopental not available|3|||
48977465|NCT00611767|157748132|FG001|Overall Study|Thiopental not available|0|||
48977466|NCT00611767|157748131|FG000|Overall Study|didn't like the medication|1|||
48977467|NCT00611767|157748132|FG001|Overall Study|didn't like the medication|1|||
48977468|NCT00611767|157748131|FG000|Overall Study|Physician Decision|1|||
48977469|NCT00611767|157748132|FG001|Overall Study|Physician Decision|0|||
48977470|NCT04599972|157748134|FG000|Overall Study|Withdrawal by Subject|6|||
48977471|NCT04599972|157748135|FG001|Overall Study|Withdrawal by Subject|1|||
48977472|NCT04599972|157748134|FG000|Overall Study|Adverse Event|1|||
48977473|NCT04599972|157748135|FG001|Overall Study|Adverse Event|1|||
48977474|NCT04599972|157748134|FG000|Overall Study|Lost to Follow-up|1|||
48977475|NCT04599972|157748135|FG001|Overall Study|Lost to Follow-up|6|||
48977476|NCT04599972|157748134|FG000|Overall Study|Protocol Violation|1|||
48977477|NCT04599972|157748135|FG001|Overall Study|Protocol Violation|0|||
48977478|NCT04599972|157748134|FG000|Overall Study|Other reason|1|||
48977479|NCT04599972|157748135|FG001|Overall Study|Other reason|0|||
48977480|NCT03342404|157748136|FG000|Blinded Treatment Phase|Withdrawal by Subject|17|||
48977481|NCT03342404|157748137|FG001|Blinded Treatment Phase|Withdrawal by Subject|10|||
48977482|NCT03342404|157748136|FG000|Blinded Treatment Phase|Lack of Efficacy|2|||
48977483|NCT03342404|157748137|FG001|Blinded Treatment Phase|Lack of Efficacy|17|||
48977484|NCT03342404|157748136|FG000|Blinded Treatment Phase|Adverse Event|5|||
48977485|NCT03342404|157748137|FG001|Blinded Treatment Phase|Adverse Event|4|||
48977486|NCT03342404|157748136|FG000|Blinded Treatment Phase|Noncompliance with study drug|1|||
48977487|NCT03342404|157748137|FG001|Blinded Treatment Phase|Noncompliance with study drug|0|||
48977488|NCT03342404|157748136|FG000|Blinded Treatment Phase|Other reasons|1|||
48977489|NCT03342404|157748137|FG001|Blinded Treatment Phase|Other reasons|0|||
48977490|NCT03342404|157748136|FG000|Blinded Treatment Phase|Physician Decision|1|||
48675725|NCT00764673|156665369|FG000|Overall Study|Lost to Follow-up|3|||
48675726|NCT00764673|156665369|FG000|Overall Study|Withdrawal by Subject|6|||
48675727|NCT00764673|156665369|FG000|Overall Study|Revision of Device|2|||
48675728|NCT01727336|156665370|FG000|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
48675729|NCT01727336|156665371|FG001|Part 1 Dalantercept Dose Escalation|Adverse Event|1|||
48675730|NCT01727336|156665372|FG002|Part 1 Dalantercept Dose Escalation|Adverse Event|5|||
48675731|NCT01727336|156665373|FG003|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
48675732|NCT01727336|156665374|FG004|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
48675733|NCT01727336|156665375|FG005|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
48675734|NCT01727336|156665370|FG000|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
48675735|NCT01727336|156665371|FG001|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1|||
48675736|NCT01727336|156665372|FG002|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
48675737|NCT01727336|156665373|FG003|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
48977491|NCT03342404|157748137|FG001|Blinded Treatment Phase|Physician Decision|0|||
48675738|NCT01727336|156665374|FG004|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
48675739|NCT01727336|156665375|FG005|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
48675740|NCT01727336|156665370|FG000|Part 2 Blinded|Death|0|||
48977492|NCT03342404|157748136|FG000|Blinded Treatment Phase|Death|1|||
48977493|NCT03342404|157748137|FG001|Blinded Treatment Phase|Death|0|||
48977494|NCT03342404|157748136|FG000|Open-Label Phase|Lost to Follow-up|0|||
48977495|NCT03342404|157748137|FG001|Open-Label Phase|Lost to Follow-up|1|||
48977496|NCT03342404|157748136|FG000|Open-Label Phase|Other reasons|0|||
48977497|NCT03342404|157748137|FG001|Open-Label Phase|Other reasons|1|||
48977498|NCT03342404|157748136|FG000|Open-Label Phase|Adverse Event|0|||
48977499|NCT03342404|157748137|FG001|Open-Label Phase|Adverse Event|3|||
48977500|NCT03342404|157748136|FG000|Open-Label Phase|Withdrawal by Subject|0|||
48977501|NCT03342404|157748137|FG001|Open-Label Phase|Withdrawal by Subject|6|||
48977502|NCT02017704|157748138|FG000|Overall Study|Withdrawal by Subject|2|||
48977503|NCT02017704|157748139|FG001|Overall Study|Withdrawal by Subject|0|||
48977504|NCT03369704|157748140|FG000|Treatment Epoch|technical problems|1|||
48977505|NCT03369704|157748141|FG001|Treatment Epoch|technical problems|0|||
48977506|NCT03369704|157748140|FG000|Treatment Epoch|Protocol Violation|1|||
48977507|NCT03369704|157748141|FG001|Treatment Epoch|Protocol Violation|0|||
48977508|NCT03369704|157748140|FG000|Treatment Epoch|Lost to Follow-up|0|||
48977509|NCT03369704|157748141|FG001|Treatment Epoch|Lost to Follow-up|1|||
48977510|NCT03369704|157748140|FG000|Treatment Epoch|Lack of Efficacy|0|||
48977511|NCT03369704|157748141|FG001|Treatment Epoch|Lack of Efficacy|2|||
48977512|NCT03369704|157748140|FG000|Treatment Epoch|Adverse Event|2|||
48977513|NCT03369704|157748141|FG001|Treatment Epoch|Adverse Event|0|||
48977514|NCT03369704|157748140|FG000|Follow-up Epoch|Lost to Follow-up|1|||
48977515|NCT03369704|157748141|FG001|Follow-up Epoch|Lost to Follow-up|0|||
48977516|NCT01025232|157748142|FG000|Overall Study|Study drug no longer available|3|||
48977517|NCT01025232|157748143|FG001|Overall Study|Study drug no longer available|6|||
48977518|NCT00552344|157748145|FG000|Overall Study|Lack of Efficacy|55|||
48977519|NCT00552344|157748145|FG000|Overall Study|Loss of efficacy|75|||
48977520|NCT00552344|157748145|FG000|Overall Study|Lost to Follow-up|8|||
48977521|NCT00552344|157748145|FG000|Overall Study|Withdrawal by Subject|48|||
48977522|NCT00552344|157748145|FG000|Overall Study|SAE, non-fatal|6|||
48977523|NCT00552344|157748145|FG000|Overall Study|AE, non-serious non-fatal|38|||
48977524|NCT00552344|157748145|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62|||
48977525|NCT00552344|157748145|FG000|Overall Study|SAE, fatal + AE, non-serious non-fatal|1|||
48977526|NCT00552344|157748145|FG000|Overall Study|Other Reason|22|||
48977527|NCT01055457|157748146|FG000|Overall Study|Lost to Follow-up|0|||
48977528|NCT01055457|157748147|FG001|Overall Study|Lost to Follow-up|1|||
48977529|NCT01055457|157748148|FG002|Overall Study|Lost to Follow-up|0|||
48977530|NCT01055457|157748149|FG003|Overall Study|Lost to Follow-up|0|||
48977531|NCT01055457|157748150|FG004|Overall Study|Lost to Follow-up|0|||
48977532|NCT01055457|157748151|FG005|Overall Study|Lost to Follow-up|1|||
48977533|NCT01055457|157748152|FG006|Overall Study|Lost to Follow-up|0|||
48977534|NCT01055457|157748153|FG007|Overall Study|Lost to Follow-up|0|||
48977535|NCT01055457|157748154|FG008|Overall Study|Lost to Follow-up|0|||
48977536|NCT01055457|157748155|FG009|Overall Study|Lost to Follow-up|0|||
48977537|NCT01055457|157748146|FG000|Overall Study|Protocol Violation|0|||
48977538|NCT01055457|157748147|FG001|Overall Study|Protocol Violation|0|||
48977539|NCT01055457|157748148|FG002|Overall Study|Protocol Violation|1|||
48977540|NCT01055457|157748149|FG003|Overall Study|Protocol Violation|1|||
48977541|NCT01055457|157748150|FG004|Overall Study|Protocol Violation|1|||
48977542|NCT01055457|157748151|FG005|Overall Study|Protocol Violation|2|||
48977543|NCT01055457|157748152|FG006|Overall Study|Protocol Violation|1|||
48977544|NCT01055457|157748153|FG007|Overall Study|Protocol Violation|0|||
48977545|NCT01055457|157748154|FG008|Overall Study|Protocol Violation|0|||
48977546|NCT01055457|157748155|FG009|Overall Study|Protocol Violation|1|||
48977547|NCT01055457|157748146|FG000|Overall Study|Subject Disinterest|0|||
48977548|NCT01055457|157748147|FG001|Overall Study|Subject Disinterest|0|||
48977549|NCT01055457|157748148|FG002|Overall Study|Subject Disinterest|0|||
48977550|NCT01055457|157748149|FG003|Overall Study|Subject Disinterest|0|||
48977551|NCT01055457|157748150|FG004|Overall Study|Subject Disinterest|0|||
48977552|NCT01055457|157748151|FG005|Overall Study|Subject Disinterest|0|||
48977553|NCT01055457|157748152|FG006|Overall Study|Subject Disinterest|0|||
48977554|NCT01055457|157748153|FG007|Overall Study|Subject Disinterest|1|||
48977555|NCT01055457|157748154|FG008|Overall Study|Subject Disinterest|0|||
48675741|NCT01727336|156665371|FG001|Part 2 Blinded|Death|0|||
48675742|NCT01727336|156665372|FG002|Part 2 Blinded|Death|0|||
48675743|NCT01727336|156665373|FG003|Part 2 Blinded|Death|0|||
48675744|NCT01727336|156665374|FG004|Part 2 Blinded|Death|20|||
48874092|NCT01470599|157376932|FG000|Overall Study|Adverse event related to study drug|2|||
48874093|NCT01470599|157376933|FG001|Overall Study|Adverse event related to study drug|5|||
48874094|NCT01470599|157376932|FG000|Overall Study|Insufficient clinical response|6|||
48977556|NCT01055457|157748155|FG009|Overall Study|Subject Disinterest|0|||
48977557|NCT01055457|157748146|FG000|Overall Study|Subject Ineligible|1|||
48977558|NCT01055457|157748147|FG001|Overall Study|Subject Ineligible|0|||
48977559|NCT01055457|157748148|FG002|Overall Study|Subject Ineligible|1|||
48977560|NCT01055457|157748149|FG003|Overall Study|Subject Ineligible|0|||
48977561|NCT01055457|157748150|FG004|Overall Study|Subject Ineligible|1|||
48977562|NCT01055457|157748151|FG005|Overall Study|Subject Ineligible|0|||
48977563|NCT01055457|157748152|FG006|Overall Study|Subject Ineligible|0|||
48977564|NCT01055457|157748153|FG007|Overall Study|Subject Ineligible|0|||
48977565|NCT01055457|157748154|FG008|Overall Study|Subject Ineligible|0|||
48977566|NCT01055457|157748155|FG009|Overall Study|Subject Ineligible|0|||
48977567|NCT01055457|157748146|FG000|Overall Study|Discomfort|0|||
48977568|NCT01055457|157748147|FG001|Overall Study|Discomfort|0|||
48977569|NCT01055457|157748148|FG002|Overall Study|Discomfort|0|||
48977570|NCT01055457|157748149|FG003|Overall Study|Discomfort|0|||
48675745|NCT01727336|156665375|FG005|Part 2 Blinded|Death|16|||
48977571|NCT01055457|157748150|FG004|Overall Study|Discomfort|1|||
48977572|NCT01055457|157748151|FG005|Overall Study|Discomfort|0|||
48977573|NCT01055457|157748152|FG006|Overall Study|Discomfort|0|||
48675746|NCT01727336|156665370|FG000|Part 2 Blinded|Lack of Efficacy|0|||
48675747|NCT01727336|156665371|FG001|Part 2 Blinded|Lack of Efficacy|0|||
48874095|NCT01470599|157376933|FG001|Overall Study|Insufficient clinical response|27|||
48874096|NCT01470599|157376932|FG000|Overall Study|Adverse event not related to study drug|1|||
48874097|NCT01470599|157376933|FG001|Overall Study|Adverse event not related to study drug|5|||
48874098|NCT00847132|157376934|FG000|Overall Study|Death|1|||
48874099|NCT00847132|157376935|FG001|Overall Study|Death|1|||
48874100|NCT04014790|157376938|FG000|Overall Study|Death|4|||
48874101|NCT04014790|157376938|FG000|Overall Study|Adverse Event|1|||
48874102|NCT04014790|157376938|FG000|Overall Study|Withdrawal by Subject|1|||
48874103|NCT02509312|157376942|FG000|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|5|||
48874104|NCT02509312|157376943|FG001|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|3|||
48874105|NCT02509312|157376942|FG000|Overall Study|Obstetrician refusal|0|||
48874106|NCT02509312|157376943|FG001|Overall Study|Obstetrician refusal|1|||
48874107|NCT02509312|157376942|FG000|Overall Study|Patient elected for TOLAC|1|||
48874108|NCT02509312|157376943|FG001|Overall Study|Patient elected for TOLAC|0|||
48874109|NCT02509312|157376942|FG000|Overall Study|Cesarean deemed stat|1|||
48874110|NCT02509312|157376943|FG001|Overall Study|Cesarean deemed stat|0|||
48874111|NCT02509312|157376942|FG000|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|0|||
48874112|NCT02509312|157376943|FG001|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|1|||
48874113|NCT01547117|157376952|FG000|Overall Study|Physician Decision|0|||
48874114|NCT01547117|157376953|FG001|Overall Study|Physician Decision|1|||
48874115|NCT01547117|157376954|FG002|Overall Study|Physician Decision|1|||
48874116|NCT01547117|157376955|FG003|Overall Study|Physician Decision|3|||
48874117|NCT01547117|157376952|FG000|Overall Study|Withdrawal by Subject|1|||
48874118|NCT01547117|157376953|FG001|Overall Study|Withdrawal by Subject|2|||
48874119|NCT01547117|157376954|FG002|Overall Study|Withdrawal by Subject|1|||
48874120|NCT01547117|157376955|FG003|Overall Study|Withdrawal by Subject|2|||
48874121|NCT00943722|157376961|FG000|Base Study|Adverse Event|0|||
48874122|NCT00943722|157376962|FG001|Base Study|Adverse Event|0|||
48874123|NCT00943722|157376963|FG002|Base Study|Adverse Event|0|||
48874124|NCT00943722|157376964|FG003|Base Study|Adverse Event|1|||
48874125|NCT00943722|157376965|FG004|Base Study|Adverse Event|0|||
48874126|NCT00943722|157376966|FG005|Base Study|Adverse Event|0|||
48874127|NCT00943722|157376967|FG006|Base Study|Adverse Event|0|||
48874128|NCT00943722|157376961|FG000|Base Study|Lost to Follow-up|12|||
48874129|NCT00943722|157376962|FG001|Base Study|Lost to Follow-up|8|||
48874130|NCT00943722|157376963|FG002|Base Study|Lost to Follow-up|10|||
48874131|NCT00943722|157376964|FG003|Base Study|Lost to Follow-up|8|||
48874132|NCT00943722|157376965|FG004|Base Study|Lost to Follow-up|11|||
48874133|NCT00943722|157376966|FG005|Base Study|Lost to Follow-up|0|||
48874134|NCT00943722|157376967|FG006|Base Study|Lost to Follow-up|0|||
48874135|NCT00943722|157376961|FG000|Base Study|Physician Decision|1|||
48874136|NCT00943722|157376962|FG001|Base Study|Physician Decision|0|||
48874137|NCT00943722|157376963|FG002|Base Study|Physician Decision|0|||
48874138|NCT00943722|157376964|FG003|Base Study|Physician Decision|0|||
48874139|NCT00943722|157376965|FG004|Base Study|Physician Decision|1|||
48874140|NCT00943722|157376966|FG005|Base Study|Physician Decision|0|||
48874141|NCT00943722|157376967|FG006|Base Study|Physician Decision|0|||
48874142|NCT00943722|157376961|FG000|Base Study|Pregnancy|0|||
48874143|NCT00943722|157376962|FG001|Base Study|Pregnancy|0|||
48874144|NCT00943722|157376963|FG002|Base Study|Pregnancy|1|||
48874145|NCT00943722|157376964|FG003|Base Study|Pregnancy|0|||
48874146|NCT00943722|157376965|FG004|Base Study|Pregnancy|2|||
48874147|NCT00943722|157376966|FG005|Base Study|Pregnancy|0|||
48874148|NCT00943722|157376967|FG006|Base Study|Pregnancy|0|||
48874149|NCT00943722|157376961|FG000|Base Study|Protocol Violation|0|||
48874150|NCT00943722|157376962|FG001|Base Study|Protocol Violation|1|||
48977574|NCT01055457|157748153|FG007|Overall Study|Discomfort|0|||
48874151|NCT00943722|157376963|FG002|Base Study|Protocol Violation|0|||
48874152|NCT00943722|157376964|FG003|Base Study|Protocol Violation|0|||
48874153|NCT00943722|157376965|FG004|Base Study|Protocol Violation|2|||
48874154|NCT00943722|157376966|FG005|Base Study|Protocol Violation|0|||
48977575|NCT01055457|157748154|FG008|Overall Study|Discomfort|0|||
48977576|NCT01055457|157748155|FG009|Overall Study|Discomfort|0|||
48675748|NCT01727336|156665372|FG002|Part 2 Blinded|Lack of Efficacy|0|||
48675749|NCT01727336|156665373|FG003|Part 2 Blinded|Lack of Efficacy|0|||
48874155|NCT00943722|157376967|FG006|Base Study|Protocol Violation|0|||
48874156|NCT00943722|157376961|FG000|Base Study|Withdrawal by Subject|12|||
48874157|NCT00943722|157376962|FG001|Base Study|Withdrawal by Subject|13|||
48874158|NCT00943722|157376963|FG002|Base Study|Withdrawal by Subject|2|||
48874159|NCT00943722|157376964|FG003|Base Study|Withdrawal by Subject|13|||
48977577|NCT01055457|157748146|FG000|Overall Study|Pregnancy|0|||
48874160|NCT00943722|157376965|FG004|Base Study|Withdrawal by Subject|8|||
48874161|NCT00943722|157376966|FG005|Base Study|Withdrawal by Subject|0|||
48874162|NCT00943722|157376967|FG006|Base Study|Withdrawal by Subject|0|||
48675750|NCT01727336|156665374|FG004|Part 2 Blinded|Lack of Efficacy|42|||
48874163|NCT00943722|157376961|FG000|Base Study|Month 12 visit not completed|0|||
48977578|NCT01055457|157748147|FG001|Overall Study|Pregnancy|0|||
48977579|NCT01055457|157748148|FG002|Overall Study|Pregnancy|0|||
48977580|NCT01055457|157748149|FG003|Overall Study|Pregnancy|1|||
48977581|NCT01055457|157748150|FG004|Overall Study|Pregnancy|0|||
48977582|NCT01055457|157748151|FG005|Overall Study|Pregnancy|0|||
48977583|NCT01055457|157748152|FG006|Overall Study|Pregnancy|0|||
48977584|NCT01055457|157748153|FG007|Overall Study|Pregnancy|0|||
48977585|NCT01055457|157748154|FG008|Overall Study|Pregnancy|0|||
48977586|NCT01055457|157748155|FG009|Overall Study|Pregnancy|0|||
48977587|NCT01055457|157748146|FG000|Overall Study|Adverse Event|0|||
48977588|NCT01055457|157748147|FG001|Overall Study|Adverse Event|0|||
48977589|NCT01055457|157748148|FG002|Overall Study|Adverse Event|0|||
48977590|NCT01055457|157748149|FG003|Overall Study|Adverse Event|1|||
48977591|NCT01055457|157748150|FG004|Overall Study|Adverse Event|0|||
48977592|NCT01055457|157748151|FG005|Overall Study|Adverse Event|0|||
48977593|NCT01055457|157748152|FG006|Overall Study|Adverse Event|0|||
48977594|NCT01055457|157748153|FG007|Overall Study|Adverse Event|0|||
48977595|NCT01055457|157748154|FG008|Overall Study|Adverse Event|0|||
48977596|NCT01055457|157748155|FG009|Overall Study|Adverse Event|0|||
48977597|NCT04055844|157748156|FG000|Overall Study|Adverse Event|12|||
48977598|NCT04055844|157748156|FG000|Overall Study|Poor Performance|1|||
48977599|NCT04055844|157748156|FG000|Overall Study|Death|1|||
48977600|NCT01039428|157748161|FG000|Overall Study|Protocol Violation|1|||
48977601|NCT01039428|157748162|FG001|Overall Study|Protocol Violation|0|||
48977602|NCT01039428|157748161|FG000|Overall Study|Withdrawal by Subject|1|||
48977603|NCT01039428|157748162|FG001|Overall Study|Withdrawal by Subject|0|||
48977604|NCT01313039|157748163|FG000|Overall Study|Physician Decision|1|||
48977605|NCT01313039|157748163|FG000|Overall Study|Adverse Event|1|||
48977606|NCT00981682|157748168|FG000|Overall Study|Adverse Event|48|||
48977607|NCT00981682|157748168|FG000|Overall Study|Withdrawal by Subject|52|||
48977608|NCT00981682|157748168|FG000|Overall Study|Lost to Follow-up|14|||
48977609|NCT00981682|157748168|FG000|Overall Study|Lack of Efficacy|13|||
48977610|NCT00981682|157748168|FG000|Overall Study|Protocol Violation|6|||
48977611|NCT00981682|157748168|FG000|Overall Study|administrative|9|||
48977612|NCT01922739|157748169|FG000|Titration/Adjustment Period|Adverse Event|3|||
48977613|NCT01922739|157748169|FG000|Titration/Adjustment Period|Withdrawal by Subject|5|||
48977614|NCT01922739|157748169|FG000|Titration/Adjustment Period|Lost to Follow-up|1|||
48977615|NCT01922739|157748169|FG000|Titration/Adjustment Period|Lack of Efficacy|3|||
48977616|NCT01922739|157748169|FG000|Open-label Treatment Period|Adverse Event|6|||
48977617|NCT01922739|157748169|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
48977618|NCT01922739|157748169|FG000|Open-label Treatment Period|Noncompliance to study medication|3|||
48977619|NCT01922739|157748169|FG000|Open-label Treatment Period|Protocol Violation|5|||
48977620|NCT01922739|157748169|FG000|Open-label Treatment Period|Pregnancy|1|||
48977621|NCT01922739|157748169|FG000|Open-label Treatment Period|Noncompliance to study procedures|1|||
48977622|NCT01922739|157748169|FG000|Open-label Treatment Period|Lost to Follow-up|2|||
48977623|NCT01922739|157748169|FG000|Open-label Treatment Period|Physician Decision|1|||
48977624|NCT01922739|157748169|FG000|Open-label Treatment Period|Sponsor request - investigator leaving|1|||
48977625|NCT00044213|157748170|FG000|Overall Study|Withdrawal by Subject|50|||
48977626|NCT00044213|157748171|FG001|Overall Study|Withdrawal by Subject|65|||
48977627|NCT00044213|157748172|FG002|Overall Study|Withdrawal by Subject|91|||
48977628|NCT00044213|157748173|FG003|Overall Study|Withdrawal by Subject|83|||
48977629|NCT00044213|157748170|FG000|Overall Study|Death|42|||
48977630|NCT00044213|157748171|FG001|Overall Study|Death|42|||
48977631|NCT00044213|157748172|FG002|Overall Study|Death|42|||
48977632|NCT00044213|157748173|FG003|Overall Study|Death|49|||
48977633|NCT00044213|157748170|FG000|Overall Study|Lost to Follow-up|8|||
48977634|NCT00044213|157748171|FG001|Overall Study|Lost to Follow-up|5|||
48977635|NCT00044213|157748172|FG002|Overall Study|Lost to Follow-up|5|||
48977636|NCT00044213|157748173|FG003|Overall Study|Lost to Follow-up|4|||
48977637|NCT03399786|157748181|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
48977638|NCT03399786|157748182|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
48977639|NCT03399786|157748183|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
48977640|NCT03399786|157748184|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
48977641|NCT03399786|157748181|FG000|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
48977642|NCT03399786|157748182|FG001|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
48977643|NCT03399786|157748183|FG002|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1|||
48977644|NCT03399786|157748184|FG003|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
48977645|NCT03399786|157748181|FG000|Open-label Treatment Period (OLTP)|Pregnancy|0|||
48977646|NCT03399786|157748182|FG001|Open-label Treatment Period (OLTP)|Pregnancy|0|||
48977647|NCT03399786|157748183|FG002|Open-label Treatment Period (OLTP)|Pregnancy|0|||
48977648|NCT03399786|157748184|FG003|Open-label Treatment Period (OLTP)|Pregnancy|1|||
48977649|NCT03964493|157748185|FG000|Overall Study|Withdrawal by Subject|4|||
48977650|NCT03964493|157748186|FG001|Overall Study|Withdrawal by Subject|1|||
48675751|NCT01727336|156665375|FG005|Part 2 Blinded|Lack of Efficacy|44|||
48675752|NCT01727336|156665370|FG000|Part 2 Blinded|Lost to Follow-up|0|||
48675753|NCT01727336|156665371|FG001|Part 2 Blinded|Lost to Follow-up|0|||
48675754|NCT01727336|156665372|FG002|Part 2 Blinded|Lost to Follow-up|0|||
48977651|NCT03964493|157748185|FG000|Overall Study|Lost to Follow-up|13|||
48977652|NCT03964493|157748186|FG001|Overall Study|Lost to Follow-up|4|||
48977653|NCT01607073|157748189|FG000|Overall Study|Adverse Event|1|||
48977654|NCT00741260|157748190|FG000|Overall Study|Disease Progression|3|||
48977655|NCT00741260|157748191|FG001|Overall Study|Disease Progression|5|||
48977656|NCT00741260|157748192|FG002|Overall Study|Disease Progression|3|||
48977657|NCT00741260|157748193|FG003|Overall Study|Disease Progression|3|||
48977658|NCT00741260|157748194|FG004|Overall Study|Disease Progression|5|||
48977659|NCT00741260|157748195|FG005|Overall Study|Disease Progression|37|||
48977660|NCT00741260|157748196|FG006|Overall Study|Disease Progression|4|||
48977661|NCT00741260|157748190|FG000|Overall Study|Death|0|||
48977662|NCT00741260|157748191|FG001|Overall Study|Death|1|||
48977663|NCT00741260|157748192|FG002|Overall Study|Death|0|||
48977664|NCT00741260|157748193|FG003|Overall Study|Death|1|||
48977665|NCT00741260|157748194|FG004|Overall Study|Death|2|||
48977666|NCT00741260|157748195|FG005|Overall Study|Death|2|||
48977667|NCT00741260|157748196|FG006|Overall Study|Death|1|||
48977668|NCT00741260|157748190|FG000|Overall Study|Withdrawal by Subject|0|||
48977669|NCT00741260|157748191|FG001|Overall Study|Withdrawal by Subject|0|||
48977670|NCT00741260|157748192|FG002|Overall Study|Withdrawal by Subject|0|||
48977671|NCT00741260|157748193|FG003|Overall Study|Withdrawal by Subject|0|||
48977672|NCT00741260|157748194|FG004|Overall Study|Withdrawal by Subject|1|||
48977673|NCT00741260|157748195|FG005|Overall Study|Withdrawal by Subject|3|||
48977674|NCT00741260|157748196|FG006|Overall Study|Withdrawal by Subject|1|||
48977675|NCT00741260|157748190|FG000|Overall Study|Physician Decision|1|||
48977676|NCT00741260|157748191|FG001|Overall Study|Physician Decision|1|||
48977677|NCT00741260|157748192|FG002|Overall Study|Physician Decision|0|||
48977678|NCT00741260|157748193|FG003|Overall Study|Physician Decision|0|||
48977679|NCT00741260|157748194|FG004|Overall Study|Physician Decision|0|||
48977680|NCT00741260|157748195|FG005|Overall Study|Physician Decision|0|||
48977681|NCT00741260|157748196|FG006|Overall Study|Physician Decision|0|||
48977682|NCT00741260|157748190|FG000|Overall Study|Other|2|||
48977683|NCT00741260|157748191|FG001|Overall Study|Other|1|||
48977684|NCT00741260|157748192|FG002|Overall Study|Other|1|||
48977685|NCT00741260|157748193|FG003|Overall Study|Other|2|||
48977686|NCT00741260|157748194|FG004|Overall Study|Other|1|||
48977687|NCT00741260|157748195|FG005|Overall Study|Other|3|||
48977688|NCT00741260|157748196|FG006|Overall Study|Other|1|||
48977689|NCT02470429|157748197|FG000|Overall Study|Adverse Event|1|||
48977690|NCT02470429|157748198|FG001|Overall Study|Adverse Event|0|||
48977691|NCT02470429|157748197|FG000|Overall Study|Withdrawal by Subject|1|||
48977692|NCT02470429|157748198|FG001|Overall Study|Withdrawal by Subject|0|||
48977693|NCT02224274|157748205|FG000|Overall Study|Death|1|||
48977694|NCT02224274|157748206|FG001|Overall Study|Death|0|||
48977695|NCT00499460|157748207|FG000|Intervention 1 (30 Days)|Withdrawal by Subject|1|||
48977696|NCT00499460|157748208|FG001|Intervention 1 (30 Days)|Withdrawal by Subject|0|||
48977697|NCT00499460|157748207|FG000|Intervention 1 (30 Days)|Fainting upon Blood Draw|1|||
48977698|NCT00499460|157748208|FG001|Intervention 1 (30 Days)|Fainting upon Blood Draw|0|||
48977699|NCT00499460|157748207|FG000|Intervention 2 (30 Days)|Withdrawal by Subject|0|||
48977700|NCT00499460|157748208|FG001|Intervention 2 (30 Days)|Withdrawal by Subject|1|||
48977701|NCT01305941|157750074|FG000|Overall Study|Adverse Event|6|||
48977702|NCT01305941|157750074|FG000|Overall Study|Clinical decline|2|||
48977703|NCT01305941|157750074|FG000|Overall Study|Withdrawal by Subject|1|||
48977704|NCT01305941|157750074|FG000|Overall Study|Death|1|||
48977705|NCT01690988|157750075|FG000|Overall Study|Withdrawal by Subject|2|||
48977706|NCT01690988|157750076|FG001|Overall Study|Withdrawal by Subject|2|||
48977707|NCT01690988|157750077|FG002|Overall Study|Withdrawal by Subject|3|||
48977708|NCT01690988|157750075|FG000|Overall Study|Physician Decision|0|||
48977709|NCT01690988|157750076|FG001|Overall Study|Physician Decision|0|||
48977710|NCT01690988|157750077|FG002|Overall Study|Physician Decision|1|||
48977711|NCT01690988|157750075|FG000|Overall Study|Operation Cancelled|1|||
48977712|NCT01690988|157750076|FG001|Overall Study|Operation Cancelled|1|||
48977713|NCT01690988|157750077|FG002|Overall Study|Operation Cancelled|0|||
48977714|NCT01690988|157750075|FG000|Overall Study|Determined ineligible|1|||
48977715|NCT01690988|157750076|FG001|Overall Study|Determined ineligible|0|||
48977716|NCT01690988|157750077|FG002|Overall Study|Determined ineligible|0|||
48977717|NCT01690988|157750075|FG000|Overall Study|Death|1|||
48977718|NCT01690988|157750076|FG001|Overall Study|Death|1|||
48977719|NCT01690988|157750077|FG002|Overall Study|Death|1|||
48977720|NCT01690988|157750075|FG000|Overall Study|Sedated|1|||
48977721|NCT01690988|157750076|FG001|Overall Study|Sedated|1|||
48977722|NCT01690988|157750077|FG002|Overall Study|Sedated|2|||
48977723|NCT02971007|157750078|FG000|Overall Study|Adverse Event|1|||
48977724|NCT02971007|157750079|FG001|Overall Study|Adverse Event|0|||
48977725|NCT02971007|157750080|FG002|Overall Study|Adverse Event|0|||
48977726|NCT02971007|157750078|FG000|Overall Study|Lost to Follow-up|0|||
48977727|NCT02971007|157750079|FG001|Overall Study|Lost to Follow-up|1|||
48977728|NCT02971007|157750080|FG002|Overall Study|Lost to Follow-up|1|||
48977729|NCT02971007|157750078|FG000|Overall Study|Withdrawal by Subject|0|||
48977730|NCT02971007|157750079|FG001|Overall Study|Withdrawal by Subject|1|||
48977731|NCT02971007|157750080|FG002|Overall Study|Withdrawal by Subject|0|||
48977732|NCT02971007|157750078|FG000|Overall Study|Patient had yeast at Day 5 visit|1|||
48977733|NCT02971007|157750079|FG001|Overall Study|Patient had yeast at Day 5 visit|0|||
48977734|NCT02971007|157750080|FG002|Overall Study|Patient had yeast at Day 5 visit|0|||
48977735|NCT02971007|157750078|FG000|Overall Study|Patient discontinued study drug|0|||
48977736|NCT02971007|157750079|FG001|Overall Study|Patient discontinued study drug|1|||
48977737|NCT02971007|157750080|FG002|Overall Study|Patient discontinued study drug|0|||
48977738|NCT00688623|157750083|FG000|Overall Study|Adverse Event|22|||
48977739|NCT00688623|157750083|FG000|Overall Study|abnormal lab value|1|||
48977740|NCT00688623|157750083|FG000|Overall Study|Withdrawal by Subject|4|||
48977741|NCT00688623|157750083|FG000|Overall Study|Death|3|||
48977742|NCT00688623|157750083|FG000|Overall Study|disease progression|23|||
48977743|NCT00688623|157750083|FG000|Overall Study|Protocol Violation|2|||
48977744|NCT02443155|157750084|FG000|Overall Study|Adverse Event|3|||
48977745|NCT02443155|157750085|FG001|Overall Study|Adverse Event|4|||
48977746|NCT02443155|157750086|FG002|Overall Study|Adverse Event|1|||
48977747|NCT02443155|157750087|FG003|Overall Study|Adverse Event|2|||
48977748|NCT02443155|157750084|FG000|Overall Study|Unclassified|0|||
48977749|NCT02443155|157750085|FG001|Overall Study|Unclassified|0|||
48977750|NCT02443155|157750086|FG002|Overall Study|Unclassified|2|||
48977751|NCT02443155|157750087|FG003|Overall Study|Unclassified|1|||
48977752|NCT02443155|157750084|FG000|Overall Study|Withdrawal by Subject|4|||
48977753|NCT02443155|157750085|FG001|Overall Study|Withdrawal by Subject|7|||
48977754|NCT02443155|157750086|FG002|Overall Study|Withdrawal by Subject|3|||
48977755|NCT02443155|157750087|FG003|Overall Study|Withdrawal by Subject|9|||
48977756|NCT02443155|157750084|FG000|Overall Study|Pregnancy|3|||
48977757|NCT02443155|157750085|FG001|Overall Study|Pregnancy|1|||
48977758|NCT02443155|157750086|FG002|Overall Study|Pregnancy|1|||
48977759|NCT02443155|157750087|FG003|Overall Study|Pregnancy|2|||
48977760|NCT02443155|157750084|FG000|Overall Study|Lost to Follow-up|1|||
48977761|NCT02443155|157750085|FG001|Overall Study|Lost to Follow-up|2|||
48977762|NCT02443155|157750086|FG002|Overall Study|Lost to Follow-up|0|||
48977763|NCT02443155|157750087|FG003|Overall Study|Lost to Follow-up|1|||
48977764|NCT02443155|157750084|FG000|Overall Study|Protocol Violation|1|||
48977765|NCT02443155|157750085|FG001|Overall Study|Protocol Violation|0|||
48977766|NCT02443155|157750086|FG002|Overall Study|Protocol Violation|1|||
48977767|NCT02443155|157750087|FG003|Overall Study|Protocol Violation|1|||
48977768|NCT02443155|157750084|FG000|Overall Study|Death|0|||
48977769|NCT02443155|157750085|FG001|Overall Study|Death|0|||
48977770|NCT02443155|157750086|FG002|Overall Study|Death|1|||
48977771|NCT02443155|157750087|FG003|Overall Study|Death|0|||
48977772|NCT01376388|157750089|FG000|Overall Study|Adverse Event|13|||
48977773|NCT01376388|157750089|FG000|Overall Study|Lack of Efficacy|2|||
48977774|NCT01376388|157750089|FG000|Overall Study|Withdrawal by Subject|3|||
48977775|NCT02853123|157750090|FG000|Treatment Period 1|Adverse Event|0|||
48977776|NCT02853123|157750091|FG001|Treatment Period 1|Adverse Event|3|||
48977777|NCT02853123|157750090|FG000|Washout Period|Worsening of COPD|0|||
48977778|NCT02853123|157750091|FG001|Washout Period|Worsening of COPD|3|||
48977779|NCT02853123|157750090|FG000|Washout Period|Adverse Event|1|||
48977780|NCT02853123|157750091|FG001|Washout Period|Adverse Event|0|||
48977781|NCT00063986|157750092|FG000|Overall Study|Withdrawal by Subject|1|||
48977782|NCT00063986|157750092|FG000|Overall Study|Ineligible|1|||
48977783|NCT00063986|157750092|FG000|Overall Study|Intra-operatively ineligible|4|||
48977784|NCT01462045|157750095|FG000|Overall Study|Family matter|0|||
48977785|NCT01462045|157750096|FG001|Overall Study|Family matter|1|||
48977786|NCT01462045|157750097|FG002|Overall Study|Family matter|0|||
48977787|NCT05283499|157750103|FG000|Overall Study|Did not receive intervention|1|||
48977788|NCT05283499|157750104|FG001|Overall Study|Did not receive intervention|2|||
48977789|NCT02408484|157750105|FG000|Overall Study|Withdrawal by Subject|3|||
48977790|NCT02408484|157750105|FG000|Overall Study|Not treated during study period|1|||
48977791|NCT01237223|157750108|FG000|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29|||
48977792|NCT01237223|157750109|FG001|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
48977793|NCT01237223|157750110|FG002|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
48675755|NCT01727336|156665373|FG003|Part 2 Blinded|Lost to Follow-up|0|||
48977794|NCT01237223|157750111|FG003|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
48977795|NCT01237223|157750112|FG004|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
48977796|NCT01237223|157750113|FG005|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
48977797|NCT01237223|157750108|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25|||
48977798|NCT01237223|157750109|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
48977799|NCT01237223|157750110|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
48675756|NCT01727336|156665374|FG004|Part 2 Blinded|Lost to Follow-up|0|||
48675757|NCT01727336|156665375|FG005|Part 2 Blinded|Lost to Follow-up|1|||
48675758|NCT01727336|156665370|FG000|Part 2 Blinded|Withdrawal by Subject|0|||
48977800|NCT01237223|157750111|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
48977801|NCT01237223|157750112|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
48977802|NCT01237223|157750113|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
48977803|NCT01237223|157750108|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308|||
48874164|NCT00943722|157376962|FG001|Base Study|Month 12 visit not completed|0|||
48874165|NCT00943722|157376963|FG002|Base Study|Month 12 visit not completed|0|||
48874166|NCT00943722|157376964|FG003|Base Study|Month 12 visit not completed|0|||
48874167|NCT00943722|157376965|FG004|Base Study|Month 12 visit not completed|2|||
48874168|NCT00943722|157376966|FG005|Base Study|Month 12 visit not completed|0|||
48874169|NCT00943722|157376967|FG006|Base Study|Month 12 visit not completed|0|||
48874170|NCT00943722|157376961|FG000|First Extension Study: EXT 1|Adverse Event|0|||
48874171|NCT00943722|157376962|FG001|First Extension Study: EXT 1|Adverse Event|0|||
48874172|NCT00943722|157376963|FG002|First Extension Study: EXT 1|Adverse Event|0|||
48874173|NCT00943722|157376964|FG003|First Extension Study: EXT 1|Adverse Event|0|||
48874174|NCT00943722|157376965|FG004|First Extension Study: EXT 1|Adverse Event|0|||
48874175|NCT00943722|157376966|FG005|First Extension Study: EXT 1|Adverse Event|1|||
48874176|NCT00943722|157376967|FG006|First Extension Study: EXT 1|Adverse Event|0|||
48874177|NCT00943722|157376961|FG000|First Extension Study: EXT 1|Lost to Follow-up|0|||
48874178|NCT00943722|157376962|FG001|First Extension Study: EXT 1|Lost to Follow-up|0|||
48874179|NCT00943722|157376963|FG002|First Extension Study: EXT 1|Lost to Follow-up|0|||
48874180|NCT00943722|157376964|FG003|First Extension Study: EXT 1|Lost to Follow-up|0|||
48874181|NCT00943722|157376965|FG004|First Extension Study: EXT 1|Lost to Follow-up|0|||
48874182|NCT00943722|157376966|FG005|First Extension Study: EXT 1|Lost to Follow-up|38|||
48874183|NCT00943722|157376967|FG006|First Extension Study: EXT 1|Lost to Follow-up|10|||
48874184|NCT00943722|157376961|FG000|First Extension Study: EXT 1|Withdrawal by Subject|0|||
48874185|NCT00943722|157376962|FG001|First Extension Study: EXT 1|Withdrawal by Subject|0|||
48874186|NCT00943722|157376963|FG002|First Extension Study: EXT 1|Withdrawal by Subject|0|||
48874187|NCT00943722|157376964|FG003|First Extension Study: EXT 1|Withdrawal by Subject|0|||
48874188|NCT00943722|157376965|FG004|First Extension Study: EXT 1|Withdrawal by Subject|0|||
48675759|NCT01727336|156665371|FG001|Part 2 Blinded|Withdrawal by Subject|0|||
48675760|NCT01727336|156665372|FG002|Part 2 Blinded|Withdrawal by Subject|0|||
48675761|NCT01727336|156665373|FG003|Part 2 Blinded|Withdrawal by Subject|0|||
48675762|NCT01727336|156665374|FG004|Part 2 Blinded|Withdrawal by Subject|0|||
48675763|NCT01727336|156665375|FG005|Part 2 Blinded|Withdrawal by Subject|4|||
48874189|NCT00943722|157376966|FG005|First Extension Study: EXT 1|Withdrawal by Subject|32|||
48874190|NCT00943722|157376967|FG006|First Extension Study: EXT 1|Withdrawal by Subject|10|||
48874191|NCT00943722|157376961|FG000|First Extension Study: EXT 1|Disposition Unknown|0|||
48675764|NCT01727336|156665370|FG000|Part 2 Blinded|use of prohibited medications|0|||
48675765|NCT01727336|156665371|FG001|Part 2 Blinded|use of prohibited medications|0|||
48675766|NCT01727336|156665372|FG002|Part 2 Blinded|use of prohibited medications|0|||
48675767|NCT01727336|156665373|FG003|Part 2 Blinded|use of prohibited medications|0|||
48675768|NCT01727336|156665374|FG004|Part 2 Blinded|use of prohibited medications|1|||
48675769|NCT01727336|156665375|FG005|Part 2 Blinded|use of prohibited medications|3|||
48675770|NCT00565136|156665377|FG000|Overall Study|Lost to Follow-up|1|||
48675771|NCT00565136|156665377|FG000|Overall Study|Withdrawal by Subject|1|||
48675772|NCT00565136|156665377|FG000|Overall Study|Protocol Violation|1|||
48675773|NCT05096312|156665380|FG000|Overall Study|Lost to Follow-up|2|||
48675774|NCT05096312|156665381|FG001|Overall Study|Lost to Follow-up|4|||
48675775|NCT05096312|156665380|FG000|Overall Study|Adverse Event|1|||
48675776|NCT05096312|156665381|FG001|Overall Study|Adverse Event|0|||
48675777|NCT01805037|156665382|FG000|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0|||
48675778|NCT01805037|156665383|FG001|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2|||
48675779|NCT01805037|156665382|FG000|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0|||
48675780|NCT01805037|156665383|FG001|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2|||
48675781|NCT01805037|156665382|FG000|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0|||
48675782|NCT01805037|156665383|FG001|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1|||
48675783|NCT01805037|156665382|FG000|1st Cycle of Maintenance (3 Weeks)|Death|0|||
48675784|NCT01805037|156665383|FG001|1st Cycle of Maintenance (3 Weeks)|Death|1|||
48675785|NCT01805037|156665382|FG000|2nd Cycle of Maintenance and Beyond|Adverse Event|0|||
48675786|NCT01805037|156665383|FG001|2nd Cycle of Maintenance and Beyond|Adverse Event|10|||
48675787|NCT01805037|156665382|FG000|2nd Cycle of Maintenance and Beyond|Progressive Disease|0|||
48675788|NCT01805037|156665383|FG001|2nd Cycle of Maintenance and Beyond|Progressive Disease|1|||
48675789|NCT01805037|156665382|FG000|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0|||
48675790|NCT01805037|156665383|FG001|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1|||
48675791|NCT01805037|156665382|FG000|Follow Up (up to 3 Years)|Death|0|||
48675792|NCT01805037|156665383|FG001|Follow Up (up to 3 Years)|Death|2|||
48675793|NCT01805037|156665382|FG000|Follow Up (up to 3 Years)|Withdrawal by Subject|0|||
48675794|NCT01805037|156665383|FG001|Follow Up (up to 3 Years)|Withdrawal by Subject|3|||
48675795|NCT01805037|156665382|FG000|Follow Up (up to 3 Years)|Lost to Follow-up|0|||
48675796|NCT01805037|156665383|FG001|Follow Up (up to 3 Years)|Lost to Follow-up|1|||
48675797|NCT03517566|156665384|FG000|Overall Study|Adverse Event|5|||
48675798|NCT03517566|156665385|FG001|Overall Study|Adverse Event|2|||
48675799|NCT03517566|156665386|FG002|Overall Study|Adverse Event|2|||
48874192|NCT00943722|157376962|FG001|First Extension Study: EXT 1|Disposition Unknown|0|||
48675800|NCT03517566|156665387|FG003|Overall Study|Adverse Event|8|||
48675801|NCT03517566|156665388|FG004|Overall Study|Adverse Event|7|||
48874193|NCT00943722|157376963|FG002|First Extension Study: EXT 1|Disposition Unknown|0|||
48874194|NCT00943722|157376964|FG003|First Extension Study: EXT 1|Disposition Unknown|0|||
48874195|NCT00943722|157376965|FG004|First Extension Study: EXT 1|Disposition Unknown|0|||
48874196|NCT00943722|157376966|FG005|First Extension Study: EXT 1|Disposition Unknown|44|||
48874197|NCT00943722|157376967|FG006|First Extension Study: EXT 1|Disposition Unknown|21|||
48874198|NCT00943722|157376961|FG000|Second Extension Study: EXT 2|Adverse Event|0|||
48874199|NCT00943722|157376962|FG001|Second Extension Study: EXT 2|Adverse Event|0|||
48874200|NCT00943722|157376963|FG002|Second Extension Study: EXT 2|Adverse Event|0|||
48874201|NCT00943722|157376964|FG003|Second Extension Study: EXT 2|Adverse Event|0|||
48874202|NCT00943722|157376965|FG004|Second Extension Study: EXT 2|Adverse Event|0|||
48874203|NCT00943722|157376966|FG005|Second Extension Study: EXT 2|Adverse Event|1|||
48874204|NCT00943722|157376967|FG006|Second Extension Study: EXT 2|Adverse Event|0|||
48874205|NCT00943722|157376961|FG000|Second Extension Study: EXT 2|Lost to Follow-up|0|||
48874206|NCT00943722|157376962|FG001|Second Extension Study: EXT 2|Lost to Follow-up|0|||
48874207|NCT00943722|157376963|FG002|Second Extension Study: EXT 2|Lost to Follow-up|0|||
48874208|NCT00943722|157376964|FG003|Second Extension Study: EXT 2|Lost to Follow-up|0|||
48977804|NCT01237223|157750109|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
48977805|NCT01237223|157750110|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
48977806|NCT01237223|157750111|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
48977807|NCT01237223|157750112|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
48977808|NCT01237223|157750113|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
48977809|NCT01237223|157750108|FG000|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28|||
48977810|NCT01237223|157750109|FG001|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
48977811|NCT01237223|157750110|FG002|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
48977812|NCT01237223|157750111|FG003|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
48977813|NCT01237223|157750112|FG004|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
48977814|NCT01237223|157750113|FG005|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
48977815|NCT01237223|157750108|FG000|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8|||
48977816|NCT01237223|157750109|FG001|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
48977817|NCT01237223|157750110|FG002|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
48977818|NCT01237223|157750111|FG003|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
48977819|NCT01237223|157750112|FG004|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
48977820|NCT01237223|157750113|FG005|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
48977821|NCT01237223|157750108|FG000|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12|||
48977822|NCT01237223|157750109|FG001|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4|||
48977823|NCT01237223|157750110|FG002|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3|||
48977824|NCT01237223|157750111|FG003|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
48977825|NCT01237223|157750112|FG004|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
48977826|NCT01237223|157750113|FG005|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1|||
48977827|NCT01237223|157750108|FG000|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20|||
48977828|NCT01237223|157750109|FG001|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6|||
48977829|NCT01237223|157750110|FG002|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7|||
48977830|NCT01237223|157750111|FG003|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
48977831|NCT01237223|157750112|FG004|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0|||
48977832|NCT01237223|157750113|FG005|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
48977833|NCT01237223|157750108|FG000|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
48977834|NCT01237223|157750109|FG001|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
48977835|NCT01237223|157750110|FG002|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
48977836|NCT01237223|157750111|FG003|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0|||
48977837|NCT01237223|157750112|FG004|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
48977838|NCT01237223|157750113|FG005|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
48977839|NCT01237223|157750108|FG000|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
48977840|NCT01237223|157750109|FG001|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
48977841|NCT01237223|157750110|FG002|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
48977842|NCT01237223|157750111|FG003|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
48977843|NCT01237223|157750112|FG004|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
48874209|NCT00943722|157376965|FG004|Second Extension Study: EXT 2|Lost to Follow-up|0|||
48874210|NCT00943722|157376966|FG005|Second Extension Study: EXT 2|Lost to Follow-up|111|||
48874211|NCT00943722|157376967|FG006|Second Extension Study: EXT 2|Lost to Follow-up|46|||
48874212|NCT00943722|157376961|FG000|Second Extension Study: EXT 2|Physician Decision|0|||
48874213|NCT00943722|157376962|FG001|Second Extension Study: EXT 2|Physician Decision|0|||
48874214|NCT00943722|157376963|FG002|Second Extension Study: EXT 2|Physician Decision|0|||
48874215|NCT00943722|157376964|FG003|Second Extension Study: EXT 2|Physician Decision|0|||
48977844|NCT01237223|157750113|FG005|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1|||
48977845|NCT01237223|157750108|FG000|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0|||
48977846|NCT01237223|157750109|FG001|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
48977847|NCT01237223|157750110|FG002|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
48977848|NCT01237223|157750111|FG003|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2|||
48977849|NCT01237223|157750112|FG004|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
48977850|NCT01237223|157750113|FG005|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
48977851|NCT00732238|157750114|FG000|Overall Study|Bacteremia|4|||
48977852|NCT00732238|157750115|FG001|Overall Study|Bacteremia|1|||
48675802|NCT03517566|156665384|FG000|Overall Study|Lack of Efficacy|3|||
48977853|NCT00732238|157750114|FG000|Overall Study|Asymptomatic bacteriuria|1|||
48977854|NCT00732238|157750115|FG001|Overall Study|Asymptomatic bacteriuria|0|||
48977855|NCT01192100|157750118|FG000|Overall Study|Withdrawal by Subject|0|||
48977856|NCT01192100|157750119|FG001|Overall Study|Withdrawal by Subject|0|||
48977857|NCT01192100|157750120|FG002|Overall Study|Withdrawal by Subject|0|||
48977858|NCT01192100|157750121|FG003|Overall Study|Withdrawal by Subject|0|||
48977859|NCT01192100|157750122|FG004|Overall Study|Withdrawal by Subject|1|||
48977860|NCT01192100|157750123|FG005|Overall Study|Withdrawal by Subject|0|||
48977861|NCT01192100|157750118|FG000|Overall Study|Protocol Violation|0|||
48977862|NCT01192100|157750119|FG001|Overall Study|Protocol Violation|0|||
48977863|NCT01192100|157750120|FG002|Overall Study|Protocol Violation|0|||
48977864|NCT01192100|157750121|FG003|Overall Study|Protocol Violation|1|||
48977865|NCT01192100|157750122|FG004|Overall Study|Protocol Violation|0|||
48977866|NCT01192100|157750123|FG005|Overall Study|Protocol Violation|0|||
48977867|NCT01782885|157750126|FG000|Overall Study|Lost to Follow-up|4|||
48977868|NCT01782885|157750127|FG001|Overall Study|Lost to Follow-up|6|||
48977869|NCT00557323|157750132|FG000|Overall Study|Death|3|||
48977870|NCT00557323|157750132|FG000|Overall Study|Withdrawal by Subject|2|||
48977871|NCT00557323|157750132|FG000|Overall Study|Administrative change|2|||
48977872|NCT00537771|157750133|FG000|Overall Study|Withdrawal by Subject|6|||
48977873|NCT00537771|157750134|FG001|Overall Study|Withdrawal by Subject|23|||
48977874|NCT00537771|157750133|FG000|Overall Study|Adverse Event|8|||
48977875|NCT00537771|157750134|FG001|Overall Study|Adverse Event|15|||
48977876|NCT00537771|157750133|FG000|Overall Study|Lost to Follow-up|9|||
48977877|NCT00537771|157750134|FG001|Overall Study|Lost to Follow-up|15|||
48977878|NCT00537771|157750133|FG000|Overall Study|Protocol Violation|2|||
48977879|NCT00537771|157750134|FG001|Overall Study|Protocol Violation|6|||
48977880|NCT00537771|157750133|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
48977881|NCT00537771|157750134|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
48977882|NCT02465489|157750139|FG000|Overall Study|Adverse Event|5|||
48977883|NCT00693693|157750140|FG000|Overall Study|Lost to Follow-up|1|||
48977884|NCT00693693|157750141|FG001|Overall Study|Lost to Follow-up|1|||
48977885|NCT00693693|157750142|FG002|Overall Study|Lost to Follow-up|2|||
48977886|NCT01855425|157750145|FG000|Overall Study|Physician Decision|20|||
48977887|NCT01641081|157750150|FG000|Period 1|Sponsor request (potential unblinding)|0|||
48977888|NCT01641081|157750151|FG001|Period 1|Sponsor request (potential unblinding)|0|||
48977889|NCT01641081|157750152|FG002|Period 1|Sponsor request (potential unblinding)|0|||
48977890|NCT01641081|157750153|FG003|Period 1|Sponsor request (potential unblinding)|0|||
48977891|NCT01641081|157750154|FG004|Period 1|Sponsor request (potential unblinding)|0|||
48977892|NCT01641081|157750155|FG005|Period 1|Sponsor request (potential unblinding)|0|||
48977893|NCT01641081|157750156|FG006|Period 1|Sponsor request (potential unblinding)|1|||
48977894|NCT01641081|157750157|FG007|Period 1|Sponsor request (potential unblinding)|0|||
48977895|NCT01641081|157750158|FG008|Period 1|Sponsor request (potential unblinding)|0|||
48977896|NCT01641081|157750159|FG009|Period 1|Sponsor request (potential unblinding)|0|||
48977897|NCT01641081|157750150|FG000|Period 1|Protocol Violation|0|||
48977898|NCT01641081|157750151|FG001|Period 1|Protocol Violation|0|||
48977899|NCT01641081|157750152|FG002|Period 1|Protocol Violation|0|||
48977900|NCT01641081|157750153|FG003|Period 1|Protocol Violation|0|||
48977901|NCT01641081|157750154|FG004|Period 1|Protocol Violation|1|||
48977902|NCT01641081|157750155|FG005|Period 1|Protocol Violation|0|||
48977903|NCT01641081|157750156|FG006|Period 1|Protocol Violation|0|||
48977904|NCT01641081|157750157|FG007|Period 1|Protocol Violation|1|||
48977905|NCT01641081|157750158|FG008|Period 1|Protocol Violation|0|||
48675803|NCT03517566|156665385|FG001|Overall Study|Lack of Efficacy|2|||
48977906|NCT01641081|157750159|FG009|Period 1|Protocol Violation|0|||
48977907|NCT01641081|157750150|FG000|Period 1|Adverse Event|1|||
48977908|NCT01641081|157750151|FG001|Period 1|Adverse Event|0|||
48977909|NCT01641081|157750152|FG002|Period 1|Adverse Event|0|||
48977910|NCT01641081|157750153|FG003|Period 1|Adverse Event|0|||
48977911|NCT01641081|157750154|FG004|Period 1|Adverse Event|0|||
48977912|NCT01641081|157750155|FG005|Period 1|Adverse Event|0|||
48977913|NCT01641081|157750156|FG006|Period 1|Adverse Event|0|||
48675804|NCT03517566|156665386|FG002|Overall Study|Lack of Efficacy|1|||
48675805|NCT03517566|156665387|FG003|Overall Study|Lack of Efficacy|1|||
48675806|NCT03517566|156665388|FG004|Overall Study|Lack of Efficacy|4|||
48675807|NCT03517566|156665384|FG000|Overall Study|Lost to Follow-up|3|||
48675808|NCT03517566|156665385|FG001|Overall Study|Lost to Follow-up|1|||
48977914|NCT01641081|157750157|FG007|Period 1|Adverse Event|2|||
48977915|NCT01641081|157750158|FG008|Period 1|Adverse Event|0|||
48977916|NCT01641081|157750159|FG009|Period 1|Adverse Event|0|||
48977917|NCT01641081|157750150|FG000|Period 2|Adverse Event|0|||
48977918|NCT01641081|157750151|FG001|Period 2|Adverse Event|0|||
48977919|NCT01641081|157750152|FG002|Period 2|Adverse Event|0|||
48977920|NCT01641081|157750153|FG003|Period 2|Adverse Event|0|||
48977921|NCT01641081|157750154|FG004|Period 2|Adverse Event|0|||
48977922|NCT01641081|157750155|FG005|Period 2|Adverse Event|1|||
48977923|NCT01641081|157750156|FG006|Period 2|Adverse Event|0|||
48977924|NCT01641081|157750157|FG007|Period 2|Adverse Event|0|||
48977925|NCT01641081|157750158|FG008|Period 2|Adverse Event|0|||
48977926|NCT01641081|157750159|FG009|Period 2|Adverse Event|0|||
48977927|NCT01641081|157750150|FG000|Period 2|Withdrawal by Subject|0|||
48977928|NCT01641081|157750151|FG001|Period 2|Withdrawal by Subject|0|||
48977929|NCT01641081|157750152|FG002|Period 2|Withdrawal by Subject|0|||
48977930|NCT01641081|157750153|FG003|Period 2|Withdrawal by Subject|1|||
48977931|NCT01641081|157750154|FG004|Period 2|Withdrawal by Subject|0|||
48977932|NCT01641081|157750155|FG005|Period 2|Withdrawal by Subject|0|||
48977933|NCT01641081|157750156|FG006|Period 2|Withdrawal by Subject|2|||
48977934|NCT01641081|157750157|FG007|Period 2|Withdrawal by Subject|0|||
48977935|NCT01641081|157750158|FG008|Period 2|Withdrawal by Subject|0|||
48762013|NCT01393405|156975738|FG002|Maintenance Period Week|Lost to Follow-up|0|||
48762014|NCT00026793|156975739|FG000|Overall Study|Death on study due to underlying disease|4|||
48762015|NCT00026793|156975739|FG000|Overall Study|Physician Decision|2|||
48762016|NCT00026793|156975739|FG000|Overall Study|Off study|2|||
48762017|NCT02226003|156975741|FG000|Overall Study|Lost to Follow-up|2|||
48762018|NCT02226003|156975742|FG001|Overall Study|Lost to Follow-up|1|||
48762019|NCT02226003|156975743|FG002|Overall Study|Lost to Follow-up|3|||
48762020|NCT02226003|156975741|FG000|Overall Study|Withdrawal by Subject|0|||
48762021|NCT02226003|156975742|FG001|Overall Study|Withdrawal by Subject|0|||
48977936|NCT01641081|157750159|FG009|Period 2|Withdrawal by Subject|0|||
48977937|NCT01641081|157750150|FG000|Period 2|Protocol Violation|1|||
48977938|NCT01641081|157750151|FG001|Period 2|Protocol Violation|0|||
48977939|NCT01641081|157750152|FG002|Period 2|Protocol Violation|0|||
48977940|NCT01641081|157750153|FG003|Period 2|Protocol Violation|0|||
48977941|NCT01641081|157750154|FG004|Period 2|Protocol Violation|0|||
48977942|NCT01641081|157750155|FG005|Period 2|Protocol Violation|0|||
48977943|NCT01641081|157750156|FG006|Period 2|Protocol Violation|0|||
48977944|NCT01641081|157750157|FG007|Period 2|Protocol Violation|0|||
48977945|NCT01641081|157750158|FG008|Period 2|Protocol Violation|0|||
48977946|NCT01641081|157750159|FG009|Period 2|Protocol Violation|0|||
48977947|NCT01641081|157750150|FG000|Period 3|Adverse Event|0|||
48977948|NCT01641081|157750151|FG001|Period 3|Adverse Event|0|||
48977949|NCT01641081|157750152|FG002|Period 3|Adverse Event|1|||
48977950|NCT01641081|157750153|FG003|Period 3|Adverse Event|0|||
48977951|NCT01641081|157750154|FG004|Period 3|Adverse Event|0|||
48977952|NCT01641081|157750155|FG005|Period 3|Adverse Event|0|||
48977953|NCT01641081|157750156|FG006|Period 3|Adverse Event|0|||
48977954|NCT01641081|157750157|FG007|Period 3|Adverse Event|0|||
48977955|NCT01641081|157750158|FG008|Period 3|Adverse Event|0|||
48977956|NCT01641081|157750159|FG009|Period 3|Adverse Event|0|||
48977957|NCT01641081|157750150|FG000|Period 3|Withdrawal by Subject|0|||
48977958|NCT01641081|157750151|FG001|Period 3|Withdrawal by Subject|0|||
48977959|NCT01641081|157750152|FG002|Period 3|Withdrawal by Subject|0|||
48977960|NCT01641081|157750153|FG003|Period 3|Withdrawal by Subject|0|||
48977961|NCT01641081|157750154|FG004|Period 3|Withdrawal by Subject|0|||
48977962|NCT01641081|157750155|FG005|Period 3|Withdrawal by Subject|0|||
48977963|NCT01641081|157750156|FG006|Period 3|Withdrawal by Subject|0|||
48977964|NCT01641081|157750157|FG007|Period 3|Withdrawal by Subject|0|||
48977965|NCT01641081|157750158|FG008|Period 3|Withdrawal by Subject|1|||
48977966|NCT01641081|157750159|FG009|Period 3|Withdrawal by Subject|0|||
48977967|NCT01641081|157750150|FG000|Period 4|Adverse Event|0|||
48977968|NCT01641081|157750151|FG001|Period 4|Adverse Event|1|||
48977969|NCT01641081|157750152|FG002|Period 4|Adverse Event|0|||
48762022|NCT02226003|156975743|FG002|Overall Study|Withdrawal by Subject|3|||
48977970|NCT01641081|157750153|FG003|Period 4|Adverse Event|1|||
48977971|NCT01641081|157750154|FG004|Period 4|Adverse Event|0|||
48977972|NCT01641081|157750155|FG005|Period 4|Adverse Event|0|||
48977973|NCT01641081|157750156|FG006|Period 4|Adverse Event|0|||
48977974|NCT01641081|157750157|FG007|Period 4|Adverse Event|0|||
48762023|NCT01400516|156975744|FG000|Primary Trial|Withdrawal by Subject|0|||
48762024|NCT01400516|156975745|FG001|Primary Trial|Withdrawal by Subject|2|||
48762025|NCT00549562|156975746|FG000|Overall Study|Adverse Event|1|||
48977975|NCT01641081|157750158|FG008|Period 4|Adverse Event|0|||
48977976|NCT01641081|157750159|FG009|Period 4|Adverse Event|0|||
48977977|NCT01641081|157750150|FG000|Period 5|Adverse Event|0|||
48977978|NCT01641081|157750151|FG001|Period 5|Adverse Event|0|||
48977979|NCT01641081|157750152|FG002|Period 5|Adverse Event|2|||
48977980|NCT01641081|157750153|FG003|Period 5|Adverse Event|0|||
48977981|NCT01641081|157750154|FG004|Period 5|Adverse Event|0|||
48977982|NCT01641081|157750155|FG005|Period 5|Adverse Event|0|||
48977983|NCT01641081|157750156|FG006|Period 5|Adverse Event|0|||
48977984|NCT01641081|157750157|FG007|Period 5|Adverse Event|0|||
48977985|NCT01641081|157750158|FG008|Period 5|Adverse Event|0|||
48977986|NCT01641081|157750159|FG009|Period 5|Adverse Event|0|||
48977987|NCT01600105|157750168|FG000|Total Participants|Withdrawal by Subject|1|||
48977988|NCT01600105|157750169|FG001|Total Participants|Withdrawal by Subject|0|||
48977989|NCT01600105|157750168|FG000|Total Participants|No images in PACS|10|||
48977990|NCT01600105|157750169|FG001|Total Participants|No images in PACS|0|||
48977991|NCT01600105|157750168|FG000|Total Participants|Insufficient image quality|30|||
48977992|NCT01600105|157750169|FG001|Total Participants|Insufficient image quality|10|||
48675809|NCT03517566|156665386|FG002|Overall Study|Lost to Follow-up|1|||
48977993|NCT01600105|157750168|FG000|Sub Study I|Insufficient image quality|0|||
48675810|NCT03517566|156665387|FG003|Overall Study|Lost to Follow-up|1|||
48675811|NCT03517566|156665388|FG004|Overall Study|Lost to Follow-up|0|||
48675812|NCT03517566|156665384|FG000|Overall Study|Physician Decision|1|||
48675813|NCT03517566|156665385|FG001|Overall Study|Physician Decision|1|||
48675814|NCT03517566|156665386|FG002|Overall Study|Physician Decision|0|||
48675815|NCT03517566|156665387|FG003|Overall Study|Physician Decision|1|||
48675816|NCT03517566|156665388|FG004|Overall Study|Physician Decision|0|||
48675817|NCT03517566|156665384|FG000|Overall Study|Pregnancy|0|||
48675818|NCT03517566|156665385|FG001|Overall Study|Pregnancy|1|||
48675819|NCT03517566|156665386|FG002|Overall Study|Pregnancy|0|||
48675820|NCT03517566|156665387|FG003|Overall Study|Pregnancy|0|||
48675821|NCT03517566|156665388|FG004|Overall Study|Pregnancy|0|||
48675822|NCT03517566|156665384|FG000|Overall Study|Protocol Deviation|0|||
48675823|NCT03517566|156665385|FG001|Overall Study|Protocol Deviation|1|||
48675824|NCT03517566|156665386|FG002|Overall Study|Protocol Deviation|0|||
48675825|NCT03517566|156665387|FG003|Overall Study|Protocol Deviation|1|||
48675826|NCT03517566|156665388|FG004|Overall Study|Protocol Deviation|1|||
48675827|NCT03517566|156665384|FG000|Overall Study|Study terminated by Sponsor|11|||
48675828|NCT03517566|156665385|FG001|Overall Study|Study terminated by Sponsor|5|||
48675829|NCT03517566|156665386|FG002|Overall Study|Study terminated by Sponsor|6|||
48675830|NCT03517566|156665387|FG003|Overall Study|Study terminated by Sponsor|14|||
48675831|NCT03517566|156665388|FG004|Overall Study|Study terminated by Sponsor|12|||
48675832|NCT03517566|156665384|FG000|Overall Study|Subject Decision /Guardian Decision|9|||
48675833|NCT03517566|156665385|FG001|Overall Study|Subject Decision /Guardian Decision|8|||
48675834|NCT03517566|156665386|FG002|Overall Study|Subject Decision /Guardian Decision|5|||
48977994|NCT01600105|157750169|FG001|Sub Study I|Insufficient image quality|10|||
48977995|NCT01600105|157750168|FG000|Sub Study II|Withdrawal by Subject|1|||
48977996|NCT01600105|157750169|FG001|Sub Study II|Withdrawal by Subject|0|||
48977997|NCT01600105|157750168|FG000|Sub Study II|No images in PACS|1|||
48977998|NCT01600105|157750169|FG001|Sub Study II|No images in PACS|0|||
48977999|NCT01600105|157750168|FG000|Sub Study II|Insufficient image quality|3|||
48978000|NCT01600105|157750169|FG001|Sub Study II|Insufficient image quality|0|||
48978001|NCT01600105|157750168|FG000|Sub Study III|Insufficient image quality|5|||
48978002|NCT01600105|157750169|FG001|Sub Study III|Insufficient image quality|0|||
48978003|NCT01600105|157750168|FG000|Sub Study V|Poor Image Quality|2|||
48978004|NCT01600105|157750169|FG001|Sub Study V|Poor Image Quality|0|||
48978005|NCT01263444|157750170|FG000|Overall Study|Adverse Event|8|||
48978006|NCT01263444|157750170|FG000|Overall Study|Withdrawal by Subject|1|||
48978007|NCT01263444|157750170|FG000|Overall Study|Protocol Violation|1|||
48978008|NCT01764022|157750172|FG000|Overall Study|Death|3|||
48978009|NCT01764022|157750173|FG001|Overall Study|Death|5|||
48978010|NCT01764022|157750172|FG000|Overall Study|Withdrawal by Subject|2|||
48978011|NCT01764022|157750173|FG001|Overall Study|Withdrawal by Subject|6|||
48978012|NCT01764022|157750172|FG000|Overall Study|Lack of Efficacy|0|||
48978013|NCT01764022|157750173|FG001|Overall Study|Lack of Efficacy|1|||
48978014|NCT01764022|157750172|FG000|Overall Study|Physician Decision|0|||
48978015|NCT01764022|157750173|FG001|Overall Study|Physician Decision|2|||
48978016|NCT01764022|157750172|FG000|Overall Study|Lost to Follow-up|2|||
48978017|NCT01764022|157750173|FG001|Overall Study|Lost to Follow-up|0|||
48978018|NCT01764022|157750172|FG000|Overall Study|Protocol Violation|1|||
48978019|NCT01764022|157750173|FG001|Overall Study|Protocol Violation|0|||
48978020|NCT01899768|157750174|FG000|Part A|Adverse Event|2|||
48978021|NCT01899768|157750174|FG000|Part A|Withdrawal by Subject|1|||
48978022|NCT01899768|157750174|FG000|Part B|Adverse Event|1|||
48978023|NCT01899768|157750174|FG000|Part B|Withdrawal by Subject|1|||
48978024|NCT00744991|157750181|FG000|Overall Study|Progressive Disease|11|||
48978025|NCT00744991|157750181|FG000|Overall Study|Withdrawal by Subject|8|||
48978026|NCT00744991|157750181|FG000|Overall Study|Physician Decision|3|||
48978027|NCT00744991|157750181|FG000|Overall Study|Adverse Event|2|||
48978028|NCT00744991|157750181|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
48675835|NCT03517566|156665387|FG003|Overall Study|Subject Decision /Guardian Decision|8|||
48675836|NCT03517566|156665388|FG004|Overall Study|Subject Decision /Guardian Decision|8|||
48675837|NCT04566692|156665389|FG000|Overall Study|Adverse Event|2|||
48978029|NCT00224003|157750183|FG000|Overall Study|Adverse Event|1|||
48978030|NCT00224003|157750183|FG000|Overall Study|Protocol Violation|2|||
48978031|NCT00224003|157750183|FG000|Overall Study|Withdrawal by Subject|1|||
48978032|NCT00224003|157750183|FG000|Overall Study|unk|3|||
48978033|NCT01512693|157750187|FG000|Overall Study|Withdrawal by Subject|0|||
48978034|NCT01512693|157750188|FG001|Overall Study|Withdrawal by Subject|1|||
48978035|NCT02996500|157750190|FG000|Overall Study|Adverse Event|1|||
48978036|NCT02996500|157750191|FG001|Overall Study|Adverse Event|1|||
48978037|NCT02996500|157750192|FG002|Overall Study|Adverse Event|4|||
48978038|NCT02996500|157750193|FG003|Overall Study|Adverse Event|3|||
48978039|NCT02996500|157750194|FG004|Overall Study|Adverse Event|1|||
48978040|NCT02996500|157750195|FG005|Overall Study|Adverse Event|2|||
48978041|NCT02996500|157750190|FG000|Overall Study|Lack of Efficacy|0|||
48978042|NCT02996500|157750191|FG001|Overall Study|Lack of Efficacy|0|||
48978043|NCT02996500|157750192|FG002|Overall Study|Lack of Efficacy|0|||
48978044|NCT02996500|157750193|FG003|Overall Study|Lack of Efficacy|0|||
48978045|NCT02996500|157750194|FG004|Overall Study|Lack of Efficacy|2|||
48978046|NCT02996500|157750195|FG005|Overall Study|Lack of Efficacy|0|||
48978047|NCT02996500|157750190|FG000|Overall Study|Lost to Follow-up|1|||
48978048|NCT02996500|157750191|FG001|Overall Study|Lost to Follow-up|0|||
48978049|NCT02996500|157750192|FG002|Overall Study|Lost to Follow-up|0|||
48978050|NCT02996500|157750193|FG003|Overall Study|Lost to Follow-up|0|||
48978051|NCT02996500|157750194|FG004|Overall Study|Lost to Follow-up|0|||
48978052|NCT02996500|157750195|FG005|Overall Study|Lost to Follow-up|1|||
48978053|NCT02996500|157750190|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
48978054|NCT02996500|157750191|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
48978055|NCT02996500|157750192|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
48978056|NCT02996500|157750193|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
48978057|NCT02996500|157750194|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
48978058|NCT02996500|157750195|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
48978059|NCT02996500|157750190|FG000|Overall Study|Non-Compliance With Study Drug|0|||
48978060|NCT02996500|157750191|FG001|Overall Study|Non-Compliance With Study Drug|0|||
48978061|NCT02996500|157750192|FG002|Overall Study|Non-Compliance With Study Drug|0|||
48978062|NCT02996500|157750193|FG003|Overall Study|Non-Compliance With Study Drug|0|||
48978063|NCT02996500|157750194|FG004|Overall Study|Non-Compliance With Study Drug|0|||
48978064|NCT02996500|157750195|FG005|Overall Study|Non-Compliance With Study Drug|1|||
48978065|NCT02996500|157750190|FG000|Overall Study|Progressive Disease|1|||
48978066|NCT02996500|157750191|FG001|Overall Study|Progressive Disease|0|||
48978067|NCT02996500|157750192|FG002|Overall Study|Progressive Disease|0|||
48978068|NCT02996500|157750193|FG003|Overall Study|Progressive Disease|0|||
48978069|NCT02996500|157750194|FG004|Overall Study|Progressive Disease|0|||
48978070|NCT02996500|157750195|FG005|Overall Study|Progressive Disease|0|||
48978071|NCT02996500|157750190|FG000|Overall Study|Other|2|||
48978072|NCT02996500|157750191|FG001|Overall Study|Other|0|||
48978073|NCT02996500|157750192|FG002|Overall Study|Other|2|||
48978074|NCT02996500|157750193|FG003|Overall Study|Other|0|||
48978075|NCT02996500|157750194|FG004|Overall Study|Other|0|||
48874216|NCT00943722|157376965|FG004|Second Extension Study: EXT 2|Physician Decision|0|||
48874217|NCT00943722|157376966|FG005|Second Extension Study: EXT 2|Physician Decision|1|||
48874218|NCT00943722|157376967|FG006|Second Extension Study: EXT 2|Physician Decision|3|||
48978076|NCT02996500|157750195|FG005|Overall Study|Other|0|||
48978077|NCT02996500|157750190|FG000|Overall Study|Protocol Violation|0|||
48978078|NCT02996500|157750191|FG001|Overall Study|Protocol Violation|0|||
48978079|NCT02996500|157750192|FG002|Overall Study|Protocol Violation|0|||
48978080|NCT02996500|157750193|FG003|Overall Study|Protocol Violation|1|||
48978081|NCT02996500|157750194|FG004|Overall Study|Protocol Violation|0|||
48978082|NCT02996500|157750195|FG005|Overall Study|Protocol Violation|0|||
48978083|NCT02996500|157750190|FG000|Overall Study|Withdrawal by Subject|3|||
48978084|NCT02996500|157750191|FG001|Overall Study|Withdrawal by Subject|0|||
48978085|NCT02996500|157750192|FG002|Overall Study|Withdrawal by Subject|3|||
48978086|NCT02996500|157750193|FG003|Overall Study|Withdrawal by Subject|0|||
48978087|NCT02996500|157750194|FG004|Overall Study|Withdrawal by Subject|2|||
48978088|NCT02996500|157750195|FG005|Overall Study|Withdrawal by Subject|0|||
48978089|NCT01678560|157750196|FG000|Overall Study|Physician Decision|4|||
48978090|NCT01678560|157750197|FG001|Overall Study|Physician Decision|4|||
48978091|NCT01678560|157750196|FG000|Overall Study|Death|0|||
48978092|NCT01678560|157750197|FG001|Overall Study|Death|1|||
48978093|NCT01678560|157750196|FG000|Overall Study|Withdrawal by Subject|0|||
48978094|NCT01678560|157750197|FG001|Overall Study|Withdrawal by Subject|1|||
48978095|NCT01624467|157750198|FG000|Overall Study|Withdrawal by Subject|2|||
48978096|NCT01624467|157750198|FG000|Overall Study|Lost to Follow-up|1|||
48675838|NCT04566692|156665390|FG001|Overall Study|Adverse Event|0|||
48978097|NCT01624467|157750198|FG000|Overall Study|Adverse Event|7|||
48978098|NCT01624467|157750198|FG000|Overall Study|Progressive Disease|19|||
48874219|NCT00943722|157376961|FG000|Second Extension Study: EXT 2|Pregnancy|0|||
48874220|NCT00943722|157376962|FG001|Second Extension Study: EXT 2|Pregnancy|0|||
48978099|NCT01624467|157750198|FG000|Overall Study|Per Sponsor Requirement|1|||
48978100|NCT01624467|157750198|FG000|Overall Study|Subject Withdrew from Treatment|1|||
48874221|NCT00943722|157376963|FG002|Second Extension Study: EXT 2|Pregnancy|0|||
48978101|NCT04498468|157750199|FG000|Overall Study|Lost to Follow-up|3|||
48978102|NCT00262314|157750203|FG000|Overall Study|Changing physicians|38|||
48978103|NCT00262314|157750203|FG000|Overall Study|Death|12|||
48978104|NCT00262314|157750203|FG000|Overall Study|Patient's decision|92|||
48978105|NCT00262314|157750203|FG000|Overall Study|Other|95|||
48978106|NCT00262314|157750203|FG000|Overall Study|Lost to Follow-up|70|||
48978107|NCT00262314|157750203|FG000|Overall Study|Administrative withdrawal|30|||
48978108|NCT01838213|157750205|FG000|Overall Study|Ineligible|166|||
48978109|NCT01838213|157750206|FG001|Overall Study|Ineligible|191|||
48978110|NCT03074318|157750207|FG000|Overall Study|Adverse Event|0|||
48978111|NCT03074318|157750208|FG001|Overall Study|Adverse Event|1|||
48978112|NCT03074318|157750209|FG002|Overall Study|Adverse Event|1|||
48978113|NCT03074318|157750210|FG003|Overall Study|Adverse Event|1|||
48978114|NCT03074318|157750207|FG000|Overall Study|Death|1|||
48978115|NCT03074318|157750208|FG001|Overall Study|Death|0|||
48978116|NCT03074318|157750209|FG002|Overall Study|Death|0|||
48978117|NCT03074318|157750210|FG003|Overall Study|Death|0|||
48978118|NCT03074318|157750207|FG000|Overall Study|Withdrawal by Subject|1|||
48978119|NCT03074318|157750208|FG001|Overall Study|Withdrawal by Subject|2|||
48978120|NCT03074318|157750209|FG002|Overall Study|Withdrawal by Subject|2|||
48978121|NCT03074318|157750210|FG003|Overall Study|Withdrawal by Subject|4|||
48978122|NCT03074318|157750207|FG000|Overall Study|Trial Closure|2|||
48978123|NCT03074318|157750208|FG001|Overall Study|Trial Closure|2|||
48978124|NCT03074318|157750209|FG002|Overall Study|Trial Closure|3|||
48978125|NCT03074318|157750210|FG003|Overall Study|Trial Closure|11|||
48978126|NCT05104749|157750211|FG000|Overall Study|Lost to Follow-up|2|||
48978127|NCT05104749|157750212|FG001|Overall Study|Lost to Follow-up|3|||
48978128|NCT00796224|157750213|FG000|Overall Study|Adverse Event|1|||
48978129|NCT00796224|157750214|FG001|Overall Study|Adverse Event|0|||
48978130|NCT00796224|157750213|FG000|Overall Study|Protocol Violation|0|||
48978131|NCT00796224|157750214|FG001|Overall Study|Protocol Violation|1|||
48978132|NCT02963766|157750215|FG000|Double-Blind Period|Adverse Event|1|||
48978133|NCT02963766|157750216|FG001|Double-Blind Period|Adverse Event|0|||
48978134|NCT02963766|157750217|FG002|Double-Blind Period|Adverse Event|1|||
48978135|NCT02963766|157750215|FG000|Double-Blind Period|Physician Decision|1|||
48978136|NCT02963766|157750216|FG001|Double-Blind Period|Physician Decision|0|||
48978137|NCT02963766|157750217|FG002|Double-Blind Period|Physician Decision|0|||
48978138|NCT02963766|157750215|FG000|Double-Blind Period|Withdrawal by Subject|1|||
48978139|NCT02963766|157750216|FG001|Double-Blind Period|Withdrawal by Subject|1|||
48978140|NCT02963766|157750217|FG002|Double-Blind Period|Withdrawal by Subject|0|||
48978141|NCT02963766|157750215|FG000|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
48978142|NCT02963766|157750216|FG001|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
48978143|NCT02963766|157750217|FG002|Double-Blind Period|Withdrawal by Parent or Guardian|1|||
48978144|NCT02963766|157750215|FG000|Double-Blind Period|Protocol Violation|1|||
48978145|NCT02963766|157750216|FG001|Double-Blind Period|Protocol Violation|0|||
48978146|NCT02963766|157750217|FG002|Double-Blind Period|Protocol Violation|0|||
48978147|NCT02963766|157750215|FG000|Double-Blind Period|Lost to Follow-up|0|||
48978148|NCT02963766|157750216|FG001|Double-Blind Period|Lost to Follow-up|1|||
48978149|NCT02963766|157750217|FG002|Double-Blind Period|Lost to Follow-up|0|||
48978150|NCT02963766|157750215|FG000|Open Label Extension (OLE)|Physician Decision|1|||
48978151|NCT02963766|157750216|FG001|Open Label Extension (OLE)|Physician Decision|2|||
48978152|NCT02963766|157750217|FG002|Open Label Extension (OLE)|Physician Decision|2|||
48978153|NCT02963766|157750215|FG000|Open Label Extension (OLE)|Withdrawal by Subject|1|||
48978154|NCT02963766|157750216|FG001|Open Label Extension (OLE)|Withdrawal by Subject|1|||
48978155|NCT02963766|157750217|FG002|Open Label Extension (OLE)|Withdrawal by Subject|0|||
48978156|NCT00398138|157750218|FG000|Overall Study|Adverse Event|2|||
48978157|NCT02943668|157750220|FG000|Overall Study|Disease Progression|1|||
48978158|NCT04157751|157750226|FG000|Overall Study|Withdrawal by Subject|12|||
48978159|NCT04157751|157750227|FG001|Overall Study|Withdrawal by Subject|17|||
48978160|NCT04157751|157750226|FG000|Overall Study|Lost to Follow-up|6|||
48978161|NCT04157751|157750227|FG001|Overall Study|Lost to Follow-up|2|||
48978162|NCT04157751|157750226|FG000|Overall Study|Adverse Event|34|||
48978163|NCT04157751|157750227|FG001|Overall Study|Adverse Event|23|||
48978164|NCT04157751|157750226|FG000|Overall Study|Not treated|1|||
48978165|NCT04157751|157750227|FG001|Overall Study|Not treated|5|||
48978166|NCT04157751|157750226|FG000|Overall Study|Other reason not stated above|10|||
48978167|NCT04157751|157750227|FG001|Overall Study|Other reason not stated above|10|||
48978168|NCT00959894|157752048|FG000|Overall Study|Lost to Follow-up|10|||
48978169|NCT00959894|157752048|FG000|Overall Study|Adverse Event|3|||
48978170|NCT00959894|157752048|FG000|Overall Study|Withdrawal by Subject|1|||
48978171|NCT00959894|157752048|FG000|Overall Study|Need for contraindicated medication|1|||
48978172|NCT00959894|157752048|FG000|Overall Study|Subject moved out of town|1|||
48978173|NCT00653068|157752050|FG000|Overall Study|Death|9|||
48978174|NCT00653068|157752050|FG000|Overall Study|Lack of Efficacy|34|||
48978175|NCT00653068|157752050|FG000|Overall Study|Physician Decision|4|||
48978176|NCT00653068|157752050|FG000|Overall Study|Withdrawal by Subject|1|||
48978177|NCT00653068|157752050|FG000|Overall Study|Ineligible|2|||
48978178|NCT01117181|157752053|FG000|Overall Study|Lost to Follow-up|1|||
48978179|NCT01117181|157752054|FG001|Overall Study|Lost to Follow-up|0|||
48978180|NCT01117181|157752053|FG000|Overall Study|Withdrawal by Subject|0|||
48978181|NCT01117181|157752054|FG001|Overall Study|Withdrawal by Subject|2|||
48978182|NCT01510028|157752057|FG000|Overall Study|Lack of Efficacy|1|||
48978183|NCT01510028|157752058|FG001|Overall Study|Lack of Efficacy|0|||
48978184|NCT01510028|157752059|FG002|Overall Study|Lack of Efficacy|0|||
48978185|NCT01510028|157752060|FG003|Overall Study|Lack of Efficacy|0|||
48978186|NCT00633893|157752061|FG000|Overall Study|Death|1|||
48978187|NCT00633893|157752062|FG001|Overall Study|Death|3|||
48978188|NCT00633893|157752063|FG002|Overall Study|Death|9|||
48978189|NCT00633893|157752061|FG000|Overall Study|Adverse Event|65|||
48978190|NCT00633893|157752062|FG001|Overall Study|Adverse Event|58|||
48978191|NCT00633893|157752063|FG002|Overall Study|Adverse Event|126|||
48978192|NCT00633893|157752061|FG000|Overall Study|Withdrawal by Subject|7|||
48978193|NCT00633893|157752062|FG001|Overall Study|Withdrawal by Subject|12|||
48978194|NCT00633893|157752063|FG002|Overall Study|Withdrawal by Subject|6|||
48978195|NCT00633893|157752061|FG000|Overall Study|Lost to Follow-up|2|||
48978196|NCT00633893|157752062|FG001|Overall Study|Lost to Follow-up|4|||
48978197|NCT00633893|157752063|FG002|Overall Study|Lost to Follow-up|8|||
48978198|NCT00633893|157752061|FG000|Overall Study|Poor/non-compliance|5|||
48978199|NCT00633893|157752062|FG001|Overall Study|Poor/non-compliance|12|||
48978200|NCT00633893|157752063|FG002|Overall Study|Poor/non-compliance|3|||
48978201|NCT00633893|157752061|FG000|Overall Study|Pregnancy|2|||
48978202|NCT00633893|157752062|FG001|Overall Study|Pregnancy|1|||
48978203|NCT00633893|157752063|FG002|Overall Study|Pregnancy|1|||
48978204|NCT00633893|157752061|FG000|Overall Study|Not meet/no longer meets criteria|4|||
48978205|NCT00633893|157752062|FG001|Overall Study|Not meet/no longer meets criteria|6|||
48978206|NCT00633893|157752063|FG002|Overall Study|Not meet/no longer meets criteria|4|||
48978207|NCT00633893|157752061|FG000|Overall Study|Other|28|||
48978208|NCT00633893|157752062|FG001|Overall Study|Other|33|||
48978209|NCT00633893|157752063|FG002|Overall Study|Other|31|||
48978210|NCT00425945|157752064|FG000|Overall Study|Concern about Supplement|2|||
48978211|NCT00425945|157752065|FG001|Overall Study|Concern about Supplement|0|||
48978212|NCT00425945|157752064|FG000|Overall Study|Inconvenience|0|||
48978213|NCT00425945|157752065|FG001|Overall Study|Inconvenience|2|||
48978214|NCT00425945|157752064|FG000|Overall Study|Lost to Follow-up|0|||
48978215|NCT00425945|157752065|FG001|Overall Study|Lost to Follow-up|2|||
48978216|NCT00425945|157752064|FG000|Overall Study|Began hypertension medication|1|||
48978217|NCT00425945|157752065|FG001|Overall Study|Began hypertension medication|0|||
48978218|NCT00425945|157752064|FG000|Overall Study|Began cancer treatments|1|||
48978219|NCT00425945|157752065|FG001|Overall Study|Began cancer treatments|0|||
48978220|NCT00425945|157752064|FG000|Overall Study|Moved from area|0|||
48978221|NCT00425945|157752065|FG001|Overall Study|Moved from area|1|||
48978222|NCT02741310|157752066|FG000|Overall Study|Sponsor Decision|2|||
48978223|NCT02741310|157752067|FG001|Overall Study|Sponsor Decision|2|||
48978224|NCT03285490|157752075|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
48978225|NCT03285490|157752076|FG001|Recurrence Follow-up Period|Withdrawal by Subject|1|||
48978226|NCT03285490|157752075|FG000|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18|||
48978227|NCT03285490|157752076|FG001|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60|||
48978228|NCT02728206|157752077|FG000|Overall Study|Death|1|||
48978229|NCT01047436|157752080|FG000|Overall Study|Protocol Violation|1|||
48978230|NCT01047436|157752081|FG001|Overall Study|Protocol Violation|0|||
48978231|NCT04539262|157752082|FG000|Overall Study|Adverse Event|0|||
48978232|NCT04539262|157752083|FG001|Overall Study|Adverse Event|0|||
48978233|NCT04539262|157752084|FG002|Overall Study|Adverse Event|1|||
48978234|NCT04539262|157752085|FG003|Overall Study|Adverse Event|0|||
48978235|NCT04539262|157752086|FG004|Overall Study|Adverse Event|0|||
48978236|NCT04539262|157752087|FG005|Overall Study|Adverse Event|0|||
48978237|NCT04539262|157752088|FG006|Overall Study|Adverse Event|0|||
48978238|NCT04539262|157752089|FG007|Overall Study|Adverse Event|0|||
48978239|NCT04539262|157752082|FG000|Overall Study|Withdrew Consent|0|||
48978240|NCT04539262|157752083|FG001|Overall Study|Withdrew Consent|0|||
48978241|NCT04539262|157752084|FG002|Overall Study|Withdrew Consent|0|||
48978242|NCT04539262|157752085|FG003|Overall Study|Withdrew Consent|1|||
48675839|NCT04566692|156665389|FG000|Overall Study|Withdrawal by Subject|1|||
48675840|NCT04566692|156665390|FG001|Overall Study|Withdrawal by Subject|1|||
48978243|NCT04539262|157752086|FG004|Overall Study|Withdrew Consent|0|||
48978244|NCT04539262|157752087|FG005|Overall Study|Withdrew Consent|0|||
48978245|NCT04539262|157752088|FG006|Overall Study|Withdrew Consent|0|||
48978246|NCT04539262|157752089|FG007|Overall Study|Withdrew Consent|0|||
48675841|NCT02690714|156665391|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1|||
48978247|NCT04539262|157752082|FG000|Overall Study|Randomized, Not treated|0|||
48978248|NCT04539262|157752083|FG001|Overall Study|Randomized, Not treated|1|||
48675842|NCT02690714|156665391|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1|||
48675843|NCT00377364|156665392|FG000|Overall Study|Lost to Follow-up|1|||
48978249|NCT04539262|157752084|FG002|Overall Study|Randomized, Not treated|0|||
48978250|NCT04539262|157752085|FG003|Overall Study|Randomized, Not treated|0|||
48978251|NCT04539262|157752086|FG004|Overall Study|Randomized, Not treated|0|||
48978252|NCT04539262|157752087|FG005|Overall Study|Randomized, Not treated|0|||
48978253|NCT04539262|157752088|FG006|Overall Study|Randomized, Not treated|1|||
48978254|NCT04539262|157752089|FG007|Overall Study|Randomized, Not treated|0|||
48978255|NCT02635867|157752091|FG000|Overall Study|Lost to Follow-up|4|||
48978256|NCT02635867|157752092|FG001|Overall Study|Lost to Follow-up|3|||
48978257|NCT02635867|157752093|FG002|Overall Study|Lost to Follow-up|3|||
48978258|NCT02635867|157752094|FG003|Overall Study|Lost to Follow-up|4|||
48978259|NCT02635867|157752095|FG004|Overall Study|Lost to Follow-up|1|||
48978260|NCT04159701|157752100|FG000|Period 1: Treatment Period|Pregnancy|1|||
48978261|NCT04159701|157752101|FG001|Period 1: Treatment Period|Pregnancy|0|||
48978262|NCT04159701|157752100|FG000|Period 1: Treatment Period|Study Terminated by sponsor|4|||
48978263|NCT04159701|157752101|FG001|Period 1: Treatment Period|Study Terminated by sponsor|1|||
48978264|NCT04159701|157752100|FG000|Period 1: Treatment Period|Withdrawal by Subject|3|||
48978265|NCT04159701|157752101|FG001|Period 1: Treatment Period|Withdrawal by Subject|0|||
48978266|NCT04159701|157752100|FG000|Washout Period|site terminated by sponsor|0|||
48978267|NCT04159701|157752101|FG001|Washout Period|site terminated by sponsor|1|||
48978268|NCT04159701|157752100|FG000|Washout Period|study terminated by sponsor|10|||
48978269|NCT04159701|157752101|FG001|Washout Period|study terminated by sponsor|3|||
48978270|NCT04159701|157752100|FG000|Washout Period|Withdrawal by Subject|1|||
48978271|NCT04159701|157752101|FG001|Washout Period|Withdrawal by Subject|0|||
48978272|NCT04159701|157752100|FG000|Washout Period|Inadvertent Enrollment|1|||
48978273|NCT04159701|157752101|FG001|Washout Period|Inadvertent Enrollment|0|||
48978274|NCT04159701|157752100|FG000|Washout Period|Miscellaneous|1|||
48978275|NCT04159701|157752101|FG001|Washout Period|Miscellaneous|0|||
48978276|NCT04159701|157752100|FG000|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|0|||
48675844|NCT00377364|156665393|FG001|Overall Study|Lost to Follow-up|0|||
48675845|NCT00377364|156665392|FG000|Overall Study|Withdrawal by Subject|1|||
48675846|NCT00377364|156665393|FG001|Overall Study|Withdrawal by Subject|0|||
48675847|NCT00410605|156665398|FG000|Overall Study|Adverse Event|12|||
48675848|NCT00410605|156665398|FG000|Overall Study|Physician Decision|3|||
48675849|NCT00410605|156665398|FG000|Overall Study|Withdrawal by Subject|5|||
48675850|NCT00410605|156665398|FG000|Overall Study|Started Non-Protocol Therapy|3|||
48675851|NCT00410605|156665398|FG000|Overall Study|Stopped treatmen to collect stem cells|1|||
48675852|NCT00410605|156665398|FG000|Overall Study|Transferred to another Institution|1|||
48675853|NCT01817959|156665399|FG000|Overall Study|Graft loss|1|||
48675854|NCT01817959|156665400|FG001|Overall Study|Graft loss|1|||
48675855|NCT01817959|156665399|FG000|Overall Study|forbidden medication|1|||
48675856|NCT01817959|156665400|FG001|Overall Study|forbidden medication|1|||
48675857|NCT01817959|156665399|FG000|Overall Study|Adverse Event|1|||
48675858|NCT01817959|156665400|FG001|Overall Study|Adverse Event|0|||
48675859|NCT01817959|156665399|FG000|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
48675860|NCT01817959|156665400|FG001|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
48675861|NCT03262441|156665401|FG000|Overall Study|Withdrawal by Subject|1|||
48675862|NCT03576716|156665411|FG000|Overall Study|Withdrawal by Subject|0|||
48675863|NCT03576716|156665412|FG001|Overall Study|Withdrawal by Subject|1|||
48675864|NCT02409342|156665414|FG000|Overall Study|Death|211|||
48675865|NCT02409342|156665415|FG001|Overall Study|Death|201|||
48675866|NCT02409342|156665414|FG000|Overall Study|Withdrawal by Subject|24|||
48675867|NCT02409342|156665415|FG001|Overall Study|Withdrawal by Subject|17|||
48675868|NCT02409342|156665414|FG000|Overall Study|Study Terminated By Sponsor|48|||
48978277|NCT04159701|157752101|FG001|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|2|||
48978278|NCT04159701|157752100|FG000|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|0|||
48675869|NCT02409342|156665415|FG001|Overall Study|Study Terminated By Sponsor|59|||
48762026|NCT00549562|156975746|FG000|Overall Study|Lack of Efficacy|1|||
48762027|NCT02355691|156977989|FG000|Overall Study|Loss of Research Personnel|7|||
48762028|NCT02355691|156977990|FG001|Overall Study|Loss of Research Personnel|9|||
48762029|NCT03989440|156977991|FG000|Overall Study|COVID-19 travel restrictions|0|||
48762030|NCT03989440|156977992|FG001|Overall Study|COVID-19 travel restrictions|0|||
48762031|NCT03989440|156977993|FG002|Overall Study|COVID-19 travel restrictions|1|||
48762032|NCT03989440|156977994|FG003|Overall Study|COVID-19 travel restrictions|0|||
48762033|NCT03989440|156977995|FG004|Overall Study|COVID-19 travel restrictions|0|||
48762034|NCT03989440|156977996|FG005|Overall Study|COVID-19 travel restrictions|0|||
48762035|NCT03989440|156977991|FG000|Overall Study|Unsuccessful lumbar puncture|0|||
48762036|NCT03989440|156977992|FG001|Overall Study|Unsuccessful lumbar puncture|0|||
48762037|NCT03989440|156977993|FG002|Overall Study|Unsuccessful lumbar puncture|0|||
48762038|NCT03989440|156977994|FG003|Overall Study|Unsuccessful lumbar puncture|1|||
48762039|NCT03989440|156977995|FG004|Overall Study|Unsuccessful lumbar puncture|0|||
48762040|NCT03989440|156977996|FG005|Overall Study|Unsuccessful lumbar puncture|0|||
48762041|NCT03265249|156977997|FG000|Overall Study|Withdrawal by Subject|0|||
48762042|NCT03265249|156977998|FG001|Overall Study|Withdrawal by Subject|1|||
48762043|NCT01277523|156977999|FG000|Overall Study|Adverse Event|1|||
48675870|NCT02409342|156665414|FG000|Overall Study|Lost to Follow-up|3|||
48762044|NCT01277523|156978000|FG001|Overall Study|Adverse Event|0|||
48762045|NCT01277523|156978001|FG002|Overall Study|Adverse Event|0|||
48762046|NCT01277523|156977999|FG000|Overall Study|Protocol Violation|2|||
48675871|NCT02409342|156665415|FG001|Overall Study|Lost to Follow-up|5|||
48675872|NCT02409342|156665414|FG000|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|0|||
48762047|NCT01277523|156978000|FG001|Overall Study|Protocol Violation|0|||
48675873|NCT02409342|156665415|FG001|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|1|||
48675874|NCT02409342|156665414|FG000|Overall Study|Participant Moved Into Roll-Over Study|0|||
48675875|NCT02409342|156665415|FG001|Overall Study|Participant Moved Into Roll-Over Study|2|||
48675876|NCT02409342|156665414|FG000|Overall Study|Sponsor Decision|1|||
48675877|NCT02409342|156665415|FG001|Overall Study|Sponsor Decision|0|||
48675878|NCT03688620|156665416|FG000|Overall Study|Other|0|||
48675879|NCT03688620|156665417|FG001|Overall Study|Other|0|||
48675880|NCT03688620|156665418|FG002|Overall Study|Other|1|||
48675881|NCT03688620|156665416|FG000|Overall Study|Unwilling to attend the scheduled visit|0|||
48675882|NCT03688620|156665417|FG001|Overall Study|Unwilling to attend the scheduled visit|1|||
48978279|NCT04159701|157752101|FG001|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|1|||
48978280|NCT04159701|157752100|FG000|Post-treatment Follow-up|Study Terminated by Sponsor|6|||
48978281|NCT04159701|157752101|FG001|Post-treatment Follow-up|Study Terminated by Sponsor|3|||
48978282|NCT04159701|157752100|FG000|Post-treatment Follow-up|Withdrawal by Subject|3|||
48978283|NCT04159701|157752101|FG001|Post-treatment Follow-up|Withdrawal by Subject|0|||
48978284|NCT04159701|157752100|FG000|Post-treatment Follow-up|Inadvertent Enrollment|1|||
48978285|NCT04159701|157752101|FG001|Post-treatment Follow-up|Inadvertent Enrollment|0|||
48978286|NCT01849562|157752102|FG000|Overall Study|Lost to Follow-up|1|||
48978287|NCT01849562|157752103|FG001|Overall Study|Lost to Follow-up|0|||
48978288|NCT01849562|157752104|FG002|Overall Study|Lost to Follow-up|0|||
48978289|NCT01849562|157752102|FG000|Overall Study|Non-compliance with Study Drug|1|||
48978290|NCT01849562|157752103|FG001|Overall Study|Non-compliance with Study Drug|0|||
48978291|NCT01849562|157752104|FG002|Overall Study|Non-compliance with Study Drug|0|||
48978292|NCT01819194|157752108|FG000|Overall Study|Loss of study articles|2|||
48978293|NCT04737759|157752110|FG000|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|12|||
48978294|NCT04737759|157752111|FG001|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|4|||
48978295|NCT04737759|157752110|FG000|Overall Study|Death|2|||
48978296|NCT04737759|157752111|FG001|Overall Study|Death|0|||
48675883|NCT03688620|156665418|FG002|Overall Study|Unwilling to attend the scheduled visit|0|||
48675884|NCT03688620|156665416|FG000|Overall Study|Lost to Follow-up|16|||
48675885|NCT03688620|156665417|FG001|Overall Study|Lost to Follow-up|0|||
48675886|NCT03688620|156665418|FG002|Overall Study|Lost to Follow-up|1|||
48675887|NCT03688620|156665416|FG000|Overall Study|Withdrawal by Subject|0|||
48675888|NCT03688620|156665417|FG001|Overall Study|Withdrawal by Subject|0|||
48675889|NCT03688620|156665418|FG002|Overall Study|Withdrawal by Subject|6|||
48675890|NCT00416455|156665426|FG000|Overall Study|PET / CT not done|3|||
48675891|NCT00416455|156665427|FG001|Overall Study|PET / CT not done|5|||
48675892|NCT00416455|156665426|FG000|Overall Study|PET / CT poor quality|2|||
48675893|NCT00416455|156665427|FG001|Overall Study|PET / CT poor quality|1|||
48675894|NCT00416455|156665426|FG000|Overall Study|Inadequate pathology|11|||
48675895|NCT00416455|156665427|FG001|Overall Study|Inadequate pathology|2|||
48675896|NCT01298765|156665428|FG000|Titration Period|Adverse Event|26|||
48675897|NCT01298765|156665428|FG000|Titration Period|Death|1|||
48675898|NCT01298765|156665428|FG000|Titration Period|Lack of Efficacy|21|||
48675899|NCT01298765|156665428|FG000|Titration Period|Lost to Follow-up|9|||
48675900|NCT01298765|156665428|FG000|Titration Period|Physician Decision|1|||
48675901|NCT01298765|156665428|FG000|Titration Period|Withdrawal by Subject|10|||
48675902|NCT01298765|156665428|FG000|Titration Period|Other: Not Lack of Analgesic Effect|8|||
48675903|NCT01298765|156665428|FG000|Long-Term Treatment Period|Adverse Event|19|||
48675904|NCT01298765|156665428|FG000|Long-Term Treatment Period|Lack of Efficacy|6|||
48675905|NCT01298765|156665428|FG000|Long-Term Treatment Period|Lost to Follow-up|8|||
48675906|NCT01298765|156665428|FG000|Long-Term Treatment Period|Withdrawal by Subject|19|||
48675907|NCT01298765|156665428|FG000|Long-Term Treatment Period|Physician Decision|1|||
48675908|NCT01298765|156665428|FG000|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46|||
48675909|NCT00847197|156665429|FG000|Overall Study|Adverse Event|21|||
48675910|NCT00847197|156665430|FG001|Overall Study|Adverse Event|3|||
48675911|NCT00847197|156665429|FG000|Overall Study|Protocol Violation|0|||
48675912|NCT00847197|156665430|FG001|Overall Study|Protocol Violation|1|||
48675913|NCT00847197|156665429|FG000|Overall Study|Withdrawal by Subject|3|||
48675914|NCT00847197|156665430|FG001|Overall Study|Withdrawal by Subject|1|||
48675915|NCT02283788|156665433|FG000|Overall Study|Adverse Event|1|||
48675916|NCT02283788|156665434|FG001|Overall Study|Adverse Event|3|||
48675917|NCT02283788|156665435|FG002|Overall Study|Adverse Event|5|||
48675918|NCT02283788|156665436|FG003|Overall Study|Adverse Event|1|||
48675919|NCT02283788|156665433|FG000|Overall Study|Withdrawal by Subject|0|||
48762048|NCT01277523|156978001|FG002|Overall Study|Protocol Violation|0|||
48762049|NCT01277523|156977999|FG000|Overall Study|Other Reason not Defined|0|||
48762050|NCT01277523|156978000|FG001|Overall Study|Other Reason not Defined|1|||
48762051|NCT01277523|156978001|FG002|Overall Study|Other Reason not Defined|0|||
48874222|NCT00943722|157376964|FG003|Second Extension Study: EXT 2|Pregnancy|0|||
48675920|NCT02283788|156665434|FG001|Overall Study|Withdrawal by Subject|1|||
48675921|NCT02283788|156665435|FG002|Overall Study|Withdrawal by Subject|0|||
48762052|NCT04608500|156978002|FG000|Overall Study|Adverse Event|2|||
48978297|NCT04737759|157752110|FG000|Overall Study|spouse dropped when adult with heart failure died|2|||
48978298|NCT04737759|157752111|FG001|Overall Study|spouse dropped when adult with heart failure died|0|||
48978299|NCT04737759|157752110|FG000|Overall Study|Lost to Follow-up|4|||
48978300|NCT04737759|157752111|FG001|Overall Study|Lost to Follow-up|12|||
48978301|NCT00633360|157752112|FG000|Overall Study|Lost to Follow-up|1|||
48978302|NCT00633360|157752113|FG001|Overall Study|Lost to Follow-up|1|||
48978303|NCT00633360|157752112|FG000|Overall Study|Adverse Event|3|||
48978304|NCT00633360|157752113|FG001|Overall Study|Adverse Event|1|||
48978305|NCT00633360|157752112|FG000|Overall Study|Protocol Violation|0|||
48978306|NCT00633360|157752113|FG001|Overall Study|Protocol Violation|1|||
48978307|NCT00329784|157752114|FG000|Overall Study|Lost to Follow-up|0|||
48978308|NCT00329784|157752115|FG001|Overall Study|Lost to Follow-up|1|||
48978309|NCT00329784|157752116|FG002|Overall Study|Lost to Follow-up|0|||
48978310|NCT00329784|157752117|FG003|Overall Study|Lost to Follow-up|0|||
48978311|NCT00329784|157752114|FG000|Overall Study|Withdrawal by Subject|4|||
48978312|NCT00329784|157752115|FG001|Overall Study|Withdrawal by Subject|2|||
48978313|NCT00329784|157752116|FG002|Overall Study|Withdrawal by Subject|0|||
48978314|NCT00329784|157752117|FG003|Overall Study|Withdrawal by Subject|0|||
48978315|NCT00329784|157752114|FG000|Overall Study|Other|1|||
48978316|NCT00329784|157752115|FG001|Overall Study|Other|2|||
48978317|NCT00329784|157752116|FG002|Overall Study|Other|0|||
48978318|NCT00329784|157752117|FG003|Overall Study|Other|0|||
48978319|NCT01505114|157752118|FG000|Overall Study|Withdrawal by Subject|5|||
48978320|NCT01505114|157752119|FG001|Overall Study|Withdrawal by Subject|4|||
48978321|NCT01505114|157752120|FG002|Overall Study|Withdrawal by Subject|4|||
48978322|NCT01505114|157752121|FG003|Overall Study|Withdrawal by Subject|7|||
48978323|NCT01505114|157752118|FG000|Overall Study|Death|1|||
48978324|NCT01505114|157752119|FG001|Overall Study|Death|0|||
48978325|NCT01505114|157752120|FG002|Overall Study|Death|0|||
48978326|NCT01505114|157752121|FG003|Overall Study|Death|1|||
48978327|NCT01505114|157752118|FG000|Overall Study|unable to adhere to visit schedule|3|||
48978328|NCT01505114|157752119|FG001|Overall Study|unable to adhere to visit schedule|2|||
48978329|NCT01505114|157752120|FG002|Overall Study|unable to adhere to visit schedule|3|||
48978330|NCT01505114|157752121|FG003|Overall Study|unable to adhere to visit schedule|3|||
48978331|NCT01505114|157752118|FG000|Overall Study|Lost to Follow-up|11|||
48978332|NCT01505114|157752119|FG001|Overall Study|Lost to Follow-up|5|||
48978333|NCT01505114|157752120|FG002|Overall Study|Lost to Follow-up|8|||
48978334|NCT01505114|157752121|FG003|Overall Study|Lost to Follow-up|7|||
48978335|NCT01505114|157752118|FG000|Overall Study|relocated|4|||
48978336|NCT01505114|157752119|FG001|Overall Study|relocated|2|||
48978337|NCT01505114|157752120|FG002|Overall Study|relocated|2|||
48978338|NCT01505114|157752121|FG003|Overall Study|relocated|3|||
48978339|NCT01505114|157752118|FG000|Overall Study|inadvertent enrollment due to peanut all|0|||
48978340|NCT01505114|157752119|FG001|Overall Study|inadvertent enrollment due to peanut all|0|||
48978341|NCT01505114|157752120|FG002|Overall Study|inadvertent enrollment due to peanut all|0|||
48978342|NCT01505114|157752121|FG003|Overall Study|inadvertent enrollment due to peanut all|1|||
48978343|NCT01505114|157752118|FG000|Overall Study|staff safety concerns|0|||
48978344|NCT01505114|157752119|FG001|Overall Study|staff safety concerns|0|||
48978345|NCT01505114|157752120|FG002|Overall Study|staff safety concerns|0|||
48978346|NCT01505114|157752121|FG003|Overall Study|staff safety concerns|1|||
48978347|NCT01505114|157752118|FG000|Overall Study|investigator decision|1|||
48978348|NCT01505114|157752119|FG001|Overall Study|investigator decision|0|||
48978349|NCT01505114|157752120|FG002|Overall Study|investigator decision|1|||
48978350|NCT01505114|157752121|FG003|Overall Study|investigator decision|0|||
48978351|NCT00481988|157752122|FG000|Overall Study|Withdrawal by Subject|1|||
48978352|NCT00481988|157752123|FG001|Overall Study|Withdrawal by Subject|1|||
48978353|NCT00654420|157752124|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
48978354|NCT00654420|157752125|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
48978355|NCT00654420|157752126|FG002|Phase I (Dose Escalation)|Adverse Event|0|||
48978356|NCT00654420|157752127|FG003|Phase I (Dose Escalation)|Adverse Event|0|||
48978357|NCT00654420|157752124|FG000|Phase I (Dose Escalation)|Progressive Disease|4|||
48978358|NCT00654420|157752125|FG001|Phase I (Dose Escalation)|Progressive Disease|15|||
48978359|NCT00654420|157752126|FG002|Phase I (Dose Escalation)|Progressive Disease|0|||
48978360|NCT00654420|157752127|FG003|Phase I (Dose Escalation)|Progressive Disease|0|||
48978361|NCT00654420|157752124|FG000|Phase II|Adverse Event|0|||
48978362|NCT00654420|157752125|FG001|Phase II|Adverse Event|0|||
48978363|NCT00654420|157752126|FG002|Phase II|Adverse Event|3|||
48978364|NCT00654420|157752127|FG003|Phase II|Adverse Event|3|||
48978365|NCT00654420|157752124|FG000|Phase II|Lost to Follow-up|0|||
48978366|NCT00654420|157752125|FG001|Phase II|Lost to Follow-up|0|||
48978367|NCT00654420|157752126|FG002|Phase II|Lost to Follow-up|0|||
48978368|NCT00654420|157752127|FG003|Phase II|Lost to Follow-up|1|||
48978369|NCT00654420|157752124|FG000|Phase II|Physician Decision|0|||
48978370|NCT00654420|157752125|FG001|Phase II|Physician Decision|0|||
48978371|NCT00654420|157752126|FG002|Phase II|Physician Decision|0|||
48978372|NCT00654420|157752127|FG003|Phase II|Physician Decision|4|||
48978373|NCT00654420|157752124|FG000|Phase II|Progressive Disease|0|||
48978374|NCT00654420|157752125|FG001|Phase II|Progressive Disease|0|||
48675922|NCT02283788|156665436|FG003|Overall Study|Withdrawal by Subject|1|||
48675923|NCT04378114|156665437|FG000|Overall Study|Withdrawal by Subject|5|||
48675924|NCT00605345|156665442|FG000|Overall Study|Withdrawal by Subject|1|||
48675925|NCT00605345|156665443|FG001|Overall Study|Withdrawal by Subject|0|||
48978375|NCT00654420|157752126|FG002|Phase II|Progressive Disease|29|||
48978376|NCT00654420|157752127|FG003|Phase II|Progressive Disease|29|||
48978377|NCT00654420|157752124|FG000|Phase II|Withdrawal by Subject|0|||
48978378|NCT00654420|157752125|FG001|Phase II|Withdrawal by Subject|0|||
48978379|NCT00654420|157752126|FG002|Phase II|Withdrawal by Subject|4|||
48978380|NCT00654420|157752127|FG003|Phase II|Withdrawal by Subject|1|||
48978381|NCT00654420|157752124|FG000|Phase II|Missing Disposition Record|0|||
48978382|NCT00654420|157752125|FG001|Phase II|Missing Disposition Record|0|||
48978383|NCT00654420|157752126|FG002|Phase II|Missing Disposition Record|1|||
48978384|NCT00654420|157752127|FG003|Phase II|Missing Disposition Record|0|||
48978385|NCT02252588|157752130|FG000|Overall Study|Withdrawal by Subject|4|||
48978386|NCT02252588|157752131|FG001|Overall Study|Withdrawal by Subject|0|||
48978387|NCT01235507|157752141|FG000|Overall Study|Adverse Event|1|||
48978388|NCT01235507|157752141|FG000|Overall Study|Withdrawal by Subject|1|||
48978389|NCT00610207|157752142|FG000|Overall Study|Lost to Follow-up|3|||
48978390|NCT00638690|157752145|FG000|Overall Study|Death|655|||
48978391|NCT00638690|157752146|FG001|Overall Study|Death|335|||
48978392|NCT00638690|157752145|FG000|Overall Study|Withdrawal by Subject|22|||
48978393|NCT00638690|157752146|FG001|Overall Study|Withdrawal by Subject|5|||
48978394|NCT00638690|157752145|FG000|Overall Study|Lost to Follow-up|4|||
48978395|NCT00638690|157752146|FG001|Overall Study|Lost to Follow-up|2|||
48978396|NCT02348840|157752150|FG000|Overall Study|Withdrawal by Subject|2|||
48978397|NCT02348840|157752151|FG001|Overall Study|Withdrawal by Subject|1|||
48978398|NCT02348840|157752152|FG002|Overall Study|Withdrawal by Subject|0|||
48978399|NCT02348840|157752153|FG003|Overall Study|Withdrawal by Subject|0|||
48978400|NCT03748420|157752156|FG000|Overall Study|No 12 month medication adherence data available|0|||
48978401|NCT03748420|157752157|FG001|Overall Study|No 12 month medication adherence data available|1|||
48978402|NCT03748420|157752156|FG000|Overall Study|Death|24|||
48978403|NCT03748420|157752157|FG001|Overall Study|Death|28|||
48978404|NCT03748420|157752156|FG000|Overall Study|Lost to Follow-up|231|||
48978405|NCT03748420|157752157|FG001|Overall Study|Lost to Follow-up|230|||
48978406|NCT00373880|157752158|FG000|Overall Study|Physician Decision|3|||
48978407|NCT00373880|157752158|FG000|Overall Study|Arrested|1|||
48978408|NCT00373880|157752158|FG000|Overall Study|Protocol Violation|14|||
48978409|NCT04007367|157752160|FG000|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|43|||
48978410|NCT04007367|157752161|FG001|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
48978411|NCT04007367|157752162|FG002|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
48978412|NCT04007367|157752160|FG000|Open-Label Phase (8-Weeks)|Adverse Event|2|||
48978413|NCT04007367|157752161|FG001|Open-Label Phase (8-Weeks)|Adverse Event|0|||
48978414|NCT04007367|157752162|FG002|Open-Label Phase (8-Weeks)|Adverse Event|0|||
48978415|NCT04007367|157752160|FG000|Open-Label Phase (8-Weeks)|Withdrawal by Participant|2|||
48978416|NCT04007367|157752161|FG001|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
48978417|NCT04007367|157752162|FG002|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
48978418|NCT04007367|157752160|FG000|Open-Label Phase (8-Weeks)|Non-compliance|1|||
48978419|NCT04007367|157752161|FG001|Open-Label Phase (8-Weeks)|Non-compliance|0|||
48978420|NCT04007367|157752162|FG002|Open-Label Phase (8-Weeks)|Non-compliance|0|||
48978421|NCT04007367|157752160|FG000|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
48978422|NCT04007367|157752161|FG001|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
48978423|NCT04007367|157752162|FG002|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|2|||
48978424|NCT03236506|157752163|FG000|Overall Study|Death|1|||
48978425|NCT03236506|157752164|FG001|Overall Study|Death|1|||
48978426|NCT03236506|157752165|FG002|Overall Study|Death|1|||
48978427|NCT03236506|157752163|FG000|Overall Study|Withdrawal by Subject|3|||
48675926|NCT00605345|156665442|FG000|Overall Study|Adverse Event|0|||
48675927|NCT00605345|156665443|FG001|Overall Study|Adverse Event|1|||
48675928|NCT00605345|156665442|FG000|Overall Study|Protocol Violation|0|||
48675929|NCT00605345|156665443|FG001|Overall Study|Protocol Violation|2|||
48675930|NCT01300572|156665445|FG000|Overall Study|HAMA + post dosimetry|1|||
48675931|NCT00384332|156665446|FG000|Overall Study|Lost to Follow-up|4|||
48675932|NCT00384332|156665447|FG001|Overall Study|Lost to Follow-up|0|||
48978428|NCT03236506|157752164|FG001|Overall Study|Withdrawal by Subject|3|||
48978429|NCT03236506|157752165|FG002|Overall Study|Withdrawal by Subject|4|||
48978430|NCT03236506|157752163|FG000|Overall Study|Did not initiate treatment|2|||
48978431|NCT03236506|157752164|FG001|Overall Study|Did not initiate treatment|1|||
48978432|NCT03236506|157752165|FG002|Overall Study|Did not initiate treatment|2|||
48978433|NCT01466062|157752166|FG000|Overall Study|Adverse Event|1|||
48978434|NCT01466062|157752166|FG000|Overall Study|Withdrawal by Subject|1|||
48978435|NCT00118040|157752167|FG000|Overall Study|Adverse Event|0|||
48978436|NCT00118040|157752168|FG001|Overall Study|Adverse Event|1|||
48978437|NCT00118040|157752169|FG002|Overall Study|Adverse Event|0|||
48675933|NCT01278797|156665450|FG000|Period 1|Adverse Event|0|||
48675934|NCT01278797|156665451|FG001|Period 1|Adverse Event|1|||
48978438|NCT00118040|157752167|FG000|Overall Study|Withdrawal by Subject|0|||
48978439|NCT00118040|157752168|FG001|Overall Study|Withdrawal by Subject|0|||
48978440|NCT00118040|157752169|FG002|Overall Study|Withdrawal by Subject|2|||
48978441|NCT00118040|157752167|FG000|Overall Study|Medical Contraindication|0|||
48978442|NCT00118040|157752168|FG001|Overall Study|Medical Contraindication|0|||
48978443|NCT00118040|157752169|FG002|Overall Study|Medical Contraindication|1|||
48978444|NCT00118040|157752167|FG000|Overall Study|Non-Compliant Participant|1|||
48978445|NCT00118040|157752168|FG001|Overall Study|Non-Compliant Participant|1|||
48978446|NCT00118040|157752169|FG002|Overall Study|Non-Compliant Participant|2|||
48978447|NCT00118040|157752167|FG000|Overall Study|Other|0|||
48978448|NCT00118040|157752168|FG001|Overall Study|Other|0|||
48978449|NCT00118040|157752169|FG002|Overall Study|Other|1|||
48978450|NCT01975376|157752170|FG000|Overall Study|Adverse Event|5|||
48675935|NCT01278797|156665450|FG000|Period 1|Protocol Violation|1|||
48978451|NCT01975376|157752171|FG001|Overall Study|Adverse Event|5|||
48978452|NCT01975376|157752170|FG000|Overall Study|Death|65|||
48978453|NCT01975376|157752171|FG001|Overall Study|Death|72|||
48978454|NCT01975376|157752170|FG000|Overall Study|Lost to Follow-up|70|||
48978455|NCT01975376|157752171|FG001|Overall Study|Lost to Follow-up|66|||
48978456|NCT01975376|157752170|FG000|Overall Study|Withdrew consent|68|||
48978457|NCT01975376|157752171|FG001|Overall Study|Withdrew consent|62|||
48978458|NCT01975376|157752170|FG000|Overall Study|Other|2|||
48978459|NCT01975376|157752171|FG001|Overall Study|Other|4|||
48978460|NCT01975376|157752170|FG000|Overall Study|Randomized, Not Treated|16|||
48978461|NCT01975376|157752171|FG001|Overall Study|Randomized, Not Treated|8|||
48978462|NCT04489940|157752172|FG000|Overall Study|Other|2|||
48978463|NCT04489940|157752172|FG000|Overall Study|Withdrawal by Subject|2|||
48978464|NCT04489940|157752172|FG000|Overall Study|Death|5|||
48978465|NCT04489940|157752172|FG000|Overall Study|Lost to Follow-up|1|||
48978466|NCT02725268|157752173|FG000|Overall Study|Death|58|||
48978467|NCT02725268|157752174|FG001|Overall Study|Death|59|||
48978468|NCT02725268|157752175|FG002|Overall Study|Death|30|||
48978469|NCT02725268|157752176|FG003|Overall Study|Death|16|||
48978470|NCT02725268|157752173|FG000|Overall Study|Lost to Follow-up|4|||
48978471|NCT02725268|157752174|FG001|Overall Study|Lost to Follow-up|3|||
48978472|NCT02725268|157752175|FG002|Overall Study|Lost to Follow-up|0|||
48978473|NCT02725268|157752176|FG003|Overall Study|Lost to Follow-up|1|||
48978474|NCT02725268|157752173|FG000|Overall Study|Site Terminated by Sponsor|0|||
48978475|NCT02725268|157752174|FG001|Overall Study|Site Terminated by Sponsor|1|||
48978476|NCT02725268|157752175|FG002|Overall Study|Site Terminated by Sponsor|0|||
48978477|NCT02725268|157752176|FG003|Overall Study|Site Terminated by Sponsor|0|||
48978478|NCT02725268|157752173|FG000|Overall Study|Withdrawal by Subject|8|||
48978479|NCT02725268|157752174|FG001|Overall Study|Withdrawal by Subject|6|||
48978480|NCT02725268|157752175|FG002|Overall Study|Withdrawal by Subject|8|||
48978481|NCT02725268|157752176|FG003|Overall Study|Withdrawal by Subject|1|||
48978482|NCT02725268|157752173|FG000|Overall Study|Reason not Specified|2|||
48978483|NCT02725268|157752174|FG001|Overall Study|Reason not Specified|1|||
48978484|NCT02725268|157752175|FG002|Overall Study|Reason not Specified|0|||
48978485|NCT02725268|157752176|FG003|Overall Study|Reason not Specified|0|||
48978486|NCT02201472|157752177|FG000|Overall Study|Lack of Efficacy|2|||
48978487|NCT00117572|157752180|FG000|Overall Study|Site withdrew before starting treatment|2|||
48978488|NCT00117572|157752181|FG001|Overall Study|Site withdrew before starting treatment|3|||
48978489|NCT00117572|157752180|FG000|Overall Study|Withdrawal by Subject|3|||
48978490|NCT00117572|157752181|FG001|Overall Study|Withdrawal by Subject|3|||
48978491|NCT00117572|157752180|FG000|Overall Study|Protocol Violation|1|||
48978492|NCT00117572|157752181|FG001|Overall Study|Protocol Violation|0|||
48978493|NCT00322387|157752187|FG000|Treatment Period|Adverse Event|0|||
48978494|NCT00322387|157752188|FG001|Treatment Period|Adverse Event|1|||
48978495|NCT00322387|157752187|FG000|Follow-up Period|Final assessment not done|1|||
48978496|NCT00322387|157752188|FG001|Follow-up Period|Final assessment not done|3|||
48978497|NCT00322387|157752187|FG000|Follow-up Period|Death|1|||
48978498|NCT00322387|157752188|FG001|Follow-up Period|Death|0|||
48978499|NCT04973085|157752189|FG000|First Intervention|Claustrophobia in the MRI machine.|1|||
48978500|NCT04973085|157752190|FG001|First Intervention|Claustrophobia in the MRI machine.|0|||
48978501|NCT00654368|157752195|FG000|Overall Study|Ineligibility determined|6|||
48978502|NCT00654368|157752196|FG001|Overall Study|Ineligibility determined|0|||
48978503|NCT00654368|157752197|FG002|Overall Study|Ineligibility determined|0|||
48978504|NCT00654368|157752195|FG000|Overall Study|Protocol deviation|3|||
48978505|NCT00654368|157752196|FG001|Overall Study|Protocol deviation|2|||
48978506|NCT00654368|157752197|FG002|Overall Study|Protocol deviation|1|||
48978507|NCT00654368|157752195|FG000|Overall Study|Non-compliance|2|||
48978508|NCT00654368|157752196|FG001|Overall Study|Non-compliance|1|||
48978509|NCT00654368|157752197|FG002|Overall Study|Non-compliance|2|||
48978510|NCT00654368|157752195|FG000|Overall Study|Withdrawal by Subject|5|||
48978511|NCT00654368|157752196|FG001|Overall Study|Withdrawal by Subject|2|||
48978512|NCT00654368|157752197|FG002|Overall Study|Withdrawal by Subject|2|||
48978513|NCT00654368|157752195|FG000|Overall Study|Disease progression|21|||
48978514|NCT00654368|157752196|FG001|Overall Study|Disease progression|31|||
48978515|NCT00654368|157752197|FG002|Overall Study|Disease progression|13|||
48978516|NCT00654368|157752195|FG000|Overall Study|Requirement for alternative therapy|1|||
48874223|NCT00943722|157376965|FG004|Second Extension Study: EXT 2|Pregnancy|0|||
48874224|NCT00943722|157376966|FG005|Second Extension Study: EXT 2|Pregnancy|1|||
48874225|NCT00943722|157376967|FG006|Second Extension Study: EXT 2|Pregnancy|0|||
48874226|NCT00943722|157376961|FG000|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
48874227|NCT00943722|157376962|FG001|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
48874228|NCT00943722|157376963|FG002|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
48874229|NCT00943722|157376964|FG003|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
48874230|NCT00943722|157376965|FG004|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
48874231|NCT00943722|157376966|FG005|Second Extension Study: EXT 2|Withdrawal by Subject|137|||
48874232|NCT00943722|157376967|FG006|Second Extension Study: EXT 2|Withdrawal by Subject|50|||
48874233|NCT01036165|157376972|FG000|Overall Study|Adverse Event|6|||
48874234|NCT01036165|157376972|FG000|Overall Study|Lost to Follow-up|2|||
48874235|NCT01036165|157376972|FG000|Overall Study|Withdrawal by Subject|3|||
48874236|NCT01036165|157376972|FG000|Overall Study|Device Related Issues|3|||
48874237|NCT01036165|157376972|FG000|Overall Study|Problems finding proper area to inject|1|||
48874238|NCT01441583|157376974|FG000|Overall Study|Withdrawal by Subject|1|||
48874239|NCT01441583|157376975|FG001|Overall Study|Withdrawal by Subject|1|||
48874240|NCT01441583|157376976|FG002|Overall Study|Withdrawal by Subject|1|||
48874241|NCT01441583|157376974|FG000|Overall Study|Death|1|||
48874242|NCT01441583|157376975|FG001|Overall Study|Death|0|||
48874243|NCT01441583|157376976|FG002|Overall Study|Death|4|||
48874244|NCT01441583|157376974|FG000|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
48874245|NCT01441583|157376975|FG001|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
48874246|NCT01441583|157376976|FG002|Overall Study|Underwent anaesthesia, but not finally implanted|4|||
48874247|NCT00412880|157376979|FG000|Overall Study|Withdrew, overdose of study treatment|1|||
48874248|NCT00412880|157376979|FG000|Overall Study|Consent withdrawn|1|||
48874249|NCT00412880|157376979|FG000|Overall Study|Adverse Event|1|||
48874250|NCT00412880|157376979|FG000|Overall Study|Progressive disease|20|||
48874251|NCT01085812|157376980|FG000|Open-Label Period|Adverse Event|0|||
48874252|NCT01085812|157376981|FG001|Open-Label Period|Adverse Event|80|||
48874253|NCT01085812|157376980|FG000|Open-Label Period|Lack of Efficacy|0|||
48874254|NCT01085812|157376981|FG001|Open-Label Period|Lack of Efficacy|26|||
48874255|NCT01085812|157376980|FG000|Open-Label Period|Protocol Violation|0|||
48874256|NCT01085812|157376981|FG001|Open-Label Period|Protocol Violation|39|||
48874257|NCT01085812|157376980|FG000|Open-Label Period|Withdrawal by Subject|0|||
48874258|NCT01085812|157376981|FG001|Open-Label Period|Withdrawal by Subject|53|||
48874259|NCT01085812|157376980|FG000|Open-Label Period|Lost to Follow-up|0|||
48874260|NCT01085812|157376981|FG001|Open-Label Period|Lost to Follow-up|42|||
48874261|NCT01085812|157376980|FG000|Double-Blind Period|Adverse Event|3|||
48978517|NCT00654368|157752196|FG001|Overall Study|Requirement for alternative therapy|1|||
48978518|NCT00654368|157752197|FG002|Overall Study|Requirement for alternative therapy|1|||
48978519|NCT00654368|157752195|FG000|Overall Study|Physician Decision|0|||
48978520|NCT00654368|157752196|FG001|Overall Study|Physician Decision|0|||
48978521|NCT00654368|157752197|FG002|Overall Study|Physician Decision|2|||
48978522|NCT00654368|157752195|FG000|Overall Study|Death|1|||
48978523|NCT00654368|157752196|FG001|Overall Study|Death|0|||
48978524|NCT00654368|157752197|FG002|Overall Study|Death|0|||
48978525|NCT00654368|157752195|FG000|Overall Study|Pregnancy|0|||
48978526|NCT00654368|157752196|FG001|Overall Study|Pregnancy|0|||
48978527|NCT00654368|157752197|FG002|Overall Study|Pregnancy|2|||
48978528|NCT00654368|157752195|FG000|Overall Study|Other|0|||
48978529|NCT00654368|157752196|FG001|Overall Study|Other|2|||
48978530|NCT00654368|157752197|FG002|Overall Study|Other|3|||
48978531|NCT00654368|157752195|FG000|Overall Study|Adverse Event|14|||
48978532|NCT00654368|157752196|FG001|Overall Study|Adverse Event|9|||
48675936|NCT01278797|156665451|FG001|Period 1|Protocol Violation|0|||
48675937|NCT00167310|156665452|FG000|Overall Study|Protocol Violation|5|||
48675938|NCT00167310|156665453|FG001|Overall Study|Protocol Violation|3|||
48675939|NCT00167310|156665452|FG000|Overall Study|Withdrawal by Subject|3|||
48675940|NCT00167310|156665453|FG001|Overall Study|Withdrawal by Subject|7|||
48675941|NCT01868477|156665459|FG000|Overall Study|Adverse Event|2|||
48675942|NCT01868477|156665460|FG001|Overall Study|Adverse Event|4|||
48675943|NCT01868477|156665459|FG000|Overall Study|Disease progression|1|||
48874262|NCT01085812|157376981|FG001|Double-Blind Period|Adverse Event|8|||
48874263|NCT01085812|157376980|FG000|Double-Blind Period|Protocol Violation|2|||
48675944|NCT01868477|156665460|FG001|Overall Study|Disease progression|1|||
48874264|NCT01085812|157376981|FG001|Double-Blind Period|Protocol Violation|7|||
48874265|NCT01085812|157376980|FG000|Double-Blind Period|Withdrawal by Subject|11|||
48874266|NCT01085812|157376981|FG001|Double-Blind Period|Withdrawal by Subject|24|||
48874267|NCT01085812|157376980|FG000|Double-Blind Period|Lost to Follow-up|5|||
48874268|NCT01085812|157376981|FG001|Double-Blind Period|Lost to Follow-up|17|||
48874269|NCT01085812|157376980|FG000|Double-Blind Period|Other Reasons|0|||
48978533|NCT00654368|157752197|FG002|Overall Study|Adverse Event|6|||
48978534|NCT02640755|157752204|FG000|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0|||
48978535|NCT02640755|157752205|FG001|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1|||
48978536|NCT02640755|157752204|FG000|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1|||
48978537|NCT02640755|157752205|FG001|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0|||
48978538|NCT02640755|157752204|FG000|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1|||
48978539|NCT02640755|157752205|FG001|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0|||
48978540|NCT00880100|157753737|FG000|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1|||
48978541|NCT00880100|157753737|FG000|Treatment Phase With Ultrase® MT12|Adverse Event|1|||
48978542|NCT00880100|157753737|FG000|Treatment Phase With Ultrase® MT12|Protocol Violation|2|||
48978543|NCT01431521|157753740|FG000|Overall Study|Withdrawal by Subject|0|||
48978544|NCT01431521|157753741|FG001|Overall Study|Withdrawal by Subject|0|||
48978545|NCT01431521|157753742|FG002|Overall Study|Withdrawal by Subject|1|||
48978546|NCT01431521|157753743|FG003|Overall Study|Withdrawal by Subject|0|||
48978547|NCT05154578|157753744|FG000|Overall Study|Withdrawal by Subject|2|||
48978548|NCT05154578|157753745|FG001|Overall Study|Withdrawal by Subject|3|||
48978549|NCT05154578|157753746|FG002|Overall Study|Withdrawal by Subject|2|||
48978550|NCT05154578|157753747|FG003|Overall Study|Withdrawal by Subject|4|||
48978551|NCT05154578|157753748|FG004|Overall Study|Withdrawal by Subject|0|||
48978552|NCT05154578|157753744|FG000|Overall Study|Lost to Follow-up|0|||
48978553|NCT05154578|157753745|FG001|Overall Study|Lost to Follow-up|1|||
48978554|NCT05154578|157753746|FG002|Overall Study|Lost to Follow-up|0|||
48978555|NCT05154578|157753747|FG003|Overall Study|Lost to Follow-up|3|||
48978556|NCT05154578|157753748|FG004|Overall Study|Lost to Follow-up|0|||
48978557|NCT05154578|157753744|FG000|Overall Study|Adverse Event|0|||
48978558|NCT05154578|157753745|FG001|Overall Study|Adverse Event|0|||
48978559|NCT05154578|157753746|FG002|Overall Study|Adverse Event|0|||
48978560|NCT05154578|157753747|FG003|Overall Study|Adverse Event|1|||
48978561|NCT05154578|157753748|FG004|Overall Study|Adverse Event|0|||
48978562|NCT05154578|157753744|FG000|Overall Study|Relocated to another province|0|||
48978563|NCT05154578|157753745|FG001|Overall Study|Relocated to another province|0|||
48978564|NCT05154578|157753746|FG002|Overall Study|Relocated to another province|1|||
48978565|NCT05154578|157753747|FG003|Overall Study|Relocated to another province|0|||
48978566|NCT05154578|157753748|FG004|Overall Study|Relocated to another province|1|||
48978567|NCT05154578|157753744|FG000|Overall Study|Baby loss|0|||
48978568|NCT05154578|157753745|FG001|Overall Study|Baby loss|1|||
48978569|NCT05154578|157753746|FG002|Overall Study|Baby loss|0|||
48978570|NCT05154578|157753747|FG003|Overall Study|Baby loss|0|||
48978571|NCT05154578|157753748|FG004|Overall Study|Baby loss|0|||
48978572|NCT00693420|157753751|FG000|Overall Study|Adverse Event|4|||
48978573|NCT00693420|157753752|FG001|Overall Study|Adverse Event|4|||
48978574|NCT00693420|157753751|FG000|Overall Study|Lost to Follow-up|0|||
48978575|NCT00693420|157753752|FG001|Overall Study|Lost to Follow-up|3|||
48978576|NCT00693420|157753751|FG000|Overall Study|Withdrawal by Subject|1|||
48978577|NCT00693420|157753752|FG001|Overall Study|Withdrawal by Subject|0|||
48978578|NCT00693420|157753751|FG000|Overall Study|Protocol Violation|0|||
48978579|NCT00693420|157753752|FG001|Overall Study|Protocol Violation|2|||
48978580|NCT00693420|157753751|FG000|Overall Study|Sponsor Request - Conflict of Interest|0|||
48978581|NCT00693420|157753752|FG001|Overall Study|Sponsor Request - Conflict of Interest|2|||
48978582|NCT00693420|157753751|FG000|Overall Study|Personal Reasons|1|||
48978583|NCT00693420|157753752|FG001|Overall Study|Personal Reasons|4|||
48978584|NCT01473355|157753759|FG000|Overall Study|Protocol Violation|2|||
48978585|NCT01473355|157753759|FG000|Overall Study|Adverse Event|2|||
48978586|NCT01473355|157753759|FG000|Overall Study|Lost to Follow-up|2|||
48978587|NCT02158728|157753762|FG000|Overall Study|no procedure according to CIP done|3|||
48978588|NCT02158728|157753762|FG000|Overall Study|no qualified dataset|24|||
48978589|NCT01518309|157753766|FG000|Overall Study|Adverse Event|6|||
48978590|NCT01518309|157753766|FG000|Overall Study|Death|6|||
48978591|NCT01518309|157753766|FG000|Overall Study|Lack of Efficacy|7|||
48978592|NCT01518309|157753766|FG000|Overall Study|Withdrawal by Subject|6|||
48978593|NCT01518309|157753766|FG000|Overall Study|Physician Decision|3|||
48978594|NCT01518309|157753766|FG000|Overall Study|Sponsor Decision|2|||
48978595|NCT01518309|157753766|FG000|Overall Study|Not in Predefined Categories|9|||
48978596|NCT02044822|157753770|FG000|Overall Study|Study Terminated by Sponsor|77|||
48978597|NCT02044822|157753770|FG000|Overall Study|Investigator's Discretion|10|||
48978598|NCT02044822|157753770|FG000|Overall Study|Withdrew Consent|3|||
48978599|NCT02044822|157753770|FG000|Overall Study|Initiation of Anti-Neoplastic Therapy|2|||
48978600|NCT02044822|157753770|FG000|Overall Study|Lost to Follow-up|1|||
48978601|NCT01366534|157753772|FG000|Overall Study|Lost to Follow-up|1|||
48978602|NCT01366534|157753773|FG001|Overall Study|Lost to Follow-up|0|||
48978603|NCT01366534|157753774|FG002|Overall Study|Lost to Follow-up|0|||
48978604|NCT01366534|157753772|FG000|Overall Study|Migrated|1|||
48978605|NCT01366534|157753773|FG001|Overall Study|Migrated|1|||
48978606|NCT01366534|157753774|FG002|Overall Study|Migrated|0|||
48978607|NCT01366534|157753772|FG000|Overall Study|Declined challenged|0|||
48978608|NCT01366534|157753773|FG001|Overall Study|Declined challenged|1|||
48978609|NCT01366534|157753774|FG002|Overall Study|Declined challenged|0|||
48978610|NCT01929018|157753775|FG000|Overall Study|Lost to Follow-up|1|||
48978611|NCT01929018|157753776|FG001|Overall Study|Lost to Follow-up|0|||
48978612|NCT01929018|157753775|FG000|Overall Study|Hospitalization|0|||
48978613|NCT01929018|157753776|FG001|Overall Study|Hospitalization|1|||
48978614|NCT02253992|157753790|FG000|Overall Study|Study drug toxicity|1|||
48978615|NCT02253992|157753791|FG001|Overall Study|Study drug toxicity|0|||
48978616|NCT02253992|157753792|FG002|Overall Study|Study drug toxicity|10|||
48978617|NCT02253992|157753790|FG000|Overall Study|Disease progression|4|||
48978618|NCT02253992|157753791|FG001|Overall Study|Disease progression|3|||
48978619|NCT02253992|157753792|FG002|Overall Study|Disease progression|98|||
48978620|NCT02253992|157753790|FG000|Overall Study|Withdrawal by Subject|0|||
48978621|NCT02253992|157753791|FG001|Overall Study|Withdrawal by Subject|0|||
48978622|NCT02253992|157753792|FG002|Overall Study|Withdrawal by Subject|3|||
48978623|NCT02253992|157753790|FG000|Overall Study|Adverse Event|0|||
48978624|NCT02253992|157753791|FG001|Overall Study|Adverse Event|0|||
48978625|NCT02253992|157753792|FG002|Overall Study|Adverse Event|8|||
48978626|NCT02253992|157753790|FG000|Overall Study|Death|0|||
48978627|NCT02253992|157753791|FG001|Overall Study|Death|0|||
48978628|NCT02253992|157753792|FG002|Overall Study|Death|1|||
48978629|NCT02253992|157753790|FG000|Overall Study|Subject discontinued study drug|1|||
48978630|NCT02253992|157753791|FG001|Overall Study|Subject discontinued study drug|0|||
48978631|NCT02253992|157753792|FG002|Overall Study|Subject discontinued study drug|1|||
48978632|NCT02253992|157753790|FG000|Overall Study|Completed treatment as per protocol|0|||
48978633|NCT02253992|157753791|FG001|Overall Study|Completed treatment as per protocol|1|||
48978634|NCT02253992|157753792|FG002|Overall Study|Completed treatment as per protocol|22|||
48978635|NCT02253992|157753790|FG000|Overall Study|Other|0|||
48978636|NCT02253992|157753791|FG001|Overall Study|Other|0|||
48978637|NCT02253992|157753792|FG002|Overall Study|Other|1|||
48978638|NCT00887068|157753802|FG000|Overall Study|Withdrawal by Subject|2|||
48978639|NCT00887068|157753803|FG001|Overall Study|Withdrawal by Subject|0|||
48978640|NCT00887068|157753802|FG000|Overall Study|Didn't meet eligibility to start cycle 1|4|||
48978641|NCT00887068|157753803|FG001|Overall Study|Didn't meet eligibility to start cycle 1|0|||
48978642|NCT04363944|157753806|FG000|Overall Study|Withdrawal by Subject|2|||
48978643|NCT04363944|157753807|FG001|Overall Study|Withdrawal by Subject|0|||
48978644|NCT01828567|157753808|FG000|Overall Study|Lost to Follow-up|27|||
48978645|NCT01828567|157753809|FG001|Overall Study|Lost to Follow-up|9|||
48978646|NCT01828567|157753808|FG000|Overall Study|Excluded - did not meet criteria|4|||
48978647|NCT01828567|157753809|FG001|Overall Study|Excluded - did not meet criteria|1|||
48978648|NCT01188811|157753814|FG000|Overall Study|Withdrawal by Subject|0|||
48978649|NCT01188811|157753815|FG001|Overall Study|Withdrawal by Subject|2|||
48978650|NCT01188811|157753814|FG000|Overall Study|Adverse Event|6|||
48978651|NCT01188811|157753815|FG001|Overall Study|Adverse Event|0|||
48978652|NCT00090766|157753818|FG000|Overall Study|Nephrectomy Planned|0|||
48978653|NCT00090766|157753819|FG001|Overall Study|Nephrectomy Planned|0|||
48978654|NCT00090766|157753820|FG002|Overall Study|Nephrectomy Planned|1|||
48978655|NCT00090766|157753818|FG000|Overall Study|Death|1|||
48978656|NCT00090766|157753819|FG001|Overall Study|Death|0|||
48978657|NCT00090766|157753820|FG002|Overall Study|Death|0|||
48978658|NCT00090766|157753818|FG000|Overall Study|Admin|0|||
48978659|NCT00090766|157753819|FG001|Overall Study|Admin|2|||
48978660|NCT00090766|157753820|FG002|Overall Study|Admin|0|||
48978661|NCT00090766|157753818|FG000|Overall Study|Lost to Follow-up|2|||
48978662|NCT00090766|157753819|FG001|Overall Study|Lost to Follow-up|0|||
48978663|NCT00090766|157753820|FG002|Overall Study|Lost to Follow-up|2|||
48978664|NCT05179057|157753822|FG000|Overall Study|Adverse Event|3|||
48978665|NCT05179057|157753823|FG001|Overall Study|Adverse Event|2|||
48978666|NCT05179057|157753822|FG000|Overall Study|Non-compliance with protocol requirements or study-related procedures|1|||
48978667|NCT05179057|157753823|FG001|Overall Study|Non-compliance with protocol requirements or study-related procedures|0|||
48978668|NCT05179057|157753822|FG000|Overall Study|Study terminated|13|||
48978669|NCT05179057|157753823|FG001|Overall Study|Study terminated|7|||
48978670|NCT05179057|157753822|FG000|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
48978671|NCT05179057|157753823|FG001|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
48978672|NCT05179057|157753822|FG000|Overall Study|Never received primary or cross-over study treatment|1|||
48978673|NCT05179057|157753823|FG001|Overall Study|Never received primary or cross-over study treatment|3|||
48978674|NCT01602744|157753824|FG000|Overall Study|Death|17|||
48978675|NCT01602744|157753825|FG001|Overall Study|Death|15|||
48978676|NCT01602744|157753824|FG000|Overall Study|Lost to Follow-up|13|||
48874270|NCT01085812|157376981|FG001|Double-Blind Period|Other Reasons|2|||
48978677|NCT01602744|157753825|FG001|Overall Study|Lost to Follow-up|8|||
48978678|NCT00804986|157753826|FG000|Overall Study|Adverse Event|0|||
48978679|NCT00804986|157753827|FG001|Overall Study|Adverse Event|1|||
48978680|NCT00804986|157753828|FG002|Overall Study|Adverse Event|2|||
48978681|NCT00804986|157753829|FG003|Overall Study|Adverse Event|1|||
48978682|NCT00804986|157753830|FG004|Overall Study|Adverse Event|3|||
48978683|NCT00804986|157753831|FG005|Overall Study|Adverse Event|0|||
48978684|NCT00804986|157753826|FG000|Overall Study|Lack of Efficacy|0|||
48978685|NCT00804986|157753827|FG001|Overall Study|Lack of Efficacy|0|||
48978686|NCT00804986|157753828|FG002|Overall Study|Lack of Efficacy|0|||
48978687|NCT00804986|157753829|FG003|Overall Study|Lack of Efficacy|1|||
48978688|NCT00804986|157753830|FG004|Overall Study|Lack of Efficacy|0|||
48978689|NCT00804986|157753831|FG005|Overall Study|Lack of Efficacy|3|||
48978690|NCT00804986|157753826|FG000|Overall Study|Lost to Follow-up|0|||
48978691|NCT00804986|157753827|FG001|Overall Study|Lost to Follow-up|0|||
48978692|NCT00804986|157753828|FG002|Overall Study|Lost to Follow-up|0|||
48978693|NCT00804986|157753829|FG003|Overall Study|Lost to Follow-up|1|||
48978694|NCT00804986|157753830|FG004|Overall Study|Lost to Follow-up|1|||
48978695|NCT00804986|157753831|FG005|Overall Study|Lost to Follow-up|3|||
48978696|NCT00804986|157753826|FG000|Overall Study|Protocol Violation|0|||
48978697|NCT00804986|157753827|FG001|Overall Study|Protocol Violation|1|||
48978698|NCT00804986|157753828|FG002|Overall Study|Protocol Violation|0|||
48978699|NCT00804986|157753829|FG003|Overall Study|Protocol Violation|1|||
48978700|NCT00804986|157753830|FG004|Overall Study|Protocol Violation|0|||
48978701|NCT00804986|157753831|FG005|Overall Study|Protocol Violation|0|||
48978702|NCT00804986|157753826|FG000|Overall Study|Withdrawal by Subject|0|||
48978703|NCT00804986|157753827|FG001|Overall Study|Withdrawal by Subject|3|||
48978704|NCT00804986|157753828|FG002|Overall Study|Withdrawal by Subject|0|||
48978705|NCT00804986|157753829|FG003|Overall Study|Withdrawal by Subject|3|||
48978706|NCT00804986|157753830|FG004|Overall Study|Withdrawal by Subject|5|||
48978707|NCT00804986|157753831|FG005|Overall Study|Withdrawal by Subject|3|||
48978708|NCT00804986|157753826|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
48978709|NCT00804986|157753827|FG001|Overall Study|Inclusion/Exclusion criteria not met|2|||
48978710|NCT00804986|157753828|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
48978711|NCT00804986|157753829|FG003|Overall Study|Inclusion/Exclusion criteria not met|1|||
48978712|NCT00804986|157753830|FG004|Overall Study|Inclusion/Exclusion criteria not met|0|||
48978713|NCT00804986|157753831|FG005|Overall Study|Inclusion/Exclusion criteria not met|1|||
48978714|NCT00804986|157753826|FG000|Overall Study|Sponsor Decision|0|||
48978715|NCT00804986|157753827|FG001|Overall Study|Sponsor Decision|1|||
48978716|NCT00804986|157753828|FG002|Overall Study|Sponsor Decision|0|||
48978717|NCT00804986|157753829|FG003|Overall Study|Sponsor Decision|0|||
48978718|NCT00804986|157753830|FG004|Overall Study|Sponsor Decision|0|||
48978719|NCT00804986|157753831|FG005|Overall Study|Sponsor Decision|0|||
48978720|NCT00804986|157753826|FG000|Overall Study|Physician Decision|1|||
48978721|NCT00804986|157753827|FG001|Overall Study|Physician Decision|0|||
48978722|NCT00804986|157753828|FG002|Overall Study|Physician Decision|0|||
48978723|NCT00804986|157753829|FG003|Overall Study|Physician Decision|0|||
48978724|NCT00804986|157753830|FG004|Overall Study|Physician Decision|0|||
48978725|NCT00804986|157753831|FG005|Overall Study|Physician Decision|0|||
48978726|NCT02187224|157753832|FG000|Overall Study|Did not show up for test day|1|||
48978727|NCT02187224|157753833|FG001|Overall Study|Did not show up for test day|0|||
48978728|NCT02975349|157753834|FG000|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
48978729|NCT02975349|157753835|FG001|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
48978730|NCT02975349|157753836|FG002|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
48978731|NCT02975349|157753837|FG003|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
48978732|NCT02975349|157753838|FG004|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
48978733|NCT02975349|157753839|FG005|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
48978734|NCT02975349|157753834|FG000|Active Treatment Period (24 Weeks)|Lost to Follow-up|1|||
48978735|NCT02975349|157753835|FG001|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
48978736|NCT02975349|157753836|FG002|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
48978737|NCT02975349|157753837|FG003|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
48978738|NCT02975349|157753838|FG004|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
48978739|NCT02975349|157753839|FG005|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
48978740|NCT02975349|157753834|FG000|Active Treatment Period (24 Weeks)|Adverse Event|4|||
48978741|NCT02975349|157753835|FG001|Active Treatment Period (24 Weeks)|Adverse Event|0|||
48978742|NCT02975349|157753836|FG002|Active Treatment Period (24 Weeks)|Adverse Event|1|||
48978743|NCT02975349|157753837|FG003|Active Treatment Period (24 Weeks)|Adverse Event|2|||
48978744|NCT02975349|157753838|FG004|Active Treatment Period (24 Weeks)|Adverse Event|6|||
48978745|NCT02975349|157753839|FG005|Active Treatment Period (24 Weeks)|Adverse Event|2|||
48978746|NCT02975349|157753834|FG000|Active Treatment Period (24 Weeks)|Un-specified|0|||
48978747|NCT02975349|157753835|FG001|Active Treatment Period (24 Weeks)|Un-specified|0|||
48978748|NCT02975349|157753836|FG002|Active Treatment Period (24 Weeks)|Un-specified|1|||
48978749|NCT02975349|157753837|FG003|Active Treatment Period (24 Weeks)|Un-specified|0|||
48978750|NCT02975349|157753838|FG004|Active Treatment Period (24 Weeks)|Un-specified|0|||
48978751|NCT02975349|157753839|FG005|Active Treatment Period (24 Weeks)|Un-specified|0|||
48978752|NCT02975349|157753834|FG000|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
48978753|NCT02975349|157753835|FG001|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
48874271|NCT01085812|157376980|FG000|Double-blind Intent-to-treat Population|Adverse Event|3|||
48978754|NCT02975349|157753836|FG002|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
48978755|NCT02975349|157753837|FG003|Blinded Extension Period (24 Weeks)|Adverse Event|2|||
48978756|NCT02975349|157753838|FG004|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
48978757|NCT02975349|157753839|FG005|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
48978758|NCT02975349|157753834|FG000|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
48978759|NCT02975349|157753835|FG001|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5|||
48978760|NCT02975349|157753836|FG002|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2|||
48978761|NCT02975349|157753837|FG003|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
48978762|NCT02975349|157753838|FG004|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
48978763|NCT02975349|157753839|FG005|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
48978764|NCT02975349|157753834|FG000|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
48978765|NCT02975349|157753835|FG001|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
48978766|NCT02975349|157753836|FG002|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1|||
48978767|NCT02975349|157753837|FG003|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
48978768|NCT02975349|157753838|FG004|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
48978769|NCT02975349|157753839|FG005|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
48978770|NCT02975349|157753834|FG000|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
48978771|NCT02975349|157753835|FG001|Blinded Extension Period (24 Weeks)|Progressive Disease|1|||
48978772|NCT02975349|157753836|FG002|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
48978773|NCT02975349|157753837|FG003|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
48675945|NCT01868477|156665459|FG000|Overall Study|Withdrawal by Subject|1|||
48675946|NCT01868477|156665460|FG001|Overall Study|Withdrawal by Subject|0|||
48675947|NCT01730586|156665461|FG000|Overall Study|Progressive Disease|2|||
48675948|NCT01730586|156665461|FG000|Overall Study|Inadequate Trial|8|||
48675949|NCT01730586|156665461|FG000|Overall Study|Adverse Event|2|||
48675950|NCT01730586|156665461|FG000|Overall Study|Hospice|1|||
48675951|NCT00061633|156665462|FG000|Overall Study|Adverse Event|1|||
48675952|NCT00061633|156665463|FG001|Overall Study|Adverse Event|2|||
48675953|NCT00061633|156665462|FG000|Overall Study|Withdrawal by Subject|2|||
48675954|NCT00061633|156665463|FG001|Overall Study|Withdrawal by Subject|2|||
48675955|NCT00061633|156665462|FG000|Overall Study|Lost to Follow-up|1|||
48675956|NCT00061633|156665463|FG001|Overall Study|Lost to Follow-up|4|||
48675957|NCT00061633|156665462|FG000|Overall Study|Other|1|||
48675958|NCT00061633|156665463|FG001|Overall Study|Other|1|||
48675959|NCT00061633|156665462|FG000|Overall Study|Never received study treatment|0|||
48675960|NCT00061633|156665463|FG001|Overall Study|Never received study treatment|2|||
48675961|NCT01408459|156665488|FG000|Overall Study|Withdrawal by Subject|1|||
48675962|NCT01408459|156665489|FG001|Overall Study|Withdrawal by Subject|1|||
48675963|NCT00534976|156665490|FG000|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0|||
48675964|NCT00534976|156665491|FG001|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1|||
48675965|NCT00534976|156665490|FG000|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1|||
48675966|NCT00534976|156665491|FG001|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0|||
48675967|NCT00534976|156665490|FG000|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1|||
48675968|NCT00534976|156665491|FG001|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0|||
48675969|NCT00811174|156665493|FG000|Overall Study|Protocol Violation|2|||
48675970|NCT00811174|156665493|FG000|Overall Study|Sponsors Decision|1|||
48978774|NCT02975349|157753838|FG004|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
48978775|NCT02975349|157753839|FG005|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
48978776|NCT02975349|157753834|FG000|Blinded Extension Period (24 Weeks)|Un-specified|0|||
48978777|NCT02975349|157753835|FG001|Blinded Extension Period (24 Weeks)|Un-specified|0|||
48978778|NCT02975349|157753836|FG002|Blinded Extension Period (24 Weeks)|Un-specified|0|||
48978779|NCT02975349|157753837|FG003|Blinded Extension Period (24 Weeks)|Un-specified|1|||
48978780|NCT02975349|157753838|FG004|Blinded Extension Period (24 Weeks)|Un-specified|0|||
48978781|NCT02975349|157753839|FG005|Blinded Extension Period (24 Weeks)|Un-specified|0|||
48978782|NCT00959699|157753840|FG000|Treatment Period|Adverse Event|3|||
48978783|NCT00959699|157753841|FG001|Treatment Period|Adverse Event|13|||
48978784|NCT00959699|157753840|FG000|Treatment Period|Lack of Efficacy|15|||
48978785|NCT00959699|157753841|FG001|Treatment Period|Lack of Efficacy|6|||
48978786|NCT00959699|157753840|FG000|Treatment Period|Lost to Follow-up|0|||
48978787|NCT00959699|157753841|FG001|Treatment Period|Lost to Follow-up|1|||
48978788|NCT00959699|157753840|FG000|Treatment Period|Withdrawal by Subject|1|||
48978789|NCT00959699|157753841|FG001|Treatment Period|Withdrawal by Subject|3|||
48978790|NCT00959699|157753840|FG000|Treatment Period|Non-Compliance with Protocol|0|||
48978791|NCT00959699|157753841|FG001|Treatment Period|Non-Compliance with Protocol|1|||
48978792|NCT00959699|157753840|FG000|Treatment Period|Did not receive treatment|0|||
48675971|NCT02831933|156667150|FG000|Overall Study|Physician Decision|11|||
48675972|NCT01161537|156667152|FG000|Part B|Withdrawal by Subject|2|||
48675973|NCT01673620|156667155|FG000|Overall Study|Adverse Event|1|||
48675974|NCT01673620|156667156|FG001|Overall Study|Adverse Event|0|||
48978793|NCT00959699|157753841|FG001|Treatment Period|Did not receive treatment|1|||
48978794|NCT00959699|157753840|FG000|Treatment Period|Futility/crossover to boceprevir|4|||
48978795|NCT00959699|157753841|FG001|Treatment Period|Futility/crossover to boceprevir|0|||
48978796|NCT00959699|157753840|FG000|Follow-up Period|Lost to Follow-up|3|||
48978797|NCT00959699|157753841|FG001|Follow-up Period|Lost to Follow-up|2|||
48675975|NCT01192568|156667157|FG000|Open Label Pre-Amendment 3|Adverse Event|0|||
48675976|NCT01192568|156667158|FG001|Open Label Pre-Amendment 3|Adverse Event|0|||
48675977|NCT01192568|156667159|FG002|Open Label Pre-Amendment 3|Adverse Event|1|||
48675978|NCT01192568|156667160|FG003|Open Label Pre-Amendment 3|Adverse Event|0|||
48978798|NCT00959699|157753840|FG000|Follow-up Period|Withdrawal by Subject|3|||
48978799|NCT00959699|157753841|FG001|Follow-up Period|Withdrawal by Subject|4|||
48978800|NCT02985684|157753844|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|5|||
48978801|NCT02985684|157753844|FG000|6-Month Closure Success Evaluation|Technical Failure (No Device)|5|||
48978802|NCT02985684|157753844|FG000|6-Month Closure Success Evaluation|Device Removal|3|||
48978803|NCT02774291|157753848|FG000|Overall Study|Lost to Follow-up|1|||
48978804|NCT00126425|157753852|FG000|Overall Study|Withdrawal by Subject|17|||
48978805|NCT00126425|157753853|FG001|Overall Study|Withdrawal by Subject|1|||
48978806|NCT00126425|157753852|FG000|Overall Study|Lost to Follow-up|8|||
48978807|NCT00126425|157753853|FG001|Overall Study|Lost to Follow-up|4|||
48978808|NCT00126425|157753852|FG000|Overall Study|Protocol Violation|9|||
48978809|NCT00126425|157753853|FG001|Overall Study|Protocol Violation|6|||
48978810|NCT00126425|157753852|FG000|Overall Study|Adverse Event|1|||
48978811|NCT00126425|157753853|FG001|Overall Study|Adverse Event|0|||
48978812|NCT00126425|157753852|FG000|Overall Study|Failed Inclusion Exclusion Criteria|1|||
48978813|NCT00126425|157753853|FG001|Overall Study|Failed Inclusion Exclusion Criteria|0|||
48978814|NCT00126425|157753852|FG000|Overall Study|Other|5|||
48978815|NCT00126425|157753853|FG001|Overall Study|Other|0|||
48978816|NCT04964557|157753857|FG000|Overall Study|Withdrawal by Subject|3|||
48978817|NCT04964557|157753858|FG001|Overall Study|Withdrawal by Subject|2|||
48978818|NCT04964557|157753857|FG000|Overall Study|Lost to Follow-up|1|||
48978819|NCT04964557|157753858|FG001|Overall Study|Lost to Follow-up|2|||
48978820|NCT04964557|157753857|FG000|Overall Study|Physician Decision|2|||
48978821|NCT04964557|157753858|FG001|Overall Study|Physician Decision|0|||
48978822|NCT04964557|157753857|FG000|Overall Study|Death|3|||
48978823|NCT04964557|157753858|FG001|Overall Study|Death|0|||
48978824|NCT04964557|157753857|FG000|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|1|||
48978825|NCT04964557|157753858|FG001|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|0|||
48978826|NCT01226472|157753859|FG000|Overall Study|Progressive Disease|1|||
48978827|NCT01347840|157753860|FG000|Overall Study|Withdrawal by Subject|1|||
48978828|NCT01894776|157753867|FG000|Overall Study|Withdrawal by Subject|1|||
48978829|NCT03573804|157753868|FG000|Overall Study|claustrophobia or MRI table problems|10|||
48978830|NCT02485860|157753869|FG000|Overall Study|Lost to Follow-up|4|||
48978831|NCT02485860|157753870|FG001|Overall Study|Lost to Follow-up|1|||
48978832|NCT02485860|157753869|FG000|Overall Study|Physician Decision|1|||
48978833|NCT02485860|157753870|FG001|Overall Study|Physician Decision|2|||
48978834|NCT02485860|157753869|FG000|Overall Study|Health context (COVID-19)|1|||
48978835|NCT02485860|157753870|FG001|Overall Study|Health context (COVID-19)|0|||
48978836|NCT03325010|157753872|FG000|Overall Study|Adverse Event|3|||
48978837|NCT03325010|157753873|FG001|Overall Study|Adverse Event|8|||
48978838|NCT03325010|157753872|FG000|Overall Study|Protocol Violation|1|||
48978839|NCT03325010|157753873|FG001|Overall Study|Protocol Violation|8|||
48978840|NCT03325010|157753872|FG000|Overall Study|Withdrawal by Subject|1|||
48978841|NCT03325010|157753873|FG001|Overall Study|Withdrawal by Subject|3|||
48978842|NCT03325010|157753872|FG000|Overall Study|Lost to Follow-up|1|||
48978843|NCT03325010|157753873|FG001|Overall Study|Lost to Follow-up|0|||
48978844|NCT03325010|157753872|FG000|Overall Study|Physician Decision|1|||
48978845|NCT03325010|157753873|FG001|Overall Study|Physician Decision|1|||
48978846|NCT03325010|157753872|FG000|Overall Study|Lack of Efficacy|2|||
48978847|NCT03325010|157753873|FG001|Overall Study|Lack of Efficacy|0|||
48978848|NCT00113555|157753883|FG000|Overall Study|Baseline Failure|59|||
48978849|NCT00113555|157753883|FG000|Overall Study|Permanently Explanted|7|||
48978850|NCT00113555|157753883|FG000|Overall Study|Death|1|||
48978851|NCT00113555|157753883|FG000|Overall Study|Missed Followup|4|||
48978852|NCT00113555|157753883|FG000|Overall Study|Lost to Follow-up|8|||
48978853|NCT00712270|157753884|FG000|Overall Study|Withdrawal by Subject|11|||
48978854|NCT00712270|157753884|FG000|Overall Study|Screen Failure|3|||
48978855|NCT00691054|157753885|FG000|Overall Study|Withdrawal by Subject|1|||
48978856|NCT03050307|157755272|FG000|Overall Study|Adverse Event|4|||
48978857|NCT03050307|157755273|FG001|Overall Study|Adverse Event|2|||
48978858|NCT03050307|157755272|FG000|Overall Study|Significant Protocol Deviation|0|||
48978859|NCT03050307|157755273|FG001|Overall Study|Significant Protocol Deviation|1|||
48675979|NCT01192568|156667157|FG000|Open Label Post-Amendment 3|Adverse Event|0|||
48978860|NCT03050307|157755272|FG000|Overall Study|Lost to Follow-up|0|||
48978861|NCT03050307|157755273|FG001|Overall Study|Lost to Follow-up|1|||
48978862|NCT03050307|157755272|FG000|Overall Study|Voluntary Withdrawal|3|||
48978863|NCT03050307|157755273|FG001|Overall Study|Voluntary Withdrawal|4|||
48978864|NCT03050307|157755272|FG000|Overall Study|Reason not Specified|1|||
48978865|NCT03050307|157755273|FG001|Overall Study|Reason not Specified|1|||
48978866|NCT00608244|157755274|FG000|Overall Study|Adverse Event|1|||
48978867|NCT00608244|157755274|FG000|Overall Study|Low trough levels|1|||
48978868|NCT00430027|157755275|FG000|Overall Study|Study terminated|8|||
48978869|NCT01625611|157755281|FG000|Overall Study|No adlib drinks Lab 1|3|||
48978870|NCT01625611|157755282|FG001|Overall Study|No adlib drinks Lab 1|0|||
48978871|NCT01625611|157755281|FG000|Overall Study|Technical issues with PET|1|||
48675980|NCT01192568|156667158|FG001|Open Label Post-Amendment 3|Adverse Event|0|||
48978872|NCT01625611|157755282|FG001|Overall Study|Technical issues with PET|0|||
48978873|NCT01625611|157755281|FG000|Overall Study|Unable to complete study procedures|1|||
48978874|NCT01625611|157755282|FG001|Overall Study|Unable to complete study procedures|0|||
48978875|NCT01625611|157755281|FG000|Overall Study|Withdrawal by Subject|3|||
48978876|NCT01625611|157755282|FG001|Overall Study|Withdrawal by Subject|0|||
48978877|NCT01405027|157755285|FG000|Overall Study|Withdrawn consent|3|||
48978878|NCT01405027|157755286|FG001|Overall Study|Withdrawn consent|0|||
48978879|NCT01405027|157755285|FG000|Overall Study|Lost to Follow-up|16|||
48978880|NCT01405027|157755286|FG001|Overall Study|Lost to Follow-up|24|||
48978881|NCT01405027|157755285|FG000|Overall Study|Investigator judgement|0|||
48978882|NCT01405027|157755286|FG001|Overall Study|Investigator judgement|2|||
48978883|NCT01405027|157755285|FG000|Overall Study|Death|1|||
48978884|NCT01405027|157755286|FG001|Overall Study|Death|0|||
48978885|NCT01405027|157755285|FG000|Overall Study|Other or Unknown|12|||
48978886|NCT01405027|157755286|FG001|Overall Study|Other or Unknown|25|||
48978887|NCT02436915|157755291|FG000|Overall Study|Withdrawal by Subject|0|||
48978888|NCT02436915|157755292|FG001|Overall Study|Withdrawal by Subject|1|||
48978889|NCT02603172|157755293|FG000|Part A (Approximately 16 Weeks)|Adverse Event|0|||
48978890|NCT02603172|157755294|FG001|Part A (Approximately 16 Weeks)|Adverse Event|0|||
48978891|NCT02603172|157755295|FG002|Part A (Approximately 16 Weeks)|Adverse Event|1|||
48978892|NCT02603172|157755296|FG003|Part A (Approximately 16 Weeks)|Adverse Event|0|||
48978893|NCT02603172|157755297|FG004|Part A (Approximately 16 Weeks)|Adverse Event|0|||
48978894|NCT02603172|157755298|FG005|Part A (Approximately 16 Weeks)|Adverse Event|0|||
48978895|NCT02603172|157755299|FG006|Part A (Approximately 16 Weeks)|Adverse Event|0|||
48978896|NCT02603172|157755300|FG007|Part A (Approximately 16 Weeks)|Adverse Event|0|||
48978897|NCT00863317|157755305|FG000|Overall Study|Lost to Follow-up|8|||
48978898|NCT00863317|157755306|FG001|Overall Study|Lost to Follow-up|9|||
48978899|NCT03745989|157755307|FG000|Overall Study|Death|3|||
48978900|NCT03745989|157755308|FG001|Overall Study|Death|7|||
48978901|NCT03745989|157755309|FG002|Overall Study|Death|4|||
48978902|NCT03745989|157755307|FG000|Overall Study|Lost to Follow-up|0|||
48978903|NCT03745989|157755308|FG001|Overall Study|Lost to Follow-up|2|||
48978904|NCT03745989|157755309|FG002|Overall Study|Lost to Follow-up|0|||
48978905|NCT03745989|157755307|FG000|Overall Study|Sponsor Decision|0|||
48978906|NCT03745989|157755308|FG001|Overall Study|Sponsor Decision|2|||
48978907|NCT03745989|157755309|FG002|Overall Study|Sponsor Decision|8|||
48978908|NCT03745989|157755307|FG000|Overall Study|Withdrawal by Subject|0|||
48978909|NCT03745989|157755308|FG001|Overall Study|Withdrawal by Subject|1|||
48978910|NCT03745989|157755309|FG002|Overall Study|Withdrawal by Subject|3|||
48978911|NCT02668692|157755312|FG000|Overall Study|Adverse Event|1|||
48978912|NCT02668692|157755313|FG001|Overall Study|Adverse Event|0|||
48978913|NCT02280096|157755314|FG000|Overall Study|Pregnancy|1|||
48978914|NCT02280096|157755315|FG001|Overall Study|Pregnancy|0|||
48978915|NCT02280096|157755314|FG000|Overall Study|Functional neurological disorder|1|||
48978916|NCT02280096|157755315|FG001|Overall Study|Functional neurological disorder|0|||
48978917|NCT02280096|157755314|FG000|Overall Study|Lack of attachment|0|||
48978918|NCT02280096|157755315|FG001|Overall Study|Lack of attachment|1|||
48978919|NCT00732472|157755316|FG000|Overall Study|Adverse Event|0|||
48978920|NCT00732472|157755317|FG001|Overall Study|Adverse Event|1|||
48978921|NCT00732472|157755318|FG002|Overall Study|Adverse Event|1|||
48978922|NCT00732472|157755319|FG003|Overall Study|Adverse Event|1|||
48978923|NCT00732472|157755316|FG000|Overall Study|Protocol Violation|0|||
48978924|NCT00732472|157755317|FG001|Overall Study|Protocol Violation|0|||
48978925|NCT00732472|157755318|FG002|Overall Study|Protocol Violation|0|||
48978926|NCT00732472|157755319|FG003|Overall Study|Protocol Violation|1|||
48978927|NCT00732472|157755316|FG000|Overall Study|Withdrawal by Subject|0|||
48978928|NCT00732472|157755317|FG001|Overall Study|Withdrawal by Subject|2|||
48978929|NCT00732472|157755318|FG002|Overall Study|Withdrawal by Subject|0|||
48978930|NCT00732472|157755319|FG003|Overall Study|Withdrawal by Subject|1|||
48978931|NCT01572480|157755320|FG000|Participants Enrolled|Withdrawal by Subject|1|||
48675981|NCT01192568|156667159|FG002|Open Label Post-Amendment 3|Adverse Event|0|||
48675982|NCT01192568|156667160|FG003|Open Label Post-Amendment 3|Adverse Event|1|||
48675983|NCT01022424|156667161|FG000|Overall Study|Adverse Event|1|||
48978932|NCT01572480|157755320|FG000|Drug Administration|Discontinued drug/Off Study|1|||
48978933|NCT01572480|157755320|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events and withdrew consent|1|||
48978934|NCT01572480|157755320|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events|2|||
48675984|NCT01022424|156667161|FG000|Overall Study|Physician Decision|1|||
48978935|NCT01553591|157755321|FG000|Overall Study|Voluntarily withdrew|94|||
48978936|NCT01553591|157755322|FG001|Overall Study|Voluntarily withdrew|79|||
48675985|NCT01022424|156667161|FG000|Overall Study|eGFR under the withdrawal criteria|2|||
48978937|NCT01553591|157755323|FG002|Overall Study|Voluntarily withdrew|96|||
48675986|NCT01971008|156667162|FG000|Overall Study|Protocol Violation|2|||
48978938|NCT01553591|157755321|FG000|Overall Study|Adverse Event|36|||
48978939|NCT01553591|157755322|FG001|Overall Study|Adverse Event|45|||
48978940|NCT01553591|157755323|FG002|Overall Study|Adverse Event|16|||
48978941|NCT01553591|157755321|FG000|Overall Study|Lost to Follow-up|25|||
48978942|NCT01553591|157755322|FG001|Overall Study|Lost to Follow-up|23|||
48978943|NCT01553591|157755323|FG002|Overall Study|Lost to Follow-up|16|||
48978944|NCT01553591|157755321|FG000|Overall Study|Physician decision: other|11|||
48978945|NCT01553591|157755322|FG001|Overall Study|Physician decision: other|14|||
48978946|NCT01553591|157755323|FG002|Overall Study|Physician decision: other|16|||
48978947|NCT01553591|157755321|FG000|Overall Study|Physician decision: lack of efficacy|2|||
48978948|NCT01553591|157755322|FG001|Overall Study|Physician decision: lack of efficacy|3|||
48978949|NCT01553591|157755323|FG002|Overall Study|Physician decision: lack of efficacy|7|||
48978950|NCT01553591|157755321|FG000|Overall Study|Protocol Violation|3|||
48978951|NCT01553591|157755322|FG001|Overall Study|Protocol Violation|4|||
48978952|NCT01553591|157755323|FG002|Overall Study|Protocol Violation|4|||
48978953|NCT01553591|157755321|FG000|Overall Study|Sponsor decision|1|||
48978954|NCT01553591|157755322|FG001|Overall Study|Sponsor decision|0|||
48978955|NCT01553591|157755323|FG002|Overall Study|Sponsor decision|3|||
48978956|NCT01553591|157755321|FG000|Overall Study|Randomized and never dispensed drug|0|||
48978957|NCT01553591|157755322|FG001|Overall Study|Randomized and never dispensed drug|1|||
48978958|NCT01553591|157755323|FG002|Overall Study|Randomized and never dispensed drug|0|||
48978959|NCT01017549|157755326|FG000|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1|||
48978960|NCT01017549|157755326|FG000|One-year Follow-up|Lost to Follow-up|2|||
48978961|NCT01017549|157755326|FG000|One-year Follow-up|Withdrawal by Subject|5|||
48978962|NCT01017549|157755326|FG000|5 Year Follow-up|Lost to Follow-up|9|||
48874272|NCT01085812|157376981|FG001|Double-blind Intent-to-treat Population|Adverse Event|8|||
48978963|NCT01017549|157755326|FG000|5 Year Follow-up|Mastectomy|3|||
48978964|NCT01098032|157755327|FG000|Overall Study|Withdrawal by Subject|1|||
48978965|NCT01098032|157755328|FG001|Overall Study|Withdrawal by Subject|1|||
48978966|NCT03152110|157755337|FG000|Overall Study|Withdrawal by Subject|3|||
48978967|NCT04476108|157755338|FG000|Overall Study|Adverse Event|4|||
48978968|NCT04476108|157755339|FG001|Overall Study|Adverse Event|1|||
48978969|NCT04476108|157755338|FG000|Overall Study|Lost to Follow-up|1|||
48978970|NCT04476108|157755339|FG001|Overall Study|Lost to Follow-up|0|||
48978971|NCT04476108|157755338|FG000|Overall Study|Inadvertent Enrollment|1|||
48978972|NCT04476108|157755339|FG001|Overall Study|Inadvertent Enrollment|0|||
48978973|NCT04476108|157755338|FG000|Overall Study|Protocol Violation|1|||
48978974|NCT04476108|157755339|FG001|Overall Study|Protocol Violation|1|||
48978975|NCT04476108|157755338|FG000|Overall Study|Withdrawal by Subject|1|||
48978976|NCT04476108|157755339|FG001|Overall Study|Withdrawal by Subject|1|||
48978977|NCT00312728|157755340|FG000|Overall Study|Progressive disease|53|||
48978978|NCT00312728|157755340|FG000|Overall Study|Adverse Event|32|||
48978979|NCT00312728|157755340|FG000|Overall Study|Withdrawal by Subject|10|||
48978980|NCT00312728|157755340|FG000|Overall Study|Required non-protocol cancer treatment|2|||
48978981|NCT00312728|157755340|FG000|Overall Study|Protocol Violation|2|||
48978982|NCT00312728|157755340|FG000|Overall Study|Other|10|||
48978983|NCT00312728|157755340|FG000|Overall Study|Other|1|||
48978984|NCT00397631|157755341|FG000|Overall Study|Adverse Event|5|||
48978985|NCT00397631|157755342|FG001|Overall Study|Adverse Event|6|||
48978986|NCT00397631|157755341|FG000|Overall Study|Lack of Efficacy|7|||
48978987|NCT00397631|157755342|FG001|Overall Study|Lack of Efficacy|10|||
48978988|NCT00397631|157755341|FG000|Overall Study|Lost to Follow-up|8|||
48978989|NCT00397631|157755342|FG001|Overall Study|Lost to Follow-up|9|||
48978990|NCT00397631|157755341|FG000|Overall Study|Physician Decision|2|||
48978991|NCT00397631|157755342|FG001|Overall Study|Physician Decision|0|||
48978992|NCT00397631|157755341|FG000|Overall Study|Protocol Violation|0|||
48978993|NCT00397631|157755342|FG001|Overall Study|Protocol Violation|1|||
48978994|NCT00397631|157755341|FG000|Overall Study|Withdrawal by Subject|7|||
48978995|NCT00397631|157755342|FG001|Overall Study|Withdrawal by Subject|14|||
48978996|NCT00397631|157755341|FG000|Overall Study|protocol discontinuation criteria|1|||
48978997|NCT00397631|157755342|FG001|Overall Study|protocol discontinuation criteria|4|||
48978998|NCT01634100|157755346|FG000|Overall Study|Withdrawal by Subject|1|||
48978999|NCT01634100|157755347|FG001|Overall Study|Withdrawal by Subject|0|||
48979000|NCT01634100|157755348|FG002|Overall Study|Withdrawal by Subject|1|||
48979001|NCT01634100|157755349|FG003|Overall Study|Withdrawal by Subject|0|||
48979002|NCT01634100|157755350|FG004|Overall Study|Withdrawal by Subject|0|||
48979003|NCT01634100|157755351|FG005|Overall Study|Withdrawal by Subject|0|||
48979004|NCT00471276|157755352|FG000|Overall Study|Death|2|||
48979005|NCT00471276|157755352|FG000|Overall Study|Adverse Event|16|||
48979006|NCT00471276|157755352|FG000|Overall Study|Protocol Violation|1|||
48979007|NCT00471276|157755352|FG000|Overall Study|Objective progression or relapse|54|||
48979008|NCT00471276|157755352|FG000|Overall Study|Global deterioration of health status|1|||
48979009|NCT00471276|157755352|FG000|Overall Study|Other|3|||
48979010|NCT00471276|157755352|FG000|Overall Study|Refused treatment|6|||
48874273|NCT01085812|157376980|FG000|Double-blind Intent-to-treat Population|Protocol Violation|2|||
48979011|NCT00085644|157755356|FG000|Double-Blind Period|Adverse Event|5|||
48979012|NCT00085644|157755357|FG001|Double-Blind Period|Adverse Event|2|||
48979013|NCT00085644|157755358|FG002|Double-Blind Period|Adverse Event|0|||
48979014|NCT00085644|157755356|FG000|Double-Blind Period|Withdrawal by Subject|3|||
48979015|NCT00085644|157755357|FG001|Double-Blind Period|Withdrawal by Subject|0|||
48979016|NCT00085644|157755358|FG002|Double-Blind Period|Withdrawal by Subject|0|||
48675987|NCT01971008|156667163|FG001|Overall Study|Protocol Violation|1|||
48675988|NCT02100969|156667164|FG000|Overall Study|Did not pass screening phase|1|||
48675989|NCT01266590|156667165|FG000|Overall Study|Adverse Event|3|||
48675990|NCT01266590|156667165|FG000|Overall Study|Lost to Follow-up|1|||
48675991|NCT01266590|156667165|FG000|Overall Study|Withdrawal by Subject|1|||
48979017|NCT00085644|157755356|FG000|Double-Blind Period|Lost to Follow-up|2|||
48979018|NCT00085644|157755357|FG001|Double-Blind Period|Lost to Follow-up|1|||
48979019|NCT00085644|157755358|FG002|Double-Blind Period|Lost to Follow-up|0|||
48979020|NCT00085644|157755356|FG000|Double-Blind Period|Lack/loss of efficacy|2|||
48979021|NCT00085644|157755357|FG001|Double-Blind Period|Lack/loss of efficacy|2|||
48979022|NCT00085644|157755358|FG002|Double-Blind Period|Lack/loss of efficacy|0|||
48979023|NCT00085644|157755356|FG000|Double-Blind Period|Contemplating pregnancy|1|||
48979024|NCT00085644|157755357|FG001|Double-Blind Period|Contemplating pregnancy|0|||
48979025|NCT00085644|157755358|FG002|Double-Blind Period|Contemplating pregnancy|0|||
48979026|NCT00085644|157755356|FG000|Double-Blind Period|Undiagnosed pre-existing condition|0|||
48979027|NCT00085644|157755357|FG001|Double-Blind Period|Undiagnosed pre-existing condition|1|||
48979028|NCT00085644|157755358|FG002|Double-Blind Period|Undiagnosed pre-existing condition|0|||
48979029|NCT00085644|157755356|FG000|Open-Label Period|Adverse Event|0|||
48979030|NCT00085644|157755357|FG001|Open-Label Period|Adverse Event|0|||
48979031|NCT00085644|157755358|FG002|Open-Label Period|Adverse Event|38|||
48979032|NCT00085644|157755356|FG000|Open-Label Period|Withdrawal by Subject|0|||
48979033|NCT00085644|157755357|FG001|Open-Label Period|Withdrawal by Subject|0|||
48979034|NCT00085644|157755358|FG002|Open-Label Period|Withdrawal by Subject|29|||
48979035|NCT00085644|157755356|FG000|Open-Label Period|Lost to Follow-up|0|||
48979036|NCT00085644|157755357|FG001|Open-Label Period|Lost to Follow-up|0|||
48979037|NCT00085644|157755358|FG002|Open-Label Period|Lost to Follow-up|13|||
48979038|NCT00085644|157755356|FG000|Open-Label Period|Lack of Efficacy|0|||
48979039|NCT00085644|157755357|FG001|Open-Label Period|Lack of Efficacy|0|||
48979040|NCT00085644|157755358|FG002|Open-Label Period|Lack of Efficacy|15|||
48979041|NCT00085644|157755356|FG000|Open-Label Period|Pregnancy|0|||
48979042|NCT00085644|157755357|FG001|Open-Label Period|Pregnancy|0|||
48979043|NCT00085644|157755358|FG002|Open-Label Period|Pregnancy|3|||
48979044|NCT00085644|157755356|FG000|Open-Label Period|Contemplating pregnancy|0|||
48979045|NCT00085644|157755357|FG001|Open-Label Period|Contemplating pregnancy|0|||
48979046|NCT00085644|157755358|FG002|Open-Label Period|Contemplating pregnancy|3|||
48979047|NCT00085644|157755356|FG000|Open-Label Period|Protocol Violation|0|||
48979048|NCT00085644|157755357|FG001|Open-Label Period|Protocol Violation|0|||
48979049|NCT00085644|157755358|FG002|Open-Label Period|Protocol Violation|4|||
48979050|NCT00085644|157755356|FG000|Open-Label Period|Personal reason|0|||
48979051|NCT00085644|157755357|FG001|Open-Label Period|Personal reason|0|||
48979052|NCT00085644|157755358|FG002|Open-Label Period|Personal reason|4|||
48979053|NCT00376675|157755366|FG000|Overall Study|Withdrawal by Subject|9|||
48979054|NCT00376675|157755367|FG001|Overall Study|Withdrawal by Subject|2|||
48979055|NCT00376675|157755366|FG000|Overall Study|Adverse Event|10|||
48979056|NCT00376675|157755367|FG001|Overall Study|Adverse Event|5|||
48979057|NCT00376675|157755366|FG000|Overall Study|Other Reason|1|||
48979058|NCT00376675|157755367|FG001|Overall Study|Other Reason|7|||
48979059|NCT00707486|157755368|FG000|Overall Study|Withdrawal by Subject|1|||
48979060|NCT04228445|157755369|FG000|Overall Study|Lost to Follow-up|1|||
48979061|NCT04228445|157755370|FG001|Overall Study|Lost to Follow-up|1|||
48979062|NCT04228445|157755369|FG000|Overall Study|Physician Decision|1|||
48979063|NCT04228445|157755370|FG001|Overall Study|Physician Decision|2|||
48979064|NCT04228445|157755369|FG000|Overall Study|Withdrawal by Subject|0|||
48979065|NCT04228445|157755370|FG001|Overall Study|Withdrawal by Subject|1|||
48979066|NCT04228445|157755369|FG000|Overall Study|Planned procedure not performed after randomization, study drug not administered|1|||
48979067|NCT04228445|157755370|FG001|Overall Study|Planned procedure not performed after randomization, study drug not administered|0|||
48979068|NCT00606294|157755371|FG000|Overall Study|Withdrawal by Subject|36|||
48979069|NCT00606294|157755372|FG001|Overall Study|Withdrawal by Subject|0|||
48979070|NCT03418376|157755377|FG000|Overall Study|Musculoskeletal injury|1|||
48979071|NCT03418376|157755378|FG001|Overall Study|Musculoskeletal injury|2|||
48979072|NCT03418376|157755379|FG002|Overall Study|Musculoskeletal injury|1|||
48675992|NCT01266590|156667165|FG000|Overall Study|Physician Decision|1|||
48675993|NCT01504841|156667166|FG000|Overall Study|Withdrawal by Subject|1|||
48979073|NCT03418376|157755380|FG003|Overall Study|Musculoskeletal injury|0|||
48979074|NCT03418376|157755377|FG000|Overall Study|Personal reasons|0|||
48979075|NCT03418376|157755378|FG001|Overall Study|Personal reasons|2|||
48979076|NCT03418376|157755379|FG002|Overall Study|Personal reasons|2|||
48979077|NCT03418376|157755380|FG003|Overall Study|Personal reasons|1|||
48979078|NCT03418376|157755377|FG000|Overall Study|Exacerbation|0|||
48979079|NCT03418376|157755378|FG001|Overall Study|Exacerbation|1|||
48979080|NCT03418376|157755379|FG002|Overall Study|Exacerbation|0|||
48979081|NCT03418376|157755380|FG003|Overall Study|Exacerbation|0|||
48979082|NCT03924427|157755381|FG000|Overall Study|Adverse Event|4|||
48979083|NCT03924427|157755381|FG000|Overall Study|Lack of Efficacy|1|||
48979084|NCT03924427|157755381|FG000|Overall Study|Withdrawal by Subject|1|||
48979085|NCT00952419|157755384|FG000|Overall Study|Adverse Event|2|||
48675994|NCT01504841|156667167|FG001|Overall Study|Withdrawal by Subject|1|||
48675995|NCT01504841|156667168|FG002|Overall Study|Withdrawal by Subject|0|||
48675996|NCT00495625|156667169|FG000|Overall Study|Did not complete at least 1 42 day cycle|10|||
48675997|NCT00630344|156667172|FG000|Overall Study|Adverse Event|5|||
48675998|NCT00630344|156667172|FG000|Overall Study|Progressive Disease|19|||
48675999|NCT00630344|156667172|FG000|Overall Study|Physician Decision|9|||
48676000|NCT00630344|156667172|FG000|Overall Study|Withdrawal by Subject|1|||
48676001|NCT00630344|156667172|FG000|Overall Study|Intercurrent Illness|1|||
48676002|NCT00630344|156667172|FG000|Overall Study|Other|1|||
48676003|NCT00720343|156667173|FG000|Overall Study|Lost to Follow-up|1|||
48676004|NCT00720343|156667174|FG001|Overall Study|Lost to Follow-up|0|||
48676005|NCT00720343|156667173|FG000|Overall Study|Protocol Violation|0|||
48676006|NCT00720343|156667174|FG001|Overall Study|Protocol Violation|2|||
48676007|NCT01754493|156667175|FG000|Overall Study|Adverse Event|1|||
48676008|NCT01754493|156667175|FG000|Overall Study|Lost to Follow-up|3|||
48676009|NCT01754493|156667175|FG000|Overall Study|Withdrawal by Subject|1|||
48676010|NCT01754493|156667175|FG000|Overall Study|Moved out of town|1|||
48676011|NCT01754493|156667175|FG000|Overall Study|Scheduling conflict|1|||
48676012|NCT02008773|156667176|FG000|Overall Study|Adverse Event|3|||
48676013|NCT02008773|156667177|FG001|Overall Study|Adverse Event|3|||
48676014|NCT02008773|156667178|FG002|Overall Study|Adverse Event|1|||
48676015|NCT02008773|156667179|FG003|Overall Study|Adverse Event|2|||
48676016|NCT02008773|156667176|FG000|Overall Study|Medication Non-compliance|2|||
48676017|NCT02008773|156667177|FG001|Overall Study|Medication Non-compliance|1|||
48676018|NCT02008773|156667178|FG002|Overall Study|Medication Non-compliance|3|||
48676019|NCT02008773|156667179|FG003|Overall Study|Medication Non-compliance|2|||
48676020|NCT02008773|156667176|FG000|Overall Study|Withdrawal by Subject|8|||
48676021|NCT02008773|156667177|FG001|Overall Study|Withdrawal by Subject|4|||
48676022|NCT02008773|156667178|FG002|Overall Study|Withdrawal by Subject|7|||
48676023|NCT02008773|156667179|FG003|Overall Study|Withdrawal by Subject|6|||
48676024|NCT02008773|156667176|FG000|Overall Study|Lost to Follow-up|0|||
48676025|NCT02008773|156667177|FG001|Overall Study|Lost to Follow-up|1|||
48676026|NCT02008773|156667178|FG002|Overall Study|Lost to Follow-up|3|||
48676027|NCT02008773|156667179|FG003|Overall Study|Lost to Follow-up|2|||
48676028|NCT00306527|156667182|FG000|Overall Study|Lost to Follow-up|3|||
48676029|NCT00306527|156667183|FG001|Overall Study|Lost to Follow-up|4|||
48676030|NCT00306527|156667184|FG002|Overall Study|Lost to Follow-up|3|||
48676031|NCT00306527|156667185|FG003|Overall Study|Lost to Follow-up|0|||
48676032|NCT00306527|156667182|FG000|Overall Study|Withdrawal by Subject|2|||
48676033|NCT00306527|156667183|FG001|Overall Study|Withdrawal by Subject|3|||
48676034|NCT00306527|156667184|FG002|Overall Study|Withdrawal by Subject|0|||
48676035|NCT00306527|156667185|FG003|Overall Study|Withdrawal by Subject|3|||
48676036|NCT00306527|156667182|FG000|Overall Study|Adverse Event|0|||
48676037|NCT00306527|156667183|FG001|Overall Study|Adverse Event|0|||
48676038|NCT00306527|156667184|FG002|Overall Study|Adverse Event|1|||
48676039|NCT00306527|156667185|FG003|Overall Study|Adverse Event|1|||
48676040|NCT00306527|156667182|FG000|Overall Study|Death|1|||
48676041|NCT00306527|156667183|FG001|Overall Study|Death|0|||
48676042|NCT00306527|156667184|FG002|Overall Study|Death|1|||
48676043|NCT00306527|156667185|FG003|Overall Study|Death|2|||
48676044|NCT03437577|156667186|FG000|Pre-Randomization|Withdrawal by Subject|0|||
48676045|NCT03437577|156667187|FG001|Pre-Randomization|Withdrawal by Subject|0|||
48676046|NCT03437577|156667188|FG002|Pre-Randomization|Withdrawal by Subject|10|||
48676047|NCT03437577|156667186|FG000|Post-Randomization|Physician Decision|0|||
48676048|NCT03437577|156667187|FG001|Post-Randomization|Physician Decision|2|||
48676049|NCT03437577|156667188|FG002|Post-Randomization|Physician Decision|0|||
48979086|NCT00952419|157755385|FG001|Overall Study|Adverse Event|0|||
48979087|NCT00952419|157755386|FG002|Overall Study|Adverse Event|0|||
48979088|NCT00952419|157755384|FG000|Overall Study|Protocol Violation|3|||
48979089|NCT00952419|157755385|FG001|Overall Study|Protocol Violation|7|||
48979090|NCT00952419|157755386|FG002|Overall Study|Protocol Violation|0|||
48979091|NCT00952419|157755384|FG000|Overall Study|Withdrawal by Subject|1|||
48979092|NCT00952419|157755385|FG001|Overall Study|Withdrawal by Subject|3|||
48979093|NCT00952419|157755386|FG002|Overall Study|Withdrawal by Subject|0|||
48979094|NCT01976624|157755387|FG000|Overall Study|Participants contraindicated|2|||
48676050|NCT00417963|156667189|FG000|Overall Study|Lost to Follow-up|3|||
48676051|NCT00417963|156667189|FG000|Overall Study|Withdrawal by Subject|18|||
48676052|NCT00417963|156667189|FG000|Overall Study|Death|17|||
48676053|NCT00417963|156667189|FG000|Overall Study|Study device could not be deployed|3|||
48676054|NCT00477152|156667191|FG000|Overall Study|Parent withdrew consent|2|||
48676055|NCT00477152|156667191|FG000|Overall Study|Adverse Event|1|||
48676056|NCT00448747|156667193|FG000|Overall Study|collapsed veins|1|||
48676057|NCT00448747|156667194|FG001|Overall Study|collapsed veins|0|||
48676058|NCT00704288|156667195|FG000|Overall Treatment Period|Adverse Event|11|||
48676059|NCT00704288|156667196|FG001|Overall Treatment Period|Adverse Event|8|||
48676060|NCT00704288|156667197|FG002|Overall Treatment Period|Adverse Event|22|||
48676061|NCT00704288|156667195|FG000|Overall Treatment Period|Death|0|||
48979095|NCT01976624|157755387|FG000|Overall Study|Participants age less than 19 years|12|||
48979096|NCT01436357|157755392|FG000|Overall Study|Death|5|||
48979097|NCT01436357|157755393|FG001|Overall Study|Death|1|||
48979098|NCT01436357|157755392|FG000|Overall Study|Enrolled but not vaccinated|1|||
48979099|NCT01436357|157755393|FG001|Overall Study|Enrolled but not vaccinated|1|||
48979100|NCT01436357|157755392|FG000|Overall Study|Incarceration|18|||
48979101|NCT01436357|157755393|FG001|Overall Study|Incarceration|20|||
48676062|NCT00704288|156667196|FG001|Overall Treatment Period|Death|0|||
48979102|NCT01436357|157755392|FG000|Overall Study|Lost to Follow-up|67|||
48979103|NCT01436357|157755393|FG001|Overall Study|Lost to Follow-up|61|||
48979104|NCT01436357|157755392|FG000|Overall Study|Protocol Violation|1|||
48979105|NCT01436357|157755393|FG001|Overall Study|Protocol Violation|0|||
48979106|NCT01436357|157755392|FG000|Overall Study|Withdrawal by Subject|26|||
48979107|NCT01436357|157755393|FG001|Overall Study|Withdrawal by Subject|38|||
48979108|NCT01436357|157755392|FG000|Overall Study|Physician Decision|3|||
48979109|NCT01436357|157755393|FG001|Overall Study|Physician Decision|4|||
48979110|NCT01436357|157755392|FG000|Overall Study|Moved out of area|1|||
48979111|NCT01436357|157755393|FG001|Overall Study|Moved out of area|2|||
48979112|NCT01436357|157755392|FG000|Overall Study|Subject in rehab|0|||
48979113|NCT01436357|157755393|FG001|Overall Study|Subject in rehab|1|||
48979114|NCT01316380|157755396|FG000|Overall Study|Adverse Event|0|||
48979115|NCT01316380|157755397|FG001|Overall Study|Adverse Event|2|||
48979116|NCT01316380|157755398|FG002|Overall Study|Adverse Event|1|||
48979117|NCT01316380|157755396|FG000|Overall Study|Protocol Violation|0|||
48979118|NCT01316380|157755397|FG001|Overall Study|Protocol Violation|0|||
48979119|NCT01316380|157755398|FG002|Overall Study|Protocol Violation|1|||
48979120|NCT01316380|157755396|FG000|Overall Study|Withdrawal by Subject|1|||
48979121|NCT01316380|157755397|FG001|Overall Study|Withdrawal by Subject|2|||
48979122|NCT01316380|157755398|FG002|Overall Study|Withdrawal by Subject|0|||
48979123|NCT01316380|157755396|FG000|Overall Study|Other|0|||
48979124|NCT01316380|157755397|FG001|Overall Study|Other|1|||
48979125|NCT01316380|157755398|FG002|Overall Study|Other|1|||
48979126|NCT01316380|157755396|FG000|Overall Study|Not treated|1|||
48979127|NCT01316380|157755397|FG001|Overall Study|Not treated|0|||
48979128|NCT01316380|157755398|FG002|Overall Study|Not treated|0|||
48979129|NCT00149890|157755399|FG000|Overall Study|Adverse Event|1|||
48979130|NCT00149890|157755400|FG001|Overall Study|Adverse Event|8|||
48979131|NCT00149890|157755399|FG000|Overall Study|Lack of Efficacy|8|||
48979132|NCT00149890|157755400|FG001|Overall Study|Lack of Efficacy|9|||
48979133|NCT00149890|157755399|FG000|Overall Study|Protocol Violation|1|||
48979134|NCT00149890|157755400|FG001|Overall Study|Protocol Violation|0|||
48979135|NCT00149890|157755399|FG000|Overall Study|Lost to Follow-up|1|||
48979136|NCT00149890|157755400|FG001|Overall Study|Lost to Follow-up|0|||
48979137|NCT00149890|157755399|FG000|Overall Study|Graft Loss|2|||
48979138|NCT00149890|157755400|FG001|Overall Study|Graft Loss|1|||
48979139|NCT01010776|157755401|FG000|Main Phase|Withdrawal by Subject|14|||
48979140|NCT01010776|157755401|FG000|Main Phase|Lack of Efficacy|8|||
48979141|NCT01010776|157755401|FG000|Main Phase|Adverse Event|7|||
48979142|NCT01010776|157755401|FG000|Main Phase|Lost to Follow-up|6|||
48979143|NCT01010776|157755401|FG000|Main Phase|Non-compliance to study medication|5|||
48979144|NCT01010776|157755401|FG000|Main Phase|Selection failure|2|||
48979145|NCT01010776|157755401|FG000|Main Phase|Inform consent withdrawal|1|||
48979146|NCT01010776|157755401|FG000|Main Phase|Other|1|||
48979147|NCT01010776|157755401|FG000|Main Phase|Did not received study medication|5|||
48979148|NCT01010776|157755401|FG000|In-Between Main Phase & Extension Phase|Extension phase was optional|15|||
48979149|NCT01010776|157755401|FG000|Extension Phase|Other|3|||
48979150|NCT00471315|157755402|FG000|Overall Study|Adverse Event|7|||
48979151|NCT00471315|157755402|FG000|Overall Study|Withdrawal by Subject|1|||
48979152|NCT00410514|157755403|FG000|Overall Study|Adverse Event|2|||
48979153|NCT00410514|157755404|FG001|Overall Study|Adverse Event|2|||
48979154|NCT00410514|157755405|FG002|Overall Study|Adverse Event|2|||
48979155|NCT00410514|157755403|FG000|Overall Study|Protocol Violation|0|||
48979156|NCT00410514|157755404|FG001|Overall Study|Protocol Violation|1|||
48979157|NCT00410514|157755405|FG002|Overall Study|Protocol Violation|1|||
48979158|NCT00410514|157755403|FG000|Overall Study|Lost to Follow-up|0|||
48979159|NCT00410514|157755404|FG001|Overall Study|Lost to Follow-up|0|||
48979160|NCT00410514|157755405|FG002|Overall Study|Lost to Follow-up|2|||
48979161|NCT00410514|157755403|FG000|Overall Study|Non-compliant with study procedures|0|||
48979162|NCT00410514|157755404|FG001|Overall Study|Non-compliant with study procedures|0|||
48979163|NCT00410514|157755405|FG002|Overall Study|Non-compliant with study procedures|2|||
48979164|NCT03277794|157755408|FG000|Overall Study|Lost to Follow-up|2|||
48979165|NCT03277794|157755409|FG001|Overall Study|Lost to Follow-up|4|||
48979166|NCT03277794|157755408|FG000|Overall Study|Withdrew due to high acuity|1|||
48979167|NCT03277794|157755409|FG001|Overall Study|Withdrew due to high acuity|0|||
48979168|NCT01307046|157755411|FG000|Overall Study|Adverse Event|3|||
48979169|NCT01307046|157755412|FG001|Overall Study|Adverse Event|3|||
48979170|NCT01307046|157755411|FG000|Overall Study|Lack of Efficacy|0|||
48979171|NCT01307046|157755412|FG001|Overall Study|Lack of Efficacy|2|||
48979172|NCT01307046|157755411|FG000|Overall Study|Physician Decision|2|||
48979173|NCT01307046|157755412|FG001|Overall Study|Physician Decision|0|||
48979174|NCT01307046|157755411|FG000|Overall Study|Withdrawal by Subject|1|||
48979175|NCT01307046|157755412|FG001|Overall Study|Withdrawal by Subject|1|||
48979176|NCT01307046|157755411|FG000|Overall Study|Serum Potassium Withdrawal Criteria Met|4|||
48979177|NCT01307046|157755412|FG001|Overall Study|Serum Potassium Withdrawal Criteria Met|2|||
48979178|NCT01307046|157755411|FG000|Overall Study|Blood Pressure Withdrawal Criteria Met|2|||
48979179|NCT01307046|157755412|FG001|Overall Study|Blood Pressure Withdrawal Criteria Met|3|||
48979180|NCT00320190|157755413|FG000|First 12 Months|Completed but did not enter extension|5|||
48979181|NCT00320190|157755414|FG001|First 12 Months|Completed but did not enter extension|3|||
48979182|NCT00320190|157755413|FG000|First 12 Months|Sponsor terminated study|2|||
48979183|NCT00320190|157755414|FG001|First 12 Months|Sponsor terminated study|2|||
48979184|NCT00320190|157755413|FG000|First 12 Months|Lost to Follow-up|0|||
48979185|NCT00320190|157755414|FG001|First 12 Months|Lost to Follow-up|1|||
48979186|NCT00320190|157755413|FG000|First 12 Months|Enrollment failure|0|||
48979187|NCT00320190|157755414|FG001|First 12 Months|Enrollment failure|1|||
48979188|NCT00320190|157755413|FG000|First 12 Months|Adverse event unrelated to study drug|1|||
48979189|NCT00320190|157755414|FG001|First 12 Months|Adverse event unrelated to study drug|0|||
48979190|NCT00320190|157755413|FG000|First 12 Months|Investigator request|0|||
48979191|NCT00320190|157755414|FG001|First 12 Months|Investigator request|1|||
48979192|NCT00320190|157755413|FG000|First 12 Months|Study drug toxicity|0|||
48979193|NCT00320190|157755414|FG001|First 12 Months|Study drug toxicity|1|||
48979194|NCT00320190|157755413|FG000|First 12 Months|Withdrawal by Subject|0|||
48979195|NCT00320190|157755414|FG001|First 12 Months|Withdrawal by Subject|1|||
48979196|NCT00320190|157755413|FG000|Long-term (12-month) Extension|Sponsor terminated study|7|||
48979197|NCT00320190|157755414|FG001|Long-term (12-month) Extension|Sponsor terminated study|0|||
48979198|NCT00320190|157755413|FG000|Long-term (12-month) Extension|Lack of major molecular response|1|||
48979199|NCT00320190|157755414|FG001|Long-term (12-month) Extension|Lack of major molecular response|2|||
48979200|NCT00320190|157755413|FG000|Long-term (12-month) Extension|Withdrawal by Subject|1|||
48979201|NCT00320190|157755414|FG001|Long-term (12-month) Extension|Withdrawal by Subject|0|||
48979202|NCT05116683|157755417|FG000|Overall Study|Physician Decision|4|||
48979203|NCT01131078|157756882|FG000|Overall Study|Adverse Event|22|||
48979204|NCT01131078|157756883|FG001|Overall Study|Adverse Event|12|||
48979205|NCT01131078|157756884|FG002|Overall Study|Adverse Event|17|||
48979206|NCT01131078|157756882|FG000|Overall Study|Progressive Disease|58|||
48979207|NCT01131078|157756883|FG001|Overall Study|Progressive Disease|77|||
48979208|NCT01131078|157756884|FG002|Overall Study|Progressive Disease|71|||
48979209|NCT01131078|157756882|FG000|Overall Study|Protocol Violation|1|||
48979210|NCT01131078|157756883|FG001|Overall Study|Protocol Violation|0|||
48979211|NCT01131078|157756884|FG002|Overall Study|Protocol Violation|0|||
48979212|NCT01131078|157756882|FG000|Overall Study|Lost to Follow-up|1|||
48979213|NCT01131078|157756883|FG001|Overall Study|Lost to Follow-up|1|||
48979214|NCT01131078|157756884|FG002|Overall Study|Lost to Follow-up|1|||
48979215|NCT01131078|157756882|FG000|Overall Study|Withdrawal by Subject|2|||
48979216|NCT01131078|157756883|FG001|Overall Study|Withdrawal by Subject|4|||
48676063|NCT00704288|156667197|FG002|Overall Treatment Period|Death|1|||
48676064|NCT00704288|156667195|FG000|Overall Treatment Period|Physician Decision|0|||
48979217|NCT01131078|157756884|FG002|Overall Study|Withdrawal by Subject|3|||
48979218|NCT01131078|157756882|FG000|Overall Study|Non-compliance|3|||
48979219|NCT01131078|157756883|FG001|Overall Study|Non-compliance|0|||
48979220|NCT01131078|157756884|FG002|Overall Study|Non-compliance|0|||
48979221|NCT01131078|157756882|FG000|Overall Study|Physician Decision|10|||
48979222|NCT01131078|157756883|FG001|Overall Study|Physician Decision|6|||
48979223|NCT01131078|157756884|FG002|Overall Study|Physician Decision|8|||
48979224|NCT01131078|157756882|FG000|Overall Study|Death|4|||
48979225|NCT01131078|157756883|FG001|Overall Study|Death|0|||
48979226|NCT01131078|157756884|FG002|Overall Study|Death|2|||
48979227|NCT01131078|157756882|FG000|Overall Study|Other|0|||
48979228|NCT01131078|157756883|FG001|Overall Study|Other|1|||
48979229|NCT01131078|157756884|FG002|Overall Study|Other|0|||
48979230|NCT00462488|157756887|FG000|Overall Study|Protocol Violation|1|||
48979231|NCT00462488|157756888|FG001|Overall Study|Protocol Violation|0|||
48979232|NCT00462488|157756887|FG000|Overall Study|Lack of Efficacy|19|||
48979233|NCT00462488|157756888|FG001|Overall Study|Lack of Efficacy|17|||
48979234|NCT02000219|157756890|FG000|14-Week Study Period|Physician Decision|1|||
48979235|NCT02000219|157756890|FG000|14-Week Study Period|Adverse Event|1|||
48979236|NCT02000219|157756890|FG000|14-Week Study Period|Underwent transplantation|1|||
48979237|NCT02000219|157756890|FG000|Continuation Period|Withdrawal by Subject|1|||
48979238|NCT02000219|157756890|FG000|Continuation Period|Had liver transplant|2|||
48979239|NCT02000219|157756890|FG000|Continuation Period|Non-compliance with study drug|2|||
48979240|NCT02667236|157756891|FG000|Overall Study|Adverse Event|1|||
48979241|NCT02667236|157756892|FG001|Overall Study|Adverse Event|1|||
48979242|NCT02667236|157756891|FG000|Overall Study|Withdrawal by Subject|2|||
48979243|NCT02667236|157756892|FG001|Overall Study|Withdrawal by Subject|0|||
48979244|NCT02579863|157756894|FG000|Overall Study|Final Disposition Unknown|2|||
48979245|NCT02579863|157756895|FG001|Overall Study|Final Disposition Unknown|1|||
48979246|NCT02579863|157756894|FG000|Overall Study|Adverse Event|18|||
48979247|NCT02579863|157756895|FG001|Overall Study|Adverse Event|11|||
48979248|NCT02579863|157756894|FG000|Overall Study|Death|31|||
48979249|NCT02579863|157756895|FG001|Overall Study|Death|29|||
48979250|NCT02579863|157756894|FG000|Overall Study|Lost to Follow-up|2|||
48979251|NCT02579863|157756895|FG001|Overall Study|Lost to Follow-up|1|||
48979252|NCT02579863|157756894|FG000|Overall Study|Physician Decision|1|||
48979253|NCT02579863|157756895|FG001|Overall Study|Physician Decision|2|||
48979254|NCT02579863|157756894|FG000|Overall Study|Screen Failure|0|||
48979255|NCT02579863|157756895|FG001|Overall Study|Screen Failure|2|||
48979256|NCT02579863|157756894|FG000|Overall Study|Study Terminated at Selected Sites|82|||
48979257|NCT02579863|157756895|FG001|Overall Study|Study Terminated at Selected Sites|88|||
48979258|NCT02579863|157756894|FG000|Overall Study|Withdrawal by Subject|20|||
48979259|NCT02579863|157756895|FG001|Overall Study|Withdrawal by Subject|20|||
48979260|NCT05091918|157756898|FG000|Overall Study|Adverse Event|1|||
48979261|NCT05091918|157756898|FG000|Overall Study|Withdrawal by Subject|81|||
48979262|NCT03878160|157756902|FG000|Overall Study|Lost to Follow-up|1|||
48979263|NCT03878160|157756903|FG001|Overall Study|Lost to Follow-up|1|||
48979264|NCT03878160|157756904|FG002|Overall Study|Lost to Follow-up|1|||
48979265|NCT03878160|157756902|FG000|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1|||
48979266|NCT03878160|157756903|FG001|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
48979267|NCT03878160|157756904|FG002|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
48979268|NCT01100658|157756908|FG000|Overall Study|Withdrawal by Subject|1|||
48979269|NCT03991936|157756909|FG000|Overall Study|Lost to Follow-up|1|||
48979270|NCT03991936|157756910|FG001|Overall Study|Lost to Follow-up|1|||
48979271|NCT03991936|157756911|FG002|Overall Study|Lost to Follow-up|1|||
48979272|NCT03991936|157756912|FG003|Overall Study|Lost to Follow-up|1|||
48979273|NCT03991936|157756913|FG004|Overall Study|Lost to Follow-up|1|||
48979274|NCT00216086|157756914|FG000|Overall Study|Protocol Violation|1|||
48979275|NCT00216086|157756914|FG000|Overall Study|Diagnosis of Metastatic Disease|1|||
48979276|NCT00216086|157756914|FG000|Overall Study|Social Reasons|2|||
48979277|NCT00364832|157756915|FG000|Core Period|Early Withdrawals|2|||
48979278|NCT00364832|157756916|FG001|Core Period|Early Withdrawals|2|||
48979279|NCT00364832|157756917|FG002|Core Period|Early Withdrawals|1|||
48979280|NCT00364832|157756918|FG003|Core Period|Early Withdrawals|1|||
48979281|NCT00364832|157756919|FG004|Core Period|Early Withdrawals|0|||
48979282|NCT00364832|157756920|FG005|Core Period|Early Withdrawals|0|||
48979283|NCT00364832|157756921|FG006|Core Period|Early Withdrawals|4|||
48979284|NCT00364832|157756922|FG007|Core Period|Early Withdrawals|1|||
48979285|NCT00364832|157756923|FG008|Core Period|Early Withdrawals|0|||
48979286|NCT00364832|157756924|FG009|Core Period|Early Withdrawals|0|||
48676065|NCT00704288|156667196|FG001|Overall Treatment Period|Physician Decision|2|||
48676066|NCT00704288|156667197|FG002|Overall Treatment Period|Physician Decision|0|||
48676067|NCT00704288|156667195|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
48676068|NCT00704288|156667196|FG001|Overall Treatment Period|Withdrawal by Subject|1|||
48676069|NCT00704288|156667197|FG002|Overall Treatment Period|Withdrawal by Subject|3|||
48676070|NCT00704288|156667195|FG000|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|30|||
48676071|NCT00704288|156667196|FG001|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
48676072|NCT00704288|156667197|FG002|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
48979287|NCT00364832|157756925|FG010|Core Period|Early Withdrawals|0|||
48979288|NCT00364832|157756926|FG011|Core Period|Early Withdrawals|0|||
48979289|NCT00364832|157756915|FG000|Extension Year 1|Early Withdrawals|0|||
48979290|NCT00364832|157756916|FG001|Extension Year 1|Early Withdrawals|0|||
48979291|NCT00364832|157756917|FG002|Extension Year 1|Early Withdrawals|0|||
48979292|NCT00364832|157756918|FG003|Extension Year 1|Early Withdrawals|0|||
48979293|NCT00364832|157756919|FG004|Extension Year 1|Early Withdrawals|0|||
48979294|NCT00364832|157756920|FG005|Extension Year 1|Early Withdrawals|0|||
48979295|NCT00364832|157756921|FG006|Extension Year 1|Early Withdrawals|0|||
48979296|NCT00364832|157756922|FG007|Extension Year 1|Early Withdrawals|0|||
48979297|NCT00364832|157756923|FG008|Extension Year 1|Early Withdrawals|0|||
48979298|NCT00364832|157756924|FG009|Extension Year 1|Early Withdrawals|4|||
48979299|NCT00364832|157756925|FG010|Extension Year 1|Early Withdrawals|2|||
48979300|NCT00364832|157756926|FG011|Extension Year 1|Early Withdrawals|10|||
48979301|NCT00364832|157756915|FG000|Extension Year 2|Early Withdrawals|0|||
48979302|NCT00364832|157756916|FG001|Extension Year 2|Early Withdrawals|0|||
48676073|NCT00704288|156667195|FG000|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|0|||
48979303|NCT00364832|157756917|FG002|Extension Year 2|Early Withdrawals|0|||
48979304|NCT00364832|157756918|FG003|Extension Year 2|Early Withdrawals|0|||
48979305|NCT00364832|157756919|FG004|Extension Year 2|Early Withdrawals|0|||
48979306|NCT00364832|157756920|FG005|Extension Year 2|Early Withdrawals|0|||
48979307|NCT00364832|157756921|FG006|Extension Year 2|Early Withdrawals|0|||
48979308|NCT00364832|157756922|FG007|Extension Year 2|Early Withdrawals|0|||
48979309|NCT00364832|157756923|FG008|Extension Year 2|Early Withdrawals|0|||
48979310|NCT00364832|157756924|FG009|Extension Year 2|Early Withdrawals|5|||
48979311|NCT00364832|157756925|FG010|Extension Year 2|Early Withdrawals|5|||
48979312|NCT00364832|157756926|FG011|Extension Year 2|Early Withdrawals|3|||
48979313|NCT03687827|157756931|FG000|Treatment Period 1|Death|0|||
48979314|NCT03687827|157756932|FG001|Treatment Period 1|Death|1|||
48979315|NCT03687827|157756931|FG000|Treatment Period 1|Lost to Follow-up|2|||
48676074|NCT00704288|156667196|FG001|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|42|||
48676075|NCT00704288|156667197|FG002|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|76|||
48676076|NCT00704288|156667195|FG000|Overall Treatment Period|Disease Progression--Clinical Deterioration|3|||
48676077|NCT00704288|156667196|FG001|Overall Treatment Period|Disease Progression--Clinical Deterioration|6|||
48676078|NCT00704288|156667197|FG002|Overall Treatment Period|Disease Progression--Clinical Deterioration|11|||
48676079|NCT00704288|156667195|FG000|Overall Treatment Period|Roll-over to another study|1|||
48676080|NCT00704288|156667196|FG001|Overall Treatment Period|Roll-over to another study|0|||
48676081|NCT00704288|156667197|FG002|Overall Treatment Period|Roll-over to another study|4|||
48676082|NCT00704288|156667195|FG000|Overall Treatment Period|Other--Subject had intracranial hemorrhage|1|||
48676083|NCT00704288|156667196|FG001|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
48676084|NCT00704288|156667197|FG002|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
48676085|NCT00704288|156667195|FG000|Extended Post Treatment Follow Up Period|Death|41|||
48762053|NCT04608500|156978003|FG001|Overall Study|Adverse Event|0|||
48762054|NCT04608500|156978002|FG000|Overall Study|Lost to Follow-up|15|||
48762055|NCT04608500|156978003|FG001|Overall Study|Lost to Follow-up|9|||
48762056|NCT04608500|156978002|FG000|Overall Study|Participant request|11|||
48762057|NCT04608500|156978003|FG001|Overall Study|Participant request|7|||
48762058|NCT04608500|156978002|FG000|Overall Study|Protocol Violation|1|||
48762059|NCT04608500|156978003|FG001|Overall Study|Protocol Violation|0|||
48762060|NCT04608500|156978002|FG000|Overall Study|Other|6|||
48762061|NCT04608500|156978003|FG001|Overall Study|Other|2|||
48762062|NCT02747420|156978004|FG000|Overall Study|Lost to Follow-up|4|||
48762063|NCT02747420|156978005|FG001|Overall Study|Lost to Follow-up|2|||
48762064|NCT02747420|156978004|FG000|Overall Study|Withdrawal by Subject|3|||
48762065|NCT02747420|156978005|FG001|Overall Study|Withdrawal by Subject|2|||
48762066|NCT05129488|156978006|FG000|Overall Study|Protocol Violation|3|||
48762067|NCT02608268|156978007|FG000|Overall Study|Adverse Event|0|||
48762068|NCT02608268|156978008|FG001|Overall Study|Adverse Event|0|||
48762069|NCT02608268|156978009|FG002|Overall Study|Adverse Event|1|||
48762070|NCT02608268|156978010|FG003|Overall Study|Adverse Event|0|||
48762071|NCT02608268|156978011|FG004|Overall Study|Adverse Event|0|||
48979316|NCT03687827|157756932|FG001|Treatment Period 1|Lost to Follow-up|2|||
48979317|NCT03687827|157756931|FG000|Treatment Period 1|Physician Decision|5|||
48979318|NCT03687827|157756932|FG001|Treatment Period 1|Physician Decision|2|||
48979319|NCT03687827|157756931|FG000|Treatment Period 1|Withdrawal by Subject|7|||
48979320|NCT03687827|157756932|FG001|Treatment Period 1|Withdrawal by Subject|3|||
48979321|NCT03687827|157756931|FG000|Treatment Period 2|Physician Decision|4|||
48979322|NCT03687827|157756932|FG001|Treatment Period 2|Physician Decision|1|||
48979323|NCT03687827|157756931|FG000|Treatment Period 2|Withdrawal by Subject|1|||
48979324|NCT03687827|157756932|FG001|Treatment Period 2|Withdrawal by Subject|2|||
48979325|NCT01291511|157756934|FG000|Cross-Titration and Stabilization Phase|Withdrawal by Subject|107|||
48979326|NCT01291511|157756935|FG001|Cross-Titration and Stabilization Phase|Withdrawal by Subject|0|||
48979327|NCT01291511|157756934|FG000|Cross-Titration and Stabilization Phase|Adverse Event|92|||
48979328|NCT01291511|157756935|FG001|Cross-Titration and Stabilization Phase|Adverse Event|0|||
48979329|NCT01291511|157756934|FG000|Cross-Titration and Stabilization Phase|Administrative problems|30|||
48979330|NCT01291511|157756935|FG001|Cross-Titration and Stabilization Phase|Administrative problems|0|||
48979331|NCT01291511|157756934|FG000|Cross-Titration and Stabilization Phase|Lack of Efficacy|28|||
48979332|NCT01291511|157756935|FG001|Cross-Titration and Stabilization Phase|Lack of Efficacy|0|||
48979333|NCT01291511|157756934|FG000|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|25|||
48979334|NCT01291511|157756935|FG001|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|0|||
48979335|NCT01291511|157756934|FG000|Cross-Titration and Stabilization Phase|Lost to Follow-up|24|||
48979336|NCT01291511|157756935|FG001|Cross-Titration and Stabilization Phase|Lost to Follow-up|0|||
48979337|NCT01291511|157756934|FG000|Cross-Titration and Stabilization Phase|Protocol Violation|13|||
48979338|NCT01291511|157756935|FG001|Cross-Titration and Stabilization Phase|Protocol Violation|0|||
48979339|NCT01291511|157756934|FG000|Cross-Titration and Stabilization Phase|Abnormal test|6|||
48979340|NCT01291511|157756935|FG001|Cross-Titration and Stabilization Phase|Abnormal test|0|||
48979341|NCT01291511|157756934|FG000|Cross-Titration and Stabilization Phase|Death|1|||
48979342|NCT01291511|157756935|FG001|Cross-Titration and Stabilization Phase|Death|0|||
48979343|NCT01291511|157756934|FG000|Double-blind Relapse Prevention Phase|Administrative problems|45|||
48979344|NCT01291511|157756935|FG001|Double-blind Relapse Prevention Phase|Administrative problems|29|||
48979345|NCT01291511|157756934|FG000|Double-blind Relapse Prevention Phase|Withdrawal by Subject|14|||
48676086|NCT00704288|156667196|FG001|Extended Post Treatment Follow Up Period|Death|50|||
48676087|NCT00704288|156667197|FG002|Extended Post Treatment Follow Up Period|Death|93|||
48676088|NCT00704288|156667195|FG000|Extended Post Treatment Follow Up Period|Lost to Follow-up|0|||
48762072|NCT02608268|156978012|FG005|Overall Study|Adverse Event|0|||
48762073|NCT02608268|156978013|FG006|Overall Study|Adverse Event|0|||
48762074|NCT02608268|156978014|FG007|Overall Study|Adverse Event|0|||
48762075|NCT02608268|156978015|FG008|Overall Study|Adverse Event|0|||
48762076|NCT02608268|156978016|FG009|Overall Study|Adverse Event|0|||
48874274|NCT01085812|157376981|FG001|Double-blind Intent-to-treat Population|Protocol Violation|7|||
48874275|NCT01085812|157376980|FG000|Double-blind Intent-to-treat Population|Withdrawal by Subject|11|||
48874276|NCT01085812|157376981|FG001|Double-blind Intent-to-treat Population|Withdrawal by Subject|22|||
48874277|NCT01085812|157376980|FG000|Double-blind Intent-to-treat Population|Lost to Follow-up|4|||
48874278|NCT01085812|157376981|FG001|Double-blind Intent-to-treat Population|Lost to Follow-up|17|||
48874279|NCT01085812|157376980|FG000|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0|||
48874280|NCT01085812|157376981|FG001|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2|||
48874281|NCT00107978|157376984|FG000|Overall Study|Adverse Event|1|||
48874282|NCT00107978|157376985|FG001|Overall Study|Adverse Event|5|||
48874283|NCT00107978|157376984|FG000|Overall Study|Death|3|||
48874284|NCT00107978|157376985|FG001|Overall Study|Death|3|||
48874285|NCT00107978|157376984|FG000|Overall Study|Lost to Follow-up|20|||
48874286|NCT00107978|157376985|FG001|Overall Study|Lost to Follow-up|28|||
48874287|NCT00107978|157376984|FG000|Overall Study|Withdrawal by Subject|4|||
48874288|NCT00107978|157376985|FG001|Overall Study|Withdrawal by Subject|9|||
48874289|NCT00107978|157376984|FG000|Overall Study|Protocol Violation|0|||
48874290|NCT00107978|157376985|FG001|Overall Study|Protocol Violation|1|||
48874291|NCT00107978|157376984|FG000|Overall Study|Other|5|||
48874292|NCT00107978|157376985|FG001|Overall Study|Other|4|||
48874293|NCT04191148|157376986|FG000|Overall Study|Withdrawal by Subject|1|||
48874294|NCT04191148|157376987|FG001|Overall Study|Withdrawal by Subject|0|||
48874295|NCT04191148|157376986|FG000|Overall Study|Adverse Event|1|||
48979346|NCT01291511|157756935|FG001|Double-blind Relapse Prevention Phase|Withdrawal by Subject|10|||
48676089|NCT00704288|156667196|FG001|Extended Post Treatment Follow Up Period|Lost to Follow-up|2|||
48676090|NCT00704288|156667197|FG002|Extended Post Treatment Follow Up Period|Lost to Follow-up|1|||
48676091|NCT00704288|156667195|FG000|Extended Post Treatment Follow Up Period|Withdrawal by Subject|0|||
48676092|NCT00704288|156667196|FG001|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
48676093|NCT00704288|156667197|FG002|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
48676094|NCT00704288|156667195|FG000|Extended Post Treatment Follow Up Period|Various reasons|5|||
48676095|NCT00704288|156667196|FG001|Extended Post Treatment Follow Up Period|Various reasons|5|||
48676096|NCT00704288|156667197|FG002|Extended Post Treatment Follow Up Period|Various reasons|21|||
48676097|NCT04680975|156667200|FG000|Overall Study|Adverse Event|3|||
48676098|NCT04680975|156667200|FG000|Overall Study|Death|1|||
48676099|NCT04680975|156667200|FG000|Overall Study|Progressive Disease|1|||
48676100|NCT04680975|156667200|FG000|Overall Study|Withdrawal by Subject|1|||
48676101|NCT01948063|156667201|FG000|Overall Study|Boston MCI halted research protocol|0|||
48676102|NCT01948063|156667202|FG001|Overall Study|Boston MCI halted research protocol|1|||
48676103|NCT01948063|156667201|FG000|Overall Study|Discovered an enrollment in other study|0|||
48676104|NCT01948063|156667202|FG001|Overall Study|Discovered an enrollment in other study|1|||
48676105|NCT01948063|156667201|FG000|Overall Study|Blood samples were accidentally thawed|1|||
48676106|NCT01948063|156667202|FG001|Overall Study|Blood samples were accidentally thawed|0|||
48676107|NCT02478164|156667206|FG000|Overall Study|Lack of Efficacy|13|||
48676108|NCT02478164|156667206|FG000|Overall Study|Adverse Event|1|||
48676109|NCT02478164|156667206|FG000|Overall Study|Withdrawal by Subject|1|||
48676110|NCT02227199|156667207|FG000|Overall Study|Physician Decision|0|||
48676111|NCT02227199|156667208|FG001|Overall Study|Physician Decision|0|||
48676112|NCT02227199|156667209|FG002|Overall Study|Physician Decision|1|||
48676113|NCT02227199|156667207|FG000|Overall Study|Adverse Event|0|||
48676114|NCT02227199|156667208|FG001|Overall Study|Adverse Event|0|||
48676115|NCT02227199|156667209|FG002|Overall Study|Adverse Event|3|||
48676116|NCT01329939|156667210|FG000|Overall Study|Lost to Follow-up|3|||
48676117|NCT01329939|156667211|FG001|Overall Study|Lost to Follow-up|0|||
48676118|NCT01329939|156667212|FG002|Overall Study|Lost to Follow-up|1|||
48676119|NCT01329939|156667213|FG003|Overall Study|Lost to Follow-up|2|||
48676120|NCT01329939|156667210|FG000|Overall Study|Withdrawal by Subject|0|||
48676121|NCT01329939|156667211|FG001|Overall Study|Withdrawal by Subject|1|||
48676122|NCT01329939|156667212|FG002|Overall Study|Withdrawal by Subject|0|||
48676123|NCT01329939|156667213|FG003|Overall Study|Withdrawal by Subject|0|||
48676124|NCT01329939|156667210|FG000|Overall Study|Adverse Event|0|||
48676125|NCT01329939|156667211|FG001|Overall Study|Adverse Event|0|||
48676126|NCT01329939|156667212|FG002|Overall Study|Adverse Event|0|||
48676127|NCT01329939|156667213|FG003|Overall Study|Adverse Event|3|||
48676128|NCT03364738|156667214|FG000|Overall Study|Early termination due to Food and Drug Administration recall of rhPTH(1-84) (Natpara)|6|||
48676129|NCT03364738|156667214|FG000|Overall Study|Withdrawal by Subject|1|||
48676130|NCT03364738|156667214|FG000|Overall Study|Adverse Event|1|||
48676131|NCT00989963|156667220|FG000|Overall Study|Adverse Event|1|||
48676132|NCT00989963|156667221|FG001|Overall Study|Adverse Event|1|||
48676133|NCT00989963|156667222|FG002|Overall Study|Adverse Event|1|||
48676134|NCT01677858|156667223|FG000|Overall Study|Adverse Event|0|||
48874296|NCT04191148|157376987|FG001|Overall Study|Adverse Event|0|||
48874297|NCT00394589|157376988|FG000|Overall Study|Adverse Event|2|||
48874298|NCT00394589|157376989|FG001|Overall Study|Adverse Event|1|||
48874299|NCT00394589|157376990|FG002|Overall Study|Adverse Event|2|||
48979347|NCT01291511|157756934|FG000|Double-blind Relapse Prevention Phase|Lost to Follow-up|6|||
48979348|NCT01291511|157756935|FG001|Double-blind Relapse Prevention Phase|Lost to Follow-up|4|||
48979349|NCT01291511|157756934|FG000|Double-blind Relapse Prevention Phase|Adverse Event|5|||
48979350|NCT01291511|157756935|FG001|Double-blind Relapse Prevention Phase|Adverse Event|0|||
48979351|NCT01291511|157756934|FG000|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|4|||
48979352|NCT01291511|157756935|FG001|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|2|||
48979353|NCT01291511|157756934|FG000|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
48979354|NCT01291511|157756935|FG001|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
48979355|NCT01291511|157756934|FG000|Double-blind Relapse Prevention Phase|Lack of Efficacy|0|||
48979356|NCT01291511|157756935|FG001|Double-blind Relapse Prevention Phase|Lack of Efficacy|2|||
48979357|NCT01291511|157756934|FG000|Double-blind Relapse Prevention Phase|Abnormal test|1|||
48979358|NCT01291511|157756935|FG001|Double-blind Relapse Prevention Phase|Abnormal test|0|||
48979359|NCT01291511|157756934|FG000|Double-blind Relapse Prevention Phase|Death|1|||
48979360|NCT01291511|157756935|FG001|Double-blind Relapse Prevention Phase|Death|0|||
48979361|NCT00729560|157756938|FG000|Overall Study|Withdrawal by Subject|3|||
48979362|NCT00764322|157756939|FG000|Overall Study|Withdrawal by Subject|11|||
48979363|NCT00764322|157756939|FG000|Overall Study|No CYP2D6 genotyping|9|||
48979364|NCT00623766|157756949|FG000|Induction Phase (Day 1 to Week 24)|Off treatment|36|||
48979365|NCT00623766|157756950|FG001|Induction Phase (Day 1 to Week 24)|Off treatment|16|||
48979366|NCT00623766|157756949|FG000|Maintenance Phase (Week 24 to Year 2)|Disease progression|4|||
48979367|NCT00623766|157756950|FG001|Maintenance Phase (Week 24 to Year 2)|Disease progression|0|||
48979368|NCT00623766|157756949|FG000|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4|||
48979369|NCT00623766|157756950|FG001|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0|||
48979370|NCT00623766|157756949|FG000|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1|||
48979371|NCT00623766|157756950|FG001|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2|||
48979372|NCT00623766|157756949|FG000|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1|||
48979373|NCT00623766|157756950|FG001|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0|||
48979374|NCT00832091|157756951|FG000|Overall Study|Adverse Event|1|||
48979375|NCT00832091|157756952|FG001|Overall Study|Adverse Event|1|||
48979376|NCT00832091|157756951|FG000|Overall Study|Protocol Violation|1|||
48979377|NCT00832091|157756952|FG001|Overall Study|Protocol Violation|0|||
48979378|NCT00832091|157756951|FG000|Overall Study|Withdrawal by Subject|2|||
48979379|NCT00832091|157756952|FG001|Overall Study|Withdrawal by Subject|1|||
48979380|NCT00832091|157756951|FG000|Overall Study|Prohibited Medication|1|||
48979381|NCT00832091|157756952|FG001|Overall Study|Prohibited Medication|0|||
48979382|NCT02750501|157756953|FG000|Overall Study|Adverse Event|4|||
48979383|NCT02750501|157756953|FG000|Overall Study|Physician Decision|1|||
48979384|NCT02750501|157756953|FG000|Overall Study|Protocol Violation|1|||
48979385|NCT02750501|157756953|FG000|Overall Study|G-tube came out|1|||
48979386|NCT02750501|157756953|FG000|Overall Study|Non-compliant use of PERT|1|||
48979387|NCT02120469|157756955|FG000|Overall Study|HER-2/neu-amplified|1|||
48979388|NCT02120469|157756956|FG001|Overall Study|HER-2/neu-amplified|0|||
48979389|NCT02120469|157756957|FG002|Overall Study|HER-2/neu-amplified|1|||
48979390|NCT02415595|157756958|FG000|Overall Study|Administrative reason by sponsor|39|||
48979391|NCT02415595|157756959|FG001|Overall Study|Administrative reason by sponsor|40|||
48979392|NCT02415595|157756960|FG002|Overall Study|Administrative reason by sponsor|41|||
48979393|NCT02415595|157756961|FG003|Overall Study|Administrative reason by sponsor|39|||
48979394|NCT02415595|157756958|FG000|Overall Study|Adverse Event|1|||
48979395|NCT02415595|157756959|FG001|Overall Study|Adverse Event|3|||
48979396|NCT02415595|157756960|FG002|Overall Study|Adverse Event|5|||
48979397|NCT02415595|157756961|FG003|Overall Study|Adverse Event|10|||
48979398|NCT02415595|157756958|FG000|Overall Study|Lack of Efficacy|4|||
48979399|NCT02415595|157756959|FG001|Overall Study|Lack of Efficacy|4|||
48979400|NCT02415595|157756960|FG002|Overall Study|Lack of Efficacy|0|||
48979401|NCT02415595|157756961|FG003|Overall Study|Lack of Efficacy|0|||
48979402|NCT02415595|157756958|FG000|Overall Study|Lost to Follow-up|1|||
48979403|NCT02415595|157756959|FG001|Overall Study|Lost to Follow-up|3|||
48979404|NCT02415595|157756960|FG002|Overall Study|Lost to Follow-up|1|||
48979405|NCT02415595|157756961|FG003|Overall Study|Lost to Follow-up|1|||
48979406|NCT02415595|157756958|FG000|Overall Study|Poor/Non-compliance|1|||
48979407|NCT02415595|157756959|FG001|Overall Study|Poor/Non-compliance|0|||
48979408|NCT02415595|157756960|FG002|Overall Study|Poor/Non-compliance|1|||
48762077|NCT02608268|156978017|FG010|Overall Study|Adverse Event|0|||
48762078|NCT02608268|156978018|FG011|Overall Study|Adverse Event|0|||
48979409|NCT02415595|157756961|FG003|Overall Study|Poor/Non-compliance|0|||
48979410|NCT02415595|157756958|FG000|Overall Study|Reached stopping criteria|0|||
48979411|NCT02415595|157756959|FG001|Overall Study|Reached stopping criteria|1|||
48979412|NCT02415595|157756960|FG002|Overall Study|Reached stopping criteria|1|||
48979413|NCT02415595|157756961|FG003|Overall Study|Reached stopping criteria|0|||
48979414|NCT02415595|157756958|FG000|Overall Study|Withdrawal by Subject|4|||
48979415|NCT02415595|157756959|FG001|Overall Study|Withdrawal by Subject|0|||
48979416|NCT02415595|157756960|FG002|Overall Study|Withdrawal by Subject|1|||
48762079|NCT02608268|156978019|FG012|Overall Study|Adverse Event|2|||
48979417|NCT02415595|157756961|FG003|Overall Study|Withdrawal by Subject|3|||
48979418|NCT02415595|157756958|FG000|Overall Study|Other|0|||
48979419|NCT02415595|157756959|FG001|Overall Study|Other|1|||
48979420|NCT02415595|157756960|FG002|Overall Study|Other|1|||
48979421|NCT02415595|157756961|FG003|Overall Study|Other|0|||
48979422|NCT02614261|157756962|FG000|Double-Blind Treatment Phase|Adverse Event|7|||
48979423|NCT02614261|157756963|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
48979424|NCT02614261|157756964|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
48979425|NCT02614261|157756965|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
48979426|NCT02614261|157756962|FG000|Double-Blind Treatment Phase|Lack of Efficacy|4|||
48979427|NCT02614261|157756963|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
48979428|NCT02614261|157756964|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
48979429|NCT02614261|157756965|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
48979430|NCT02614261|157756962|FG000|Double-Blind Treatment Phase|Lost to Follow-up|9|||
48979431|NCT02614261|157756963|FG001|Double-Blind Treatment Phase|Lost to Follow-up|4|||
48979432|NCT02614261|157756964|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
48979433|NCT02614261|157756965|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
48979434|NCT02614261|157756962|FG000|Double-Blind Treatment Phase|Physician Decision|2|||
48979435|NCT02614261|157756963|FG001|Double-Blind Treatment Phase|Physician Decision|1|||
48979436|NCT02614261|157756964|FG002|Double-Blind Treatment Phase|Physician Decision|1|||
48979437|NCT02614261|157756965|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
48979438|NCT02614261|157756962|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
48979439|NCT02614261|157756963|FG001|Double-Blind Treatment Phase|Pregnancy|2|||
48979440|NCT02614261|157756964|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
48979441|NCT02614261|157756965|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
48979442|NCT02614261|157756962|FG000|Double-Blind Treatment Phase|Protocol Violation|6|||
48979443|NCT02614261|157756963|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
48979444|NCT02614261|157756964|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
48979445|NCT02614261|157756965|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
48979446|NCT02614261|157756962|FG000|Double-Blind Treatment Phase|Screen failure|0|||
48979447|NCT02614261|157756963|FG001|Double-Blind Treatment Phase|Screen failure|1|||
48979448|NCT02614261|157756964|FG002|Double-Blind Treatment Phase|Screen failure|2|||
48979449|NCT02614261|157756965|FG003|Double-Blind Treatment Phase|Screen failure|0|||
48979450|NCT02614261|157756962|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|20|||
48979451|NCT02614261|157756963|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
48979452|NCT02614261|157756964|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|7|||
48979453|NCT02614261|157756965|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
48979454|NCT02614261|157756962|FG000|Open-Label Extension Phase|Adverse Event|23|||
48979455|NCT02614261|157756963|FG001|Open-Label Extension Phase|Adverse Event|12|||
48979456|NCT02614261|157756964|FG002|Open-Label Extension Phase|Adverse Event|11|||
48979457|NCT02614261|157756965|FG003|Open-Label Extension Phase|Adverse Event|0|||
48979458|NCT02614261|157756962|FG000|Open-Label Extension Phase|Lack of Efficacy|14|||
48979459|NCT02614261|157756963|FG001|Open-Label Extension Phase|Lack of Efficacy|12|||
48979460|NCT02614261|157756964|FG002|Open-Label Extension Phase|Lack of Efficacy|14|||
48979461|NCT02614261|157756965|FG003|Open-Label Extension Phase|Lack of Efficacy|0|||
48979462|NCT02614261|157756962|FG000|Open-Label Extension Phase|Lost to Follow-up|15|||
48979463|NCT02614261|157756963|FG001|Open-Label Extension Phase|Lost to Follow-up|7|||
48979464|NCT02614261|157756964|FG002|Open-Label Extension Phase|Lost to Follow-up|9|||
48979465|NCT02614261|157756965|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
48979466|NCT02614261|157756962|FG000|Open-Label Extension Phase|Physician Decision|2|||
48979467|NCT02614261|157756963|FG001|Open-Label Extension Phase|Physician Decision|0|||
48979468|NCT02614261|157756964|FG002|Open-Label Extension Phase|Physician Decision|0|||
48979469|NCT02614261|157756965|FG003|Open-Label Extension Phase|Physician Decision|0|||
48979470|NCT02614261|157756962|FG000|Open-Label Extension Phase|Pregnancy|1|||
48762080|NCT02608268|156978020|FG013|Overall Study|Adverse Event|0|||
48762081|NCT02608268|156978021|FG014|Overall Study|Adverse Event|0|||
48762082|NCT02608268|156978022|FG015|Overall Study|Adverse Event|0|||
48762083|NCT02608268|156978023|FG016|Overall Study|Adverse Event|0|||
48762084|NCT02608268|156978024|FG017|Overall Study|Adverse Event|0|||
48762085|NCT02608268|156978025|FG018|Overall Study|Adverse Event|0|||
48762086|NCT02608268|156978026|FG019|Overall Study|Adverse Event|0|||
48762087|NCT02608268|156978027|FG020|Overall Study|Adverse Event|1|||
48762088|NCT02608268|156978028|FG021|Overall Study|Adverse Event|1|||
48762089|NCT02608268|156978029|FG022|Overall Study|Adverse Event|0|||
48762090|NCT02608268|156978030|FG023|Overall Study|Adverse Event|0|||
48762091|NCT02608268|156978031|FG024|Overall Study|Adverse Event|1|||
48762092|NCT02608268|156978032|FG025|Overall Study|Adverse Event|0|||
48762093|NCT02608268|156978033|FG026|Overall Study|Adverse Event|0|||
48979471|NCT02614261|157756963|FG001|Open-Label Extension Phase|Pregnancy|2|||
48979472|NCT02614261|157756964|FG002|Open-Label Extension Phase|Pregnancy|1|||
48979473|NCT02614261|157756965|FG003|Open-Label Extension Phase|Pregnancy|0|||
48762094|NCT02608268|156978034|FG027|Overall Study|Adverse Event|0|||
48762095|NCT02608268|156978035|FG028|Overall Study|Adverse Event|1|||
48762096|NCT02608268|156978036|FG029|Overall Study|Adverse Event|0|||
48676135|NCT01677858|156667224|FG001|Overall Study|Adverse Event|0|||
48874300|NCT00394589|157376988|FG000|Overall Study|Lack of Efficacy|2|||
48874301|NCT00394589|157376989|FG001|Overall Study|Lack of Efficacy|2|||
48874302|NCT00394589|157376990|FG002|Overall Study|Lack of Efficacy|3|||
48874303|NCT00394589|157376988|FG000|Overall Study|Protocol Violation|4|||
48874304|NCT00394589|157376989|FG001|Overall Study|Protocol Violation|0|||
48874305|NCT00394589|157376990|FG002|Overall Study|Protocol Violation|2|||
48874306|NCT03409731|157376992|FG000|Overall Study|Withdrawal by Subject|17|||
48874307|NCT03409731|157376992|FG000|Overall Study|Death|4|||
48874308|NCT01114672|157376993|FG000|Overall Study|Death|0|||
48874309|NCT01114672|157376994|FG001|Overall Study|Death|1|||
48874310|NCT01114672|157376993|FG000|Overall Study|Withdrawal by Subject|2|||
48874311|NCT01114672|157376994|FG001|Overall Study|Withdrawal by Subject|1|||
48874312|NCT01114672|157376993|FG000|Overall Study|Lost to Follow-up|1|||
48874313|NCT01114672|157376994|FG001|Overall Study|Lost to Follow-up|0|||
48874314|NCT01114672|157376993|FG000|Overall Study|transplanted|1|||
48874315|NCT01114672|157376994|FG001|Overall Study|transplanted|0|||
48676136|NCT01677858|156667225|FG002|Overall Study|Adverse Event|2|||
48676137|NCT01677858|156667226|FG003|Overall Study|Adverse Event|3|||
48676138|NCT01677858|156667227|FG004|Overall Study|Adverse Event|13|||
48676139|NCT01677858|156667223|FG000|Overall Study|Death|0|||
48676140|NCT01677858|156667224|FG001|Overall Study|Death|0|||
48676141|NCT01677858|156667225|FG002|Overall Study|Death|0|||
48676142|NCT01677858|156667226|FG003|Overall Study|Death|0|||
48676143|NCT01677858|156667227|FG004|Overall Study|Death|1|||
48676144|NCT01677858|156667223|FG000|Overall Study|Physician Decision|1|||
48676145|NCT01677858|156667224|FG001|Overall Study|Physician Decision|0|||
48676146|NCT01677858|156667225|FG002|Overall Study|Physician Decision|2|||
48676147|NCT01677858|156667226|FG003|Overall Study|Physician Decision|0|||
48874316|NCT01710800|157377001|FG000|Overall Study|Withdrawal by Subject|21|||
48874317|NCT01710800|157377001|FG000|Overall Study|Protocol Violation|1|||
48874318|NCT00458393|157377002|FG000|Overall Study|Withdrawal by Subject|67|||
48874319|NCT00458393|157377003|FG001|Overall Study|Withdrawal by Subject|80|||
48874320|NCT00458393|157377002|FG000|Overall Study|Physician Decision|31|||
48874321|NCT00458393|157377003|FG001|Overall Study|Physician Decision|22|||
48874322|NCT00458393|157377002|FG000|Overall Study|Relocated|77|||
48874323|NCT00458393|157377003|FG001|Overall Study|Relocated|81|||
48874324|NCT00458393|157377002|FG000|Overall Study|Lost to Follow-up|115|||
48874325|NCT00458393|157377003|FG001|Overall Study|Lost to Follow-up|92|||
48874326|NCT00458393|157377002|FG000|Overall Study|Sites marked other on the form.|19|||
48874327|NCT00458393|157377003|FG001|Overall Study|Sites marked other on the form.|20|||
48874328|NCT00937521|157377005|FG000|Overall Study - Prior to Booster Dose|Adverse Event|0|||
48874329|NCT00937521|157377006|FG001|Overall Study - Prior to Booster Dose|Adverse Event|0|||
48874330|NCT00937521|157377007|FG002|Overall Study - Prior to Booster Dose|Adverse Event|2|||
48874331|NCT00937521|157377008|FG003|Overall Study - Prior to Booster Dose|Adverse Event|0|||
48874332|NCT00937521|157377009|FG004|Overall Study - Prior to Booster Dose|Adverse Event|0|||
48874333|NCT00937521|157377010|FG005|Overall Study - Prior to Booster Dose|Adverse Event|0|||
48676148|NCT01677858|156667227|FG004|Overall Study|Physician Decision|12|||
48676149|NCT01677858|156667223|FG000|Overall Study|Progressive Disease|2|||
48676150|NCT01677858|156667224|FG001|Overall Study|Progressive Disease|1|||
48676151|NCT01677858|156667225|FG002|Overall Study|Progressive Disease|9|||
48676152|NCT01677858|156667226|FG003|Overall Study|Progressive Disease|3|||
48676153|NCT01677858|156667227|FG004|Overall Study|Progressive Disease|43|||
48676154|NCT01677858|156667223|FG000|Overall Study|Withdrawal by Subject|0|||
48676155|NCT01677858|156667224|FG001|Overall Study|Withdrawal by Subject|1|||
48676156|NCT01677858|156667225|FG002|Overall Study|Withdrawal by Subject|1|||
48676157|NCT01677858|156667226|FG003|Overall Study|Withdrawal by Subject|0|||
48676158|NCT01677858|156667227|FG004|Overall Study|Withdrawal by Subject|15|||
48676159|NCT01677858|156667223|FG000|Overall Study|Lost to Follow-up|0|||
48676160|NCT01677858|156667224|FG001|Overall Study|Lost to Follow-up|0|||
48676161|NCT01677858|156667225|FG002|Overall Study|Lost to Follow-up|0|||
48676162|NCT01677858|156667226|FG003|Overall Study|Lost to Follow-up|0|||
48676163|NCT01677858|156667227|FG004|Overall Study|Lost to Follow-up|1|||
48676164|NCT00077649|156667229|FG000|Overall Study|Adverse Event|5|||
48676165|NCT00077649|156667230|FG001|Overall Study|Adverse Event|1|||
48676166|NCT00077649|156667231|FG002|Overall Study|Adverse Event|7|||
48676167|NCT00077649|156667232|FG003|Overall Study|Adverse Event|9|||
48676168|NCT00077649|156667229|FG000|Overall Study|Lack of Efficacy|5|||
48676169|NCT00077649|156667230|FG001|Overall Study|Lack of Efficacy|3|||
48676170|NCT00077649|156667231|FG002|Overall Study|Lack of Efficacy|3|||
48874334|NCT00937521|157377011|FG006|Overall Study - Prior to Booster Dose|Adverse Event|1|||
48874335|NCT00937521|157377012|FG007|Overall Study - Prior to Booster Dose|Adverse Event|0|||
48874336|NCT00937521|157377005|FG000|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
48874337|NCT00937521|157377006|FG001|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
48874338|NCT00937521|157377007|FG002|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3|||
48874339|NCT00937521|157377008|FG003|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
48874340|NCT00937521|157377009|FG004|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
48979474|NCT02614261|157756962|FG000|Open-Label Extension Phase|Protocol Violation|3|||
48979475|NCT02614261|157756963|FG001|Open-Label Extension Phase|Protocol Violation|4|||
48979476|NCT02614261|157756964|FG002|Open-Label Extension Phase|Protocol Violation|1|||
48979477|NCT02614261|157756965|FG003|Open-Label Extension Phase|Protocol Violation|0|||
48979478|NCT02614261|157756962|FG000|Open-Label Extension Phase|Withdrawal by Subject|30|||
48979479|NCT02614261|157756963|FG001|Open-Label Extension Phase|Withdrawal by Subject|18|||
48979480|NCT02614261|157756964|FG002|Open-Label Extension Phase|Withdrawal by Subject|18|||
48979481|NCT02614261|157756965|FG003|Open-Label Extension Phase|Withdrawal by Subject|0|||
48979482|NCT02614261|157756962|FG000|Follow-up Phase|Adverse Event|2|||
48979483|NCT02614261|157756963|FG001|Follow-up Phase|Adverse Event|0|||
48979484|NCT02614261|157756964|FG002|Follow-up Phase|Adverse Event|1|||
48979485|NCT02614261|157756965|FG003|Follow-up Phase|Adverse Event|0|||
48979486|NCT02614261|157756962|FG000|Follow-up Phase|Lost to Follow-up|12|||
48979487|NCT02614261|157756963|FG001|Follow-up Phase|Lost to Follow-up|5|||
48979488|NCT02614261|157756964|FG002|Follow-up Phase|Lost to Follow-up|2|||
48979489|NCT02614261|157756965|FG003|Follow-up Phase|Lost to Follow-up|0|||
48979490|NCT02614261|157756962|FG000|Follow-up Phase|Physician Decision|5|||
48979491|NCT02614261|157756963|FG001|Follow-up Phase|Physician Decision|1|||
48979492|NCT02614261|157756964|FG002|Follow-up Phase|Physician Decision|0|||
48979493|NCT02614261|157756965|FG003|Follow-up Phase|Physician Decision|0|||
48979494|NCT02614261|157756962|FG000|Follow-up Phase|Pregnancy|0|||
48979495|NCT02614261|157756963|FG001|Follow-up Phase|Pregnancy|1|||
48979496|NCT02614261|157756964|FG002|Follow-up Phase|Pregnancy|0|||
48979497|NCT02614261|157756965|FG003|Follow-up Phase|Pregnancy|0|||
48979498|NCT02614261|157756962|FG000|Follow-up Phase|Protocol Violation|1|||
48979499|NCT02614261|157756963|FG001|Follow-up Phase|Protocol Violation|0|||
48979500|NCT02614261|157756964|FG002|Follow-up Phase|Protocol Violation|0|||
48979501|NCT02614261|157756965|FG003|Follow-up Phase|Protocol Violation|0|||
48979502|NCT02614261|157756962|FG000|Follow-up Phase|Withdrawal by Subject|12|||
48979503|NCT02614261|157756963|FG001|Follow-up Phase|Withdrawal by Subject|4|||
48979504|NCT02614261|157756964|FG002|Follow-up Phase|Withdrawal by Subject|11|||
48979505|NCT02614261|157756965|FG003|Follow-up Phase|Withdrawal by Subject|0|||
48979506|NCT02614261|157756962|FG000|Israel Addendum|Withdrawal by Subject|0|||
48979507|NCT02614261|157756963|FG001|Israel Addendum|Withdrawal by Subject|0|||
48979508|NCT02614261|157756964|FG002|Israel Addendum|Withdrawal by Subject|0|||
48979509|NCT02614261|157756965|FG003|Israel Addendum|Withdrawal by Subject|4|||
48979510|NCT03860844|157756975|FG000|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
48979511|NCT03860844|157756976|FG001|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|2|||
48979512|NCT03860844|157756977|FG002|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
48979513|NCT03860844|157756975|FG000|Overall Study|Progressive disease|5|||
48979514|NCT03860844|157756976|FG001|Overall Study|Progressive disease|3|||
48979515|NCT03860844|157756977|FG002|Overall Study|Progressive disease|4|||
48979516|NCT03860844|157756975|FG000|Overall Study|Other, Not related to COVID-19|0|||
48979517|NCT03860844|157756976|FG001|Overall Study|Other, Not related to COVID-19|1|||
48979518|NCT03860844|157756977|FG002|Overall Study|Other, Not related to COVID-19|0|||
48979519|NCT04350372|157756978|FG000|Overall Study|Death|1|||
48979520|NCT03887052|157756980|FG000|Overall Study|Adverse Event|2|||
48979521|NCT03887052|157756980|FG000|Overall Study|Physician Decision|2|||
48979522|NCT03887052|157756980|FG000|Overall Study|Withdrawal by Subject|3|||
48979523|NCT03887052|157756980|FG000|Overall Study|Motor Vehicle Accident, unrelated to study participation|1|||
48979524|NCT03887052|157756980|FG000|Overall Study|Subject Hospitalized, unrelated to study participation|1|||
48979525|NCT01804842|157756981|FG000|Overall Study|Adverse Event|1|||
48979526|NCT01804842|157756982|FG001|Overall Study|Adverse Event|1|||
48979527|NCT01804842|157756983|FG002|Overall Study|Adverse Event|0|||
48979528|NCT01804842|157756981|FG000|Overall Study|Lost to Follow-up|1|||
48979529|NCT01804842|157756982|FG001|Overall Study|Lost to Follow-up|0|||
48979530|NCT01804842|157756983|FG002|Overall Study|Lost to Follow-up|0|||
48979531|NCT01804842|157756981|FG000|Overall Study|Non-Compliance|1|||
48979532|NCT01804842|157756982|FG001|Overall Study|Non-Compliance|1|||
48979533|NCT01804842|157756983|FG002|Overall Study|Non-Compliance|0|||
48762097|NCT02608268|156978007|FG000|Overall Study|Death|1|||
48762098|NCT02608268|156978008|FG001|Overall Study|Death|0|||
48762099|NCT02608268|156978009|FG002|Overall Study|Death|0|||
48979534|NCT01804842|157756981|FG000|Overall Study|Personal Reason|0|||
48979535|NCT01804842|157756982|FG001|Overall Study|Personal Reason|0|||
48979536|NCT01804842|157756983|FG002|Overall Study|Personal Reason|1|||
48979537|NCT00839436|157756984|FG000|Overall Study|Developed exclusionary condition|1|||
48979538|NCT00839436|157756985|FG001|Overall Study|Developed exclusionary condition|0|||
48979539|NCT00839436|157756986|FG002|Overall Study|Developed exclusionary condition|0|||
48979540|NCT00839436|157756984|FG000|Overall Study|Withdrawal by Subject|0|||
48979541|NCT00839436|157756985|FG001|Overall Study|Withdrawal by Subject|1|||
48979542|NCT00839436|157756986|FG002|Overall Study|Withdrawal by Subject|0|||
48762100|NCT02608268|156978010|FG003|Overall Study|Death|0|||
48979543|NCT00839436|157756984|FG000|Overall Study|Study drug no longer available|0|||
48762101|NCT02608268|156978011|FG004|Overall Study|Death|0|||
48676171|NCT00077649|156667232|FG003|Overall Study|Lack of Efficacy|2|||
48676172|NCT00077649|156667229|FG000|Overall Study|Withdrawal by Subject|0|||
48676173|NCT00077649|156667230|FG001|Overall Study|Withdrawal by Subject|1|||
48676174|NCT00077649|156667231|FG002|Overall Study|Withdrawal by Subject|1|||
48676175|NCT00077649|156667232|FG003|Overall Study|Withdrawal by Subject|2|||
48676176|NCT00077649|156667229|FG000|Overall Study|Lost to Follow-up|2|||
48676177|NCT00077649|156667230|FG001|Overall Study|Lost to Follow-up|2|||
48676178|NCT00077649|156667231|FG002|Overall Study|Lost to Follow-up|3|||
48676179|NCT00077649|156667232|FG003|Overall Study|Lost to Follow-up|2|||
48676180|NCT00077649|156667229|FG000|Overall Study|Abnormality of Laboratory Test|1|||
48676181|NCT00077649|156667230|FG001|Overall Study|Abnormality of Laboratory Test|2|||
48676182|NCT00077649|156667231|FG002|Overall Study|Abnormality of Laboratory Test|1|||
48676183|NCT00077649|156667232|FG003|Overall Study|Abnormality of Laboratory Test|2|||
48676184|NCT00077649|156667229|FG000|Overall Study|Randomized but never dosed|1|||
48676185|NCT00077649|156667230|FG001|Overall Study|Randomized but never dosed|0|||
48676186|NCT00077649|156667231|FG002|Overall Study|Randomized but never dosed|0|||
48676187|NCT00077649|156667232|FG003|Overall Study|Randomized but never dosed|0|||
48676188|NCT00588094|156667235|FG000|Overall Study|Adverse Event|3|||
48676189|NCT00588094|156667235|FG000|Overall Study|Progression of Disease|2|||
48676190|NCT00391625|156667238|FG000|Month 14|Withdrawal by Subject|1|||
48676191|NCT00391625|156667238|FG000|Month 50|Physician Decision|1|||
48762102|NCT02608268|156978012|FG005|Overall Study|Death|0|||
48979544|NCT00839436|157756985|FG001|Overall Study|Study drug no longer available|0|||
48979545|NCT00839436|157756986|FG002|Overall Study|Study drug no longer available|1|||
48979546|NCT04728815|157756987|FG000|Overall Study|Lost to Follow-up|3|||
48979547|NCT04728815|157756988|FG001|Overall Study|Lost to Follow-up|0|||
48979548|NCT04728815|157756989|FG002|Overall Study|Lost to Follow-up|0|||
48979549|NCT04728815|157756990|FG003|Overall Study|Lost to Follow-up|1|||
48979550|NCT04728815|157756991|FG004|Overall Study|Lost to Follow-up|1|||
48979551|NCT04728815|157756992|FG005|Overall Study|Lost to Follow-up|0|||
48979552|NCT04728815|157756993|FG006|Overall Study|Lost to Follow-up|2|||
48979553|NCT04728815|157756994|FG007|Overall Study|Lost to Follow-up|0|||
48979554|NCT04728815|157756987|FG000|Overall Study|Physician Decision|0|||
48979555|NCT04728815|157756988|FG001|Overall Study|Physician Decision|0|||
48979556|NCT04728815|157756989|FG002|Overall Study|Physician Decision|1|||
48979557|NCT04728815|157756990|FG003|Overall Study|Physician Decision|0|||
48979558|NCT04728815|157756991|FG004|Overall Study|Physician Decision|0|||
48979559|NCT04728815|157756992|FG005|Overall Study|Physician Decision|0|||
48979560|NCT04728815|157756993|FG006|Overall Study|Physician Decision|0|||
48979561|NCT04728815|157756994|FG007|Overall Study|Physician Decision|0|||
48979562|NCT04728815|157756987|FG000|Overall Study|Treatment drop|0|||
48979563|NCT04728815|157756988|FG001|Overall Study|Treatment drop|2|||
48979564|NCT04728815|157756989|FG002|Overall Study|Treatment drop|1|||
48979565|NCT04728815|157756990|FG003|Overall Study|Treatment drop|0|||
48979566|NCT04728815|157756991|FG004|Overall Study|Treatment drop|3|||
48979567|NCT04728815|157756992|FG005|Overall Study|Treatment drop|1|||
48979568|NCT04728815|157756993|FG006|Overall Study|Treatment drop|3|||
48979569|NCT04728815|157756994|FG007|Overall Study|Treatment drop|0|||
48979570|NCT04728815|157756987|FG000|Overall Study|Study drop|0|||
48979571|NCT04728815|157756988|FG001|Overall Study|Study drop|3|||
48979572|NCT04728815|157756989|FG002|Overall Study|Study drop|3|||
48979573|NCT04728815|157756990|FG003|Overall Study|Study drop|0|||
48979574|NCT04728815|157756991|FG004|Overall Study|Study drop|0|||
48979575|NCT04728815|157756992|FG005|Overall Study|Study drop|0|||
48979576|NCT04728815|157756993|FG006|Overall Study|Study drop|7|||
48979577|NCT04728815|157756994|FG007|Overall Study|Study drop|0|||
48979578|NCT01885104|157756998|FG000|Overall Study|Withdrawal of Consent|1|||
48979579|NCT01885104|157756999|FG001|Overall Study|Withdrawal of Consent|0|||
48979580|NCT01885104|157756998|FG000|Overall Study|Lost to Follow-up|0|||
48979581|NCT01885104|157756999|FG001|Overall Study|Lost to Follow-up|1|||
48979582|NCT01885104|157756998|FG000|Overall Study|Physician Decision|1|||
48979583|NCT01885104|157756999|FG001|Overall Study|Physician Decision|0|||
48979584|NCT03073200|157757000|FG000|Double Blind Treatment Period|Protocol Violation|1|||
48979585|NCT03073200|157757001|FG001|Double Blind Treatment Period|Protocol Violation|0|||
48979586|NCT03073200|157757002|FG002|Double Blind Treatment Period|Protocol Violation|0|||
48979587|NCT03073200|157757003|FG003|Double Blind Treatment Period|Protocol Violation|0|||
48979588|NCT03073200|157757004|FG004|Double Blind Treatment Period|Protocol Violation|0|||
48979589|NCT03073200|157757005|FG005|Double Blind Treatment Period|Protocol Violation|0|||
48979590|NCT03073200|157757006|FG006|Double Blind Treatment Period|Protocol Violation|0|||
48979591|NCT03073200|157757007|FG007|Double Blind Treatment Period|Protocol Violation|0|||
48979592|NCT03073200|157757008|FG008|Double Blind Treatment Period|Protocol Violation|0|||
48979593|NCT03073200|157757009|FG009|Double Blind Treatment Period|Protocol Violation|0|||
48676192|NCT03997825|156667239|FG000|Overall Study|Death|3|||
48676193|NCT03997825|156667239|FG000|Overall Study|Lost to Follow-up|10|||
48979594|NCT03073200|157757010|FG010|Double Blind Treatment Period|Protocol Violation|0|||
48979595|NCT03073200|157757011|FG011|Double Blind Treatment Period|Protocol Violation|0|||
48979596|NCT03073200|157757012|FG012|Double Blind Treatment Period|Protocol Violation|0|||
48979597|NCT03073200|157757013|FG013|Double Blind Treatment Period|Protocol Violation|0|||
48874341|NCT00937521|157377010|FG005|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
48874342|NCT00937521|157377011|FG006|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
48874343|NCT00937521|157377012|FG007|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
48874344|NCT00937521|157377005|FG000|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
48874345|NCT00937521|157377006|FG001|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
48874346|NCT00937521|157377007|FG002|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
48874347|NCT00937521|157377008|FG003|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
48874348|NCT00937521|157377009|FG004|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
48874349|NCT00937521|157377010|FG005|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
48874350|NCT00937521|157377011|FG006|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
48874351|NCT00937521|157377012|FG007|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
48874352|NCT00937521|157377005|FG000|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
48874353|NCT00937521|157377006|FG001|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4|||
48874354|NCT00937521|157377007|FG002|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
48874355|NCT00937521|157377008|FG003|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
48874356|NCT00937521|157377009|FG004|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2|||
48874357|NCT00937521|157377010|FG005|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
48874358|NCT00937521|157377011|FG006|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
48874359|NCT00937521|157377012|FG007|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
48874360|NCT00937521|157377005|FG000|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
48874361|NCT00937521|157377006|FG001|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
48874362|NCT00937521|157377007|FG002|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
48979598|NCT03073200|157757014|FG014|Double Blind Treatment Period|Protocol Violation|0|||
48676194|NCT03997825|156667239|FG000|Overall Study|Withdrawal by Subject|3|||
48676195|NCT03997825|156667239|FG000|Overall Study|Refused participation|1|||
48676196|NCT00699335|156667242|FG000|Overall Study|Combination of multiple reasons|176|||
48676197|NCT00699335|156667242|FG000|Overall Study|Missing data|52|||
48676198|NCT04390841|156667243|FG000|Overall Study|Withdrawal by Subject|2|||
48676199|NCT02188849|156667247|FG000|Overall Study|Lost to Follow-up|3|||
48676200|NCT02188849|156667248|FG001|Overall Study|Lost to Follow-up|8|||
48676201|NCT00148941|156667249|FG000|Overall Study|Lost to Follow-up|17|||
48676202|NCT00148941|156667250|FG001|Overall Study|Lost to Follow-up|24|||
48676203|NCT00148941|156667251|FG002|Overall Study|Lost to Follow-up|18|||
48676204|NCT00148941|156667252|FG003|Overall Study|Lost to Follow-up|22|||
48676205|NCT00148941|156667249|FG000|Overall Study|Withdrawal by Subject|1|||
48676206|NCT00148941|156667250|FG001|Overall Study|Withdrawal by Subject|0|||
48676207|NCT00148941|156667251|FG002|Overall Study|Withdrawal by Subject|1|||
48676208|NCT00148941|156667252|FG003|Overall Study|Withdrawal by Subject|0|||
48676209|NCT00148941|156667249|FG000|Overall Study|Other|0|||
48676210|NCT00148941|156667250|FG001|Overall Study|Other|0|||
48676211|NCT00148941|156667251|FG002|Overall Study|Other|1|||
48676212|NCT00148941|156667252|FG003|Overall Study|Other|2|||
48762103|NCT02608268|156978013|FG006|Overall Study|Death|0|||
48762104|NCT02608268|156978014|FG007|Overall Study|Death|0|||
48762105|NCT02608268|156978015|FG008|Overall Study|Death|1|||
48762106|NCT02608268|156978016|FG009|Overall Study|Death|1|||
48762107|NCT02608268|156978017|FG010|Overall Study|Death|0|||
48762108|NCT02608268|156978018|FG011|Overall Study|Death|0|||
48762109|NCT02608268|156978019|FG012|Overall Study|Death|0|||
48762110|NCT02608268|156978020|FG013|Overall Study|Death|0|||
48762111|NCT02608268|156978021|FG014|Overall Study|Death|0|||
48762112|NCT02608268|156978022|FG015|Overall Study|Death|1|||
48762113|NCT02608268|156978023|FG016|Overall Study|Death|0|||
48762114|NCT02608268|156978024|FG017|Overall Study|Death|1|||
48762115|NCT02608268|156978025|FG018|Overall Study|Death|0|||
48762116|NCT02608268|156978026|FG019|Overall Study|Death|1|||
48762117|NCT02608268|156978027|FG020|Overall Study|Death|1|||
48762118|NCT02608268|156978028|FG021|Overall Study|Death|0|||
48762119|NCT02608268|156978029|FG022|Overall Study|Death|0|||
48762120|NCT02608268|156978030|FG023|Overall Study|Death|0|||
48762121|NCT02608268|156978031|FG024|Overall Study|Death|1|||
48762122|NCT02608268|156978032|FG025|Overall Study|Death|2|||
48762123|NCT02608268|156978033|FG026|Overall Study|Death|0|||
48762124|NCT02608268|156978034|FG027|Overall Study|Death|1|||
48676213|NCT04356352|156667253|FG000|Overall Study|PIV in location that was excluded, surgery cancelled|2|||
48762125|NCT02608268|156978035|FG028|Overall Study|Death|4|||
48762126|NCT02608268|156978036|FG029|Overall Study|Death|0|||
48762127|NCT02608268|156978007|FG000|Overall Study|Physician Decision|0|||
48762128|NCT02608268|156978008|FG001|Overall Study|Physician Decision|0|||
48762129|NCT02608268|156978009|FG002|Overall Study|Physician Decision|0|||
48762130|NCT02608268|156978010|FG003|Overall Study|Physician Decision|0|||
48762131|NCT02608268|156978011|FG004|Overall Study|Physician Decision|0|||
48762132|NCT02608268|156978012|FG005|Overall Study|Physician Decision|0|||
48762133|NCT02608268|156978013|FG006|Overall Study|Physician Decision|0|||
48874363|NCT00937521|157377008|FG003|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
48979599|NCT03073200|157757000|FG000|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
48979600|NCT03073200|157757001|FG001|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1|||
48979601|NCT03073200|157757002|FG002|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
48979602|NCT03073200|157757003|FG003|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
48979603|NCT03073200|157757004|FG004|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
48979604|NCT03073200|157757005|FG005|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
48979605|NCT03073200|157757006|FG006|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
48979606|NCT03073200|157757007|FG007|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
48979607|NCT03073200|157757008|FG008|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
48979608|NCT03073200|157757009|FG009|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
48979609|NCT03073200|157757010|FG010|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
48979610|NCT03073200|157757011|FG011|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
48979611|NCT03073200|157757012|FG012|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
48979612|NCT03073200|157757013|FG013|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
48979613|NCT03073200|157757014|FG014|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
48979614|NCT03073200|157757000|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
48979615|NCT03073200|157757001|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
48979616|NCT03073200|157757002|FG002|Double Blind Treatment Period|Withdrawal by Subject|0|||
48979617|NCT03073200|157757003|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
48979618|NCT03073200|157757004|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
48979619|NCT03073200|157757005|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
48979620|NCT03073200|157757006|FG006|Double Blind Treatment Period|Withdrawal by Subject|0|||
48979621|NCT03073200|157757007|FG007|Double Blind Treatment Period|Withdrawal by Subject|0|||
48979622|NCT03073200|157757008|FG008|Double Blind Treatment Period|Withdrawal by Subject|0|||
48979623|NCT03073200|157757009|FG009|Double Blind Treatment Period|Withdrawal by Subject|0|||
48979624|NCT03073200|157757010|FG010|Double Blind Treatment Period|Withdrawal by Subject|0|||
48979625|NCT03073200|157757011|FG011|Double Blind Treatment Period|Withdrawal by Subject|0|||
48979626|NCT03073200|157757012|FG012|Double Blind Treatment Period|Withdrawal by Subject|0|||
48979627|NCT03073200|157757013|FG013|Double Blind Treatment Period|Withdrawal by Subject|0|||
48979628|NCT03073200|157757014|FG014|Double Blind Treatment Period|Withdrawal by Subject|0|||
48979629|NCT03073200|157757000|FG000|Open-Label Maintenance Period|Lost to Follow-up|0|||
48979630|NCT03073200|157757001|FG001|Open-Label Maintenance Period|Lost to Follow-up|0|||
48979631|NCT03073200|157757002|FG002|Open-Label Maintenance Period|Lost to Follow-up|0|||
48979632|NCT03073200|157757003|FG003|Open-Label Maintenance Period|Lost to Follow-up|1|||
48979633|NCT03073200|157757004|FG004|Open-Label Maintenance Period|Lost to Follow-up|2|||
48979634|NCT03073200|157757005|FG005|Open-Label Maintenance Period|Lost to Follow-up|0|||
48979635|NCT03073200|157757006|FG006|Open-Label Maintenance Period|Lost to Follow-up|0|||
48979636|NCT03073200|157757007|FG007|Open-Label Maintenance Period|Lost to Follow-up|0|||
48979637|NCT03073200|157757008|FG008|Open-Label Maintenance Period|Lost to Follow-up|0|||
48979638|NCT03073200|157757009|FG009|Open-Label Maintenance Period|Lost to Follow-up|0|||
48979639|NCT03073200|157757010|FG010|Open-Label Maintenance Period|Lost to Follow-up|0|||
48979640|NCT03073200|157757011|FG011|Open-Label Maintenance Period|Lost to Follow-up|0|||
48979641|NCT03073200|157757012|FG012|Open-Label Maintenance Period|Lost to Follow-up|0|||
48979642|NCT03073200|157757013|FG013|Open-Label Maintenance Period|Lost to Follow-up|0|||
48979643|NCT03073200|157757014|FG014|Open-Label Maintenance Period|Lost to Follow-up|0|||
48979644|NCT03073200|157757000|FG000|Open-Label Maintenance Period|Participant moved to another city|0|||
48979645|NCT03073200|157757001|FG001|Open-Label Maintenance Period|Participant moved to another city|0|||
48979646|NCT03073200|157757002|FG002|Open-Label Maintenance Period|Participant moved to another city|0|||
48979647|NCT03073200|157757003|FG003|Open-Label Maintenance Period|Participant moved to another city|1|||
48979648|NCT03073200|157757004|FG004|Open-Label Maintenance Period|Participant moved to another city|0|||
48979649|NCT03073200|157757005|FG005|Open-Label Maintenance Period|Participant moved to another city|0|||
48979650|NCT03073200|157757006|FG006|Open-Label Maintenance Period|Participant moved to another city|0|||
48979651|NCT03073200|157757007|FG007|Open-Label Maintenance Period|Participant moved to another city|0|||
48979652|NCT03073200|157757008|FG008|Open-Label Maintenance Period|Participant moved to another city|0|||
48979653|NCT03073200|157757009|FG009|Open-Label Maintenance Period|Participant moved to another city|0|||
48979654|NCT03073200|157757010|FG010|Open-Label Maintenance Period|Participant moved to another city|0|||
48979655|NCT03073200|157757011|FG011|Open-Label Maintenance Period|Participant moved to another city|0|||
48979656|NCT03073200|157757012|FG012|Open-Label Maintenance Period|Participant moved to another city|0|||
48979657|NCT03073200|157757013|FG013|Open-Label Maintenance Period|Participant moved to another city|0|||
48979658|NCT03073200|157757014|FG014|Open-Label Maintenance Period|Participant moved to another city|0|||
48979659|NCT03073200|157757000|FG000|Open-Label Maintenance Period|Lack of Efficacy|0|||
48979660|NCT03073200|157757001|FG001|Open-Label Maintenance Period|Lack of Efficacy|0|||
48979661|NCT03073200|157757002|FG002|Open-Label Maintenance Period|Lack of Efficacy|0|||
48979662|NCT03073200|157757003|FG003|Open-Label Maintenance Period|Lack of Efficacy|0|||
48979663|NCT03073200|157757004|FG004|Open-Label Maintenance Period|Lack of Efficacy|1|||
48979664|NCT03073200|157757005|FG005|Open-Label Maintenance Period|Lack of Efficacy|0|||
48979665|NCT03073200|157757006|FG006|Open-Label Maintenance Period|Lack of Efficacy|0|||
48979666|NCT03073200|157757007|FG007|Open-Label Maintenance Period|Lack of Efficacy|0|||
48979667|NCT03073200|157757008|FG008|Open-Label Maintenance Period|Lack of Efficacy|0|||
48979668|NCT03073200|157757009|FG009|Open-Label Maintenance Period|Lack of Efficacy|0|||
48979669|NCT03073200|157757010|FG010|Open-Label Maintenance Period|Lack of Efficacy|0|||
48979670|NCT03073200|157757011|FG011|Open-Label Maintenance Period|Lack of Efficacy|0|||
48979671|NCT03073200|157757012|FG012|Open-Label Maintenance Period|Lack of Efficacy|0|||
48979672|NCT03073200|157757013|FG013|Open-Label Maintenance Period|Lack of Efficacy|0|||
48979673|NCT03073200|157757014|FG014|Open-Label Maintenance Period|Lack of Efficacy|0|||
48979674|NCT03073200|157757000|FG000|Open-Label Maintenance Period|Withdrawal by Subject|0|||
48979675|NCT03073200|157757001|FG001|Open-Label Maintenance Period|Withdrawal by Subject|0|||
48979676|NCT03073200|157757002|FG002|Open-Label Maintenance Period|Withdrawal by Subject|0|||
48979677|NCT03073200|157757003|FG003|Open-Label Maintenance Period|Withdrawal by Subject|2|||
48979678|NCT03073200|157757004|FG004|Open-Label Maintenance Period|Withdrawal by Subject|1|||
48979679|NCT03073200|157757005|FG005|Open-Label Maintenance Period|Withdrawal by Subject|0|||
48979680|NCT03073200|157757006|FG006|Open-Label Maintenance Period|Withdrawal by Subject|0|||
48979681|NCT03073200|157757007|FG007|Open-Label Maintenance Period|Withdrawal by Subject|0|||
48979682|NCT03073200|157757008|FG008|Open-Label Maintenance Period|Withdrawal by Subject|0|||
48979683|NCT03073200|157757009|FG009|Open-Label Maintenance Period|Withdrawal by Subject|0|||
48979684|NCT03073200|157757010|FG010|Open-Label Maintenance Period|Withdrawal by Subject|0|||
48979685|NCT03073200|157757011|FG011|Open-Label Maintenance Period|Withdrawal by Subject|0|||
48979686|NCT03073200|157757012|FG012|Open-Label Maintenance Period|Withdrawal by Subject|0|||
48979687|NCT03073200|157757013|FG013|Open-Label Maintenance Period|Withdrawal by Subject|0|||
48979688|NCT03073200|157757014|FG014|Open-Label Maintenance Period|Withdrawal by Subject|0|||
48979689|NCT03073200|157757000|FG000|Extension Period|Lost to Follow-up|0|||
48979690|NCT03073200|157757001|FG001|Extension Period|Lost to Follow-up|0|||
48979691|NCT03073200|157757002|FG002|Extension Period|Lost to Follow-up|0|||
48979692|NCT03073200|157757003|FG003|Extension Period|Lost to Follow-up|0|||
48979693|NCT03073200|157757004|FG004|Extension Period|Lost to Follow-up|0|||
48979694|NCT03073200|157757005|FG005|Extension Period|Lost to Follow-up|0|||
48979695|NCT03073200|157757006|FG006|Extension Period|Lost to Follow-up|1|||
48979696|NCT03073200|157757007|FG007|Extension Period|Lost to Follow-up|1|||
48979697|NCT03073200|157757008|FG008|Extension Period|Lost to Follow-up|0|||
48979698|NCT03073200|157757009|FG009|Extension Period|Lost to Follow-up|0|||
48979699|NCT03073200|157757010|FG010|Extension Period|Lost to Follow-up|0|||
48979700|NCT03073200|157757011|FG011|Extension Period|Lost to Follow-up|0|||
48979701|NCT03073200|157757012|FG012|Extension Period|Lost to Follow-up|0|||
48979702|NCT03073200|157757013|FG013|Extension Period|Lost to Follow-up|0|||
48979703|NCT03073200|157757014|FG014|Extension Period|Lost to Follow-up|0|||
48979704|NCT03073200|157757000|FG000|Extension Period|Sponsor Decision|0|||
48979705|NCT03073200|157757001|FG001|Extension Period|Sponsor Decision|0|||
48979706|NCT03073200|157757002|FG002|Extension Period|Sponsor Decision|0|||
48979707|NCT03073200|157757003|FG003|Extension Period|Sponsor Decision|0|||
48979708|NCT03073200|157757004|FG004|Extension Period|Sponsor Decision|0|||
48979709|NCT03073200|157757005|FG005|Extension Period|Sponsor Decision|0|||
48979710|NCT03073200|157757006|FG006|Extension Period|Sponsor Decision|0|||
48979711|NCT03073200|157757007|FG007|Extension Period|Sponsor Decision|0|||
48979712|NCT03073200|157757008|FG008|Extension Period|Sponsor Decision|1|||
48979713|NCT03073200|157757009|FG009|Extension Period|Sponsor Decision|0|||
48979714|NCT03073200|157757010|FG010|Extension Period|Sponsor Decision|0|||
48979715|NCT03073200|157757011|FG011|Extension Period|Sponsor Decision|0|||
48979716|NCT03073200|157757012|FG012|Extension Period|Sponsor Decision|0|||
48979717|NCT03073200|157757013|FG013|Extension Period|Sponsor Decision|0|||
48979718|NCT03073200|157757014|FG014|Extension Period|Sponsor Decision|0|||
48676214|NCT04356352|156667254|FG001|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
48676215|NCT04356352|156667255|FG002|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
48676216|NCT04356352|156667253|FG000|Overall Study|Protocol Violation|0|||
48676217|NCT04356352|156667254|FG001|Overall Study|Protocol Violation|3|||
48676218|NCT04356352|156667255|FG002|Overall Study|Protocol Violation|1|||
48874364|NCT00937521|157377009|FG004|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
48979719|NCT03073200|157757000|FG000|Extension Period|Withdrawal by Parent/Guardian|0|||
48979720|NCT03073200|157757001|FG001|Extension Period|Withdrawal by Parent/Guardian|0|||
48979721|NCT03073200|157757002|FG002|Extension Period|Withdrawal by Parent/Guardian|0|||
48979722|NCT03073200|157757003|FG003|Extension Period|Withdrawal by Parent/Guardian|0|||
48676219|NCT00781859|156667256|FG000|Overall Study|Adverse Event|2|||
48676220|NCT00781859|156667257|FG001|Overall Study|Adverse Event|2|||
48874365|NCT00937521|157377010|FG005|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
48979723|NCT03073200|157757004|FG004|Extension Period|Withdrawal by Parent/Guardian|0|||
48979724|NCT03073200|157757005|FG005|Extension Period|Withdrawal by Parent/Guardian|0|||
48979725|NCT03073200|157757006|FG006|Extension Period|Withdrawal by Parent/Guardian|1|||
48979726|NCT03073200|157757007|FG007|Extension Period|Withdrawal by Parent/Guardian|3|||
48979727|NCT03073200|157757008|FG008|Extension Period|Withdrawal by Parent/Guardian|1|||
48979728|NCT03073200|157757009|FG009|Extension Period|Withdrawal by Parent/Guardian|0|||
48979729|NCT03073200|157757010|FG010|Extension Period|Withdrawal by Parent/Guardian|0|||
48979730|NCT03073200|157757011|FG011|Extension Period|Withdrawal by Parent/Guardian|0|||
48979731|NCT03073200|157757012|FG012|Extension Period|Withdrawal by Parent/Guardian|0|||
48979732|NCT03073200|157757013|FG013|Extension Period|Withdrawal by Parent/Guardian|0|||
48979733|NCT03073200|157757014|FG014|Extension Period|Withdrawal by Parent/Guardian|0|||
48979734|NCT03073200|157757000|FG000|Extension Period|Withdrawal by Subject|0|||
48979735|NCT03073200|157757001|FG001|Extension Period|Withdrawal by Subject|0|||
48979736|NCT03073200|157757002|FG002|Extension Period|Withdrawal by Subject|0|||
48979737|NCT03073200|157757003|FG003|Extension Period|Withdrawal by Subject|0|||
48979738|NCT03073200|157757004|FG004|Extension Period|Withdrawal by Subject|0|||
48979739|NCT03073200|157757005|FG005|Extension Period|Withdrawal by Subject|0|||
48979740|NCT03073200|157757006|FG006|Extension Period|Withdrawal by Subject|1|||
48979741|NCT03073200|157757007|FG007|Extension Period|Withdrawal by Subject|2|||
48979742|NCT03073200|157757008|FG008|Extension Period|Withdrawal by Subject|0|||
48979743|NCT03073200|157757009|FG009|Extension Period|Withdrawal by Subject|0|||
48979744|NCT03073200|157757010|FG010|Extension Period|Withdrawal by Subject|0|||
48979745|NCT03073200|157757011|FG011|Extension Period|Withdrawal by Subject|0|||
48979746|NCT03073200|157757012|FG012|Extension Period|Withdrawal by Subject|0|||
48979747|NCT03073200|157757013|FG013|Extension Period|Withdrawal by Subject|0|||
48979748|NCT03073200|157757014|FG014|Extension Period|Withdrawal by Subject|0|||
48979749|NCT03073200|157757000|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
48979750|NCT03073200|157757001|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
48979751|NCT03073200|157757002|FG002|Randomized Withdrawal Period|Lost to Follow-up|0|||
48979752|NCT03073200|157757003|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
48979753|NCT03073200|157757004|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
48979754|NCT03073200|157757005|FG005|Randomized Withdrawal Period|Lost to Follow-up|0|||
48979755|NCT03073200|157757006|FG006|Randomized Withdrawal Period|Lost to Follow-up|0|||
48979756|NCT03073200|157757007|FG007|Randomized Withdrawal Period|Lost to Follow-up|0|||
48979757|NCT03073200|157757008|FG008|Randomized Withdrawal Period|Lost to Follow-up|0|||
48979758|NCT03073200|157757009|FG009|Randomized Withdrawal Period|Lost to Follow-up|0|||
48979759|NCT03073200|157757010|FG010|Randomized Withdrawal Period|Lost to Follow-up|0|||
48979760|NCT03073200|157757011|FG011|Randomized Withdrawal Period|Lost to Follow-up|1|||
48979761|NCT03073200|157757012|FG012|Randomized Withdrawal Period|Lost to Follow-up|0|||
48979762|NCT03073200|157757013|FG013|Randomized Withdrawal Period|Lost to Follow-up|0|||
48979763|NCT03073200|157757014|FG014|Randomized Withdrawal Period|Lost to Follow-up|0|||
48979764|NCT03073200|157757000|FG000|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
48979765|NCT03073200|157757001|FG001|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
48979766|NCT03073200|157757002|FG002|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
48979767|NCT03073200|157757003|FG003|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
48979768|NCT03073200|157757004|FG004|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
48979769|NCT03073200|157757005|FG005|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
48979770|NCT03073200|157757006|FG006|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
48979771|NCT03073200|157757007|FG007|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
48979772|NCT03073200|157757008|FG008|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
48979773|NCT03073200|157757009|FG009|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
48676221|NCT00781859|156667256|FG000|Overall Study|Withdrawal by Subject|8|||
48676222|NCT00781859|156667257|FG001|Overall Study|Withdrawal by Subject|4|||
48979774|NCT03073200|157757010|FG010|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
48979775|NCT03073200|157757011|FG011|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1|||
48979776|NCT03073200|157757012|FG012|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
48979777|NCT03073200|157757013|FG013|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
48979778|NCT03073200|157757014|FG014|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
48979779|NCT03073200|157757000|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
48979780|NCT03073200|157757001|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
48979781|NCT03073200|157757002|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
48979782|NCT03073200|157757003|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
48979783|NCT03073200|157757004|FG004|Randomized Withdrawal Period|Withdrawal by Subject|0|||
48979784|NCT03073200|157757005|FG005|Randomized Withdrawal Period|Withdrawal by Subject|0|||
48979785|NCT03073200|157757006|FG006|Randomized Withdrawal Period|Withdrawal by Subject|0|||
48979786|NCT03073200|157757007|FG007|Randomized Withdrawal Period|Withdrawal by Subject|0|||
48979787|NCT03073200|157757008|FG008|Randomized Withdrawal Period|Withdrawal by Subject|0|||
48979788|NCT03073200|157757009|FG009|Randomized Withdrawal Period|Withdrawal by Subject|0|||
48979789|NCT03073200|157757010|FG010|Randomized Withdrawal Period|Withdrawal by Subject|1|||
48979790|NCT03073200|157757011|FG011|Randomized Withdrawal Period|Withdrawal by Subject|1|||
48676223|NCT00781859|156667256|FG000|Overall Study|Lost to Follow-up|6|||
48676224|NCT00781859|156667257|FG001|Overall Study|Lost to Follow-up|3|||
48979791|NCT03073200|157757012|FG012|Randomized Withdrawal Period|Withdrawal by Subject|0|||
48979792|NCT03073200|157757013|FG013|Randomized Withdrawal Period|Withdrawal by Subject|0|||
48979793|NCT03073200|157757014|FG014|Randomized Withdrawal Period|Withdrawal by Subject|0|||
48979794|NCT03073200|157757000|FG000|Randomized Withdrawal Period|Adverse Event|0|||
48979795|NCT03073200|157757001|FG001|Randomized Withdrawal Period|Adverse Event|0|||
48979796|NCT03073200|157757002|FG002|Randomized Withdrawal Period|Adverse Event|0|||
48979797|NCT03073200|157757003|FG003|Randomized Withdrawal Period|Adverse Event|0|||
48979798|NCT03073200|157757004|FG004|Randomized Withdrawal Period|Adverse Event|0|||
48979799|NCT03073200|157757005|FG005|Randomized Withdrawal Period|Adverse Event|0|||
48979800|NCT03073200|157757006|FG006|Randomized Withdrawal Period|Adverse Event|0|||
48979801|NCT03073200|157757007|FG007|Randomized Withdrawal Period|Adverse Event|0|||
48979802|NCT03073200|157757008|FG008|Randomized Withdrawal Period|Adverse Event|0|||
48979803|NCT03073200|157757009|FG009|Randomized Withdrawal Period|Adverse Event|0|||
48979804|NCT03073200|157757010|FG010|Randomized Withdrawal Period|Adverse Event|1|||
48979805|NCT03073200|157757011|FG011|Randomized Withdrawal Period|Adverse Event|0|||
48979806|NCT03073200|157757012|FG012|Randomized Withdrawal Period|Adverse Event|0|||
48979807|NCT03073200|157757013|FG013|Randomized Withdrawal Period|Adverse Event|0|||
48979808|NCT03073200|157757014|FG014|Randomized Withdrawal Period|Adverse Event|0|||
48979809|NCT03073200|157757000|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
48979810|NCT03073200|157757001|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
48979811|NCT03073200|157757002|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
48979812|NCT03073200|157757003|FG003|Post-Treatment Follow-Up Period|Adverse Event|0|||
48979813|NCT03073200|157757004|FG004|Post-Treatment Follow-Up Period|Adverse Event|0|||
48979814|NCT03073200|157757005|FG005|Post-Treatment Follow-Up Period|Adverse Event|0|||
48979815|NCT03073200|157757006|FG006|Post-Treatment Follow-Up Period|Adverse Event|0|||
48979816|NCT03073200|157757007|FG007|Post-Treatment Follow-Up Period|Adverse Event|0|||
48979817|NCT03073200|157757008|FG008|Post-Treatment Follow-Up Period|Adverse Event|0|||
48979818|NCT03073200|157757009|FG009|Post-Treatment Follow-Up Period|Adverse Event|0|||
48979819|NCT03073200|157757010|FG010|Post-Treatment Follow-Up Period|Adverse Event|0|||
48979820|NCT03073200|157757011|FG011|Post-Treatment Follow-Up Period|Adverse Event|0|||
48979821|NCT03073200|157757012|FG012|Post-Treatment Follow-Up Period|Adverse Event|0|||
48979822|NCT03073200|157757013|FG013|Post-Treatment Follow-Up Period|Adverse Event|2|||
48979823|NCT03073200|157757014|FG014|Post-Treatment Follow-Up Period|Adverse Event|0|||
48979824|NCT03073200|157757000|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
48979825|NCT03073200|157757001|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
48979826|NCT03073200|157757002|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
48979827|NCT03073200|157757003|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
48979828|NCT03073200|157757004|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
48979829|NCT03073200|157757005|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
48676225|NCT00781859|156667256|FG000|Overall Study|Death|3|||
48676226|NCT00781859|156667257|FG001|Overall Study|Death|0|||
48676227|NCT00622388|156667258|FG000|Overall Study|Disease Progression|47|||
48676228|NCT00622388|156667258|FG000|Overall Study|Adverse Event|6|||
48676229|NCT00622388|156667258|FG000|Overall Study|Protocol Violation|3|||
48676230|NCT00622388|156667258|FG000|Overall Study|Participant Refusal|1|||
48676231|NCT00622388|156667258|FG000|Overall Study|Death|3|||
48676232|NCT00622388|156667258|FG000|Overall Study|Received Alternate Anticancer Therapy|8|||
48676233|NCT00622388|156667258|FG000|Overall Study|Took Prohibited Medication|2|||
48676234|NCT00622388|156667258|FG000|Overall Study|Withdrew Consent|1|||
48676235|NCT00622388|156667258|FG000|Overall Study|Insurance Expired|1|||
48676236|NCT04405076|156667260|FG000|Part A (Blinded Phase)|Lost to Follow-up|6|||
48676237|NCT04405076|156667261|FG001|Part A (Blinded Phase)|Lost to Follow-up|6|||
48676238|NCT04405076|156667262|FG002|Part A (Blinded Phase)|Lost to Follow-up|7|||
48676239|NCT04405076|156667263|FG003|Part A (Blinded Phase)|Lost to Follow-up|0|||
48676240|NCT04405076|156667264|FG004|Part A (Blinded Phase)|Lost to Follow-up|0|||
48874366|NCT00937521|157377011|FG006|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
48874367|NCT00937521|157377012|FG007|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
48874368|NCT00937521|157377005|FG000|Booster Phase|Adverse Event|0|||
48874369|NCT00937521|157377006|FG001|Booster Phase|Adverse Event|0|||
48874370|NCT00937521|157377007|FG002|Booster Phase|Adverse Event|0|||
48979830|NCT03073200|157757006|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
48979831|NCT03073200|157757007|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
48676241|NCT04405076|156667265|FG005|Part A (Blinded Phase)|Lost to Follow-up|0|||
48676242|NCT04405076|156667266|FG006|Part A (Blinded Phase)|Lost to Follow-up|0|||
48676243|NCT04405076|156667267|FG007|Part A (Blinded Phase)|Lost to Follow-up|0|||
48874371|NCT00937521|157377008|FG003|Booster Phase|Adverse Event|0|||
48979832|NCT03073200|157757008|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
48676244|NCT04405076|156667268|FG008|Part A (Blinded Phase)|Lost to Follow-up|0|||
48676245|NCT04405076|156667260|FG000|Part A (Blinded Phase)|Physician Decision|1|||
48676246|NCT04405076|156667261|FG001|Part A (Blinded Phase)|Physician Decision|2|||
48676247|NCT04405076|156667262|FG002|Part A (Blinded Phase)|Physician Decision|0|||
48874372|NCT00937521|157377009|FG004|Booster Phase|Adverse Event|0|||
48874373|NCT00937521|157377010|FG005|Booster Phase|Adverse Event|0|||
48874374|NCT00937521|157377011|FG006|Booster Phase|Adverse Event|1|||
48874375|NCT00937521|157377012|FG007|Booster Phase|Adverse Event|0|||
48979833|NCT03073200|157757009|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
48979834|NCT03073200|157757010|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
48979835|NCT03073200|157757011|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
48979836|NCT03073200|157757012|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
48979837|NCT03073200|157757013|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
48979838|NCT03073200|157757014|FG014|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
48979839|NCT03073200|157757000|FG000|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
48979840|NCT03073200|157757001|FG001|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
48979841|NCT03073200|157757002|FG002|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
48979842|NCT03073200|157757003|FG003|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
48979843|NCT03073200|157757004|FG004|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
48979844|NCT03073200|157757005|FG005|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
48979845|NCT03073200|157757006|FG006|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
48979846|NCT03073200|157757007|FG007|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
48979847|NCT03073200|157757008|FG008|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
48979848|NCT03073200|157757009|FG009|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
48979849|NCT03073200|157757010|FG010|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
48979850|NCT03073200|157757011|FG011|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
48676248|NCT04405076|156667263|FG003|Part A (Blinded Phase)|Physician Decision|0|||
48676249|NCT04405076|156667264|FG004|Part A (Blinded Phase)|Physician Decision|0|||
48874376|NCT00937521|157377005|FG000|Booster Phase|Withdrawal by Subject|1|||
48874377|NCT00937521|157377006|FG001|Booster Phase|Withdrawal by Subject|0|||
48874378|NCT00937521|157377007|FG002|Booster Phase|Withdrawal by Subject|0|||
48874379|NCT00937521|157377008|FG003|Booster Phase|Withdrawal by Subject|1|||
48874380|NCT00937521|157377009|FG004|Booster Phase|Withdrawal by Subject|0|||
48874381|NCT00937521|157377010|FG005|Booster Phase|Withdrawal by Subject|0|||
48874382|NCT00937521|157377011|FG006|Booster Phase|Withdrawal by Subject|0|||
48874383|NCT00937521|157377012|FG007|Booster Phase|Withdrawal by Subject|2|||
48874384|NCT00937521|157377005|FG000|Booster Phase|Lost to Follow-up|2|||
48874385|NCT00937521|157377006|FG001|Booster Phase|Lost to Follow-up|2|||
48874386|NCT00937521|157377007|FG002|Booster Phase|Lost to Follow-up|4|||
48979851|NCT03073200|157757012|FG012|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
48979852|NCT03073200|157757013|FG013|Post-Treatment Follow-Up Period|Participant moved to another city|1|||
48979853|NCT03073200|157757014|FG014|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
48979854|NCT03073200|157757000|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
48979855|NCT03073200|157757001|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
48979856|NCT03073200|157757002|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
48979857|NCT03073200|157757003|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
48979858|NCT03073200|157757004|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
48979859|NCT03073200|157757005|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
48979860|NCT03073200|157757006|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
48979861|NCT03073200|157757007|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
48979862|NCT03073200|157757008|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
48979863|NCT03073200|157757009|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
48979864|NCT03073200|157757010|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
48979865|NCT03073200|157757011|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
48979866|NCT03073200|157757012|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
48979867|NCT03073200|157757013|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
48979868|NCT03073200|157757014|FG014|Post-Treatment Follow-Up Period|Protocol Violation|0|||
48979869|NCT03073200|157757000|FG000|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
48979870|NCT03073200|157757001|FG001|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
48979871|NCT03073200|157757002|FG002|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
48979872|NCT03073200|157757003|FG003|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
48979873|NCT03073200|157757004|FG004|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
48979874|NCT03073200|157757005|FG005|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
48979875|NCT03073200|157757006|FG006|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
48979876|NCT03073200|157757007|FG007|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
48676250|NCT04405076|156667265|FG005|Part A (Blinded Phase)|Physician Decision|0|||
48676251|NCT04405076|156667266|FG006|Part A (Blinded Phase)|Physician Decision|0|||
48676252|NCT04405076|156667267|FG007|Part A (Blinded Phase)|Physician Decision|0|||
48676253|NCT04405076|156667268|FG008|Part A (Blinded Phase)|Physician Decision|0|||
48874387|NCT00937521|157377008|FG003|Booster Phase|Lost to Follow-up|2|||
48874388|NCT00937521|157377009|FG004|Booster Phase|Lost to Follow-up|4|||
48874389|NCT00937521|157377010|FG005|Booster Phase|Lost to Follow-up|4|||
48874390|NCT00937521|157377011|FG006|Booster Phase|Lost to Follow-up|3|||
48979877|NCT03073200|157757008|FG008|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
48979878|NCT03073200|157757009|FG009|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
48979879|NCT03073200|157757010|FG010|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
48979880|NCT03073200|157757011|FG011|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
48979881|NCT03073200|157757012|FG012|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
48979882|NCT03073200|157757013|FG013|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
48979883|NCT03073200|157757014|FG014|Post-Treatment Follow-Up Period|Site terminated by sponsor|1|||
48979884|NCT03073200|157757000|FG000|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
48979885|NCT03073200|157757001|FG001|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
48979886|NCT03073200|157757002|FG002|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
48979887|NCT03073200|157757003|FG003|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
48979888|NCT03073200|157757004|FG004|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
48979889|NCT03073200|157757005|FG005|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
48979890|NCT03073200|157757006|FG006|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
48979891|NCT03073200|157757007|FG007|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
48979892|NCT03073200|157757008|FG008|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
48979893|NCT03073200|157757009|FG009|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
48979894|NCT03073200|157757010|FG010|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
48979895|NCT03073200|157757011|FG011|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
48979896|NCT03073200|157757012|FG012|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
48979897|NCT03073200|157757013|FG013|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11|||
48979898|NCT03073200|157757014|FG014|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
48979899|NCT03073200|157757000|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
48979900|NCT03073200|157757001|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
48979901|NCT03073200|157757002|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
48979902|NCT03073200|157757003|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
48979903|NCT03073200|157757004|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
48979904|NCT03073200|157757005|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
48979905|NCT03073200|157757006|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
48979906|NCT03073200|157757007|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
48979907|NCT03073200|157757008|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
48979908|NCT03073200|157757009|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
48979909|NCT03073200|157757010|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
48979910|NCT03073200|157757011|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
48979911|NCT03073200|157757012|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
48979912|NCT03073200|157757013|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|9|||
48979913|NCT03073200|157757014|FG014|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
48979914|NCT03073200|157757000|FG000|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
48979915|NCT03073200|157757001|FG001|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
48979916|NCT03073200|157757002|FG002|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
48979917|NCT03073200|157757003|FG003|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
48979918|NCT03073200|157757004|FG004|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
48979919|NCT03073200|157757005|FG005|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
48979920|NCT03073200|157757006|FG006|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
48979921|NCT03073200|157757007|FG007|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
48979922|NCT03073200|157757008|FG008|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
48979923|NCT03073200|157757009|FG009|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
48979924|NCT03073200|157757010|FG010|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
48979925|NCT03073200|157757011|FG011|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
48979926|NCT03073200|157757012|FG012|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
48979927|NCT03073200|157757013|FG013|Post-Treatment Follow-Up Period|Other-determined by Investigator|2|||
48979928|NCT03073200|157757014|FG014|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
48979929|NCT04063865|157757016|FG000|Overall Study|Physician Decision|1|||
48979930|NCT04063865|157757017|FG001|Overall Study|Physician Decision|3|||
48979931|NCT04063865|157757016|FG000|Overall Study|Study Closed Prior to Completion|4|||
48979932|NCT04063865|157757017|FG001|Overall Study|Study Closed Prior to Completion|4|||
48979933|NCT04063865|157757016|FG000|Overall Study|Withdrawal by Subject|1|||
48979934|NCT04063865|157757017|FG001|Overall Study|Withdrawal by Subject|1|||
48979935|NCT00609167|157757018|FG000|Overall Study|Withdrawal by Subject|1|||
48979936|NCT00609167|157757019|FG001|Overall Study|Withdrawal by Subject|0|||
48979937|NCT00609167|157757018|FG000|Overall Study|Lack of Efficacy|1|||
48979938|NCT00609167|157757019|FG001|Overall Study|Lack of Efficacy|0|||
48979939|NCT00609167|157757018|FG000|Overall Study|Adverse Event|5|||
48979940|NCT00609167|157757019|FG001|Overall Study|Adverse Event|1|||
49015506|NCT01393990|157893784|FG014|Overall Study|Withdrawal by Subject|1|||
48979941|NCT00609167|157757018|FG000|Overall Study|Disease Progression|1|||
48979942|NCT00609167|157757019|FG001|Overall Study|Disease Progression|0|||
48979943|NCT00609167|157757018|FG000|Overall Study|Stem Cell Transplant|0|||
48979944|NCT00609167|157757019|FG001|Overall Study|Stem Cell Transplant|6|||
48762134|NCT02608268|156978014|FG007|Overall Study|Physician Decision|0|||
48874391|NCT00937521|157377012|FG007|Booster Phase|Lost to Follow-up|0|||
48874392|NCT00937521|157377005|FG000|Booster Phase|Administrative Reason|0|||
48874393|NCT00937521|157377006|FG001|Booster Phase|Administrative Reason|0|||
48874394|NCT00937521|157377007|FG002|Booster Phase|Administrative Reason|1|||
48874395|NCT00937521|157377008|FG003|Booster Phase|Administrative Reason|0|||
48874396|NCT00937521|157377009|FG004|Booster Phase|Administrative Reason|1|||
48874397|NCT00937521|157377010|FG005|Booster Phase|Administrative Reason|1|||
48874398|NCT00937521|157377011|FG006|Booster Phase|Administrative Reason|0|||
48874399|NCT00937521|157377012|FG007|Booster Phase|Administrative Reason|0|||
48874400|NCT00937521|157377005|FG000|Booster Phase|Protocol Deviation|0|||
48874401|NCT00937521|157377006|FG001|Booster Phase|Protocol Deviation|0|||
48874402|NCT00937521|157377007|FG002|Booster Phase|Protocol Deviation|0|||
48874403|NCT00937521|157377008|FG003|Booster Phase|Protocol Deviation|0|||
48874404|NCT00937521|157377009|FG004|Booster Phase|Protocol Deviation|0|||
48874405|NCT00937521|157377010|FG005|Booster Phase|Protocol Deviation|0|||
48874406|NCT00937521|157377011|FG006|Booster Phase|Protocol Deviation|1|||
48874407|NCT00937521|157377012|FG007|Booster Phase|Protocol Deviation|0|||
48874408|NCT01255761|157377016|FG000|Overall Study|Adverse Event|29|||
48874409|NCT01255761|157377017|FG001|Overall Study|Adverse Event|43|||
48874410|NCT01255761|157377016|FG000|Overall Study|Lack of Efficacy|86|||
48874411|NCT01255761|157377017|FG001|Overall Study|Lack of Efficacy|74|||
48874412|NCT01255761|157377016|FG000|Overall Study|Protocol Violation|9|||
48874413|NCT01255761|157377017|FG001|Overall Study|Protocol Violation|5|||
48874414|NCT01255761|157377016|FG000|Overall Study|Lost to Follow-up|10|||
48874415|NCT01255761|157377017|FG001|Overall Study|Lost to Follow-up|8|||
48874416|NCT01255761|157377016|FG000|Overall Study|Withdrawal by Subject|11|||
48874417|NCT01255761|157377017|FG001|Overall Study|Withdrawal by Subject|27|||
48874418|NCT01255761|157377016|FG000|Overall Study|Other Reasons|37|||
48874419|NCT01255761|157377017|FG001|Overall Study|Other Reasons|18|||
48979945|NCT01040728|157757021|FG000|Overall Study|Adverse Event|4|||
48979946|NCT01040728|157757022|FG001|Overall Study|Adverse Event|8|||
48979947|NCT01040728|157757023|FG002|Overall Study|Adverse Event|0|||
48979948|NCT01040728|157757024|FG003|Overall Study|Adverse Event|4|||
48979949|NCT01040728|157757021|FG000|Overall Study|Withdrawal by Subject|0|||
48762135|NCT02608268|156978015|FG008|Overall Study|Physician Decision|0|||
48762136|NCT02608268|156978016|FG009|Overall Study|Physician Decision|0|||
48762137|NCT02608268|156978017|FG010|Overall Study|Physician Decision|1|||
48762138|NCT02608268|156978018|FG011|Overall Study|Physician Decision|0|||
48762139|NCT02608268|156978019|FG012|Overall Study|Physician Decision|0|||
48762140|NCT02608268|156978020|FG013|Overall Study|Physician Decision|1|||
48762141|NCT02608268|156978021|FG014|Overall Study|Physician Decision|0|||
48762142|NCT02608268|156978022|FG015|Overall Study|Physician Decision|0|||
48762143|NCT02608268|156978023|FG016|Overall Study|Physician Decision|0|||
48762144|NCT02608268|156978024|FG017|Overall Study|Physician Decision|0|||
48762145|NCT02608268|156978025|FG018|Overall Study|Physician Decision|0|||
48762146|NCT02608268|156978026|FG019|Overall Study|Physician Decision|0|||
48762147|NCT02608268|156978027|FG020|Overall Study|Physician Decision|0|||
48762148|NCT02608268|156978028|FG021|Overall Study|Physician Decision|0|||
48762149|NCT02608268|156978029|FG022|Overall Study|Physician Decision|1|||
48762150|NCT02608268|156978030|FG023|Overall Study|Physician Decision|1|||
48762151|NCT02608268|156978031|FG024|Overall Study|Physician Decision|1|||
48762152|NCT02608268|156978032|FG025|Overall Study|Physician Decision|0|||
48762153|NCT02608268|156978033|FG026|Overall Study|Physician Decision|0|||
48762154|NCT02608268|156978034|FG027|Overall Study|Physician Decision|2|||
48762155|NCT02608268|156978035|FG028|Overall Study|Physician Decision|1|||
48762156|NCT02608268|156978036|FG029|Overall Study|Physician Decision|1|||
48762157|NCT02608268|156978007|FG000|Overall Study|Progressive disease|12|||
48762158|NCT02608268|156978008|FG001|Overall Study|Progressive disease|8|||
48762159|NCT02608268|156978009|FG002|Overall Study|Progressive disease|13|||
48979950|NCT01040728|157757022|FG001|Overall Study|Withdrawal by Subject|1|||
48762160|NCT02608268|156978010|FG003|Overall Study|Progressive disease|5|||
48762161|NCT02608268|156978011|FG004|Overall Study|Progressive disease|2|||
48762162|NCT02608268|156978012|FG005|Overall Study|Progressive disease|4|||
48762163|NCT02608268|156978013|FG006|Overall Study|Progressive disease|6|||
48762164|NCT02608268|156978014|FG007|Overall Study|Progressive disease|2|||
48762165|NCT02608268|156978015|FG008|Overall Study|Progressive disease|5|||
48762166|NCT02608268|156978016|FG009|Overall Study|Progressive disease|6|||
48874420|NCT00104637|157377018|FG000|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1|||
48874421|NCT00104637|157377019|FG001|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0|||
48874422|NCT00846768|157377020|FG000|Overall Study|Adverse Event|0|||
48874423|NCT00846768|157377021|FG001|Overall Study|Adverse Event|1|||
48874424|NCT00846768|157377022|FG002|Overall Study|Adverse Event|0|||
48874425|NCT00846768|157377023|FG003|Overall Study|Adverse Event|0|||
48874426|NCT01587118|157377024|FG000|Overall Study|Adverse Event|3|||
48874427|NCT01587118|157377024|FG000|Overall Study|Lost to Follow-up|2|||
48979951|NCT01040728|157757023|FG002|Overall Study|Withdrawal by Subject|1|||
48979952|NCT01040728|157757024|FG003|Overall Study|Withdrawal by Subject|0|||
48979953|NCT01040728|157757021|FG000|Overall Study|Protocol Violation|0|||
48979954|NCT01040728|157757022|FG001|Overall Study|Protocol Violation|0|||
48979955|NCT01040728|157757023|FG002|Overall Study|Protocol Violation|0|||
48979956|NCT01040728|157757024|FG003|Overall Study|Protocol Violation|1|||
48979957|NCT01040728|157757021|FG000|Overall Study|Lack of Efficacy|0|||
48979958|NCT01040728|157757022|FG001|Overall Study|Lack of Efficacy|1|||
48979959|NCT01040728|157757023|FG002|Overall Study|Lack of Efficacy|0|||
48979960|NCT01040728|157757024|FG003|Overall Study|Lack of Efficacy|1|||
48979961|NCT01040728|157757021|FG000|Overall Study|Other reasons not listed above|0|||
48979962|NCT01040728|157757022|FG001|Overall Study|Other reasons not listed above|1|||
48979963|NCT01040728|157757023|FG002|Overall Study|Other reasons not listed above|0|||
48979964|NCT01040728|157757024|FG003|Overall Study|Other reasons not listed above|0|||
48979965|NCT02583711|157757025|FG000|Overall Study|Withdrawal by Subject|0|||
48979966|NCT02583711|157757026|FG001|Overall Study|Withdrawal by Subject|10|||
48979967|NCT02583711|157757027|FG002|Overall Study|Withdrawal by Subject|0|||
48979968|NCT01868594|157757036|FG000|Overall Study|Do not meet inclusion criteria|4|||
48979969|NCT01868594|157757037|FG001|Overall Study|Do not meet inclusion criteria|3|||
48979970|NCT01365091|157757040|FG000|Period 1|Adverse Event|1|||
48979971|NCT01365091|157757041|FG001|Period 1|Adverse Event|0|||
48979972|NCT01365091|157757042|FG002|Period 1|Adverse Event|2|||
48979973|NCT01365091|157757043|FG003|Period 1|Adverse Event|3|||
48979974|NCT01365091|157757040|FG000|Period 1|Positive test result for drugs of abuse|1|||
48979975|NCT01365091|157757041|FG001|Period 1|Positive test result for drugs of abuse|0|||
48979976|NCT01365091|157757042|FG002|Period 1|Positive test result for drugs of abuse|0|||
48979977|NCT01365091|157757043|FG003|Period 1|Positive test result for drugs of abuse|0|||
48979978|NCT01365091|157757040|FG000|Period 1|No longer met study criteria|0|||
48979979|NCT01365091|157757041|FG001|Period 1|No longer met study criteria|1|||
48979980|NCT01365091|157757042|FG002|Period 1|No longer met study criteria|0|||
48979981|NCT01365091|157757043|FG003|Period 1|No longer met study criteria|0|||
48979982|NCT01365091|157757040|FG000|Period 1|Withdrawal by Subject|0|||
48979983|NCT01365091|157757041|FG001|Period 1|Withdrawal by Subject|1|||
48979984|NCT01365091|157757042|FG002|Period 1|Withdrawal by Subject|0|||
48979985|NCT01365091|157757043|FG003|Period 1|Withdrawal by Subject|0|||
48979986|NCT01365091|157757040|FG000|Period 1|Personal reasons|0|||
48979987|NCT01365091|157757041|FG001|Period 1|Personal reasons|0|||
48979988|NCT01365091|157757042|FG002|Period 1|Personal reasons|1|||
48979989|NCT01365091|157757043|FG003|Period 1|Personal reasons|0|||
48979990|NCT01365091|157757040|FG000|Period 2|Withdrawal by Subject|1|||
48979991|NCT01365091|157757041|FG001|Period 2|Withdrawal by Subject|0|||
48979992|NCT01365091|157757042|FG002|Period 2|Withdrawal by Subject|0|||
48979993|NCT01365091|157757043|FG003|Period 2|Withdrawal by Subject|0|||
48979994|NCT01365091|157757040|FG000|Period 2|Adverse Event|0|||
48979995|NCT01365091|157757041|FG001|Period 2|Adverse Event|0|||
48979996|NCT01365091|157757042|FG002|Period 2|Adverse Event|1|||
48979997|NCT01365091|157757043|FG003|Period 2|Adverse Event|0|||
48979998|NCT00068822|157757044|FG000|First Randomized Intervention|Lost to Follow-up|1|||
48979999|NCT00068822|157757045|FG001|First Randomized Intervention|Lost to Follow-up|2|||
48980000|NCT03458234|157757046|FG000|Overall Study|Withdrawal by Subject|1|||
48980001|NCT01060124|157757048|FG000|Overall Study|Other|16|||
48980002|NCT01060124|157757048|FG000|Overall Study|Adverse Event|14|||
48980003|NCT01060124|157757048|FG000|Overall Study|Withdrawal by Subject|7|||
48980004|NCT00415623|157757049|FG000|Overall Study|Adverse Event|3|||
48980005|NCT00415623|157757050|FG001|Overall Study|Adverse Event|4|||
48980006|NCT00415623|157757049|FG000|Overall Study|Death|1|||
48980007|NCT00415623|157757050|FG001|Overall Study|Death|0|||
48980008|NCT00415623|157757049|FG000|Overall Study|Withdrawal by Subject|1|||
48980009|NCT00415623|157757050|FG001|Overall Study|Withdrawal by Subject|1|||
48980010|NCT01435122|157757054|FG000|Overall Study|Early withdrawal due to toxicity|8|||
48980011|NCT00777257|157758825|FG000|Overall Study|Adverse Event|3|||
48980012|NCT00777257|157758826|FG001|Overall Study|Adverse Event|1|||
48676254|NCT04405076|156667260|FG000|Part A (Blinded Phase)|Protocol Violation|3|||
48676255|NCT04405076|156667261|FG001|Part A (Blinded Phase)|Protocol Violation|3|||
48676256|NCT04405076|156667262|FG002|Part A (Blinded Phase)|Protocol Violation|8|||
48676257|NCT04405076|156667263|FG003|Part A (Blinded Phase)|Protocol Violation|0|||
48980013|NCT00777257|157758827|FG002|Overall Study|Adverse Event|0|||
48676258|NCT04405076|156667264|FG004|Part A (Blinded Phase)|Protocol Violation|0|||
48980014|NCT00777257|157758825|FG000|Overall Study|Lost to Follow-up|3|||
48980015|NCT00777257|157758826|FG001|Overall Study|Lost to Follow-up|3|||
48980016|NCT00777257|157758827|FG002|Overall Study|Lost to Follow-up|2|||
48980017|NCT00777257|157758825|FG000|Overall Study|Protocol Violation|2|||
48980018|NCT00777257|157758826|FG001|Overall Study|Protocol Violation|2|||
48980019|NCT00777257|157758827|FG002|Overall Study|Protocol Violation|2|||
48980020|NCT00777257|157758825|FG000|Overall Study|Withdrawal by Subject|3|||
48980021|NCT00777257|157758826|FG001|Overall Study|Withdrawal by Subject|6|||
48676259|NCT04405076|156667265|FG005|Part A (Blinded Phase)|Protocol Violation|0|||
48980022|NCT00777257|157758827|FG002|Overall Study|Withdrawal by Subject|5|||
48980023|NCT02254304|157758833|FG000|Overall Study|Adverse Event|2|||
48980024|NCT02254304|157758834|FG001|Overall Study|Adverse Event|1|||
48980025|NCT02254304|157758833|FG000|Overall Study|Lost to Follow-up|2|||
48980026|NCT02254304|157758834|FG001|Overall Study|Lost to Follow-up|2|||
48980027|NCT02254304|157758833|FG000|Overall Study|Protocol Violation|1|||
48980028|NCT02254304|157758834|FG001|Overall Study|Protocol Violation|0|||
48980029|NCT02254304|157758833|FG000|Overall Study|Withdrawal by Subject|3|||
48980030|NCT02254304|157758834|FG001|Overall Study|Withdrawal by Subject|0|||
48980031|NCT02254304|157758833|FG000|Overall Study|Injection site pain and Injection fear|1|||
48676260|NCT04405076|156667266|FG006|Part A (Blinded Phase)|Protocol Violation|0|||
48676261|NCT04405076|156667267|FG007|Part A (Blinded Phase)|Protocol Violation|0|||
48980032|NCT02254304|157758834|FG001|Overall Study|Injection site pain and Injection fear|0|||
48980033|NCT02254304|157758833|FG000|Overall Study|Personal causes|4|||
48980034|NCT02254304|157758834|FG001|Overall Study|Personal causes|1|||
48980035|NCT02254304|157758833|FG000|Overall Study|Personal decision|1|||
48980036|NCT02254304|157758834|FG001|Overall Study|Personal decision|0|||
48980037|NCT02431793|157758835|FG000|Overall Study|Ineligible doe to not filling Rx|11|||
48980038|NCT02431793|157758836|FG001|Overall Study|Ineligible doe to not filling Rx|7|||
48980039|NCT02431793|157758837|FG002|Overall Study|Ineligible doe to not filling Rx|8|||
48980040|NCT02431793|157758835|FG000|Overall Study|Withdrawal by Subject|7|||
48980041|NCT02431793|157758836|FG001|Overall Study|Withdrawal by Subject|5|||
48980042|NCT02431793|157758837|FG002|Overall Study|Withdrawal by Subject|5|||
48980043|NCT02431793|157758835|FG000|Overall Study|Lost to Follow-up|101|||
48980044|NCT02431793|157758836|FG001|Overall Study|Lost to Follow-up|122|||
48980045|NCT02431793|157758837|FG002|Overall Study|Lost to Follow-up|104|||
48980046|NCT01495689|157758838|FG000|Overall Study|Death|0|||
48980047|NCT01495689|157758839|FG001|Overall Study|Death|1|||
49015507|NCT01393990|157893785|FG015|Overall Study|Withdrawal by Subject|1|||
49015508|NCT01393990|157893786|FG016|Overall Study|Withdrawal by Subject|0|||
49015509|NCT01393990|157893787|FG017|Overall Study|Withdrawal by Subject|0|||
49015510|NCT00658320|157893788|FG000|Core Study: 12 Months|Subject withdrew consent|5|||
49015511|NCT00658320|157893789|FG001|Core Study: 12 Months|Subject withdrew consent|3|||
49015512|NCT00658320|157893788|FG000|Extension Study: Month 12 to Month 24|Subject withdrew consent|3|||
49015513|NCT00658320|157893789|FG001|Extension Study: Month 12 to Month 24|Subject withdrew consent|0|||
49015514|NCT00658320|157893788|FG000|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3|||
49015515|NCT00658320|157893789|FG001|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7|||
49015516|NCT00658320|157893788|FG000|Extension Study: After Month 24|Subject withdrew consent|2|||
49015517|NCT00658320|157893789|FG001|Extension Study: After Month 24|Subject withdrew consent|0|||
49015518|NCT00685919|157893792|FG000|Overall Study|Withdrawal by Subject|0|||
49015519|NCT00685919|157893793|FG001|Overall Study|Withdrawal by Subject|0|||
49015520|NCT00685919|157893794|FG002|Overall Study|Withdrawal by Subject|1|||
49015521|NCT00685919|157893795|FG003|Overall Study|Withdrawal by Subject|0|||
49015522|NCT00685919|157893792|FG000|Overall Study|Physician Decision|1|||
49015523|NCT00685919|157893793|FG001|Overall Study|Physician Decision|0|||
49015524|NCT00685919|157893794|FG002|Overall Study|Physician Decision|0|||
49015525|NCT00685919|157893795|FG003|Overall Study|Physician Decision|0|||
49015526|NCT02732561|157893796|FG000|Overall Study|Lost to Follow-up|1|||
49015527|NCT02732561|157893797|FG001|Overall Study|Lost to Follow-up|1|||
49015528|NCT02732561|157893796|FG000|Overall Study|Withdrawal by Subject|1|||
49015529|NCT02732561|157893797|FG001|Overall Study|Withdrawal by Subject|0|||
49015530|NCT00832078|157893798|FG000|Test Day 1-2 Period|Lack of Efficacy|0|||
49015531|NCT00832078|157893799|FG001|Test Day 1-2 Period|Lack of Efficacy|2|||
49015532|NCT00832078|157893798|FG000|Test Day 2 - 2 Period|Lack of Efficacy|1|||
49015533|NCT00832078|157893799|FG001|Test Day 2 - 2 Period|Lack of Efficacy|0|||
49015534|NCT01165684|157893819|FG000|Overall Study|Adverse Event|1|||
48676262|NCT04405076|156667268|FG008|Part A (Blinded Phase)|Protocol Violation|0|||
48676263|NCT04405076|156667260|FG000|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|1|||
48980048|NCT01495689|157758838|FG000|Overall Study|Withdrawal by Subject|3|||
48980049|NCT01495689|157758839|FG001|Overall Study|Withdrawal by Subject|0|||
48980050|NCT01495689|157758838|FG000|Overall Study|Lost to Follow-up|7|||
48980051|NCT01495689|157758839|FG001|Overall Study|Lost to Follow-up|6|||
48980052|NCT00038142|157758849|FG000|Overall Study|Ineligible|1|||
48980053|NCT00038142|157758850|FG001|Overall Study|Ineligible|0|||
48980054|NCT00038142|157758849|FG000|Overall Study|Progressive Disease|11|||
48980055|NCT00038142|157758850|FG001|Overall Study|Progressive Disease|7|||
48980056|NCT00038142|157758849|FG000|Overall Study|Death|1|||
48980057|NCT00038142|157758850|FG001|Overall Study|Death|0|||
48980058|NCT00038142|157758849|FG000|Overall Study|Adverse Event|1|||
48980059|NCT00038142|157758850|FG001|Overall Study|Adverse Event|0|||
48980060|NCT00038142|157758849|FG000|Overall Study|Unknown Reason|8|||
48980061|NCT00038142|157758850|FG001|Overall Study|Unknown Reason|0|||
49015535|NCT01165684|157893820|FG001|Overall Study|Adverse Event|1|||
49015536|NCT01165684|157893819|FG000|Overall Study|Lack of Efficacy|2|||
49015537|NCT01165684|157893820|FG001|Overall Study|Lack of Efficacy|1|||
49015538|NCT01165684|157893819|FG000|Overall Study|Protocol Violation|7|||
49015539|NCT01165684|157893820|FG001|Overall Study|Protocol Violation|15|||
48980062|NCT02954952|157758871|FG000|Overall Study|Withdrawal by Subject|1|||
48980063|NCT02954952|157758872|FG001|Overall Study|Withdrawal by Subject|0|||
48980064|NCT02954952|157758873|FG002|Overall Study|Withdrawal by Subject|0|||
48980065|NCT02954952|157758871|FG000|Overall Study|No data collected|0|||
48980066|NCT02954952|157758872|FG001|Overall Study|No data collected|1|||
48980067|NCT02954952|157758873|FG002|Overall Study|No data collected|0|||
48980068|NCT02365506|157758880|FG000|Overall Study|Investigator's Discretion|0|||
48980069|NCT02365506|157758881|FG001|Overall Study|Investigator's Discretion|0|||
48980070|NCT02365506|157758882|FG002|Overall Study|Investigator's Discretion|1|||
48980071|NCT01685372|157758883|FG000|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3|||
48980072|NCT01685372|157758884|FG001|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4|||
48980073|NCT01408732|157758885|FG000|Overall Study|Withdrawal by Subject|2|||
48980074|NCT01408732|157758886|FG001|Overall Study|Withdrawal by Subject|2|||
48980075|NCT02354690|157758890|FG000|Overall Study|Physician Decision|1|||
48980076|NCT04005755|157758891|FG000|Overall Study|Adverse Event|6|||
48980077|NCT04005755|157758891|FG000|Overall Study|Physician Decision|3|||
48980078|NCT04005755|157758891|FG000|Overall Study|Administrative reason, temporary site closure due to COVID-19|4|||
48980079|NCT04005755|157758891|FG000|Overall Study|Withdrawal by Subject|3|||
48980080|NCT04005755|157758891|FG000|Overall Study|Lost to Follow-up|1|||
48980081|NCT00958191|157758896|FG000|Overall Study|Death|4|||
48980082|NCT00958191|157758896|FG000|Overall Study|Lost to Follow-up|5|||
48980083|NCT00958191|157758896|FG000|Overall Study|Inadequate 5 yr x-ray quality|10|||
48980084|NCT00958191|157758896|FG000|Overall Study|Unable/Unwilling to Return/Withdrawal|21|||
48980085|NCT00958191|157758896|FG000|Overall Study|Revision of study device|4|||
48980086|NCT00958191|157758896|FG000|Overall Study|Site termination|11|||
48980087|NCT00958191|157758896|FG000|Overall Study|No 5 yr x-rays|56|||
48980088|NCT00515099|157758897|FG000|Overall Study|Lost to Follow-up|0|||
48980089|NCT00515099|157758898|FG001|Overall Study|Lost to Follow-up|4|||
48980090|NCT00515099|157758897|FG000|Overall Study|Withdrawal by Subject|2|||
48980091|NCT00515099|157758898|FG001|Overall Study|Withdrawal by Subject|0|||
48980092|NCT00515099|157758897|FG000|Overall Study|IRB Recommendation|1|||
48980093|NCT00515099|157758898|FG001|Overall Study|IRB Recommendation|0|||
48980094|NCT04362189|157758899|FG000|Overall Study|Lost to Follow-up|0|||
48980095|NCT04362189|157758900|FG001|Overall Study|Lost to Follow-up|1|||
48980096|NCT04362189|157758899|FG000|Overall Study|Withdrawal by Subject|1|||
48980097|NCT04362189|157758900|FG001|Overall Study|Withdrawal by Subject|0|||
48980098|NCT04362189|157758899|FG000|Overall Study|FDA Clinical Hold|7|||
48980099|NCT04362189|157758900|FG001|Overall Study|FDA Clinical Hold|2|||
48980100|NCT04362189|157758899|FG000|Overall Study|Discharge or Transfer to other Hospital|3|||
48980101|NCT04362189|157758900|FG001|Overall Study|Discharge or Transfer to other Hospital|0|||
48980102|NCT04362189|157758899|FG000|Overall Study|Adverse Event|0|||
48980103|NCT04362189|157758900|FG001|Overall Study|Adverse Event|2|||
48980104|NCT04362189|157758899|FG000|Overall Study|Death|4|||
48676264|NCT04405076|156667261|FG001|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
48676265|NCT04405076|156667262|FG002|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
48980105|NCT04362189|157758900|FG001|Overall Study|Death|1|||
48980106|NCT02718625|157758901|FG000|Overall Study|Adverse Event|0|||
48980107|NCT02718625|157758902|FG001|Overall Study|Adverse Event|1|||
48980108|NCT02718625|157758901|FG000|Overall Study|Termination of Study by Sponsor|0|||
48980109|NCT02718625|157758902|FG001|Overall Study|Termination of Study by Sponsor|1|||
48980110|NCT01925014|157758903|FG000|Overall Study|Inappropriate enrollment|4|||
48980111|NCT01925014|157758904|FG001|Overall Study|Inappropriate enrollment|6|||
48980112|NCT01925014|157758903|FG000|Overall Study|Withdrawal by Subject|5|||
48980113|NCT01925014|157758904|FG001|Overall Study|Withdrawal by Subject|13|||
48980114|NCT00372489|157758908|FG000|Overall Study|Adverse Event|18|||
48980115|NCT00372489|157758908|FG000|Overall Study|Lack of Efficacy|1|||
48980116|NCT00372489|157758908|FG000|Overall Study|Lost to Follow-up|3|||
48980117|NCT00372489|157758908|FG000|Overall Study|Physician Decision|3|||
48980118|NCT00372489|157758908|FG000|Overall Study|Withdrawal by Subject|5|||
48980119|NCT00372489|157758908|FG000|Overall Study|Patient Relocation|2|||
48676266|NCT04405076|156667263|FG003|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
48980120|NCT00372489|157758908|FG000|Overall Study|Renal transplant|6|||
48676267|NCT04405076|156667264|FG004|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
48676268|NCT04405076|156667265|FG005|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
48676269|NCT04405076|156667266|FG006|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
48676270|NCT04405076|156667267|FG007|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
48980121|NCT00372489|157758908|FG000|Overall Study|Sponsor Decision to Terminate Study|41|||
48980122|NCT00736450|157758909|FG000|Overall Study|Not ABC gene eligible|19|||
48980123|NCT00736450|157758909|FG000|Overall Study|Withdrawal by Subject|5|||
48980124|NCT00736450|157758909|FG000|Overall Study|Physician Decision|1|||
48980125|NCT01387594|157758910|FG000|Overall Study|Withdrawal by Subject|0|||
48980126|NCT01387594|157758911|FG001|Overall Study|Withdrawal by Subject|2|||
48980127|NCT01387594|157758910|FG000|Overall Study|Lost to Follow-up|0|||
48980128|NCT01387594|157758911|FG001|Overall Study|Lost to Follow-up|1|||
48980129|NCT02332876|157758913|FG000|Overall Study|Lost to Follow-up|1|||
48980130|NCT02332876|157758914|FG001|Overall Study|Lost to Follow-up|1|||
48980131|NCT00998985|157758917|FG000|Overall Study|Withdrawal by Subject|0|||
48980132|NCT00998985|157758918|FG001|Overall Study|Withdrawal by Subject|0|||
48980133|NCT00998985|157758919|FG002|Overall Study|Withdrawal by Subject|0|||
48980134|NCT00998985|157758920|FG003|Overall Study|Withdrawal by Subject|0|||
48980135|NCT00998985|157758921|FG004|Overall Study|Withdrawal by Subject|0|||
48980136|NCT00998985|157758922|FG005|Overall Study|Withdrawal by Subject|0|||
48980137|NCT00998985|157758923|FG006|Overall Study|Withdrawal by Subject|0|||
48980138|NCT00998985|157758924|FG007|Overall Study|Withdrawal by Subject|0|||
48980139|NCT00998985|157758925|FG008|Overall Study|Withdrawal by Subject|1|||
48980140|NCT00998985|157758926|FG009|Overall Study|Withdrawal by Subject|0|||
48980141|NCT00998985|157758927|FG010|Overall Study|Withdrawal by Subject|0|||
48980142|NCT00998985|157758928|FG011|Overall Study|Withdrawal by Subject|0|||
49015540|NCT01165684|157893819|FG000|Overall Study|Withdrawal Criteria|2|||
49015541|NCT01165684|157893820|FG001|Overall Study|Withdrawal Criteria|13|||
49015542|NCT01165684|157893819|FG000|Overall Study|Unclassified|16|||
49015543|NCT01165684|157893820|FG001|Overall Study|Unclassified|22|||
49015544|NCT03347695|157893821|FG000|Overall Study|Death|0|||
49015545|NCT03347695|157893822|FG001|Overall Study|Death|4|||
49015546|NCT03347695|157893821|FG000|Overall Study|Lost to Follow-up|0|||
49015547|NCT03347695|157893822|FG001|Overall Study|Lost to Follow-up|1|||
48980143|NCT00998985|157758929|FG012|Overall Study|Withdrawal by Subject|0|||
48980144|NCT00998985|157758930|FG013|Overall Study|Withdrawal by Subject|0|||
48980145|NCT00998985|157758917|FG000|Overall Study|Protocol Violation|0|||
48676271|NCT04405076|156667268|FG008|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
48676272|NCT04405076|156667260|FG000|Part A (Blinded Phase)|Withdrawal of consent (other)|1|||
48980146|NCT00998985|157758918|FG001|Overall Study|Protocol Violation|0|||
48980147|NCT00998985|157758919|FG002|Overall Study|Protocol Violation|0|||
49015548|NCT00614055|157893823|FG000|Overall Study|Adverse Event|1|||
49015549|NCT00614055|157893824|FG001|Overall Study|Adverse Event|0|||
48980148|NCT00998985|157758920|FG003|Overall Study|Protocol Violation|0|||
48980149|NCT00998985|157758921|FG004|Overall Study|Protocol Violation|0|||
48980150|NCT00998985|157758922|FG005|Overall Study|Protocol Violation|1|||
48980151|NCT00998985|157758923|FG006|Overall Study|Protocol Violation|0|||
48980152|NCT00998985|157758924|FG007|Overall Study|Protocol Violation|0|||
48980153|NCT00998985|157758925|FG008|Overall Study|Protocol Violation|0|||
48980154|NCT00998985|157758926|FG009|Overall Study|Protocol Violation|0|||
48980155|NCT00998985|157758927|FG010|Overall Study|Protocol Violation|0|||
48980156|NCT00998985|157758928|FG011|Overall Study|Protocol Violation|0|||
48980157|NCT00998985|157758929|FG012|Overall Study|Protocol Violation|0|||
48980158|NCT00998985|157758930|FG013|Overall Study|Protocol Violation|0|||
48980159|NCT04474366|157758931|FG000|Overall Study|Lost to Follow-up|2|||
48980160|NCT04474366|157758932|FG001|Overall Study|Lost to Follow-up|5|||
48980161|NCT02574520|157758933|FG000|Overall Study|Not dosed|2|||
48980162|NCT02574520|157758934|FG001|Overall Study|Not dosed|0|||
48980163|NCT02574520|157758935|FG002|Overall Study|Not dosed|5|||
48980164|NCT02574520|157758936|FG003|Overall Study|Not dosed|4|||
48980165|NCT02574520|157758933|FG000|Overall Study|Adverse Event|0|||
48980166|NCT02574520|157758934|FG001|Overall Study|Adverse Event|0|||
48980167|NCT02574520|157758935|FG002|Overall Study|Adverse Event|0|||
48980168|NCT02574520|157758936|FG003|Overall Study|Adverse Event|1|||
48980169|NCT02574520|157758933|FG000|Overall Study|Withdrawal by Subject|0|||
48980170|NCT02574520|157758934|FG001|Overall Study|Withdrawal by Subject|0|||
48980171|NCT02574520|157758935|FG002|Overall Study|Withdrawal by Subject|0|||
48980172|NCT02574520|157758936|FG003|Overall Study|Withdrawal by Subject|1|||
48980173|NCT02574520|157758933|FG000|Overall Study|Other|0|||
48980174|NCT02574520|157758934|FG001|Overall Study|Other|0|||
48980175|NCT02574520|157758935|FG002|Overall Study|Other|0|||
48980176|NCT02574520|157758936|FG003|Overall Study|Other|2|||
48980177|NCT03099304|157758941|FG000|DB Period: Day 1 to Week 24|Adverse Event|1|||
48980178|NCT03099304|157758942|FG001|DB Period: Day 1 to Week 24|Adverse Event|1|||
48980179|NCT03099304|157758943|FG002|DB Period: Day 1 to Week 24|Adverse Event|0|||
48980180|NCT03099304|157758944|FG003|DB Period: Day 1 to Week 24|Adverse Event|0|||
48980181|NCT03099304|157758945|FG004|DB Period: Day 1 to Week 24|Adverse Event|1|||
48980182|NCT03099304|157758946|FG005|DB Period: Day 1 to Week 24|Adverse Event|0|||
48676273|NCT04405076|156667261|FG001|Part A (Blinded Phase)|Withdrawal of consent (other)|4|||
48676274|NCT04405076|156667262|FG002|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
48676275|NCT04405076|156667263|FG003|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
48980183|NCT03099304|157758941|FG000|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
48980184|NCT03099304|157758942|FG001|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
48980185|NCT03099304|157758943|FG002|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
48980186|NCT03099304|157758944|FG003|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
48980187|NCT03099304|157758945|FG004|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
48980188|NCT03099304|157758946|FG005|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
48980189|NCT03099304|157758941|FG000|DB Period: Day 1 to Week 24|Reason not specified|0|||
48980190|NCT03099304|157758942|FG001|DB Period: Day 1 to Week 24|Reason not specified|0|||
49015550|NCT00614055|157893825|FG002|Overall Study|Adverse Event|0|||
48980191|NCT03099304|157758943|FG002|DB Period: Day 1 to Week 24|Reason not specified|0|||
48980192|NCT03099304|157758944|FG003|DB Period: Day 1 to Week 24|Reason not specified|1|||
48980193|NCT03099304|157758945|FG004|DB Period: Day 1 to Week 24|Reason not specified|0|||
48980194|NCT03099304|157758946|FG005|DB Period: Day 1 to Week 24|Reason not specified|0|||
48980195|NCT03099304|157758941|FG000|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
48980196|NCT03099304|157758942|FG001|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
48980197|NCT03099304|157758943|FG002|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
48980198|NCT03099304|157758944|FG003|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
48980199|NCT03099304|157758945|FG004|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
48980200|NCT03099304|157758946|FG005|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
48980201|NCT03099304|157758941|FG000|DB Period: Day 1 to Week 24|Protocol Violation|0|||
48980202|NCT03099304|157758942|FG001|DB Period: Day 1 to Week 24|Protocol Violation|0|||
48980203|NCT03099304|157758943|FG002|DB Period: Day 1 to Week 24|Protocol Violation|1|||
48980204|NCT03099304|157758944|FG003|DB Period: Day 1 to Week 24|Protocol Violation|1|||
48980205|NCT03099304|157758945|FG004|DB Period: Day 1 to Week 24|Protocol Violation|0|||
48980206|NCT03099304|157758946|FG005|DB Period: Day 1 to Week 24|Protocol Violation|0|||
48980207|NCT03099304|157758941|FG000|DB Period: Weeks 24 to 52|Protocol Violation|0|||
48980208|NCT03099304|157758942|FG001|DB Period: Weeks 24 to 52|Protocol Violation|0|||
48980209|NCT03099304|157758943|FG002|DB Period: Weeks 24 to 52|Protocol Violation|1|||
48980210|NCT03099304|157758944|FG003|DB Period: Weeks 24 to 52|Protocol Violation|0|||
48980211|NCT03099304|157758945|FG004|DB Period: Weeks 24 to 52|Protocol Violation|0|||
48980212|NCT03099304|157758946|FG005|DB Period: Weeks 24 to 52|Protocol Violation|0|||
48980213|NCT03099304|157758941|FG000|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
48980214|NCT03099304|157758942|FG001|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
48980215|NCT03099304|157758943|FG002|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
48980216|NCT03099304|157758944|FG003|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
48980217|NCT03099304|157758945|FG004|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
48980218|NCT03099304|157758946|FG005|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
48980219|NCT03099304|157758941|FG000|DB Period: Weeks 24 to 52|Adverse Event|0|||
48980220|NCT03099304|157758942|FG001|DB Period: Weeks 24 to 52|Adverse Event|0|||
48980221|NCT03099304|157758943|FG002|DB Period: Weeks 24 to 52|Adverse Event|0|||
48980222|NCT03099304|157758944|FG003|DB Period: Weeks 24 to 52|Adverse Event|1|||
49015551|NCT00614055|157893823|FG000|Overall Study|Protocol Violation|2|||
49015552|NCT00614055|157893824|FG001|Overall Study|Protocol Violation|2|||
49015553|NCT00614055|157893825|FG002|Overall Study|Protocol Violation|1|||
49015554|NCT00614055|157893823|FG000|Overall Study|Lack of Efficacy|0|||
49015555|NCT00614055|157893824|FG001|Overall Study|Lack of Efficacy|0|||
49015556|NCT00614055|157893825|FG002|Overall Study|Lack of Efficacy|2|||
49015557|NCT00614055|157893823|FG000|Overall Study|Unclassified|1|||
49015558|NCT00614055|157893824|FG001|Overall Study|Unclassified|4|||
49015559|NCT00614055|157893825|FG002|Overall Study|Unclassified|2|||
49015560|NCT00671879|157893832|FG000|Overall Study|Withdrawal by Subject|0|||
49015561|NCT00671879|157893833|FG001|Overall Study|Withdrawal by Subject|4|||
49015562|NCT00671879|157893834|FG002|Overall Study|Withdrawal by Subject|6|||
49015563|NCT04633837|157893854|FG000|Overall Study|Participant outcomes data not collected due to technical errors.|5|||
49015564|NCT04633837|157893855|FG001|Overall Study|Participant outcomes data not collected due to technical errors.|0|||
49015565|NCT01886300|157893856|FG000|Overall Study|Trial terminated by sponsor|16|||
49015566|NCT04527471|157893859|FG000|Overall Study|Adverse Event|1|||
49015567|NCT04527471|157893860|FG001|Overall Study|Adverse Event|0|||
49015568|NCT04527471|157893859|FG000|Overall Study|Lost to Follow-up|1|||
49015569|NCT04527471|157893860|FG001|Overall Study|Lost to Follow-up|0|||
49015570|NCT02668783|157893861|FG000|Overall Study|Pregnancy|0|||
49015571|NCT02668783|157893862|FG001|Overall Study|Pregnancy|1|||
49015572|NCT02668783|157893861|FG000|Overall Study|Protocol Violation|2|||
48676276|NCT04405076|156667264|FG004|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
48676277|NCT04405076|156667265|FG005|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
48676278|NCT04405076|156667266|FG006|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
48676279|NCT04405076|156667267|FG007|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
48676280|NCT04405076|156667268|FG008|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
48676281|NCT04405076|156667260|FG000|Part A (Blinded Phase)|Other than Specified|0|||
48676282|NCT04405076|156667261|FG001|Part A (Blinded Phase)|Other than Specified|0|||
48676283|NCT04405076|156667262|FG002|Part A (Blinded Phase)|Other than Specified|3|||
48676284|NCT04405076|156667263|FG003|Part A (Blinded Phase)|Other than Specified|0|||
48676285|NCT04405076|156667264|FG004|Part A (Blinded Phase)|Other than Specified|0|||
48676286|NCT04405076|156667265|FG005|Part A (Blinded Phase)|Other than Specified|0|||
48676287|NCT04405076|156667266|FG006|Part A (Blinded Phase)|Other than Specified|0|||
48980223|NCT03099304|157758945|FG004|DB Period: Weeks 24 to 52|Adverse Event|1|||
48980224|NCT03099304|157758946|FG005|DB Period: Weeks 24 to 52|Adverse Event|0|||
48980225|NCT03099304|157758941|FG000|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
48980226|NCT03099304|157758942|FG001|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
49015573|NCT02668783|157893862|FG001|Overall Study|Protocol Violation|1|||
49015574|NCT02668783|157893861|FG000|Overall Study|Study terminated by sponsor|9|||
48980227|NCT03099304|157758943|FG002|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
48980228|NCT03099304|157758944|FG003|DB Period: Weeks 24 to 52|Withdrawal by Subject|4|||
48980229|NCT03099304|157758945|FG004|DB Period: Weeks 24 to 52|Withdrawal by Subject|1|||
48980230|NCT03099304|157758946|FG005|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
48980231|NCT03099304|157758941|FG000|DB Period: Weeks 24 to 52|Reason not specified|0|||
48980232|NCT03099304|157758942|FG001|DB Period: Weeks 24 to 52|Reason not specified|0|||
48980233|NCT03099304|157758943|FG002|DB Period: Weeks 24 to 52|Reason not specified|0|||
48980234|NCT03099304|157758944|FG003|DB Period: Weeks 24 to 52|Reason not specified|1|||
48980235|NCT03099304|157758945|FG004|DB Period: Weeks 24 to 52|Reason not specified|0|||
48980236|NCT03099304|157758946|FG005|DB Period: Weeks 24 to 52|Reason not specified|0|||
48980237|NCT03099304|157758941|FG000|104-week Open-Label Extension Period|Adverse Event|0|||
48980238|NCT03099304|157758942|FG001|104-week Open-Label Extension Period|Adverse Event|0|||
48980239|NCT03099304|157758943|FG002|104-week Open-Label Extension Period|Adverse Event|1|||
48980240|NCT03099304|157758944|FG003|104-week Open-Label Extension Period|Adverse Event|0|||
48980241|NCT03099304|157758945|FG004|104-week Open-Label Extension Period|Adverse Event|0|||
48980242|NCT03099304|157758946|FG005|104-week Open-Label Extension Period|Adverse Event|0|||
48980243|NCT03099304|157758941|FG000|104-week Open-Label Extension Period|Lost to Follow-up|0|||
48980244|NCT03099304|157758942|FG001|104-week Open-Label Extension Period|Lost to Follow-up|0|||
48980245|NCT03099304|157758943|FG002|104-week Open-Label Extension Period|Lost to Follow-up|3|||
48980246|NCT03099304|157758944|FG003|104-week Open-Label Extension Period|Lost to Follow-up|2|||
48980247|NCT03099304|157758945|FG004|104-week Open-Label Extension Period|Lost to Follow-up|1|||
48980248|NCT03099304|157758946|FG005|104-week Open-Label Extension Period|Lost to Follow-up|6|||
48980249|NCT03099304|157758941|FG000|104-week Open-Label Extension Period|Physician Decision|0|||
48980250|NCT03099304|157758942|FG001|104-week Open-Label Extension Period|Physician Decision|0|||
48980251|NCT03099304|157758943|FG002|104-week Open-Label Extension Period|Physician Decision|0|||
48980252|NCT03099304|157758944|FG003|104-week Open-Label Extension Period|Physician Decision|0|||
48980253|NCT03099304|157758945|FG004|104-week Open-Label Extension Period|Physician Decision|1|||
48980254|NCT03099304|157758946|FG005|104-week Open-Label Extension Period|Physician Decision|0|||
48980255|NCT03099304|157758941|FG000|104-week Open-Label Extension Period|Pregnancy|0|||
48980256|NCT03099304|157758942|FG001|104-week Open-Label Extension Period|Pregnancy|0|||
48980257|NCT03099304|157758943|FG002|104-week Open-Label Extension Period|Pregnancy|0|||
48980258|NCT03099304|157758944|FG003|104-week Open-Label Extension Period|Pregnancy|0|||
48980259|NCT03099304|157758945|FG004|104-week Open-Label Extension Period|Pregnancy|0|||
48980260|NCT03099304|157758946|FG005|104-week Open-Label Extension Period|Pregnancy|1|||
48980261|NCT03099304|157758941|FG000|104-week Open-Label Extension Period|Protocol Violation|0|||
48980262|NCT03099304|157758942|FG001|104-week Open-Label Extension Period|Protocol Violation|0|||
48980263|NCT03099304|157758943|FG002|104-week Open-Label Extension Period|Protocol Violation|0|||
48980264|NCT03099304|157758944|FG003|104-week Open-Label Extension Period|Protocol Violation|0|||
49015575|NCT02668783|157893862|FG001|Overall Study|Study terminated by sponsor|10|||
49015576|NCT02668783|157893861|FG000|Overall Study|Subject moved|1|||
49015577|NCT02668783|157893862|FG001|Overall Study|Subject moved|0|||
49015578|NCT02668783|157893861|FG000|Overall Study|Withdrawal by Subject|1|||
49015579|NCT02668783|157893862|FG001|Overall Study|Withdrawal by Subject|0|||
49015580|NCT02008721|157893865|FG000|Overall Study|Withdrawal by Subject|5|||
49015581|NCT02008721|157893866|FG001|Overall Study|Withdrawal by Subject|1|||
49015582|NCT02008721|157893865|FG000|Overall Study|Death|4|||
49015583|NCT02008721|157893866|FG001|Overall Study|Death|2|||
49015584|NCT02008721|157893865|FG000|Overall Study|Adverse Event|3|||
49015585|NCT02008721|157893866|FG001|Overall Study|Adverse Event|5|||
49015586|NCT02008721|157893865|FG000|Overall Study|Protocol Violation|3|||
49015587|NCT02008721|157893866|FG001|Overall Study|Protocol Violation|2|||
49015588|NCT00947427|157893867|FG000|Overall Study|Withdrawal by Subject|1|||
49015589|NCT00947427|157893868|FG001|Overall Study|Withdrawal by Subject|3|||
49015590|NCT00947427|157893867|FG000|Overall Study|Protocol Violation|0|||
48676288|NCT04405076|156667267|FG007|Part A (Blinded Phase)|Other than Specified|0|||
48676289|NCT04405076|156667268|FG008|Part A (Blinded Phase)|Other than Specified|0|||
48980265|NCT03099304|157758945|FG004|104-week Open-Label Extension Period|Protocol Violation|0|||
48980266|NCT03099304|157758946|FG005|104-week Open-Label Extension Period|Protocol Violation|1|||
48980267|NCT03099304|157758941|FG000|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
48980268|NCT03099304|157758942|FG001|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
48980269|NCT03099304|157758943|FG002|104-week Open-Label Extension Period|Withdrawal by Subject|9|||
48980270|NCT03099304|157758944|FG003|104-week Open-Label Extension Period|Withdrawal by Subject|10|||
48980271|NCT03099304|157758945|FG004|104-week Open-Label Extension Period|Withdrawal by Subject|13|||
48980272|NCT03099304|157758946|FG005|104-week Open-Label Extension Period|Withdrawal by Subject|15|||
48980273|NCT03099304|157758941|FG000|104-week Open-Label Extension Period|Other Reason not specified|0|||
48980274|NCT03099304|157758942|FG001|104-week Open-Label Extension Period|Other Reason not specified|0|||
48980275|NCT03099304|157758943|FG002|104-week Open-Label Extension Period|Other Reason not specified|4|||
48980276|NCT03099304|157758944|FG003|104-week Open-Label Extension Period|Other Reason not specified|1|||
49015591|NCT00947427|157893868|FG001|Overall Study|Protocol Violation|1|||
48980277|NCT03099304|157758945|FG004|104-week Open-Label Extension Period|Other Reason not specified|1|||
48980278|NCT03099304|157758946|FG005|104-week Open-Label Extension Period|Other Reason not specified|0|||
48980279|NCT01012037|157758947|FG000|Overall Study|Adverse Event|0|||
48980280|NCT01012037|157758948|FG001|Overall Study|Adverse Event|8|||
48980281|NCT01012037|157758949|FG002|Overall Study|Adverse Event|3|||
48980282|NCT01012037|157758947|FG000|Overall Study|Protocol Violation|0|||
48980283|NCT01012037|157758948|FG001|Overall Study|Protocol Violation|3|||
48980284|NCT01012037|157758949|FG002|Overall Study|Protocol Violation|5|||
48980285|NCT01012037|157758947|FG000|Overall Study|Withdrawal by Subject|0|||
48980286|NCT01012037|157758948|FG001|Overall Study|Withdrawal by Subject|4|||
48980287|NCT01012037|157758949|FG002|Overall Study|Withdrawal by Subject|1|||
48980288|NCT01012037|157758947|FG000|Overall Study|Other reason (not specified)|1|||
48980289|NCT01012037|157758948|FG001|Overall Study|Other reason (not specified)|1|||
48676290|NCT04405076|156667260|FG000|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
48676291|NCT04405076|156667261|FG001|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
48676292|NCT04405076|156667262|FG002|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
48676293|NCT04405076|156667263|FG003|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|6|||
48676294|NCT04405076|156667264|FG004|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|1|||
48676295|NCT04405076|156667265|FG005|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|4|||
48676296|NCT04405076|156667266|FG006|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
48676297|NCT04405076|156667267|FG007|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
48676298|NCT04405076|156667268|FG008|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
48980290|NCT01012037|157758949|FG002|Overall Study|Other reason (not specified)|1|||
48980291|NCT01700140|157758953|FG000|Overall Study|Use of rescue drugs|3|||
48980292|NCT01700140|157758954|FG001|Overall Study|Use of rescue drugs|3|||
48980293|NCT01700140|157758955|FG002|Overall Study|Use of rescue drugs|1|||
48980294|NCT01700140|157758953|FG000|Overall Study|Discontinuation of radiotherapy|1|||
48980295|NCT01700140|157758954|FG001|Overall Study|Discontinuation of radiotherapy|0|||
48980296|NCT01700140|157758955|FG002|Overall Study|Discontinuation of radiotherapy|0|||
48980297|NCT01700140|157758953|FG000|Overall Study|Use of chemotherapy or surgical therapy|0|||
48980298|NCT01700140|157758954|FG001|Overall Study|Use of chemotherapy or surgical therapy|1|||
48980299|NCT01700140|157758955|FG002|Overall Study|Use of chemotherapy or surgical therapy|0|||
48980300|NCT01700140|157758953|FG000|Overall Study|Aggravation of symptoms|1|||
48980301|NCT01700140|157758954|FG001|Overall Study|Aggravation of symptoms|0|||
48980302|NCT01700140|157758955|FG002|Overall Study|Aggravation of symptoms|0|||
48980303|NCT01700140|157758953|FG000|Overall Study|Adverse Event|0|||
48980304|NCT01700140|157758954|FG001|Overall Study|Adverse Event|1|||
48980305|NCT01700140|157758955|FG002|Overall Study|Adverse Event|0|||
48980306|NCT01700140|157758953|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
48980307|NCT01700140|157758954|FG001|Overall Study|Inclusion/exclusion criteria deviation|4|||
48980308|NCT01700140|157758955|FG002|Overall Study|Inclusion/exclusion criteria deviation|0|||
48980309|NCT02343952|157758959|FG000|Study Treatment|Disease Progression|23|||
48980310|NCT02343952|157758959|FG000|Study Treatment|Death|3|||
48980311|NCT02343952|157758959|FG000|Study Treatment|Adverse Event|19|||
48980312|NCT02343952|157758959|FG000|Study Treatment|Withdrawal by Subject|7|||
48980313|NCT02343952|157758959|FG000|Study Treatment|other complicating Diseases|1|||
48980314|NCT02343952|157758959|FG000|Follow up|Withdrawal by Subject|3|||
48980315|NCT02343952|157758959|FG000|Follow up|Death|33|||
48980316|NCT02343952|157758959|FG000|Follow up|Patient does not meet eligibility for study.|1|||
48980317|NCT02343952|157758959|FG000|Follow up|Research department closed by the practice.|5|||
48980318|NCT02343952|157758959|FG000|Follow up|Patient went home to Russia|1|||
48980319|NCT02343952|157758959|FG000|Follow up|Disease Progression|1|||
48980320|NCT02343952|157758959|FG000|Follow up|study terminated|1|||
48980321|NCT05307523|157758960|FG000|First Condition (3 Weeks)|Lost to Follow-up|1|||
48980322|NCT05307523|157758961|FG001|First Condition (3 Weeks)|Lost to Follow-up|0|||
48980323|NCT05307523|157758960|FG000|First Condition (3 Weeks)|Withdrawal by Subject|1|||
48980324|NCT05307523|157758961|FG001|First Condition (3 Weeks)|Withdrawal by Subject|0|||
48980325|NCT00901394|157758963|FG000|Overall Study|Physician Decision|1|||
48980326|NCT00901394|157758964|FG001|Overall Study|Physician Decision|1|||
48980327|NCT00901394|157758965|FG002|Overall Study|Physician Decision|2|||
48980328|NCT01474889|157758966|FG000|Overall Study|Physician Decision|1|||
48980329|NCT01474889|157758967|FG001|Overall Study|Physician Decision|0|||
48874428|NCT01587118|157377024|FG000|Overall Study|Relocation|1|||
48874429|NCT01587118|157377024|FG000|Overall Study|nonresponse|1|||
48980330|NCT01474889|157758968|FG002|Overall Study|Physician Decision|0|||
48980331|NCT01474889|157758966|FG000|Overall Study|Did not meet inclusion|1|||
48980332|NCT01474889|157758967|FG001|Overall Study|Did not meet inclusion|0|||
48980333|NCT01474889|157758968|FG002|Overall Study|Did not meet inclusion|0|||
48980334|NCT01474889|157758966|FG000|Overall Study|Withdrawal by Subject|0|||
48980335|NCT01474889|157758967|FG001|Overall Study|Withdrawal by Subject|1|||
48980336|NCT01474889|157758968|FG002|Overall Study|Withdrawal by Subject|0|||
48980337|NCT02886338|157758973|FG000|Overall Study|Withdrawal by Subject|1|||
48980338|NCT00122317|157758974|FG000|Overall Study|Death|3|||
48980339|NCT00122317|157758974|FG000|Overall Study|Adverse Event|4|||
48980340|NCT00122317|157758974|FG000|Overall Study|Physician Decision|2|||
48980341|NCT00122317|157758974|FG000|Overall Study|patient non-compliance|1|||
48980342|NCT00122317|157758974|FG000|Overall Study|Withdrawal by Subject|1|||
48980343|NCT03267576|157758981|FG000|Period 2: Day 44 to 71|Lost to Follow-up|0|||
48980344|NCT03267576|157758982|FG001|Period 2: Day 44 to 71|Lost to Follow-up|1|||
48980345|NCT03267576|157758981|FG000|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
48980346|NCT03267576|157758982|FG001|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
48980347|NCT03662789|157758988|FG000|Overall Study|Lost to Follow-up|1|||
48980348|NCT03662789|157758989|FG001|Overall Study|Lost to Follow-up|2|||
48980349|NCT03662789|157758988|FG000|Overall Study|Could not perform treadmill test|4|||
48980350|NCT03662789|157758989|FG001|Overall Study|Could not perform treadmill test|4|||
48980351|NCT03662789|157758988|FG000|Overall Study|Death|0|||
48980352|NCT03662789|157758989|FG001|Overall Study|Death|1|||
48980353|NCT02692560|157758990|FG000|Overall Study|Withdrawal by Subject|0|||
48980354|NCT02692560|157758991|FG001|Overall Study|Withdrawal by Subject|6|||
48980355|NCT04412668|157758996|FG000|Overall Study|Death - multiple comorbidities|2|||
48980356|NCT04412668|157758997|FG001|Overall Study|Death - multiple comorbidities|0|||
48980357|NCT04412668|157758998|FG002|Overall Study|Death - multiple comorbidities|0|||
48980358|NCT04412668|157758996|FG000|Overall Study|Withdrawal by Subject|3|||
48980359|NCT04412668|157758997|FG001|Overall Study|Withdrawal by Subject|0|||
48980360|NCT04412668|157758998|FG002|Overall Study|Withdrawal by Subject|0|||
48980361|NCT04412668|157758996|FG000|Overall Study|Other than Specified|2|||
48980362|NCT04412668|157758997|FG001|Overall Study|Other than Specified|0|||
48980363|NCT04412668|157758998|FG002|Overall Study|Other than Specified|0|||
48980364|NCT00102804|157758999|FG000|Overall Study|Progressive Disease (PD)|307|||
48980365|NCT00102804|157759000|FG001|Overall Study|Progressive Disease (PD)|196|||
48980366|NCT00102804|157758999|FG000|Overall Study|Withdrawal by Subject|46|||
48980367|NCT00102804|157759000|FG001|Overall Study|Withdrawal by Subject|7|||
48980368|NCT00102804|157758999|FG000|Overall Study|Adverse Event|37|||
48980369|NCT00102804|157759000|FG001|Overall Study|Adverse Event|3|||
48980370|NCT00102804|157758999|FG000|Overall Study|Physician Decision|24|||
48980371|NCT00102804|157759000|FG001|Overall Study|Physician Decision|6|||
48980372|NCT00102804|157758999|FG000|Overall Study|Death|5|||
48980373|NCT00102804|157759000|FG001|Overall Study|Death|6|||
48980374|NCT00102804|157758999|FG000|Overall Study|Enrollment Criteria Not Met|6|||
48980375|NCT00102804|157759000|FG001|Overall Study|Enrollment Criteria Not Met|0|||
48980376|NCT00102804|157758999|FG000|Overall Study|Lost to Follow-up|4|||
48980377|NCT00102804|157759000|FG001|Overall Study|Lost to Follow-up|1|||
48980378|NCT00102804|157758999|FG000|Overall Study|Protocol Violation|2|||
48980379|NCT00102804|157759000|FG001|Overall Study|Protocol Violation|1|||
48980380|NCT00102804|157758999|FG000|Overall Study|Satisfactory Response|2|||
48980381|NCT00102804|157759000|FG001|Overall Study|Satisfactory Response|0|||
49015592|NCT00112489|157893873|FG000|Overall Study|Refused further treatment|8|||
49015593|NCT00112489|157893873|FG000|Overall Study|Adverse Event|12|||
49015594|NCT00112489|157893873|FG000|Overall Study|Death|2|||
49015595|NCT00112489|157893873|FG000|Overall Study|Other, Not Specified|9|||
49015596|NCT00112489|157893873|FG000|Overall Study|Patient never treated|2|||
49015597|NCT00112489|157893873|FG000|Overall Study|Ineligible|7|||
49015598|NCT01797120|157893874|FG000|Overall Study|Disesae progression|37|||
49015599|NCT01797120|157893875|FG001|Overall Study|Disesae progression|49|||
49015600|NCT01797120|157893874|FG000|Overall Study|Adverse Event|13|||
49015601|NCT01797120|157893875|FG001|Overall Study|Adverse Event|5|||
49015602|NCT01797120|157893874|FG000|Overall Study|Withdrawal by Subject|6|||
49015603|NCT01797120|157893875|FG001|Overall Study|Withdrawal by Subject|6|||
49015604|NCT01797120|157893874|FG000|Overall Study|Symptomatic progression|2|||
49015605|NCT01797120|157893875|FG001|Overall Study|Symptomatic progression|1|||
49015606|NCT01797120|157893874|FG000|Overall Study|Non-compliance|1|||
49015607|NCT01797120|157893875|FG001|Overall Study|Non-compliance|0|||
49015608|NCT01797120|157893874|FG000|Overall Study|Physician Decision|3|||
49015609|NCT01797120|157893875|FG001|Overall Study|Physician Decision|0|||
49015610|NCT01797120|157893874|FG000|Overall Study|still on treatment|2|||
49015611|NCT01797120|157893875|FG001|Overall Study|still on treatment|4|||
49015612|NCT01797120|157893874|FG000|Overall Study|never start protocol therapy|2|||
49015613|NCT01797120|157893875|FG001|Overall Study|never start protocol therapy|0|||
49015614|NCT01003886|157893877|FG000|Overall Study|Lack of Efficacy|5|||
49015615|NCT01003886|157893877|FG000|Overall Study|Lost to Follow-up|169|||
49015616|NCT01003886|157893877|FG000|Overall Study|Withdrawal by Subject|39|||
49015617|NCT01003886|157893877|FG000|Overall Study|Other|14|||
49015618|NCT01003886|157893877|FG000|Overall Study|Adverse Event|3|||
49015619|NCT01165996|157893878|FG000|Overall Study|Death|1|||
49015620|NCT01165996|157893878|FG000|Overall Study|Physician Decision|1|||
49015621|NCT01612000|157893880|FG000|Overall Study|Lost to Follow-up|6|||
49015622|NCT01612000|157893881|FG001|Overall Study|Lost to Follow-up|4|||
49015623|NCT01612000|157893882|FG002|Overall Study|Lost to Follow-up|4|||
49015624|NCT01612000|157893883|FG003|Overall Study|Lost to Follow-up|8|||
49015625|NCT01612000|157893880|FG000|Overall Study|Physician Decision|0|||
49015626|NCT01612000|157893881|FG001|Overall Study|Physician Decision|0|||
48980382|NCT00102804|157758999|FG000|Overall Study|Sponsor Decision|1|||
48980383|NCT00102804|157759000|FG001|Overall Study|Sponsor Decision|0|||
48980384|NCT00102804|157758999|FG000|Overall Study|Alive, Receiving Treatment|7|||
48980385|NCT00102804|157759000|FG001|Overall Study|Alive, Receiving Treatment|2|||
48980386|NCT03954704|157759001|FG000|Overall Study|Death|1|||
48980387|NCT03954704|157759002|FG001|Overall Study|Death|1|||
48980388|NCT03954704|157759003|FG002|Overall Study|Death|1|||
48980389|NCT03954704|157759004|FG003|Overall Study|Death|3|||
48980390|NCT03954704|157759005|FG004|Overall Study|Death|2|||
48980391|NCT03954704|157759006|FG005|Overall Study|Death|2|||
48980392|NCT03954704|157759007|FG006|Overall Study|Death|0|||
48980393|NCT03954704|157759001|FG000|Overall Study|Withdrew Consent|0|||
48980394|NCT03954704|157759002|FG001|Overall Study|Withdrew Consent|0|||
48980395|NCT03954704|157759003|FG002|Overall Study|Withdrew Consent|1|||
48980396|NCT03954704|157759004|FG003|Overall Study|Withdrew Consent|0|||
48980397|NCT03954704|157759005|FG004|Overall Study|Withdrew Consent|0|||
48980398|NCT03954704|157759006|FG005|Overall Study|Withdrew Consent|1|||
48980399|NCT03954704|157759007|FG006|Overall Study|Withdrew Consent|0|||
48980400|NCT03954704|157759001|FG000|Overall Study|Lost to Follow-up|0|||
48980401|NCT03954704|157759002|FG001|Overall Study|Lost to Follow-up|0|||
48980402|NCT03954704|157759003|FG002|Overall Study|Lost to Follow-up|0|||
48980403|NCT03954704|157759004|FG003|Overall Study|Lost to Follow-up|0|||
48980404|NCT03954704|157759005|FG004|Overall Study|Lost to Follow-up|0|||
48980405|NCT03954704|157759006|FG005|Overall Study|Lost to Follow-up|0|||
48980406|NCT03954704|157759007|FG006|Overall Study|Lost to Follow-up|1|||
48980407|NCT03954704|157759001|FG000|Overall Study|Study Terminated by Sponsor|0|||
48980408|NCT03954704|157759002|FG001|Overall Study|Study Terminated by Sponsor|0|||
48980409|NCT03954704|157759003|FG002|Overall Study|Study Terminated by Sponsor|1|||
48980410|NCT03954704|157759004|FG003|Overall Study|Study Terminated by Sponsor|0|||
48980411|NCT03954704|157759005|FG004|Overall Study|Study Terminated by Sponsor|1|||
48980412|NCT03954704|157759006|FG005|Overall Study|Study Terminated by Sponsor|4|||
48980413|NCT03954704|157759007|FG006|Overall Study|Study Terminated by Sponsor|2|||
48980414|NCT03954704|157759001|FG000|Overall Study|Enrolled but not Treated|0|||
48980415|NCT03954704|157759002|FG001|Overall Study|Enrolled but not Treated|0|||
48980416|NCT03954704|157759003|FG002|Overall Study|Enrolled but not Treated|0|||
48980417|NCT03954704|157759004|FG003|Overall Study|Enrolled but not Treated|0|||
48980418|NCT03954704|157759005|FG004|Overall Study|Enrolled but not Treated|0|||
48980419|NCT03954704|157759006|FG005|Overall Study|Enrolled but not Treated|1|||
48980420|NCT03954704|157759007|FG006|Overall Study|Enrolled but not Treated|0|||
48980421|NCT02038790|157760340|FG000|Day 0 - First Treatment|Withdrawal by Subject|1|||
48980422|NCT02038790|157760341|FG001|Day 0 - First Treatment|Withdrawal by Subject|1|||
48980423|NCT00948194|157760342|FG000|Overall Study|Blood drawn using incorrect test tube; sample invalid|1|||
48980424|NCT00948194|157760343|FG001|Overall Study|Blood drawn using incorrect test tube; sample invalid|0|||
48980425|NCT00634751|157760345|FG000|Phase I: 200mg Sorafenib+2DOC|Death|1|||
48980426|NCT00634751|157760346|FG001|Phase I: 200mg Sorafenib+2DOC|Death|0|||
48980427|NCT00634751|157760347|FG002|Phase I: 200mg Sorafenib+2DOC|Death|0|||
48980428|NCT00634751|157760348|FG003|Phase I: 200mg Sorafenib+2DOC|Death|0|||
48980429|NCT00634751|157760345|FG000|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
48980430|NCT00634751|157760346|FG001|Phase I: 400mg Sorafenib BID+2DOC|Death|1|||
48980431|NCT00634751|157760347|FG002|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
48980432|NCT00634751|157760348|FG003|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
48980433|NCT00634751|157760345|FG000|Pancreatic and Bilial Tract Cancer|Death|0|||
48980434|NCT00634751|157760346|FG001|Pancreatic and Bilial Tract Cancer|Death|0|||
48980435|NCT00634751|157760347|FG002|Pancreatic and Bilial Tract Cancer|Death|1|||
48980436|NCT00634751|157760348|FG003|Pancreatic and Bilial Tract Cancer|Death|1|||
48980437|NCT04402385|157760351|FG000|Overall Study|Withdrawal by Subject|4|||
48980438|NCT04402385|157760352|FG001|Overall Study|Withdrawal by Subject|4|||
48980439|NCT04402385|157760351|FG000|Overall Study|Lost to Follow-up|1|||
48980440|NCT04402385|157760352|FG001|Overall Study|Lost to Follow-up|1|||
48980441|NCT04402385|157760351|FG000|Overall Study|Physician Decision|0|||
48980442|NCT04402385|157760352|FG001|Overall Study|Physician Decision|1|||
48980443|NCT00402285|157760353|FG000|Overall Study|insufficient RNA quality|7|||
48980444|NCT00402285|157760354|FG001|Overall Study|insufficient RNA quality|6|||
48980445|NCT00402285|157760355|FG002|Overall Study|insufficient RNA quality|2|||
48980446|NCT00233324|157760358|FG000|Main Study|Death|68|||
48980447|NCT00233324|157760359|FG001|Main Study|Death|60|||
48980448|NCT00233324|157760360|FG002|Main Study|Death|62|||
48980449|NCT00233324|157760361|FG003|Main Study|Death|47|||
48980450|NCT00233324|157760358|FG000|Follow up at 18-22 Months Corrected Age|Death|5|||
48980451|NCT00233324|157760359|FG001|Follow up at 18-22 Months Corrected Age|Death|7|||
48980452|NCT00233324|157760360|FG002|Follow up at 18-22 Months Corrected Age|Death|5|||
48980453|NCT00233324|157760361|FG003|Follow up at 18-22 Months Corrected Age|Death|4|||
48980454|NCT00233324|157760358|FG000|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8|||
48980455|NCT00233324|157760359|FG001|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
48980456|NCT00233324|157760360|FG002|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13|||
48980457|NCT00233324|157760361|FG003|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
48980458|NCT00405275|157760362|FG000|Overall Study|Death|1|||
48980459|NCT00405275|157760363|FG001|Overall Study|Death|0|||
48980460|NCT00405275|157760362|FG000|Overall Study|Lost to Follow-up|5|||
48980461|NCT00405275|157760363|FG001|Overall Study|Lost to Follow-up|1|||
48980462|NCT00405275|157760362|FG000|Overall Study|Withdrawal by Subject|7|||
48980463|NCT00405275|157760363|FG001|Overall Study|Withdrawal by Subject|9|||
48980464|NCT00405275|157760362|FG000|Overall Study|Unwilling to continue|10|||
48980465|NCT00405275|157760363|FG001|Overall Study|Unwilling to continue|9|||
48980466|NCT01675141|157760371|FG000|Overall Study|Lenalidomide outside NIH|3|||
48980467|NCT01675141|157760371|FG000|Overall Study|Withdrawal by Subject|3|||
48980468|NCT01675141|157760371|FG000|Overall Study|Physician Decision|4|||
48980469|NCT01675141|157760371|FG000|Overall Study|No treatment, per protocol|1|||
48980470|NCT02723019|157760376|FG000|Overall Study|Death|17|||
48980471|NCT02723019|157760377|FG001|Overall Study|Death|13|||
48980472|NCT02723019|157760376|FG000|Overall Study|Withdrawal by Subject|11|||
48980473|NCT02723019|157760377|FG001|Overall Study|Withdrawal by Subject|7|||
48980474|NCT02723019|157760376|FG000|Overall Study|Lost to Follow-up|57|||
48980475|NCT02723019|157760377|FG001|Overall Study|Lost to Follow-up|70|||
48980476|NCT02756845|157760378|FG000|Overall Study|Death|12|||
48980477|NCT02756845|157760379|FG001|Overall Study|Death|2|||
48980478|NCT02756845|157760378|FG000|Overall Study|Withdrawal by Subject|1|||
48980479|NCT02756845|157760379|FG001|Overall Study|Withdrawal by Subject|0|||
48980480|NCT00498368|157760380|FG000|Overall Study|Withdrawal by Subject|3|||
48980481|NCT00498368|157760381|FG001|Overall Study|Withdrawal by Subject|2|||
48980482|NCT02736929|157760382|FG000|Main Study|Lost to Follow-up|7|||
48980483|NCT02736929|157760383|FG001|Main Study|Lost to Follow-up|1|||
48980484|NCT02736929|157760384|FG002|Main Study|Lost to Follow-up|0|||
48980485|NCT02736929|157760382|FG000|Main Study|Withdrawal by Subject|1|||
48980486|NCT02736929|157760383|FG001|Main Study|Withdrawal by Subject|1|||
48980487|NCT02736929|157760384|FG002|Main Study|Withdrawal by Subject|0|||
48980488|NCT02736929|157760382|FG000|Optional Cross-Over|Withdrawal by Subject|0|||
48980489|NCT02736929|157760383|FG001|Optional Cross-Over|Withdrawal by Subject|0|||
48980490|NCT02736929|157760384|FG002|Optional Cross-Over|Withdrawal by Subject|6|||
48980491|NCT00285649|157760385|FG000|Overall Study|Lost to Follow-up|6|||
48980492|NCT00285649|157760386|FG001|Overall Study|Lost to Follow-up|4|||
48980493|NCT00285649|157760387|FG002|Overall Study|Lost to Follow-up|4|||
48980494|NCT00285649|157760385|FG000|Overall Study|Withdrawal by Subject|3|||
48980495|NCT00285649|157760386|FG001|Overall Study|Withdrawal by Subject|2|||
48980496|NCT00285649|157760387|FG002|Overall Study|Withdrawal by Subject|2|||
48980497|NCT02972593|157760388|FG000|Overall Study|Lost to Follow-up|19|||
48980498|NCT02972593|157760389|FG001|Overall Study|Lost to Follow-up|15|||
48762167|NCT02608268|156978017|FG010|Overall Study|Progressive disease|5|||
48762168|NCT02608268|156978018|FG011|Overall Study|Progressive disease|5|||
48762169|NCT02608268|156978019|FG012|Overall Study|Progressive disease|4|||
48980499|NCT02972593|157760388|FG000|Overall Study|Protocol Violation|1|||
48980500|NCT02972593|157760389|FG001|Overall Study|Protocol Violation|0|||
48980501|NCT01818765|157760393|FG000|Overall Study|Death|2|||
48980502|NCT01347073|157760395|FG000|Overall Study|Adverse Event|1|||
48980503|NCT01347073|157760395|FG000|Overall Study|Liver Transplant|1|||
48980504|NCT02865928|157760400|FG000|Overall Study|Withdrawal by Subject|1|||
48980505|NCT02865928|157760401|FG001|Overall Study|Withdrawal by Subject|0|||
48980506|NCT02865928|157760400|FG000|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|1|||
48980507|NCT02865928|157760401|FG001|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|0|||
48980508|NCT02865928|157760400|FG000|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
48980509|NCT02865928|157760401|FG001|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
48980510|NCT01487863|157760404|FG000|Overall Study|Death|19|||
48980511|NCT01487863|157760405|FG001|Overall Study|Death|19|||
48980512|NCT04259346|157760406|FG000|Overall Study|Lost to Follow-up|1|||
48980513|NCT04259346|157760407|FG001|Overall Study|Lost to Follow-up|3|||
48980514|NCT04259346|157760406|FG000|Overall Study|Protocol Violation|1|||
48980515|NCT04259346|157760407|FG001|Overall Study|Protocol Violation|0|||
48980516|NCT04259346|157760406|FG000|Overall Study|Withdrawal by Subject|1|||
48980517|NCT04259346|157760407|FG001|Overall Study|Withdrawal by Subject|0|||
48980518|NCT04259346|157760406|FG000|Overall Study|Adverse Event|1|||
48980519|NCT04259346|157760407|FG001|Overall Study|Adverse Event|1|||
48980520|NCT00893763|157760409|FG000|Overall Study|extubated|110|||
48980521|NCT00893763|157760410|FG001|Overall Study|extubated|110|||
48980522|NCT02159365|157760411|FG000|Overall Study|Disease Progression|23|||
48980523|NCT02159365|157760411|FG000|Overall Study|Other reasons|11|||
48762170|NCT02608268|156978020|FG013|Overall Study|Progressive disease|11|||
48980524|NCT02159365|157760411|FG000|Overall Study|Administrative reason by Sponsor|9|||
48980525|NCT02159365|157760411|FG000|Overall Study|Adverse Event unrelated to study drug|9|||
48980526|NCT02159365|157760411|FG000|Overall Study|Study drug toxicity|7|||
48980527|NCT02159365|157760411|FG000|Overall Study|Maximum clinical benefit|3|||
48762171|NCT02608268|156978021|FG014|Overall Study|Progressive disease|6|||
48980528|NCT02159365|157760411|FG000|Overall Study|Subject request to discontinue treatment|3|||
48980529|NCT02159365|157760411|FG000|Overall Study|Subject withdrew consent|3|||
48980530|NCT02159365|157760411|FG000|Overall Study|Death|1|||
48980531|NCT02159365|157760411|FG000|Overall Study|Lost to Follow-up|1|||
48980532|NCT03198728|157760412|FG000|Overall Study|Adverse Event|10|||
48980533|NCT03198728|157760413|FG001|Overall Study|Adverse Event|5|||
48980534|NCT03198728|157760412|FG000|Overall Study|Lost to Follow-up|21|||
48980535|NCT03198728|157760413|FG001|Overall Study|Lost to Follow-up|7|||
48980536|NCT03198728|157760412|FG000|Overall Study|Physician Decision|7|||
48980537|NCT03198728|157760413|FG001|Overall Study|Physician Decision|2|||
48980538|NCT03198728|157760412|FG000|Overall Study|Withdrawal by Subject|14|||
48980539|NCT03198728|157760413|FG001|Overall Study|Withdrawal by Subject|10|||
48980540|NCT01594411|157760414|FG000|Overall Study|Lost to Follow-up|2|||
48980541|NCT00796549|157760419|FG000|Overall Study|Adverse Event|11|||
48980542|NCT00796549|157760419|FG000|Overall Study|not entered|149|||
48980543|NCT00796549|157760419|FG000|Overall Study|Other|2|||
48980544|NCT00796549|157760419|FG000|Overall Study|Progressive disease|56|||
48980545|NCT01878175|157760420|FG000|Overall Study|Developed contraindicated health problem|2|||
48980546|NCT00952588|157760421|FG000|Overall Study|Death|28|||
48980547|NCT00952588|157760422|FG001|Overall Study|Death|13|||
49015627|NCT01612000|157893882|FG002|Overall Study|Physician Decision|1|||
49015628|NCT01612000|157893883|FG003|Overall Study|Physician Decision|0|||
49015629|NCT01612000|157893880|FG000|Overall Study|Withdrawal by Subject|3|||
49015630|NCT01612000|157893881|FG001|Overall Study|Withdrawal by Subject|1|||
49015631|NCT01612000|157893882|FG002|Overall Study|Withdrawal by Subject|2|||
49015632|NCT01612000|157893883|FG003|Overall Study|Withdrawal by Subject|2|||
49015633|NCT00419926|157893884|FG000|Overall Study|Withdrawal by Subject|7|||
48676299|NCT04405076|156667260|FG000|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
48676300|NCT04405076|156667261|FG001|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
48676301|NCT04405076|156667262|FG002|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
48676302|NCT04405076|156667263|FG003|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
48676303|NCT04405076|156667264|FG004|Part B (Open-Label Interventional Phase)|Physician Decision|1|||
48676304|NCT04405076|156667265|FG005|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
48676305|NCT04405076|156667266|FG006|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
48676306|NCT04405076|156667267|FG007|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
48676307|NCT04405076|156667268|FG008|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
48676308|NCT04405076|156667260|FG000|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
49015634|NCT00419926|157893885|FG001|Overall Study|Withdrawal by Subject|3|||
49015635|NCT00419926|157893884|FG000|Overall Study|Administrative Problem|4|||
49015636|NCT00419926|157893885|FG001|Overall Study|Administrative Problem|4|||
49015637|NCT00419926|157893884|FG000|Overall Study|Lost to Follow-up|1|||
49015638|NCT00419926|157893885|FG001|Overall Study|Lost to Follow-up|2|||
49015639|NCT00419926|157893884|FG000|Overall Study|Death|2|||
49015640|NCT00419926|157893885|FG001|Overall Study|Death|1|||
49015641|NCT02354586|157893887|FG000|Overall Study|Death|230|||
49015642|NCT02354586|157893887|FG000|Overall Study|Withdrawal by Subject|59|||
49015643|NCT02354586|157893887|FG000|Overall Study|Lost to Follow-up|11|||
49015644|NCT02354586|157893887|FG000|Overall Study|Sponsor decision|51|||
49015645|NCT02354586|157893887|FG000|Overall Study|Site closure|2|||
49015646|NCT02354586|157893887|FG000|Overall Study|Intercurrent illness|1|||
49015647|NCT02354586|157893887|FG000|Overall Study|Protocol Violation|3|||
49015648|NCT02354586|157893887|FG000|Overall Study|Physician Decision|13|||
49015649|NCT02354586|157893887|FG000|Overall Study|Lack of Efficacy|86|||
49015650|NCT02354586|157893887|FG000|Overall Study|Adverse Event|7|||
49015651|NCT03870997|157893889|FG000|Overall Study|Did not complete mid-study/final survey|10544|||
49015652|NCT03870997|157893890|FG001|Overall Study|Did not complete mid-study/final survey|10431|||
49015653|NCT03870997|157893891|FG002|Overall Study|Did not complete mid-study/final survey|10978|||
48874430|NCT02980705|157377025|FG000|Overall Study|Adverse Event|0|||
49015654|NCT03870997|157893892|FG003|Overall Study|Did not complete mid-study/final survey|10947|||
49015655|NCT03870997|157893893|FG004|Overall Study|Did not complete mid-study/final survey|10588|||
49015656|NCT03870997|157893894|FG005|Overall Study|Did not complete mid-study/final survey|10531|||
49015657|NCT02419313|157893895|FG000|First Intervention|Lost to Follow-up|2|||
49015658|NCT02419313|157893896|FG001|First Intervention|Lost to Follow-up|0|||
49015659|NCT02419313|157893895|FG000|Second Intervention|Lost to Follow-up|1|||
49015660|NCT02419313|157893896|FG001|Second Intervention|Lost to Follow-up|0|||
49015661|NCT01338636|157893897|FG000|Overall Study|Withdrawn due to lack of improvement|8|||
49015662|NCT03567057|157893899|FG000|Overall Study|Adverse Event|56|||
49015663|NCT03567057|157893900|FG001|Overall Study|Adverse Event|53|||
49015664|NCT03567057|157893901|FG002|Overall Study|Adverse Event|28|||
49015665|NCT03567057|157893899|FG000|Overall Study|Withdrawal by Subject|22|||
49015666|NCT03567057|157893900|FG001|Overall Study|Withdrawal by Subject|24|||
49015667|NCT03567057|157893901|FG002|Overall Study|Withdrawal by Subject|13|||
48762172|NCT02608268|156978022|FG015|Overall Study|Progressive disease|3|||
48980548|NCT00952588|157760421|FG000|Overall Study|Withdrawal by Subject|2|||
48980549|NCT00952588|157760422|FG001|Overall Study|Withdrawal by Subject|5|||
48980550|NCT00952588|157760421|FG000|Overall Study|Adverse Event|2|||
49015668|NCT03567057|157893899|FG000|Overall Study|Lost to Follow-up|3|||
49015669|NCT03567057|157893900|FG001|Overall Study|Lost to Follow-up|5|||
49015670|NCT03567057|157893901|FG002|Overall Study|Lost to Follow-up|2|||
49015671|NCT03567057|157893899|FG000|Overall Study|COVID-19 pandemic|4|||
49015672|NCT03567057|157893900|FG001|Overall Study|COVID-19 pandemic|3|||
49015673|NCT03567057|157893901|FG002|Overall Study|COVID-19 pandemic|0|||
49015674|NCT03567057|157893899|FG000|Overall Study|Non-compliance with study drug|4|||
49015675|NCT03567057|157893900|FG001|Overall Study|Non-compliance with study drug|2|||
49015676|NCT03567057|157893901|FG002|Overall Study|Non-compliance with study drug|0|||
49015677|NCT03567057|157893899|FG000|Overall Study|Lack of Efficacy|3|||
49015678|NCT03567057|157893900|FG001|Overall Study|Lack of Efficacy|0|||
49015679|NCT03567057|157893901|FG002|Overall Study|Lack of Efficacy|1|||
49015680|NCT03567057|157893899|FG000|Overall Study|Death|1|||
49015681|NCT03567057|157893900|FG001|Overall Study|Death|0|||
49015682|NCT03567057|157893901|FG002|Overall Study|Death|0|||
49015683|NCT03567057|157893899|FG000|Overall Study|Physician Decision|1|||
49015684|NCT03567057|157893900|FG001|Overall Study|Physician Decision|0|||
49015685|NCT03567057|157893901|FG002|Overall Study|Physician Decision|0|||
49015686|NCT03567057|157893899|FG000|Overall Study|Unstable medical condition|1|||
49015687|NCT03567057|157893900|FG001|Overall Study|Unstable medical condition|0|||
49015688|NCT03567057|157893901|FG002|Overall Study|Unstable medical condition|0|||
49015689|NCT03567057|157893899|FG000|Overall Study|Medical history event|0|||
49015690|NCT03567057|157893900|FG001|Overall Study|Medical history event|0|||
49015691|NCT03567057|157893901|FG002|Overall Study|Medical history event|1|||
49015692|NCT03567057|157893899|FG000|Overall Study|Other|0|||
49015693|NCT03567057|157893900|FG001|Overall Study|Other|0|||
49015694|NCT03567057|157893901|FG002|Overall Study|Other|1|||
49015695|NCT01006707|157893902|FG000|Study Session 1|Lost to Follow-up|2|||
49015696|NCT01006707|157893903|FG001|Study Session 1|Lost to Follow-up|0|||
49015697|NCT01006707|157893904|FG002|Study Session 1|Lost to Follow-up|0|||
49015698|NCT01006707|157893902|FG000|Study Session 1|Could not tolerate withdrawal in scanner|3|||
49015699|NCT01006707|157893903|FG001|Study Session 1|Could not tolerate withdrawal in scanner|0|||
49015700|NCT01006707|157893904|FG002|Study Session 1|Could not tolerate withdrawal in scanner|0|||
49015701|NCT01507896|157893905|FG000|Overall Study|Withdrawal by Subject|1|||
49015702|NCT01507896|157893905|FG000|Overall Study|The surgery was denied by the sponsor.|1|||
49015703|NCT02985151|157893906|FG000|Original Randomization|Withdrawal by Subject|0|||
49015704|NCT02985151|157893907|FG001|Original Randomization|Withdrawal by Subject|1|||
49015705|NCT00886483|157893910|FG000|Overall Study|Lost to Follow-up|0|||
49015706|NCT00886483|157893911|FG001|Overall Study|Lost to Follow-up|1|||
49015707|NCT00886483|157893910|FG000|Overall Study|Pursue medications|1|||
49015708|NCT00886483|157893911|FG001|Overall Study|Pursue medications|2|||
49015709|NCT00886483|157893910|FG000|Overall Study|Distance to center, poor grades|1|||
49015710|NCT00886483|157893911|FG001|Overall Study|Distance to center, poor grades|0|||
49015711|NCT00760383|157893912|FG000|Overall Study|moved away; withdrew; medical reasons|5|||
49015712|NCT00760383|157893913|FG001|Overall Study|moved away; withdrew; medical reasons|7|||
49015713|NCT01821625|157893915|FG000|Overall Study|Withdrawal by Subject|2|||
49015714|NCT01821625|157893915|FG000|Overall Study|Lack of Efficacy|2|||
49015715|NCT01821625|157893915|FG000|Overall Study|Adverse Event|1|||
49015716|NCT01821625|157893915|FG000|Overall Study|Medical contraindication|1|||
48676309|NCT04405076|156667261|FG001|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
48676310|NCT04405076|156667262|FG002|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
48676311|NCT04405076|156667263|FG003|Part B (Open-Label Interventional Phase)|Lost to Follow-up|6|||
49015717|NCT02015793|157893918|FG000|Overall Study|Adverse Event|3|||
49015718|NCT02015793|157893919|FG001|Overall Study|Adverse Event|3|||
49015719|NCT02015793|157893918|FG000|Overall Study|Withdrawal by Subject|1|||
49015720|NCT02015793|157893919|FG001|Overall Study|Withdrawal by Subject|1|||
49015721|NCT00686036|157893920|FG000|Overall Study|Adverse Event|3|||
49015722|NCT00686036|157893921|FG001|Overall Study|Adverse Event|0|||
49015723|NCT00686036|157893920|FG000|Overall Study|Withdrawal by Subject|3|||
49015724|NCT00686036|157893921|FG001|Overall Study|Withdrawal by Subject|1|||
49015725|NCT00686036|157893920|FG000|Overall Study|Study terminated by AstraZeneca|2|||
49015726|NCT00686036|157893921|FG001|Overall Study|Study terminated by AstraZeneca|1|||
49015727|NCT00686036|157893920|FG000|Overall Study|PSA ≥ 10ng/mL|1|||
48676312|NCT04405076|156667264|FG004|Part B (Open-Label Interventional Phase)|Lost to Follow-up|3|||
49015728|NCT00686036|157893921|FG001|Overall Study|PSA ≥ 10ng/mL|0|||
49015729|NCT00686036|157893920|FG000|Overall Study|Other reasons not identified|0|||
49015730|NCT00686036|157893921|FG001|Overall Study|Other reasons not identified|4|||
48676313|NCT04405076|156667265|FG005|Part B (Open-Label Interventional Phase)|Lost to Follow-up|2|||
48676314|NCT04405076|156667266|FG006|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
48676315|NCT04405076|156667267|FG007|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
48676316|NCT04405076|156667268|FG008|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
48676317|NCT04405076|156667260|FG000|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
49015731|NCT00753714|157893923|FG000|Overall Study|Lack of Efficacy|21|||
49015732|NCT00753714|157893924|FG001|Overall Study|Lack of Efficacy|34|||
49015733|NCT00753714|157893923|FG000|Overall Study|Adverse Event|26|||
49015734|NCT00753714|157893924|FG001|Overall Study|Adverse Event|18|||
49015735|NCT00753714|157893923|FG000|Overall Study|Protocol Violation|1|||
49015736|NCT00753714|157893924|FG001|Overall Study|Protocol Violation|0|||
49015737|NCT00753714|157893923|FG000|Overall Study|Lost to Follow-up|0|||
49015738|NCT00753714|157893924|FG001|Overall Study|Lost to Follow-up|1|||
48874431|NCT02980705|157377026|FG001|Overall Study|Adverse Event|1|||
48874432|NCT02980705|157377025|FG000|Overall Study|Withdrawal by Subject|6|||
48874433|NCT02980705|157377026|FG001|Overall Study|Withdrawal by Subject|9|||
48874434|NCT02980705|157377025|FG000|Overall Study|withdrew participation|0|||
48874435|NCT02980705|157377026|FG001|Overall Study|withdrew participation|1|||
48874436|NCT02980705|157377025|FG000|Overall Study|Lost to Follow-up|2|||
48874437|NCT02980705|157377026|FG001|Overall Study|Lost to Follow-up|0|||
48874438|NCT03599622|157377027|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
48874439|NCT03599622|157377028|FG001|Pre-Treatment Period|Withdrawal by Subject|1|||
48874440|NCT03599622|157377029|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
48874441|NCT03599622|157377030|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
48874442|NCT03599622|157377027|FG000|Pre-Treatment Period|Other reasons|1|||
48874443|NCT03599622|157377028|FG001|Pre-Treatment Period|Other reasons|1|||
48874444|NCT03599622|157377029|FG002|Pre-Treatment Period|Other reasons|1|||
48874445|NCT03599622|157377030|FG003|Pre-Treatment Period|Other reasons|0|||
48874446|NCT03599622|157377027|FG000|Treatment Period|Adverse Event|11|||
48874447|NCT03599622|157377028|FG001|Treatment Period|Adverse Event|20|||
48874448|NCT03599622|157377029|FG002|Treatment Period|Adverse Event|18|||
48874449|NCT03599622|157377030|FG003|Treatment Period|Adverse Event|2|||
48874450|NCT03599622|157377027|FG000|Treatment Period|Lack of Efficacy|18|||
48874451|NCT03599622|157377028|FG001|Treatment Period|Lack of Efficacy|12|||
48874452|NCT03599622|157377029|FG002|Treatment Period|Lack of Efficacy|13|||
48874453|NCT03599622|157377030|FG003|Treatment Period|Lack of Efficacy|2|||
48874454|NCT03599622|157377027|FG000|Treatment Period|Withdrawal by Subject|5|||
48874455|NCT03599622|157377028|FG001|Treatment Period|Withdrawal by Subject|11|||
48874456|NCT03599622|157377029|FG002|Treatment Period|Withdrawal by Subject|16|||
48874457|NCT03599622|157377030|FG003|Treatment Period|Withdrawal by Subject|1|||
48874458|NCT03599622|157377027|FG000|Treatment Period|Other reasons|4|||
48874459|NCT03599622|157377028|FG001|Treatment Period|Other reasons|6|||
48874460|NCT03599622|157377029|FG002|Treatment Period|Other reasons|7|||
48874461|NCT03599622|157377030|FG003|Treatment Period|Other reasons|0|||
48874462|NCT03599622|157377027|FG000|Treatment Period|Lost to Follow-up|1|||
48874463|NCT03599622|157377028|FG001|Treatment Period|Lost to Follow-up|0|||
48874464|NCT03599622|157377029|FG002|Treatment Period|Lost to Follow-up|0|||
48874465|NCT03599622|157377030|FG003|Treatment Period|Lost to Follow-up|0|||
48874466|NCT03599622|157377027|FG000|Treatment Period|Study terminated by sponsor|7|||
48874467|NCT03599622|157377028|FG001|Treatment Period|Study terminated by sponsor|20|||
48874468|NCT03599622|157377029|FG002|Treatment Period|Study terminated by sponsor|15|||
48874469|NCT03599622|157377030|FG003|Treatment Period|Study terminated by sponsor|0|||
48874470|NCT03599622|157377027|FG000|Treatment Period|Site terminated by sponsor|0|||
48874471|NCT03599622|157377028|FG001|Treatment Period|Site terminated by sponsor|1|||
48874472|NCT03599622|157377029|FG002|Treatment Period|Site terminated by sponsor|0|||
48874473|NCT03599622|157377030|FG003|Treatment Period|Site terminated by sponsor|0|||
48874474|NCT00665223|157377032|FG000|Randomized Phase (26 Weeks)|Adverse Event|13|||
48874475|NCT00665223|157377033|FG001|Randomized Phase (26 Weeks)|Adverse Event|9|||
48874476|NCT00665223|157377034|FG002|Randomized Phase (26 Weeks)|Adverse Event|15|||
48874477|NCT00665223|157377032|FG000|Randomized Phase (26 Weeks)|Death|0|||
48874478|NCT00665223|157377033|FG001|Randomized Phase (26 Weeks)|Death|0|||
48874479|NCT00665223|157377034|FG002|Randomized Phase (26 Weeks)|Death|1|||
48874480|NCT00665223|157377032|FG000|Randomized Phase (26 Weeks)|Withdrawal by Subject|5|||
48874481|NCT00665223|157377033|FG001|Randomized Phase (26 Weeks)|Withdrawal by Subject|2|||
48874482|NCT00665223|157377034|FG002|Randomized Phase (26 Weeks)|Withdrawal by Subject|3|||
48874483|NCT00665223|157377032|FG000|Randomized Phase (26 Weeks)|Protocol Violation|0|||
49015739|NCT00753714|157893923|FG000|Overall Study|Withdrawal by Subject|2|||
49015740|NCT00753714|157893924|FG001|Overall Study|Withdrawal by Subject|1|||
49015741|NCT00753714|157893923|FG000|Overall Study|Death|3|||
49015742|NCT00753714|157893924|FG001|Overall Study|Death|3|||
49015743|NCT00753714|157893923|FG000|Overall Study|Other|7|||
49015744|NCT00753714|157893924|FG001|Overall Study|Other|5|||
48874484|NCT00665223|157377033|FG001|Randomized Phase (26 Weeks)|Protocol Violation|1|||
48874485|NCT00665223|157377034|FG002|Randomized Phase (26 Weeks)|Protocol Violation|1|||
48874486|NCT00665223|157377032|FG000|Randomized Phase (26 Weeks)|Other than specified|0|||
49015745|NCT01868009|157893929|FG000|Period 1 (5-9 Days)|Adverse Event|0|||
49015746|NCT01868009|157893930|FG001|Period 1 (5-9 Days)|Adverse Event|2|||
48874487|NCT00665223|157377033|FG001|Randomized Phase (26 Weeks)|Other than specified|0|||
48874488|NCT00665223|157377034|FG002|Randomized Phase (26 Weeks)|Other than specified|1|||
49015747|NCT01868009|157893929|FG000|Period 2 (5-9 Days)|Adverse Event|1|||
49015748|NCT01868009|157893930|FG001|Period 2 (5-9 Days)|Adverse Event|0|||
49015749|NCT01868009|157893929|FG000|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1|||
48762173|NCT02608268|156978023|FG016|Overall Study|Progressive disease|5|||
48874489|NCT00665223|157377032|FG000|Open-Label Period (26 Weeks)|Adverse Event|8|||
48874490|NCT00665223|157377033|FG001|Open-Label Period (26 Weeks)|Adverse Event|11|||
49015750|NCT01868009|157893930|FG001|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0|||
49015751|NCT02669264|157893931|FG000|Overall Study|Death|5|||
49015752|NCT02669264|157893932|FG001|Overall Study|Death|5|||
49015753|NCT02669264|157893933|FG002|Overall Study|Death|3|||
49015754|NCT02669264|157893934|FG003|Overall Study|Death|3|||
49015755|NCT02669264|157893935|FG004|Overall Study|Death|3|||
49015756|NCT02669264|157893936|FG005|Overall Study|Death|6|||
49015757|NCT02669264|157893937|FG006|Overall Study|Death|3|||
49015758|NCT02669264|157893931|FG000|Overall Study|Withdrawal by Subject|0|||
49015759|NCT02669264|157893932|FG001|Overall Study|Withdrawal by Subject|1|||
49015760|NCT02669264|157893933|FG002|Overall Study|Withdrawal by Subject|0|||
49015761|NCT02669264|157893934|FG003|Overall Study|Withdrawal by Subject|0|||
49015762|NCT02669264|157893935|FG004|Overall Study|Withdrawal by Subject|1|||
49015763|NCT02669264|157893936|FG005|Overall Study|Withdrawal by Subject|0|||
49015764|NCT02669264|157893937|FG006|Overall Study|Withdrawal by Subject|0|||
49015765|NCT02669264|157893931|FG000|Overall Study|Lost to Follow-up|0|||
49015766|NCT02669264|157893932|FG001|Overall Study|Lost to Follow-up|0|||
49015767|NCT02669264|157893933|FG002|Overall Study|Lost to Follow-up|0|||
49015768|NCT02669264|157893934|FG003|Overall Study|Lost to Follow-up|0|||
49015769|NCT02669264|157893935|FG004|Overall Study|Lost to Follow-up|1|||
49015770|NCT02669264|157893936|FG005|Overall Study|Lost to Follow-up|0|||
49015771|NCT02669264|157893937|FG006|Overall Study|Lost to Follow-up|0|||
49015772|NCT02669264|157893931|FG000|Overall Study|Miscellaneous|0|||
49015773|NCT02669264|157893932|FG001|Overall Study|Miscellaneous|0|||
49015774|NCT02669264|157893933|FG002|Overall Study|Miscellaneous|0|||
49015775|NCT02669264|157893934|FG003|Overall Study|Miscellaneous|0|||
49015776|NCT02669264|157893935|FG004|Overall Study|Miscellaneous|0|||
49015777|NCT02669264|157893936|FG005|Overall Study|Miscellaneous|0|||
49015778|NCT02669264|157893937|FG006|Overall Study|Miscellaneous|2|||
49015779|NCT01361126|157893938|FG000|Overall Study|Sponsor decision|0|||
49015780|NCT01361126|157893939|FG001|Overall Study|Sponsor decision|2|||
49015781|NCT03529955|157893940|FG000|Overall Study|Adverse Event|1|||
49015782|NCT03529955|157893940|FG000|Overall Study|Lack of Efficacy|1|||
49015783|NCT02199509|157893941|FG000|Overall Study|Suicidal Ideation|0|||
49015784|NCT02199509|157893942|FG001|Overall Study|Suicidal Ideation|1|||
49015785|NCT02199509|157893941|FG000|Overall Study|Misunderstood titration schedule|1|||
49015786|NCT02199509|157893942|FG001|Overall Study|Misunderstood titration schedule|0|||
49015787|NCT03384745|157893943|FG000|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
49015788|NCT03384745|157893944|FG001|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
49015789|NCT03384745|157893945|FG002|Placebo Controlled Induction (W0 - W12)|Adverse Event|1|||
49015790|NCT03384745|157893946|FG003|Placebo Controlled Induction (W0 - W12)|Adverse Event|2|||
49015791|NCT03384745|157893947|FG004|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
49015792|NCT03384745|157893948|FG005|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
49015793|NCT03384745|157893943|FG000|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
49015794|NCT03384745|157893944|FG001|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
49015795|NCT03384745|157893945|FG002|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
49015796|NCT03384745|157893946|FG003|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
49015797|NCT03384745|157893947|FG004|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3|||
49015798|NCT03384745|157893948|FG005|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1|||
49015799|NCT03384745|157893943|FG000|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
49015800|NCT03384745|157893944|FG001|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
49015801|NCT03384745|157893945|FG002|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
49015802|NCT03384745|157893946|FG003|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
49015803|NCT03384745|157893947|FG004|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
48676318|NCT04405076|156667261|FG001|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
48676319|NCT04405076|156667262|FG002|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
48676320|NCT04405076|156667263|FG003|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
48676321|NCT04405076|156667264|FG004|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
48676322|NCT04405076|156667265|FG005|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
48676323|NCT04405076|156667266|FG006|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
48762174|NCT02608268|156978024|FG017|Overall Study|Progressive disease|5|||
49015804|NCT03384745|157893948|FG005|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
49015805|NCT03384745|157893943|FG000|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
49015806|NCT03384745|157893944|FG001|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
49015807|NCT03384745|157893945|FG002|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1|||
49015808|NCT03384745|157893946|FG003|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
49015809|NCT03384745|157893947|FG004|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
49015810|NCT03384745|157893948|FG005|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
49015811|NCT03384745|157893943|FG000|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
49015812|NCT03384745|157893944|FG001|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
49015813|NCT03384745|157893945|FG002|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
49015814|NCT03384745|157893946|FG003|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
49015815|NCT03384745|157893947|FG004|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
49015816|NCT03384745|157893948|FG005|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
49015817|NCT03384745|157893943|FG000|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
49015818|NCT03384745|157893944|FG001|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
49015819|NCT03384745|157893945|FG002|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
49015820|NCT03384745|157893946|FG003|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
49015821|NCT03384745|157893947|FG004|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1|||
49015822|NCT03384745|157893948|FG005|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
49015823|NCT03384745|157893943|FG000|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
49015824|NCT03384745|157893944|FG001|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
49015825|NCT03384745|157893945|FG002|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
49015826|NCT03384745|157893946|FG003|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
49015827|NCT03384745|157893947|FG004|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
49015828|NCT03384745|157893948|FG005|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
49015829|NCT03384745|157893943|FG000|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
49015830|NCT03384745|157893944|FG001|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
49015831|NCT03384745|157893945|FG002|Response Assess/Dose Hold (W24-W48)|Adverse Event|3|||
49015832|NCT03384745|157893946|FG003|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
49015833|NCT03384745|157893947|FG004|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
49015834|NCT03384745|157893948|FG005|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
49015835|NCT03384745|157893943|FG000|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
49015836|NCT03384745|157893944|FG001|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
49015837|NCT03384745|157893945|FG002|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
49015838|NCT03384745|157893946|FG003|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
49015839|NCT03384745|157893947|FG004|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
49015840|NCT03384745|157893948|FG005|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
49015841|NCT03384745|157893943|FG000|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
49015842|NCT03384745|157893944|FG001|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
49015843|NCT03384745|157893945|FG002|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
49015844|NCT03384745|157893946|FG003|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2|||
49015845|NCT03384745|157893947|FG004|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
49015846|NCT03384745|157893948|FG005|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
49015847|NCT03384745|157893943|FG000|Response Assess/Dose Hold (W24-W48)|Death|0|||
49015848|NCT03384745|157893944|FG001|Response Assess/Dose Hold (W24-W48)|Death|1|||
49015849|NCT03384745|157893945|FG002|Response Assess/Dose Hold (W24-W48)|Death|0|||
49015850|NCT03384745|157893946|FG003|Response Assess/Dose Hold (W24-W48)|Death|0|||
49015851|NCT03384745|157893947|FG004|Response Assess/Dose Hold (W24-W48)|Death|0|||
49015852|NCT03384745|157893948|FG005|Response Assess/Dose Hold (W24-W48)|Death|0|||
49015853|NCT01618305|157893950|FG000|Overall Study|Death|0|||
49015854|NCT01618305|157893951|FG001|Overall Study|Death|1|||
49015855|NCT01618305|157893950|FG000|Overall Study|Lost to Follow-up|11|||
49015856|NCT01618305|157893951|FG001|Overall Study|Lost to Follow-up|7|||
49015857|NCT01618305|157893950|FG000|Overall Study|Protocol Violation|1|||
49015858|NCT01618305|157893951|FG001|Overall Study|Protocol Violation|0|||
49015859|NCT01618305|157893950|FG000|Overall Study|Withdrawal by Subject|3|||
49015860|NCT01618305|157893951|FG001|Overall Study|Withdrawal by Subject|2|||
49015861|NCT01346410|157893956|FG000|Overall Study|Death|1|||
49015862|NCT02576990|157893957|FG000|Overall Study|Death|29|||
49015863|NCT02576990|157893958|FG001|Overall Study|Death|18|||
49015864|NCT02576990|157893957|FG000|Overall Study|Physician Decision|1|||
49015865|NCT02576990|157893958|FG001|Overall Study|Physician Decision|0|||
49015866|NCT02576990|157893957|FG000|Overall Study|Screen failure|2|||
49015867|NCT02576990|157893958|FG001|Overall Study|Screen failure|0|||
48676324|NCT04405076|156667267|FG007|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|2|||
48676325|NCT04405076|156667268|FG008|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|1|||
48676326|NCT04405076|156667260|FG000|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
48676327|NCT04405076|156667261|FG001|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
48676328|NCT04405076|156667262|FG002|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
48676329|NCT04405076|156667263|FG003|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
48676330|NCT04405076|156667264|FG004|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
48676331|NCT04405076|156667265|FG005|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
48676332|NCT04405076|156667266|FG006|Part C (Rollover Proof of Concept)|Lost to Follow-up|2|||
48676333|NCT04405076|156667267|FG007|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
48762175|NCT02608268|156978025|FG018|Overall Study|Progressive disease|5|||
49015868|NCT02576990|157893957|FG000|Overall Study|Sponsor's decision|24|||
49015869|NCT02576990|157893958|FG001|Overall Study|Sponsor's decision|4|||
49015870|NCT02576990|157893957|FG000|Overall Study|Withdrawal by Subject|0|||
49015871|NCT02576990|157893958|FG001|Overall Study|Withdrawal by Subject|2|||
49015872|NCT03118739|157893959|FG000|Overall Study|Physician Decision|0|||
49015873|NCT03118739|157893960|FG001|Overall Study|Physician Decision|1|||
48676334|NCT04405076|156667268|FG008|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
48676335|NCT00392990|156667271|FG000|Treatment on Study|Adverse Event|3|||
48676336|NCT00392990|156667272|FG001|Treatment on Study|Adverse Event|1|||
48676337|NCT00392990|156667271|FG000|Follow up for 2 Years|Death|4|||
48676338|NCT00392990|156667272|FG001|Follow up for 2 Years|Death|0|||
48676339|NCT04667104|156667273|FG000|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
48676340|NCT04667104|156667274|FG001|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
48676341|NCT04667104|156667275|FG002|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|1|||
48676342|NCT04186871|156667278|FG000|Overall Study|Lack of Efficacy|0|||
48676343|NCT04186871|156667279|FG001|Overall Study|Lack of Efficacy|1|||
48676344|NCT04186871|156667280|FG002|Overall Study|Lack of Efficacy|0|||
48676345|NCT04186871|156667281|FG003|Overall Study|Lack of Efficacy|0|||
48676346|NCT04186871|156667282|FG004|Overall Study|Lack of Efficacy|1|||
48676347|NCT04186871|156667283|FG005|Overall Study|Lack of Efficacy|1|||
48676348|NCT04186871|156667278|FG000|Overall Study|Adverse Event|1|||
48676349|NCT04186871|156667279|FG001|Overall Study|Adverse Event|1|||
48676350|NCT04186871|156667280|FG002|Overall Study|Adverse Event|0|||
48676351|NCT04186871|156667281|FG003|Overall Study|Adverse Event|0|||
48676352|NCT04186871|156667282|FG004|Overall Study|Adverse Event|0|||
48676353|NCT04186871|156667283|FG005|Overall Study|Adverse Event|2|||
48676354|NCT04186871|156667278|FG000|Overall Study|Study terminated by sponsor|1|||
48762176|NCT02608268|156978026|FG019|Overall Study|Progressive disease|2|||
48762177|NCT02608268|156978027|FG020|Overall Study|Progressive disease|10|||
48762178|NCT02608268|156978028|FG021|Overall Study|Progressive disease|4|||
48762179|NCT02608268|156978029|FG022|Overall Study|Progressive disease|5|||
48762180|NCT02608268|156978030|FG023|Overall Study|Progressive disease|5|||
48762181|NCT02608268|156978031|FG024|Overall Study|Progressive disease|3|||
48762182|NCT02608268|156978032|FG025|Overall Study|Progressive disease|11|||
48762183|NCT02608268|156978033|FG026|Overall Study|Progressive disease|16|||
48980551|NCT00952588|157760422|FG001|Overall Study|Adverse Event|3|||
48980552|NCT00952588|157760421|FG000|Overall Study|Lost to Follow-up|2|||
48980553|NCT00952588|157760422|FG001|Overall Study|Lost to Follow-up|0|||
48980554|NCT00952588|157760421|FG000|Overall Study|Physician Decision|0|||
48980555|NCT00952588|157760422|FG001|Overall Study|Physician Decision|1|||
48980556|NCT00952588|157760421|FG000|Overall Study|Lack of Efficacy|2|||
48980557|NCT00952588|157760422|FG001|Overall Study|Lack of Efficacy|2|||
48980558|NCT00606229|157760424|FG000|Overall Study|Adverse Event|11|||
48980559|NCT00606229|157760424|FG000|Overall Study|Lack of Efficacy|1|||
48980560|NCT00606229|157760424|FG000|Overall Study|Withdrawal by Subject|4|||
48980561|NCT00606229|157760424|FG000|Overall Study|does not meet inclusion criterion 1-3|4|||
48980562|NCT00606229|157760424|FG000|Overall Study|change of residence or other commitments|2|||
48980563|NCT03523715|157760425|FG000|Overall Study|Lost to Follow-up|11|||
48980564|NCT03523715|157760426|FG001|Overall Study|Lost to Follow-up|14|||
48980565|NCT03523715|157760425|FG000|Overall Study|Did not meet inclusion criteria|1|||
48980566|NCT03523715|157760426|FG001|Overall Study|Did not meet inclusion criteria|0|||
48980567|NCT03523715|157760425|FG000|Overall Study|Internally inconsistent reporting|0|||
48980568|NCT03523715|157760426|FG001|Overall Study|Internally inconsistent reporting|2|||
48980569|NCT03512275|157760427|FG000|Overall Study|Withdrawal by Subject|1|||
48980570|NCT03512275|157760428|FG001|Overall Study|Withdrawal by Subject|3|||
48980571|NCT03512275|157760427|FG000|Overall Study|Physician Decision|0|||
48980572|NCT03512275|157760428|FG001|Overall Study|Physician Decision|1|||
48980573|NCT03512275|157760427|FG000|Overall Study|Lost to Follow-up|0|||
48980574|NCT03512275|157760428|FG001|Overall Study|Lost to Follow-up|3|||
48980575|NCT03512275|157760427|FG000|Overall Study|Other|1|||
48980576|NCT03512275|157760428|FG001|Overall Study|Other|0|||
48980577|NCT04757376|157760429|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|8|||
48980578|NCT04757376|157760430|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|24|||
48980579|NCT04757376|157760431|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
48980580|NCT04757376|157760432|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
48980581|NCT04757376|157760433|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
48980582|NCT04757376|157760429|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|4|||
48980583|NCT04757376|157760430|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|5|||
48980584|NCT04757376|157760431|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
48980585|NCT04757376|157760432|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
48980586|NCT04757376|157760433|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
48980587|NCT04757376|157760429|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|5|||
48980588|NCT04757376|157760430|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|4|||
48980589|NCT04757376|157760431|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
48980590|NCT04757376|157760432|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
48676355|NCT04186871|156667279|FG001|Overall Study|Study terminated by sponsor|2|||
48676356|NCT04186871|156667280|FG002|Overall Study|Study terminated by sponsor|0|||
48676357|NCT04186871|156667281|FG003|Overall Study|Study terminated by sponsor|1|||
48762184|NCT02608268|156978034|FG027|Overall Study|Progressive disease|11|||
48762185|NCT02608268|156978035|FG028|Overall Study|Progressive disease|10|||
48676358|NCT04186871|156667282|FG004|Overall Study|Study terminated by sponsor|0|||
49015874|NCT03118739|157893959|FG000|Overall Study|Withdrawal by Subject|5|||
49015875|NCT03118739|157893960|FG001|Overall Study|Withdrawal by Subject|3|||
49015876|NCT03118739|157893959|FG000|Overall Study|Lost to Follow-up|2|||
49015877|NCT03118739|157893960|FG001|Overall Study|Lost to Follow-up|0|||
49015878|NCT02004847|157895288|FG000|Overall Study|Protocol Violation|1|||
49015879|NCT02004847|157895289|FG001|Overall Study|Protocol Violation|1|||
49015880|NCT02034799|157895292|FG000|Overall Study|Withdrawal by Subject|0|||
49015881|NCT02034799|157895293|FG001|Overall Study|Withdrawal by Subject|2|||
49015882|NCT02034799|157895292|FG000|Overall Study|Lost to Follow-up|0|||
49015883|NCT02034799|157895293|FG001|Overall Study|Lost to Follow-up|1|||
49015884|NCT02034799|157895292|FG000|Overall Study|Death|2|||
49015885|NCT02034799|157895293|FG001|Overall Study|Death|1|||
49015886|NCT00275028|157895296|FG000|Overall Study|Withdrew consent before treatment began|1|||
49015887|NCT00275028|157895296|FG000|Overall Study|Withdrawal by Subject|5|||
49015888|NCT00275028|157895296|FG000|Overall Study|Adverse Event|9|||
49015889|NCT00275028|157895296|FG000|Overall Study|Progressive Disease|30|||
49015890|NCT00275028|157895296|FG000|Overall Study|Physician Decision|2|||
49015891|NCT00331630|157895302|FG000|Evaluated for and Completed SOC Surgery|Progressive Disease|1|||
49015892|NCT00331630|157895302|FG000|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1|||
49015893|NCT00331630|157895302|FG000|Follow up for 5 Years|Death|5|||
49015894|NCT00331630|157895302|FG000|Follow up for 5 Years|Data collection was stopped|24|||
49015895|NCT00387712|157895306|FG000|Overall Study|Physician Decision|6|||
49015896|NCT00387712|157895307|FG001|Overall Study|Physician Decision|4|||
49015897|NCT00387712|157895306|FG000|Overall Study|Lost to Follow-up|17|||
49015898|NCT00387712|157895307|FG001|Overall Study|Lost to Follow-up|20|||
49015899|NCT00387712|157895306|FG000|Overall Study|Withdrawal by Subject|6|||
49015900|NCT00387712|157895307|FG001|Overall Study|Withdrawal by Subject|12|||
49015901|NCT01299038|157895310|FG000|Overall Study|Withdrawal by Subject|1|||
49015902|NCT01299038|157895311|FG001|Overall Study|Withdrawal by Subject|0|||
49015903|NCT00322556|157895312|FG000|Overall Study|Adverse Event|1|||
49015904|NCT00322556|157895312|FG000|Overall Study|Withdrawal by Subject|1|||
49015905|NCT00322556|157895312|FG000|Overall Study|Lost to Follow-up|3|||
49015906|NCT00322556|157895312|FG000|Overall Study|Other Reason|7|||
49015907|NCT01767597|157895315|FG000|Overall Study|Incomplete intervention|3|||
49015908|NCT01767597|157895316|FG001|Overall Study|Incomplete intervention|1|||
49015909|NCT01767597|157895315|FG000|Overall Study|Withdrawal by Subject|1|||
49015910|NCT01767597|157895316|FG001|Overall Study|Withdrawal by Subject|0|||
49015911|NCT03355742|157895317|FG000|Overall Study|Lost to Follow-up|4|||
49015912|NCT03355742|157895317|FG000|Overall Study|Withdrawal by Subject|29|||
49015913|NCT03355742|157895317|FG000|Overall Study|Physician Decision|6|||
49015914|NCT03355742|157895317|FG000|Overall Study|Death|55|||
49015915|NCT03355742|157895317|FG000|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5|||
49015916|NCT02961920|157895320|FG000|Overall Study|did not achive stydy protocol schedule|1|||
49015917|NCT02961920|157895321|FG001|Overall Study|did not achive stydy protocol schedule|1|||
49015918|NCT00836927|157895322|FG000|Overall Study|Progressive disease|2|||
49015919|NCT00836927|157895323|FG001|Overall Study|Progressive disease|0|||
49015920|NCT00836927|157895324|FG002|Overall Study|Progressive disease|0|||
49015921|NCT00836927|157895325|FG003|Overall Study|Progressive disease|1|||
49015922|NCT00836927|157895326|FG004|Overall Study|Progressive disease|1|||
49015923|NCT00836927|157895322|FG000|Overall Study|Withdrawal by Subject|1|||
49015924|NCT00836927|157895323|FG001|Overall Study|Withdrawal by Subject|0|||
49015925|NCT00836927|157895324|FG002|Overall Study|Withdrawal by Subject|0|||
49015926|NCT00836927|157895325|FG003|Overall Study|Withdrawal by Subject|0|||
49015927|NCT00836927|157895326|FG004|Overall Study|Withdrawal by Subject|0|||
48676359|NCT04186871|156667283|FG005|Overall Study|Study terminated by sponsor|0|||
48676360|NCT04186871|156667278|FG000|Overall Study|Other reasons|0|||
48676361|NCT04186871|156667279|FG001|Overall Study|Other reasons|0|||
48676362|NCT04186871|156667280|FG002|Overall Study|Other reasons|0|||
48676363|NCT04186871|156667281|FG003|Overall Study|Other reasons|0|||
48676364|NCT04186871|156667282|FG004|Overall Study|Other reasons|0|||
48676365|NCT04186871|156667283|FG005|Overall Study|Other reasons|1|||
49015928|NCT01772368|157895327|FG000|Overall Study|Adverse Event|1|||
49015929|NCT01772368|157895327|FG000|Overall Study|Withdrawal by Subject|3|||
49015930|NCT01772368|157895327|FG000|Overall Study|Protocol Violation|2|||
49015931|NCT01772368|157895327|FG000|Overall Study|Other|1|||
49015932|NCT01452529|157895328|FG000|Run-in Period|Adverse Event|96|||
49015933|NCT01452529|157895329|FG001|Run-in Period|Adverse Event|0|||
49015934|NCT01452529|157895330|FG002|Run-in Period|Adverse Event|0|||
49015935|NCT01452529|157895328|FG000|Run-in Period|Withdrawal by Subject|49|||
49015936|NCT01452529|157895329|FG001|Run-in Period|Withdrawal by Subject|0|||
49015937|NCT01452529|157895330|FG002|Run-in Period|Withdrawal by Subject|0|||
49015938|NCT01452529|157895328|FG000|Run-in Period|Lost to Follow-up|19|||
49015939|NCT01452529|157895329|FG001|Run-in Period|Lost to Follow-up|0|||
49015940|NCT01452529|157895330|FG002|Run-in Period|Lost to Follow-up|0|||
49015941|NCT01452529|157895328|FG000|Run-in Period|Lack of Efficacy|46|||
48676366|NCT04186871|156667278|FG000|Overall Study|Withdrawal by Subject|0|||
49015942|NCT01452529|157895329|FG001|Run-in Period|Lack of Efficacy|0|||
49015943|NCT01452529|157895330|FG002|Run-in Period|Lack of Efficacy|0|||
49015944|NCT01452529|157895328|FG000|Run-in Period|Confirmed or suspected diversion|23|||
49015945|NCT01452529|157895329|FG001|Run-in Period|Confirmed or suspected diversion|0|||
49015946|NCT01452529|157895330|FG002|Run-in Period|Confirmed or suspected diversion|0|||
49015947|NCT01452529|157895328|FG000|Run-in Period|Administrative|21|||
49015948|NCT01452529|157895329|FG001|Run-in Period|Administrative|0|||
49015949|NCT01452529|157895330|FG002|Run-in Period|Administrative|0|||
49015950|NCT01452529|157895328|FG000|Run-in Period|Did not qualify for Double-Blind Phase|59|||
49015951|NCT01452529|157895329|FG001|Run-in Period|Did not qualify for Double-Blind Phase|0|||
49015952|NCT01452529|157895330|FG002|Run-in Period|Did not qualify for Double-Blind Phase|0|||
49015953|NCT01452529|157895328|FG000|Double-blind (DB) Period|Adverse Event|0|||
49015954|NCT01452529|157895329|FG001|Double-blind (DB) Period|Adverse Event|18|||
49015955|NCT01452529|157895330|FG002|Double-blind (DB) Period|Adverse Event|11|||
49015956|NCT01452529|157895328|FG000|Double-blind (DB) Period|Withdrawal by Subject|0|||
49015957|NCT01452529|157895329|FG001|Double-blind (DB) Period|Withdrawal by Subject|15|||
49015958|NCT01452529|157895330|FG002|Double-blind (DB) Period|Withdrawal by Subject|14|||
49015959|NCT01452529|157895328|FG000|Double-blind (DB) Period|Lost to Follow-up|0|||
49015960|NCT01452529|157895329|FG001|Double-blind (DB) Period|Lost to Follow-up|5|||
49015961|NCT01452529|157895330|FG002|Double-blind (DB) Period|Lost to Follow-up|3|||
49015962|NCT01452529|157895328|FG000|Double-blind (DB) Period|Lack of Efficacy|0|||
49015963|NCT01452529|157895329|FG001|Double-blind (DB) Period|Lack of Efficacy|16|||
49015964|NCT01452529|157895330|FG002|Double-blind (DB) Period|Lack of Efficacy|44|||
49015965|NCT01452529|157895328|FG000|Double-blind (DB) Period|Confirmed or suspected diversion|0|||
49015966|NCT01452529|157895329|FG001|Double-blind (DB) Period|Confirmed or suspected diversion|2|||
49015967|NCT01452529|157895330|FG002|Double-blind (DB) Period|Confirmed or suspected diversion|3|||
49015968|NCT01452529|157895328|FG000|Double-blind (DB) Period|Administrative|0|||
49015969|NCT01452529|157895329|FG001|Double-blind (DB) Period|Administrative|11|||
49015970|NCT01452529|157895330|FG002|Double-blind (DB) Period|Administrative|7|||
49015971|NCT03551730|157895332|FG000|Overall Study|Adverse Event|1|||
49015972|NCT03551730|157895333|FG001|Overall Study|Adverse Event|0|||
49015973|NCT03551730|157895334|FG002|Overall Study|Adverse Event|0|||
49015974|NCT03551730|157895335|FG003|Overall Study|Adverse Event|0|||
49015975|NCT00901628|157895339|FG000|Overall Study|disconnection of catheter|4|||
49015976|NCT00901628|157895340|FG001|Overall Study|disconnection of catheter|8|||
49015977|NCT00901628|157895339|FG000|Overall Study|disconnection of drain|0|||
49015978|NCT00901628|157895340|FG001|Overall Study|disconnection of drain|1|||
49015979|NCT00901628|157895339|FG000|Overall Study|peroneal nerve palsy|0|||
49015980|NCT00901628|157895340|FG001|Overall Study|peroneal nerve palsy|1|||
48676367|NCT04186871|156667279|FG001|Overall Study|Withdrawal by Subject|0|||
48676368|NCT04186871|156667280|FG002|Overall Study|Withdrawal by Subject|0|||
48676369|NCT04186871|156667281|FG003|Overall Study|Withdrawal by Subject|0|||
48676370|NCT04186871|156667282|FG004|Overall Study|Withdrawal by Subject|0|||
48676371|NCT04186871|156667283|FG005|Overall Study|Withdrawal by Subject|1|||
48676372|NCT04186871|156667278|FG000|Overall Study|Lost to Follow-up|0|||
49015981|NCT00608205|157895343|FG000|Overall Study|Adverse Event|3|||
49015982|NCT00608205|157895344|FG001|Overall Study|Adverse Event|2|||
49015983|NCT00608205|157895343|FG000|Overall Study|Patient non-compliant|0|||
49015984|NCT00608205|157895344|FG001|Overall Study|Patient non-compliant|1|||
49015985|NCT01506323|157895350|FG000|Overall Study|Lost to Follow-up|5|||
49015986|NCT01506323|157895351|FG001|Overall Study|Lost to Follow-up|4|||
49015987|NCT01506323|157895350|FG000|Overall Study|Withdrawal by Subject|4|||
49015988|NCT01506323|157895351|FG001|Overall Study|Withdrawal by Subject|4|||
49015989|NCT01506323|157895350|FG000|Overall Study|Lack of Efficacy|1|||
49015990|NCT01506323|157895351|FG001|Overall Study|Lack of Efficacy|3|||
49015991|NCT01506323|157895350|FG000|Overall Study|Moved out of area|5|||
49015992|NCT01506323|157895351|FG001|Overall Study|Moved out of area|2|||
49015993|NCT01506323|157895350|FG000|Overall Study|Schedule or Transportation conflict|8|||
49015994|NCT01506323|157895351|FG001|Overall Study|Schedule or Transportation conflict|0|||
49015995|NCT01506323|157895350|FG000|Overall Study|Started another treatment|1|||
48676373|NCT04186871|156667279|FG001|Overall Study|Lost to Follow-up|0|||
48676374|NCT04186871|156667280|FG002|Overall Study|Lost to Follow-up|0|||
48762186|NCT02608268|156978036|FG029|Overall Study|Progressive disease|15|||
49015996|NCT01506323|157895351|FG001|Overall Study|Started another treatment|0|||
49015997|NCT02192905|157895353|FG000|Overall Study|Lost to Follow-up|1|||
49015998|NCT04467697|157895354|FG000|Overall Study|Adverse Event|2|||
49015999|NCT04467697|157895354|FG000|Overall Study|Lost to Follow-up|6|||
49016000|NCT04467697|157895354|FG000|Overall Study|Withdrawal by Subject|9|||
49016001|NCT04467697|157895354|FG000|Overall Study|Protocol Violation|3|||
49016002|NCT03907280|157895355|FG000|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
49016003|NCT03907280|157895356|FG001|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|1|||
49016004|NCT03907280|157895357|FG002|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
48676375|NCT04186871|156667281|FG003|Overall Study|Lost to Follow-up|0|||
49016005|NCT00909727|157895358|FG000|Overall Study|Adverse Event|1|||
49016006|NCT00909727|157895359|FG001|Overall Study|Adverse Event|0|||
49016007|NCT00909727|157895358|FG000|Overall Study|Wrong Genotype|1|||
49016008|NCT00909727|157895359|FG001|Overall Study|Wrong Genotype|0|||
49016009|NCT00909727|157895358|FG000|Overall Study|Withdrawal of Consent|1|||
49016010|NCT00909727|157895359|FG001|Overall Study|Withdrawal of Consent|0|||
49016011|NCT00909727|157895358|FG000|Overall Study|Prohibited Medication|1|||
49016012|NCT00909727|157895359|FG001|Overall Study|Prohibited Medication|0|||
49016013|NCT01909466|157895362|FG000|Overall Study|Lost to Follow-up|5|||
48676376|NCT04186871|156667282|FG004|Overall Study|Lost to Follow-up|0|||
48676377|NCT04186871|156667283|FG005|Overall Study|Lost to Follow-up|1|||
48676378|NCT03188510|156667289|FG000|Overall Study|Inappropriate behavior with site staff|0|||
48676379|NCT03188510|156667290|FG001|Overall Study|Inappropriate behavior with site staff|1|||
48676380|NCT03188510|156667291|FG002|Overall Study|Inappropriate behavior with site staff|0|||
49016014|NCT01909466|157895363|FG001|Overall Study|Lost to Follow-up|7|||
49016015|NCT01909466|157895362|FG000|Overall Study|Adverse Event|3|||
49016016|NCT01909466|157895363|FG001|Overall Study|Adverse Event|4|||
49016017|NCT01909466|157895362|FG000|Overall Study|Met Withdrawal Criteria|0|||
49016018|NCT01909466|157895363|FG001|Overall Study|Met Withdrawal Criteria|3|||
49016019|NCT01909466|157895362|FG000|Overall Study|Physician Decision|2|||
49016020|NCT01909466|157895363|FG001|Overall Study|Physician Decision|0|||
49016021|NCT01909466|157895362|FG000|Overall Study|Withdrawal by Subject|11|||
49016022|NCT01909466|157895363|FG001|Overall Study|Withdrawal by Subject|9|||
49016023|NCT01909466|157895362|FG000|Overall Study|Lack of Efficacy|1|||
49016024|NCT01909466|157895363|FG001|Overall Study|Lack of Efficacy|0|||
49016025|NCT04480463|157895364|FG000|Overall Study|Death|0|||
49016026|NCT04480463|157895365|FG001|Overall Study|Death|1|||
49016027|NCT04480463|157895364|FG000|Overall Study|Adverse Event|6|||
49016028|NCT04480463|157895365|FG001|Overall Study|Adverse Event|8|||
49016029|NCT04480463|157895364|FG000|Overall Study|Lost to Follow-up|3|||
49016030|NCT04480463|157895365|FG001|Overall Study|Lost to Follow-up|2|||
49016031|NCT04480463|157895364|FG000|Overall Study|Physician Decision|2|||
49016032|NCT04480463|157895365|FG001|Overall Study|Physician Decision|5|||
49016033|NCT04480463|157895364|FG000|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|2|||
49016034|NCT04480463|157895365|FG001|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|3|||
49016035|NCT04480463|157895364|FG000|Overall Study|Protocol Violation|2|||
49016036|NCT04480463|157895365|FG001|Overall Study|Protocol Violation|1|||
49016037|NCT04480463|157895364|FG000|Overall Study|Withdrawal by Subject|6|||
49016038|NCT04480463|157895365|FG001|Overall Study|Withdrawal by Subject|7|||
49016039|NCT04480463|157895364|FG000|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|0|||
49016040|NCT04480463|157895365|FG001|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|1|||
49016041|NCT04480463|157895364|FG000|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|1|||
49016042|NCT04480463|157895365|FG001|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|0|||
49016043|NCT04480463|157895364|FG000|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|1|||
49016044|NCT04480463|157895365|FG001|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|0|||
49016045|NCT04480463|157895364|FG000|Overall Study|Other|6|||
49016046|NCT04480463|157895365|FG001|Overall Study|Other|4|||
49016047|NCT00444795|157895367|FG000|Overall Study|Not Treated|1|||
49016048|NCT00444795|157895367|FG000|Overall Study|Treated Prior to the Contract Date|2|||
49016049|NCT02231710|157895368|FG000|Overall Study|Physician Decision|1|||
49016050|NCT01793610|157895369|FG000|Overall Study|Withdrawal by Subject|1|||
49016051|NCT01793610|157895370|FG001|Overall Study|Withdrawal by Subject|0|||
49016052|NCT01793610|157895371|FG002|Overall Study|Withdrawal by Subject|1|||
48676381|NCT03052049|156667292|FG000|Overall Study|Withdrawal by Subject|2|||
48676382|NCT03319212|156667293|FG000|Overall Study|Discontinued as moving out of local area|0|||
48676383|NCT03319212|156667294|FG001|Overall Study|Discontinued as moving out of local area|1|||
49016053|NCT01339910|157895372|FG000|Overall Study|Withdrawal by Subject|1|||
49016054|NCT01339910|157895373|FG001|Overall Study|Withdrawal by Subject|0|||
49016055|NCT01339910|157895372|FG000|Overall Study|Physician Decision|1|||
48676384|NCT03319212|156667293|FG000|Overall Study|Adverse Event|2|||
48676385|NCT03319212|156667294|FG001|Overall Study|Adverse Event|2|||
48762187|NCT02608268|156978007|FG000|Overall Study|Subject/guardian decision|1|||
48762188|NCT02608268|156978008|FG001|Overall Study|Subject/guardian decision|1|||
48762189|NCT02608268|156978009|FG002|Overall Study|Subject/guardian decision|2|||
48762190|NCT02608268|156978010|FG003|Overall Study|Subject/guardian decision|0|||
48762191|NCT02608268|156978011|FG004|Overall Study|Subject/guardian decision|0|||
49016056|NCT01339910|157895373|FG001|Overall Study|Physician Decision|0|||
49016057|NCT01339910|157895372|FG000|Overall Study|Disease relapse|1|||
49016058|NCT01339910|157895373|FG001|Overall Study|Disease relapse|4|||
49016059|NCT00988169|157895374|FG000|Overall Study|Withdrawal by Subject|1|||
49016060|NCT01399723|157895375|FG000|Overall Study|Lost to Follow-up|0|||
49016061|NCT01399723|157895376|FG001|Overall Study|Lost to Follow-up|1|||
49016062|NCT00704418|157895377|FG000|Overall Study|Withdrawal by Subject|2|||
49016063|NCT00704418|157895378|FG001|Overall Study|Withdrawal by Subject|0|||
49016064|NCT00704418|157895377|FG000|Overall Study|Over-enrolled/surgery postponed|3|||
49016065|NCT00704418|157895378|FG001|Overall Study|Over-enrolled/surgery postponed|6|||
49016066|NCT02322879|157895380|FG000|First Intervention|Physician Decision|1|||
49016067|NCT02322879|157895381|FG001|First Intervention|Physician Decision|0|||
49016068|NCT00295854|157895384|FG000|Overall Study|Adverse Event|7|||
49016069|NCT00295854|157895385|FG001|Overall Study|Adverse Event|7|||
49016070|NCT00295854|157895386|FG002|Overall Study|Adverse Event|6|||
49016071|NCT00295854|157895384|FG000|Overall Study|Protocol Violation|1|||
49016072|NCT00295854|157895385|FG001|Overall Study|Protocol Violation|1|||
49016073|NCT00295854|157895386|FG002|Overall Study|Protocol Violation|1|||
49016074|NCT00295854|157895384|FG000|Overall Study|Lost to Follow-up|2|||
49016075|NCT00295854|157895385|FG001|Overall Study|Lost to Follow-up|0|||
49016076|NCT00295854|157895386|FG002|Overall Study|Lost to Follow-up|1|||
49016077|NCT00295854|157895384|FG000|Overall Study|Withdrawal by Subject|3|||
49016078|NCT00295854|157895385|FG001|Overall Study|Withdrawal by Subject|7|||
49016079|NCT00295854|157895386|FG002|Overall Study|Withdrawal by Subject|4|||
49016080|NCT00295854|157895384|FG000|Overall Study|did not continue to meet criteria|1|||
49016081|NCT00295854|157895385|FG001|Overall Study|did not continue to meet criteria|1|||
49016082|NCT00295854|157895386|FG002|Overall Study|did not continue to meet criteria|2|||
49016083|NCT00295854|157895384|FG000|Overall Study|required a prohibited medication|1|||
49016084|NCT00295854|157895385|FG001|Overall Study|required a prohibited medication|0|||
49016085|NCT00295854|157895386|FG002|Overall Study|required a prohibited medication|0|||
49016086|NCT00295854|157895384|FG000|Overall Study|Other|3|||
49016087|NCT00295854|157895385|FG001|Overall Study|Other|5|||
49016088|NCT00295854|157895386|FG002|Overall Study|Other|1|||
49016089|NCT00672620|157895387|FG000|Overall Study|Adverse Event|7|||
49016090|NCT00672620|157895388|FG001|Overall Study|Adverse Event|7|||
49016091|NCT00672620|157895389|FG002|Overall Study|Adverse Event|12|||
49016092|NCT00672620|157895390|FG003|Overall Study|Adverse Event|17|||
49016093|NCT00672620|157895387|FG000|Overall Study|Lack of Efficacy|1|||
49016094|NCT00672620|157895388|FG001|Overall Study|Lack of Efficacy|2|||
49016095|NCT00672620|157895389|FG002|Overall Study|Lack of Efficacy|2|||
49016096|NCT00672620|157895390|FG003|Overall Study|Lack of Efficacy|0|||
49016097|NCT00672620|157895387|FG000|Overall Study|Noncompliance with Study Drug|3|||
49016098|NCT00672620|157895388|FG001|Overall Study|Noncompliance with Study Drug|4|||
49016099|NCT00672620|157895389|FG002|Overall Study|Noncompliance with Study Drug|0|||
49016100|NCT00672620|157895390|FG003|Overall Study|Noncompliance with Study Drug|2|||
49016101|NCT00672620|157895387|FG000|Overall Study|Protocol Deviations|5|||
49016102|NCT00672620|157895388|FG001|Overall Study|Protocol Deviations|7|||
49016103|NCT00672620|157895389|FG002|Overall Study|Protocol Deviations|2|||
49016104|NCT00672620|157895390|FG003|Overall Study|Protocol Deviations|5|||
49016105|NCT00672620|157895387|FG000|Overall Study|Withdrawal of Consent|6|||
49016106|NCT00672620|157895388|FG001|Overall Study|Withdrawal of Consent|12|||
49016107|NCT00672620|157895389|FG002|Overall Study|Withdrawal of Consent|5|||
49016108|NCT00672620|157895390|FG003|Overall Study|Withdrawal of Consent|6|||
49016109|NCT00672620|157895387|FG000|Overall Study|Lost to Follow-up|8|||
49016110|NCT00672620|157895388|FG001|Overall Study|Lost to Follow-up|19|||
49016111|NCT00672620|157895389|FG002|Overall Study|Lost to Follow-up|8|||
49016112|NCT00672620|157895390|FG003|Overall Study|Lost to Follow-up|11|||
49016113|NCT00672620|157895387|FG000|Overall Study|Reason not Specified|3|||
49016114|NCT00672620|157895388|FG001|Overall Study|Reason not Specified|3|||
49016115|NCT00672620|157895389|FG002|Overall Study|Reason not Specified|2|||
49016116|NCT00672620|157895390|FG003|Overall Study|Reason not Specified|1|||
49016117|NCT00772577|157895391|FG000|Overall Study|Adverse Event|6|||
49016118|NCT00772577|157895392|FG001|Overall Study|Adverse Event|3|||
49016119|NCT00772577|157895391|FG000|Overall Study|Abnormal laboratory values|0|||
49016120|NCT00772577|157895392|FG001|Overall Study|Abnormal laboratory values|1|||
49016121|NCT00772577|157895391|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
49016122|NCT00772577|157895392|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
49016123|NCT00772577|157895391|FG000|Overall Study|Patient withdrew consent|8|||
49016124|NCT00772577|157895392|FG001|Overall Study|Patient withdrew consent|5|||
49016125|NCT00772577|157895391|FG000|Overall Study|Lost to Follow-up|4|||
49016126|NCT00772577|157895392|FG001|Overall Study|Lost to Follow-up|3|||
49016127|NCT00772577|157895391|FG000|Overall Study|Administrative problems|2|||
49016128|NCT00772577|157895392|FG001|Overall Study|Administrative problems|1|||
49016129|NCT00772577|157895391|FG000|Overall Study|Protocol Deviation|3|||
49016130|NCT00772577|157895392|FG001|Overall Study|Protocol Deviation|2|||
49016131|NCT00952484|157895407|FG000|Overall Study|Withdrawal by Subject|0|||
49016132|NCT00952484|157895408|FG001|Overall Study|Withdrawal by Subject|1|||
49016133|NCT00952484|157895409|FG002|Overall Study|Withdrawal by Subject|0|||
49016134|NCT02750306|157895414|FG000|Overall Study|Withdrawal by Subject|5|||
49016135|NCT02750306|157895415|FG001|Overall Study|Withdrawal by Subject|2|||
48676386|NCT03319212|156667293|FG000|Overall Study|Withdrawal by Subject|0|||
49016136|NCT02750306|157895414|FG000|Overall Study|Protocol Violation|1|||
49016137|NCT02750306|157895415|FG001|Overall Study|Protocol Violation|0|||
49016138|NCT00585351|157895423|FG000|Notification Period (Informed Consent)|Physician Decision|0|||
49016139|NCT00585351|157895424|FG001|Notification Period (Informed Consent)|Physician Decision|2|||
49016140|NCT00585351|157895425|FG002|Notification Period (Informed Consent)|Physician Decision|0|||
49016141|NCT00585351|157895426|FG003|Notification Period (Informed Consent)|Physician Decision|0|||
49016142|NCT00585351|157895427|FG004|Notification Period (Informed Consent)|Physician Decision|0|||
49016143|NCT00585351|157895428|FG005|Notification Period (Informed Consent)|Physician Decision|0|||
49016144|NCT00585351|157895429|FG006|Notification Period (Informed Consent)|Physician Decision|0|||
49016145|NCT00585351|157895430|FG007|Notification Period (Informed Consent)|Physician Decision|0|||
49016146|NCT00585351|157895423|FG000|Notification Period (Informed Consent)|Flight aborted|2|||
49016147|NCT00585351|157895424|FG001|Notification Period (Informed Consent)|Flight aborted|1|||
49016148|NCT00585351|157895425|FG002|Notification Period (Informed Consent)|Flight aborted|0|||
49016149|NCT00585351|157895426|FG003|Notification Period (Informed Consent)|Flight aborted|0|||
49016150|NCT00585351|157895427|FG004|Notification Period (Informed Consent)|Flight aborted|0|||
49016151|NCT00585351|157895428|FG005|Notification Period (Informed Consent)|Flight aborted|0|||
49016152|NCT00585351|157895429|FG006|Notification Period (Informed Consent)|Flight aborted|0|||
49016153|NCT00585351|157895430|FG007|Notification Period (Informed Consent)|Flight aborted|0|||
49016154|NCT00585351|157895423|FG000|Notification Period (Informed Consent)|No study medication on flight|0|||
49016155|NCT00585351|157895424|FG001|Notification Period (Informed Consent)|No study medication on flight|1|||
49016156|NCT00585351|157895425|FG002|Notification Period (Informed Consent)|No study medication on flight|0|||
49016157|NCT00585351|157895426|FG003|Notification Period (Informed Consent)|No study medication on flight|0|||
49016158|NCT00585351|157895427|FG004|Notification Period (Informed Consent)|No study medication on flight|0|||
49016159|NCT00585351|157895428|FG005|Notification Period (Informed Consent)|No study medication on flight|0|||
49016160|NCT00585351|157895429|FG006|Notification Period (Informed Consent)|No study medication on flight|0|||
49016161|NCT00585351|157895430|FG007|Notification Period (Informed Consent)|No study medication on flight|0|||
49016162|NCT00585351|157895423|FG000|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
49016163|NCT00585351|157895424|FG001|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
49016164|NCT00585351|157895425|FG002|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
49016165|NCT00585351|157895426|FG003|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
49016166|NCT00585351|157895427|FG004|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
49016167|NCT00585351|157895428|FG005|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
49016168|NCT00585351|157895429|FG006|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
48676387|NCT03319212|156667294|FG001|Overall Study|Withdrawal by Subject|1|||
48676388|NCT03319212|156667293|FG000|Overall Study|Lost to Follow-up|0|||
48676389|NCT03319212|156667294|FG001|Overall Study|Lost to Follow-up|1|||
48676390|NCT03319212|156667293|FG000|Overall Study|Physician Decision|1|||
48676391|NCT03319212|156667294|FG001|Overall Study|Physician Decision|0|||
48676392|NCT00250276|156667295|FG000|Overall Study|Serious Adverse Event|0|||
48676393|NCT00250276|156667296|FG001|Overall Study|Serious Adverse Event|0|||
48676394|NCT00250276|156667297|FG002|Overall Study|Serious Adverse Event|1|||
48676395|NCT00250276|156667298|FG003|Overall Study|Serious Adverse Event|0|||
48676396|NCT00250276|156667295|FG000|Overall Study|Non-serious Adverse Event|2|||
48676397|NCT00250276|156667296|FG001|Overall Study|Non-serious Adverse Event|0|||
48676398|NCT00250276|156667297|FG002|Overall Study|Non-serious Adverse Event|0|||
48676399|NCT00250276|156667298|FG003|Overall Study|Non-serious Adverse Event|2|||
48676400|NCT00250276|156667295|FG000|Overall Study|Protocol Violation|0|||
48676401|NCT00250276|156667296|FG001|Overall Study|Protocol Violation|1|||
48676402|NCT00250276|156667297|FG002|Overall Study|Protocol Violation|0|||
48676403|NCT00250276|156667298|FG003|Overall Study|Protocol Violation|0|||
48676404|NCT00250276|156667295|FG000|Overall Study|Withdrawal by Subject|1|||
48676405|NCT00250276|156667296|FG001|Overall Study|Withdrawal by Subject|2|||
48676406|NCT00250276|156667297|FG002|Overall Study|Withdrawal by Subject|3|||
48676407|NCT00250276|156667298|FG003|Overall Study|Withdrawal by Subject|2|||
48676408|NCT00250276|156667295|FG000|Overall Study|Migrated/moved from study area|3|||
48676409|NCT00250276|156667296|FG001|Overall Study|Migrated/moved from study area|0|||
48676410|NCT00250276|156667297|FG002|Overall Study|Migrated/moved from study area|2|||
48676411|NCT00250276|156667298|FG003|Overall Study|Migrated/moved from study area|7|||
48676412|NCT00250276|156667295|FG000|Overall Study|Lost to Follow-up|11|||
48676413|NCT00250276|156667296|FG001|Overall Study|Lost to Follow-up|18|||
48676414|NCT00250276|156667297|FG002|Overall Study|Lost to Follow-up|13|||
48676415|NCT00250276|156667298|FG003|Overall Study|Lost to Follow-up|8|||
48676416|NCT01088399|156667299|FG000|Overall Study|Adverse Event|211|||
48676417|NCT01088399|156667300|FG001|Overall Study|Adverse Event|16|||
48676418|NCT01088399|156667301|FG002|Overall Study|Adverse Event|0|||
48676419|NCT01088399|156667299|FG000|Overall Study|Death|204|||
48676420|NCT01088399|156667300|FG001|Overall Study|Death|45|||
48676421|NCT01088399|156667301|FG002|Overall Study|Death|0|||
48676422|NCT01088399|156667299|FG000|Overall Study|Lack of Efficacy|298|||
48676423|NCT01088399|156667300|FG001|Overall Study|Lack of Efficacy|7|||
48676424|NCT01088399|156667301|FG002|Overall Study|Lack of Efficacy|5|||
48676425|NCT01088399|156667299|FG000|Overall Study|Lost to Follow-up|1070|||
48676426|NCT01088399|156667300|FG001|Overall Study|Lost to Follow-up|278|||
49016169|NCT00585351|157895430|FG007|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
49016170|NCT00585351|157895423|FG000|Enrollment Period (Intervention)|Lost to Follow-up|0|||
49016171|NCT00585351|157895424|FG001|Enrollment Period (Intervention)|Lost to Follow-up|0|||
49016172|NCT00585351|157895425|FG002|Enrollment Period (Intervention)|Lost to Follow-up|0|||
49016173|NCT00585351|157895426|FG003|Enrollment Period (Intervention)|Lost to Follow-up|0|||
49016174|NCT00585351|157895427|FG004|Enrollment Period (Intervention)|Lost to Follow-up|0|||
49016175|NCT00585351|157895428|FG005|Enrollment Period (Intervention)|Lost to Follow-up|0|||
49016176|NCT00585351|157895429|FG006|Enrollment Period (Intervention)|Lost to Follow-up|1|||
49016177|NCT00585351|157895430|FG007|Enrollment Period (Intervention)|Lost to Follow-up|1|||
49016178|NCT00585351|157895423|FG000|Enrollment Period (Intervention)|Death|0|||
49016179|NCT00585351|157895424|FG001|Enrollment Period (Intervention)|Death|0|||
49016180|NCT00585351|157895425|FG002|Enrollment Period (Intervention)|Death|0|||
49016181|NCT00585351|157895426|FG003|Enrollment Period (Intervention)|Death|0|||
49016182|NCT00585351|157895427|FG004|Enrollment Period (Intervention)|Death|1|||
49016183|NCT00585351|157895428|FG005|Enrollment Period (Intervention)|Death|0|||
49016184|NCT00585351|157895429|FG006|Enrollment Period (Intervention)|Death|1|||
49016185|NCT00585351|157895430|FG007|Enrollment Period (Intervention)|Death|0|||
49016186|NCT00585351|157895423|FG000|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
49016187|NCT00585351|157895424|FG001|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
49016188|NCT00585351|157895425|FG002|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
49016189|NCT00585351|157895426|FG003|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
49016190|NCT00585351|157895427|FG004|Enrollment Period (Intervention)|Unknown if alive or deceased|1|||
49016191|NCT00585351|157895428|FG005|Enrollment Period (Intervention)|Unknown if alive or deceased|2|||
49016192|NCT00585351|157895429|FG006|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
49016193|NCT00585351|157895430|FG007|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
49016194|NCT01893138|157895435|FG000|Double-Blind Period|Withdrawal by Subject|1|||
49016195|NCT01893138|157895436|FG001|Double-Blind Period|Withdrawal by Subject|1|||
49016196|NCT01893138|157895435|FG000|Open Label - Unblinded Period|Lack of Efficacy|9|||
49016197|NCT01893138|157895436|FG001|Open Label - Unblinded Period|Lack of Efficacy|0|||
49016198|NCT01893138|157895435|FG000|Open Label - Unblinded Period|Lost to Follow-up|4|||
49016199|NCT01893138|157895436|FG001|Open Label - Unblinded Period|Lost to Follow-up|3|||
49016200|NCT01893138|157895435|FG000|Open Label - Unblinded Period|Withdrawal by Subject|18|||
49016201|NCT01893138|157895436|FG001|Open Label - Unblinded Period|Withdrawal by Subject|7|||
49016202|NCT01893138|157895435|FG000|Open Label - Unblinded Period|Adverse Event|1|||
48676427|NCT01088399|156667301|FG002|Overall Study|Lost to Follow-up|58|||
48676428|NCT01088399|156667299|FG000|Overall Study|Physician Decision|531|||
48676429|NCT01088399|156667300|FG001|Overall Study|Physician Decision|88|||
48676430|NCT01088399|156667301|FG002|Overall Study|Physician Decision|16|||
48676431|NCT01088399|156667299|FG000|Overall Study|Withdrawal by Subject|544|||
48676432|NCT01088399|156667300|FG001|Overall Study|Withdrawal by Subject|195|||
48676433|NCT01088399|156667301|FG002|Overall Study|Withdrawal by Subject|33|||
48676434|NCT01088399|156667299|FG000|Overall Study|Change to or start of somatropin therapy|234|||
48676435|NCT01088399|156667300|FG001|Overall Study|Change to or start of somatropin therapy|17|||
48676436|NCT01088399|156667301|FG002|Overall Study|Change to or start of somatropin therapy|12|||
48676437|NCT01088399|156667299|FG000|Overall Study|Sponsor decision|1573|||
48676438|NCT01088399|156667300|FG001|Overall Study|Sponsor decision|298|||
48676439|NCT01088399|156667301|FG002|Overall Study|Sponsor decision|7|||
48676440|NCT01088399|156667299|FG000|Overall Study|Protocol Violation|10|||
49016203|NCT01893138|157895436|FG001|Open Label - Unblinded Period|Adverse Event|0|||
49016204|NCT00720798|157896826|FG000|Overall Study|Adverse Event|304|||
49016205|NCT00720798|157896826|FG000|Overall Study|Death|39|||
49016206|NCT00720798|157896826|FG000|Overall Study|Insufficient Therapeutic Response|129|||
49016207|NCT00720798|157896826|FG000|Overall Study|Protocol Violation|4|||
49016208|NCT00720798|157896826|FG000|Overall Study|Refused Treatment|151|||
49016209|NCT00720798|157896826|FG000|Overall Study|Failure to Return|46|||
49016210|NCT00720798|157896826|FG000|Overall Study|Reason not Specified|83|||
49016211|NCT01628120|157896830|FG000|Overall Study|Withdrawal by Subject|7|||
49016212|NCT01628120|157896830|FG000|Overall Study|Adverse Event|12|||
49016213|NCT01628120|157896830|FG000|Overall Study|Lost to Follow-up|1|||
49016214|NCT01628120|157896830|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|2|||
49016215|NCT01628120|157896830|FG000|Overall Study|Non-compliant with Study Procedures|1|||
48676441|NCT01088399|156667300|FG001|Overall Study|Protocol Violation|1|||
48676442|NCT01088399|156667301|FG002|Overall Study|Protocol Violation|0|||
48676443|NCT01088399|156667299|FG000|Overall Study|Enrollment criteria not met|48|||
48762192|NCT02608268|156978012|FG005|Overall Study|Subject/guardian decision|0|||
48762193|NCT02608268|156978013|FG006|Overall Study|Subject/guardian decision|0|||
48762194|NCT02608268|156978014|FG007|Overall Study|Subject/guardian decision|0|||
49016216|NCT01628120|157896830|FG000|Overall Study|Not Treated|3|||
49016217|NCT01628120|157896830|FG000|Overall Study|Sponsor Decision|5|||
49016218|NCT01628120|157896830|FG000|Overall Study|Switched Dialysis Method|2|||
49016219|NCT01628120|157896830|FG000|Overall Study|Missed Study Drug More than 2 Weeks|3|||
48762195|NCT02608268|156978015|FG008|Overall Study|Subject/guardian decision|2|||
49016220|NCT01628120|157896830|FG000|Overall Study|Moved or Relocated|5|||
49016221|NCT01628120|157896830|FG000|Overall Study|Kidney Transplant|2|||
49016222|NCT01628120|157896830|FG000|Overall Study|Use of Standard of Care|1|||
49016223|NCT02891200|157896848|FG000|Overall Study|Lost to Follow-up|31|||
49016224|NCT02891200|157896849|FG001|Overall Study|Lost to Follow-up|36|||
49016225|NCT02891200|157896848|FG000|Overall Study|Death|10|||
49016226|NCT02891200|157896849|FG001|Overall Study|Death|9|||
48676444|NCT01088399|156667300|FG001|Overall Study|Enrollment criteria not met|119|||
48676445|NCT01088399|156667301|FG002|Overall Study|Enrollment criteria not met|70|||
48676446|NCT01088399|156667299|FG000|Overall Study|Study summary visit not completed|2398|||
48676447|NCT01088399|156667300|FG001|Overall Study|Study summary visit not completed|283|||
48676448|NCT01088399|156667301|FG002|Overall Study|Study summary visit not completed|80|||
48676449|NCT01052077|156667304|FG000|Phase A|Lost to Follow-up|22|||
48676450|NCT01052077|156667305|FG001|Phase A|Lost to Follow-up|0|||
48676451|NCT01052077|156667306|FG002|Phase A|Lost to Follow-up|0|||
48762196|NCT02608268|156978016|FG009|Overall Study|Subject/guardian decision|2|||
48762197|NCT02608268|156978017|FG010|Overall Study|Subject/guardian decision|0|||
48762198|NCT02608268|156978018|FG011|Overall Study|Subject/guardian decision|1|||
48762199|NCT02608268|156978019|FG012|Overall Study|Subject/guardian decision|0|||
48762200|NCT02608268|156978020|FG013|Overall Study|Subject/guardian decision|1|||
48762201|NCT02608268|156978021|FG014|Overall Study|Subject/guardian decision|0|||
48762202|NCT02608268|156978022|FG015|Overall Study|Subject/guardian decision|1|||
48762203|NCT02608268|156978023|FG016|Overall Study|Subject/guardian decision|0|||
48762204|NCT02608268|156978024|FG017|Overall Study|Subject/guardian decision|0|||
48762205|NCT02608268|156978025|FG018|Overall Study|Subject/guardian decision|1|||
48762206|NCT02608268|156978026|FG019|Overall Study|Subject/guardian decision|0|||
48762207|NCT02608268|156978027|FG020|Overall Study|Subject/guardian decision|0|||
48762208|NCT02608268|156978028|FG021|Overall Study|Subject/guardian decision|0|||
48762209|NCT02608268|156978029|FG022|Overall Study|Subject/guardian decision|1|||
48762210|NCT02608268|156978030|FG023|Overall Study|Subject/guardian decision|0|||
48762211|NCT02608268|156978031|FG024|Overall Study|Subject/guardian decision|0|||
48762212|NCT02608268|156978032|FG025|Overall Study|Subject/guardian decision|1|||
48762213|NCT02608268|156978033|FG026|Overall Study|Subject/guardian decision|1|||
48762214|NCT02608268|156978034|FG027|Overall Study|Subject/guardian decision|1|||
48762215|NCT02608268|156978035|FG028|Overall Study|Subject/guardian decision|1|||
48762216|NCT02608268|156978036|FG029|Overall Study|Subject/guardian decision|0|||
48762217|NCT04865354|156978037|FG000|First Wear Period (8 Days)|Withdrawal by Subject|1|||
48762218|NCT04865354|156978038|FG001|First Wear Period (8 Days)|Withdrawal by Subject|0|||
48762219|NCT04865354|156978037|FG000|First Wear Period (8 Days)|Lost to Follow-up|0|||
48762220|NCT04865354|156978038|FG001|First Wear Period (8 Days)|Lost to Follow-up|1|||
48762221|NCT04865354|156978037|FG000|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|1|||
48762222|NCT04865354|156978038|FG001|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|0|||
48762223|NCT04782856|156978042|FG000|Overall Study|Withdrawal by Subject|0|||
48762224|NCT04782856|156978043|FG001|Overall Study|Withdrawal by Subject|1|||
48762225|NCT01030523|156978044|FG000|Initial Study (5 Years)|Death|1|||
48762226|NCT01030523|156978045|FG001|Initial Study (5 Years)|Death|0|||
48762227|NCT01030523|156978044|FG000|Initial Study (5 Years)|Lost to Follow-up|4|||
48762228|NCT01030523|156978045|FG001|Initial Study (5 Years)|Lost to Follow-up|5|||
48762229|NCT01030523|156978044|FG000|Initial Study (5 Years)|Implant failure|1|||
48762230|NCT01030523|156978045|FG001|Initial Study (5 Years)|Implant failure|0|||
48762231|NCT01030523|156978044|FG000|Follow-up Extension (10 Years)|Lost to Follow-up|5|||
48762232|NCT01030523|156978045|FG001|Follow-up Extension (10 Years)|Lost to Follow-up|4|||
49016227|NCT02891200|157896848|FG000|Overall Study|Withdrawal by Subject|1|||
49016228|NCT02891200|157896849|FG001|Overall Study|Withdrawal by Subject|4|||
49016229|NCT02232074|157896854|FG000|Overall Study|Withdrawal by Subject|5|||
49016230|NCT02232074|157896855|FG001|Overall Study|Withdrawal by Subject|3|||
48676452|NCT01052077|156667307|FG003|Phase A|Lost to Follow-up|0|||
48676453|NCT01052077|156667304|FG000|Phase A|Adverse Event|32|||
48676454|NCT01052077|156667305|FG001|Phase A|Adverse Event|0|||
48676455|NCT01052077|156667306|FG002|Phase A|Adverse Event|0|||
48676456|NCT01052077|156667307|FG003|Phase A|Adverse Event|0|||
48676457|NCT01052077|156667304|FG000|Phase A|Met Withdrawal Criteria|26|||
49016231|NCT02232074|157896854|FG000|Overall Study|No legal concerns at baseline|36|||
49016232|NCT02232074|157896855|FG001|Overall Study|No legal concerns at baseline|41|||
49016233|NCT02232074|157896854|FG000|Overall Study|deemed ineligible|0|||
49016234|NCT02232074|157896855|FG001|Overall Study|deemed ineligible|1|||
49016235|NCT05751629|157896856|FG000|Overall Study|Withdrawal by Subject|6|||
48676458|NCT01052077|156667305|FG001|Phase A|Met Withdrawal Criteria|0|||
48762233|NCT01030523|156978044|FG000|Follow-up Extension (10 Years)|Withdrawal by Subject|1|||
48762234|NCT01030523|156978045|FG001|Follow-up Extension (10 Years)|Withdrawal by Subject|3|||
48762235|NCT01030523|156978044|FG000|Follow-up Extension (10 Years)|Adverse Event|1|||
49016236|NCT05751629|157896856|FG000|Overall Study|Death|25|||
49016237|NCT05751629|157896856|FG000|Overall Study|Study Site Closed|9|||
49016238|NCT05751629|157896856|FG000|Overall Study|Physician Decision|1|||
48676459|NCT01052077|156667306|FG002|Phase A|Met Withdrawal Criteria|0|||
48762236|NCT01030523|156978045|FG001|Follow-up Extension (10 Years)|Adverse Event|2|||
48676460|NCT01052077|156667307|FG003|Phase A|Met Withdrawal Criteria|0|||
48676461|NCT01052077|156667304|FG000|Phase A|Physician Decision|10|||
48676462|NCT01052077|156667305|FG001|Phase A|Physician Decision|0|||
48676463|NCT01052077|156667306|FG002|Phase A|Physician Decision|0|||
48676464|NCT01052077|156667307|FG003|Phase A|Physician Decision|0|||
48676465|NCT01052077|156667304|FG000|Phase A|Withdrawal by Subject|29|||
48676466|NCT01052077|156667305|FG001|Phase A|Withdrawal by Subject|0|||
48676467|NCT01052077|156667306|FG002|Phase A|Withdrawal by Subject|0|||
48676468|NCT01052077|156667307|FG003|Phase A|Withdrawal by Subject|0|||
48676469|NCT01052077|156667304|FG000|Phase A|Protocol Deviation|27|||
48676470|NCT01052077|156667305|FG001|Phase A|Protocol Deviation|0|||
48676471|NCT01052077|156667306|FG002|Phase A|Protocol Deviation|0|||
48676472|NCT01052077|156667307|FG003|Phase A|Protocol Deviation|0|||
48676473|NCT01052077|156667304|FG000|Phase B|Lost to Follow-up|0|||
48676474|NCT01052077|156667305|FG001|Phase B|Lost to Follow-up|2|||
48676475|NCT01052077|156667306|FG002|Phase B|Lost to Follow-up|3|||
48676476|NCT01052077|156667307|FG003|Phase B|Lost to Follow-up|0|||
48676477|NCT01052077|156667304|FG000|Phase B|Adverse Event|0|||
48676478|NCT01052077|156667305|FG001|Phase B|Adverse Event|9|||
48676479|NCT01052077|156667306|FG002|Phase B|Adverse Event|2|||
48676480|NCT01052077|156667307|FG003|Phase B|Adverse Event|0|||
48676481|NCT01052077|156667304|FG000|Phase B|Met Withdrawal Criteria|0|||
48676482|NCT01052077|156667305|FG001|Phase B|Met Withdrawal Criteria|2|||
48676483|NCT01052077|156667306|FG002|Phase B|Met Withdrawal Criteria|1|||
48676484|NCT01052077|156667307|FG003|Phase B|Met Withdrawal Criteria|0|||
48676485|NCT01052077|156667304|FG000|Phase B|Physician Decision|0|||
48676486|NCT01052077|156667305|FG001|Phase B|Physician Decision|1|||
48676487|NCT01052077|156667306|FG002|Phase B|Physician Decision|1|||
48676488|NCT01052077|156667307|FG003|Phase B|Physician Decision|0|||
48676489|NCT01052077|156667304|FG000|Phase B|Withdrawal by Subject|0|||
48676490|NCT01052077|156667305|FG001|Phase B|Withdrawal by Subject|0|||
48676491|NCT01052077|156667306|FG002|Phase B|Withdrawal by Subject|5|||
48676492|NCT01052077|156667307|FG003|Phase B|Withdrawal by Subject|0|||
48676493|NCT01052077|156667304|FG000|Phase B|Protocol Deviation|0|||
48676494|NCT01052077|156667305|FG001|Phase B|Protocol Deviation|3|||
48676495|NCT01052077|156667306|FG002|Phase B|Protocol Deviation|4|||
48676496|NCT01052077|156667307|FG003|Phase B|Protocol Deviation|0|||
48676497|NCT01052077|156667304|FG000|Phase B|Lack of Efficacy|0|||
48676498|NCT01052077|156667305|FG001|Phase B|Lack of Efficacy|1|||
48676499|NCT01052077|156667306|FG002|Phase B|Lack of Efficacy|0|||
48676500|NCT01052077|156667307|FG003|Phase B|Lack of Efficacy|0|||
48676501|NCT01052077|156667304|FG000|Phase A+|Lost to Follow-up|0|||
48676502|NCT01052077|156667305|FG001|Phase A+|Lost to Follow-up|0|||
48676503|NCT01052077|156667306|FG002|Phase A+|Lost to Follow-up|0|||
48676504|NCT01052077|156667307|FG003|Phase A+|Lost to Follow-up|8|||
48676505|NCT01052077|156667304|FG000|Phase A+|Adverse Event|0|||
48676506|NCT01052077|156667305|FG001|Phase A+|Adverse Event|0|||
48762237|NCT03020823|156978050|FG000|Overall Study|Physician Decision|4|||
48762238|NCT03020823|156978050|FG000|Overall Study|Lack of Efficacy|4|||
48762239|NCT03020823|156978050|FG000|Overall Study|Adverse Event|2|||
48762240|NCT04307446|156978052|FG000|Overall Study|Lost to Follow-up|2|||
48762241|NCT04307446|156978053|FG001|Overall Study|Lost to Follow-up|0|||
48762242|NCT01859494|156978054|FG000|Overall Study|Adverse Event|1|||
48762243|NCT01957462|156978055|FG000|Test Period 1|Withdrawal by Subject|1|||
48762244|NCT01957462|156978056|FG001|Test Period 1|Withdrawal by Subject|0|||
48762245|NCT01957462|156978055|FG000|Test Period 1|Adverse Event|1|||
48762246|NCT01957462|156978056|FG001|Test Period 1|Adverse Event|0|||
48762247|NCT02529137|156978057|FG000|Overall Study|Discontinuation for different reasons|8|||
48762248|NCT02476968|156978058|FG000|Overall Study|Other|0|||
48762249|NCT02476968|156978059|FG001|Overall Study|Other|2|||
48762250|NCT02476968|156978060|FG002|Overall Study|Other|0|||
48762251|NCT02476968|156978058|FG000|Overall Study|Lost to Follow-up|10|||
48762252|NCT02476968|156978059|FG001|Overall Study|Lost to Follow-up|0|||
48762253|NCT02476968|156978060|FG002|Overall Study|Lost to Follow-up|1|||
48676507|NCT01052077|156667306|FG002|Phase A+|Adverse Event|0|||
48676508|NCT01052077|156667307|FG003|Phase A+|Adverse Event|4|||
48676509|NCT01052077|156667304|FG000|Phase A+|Met Withdrawal Criteria|0|||
48676510|NCT01052077|156667305|FG001|Phase A+|Met Withdrawal Criteria|0|||
48676511|NCT01052077|156667306|FG002|Phase A+|Met Withdrawal Criteria|0|||
48676512|NCT01052077|156667307|FG003|Phase A+|Met Withdrawal Criteria|2|||
48676513|NCT01052077|156667304|FG000|Phase A+|Withdrawal by Subject|0|||
48676514|NCT01052077|156667305|FG001|Phase A+|Withdrawal by Subject|0|||
48762254|NCT02476968|156978058|FG000|Overall Study|Death|48|||
48762255|NCT02476968|156978059|FG001|Overall Study|Death|8|||
48676515|NCT01052077|156667306|FG002|Phase A+|Withdrawal by Subject|0|||
48676516|NCT01052077|156667307|FG003|Phase A+|Withdrawal by Subject|7|||
48676517|NCT01811186|156667309|FG000|Overall Study|Adverse Event|54|||
48676518|NCT01811186|156667310|FG001|Overall Study|Adverse Event|38|||
48676519|NCT01811186|156667309|FG000|Overall Study|Protocol Violation|5|||
48676520|NCT01811186|156667310|FG001|Overall Study|Protocol Violation|6|||
48676521|NCT01811186|156667309|FG000|Overall Study|Withdrawal by Subject|5|||
48762256|NCT02476968|156978060|FG002|Overall Study|Death|1|||
49016239|NCT01927757|157896858|FG000|Overall Study|Withdrawal by Subject|14|||
49016240|NCT01927757|157896858|FG000|Overall Study|Lost to Follow-up|2|||
49016241|NCT01927757|157896858|FG000|Overall Study|Decision by Sponsor|2|||
49016242|NCT01927757|157896858|FG000|Overall Study|Other|1|||
49016243|NCT01927757|157896858|FG000|Overall Study|Ethical Reasons|4|||
49016244|NCT04583579|157896859|FG000|Overall Study|Lost to Follow-up|4|||
49016245|NCT01691859|157896860|FG000|Overall Study|Adverse Event|19|||
49016246|NCT01691859|157896860|FG000|Overall Study|Lack of Efficacy|11|||
49016247|NCT01691859|157896860|FG000|Overall Study|Protocol Violation|4|||
49016248|NCT01691859|157896860|FG000|Overall Study|Product commercially available|221|||
49016249|NCT01691859|157896860|FG000|Overall Study|Study closed/terminated|50|||
49016250|NCT01691859|157896860|FG000|Overall Study|Lost to Follow-up|5|||
49016251|NCT01691859|157896860|FG000|Overall Study|Physician Decision|6|||
49016252|NCT01691859|157896860|FG000|Overall Study|Withdrawal by Subject|31|||
49016253|NCT04820842|157896861|FG000|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
49016254|NCT04820842|157896862|FG001|Active Drug Extension Period (8 Weeks)|Adverse Event|1|||
49016255|NCT04820842|157896863|FG002|Active Drug Extension Period (8 Weeks)|Adverse Event|2|||
49016256|NCT04820842|157896864|FG003|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
49016257|NCT04820842|157896865|FG004|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
49016258|NCT04820842|157896866|FG005|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
49016259|NCT04820842|157896867|FG006|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
49016260|NCT04820842|157896861|FG000|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|3|||
49016261|NCT04820842|157896862|FG001|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|6|||
49016262|NCT04820842|157896863|FG002|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|5|||
49016263|NCT04820842|157896864|FG003|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
49016264|NCT04820842|157896865|FG004|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
49016265|NCT04820842|157896866|FG005|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
49016266|NCT04820842|157896867|FG006|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
49016267|NCT04820842|157896861|FG000|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
48676522|NCT01811186|156667310|FG001|Overall Study|Withdrawal by Subject|10|||
48676523|NCT01811186|156667309|FG000|Overall Study|Lack of Efficacy|3|||
48676524|NCT01811186|156667310|FG001|Overall Study|Lack of Efficacy|6|||
48676525|NCT01811186|156667309|FG000|Overall Study|Lost to Follow-up|4|||
48676526|NCT01811186|156667310|FG001|Overall Study|Lost to Follow-up|2|||
48676527|NCT00042991|156667313|FG000|Overall Study|Adverse Event|1|||
48676528|NCT00042991|156667314|FG001|Overall Study|Adverse Event|4|||
48676529|NCT00042991|156667315|FG002|Overall Study|Adverse Event|2|||
48676530|NCT00042991|156667316|FG003|Overall Study|Adverse Event|0|||
48676531|NCT00042991|156667317|FG004|Overall Study|Adverse Event|0|||
48676532|NCT00042991|156667318|FG005|Overall Study|Adverse Event|1|||
48676533|NCT00042991|156667319|FG006|Overall Study|Adverse Event|0|||
48676534|NCT00042991|156667313|FG000|Overall Study|Withdrawal by Subject|0|||
48676535|NCT00042991|156667314|FG001|Overall Study|Withdrawal by Subject|7|||
48676536|NCT00042991|156667315|FG002|Overall Study|Withdrawal by Subject|2|||
48676537|NCT00042991|156667316|FG003|Overall Study|Withdrawal by Subject|0|||
48676538|NCT00042991|156667317|FG004|Overall Study|Withdrawal by Subject|1|||
48676539|NCT00042991|156667318|FG005|Overall Study|Withdrawal by Subject|0|||
48676540|NCT00042991|156667319|FG006|Overall Study|Withdrawal by Subject|0|||
48676541|NCT00042991|156667313|FG000|Overall Study|Disease Progression|5|||
48676542|NCT00042991|156667314|FG001|Overall Study|Disease Progression|29|||
48676543|NCT00042991|156667315|FG002|Overall Study|Disease Progression|2|||
48676544|NCT00042991|156667316|FG003|Overall Study|Disease Progression|2|||
48676545|NCT00042991|156667317|FG004|Overall Study|Disease Progression|1|||
48676546|NCT00042991|156667318|FG005|Overall Study|Disease Progression|4|||
48676547|NCT00042991|156667319|FG006|Overall Study|Disease Progression|2|||
48676548|NCT00042991|156667313|FG000|Overall Study|Alternative Therapy|0|||
48676549|NCT00042991|156667314|FG001|Overall Study|Alternative Therapy|0|||
48676550|NCT00042991|156667315|FG002|Overall Study|Alternative Therapy|0|||
48676551|NCT00042991|156667316|FG003|Overall Study|Alternative Therapy|0|||
48676552|NCT00042991|156667317|FG004|Overall Study|Alternative Therapy|1|||
48676553|NCT00042991|156667318|FG005|Overall Study|Alternative Therapy|0|||
48676554|NCT00042991|156667319|FG006|Overall Study|Alternative Therapy|0|||
48676555|NCT03193736|156667320|FG000|Overall Study|Death|2|||
48676556|NCT03193736|156667320|FG000|Overall Study|Withdrawal by Subject|1|||
48676557|NCT03193736|156667320|FG000|Overall Study|Lost to Follow-up|1|||
48676558|NCT03193736|156667320|FG000|Overall Study|implant not received|1|||
48676559|NCT02508428|156667321|FG000|Overall Study|Death|32|||
48676560|NCT02508428|156667322|FG001|Overall Study|Death|33|||
48676561|NCT02508428|156667321|FG000|Overall Study|Liner revised|3|||
48676562|NCT02508428|156667322|FG001|Overall Study|Liner revised|19|||
48676563|NCT02508428|156667321|FG000|Overall Study|Incomplete follow-up|17|||
49016268|NCT04820842|157896862|FG001|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|1|||
49016269|NCT04820842|157896863|FG002|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
49016270|NCT04820842|157896864|FG003|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
49016271|NCT04820842|157896865|FG004|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
49016272|NCT04820842|157896866|FG005|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
49016273|NCT04820842|157896867|FG006|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
49016274|NCT04820842|157896861|FG000|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
49016275|NCT04820842|157896862|FG001|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
49016276|NCT04820842|157896863|FG002|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
49016277|NCT04820842|157896864|FG003|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|2|||
49016278|NCT04820842|157896865|FG004|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
49016279|NCT04820842|157896866|FG005|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
49016280|NCT04820842|157896867|FG006|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|1|||
49016281|NCT04081337|157896868|FG000|Overall Study|Adverse Event|0|||
49016282|NCT04081337|157896869|FG001|Overall Study|Adverse Event|1|||
49016283|NCT04081337|157896868|FG000|Overall Study|Withdrawal by Subject|2|||
49016284|NCT04081337|157896869|FG001|Overall Study|Withdrawal by Subject|0|||
49016285|NCT04081337|157896868|FG000|Overall Study|Physician Decision|1|||
49016286|NCT04081337|157896869|FG001|Overall Study|Physician Decision|2|||
49016287|NCT04081337|157896868|FG000|Overall Study|Lost to Follow-up|1|||
49016288|NCT04081337|157896869|FG001|Overall Study|Lost to Follow-up|0|||
49016289|NCT01579474|157896872|FG000|Overall Study|Adverse Event|1|||
49016290|NCT01579474|157896873|FG001|Overall Study|Adverse Event|13|||
49016291|NCT01579474|157896874|FG002|Overall Study|Adverse Event|2|||
49016292|NCT01579474|157896875|FG003|Overall Study|Adverse Event|0|||
49016293|NCT01579474|157896876|FG004|Overall Study|Adverse Event|0|||
49016294|NCT01579474|157896877|FG005|Overall Study|Adverse Event|1|||
49016295|NCT01579474|157896872|FG000|Overall Study|Lack of Efficacy|1|||
49016296|NCT01579474|157896873|FG001|Overall Study|Lack of Efficacy|0|||
49016297|NCT01579474|157896874|FG002|Overall Study|Lack of Efficacy|0|||
49016298|NCT01579474|157896875|FG003|Overall Study|Lack of Efficacy|0|||
49016299|NCT01579474|157896876|FG004|Overall Study|Lack of Efficacy|1|||
49016300|NCT01579474|157896877|FG005|Overall Study|Lack of Efficacy|0|||
49016301|NCT01579474|157896872|FG000|Overall Study|Withdrawal by Subject|1|||
49016302|NCT01579474|157896873|FG001|Overall Study|Withdrawal by Subject|0|||
49016303|NCT01579474|157896874|FG002|Overall Study|Withdrawal by Subject|0|||
49016304|NCT01579474|157896875|FG003|Overall Study|Withdrawal by Subject|0|||
49016305|NCT01579474|157896876|FG004|Overall Study|Withdrawal by Subject|0|||
49016306|NCT01579474|157896877|FG005|Overall Study|Withdrawal by Subject|0|||
49016307|NCT02637076|157896878|FG000|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
49016308|NCT02637076|157896879|FG001|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
49016309|NCT02637076|157896878|FG000|Overall Study|Withdrawal by Subject|0|||
49016310|NCT02637076|157896879|FG001|Overall Study|Withdrawal by Subject|4|||
49016311|NCT02688400|157896884|FG000|Overall Study|Protocol Violation|2|||
49016312|NCT02688400|157896885|FG001|Overall Study|Protocol Violation|5|||
49016313|NCT02688400|157896884|FG000|Overall Study|Lack of Efficacy|7|||
49016314|NCT02688400|157896885|FG001|Overall Study|Lack of Efficacy|7|||
49016315|NCT02688400|157896884|FG000|Overall Study|Adverse Event|21|||
49016316|NCT02688400|157896885|FG001|Overall Study|Adverse Event|12|||
49016317|NCT02688400|157896884|FG000|Overall Study|Withdrawal by Subject|15|||
49016318|NCT02688400|157896885|FG001|Overall Study|Withdrawal by Subject|13|||
49016319|NCT02688400|157896884|FG000|Overall Study|No study medication intake|1|||
49016320|NCT02688400|157896885|FG001|Overall Study|No study medication intake|4|||
49016321|NCT02688400|157896884|FG000|Overall Study|Lost to Follow-up|0|||
49016322|NCT02688400|157896885|FG001|Overall Study|Lost to Follow-up|3|||
49016323|NCT02207621|157896889|FG000|Overall Study|Adverse Event|71|||
49016324|NCT02207621|157896890|FG001|Overall Study|Adverse Event|15|||
49016325|NCT02207621|157896891|FG002|Overall Study|Adverse Event|132|||
49016326|NCT02207621|157896889|FG000|Overall Study|Withdrawal by Subject|9|||
49016327|NCT02207621|157896890|FG001|Overall Study|Withdrawal by Subject|9|||
49016328|NCT02207621|157896891|FG002|Overall Study|Withdrawal by Subject|13|||
49016329|NCT02207621|157896889|FG000|Overall Study|Non-Compliant|3|||
49016330|NCT02207621|157896890|FG001|Overall Study|Non-Compliant|3|||
49016331|NCT02207621|157896891|FG002|Overall Study|Non-Compliant|1|||
49016332|NCT02207621|157896889|FG000|Overall Study|Lost to Follow-up|1|||
49016333|NCT02207621|157896890|FG001|Overall Study|Lost to Follow-up|0|||
49016334|NCT02207621|157896891|FG002|Overall Study|Lost to Follow-up|3|||
49016335|NCT02207621|157896889|FG000|Overall Study|Lack of Efficacy|10|||
49016336|NCT02207621|157896890|FG001|Overall Study|Lack of Efficacy|2|||
49016337|NCT02207621|157896891|FG002|Overall Study|Lack of Efficacy|4|||
49016338|NCT02207621|157896889|FG000|Overall Study|Disallowed Concurrent Medication|2|||
49016339|NCT02207621|157896890|FG001|Overall Study|Disallowed Concurrent Medication|5|||
49016340|NCT02207621|157896891|FG002|Overall Study|Disallowed Concurrent Medication|2|||
49016341|NCT02207621|157896889|FG000|Overall Study|Physician Decision|1|||
49016342|NCT02207621|157896890|FG001|Overall Study|Physician Decision|2|||
49016343|NCT02207621|157896891|FG002|Overall Study|Physician Decision|2|||
49016344|NCT02207621|157896889|FG000|Overall Study|Protocol Violation|4|||
49016345|NCT02207621|157896890|FG001|Overall Study|Protocol Violation|10|||
49016346|NCT02207621|157896891|FG002|Overall Study|Protocol Violation|6|||
49016347|NCT02207621|157896889|FG000|Overall Study|Death|2|||
49016348|NCT02207621|157896890|FG001|Overall Study|Death|0|||
49016349|NCT02207621|157896891|FG002|Overall Study|Death|0|||
49016350|NCT02207621|157896889|FG000|Overall Study|Other(Site,Sponsor and Subject request)|2|||
49016351|NCT02207621|157896890|FG001|Overall Study|Other(Site,Sponsor and Subject request)|1|||
49016352|NCT02207621|157896891|FG002|Overall Study|Other(Site,Sponsor and Subject request)|5|||
49016353|NCT02204371|157896893|FG000|Overall Study|Adverse Event|1|||
49016354|NCT01894984|157896894|FG000|Overall Study|Other|314|||
49016355|NCT01894984|157896895|FG001|Overall Study|Other|175|||
49016356|NCT00524459|157896896|FG000|Overall Study|Withdrawal by Subject|1|||
49016357|NCT00524459|157896896|FG000|Overall Study|Other|1|||
49016358|NCT02866175|157896897|FG000|Overall Study|Adverse Event|56|||
49016359|NCT02866175|157896898|FG001|Overall Study|Adverse Event|54|||
49016360|NCT02866175|157896897|FG000|Overall Study|Withdrawal by Subject|31|||
49016361|NCT02866175|157896898|FG001|Overall Study|Withdrawal by Subject|52|||
49016362|NCT02866175|157896897|FG000|Overall Study|Death|30|||
49016363|NCT02866175|157896898|FG001|Overall Study|Death|23|||
49016364|NCT02866175|157896897|FG000|Overall Study|Other|7|||
49016365|NCT02866175|157896898|FG001|Overall Study|Other|14|||
49016366|NCT02866175|157896897|FG000|Overall Study|Progressive disease|1|||
49016367|NCT02866175|157896898|FG001|Overall Study|Progressive disease|1|||
49016368|NCT02866175|157896897|FG000|Overall Study|Lost to Follow-up|2|||
49016369|NCT02866175|157896898|FG001|Overall Study|Lost to Follow-up|0|||
49016370|NCT02866175|157896897|FG000|Overall Study|Lack of Efficacy|0|||
49016371|NCT02866175|157896898|FG001|Overall Study|Lack of Efficacy|1|||
49016372|NCT02866175|157896897|FG000|Overall Study|Physician Decision|3|||
49016373|NCT02866175|157896898|FG001|Overall Study|Physician Decision|15|||
49016374|NCT02866175|157896897|FG000|Overall Study|Did not receive treatment|5|||
49016375|NCT02866175|157896898|FG001|Overall Study|Did not receive treatment|15|||
49016376|NCT00729859|157896899|FG000|Overall Study|Adverse Event|0|||
49016377|NCT00729859|157896900|FG001|Overall Study|Adverse Event|1|||
49016378|NCT00729859|157896901|FG002|Overall Study|Adverse Event|0|||
49016379|NCT00729859|157896899|FG000|Overall Study|Withdrawal by Subject|0|||
49016380|NCT00729859|157896900|FG001|Overall Study|Withdrawal by Subject|1|||
49016381|NCT00729859|157896901|FG002|Overall Study|Withdrawal by Subject|0|||
49016382|NCT00290745|157896904|FG000|Overall Study|Withdrawal by Subject|4|||
49016383|NCT00290745|157896904|FG000|Overall Study|Physician Decision|2|||
49016384|NCT00290745|157896904|FG000|Overall Study|Surgery after 3 months for progression|3|||
49016385|NCT00290745|157896904|FG000|Overall Study|Baseline MRI not available|3|||
49016386|NCT01842958|157896905|FG000|Overall Study|Lost to Follow-up|1|||
49016387|NCT01842958|157896906|FG001|Overall Study|Lost to Follow-up|1|||
49016388|NCT00626925|157896907|FG000|Overall Study|Lost to Follow-up|1|||
49016389|NCT00626925|157896908|FG001|Overall Study|Lost to Follow-up|2|||
49016390|NCT00626925|157896907|FG000|Overall Study|relapse|1|||
49016391|NCT00626925|157896908|FG001|Overall Study|relapse|0|||
49016392|NCT00626925|157896907|FG000|Overall Study|Adverse effect|6|||
49016393|NCT00626925|157896908|FG001|Overall Study|Adverse effect|2|||
49016394|NCT00626925|157896907|FG000|Overall Study|Lack of Efficacy|1|||
49016395|NCT00626925|157896908|FG001|Overall Study|Lack of Efficacy|4|||
49016396|NCT00626925|157896907|FG000|Overall Study|Time constraints|3|||
49016397|NCT00626925|157896908|FG001|Overall Study|Time constraints|1|||
49016398|NCT01829477|157896909|FG000|Overall Study|Study Terminated by Sponsor|15|||
49016399|NCT01829477|157896910|FG001|Overall Study|Study Terminated by Sponsor|15|||
49016400|NCT01829477|157896909|FG000|Overall Study|Withdrawal by Subject|1|||
49016401|NCT01829477|157896910|FG001|Overall Study|Withdrawal by Subject|0|||
49016402|NCT01215942|157896912|FG000|Treatment Period|Adverse Event|15|||
49016403|NCT01215942|157896913|FG001|Treatment Period|Adverse Event|26|||
49016404|NCT01215942|157896912|FG000|Treatment Period|Death|2|||
49016405|NCT01215942|157896913|FG001|Treatment Period|Death|4|||
49016406|NCT01215942|157896912|FG000|Treatment Period|Lack of Efficacy|23|||
49016407|NCT01215942|157896913|FG001|Treatment Period|Lack of Efficacy|62|||
49016408|NCT01215942|157896912|FG000|Treatment Period|Lost to Follow-up|3|||
49016409|NCT01215942|157896913|FG001|Treatment Period|Lost to Follow-up|4|||
49016410|NCT01215942|157896912|FG000|Treatment Period|Withdrawal by Subject|17|||
49016411|NCT01215942|157896913|FG001|Treatment Period|Withdrawal by Subject|40|||
49016412|NCT01215942|157896912|FG000|Treatment Period|Physician Decision|5|||
49016413|NCT01215942|157896913|FG001|Treatment Period|Physician Decision|5|||
49016414|NCT01215942|157896912|FG000|Treatment Period|Protocol Violation|0|||
49016415|NCT01215942|157896913|FG001|Treatment Period|Protocol Violation|1|||
49016416|NCT01215942|157896912|FG000|Treatment Period|Sponsor Decision|349|||
49016417|NCT01215942|157896913|FG001|Treatment Period|Sponsor Decision|530|||
49016418|NCT01215942|157896912|FG000|Post-Treatment Follow-Up Period|Death|0|||
49016419|NCT01215942|157896913|FG001|Post-Treatment Follow-Up Period|Death|1|||
49016420|NCT01215942|157896912|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
49016421|NCT01215942|157896913|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
49016422|NCT01215942|157896912|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|43|||
49016423|NCT01215942|157896913|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|69|||
49016424|NCT01215942|157896912|FG000|Post-Treatment Follow-Up Period|Physician Decision|1|||
49016425|NCT01215942|157896913|FG001|Post-Treatment Follow-Up Period|Physician Decision|2|||
49016426|NCT01215942|157896912|FG000|Post-Treatment Follow-Up Period|Sponsor Decision|28|||
49016427|NCT01215942|157896913|FG001|Post-Treatment Follow-Up Period|Sponsor Decision|61|||
49016428|NCT00927810|157896914|FG000|Overall Study|Withdrawal by Subject|0|||
49016429|NCT00927810|157896915|FG001|Overall Study|Withdrawal by Subject|3|||
49016430|NCT00927810|157896916|FG002|Overall Study|Withdrawal by Subject|0|||
49016431|NCT00927810|157896917|FG003|Overall Study|Withdrawal by Subject|1|||
49016432|NCT00927810|157896914|FG000|Overall Study|Lost to Follow-up|0|||
49016433|NCT00927810|157896915|FG001|Overall Study|Lost to Follow-up|2|||
49016434|NCT00927810|157896916|FG002|Overall Study|Lost to Follow-up|1|||
49016435|NCT00927810|157896917|FG003|Overall Study|Lost to Follow-up|1|||
49016436|NCT00927810|157896914|FG000|Overall Study|Death|0|||
49016437|NCT00927810|157896915|FG001|Overall Study|Death|2|||
49016438|NCT00927810|157896916|FG002|Overall Study|Death|0|||
49016439|NCT00927810|157896917|FG003|Overall Study|Death|0|||
49016440|NCT00927810|157896914|FG000|Overall Study|Abnormal laboratory value(s)|0|||
49016441|NCT00927810|157896915|FG001|Overall Study|Abnormal laboratory value(s)|1|||
49016442|NCT00927810|157896916|FG002|Overall Study|Abnormal laboratory value(s)|0|||
49016443|NCT00927810|157896917|FG003|Overall Study|Abnormal laboratory value(s)|0|||
49016444|NCT00798889|157896918|FG000|Overall Study|Adverse Event|53|||
49016445|NCT00798889|157896918|FG000|Overall Study|Protocol Violation|2|||
49016446|NCT00798889|157896918|FG000|Overall Study|Withdrawal by Subject|31|||
49016447|NCT00798889|157896918|FG000|Overall Study|Lost to Follow-up|1|||
49016448|NCT00798889|157896918|FG000|Overall Study|Lack of Efficacy|213|||
49016449|NCT00798889|157896918|FG000|Overall Study|Decision of Sponsor|11|||
49016450|NCT00798889|157896918|FG000|Overall Study|Enrolled, Not treated|3|||
49016451|NCT01656889|157896926|FG000|Treatment Period, 12 Weeks|Adverse Event|10|||
49016452|NCT01656889|157896927|FG001|Treatment Period, 12 Weeks|Adverse Event|4|||
49016453|NCT01656889|157896926|FG000|Treatment Period, 12 Weeks|Death|0|||
49016454|NCT01656889|157896927|FG001|Treatment Period, 12 Weeks|Death|1|||
49016455|NCT01656889|157896926|FG000|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
49016456|NCT01656889|157896927|FG001|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
49016457|NCT01656889|157896926|FG000|Treatment Period, 12 Weeks|Withdrawal by Subject|1|||
49016458|NCT01656889|157896927|FG001|Treatment Period, 12 Weeks|Withdrawal by Subject|2|||
49016459|NCT01656889|157896926|FG000|Treatment Period, 12 Weeks|Protocol Violation|0|||
49016460|NCT01656889|157896927|FG001|Treatment Period, 12 Weeks|Protocol Violation|1|||
49016461|NCT01656889|157896926|FG000|Treatment Period, 12 Weeks|Moved out of the area|0|||
49016462|NCT01656889|157896927|FG001|Treatment Period, 12 Weeks|Moved out of the area|2|||
49016463|NCT01656889|157896926|FG000|Post Treatment Follow-Up, 3 Months|Death|1|||
49016464|NCT01656889|157896927|FG001|Post Treatment Follow-Up, 3 Months|Death|5|||
49016465|NCT01656889|157896926|FG000|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1|||
49016466|NCT01656889|157896927|FG001|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2|||
49016467|NCT01656889|157896926|FG000|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2|||
49016468|NCT01656889|157896927|FG001|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1|||
49016469|NCT01656889|157896926|FG000|Post Treatment Follow-Up, 3 Months|Site Closure|0|||
49016470|NCT01656889|157896927|FG001|Post Treatment Follow-Up, 3 Months|Site Closure|1|||
49016471|NCT00278512|157896936|FG000|Overall Study|Death|1|||
49016472|NCT00278512|157896937|FG001|Overall Study|Death|0|||
49016473|NCT01620177|157896940|FG000|Overall Study|Failure at Screening Visit|43|||
49016474|NCT01620177|157896940|FG000|Overall Study|Withdrawal by Subject|26|||
49016475|NCT01620177|157896940|FG000|Overall Study|Lost to Follow-up|7|||
48676564|NCT02508428|156667322|FG001|Overall Study|Incomplete follow-up|15|||
48676565|NCT02476006|156667327|FG000|Overall Study|Death|4|||
49016476|NCT01620177|157896940|FG000|Overall Study|Physician Decision|2|||
49016477|NCT01620177|157896940|FG000|Overall Study|Randomized, Not Active due to Scheduling|1|||
49016478|NCT00679783|157896941|FG000|Overall Study|Adverse Event|0|||
48676566|NCT02476006|156667327|FG000|Overall Study|Lack of treatment efficacy|2|||
49016479|NCT00679783|157896942|FG001|Overall Study|Adverse Event|0|||
49016480|NCT00679783|157896943|FG002|Overall Study|Adverse Event|0|||
49016481|NCT00679783|157896944|FG003|Overall Study|Adverse Event|3|||
49016482|NCT00679783|157896945|FG004|Overall Study|Adverse Event|0|||
49016483|NCT00679783|157896946|FG005|Overall Study|Adverse Event|0|||
49016484|NCT00679783|157896947|FG006|Overall Study|Adverse Event|1|||
49016485|NCT00679783|157896941|FG000|Overall Study|Lack of Efficacy|0|||
49016486|NCT00679783|157896942|FG001|Overall Study|Lack of Efficacy|1|||
49016487|NCT00679783|157896943|FG002|Overall Study|Lack of Efficacy|0|||
48676567|NCT02476006|156667327|FG000|Overall Study|Pregnancy|1|||
48676568|NCT02476006|156667327|FG000|Overall Study|Participant did not wish to continue|39|||
48676569|NCT02476006|156667327|FG000|Overall Study|Adverse Event|41|||
48676570|NCT02476006|156667327|FG000|Overall Study|Poor compliance to study protocol|3|||
48676571|NCT02476006|156667327|FG000|Overall Study|Sponsor decision|6|||
48676572|NCT02476006|156667327|FG000|Overall Study|Lost to Follow-up|5|||
48676573|NCT02476006|156667327|FG000|Overall Study|Physician Decision|5|||
48676574|NCT02476006|156667327|FG000|Overall Study|Study ended treatment not available|4|||
48676575|NCT02476006|156667327|FG000|Overall Study|Switched to commercial drug|4|||
48676576|NCT02476006|156667327|FG000|Overall Study|Excluded from study|1|||
48874491|NCT00665223|157377034|FG002|Open-Label Period (26 Weeks)|Adverse Event|7|||
48874492|NCT00665223|157377032|FG000|Open-Label Period (26 Weeks)|Death|0|||
48874493|NCT00665223|157377033|FG001|Open-Label Period (26 Weeks)|Death|1|||
48874494|NCT00665223|157377034|FG002|Open-Label Period (26 Weeks)|Death|0|||
48874495|NCT00665223|157377032|FG000|Open-Label Period (26 Weeks)|Lost to Follow-up|3|||
48874496|NCT00665223|157377033|FG001|Open-Label Period (26 Weeks)|Lost to Follow-up|1|||
48874497|NCT00665223|157377034|FG002|Open-Label Period (26 Weeks)|Lost to Follow-up|2|||
48874498|NCT00665223|157377032|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|5|||
48874499|NCT00665223|157377033|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|3|||
48874500|NCT00665223|157377034|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|4|||
48874501|NCT00665223|157377032|FG000|Open-Label Period (26 Weeks)|Protocol Violation|0|||
48874502|NCT00665223|157377033|FG001|Open-Label Period (26 Weeks)|Protocol Violation|1|||
48874503|NCT00665223|157377034|FG002|Open-Label Period (26 Weeks)|Protocol Violation|0|||
48874504|NCT00665223|157377032|FG000|Open-Label Period (26 Weeks)|Other than specified|0|||
48874505|NCT00665223|157377033|FG001|Open-Label Period (26 Weeks)|Other than specified|0|||
48874506|NCT00665223|157377034|FG002|Open-Label Period (26 Weeks)|Other than specified|2|||
48874507|NCT01013740|157377035|FG000|Overall Study|Lost to Follow-up|3|||
48874508|NCT01013740|157377036|FG001|Overall Study|Lost to Follow-up|5|||
48874509|NCT01013740|157377035|FG000|Overall Study|Physician Decision|2|||
48874510|NCT01013740|157377036|FG001|Overall Study|Physician Decision|0|||
48874511|NCT01013740|157377035|FG000|Overall Study|Withdrawal by Subject|2|||
48874512|NCT01013740|157377036|FG001|Overall Study|Withdrawal by Subject|10|||
48874513|NCT01013740|157377035|FG000|Overall Study|study close / terminated : done in error|2|||
48874514|NCT01013740|157377036|FG001|Overall Study|study close / terminated : done in error|1|||
48874515|NCT01013740|157377035|FG000|Overall Study|Missing|2|||
48874516|NCT01013740|157377036|FG001|Overall Study|Missing|1|||
48874517|NCT01013740|157377035|FG000|Overall Study|Ongoing: Study records not completed|0|||
48874518|NCT01013740|157377036|FG001|Overall Study|Ongoing: Study records not completed|2|||
48874519|NCT02654132|157377037|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
48874520|NCT02654132|157377038|FG001|Pre-Treatment Period|Participant Withdrew Consent|2|||
48874521|NCT02654132|157377037|FG000|Treatment Period|Disease progression|43|||
48874522|NCT02654132|157377038|FG001|Treatment Period|Disease progression|38|||
48874523|NCT02654132|157377037|FG000|Treatment Period|Adverse Event unrelated to study drug|6|||
48874524|NCT02654132|157377038|FG001|Treatment Period|Adverse Event unrelated to study drug|9|||
48874525|NCT02654132|157377037|FG000|Treatment Period|Other reasons|4|||
48874526|NCT02654132|157377038|FG001|Treatment Period|Other reasons|2|||
48874527|NCT02654132|157377037|FG000|Treatment Period|Study drug toxicity|2|||
48874528|NCT02654132|157377038|FG001|Treatment Period|Study drug toxicity|2|||
48874529|NCT02654132|157377037|FG000|Treatment Period|Withdrawal by Subject|2|||
48874530|NCT02654132|157377038|FG001|Treatment Period|Withdrawal by Subject|1|||
48874531|NCT02654132|157377037|FG000|Treatment Period|Maximum Clinical Benefit|0|||
48874532|NCT02654132|157377038|FG001|Treatment Period|Maximum Clinical Benefit|2|||
48874533|NCT02654132|157377037|FG000|Treatment Period|Participant request to discontinue|2|||
48874534|NCT02654132|157377038|FG001|Treatment Period|Participant request to discontinue|0|||
48676577|NCT02476006|156667327|FG000|Overall Study|Protocol Violation|1|||
48676578|NCT02476006|156667327|FG000|Overall Study|Enrolled but not treated|4|||
48874535|NCT02654132|157377037|FG000|Treatment Period|Administrative reasons by sponsor|0|||
48874536|NCT02654132|157377038|FG001|Treatment Period|Administrative reasons by sponsor|1|||
48874537|NCT02654132|157377037|FG000|Treatment Period|Death|1|||
48874538|NCT02654132|157377038|FG001|Treatment Period|Death|0|||
49016488|NCT00679783|157896944|FG003|Overall Study|Lack of Efficacy|2|||
48676579|NCT03772665|156667328|FG000|Overall Study|Protocol Violation|1|||
48676580|NCT03772665|156667329|FG001|Overall Study|Protocol Violation|0|||
48676581|NCT02688985|156669062|FG000|Overall Study|Adverse Event|1|||
48676582|NCT02688985|156669063|FG001|Overall Study|Adverse Event|2|||
48676583|NCT02688985|156669064|FG002|Overall Study|Adverse Event|2|||
48676584|NCT02688985|156669065|FG003|Overall Study|Adverse Event|0|||
48676585|NCT02688985|156669066|FG004|Overall Study|Adverse Event|0|||
48676586|NCT02688985|156669062|FG000|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
48676587|NCT02688985|156669063|FG001|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
48676588|NCT02688985|156669064|FG002|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
48676589|NCT02688985|156669065|FG003|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
48676590|NCT02688985|156669066|FG004|Overall Study|Continued Onto Commercially Available Ocrelizumab|21|||
49016489|NCT00679783|157896945|FG004|Overall Study|Lack of Efficacy|0|||
49016490|NCT00679783|157896946|FG005|Overall Study|Lack of Efficacy|0|||
49016491|NCT00679783|157896947|FG006|Overall Study|Lack of Efficacy|0|||
49016492|NCT00679783|157896941|FG000|Overall Study|Withdrawal by Subject|0|||
49016493|NCT00679783|157896942|FG001|Overall Study|Withdrawal by Subject|0|||
49016494|NCT00679783|157896943|FG002|Overall Study|Withdrawal by Subject|1|||
49016495|NCT00679783|157896944|FG003|Overall Study|Withdrawal by Subject|1|||
49016496|NCT00679783|157896945|FG004|Overall Study|Withdrawal by Subject|0|||
49016497|NCT00679783|157896946|FG005|Overall Study|Withdrawal by Subject|0|||
49016498|NCT00679783|157896947|FG006|Overall Study|Withdrawal by Subject|0|||
49016499|NCT00679783|157896941|FG000|Overall Study|Not Captured|0|||
49016500|NCT00679783|157896942|FG001|Overall Study|Not Captured|0|||
49016501|NCT00679783|157896943|FG002|Overall Study|Not Captured|0|||
49016502|NCT00679783|157896944|FG003|Overall Study|Not Captured|5|||
49016503|NCT00679783|157896945|FG004|Overall Study|Not Captured|0|||
49016504|NCT00679783|157896946|FG005|Overall Study|Not Captured|0|||
49016505|NCT00679783|157896947|FG006|Overall Study|Not Captured|0|||
49016506|NCT00679783|157896941|FG000|Overall Study|Ongoing at data cut-off|2|||
49016507|NCT00679783|157896942|FG001|Overall Study|Ongoing at data cut-off|2|||
49016508|NCT00679783|157896943|FG002|Overall Study|Ongoing at data cut-off|0|||
49016509|NCT00679783|157896944|FG003|Overall Study|Ongoing at data cut-off|9|||
48676591|NCT02688985|156669062|FG000|Overall Study|Death|0|||
48676592|NCT02688985|156669063|FG001|Overall Study|Death|0|||
48874539|NCT01407276|157377039|FG000|Overall Study|Withdrawal by Subject|0|||
49016510|NCT00679783|157896945|FG004|Overall Study|Ongoing at data cut-off|1|||
49016511|NCT00679783|157896946|FG005|Overall Study|Ongoing at data cut-off|0|||
49016512|NCT00679783|157896947|FG006|Overall Study|Ongoing at data cut-off|0|||
49016513|NCT02153736|157896954|FG000|Overall Study|Lost to Follow-up|1|||
49016514|NCT02153736|157896955|FG001|Overall Study|Lost to Follow-up|0|||
49016515|NCT02153736|157896954|FG000|Overall Study|Medical status change made ineligible|1|||
49016516|NCT02153736|157896955|FG001|Overall Study|Medical status change made ineligible|0|||
49016517|NCT02153736|157896954|FG000|Overall Study|Death|0|||
49016518|NCT02153736|157896955|FG001|Overall Study|Death|1|||
49016519|NCT02153736|157896954|FG000|Overall Study|Withdrawal by Subject|0|||
49016520|NCT02153736|157896955|FG001|Overall Study|Withdrawal by Subject|1|||
49016521|NCT03775681|157896956|FG000|Overall Study|Physician Decision|3|||
49016522|NCT03283709|157896957|FG000|Overall Study|trial terminated|0|||
49016523|NCT03283709|157896958|FG001|Overall Study|trial terminated|1|||
49016524|NCT00969332|157896961|FG000|Overall Study|Physician Decision|8|||
49016525|NCT00969332|157896961|FG000|Overall Study|Withdrawal by Subject|3|||
49016526|NCT00582309|157896962|FG000|Overall Study|Protocol Violation|0|||
49016527|NCT00582309|157896963|FG001|Overall Study|Protocol Violation|0|||
49016528|NCT00582309|157896964|FG002|Overall Study|Protocol Violation|2|||
49016529|NCT01565083|157896967|FG000|Overall Study|Withdrawal by Subject|6|||
49016530|NCT01565083|157896968|FG001|Overall Study|Withdrawal by Subject|4|||
49016531|NCT01565083|157896967|FG000|Overall Study|Lost to Follow-up|2|||
49016532|NCT01565083|157896968|FG001|Overall Study|Lost to Follow-up|7|||
49016533|NCT01565083|157896967|FG000|Overall Study|Death|22|||
49016534|NCT01565083|157896968|FG001|Overall Study|Death|23|||
49016535|NCT01565083|157896967|FG000|Overall Study|Other|3|||
49016536|NCT01565083|157896968|FG001|Overall Study|Other|5|||
49016537|NCT02708277|157896969|FG000|Overall Study|Lost to Follow-up|7|||
49016538|NCT02708277|157896970|FG001|Overall Study|Lost to Follow-up|4|||
49016539|NCT00996736|157896971|FG000|Overall Study|Death|1|||
49016540|NCT00996736|157896972|FG001|Overall Study|Death|1|||
49016541|NCT00996736|157896971|FG000|Overall Study|Lost to Follow-up|15|||
49016542|NCT00996736|157896972|FG001|Overall Study|Lost to Follow-up|14|||
49016543|NCT00996736|157896971|FG000|Overall Study|Visit not within 3-month window|5|||
49016544|NCT00996736|157896972|FG001|Overall Study|Visit not within 3-month window|3|||
49016545|NCT00433381|157898622|FG000|Overall Study|Ineligible / no protocol treatment|3|||
49016546|NCT00433381|157898623|FG001|Overall Study|Ineligible / no protocol treatment|3|||
49016547|NCT02806232|157898624|FG000|Overall Study|Lost to Follow-up|1|||
49016548|NCT02806232|157898625|FG001|Overall Study|Lost to Follow-up|2|||
49016549|NCT02806232|157898626|FG002|Overall Study|Lost to Follow-up|1|||
49016550|NCT02806232|157898627|FG003|Overall Study|Lost to Follow-up|0|||
49016551|NCT02806232|157898628|FG004|Overall Study|Lost to Follow-up|0|||
49016552|NCT02806232|157898629|FG005|Overall Study|Lost to Follow-up|1|||
49016553|NCT02806232|157898630|FG006|Overall Study|Lost to Follow-up|0|||
49016554|NCT02806232|157898631|FG007|Overall Study|Lost to Follow-up|0|||
49016555|NCT02806232|157898632|FG008|Overall Study|Lost to Follow-up|0|||
49016556|NCT02806232|157898624|FG000|Overall Study|Withdrawal by Subject|0|||
49016557|NCT02806232|157898625|FG001|Overall Study|Withdrawal by Subject|2|||
49016558|NCT02806232|157898626|FG002|Overall Study|Withdrawal by Subject|0|||
49016559|NCT02806232|157898627|FG003|Overall Study|Withdrawal by Subject|0|||
49016560|NCT02806232|157898628|FG004|Overall Study|Withdrawal by Subject|2|||
49016561|NCT02806232|157898629|FG005|Overall Study|Withdrawal by Subject|1|||
49016562|NCT02806232|157898630|FG006|Overall Study|Withdrawal by Subject|0|||
49016563|NCT02806232|157898631|FG007|Overall Study|Withdrawal by Subject|0|||
49016564|NCT02806232|157898632|FG008|Overall Study|Withdrawal by Subject|0|||
48676593|NCT02688985|156669064|FG002|Overall Study|Death|0|||
48676594|NCT02688985|156669065|FG003|Overall Study|Death|0|||
48676595|NCT02688985|156669066|FG004|Overall Study|Death|1|||
48676596|NCT02688985|156669062|FG000|Overall Study|Lack of Efficacy|0|||
49016565|NCT00598559|157898633|FG000|Overall Study|Adverse Event|11|||
49016566|NCT00598559|157898634|FG001|Overall Study|Adverse Event|7|||
49016567|NCT00598559|157898635|FG002|Overall Study|Adverse Event|0|||
49016568|NCT00598559|157898633|FG000|Overall Study|Withdrawal by Subject|2|||
49016569|NCT00598559|157898634|FG001|Overall Study|Withdrawal by Subject|2|||
49016570|NCT00598559|157898635|FG002|Overall Study|Withdrawal by Subject|0|||
49016571|NCT00598559|157898633|FG000|Overall Study|Protocol Non-compliance|1|||
49016572|NCT00598559|157898634|FG001|Overall Study|Protocol Non-compliance|0|||
49016573|NCT00598559|157898635|FG002|Overall Study|Protocol Non-compliance|0|||
49016574|NCT00598559|157898633|FG000|Overall Study|Early discharge from hospital|9|||
49016575|NCT00598559|157898634|FG001|Overall Study|Early discharge from hospital|12|||
49016576|NCT00598559|157898635|FG002|Overall Study|Early discharge from hospital|3|||
49016577|NCT00598559|157898633|FG000|Overall Study|Subject unable/unwilling to attend visit|4|||
49016578|NCT00598559|157898634|FG001|Overall Study|Subject unable/unwilling to attend visit|7|||
49016579|NCT00598559|157898635|FG002|Overall Study|Subject unable/unwilling to attend visit|0|||
49016580|NCT01059071|157898636|FG000|Overall Study|Lack of Efficacy|1|||
49016581|NCT01059071|157898637|FG001|Overall Study|Lack of Efficacy|4|||
49016582|NCT01059071|157898638|FG002|Overall Study|Lack of Efficacy|2|||
49016583|NCT01059071|157898639|FG003|Overall Study|Lack of Efficacy|3|||
49016584|NCT01059071|157898636|FG000|Overall Study|Withdrawal by Subject|1|||
49016585|NCT01059071|157898637|FG001|Overall Study|Withdrawal by Subject|0|||
49016586|NCT01059071|157898638|FG002|Overall Study|Withdrawal by Subject|0|||
49016587|NCT01059071|157898639|FG003|Overall Study|Withdrawal by Subject|2|||
49016588|NCT01059071|157898636|FG000|Overall Study|Physician Decision|0|||
49016589|NCT01059071|157898637|FG001|Overall Study|Physician Decision|0|||
49016590|NCT01059071|157898638|FG002|Overall Study|Physician Decision|0|||
49016591|NCT01059071|157898639|FG003|Overall Study|Physician Decision|1|||
49016592|NCT03922477|157898641|FG000|Overall Study|Death|9|||
49016593|NCT03922477|157898641|FG000|Overall Study|Fall leading to death prior to treatment initiation.|1|||
49016594|NCT03922477|157898641|FG000|Overall Study|Physician Decision|1|||
49016595|NCT03922477|157898641|FG000|Overall Study|Withdrawal by Subject|2|||
49016596|NCT00278200|157898642|FG000|Overall Study|Death|1|||
49016597|NCT00278200|157898643|FG001|Overall Study|Death|3|||
49016598|NCT00278200|157898642|FG000|Overall Study|Physician Decision|0|||
49016599|NCT00278200|157898643|FG001|Overall Study|Physician Decision|1|||
49016600|NCT01296932|157898644|FG000|Overall Study|Dose limiting toxicity|0|||
49016601|NCT01296932|157898645|FG001|Overall Study|Dose limiting toxicity|0|||
49016602|NCT01296932|157898646|FG002|Overall Study|Dose limiting toxicity|0|||
49016603|NCT01296932|157898647|FG003|Overall Study|Dose limiting toxicity|0|||
49016604|NCT01296932|157898648|FG004|Overall Study|Dose limiting toxicity|0|||
49016605|NCT01296932|157898649|FG005|Overall Study|Dose limiting toxicity|0|||
49016606|NCT01296932|157898650|FG006|Overall Study|Dose limiting toxicity|1|||
49016607|NCT01296932|157898651|FG007|Overall Study|Dose limiting toxicity|0|||
49016608|NCT01296932|157898652|FG008|Overall Study|Dose limiting toxicity|1|||
49016609|NCT01296932|157898644|FG000|Overall Study|Progressive disease|2|||
49016610|NCT01296932|157898645|FG001|Overall Study|Progressive disease|0|||
49016611|NCT01296932|157898646|FG002|Overall Study|Progressive disease|1|||
49016612|NCT01296932|157898647|FG003|Overall Study|Progressive disease|1|||
49016613|NCT01296932|157898648|FG004|Overall Study|Progressive disease|2|||
49016614|NCT01296932|157898649|FG005|Overall Study|Progressive disease|3|||
49016615|NCT01296932|157898650|FG006|Overall Study|Progressive disease|1|||
49016616|NCT01296932|157898651|FG007|Overall Study|Progressive disease|0|||
49016617|NCT01296932|157898652|FG008|Overall Study|Progressive disease|0|||
49016618|NCT01296932|157898644|FG000|Overall Study|Withdrawal by Subject|0|||
49016619|NCT01296932|157898645|FG001|Overall Study|Withdrawal by Subject|0|||
49016620|NCT01296932|157898646|FG002|Overall Study|Withdrawal by Subject|1|||
49016621|NCT01296932|157898647|FG003|Overall Study|Withdrawal by Subject|1|||
49016622|NCT01296932|157898648|FG004|Overall Study|Withdrawal by Subject|0|||
49016623|NCT01296932|157898649|FG005|Overall Study|Withdrawal by Subject|0|||
48676597|NCT02688985|156669063|FG001|Overall Study|Lack of Efficacy|0|||
48676598|NCT02688985|156669064|FG002|Overall Study|Lack of Efficacy|0|||
48676599|NCT02688985|156669065|FG003|Overall Study|Lack of Efficacy|0|||
49016624|NCT01296932|157898650|FG006|Overall Study|Withdrawal by Subject|3|||
49016625|NCT01296932|157898651|FG007|Overall Study|Withdrawal by Subject|0|||
49016626|NCT01296932|157898652|FG008|Overall Study|Withdrawal by Subject|0|||
49016627|NCT01296932|157898644|FG000|Overall Study|Adverse Event|1|||
49016628|NCT01296932|157898645|FG001|Overall Study|Adverse Event|1|||
49016629|NCT01296932|157898646|FG002|Overall Study|Adverse Event|1|||
49016630|NCT01296932|157898647|FG003|Overall Study|Adverse Event|2|||
48676600|NCT02688985|156669066|FG004|Overall Study|Lack of Efficacy|1|||
48676601|NCT02688985|156669062|FG000|Overall Study|Lost to Follow-up|2|||
49016631|NCT01296932|157898648|FG004|Overall Study|Adverse Event|1|||
49016632|NCT01296932|157898649|FG005|Overall Study|Adverse Event|0|||
49016633|NCT01296932|157898650|FG006|Overall Study|Adverse Event|0|||
49016634|NCT01296932|157898651|FG007|Overall Study|Adverse Event|0|||
49016635|NCT01296932|157898652|FG008|Overall Study|Adverse Event|1|||
49016636|NCT01296932|157898644|FG000|Overall Study|Investigator decision|0|||
49016637|NCT01296932|157898645|FG001|Overall Study|Investigator decision|1|||
49016638|NCT01296932|157898646|FG002|Overall Study|Investigator decision|0|||
49016639|NCT01296932|157898647|FG003|Overall Study|Investigator decision|1|||
49016640|NCT01296932|157898648|FG004|Overall Study|Investigator decision|0|||
49016641|NCT01296932|157898649|FG005|Overall Study|Investigator decision|0|||
49016642|NCT01296932|157898650|FG006|Overall Study|Investigator decision|1|||
49016643|NCT01296932|157898651|FG007|Overall Study|Investigator decision|0|||
49016644|NCT01296932|157898652|FG008|Overall Study|Investigator decision|1|||
49016645|NCT01296932|157898644|FG000|Overall Study|No clinical benefit anymore|0|||
49016646|NCT01296932|157898645|FG001|Overall Study|No clinical benefit anymore|1|||
49016647|NCT01296932|157898646|FG002|Overall Study|No clinical benefit anymore|0|||
49016648|NCT01296932|157898647|FG003|Overall Study|No clinical benefit anymore|0|||
49016649|NCT01296932|157898648|FG004|Overall Study|No clinical benefit anymore|0|||
49016650|NCT01296932|157898649|FG005|Overall Study|No clinical benefit anymore|0|||
49016651|NCT01296932|157898650|FG006|Overall Study|No clinical benefit anymore|0|||
49016652|NCT01296932|157898651|FG007|Overall Study|No clinical benefit anymore|0|||
49016653|NCT01296932|157898652|FG008|Overall Study|No clinical benefit anymore|0|||
49016654|NCT01296932|157898644|FG000|Overall Study|Physician Decision|0|||
49016655|NCT01296932|157898645|FG001|Overall Study|Physician Decision|0|||
49016656|NCT01296932|157898646|FG002|Overall Study|Physician Decision|1|||
49016657|NCT01296932|157898647|FG003|Overall Study|Physician Decision|0|||
49016658|NCT01296932|157898648|FG004|Overall Study|Physician Decision|0|||
49016659|NCT01296932|157898649|FG005|Overall Study|Physician Decision|0|||
49016660|NCT01296932|157898650|FG006|Overall Study|Physician Decision|0|||
49016661|NCT01296932|157898651|FG007|Overall Study|Physician Decision|0|||
49016662|NCT01296932|157898652|FG008|Overall Study|Physician Decision|0|||
49016663|NCT01296932|157898644|FG000|Overall Study|IV problems, administration not possible|0|||
49016664|NCT01296932|157898645|FG001|Overall Study|IV problems, administration not possible|0|||
49016665|NCT01296932|157898646|FG002|Overall Study|IV problems, administration not possible|1|||
49016666|NCT01296932|157898647|FG003|Overall Study|IV problems, administration not possible|0|||
49016667|NCT01296932|157898648|FG004|Overall Study|IV problems, administration not possible|0|||
49016668|NCT01296932|157898649|FG005|Overall Study|IV problems, administration not possible|0|||
49016669|NCT01296932|157898650|FG006|Overall Study|IV problems, administration not possible|0|||
49016670|NCT01296932|157898651|FG007|Overall Study|IV problems, administration not possible|0|||
49016671|NCT01296932|157898652|FG008|Overall Study|IV problems, administration not possible|0|||
49016672|NCT01296932|157898644|FG000|Overall Study|per protocol|0|||
49016673|NCT01296932|157898645|FG001|Overall Study|per protocol|0|||
49016674|NCT01296932|157898646|FG002|Overall Study|per protocol|1|||
49016675|NCT01296932|157898647|FG003|Overall Study|per protocol|1|||
49016676|NCT01296932|157898648|FG004|Overall Study|per protocol|0|||
49016677|NCT01296932|157898649|FG005|Overall Study|per protocol|0|||
49016678|NCT01296932|157898650|FG006|Overall Study|per protocol|0|||
49016679|NCT01296932|157898651|FG007|Overall Study|per protocol|0|||
49016680|NCT01296932|157898652|FG008|Overall Study|per protocol|0|||
49016681|NCT01296932|157898644|FG000|Overall Study|Low benefit and too many side effects|0|||
49016682|NCT01296932|157898645|FG001|Overall Study|Low benefit and too many side effects|0|||
49016683|NCT01296932|157898646|FG002|Overall Study|Low benefit and too many side effects|0|||
49016684|NCT01296932|157898647|FG003|Overall Study|Low benefit and too many side effects|0|||
49016685|NCT01296932|157898648|FG004|Overall Study|Low benefit and too many side effects|0|||
49016686|NCT01296932|157898649|FG005|Overall Study|Low benefit and too many side effects|0|||
49016687|NCT01296932|157898650|FG006|Overall Study|Low benefit and too many side effects|0|||
49016688|NCT01296932|157898651|FG007|Overall Study|Low benefit and too many side effects|1|||
49016689|NCT01296932|157898652|FG008|Overall Study|Low benefit and too many side effects|0|||
49016690|NCT01296932|157898644|FG000|Overall Study|No adequate treatment response|0|||
49016691|NCT01296932|157898645|FG001|Overall Study|No adequate treatment response|0|||
49016692|NCT01296932|157898646|FG002|Overall Study|No adequate treatment response|0|||
49016693|NCT01296932|157898647|FG003|Overall Study|No adequate treatment response|0|||
49016694|NCT01296932|157898648|FG004|Overall Study|No adequate treatment response|0|||
49016695|NCT01296932|157898649|FG005|Overall Study|No adequate treatment response|0|||
49016696|NCT01296932|157898650|FG006|Overall Study|No adequate treatment response|0|||
49016697|NCT01296932|157898651|FG007|Overall Study|No adequate treatment response|1|||
49016698|NCT01296932|157898652|FG008|Overall Study|No adequate treatment response|0|||
49016699|NCT01296932|157898644|FG000|Overall Study|Dosage already reduced, AE still present|0|||
49016700|NCT01296932|157898645|FG001|Overall Study|Dosage already reduced, AE still present|0|||
49016701|NCT01296932|157898646|FG002|Overall Study|Dosage already reduced, AE still present|0|||
49016702|NCT01296932|157898647|FG003|Overall Study|Dosage already reduced, AE still present|0|||
49016703|NCT01296932|157898648|FG004|Overall Study|Dosage already reduced, AE still present|0|||
49016704|NCT01296932|157898649|FG005|Overall Study|Dosage already reduced, AE still present|0|||
49016705|NCT01296932|157898650|FG006|Overall Study|Dosage already reduced, AE still present|0|||
48676602|NCT02688985|156669063|FG001|Overall Study|Lost to Follow-up|0|||
48676603|NCT02688985|156669064|FG002|Overall Study|Lost to Follow-up|1|||
48676604|NCT02688985|156669065|FG003|Overall Study|Lost to Follow-up|1|||
48676605|NCT02688985|156669066|FG004|Overall Study|Lost to Follow-up|1|||
48676606|NCT02688985|156669062|FG000|Overall Study|Non-Compliance With Study Drug|1|||
48676607|NCT02688985|156669063|FG001|Overall Study|Non-Compliance With Study Drug|3|||
48676608|NCT02688985|156669064|FG002|Overall Study|Non-Compliance With Study Drug|1|||
48676609|NCT02688985|156669065|FG003|Overall Study|Non-Compliance With Study Drug|0|||
48676610|NCT02688985|156669066|FG004|Overall Study|Non-Compliance With Study Drug|1|||
48676611|NCT02688985|156669062|FG000|Overall Study|Other|3|||
48676612|NCT02688985|156669063|FG001|Overall Study|Other|4|||
48676613|NCT02688985|156669064|FG002|Overall Study|Other|1|||
48676614|NCT02688985|156669065|FG003|Overall Study|Other|0|||
48676615|NCT02688985|156669066|FG004|Overall Study|Other|0|||
48676616|NCT02688985|156669062|FG000|Overall Study|Physician Decision|2|||
48676617|NCT02688985|156669063|FG001|Overall Study|Physician Decision|2|||
48676618|NCT02688985|156669064|FG002|Overall Study|Physician Decision|0|||
48676619|NCT02688985|156669065|FG003|Overall Study|Physician Decision|0|||
48676620|NCT02688985|156669066|FG004|Overall Study|Physician Decision|1|||
48676621|NCT02688985|156669062|FG000|Overall Study|Pregnancy|0|||
48676622|NCT02688985|156669063|FG001|Overall Study|Pregnancy|0|||
48676623|NCT02688985|156669064|FG002|Overall Study|Pregnancy|2|||
48676624|NCT02688985|156669065|FG003|Overall Study|Pregnancy|1|||
48676625|NCT02688985|156669066|FG004|Overall Study|Pregnancy|0|||
48676626|NCT02688985|156669062|FG000|Overall Study|Study Terminated By Sponsor|0|||
48676627|NCT02688985|156669063|FG001|Overall Study|Study Terminated By Sponsor|0|||
48676628|NCT02688985|156669064|FG002|Overall Study|Study Terminated By Sponsor|0|||
48676629|NCT02688985|156669065|FG003|Overall Study|Study Terminated By Sponsor|1|||
48676630|NCT02688985|156669066|FG004|Overall Study|Study Terminated By Sponsor|0|||
48676631|NCT02688985|156669062|FG000|Overall Study|Withdrawal by Subject|2|||
48676632|NCT02688985|156669063|FG001|Overall Study|Withdrawal by Subject|8|||
48676633|NCT02688985|156669064|FG002|Overall Study|Withdrawal by Subject|7|||
48676634|NCT02688985|156669065|FG003|Overall Study|Withdrawal by Subject|1|||
48676635|NCT02688985|156669066|FG004|Overall Study|Withdrawal by Subject|4|||
48676636|NCT01023672|156669067|FG000|Overall Study|Worsening disease|2|||
48676637|NCT01023672|156669067|FG000|Overall Study|Death|1|||
48676638|NCT01055314|156669068|FG000|Overall Study|Adverse Event|7|||
48676639|NCT01055314|156669069|FG001|Overall Study|Adverse Event|4|||
48676640|NCT01055314|156669068|FG000|Overall Study|Death|2|||
48676641|NCT01055314|156669069|FG001|Overall Study|Death|1|||
48676642|NCT01055314|156669068|FG000|Overall Study|Lack of Efficacy|11|||
48676643|NCT01055314|156669069|FG001|Overall Study|Lack of Efficacy|19|||
48676644|NCT01055314|156669068|FG000|Overall Study|Physician Decision|10|||
48676645|NCT01055314|156669069|FG001|Overall Study|Physician Decision|5|||
48676646|NCT01055314|156669068|FG000|Overall Study|Withdrawal by Subject|1|||
48676647|NCT01055314|156669069|FG001|Overall Study|Withdrawal by Subject|0|||
48676648|NCT01055314|156669068|FG000|Overall Study|Ineligible|3|||
49016706|NCT01296932|157898651|FG007|Overall Study|Dosage already reduced, AE still present|0|||
49016707|NCT01296932|157898652|FG008|Overall Study|Dosage already reduced, AE still present|1|||
48676649|NCT01055314|156669069|FG001|Overall Study|Ineligible|5|||
48676650|NCT01055314|156669068|FG000|Overall Study|Refusal of further protocol therapy|10|||
49016708|NCT03211156|157898657|FG000|Overall Study|Withdrawal by Subject|0|||
48676651|NCT01055314|156669069|FG001|Overall Study|Refusal of further protocol therapy|4|||
48676652|NCT01055314|156669068|FG000|Overall Study|No treatment|1|||
48676653|NCT01055314|156669069|FG001|Overall Study|No treatment|0|||
48676654|NCT00568126|156669070|FG000|Overall Study|Adverse Event|3|||
48676655|NCT00568126|156669071|FG001|Overall Study|Adverse Event|0|||
48676656|NCT00568126|156669070|FG000|Overall Study|Withdrawal by Subject|2|||
48676657|NCT00568126|156669071|FG001|Overall Study|Withdrawal by Subject|3|||
48676658|NCT00568126|156669070|FG000|Overall Study|Lost to Follow-up|4|||
48676659|NCT00568126|156669071|FG001|Overall Study|Lost to Follow-up|3|||
48676660|NCT00568126|156669070|FG000|Overall Study|Lack of Efficacy|0|||
48676661|NCT00568126|156669071|FG001|Overall Study|Lack of Efficacy|1|||
48676662|NCT00568126|156669070|FG000|Overall Study|Physician Decision|2|||
48676663|NCT00568126|156669071|FG001|Overall Study|Physician Decision|2|||
48676664|NCT02241343|156669074|FG000|Overall Study|Adverse Event|1|||
48676665|NCT00753454|156669075|FG000|Overall Study|Adverse Event|4|||
48676666|NCT00753454|156669075|FG000|Overall Study|Lack of Efficacy|1|||
48676667|NCT00753454|156669075|FG000|Overall Study|Lost to Follow-up|3|||
48676668|NCT00753454|156669075|FG000|Overall Study|Withdrawal by Subject|5|||
48676669|NCT00753454|156669075|FG000|Overall Study|Investigator Decision|1|||
48676670|NCT03927144|156669076|FG000|Core Phase|Adverse Event|9|||
48676671|NCT03927144|156669077|FG001|Core Phase|Adverse Event|5|||
48676672|NCT03927144|156669076|FG000|Core Phase|Lost to Follow-up|3|||
48676673|NCT03927144|156669077|FG001|Core Phase|Lost to Follow-up|2|||
48676674|NCT03927144|156669076|FG000|Core Phase|New Therapy for Study Indication|0|||
48676675|NCT03927144|156669077|FG001|Core Phase|New Therapy for Study Indication|1|||
48676676|NCT03927144|156669076|FG000|Core Phase|No Longer Clinically Benefiting|4|||
48676677|NCT03927144|156669077|FG001|Core Phase|No Longer Clinically Benefiting|4|||
49016709|NCT03211156|157898658|FG001|Overall Study|Withdrawal by Subject|2|||
49016710|NCT03211156|157898657|FG000|Overall Study|Lost to Follow-up|1|||
49016711|NCT03211156|157898658|FG001|Overall Study|Lost to Follow-up|1|||
49016712|NCT03211156|157898657|FG000|Overall Study|Adverse Event|1|||
49016713|NCT03211156|157898658|FG001|Overall Study|Adverse Event|0|||
49016714|NCT01567306|157898664|FG000|Overall Study|Protocol Violation|2|||
49016715|NCT01567306|157898665|FG001|Overall Study|Protocol Violation|2|||
49016716|NCT01567306|157898666|FG002|Overall Study|Protocol Violation|0|||
49016717|NCT01567306|157898667|FG003|Overall Study|Protocol Violation|3|||
49016718|NCT01567306|157898668|FG004|Overall Study|Protocol Violation|1|||
49016719|NCT01567306|157898669|FG005|Overall Study|Protocol Violation|1|||
49016720|NCT01567306|157898664|FG000|Overall Study|Change site living|1|||
49016721|NCT01567306|157898665|FG001|Overall Study|Change site living|0|||
49016722|NCT01567306|157898666|FG002|Overall Study|Change site living|0|||
49016723|NCT01567306|157898667|FG003|Overall Study|Change site living|0|||
49016724|NCT01567306|157898668|FG004|Overall Study|Change site living|0|||
49016725|NCT01567306|157898669|FG005|Overall Study|Change site living|0|||
49016726|NCT01567306|157898664|FG000|Overall Study|Adverse Event|0|||
49016727|NCT01567306|157898665|FG001|Overall Study|Adverse Event|0|||
49016728|NCT01567306|157898666|FG002|Overall Study|Adverse Event|0|||
49016729|NCT01567306|157898667|FG003|Overall Study|Adverse Event|2|||
49016730|NCT01567306|157898668|FG004|Overall Study|Adverse Event|4|||
49016731|NCT01567306|157898669|FG005|Overall Study|Adverse Event|1|||
49016732|NCT01567306|157898664|FG000|Overall Study|Lost to Follow-up|0|||
49016733|NCT01567306|157898665|FG001|Overall Study|Lost to Follow-up|0|||
49016734|NCT01567306|157898666|FG002|Overall Study|Lost to Follow-up|0|||
49016735|NCT01567306|157898667|FG003|Overall Study|Lost to Follow-up|0|||
49016736|NCT01567306|157898668|FG004|Overall Study|Lost to Follow-up|2|||
49016737|NCT01567306|157898669|FG005|Overall Study|Lost to Follow-up|0|||
49016738|NCT01567306|157898664|FG000|Overall Study|Withdrawal by Subject|0|||
49016739|NCT01567306|157898665|FG001|Overall Study|Withdrawal by Subject|0|||
49016740|NCT01567306|157898666|FG002|Overall Study|Withdrawal by Subject|0|||
49016741|NCT01567306|157898667|FG003|Overall Study|Withdrawal by Subject|0|||
49016742|NCT01567306|157898668|FG004|Overall Study|Withdrawal by Subject|0|||
49016743|NCT01567306|157898669|FG005|Overall Study|Withdrawal by Subject|1|||
49016744|NCT00829413|157898670|FG000|Overall Study|No study drug admimnistered|13|||
49016745|NCT00829413|157898670|FG000|Overall Study|Training Patients|67|||
49016746|NCT00829413|157898670|FG000|Overall Study|No truth standard procedure available|9|||
49016747|NCT00829413|157898670|FG000|Overall Study|Technically inadequate truth standard|2|||
49016748|NCT00829413|157898670|FG000|Overall Study|Indeterminate diagnosis from truth stand|3|||
49016749|NCT02737306|157898681|FG000|Overall Study|Adverse Event|3|||
49016750|NCT02737306|157898682|FG001|Overall Study|Adverse Event|0|||
49016751|NCT02737306|157898681|FG000|Overall Study|Enrolment and treatment halted by sponsor.|1|||
49016752|NCT02737306|157898682|FG001|Overall Study|Enrolment and treatment halted by sponsor.|0|||
49016753|NCT03361423|157898684|FG000|Overall Study|Withdrawal by Subject|4|||
49016754|NCT03361423|157898685|FG001|Overall Study|Withdrawal by Subject|3|||
49016755|NCT03361423|157898684|FG000|Overall Study|Did not treat|19|||
49016756|NCT03361423|157898685|FG001|Overall Study|Did not treat|18|||
49016757|NCT03361423|157898684|FG000|Overall Study|Started >60 minutes from migraine onset|0|||
49016758|NCT03361423|157898685|FG001|Overall Study|Started >60 minutes from migraine onset|1|||
49016759|NCT03361423|157898684|FG000|Overall Study|Missing data|4|||
49016760|NCT03361423|157898685|FG001|Overall Study|Missing data|1|||
49016761|NCT03267264|157898688|FG000|Overall Study|Withdrawal by Subject|1|||
49016762|NCT03267264|157898689|FG001|Overall Study|Withdrawal by Subject|0|||
49016763|NCT03267264|157898690|FG002|Overall Study|Withdrawal by Subject|2|||
49016764|NCT03267264|157898691|FG003|Overall Study|Withdrawal by Subject|4|||
49016765|NCT00358826|157898692|FG000|Core Study|Adverse Event|1|||
49016766|NCT00358826|157898693|FG001|Core Study|Adverse Event|3|||
49016767|NCT00358826|157898694|FG002|Core Study|Adverse Event|1|||
49016768|NCT00358826|157898695|FG003|Core Study|Adverse Event|1|||
49016769|NCT00358826|157898696|FG004|Core Study|Adverse Event|0|||
49016770|NCT00358826|157898697|FG005|Core Study|Adverse Event|0|||
49016771|NCT00358826|157898698|FG006|Core Study|Adverse Event|0|||
49016772|NCT00358826|157898699|FG007|Core Study|Adverse Event|0|||
49016773|NCT00358826|157898692|FG000|Core Study|Withdrawal by Subject|2|||
49016774|NCT00358826|157898693|FG001|Core Study|Withdrawal by Subject|2|||
49016775|NCT00358826|157898694|FG002|Core Study|Withdrawal by Subject|0|||
49016776|NCT00358826|157898695|FG003|Core Study|Withdrawal by Subject|0|||
49016777|NCT00358826|157898696|FG004|Core Study|Withdrawal by Subject|0|||
49016778|NCT00358826|157898697|FG005|Core Study|Withdrawal by Subject|0|||
49016779|NCT00358826|157898698|FG006|Core Study|Withdrawal by Subject|0|||
49016780|NCT00358826|157898699|FG007|Core Study|Withdrawal by Subject|0|||
49016781|NCT00358826|157898692|FG000|Core Study|Lost to Follow-up|0|||
48676678|NCT03927144|156669076|FG000|Core Phase|Physician Decision|2|||
48676679|NCT03927144|156669077|FG001|Core Phase|Physician Decision|8|||
48676680|NCT03927144|156669076|FG000|Core Phase|Protocol Violation|2|||
49016782|NCT00358826|157898693|FG001|Core Study|Lost to Follow-up|0|||
49016783|NCT00358826|157898694|FG002|Core Study|Lost to Follow-up|0|||
49016784|NCT00358826|157898695|FG003|Core Study|Lost to Follow-up|1|||
49016785|NCT00358826|157898696|FG004|Core Study|Lost to Follow-up|0|||
49016786|NCT00358826|157898697|FG005|Core Study|Lost to Follow-up|0|||
49016787|NCT00358826|157898698|FG006|Core Study|Lost to Follow-up|0|||
49016788|NCT00358826|157898699|FG007|Core Study|Lost to Follow-up|0|||
49016789|NCT00358826|157898692|FG000|Core Study|Physician Decision|0|||
49016790|NCT00358826|157898693|FG001|Core Study|Physician Decision|0|||
49016791|NCT00358826|157898694|FG002|Core Study|Physician Decision|1|||
49016792|NCT00358826|157898695|FG003|Core Study|Physician Decision|0|||
49016793|NCT00358826|157898696|FG004|Core Study|Physician Decision|0|||
49016794|NCT00358826|157898697|FG005|Core Study|Physician Decision|0|||
49016795|NCT00358826|157898698|FG006|Core Study|Physician Decision|0|||
49016796|NCT00358826|157898699|FG007|Core Study|Physician Decision|0|||
49016797|NCT00358826|157898692|FG000|MDCT Substudy|Adverse Event|0|||
49016798|NCT00358826|157898693|FG001|MDCT Substudy|Adverse Event|0|||
48874540|NCT01407276|157377040|FG001|Overall Study|Withdrawal by Subject|0|||
48874541|NCT01407276|157377041|FG002|Overall Study|Withdrawal by Subject|0|||
48874542|NCT01407276|157377042|FG003|Overall Study|Withdrawal by Subject|0|||
48874543|NCT01407276|157377043|FG004|Overall Study|Withdrawal by Subject|0|||
48874544|NCT01407276|157377044|FG005|Overall Study|Withdrawal by Subject|0|||
48874545|NCT01407276|157377045|FG006|Overall Study|Withdrawal by Subject|0|||
48874546|NCT01407276|157377046|FG007|Overall Study|Withdrawal by Subject|1|||
48874547|NCT02760485|157377049|FG000|Phase 1|Death|3|||
48874548|NCT02760485|157377050|FG001|Phase 1|Death|6|||
48874549|NCT02760485|157377051|FG002|Phase 1|Death|0|||
48874550|NCT02760485|157377049|FG000|Phase 1|Withdrawal by Subject|2|||
48874551|NCT02760485|157377050|FG001|Phase 1|Withdrawal by Subject|0|||
48874552|NCT02760485|157377051|FG002|Phase 1|Withdrawal by Subject|0|||
48874553|NCT02760485|157377049|FG000|Phase 1|Progressive Disease|1|||
48874554|NCT02760485|157377050|FG001|Phase 1|Progressive Disease|0|||
48874555|NCT02760485|157377051|FG002|Phase 1|Progressive Disease|0|||
48874556|NCT02760485|157377049|FG000|Phase 1|Amendment Removed Survival Follow-up|0|||
48874557|NCT02760485|157377050|FG001|Phase 1|Amendment Removed Survival Follow-up|1|||
48874558|NCT02760485|157377051|FG002|Phase 1|Amendment Removed Survival Follow-up|0|||
48874559|NCT02760485|157377049|FG000|Phase 1|Unknown; Did Not Complete End-of-Study Visit|1|||
48874560|NCT02760485|157377050|FG001|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
48874561|NCT02760485|157377051|FG002|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
48874562|NCT02760485|157377049|FG000|Phase 2|Death|0|||
48874563|NCT02760485|157377050|FG001|Phase 2|Death|0|||
48874564|NCT02760485|157377051|FG002|Phase 2|Death|12|||
49016799|NCT00358826|157898694|FG002|MDCT Substudy|Adverse Event|0|||
49016800|NCT00358826|157898695|FG003|MDCT Substudy|Adverse Event|0|||
49016801|NCT00358826|157898696|FG004|MDCT Substudy|Adverse Event|1|||
49016802|NCT00358826|157898697|FG005|MDCT Substudy|Adverse Event|0|||
49016803|NCT00358826|157898698|FG006|MDCT Substudy|Adverse Event|0|||
49016804|NCT00358826|157898699|FG007|MDCT Substudy|Adverse Event|0|||
49016805|NCT00358826|157898692|FG000|MDCT Substudy|Lost to Follow-up|0|||
49016806|NCT00358826|157898693|FG001|MDCT Substudy|Lost to Follow-up|0|||
49016807|NCT00358826|157898694|FG002|MDCT Substudy|Lost to Follow-up|0|||
49016808|NCT00358826|157898695|FG003|MDCT Substudy|Lost to Follow-up|0|||
49016809|NCT00358826|157898696|FG004|MDCT Substudy|Lost to Follow-up|0|||
49016810|NCT00358826|157898697|FG005|MDCT Substudy|Lost to Follow-up|1|||
49016811|NCT00358826|157898698|FG006|MDCT Substudy|Lost to Follow-up|0|||
49016812|NCT00358826|157898699|FG007|MDCT Substudy|Lost to Follow-up|0|||
49016813|NCT00358826|157898692|FG000|MDCT Substudy|Withdrawal by Subject|0|||
49016814|NCT00358826|157898693|FG001|MDCT Substudy|Withdrawal by Subject|0|||
49016815|NCT00358826|157898694|FG002|MDCT Substudy|Withdrawal by Subject|0|||
49016816|NCT00358826|157898695|FG003|MDCT Substudy|Withdrawal by Subject|0|||
49016817|NCT00358826|157898696|FG004|MDCT Substudy|Withdrawal by Subject|0|||
49016818|NCT00358826|157898697|FG005|MDCT Substudy|Withdrawal by Subject|1|||
49016819|NCT00358826|157898698|FG006|MDCT Substudy|Withdrawal by Subject|0|||
49016820|NCT00358826|157898699|FG007|MDCT Substudy|Withdrawal by Subject|0|||
49016821|NCT04117607|157898700|FG000|Overall Study|Early Termination|0|||
49016822|NCT04117607|157898701|FG001|Overall Study|Early Termination|1|||
49016823|NCT04117607|157898702|FG002|Overall Study|Early Termination|0|||
49016824|NCT04117607|157898703|FG003|Overall Study|Early Termination|0|||
49016825|NCT04117607|157898704|FG004|Overall Study|Early Termination|0|||
48874565|NCT02760485|157377049|FG000|Phase 2|Withdrawal by Subject|0|||
49016826|NCT04117607|157898705|FG005|Overall Study|Early Termination|0|||
49016827|NCT04117607|157898706|FG006|Overall Study|Early Termination|1|||
49016828|NCT04117607|157898707|FG007|Overall Study|Early Termination|0|||
49016829|NCT04117607|157898708|FG008|Overall Study|Early Termination|0|||
49016830|NCT04117607|157898709|FG009|Overall Study|Early Termination|0|||
48874566|NCT02760485|157377050|FG001|Phase 2|Withdrawal by Subject|0|||
49016831|NCT04117607|157898710|FG010|Overall Study|Early Termination|0|||
48874567|NCT02760485|157377051|FG002|Phase 2|Withdrawal by Subject|3|||
48874568|NCT02760485|157377049|FG000|Phase 2|Progressive Disease|0|||
49016832|NCT04117607|157898711|FG011|Overall Study|Early Termination|0|||
49016833|NCT04117607|157898712|FG012|Overall Study|Early Termination|0|||
49016834|NCT04117607|157898713|FG013|Overall Study|Early Termination|0|||
49016835|NCT03982433|157898717|FG000|Overall Study|Lost to Follow-up|1|||
49016836|NCT01498484|157898718|FG000|Overall Study|Death|6|||
49016837|NCT01498484|157898719|FG001|Overall Study|Death|3|||
49016838|NCT01498484|157898720|FG002|Overall Study|Death|1|||
49016839|NCT01498484|157898721|FG003|Overall Study|Death|1|||
49016840|NCT01498484|157898722|FG004|Overall Study|Death|0|||
49016841|NCT01498484|157898723|FG005|Overall Study|Death|0|||
49016842|NCT01498484|157898724|FG006|Overall Study|Death|10|||
49016843|NCT01498484|157898725|FG007|Overall Study|Death|1|||
49016844|NCT01498484|157898726|FG008|Overall Study|Death|0|||
49016845|NCT01498484|157898718|FG000|Overall Study|Physician Decision|3|||
49016846|NCT01498484|157898719|FG001|Overall Study|Physician Decision|2|||
49016847|NCT01498484|157898720|FG002|Overall Study|Physician Decision|1|||
49016848|NCT01498484|157898721|FG003|Overall Study|Physician Decision|1|||
49016849|NCT01498484|157898722|FG004|Overall Study|Physician Decision|0|||
49016850|NCT01498484|157898723|FG005|Overall Study|Physician Decision|0|||
49016851|NCT01498484|157898724|FG006|Overall Study|Physician Decision|8|||
49016852|NCT01498484|157898725|FG007|Overall Study|Physician Decision|13|||
49016853|NCT01498484|157898726|FG008|Overall Study|Physician Decision|1|||
49016854|NCT01498484|157898718|FG000|Overall Study|Adverse Event|0|||
49016855|NCT01498484|157898719|FG001|Overall Study|Adverse Event|0|||
49016856|NCT01498484|157898720|FG002|Overall Study|Adverse Event|0|||
49016857|NCT01498484|157898721|FG003|Overall Study|Adverse Event|0|||
49016858|NCT01498484|157898722|FG004|Overall Study|Adverse Event|0|||
49016859|NCT01498484|157898723|FG005|Overall Study|Adverse Event|1|||
49016860|NCT01498484|157898724|FG006|Overall Study|Adverse Event|0|||
49016861|NCT01498484|157898725|FG007|Overall Study|Adverse Event|0|||
49016862|NCT01498484|157898726|FG008|Overall Study|Adverse Event|0|||
49016863|NCT01498484|157898718|FG000|Overall Study|Withdrawal by Subject|0|||
49016864|NCT01498484|157898719|FG001|Overall Study|Withdrawal by Subject|0|||
49016865|NCT01498484|157898720|FG002|Overall Study|Withdrawal by Subject|0|||
49016866|NCT01498484|157898721|FG003|Overall Study|Withdrawal by Subject|1|||
49016867|NCT01498484|157898722|FG004|Overall Study|Withdrawal by Subject|0|||
49016868|NCT01498484|157898723|FG005|Overall Study|Withdrawal by Subject|0|||
49016869|NCT01498484|157898724|FG006|Overall Study|Withdrawal by Subject|1|||
49016870|NCT01498484|157898725|FG007|Overall Study|Withdrawal by Subject|0|||
49016871|NCT01498484|157898726|FG008|Overall Study|Withdrawal by Subject|0|||
49016872|NCT01498484|157898718|FG000|Overall Study|Other|5|||
49016873|NCT01498484|157898719|FG001|Overall Study|Other|2|||
49016874|NCT01498484|157898720|FG002|Overall Study|Other|0|||
49016875|NCT01498484|157898721|FG003|Overall Study|Other|0|||
49016876|NCT01498484|157898722|FG004|Overall Study|Other|1|||
49016877|NCT01498484|157898723|FG005|Overall Study|Other|0|||
49016878|NCT01498484|157898724|FG006|Overall Study|Other|3|||
49016879|NCT01498484|157898725|FG007|Overall Study|Other|0|||
49016880|NCT01498484|157898726|FG008|Overall Study|Other|1|||
49016881|NCT02607800|157898728|FG000|Overall Study|Lost to Follow-up|7|||
49016882|NCT02607800|157898729|FG001|Overall Study|Lost to Follow-up|10|||
49016883|NCT02607800|157898728|FG000|Overall Study|Withdrew Consent|2|||
49016884|NCT02607800|157898729|FG001|Overall Study|Withdrew Consent|0|||
49016885|NCT02607800|157898728|FG000|Overall Study|Randomized/Enrolled but Not Treated|1|||
49016886|NCT02607800|157898729|FG001|Overall Study|Randomized/Enrolled but Not Treated|1|||
49016887|NCT02427607|157898732|FG000|Overall Study|Withdrawal by Subject|1|||
49016888|NCT04000009|157898733|FG000|Overall Study|Adverse Event|13|||
49016889|NCT04000009|157898733|FG000|Overall Study|Lack of Efficacy|7|||
49016890|NCT04000009|157898733|FG000|Overall Study|Lost to Follow-up|8|||
49016891|NCT04000009|157898733|FG000|Overall Study|Noncompliance with study drug|4|||
49016892|NCT04000009|157898733|FG000|Overall Study|Physician Decision|1|||
49016893|NCT04000009|157898733|FG000|Overall Study|Use of prohibited medication|3|||
49016894|NCT04000009|157898733|FG000|Overall Study|Pregnancy|1|||
49016895|NCT04000009|157898733|FG000|Overall Study|Withdrawal by Subject|22|||
49016896|NCT04000009|157898733|FG000|Overall Study|Study terminated by sponsor|98|||
49016897|NCT04000009|157898733|FG000|Overall Study|Not further specified|8|||
49016898|NCT01485536|157898736|FG000|Overall Study|Withdrawal by Subject|3|||
49016899|NCT01485536|157898736|FG000|Overall Study|Adverse Event|1|||
49016900|NCT00720122|157898737|FG000|Overall Study|Lost to Follow-up|1|||
49016901|NCT00720122|157898737|FG000|Overall Study|Physician Decision|1|||
49016902|NCT00720122|157898737|FG000|Overall Study|Withdrawal by Subject|7|||
49016903|NCT01364870|157898738|FG000|Overall Study|Withdrawal by Subject|13|||
49016904|NCT01364870|157898739|FG001|Overall Study|Withdrawal by Subject|24|||
49016905|NCT01364870|157898740|FG002|Overall Study|Withdrawal by Subject|10|||
49016906|NCT01364870|157898738|FG000|Overall Study|Adverse Event|8|||
49016907|NCT01364870|157898739|FG001|Overall Study|Adverse Event|6|||
49016908|NCT01364870|157898740|FG002|Overall Study|Adverse Event|4|||
49016909|NCT01364870|157898738|FG000|Overall Study|Protocol Violation|1|||
49016910|NCT01364870|157898739|FG001|Overall Study|Protocol Violation|0|||
49016911|NCT01364870|157898740|FG002|Overall Study|Protocol Violation|0|||
49016912|NCT01873859|157898741|FG000|Overall Study|Withdrawal by Subject|0|||
49016913|NCT01873859|157898742|FG001|Overall Study|Withdrawal by Subject|4|||
49016914|NCT03072459|157898743|FG000|Overall Study|Device revised/removed|1|||
49016915|NCT03072459|157898743|FG000|Overall Study|Subject not able to return|1|||
49016916|NCT05200858|157898747|FG000|Blinded Phase (4 Weeks)|Lost to Follow-up|3|||
49016917|NCT05200858|157898748|FG001|Blinded Phase (4 Weeks)|Lost to Follow-up|2|||
49016918|NCT05200858|157898749|FG002|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
49016919|NCT05200858|157898750|FG003|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
49016920|NCT00264810|157898751|FG000|Baseline|Withdrawal by Subject|10|||
49016921|NCT00264810|157898752|FG001|Baseline|Withdrawal by Subject|10|||
49016922|NCT00264810|157898751|FG000|Baseline|Physician Decision|7|||
49016923|NCT00264810|157898752|FG001|Baseline|Physician Decision|8|||
49016924|NCT00264810|157898751|FG000|Baseline|Subject Compliance Failure|3|||
49016925|NCT00264810|157898752|FG001|Baseline|Subject Compliance Failure|3|||
49016926|NCT00264810|157898751|FG000|Baseline|Insufficient Seizure Frequency|2|||
49016927|NCT00264810|157898752|FG001|Baseline|Insufficient Seizure Frequency|2|||
49016928|NCT00264810|157898751|FG000|Baseline|Did not Meet/Maintain Study I/E Criteria|1|||
49016929|NCT00264810|157898752|FG001|Baseline|Did not Meet/Maintain Study I/E Criteria|2|||
49016930|NCT00264810|157898751|FG000|Baseline|Other|0|||
49016931|NCT00264810|157898752|FG001|Baseline|Other|1|||
49016932|NCT00264810|157898751|FG000|Stimulation Optimization Period|Withdrawal by Subject|1|||
49016933|NCT00264810|157898752|FG001|Stimulation Optimization Period|Withdrawal by Subject|0|||
49016934|NCT00264810|157898751|FG000|Stimulation Optimization Period|Death|0|||
49016935|NCT00264810|157898752|FG001|Stimulation Optimization Period|Death|1|||
49016936|NCT00264810|157898751|FG000|Blinded Evaluation Period|Explant due to infection|1|||
49016937|NCT00264810|157898752|FG001|Blinded Evaluation Period|Explant due to infection|1|||
49016938|NCT00264810|157898751|FG000|Open Label Evaluation Period|Explant due to infection|1|||
49016939|NCT00264810|157898752|FG001|Open Label Evaluation Period|Explant due to infection|1|||
49016940|NCT00264810|157898751|FG000|Open Label Evaluation Period|Death|3|||
49016941|NCT00264810|157898752|FG001|Open Label Evaluation Period|Death|2|||
49016942|NCT00264810|157898751|FG000|Open Label Evaluation Period|Pursue Other Treatment Options|2|||
49016943|NCT00264810|157898752|FG001|Open Label Evaluation Period|Pursue Other Treatment Options|3|||
49016944|NCT01347710|157898753|FG000|Overall Study|Withdrawal by Subject|2|||
49016945|NCT01347710|157898753|FG000|Overall Study|Adverse Event|4|||
49016946|NCT01347710|157898753|FG000|Overall Study|Angio or SPECT not completed|18|||
49016947|NCT01347710|157898753|FG000|Overall Study|issue with vitals prior to dosing|1|||
49016948|NCT01347710|157898753|FG000|Overall Study|Lost to Follow-up|1|||
49016949|NCT01347710|157898753|FG000|Overall Study|Physician Decision|2|||
49016950|NCT01347710|157898753|FG000|Overall Study|Other|3|||
49016951|NCT03850509|157898754|FG000|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2|||
49016952|NCT03850509|157898755|FG001|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1|||
49016953|NCT00329602|157898756|FG000|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119|||
49016954|NCT00329602|157898757|FG001|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99|||
49016955|NCT00329602|157898758|FG002|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0|||
49016956|NCT00329602|157898756|FG000|40-Week Open-Label Treatment Phase|Adverse Event|0|||
49016957|NCT00329602|157898757|FG001|40-Week Open-Label Treatment Phase|Adverse Event|0|||
49016958|NCT00329602|157898758|FG002|40-Week Open-Label Treatment Phase|Adverse Event|20|||
49016959|NCT00329602|157898756|FG000|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
49016960|NCT00329602|157898757|FG001|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
49016961|NCT00329602|157898758|FG002|40-Week Open-Label Treatment Phase|Lost to Follow-up|1|||
49016962|NCT00329602|157898756|FG000|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
49016963|NCT00329602|157898757|FG001|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
49016964|NCT00329602|157898758|FG002|40-Week Open-Label Treatment Phase|Protocol Violation|2|||
49016965|NCT00329602|157898756|FG000|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
49016966|NCT00329602|157898757|FG001|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
48676681|NCT03927144|156669077|FG001|Core Phase|Protocol Violation|2|||
48676682|NCT03927144|156669076|FG000|Core Phase|Withdrawal by Subject|16|||
48676683|NCT03927144|156669077|FG001|Core Phase|Withdrawal by Subject|40|||
48676684|NCT03927144|156669076|FG000|Extension Phase|Adverse Event|2|||
48676685|NCT03927144|156669077|FG001|Extension Phase|Adverse Event|1|||
48676686|NCT03927144|156669076|FG000|Extension Phase|No longer clinically benefiting|4|||
48676687|NCT03927144|156669077|FG001|Extension Phase|No longer clinically benefiting|5|||
48676688|NCT03927144|156669076|FG000|Extension Phase|Pregnancy|1|||
49016967|NCT00329602|157898758|FG002|40-Week Open-Label Treatment Phase|Lack of Efficacy|9|||
49016968|NCT00329602|157898756|FG000|40-Week Open-Label Treatment Phase|Captured as Other|0|||
49016969|NCT00329602|157898757|FG001|40-Week Open-Label Treatment Phase|Captured as Other|0|||
49016970|NCT00329602|157898758|FG002|40-Week Open-Label Treatment Phase|Captured as Other|4|||
49016971|NCT01867242|157898759|FG000|Overall Study|Lost to follow-up, personal reasons|24|||
48676689|NCT03927144|156669077|FG001|Extension Phase|Pregnancy|0|||
48676690|NCT03927144|156669076|FG000|Extension Phase|Protocol Violation|0|||
48676691|NCT03927144|156669077|FG001|Extension Phase|Protocol Violation|1|||
49016972|NCT01867242|157898760|FG001|Overall Study|Lost to follow-up, personal reasons|16|||
49016973|NCT01867242|157898761|FG002|Overall Study|Lost to follow-up, personal reasons|8|||
48676692|NCT03927144|156669076|FG000|Extension Phase|Withdrawal by Subject|8|||
48676693|NCT03927144|156669077|FG001|Extension Phase|Withdrawal by Subject|3|||
49016974|NCT02275364|157898764|FG000|Period 1|Withdrawal by Subject|1|||
49016975|NCT02275364|157898765|FG001|Period 1|Withdrawal by Subject|0|||
49016976|NCT02275364|157898764|FG000|Period 1|Other reason|1|||
49016977|NCT02275364|157898765|FG001|Period 1|Other reason|0|||
49016978|NCT03504852|157898766|FG000|Overall Study|Withdrawal of informed consent|2|||
49016979|NCT03504852|157898767|FG001|Overall Study|Withdrawal of informed consent|1|||
49016980|NCT03504852|157898768|FG002|Overall Study|Withdrawal of informed consent|0|||
49016981|NCT03504852|157898766|FG000|Overall Study|Withdrawal by Subject|5|||
49016982|NCT03504852|157898767|FG001|Overall Study|Withdrawal by Subject|5|||
49016983|NCT03504852|157898768|FG002|Overall Study|Withdrawal by Subject|1|||
49016984|NCT03504852|157898766|FG000|Overall Study|Lost to Follow-up|4|||
49016985|NCT03504852|157898767|FG001|Overall Study|Lost to Follow-up|1|||
49016986|NCT03504852|157898768|FG002|Overall Study|Lost to Follow-up|0|||
49016987|NCT03504852|157898766|FG000|Overall Study|New therapy for study indication|1|||
49016988|NCT03504852|157898767|FG001|Overall Study|New therapy for study indication|0|||
49016989|NCT03504852|157898768|FG002|Overall Study|New therapy for study indication|0|||
49016990|NCT03504852|157898766|FG000|Overall Study|Lack of Efficacy|1|||
49016991|NCT03504852|157898767|FG001|Overall Study|Lack of Efficacy|2|||
49016992|NCT03504852|157898768|FG002|Overall Study|Lack of Efficacy|0|||
49016993|NCT03504852|157898766|FG000|Overall Study|Death|0|||
49016994|NCT03504852|157898767|FG001|Overall Study|Death|1|||
49016995|NCT03504852|157898768|FG002|Overall Study|Death|0|||
49016996|NCT03504852|157898766|FG000|Overall Study|Adverse Event|4|||
49016997|NCT03504852|157898767|FG001|Overall Study|Adverse Event|8|||
49016998|NCT03504852|157898768|FG002|Overall Study|Adverse Event|2|||
49016999|NCT01066052|157898769|FG000|Overall Study|Enrolled But Not Treated|3|||
49017000|NCT01066052|157898770|FG001|Overall Study|Enrolled But Not Treated|0|||
49017001|NCT02220907|157898771|FG000|Overall Study|Adverse Event|7|||
49017002|NCT02220907|157898771|FG000|Overall Study|Physician Decision|1|||
49017003|NCT02220907|157898771|FG000|Overall Study|Withdrawal by Subject|2|||
49017004|NCT02220907|157898771|FG000|Overall Study|Conflict with the stopping criteria|1|||
49017005|NCT02729896|157898776|FG000|Overall Study|Death|0|||
49017006|NCT02729896|157898777|FG001|Overall Study|Death|2|||
49017007|NCT02729896|157898778|FG002|Overall Study|Death|13|||
49017008|NCT02729896|157898776|FG000|Overall Study|Lost to Follow-up|0|||
48762257|NCT02476968|156978058|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
48762258|NCT02476968|156978059|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
48762259|NCT02476968|156978060|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
48762260|NCT02476968|156978058|FG000|Overall Study|Patient decision|37|||
49017009|NCT02729896|157898777|FG001|Overall Study|Lost to Follow-up|2|||
49017010|NCT02729896|157898778|FG002|Overall Study|Lost to Follow-up|3|||
49017011|NCT02729896|157898776|FG000|Overall Study|Other|0|||
49017012|NCT02729896|157898777|FG001|Overall Study|Other|2|||
49017013|NCT02729896|157898778|FG002|Overall Study|Other|0|||
49017014|NCT02729896|157898776|FG000|Overall Study|Physician Decision|1|||
49017015|NCT02729896|157898777|FG001|Overall Study|Physician Decision|2|||
49017016|NCT02729896|157898778|FG002|Overall Study|Physician Decision|3|||
49017017|NCT02729896|157898776|FG000|Overall Study|Progressive Disease|0|||
49017018|NCT02729896|157898777|FG001|Overall Study|Progressive Disease|1|||
49017019|NCT02729896|157898778|FG002|Overall Study|Progressive Disease|0|||
49017020|NCT02729896|157898776|FG000|Overall Study|Withdrawal by Subject|1|||
49017021|NCT02729896|157898777|FG001|Overall Study|Withdrawal by Subject|0|||
49017022|NCT02729896|157898778|FG002|Overall Study|Withdrawal by Subject|3|||
49017023|NCT01046253|157898779|FG000|Second Intervention|Adverse Event|0|||
49017024|NCT01046253|157898780|FG001|Second Intervention|Adverse Event|1|||
48676694|NCT02649894|156669084|FG000|Overall Study|Adverse Event|1|||
48676695|NCT02649894|156669085|FG001|Overall Study|Adverse Event|0|||
48676696|NCT02649894|156669084|FG000|Overall Study|Physician Decision|0|||
48676697|NCT02649894|156669085|FG001|Overall Study|Physician Decision|1|||
48676698|NCT02649894|156669084|FG000|Overall Study|Withdrawal by Subject|5|||
48676699|NCT02649894|156669085|FG001|Overall Study|Withdrawal by Subject|2|||
48676700|NCT02649894|156669084|FG000|Overall Study|Lost to Follow-up|2|||
48676701|NCT02649894|156669085|FG001|Overall Study|Lost to Follow-up|1|||
48676702|NCT02649894|156669084|FG000|Overall Study|Death|30|||
48676703|NCT02649894|156669085|FG001|Overall Study|Death|7|||
48676704|NCT02649894|156669084|FG000|Overall Study|Other, not specified|6|||
48676705|NCT02649894|156669085|FG001|Overall Study|Other, not specified|0|||
48676706|NCT00646399|156669088|FG000|Overall Study|Death|63|||
48676707|NCT00646399|156669089|FG001|Overall Study|Death|53|||
48676708|NCT00646399|156669088|FG000|Overall Study|Withdrawal by Subject|9|||
48676709|NCT00646399|156669089|FG001|Overall Study|Withdrawal by Subject|10|||
48676710|NCT00646399|156669088|FG000|Overall Study|Other Reason|11|||
48676711|NCT00646399|156669089|FG001|Overall Study|Other Reason|11|||
48676712|NCT04071158|156669090|FG000|Overall Study|Lost to Follow-up|1|||
48676713|NCT04071158|156669091|FG001|Overall Study|Lost to Follow-up|2|||
48676714|NCT04071158|156669092|FG002|Overall Study|Lost to Follow-up|3|||
49017025|NCT01046253|157898779|FG000|Second Intervention|Protocol Violation|0|||
49017026|NCT01046253|157898780|FG001|Second Intervention|Protocol Violation|1|||
49017027|NCT01058421|157898784|FG000|1 Month Outcomes|Death|10|||
49017028|NCT01058421|157898785|FG001|1 Month Outcomes|Death|6|||
49017029|NCT01058421|157898784|FG000|1 Month Outcomes|Lost to Follow-up|8|||
49017030|NCT01058421|157898785|FG001|1 Month Outcomes|Lost to Follow-up|7|||
49017031|NCT01058421|157898784|FG000|1 Month Outcomes|Remained in Hospital|5|||
49017032|NCT01058421|157898785|FG001|1 Month Outcomes|Remained in Hospital|12|||
49017033|NCT01058421|157898784|FG000|1 Month Outcomes|Remained in Other Facility|16|||
48676715|NCT04071158|156669093|FG003|Overall Study|Lost to Follow-up|3|||
48676716|NCT04071158|156669094|FG004|Overall Study|Lost to Follow-up|5|||
48676717|NCT04071158|156669090|FG000|Overall Study|Randomized but not treated|2|||
48676718|NCT04071158|156669091|FG001|Overall Study|Randomized but not treated|2|||
48676719|NCT04071158|156669092|FG002|Overall Study|Randomized but not treated|0|||
48676720|NCT04071158|156669093|FG003|Overall Study|Randomized but not treated|0|||
48676721|NCT04071158|156669094|FG004|Overall Study|Randomized but not treated|0|||
48676722|NCT05198843|156669095|FG000|Overall Study|Lack of Efficacy|1|||
48676723|NCT02473367|156669098|FG000|Wait 1|Withdrawal by Subject|1|||
48676724|NCT02473367|156669098|FG000|Period 4|Lost to Follow-up|1|||
48676725|NCT03160885|156669099|FG000|Initial Treatment Period|Not dosed|2|||
48676726|NCT03160885|156669100|FG001|Initial Treatment Period|Not dosed|0|||
48676727|NCT03160885|156669101|FG002|Initial Treatment Period|Not dosed|0|||
48676728|NCT03160885|156669102|FG003|Initial Treatment Period|Not dosed|0|||
48676729|NCT03160885|156669103|FG004|Initial Treatment Period|Not dosed|0|||
48676730|NCT03160885|156669104|FG005|Initial Treatment Period|Not dosed|0|||
48676731|NCT03160885|156669105|FG006|Initial Treatment Period|Not dosed|0|||
48676732|NCT03160885|156669099|FG000|Initial Treatment Period|Discontinued IMP before Week 16|33|||
48676733|NCT03160885|156669100|FG001|Initial Treatment Period|Discontinued IMP before Week 16|22|||
48676734|NCT03160885|156669101|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
48676735|NCT03160885|156669102|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
48676736|NCT03160885|156669103|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
48676737|NCT03160885|156669104|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
48676738|NCT03160885|156669105|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
48676739|NCT03160885|156669099|FG000|Open-label Treatment|Not dosed|0|||
48676740|NCT03160885|156669100|FG001|Open-label Treatment|Not dosed|0|||
48676741|NCT03160885|156669101|FG002|Open-label Treatment|Not dosed|0|||
48676742|NCT03160885|156669102|FG003|Open-label Treatment|Not dosed|0|||
48676743|NCT03160885|156669103|FG004|Open-label Treatment|Not dosed|0|||
48676744|NCT03160885|156669104|FG005|Open-label Treatment|Not dosed|0|||
48676745|NCT03160885|156669105|FG006|Open-label Treatment|Not dosed|2|||
48676746|NCT03160885|156669099|FG000|Open-label Treatment|Discontinued IMP|0|||
48676747|NCT03160885|156669100|FG001|Open-label Treatment|Discontinued IMP|0|||
48676748|NCT03160885|156669101|FG002|Open-label Treatment|Discontinued IMP|0|||
48676749|NCT03160885|156669102|FG003|Open-label Treatment|Discontinued IMP|0|||
48676750|NCT03160885|156669103|FG004|Open-label Treatment|Discontinued IMP|0|||
48676751|NCT03160885|156669104|FG005|Open-label Treatment|Discontinued IMP|0|||
48676752|NCT03160885|156669105|FG006|Open-label Treatment|Discontinued IMP|131|||
48676753|NCT03160885|156669099|FG000|Open-label Treatment|Completed Week 50|0|||
48676754|NCT03160885|156669100|FG001|Open-label Treatment|Completed Week 50|0|||
48676755|NCT03160885|156669101|FG002|Open-label Treatment|Completed Week 50|0|||
48676756|NCT03160885|156669102|FG003|Open-label Treatment|Completed Week 50|0|||
48676757|NCT03160885|156669103|FG004|Open-label Treatment|Completed Week 50|0|||
48676758|NCT03160885|156669104|FG005|Open-label Treatment|Completed Week 50|0|||
48676759|NCT03160885|156669105|FG006|Open-label Treatment|Completed Week 50|4|||
48676760|NCT03160885|156669099|FG000|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
48676761|NCT03160885|156669100|FG001|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
48676762|NCT03160885|156669101|FG002|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
48762261|NCT02476968|156978059|FG001|Overall Study|Patient decision|8|||
48762262|NCT02476968|156978060|FG002|Overall Study|Patient decision|0|||
48762263|NCT00778700|156978065|FG000|Overall Study|Adverse Event|6|||
48762264|NCT00778700|156978066|FG001|Overall Study|Adverse Event|1|||
48762265|NCT00778700|156978067|FG002|Overall Study|Adverse Event|3|||
48762266|NCT00778700|156978068|FG003|Overall Study|Adverse Event|5|||
48762267|NCT00778700|156978065|FG000|Overall Study|Protocol Violation|1|||
48762268|NCT00778700|156978066|FG001|Overall Study|Protocol Violation|1|||
48762269|NCT00778700|156978067|FG002|Overall Study|Protocol Violation|0|||
48762270|NCT00778700|156978068|FG003|Overall Study|Protocol Violation|0|||
48762271|NCT00778700|156978065|FG000|Overall Study|Subject Withdrew Consent|6|||
48762272|NCT00778700|156978066|FG001|Overall Study|Subject Withdrew Consent|4|||
48762273|NCT00778700|156978067|FG002|Overall Study|Subject Withdrew Consent|1|||
48762274|NCT00778700|156978068|FG003|Overall Study|Subject Withdrew Consent|4|||
49017034|NCT01058421|157898785|FG001|1 Month Outcomes|Remained in Other Facility|17|||
49017035|NCT01058421|157898784|FG000|3 Month Outcomes|Death|3|||
48676763|NCT03160885|156669102|FG003|Maintenance Treatment Period|Not dosed - transfer to open-label|1|||
48676764|NCT03160885|156669103|FG004|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
48676765|NCT03160885|156669104|FG005|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
48762275|NCT00778700|156978065|FG000|Overall Study|Lost to Follow-up|3|||
48762276|NCT00778700|156978066|FG001|Overall Study|Lost to Follow-up|1|||
49017036|NCT01058421|157898785|FG001|3 Month Outcomes|Death|5|||
48676766|NCT03160885|156669105|FG006|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
48676767|NCT03160885|156669099|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
49017037|NCT01058421|157898784|FG000|3 Month Outcomes|Lost to Follow-up|12|||
49017038|NCT01058421|157898785|FG001|3 Month Outcomes|Lost to Follow-up|11|||
49017039|NCT01058421|157898784|FG000|3 Month Outcomes|Remained in Hospital|0|||
49017040|NCT01058421|157898785|FG001|3 Month Outcomes|Remained in Hospital|2|||
49017041|NCT01058421|157898784|FG000|3 Month Outcomes|Remained in Other Facility|5|||
49017042|NCT01058421|157898785|FG001|3 Month Outcomes|Remained in Other Facility|8|||
49017043|NCT01058421|157898784|FG000|6 Month Outcomes|Death|2|||
49017044|NCT01058421|157898785|FG001|6 Month Outcomes|Death|2|||
49017045|NCT01058421|157898784|FG000|6 Month Outcomes|Lost to Follow-up|16|||
49017046|NCT01058421|157898785|FG001|6 Month Outcomes|Lost to Follow-up|21|||
49017047|NCT01058421|157898784|FG000|6 Month Outcomes|Remained in Other Facility|1|||
49017048|NCT01058421|157898785|FG001|6 Month Outcomes|Remained in Other Facility|3|||
49017049|NCT02093689|157898786|FG000|Overall Study|Physician Decision|4|||
49017050|NCT02093689|157898787|FG001|Overall Study|Physician Decision|0|||
49017051|NCT02093689|157898788|FG002|Overall Study|Physician Decision|0|||
49017052|NCT01048333|157898789|FG000|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
49017053|NCT01048333|157898790|FG001|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1|||
49017054|NCT01048333|157898791|FG002|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
49017055|NCT01048333|157898792|FG003|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
49017056|NCT01048333|157898793|FG004|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
49017057|NCT01048333|157898794|FG005|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
49017058|NCT03008460|157898795|FG000|Overall Study|Protocol deviation|0|||
49017059|NCT03008460|157898796|FG001|Overall Study|Protocol deviation|2|||
49017060|NCT03008460|157898795|FG000|Overall Study|Study drug not dispensed|0|||
49017061|NCT03008460|157898796|FG001|Overall Study|Study drug not dispensed|1|||
49017062|NCT03008460|157898795|FG000|Overall Study|Adverse Event|0|||
49017063|NCT03008460|157898796|FG001|Overall Study|Adverse Event|1|||
49017064|NCT03008460|157898795|FG000|Overall Study|Withdrawal by Subject|5|||
49017065|NCT03008460|157898796|FG001|Overall Study|Withdrawal by Subject|6|||
49017066|NCT03008460|157898795|FG000|Overall Study|COVID-19 pandemic - consent withdrawn|1|||
49017067|NCT03008460|157898796|FG001|Overall Study|COVID-19 pandemic - consent withdrawn|0|||
49017068|NCT03008460|157898795|FG000|Overall Study|End of study visit outside permitted time window|0|||
49017069|NCT03008460|157898796|FG001|Overall Study|End of study visit outside permitted time window|1|||
49017070|NCT03008460|157898795|FG000|Overall Study|Lost to Follow-up|1|||
49017071|NCT03008460|157898796|FG001|Overall Study|Lost to Follow-up|3|||
49017072|NCT04947579|157898799|FG000|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
49017073|NCT04947579|157898800|FG001|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
49017074|NCT04947579|157898801|FG002|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
49017075|NCT04947579|157898802|FG003|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|1|||
49017076|NCT04947579|157898803|FG004|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
49017077|NCT04947579|157898804|FG005|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
49017078|NCT04947579|157898799|FG000|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
49017079|NCT04947579|157898800|FG001|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
49017080|NCT04947579|157898801|FG002|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|1|||
49017081|NCT04947579|157898802|FG003|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
49017082|NCT04947579|157898803|FG004|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
49017083|NCT04947579|157898804|FG005|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
49017084|NCT04947579|157898799|FG000|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
49017085|NCT04947579|157898800|FG001|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
49017086|NCT04947579|157898801|FG002|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
49017087|NCT04947579|157898802|FG003|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
49017088|NCT04947579|157898803|FG004|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
49017089|NCT04947579|157898804|FG005|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
49017090|NCT04947579|157898799|FG000|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|5|||
49017091|NCT04947579|157898800|FG001|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|6|||
49017092|NCT04947579|157898801|FG002|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|7|||
48676768|NCT03160885|156669100|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
49017093|NCT04947579|157898802|FG003|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
49017094|NCT04947579|157898803|FG004|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|0|||
48676769|NCT03160885|156669101|FG002|Maintenance Treatment Period|Discontinued IMP|9|||
48676770|NCT03160885|156669102|FG003|Maintenance Treatment Period|Discontinued IMP|13|||
48676771|NCT03160885|156669103|FG004|Maintenance Treatment Period|Discontinued IMP|5|||
48676772|NCT03160885|156669104|FG005|Maintenance Treatment Period|Discontinued IMP|7|||
48676773|NCT03160885|156669105|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
49017095|NCT04947579|157898804|FG005|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
49017096|NCT04947579|157898799|FG000|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|1|||
49017097|NCT04947579|157898800|FG001|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
48874569|NCT02760485|157377050|FG001|Phase 2|Progressive Disease|0|||
48874570|NCT02760485|157377051|FG002|Phase 2|Progressive Disease|1|||
48874571|NCT02760485|157377049|FG000|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
48874572|NCT02760485|157377050|FG001|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
48874573|NCT02760485|157377051|FG002|Phase 2|Unknown; Did Not Complete End-of-Study Visit|3|||
48874574|NCT02658175|157377058|FG000|Treatment Period: Weeks 1 to 52|Investigator Judgment|1|||
48874575|NCT02658175|157377059|FG001|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
48874576|NCT02658175|157377060|FG002|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
48874577|NCT02658175|157377058|FG000|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6|||
48874578|NCT02658175|157377059|FG001|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2|||
48874579|NCT02658175|157377060|FG002|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0|||
48874580|NCT02658175|157377058|FG000|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8|||
48874581|NCT02658175|157377059|FG001|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5|||
48874582|NCT02658175|157377060|FG002|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0|||
48874583|NCT02658175|157377058|FG000|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1|||
48874584|NCT02658175|157377059|FG001|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
48874585|NCT02658175|157377060|FG002|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
48874586|NCT02658175|157377058|FG000|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4|||
48874587|NCT02658175|157377059|FG001|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0|||
48874588|NCT02658175|157377060|FG002|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1|||
48874589|NCT02658175|157377058|FG000|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7|||
48874590|NCT02658175|157377059|FG001|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
48874591|NCT02658175|157377060|FG002|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
48874592|NCT02658175|157377058|FG000|1st Extended Treatment: Weeks 53 to 104|Other|1|||
48874593|NCT02658175|157377059|FG001|1st Extended Treatment: Weeks 53 to 104|Other|0|||
48874594|NCT02658175|157377060|FG002|1st Extended Treatment: Weeks 53 to 104|Other|1|||
48874595|NCT02658175|157377058|FG000|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8|||
48874596|NCT02658175|157377059|FG001|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2|||
48874597|NCT02658175|157377060|FG002|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0|||
48874598|NCT02658175|157377058|FG000|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
48874599|NCT02658175|157377059|FG001|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
49017098|NCT04947579|157898801|FG002|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
49017099|NCT04947579|157898802|FG003|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
49017100|NCT04947579|157898803|FG004|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
49017101|NCT04947579|157898804|FG005|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
49017102|NCT04947579|157898799|FG000|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
49017103|NCT04947579|157898800|FG001|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
49017104|NCT04947579|157898801|FG002|Week 12 - Week 64 (Long-Term Extension)|Death|1|||
49017105|NCT04947579|157898802|FG003|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
49017106|NCT04947579|157898803|FG004|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
49017107|NCT04947579|157898804|FG005|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
49017108|NCT04947579|157898799|FG000|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
48676774|NCT03160885|156669099|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
48676775|NCT03160885|156669100|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
48676776|NCT03160885|156669101|FG002|Maintenance Treatment Period|Transfer to open-label treatment|29|||
48676777|NCT03160885|156669102|FG003|Maintenance Treatment Period|Transfer to open-label treatment|26|||
48676778|NCT03160885|156669103|FG004|Maintenance Treatment Period|Transfer to open-label treatment|26|||
48676779|NCT03160885|156669104|FG005|Maintenance Treatment Period|Transfer to open-label treatment|8|||
48676780|NCT03160885|156669105|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
48676781|NCT03160885|156669099|FG000|Maintenance Treatment Period|Completed Week 50|0|||
48676782|NCT03160885|156669100|FG001|Maintenance Treatment Period|Completed Week 50|0|||
48676783|NCT03160885|156669101|FG002|Maintenance Treatment Period|Completed Week 50|1|||
48676784|NCT03160885|156669102|FG003|Maintenance Treatment Period|Completed Week 50|0|||
48676785|NCT03160885|156669103|FG004|Maintenance Treatment Period|Completed Week 50|0|||
48676786|NCT03160885|156669104|FG005|Maintenance Treatment Period|Completed Week 50|0|||
49017109|NCT04947579|157898800|FG001|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
49017110|NCT04947579|157898801|FG002|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
49017111|NCT04947579|157898802|FG003|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
49017112|NCT04947579|157898803|FG004|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
49017113|NCT04947579|157898804|FG005|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
49017114|NCT04947579|157898799|FG000|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
49017115|NCT04947579|157898800|FG001|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
48676787|NCT03160885|156669105|FG006|Maintenance Treatment Period|Completed Week 50|0|||
48676788|NCT03129360|156669106|FG000|Overall Study|Did not meet entry criteria|0|||
49017116|NCT04947579|157898801|FG002|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|1|||
49017117|NCT04947579|157898802|FG003|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
49017118|NCT04947579|157898803|FG004|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
49017119|NCT04947579|157898804|FG005|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
49017120|NCT04947579|157898799|FG000|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
49017121|NCT04947579|157898800|FG001|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|54|||
49017122|NCT04947579|157898801|FG002|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|46|||
49017123|NCT04947579|157898802|FG003|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
49017124|NCT04947579|157898803|FG004|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|5|||
49017125|NCT04947579|157898804|FG005|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|4|||
49017126|NCT04947579|157898799|FG000|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
49017127|NCT04947579|157898800|FG001|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|2|||
49017128|NCT04947579|157898801|FG002|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|4|||
49017129|NCT04947579|157898802|FG003|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
49017130|NCT04947579|157898803|FG004|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|1|||
49017131|NCT04947579|157898804|FG005|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|3|||
49017132|NCT04947579|157898799|FG000|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
49017133|NCT04947579|157898800|FG001|Week 12 - Week 64 (Long-Term Extension)|Other reasons|5|||
49017134|NCT04947579|157898801|FG002|Week 12 - Week 64 (Long-Term Extension)|Other reasons|8|||
49017135|NCT04947579|157898802|FG003|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
49017136|NCT04947579|157898803|FG004|Week 12 - Week 64 (Long-Term Extension)|Other reasons|1|||
49017137|NCT04947579|157898804|FG005|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
49017138|NCT02456909|157898805|FG000|Overall Study|Did not receive allocated intervention|24|||
49017139|NCT02456909|157898806|FG001|Overall Study|Did not receive allocated intervention|26|||
49017140|NCT02456909|157898805|FG000|Overall Study|Did not complete the primary outcome|0|||
49017141|NCT02456909|157898806|FG001|Overall Study|Did not complete the primary outcome|1|||
49017142|NCT00929708|157898807|FG000|Overall Study|Protocol Violation|2|||
49017143|NCT00929708|157898808|FG001|Overall Study|Protocol Violation|1|||
49017144|NCT00929708|157898809|FG002|Overall Study|Protocol Violation|1|||
49017145|NCT00929708|157898810|FG003|Overall Study|Protocol Violation|1|||
49017146|NCT00929708|157898811|FG004|Overall Study|Protocol Violation|1|||
49017147|NCT00929708|157898807|FG000|Overall Study|Withdrawal by Subject|2|||
49017148|NCT00929708|157898808|FG001|Overall Study|Withdrawal by Subject|0|||
49017149|NCT00929708|157898809|FG002|Overall Study|Withdrawal by Subject|0|||
49017150|NCT00929708|157898810|FG003|Overall Study|Withdrawal by Subject|2|||
49017151|NCT00929708|157898811|FG004|Overall Study|Withdrawal by Subject|1|||
49017152|NCT00929708|157898807|FG000|Overall Study|Adverse Event|0|||
49017153|NCT00929708|157898808|FG001|Overall Study|Adverse Event|0|||
49017154|NCT00929708|157898809|FG002|Overall Study|Adverse Event|0|||
49017155|NCT00929708|157898810|FG003|Overall Study|Adverse Event|0|||
49017156|NCT00929708|157898811|FG004|Overall Study|Adverse Event|3|||
49017157|NCT00929708|157898807|FG000|Overall Study|Physician Decision|0|||
49017158|NCT00929708|157898808|FG001|Overall Study|Physician Decision|2|||
49017159|NCT00929708|157898809|FG002|Overall Study|Physician Decision|2|||
49017160|NCT00929708|157898810|FG003|Overall Study|Physician Decision|2|||
49017161|NCT00929708|157898811|FG004|Overall Study|Physician Decision|1|||
49017162|NCT00929708|157898807|FG000|Overall Study|Lost to Follow-up|0|||
49017163|NCT00929708|157898808|FG001|Overall Study|Lost to Follow-up|0|||
49017164|NCT00929708|157898809|FG002|Overall Study|Lost to Follow-up|0|||
49017165|NCT00929708|157898810|FG003|Overall Study|Lost to Follow-up|1|||
49017166|NCT00929708|157898811|FG004|Overall Study|Lost to Follow-up|0|||
49017167|NCT02768298|157898814|FG000|Overall Study|Adverse Event|1|||
49017168|NCT02768298|157898815|FG001|Overall Study|Adverse Event|4|||
49017169|NCT02768298|157898814|FG000|Overall Study|Death|2|||
49017170|NCT02768298|157898815|FG001|Overall Study|Death|1|||
49017171|NCT02768298|157898814|FG000|Overall Study|Non-compliance with study treatment|0|||
49017172|NCT02768298|157898815|FG001|Overall Study|Non-compliance with study treatment|1|||
49017173|NCT02768298|157898814|FG000|Overall Study|Subject/guardian decision|1|||
49017174|NCT02768298|157898815|FG001|Overall Study|Subject/guardian decision|0|||
49017175|NCT02768298|157898814|FG000|Overall Study|Withdrawal of informed consent|0|||
49017176|NCT02768298|157898815|FG001|Overall Study|Withdrawal of informed consent|1|||
49017177|NCT02154529|157898816|FG000|Overall Study|Death|1|||
48676789|NCT03129360|156669107|FG001|Overall Study|Did not meet entry criteria|2|||
48676790|NCT03129360|156669108|FG002|Overall Study|Did not meet entry criteria|1|||
49017178|NCT02154529|157898817|FG001|Overall Study|Death|1|||
49017179|NCT02154529|157898818|FG002|Overall Study|Death|5|||
49017180|NCT02154529|157898819|FG003|Overall Study|Death|1|||
49017181|NCT02154529|157898816|FG000|Overall Study|Termination of study by sponsor|2|||
49017182|NCT02154529|157898817|FG001|Overall Study|Termination of study by sponsor|2|||
49017183|NCT02154529|157898818|FG002|Overall Study|Termination of study by sponsor|3|||
49017184|NCT02154529|157898819|FG003|Overall Study|Termination of study by sponsor|1|||
48676791|NCT03129360|156669106|FG000|Overall Study|Excluded due to motion in scanner|1|||
49017185|NCT02154529|157898816|FG000|Overall Study|Lost to Follow-up|1|||
49017186|NCT02154529|157898817|FG001|Overall Study|Lost to Follow-up|0|||
49017187|NCT02154529|157898818|FG002|Overall Study|Lost to Follow-up|0|||
49017188|NCT02154529|157898819|FG003|Overall Study|Lost to Follow-up|0|||
49017189|NCT00365352|157898820|FG000|Overall Study|Adverse Event|6|||
49017190|NCT00365352|157898821|FG001|Overall Study|Adverse Event|7|||
49017191|NCT00365352|157898822|FG002|Overall Study|Adverse Event|8|||
49017192|NCT00365352|157898820|FG000|Overall Study|Participant Withdrew Consent|8|||
49017193|NCT00365352|157898821|FG001|Overall Study|Participant Withdrew Consent|3|||
49017194|NCT00365352|157898822|FG002|Overall Study|Participant Withdrew Consent|4|||
49017195|NCT00365352|157898820|FG000|Overall Study|Lack of Efficacy|3|||
49017196|NCT00365352|157898821|FG001|Overall Study|Lack of Efficacy|0|||
49017197|NCT00365352|157898822|FG002|Overall Study|Lack of Efficacy|0|||
49017198|NCT00365352|157898820|FG000|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
49017199|NCT00365352|157898821|FG001|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
49017200|NCT00365352|157898822|FG002|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2|||
49017201|NCT00365352|157898820|FG000|Overall Study|Non-Compliance (after Randomization)|1|||
49017202|NCT00365352|157898821|FG001|Overall Study|Non-Compliance (after Randomization)|0|||
49017203|NCT00365352|157898822|FG002|Overall Study|Non-Compliance (after Randomization)|1|||
49017204|NCT00365352|157898820|FG000|Overall Study|Lost to Follow-up|1|||
48676792|NCT03129360|156669107|FG001|Overall Study|Excluded due to motion in scanner|0|||
48676793|NCT03129360|156669108|FG002|Overall Study|Excluded due to motion in scanner|0|||
48676794|NCT02409719|156669116|FG000|Overall Study|Lost to Follow-up|3|||
48676795|NCT02409719|156669117|FG001|Overall Study|Lost to Follow-up|3|||
48676796|NCT00231413|156669118|FG000|Overall Study|Non-serious AE|0|||
48676797|NCT00231413|156669119|FG001|Overall Study|Non-serious AE|0|||
48676798|NCT00231413|156669120|FG002|Overall Study|Non-serious AE|1|||
48676799|NCT00231413|156669121|FG003|Overall Study|Non-serious AE|0|||
48676800|NCT00231413|156669122|FG004|Overall Study|Non-serious AE|0|||
48676801|NCT00231413|156669123|FG005|Overall Study|Non-serious AE|0|||
48676802|NCT00231413|156669124|FG006|Overall Study|Non-serious AE|1|||
48676803|NCT00231413|156669118|FG000|Overall Study|Withdrawal by Subject|3|||
48676804|NCT00231413|156669119|FG001|Overall Study|Withdrawal by Subject|1|||
48676805|NCT00231413|156669120|FG002|Overall Study|Withdrawal by Subject|4|||
48676806|NCT00231413|156669121|FG003|Overall Study|Withdrawal by Subject|2|||
49017205|NCT00365352|157898821|FG001|Overall Study|Lost to Follow-up|1|||
49017206|NCT00365352|157898822|FG002|Overall Study|Lost to Follow-up|0|||
49017207|NCT00365352|157898820|FG000|Overall Study|Withdrawal of Participant by Sponsor|1|||
49017208|NCT00365352|157898821|FG001|Overall Study|Withdrawal of Participant by Sponsor|0|||
49017209|NCT00365352|157898822|FG002|Overall Study|Withdrawal of Participant by Sponsor|0|||
49017210|NCT00906347|157900144|FG000|Received Study Drug|8 cm prior to initiation of study drug|18|||
49017211|NCT00906347|157900145|FG001|Received Study Drug|8 cm prior to initiation of study drug|30|||
49017212|NCT00906347|157900144|FG000|Received Study Drug|Nonreassuring fetal heart rate|13|||
49017213|NCT00906347|157900145|FG001|Received Study Drug|Nonreassuring fetal heart rate|1|||
49017214|NCT00906347|157900144|FG000|Received Study Drug|Refused study drug|1|||
49017215|NCT00906347|157900145|FG001|Received Study Drug|Refused study drug|0|||
49017216|NCT00906347|157900144|FG000|Received Study Drug|Uterine tachysystole or hypertonus|8|||
49017217|NCT00906347|157900145|FG001|Received Study Drug|Uterine tachysystole or hypertonus|0|||
49017218|NCT00759148|157900146|FG000|Overall Study|Adverse Event|1|||
49017219|NCT00759148|157900147|FG001|Overall Study|Adverse Event|6|||
49017220|NCT00759148|157900146|FG000|Overall Study|Withdrawal by Subject|3|||
49017221|NCT00759148|157900147|FG001|Overall Study|Withdrawal by Subject|7|||
49017222|NCT00759148|157900146|FG000|Overall Study|Lost to Follow-up|3|||
49017223|NCT00759148|157900147|FG001|Overall Study|Lost to Follow-up|9|||
49017224|NCT00759148|157900146|FG000|Overall Study|Treatment Failure|6|||
49017225|NCT00759148|157900147|FG001|Overall Study|Treatment Failure|10|||
49017226|NCT00759148|157900146|FG000|Overall Study|Reason not given|1|||
49017227|NCT00759148|157900147|FG001|Overall Study|Reason not given|0|||
49017228|NCT03381248|157900148|FG000|0-6 Months|Withdrawal by Subject|4|||
49017229|NCT03381248|157900149|FG001|0-6 Months|Withdrawal by Subject|1|||
49017230|NCT03381248|157900148|FG000|0-6 Months|Lost to Follow-up|3|||
49017231|NCT03381248|157900149|FG001|0-6 Months|Lost to Follow-up|2|||
48676807|NCT00231413|156669122|FG004|Overall Study|Withdrawal by Subject|2|||
48676808|NCT00231413|156669123|FG005|Overall Study|Withdrawal by Subject|0|||
48676809|NCT00231413|156669124|FG006|Overall Study|Withdrawal by Subject|3|||
48676810|NCT00231413|156669118|FG000|Overall Study|Migrated/moved from study area|0|||
49017232|NCT03381248|157900148|FG000|0-6 Months|Lack of Efficacy|1|||
49017233|NCT03381248|157900149|FG001|0-6 Months|Lack of Efficacy|0|||
49017234|NCT03381248|157900148|FG000|0-6 Months|Adverse Event|1|||
49017235|NCT03381248|157900149|FG001|0-6 Months|Adverse Event|0|||
48676811|NCT00231413|156669119|FG001|Overall Study|Migrated/moved from study area|0|||
48676812|NCT00231413|156669120|FG002|Overall Study|Migrated/moved from study area|1|||
48676813|NCT00231413|156669121|FG003|Overall Study|Migrated/moved from study area|0|||
48676814|NCT00231413|156669122|FG004|Overall Study|Migrated/moved from study area|0|||
48676815|NCT00231413|156669123|FG005|Overall Study|Migrated/moved from study area|1|||
48762277|NCT00778700|156978067|FG002|Overall Study|Lost to Follow-up|0|||
48762278|NCT00778700|156978068|FG003|Overall Study|Lost to Follow-up|1|||
48762279|NCT00778700|156978065|FG000|Overall Study|Reason not Specified|2|||
48762280|NCT00778700|156978066|FG001|Overall Study|Reason not Specified|0|||
48762281|NCT00778700|156978067|FG002|Overall Study|Reason not Specified|1|||
49017236|NCT03381248|157900148|FG000|0-6 Months|Protocol Violation|2|||
49017237|NCT03381248|157900149|FG001|0-6 Months|Protocol Violation|1|||
49017238|NCT03381248|157900148|FG000|0-6 Months|Physician Decision|1|||
49017239|NCT03381248|157900149|FG001|0-6 Months|Physician Decision|0|||
49017240|NCT03381248|157900148|FG000|0-6 Months|Planning another procedure|1|||
49017241|NCT03381248|157900149|FG001|0-6 Months|Planning another procedure|2|||
49017242|NCT03381248|157900148|FG000|6-12 Months|Withdrawal by Subject|1|||
49017243|NCT03381248|157900149|FG001|6-12 Months|Withdrawal by Subject|3|||
49017244|NCT03381248|157900148|FG000|6-12 Months|Lost to Follow-up|0|||
49017245|NCT03381248|157900149|FG001|6-12 Months|Lost to Follow-up|2|||
49017246|NCT03381248|157900148|FG000|6-12 Months|Protocol Violation|3|||
49017247|NCT03381248|157900149|FG001|6-12 Months|Protocol Violation|2|||
49017248|NCT03381248|157900148|FG000|6-12 Months|Planning another procedure|6|||
49017249|NCT03381248|157900149|FG001|6-12 Months|Planning another procedure|2|||
49017250|NCT03381248|157900148|FG000|12 - 24 Months (Extension Study)|Withdrawal by Subject|3|||
49017251|NCT03381248|157900149|FG001|12 - 24 Months (Extension Study)|Withdrawal by Subject|0|||
49017252|NCT03381248|157900148|FG000|12 - 24 Months (Extension Study)|Lost to Follow-up|1|||
49017253|NCT03381248|157900149|FG001|12 - 24 Months (Extension Study)|Lost to Follow-up|0|||
49017254|NCT03381248|157900148|FG000|12 - 24 Months (Extension Study)|Received another procedure|5|||
49017255|NCT03381248|157900149|FG001|12 - 24 Months (Extension Study)|Received another procedure|0|||
49017256|NCT02965820|157900150|FG000|Period 2, Second 30 Days|Adverse Event|1|||
49017257|NCT02965820|157900151|FG001|Period 2, Second 30 Days|Adverse Event|1|||
48676816|NCT00231413|156669124|FG006|Overall Study|Migrated/moved from study area|0|||
48676817|NCT00231413|156669118|FG000|Overall Study|Lost to Follow-up|4|||
48676818|NCT00231413|156669119|FG001|Overall Study|Lost to Follow-up|4|||
48676819|NCT00231413|156669120|FG002|Overall Study|Lost to Follow-up|1|||
48676820|NCT00231413|156669121|FG003|Overall Study|Lost to Follow-up|1|||
48676821|NCT00231413|156669122|FG004|Overall Study|Lost to Follow-up|1|||
48676822|NCT00231413|156669123|FG005|Overall Study|Lost to Follow-up|4|||
48676823|NCT00231413|156669124|FG006|Overall Study|Lost to Follow-up|0|||
48676824|NCT00231413|156669118|FG000|Overall Study|Pregnancy|1|||
48676825|NCT00231413|156669119|FG001|Overall Study|Pregnancy|0|||
48676826|NCT00231413|156669120|FG002|Overall Study|Pregnancy|0|||
48676827|NCT00231413|156669121|FG003|Overall Study|Pregnancy|0|||
48762282|NCT00778700|156978068|FG003|Overall Study|Reason not Specified|3|||
49017258|NCT00130520|157900152|FG000|Overall Study|Adverse Event|11|||
49017259|NCT00130520|157900152|FG000|Overall Study|Death|1|||
49017260|NCT00130520|157900152|FG000|Overall Study|Physician Decision|1|||
49017261|NCT00130520|157900152|FG000|Overall Study|Withdrawal by Subject|1|||
49017262|NCT00130520|157900152|FG000|Overall Study|Disease Progression|23|||
49017263|NCT00130520|157900152|FG000|Overall Study|Protocol non-compliance|1|||
49017264|NCT00130520|157900152|FG000|Overall Study|Did not meet re-treatment criteria|1|||
49017265|NCT00673361|157900156|FG000|Overall Study|Screen Failure|2|||
49017266|NCT01464827|157900158|FG000|Overall Study|Adverse Event|0|||
49017267|NCT01464827|157900159|FG001|Overall Study|Adverse Event|0|||
49017268|NCT01464827|157900160|FG002|Overall Study|Adverse Event|0|||
49017269|NCT01464827|157900161|FG003|Overall Study|Adverse Event|0|||
49017270|NCT01464827|157900162|FG004|Overall Study|Adverse Event|0|||
49017271|NCT01464827|157900163|FG005|Overall Study|Adverse Event|0|||
49017272|NCT01464827|157900164|FG006|Overall Study|Adverse Event|0|||
49017273|NCT01464827|157900165|FG007|Overall Study|Adverse Event|0|||
49017274|NCT01464827|157900166|FG008|Overall Study|Adverse Event|0|||
49017275|NCT01464827|157900167|FG009|Overall Study|Adverse Event|0|||
49017276|NCT01464827|157900168|FG010|Overall Study|Adverse Event|0|||
49017277|NCT01464827|157900169|FG011|Overall Study|Adverse Event|0|||
49017278|NCT01464827|157900170|FG012|Overall Study|Adverse Event|1|||
49017279|NCT01464827|157900171|FG013|Overall Study|Adverse Event|0|||
49017280|NCT01464827|157900158|FG000|Overall Study|Withdrawal by Subject|1|||
49017281|NCT01464827|157900159|FG001|Overall Study|Withdrawal by Subject|0|||
49017282|NCT01464827|157900160|FG002|Overall Study|Withdrawal by Subject|0|||
49017283|NCT01464827|157900161|FG003|Overall Study|Withdrawal by Subject|0|||
49017284|NCT01464827|157900162|FG004|Overall Study|Withdrawal by Subject|1|||
49017285|NCT01464827|157900163|FG005|Overall Study|Withdrawal by Subject|0|||
49017286|NCT01464827|157900164|FG006|Overall Study|Withdrawal by Subject|0|||
49017287|NCT01464827|157900165|FG007|Overall Study|Withdrawal by Subject|1|||
49017288|NCT01464827|157900166|FG008|Overall Study|Withdrawal by Subject|0|||
49017289|NCT01464827|157900167|FG009|Overall Study|Withdrawal by Subject|0|||
49017290|NCT01464827|157900168|FG010|Overall Study|Withdrawal by Subject|0|||
48676828|NCT00231413|156669122|FG004|Overall Study|Pregnancy|0|||
48676829|NCT00231413|156669123|FG005|Overall Study|Pregnancy|0|||
48676830|NCT00231413|156669124|FG006|Overall Study|Pregnancy|0|||
48762283|NCT00778700|156978065|FG000|Overall Study|Other|0|||
48762284|NCT00778700|156978066|FG001|Overall Study|Other|0|||
48676831|NCT01331291|156669126|FG000|Overall Study|Lack of Efficacy|2|||
48676832|NCT01331291|156669127|FG001|Overall Study|Lack of Efficacy|8|||
48874600|NCT02658175|157377060|FG002|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1|||
48676833|NCT01331291|156669126|FG000|Overall Study|Death|0|||
48676834|NCT01331291|156669127|FG001|Overall Study|Death|1|||
48676835|NCT00866814|156669128|FG000|Overall Study|Lost to Follow-up|12|||
48676836|NCT00866814|156669128|FG000|Overall Study|Adverse Event|2|||
48676837|NCT00866814|156669128|FG000|Overall Study|Physician Decision|1|||
48676838|NCT00866814|156669128|FG000|Overall Study|Death|1|||
48676839|NCT00866814|156669128|FG000|Overall Study|No longer wished to participate|1|||
48676840|NCT00866814|156669128|FG000|Overall Study|Unable to meet follow-up requirements|2|||
48874601|NCT02658175|157377058|FG000|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1|||
48874602|NCT02658175|157377059|FG001|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
48874603|NCT02658175|157377060|FG002|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
48874604|NCT00746356|157377061|FG000|Overall Study|Withdrawal by Subject|2|||
48874605|NCT00746356|157377062|FG001|Overall Study|Withdrawal by Subject|3|||
48874606|NCT00746356|157377061|FG000|Overall Study|Death|7|||
48874607|NCT00746356|157377062|FG001|Overall Study|Death|3|||
48874608|NCT00746356|157377061|FG000|Overall Study|Lost to Follow-up|1|||
48874609|NCT00746356|157377062|FG001|Overall Study|Lost to Follow-up|0|||
48874610|NCT00746356|157377061|FG000|Overall Study|Removal of Device|0|||
48874611|NCT00746356|157377062|FG001|Overall Study|Removal of Device|1|||
48874612|NCT00746356|157377061|FG000|Overall Study|Patient relocated|1|||
48874613|NCT00746356|157377062|FG001|Overall Study|Patient relocated|0|||
48874614|NCT01263925|157377063|FG000|Overall Study|Protocol Violation|1|||
48874615|NCT01263925|157377064|FG001|Overall Study|Protocol Violation|0|||
48874616|NCT01263925|157377063|FG000|Overall Study|Lack of Efficacy|0|||
48874617|NCT01263925|157377064|FG001|Overall Study|Lack of Efficacy|1|||
48874618|NCT01263925|157377063|FG000|Overall Study|Adverse Event|23|||
48874619|NCT01263925|157377064|FG001|Overall Study|Adverse Event|22|||
48874620|NCT01263925|157377063|FG000|Overall Study|Unsatisfactory Compliance of Subject|8|||
48874621|NCT01263925|157377064|FG001|Overall Study|Unsatisfactory Compliance of Subject|5|||
48874622|NCT01263925|157377063|FG000|Overall Study|Withdrawal by Subject|6|||
48874623|NCT01263925|157377064|FG001|Overall Study|Withdrawal by Subject|8|||
48874624|NCT01263925|157377063|FG000|Overall Study|Other|4|||
48874625|NCT01263925|157377064|FG001|Overall Study|Other|4|||
48874626|NCT01263925|157377063|FG000|Overall Study|Lost to Follow-up|3|||
48874627|NCT01263925|157377064|FG001|Overall Study|Lost to Follow-up|1|||
48874628|NCT01263925|157377063|FG000|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
48874629|NCT01263925|157377064|FG001|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
48874630|NCT01263925|157377063|FG000|Overall Study|AE/ Unsatisfactory Compliance|2|||
48874631|NCT01263925|157377064|FG001|Overall Study|AE/ Unsatisfactory Compliance|2|||
48874632|NCT01263925|157377063|FG000|Overall Study|AE/ Withdrawal|1|||
48874633|NCT01263925|157377064|FG001|Overall Study|AE/ Withdrawal|4|||
48874634|NCT01263925|157377063|FG000|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
48874635|NCT01263925|157377064|FG001|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
48874636|NCT01263925|157377063|FG000|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1|||
48874637|NCT01263925|157377064|FG001|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2|||
49017291|NCT01464827|157900169|FG011|Overall Study|Withdrawal by Subject|0|||
49017292|NCT01464827|157900170|FG012|Overall Study|Withdrawal by Subject|0|||
49017293|NCT01464827|157900171|FG013|Overall Study|Withdrawal by Subject|0|||
49017294|NCT01464827|157900158|FG000|Overall Study|Lost to Follow-up|0|||
49017295|NCT01464827|157900159|FG001|Overall Study|Lost to Follow-up|2|||
49017296|NCT01464827|157900160|FG002|Overall Study|Lost to Follow-up|0|||
49017297|NCT01464827|157900161|FG003|Overall Study|Lost to Follow-up|2|||
49017298|NCT01464827|157900162|FG004|Overall Study|Lost to Follow-up|3|||
49017299|NCT01464827|157900163|FG005|Overall Study|Lost to Follow-up|1|||
49017300|NCT01464827|157900164|FG006|Overall Study|Lost to Follow-up|2|||
49017301|NCT01464827|157900165|FG007|Overall Study|Lost to Follow-up|2|||
49017302|NCT01464827|157900166|FG008|Overall Study|Lost to Follow-up|0|||
49017303|NCT01464827|157900167|FG009|Overall Study|Lost to Follow-up|0|||
49017304|NCT01464827|157900168|FG010|Overall Study|Lost to Follow-up|0|||
49017305|NCT01464827|157900169|FG011|Overall Study|Lost to Follow-up|1|||
49017306|NCT01464827|157900170|FG012|Overall Study|Lost to Follow-up|0|||
48874638|NCT01263925|157377063|FG000|Overall Study|Withdrawal/ Not specified|0|||
48874639|NCT01263925|157377064|FG001|Overall Study|Withdrawal/ Not specified|1|||
48874640|NCT02554383|157377066|FG000|Overall Study|Ineligible|3|||
49017307|NCT01464827|157900171|FG013|Overall Study|Lost to Follow-up|1|||
48874641|NCT02554383|157377067|FG001|Overall Study|Ineligible|2|||
48874642|NCT02554383|157377066|FG000|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|8|||
49017308|NCT01464827|157900158|FG000|Overall Study|Other|2|||
49017309|NCT01464827|157900159|FG001|Overall Study|Other|3|||
49017310|NCT01464827|157900160|FG002|Overall Study|Other|0|||
48676841|NCT00866814|156669128|FG000|Overall Study|Moved to area without study site|1|||
48676842|NCT01620762|156669129|FG000|Overall Study|Protocol Violation|1|||
49017311|NCT01464827|157900161|FG003|Overall Study|Other|2|||
49017312|NCT01464827|157900162|FG004|Overall Study|Other|3|||
48874643|NCT02554383|157377067|FG001|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|6|||
48874644|NCT02554383|157377066|FG000|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|0|||
48874645|NCT02554383|157377067|FG001|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|2|||
48874646|NCT02554383|157377066|FG000|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|12|||
48874647|NCT02554383|157377067|FG001|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|9|||
48874648|NCT00826228|157378911|FG000|Overall Study|Withdrawal by Subject|1|||
48874649|NCT02104505|157378912|FG000|First Intervention (14 Days)|Adverse Event|2|||
48874650|NCT02104505|157378913|FG001|First Intervention (14 Days)|Adverse Event|0|||
48874651|NCT02104505|157378912|FG000|First Intervention (14 Days)|Withdrawal by Subject|0|||
48874652|NCT02104505|157378913|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
48874653|NCT02104505|157378912|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
48874654|NCT02104505|157378913|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
48874655|NCT02104505|157378912|FG000|First Intervention (14 Days)|exclusionary condition|0|||
48874656|NCT02104505|157378913|FG001|First Intervention (14 Days)|exclusionary condition|1|||
48874657|NCT02104505|157378912|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
48874658|NCT02104505|157378913|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
48874659|NCT02104505|157378912|FG000|Second Intervention (14 Days)|Adverse Event|2|||
48874660|NCT02104505|157378913|FG001|Second Intervention (14 Days)|Adverse Event|0|||
48874661|NCT03991988|157378914|FG000|Overall Study|Withdrawal by Subject|2|||
48874662|NCT03991988|157378915|FG001|Overall Study|Withdrawal by Subject|2|||
48874663|NCT00684203|157378916|FG000|Overall Study|Adverse Event|6|||
48874664|NCT00684203|157378917|FG001|Overall Study|Adverse Event|4|||
48874665|NCT00684203|157378918|FG002|Overall Study|Adverse Event|8|||
48874666|NCT00684203|157378919|FG003|Overall Study|Adverse Event|0|||
48874667|NCT00684203|157378920|FG004|Overall Study|Adverse Event|0|||
48874668|NCT00684203|157378921|FG005|Overall Study|Adverse Event|0|||
48874669|NCT00684203|157378916|FG000|Overall Study|Protocol-defined clinical event|3|||
48874670|NCT00684203|157378917|FG001|Overall Study|Protocol-defined clinical event|1|||
48874671|NCT00684203|157378918|FG002|Overall Study|Protocol-defined clinical event|0|||
48874672|NCT00684203|157378919|FG003|Overall Study|Protocol-defined clinical event|0|||
48874673|NCT00684203|157378920|FG004|Overall Study|Protocol-defined clinical event|0|||
48874674|NCT00684203|157378921|FG005|Overall Study|Protocol-defined clinical event|0|||
48874675|NCT00684203|157378916|FG000|Overall Study|Withdrawal by Subject|0|||
48874676|NCT00684203|157378917|FG001|Overall Study|Withdrawal by Subject|2|||
49017313|NCT01464827|157900163|FG005|Overall Study|Other|0|||
49017314|NCT01464827|157900164|FG006|Overall Study|Other|1|||
48676843|NCT01620762|156669130|FG001|Overall Study|Protocol Violation|1|||
48676844|NCT01620762|156669131|FG002|Overall Study|Protocol Violation|1|||
48676845|NCT01620762|156669129|FG000|Overall Study|Adverse Event|9|||
48676846|NCT01620762|156669130|FG001|Overall Study|Adverse Event|5|||
48676847|NCT01620762|156669131|FG002|Overall Study|Adverse Event|2|||
48676848|NCT01620762|156669129|FG000|Overall Study|Withdrawal by Subject|23|||
48676849|NCT01620762|156669130|FG001|Overall Study|Withdrawal by Subject|26|||
48676850|NCT01620762|156669131|FG002|Overall Study|Withdrawal by Subject|27|||
48676851|NCT01620762|156669129|FG000|Overall Study|Lost to Follow-up|11|||
48676852|NCT01620762|156669130|FG001|Overall Study|Lost to Follow-up|17|||
48676853|NCT01620762|156669131|FG002|Overall Study|Lost to Follow-up|10|||
48676854|NCT01620762|156669129|FG000|Overall Study|Protocol deviation|1|||
48676855|NCT01620762|156669130|FG001|Overall Study|Protocol deviation|1|||
48676856|NCT01620762|156669131|FG002|Overall Study|Protocol deviation|6|||
48676857|NCT01620762|156669129|FG000|Overall Study|Subject deterioration|0|||
48676858|NCT01620762|156669130|FG001|Overall Study|Subject deterioration|1|||
48676859|NCT01620762|156669131|FG002|Overall Study|Subject deterioration|1|||
48676860|NCT01620762|156669129|FG000|Overall Study|Non-specified|3|||
48676861|NCT01620762|156669130|FG001|Overall Study|Non-specified|6|||
48676862|NCT01620762|156669131|FG002|Overall Study|Non-specified|5|||
48676863|NCT01620762|156669129|FG000|Overall Study|Use of prohibted therapies|0|||
48676864|NCT01620762|156669130|FG001|Overall Study|Use of prohibted therapies|1|||
48676865|NCT01620762|156669131|FG002|Overall Study|Use of prohibted therapies|1|||
48676866|NCT00705146|156669136|FG000|Overall Study|Lost to Follow-up|1|||
48676867|NCT00705146|156669137|FG001|Overall Study|Lost to Follow-up|1|||
49017315|NCT01464827|157900165|FG007|Overall Study|Other|0|||
49017316|NCT01464827|157900166|FG008|Overall Study|Other|3|||
49017317|NCT01464827|157900167|FG009|Overall Study|Other|1|||
49017318|NCT01464827|157900168|FG010|Overall Study|Other|2|||
48676868|NCT00465647|156669141|FG000|Overall Study|Administrative|2|||
48762285|NCT00778700|156978067|FG002|Overall Study|Other|1|||
48676869|NCT00465647|156669142|FG001|Overall Study|Administrative|2|||
48874677|NCT00684203|157378918|FG002|Overall Study|Withdrawal by Subject|1|||
48676870|NCT00465647|156669143|FG002|Overall Study|Administrative|3|||
48676871|NCT00465647|156669144|FG003|Overall Study|Administrative|2|||
48676872|NCT00465647|156669141|FG000|Overall Study|Adverse Event|2|||
48676873|NCT00465647|156669142|FG001|Overall Study|Adverse Event|0|||
48676874|NCT00465647|156669143|FG002|Overall Study|Adverse Event|3|||
48874678|NCT00684203|157378919|FG003|Overall Study|Withdrawal by Subject|0|||
48874679|NCT00684203|157378920|FG004|Overall Study|Withdrawal by Subject|0|||
48874680|NCT00684203|157378921|FG005|Overall Study|Withdrawal by Subject|0|||
48874681|NCT00684203|157378916|FG000|Overall Study|Did not meet protocol eligibility|0|||
48874682|NCT00684203|157378917|FG001|Overall Study|Did not meet protocol eligibility|1|||
48874683|NCT00684203|157378918|FG002|Overall Study|Did not meet protocol eligibility|0|||
48874684|NCT00684203|157378919|FG003|Overall Study|Did not meet protocol eligibility|0|||
48874685|NCT00684203|157378920|FG004|Overall Study|Did not meet protocol eligibility|0|||
48874686|NCT00684203|157378921|FG005|Overall Study|Did not meet protocol eligibility|0|||
48874687|NCT00478647|157378924|FG000|Overall Study|Adverse Event|1|||
48874688|NCT00478647|157378924|FG000|Overall Study|Withdrawal by Subject|1|||
48874689|NCT00320398|157378925|FG000|Overall Study|Adverse Event|1|||
48874690|NCT00320398|157378926|FG001|Overall Study|Adverse Event|4|||
48874691|NCT00320398|157378925|FG000|Overall Study|Other|1|||
48874692|NCT00320398|157378926|FG001|Overall Study|Other|0|||
48874693|NCT04698915|157378928|FG000|Overall Study|Adverse Event|2|||
48874694|NCT04698915|157378929|FG001|Overall Study|Adverse Event|0|||
48874695|NCT04698915|157378928|FG000|Overall Study|Death|23|||
48874696|NCT04698915|157378929|FG001|Overall Study|Death|20|||
48874697|NCT04698915|157378928|FG000|Overall Study|Physician Decision|1|||
48874698|NCT04698915|157378929|FG001|Overall Study|Physician Decision|1|||
48874699|NCT04698915|157378928|FG000|Overall Study|Lost to Follow-up|1|||
48874700|NCT04698915|157378929|FG001|Overall Study|Lost to Follow-up|0|||
48874701|NCT04698915|157378928|FG000|Overall Study|Study Terminated by Sponsor|55|||
48874702|NCT04698915|157378929|FG001|Overall Study|Study Terminated by Sponsor|60|||
48874703|NCT04698915|157378928|FG000|Overall Study|Withdrawal by Subject|2|||
48874704|NCT04698915|157378929|FG001|Overall Study|Withdrawal by Subject|3|||
48874705|NCT00639769|157378930|FG000|Overall Study|Death|2|||
48874706|NCT00639769|157378930|FG000|Overall Study|Adverse Event|7|||
48874707|NCT00639769|157378930|FG000|Overall Study|Lack of Efficacy|1|||
49017319|NCT01464827|157900169|FG011|Overall Study|Other|0|||
49017320|NCT01464827|157900170|FG012|Overall Study|Other|1|||
49017321|NCT01464827|157900171|FG013|Overall Study|Other|0|||
49017322|NCT01464827|157900158|FG000|Overall Study|Not Treated|0|||
48676875|NCT00465647|156669144|FG003|Overall Study|Adverse Event|2|||
48676876|NCT00465647|156669141|FG000|Overall Study|Withdrawal by Subject|1|||
48676877|NCT00465647|156669142|FG001|Overall Study|Withdrawal by Subject|2|||
48676878|NCT00465647|156669143|FG002|Overall Study|Withdrawal by Subject|2|||
48676879|NCT00465647|156669144|FG003|Overall Study|Withdrawal by Subject|7|||
48676880|NCT00465647|156669141|FG000|Overall Study|"The other reasons included loss of IV"|8|||
48676881|NCT00465647|156669142|FG001|Overall Study|"The other reasons included loss of IV"|4|||
48676882|NCT00465647|156669143|FG002|Overall Study|"The other reasons included loss of IV"|3|||
48676883|NCT00465647|156669144|FG003|Overall Study|"The other reasons included loss of IV"|2|||
48676884|NCT01240135|156669148|FG000|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
48676885|NCT01240135|156669149|FG001|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
48676886|NCT01240135|156669148|FG000|Period Two, 14 Days of Wear|Adverse Event|0|||
48676887|NCT01240135|156669149|FG001|Period Two, 14 Days of Wear|Adverse Event|1|||
48676888|NCT02106403|156669150|FG000|Follow-Up Visit 3|Other Reason|0|||
48676889|NCT02106403|156669151|FG001|Follow-Up Visit 3|Other Reason|0|||
48676890|NCT02106403|156669152|FG002|Follow-Up Visit 3|Other Reason|0|||
48676891|NCT02106403|156669153|FG003|Follow-Up Visit 3|Other Reason|0|||
48676892|NCT02106403|156669154|FG004|Follow-Up Visit 3|Other Reason|0|||
48676893|NCT02106403|156669155|FG005|Follow-Up Visit 3|Other Reason|1|||
48676894|NCT01887353|156669156|FG000|Overall Study|Study stopped early|4|||
48676895|NCT01887353|156669157|FG001|Overall Study|Study stopped early|3|||
48676896|NCT04038567|156669158|FG000|Overall Study|Lost to Follow-up|6|||
48676897|NCT04038567|156669159|FG001|Overall Study|Lost to Follow-up|4|||
48676898|NCT04038567|156669160|FG002|Overall Study|Lost to Follow-up|5|||
48676899|NCT04038567|156669161|FG003|Overall Study|Lost to Follow-up|4|||
48676900|NCT04038567|156669162|FG004|Overall Study|Lost to Follow-up|6|||
48676901|NCT04038567|156669163|FG005|Overall Study|Lost to Follow-up|4|||
48676902|NCT04038567|156669164|FG006|Overall Study|Lost to Follow-up|4|||
48676903|NCT04038567|156669165|FG007|Overall Study|Lost to Follow-up|1|||
48676904|NCT04038567|156669158|FG000|Overall Study|Withdrawal by Subject|2|||
48874708|NCT00639769|157378930|FG000|Overall Study|Disease progression|26|||
48874709|NCT00639769|157378930|FG000|Overall Study|Withdrawal by Subject|4|||
48874710|NCT01917006|157378931|FG000|Randomized-treatment Period|Lost to Follow-up|1|||
49017323|NCT01464827|157900159|FG001|Overall Study|Not Treated|2|||
49017324|NCT01464827|157900160|FG002|Overall Study|Not Treated|0|||
48676905|NCT04038567|156669159|FG001|Overall Study|Withdrawal by Subject|1|||
48676906|NCT04038567|156669160|FG002|Overall Study|Withdrawal by Subject|1|||
48762286|NCT00778700|156978068|FG003|Overall Study|Other|0|||
48874711|NCT01917006|157378932|FG001|Randomized-treatment Period|Lost to Follow-up|0|||
48874712|NCT01917006|157378933|FG002|Randomized-treatment Period|Lost to Follow-up|0|||
48874713|NCT01917006|157378934|FG003|Randomized-treatment Period|Lost to Follow-up|1|||
48874714|NCT01917006|157378935|FG004|Randomized-treatment Period|Lost to Follow-up|0|||
49017325|NCT01464827|157900161|FG003|Overall Study|Not Treated|0|||
49017326|NCT01464827|157900162|FG004|Overall Study|Not Treated|1|||
49017327|NCT01464827|157900163|FG005|Overall Study|Not Treated|0|||
49017328|NCT01464827|157900164|FG006|Overall Study|Not Treated|1|||
49017329|NCT01464827|157900165|FG007|Overall Study|Not Treated|0|||
49017330|NCT01464827|157900166|FG008|Overall Study|Not Treated|0|||
49017331|NCT01464827|157900167|FG009|Overall Study|Not Treated|2|||
49017332|NCT01464827|157900168|FG010|Overall Study|Not Treated|0|||
49017333|NCT01464827|157900169|FG011|Overall Study|Not Treated|1|||
49017334|NCT01464827|157900170|FG012|Overall Study|Not Treated|0|||
49017335|NCT01464827|157900171|FG013|Overall Study|Not Treated|2|||
49017336|NCT02295774|157900174|FG000|Overall Study|Physician Decision|1|||
49017337|NCT02295774|157900174|FG000|Overall Study|Withdrawal by Subject|2|||
49017338|NCT03487796|157900175|FG000|Overall Study|Lost to Follow-up|18|||
49017339|NCT03487796|157900176|FG001|Overall Study|Lost to Follow-up|6|||
49017340|NCT01075763|157900177|FG000|Overall Study|Lost to Follow-up|2|||
49017341|NCT01075763|157900178|FG001|Overall Study|Lost to Follow-up|1|||
49017342|NCT01075763|157900177|FG000|Overall Study|Lack of Efficacy|0|||
49017343|NCT01075763|157900178|FG001|Overall Study|Lack of Efficacy|1|||
49017344|NCT01075763|157900177|FG000|Overall Study|Withdrawal by Subject|2|||
49017345|NCT01075763|157900178|FG001|Overall Study|Withdrawal by Subject|2|||
49017346|NCT00586521|157900179|FG000|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1|||
49017347|NCT04272775|157900180|FG000|Overall Study|Study Terminated by Sponsor|1|||
49017348|NCT04272775|157900181|FG001|Overall Study|Study Terminated by Sponsor|0|||
49017349|NCT04272775|157900180|FG000|Overall Study|Protocol Violation|0|||
49017350|NCT04272775|157900181|FG001|Overall Study|Protocol Violation|1|||
49017351|NCT04272775|157900180|FG000|Overall Study|Symptomatic Deterioration|1|||
49017352|NCT04272775|157900181|FG001|Overall Study|Symptomatic Deterioration|1|||
49017353|NCT04272775|157900180|FG000|Overall Study|Withdrawal by Subject|1|||
49017354|NCT04272775|157900181|FG001|Overall Study|Withdrawal by Subject|2|||
49017355|NCT04272775|157900180|FG000|Overall Study|Adverse Event|1|||
49017356|NCT04272775|157900181|FG001|Overall Study|Adverse Event|2|||
49017357|NCT04272775|157900180|FG000|Overall Study|Progressive Disease|3|||
49017358|NCT04272775|157900181|FG001|Overall Study|Progressive Disease|1|||
49017359|NCT02710071|157900198|FG000|First Intervention (6 Weeks).|Withdrawal by Subject|3|||
49017360|NCT02710071|157900199|FG001|First Intervention (6 Weeks).|Withdrawal by Subject|4|||
49017361|NCT02710071|157900198|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|1|||
49017362|NCT02710071|157900199|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
49017363|NCT00124020|157900202|FG000|Overall Study|Death|67|||
49017364|NCT00124020|157900203|FG001|Overall Study|Death|71|||
49017365|NCT00124020|157900202|FG000|Overall Study|Withdrawal by Subject|13|||
49017366|NCT00124020|157900203|FG001|Overall Study|Withdrawal by Subject|11|||
49017367|NCT00124020|157900202|FG000|Overall Study|Lost to Follow-up|5|||
49017368|NCT00124020|157900203|FG001|Overall Study|Lost to Follow-up|8|||
49017369|NCT00124020|157900202|FG000|Overall Study|Other|1|||
49017370|NCT00124020|157900203|FG001|Overall Study|Other|1|||
49017371|NCT00124020|157900202|FG000|Overall Study|Transfer to another hospital|2|||
49017372|NCT00124020|157900203|FG001|Overall Study|Transfer to another hospital|0|||
49017373|NCT03731182|157900204|FG000|Overall Study|Lost to Follow-up|2|||
49017374|NCT03731182|157900205|FG001|Overall Study|Lost to Follow-up|0|||
49017375|NCT03731182|157900204|FG000|Overall Study|Physician Decision|1|||
49017376|NCT03731182|157900205|FG001|Overall Study|Physician Decision|0|||
49017377|NCT03731182|157900204|FG000|Overall Study|Withdrawal By Parent/Guardian|2|||
49017378|NCT03731182|157900205|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
49017379|NCT02637557|157900206|FG000|Overall Study|Adverse Event|3|||
49017380|NCT02637557|157900207|FG001|Overall Study|Adverse Event|1|||
49017381|NCT02637557|157900208|FG002|Overall Study|Adverse Event|3|||
49017382|NCT02637557|157900209|FG003|Overall Study|Adverse Event|3|||
49017383|NCT02637557|157900206|FG000|Overall Study|Lost to Follow-up|1|||
49017384|NCT02637557|157900207|FG001|Overall Study|Lost to Follow-up|1|||
49017385|NCT02637557|157900208|FG002|Overall Study|Lost to Follow-up|0|||
49017386|NCT02637557|157900209|FG003|Overall Study|Lost to Follow-up|1|||
49017387|NCT02637557|157900206|FG000|Overall Study|Physician Decision|1|||
48676907|NCT04038567|156669161|FG003|Overall Study|Withdrawal by Subject|1|||
49017388|NCT02637557|157900207|FG001|Overall Study|Physician Decision|0|||
49017389|NCT02637557|157900208|FG002|Overall Study|Physician Decision|0|||
48676908|NCT04038567|156669162|FG004|Overall Study|Withdrawal by Subject|4|||
49017390|NCT02637557|157900209|FG003|Overall Study|Physician Decision|0|||
49017391|NCT02637557|157900206|FG000|Overall Study|Protocol Violation|2|||
49017392|NCT02637557|157900207|FG001|Overall Study|Protocol Violation|0|||
49017393|NCT02637557|157900208|FG002|Overall Study|Protocol Violation|2|||
49017394|NCT02637557|157900209|FG003|Overall Study|Protocol Violation|1|||
49017395|NCT02637557|157900206|FG000|Overall Study|Withdrawal by Subject|1|||
49017396|NCT02637557|157900207|FG001|Overall Study|Withdrawal by Subject|3|||
49017397|NCT02637557|157900208|FG002|Overall Study|Withdrawal by Subject|4|||
49017398|NCT02637557|157900209|FG003|Overall Study|Withdrawal by Subject|2|||
49017399|NCT00268346|157900210|FG000|Overall Study|Adverse Event|0|||
49017400|NCT00268346|157900211|FG001|Overall Study|Adverse Event|1|||
49017401|NCT00268346|157900210|FG000|Overall Study|Death|0|||
49017402|NCT00268346|157900211|FG001|Overall Study|Death|1|||
49017403|NCT00268346|157900210|FG000|Overall Study|Withdrawal by Subject|0|||
49017404|NCT00268346|157900211|FG001|Overall Study|Withdrawal by Subject|1|||
49017405|NCT00613574|157900212|FG000|Overall Study|Adverse Event|3|||
49017406|NCT00613574|157900212|FG000|Overall Study|Lost to Follow-up|2|||
49017407|NCT00613574|157900212|FG000|Overall Study|Other|1|||
49017408|NCT04604184|157900219|FG000|Overall Study|Adverse Event|5|||
49017409|NCT04604184|157900220|FG001|Overall Study|Adverse Event|5|||
49017410|NCT04604184|157900219|FG000|Overall Study|Death|2|||
49017411|NCT04604184|157900220|FG001|Overall Study|Death|1|||
49017412|NCT04604184|157900219|FG000|Overall Study|Withdrawal by Subject|1|||
49017413|NCT04604184|157900220|FG001|Overall Study|Withdrawal by Subject|3|||
49017414|NCT04604184|157900219|FG000|Overall Study|Not treated|2|||
49017415|NCT04604184|157900220|FG001|Overall Study|Not treated|2|||
49017416|NCT04604184|157900219|FG000|Overall Study|Due to sponsor decision|9|||
49017417|NCT04604184|157900220|FG001|Overall Study|Due to sponsor decision|7|||
49017418|NCT04604184|157900219|FG000|Overall Study|Physician Decision|0|||
49017419|NCT04604184|157900220|FG001|Overall Study|Physician Decision|1|||
49017420|NCT04604184|157900219|FG000|Overall Study|Transfer to healthcare|1|||
49017421|NCT04604184|157900220|FG001|Overall Study|Transfer to healthcare|0|||
49017422|NCT01751412|157900221|FG000|Overall Study|Disease Progression Before Treatment|1|||
49017423|NCT01673009|157900224|FG000|Overall Study|Physician Decision|5|||
49017424|NCT01673009|157900224|FG000|Overall Study|Withdrawal by Subject|8|||
49017425|NCT01844583|157900225|FG000|Overall Study|Didn't complete dosing;PK/ECG assessment|8|||
49017426|NCT01844583|157900226|FG001|Overall Study|Didn't complete dosing;PK/ECG assessment|10|||
49017427|NCT02043366|157900229|FG000|Overall Study|Lost to Follow-up|2|||
49017428|NCT02043366|157900230|FG001|Overall Study|Lost to Follow-up|2|||
49017429|NCT02043366|157900231|FG002|Overall Study|Lost to Follow-up|2|||
49017430|NCT02043366|157900232|FG003|Overall Study|Lost to Follow-up|2|||
49017431|NCT02043366|157900233|FG004|Overall Study|Lost to Follow-up|2|||
49017432|NCT02043366|157900234|FG005|Overall Study|Lost to Follow-up|2|||
49017433|NCT00449072|157900238|FG000|Overall Study|Adverse Event|3|||
49017434|NCT00449072|157900239|FG001|Overall Study|Adverse Event|1|||
49017435|NCT00449072|157900238|FG000|Overall Study|Protocol Violation|14|||
49017436|NCT00449072|157900239|FG001|Overall Study|Protocol Violation|12|||
49017437|NCT00449072|157900238|FG000|Overall Study|Lost to Follow-up|5|||
49017438|NCT00449072|157900239|FG001|Overall Study|Lost to Follow-up|7|||
49017439|NCT00449072|157900238|FG000|Overall Study|Withdrawal by Subject|11|||
49017440|NCT00449072|157900239|FG001|Overall Study|Withdrawal by Subject|8|||
49017441|NCT00449072|157900238|FG000|Overall Study|Lack of Efficacy|1|||
49017442|NCT00449072|157900239|FG001|Overall Study|Lack of Efficacy|1|||
49017443|NCT00449072|157900238|FG000|Overall Study|Physician Decision|1|||
49017444|NCT00449072|157900239|FG001|Overall Study|Physician Decision|0|||
49017445|NCT00449072|157900238|FG000|Overall Study|Not treated|0|||
49017446|NCT00449072|157900239|FG001|Overall Study|Not treated|1|||
49017447|NCT00449072|157900238|FG000|Overall Study|Excluded medication|0|||
49017448|NCT00449072|157900239|FG001|Overall Study|Excluded medication|2|||
49017449|NCT00449072|157900238|FG000|Overall Study|Non-compliance|2|||
49017450|NCT00449072|157900239|FG001|Overall Study|Non-compliance|5|||
49017451|NCT00449072|157900238|FG000|Overall Study|Sponsor decision|1|||
49017452|NCT00449072|157900239|FG001|Overall Study|Sponsor decision|3|||
48676909|NCT04038567|156669163|FG005|Overall Study|Withdrawal by Subject|1|||
48676910|NCT04038567|156669164|FG006|Overall Study|Withdrawal by Subject|1|||
48676911|NCT04038567|156669165|FG007|Overall Study|Withdrawal by Subject|1|||
48676912|NCT04038567|156669158|FG000|Overall Study|missed survey window|1|||
48676913|NCT04038567|156669159|FG001|Overall Study|missed survey window|2|||
48676914|NCT04038567|156669160|FG002|Overall Study|missed survey window|0|||
48676915|NCT04038567|156669161|FG003|Overall Study|missed survey window|0|||
48676916|NCT04038567|156669162|FG004|Overall Study|missed survey window|1|||
48676917|NCT04038567|156669163|FG005|Overall Study|missed survey window|1|||
48676918|NCT04038567|156669164|FG006|Overall Study|missed survey window|2|||
48676919|NCT04038567|156669165|FG007|Overall Study|missed survey window|2|||
49017453|NCT00449072|157900238|FG000|Overall Study|Relocation|3|||
49017454|NCT00449072|157900239|FG001|Overall Study|Relocation|2|||
49017455|NCT03222141|157900244|FG000|Overall Study|Death|15|||
49017456|NCT03222141|157900244|FG000|Overall Study|Lost to Follow-up|3|||
49017457|NCT03532009|157900245|FG000|Overall Study|Other|1|||
49017458|NCT03532009|157900246|FG001|Overall Study|Other|1|||
49017459|NCT03532009|157900245|FG000|Overall Study|Death|1|||
49017460|NCT03532009|157900246|FG001|Overall Study|Death|1|||
49017461|NCT03532009|157900245|FG000|Overall Study|Withdrawal by Patient|0|||
49017462|NCT03532009|157900246|FG001|Overall Study|Withdrawal by Patient|2|||
49017463|NCT01595009|157900247|FG000|Core|Patients completed per protocol|85|||
49017464|NCT01595009|157900248|FG001|Core|Patients completed per protocol|44|||
49017465|NCT01595009|157900249|FG002|Core|Patients completed per protocol|0|||
49017466|NCT01595009|157900250|FG003|Core|Patients completed per protocol|0|||
49017467|NCT01595009|157900247|FG000|Core|Adverse Event|19|||
49017468|NCT01595009|157900248|FG001|Core|Adverse Event|23|||
49017469|NCT01595009|157900249|FG002|Core|Adverse Event|0|||
48676920|NCT04038567|156669158|FG000|Overall Study|technical issues|0|||
49017470|NCT01595009|157900250|FG003|Core|Adverse Event|0|||
49017471|NCT01595009|157900247|FG000|Core|Disease progression|14|||
49017472|NCT01595009|157900248|FG001|Core|Disease progression|26|||
48676921|NCT04038567|156669159|FG001|Overall Study|technical issues|0|||
48874715|NCT01917006|157378936|FG005|Randomized-treatment Period|Lost to Follow-up|0|||
48874716|NCT01917006|157378937|FG006|Randomized-treatment Period|Lost to Follow-up|0|||
48874717|NCT01917006|157378938|FG007|Randomized-treatment Period|Lost to Follow-up|0|||
48874718|NCT01917006|157378931|FG000|Randomized-treatment Period|Personal Reasons|0|||
48874719|NCT01917006|157378932|FG001|Randomized-treatment Period|Personal Reasons|0|||
48874720|NCT01917006|157378933|FG002|Randomized-treatment Period|Personal Reasons|0|||
48874721|NCT01917006|157378934|FG003|Randomized-treatment Period|Personal Reasons|0|||
48874722|NCT01917006|157378935|FG004|Randomized-treatment Period|Personal Reasons|0|||
48874723|NCT01917006|157378936|FG005|Randomized-treatment Period|Personal Reasons|1|||
48874724|NCT01917006|157378937|FG006|Randomized-treatment Period|Personal Reasons|0|||
48874725|NCT01917006|157378938|FG007|Randomized-treatment Period|Personal Reasons|0|||
48874726|NCT01917006|157378931|FG000|Randomized-treatment Period|Protocol Violation|1|||
48874727|NCT01917006|157378932|FG001|Randomized-treatment Period|Protocol Violation|0|||
48874728|NCT01917006|157378933|FG002|Randomized-treatment Period|Protocol Violation|0|||
48874729|NCT01917006|157378934|FG003|Randomized-treatment Period|Protocol Violation|0|||
48874730|NCT01917006|157378935|FG004|Randomized-treatment Period|Protocol Violation|0|||
48874731|NCT01917006|157378936|FG005|Randomized-treatment Period|Protocol Violation|0|||
48874732|NCT01917006|157378937|FG006|Randomized-treatment Period|Protocol Violation|0|||
48874733|NCT01917006|157378938|FG007|Randomized-treatment Period|Protocol Violation|0|||
48874734|NCT01917006|157378931|FG000|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
48874735|NCT01917006|157378932|FG001|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
48874736|NCT01917006|157378933|FG002|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
48874737|NCT01917006|157378934|FG003|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
48874738|NCT01917006|157378935|FG004|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
48874739|NCT01917006|157378936|FG005|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
48874740|NCT01917006|157378937|FG006|Randomized-treatment Period|Other Miscellaneous Reasons|1|||
48874741|NCT01917006|157378938|FG007|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
48874742|NCT01917006|157378931|FG000|Open-label Period|Adverse Event|0|||
48874743|NCT01917006|157378932|FG001|Open-label Period|Adverse Event|0|||
48874744|NCT01917006|157378933|FG002|Open-label Period|Adverse Event|0|||
48874745|NCT01917006|157378934|FG003|Open-label Period|Adverse Event|0|||
48874746|NCT01917006|157378935|FG004|Open-label Period|Adverse Event|0|||
48874747|NCT01917006|157378936|FG005|Open-label Period|Adverse Event|0|||
48874748|NCT01917006|157378937|FG006|Open-label Period|Adverse Event|0|||
48874749|NCT01917006|157378938|FG007|Open-label Period|Adverse Event|1|||
49017473|NCT01595009|157900249|FG002|Core|Disease progression|0|||
49017474|NCT01595009|157900250|FG003|Core|Disease progression|0|||
49017475|NCT01595009|157900247|FG000|Core|Withdrawal by Subject|4|||
49017476|NCT01595009|157900248|FG001|Core|Withdrawal by Subject|17|||
49017477|NCT01595009|157900249|FG002|Core|Withdrawal by Subject|0|||
49017478|NCT01595009|157900250|FG003|Core|Withdrawal by Subject|0|||
49017479|NCT01595009|157900247|FG000|Core|Death|3|||
49017480|NCT01595009|157900248|FG001|Core|Death|6|||
48676922|NCT04038567|156669160|FG002|Overall Study|technical issues|0|||
48676923|NCT04038567|156669161|FG003|Overall Study|technical issues|0|||
48676924|NCT04038567|156669162|FG004|Overall Study|technical issues|0|||
48676925|NCT04038567|156669163|FG005|Overall Study|technical issues|0|||
48676926|NCT04038567|156669164|FG006|Overall Study|technical issues|1|||
48676927|NCT04038567|156669165|FG007|Overall Study|technical issues|0|||
48676928|NCT04038567|156669158|FG000|Overall Study|Medical issues (i.e., illness)|0|||
48676929|NCT04038567|156669159|FG001|Overall Study|Medical issues (i.e., illness)|1|||
48676930|NCT04038567|156669160|FG002|Overall Study|Medical issues (i.e., illness)|2|||
48676931|NCT04038567|156669161|FG003|Overall Study|Medical issues (i.e., illness)|1|||
48676932|NCT04038567|156669162|FG004|Overall Study|Medical issues (i.e., illness)|1|||
48676933|NCT04038567|156669163|FG005|Overall Study|Medical issues (i.e., illness)|1|||
48676934|NCT04038567|156669164|FG006|Overall Study|Medical issues (i.e., illness)|0|||
48676935|NCT04038567|156669165|FG007|Overall Study|Medical issues (i.e., illness)|0|||
48676936|NCT04038567|156669158|FG000|Overall Study|Death|0|||
48676937|NCT04038567|156669159|FG001|Overall Study|Death|0|||
48676938|NCT04038567|156669160|FG002|Overall Study|Death|0|||
48676939|NCT04038567|156669161|FG003|Overall Study|Death|1|||
48676940|NCT04038567|156669162|FG004|Overall Study|Death|1|||
48874750|NCT01917006|157378931|FG000|Open-label Period|Lost to Follow-up|0|||
49017481|NCT01595009|157900249|FG002|Core|Death|0|||
49017482|NCT01595009|157900250|FG003|Core|Death|0|||
48676941|NCT04038567|156669163|FG005|Overall Study|Death|0|||
48676942|NCT04038567|156669164|FG006|Overall Study|Death|0|||
48676943|NCT04038567|156669165|FG007|Overall Study|Death|1|||
48676944|NCT01628965|156669178|FG000|Overall Study|Adverse Event|30|||
48676945|NCT01628965|156669178|FG000|Overall Study|Lack of Efficacy|7|||
48676946|NCT01628965|156669178|FG000|Overall Study|Withdrawal by Subject|3|||
48874751|NCT01917006|157378932|FG001|Open-label Period|Lost to Follow-up|0|||
49017483|NCT01595009|157900247|FG000|Core|Lost to Follow-up|1|||
49017484|NCT01595009|157900248|FG001|Core|Lost to Follow-up|2|||
49017485|NCT01595009|157900249|FG002|Core|Lost to Follow-up|0|||
49017486|NCT01595009|157900250|FG003|Core|Lost to Follow-up|0|||
49017487|NCT01595009|157900247|FG000|Core|Protocol deviation|0|||
49017488|NCT01595009|157900248|FG001|Core|Protocol deviation|1|||
49017489|NCT01595009|157900249|FG002|Core|Protocol deviation|0|||
49017490|NCT01595009|157900250|FG003|Core|Protocol deviation|0|||
49017491|NCT01595009|157900247|FG000|Core|Administrative problems|0|||
49017492|NCT01595009|157900248|FG001|Core|Administrative problems|1|||
49017493|NCT01595009|157900249|FG002|Core|Administrative problems|0|||
49017494|NCT01595009|157900250|FG003|Core|Administrative problems|0|||
49017495|NCT01595009|157900247|FG000|Extension|Administrative problems|0|||
49017496|NCT01595009|157900248|FG001|Extension|Administrative problems|0|||
49017497|NCT01595009|157900249|FG002|Extension|Administrative problems|0|||
49017498|NCT01595009|157900250|FG003|Extension|Administrative problems|1|||
49017499|NCT01595009|157900247|FG000|Extension|Patients completed per protocol|0|||
49017500|NCT01595009|157900248|FG001|Extension|Patients completed per protocol|0|||
49017501|NCT01595009|157900249|FG002|Extension|Patients completed per protocol|0|||
49017502|NCT01595009|157900250|FG003|Extension|Patients completed per protocol|2|||
49017503|NCT01595009|157900247|FG000|Extension|Disease progression|0|||
49017504|NCT01595009|157900248|FG001|Extension|Disease progression|0|||
49017505|NCT01595009|157900249|FG002|Extension|Disease progression|4|||
49017506|NCT01595009|157900250|FG003|Extension|Disease progression|7|||
49017507|NCT01595009|157900247|FG000|Extension|Adverse Event|0|||
49017508|NCT01595009|157900248|FG001|Extension|Adverse Event|0|||
49017509|NCT01595009|157900249|FG002|Extension|Adverse Event|0|||
49017510|NCT01595009|157900250|FG003|Extension|Adverse Event|1|||
49017511|NCT04956666|157900251|FG000|Overall Study|Adverse Event|18|||
49017512|NCT04956666|157900251|FG000|Overall Study|Physician Decision|5|||
49017513|NCT02623829|157900252|FG000|Overall Study|Lost to Follow-up|1|||
49017514|NCT02623829|157900253|FG001|Overall Study|Lost to Follow-up|1|||
49017515|NCT00192296|157900256|FG000|Overall Study|Withdrawal by Subject|0|||
49017516|NCT00192296|157900257|FG001|Overall Study|Withdrawal by Subject|1|||
49017517|NCT00192296|157900258|FG002|Overall Study|Withdrawal by Subject|0|||
49017518|NCT00192296|157900259|FG003|Overall Study|Withdrawal by Subject|0|||
49017519|NCT00783796|157900261|FG000|Overall Study|Did not receive any stent|4|||
49017520|NCT00783796|157900261|FG000|Overall Study|Received non-XIENCE V stent|1|||
49017521|NCT00783796|157900261|FG000|Overall Study|Received commercial XIENCE V stent|1|||
49017522|NCT03465891|157900264|FG000|Overall Study|Withdrawal by Subject|0|||
49017523|NCT03465891|157900265|FG001|Overall Study|Withdrawal by Subject|1|||
49017524|NCT03465891|157900264|FG000|Overall Study|Disease progression|1|||
49017525|NCT03465891|157900265|FG001|Overall Study|Disease progression|0|||
49017526|NCT01966042|157900266|FG000|Overall Study|Death|2|||
49017527|NCT00625807|157900267|FG000|Overall Study|schedule conflict|2|||
49017528|NCT00625807|157900268|FG001|Overall Study|schedule conflict|8|||
49017529|NCT02315898|157900269|FG000|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|2|||
49017530|NCT02315898|157900270|FG001|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
49017531|NCT02315898|157900271|FG002|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
49017532|NCT02315898|157900272|FG003|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|1|||
49017533|NCT04543136|157900273|FG000|Overall Study|Withdrawal by Subject|0|||
49017534|NCT04543136|157900274|FG001|Overall Study|Withdrawal by Subject|1|||
49017535|NCT04543136|157900275|FG002|Overall Study|Withdrawal by Subject|0|||
49017536|NCT04543136|157900276|FG003|Overall Study|Withdrawal by Subject|1|||
48676947|NCT01628965|156669178|FG000|Overall Study|Lost to Follow-up|1|||
48676948|NCT01628965|156669178|FG000|Overall Study|Discontinuation criteria|8|||
48676949|NCT00398320|156669179|FG000|Overall Study|Death|1|||
48676950|NCT00398320|156669179|FG000|Overall Study|Adverse Event|4|||
48676951|NCT00398320|156669179|FG000|Overall Study|Physician Decision|1|||
48676952|NCT05090852|156669180|FG000|Overall Study|Physician Decision|5|||
48676953|NCT02578186|156669186|FG000|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
48676954|NCT02578186|156669187|FG001|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
48676955|NCT02578186|156669186|FG000|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
48676956|NCT02578186|156669187|FG001|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
48676957|NCT02873338|156669189|FG000|Overall Study|Adverse Event|0|||
49017537|NCT04543136|157900277|FG004|Overall Study|Withdrawal by Subject|0|||
49017538|NCT04543136|157900278|FG005|Overall Study|Withdrawal by Subject|0|||
49017539|NCT00617461|157900279|FG000|First Treatment Intervention Period|Adverse Event|2|||
49017540|NCT00617461|157900280|FG001|First Treatment Intervention Period|Adverse Event|0|||
49017541|NCT00617461|157900279|FG000|First Treatment Intervention Period|Lack of Efficacy|1|||
49017542|NCT00617461|157900280|FG001|First Treatment Intervention Period|Lack of Efficacy|0|||
49017543|NCT00617461|157900279|FG000|First Treatment Intervention Period|Protocol Violation|2|||
49017544|NCT00617461|157900280|FG001|First Treatment Intervention Period|Protocol Violation|1|||
49017545|NCT00617461|157900279|FG000|First Treatment Intervention Period|Lost to Follow-up|0|||
49017546|NCT00617461|157900280|FG001|First Treatment Intervention Period|Lost to Follow-up|1|||
49017547|NCT00617461|157900279|FG000|First Treatment Intervention Period|Investigator Discretion|1|||
49017548|NCT00617461|157900280|FG001|First Treatment Intervention Period|Investigator Discretion|1|||
49017549|NCT00617461|157900279|FG000|First Treatment Intervention Period|Withdrawal by Subject|4|||
49017550|NCT00617461|157900280|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
49017551|NCT00617461|157900279|FG000|4-Day Crossover Period|Withdrawal by Subject|1|||
49017552|NCT00617461|157900280|FG001|4-Day Crossover Period|Withdrawal by Subject|0|||
49017553|NCT00617461|157900279|FG000|Second Treatment Intervention Period|Adverse Event|0|||
49017554|NCT00617461|157900280|FG001|Second Treatment Intervention Period|Adverse Event|1|||
49017555|NCT00617461|157900279|FG000|Second Treatment Intervention Period|Lack of Efficacy|0|||
49017556|NCT00617461|157900280|FG001|Second Treatment Intervention Period|Lack of Efficacy|3|||
49017557|NCT00617461|157900279|FG000|6-Day Down-Titration Period|Withdrawal by Subject|1|||
49017558|NCT00617461|157900280|FG001|6-Day Down-Titration Period|Withdrawal by Subject|0|||
49017559|NCT00617461|157900279|FG000|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1|||
49017560|NCT00617461|157900280|FG001|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2|||
49017561|NCT00198029|157900283|FG000|Overall Study|Withdrawal by Subject|4|||
48874752|NCT01917006|157378933|FG002|Open-label Period|Lost to Follow-up|0|||
48874753|NCT01917006|157378934|FG003|Open-label Period|Lost to Follow-up|0|||
48874754|NCT01917006|157378935|FG004|Open-label Period|Lost to Follow-up|0|||
48874755|NCT01917006|157378936|FG005|Open-label Period|Lost to Follow-up|0|||
48874756|NCT01917006|157378937|FG006|Open-label Period|Lost to Follow-up|0|||
48874757|NCT01917006|157378938|FG007|Open-label Period|Lost to Follow-up|1|||
48874758|NCT01649557|157378942|FG000|Overall Study|Lost to Follow-up|5|||
48874759|NCT01649557|157378943|FG001|Overall Study|Lost to Follow-up|0|||
48874760|NCT01649557|157378944|FG002|Overall Study|Lost to Follow-up|3|||
48874761|NCT01649557|157378942|FG000|Overall Study|Adverse Event|7|||
48874762|NCT01649557|157378943|FG001|Overall Study|Adverse Event|5|||
48874763|NCT01649557|157378944|FG002|Overall Study|Adverse Event|1|||
48874764|NCT01649557|157378942|FG000|Overall Study|Met withdrawal criteria|4|||
48874765|NCT01649557|157378943|FG001|Overall Study|Met withdrawal criteria|0|||
48676958|NCT02873338|156669190|FG001|Overall Study|Adverse Event|2|||
48676959|NCT02873338|156669191|FG002|Overall Study|Adverse Event|1|||
48676960|NCT02873338|156669189|FG000|Overall Study|Death|2|||
48676961|NCT02873338|156669190|FG001|Overall Study|Death|1|||
49017562|NCT00429923|157900287|FG000|Overall Study|Adverse Event|0|||
48874766|NCT01649557|157378944|FG002|Overall Study|Met withdrawal criteria|0|||
48874767|NCT01649557|157378942|FG000|Overall Study|Physician Decision|8|||
48874768|NCT01649557|157378943|FG001|Overall Study|Physician Decision|2|||
49017563|NCT00429923|157900288|FG001|Overall Study|Adverse Event|2|||
49017564|NCT00429923|157900289|FG002|Overall Study|Adverse Event|3|||
49017565|NCT00429923|157900287|FG000|Overall Study|Lack of Efficacy|4|||
49017566|NCT00429923|157900288|FG001|Overall Study|Lack of Efficacy|1|||
49017567|NCT00429923|157900289|FG002|Overall Study|Lack of Efficacy|33|||
49017568|NCT00429923|157900287|FG000|Overall Study|Lost to Follow-up|0|||
49017569|NCT00429923|157900288|FG001|Overall Study|Lost to Follow-up|0|||
48676962|NCT02873338|156669191|FG002|Overall Study|Death|1|||
48676963|NCT02873338|156669189|FG000|Overall Study|Withdrawal by Subject|2|||
48676964|NCT02873338|156669190|FG001|Overall Study|Withdrawal by Subject|1|||
48676965|NCT02873338|156669191|FG002|Overall Study|Withdrawal by Subject|3|||
48676966|NCT02873338|156669189|FG000|Overall Study|Lack of Efficacy|0|||
48676967|NCT02873338|156669190|FG001|Overall Study|Lack of Efficacy|2|||
48676968|NCT02873338|156669191|FG002|Overall Study|Lack of Efficacy|0|||
48676969|NCT02873338|156669189|FG000|Overall Study|Other or Missing|14|||
48676970|NCT02873338|156669190|FG001|Overall Study|Other or Missing|15|||
48676971|NCT02873338|156669191|FG002|Overall Study|Other or Missing|13|||
48676972|NCT00428389|156669194|FG000|Core Phase|Adverse Event|6|||
48676973|NCT00428389|156669195|FG001|Core Phase|Adverse Event|4|||
48676974|NCT00428389|156669194|FG000|Core Phase|Lack of Efficacy|2|||
48676975|NCT00428389|156669195|FG001|Core Phase|Lack of Efficacy|0|||
48676976|NCT00428389|156669194|FG000|Core Phase|Abnormal test procedure result(s)|0|||
48676977|NCT00428389|156669195|FG001|Core Phase|Abnormal test procedure result(s)|1|||
48676978|NCT00428389|156669194|FG000|Core Phase|Withdrawal by Subject|3|||
48676979|NCT00428389|156669195|FG001|Core Phase|Withdrawal by Subject|4|||
48676980|NCT00428389|156669194|FG000|Core Phase|Protocol deviation|0|||
48676981|NCT00428389|156669195|FG001|Core Phase|Protocol deviation|2|||
48874769|NCT01649557|157378944|FG002|Overall Study|Physician Decision|1|||
48676982|NCT00428389|156669194|FG000|Extension Phase|Adverse Event|17|||
48676983|NCT00428389|156669195|FG001|Extension Phase|Adverse Event|11|||
48676984|NCT00428389|156669194|FG000|Extension Phase|Lack of Efficacy|4|||
49017570|NCT00429923|157900289|FG002|Overall Study|Lost to Follow-up|2|||
49017571|NCT00429923|157900287|FG000|Overall Study|Withdrew Consent|1|||
49017572|NCT00429923|157900288|FG001|Overall Study|Withdrew Consent|0|||
49017573|NCT00429923|157900289|FG002|Overall Study|Withdrew Consent|1|||
49017574|NCT00429923|157900287|FG000|Overall Study|Early Termination|0|||
48874770|NCT01649557|157378942|FG000|Overall Study|Withdrawal by Subject|15|||
48874771|NCT01649557|157378943|FG001|Overall Study|Withdrawal by Subject|5|||
48676985|NCT00428389|156669195|FG001|Extension Phase|Lack of Efficacy|3|||
48676986|NCT00428389|156669194|FG000|Extension Phase|Withdrawal by Subject|6|||
48676987|NCT00428389|156669195|FG001|Extension Phase|Withdrawal by Subject|6|||
49017575|NCT00429923|157900288|FG001|Overall Study|Early Termination|1|||
49017576|NCT00429923|157900289|FG002|Overall Study|Early Termination|0|||
49017577|NCT00249821|157900290|FG000|Overall Study|Technical problem|0|||
49017578|NCT00249821|157900291|FG001|Overall Study|Technical problem|1|||
49017579|NCT00865709|157900292|FG000|Treatment|Adverse Event|9|||
49017580|NCT00865709|157900293|FG001|Treatment|Adverse Event|6|||
49017581|NCT00865709|157900292|FG000|Treatment|Withdrawal by Subject|10|||
49017582|NCT00865709|157900293|FG001|Treatment|Withdrawal by Subject|7|||
49017583|NCT00865709|157900292|FG000|Treatment|Physician Decision|3|||
49017584|NCT00865709|157900293|FG001|Treatment|Physician Decision|2|||
49017585|NCT00865709|157900292|FG000|Treatment|Surgery|8|||
49017586|NCT00865709|157900293|FG001|Treatment|Surgery|3|||
49017587|NCT01133821|157902327|FG000|Overall Study|Lost to Follow-up|8|||
49017588|NCT01133821|157902328|FG001|Overall Study|Lost to Follow-up|11|||
49017589|NCT01133821|157902327|FG000|Overall Study|Withdrawal by Subject|8|||
49017590|NCT01133821|157902328|FG001|Overall Study|Withdrawal by Subject|3|||
49017591|NCT01133821|157902327|FG000|Overall Study|preferred other treatment|1|||
49017592|NCT01133821|157902328|FG001|Overall Study|preferred other treatment|1|||
49017593|NCT01133821|157902327|FG000|Overall Study|Protocol Violation|0|||
49017594|NCT01133821|157902328|FG001|Overall Study|Protocol Violation|1|||
49017595|NCT01133821|157902327|FG000|Overall Study|Refused participation|1|||
49017596|NCT01133821|157902328|FG001|Overall Study|Refused participation|3|||
49017597|NCT04588259|157902329|FG000|Run-in Period|Run-in failure|0|||
49017598|NCT04588259|157902330|FG001|Run-in Period|Run-in failure|23|||
49017599|NCT04588259|157902329|FG000|Run-in Period|Withdrawn before randomisation|0|||
49017600|NCT04588259|157902330|FG001|Run-in Period|Withdrawn before randomisation|8|||
49017601|NCT04588259|157902329|FG000|Treatment Period|Withdrawal by Subject|6|||
49017602|NCT04588259|157902330|FG001|Treatment Period|Withdrawal by Subject|6|||
49017603|NCT00434161|157902333|FG000|Overall Study|Adverse Event|5|||
49017604|NCT00434161|157902334|FG001|Overall Study|Adverse Event|1|||
49017605|NCT00434161|157902335|FG002|Overall Study|Adverse Event|4|||
49017606|NCT00434161|157902333|FG000|Overall Study|Lost to Follow-up|0|||
49017607|NCT00434161|157902334|FG001|Overall Study|Lost to Follow-up|1|||
49017608|NCT00434161|157902335|FG002|Overall Study|Lost to Follow-up|0|||
49017609|NCT00434161|157902333|FG000|Overall Study|Death|1|||
49017610|NCT00434161|157902334|FG001|Overall Study|Death|0|||
49017611|NCT00434161|157902335|FG002|Overall Study|Death|1|||
49017612|NCT00434161|157902333|FG000|Overall Study|Non-Compliance|1|||
49017613|NCT00434161|157902334|FG001|Overall Study|Non-Compliance|1|||
49017614|NCT00434161|157902335|FG002|Overall Study|Non-Compliance|0|||
49017615|NCT00434161|157902333|FG000|Overall Study|Withdrawal by Subject|2|||
49017616|NCT00434161|157902334|FG001|Overall Study|Withdrawal by Subject|0|||
49017617|NCT00434161|157902335|FG002|Overall Study|Withdrawal by Subject|3|||
49017618|NCT00434161|157902333|FG000|Overall Study|Logistical error study assessments|1|||
49017619|NCT00434161|157902334|FG001|Overall Study|Logistical error study assessments|0|||
49017620|NCT00434161|157902335|FG002|Overall Study|Logistical error study assessments|3|||
49017621|NCT03342898|157902336|FG000|Overall Study|Adverse Event|3|||
49017622|NCT03342898|157902337|FG001|Overall Study|Adverse Event|1|||
49017623|NCT03342898|157902338|FG002|Overall Study|Adverse Event|0|||
49017624|NCT03342898|157902336|FG000|Overall Study|Lost to Follow-up|44|||
49017625|NCT03342898|157902337|FG001|Overall Study|Lost to Follow-up|40|||
49017626|NCT03342898|157902338|FG002|Overall Study|Lost to Follow-up|42|||
49017627|NCT03342898|157902336|FG000|Overall Study|Withdrawal of Consent|5|||
49017628|NCT03342898|157902337|FG001|Overall Study|Withdrawal of Consent|9|||
49017629|NCT03342898|157902338|FG002|Overall Study|Withdrawal of Consent|11|||
49017630|NCT03342898|157902336|FG000|Overall Study|Death|0|||
49017631|NCT03342898|157902337|FG001|Overall Study|Death|1|||
49017632|NCT03342898|157902338|FG002|Overall Study|Death|1|||
49017633|NCT03342898|157902336|FG000|Overall Study|Reason not Specified|2|||
48874772|NCT01649557|157378944|FG002|Overall Study|Withdrawal by Subject|4|||
49017634|NCT03342898|157902337|FG001|Overall Study|Reason not Specified|2|||
49017635|NCT03342898|157902338|FG002|Overall Study|Reason not Specified|0|||
49017636|NCT01387282|157902343|FG000|Overall Study|Death|47|||
49017637|NCT01387282|157902344|FG001|Overall Study|Death|16|||
49017638|NCT01387282|157902343|FG000|Overall Study|Other|5|||
49017639|NCT01387282|157902344|FG001|Overall Study|Other|1|||
49017640|NCT01387282|157902343|FG000|Overall Study|Unrelated AE|6|||
49017641|NCT01387282|157902344|FG001|Overall Study|Unrelated AE|4|||
49017642|NCT01387282|157902343|FG000|Overall Study|Withdrawal by patient|33|||
49017643|NCT01387282|157902344|FG001|Overall Study|Withdrawal by patient|23|||
49017644|NCT01387282|157902343|FG000|Overall Study|Study drug-related AE|2|||
49017645|NCT01387282|157902344|FG001|Overall Study|Study drug-related AE|2|||
49017646|NCT01387282|157902343|FG000|Overall Study|Lost to Follow-up|4|||
48874773|NCT01649557|157378942|FG000|Overall Study|Protocol deviation|0|||
49017647|NCT01387282|157902344|FG001|Overall Study|Lost to Follow-up|1|||
49017648|NCT02507375|157902345|FG000|Overall Study|Progressive Disease|4|||
49017649|NCT02507375|157902346|FG001|Overall Study|Progressive Disease|5|||
49017650|NCT02507375|157902345|FG000|Overall Study|Death|0|||
49017651|NCT02507375|157902346|FG001|Overall Study|Death|1|||
49017652|NCT02507375|157902345|FG000|Overall Study|Refused treatment|0|||
49017653|NCT02507375|157902346|FG001|Overall Study|Refused treatment|1|||
49017654|NCT02507375|157902345|FG000|Overall Study|Adverse Event|0|||
49017655|NCT02507375|157902346|FG001|Overall Study|Adverse Event|1|||
49017656|NCT01625377|157902347|FG000|Overall Study|Death|1|||
49017657|NCT01625377|157902348|FG001|Overall Study|Death|1|||
49017658|NCT01625377|157902347|FG000|Overall Study|Administrative Problem|1|||
49017659|NCT01625377|157902348|FG001|Overall Study|Administrative Problem|1|||
49017660|NCT01625377|157902347|FG000|Overall Study|Protocol Violation|0|||
48676988|NCT00428389|156669194|FG000|Extension Phase|Lost to Follow-up|0|||
48676989|NCT00428389|156669195|FG001|Extension Phase|Lost to Follow-up|3|||
48676990|NCT00428389|156669194|FG000|Extension Phase|Death|1|||
48676991|NCT00428389|156669195|FG001|Extension Phase|Death|0|||
48676992|NCT00428389|156669194|FG000|Extension Phase|Protocol Violation|3|||
48676993|NCT00428389|156669195|FG001|Extension Phase|Protocol Violation|2|||
48676994|NCT00428389|156669194|FG000|Extension Phase|Administrative problems|1|||
48676995|NCT00428389|156669195|FG001|Extension Phase|Administrative problems|1|||
48676996|NCT01320202|156669197|FG000|Overall Study|Adverse Event|5|||
48676997|NCT01320202|156669198|FG001|Overall Study|Adverse Event|5|||
48676998|NCT01320202|156669197|FG000|Overall Study|Death|5|||
48676999|NCT01320202|156669198|FG001|Overall Study|Death|3|||
48677000|NCT01320202|156669197|FG000|Overall Study|Lost to Follow-up|1|||
48677001|NCT01320202|156669198|FG001|Overall Study|Lost to Follow-up|0|||
48677002|NCT01320202|156669197|FG000|Overall Study|Physician Decision|3|||
49017661|NCT01625377|157902348|FG001|Overall Study|Protocol Violation|3|||
49017662|NCT01625377|157902347|FG000|Overall Study|Adverse Event|3|||
49017663|NCT01625377|157902348|FG001|Overall Study|Adverse Event|16|||
49017664|NCT01625377|157902347|FG000|Overall Study|Graft loss|1|||
49017665|NCT01625377|157902348|FG001|Overall Study|Graft loss|0|||
49017666|NCT01625377|157902347|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
49017667|NCT01625377|157902348|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
49017668|NCT01625377|157902347|FG000|Overall Study|Abnormal laboratory values|1|||
49017669|NCT01625377|157902348|FG001|Overall Study|Abnormal laboratory values|0|||
49017670|NCT00294723|157902351|FG000|Double-Blind Period 52 Weeks|Adverse Event|18|||
49017671|NCT00294723|157902352|FG001|Double-Blind Period 52 Weeks|Adverse Event|25|||
49017672|NCT00294723|157902353|FG002|Double-Blind Period 52 Weeks|Adverse Event|15|||
49017673|NCT00294723|157902351|FG000|Double-Blind Period 52 Weeks|Lack of Efficacy|9|||
49017674|NCT00294723|157902352|FG001|Double-Blind Period 52 Weeks|Lack of Efficacy|15|||
48677003|NCT01320202|156669198|FG001|Overall Study|Physician Decision|1|||
48677004|NCT01320202|156669197|FG000|Overall Study|Protocol Violation|2|||
48677005|NCT01320202|156669198|FG001|Overall Study|Protocol Violation|1|||
48762287|NCT00076011|156978069|FG000|Overall Study|Death|1|||
48762288|NCT00076011|156978069|FG000|Overall Study|Adverse Event|10|||
48762289|NCT00076011|156978069|FG000|Overall Study|Lack of Efficacy|25|||
48677006|NCT01320202|156669197|FG000|Overall Study|Withdrawal by Subject|10|||
48762290|NCT00076011|156978069|FG000|Overall Study|Withdrawal by Subject|1|||
48762291|NCT00076011|156978069|FG000|Overall Study|Study terminated by sponsor|3|||
48762292|NCT00076011|156978069|FG000|Overall Study|Other|11|||
48762293|NCT00076011|156978069|FG000|Overall Study|Ongoing|1|||
48762294|NCT03406858|156978070|FG000|Overall Study|Failure to receive treatment drug.|1|||
48762295|NCT03406858|156978070|FG000|Overall Study|ineligible|1|||
48762296|NCT00930579|156978073|FG000|Overall Study|Withdrawal by Subject|1|||
48762297|NCT00930579|156978073|FG000|Overall Study|Discontinued due to rescheduled surgery|1|||
48762298|NCT02672423|156978076|FG000|Period 1|Adverse Event|0|||
48762299|NCT02672423|156978077|FG001|Period 1|Adverse Event|0|||
48762300|NCT02672423|156978078|FG002|Period 1|Adverse Event|0|||
48762301|NCT02672423|156978079|FG003|Period 1|Adverse Event|0|||
48762302|NCT02672423|156978080|FG004|Period 1|Adverse Event|1|||
48762303|NCT02672423|156978081|FG005|Period 1|Adverse Event|0|||
48762304|NCT02672423|156978082|FG006|Period 1|Adverse Event|0|||
48762305|NCT02672423|156978083|FG007|Period 1|Adverse Event|0|||
48762306|NCT02672423|156978084|FG008|Period 1|Adverse Event|0|||
48762307|NCT02672423|156978085|FG009|Period 1|Adverse Event|0|||
48677007|NCT01320202|156669198|FG001|Overall Study|Withdrawal by Subject|3|||
48762308|NCT02672423|156978076|FG000|Period 2|Withdrawal by Subject|0|||
48762309|NCT02672423|156978077|FG001|Period 2|Withdrawal by Subject|0|||
48762310|NCT02672423|156978078|FG002|Period 2|Withdrawal by Subject|1|||
48874774|NCT01649557|157378943|FG001|Overall Study|Protocol deviation|2|||
49017675|NCT00294723|157902353|FG002|Double-Blind Period 52 Weeks|Lack of Efficacy|25|||
49017676|NCT00294723|157902351|FG000|Double-Blind Period 52 Weeks|Protocol Violation|11|||
49017677|NCT00294723|157902352|FG001|Double-Blind Period 52 Weeks|Protocol Violation|11|||
49017678|NCT00294723|157902353|FG002|Double-Blind Period 52 Weeks|Protocol Violation|5|||
49017679|NCT00294723|157902351|FG000|Double-Blind Period 52 Weeks|Not specified in study report|36|||
49017680|NCT00294723|157902352|FG001|Double-Blind Period 52 Weeks|Not specified in study report|38|||
48677008|NCT01320202|156669197|FG000|Overall Study|non-protocol change to ESA or IV iron|17|||
48762311|NCT02672423|156978079|FG003|Period 2|Withdrawal by Subject|0|||
48677009|NCT01320202|156669198|FG001|Overall Study|non-protocol change to ESA or IV iron|20|||
48762312|NCT02672423|156978080|FG004|Period 2|Withdrawal by Subject|0|||
48762313|NCT02672423|156978081|FG005|Period 2|Withdrawal by Subject|0|||
48762314|NCT02672423|156978082|FG006|Period 2|Withdrawal by Subject|0|||
48677010|NCT01320202|156669197|FG000|Overall Study|kidney transplant|1|||
48677011|NCT01320202|156669198|FG001|Overall Study|kidney transplant|2|||
48677012|NCT01320202|156669197|FG000|Overall Study|blood transfusion|1|||
48677013|NCT01320202|156669198|FG001|Overall Study|blood transfusion|7|||
48677014|NCT01320202|156669197|FG000|Overall Study|moved/changed dialysis|5|||
48677015|NCT01320202|156669198|FG001|Overall Study|moved/changed dialysis|2|||
48677016|NCT01320202|156669197|FG000|Overall Study|sponsor request|2|||
48677017|NCT01320202|156669198|FG001|Overall Study|sponsor request|0|||
48677018|NCT01320202|156669197|FG000|Overall Study|ineligible|3|||
48677019|NCT01320202|156669198|FG001|Overall Study|ineligible|0|||
48677020|NCT01320202|156669197|FG000|Overall Study|regained renal function|1|||
48677021|NCT01320202|156669198|FG001|Overall Study|regained renal function|0|||
48677022|NCT02513472|156669199|FG000|Overall Study|Radiological Disease Progression|45|||
48677023|NCT02513472|156669200|FG001|Overall Study|Radiological Disease Progression|57|||
48677024|NCT02513472|156669199|FG000|Overall Study|Clinical Disease Progression|5|||
48677025|NCT02513472|156669200|FG001|Overall Study|Clinical Disease Progression|13|||
48677026|NCT02513472|156669199|FG000|Overall Study|Adverse Event|8|||
48677027|NCT02513472|156669200|FG001|Overall Study|Adverse Event|11|||
48677028|NCT02513472|156669199|FG000|Overall Study|Withdrawal by Subject|0|||
48677029|NCT02513472|156669200|FG001|Overall Study|Withdrawal by Subject|4|||
48677030|NCT02513472|156669199|FG000|Overall Study|Subject Choice|2|||
48677031|NCT02513472|156669200|FG001|Overall Study|Subject Choice|7|||
48874775|NCT01649557|157378944|FG002|Overall Study|Protocol deviation|0|||
48874776|NCT01649557|157378942|FG000|Overall Study|Lack of Efficacy|5|||
48980591|NCT04757376|157760433|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
48980592|NCT04757376|157760429|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
48980593|NCT04757376|157760430|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|3|||
48980594|NCT04757376|157760431|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
48980595|NCT04757376|157760432|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
48980596|NCT04757376|157760433|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
48980597|NCT04757376|157760429|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|1|||
48980598|NCT04757376|157760430|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
48980599|NCT04757376|157760431|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
48980600|NCT04757376|157760432|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
48980601|NCT04757376|157760433|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
48980602|NCT04757376|157760429|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
48980603|NCT04757376|157760430|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|1|||
48980604|NCT04757376|157760431|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
48980605|NCT04757376|157760432|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
48980606|NCT04757376|157760433|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
48980607|NCT04757376|157760429|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
48980608|NCT04757376|157760430|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
48980609|NCT04757376|157760431|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
48980610|NCT04757376|157760432|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
48980611|NCT04757376|157760433|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
48980612|NCT04757376|157760429|FG000|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
48980613|NCT04757376|157760430|FG001|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
48980614|NCT04757376|157760431|FG002|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|1|||
48980615|NCT04757376|157760432|FG003|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
48980616|NCT04757376|157760433|FG004|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
48980617|NCT03898323|157760434|FG000|Overall Study|Physician Decision|1|||
48980618|NCT05654662|157760435|FG000|Overall Study|Withdrawal by Subject|1|||
48980619|NCT05654662|157760436|FG001|Overall Study|Withdrawal by Subject|0|||
48980620|NCT05654662|157760435|FG000|Overall Study|A death in the family|1|||
48980621|NCT05654662|157760436|FG001|Overall Study|A death in the family|0|||
48980622|NCT00394654|157760441|FG000|Overall Study|Lost to Follow-up|1|||
48980623|NCT00394654|157760442|FG001|Overall Study|Lost to Follow-up|0|||
48980624|NCT00394654|157760441|FG000|Overall Study|PARTICIPANT LEFT STDUY REGION|1|||
48980625|NCT00394654|157760442|FG001|Overall Study|PARTICIPANT LEFT STDUY REGION|0|||
48980626|NCT02933489|157760443|FG000|Overall Study|Ineligible|3|||
48980627|NCT02933489|157760444|FG001|Overall Study|Ineligible|3|||
48980628|NCT02933489|157760443|FG000|Overall Study|Withdrawal by Subject|27|||
48980629|NCT02933489|157760444|FG001|Overall Study|Withdrawal by Subject|18|||
48980630|NCT02933489|157760443|FG000|Overall Study|Unable to complete exams (other)|14|||
48980631|NCT02933489|157760444|FG001|Overall Study|Unable to complete exams (other)|7|||
48980632|NCT00636155|157760445|FG000|Overall Study|Adverse Event|8|||
49017681|NCT00294723|157902353|FG002|Double-Blind Period 52 Weeks|Not specified in study report|51|||
49017682|NCT00294723|157902351|FG000|Open-Label Extension 52 Weeks|Adverse Event|5|||
49017683|NCT00294723|157902352|FG001|Open-Label Extension 52 Weeks|Adverse Event|5|||
49017684|NCT00294723|157902353|FG002|Open-Label Extension 52 Weeks|Adverse Event|2|||
49017685|NCT00294723|157902351|FG000|Open-Label Extension 52 Weeks|Lack of Efficacy|12|||
49017686|NCT00294723|157902352|FG001|Open-Label Extension 52 Weeks|Lack of Efficacy|15|||
49017687|NCT00294723|157902353|FG002|Open-Label Extension 52 Weeks|Lack of Efficacy|21|||
49017688|NCT00294723|157902351|FG000|Open-Label Extension 52 Weeks|Protocol Violation|4|||
49017689|NCT00294723|157902352|FG001|Open-Label Extension 52 Weeks|Protocol Violation|3|||
49017690|NCT00294723|157902353|FG002|Open-Label Extension 52 Weeks|Protocol Violation|3|||
49017691|NCT00294723|157902351|FG000|Open-Label Extension 52 Weeks|Not specified in study report|19|||
49017692|NCT00294723|157902352|FG001|Open-Label Extension 52 Weeks|Not specified in study report|16|||
49017693|NCT00294723|157902353|FG002|Open-Label Extension 52 Weeks|Not specified in study report|14|||
49017694|NCT00294723|157902351|FG000|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
49017695|NCT00294723|157902352|FG001|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
49017696|NCT00294723|157902353|FG002|Additional Open-Label Extension 91 Weeks|Adverse Event|0|||
49017697|NCT00294723|157902351|FG000|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24|||
49017698|NCT00294723|157902352|FG001|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14|||
49017699|NCT00294723|157902353|FG002|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16|||
49017700|NCT00294723|157902351|FG000|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
49017701|NCT00294723|157902352|FG001|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
49017702|NCT00294723|157902353|FG002|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
49017703|NCT00294723|157902351|FG000|Additional Open-Label Extension 91 Weeks|Not specified in study report|2|||
49017704|NCT00294723|157902352|FG001|Additional Open-Label Extension 91 Weeks|Not specified in study report|5|||
49017705|NCT00294723|157902353|FG002|Additional Open-Label Extension 91 Weeks|Not specified in study report|3|||
49017706|NCT03692676|157902354|FG000|Overall Study|exclude patients with prior use|4424|||
49017707|NCT03692676|157902355|FG001|Overall Study|exclude patients with prior use|24726|||
49017708|NCT03692676|157902356|FG002|Overall Study|exclude patients with prior use|0|||
49017709|NCT03692676|157902357|FG003|Overall Study|exclude patients with prior use|0|||
49017710|NCT03692676|157902354|FG000|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480|||
49017711|NCT03692676|157902355|FG001|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037|||
49017712|NCT03692676|157902356|FG002|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
49017713|NCT03692676|157902357|FG003|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
49017714|NCT03692676|157902354|FG000|Overall Study|exclude patients without prior recorded asthma diagnosis|881|||
49017715|NCT03692676|157902355|FG001|Overall Study|exclude patients without prior recorded asthma diagnosis|563|||
49017716|NCT03692676|157902356|FG002|Overall Study|exclude patients without prior recorded asthma diagnosis|6281|||
49017717|NCT03692676|157902357|FG003|Overall Study|exclude patients without prior recorded asthma diagnosis|558|||
49017718|NCT03692676|157902354|FG000|Overall Study|exclude patients less than 18 years of age on index date|8|||
49017719|NCT03692676|157902355|FG001|Overall Study|exclude patients less than 18 years of age on index date|613|||
49017720|NCT03692676|157902356|FG002|Overall Study|exclude patients less than 18 years of age on index date|836|||
49017721|NCT03692676|157902357|FG003|Overall Study|exclude patients less than 18 years of age on index date|193|||
49017722|NCT03692676|157902354|FG000|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149|||
49017723|NCT03692676|157902355|FG001|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717|||
49017724|NCT03692676|157902356|FG002|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723|||
49017725|NCT03692676|157902357|FG003|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273|||
49017726|NCT03692676|157902354|FG000|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208|||
49017727|NCT03692676|157902355|FG001|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759|||
49017728|NCT03692676|157902356|FG002|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419|||
49017729|NCT03692676|157902357|FG003|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684|||
49017730|NCT03692676|157902354|FG000|Overall Study|exclude patients with prior recorded COPD diagnosis|275|||
49017731|NCT03692676|157902355|FG001|Overall Study|exclude patients with prior recorded COPD diagnosis|218|||
49017732|NCT03692676|157902356|FG002|Overall Study|exclude patients with prior recorded COPD diagnosis|1515|||
49017733|NCT03692676|157902357|FG003|Overall Study|exclude patients with prior recorded COPD diagnosis|173|||
49017734|NCT03692676|157902354|FG000|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
49017735|NCT03692676|157902355|FG001|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
49017736|NCT03692676|157902356|FG002|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147|||
49017737|NCT03692676|157902357|FG003|Overall Study|exclude patients with multiple FDC prescriptions on index date|4|||
48677032|NCT02513472|156669199|FG000|Overall Study|Treatment Completed as per Protocol|3|||
48677033|NCT02513472|156669200|FG001|Overall Study|Treatment Completed as per Protocol|3|||
48677034|NCT02513472|156669199|FG000|Overall Study|Other|3|||
48677035|NCT02513472|156669200|FG001|Overall Study|Other|6|||
48874777|NCT01649557|157378943|FG001|Overall Study|Lack of Efficacy|0|||
48874778|NCT01649557|157378944|FG002|Overall Study|Lack of Efficacy|0|||
48874779|NCT01010204|157378945|FG000|Overall Study|Lost to Follow-up|2|||
48874780|NCT01010204|157378946|FG001|Overall Study|Lost to Follow-up|2|||
48874781|NCT01010204|157378945|FG000|Overall Study|Adverse Event|1|||
48874782|NCT01010204|157378946|FG001|Overall Study|Adverse Event|3|||
48874783|NCT01010204|157378945|FG000|Overall Study|Withdrawal by Subject|2|||
48874784|NCT01010204|157378946|FG001|Overall Study|Withdrawal by Subject|3|||
48874785|NCT01010204|157378945|FG000|Overall Study|psychiatric hospitalization|2|||
48874786|NCT01010204|157378946|FG001|Overall Study|psychiatric hospitalization|1|||
48874787|NCT04629443|157378949|FG000|Overall Study|Adverse Event|2|||
48874788|NCT04629443|157378950|FG001|Overall Study|Adverse Event|1|||
48874789|NCT04629443|157378951|FG002|Overall Study|Adverse Event|2|||
48874790|NCT04629443|157378949|FG000|Overall Study|Progressive Disease|2|||
48874791|NCT04629443|157378950|FG001|Overall Study|Progressive Disease|3|||
48874792|NCT04629443|157378951|FG002|Overall Study|Progressive Disease|3|||
48874793|NCT04629443|157378949|FG000|Overall Study|Physician Decision|1|||
48874794|NCT04629443|157378950|FG001|Overall Study|Physician Decision|3|||
48874795|NCT04629443|157378951|FG002|Overall Study|Physician Decision|0|||
48874796|NCT00913523|157378953|FG000|Overall Study|Withdrawal by Subject|3|||
48874797|NCT00913523|157378954|FG001|Overall Study|Withdrawal by Subject|2|||
48874798|NCT00913523|157378955|FG002|Overall Study|Withdrawal by Subject|2|||
48874799|NCT00913523|157378953|FG000|Overall Study|Lost to Follow-up|1|||
48874800|NCT00913523|157378954|FG001|Overall Study|Lost to Follow-up|1|||
48874801|NCT00913523|157378955|FG002|Overall Study|Lost to Follow-up|1|||
48874802|NCT00913523|157378953|FG000|Overall Study|Adverse Event|1|||
48874803|NCT00913523|157378954|FG001|Overall Study|Adverse Event|0|||
48874804|NCT00913523|157378955|FG002|Overall Study|Adverse Event|0|||
48874805|NCT00913523|157378953|FG000|Overall Study|Protocol Violation|5|||
48874806|NCT00913523|157378954|FG001|Overall Study|Protocol Violation|8|||
48874807|NCT00913523|157378955|FG002|Overall Study|Protocol Violation|8|||
48874808|NCT00913523|157378953|FG000|Overall Study|Pregnancy|1|||
48874809|NCT00913523|157378954|FG001|Overall Study|Pregnancy|3|||
48874810|NCT00913523|157378955|FG002|Overall Study|Pregnancy|0|||
48874811|NCT00913523|157378953|FG000|Overall Study|Inadequate Number of Tampons Used|7|||
48874812|NCT00913523|157378954|FG001|Overall Study|Inadequate Number of Tampons Used|2|||
48874813|NCT00913523|157378955|FG002|Overall Study|Inadequate Number of Tampons Used|3|||
48874814|NCT02895360|157378956|FG000|Phase 1 - 30 mg/m² Cohort|Progressive disease|4|||
48874815|NCT02895360|157378957|FG001|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
48874816|NCT02895360|157378958|FG002|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
48874817|NCT02895360|157378959|FG003|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
48874818|NCT02895360|157378960|FG004|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
48874819|NCT02895360|157378961|FG005|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
48874820|NCT02895360|157378956|FG000|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
48874821|NCT02895360|157378957|FG001|Phase 1 - 45 mg/m² Cohort|Progressive disease|3|||
48874822|NCT02895360|157378958|FG002|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
48874823|NCT02895360|157378959|FG003|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
48874824|NCT02895360|157378960|FG004|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
48677036|NCT02292706|156669201|FG000|Overall Study|Lost to Follow-up|20|||
48677037|NCT02292706|156669202|FG001|Overall Study|Lost to Follow-up|44|||
48677038|NCT02292706|156669203|FG002|Overall Study|Lost to Follow-up|24|||
48677039|NCT02292706|156669204|FG003|Overall Study|Lost to Follow-up|61|||
48677040|NCT02292706|156669205|FG004|Overall Study|Lost to Follow-up|21|||
48677041|NCT02292706|156669206|FG005|Overall Study|Lost to Follow-up|52|||
48677042|NCT02292706|156669207|FG006|Overall Study|Lost to Follow-up|25|||
48677043|NCT02292706|156669208|FG007|Overall Study|Lost to Follow-up|0|||
48677044|NCT02292706|156669201|FG000|Overall Study|Withdrew consent|15|||
48677045|NCT02292706|156669202|FG001|Overall Study|Withdrew consent|56|||
48677046|NCT02292706|156669203|FG002|Overall Study|Withdrew consent|43|||
48677047|NCT02292706|156669204|FG003|Overall Study|Withdrew consent|36|||
48874825|NCT02895360|157378961|FG005|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
48874826|NCT02895360|157378956|FG000|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
48874827|NCT02895360|157378957|FG001|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
48874828|NCT02895360|157378958|FG002|Phase 1 - 70 mg/m² Cohort|Adverse Event|2|||
48874829|NCT02895360|157378959|FG003|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
48677048|NCT02292706|156669205|FG004|Overall Study|Withdrew consent|13|||
48677049|NCT02292706|156669206|FG005|Overall Study|Withdrew consent|51|||
48677050|NCT02292706|156669207|FG006|Overall Study|Withdrew consent|20|||
48677051|NCT02292706|156669208|FG007|Overall Study|Withdrew consent|0|||
48874830|NCT02895360|157378960|FG004|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
48874831|NCT02895360|157378961|FG005|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
48874832|NCT02895360|157378956|FG000|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
48874833|NCT02895360|157378957|FG001|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
49098989|NCT04064411|158197010|FG000|Overall Study|Other than Specified|4|||
48677052|NCT02292706|156669201|FG000|Overall Study|Death|3|||
48677053|NCT02292706|156669202|FG001|Overall Study|Death|11|||
48677054|NCT02292706|156669203|FG002|Overall Study|Death|16|||
48762315|NCT02672423|156978083|FG007|Period 2|Withdrawal by Subject|0|||
49017738|NCT03692676|157902354|FG000|Overall Study|exclude patients with prior use of same substances and device|0|||
49017739|NCT03692676|157902355|FG001|Overall Study|exclude patients with prior use of same substances and device|0|||
49017740|NCT03692676|157902356|FG002|Overall Study|exclude patients with prior use of same substances and device|3700|||
49017741|NCT03692676|157902357|FG003|Overall Study|exclude patients with prior use of same substances and device|0|||
49017742|NCT03692676|157902354|FG000|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
49017743|NCT03692676|157902355|FG001|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
49017744|NCT03692676|157902356|FG002|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965|||
49017745|NCT03692676|157902357|FG003|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198|||
49017746|NCT03692676|157902354|FG000|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
49017747|NCT03692676|157902355|FG001|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
49017748|NCT03692676|157902356|FG002|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
49017749|NCT03692676|157902357|FG003|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223|||
49017750|NCT03692676|157902354|FG000|Overall Study|Other|0|||
49017751|NCT03692676|157902355|FG001|Overall Study|Other|805|||
49017752|NCT03692676|157902356|FG002|Overall Study|Other|758|||
49017753|NCT03692676|157902357|FG003|Overall Study|Other|277|||
49017754|NCT03692676|157902354|FG000|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
49017755|NCT03692676|157902355|FG001|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
49017756|NCT03692676|157902356|FG002|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
49017757|NCT03692676|157902357|FG003|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3|||
49017758|NCT02736227|157902358|FG000|Overall Study|Withdrawal by Subject|0|||
49017759|NCT02736227|157902359|FG001|Overall Study|Withdrawal by Subject|0|||
49017760|NCT02736227|157902360|FG002|Overall Study|Withdrawal by Subject|1|||
49017761|NCT02736227|157902358|FG000|Overall Study|Physician Decision|0|||
49017762|NCT02736227|157902359|FG001|Overall Study|Physician Decision|0|||
49017763|NCT02736227|157902360|FG002|Overall Study|Physician Decision|5|||
49017764|NCT02736227|157902358|FG000|Overall Study|Non Compliant|0|||
49017765|NCT02736227|157902359|FG001|Overall Study|Non Compliant|0|||
49017766|NCT02736227|157902360|FG002|Overall Study|Non Compliant|2|||
49017767|NCT00752791|157902361|FG000|Overall Study|Adverse Event|7|||
49017768|NCT00752791|157902361|FG000|Overall Study|Withdrawal by Subject|1|||
49017769|NCT00752791|157902361|FG000|Overall Study|Physician Decision|1|||
49017770|NCT00752791|157902361|FG000|Overall Study|Death|1|||
49017771|NCT00752791|157902361|FG000|Overall Study|Renal transplant|3|||
49017772|NCT00752791|157902361|FG000|Overall Study|Switched to hemodialysis|2|||
49017773|NCT00752791|157902361|FG000|Overall Study|Protocol deviation|1|||
49017774|NCT04161144|157902362|FG000|Overall Study|Withdrawal by Subject|0|||
49017775|NCT04161144|157902363|FG001|Overall Study|Withdrawal by Subject|1|||
49017776|NCT04161144|157902362|FG000|Overall Study|Protocol Violation|1|||
49017777|NCT04161144|157902363|FG001|Overall Study|Protocol Violation|0|||
49017778|NCT01054599|157902369|FG000|Overall Study|Dizziness due to phenytoin toxicity|1|||
49017779|NCT01054599|157902370|FG001|Overall Study|Dizziness due to phenytoin toxicity|0|||
49017780|NCT01054599|157902369|FG000|Overall Study|Protocol Violation|1|||
49017781|NCT01054599|157902370|FG001|Overall Study|Protocol Violation|0|||
49017782|NCT01054599|157902369|FG000|Overall Study|Spells/seizure-like episodes|1|||
49017783|NCT01054599|157902370|FG001|Overall Study|Spells/seizure-like episodes|1|||
49017784|NCT01054599|157902369|FG000|Overall Study|Timing/scheduling difficulties|1|||
49017785|NCT01054599|157902370|FG001|Overall Study|Timing/scheduling difficulties|1|||
49017786|NCT01054599|157902369|FG000|Overall Study|Visual impairment, WTAR <80|0|||
49017787|NCT01054599|157902370|FG001|Overall Study|Visual impairment, WTAR <80|1|||
49017788|NCT01054599|157902369|FG000|Overall Study|Lost to Follow-up|0|||
49017789|NCT01054599|157902370|FG001|Overall Study|Lost to Follow-up|2|||
49017790|NCT01054599|157902369|FG000|Overall Study|Adverse Event|0|||
49017791|NCT01054599|157902370|FG001|Overall Study|Adverse Event|1|||
49017792|NCT01054599|157902369|FG000|Overall Study|Withdrawal by Subject|0|||
49017793|NCT01054599|157902370|FG001|Overall Study|Withdrawal by Subject|1|||
49017794|NCT05431153|157902373|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
49017795|NCT05431153|157902374|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
49017796|NCT05431153|157902375|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
49017797|NCT05431153|157902376|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
49017798|NCT05431153|157902377|FG004|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
49017799|NCT05431153|157902378|FG005|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
49017800|NCT02374918|157902382|FG000|Overall Study|Protocol Violation|2|||
49017801|NCT02374918|157902383|FG001|Overall Study|Protocol Violation|0|||
49017802|NCT02374918|157902384|FG002|Overall Study|Protocol Violation|2|||
49017803|NCT02374918|157902385|FG003|Overall Study|Protocol Violation|1|||
49017804|NCT02374918|157902382|FG000|Overall Study|Withdrawal by Subject|1|||
49017805|NCT02374918|157902383|FG001|Overall Study|Withdrawal by Subject|1|||
48677055|NCT02292706|156669204|FG003|Overall Study|Death|22|||
49017806|NCT02374918|157902384|FG002|Overall Study|Withdrawal by Subject|1|||
49017807|NCT02374918|157902385|FG003|Overall Study|Withdrawal by Subject|0|||
49017808|NCT02374918|157902382|FG000|Overall Study|Lack of Efficacy|0|||
49017809|NCT02374918|157902383|FG001|Overall Study|Lack of Efficacy|0|||
49017810|NCT02374918|157902384|FG002|Overall Study|Lack of Efficacy|1|||
49017811|NCT02374918|157902385|FG003|Overall Study|Lack of Efficacy|1|||
49017812|NCT01957488|157902386|FG000|Test Period 1 (2 Weeks)|Lost to Follow-up|2|||
49017813|NCT01957488|157902387|FG001|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
49017814|NCT01957488|157902388|FG002|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
49017815|NCT01957488|157902389|FG003|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
49017816|NCT01957488|157902390|FG004|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
49017817|NCT01957488|157902391|FG005|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
49017818|NCT01957488|157902386|FG000|Test Period 1 (2 Weeks)|Protocol Violation|1|||
49017819|NCT01957488|157902387|FG001|Test Period 1 (2 Weeks)|Protocol Violation|2|||
49017820|NCT01957488|157902388|FG002|Test Period 1 (2 Weeks)|Protocol Violation|2|||
49017821|NCT01957488|157902389|FG003|Test Period 1 (2 Weeks)|Protocol Violation|1|||
49017822|NCT01957488|157902390|FG004|Test Period 1 (2 Weeks)|Protocol Violation|0|||
49017823|NCT01957488|157902391|FG005|Test Period 1 (2 Weeks)|Protocol Violation|3|||
49017824|NCT01957488|157902386|FG000|Test Period 1 (2 Weeks)|Adverse Event|0|||
49017825|NCT01957488|157902387|FG001|Test Period 1 (2 Weeks)|Adverse Event|1|||
49017826|NCT01957488|157902388|FG002|Test Period 1 (2 Weeks)|Adverse Event|1|||
49017827|NCT01957488|157902389|FG003|Test Period 1 (2 Weeks)|Adverse Event|0|||
49017828|NCT01957488|157902390|FG004|Test Period 1 (2 Weeks)|Adverse Event|1|||
49017829|NCT01957488|157902391|FG005|Test Period 1 (2 Weeks)|Adverse Event|0|||
49017830|NCT01957488|157902386|FG000|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
49017831|NCT01957488|157902387|FG001|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
49017832|NCT01957488|157902388|FG002|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
49017833|NCT01957488|157902389|FG003|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
49017834|NCT01957488|157902390|FG004|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
49017835|NCT01957488|157902391|FG005|Test Period 1 (2 Weeks)|Withdrawal by Subject|2|||
49017836|NCT01957488|157902386|FG000|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
48677056|NCT02292706|156669205|FG004|Overall Study|Death|8|||
48677057|NCT02292706|156669206|FG005|Overall Study|Death|17|||
48677058|NCT02292706|156669207|FG006|Overall Study|Death|3|||
48677059|NCT02292706|156669208|FG007|Overall Study|Death|0|||
48677060|NCT02292706|156669201|FG000|Overall Study|Study terminated by sponsor|0|||
48677061|NCT02292706|156669202|FG001|Overall Study|Study terminated by sponsor|9|||
48762316|NCT02672423|156978084|FG008|Period 2|Withdrawal by Subject|0|||
49017837|NCT01957488|157902387|FG001|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
49017838|NCT01957488|157902388|FG002|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
49017839|NCT01957488|157902389|FG003|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
49017840|NCT01957488|157902390|FG004|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1|||
49017841|NCT01957488|157902391|FG005|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
49017842|NCT01957488|157902386|FG000|Test Period 1 (2 Weeks)|screen failure|0|||
49017843|NCT01957488|157902387|FG001|Test Period 1 (2 Weeks)|screen failure|0|||
49017844|NCT01957488|157902388|FG002|Test Period 1 (2 Weeks)|screen failure|0|||
49017845|NCT01957488|157902389|FG003|Test Period 1 (2 Weeks)|screen failure|0|||
49017846|NCT01957488|157902390|FG004|Test Period 1 (2 Weeks)|screen failure|0|||
49017847|NCT01957488|157902391|FG005|Test Period 1 (2 Weeks)|screen failure|1|||
49017848|NCT01957488|157902386|FG000|Test Period 2 (2 Weeks)|Protocol Violation|2|||
49017849|NCT01957488|157902387|FG001|Test Period 2 (2 Weeks)|Protocol Violation|0|||
49017850|NCT01957488|157902388|FG002|Test Period 2 (2 Weeks)|Protocol Violation|1|||
49017851|NCT01957488|157902389|FG003|Test Period 2 (2 Weeks)|Protocol Violation|1|||
49017852|NCT01957488|157902390|FG004|Test Period 2 (2 Weeks)|Protocol Violation|0|||
49017853|NCT01957488|157902391|FG005|Test Period 2 (2 Weeks)|Protocol Violation|0|||
49017854|NCT01957488|157902386|FG000|Test Period 2 (2 Weeks)|Other|1|||
49017855|NCT01957488|157902387|FG001|Test Period 2 (2 Weeks)|Other|0|||
49017856|NCT01957488|157902388|FG002|Test Period 2 (2 Weeks)|Other|0|||
49017857|NCT01957488|157902389|FG003|Test Period 2 (2 Weeks)|Other|0|||
48762317|NCT02672423|156978085|FG009|Period 2|Withdrawal by Subject|0|||
49017858|NCT01957488|157902390|FG004|Test Period 2 (2 Weeks)|Other|0|||
48677062|NCT02292706|156669203|FG002|Overall Study|Study terminated by sponsor|4|||
48762318|NCT02672423|156978076|FG000|Period 3|Withdrawal by Subject|0|||
48762319|NCT02672423|156978077|FG001|Period 3|Withdrawal by Subject|0|||
48677063|NCT02292706|156669204|FG003|Overall Study|Study terminated by sponsor|21|||
48677064|NCT02292706|156669205|FG004|Overall Study|Study terminated by sponsor|11|||
48677065|NCT02292706|156669206|FG005|Overall Study|Study terminated by sponsor|13|||
48762320|NCT02672423|156978078|FG002|Period 3|Withdrawal by Subject|0|||
49017859|NCT01957488|157902391|FG005|Test Period 2 (2 Weeks)|Other|0|||
49017860|NCT01957488|157902386|FG000|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
49017861|NCT01957488|157902387|FG001|Test Period 2 (2 Weeks)|Withdrawal by Subject|1|||
49017862|NCT01957488|157902388|FG002|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
49017863|NCT01957488|157902389|FG003|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
49017864|NCT01957488|157902390|FG004|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
48874834|NCT02895360|157378958|FG002|Phase 1 - 70 mg/m² Cohort|Progressive disease|7|||
48874835|NCT02895360|157378959|FG003|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
48874836|NCT02895360|157378960|FG004|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
48874837|NCT02895360|157378961|FG005|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
48874838|NCT02895360|157378956|FG000|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
48874839|NCT02895360|157378957|FG001|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
48762321|NCT02672423|156978079|FG003|Period 3|Withdrawal by Subject|0|||
48677066|NCT02292706|156669207|FG006|Overall Study|Study terminated by sponsor|3|||
48874840|NCT02895360|157378958|FG002|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
48874841|NCT02895360|157378959|FG003|Phase 1 - 90 mg/m² Cohort|Progressive disease|4|||
48874842|NCT02895360|157378960|FG004|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
48874843|NCT02895360|157378961|FG005|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
48874844|NCT02895360|157378956|FG000|Phase 2a|Adverse Event|0|||
48874845|NCT02895360|157378957|FG001|Phase 2a|Adverse Event|0|||
48874846|NCT02895360|157378958|FG002|Phase 2a|Adverse Event|0|||
48874847|NCT02895360|157378959|FG003|Phase 2a|Adverse Event|0|||
48874848|NCT02895360|157378960|FG004|Phase 2a|Adverse Event|0|||
48874849|NCT02895360|157378961|FG005|Phase 2a|Adverse Event|1|||
48874850|NCT02895360|157378956|FG000|Phase 2a|Progressive disease|0|||
48874851|NCT02895360|157378957|FG001|Phase 2a|Progressive disease|0|||
48874852|NCT02895360|157378958|FG002|Phase 2a|Progressive disease|0|||
48874853|NCT02895360|157378959|FG003|Phase 2a|Progressive disease|0|||
48874854|NCT02895360|157378960|FG004|Phase 2a|Progressive disease|11|||
48874855|NCT02895360|157378961|FG005|Phase 2a|Progressive disease|11|||
48874856|NCT01844726|157378962|FG000|Overall Study|Withdrawal by Subject|0|||
48874857|NCT01844726|157378963|FG001|Overall Study|Withdrawal by Subject|1|||
48874858|NCT01844726|157378962|FG000|Overall Study|Excessive motion in MRI resulted in discontinuation.|1|||
48874859|NCT01844726|157378963|FG001|Overall Study|Excessive motion in MRI resulted in discontinuation.|0|||
48874860|NCT00469456|157378966|FG000|Overall Study|Adverse Event|4|||
48874861|NCT00469456|157378967|FG001|Overall Study|Adverse Event|3|||
48874862|NCT00469456|157378966|FG000|Overall Study|Protocol Violation|1|||
48677067|NCT02292706|156669208|FG007|Overall Study|Study terminated by sponsor|0|||
48677068|NCT02292706|156669201|FG000|Overall Study|Investigator's discretion|4|||
48677069|NCT02292706|156669202|FG001|Overall Study|Investigator's discretion|9|||
48677070|NCT02292706|156669203|FG002|Overall Study|Investigator's discretion|7|||
48677071|NCT02292706|156669204|FG003|Overall Study|Investigator's discretion|11|||
48677072|NCT02292706|156669205|FG004|Overall Study|Investigator's discretion|4|||
48677073|NCT02292706|156669206|FG005|Overall Study|Investigator's discretion|10|||
48677074|NCT02292706|156669207|FG006|Overall Study|Investigator's discretion|1|||
48677075|NCT02292706|156669208|FG007|Overall Study|Investigator's discretion|0|||
48677076|NCT02292706|156669201|FG000|Overall Study|Liver transplant|1|||
48762322|NCT02672423|156978080|FG004|Period 3|Withdrawal by Subject|0|||
48762323|NCT02672423|156978081|FG005|Period 3|Withdrawal by Subject|0|||
48762324|NCT02672423|156978082|FG006|Period 3|Withdrawal by Subject|0|||
48762325|NCT02672423|156978083|FG007|Period 3|Withdrawal by Subject|1|||
48762326|NCT02672423|156978084|FG008|Period 3|Withdrawal by Subject|0|||
48762327|NCT02672423|156978085|FG009|Period 3|Withdrawal by Subject|0|||
48762328|NCT02672423|156978076|FG000|Period 3|Physician Decision|0|||
48762329|NCT02672423|156978077|FG001|Period 3|Physician Decision|0|||
48762330|NCT02672423|156978078|FG002|Period 3|Physician Decision|0|||
48762331|NCT02672423|156978079|FG003|Period 3|Physician Decision|0|||
48762332|NCT02672423|156978080|FG004|Period 3|Physician Decision|0|||
48762333|NCT02672423|156978081|FG005|Period 3|Physician Decision|1|||
48762334|NCT02672423|156978082|FG006|Period 3|Physician Decision|0|||
48874863|NCT00469456|157378967|FG001|Overall Study|Protocol Violation|0|||
48874864|NCT00469456|157378966|FG000|Overall Study|Withdrawal by Subject|4|||
49017865|NCT01957488|157902391|FG005|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
49017866|NCT01957488|157902386|FG000|Test Period 2 (2 Weeks)|Adverse Event|0|||
49017867|NCT01957488|157902387|FG001|Test Period 2 (2 Weeks)|Adverse Event|0|||
49017868|NCT01957488|157902388|FG002|Test Period 2 (2 Weeks)|Adverse Event|0|||
49017869|NCT01957488|157902389|FG003|Test Period 2 (2 Weeks)|Adverse Event|0|||
49017870|NCT01957488|157902390|FG004|Test Period 2 (2 Weeks)|Adverse Event|2|||
48677077|NCT02292706|156669202|FG001|Overall Study|Liver transplant|1|||
48677078|NCT02292706|156669203|FG002|Overall Study|Liver transplant|11|||
48677079|NCT02292706|156669204|FG003|Overall Study|Liver transplant|16|||
48762335|NCT02672423|156978083|FG007|Period 3|Physician Decision|0|||
48762336|NCT02672423|156978084|FG008|Period 3|Physician Decision|0|||
48762337|NCT02672423|156978085|FG009|Period 3|Physician Decision|0|||
48874865|NCT00469456|157378967|FG001|Overall Study|Withdrawal by Subject|1|||
49017871|NCT01957488|157902391|FG005|Test Period 2 (2 Weeks)|Adverse Event|0|||
49017872|NCT01957488|157902386|FG000|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
48874866|NCT03016598|157378970|FG000|Overall Study|Lost to Follow-up|0|||
48874867|NCT03016598|157378971|FG001|Overall Study|Lost to Follow-up|2|||
48874868|NCT03634839|157378973|FG000|First Intervention (2 Hours)|Adverse Event|0|||
48762338|NCT05071183|156978086|FG000|Overall Study|Death|1|||
48874869|NCT03634839|157378974|FG001|First Intervention (2 Hours)|Adverse Event|2|||
49017873|NCT01957488|157902387|FG001|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
48677080|NCT02292706|156669205|FG004|Overall Study|Liver transplant|5|||
48677081|NCT02292706|156669206|FG005|Overall Study|Liver transplant|6|||
48677082|NCT02292706|156669207|FG006|Overall Study|Liver transplant|5|||
48677083|NCT02292706|156669208|FG007|Overall Study|Liver transplant|0|||
48677084|NCT02292706|156669201|FG000|Overall Study|Enrolled but not met eligibility criteria|1|||
48677085|NCT02292706|156669202|FG001|Overall Study|Enrolled but not met eligibility criteria|2|||
48677086|NCT02292706|156669203|FG002|Overall Study|Enrolled but not met eligibility criteria|2|||
48677087|NCT02292706|156669204|FG003|Overall Study|Enrolled but not met eligibility criteria|2|||
48677088|NCT02292706|156669205|FG004|Overall Study|Enrolled but not met eligibility criteria|2|||
48677089|NCT02292706|156669206|FG005|Overall Study|Enrolled but not met eligibility criteria|6|||
48677090|NCT02292706|156669207|FG006|Overall Study|Enrolled but not met eligibility criteria|2|||
48677091|NCT02292706|156669208|FG007|Overall Study|Enrolled but not met eligibility criteria|19|||
48677092|NCT02292706|156669201|FG000|Overall Study|Subject terminated by sponsor|1|||
48677093|NCT02292706|156669202|FG001|Overall Study|Subject terminated by sponsor|0|||
48677094|NCT02292706|156669203|FG002|Overall Study|Subject terminated by sponsor|0|||
48677095|NCT02292706|156669204|FG003|Overall Study|Subject terminated by sponsor|2|||
48677096|NCT02292706|156669205|FG004|Overall Study|Subject terminated by sponsor|1|||
48677097|NCT02292706|156669206|FG005|Overall Study|Subject terminated by sponsor|0|||
48677098|NCT02292706|156669207|FG006|Overall Study|Subject terminated by sponsor|0|||
48677099|NCT02292706|156669208|FG007|Overall Study|Subject terminated by sponsor|0|||
48677100|NCT02292706|156669201|FG000|Overall Study|Missing|0|||
48677101|NCT02292706|156669202|FG001|Overall Study|Missing|0|||
48762339|NCT05071183|156978087|FG001|Overall Study|Death|2|||
48762340|NCT05071183|156978088|FG002|Overall Study|Death|0|||
48762341|NCT05071183|156978086|FG000|Overall Study|Other Reasons|1|||
48762342|NCT05071183|156978087|FG001|Overall Study|Other Reasons|3|||
48762343|NCT05071183|156978088|FG002|Overall Study|Other Reasons|2|||
48677102|NCT02292706|156669203|FG002|Overall Study|Missing|1|||
48677103|NCT02292706|156669204|FG003|Overall Study|Missing|1|||
48677104|NCT02292706|156669205|FG004|Overall Study|Missing|0|||
48677105|NCT02292706|156669206|FG005|Overall Study|Missing|1|||
48677106|NCT02292706|156669207|FG006|Overall Study|Missing|0|||
48677107|NCT02292706|156669208|FG007|Overall Study|Missing|0|||
48677108|NCT02292706|156669201|FG000|Overall Study|Virologic relapse or reinfection|1|||
48677109|NCT02292706|156669202|FG001|Overall Study|Virologic relapse or reinfection|0|||
48677110|NCT02292706|156669203|FG002|Overall Study|Virologic relapse or reinfection|0|||
48677111|NCT02292706|156669204|FG003|Overall Study|Virologic relapse or reinfection|1|||
48677112|NCT02292706|156669205|FG004|Overall Study|Virologic relapse or reinfection|0|||
48677113|NCT02292706|156669206|FG005|Overall Study|Virologic relapse or reinfection|1|||
48677114|NCT02292706|156669207|FG006|Overall Study|Virologic relapse or reinfection|0|||
48677115|NCT02292706|156669208|FG007|Overall Study|Virologic relapse or reinfection|0|||
48677116|NCT04565951|156669214|FG000|Overall Study|Lost to Follow-up|66|||
48677117|NCT04565951|156669215|FG001|Overall Study|Lost to Follow-up|38|||
48677118|NCT04565951|156669214|FG000|Overall Study|Withdrawal by Subject|14|||
48677119|NCT04565951|156669215|FG001|Overall Study|Withdrawal by Subject|7|||
48677120|NCT04565951|156669214|FG000|Overall Study|Death|0|||
48677121|NCT04565951|156669215|FG001|Overall Study|Death|1|||
48677122|NCT03182907|156669216|FG000|Overall Study|Death|3|||
48677123|NCT03182907|156669217|FG001|Overall Study|Death|0|||
48677124|NCT03182907|156669216|FG000|Overall Study|Protocol Violation|4|||
48677125|NCT03182907|156669217|FG001|Overall Study|Protocol Violation|0|||
48677126|NCT03182907|156669216|FG000|Overall Study|Lost to Follow-up|1|||
48677127|NCT03182907|156669217|FG001|Overall Study|Lost to Follow-up|0|||
48677128|NCT03182907|156669216|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
48677129|NCT03182907|156669217|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
48677130|NCT01123395|156669220|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
48677131|NCT01123395|156669221|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
48677132|NCT01368081|156669222|FG000|Overall Study|Adverse Event|4|||
48762344|NCT01990495|156978093|FG000|Overall Study|Physician Decision|5|||
48762345|NCT01990495|156978094|FG001|Overall Study|Physician Decision|4|||
48677133|NCT01368081|156669223|FG001|Overall Study|Adverse Event|4|||
48677134|NCT01368081|156669224|FG002|Overall Study|Adverse Event|3|||
48677135|NCT01368081|156669225|FG003|Overall Study|Adverse Event|2|||
48677136|NCT01368081|156669226|FG004|Overall Study|Adverse Event|2|||
48677137|NCT01368081|156669227|FG005|Overall Study|Adverse Event|5|||
48677138|NCT01368081|156669228|FG006|Overall Study|Adverse Event|6|||
48677139|NCT01368081|156669229|FG007|Overall Study|Adverse Event|2|||
48677140|NCT01368081|156669230|FG008|Overall Study|Adverse Event|3|||
48677141|NCT01368081|156669231|FG009|Overall Study|Adverse Event|5|||
48677142|NCT01368081|156669232|FG010|Overall Study|Adverse Event|6|||
48677143|NCT01368081|156669233|FG011|Overall Study|Adverse Event|1|||
48677144|NCT01368081|156669234|FG012|Overall Study|Adverse Event|3|||
48677145|NCT01368081|156669222|FG000|Overall Study|Lack of Efficacy|0|||
48677146|NCT01368081|156669223|FG001|Overall Study|Lack of Efficacy|1|||
48677147|NCT01368081|156669224|FG002|Overall Study|Lack of Efficacy|0|||
48677148|NCT01368081|156669225|FG003|Overall Study|Lack of Efficacy|1|||
48677149|NCT01368081|156669226|FG004|Overall Study|Lack of Efficacy|0|||
48677150|NCT01368081|156669227|FG005|Overall Study|Lack of Efficacy|0|||
48677151|NCT01368081|156669228|FG006|Overall Study|Lack of Efficacy|0|||
48677152|NCT01368081|156669229|FG007|Overall Study|Lack of Efficacy|2|||
48677153|NCT01368081|156669230|FG008|Overall Study|Lack of Efficacy|0|||
48677154|NCT01368081|156669231|FG009|Overall Study|Lack of Efficacy|0|||
48874870|NCT01086384|157378975|FG000|2-week Run-in Period|Adverse Event|1|||
49017874|NCT01957488|157902388|FG002|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
49017875|NCT01957488|157902389|FG003|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
49017876|NCT01957488|157902390|FG004|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
49017877|NCT01957488|157902391|FG005|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1|||
49017878|NCT01957488|157902386|FG000|Test Period 3 (2 Weeks)|Withdrawal by Subject|1|||
49017879|NCT01957488|157902387|FG001|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
49017880|NCT01957488|157902388|FG002|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
49017881|NCT01957488|157902389|FG003|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
49017882|NCT01957488|157902390|FG004|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
49017883|NCT01957488|157902391|FG005|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
49017884|NCT01957488|157902386|FG000|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
49017885|NCT01957488|157902387|FG001|Test Period 3 (2 Weeks)|Lack of Efficacy|1|||
49017886|NCT01957488|157902388|FG002|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
49017887|NCT01957488|157902389|FG003|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
49017888|NCT01957488|157902390|FG004|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
48677155|NCT01368081|156669232|FG010|Overall Study|Lack of Efficacy|0|||
48677156|NCT01368081|156669233|FG011|Overall Study|Lack of Efficacy|0|||
49017889|NCT01957488|157902391|FG005|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
49017890|NCT02497781|157902392|FG000|Overall Study|Withdrawal by Subject|2|||
49017891|NCT02497781|157902393|FG001|Overall Study|Withdrawal by Subject|0|||
49017892|NCT02497781|157902392|FG000|Overall Study|Lack of Efficacy|0|||
49017893|NCT02497781|157902393|FG001|Overall Study|Lack of Efficacy|1|||
49017894|NCT02497781|157902392|FG000|Overall Study|Randomised but not treated|1|||
49017895|NCT02497781|157902393|FG001|Overall Study|Randomised but not treated|1|||
49017896|NCT02497781|157902392|FG000|Overall Study|Lost to Follow-up|1|||
49017897|NCT02497781|157902393|FG001|Overall Study|Lost to Follow-up|1|||
49017898|NCT01001169|157902394|FG000|Overall Study|Withdrawal by Subject|2|||
49017899|NCT01001169|157902395|FG001|Overall Study|Withdrawal by Subject|1|||
49017900|NCT01336894|157902396|FG000|Follow-up|Study terminated prematurely|2|||
49017901|NCT01336894|157902397|FG001|Follow-up|Study terminated prematurely|7|||
49017902|NCT02752776|157902398|FG000|Overall Study|Adverse Event|15|||
49017903|NCT02752776|157902399|FG001|Overall Study|Adverse Event|23|||
49017904|NCT02752776|157902400|FG002|Overall Study|Adverse Event|11|||
49017905|NCT02752776|157902398|FG000|Overall Study|Lack of Efficacy|2|||
49017906|NCT02752776|157902399|FG001|Overall Study|Lack of Efficacy|6|||
49017907|NCT02752776|157902400|FG002|Overall Study|Lack of Efficacy|14|||
49017908|NCT02752776|157902398|FG000|Overall Study|Lost to Follow-up|11|||
49017909|NCT02752776|157902399|FG001|Overall Study|Lost to Follow-up|12|||
49017910|NCT02752776|157902400|FG002|Overall Study|Lost to Follow-up|4|||
49017911|NCT02752776|157902398|FG000|Overall Study|Non-compliance with study treatment|0|||
49017912|NCT02752776|157902399|FG001|Overall Study|Non-compliance with study treatment|0|||
49017913|NCT02752776|157902400|FG002|Overall Study|Non-compliance with study treatment|1|||
49017914|NCT02752776|157902398|FG000|Overall Study|Physician Decision|2|||
49017915|NCT02752776|157902399|FG001|Overall Study|Physician Decision|6|||
49017916|NCT02752776|157902400|FG002|Overall Study|Physician Decision|2|||
49017917|NCT02752776|157902398|FG000|Overall Study|Pregnancy|1|||
49017918|NCT02752776|157902399|FG001|Overall Study|Pregnancy|6|||
49017919|NCT02752776|157902400|FG002|Overall Study|Pregnancy|3|||
49017920|NCT02752776|157902398|FG000|Overall Study|Protocol Violation|10|||
49017921|NCT02752776|157902399|FG001|Overall Study|Protocol Violation|13|||
49017922|NCT02752776|157902400|FG002|Overall Study|Protocol Violation|6|||
49017923|NCT02752776|157902398|FG000|Overall Study|Subject/guardian decision|8|||
49017924|NCT02752776|157902399|FG001|Overall Study|Subject/guardian decision|6|||
49017925|NCT02752776|157902400|FG002|Overall Study|Subject/guardian decision|4|||
49017926|NCT02752776|157902398|FG000|Overall Study|Death|0|||
49017927|NCT02752776|157902399|FG001|Overall Study|Death|0|||
49017928|NCT02752776|157902400|FG002|Overall Study|Death|1|||
48677157|NCT01368081|156669234|FG012|Overall Study|Lack of Efficacy|0|||
48677158|NCT01368081|156669222|FG000|Overall Study|Protocol Violation|0|||
48677159|NCT01368081|156669223|FG001|Overall Study|Protocol Violation|0|||
48677160|NCT01368081|156669224|FG002|Overall Study|Protocol Violation|0|||
49017929|NCT02752776|157902398|FG000|Overall Study|Withdrawal by Subject|3|||
49017930|NCT02752776|157902399|FG001|Overall Study|Withdrawal by Subject|4|||
49017931|NCT02752776|157902400|FG002|Overall Study|Withdrawal by Subject|2|||
49017932|NCT02224391|157902401|FG000|Overall Study|Lost to Follow-up|26|||
49017933|NCT02224391|157902402|FG001|Overall Study|Lost to Follow-up|19|||
49017934|NCT02224391|157902401|FG000|Overall Study|Withdrawal by Subject|6|||
49017935|NCT02224391|157902402|FG001|Overall Study|Withdrawal by Subject|5|||
49017936|NCT02492958|157902403|FG000|Overall Study|Withdrawal by Subject|0|||
49017937|NCT02492958|157902404|FG001|Overall Study|Withdrawal by Subject|0|||
49017938|NCT02492958|157902405|FG002|Overall Study|Withdrawal by Subject|1|||
49017939|NCT02492958|157902406|FG003|Overall Study|Withdrawal by Subject|0|||
49017940|NCT02492958|157902403|FG000|Overall Study|Adverse Event|1|||
49017941|NCT02492958|157902404|FG001|Overall Study|Adverse Event|0|||
49017942|NCT02492958|157902405|FG002|Overall Study|Adverse Event|1|||
49017943|NCT02492958|157902406|FG003|Overall Study|Adverse Event|0|||
49017944|NCT01193608|157902407|FG000|Overall Study|Other|0|||
49017945|NCT01193608|157902408|FG001|Overall Study|Other|1|||
49017946|NCT01193608|157902409|FG002|Overall Study|Other|0|||
49017947|NCT01193608|157902410|FG003|Overall Study|Other|0|||
49017948|NCT01193608|157902411|FG004|Overall Study|Other|0|||
49017949|NCT01193608|157902412|FG005|Overall Study|Other|0|||
49017950|NCT01193608|157902407|FG000|Overall Study|Withdrawal by Subject|0|||
49017951|NCT01193608|157902408|FG001|Overall Study|Withdrawal by Subject|1|||
49017952|NCT01193608|157902409|FG002|Overall Study|Withdrawal by Subject|2|||
49017953|NCT01193608|157902410|FG003|Overall Study|Withdrawal by Subject|3|||
49017954|NCT01193608|157902411|FG004|Overall Study|Withdrawal by Subject|3|||
49017955|NCT01193608|157902412|FG005|Overall Study|Withdrawal by Subject|0|||
49017956|NCT01193608|157902407|FG000|Overall Study|Lost to Follow-up|0|||
49017957|NCT01193608|157902408|FG001|Overall Study|Lost to Follow-up|0|||
49017958|NCT01193608|157902409|FG002|Overall Study|Lost to Follow-up|0|||
49017959|NCT01193608|157902410|FG003|Overall Study|Lost to Follow-up|0|||
49017960|NCT01193608|157902411|FG004|Overall Study|Lost to Follow-up|1|||
49017961|NCT01193608|157902412|FG005|Overall Study|Lost to Follow-up|2|||
49017962|NCT01193608|157902407|FG000|Overall Study|Adverse Event|0|||
49017963|NCT01193608|157902408|FG001|Overall Study|Adverse Event|0|||
49017964|NCT01193608|157902409|FG002|Overall Study|Adverse Event|0|||
49017965|NCT01193608|157902410|FG003|Overall Study|Adverse Event|0|||
49017966|NCT01193608|157902411|FG004|Overall Study|Adverse Event|1|||
49017967|NCT01193608|157902412|FG005|Overall Study|Adverse Event|0|||
49017968|NCT01047345|157902413|FG000|Base Study|Adverse Event|3|||
49017969|NCT01047345|157902414|FG001|Base Study|Adverse Event|0|||
49017970|NCT01047345|157902415|FG002|Base Study|Adverse Event|0|||
49017971|NCT01047345|157902413|FG000|Base Study|Lost to Follow-up|4|||
49017972|NCT01047345|157902414|FG001|Base Study|Lost to Follow-up|1|||
49017973|NCT01047345|157902415|FG002|Base Study|Lost to Follow-up|0|||
49017974|NCT01047345|157902413|FG000|Base Study|Protocol Violation|3|||
49017975|NCT01047345|157902414|FG001|Base Study|Protocol Violation|1|||
49017976|NCT01047345|157902415|FG002|Base Study|Protocol Violation|0|||
49017977|NCT01047345|157902413|FG000|Base Study|Withdrawal by Subject|12|||
49017978|NCT01047345|157902414|FG001|Base Study|Withdrawal by Subject|4|||
49017979|NCT01047345|157902415|FG002|Base Study|Withdrawal by Subject|0|||
49017980|NCT01047345|157902413|FG000|Extension|Withdrawal by Subject|0|||
49017981|NCT01047345|157902414|FG001|Extension|Withdrawal by Subject|0|||
49017982|NCT01047345|157902415|FG002|Extension|Withdrawal by Subject|1|||
48762346|NCT00325754|156978095|FG000|Overall Study|Adverse Event|4|||
48762347|NCT00325754|156978096|FG001|Overall Study|Adverse Event|1|||
48762348|NCT01852812|156978097|FG000|Overall Study|Adverse Event|0|||
48762349|NCT01852812|156978098|FG001|Overall Study|Adverse Event|0|||
48762350|NCT01852812|156978099|FG002|Overall Study|Adverse Event|1|||
48762351|NCT01852812|156978097|FG000|Overall Study|Non-compliance With Study Drug|0|||
48762352|NCT01852812|156978098|FG001|Overall Study|Non-compliance With Study Drug|1|||
48762353|NCT01852812|156978099|FG002|Overall Study|Non-compliance With Study Drug|0|||
48762354|NCT01478321|156978100|FG000|Concurrent Therapy (5 Weeks)|Adverse Event|4|||
48762355|NCT01478321|156978100|FG000|Concurrent Therapy (5 Weeks)|Death|2|||
48762356|NCT01478321|156978100|FG000|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5|||
48762357|NCT01478321|156978100|FG000|Concurrent Therapy (5 Weeks)|Progressive Disease|5|||
48762358|NCT01478321|156978100|FG000|Started Adjuvant Therapy|Withdrawal by Subject|1|||
48762359|NCT01478321|156978100|FG000|Adjuvant Therapy Until PD or Toxicity|Death|1|||
48762360|NCT01478321|156978100|FG000|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1|||
48762361|NCT01478321|156978100|FG000|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8|||
48762362|NCT00481195|156978102|FG000|Overall Study|Adverse Event|16|||
48762363|NCT00481195|156978103|FG001|Overall Study|Adverse Event|11|||
48762364|NCT00481195|156978102|FG000|Overall Study|Lack of Efficacy|1|||
48762365|NCT00481195|156978103|FG001|Overall Study|Lack of Efficacy|3|||
48762366|NCT00481195|156978102|FG000|Overall Study|Lost to Follow-up|4|||
48762367|NCT00481195|156978103|FG001|Overall Study|Lost to Follow-up|6|||
48762368|NCT00481195|156978102|FG000|Overall Study|Physician Decision|3|||
48762369|NCT00481195|156978103|FG001|Overall Study|Physician Decision|1|||
49017983|NCT01047345|157902413|FG000|Extension|Lost to Follow-up|0|||
49017984|NCT01047345|157902414|FG001|Extension|Lost to Follow-up|0|||
49017985|NCT01047345|157902415|FG002|Extension|Lost to Follow-up|5|||
49017986|NCT01816477|157902418|FG000|Overall Study|Withdrawal by Subject|13|||
49017987|NCT01816477|157902419|FG001|Overall Study|Withdrawal by Subject|1|||
49017988|NCT01816477|157902418|FG000|Overall Study|Unable to tolerate catheter placement|3|||
48762370|NCT00481195|156978102|FG000|Overall Study|Protocol Violation|10|||
48762371|NCT00481195|156978103|FG001|Overall Study|Protocol Violation|7|||
49017989|NCT01816477|157902419|FG001|Overall Study|Unable to tolerate catheter placement|0|||
49017990|NCT02001558|157902423|FG000|Overall Study|Lost to Follow-up|8|||
49017991|NCT02001558|157902424|FG001|Overall Study|Lost to Follow-up|14|||
48874871|NCT01086384|157378976|FG001|2-week Run-in Period|Adverse Event|0|||
48874872|NCT01086384|157378977|FG002|2-week Run-in Period|Adverse Event|0|||
48874873|NCT01086384|157378975|FG000|2-week Run-in Period|Protocol Violation|1|||
48874874|NCT01086384|157378976|FG001|2-week Run-in Period|Protocol Violation|0|||
48874875|NCT01086384|157378977|FG002|2-week Run-in Period|Protocol Violation|0|||
48874876|NCT01086384|157378975|FG000|2-week Run-in Period|Lost to Follow-up|1|||
48874877|NCT01086384|157378976|FG001|2-week Run-in Period|Lost to Follow-up|0|||
48874878|NCT01086384|157378977|FG002|2-week Run-in Period|Lost to Follow-up|0|||
48874879|NCT01086384|157378975|FG000|2-week Run-in Period|Physician Decision|6|||
48874880|NCT01086384|157378976|FG001|2-week Run-in Period|Physician Decision|0|||
48874881|NCT01086384|157378977|FG002|2-week Run-in Period|Physician Decision|0|||
48874882|NCT01086384|157378975|FG000|2-week Run-in Period|Withdrawal by Subject|19|||
48874883|NCT01086384|157378976|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
48874884|NCT01086384|157378977|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
48874885|NCT01086384|157378975|FG000|2-week Run-in Period|Study Closed/Terminated|42|||
48874886|NCT01086384|157378976|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
48874887|NCT01086384|157378977|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
48874888|NCT01086384|157378975|FG000|2-week Run-in Period|Continuation Criteria Not Met|92|||
48874889|NCT01086384|157378976|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
48874890|NCT01086384|157378977|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
48874891|NCT01086384|157378975|FG000|2-week Run-in Period|Randomized in Error|1|||
48874892|NCT01086384|157378976|FG001|2-week Run-in Period|Randomized in Error|0|||
48874893|NCT01086384|157378977|FG002|2-week Run-in Period|Randomized in Error|0|||
48874894|NCT01086384|157378975|FG000|Treatment Period|Withdrawal by Subject|0|||
48874895|NCT01086384|157378976|FG001|Treatment Period|Withdrawal by Subject|53|||
48874896|NCT01086384|157378977|FG002|Treatment Period|Withdrawal by Subject|55|||
48874897|NCT01086384|157378975|FG000|Treatment Period|Protocol Violation|0|||
48874898|NCT01086384|157378976|FG001|Treatment Period|Protocol Violation|26|||
48874899|NCT01086384|157378977|FG002|Treatment Period|Protocol Violation|17|||
48874900|NCT01086384|157378975|FG000|Treatment Period|Lack of Efficacy|0|||
48874901|NCT01086384|157378976|FG001|Treatment Period|Lack of Efficacy|22|||
48874902|NCT01086384|157378977|FG002|Treatment Period|Lack of Efficacy|13|||
48874903|NCT01086384|157378975|FG000|Treatment Period|Adverse Event|0|||
48874904|NCT01086384|157378976|FG001|Treatment Period|Adverse Event|19|||
48874905|NCT01086384|157378977|FG002|Treatment Period|Adverse Event|15|||
48874906|NCT01086384|157378975|FG000|Treatment Period|Lost to Follow-up|0|||
48874907|NCT01086384|157378976|FG001|Treatment Period|Lost to Follow-up|11|||
48874908|NCT01086384|157378977|FG002|Treatment Period|Lost to Follow-up|9|||
48874909|NCT01086384|157378975|FG000|Treatment Period|Physician Decision|0|||
48874910|NCT01086384|157378976|FG001|Treatment Period|Physician Decision|9|||
48874911|NCT01086384|157378977|FG002|Treatment Period|Physician Decision|6|||
48874912|NCT01086384|157378975|FG000|Treatment Period|Study Closed/Terminated|0|||
48874913|NCT01086384|157378976|FG001|Treatment Period|Study Closed/Terminated|7|||
48874914|NCT01086384|157378977|FG002|Treatment Period|Study Closed/Terminated|8|||
48874915|NCT01086384|157378975|FG000|Treatment Period|Protocol-Defined Stopping Criteria|0|||
48874916|NCT01086384|157378976|FG001|Treatment Period|Protocol-Defined Stopping Criteria|0|||
48874917|NCT01086384|157378977|FG002|Treatment Period|Protocol-Defined Stopping Criteria|1|||
48874918|NCT01086384|157378975|FG000|Treatment Period|Received Treatment in Error|0|||
48874919|NCT01086384|157378976|FG001|Treatment Period|Received Treatment in Error|1|||
48874920|NCT01086384|157378977|FG002|Treatment Period|Received Treatment in Error|0|||
48874921|NCT01313624|157378982|FG000|Double-Blind Phase|Adverse Event|27|||
48874922|NCT01313624|157378983|FG001|Double-Blind Phase|Adverse Event|4|||
48874923|NCT01313624|157378982|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
48874924|NCT01313624|157378983|FG001|Double-Blind Phase|Withdrawal by Subject|4|||
48874925|NCT01313624|157378982|FG000|Double-Blind Phase|Lost to Follow-up|0|||
48874926|NCT01313624|157378983|FG001|Double-Blind Phase|Lost to Follow-up|2|||
48874927|NCT01313624|157378982|FG000|Double-Blind Phase|Physician Decision|1|||
48874928|NCT01313624|157378983|FG001|Double-Blind Phase|Physician Decision|0|||
48874929|NCT01313624|157378982|FG000|Double-Blind Phase|Lack of Efficacy|1|||
48874930|NCT01313624|157378983|FG001|Double-Blind Phase|Lack of Efficacy|0|||
48874931|NCT01313624|157378982|FG000|Open-Label Phase|Adverse Event|1|||
49017992|NCT04128007|157902428|FG000|Overall Study|Withdrawal by Subject|9|||
49017993|NCT04128007|157902429|FG001|Overall Study|Withdrawal by Subject|6|||
49017994|NCT04128007|157902428|FG000|Overall Study|Protocol Violation|1|||
48874932|NCT01313624|157378983|FG001|Open-Label Phase|Adverse Event|10|||
48874933|NCT01313624|157378982|FG000|Open-Label Phase|Withdrawal by Subject|2|||
48874934|NCT01313624|157378983|FG001|Open-Label Phase|Withdrawal by Subject|2|||
48874935|NCT01313624|157378982|FG000|Open-Label Phase|Lost to Follow-up|1|||
48874936|NCT01313624|157378983|FG001|Open-Label Phase|Lost to Follow-up|1|||
48874937|NCT01776008|157378984|FG000|Overall Study|ineligible|2|||
48874938|NCT02804399|157378987|FG000|Period 2|Adverse Event|0|||
48874939|NCT02804399|157378988|FG001|Period 2|Adverse Event|1|||
48874940|NCT01163474|157378989|FG000|Overall Study|Withdrawal by Subject|1|||
48874941|NCT01163474|157378989|FG000|Overall Study|Tech barriers to videoteleconference vis|12|||
48874942|NCT01163474|157378989|FG000|Overall Study|Lost to Follow-up|3|||
49017995|NCT04128007|157902429|FG001|Overall Study|Protocol Violation|0|||
49017996|NCT04128007|157902428|FG000|Overall Study|Lost to Follow-up|8|||
49017997|NCT04128007|157902429|FG001|Overall Study|Lost to Follow-up|7|||
49017998|NCT04128007|157902428|FG000|Overall Study|Adverse Event|5|||
49017999|NCT04128007|157902429|FG001|Overall Study|Adverse Event|2|||
49018000|NCT04128007|157902428|FG000|Overall Study|Not reported|0|||
49018001|NCT04128007|157902429|FG001|Overall Study|Not reported|2|||
49018002|NCT02978326|157902430|FG000|Part B (Up to 45 Days)|Adverse Event|0|||
49018003|NCT02978326|157902431|FG001|Part B (Up to 45 Days)|Adverse Event|0|||
49018004|NCT02978326|157902432|FG002|Part B (Up to 45 Days)|Adverse Event|1|||
49018005|NCT02978326|157902430|FG000|Part B (Up to 45 Days)|Lost to Follow-up|0|||
49018006|NCT02978326|157902431|FG001|Part B (Up to 45 Days)|Lost to Follow-up|3|||
49018007|NCT02978326|157902432|FG002|Part B (Up to 45 Days)|Lost to Follow-up|0|||
49018008|NCT02978326|157902430|FG000|Part B (Up to 45 Days)|Non-compliance|0|||
49018009|NCT02978326|157902431|FG001|Part B (Up to 45 Days)|Non-compliance|2|||
49018010|NCT02978326|157902432|FG002|Part B (Up to 45 Days)|Non-compliance|0|||
49018011|NCT02978326|157902430|FG000|Part B (Up to 45 Days)|Withdrawal by Subject|0|||
49018012|NCT02978326|157902431|FG001|Part B (Up to 45 Days)|Withdrawal by Subject|2|||
49018013|NCT02978326|157902432|FG002|Part B (Up to 45 Days)|Withdrawal by Subject|3|||
49018014|NCT01709383|157902435|FG000|Overall Study|Lost to Follow-up|1|||
49018015|NCT01709383|157902436|FG001|Overall Study|Lost to Follow-up|0|||
49018016|NCT03402893|157902437|FG000|Overall Study|Withdrawal by Subject|1|||
49018017|NCT01411995|157902438|FG000|Overall Study|Failed IUD insertion|0|||
49018018|NCT01411995|157902439|FG001|Overall Study|Failed IUD insertion|1|||
49018019|NCT00319956|157902440|FG000|Overall Study|Death|20|||
49018020|NCT00319956|157902441|FG001|Overall Study|Death|24|||
49018021|NCT00788957|157902442|FG000|Part 1|Death|8|||
49018022|NCT00788957|157902443|FG001|Part 1|Death|0|||
49018023|NCT00788957|157902444|FG002|Part 1|Death|0|||
49018024|NCT00788957|157902445|FG003|Part 1|Death|0|||
49018025|NCT00788957|157902446|FG004|Part 1|Death|0|||
49018026|NCT00788957|157902447|FG005|Part 1|Death|0|||
49018027|NCT00788957|157902442|FG000|Part 1|Lost to Follow-up|1|||
49018028|NCT00788957|157902443|FG001|Part 1|Lost to Follow-up|0|||
49018029|NCT00788957|157902444|FG002|Part 1|Lost to Follow-up|0|||
49018030|NCT00788957|157902445|FG003|Part 1|Lost to Follow-up|0|||
49018031|NCT00788957|157902446|FG004|Part 1|Lost to Follow-up|0|||
49018032|NCT00788957|157902447|FG005|Part 1|Lost to Follow-up|0|||
49018033|NCT00788957|157902442|FG000|Part 2|Withdrawal by Subject|0|||
49018034|NCT00788957|157902443|FG001|Part 2|Withdrawal by Subject|9|||
49018035|NCT00788957|157902444|FG002|Part 2|Withdrawal by Subject|5|||
49018036|NCT00788957|157902445|FG003|Part 2|Withdrawal by Subject|3|||
49018037|NCT00788957|157902446|FG004|Part 2|Withdrawal by Subject|0|||
49018038|NCT00788957|157902447|FG005|Part 2|Withdrawal by Subject|0|||
49018039|NCT00788957|157902442|FG000|Part 2|Death|0|||
49018040|NCT00788957|157902443|FG001|Part 2|Death|32|||
49018041|NCT00788957|157902444|FG002|Part 2|Death|35|||
49018042|NCT00788957|157902445|FG003|Part 2|Death|37|||
49018043|NCT00788957|157902446|FG004|Part 2|Death|0|||
49018044|NCT00788957|157902447|FG005|Part 2|Death|0|||
49018045|NCT00788957|157902442|FG000|Part 2|Lost to Follow-up|0|||
49018046|NCT00788957|157902443|FG001|Part 2|Lost to Follow-up|0|||
49018047|NCT00788957|157902444|FG002|Part 2|Lost to Follow-up|3|||
49018048|NCT00788957|157902445|FG003|Part 2|Lost to Follow-up|0|||
49018049|NCT00788957|157902446|FG004|Part 2|Lost to Follow-up|0|||
49018050|NCT00788957|157902447|FG005|Part 2|Lost to Follow-up|0|||
49018051|NCT00788957|157902442|FG000|Part 2|On-study at time of data cut-off|0|||
49018052|NCT00788957|157902443|FG001|Part 2|On-study at time of data cut-off|1|||
49018053|NCT00788957|157902444|FG002|Part 2|On-study at time of data cut-off|1|||
49018054|NCT00788957|157902445|FG003|Part 2|On-study at time of data cut-off|1|||
49018055|NCT00788957|157902446|FG004|Part 2|On-study at time of data cut-off|0|||
49018056|NCT00788957|157902447|FG005|Part 2|On-study at time of data cut-off|0|||
49018057|NCT00788957|157902442|FG000|Part 3|Withdrawal by Subject|0|||
49018058|NCT00788957|157902443|FG001|Part 3|Withdrawal by Subject|0|||
49018059|NCT00788957|157902444|FG002|Part 3|Withdrawal by Subject|0|||
49018060|NCT00788957|157902445|FG003|Part 3|Withdrawal by Subject|0|||
49018061|NCT00788957|157902446|FG004|Part 3|Withdrawal by Subject|0|||
49018062|NCT00788957|157902447|FG005|Part 3|Withdrawal by Subject|2|||
49018063|NCT00788957|157902442|FG000|Part 3|Death|0|||
49018064|NCT00788957|157902443|FG001|Part 3|Death|0|||
49018065|NCT00788957|157902444|FG002|Part 3|Death|0|||
49018066|NCT00788957|157902445|FG003|Part 3|Death|0|||
49018067|NCT00788957|157902446|FG004|Part 3|Death|8|||
49018068|NCT00788957|157902447|FG005|Part 3|Death|8|||
49018069|NCT00788957|157902442|FG000|Part 3|On-study at time of data cut-off|0|||
49018070|NCT00788957|157902443|FG001|Part 3|On-study at time of data cut-off|0|||
49018071|NCT00788957|157902444|FG002|Part 3|On-study at time of data cut-off|0|||
49018072|NCT00788957|157902445|FG003|Part 3|On-study at time of data cut-off|0|||
49018073|NCT00788957|157902446|FG004|Part 3|On-study at time of data cut-off|1|||
49018074|NCT00788957|157902447|FG005|Part 3|On-study at time of data cut-off|0|||
49018075|NCT02545998|157902448|FG000|Overall Study|Lost to Follow-up|12|||
49018076|NCT02545998|157902449|FG001|Overall Study|Lost to Follow-up|3|||
49018077|NCT02545998|157902448|FG000|Overall Study|Withdrawal by Subject|3|||
49018078|NCT02545998|157902449|FG001|Overall Study|Withdrawal by Subject|2|||
49018079|NCT02486796|157902450|FG000|Overall Study|Withdrawal by Subject|1|||
49018080|NCT02486796|157902451|FG001|Overall Study|Withdrawal by Subject|1|||
49018081|NCT02486796|157902450|FG000|Overall Study|Physician Decision|1|||
49018082|NCT02486796|157902451|FG001|Overall Study|Physician Decision|0|||
49018083|NCT03387098|157902452|FG000|Overall Study|progressive disease|1|||
49018084|NCT03387098|157902452|FG000|Overall Study|Withdrawal by Subject|2|||
49018085|NCT03387098|157902452|FG000|Overall Study|study terminated by sponsor|1|||
49018086|NCT00662129|157902453|FG000|Overall Study|Protocol Violation|1|||
49018087|NCT00662129|157902453|FG000|Overall Study|Cancel prior to beginning treatment|1|||
49018088|NCT00662129|157902453|FG000|Overall Study|Ineligible|1|||
49018089|NCT02568384|157902454|FG000|Overall Study|Mobile devices incompatible with App|2|||
49018090|NCT00796510|157902456|FG000|Overall Study|Death|1|||
49018091|NCT00796510|157902457|FG001|Overall Study|Death|0|||
49018092|NCT00796510|157902456|FG000|Overall Study|Study Terminated|2|||
49018093|NCT00796510|157902457|FG001|Overall Study|Study Terminated|0|||
49018094|NCT00203307|157902458|FG000|First Intervention|Adverse Event|2|||
49018095|NCT00203307|157902459|FG001|First Intervention|Adverse Event|0|||
49018096|NCT01734772|157902460|FG000|Overall Study|Adverse Event|1|||
49018097|NCT01734772|157902461|FG001|Overall Study|Adverse Event|2|||
49018098|NCT01734772|157902460|FG000|Overall Study|Withdrawal by Subject|0|||
49018099|NCT01734772|157902461|FG001|Overall Study|Withdrawal by Subject|1|||
49018100|NCT02579096|157902462|FG000|Phase 1, Weeks 0 - 24|Side effects with study medications|10|||
49018101|NCT02579096|157902463|FG001|Phase 1, Weeks 0 - 24|Side effects with study medications|6|||
49018102|NCT02579096|157902462|FG000|Phase 1, Weeks 0 - 24|Physician Decision|2|||
49018103|NCT02579096|157902463|FG001|Phase 1, Weeks 0 - 24|Physician Decision|1|||
49018104|NCT02579096|157902462|FG000|Phase 1, Weeks 0 - 24|Withdrawal by Subject|32|||
49018105|NCT02579096|157902463|FG001|Phase 1, Weeks 0 - 24|Withdrawal by Subject|36|||
49018106|NCT02579096|157902462|FG000|Phase 1, Weeks 0 - 24|Lost to Follow-up|9|||
49018107|NCT02579096|157902463|FG001|Phase 1, Weeks 0 - 24|Lost to Follow-up|4|||
49018108|NCT02579096|157902462|FG000|Phase 1, Weeks 0 - 24|Other reasons|4|||
49018109|NCT02579096|157902463|FG001|Phase 1, Weeks 0 - 24|Other reasons|3|||
49018110|NCT02579096|157902462|FG000|Phase 2, Weeks 25 - 48|Death|2|||
49018111|NCT02579096|157902463|FG001|Phase 2, Weeks 25 - 48|Death|4|||
49018112|NCT02579096|157902462|FG000|Phase 2, Weeks 25 - 48|Side effects with study medications|3|||
49018113|NCT02579096|157902463|FG001|Phase 2, Weeks 25 - 48|Side effects with study medications|1|||
49018114|NCT02579096|157902462|FG000|Phase 2, Weeks 25 - 48|Physician Decision|4|||
49018115|NCT02579096|157902463|FG001|Phase 2, Weeks 25 - 48|Physician Decision|0|||
49018116|NCT02579096|157902462|FG000|Phase 2, Weeks 25 - 48|Withdrawal by Subject|9|||
49018117|NCT02579096|157902463|FG001|Phase 2, Weeks 25 - 48|Withdrawal by Subject|12|||
49018118|NCT02579096|157902462|FG000|Phase 2, Weeks 25 - 48|Lost to Follow-up|4|||
49018119|NCT02579096|157902463|FG001|Phase 2, Weeks 25 - 48|Lost to Follow-up|9|||
49018120|NCT02579096|157902462|FG000|Phase 2, Weeks 25 - 48|Other reasons|0|||
49018121|NCT02579096|157902463|FG001|Phase 2, Weeks 25 - 48|Other reasons|5|||
49018122|NCT02579096|157902462|FG000|Phase 3, Weeks 49 - 72|Death|3|||
49018123|NCT02579096|157902463|FG001|Phase 3, Weeks 49 - 72|Death|2|||
49018124|NCT02579096|157902462|FG000|Phase 3, Weeks 49 - 72|Side effects with study medications|0|||
49018125|NCT02579096|157902463|FG001|Phase 3, Weeks 49 - 72|Side effects with study medications|1|||
49018126|NCT02579096|157902462|FG000|Phase 3, Weeks 49 - 72|Physician Decision|0|||
49018127|NCT02579096|157902463|FG001|Phase 3, Weeks 49 - 72|Physician Decision|5|||
49018128|NCT02579096|157902462|FG000|Phase 3, Weeks 49 - 72|Withdrawal by Subject|6|||
49018129|NCT02579096|157902463|FG001|Phase 3, Weeks 49 - 72|Withdrawal by Subject|4|||
49018130|NCT02579096|157902462|FG000|Phase 3, Weeks 49 - 72|Lost to Follow-up|10|||
49018131|NCT02579096|157902463|FG001|Phase 3, Weeks 49 - 72|Lost to Follow-up|5|||
49018132|NCT02579096|157902462|FG000|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|0|||
49018133|NCT02579096|157902463|FG001|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|1|||
49018134|NCT02579096|157902462|FG000|Phase 3, Weeks 49 - 72|Other reasons|3|||
49018135|NCT02579096|157902463|FG001|Phase 3, Weeks 49 - 72|Other reasons|0|||
49018136|NCT00522457|157902467|FG000|Overall Study|Due to disease progression|16|||
49018137|NCT00522457|157902467|FG000|Overall Study|Adverse Event|2|||
49018138|NCT00601484|157902472|FG000|Overall Study|Adverse Event|0|||
49018139|NCT00601484|157902473|FG001|Overall Study|Adverse Event|1|||
49018140|NCT00601484|157902472|FG000|Overall Study|Lost to Follow-up|4|||
49018141|NCT00601484|157902473|FG001|Overall Study|Lost to Follow-up|3|||
49018142|NCT00601484|157902472|FG000|Overall Study|Lack of Efficacy|0|||
49018143|NCT00601484|157902473|FG001|Overall Study|Lack of Efficacy|2|||
49018144|NCT00601484|157902472|FG000|Overall Study|Withdrawal by Subject|1|||
49018145|NCT00601484|157902473|FG001|Overall Study|Withdrawal by Subject|1|||
49018146|NCT00601484|157902472|FG000|Overall Study|Randomized, but not treated|0|||
49018147|NCT00601484|157902473|FG001|Overall Study|Randomized, but not treated|1|||
48677161|NCT01368081|156669225|FG003|Overall Study|Protocol Violation|0|||
48677162|NCT01368081|156669226|FG004|Overall Study|Protocol Violation|0|||
49018148|NCT01475474|157902474|FG000|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4|||
49018149|NCT01475474|157902474|FG000|Baseline Period - 4 Weeks|Withdrawal by Subject|2|||
49018150|NCT02343120|157902475|FG000|Part 1: Dose Escalation|Sponsor decision|1|||
49018151|NCT02343120|157902476|FG001|Part 1: Dose Escalation|Sponsor decision|2|||
49018152|NCT02343120|157902477|FG002|Part 1: Dose Escalation|Sponsor decision|3|||
49018153|NCT02343120|157902478|FG003|Part 1: Dose Escalation|Sponsor decision|2|||
49018154|NCT02343120|157902479|FG004|Part 1: Dose Escalation|Sponsor decision|0|||
49018155|NCT02343120|157902475|FG000|Part 1: Dose Escalation|Death|1|||
49018156|NCT02343120|157902476|FG001|Part 1: Dose Escalation|Death|2|||
49018157|NCT02343120|157902477|FG002|Part 1: Dose Escalation|Death|2|||
49018158|NCT02343120|157902478|FG003|Part 1: Dose Escalation|Death|2|||
49018159|NCT02343120|157902479|FG004|Part 1: Dose Escalation|Death|1|||
49018160|NCT02343120|157902475|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
49018161|NCT02343120|157902476|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
49018162|NCT02343120|157902477|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
49018163|NCT02343120|157902478|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
49018164|NCT02343120|157902479|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
49018165|NCT02343120|157902475|FG000|Part 2: Expansion|Sponsor decision|0|||
49018166|NCT02343120|157902476|FG001|Part 2: Expansion|Sponsor decision|0|||
49018167|NCT02343120|157902477|FG002|Part 2: Expansion|Sponsor decision|0|||
49018168|NCT02343120|157902478|FG003|Part 2: Expansion|Sponsor decision|165|||
49018169|NCT02343120|157902479|FG004|Part 2: Expansion|Sponsor decision|67|||
49018170|NCT02343120|157902475|FG000|Part 2: Expansion|Death|0|||
49018171|NCT02343120|157902476|FG001|Part 2: Expansion|Death|0|||
49018172|NCT02343120|157902477|FG002|Part 2: Expansion|Death|0|||
49018173|NCT02343120|157902478|FG003|Part 2: Expansion|Death|74|||
49018174|NCT02343120|157902479|FG004|Part 2: Expansion|Death|17|||
49018175|NCT02343120|157902475|FG000|Part 2: Expansion|Withdrawal by Subject|0|||
49018176|NCT02343120|157902476|FG001|Part 2: Expansion|Withdrawal by Subject|0|||
49018177|NCT02343120|157902477|FG002|Part 2: Expansion|Withdrawal by Subject|0|||
49018178|NCT02343120|157902478|FG003|Part 2: Expansion|Withdrawal by Subject|28|||
49018179|NCT02343120|157902479|FG004|Part 2: Expansion|Withdrawal by Subject|2|||
49018180|NCT02343120|157902475|FG000|Part 2: Expansion|Lost to Follow-up|0|||
49018181|NCT02343120|157902476|FG001|Part 2: Expansion|Lost to Follow-up|0|||
49018182|NCT02343120|157902477|FG002|Part 2: Expansion|Lost to Follow-up|0|||
49018183|NCT02343120|157902478|FG003|Part 2: Expansion|Lost to Follow-up|5|||
49018184|NCT02343120|157902479|FG004|Part 2: Expansion|Lost to Follow-up|2|||
49018185|NCT02343120|157902475|FG000|Part 2: Expansion|Other|0|||
49018186|NCT02343120|157902476|FG001|Part 2: Expansion|Other|0|||
49018187|NCT02343120|157902477|FG002|Part 2: Expansion|Other|0|||
49018188|NCT02343120|157902478|FG003|Part 2: Expansion|Other|1|||
49018189|NCT02343120|157902479|FG004|Part 2: Expansion|Other|5|||
49018190|NCT02343120|157902475|FG000|Part 2: Expansion|Adverse Event|0|||
49018191|NCT02343120|157902476|FG001|Part 2: Expansion|Adverse Event|0|||
49018192|NCT02343120|157902477|FG002|Part 2: Expansion|Adverse Event|0|||
49018193|NCT02343120|157902478|FG003|Part 2: Expansion|Adverse Event|1|||
49018194|NCT02343120|157902479|FG004|Part 2: Expansion|Adverse Event|1|||
49018195|NCT02928848|157902481|FG000|Arm 2|Withdrawal by Subject|1|||
49018196|NCT02928848|157902482|FG001|Arm 2|Withdrawal by Subject|0|||
49018197|NCT00663871|157902485|FG000|Overall Study|Lost to Follow-up|5|||
49018198|NCT00663871|157902486|FG001|Overall Study|Lost to Follow-up|5|||
49018199|NCT00663871|157902485|FG000|Overall Study|Withdrawal by Subject|5|||
49018200|NCT00663871|157902486|FG001|Overall Study|Withdrawal by Subject|2|||
49018201|NCT00743197|157902489|FG000|Overall Study|Study terminated due to departure of PI.|1|||
49018202|NCT00743197|157902490|FG001|Overall Study|Study terminated due to departure of PI.|2|||
49018203|NCT03997448|157904327|FG000|Study Treatment|Disease Progression|1|||
49018204|NCT03997448|157904327|FG000|Study Treatment|Symptomatic Deterioration|1|||
49018205|NCT03997448|157904327|FG000|Follow up|Death|2|||
49018206|NCT03997448|157904327|FG000|Follow up|study terminated|1|||
49018207|NCT04582266|157904328|FG000|Overall Study|Lost to Follow-up|7|||
49018208|NCT04582266|157904329|FG001|Overall Study|Lost to Follow-up|5|||
49018209|NCT04582266|157904328|FG000|Overall Study|Withdrawal by Subject|1|||
49018210|NCT04582266|157904329|FG001|Overall Study|Withdrawal by Subject|0|||
49018211|NCT04582266|157904328|FG000|Overall Study|Logistical and Personnel Constraints at Time of Infusion|1|||
49018212|NCT04582266|157904329|FG001|Overall Study|Logistical and Personnel Constraints at Time of Infusion|0|||
49018213|NCT01341639|157904330|FG000|Infant Series|Protocol Violation|1|||
49018214|NCT01341639|157904331|FG001|Infant Series|Protocol Violation|0|||
49018215|NCT01341639|157904330|FG000|Infant Series|Not Vaccinated|0|||
49018216|NCT01341639|157904331|FG001|Infant Series|Not Vaccinated|1|||
49018217|NCT01341639|157904330|FG000|Infant Series|Adverse Event|0|||
49018218|NCT01341639|157904331|FG001|Infant Series|Adverse Event|5|||
49018219|NCT01341639|157904330|FG000|Infant Series|Withdrawal by Subject|11|||
49018220|NCT01341639|157904331|FG001|Infant Series|Withdrawal by Subject|8|||
49018221|NCT01341639|157904330|FG000|Infant Series|Lost to Follow-up|0|||
49018222|NCT01341639|157904331|FG001|Infant Series|Lost to Follow-up|2|||
49018223|NCT01341639|157904330|FG000|Infant Series|Site 0048 Participants|17|||
49018224|NCT01341639|157904331|FG001|Infant Series|Site 0048 Participants|16|||
49018225|NCT01341639|157904330|FG000|Interim Period|Withdrawal by Subject|6|||
49018226|NCT01341639|157904331|FG001|Interim Period|Withdrawal by Subject|7|||
49018227|NCT01341639|157904330|FG000|Interim Period|Lost to Follow-up|2|||
49018228|NCT01341639|157904331|FG001|Interim Period|Lost to Follow-up|0|||
49018229|NCT01341639|157904330|FG000|Interim Period|Physician Decision|0|||
49018230|NCT01341639|157904331|FG001|Interim Period|Physician Decision|1|||
49018231|NCT01341639|157904330|FG000|Interim Period|Protocol Violation|0|||
49018232|NCT01341639|157904331|FG001|Interim Period|Protocol Violation|1|||
49018233|NCT01341639|157904330|FG000|Post-Treatment|Withdrawal by Subject|0|||
49018234|NCT01341639|157904331|FG001|Post-Treatment|Withdrawal by Subject|1|||
49018235|NCT01341639|157904330|FG000|Post-Treatment|Adverse Event|0|||
49018236|NCT01341639|157904331|FG001|Post-Treatment|Adverse Event|2|||
49018237|NCT03083483|157904333|FG000|Overall Study|Adverse Event|1|||
49018238|NCT03083483|157904334|FG001|Overall Study|Adverse Event|1|||
49018239|NCT03083483|157904335|FG002|Overall Study|Adverse Event|1|||
49018240|NCT03083483|157904333|FG000|Overall Study|Lost to Follow-up|2|||
49018241|NCT03083483|157904334|FG001|Overall Study|Lost to Follow-up|1|||
49018242|NCT03083483|157904335|FG002|Overall Study|Lost to Follow-up|1|||
49018243|NCT03083483|157904333|FG000|Overall Study|technological issues|1|||
49018244|NCT03083483|157904334|FG001|Overall Study|technological issues|0|||
49018245|NCT03083483|157904335|FG002|Overall Study|technological issues|1|||
49018246|NCT00738673|157904341|FG000|Overall Study|Adverse Event|1|||
49018247|NCT00738673|157904342|FG001|Overall Study|Adverse Event|0|||
49018248|NCT00738673|157904341|FG000|Overall Study|Lack of Efficacy|19|||
49018249|NCT00738673|157904342|FG001|Overall Study|Lack of Efficacy|8|||
49018250|NCT00738673|157904341|FG000|Overall Study|Protocol Violation|1|||
49018251|NCT00738673|157904342|FG001|Overall Study|Protocol Violation|2|||
49018252|NCT00738673|157904341|FG000|Overall Study|Withdrawal by Subject|3|||
49018253|NCT00738673|157904342|FG001|Overall Study|Withdrawal by Subject|1|||
49018254|NCT01799590|157904344|FG000|Overall Study|Adverse Event|13|||
49018255|NCT01799590|157904345|FG001|Overall Study|Adverse Event|7|||
49018256|NCT01799590|157904346|FG002|Overall Study|Adverse Event|5|||
49018257|NCT01799590|157904344|FG000|Overall Study|Pregnancy|2|||
49018258|NCT01799590|157904345|FG001|Overall Study|Pregnancy|0|||
49018259|NCT01799590|157904346|FG002|Overall Study|Pregnancy|0|||
49018260|NCT01799590|157904344|FG000|Overall Study|Lack of Efficacy|3|||
49018261|NCT01799590|157904345|FG001|Overall Study|Lack of Efficacy|1|||
49018262|NCT01799590|157904346|FG002|Overall Study|Lack of Efficacy|3|||
49018263|NCT01799590|157904344|FG000|Overall Study|Participants convenience|4|||
49018264|NCT01799590|157904345|FG001|Overall Study|Participants convenience|4|||
49018265|NCT01799590|157904346|FG002|Overall Study|Participants convenience|2|||
49018266|NCT01799590|157904344|FG000|Overall Study|Aggravation of complications|0|||
49018267|NCT01799590|157904345|FG001|Overall Study|Aggravation of complications|1|||
49018268|NCT01799590|157904346|FG002|Overall Study|Aggravation of complications|1|||
49018269|NCT01799590|157904344|FG000|Overall Study|Using drugs with restricted days of use|0|||
49018270|NCT01799590|157904345|FG001|Overall Study|Using drugs with restricted days of use|3|||
49018271|NCT01799590|157904346|FG002|Overall Study|Using drugs with restricted days of use|2|||
49018272|NCT01799590|157904344|FG000|Overall Study|Use of prohibited concomitant drugs|1|||
49018273|NCT01799590|157904345|FG001|Overall Study|Use of prohibited concomitant drugs|0|||
49018274|NCT01799590|157904346|FG002|Overall Study|Use of prohibited concomitant drugs|0|||
49018275|NCT01799590|157904344|FG000|Overall Study|Other|3|||
49018276|NCT01799590|157904345|FG001|Overall Study|Other|0|||
49018277|NCT01799590|157904346|FG002|Overall Study|Other|1|||
49018278|NCT02006706|157904347|FG000|Overall Study|Lost to Follow-up|1|||
49018279|NCT00582036|157904348|FG000|Overall Study|Withdrawal by Subject|0|||
49018280|NCT00582036|157904349|FG001|Overall Study|Withdrawal by Subject|1|||
49018281|NCT03734237|157904350|FG000|Overall Study|Lost to Follow-up|1|||
49018282|NCT03734237|157904351|FG001|Overall Study|Lost to Follow-up|3|||
49018283|NCT03734237|157904352|FG002|Overall Study|Lost to Follow-up|0|||
49018284|NCT03734237|157904350|FG000|Overall Study|Withdrawal by Subject|7|||
49018285|NCT03734237|157904351|FG001|Overall Study|Withdrawal by Subject|9|||
49018286|NCT03734237|157904352|FG002|Overall Study|Withdrawal by Subject|10|||
49018287|NCT02711956|157904353|FG000|Overall Study|Adverse Event|0|||
49018288|NCT02711956|157904354|FG001|Overall Study|Adverse Event|0|||
49018289|NCT02711956|157904355|FG002|Overall Study|Adverse Event|0|||
49018290|NCT02711956|157904356|FG003|Overall Study|Adverse Event|1|||
49018291|NCT02711956|157904357|FG004|Overall Study|Adverse Event|2|||
49018292|NCT02711956|157904358|FG005|Overall Study|Adverse Event|0|||
49018293|NCT02711956|157904359|FG006|Overall Study|Adverse Event|0|||
49018294|NCT02711956|157904360|FG007|Overall Study|Adverse Event|1|||
49018295|NCT02711956|157904361|FG008|Overall Study|Adverse Event|1|||
49018296|NCT02711956|157904362|FG009|Overall Study|Adverse Event|1|||
49018297|NCT02711956|157904363|FG010|Overall Study|Adverse Event|1|||
49018298|NCT02711956|157904364|FG011|Overall Study|Adverse Event|0|||
49018299|NCT02711956|157904365|FG012|Overall Study|Adverse Event|0|||
49018300|NCT02711956|157904366|FG013|Overall Study|Adverse Event|0|||
49018301|NCT02711956|157904367|FG014|Overall Study|Adverse Event|2|||
49018302|NCT02711956|157904353|FG000|Overall Study|Physician Decision|0|||
49018303|NCT02711956|157904354|FG001|Overall Study|Physician Decision|0|||
49018304|NCT02711956|157904355|FG002|Overall Study|Physician Decision|0|||
49018305|NCT02711956|157904356|FG003|Overall Study|Physician Decision|2|||
49018306|NCT02711956|157904357|FG004|Overall Study|Physician Decision|0|||
49018307|NCT02711956|157904358|FG005|Overall Study|Physician Decision|0|||
49018308|NCT02711956|157904359|FG006|Overall Study|Physician Decision|0|||
49018309|NCT02711956|157904360|FG007|Overall Study|Physician Decision|0|||
49018310|NCT02711956|157904361|FG008|Overall Study|Physician Decision|0|||
49018311|NCT02711956|157904362|FG009|Overall Study|Physician Decision|0|||
49018312|NCT02711956|157904363|FG010|Overall Study|Physician Decision|0|||
49018313|NCT02711956|157904364|FG011|Overall Study|Physician Decision|0|||
49018314|NCT02711956|157904365|FG012|Overall Study|Physician Decision|0|||
49018315|NCT02711956|157904366|FG013|Overall Study|Physician Decision|0|||
49018316|NCT02711956|157904367|FG014|Overall Study|Physician Decision|0|||
49018317|NCT02711956|157904353|FG000|Overall Study|Withdrawal by Subject|0|||
49018318|NCT02711956|157904354|FG001|Overall Study|Withdrawal by Subject|0|||
49018319|NCT02711956|157904355|FG002|Overall Study|Withdrawal by Subject|0|||
49018320|NCT02711956|157904356|FG003|Overall Study|Withdrawal by Subject|0|||
49018321|NCT02711956|157904357|FG004|Overall Study|Withdrawal by Subject|0|||
49018322|NCT02711956|157904358|FG005|Overall Study|Withdrawal by Subject|0|||
49018323|NCT02711956|157904359|FG006|Overall Study|Withdrawal by Subject|1|||
49018324|NCT02711956|157904360|FG007|Overall Study|Withdrawal by Subject|0|||
49018325|NCT02711956|157904361|FG008|Overall Study|Withdrawal by Subject|0|||
49018326|NCT02711956|157904362|FG009|Overall Study|Withdrawal by Subject|0|||
49018327|NCT02711956|157904363|FG010|Overall Study|Withdrawal by Subject|0|||
49018328|NCT02711956|157904364|FG011|Overall Study|Withdrawal by Subject|1|||
49018329|NCT02711956|157904365|FG012|Overall Study|Withdrawal by Subject|6|||
49018330|NCT02711956|157904366|FG013|Overall Study|Withdrawal by Subject|0|||
49018331|NCT02711956|157904367|FG014|Overall Study|Withdrawal by Subject|1|||
49018332|NCT02711956|157904353|FG000|Overall Study|Clinical progression|1|||
49018333|NCT02711956|157904354|FG001|Overall Study|Clinical progression|0|||
49018334|NCT02711956|157904355|FG002|Overall Study|Clinical progression|0|||
49018335|NCT02711956|157904356|FG003|Overall Study|Clinical progression|0|||
49018336|NCT02711956|157904357|FG004|Overall Study|Clinical progression|0|||
49018337|NCT02711956|157904358|FG005|Overall Study|Clinical progression|0|||
49018338|NCT02711956|157904359|FG006|Overall Study|Clinical progression|1|||
49018339|NCT02711956|157904360|FG007|Overall Study|Clinical progression|0|||
49018340|NCT02711956|157904361|FG008|Overall Study|Clinical progression|1|||
49018341|NCT02711956|157904362|FG009|Overall Study|Clinical progression|0|||
49018342|NCT02711956|157904363|FG010|Overall Study|Clinical progression|0|||
49018343|NCT02711956|157904364|FG011|Overall Study|Clinical progression|2|||
49018344|NCT02711956|157904365|FG012|Overall Study|Clinical progression|4|||
49018345|NCT02711956|157904366|FG013|Overall Study|Clinical progression|1|||
49018346|NCT02711956|157904367|FG014|Overall Study|Clinical progression|1|||
49018347|NCT02711956|157904353|FG000|Overall Study|Radiographic progression|1|||
49018348|NCT02711956|157904354|FG001|Overall Study|Radiographic progression|1|||
49018349|NCT02711956|157904355|FG002|Overall Study|Radiographic progression|2|||
49018350|NCT02711956|157904356|FG003|Overall Study|Radiographic progression|0|||
49018351|NCT02711956|157904357|FG004|Overall Study|Radiographic progression|1|||
49018352|NCT02711956|157904358|FG005|Overall Study|Radiographic progression|0|||
49018353|NCT02711956|157904359|FG006|Overall Study|Radiographic progression|0|||
49018354|NCT02711956|157904360|FG007|Overall Study|Radiographic progression|0|||
49018355|NCT02711956|157904361|FG008|Overall Study|Radiographic progression|2|||
49018356|NCT02711956|157904362|FG009|Overall Study|Radiographic progression|1|||
49018357|NCT02711956|157904363|FG010|Overall Study|Radiographic progression|0|||
49018358|NCT02711956|157904364|FG011|Overall Study|Radiographic progression|5|||
49018359|NCT02711956|157904365|FG012|Overall Study|Radiographic progression|3|||
49018360|NCT02711956|157904366|FG013|Overall Study|Radiographic progression|0|||
49018361|NCT02711956|157904367|FG014|Overall Study|Radiographic progression|1|||
49018362|NCT02711956|157904353|FG000|Overall Study|PSA progression with clinical progression|0|||
49018363|NCT02711956|157904354|FG001|Overall Study|PSA progression with clinical progression|0|||
49018364|NCT02711956|157904355|FG002|Overall Study|PSA progression with clinical progression|0|||
49018365|NCT02711956|157904356|FG003|Overall Study|PSA progression with clinical progression|0|||
49018366|NCT02711956|157904357|FG004|Overall Study|PSA progression with clinical progression|1|||
49018367|NCT02711956|157904358|FG005|Overall Study|PSA progression with clinical progression|0|||
49018368|NCT02711956|157904359|FG006|Overall Study|PSA progression with clinical progression|0|||
49018369|NCT02711956|157904360|FG007|Overall Study|PSA progression with clinical progression|0|||
49018370|NCT02711956|157904361|FG008|Overall Study|PSA progression with clinical progression|0|||
48677163|NCT01368081|156669227|FG005|Overall Study|Protocol Violation|1|||
49018371|NCT02711956|157904362|FG009|Overall Study|PSA progression with clinical progression|0|||
49018372|NCT02711956|157904363|FG010|Overall Study|PSA progression with clinical progression|0|||
49018373|NCT02711956|157904364|FG011|Overall Study|PSA progression with clinical progression|0|||
49018374|NCT02711956|157904365|FG012|Overall Study|PSA progression with clinical progression|1|||
49018375|NCT02711956|157904366|FG013|Overall Study|PSA progression with clinical progression|1|||
48677164|NCT01368081|156669228|FG006|Overall Study|Protocol Violation|0|||
49018376|NCT02711956|157904367|FG014|Overall Study|PSA progression with clinical progression|0|||
49018377|NCT02711956|157904353|FG000|Overall Study|PSA progression with radiographic progression|0|||
49018378|NCT02711956|157904354|FG001|Overall Study|PSA progression with radiographic progression|1|||
49018379|NCT02711956|157904355|FG002|Overall Study|PSA progression with radiographic progression|0|||
49018380|NCT02711956|157904356|FG003|Overall Study|PSA progression with radiographic progression|0|||
49018381|NCT02711956|157904357|FG004|Overall Study|PSA progression with radiographic progression|0|||
49018382|NCT02711956|157904358|FG005|Overall Study|PSA progression with radiographic progression|2|||
49018383|NCT02711956|157904359|FG006|Overall Study|PSA progression with radiographic progression|2|||
49018384|NCT02711956|157904360|FG007|Overall Study|PSA progression with radiographic progression|1|||
49018385|NCT02711956|157904361|FG008|Overall Study|PSA progression with radiographic progression|0|||
49018386|NCT02711956|157904362|FG009|Overall Study|PSA progression with radiographic progression|1|||
49018387|NCT02711956|157904363|FG010|Overall Study|PSA progression with radiographic progression|0|||
49018388|NCT02711956|157904364|FG011|Overall Study|PSA progression with radiographic progression|1|||
49018389|NCT02711956|157904365|FG012|Overall Study|PSA progression with radiographic progression|2|||
49018390|NCT02711956|157904366|FG013|Overall Study|PSA progression with radiographic progression|3|||
49018391|NCT02711956|157904367|FG014|Overall Study|PSA progression with radiographic progression|3|||
49018392|NCT05487456|157904368|FG000|Overall Study|Withdrawal by Subject|0|||
49018393|NCT05487456|157904369|FG001|Overall Study|Withdrawal by Subject|0|||
49018394|NCT05487456|157904370|FG002|Overall Study|Withdrawal by Subject|1|||
49018395|NCT05487456|157904371|FG003|Overall Study|Withdrawal by Subject|0|||
49018396|NCT03294538|157904375|FG000|Overall Study|Adverse Event|0|||
49018397|NCT03294538|157904376|FG001|Overall Study|Adverse Event|1|||
49018398|NCT03294538|157904377|FG002|Overall Study|Adverse Event|1|||
49018399|NCT03294538|157904375|FG000|Overall Study|Lost to Follow-up|1|||
49018400|NCT03294538|157904376|FG001|Overall Study|Lost to Follow-up|0|||
49018401|NCT03294538|157904377|FG002|Overall Study|Lost to Follow-up|0|||
49018402|NCT03294538|157904375|FG000|Overall Study|Outside of Visit Window|4|||
49018403|NCT03294538|157904376|FG001|Overall Study|Outside of Visit Window|4|||
49018404|NCT03294538|157904377|FG002|Overall Study|Outside of Visit Window|1|||
49018405|NCT00958256|157904384|FG000|Overall Study|Adverse Event|3|||
49018406|NCT02322047|157904386|FG000|Overall Study|Physician Decision|1|||
49018407|NCT02322047|157904387|FG001|Overall Study|Physician Decision|0|||
49018408|NCT02322047|157904388|FG002|Overall Study|Physician Decision|0|||
49018409|NCT02322047|157904389|FG003|Overall Study|Physician Decision|0|||
49018410|NCT02322047|157904386|FG000|Overall Study|Withdrawal by Subject|1|||
49018411|NCT02322047|157904387|FG001|Overall Study|Withdrawal by Subject|0|||
49018412|NCT02322047|157904388|FG002|Overall Study|Withdrawal by Subject|0|||
49018413|NCT02322047|157904389|FG003|Overall Study|Withdrawal by Subject|1|||
49018414|NCT02322047|157904386|FG000|Overall Study|Adverse Event|0|||
49018415|NCT02322047|157904387|FG001|Overall Study|Adverse Event|1|||
49018416|NCT02322047|157904388|FG002|Overall Study|Adverse Event|0|||
49018417|NCT02322047|157904389|FG003|Overall Study|Adverse Event|0|||
49018418|NCT02322047|157904386|FG000|Overall Study|Lost to Follow-up|0|||
49018419|NCT02322047|157904387|FG001|Overall Study|Lost to Follow-up|0|||
49018420|NCT02322047|157904388|FG002|Overall Study|Lost to Follow-up|1|||
49018421|NCT02322047|157904389|FG003|Overall Study|Lost to Follow-up|1|||
49018422|NCT03036579|157904390|FG000|2 Years|Lost to Follow-up|1|||
49018423|NCT03036579|157904391|FG001|2 Years|Lost to Follow-up|0|||
49018424|NCT03036579|157904390|FG000|3 Years|Lost to Follow-up|0|||
49018425|NCT03036579|157904391|FG001|3 Years|Lost to Follow-up|1|||
49018426|NCT01769378|157904392|FG000|Overall Study|Adverse Event|10|||
49018427|NCT01769378|157904393|FG001|Overall Study|Adverse Event|0|||
49018428|NCT01769378|157904392|FG000|Overall Study|Entry criteria not met|1|||
49018429|NCT01769378|157904393|FG001|Overall Study|Entry criteria not met|0|||
49018430|NCT01769378|157904392|FG000|Overall Study|Protocol Violation|1|||
49018431|NCT01769378|157904393|FG001|Overall Study|Protocol Violation|1|||
49018432|NCT01769378|157904392|FG000|Overall Study|Withdrawal by Subject|10|||
49018433|NCT01769378|157904393|FG001|Overall Study|Withdrawal by Subject|3|||
49018434|NCT01769378|157904392|FG000|Overall Study|Sponsor Decision|1|||
49018435|NCT01769378|157904393|FG001|Overall Study|Sponsor Decision|0|||
48677165|NCT01368081|156669229|FG007|Overall Study|Protocol Violation|1|||
48677166|NCT01368081|156669230|FG008|Overall Study|Protocol Violation|0|||
48677167|NCT01368081|156669231|FG009|Overall Study|Protocol Violation|0|||
48677168|NCT01368081|156669232|FG010|Overall Study|Protocol Violation|0|||
49018436|NCT01769378|157904392|FG000|Overall Study|Lost to Follow-up|2|||
48677169|NCT01368081|156669233|FG011|Overall Study|Protocol Violation|0|||
48677170|NCT01368081|156669234|FG012|Overall Study|Protocol Violation|0|||
48677171|NCT01368081|156669222|FG000|Overall Study|Lost to Follow-up|0|||
48677172|NCT01368081|156669223|FG001|Overall Study|Lost to Follow-up|0|||
48677173|NCT01368081|156669224|FG002|Overall Study|Lost to Follow-up|0|||
49018437|NCT01769378|157904393|FG001|Overall Study|Lost to Follow-up|0|||
49018438|NCT02848599|157904394|FG000|Overall Study|Protocol Violation|7|||
49018439|NCT02848599|157904395|FG001|Overall Study|Protocol Violation|9|||
49018440|NCT03519256|157904396|FG000|Overall Study|Disease recurrence|4|||
49018441|NCT03519256|157904397|FG001|Overall Study|Disease recurrence|4|||
49018442|NCT03519256|157904398|FG002|Overall Study|Disease recurrence|5|||
49018443|NCT03519256|157904399|FG003|Overall Study|Disease recurrence|2|||
48677174|NCT01368081|156669225|FG003|Overall Study|Lost to Follow-up|0|||
49018444|NCT03519256|157904396|FG000|Overall Study|Study drug toxicity|0|||
49018445|NCT03519256|157904397|FG001|Overall Study|Study drug toxicity|2|||
49018446|NCT03519256|157904398|FG002|Overall Study|Study drug toxicity|5|||
49018447|NCT03519256|157904399|FG003|Overall Study|Study drug toxicity|2|||
49018448|NCT03519256|157904396|FG000|Overall Study|Adverse event unrelated to study drug|0|||
49018449|NCT03519256|157904397|FG001|Overall Study|Adverse event unrelated to study drug|1|||
49018450|NCT03519256|157904398|FG002|Overall Study|Adverse event unrelated to study drug|1|||
49018451|NCT03519256|157904399|FG003|Overall Study|Adverse event unrelated to study drug|0|||
49018452|NCT03519256|157904396|FG000|Overall Study|Participant request to discontinue study treatment|0|||
49018453|NCT03519256|157904397|FG001|Overall Study|Participant request to discontinue study treatment|0|||
49018454|NCT03519256|157904398|FG002|Overall Study|Participant request to discontinue study treatment|0|||
49018455|NCT03519256|157904399|FG003|Overall Study|Participant request to discontinue study treatment|2|||
49018456|NCT03519256|157904396|FG000|Overall Study|Other reasons|0|||
49018457|NCT03519256|157904397|FG001|Overall Study|Other reasons|0|||
49018458|NCT03519256|157904398|FG002|Overall Study|Other reasons|2|||
49018459|NCT03519256|157904399|FG003|Overall Study|Other reasons|0|||
49018460|NCT03519256|157904396|FG000|Overall Study|Disease progression|6|||
49018461|NCT03519256|157904397|FG001|Overall Study|Disease progression|3|||
49018462|NCT03519256|157904398|FG002|Overall Study|Disease progression|2|||
49018463|NCT03519256|157904399|FG003|Overall Study|Disease progression|1|||
49018464|NCT03519256|157904396|FG000|Overall Study|Lost to Follow-up|0|||
49018465|NCT03519256|157904397|FG001|Overall Study|Lost to Follow-up|1|||
49018466|NCT03519256|157904398|FG002|Overall Study|Lost to Follow-up|0|||
49018467|NCT03519256|157904399|FG003|Overall Study|Lost to Follow-up|0|||
49018468|NCT04828161|157904400|FG000|Overall Study|Withdrawal by Subject|0|||
49018469|NCT04828161|157904401|FG001|Overall Study|Withdrawal by Subject|3|||
49018470|NCT04828161|157904402|FG002|Overall Study|Withdrawal by Subject|3|||
49018471|NCT04828161|157904403|FG003|Overall Study|Withdrawal by Subject|4|||
48677175|NCT01368081|156669226|FG004|Overall Study|Lost to Follow-up|0|||
48677176|NCT01368081|156669227|FG005|Overall Study|Lost to Follow-up|0|||
48677177|NCT01368081|156669228|FG006|Overall Study|Lost to Follow-up|0|||
48677178|NCT01368081|156669229|FG007|Overall Study|Lost to Follow-up|0|||
48677179|NCT01368081|156669230|FG008|Overall Study|Lost to Follow-up|0|||
48677180|NCT01368081|156669231|FG009|Overall Study|Lost to Follow-up|0|||
48677181|NCT01368081|156669232|FG010|Overall Study|Lost to Follow-up|0|||
48762372|NCT00481195|156978102|FG000|Overall Study|Withdrawal by Subject|3|||
49018472|NCT04828161|157904400|FG000|Overall Study|Lost to Follow-up|1|||
49018473|NCT04828161|157904401|FG001|Overall Study|Lost to Follow-up|4|||
49018474|NCT04828161|157904402|FG002|Overall Study|Lost to Follow-up|2|||
49018475|NCT04828161|157904403|FG003|Overall Study|Lost to Follow-up|2|||
49018476|NCT04828161|157904400|FG000|Overall Study|Other|2|||
49018477|NCT04828161|157904401|FG001|Overall Study|Other|0|||
49018478|NCT04828161|157904402|FG002|Overall Study|Other|2|||
49018479|NCT04828161|157904403|FG003|Overall Study|Other|0|||
49018480|NCT04828161|157904400|FG000|Overall Study|Death|0|||
49018481|NCT04828161|157904401|FG001|Overall Study|Death|0|||
49018482|NCT04828161|157904402|FG002|Overall Study|Death|0|||
49018483|NCT04828161|157904403|FG003|Overall Study|Death|2|||
49018484|NCT02352337|157904404|FG000|Overall Study|Patients never treated|4|||
49018485|NCT02352337|157904405|FG001|Overall Study|Patients never treated|1|||
49018486|NCT02352337|157904406|FG002|Overall Study|Patients never treated|2|||
49018487|NCT03175120|157904409|FG000|Overall Study|Adverse Event|2|||
49018488|NCT03175120|157904410|FG001|Overall Study|Adverse Event|2|||
49018489|NCT03175120|157904409|FG000|Overall Study|Protocol Violation|5|||
49018490|NCT03175120|157904410|FG001|Overall Study|Protocol Violation|2|||
49018491|NCT03175120|157904409|FG000|Overall Study|Lost to Follow-up|1|||
49018492|NCT03175120|157904410|FG001|Overall Study|Lost to Follow-up|0|||
49018493|NCT03175120|157904409|FG000|Overall Study|Withdrawal by Subject|2|||
49018494|NCT03175120|157904410|FG001|Overall Study|Withdrawal by Subject|5|||
49018495|NCT03175120|157904409|FG000|Overall Study|Other|2|||
49018496|NCT03175120|157904410|FG001|Overall Study|Other|3|||
49018497|NCT00922974|157904411|FG000|Phase II Component|Protocol Violation|2|||
49018498|NCT00922974|157904412|FG001|Phase II Component|Protocol Violation|0|||
49018499|NCT00922974|157904411|FG000|Phase II Component|Not evaluable for treatment review|5|||
49018500|NCT00922974|157904412|FG001|Phase II Component|Not evaluable for treatment review|0|||
49018501|NCT00922974|157904411|FG000|Phase III Component|Protocol Violation|8|||
49018502|NCT00922974|157904412|FG001|Phase III Component|Protocol Violation|6|||
49018503|NCT04120194|157904413|FG000|Overall Study|Lost to Follow-up|11|||
49018504|NCT04120194|157904414|FG001|Overall Study|Lost to Follow-up|8|||
49018505|NCT04120194|157904413|FG000|Overall Study|Adverse Event|4|||
49018506|NCT04120194|157904414|FG001|Overall Study|Adverse Event|5|||
48762373|NCT00481195|156978103|FG001|Overall Study|Withdrawal by Subject|9|||
48677182|NCT01368081|156669233|FG011|Overall Study|Lost to Follow-up|0|||
48677183|NCT01368081|156669234|FG012|Overall Study|Lost to Follow-up|1|||
49018507|NCT04120194|157904413|FG000|Overall Study|Voluntary withdrawal unrelated to adverse event|1|||
49018508|NCT04120194|157904414|FG001|Overall Study|Voluntary withdrawal unrelated to adverse event|2|||
49018509|NCT04120194|157904413|FG000|Overall Study|Miscellaneous|4|||
48677184|NCT01368081|156669222|FG000|Overall Study|Withdrawal by Subject|4|||
48677185|NCT01368081|156669223|FG001|Overall Study|Withdrawal by Subject|4|||
48677186|NCT01368081|156669224|FG002|Overall Study|Withdrawal by Subject|1|||
48677187|NCT01368081|156669225|FG003|Overall Study|Withdrawal by Subject|1|||
48677188|NCT01368081|156669226|FG004|Overall Study|Withdrawal by Subject|0|||
48677189|NCT01368081|156669227|FG005|Overall Study|Withdrawal by Subject|3|||
48677190|NCT01368081|156669228|FG006|Overall Study|Withdrawal by Subject|4|||
48677191|NCT01368081|156669229|FG007|Overall Study|Withdrawal by Subject|2|||
48677192|NCT01368081|156669230|FG008|Overall Study|Withdrawal by Subject|5|||
48677193|NCT01368081|156669231|FG009|Overall Study|Withdrawal by Subject|4|||
48677194|NCT01368081|156669232|FG010|Overall Study|Withdrawal by Subject|3|||
48677195|NCT01368081|156669233|FG011|Overall Study|Withdrawal by Subject|2|||
48677196|NCT01368081|156669234|FG012|Overall Study|Withdrawal by Subject|0|||
48677197|NCT01368081|156669222|FG000|Overall Study|Other reason not defined above|2|||
48677198|NCT01368081|156669223|FG001|Overall Study|Other reason not defined above|0|||
48677199|NCT01368081|156669224|FG002|Overall Study|Other reason not defined above|0|||
48677200|NCT01368081|156669225|FG003|Overall Study|Other reason not defined above|1|||
48677201|NCT01368081|156669226|FG004|Overall Study|Other reason not defined above|0|||
48677202|NCT01368081|156669227|FG005|Overall Study|Other reason not defined above|1|||
48677203|NCT01368081|156669228|FG006|Overall Study|Other reason not defined above|2|||
48677204|NCT01368081|156669229|FG007|Overall Study|Other reason not defined above|0|||
48677205|NCT01368081|156669230|FG008|Overall Study|Other reason not defined above|0|||
48677206|NCT01368081|156669231|FG009|Overall Study|Other reason not defined above|1|||
48677207|NCT01368081|156669232|FG010|Overall Study|Other reason not defined above|0|||
48677208|NCT01368081|156669233|FG011|Overall Study|Other reason not defined above|0|||
48677209|NCT01368081|156669234|FG012|Overall Study|Other reason not defined above|3|||
48677210|NCT00422383|156669235|FG000|Overall Study|Adverse Event|5|||
48677211|NCT00422383|156669236|FG001|Overall Study|Adverse Event|3|||
48677212|NCT00422383|156669237|FG002|Overall Study|Adverse Event|1|||
48677213|NCT00422383|156669238|FG003|Overall Study|Adverse Event|1|||
48677214|NCT00422383|156669239|FG004|Overall Study|Adverse Event|0|||
48677215|NCT00422383|156669235|FG000|Overall Study|Lack of Efficacy|4|||
48677216|NCT00422383|156669236|FG001|Overall Study|Lack of Efficacy|4|||
48762374|NCT00481195|156978102|FG000|Overall Study|Miscellaneous|2|||
48762375|NCT00481195|156978103|FG001|Overall Study|Miscellaneous|2|||
48762376|NCT04105998|156978106|FG000|Second Study Day|Altered frequency and times of measurements on both study days|2|||
49018510|NCT04120194|157904414|FG001|Overall Study|Miscellaneous|5|||
49018511|NCT01090765|157904415|FG000|Overall Study|Patient withdrew consent|0|||
49018512|NCT01090765|157904416|FG001|Overall Study|Patient withdrew consent|0|||
49018513|NCT01090765|157904417|FG002|Overall Study|Patient withdrew consent|0|||
49018514|NCT01090765|157904418|FG003|Overall Study|Patient withdrew consent|0|||
49018515|NCT01090765|157904419|FG004|Overall Study|Patient withdrew consent|1|||
49018516|NCT01090765|157904420|FG005|Overall Study|Patient withdrew consent|1|||
49018517|NCT01090765|157904415|FG000|Overall Study|Developed a DVT, needed anticoagulation|0|||
49018518|NCT01090765|157904416|FG001|Overall Study|Developed a DVT, needed anticoagulation|0|||
49018519|NCT01090765|157904417|FG002|Overall Study|Developed a DVT, needed anticoagulation|0|||
49018520|NCT01090765|157904418|FG003|Overall Study|Developed a DVT, needed anticoagulation|1|||
49018521|NCT01090765|157904419|FG004|Overall Study|Developed a DVT, needed anticoagulation|0|||
49018522|NCT01090765|157904420|FG005|Overall Study|Developed a DVT, needed anticoagulation|0|||
49018523|NCT01090765|157904415|FG000|Overall Study|Vasovagal reaction with first infusion|0|||
49018524|NCT01090765|157904416|FG001|Overall Study|Vasovagal reaction with first infusion|0|||
49018525|NCT01090765|157904417|FG002|Overall Study|Vasovagal reaction with first infusion|0|||
49018526|NCT01090765|157904418|FG003|Overall Study|Vasovagal reaction with first infusion|0|||
49018527|NCT01090765|157904419|FG004|Overall Study|Vasovagal reaction with first infusion|1|||
49018528|NCT01090765|157904420|FG005|Overall Study|Vasovagal reaction with first infusion|0|||
49018529|NCT01977092|157904423|FG000|Overall Study|Death|3|||
49018530|NCT01977092|157904424|FG001|Overall Study|Death|4|||
49018531|NCT01977092|157904423|FG000|Overall Study|Lost to Follow-up|23|||
49018532|NCT01977092|157904424|FG001|Overall Study|Lost to Follow-up|14|||
49018533|NCT01977092|157904423|FG000|Overall Study|Withdrawal by Subject|2|||
49018534|NCT01977092|157904424|FG001|Overall Study|Withdrawal by Subject|1|||
49018535|NCT01977092|157904423|FG000|Overall Study|In prison|3|||
49018536|NCT01977092|157904424|FG001|Overall Study|In prison|11|||
49018537|NCT03038113|157904425|FG000|Overall Study|Withdrawal by Subject|0|||
49018538|NCT03038113|157904426|FG001|Overall Study|Withdrawal by Subject|0|||
49018539|NCT03038113|157904427|FG002|Overall Study|Withdrawal by Subject|1|||
49018540|NCT03038113|157904428|FG003|Overall Study|Withdrawal by Subject|0|||
49018541|NCT03038113|157904429|FG004|Overall Study|Withdrawal by Subject|0|||
48677217|NCT00422383|156669237|FG002|Overall Study|Lack of Efficacy|2|||
48677218|NCT00422383|156669238|FG003|Overall Study|Lack of Efficacy|1|||
48677219|NCT00422383|156669239|FG004|Overall Study|Lack of Efficacy|1|||
49018542|NCT03038113|157904430|FG005|Overall Study|Withdrawal by Subject|0|||
49018543|NCT03038113|157904431|FG006|Overall Study|Withdrawal by Subject|0|||
49018544|NCT03038113|157904432|FG007|Overall Study|Withdrawal by Subject|0|||
48677220|NCT00422383|156669235|FG000|Overall Study|Lost to Follow-up|0|||
48677221|NCT00422383|156669236|FG001|Overall Study|Lost to Follow-up|1|||
48677222|NCT00422383|156669237|FG002|Overall Study|Lost to Follow-up|0|||
48677223|NCT00422383|156669238|FG003|Overall Study|Lost to Follow-up|0|||
48677224|NCT00422383|156669239|FG004|Overall Study|Lost to Follow-up|1|||
48677225|NCT00422383|156669235|FG000|Overall Study|Protocol Violation|1|||
48677226|NCT00422383|156669236|FG001|Overall Study|Protocol Violation|1|||
48677227|NCT00422383|156669237|FG002|Overall Study|Protocol Violation|1|||
48677228|NCT00422383|156669238|FG003|Overall Study|Protocol Violation|0|||
48677229|NCT00422383|156669239|FG004|Overall Study|Protocol Violation|0|||
48677230|NCT00422383|156669235|FG000|Overall Study|Withdrawal by Subject|5|||
48677231|NCT00422383|156669236|FG001|Overall Study|Withdrawal by Subject|5|||
48677232|NCT00422383|156669237|FG002|Overall Study|Withdrawal by Subject|0|||
48677233|NCT00422383|156669238|FG003|Overall Study|Withdrawal by Subject|0|||
48677234|NCT00422383|156669239|FG004|Overall Study|Withdrawal by Subject|1|||
48677235|NCT02560012|156669241|FG000|Overall Study|Study Terminated|2|||
48677236|NCT01108523|156669242|FG000|Overall Study|Protocol Violation|4|||
48762377|NCT04105998|156978107|FG001|Second Study Day|Altered frequency and times of measurements on both study days|0|||
48762378|NCT02738333|156978108|FG000|Overall Study|Death|1|||
48762379|NCT02738333|156978109|FG001|Overall Study|Death|0|||
48762380|NCT02738333|156978110|FG002|Overall Study|Death|0|||
48762381|NCT02738333|156978108|FG000|Overall Study|Lost to Follow-up|1|||
48762382|NCT02738333|156978109|FG001|Overall Study|Lost to Follow-up|0|||
48762383|NCT02738333|156978110|FG002|Overall Study|Lost to Follow-up|0|||
48762384|NCT02488681|156978111|FG000|Overall Study|Implant unsuccessful|7|||
48762385|NCT02580357|156978112|FG000|Overall Study|Lost to Follow-up|2|||
48762386|NCT02580357|156978113|FG001|Overall Study|Lost to Follow-up|0|||
48762387|NCT02580357|156978114|FG002|Overall Study|Lost to Follow-up|0|||
48762388|NCT02580357|156978112|FG000|Overall Study|Protocol Violation|1|||
48762389|NCT02580357|156978113|FG001|Overall Study|Protocol Violation|0|||
48762390|NCT02580357|156978114|FG002|Overall Study|Protocol Violation|0|||
48762391|NCT03261947|156978115|FG000|Overall Study|Death|10|||
48762392|NCT03261947|156978116|FG001|Overall Study|Death|13|||
48762393|NCT03261947|156978117|FG002|Overall Study|Death|17|||
48762394|NCT03261947|156978118|FG003|Overall Study|Death|12|||
48762395|NCT03261947|156978119|FG004|Overall Study|Death|8|||
48762396|NCT03261947|156978115|FG000|Overall Study|Lost to Follow-up|0|||
48762397|NCT03261947|156978116|FG001|Overall Study|Lost to Follow-up|0|||
48762398|NCT03261947|156978117|FG002|Overall Study|Lost to Follow-up|2|||
48762399|NCT03261947|156978118|FG003|Overall Study|Lost to Follow-up|1|||
48762400|NCT03261947|156978119|FG004|Overall Study|Lost to Follow-up|0|||
48762401|NCT03261947|156978115|FG000|Overall Study|Withdrawal by Subject|0|||
48762402|NCT03261947|156978116|FG001|Overall Study|Withdrawal by Subject|0|||
48762403|NCT03261947|156978117|FG002|Overall Study|Withdrawal by Subject|3|||
48762404|NCT03261947|156978118|FG003|Overall Study|Withdrawal by Subject|0|||
48762405|NCT03261947|156978119|FG004|Overall Study|Withdrawal by Subject|1|||
48762406|NCT03261947|156978115|FG000|Overall Study|Site Terminated by Sponsor|0|||
48762407|NCT03261947|156978116|FG001|Overall Study|Site Terminated by Sponsor|0|||
48762408|NCT03261947|156978117|FG002|Overall Study|Site Terminated by Sponsor|4|||
48762409|NCT03261947|156978118|FG003|Overall Study|Site Terminated by Sponsor|7|||
48762410|NCT03261947|156978119|FG004|Overall Study|Site Terminated by Sponsor|5|||
48762411|NCT03261947|156978115|FG000|Overall Study|Reason not Specified|2|||
48762412|NCT03261947|156978116|FG001|Overall Study|Reason not Specified|0|||
48762413|NCT03261947|156978117|FG002|Overall Study|Reason not Specified|4|||
48762414|NCT03261947|156978118|FG003|Overall Study|Reason not Specified|1|||
48762415|NCT03261947|156978119|FG004|Overall Study|Reason not Specified|3|||
48762416|NCT04007523|156978125|FG000|Overall Study|Withdrawal by Subject|0|||
48762417|NCT04007523|156978126|FG001|Overall Study|Withdrawal by Subject|1|||
48762418|NCT04007523|156978127|FG002|Overall Study|Withdrawal by Subject|1|||
48762419|NCT04007523|156978128|FG003|Overall Study|Withdrawal by Subject|0|||
48762420|NCT04007523|156978125|FG000|Overall Study|ICU Transfer|0|||
48762421|NCT04007523|156978126|FG001|Overall Study|ICU Transfer|1|||
48762422|NCT04007523|156978127|FG002|Overall Study|ICU Transfer|0|||
48762423|NCT04007523|156978128|FG003|Overall Study|ICU Transfer|0|||
48762424|NCT04007523|156978125|FG000|Overall Study|COVID hospital closure|0|||
48762425|NCT04007523|156978126|FG001|Overall Study|COVID hospital closure|0|||
48762426|NCT04007523|156978127|FG002|Overall Study|COVID hospital closure|1|||
48762427|NCT04007523|156978128|FG003|Overall Study|COVID hospital closure|2|||
48677237|NCT00483938|156669243|FG000|Overall Study|Protocol Violation|0|||
48677238|NCT00483938|156669244|FG001|Overall Study|Protocol Violation|0|||
48677239|NCT00483938|156669245|FG002|Overall Study|Protocol Violation|0|||
48677240|NCT00483938|156669246|FG003|Overall Study|Protocol Violation|0|||
48762428|NCT04007523|156978125|FG000|Overall Study|Surgery cancelled|0|||
48762429|NCT04007523|156978126|FG001|Overall Study|Surgery cancelled|0|||
48762430|NCT04007523|156978127|FG002|Overall Study|Surgery cancelled|1|||
48762431|NCT04007523|156978128|FG003|Overall Study|Surgery cancelled|1|||
48762432|NCT01358357|156978129|FG000|Open Label Phase|Adverse Event|0|||
48762433|NCT01358357|156978130|FG001|Open Label Phase|Adverse Event|0|||
48762434|NCT01358357|156978131|FG002|Open Label Phase|Adverse Event|59|||
48677241|NCT00483938|156669247|FG004|Overall Study|Protocol Violation|0|||
48677242|NCT00483938|156669248|FG005|Overall Study|Protocol Violation|0|||
48677243|NCT00483938|156669249|FG006|Overall Study|Protocol Violation|3|||
48677244|NCT00483938|156669243|FG000|Overall Study|Withdrawal by Subject|1|||
48980633|NCT00636155|157760445|FG000|Overall Study|Lack of Efficacy|1|||
48980634|NCT00636155|157760445|FG000|Overall Study|Withdrawal by Subject|3|||
48980635|NCT00636155|157760445|FG000|Overall Study|Stem cell transplant|1|||
48980636|NCT00636155|157760445|FG000|Overall Study|Physician Decision|5|||
48980637|NCT01424306|157760446|FG000|Overall Study|Protocol Violation|0|||
48980638|NCT01424306|157760447|FG001|Overall Study|Protocol Violation|0|||
48980639|NCT01424306|157760448|FG002|Overall Study|Protocol Violation|0|||
48980640|NCT01424306|157760449|FG003|Overall Study|Protocol Violation|0|||
48980641|NCT01424306|157760450|FG004|Overall Study|Protocol Violation|1|||
48980642|NCT01424306|157760451|FG005|Overall Study|Protocol Violation|0|||
48980643|NCT03077711|157760452|FG000|Overall Study|Lost to Follow-up|2|||
48980644|NCT03077711|157760453|FG001|Overall Study|Lost to Follow-up|2|||
48980645|NCT03077711|157760452|FG000|Overall Study|noncompliant taking medication|2|||
48980646|NCT03077711|157760453|FG001|Overall Study|noncompliant taking medication|0|||
48980647|NCT02352090|157760459|FG000|Overall Study|general malaise|1|||
48980648|NCT02352090|157760460|FG001|Overall Study|general malaise|0|||
48980649|NCT02352090|157760461|FG002|Overall Study|general malaise|0|||
48980650|NCT02352090|157760459|FG000|Overall Study|non-specified mild side-effects|0|||
48980651|NCT02352090|157760460|FG001|Overall Study|non-specified mild side-effects|0|||
48980652|NCT02352090|157760461|FG002|Overall Study|non-specified mild side-effects|2|||
48980653|NCT03231228|157760465|FG000|Overall Study|Lost to Follow-up|2|||
48980654|NCT03231228|157760466|FG001|Overall Study|Lost to Follow-up|0|||
48980655|NCT03231228|157760465|FG000|Overall Study|Physician Decision|1|||
48980656|NCT03231228|157760466|FG001|Overall Study|Physician Decision|0|||
48980657|NCT00590031|157760467|FG000|Overall Study|Adverse Event|3|||
48980658|NCT00590031|157760467|FG000|Overall Study|Withdrawal by Subject|1|||
48980659|NCT00590031|157760467|FG000|Overall Study|Metastatic Disease|1|||
48980660|NCT00590031|157760467|FG000|Overall Study|Admin Hold|1|||
48980661|NCT01610414|157760468|FG000|Study Start - Month 13|Serious Adverse Event|65|||
48980662|NCT01610414|157760469|FG001|Study Start - Month 13|Serious Adverse Event|67|||
48980663|NCT01610414|157760468|FG000|Study Start - Month 13|Adverse Event|14|||
48980664|NCT01610414|157760469|FG001|Study Start - Month 13|Adverse Event|14|||
48980665|NCT01610414|157760468|FG000|Study Start - Month 13|Protocol Violation|3|||
48980666|NCT01610414|157760469|FG001|Study Start - Month 13|Protocol Violation|1|||
48980667|NCT01610414|157760468|FG000|Study Start - Month 13|Withdrawal by Subject|23|||
48980668|NCT01610414|157760469|FG001|Study Start - Month 13|Withdrawal by Subject|30|||
48980669|NCT01610414|157760468|FG000|Study Start - Month 13|Migrated/moved from study area|2|||
48980670|NCT01610414|157760469|FG001|Study Start - Month 13|Migrated/moved from study area|4|||
48980671|NCT01610414|157760468|FG000|Study Start - Month 13|Lost to Follow-up|4|||
48980672|NCT01610414|157760469|FG001|Study Start - Month 13|Lost to Follow-up|6|||
48980673|NCT01610414|157760468|FG000|Study Start - Month 13|Suspected HZ episode|1|||
48980674|NCT01610414|157760469|FG001|Study Start - Month 13|Suspected HZ episode|3|||
48980675|NCT01610414|157760468|FG000|Study Start - Month 13|Other reasons for withdrawal|3|||
48980676|NCT01610414|157760469|FG001|Study Start - Month 13|Other reasons for withdrawal|4|||
48980677|NCT01610414|157760468|FG000|Month 13 - Month 25|Serious Adverse Event|35|||
48980678|NCT01610414|157760469|FG001|Month 13 - Month 25|Serious Adverse Event|38|||
48980679|NCT01610414|157760468|FG000|Month 13 - Month 25|Adverse Event|8|||
48980680|NCT01610414|157760469|FG001|Month 13 - Month 25|Adverse Event|4|||
48980681|NCT01610414|157760468|FG000|Month 13 - Month 25|Withdrawal by Subject|7|||
48980682|NCT01610414|157760469|FG001|Month 13 - Month 25|Withdrawal by Subject|8|||
48980683|NCT01610414|157760468|FG000|Month 13 - Month 25|Migrated/moved from study area|4|||
48980684|NCT01610414|157760469|FG001|Month 13 - Month 25|Migrated/moved from study area|2|||
48980685|NCT01610414|157760468|FG000|Month 13 - Month 25|Protocol Violation|0|||
48980686|NCT01610414|157760469|FG001|Month 13 - Month 25|Protocol Violation|2|||
48980687|NCT01610414|157760468|FG000|Month 13 - Month 25|Lost to Follow-up|5|||
48980688|NCT01610414|157760469|FG001|Month 13 - Month 25|Lost to Follow-up|9|||
48980689|NCT01610414|157760468|FG000|Month 13 - Month 25|Other reasons for withdrawal|6|||
48980690|NCT01610414|157760469|FG001|Month 13 - Month 25|Other reasons for withdrawal|7|||
48980691|NCT01610414|157760468|FG000|After Month 25|Study end not reached|48|||
48980692|NCT01610414|157760469|FG001|After Month 25|Study end not reached|53|||
48980693|NCT00464620|157762131|FG000|Overall Study|Physician Decision|1|||
48980694|NCT00464620|157762132|FG001|Overall Study|Physician Decision|0|||
48980695|NCT00464620|157762133|FG002|Overall Study|Physician Decision|0|||
48980696|NCT00464620|157762131|FG000|Overall Study|Withdrawal by Subject|1|||
48980697|NCT00464620|157762132|FG001|Overall Study|Withdrawal by Subject|0|||
48980698|NCT00464620|157762133|FG002|Overall Study|Withdrawal by Subject|3|||
48980699|NCT00464620|157762131|FG000|Overall Study|Ineligible sarcoma subtype|0|||
48980700|NCT00464620|157762132|FG001|Overall Study|Ineligible sarcoma subtype|2|||
48980701|NCT00464620|157762133|FG002|Overall Study|Ineligible sarcoma subtype|2|||
48980702|NCT00464620|157762131|FG000|Overall Study|Use of prohibited concomitant medication|0|||
48980703|NCT00464620|157762132|FG001|Overall Study|Use of prohibited concomitant medication|0|||
49018545|NCT03038113|157904433|FG008|Overall Study|Withdrawal by Subject|0|||
48762435|NCT01358357|156978129|FG000|Open Label Phase|Lack of Efficacy|0|||
49018546|NCT03038113|157904434|FG009|Overall Study|Withdrawal by Subject|0|||
49018547|NCT03038113|157904435|FG010|Overall Study|Withdrawal by Subject|0|||
49018548|NCT03038113|157904436|FG011|Overall Study|Withdrawal by Subject|0|||
49018549|NCT03038113|157904437|FG012|Overall Study|Withdrawal by Subject|0|||
49018550|NCT03038113|157904438|FG013|Overall Study|Withdrawal by Subject|1|||
49018551|NCT03038113|157904425|FG000|Overall Study|Lost to Follow-up|0|||
49018552|NCT03038113|157904426|FG001|Overall Study|Lost to Follow-up|0|||
49018553|NCT03038113|157904427|FG002|Overall Study|Lost to Follow-up|0|||
49018554|NCT03038113|157904428|FG003|Overall Study|Lost to Follow-up|0|||
49018555|NCT03038113|157904429|FG004|Overall Study|Lost to Follow-up|0|||
49018556|NCT03038113|157904430|FG005|Overall Study|Lost to Follow-up|0|||
49018557|NCT03038113|157904431|FG006|Overall Study|Lost to Follow-up|1|||
49018558|NCT03038113|157904432|FG007|Overall Study|Lost to Follow-up|0|||
49018559|NCT03038113|157904433|FG008|Overall Study|Lost to Follow-up|0|||
49018560|NCT03038113|157904434|FG009|Overall Study|Lost to Follow-up|0|||
49018561|NCT03038113|157904435|FG010|Overall Study|Lost to Follow-up|0|||
49018562|NCT03038113|157904436|FG011|Overall Study|Lost to Follow-up|0|||
49018563|NCT03038113|157904437|FG012|Overall Study|Lost to Follow-up|0|||
49018564|NCT03038113|157904438|FG013|Overall Study|Lost to Follow-up|0|||
49018565|NCT02623959|157904444|FG000|Overall Study|Progression|0|||
49018566|NCT02623959|157904445|FG001|Overall Study|Progression|1|||
49018567|NCT01787825|157904450|FG000|Overall Study|Subject Did Not Ingest Capsules|1|||
49018568|NCT01787825|157904451|FG001|Overall Study|Subject Did Not Ingest Capsules|0|||
49018569|NCT01787825|157904450|FG000|Overall Study|Data Not Analyzable|5|||
49018570|NCT01787825|157904451|FG001|Overall Study|Data Not Analyzable|1|||
49018571|NCT00601354|157904455|FG000|Overall Study|Lost to Follow-up|4|||
49018572|NCT00601354|157904456|FG001|Overall Study|Lost to Follow-up|5|||
49018573|NCT02292238|157904461|FG000|Overall Study|Protocol Violation|1|||
49018574|NCT02292238|157904462|FG001|Overall Study|Protocol Violation|2|||
49018575|NCT02292238|157904461|FG000|Overall Study|Withdrawal by Subject|2|||
49018576|NCT02292238|157904462|FG001|Overall Study|Withdrawal by Subject|1|||
49018577|NCT02292238|157904461|FG000|Overall Study|Lost to Follow-up|1|||
49018578|NCT02292238|157904462|FG001|Overall Study|Lost to Follow-up|0|||
49018579|NCT02292238|157904461|FG000|Overall Study|Physician Decision|0|||
49018580|NCT02292238|157904462|FG001|Overall Study|Physician Decision|1|||
49018581|NCT02277769|157904463|FG000|Overall Study|Protocol Violation|3|||
49018582|NCT02277769|157904464|FG001|Overall Study|Protocol Violation|3|||
49018583|NCT02277769|157904465|FG002|Overall Study|Protocol Violation|5|||
49018584|NCT02277769|157904463|FG000|Overall Study|Lack of Efficacy|17|||
49018585|NCT02277769|157904464|FG001|Overall Study|Lack of Efficacy|0|||
49018586|NCT02277769|157904465|FG002|Overall Study|Lack of Efficacy|4|||
49018587|NCT02277769|157904463|FG000|Overall Study|Adverse Event|14|||
49018588|NCT02277769|157904464|FG001|Overall Study|Adverse Event|2|||
49018589|NCT02277769|157904465|FG002|Overall Study|Adverse Event|4|||
49018590|NCT02277769|157904463|FG000|Overall Study|Other than specified above|12|||
49018591|NCT02277769|157904464|FG001|Overall Study|Other than specified above|8|||
49018592|NCT02277769|157904465|FG002|Overall Study|Other than specified above|5|||
49018593|NCT01789320|157904467|FG000|Overall Study|Re-enrolled into study|1|||
49018594|NCT01789320|157904467|FG000|Overall Study|Lost to Follow-up|1|||
49018595|NCT00491504|157904468|FG000|Overall Study|Adverse Event|0|||
49018596|NCT00491504|157904469|FG001|Overall Study|Adverse Event|1|||
49018597|NCT00491504|157904470|FG002|Overall Study|Adverse Event|0|||
49018598|NCT00491504|157904471|FG003|Overall Study|Adverse Event|0|||
49018599|NCT00491504|157904468|FG000|Overall Study|Withdrawal by Subject|0|||
49018600|NCT00491504|157904469|FG001|Overall Study|Withdrawal by Subject|0|||
48762436|NCT01358357|156978130|FG001|Open Label Phase|Lack of Efficacy|0|||
48762437|NCT01358357|156978131|FG002|Open Label Phase|Lack of Efficacy|107|||
49018601|NCT00491504|157904470|FG002|Overall Study|Withdrawal by Subject|1|||
49018602|NCT00491504|157904471|FG003|Overall Study|Withdrawal by Subject|2|||
49018603|NCT00491504|157904468|FG000|Overall Study|Protocol Violation|0|||
49018604|NCT00491504|157904469|FG001|Overall Study|Protocol Violation|0|||
49018605|NCT00491504|157904470|FG002|Overall Study|Protocol Violation|3|||
49018606|NCT00491504|157904471|FG003|Overall Study|Protocol Violation|2|||
49018607|NCT00745095|157904472|FG000|Overall Study|Declined to participate|1|||
49018608|NCT00745095|157904473|FG001|Overall Study|Declined to participate|0|||
49018609|NCT00745095|157904474|FG002|Overall Study|Declined to participate|0|||
49018610|NCT00745095|157904475|FG003|Overall Study|Declined to participate|0|||
49018611|NCT00745095|157904476|FG004|Overall Study|Declined to participate|92|||
49018612|NCT00745095|157904477|FG005|Overall Study|Declined to participate|95|||
49018613|NCT00745095|157904472|FG000|Overall Study|Ineligible due to GFR criteria|0|||
49018614|NCT00745095|157904473|FG001|Overall Study|Ineligible due to GFR criteria|2|||
49018615|NCT00745095|157904474|FG002|Overall Study|Ineligible due to GFR criteria|3|||
49018616|NCT00745095|157904475|FG003|Overall Study|Ineligible due to GFR criteria|3|||
49018617|NCT00745095|157904476|FG004|Overall Study|Ineligible due to GFR criteria|30|||
49018618|NCT00745095|157904477|FG005|Overall Study|Ineligible due to GFR criteria|28|||
49018619|NCT02041702|157904489|FG000|Overall Study|Lost to Follow-up|1|||
48762438|NCT01358357|156978129|FG000|Open Label Phase|Lost to Follow-up|0|||
48762439|NCT01358357|156978130|FG001|Open Label Phase|Lost to Follow-up|0|||
48762440|NCT01358357|156978131|FG002|Open Label Phase|Lost to Follow-up|76|||
48762441|NCT01358357|156978129|FG000|Open Label Phase|Protocol Violation|0|||
48980704|NCT00464620|157762133|FG002|Overall Study|Use of prohibited concomitant medication|2|||
48980705|NCT00673816|157762136|FG000|Overall Study|Adverse Event|1|||
48980706|NCT00673816|157762136|FG000|Overall Study|Withdrawal by Subject|1|||
48980707|NCT02658149|157762139|FG000|Overall Study|Physician Decision|1|||
48980708|NCT02658149|157762140|FG001|Overall Study|Physician Decision|0|||
48980709|NCT00610714|157762141|FG000|Overall Study|Adverse Event|3|||
48980710|NCT00610714|157762142|FG001|Overall Study|Adverse Event|1|||
48980711|NCT00610714|157762141|FG000|Overall Study|Death|12|||
48980712|NCT00610714|157762142|FG001|Overall Study|Death|18|||
48980713|NCT00610714|157762141|FG000|Overall Study|Withdrawal by Subject|9|||
48980714|NCT00610714|157762142|FG001|Overall Study|Withdrawal by Subject|3|||
48980715|NCT00610714|157762141|FG000|Overall Study|Study completion at 120 PFS events|2|||
48980716|NCT00610714|157762142|FG001|Overall Study|Study completion at 120 PFS events|2|||
48980717|NCT01327573|157762143|FG000|Overall Study|Physician Decision|3|||
48980718|NCT01327573|157762144|FG001|Overall Study|Physician Decision|1|||
48980719|NCT00939341|157762145|FG000|Overall Study|Adverse Event|15|||
48980720|NCT00939341|157762145|FG000|Overall Study|Pregnancy|1|||
48980721|NCT00939341|157762145|FG000|Overall Study|Lost to Follow-up|23|||
48980722|NCT00939341|157762145|FG000|Overall Study|Withdrawal by Subject|13|||
48980723|NCT00939341|157762145|FG000|Overall Study|Protocol Violation|6|||
48980724|NCT00939341|157762145|FG000|Overall Study|Incorrect enrolment|8|||
48980725|NCT01023516|157762146|FG000|Overall Study|Voluntary discontinuation|7|||
48980726|NCT01023516|157762147|FG001|Overall Study|Voluntary discontinuation|5|||
48980727|NCT01023516|157762146|FG000|Overall Study|Adverse Event|9|||
48980728|NCT01023516|157762147|FG001|Overall Study|Adverse Event|6|||
48980729|NCT01023516|157762146|FG000|Overall Study|Safety reason|0|||
48980730|NCT01023516|157762147|FG001|Overall Study|Safety reason|3|||
48980731|NCT01023516|157762146|FG000|Overall Study|Study-specific criteria|4|||
48980732|NCT01023516|157762147|FG001|Overall Study|Study-specific criteria|2|||
48980733|NCT01023516|157762146|FG000|Overall Study|Incorrect enrolment|4|||
48980734|NCT01023516|157762147|FG001|Overall Study|Incorrect enrolment|2|||
48980735|NCT00976963|157762151|FG000|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|2|||
48980736|NCT00976963|157762152|FG001|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|0|||
48980737|NCT00976963|157762151|FG000|Overall Study|administrative error|1|||
48980738|NCT00976963|157762152|FG001|Overall Study|administrative error|0|||
48980739|NCT00976963|157762151|FG000|Overall Study|allergic reaction due to previously unknown allergy|1|||
48980740|NCT00976963|157762152|FG001|Overall Study|allergic reaction due to previously unknown allergy|0|||
48980741|NCT02871791|157762158|FG000|Phase 1b|Death|0|||
48980742|NCT02871791|157762159|FG001|Phase 1b|Death|1|||
48980743|NCT02871791|157762158|FG000|Phase 1b|progressive disease|6|||
48980744|NCT02871791|157762159|FG001|Phase 1b|progressive disease|2|||
48980745|NCT02871791|157762158|FG000|Phase 2|Death|1|||
48980746|NCT02871791|157762159|FG001|Phase 2|Death|0|||
48980747|NCT02871791|157762158|FG000|Phase 2|Lost to Follow-up|2|||
48980748|NCT02871791|157762159|FG001|Phase 2|Lost to Follow-up|0|||
48980749|NCT02691468|157762160|FG000|Overall Study|Bronchial blocker use|2|||
48980750|NCT02691468|157762161|FG001|Overall Study|Bronchial blocker use|1|||
48980751|NCT02691468|157762160|FG000|Overall Study|Lost to Follow-up|2|||
48980752|NCT02691468|157762161|FG001|Overall Study|Lost to Follow-up|1|||
48980753|NCT02691468|157762160|FG000|Overall Study|Failure to advance FOB|2|||
48980754|NCT02691468|157762161|FG001|Overall Study|Failure to advance FOB|0|||
48980755|NCT02182999|157762168|FG000|Overall Study|Adverse Event|4|||
48980756|NCT02182999|157762169|FG001|Overall Study|Adverse Event|3|||
48980757|NCT02182999|157762168|FG000|Overall Study|Physician Decision|1|||
48980758|NCT02182999|157762169|FG001|Overall Study|Physician Decision|0|||
48980759|NCT03442595|157762171|FG000|Overall Study|Lost to Follow-up|94|||
48980760|NCT03442595|157762172|FG001|Overall Study|Lost to Follow-up|0|||
48980761|NCT02015104|157762173|FG000|Overall Study|Withdrew consent after first dose drug|1|||
48980762|NCT02015104|157762174|FG001|Overall Study|Withdrew consent after first dose drug|0|||
48980763|NCT02015104|157762173|FG000|Overall Study|Withdrew consent prior to treatment|0|||
48980764|NCT02015104|157762174|FG001|Overall Study|Withdrew consent prior to treatment|1|||
49018620|NCT02041702|157904490|FG001|Overall Study|Lost to Follow-up|6|||
49018621|NCT02041702|157904489|FG000|Overall Study|Death|4|||
49018622|NCT02041702|157904490|FG001|Overall Study|Death|0|||
49018623|NCT02041702|157904489|FG000|Overall Study|Withdrawal by Subject|4|||
49018624|NCT02041702|157904490|FG001|Overall Study|Withdrawal by Subject|3|||
48980765|NCT00592072|157762175|FG000|Wash Out Period|Lost to Follow-up|1|||
48980766|NCT00592072|157762176|FG001|Wash Out Period|Lost to Follow-up|1|||
48980767|NCT02203916|157762179|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
48980768|NCT02203916|157762180|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
48980769|NCT02203916|157762181|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
48980770|NCT02203916|157762179|FG000|Overall Study|Major Protocol Deviation|1|||
48980771|NCT02203916|157762180|FG001|Overall Study|Major Protocol Deviation|1|||
49018625|NCT02041702|157904489|FG000|Overall Study|Patient not confirmed as MRI compatible|1|||
49018626|NCT02041702|157904490|FG001|Overall Study|Patient not confirmed as MRI compatible|0|||
49018627|NCT02041702|157904489|FG000|Overall Study|Cardiac Resynchronization Therapy|1|||
49018628|NCT02041702|157904490|FG001|Overall Study|Cardiac Resynchronization Therapy|0|||
49018629|NCT03977584|157904492|FG000|Overall Study|Reason not disclosed to prevent genetic unblinding|2|||
49018630|NCT03977584|157904493|FG001|Overall Study|Reason not disclosed to prevent genetic unblinding|0|||
49018631|NCT03977584|157904494|FG002|Overall Study|Reason not disclosed to prevent genetic unblinding|4|||
49018632|NCT01766778|157904495|FG000|Overall Study|Adverse Event|4|||
49018633|NCT01766778|157904496|FG001|Overall Study|Adverse Event|4|||
49018634|NCT01766778|157904495|FG000|Overall Study|Withdrawal by Subject|1|||
49018635|NCT01766778|157904496|FG001|Overall Study|Withdrawal by Subject|0|||
49018636|NCT01104662|157904497|FG000|Overall Study|Adverse Event|2|||
49018637|NCT01104662|157904498|FG001|Overall Study|Adverse Event|2|||
49018638|NCT01104662|157904499|FG002|Overall Study|Adverse Event|0|||
49018639|NCT01104662|157904500|FG003|Overall Study|Adverse Event|1|||
49018640|NCT01104662|157904501|FG004|Overall Study|Adverse Event|1|||
49018641|NCT01104662|157904502|FG005|Overall Study|Adverse Event|1|||
49018642|NCT01104662|157904503|FG006|Overall Study|Adverse Event|0|||
49018643|NCT01104662|157904504|FG007|Overall Study|Adverse Event|0|||
49018644|NCT01104662|157904497|FG000|Overall Study|Clinical Failure|1|||
49018645|NCT01104662|157904498|FG001|Overall Study|Clinical Failure|0|||
49018646|NCT01104662|157904499|FG002|Overall Study|Clinical Failure|0|||
49018647|NCT01104662|157904500|FG003|Overall Study|Clinical Failure|0|||
49018648|NCT01104662|157904501|FG004|Overall Study|Clinical Failure|0|||
49018649|NCT01104662|157904502|FG005|Overall Study|Clinical Failure|1|||
49018650|NCT01104662|157904503|FG006|Overall Study|Clinical Failure|0|||
49018651|NCT01104662|157904504|FG007|Overall Study|Clinical Failure|0|||
49018652|NCT01104662|157904497|FG000|Overall Study|Participant left investigator's care|1|||
49018653|NCT01104662|157904498|FG001|Overall Study|Participant left investigator's care|1|||
49018654|NCT01104662|157904499|FG002|Overall Study|Participant left investigator's care|0|||
49018655|NCT01104662|157904500|FG003|Overall Study|Participant left investigator's care|0|||
49018656|NCT01104662|157904501|FG004|Overall Study|Participant left investigator's care|0|||
49018657|NCT01104662|157904502|FG005|Overall Study|Participant left investigator's care|0|||
49018658|NCT01104662|157904503|FG006|Overall Study|Participant left investigator's care|0|||
49018659|NCT01104662|157904504|FG007|Overall Study|Participant left investigator's care|0|||
49018660|NCT01104662|157904497|FG000|Overall Study|Reason not specified|3|||
49018661|NCT01104662|157904498|FG001|Overall Study|Reason not specified|3|||
49018662|NCT01104662|157904499|FG002|Overall Study|Reason not specified|0|||
49018663|NCT01104662|157904500|FG003|Overall Study|Reason not specified|0|||
49018664|NCT01104662|157904501|FG004|Overall Study|Reason not specified|0|||
49018665|NCT01104662|157904502|FG005|Overall Study|Reason not specified|1|||
49018666|NCT01104662|157904503|FG006|Overall Study|Reason not specified|0|||
49018667|NCT01104662|157904504|FG007|Overall Study|Reason not specified|0|||
49018668|NCT01104662|157904497|FG000|Overall Study|Randomized but not treated|3|||
49018669|NCT01104662|157904498|FG001|Overall Study|Randomized but not treated|4|||
49018670|NCT01104662|157904499|FG002|Overall Study|Randomized but not treated|1|||
49018671|NCT01104662|157904500|FG003|Overall Study|Randomized but not treated|0|||
49018672|NCT01104662|157904501|FG004|Overall Study|Randomized but not treated|0|||
49018673|NCT01104662|157904502|FG005|Overall Study|Randomized but not treated|1|||
49018674|NCT01104662|157904503|FG006|Overall Study|Randomized but not treated|0|||
49018675|NCT01104662|157904504|FG007|Overall Study|Randomized but not treated|0|||
49018676|NCT01478620|157904505|FG000|Overall Study|Lost to Follow-up|6|||
49018677|NCT00475020|157904506|FG000|Overall Study|Physician Decision|3|||
49018678|NCT00475020|157904506|FG000|Overall Study|Insurance Denial|1|||
49018679|NCT00475020|157904506|FG000|Overall Study|Donor not able to donate the last minute|1|||
49018680|NCT02514174|157904507|FG000|Overall Study|Patient refused to continue medication|1|||
49018681|NCT02514174|157904507|FG000|Overall Study|Adverse Event|2|||
49018682|NCT02514174|157904507|FG000|Overall Study|Study closed by sponsor|9|||
49018683|NCT02514174|157904507|FG000|Overall Study|Progressive disease|11|||
49018684|NCT02514174|157904507|FG000|Overall Study|Treatment change|1|||
49018685|NCT02514174|157904507|FG000|Overall Study|Treated off study with Afatinib.|1|||
49018686|NCT02346201|157904512|FG000|Overall Study|Adverse Event|3|||
49018687|NCT02346201|157904513|FG001|Overall Study|Adverse Event|2|||
49018688|NCT02346201|157904512|FG000|Overall Study|Lost to Follow-up|1|||
49018689|NCT02346201|157904513|FG001|Overall Study|Lost to Follow-up|0|||
49018690|NCT02346201|157904512|FG000|Overall Study|Withdrawal by Subject|6|||
49018691|NCT02346201|157904513|FG001|Overall Study|Withdrawal by Subject|3|||
49018692|NCT02346201|157904512|FG000|Overall Study|Unavailable for future follow-up|0|||
49018693|NCT02346201|157904513|FG001|Overall Study|Unavailable for future follow-up|1|||
49018694|NCT02346201|157904512|FG000|Overall Study|Physician Decision|0|||
49018695|NCT02346201|157904513|FG001|Overall Study|Physician Decision|1|||
49018696|NCT02346201|157904512|FG000|Overall Study|Missed final visit|0|||
49018697|NCT02346201|157904513|FG001|Overall Study|Missed final visit|2|||
49018698|NCT02130466|157904514|FG000|Overall Study|Death|4|||
49018699|NCT02130466|157904515|FG001|Overall Study|Death|1|||
49018700|NCT02130466|157904516|FG002|Overall Study|Death|1|||
49018701|NCT02130466|157904517|FG003|Overall Study|Death|3|||
49018702|NCT02130466|157904518|FG004|Overall Study|Death|2|||
49018703|NCT02130466|157904519|FG005|Overall Study|Death|30|||
49018704|NCT02130466|157904520|FG006|Overall Study|Death|45|||
49018705|NCT02130466|157904521|FG007|Overall Study|Death|2|||
49018706|NCT02130466|157904522|FG008|Overall Study|Death|3|||
49018707|NCT02130466|157904523|FG009|Overall Study|Death|4|||
49018708|NCT02130466|157904524|FG010|Overall Study|Death|5|||
49018709|NCT02130466|157904525|FG011|Overall Study|Death|3|||
49018710|NCT02130466|157904526|FG012|Overall Study|Death|11|||
49018711|NCT02130466|157904527|FG013|Overall Study|Death|7|||
49018712|NCT02130466|157904514|FG000|Overall Study|Lost to Follow-up|1|||
49018713|NCT02130466|157904515|FG001|Overall Study|Lost to Follow-up|0|||
49018714|NCT02130466|157904516|FG002|Overall Study|Lost to Follow-up|0|||
49018715|NCT02130466|157904517|FG003|Overall Study|Lost to Follow-up|0|||
49018716|NCT02130466|157904518|FG004|Overall Study|Lost to Follow-up|0|||
49018717|NCT02130466|157904519|FG005|Overall Study|Lost to Follow-up|1|||
49018718|NCT02130466|157904520|FG006|Overall Study|Lost to Follow-up|0|||
49018719|NCT02130466|157904521|FG007|Overall Study|Lost to Follow-up|0|||
49018720|NCT02130466|157904522|FG008|Overall Study|Lost to Follow-up|0|||
49018721|NCT02130466|157904523|FG009|Overall Study|Lost to Follow-up|0|||
49018722|NCT02130466|157904524|FG010|Overall Study|Lost to Follow-up|0|||
49018723|NCT02130466|157904525|FG011|Overall Study|Lost to Follow-up|0|||
49018724|NCT02130466|157904526|FG012|Overall Study|Lost to Follow-up|1|||
49018725|NCT02130466|157904527|FG013|Overall Study|Lost to Follow-up|0|||
49018726|NCT02130466|157904514|FG000|Overall Study|Physician Decision|0|||
49018727|NCT02130466|157904515|FG001|Overall Study|Physician Decision|0|||
49018728|NCT02130466|157904516|FG002|Overall Study|Physician Decision|0|||
49018729|NCT02130466|157904517|FG003|Overall Study|Physician Decision|0|||
49018730|NCT02130466|157904518|FG004|Overall Study|Physician Decision|0|||
49018731|NCT02130466|157904519|FG005|Overall Study|Physician Decision|1|||
49018732|NCT02130466|157904520|FG006|Overall Study|Physician Decision|1|||
49018733|NCT02130466|157904521|FG007|Overall Study|Physician Decision|0|||
49018734|NCT02130466|157904522|FG008|Overall Study|Physician Decision|0|||
49018735|NCT02130466|157904523|FG009|Overall Study|Physician Decision|0|||
49018736|NCT02130466|157904524|FG010|Overall Study|Physician Decision|0|||
49018737|NCT02130466|157904525|FG011|Overall Study|Physician Decision|0|||
49018738|NCT02130466|157904526|FG012|Overall Study|Physician Decision|0|||
49018739|NCT02130466|157904527|FG013|Overall Study|Physician Decision|0|||
49018740|NCT02130466|157904514|FG000|Overall Study|Participation in Study Discontinued by Sponsor|1|||
49018741|NCT02130466|157904515|FG001|Overall Study|Participation in Study Discontinued by Sponsor|2|||
49018742|NCT02130466|157904516|FG002|Overall Study|Participation in Study Discontinued by Sponsor|1|||
49018743|NCT02130466|157904517|FG003|Overall Study|Participation in Study Discontinued by Sponsor|5|||
49018744|NCT02130466|157904518|FG004|Overall Study|Participation in Study Discontinued by Sponsor|0|||
49018745|NCT02130466|157904519|FG005|Overall Study|Participation in Study Discontinued by Sponsor|27|||
49018746|NCT02130466|157904520|FG006|Overall Study|Participation in Study Discontinued by Sponsor|14|||
49018747|NCT02130466|157904521|FG007|Overall Study|Participation in Study Discontinued by Sponsor|1|||
49018748|NCT02130466|157904522|FG008|Overall Study|Participation in Study Discontinued by Sponsor|0|||
49018749|NCT02130466|157904523|FG009|Overall Study|Participation in Study Discontinued by Sponsor|1|||
49018750|NCT02130466|157904524|FG010|Overall Study|Participation in Study Discontinued by Sponsor|1|||
49018751|NCT02130466|157904525|FG011|Overall Study|Participation in Study Discontinued by Sponsor|0|||
49018752|NCT02130466|157904526|FG012|Overall Study|Participation in Study Discontinued by Sponsor|0|||
49018753|NCT02130466|157904527|FG013|Overall Study|Participation in Study Discontinued by Sponsor|2|||
49018754|NCT02130466|157904514|FG000|Overall Study|Withdrawal by Subject|1|||
49018755|NCT02130466|157904515|FG001|Overall Study|Withdrawal by Subject|0|||
49018756|NCT02130466|157904516|FG002|Overall Study|Withdrawal by Subject|0|||
49018757|NCT02130466|157904517|FG003|Overall Study|Withdrawal by Subject|0|||
49018758|NCT02130466|157904518|FG004|Overall Study|Withdrawal by Subject|0|||
49018759|NCT02130466|157904519|FG005|Overall Study|Withdrawal by Subject|1|||
49018760|NCT02130466|157904520|FG006|Overall Study|Withdrawal by Subject|0|||
49018761|NCT02130466|157904521|FG007|Overall Study|Withdrawal by Subject|0|||
49018762|NCT02130466|157904522|FG008|Overall Study|Withdrawal by Subject|1|||
49018763|NCT02130466|157904523|FG009|Overall Study|Withdrawal by Subject|0|||
49018764|NCT02130466|157904524|FG010|Overall Study|Withdrawal by Subject|0|||
49018765|NCT02130466|157904525|FG011|Overall Study|Withdrawal by Subject|0|||
49018766|NCT02130466|157904526|FG012|Overall Study|Withdrawal by Subject|0|||
49018767|NCT02130466|157904527|FG013|Overall Study|Withdrawal by Subject|0|||
49018768|NCT00458302|157906671|FG000|Overall Study|Adverse Event|4|||
49018769|NCT00458302|157906672|FG001|Overall Study|Adverse Event|14|||
49018770|NCT00458302|157906671|FG000|Overall Study|Pregnancy|2|||
49018771|NCT00458302|157906672|FG001|Overall Study|Pregnancy|1|||
49018772|NCT00458302|157906671|FG000|Overall Study|Protocol Violation|0|||
49018773|NCT00458302|157906672|FG001|Overall Study|Protocol Violation|2|||
49018774|NCT00458302|157906671|FG000|Overall Study|Withdrawal by Subject|6|||
49018775|NCT00458302|157906672|FG001|Overall Study|Withdrawal by Subject|4|||
48980772|NCT02203916|157762181|FG002|Overall Study|Major Protocol Deviation|0|||
48980773|NCT02203916|157762179|FG000|Overall Study|Lost to Follow-up|0|||
48980774|NCT02203916|157762180|FG001|Overall Study|Lost to Follow-up|1|||
48980775|NCT02203916|157762181|FG002|Overall Study|Lost to Follow-up|0|||
48980776|NCT02203916|157762179|FG000|Overall Study|Voluntary Withdrawal|3|||
48980777|NCT02203916|157762180|FG001|Overall Study|Voluntary Withdrawal|3|||
48980778|NCT02203916|157762181|FG002|Overall Study|Voluntary Withdrawal|8|||
48980779|NCT02203916|157762179|FG000|Overall Study|Lack of Efficacy|3|||
48980780|NCT02203916|157762180|FG001|Overall Study|Lack of Efficacy|0|||
48980781|NCT02203916|157762181|FG002|Overall Study|Lack of Efficacy|0|||
48980782|NCT02203916|157762179|FG000|Overall Study|Reason Not Specified|0|||
48980783|NCT02203916|157762180|FG001|Overall Study|Reason Not Specified|2|||
48980784|NCT02203916|157762181|FG002|Overall Study|Reason Not Specified|1|||
48980785|NCT04043416|157762183|FG000|Washout|Change in health condition|0|||
48980786|NCT04043416|157762184|FG001|Washout|Change in health condition|1|||
48980787|NCT00338806|157762186|FG000|Acute Phase|Withdrawal by Subject|0|||
48980788|NCT00338806|157762187|FG001|Acute Phase|Withdrawal by Subject|1|||
48980789|NCT00338806|157762186|FG000|Follow-up|Lost to Follow-up|1|||
48980790|NCT00338806|157762187|FG001|Follow-up|Lost to Follow-up|3|||
48980791|NCT01662986|157762190|FG000|Overall Study|Adverse Event|5|||
48980792|NCT01662986|157762191|FG001|Overall Study|Adverse Event|4|||
48980793|NCT01662986|157762190|FG000|Overall Study|Protocol Violation|2|||
48980794|NCT01662986|157762191|FG001|Overall Study|Protocol Violation|3|||
48980795|NCT01662986|157762190|FG000|Overall Study|Lost to Follow-up|5|||
48980796|NCT01662986|157762191|FG001|Overall Study|Lost to Follow-up|4|||
48980797|NCT01662986|157762190|FG000|Overall Study|Withdrawal by Subject|2|||
48980798|NCT01662986|157762191|FG001|Overall Study|Withdrawal by Subject|2|||
48980799|NCT01662986|157762190|FG000|Overall Study|Not Treated|1|||
48980800|NCT01662986|157762191|FG001|Overall Study|Not Treated|0|||
48980801|NCT01662986|157762190|FG000|Overall Study|Other than stated above|3|||
48980802|NCT01662986|157762191|FG001|Overall Study|Other than stated above|0|||
48980803|NCT00486889|157762197|FG000|Overall Study|Death|3|||
48980804|NCT00486889|157762197|FG000|Overall Study|Non-compliant|2|||
48980805|NCT00486889|157762197|FG000|Overall Study|Withdrawal by Subject|6|||
48980806|NCT03797144|157762200|FG000|Enrollment|Protocol Violation|4|||
48980807|NCT03797144|157762201|FG001|Enrollment|Protocol Violation|1|||
48980808|NCT03797144|157762200|FG000|Surgery|Protocol Violation|1|||
48980809|NCT03797144|157762201|FG001|Surgery|Protocol Violation|0|||
48980810|NCT03797144|157762200|FG000|3 Month|Early termination cut-off date|2|||
48980811|NCT03797144|157762201|FG001|3 Month|Early termination cut-off date|0|||
48980812|NCT03797144|157762200|FG000|12 Month|Early termination cut-off date|8|||
48980813|NCT03797144|157762201|FG001|12 Month|Early termination cut-off date|9|||
48980814|NCT03797144|157762200|FG000|24 Month|Early termination cut-off date|1|||
48980815|NCT03797144|157762201|FG001|24 Month|Early termination cut-off date|1|||
48980816|NCT02139280|157762202|FG000|Overall Study|No longer eligible|2|||
48980817|NCT02139280|157762203|FG001|Overall Study|No longer eligible|0|||
48980818|NCT02181504|157762212|FG000|Overall Study|Adverse Event|1|||
48980819|NCT02181504|157762213|FG001|Overall Study|Adverse Event|1|||
48980820|NCT02181504|157762214|FG002|Overall Study|Adverse Event|1|||
48980821|NCT03935594|157762215|FG000|Overall Study|Physician Decision|3|||
48980822|NCT00542425|157762218|FG000|Initial 24 Weeks|Administrative reasons|0|||
48980823|NCT00542425|157762219|FG001|Initial 24 Weeks|Administrative reasons|0|||
48980824|NCT00542425|157762220|FG002|Initial 24 Weeks|Administrative reasons|1|||
48980825|NCT00542425|157762221|FG003|Initial 24 Weeks|Administrative reasons|1|||
48980826|NCT00542425|157762222|FG004|Initial 24 Weeks|Administrative reasons|0|||
48980827|NCT00542425|157762218|FG000|Initial 24 Weeks|Adverse Event|0|||
48980828|NCT00542425|157762219|FG001|Initial 24 Weeks|Adverse Event|1|||
48980829|NCT00542425|157762220|FG002|Initial 24 Weeks|Adverse Event|1|||
48980830|NCT00542425|157762221|FG003|Initial 24 Weeks|Adverse Event|3|||
48980831|NCT00542425|157762222|FG004|Initial 24 Weeks|Adverse Event|2|||
48980832|NCT00542425|157762218|FG000|Initial 24 Weeks|Inability to complete procedures|0|||
48980833|NCT00542425|157762219|FG001|Initial 24 Weeks|Inability to complete procedures|3|||
48980834|NCT00542425|157762220|FG002|Initial 24 Weeks|Inability to complete procedures|2|||
48980835|NCT00542425|157762221|FG003|Initial 24 Weeks|Inability to complete procedures|1|||
48980836|NCT00542425|157762222|FG004|Initial 24 Weeks|Inability to complete procedures|2|||
48980837|NCT00542425|157762218|FG000|Initial 24 Weeks|Lost to Follow-up|2|||
48980838|NCT00542425|157762219|FG001|Initial 24 Weeks|Lost to Follow-up|2|||
48980839|NCT00542425|157762220|FG002|Initial 24 Weeks|Lost to Follow-up|1|||
48980840|NCT00542425|157762221|FG003|Initial 24 Weeks|Lost to Follow-up|0|||
48980841|NCT00542425|157762222|FG004|Initial 24 Weeks|Lost to Follow-up|0|||
48980842|NCT00542425|157762218|FG000|Initial 24 Weeks|Non-compliance|0|||
48980843|NCT00542425|157762219|FG001|Initial 24 Weeks|Non-compliance|0|||
49018776|NCT00458302|157906671|FG000|Overall Study|Inc/Exc Criteria Not Met|1|||
49018777|NCT00458302|157906672|FG001|Overall Study|Inc/Exc Criteria Not Met|1|||
49018778|NCT00458302|157906671|FG000|Overall Study|Study Termination By Sponsor|1|||
48980844|NCT00542425|157762220|FG002|Initial 24 Weeks|Non-compliance|0|||
48980845|NCT00542425|157762221|FG003|Initial 24 Weeks|Non-compliance|1|||
48980846|NCT00542425|157762222|FG004|Initial 24 Weeks|Non-compliance|1|||
48762442|NCT01358357|156978130|FG001|Open Label Phase|Protocol Violation|0|||
48762443|NCT01358357|156978131|FG002|Open Label Phase|Protocol Violation|45|||
48762444|NCT01358357|156978129|FG000|Open Label Phase|Withdrawal by Subject|0|||
48762445|NCT01358357|156978130|FG001|Open Label Phase|Withdrawal by Subject|0|||
48762446|NCT01358357|156978131|FG002|Open Label Phase|Withdrawal by Subject|112|||
48762447|NCT01358357|156978129|FG000|Open Label Phase|Did not meet criteria for DB phase|0|||
48762448|NCT01358357|156978130|FG001|Open Label Phase|Did not meet criteria for DB phase|0|||
48762449|NCT01358357|156978131|FG002|Open Label Phase|Did not meet criteria for DB phase|16|||
48762450|NCT01358357|156978129|FG000|Open Label Phase|Terminated at study completion|0|||
48677245|NCT00483938|156669244|FG001|Overall Study|Withdrawal by Subject|6|||
48677246|NCT00483938|156669245|FG002|Overall Study|Withdrawal by Subject|0|||
48677247|NCT00483938|156669246|FG003|Overall Study|Withdrawal by Subject|0|||
48677248|NCT00483938|156669247|FG004|Overall Study|Withdrawal by Subject|1|||
48677249|NCT00483938|156669248|FG005|Overall Study|Withdrawal by Subject|3|||
48677250|NCT00483938|156669249|FG006|Overall Study|Withdrawal by Subject|2|||
48677251|NCT00483938|156669243|FG000|Overall Study|Lost to Follow-up|1|||
48677252|NCT00483938|156669244|FG001|Overall Study|Lost to Follow-up|2|||
48677253|NCT00483938|156669245|FG002|Overall Study|Lost to Follow-up|0|||
48677254|NCT00483938|156669246|FG003|Overall Study|Lost to Follow-up|2|||
48677255|NCT00483938|156669247|FG004|Overall Study|Lost to Follow-up|1|||
48677256|NCT00483938|156669248|FG005|Overall Study|Lost to Follow-up|1|||
48677257|NCT00483938|156669249|FG006|Overall Study|Lost to Follow-up|3|||
48677258|NCT00483938|156669243|FG000|Overall Study|Death|0|||
48677259|NCT00483938|156669244|FG001|Overall Study|Death|2|||
48677260|NCT00483938|156669245|FG002|Overall Study|Death|0|||
48677261|NCT00483938|156669246|FG003|Overall Study|Death|0|||
48677262|NCT00483938|156669247|FG004|Overall Study|Death|0|||
48677263|NCT00483938|156669248|FG005|Overall Study|Death|0|||
48677264|NCT00483938|156669249|FG006|Overall Study|Death|0|||
48677265|NCT00483938|156669243|FG000|Overall Study|Other|3|||
48677266|NCT00483938|156669244|FG001|Overall Study|Other|9|||
48677267|NCT00483938|156669245|FG002|Overall Study|Other|0|||
48677268|NCT00483938|156669246|FG003|Overall Study|Other|4|||
48677269|NCT00483938|156669247|FG004|Overall Study|Other|0|||
48677270|NCT00483938|156669248|FG005|Overall Study|Other|4|||
48677271|NCT00483938|156669249|FG006|Overall Study|Other|32|||
48677272|NCT03691571|156669250|FG000|Overall Study|Withdrawal by Subject|9|||
48677273|NCT03691571|156669251|FG001|Overall Study|Withdrawal by Subject|2|||
48677274|NCT02465203|156669253|FG000|Overall Study|Protocol Violation|1|||
48677275|NCT02465203|156669254|FG001|Overall Study|Protocol Violation|1|||
48677276|NCT02465203|156669255|FG002|Overall Study|Protocol Violation|1|||
48677277|NCT02465203|156669253|FG000|Overall Study|Study terminated by sponsor|50|||
48677278|NCT02465203|156669254|FG001|Overall Study|Study terminated by sponsor|34|||
48677279|NCT02465203|156669255|FG002|Overall Study|Study terminated by sponsor|11|||
48677280|NCT02465203|156669253|FG000|Overall Study|New therapy for study indication|4|||
48677281|NCT02465203|156669254|FG001|Overall Study|New therapy for study indication|0|||
48677282|NCT02465203|156669255|FG002|Overall Study|New therapy for study indication|0|||
48677283|NCT02465203|156669253|FG000|Overall Study|Patient/guardian decision|1|||
48677284|NCT02465203|156669254|FG001|Overall Study|Patient/guardian decision|1|||
48677285|NCT02465203|156669255|FG002|Overall Study|Patient/guardian decision|1|||
48677286|NCT03761810|156669256|FG000|Overall Study|Adverse Event|12|||
48677287|NCT03761810|156669257|FG001|Overall Study|Adverse Event|0|||
48677288|NCT03761810|156669256|FG000|Overall Study|Lost to Follow-up|15|||
48677289|NCT03761810|156669257|FG001|Overall Study|Lost to Follow-up|7|||
48677290|NCT03761810|156669256|FG000|Overall Study|Pregnancy|1|||
48677291|NCT03761810|156669257|FG001|Overall Study|Pregnancy|0|||
48677292|NCT03761810|156669256|FG000|Overall Study|Withdrawal by Subject|14|||
48677293|NCT03761810|156669257|FG001|Overall Study|Withdrawal by Subject|5|||
48677294|NCT03761810|156669256|FG000|Overall Study|Physician Decision|1|||
48677295|NCT03761810|156669257|FG001|Overall Study|Physician Decision|0|||
48677296|NCT03761810|156669256|FG000|Overall Study|Withdrawal by Parent/Guardian|4|||
48677297|NCT03761810|156669257|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
48677298|NCT03761810|156669256|FG000|Overall Study|Other Than Specified|1|||
48677299|NCT03761810|156669257|FG001|Overall Study|Other Than Specified|0|||
48677300|NCT00947115|156669260|FG000|Overall Study|Missed reporting interval|3|||
48677301|NCT00947115|156669261|FG001|Overall Study|Missed reporting interval|4|||
48677302|NCT00947115|156669262|FG002|Overall Study|Missed reporting interval|2|||
48677303|NCT00947115|156669260|FG000|Overall Study|Physician Decision|0|||
48677304|NCT00947115|156669261|FG001|Overall Study|Physician Decision|2|||
48677305|NCT00947115|156669262|FG002|Overall Study|Physician Decision|0|||
48677306|NCT00947115|156669260|FG000|Overall Study|Death|0|||
48677307|NCT00947115|156669261|FG001|Overall Study|Death|1|||
48677308|NCT00947115|156669262|FG002|Overall Study|Death|1|||
48677309|NCT00947115|156669260|FG000|Overall Study|Migrated from study area|2|||
48677310|NCT00947115|156669261|FG001|Overall Study|Migrated from study area|0|||
48874943|NCT00358644|157378990|FG000|Overall Study|Progressive Disease|21|||
48677311|NCT00947115|156669262|FG002|Overall Study|Migrated from study area|0|||
48677312|NCT00947115|156669260|FG000|Overall Study|Withdrawal by Subject|1|||
48677313|NCT00947115|156669261|FG001|Overall Study|Withdrawal by Subject|3|||
49018779|NCT00458302|157906672|FG001|Overall Study|Study Termination By Sponsor|0|||
48677314|NCT00947115|156669262|FG002|Overall Study|Withdrawal by Subject|4|||
48677315|NCT00947115|156669260|FG000|Overall Study|Lost to Follow-up|11|||
48677316|NCT00947115|156669261|FG001|Overall Study|Lost to Follow-up|12|||
48677317|NCT00947115|156669262|FG002|Overall Study|Lost to Follow-up|8|||
48677318|NCT01223183|156669263|FG000|Imaging Day 1|Physician Decision|0|||
48677319|NCT01223183|156669264|FG001|Imaging Day 1|Physician Decision|1|||
48677320|NCT01223183|156669263|FG000|Washout Period (5-24 Days)|Lost to Follow-up|1|||
48677321|NCT01223183|156669264|FG001|Washout Period (5-24 Days)|Lost to Follow-up|0|||
48677322|NCT01223183|156669263|FG000|Washout Period (5-24 Days)|Physician Decision|1|||
48677323|NCT01223183|156669264|FG001|Washout Period (5-24 Days)|Physician Decision|0|||
48677324|NCT00900029|156669265|FG000|Overall Study|Lost to Follow-up|0|||
48677325|NCT00900029|156669266|FG001|Overall Study|Lost to Follow-up|2|||
48677326|NCT00900029|156669267|FG002|Overall Study|Lost to Follow-up|1|||
48677327|NCT00900029|156669268|FG003|Overall Study|Lost to Follow-up|4|||
48677328|NCT00900029|156669269|FG004|Overall Study|Lost to Follow-up|4|||
48677329|NCT00900029|156669265|FG000|Overall Study|Withdrawal by Subject|2|||
48677330|NCT00900029|156669266|FG001|Overall Study|Withdrawal by Subject|2|||
48677331|NCT00900029|156669267|FG002|Overall Study|Withdrawal by Subject|1|||
48677332|NCT00900029|156669268|FG003|Overall Study|Withdrawal by Subject|1|||
48677333|NCT00900029|156669269|FG004|Overall Study|Withdrawal by Subject|1|||
48677334|NCT00900029|156669265|FG000|Overall Study|Adverse Event|0|||
48677335|NCT00900029|156669266|FG001|Overall Study|Adverse Event|0|||
48677336|NCT00900029|156669267|FG002|Overall Study|Adverse Event|1|||
48677337|NCT00900029|156669268|FG003|Overall Study|Adverse Event|1|||
48677338|NCT00900029|156669269|FG004|Overall Study|Adverse Event|1|||
48677339|NCT00900029|156669265|FG000|Overall Study|Death|1|||
48677340|NCT00900029|156669266|FG001|Overall Study|Death|0|||
48677341|NCT00900029|156669267|FG002|Overall Study|Death|0|||
48677342|NCT00900029|156669268|FG003|Overall Study|Death|1|||
48677343|NCT00900029|156669269|FG004|Overall Study|Death|0|||
48677344|NCT03268941|156671317|FG000|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
48677345|NCT03268941|156671318|FG001|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
48677346|NCT03268941|156671319|FG002|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
48677347|NCT03268941|156671320|FG003|Part 1 (Days 1 to 9)|Withdrawal by Subject|1|||
48762451|NCT01358357|156978130|FG001|Open Label Phase|Terminated at study completion|0|||
48762452|NCT01358357|156978131|FG002|Open Label Phase|Terminated at study completion|5|||
48762453|NCT01358357|156978129|FG000|Open Label Phase|Mood episode|0|||
48762454|NCT01358357|156978130|FG001|Open Label Phase|Mood episode|0|||
48762455|NCT01358357|156978131|FG002|Open Label Phase|Mood episode|42|||
48762456|NCT01358357|156978129|FG000|Double-Blind Phase|Adverse Event|8|||
48762457|NCT01358357|156978130|FG001|Double-Blind Phase|Adverse Event|5|||
48762458|NCT01358357|156978131|FG002|Double-Blind Phase|Adverse Event|0|||
48762459|NCT01358357|156978129|FG000|Double-Blind Phase|Lost to Follow-up|5|||
48762460|NCT01358357|156978130|FG001|Double-Blind Phase|Lost to Follow-up|7|||
48762461|NCT01358357|156978131|FG002|Double-Blind Phase|Lost to Follow-up|0|||
48762462|NCT01358357|156978129|FG000|Double-Blind Phase|Protocol Violation|1|||
48762463|NCT01358357|156978130|FG001|Double-Blind Phase|Protocol Violation|11|||
48762464|NCT01358357|156978131|FG002|Double-Blind Phase|Protocol Violation|0|||
48762465|NCT01358357|156978129|FG000|Double-Blind Phase|Protocol Violation|16|||
48762466|NCT01358357|156978130|FG001|Double-Blind Phase|Protocol Violation|12|||
48762467|NCT01358357|156978131|FG002|Double-Blind Phase|Protocol Violation|0|||
48762468|NCT01358357|156978129|FG000|Double-Blind Phase|Terminated at study completion|2|||
48762469|NCT01358357|156978130|FG001|Double-Blind Phase|Terminated at study completion|0|||
48762470|NCT01358357|156978131|FG002|Double-Blind Phase|Terminated at study completion|0|||
48762471|NCT01358357|156978129|FG000|Double-Blind Phase|Recurrence of mood event|48|||
48762472|NCT01358357|156978130|FG001|Double-Blind Phase|Recurrence of mood event|64|||
48762473|NCT01358357|156978131|FG002|Double-Blind Phase|Recurrence of mood event|0|||
48762474|NCT01358357|156978129|FG000|Double-Blind Phase|Administrative|0|||
48762475|NCT01358357|156978130|FG001|Double-Blind Phase|Administrative|1|||
48677348|NCT03268941|156671321|FG004|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
48677349|NCT03268941|156671322|FG005|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
48677350|NCT03268941|156671323|FG006|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
48762476|NCT01358357|156978131|FG002|Double-Blind Phase|Administrative|0|||
48762477|NCT04351087|156978132|FG000|Overall Study|Lost to Follow-up|7|||
48762478|NCT04351087|156978133|FG001|Overall Study|Lost to Follow-up|3|||
48677351|NCT03268941|156671317|FG000|Part 1 (Days 1 to 9)|Adverse Event|0|||
48677352|NCT03268941|156671318|FG001|Part 1 (Days 1 to 9)|Adverse Event|0|||
48677353|NCT03268941|156671319|FG002|Part 1 (Days 1 to 9)|Adverse Event|0|||
48677354|NCT03268941|156671320|FG003|Part 1 (Days 1 to 9)|Adverse Event|1|||
48677355|NCT03268941|156671321|FG004|Part 1 (Days 1 to 9)|Adverse Event|0|||
48762479|NCT04351087|156978132|FG000|Overall Study|Withdrawal by Subject|3|||
48762480|NCT04351087|156978133|FG001|Overall Study|Withdrawal by Subject|4|||
48762481|NCT04351087|156978132|FG000|Overall Study|Lack of Efficacy|3|||
48677356|NCT03268941|156671322|FG005|Part 1 (Days 1 to 9)|Adverse Event|0|||
48677357|NCT03268941|156671323|FG006|Part 1 (Days 1 to 9)|Adverse Event|0|||
48677358|NCT03268941|156671317|FG000|Part 1 (Days 1 to 9)|Protocol Deviation|1|||
48677359|NCT03268941|156671318|FG001|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
48980847|NCT00542425|157762218|FG000|Initial 24 Weeks|Protocol Violation|0|||
48980848|NCT00542425|157762219|FG001|Initial 24 Weeks|Protocol Violation|0|||
48980849|NCT00542425|157762220|FG002|Initial 24 Weeks|Protocol Violation|0|||
48980850|NCT00542425|157762221|FG003|Initial 24 Weeks|Protocol Violation|1|||
48980851|NCT00542425|157762222|FG004|Initial 24 Weeks|Protocol Violation|0|||
48980852|NCT00542425|157762218|FG000|Initial 24 Weeks|Refusal of treatment|2|||
48980853|NCT00542425|157762219|FG001|Initial 24 Weeks|Refusal of treatment|2|||
48980854|NCT00542425|157762220|FG002|Initial 24 Weeks|Refusal of treatment|1|||
48980855|NCT00542425|157762221|FG003|Initial 24 Weeks|Refusal of treatment|4|||
48980856|NCT00542425|157762222|FG004|Initial 24 Weeks|Refusal of treatment|1|||
48980857|NCT00542425|157762218|FG000|Initial 24 Weeks|Other|0|||
48980858|NCT00542425|157762219|FG001|Initial 24 Weeks|Other|2|||
48980859|NCT00542425|157762220|FG002|Initial 24 Weeks|Other|1|||
48980860|NCT00542425|157762221|FG003|Initial 24 Weeks|Other|0|||
48980861|NCT00542425|157762222|FG004|Initial 24 Weeks|Other|0|||
48980862|NCT00542425|157762218|FG000|Extended 24 Weeks of Treatment|Adverse Event|0|||
48980863|NCT00542425|157762219|FG001|Extended 24 Weeks of Treatment|Adverse Event|0|||
48980864|NCT00542425|157762220|FG002|Extended 24 Weeks of Treatment|Adverse Event|1|||
48980865|NCT00542425|157762221|FG003|Extended 24 Weeks of Treatment|Adverse Event|1|||
48980866|NCT00542425|157762222|FG004|Extended 24 Weeks of Treatment|Adverse Event|0|||
48980867|NCT00542425|157762218|FG000|Extended 24 Weeks of Treatment|Protocol Violation|0|||
48980868|NCT00542425|157762219|FG001|Extended 24 Weeks of Treatment|Protocol Violation|0|||
48980869|NCT00542425|157762220|FG002|Extended 24 Weeks of Treatment|Protocol Violation|1|||
48980870|NCT00542425|157762221|FG003|Extended 24 Weeks of Treatment|Protocol Violation|0|||
48980871|NCT00542425|157762222|FG004|Extended 24 Weeks of Treatment|Protocol Violation|0|||
48980872|NCT00542425|157762218|FG000|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
48980873|NCT00542425|157762219|FG001|Extended 24 Weeks of Treatment|Refusal of treatment|1|||
48980874|NCT00542425|157762220|FG002|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
48980875|NCT00542425|157762221|FG003|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
49018780|NCT00458302|157906671|FG000|Overall Study|Lost to Follow-up|2|||
48980876|NCT00542425|157762222|FG004|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
48980877|NCT00542425|157762218|FG000|Extended 24 Weeks of Treatment|Other|1|||
48980878|NCT00542425|157762219|FG001|Extended 24 Weeks of Treatment|Other|1|||
48980879|NCT00542425|157762220|FG002|Extended 24 Weeks of Treatment|Other|0|||
48980880|NCT00542425|157762221|FG003|Extended 24 Weeks of Treatment|Other|0|||
48980881|NCT00542425|157762222|FG004|Extended 24 Weeks of Treatment|Other|1|||
48980882|NCT01846208|157762223|FG000|Overall Study|Withdrew prior to treatment|1|||
48980883|NCT01846208|157762224|FG001|Overall Study|Withdrew prior to treatment|1|||
48980884|NCT01846208|157762225|FG002|Overall Study|Withdrew prior to treatment|1|||
48980885|NCT01846208|157762223|FG000|Overall Study|Dosing Symptoms|1|||
48980886|NCT01846208|157762224|FG001|Overall Study|Dosing Symptoms|2|||
48980887|NCT01846208|157762225|FG002|Overall Study|Dosing Symptoms|6|||
48980888|NCT01846208|157762223|FG000|Overall Study|Withdrawal by Subject|5|||
48980889|NCT01846208|157762224|FG001|Overall Study|Withdrawal by Subject|0|||
49018781|NCT00458302|157906672|FG001|Overall Study|Lost to Follow-up|0|||
49018782|NCT00458302|157906671|FG000|Overall Study|Other|4|||
49018783|NCT00458302|157906672|FG001|Overall Study|Other|2|||
49018784|NCT05188521|157906673|FG000|Baricitinib 2mg Initial Study|Travel issues|1|||
49018785|NCT05188521|157906674|FG001|Baricitinib 2mg Initial Study|Travel issues|0|||
49018786|NCT01621490|157906679|FG000|Overall Study|Subject no longer meets study criteria|0|||
49018787|NCT01621490|157906680|FG001|Overall Study|Subject no longer meets study criteria|0|||
49018788|NCT01621490|157906681|FG002|Overall Study|Subject no longer meets study criteria|0|||
49018789|NCT01621490|157906682|FG003|Overall Study|Subject no longer meets study criteria|0|||
49018790|NCT01621490|157906683|FG004|Overall Study|Subject no longer meets study criteria|1|||
49018791|NCT01621490|157906684|FG005|Overall Study|Subject no longer meets study criteria|0|||
49018792|NCT01621490|157906685|FG006|Overall Study|Subject no longer meets study criteria|0|||
49018793|NCT01621490|157906686|FG007|Overall Study|Subject no longer meets study criteria|0|||
49018794|NCT01621490|157906687|FG008|Overall Study|Subject no longer meets study criteria|0|||
49018795|NCT01621490|157906688|FG009|Overall Study|Subject no longer meets study criteria|0|||
49018796|NCT01621490|157906689|FG010|Overall Study|Subject no longer meets study criteria|0|||
49018797|NCT01621490|157906679|FG000|Overall Study|Maximum clinical benefit|3|||
49018798|NCT01621490|157906680|FG001|Overall Study|Maximum clinical benefit|2|||
49018799|NCT01621490|157906681|FG002|Overall Study|Maximum clinical benefit|0|||
49018800|NCT01621490|157906682|FG003|Overall Study|Maximum clinical benefit|0|||
49018801|NCT01621490|157906683|FG004|Overall Study|Maximum clinical benefit|0|||
49018802|NCT01621490|157906684|FG005|Overall Study|Maximum clinical benefit|0|||
49018803|NCT01621490|157906685|FG006|Overall Study|Maximum clinical benefit|1|||
49018804|NCT01621490|157906686|FG007|Overall Study|Maximum clinical benefit|2|||
49018805|NCT01621490|157906687|FG008|Overall Study|Maximum clinical benefit|2|||
49018806|NCT01621490|157906688|FG009|Overall Study|Maximum clinical benefit|0|||
49018807|NCT01621490|157906689|FG010|Overall Study|Maximum clinical benefit|0|||
48677360|NCT03268941|156671319|FG002|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
48677361|NCT03268941|156671320|FG003|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
48677362|NCT03268941|156671321|FG004|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
48677363|NCT03268941|156671322|FG005|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
48677364|NCT03268941|156671323|FG006|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
48677365|NCT03268941|156671317|FG000|Part 2: Days 17 to 25|Reason not specified|0|||
48677366|NCT03268941|156671318|FG001|Part 2: Days 17 to 25|Reason not specified|0|||
48677367|NCT03268941|156671319|FG002|Part 2: Days 17 to 25|Reason not specified|0|||
48677368|NCT03268941|156671320|FG003|Part 2: Days 17 to 25|Reason not specified|0|||
48677369|NCT03268941|156671321|FG004|Part 2: Days 17 to 25|Reason not specified|0|||
48677370|NCT03268941|156671322|FG005|Part 2: Days 17 to 25|Reason not specified|0|||
48677371|NCT03268941|156671323|FG006|Part 2: Days 17 to 25|Reason not specified|1|||
48677372|NCT03268941|156671317|FG000|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
48677373|NCT03268941|156671318|FG001|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
48677374|NCT03268941|156671319|FG002|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
48677375|NCT03268941|156671320|FG003|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
48762482|NCT04351087|156978133|FG001|Overall Study|Lack of Efficacy|2|||
48762483|NCT01774786|156978136|FG000|Overall Study|Death|300|||
48762484|NCT01774786|156978137|FG001|Overall Study|Death|319|||
48762485|NCT01774786|156978136|FG000|Overall Study|Lost to Follow-up|6|||
48762486|NCT01774786|156978137|FG001|Overall Study|Lost to Follow-up|7|||
48762487|NCT01774786|156978136|FG000|Overall Study|Withdrawal by Subject|18|||
48762488|NCT01774786|156978137|FG001|Overall Study|Withdrawal by Subject|14|||
48762489|NCT01774786|156978136|FG000|Overall Study|Physician Decision|2|||
48762490|NCT01774786|156978137|FG001|Overall Study|Physician Decision|0|||
48762491|NCT01774786|156978136|FG000|Overall Study|Non-compliance|0|||
48762492|NCT01774786|156978137|FG001|Overall Study|Non-compliance|1|||
48762493|NCT01774786|156978136|FG000|Overall Study|Reason Not Specified|2|||
48762494|NCT01774786|156978137|FG001|Overall Study|Reason Not Specified|5|||
48762495|NCT02268812|156978138|FG000|Overall Study|Adverse Event|8|||
48762496|NCT02268812|156978139|FG001|Overall Study|Adverse Event|26|||
48677376|NCT03268941|156671321|FG004|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
48677377|NCT03268941|156671322|FG005|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
48677378|NCT03268941|156671323|FG006|Part 2: Days 17 to 25|Withdrawal by Subject|1|||
48677379|NCT04599465|156671324|FG000|Overall Study|Physician Decision|1|||
48677380|NCT04599465|156671324|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
48677381|NCT00994643|156671326|FG000|Overall Study|Withdrawal by Subject|1|||
48677382|NCT00652951|156671327|FG000|Booster Phase|Adverse event, non-fatal|0|||
48677383|NCT00652951|156671328|FG001|Booster Phase|Adverse event, non-fatal|1|||
48677384|NCT00652951|156671329|FG002|Booster Phase|Adverse event, non-fatal|0|||
48677385|NCT00652951|156671327|FG000|Booster Phase|Other|1|||
48677386|NCT00652951|156671328|FG001|Booster Phase|Other|0|||
48677387|NCT00652951|156671329|FG002|Booster Phase|Other|0|||
48677388|NCT01206582|156671332|FG000|Overall Study|Withdrew prior to study|1|||
48677389|NCT01206582|156671333|FG001|Overall Study|Withdrew prior to study|0|||
48677390|NCT01206582|156671332|FG000|Overall Study|Discontinued intervention before week 8|1|||
48677391|NCT01206582|156671333|FG001|Overall Study|Discontinued intervention before week 8|2|||
48762497|NCT02268812|156978140|FG002|Overall Study|Adverse Event|7|||
49018808|NCT01621490|157906679|FG000|Overall Study|Withdrawal by Subject|1|||
49018809|NCT01621490|157906680|FG001|Overall Study|Withdrawal by Subject|0|||
49018810|NCT01621490|157906681|FG002|Overall Study|Withdrawal by Subject|0|||
49018811|NCT01621490|157906682|FG003|Overall Study|Withdrawal by Subject|0|||
49018812|NCT01621490|157906683|FG004|Overall Study|Withdrawal by Subject|0|||
49018813|NCT01621490|157906684|FG005|Overall Study|Withdrawal by Subject|1|||
49018814|NCT01621490|157906685|FG006|Overall Study|Withdrawal by Subject|0|||
49018815|NCT01621490|157906686|FG007|Overall Study|Withdrawal by Subject|0|||
49018816|NCT01621490|157906687|FG008|Overall Study|Withdrawal by Subject|0|||
49018817|NCT01621490|157906688|FG009|Overall Study|Withdrawal by Subject|0|||
49018818|NCT01621490|157906689|FG010|Overall Study|Withdrawal by Subject|0|||
49018819|NCT01621490|157906679|FG000|Overall Study|Subject request to discontinue study|1|||
48677392|NCT01363661|156671334|FG000|Overall Study|Adverse Event|9|||
48874944|NCT00358644|157378990|FG000|Overall Study|Adverse Event|7|||
48677393|NCT01363661|156671335|FG001|Overall Study|Adverse Event|2|||
48677394|NCT01363661|156671334|FG000|Overall Study|Withdrawal by Subject|1|||
48677395|NCT01363661|156671335|FG001|Overall Study|Withdrawal by Subject|1|||
48677396|NCT01363661|156671334|FG000|Overall Study|Protocol Violation|1|||
48677397|NCT01363661|156671335|FG001|Overall Study|Protocol Violation|0|||
48677398|NCT01363661|156671334|FG000|Overall Study|Lost to Follow-up|3|||
48677399|NCT01363661|156671335|FG001|Overall Study|Lost to Follow-up|1|||
48677400|NCT03472586|156671336|FG000|Overall Study|Physician Decision|6|||
48762498|NCT02268812|156978141|FG003|Overall Study|Adverse Event|10|||
48762499|NCT02268812|156978138|FG000|Overall Study|Protocol deviation|0|||
48762500|NCT02268812|156978139|FG001|Overall Study|Protocol deviation|0|||
48874945|NCT00358644|157378990|FG000|Overall Study|Death|11|||
49018820|NCT01621490|157906680|FG001|Overall Study|Subject request to discontinue study|3|||
49018821|NCT01621490|157906681|FG002|Overall Study|Subject request to discontinue study|1|||
49018822|NCT01621490|157906682|FG003|Overall Study|Subject request to discontinue study|1|||
49018823|NCT01621490|157906683|FG004|Overall Study|Subject request to discontinue study|0|||
49018824|NCT01621490|157906684|FG005|Overall Study|Subject request to discontinue study|2|||
49018825|NCT01621490|157906685|FG006|Overall Study|Subject request to discontinue study|1|||
49018826|NCT01621490|157906686|FG007|Overall Study|Subject request to discontinue study|0|||
49018827|NCT01621490|157906687|FG008|Overall Study|Subject request to discontinue study|1|||
49018828|NCT01621490|157906688|FG009|Overall Study|Subject request to discontinue study|0|||
49018829|NCT01621490|157906689|FG010|Overall Study|Subject request to discontinue study|0|||
49018830|NCT01621490|157906679|FG000|Overall Study|Adverse event unrelated to study drug|1|||
49018831|NCT01621490|157906680|FG001|Overall Study|Adverse event unrelated to study drug|1|||
49018832|NCT01621490|157906681|FG002|Overall Study|Adverse event unrelated to study drug|0|||
49018833|NCT01621490|157906682|FG003|Overall Study|Adverse event unrelated to study drug|0|||
49018834|NCT01621490|157906683|FG004|Overall Study|Adverse event unrelated to study drug|0|||
49018835|NCT01621490|157906684|FG005|Overall Study|Adverse event unrelated to study drug|0|||
49018836|NCT01621490|157906685|FG006|Overall Study|Adverse event unrelated to study drug|0|||
49018837|NCT01621490|157906686|FG007|Overall Study|Adverse event unrelated to study drug|2|||
49018838|NCT01621490|157906687|FG008|Overall Study|Adverse event unrelated to study drug|0|||
49018839|NCT01621490|157906688|FG009|Overall Study|Adverse event unrelated to study drug|0|||
49018840|NCT01621490|157906689|FG010|Overall Study|Adverse event unrelated to study drug|0|||
49018841|NCT01621490|157906679|FG000|Overall Study|Disease progression|27|||
49018842|NCT01621490|157906680|FG001|Overall Study|Disease progression|28|||
49018843|NCT01621490|157906681|FG002|Overall Study|Disease progression|1|||
49018844|NCT01621490|157906682|FG003|Overall Study|Disease progression|5|||
49018845|NCT01621490|157906683|FG004|Overall Study|Disease progression|3|||
49018846|NCT01621490|157906684|FG005|Overall Study|Disease progression|8|||
49018847|NCT01621490|157906685|FG006|Overall Study|Disease progression|7|||
49018848|NCT01621490|157906686|FG007|Overall Study|Disease progression|1|||
49018849|NCT01621490|157906687|FG008|Overall Study|Disease progression|4|||
49018850|NCT01621490|157906688|FG009|Overall Study|Disease progression|1|||
49018851|NCT01621490|157906689|FG010|Overall Study|Disease progression|1|||
49018852|NCT01621490|157906679|FG000|Overall Study|Study drug toxicity|1|||
49018853|NCT01621490|157906680|FG001|Overall Study|Study drug toxicity|4|||
49018854|NCT01621490|157906681|FG002|Overall Study|Study drug toxicity|5|||
49018855|NCT01621490|157906682|FG003|Overall Study|Study drug toxicity|3|||
49018856|NCT01621490|157906683|FG004|Overall Study|Study drug toxicity|1|||
49018857|NCT01621490|157906684|FG005|Overall Study|Study drug toxicity|10|||
49018858|NCT01621490|157906685|FG006|Overall Study|Study drug toxicity|1|||
49018859|NCT01621490|157906686|FG007|Overall Study|Study drug toxicity|4|||
49018860|NCT01621490|157906687|FG008|Overall Study|Study drug toxicity|1|||
49018861|NCT01621490|157906688|FG009|Overall Study|Study drug toxicity|0|||
49018862|NCT01621490|157906689|FG010|Overall Study|Study drug toxicity|0|||
49018863|NCT01621490|157906679|FG000|Overall Study|Death|0|||
49018864|NCT01621490|157906680|FG001|Overall Study|Death|0|||
49018865|NCT01621490|157906681|FG002|Overall Study|Death|0|||
49018866|NCT01621490|157906682|FG003|Overall Study|Death|0|||
49018867|NCT01621490|157906683|FG004|Overall Study|Death|0|||
49018868|NCT01621490|157906684|FG005|Overall Study|Death|0|||
49018869|NCT01621490|157906685|FG006|Overall Study|Death|0|||
49018870|NCT01621490|157906686|FG007|Overall Study|Death|0|||
49018871|NCT01621490|157906687|FG008|Overall Study|Death|1|||
49018872|NCT01621490|157906688|FG009|Overall Study|Death|0|||
49018873|NCT01621490|157906689|FG010|Overall Study|Death|0|||
49018874|NCT01621490|157906679|FG000|Overall Study|Other reasons|7|||
49018875|NCT01621490|157906680|FG001|Overall Study|Other reasons|6|||
49018876|NCT01621490|157906681|FG002|Overall Study|Other reasons|4|||
49018877|NCT01621490|157906682|FG003|Overall Study|Other reasons|1|||
49018878|NCT01621490|157906683|FG004|Overall Study|Other reasons|1|||
49018879|NCT01621490|157906684|FG005|Overall Study|Other reasons|3|||
49018880|NCT01621490|157906685|FG006|Overall Study|Other reasons|1|||
49018881|NCT01621490|157906686|FG007|Overall Study|Other reasons|1|||
49018882|NCT01621490|157906687|FG008|Overall Study|Other reasons|1|||
49018883|NCT01621490|157906688|FG009|Overall Study|Other reasons|0|||
49018884|NCT01621490|157906689|FG010|Overall Study|Other reasons|0|||
49018885|NCT00506753|157906690|FG000|Overall Study|Lost to Follow-up|21|||
49018886|NCT00506753|157906691|FG001|Overall Study|Lost to Follow-up|15|||
49018887|NCT00125359|157906693|FG000|Overall Study|Death|4|||
49018888|NCT00125359|157906693|FG000|Overall Study|Adverse Event|5|||
49018889|NCT00125359|157906693|FG000|Overall Study|Physician Decision|14|||
49018890|NCT02224456|157906700|FG000|Overall Study|Lack of Efficacy|1|||
49018891|NCT02224456|157906700|FG000|Overall Study|Lost to Follow-up|15|||
49018892|NCT02224456|157906700|FG000|Overall Study|Withdrawal by Subject|9|||
49018893|NCT02224456|157906700|FG000|Overall Study|Physician Decision|3|||
49018894|NCT02224456|157906700|FG000|Overall Study|Death|2|||
49018895|NCT02224456|157906700|FG000|Overall Study|Pregnancy|4|||
49018896|NCT02224456|157906700|FG000|Overall Study|Protocol Violation|1|||
49018897|NCT02224456|157906700|FG000|Overall Study|Treatment Interruptions of ≥28 days|1|||
49018898|NCT00678392|157906701|FG000|Overall Study|Adverse Event|0|||
49018899|NCT00678392|157906702|FG001|Overall Study|Adverse Event|6|||
49018900|NCT00678392|157906701|FG000|Overall Study|Death|280|||
49018901|NCT00678392|157906702|FG001|Overall Study|Death|269|||
49018902|NCT00678392|157906701|FG000|Overall Study|Lost to Follow-up|15|||
49018903|NCT00678392|157906702|FG001|Overall Study|Lost to Follow-up|13|||
49018904|NCT00678392|157906701|FG000|Overall Study|Objective Progression or Relapse|3|||
49018905|NCT00678392|157906702|FG001|Overall Study|Objective Progression or Relapse|8|||
49018906|NCT00678392|157906701|FG000|Overall Study|Sponsor's Decision|1|||
49018907|NCT00678392|157906702|FG001|Overall Study|Sponsor's Decision|2|||
49018908|NCT00678392|157906701|FG000|Overall Study|Withdrawal by Subject|4|||
49018909|NCT00678392|157906702|FG001|Overall Study|Withdrawal by Subject|4|||
49018910|NCT00678392|157906701|FG000|Overall Study|Randomized But Not Treated|2|||
49018911|NCT00678392|157906702|FG001|Overall Study|Randomized But Not Treated|7|||
49018912|NCT00678392|157906701|FG000|Overall Study|Other|56|||
48762501|NCT02268812|156978140|FG002|Overall Study|Protocol deviation|1|||
48762502|NCT02268812|156978141|FG003|Overall Study|Protocol deviation|0|||
48762503|NCT02268812|156978138|FG000|Overall Study|Withdrawal by Subject|0|||
48762504|NCT02268812|156978139|FG001|Overall Study|Withdrawal by Subject|1|||
48762505|NCT02268812|156978140|FG002|Overall Study|Withdrawal by Subject|0|||
48762506|NCT02268812|156978141|FG003|Overall Study|Withdrawal by Subject|0|||
48762507|NCT02268812|156978138|FG000|Overall Study|Physician Decision|3|||
49018913|NCT00678392|157906702|FG001|Overall Study|Other|53|||
49018914|NCT01958281|157906705|FG000|Overall Study|Lack of Efficacy|5|||
49018915|NCT01958281|157906706|FG001|Overall Study|Lack of Efficacy|2|||
49018916|NCT01958281|157906707|FG002|Overall Study|Lack of Efficacy|0|||
49018917|NCT01958281|157906705|FG000|Overall Study|Adverse Event|0|||
49018918|NCT01958281|157906706|FG001|Overall Study|Adverse Event|2|||
49018919|NCT01958281|157906707|FG002|Overall Study|Adverse Event|0|||
49018920|NCT01958281|157906705|FG000|Overall Study|Withdrew Consent|1|||
49018921|NCT01958281|157906706|FG001|Overall Study|Withdrew Consent|0|||
49018922|NCT01958281|157906707|FG002|Overall Study|Withdrew Consent|0|||
49018923|NCT04635423|157906708|FG000|Overall Study|Ongoing|493|||
49018924|NCT04635423|157906709|FG001|Overall Study|Ongoing|501|||
49018925|NCT04635423|157906708|FG000|Overall Study|Withdrawal by Subject|36|||
49018926|NCT04635423|157906709|FG001|Overall Study|Withdrawal by Subject|29|||
49018927|NCT02784106|157906710|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3|||
49018928|NCT02784106|157906711|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5|||
49018929|NCT02784106|157906712|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
49018930|NCT02784106|157906713|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
49018931|NCT02784106|157906710|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
49018932|NCT02784106|157906711|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
49018933|NCT02784106|157906712|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
49018934|NCT02784106|157906713|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
49018935|NCT02784106|157906710|FG000|Double-Blind Treatment Period (12 Weeks)|Other|2|||
49018936|NCT02784106|157906711|FG001|Double-Blind Treatment Period (12 Weeks)|Other|0|||
49018937|NCT02784106|157906712|FG002|Double-Blind Treatment Period (12 Weeks)|Other|0|||
49018938|NCT02784106|157906713|FG003|Double-Blind Treatment Period (12 Weeks)|Other|0|||
49018939|NCT02784106|157906710|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
49018940|NCT02784106|157906711|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
49018941|NCT02784106|157906712|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
49018942|NCT02784106|157906713|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
49018943|NCT02784106|157906710|FG000|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
49018944|NCT02784106|157906711|FG001|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
49018945|NCT02784106|157906712|FG002|Open-Label Extension Period (26 Weeks)|Adverse Event|2|||
49018946|NCT02784106|157906713|FG003|Open-Label Extension Period (26 Weeks)|Adverse Event|1|||
49018947|NCT02784106|157906710|FG000|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
49018948|NCT02784106|157906711|FG001|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
49018949|NCT02784106|157906712|FG002|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
49018950|NCT02784106|157906713|FG003|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
49018951|NCT00135707|157906714|FG000|Overall Study|Lost to Follow-up|94|||
49018952|NCT00135707|157906715|FG001|Overall Study|Lost to Follow-up|89|||
48762508|NCT02268812|156978139|FG001|Overall Study|Physician Decision|1|||
48762509|NCT02268812|156978140|FG002|Overall Study|Physician Decision|0|||
49018953|NCT00135707|157906714|FG000|Overall Study|Withdrawal by Subject|0|||
49018954|NCT00135707|157906715|FG001|Overall Study|Withdrawal by Subject|1|||
49018955|NCT00135707|157906714|FG000|Overall Study|Institutional review board request|1|||
49018956|NCT00135707|157906715|FG001|Overall Study|Institutional review board request|0|||
49018957|NCT01829464|157906719|FG000|Overall Study|Adverse Event|1|||
49018958|NCT01829464|157906720|FG001|Overall Study|Adverse Event|0|||
49018959|NCT01829464|157906721|FG002|Overall Study|Adverse Event|0|||
48762510|NCT02268812|156978141|FG003|Overall Study|Physician Decision|1|||
48762511|NCT02268812|156978138|FG000|Overall Study|Other|5|||
48762512|NCT02268812|156978139|FG001|Overall Study|Other|4|||
48762513|NCT02268812|156978140|FG002|Overall Study|Other|1|||
49018960|NCT01829464|157906719|FG000|Overall Study|Lost to Follow-up|0|||
49018961|NCT01829464|157906720|FG001|Overall Study|Lost to Follow-up|0|||
49018962|NCT01829464|157906721|FG002|Overall Study|Lost to Follow-up|1|||
49018963|NCT01829464|157906719|FG000|Overall Study|Withdrawal by Subject|2|||
49018964|NCT01829464|157906720|FG001|Overall Study|Withdrawal by Subject|0|||
49018965|NCT01829464|157906721|FG002|Overall Study|Withdrawal by Subject|0|||
49018966|NCT01829464|157906719|FG000|Overall Study|Study terminated by sponsor|25|||
49018967|NCT01829464|157906720|FG001|Overall Study|Study terminated by sponsor|28|||
49018968|NCT01829464|157906721|FG002|Overall Study|Study terminated by sponsor|25|||
49018969|NCT01829464|157906719|FG000|Overall Study|Lack of Efficacy|0|||
49018970|NCT01829464|157906720|FG001|Overall Study|Lack of Efficacy|1|||
49018971|NCT01829464|157906721|FG002|Overall Study|Lack of Efficacy|0|||
49018972|NCT00992407|157906722|FG000|Overall Study|Protocol Violation|2|||
49018973|NCT00992407|157906723|FG001|Overall Study|Protocol Violation|1|||
49018974|NCT00992407|157906722|FG000|Overall Study|Lost to Follow-up|3|||
49018975|NCT00992407|157906723|FG001|Overall Study|Lost to Follow-up|3|||
49018976|NCT00992407|157906722|FG000|Overall Study|Adverse Event|3|||
49018977|NCT00992407|157906723|FG001|Overall Study|Adverse Event|2|||
49018978|NCT00992407|157906722|FG000|Overall Study|protocol Violation & Adverse events|2|||
49018979|NCT00992407|157906723|FG001|Overall Study|protocol Violation & Adverse events|4|||
49018980|NCT00992407|157906722|FG000|Overall Study|Other|2|||
48677401|NCT03472586|156671336|FG000|Overall Study|Death|6|||
48677402|NCT03472586|156671336|FG000|Overall Study|Adverse Event|1|||
48677403|NCT01835223|156671337|FG000|Overall Study|Adverse Event|1|||
49018981|NCT00992407|157906723|FG001|Overall Study|Other|0|||
49018982|NCT00992407|157906722|FG000|Overall Study|Loss of follow-up & Adverse events|2|||
49018983|NCT00992407|157906723|FG001|Overall Study|Loss of follow-up & Adverse events|1|||
49018984|NCT00992407|157906722|FG000|Overall Study|Study medication not administered|17|||
49018985|NCT00992407|157906723|FG001|Overall Study|Study medication not administered|13|||
49018986|NCT00989261|157906728|FG000|Overall Study|Still in follow up|12|||
49018987|NCT00989261|157906729|FG001|Overall Study|Still in follow up|21|||
49018988|NCT00989261|157906728|FG000|Overall Study|Withdrawal by Subject|0|||
49018989|NCT00989261|157906729|FG001|Overall Study|Withdrawal by Subject|1|||
49018990|NCT00989261|157906728|FG000|Overall Study|Lost to Follow-up|3|||
49018991|NCT00989261|157906729|FG001|Overall Study|Lost to Follow-up|0|||
49018992|NCT01521559|157906732|FG000|Overall Study|Adverse Event|0|||
49018993|NCT01521559|157906733|FG001|Overall Study|Adverse Event|4|||
49018994|NCT01521559|157906732|FG000|Overall Study|Death|1|||
49018995|NCT01521559|157906733|FG001|Overall Study|Death|0|||
49018996|NCT01521559|157906732|FG000|Overall Study|Withdrawal by Subject|9|||
49018997|NCT01521559|157906733|FG001|Overall Study|Withdrawal by Subject|11|||
49018998|NCT01521559|157906732|FG000|Overall Study|Lost to Follow-up|3|||
49018999|NCT01521559|157906733|FG001|Overall Study|Lost to Follow-up|1|||
49019000|NCT01521559|157906732|FG000|Overall Study|Protocol Violation|1|||
49019001|NCT01521559|157906733|FG001|Overall Study|Protocol Violation|0|||
49019002|NCT01521559|157906732|FG000|Overall Study|Other|1|||
49019003|NCT01521559|157906733|FG001|Overall Study|Other|2|||
49019004|NCT02336737|157906734|FG000|Overall Study|Withdrawal by Subject|5|||
49019005|NCT02336737|157906734|FG000|Overall Study|Physician Decision|8|||
49019006|NCT00536575|157906738|FG000|Overall Study|Withdrawal by Subject|1|||
49019007|NCT00536575|157906738|FG000|Overall Study|Death|1|||
49019008|NCT00810368|157906742|FG000|Overall Study|Lost to Follow-up|4|||
49019009|NCT00810368|157906743|FG001|Overall Study|Lost to Follow-up|2|||
49019010|NCT00810368|157906742|FG000|Overall Study|Lack of Efficacy|2|||
49019011|NCT00810368|157906743|FG001|Overall Study|Lack of Efficacy|0|||
49019012|NCT00623103|157906744|FG000|Overall Study|Adverse Event|70|||
49019013|NCT00623103|157906745|FG001|Overall Study|Adverse Event|60|||
49019014|NCT00623103|157906744|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
49019015|NCT00623103|157906745|FG001|Overall Study|Unsatisfactory therapeutic effect|12|||
49019016|NCT00623103|157906744|FG000|Overall Study|Withdrawal by Subject|18|||
49019017|NCT00623103|157906745|FG001|Overall Study|Withdrawal by Subject|24|||
49019018|NCT00623103|157906744|FG000|Overall Study|Lost to Follow-up|4|||
49019019|NCT00623103|157906745|FG001|Overall Study|Lost to Follow-up|1|||
49019020|NCT00623103|157906744|FG000|Overall Study|Administrative problems|2|||
49019021|NCT00623103|157906745|FG001|Overall Study|Administrative problems|4|||
49019022|NCT00623103|157906744|FG000|Overall Study|Death|11|||
48677404|NCT01835223|156671338|FG001|Overall Study|Adverse Event|0|||
48677405|NCT01835223|156671337|FG000|Overall Study|Withdrawal by Subject|2|||
49019023|NCT00623103|157906745|FG001|Overall Study|Death|11|||
49019024|NCT00623103|157906744|FG000|Overall Study|Protocol deviation|2|||
49019025|NCT00623103|157906745|FG001|Overall Study|Protocol deviation|1|||
49019026|NCT05034731|157906749|FG000|Overall Study|Screen fail|1|||
49019027|NCT05034731|157906750|FG001|Overall Study|Screen fail|1|||
49019028|NCT03522948|157906751|FG000|Overall Study|Lost to Follow-up|1|||
49019029|NCT03937466|157906752|FG000|Overall Study|not eligbile after the 2-week diary|9|||
49019030|NCT03937466|157906752|FG000|Overall Study|never returned their diary|6|||
49019031|NCT03937466|157906752|FG000|Overall Study|dropped out of study before getting Chilipad|5|||
49019032|NCT03937466|157906752|FG000|Overall Study|3 did not complete follow-up questionnaire.|3|||
48677406|NCT01835223|156671338|FG001|Overall Study|Withdrawal by Subject|0|||
49019033|NCT03305055|157906753|FG000|Overall Study|Withdrawal by Subject|0|||
49019034|NCT03305055|157906754|FG001|Overall Study|Withdrawal by Subject|1|||
49019035|NCT03305055|157906753|FG000|Overall Study|Adverse Event|1|||
49019036|NCT03305055|157906754|FG001|Overall Study|Adverse Event|1|||
48677407|NCT01835223|156671337|FG000|Overall Study|Disease progression|2|||
48677408|NCT01835223|156671338|FG001|Overall Study|Disease progression|1|||
48677409|NCT01835223|156671337|FG000|Overall Study|Became Inelligible|4|||
48677410|NCT01835223|156671338|FG001|Overall Study|Became Inelligible|0|||
48677411|NCT00303485|156671340|FG000|Overall Study|Adverse Event/Intercurrent Illness|0|||
48677412|NCT00303485|156671341|FG001|Overall Study|Adverse Event/Intercurrent Illness|1|||
48677413|NCT00303485|156671340|FG000|Overall Study|Failure to return|0|||
48677414|NCT00303485|156671341|FG001|Overall Study|Failure to return|1|||
48677415|NCT00303485|156671340|FG000|Overall Study|Withdrawal by Subject|1|||
49019037|NCT00622908|157906756|FG000|Overall Study|Protocol Violation|1|||
49019038|NCT00622908|157906757|FG001|Overall Study|Protocol Violation|0|||
49019039|NCT00622908|157906756|FG000|Overall Study|Adverse Event|0|||
49019040|NCT00622908|157906757|FG001|Overall Study|Adverse Event|1|||
49019041|NCT00622908|157906756|FG000|Overall Study|Lack of Efficacy|1|||
49019042|NCT00622908|157906757|FG001|Overall Study|Lack of Efficacy|7|||
49019043|NCT00622908|157906756|FG000|Overall Study|Lost to Follow-up|1|||
49019044|NCT00622908|157906757|FG001|Overall Study|Lost to Follow-up|0|||
49019045|NCT00622908|157906756|FG000|Overall Study|Refusal|0|||
49019046|NCT00622908|157906757|FG001|Overall Study|Refusal|1|||
49019047|NCT00622908|157906756|FG000|Overall Study|Termination by study sponser|0|||
49019048|NCT00622908|157906757|FG001|Overall Study|Termination by study sponser|1|||
49019049|NCT02158936|157906758|FG000|Overall Study|Study closed/ terminated|57|||
49019050|NCT02158936|157906759|FG001|Overall Study|Study closed/ terminated|77|||
49019051|NCT02158936|157906758|FG000|Overall Study|Azacitidine tx discontinued|53|||
49019052|NCT02158936|157906759|FG001|Overall Study|Azacitidine tx discontinued|46|||
49019053|NCT02158936|157906758|FG000|Overall Study|Adverse Event|39|||
49019054|NCT02158936|157906759|FG001|Overall Study|Adverse Event|24|||
49019055|NCT02158936|157906758|FG000|Overall Study|Withdrawal by Subject|15|||
49019056|NCT02158936|157906759|FG001|Overall Study|Withdrawal by Subject|16|||
49019057|NCT02158936|157906758|FG000|Overall Study|Physician Decision|15|||
49019058|NCT02158936|157906759|FG001|Overall Study|Physician Decision|13|||
49019059|NCT02158936|157906758|FG000|Overall Study|Lost to Follow-up|0|||
49019060|NCT02158936|157906759|FG001|Overall Study|Lost to Follow-up|1|||
49019061|NCT01802879|157906760|FG000|Overall Study|Administrative problems|2|||
49019062|NCT01802879|157906760|FG000|Overall Study|Disease progression|6|||
49019063|NCT00266409|157906761|FG000|Overall Study|Lack of Efficacy|2|||
49019064|NCT00266409|157906762|FG001|Overall Study|Lack of Efficacy|6|||
49019065|NCT00266409|157906763|FG002|Overall Study|Lack of Efficacy|1|||
49019066|NCT00266409|157906764|FG003|Overall Study|Lack of Efficacy|2|||
49019067|NCT00266409|157906761|FG000|Overall Study|Adverse Event|7|||
49019068|NCT00266409|157906762|FG001|Overall Study|Adverse Event|2|||
49019069|NCT00266409|157906763|FG002|Overall Study|Adverse Event|1|||
49019070|NCT00266409|157906764|FG003|Overall Study|Adverse Event|1|||
49019071|NCT00266409|157906761|FG000|Overall Study|Lost to Follow-up|18|||
49019072|NCT00266409|157906762|FG001|Overall Study|Lost to Follow-up|21|||
49019073|NCT00266409|157906763|FG002|Overall Study|Lost to Follow-up|6|||
49019074|NCT00266409|157906764|FG003|Overall Study|Lost to Follow-up|8|||
49019075|NCT00266409|157906761|FG000|Overall Study|Withdrawal by Subject|6|||
49019076|NCT00266409|157906762|FG001|Overall Study|Withdrawal by Subject|10|||
49019077|NCT00266409|157906763|FG002|Overall Study|Withdrawal by Subject|3|||
49019078|NCT00266409|157906764|FG003|Overall Study|Withdrawal by Subject|9|||
49019079|NCT00266409|157906761|FG000|Overall Study|Protocol Violation|5|||
49019080|NCT00266409|157906762|FG001|Overall Study|Protocol Violation|3|||
49019081|NCT00266409|157906763|FG002|Overall Study|Protocol Violation|4|||
49019082|NCT00266409|157906764|FG003|Overall Study|Protocol Violation|2|||
49019083|NCT00266409|157906761|FG000|Overall Study|Other|7|||
49019084|NCT00266409|157906762|FG001|Overall Study|Other|4|||
49019085|NCT00266409|157906763|FG002|Overall Study|Other|2|||
49019086|NCT00266409|157906764|FG003|Overall Study|Other|0|||
49019087|NCT00113490|157906768|FG000|Overall Study|Withdrawal by Subject|1|||
49019088|NCT00113490|157906769|FG001|Overall Study|Withdrawal by Subject|3|||
49019089|NCT00113490|157906768|FG000|Overall Study|Lost to Follow-up|1|||
48677416|NCT00303485|156671341|FG001|Overall Study|Withdrawal by Subject|0|||
49019090|NCT00113490|157906769|FG001|Overall Study|Lost to Follow-up|0|||
49019091|NCT02236130|157906770|FG000|Overall Study|Lost to Follow-up|7|||
49019092|NCT02236130|157906771|FG001|Overall Study|Lost to Follow-up|12|||
49019093|NCT00819247|157906776|FG000|Overall Study|Adverse Event|0|||
49019094|NCT00819247|157906777|FG001|Overall Study|Adverse Event|5|||
49019095|NCT00819247|157906778|FG002|Overall Study|Adverse Event|3|||
48677417|NCT06359080|156671346|FG000|Overall Study|Withdrawal by Subject|3|||
49019096|NCT00819247|157906776|FG000|Overall Study|Insufficient testosterone response|5|||
49019097|NCT00819247|157906777|FG001|Overall Study|Insufficient testosterone response|8|||
49019098|NCT00819247|157906778|FG002|Overall Study|Insufficient testosterone response|10|||
49019099|NCT00819247|157906776|FG000|Overall Study|Withdrawal by Subject|1|||
49019100|NCT00819247|157906777|FG001|Overall Study|Withdrawal by Subject|0|||
48677418|NCT01378325|156671348|FG000|Overall Study|Protocol Violation|0|||
48677419|NCT01378325|156671349|FG001|Overall Study|Protocol Violation|1|||
48677420|NCT00193180|156671352|FG000|Overall Study|Lack of Efficacy|1|||
48762514|NCT02268812|156978141|FG003|Overall Study|Other|3|||
48762515|NCT00741039|156978142|FG000|Overall Study|Patient non-compliance|2|||
48762516|NCT00741039|156978143|FG001|Overall Study|Patient non-compliance|0|||
48762517|NCT02171260|156978150|FG000|Overall Study|Death|0|||
48762518|NCT02171260|156978151|FG001|Overall Study|Death|0|||
48762519|NCT02171260|156978152|FG002|Overall Study|Death|0|||
49019101|NCT00819247|157906778|FG002|Overall Study|Withdrawal by Subject|0|||
49019102|NCT00819247|157906776|FG000|Overall Study|Protocol Violation|1|||
49019103|NCT00819247|157906777|FG001|Overall Study|Protocol Violation|0|||
49019104|NCT00819247|157906778|FG002|Overall Study|Protocol Violation|1|||
49019105|NCT00819247|157906776|FG000|Overall Study|Mistakenly withdrawn|0|||
49019106|NCT00819247|157906777|FG001|Overall Study|Mistakenly withdrawn|1|||
49019107|NCT00819247|157906778|FG002|Overall Study|Mistakenly withdrawn|0|||
49019108|NCT00819247|157906776|FG000|Overall Study|Bad prostate-specific antigen response|3|||
49019109|NCT00819247|157906777|FG001|Overall Study|Bad prostate-specific antigen response|2|||
49019110|NCT00819247|157906778|FG002|Overall Study|Bad prostate-specific antigen response|0|||
49019111|NCT00819247|157906776|FG000|Overall Study|Other|1|||
49019112|NCT00819247|157906777|FG001|Overall Study|Other|0|||
49019113|NCT00819247|157906778|FG002|Overall Study|Other|0|||
49019114|NCT02187042|157906781|FG000|Overall Study|Death|1|||
49019115|NCT02187042|157906782|FG001|Overall Study|Death|1|||
49019116|NCT02187042|157906781|FG000|Overall Study|Toxicity|6|||
49019117|NCT02187042|157906782|FG001|Overall Study|Toxicity|5|||
49019118|NCT02187042|157906781|FG000|Overall Study|Participant choice|1|||
49019119|NCT02187042|157906782|FG001|Overall Study|Participant choice|0|||
49019120|NCT02187042|157906781|FG000|Overall Study|Doctor choice|1|||
49019121|NCT02187042|157906782|FG001|Overall Study|Doctor choice|0|||
49019122|NCT02187042|157906781|FG000|Overall Study|Progressive disease|4|||
49019123|NCT02187042|157906782|FG001|Overall Study|Progressive disease|8|||
49019124|NCT00108732|157906783|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1|||
49019125|NCT00108732|157906783|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2|||
49019126|NCT00108732|157906783|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10|||
49019127|NCT00108732|157906783|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1|||
49019128|NCT00108732|157906783|FG000|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3|||
49019129|NCT00108732|157906783|FG000|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1|||
49019130|NCT00108732|157906783|FG000|Step 2 (Androgen Ablation and Vaccine)|Other|1|||
49019131|NCT02116803|157906786|FG000|Overall Study|Adverse Event|2|||
49019132|NCT02116803|157906787|FG001|Overall Study|Adverse Event|1|||
48677421|NCT00193180|156671352|FG000|Overall Study|Adverse Event|8|||
48677422|NCT00193180|156671352|FG000|Overall Study|Protocol Violation|1|||
48677423|NCT01235234|156671353|FG000|Overall Study|Adverse Event|2|||
48677424|NCT01235234|156671354|FG001|Overall Study|Adverse Event|2|||
48677425|NCT01235234|156671355|FG002|Overall Study|Adverse Event|1|||
48677426|NCT00344500|156671356|FG000|Overall Study|Adverse Event|6|||
48677427|NCT00344500|156671357|FG001|Overall Study|Adverse Event|2|||
48677428|NCT00344500|156671358|FG002|Overall Study|Adverse Event|0|||
48677429|NCT00344500|156671356|FG000|Overall Study|Lost to Follow-up|5|||
48677430|NCT00344500|156671357|FG001|Overall Study|Lost to Follow-up|13|||
48677431|NCT00344500|156671358|FG002|Overall Study|Lost to Follow-up|1|||
48677432|NCT00344500|156671356|FG000|Overall Study|Withdrawal by Subject|7|||
48677433|NCT00344500|156671357|FG001|Overall Study|Withdrawal by Subject|10|||
48677434|NCT00344500|156671358|FG002|Overall Study|Withdrawal by Subject|0|||
48677435|NCT00344500|156671356|FG000|Overall Study|Protocol Violation|4|||
48677436|NCT00344500|156671357|FG001|Overall Study|Protocol Violation|7|||
48677437|NCT00344500|156671358|FG002|Overall Study|Protocol Violation|1|||
48677438|NCT00344500|156671356|FG000|Overall Study|Not Noted|1|||
48677439|NCT00344500|156671357|FG001|Overall Study|Not Noted|3|||
48677440|NCT00344500|156671358|FG002|Overall Study|Not Noted|0|||
48677441|NCT02207491|156671359|FG000|Overall Study|Adverse Event|20|||
48677442|NCT02207491|156671360|FG001|Overall Study|Adverse Event|4|||
48677443|NCT02207491|156671359|FG000|Overall Study|Withdrawal by Subject|3|||
48677444|NCT02207491|156671360|FG001|Overall Study|Withdrawal by Subject|2|||
48677445|NCT02207491|156671359|FG000|Overall Study|Non-compliant|0|||
48677446|NCT02207491|156671360|FG001|Overall Study|Non-compliant|1|||
48677447|NCT02207491|156671359|FG000|Overall Study|Lost to Follow-up|0|||
48677448|NCT02207491|156671360|FG001|Overall Study|Lost to Follow-up|1|||
48677449|NCT02207491|156671359|FG000|Overall Study|Lack of Efficacy|3|||
48677450|NCT02207491|156671360|FG001|Overall Study|Lack of Efficacy|0|||
48677451|NCT02207491|156671359|FG000|Overall Study|Physician Decision|2|||
48677452|NCT02207491|156671360|FG001|Overall Study|Physician Decision|0|||
48762520|NCT02171260|156978153|FG003|Overall Study|Death|1|||
48677453|NCT02207491|156671359|FG000|Overall Study|Protocol Violation|3|||
48762521|NCT02171260|156978150|FG000|Overall Study|Physician Decision|1|||
48762522|NCT02171260|156978151|FG001|Overall Study|Physician Decision|0|||
48677454|NCT02207491|156671360|FG001|Overall Study|Protocol Violation|5|||
48762523|NCT02171260|156978152|FG002|Overall Study|Physician Decision|1|||
49019133|NCT02116803|157906786|FG000|Overall Study|Physician Decision|1|||
49019134|NCT02116803|157906787|FG001|Overall Study|Physician Decision|0|||
49019135|NCT02116803|157906786|FG000|Overall Study|Progressive disease|4|||
49019136|NCT02116803|157906787|FG001|Overall Study|Progressive disease|0|||
49019137|NCT02116803|157906786|FG000|Overall Study|Study terminated by sponsor|2|||
49019138|NCT02116803|157906787|FG001|Overall Study|Study terminated by sponsor|1|||
49019139|NCT02116803|157906786|FG000|Overall Study|Death|1|||
49019140|NCT02116803|157906787|FG001|Overall Study|Death|0|||
49019141|NCT02040766|157906788|FG000|Overall Study|Adverse Event|1|||
49019142|NCT02040766|157906789|FG001|Overall Study|Adverse Event|1|||
49019143|NCT02040766|157906790|FG002|Overall Study|Adverse Event|1|||
49019144|NCT02040766|157906791|FG003|Overall Study|Adverse Event|0|||
49019145|NCT02040766|157906792|FG004|Overall Study|Adverse Event|2|||
49019146|NCT02040766|157906788|FG000|Overall Study|Withdrawal by Subject|4|||
49019147|NCT02040766|157906789|FG001|Overall Study|Withdrawal by Subject|3|||
49019148|NCT02040766|157906790|FG002|Overall Study|Withdrawal by Subject|2|||
49019149|NCT02040766|157906791|FG003|Overall Study|Withdrawal by Subject|3|||
49019150|NCT02040766|157906792|FG004|Overall Study|Withdrawal by Subject|2|||
49019151|NCT02040766|157906788|FG000|Overall Study|Non-compliance|0|||
49019152|NCT02040766|157906789|FG001|Overall Study|Non-compliance|1|||
49019153|NCT02040766|157906790|FG002|Overall Study|Non-compliance|0|||
49019154|NCT02040766|157906791|FG003|Overall Study|Non-compliance|0|||
49019155|NCT02040766|157906792|FG004|Overall Study|Non-compliance|0|||
49019156|NCT02040766|157906788|FG000|Overall Study|Protocol Violation|2|||
49019157|NCT02040766|157906789|FG001|Overall Study|Protocol Violation|1|||
49019158|NCT02040766|157906790|FG002|Overall Study|Protocol Violation|2|||
49019159|NCT02040766|157906791|FG003|Overall Study|Protocol Violation|3|||
49019160|NCT02040766|157906792|FG004|Overall Study|Protocol Violation|0|||
49019161|NCT02040766|157906788|FG000|Overall Study|Lost to Follow-up|4|||
49019162|NCT02040766|157906789|FG001|Overall Study|Lost to Follow-up|1|||
49019163|NCT02040766|157906790|FG002|Overall Study|Lost to Follow-up|3|||
49019164|NCT02040766|157906791|FG003|Overall Study|Lost to Follow-up|1|||
49019165|NCT02040766|157906792|FG004|Overall Study|Lost to Follow-up|4|||
49019166|NCT02040766|157906788|FG000|Overall Study|Not reported|1|||
49019167|NCT02040766|157906789|FG001|Overall Study|Not reported|0|||
49019168|NCT02040766|157906790|FG002|Overall Study|Not reported|0|||
49019169|NCT02040766|157906791|FG003|Overall Study|Not reported|0|||
49019170|NCT02040766|157906792|FG004|Overall Study|Not reported|0|||
49019171|NCT02040766|157906788|FG000|Overall Study|Lack of Efficacy|6|||
49019172|NCT02040766|157906789|FG001|Overall Study|Lack of Efficacy|3|||
49019173|NCT02040766|157906790|FG002|Overall Study|Lack of Efficacy|4|||
49019174|NCT02040766|157906791|FG003|Overall Study|Lack of Efficacy|6|||
49019175|NCT02040766|157906792|FG004|Overall Study|Lack of Efficacy|5|||
49019176|NCT01946165|157906793|FG000|Overall Study|Physician Decision|2|||
49019177|NCT01946165|157906794|FG001|Overall Study|Physician Decision|0|||
49019178|NCT01946165|157906793|FG000|Overall Study|Withdrawal by Subject|0|||
49019179|NCT01946165|157906794|FG001|Overall Study|Withdrawal by Subject|2|||
49019180|NCT01766921|157906799|FG000|Overall Study|Administrative Reason|5|||
49019181|NCT01766921|157906800|FG001|Overall Study|Administrative Reason|5|||
49019182|NCT01766921|157906799|FG000|Overall Study|Death|1|||
49019183|NCT01766921|157906800|FG001|Overall Study|Death|1|||
49019184|NCT01766921|157906799|FG000|Overall Study|Lost to Follow-up|1|||
49019185|NCT01766921|157906800|FG001|Overall Study|Lost to Follow-up|3|||
49019186|NCT01766921|157906799|FG000|Overall Study|Unclassified|2|||
49019187|NCT01766921|157906800|FG001|Overall Study|Unclassified|2|||
49019188|NCT01766921|157906799|FG000|Overall Study|Protocol Violation|1|||
49019189|NCT01766921|157906800|FG001|Overall Study|Protocol Violation|1|||
49019190|NCT01766921|157906799|FG000|Overall Study|Withdrawal by Subject|14|||
49019191|NCT01766921|157906800|FG001|Overall Study|Withdrawal by Subject|5|||
49019192|NCT00619385|157906803|FG000|Overall Study|Adverse Event|0|||
49019193|NCT00619385|157906804|FG001|Overall Study|Adverse Event|0|||
49019194|NCT00619385|157906805|FG002|Overall Study|Adverse Event|3|||
49019195|NCT00619385|157906803|FG000|Overall Study|Other|1|||
49019196|NCT00619385|157906804|FG001|Overall Study|Other|2|||
49019197|NCT00619385|157906805|FG002|Overall Study|Other|1|||
49019198|NCT01922349|157906806|FG000|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
49019199|NCT01922349|157906807|FG001|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
49019200|NCT01922349|157906808|FG002|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
49019201|NCT01922349|157906809|FG003|Multiple Rising Dose (MRD) Period|Adverse Event|1|||
49019202|NCT02097121|157906810|FG000|Overall Study|Other, not specified|4|||
49019203|NCT02097121|157906811|FG001|Overall Study|Other, not specified|2|||
49019204|NCT02097121|157906812|FG002|Overall Study|Other, not specified|3|||
49019205|NCT02097121|157906810|FG000|Overall Study|Lack of Efficacy|2|||
49019206|NCT02097121|157906811|FG001|Overall Study|Lack of Efficacy|1|||
49019207|NCT02097121|157906812|FG002|Overall Study|Lack of Efficacy|3|||
49019208|NCT02097121|157906810|FG000|Overall Study|Withdrawal by Subject|0|||
49019209|NCT02097121|157906811|FG001|Overall Study|Withdrawal by Subject|1|||
49019210|NCT02097121|157906812|FG002|Overall Study|Withdrawal by Subject|2|||
49019211|NCT02097121|157906810|FG000|Overall Study|Adverse Event|0|||
49019212|NCT02097121|157906811|FG001|Overall Study|Adverse Event|1|||
49019213|NCT02097121|157906812|FG002|Overall Study|Adverse Event|0|||
48677455|NCT00539305|156671361|FG000|Overall Study|Adverse Event|1|||
48677456|NCT00539305|156671362|FG001|Overall Study|Adverse Event|0|||
48677457|NCT00539305|156671361|FG000|Overall Study|Substance Use|0|||
48762524|NCT02171260|156978153|FG003|Overall Study|Physician Decision|0|||
48762525|NCT02171260|156978150|FG000|Overall Study|Withdrawal by Subject|1|||
49019214|NCT02097121|157906810|FG000|Overall Study|Lost to Follow-up|1|||
49019215|NCT02097121|157906811|FG001|Overall Study|Lost to Follow-up|1|||
49019216|NCT02097121|157906812|FG002|Overall Study|Lost to Follow-up|2|||
49019217|NCT01575054|157906815|FG000|Overall Study|Other Reasons|5|||
49019218|NCT01575054|157906816|FG001|Overall Study|Other Reasons|3|||
49019219|NCT01575054|157906815|FG000|Overall Study|Protocol Violation|2|||
48677458|NCT00539305|156671362|FG001|Overall Study|Substance Use|1|||
48677459|NCT00539305|156671361|FG000|Overall Study|Withdrawal by Subject|0|||
49019220|NCT01575054|157906816|FG001|Overall Study|Protocol Violation|1|||
49019221|NCT01575054|157906815|FG000|Overall Study|Personal Reasons|10|||
49019222|NCT01575054|157906816|FG001|Overall Study|Personal Reasons|11|||
49019223|NCT01575054|157906815|FG000|Overall Study|Lost to Follow-up|3|||
49019224|NCT01575054|157906816|FG001|Overall Study|Lost to Follow-up|3|||
49019225|NCT01575054|157906815|FG000|Overall Study|Adverse Event|9|||
49019226|NCT01575054|157906816|FG001|Overall Study|Adverse Event|8|||
49019227|NCT00462982|157906819|FG000|Overall Study|Adverse Event|1|||
49019228|NCT00462982|157906819|FG000|Overall Study|Patient Not Treated|2|||
49019229|NCT02801877|157906820|FG000|Overall Study|Lost to Follow-up|1|||
49019230|NCT02801877|157906821|FG001|Overall Study|Lost to Follow-up|1|||
49019231|NCT02801877|157906822|FG002|Overall Study|Lost to Follow-up|2|||
49019232|NCT02801877|157906823|FG003|Overall Study|Lost to Follow-up|0|||
49019233|NCT02801877|157906820|FG000|Overall Study|Never Started Treatment|2|||
49019234|NCT02801877|157906821|FG001|Overall Study|Never Started Treatment|0|||
49019235|NCT02801877|157906822|FG002|Overall Study|Never Started Treatment|4|||
49019236|NCT02801877|157906823|FG003|Overall Study|Never Started Treatment|0|||
49019237|NCT01241461|157908923|FG000|Overall Study|Progressive Disease|3|||
49019238|NCT01241461|157908924|FG001|Overall Study|Progressive Disease|6|||
49019239|NCT01144663|157908925|FG000|Primary Vaccination Phase|Serious adverse event, fatal|2|||
49019240|NCT01144663|157908926|FG001|Primary Vaccination Phase|Serious adverse event, fatal|0|||
49019241|NCT01144663|157908927|FG002|Primary Vaccination Phase|Serious adverse event, fatal|1|||
49019242|NCT01144663|157908928|FG003|Primary Vaccination Phase|Serious adverse event, fatal|0|||
49019243|NCT01144663|157908925|FG000|Primary Vaccination Phase|Adverse Event|1|||
49019244|NCT01144663|157908926|FG001|Primary Vaccination Phase|Adverse Event|0|||
49019245|NCT01144663|157908927|FG002|Primary Vaccination Phase|Adverse Event|0|||
49019246|NCT01144663|157908928|FG003|Primary Vaccination Phase|Adverse Event|1|||
49019247|NCT01144663|157908925|FG000|Primary Vaccination Phase|Protocol Violation|2|||
49019248|NCT01144663|157908926|FG001|Primary Vaccination Phase|Protocol Violation|0|||
49019249|NCT01144663|157908927|FG002|Primary Vaccination Phase|Protocol Violation|1|||
49019250|NCT01144663|157908928|FG003|Primary Vaccination Phase|Protocol Violation|0|||
49019251|NCT01144663|157908925|FG000|Primary Vaccination Phase|Withdrawal by Subject|9|||
49019252|NCT01144663|157908926|FG001|Primary Vaccination Phase|Withdrawal by Subject|5|||
49019253|NCT01144663|157908927|FG002|Primary Vaccination Phase|Withdrawal by Subject|3|||
49019254|NCT01144663|157908928|FG003|Primary Vaccination Phase|Withdrawal by Subject|10|||
49019255|NCT01144663|157908925|FG000|Primary Vaccination Phase|Migrated/moved from study area|4|||
49019256|NCT01144663|157908926|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
49019257|NCT01144663|157908927|FG002|Primary Vaccination Phase|Migrated/moved from study area|2|||
49019258|NCT01144663|157908928|FG003|Primary Vaccination Phase|Migrated/moved from study area|3|||
49019259|NCT01144663|157908925|FG000|Primary Vaccination Phase|Lost to Follow-up|2|||
48677460|NCT00539305|156671362|FG001|Overall Study|Withdrawal by Subject|1|||
48677461|NCT00711971|156671363|FG000|Overall Study|Lost to Follow-up|3|||
48677462|NCT00711971|156671364|FG001|Overall Study|Lost to Follow-up|4|||
48677463|NCT00711971|156671365|FG002|Overall Study|Lost to Follow-up|1|||
48677464|NCT00126776|156671368|FG000|Overall Study|follow up complete on all patients|0|||
48677465|NCT00126776|156671369|FG001|Overall Study|follow up complete on all patients|0|||
48677466|NCT00599755|156671370|FG000|Overall Study|Adverse Event|11|||
48677467|NCT00599755|156671370|FG000|Overall Study|Withdrawal by Subject|2|||
48677468|NCT00599755|156671370|FG000|Overall Study|Progression of Disease|3|||
48677469|NCT00599755|156671370|FG000|Overall Study|Other Reason|2|||
48762526|NCT02171260|156978151|FG001|Overall Study|Withdrawal by Subject|0|||
48762527|NCT02171260|156978152|FG002|Overall Study|Withdrawal by Subject|0|||
49019260|NCT01144663|157908926|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
49019261|NCT01144663|157908927|FG002|Primary Vaccination Phase|Lost to Follow-up|1|||
48762528|NCT02171260|156978153|FG003|Overall Study|Withdrawal by Subject|0|||
49019262|NCT01144663|157908928|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
49019263|NCT01144663|157908925|FG000|Primary Vaccination Phase|Other|0|||
49019264|NCT01144663|157908926|FG001|Primary Vaccination Phase|Other|1|||
49019265|NCT01144663|157908927|FG002|Primary Vaccination Phase|Other|0|||
49019266|NCT01144663|157908928|FG003|Primary Vaccination Phase|Other|2|||
49019267|NCT01144663|157908925|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
49019268|NCT01144663|157908926|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
49019269|NCT01144663|157908927|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
49019270|NCT01144663|157908928|FG003|Booster Vaccination Phase|Withdrawal by Subject|1|||
49019271|NCT01144663|157908925|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
49019272|NCT01144663|157908926|FG001|Booster Vaccination Phase|Migrated/moved from study area|1|||
49019273|NCT01144663|157908927|FG002|Booster Vaccination Phase|Migrated/moved from study area|1|||
49019274|NCT01144663|157908928|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
49019275|NCT01144663|157908925|FG000|Booster Vaccination Phase|Lost to Follow-up|2|||
49019276|NCT01144663|157908926|FG001|Booster Vaccination Phase|Lost to Follow-up|1|||
49019277|NCT01144663|157908927|FG002|Booster Vaccination Phase|Lost to Follow-up|3|||
49019278|NCT01144663|157908928|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
49019279|NCT01144663|157908925|FG000|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
49019280|NCT01144663|157908926|FG001|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
49019281|NCT01144663|157908927|FG002|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
49019282|NCT01144663|157908928|FG003|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
49019283|NCT01144663|157908925|FG000|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
49019284|NCT01144663|157908926|FG001|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3|||
49019285|NCT01144663|157908927|FG002|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
49019286|NCT01144663|157908928|FG003|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0|||
49019287|NCT01144663|157908925|FG000|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4|||
49019288|NCT01144663|157908926|FG001|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6|||
49019289|NCT01144663|157908927|FG002|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5|||
49019290|NCT01144663|157908928|FG003|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0|||
49019291|NCT03341507|157908933|FG000|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34|||
49019292|NCT03093454|157908935|FG000|Overall Study|Withdrawal by Subject|1|||
49019293|NCT03093454|157908936|FG001|Overall Study|Withdrawal by Subject|1|||
49019294|NCT03093454|157908935|FG000|Overall Study|Scheduling conflict|3|||
49019295|NCT03093454|157908936|FG001|Overall Study|Scheduling conflict|1|||
49019296|NCT03093454|157908935|FG000|Overall Study|Physician Decision|2|||
49019297|NCT03093454|157908936|FG001|Overall Study|Physician Decision|1|||
49019298|NCT00421174|157908938|FG000|Overall Study|Withdrawal by Subject|0|||
49019299|NCT00421174|157908939|FG001|Overall Study|Withdrawal by Subject|1|||
49019300|NCT00421174|157908938|FG000|Overall Study|Ineligible due to infection|2|||
49019301|NCT00421174|157908939|FG001|Overall Study|Ineligible due to infection|0|||
49019302|NCT00084084|157908947|FG000|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1|||
49019303|NCT00084084|157908947|FG000|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1|||
49019304|NCT00712010|157908948|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
49019305|NCT02162758|157908949|FG000|Overall Study|Study termination|0|||
49019306|NCT02162758|157908950|FG001|Overall Study|Study termination|1|||
49019307|NCT04471935|157908951|FG000|Overall Study|Withdrawal by Subject|1|||
49019308|NCT04471935|157908951|FG000|Overall Study|Deemed ineligible to participate|1|||
49019309|NCT02974114|157908952|FG000|Overall Study|Other (Not specified)|0|||
49019310|NCT02974114|157908953|FG001|Overall Study|Other (Not specified)|1|||
49019311|NCT02974114|157908954|FG002|Overall Study|Other (Not specified)|2|||
49019312|NCT00818623|157908955|FG000|Overall Study|Adverse Event|1|||
49019313|NCT00818623|157908956|FG001|Overall Study|Adverse Event|0|||
49019314|NCT00818623|157908957|FG002|Overall Study|Adverse Event|1|||
49019315|NCT00818623|157908958|FG003|Overall Study|Adverse Event|0|||
49019316|NCT00818623|157908959|FG004|Overall Study|Adverse Event|0|||
48677470|NCT00599755|156671370|FG000|Overall Study|No data available|1|||
48677471|NCT01393639|156671371|FG000|Overall Study|Protocol Violation|0|||
48677472|NCT01393639|156671372|FG001|Overall Study|Protocol Violation|0|||
48677473|NCT01393639|156671373|FG002|Overall Study|Protocol Violation|0|||
48677474|NCT01393639|156671374|FG003|Overall Study|Protocol Violation|1|||
48677475|NCT01393639|156671375|FG004|Overall Study|Protocol Violation|0|||
49019317|NCT00818623|157908960|FG005|Overall Study|Adverse Event|1|||
48677476|NCT01393639|156671376|FG005|Overall Study|Protocol Violation|0|||
49019318|NCT00818623|157908961|FG006|Overall Study|Adverse Event|0|||
49019319|NCT00818623|157908962|FG007|Overall Study|Adverse Event|0|||
48677477|NCT01393639|156671377|FG006|Overall Study|Protocol Violation|0|||
48677478|NCT01393639|156671371|FG000|Overall Study|Other|0|||
48677479|NCT01393639|156671372|FG001|Overall Study|Other|2|||
48677480|NCT01393639|156671373|FG002|Overall Study|Other|0|||
48677481|NCT01393639|156671374|FG003|Overall Study|Other|2|||
48677482|NCT01393639|156671375|FG004|Overall Study|Other|1|||
48677483|NCT01393639|156671376|FG005|Overall Study|Other|0|||
48677484|NCT01393639|156671377|FG006|Overall Study|Other|1|||
48677485|NCT01393639|156671371|FG000|Overall Study|Withdrawal by Subject|1|||
48677486|NCT01393639|156671372|FG001|Overall Study|Withdrawal by Subject|1|||
48677487|NCT01393639|156671373|FG002|Overall Study|Withdrawal by Subject|0|||
48677488|NCT01393639|156671374|FG003|Overall Study|Withdrawal by Subject|0|||
48874946|NCT00358644|157378990|FG000|Overall Study|Withdrawal by Subject|4|||
48874947|NCT00358644|157378990|FG000|Overall Study|Physician Decision|6|||
48874948|NCT00358644|157378990|FG000|Overall Study|Patient not eligible for study|1|||
49019320|NCT00818623|157908955|FG000|Overall Study|Bad prostate specific antigen response|0|||
48677489|NCT01393639|156671375|FG004|Overall Study|Withdrawal by Subject|0|||
48677490|NCT01393639|156671376|FG005|Overall Study|Withdrawal by Subject|0|||
48677491|NCT01393639|156671377|FG006|Overall Study|Withdrawal by Subject|1|||
48677492|NCT01393639|156671371|FG000|Overall Study|Medication error without associated AE|0|||
48677493|NCT01393639|156671372|FG001|Overall Study|Medication error without associated AE|0|||
48677494|NCT01393639|156671373|FG002|Overall Study|Medication error without associated AE|0|||
48677495|NCT01393639|156671374|FG003|Overall Study|Medication error without associated AE|0|||
48677496|NCT01393639|156671375|FG004|Overall Study|Medication error without associated AE|0|||
48677497|NCT01393639|156671376|FG005|Overall Study|Medication error without associated AE|0|||
48677498|NCT01393639|156671377|FG006|Overall Study|Medication error without associated AE|1|||
48677499|NCT01393639|156671371|FG000|Overall Study|Lost to Follow-up|0|||
48677500|NCT01393639|156671372|FG001|Overall Study|Lost to Follow-up|1|||
48677501|NCT01393639|156671373|FG002|Overall Study|Lost to Follow-up|0|||
48677502|NCT01393639|156671374|FG003|Overall Study|Lost to Follow-up|0|||
48677503|NCT01393639|156671375|FG004|Overall Study|Lost to Follow-up|0|||
48677504|NCT01393639|156671376|FG005|Overall Study|Lost to Follow-up|0|||
48677505|NCT01393639|156671377|FG006|Overall Study|Lost to Follow-up|1|||
48677506|NCT01393639|156671371|FG000|Overall Study|Lack of Efficacy|0|||
48677507|NCT01393639|156671372|FG001|Overall Study|Lack of Efficacy|0|||
48677508|NCT01393639|156671373|FG002|Overall Study|Lack of Efficacy|0|||
48677509|NCT01393639|156671374|FG003|Overall Study|Lack of Efficacy|0|||
48677510|NCT01393639|156671375|FG004|Overall Study|Lack of Efficacy|0|||
48677511|NCT01393639|156671376|FG005|Overall Study|Lack of Efficacy|0|||
48677512|NCT01393639|156671377|FG006|Overall Study|Lack of Efficacy|1|||
48677513|NCT01393639|156671371|FG000|Overall Study|Adverse Event|2|||
48677514|NCT01393639|156671372|FG001|Overall Study|Adverse Event|3|||
48677515|NCT01393639|156671373|FG002|Overall Study|Adverse Event|1|||
48677516|NCT01393639|156671374|FG003|Overall Study|Adverse Event|2|||
48677517|NCT01393639|156671375|FG004|Overall Study|Adverse Event|0|||
48677518|NCT01393639|156671376|FG005|Overall Study|Adverse Event|2|||
48762529|NCT02171260|156978150|FG000|Overall Study|Evidence of progressive disease|4|||
48762530|NCT02171260|156978151|FG001|Overall Study|Evidence of progressive disease|6|||
48762531|NCT02171260|156978152|FG002|Overall Study|Evidence of progressive disease|4|||
48762532|NCT02171260|156978153|FG003|Overall Study|Evidence of progressive disease|4|||
48762533|NCT03886220|156978154|FG000|Treatment Period|Discontinued study drug during the treatment period|5|||
48762534|NCT03886220|156978155|FG001|Treatment Period|Discontinued study drug during the treatment period|12|||
48762535|NCT03886220|156978154|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
48762536|NCT03886220|156978155|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
48762537|NCT03886220|156978154|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
48762538|NCT03886220|156978155|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
48762539|NCT01523886|156978161|FG000|Overall Study|surgery cancelled|0|||
48762540|NCT01523886|156978162|FG001|Overall Study|surgery cancelled|1|||
48762541|NCT00858442|156980201|FG000|Compression:Start to Finish|Lost to Follow-up|1|||
48762542|NCT00858442|156980202|FG001|Compression:Start to Finish|Lost to Follow-up|3|||
48762543|NCT02734810|156980205|FG000|Overall Study|Adverse Event|1|||
48762544|NCT02734810|156980206|FG001|Overall Study|Adverse Event|0|||
48762545|NCT02734810|156980205|FG000|Overall Study|Lack of Efficacy|1|||
48762546|NCT02734810|156980206|FG001|Overall Study|Lack of Efficacy|0|||
48762547|NCT00127712|156980210|FG000|Overall Study|Adverse Event|3|||
48762548|NCT00127712|156980211|FG001|Overall Study|Adverse Event|0|||
48762549|NCT00127712|156980210|FG000|Overall Study|Lack of GI access to continue|2|||
48762550|NCT00127712|156980211|FG001|Overall Study|Lack of GI access to continue|0|||
48762551|NCT00903617|156980212|FG000|Overall Study|Adverse Event|0|||
48762552|NCT00903617|156980213|FG001|Overall Study|Adverse Event|1|||
48762553|NCT00903617|156980214|FG002|Overall Study|Adverse Event|1|||
48762554|NCT00903617|156980215|FG003|Overall Study|Adverse Event|0|||
48762555|NCT00903617|156980212|FG000|Overall Study|Protocol-defined stopping criteria|0|||
48762556|NCT00903617|156980213|FG001|Overall Study|Protocol-defined stopping criteria|2|||
48762557|NCT00903617|156980214|FG002|Overall Study|Protocol-defined stopping criteria|0|||
48762558|NCT00903617|156980215|FG003|Overall Study|Protocol-defined stopping criteria|0|||
48762559|NCT00903617|156980212|FG000|Overall Study|Lost to Follow-up|2|||
48762560|NCT00903617|156980213|FG001|Overall Study|Lost to Follow-up|0|||
48677519|NCT01393639|156671377|FG006|Overall Study|Adverse Event|3|||
48677520|NCT00793325|156671378|FG000|Overall Study|Protocol Violation|18|||
48677521|NCT00793325|156671378|FG000|Overall Study|Lost to Follow-up|1|||
48677522|NCT00856544|156671379|FG000|Overall Study|Randomized but not treated|3|||
48677523|NCT00856544|156671380|FG001|Overall Study|Randomized but not treated|0|||
48762561|NCT00903617|156980214|FG002|Overall Study|Lost to Follow-up|1|||
48762562|NCT00903617|156980215|FG003|Overall Study|Lost to Follow-up|1|||
48762563|NCT00903617|156980212|FG000|Overall Study|Withdrawal by Subject|1|||
48762564|NCT00903617|156980213|FG001|Overall Study|Withdrawal by Subject|2|||
48762565|NCT00903617|156980214|FG002|Overall Study|Withdrawal by Subject|3|||
48677524|NCT00856544|156671381|FG002|Overall Study|Randomized but not treated|0|||
48677525|NCT00856544|156671382|FG003|Overall Study|Randomized but not treated|0|||
49019321|NCT00818623|157908956|FG001|Overall Study|Bad prostate specific antigen response|3|||
49019322|NCT00818623|157908957|FG002|Overall Study|Bad prostate specific antigen response|2|||
49019323|NCT00818623|157908958|FG003|Overall Study|Bad prostate specific antigen response|5|||
49019324|NCT00818623|157908959|FG004|Overall Study|Bad prostate specific antigen response|0|||
49019325|NCT00818623|157908960|FG005|Overall Study|Bad prostate specific antigen response|1|||
49019326|NCT00818623|157908961|FG006|Overall Study|Bad prostate specific antigen response|0|||
49019327|NCT00818623|157908962|FG007|Overall Study|Bad prostate specific antigen response|0|||
49019328|NCT00818623|157908955|FG000|Overall Study|Withdrawal by Subject|0|||
49019329|NCT00818623|157908956|FG001|Overall Study|Withdrawal by Subject|1|||
49019330|NCT00818623|157908957|FG002|Overall Study|Withdrawal by Subject|1|||
49019331|NCT00818623|157908958|FG003|Overall Study|Withdrawal by Subject|0|||
49019332|NCT00818623|157908959|FG004|Overall Study|Withdrawal by Subject|0|||
49019333|NCT00818623|157908960|FG005|Overall Study|Withdrawal by Subject|1|||
49019334|NCT00818623|157908961|FG006|Overall Study|Withdrawal by Subject|1|||
49019335|NCT00818623|157908962|FG007|Overall Study|Withdrawal by Subject|1|||
49019336|NCT00818623|157908955|FG000|Overall Study|Protocol Violation|1|||
49019337|NCT00818623|157908956|FG001|Overall Study|Protocol Violation|0|||
49019338|NCT00818623|157908957|FG002|Overall Study|Protocol Violation|0|||
49019339|NCT00818623|157908958|FG003|Overall Study|Protocol Violation|0|||
49019340|NCT00818623|157908959|FG004|Overall Study|Protocol Violation|1|||
49019341|NCT00818623|157908960|FG005|Overall Study|Protocol Violation|0|||
49019342|NCT00818623|157908961|FG006|Overall Study|Protocol Violation|1|||
49019343|NCT00818623|157908962|FG007|Overall Study|Protocol Violation|0|||
49019344|NCT00818623|157908955|FG000|Overall Study|Need of additional treatment|0|||
49019345|NCT00818623|157908956|FG001|Overall Study|Need of additional treatment|0|||
49019346|NCT00818623|157908957|FG002|Overall Study|Need of additional treatment|0|||
49019347|NCT00818623|157908958|FG003|Overall Study|Need of additional treatment|0|||
49019348|NCT00818623|157908959|FG004|Overall Study|Need of additional treatment|1|||
49019349|NCT00818623|157908960|FG005|Overall Study|Need of additional treatment|0|||
49019350|NCT00818623|157908961|FG006|Overall Study|Need of additional treatment|0|||
49019351|NCT00818623|157908962|FG007|Overall Study|Need of additional treatment|0|||
49019352|NCT00818623|157908955|FG000|Overall Study|Lack of trial drug at site|0|||
49019353|NCT00818623|157908956|FG001|Overall Study|Lack of trial drug at site|0|||
49019354|NCT00818623|157908957|FG002|Overall Study|Lack of trial drug at site|0|||
49019355|NCT00818623|157908958|FG003|Overall Study|Lack of trial drug at site|0|||
49019356|NCT00818623|157908959|FG004|Overall Study|Lack of trial drug at site|2|||
49019357|NCT00818623|157908960|FG005|Overall Study|Lack of trial drug at site|0|||
49019358|NCT00818623|157908961|FG006|Overall Study|Lack of trial drug at site|1|||
49019359|NCT00818623|157908962|FG007|Overall Study|Lack of trial drug at site|0|||
49019360|NCT00818623|157908955|FG000|Overall Study|Disease progression|0|||
49019361|NCT00818623|157908956|FG001|Overall Study|Disease progression|0|||
49019362|NCT00818623|157908957|FG002|Overall Study|Disease progression|0|||
49019363|NCT00818623|157908958|FG003|Overall Study|Disease progression|0|||
49019364|NCT00818623|157908959|FG004|Overall Study|Disease progression|0|||
49019365|NCT00818623|157908960|FG005|Overall Study|Disease progression|0|||
49019366|NCT00818623|157908961|FG006|Overall Study|Disease progression|1|||
49019367|NCT00818623|157908962|FG007|Overall Study|Disease progression|0|||
49019368|NCT01249664|157908963|FG000|Overall Study|Withdrawal by Subject|5|||
49019369|NCT01249664|157908964|FG001|Overall Study|Withdrawal by Subject|0|||
49019370|NCT01249664|157908963|FG000|Overall Study|Adverse Event|1|||
49019371|NCT01249664|157908964|FG001|Overall Study|Adverse Event|0|||
49019372|NCT01400113|157908965|FG000|Overall Study|Withdrawal by Subject|1|||
49019373|NCT01400113|157908966|FG001|Overall Study|Withdrawal by Subject|1|||
49019374|NCT03213210|157908967|FG000|Overall Study|Lost to Follow-up|2|||
49019375|NCT03213210|157908967|FG000|Overall Study|Study termination|3|||
49019376|NCT00698685|157908978|FG000|Overall Study|Sister withdrew as donor|1|||
49019377|NCT00698685|157908978|FG000|Overall Study|Off study pre transplant by clinic MD|1|||
49019378|NCT00806156|157908979|FG000|Overall Study|Death|35|||
49019379|NCT00806156|157908980|FG001|Overall Study|Death|95|||
49019380|NCT00806156|157908979|FG000|Overall Study|Did not meet eligibility criteria|1|||
49019381|NCT00806156|157908980|FG001|Overall Study|Did not meet eligibility criteria|0|||
49019382|NCT00806156|157908979|FG000|Overall Study|Study terminated by Sponsor|2|||
49019383|NCT00806156|157908980|FG001|Overall Study|Study terminated by Sponsor|40|||
49019384|NCT00806156|157908979|FG000|Overall Study|Consent withdrawn by subject|1|||
49019385|NCT00806156|157908980|FG001|Overall Study|Consent withdrawn by subject|3|||
49019386|NCT00806156|157908979|FG000|Overall Study|Lost to Follow-up|0|||
48762566|NCT00903617|156980215|FG003|Overall Study|Withdrawal by Subject|0|||
49019387|NCT00806156|157908980|FG001|Overall Study|Lost to Follow-up|1|||
49019388|NCT01325207|157908981|FG000|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
49019389|NCT01325207|157908982|FG001|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
49019390|NCT01325207|157908983|FG002|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
49019391|NCT01325207|157908984|FG003|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
49019392|NCT01325207|157908985|FG004|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2|||
49019393|NCT01325207|157908986|FG005|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
49019394|NCT01325207|157908981|FG000|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
49019395|NCT01325207|157908982|FG001|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
49019396|NCT01325207|157908983|FG002|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
49019397|NCT01325207|157908984|FG003|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
49019398|NCT01325207|157908985|FG004|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2|||
49019399|NCT01325207|157908986|FG005|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5|||
49019400|NCT01325207|157908981|FG000|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
49019401|NCT01325207|157908982|FG001|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
49019402|NCT01325207|157908983|FG002|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
49019403|NCT01325207|157908984|FG003|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
49019404|NCT01325207|157908985|FG004|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0|||
49019405|NCT01325207|157908986|FG005|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4|||
49019406|NCT01325207|157908981|FG000|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
49019407|NCT01325207|157908982|FG001|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1|||
49019408|NCT01325207|157908983|FG002|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
49019409|NCT01325207|157908984|FG003|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
49019410|NCT01325207|157908985|FG004|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
49019411|NCT01325207|157908986|FG005|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
49019412|NCT01325207|157908981|FG000|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
49019413|NCT01325207|157908982|FG001|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
49019414|NCT01325207|157908983|FG002|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
49019415|NCT01325207|157908984|FG003|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
49019416|NCT01325207|157908985|FG004|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
49019417|NCT01325207|157908986|FG005|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1|||
49019418|NCT01325207|157908981|FG000|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
49019419|NCT01325207|157908982|FG001|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
49019420|NCT01325207|157908983|FG002|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
49019421|NCT01325207|157908984|FG003|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
49019422|NCT01325207|157908985|FG004|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
49019423|NCT01325207|157908986|FG005|Follow-up Every 3 Months Until Death|Lost to Follow-up|1|||
49019424|NCT01325207|157908981|FG000|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
49019425|NCT01325207|157908982|FG001|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
49019426|NCT01325207|157908983|FG002|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
49019427|NCT01325207|157908984|FG003|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
49019428|NCT01325207|157908985|FG004|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1|||
49019429|NCT01325207|157908986|FG005|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
48677526|NCT00856544|156671379|FG000|Overall Study|Death|0|||
49019430|NCT00708422|157908987|FG000|Overall Study|Adverse Event|3|||
49019431|NCT00708422|157908988|FG001|Overall Study|Adverse Event|1|||
49019432|NCT00708422|157908987|FG000|Overall Study|Withdrawal by Subject|1|||
49019433|NCT00708422|157908988|FG001|Overall Study|Withdrawal by Subject|0|||
49019434|NCT01254409|157908989|FG000|Overall Study|Adverse Event|0|||
49019435|NCT01254409|157908990|FG001|Overall Study|Adverse Event|1|||
49019436|NCT01254409|157908991|FG002|Overall Study|Adverse Event|0|||
49019437|NCT01254409|157908992|FG003|Overall Study|Adverse Event|0|||
49019438|NCT00299156|157908997|FG000|Period 2 (Randomized)|Screen Failure|0|||
49019439|NCT00299156|157908998|FG001|Period 2 (Randomized)|Screen Failure|1|||
49019440|NCT00299156|157908999|FG002|Period 2 (Randomized)|Screen Failure|0|||
49019441|NCT00635154|157909001|FG000|Overall Study|Alternative Treatment|8|||
49019442|NCT00635154|157909001|FG000|Overall Study|Other|4|||
49019443|NCT00635154|157909001|FG000|Overall Study|Still on treatment|21|||
48677527|NCT00856544|156671380|FG001|Overall Study|Death|2|||
48677528|NCT00856544|156671381|FG002|Overall Study|Death|0|||
49019444|NCT03980483|157909002|FG000|Overall Study|Adverse Event|13|||
49019445|NCT03980483|157909003|FG001|Overall Study|Adverse Event|29|||
49019446|NCT03980483|157909004|FG002|Overall Study|Adverse Event|11|||
49019447|NCT03980483|157909005|FG003|Overall Study|Adverse Event|2|||
49019448|NCT03980483|157909006|FG004|Overall Study|Adverse Event|2|||
49019449|NCT03980483|157909007|FG005|Overall Study|Adverse Event|2|||
49019450|NCT03980483|157909002|FG000|Overall Study|Lack of Efficacy|7|||
49019451|NCT03980483|157909003|FG001|Overall Study|Lack of Efficacy|6|||
49019452|NCT03980483|157909004|FG002|Overall Study|Lack of Efficacy|0|||
49019453|NCT03980483|157909005|FG003|Overall Study|Lack of Efficacy|3|||
49019454|NCT03980483|157909006|FG004|Overall Study|Lack of Efficacy|1|||
48677529|NCT00856544|156671382|FG003|Overall Study|Death|0|||
49019455|NCT03980483|157909007|FG005|Overall Study|Lack of Efficacy|1|||
49019456|NCT03980483|157909002|FG000|Overall Study|Lost to Follow-up|2|||
49019457|NCT03980483|157909003|FG001|Overall Study|Lost to Follow-up|4|||
49019458|NCT03980483|157909004|FG002|Overall Study|Lost to Follow-up|2|||
49019459|NCT03980483|157909005|FG003|Overall Study|Lost to Follow-up|1|||
48677530|NCT00856544|156671379|FG000|Overall Study|Adverse Event|20|||
49019460|NCT03980483|157909006|FG004|Overall Study|Lost to Follow-up|2|||
49019461|NCT03980483|157909007|FG005|Overall Study|Lost to Follow-up|0|||
49019462|NCT03980483|157909002|FG000|Overall Study|Protocol Violation|4|||
49019463|NCT03980483|157909003|FG001|Overall Study|Protocol Violation|2|||
49019464|NCT03980483|157909004|FG002|Overall Study|Protocol Violation|1|||
49019465|NCT03980483|157909005|FG003|Overall Study|Protocol Violation|1|||
49019466|NCT03980483|157909006|FG004|Overall Study|Protocol Violation|0|||
49019467|NCT03980483|157909007|FG005|Overall Study|Protocol Violation|0|||
49019468|NCT03980483|157909002|FG000|Overall Study|Physician Decision|14|||
49019469|NCT03980483|157909003|FG001|Overall Study|Physician Decision|10|||
49019470|NCT03980483|157909004|FG002|Overall Study|Physician Decision|7|||
49019471|NCT03980483|157909005|FG003|Overall Study|Physician Decision|4|||
49019472|NCT03980483|157909006|FG004|Overall Study|Physician Decision|4|||
49019473|NCT03980483|157909007|FG005|Overall Study|Physician Decision|2|||
49019474|NCT03980483|157909002|FG000|Overall Study|Withdrawal by Subject|38|||
49019475|NCT03980483|157909003|FG001|Overall Study|Withdrawal by Subject|21|||
49019476|NCT03980483|157909004|FG002|Overall Study|Withdrawal by Subject|15|||
49019477|NCT03980483|157909005|FG003|Overall Study|Withdrawal by Subject|5|||
49019478|NCT03980483|157909006|FG004|Overall Study|Withdrawal by Subject|3|||
49019479|NCT03980483|157909007|FG005|Overall Study|Withdrawal by Subject|4|||
49019480|NCT03980483|157909002|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|4|||
49019481|NCT03980483|157909003|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
49019482|NCT03980483|157909004|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
49019483|NCT03980483|157909005|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
49019484|NCT03980483|157909006|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
49019485|NCT03980483|157909007|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
49019486|NCT03980483|157909002|FG000|Overall Study|INVESTIGATOR SITE CLOSED|0|||
49019487|NCT03980483|157909003|FG001|Overall Study|INVESTIGATOR SITE CLOSED|1|||
49019488|NCT03980483|157909004|FG002|Overall Study|INVESTIGATOR SITE CLOSED|0|||
49019489|NCT03980483|157909005|FG003|Overall Study|INVESTIGATOR SITE CLOSED|0|||
49019490|NCT03980483|157909006|FG004|Overall Study|INVESTIGATOR SITE CLOSED|0|||
49019491|NCT03980483|157909007|FG005|Overall Study|INVESTIGATOR SITE CLOSED|0|||
49019492|NCT03980483|157909002|FG000|Overall Study|Other|0|||
49019493|NCT03980483|157909003|FG001|Overall Study|Other|1|||
49019494|NCT03980483|157909004|FG002|Overall Study|Other|0|||
49019495|NCT03980483|157909005|FG003|Overall Study|Other|0|||
49019496|NCT03980483|157909006|FG004|Overall Study|Other|0|||
49019497|NCT03980483|157909007|FG005|Overall Study|Other|0|||
49019498|NCT01225146|157909011|FG000|Overall Study|Sponsor discontinued making 2mg drug|0|||
49019499|NCT01225146|157909012|FG001|Overall Study|Sponsor discontinued making 2mg drug|2|||
49019500|NCT00950807|157909013|FG000|Treatment Period 1|Lack of Efficacy|1|||
49019501|NCT00950807|157909014|FG001|Treatment Period 1|Lack of Efficacy|0|||
49019502|NCT00950807|157909015|FG002|Treatment Period 1|Lack of Efficacy|0|||
49019503|NCT00950807|157909016|FG003|Treatment Period 1|Lack of Efficacy|0|||
49019504|NCT00950807|157909017|FG004|Treatment Period 1|Lack of Efficacy|0|||
49019505|NCT00950807|157909018|FG005|Treatment Period 1|Lack of Efficacy|1|||
49019506|NCT00950807|157909019|FG006|Treatment Period 1|Lack of Efficacy|0|||
49019507|NCT00950807|157909020|FG007|Treatment Period 1|Lack of Efficacy|0|||
49019508|NCT00950807|157909021|FG008|Treatment Period 1|Lack of Efficacy|0|||
49019509|NCT00950807|157909022|FG009|Treatment Period 1|Lack of Efficacy|0|||
49019510|NCT00950807|157909013|FG000|Treatment Period 1|Protocol Violation|1|||
49019511|NCT00950807|157909014|FG001|Treatment Period 1|Protocol Violation|0|||
49019512|NCT00950807|157909015|FG002|Treatment Period 1|Protocol Violation|0|||
49019513|NCT00950807|157909016|FG003|Treatment Period 1|Protocol Violation|0|||
49019514|NCT00950807|157909017|FG004|Treatment Period 1|Protocol Violation|0|||
49019515|NCT00950807|157909018|FG005|Treatment Period 1|Protocol Violation|0|||
49019516|NCT00950807|157909019|FG006|Treatment Period 1|Protocol Violation|0|||
49019517|NCT00950807|157909020|FG007|Treatment Period 1|Protocol Violation|0|||
48677531|NCT00856544|156671380|FG001|Overall Study|Adverse Event|29|||
48677532|NCT00856544|156671381|FG002|Overall Study|Adverse Event|2|||
48677533|NCT00856544|156671382|FG003|Overall Study|Adverse Event|3|||
49019518|NCT00950807|157909021|FG008|Treatment Period 1|Protocol Violation|0|||
48677534|NCT00856544|156671379|FG000|Overall Study|Lack of Efficacy|16|||
49019519|NCT00950807|157909022|FG009|Treatment Period 1|Protocol Violation|0|||
49019520|NCT00950807|157909013|FG000|Treatment Period 1|Lost to Follow-up|0|||
49019521|NCT00950807|157909014|FG001|Treatment Period 1|Lost to Follow-up|0|||
49019522|NCT00950807|157909015|FG002|Treatment Period 1|Lost to Follow-up|1|||
49019523|NCT00950807|157909016|FG003|Treatment Period 1|Lost to Follow-up|0|||
49019524|NCT00950807|157909017|FG004|Treatment Period 1|Lost to Follow-up|0|||
49019525|NCT00950807|157909018|FG005|Treatment Period 1|Lost to Follow-up|0|||
49019526|NCT00950807|157909019|FG006|Treatment Period 1|Lost to Follow-up|0|||
49019527|NCT00950807|157909020|FG007|Treatment Period 1|Lost to Follow-up|0|||
49019528|NCT00950807|157909021|FG008|Treatment Period 1|Lost to Follow-up|0|||
49019529|NCT00950807|157909022|FG009|Treatment Period 1|Lost to Follow-up|0|||
49019530|NCT00950807|157909013|FG000|Treatment Period 1|Withdrawal by Subject|1|||
49019531|NCT00950807|157909014|FG001|Treatment Period 1|Withdrawal by Subject|0|||
48874949|NCT01427738|157378991|FG000|Overall Study|Death|12|||
48874950|NCT01427738|157378992|FG001|Overall Study|Death|9|||
48874951|NCT01427738|157378991|FG000|Overall Study|Severe debilitation, unable to continue|0|||
48874952|NCT01427738|157378992|FG001|Overall Study|Severe debilitation, unable to continue|1|||
48874953|NCT01427738|157378991|FG000|Overall Study|Subject unable to get to clinic|5|||
48874954|NCT01427738|157378992|FG001|Overall Study|Subject unable to get to clinic|2|||
48677535|NCT00856544|156671380|FG001|Overall Study|Lack of Efficacy|12|||
48677536|NCT00856544|156671381|FG002|Overall Study|Lack of Efficacy|3|||
48677537|NCT00856544|156671382|FG003|Overall Study|Lack of Efficacy|3|||
48677538|NCT00856544|156671379|FG000|Overall Study|Other|9|||
48677539|NCT00856544|156671380|FG001|Overall Study|Other|16|||
48677540|NCT00856544|156671381|FG002|Overall Study|Other|1|||
48677541|NCT00856544|156671382|FG003|Overall Study|Other|6|||
48677542|NCT00856544|156671379|FG000|Overall Study|Lost to Follow-up|1|||
48762567|NCT01706003|156980218|FG000|Overall Study|Withdrawal by Subject|2|||
48677543|NCT00856544|156671380|FG001|Overall Study|Lost to Follow-up|2|||
48677544|NCT00856544|156671381|FG002|Overall Study|Lost to Follow-up|2|||
48677545|NCT00856544|156671382|FG003|Overall Study|Lost to Follow-up|0|||
48677546|NCT00856544|156671379|FG000|Overall Study|Withdrawal by Subject|8|||
48677547|NCT00856544|156671380|FG001|Overall Study|Withdrawal by Subject|5|||
48677548|NCT00856544|156671381|FG002|Overall Study|Withdrawal by Subject|0|||
48677549|NCT00856544|156671382|FG003|Overall Study|Withdrawal by Subject|1|||
48677550|NCT02462720|156671383|FG000|Part 2|Withdrawal by Subject|1|||
48677551|NCT02462720|156671384|FG001|Part 2|Withdrawal by Subject|0|||
48677552|NCT02462720|156671383|FG000|Part 2|Protocol Violation|0|||
48677553|NCT02462720|156671384|FG001|Part 2|Protocol Violation|1|||
48677554|NCT03282097|156671385|FG000|Randomized and Completed Baseline|Randomized no Baseline|1|||
48677555|NCT03282097|156671386|FG001|Randomized and Completed Baseline|Randomized no Baseline|1|||
48677556|NCT03282097|156671385|FG000|Intervention Visit Complete|Patient Death|13|||
48677557|NCT03282097|156671386|FG001|Intervention Visit Complete|Patient Death|15|||
48762568|NCT01706003|156980219|FG001|Overall Study|Withdrawal by Subject|0|||
48762569|NCT01706003|156980218|FG000|Overall Study|Not scheduled|3|||
48762570|NCT01706003|156980219|FG001|Overall Study|Not scheduled|0|||
48762571|NCT01706003|156980218|FG000|Overall Study|Lost to Follow-up|6|||
48762572|NCT01706003|156980219|FG001|Overall Study|Lost to Follow-up|4|||
48762573|NCT00407563|156980220|FG000|Overall Study|Patient continues on treatment|1|||
48762574|NCT02356783|156980221|FG000|Overall Study|Lost to Follow-up|1|||
48762575|NCT02356783|156980222|FG001|Overall Study|Lost to Follow-up|3|||
48762576|NCT01853046|156980223|FG000|Overall Study|Withdrawal by Subject|1|||
48762577|NCT01853046|156980224|FG001|Overall Study|Withdrawal by Subject|1|||
48762578|NCT01853046|156980223|FG000|Overall Study|Adverse Event|4|||
48762579|NCT01853046|156980224|FG001|Overall Study|Adverse Event|2|||
48762580|NCT01853046|156980223|FG000|Overall Study|Disease progression|13|||
48762581|NCT01853046|156980224|FG001|Overall Study|Disease progression|3|||
48762582|NCT00192504|156980227|FG000|Overall Study|Lost to Follow-up|1|||
48762583|NCT00192504|156980228|FG001|Overall Study|Lost to Follow-up|0|||
48762584|NCT00192504|156980229|FG002|Overall Study|Lost to Follow-up|0|||
48762585|NCT00192504|156980230|FG003|Overall Study|Lost to Follow-up|0|||
48762586|NCT00192504|156980227|FG000|Overall Study|Dosing window missed|0|||
48762587|NCT00192504|156980228|FG001|Overall Study|Dosing window missed|0|||
48762588|NCT00192504|156980229|FG002|Overall Study|Dosing window missed|1|||
48762589|NCT00192504|156980230|FG003|Overall Study|Dosing window missed|0|||
48762590|NCT05333900|156980231|FG000|Overall Study|Protocol Violation|0|||
48762591|NCT05333900|156980232|FG001|Overall Study|Protocol Violation|1|||
48762592|NCT05333900|156980231|FG000|Overall Study|Withdrawal by Subject|0|||
48762593|NCT05333900|156980232|FG001|Overall Study|Withdrawal by Subject|1|||
48762594|NCT05333900|156980231|FG000|Overall Study|COVID-19 Pandemic|1|||
48762595|NCT05333900|156980232|FG001|Overall Study|COVID-19 Pandemic|1|||
48762596|NCT02385266|156980233|FG000|Overall Study|Withdrawal by Subject|1|||
48762597|NCT02385266|156980234|FG001|Overall Study|Withdrawal by Subject|3|||
48762598|NCT00265343|156980235|FG000|Overall Study|Adverse Event|10|||
48762599|NCT00265343|156980236|FG001|Overall Study|Adverse Event|7|||
48762600|NCT00265343|156980235|FG000|Overall Study|Withdrawal by Subject|3|||
48762601|NCT00265343|156980236|FG001|Overall Study|Withdrawal by Subject|9|||
48762602|NCT00265343|156980235|FG000|Overall Study|Other|8|||
48762603|NCT00265343|156980236|FG001|Overall Study|Other|3|||
48762604|NCT00573755|156980241|FG000|Overall Study|Still receiving treatment|1|||
48677558|NCT03282097|156671385|FG000|Intervention Visit Complete|Caregiver Death|0|||
48677559|NCT03282097|156671386|FG001|Intervention Visit Complete|Caregiver Death|3|||
48677560|NCT03282097|156671385|FG000|Intervention Visit Complete|Withdrawal by Subject|14|||
48677561|NCT03282097|156671386|FG001|Intervention Visit Complete|Withdrawal by Subject|13|||
48762605|NCT00573755|156980242|FG001|Overall Study|Still receiving treatment|0|||
48762606|NCT02276872|156980243|FG000|Overall Study|Adverse Event|1|||
48762607|NCT02276872|156980244|FG001|Overall Study|Adverse Event|0|||
48762608|NCT02276872|156980245|FG002|Overall Study|Adverse Event|0|||
48762609|NCT02132767|156980251|FG000|Overall Study|Death|3|||
48874955|NCT01427738|157378991|FG000|Overall Study|Withdrawal by Subject|0|||
48762610|NCT02132767|156980252|FG001|Overall Study|Death|2|||
49019532|NCT00950807|157909015|FG002|Treatment Period 1|Withdrawal by Subject|0|||
49019533|NCT00950807|157909016|FG003|Treatment Period 1|Withdrawal by Subject|0|||
49019534|NCT00950807|157909017|FG004|Treatment Period 1|Withdrawal by Subject|1|||
49019535|NCT00950807|157909018|FG005|Treatment Period 1|Withdrawal by Subject|0|||
49019536|NCT00950807|157909019|FG006|Treatment Period 1|Withdrawal by Subject|0|||
49019537|NCT00950807|157909020|FG007|Treatment Period 1|Withdrawal by Subject|0|||
49019538|NCT00950807|157909021|FG008|Treatment Period 1|Withdrawal by Subject|1|||
49019539|NCT00950807|157909022|FG009|Treatment Period 1|Withdrawal by Subject|0|||
49019540|NCT00950807|157909013|FG000|Treatment Period 1|Adverse Event|0|||
49019541|NCT00950807|157909014|FG001|Treatment Period 1|Adverse Event|0|||
49019542|NCT00950807|157909015|FG002|Treatment Period 1|Adverse Event|0|||
49019543|NCT00950807|157909016|FG003|Treatment Period 1|Adverse Event|0|||
49019544|NCT00950807|157909017|FG004|Treatment Period 1|Adverse Event|0|||
49019545|NCT00950807|157909018|FG005|Treatment Period 1|Adverse Event|1|||
49019546|NCT00950807|157909019|FG006|Treatment Period 1|Adverse Event|0|||
49019547|NCT00950807|157909020|FG007|Treatment Period 1|Adverse Event|0|||
49019548|NCT00950807|157909021|FG008|Treatment Period 1|Adverse Event|0|||
49019549|NCT00950807|157909022|FG009|Treatment Period 1|Adverse Event|0|||
49019550|NCT00950807|157909013|FG000|Washout Period 1|Lack of Efficacy|0|||
49019551|NCT00950807|157909014|FG001|Washout Period 1|Lack of Efficacy|0|||
49019552|NCT00950807|157909015|FG002|Washout Period 1|Lack of Efficacy|0|||
49019553|NCT00950807|157909016|FG003|Washout Period 1|Lack of Efficacy|0|||
49019554|NCT00950807|157909017|FG004|Washout Period 1|Lack of Efficacy|0|||
49019555|NCT00950807|157909018|FG005|Washout Period 1|Lack of Efficacy|0|||
49019556|NCT00950807|157909019|FG006|Washout Period 1|Lack of Efficacy|1|||
49019557|NCT00950807|157909020|FG007|Washout Period 1|Lack of Efficacy|0|||
49019558|NCT00950807|157909021|FG008|Washout Period 1|Lack of Efficacy|0|||
49019559|NCT00950807|157909022|FG009|Washout Period 1|Lack of Efficacy|0|||
49019560|NCT00950807|157909013|FG000|Washout Period 1|Withdrawal by Subject|0|||
49019561|NCT00950807|157909014|FG001|Washout Period 1|Withdrawal by Subject|0|||
49019562|NCT00950807|157909015|FG002|Washout Period 1|Withdrawal by Subject|0|||
49019563|NCT00950807|157909016|FG003|Washout Period 1|Withdrawal by Subject|0|||
49019564|NCT00950807|157909017|FG004|Washout Period 1|Withdrawal by Subject|0|||
49019565|NCT00950807|157909018|FG005|Washout Period 1|Withdrawal by Subject|0|||
49019566|NCT00950807|157909019|FG006|Washout Period 1|Withdrawal by Subject|0|||
49019567|NCT00950807|157909020|FG007|Washout Period 1|Withdrawal by Subject|0|||
49019568|NCT00950807|157909021|FG008|Washout Period 1|Withdrawal by Subject|1|||
49019569|NCT00950807|157909022|FG009|Washout Period 1|Withdrawal by Subject|0|||
49019570|NCT00950807|157909013|FG000|Washout Period 1|Protocol-defined Stopping Criteria|3|||
49019571|NCT00950807|157909014|FG001|Washout Period 1|Protocol-defined Stopping Criteria|0|||
49019572|NCT00950807|157909015|FG002|Washout Period 1|Protocol-defined Stopping Criteria|0|||
49019573|NCT00950807|157909016|FG003|Washout Period 1|Protocol-defined Stopping Criteria|0|||
49019574|NCT00950807|157909017|FG004|Washout Period 1|Protocol-defined Stopping Criteria|0|||
49019575|NCT00950807|157909018|FG005|Washout Period 1|Protocol-defined Stopping Criteria|0|||
49019576|NCT00950807|157909019|FG006|Washout Period 1|Protocol-defined Stopping Criteria|1|||
49019577|NCT00950807|157909020|FG007|Washout Period 1|Protocol-defined Stopping Criteria|1|||
49019578|NCT00950807|157909021|FG008|Washout Period 1|Protocol-defined Stopping Criteria|0|||
49019579|NCT00950807|157909022|FG009|Washout Period 1|Protocol-defined Stopping Criteria|0|||
49019580|NCT00950807|157909013|FG000|Washout Period 1|Adverse Event|2|||
49019581|NCT00950807|157909014|FG001|Washout Period 1|Adverse Event|0|||
49019582|NCT00950807|157909015|FG002|Washout Period 1|Adverse Event|0|||
49019583|NCT00950807|157909016|FG003|Washout Period 1|Adverse Event|1|||
49019584|NCT00950807|157909017|FG004|Washout Period 1|Adverse Event|1|||
49019585|NCT00950807|157909018|FG005|Washout Period 1|Adverse Event|0|||
49019586|NCT00950807|157909019|FG006|Washout Period 1|Adverse Event|0|||
49019587|NCT00950807|157909020|FG007|Washout Period 1|Adverse Event|0|||
49019588|NCT00950807|157909021|FG008|Washout Period 1|Adverse Event|0|||
49019589|NCT00950807|157909022|FG009|Washout Period 1|Adverse Event|0|||
48677562|NCT03282097|156671385|FG000|Intervention Visit Complete|Became Ineligible before PCP Index visit|12|||
48677563|NCT03282097|156671386|FG001|Intervention Visit Complete|Became Ineligible before PCP Index visit|21|||
49019590|NCT00950807|157909013|FG000|Treatment Period 2|Lack of Efficacy|1|||
49019591|NCT00950807|157909014|FG001|Treatment Period 2|Lack of Efficacy|0|||
49019592|NCT00950807|157909015|FG002|Treatment Period 2|Lack of Efficacy|0|||
49019593|NCT00950807|157909016|FG003|Treatment Period 2|Lack of Efficacy|0|||
49019594|NCT00950807|157909017|FG004|Treatment Period 2|Lack of Efficacy|0|||
49019595|NCT00950807|157909018|FG005|Treatment Period 2|Lack of Efficacy|0|||
49019596|NCT00950807|157909019|FG006|Treatment Period 2|Lack of Efficacy|0|||
49019597|NCT00950807|157909020|FG007|Treatment Period 2|Lack of Efficacy|0|||
49019598|NCT00950807|157909021|FG008|Treatment Period 2|Lack of Efficacy|0|||
49019599|NCT00950807|157909022|FG009|Treatment Period 2|Lack of Efficacy|0|||
49019600|NCT00950807|157909013|FG000|Treatment Period 2|Withdrawal by Subject|0|||
49019601|NCT00950807|157909014|FG001|Treatment Period 2|Withdrawal by Subject|0|||
49019602|NCT00950807|157909015|FG002|Treatment Period 2|Withdrawal by Subject|0|||
49019603|NCT00950807|157909016|FG003|Treatment Period 2|Withdrawal by Subject|0|||
49019604|NCT00950807|157909017|FG004|Treatment Period 2|Withdrawal by Subject|0|||
49019605|NCT00950807|157909018|FG005|Treatment Period 2|Withdrawal by Subject|0|||
49019606|NCT00950807|157909019|FG006|Treatment Period 2|Withdrawal by Subject|1|||
49019607|NCT00950807|157909020|FG007|Treatment Period 2|Withdrawal by Subject|2|||
49019608|NCT00950807|157909021|FG008|Treatment Period 2|Withdrawal by Subject|0|||
49019609|NCT00950807|157909022|FG009|Treatment Period 2|Withdrawal by Subject|0|||
49019610|NCT00950807|157909013|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
49019611|NCT00950807|157909014|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
49019612|NCT00950807|157909015|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
49019613|NCT00950807|157909016|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
49019614|NCT00950807|157909017|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
49019615|NCT00950807|157909018|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
49019616|NCT00950807|157909019|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
49019617|NCT00950807|157909020|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
49019618|NCT00950807|157909021|FG008|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
49019619|NCT00950807|157909022|FG009|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
49019620|NCT00950807|157909013|FG000|Treatment Period 2|Adverse Event|0|||
49019621|NCT00950807|157909014|FG001|Treatment Period 2|Adverse Event|1|||
49019622|NCT00950807|157909015|FG002|Treatment Period 2|Adverse Event|0|||
49019623|NCT00950807|157909016|FG003|Treatment Period 2|Adverse Event|1|||
49019624|NCT00950807|157909017|FG004|Treatment Period 2|Adverse Event|0|||
49019625|NCT00950807|157909018|FG005|Treatment Period 2|Adverse Event|1|||
49019626|NCT00950807|157909019|FG006|Treatment Period 2|Adverse Event|0|||
49019627|NCT00950807|157909020|FG007|Treatment Period 2|Adverse Event|1|||
49019628|NCT00950807|157909021|FG008|Treatment Period 2|Adverse Event|0|||
49019629|NCT00950807|157909022|FG009|Treatment Period 2|Adverse Event|0|||
49019630|NCT00950807|157909013|FG000|Washout Period 2|Lack of Efficacy|1|||
49019631|NCT00950807|157909014|FG001|Washout Period 2|Lack of Efficacy|0|||
49019632|NCT00950807|157909015|FG002|Washout Period 2|Lack of Efficacy|0|||
49019633|NCT00950807|157909016|FG003|Washout Period 2|Lack of Efficacy|0|||
49019634|NCT00950807|157909017|FG004|Washout Period 2|Lack of Efficacy|0|||
49019635|NCT00950807|157909018|FG005|Washout Period 2|Lack of Efficacy|0|||
49019636|NCT00950807|157909019|FG006|Washout Period 2|Lack of Efficacy|0|||
49019637|NCT00950807|157909020|FG007|Washout Period 2|Lack of Efficacy|0|||
49019638|NCT00950807|157909021|FG008|Washout Period 2|Lack of Efficacy|0|||
49019639|NCT00950807|157909022|FG009|Washout Period 2|Lack of Efficacy|0|||
49019640|NCT00950807|157909013|FG000|Washout Period 2|Protocol-defined Stopping Criteria|0|||
49019641|NCT00950807|157909014|FG001|Washout Period 2|Protocol-defined Stopping Criteria|1|||
49019642|NCT00950807|157909015|FG002|Washout Period 2|Protocol-defined Stopping Criteria|0|||
49019643|NCT00950807|157909016|FG003|Washout Period 2|Protocol-defined Stopping Criteria|0|||
49019644|NCT00950807|157909017|FG004|Washout Period 2|Protocol-defined Stopping Criteria|1|||
49019645|NCT00950807|157909018|FG005|Washout Period 2|Protocol-defined Stopping Criteria|0|||
49019646|NCT00950807|157909019|FG006|Washout Period 2|Protocol-defined Stopping Criteria|1|||
49019647|NCT00950807|157909020|FG007|Washout Period 2|Protocol-defined Stopping Criteria|1|||
49019648|NCT00950807|157909021|FG008|Washout Period 2|Protocol-defined Stopping Criteria|0|||
49019649|NCT00950807|157909022|FG009|Washout Period 2|Protocol-defined Stopping Criteria|0|||
49019650|NCT00950807|157909013|FG000|Washout Period 2|Adverse Event|3|||
49019651|NCT00950807|157909014|FG001|Washout Period 2|Adverse Event|0|||
49019652|NCT00950807|157909015|FG002|Washout Period 2|Adverse Event|0|||
49019653|NCT00950807|157909016|FG003|Washout Period 2|Adverse Event|1|||
49019654|NCT00950807|157909017|FG004|Washout Period 2|Adverse Event|0|||
49019655|NCT00950807|157909018|FG005|Washout Period 2|Adverse Event|0|||
49019656|NCT00950807|157909019|FG006|Washout Period 2|Adverse Event|0|||
49019657|NCT00950807|157909020|FG007|Washout Period 2|Adverse Event|0|||
48762611|NCT02132767|156980251|FG000|Overall Study|Withdrawal by Subject|10|||
48762612|NCT02132767|156980252|FG001|Overall Study|Withdrawal by Subject|9|||
48762613|NCT02132767|156980251|FG000|Overall Study|Lost to Follow-up|4|||
48762614|NCT02132767|156980252|FG001|Overall Study|Lost to Follow-up|4|||
49019658|NCT00950807|157909021|FG008|Washout Period 2|Adverse Event|0|||
49019659|NCT00950807|157909022|FG009|Washout Period 2|Adverse Event|0|||
49019660|NCT00950807|157909013|FG000|Treatment Period 3|Withdrawal by Subject|0|||
49019661|NCT00950807|157909014|FG001|Treatment Period 3|Withdrawal by Subject|0|||
49019662|NCT00950807|157909015|FG002|Treatment Period 3|Withdrawal by Subject|0|||
49019663|NCT00950807|157909016|FG003|Treatment Period 3|Withdrawal by Subject|0|||
49019664|NCT00950807|157909017|FG004|Treatment Period 3|Withdrawal by Subject|0|||
49019665|NCT00950807|157909018|FG005|Treatment Period 3|Withdrawal by Subject|0|||
49019666|NCT00950807|157909019|FG006|Treatment Period 3|Withdrawal by Subject|0|||
49019667|NCT00950807|157909020|FG007|Treatment Period 3|Withdrawal by Subject|0|||
49019668|NCT00950807|157909021|FG008|Treatment Period 3|Withdrawal by Subject|0|||
49019669|NCT00950807|157909022|FG009|Treatment Period 3|Withdrawal by Subject|1|||
49019670|NCT00950807|157909013|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
49019671|NCT00950807|157909014|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
49019672|NCT00950807|157909015|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
49019673|NCT00950807|157909016|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
49019674|NCT00950807|157909017|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
48677564|NCT03282097|156671385|FG000|Intervention Visit Complete|PCP Index Visit Not Completed|3|||
48677565|NCT03282097|156671386|FG001|Intervention Visit Complete|PCP Index Visit Not Completed|7|||
48677566|NCT03282097|156671385|FG000|Primary Outcome Data Collection Complete|Missing|2|||
48677567|NCT03282097|156671386|FG001|Primary Outcome Data Collection Complete|Missing|3|||
48677568|NCT03282097|156671385|FG000|Primary Outcome Data Collection Complete|Withdrawal by Subject|1|||
48677569|NCT03282097|156671386|FG001|Primary Outcome Data Collection Complete|Withdrawal by Subject|0|||
48677570|NCT03282097|156671385|FG000|15 Month Follow-up Complete|Withdrawal by Subject|0|||
48762615|NCT01132547|156980259|FG000|Overall Study|Withdrawal by Subject|3|||
48762616|NCT01132547|156980260|FG001|Overall Study|Withdrawal by Subject|1|||
48762617|NCT01132547|156980259|FG000|Overall Study|Death|1|||
48762618|NCT01132547|156980260|FG001|Overall Study|Death|0|||
48762619|NCT03412084|156980264|FG000|Overall Study|Withdrawal by Subject|2|||
49019675|NCT00950807|157909018|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
48677571|NCT03282097|156671386|FG001|15 Month Follow-up Complete|Withdrawal by Subject|1|||
48677572|NCT03282097|156671385|FG000|15 Month Follow-up Complete|Lost to Follow-up|6|||
48677573|NCT03282097|156671386|FG001|15 Month Follow-up Complete|Lost to Follow-up|8|||
48677574|NCT01858740|156671387|FG000|Overall Study|Death|4|||
48677575|NCT00517361|156671390|FG000|Overall Study|Death|6|||
48677576|NCT00517361|156671390|FG000|Overall Study|The study was terminated|5|||
48677577|NCT03916081|156671406|FG000|Overall Study|Adverse Event|1|||
48677578|NCT03916081|156671407|FG001|Overall Study|Adverse Event|0|||
48677579|NCT03916081|156671408|FG002|Overall Study|Adverse Event|0|||
48677580|NCT03916081|156671406|FG000|Overall Study|Physician Decision|0|||
48677581|NCT03916081|156671407|FG001|Overall Study|Physician Decision|0|||
48677582|NCT03916081|156671408|FG002|Overall Study|Physician Decision|1|||
48677583|NCT03916081|156671406|FG000|Overall Study|Lost to Follow-up|0|||
48677584|NCT03916081|156671407|FG001|Overall Study|Lost to Follow-up|1|||
48677585|NCT03916081|156671408|FG002|Overall Study|Lost to Follow-up|0|||
48677586|NCT03916081|156671406|FG000|Overall Study|Withdrawal by Subject|3|||
48677587|NCT03916081|156671407|FG001|Overall Study|Withdrawal by Subject|0|||
48677588|NCT03916081|156671408|FG002|Overall Study|Withdrawal by Subject|1|||
48677589|NCT03916081|156671406|FG000|Overall Study|Worsening of AD|0|||
48677590|NCT03916081|156671407|FG001|Overall Study|Worsening of AD|0|||
48677591|NCT03916081|156671408|FG002|Overall Study|Worsening of AD|1|||
48677592|NCT01371734|156671411|FG000|Overall Study|Other|2|||
48677593|NCT01371734|156671412|FG001|Overall Study|Other|1|||
48677594|NCT01371734|156671413|FG002|Overall Study|Other|2|||
48677595|NCT01371734|156671411|FG000|Overall Study|Withdrawal by Subject|3|||
48677596|NCT01371734|156671412|FG001|Overall Study|Withdrawal by Subject|4|||
48677597|NCT01371734|156671413|FG002|Overall Study|Withdrawal by Subject|9|||
48677598|NCT01371734|156671411|FG000|Overall Study|Lost to Follow-up|5|||
48677599|NCT01371734|156671412|FG001|Overall Study|Lost to Follow-up|3|||
48677600|NCT01371734|156671413|FG002|Overall Study|Lost to Follow-up|1|||
48677601|NCT01371734|156671411|FG000|Overall Study|Protocol Violation|3|||
48677602|NCT01371734|156671412|FG001|Overall Study|Protocol Violation|1|||
48677603|NCT01371734|156671413|FG002|Overall Study|Protocol Violation|2|||
48677604|NCT01371734|156671411|FG000|Overall Study|Adverse Event|8|||
48677605|NCT01371734|156671412|FG001|Overall Study|Adverse Event|8|||
48677606|NCT01371734|156671413|FG002|Overall Study|Adverse Event|3|||
48677607|NCT01371734|156671411|FG000|Overall Study|Lack of Efficacy|2|||
48677608|NCT01371734|156671412|FG001|Overall Study|Lack of Efficacy|2|||
48677609|NCT01371734|156671413|FG002|Overall Study|Lack of Efficacy|0|||
48677610|NCT04079114|156671414|FG000|Overall Study|Study prematuely terminated.|166|||
48677611|NCT01098305|156671415|FG000|Overall Study|Lost to Follow-up|31|||
48762620|NCT03412084|156980265|FG001|Overall Study|Withdrawal by Subject|0|||
48677612|NCT01098305|156671416|FG001|Overall Study|Lost to Follow-up|33|||
48677613|NCT02577016|156671417|FG000|Overall Study|Adverse Event|2|||
48677614|NCT02577016|156671418|FG001|Overall Study|Adverse Event|1|||
48677615|NCT02577016|156671417|FG000|Overall Study|Physician Decision|0|||
49019676|NCT00950807|157909019|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
48677616|NCT02577016|156671418|FG001|Overall Study|Physician Decision|1|||
48677617|NCT02218008|156671419|FG000|Stage 1 (S1)|Adverse Event|6|||
48677618|NCT02218008|156671420|FG001|Stage 1 (S1)|Adverse Event|5|||
48677619|NCT02218008|156671421|FG002|Stage 1 (S1)|Adverse Event|11|||
48677620|NCT02218008|156671422|FG003|Stage 1 (S1)|Adverse Event|0|||
48677621|NCT02218008|156671423|FG004|Stage 1 (S1)|Adverse Event|0|||
48677622|NCT02218008|156671424|FG005|Stage 1 (S1)|Adverse Event|0|||
48677623|NCT02218008|156671419|FG000|Stage 1 (S1)|Withdrawal by Subject|6|||
48677624|NCT02218008|156671420|FG001|Stage 1 (S1)|Withdrawal by Subject|1|||
48677625|NCT02218008|156671421|FG002|Stage 1 (S1)|Withdrawal by Subject|1|||
48677626|NCT02218008|156671422|FG003|Stage 1 (S1)|Withdrawal by Subject|0|||
48677627|NCT02218008|156671423|FG004|Stage 1 (S1)|Withdrawal by Subject|0|||
48677628|NCT02218008|156671424|FG005|Stage 1 (S1)|Withdrawal by Subject|0|||
48677629|NCT02218008|156671419|FG000|Stage 1 (S1)|Lack of Efficacy|3|||
48762621|NCT03412084|156980264|FG000|Overall Study|Participant moved|1|||
48677630|NCT02218008|156671420|FG001|Stage 1 (S1)|Lack of Efficacy|0|||
48677631|NCT02218008|156671421|FG002|Stage 1 (S1)|Lack of Efficacy|0|||
48762622|NCT03412084|156980265|FG001|Overall Study|Participant moved|0|||
48762623|NCT03412084|156980264|FG000|Overall Study|Lost to Follow-up|1|||
48762624|NCT03412084|156980265|FG001|Overall Study|Lost to Follow-up|1|||
48762625|NCT00634088|156980267|FG000|Time Period 1: Dose Level 1|Disease progression|2|||
48762626|NCT00634088|156980268|FG001|Time Period 1: Dose Level 1|Disease progression|0|||
48762627|NCT00634088|156980269|FG002|Time Period 1: Dose Level 1|Disease progression|0|||
48762628|NCT00634088|156980270|FG003|Time Period 1: Dose Level 1|Disease progression|0|||
48762629|NCT00634088|156980267|FG000|Time Period 1: Dose Level 1|Physician Decision|1|||
48762630|NCT00634088|156980268|FG001|Time Period 1: Dose Level 1|Physician Decision|0|||
48762631|NCT00634088|156980269|FG002|Time Period 1: Dose Level 1|Physician Decision|0|||
48762632|NCT00634088|156980270|FG003|Time Period 1: Dose Level 1|Physician Decision|0|||
48762633|NCT00634088|156980267|FG000|Time Period 1: Dose Level 1|Adverse Event|3|||
49019677|NCT00950807|157909020|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
49019678|NCT00950807|157909021|FG008|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
48677632|NCT02218008|156671422|FG003|Stage 1 (S1)|Lack of Efficacy|0|||
48677633|NCT02218008|156671423|FG004|Stage 1 (S1)|Lack of Efficacy|0|||
48677634|NCT02218008|156671424|FG005|Stage 1 (S1)|Lack of Efficacy|0|||
48677635|NCT02218008|156671419|FG000|Stage 1 (S1)|Lost to Follow-up|3|||
48677636|NCT02218008|156671420|FG001|Stage 1 (S1)|Lost to Follow-up|0|||
48677637|NCT02218008|156671421|FG002|Stage 1 (S1)|Lost to Follow-up|1|||
48677638|NCT02218008|156671422|FG003|Stage 1 (S1)|Lost to Follow-up|0|||
48677639|NCT02218008|156671423|FG004|Stage 1 (S1)|Lost to Follow-up|0|||
48677640|NCT02218008|156671424|FG005|Stage 1 (S1)|Lost to Follow-up|0|||
48677641|NCT02218008|156671419|FG000|Stage 1 (S1)|Non-compliance with Study Drug|2|||
48677642|NCT02218008|156671420|FG001|Stage 1 (S1)|Non-compliance with Study Drug|1|||
48677643|NCT02218008|156671421|FG002|Stage 1 (S1)|Non-compliance with Study Drug|0|||
48677644|NCT02218008|156671422|FG003|Stage 1 (S1)|Non-compliance with Study Drug|0|||
48677645|NCT02218008|156671423|FG004|Stage 1 (S1)|Non-compliance with Study Drug|0|||
48677646|NCT02218008|156671424|FG005|Stage 1 (S1)|Non-compliance with Study Drug|0|||
48677647|NCT02218008|156671419|FG000|Stage 1 (S1)|Non-compliance; drug use|1|||
48677648|NCT02218008|156671420|FG001|Stage 1 (S1)|Non-compliance; drug use|0|||
48677649|NCT02218008|156671421|FG002|Stage 1 (S1)|Non-compliance; drug use|0|||
48677650|NCT02218008|156671422|FG003|Stage 1 (S1)|Non-compliance; drug use|0|||
48677651|NCT02218008|156671423|FG004|Stage 1 (S1)|Non-compliance; drug use|0|||
48677652|NCT02218008|156671424|FG005|Stage 1 (S1)|Non-compliance; drug use|0|||
48677653|NCT02218008|156671419|FG000|Stage 1 (S1)|Pregnancy|0|||
48677654|NCT02218008|156671420|FG001|Stage 1 (S1)|Pregnancy|0|||
48677655|NCT02218008|156671421|FG002|Stage 1 (S1)|Pregnancy|1|||
48677656|NCT02218008|156671422|FG003|Stage 1 (S1)|Pregnancy|0|||
48677657|NCT02218008|156671423|FG004|Stage 1 (S1)|Pregnancy|0|||
48677658|NCT02218008|156671424|FG005|Stage 1 (S1)|Pregnancy|0|||
48677659|NCT02218008|156671419|FG000|Stage 1 (S1)|Protocol Violation|0|||
48677660|NCT02218008|156671420|FG001|Stage 1 (S1)|Protocol Violation|0|||
48677661|NCT02218008|156671421|FG002|Stage 1 (S1)|Protocol Violation|1|||
48677662|NCT02218008|156671422|FG003|Stage 1 (S1)|Protocol Violation|0|||
48677663|NCT02218008|156671423|FG004|Stage 1 (S1)|Protocol Violation|0|||
48677664|NCT02218008|156671424|FG005|Stage 1 (S1)|Protocol Violation|0|||
48677665|NCT02218008|156671419|FG000|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1|||
48677666|NCT02218008|156671420|FG001|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
48677667|NCT02218008|156671421|FG002|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
48677668|NCT02218008|156671422|FG003|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
48677669|NCT02218008|156671423|FG004|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
48677670|NCT02218008|156671424|FG005|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
48677671|NCT02218008|156671419|FG000|Stage 2 (S2)|Adverse Event|0|||
48677672|NCT02218008|156671420|FG001|Stage 2 (S2)|Adverse Event|0|||
48677673|NCT02218008|156671421|FG002|Stage 2 (S2)|Adverse Event|0|||
48677674|NCT02218008|156671422|FG003|Stage 2 (S2)|Adverse Event|2|||
48677675|NCT02218008|156671423|FG004|Stage 2 (S2)|Adverse Event|3|||
48677676|NCT02218008|156671424|FG005|Stage 2 (S2)|Adverse Event|3|||
48677677|NCT02218008|156671419|FG000|Stage 2 (S2)|Withdrawal by Subject|0|||
48677678|NCT02218008|156671420|FG001|Stage 2 (S2)|Withdrawal by Subject|0|||
48677679|NCT02218008|156671421|FG002|Stage 2 (S2)|Withdrawal by Subject|0|||
48677680|NCT02218008|156671422|FG003|Stage 2 (S2)|Withdrawal by Subject|1|||
48677681|NCT02218008|156671423|FG004|Stage 2 (S2)|Withdrawal by Subject|1|||
48677682|NCT02218008|156671424|FG005|Stage 2 (S2)|Withdrawal by Subject|0|||
48677683|NCT02218008|156671419|FG000|Stage 2 (S2)|Lack of Efficacy|0|||
48677684|NCT02218008|156671420|FG001|Stage 2 (S2)|Lack of Efficacy|0|||
48677685|NCT02218008|156671421|FG002|Stage 2 (S2)|Lack of Efficacy|0|||
48677686|NCT02218008|156671422|FG003|Stage 2 (S2)|Lack of Efficacy|0|||
48677687|NCT02218008|156671423|FG004|Stage 2 (S2)|Lack of Efficacy|0|||
48677688|NCT02218008|156671424|FG005|Stage 2 (S2)|Lack of Efficacy|2|||
48677689|NCT02218008|156671419|FG000|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
48762634|NCT00634088|156980268|FG001|Time Period 1: Dose Level 1|Adverse Event|0|||
48762635|NCT00634088|156980269|FG002|Time Period 1: Dose Level 1|Adverse Event|0|||
48677690|NCT02218008|156671420|FG001|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
48677691|NCT02218008|156671421|FG002|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
49019679|NCT00950807|157909022|FG009|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
49019680|NCT00950807|157909013|FG000|Treatment Period 3|Adverse Event|0|||
49019681|NCT00950807|157909014|FG001|Treatment Period 3|Adverse Event|0|||
48762636|NCT00634088|156980270|FG003|Time Period 1: Dose Level 1|Adverse Event|0|||
48762637|NCT00634088|156980267|FG000|Time Period 2: Dose Level 2|Adverse Event|0|||
48762638|NCT00634088|156980268|FG001|Time Period 2: Dose Level 2|Adverse Event|2|||
48762639|NCT00634088|156980269|FG002|Time Period 2: Dose Level 2|Adverse Event|0|||
48762640|NCT00634088|156980270|FG003|Time Period 2: Dose Level 2|Adverse Event|0|||
48762641|NCT00634088|156980267|FG000|Time Period 2: Dose Level 2|Progressive disease|0|||
48762642|NCT00634088|156980268|FG001|Time Period 2: Dose Level 2|Progressive disease|1|||
48762643|NCT00634088|156980269|FG002|Time Period 2: Dose Level 2|Progressive disease|0|||
48677692|NCT02218008|156671422|FG003|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1|||
48677693|NCT02218008|156671423|FG004|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
48677694|NCT02218008|156671424|FG005|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
48677695|NCT02218008|156671419|FG000|Stage 2 (S2)|Lost to Follow-up|0|||
48677696|NCT02218008|156671420|FG001|Stage 2 (S2)|Lost to Follow-up|0|||
48677697|NCT02218008|156671421|FG002|Stage 2 (S2)|Lost to Follow-up|0|||
48677698|NCT02218008|156671422|FG003|Stage 2 (S2)|Lost to Follow-up|0|||
48677699|NCT02218008|156671423|FG004|Stage 2 (S2)|Lost to Follow-up|0|||
48677700|NCT02218008|156671424|FG005|Stage 2 (S2)|Lost to Follow-up|1|||
48677701|NCT02038075|156671425|FG000|Overall Study|Withdrawal by Subject|3|||
48677702|NCT02038075|156671426|FG001|Overall Study|Withdrawal by Subject|0|||
48677703|NCT04039217|156671427|FG000|Overall Study|Lost to Follow-up|1|||
48677704|NCT00106353|156671428|FG000|Part 1|Disease progression|3|||
48677705|NCT00106353|156671429|FG001|Part 1|Disease progression|4|||
48677706|NCT00106353|156671430|FG002|Part 1|Disease progression|1|||
48677707|NCT00106353|156671431|FG003|Part 1|Disease progression|3|||
48677708|NCT00106353|156671432|FG004|Part 1|Disease progression|0|||
48677709|NCT00106353|156671433|FG005|Part 1|Disease progression|0|||
48677710|NCT00106353|156671434|FG006|Part 1|Disease progression|0|||
48677711|NCT00106353|156671428|FG000|Part 1|Withdrawal by Subject|0|||
48677712|NCT00106353|156671429|FG001|Part 1|Withdrawal by Subject|0|||
48677713|NCT00106353|156671430|FG002|Part 1|Withdrawal by Subject|1|||
48677714|NCT00106353|156671431|FG003|Part 1|Withdrawal by Subject|2|||
48677715|NCT00106353|156671432|FG004|Part 1|Withdrawal by Subject|0|||
48677716|NCT00106353|156671433|FG005|Part 1|Withdrawal by Subject|0|||
48677717|NCT00106353|156671434|FG006|Part 1|Withdrawal by Subject|0|||
48677718|NCT00106353|156671428|FG000|Part 1|Symptomatic deterioration|0|||
48677719|NCT00106353|156671429|FG001|Part 1|Symptomatic deterioration|0|||
48677720|NCT00106353|156671430|FG002|Part 1|Symptomatic deterioration|1|||
48677721|NCT00106353|156671431|FG003|Part 1|Symptomatic deterioration|0|||
48677722|NCT00106353|156671432|FG004|Part 1|Symptomatic deterioration|0|||
48677723|NCT00106353|156671433|FG005|Part 1|Symptomatic deterioration|0|||
48677724|NCT00106353|156671434|FG006|Part 1|Symptomatic deterioration|0|||
48677725|NCT00106353|156671428|FG000|Part 1|Entered follow-up phase|1|||
48677726|NCT00106353|156671429|FG001|Part 1|Entered follow-up phase|1|||
48677727|NCT00106353|156671430|FG002|Part 1|Entered follow-up phase|0|||
48677728|NCT00106353|156671431|FG003|Part 1|Entered follow-up phase|1|||
48677729|NCT00106353|156671432|FG004|Part 1|Entered follow-up phase|0|||
48677730|NCT00106353|156671433|FG005|Part 1|Entered follow-up phase|0|||
48677731|NCT00106353|156671434|FG006|Part 1|Entered follow-up phase|0|||
48677732|NCT00106353|156671428|FG000|Part 1|Adverse Event|0|||
48677733|NCT00106353|156671429|FG001|Part 1|Adverse Event|0|||
48677734|NCT00106353|156671430|FG002|Part 1|Adverse Event|0|||
48677735|NCT00106353|156671431|FG003|Part 1|Adverse Event|1|||
48677736|NCT00106353|156671432|FG004|Part 1|Adverse Event|0|||
48677737|NCT00106353|156671433|FG005|Part 1|Adverse Event|0|||
48677738|NCT00106353|156671434|FG006|Part 1|Adverse Event|0|||
48677739|NCT00106353|156671428|FG000|Part 2|Disease progression|0|||
48677740|NCT00106353|156671429|FG001|Part 2|Disease progression|0|||
48677741|NCT00106353|156671430|FG002|Part 2|Disease progression|0|||
48677742|NCT00106353|156671431|FG003|Part 2|Disease progression|0|||
48677743|NCT00106353|156671432|FG004|Part 2|Disease progression|8|||
48677744|NCT00106353|156671433|FG005|Part 2|Disease progression|14|||
48677745|NCT00106353|156671434|FG006|Part 2|Disease progression|13|||
48677746|NCT00106353|156671428|FG000|Part 2|Death|0|||
48762644|NCT00634088|156980270|FG003|Time Period 2: Dose Level 2|Progressive disease|0|||
48762645|NCT00634088|156980267|FG000|Time Period 3: Dose Level 3|Progressive disease|0|||
48677747|NCT00106353|156671429|FG001|Part 2|Death|0|||
48677748|NCT00106353|156671430|FG002|Part 2|Death|0|||
48677749|NCT00106353|156671431|FG003|Part 2|Death|0|||
48677750|NCT00106353|156671432|FG004|Part 2|Death|3|||
48677751|NCT00106353|156671433|FG005|Part 2|Death|0|||
48677752|NCT00106353|156671434|FG006|Part 2|Death|1|||
48677753|NCT00106353|156671428|FG000|Part 2|Symptomatic deterioration|0|||
48762646|NCT00634088|156980268|FG001|Time Period 3: Dose Level 3|Progressive disease|0|||
48677754|NCT00106353|156671429|FG001|Part 2|Symptomatic deterioration|0|||
48677755|NCT00106353|156671430|FG002|Part 2|Symptomatic deterioration|0|||
48677756|NCT00106353|156671431|FG003|Part 2|Symptomatic deterioration|0|||
48677757|NCT00106353|156671432|FG004|Part 2|Symptomatic deterioration|3|||
48677758|NCT00106353|156671433|FG005|Part 2|Symptomatic deterioration|0|||
49019682|NCT00950807|157909015|FG002|Treatment Period 3|Adverse Event|0|||
49019683|NCT00950807|157909016|FG003|Treatment Period 3|Adverse Event|0|||
49019684|NCT00950807|157909017|FG004|Treatment Period 3|Adverse Event|0|||
49019685|NCT00950807|157909018|FG005|Treatment Period 3|Adverse Event|0|||
49019686|NCT00950807|157909019|FG006|Treatment Period 3|Adverse Event|1|||
49019687|NCT00950807|157909020|FG007|Treatment Period 3|Adverse Event|0|||
49019688|NCT00950807|157909021|FG008|Treatment Period 3|Adverse Event|0|||
49019689|NCT00950807|157909022|FG009|Treatment Period 3|Adverse Event|0|||
49019690|NCT04534283|157909023|FG000|Overall Study|Physician Decision|2|||
49019691|NCT04534283|157909023|FG000|Overall Study|Withdrawal by Subject|1|||
49019692|NCT04534283|157909023|FG000|Overall Study|Disease Progression|12|||
49019693|NCT04534283|157909023|FG000|Overall Study|Adverse Event|1|||
49019694|NCT00661505|157909024|FG000|Overall Study|Adverse Event|3|||
49019695|NCT00661505|157909024|FG000|Overall Study|Protocol Violation|14|||
49019696|NCT00661505|157909024|FG000|Overall Study|Withdrawal by Subject|8|||
49019697|NCT00661505|157909024|FG000|Overall Study|Lost to Follow-up|3|||
49019698|NCT00661505|157909024|FG000|Overall Study|Other|2|||
49019699|NCT04799158|157909025|FG000|Run-In Period|Adverse Event|6|||
49019700|NCT04799158|157909026|FG001|Run-In Period|Adverse Event|0|||
49019701|NCT04799158|157909027|FG002|Run-In Period|Adverse Event|0|||
49019702|NCT04799158|157909028|FG003|Run-In Period|Adverse Event|0|||
49019703|NCT04799158|157909029|FG004|Run-In Period|Adverse Event|0|||
49019704|NCT04799158|157909025|FG000|Run-In Period|Lost to Follow-up|4|||
49019705|NCT04799158|157909026|FG001|Run-In Period|Lost to Follow-up|0|||
49019706|NCT04799158|157909027|FG002|Run-In Period|Lost to Follow-up|0|||
49019707|NCT04799158|157909028|FG003|Run-In Period|Lost to Follow-up|0|||
49019708|NCT04799158|157909029|FG004|Run-In Period|Lost to Follow-up|0|||
49019709|NCT04799158|157909025|FG000|Run-In Period|Significant Protocol Deviation|1|||
49019710|NCT04799158|157909026|FG001|Run-In Period|Significant Protocol Deviation|0|||
49019711|NCT04799158|157909027|FG002|Run-In Period|Significant Protocol Deviation|0|||
49019712|NCT04799158|157909028|FG003|Run-In Period|Significant Protocol Deviation|0|||
49019713|NCT04799158|157909029|FG004|Run-In Period|Significant Protocol Deviation|0|||
49019714|NCT04799158|157909025|FG000|Run-In Period|Withdrawal by Subject|11|||
49019715|NCT04799158|157909026|FG001|Run-In Period|Withdrawal by Subject|0|||
49019716|NCT04799158|157909027|FG002|Run-In Period|Withdrawal by Subject|0|||
49019717|NCT04799158|157909028|FG003|Run-In Period|Withdrawal by Subject|0|||
49019718|NCT04799158|157909029|FG004|Run-In Period|Withdrawal by Subject|0|||
49019719|NCT04799158|157909025|FG000|Run-In Period|Miscellaneous|3|||
49019720|NCT04799158|157909026|FG001|Run-In Period|Miscellaneous|0|||
49019721|NCT04799158|157909027|FG002|Run-In Period|Miscellaneous|0|||
49019722|NCT04799158|157909028|FG003|Run-In Period|Miscellaneous|0|||
49019723|NCT04799158|157909029|FG004|Run-In Period|Miscellaneous|0|||
49019724|NCT04799158|157909025|FG000|Run-In Period|Did not meet On-Demand Eligibility Criteria|226|||
49019725|NCT04799158|157909026|FG001|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
49019726|NCT04799158|157909027|FG002|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
49019727|NCT04799158|157909028|FG003|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
49019728|NCT04799158|157909029|FG004|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
49019729|NCT04799158|157909025|FG000|On-Demand Treatment Period|Adverse Event|0|||
49019730|NCT04799158|157909026|FG001|On-Demand Treatment Period|Adverse Event|1|||
49019731|NCT04799158|157909027|FG002|On-Demand Treatment Period|Adverse Event|0|||
49019732|NCT04799158|157909028|FG003|On-Demand Treatment Period|Adverse Event|0|||
49019733|NCT04799158|157909029|FG004|On-Demand Treatment Period|Adverse Event|1|||
49019734|NCT04799158|157909025|FG000|On-Demand Treatment Period|Lost to Follow-up|0|||
49019735|NCT04799158|157909026|FG001|On-Demand Treatment Period|Lost to Follow-up|0|||
49019736|NCT04799158|157909027|FG002|On-Demand Treatment Period|Lost to Follow-up|0|||
49019737|NCT04799158|157909028|FG003|On-Demand Treatment Period|Lost to Follow-up|0|||
49019738|NCT04799158|157909029|FG004|On-Demand Treatment Period|Lost to Follow-up|1|||
49019739|NCT04799158|157909025|FG000|On-Demand Treatment Period|Significant Protocol Deviation|0|||
49019740|NCT04799158|157909026|FG001|On-Demand Treatment Period|Significant Protocol Deviation|0|||
49019741|NCT04799158|157909027|FG002|On-Demand Treatment Period|Significant Protocol Deviation|0|||
49019742|NCT04799158|157909028|FG003|On-Demand Treatment Period|Significant Protocol Deviation|1|||
49019743|NCT04799158|157909029|FG004|On-Demand Treatment Period|Significant Protocol Deviation|0|||
49019744|NCT04799158|157909025|FG000|On-Demand Treatment Period|Withdrawal by Subject|0|||
49019745|NCT04799158|157909026|FG001|On-Demand Treatment Period|Withdrawal by Subject|0|||
49019746|NCT04799158|157909027|FG002|On-Demand Treatment Period|Withdrawal by Subject|0|||
49019747|NCT04799158|157909028|FG003|On-Demand Treatment Period|Withdrawal by Subject|1|||
49019748|NCT04799158|157909029|FG004|On-Demand Treatment Period|Withdrawal by Subject|0|||
49019749|NCT04799158|157909025|FG000|On-Demand Treatment Period|Lack of Efficacy|0|||
49019750|NCT04799158|157909026|FG001|On-Demand Treatment Period|Lack of Efficacy|0|||
49019751|NCT04799158|157909027|FG002|On-Demand Treatment Period|Lack of Efficacy|0|||
49019752|NCT04799158|157909028|FG003|On-Demand Treatment Period|Lack of Efficacy|0|||
49019753|NCT04799158|157909029|FG004|On-Demand Treatment Period|Lack of Efficacy|1|||
49019754|NCT04799158|157909025|FG000|On-Demand Treatment Period|Miscellaneous|0|||
49019755|NCT04799158|157909026|FG001|On-Demand Treatment Period|Miscellaneous|0|||
49019756|NCT04799158|157909027|FG002|On-Demand Treatment Period|Miscellaneous|0|||
49019757|NCT04799158|157909028|FG003|On-Demand Treatment Period|Miscellaneous|0|||
49019758|NCT04799158|157909029|FG004|On-Demand Treatment Period|Miscellaneous|1|||
49019759|NCT02974153|157909030|FG000|Overall Study|Adverse Event|6|||
49019760|NCT02974153|157909031|FG001|Overall Study|Adverse Event|0|||
49019761|NCT02974153|157909032|FG002|Overall Study|Adverse Event|1|||
49019762|NCT02974153|157909030|FG000|Overall Study|Lack of Efficacy|6|||
49019763|NCT02974153|157909031|FG001|Overall Study|Lack of Efficacy|5|||
49019764|NCT02974153|157909032|FG002|Overall Study|Lack of Efficacy|10|||
49019765|NCT02974153|157909030|FG000|Overall Study|Lost to Follow-up|9|||
49019766|NCT02974153|157909031|FG001|Overall Study|Lost to Follow-up|10|||
49019767|NCT02974153|157909032|FG002|Overall Study|Lost to Follow-up|17|||
49019768|NCT02974153|157909030|FG000|Overall Study|Physician Decision|0|||
49019769|NCT02974153|157909031|FG001|Overall Study|Physician Decision|2|||
49019770|NCT02974153|157909032|FG002|Overall Study|Physician Decision|1|||
48677759|NCT00106353|156671434|FG006|Part 2|Symptomatic deterioration|0|||
48677760|NCT00106353|156671428|FG000|Part 2|Adverse Event|0|||
48677761|NCT00106353|156671429|FG001|Part 2|Adverse Event|0|||
48677762|NCT00106353|156671430|FG002|Part 2|Adverse Event|0|||
49019771|NCT02974153|157909030|FG000|Overall Study|Withdrawal by Subject|9|||
49019772|NCT02974153|157909031|FG001|Overall Study|Withdrawal by Subject|16|||
49019773|NCT02974153|157909032|FG002|Overall Study|Withdrawal by Subject|11|||
49019774|NCT02974153|157909030|FG000|Overall Study|Study Burden|8|||
49019775|NCT02974153|157909031|FG001|Overall Study|Study Burden|7|||
49019776|NCT02974153|157909032|FG002|Overall Study|Study Burden|3|||
49019777|NCT02974153|157909030|FG000|Overall Study|Other|14|||
49019778|NCT02974153|157909031|FG001|Overall Study|Other|8|||
49019779|NCT02974153|157909032|FG002|Overall Study|Other|7|||
49019780|NCT01202747|157909034|FG000|Overall Study|Withdrawal by Subject|1|||
49019781|NCT02603952|157909038|FG000|Overall Study|Withdrawal by Subject|1|||
49019782|NCT02603952|157909039|FG001|Overall Study|Withdrawal by Subject|0|||
49019783|NCT02603952|157909040|FG002|Overall Study|Withdrawal by Subject|0|||
49019784|NCT02603952|157909041|FG003|Overall Study|Withdrawal by Subject|0|||
49019785|NCT02603952|157909038|FG000|Overall Study|Received oseltamivir by error|0|||
49019786|NCT02603952|157909039|FG001|Overall Study|Received oseltamivir by error|0|||
49019787|NCT02603952|157909040|FG002|Overall Study|Received oseltamivir by error|0|||
49019788|NCT02603952|157909041|FG003|Overall Study|Received oseltamivir by error|1|||
49019789|NCT04591626|157909047|FG000|Overall Study|Adverse Event|4|||
49019790|NCT04591626|157909048|FG001|Overall Study|Adverse Event|0|||
49019791|NCT04591626|157909047|FG000|Overall Study|Withdrawal by Subject|5|||
49019792|NCT04591626|157909048|FG001|Overall Study|Withdrawal by Subject|3|||
48677763|NCT00106353|156671431|FG003|Part 2|Adverse Event|0|||
48677764|NCT00106353|156671432|FG004|Part 2|Adverse Event|0|||
48677765|NCT00106353|156671433|FG005|Part 2|Adverse Event|2|||
48677766|NCT00106353|156671434|FG006|Part 2|Adverse Event|1|||
48677767|NCT00106353|156671428|FG000|Part 2|Other|0|||
48677768|NCT00106353|156671429|FG001|Part 2|Other|0|||
48677769|NCT00106353|156671430|FG002|Part 2|Other|0|||
48677770|NCT00106353|156671431|FG003|Part 2|Other|0|||
48677771|NCT00106353|156671432|FG004|Part 2|Other|1|||
48677772|NCT00106353|156671433|FG005|Part 2|Other|1|||
48677773|NCT00106353|156671434|FG006|Part 2|Other|1|||
48677774|NCT00106353|156671428|FG000|Part 2|Withdrawal by Subject|0|||
48677775|NCT00106353|156671429|FG001|Part 2|Withdrawal by Subject|0|||
48677776|NCT00106353|156671430|FG002|Part 2|Withdrawal by Subject|0|||
48677777|NCT00106353|156671431|FG003|Part 2|Withdrawal by Subject|0|||
48677778|NCT00106353|156671432|FG004|Part 2|Withdrawal by Subject|1|||
48677779|NCT00106353|156671433|FG005|Part 2|Withdrawal by Subject|0|||
48677780|NCT00106353|156671434|FG006|Part 2|Withdrawal by Subject|0|||
48677781|NCT00106353|156671428|FG000|Part 2|Physician Decision|0|||
48677782|NCT00106353|156671429|FG001|Part 2|Physician Decision|0|||
48677783|NCT00106353|156671430|FG002|Part 2|Physician Decision|0|||
48677784|NCT00106353|156671431|FG003|Part 2|Physician Decision|0|||
48677785|NCT00106353|156671432|FG004|Part 2|Physician Decision|0|||
48677786|NCT00106353|156671433|FG005|Part 2|Physician Decision|1|||
48677787|NCT00106353|156671434|FG006|Part 2|Physician Decision|0|||
48762647|NCT00634088|156980269|FG002|Time Period 3: Dose Level 3|Progressive disease|1|||
48762648|NCT00634088|156980270|FG003|Time Period 3: Dose Level 3|Progressive disease|0|||
48762649|NCT02290821|156980271|FG000|Overall Study|Withdrawal by Subject|1|||
48762650|NCT02290821|156980272|FG001|Overall Study|Withdrawal by Subject|1|||
49019793|NCT04591626|157909047|FG000|Overall Study|Physician Decision|0|||
48677788|NCT04000581|156671435|FG000|Overall Study|Withdrawal by Subject|0|||
48677789|NCT04000581|156671436|FG001|Overall Study|Withdrawal by Subject|1|||
48677790|NCT00588354|156671437|FG000|Baseline to 2 Weeks|Adverse Event|1|||
48677791|NCT00588354|156671438|FG001|Baseline to 2 Weeks|Adverse Event|0|||
48677792|NCT00588354|156671437|FG000|Baseline to 2 Weeks|Lack of Efficacy|1|||
48677793|NCT00588354|156671438|FG001|Baseline to 2 Weeks|Lack of Efficacy|0|||
48677794|NCT00588354|156671437|FG000|Baseline to 4 Weeks|Lost to Follow-up|0|||
48677795|NCT00588354|156671438|FG001|Baseline to 4 Weeks|Lost to Follow-up|1|||
48677796|NCT03790917|156671439|FG000|Overall Study|Death|1|||
48677797|NCT03508609|156671440|FG000|Overall Study|Withdrawal by Subject|1|||
49019794|NCT04591626|157909048|FG001|Overall Study|Physician Decision|1|||
49019795|NCT04591626|157909047|FG000|Overall Study|Death|0|||
49019796|NCT04591626|157909048|FG001|Overall Study|Death|1|||
49019797|NCT04591626|157909047|FG000|Overall Study|Non-Compliance with Study Drug|1|||
49019798|NCT04591626|157909048|FG001|Overall Study|Non-Compliance with Study Drug|0|||
49019799|NCT01611090|157909050|FG000|Randomized Period|Lost to Follow-up|8|||
49019800|NCT01611090|157909051|FG001|Randomized Period|Lost to Follow-up|3|||
49019801|NCT01611090|157909052|FG002|Randomized Period|Lost to Follow-up|0|||
48762651|NCT02290821|156980271|FG000|Overall Study|Unable or unwilling to cooperate with|2|||
48762652|NCT02290821|156980272|FG001|Overall Study|Unable or unwilling to cooperate with|0|||
48762653|NCT02290821|156980271|FG000|Overall Study|Lost to Follow-up|3|||
48762654|NCT02290821|156980272|FG001|Overall Study|Lost to Follow-up|2|||
48762655|NCT04356963|156980273|FG000|First Session|Withdrawal by Subject|1|||
48762656|NCT04356963|156980273|FG000|Second Session|Withdrawal by Subject|3|||
48762657|NCT04356963|156980273|FG000|Second Session|Lost to Follow-up|1|||
48762658|NCT04356963|156980273|FG000|Third Session|Lost to Follow-up|6|||
48762659|NCT04356963|156980273|FG000|Third Session|Withdrawal by Subject|1|||
48762660|NCT01498952|156980281|FG000|Overall Study|Death|2|||
48762661|NCT01498952|156980282|FG001|Overall Study|Death|2|||
48762662|NCT01498952|156980283|FG002|Overall Study|Death|0|||
48762663|NCT01498952|156980284|FG003|Overall Study|Death|0|||
48762664|NCT01498952|156980285|FG004|Overall Study|Death|0|||
48762665|NCT00228917|156980286|FG000|Overall Study|Migrated/moved from study area|0|||
49019802|NCT01611090|157909050|FG000|Randomized Period|Withdrawal by Subject|22|||
49019803|NCT01611090|157909051|FG001|Randomized Period|Withdrawal by Subject|26|||
49019804|NCT01611090|157909052|FG002|Randomized Period|Withdrawal by Subject|0|||
49019805|NCT01611090|157909050|FG000|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
48677798|NCT00782483|156671441|FG000|Overall Study|Early Termination of Protocol - PI Reloc|6|||
48677799|NCT04072887|156671442|FG000|Overall Study|Withdrawal by Subject|3|||
48677800|NCT04072887|156671443|FG001|Overall Study|Withdrawal by Subject|8|||
48677801|NCT04072887|156671444|FG002|Overall Study|Withdrawal by Subject|1|||
48677802|NCT04072887|156671445|FG003|Overall Study|Withdrawal by Subject|3|||
48677803|NCT04072887|156671446|FG004|Overall Study|Withdrawal by Subject|3|||
49019806|NCT01611090|157909051|FG001|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
49019807|NCT01611090|157909052|FG002|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4|||
49019808|NCT01611090|157909050|FG000|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
49019809|NCT01611090|157909051|FG001|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
49019810|NCT01611090|157909052|FG002|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1|||
49019811|NCT02672553|157909056|FG000|Overall Study|Death|3|||
49019812|NCT02672553|157909057|FG001|Overall Study|Death|5|||
49019813|NCT02672553|157909056|FG000|Overall Study|Valve Explant|1|||
49019814|NCT02672553|157909057|FG001|Overall Study|Valve Explant|0|||
49019815|NCT02672553|157909056|FG000|Overall Study|Conversion to Commercial Valve|3|||
49019816|NCT02672553|157909057|FG001|Overall Study|Conversion to Commercial Valve|0|||
49019817|NCT02672553|157909056|FG000|Overall Study|Withdrawal by Subject|3|||
49019818|NCT02672553|157909057|FG001|Overall Study|Withdrawal by Subject|3|||
49019819|NCT02672553|157909056|FG000|Overall Study|Intraoperative screen failure|2|||
49019820|NCT02672553|157909057|FG001|Overall Study|Intraoperative screen failure|0|||
49019821|NCT01004172|157909058|FG000|Overall Study|Progressive Disease in CNS Only|16|||
49019822|NCT01004172|157909058|FG000|Overall Study|Progressive Disease in Non-CNS Only|16|||
49019823|NCT01004172|157909058|FG000|Overall Study|Progressive Disease in CNS and Non-CNS|2|||
49019824|NCT01004172|157909058|FG000|Overall Study|Adverse Event|1|||
49019825|NCT01004172|157909058|FG000|Overall Study|Physician Decision|1|||
49019826|NCT01004172|157909058|FG000|Overall Study|Symptomatic Deterioration|2|||
49019827|NCT03066999|157909059|FG000|Overall Study|abnormal urethraBladder neck contracture|0|||
49019828|NCT03066999|157909060|FG001|Overall Study|abnormal urethraBladder neck contracture|2|||
49019829|NCT00661999|157909061|FG000|Overall Study|Adverse Event|11|||
49019830|NCT00661999|157909062|FG001|Overall Study|Adverse Event|5|||
48677804|NCT04072887|156671447|FG005|Overall Study|Withdrawal by Subject|13|||
48762666|NCT00228917|156980287|FG001|Overall Study|Migrated/moved from study area|0|||
49019831|NCT00661999|157909063|FG002|Overall Study|Adverse Event|8|||
49019832|NCT00661999|157909061|FG000|Overall Study|Death|8|||
49019833|NCT00661999|157909062|FG001|Overall Study|Death|6|||
49019834|NCT00661999|157909063|FG002|Overall Study|Death|3|||
49019835|NCT00661999|157909061|FG000|Overall Study|Other Reasons|5|||
48677805|NCT04072887|156671442|FG000|Overall Study|Adverse Event|2|||
48677806|NCT04072887|156671443|FG001|Overall Study|Adverse Event|4|||
48677807|NCT04072887|156671444|FG002|Overall Study|Adverse Event|1|||
48677808|NCT04072887|156671445|FG003|Overall Study|Adverse Event|4|||
48762667|NCT00228917|156980288|FG002|Overall Study|Migrated/moved from study area|0|||
48762668|NCT00228917|156980289|FG003|Overall Study|Migrated/moved from study area|0|||
48762669|NCT00228917|156980290|FG004|Overall Study|Migrated/moved from study area|0|||
48762670|NCT00228917|156980291|FG005|Overall Study|Migrated/moved from study area|2|||
48762671|NCT00228917|156980292|FG006|Overall Study|Migrated/moved from study area|0|||
48677809|NCT04072887|156671446|FG004|Overall Study|Adverse Event|0|||
48874956|NCT01427738|157378992|FG001|Overall Study|Withdrawal by Subject|2|||
48874957|NCT01427738|157378991|FG000|Overall Study|Subject not willing to adhere to reqs|1|||
48874958|NCT01427738|157378992|FG001|Overall Study|Subject not willing to adhere to reqs|2|||
48874959|NCT01427738|157378991|FG000|Overall Study|Lost to Follow-up|1|||
48874960|NCT01427738|157378992|FG001|Overall Study|Lost to Follow-up|5|||
48874961|NCT00115336|157378994|FG000|Overall Study|Hospital discharge before study drug|0|||
48874962|NCT00115336|157378995|FG001|Overall Study|Hospital discharge before study drug|1|||
48874963|NCT03029819|157378996|FG000|Overall Study|Lost to Follow-up|3|||
48874964|NCT03029819|157378997|FG001|Overall Study|Lost to Follow-up|5|||
48874965|NCT03029819|157378996|FG000|Overall Study|Removed due to disruptive behavior|0|||
48874966|NCT03029819|157378997|FG001|Overall Study|Removed due to disruptive behavior|1|||
48874967|NCT01801982|157378998|FG000|Overall Study|Lost to Follow-up|1|||
48874968|NCT02881047|157379000|FG000|Overall Study|Adverse Event|1|||
48874969|NCT02881047|157379000|FG000|Overall Study|Withdrawal by Subject|1|||
48874970|NCT01536171|157379004|FG000|Overall Study|Withdrawal by Subject|1|||
48874971|NCT00585078|157379005|FG000|Overall Study|Withdrawal by Subject|4|||
48874972|NCT00585078|157379005|FG000|Overall Study|Poor performance status|1|||
48874973|NCT00585078|157379005|FG000|Overall Study|Disease Progression|24|||
48874974|NCT00585078|157379005|FG000|Overall Study|Adverse Event|10|||
48874975|NCT00585078|157379005|FG000|Overall Study|Death|1|||
48874976|NCT03783689|157379007|FG000|Overall Study|Adverse Event|2|||
48874977|NCT03783689|157379008|FG001|Overall Study|Adverse Event|0|||
48874978|NCT03783689|157379007|FG000|Overall Study|Lost to Follow-up|2|||
48874979|NCT03783689|157379008|FG001|Overall Study|Lost to Follow-up|1|||
48874980|NCT03783689|157379007|FG000|Overall Study|Physician Decision|2|||
48874981|NCT03783689|157379008|FG001|Overall Study|Physician Decision|1|||
48874982|NCT03783689|157379007|FG000|Overall Study|Withdrawal by Subject|3|||
48874983|NCT03783689|157379008|FG001|Overall Study|Withdrawal by Subject|3|||
48874984|NCT01813305|157379009|FG000|Overall Study|Withdrawal by Subject|12|||
48874985|NCT01813305|157379010|FG001|Overall Study|Withdrawal by Subject|5|||
48874986|NCT01813305|157379009|FG000|Overall Study|Safety Concern|4|||
48874987|NCT01813305|157379010|FG001|Overall Study|Safety Concern|0|||
49019836|NCT00661999|157909062|FG001|Overall Study|Other Reasons|12|||
49019837|NCT00661999|157909063|FG002|Overall Study|Other Reasons|23|||
49019838|NCT00661999|157909061|FG000|Overall Study|Withdrawal by Subject|30|||
49019839|NCT00661999|157909062|FG001|Overall Study|Withdrawal by Subject|23|||
49019840|NCT00661999|157909063|FG002|Overall Study|Withdrawal by Subject|14|||
49019841|NCT00661999|157909061|FG000|Overall Study|Alternative Treatment|1|||
49019842|NCT00661999|157909062|FG001|Overall Study|Alternative Treatment|0|||
49019843|NCT00661999|157909063|FG002|Overall Study|Alternative Treatment|0|||
49019844|NCT00661999|157909061|FG000|Overall Study|Other Medical Problems|4|||
49019845|NCT00661999|157909062|FG001|Overall Study|Other Medical Problems|4|||
49019846|NCT00661999|157909063|FG002|Overall Study|Other Medical Problems|9|||
49019847|NCT01606306|157909064|FG000|Overall Study|Lack of Efficacy|2|||
49019848|NCT01606306|157909065|FG001|Overall Study|Lack of Efficacy|1|||
49019849|NCT01606306|157909066|FG002|Overall Study|Lack of Efficacy|4|||
49019850|NCT01606306|157909067|FG003|Overall Study|Lack of Efficacy|4|||
49019851|NCT01606306|157909068|FG004|Overall Study|Lack of Efficacy|1|||
49019852|NCT01606306|157909069|FG005|Overall Study|Lack of Efficacy|2|||
49019853|NCT01606306|157909064|FG000|Overall Study|Adverse Event|1|||
49019854|NCT01606306|157909065|FG001|Overall Study|Adverse Event|0|||
48762672|NCT00228917|156980293|FG007|Overall Study|Migrated/moved from study area|0|||
48762673|NCT00409617|156980294|FG000|Overall Study|Adverse Event|57|||
48762674|NCT00409617|156980294|FG000|Overall Study|Lack of Efficacy|54|||
48762675|NCT00409617|156980294|FG000|Overall Study|Lost to Follow-up|2|||
48762676|NCT00409617|156980294|FG000|Overall Study|Protocol Violation|24|||
48762677|NCT00409617|156980294|FG000|Overall Study|Withdrawal by Subject|8|||
48762678|NCT00409617|156980294|FG000|Overall Study|Administrative reasons|1|||
48762679|NCT00409617|156980294|FG000|Overall Study|Not described|14|||
48762680|NCT02159521|156980300|FG000|Overall Study|Enrolled but not treated|3|||
49019855|NCT01606306|157909066|FG002|Overall Study|Adverse Event|1|||
49019856|NCT01606306|157909067|FG003|Overall Study|Adverse Event|1|||
49019857|NCT01606306|157909068|FG004|Overall Study|Adverse Event|2|||
49019858|NCT01606306|157909069|FG005|Overall Study|Adverse Event|0|||
48762681|NCT02159521|156980300|FG000|Overall Study|Withdrawal by Subject|7|||
49019859|NCT01606306|157909064|FG000|Overall Study|Lost to Follow-up|7|||
49019860|NCT01606306|157909065|FG001|Overall Study|Lost to Follow-up|4|||
49019861|NCT01606306|157909066|FG002|Overall Study|Lost to Follow-up|5|||
48762682|NCT02159521|156980300|FG000|Overall Study|Lost to Follow-up|6|||
48762683|NCT02159521|156980300|FG000|Overall Study|Death|1|||
48874988|NCT01813305|157379009|FG000|Overall Study|Ulcer became worse|4|||
48874989|NCT01813305|157379010|FG001|Overall Study|Ulcer became worse|0|||
48874990|NCT01813305|157379009|FG000|Overall Study|Physician Decision|4|||
48874991|NCT01813305|157379010|FG001|Overall Study|Physician Decision|0|||
48874992|NCT01813305|157379009|FG000|Overall Study|Lost to Follow-up|3|||
48874993|NCT01813305|157379010|FG001|Overall Study|Lost to Follow-up|1|||
48874994|NCT01813305|157379009|FG000|Overall Study|Protocol Violation|1|||
48874995|NCT01813305|157379010|FG001|Overall Study|Protocol Violation|0|||
49019862|NCT01606306|157909067|FG003|Overall Study|Lost to Follow-up|4|||
49019863|NCT01606306|157909068|FG004|Overall Study|Lost to Follow-up|3|||
49019864|NCT01606306|157909069|FG005|Overall Study|Lost to Follow-up|5|||
49019865|NCT01606306|157909064|FG000|Overall Study|Withdrawal by Subject|4|||
49019866|NCT01606306|157909065|FG001|Overall Study|Withdrawal by Subject|3|||
49019867|NCT01606306|157909066|FG002|Overall Study|Withdrawal by Subject|4|||
49019868|NCT01606306|157909067|FG003|Overall Study|Withdrawal by Subject|4|||
49019869|NCT01606306|157909068|FG004|Overall Study|Withdrawal by Subject|5|||
49019870|NCT01606306|157909069|FG005|Overall Study|Withdrawal by Subject|4|||
49019871|NCT01606306|157909064|FG000|Overall Study|Physician Decision|1|||
49019872|NCT01606306|157909065|FG001|Overall Study|Physician Decision|2|||
49019873|NCT01606306|157909066|FG002|Overall Study|Physician Decision|0|||
49019874|NCT01606306|157909067|FG003|Overall Study|Physician Decision|0|||
49019875|NCT01606306|157909068|FG004|Overall Study|Physician Decision|0|||
49019876|NCT01606306|157909069|FG005|Overall Study|Physician Decision|0|||
49019877|NCT02097290|157909074|FG000|Overall Study|Death|6|||
49019878|NCT02097290|157909074|FG000|Overall Study|Total Withdrawals|3|||
49019879|NCT02097290|157909074|FG000|Overall Study|Attempt|8|||
49019880|NCT00182091|157909075|FG000|Overall Study|Withdrawal by Subject|1|||
49019881|NCT00182091|157909076|FG001|Overall Study|Withdrawal by Subject|0|||
49019882|NCT00182091|157909077|FG002|Overall Study|Withdrawal by Subject|0|||
49019883|NCT00182091|157909078|FG003|Overall Study|Withdrawal by Subject|0|||
49019884|NCT04094870|157909081|FG000|Overall Study|Lost to Follow-up|1|||
49019885|NCT04094870|157909082|FG001|Overall Study|Lost to Follow-up|1|||
49019886|NCT01691248|157909083|FG000|Overall Study|Protocol Violation|43|||
49019887|NCT01691248|157909084|FG001|Overall Study|Protocol Violation|27|||
49019888|NCT01691248|157909083|FG000|Overall Study|Adverse Event|24|||
49019889|NCT01691248|157909084|FG001|Overall Study|Adverse Event|22|||
49019890|NCT01691248|157909083|FG000|Overall Study|Withdrawal by Subject|20|||
49019891|NCT01691248|157909084|FG001|Overall Study|Withdrawal by Subject|18|||
49019892|NCT01691248|157909083|FG000|Overall Study|Confirmed CDAD|14|||
49019893|NCT01691248|157909084|FG001|Overall Study|Confirmed CDAD|31|||
49019894|NCT01691248|157909083|FG000|Overall Study|Lost to Follow-up|2|||
49019895|NCT01691248|157909084|FG001|Overall Study|Lost to Follow-up|5|||
49019896|NCT01691248|157909083|FG000|Overall Study|Reason not provided|4|||
49019897|NCT01691248|157909084|FG001|Overall Study|Reason not provided|4|||
49019898|NCT01691248|157909083|FG000|Overall Study|Not Treated|4|||
49019899|NCT01691248|157909084|FG001|Overall Study|Not Treated|7|||
49019900|NCT01569152|157909086|FG000|Phase IIa, Period 1|Early Escape|5|||
49019901|NCT01569152|157909087|FG001|Phase IIa, Period 1|Early Escape|22|||
49019902|NCT01569152|157909088|FG002|Phase IIa, Period 1|Early Escape|0|||
49019903|NCT01569152|157909086|FG000|Phase IIa, Period 1|Adverse Event|4|||
49019904|NCT01569152|157909087|FG001|Phase IIa, Period 1|Adverse Event|0|||
49019905|NCT01569152|157909088|FG002|Phase IIa, Period 1|Adverse Event|0|||
49019906|NCT01569152|157909086|FG000|Phase IIa, Period 1|Lost to Follow-up|1|||
49019907|NCT01569152|157909087|FG001|Phase IIa, Period 1|Lost to Follow-up|0|||
49019908|NCT01569152|157909088|FG002|Phase IIa, Period 1|Lost to Follow-up|0|||
49019909|NCT01569152|157909086|FG000|Phase IIa, Period 1|Study Terminated by Sponsor|9|||
49019910|NCT01569152|157909087|FG001|Phase IIa, Period 1|Study Terminated by Sponsor|8|||
49019911|NCT01569152|157909088|FG002|Phase IIa, Period 1|Study Terminated by Sponsor|0|||
49019912|NCT01569152|157909086|FG000|Phase IIa, Period 1|Protocol Violation|0|||
49019913|NCT01569152|157909087|FG001|Phase IIa, Period 1|Protocol Violation|1|||
49019914|NCT01569152|157909088|FG002|Phase IIa, Period 1|Protocol Violation|0|||
49019915|NCT01569152|157909086|FG000|Phase IIa, Period 1|Withdrawal by Subject|2|||
49019916|NCT01569152|157909087|FG001|Phase IIa, Period 1|Withdrawal by Subject|1|||
49019917|NCT01569152|157909088|FG002|Phase IIa, Period 1|Withdrawal by Subject|0|||
49019918|NCT01569152|157909086|FG000|Safety Extension, Period 3|Adverse Event|0|||
49019919|NCT01569152|157909087|FG001|Safety Extension, Period 3|Adverse Event|0|||
49019920|NCT01569152|157909088|FG002|Safety Extension, Period 3|Adverse Event|4|||
49019921|NCT01569152|157909086|FG000|Safety Extension, Period 3|Withdrawal by Subject|0|||
49019922|NCT01569152|157909087|FG001|Safety Extension, Period 3|Withdrawal by Subject|0|||
48677810|NCT04072887|156671447|FG005|Overall Study|Adverse Event|1|||
48677811|NCT04072887|156671442|FG000|Overall Study|Physician Decision|2|||
48677812|NCT04072887|156671443|FG001|Overall Study|Physician Decision|0|||
48677813|NCT04072887|156671444|FG002|Overall Study|Physician Decision|0|||
48677814|NCT04072887|156671445|FG003|Overall Study|Physician Decision|0|||
49019923|NCT01569152|157909088|FG002|Safety Extension, Period 3|Withdrawal by Subject|2|||
49019924|NCT01569152|157909086|FG000|Safety Extension, Period 3|Physician Decision|0|||
49019925|NCT01569152|157909087|FG001|Safety Extension, Period 3|Physician Decision|0|||
49019926|NCT01569152|157909088|FG002|Safety Extension, Period 3|Physician Decision|2|||
49019927|NCT01569152|157909086|FG000|Safety Extension, Period 3|Study terminated by Sponsor|0|||
49019928|NCT01569152|157909087|FG001|Safety Extension, Period 3|Study terminated by Sponsor|0|||
49019929|NCT01569152|157909088|FG002|Safety Extension, Period 3|Study terminated by Sponsor|47|||
49019930|NCT02070744|157909092|FG000|PC Phase (12 Weeks)|Randomized, but not treated|0|||
49019931|NCT02070744|157909093|FG001|PC Phase (12 Weeks)|Randomized, but not treated|0|||
48677815|NCT04072887|156671446|FG004|Overall Study|Physician Decision|0|||
48677816|NCT04072887|156671447|FG005|Overall Study|Physician Decision|1|||
49019932|NCT02070744|157909094|FG002|PC Phase (12 Weeks)|Randomized, but not treated|0|||
49019933|NCT02070744|157909095|FG003|PC Phase (12 Weeks)|Randomized, but not treated|1|||
49019934|NCT02070744|157909096|FG004|PC Phase (12 Weeks)|Randomized, but not treated|0|||
49019935|NCT02070744|157909092|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
49019936|NCT02070744|157909093|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
49019937|NCT02070744|157909094|FG002|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
49019938|NCT02070744|157909095|FG003|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
49019939|NCT02070744|157909096|FG004|OLE Phase (48 Weeks)|Withdrawal by Subject|2|||
49019940|NCT02070744|157909092|FG000|OLE Phase (48 Weeks)|Other|0|||
49019941|NCT02070744|157909093|FG001|OLE Phase (48 Weeks)|Other|0|||
49019942|NCT02070744|157909094|FG002|OLE Phase (48 Weeks)|Other|0|||
49019943|NCT02070744|157909095|FG003|OLE Phase (48 Weeks)|Other|0|||
49019944|NCT02070744|157909096|FG004|OLE Phase (48 Weeks)|Other|1|||
49019945|NCT02888171|157909099|FG000|Overall Study|Lost to Follow-up|2|||
49019946|NCT02888171|157909100|FG001|Overall Study|Lost to Follow-up|1|||
49019947|NCT02888171|157909099|FG000|Overall Study|Withdrawal by Subject|3|||
49019948|NCT02888171|157909100|FG001|Overall Study|Withdrawal by Subject|2|||
48677817|NCT04072887|156671442|FG000|Overall Study|Lost to Follow-up|1|||
48677818|NCT04072887|156671443|FG001|Overall Study|Lost to Follow-up|3|||
49019949|NCT02888171|157909099|FG000|Overall Study|Adverse Event|0|||
49019950|NCT02888171|157909100|FG001|Overall Study|Adverse Event|1|||
49019951|NCT02178709|157910780|FG000|Overall Study|Adverse Event|5|||
49019952|NCT02178709|157910780|FG000|Overall Study|Death|2|||
49019953|NCT02178709|157910780|FG000|Overall Study|Withdrawal by Subject|2|||
49019954|NCT02178709|157910780|FG000|Overall Study|Physician Decision|2|||
49019955|NCT02178709|157910780|FG000|Overall Study|Disease Progression|5|||
49019956|NCT02946385|157910781|FG000|Overall Study|Lost to Follow-up|0|||
49019957|NCT02946385|157910782|FG001|Overall Study|Lost to Follow-up|0|||
49019958|NCT02946385|157910783|FG002|Overall Study|Lost to Follow-up|3|||
49019959|NCT02946385|157910784|FG003|Overall Study|Lost to Follow-up|0|||
49019960|NCT02946385|157910785|FG004|Overall Study|Lost to Follow-up|2|||
49019961|NCT02946385|157910786|FG005|Overall Study|Lost to Follow-up|1|||
49019962|NCT02524379|157910789|FG000|Overall Study|Death|1|||
49019963|NCT01367275|157910790|FG000|Overall Study|Ineligible|1|||
49019964|NCT01367275|157910790|FG000|Overall Study|Disease Progression|2|||
49019965|NCT01290263|157910796|FG000|Overall Study|Adverse Event|0|||
49019966|NCT01290263|157910797|FG001|Overall Study|Adverse Event|0|||
49019967|NCT01290263|157910798|FG002|Overall Study|Adverse Event|0|||
49019968|NCT01290263|157910799|FG003|Overall Study|Adverse Event|1|||
49019969|NCT01290263|157910800|FG004|Overall Study|Adverse Event|1|||
49019970|NCT01290263|157910796|FG000|Overall Study|Lack of Efficacy|8|||
49019971|NCT01290263|157910797|FG001|Overall Study|Lack of Efficacy|2|||
49019972|NCT01290263|157910798|FG002|Overall Study|Lack of Efficacy|7|||
49019973|NCT01290263|157910799|FG003|Overall Study|Lack of Efficacy|24|||
49019974|NCT01290263|157910800|FG004|Overall Study|Lack of Efficacy|33|||
49019975|NCT01290263|157910796|FG000|Overall Study|Withdrawal by Subject|3|||
49019976|NCT01290263|157910797|FG001|Overall Study|Withdrawal by Subject|1|||
49019977|NCT01290263|157910798|FG002|Overall Study|Withdrawal by Subject|0|||
49019978|NCT01290263|157910799|FG003|Overall Study|Withdrawal by Subject|1|||
49019979|NCT01290263|157910800|FG004|Overall Study|Withdrawal by Subject|2|||
49019980|NCT01290263|157910796|FG000|Overall Study|Participant Non-Compliance|0|||
49019981|NCT01290263|157910797|FG001|Overall Study|Participant Non-Compliance|0|||
49019982|NCT01290263|157910798|FG002|Overall Study|Participant Non-Compliance|0|||
49019983|NCT01290263|157910799|FG003|Overall Study|Participant Non-Compliance|1|||
49019984|NCT01290263|157910800|FG004|Overall Study|Participant Non-Compliance|1|||
49019985|NCT05346055|157910801|FG000|Overall Study|Withdrawal by Subject|1|||
49019986|NCT05346055|157910801|FG000|Overall Study|Protocol Violation|1|||
49019987|NCT05346055|157910801|FG000|Overall Study|Therapist decision|1|||
49019988|NCT00718159|157910802|FG000|Overall Study|Progressive Disease|3|||
49019989|NCT00718159|157910803|FG001|Overall Study|Progressive Disease|3|||
49019990|NCT00718159|157910804|FG002|Overall Study|Progressive Disease|2|||
49019991|NCT00718159|157910805|FG003|Overall Study|Progressive Disease|0|||
49019992|NCT00718159|157910806|FG004|Overall Study|Progressive Disease|6|||
49019993|NCT00718159|157910807|FG005|Overall Study|Progressive Disease|0|||
49019994|NCT00718159|157910808|FG006|Overall Study|Progressive Disease|0|||
49019995|NCT00718159|157910802|FG000|Overall Study|Death due to Adverse Event|0|||
49019996|NCT00718159|157910803|FG001|Overall Study|Death due to Adverse Event|0|||
49019997|NCT00718159|157910804|FG002|Overall Study|Death due to Adverse Event|0|||
49019998|NCT00718159|157910805|FG003|Overall Study|Death due to Adverse Event|2|||
48677819|NCT04072887|156671444|FG002|Overall Study|Lost to Follow-up|0|||
49019999|NCT00718159|157910806|FG004|Overall Study|Death due to Adverse Event|2|||
49020000|NCT00718159|157910807|FG005|Overall Study|Death due to Adverse Event|0|||
49020001|NCT00718159|157910808|FG006|Overall Study|Death due to Adverse Event|0|||
49020002|NCT00718159|157910802|FG000|Overall Study|Death due to Study Drug Toxicity|0|||
49020003|NCT00718159|157910803|FG001|Overall Study|Death due to Study Drug Toxicity|0|||
49020004|NCT00718159|157910804|FG002|Overall Study|Death due to Study Drug Toxicity|1|||
49020005|NCT00718159|157910805|FG003|Overall Study|Death due to Study Drug Toxicity|2|||
48677820|NCT04072887|156671445|FG003|Overall Study|Lost to Follow-up|0|||
49020006|NCT00718159|157910806|FG004|Overall Study|Death due to Study Drug Toxicity|0|||
49020007|NCT00718159|157910807|FG005|Overall Study|Death due to Study Drug Toxicity|0|||
49020008|NCT00718159|157910808|FG006|Overall Study|Death due to Study Drug Toxicity|0|||
49020009|NCT00718159|157910802|FG000|Overall Study|Investigator Decision|0|||
49020010|NCT00718159|157910803|FG001|Overall Study|Investigator Decision|0|||
49020011|NCT00718159|157910804|FG002|Overall Study|Investigator Decision|0|||
49020012|NCT00718159|157910805|FG003|Overall Study|Investigator Decision|0|||
49020013|NCT00718159|157910806|FG004|Overall Study|Investigator Decision|0|||
49020014|NCT00718159|157910807|FG005|Overall Study|Investigator Decision|1|||
49020015|NCT00718159|157910808|FG006|Overall Study|Investigator Decision|1|||
49020016|NCT04700449|157910811|FG000|Stage 1: Double-Blind Period|Adverse Event|5|||
49020017|NCT04700449|157910812|FG001|Stage 1: Double-Blind Period|Adverse Event|0|||
49020018|NCT04700449|157910813|FG002|Stage 1: Double-Blind Period|Adverse Event|1|||
49020019|NCT04700449|157910814|FG003|Stage 1: Double-Blind Period|Adverse Event|0|||
49020020|NCT04700449|157910811|FG000|Stage 1: Double-Blind Period|Protocol Violation|0|||
49020021|NCT04700449|157910812|FG001|Stage 1: Double-Blind Period|Protocol Violation|1|||
49020022|NCT04700449|157910813|FG002|Stage 1: Double-Blind Period|Protocol Violation|0|||
49020023|NCT04700449|157910814|FG003|Stage 1: Double-Blind Period|Protocol Violation|0|||
49020024|NCT04700449|157910811|FG000|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
49020025|NCT04700449|157910812|FG001|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
49020026|NCT04700449|157910813|FG002|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
49020027|NCT04700449|157910814|FG003|Stage 1: Double-Blind Period|Withdrawal by Subject|0|||
49020028|NCT04700449|157910811|FG000|Stage 1: Double-Blind Period|Lack of Efficacy|1|||
49020029|NCT04700449|157910812|FG001|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
49020030|NCT04700449|157910813|FG002|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
49020031|NCT04700449|157910814|FG003|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
49020032|NCT04700449|157910811|FG000|Stage 1: Double-Blind Period|COVID-19 Restriction|3|||
49020033|NCT04700449|157910812|FG001|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
49020034|NCT04700449|157910813|FG002|Stage 1: Double-Blind Period|COVID-19 Restriction|1|||
49020035|NCT04700449|157910814|FG003|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
49020036|NCT04700449|157910811|FG000|Stage 1: Double-Blind Period|Other|0|||
49020037|NCT04700449|157910812|FG001|Stage 1: Double-Blind Period|Other|0|||
49020038|NCT04700449|157910813|FG002|Stage 1: Double-Blind Period|Other|1|||
49020039|NCT04700449|157910814|FG003|Stage 1: Double-Blind Period|Other|0|||
49020040|NCT04700449|157910811|FG000|Stage 2 Sub-study 1|Adverse Event|0|||
49020041|NCT04700449|157910812|FG001|Stage 2 Sub-study 1|Adverse Event|1|||
49020042|NCT04700449|157910813|FG002|Stage 2 Sub-study 1|Adverse Event|0|||
49020043|NCT04700449|157910814|FG003|Stage 2 Sub-study 1|Adverse Event|0|||
49020044|NCT04700449|157910811|FG000|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
49020045|NCT04700449|157910812|FG001|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
49020046|NCT04700449|157910813|FG002|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
48874996|NCT01813305|157379009|FG000|Overall Study|Prohibited Medication Administration or Condition Worsening|7|||
48677821|NCT04072887|156671446|FG004|Overall Study|Lost to Follow-up|0|||
48677822|NCT04072887|156671447|FG005|Overall Study|Lost to Follow-up|0|||
48677823|NCT04072887|156671442|FG000|Overall Study|Death|0|||
48677824|NCT04072887|156671443|FG001|Overall Study|Death|2|||
48677825|NCT04072887|156671444|FG002|Overall Study|Death|0|||
48677826|NCT04072887|156671445|FG003|Overall Study|Death|2|||
48677827|NCT04072887|156671446|FG004|Overall Study|Death|3|||
48677828|NCT04072887|156671447|FG005|Overall Study|Death|0|||
48677829|NCT00367835|156671453|FG000|Overall Study|Adverse Event|14|||
48677830|NCT00367835|156671454|FG001|Overall Study|Adverse Event|1|||
48677831|NCT00367835|156671453|FG000|Overall Study|Protocol Violation|1|||
48677832|NCT00367835|156671454|FG001|Overall Study|Protocol Violation|7|||
48677833|NCT00367835|156671453|FG000|Overall Study|Withdrawal by Subject|7|||
48677834|NCT00367835|156671454|FG001|Overall Study|Withdrawal by Subject|6|||
48677835|NCT00367835|156671453|FG000|Overall Study|Lost to Follow-up|1|||
48677836|NCT00367835|156671454|FG001|Overall Study|Lost to Follow-up|4|||
48677837|NCT00367835|156671453|FG000|Overall Study|Lack of Efficacy|3|||
48677838|NCT00367835|156671454|FG001|Overall Study|Lack of Efficacy|12|||
48677839|NCT00367835|156671453|FG000|Overall Study|Subject in juvenile detention center|1|||
48677840|NCT00367835|156671454|FG001|Overall Study|Subject in juvenile detention center|0|||
48677841|NCT00367835|156671453|FG000|Overall Study|refused blood collection|1|||
48677842|NCT00367835|156671454|FG001|Overall Study|refused blood collection|0|||
48677843|NCT00367835|156671453|FG000|Overall Study|Did not respond to calls|1|||
48677844|NCT00367835|156671454|FG001|Overall Study|Did not respond to calls|0|||
48677845|NCT00367835|156671453|FG000|Overall Study|History of lead poisoning|0|||
48677846|NCT00367835|156671454|FG001|Overall Study|History of lead poisoning|1|||
49020047|NCT04700449|157910814|FG003|Stage 2 Sub-study 1|Withdrawal by Subject|0|||
49020048|NCT04700449|157910811|FG000|Stage 2 Sub-study 1|Lack of Efficacy|0|||
48677847|NCT04371666|156671455|FG000|DB Treatment Period (52 Weeks)|Adverse Event|3|||
48677848|NCT04371666|156671456|FG001|DB Treatment Period (52 Weeks)|Adverse Event|1|||
49020049|NCT04700449|157910812|FG001|Stage 2 Sub-study 1|Lack of Efficacy|0|||
49020050|NCT04700449|157910813|FG002|Stage 2 Sub-study 1|Lack of Efficacy|2|||
49020051|NCT04700449|157910814|FG003|Stage 2 Sub-study 1|Lack of Efficacy|0|||
49020052|NCT04700449|157910811|FG000|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
49020053|NCT04700449|157910812|FG001|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
49020054|NCT04700449|157910813|FG002|Stage 2 Sub-study 1|COVID-19 Restriction|1|||
49020055|NCT04700449|157910814|FG003|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
49020056|NCT04700449|157910811|FG000|Stage 2 Sub-study 1|Other|1|||
48677849|NCT04371666|156671455|FG000|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|1|||
48677850|NCT04371666|156671456|FG001|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
49020057|NCT04700449|157910812|FG001|Stage 2 Sub-study 1|Other|2|||
49020058|NCT04700449|157910813|FG002|Stage 2 Sub-study 1|Other|0|||
49020059|NCT04700449|157910814|FG003|Stage 2 Sub-study 1|Other|0|||
49020060|NCT04700449|157910811|FG000|Stage 2 Sub-study 2|Adverse Event|0|||
49020061|NCT04700449|157910812|FG001|Stage 2 Sub-study 2|Adverse Event|0|||
49020062|NCT04700449|157910813|FG002|Stage 2 Sub-study 2|Adverse Event|0|||
49020063|NCT04700449|157910814|FG003|Stage 2 Sub-study 2|Adverse Event|7|||
49020064|NCT04700449|157910811|FG000|Stage 2 Sub-study 2|Lost to Follow-up|0|||
49020065|NCT04700449|157910812|FG001|Stage 2 Sub-study 2|Lost to Follow-up|0|||
49020066|NCT04700449|157910813|FG002|Stage 2 Sub-study 2|Lost to Follow-up|0|||
49020067|NCT04700449|157910814|FG003|Stage 2 Sub-study 2|Lost to Follow-up|1|||
49020068|NCT04700449|157910811|FG000|Stage 2 Sub-study 2|Lack of Efficacy|0|||
49020069|NCT04700449|157910812|FG001|Stage 2 Sub-study 2|Lack of Efficacy|0|||
49020070|NCT04700449|157910813|FG002|Stage 2 Sub-study 2|Lack of Efficacy|0|||
49020071|NCT04700449|157910814|FG003|Stage 2 Sub-study 2|Lack of Efficacy|9|||
49020072|NCT04700449|157910811|FG000|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
49020073|NCT04700449|157910812|FG001|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
49020074|NCT04700449|157910813|FG002|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
49020075|NCT04700449|157910814|FG003|Stage 2 Sub-study 2|COVID-19 Restriction|1|||
49020076|NCT04700449|157910811|FG000|Stage 2 Sub-study 2|Other|0|||
49020077|NCT04700449|157910812|FG001|Stage 2 Sub-study 2|Other|0|||
49020078|NCT04700449|157910813|FG002|Stage 2 Sub-study 2|Other|0|||
49020079|NCT04700449|157910814|FG003|Stage 2 Sub-study 2|Other|5|||
49020080|NCT03738332|157910815|FG000|Overall Study|Withdrawal by Subject|1|||
49020081|NCT00502775|157910816|FG000|Overall Study|Adverse Event|1|||
49020082|NCT00502775|157910817|FG001|Overall Study|Adverse Event|2|||
49020083|NCT00502775|157910818|FG002|Overall Study|Adverse Event|1|||
49020084|NCT00502775|157910816|FG000|Overall Study|Protocol Violation|1|||
49020085|NCT00502775|157910817|FG001|Overall Study|Protocol Violation|5|||
49020086|NCT00502775|157910818|FG002|Overall Study|Protocol Violation|2|||
49020087|NCT00502775|157910816|FG000|Overall Study|Withdrawal by Subject|1|||
49020088|NCT00502775|157910817|FG001|Overall Study|Withdrawal by Subject|1|||
49020089|NCT00502775|157910818|FG002|Overall Study|Withdrawal by Subject|2|||
49020090|NCT00502775|157910816|FG000|Overall Study|Sponsor Terminated Study|1|||
49020091|NCT00502775|157910817|FG001|Overall Study|Sponsor Terminated Study|0|||
49020092|NCT00502775|157910818|FG002|Overall Study|Sponsor Terminated Study|1|||
49020093|NCT00502775|157910816|FG000|Overall Study|Non-compliance with eDiary|4|||
49020094|NCT00502775|157910817|FG001|Overall Study|Non-compliance with eDiary|1|||
49020095|NCT00502775|157910818|FG002|Overall Study|Non-compliance with eDiary|1|||
49020096|NCT00502775|157910816|FG000|Overall Study|Subject unable to swallow capsule|1|||
49020097|NCT00502775|157910817|FG001|Overall Study|Subject unable to swallow capsule|0|||
49020098|NCT00502775|157910818|FG002|Overall Study|Subject unable to swallow capsule|1|||
49020099|NCT00502775|157910816|FG000|Overall Study|Logpad compliance <80%|1|||
49020100|NCT00502775|157910817|FG001|Overall Study|Logpad compliance <80%|0|||
49020101|NCT00502775|157910818|FG002|Overall Study|Logpad compliance <80%|0|||
49020102|NCT00502775|157910816|FG000|Overall Study|Randomized in error|0|||
49020103|NCT00502775|157910817|FG001|Overall Study|Randomized in error|1|||
49020104|NCT00502775|157910818|FG002|Overall Study|Randomized in error|1|||
49020105|NCT00502775|157910816|FG000|Overall Study|Non-compliance|0|||
49020106|NCT00502775|157910817|FG001|Overall Study|Non-compliance|2|||
49020107|NCT00502775|157910818|FG002|Overall Study|Non-compliance|2|||
49020108|NCT00502775|157910816|FG000|Overall Study|Outside pollen area more than 48 hours|0|||
49020109|NCT00502775|157910817|FG001|Overall Study|Outside pollen area more than 48 hours|1|||
48677851|NCT04371666|156671455|FG000|DB Treatment Period (52 Weeks)|Other than specified|1|||
48677852|NCT04371666|156671456|FG001|DB Treatment Period (52 Weeks)|Other than specified|0|||
48677853|NCT04371666|156671455|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
48677854|NCT04371666|156671456|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
48677855|NCT04371666|156671455|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|40|||
48677856|NCT04371666|156671456|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|41|||
48677857|NCT04371666|156671455|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|1|||
48677858|NCT04371666|156671456|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|0|||
48677859|NCT02147288|156671470|FG000|Overall Study|post-operative hematoma|1|||
48677860|NCT02147288|156671471|FG001|Overall Study|post-operative hematoma|1|||
48677861|NCT02147288|156671472|FG002|Overall Study|post-operative hematoma|0|||
49020110|NCT00502775|157910818|FG002|Overall Study|Outside pollen area more than 48 hours|0|||
49020111|NCT00502775|157910816|FG000|Overall Study|Declining pollen counts|0|||
49020112|NCT00502775|157910817|FG001|Overall Study|Declining pollen counts|1|||
49020113|NCT00502775|157910818|FG002|Overall Study|Declining pollen counts|1|||
49020114|NCT00502775|157910816|FG000|Overall Study|Subject in jail|0|||
49020115|NCT00502775|157910817|FG001|Overall Study|Subject in jail|1|||
49020116|NCT00502775|157910818|FG002|Overall Study|Subject in jail|0|||
49020117|NCT00502775|157910816|FG000|Overall Study|Subject took disallowed drug|0|||
49020118|NCT00502775|157910817|FG001|Overall Study|Subject took disallowed drug|0|||
48677862|NCT02147288|156671473|FG003|Overall Study|post-operative hematoma|0|||
48677863|NCT02147288|156671474|FG004|Overall Study|post-operative hematoma|0|||
48677864|NCT02147288|156671475|FG005|Overall Study|post-operative hematoma|0|||
48677865|NCT02147288|156671476|FG006|Overall Study|post-operative hematoma|0|||
48677866|NCT02147288|156671477|FG007|Overall Study|post-operative hematoma|0|||
48677867|NCT02147288|156671478|FG008|Overall Study|post-operative hematoma|0|||
48677868|NCT02147288|156671479|FG009|Overall Study|post-operative hematoma|0|||
48677869|NCT02147288|156671470|FG000|Overall Study|complications from concurrent hernia rep|0|||
48677870|NCT02147288|156671471|FG001|Overall Study|complications from concurrent hernia rep|1|||
48677871|NCT02147288|156671472|FG002|Overall Study|complications from concurrent hernia rep|0|||
48677872|NCT02147288|156671473|FG003|Overall Study|complications from concurrent hernia rep|0|||
48677873|NCT02147288|156671474|FG004|Overall Study|complications from concurrent hernia rep|0|||
48677874|NCT02147288|156671475|FG005|Overall Study|complications from concurrent hernia rep|0|||
48677875|NCT02147288|156671476|FG006|Overall Study|complications from concurrent hernia rep|0|||
48677876|NCT02147288|156671477|FG007|Overall Study|complications from concurrent hernia rep|0|||
48677877|NCT02147288|156671478|FG008|Overall Study|complications from concurrent hernia rep|0|||
48677878|NCT02147288|156671479|FG009|Overall Study|complications from concurrent hernia rep|0|||
48677879|NCT01114828|156671480|FG000|Overall Study|Adverse Event|1|||
48677880|NCT01114828|156671481|FG001|Overall Study|Adverse Event|1|||
48677881|NCT01114828|156671480|FG000|Overall Study|Lack of Efficacy|0|||
48677882|NCT01114828|156671481|FG001|Overall Study|Lack of Efficacy|2|||
48677883|NCT01114828|156671480|FG000|Overall Study|Protocol Violation|2|||
48677884|NCT01114828|156671481|FG001|Overall Study|Protocol Violation|0|||
48677885|NCT01114828|156671480|FG000|Overall Study|Withdrawal by Subject|0|||
48677886|NCT01114828|156671481|FG001|Overall Study|Withdrawal by Subject|1|||
48677887|NCT01740401|156672900|FG000|Overall Study|Progression of disease|6|||
48677888|NCT01740401|156672900|FG000|Overall Study|Adverse Event|2|||
48677889|NCT01740401|156672900|FG000|Overall Study|Did not reach primary endpoint|2|||
48677890|NCT03878758|156672901|FG000|Overall Study|Withdrawal by Subject|1|||
48677891|NCT03878758|156672901|FG000|Overall Study|Protocol defined|2|||
48677892|NCT03878758|156672901|FG000|Overall Study|Improper consent documentation|1|||
48677893|NCT00358436|156672904|FG000|Overall Study|Adverse Event|29|||
48677894|NCT00358436|156672905|FG001|Overall Study|Adverse Event|13|||
48677895|NCT00358436|156672904|FG000|Overall Study|Lack of Efficacy|34|||
48677896|NCT00358436|156672905|FG001|Overall Study|Lack of Efficacy|36|||
48677897|NCT00358436|156672904|FG000|Overall Study|Lost to Follow-up|11|||
48677898|NCT00358436|156672905|FG001|Overall Study|Lost to Follow-up|6|||
48677899|NCT00358436|156672904|FG000|Overall Study|Protocol Violation|8|||
48677900|NCT00358436|156672905|FG001|Overall Study|Protocol Violation|3|||
48677901|NCT00358436|156672904|FG000|Overall Study|Withdrawal by Subject|40|||
48677902|NCT00358436|156672905|FG001|Overall Study|Withdrawal by Subject|17|||
48677903|NCT00358436|156672904|FG000|Overall Study|Non-fulfilment of inclusion/exclusion|4|||
48677904|NCT00358436|156672905|FG001|Overall Study|Non-fulfilment of inclusion/exclusion|0|||
48677905|NCT00358436|156672904|FG000|Overall Study|COPD exacerbation|22|||
48677906|NCT00358436|156672905|FG001|Overall Study|COPD exacerbation|10|||
48677907|NCT00358436|156672904|FG000|Overall Study|Other|6|||
48677908|NCT00358436|156672905|FG001|Overall Study|Other|1|||
48677909|NCT03614325|156672908|FG000|Overall Study|Withdrawal by Subject|0|||
48677910|NCT03614325|156672909|FG001|Overall Study|Withdrawal by Subject|2|||
48677911|NCT03614325|156672908|FG000|Overall Study|Surgery Cancelled|2|||
48677912|NCT03614325|156672909|FG001|Overall Study|Surgery Cancelled|1|||
48677913|NCT03614325|156672908|FG000|Overall Study|Lost to Follow-up|2|||
48677914|NCT03614325|156672909|FG001|Overall Study|Lost to Follow-up|1|||
48677915|NCT03614325|156672908|FG000|Overall Study|Surgery never scheduled|1|||
48677916|NCT03614325|156672909|FG001|Overall Study|Surgery never scheduled|0|||
48677917|NCT00321464|156672912|FG000|Overall Study|Death|169|||
48677918|NCT00321464|156672913|FG001|Overall Study|Death|174|||
48677919|NCT00321464|156672912|FG000|Overall Study|Disease progression|124|||
48677920|NCT00321464|156672913|FG001|Overall Study|Disease progression|124|||
48677921|NCT00321464|156672912|FG000|Overall Study|Withdrawal by Subject|117|||
48677922|NCT00321464|156672913|FG001|Overall Study|Withdrawal by Subject|118|||
48677923|NCT00321464|156672912|FG000|Overall Study|Participant request|57|||
48677924|NCT00321464|156672913|FG001|Overall Study|Participant request|61|||
48677925|NCT00321464|156672912|FG000|Overall Study|Adverse Event|43|||
49020119|NCT00502775|157910818|FG002|Overall Study|Subject took disallowed drug|1|||
48677926|NCT00321464|156672913|FG001|Overall Study|Adverse Event|28|||
48677927|NCT00321464|156672912|FG000|Overall Study|Physician Decision|15|||
48677928|NCT00321464|156672913|FG001|Overall Study|Physician Decision|14|||
48677929|NCT00321464|156672912|FG000|Overall Study|Noncompliance|4|||
48677930|NCT00321464|156672913|FG001|Overall Study|Noncompliance|10|||
48677931|NCT00321464|156672912|FG000|Overall Study|Lost to Follow-up|7|||
48677932|NCT00321464|156672913|FG001|Overall Study|Lost to Follow-up|8|||
48677933|NCT00321464|156672912|FG000|Overall Study|Protocol deviation|0|||
48677934|NCT00321464|156672913|FG001|Overall Study|Protocol deviation|2|||
48677935|NCT00321464|156672912|FG000|Overall Study|Ineligibility determined|2|||
48677936|NCT00321464|156672913|FG001|Overall Study|Ineligibility determined|1|||
48677937|NCT00321464|156672912|FG000|Overall Study|Other|21|||
48677938|NCT00321464|156672913|FG001|Overall Study|Other|18|||
48677939|NCT01450098|156672919|FG000|Period 3|Protocol Violation|0|||
48677940|NCT01450098|156672920|FG001|Period 3|Protocol Violation|1|||
48677941|NCT01450098|156672919|FG000|Period 3|Withdrawal by Subject|0|||
48677942|NCT01450098|156672920|FG001|Period 3|Withdrawal by Subject|2|||
48677943|NCT02352753|156672926|FG000|6-Month Dosing Period|Decision by sponsor|2|||
48677944|NCT02352753|156672926|FG000|6-Month Dosing Period|Withdrawal by Subject|34|||
48677945|NCT02352753|156672926|FG000|6-Month Dosing Period|Lost to Follow-up|2|||
48677946|NCT02352753|156672926|FG000|6-Month Dosing Period|Transitioning to Q3M|60|||
48677947|NCT02352753|156672926|FG000|3-Month Dosing Period|Decision by sponsor|14|||
48677948|NCT02352753|156672926|FG000|3-Month Dosing Period|Withdrawal by Subject|6|||
48677949|NCT01363908|156672927|FG000|Chronic Dosing (CD) Phase|Adverse Event|1|||
48677950|NCT01363908|156672928|FG001|Chronic Dosing (CD) Phase|Adverse Event|1|||
48677951|NCT01363908|156672927|FG000|Chronic Dosing (CD) Phase|Patient decision|0|||
48677952|NCT01363908|156672928|FG001|Chronic Dosing (CD) Phase|Patient decision|1|||
48677953|NCT01363908|156672927|FG000|Chronic Dosing (CD) Phase|Physician Decision|0|||
48677954|NCT01363908|156672928|FG001|Chronic Dosing (CD) Phase|Physician Decision|1|||
48677955|NCT01363908|156672927|FG000|Chronic Dosing (CD) Phase|Early study termination|9|||
48762684|NCT02159521|156980300|FG000|Overall Study|Other than specified|1|||
48762685|NCT00304356|156980301|FG000|Nitazoxanide|Physician Decision|5|||
48762686|NCT00304356|156980301|FG000|Nitazoxanide|Physician Decision|1|||
48762687|NCT00304356|156980301|FG000|Nitazoxanide|number is 0|1|||
48762688|NCT00304356|156980301|FG000|Nitazoxanide|Physician Decision|1|||
48762689|NCT00304356|156980301|FG000|Nitazoxanide|Physician Decision|1|||
48762690|NCT00304356|156980301|FG000|Nitazoxanide|Physician Decision|1|||
48762691|NCT02590939|156980303|FG000|Overall Study|Withdrawal by Subject|3|||
49020120|NCT00576901|157910823|FG000|Overall Study|Withdrawal by Subject|1|||
49020121|NCT00576901|157910823|FG000|Overall Study|Disease course|1|||
49020122|NCT00576901|157910823|FG000|Overall Study|Protocol Violation|1|||
49020123|NCT00553540|157910824|FG000|Overall Study|discharged after first visit|2|||
49020124|NCT00553540|157910825|FG001|Overall Study|discharged after first visit|5|||
49020125|NCT01755858|157910828|FG000|Overall Study|Adverse Event|1|||
49020126|NCT01755858|157910829|FG001|Overall Study|Adverse Event|1|||
49020127|NCT02396381|157910830|FG000|Overall Study|Adverse Event|3|||
49020128|NCT02396381|157910831|FG001|Overall Study|Adverse Event|2|||
49020129|NCT02396381|157910830|FG000|Overall Study|Withdrawal by Subject|33|||
49020130|NCT02396381|157910831|FG001|Overall Study|Withdrawal by Subject|24|||
49020131|NCT02396381|157910830|FG000|Overall Study|Lost to Follow-up|49|||
49020132|NCT02396381|157910831|FG001|Overall Study|Lost to Follow-up|31|||
49020133|NCT02396381|157910830|FG000|Overall Study|Protocol Violation|1|||
49020134|NCT02396381|157910831|FG001|Overall Study|Protocol Violation|0|||
49020135|NCT02396381|157910830|FG000|Overall Study|Site terminated by sponsor|7|||
49020136|NCT02396381|157910831|FG001|Overall Study|Site terminated by sponsor|8|||
49020137|NCT02396381|157910830|FG000|Overall Study|Physician Decision|5|||
49020138|NCT02396381|157910831|FG001|Overall Study|Physician Decision|5|||
49020139|NCT02396381|157910830|FG000|Overall Study|Pregnancy|2|||
48762692|NCT02590939|156980304|FG001|Overall Study|Withdrawal by Subject|1|||
48874997|NCT01813305|157379010|FG001|Overall Study|Prohibited Medication Administration or Condition Worsening|2|||
49020140|NCT02396381|157910831|FG001|Overall Study|Pregnancy|0|||
49020141|NCT02396381|157910830|FG000|Overall Study|Non-compliance with study procedures|1|||
49020142|NCT02396381|157910831|FG001|Overall Study|Non-compliance with study procedures|0|||
49020143|NCT02396381|157910830|FG000|Overall Study|Moved out of town/state|1|||
49020144|NCT02396381|157910831|FG001|Overall Study|Moved out of town/state|3|||
49020145|NCT02396381|157910830|FG000|Overall Study|Could not complete visit|1|||
48874998|NCT04594733|157379011|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
49020146|NCT02396381|157910831|FG001|Overall Study|Could not complete visit|0|||
49020147|NCT02396381|157910830|FG000|Overall Study|Possible conflict of interest|1|||
49020148|NCT02396381|157910831|FG001|Overall Study|Possible conflict of interest|0|||
49020149|NCT02396381|157910830|FG000|Overall Study|Randomization/Screening Error|3|||
49020150|NCT02396381|157910831|FG001|Overall Study|Randomization/Screening Error|1|||
48677956|NCT01363908|156672928|FG001|Chronic Dosing (CD) Phase|Early study termination|3|||
48677957|NCT01815840|156672930|FG000|Overall Study|Missing|1|||
48677958|NCT01815840|156672931|FG001|Overall Study|Missing|0|||
48677959|NCT01815840|156672930|FG000|Overall Study|Withdrew Consent|31|||
48677960|NCT01815840|156672931|FG001|Overall Study|Withdrew Consent|30|||
48677961|NCT01815840|156672930|FG000|Overall Study|Administrative/Other|1|||
49020151|NCT00265759|157910832|FG000|Overall Study|Withdrawal by Subject|0|||
49020152|NCT00265759|157910833|FG001|Overall Study|Withdrawal by Subject|1|||
48677962|NCT01815840|156672931|FG001|Overall Study|Administrative/Other|3|||
48677963|NCT01815840|156672930|FG000|Overall Study|Adverse Event|10|||
48677964|NCT01815840|156672931|FG001|Overall Study|Adverse Event|16|||
48677965|NCT01815840|156672930|FG000|Overall Study|Death|2|||
48677966|NCT01815840|156672931|FG001|Overall Study|Death|2|||
48677967|NCT01815840|156672930|FG000|Overall Study|Disease progression|3|||
48677968|NCT01815840|156672931|FG001|Overall Study|Disease progression|2|||
48677969|NCT01815840|156672930|FG000|Overall Study|Investigators Decision|2|||
48677970|NCT01815840|156672931|FG001|Overall Study|Investigators Decision|3|||
48677971|NCT01815840|156672930|FG000|Overall Study|Lost to Follow-up|3|||
48677972|NCT01815840|156672931|FG001|Overall Study|Lost to Follow-up|6|||
48677973|NCT01815840|156672930|FG000|Overall Study|Refused Treatment|5|||
48677974|NCT01815840|156672931|FG001|Overall Study|Refused Treatment|1|||
48677975|NCT01815840|156672930|FG000|Overall Study|Sponsor Termination Treatment|1|||
48677976|NCT01815840|156672931|FG001|Overall Study|Sponsor Termination Treatment|0|||
48677977|NCT02504580|156672932|FG000|Overall Study|Other|1|||
48677978|NCT02504580|156672933|FG001|Overall Study|Other|0|||
48677979|NCT02504580|156672934|FG002|Overall Study|Other|0|||
48677980|NCT02504580|156672935|FG003|Overall Study|Other|2|||
48677981|NCT02504580|156672936|FG004|Overall Study|Other|1|||
48677982|NCT02504580|156672937|FG005|Overall Study|Other|1|||
48677983|NCT02504580|156672938|FG006|Overall Study|Other|1|||
48677984|NCT02504580|156672939|FG007|Overall Study|Other|2|||
48677985|NCT02504580|156672940|FG008|Overall Study|Other|0|||
48762693|NCT02590939|156980303|FG000|Overall Study|Failed the nociceptive test|2|||
48762694|NCT02590939|156980304|FG001|Overall Study|Failed the nociceptive test|1|||
48762695|NCT03717480|156980305|FG000|Overall Study|Never received investigational product due to product viability limitations.|1|||
48762696|NCT05045144|156980306|FG000|Overall Study|Lost to Follow-up|3|||
48762697|NCT05045144|156980307|FG001|Overall Study|Lost to Follow-up|2|||
48762698|NCT05045144|156980308|FG002|Overall Study|Lost to Follow-up|3|||
48762699|NCT05045144|156980309|FG003|Overall Study|Lost to Follow-up|5|||
48762700|NCT05045144|156980310|FG004|Overall Study|Lost to Follow-up|13|||
48762701|NCT05045144|156980306|FG000|Overall Study|Withdrawal by Subject|0|||
48762702|NCT05045144|156980307|FG001|Overall Study|Withdrawal by Subject|1|||
48762703|NCT05045144|156980308|FG002|Overall Study|Withdrawal by Subject|0|||
48762704|NCT05045144|156980309|FG003|Overall Study|Withdrawal by Subject|0|||
48762705|NCT05045144|156980310|FG004|Overall Study|Withdrawal by Subject|0|||
48762706|NCT05045144|156980306|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48762707|NCT05045144|156980307|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48762708|NCT05045144|156980308|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
48762709|NCT05045144|156980309|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48762710|NCT05045144|156980310|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48762711|NCT00768144|156980311|FG000|Overall Study|Adverse Event|13|||
48762712|NCT00768144|156980311|FG000|Overall Study|Progressive Disease|21|||
48762713|NCT00768144|156980311|FG000|Overall Study|Patient or MD Decision to End Treatment|1|||
48762714|NCT00768144|156980311|FG000|Overall Study|Pt Withdrew Consent|1|||
48762715|NCT03011307|156980312|FG000|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|3|||
48762716|NCT03011307|156980313|FG001|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|2|||
48762717|NCT03011307|156980312|FG000|Overall Study|Did not receive study drug: unable to place spinal needle|2|||
48762718|NCT03011307|156980313|FG001|Overall Study|Did not receive study drug: unable to place spinal needle|0|||
48762719|NCT03011307|156980312|FG000|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|1|||
48762720|NCT03011307|156980313|FG001|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|0|||
48762721|NCT02968979|156980314|FG000|Overall Study|Protocol Violation|7|||
48762722|NCT02968979|156980314|FG000|Overall Study|Withdrawal by Subject|1|||
48762723|NCT02466555|156980321|FG000|Overall Study|Lost to Follow-up|2|||
48762724|NCT01527682|156980322|FG000|Overall Study|Protocol Violation|8|||
48762725|NCT03760146|156980323|FG000|Overall Study|Adverse Event|11|||
48762726|NCT03760146|156980324|FG001|Overall Study|Adverse Event|8|||
48762727|NCT03760146|156980325|FG002|Overall Study|Adverse Event|0|||
48762728|NCT03760146|156980326|FG003|Overall Study|Adverse Event|0|||
48762729|NCT03760146|156980327|FG004|Overall Study|Adverse Event|0|||
49020153|NCT00265759|157910834|FG002|Overall Study|Withdrawal by Subject|2|||
48762730|NCT03760146|156980328|FG005|Overall Study|Adverse Event|0|||
48762731|NCT03760146|156980323|FG000|Overall Study|Death|1|||
48677986|NCT02504580|156672941|FG009|Overall Study|Other|0|||
48677987|NCT02504580|156672942|FG010|Overall Study|Other|0|||
48677988|NCT02504580|156672943|FG011|Overall Study|Other|2|||
48677989|NCT02504580|156672932|FG000|Overall Study|Subject refusal to continue|0|||
48762732|NCT03760146|156980324|FG001|Overall Study|Death|0|||
48762733|NCT03760146|156980325|FG002|Overall Study|Death|0|||
48677990|NCT02504580|156672933|FG001|Overall Study|Subject refusal to continue|1|||
48677991|NCT02504580|156672934|FG002|Overall Study|Subject refusal to continue|0|||
48677992|NCT02504580|156672935|FG003|Overall Study|Subject refusal to continue|0|||
48677993|NCT02504580|156672936|FG004|Overall Study|Subject refusal to continue|0|||
48677994|NCT02504580|156672937|FG005|Overall Study|Subject refusal to continue|0|||
49020154|NCT00265759|157910835|FG003|Overall Study|Withdrawal by Subject|2|||
49020155|NCT00265759|157910832|FG000|Overall Study|Cancel|0|||
48677995|NCT02504580|156672938|FG006|Overall Study|Subject refusal to continue|0|||
48677996|NCT02504580|156672939|FG007|Overall Study|Subject refusal to continue|0|||
48677997|NCT02504580|156672940|FG008|Overall Study|Subject refusal to continue|0|||
48677998|NCT02504580|156672941|FG009|Overall Study|Subject refusal to continue|0|||
48677999|NCT02504580|156672942|FG010|Overall Study|Subject refusal to continue|0|||
48678000|NCT02504580|156672943|FG011|Overall Study|Subject refusal to continue|0|||
48678001|NCT01564732|156672944|FG000|Overall Study|Early termination by the study sponsor|6|||
48678002|NCT01564732|156672945|FG001|Overall Study|Early termination by the study sponsor|5|||
48678003|NCT01957202|156672946|FG000|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
48678004|NCT01957202|156672947|FG001|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
48678005|NCT01957202|156672948|FG002|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
48678006|NCT01957202|156672949|FG003|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
48678007|NCT01957202|156672950|FG004|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
48678008|NCT01957202|156672951|FG005|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
48678009|NCT01957202|156672952|FG006|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
48678010|NCT01957202|156672953|FG007|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
48678011|NCT01957202|156672954|FG008|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
49020156|NCT00265759|157910833|FG001|Overall Study|Cancel|0|||
49020157|NCT00265759|157910834|FG002|Overall Study|Cancel|0|||
49020158|NCT00265759|157910835|FG003|Overall Study|Cancel|3|||
49020159|NCT00265759|157910832|FG000|Overall Study|Ineligible|0|||
49020160|NCT00265759|157910833|FG001|Overall Study|Ineligible|0|||
49020161|NCT00265759|157910834|FG002|Overall Study|Ineligible|0|||
49020162|NCT00265759|157910835|FG003|Overall Study|Ineligible|1|||
49020163|NCT00265759|157910832|FG000|Overall Study|Bilateral disease|0|||
49020164|NCT00265759|157910833|FG001|Overall Study|Bilateral disease|0|||
49020165|NCT00265759|157910834|FG002|Overall Study|Bilateral disease|0|||
49020166|NCT00265759|157910835|FG003|Overall Study|Bilateral disease|2|||
49020167|NCT00265759|157910832|FG000|Overall Study|Discontinued due to intolerability|0|||
49020168|NCT00265759|157910833|FG001|Overall Study|Discontinued due to intolerability|0|||
49020169|NCT00265759|157910834|FG002|Overall Study|Discontinued due to intolerability|0|||
49020170|NCT00265759|157910835|FG003|Overall Study|Discontinued due to intolerability|1|||
49020171|NCT02309099|157910836|FG000|Overall Study|Adverse Event|2|||
49020172|NCT02309099|157910837|FG001|Overall Study|Adverse Event|0|||
49020173|NCT02016300|157910838|FG000|Overall Study|Lost to Follow-up|0|||
48678012|NCT01957202|156672955|FG009|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
48678013|NCT01957202|156672956|FG010|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
48678014|NCT01957202|156672957|FG011|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
48678015|NCT01957202|156672958|FG012|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
48678016|NCT01957202|156672959|FG013|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
48678017|NCT01957202|156672960|FG014|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
48678018|NCT01957202|156672961|FG015|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
48678019|NCT01957202|156672962|FG016|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
48678020|NCT01957202|156672963|FG017|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
48678021|NCT01957202|156672946|FG000|Treatment Period 3 (8 Days)|Adverse Event|0|||
48678022|NCT01957202|156672947|FG001|Treatment Period 3 (8 Days)|Adverse Event|0|||
48678023|NCT01957202|156672948|FG002|Treatment Period 3 (8 Days)|Adverse Event|0|||
48678024|NCT01957202|156672949|FG003|Treatment Period 3 (8 Days)|Adverse Event|0|||
49020174|NCT02016300|157910839|FG001|Overall Study|Lost to Follow-up|3|||
49020175|NCT00356200|157910844|FG000|Cohort 1: 10 ug/ml|Lack of Efficacy|1|||
49020176|NCT00356200|157910845|FG001|Cohort 1: 10 ug/ml|Lack of Efficacy|0|||
49020177|NCT00356200|157910844|FG000|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0|||
49020178|NCT00356200|157910845|FG001|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2|||
49020179|NCT00782509|157910846|FG000|Overall Study|Adverse Event|20|||
48678025|NCT01957202|156672950|FG004|Treatment Period 3 (8 Days)|Adverse Event|0|||
48678026|NCT01957202|156672951|FG005|Treatment Period 3 (8 Days)|Adverse Event|0|||
48678027|NCT01957202|156672952|FG006|Treatment Period 3 (8 Days)|Adverse Event|0|||
48678028|NCT01957202|156672953|FG007|Treatment Period 3 (8 Days)|Adverse Event|0|||
48678029|NCT01957202|156672954|FG008|Treatment Period 3 (8 Days)|Adverse Event|0|||
48678030|NCT01957202|156672955|FG009|Treatment Period 3 (8 Days)|Adverse Event|0|||
48678031|NCT01957202|156672956|FG010|Treatment Period 3 (8 Days)|Adverse Event|0|||
48678032|NCT01957202|156672957|FG011|Treatment Period 3 (8 Days)|Adverse Event|0|||
48678033|NCT01957202|156672958|FG012|Treatment Period 3 (8 Days)|Adverse Event|0|||
48762734|NCT03760146|156980326|FG003|Overall Study|Death|0|||
49020180|NCT00782509|157910847|FG001|Overall Study|Adverse Event|10|||
49020181|NCT00782509|157910848|FG002|Overall Study|Adverse Event|20|||
49020182|NCT00782509|157910846|FG000|Overall Study|Lost to Follow-up|1|||
49020183|NCT00782509|157910847|FG001|Overall Study|Lost to Follow-up|2|||
49020184|NCT00782509|157910848|FG002|Overall Study|Lost to Follow-up|3|||
49020185|NCT00782509|157910846|FG000|Overall Study|Withdrawal by Subject|3|||
49020186|NCT00782509|157910847|FG001|Overall Study|Withdrawal by Subject|5|||
49020187|NCT00782509|157910848|FG002|Overall Study|Withdrawal by Subject|8|||
48678034|NCT01957202|156672959|FG013|Treatment Period 3 (8 Days)|Adverse Event|0|||
48678035|NCT01957202|156672960|FG014|Treatment Period 3 (8 Days)|Adverse Event|0|||
48678036|NCT01957202|156672961|FG015|Treatment Period 3 (8 Days)|Adverse Event|0|||
48678037|NCT01957202|156672962|FG016|Treatment Period 3 (8 Days)|Adverse Event|1|||
48678038|NCT01957202|156672963|FG017|Treatment Period 3 (8 Days)|Adverse Event|0|||
48678039|NCT04207060|156672968|FG000|Overall Study|Lost to Follow-up|2|||
48678040|NCT04207060|156672969|FG001|Overall Study|Lost to Follow-up|0|||
48678041|NCT01452919|156672970|FG000|Open-Label Treatment|Adverse Event|5|||
48678042|NCT01452919|156672971|FG001|Open-Label Treatment|Adverse Event|0|||
48678043|NCT01452919|156672972|FG002|Open-Label Treatment|Adverse Event|0|||
48678044|NCT01452919|156672970|FG000|Open-Label Treatment|Lost to Follow-up|4|||
48678045|NCT01452919|156672971|FG001|Open-Label Treatment|Lost to Follow-up|0|||
48678046|NCT01452919|156672972|FG002|Open-Label Treatment|Lost to Follow-up|0|||
48678047|NCT01452919|156672970|FG000|Open-Label Treatment|Perceived lack of efficacy|3|||
48678048|NCT01452919|156672971|FG001|Open-Label Treatment|Perceived lack of efficacy|0|||
48678049|NCT01452919|156672972|FG002|Open-Label Treatment|Perceived lack of efficacy|0|||
48678050|NCT01452919|156672970|FG000|Open-Label Treatment|Protocol Violation|4|||
48678051|NCT01452919|156672971|FG001|Open-Label Treatment|Protocol Violation|0|||
48678052|NCT01452919|156672972|FG002|Open-Label Treatment|Protocol Violation|0|||
48678053|NCT01452919|156672970|FG000|Open-Label Treatment|Sponsor Decision|1|||
48678054|NCT01452919|156672971|FG001|Open-Label Treatment|Sponsor Decision|0|||
48678055|NCT01452919|156672972|FG002|Open-Label Treatment|Sponsor Decision|0|||
48678056|NCT01452919|156672970|FG000|Open-Label Treatment|Withdrawal by Subject|2|||
48762735|NCT03760146|156980327|FG004|Overall Study|Death|0|||
49020188|NCT00782509|157910846|FG000|Overall Study|Non compliance with protocol|2|||
49020189|NCT00782509|157910847|FG001|Overall Study|Non compliance with protocol|0|||
49020190|NCT00782509|157910848|FG002|Overall Study|Non compliance with protocol|0|||
49020191|NCT00782509|157910846|FG000|Overall Study|Other reasons not stated above|5|||
49020192|NCT00782509|157910847|FG001|Overall Study|Other reasons not stated above|2|||
49020193|NCT00782509|157910848|FG002|Overall Study|Other reasons not stated above|3|||
49020194|NCT00782509|157910846|FG000|Overall Study|Lack of Efficacy|10|||
49020195|NCT00782509|157910847|FG001|Overall Study|Lack of Efficacy|5|||
49020196|NCT00782509|157910848|FG002|Overall Study|Lack of Efficacy|2|||
49020197|NCT02398188|157910849|FG000|Overall Study|Adverse Event|2|||
49020198|NCT02398188|157910850|FG001|Overall Study|Adverse Event|3|||
49020199|NCT02398188|157910849|FG000|Overall Study|Lost to Follow-up|5|||
49020200|NCT02398188|157910850|FG001|Overall Study|Lost to Follow-up|0|||
49020201|NCT02398188|157910849|FG000|Overall Study|Non-compliance|4|||
49020202|NCT02398188|157910850|FG001|Overall Study|Non-compliance|4|||
49020203|NCT02398188|157910849|FG000|Overall Study|Protocol Violation|6|||
49020204|NCT02398188|157910850|FG001|Overall Study|Protocol Violation|10|||
49020205|NCT02398188|157910849|FG000|Overall Study|Sponsor Decision|2|||
49020206|NCT02398188|157910850|FG001|Overall Study|Sponsor Decision|1|||
49020207|NCT02398188|157910849|FG000|Overall Study|Pregnancy|1|||
49020208|NCT02398188|157910850|FG001|Overall Study|Pregnancy|0|||
49020209|NCT02398188|157910849|FG000|Overall Study|Withdrawal by Subject|7|||
49020210|NCT02398188|157910850|FG001|Overall Study|Withdrawal by Subject|16|||
49020211|NCT00635778|157910851|FG000|Overall Study|Adverse Event|1|||
49020212|NCT00635778|157910852|FG001|Overall Study|Adverse Event|0|||
49020213|NCT00635778|157910853|FG002|Overall Study|Adverse Event|0|||
49020214|NCT00635778|157910854|FG003|Overall Study|Adverse Event|3|||
49020215|NCT00635778|157910855|FG004|Overall Study|Adverse Event|3|||
49020216|NCT00635778|157910856|FG005|Overall Study|Adverse Event|6|||
49020217|NCT00635778|157910857|FG006|Overall Study|Adverse Event|1|||
49020218|NCT00635778|157910851|FG000|Overall Study|Withdrawal by Subject|0|||
49020219|NCT00635778|157910852|FG001|Overall Study|Withdrawal by Subject|0|||
49020220|NCT00635778|157910853|FG002|Overall Study|Withdrawal by Subject|0|||
49020221|NCT00635778|157910854|FG003|Overall Study|Withdrawal by Subject|1|||
49020222|NCT00635778|157910855|FG004|Overall Study|Withdrawal by Subject|0|||
48678057|NCT01452919|156672971|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
48678058|NCT01452919|156672972|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
48678059|NCT01452919|156672970|FG000|Open-Label Treatment|Subject is moving or has moved|1|||
48678060|NCT01452919|156672971|FG001|Open-Label Treatment|Subject is moving or has moved|0|||
48678061|NCT01452919|156672972|FG002|Open-Label Treatment|Subject is moving or has moved|0|||
48678062|NCT01452919|156672970|FG000|Randomization Treatment|Adverse Event|0|||
48678063|NCT01452919|156672971|FG001|Randomization Treatment|Adverse Event|0|||
48678064|NCT01452919|156672972|FG002|Randomization Treatment|Adverse Event|2|||
48762736|NCT03760146|156980328|FG005|Overall Study|Death|0|||
49020223|NCT00635778|157910856|FG005|Overall Study|Withdrawal by Subject|1|||
49020224|NCT00635778|157910857|FG006|Overall Study|Withdrawal by Subject|1|||
49020225|NCT00635778|157910851|FG000|Overall Study|Progressive disease|0|||
49020226|NCT00635778|157910852|FG001|Overall Study|Progressive disease|3|||
49020227|NCT00635778|157910853|FG002|Overall Study|Progressive disease|3|||
49020228|NCT00635778|157910854|FG003|Overall Study|Progressive disease|4|||
49020229|NCT00635778|157910855|FG004|Overall Study|Progressive disease|5|||
49020230|NCT00635778|157910856|FG005|Overall Study|Progressive disease|14|||
49020231|NCT00635778|157910857|FG006|Overall Study|Progressive disease|4|||
49020232|NCT01884025|157910858|FG000|Overall Study|Lost to Follow-up|3|||
48678065|NCT01452919|156672970|FG000|Randomization Treatment|Sponsor Decision|0|||
48678066|NCT01452919|156672971|FG001|Randomization Treatment|Sponsor Decision|1|||
48678067|NCT01452919|156672972|FG002|Randomization Treatment|Sponsor Decision|0|||
48678068|NCT01452919|156672970|FG000|Randomization Treatment|Withdrawal by Subject|0|||
48678069|NCT01452919|156672971|FG001|Randomization Treatment|Withdrawal by Subject|1|||
48678070|NCT01452919|156672972|FG002|Randomization Treatment|Withdrawal by Subject|0|||
48678071|NCT01452919|156672970|FG000|Randomization Treatment|Subject is moving or has moved|0|||
48678072|NCT01452919|156672971|FG001|Randomization Treatment|Subject is moving or has moved|1|||
48678073|NCT01452919|156672972|FG002|Randomization Treatment|Subject is moving or has moved|0|||
48678074|NCT04752358|156672975|FG000|Overall Study|Death|2|||
48678075|NCT04752358|156672976|FG001|Overall Study|Death|1|||
48678076|NCT02718716|156672977|FG000|Overall Study|Lack of Efficacy|1|||
48678077|NCT02718716|156672978|FG001|Overall Study|Lack of Efficacy|0|||
48678078|NCT02718716|156672979|FG002|Overall Study|Lack of Efficacy|0|||
48678079|NCT02718716|156672980|FG003|Overall Study|Lack of Efficacy|0|||
48678080|NCT02718716|156672981|FG004|Overall Study|Lack of Efficacy|0|||
48678081|NCT01359943|156672982|FG000|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1|||
48678082|NCT01359943|156672983|FG001|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
48678083|NCT01359943|156672984|FG002|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
48678084|NCT01359943|156672982|FG000|Double-blind (Weeks 0 - 16)|Adverse Event|1|||
48678085|NCT01359943|156672983|FG001|Double-blind (Weeks 0 - 16)|Adverse Event|2|||
48678086|NCT01359943|156672984|FG002|Double-blind (Weeks 0 - 16)|Adverse Event|0|||
48678087|NCT01359943|156672982|FG000|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
48678088|NCT01359943|156672983|FG001|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2|||
48678089|NCT01359943|156672984|FG002|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
48678090|NCT01359943|156672982|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1|||
48874999|NCT04594733|157379012|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
48875000|NCT04594733|157379011|FG000|First Intervention (8 Weeks)|Lost to Follow-up|0|||
48678091|NCT01359943|156672983|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
48678092|NCT01359943|156672984|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
48678093|NCT01359943|156672982|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1|||
48678094|NCT01359943|156672983|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3|||
48678095|NCT01359943|156672984|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4|||
48678096|NCT01359943|156672982|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
48678097|NCT01359943|156672983|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1|||
48678098|NCT01359943|156672984|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
48678099|NCT01359943|156672982|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
48678100|NCT01359943|156672983|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
48678101|NCT01359943|156672984|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
48678102|NCT01359943|156672982|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
48678103|NCT01359943|156672983|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1|||
48678104|NCT01359943|156672984|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
48678105|NCT01359943|156672982|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3|||
48678106|NCT01359943|156672983|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5|||
48678107|NCT01359943|156672984|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1|||
48678108|NCT01359943|156672982|FG000|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1|||
48678109|NCT01359943|156672983|FG001|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5|||
48678110|NCT01359943|156672984|FG002|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4|||
48678111|NCT01359943|156672982|FG000|Follow-up (Weeks 52 - 60)|Administrative problems|1|||
48678112|NCT01359943|156672983|FG001|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
48678113|NCT01359943|156672984|FG002|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
48678114|NCT01359943|156672982|FG000|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
48678115|NCT01359943|156672983|FG001|Follow-up (Weeks 52 - 60)|Protocol deviation|1|||
48678116|NCT01359943|156672984|FG002|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
48678117|NCT01359943|156672982|FG000|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
48678118|NCT01359943|156672983|FG001|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
48678119|NCT01359943|156672984|FG002|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
48678120|NCT01359943|156672982|FG000|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
48678121|NCT01359943|156672983|FG001|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1|||
48678122|NCT01359943|156672984|FG002|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
48678123|NCT01359943|156672982|FG000|Follow-up (Weeks 52 - 60)|Adverse Event|3|||
48678124|NCT01359943|156672983|FG001|Follow-up (Weeks 52 - 60)|Adverse Event|5|||
48678125|NCT01359943|156672984|FG002|Follow-up (Weeks 52 - 60)|Adverse Event|1|||
48678126|NCT03722524|156672987|FG000|Overall Study|Protocol Violation|86|||
48875001|NCT04594733|157379012|FG001|First Intervention (8 Weeks)|Lost to Follow-up|3|||
48875002|NCT04594733|157379011|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|2|||
48678127|NCT03722524|156672987|FG000|Overall Study|Adverse Event|7|||
48875003|NCT04594733|157379012|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
48875004|NCT03842436|157379015|FG000|Overall Study|Lost to Follow-up|1|||
48875005|NCT04969276|157379020|FG000|Overall Study|Protocol Deviation|0|||
48678128|NCT03722524|156672987|FG000|Overall Study|Lost to Follow-up|1|||
48678129|NCT03722524|156672987|FG000|Overall Study|Reason is not stated|1|||
48678130|NCT03722524|156672987|FG000|Overall Study|Physician Decision|1|||
48678131|NCT03722524|156672987|FG000|Overall Study|Patient's decision (refusal to continue participation)|3|||
48678132|NCT02942485|156672988|FG000|Overall Study|Lost to Follow-up|1|||
48678133|NCT02942485|156672989|FG001|Overall Study|Lost to Follow-up|0|||
48678134|NCT03245398|156672995|FG000|Overall Study|Travelled to another island|1|||
48678135|NCT03245398|156672996|FG001|Overall Study|Travelled to another island|0|||
48678136|NCT00880191|156673002|FG000|Overall Study|Refused further treatment|4|||
48678137|NCT00880191|156673003|FG001|Overall Study|Refused further treatment|1|||
48678138|NCT00880191|156673002|FG000|Overall Study|Adverse Event|8|||
48678139|NCT00880191|156673003|FG001|Overall Study|Adverse Event|6|||
48678140|NCT00880191|156673002|FG000|Overall Study|Hospitalization/efficacy|1|||
48678141|NCT00880191|156673003|FG001|Overall Study|Hospitalization/efficacy|1|||
48678142|NCT00774800|156673007|FG000|Intervention 4|Withdrawal by Subject|1|||
48678143|NCT01240200|156673008|FG000|12-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
48678144|NCT01240200|156673009|FG001|12-week Crossover Phase - Period 1|Withdrawal by Subject|1|||
48678145|NCT01331109|156673010|FG000|Overall Study|Adverse Event|6|||
48678146|NCT01331109|156673010|FG000|Overall Study|Lack of Efficacy|2|||
48678147|NCT01331109|156673010|FG000|Overall Study|Protocol Violation|3|||
48678148|NCT01331109|156673010|FG000|Overall Study|Withdrawal by Subject|7|||
48678149|NCT01331109|156673010|FG000|Overall Study|Lost to Follow-up|1|||
48678150|NCT01331109|156673010|FG000|Overall Study|Study Terminated by Sponsor|38|||
48678151|NCT00988091|156673014|FG000|Double-blind Period|Withdrawal by Subject|15|||
48678152|NCT00988091|156673015|FG001|Double-blind Period|Withdrawal by Subject|13|||
48678153|NCT00988091|156673014|FG000|Double-blind Period|Lost to Follow-up|12|||
48678154|NCT00988091|156673015|FG001|Double-blind Period|Lost to Follow-up|14|||
48678155|NCT00988091|156673014|FG000|Double-blind Period|Other|8|||
48678156|NCT00988091|156673015|FG001|Double-blind Period|Other|8|||
48678157|NCT00988091|156673014|FG000|Double-blind Period|Adverse Event|6|||
48678158|NCT00988091|156673015|FG001|Double-blind Period|Adverse Event|9|||
48678159|NCT00988091|156673014|FG000|Double-blind Period|Use of exclusionary medication|2|||
48678160|NCT00988091|156673015|FG001|Double-blind Period|Use of exclusionary medication|3|||
48678161|NCT00988091|156673014|FG000|Open-label Period|Adverse Event|4|||
48678162|NCT00988091|156673015|FG001|Open-label Period|Adverse Event|7|||
48678163|NCT00988091|156673014|FG000|Open-label Period|Use of exclusionary medication|1|||
48678164|NCT00988091|156673015|FG001|Open-label Period|Use of exclusionary medication|1|||
48678165|NCT00988091|156673014|FG000|Open-label Period|Protocol Violation|1|||
48678166|NCT00988091|156673015|FG001|Open-label Period|Protocol Violation|1|||
48678167|NCT00988091|156673014|FG000|Open-label Period|Withdrawal by Subject|10|||
48678168|NCT00988091|156673015|FG001|Open-label Period|Withdrawal by Subject|16|||
48678169|NCT00988091|156673014|FG000|Open-label Period|Lost to Follow-up|3|||
48678170|NCT00988091|156673015|FG001|Open-label Period|Lost to Follow-up|5|||
48678171|NCT00988091|156673014|FG000|Open-label Period|Other|2|||
48678172|NCT00988091|156673015|FG001|Open-label Period|Other|3|||
48678173|NCT01529034|156673016|FG000|Overall Study|Discontinued prior to study treatment|14|||
48678174|NCT01529034|156673016|FG000|Overall Study|Site closure|62|||
48678175|NCT01529034|156673016|FG000|Overall Study|Study termination|29|||
48678176|NCT01529034|156673016|FG000|Overall Study|Withdrawal by Subject|25|||
48762737|NCT03760146|156980323|FG000|Overall Study|Lost to Follow-up|41|||
48678177|NCT01529034|156673016|FG000|Overall Study|No treated SCs within protocol window|13|||
48678178|NCT01529034|156673016|FG000|Overall Study|Noncompliance|8|||
48678179|NCT01529034|156673016|FG000|Overall Study|Caregiver no longer available|7|||
48678180|NCT01529034|156673016|FG000|Overall Study|Adverse Event|4|||
48678181|NCT01529034|156673016|FG000|Overall Study|Protocol Violation|4|||
48678182|NCT01529034|156673016|FG000|Overall Study|Lack of Efficacy|4|||
48678183|NCT01529034|156673016|FG000|Overall Study|Investigator no longer available|2|||
48678184|NCT01529034|156673016|FG000|Overall Study|Study drug not available|2|||
48678185|NCT00770601|156673024|FG000|Overall Study|Withdrawal by Subject|1|||
48678186|NCT00532298|156673027|FG000|Overall Study|Adverse Event|1|||
48762738|NCT03760146|156980324|FG001|Overall Study|Lost to Follow-up|28|||
48762739|NCT03760146|156980325|FG002|Overall Study|Lost to Follow-up|9|||
49020233|NCT01884025|157910859|FG001|Overall Study|Lost to Follow-up|4|||
49020234|NCT00721409|157910866|FG000|Overall Study|Global deterioration of health status|2|||
49020235|NCT00721409|157910867|FG001|Overall Study|Global deterioration of health status|6|||
48762740|NCT03760146|156980326|FG003|Overall Study|Lost to Follow-up|2|||
49020236|NCT00721409|157910868|FG002|Overall Study|Global deterioration of health status|3|||
48678187|NCT00532298|156673028|FG001|Overall Study|Adverse Event|0|||
48678188|NCT00532298|156673029|FG002|Overall Study|Adverse Event|0|||
48678189|NCT00532298|156673030|FG003|Overall Study|Adverse Event|0|||
48678190|NCT00532298|156673031|FG004|Overall Study|Adverse Event|1|||
48678191|NCT00532298|156673032|FG005|Overall Study|Adverse Event|1|||
48678192|NCT00532298|156673027|FG000|Overall Study|Lost to Follow-up|1|||
48678193|NCT00532298|156673028|FG001|Overall Study|Lost to Follow-up|1|||
48678194|NCT00532298|156673029|FG002|Overall Study|Lost to Follow-up|1|||
49020237|NCT00721409|157910866|FG000|Overall Study|Death|0|||
48678195|NCT00532298|156673030|FG003|Overall Study|Lost to Follow-up|0|||
48678196|NCT00532298|156673031|FG004|Overall Study|Lost to Follow-up|0|||
48678197|NCT00532298|156673032|FG005|Overall Study|Lost to Follow-up|1|||
48678198|NCT00479856|156673033|FG000|Overall Study|Adverse Event|1|||
48678199|NCT00479856|156673033|FG000|Overall Study|Withdrawal by Subject|1|||
48678200|NCT00479856|156673033|FG000|Overall Study|Physician Decision|1|||
48678201|NCT00527904|156673037|FG000|Overall Study|Adverse Event|45|||
48678202|NCT00527904|156673037|FG000|Overall Study|Withdrawal by Subject|21|||
48678203|NCT00527904|156673037|FG000|Overall Study|Lost to Follow-up|8|||
48678204|NCT00527904|156673037|FG000|Overall Study|misc|22|||
48678205|NCT01339897|156673038|FG000|Overall Study|Adverse Event|1|||
48678206|NCT01339897|156673039|FG001|Overall Study|Adverse Event|0|||
48678207|NCT01339897|156673040|FG002|Overall Study|Adverse Event|0|||
48678208|NCT01339897|156673041|FG003|Overall Study|Adverse Event|1|||
48678209|NCT01832532|156673042|FG000|Overall Study|Withdrawal by Subject|5|||
48678210|NCT01832532|156673043|FG001|Overall Study|Withdrawal by Subject|2|||
48678211|NCT02006979|156673048|FG000|Overall Study|Withdrawal by Subject|1|||
48678212|NCT02006979|156673049|FG001|Overall Study|Withdrawal by Subject|1|||
48678213|NCT02006979|156673048|FG000|Overall Study|Protocol Violation|0|||
48678214|NCT02006979|156673049|FG001|Overall Study|Protocol Violation|1|||
48678215|NCT01546688|156673050|FG000|Overall Study|Adverse Event|0|||
48678216|NCT01546688|156673051|FG001|Overall Study|Adverse Event|4|||
48678217|NCT01546688|156673050|FG000|Overall Study|Withdrawal by Subject|2|||
48678218|NCT01546688|156673051|FG001|Overall Study|Withdrawal by Subject|1|||
48678219|NCT01546688|156673050|FG000|Overall Study|Lack of Efficacy|1|||
48678220|NCT01546688|156673051|FG001|Overall Study|Lack of Efficacy|0|||
48678221|NCT01445080|156673055|FG000|Overall Study|Adverse Event|5|||
48678222|NCT01445080|156673056|FG001|Overall Study|Adverse Event|3|||
48678223|NCT01445080|156673057|FG002|Overall Study|Adverse Event|11|||
48678224|NCT01445080|156673058|FG003|Overall Study|Adverse Event|6|||
48678225|NCT01445080|156673059|FG004|Overall Study|Adverse Event|2|||
48678226|NCT01445080|156673060|FG005|Overall Study|Adverse Event|3|||
48678227|NCT01445080|156673061|FG006|Overall Study|Adverse Event|0|||
48678228|NCT01445080|156673062|FG007|Overall Study|Adverse Event|3|||
48678229|NCT01445080|156673063|FG008|Overall Study|Adverse Event|10|||
48678230|NCT01445080|156673055|FG000|Overall Study|Physician Decision|0|||
48678231|NCT01445080|156673056|FG001|Overall Study|Physician Decision|0|||
48678232|NCT01445080|156673057|FG002|Overall Study|Physician Decision|1|||
48678233|NCT01445080|156673058|FG003|Overall Study|Physician Decision|0|||
48678234|NCT01445080|156673059|FG004|Overall Study|Physician Decision|0|||
48678235|NCT01445080|156673060|FG005|Overall Study|Physician Decision|3|||
48678236|NCT01445080|156673061|FG006|Overall Study|Physician Decision|2|||
48678237|NCT01445080|156673062|FG007|Overall Study|Physician Decision|2|||
48678238|NCT01445080|156673063|FG008|Overall Study|Physician Decision|0|||
48678239|NCT01445080|156673055|FG000|Overall Study|Withdrawal by Subject|1|||
48678240|NCT01445080|156673056|FG001|Overall Study|Withdrawal by Subject|0|||
48678241|NCT01445080|156673057|FG002|Overall Study|Withdrawal by Subject|0|||
48678242|NCT01445080|156673058|FG003|Overall Study|Withdrawal by Subject|1|||
48678243|NCT01445080|156673059|FG004|Overall Study|Withdrawal by Subject|0|||
48678244|NCT01445080|156673060|FG005|Overall Study|Withdrawal by Subject|0|||
48678245|NCT01445080|156673061|FG006|Overall Study|Withdrawal by Subject|0|||
48678246|NCT01445080|156673062|FG007|Overall Study|Withdrawal by Subject|0|||
48678247|NCT01445080|156673063|FG008|Overall Study|Withdrawal by Subject|2|||
48678248|NCT01445080|156673055|FG000|Overall Study|Ineligible/Inevaluable|1|||
48678249|NCT01445080|156673056|FG001|Overall Study|Ineligible/Inevaluable|2|||
48678250|NCT01445080|156673057|FG002|Overall Study|Ineligible/Inevaluable|0|||
48678251|NCT01445080|156673058|FG003|Overall Study|Ineligible/Inevaluable|1|||
48678252|NCT01445080|156673059|FG004|Overall Study|Ineligible/Inevaluable|2|||
48678253|NCT01445080|156673060|FG005|Overall Study|Ineligible/Inevaluable|3|||
48678254|NCT01445080|156673061|FG006|Overall Study|Ineligible/Inevaluable|0|||
48678255|NCT01445080|156673062|FG007|Overall Study|Ineligible/Inevaluable|0|||
48678256|NCT01445080|156673063|FG008|Overall Study|Ineligible/Inevaluable|6|||
48678257|NCT02069392|156673064|FG000|Overall Study|Withdrawal by Subject|4|||
48678258|NCT02069392|156673065|FG001|Overall Study|Withdrawal by Subject|2|||
48678259|NCT00869518|156673066|FG000|Overall Study|Lost to Follow-up|1|||
48762741|NCT03760146|156980327|FG004|Overall Study|Lost to Follow-up|14|||
48678260|NCT00869518|156673067|FG001|Overall Study|Lost to Follow-up|1|||
48678261|NCT02487030|156673068|FG000|Overall Study|Lack of Efficacy|2|||
48678262|NCT02487030|156673069|FG001|Overall Study|Lack of Efficacy|4|||
48678263|NCT02487030|156673070|FG002|Overall Study|Lack of Efficacy|1|||
48678264|NCT02487030|156673071|FG003|Overall Study|Lack of Efficacy|0|||
48678265|NCT02487030|156673072|FG004|Overall Study|Lack of Efficacy|1|||
48678266|NCT02487030|156673073|FG005|Overall Study|Lack of Efficacy|0|||
48678267|NCT02487030|156673074|FG006|Overall Study|Lack of Efficacy|0|||
48678268|NCT02487030|156673068|FG000|Overall Study|Lost to Follow-up|0|||
48678269|NCT02487030|156673069|FG001|Overall Study|Lost to Follow-up|0|||
48678270|NCT02487030|156673070|FG002|Overall Study|Lost to Follow-up|1|||
48762742|NCT03760146|156980328|FG005|Overall Study|Lost to Follow-up|8|||
48678271|NCT02487030|156673071|FG003|Overall Study|Lost to Follow-up|1|||
48678272|NCT02487030|156673072|FG004|Overall Study|Lost to Follow-up|0|||
48678273|NCT02487030|156673073|FG005|Overall Study|Lost to Follow-up|1|||
48678274|NCT02487030|156673074|FG006|Overall Study|Lost to Follow-up|0|||
48678275|NCT02487030|156673068|FG000|Overall Study|Adverse Event|0|||
48678276|NCT02487030|156673069|FG001|Overall Study|Adverse Event|0|||
48678277|NCT02487030|156673070|FG002|Overall Study|Adverse Event|0|||
48678278|NCT02487030|156673071|FG003|Overall Study|Adverse Event|1|||
48678279|NCT02487030|156673072|FG004|Overall Study|Adverse Event|0|||
48678280|NCT02487030|156673073|FG005|Overall Study|Adverse Event|0|||
48678281|NCT02487030|156673074|FG006|Overall Study|Adverse Event|0|||
48678282|NCT02487030|156673068|FG000|Overall Study|Death|0|||
48678283|NCT02487030|156673069|FG001|Overall Study|Death|0|||
48678284|NCT02487030|156673070|FG002|Overall Study|Death|0|||
48678285|NCT02487030|156673071|FG003|Overall Study|Death|0|||
48678286|NCT02487030|156673072|FG004|Overall Study|Death|1|||
48678287|NCT02487030|156673073|FG005|Overall Study|Death|0|||
48678288|NCT02487030|156673074|FG006|Overall Study|Death|0|||
48678289|NCT00983385|156673075|FG000|Observation Period|Not eligible to be dosed|20|||
48678290|NCT00983385|156673075|FG000|Observation Period|Not Evaluable due to Non Compliance|12|||
48678291|NCT02092025|156673076|FG000|Overall Study|Case Report Forms Uncollected|44|||
48678292|NCT02092025|156673076|FG000|Overall Study|Protocol Deviation|24|||
48678293|NCT04725500|156673077|FG000|Screening|Screen Failure|26|||
48678294|NCT04725500|156673077|FG000|Screening|Withdrawal by Subject|1|||
48678295|NCT04725500|156673077|FG000|2 Week Take Home|Screen Fail|5|||
48678296|NCT03228212|156673080|FG000|Period 1|Adverse Event|1|||
48678297|NCT03228212|156673081|FG001|Period 1|Adverse Event|0|||
48678298|NCT03228212|156673080|FG000|Period 1|no longer meets eligibility criteria|0|||
48678299|NCT03228212|156673081|FG001|Period 1|no longer meets eligibility criteria|1|||
48678300|NCT03228212|156673080|FG000|Period 2|Lost to Follow-up|1|||
48678301|NCT03228212|156673081|FG001|Period 2|Lost to Follow-up|0|||
48678302|NCT00934128|156673082|FG000|First Intervention (2 Hours)|Withdrawal by Subject|0|||
48678303|NCT00934128|156673083|FG001|First Intervention (2 Hours)|Withdrawal by Subject|1|||
48678304|NCT00934128|156673082|FG000|First Intervention (2 Hours)|Adverse Event|4|||
48678305|NCT00934128|156673083|FG001|First Intervention (2 Hours)|Adverse Event|1|||
48678306|NCT00934128|156673082|FG000|First Intervention (2 Hours)|Treatment Delivery Order Switched|1|||
48678307|NCT00934128|156673083|FG001|First Intervention (2 Hours)|Treatment Delivery Order Switched|0|||
48678308|NCT00934128|156673082|FG000|Washout Period (1 Hour)|Patient preference|1|||
48678309|NCT00934128|156673083|FG001|Washout Period (1 Hour)|Patient preference|3|||
48678310|NCT00934128|156673082|FG000|Washout Period (1 Hour)|Pain|1|||
48678311|NCT00934128|156673083|FG001|Washout Period (1 Hour)|Pain|0|||
48678312|NCT00934128|156673082|FG000|Washout Period (1 Hour)|Too tired|1|||
48678313|NCT00934128|156673083|FG001|Washout Period (1 Hour)|Too tired|0|||
48678314|NCT00934128|156673082|FG000|Washout Period (1 Hour)|Dyspnea too low to continue|4|||
48678315|NCT00934128|156673083|FG001|Washout Period (1 Hour)|Dyspnea too low to continue|2|||
48678316|NCT00934128|156673082|FG000|Second Intervention (2 Hours)|Claustrophobia/anxiety|0|||
48678317|NCT00934128|156673083|FG001|Second Intervention (2 Hours)|Claustrophobia/anxiety|3|||
48678318|NCT01357551|156674879|FG000|Overall Study|Withdrawal by Subject|6|||
48678319|NCT01357551|156674880|FG001|Overall Study|Withdrawal by Subject|4|||
48678320|NCT01357551|156674879|FG000|Overall Study|Death|0|||
48678321|NCT01357551|156674880|FG001|Overall Study|Death|1|||
48678322|NCT01357551|156674879|FG000|Overall Study|Lost to Follow-up|16|||
48678323|NCT01357551|156674880|FG001|Overall Study|Lost to Follow-up|6|||
48678324|NCT00858208|156674881|FG000|Overall Study|Adverse Event|3|||
48678325|NCT00858208|156674881|FG000|Overall Study|Lost to Follow-up|26|||
48678326|NCT00858208|156674881|FG000|Overall Study|Participant refused|40|||
48678327|NCT00858208|156674881|FG000|Overall Study|Other|10|||
48678328|NCT01272635|156674882|FG000|Overall Study|Lost to Follow-up|31|||
48678329|NCT01272635|156674883|FG001|Overall Study|Lost to Follow-up|20|||
48678330|NCT01272635|156674884|FG002|Overall Study|Lost to Follow-up|31|||
48678331|NCT01272635|156674885|FG003|Overall Study|Lost to Follow-up|23|||
48678332|NCT00891228|156674886|FG000|Overall Study|Adverse Event|0|||
48678333|NCT00891228|156674887|FG001|Overall Study|Adverse Event|2|||
48678334|NCT00891228|156674888|FG002|Overall Study|Adverse Event|3|||
48678335|NCT00891228|156674886|FG000|Overall Study|Withdrawal by Subject|2|||
48678336|NCT00891228|156674887|FG001|Overall Study|Withdrawal by Subject|4|||
48678337|NCT00891228|156674888|FG002|Overall Study|Withdrawal by Subject|5|||
48762743|NCT03760146|156980323|FG000|Overall Study|No longer met eligibility criteria|3|||
48762744|NCT03760146|156980324|FG001|Overall Study|No longer met eligibility criteria|9|||
48762745|NCT03760146|156980325|FG002|Overall Study|No longer met eligibility criteria|0|||
48678338|NCT00891228|156674886|FG000|Overall Study|Protocol Violation|3|||
48678339|NCT00891228|156674887|FG001|Overall Study|Protocol Violation|1|||
48678340|NCT00891228|156674888|FG002|Overall Study|Protocol Violation|2|||
48678341|NCT00891228|156674886|FG000|Overall Study|Physician Decision|2|||
48678342|NCT00891228|156674887|FG001|Overall Study|Physician Decision|1|||
48678343|NCT00891228|156674888|FG002|Overall Study|Physician Decision|0|||
48678344|NCT00891228|156674886|FG000|Overall Study|Lost to Follow-up|4|||
48678345|NCT00891228|156674887|FG001|Overall Study|Lost to Follow-up|4|||
48678346|NCT00891228|156674888|FG002|Overall Study|Lost to Follow-up|5|||
48678347|NCT00891228|156674886|FG000|Overall Study|Pregnancy|0|||
48678348|NCT00891228|156674887|FG001|Overall Study|Pregnancy|1|||
48678349|NCT00891228|156674888|FG002|Overall Study|Pregnancy|0|||
48678350|NCT02702180|156674889|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
48678351|NCT02702180|156674890|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
48678352|NCT02702180|156674891|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
48678353|NCT02702180|156674889|FG000|Double-blind Treatment Period|Adverse Event|0|||
48678354|NCT02702180|156674890|FG001|Double-blind Treatment Period|Adverse Event|0|||
48678355|NCT02702180|156674891|FG002|Double-blind Treatment Period|Adverse Event|1|||
48678356|NCT02702180|156674889|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
48678357|NCT02702180|156674890|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
48678358|NCT02702180|156674891|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
48678359|NCT02702180|156674889|FG000|Double-blind Treatment Period|Protocol Violation|0|||
48678360|NCT02702180|156674890|FG001|Double-blind Treatment Period|Protocol Violation|0|||
48678361|NCT02702180|156674891|FG002|Double-blind Treatment Period|Protocol Violation|2|||
48678362|NCT02702180|156674889|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
48678363|NCT02702180|156674890|FG001|Open-label Treatment Period|Withdrawal by Subject|1|||
48678364|NCT02702180|156674891|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
48678365|NCT02702180|156674889|FG000|Open-label Treatment Period|Withdrawn in error|0|||
48678366|NCT02702180|156674890|FG001|Open-label Treatment Period|Withdrawn in error|0|||
48678367|NCT02702180|156674891|FG002|Open-label Treatment Period|Withdrawn in error|1|||
48678368|NCT01832155|156674892|FG000|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1|||
48678369|NCT01832155|156674893|FG001|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0|||
48678370|NCT01832155|156674892|FG000|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1|||
48678371|NCT01832155|156674893|FG001|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0|||
48678372|NCT04395690|156674894|FG000|Overall Study|Lost to Follow-up|1|||
48678373|NCT04395690|156674895|FG001|Overall Study|Lost to Follow-up|1|||
48678374|NCT01279616|156674896|FG000|Overall Study|donor could not be located|5|||
48678375|NCT01279616|156674896|FG000|Overall Study|no signs of sickle cell disease|2|||
48678376|NCT01934010|156674897|FG000|Overall Study|Adverse Event|1|||
48678377|NCT01934010|156674898|FG001|Overall Study|Adverse Event|1|||
48678378|NCT01934010|156674899|FG002|Overall Study|Adverse Event|0|||
48678379|NCT01934010|156674897|FG000|Overall Study|Withdrawal by Subject|15|||
48678380|NCT01934010|156674898|FG001|Overall Study|Withdrawal by Subject|6|||
48678381|NCT01934010|156674899|FG002|Overall Study|Withdrawal by Subject|2|||
48678382|NCT01934010|156674897|FG000|Overall Study|Lost to Follow-up|7|||
48678383|NCT01934010|156674898|FG001|Overall Study|Lost to Follow-up|4|||
48678384|NCT01934010|156674899|FG002|Overall Study|Lost to Follow-up|0|||
48678385|NCT03386487|156674900|FG000|Overall Study|Lost to Follow-up|5|||
48678386|NCT03386487|156674901|FG001|Overall Study|Lost to Follow-up|6|||
48678387|NCT03386487|156674900|FG000|Overall Study|Withdrawal by Subject|11|||
48678388|NCT03386487|156674901|FG001|Overall Study|Withdrawal by Subject|7|||
48678389|NCT03386487|156674900|FG000|Overall Study|Physician Decision|11|||
48678390|NCT03386487|156674901|FG001|Overall Study|Physician Decision|8|||
48678391|NCT02141360|156674904|FG000|Overall Study|Withdrawal by Subject|6|||
48678392|NCT02141360|156674905|FG001|Overall Study|Withdrawal by Subject|0|||
48678393|NCT02141360|156674906|FG002|Overall Study|Withdrawal by Subject|0|||
48678394|NCT02141360|156674904|FG000|Overall Study|Study Terminated before Visit|1|||
48678395|NCT02141360|156674905|FG001|Overall Study|Study Terminated before Visit|0|||
48678396|NCT02141360|156674906|FG002|Overall Study|Study Terminated before Visit|0|||
48678397|NCT01702246|156674907|FG000|Overall Study|Lost to Follow-up|2|||
48678398|NCT01702246|156674907|FG000|Overall Study|Withdrawal by Subject|2|||
48678399|NCT01702246|156674907|FG000|Overall Study|Physician Decision|1|||
48678400|NCT04856904|156674915|FG000|Overall Study|Physician Decision|1|||
48678401|NCT04856904|156674916|FG001|Overall Study|Physician Decision|1|||
48678402|NCT04856904|156674915|FG000|Overall Study|Withdrawal by Subject|13|||
48678403|NCT04856904|156674916|FG001|Overall Study|Withdrawal by Subject|13|||
48762746|NCT03760146|156980326|FG003|Overall Study|No longer met eligibility criteria|0|||
48762747|NCT03760146|156980327|FG004|Overall Study|No longer met eligibility criteria|1|||
48762748|NCT03760146|156980328|FG005|Overall Study|No longer met eligibility criteria|0|||
48762749|NCT03760146|156980323|FG000|Overall Study|Protocol Violation|21|||
48762750|NCT03760146|156980324|FG001|Overall Study|Protocol Violation|13|||
48762751|NCT03760146|156980325|FG002|Overall Study|Protocol Violation|1|||
48678404|NCT04856904|156674915|FG000|Overall Study|Adverse Event|1|||
48678405|NCT04856904|156674916|FG001|Overall Study|Adverse Event|1|||
48678406|NCT04856904|156674915|FG000|Overall Study|Non-compliance with study drug|1|||
48678407|NCT04856904|156674916|FG001|Overall Study|Non-compliance with study drug|1|||
48678408|NCT04856904|156674915|FG000|Overall Study|Lost to Follow-up|4|||
48762752|NCT03760146|156980326|FG003|Overall Study|Protocol Violation|0|||
48762753|NCT03760146|156980327|FG004|Overall Study|Protocol Violation|1|||
48762754|NCT03760146|156980328|FG005|Overall Study|Protocol Violation|0|||
48678409|NCT04856904|156674916|FG001|Overall Study|Lost to Follow-up|4|||
48678410|NCT04856904|156674915|FG000|Overall Study|Withdrawal by Subject|1|||
48678411|NCT04856904|156674916|FG001|Overall Study|Withdrawal by Subject|1|||
48678412|NCT04856904|156674915|FG000|Overall Study|Protocol Violation|1|||
48678413|NCT04856904|156674916|FG001|Overall Study|Protocol Violation|1|||
48678414|NCT04896593|156674923|FG000|Overall Study|Withdrawal by Subject|2|||
48678415|NCT04896593|156674923|FG000|Overall Study|Lost to Follow-up|1|||
48678416|NCT04896593|156674923|FG000|Overall Study|Did not complete onboarding|2|||
48678417|NCT02915978|156674924|FG000|Overall Study|Adverse Event|2|||
48678418|NCT02915978|156674925|FG001|Overall Study|Adverse Event|1|||
48678419|NCT02915978|156674926|FG002|Overall Study|Adverse Event|0|||
48678420|NCT02777827|156674927|FG000|Washout Between Periods 3 and 4|Protocol Violation|0|||
48678421|NCT02777827|156674928|FG001|Washout Between Periods 3 and 4|Protocol Violation|0|||
48678422|NCT02777827|156674929|FG002|Washout Between Periods 3 and 4|Protocol Violation|1|||
48678423|NCT02777827|156674930|FG003|Washout Between Periods 3 and 4|Protocol Violation|0|||
48678424|NCT02777827|156674931|FG004|Washout Between Periods 3 and 4|Protocol Violation|0|||
48678425|NCT02777827|156674932|FG005|Washout Between Periods 3 and 4|Protocol Violation|0|||
48678426|NCT00924443|156674936|FG000|Overall Study|Physician Decision|2|||
48678427|NCT00924443|156674936|FG000|Overall Study|Protocol Violation|1|||
48678428|NCT01846741|156674941|FG000|Baseline Visit|Subject did not meet entry criteria|2|||
48678429|NCT01853878|156674942|FG000|Overall Study|Recurrence|2|||
48678430|NCT01853878|156674943|FG001|Overall Study|Recurrence|0|||
48678431|NCT01853878|156674942|FG000|Overall Study|Adverse Event|2|||
48678432|NCT01853878|156674943|FG001|Overall Study|Adverse Event|0|||
48678433|NCT01853878|156674942|FG000|Overall Study|Withdrawal by Subject|3|||
48678434|NCT01853878|156674943|FG001|Overall Study|Withdrawal by Subject|1|||
48678435|NCT01853878|156674942|FG000|Overall Study|Migrated/moved from the study area|1|||
48678436|NCT01853878|156674943|FG001|Overall Study|Migrated/moved from the study area|0|||
48678437|NCT01853878|156674942|FG000|Overall Study|Other|55|||
48678438|NCT01853878|156674943|FG001|Overall Study|Other|43|||
48678439|NCT01361178|156674944|FG000|Overall Study|Death|13|||
48678440|NCT01361178|156674945|FG001|Overall Study|Death|0|||
48678441|NCT00767819|156674946|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
48678442|NCT00767819|156674947|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
48678443|NCT00767819|156674948|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
48678444|NCT00767819|156674946|FG000|Overall Study|Withdrawal by Subject|1|||
48678445|NCT00767819|156674947|FG001|Overall Study|Withdrawal by Subject|1|||
48678446|NCT00767819|156674948|FG002|Overall Study|Withdrawal by Subject|0|||
48678447|NCT00767819|156674946|FG000|Overall Study|Administrative problems|0|||
48678448|NCT00767819|156674947|FG001|Overall Study|Administrative problems|1|||
48678449|NCT00767819|156674948|FG002|Overall Study|Administrative problems|0|||
48678450|NCT00767819|156674946|FG000|Overall Study|Death|2|||
48678451|NCT00767819|156674947|FG001|Overall Study|Death|3|||
48678452|NCT00767819|156674948|FG002|Overall Study|Death|0|||
48678453|NCT00767819|156674946|FG000|Overall Study|Adverse Event|2|||
48678454|NCT00767819|156674947|FG001|Overall Study|Adverse Event|0|||
48678455|NCT00767819|156674948|FG002|Overall Study|Adverse Event|0|||
48678456|NCT00767819|156674946|FG000|Overall Study|Abnormal lab values|1|||
48678457|NCT00767819|156674947|FG001|Overall Study|Abnormal lab values|0|||
48678458|NCT00767819|156674948|FG002|Overall Study|Abnormal lab values|0|||
48678459|NCT00767819|156674946|FG000|Overall Study|Lost to Follow-up|1|||
48678460|NCT00767819|156674947|FG001|Overall Study|Lost to Follow-up|0|||
48678461|NCT00767819|156674948|FG002|Overall Study|Lost to Follow-up|0|||
48678462|NCT01090063|156674952|FG000|Screen|Screen Failed|4|||
48678463|NCT01090063|156674952|FG000|Treatment|Withdrawal by Subject|4|||
48678464|NCT01496846|156674957|FG000|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
48678465|NCT01496846|156674958|FG001|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
48678466|NCT01496846|156674959|FG002|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
48678467|NCT01496846|156674960|FG003|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
48678468|NCT01496846|156674961|FG004|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
48875006|NCT04969276|157379021|FG001|Overall Study|Protocol Deviation|1|||
48875007|NCT04969276|157379022|FG002|Overall Study|Protocol Deviation|0|||
48678469|NCT01496846|156674962|FG005|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
48678470|NCT02863328|156674970|FG000|Overall Study|Lost to Follow-up|4|||
48678471|NCT02863328|156674971|FG001|Overall Study|Lost to Follow-up|10|||
48875008|NCT04969276|157379020|FG000|Overall Study|Withdrawal by Subject|1|||
48678472|NCT02863328|156674970|FG000|Overall Study|Withdrawal by Subject|7|||
48678473|NCT02863328|156674971|FG001|Overall Study|Withdrawal by Subject|12|||
48678474|NCT02863328|156674970|FG000|Overall Study|Died|0|||
48678475|NCT02863328|156674971|FG001|Overall Study|Died|1|||
48678476|NCT00699660|156674972|FG000|Overall Study|Lost to Follow-up|4|||
48678477|NCT00699660|156674973|FG001|Overall Study|Lost to Follow-up|2|||
48678478|NCT00699660|156674972|FG000|Overall Study|missing reports and recording failures|10|||
48678479|NCT00699660|156674973|FG001|Overall Study|missing reports and recording failures|6|||
48678480|NCT01196416|156674974|FG000|Overall Study|Withdrawal by Subject|2|||
48678481|NCT00064792|156674976|FG000|Overall Study|Withdrawal by Subject|2|||
48678482|NCT00064792|156674977|FG001|Overall Study|Withdrawal by Subject|0|||
48678483|NCT00064792|156674976|FG000|Overall Study|Adverse Event|3|||
48678484|NCT00064792|156674977|FG001|Overall Study|Adverse Event|0|||
48678485|NCT01870726|156674978|FG000|Overall Study|Withdrawal of informed consent|0|||
49020238|NCT00721409|157910867|FG001|Overall Study|Death|1|||
48678486|NCT01870726|156674979|FG001|Overall Study|Withdrawal of informed consent|0|||
48678487|NCT01870726|156674980|FG002|Overall Study|Withdrawal of informed consent|0|||
48678488|NCT01870726|156674981|FG003|Overall Study|Withdrawal of informed consent|1|||
48678489|NCT01870726|156674982|FG004|Overall Study|Withdrawal of informed consent|0|||
48678490|NCT01870726|156674983|FG005|Overall Study|Withdrawal of informed consent|0|||
48678491|NCT01870726|156674984|FG006|Overall Study|Withdrawal of informed consent|0|||
48678492|NCT01870726|156674978|FG000|Overall Study|Withdrawal by Subject|0|||
48678493|NCT01870726|156674979|FG001|Overall Study|Withdrawal by Subject|1|||
48678494|NCT01870726|156674980|FG002|Overall Study|Withdrawal by Subject|0|||
48678495|NCT01870726|156674981|FG003|Overall Study|Withdrawal by Subject|0|||
48678496|NCT01870726|156674982|FG004|Overall Study|Withdrawal by Subject|0|||
48678497|NCT01870726|156674983|FG005|Overall Study|Withdrawal by Subject|0|||
48678498|NCT01870726|156674984|FG006|Overall Study|Withdrawal by Subject|0|||
48678499|NCT01870726|156674978|FG000|Overall Study|Adverse Event|0|||
48678500|NCT01870726|156674979|FG001|Overall Study|Adverse Event|0|||
48678501|NCT01870726|156674980|FG002|Overall Study|Adverse Event|0|||
48678502|NCT01870726|156674981|FG003|Overall Study|Adverse Event|0|||
48678503|NCT01870726|156674982|FG004|Overall Study|Adverse Event|1|||
48678504|NCT01870726|156674983|FG005|Overall Study|Adverse Event|1|||
48678505|NCT01870726|156674984|FG006|Overall Study|Adverse Event|0|||
48678506|NCT01870726|156674978|FG000|Overall Study|Progressive disease|5|||
48678507|NCT01870726|156674979|FG001|Overall Study|Progressive disease|5|||
48678508|NCT01870726|156674980|FG002|Overall Study|Progressive disease|4|||
48678509|NCT01870726|156674981|FG003|Overall Study|Progressive disease|5|||
48678510|NCT01870726|156674982|FG004|Overall Study|Progressive disease|6|||
48678511|NCT01870726|156674983|FG005|Overall Study|Progressive disease|4|||
48678512|NCT01870726|156674984|FG006|Overall Study|Progressive disease|10|||
48678513|NCT01248949|156674988|FG000|Overall Study|Lost to Follow-up|2|||
48678514|NCT01248949|156674989|FG001|Overall Study|Lost to Follow-up|2|||
48678515|NCT01248949|156674990|FG002|Overall Study|Lost to Follow-up|2|||
48678516|NCT01248949|156674991|FG003|Overall Study|Lost to Follow-up|1|||
48678517|NCT01248949|156674992|FG004|Overall Study|Lost to Follow-up|0|||
48678518|NCT01248949|156674988|FG000|Overall Study|Withdrawal by Subject|5|||
48678519|NCT01248949|156674989|FG001|Overall Study|Withdrawal by Subject|3|||
48678520|NCT01248949|156674990|FG002|Overall Study|Withdrawal by Subject|11|||
48678521|NCT01248949|156674991|FG003|Overall Study|Withdrawal by Subject|3|||
48678522|NCT01248949|156674992|FG004|Overall Study|Withdrawal by Subject|1|||
48678523|NCT01248949|156674988|FG000|Overall Study|Death|22|||
49020239|NCT00721409|157910868|FG002|Overall Study|Death|0|||
49020240|NCT00721409|157910866|FG000|Overall Study|Randomized not Treated|0|||
49020241|NCT00721409|157910867|FG001|Overall Study|Randomized not Treated|1|||
49020242|NCT00721409|157910868|FG002|Overall Study|Randomized not Treated|4|||
49020243|NCT00721409|157910866|FG000|Overall Study|Reason not specified|1|||
49020244|NCT00721409|157910867|FG001|Overall Study|Reason not specified|0|||
49020245|NCT00721409|157910868|FG002|Overall Study|Reason not specified|2|||
49020246|NCT00721409|157910866|FG000|Overall Study|Adverse Event|0|||
49020247|NCT00721409|157910867|FG001|Overall Study|Adverse Event|13|||
49020248|NCT00721409|157910868|FG002|Overall Study|Adverse Event|2|||
49020249|NCT00721409|157910866|FG000|Overall Study|Lost to Follow-up|0|||
49020250|NCT00721409|157910867|FG001|Overall Study|Lost to Follow-up|0|||
48678524|NCT01248949|156674989|FG001|Overall Study|Death|7|||
48678525|NCT01248949|156674990|FG002|Overall Study|Death|21|||
48678526|NCT01248949|156674991|FG003|Overall Study|Death|6|||
48678527|NCT01248949|156674992|FG004|Overall Study|Death|2|||
48678528|NCT01248949|156674988|FG000|Overall Study|Alternative Therapy|1|||
49020251|NCT00721409|157910868|FG002|Overall Study|Lost to Follow-up|1|||
49020252|NCT00721409|157910866|FG000|Overall Study|Withdrawal by Subject|1|||
49020253|NCT00721409|157910867|FG001|Overall Study|Withdrawal by Subject|6|||
49020254|NCT00721409|157910868|FG002|Overall Study|Withdrawal by Subject|5|||
49020255|NCT00721409|157910866|FG000|Overall Study|Objective progression or relapse|8|||
49020256|NCT00721409|157910867|FG001|Overall Study|Objective progression or relapse|55|||
48678529|NCT01248949|156674989|FG001|Overall Study|Alternative Therapy|0|||
48678530|NCT01248949|156674990|FG002|Overall Study|Alternative Therapy|0|||
48678531|NCT01248949|156674991|FG003|Overall Study|Alternative Therapy|0|||
48678532|NCT01248949|156674992|FG004|Overall Study|Alternative Therapy|0|||
48678533|NCT01248949|156674988|FG000|Overall Study|Alternative Therapy.|1|||
48678534|NCT01248949|156674989|FG001|Overall Study|Alternative Therapy.|0|||
48678535|NCT01248949|156674990|FG002|Overall Study|Alternative Therapy.|0|||
48678536|NCT01248949|156674991|FG003|Overall Study|Alternative Therapy.|0|||
48678537|NCT01248949|156674992|FG004|Overall Study|Alternative Therapy.|0|||
48678538|NCT01248949|156674988|FG000|Overall Study|Palliative Radiation To Brain Metastases|1|||
48678539|NCT01248949|156674989|FG001|Overall Study|Palliative Radiation To Brain Metastases|0|||
48678540|NCT01248949|156674990|FG002|Overall Study|Palliative Radiation To Brain Metastases|0|||
48678541|NCT01248949|156674991|FG003|Overall Study|Palliative Radiation To Brain Metastases|0|||
48678542|NCT01248949|156674992|FG004|Overall Study|Palliative Radiation To Brain Metastases|0|||
48678543|NCT01248949|156674988|FG000|Overall Study|Entered Hospice And Refused Follow Up|0|||
48678544|NCT01248949|156674989|FG001|Overall Study|Entered Hospice And Refused Follow Up|0|||
48678545|NCT01248949|156674990|FG002|Overall Study|Entered Hospice And Refused Follow Up|0|||
48678546|NCT01248949|156674991|FG003|Overall Study|Entered Hospice And Refused Follow Up|0|||
48678547|NCT01248949|156674992|FG004|Overall Study|Entered Hospice And Refused Follow Up|1|||
48678548|NCT01248949|156674988|FG000|Overall Study|Participant Went To Hospice|0|||
48678549|NCT01248949|156674989|FG001|Overall Study|Participant Went To Hospice|0|||
48678550|NCT01248949|156674990|FG002|Overall Study|Participant Went To Hospice|1|||
48762755|NCT03760146|156980323|FG000|Overall Study|Withdrawal by Subject|19|||
48678551|NCT01248949|156674991|FG003|Overall Study|Participant Went To Hospice|0|||
48678552|NCT01248949|156674992|FG004|Overall Study|Participant Went To Hospice|0|||
48762756|NCT03760146|156980324|FG001|Overall Study|Withdrawal by Subject|20|||
49020257|NCT00721409|157910868|FG002|Overall Study|Objective progression or relapse|62|||
49020258|NCT00368966|157910869|FG000|Infant Series|Withdrawal by Subject|11|||
49020259|NCT00368966|157910870|FG001|Infant Series|Withdrawal by Subject|6|||
49020260|NCT00368966|157910869|FG000|Infant Series|Protocol Violation|2|||
49020261|NCT00368966|157910870|FG001|Infant Series|Protocol Violation|1|||
49020262|NCT00368966|157910869|FG000|Infant Series|Lost to Follow-up|2|||
49020263|NCT00368966|157910870|FG001|Infant Series|Lost to Follow-up|0|||
49020264|NCT00368966|157910869|FG000|Infant Series|Randomization error|0|||
49020265|NCT00368966|157910870|FG001|Infant Series|Randomization error|1|||
49020266|NCT00368966|157910869|FG000|Infant Series|Failed to meet eligibility criteria|0|||
49020267|NCT00368966|157910870|FG001|Infant Series|Failed to meet eligibility criteria|1|||
49020268|NCT00368966|157910869|FG000|Infant Series|Adverse Event|0|||
49020269|NCT00368966|157910870|FG001|Infant Series|Adverse Event|1|||
49020270|NCT00368966|157910869|FG000|Infant Series|Failed to return|1|||
49020271|NCT00368966|157910870|FG001|Infant Series|Failed to return|0|||
49020272|NCT00368966|157910869|FG000|After Infant|Failed to return|3|||
49020273|NCT00368966|157910870|FG001|After Infant|Failed to return|1|||
49020274|NCT00368966|157910869|FG000|After Infant|Adverse Event|1|||
49020275|NCT00368966|157910870|FG001|After Infant|Adverse Event|2|||
49020276|NCT00368966|157910869|FG000|After Infant|Withdrawal by Subject|1|||
49020277|NCT00368966|157910870|FG001|After Infant|Withdrawal by Subject|1|||
49020278|NCT00368966|157910869|FG000|After Infant|Death|1|||
49020279|NCT00368966|157910870|FG001|After Infant|Death|0|||
49020280|NCT00368966|157910869|FG000|After Infant|Lost to Follow-up|0|||
49020281|NCT00368966|157910870|FG001|After Infant|Lost to Follow-up|1|||
49020282|NCT00368966|157910869|FG000|Toddler Dose|Withdrawal by Subject|1|||
49020283|NCT00368966|157910870|FG001|Toddler Dose|Withdrawal by Subject|1|||
49020284|NCT00368966|157910869|FG000|Toddler Dose|Lost to Follow-up|0|||
49020285|NCT00368966|157910870|FG001|Toddler Dose|Lost to Follow-up|2|||
49020286|NCT01901055|157910875|FG000|Randomization But Not Titrated|Did not come to titration study|1|||
49020287|NCT01901055|157910876|FG001|Randomization But Not Titrated|Did not come to titration study|1|||
49020288|NCT01901055|157910875|FG000|Randomization But Not Titrated|Physician Decision|0|||
49020289|NCT01901055|157910876|FG001|Randomization But Not Titrated|Physician Decision|1|||
49020290|NCT01901055|157910875|FG000|Started Protocol to Week 6|Physician Decision|2|||
49020291|NCT01901055|157910876|FG001|Started Protocol to Week 6|Physician Decision|1|||
49020292|NCT01901055|157910875|FG000|Started Protocol to Week 6|complains of difficulty with wearing mask|0|||
49020293|NCT01901055|157910876|FG001|Started Protocol to Week 6|complains of difficulty with wearing mask|2|||
48678553|NCT01248949|156674988|FG000|Overall Study|Per Sponsor Request o Discontinue Drug|1|||
48678554|NCT01248949|156674989|FG001|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
48762757|NCT03760146|156980325|FG002|Overall Study|Withdrawal by Subject|1|||
48762758|NCT03760146|156980326|FG003|Overall Study|Withdrawal by Subject|0|||
49020294|NCT01901055|157910875|FG000|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1|||
49020295|NCT01901055|157910876|FG001|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0|||
49020296|NCT01901055|157910875|FG000|Started Protocol to Week 6|Withdrawal by Subject|0|||
49020297|NCT01901055|157910876|FG001|Started Protocol to Week 6|Withdrawal by Subject|1|||
49020298|NCT01901055|157910875|FG000|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1|||
49020299|NCT01901055|157910876|FG001|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0|||
49020300|NCT01901055|157910875|FG000|Week 12 Assessment|Withdrawal by Subject|0|||
49020301|NCT01901055|157910876|FG001|Week 12 Assessment|Withdrawal by Subject|4|||
49020302|NCT01901055|157910875|FG000|Week 24|Withdrawal by Subject|13|||
49020303|NCT01901055|157910876|FG001|Week 24|Withdrawal by Subject|19|||
49020304|NCT01901055|157910875|FG000|Week 24|Physician Decision|1|||
49020305|NCT01901055|157910876|FG001|Week 24|Physician Decision|0|||
49020306|NCT01901055|157910875|FG000|Week 36|Withdrawal by Subject|0|||
48762759|NCT03760146|156980327|FG004|Overall Study|Withdrawal by Subject|1|||
48762760|NCT03760146|156980328|FG005|Overall Study|Withdrawal by Subject|0|||
48762761|NCT03745144|156980330|FG000|Run-in-Period (Day 0 to Day 28)|Other|4|||
48762762|NCT03745144|156980331|FG001|Run-in-Period (Day 0 to Day 28)|Other|0|||
48762763|NCT03745144|156980332|FG002|Run-in-Period (Day 0 to Day 28)|Other|0|||
48678555|NCT01248949|156674990|FG002|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
48678556|NCT01248949|156674991|FG003|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
48678557|NCT01248949|156674992|FG004|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
48678558|NCT01248949|156674988|FG000|Overall Study|Pi Decision Due To Declining Status|0|||
48678559|NCT01248949|156674989|FG001|Overall Study|Pi Decision Due To Declining Status|0|||
48678560|NCT01248949|156674990|FG002|Overall Study|Pi Decision Due To Declining Status|1|||
48678561|NCT01248949|156674991|FG003|Overall Study|Pi Decision Due To Declining Status|0|||
48678562|NCT01248949|156674992|FG004|Overall Study|Pi Decision Due To Declining Status|0|||
48678563|NCT01248949|156674988|FG000|Overall Study|Pi Discretion Due To Hospitalisation|0|||
48678564|NCT01248949|156674989|FG001|Overall Study|Pi Discretion Due To Hospitalisation|1|||
48678565|NCT01248949|156674990|FG002|Overall Study|Pi Discretion Due To Hospitalisation|0|||
48678566|NCT01248949|156674991|FG003|Overall Study|Pi Discretion Due To Hospitalisation|0|||
48678567|NCT01248949|156674992|FG004|Overall Study|Pi Discretion Due To Hospitalisation|0|||
48678568|NCT01248949|156674988|FG000|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
48678569|NCT01248949|156674989|FG001|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
48678570|NCT01248949|156674990|FG002|Overall Study|Lesion In ThoracicSpine Requires Therapy|1|||
48678571|NCT01248949|156674991|FG003|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
48678572|NCT01248949|156674992|FG004|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
48678573|NCT00379912|156674993|FG000|Overall Study|Lack of Efficacy|1|||
48678574|NCT00379912|156674994|FG001|Overall Study|Lack of Efficacy|0|||
48678575|NCT01128946|156674995|FG000|Period I|Protocol Violation|0|||
48678576|NCT01128946|156674996|FG001|Period I|Protocol Violation|1|||
48678577|NCT01128946|156674997|FG002|Period I|Protocol Violation|0|||
48678578|NCT01128946|156674998|FG003|Period I|Protocol Violation|0|||
48678579|NCT01128946|156674995|FG000|Period I|Withdrawal by Subject|0|||
48678580|NCT01128946|156674996|FG001|Period I|Withdrawal by Subject|0|||
48678581|NCT01128946|156674997|FG002|Period I|Withdrawal by Subject|1|||
48678582|NCT01128946|156674998|FG003|Period I|Withdrawal by Subject|1|||
48678583|NCT01128946|156674995|FG000|Period II|Protocol Violation|0|||
48678584|NCT01128946|156674996|FG001|Period II|Protocol Violation|1|||
48678585|NCT01128946|156674997|FG002|Period II|Protocol Violation|0|||
48678586|NCT01128946|156674998|FG003|Period II|Protocol Violation|0|||
48678587|NCT01128946|156674995|FG000|Period II|Withdrawal by Subject|0|||
48678588|NCT01128946|156674996|FG001|Period II|Withdrawal by Subject|0|||
48678589|NCT01128946|156674997|FG002|Period II|Withdrawal by Subject|0|||
48678590|NCT01128946|156674998|FG003|Period II|Withdrawal by Subject|1|||
48678591|NCT01128946|156674995|FG000|Period III|Protocol Violation|1|||
48678592|NCT01128946|156674996|FG001|Period III|Protocol Violation|0|||
48678593|NCT01128946|156674997|FG002|Period III|Protocol Violation|0|||
48678594|NCT01128946|156674998|FG003|Period III|Protocol Violation|0|||
48678595|NCT04698993|156674999|FG000|Overall Study|PCR results not accessible|2|||
48678596|NCT04698993|156675000|FG001|Overall Study|PCR results not accessible|7|||
48678597|NCT04698993|156674999|FG000|Overall Study|incomplete documentation of kit assessment prior to testing|1|||
48678598|NCT04698993|156675000|FG001|Overall Study|incomplete documentation of kit assessment prior to testing|0|||
48678599|NCT00145574|156675001|FG000|Double Blind|Adverse Event|0|||
48678600|NCT00145574|156675002|FG001|Double Blind|Adverse Event|3|||
48678601|NCT00145574|156675003|FG002|Double Blind|Adverse Event|1|||
48678602|NCT00145574|156675001|FG000|Double Blind|Withdrawal by Subject|1|||
48678603|NCT00145574|156675002|FG001|Double Blind|Withdrawal by Subject|1|||
48678604|NCT00145574|156675003|FG002|Double Blind|Withdrawal by Subject|1|||
48678605|NCT00145574|156675001|FG000|Double Blind|required restricted medicine|0|||
48678606|NCT00145574|156675002|FG001|Double Blind|required restricted medicine|1|||
48678607|NCT00145574|156675003|FG002|Double Blind|required restricted medicine|0|||
48678608|NCT00145574|156675001|FG000|Open Label Long-term Extension|Adverse Event|0|||
48678609|NCT00145574|156675002|FG001|Open Label Long-term Extension|Adverse Event|0|||
48678610|NCT00145574|156675003|FG002|Open Label Long-term Extension|Adverse Event|5|||
48678611|NCT00145574|156675001|FG000|Open Label Long-term Extension|Lost to Follow-up|0|||
48678612|NCT00145574|156675002|FG001|Open Label Long-term Extension|Lost to Follow-up|0|||
48678613|NCT00145574|156675003|FG002|Open Label Long-term Extension|Lost to Follow-up|1|||
48762764|NCT03745144|156980330|FG000|Period 1|Other|0|||
48762765|NCT03745144|156980331|FG001|Period 1|Other|0|||
48678614|NCT00145574|156675001|FG000|Open Label Long-term Extension|Withdrawal by Subject|0|||
48678615|NCT00145574|156675002|FG001|Open Label Long-term Extension|Withdrawal by Subject|0|||
48678616|NCT00145574|156675003|FG002|Open Label Long-term Extension|Withdrawal by Subject|4|||
48678617|NCT00145574|156675001|FG000|Open Label Long-term Extension|required restricted medicine|0|||
48678618|NCT00145574|156675002|FG001|Open Label Long-term Extension|required restricted medicine|0|||
48678619|NCT00145574|156675003|FG002|Open Label Long-term Extension|required restricted medicine|1|||
48678620|NCT00206440|156675004|FG000|Overall Study|Protocol Violation|1|||
48678621|NCT00206440|156675005|FG001|Overall Study|Protocol Violation|2|||
48678622|NCT00206440|156675004|FG000|Overall Study|Adverse Event|4|||
48678623|NCT00206440|156675005|FG001|Overall Study|Adverse Event|2|||
48678624|NCT00595478|156675011|FG000|36-week Follow-up Period|Lost to Follow-up|5|||
48678625|NCT00595478|156675012|FG001|36-week Follow-up Period|Lost to Follow-up|4|||
48678626|NCT00595478|156675011|FG000|36-week Follow-up Period|Withdrawal by Subject|4|||
48678627|NCT00595478|156675012|FG001|36-week Follow-up Period|Withdrawal by Subject|4|||
48678628|NCT00348309|156675013|FG000|Overall Study|Adverse Event|56|||
48678629|NCT00348309|156675014|FG001|Overall Study|Adverse Event|28|||
48678630|NCT00348309|156675015|FG002|Overall Study|Adverse Event|63|||
48678631|NCT00348309|156675013|FG000|Overall Study|Lost to Follow-up|6|||
48678632|NCT00348309|156675014|FG001|Overall Study|Lost to Follow-up|7|||
48678633|NCT00348309|156675015|FG002|Overall Study|Lost to Follow-up|4|||
48678634|NCT00348309|156675013|FG000|Overall Study|Protocol Violation|7|||
48678635|NCT00348309|156675014|FG001|Overall Study|Protocol Violation|12|||
48678636|NCT00348309|156675015|FG002|Overall Study|Protocol Violation|7|||
48678637|NCT00348309|156675013|FG000|Overall Study|Withdrawal by Subject|33|||
48678638|NCT00348309|156675014|FG001|Overall Study|Withdrawal by Subject|37|||
48678639|NCT00348309|156675015|FG002|Overall Study|Withdrawal by Subject|40|||
48678640|NCT00348309|156675013|FG000|Overall Study|Non-compliance|8|||
48678641|NCT00348309|156675014|FG001|Overall Study|Non-compliance|6|||
48678642|NCT00348309|156675015|FG002|Overall Study|Non-compliance|8|||
48678643|NCT00348309|156675013|FG000|Overall Study|Death of caregiver|1|||
48678644|NCT00348309|156675014|FG001|Overall Study|Death of caregiver|0|||
48678645|NCT00348309|156675015|FG002|Overall Study|Death of caregiver|1|||
48678646|NCT00348309|156675013|FG000|Overall Study|Lack of insight, dementia|1|||
48678647|NCT00348309|156675014|FG001|Overall Study|Lack of insight, dementia|0|||
48678648|NCT00348309|156675015|FG002|Overall Study|Lack of insight, dementia|0|||
48678649|NCT00348309|156675013|FG000|Overall Study|Wrong bottle allocated|1|||
48678650|NCT00348309|156675014|FG001|Overall Study|Wrong bottle allocated|0|||
48678651|NCT00348309|156675015|FG002|Overall Study|Wrong bottle allocated|0|||
48678652|NCT00348309|156675013|FG000|Overall Study|Caregiver sick|1|||
48678653|NCT00348309|156675014|FG001|Overall Study|Caregiver sick|0|||
48678654|NCT00348309|156675015|FG002|Overall Study|Caregiver sick|0|||
48678655|NCT00348309|156675013|FG000|Overall Study|Use of prohibited medication|5|||
48678656|NCT00348309|156675014|FG001|Overall Study|Use of prohibited medication|2|||
48678657|NCT00348309|156675015|FG002|Overall Study|Use of prohibited medication|2|||
48678658|NCT00348309|156675013|FG000|Overall Study|Caregiver withdrawal|3|||
48678659|NCT00348309|156675014|FG001|Overall Study|Caregiver withdrawal|0|||
48678660|NCT00348309|156675015|FG002|Overall Study|Caregiver withdrawal|7|||
48678661|NCT00348309|156675013|FG000|Overall Study|Unable to complete ET visit|1|||
48678662|NCT00348309|156675014|FG001|Overall Study|Unable to complete ET visit|0|||
48678663|NCT00348309|156675015|FG002|Overall Study|Unable to complete ET visit|0|||
48678664|NCT00348309|156675013|FG000|Overall Study|PI closing medical practice|1|||
48678665|NCT00348309|156675014|FG001|Overall Study|PI closing medical practice|0|||
48678666|NCT00348309|156675015|FG002|Overall Study|PI closing medical practice|0|||
48678667|NCT00348309|156675013|FG000|Overall Study|Principal investigator's decision|1|||
48678668|NCT00348309|156675014|FG001|Overall Study|Principal investigator's decision|0|||
48678669|NCT00348309|156675015|FG002|Overall Study|Principal investigator's decision|0|||
48678670|NCT00348309|156675013|FG000|Overall Study|No disponibility of medication|1|||
48678671|NCT00348309|156675014|FG001|Overall Study|No disponibility of medication|0|||
48678672|NCT00348309|156675015|FG002|Overall Study|No disponibility of medication|0|||
48678673|NCT00348309|156675013|FG000|Overall Study|Worsened neurodegenerative disease|1|||
48678674|NCT00348309|156675014|FG001|Overall Study|Worsened neurodegenerative disease|0|||
48678675|NCT00348309|156675015|FG002|Overall Study|Worsened neurodegenerative disease|0|||
48678676|NCT00348309|156675013|FG000|Overall Study|Cognitive and behaviour worsening|2|||
48678677|NCT00348309|156675014|FG001|Overall Study|Cognitive and behaviour worsening|0|||
48678678|NCT00348309|156675015|FG002|Overall Study|Cognitive and behaviour worsening|0|||
48678679|NCT00348309|156675013|FG000|Overall Study|Worsening of alzheimer|1|||
48678680|NCT00348309|156675014|FG001|Overall Study|Worsening of alzheimer|0|||
48678681|NCT00348309|156675015|FG002|Overall Study|Worsening of alzheimer|1|||
48678682|NCT00348309|156675013|FG000|Overall Study|Did not appear in time for Visit 3|1|||
48678683|NCT00348309|156675014|FG001|Overall Study|Did not appear in time for Visit 3|0|||
48678684|NCT00348309|156675015|FG002|Overall Study|Did not appear in time for Visit 3|0|||
48678685|NCT00348309|156675013|FG000|Overall Study|Participant died|2|||
48678686|NCT00348309|156675014|FG001|Overall Study|Participant died|1|||
48678687|NCT00348309|156675015|FG002|Overall Study|Participant died|1|||
48678688|NCT00348309|156675013|FG000|Overall Study|Decision of sponsor|1|||
48678689|NCT00348309|156675014|FG001|Overall Study|Decision of sponsor|0|||
48678690|NCT00348309|156675015|FG002|Overall Study|Decision of sponsor|0|||
48678691|NCT00348309|156675013|FG000|Overall Study|Ineffectiveness of treatment|0|||
48678692|NCT00348309|156675014|FG001|Overall Study|Ineffectiveness of treatment|1|||
48678693|NCT00348309|156675015|FG002|Overall Study|Ineffectiveness of treatment|0|||
48678694|NCT00348309|156675013|FG000|Overall Study|A foul of exclusion criteria|0|||
48678695|NCT00348309|156675014|FG001|Overall Study|A foul of exclusion criteria|1|||
48678696|NCT00348309|156675015|FG002|Overall Study|A foul of exclusion criteria|0|||
48678697|NCT00348309|156675013|FG000|Overall Study|Participant was hospitalized|0|||
48678698|NCT00348309|156675014|FG001|Overall Study|Participant was hospitalized|1|||
48678699|NCT00348309|156675015|FG002|Overall Study|Participant was hospitalized|0|||
48678700|NCT00348309|156675013|FG000|Overall Study|Sponsor refuseal|0|||
48678701|NCT00348309|156675014|FG001|Overall Study|Sponsor refuseal|1|||
48678702|NCT00348309|156675015|FG002|Overall Study|Sponsor refuseal|1|||
48678703|NCT00348309|156675013|FG000|Overall Study|Forgot often medication|0|||
48678704|NCT00348309|156675014|FG001|Overall Study|Forgot often medication|1|||
48678705|NCT00348309|156675015|FG002|Overall Study|Forgot often medication|0|||
48678706|NCT00348309|156675013|FG000|Overall Study|Medical Monitor decision|0|||
48678707|NCT00348309|156675014|FG001|Overall Study|Medical Monitor decision|0|||
48678708|NCT00348309|156675015|FG002|Overall Study|Medical Monitor decision|1|||
48678709|NCT00348309|156675013|FG000|Overall Study|Increased dose of Aricept|0|||
48678710|NCT00348309|156675014|FG001|Overall Study|Increased dose of Aricept|0|||
48678711|NCT00348309|156675015|FG002|Overall Study|Increased dose of Aricept|1|||
48678712|NCT00348309|156675013|FG000|Overall Study|Site closure|0|||
48678713|NCT00348309|156675014|FG001|Overall Study|Site closure|0|||
48678714|NCT00348309|156675015|FG002|Overall Study|Site closure|1|||
48678715|NCT00348309|156675013|FG000|Overall Study|Adverse event not attended|0|||
48678716|NCT00348309|156675014|FG001|Overall Study|Adverse event not attended|0|||
48678717|NCT00348309|156675015|FG002|Overall Study|Adverse event not attended|1|||
48678718|NCT00348309|156675013|FG000|Overall Study|ECG abnormal|0|||
48678719|NCT00348309|156675014|FG001|Overall Study|ECG abnormal|0|||
48678720|NCT00348309|156675015|FG002|Overall Study|ECG abnormal|2|||
48678721|NCT00348309|156675013|FG000|Overall Study|Cardiologist recommendations|0|||
48678722|NCT00348309|156675014|FG001|Overall Study|Cardiologist recommendations|0|||
48678723|NCT00348309|156675015|FG002|Overall Study|Cardiologist recommendations|1|||
48678724|NCT00348309|156675013|FG000|Overall Study|HCV career|0|||
48678725|NCT00348309|156675014|FG001|Overall Study|HCV career|0|||
48678726|NCT00348309|156675015|FG002|Overall Study|HCV career|1|||
48678727|NCT03245775|156675018|FG000|Overall Study|Lost to Follow-up|25|||
48678728|NCT03245775|156675019|FG001|Overall Study|Lost to Follow-up|26|||
48678729|NCT03245775|156675020|FG002|Overall Study|Lost to Follow-up|16|||
48678730|NCT03245775|156675021|FG003|Overall Study|Lost to Follow-up|16|||
48678731|NCT00429169|156675023|FG000|Overall Study|Lost to Follow-up|0|||
48678732|NCT00429169|156675024|FG001|Overall Study|Lost to Follow-up|1|||
48678733|NCT00429169|156675023|FG000|Overall Study|Ineligibility discovered after entry|2|||
48678734|NCT00429169|156675024|FG001|Overall Study|Ineligibility discovered after entry|1|||
48678735|NCT02396589|156675027|FG000|Intervention|Lost to Follow-up|1|||
48678736|NCT02396589|156675028|FG001|Intervention|Lost to Follow-up|0|||
48678737|NCT02396589|156675027|FG000|6 Month Follow-up|change in health status|0|||
48678738|NCT02396589|156675028|FG001|6 Month Follow-up|change in health status|1|||
48678739|NCT02396589|156675027|FG000|9 Month Follow-up|Death|0|||
48678740|NCT02396589|156675028|FG001|9 Month Follow-up|Death|1|||
48678741|NCT02396589|156675027|FG000|12 Month Follow up|Lost to Follow-up|0|||
48678742|NCT02396589|156675028|FG001|12 Month Follow up|Lost to Follow-up|2|||
48678743|NCT03364309|156675042|FG000|Induction Period|Adverse Event|4|||
48678744|NCT03364309|156675043|FG001|Induction Period|Adverse Event|0|||
48678745|NCT03364309|156675044|FG002|Induction Period|Adverse Event|1|||
48678746|NCT03364309|156675045|FG003|Induction Period|Adverse Event|0|||
48678747|NCT03364309|156675046|FG004|Induction Period|Adverse Event|0|||
48678748|NCT03364309|156675047|FG005|Induction Period|Adverse Event|0|||
48678749|NCT03364309|156675048|FG006|Induction Period|Adverse Event|0|||
48678750|NCT03364309|156675049|FG007|Induction Period|Adverse Event|0|||
48678751|NCT03364309|156675050|FG008|Induction Period|Adverse Event|0|||
48678752|NCT03364309|156675051|FG009|Induction Period|Adverse Event|0|||
48678753|NCT03364309|156675052|FG010|Induction Period|Adverse Event|0|||
48678754|NCT03364309|156675053|FG011|Induction Period|Adverse Event|0|||
48678755|NCT03364309|156675054|FG012|Induction Period|Adverse Event|0|||
48678756|NCT03364309|156675055|FG013|Induction Period|Adverse Event|0|||
48678757|NCT03364309|156675056|FG014|Induction Period|Adverse Event|0|||
48678758|NCT03364309|156675057|FG015|Induction Period|Adverse Event|0|||
48678759|NCT03364309|156675058|FG016|Induction Period|Adverse Event|0|||
48875009|NCT04969276|157379021|FG001|Overall Study|Withdrawal by Subject|10|||
48875010|NCT04969276|157379022|FG002|Overall Study|Withdrawal by Subject|0|||
48678760|NCT03364309|156675059|FG017|Induction Period|Adverse Event|0|||
48678761|NCT03364309|156675060|FG018|Induction Period|Adverse Event|0|||
48678762|NCT03364309|156675042|FG000|Induction Period|Withdrawal by Subject|1|||
48678763|NCT03364309|156675043|FG001|Induction Period|Withdrawal by Subject|3|||
48678764|NCT03364309|156675044|FG002|Induction Period|Withdrawal by Subject|0|||
48678765|NCT03364309|156675045|FG003|Induction Period|Withdrawal by Subject|0|||
48678766|NCT03364309|156675046|FG004|Induction Period|Withdrawal by Subject|0|||
48678767|NCT03364309|156675047|FG005|Induction Period|Withdrawal by Subject|0|||
48678768|NCT03364309|156675048|FG006|Induction Period|Withdrawal by Subject|0|||
48678769|NCT03364309|156675049|FG007|Induction Period|Withdrawal by Subject|0|||
48678770|NCT03364309|156675050|FG008|Induction Period|Withdrawal by Subject|0|||
48678771|NCT03364309|156675051|FG009|Induction Period|Withdrawal by Subject|0|||
48678772|NCT03364309|156675052|FG010|Induction Period|Withdrawal by Subject|0|||
48678773|NCT03364309|156675053|FG011|Induction Period|Withdrawal by Subject|0|||
48678774|NCT03364309|156675054|FG012|Induction Period|Withdrawal by Subject|0|||
48678775|NCT03364309|156675055|FG013|Induction Period|Withdrawal by Subject|0|||
48678776|NCT03364309|156675056|FG014|Induction Period|Withdrawal by Subject|0|||
48678777|NCT03364309|156675057|FG015|Induction Period|Withdrawal by Subject|0|||
48678778|NCT03364309|156675058|FG016|Induction Period|Withdrawal by Subject|0|||
48678779|NCT03364309|156675059|FG017|Induction Period|Withdrawal by Subject|0|||
48678780|NCT03364309|156675060|FG018|Induction Period|Withdrawal by Subject|0|||
48678781|NCT03364309|156675042|FG000|Induction Period|Lost to Follow-up|1|||
48678782|NCT03364309|156675043|FG001|Induction Period|Lost to Follow-up|0|||
48678783|NCT03364309|156675044|FG002|Induction Period|Lost to Follow-up|0|||
48678784|NCT03364309|156675045|FG003|Induction Period|Lost to Follow-up|0|||
48678785|NCT03364309|156675046|FG004|Induction Period|Lost to Follow-up|0|||
48678786|NCT03364309|156675047|FG005|Induction Period|Lost to Follow-up|0|||
48678787|NCT03364309|156675048|FG006|Induction Period|Lost to Follow-up|0|||
48678788|NCT03364309|156675049|FG007|Induction Period|Lost to Follow-up|0|||
48678789|NCT03364309|156675050|FG008|Induction Period|Lost to Follow-up|0|||
48678790|NCT03364309|156675051|FG009|Induction Period|Lost to Follow-up|0|||
48678791|NCT03364309|156675052|FG010|Induction Period|Lost to Follow-up|0|||
48678792|NCT03364309|156675053|FG011|Induction Period|Lost to Follow-up|0|||
48678793|NCT03364309|156675054|FG012|Induction Period|Lost to Follow-up|0|||
48678794|NCT03364309|156675055|FG013|Induction Period|Lost to Follow-up|0|||
48678795|NCT03364309|156675056|FG014|Induction Period|Lost to Follow-up|0|||
48678796|NCT03364309|156675057|FG015|Induction Period|Lost to Follow-up|0|||
48678797|NCT03364309|156675058|FG016|Induction Period|Lost to Follow-up|0|||
48678798|NCT03364309|156675059|FG017|Induction Period|Lost to Follow-up|0|||
48678799|NCT03364309|156675060|FG018|Induction Period|Lost to Follow-up|0|||
48678800|NCT03364309|156675042|FG000|Induction Period|Physician Decision|0|||
48678801|NCT03364309|156675043|FG001|Induction Period|Physician Decision|1|||
48678802|NCT03364309|156675044|FG002|Induction Period|Physician Decision|0|||
48678803|NCT03364309|156675045|FG003|Induction Period|Physician Decision|0|||
48678804|NCT03364309|156675046|FG004|Induction Period|Physician Decision|0|||
48678805|NCT03364309|156675047|FG005|Induction Period|Physician Decision|0|||
48678806|NCT03364309|156675048|FG006|Induction Period|Physician Decision|0|||
48678807|NCT03364309|156675049|FG007|Induction Period|Physician Decision|0|||
48678808|NCT03364309|156675050|FG008|Induction Period|Physician Decision|0|||
48678809|NCT03364309|156675051|FG009|Induction Period|Physician Decision|0|||
48678810|NCT03364309|156675052|FG010|Induction Period|Physician Decision|0|||
48678811|NCT03364309|156675053|FG011|Induction Period|Physician Decision|0|||
48678812|NCT03364309|156675054|FG012|Induction Period|Physician Decision|0|||
48678813|NCT03364309|156675055|FG013|Induction Period|Physician Decision|0|||
48678814|NCT03364309|156675056|FG014|Induction Period|Physician Decision|0|||
48678815|NCT03364309|156675057|FG015|Induction Period|Physician Decision|0|||
48678816|NCT03364309|156675058|FG016|Induction Period|Physician Decision|0|||
48678817|NCT03364309|156675059|FG017|Induction Period|Physician Decision|0|||
48678818|NCT03364309|156675060|FG018|Induction Period|Physician Decision|0|||
48678819|NCT03364309|156675042|FG000|Maintenance Period|Withdrawal by Subject|0|||
48678820|NCT03364309|156675043|FG001|Maintenance Period|Withdrawal by Subject|0|||
48678821|NCT03364309|156675044|FG002|Maintenance Period|Withdrawal by Subject|0|||
48678822|NCT03364309|156675045|FG003|Maintenance Period|Withdrawal by Subject|1|||
48678823|NCT03364309|156675046|FG004|Maintenance Period|Withdrawal by Subject|3|||
48678824|NCT03364309|156675047|FG005|Maintenance Period|Withdrawal by Subject|1|||
48678825|NCT03364309|156675048|FG006|Maintenance Period|Withdrawal by Subject|3|||
48678826|NCT03364309|156675049|FG007|Maintenance Period|Withdrawal by Subject|0|||
48678827|NCT03364309|156675050|FG008|Maintenance Period|Withdrawal by Subject|1|||
48678828|NCT03364309|156675051|FG009|Maintenance Period|Withdrawal by Subject|1|||
48678829|NCT03364309|156675052|FG010|Maintenance Period|Withdrawal by Subject|2|||
48678830|NCT03364309|156675053|FG011|Maintenance Period|Withdrawal by Subject|0|||
48678831|NCT03364309|156675054|FG012|Maintenance Period|Withdrawal by Subject|0|||
48678832|NCT03364309|156675055|FG013|Maintenance Period|Withdrawal by Subject|0|||
48678833|NCT03364309|156675056|FG014|Maintenance Period|Withdrawal by Subject|0|||
48678834|NCT03364309|156675057|FG015|Maintenance Period|Withdrawal by Subject|0|||
48678835|NCT03364309|156675058|FG016|Maintenance Period|Withdrawal by Subject|0|||
48762766|NCT03745144|156980332|FG002|Period 1|Other|1|||
48980890|NCT01846208|157762225|FG002|Overall Study|Withdrawal by Subject|0|||
48980891|NCT01846208|157762223|FG000|Overall Study|Non-compliance|1|||
48980892|NCT01846208|157762224|FG001|Overall Study|Non-compliance|1|||
48980893|NCT01846208|157762225|FG002|Overall Study|Non-compliance|0|||
48980894|NCT01846208|157762223|FG000|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1|||
48980895|NCT01846208|157762224|FG001|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
48980896|NCT01846208|157762225|FG002|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
48980897|NCT01846208|157762223|FG000|Overall Study|Refused SU OFC|0|||
48980898|NCT01846208|157762224|FG001|Overall Study|Refused SU OFC|0|||
48980899|NCT01846208|157762225|FG002|Overall Study|Refused SU OFC|1|||
48980900|NCT01268514|157762227|FG000|Overall Study|Adverse Event|20|||
48980901|NCT01268514|157762227|FG000|Overall Study|Death|8|||
48980902|NCT01268514|157762227|FG000|Overall Study|Lost to Follow-up|5|||
48980903|NCT01268514|157762227|FG000|Overall Study|Withdrawal by Subject|3|||
48980904|NCT01268514|157762227|FG000|Overall Study|Withdrawal by Surgeon|5|||
48980905|NCT01432938|157762228|FG000|First Intervention|Protocol Violation|1|||
48980906|NCT01432938|157762229|FG001|First Intervention|Protocol Violation|0|||
48980907|NCT01432938|157762228|FG000|First Intervention|Physician Decision|1|||
48980908|NCT01432938|157762229|FG001|First Intervention|Physician Decision|0|||
48980909|NCT01432938|157762228|FG000|Second Intervention|Adverse Event|1|||
48980910|NCT01432938|157762229|FG001|Second Intervention|Adverse Event|0|||
48980911|NCT01875874|157762230|FG000|Overall Study|Death|3|||
48980912|NCT01601873|157762231|FG000|Overall Study|Lost to Follow-up|2|||
48980913|NCT01601873|157762232|FG001|Overall Study|Lost to Follow-up|3|||
48980914|NCT01440972|157762233|FG000|Overall Study|Withdrawal by Subject|3|||
48980915|NCT01440972|157762234|FG001|Overall Study|Withdrawal by Subject|2|||
48980916|NCT01680991|157762235|FG000|Overall Study|Adverse Event|1|||
48980917|NCT01680991|157762236|FG001|Overall Study|Adverse Event|0|||
48980918|NCT01680991|157762237|FG002|Overall Study|Adverse Event|0|||
48980919|NCT01680991|157762235|FG000|Overall Study|Death|1|||
48980920|NCT01680991|157762236|FG001|Overall Study|Death|0|||
48980921|NCT01680991|157762237|FG002|Overall Study|Death|1|||
48980922|NCT01680991|157762235|FG000|Overall Study|Protocol Violation|0|||
48980923|NCT01680991|157762236|FG001|Overall Study|Protocol Violation|1|||
48980924|NCT01680991|157762237|FG002|Overall Study|Protocol Violation|0|||
48980925|NCT01680991|157762235|FG000|Overall Study|Withdrawal by Subject|5|||
48980926|NCT01680991|157762236|FG001|Overall Study|Withdrawal by Subject|1|||
48980927|NCT01680991|157762237|FG002|Overall Study|Withdrawal by Subject|0|||
48980928|NCT01680991|157762235|FG000|Overall Study|Progressive disease (PD)|0|||
48980929|NCT01680991|157762236|FG001|Overall Study|Progressive disease (PD)|10|||
48980930|NCT01680991|157762237|FG002|Overall Study|Progressive disease (PD)|0|||
48980931|NCT01680991|157762235|FG000|Overall Study|Physician Decision|0|||
48980932|NCT01680991|157762236|FG001|Overall Study|Physician Decision|7|||
48980933|NCT01680991|157762237|FG002|Overall Study|Physician Decision|2|||
48980934|NCT01680991|157762235|FG000|Overall Study|Bad physical condition|0|||
48980935|NCT01680991|157762236|FG001|Overall Study|Bad physical condition|0|||
48980936|NCT01680991|157762237|FG002|Overall Study|Bad physical condition|1|||
48980937|NCT01680991|157762235|FG000|Overall Study|PD confirmed in other hospital|1|||
48980938|NCT01680991|157762236|FG001|Overall Study|PD confirmed in other hospital|0|||
48980939|NCT01680991|157762237|FG002|Overall Study|PD confirmed in other hospital|0|||
48980940|NCT01681836|157762238|FG000|Second Intervention|Withdrawal by Subject|0|||
48980941|NCT01681836|157762239|FG001|Second Intervention|Withdrawal by Subject|1|||
48678836|NCT03364309|156675059|FG017|Maintenance Period|Withdrawal by Subject|0|||
48678837|NCT03364309|156675060|FG018|Maintenance Period|Withdrawal by Subject|0|||
48678838|NCT03364309|156675042|FG000|Maintenance Period|Adverse Event|0|||
48678839|NCT03364309|156675043|FG001|Maintenance Period|Adverse Event|0|||
48678840|NCT03364309|156675044|FG002|Maintenance Period|Adverse Event|0|||
48678841|NCT03364309|156675045|FG003|Maintenance Period|Adverse Event|0|||
48678842|NCT03364309|156675046|FG004|Maintenance Period|Adverse Event|2|||
48678843|NCT03364309|156675047|FG005|Maintenance Period|Adverse Event|0|||
48678844|NCT03364309|156675048|FG006|Maintenance Period|Adverse Event|3|||
48678845|NCT03364309|156675049|FG007|Maintenance Period|Adverse Event|0|||
48678846|NCT03364309|156675050|FG008|Maintenance Period|Adverse Event|1|||
48678847|NCT03364309|156675051|FG009|Maintenance Period|Adverse Event|0|||
48678848|NCT03364309|156675052|FG010|Maintenance Period|Adverse Event|2|||
48678849|NCT03364309|156675053|FG011|Maintenance Period|Adverse Event|0|||
48678850|NCT03364309|156675054|FG012|Maintenance Period|Adverse Event|0|||
48678851|NCT03364309|156675055|FG013|Maintenance Period|Adverse Event|0|||
48678852|NCT03364309|156675056|FG014|Maintenance Period|Adverse Event|0|||
48678853|NCT03364309|156675057|FG015|Maintenance Period|Adverse Event|0|||
48678854|NCT03364309|156675058|FG016|Maintenance Period|Adverse Event|0|||
48678855|NCT03364309|156675059|FG017|Maintenance Period|Adverse Event|0|||
48678856|NCT03364309|156675060|FG018|Maintenance Period|Adverse Event|0|||
48678857|NCT03364309|156675042|FG000|Maintenance Period|Relapsed|0|||
48678858|NCT03364309|156675043|FG001|Maintenance Period|Relapsed|0|||
48678859|NCT03364309|156675044|FG002|Maintenance Period|Relapsed|0|||
48678860|NCT03364309|156675045|FG003|Maintenance Period|Relapsed|43|||
48678861|NCT03364309|156675046|FG004|Maintenance Period|Relapsed|7|||
48678862|NCT03364309|156675047|FG005|Maintenance Period|Relapsed|45|||
48678863|NCT03364309|156675048|FG006|Maintenance Period|Relapsed|10|||
48678864|NCT03364309|156675049|FG007|Maintenance Period|Relapsed|2|||
48678865|NCT03364309|156675050|FG008|Maintenance Period|Relapsed|0|||
48678866|NCT03364309|156675051|FG009|Maintenance Period|Relapsed|0|||
48678867|NCT03364309|156675052|FG010|Maintenance Period|Relapsed|0|||
48678868|NCT03364309|156675053|FG011|Maintenance Period|Relapsed|0|||
48678869|NCT03364309|156675054|FG012|Maintenance Period|Relapsed|0|||
48678870|NCT03364309|156675055|FG013|Maintenance Period|Relapsed|0|||
48678871|NCT03364309|156675056|FG014|Maintenance Period|Relapsed|0|||
48678872|NCT03364309|156675057|FG015|Maintenance Period|Relapsed|0|||
48678873|NCT03364309|156675058|FG016|Maintenance Period|Relapsed|0|||
48678874|NCT03364309|156675059|FG017|Maintenance Period|Relapsed|0|||
48678875|NCT03364309|156675060|FG018|Maintenance Period|Relapsed|0|||
48678876|NCT03364309|156675042|FG000|Maintenance Period|Lack of Efficacy|0|||
48678877|NCT03364309|156675043|FG001|Maintenance Period|Lack of Efficacy|0|||
48678878|NCT03364309|156675044|FG002|Maintenance Period|Lack of Efficacy|0|||
48678879|NCT03364309|156675045|FG003|Maintenance Period|Lack of Efficacy|0|||
48678880|NCT03364309|156675046|FG004|Maintenance Period|Lack of Efficacy|0|||
48678881|NCT03364309|156675047|FG005|Maintenance Period|Lack of Efficacy|0|||
48678882|NCT03364309|156675048|FG006|Maintenance Period|Lack of Efficacy|0|||
48678883|NCT03364309|156675049|FG007|Maintenance Period|Lack of Efficacy|0|||
48678884|NCT03364309|156675050|FG008|Maintenance Period|Lack of Efficacy|1|||
48678885|NCT03364309|156675051|FG009|Maintenance Period|Lack of Efficacy|3|||
48678886|NCT03364309|156675052|FG010|Maintenance Period|Lack of Efficacy|2|||
48678887|NCT03364309|156675053|FG011|Maintenance Period|Lack of Efficacy|0|||
48678888|NCT03364309|156675054|FG012|Maintenance Period|Lack of Efficacy|0|||
48678889|NCT03364309|156675055|FG013|Maintenance Period|Lack of Efficacy|0|||
48678890|NCT03364309|156675056|FG014|Maintenance Period|Lack of Efficacy|0|||
48678891|NCT03364309|156675057|FG015|Maintenance Period|Lack of Efficacy|0|||
48678892|NCT03364309|156675058|FG016|Maintenance Period|Lack of Efficacy|0|||
48678893|NCT03364309|156675059|FG017|Maintenance Period|Lack of Efficacy|0|||
48678894|NCT03364309|156675060|FG018|Maintenance Period|Lack of Efficacy|0|||
48678895|NCT03364309|156675042|FG000|Maintenance Period|Death|0|||
48678896|NCT03364309|156675043|FG001|Maintenance Period|Death|0|||
48678897|NCT03364309|156675044|FG002|Maintenance Period|Death|0|||
48678898|NCT03364309|156675045|FG003|Maintenance Period|Death|0|||
48678899|NCT03364309|156675046|FG004|Maintenance Period|Death|0|||
48678900|NCT03364309|156675047|FG005|Maintenance Period|Death|0|||
48678901|NCT03364309|156675048|FG006|Maintenance Period|Death|0|||
48678902|NCT03364309|156675049|FG007|Maintenance Period|Death|0|||
49020307|NCT01901055|157910876|FG001|Week 36|Withdrawal by Subject|5|||
48678903|NCT03364309|156675050|FG008|Maintenance Period|Death|1|||
48678904|NCT03364309|156675051|FG009|Maintenance Period|Death|0|||
48678905|NCT03364309|156675052|FG010|Maintenance Period|Death|0|||
48678906|NCT03364309|156675053|FG011|Maintenance Period|Death|0|||
48678907|NCT03364309|156675054|FG012|Maintenance Period|Death|0|||
48678908|NCT03364309|156675055|FG013|Maintenance Period|Death|0|||
48678909|NCT03364309|156675056|FG014|Maintenance Period|Death|0|||
48678910|NCT03364309|156675057|FG015|Maintenance Period|Death|0|||
48678911|NCT03364309|156675058|FG016|Maintenance Period|Death|0|||
48678912|NCT03364309|156675059|FG017|Maintenance Period|Death|0|||
48678913|NCT03364309|156675060|FG018|Maintenance Period|Death|0|||
48678914|NCT03364309|156675042|FG000|Maintenance Period|Lost to Follow-up|0|||
48678915|NCT03364309|156675043|FG001|Maintenance Period|Lost to Follow-up|0|||
48678916|NCT03364309|156675044|FG002|Maintenance Period|Lost to Follow-up|0|||
48678917|NCT03364309|156675045|FG003|Maintenance Period|Lost to Follow-up|0|||
48678918|NCT03364309|156675046|FG004|Maintenance Period|Lost to Follow-up|0|||
49020308|NCT00454636|157910879|FG000|Overall Study|Adverse Event|10|||
49020309|NCT00454636|157910880|FG001|Overall Study|Adverse Event|6|||
49020310|NCT00454636|157910881|FG002|Overall Study|Adverse Event|9|||
49020311|NCT00454636|157910882|FG003|Overall Study|Adverse Event|15|||
49020312|NCT00454636|157910879|FG000|Overall Study|Disease Progression|11|||
49020313|NCT00454636|157910880|FG001|Overall Study|Disease Progression|12|||
49020314|NCT00454636|157910881|FG002|Overall Study|Disease Progression|4|||
49020315|NCT00454636|157910882|FG003|Overall Study|Disease Progression|11|||
49020316|NCT00454636|157910879|FG000|Overall Study|Protocol Violation|3|||
49020317|NCT00454636|157910880|FG001|Overall Study|Protocol Violation|2|||
49020318|NCT00454636|157910881|FG002|Overall Study|Protocol Violation|3|||
49020319|NCT00454636|157910882|FG003|Overall Study|Protocol Violation|3|||
49020320|NCT00454636|157910879|FG000|Overall Study|Death|6|||
49020321|NCT00454636|157910880|FG001|Overall Study|Death|1|||
49020322|NCT00454636|157910881|FG002|Overall Study|Death|1|||
49020323|NCT00454636|157910882|FG003|Overall Study|Death|1|||
49020324|NCT00454636|157910879|FG000|Overall Study|Patient refusal|1|||
49020325|NCT00454636|157910880|FG001|Overall Study|Patient refusal|1|||
48678919|NCT03364309|156675047|FG005|Maintenance Period|Lost to Follow-up|0|||
48678920|NCT03364309|156675048|FG006|Maintenance Period|Lost to Follow-up|0|||
48678921|NCT03364309|156675049|FG007|Maintenance Period|Lost to Follow-up|0|||
48678922|NCT03364309|156675050|FG008|Maintenance Period|Lost to Follow-up|1|||
48762767|NCT00896337|156980335|FG000|Overall Study|Death|7|||
48762768|NCT00896337|156980335|FG000|Overall Study|Withdrawal by Subject|7|||
48762769|NCT00896337|156980335|FG000|Overall Study|Lost to Follow-up|11|||
48762770|NCT01359254|156980336|FG000|Overall Study|Death|1|||
48762771|NCT01359254|156980337|FG001|Overall Study|Death|0|||
48762772|NCT04668950|156980341|FG000|Overall Study|Started medication more than 7 days after symptom onset|18|||
48762773|NCT04668950|156980342|FG001|Overall Study|Started medication more than 7 days after symptom onset|14|||
48762774|NCT04668950|156980341|FG000|Overall Study|Could not confirm started study medication|15|||
48762775|NCT04668950|156980342|FG001|Overall Study|Could not confirm started study medication|15|||
48762776|NCT04668950|156980341|FG000|Overall Study|Could not confirm baseline status|6|||
48762777|NCT04668950|156980342|FG001|Overall Study|Could not confirm baseline status|2|||
48762778|NCT04668950|156980341|FG000|Overall Study|Drop out and did not start medication|15|||
48762779|NCT04668950|156980342|FG001|Overall Study|Drop out and did not start medication|17|||
48762780|NCT04668950|156980341|FG000|Overall Study|Deteriorated at or before baseline assessment|6|||
48762781|NCT04668950|156980342|FG001|Overall Study|Deteriorated at or before baseline assessment|9|||
48762782|NCT04668950|156980341|FG000|Overall Study|Other|2|||
48762783|NCT04668950|156980342|FG001|Overall Study|Other|4|||
48762784|NCT00445965|156980345|FG000|Overall Study|Adverse Event|2|||
48762785|NCT00445965|156980345|FG000|Overall Study|Physician Decision|1|||
48762786|NCT00445965|156980345|FG000|Overall Study|Enrolled but not treated|1|||
48762787|NCT00445965|156980345|FG000|Overall Study|Removed due to progressive disease|29|||
48762788|NCT00600938|156980346|FG000|Core Study|Abnormal test procedure result(s)|3|||
48762789|NCT00600938|156980347|FG001|Core Study|Abnormal test procedure result(s)|2|||
48762790|NCT00600938|156980348|FG002|Core Study|Abnormal test procedure result(s)|0|||
48762791|NCT00600938|156980349|FG003|Core Study|Abnormal test procedure result(s)|0|||
48762792|NCT00600938|156980346|FG000|Core Study|Unsatisfactory therapeutic effect|1|||
48762793|NCT00600938|156980347|FG001|Core Study|Unsatisfactory therapeutic effect|2|||
48762794|NCT00600938|156980348|FG002|Core Study|Unsatisfactory therapeutic effect|0|||
48762795|NCT00600938|156980349|FG003|Core Study|Unsatisfactory therapeutic effect|0|||
48762796|NCT00600938|156980346|FG000|Core Study|Patient withdrew consent|7|||
48762797|NCT00600938|156980347|FG001|Core Study|Patient withdrew consent|12|||
48762798|NCT00600938|156980348|FG002|Core Study|Patient withdrew consent|0|||
48762799|NCT00600938|156980349|FG003|Core Study|Patient withdrew consent|0|||
48762800|NCT00600938|156980346|FG000|Core Study|Lost to Follow-up|3|||
48762801|NCT00600938|156980347|FG001|Core Study|Lost to Follow-up|2|||
48762802|NCT00600938|156980348|FG002|Core Study|Lost to Follow-up|0|||
48762803|NCT00600938|156980349|FG003|Core Study|Lost to Follow-up|0|||
48762804|NCT00600938|156980346|FG000|Core Study|Death|1|||
49020326|NCT00454636|157910881|FG002|Overall Study|Patient refusal|3|||
48678923|NCT03364309|156675051|FG009|Maintenance Period|Lost to Follow-up|0|||
48678924|NCT03364309|156675052|FG010|Maintenance Period|Lost to Follow-up|0|||
48678925|NCT03364309|156675053|FG011|Maintenance Period|Lost to Follow-up|0|||
48678926|NCT03364309|156675054|FG012|Maintenance Period|Lost to Follow-up|0|||
48678927|NCT03364309|156675055|FG013|Maintenance Period|Lost to Follow-up|0|||
48678928|NCT03364309|156675056|FG014|Maintenance Period|Lost to Follow-up|0|||
48678929|NCT03364309|156675057|FG015|Maintenance Period|Lost to Follow-up|0|||
49020327|NCT00454636|157910882|FG003|Overall Study|Patient refusal|2|||
49020328|NCT00454636|157910879|FG000|Overall Study|Lost to Follow-up|0|||
49020329|NCT00454636|157910880|FG001|Overall Study|Lost to Follow-up|1|||
49020330|NCT00454636|157910881|FG002|Overall Study|Lost to Follow-up|0|||
49020331|NCT00454636|157910882|FG003|Overall Study|Lost to Follow-up|0|||
48678930|NCT03364309|156675058|FG016|Maintenance Period|Lost to Follow-up|0|||
48678931|NCT03364309|156675059|FG017|Maintenance Period|Lost to Follow-up|0|||
48678932|NCT03364309|156675060|FG018|Maintenance Period|Lost to Follow-up|0|||
48678933|NCT03364309|156675042|FG000|Maintenance Period|Miscellaneous|0|||
48678934|NCT03364309|156675043|FG001|Maintenance Period|Miscellaneous|0|||
48678935|NCT03364309|156675044|FG002|Maintenance Period|Miscellaneous|0|||
48678936|NCT03364309|156675045|FG003|Maintenance Period|Miscellaneous|0|||
48678937|NCT03364309|156675046|FG004|Maintenance Period|Miscellaneous|0|||
48678938|NCT03364309|156675047|FG005|Maintenance Period|Miscellaneous|0|||
48678939|NCT03364309|156675048|FG006|Maintenance Period|Miscellaneous|0|||
48678940|NCT03364309|156675049|FG007|Maintenance Period|Miscellaneous|0|||
48678941|NCT03364309|156675050|FG008|Maintenance Period|Miscellaneous|1|||
48678942|NCT03364309|156675051|FG009|Maintenance Period|Miscellaneous|0|||
48678943|NCT03364309|156675052|FG010|Maintenance Period|Miscellaneous|0|||
48678944|NCT03364309|156675053|FG011|Maintenance Period|Miscellaneous|0|||
48678945|NCT03364309|156675054|FG012|Maintenance Period|Miscellaneous|0|||
48678946|NCT03364309|156675055|FG013|Maintenance Period|Miscellaneous|0|||
48678947|NCT03364309|156675056|FG014|Maintenance Period|Miscellaneous|0|||
48678948|NCT03364309|156675057|FG015|Maintenance Period|Miscellaneous|0|||
48678949|NCT03364309|156675058|FG016|Maintenance Period|Miscellaneous|0|||
48678950|NCT03364309|156675059|FG017|Maintenance Period|Miscellaneous|0|||
48678951|NCT03364309|156675060|FG018|Maintenance Period|Miscellaneous|0|||
48678952|NCT03364309|156675042|FG000|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
48678953|NCT03364309|156675043|FG001|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
48678954|NCT03364309|156675044|FG002|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
48678955|NCT03364309|156675045|FG003|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
48678956|NCT03364309|156675046|FG004|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
48678957|NCT03364309|156675047|FG005|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
48678958|NCT03364309|156675048|FG006|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
48678959|NCT03364309|156675049|FG007|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
48678960|NCT03364309|156675050|FG008|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
48678961|NCT03364309|156675051|FG009|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
48678962|NCT03364309|156675052|FG010|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
48678963|NCT03364309|156675053|FG011|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
48678964|NCT03364309|156675054|FG012|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
48678965|NCT03364309|156675055|FG013|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
48678966|NCT03364309|156675056|FG014|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
48678967|NCT03364309|156675057|FG015|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
48678968|NCT03364309|156675058|FG016|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
48678969|NCT03364309|156675059|FG017|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
48678970|NCT03364309|156675060|FG018|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
48678971|NCT03364309|156675042|FG000|Re-treatment (Maintenance) Period|Adverse Event|0|||
48678972|NCT03364309|156675043|FG001|Re-treatment (Maintenance) Period|Adverse Event|0|||
48678973|NCT03364309|156675044|FG002|Re-treatment (Maintenance) Period|Adverse Event|0|||
48678974|NCT03364309|156675045|FG003|Re-treatment (Maintenance) Period|Adverse Event|0|||
48678975|NCT03364309|156675046|FG004|Re-treatment (Maintenance) Period|Adverse Event|0|||
48678976|NCT03364309|156675047|FG005|Re-treatment (Maintenance) Period|Adverse Event|0|||
48678977|NCT03364309|156675048|FG006|Re-treatment (Maintenance) Period|Adverse Event|0|||
48678978|NCT03364309|156675049|FG007|Re-treatment (Maintenance) Period|Adverse Event|0|||
48678979|NCT03364309|156675050|FG008|Re-treatment (Maintenance) Period|Adverse Event|0|||
48678980|NCT03364309|156675051|FG009|Re-treatment (Maintenance) Period|Adverse Event|0|||
48678981|NCT03364309|156675052|FG010|Re-treatment (Maintenance) Period|Adverse Event|0|||
48678982|NCT03364309|156675053|FG011|Re-treatment (Maintenance) Period|Adverse Event|0|||
48678983|NCT03364309|156675054|FG012|Re-treatment (Maintenance) Period|Adverse Event|0|||
48678984|NCT03364309|156675055|FG013|Re-treatment (Maintenance) Period|Adverse Event|0|||
48678985|NCT03364309|156675056|FG014|Re-treatment (Maintenance) Period|Adverse Event|1|||
48678986|NCT03364309|156675057|FG015|Re-treatment (Maintenance) Period|Adverse Event|0|||
48678987|NCT03364309|156675058|FG016|Re-treatment (Maintenance) Period|Adverse Event|0|||
48678988|NCT03364309|156675059|FG017|Re-treatment (Maintenance) Period|Adverse Event|0|||
49020332|NCT02536378|157910883|FG000|Overall Study|Physician Decision|0|||
49020333|NCT02536378|157910884|FG001|Overall Study|Physician Decision|2|||
49020334|NCT02536378|157910883|FG000|Overall Study|Withdrawal by Subject|0|||
48678989|NCT03364309|156675060|FG018|Re-treatment (Maintenance) Period|Adverse Event|0|||
48678990|NCT03364309|156675042|FG000|Re-treatment (Maintenance) Period|Relapse|0|||
48678991|NCT03364309|156675043|FG001|Re-treatment (Maintenance) Period|Relapse|0|||
48678992|NCT03364309|156675044|FG002|Re-treatment (Maintenance) Period|Relapse|0|||
48678993|NCT03364309|156675045|FG003|Re-treatment (Maintenance) Period|Relapse|0|||
48678994|NCT03364309|156675046|FG004|Re-treatment (Maintenance) Period|Relapse|0|||
48762805|NCT00600938|156980347|FG001|Core Study|Death|1|||
48762806|NCT00600938|156980348|FG002|Core Study|Death|0|||
48678995|NCT03364309|156675047|FG005|Re-treatment (Maintenance) Period|Relapse|0|||
48678996|NCT03364309|156675048|FG006|Re-treatment (Maintenance) Period|Relapse|0|||
49020335|NCT02536378|157910884|FG001|Overall Study|Withdrawal by Subject|1|||
48678997|NCT03364309|156675049|FG007|Re-treatment (Maintenance) Period|Relapse|0|||
48678998|NCT03364309|156675050|FG008|Re-treatment (Maintenance) Period|Relapse|0|||
48678999|NCT03364309|156675051|FG009|Re-treatment (Maintenance) Period|Relapse|0|||
48679000|NCT03364309|156675052|FG010|Re-treatment (Maintenance) Period|Relapse|0|||
48679001|NCT03364309|156675053|FG011|Re-treatment (Maintenance) Period|Relapse|0|||
48679002|NCT03364309|156675054|FG012|Re-treatment (Maintenance) Period|Relapse|1|||
48679003|NCT03364309|156675055|FG013|Re-treatment (Maintenance) Period|Relapse|0|||
48679004|NCT03364309|156675056|FG014|Re-treatment (Maintenance) Period|Relapse|0|||
48679005|NCT03364309|156675057|FG015|Re-treatment (Maintenance) Period|Relapse|1|||
48679006|NCT03364309|156675058|FG016|Re-treatment (Maintenance) Period|Relapse|0|||
48679007|NCT03364309|156675059|FG017|Re-treatment (Maintenance) Period|Relapse|0|||
48679008|NCT03364309|156675060|FG018|Re-treatment (Maintenance) Period|Relapse|0|||
48679009|NCT03364309|156675042|FG000|Post-Treatment Followup Period|Withdrawal by Subject|0|||
48679010|NCT03364309|156675043|FG001|Post-Treatment Followup Period|Withdrawal by Subject|0|||
48679011|NCT03364309|156675044|FG002|Post-Treatment Followup Period|Withdrawal by Subject|0|||
48679012|NCT03364309|156675045|FG003|Post-Treatment Followup Period|Withdrawal by Subject|0|||
48679013|NCT03364309|156675046|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
48679014|NCT03364309|156675047|FG005|Post-Treatment Followup Period|Withdrawal by Subject|0|||
48679015|NCT03364309|156675048|FG006|Post-Treatment Followup Period|Withdrawal by Subject|0|||
48679016|NCT03364309|156675049|FG007|Post-Treatment Followup Period|Withdrawal by Subject|0|||
48679017|NCT03364309|156675050|FG008|Post-Treatment Followup Period|Withdrawal by Subject|0|||
48679018|NCT03364309|156675051|FG009|Post-Treatment Followup Period|Withdrawal by Subject|0|||
48679019|NCT03364309|156675052|FG010|Post-Treatment Followup Period|Withdrawal by Subject|0|||
48679020|NCT03364309|156675053|FG011|Post-Treatment Followup Period|Withdrawal by Subject|0|||
48679021|NCT03364309|156675054|FG012|Post-Treatment Followup Period|Withdrawal by Subject|0|||
48679022|NCT03364309|156675055|FG013|Post-Treatment Followup Period|Withdrawal by Subject|0|||
48679023|NCT03364309|156675056|FG014|Post-Treatment Followup Period|Withdrawal by Subject|0|||
48679024|NCT03364309|156675057|FG015|Post-Treatment Followup Period|Withdrawal by Subject|0|||
48679025|NCT03364309|156675058|FG016|Post-Treatment Followup Period|Withdrawal by Subject|3|||
48679026|NCT03364309|156675059|FG017|Post-Treatment Followup Period|Withdrawal by Subject|19|||
48679027|NCT03364309|156675060|FG018|Post-Treatment Followup Period|Withdrawal by Subject|1|||
48679028|NCT03364309|156675042|FG000|Post-Treatment Followup Period|Adverse Event|0|||
48679029|NCT03364309|156675043|FG001|Post-Treatment Followup Period|Adverse Event|0|||
48679030|NCT03364309|156675044|FG002|Post-Treatment Followup Period|Adverse Event|0|||
48679031|NCT03364309|156675045|FG003|Post-Treatment Followup Period|Adverse Event|0|||
48679032|NCT03364309|156675046|FG004|Post-Treatment Followup Period|Adverse Event|0|||
48679033|NCT03364309|156675047|FG005|Post-Treatment Followup Period|Adverse Event|0|||
48679034|NCT03364309|156675048|FG006|Post-Treatment Followup Period|Adverse Event|0|||
48679035|NCT03364309|156675049|FG007|Post-Treatment Followup Period|Adverse Event|0|||
48679036|NCT03364309|156675050|FG008|Post-Treatment Followup Period|Adverse Event|0|||
48679037|NCT03364309|156675051|FG009|Post-Treatment Followup Period|Adverse Event|0|||
48679038|NCT03364309|156675052|FG010|Post-Treatment Followup Period|Adverse Event|0|||
48679039|NCT03364309|156675053|FG011|Post-Treatment Followup Period|Adverse Event|0|||
48679040|NCT03364309|156675054|FG012|Post-Treatment Followup Period|Adverse Event|0|||
48679041|NCT03364309|156675055|FG013|Post-Treatment Followup Period|Adverse Event|0|||
48679042|NCT03364309|156675056|FG014|Post-Treatment Followup Period|Adverse Event|0|||
48679043|NCT03364309|156675057|FG015|Post-Treatment Followup Period|Adverse Event|0|||
48679044|NCT03364309|156675058|FG016|Post-Treatment Followup Period|Adverse Event|2|||
48679045|NCT03364309|156675059|FG017|Post-Treatment Followup Period|Adverse Event|6|||
48679046|NCT03364309|156675060|FG018|Post-Treatment Followup Period|Adverse Event|1|||
48679047|NCT03364309|156675042|FG000|Post-Treatment Followup Period|Lost to Follow-up|0|||
48679048|NCT03364309|156675043|FG001|Post-Treatment Followup Period|Lost to Follow-up|0|||
48679049|NCT03364309|156675044|FG002|Post-Treatment Followup Period|Lost to Follow-up|0|||
48679050|NCT03364309|156675045|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
48679051|NCT03364309|156675046|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
48679052|NCT03364309|156675047|FG005|Post-Treatment Followup Period|Lost to Follow-up|0|||
48679053|NCT03364309|156675048|FG006|Post-Treatment Followup Period|Lost to Follow-up|0|||
48679054|NCT03364309|156675049|FG007|Post-Treatment Followup Period|Lost to Follow-up|0|||
48679055|NCT03364309|156675050|FG008|Post-Treatment Followup Period|Lost to Follow-up|0|||
48679056|NCT03364309|156675051|FG009|Post-Treatment Followup Period|Lost to Follow-up|0|||
48679057|NCT03364309|156675052|FG010|Post-Treatment Followup Period|Lost to Follow-up|0|||
48679058|NCT03364309|156675053|FG011|Post-Treatment Followup Period|Lost to Follow-up|0|||
48762807|NCT00600938|156980349|FG003|Core Study|Death|0|||
48679059|NCT03364309|156675054|FG012|Post-Treatment Followup Period|Lost to Follow-up|0|||
48679060|NCT03364309|156675055|FG013|Post-Treatment Followup Period|Lost to Follow-up|0|||
48679061|NCT03364309|156675056|FG014|Post-Treatment Followup Period|Lost to Follow-up|0|||
48679062|NCT03364309|156675057|FG015|Post-Treatment Followup Period|Lost to Follow-up|0|||
48679063|NCT03364309|156675058|FG016|Post-Treatment Followup Period|Lost to Follow-up|0|||
48762808|NCT00600938|156980346|FG000|Core Study|Protocol Violation|1|||
48679064|NCT03364309|156675059|FG017|Post-Treatment Followup Period|Lost to Follow-up|2|||
48679065|NCT03364309|156675060|FG018|Post-Treatment Followup Period|Lost to Follow-up|0|||
48679066|NCT03364309|156675042|FG000|Post-Treatment Followup Period|Miscellaneous|0|||
48679067|NCT03364309|156675043|FG001|Post-Treatment Followup Period|Miscellaneous|0|||
48679068|NCT03364309|156675044|FG002|Post-Treatment Followup Period|Miscellaneous|0|||
48679069|NCT03364309|156675045|FG003|Post-Treatment Followup Period|Miscellaneous|0|||
48679070|NCT03364309|156675046|FG004|Post-Treatment Followup Period|Miscellaneous|0|||
48679071|NCT03364309|156675047|FG005|Post-Treatment Followup Period|Miscellaneous|0|||
48679072|NCT03364309|156675048|FG006|Post-Treatment Followup Period|Miscellaneous|0|||
48679073|NCT03364309|156675049|FG007|Post-Treatment Followup Period|Miscellaneous|0|||
48679074|NCT03364309|156675050|FG008|Post-Treatment Followup Period|Miscellaneous|0|||
48679075|NCT03364309|156675051|FG009|Post-Treatment Followup Period|Miscellaneous|0|||
48679076|NCT03364309|156675052|FG010|Post-Treatment Followup Period|Miscellaneous|0|||
48679077|NCT03364309|156675053|FG011|Post-Treatment Followup Period|Miscellaneous|0|||
48679078|NCT03364309|156675054|FG012|Post-Treatment Followup Period|Miscellaneous|0|||
48679079|NCT03364309|156675055|FG013|Post-Treatment Followup Period|Miscellaneous|0|||
48679080|NCT03364309|156675056|FG014|Post-Treatment Followup Period|Miscellaneous|0|||
48679081|NCT03364309|156675057|FG015|Post-Treatment Followup Period|Miscellaneous|0|||
48679082|NCT03364309|156675058|FG016|Post-Treatment Followup Period|Miscellaneous|0|||
48679083|NCT03364309|156675059|FG017|Post-Treatment Followup Period|Miscellaneous|4|||
48679084|NCT03364309|156675060|FG018|Post-Treatment Followup Period|Miscellaneous|0|||
48679085|NCT03477838|156675061|FG000|Overall Study|Lost to Follow-up|14|||
48679086|NCT01345669|156675062|FG000|Overall Study|Primary tumour recurrence|53|||
48679087|NCT01345669|156675063|FG001|Overall Study|Primary tumour recurrence|32|||
48679088|NCT01345669|156675062|FG000|Overall Study|Second primary tumour|4|||
48679089|NCT01345669|156675063|FG001|Overall Study|Second primary tumour|3|||
48679090|NCT01345669|156675062|FG000|Overall Study|Adverse Event|63|||
48679091|NCT01345669|156675063|FG001|Overall Study|Adverse Event|9|||
48679092|NCT01345669|156675062|FG000|Overall Study|Protocol Violation|3|||
48679093|NCT01345669|156675063|FG001|Overall Study|Protocol Violation|1|||
48679094|NCT01345669|156675062|FG000|Overall Study|Lost to Follow-up|1|||
48679095|NCT01345669|156675063|FG001|Overall Study|Lost to Follow-up|1|||
48679096|NCT01345669|156675062|FG000|Overall Study|Withdrawal by Subject|52|||
48679097|NCT01345669|156675063|FG001|Overall Study|Withdrawal by Subject|13|||
48679098|NCT01345669|156675062|FG000|Overall Study|Other Reasons|111|||
48679099|NCT01345669|156675063|FG001|Overall Study|Other Reasons|60|||
48679100|NCT00615992|156675064|FG000|Overall Study|Protocol Violation|67|||
48679101|NCT03992846|156675067|FG000|Overall Study|Adverse Event|8|||
48679102|NCT03992846|156675068|FG001|Overall Study|Adverse Event|6|||
48679103|NCT03992846|156675069|FG002|Overall Study|Adverse Event|3|||
48679104|NCT03992846|156675067|FG000|Overall Study|Lost to Follow-up|0|||
48679105|NCT03992846|156675068|FG001|Overall Study|Lost to Follow-up|1|||
48679106|NCT03992846|156675069|FG002|Overall Study|Lost to Follow-up|1|||
48679107|NCT03992846|156675067|FG000|Overall Study|Pregnancy|2|||
48679108|NCT03992846|156675068|FG001|Overall Study|Pregnancy|0|||
48679109|NCT03992846|156675069|FG002|Overall Study|Pregnancy|1|||
48679110|NCT03992846|156675067|FG000|Overall Study|Protocol Violation|1|||
48679111|NCT03992846|156675068|FG001|Overall Study|Protocol Violation|2|||
48679112|NCT03992846|156675069|FG002|Overall Study|Protocol Violation|0|||
48679113|NCT03992846|156675067|FG000|Overall Study|Withdrawal by Subject|8|||
48679114|NCT03992846|156675068|FG001|Overall Study|Withdrawal by Subject|10|||
48679115|NCT03992846|156675069|FG002|Overall Study|Withdrawal by Subject|20|||
48679116|NCT03992846|156675067|FG000|Overall Study|Sponsor decided to exclude the patient|1|||
48679117|NCT03992846|156675068|FG001|Overall Study|Sponsor decided to exclude the patient|0|||
48679118|NCT03992846|156675069|FG002|Overall Study|Sponsor decided to exclude the patient|0|||
48679119|NCT02720692|156676559|FG000|Overall Study|Withdrawal by Subject|3|||
49020336|NCT02536378|157910883|FG000|Overall Study|Death|1|||
49020337|NCT02536378|157910884|FG001|Overall Study|Death|2|||
49020338|NCT02536378|157910883|FG000|Overall Study|Patient refused further follow up|6|||
49020339|NCT02536378|157910884|FG001|Overall Study|Patient refused further follow up|2|||
49020340|NCT03019965|157910887|FG000|Overall Study|Withdrawal by Subject|1|||
49020341|NCT03019965|157910888|FG001|Overall Study|Withdrawal by Subject|0|||
48679120|NCT02720692|156676560|FG001|Overall Study|Withdrawal by Subject|0|||
48679121|NCT02720692|156676559|FG000|Overall Study|Physician Decision|1|||
48679122|NCT02720692|156676560|FG001|Overall Study|Physician Decision|0|||
48679123|NCT02720692|156676559|FG000|Overall Study|Lost to Follow-up|8|||
48679124|NCT02720692|156676560|FG001|Overall Study|Lost to Follow-up|3|||
48679125|NCT02720692|156676559|FG000|Overall Study|Subject unable to return for visit|1|||
48679126|NCT02720692|156676560|FG001|Overall Study|Subject unable to return for visit|0|||
48679127|NCT05011513|156676561|FG000|Overall Study|Death|0|||
48679128|NCT05011513|156676562|FG001|Overall Study|Death|1|||
48679129|NCT05011513|156676561|FG000|Overall Study|Lost to Follow-up|4|||
48679130|NCT05011513|156676562|FG001|Overall Study|Lost to Follow-up|0|||
48679131|NCT05011513|156676561|FG000|Overall Study|Withdrawal by Subject|18|||
48679132|NCT05011513|156676562|FG001|Overall Study|Withdrawal by Subject|17|||
48679133|NCT05011513|156676561|FG000|Overall Study|Other|4|||
48679134|NCT05011513|156676562|FG001|Overall Study|Other|2|||
48679135|NCT02503501|156676563|FG000|Overall Study|Physician Decision|1|||
48679136|NCT02503501|156676564|FG001|Overall Study|Physician Decision|0|||
48679137|NCT02503501|156676563|FG000|Overall Study|Protocol Violation|0|||
48679138|NCT02503501|156676564|FG001|Overall Study|Protocol Violation|1|||
48679139|NCT02503501|156676563|FG000|Overall Study|Withdrawal by Subject|0|||
48679140|NCT02503501|156676564|FG001|Overall Study|Withdrawal by Subject|2|||
48679141|NCT02806960|156676565|FG000|Period 1|Study Terminated (withdrawn by sponsor)|3|||
48875011|NCT04969276|157379020|FG000|Overall Study|Lost to Follow-up|0|||
48875012|NCT04969276|157379021|FG001|Overall Study|Lost to Follow-up|1|||
49020342|NCT03019965|157910887|FG000|Overall Study|Protocol Violation|1|||
49020343|NCT03019965|157910888|FG001|Overall Study|Protocol Violation|3|||
49020344|NCT03019965|157910887|FG000|Overall Study|viral or fungal infection|3|||
49020345|NCT03019965|157910888|FG001|Overall Study|viral or fungal infection|4|||
48679142|NCT02806960|156676566|FG001|Period 1|Study Terminated (withdrawn by sponsor)|3|||
48679143|NCT02806960|156676567|FG002|Period 1|Study Terminated (withdrawn by sponsor)|3|||
48679144|NCT02806960|156676568|FG003|Period 1|Study Terminated (withdrawn by sponsor)|3|||
48679145|NCT02315560|156676569|FG000|Overall Study|noncompliance by subjects|3|||
48679146|NCT04327024|156676570|FG000|Overall Study|Death|1|||
48679147|NCT04327024|156676571|FG001|Overall Study|Death|2|||
48679148|NCT04327024|156676572|FG002|Overall Study|Death|1|||
48679149|NCT04327024|156676570|FG000|Overall Study|Non-compliance with study drug|0|||
48679150|NCT04327024|156676571|FG001|Overall Study|Non-compliance with study drug|1|||
48679151|NCT04327024|156676572|FG002|Overall Study|Non-compliance with study drug|0|||
48679152|NCT04327024|156676570|FG000|Overall Study|Withdrawal by Subject|1|||
48679153|NCT04327024|156676571|FG001|Overall Study|Withdrawal by Subject|1|||
48679154|NCT04327024|156676572|FG002|Overall Study|Withdrawal by Subject|2|||
48679155|NCT03056339|156676575|FG000|Overall Study|Failed Requirements|0|||
48679156|NCT03056339|156676576|FG001|Overall Study|Failed Requirements|2|||
48679157|NCT03056339|156676577|FG002|Overall Study|Failed Requirements|7|||
48679158|NCT03056339|156676578|FG003|Overall Study|Failed Requirements|1|||
48679159|NCT01483183|156676582|FG000|Overall Study|Physician Decision|0|||
48679160|NCT01483183|156676583|FG001|Overall Study|Physician Decision|0|||
48679161|NCT01483183|156676584|FG002|Overall Study|Physician Decision|0|||
48679162|NCT01483183|156676585|FG003|Overall Study|Physician Decision|0|||
48679163|NCT01483183|156676586|FG004|Overall Study|Physician Decision|0|||
48679164|NCT01483183|156676587|FG005|Overall Study|Physician Decision|0|||
48679165|NCT01483183|156676588|FG006|Overall Study|Physician Decision|2|||
48679166|NCT01483183|156676589|FG007|Overall Study|Physician Decision|0|||
48679167|NCT01483183|156676590|FG008|Overall Study|Physician Decision|0|||
48679168|NCT01483183|156676591|FG009|Overall Study|Physician Decision|0|||
48679169|NCT01483183|156676582|FG000|Overall Study|Withdrawal by Subject|0|||
48679170|NCT01483183|156676583|FG001|Overall Study|Withdrawal by Subject|0|||
48679171|NCT01483183|156676584|FG002|Overall Study|Withdrawal by Subject|0|||
48679172|NCT01483183|156676585|FG003|Overall Study|Withdrawal by Subject|0|||
48679173|NCT01483183|156676586|FG004|Overall Study|Withdrawal by Subject|0|||
48679174|NCT01483183|156676587|FG005|Overall Study|Withdrawal by Subject|0|||
48679175|NCT01483183|156676588|FG006|Overall Study|Withdrawal by Subject|0|||
48679176|NCT01483183|156676589|FG007|Overall Study|Withdrawal by Subject|0|||
48679177|NCT01483183|156676590|FG008|Overall Study|Withdrawal by Subject|0|||
48679178|NCT01483183|156676591|FG009|Overall Study|Withdrawal by Subject|1|||
48679179|NCT02596230|156676592|FG000|Screening Period for Objective 2|Participants not participating in obj 2|3714|||
48679180|NCT02596230|156676593|FG001|Screening Period for Objective 2|Participants not participating in obj 2|228|||
48679181|NCT02596230|156676594|FG002|Screening Period for Objective 2|Participants not participating in obj 2|0|||
48679182|NCT02596230|156676595|FG003|Screening Period for Objective 2|Participants not participating in obj 2|846|||
48679183|NCT02596230|156676596|FG004|Screening Period for Objective 2|Participants not participating in obj 2|0|||
48679184|NCT02596230|156676592|FG000|Objective 2, One Year|Lost to Follow-up|0|||
48679185|NCT02596230|156676593|FG001|Objective 2, One Year|Lost to Follow-up|41|||
48679186|NCT02596230|156676594|FG002|Objective 2, One Year|Lost to Follow-up|41|||
48679187|NCT02596230|156676595|FG003|Objective 2, One Year|Lost to Follow-up|32|||
48679188|NCT02596230|156676596|FG004|Objective 2, One Year|Lost to Follow-up|46|||
48679189|NCT02596230|156676592|FG000|Objective 2, One Year|Withdrawal by Subject|0|||
48679190|NCT02596230|156676593|FG001|Objective 2, One Year|Withdrawal by Subject|11|||
48679191|NCT02596230|156676594|FG002|Objective 2, One Year|Withdrawal by Subject|14|||
48679192|NCT02596230|156676595|FG003|Objective 2, One Year|Withdrawal by Subject|5|||
48679193|NCT02596230|156676596|FG004|Objective 2, One Year|Withdrawal by Subject|2|||
48679194|NCT02596230|156676592|FG000|Objective 2, One Year|Adverse drug reaction|0|||
48679195|NCT02596230|156676593|FG001|Objective 2, One Year|Adverse drug reaction|1|||
48679196|NCT02596230|156676594|FG002|Objective 2, One Year|Adverse drug reaction|0|||
48679197|NCT02596230|156676595|FG003|Objective 2, One Year|Adverse drug reaction|0|||
48679198|NCT02596230|156676596|FG004|Objective 2, One Year|Adverse drug reaction|0|||
48679199|NCT02596230|156676592|FG000|Objective 2, One Year|Death|0|||
49020346|NCT03019965|157910887|FG000|Overall Study|acute liver failure in the first 24 hours of randomization|4|||
48679200|NCT02596230|156676593|FG001|Objective 2, One Year|Death|12|||
48679201|NCT02596230|156676594|FG002|Objective 2, One Year|Death|41|||
48875013|NCT04969276|157379022|FG002|Overall Study|Lost to Follow-up|0|||
48875014|NCT01151423|157379023|FG000|Overall Study|Study terminated by Sponsor|9|||
48875015|NCT01151423|157379024|FG001|Overall Study|Study terminated by Sponsor|10|||
48875016|NCT01151423|157379023|FG000|Overall Study|Protocol Violation|0|||
48875017|NCT01151423|157379024|FG001|Overall Study|Protocol Violation|1|||
48875018|NCT01151423|157379023|FG000|Overall Study|Physician Decision|1|||
48875019|NCT01151423|157379024|FG001|Overall Study|Physician Decision|1|||
48875020|NCT01151423|157379023|FG000|Overall Study|Pregnancy|0|||
48875021|NCT01151423|157379024|FG001|Overall Study|Pregnancy|1|||
48875022|NCT01151423|157379023|FG000|Overall Study|Death|0|||
48875023|NCT01151423|157379024|FG001|Overall Study|Death|1|||
48875024|NCT01151423|157379023|FG000|Overall Study|Adverse Event|3|||
48875025|NCT01151423|157379024|FG001|Overall Study|Adverse Event|0|||
48875026|NCT01151423|157379023|FG000|Overall Study|Withdrawal by Subject|1|||
48875027|NCT01151423|157379024|FG001|Overall Study|Withdrawal by Subject|3|||
48875028|NCT01151423|157379023|FG000|Overall Study|Lost to Follow-up|1|||
48875029|NCT01151423|157379024|FG001|Overall Study|Lost to Follow-up|0|||
48875030|NCT01151423|157379023|FG000|Overall Study|Diagnosed as non-TTP patient|0|||
48875031|NCT01151423|157379024|FG001|Overall Study|Diagnosed as non-TTP patient|1|||
48875032|NCT01151423|157379023|FG000|Overall Study|Participated in other clinical trial|1|||
48875033|NCT01151423|157379024|FG001|Overall Study|Participated in other clinical trial|0|||
48875034|NCT03371823|157379025|FG000|Overall Study|Screen fail (did not meet inclusion criteria)|1|||
48875035|NCT03371823|157379026|FG001|Overall Study|Screen fail (did not meet inclusion criteria)|0|||
48875036|NCT01466790|157379028|FG000|Overall Study|Adverse Event|1|||
48875037|NCT01466790|157379029|FG001|Overall Study|Adverse Event|0|||
48875038|NCT01466790|157379030|FG002|Overall Study|Adverse Event|0|||
48875039|NCT01466790|157379031|FG003|Overall Study|Adverse Event|0|||
48875040|NCT01466790|157379032|FG004|Overall Study|Adverse Event|2|||
48875041|NCT01466790|157379033|FG005|Overall Study|Adverse Event|0|||
48875042|NCT01466790|157379034|FG006|Overall Study|Adverse Event|0|||
48875043|NCT01466790|157379035|FG007|Overall Study|Adverse Event|0|||
48875044|NCT01466790|157379028|FG000|Overall Study|Lost to Follow-up|2|||
48875045|NCT01466790|157379029|FG001|Overall Study|Lost to Follow-up|0|||
48875046|NCT01466790|157379030|FG002|Overall Study|Lost to Follow-up|0|||
48875047|NCT01466790|157379031|FG003|Overall Study|Lost to Follow-up|0|||
48875048|NCT01466790|157379032|FG004|Overall Study|Lost to Follow-up|0|||
48875049|NCT01466790|157379033|FG005|Overall Study|Lost to Follow-up|0|||
48875050|NCT01466790|157379034|FG006|Overall Study|Lost to Follow-up|0|||
48875051|NCT01466790|157379035|FG007|Overall Study|Lost to Follow-up|0|||
48875052|NCT01466790|157379028|FG000|Overall Study|Withdrawal by Subject|1|||
48875053|NCT01466790|157379029|FG001|Overall Study|Withdrawal by Subject|1|||
48875054|NCT01466790|157379030|FG002|Overall Study|Withdrawal by Subject|0|||
48875055|NCT01466790|157379031|FG003|Overall Study|Withdrawal by Subject|0|||
48875056|NCT01466790|157379032|FG004|Overall Study|Withdrawal by Subject|1|||
48875057|NCT01466790|157379033|FG005|Overall Study|Withdrawal by Subject|0|||
48875058|NCT01466790|157379034|FG006|Overall Study|Withdrawal by Subject|1|||
48875059|NCT01466790|157379035|FG007|Overall Study|Withdrawal by Subject|1|||
48875060|NCT01263054|157379037|FG000|Overall Study|Death|1|||
48875061|NCT01263054|157379038|FG001|Overall Study|Death|0|||
48875062|NCT01263054|157379037|FG000|Overall Study|Lost to Follow-up|2|||
48875063|NCT01263054|157379038|FG001|Overall Study|Lost to Follow-up|2|||
48875064|NCT01263054|157379037|FG000|Overall Study|Withdrawal by Subject|1|||
48875065|NCT01263054|157379038|FG001|Overall Study|Withdrawal by Subject|3|||
48875066|NCT01263054|157379037|FG000|Overall Study|Qualification Violation|1|||
48875067|NCT01263054|157379038|FG001|Overall Study|Qualification Violation|0|||
48875068|NCT01263054|157379037|FG000|Overall Study|Other|0|||
48875069|NCT01263054|157379038|FG001|Overall Study|Other|1|||
48875070|NCT01310699|157379039|FG000|Overall Study|Patients did not complete tandem.|4|||
48875071|NCT01310699|157379040|FG001|Overall Study|Patients did not complete tandem.|6|||
48679202|NCT02596230|156676595|FG003|Objective 2, One Year|Death|21|||
48679203|NCT02596230|156676596|FG004|Objective 2, One Year|Death|30|||
48679204|NCT02596230|156676592|FG000|Objective 2, One Year|Other|0|||
48679205|NCT02596230|156676593|FG001|Objective 2, One Year|Other|3|||
48875072|NCT02386839|157379041|FG000|Overall Study|Death|1|||
48875073|NCT02386839|157379042|FG001|Overall Study|Death|0|||
48875074|NCT02386839|157379041|FG000|Overall Study|Withdrawal by Subject|9|||
48875075|NCT02386839|157379042|FG001|Overall Study|Withdrawal by Subject|10|||
48875076|NCT02386839|157379041|FG000|Overall Study|Lost to Follow-up|4|||
48875077|NCT02386839|157379042|FG001|Overall Study|Lost to Follow-up|4|||
48875078|NCT02386839|157379041|FG000|Overall Study|Other (Site Terminated by Sponsor)|1|||
48875079|NCT02386839|157379042|FG001|Overall Study|Other (Site Terminated by Sponsor)|0|||
48875080|NCT02386839|157379041|FG000|Overall Study|Other (Covid 19 Pandemic)|0|||
48875081|NCT02386839|157379042|FG001|Overall Study|Other (Covid 19 Pandemic)|1|||
48875082|NCT02386839|157379041|FG000|Overall Study|Other (unspecified)|1|||
48875083|NCT02386839|157379042|FG001|Overall Study|Other (unspecified)|0|||
48875084|NCT00926575|157379043|FG000|Overall Study|Adverse Event|1|||
48875085|NCT00926575|157379044|FG001|Overall Study|Adverse Event|1|||
48875086|NCT00926575|157379043|FG000|Overall Study|Death|4|||
48679206|NCT02596230|156676594|FG002|Objective 2, One Year|Other|2|||
48679207|NCT02596230|156676595|FG003|Objective 2, One Year|Other|0|||
48679208|NCT02596230|156676596|FG004|Objective 2, One Year|Other|0|||
48679209|NCT00466921|156676597|FG000|First 3 Cycles of Treatment|Adverse Event|2|||
48679210|NCT00466921|156676597|FG000|First 3 Cycles of Treatment|Withdrawal by Subject|5|||
48679211|NCT00466921|156676597|FG000|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2|||
48679212|NCT00466921|156676597|FG000|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2|||
48679213|NCT00466921|156676597|FG000|Completed 4 Cycles/Reached 1st Response|Other|1|||
48679214|NCT00466921|156676597|FG000|Follow up for a Minimum of 1 Year|Death|6|||
48679215|NCT02881762|156676598|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
48679216|NCT02881762|156676599|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
48679217|NCT00245037|156676600|FG000|Overall Study|Death|17|||
48679218|NCT02524158|156676601|FG000|12-weeks Assessment|Withdrawal by Subject|1|||
48679219|NCT02524158|156676602|FG001|12-weeks Assessment|Withdrawal by Subject|1|||
48679220|NCT02524158|156676601|FG000|12-weeks Assessment|Lost to Follow-up|18|||
48679221|NCT02524158|156676602|FG001|12-weeks Assessment|Lost to Follow-up|12|||
48679222|NCT02524158|156676601|FG000|6-month Assessment|Withdrawal by Subject|1|||
48679223|NCT02524158|156676602|FG001|6-month Assessment|Withdrawal by Subject|1|||
48679224|NCT02524158|156676601|FG000|6-month Assessment|Lost to Follow-up|21|||
48679225|NCT02524158|156676602|FG001|6-month Assessment|Lost to Follow-up|20|||
48679226|NCT03100058|156676603|FG000|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
48679227|NCT03100058|156676604|FG001|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
48679228|NCT03100058|156676605|FG002|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4|||
48679229|NCT03100058|156676606|FG003|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8|||
48679230|NCT03100058|156676607|FG004|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1|||
48679231|NCT03100058|156676608|FG005|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
48679232|NCT03100058|156676609|FG006|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3|||
48679233|NCT03100058|156676610|FG007|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11|||
48679234|NCT03100058|156676611|FG008|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2|||
48679235|NCT03100058|156676612|FG009|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
48679236|NCT03100058|156676613|FG010|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
48679237|NCT03100058|156676614|FG011|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
48679238|NCT03100058|156676615|FG012|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
48679239|NCT03100058|156676603|FG000|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
48679240|NCT03100058|156676604|FG001|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
48679241|NCT03100058|156676605|FG002|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3|||
48679242|NCT03100058|156676606|FG003|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
48679243|NCT03100058|156676607|FG004|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
48679244|NCT03100058|156676608|FG005|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
48679245|NCT03100058|156676609|FG006|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
48679246|NCT03100058|156676610|FG007|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
48679247|NCT03100058|156676611|FG008|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
48679248|NCT03100058|156676612|FG009|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
48679249|NCT03100058|156676613|FG010|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
48679250|NCT03100058|156676614|FG011|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
48679251|NCT03100058|156676615|FG012|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
48679252|NCT03100058|156676603|FG000|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
48679253|NCT03100058|156676604|FG001|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
48679254|NCT03100058|156676605|FG002|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
48679255|NCT03100058|156676606|FG003|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
48679256|NCT03100058|156676607|FG004|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
48679257|NCT03100058|156676608|FG005|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
48679258|NCT03100058|156676609|FG006|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
48679259|NCT03100058|156676610|FG007|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
48679260|NCT03100058|156676611|FG008|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
48679261|NCT03100058|156676612|FG009|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
48679262|NCT03100058|156676613|FG010|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
48679263|NCT03100058|156676614|FG011|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
48679264|NCT03100058|156676615|FG012|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
48679265|NCT03100058|156676603|FG000|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
48679266|NCT03100058|156676604|FG001|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
48679267|NCT03100058|156676605|FG002|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
48679268|NCT03100058|156676606|FG003|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
48679269|NCT03100058|156676607|FG004|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
48679270|NCT03100058|156676608|FG005|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
48679271|NCT03100058|156676609|FG006|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
48679272|NCT03100058|156676610|FG007|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
48679273|NCT03100058|156676611|FG008|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
48679274|NCT03100058|156676612|FG009|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
48679275|NCT03100058|156676613|FG010|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
48679276|NCT03100058|156676614|FG011|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
48679277|NCT03100058|156676615|FG012|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
48679278|NCT03100058|156676603|FG000|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
48679279|NCT03100058|156676604|FG001|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
48679280|NCT03100058|156676605|FG002|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
48679281|NCT03100058|156676606|FG003|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
48679282|NCT03100058|156676607|FG004|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
48679283|NCT03100058|156676608|FG005|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
48679284|NCT03100058|156676609|FG006|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
48679285|NCT03100058|156676610|FG007|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
48679286|NCT03100058|156676611|FG008|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
48679287|NCT03100058|156676612|FG009|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
48679288|NCT03100058|156676613|FG010|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
48679289|NCT03100058|156676614|FG011|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
48679290|NCT03100058|156676615|FG012|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
48679291|NCT03100058|156676603|FG000|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
48679292|NCT03100058|156676604|FG001|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
48679293|NCT03100058|156676605|FG002|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
48679294|NCT03100058|156676606|FG003|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
48679295|NCT03100058|156676607|FG004|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
48679296|NCT03100058|156676608|FG005|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
48679297|NCT03100058|156676609|FG006|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
48679298|NCT03100058|156676610|FG007|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
48679299|NCT03100058|156676611|FG008|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
48679300|NCT03100058|156676612|FG009|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
48679301|NCT03100058|156676613|FG010|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
48679302|NCT03100058|156676614|FG011|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
48679303|NCT03100058|156676615|FG012|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
48679304|NCT03100058|156676603|FG000|Epoch 3 (24 Weeks of Treatment)|Death|0|||
48679305|NCT03100058|156676604|FG001|Epoch 3 (24 Weeks of Treatment)|Death|1|||
48679306|NCT03100058|156676605|FG002|Epoch 3 (24 Weeks of Treatment)|Death|0|||
48679307|NCT03100058|156676606|FG003|Epoch 3 (24 Weeks of Treatment)|Death|0|||
48679308|NCT03100058|156676607|FG004|Epoch 3 (24 Weeks of Treatment)|Death|0|||
48679309|NCT03100058|156676608|FG005|Epoch 3 (24 Weeks of Treatment)|Death|0|||
48679310|NCT03100058|156676609|FG006|Epoch 3 (24 Weeks of Treatment)|Death|0|||
48679311|NCT03100058|156676610|FG007|Epoch 3 (24 Weeks of Treatment)|Death|0|||
48679312|NCT03100058|156676611|FG008|Epoch 3 (24 Weeks of Treatment)|Death|0|||
48679313|NCT03100058|156676612|FG009|Epoch 3 (24 Weeks of Treatment)|Death|0|||
48679314|NCT03100058|156676613|FG010|Epoch 3 (24 Weeks of Treatment)|Death|0|||
48679315|NCT03100058|156676614|FG011|Epoch 3 (24 Weeks of Treatment)|Death|0|||
48679316|NCT03100058|156676615|FG012|Epoch 3 (24 Weeks of Treatment)|Death|0|||
48679317|NCT03100058|156676603|FG000|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1|||
48679318|NCT03100058|156676604|FG001|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
48679319|NCT03100058|156676605|FG002|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
48679320|NCT03100058|156676606|FG003|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
48679321|NCT03100058|156676607|FG004|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
48679322|NCT03100058|156676608|FG005|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
48679323|NCT03100058|156676609|FG006|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
48679324|NCT03100058|156676610|FG007|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
48679325|NCT03100058|156676611|FG008|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
48679326|NCT03100058|156676612|FG009|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
48679327|NCT03100058|156676613|FG010|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
48679328|NCT03100058|156676614|FG011|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
48679329|NCT03100058|156676615|FG012|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
48679330|NCT03100058|156676603|FG000|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
48679331|NCT03100058|156676604|FG001|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
48679332|NCT03100058|156676605|FG002|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
48679333|NCT03100058|156676606|FG003|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
48679334|NCT03100058|156676607|FG004|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
48679335|NCT03100058|156676608|FG005|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
48679336|NCT03100058|156676609|FG006|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1|||
48679337|NCT03100058|156676610|FG007|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
48679338|NCT03100058|156676611|FG008|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
48679339|NCT03100058|156676612|FG009|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
48679340|NCT03100058|156676613|FG010|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
48679341|NCT03100058|156676614|FG011|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
48679342|NCT03100058|156676615|FG012|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
48679343|NCT03100058|156676603|FG000|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
48679344|NCT03100058|156676604|FG001|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
48679345|NCT03100058|156676605|FG002|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
48679346|NCT03100058|156676606|FG003|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
48679347|NCT03100058|156676607|FG004|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
48679348|NCT03100058|156676608|FG005|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
48679349|NCT03100058|156676609|FG006|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
48679350|NCT03100058|156676610|FG007|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
48679351|NCT03100058|156676611|FG008|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
48679352|NCT03100058|156676612|FG009|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
48679353|NCT03100058|156676613|FG010|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4|||
48679354|NCT03100058|156676614|FG011|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2|||
48679355|NCT03100058|156676615|FG012|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1|||
48679356|NCT03100058|156676603|FG000|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
48679357|NCT03100058|156676604|FG001|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
48679358|NCT03100058|156676605|FG002|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
48679359|NCT03100058|156676606|FG003|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
48679360|NCT03100058|156676607|FG004|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
48679361|NCT03100058|156676608|FG005|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
48679362|NCT03100058|156676609|FG006|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
48679363|NCT03100058|156676610|FG007|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
48679364|NCT03100058|156676611|FG008|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
48679365|NCT03100058|156676612|FG009|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
48679366|NCT03100058|156676613|FG010|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3|||
48679367|NCT03100058|156676614|FG011|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1|||
48679368|NCT03100058|156676615|FG012|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
48679369|NCT03100058|156676603|FG000|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
48679370|NCT03100058|156676604|FG001|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
48679371|NCT03100058|156676605|FG002|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
48679372|NCT03100058|156676606|FG003|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
48679373|NCT03100058|156676607|FG004|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
48679374|NCT03100058|156676608|FG005|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
48679375|NCT03100058|156676609|FG006|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
48679376|NCT03100058|156676610|FG007|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
48679377|NCT03100058|156676611|FG008|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
48679378|NCT03100058|156676612|FG009|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4|||
48679379|NCT03100058|156676613|FG010|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7|||
48679380|NCT03100058|156676614|FG011|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
48679381|NCT03100058|156676615|FG012|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2|||
48679382|NCT03100058|156676603|FG000|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
48679383|NCT03100058|156676604|FG001|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
48679384|NCT03100058|156676605|FG002|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
48679385|NCT03100058|156676606|FG003|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
48679386|NCT03100058|156676607|FG004|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
48679387|NCT03100058|156676608|FG005|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
48679388|NCT03100058|156676609|FG006|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
48679389|NCT03100058|156676610|FG007|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
48679390|NCT03100058|156676611|FG008|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
48679391|NCT03100058|156676612|FG009|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
48679392|NCT03100058|156676613|FG010|Epoch 4 (Last 24 Weeks of the Study)|Death|1|||
48679393|NCT03100058|156676614|FG011|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
48679394|NCT03100058|156676615|FG012|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
48679395|NCT03100058|156676603|FG000|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
48679396|NCT03100058|156676604|FG001|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
48679397|NCT03100058|156676605|FG002|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
48679398|NCT03100058|156676606|FG003|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
48679399|NCT03100058|156676607|FG004|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
48679400|NCT03100058|156676608|FG005|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
48679401|NCT03100058|156676609|FG006|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
48679402|NCT03100058|156676610|FG007|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
48679403|NCT03100058|156676611|FG008|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
48679404|NCT03100058|156676612|FG009|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
48679405|NCT03100058|156676613|FG010|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
48679406|NCT03100058|156676614|FG011|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
48679407|NCT03100058|156676615|FG012|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1|||
48762809|NCT00600938|156980347|FG001|Core Study|Protocol Violation|2|||
48762810|NCT00600938|156980348|FG002|Core Study|Protocol Violation|0|||
48679408|NCT03100058|156676603|FG000|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
48679409|NCT03100058|156676604|FG001|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
48679410|NCT03100058|156676605|FG002|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
48679411|NCT03100058|156676606|FG003|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
48679412|NCT03100058|156676607|FG004|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
48679413|NCT03100058|156676608|FG005|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
48679414|NCT03100058|156676609|FG006|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
48679415|NCT03100058|156676610|FG007|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
48679416|NCT03100058|156676611|FG008|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
48679417|NCT03100058|156676612|FG009|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1|||
48679418|NCT03100058|156676613|FG010|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
48679419|NCT03100058|156676614|FG011|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
48679420|NCT03100058|156676615|FG012|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
48679421|NCT00555672|156676617|FG000|Overall Study|Death|0|||
48679422|NCT00555672|156676618|FG001|Overall Study|Death|2|||
48679423|NCT00555672|156676617|FG000|Overall Study|Adverse Event|8|||
48679424|NCT00555672|156676618|FG001|Overall Study|Adverse Event|2|||
48679425|NCT00555672|156676617|FG000|Overall Study|Objective progression or relapse|11|||
48679426|NCT00555672|156676618|FG001|Overall Study|Objective progression or relapse|5|||
48679427|NCT00555672|156676617|FG000|Overall Study|Other|3|||
48679428|NCT00555672|156676618|FG001|Overall Study|Other|1|||
48679429|NCT00555672|156676617|FG000|Overall Study|Participant refused|2|||
48679430|NCT00555672|156676618|FG001|Overall Study|Participant refused|0|||
48679431|NCT01919801|156676620|FG000|Overall Study|Withdrawal by Subject|1|||
48679432|NCT01919801|156676621|FG001|Overall Study|Withdrawal by Subject|0|||
48679433|NCT01919801|156676620|FG000|Overall Study|Physician Decision|0|||
48679434|NCT01919801|156676621|FG001|Overall Study|Physician Decision|1|||
48679435|NCT01919801|156676620|FG000|Overall Study|Lost to Follow-up|0|||
48679436|NCT01919801|156676621|FG001|Overall Study|Lost to Follow-up|1|||
48679437|NCT01919801|156676620|FG000|Overall Study|Other|0|||
48679438|NCT01919801|156676621|FG001|Overall Study|Other|1|||
48679439|NCT01625000|156676628|FG000|Overall Study|Physician Decision|15|||
48679440|NCT01625000|156676629|FG001|Overall Study|Physician Decision|7|||
48679441|NCT01625000|156676630|FG002|Overall Study|Physician Decision|7|||
48679442|NCT01625000|156676631|FG003|Overall Study|Physician Decision|2|||
48679443|NCT01625000|156676632|FG004|Overall Study|Physician Decision|15|||
48679444|NCT01625000|156676628|FG000|Overall Study|Protocol Violation|3|||
48679445|NCT01625000|156676629|FG001|Overall Study|Protocol Violation|10|||
48679446|NCT01625000|156676630|FG002|Overall Study|Protocol Violation|4|||
48679447|NCT01625000|156676631|FG003|Overall Study|Protocol Violation|1|||
48679448|NCT01625000|156676632|FG004|Overall Study|Protocol Violation|2|||
48679449|NCT01625000|156676628|FG000|Overall Study|Withdrawal by Subject|19|||
48679450|NCT01625000|156676629|FG001|Overall Study|Withdrawal by Subject|16|||
48679451|NCT01625000|156676630|FG002|Overall Study|Withdrawal by Subject|11|||
48679452|NCT01625000|156676631|FG003|Overall Study|Withdrawal by Subject|9|||
48679453|NCT01625000|156676632|FG004|Overall Study|Withdrawal by Subject|17|||
48679454|NCT01625000|156676628|FG000|Overall Study|Adverse Event (including Death)|15|||
48679455|NCT01625000|156676629|FG001|Overall Study|Adverse Event (including Death)|19|||
48679456|NCT01625000|156676630|FG002|Overall Study|Adverse Event (including Death)|11|||
48679457|NCT01625000|156676631|FG003|Overall Study|Adverse Event (including Death)|7|||
48679458|NCT01625000|156676632|FG004|Overall Study|Adverse Event (including Death)|21|||
48679459|NCT02161380|156676633|FG000|Overall Study|Lost to Follow-up|0|||
48679460|NCT02161380|156676634|FG001|Overall Study|Lost to Follow-up|1|||
48679461|NCT02161380|156676635|FG002|Overall Study|Lost to Follow-up|0|||
48679462|NCT02161380|156676636|FG003|Overall Study|Lost to Follow-up|0|||
48679463|NCT00892775|156676638|FG000|Overall Study|Protocol Violation|1|||
48679464|NCT00892775|156676639|FG001|Overall Study|Protocol Violation|0|||
48679465|NCT00892775|156676638|FG000|Overall Study|Subject difficulties with blood drawing|1|||
48679466|NCT00892775|156676639|FG001|Overall Study|Subject difficulties with blood drawing|0|||
49020347|NCT03019965|157910888|FG001|Overall Study|acute liver failure in the first 24 hours of randomization|5|||
49020348|NCT03019965|157910887|FG000|Overall Study|Physician Decision|1|||
49020349|NCT03019965|157910888|FG001|Overall Study|Physician Decision|1|||
48679467|NCT00892775|156676638|FG000|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1|||
48679468|NCT00892775|156676639|FG001|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0|||
48679469|NCT00892775|156676638|FG000|Overall Study|Migrated/ moved from study area|1|||
48679470|NCT00892775|156676639|FG001|Overall Study|Migrated/ moved from study area|0|||
48679471|NCT00892775|156676638|FG000|Overall Study|Withdrawal by Subject|0|||
48679472|NCT00892775|156676639|FG001|Overall Study|Withdrawal by Subject|1|||
48679473|NCT00892775|156676638|FG000|Overall Study|Lost to Follow-up|1|||
48679474|NCT00892775|156676639|FG001|Overall Study|Lost to Follow-up|0|||
48679475|NCT00958165|156676640|FG000|Overall Study|Lost to Follow-up|5|||
48679476|NCT00958165|156676640|FG000|Overall Study|Not eligible|9|||
49020350|NCT01659567|157910889|FG000|Overall Study|Lack of Efficacy|22|||
48679477|NCT03405818|156676641|FG000|Overall Study|Withdrawal by Subject|4|||
48679478|NCT03405818|156676641|FG000|Overall Study|Lost to Follow-up|4|||
48679479|NCT00766051|156676642|FG000|Overall Study|Withdrawal by Subject|2|||
48679480|NCT00766051|156676643|FG001|Overall Study|Withdrawal by Subject|0|||
48679481|NCT02713828|156676646|FG000|Overall Study|Death|2|||
48679482|NCT02713828|156676647|FG001|Overall Study|Death|0|||
48679483|NCT02713828|156676646|FG000|Overall Study|Withdrawal by Subject|1|||
48679484|NCT02713828|156676647|FG001|Overall Study|Withdrawal by Subject|0|||
48679485|NCT02713828|156676646|FG000|Overall Study|study terminated but patient allowed to|2|||
48679486|NCT02713828|156676647|FG001|Overall Study|study terminated but patient allowed to|0|||
48679487|NCT01534195|156676648|FG000|Overall Study|Withdrawal by Subject|1|||
48679488|NCT01534195|156676649|FG001|Overall Study|Withdrawal by Subject|1|||
48679489|NCT01635855|156676650|FG000|Overall Study|Withdrawal by Subject|4|||
48679490|NCT03302247|156676651|FG000|Overall Study|the study has closed prematurely|2|||
48679491|NCT03302247|156676651|FG000|Overall Study|Death|1|||
48679492|NCT02669121|156676652|FG000|Overall Study|Adverse Event|4|||
48679493|NCT02669121|156676653|FG001|Overall Study|Adverse Event|5|||
48679494|NCT02669121|156676652|FG000|Overall Study|Lost to Follow-up|15|||
48679495|NCT02669121|156676653|FG001|Overall Study|Lost to Follow-up|27|||
48679496|NCT02669121|156676652|FG000|Overall Study|Withdrawal by Subject|132|||
48679497|NCT02669121|156676653|FG001|Overall Study|Withdrawal by Subject|140|||
48679498|NCT02669121|156676652|FG000|Overall Study|Pregnancy|0|||
48679499|NCT02669121|156676653|FG001|Overall Study|Pregnancy|1|||
48679500|NCT02669121|156676652|FG000|Overall Study|Discharged from US Military Active Service|117|||
48679501|NCT02669121|156676653|FG001|Overall Study|Discharged from US Military Active Service|91|||
48679502|NCT02669121|156676652|FG000|Overall Study|Reason not Specified|22|||
48679503|NCT02669121|156676653|FG001|Overall Study|Reason not Specified|18|||
48679504|NCT00635882|156676654|FG000|Overall Study|Protocol Violation|1|||
48679505|NCT00635882|156676655|FG001|Overall Study|Protocol Violation|0|||
48679506|NCT00635882|156676656|FG002|Overall Study|Protocol Violation|0|||
48679507|NCT00635882|156676657|FG003|Overall Study|Protocol Violation|0|||
48679508|NCT00635882|156676658|FG004|Overall Study|Protocol Violation|0|||
48679509|NCT00635882|156676659|FG005|Overall Study|Protocol Violation|0|||
48679510|NCT00858637|156676660|FG000|Active Comparison Phase|Adverse Event|14|||
48679511|NCT00858637|156676661|FG001|Active Comparison Phase|Adverse Event|0|||
48679512|NCT00858637|156676662|FG002|Active Comparison Phase|Adverse Event|0|||
48679513|NCT00858637|156676663|FG003|Active Comparison Phase|Adverse Event|9|||
48679514|NCT00858637|156676664|FG004|Active Comparison Phase|Adverse Event|0|||
48679515|NCT00858637|156676665|FG005|Active Comparison Phase|Adverse Event|0|||
48679516|NCT00858637|156676660|FG000|Active Comparison Phase|Death|1|||
48679517|NCT00858637|156676661|FG001|Active Comparison Phase|Death|0|||
48679518|NCT00858637|156676662|FG002|Active Comparison Phase|Death|0|||
48679519|NCT00858637|156676663|FG003|Active Comparison Phase|Death|1|||
48679520|NCT00858637|156676664|FG004|Active Comparison Phase|Death|0|||
48679521|NCT00858637|156676665|FG005|Active Comparison Phase|Death|0|||
48679522|NCT00858637|156676660|FG000|Active Comparison Phase|Physician Decision|1|||
48679523|NCT00858637|156676661|FG001|Active Comparison Phase|Physician Decision|0|||
48679524|NCT00858637|156676662|FG002|Active Comparison Phase|Physician Decision|0|||
48679525|NCT00858637|156676663|FG003|Active Comparison Phase|Physician Decision|1|||
48679526|NCT00858637|156676664|FG004|Active Comparison Phase|Physician Decision|0|||
48679527|NCT00858637|156676665|FG005|Active Comparison Phase|Physician Decision|0|||
48679528|NCT00858637|156676660|FG000|Active Comparison Phase|Withdrawal by Subject|7|||
48679529|NCT00858637|156676661|FG001|Active Comparison Phase|Withdrawal by Subject|0|||
48679530|NCT00858637|156676662|FG002|Active Comparison Phase|Withdrawal by Subject|0|||
48679531|NCT00858637|156676663|FG003|Active Comparison Phase|Withdrawal by Subject|6|||
48679532|NCT00858637|156676664|FG004|Active Comparison Phase|Withdrawal by Subject|0|||
48679533|NCT00858637|156676665|FG005|Active Comparison Phase|Withdrawal by Subject|0|||
48679534|NCT00858637|156676660|FG000|Active Comparison Phase|Other Reasons|1|||
48679535|NCT00858637|156676661|FG001|Active Comparison Phase|Other Reasons|0|||
48679536|NCT00858637|156676662|FG002|Active Comparison Phase|Other Reasons|0|||
48679537|NCT00858637|156676663|FG003|Active Comparison Phase|Other Reasons|1|||
48679538|NCT00858637|156676664|FG004|Active Comparison Phase|Other Reasons|0|||
48679539|NCT00858637|156676665|FG005|Active Comparison Phase|Other Reasons|0|||
48679540|NCT00858637|156676660|FG000|Placebo-controlled Withdrawal Phase|Death|0|||
48679541|NCT00858637|156676661|FG001|Placebo-controlled Withdrawal Phase|Death|0|||
48679542|NCT00858637|156676662|FG002|Placebo-controlled Withdrawal Phase|Death|1|||
48679543|NCT00858637|156676663|FG003|Placebo-controlled Withdrawal Phase|Death|0|||
48679544|NCT00858637|156676664|FG004|Placebo-controlled Withdrawal Phase|Death|1|||
48679545|NCT00858637|156676665|FG005|Placebo-controlled Withdrawal Phase|Death|0|||
48679546|NCT00858637|156676660|FG000|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
48679547|NCT00858637|156676661|FG001|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
48679548|NCT00858637|156676662|FG002|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
48679549|NCT00858637|156676663|FG003|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
48679550|NCT00858637|156676664|FG004|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
48679551|NCT00858637|156676665|FG005|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1|||
48679552|NCT00195663|156676668|FG000|2-year Double-blind Treatment Period|Adverse Event|21|||
48679553|NCT00195663|156676669|FG001|2-year Double-blind Treatment Period|Adverse Event|27|||
48679554|NCT00195663|156676670|FG002|2-year Double-blind Treatment Period|Adverse Event|32|||
48679555|NCT00195663|156676668|FG000|2-year Double-blind Treatment Period|Death|0|||
48679556|NCT00195663|156676669|FG001|2-year Double-blind Treatment Period|Death|2|||
48679557|NCT00195663|156676670|FG002|2-year Double-blind Treatment Period|Death|0|||
48679558|NCT00195663|156676668|FG000|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
48679559|NCT00195663|156676669|FG001|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
48679560|NCT00195663|156676670|FG002|2-year Double-blind Treatment Period|Lost to Follow-up|1|||
48679561|NCT00195663|156676668|FG000|2-year Double-blind Treatment Period|Withdrawal by Subject|15|||
48679562|NCT00195663|156676669|FG001|2-year Double-blind Treatment Period|Withdrawal by Subject|18|||
48679563|NCT00195663|156676670|FG002|2-year Double-blind Treatment Period|Withdrawal by Subject|12|||
48679564|NCT00195663|156676668|FG000|2-year Double-blind Treatment Period|Lack of Efficacy|47|||
48679565|NCT00195663|156676669|FG001|2-year Double-blind Treatment Period|Lack of Efficacy|52|||
48679566|NCT00195663|156676670|FG002|2-year Double-blind Treatment Period|Lack of Efficacy|13|||
48679567|NCT00195663|156676668|FG000|2-year Double-blind Treatment Period|Protocol Violation|6|||
48679568|NCT00195663|156676669|FG001|2-year Double-blind Treatment Period|Protocol Violation|6|||
48679569|NCT00195663|156676670|FG002|2-year Double-blind Treatment Period|Protocol Violation|4|||
48679570|NCT00195663|156676668|FG000|2-year Double-blind Treatment Period|Planned selection criteria|0|||
48679571|NCT00195663|156676669|FG001|2-year Double-blind Treatment Period|Planned selection criteria|1|||
48679572|NCT00195663|156676670|FG002|2-year Double-blind Treatment Period|Planned selection criteria|0|||
48679573|NCT00195663|156676668|FG000|2-year Double-blind Treatment Period|Recovery|1|||
48679574|NCT00195663|156676669|FG001|2-year Double-blind Treatment Period|Recovery|0|||
48679575|NCT00195663|156676670|FG002|2-year Double-blind Treatment Period|Recovery|1|||
48679576|NCT00195663|156676668|FG000|2-year Double-blind Treatment Period|Administrative reasons|3|||
48679577|NCT00195663|156676669|FG001|2-year Double-blind Treatment Period|Administrative reasons|2|||
48679578|NCT00195663|156676670|FG002|2-year Double-blind Treatment Period|Administrative reasons|9|||
48679579|NCT00195663|156676668|FG000|Open-Label Extension Period|Adverse Event|21|||
48679580|NCT00195663|156676669|FG001|Open-Label Extension Period|Adverse Event|32|||
48679581|NCT00195663|156676670|FG002|Open-Label Extension Period|Adverse Event|36|||
48679582|NCT00195663|156676668|FG000|Open-Label Extension Period|Lost to Follow-up|9|||
48679583|NCT00195663|156676669|FG001|Open-Label Extension Period|Lost to Follow-up|2|||
48679584|NCT00195663|156676670|FG002|Open-Label Extension Period|Lost to Follow-up|6|||
48679585|NCT00195663|156676668|FG000|Open-Label Extension Period|Recovery|0|||
48679586|NCT00195663|156676669|FG001|Open-Label Extension Period|Recovery|2|||
48679587|NCT00195663|156676670|FG002|Open-Label Extension Period|Recovery|2|||
48679588|NCT00195663|156676668|FG000|Open-Label Extension Period|Protocol Violation|3|||
48679589|NCT00195663|156676669|FG001|Open-Label Extension Period|Protocol Violation|4|||
48679590|NCT00195663|156676670|FG002|Open-Label Extension Period|Protocol Violation|4|||
48679591|NCT00195663|156676668|FG000|Open-Label Extension Period|Death|2|||
48679592|NCT00195663|156676669|FG001|Open-Label Extension Period|Death|2|||
48679593|NCT00195663|156676670|FG002|Open-Label Extension Period|Death|2|||
48679594|NCT00195663|156676668|FG000|Open-Label Extension Period|Withdrawal by Subject|16|||
48679595|NCT00195663|156676669|FG001|Open-Label Extension Period|Withdrawal by Subject|15|||
48679596|NCT00195663|156676670|FG002|Open-Label Extension Period|Withdrawal by Subject|22|||
48679597|NCT00195663|156676668|FG000|Open-Label Extension Period|Lack of Efficacy|14|||
48679598|NCT00195663|156676669|FG001|Open-Label Extension Period|Lack of Efficacy|6|||
48679599|NCT00195663|156676670|FG002|Open-Label Extension Period|Lack of Efficacy|12|||
48679600|NCT00195663|156676668|FG000|Open-Label Extension Period|Administrative reasons|11|||
48679601|NCT00195663|156676669|FG001|Open-Label Extension Period|Administrative reasons|11|||
48679602|NCT00195663|156676670|FG002|Open-Label Extension Period|Administrative reasons|13|||
48679603|NCT01380834|156676671|FG000|Overall Study|Physician Decision|1|||
48679604|NCT01380834|156676672|FG001|Overall Study|Physician Decision|0|||
48679605|NCT00604695|156676673|FG000|Overall Study|Did not receive first bolus.|0|||
48679606|NCT00604695|156676674|FG001|Overall Study|Did not receive first bolus.|4|||
48679607|NCT03214406|156676675|FG000|Overall Study|did not meet enrollment criteria|9|||
48679608|NCT03214406|156676676|FG001|Overall Study|did not meet enrollment criteria|13|||
48679609|NCT03214406|156676675|FG000|Overall Study|Withdrawal by Subject|1|||
48679610|NCT03214406|156676676|FG001|Overall Study|Withdrawal by Subject|0|||
48679611|NCT03214406|156676675|FG000|Overall Study|Lost to Follow-up|0|||
48679612|NCT03214406|156676676|FG001|Overall Study|Lost to Follow-up|2|||
48679613|NCT04310566|156676682|FG000|Period 1|Study Termination due to COVID-19|15|||
48679614|NCT04310566|156676683|FG001|Period 1|Study Termination due to COVID-19|17|||
48679615|NCT04310566|156676682|FG000|Period 1|Protocol Violation|0|||
48679616|NCT04310566|156676683|FG001|Period 1|Protocol Violation|1|||
48679617|NCT04310566|156676682|FG000|Period 1|Subject no longer meets eligbility criteria|0|||
48762811|NCT00600938|156980349|FG003|Core Study|Protocol Violation|0|||
48679618|NCT04310566|156676683|FG001|Period 1|Subject no longer meets eligbility criteria|1|||
48679619|NCT04310566|156676682|FG000|Period 1|Lost to Follow-up|1|||
48762812|NCT00600938|156980346|FG000|Extension Study|Adverse Event|1|||
48679620|NCT04310566|156676683|FG001|Period 1|Lost to Follow-up|0|||
48679621|NCT04310566|156676682|FG000|Period 1|Withdrawal by Subject|0|||
48679622|NCT04310566|156676683|FG001|Period 1|Withdrawal by Subject|1|||
48679623|NCT04310566|156676682|FG000|Period 2|Study Termination|7|||
48679624|NCT04310566|156676683|FG001|Period 2|Study Termination|5|||
48679625|NCT04677504|156676684|FG000|Overall Study|Death|51|||
48679626|NCT04677504|156676685|FG001|Overall Study|Death|49|||
48679627|NCT04677504|156676684|FG000|Overall Study|Progressive Disease|1|||
48679628|NCT04677504|156676685|FG001|Overall Study|Progressive Disease|0|||
48679629|NCT04677504|156676684|FG000|Overall Study|Symptomatic Deterioration|1|||
48679630|NCT04677504|156676685|FG001|Overall Study|Symptomatic Deterioration|0|||
48679631|NCT04677504|156676684|FG000|Overall Study|Withdrawal by Subject|2|||
48679632|NCT04677504|156676685|FG001|Overall Study|Withdrawal by Subject|5|||
48679633|NCT04677504|156676684|FG000|Overall Study|Study Terminated By Sponsor|28|||
48679634|NCT04677504|156676685|FG001|Overall Study|Study Terminated By Sponsor|24|||
48679635|NCT04677504|156676684|FG000|Overall Study|Adverse Event|0|||
48679636|NCT04677504|156676685|FG001|Overall Study|Adverse Event|1|||
48679637|NCT01771250|156676686|FG000|Period 1|Met exclusion criteria|1|||
48679638|NCT01771250|156676687|FG001|Period 1|Met exclusion criteria|0|||
48679639|NCT01059318|156676690|FG000|Core Study (26 Week)|Adverse Event|3|||
48679640|NCT01059318|156676690|FG000|Core Study (26 Week)|Withdrawal by Subject|1|||
48679641|NCT01059318|156676690|FG000|Extension (36 Week)|Adverse Event|3|||
48679642|NCT01371552|156676691|FG000|Part 1, First 3 Days|Inconvenience|0|||
48679643|NCT01371552|156676692|FG001|Part 1, First 3 Days|Inconvenience|0|||
48679644|NCT01371552|156676693|FG002|Part 1, First 3 Days|Inconvenience|1|||
48679645|NCT01371552|156676694|FG003|Part 1, First 3 Days|Inconvenience|0|||
48679646|NCT01371552|156676695|FG004|Part 1, First 3 Days|Inconvenience|0|||
48679647|NCT01371552|156676696|FG005|Part 1, First 3 Days|Inconvenience|0|||
48679648|NCT02519595|156676698|FG000|Overall Study|Protocol Violation|8|||
48679649|NCT02519595|156676699|FG001|Overall Study|Protocol Violation|22|||
48679650|NCT02519595|156676700|FG002|Overall Study|Protocol Violation|16|||
48679651|NCT04522141|156676702|FG000|Overall Study|Withdrawal by Subject|1|||
48679652|NCT04522141|156676703|FG001|Overall Study|Withdrawal by Subject|0|||
48679653|NCT02397057|156676707|FG000|Overall Study|Withdrawal by Subject|6|||
48679654|NCT02397057|156676708|FG001|Overall Study|Withdrawal by Subject|7|||
48679655|NCT02397057|156676707|FG000|Overall Study|Lost to Follow-up|4|||
48679656|NCT02397057|156676708|FG001|Overall Study|Lost to Follow-up|3|||
48679657|NCT02397057|156676707|FG000|Overall Study|Death|1|||
48679658|NCT02397057|156676708|FG001|Overall Study|Death|0|||
48679659|NCT02397057|156676707|FG000|Overall Study|Adverse Event|0|||
48679660|NCT02397057|156676708|FG001|Overall Study|Adverse Event|1|||
48679661|NCT02397057|156676707|FG000|Overall Study|Physician Decision|0|||
48679662|NCT02397057|156676708|FG001|Overall Study|Physician Decision|1|||
48679663|NCT02397057|156676707|FG000|Overall Study|Subject did not receive study drug|0|||
48679664|NCT02397057|156676708|FG001|Overall Study|Subject did not receive study drug|1|||
48679665|NCT03543137|156676709|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
48679666|NCT03543137|156676710|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
48679667|NCT03543137|156676709|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
48679668|NCT03543137|156676710|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
48679669|NCT03543137|156676709|FG000|Study Period 2: Up to Day 8|Adverse Event|0|||
48679670|NCT03543137|156676710|FG001|Study Period 2: Up to Day 8|Adverse Event|1|||
48679671|NCT00176462|156676712|FG000|Induction (4 Weeks)|Withdrawal by Subject|0|||
48679672|NCT00176462|156676713|FG001|Induction (4 Weeks)|Withdrawal by Subject|2|||
48679673|NCT00176462|156676712|FG000|Induction (4 Weeks)|Death|1|||
48679674|NCT00176462|156676713|FG001|Induction (4 Weeks)|Death|2|||
48679675|NCT00176462|156676712|FG000|Induction (4 Weeks)|Lack of Efficacy|0|||
48679676|NCT00176462|156676713|FG001|Induction (4 Weeks)|Lack of Efficacy|1|||
48679677|NCT00176462|156676712|FG000|Consolidation (12 Weeks)|Patient moved to another state|0|||
48679678|NCT00176462|156676713|FG001|Consolidation (12 Weeks)|Patient moved to another state|1|||
48679679|NCT00176462|156676712|FG000|Consolidation (12 Weeks)|Adverse Event|0|||
48679680|NCT00176462|156676713|FG001|Consolidation (12 Weeks)|Adverse Event|1|||
48679681|NCT00176462|156676712|FG000|Consolidation (12 Weeks)|Lack of Efficacy|0|||
48679682|NCT00176462|156676713|FG001|Consolidation (12 Weeks)|Lack of Efficacy|2|||
48679683|NCT00176462|156676712|FG000|Consolidation (12 Weeks)|Not documented|0|||
48679684|NCT00176462|156676713|FG001|Consolidation (12 Weeks)|Not documented|1|||
48679685|NCT00176462|156676712|FG000|Intensive Continuation (8X8-week Cycles)|Death|1|||
48679686|NCT00176462|156676713|FG001|Intensive Continuation (8X8-week Cycles)|Death|0|||
48679687|NCT00176462|156676712|FG000|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0|||
48679688|NCT00176462|156676713|FG001|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3|||
48679689|NCT01099397|156676720|FG000|Overall Study|Lost to Follow-up|4|||
48679690|NCT01099397|156676720|FG000|Overall Study|Protocol Violation|4|||
48762813|NCT00600938|156980347|FG001|Extension Study|Adverse Event|0|||
48679691|NCT01099397|156676720|FG000|Overall Study|Withdrawal by Subject|5|||
48679692|NCT01279681|156676721|FG000|Overall Study|Disease Progression|9|||
48679693|NCT01279681|156676722|FG001|Overall Study|Disease Progression|6|||
48679694|NCT01279681|156676721|FG000|Overall Study|Withdrawal by Subject|3|||
48679695|NCT01279681|156676722|FG001|Overall Study|Withdrawal by Subject|4|||
48679696|NCT01279681|156676721|FG000|Overall Study|Adverse Event|2|||
48679697|NCT01279681|156676722|FG001|Overall Study|Adverse Event|3|||
48679698|NCT01279681|156676721|FG000|Overall Study|Death|0|||
48679699|NCT01279681|156676722|FG001|Overall Study|Death|1|||
48679700|NCT01279681|156676721|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
48679701|NCT01279681|156676722|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
48679702|NCT01279681|156676721|FG000|Overall Study|Physician Decision|1|||
48679703|NCT01279681|156676722|FG001|Overall Study|Physician Decision|0|||
48679704|NCT01279681|156676721|FG000|Overall Study|Other Reason|0|||
48679705|NCT01279681|156676722|FG001|Overall Study|Other Reason|2|||
48679706|NCT01943591|156676723|FG000|Overall Study|Lost to Follow-up|3|||
48679707|NCT01943591|156676724|FG001|Overall Study|Lost to Follow-up|4|||
48679708|NCT01943591|156676723|FG000|Overall Study|Death|2|||
48679709|NCT01943591|156676724|FG001|Overall Study|Death|7|||
48679710|NCT00511238|156676727|FG000|Overall Study|Adverse Event|13|||
48679711|NCT00511238|156676728|FG001|Overall Study|Adverse Event|33|||
48679712|NCT00511238|156676727|FG000|Overall Study|Withdrawal by Subject|2|||
48679713|NCT00511238|156676728|FG001|Overall Study|Withdrawal by Subject|22|||
48679714|NCT00511238|156676727|FG000|Overall Study|Progressive Disease|23|||
48679715|NCT00511238|156676728|FG001|Overall Study|Progressive Disease|157|||
48679716|NCT00511238|156676727|FG000|Overall Study|various reasons|4|||
48679717|NCT00511238|156676728|FG001|Overall Study|various reasons|14|||
48679718|NCT02008227|156678374|FG000|Overall Study|Lost to Follow-up|7|||
48679719|NCT02008227|156678375|FG001|Overall Study|Lost to Follow-up|9|||
48679720|NCT02008227|156678374|FG000|Overall Study|Death|494|||
48679721|NCT02008227|156678375|FG001|Overall Study|Death|485|||
48679722|NCT02008227|156678374|FG000|Overall Study|Withdrawal by Subject|67|||
48679723|NCT02008227|156678375|FG001|Overall Study|Withdrawal by Subject|36|||
48679724|NCT02008227|156678374|FG000|Overall Study|Study Terminated By Sponsor|44|||
48679725|NCT02008227|156678375|FG001|Overall Study|Study Terminated By Sponsor|83|||
48679726|NCT01769196|156678376|FG000|Overall Study|Adverse Event|24|||
48679727|NCT01769196|156678377|FG001|Overall Study|Adverse Event|20|||
48679728|NCT01769196|156678376|FG000|Overall Study|Death|21|||
48679729|NCT01769196|156678377|FG001|Overall Study|Death|26|||
48679730|NCT01769196|156678376|FG000|Overall Study|Investigator Discretion|7|||
48679731|NCT01769196|156678377|FG001|Overall Study|Investigator Discretion|3|||
48679732|NCT01769196|156678376|FG000|Overall Study|Lack of Efficacy|3|||
48679733|NCT01769196|156678377|FG001|Overall Study|Lack of Efficacy|2|||
48679734|NCT01769196|156678376|FG000|Overall Study|Progressive disease|11|||
48679735|NCT01769196|156678377|FG001|Overall Study|Progressive disease|6|||
48679736|NCT01769196|156678376|FG000|Overall Study|Protocol defined criteria for withdrawal|9|||
48679737|NCT01769196|156678377|FG001|Overall Study|Protocol defined criteria for withdrawal|11|||
48679738|NCT01769196|156678376|FG000|Overall Study|Protocol Violation|0|||
48679739|NCT01769196|156678377|FG001|Overall Study|Protocol Violation|3|||
48679740|NCT01769196|156678376|FG000|Overall Study|Study terminated by sponsor|160|||
48679741|NCT01769196|156678377|FG001|Overall Study|Study terminated by sponsor|161|||
48679742|NCT01769196|156678376|FG000|Overall Study|Participant never dosed with study drug|1|||
48679743|NCT01769196|156678377|FG001|Overall Study|Participant never dosed with study drug|0|||
48679744|NCT01769196|156678376|FG000|Overall Study|Withdrew consent|36|||
48679745|NCT01769196|156678377|FG001|Overall Study|Withdrew consent|40|||
48679746|NCT01618695|156678384|FG000|Core Phase|Adverse Event|4|||
48679747|NCT01618695|156678385|FG001|Core Phase|Adverse Event|5|||
48679748|NCT01618695|156678386|FG002|Core Phase|Adverse Event|15|||
48679749|NCT01618695|156678387|FG003|Core Phase|Adverse Event|20|||
48679750|NCT01618695|156678384|FG000|Core Phase|Lost to Follow-up|0|||
48679751|NCT01618695|156678385|FG001|Core Phase|Lost to Follow-up|0|||
48679752|NCT01618695|156678386|FG002|Core Phase|Lost to Follow-up|1|||
48679753|NCT01618695|156678387|FG003|Core Phase|Lost to Follow-up|0|||
48679754|NCT01618695|156678384|FG000|Core Phase|Withdrawal by Subject|16|||
48679755|NCT01618695|156678385|FG001|Core Phase|Withdrawal by Subject|11|||
48679756|NCT01618695|156678386|FG002|Core Phase|Withdrawal by Subject|9|||
48679757|NCT01618695|156678387|FG003|Core Phase|Withdrawal by Subject|13|||
48679758|NCT01618695|156678384|FG000|Core Phase|Pregnancy|2|||
48679759|NCT01618695|156678385|FG001|Core Phase|Pregnancy|0|||
48679760|NCT01618695|156678386|FG002|Core Phase|Pregnancy|0|||
48679761|NCT01618695|156678387|FG003|Core Phase|Pregnancy|0|||
48679762|NCT01618695|156678384|FG000|Core Phase|Lack of Efficacy|1|||
48679763|NCT01618695|156678385|FG001|Core Phase|Lack of Efficacy|2|||
48679764|NCT01618695|156678386|FG002|Core Phase|Lack of Efficacy|1|||
48679765|NCT01618695|156678387|FG003|Core Phase|Lack of Efficacy|1|||
48679766|NCT01618695|156678384|FG000|Core Phase|Other than specified|1|||
48679767|NCT01618695|156678385|FG001|Core Phase|Other than specified|2|||
48679768|NCT01618695|156678386|FG002|Core Phase|Other than specified|2|||
48679769|NCT01618695|156678387|FG003|Core Phase|Other than specified|2|||
48679770|NCT01618695|156678384|FG000|Core Phase|Not treated|1|||
48679771|NCT01618695|156678385|FG001|Core Phase|Not treated|0|||
48679772|NCT01618695|156678386|FG002|Core Phase|Not treated|2|||
48679773|NCT01618695|156678387|FG003|Core Phase|Not treated|0|||
48679774|NCT01618695|156678384|FG000|Extension Phase|Lack of Efficacy|17|||
48679775|NCT01618695|156678385|FG001|Extension Phase|Lack of Efficacy|33|||
48679776|NCT01618695|156678386|FG002|Extension Phase|Lack of Efficacy|26|||
48679777|NCT01618695|156678387|FG003|Extension Phase|Lack of Efficacy|24|||
48679778|NCT01618695|156678384|FG000|Extension Phase|Pregnancy|2|||
48679779|NCT01618695|156678385|FG001|Extension Phase|Pregnancy|0|||
48679780|NCT01618695|156678386|FG002|Extension Phase|Pregnancy|1|||
48679781|NCT01618695|156678387|FG003|Extension Phase|Pregnancy|1|||
48679782|NCT01618695|156678384|FG000|Extension Phase|Withdrawal by Subject|43|||
48679783|NCT01618695|156678385|FG001|Extension Phase|Withdrawal by Subject|48|||
48679784|NCT01618695|156678386|FG002|Extension Phase|Withdrawal by Subject|42|||
48679785|NCT01618695|156678387|FG003|Extension Phase|Withdrawal by Subject|33|||
48679786|NCT01618695|156678384|FG000|Extension Phase|Adverse Event|18|||
48679787|NCT01618695|156678385|FG001|Extension Phase|Adverse Event|16|||
48679788|NCT01618695|156678386|FG002|Extension Phase|Adverse Event|9|||
48679789|NCT01618695|156678387|FG003|Extension Phase|Adverse Event|20|||
48679790|NCT01618695|156678384|FG000|Extension Phase|Lost to Follow-up|2|||
48679791|NCT01618695|156678385|FG001|Extension Phase|Lost to Follow-up|1|||
48679792|NCT01618695|156678386|FG002|Extension Phase|Lost to Follow-up|1|||
48679793|NCT01618695|156678387|FG003|Extension Phase|Lost to Follow-up|1|||
48679794|NCT01618695|156678384|FG000|Extension Phase|Other than specified|13|||
48679795|NCT01618695|156678385|FG001|Extension Phase|Other than specified|18|||
48679796|NCT01618695|156678386|FG002|Extension Phase|Other than specified|13|||
48679797|NCT01618695|156678387|FG003|Extension Phase|Other than specified|18|||
48679798|NCT03688074|156678392|FG000|Overall Study|Adverse Event|0|||
48679799|NCT03688074|156678393|FG001|Overall Study|Adverse Event|1|||
48679800|NCT03688074|156678392|FG000|Overall Study|Other|1|||
48679801|NCT03688074|156678393|FG001|Overall Study|Other|0|||
48679802|NCT02489942|156678397|FG000|Overall Study|Request by patient|602|||
48679803|NCT02489942|156678397|FG000|Overall Study|Improvement/remission|157|||
48679804|NCT02489942|156678397|FG000|Overall Study|No change/Progressive disease|263|||
48679805|NCT02489942|156678397|FG000|Overall Study|Adverse Event|522|||
48679806|NCT02489942|156678397|FG000|Overall Study|Other personal reasons|1218|||
48679807|NCT02489942|156678397|FG000|Overall Study|Lost to Follow-up|456|||
48679808|NCT02489942|156678397|FG000|Overall Study|Not continuously investigated|7|||
48679809|NCT02489942|156678397|FG000|Overall Study|Patient started jardiance treatment out of registration period|1|||
48679810|NCT02489942|156678397|FG000|Overall Study|Multiple registration|1|||
48679811|NCT02489942|156678397|FG000|Overall Study|No patient visit after entry|100|||
48679812|NCT02489942|156678397|FG000|Overall Study|No treatment with Jardiance|2|||
48679813|NCT02489942|156678397|FG000|Overall Study|Patient received Jardiance before registration|1|||
48679814|NCT02489942|156678397|FG000|Overall Study|No CRF collected|86|||
48679815|NCT02828436|156678398|FG000|Period 1|Did Not Meet Inclusion Criteria|0|||
48679816|NCT02828436|156678399|FG001|Period 1|Did Not Meet Inclusion Criteria|3|||
48679817|NCT02828436|156678398|FG000|Period 1|Lost to Follow-up|0|||
48679818|NCT02828436|156678399|FG001|Period 1|Lost to Follow-up|1|||
48679819|NCT02828436|156678398|FG000|Period 2|Withdrawal by Subject|4|||
48679820|NCT02828436|156678399|FG001|Period 2|Withdrawal by Subject|0|||
48679821|NCT02828436|156678398|FG000|Period 2|Did Not Meet Inclusion Criteria|3|||
48679822|NCT02828436|156678399|FG001|Period 2|Did Not Meet Inclusion Criteria|0|||
48679823|NCT02828436|156678398|FG000|Period 2|Lost to Follow-up|1|||
48679824|NCT02828436|156678399|FG001|Period 2|Lost to Follow-up|0|||
48679825|NCT00536471|156678406|FG000|Overall Study|Lost to Follow-up|48|||
48679826|NCT00536471|156678407|FG001|Overall Study|Lost to Follow-up|23|||
48679827|NCT00536471|156678408|FG002|Overall Study|Lost to Follow-up|48|||
48679828|NCT00536471|156678409|FG003|Overall Study|Lost to Follow-up|22|||
48679829|NCT00536471|156678406|FG000|Overall Study|Adverse Event|32|||
48679830|NCT00536471|156678407|FG001|Overall Study|Adverse Event|16|||
48679831|NCT00536471|156678408|FG002|Overall Study|Adverse Event|28|||
48679832|NCT00536471|156678409|FG003|Overall Study|Adverse Event|13|||
48679833|NCT00536471|156678406|FG000|Overall Study|Withdrawal by Subject|40|||
48679834|NCT00536471|156678407|FG001|Overall Study|Withdrawal by Subject|24|||
48679835|NCT00536471|156678408|FG002|Overall Study|Withdrawal by Subject|43|||
48679836|NCT00536471|156678409|FG003|Overall Study|Withdrawal by Subject|21|||
48679837|NCT00536471|156678406|FG000|Overall Study|Lack of Efficacy|17|||
48679838|NCT00536471|156678407|FG001|Overall Study|Lack of Efficacy|18|||
48679839|NCT00536471|156678408|FG002|Overall Study|Lack of Efficacy|11|||
48679840|NCT00536471|156678409|FG003|Overall Study|Lack of Efficacy|9|||
48762814|NCT00600938|156980348|FG002|Extension Study|Adverse Event|2|||
48762815|NCT00600938|156980349|FG003|Extension Study|Adverse Event|0|||
48679841|NCT00536471|156678406|FG000|Overall Study|Protocol Violation|8|||
48679842|NCT00536471|156678407|FG001|Overall Study|Protocol Violation|1|||
48762816|NCT00600938|156980346|FG000|Extension Study|Abnormal test procedure results|0|||
48762817|NCT00600938|156980347|FG001|Extension Study|Abnormal test procedure results|1|||
48679843|NCT00536471|156678408|FG002|Overall Study|Protocol Violation|2|||
48679844|NCT00536471|156678409|FG003|Overall Study|Protocol Violation|3|||
48679845|NCT00536471|156678406|FG000|Overall Study|Physician Decision|11|||
48679846|NCT00536471|156678407|FG001|Overall Study|Physician Decision|1|||
48679847|NCT00536471|156678408|FG002|Overall Study|Physician Decision|3|||
48679848|NCT00536471|156678409|FG003|Overall Study|Physician Decision|2|||
48679849|NCT00536471|156678406|FG000|Overall Study|Death|0|||
48762818|NCT00600938|156980348|FG002|Extension Study|Abnormal test procedure results|1|||
49020351|NCT01659567|157910889|FG000|Overall Study|Switched to Pegferon|6|||
49020352|NCT01659567|157910889|FG000|Overall Study|Adverse Event|12|||
49020353|NCT01659567|157910889|FG000|Overall Study|Good result at early stage of treatment|5|||
49020354|NCT01659567|157910889|FG000|Overall Study|Withdrawal by Subject|64|||
49020355|NCT01659567|157910889|FG000|Overall Study|Progression of the main disease|1|||
49020356|NCT01659567|157910889|FG000|Overall Study|Other|13|||
49020357|NCT01179919|157910892|FG000|Overall Study|Protocol Violation|1|||
49020358|NCT01179919|157910892|FG000|Overall Study|Adverse Event|1|||
49020359|NCT01915732|157910893|FG000|Overall Study|Withdrawal by Subject|18|||
49020360|NCT01915732|157910894|FG001|Overall Study|Withdrawal by Subject|18|||
49020361|NCT01915732|157910893|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
49020362|NCT01915732|157910894|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
49020363|NCT01915732|157910893|FG000|Overall Study|Adverse Event|12|||
49020364|NCT01915732|157910894|FG001|Overall Study|Adverse Event|4|||
49020365|NCT01915732|157910893|FG000|Overall Study|Protocol Violation|5|||
49020366|NCT01915732|157910894|FG001|Overall Study|Protocol Violation|5|||
48679850|NCT00536471|156678407|FG001|Overall Study|Death|0|||
48679851|NCT00536471|156678408|FG002|Overall Study|Death|1|||
48679852|NCT00536471|156678409|FG003|Overall Study|Death|2|||
48679853|NCT00536471|156678406|FG000|Overall Study|Sponsor Decision|0|||
48679854|NCT00536471|156678407|FG001|Overall Study|Sponsor Decision|1|||
48679855|NCT00536471|156678408|FG002|Overall Study|Sponsor Decision|3|||
48679856|NCT00536471|156678409|FG003|Overall Study|Sponsor Decision|2|||
48679857|NCT05274269|156678410|FG000|Overall Study|Adverse Event|0|||
48679858|NCT05274269|156678411|FG001|Overall Study|Adverse Event|3|||
48679859|NCT05274269|156678410|FG000|Overall Study|Death|0|||
48679860|NCT05274269|156678411|FG001|Overall Study|Death|1|||
48679861|NCT05274269|156678410|FG000|Overall Study|Other|0|||
48679862|NCT05274269|156678411|FG001|Overall Study|Other|2|||
48679863|NCT05274269|156678410|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
48679864|NCT05274269|156678411|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
48679865|NCT02206035|156678412|FG000|Overall Study|Physician Decision|10|||
48679866|NCT02206035|156678413|FG001|Overall Study|Physician Decision|0|||
48679867|NCT02206035|156678414|FG002|Overall Study|Physician Decision|175|||
48679868|NCT05249569|156678415|FG000|Overall Study|Sponsor pulled support for one of the study drugs.|1|||
48679869|NCT00726232|156678417|FG000|Initial Phase (Dose-finding)|Death|0|||
48679870|NCT00726232|156678418|FG001|Initial Phase (Dose-finding)|Death|0|||
48679871|NCT00726232|156678419|FG002|Initial Phase (Dose-finding)|Death|0|||
48679872|NCT00726232|156678420|FG003|Initial Phase (Dose-finding)|Death|0|||
48679873|NCT00726232|156678421|FG004|Initial Phase (Dose-finding)|Death|1|||
48679874|NCT00726232|156678422|FG005|Initial Phase (Dose-finding)|Death|0|||
48679875|NCT00726232|156678423|FG006|Initial Phase (Dose-finding)|Death|0|||
49020367|NCT01915732|157910893|FG000|Overall Study|Lack of Efficacy|6|||
49020368|NCT01915732|157910894|FG001|Overall Study|Lack of Efficacy|11|||
49020369|NCT01915732|157910893|FG000|Overall Study|Lost to Follow-up|22|||
48679876|NCT00726232|156678424|FG007|Initial Phase (Dose-finding)|Death|0|||
48679877|NCT00726232|156678417|FG000|Initial Phase (Dose-finding)|Adverse Event|2|||
48679878|NCT00726232|156678418|FG001|Initial Phase (Dose-finding)|Adverse Event|2|||
48679879|NCT00726232|156678419|FG002|Initial Phase (Dose-finding)|Adverse Event|2|||
48679880|NCT00726232|156678420|FG003|Initial Phase (Dose-finding)|Adverse Event|1|||
48679881|NCT00726232|156678421|FG004|Initial Phase (Dose-finding)|Adverse Event|7|||
48679882|NCT00726232|156678422|FG005|Initial Phase (Dose-finding)|Adverse Event|3|||
48679883|NCT00726232|156678423|FG006|Initial Phase (Dose-finding)|Adverse Event|0|||
48679884|NCT00726232|156678424|FG007|Initial Phase (Dose-finding)|Adverse Event|0|||
48679885|NCT00726232|156678417|FG000|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
48679886|NCT00726232|156678418|FG001|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
48679887|NCT00726232|156678419|FG002|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
48679888|NCT00726232|156678420|FG003|Initial Phase (Dose-finding)|Withdrawal by Subject|1|||
48679889|NCT00726232|156678421|FG004|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
48679890|NCT00726232|156678422|FG005|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
48679891|NCT00726232|156678423|FG006|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
48679892|NCT00726232|156678424|FG007|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
48679893|NCT00726232|156678417|FG000|Initial Phase (Dose-finding)|Disease progression|3|||
48679894|NCT00726232|156678418|FG001|Initial Phase (Dose-finding)|Disease progression|1|||
48679895|NCT00726232|156678419|FG002|Initial Phase (Dose-finding)|Disease progression|0|||
48679896|NCT00726232|156678420|FG003|Initial Phase (Dose-finding)|Disease progression|0|||
48679897|NCT00726232|156678421|FG004|Initial Phase (Dose-finding)|Disease progression|0|||
48679898|NCT00726232|156678422|FG005|Initial Phase (Dose-finding)|Disease progression|0|||
48679899|NCT00726232|156678423|FG006|Initial Phase (Dose-finding)|Disease progression|0|||
48679900|NCT00726232|156678424|FG007|Initial Phase (Dose-finding)|Disease progression|0|||
48679901|NCT00726232|156678417|FG000|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
48875087|NCT00926575|157379044|FG001|Overall Study|Death|4|||
49020370|NCT01915732|157910894|FG001|Overall Study|Lost to Follow-up|26|||
49020371|NCT01915732|157910893|FG000|Overall Study|Par. Improved, Voluntary (Vol) exit|1|||
48679902|NCT00726232|156678418|FG001|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
48679903|NCT00726232|156678419|FG002|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
48679904|NCT00726232|156678420|FG003|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
48679905|NCT00726232|156678421|FG004|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9|||
48679906|NCT00726232|156678422|FG005|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
48679907|NCT00726232|156678423|FG006|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
48679908|NCT00726232|156678424|FG007|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
48679909|NCT00726232|156678417|FG000|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
48679910|NCT00726232|156678418|FG001|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
48679911|NCT00726232|156678419|FG002|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
48679912|NCT00726232|156678420|FG003|Initial Phase (Dose-finding)|Per Investigator: lack of response|2|||
48679913|NCT00726232|156678421|FG004|Initial Phase (Dose-finding)|Per Investigator: lack of response|4|||
48679914|NCT00726232|156678422|FG005|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
48679915|NCT00726232|156678423|FG006|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
48679916|NCT00726232|156678424|FG007|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
48679917|NCT00726232|156678417|FG000|Initial Phase (Dose-finding)|Unspecified reason|1|||
48679918|NCT00726232|156678418|FG001|Initial Phase (Dose-finding)|Unspecified reason|0|||
48679919|NCT00726232|156678419|FG002|Initial Phase (Dose-finding)|Unspecified reason|0|||
48679920|NCT00726232|156678420|FG003|Initial Phase (Dose-finding)|Unspecified reason|0|||
48679921|NCT00726232|156678421|FG004|Initial Phase (Dose-finding)|Unspecified reason|0|||
48679922|NCT00726232|156678422|FG005|Initial Phase (Dose-finding)|Unspecified reason|0|||
48679923|NCT00726232|156678423|FG006|Initial Phase (Dose-finding)|Unspecified reason|0|||
48679924|NCT00726232|156678424|FG007|Initial Phase (Dose-finding)|Unspecified reason|0|||
48679925|NCT00726232|156678417|FG000|Expansion Phase|Death|0|||
48679926|NCT00726232|156678418|FG001|Expansion Phase|Death|0|||
48679927|NCT00726232|156678419|FG002|Expansion Phase|Death|0|||
48679928|NCT00726232|156678420|FG003|Expansion Phase|Death|0|||
48679929|NCT00726232|156678421|FG004|Expansion Phase|Death|0|||
48679930|NCT00726232|156678422|FG005|Expansion Phase|Death|0|||
48679931|NCT00726232|156678423|FG006|Expansion Phase|Death|0|||
48679932|NCT00726232|156678424|FG007|Expansion Phase|Death|1|||
48679933|NCT00726232|156678417|FG000|Expansion Phase|Adverse Event|0|||
48679934|NCT00726232|156678418|FG001|Expansion Phase|Adverse Event|0|||
48679935|NCT00726232|156678419|FG002|Expansion Phase|Adverse Event|0|||
48679936|NCT00726232|156678420|FG003|Expansion Phase|Adverse Event|0|||
48679937|NCT00726232|156678421|FG004|Expansion Phase|Adverse Event|0|||
48679938|NCT00726232|156678422|FG005|Expansion Phase|Adverse Event|0|||
48679939|NCT00726232|156678423|FG006|Expansion Phase|Adverse Event|6|||
48679940|NCT00726232|156678424|FG007|Expansion Phase|Adverse Event|11|||
48679941|NCT00726232|156678417|FG000|Expansion Phase|Withdrawal by Subject|0|||
48679942|NCT00726232|156678418|FG001|Expansion Phase|Withdrawal by Subject|0|||
48679943|NCT00726232|156678419|FG002|Expansion Phase|Withdrawal by Subject|0|||
48679944|NCT00726232|156678420|FG003|Expansion Phase|Withdrawal by Subject|0|||
48679945|NCT00726232|156678421|FG004|Expansion Phase|Withdrawal by Subject|0|||
48679946|NCT00726232|156678422|FG005|Expansion Phase|Withdrawal by Subject|0|||
48679947|NCT00726232|156678423|FG006|Expansion Phase|Withdrawal by Subject|2|||
48679948|NCT00726232|156678424|FG007|Expansion Phase|Withdrawal by Subject|3|||
48679949|NCT00726232|156678417|FG000|Expansion Phase|Disease progression|0|||
48679950|NCT00726232|156678418|FG001|Expansion Phase|Disease progression|0|||
48679951|NCT00726232|156678419|FG002|Expansion Phase|Disease progression|0|||
48679952|NCT00726232|156678420|FG003|Expansion Phase|Disease progression|0|||
48679953|NCT00726232|156678421|FG004|Expansion Phase|Disease progression|0|||
48679954|NCT00726232|156678422|FG005|Expansion Phase|Disease progression|0|||
48679955|NCT00726232|156678423|FG006|Expansion Phase|Disease progression|4|||
48679956|NCT00726232|156678424|FG007|Expansion Phase|Disease progression|0|||
48679957|NCT00726232|156678417|FG000|Expansion Phase|Termination of the trial by sponsor|0|||
48679958|NCT00726232|156678418|FG001|Expansion Phase|Termination of the trial by sponsor|0|||
48679959|NCT00726232|156678419|FG002|Expansion Phase|Termination of the trial by sponsor|0|||
48679960|NCT00726232|156678420|FG003|Expansion Phase|Termination of the trial by sponsor|0|||
48679961|NCT00726232|156678421|FG004|Expansion Phase|Termination of the trial by sponsor|0|||
48679962|NCT00726232|156678422|FG005|Expansion Phase|Termination of the trial by sponsor|0|||
49020372|NCT01915732|157910894|FG001|Overall Study|Par. Improved, Voluntary (Vol) exit|0|||
48679963|NCT00726232|156678423|FG006|Expansion Phase|Termination of the trial by sponsor|10|||
48679964|NCT00726232|156678424|FG007|Expansion Phase|Termination of the trial by sponsor|16|||
48679965|NCT00726232|156678417|FG000|Expansion Phase|Per Investigator: lack of response|0|||
48679966|NCT00726232|156678418|FG001|Expansion Phase|Per Investigator: lack of response|0|||
48679967|NCT00726232|156678419|FG002|Expansion Phase|Per Investigator: lack of response|0|||
49020373|NCT01915732|157910893|FG000|Overall Study|Par. Conscious Ineffective Vol Exit|1|||
49020374|NCT01915732|157910894|FG001|Overall Study|Par. Conscious Ineffective Vol Exit|0|||
48679968|NCT00726232|156678420|FG003|Expansion Phase|Per Investigator: lack of response|0|||
48875088|NCT00926575|157379043|FG000|Overall Study|Lost to Follow-up|1|||
48679969|NCT00726232|156678421|FG004|Expansion Phase|Per Investigator: lack of response|0|||
48679970|NCT00726232|156678422|FG005|Expansion Phase|Per Investigator: lack of response|0|||
48679971|NCT00726232|156678423|FG006|Expansion Phase|Per Investigator: lack of response|1|||
48679972|NCT00726232|156678424|FG007|Expansion Phase|Per Investigator: lack of response|7|||
48679973|NCT00726232|156678417|FG000|Expansion Phase|Unspecified reason|0|||
48679974|NCT00726232|156678418|FG001|Expansion Phase|Unspecified reason|0|||
48679975|NCT00726232|156678419|FG002|Expansion Phase|Unspecified reason|0|||
48679976|NCT00726232|156678420|FG003|Expansion Phase|Unspecified reason|0|||
48679977|NCT00726232|156678421|FG004|Expansion Phase|Unspecified reason|0|||
48679978|NCT00726232|156678422|FG005|Expansion Phase|Unspecified reason|0|||
48679979|NCT00726232|156678423|FG006|Expansion Phase|Unspecified reason|1|||
48679980|NCT00726232|156678424|FG007|Expansion Phase|Unspecified reason|0|||
48679981|NCT00842543|156678425|FG000|Overall Study|Withdrawal by Subject|2|||
48679982|NCT00842543|156678426|FG001|Overall Study|Withdrawal by Subject|0|||
48679983|NCT00842543|156678427|FG002|Overall Study|Withdrawal by Subject|3|||
48679984|NCT00842543|156678428|FG003|Overall Study|Withdrawal by Subject|4|||
48679985|NCT01858766|156678429|FG000|Overall Study|Randomized but Never Treated|0|||
48679986|NCT01858766|156678430|FG001|Overall Study|Randomized but Never Treated|0|||
48679987|NCT01858766|156678431|FG002|Overall Study|Randomized but Never Treated|0|||
48679988|NCT01858766|156678432|FG003|Overall Study|Randomized but Never Treated|0|||
48679989|NCT01858766|156678433|FG004|Overall Study|Randomized but Never Treated|0|||
48679990|NCT01858766|156678434|FG005|Overall Study|Randomized but Never Treated|1|||
48679991|NCT01858766|156678435|FG006|Overall Study|Randomized but Never Treated|0|||
48679992|NCT01858766|156678436|FG007|Overall Study|Randomized but Never Treated|0|||
48679993|NCT01858766|156678437|FG008|Overall Study|Randomized but Never Treated|0|||
48679994|NCT01858766|156678438|FG009|Overall Study|Randomized but Never Treated|0|||
48679995|NCT01858766|156678439|FG010|Overall Study|Randomized but Never Treated|0|||
48679996|NCT01858766|156678440|FG011|Overall Study|Randomized but Never Treated|0|||
48679997|NCT01858766|156678441|FG012|Overall Study|Randomized but Never Treated|0|||
48679998|NCT01858766|156678442|FG013|Overall Study|Randomized but Never Treated|0|||
48679999|NCT01858766|156678443|FG014|Overall Study|Randomized but Never Treated|0|||
48680000|NCT01858766|156678444|FG015|Overall Study|Randomized but Never Treated|0|||
48680001|NCT01858766|156678445|FG016|Overall Study|Randomized but Never Treated|0|||
48680002|NCT01858766|156678446|FG017|Overall Study|Randomized but Never Treated|1|||
48680003|NCT01858766|156678447|FG018|Overall Study|Randomized but Never Treated|0|||
48680004|NCT01858766|156678429|FG000|Overall Study|Death|0|||
48680005|NCT01858766|156678430|FG001|Overall Study|Death|0|||
48680006|NCT01858766|156678431|FG002|Overall Study|Death|1|||
48680007|NCT01858766|156678432|FG003|Overall Study|Death|0|||
48680008|NCT01858766|156678433|FG004|Overall Study|Death|0|||
48680009|NCT01858766|156678434|FG005|Overall Study|Death|0|||
48680010|NCT01858766|156678435|FG006|Overall Study|Death|0|||
48680011|NCT01858766|156678436|FG007|Overall Study|Death|0|||
48875089|NCT00926575|157379044|FG001|Overall Study|Lost to Follow-up|1|||
48680012|NCT01858766|156678437|FG008|Overall Study|Death|0|||
48680013|NCT01858766|156678438|FG009|Overall Study|Death|0|||
48680014|NCT01858766|156678439|FG010|Overall Study|Death|0|||
48680015|NCT01858766|156678440|FG011|Overall Study|Death|0|||
48680016|NCT01858766|156678441|FG012|Overall Study|Death|0|||
48680017|NCT01858766|156678442|FG013|Overall Study|Death|0|||
48680018|NCT01858766|156678443|FG014|Overall Study|Death|0|||
48680019|NCT01858766|156678444|FG015|Overall Study|Death|0|||
48680020|NCT01858766|156678445|FG016|Overall Study|Death|0|||
48680021|NCT01858766|156678446|FG017|Overall Study|Death|0|||
48680022|NCT01858766|156678447|FG018|Overall Study|Death|0|||
48680023|NCT01858766|156678429|FG000|Overall Study|Lack of Efficacy|1|||
48680024|NCT01858766|156678430|FG001|Overall Study|Lack of Efficacy|0|||
48680025|NCT01858766|156678431|FG002|Overall Study|Lack of Efficacy|0|||
48680026|NCT01858766|156678432|FG003|Overall Study|Lack of Efficacy|0|||
48680027|NCT01858766|156678433|FG004|Overall Study|Lack of Efficacy|1|||
48680028|NCT01858766|156678434|FG005|Overall Study|Lack of Efficacy|2|||
48680029|NCT01858766|156678435|FG006|Overall Study|Lack of Efficacy|0|||
48875090|NCT00926575|157379043|FG000|Overall Study|Physician Decision|1|||
48875091|NCT00926575|157379044|FG001|Overall Study|Physician Decision|2|||
49020375|NCT01915732|157910893|FG000|Overall Study|Drug Release Error|1|||
48680030|NCT01858766|156678436|FG007|Overall Study|Lack of Efficacy|0|||
48680031|NCT01858766|156678437|FG008|Overall Study|Lack of Efficacy|0|||
48680032|NCT01858766|156678438|FG009|Overall Study|Lack of Efficacy|0|||
48680033|NCT01858766|156678439|FG010|Overall Study|Lack of Efficacy|0|||
48680034|NCT01858766|156678440|FG011|Overall Study|Lack of Efficacy|3|||
48680035|NCT01858766|156678441|FG012|Overall Study|Lack of Efficacy|5|||
49020376|NCT01915732|157910894|FG001|Overall Study|Drug Release Error|0|||
48680036|NCT01858766|156678442|FG013|Overall Study|Lack of Efficacy|3|||
48680037|NCT01858766|156678443|FG014|Overall Study|Lack of Efficacy|5|||
48680038|NCT01858766|156678444|FG015|Overall Study|Lack of Efficacy|5|||
48680039|NCT01858766|156678445|FG016|Overall Study|Lack of Efficacy|2|||
48680040|NCT01858766|156678446|FG017|Overall Study|Lack of Efficacy|3|||
48680041|NCT01858766|156678447|FG018|Overall Study|Lack of Efficacy|3|||
48680042|NCT01858766|156678429|FG000|Overall Study|Lost to Follow-up|0|||
48680043|NCT01858766|156678430|FG001|Overall Study|Lost to Follow-up|0|||
48680044|NCT01858766|156678431|FG002|Overall Study|Lost to Follow-up|0|||
48680045|NCT01858766|156678432|FG003|Overall Study|Lost to Follow-up|0|||
48680046|NCT01858766|156678433|FG004|Overall Study|Lost to Follow-up|0|||
48680047|NCT01858766|156678434|FG005|Overall Study|Lost to Follow-up|1|||
48680048|NCT01858766|156678435|FG006|Overall Study|Lost to Follow-up|0|||
48680049|NCT01858766|156678436|FG007|Overall Study|Lost to Follow-up|2|||
48680050|NCT01858766|156678437|FG008|Overall Study|Lost to Follow-up|0|||
48680051|NCT01858766|156678438|FG009|Overall Study|Lost to Follow-up|0|||
48680052|NCT01858766|156678439|FG010|Overall Study|Lost to Follow-up|0|||
48680053|NCT01858766|156678440|FG011|Overall Study|Lost to Follow-up|1|||
48680054|NCT01858766|156678441|FG012|Overall Study|Lost to Follow-up|0|||
48680055|NCT01858766|156678442|FG013|Overall Study|Lost to Follow-up|0|||
48680056|NCT01858766|156678443|FG014|Overall Study|Lost to Follow-up|3|||
48680057|NCT01858766|156678444|FG015|Overall Study|Lost to Follow-up|1|||
48680058|NCT01858766|156678445|FG016|Overall Study|Lost to Follow-up|1|||
48680059|NCT01858766|156678446|FG017|Overall Study|Lost to Follow-up|0|||
48680060|NCT01858766|156678447|FG018|Overall Study|Lost to Follow-up|1|||
48680061|NCT01858766|156678429|FG000|Overall Study|Withdrew Consent|0|||
48680062|NCT01858766|156678430|FG001|Overall Study|Withdrew Consent|0|||
48680063|NCT01858766|156678431|FG002|Overall Study|Withdrew Consent|0|||
48680064|NCT01858766|156678432|FG003|Overall Study|Withdrew Consent|0|||
48680065|NCT01858766|156678433|FG004|Overall Study|Withdrew Consent|0|||
48680066|NCT01858766|156678434|FG005|Overall Study|Withdrew Consent|0|||
48680067|NCT01858766|156678435|FG006|Overall Study|Withdrew Consent|0|||
48680068|NCT01858766|156678436|FG007|Overall Study|Withdrew Consent|0|||
48680069|NCT01858766|156678437|FG008|Overall Study|Withdrew Consent|0|||
48680070|NCT01858766|156678438|FG009|Overall Study|Withdrew Consent|0|||
48680071|NCT01858766|156678439|FG010|Overall Study|Withdrew Consent|0|||
48680072|NCT01858766|156678440|FG011|Overall Study|Withdrew Consent|1|||
48680073|NCT01858766|156678441|FG012|Overall Study|Withdrew Consent|0|||
48680074|NCT01858766|156678442|FG013|Overall Study|Withdrew Consent|0|||
48680075|NCT01858766|156678443|FG014|Overall Study|Withdrew Consent|0|||
48680076|NCT01858766|156678444|FG015|Overall Study|Withdrew Consent|0|||
48680077|NCT01858766|156678445|FG016|Overall Study|Withdrew Consent|0|||
48680078|NCT01858766|156678446|FG017|Overall Study|Withdrew Consent|0|||
48680079|NCT01858766|156678447|FG018|Overall Study|Withdrew Consent|0|||
48680080|NCT03671304|156678448|FG000|Overall Study|study terminated|7|||
48680081|NCT00596830|156678453|FG000|Overall Study|Death|258|||
48680082|NCT00596830|156678454|FG001|Overall Study|Death|247|||
48680083|NCT00596830|156678453|FG000|Overall Study|Lost to Follow-up|7|||
48680084|NCT00596830|156678454|FG001|Overall Study|Lost to Follow-up|11|||
48680085|NCT00596830|156678453|FG000|Overall Study|Withdrawal by Subject|22|||
48680086|NCT00596830|156678454|FG001|Overall Study|Withdrawal by Subject|12|||
48680087|NCT00596830|156678453|FG000|Overall Study|Study terminated by sponsor|51|||
48680088|NCT00596830|156678454|FG001|Overall Study|Study terminated by sponsor|62|||
48680089|NCT00596830|156678453|FG000|Overall Study|Follow-up was discontinued|1|||
48680090|NCT00596830|156678454|FG001|Overall Study|Follow-up was discontinued|0|||
48680091|NCT00596830|156678453|FG000|Overall Study|Randomized but not treated|3|||
48680092|NCT00596830|156678454|FG001|Overall Study|Randomized but not treated|7|||
48680093|NCT00887926|156678455|FG000|Overall Study|Withdrawal by Subject|0|||
48680094|NCT00887926|156678456|FG001|Overall Study|Withdrawal by Subject|1|||
48680095|NCT00887926|156678457|FG002|Overall Study|Withdrawal by Subject|0|||
48680096|NCT00887926|156678458|FG003|Overall Study|Withdrawal by Subject|0|||
48680097|NCT03549104|156678459|FG000|Overall Study|Withdrawal by Subject|5|||
48680098|NCT03549104|156678460|FG001|Overall Study|Withdrawal by Subject|2|||
48680099|NCT03549104|156678459|FG000|Overall Study|Covid shelter in place|1|||
48680100|NCT03549104|156678460|FG001|Overall Study|Covid shelter in place|2|||
48680101|NCT01973998|156678461|FG000|Overall Study|Death|2|||
48680102|NCT01973998|156678462|FG001|Overall Study|Death|2|||
48680103|NCT01178099|156678465|FG000|Overall Study|Physician Decision|0|||
48680104|NCT01178099|156678466|FG001|Overall Study|Physician Decision|1|||
48680105|NCT01518374|156678467|FG000|Overall Study|Withdrawal by Subject|2|||
48680106|NCT01518374|156678467|FG000|Overall Study|Protocol Violation|3|||
48875092|NCT00926575|157379043|FG000|Overall Study|Protocol Violation|1|||
48680107|NCT01518374|156678467|FG000|Overall Study|Lost to Follow-up|2|||
48680108|NCT03068754|156678468|FG000|Randomized Treatment Period (RTP)|Adverse Event|1|||
48680109|NCT03068754|156678469|FG001|Randomized Treatment Period (RTP)|Adverse Event|3|||
48680110|NCT03068754|156678470|FG002|Randomized Treatment Period (RTP)|Adverse Event|0|||
48680111|NCT03068754|156678471|FG003|Randomized Treatment Period (RTP)|Adverse Event|0|||
48680112|NCT03068754|156678468|FG000|Randomized Treatment Period (RTP)|Death|2|||
48680113|NCT03068754|156678469|FG001|Randomized Treatment Period (RTP)|Death|2|||
48680114|NCT03068754|156678470|FG002|Randomized Treatment Period (RTP)|Death|0|||
48680115|NCT03068754|156678471|FG003|Randomized Treatment Period (RTP)|Death|0|||
48680116|NCT03068754|156678468|FG000|Randomized Treatment Period (RTP)|Disease progression|1|||
48680117|NCT03068754|156678469|FG001|Randomized Treatment Period (RTP)|Disease progression|2|||
48875093|NCT00926575|157379044|FG001|Overall Study|Protocol Violation|0|||
48875094|NCT00926575|157379043|FG000|Overall Study|Withdrawal by Subject|8|||
48680118|NCT03068754|156678470|FG002|Randomized Treatment Period (RTP)|Disease progression|0|||
48680119|NCT03068754|156678471|FG003|Randomized Treatment Period (RTP)|Disease progression|0|||
48680120|NCT03068754|156678468|FG000|Randomized Treatment Period (RTP)|Lost to Follow-up|1|||
48680121|NCT03068754|156678469|FG001|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
48680122|NCT03068754|156678470|FG002|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
48680123|NCT03068754|156678471|FG003|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
48680124|NCT03068754|156678468|FG000|Randomized Treatment Period (RTP)|Withdrawal by Subject|6|||
48680125|NCT03068754|156678469|FG001|Randomized Treatment Period (RTP)|Withdrawal by Subject|2|||
48680126|NCT03068754|156678470|FG002|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
48680127|NCT03068754|156678471|FG003|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
48680128|NCT03068754|156678468|FG000|Randomized Treatment Period (RTP)|Discontinued by Physician|1|||
48680129|NCT03068754|156678469|FG001|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
48680130|NCT03068754|156678470|FG002|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
48680131|NCT03068754|156678471|FG003|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
48680132|NCT03068754|156678468|FG000|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
48680133|NCT03068754|156678469|FG001|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1|||
48680134|NCT03068754|156678470|FG002|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
48680135|NCT03068754|156678471|FG003|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
48680136|NCT03068754|156678468|FG000|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55|||
48680137|NCT03068754|156678469|FG001|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29|||
48680138|NCT03068754|156678470|FG002|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
48680139|NCT03068754|156678471|FG003|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
48680140|NCT03068754|156678468|FG000|Open Label Extension Period (OLE)|Adverse Event|0|||
48680141|NCT03068754|156678469|FG001|Open Label Extension Period (OLE)|Adverse Event|0|||
48680142|NCT03068754|156678470|FG002|Open Label Extension Period (OLE)|Adverse Event|0|||
48680143|NCT03068754|156678471|FG003|Open Label Extension Period (OLE)|Adverse Event|1|||
48680144|NCT03068754|156678468|FG000|Open Label Extension Period (OLE)|Death|0|||
48680145|NCT03068754|156678469|FG001|Open Label Extension Period (OLE)|Death|0|||
48680146|NCT03068754|156678470|FG002|Open Label Extension Period (OLE)|Death|0|||
48680147|NCT03068754|156678471|FG003|Open Label Extension Period (OLE)|Death|1|||
48680148|NCT03068754|156678468|FG000|Open Label Extension Period (OLE)|Disease progression|0|||
48680149|NCT03068754|156678469|FG001|Open Label Extension Period (OLE)|Disease progression|0|||
48680150|NCT03068754|156678470|FG002|Open Label Extension Period (OLE)|Disease progression|3|||
48680151|NCT03068754|156678471|FG003|Open Label Extension Period (OLE)|Disease progression|1|||
48680152|NCT03068754|156678468|FG000|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
48680153|NCT03068754|156678469|FG001|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
48680154|NCT03068754|156678470|FG002|Open Label Extension Period (OLE)|Withdrawal by Subject|5|||
48680155|NCT03068754|156678471|FG003|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
48680156|NCT03068754|156678468|FG000|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
48680157|NCT03068754|156678469|FG001|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
48680158|NCT03068754|156678470|FG002|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1|||
48680159|NCT03068754|156678471|FG003|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
48680160|NCT03068754|156678468|FG000|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
48680161|NCT03068754|156678469|FG001|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
48680162|NCT03068754|156678470|FG002|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12|||
48680163|NCT03068754|156678471|FG003|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3|||
48680164|NCT00048347|156678475|FG000|Overall Study|Screen failure|2|||
48680165|NCT02451124|156678477|FG000|Overall Study|Withdrawal by Subject|1|||
48680166|NCT02119663|156678478|FG000|Overall Study|Disease progression|26|||
48680167|NCT02119663|156678479|FG001|Overall Study|Disease progression|27|||
48680168|NCT02119663|156678478|FG000|Overall Study|Adverse Event|5|||
48680169|NCT02119663|156678479|FG001|Overall Study|Adverse Event|5|||
48762819|NCT00600938|156980349|FG003|Extension Study|Abnormal test procedure results|1|||
48762820|NCT00600938|156980346|FG000|Extension Study|Unsatisfactory therapeutic effect|4|||
48762821|NCT00600938|156980347|FG001|Extension Study|Unsatisfactory therapeutic effect|1|||
48762822|NCT00600938|156980348|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
48762823|NCT00600938|156980349|FG003|Extension Study|Unsatisfactory therapeutic effect|0|||
48762824|NCT00600938|156980346|FG000|Extension Study|Withdrawal by Subject|2|||
48762825|NCT00600938|156980347|FG001|Extension Study|Withdrawal by Subject|2|||
48680170|NCT02119663|156678478|FG000|Overall Study|Death|3|||
48680171|NCT02119663|156678479|FG001|Overall Study|Death|2|||
48680172|NCT02119663|156678478|FG000|Overall Study|Physician Decision|1|||
48680173|NCT02119663|156678479|FG001|Overall Study|Physician Decision|2|||
48680174|NCT02119663|156678478|FG000|Overall Study|Other unspecified|2|||
48680175|NCT02119663|156678479|FG001|Overall Study|Other unspecified|0|||
48680176|NCT02119663|156678478|FG000|Overall Study|Subject decision|0|||
48762826|NCT00600938|156980348|FG002|Extension Study|Withdrawal by Subject|3|||
48762827|NCT00600938|156980349|FG003|Extension Study|Withdrawal by Subject|0|||
48680177|NCT02119663|156678479|FG001|Overall Study|Subject decision|1|||
48680178|NCT02119663|156678478|FG000|Overall Study|Study Terminated by the Sponsor|3|||
48680179|NCT02119663|156678479|FG001|Overall Study|Study Terminated by the Sponsor|4|||
48680180|NCT03197376|156678482|FG000|Primary and Booster Phase|Adverse Event|0|||
48680181|NCT03197376|156678483|FG001|Primary and Booster Phase|Adverse Event|0|||
48680182|NCT03197376|156678484|FG002|Primary and Booster Phase|Adverse Event|0|||
48680183|NCT03197376|156678485|FG003|Primary and Booster Phase|Adverse Event|1|||
48680184|NCT03197376|156678482|FG000|Primary and Booster Phase|Death|1|||
48680185|NCT03197376|156678483|FG001|Primary and Booster Phase|Death|0|||
48680186|NCT03197376|156678484|FG002|Primary and Booster Phase|Death|0|||
48680187|NCT03197376|156678485|FG003|Primary and Booster Phase|Death|2|||
48680188|NCT03197376|156678482|FG000|Primary and Booster Phase|Lost to Follow-up|0|||
48680189|NCT03197376|156678483|FG001|Primary and Booster Phase|Lost to Follow-up|0|||
48680190|NCT03197376|156678484|FG002|Primary and Booster Phase|Lost to Follow-up|1|||
48680191|NCT03197376|156678485|FG003|Primary and Booster Phase|Lost to Follow-up|0|||
48680192|NCT03197376|156678482|FG000|Primary and Booster Phase|Physician Decision|1|||
48680193|NCT03197376|156678483|FG001|Primary and Booster Phase|Physician Decision|0|||
48680194|NCT03197376|156678484|FG002|Primary and Booster Phase|Physician Decision|1|||
48680195|NCT03197376|156678485|FG003|Primary and Booster Phase|Physician Decision|3|||
48680196|NCT03197376|156678482|FG000|Primary and Booster Phase|Withdrawal by subject's parents|11|||
48680197|NCT03197376|156678483|FG001|Primary and Booster Phase|Withdrawal by subject's parents|10|||
48680198|NCT03197376|156678484|FG002|Primary and Booster Phase|Withdrawal by subject's parents|14|||
48680199|NCT03197376|156678485|FG003|Primary and Booster Phase|Withdrawal by subject's parents|11|||
48680200|NCT03197376|156678482|FG000|Primary and Booster Phase|Ineligibility criteria|1|||
48680201|NCT03197376|156678483|FG001|Primary and Booster Phase|Ineligibility criteria|1|||
48680202|NCT03197376|156678484|FG002|Primary and Booster Phase|Ineligibility criteria|4|||
48680203|NCT03197376|156678485|FG003|Primary and Booster Phase|Ineligibility criteria|2|||
48680204|NCT03197376|156678482|FG000|Primary and Booster Phase|Not vaccine related|1|||
48680205|NCT03197376|156678483|FG001|Primary and Booster Phase|Not vaccine related|2|||
48680206|NCT03197376|156678484|FG002|Primary and Booster Phase|Not vaccine related|0|||
48680207|NCT03197376|156678485|FG003|Primary and Booster Phase|Not vaccine related|6|||
48680208|NCT03197376|156678482|FG000|Immune Persistence Phase|Lost to Follow-up|0|||
48680209|NCT03197376|156678483|FG001|Immune Persistence Phase|Lost to Follow-up|0|||
48680210|NCT03197376|156678484|FG002|Immune Persistence Phase|Lost to Follow-up|2|||
48680211|NCT03197376|156678485|FG003|Immune Persistence Phase|Lost to Follow-up|1|||
48680212|NCT03197376|156678482|FG000|Immune Persistence Phase|Withdrawal by subject's parents|4|||
48680213|NCT03197376|156678483|FG001|Immune Persistence Phase|Withdrawal by subject's parents|4|||
48680214|NCT03197376|156678484|FG002|Immune Persistence Phase|Withdrawal by subject's parents|2|||
48680215|NCT03197376|156678485|FG003|Immune Persistence Phase|Withdrawal by subject's parents|3|||
48680216|NCT03197376|156678482|FG000|Immune Persistence Phase|Not vaccine related|1|||
48680217|NCT03197376|156678483|FG001|Immune Persistence Phase|Not vaccine related|0|||
48680218|NCT03197376|156678484|FG002|Immune Persistence Phase|Not vaccine related|1|||
48680219|NCT03197376|156678485|FG003|Immune Persistence Phase|Not vaccine related|1|||
48680220|NCT00825812|156678486|FG000|Overall Study|Never entered follow up|0|||
48680221|NCT00825812|156678487|FG001|Overall Study|Never entered follow up|0|||
48680222|NCT00825812|156678488|FG002|Overall Study|Never entered follow up|0|||
48680223|NCT00825812|156678489|FG003|Overall Study|Never entered follow up|1|||
48680224|NCT00825812|156678486|FG000|Overall Study|Adverse Event|0|||
48680225|NCT00825812|156678487|FG001|Overall Study|Adverse Event|0|||
48680226|NCT00825812|156678488|FG002|Overall Study|Adverse Event|0|||
48680227|NCT00825812|156678489|FG003|Overall Study|Adverse Event|1|||
48680228|NCT00825812|156678486|FG000|Overall Study|Subject withdrew consent|0|||
48680229|NCT00825812|156678487|FG001|Overall Study|Subject withdrew consent|0|||
48680230|NCT00825812|156678488|FG002|Overall Study|Subject withdrew consent|3|||
48680231|NCT00825812|156678489|FG003|Overall Study|Subject withdrew consent|2|||
48680232|NCT00825812|156678486|FG000|Overall Study|Non-compliance with protocol|0|||
48762828|NCT00600938|156980346|FG000|Extension Study|Lost to Follow-up|1|||
48762829|NCT00600938|156980347|FG001|Extension Study|Lost to Follow-up|1|||
49020377|NCT01915732|157910893|FG000|Overall Study|Recovered|1|||
49020378|NCT01915732|157910894|FG001|Overall Study|Recovered|0|||
49020379|NCT01915732|157910893|FG000|Overall Study|Pregnancy|1|||
49020380|NCT01915732|157910894|FG001|Overall Study|Pregnancy|0|||
48680233|NCT00825812|156678487|FG001|Overall Study|Non-compliance with protocol|0|||
48680234|NCT00825812|156678488|FG002|Overall Study|Non-compliance with protocol|0|||
48680235|NCT00825812|156678489|FG003|Overall Study|Non-compliance with protocol|1|||
48680236|NCT00825812|156678486|FG000|Overall Study|Administrative|0|||
48680237|NCT00825812|156678487|FG001|Overall Study|Administrative|1|||
48680238|NCT00825812|156678488|FG002|Overall Study|Administrative|3|||
48680239|NCT00825812|156678489|FG003|Overall Study|Administrative|5|||
48680240|NCT02058563|156678490|FG000|Overall Study|Lost to Follow-up|26|||
48680241|NCT02058563|156678491|FG001|Overall Study|Lost to Follow-up|22|||
48875095|NCT00926575|157379044|FG001|Overall Study|Withdrawal by Subject|9|||
48875096|NCT03128671|157379054|FG000|Allocation|ICU discharge prior to intervention initiation|4|||
48680242|NCT02058563|156678490|FG000|Overall Study|Other (vaccinated later as new subject)|1|||
48680243|NCT02058563|156678491|FG001|Overall Study|Other (vaccinated later as new subject)|0|||
48680244|NCT02058563|156678490|FG000|Overall Study|Consent Withdrawal|1|||
48680245|NCT02058563|156678491|FG001|Overall Study|Consent Withdrawal|1|||
48680246|NCT02058563|156678490|FG000|Overall Study|Other (patient incarcerated)|0|||
48680247|NCT02058563|156678491|FG001|Overall Study|Other (patient incarcerated)|1|||
48680248|NCT00166439|156678492|FG000|Overall Study|Ineligible|5|||
48680249|NCT02363959|156678495|FG000|Overall Study|Medical instability|1|||
48680250|NCT02363959|156678496|FG001|Overall Study|Medical instability|0|||
48680251|NCT00003199|156678499|FG000|Overall Study|Refused Post-Transplant Immunotherapy|5|||
48680252|NCT00003199|156678499|FG000|Overall Study|Lack of insurance clearance|2|||
48680253|NCT00003199|156678499|FG000|Overall Study|Screen fail|15|||
48680254|NCT00940498|156678500|FG000|Overall Study|Death|2|||
48680255|NCT00940498|156678501|FG001|Overall Study|Death|0|||
48680256|NCT00940498|156678502|FG002|Overall Study|Death|0|||
48680257|NCT00940498|156678503|FG003|Overall Study|Death|1|||
48680258|NCT00940498|156678504|FG004|Overall Study|Death|5|||
48680259|NCT00940498|156678505|FG005|Overall Study|Death|0|||
48680260|NCT00940498|156678506|FG006|Overall Study|Death|1|||
48680261|NCT00940498|156678507|FG007|Overall Study|Death|0|||
48680262|NCT00940498|156678500|FG000|Overall Study|Lost to Follow-up|1|||
48680263|NCT00940498|156678501|FG001|Overall Study|Lost to Follow-up|1|||
48680264|NCT00940498|156678502|FG002|Overall Study|Lost to Follow-up|2|||
48680265|NCT00940498|156678503|FG003|Overall Study|Lost to Follow-up|0|||
48680266|NCT00940498|156678504|FG004|Overall Study|Lost to Follow-up|1|||
48680267|NCT00940498|156678505|FG005|Overall Study|Lost to Follow-up|0|||
48680268|NCT00940498|156678506|FG006|Overall Study|Lost to Follow-up|0|||
48680269|NCT00940498|156678507|FG007|Overall Study|Lost to Follow-up|1|||
48680270|NCT00940498|156678500|FG000|Overall Study|Disease Progression|0|||
48680271|NCT00940498|156678501|FG001|Overall Study|Disease Progression|0|||
48680272|NCT00940498|156678502|FG002|Overall Study|Disease Progression|1|||
48680273|NCT00940498|156678503|FG003|Overall Study|Disease Progression|1|||
48680274|NCT00940498|156678504|FG004|Overall Study|Disease Progression|0|||
48680275|NCT00940498|156678505|FG005|Overall Study|Disease Progression|1|||
48680276|NCT00940498|156678506|FG006|Overall Study|Disease Progression|0|||
48680277|NCT00940498|156678507|FG007|Overall Study|Disease Progression|0|||
48680278|NCT00940498|156678500|FG000|Overall Study|Physician Decision|0|||
48680279|NCT00940498|156678501|FG001|Overall Study|Physician Decision|0|||
48680280|NCT00940498|156678502|FG002|Overall Study|Physician Decision|0|||
48680281|NCT00940498|156678503|FG003|Overall Study|Physician Decision|0|||
48680282|NCT00940498|156678504|FG004|Overall Study|Physician Decision|2|||
48680283|NCT00940498|156678505|FG005|Overall Study|Physician Decision|0|||
48680284|NCT00940498|156678506|FG006|Overall Study|Physician Decision|0|||
48680285|NCT00940498|156678507|FG007|Overall Study|Physician Decision|0|||
48680286|NCT00940498|156678500|FG000|Overall Study|Not treated due to disease related pain|0|||
48680287|NCT00940498|156678501|FG001|Overall Study|Not treated due to disease related pain|0|||
48680288|NCT00940498|156678502|FG002|Overall Study|Not treated due to disease related pain|0|||
48680289|NCT00940498|156678503|FG003|Overall Study|Not treated due to disease related pain|0|||
48680290|NCT00940498|156678504|FG004|Overall Study|Not treated due to disease related pain|1|||
48680291|NCT00940498|156678505|FG005|Overall Study|Not treated due to disease related pain|0|||
48680292|NCT00940498|156678506|FG006|Overall Study|Not treated due to disease related pain|0|||
48680293|NCT00940498|156678507|FG007|Overall Study|Not treated due to disease related pain|0|||
48680294|NCT01657292|156678508|FG000|Overall Study|Adverse Event|6|||
48680295|NCT01657292|156678508|FG000|Overall Study|Withdrawal by Subject|2|||
48680296|NCT01657292|156678508|FG000|Overall Study|Violation of eligibility criteria|1|||
48680297|NCT01657292|156678508|FG000|Overall Study|Change of therapy|1|||
48680298|NCT01792115|156678518|FG000|Overall Study|Lost to Follow-up|0|||
48680299|NCT01792115|156678519|FG001|Overall Study|Lost to Follow-up|1|||
48680300|NCT01792115|156678520|FG002|Overall Study|Lost to Follow-up|0|||
48680301|NCT02587819|156678522|FG000|Overall Study|Adverse Event|1|||
48680302|NCT02587819|156678522|FG000|Overall Study|Lost to Follow-up|1|||
48680303|NCT01286740|156679515|FG000|Overall Study|Enrolled but not treated|1|||
48680304|NCT01286740|156679515|FG000|Overall Study|Protocol Violation|1|||
48680305|NCT01031979|156679516|FG000|Overall Study|Lost to Follow-up|5|||
48680306|NCT01031979|156679517|FG001|Overall Study|Lost to Follow-up|4|||
48680307|NCT03592368|156679518|FG000|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
48680308|NCT03592368|156679519|FG001|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|1|||
48680309|NCT03592368|156679520|FG002|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
48680310|NCT03592368|156679521|FG003|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
48680311|NCT03592368|156679518|FG000|Overall Study|Adverse Event|0|||
48680312|NCT03592368|156679519|FG001|Overall Study|Adverse Event|0|||
48680313|NCT03592368|156679520|FG002|Overall Study|Adverse Event|0|||
48680314|NCT03592368|156679521|FG003|Overall Study|Adverse Event|1|||
48680315|NCT03592368|156679518|FG000|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
48680316|NCT03592368|156679519|FG001|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
48680317|NCT03592368|156679520|FG002|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
48680318|NCT03592368|156679521|FG003|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
48680319|NCT01732770|156679525|FG000|Overall Study|Lost to Follow-up|2|||
48680320|NCT01732770|156679526|FG001|Overall Study|Lost to Follow-up|3|||
48680321|NCT01732770|156679525|FG000|Overall Study|Withdrawal by Subject|5|||
48680322|NCT01732770|156679526|FG001|Overall Study|Withdrawal by Subject|3|||
48680323|NCT01732770|156679525|FG000|Overall Study|Decision by Sponsor|2|||
48680324|NCT01732770|156679526|FG001|Overall Study|Decision by Sponsor|2|||
48680325|NCT01732770|156679525|FG000|Overall Study|Death|1|||
49020381|NCT01915732|157910893|FG000|Overall Study|Poor Perceived Efficacy|1|||
49020382|NCT01915732|157910894|FG001|Overall Study|Poor Perceived Efficacy|0|||
48680326|NCT01732770|156679526|FG001|Overall Study|Death|0|||
48680327|NCT02814175|156679529|FG000|Part 1|Adverse Event|2|||
48680328|NCT02814175|156679530|FG001|Part 1|Adverse Event|3|||
48680329|NCT02814175|156679531|FG002|Part 1|Adverse Event|0|||
48680330|NCT02814175|156679532|FG003|Part 1|Adverse Event|0|||
48680331|NCT02814175|156679533|FG004|Part 1|Adverse Event|0|||
48680332|NCT02814175|156679534|FG005|Part 1|Adverse Event|0|||
48680333|NCT02814175|156679529|FG000|Part 1|Withdrawal Consent|8|||
48680334|NCT02814175|156679530|FG001|Part 1|Withdrawal Consent|1|||
48680335|NCT02814175|156679531|FG002|Part 1|Withdrawal Consent|0|||
48680336|NCT02814175|156679532|FG003|Part 1|Withdrawal Consent|0|||
48680337|NCT02814175|156679533|FG004|Part 1|Withdrawal Consent|0|||
48680338|NCT02814175|156679534|FG005|Part 1|Withdrawal Consent|0|||
48680339|NCT02814175|156679529|FG000|Part 1|Lost to Follow-up|1|||
48680340|NCT02814175|156679530|FG001|Part 1|Lost to Follow-up|0|||
48680341|NCT02814175|156679531|FG002|Part 1|Lost to Follow-up|0|||
48680342|NCT02814175|156679532|FG003|Part 1|Lost to Follow-up|0|||
48680343|NCT02814175|156679533|FG004|Part 1|Lost to Follow-up|0|||
48680344|NCT02814175|156679534|FG005|Part 1|Lost to Follow-up|0|||
48680345|NCT02814175|156679529|FG000|Part 1|Lack of Efficacy|1|||
48680346|NCT02814175|156679530|FG001|Part 1|Lack of Efficacy|2|||
48680347|NCT02814175|156679531|FG002|Part 1|Lack of Efficacy|0|||
48680348|NCT02814175|156679532|FG003|Part 1|Lack of Efficacy|0|||
48680349|NCT02814175|156679533|FG004|Part 1|Lack of Efficacy|0|||
48680350|NCT02814175|156679534|FG005|Part 1|Lack of Efficacy|0|||
48680351|NCT02814175|156679529|FG000|Part 2|Adverse Event|0|||
48680352|NCT02814175|156679530|FG001|Part 2|Adverse Event|0|||
48680353|NCT02814175|156679531|FG002|Part 2|Adverse Event|0|||
48680354|NCT02814175|156679532|FG003|Part 2|Adverse Event|1|||
48680355|NCT02814175|156679533|FG004|Part 2|Adverse Event|1|||
48680356|NCT02814175|156679534|FG005|Part 2|Adverse Event|2|||
48680357|NCT02814175|156679529|FG000|Part 2|Withdrawal Consent|0|||
48680358|NCT02814175|156679530|FG001|Part 2|Withdrawal Consent|0|||
48680359|NCT02814175|156679531|FG002|Part 2|Withdrawal Consent|0|||
48680360|NCT02814175|156679532|FG003|Part 2|Withdrawal Consent|2|||
48680361|NCT02814175|156679533|FG004|Part 2|Withdrawal Consent|1|||
48680362|NCT02814175|156679534|FG005|Part 2|Withdrawal Consent|1|||
48680363|NCT02814175|156679529|FG000|Part 2|Lost to Follow-up|0|||
48680364|NCT02814175|156679530|FG001|Part 2|Lost to Follow-up|0|||
48680365|NCT02814175|156679531|FG002|Part 2|Lost to Follow-up|0|||
48680366|NCT02814175|156679532|FG003|Part 2|Lost to Follow-up|1|||
48680367|NCT02814175|156679533|FG004|Part 2|Lost to Follow-up|0|||
48680368|NCT02814175|156679534|FG005|Part 2|Lost to Follow-up|0|||
48680369|NCT02814175|156679529|FG000|Part 2|Lack of Efficacy|0|||
48680370|NCT02814175|156679530|FG001|Part 2|Lack of Efficacy|0|||
48680371|NCT02814175|156679531|FG002|Part 2|Lack of Efficacy|0|||
48680372|NCT02814175|156679532|FG003|Part 2|Lack of Efficacy|0|||
48680373|NCT02814175|156679533|FG004|Part 2|Lack of Efficacy|0|||
48680374|NCT02814175|156679534|FG005|Part 2|Lack of Efficacy|3|||
48680375|NCT03521141|156679535|FG000|Overall Study|Death|1|||
48680376|NCT03521141|156679536|FG001|Overall Study|Death|0|||
48680377|NCT03521141|156679537|FG002|Overall Study|Death|1|||
48680378|NCT03775512|156679543|FG000|Overall Study|Death|1|||
48680379|NCT03775512|156679544|FG001|Overall Study|Death|1|||
48680380|NCT03775512|156679543|FG000|Overall Study|Withdrawal by Subject|7|||
48680381|NCT03775512|156679544|FG001|Overall Study|Withdrawal by Subject|4|||
48680382|NCT03775512|156679543|FG000|Overall Study|Lost to Follow-up|5|||
48680383|NCT03775512|156679544|FG001|Overall Study|Lost to Follow-up|5|||
48680384|NCT03775512|156679543|FG000|Overall Study|Excluded before Catheter insertion|14|||
48680385|NCT03775512|156679544|FG001|Overall Study|Excluded before Catheter insertion|5|||
48875097|NCT03128671|157379055|FG001|Allocation|ICU discharge prior to intervention initiation|0|||
48680386|NCT03775512|156679543|FG000|Overall Study|Discontinued before RF energy applied on inserted catheter|2|||
48680387|NCT03775512|156679544|FG001|Overall Study|Discontinued before RF energy applied on inserted catheter|1|||
48680388|NCT03775512|156679543|FG000|Overall Study|Due to a late entrance criteria deviation|0|||
48680389|NCT03775512|156679544|FG001|Overall Study|Due to a late entrance criteria deviation|1|||
48680390|NCT00741013|156679545|FG000|Overall Study|Adverse Event|1|||
48680391|NCT00741013|156679546|FG001|Overall Study|Adverse Event|0|||
48680392|NCT00741013|156679547|FG002|Overall Study|Adverse Event|0|||
48680393|NCT00741013|156679545|FG000|Overall Study|Withdrawal by Subject|0|||
48680394|NCT00741013|156679546|FG001|Overall Study|Withdrawal by Subject|0|||
49020383|NCT01915732|157910893|FG000|Overall Study|Par. Unable to Come to the Hospital|0|||
49020384|NCT01915732|157910894|FG001|Overall Study|Par. Unable to Come to the Hospital|1|||
49020385|NCT01915732|157910893|FG000|Overall Study|Got Well|0|||
49020386|NCT01915732|157910894|FG001|Overall Study|Got Well|1|||
49020387|NCT01915732|157910893|FG000|Overall Study|Par. not Willing to Continue Treatment|0|||
49020388|NCT01915732|157910894|FG001|Overall Study|Par. not Willing to Continue Treatment|1|||
49020389|NCT01915732|157910893|FG000|Overall Study|Par. Refused to Hospital Visits|0|||
49020390|NCT01915732|157910894|FG001|Overall Study|Par. Refused to Hospital Visits|1|||
49020391|NCT01915732|157910893|FG000|Overall Study|Job Transfer|0|||
49020392|NCT01915732|157910894|FG001|Overall Study|Job Transfer|1|||
49020393|NCT01915732|157910893|FG000|Overall Study|Improper Facial Procedure|0|||
48680395|NCT00741013|156679547|FG002|Overall Study|Withdrawal by Subject|1|||
48680396|NCT00741013|156679545|FG000|Overall Study|Discovered failed screen after enrolled|0|||
48680397|NCT00741013|156679546|FG001|Overall Study|Discovered failed screen after enrolled|2|||
48680398|NCT00741013|156679547|FG002|Overall Study|Discovered failed screen after enrolled|0|||
48680399|NCT00660179|156679548|FG000|Overall Study|Death|44|||
48680400|NCT00660179|156679549|FG001|Overall Study|Death|47|||
48680401|NCT00660179|156679550|FG002|Overall Study|Death|34|||
48680402|NCT00660179|156679548|FG000|Overall Study|Withdrawal of consent|4|||
48680403|NCT00660179|156679549|FG001|Overall Study|Withdrawal of consent|6|||
48680404|NCT00660179|156679550|FG002|Overall Study|Withdrawal of consent|4|||
48680405|NCT00660179|156679548|FG000|Overall Study|Lost to Follow-up|7|||
48680406|NCT00660179|156679549|FG001|Overall Study|Lost to Follow-up|5|||
48680407|NCT00660179|156679550|FG002|Overall Study|Lost to Follow-up|2|||
48680408|NCT00660179|156679548|FG000|Overall Study|Administrative reason|0|||
48680409|NCT00660179|156679549|FG001|Overall Study|Administrative reason|0|||
48680410|NCT00660179|156679550|FG002|Overall Study|Administrative reason|1|||
48680411|NCT00660179|156679548|FG000|Overall Study|Incorrect randomization|1|||
48680412|NCT00660179|156679549|FG001|Overall Study|Incorrect randomization|0|||
48680413|NCT00660179|156679550|FG002|Overall Study|Incorrect randomization|0|||
48680414|NCT00567359|156679555|FG000|Overall Study|Withdrawal by Subject|1|||
48680415|NCT04829916|156679556|FG000|Overall Study|Withdrawal by Subject|1|||
48680416|NCT04829916|156679557|FG001|Overall Study|Withdrawal by Subject|0|||
48680417|NCT01440816|156679561|FG000|Overall Study|Disease Progression|0|||
48680418|NCT01440816|156679562|FG001|Overall Study|Disease Progression|9|||
48680419|NCT01440816|156679561|FG000|Overall Study|To Be Seen By Local Oncologist|1|||
48680420|NCT01440816|156679562|FG001|Overall Study|To Be Seen By Local Oncologist|2|||
48680421|NCT00847886|156679563|FG000|Overall Study|Adverse Event|0|||
48680422|NCT00847886|156679564|FG001|Overall Study|Adverse Event|1|||
48680423|NCT00183625|156679567|FG000|Overall Study|Withdrawal by Subject|18|||
48680424|NCT00183625|156679568|FG001|Overall Study|Withdrawal by Subject|18|||
48680425|NCT00183625|156679569|FG002|Overall Study|Withdrawal by Subject|19|||
48680426|NCT00183625|156679570|FG003|Overall Study|Withdrawal by Subject|14|||
48680427|NCT02652156|156679572|FG000|Overall Study|Physician Decision|1|||
48680428|NCT02652156|156679573|FG001|Overall Study|Physician Decision|0|||
48680429|NCT02652156|156679574|FG002|Overall Study|Physician Decision|0|||
48680430|NCT03250182|156679575|FG000|Overall Study|Withdrawal by Subject|1|||
48680431|NCT03040674|156679576|FG000|Overall Study|Lost to Follow-up|225|||
48680432|NCT03040674|156679576|FG000|Overall Study|Death|23|||
48680433|NCT00193206|156679577|FG000|Preoperative Therapy|Lack of Efficacy|2|||
48680434|NCT00193206|156679577|FG000|Preoperative Therapy|Adverse Event|2|||
48680435|NCT00193206|156679577|FG000|Preoperative Therapy|Withdrawal by Subject|2|||
48680436|NCT00193206|156679577|FG000|Preoperative Therapy|False Positive Pregnancy Test|1|||
48680437|NCT00193206|156679577|FG000|Postoperative Therapy|Withdrawal by Subject|7|||
48680438|NCT00193206|156679577|FG000|Postoperative Therapy|Physician Decision|3|||
48680439|NCT00193206|156679577|FG000|Postoperative Therapy|Intercurrent Illness|2|||
48680440|NCT00193206|156679577|FG000|Postoperative Therapy|Lack of Efficacy|1|||
48680441|NCT00193206|156679577|FG000|Postoperative Therapy|Protocol Violation|1|||
48680442|NCT01200368|156679578|FG000|Infant Series|Adverse Event|2|||
48680443|NCT01200368|156679579|FG001|Infant Series|Adverse Event|2|||
48680444|NCT01200368|156679580|FG002|Infant Series|Adverse Event|3|||
48680445|NCT01200368|156679578|FG000|Infant Series|Withdrawal by Subject|0|||
48680446|NCT01200368|156679579|FG001|Infant Series|Withdrawal by Subject|2|||
48680447|NCT01200368|156679580|FG002|Infant Series|Withdrawal by Subject|2|||
48680448|NCT01200368|156679578|FG000|Infant Series|Did not meet entrance criteria|0|||
48680449|NCT01200368|156679579|FG001|Infant Series|Did not meet entrance criteria|1|||
48680450|NCT01200368|156679580|FG002|Infant Series|Did not meet entrance criteria|0|||
49020394|NCT01915732|157910894|FG001|Overall Study|Improper Facial Procedure|1|||
49020395|NCT01915732|157910893|FG000|Overall Study|Poor Conscious Effect|0|||
48680451|NCT01200368|156679578|FG000|Infant Series|Randomized, not vaccinated|0|||
48680452|NCT01200368|156679579|FG001|Infant Series|Randomized, not vaccinated|1|||
48680453|NCT01200368|156679580|FG002|Infant Series|Randomized, not vaccinated|1|||
48680454|NCT01200368|156679578|FG000|Infant Series|Other|1|||
48680455|NCT01200368|156679579|FG001|Infant Series|Other|0|||
48680456|NCT01200368|156679580|FG002|Infant Series|Other|0|||
48680457|NCT01200368|156679578|FG000|After Infant Series|Adverse Event|6|||
48680458|NCT01200368|156679579|FG001|After Infant Series|Adverse Event|6|||
48680459|NCT01200368|156679580|FG002|After Infant Series|Adverse Event|3|||
48680460|NCT01200368|156679578|FG000|After Infant Series|Withdrawal by Subject|10|||
48680461|NCT01200368|156679579|FG001|After Infant Series|Withdrawal by Subject|8|||
48680462|NCT01200368|156679580|FG002|After Infant Series|Withdrawal by Subject|4|||
48680463|NCT01200368|156679578|FG000|After Infant Series|Lost to Follow-up|1|||
48680464|NCT01200368|156679579|FG001|After Infant Series|Lost to Follow-up|0|||
48680465|NCT01200368|156679580|FG002|After Infant Series|Lost to Follow-up|0|||
48680466|NCT01200368|156679578|FG000|After Infant Series|Other|1|||
48680467|NCT01200368|156679579|FG001|After Infant Series|Other|2|||
48680468|NCT01200368|156679580|FG002|After Infant Series|Other|2|||
48680469|NCT01200368|156679578|FG000|Toddler Dose|Adverse Event|0|||
48680470|NCT01200368|156679579|FG001|Toddler Dose|Adverse Event|3|||
48680471|NCT01200368|156679580|FG002|Toddler Dose|Adverse Event|1|||
48680472|NCT00709618|156679588|FG000|Overall Study|Withdrawal by Subject|4|||
48680473|NCT00709618|156679588|FG000|Overall Study|Lost to Follow-up|1|||
48680474|NCT00709618|156679588|FG000|Overall Study|Study Closed/Terminated|25|||
48680475|NCT02703324|156679589|FG000|Period Two|Withdrawal by Subject|0|||
48680476|NCT02703324|156679590|FG001|Period Two|Withdrawal by Subject|0|||
48680477|NCT02703324|156679591|FG002|Period Two|Withdrawal by Subject|1|||
48680478|NCT02703324|156679592|FG003|Period Two|Withdrawal by Subject|0|||
48680479|NCT02703324|156679593|FG004|Period Two|Withdrawal by Subject|0|||
48680480|NCT02703324|156679594|FG005|Period Two|Withdrawal by Subject|0|||
48680481|NCT03517228|156679599|FG000|Overall Study|Withdrawal by Subject|2|||
48680482|NCT03517228|156679599|FG000|Overall Study|Hard drive issues, abandoned prior to surgery|2|||
48680483|NCT03517228|156679599|FG000|Overall Study|Anatomy issue - abandoned prior to surgery|1|||
48680484|NCT03517228|156679599|FG000|Overall Study|Surgery was at MAIN, could not change location to JOSIE|1|||
48680485|NCT03517228|156679599|FG000|Overall Study|Canceled due to device being updated|1|||
48680486|NCT03517228|156679599|FG000|Overall Study|No V Cares in stock|1|||
48680487|NCT03517228|156679599|FG000|Overall Study|Service issue, use of device cancelled prior to surgery|2|||
48680488|NCT00894361|156679600|FG000|Overall Study|deaths and less than 2 years followup|24|||
48680489|NCT00894361|156679601|FG001|Overall Study|deaths and less than 2 years followup|64|||
48680490|NCT01979952|156679602|FG000|Overall Study|Adverse Event|4|||
48680491|NCT01979952|156679603|FG001|Overall Study|Adverse Event|5|||
48680492|NCT01979952|156679602|FG000|Overall Study|Protocol Violation|1|||
48680493|NCT01979952|156679603|FG001|Overall Study|Protocol Violation|0|||
48762830|NCT00600938|156980348|FG002|Extension Study|Lost to Follow-up|2|||
48762831|NCT00600938|156980349|FG003|Extension Study|Lost to Follow-up|0|||
48762832|NCT00600938|156980346|FG000|Extension Study|Death|1|||
48762833|NCT00600938|156980347|FG001|Extension Study|Death|0|||
49020396|NCT01915732|157910894|FG001|Overall Study|Poor Conscious Effect|1|||
49020397|NCT02518685|157910897|FG000|Overall Study|Adverse Event|29|||
49020398|NCT02518685|157910898|FG001|Overall Study|Adverse Event|1|||
49020399|NCT02518685|157910897|FG000|Overall Study|Withdrawal by Subject|10|||
49020400|NCT02518685|157910898|FG001|Overall Study|Withdrawal by Subject|3|||
49020401|NCT02518685|157910897|FG000|Overall Study|relocation, study fatigue|7|||
49020402|NCT02518685|157910898|FG001|Overall Study|relocation, study fatigue|2|||
49020403|NCT02518685|157910897|FG000|Overall Study|Pregnancy|1|||
49020404|NCT02518685|157910898|FG001|Overall Study|Pregnancy|0|||
49020405|NCT02518685|157910897|FG000|Overall Study|Physician Decision|1|||
49020406|NCT02518685|157910898|FG001|Overall Study|Physician Decision|0|||
49020407|NCT02518685|157910897|FG000|Overall Study|Lost to Follow-up|1|||
49020408|NCT02518685|157910898|FG001|Overall Study|Lost to Follow-up|4|||
49020409|NCT00282256|157910899|FG000|Pharmacokinetic Treatment Period|Poor venous access|1|||
49020410|NCT00282256|157910899|FG000|Extension Treatment Period|Adverse Event|2|||
49020411|NCT00602030|157910900|FG000|Lead-in Phase|Disease Progression|2|||
49020412|NCT00602030|157910901|FG001|Lead-in Phase|Disease Progression|3|||
49020413|NCT00602030|157910902|FG002|Lead-in Phase|Disease Progression|0|||
49020414|NCT00602030|157910903|FG003|Lead-in Phase|Disease Progression|0|||
49020415|NCT00602030|157910904|FG004|Lead-in Phase|Disease Progression|0|||
49020416|NCT00602030|157910900|FG000|Lead-in Phase|Adverse Event|0|||
49020417|NCT00602030|157910901|FG001|Lead-in Phase|Adverse Event|2|||
49020418|NCT00602030|157910902|FG002|Lead-in Phase|Adverse Event|0|||
49020419|NCT00602030|157910903|FG003|Lead-in Phase|Adverse Event|0|||
48680494|NCT01979952|156679602|FG000|Overall Study|Withdrawal by Subject|2|||
48680495|NCT01979952|156679603|FG001|Overall Study|Withdrawal by Subject|1|||
48680496|NCT01979952|156679602|FG000|Overall Study|Other than specified above|1|||
48680497|NCT01979952|156679603|FG001|Overall Study|Other than specified above|0|||
48680498|NCT03088917|156679604|FG000|Overall Study|In care/cured elsewhere|15|||
48680499|NCT03088917|156679604|FG000|Overall Study|Refuse re-evaluation|13|||
48680500|NCT03088917|156679604|FG000|Overall Study|Contact not established|13|||
48680501|NCT03088917|156679604|FG000|Overall Study|Severe comorbidity/short life expectancy|5|||
48680502|NCT03088917|156679604|FG000|Overall Study|Moved outside study region|50|||
48680503|NCT01053988|156679605|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220|||
48680504|NCT01053988|156679606|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
48762834|NCT00600938|156980348|FG002|Extension Study|Death|0|||
49020420|NCT00602030|157910904|FG004|Lead-in Phase|Adverse Event|0|||
49020421|NCT00602030|157910900|FG000|Double-blind Phase|Disease progression|0|||
49020422|NCT00602030|157910901|FG001|Double-blind Phase|Disease progression|0|||
49020423|NCT00602030|157910902|FG002|Double-blind Phase|Disease progression|33|||
49020424|NCT00602030|157910903|FG003|Double-blind Phase|Disease progression|30|||
49020425|NCT00602030|157910904|FG004|Double-blind Phase|Disease progression|0|||
49020426|NCT00602030|157910900|FG000|Double-blind Phase|Adverse Event|0|||
49020427|NCT00602030|157910901|FG001|Double-blind Phase|Adverse Event|0|||
49020428|NCT00602030|157910902|FG002|Double-blind Phase|Adverse Event|9|||
49020429|NCT00602030|157910903|FG003|Double-blind Phase|Adverse Event|18|||
49020430|NCT00602030|157910904|FG004|Double-blind Phase|Adverse Event|0|||
49020431|NCT00602030|157910900|FG000|Double-blind Phase|Consent withdrawal|0|||
49020432|NCT00602030|157910901|FG001|Double-blind Phase|Consent withdrawal|0|||
49020433|NCT00602030|157910902|FG002|Double-blind Phase|Consent withdrawal|4|||
49020434|NCT00602030|157910903|FG003|Double-blind Phase|Consent withdrawal|3|||
49020435|NCT00602030|157910904|FG004|Double-blind Phase|Consent withdrawal|0|||
49020436|NCT00602030|157910900|FG000|Double-blind Phase|Death|0|||
49020437|NCT00602030|157910901|FG001|Double-blind Phase|Death|0|||
49020438|NCT00602030|157910902|FG002|Double-blind Phase|Death|3|||
49020439|NCT00602030|157910903|FG003|Double-blind Phase|Death|3|||
49020440|NCT00602030|157910904|FG004|Double-blind Phase|Death|0|||
49020441|NCT00602030|157910900|FG000|Double-blind Phase|Administrative decision|0|||
49020442|NCT00602030|157910901|FG001|Double-blind Phase|Administrative decision|0|||
49020443|NCT00602030|157910902|FG002|Double-blind Phase|Administrative decision|0|||
49020444|NCT00602030|157910903|FG003|Double-blind Phase|Administrative decision|2|||
49020445|NCT00602030|157910904|FG004|Double-blind Phase|Administrative decision|0|||
49020446|NCT00602030|157910900|FG000|Double-blind Phase|Ineligibility|0|||
49020447|NCT00602030|157910901|FG001|Double-blind Phase|Ineligibility|0|||
49020448|NCT00602030|157910902|FG002|Double-blind Phase|Ineligibility|0|||
49020449|NCT00602030|157910903|FG003|Double-blind Phase|Ineligibility|1|||
49020450|NCT00602030|157910904|FG004|Double-blind Phase|Ineligibility|0|||
49020451|NCT00602030|157910900|FG000|Double-blind Phase|Protocol deviation/noncompliance|0|||
49020452|NCT00602030|157910901|FG001|Double-blind Phase|Protocol deviation/noncompliance|0|||
49020453|NCT00602030|157910902|FG002|Double-blind Phase|Protocol deviation/noncompliance|1|||
49020454|NCT00602030|157910903|FG003|Double-blind Phase|Protocol deviation/noncompliance|0|||
49020455|NCT00602030|157910904|FG004|Double-blind Phase|Protocol deviation/noncompliance|0|||
48680505|NCT01053988|156679607|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
48680506|NCT01053988|156679608|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
48680507|NCT01053988|156679609|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
48680508|NCT01053988|156679610|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
48680509|NCT01053988|156679605|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|98|||
48680510|NCT01053988|156679606|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
48680511|NCT01053988|156679607|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
48680512|NCT01053988|156679608|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
48680513|NCT01053988|156679609|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
48680514|NCT01053988|156679610|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
48680515|NCT01053988|156679605|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|30|||
48680516|NCT01053988|156679606|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
48680517|NCT01053988|156679607|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
48680518|NCT01053988|156679608|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
48680519|NCT01053988|156679609|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
48680520|NCT01053988|156679610|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
48680521|NCT01053988|156679605|FG000|2-week, Single-blind Run-In Period|Adverse Event|6|||
48680522|NCT01053988|156679606|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
48680523|NCT01053988|156679607|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
48680524|NCT01053988|156679608|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
48680525|NCT01053988|156679609|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
48680526|NCT01053988|156679610|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
48680527|NCT01053988|156679605|FG000|2-week, Single-blind Run-In Period|Physician Decision|5|||
48680528|NCT01053988|156679606|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
48680529|NCT01053988|156679607|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
49020456|NCT00602030|157910900|FG000|Double-blind Phase|Reason not specified|0|||
48680530|NCT01053988|156679608|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
48680531|NCT01053988|156679609|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
48680532|NCT01053988|156679610|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
48762835|NCT00600938|156980349|FG003|Extension Study|Death|0|||
49020457|NCT00602030|157910901|FG001|Double-blind Phase|Reason not specified|0|||
49020458|NCT00602030|157910902|FG002|Double-blind Phase|Reason not specified|4|||
49020459|NCT00602030|157910903|FG003|Double-blind Phase|Reason not specified|2|||
49020460|NCT00602030|157910904|FG004|Double-blind Phase|Reason not specified|0|||
49020461|NCT00602030|157910900|FG000|Crossover Phase|Disease Progression|0|||
49020462|NCT00602030|157910901|FG001|Crossover Phase|Disease Progression|0|||
49020463|NCT00602030|157910902|FG002|Crossover Phase|Disease Progression|0|||
49020464|NCT00602030|157910903|FG003|Crossover Phase|Disease Progression|0|||
49020465|NCT00602030|157910904|FG004|Crossover Phase|Disease Progression|11|||
49020466|NCT00602030|157910900|FG000|Crossover Phase|Adverse Event|0|||
49020467|NCT00602030|157910901|FG001|Crossover Phase|Adverse Event|0|||
49020468|NCT00602030|157910902|FG002|Crossover Phase|Adverse Event|0|||
49020469|NCT00602030|157910903|FG003|Crossover Phase|Adverse Event|0|||
49020470|NCT00602030|157910904|FG004|Crossover Phase|Adverse Event|3|||
48680533|NCT01053988|156679605|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
48680534|NCT01053988|156679606|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
48680535|NCT01053988|156679607|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
48680536|NCT01053988|156679608|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
48680537|NCT01053988|156679609|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
48680538|NCT01053988|156679610|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
48680539|NCT01053988|156679605|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
48680540|NCT01053988|156679606|FG001|24-week, Double-blind Treatment Period|Adverse Event|15|||
48680541|NCT01053988|156679607|FG002|24-week, Double-blind Treatment Period|Adverse Event|23|||
48680542|NCT01053988|156679608|FG003|24-week, Double-blind Treatment Period|Adverse Event|24|||
48680543|NCT01053988|156679609|FG004|24-week, Double-blind Treatment Period|Adverse Event|17|||
48680544|NCT01053988|156679610|FG005|24-week, Double-blind Treatment Period|Adverse Event|14|||
48680545|NCT01053988|156679605|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
48680546|NCT01053988|156679606|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
48875098|NCT03128671|157379054|FG000|Allocation|Death|1|||
48680547|NCT01053988|156679607|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
48680548|NCT01053988|156679608|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
48875099|NCT03128671|157379055|FG001|Allocation|Death|0|||
49020471|NCT00602030|157910900|FG000|Crossover Phase|Consent withdrawal|0|||
48680549|NCT01053988|156679609|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
48680550|NCT01053988|156679610|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
48680551|NCT01053988|156679605|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
48680552|NCT01053988|156679606|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17|||
48680553|NCT01053988|156679607|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16|||
48680554|NCT01053988|156679608|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
48680555|NCT01053988|156679609|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9|||
48680556|NCT01053988|156679610|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
48680557|NCT01053988|156679605|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
48680558|NCT01053988|156679606|FG001|24-week, Double-blind Treatment Period|Protocol Violation|3|||
48680559|NCT01053988|156679607|FG002|24-week, Double-blind Treatment Period|Protocol Violation|4|||
48680560|NCT01053988|156679608|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
48680561|NCT01053988|156679609|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
48680562|NCT01053988|156679610|FG005|24-week, Double-blind Treatment Period|Protocol Violation|4|||
48680563|NCT01053988|156679605|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
48680564|NCT01053988|156679606|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
48680565|NCT01053988|156679607|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5|||
48680566|NCT01053988|156679608|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8|||
48680567|NCT01053988|156679609|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
48680568|NCT01053988|156679610|FG005|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
48680569|NCT01053988|156679605|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
48680570|NCT01053988|156679606|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|4|||
48680571|NCT01053988|156679607|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
48680572|NCT01053988|156679608|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
48680573|NCT01053988|156679609|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
48680574|NCT01053988|156679610|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
48680575|NCT01053988|156679605|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
48762836|NCT02295995|156980351|FG000|Overall Study|Lost to Follow-up|5|||
48875100|NCT03128671|157379054|FG000|Allocation|Withdrawal by Subject|4|||
48875101|NCT03128671|157379055|FG001|Allocation|Withdrawal by Subject|0|||
48875102|NCT03128671|157379054|FG000|Intervention|Withdrawal by Subject|11|||
48875103|NCT03128671|157379055|FG001|Intervention|Withdrawal by Subject|10|||
48875104|NCT03128671|157379054|FG000|Intervention|Palliative/hospice care initiated|9|||
48875105|NCT03128671|157379055|FG001|Intervention|Palliative/hospice care initiated|10|||
48875106|NCT03128671|157379054|FG000|Intervention|Death|13|||
48875107|NCT03128671|157379055|FG001|Intervention|Death|11|||
49020472|NCT00602030|157910901|FG001|Crossover Phase|Consent withdrawal|0|||
49020473|NCT00602030|157910902|FG002|Crossover Phase|Consent withdrawal|0|||
49020474|NCT00602030|157910903|FG003|Crossover Phase|Consent withdrawal|0|||
49020475|NCT00602030|157910904|FG004|Crossover Phase|Consent withdrawal|2|||
49020476|NCT01890915|157910908|FG000|Overall Study|Adverse Event|1|||
49020477|NCT01890915|157910909|FG001|Overall Study|Adverse Event|0|||
49020478|NCT01890915|157910908|FG000|Overall Study|Protocol Violation|2|||
49020479|NCT01890915|157910909|FG001|Overall Study|Protocol Violation|0|||
49020480|NCT01890915|157910908|FG000|Overall Study|Equipment Malfunction|0|||
49020481|NCT01890915|157910909|FG001|Overall Study|Equipment Malfunction|1|||
49020482|NCT01974895|157910912|FG000|Overall Study|Protocol Violation|1|||
49020483|NCT01974895|157910913|FG001|Overall Study|Protocol Violation|0|||
49020484|NCT01974895|157910912|FG000|Overall Study|Lost to Follow-up|4|||
49020485|NCT01974895|157910913|FG001|Overall Study|Lost to Follow-up|6|||
49020486|NCT01974895|157910912|FG000|Overall Study|Withdrawal by Subject|0|||
49020487|NCT01974895|157910913|FG001|Overall Study|Withdrawal by Subject|1|||
49020488|NCT01974895|157910912|FG000|Overall Study|Other (Missed Visit)|1|||
49020489|NCT01974895|157910913|FG001|Overall Study|Other (Missed Visit)|0|||
49020490|NCT01974895|157910912|FG000|Overall Study|Other (Reason unknown)|9|||
49020491|NCT01974895|157910913|FG001|Overall Study|Other (Reason unknown)|8|||
49020492|NCT02540356|157910918|FG000|Overall Study|Terminated due to disease progression|1|||
49020493|NCT02540356|157910919|FG001|Overall Study|Terminated due to disease progression|0|||
49020494|NCT02448771|157910920|FG000|Overall Study|Disease Progression|30|||
49020495|NCT02448771|157910920|FG000|Overall Study|Unacceptable Toxicity|1|||
49020496|NCT02448771|157910920|FG000|Overall Study|Physician Decision|3|||
49020497|NCT02448771|157910920|FG000|Overall Study|Started new therapy|2|||
49020498|NCT02114697|157910921|FG000|Overall Study|Study terminated|5|||
49020499|NCT02114697|157910922|FG001|Overall Study|Study terminated|4|||
49020500|NCT02795104|157910923|FG000|Overall Study|Determined to be Ineligible with Exit Data|7|||
49020501|NCT02795104|157910924|FG001|Overall Study|Determined to be Ineligible with Exit Data|5|||
49020502|NCT02795104|157910925|FG002|Overall Study|Determined to be Ineligible with Exit Data|7|||
49020503|NCT02795104|157910923|FG000|Overall Study|Withdrawal by Subject|0|||
49020504|NCT02795104|157910924|FG001|Overall Study|Withdrawal by Subject|2|||
49020505|NCT02795104|157910925|FG002|Overall Study|Withdrawal by Subject|0|||
49020506|NCT02795104|157910923|FG000|Overall Study|Lost to Follow-up|0|||
49020507|NCT02795104|157910924|FG001|Overall Study|Lost to Follow-up|0|||
49020508|NCT02795104|157910925|FG002|Overall Study|Lost to Follow-up|1|||
49020509|NCT01089647|157910926|FG000|Overall Study|Lost to Follow-up|2|||
49020510|NCT01089647|157910927|FG001|Overall Study|Lost to Follow-up|2|||
49020511|NCT01089647|157910926|FG000|Overall Study|Withdrawal by Subject|2|||
49020512|NCT01089647|157910927|FG001|Overall Study|Withdrawal by Subject|1|||
49020513|NCT01089647|157910926|FG000|Overall Study|Adverse Event|0|||
49020514|NCT01089647|157910927|FG001|Overall Study|Adverse Event|1|||
49020515|NCT00995553|157910928|FG000|Overall Study|Withdrawal by Subject|2|||
49020516|NCT00995553|157910929|FG001|Overall Study|Withdrawal by Subject|6|||
49020517|NCT00777829|157910935|FG000|Overall Study|Withdrawal by Subject|0|||
49020518|NCT00777829|157910936|FG001|Overall Study|Withdrawal by Subject|2|||
49020519|NCT00918567|157910939|FG000|Overall Study|Lack of Efficacy|3|||
49020520|NCT00918567|157910940|FG001|Overall Study|Lack of Efficacy|1|||
49020521|NCT00918567|157910939|FG000|Overall Study|Withdrawal by Subject|1|||
49020522|NCT00918567|157910940|FG001|Overall Study|Withdrawal by Subject|1|||
49020523|NCT00918567|157910939|FG000|Overall Study|Adverse Event|1|||
49020524|NCT00918567|157910940|FG001|Overall Study|Adverse Event|0|||
49020525|NCT01513551|157912641|FG000|Overall Study|Death|0|||
49020526|NCT01513551|157912642|FG001|Overall Study|Death|1|||
49020527|NCT01513551|157912643|FG002|Overall Study|Death|0|||
49020528|NCT01513551|157912641|FG000|Overall Study|Lost to Follow-up|3|||
48680576|NCT01053988|156679606|FG001|24-week, Double-blind Treatment Period|Physician Decision|5|||
48680577|NCT01053988|156679607|FG002|24-week, Double-blind Treatment Period|Physician Decision|2|||
48680578|NCT01053988|156679608|FG003|24-week, Double-blind Treatment Period|Physician Decision|5|||
48680579|NCT01053988|156679609|FG004|24-week, Double-blind Treatment Period|Physician Decision|5|||
48680580|NCT01053988|156679610|FG005|24-week, Double-blind Treatment Period|Physician Decision|4|||
48680581|NCT01053988|156679605|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
48680582|NCT01053988|156679606|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|11|||
49020529|NCT01513551|157912642|FG001|Overall Study|Lost to Follow-up|5|||
49020530|NCT01513551|157912643|FG002|Overall Study|Lost to Follow-up|2|||
49020531|NCT01513551|157912641|FG000|Overall Study|Withdrawal by Subject|1|||
49020532|NCT01513551|157912642|FG001|Overall Study|Withdrawal by Subject|0|||
49020533|NCT01513551|157912643|FG002|Overall Study|Withdrawal by Subject|2|||
49020534|NCT01513551|157912641|FG000|Overall Study|Randomized but not vaccinated|0|||
49020535|NCT01513551|157912642|FG001|Overall Study|Randomized but not vaccinated|0|||
49020536|NCT01513551|157912643|FG002|Overall Study|Randomized but not vaccinated|1|||
49020537|NCT01267266|157912644|FG000|Enrollment Phase|Withdrawal by Subject|2|||
49020538|NCT01267266|157912645|FG001|Enrollment Phase|Withdrawal by Subject|0|||
49020539|NCT01267266|157912644|FG000|Lead-in Phase|Lack of Efficacy|20|||
49020540|NCT01267266|157912645|FG001|Lead-in Phase|Lack of Efficacy|0|||
49020541|NCT01267266|157912644|FG000|Lead-in Phase|Adverse Event|2|||
49020542|NCT01267266|157912645|FG001|Lead-in Phase|Adverse Event|0|||
49020543|NCT01267266|157912644|FG000|Lead-in Phase|Withdrawal by Subject|1|||
49020544|NCT01267266|157912645|FG001|Lead-in Phase|Withdrawal by Subject|0|||
49020545|NCT01379781|157912646|FG000|Overall Study|Lost to Follow-up|11|||
49020546|NCT01379781|157912647|FG001|Overall Study|Lost to Follow-up|8|||
49020547|NCT02247479|157912648|FG000|Overall Study|Adverse Event|8|||
49020548|NCT02247479|157912649|FG001|Overall Study|Adverse Event|9|||
49020549|NCT02247479|157912650|FG002|Overall Study|Adverse Event|8|||
49020550|NCT02247479|157912648|FG000|Overall Study|Death|5|||
49020551|NCT02247479|157912649|FG001|Overall Study|Death|4|||
49020552|NCT02247479|157912650|FG002|Overall Study|Death|6|||
49020553|NCT02247479|157912648|FG000|Overall Study|Lost to Follow-up|3|||
49020554|NCT02247479|157912649|FG001|Overall Study|Lost to Follow-up|3|||
49020555|NCT02247479|157912650|FG002|Overall Study|Lost to Follow-up|1|||
49020556|NCT02247479|157912648|FG000|Overall Study|Non-compliance|0|||
49020557|NCT02247479|157912649|FG001|Overall Study|Non-compliance|0|||
49020558|NCT02247479|157912650|FG002|Overall Study|Non-compliance|1|||
49020559|NCT02247479|157912648|FG000|Overall Study|Withdrawal by Subject|25|||
49020560|NCT02247479|157912649|FG001|Overall Study|Withdrawal by Subject|29|||
49020561|NCT02247479|157912650|FG002|Overall Study|Withdrawal by Subject|24|||
49020562|NCT02247479|157912648|FG000|Overall Study|Study Terminated by Sponsor|98|||
49020563|NCT02247479|157912649|FG001|Overall Study|Study Terminated by Sponsor|88|||
49020564|NCT02247479|157912650|FG002|Overall Study|Study Terminated by Sponsor|94|||
49020565|NCT02247479|157912648|FG000|Overall Study|Physician Decision|1|||
49020566|NCT02247479|157912649|FG001|Overall Study|Physician Decision|0|||
49020567|NCT02247479|157912650|FG002|Overall Study|Physician Decision|2|||
49020568|NCT02247479|157912648|FG000|Overall Study|Unspecified Reason|2|||
49020569|NCT02247479|157912649|FG001|Overall Study|Unspecified Reason|5|||
49020570|NCT02247479|157912650|FG002|Overall Study|Unspecified Reason|2|||
49020571|NCT02927847|157912651|FG000|Overall Study|Lost to Follow-up|1|||
49020572|NCT02927847|157912652|FG001|Overall Study|Lost to Follow-up|0|||
49020573|NCT02927847|157912651|FG000|Overall Study|Withdrawal by Subject|4|||
49020574|NCT02927847|157912652|FG001|Overall Study|Withdrawal by Subject|2|||
49020575|NCT02927847|157912651|FG000|Overall Study|PI withdrawn due to missed visits|1|||
49020576|NCT02927847|157912652|FG001|Overall Study|PI withdrawn due to missed visits|1|||
49020577|NCT00175019|157912655|FG000|Overall Study|Adverse Event|54|||
49020578|NCT00175019|157912656|FG001|Overall Study|Adverse Event|22|||
49020579|NCT00175019|157912657|FG002|Overall Study|Adverse Event|2|||
49020580|NCT00175019|157912655|FG000|Overall Study|Protocol Violation|6|||
49020581|NCT00175019|157912656|FG001|Overall Study|Protocol Violation|3|||
49020582|NCT00175019|157912657|FG002|Overall Study|Protocol Violation|3|||
49020583|NCT00175019|157912655|FG000|Overall Study|Lost to Follow-up|42|||
49020584|NCT00175019|157912656|FG001|Overall Study|Lost to Follow-up|39|||
49020585|NCT00175019|157912657|FG002|Overall Study|Lost to Follow-up|9|||
49020586|NCT00175019|157912655|FG000|Overall Study|Did not continue under Amendment 4|1|||
49020587|NCT00175019|157912656|FG001|Overall Study|Did not continue under Amendment 4|1|||
49020588|NCT00175019|157912657|FG002|Overall Study|Did not continue under Amendment 4|2|||
49020589|NCT00175019|157912655|FG000|Overall Study|Personal Reason(s)|39|||
49020590|NCT00175019|157912656|FG001|Overall Study|Personal Reason(s)|31|||
49020591|NCT00175019|157912657|FG002|Overall Study|Personal Reason(s)|8|||
49020592|NCT00175019|157912655|FG000|Overall Study|Therapeutic Failure|10|||
49020593|NCT00175019|157912656|FG001|Overall Study|Therapeutic Failure|38|||
49020594|NCT00175019|157912657|FG002|Overall Study|Therapeutic Failure|22|||
49020595|NCT00175019|157912655|FG000|Overall Study|Gout Flare|2|||
49020596|NCT00175019|157912656|FG001|Overall Study|Gout Flare|3|||
49020597|NCT00175019|157912657|FG002|Overall Study|Gout Flare|0|||
49020598|NCT00175019|157912655|FG000|Overall Study|Reason Not Specified|40|||
49020599|NCT00175019|157912656|FG001|Overall Study|Reason Not Specified|34|||
48680583|NCT01053988|156679607|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
48680584|NCT01053988|156679608|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
48680585|NCT01053988|156679609|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|10|||
49020600|NCT00175019|157912657|FG002|Overall Study|Reason Not Specified|11|||
49020601|NCT02324465|157912661|FG000|Overall Study|device failure|0|||
48680586|NCT01053988|156679610|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
48680587|NCT01502228|156679611|FG000|Overall Study|Death|1|||
48680588|NCT00719355|156679612|FG000|Overall Study|Death|0|||
48680589|NCT00719355|156679613|FG001|Overall Study|Death|1|||
49020602|NCT02324465|157912662|FG001|Overall Study|device failure|1|||
49020603|NCT02270736|157912663|FG000|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
49020604|NCT02270736|157912664|FG001|Main Period (MP) (up to 16 Weeks)|Adverse Event|1|||
48680590|NCT00719355|156679612|FG000|Overall Study|Medical|14|||
49020605|NCT02270736|157912665|FG002|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
49020606|NCT02270736|157912666|FG003|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
49020607|NCT02270736|157912667|FG004|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
49020608|NCT02270736|157912663|FG000|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2|||
48680591|NCT00719355|156679613|FG001|Overall Study|Medical|5|||
49020609|NCT02270736|157912664|FG001|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
49020610|NCT02270736|157912665|FG002|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1|||
49020611|NCT02270736|157912666|FG003|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
49020612|NCT02270736|157912667|FG004|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
49020613|NCT02270736|157912663|FG000|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
49020614|NCT02270736|157912664|FG001|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1|||
49020615|NCT02270736|157912665|FG002|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
49020616|NCT02270736|157912666|FG003|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
49020617|NCT02270736|157912667|FG004|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
49020618|NCT02270736|157912663|FG000|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
49020619|NCT02270736|157912664|FG001|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
49020620|NCT02270736|157912665|FG002|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1|||
49020621|NCT02270736|157912666|FG003|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
49020622|NCT02270736|157912667|FG004|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
49020623|NCT02270736|157912663|FG000|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
49020624|NCT02270736|157912664|FG001|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
49020625|NCT02270736|157912665|FG002|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
49020626|NCT02270736|157912666|FG003|OLEX Period (up to 48 Weeks)|Physician Decision|1|||
49020627|NCT02270736|157912667|FG004|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
48680592|NCT00719355|156679612|FG000|Overall Study|Compliance|4|||
48680593|NCT00719355|156679613|FG001|Overall Study|Compliance|6|||
48680594|NCT00719355|156679612|FG000|Overall Study|Moved|0|||
48680595|NCT00719355|156679613|FG001|Overall Study|Moved|1|||
48680596|NCT01415401|156679614|FG000|Overall Study|Adverse Event|5|||
48680597|NCT01415401|156679614|FG000|Overall Study|DId not meet inclusion/exclusion criteri|1|||
48680598|NCT01415401|156679614|FG000|Overall Study|Terminated by Sponsor|1|||
48680599|NCT01843062|156679615|FG000|Overall Study|Protocol Violation|1|||
48680600|NCT01843062|156679616|FG001|Overall Study|Protocol Violation|0|||
48680601|NCT01843062|156679615|FG000|Overall Study|New treatment following progression|2|||
48680602|NCT01843062|156679616|FG001|Overall Study|New treatment following progression|0|||
48680603|NCT01843062|156679615|FG000|Overall Study|Pregnancy|1|||
48680604|NCT01843062|156679616|FG001|Overall Study|Pregnancy|0|||
48680605|NCT01843062|156679615|FG000|Overall Study|Adverse Event|2|||
48680606|NCT01843062|156679616|FG001|Overall Study|Adverse Event|0|||
48680607|NCT01843062|156679615|FG000|Overall Study|Incorrect randomisation|1|||
48680608|NCT01843062|156679616|FG001|Overall Study|Incorrect randomisation|0|||
48680609|NCT01843062|156679615|FG000|Overall Study|Withdrawal by Subject|12|||
48680610|NCT01843062|156679616|FG001|Overall Study|Withdrawal by Subject|3|||
48680611|NCT01843062|156679615|FG000|Overall Study|Death|1|||
48680612|NCT01843062|156679616|FG001|Overall Study|Death|2|||
48680613|NCT01843062|156679615|FG000|Overall Study|Lost to Follow-up|2|||
48680614|NCT01843062|156679616|FG001|Overall Study|Lost to Follow-up|4|||
48680615|NCT00994422|156679617|FG000|Overall Study|Lost to Follow-up|7|||
48680616|NCT00994422|156679618|FG001|Overall Study|Lost to Follow-up|1|||
48680617|NCT00132808|156679626|FG000|Stratum I|Adverse Event|2|||
48680618|NCT00132808|156679627|FG001|Stratum I|Adverse Event|1|||
48680619|NCT00132808|156679628|FG002|Stratum I|Adverse Event|0|||
48680620|NCT00132808|156679626|FG000|Stratum I|Lost to Follow-up|3|||
48680621|NCT00132808|156679627|FG001|Stratum I|Lost to Follow-up|4|||
48680622|NCT00132808|156679628|FG002|Stratum I|Lost to Follow-up|1|||
48680623|NCT00132808|156679626|FG000|Stratum I|Withdrawal by Subject|4|||
48680624|NCT00132808|156679627|FG001|Stratum I|Withdrawal by Subject|7|||
48680625|NCT00132808|156679628|FG002|Stratum I|Withdrawal by Subject|3|||
48680626|NCT00132808|156679626|FG000|Stratum I|Abnormal test procedure result (s)|0|||
48680627|NCT00132808|156679627|FG001|Stratum I|Abnormal test procedure result (s)|0|||
48680628|NCT00132808|156679628|FG002|Stratum I|Abnormal test procedure result (s)|1|||
48680629|NCT00132808|156679626|FG000|Stratum II|Adverse Event|1|||
48680630|NCT00132808|156679627|FG001|Stratum II|Adverse Event|2|||
48680631|NCT00132808|156679628|FG002|Stratum II|Adverse Event|1|||
48680632|NCT00132808|156679626|FG000|Stratum II|Death|1|||
48680633|NCT00132808|156679627|FG001|Stratum II|Death|0|||
48680634|NCT00132808|156679628|FG002|Stratum II|Death|0|||
48680635|NCT00132808|156679626|FG000|Stratum II|Lost to Follow-up|2|||
48680636|NCT00132808|156679627|FG001|Stratum II|Lost to Follow-up|2|||
48680637|NCT00132808|156679628|FG002|Stratum II|Lost to Follow-up|1|||
48680638|NCT00132808|156679626|FG000|Stratum II|Protocol Violation|0|||
48680639|NCT00132808|156679627|FG001|Stratum II|Protocol Violation|2|||
49020628|NCT02270736|157912663|FG000|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
48680640|NCT00132808|156679628|FG002|Stratum II|Protocol Violation|1|||
48680641|NCT00132808|156679626|FG000|Stratum II|Withdrawal by Subject|4|||
48680642|NCT00132808|156679627|FG001|Stratum II|Withdrawal by Subject|9|||
48680643|NCT00132808|156679628|FG002|Stratum II|Withdrawal by Subject|6|||
48680644|NCT03078855|156679629|FG000|Overall Study|Lack of Efficacy|62|||
48680645|NCT03078855|156679630|FG001|Overall Study|Lack of Efficacy|31|||
48680646|NCT03078855|156679629|FG000|Overall Study|Death|1|||
48680647|NCT03078855|156679630|FG001|Overall Study|Death|0|||
48680648|NCT03078855|156679629|FG000|Overall Study|Withdrawal by Subject|12|||
48680649|NCT03078855|156679630|FG001|Overall Study|Withdrawal by Subject|6|||
48680650|NCT03078855|156679629|FG000|Overall Study|Physician Decision|3|||
48680651|NCT03078855|156679630|FG001|Overall Study|Physician Decision|2|||
48680652|NCT03078855|156679629|FG000|Overall Study|Second Malignancy|4|||
49020629|NCT02270736|157912664|FG001|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
49020630|NCT02270736|157912665|FG002|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
49020631|NCT02270736|157912666|FG003|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2|||
49020632|NCT02270736|157912667|FG004|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
49020633|NCT02270736|157912663|FG000|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
49020634|NCT02270736|157912664|FG001|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
49020635|NCT02270736|157912665|FG002|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
49020636|NCT02270736|157912666|FG003|OLEX Period (up to 48 Weeks)|Adverse Event|4|||
49020637|NCT02270736|157912667|FG004|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
49020638|NCT02270736|157912663|FG000|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
49020639|NCT02270736|157912664|FG001|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
49020640|NCT02270736|157912665|FG002|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
49020641|NCT02270736|157912666|FG003|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16|||
49020642|NCT02270736|157912667|FG004|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
49020643|NCT02270736|157912663|FG000|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
49020644|NCT02270736|157912664|FG001|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
49020645|NCT02270736|157912665|FG002|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
49020646|NCT02270736|157912666|FG003|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2|||
49020647|NCT02270736|157912667|FG004|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
49020648|NCT01631864|157912668|FG000|Overall Study|Withdrawal by Subject|0|||
49020649|NCT01631864|157912669|FG001|Overall Study|Withdrawal by Subject|1|||
49020650|NCT01631864|157912668|FG000|Overall Study|Adverse Event|2|||
49020651|NCT01631864|157912669|FG001|Overall Study|Adverse Event|3|||
49020652|NCT03823300|157912681|FG000|Overall Study|Withdrawal by Subject|16|||
49020653|NCT03823300|157912682|FG001|Overall Study|Withdrawal by Subject|22|||
49020654|NCT03823300|157912681|FG000|Overall Study|Death|10|||
49020655|NCT03823300|157912682|FG001|Overall Study|Death|14|||
49020656|NCT03823300|157912681|FG000|Overall Study|Adverse Event|3|||
48680653|NCT03078855|156679630|FG001|Overall Study|Second Malignancy|0|||
48680654|NCT03078855|156679629|FG000|Overall Study|Ineligible|2|||
48680655|NCT03078855|156679630|FG001|Overall Study|Ineligible|0|||
48680656|NCT03078855|156679629|FG000|Overall Study|Withdrew before day 1 treatment|2|||
48680657|NCT03078855|156679630|FG001|Overall Study|Withdrew before day 1 treatment|1|||
49020657|NCT03823300|157912682|FG001|Overall Study|Adverse Event|5|||
49020658|NCT03823300|157912681|FG000|Overall Study|Physician Decision|1|||
49020659|NCT03823300|157912682|FG001|Overall Study|Physician Decision|7|||
49020660|NCT03823300|157912681|FG000|Overall Study|Lost to Follow-up|1|||
49020661|NCT03823300|157912682|FG001|Overall Study|Lost to Follow-up|3|||
49020662|NCT03823300|157912681|FG000|Overall Study|Protocol Violation|1|||
49020663|NCT03823300|157912682|FG001|Overall Study|Protocol Violation|1|||
49020664|NCT03823300|157912681|FG000|Overall Study|Lack of Efficacy|1|||
49020665|NCT03823300|157912682|FG001|Overall Study|Lack of Efficacy|1|||
49020666|NCT03823300|157912681|FG000|Overall Study|Not Eligible|0|||
49020667|NCT03823300|157912682|FG001|Overall Study|Not Eligible|1|||
49020668|NCT03823300|157912681|FG000|Overall Study|Other|1|||
49020669|NCT03823300|157912682|FG001|Overall Study|Other|0|||
49020670|NCT00337571|157912684|FG000|Overall Study|Lack of Efficacy|3|||
49020671|NCT00337571|157912685|FG001|Overall Study|Lack of Efficacy|0|||
49020672|NCT00337571|157912686|FG002|Overall Study|Lack of Efficacy|0|||
49020673|NCT00337571|157912687|FG003|Overall Study|Lack of Efficacy|0|||
49020674|NCT00337571|157912684|FG000|Overall Study|Adverse Event|4|||
49020675|NCT00337571|157912685|FG001|Overall Study|Adverse Event|5|||
49020676|NCT00337571|157912686|FG002|Overall Study|Adverse Event|8|||
49020677|NCT00337571|157912687|FG003|Overall Study|Adverse Event|4|||
49020678|NCT00337571|157912684|FG000|Overall Study|Withdrawal by Subject|2|||
49020679|NCT00337571|157912685|FG001|Overall Study|Withdrawal by Subject|2|||
49020680|NCT00337571|157912686|FG002|Overall Study|Withdrawal by Subject|1|||
49020681|NCT00337571|157912687|FG003|Overall Study|Withdrawal by Subject|0|||
49020682|NCT00337571|157912684|FG000|Overall Study|Lost to Follow-up|3|||
49020683|NCT00337571|157912685|FG001|Overall Study|Lost to Follow-up|1|||
49020684|NCT00337571|157912686|FG002|Overall Study|Lost to Follow-up|0|||
49020685|NCT00337571|157912687|FG003|Overall Study|Lost to Follow-up|1|||
49020686|NCT00337571|157912684|FG000|Overall Study|Poor/noncompliance|1|||
49020687|NCT00337571|157912685|FG001|Overall Study|Poor/noncompliance|1|||
49020688|NCT00337571|157912686|FG002|Overall Study|Poor/noncompliance|1|||
48680658|NCT00577824|156679631|FG000|Overall Study|Adverse Event|6|||
49020689|NCT00337571|157912687|FG003|Overall Study|Poor/noncompliance|1|||
49020690|NCT00337571|157912684|FG000|Overall Study|No longer met study criteria|1|||
48680659|NCT00577824|156679632|FG001|Overall Study|Adverse Event|18|||
49020691|NCT00337571|157912685|FG001|Overall Study|No longer met study criteria|0|||
49020692|NCT00337571|157912686|FG002|Overall Study|No longer met study criteria|0|||
49020693|NCT00337571|157912687|FG003|Overall Study|No longer met study criteria|0|||
49020694|NCT00337571|157912684|FG000|Overall Study|High Potassium level|0|||
49020695|NCT00337571|157912685|FG001|Overall Study|High Potassium level|0|||
49020696|NCT00337571|157912686|FG002|Overall Study|High Potassium level|0|||
49020697|NCT00337571|157912687|FG003|Overall Study|High Potassium level|1|||
48680660|NCT00577824|156679633|FG002|Overall Study|Adverse Event|1|||
48680661|NCT00577824|156679631|FG000|Overall Study|Patient decision|0|||
48680662|NCT00577824|156679632|FG001|Overall Study|Patient decision|1|||
48680663|NCT00577824|156679633|FG002|Overall Study|Patient decision|1|||
48680664|NCT00577824|156679631|FG000|Overall Study|Protocol Violation|1|||
48680665|NCT00577824|156679632|FG001|Overall Study|Protocol Violation|1|||
48680666|NCT00577824|156679633|FG002|Overall Study|Protocol Violation|0|||
48680667|NCT00836186|156679634|FG000|Overall Study|Blood could not be drawn|1|||
48680668|NCT04079816|156679635|FG000|Overall Study|Request of Subject|2|||
48680669|NCT04079816|156679635|FG000|Overall Study|Unable to draw samples|1|||
48680670|NCT04137731|156679636|FG000|Overall Study|Surgery Cancellation|1|||
48680671|NCT04137731|156679637|FG001|Overall Study|Surgery Cancellation|2|||
48680672|NCT04137731|156679636|FG000|Overall Study|Withdrawal by Subject|2|||
48680673|NCT04137731|156679637|FG001|Overall Study|Withdrawal by Subject|0|||
48680674|NCT04137731|156679636|FG000|Overall Study|Protocol Violation|0|||
48680675|NCT04137731|156679637|FG001|Overall Study|Protocol Violation|1|||
48680676|NCT00666224|156680859|FG000|Double-Blind|Adverse Event|15|||
48680677|NCT00666224|156680860|FG001|Double-Blind|Adverse Event|5|||
48680678|NCT00666224|156680859|FG000|Double-Blind|Lost to Follow-up|2|||
48680679|NCT00666224|156680860|FG001|Double-Blind|Lost to Follow-up|2|||
48680680|NCT00666224|156680859|FG000|Double-Blind|Withdrawal by Subject|18|||
48680681|NCT00666224|156680860|FG001|Double-Blind|Withdrawal by Subject|14|||
48680682|NCT00666224|156680859|FG000|Double-Blind|Physician Decision|0|||
48680683|NCT00666224|156680860|FG001|Double-Blind|Physician Decision|3|||
48680684|NCT00666224|156680859|FG000|Double-Blind|Sponsor decision|1|||
48680685|NCT00666224|156680860|FG001|Double-Blind|Sponsor decision|0|||
48680686|NCT00666224|156680859|FG000|Double-Blind|Pregnancy|3|||
48680687|NCT00666224|156680860|FG001|Double-Blind|Pregnancy|2|||
48680688|NCT00666224|156680859|FG000|Double-Blind|Noncompliance|1|||
48680689|NCT00666224|156680860|FG001|Double-Blind|Noncompliance|0|||
48680690|NCT00666224|156680859|FG000|Double-Blind|Death|1|||
48680691|NCT00666224|156680860|FG001|Double-Blind|Death|0|||
48680692|NCT00666224|156680859|FG000|Double-Blind|Undefined/Unknown|4|||
48680693|NCT00666224|156680860|FG001|Double-Blind|Undefined/Unknown|1|||
48680694|NCT00666224|156680859|FG000|Open-Label|Adverse Event|8|||
48680695|NCT00666224|156680860|FG001|Open-Label|Adverse Event|43|||
48680696|NCT00666224|156680859|FG000|Open-Label|Lost to Follow-up|4|||
48680697|NCT00666224|156680860|FG001|Open-Label|Lost to Follow-up|5|||
48680698|NCT00666224|156680859|FG000|Open-Label|Withdrawal by Subject|12|||
48680699|NCT00666224|156680860|FG001|Open-Label|Withdrawal by Subject|25|||
48680700|NCT00666224|156680859|FG000|Open-Label|Physician Decision|7|||
48680701|NCT00666224|156680860|FG001|Open-Label|Physician Decision|5|||
48680702|NCT00666224|156680859|FG000|Open-Label|Pregnancy|1|||
48680703|NCT00666224|156680860|FG001|Open-Label|Pregnancy|5|||
48680704|NCT00666224|156680859|FG000|Open-Label|Noncompliance|2|||
48680705|NCT00666224|156680860|FG001|Open-Label|Noncompliance|1|||
48680706|NCT00666224|156680859|FG000|Open-Label|Undefined/Unknown|1|||
48680707|NCT00666224|156680860|FG001|Open-Label|Undefined/Unknown|1|||
48680708|NCT01424501|156680868|FG000|Overall Study|Withdrawal by Subject|1|||
48680709|NCT01424501|156680869|FG001|Overall Study|Withdrawal by Subject|0|||
48680710|NCT01424501|156680870|FG002|Overall Study|Withdrawal by Subject|1|||
48680711|NCT01424501|156680871|FG003|Overall Study|Withdrawal by Subject|0|||
48762837|NCT02295995|156980352|FG001|Overall Study|Lost to Follow-up|1|||
48762838|NCT01324349|156980362|FG000|Overall Study|Death|1|||
48762839|NCT01324349|156980363|FG001|Overall Study|Death|1|||
48680712|NCT01424501|156680872|FG004|Overall Study|Withdrawal by Subject|0|||
48680713|NCT01424501|156680873|FG005|Overall Study|Withdrawal by Subject|0|||
48680714|NCT01424501|156680868|FG000|Overall Study|Lost to Follow-up|0|||
48680715|NCT01424501|156680869|FG001|Overall Study|Lost to Follow-up|1|||
48980942|NCT02096471|157762244|FG000|Overall Study|Adverse Event|1|||
48980943|NCT02096471|157762244|FG000|Overall Study|Lack of Efficacy|7|||
48980944|NCT02096471|157762244|FG000|Overall Study|Withdrawal by Subject|3|||
48980945|NCT02096471|157762244|FG000|Overall Study|Non-Compliant|2|||
48980946|NCT01332851|157762247|FG000|Overall Study|Withdrawal by Subject|4|||
48980947|NCT01332851|157762248|FG001|Overall Study|Withdrawal by Subject|2|||
48980948|NCT01332851|157762247|FG000|Overall Study|Lost to Follow-up|7|||
48980949|NCT01332851|157762248|FG001|Overall Study|Lost to Follow-up|11|||
48980950|NCT01809327|157762250|FG000|Overall Study|Lost to Follow-up|5|||
48680716|NCT01424501|156680870|FG002|Overall Study|Lost to Follow-up|1|||
48680717|NCT01424501|156680871|FG003|Overall Study|Lost to Follow-up|0|||
48680718|NCT01424501|156680872|FG004|Overall Study|Lost to Follow-up|0|||
48680719|NCT01424501|156680873|FG005|Overall Study|Lost to Follow-up|0|||
48680720|NCT00546000|156680874|FG000|Overall Study|Adverse Event|1|||
48680721|NCT00546000|156680874|FG000|Overall Study|Lost to Follow-up|1|||
48680722|NCT00546000|156680874|FG000|Overall Study|Baseline HPA Axis Supression|2|||
48680723|NCT04207749|156680875|FG000|Overall Study|Lost to Follow-up|0|||
48680724|NCT04207749|156680876|FG001|Overall Study|Lost to Follow-up|2|||
48680725|NCT04207749|156680875|FG000|Overall Study|Protocol Violation|0|||
48680726|NCT04207749|156680876|FG001|Overall Study|Protocol Violation|1|||
48680727|NCT04207749|156680875|FG000|Overall Study|Withdrawal by Subject|3|||
48980951|NCT01809327|157762251|FG001|Overall Study|Lost to Follow-up|2|||
48680728|NCT04207749|156680876|FG001|Overall Study|Withdrawal by Subject|0|||
48680729|NCT04207749|156680875|FG000|Overall Study|Unable to attend study visits due to COVID-19 pandemic|1|||
48680730|NCT04207749|156680876|FG001|Overall Study|Unable to attend study visits due to COVID-19 pandemic|4|||
48680731|NCT02581215|156680877|FG000|Overall Study|Screen Failure Before Therapy Start|0|||
48680732|NCT02581215|156680878|FG001|Overall Study|Screen Failure Before Therapy Start|1|||
48680733|NCT02581215|156680877|FG000|Overall Study|Eligibility Criteria Not Met|0|||
48680734|NCT02581215|156680878|FG001|Overall Study|Eligibility Criteria Not Met|1|||
48680735|NCT00705367|156680885|FG000|Long-term Extension Period|Adverse Event|2|||
48680736|NCT00705367|156680886|FG001|Long-term Extension Period|Adverse Event|0|||
48680737|NCT00705367|156680885|FG000|Long-term Extension Period|Withdrawal by Subject|2|||
48680738|NCT00705367|156680886|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
48680739|NCT00705367|156680885|FG000|Long-term Extension Period|Lack of Efficacy|1|||
48680740|NCT00705367|156680886|FG001|Long-term Extension Period|Lack of Efficacy|0|||
48680741|NCT00705367|156680885|FG000|Long-term Extension Period|No longer met study criteria|1|||
48680742|NCT00705367|156680886|FG001|Long-term Extension Period|No longer met study criteria|0|||
48680743|NCT00705367|156680885|FG000|Long-term Extension Period|Administrative reason by sponsor|3|||
48680744|NCT00705367|156680886|FG001|Long-term Extension Period|Administrative reason by sponsor|0|||
48680745|NCT03781778|156680895|FG000|Overall Study|Withdrawal by Subject|2|||
48680746|NCT03781778|156680896|FG001|Overall Study|Withdrawal by Subject|2|||
48680747|NCT02152761|156680898|FG000|Epoch: Treatment Epoch|Technical problems|0|||
48680748|NCT02152761|156680899|FG001|Epoch: Treatment Epoch|Technical problems|0|||
48680749|NCT02152761|156680900|FG002|Epoch: Treatment Epoch|Technical problems|0|||
48680750|NCT02152761|156680901|FG003|Epoch: Treatment Epoch|Technical problems|1|||
48680751|NCT02152761|156680898|FG000|Epoch: Treatment Epoch|Lost to Follow-up|0|||
48680752|NCT02152761|156680899|FG001|Epoch: Treatment Epoch|Lost to Follow-up|2|||
48680753|NCT02152761|156680900|FG002|Epoch: Treatment Epoch|Lost to Follow-up|0|||
48680754|NCT02152761|156680901|FG003|Epoch: Treatment Epoch|Lost to Follow-up|0|||
48680755|NCT02152761|156680898|FG000|Epoch: Treatment Epoch|Withdrawal by Subject|7|||
48680756|NCT02152761|156680899|FG001|Epoch: Treatment Epoch|Withdrawal by Subject|8|||
48680757|NCT02152761|156680900|FG002|Epoch: Treatment Epoch|Withdrawal by Subject|3|||
48680758|NCT02152761|156680901|FG003|Epoch: Treatment Epoch|Withdrawal by Subject|5|||
48680759|NCT02152761|156680898|FG000|Epoch: Treatment Epoch|Adverse Event|3|||
48680760|NCT02152761|156680899|FG001|Epoch: Treatment Epoch|Adverse Event|6|||
48680761|NCT02152761|156680900|FG002|Epoch: Treatment Epoch|Adverse Event|1|||
48680762|NCT02152761|156680901|FG003|Epoch: Treatment Epoch|Adverse Event|2|||
48680763|NCT02152761|156680898|FG000|Epoch: Treatment Epoch|Death|0|||
48680764|NCT02152761|156680899|FG001|Epoch: Treatment Epoch|Death|3|||
48680765|NCT02152761|156680900|FG002|Epoch: Treatment Epoch|Death|1|||
48680766|NCT02152761|156680901|FG003|Epoch: Treatment Epoch|Death|0|||
48680767|NCT02152761|156680898|FG000|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
48680768|NCT02152761|156680899|FG001|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
48680769|NCT02152761|156680900|FG002|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
48680770|NCT02152761|156680901|FG003|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
48680771|NCT02152761|156680898|FG000|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
48680772|NCT02152761|156680899|FG001|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3|||
48680773|NCT02152761|156680900|FG002|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0|||
48680774|NCT02152761|156680901|FG003|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
48680775|NCT02152761|156680898|FG000|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1|||
48680776|NCT02152761|156680899|FG001|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4|||
48680777|NCT02152761|156680900|FG002|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
48680778|NCT02152761|156680901|FG003|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
48680779|NCT02152761|156680898|FG000|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1|||
48680780|NCT02152761|156680899|FG001|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
48680781|NCT02152761|156680900|FG002|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
48680782|NCT02152761|156680901|FG003|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
48680783|NCT02152761|156680898|FG000|Epoch: Post-treatment Follow-up Epoch|Death|1|||
48680784|NCT02152761|156680899|FG001|Epoch: Post-treatment Follow-up Epoch|Death|0|||
48680785|NCT02152761|156680900|FG002|Epoch: Post-treatment Follow-up Epoch|Death|0|||
48680786|NCT02152761|156680901|FG003|Epoch: Post-treatment Follow-up Epoch|Death|1|||
48680787|NCT04343755|156680902|FG000|Overall Study|Death|11|||
48680788|NCT04343755|156680902|FG000|Overall Study|Screen Failure|1|||
49020698|NCT01399736|157912688|FG000|Overall Study|Withdrawal by Subject|4|||
49020699|NCT01399736|157912689|FG001|Overall Study|Withdrawal by Subject|2|||
49020700|NCT01399736|157912688|FG000|Overall Study|Lost to Follow-up|0|||
48680789|NCT03755882|156680903|FG000|Period 1|Protocol Violation|1|||
48680790|NCT03755882|156680904|FG001|Period 1|Protocol Violation|0|||
48680791|NCT03755882|156680903|FG000|Period 1|Unsatisfactory Lens Fitting Test Article|3|||
48680792|NCT03755882|156680904|FG001|Period 1|Unsatisfactory Lens Fitting Test Article|0|||
48680793|NCT01687101|156680905|FG000|Overall Study|Lost to Follow-up|7|||
48680794|NCT03792256|156680914|FG000|Overall Study|Death|0|||
48680795|NCT03792256|156680915|FG001|Overall Study|Death|1|||
49020701|NCT01399736|157912689|FG001|Overall Study|Lost to Follow-up|2|||
49020702|NCT03335371|157912690|FG000|Overall Study|Lost to Follow-up|0|||
49020703|NCT03335371|157912691|FG001|Overall Study|Lost to Follow-up|0|||
49020704|NCT03335371|157912692|FG002|Overall Study|Lost to Follow-up|0|||
49020705|NCT03335371|157912693|FG003|Overall Study|Lost to Follow-up|0|||
49020706|NCT03335371|157912694|FG004|Overall Study|Lost to Follow-up|1|||
49020707|NCT03335371|157912690|FG000|Overall Study|Withdrawal by Subject|0|||
49020708|NCT03335371|157912691|FG001|Overall Study|Withdrawal by Subject|0|||
49020709|NCT03335371|157912692|FG002|Overall Study|Withdrawal by Subject|0|||
48680796|NCT03792256|156680914|FG000|Overall Study|Lack of Efficacy|0|||
48680797|NCT03792256|156680915|FG001|Overall Study|Lack of Efficacy|1|||
48680798|NCT03792256|156680914|FG000|Overall Study|Withdrawal by Subject|0|||
48680799|NCT03792256|156680915|FG001|Overall Study|Withdrawal by Subject|1|||
48680800|NCT00991939|156680916|FG000|Overall Study|Lost to Follow-up|0|||
49020710|NCT03335371|157912693|FG003|Overall Study|Withdrawal by Subject|0|||
48680801|NCT00991939|156680917|FG001|Overall Study|Lost to Follow-up|1|||
48680802|NCT00991939|156680916|FG000|Overall Study|Withdrawal by Subject|1|||
48680803|NCT00991939|156680917|FG001|Overall Study|Withdrawal by Subject|0|||
49020711|NCT03335371|157912694|FG004|Overall Study|Withdrawal by Subject|1|||
48680804|NCT00991939|156680916|FG000|Overall Study|Entire study terminated|4|||
48680805|NCT00991939|156680917|FG001|Overall Study|Entire study terminated|1|||
48680806|NCT00714415|156680918|FG000|Overall Study|Lack of Efficacy|1|||
48680807|NCT00714415|156680919|FG001|Overall Study|Lack of Efficacy|0|||
48680808|NCT00714415|156680918|FG000|Overall Study|Death|1|||
48680809|NCT00714415|156680919|FG001|Overall Study|Death|0|||
48680810|NCT04303572|156680922|FG000|Overall Study|Study closed due to poor enrollment|1|||
48680811|NCT02073682|156680923|FG000|Overall Study|Low Creatinine Clearance|1|||
48680812|NCT02073682|156680924|FG001|Overall Study|Low Creatinine Clearance|2|||
48680813|NCT02073682|156680923|FG000|Overall Study|Death|86|||
48680814|NCT02073682|156680924|FG001|Overall Study|Death|100|||
48680815|NCT02073682|156680923|FG000|Overall Study|Cancer Cured|10|||
48680816|NCT02073682|156680924|FG001|Overall Study|Cancer Cured|15|||
48680817|NCT02073682|156680923|FG000|Overall Study|ID: Patient Noncompliance|1|||
48680818|NCT02073682|156680924|FG001|Overall Study|ID: Patient Noncompliance|2|||
48680819|NCT02073682|156680923|FG000|Overall Study|ID: Palliative Treatment Only|10|||
48680820|NCT02073682|156680924|FG001|Overall Study|ID: Palliative Treatment Only|7|||
48680821|NCT02073682|156680923|FG000|Overall Study|Prohibited Concomitant Medication Use|0|||
48680822|NCT02073682|156680924|FG001|Overall Study|Prohibited Concomitant Medication Use|1|||
48680823|NCT02073682|156680923|FG000|Overall Study|Platelet Count <50,000/mL|1|||
48680824|NCT02073682|156680924|FG001|Overall Study|Platelet Count <50,000/mL|2|||
48680825|NCT02073682|156680923|FG000|Overall Study|Surgery/Medical Procedure|3|||
48680826|NCT02073682|156680924|FG001|Overall Study|Surgery/Medical Procedure|1|||
48680827|NCT02073682|156680923|FG000|Overall Study|Withdrawal by Subject|6|||
48680828|NCT02073682|156680924|FG001|Overall Study|Withdrawal by Subject|8|||
48680829|NCT02073682|156680923|FG000|Overall Study|Start of New Chemotherapy Regimen|6|||
48680830|NCT02073682|156680924|FG001|Overall Study|Start of New Chemotherapy Regimen|3|||
48680831|NCT02073682|156680923|FG000|Overall Study|Cancer Progression|53|||
48680832|NCT02073682|156680924|FG001|Overall Study|Cancer Progression|33|||
48680833|NCT02073682|156680923|FG000|Overall Study|Protocol Violation|1|||
48680834|NCT02073682|156680924|FG001|Overall Study|Protocol Violation|0|||
48680835|NCT02073682|156680923|FG000|Overall Study|Adverse Event|79|||
48680836|NCT02073682|156680924|FG001|Overall Study|Adverse Event|62|||
48680837|NCT02073682|156680923|FG000|Overall Study|No reason provided|11|||
48680838|NCT02073682|156680924|FG001|Overall Study|No reason provided|9|||
48680839|NCT02073682|156680923|FG000|Overall Study|PD: Inconvenience of Dosing|21|||
48680840|NCT02073682|156680924|FG001|Overall Study|PD: Inconvenience of Dosing|78|||
48680841|NCT02073682|156680923|FG000|Overall Study|Lost to Follow-up|1|||
48680842|NCT02073682|156680924|FG001|Overall Study|Lost to Follow-up|1|||
48680843|NCT02073682|156680923|FG000|Overall Study|ID: Benefit/Risk Judgment|32|||
48680844|NCT02073682|156680924|FG001|Overall Study|ID: Benefit/Risk Judgment|46|||
48680845|NCT04034004|156680925|FG000|Overall Study|Withdrawal by Subject|1|||
48680846|NCT04034004|156680926|FG001|Overall Study|Withdrawal by Subject|2|||
48680847|NCT04034004|156680927|FG002|Overall Study|Withdrawal by Subject|2|||
48680848|NCT04034004|156680928|FG003|Overall Study|Withdrawal by Subject|3|||
48680849|NCT04034004|156680925|FG000|Overall Study|could not find vein to administer IV|2|||
48680850|NCT04034004|156680926|FG001|Overall Study|could not find vein to administer IV|1|||
48680851|NCT04034004|156680927|FG002|Overall Study|could not find vein to administer IV|0|||
48680852|NCT04034004|156680928|FG003|Overall Study|could not find vein to administer IV|0|||
48680853|NCT04034004|156680925|FG000|Overall Study|nurse accidentally unblinded subject|0|||
48680854|NCT04034004|156680926|FG001|Overall Study|nurse accidentally unblinded subject|0|||
48680855|NCT04034004|156680927|FG002|Overall Study|nurse accidentally unblinded subject|0|||
48680856|NCT04034004|156680928|FG003|Overall Study|nurse accidentally unblinded subject|1|||
48680857|NCT03672292|156680929|FG000|Overall Study|Adverse Event|3|||
48680858|NCT03672292|156680930|FG001|Overall Study|Adverse Event|1|||
49020712|NCT03335371|157912690|FG000|Overall Study|Randomization Error|0|||
49020713|NCT03335371|157912691|FG001|Overall Study|Randomization Error|0|||
48680859|NCT03672292|156680929|FG000|Overall Study|Physician Decision|0|||
48680860|NCT03672292|156680930|FG001|Overall Study|Physician Decision|1|||
48680861|NCT03672292|156680929|FG000|Overall Study|Withdrawal by Subject|1|||
48680862|NCT03672292|156680930|FG001|Overall Study|Withdrawal by Subject|2|||
48680863|NCT04124705|156680932|FG000|Titration Period|Adverse Event|9|||
48680864|NCT04124705|156680933|FG001|Titration Period|Adverse Event|5|||
48680865|NCT04124705|156680932|FG000|Titration Period|Withdrawal by Subject|6|||
48680866|NCT04124705|156680933|FG001|Titration Period|Withdrawal by Subject|3|||
48680867|NCT04124705|156680932|FG000|Titration Period|Lost to Follow-up|0|||
48680868|NCT04124705|156680933|FG001|Titration Period|Lost to Follow-up|1|||
48680869|NCT04124705|156680932|FG000|Titration Period|Death|1|||
48680870|NCT04124705|156680933|FG001|Titration Period|Death|1|||
48680871|NCT04124705|156680932|FG000|Titration Period|Lack of Efficacy|2|||
48680872|NCT04124705|156680933|FG001|Titration Period|Lack of Efficacy|0|||
48680873|NCT04124705|156680932|FG000|Titration Period|Physician Decision|2|||
48680874|NCT04124705|156680933|FG001|Titration Period|Physician Decision|0|||
48680875|NCT04124705|156680932|FG000|Titration Period|Non-compliance with Study Drug|2|||
48680876|NCT04124705|156680933|FG001|Titration Period|Non-compliance with Study Drug|0|||
48680877|NCT04124705|156680932|FG000|Titration Period|Other|4|||
48680878|NCT04124705|156680933|FG001|Titration Period|Other|9|||
48680879|NCT04124705|156680932|FG000|Stabilization Period|Adverse Event|4|||
48680880|NCT04124705|156680933|FG001|Stabilization Period|Adverse Event|2|||
48680881|NCT04124705|156680932|FG000|Stabilization Period|Withdrawal by Subject|1|||
48762840|NCT01324349|156980362|FG000|Overall Study|Withdrawal by Subject|0|||
48762841|NCT01324349|156980363|FG001|Overall Study|Withdrawal by Subject|1|||
48762842|NCT01367158|156980364|FG000|Overall Study|Withdrew consent|0|||
48762843|NCT01367158|156980365|FG001|Overall Study|Withdrew consent|2|||
48762844|NCT01367158|156980366|FG002|Overall Study|Withdrew consent|1|||
48762845|NCT01367158|156980367|FG003|Overall Study|Withdrew consent|0|||
48762846|NCT01367158|156980368|FG004|Overall Study|Withdrew consent|2|||
48762847|NCT01367158|156980369|FG005|Overall Study|Withdrew consent|0|||
48762848|NCT01367158|156980370|FG006|Overall Study|Withdrew consent|0|||
48762849|NCT01367158|156980371|FG007|Overall Study|Withdrew consent|1|||
48762850|NCT01367158|156980372|FG008|Overall Study|Withdrew consent|0|||
48762851|NCT01367158|156980373|FG009|Overall Study|Withdrew consent|0|||
48762852|NCT01367158|156980374|FG010|Overall Study|Withdrew consent|0|||
48762853|NCT01367158|156980364|FG000|Overall Study|Lost to Follow-up|0|||
48680882|NCT04124705|156680933|FG001|Stabilization Period|Withdrawal by Subject|1|||
48680883|NCT04124705|156680932|FG000|Stabilization Period|Lost to Follow-up|0|||
48680884|NCT04124705|156680933|FG001|Stabilization Period|Lost to Follow-up|1|||
48680885|NCT04124705|156680932|FG000|Stabilization Period|Lack of Efficacy|4|||
48680886|NCT04124705|156680933|FG001|Stabilization Period|Lack of Efficacy|2|||
48680887|NCT04124705|156680932|FG000|Stabilization Period|Protocol Deviation|0|||
48680888|NCT04124705|156680933|FG001|Stabilization Period|Protocol Deviation|2|||
48762854|NCT01367158|156980365|FG001|Overall Study|Lost to Follow-up|0|||
48762855|NCT01367158|156980366|FG002|Overall Study|Lost to Follow-up|0|||
48762856|NCT01367158|156980367|FG003|Overall Study|Lost to Follow-up|1|||
48680889|NCT04124705|156680932|FG000|Stabilization Period|Other|2|||
48680890|NCT04124705|156680933|FG001|Stabilization Period|Other|2|||
48680891|NCT05236257|156680947|FG000|Overall Study|Ongoing with study treatment|29|||
48680892|NCT05236257|156680948|FG001|Overall Study|Ongoing with study treatment|1|||
48680893|NCT05236257|156680947|FG000|Overall Study|Discontinued study treatment|22|||
48680894|NCT05236257|156680948|FG001|Overall Study|Discontinued study treatment|41|||
48680895|NCT01611194|156680949|FG000|Overall Study|Lost to Follow-up|0|||
48680896|NCT01611194|156680950|FG001|Overall Study|Lost to Follow-up|1|||
48680897|NCT01611194|156680949|FG000|Overall Study|Withdrawal by Subject|0|||
48680898|NCT01611194|156680950|FG001|Overall Study|Withdrawal by Subject|1|||
48680899|NCT01611194|156680949|FG000|Overall Study|drug use|0|||
48680900|NCT01611194|156680950|FG001|Overall Study|drug use|1|||
48680901|NCT00874848|156680954|FG000|Overall Study|Adverse Event|13|||
48762857|NCT01367158|156980368|FG004|Overall Study|Lost to Follow-up|0|||
48680902|NCT00874848|156680955|FG001|Overall Study|Adverse Event|2|||
48680903|NCT00874848|156680954|FG000|Overall Study|Progressive neoplastic disease|38|||
48680904|NCT00874848|156680955|FG001|Overall Study|Progressive neoplastic disease|18|||
48680905|NCT00874848|156680954|FG000|Overall Study|Withdrawal by Subject|7|||
48680906|NCT00874848|156680955|FG001|Overall Study|Withdrawal by Subject|4|||
48680907|NCT00874848|156680954|FG000|Overall Study|Noncompliance|1|||
48680908|NCT00874848|156680955|FG001|Overall Study|Noncompliance|1|||
48875108|NCT03128671|157379054|FG000|Intervention|Interrupted by hurricane|1|||
48875109|NCT03128671|157379055|FG001|Intervention|Interrupted by hurricane|0|||
48875110|NCT03128671|157379054|FG000|Intervention|Physician Decision|2|||
48680909|NCT00874848|156680954|FG000|Overall Study|Failure to comply with protocol|0|||
48680910|NCT00874848|156680955|FG001|Overall Study|Failure to comply with protocol|1|||
48680911|NCT00874848|156680954|FG000|Overall Study|Physician Decision|0|||
48680912|NCT00874848|156680955|FG001|Overall Study|Physician Decision|2|||
48762858|NCT01367158|156980369|FG005|Overall Study|Lost to Follow-up|2|||
48762859|NCT01367158|156980370|FG006|Overall Study|Lost to Follow-up|0|||
48875111|NCT03128671|157379055|FG001|Intervention|Physician Decision|3|||
48680913|NCT02978833|156680968|FG000|Overall Study|Study terminated|1|||
48680914|NCT02978833|156680969|FG001|Overall Study|Study terminated|1|||
48680915|NCT01712204|156680972|FG000|Overall Study|Adverse Event|3|||
48680916|NCT01712204|156680973|FG001|Overall Study|Adverse Event|1|||
48680917|NCT01712204|156680972|FG000|Overall Study|Withdrawal by Subject|3|||
48680918|NCT01712204|156680973|FG001|Overall Study|Withdrawal by Subject|3|||
48680919|NCT01712204|156680972|FG000|Overall Study|Lost to Follow-up|1|||
48680920|NCT01712204|156680973|FG001|Overall Study|Lost to Follow-up|0|||
48680921|NCT01712204|156680972|FG000|Overall Study|Protocol Violation|1|||
48680922|NCT01712204|156680973|FG001|Overall Study|Protocol Violation|1|||
48680923|NCT02360228|156680974|FG000|Overall Study|Withdrawal by Subject|1|||
48680924|NCT02360228|156680975|FG001|Overall Study|Withdrawal by Subject|0|||
48680925|NCT02360228|156680976|FG002|Overall Study|Withdrawal by Subject|0|||
48680926|NCT02360228|156680974|FG000|Overall Study|Self-discontinued medication|0|||
48680927|NCT02360228|156680975|FG001|Overall Study|Self-discontinued medication|1|||
48680928|NCT02360228|156680976|FG002|Overall Study|Self-discontinued medication|0|||
49020714|NCT03335371|157912692|FG002|Overall Study|Randomization Error|1|||
49020715|NCT03335371|157912693|FG003|Overall Study|Randomization Error|0|||
49020716|NCT03335371|157912694|FG004|Overall Study|Randomization Error|0|||
49020717|NCT00684671|157912695|FG000|Overall Study|Adverse Event|1|||
49020718|NCT00684671|157912696|FG001|Overall Study|Adverse Event|0|||
49020719|NCT00684671|157912697|FG002|Overall Study|Adverse Event|0|||
49020720|NCT00684671|157912695|FG000|Overall Study|Lost to Follow-up|1|||
49020721|NCT00684671|157912696|FG001|Overall Study|Lost to Follow-up|0|||
49020722|NCT00684671|157912697|FG002|Overall Study|Lost to Follow-up|0|||
49020723|NCT00684671|157912695|FG000|Overall Study|Alcoholic dependance|1|||
49020724|NCT00684671|157912696|FG001|Overall Study|Alcoholic dependance|0|||
49020725|NCT00684671|157912697|FG002|Overall Study|Alcoholic dependance|0|||
49020726|NCT04276883|157912699|FG000|Overall Study|Withdrawal by Subject|2|||
49020727|NCT04276883|157912700|FG001|Overall Study|Withdrawal by Subject|3|||
48680929|NCT02360228|156680974|FG000|Overall Study|Unstable symptoms during screening|0|||
48680930|NCT02360228|156680975|FG001|Overall Study|Unstable symptoms during screening|0|||
48680931|NCT02360228|156680976|FG002|Overall Study|Unstable symptoms during screening|1|||
48680932|NCT05513053|156680977|FG000|Overall Study|Lost to Follow-up|9|||
48680933|NCT05513053|156680978|FG001|Overall Study|Lost to Follow-up|11|||
48680934|NCT05513053|156680977|FG000|Overall Study|Withdrawal by parent/guardian|2|||
48680935|NCT05513053|156680978|FG001|Overall Study|Withdrawal by parent/guardian|0|||
48680936|NCT05513053|156680977|FG000|Overall Study|Withdrawal by Subject|2|||
48680937|NCT05513053|156680978|FG001|Overall Study|Withdrawal by Subject|9|||
48680938|NCT05513053|156680977|FG000|Overall Study|Protocol Violation|6|||
48680939|NCT05513053|156680978|FG001|Overall Study|Protocol Violation|3|||
48680940|NCT05513053|156680977|FG000|Overall Study|Adverse Event|0|||
48680941|NCT05513053|156680978|FG001|Overall Study|Adverse Event|2|||
48680942|NCT01463306|156680979|FG000|Overall Study|Adverse Event|6|||
48680943|NCT01463306|156680980|FG001|Overall Study|Adverse Event|9|||
48680944|NCT01463306|156680981|FG002|Overall Study|Adverse Event|3|||
48680945|NCT01463306|156680979|FG000|Overall Study|Death|3|||
48680946|NCT01463306|156680980|FG001|Overall Study|Death|3|||
48680947|NCT01463306|156680981|FG002|Overall Study|Death|0|||
48680948|NCT01463306|156680979|FG000|Overall Study|Lack of Efficacy|22|||
48680949|NCT01463306|156680980|FG001|Overall Study|Lack of Efficacy|16|||
48680950|NCT01463306|156680981|FG002|Overall Study|Lack of Efficacy|1|||
48680951|NCT01463306|156680979|FG000|Overall Study|Lost to Follow-up|5|||
48680952|NCT01463306|156680980|FG001|Overall Study|Lost to Follow-up|2|||
48680953|NCT01463306|156680981|FG002|Overall Study|Lost to Follow-up|0|||
48680954|NCT01463306|156680979|FG000|Overall Study|Protocol Violation|4|||
48680955|NCT01463306|156680980|FG001|Overall Study|Protocol Violation|0|||
48680956|NCT01463306|156680981|FG002|Overall Study|Protocol Violation|0|||
48680957|NCT01463306|156680979|FG000|Overall Study|Withdrawal by Subject|19|||
48680958|NCT01463306|156680980|FG001|Overall Study|Withdrawal by Subject|9|||
48680959|NCT01463306|156680981|FG002|Overall Study|Withdrawal by Subject|1|||
48680960|NCT01463306|156680979|FG000|Overall Study|Other|26|||
48680961|NCT01463306|156680980|FG001|Overall Study|Other|13|||
48680962|NCT01463306|156680981|FG002|Overall Study|Other|0|||
48680963|NCT01463306|156680979|FG000|Overall Study|Approval expiry at site|1|||
48680964|NCT01463306|156680980|FG001|Overall Study|Approval expiry at site|0|||
48680965|NCT01463306|156680981|FG002|Overall Study|Approval expiry at site|0|||
48680966|NCT00850538|156680985|FG000|Overall Study|unable/unwilling to complete MRI|13|||
48875112|NCT00738283|157379060|FG000|Overall Study|Death|1|||
48680967|NCT00850538|156680985|FG000|Overall Study|specimen missed due to scheduling error|14|||
49020728|NCT04276883|157912701|FG002|Overall Study|Withdrawal by Subject|6|||
48680968|NCT00850538|156680985|FG000|Overall Study|specimen unusable|7|||
48680969|NCT00850538|156680985|FG000|Overall Study|Withdrawal by Subject|3|||
48680970|NCT00850538|156680985|FG000|Overall Study|radiology error|2|||
48680971|NCT00850538|156680985|FG000|Overall Study|Protocol Violation|2|||
48680972|NCT02464410|156680986|FG000|Overall Study|Death|3|||
48680973|NCT02464410|156680987|FG001|Overall Study|Death|4|||
49020729|NCT04276883|157912699|FG000|Overall Study|Lost to Follow-up|1|||
49020730|NCT04276883|157912700|FG001|Overall Study|Lost to Follow-up|3|||
48680974|NCT02464410|156680986|FG000|Overall Study|Lost to Follow-up|7|||
48680975|NCT02464410|156680987|FG001|Overall Study|Lost to Follow-up|9|||
48680976|NCT02464410|156680986|FG000|Overall Study|Withdrawal by Subject|12|||
48680977|NCT02464410|156680987|FG001|Overall Study|Withdrawal by Subject|3|||
48680978|NCT00950248|156680988|FG000|Year 1: Baseline|Withdrawal by Subject|6|||
48680979|NCT00950248|156680989|FG001|Year 1: Baseline|Withdrawal by Subject|0|||
48680980|NCT00950248|156680990|FG002|Year 1: Baseline|Withdrawal by Subject|0|||
48680981|NCT00950248|156680988|FG000|Year 1: Baseline|worsening of symptoms|2|||
48680982|NCT00950248|156680989|FG001|Year 1: Baseline|worsening of symptoms|0|||
48680983|NCT00950248|156680990|FG002|Year 1: Baseline|worsening of symptoms|0|||
48680984|NCT00950248|156680988|FG000|Year 2&3 Treatment Randomization|worsening of symptoms|0|||
48680985|NCT00950248|156680989|FG001|Year 2&3 Treatment Randomization|worsening of symptoms|2|||
48680986|NCT00950248|156680990|FG002|Year 2&3 Treatment Randomization|worsening of symptoms|4|||
48680987|NCT00950248|156680988|FG000|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
48680988|NCT00950248|156680989|FG001|Year 2&3 Treatment Randomization|Withdrawal by Subject|3|||
48680989|NCT00950248|156680990|FG002|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
48680990|NCT00950248|156680988|FG000|Year 2&3 Treatment Randomization|Death|0|||
48680991|NCT00950248|156680989|FG001|Year 2&3 Treatment Randomization|Death|0|||
48680992|NCT00950248|156680990|FG002|Year 2&3 Treatment Randomization|Death|1|||
48680993|NCT00950248|156680988|FG000|Year 2&3 Treatment Randomization|MRI contraindication|0|||
48680994|NCT00950248|156680989|FG001|Year 2&3 Treatment Randomization|MRI contraindication|1|||
48680995|NCT00950248|156680990|FG002|Year 2&3 Treatment Randomization|MRI contraindication|0|||
48680996|NCT00320515|156680991|FG000|Overall Study|Death|33|||
48680997|NCT00320515|156680991|FG000|Overall Study|Lost to Follow-up|6|||
48680998|NCT00320515|156680991|FG000|Overall Study|Physician Decision|2|||
48680999|NCT00320515|156680991|FG000|Overall Study|Withdrawal by Subject|8|||
48681000|NCT02485704|156680992|FG000|Overall Study|Lost to Follow-up|4|||
48681001|NCT02485704|156680993|FG001|Overall Study|Lost to Follow-up|5|||
48681002|NCT02485704|156680992|FG000|Overall Study|Withdrawal by Subject|0|||
48681003|NCT02485704|156680993|FG001|Overall Study|Withdrawal by Subject|3|||
48681004|NCT02485704|156680992|FG000|Overall Study|Did Not Meet Inclusion Criteria #2|1|||
48681005|NCT02485704|156680993|FG001|Overall Study|Did Not Meet Inclusion Criteria #2|0|||
48681006|NCT01900652|156680994|FG000|Overall Study|Progressive Disease|1|||
48681007|NCT01900652|156680995|FG001|Overall Study|Progressive Disease|0|||
48681008|NCT01900652|156680994|FG000|Overall Study|Consent withdrawn by subject|1|||
48681009|NCT01900652|156680995|FG001|Overall Study|Consent withdrawn by subject|1|||
48681010|NCT01900652|156680994|FG000|Overall Study|Death|3|||
48681011|NCT01900652|156680995|FG001|Overall Study|Death|0|||
48681012|NCT01900652|156680994|FG000|Overall Study|Adverse Event|2|||
48681013|NCT01900652|156680995|FG001|Overall Study|Adverse Event|1|||
48681014|NCT01900652|156680994|FG000|Overall Study|Physician Decision|1|||
48681015|NCT01900652|156680995|FG001|Overall Study|Physician Decision|1|||
48681016|NCT03932760|156680996|FG000|Overall Study|Became Ineligible|2|||
48681017|NCT03932760|156680997|FG001|Overall Study|Became Ineligible|5|||
48681018|NCT03932760|156680996|FG000|Overall Study|Withdrawal by Subject|6|||
48681019|NCT03932760|156680997|FG001|Overall Study|Withdrawal by Subject|6|||
48681020|NCT01574651|156680998|FG000|Overall Study|Lost to Follow-up|2|||
48681021|NCT01574651|156680999|FG001|Overall Study|Lost to Follow-up|4|||
48681022|NCT01574651|156680998|FG000|Overall Study|Administrative problems|0|||
48681023|NCT01574651|156680999|FG001|Overall Study|Administrative problems|1|||
48681024|NCT01574651|156680998|FG000|Overall Study|Death|3|||
48681025|NCT01574651|156680999|FG001|Overall Study|Death|3|||
48681026|NCT01574651|156680998|FG000|Overall Study|Patient's inability to use the device|0|||
48681027|NCT01574651|156680999|FG001|Overall Study|Patient's inability to use the device|1|||
48681028|NCT01574651|156680998|FG000|Overall Study|Adverse Event|36|||
48681029|NCT01574651|156680999|FG001|Overall Study|Adverse Event|27|||
48681030|NCT01574651|156680998|FG000|Overall Study|Abnormal laboratory value(s)|1|||
48681031|NCT01574651|156680999|FG001|Overall Study|Abnormal laboratory value(s)|0|||
48681032|NCT01574651|156680998|FG000|Overall Study|Abnormal test procedure result(s)|1|||
48681033|NCT01574651|156680999|FG001|Overall Study|Abnormal test procedure result(s)|1|||
48681034|NCT01574651|156680998|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
48681035|NCT01574651|156680999|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
48681036|NCT01574651|156680998|FG000|Overall Study|Protocol Violation|3|||
48681037|NCT01574651|156680999|FG001|Overall Study|Protocol Violation|5|||
48681038|NCT01574651|156680998|FG000|Overall Study|Withdrawal by Subject|9|||
48681039|NCT01574651|156680999|FG001|Overall Study|Withdrawal by Subject|10|||
48681040|NCT03922620|156681000|FG000|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|1|||
48681041|NCT03922620|156681001|FG001|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|0|||
49020731|NCT04276883|157912701|FG002|Overall Study|Lost to Follow-up|0|||
48681042|NCT04177212|156681002|FG000|Overall Study|Withdrawal by Subject|9|||
48681043|NCT04177212|156681003|FG001|Overall Study|Withdrawal by Subject|7|||
48681044|NCT04177212|156681002|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
48762860|NCT01367158|156980371|FG007|Overall Study|Lost to Follow-up|1|||
48875113|NCT00738283|157379060|FG000|Overall Study|Transfer to another facility|2|||
48762861|NCT01367158|156980372|FG008|Overall Study|Lost to Follow-up|0|||
49020732|NCT04276883|157912699|FG000|Overall Study|Adverse Event|0|||
49020733|NCT04276883|157912700|FG001|Overall Study|Adverse Event|1|||
49020734|NCT04276883|157912701|FG002|Overall Study|Adverse Event|0|||
49020735|NCT04276883|157912699|FG000|Overall Study|Randomized in error - di dnot receive treatment|1|||
48681045|NCT04177212|156681003|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
48681046|NCT04177212|156681002|FG000|Overall Study|Physician Decision|1|||
49020736|NCT04276883|157912700|FG001|Overall Study|Randomized in error - di dnot receive treatment|1|||
49020737|NCT04276883|157912701|FG002|Overall Study|Randomized in error - di dnot receive treatment|0|||
49020738|NCT03561883|157912702|FG000|Overall Study|Adverse Event|10|||
49020739|NCT03561883|157912703|FG001|Overall Study|Adverse Event|13|||
49020740|NCT03561883|157912702|FG000|Overall Study|Non-Compliance With Study Drug|1|||
49020741|NCT03561883|157912703|FG001|Overall Study|Non-Compliance With Study Drug|2|||
49020742|NCT03561883|157912702|FG000|Overall Study|Protocol Violation|2|||
48681047|NCT04177212|156681003|FG001|Overall Study|Physician Decision|0|||
48681048|NCT04177212|156681002|FG000|Overall Study|Lost to Follow-up|0|||
48681049|NCT04177212|156681003|FG001|Overall Study|Lost to Follow-up|3|||
48681050|NCT04177212|156681002|FG000|Overall Study|Adverse Event|0|||
48681051|NCT04177212|156681003|FG001|Overall Study|Adverse Event|1|||
48681052|NCT04177212|156681002|FG000|Overall Study|Other|1|||
48681053|NCT04177212|156681003|FG001|Overall Study|Other|2|||
48681054|NCT01487265|156682545|FG000|Overall Study|Adverse Event|8|||
48681055|NCT01487265|156682545|FG000|Overall Study|Withdrawal by Subject|5|||
48681056|NCT01487265|156682545|FG000|Overall Study|Disease Progression|21|||
48681057|NCT01487265|156682545|FG000|Overall Study|Death|2|||
48681058|NCT01487265|156682545|FG000|Overall Study|Still on Treatment|1|||
48681059|NCT00965575|156682546|FG000|Overall Study|subject unwillingness to swallow study c|1|||
48681060|NCT00965575|156682547|FG001|Overall Study|subject unwillingness to swallow study c|0|||
48681061|NCT02629822|156682548|FG000|Base Study|Lost to Follow-up|2|||
48681062|NCT02629822|156682548|FG000|Base Study|Non-Compliance With Study Drug|1|||
48681063|NCT02629822|156682548|FG000|Extension Study|Adverse Event|1|||
48681064|NCT02629822|156682548|FG000|Extension Study|Lost to Follow-up|1|||
48762862|NCT01367158|156980373|FG009|Overall Study|Lost to Follow-up|0|||
49020743|NCT03561883|157912703|FG001|Overall Study|Protocol Violation|3|||
49020744|NCT03561883|157912702|FG000|Overall Study|Withdrawal by Subject|14|||
49020745|NCT03561883|157912703|FG001|Overall Study|Withdrawal by Subject|6|||
49020746|NCT03561883|157912702|FG000|Overall Study|Lost to Follow-up|2|||
49020747|NCT03561883|157912703|FG001|Overall Study|Lost to Follow-up|6|||
49020748|NCT03561883|157912702|FG000|Overall Study|Study Terminated by Sponsor|12|||
49020749|NCT03561883|157912703|FG001|Overall Study|Study Terminated by Sponsor|11|||
49020750|NCT03561883|157912702|FG000|Overall Study|Physician Decision|1|||
49020751|NCT03561883|157912703|FG001|Overall Study|Physician Decision|0|||
49020752|NCT03561883|157912702|FG000|Overall Study|Randomized by Mistake|1|||
49020753|NCT03561883|157912703|FG001|Overall Study|Randomized by Mistake|0|||
49020754|NCT03561883|157912702|FG000|Overall Study|Other, Not Specified|3|||
49020755|NCT03561883|157912703|FG001|Overall Study|Other, Not Specified|2|||
49020756|NCT00958243|157912722|FG000|Overall Study|Withdrawal by Subject|0|||
49020757|NCT00958243|157912723|FG001|Overall Study|Withdrawal by Subject|1|||
49020758|NCT00958243|157912724|FG002|Overall Study|Withdrawal by Subject|3|||
49020759|NCT00958243|157912725|FG003|Overall Study|Withdrawal by Subject|1|||
49020760|NCT00958243|157912726|FG004|Overall Study|Withdrawal by Subject|1|||
49020761|NCT00958243|157912727|FG005|Overall Study|Withdrawal by Subject|5|||
49020762|NCT00958243|157912722|FG000|Overall Study|Lost to Follow-up|2|||
49020763|NCT00958243|157912723|FG001|Overall Study|Lost to Follow-up|5|||
49020764|NCT00958243|157912724|FG002|Overall Study|Lost to Follow-up|11|||
49020765|NCT00958243|157912725|FG003|Overall Study|Lost to Follow-up|2|||
49020766|NCT00958243|157912726|FG004|Overall Study|Lost to Follow-up|8|||
49020767|NCT00958243|157912727|FG005|Overall Study|Lost to Follow-up|5|||
49020768|NCT00117949|157912736|FG000|Overall Study|Testosterone >1.0 ng/mL|10|||
49020769|NCT00117949|157912737|FG001|Overall Study|Testosterone >1.0 ng/mL|18|||
49020770|NCT00117949|157912738|FG002|Overall Study|Testosterone >1.0 ng/mL|17|||
49020771|NCT00117949|157912739|FG003|Overall Study|Testosterone >1.0 ng/mL|15|||
48681065|NCT01610336|156682549|FG000|Overall Study|Progressive Disease|4|||
48762863|NCT01367158|156980374|FG010|Overall Study|Lost to Follow-up|1|||
48681066|NCT01610336|156682550|FG001|Overall Study|Progressive Disease|6|||
49020772|NCT00117949|157912736|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
49020773|NCT00117949|157912737|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
49020774|NCT00117949|157912738|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
48681067|NCT01610336|156682551|FG002|Overall Study|Progressive Disease|6|||
48681068|NCT01610336|156682552|FG003|Overall Study|Progressive Disease|5|||
48681069|NCT01610336|156682553|FG004|Overall Study|Progressive Disease|3|||
48681070|NCT01610336|156682554|FG005|Overall Study|Progressive Disease|10|||
49020775|NCT00117949|157912739|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
49020776|NCT00117949|157912736|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
49020777|NCT00117949|157912737|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
48762864|NCT01367158|156980364|FG000|Overall Study|Protocol Violation|0|||
48681071|NCT01610336|156682555|FG006|Overall Study|Progressive Disease|1|||
48681072|NCT01610336|156682556|FG007|Overall Study|Progressive Disease|6|||
48681073|NCT01610336|156682557|FG008|Overall Study|Progressive Disease|6|||
48681074|NCT01610336|156682558|FG009|Overall Study|Progressive Disease|40|||
48681075|NCT01610336|156682559|FG010|Overall Study|Progressive Disease|36|||
48681076|NCT01610336|156682549|FG000|Overall Study|Adverse Event|0|||
48681077|NCT01610336|156682550|FG001|Overall Study|Adverse Event|0|||
48681078|NCT01610336|156682551|FG002|Overall Study|Adverse Event|0|||
48681079|NCT01610336|156682552|FG003|Overall Study|Adverse Event|1|||
48681080|NCT01610336|156682553|FG004|Overall Study|Adverse Event|1|||
48681081|NCT01610336|156682554|FG005|Overall Study|Adverse Event|1|||
48681082|NCT01610336|156682555|FG006|Overall Study|Adverse Event|0|||
48681083|NCT01610336|156682556|FG007|Overall Study|Adverse Event|0|||
48681084|NCT01610336|156682557|FG008|Overall Study|Adverse Event|2|||
48681085|NCT01610336|156682558|FG009|Overall Study|Adverse Event|8|||
48681086|NCT01610336|156682559|FG010|Overall Study|Adverse Event|6|||
49020778|NCT00117949|157912738|FG002|Overall Study|Prostate-specific antigen increase >=25%|1|||
49020779|NCT00117949|157912739|FG003|Overall Study|Prostate-specific antigen increase >=25%|2|||
49020780|NCT00117949|157912736|FG000|Overall Study|PSA increase >=10ng/mL|0|||
49020781|NCT00117949|157912737|FG001|Overall Study|PSA increase >=10ng/mL|1|||
49020782|NCT00117949|157912738|FG002|Overall Study|PSA increase >=10ng/mL|1|||
49020783|NCT00117949|157912739|FG003|Overall Study|PSA increase >=10ng/mL|0|||
49020784|NCT00117949|157912736|FG000|Overall Study|PSA reduction <=50%|0|||
49020785|NCT00117949|157912737|FG001|Overall Study|PSA reduction <=50%|2|||
49020786|NCT00117949|157912738|FG002|Overall Study|PSA reduction <=50%|2|||
49020787|NCT00117949|157912739|FG003|Overall Study|PSA reduction <=50%|4|||
49020788|NCT00117949|157912736|FG000|Overall Study|Hepatic abnormalities|0|||
49020789|NCT00117949|157912737|FG001|Overall Study|Hepatic abnormalities|1|||
48681087|NCT01610336|156682549|FG000|Overall Study|Subject/Guardian decision|1|||
48681088|NCT01610336|156682550|FG001|Overall Study|Subject/Guardian decision|1|||
48681089|NCT01610336|156682551|FG002|Overall Study|Subject/Guardian decision|0|||
48681090|NCT01610336|156682552|FG003|Overall Study|Subject/Guardian decision|1|||
48681091|NCT01610336|156682553|FG004|Overall Study|Subject/Guardian decision|0|||
48681092|NCT01610336|156682554|FG005|Overall Study|Subject/Guardian decision|0|||
48681093|NCT01610336|156682555|FG006|Overall Study|Subject/Guardian decision|0|||
48681094|NCT01610336|156682556|FG007|Overall Study|Subject/Guardian decision|1|||
48681095|NCT01610336|156682557|FG008|Overall Study|Subject/Guardian decision|0|||
48681096|NCT01610336|156682558|FG009|Overall Study|Subject/Guardian decision|2|||
48681097|NCT01610336|156682559|FG010|Overall Study|Subject/Guardian decision|2|||
48681098|NCT01610336|156682549|FG000|Overall Study|Death|0|||
48681099|NCT01610336|156682550|FG001|Overall Study|Death|0|||
48681100|NCT01610336|156682551|FG002|Overall Study|Death|0|||
49020790|NCT00117949|157912738|FG002|Overall Study|Hepatic abnormalities|0|||
49020791|NCT00117949|157912739|FG003|Overall Study|Hepatic abnormalities|1|||
49020792|NCT01226797|157912740|FG000|Overall Study|Adverse Event|1|||
49020793|NCT01226797|157912741|FG001|Overall Study|Adverse Event|0|||
49020794|NCT01226797|157912740|FG000|Overall Study|No longer willing to participate|1|||
49020795|NCT01226797|157912741|FG001|Overall Study|No longer willing to participate|0|||
49020796|NCT01226797|157912740|FG000|Overall Study|Protocol Violation|0|||
49020797|NCT01226797|157912741|FG001|Overall Study|Protocol Violation|1|||
49020798|NCT02799602|157912742|FG000|Overall Study|Protocol Violation|1|||
49020799|NCT02799602|157912743|FG001|Overall Study|Protocol Violation|0|||
49020800|NCT02799602|157912742|FG000|Overall Study|Physician Decision|5|||
48681101|NCT01610336|156682552|FG003|Overall Study|Death|0|||
48681102|NCT01610336|156682553|FG004|Overall Study|Death|0|||
48681103|NCT01610336|156682554|FG005|Overall Study|Death|1|||
48681104|NCT01610336|156682555|FG006|Overall Study|Death|3|||
48681105|NCT01610336|156682556|FG007|Overall Study|Death|0|||
49020801|NCT02799602|157912743|FG001|Overall Study|Physician Decision|6|||
49020802|NCT02799602|157912742|FG000|Overall Study|Lost to Follow-up|4|||
49020803|NCT02799602|157912743|FG001|Overall Study|Lost to Follow-up|2|||
48681106|NCT01610336|156682557|FG008|Overall Study|Death|0|||
49020804|NCT02799602|157912742|FG000|Overall Study|Additional primary malignancy|11|||
49020805|NCT02799602|157912743|FG001|Overall Study|Additional primary malignancy|6|||
48681107|NCT01610336|156682558|FG009|Overall Study|Death|1|||
48681108|NCT01610336|156682559|FG010|Overall Study|Death|2|||
48681109|NCT01610336|156682549|FG000|Overall Study|Non-Compliance with study treatment|0|||
48681110|NCT01610336|156682550|FG001|Overall Study|Non-Compliance with study treatment|0|||
48681111|NCT01610336|156682551|FG002|Overall Study|Non-Compliance with study treatment|0|||
49020806|NCT02799602|157912742|FG000|Overall Study|Non-compliance with study drug|14|||
48681112|NCT01610336|156682552|FG003|Overall Study|Non-Compliance with study treatment|0|||
48681113|NCT01610336|156682553|FG004|Overall Study|Non-Compliance with study treatment|0|||
48681114|NCT01610336|156682554|FG005|Overall Study|Non-Compliance with study treatment|0|||
49020807|NCT02799602|157912743|FG001|Overall Study|Non-compliance with study drug|12|||
48681115|NCT01610336|156682555|FG006|Overall Study|Non-Compliance with study treatment|0|||
48681116|NCT01610336|156682556|FG007|Overall Study|Non-Compliance with study treatment|0|||
48681117|NCT01610336|156682557|FG008|Overall Study|Non-Compliance with study treatment|0|||
48681118|NCT01610336|156682558|FG009|Overall Study|Non-Compliance with study treatment|1|||
49020808|NCT02799602|157912742|FG000|Overall Study|Adverse event associated with clinical disease progression|24|||
49020809|NCT02799602|157912743|FG001|Overall Study|Adverse event associated with clinical disease progression|26|||
49020810|NCT02799602|157912742|FG000|Overall Study|Withdrawal by Subject|26|||
49020811|NCT02799602|157912743|FG001|Overall Study|Withdrawal by Subject|40|||
49020812|NCT02799602|157912742|FG000|Overall Study|Progressive disease - clinical progression|131|||
49020813|NCT02799602|157912743|FG001|Overall Study|Progressive disease - clinical progression|276|||
49020814|NCT02799602|157912742|FG000|Overall Study|Progressive disease - radiological progression|90|||
49020815|NCT02799602|157912743|FG001|Overall Study|Progressive disease - radiological progression|133|||
49020816|NCT02799602|157912742|FG000|Overall Study|Adverse event not associated with clinical disease progression|49|||
49020817|NCT02799602|157912743|FG001|Overall Study|Adverse event not associated with clinical disease progression|27|||
49020818|NCT02799602|157912742|FG000|Overall Study|Death|9|||
49020819|NCT02799602|157912743|FG001|Overall Study|Death|5|||
49020820|NCT02799602|157912742|FG000|Overall Study|Other|287|||
49020821|NCT02799602|157912743|FG001|Overall Study|Other|118|||
49020822|NCT02799602|157912742|FG000|Overall Study|Study drug never administered|0|||
49020823|NCT02799602|157912743|FG001|Overall Study|Study drug never administered|3|||
49020824|NCT00577460|157912744|FG000|Overall Study|Adverse Event|11|||
49020825|NCT00577460|157912745|FG001|Overall Study|Adverse Event|7|||
49020826|NCT00577460|157912746|FG002|Overall Study|Adverse Event|14|||
49020827|NCT00577460|157912744|FG000|Overall Study|Protocol Violation|0|||
49020828|NCT00577460|157912745|FG001|Overall Study|Protocol Violation|1|||
49020829|NCT00577460|157912746|FG002|Overall Study|Protocol Violation|1|||
49020830|NCT00577460|157912744|FG000|Overall Study|Lost to Follow-up|0|||
49020831|NCT00577460|157912745|FG001|Overall Study|Lost to Follow-up|3|||
49020832|NCT00577460|157912746|FG002|Overall Study|Lost to Follow-up|4|||
49020833|NCT00577460|157912744|FG000|Overall Study|Withdrawal by Subject|5|||
48681119|NCT01610336|156682559|FG010|Overall Study|Non-Compliance with study treatment|0|||
48681120|NCT01610336|156682549|FG000|Overall Study|Physician Decision|0|||
48681121|NCT01610336|156682550|FG001|Overall Study|Physician Decision|0|||
48681122|NCT01610336|156682551|FG002|Overall Study|Physician Decision|0|||
48681123|NCT01610336|156682552|FG003|Overall Study|Physician Decision|0|||
48681124|NCT01610336|156682553|FG004|Overall Study|Physician Decision|0|||
48681125|NCT01610336|156682554|FG005|Overall Study|Physician Decision|0|||
48681126|NCT01610336|156682555|FG006|Overall Study|Physician Decision|1|||
48681127|NCT01610336|156682556|FG007|Overall Study|Physician Decision|0|||
48681128|NCT01610336|156682557|FG008|Overall Study|Physician Decision|0|||
48681129|NCT01610336|156682558|FG009|Overall Study|Physician Decision|0|||
48681130|NCT01610336|156682559|FG010|Overall Study|Physician Decision|0|||
48681131|NCT01610336|156682549|FG000|Overall Study|Protocol Deviation|0|||
48681132|NCT01610336|156682550|FG001|Overall Study|Protocol Deviation|0|||
48681133|NCT01610336|156682551|FG002|Overall Study|Protocol Deviation|0|||
48681134|NCT01610336|156682552|FG003|Overall Study|Protocol Deviation|0|||
48681135|NCT01610336|156682553|FG004|Overall Study|Protocol Deviation|0|||
48681136|NCT01610336|156682554|FG005|Overall Study|Protocol Deviation|0|||
48681137|NCT01610336|156682555|FG006|Overall Study|Protocol Deviation|0|||
48681138|NCT01610336|156682556|FG007|Overall Study|Protocol Deviation|0|||
48681139|NCT01610336|156682557|FG008|Overall Study|Protocol Deviation|0|||
48681140|NCT01610336|156682558|FG009|Overall Study|Protocol Deviation|1|||
48681141|NCT01610336|156682559|FG010|Overall Study|Protocol Deviation|0|||
49020834|NCT00577460|157912745|FG001|Overall Study|Withdrawal by Subject|5|||
49020835|NCT00577460|157912746|FG002|Overall Study|Withdrawal by Subject|6|||
49020836|NCT00577460|157912744|FG000|Overall Study|Other|0|||
49020837|NCT00577460|157912745|FG001|Overall Study|Other|3|||
49020838|NCT00577460|157912746|FG002|Overall Study|Other|2|||
49020839|NCT03730103|157912747|FG000|Overall Study|Did not meet inclusion criteria|0|||
49020840|NCT03730103|157912748|FG001|Overall Study|Did not meet inclusion criteria|5|||
49020841|NCT00162123|157912749|FG000|Overall Study|Disease progression|27|||
49020842|NCT00162123|157912750|FG001|Overall Study|Disease progression|19|||
48681142|NCT01610336|156682549|FG000|Overall Study|Transfer to another trial|0|||
48681143|NCT01610336|156682550|FG001|Overall Study|Transfer to another trial|0|||
48681144|NCT01610336|156682551|FG002|Overall Study|Transfer to another trial|0|||
48681145|NCT01610336|156682552|FG003|Overall Study|Transfer to another trial|0|||
48681146|NCT01610336|156682553|FG004|Overall Study|Transfer to another trial|0|||
49020843|NCT00162123|157912751|FG002|Overall Study|Disease progression|10|||
49020844|NCT00162123|157912752|FG003|Overall Study|Disease progression|4|||
49020845|NCT00162123|157912753|FG004|Overall Study|Disease progression|8|||
49020846|NCT00162123|157912754|FG005|Overall Study|Disease progression|3|||
49020847|NCT00162123|157912755|FG006|Overall Study|Disease progression|1|||
49020848|NCT00162123|157912756|FG007|Overall Study|Disease progression|0|||
48681147|NCT01610336|156682554|FG005|Overall Study|Transfer to another trial|0|||
48681148|NCT01610336|156682555|FG006|Overall Study|Transfer to another trial|0|||
48681149|NCT01610336|156682556|FG007|Overall Study|Transfer to another trial|0|||
48681150|NCT01610336|156682557|FG008|Overall Study|Transfer to another trial|0|||
48681151|NCT01610336|156682558|FG009|Overall Study|Transfer to another trial|0|||
48681152|NCT01610336|156682559|FG010|Overall Study|Transfer to another trial|1|||
48681153|NCT04440813|156682560|FG000|Overall Study|Lost to Follow-up|5|||
48681154|NCT04440813|156682561|FG001|Overall Study|Lost to Follow-up|5|||
49020849|NCT00162123|157912749|FG000|Overall Study|Study drug toxicity|6|||
49020850|NCT00162123|157912750|FG001|Overall Study|Study drug toxicity|1|||
49020851|NCT00162123|157912751|FG002|Overall Study|Study drug toxicity|5|||
48681155|NCT01128244|156682565|FG000|Overall Study|Adverse Event|1|||
48681156|NCT01128244|156682565|FG000|Overall Study|Scheduling conflict|2|||
48681157|NCT03464019|156682566|FG000|NODE-301 Part 1|Withdrawal by Subject|0|||
48681158|NCT03464019|156682567|FG001|NODE-301 Part 1|Withdrawal by Subject|0|||
48681159|NCT03464019|156682568|FG002|NODE-301 Part 1|Withdrawal by Subject|18|||
48681160|NCT03464019|156682566|FG000|NODE-301 Part 1|Ablation|0|||
48681161|NCT03464019|156682567|FG001|NODE-301 Part 1|Ablation|0|||
48681162|NCT03464019|156682568|FG002|NODE-301 Part 1|Ablation|16|||
48681163|NCT03464019|156682566|FG000|NODE-301 Part 1|Test Dose Failure|0|||
48681164|NCT03464019|156682567|FG001|NODE-301 Part 1|Test Dose Failure|0|||
48681165|NCT03464019|156682568|FG002|NODE-301 Part 1|Test Dose Failure|8|||
48681166|NCT03464019|156682566|FG000|NODE-301 Part 1|Adverse Event|0|||
48681167|NCT03464019|156682567|FG001|NODE-301 Part 1|Adverse Event|0|||
48681168|NCT03464019|156682568|FG002|NODE-301 Part 1|Adverse Event|5|||
48681169|NCT03464019|156682566|FG000|NODE-301 Part 1|Physician Decision|0|||
48681170|NCT03464019|156682567|FG001|NODE-301 Part 1|Physician Decision|0|||
48681171|NCT03464019|156682568|FG002|NODE-301 Part 1|Physician Decision|4|||
48681172|NCT03464019|156682566|FG000|NODE-301 Part 1|Lost to Follow-up|0|||
48681173|NCT03464019|156682567|FG001|NODE-301 Part 1|Lost to Follow-up|0|||
48681174|NCT03464019|156682568|FG002|NODE-301 Part 1|Lost to Follow-up|3|||
48681175|NCT03464019|156682566|FG000|NODE-301 Part 1|Protocol Violation|0|||
48681176|NCT03464019|156682567|FG001|NODE-301 Part 1|Protocol Violation|0|||
48681177|NCT03464019|156682568|FG002|NODE-301 Part 1|Protocol Violation|2|||
48681178|NCT03464019|156682566|FG000|NODE-301 Part 1|Reason was not provided by the participant|0|||
48681179|NCT03464019|156682567|FG001|NODE-301 Part 1|Reason was not provided by the participant|0|||
48681180|NCT03464019|156682568|FG002|NODE-301 Part 1|Reason was not provided by the participant|15|||
48681181|NCT03464019|156682566|FG000|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
48681182|NCT03464019|156682567|FG001|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
48681183|NCT03464019|156682568|FG002|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|82|||
48681184|NCT03464019|156682566|FG000|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
48681185|NCT03464019|156682567|FG001|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
48681186|NCT03464019|156682568|FG002|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|80|||
48681187|NCT03464019|156682566|FG000|NODE-301 Part 2 and Part 3|Withdrawal by Subject|5|||
48681188|NCT03464019|156682567|FG001|NODE-301 Part 2 and Part 3|Withdrawal by Subject|1|||
48681189|NCT03464019|156682568|FG002|NODE-301 Part 2 and Part 3|Withdrawal by Subject|32|||
48681190|NCT03464019|156682566|FG000|NODE-301 Part 2 and Part 3|Ablation|8|||
48681191|NCT03464019|156682567|FG001|NODE-301 Part 2 and Part 3|Ablation|11|||
48681192|NCT03464019|156682568|FG002|NODE-301 Part 2 and Part 3|Ablation|46|||
48681193|NCT03464019|156682566|FG000|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
49020852|NCT00162123|157912752|FG003|Overall Study|Study drug toxicity|0|||
49020853|NCT00162123|157912753|FG004|Overall Study|Study drug toxicity|4|||
48681194|NCT03464019|156682567|FG001|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
48681195|NCT03464019|156682568|FG002|NODE-301 Part 2 and Part 3|Test Dose failure|8|||
48681196|NCT03464019|156682566|FG000|NODE-301 Part 2 and Part 3|Adverse Event|1|||
48681197|NCT03464019|156682567|FG001|NODE-301 Part 2 and Part 3|Adverse Event|3|||
48681198|NCT03464019|156682568|FG002|NODE-301 Part 2 and Part 3|Adverse Event|14|||
48681199|NCT03464019|156682566|FG000|NODE-301 Part 2 and Part 3|Physician Decision|0|||
48681200|NCT03464019|156682567|FG001|NODE-301 Part 2 and Part 3|Physician Decision|0|||
48681201|NCT03464019|156682568|FG002|NODE-301 Part 2 and Part 3|Physician Decision|2|||
48681202|NCT03464019|156682566|FG000|NODE-301 Part 2 and Part 3|Lost to Follow-up|1|||
48681203|NCT03464019|156682567|FG001|NODE-301 Part 2 and Part 3|Lost to Follow-up|0|||
48681204|NCT03464019|156682568|FG002|NODE-301 Part 2 and Part 3|Lost to Follow-up|7|||
48681205|NCT03464019|156682566|FG000|NODE-301 Part 2 and Part 3|Protocol Violation|0|||
48762865|NCT01367158|156980365|FG001|Overall Study|Protocol Violation|1|||
48762866|NCT01367158|156980366|FG002|Overall Study|Protocol Violation|0|||
49020854|NCT00162123|157912754|FG005|Overall Study|Study drug toxicity|1|||
49020855|NCT00162123|157912755|FG006|Overall Study|Study drug toxicity|1|||
49020856|NCT00162123|157912756|FG007|Overall Study|Study drug toxicity|0|||
49020857|NCT00162123|157912749|FG000|Overall Study|Death|3|||
49020858|NCT00162123|157912750|FG001|Overall Study|Death|3|||
49020859|NCT00162123|157912751|FG002|Overall Study|Death|1|||
49020860|NCT00162123|157912752|FG003|Overall Study|Death|1|||
49020861|NCT00162123|157912753|FG004|Overall Study|Death|1|||
48681206|NCT03464019|156682567|FG001|NODE-301 Part 2 and Part 3|Protocol Violation|1|||
48681207|NCT03464019|156682568|FG002|NODE-301 Part 2 and Part 3|Protocol Violation|2|||
48681208|NCT03464019|156682566|FG000|NODE-301 Part 2 and Part 3|Pregnancy|0|||
48681209|NCT03464019|156682567|FG001|NODE-301 Part 2 and Part 3|Pregnancy|0|||
49020862|NCT00162123|157912754|FG005|Overall Study|Death|1|||
49020863|NCT00162123|157912755|FG006|Overall Study|Death|0|||
49020864|NCT00162123|157912756|FG007|Overall Study|Death|0|||
48681210|NCT03464019|156682568|FG002|NODE-301 Part 2 and Part 3|Pregnancy|1|||
49020865|NCT00162123|157912749|FG000|Overall Study|Withdrawal by Subject|2|||
48681211|NCT03464019|156682566|FG000|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
48681212|NCT03464019|156682567|FG001|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
48681213|NCT03464019|156682568|FG002|NODE-301 Part 2 and Part 3|Prohibited Medication|4|||
48681214|NCT03464019|156682566|FG000|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|46|||
48681215|NCT03464019|156682567|FG001|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|61|||
48681216|NCT03464019|156682568|FG002|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|314|||
48681217|NCT03464019|156682566|FG000|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|5|||
48681218|NCT03464019|156682567|FG001|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|1|||
48681219|NCT03464019|156682568|FG002|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|15|||
48681220|NCT01726582|156682572|FG000|Overall Study|Physician Decision|99|||
48681221|NCT01726582|156682572|FG000|Overall Study|Death|85|||
48681222|NCT00571038|156682573|FG000|Overall Study|Lost to Follow-up|1|||
48681223|NCT00571038|156682574|FG001|Overall Study|Lost to Follow-up|4|||
48681224|NCT00571038|156682573|FG000|Overall Study|Death|7|||
48681225|NCT00571038|156682574|FG001|Overall Study|Death|5|||
48681226|NCT00571038|156682573|FG000|Overall Study|Withdrawal by Subject|1|||
48681227|NCT00571038|156682574|FG001|Overall Study|Withdrawal by Subject|3|||
48681228|NCT00571038|156682573|FG000|Overall Study|Moved out of state|2|||
48681229|NCT00571038|156682574|FG001|Overall Study|Moved out of state|2|||
48681230|NCT03539601|156682577|FG000|Overall Study|Withdraw by parent/guardian|1|||
48681231|NCT03539601|156682578|FG001|Overall Study|Withdraw by parent/guardian|0|||
48681232|NCT03539601|156682579|FG002|Overall Study|Withdraw by parent/guardian|1|||
48681233|NCT03539601|156682580|FG003|Overall Study|Withdraw by parent/guardian|0|||
48980952|NCT01809327|157762252|FG002|Overall Study|Lost to Follow-up|4|||
48980953|NCT01809327|157762253|FG003|Overall Study|Lost to Follow-up|2|||
48980954|NCT01809327|157762254|FG004|Overall Study|Lost to Follow-up|3|||
48980955|NCT01809327|157762250|FG000|Overall Study|Withdrawal by Subject|6|||
48980956|NCT01809327|157762251|FG001|Overall Study|Withdrawal by Subject|4|||
48980957|NCT01809327|157762252|FG002|Overall Study|Withdrawal by Subject|4|||
48681234|NCT03539601|156682577|FG000|Overall Study|Adverse Event|0|||
48681235|NCT03539601|156682578|FG001|Overall Study|Adverse Event|2|||
48681236|NCT03539601|156682579|FG002|Overall Study|Adverse Event|0|||
48681237|NCT03539601|156682580|FG003|Overall Study|Adverse Event|0|||
48681238|NCT03539601|156682577|FG000|Overall Study|Lost to Follow-up|2|||
48681239|NCT03539601|156682578|FG001|Overall Study|Lost to Follow-up|4|||
48681240|NCT03539601|156682579|FG002|Overall Study|Lost to Follow-up|5|||
48681241|NCT03539601|156682580|FG003|Overall Study|Lost to Follow-up|0|||
48681242|NCT03539601|156682577|FG000|Overall Study|Withdrawal by Subject|2|||
48681243|NCT03539601|156682578|FG001|Overall Study|Withdrawal by Subject|0|||
48681244|NCT03539601|156682579|FG002|Overall Study|Withdrawal by Subject|0|||
48681245|NCT03539601|156682580|FG003|Overall Study|Withdrawal by Subject|1|||
48681246|NCT03539601|156682577|FG000|Overall Study|Randomized but not treated|1|||
48681247|NCT03539601|156682578|FG001|Overall Study|Randomized but not treated|1|||
48681248|NCT03539601|156682579|FG002|Overall Study|Randomized but not treated|0|||
48681249|NCT03539601|156682580|FG003|Overall Study|Randomized but not treated|0|||
48681250|NCT01427933|156682582|FG000|Overall Study|Withdrawal by Subject|5|||
48681251|NCT01427933|156682583|FG001|Overall Study|Withdrawal by Subject|8|||
48681252|NCT01427933|156682582|FG000|Overall Study|Lost to Follow-up|1|||
48681253|NCT01427933|156682583|FG001|Overall Study|Lost to Follow-up|5|||
48681254|NCT01427933|156682582|FG000|Overall Study|Other|1|||
48681255|NCT01427933|156682583|FG001|Overall Study|Other|0|||
48681256|NCT01427933|156682582|FG000|Overall Study|Investigator's Decision|1|||
48681257|NCT01427933|156682583|FG001|Overall Study|Investigator's Decision|0|||
48681258|NCT00475709|156682584|FG000|Overall Study|Did not meet eligibility criteria|8|||
48681259|NCT00475709|156682584|FG000|Overall Study|Death|41|||
48980958|NCT01809327|157762253|FG003|Overall Study|Withdrawal by Subject|2|||
48980959|NCT01809327|157762254|FG004|Overall Study|Withdrawal by Subject|5|||
48980960|NCT01809327|157762250|FG000|Overall Study|Adverse Event|4|||
48980961|NCT01809327|157762251|FG001|Overall Study|Adverse Event|3|||
48980962|NCT01809327|157762252|FG002|Overall Study|Adverse Event|7|||
48980963|NCT01809327|157762253|FG003|Overall Study|Adverse Event|4|||
48980964|NCT01809327|157762254|FG004|Overall Study|Adverse Event|8|||
48980965|NCT01809327|157762250|FG000|Overall Study|Death|1|||
48980966|NCT01809327|157762251|FG001|Overall Study|Death|0|||
48980967|NCT01809327|157762252|FG002|Overall Study|Death|0|||
48980968|NCT01809327|157762253|FG003|Overall Study|Death|0|||
48980969|NCT01809327|157762254|FG004|Overall Study|Death|0|||
48980970|NCT01809327|157762250|FG000|Overall Study|Protocol Violation|0|||
48980971|NCT01809327|157762251|FG001|Overall Study|Protocol Violation|1|||
48980972|NCT01809327|157762252|FG002|Overall Study|Protocol Violation|0|||
48980973|NCT01809327|157762253|FG003|Overall Study|Protocol Violation|0|||
48980974|NCT01809327|157762254|FG004|Overall Study|Protocol Violation|0|||
48980975|NCT01809327|157762250|FG000|Overall Study|Physician Decision|1|||
48980976|NCT01809327|157762251|FG001|Overall Study|Physician Decision|1|||
48980977|NCT01809327|157762252|FG002|Overall Study|Physician Decision|0|||
48980978|NCT01809327|157762253|FG003|Overall Study|Physician Decision|0|||
48980979|NCT01809327|157762254|FG004|Overall Study|Physician Decision|0|||
48980980|NCT01809327|157762250|FG000|Overall Study|Pregnancy|1|||
48681260|NCT00475709|156682584|FG000|Overall Study|Device Explant|6|||
48681261|NCT00475709|156682584|FG000|Overall Study|Lost to Follow-up|21|||
48681262|NCT01835158|156682587|FG000|Overall Study|Withdrawal by Subject|1|||
48681263|NCT01835158|156682588|FG001|Overall Study|Withdrawal by Subject|6|||
48681264|NCT02717494|156682600|FG000|First Intervention (Step 1)|Lost to Follow-up|4|||
48681265|NCT02717494|156682601|FG001|First Intervention (Step 1)|Lost to Follow-up|7|||
48681266|NCT02717494|156682602|FG002|First Intervention (Step 1)|Lost to Follow-up|3|||
48681267|NCT02717494|156682600|FG000|First Intervention (Step 1)|Withdrawal by Subject|2|||
48681268|NCT02717494|156682601|FG001|First Intervention (Step 1)|Withdrawal by Subject|0|||
48681269|NCT02717494|156682602|FG002|First Intervention (Step 1)|Withdrawal by Subject|1|||
48681270|NCT02717494|156682600|FG000|First Intervention (Step 1)|Death|0|||
48681271|NCT02717494|156682601|FG001|First Intervention (Step 1)|Death|0|||
48681272|NCT02717494|156682602|FG002|First Intervention (Step 1)|Death|1|||
48681273|NCT02717494|156682600|FG000|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
48681274|NCT02717494|156682601|FG001|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
48681275|NCT02717494|156682602|FG002|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4|||
48681276|NCT02669212|156682605|FG000|Overall Study|Lost to Follow-up|1|||
48681277|NCT02669212|156682606|FG001|Overall Study|Lost to Follow-up|0|||
48681278|NCT02669212|156682605|FG000|Overall Study|Medical Condition|3|||
48681279|NCT02669212|156682606|FG001|Overall Study|Medical Condition|4|||
48681280|NCT02669212|156682605|FG000|Overall Study|Withdrawal by Subject|0|||
48681281|NCT02669212|156682606|FG001|Overall Study|Withdrawal by Subject|2|||
48681282|NCT02669212|156682605|FG000|Overall Study|Excluded - determined NOT post-infectious|0|||
48681283|NCT02669212|156682606|FG001|Overall Study|Excluded - determined NOT post-infectious|4|||
48681284|NCT00637416|156682607|FG000|Overall Study|Lost to Follow-up|1|||
48681285|NCT00637416|156682608|FG001|Overall Study|Lost to Follow-up|1|||
48681286|NCT00637416|156682607|FG000|Overall Study|Unable to take study drug|0|||
48681287|NCT00637416|156682608|FG001|Overall Study|Unable to take study drug|1|||
48681288|NCT00566852|156682611|FG000|Overall Study|Protocol Violation|22|||
48681289|NCT00566852|156682612|FG001|Overall Study|Protocol Violation|24|||
48681290|NCT00566852|156682611|FG000|Overall Study|Death|95|||
48681291|NCT00566852|156682612|FG001|Overall Study|Death|78|||
48681292|NCT00566852|156682611|FG000|Overall Study|Withdrawal by Subject|30|||
48681293|NCT00566852|156682612|FG001|Overall Study|Withdrawal by Subject|25|||
48681294|NCT00566852|156682611|FG000|Overall Study|Patient refusal|37|||
48681295|NCT00566852|156682612|FG001|Overall Study|Patient refusal|37|||
48681296|NCT00566852|156682611|FG000|Overall Study|Not tested due to disability|6|||
48681297|NCT00566852|156682612|FG001|Overall Study|Not tested due to disability|12|||
48681298|NCT00566852|156682611|FG000|Overall Study|Missing reason not specified|1|||
48681299|NCT00566852|156682612|FG001|Overall Study|Missing reason not specified|2|||
48681300|NCT00566852|156682611|FG000|Overall Study|Missing reason not reported|16|||
48681301|NCT00566852|156682612|FG001|Overall Study|Missing reason not reported|20|||
48681302|NCT00391027|156682613|FG000|Overall Study|Adverse Event|8|||
48681303|NCT00391027|156682614|FG001|Overall Study|Adverse Event|8|||
48681304|NCT00391027|156682613|FG000|Overall Study|Lack of Efficacy|3|||
48681305|NCT00391027|156682614|FG001|Overall Study|Lack of Efficacy|0|||
48681306|NCT00391027|156682613|FG000|Overall Study|Withdrawal by Subject|10|||
48681307|NCT00391027|156682614|FG001|Overall Study|Withdrawal by Subject|1|||
48681308|NCT00391027|156682613|FG000|Overall Study|Other|4|||
48681309|NCT00391027|156682614|FG001|Overall Study|Other|3|||
48681310|NCT00719680|156682618|FG000|Overall Study|Adverse Event|1|||
48681311|NCT00719680|156682618|FG000|Overall Study|Lost to Follow-up|1|||
48681312|NCT00719680|156682618|FG000|Overall Study|Withdrawal by Subject|3|||
48681313|NCT00310817|156682621|FG000|Overall Study|AE or Death|3|||
48681314|NCT00310817|156682622|FG001|Overall Study|AE or Death|1|||
48681315|NCT00310817|156682623|FG002|Overall Study|AE or Death|0|||
48681316|NCT00310817|156682624|FG003|Overall Study|AE or Death|0|||
48681317|NCT00310817|156682621|FG000|Overall Study|Withdrawal by Subject|1|||
48681318|NCT00310817|156682622|FG001|Overall Study|Withdrawal by Subject|4|||
48681319|NCT00310817|156682623|FG002|Overall Study|Withdrawal by Subject|6|||
48681320|NCT00310817|156682624|FG003|Overall Study|Withdrawal by Subject|7|||
48681321|NCT00310817|156682621|FG000|Overall Study|Lost to Follow-up|2|||
48681322|NCT00310817|156682622|FG001|Overall Study|Lost to Follow-up|1|||
48681323|NCT00310817|156682623|FG002|Overall Study|Lost to Follow-up|0|||
48681324|NCT00310817|156682624|FG003|Overall Study|Lost to Follow-up|0|||
48681325|NCT00310817|156682621|FG000|Overall Study|Inappropriate Enrollment|1|||
48681326|NCT00310817|156682622|FG001|Overall Study|Inappropriate Enrollment|0|||
48681327|NCT00310817|156682623|FG002|Overall Study|Inappropriate Enrollment|1|||
48681328|NCT00310817|156682624|FG003|Overall Study|Inappropriate Enrollment|0|||
48681329|NCT00310817|156682621|FG000|Overall Study|Protocol Violation|1|||
48681330|NCT00310817|156682622|FG001|Overall Study|Protocol Violation|1|||
48681331|NCT00310817|156682623|FG002|Overall Study|Protocol Violation|1|||
48681332|NCT00310817|156682624|FG003|Overall Study|Protocol Violation|1|||
48681333|NCT00310817|156682621|FG000|Overall Study|Unable to classify|3|||
48681334|NCT00310817|156682622|FG001|Overall Study|Unable to classify|1|||
48681335|NCT00310817|156682623|FG002|Overall Study|Unable to classify|0|||
48681336|NCT00310817|156682624|FG003|Overall Study|Unable to classify|0|||
49020866|NCT00162123|157912750|FG001|Overall Study|Withdrawal by Subject|0|||
49020867|NCT00162123|157912751|FG002|Overall Study|Withdrawal by Subject|2|||
49020868|NCT00162123|157912752|FG003|Overall Study|Withdrawal by Subject|1|||
49020869|NCT00162123|157912753|FG004|Overall Study|Withdrawal by Subject|1|||
49020870|NCT00162123|157912754|FG005|Overall Study|Withdrawal by Subject|2|||
49020871|NCT00162123|157912755|FG006|Overall Study|Withdrawal by Subject|1|||
49020872|NCT00162123|157912756|FG007|Overall Study|Withdrawal by Subject|0|||
49020873|NCT00162123|157912749|FG000|Overall Study|Deterioration without progression|2|||
49020874|NCT00162123|157912750|FG001|Overall Study|Deterioration without progression|2|||
48681337|NCT02362464|156682625|FG000|Overall Study|Switched to alternative therapy|1|||
48681338|NCT02362464|156682625|FG000|Overall Study|Refused further treatment|1|||
48681339|NCT02362464|156682625|FG000|Overall Study|Physician Decision|4|||
48681340|NCT02023996|156682635|FG000|Overall Study|Protocol Violation|6|||
48681341|NCT02343406|156682638|FG000|Overall Study|Progressive disease|72|||
48681342|NCT02343406|156682639|FG001|Overall Study|Progressive disease|70|||
48681343|NCT02343406|156682640|FG002|Overall Study|Progressive disease|43|||
48681344|NCT02343406|156682641|FG003|Overall Study|Progressive disease|15|||
48681345|NCT02343406|156682642|FG004|Overall Study|Progressive disease|5|||
48681346|NCT02343406|156682638|FG000|Overall Study|Adverse Event|6|||
48681347|NCT02343406|156682639|FG001|Overall Study|Adverse Event|8|||
48681348|NCT02343406|156682640|FG002|Overall Study|Adverse Event|6|||
48681349|NCT02343406|156682641|FG003|Overall Study|Adverse Event|3|||
48681350|NCT02343406|156682642|FG004|Overall Study|Adverse Event|0|||
48681351|NCT02343406|156682638|FG000|Overall Study|Withdrawal by Subject|6|||
48681352|NCT02343406|156682639|FG001|Overall Study|Withdrawal by Subject|4|||
48681353|NCT02343406|156682640|FG002|Overall Study|Withdrawal by Subject|8|||
48681354|NCT02343406|156682641|FG003|Overall Study|Withdrawal by Subject|3|||
48681355|NCT02343406|156682642|FG004|Overall Study|Withdrawal by Subject|0|||
48681356|NCT02343406|156682638|FG000|Overall Study|Death|2|||
48681357|NCT02343406|156682639|FG001|Overall Study|Death|1|||
48681358|NCT02343406|156682640|FG002|Overall Study|Death|0|||
48681359|NCT02343406|156682641|FG003|Overall Study|Death|0|||
48681360|NCT02343406|156682642|FG004|Overall Study|Death|0|||
48681361|NCT02343406|156682638|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
48681362|NCT02343406|156682639|FG001|Overall Study|Start of a new anti-cancer treatment|1|||
48681363|NCT02343406|156682640|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
48681364|NCT02343406|156682641|FG003|Overall Study|Start of a new anti-cancer treatment|1|||
48681365|NCT02343406|156682642|FG004|Overall Study|Start of a new anti-cancer treatment|0|||
48681366|NCT02343406|156682638|FG000|Overall Study|Other primary malignancy|0|||
48681367|NCT02343406|156682639|FG001|Overall Study|Other primary malignancy|1|||
48681368|NCT02343406|156682640|FG002|Overall Study|Other primary malignancy|0|||
48681369|NCT02343406|156682641|FG003|Overall Study|Other primary malignancy|0|||
48681370|NCT02343406|156682642|FG004|Overall Study|Other primary malignancy|0|||
48681371|NCT02343406|156682638|FG000|Overall Study|Other, not specified|2|||
48681372|NCT02343406|156682639|FG001|Overall Study|Other, not specified|1|||
48681373|NCT02343406|156682640|FG002|Overall Study|Other, not specified|1|||
48681374|NCT02343406|156682641|FG003|Overall Study|Other, not specified|4|||
48681375|NCT02343406|156682642|FG004|Overall Study|Other, not specified|0|||
48681376|NCT00548145|156682643|FG000|Overall Study|Death|0|||
48681377|NCT00548145|156682644|FG001|Overall Study|Death|1|||
48681378|NCT00548145|156682643|FG000|Overall Study|Withdrawal by Subject|0|||
48681379|NCT00548145|156682644|FG001|Overall Study|Withdrawal by Subject|2|||
48681380|NCT00548145|156682643|FG000|Overall Study|Physician Decision|1|||
48681381|NCT00548145|156682644|FG001|Overall Study|Physician Decision|1|||
48681382|NCT00348673|156682647|FG000|Stage 1|Randomized but not Treated|0|||
48681383|NCT00348673|156682648|FG001|Stage 1|Randomized but not Treated|0|||
48681384|NCT00348673|156682649|FG002|Stage 1|Randomized but not Treated|1|||
48875114|NCT00738283|157379060|FG000|Overall Study|Discharge home prior to end of study|1|||
49020875|NCT00162123|157912751|FG002|Overall Study|Deterioration without progression|3|||
49020876|NCT00162123|157912752|FG003|Overall Study|Deterioration without progression|0|||
48681385|NCT00348673|156682650|FG003|Stage 1|Randomized but not Treated|0|||
48681386|NCT00348673|156682651|FG004|Stage 1|Randomized but not Treated|0|||
48681387|NCT00348673|156682652|FG005|Stage 1|Randomized but not Treated|0|||
48681388|NCT00348673|156682653|FG006|Stage 1|Randomized but not Treated|0|||
48681389|NCT00348673|156682654|FG007|Stage 1|Randomized but not Treated|0|||
48681390|NCT00348673|156682655|FG008|Stage 1|Randomized but not Treated|0|||
48681391|NCT04090242|156682656|FG000|Overall Study|Withdrawal by Subject|1|||
48681392|NCT04090242|156682657|FG001|Overall Study|Withdrawal by Subject|0|||
48681393|NCT01180296|156682659|FG000|Overall Study|Protocol Violation|1|||
48681394|NCT01180296|156682660|FG001|Overall Study|Protocol Violation|2|||
48681395|NCT02564978|156682673|FG000|Overall Study|Adverse Event|8|||
48681396|NCT02564978|156682673|FG000|Overall Study|Death|1|||
48681397|NCT02564978|156682673|FG000|Overall Study|Lost to Follow-up|1|||
48681398|NCT02564978|156682673|FG000|Overall Study|Withdrawal by Subject|15|||
48681399|NCT02564978|156682673|FG000|Overall Study|Early Study Closure|2|||
48681400|NCT02564978|156682673|FG000|Overall Study|Other Reason|5|||
48681401|NCT00291486|156682674|FG000|Overall Study|Adverse Event|0|||
48681402|NCT00291486|156682675|FG001|Overall Study|Adverse Event|3|||
48681403|NCT00291486|156682676|FG002|Overall Study|Adverse Event|0|||
48681404|NCT00291486|156682677|FG003|Overall Study|Adverse Event|1|||
48681405|NCT00291486|156682678|FG004|Overall Study|Adverse Event|0|||
48681406|NCT00291486|156682674|FG000|Overall Study|Withdrawal by Subject|0|||
48681407|NCT00291486|156682675|FG001|Overall Study|Withdrawal by Subject|0|||
48681408|NCT00291486|156682676|FG002|Overall Study|Withdrawal by Subject|0|||
48681409|NCT00291486|156682677|FG003|Overall Study|Withdrawal by Subject|0|||
48681410|NCT00291486|156682678|FG004|Overall Study|Withdrawal by Subject|1|||
48681411|NCT00291486|156682674|FG000|Overall Study|Disease progression|1|||
48681412|NCT00291486|156682675|FG001|Overall Study|Disease progression|0|||
48681413|NCT00291486|156682676|FG002|Overall Study|Disease progression|1|||
48681414|NCT00291486|156682677|FG003|Overall Study|Disease progression|0|||
48681415|NCT00291486|156682678|FG004|Overall Study|Disease progression|0|||
48681416|NCT02679287|156682679|FG000|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2|||
48681417|NCT02679287|156682680|FG001|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1|||
48681418|NCT02679287|156682679|FG000|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2|||
48681419|NCT02679287|156682680|FG001|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3|||
48681420|NCT02679287|156682679|FG000|Period 1: Randomization-Study Session 1|Disliked mobile system|0|||
48681421|NCT02679287|156682680|FG001|Period 1: Randomization-Study Session 1|Disliked mobile system|1|||
48681422|NCT02679287|156682679|FG000|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0|||
48681423|NCT02679287|156682680|FG001|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1|||
48681424|NCT02679287|156682679|FG000|Period 2|Work/Scheduling Conflict|1|||
48681425|NCT02679287|156682680|FG001|Period 2|Work/Scheduling Conflict|0|||
48681426|NCT02679287|156682679|FG000|Period 2|Disliked Mobile System|2|||
48681427|NCT02679287|156682680|FG001|Period 2|Disliked Mobile System|0|||
48681428|NCT02679287|156682679|FG000|Period 3|Work/Scheduling Conflict|0|||
48681429|NCT02679287|156682680|FG001|Period 3|Work/Scheduling Conflict|1|||
48681430|NCT01045694|156682682|FG000|Overall Study|Withdrawal by Subject|2|||
48681431|NCT00423449|156682683|FG000|Overall Study|Clinical Adverse Event|1|||
48681432|NCT00423449|156682684|FG001|Overall Study|Clinical Adverse Event|0|||
48681433|NCT00423449|156682685|FG002|Overall Study|Clinical Adverse Event|1|||
48681434|NCT00423449|156682686|FG003|Overall Study|Clinical Adverse Event|8|||
48681435|NCT00423449|156682687|FG004|Overall Study|Clinical Adverse Event|2|||
48681436|NCT00423449|156682683|FG000|Overall Study|Death|1|||
48681437|NCT00423449|156682684|FG001|Overall Study|Death|0|||
48681438|NCT00423449|156682685|FG002|Overall Study|Death|2|||
48681439|NCT00423449|156682686|FG003|Overall Study|Death|1|||
48681440|NCT00423449|156682687|FG004|Overall Study|Death|1|||
48681441|NCT00423449|156682683|FG000|Overall Study|Progressive Disease|1|||
48681442|NCT00423449|156682684|FG001|Overall Study|Progressive Disease|3|||
48681443|NCT00423449|156682685|FG002|Overall Study|Progressive Disease|8|||
48681444|NCT00423449|156682686|FG003|Overall Study|Progressive Disease|11|||
48681445|NCT00423449|156682687|FG004|Overall Study|Progressive Disease|4|||
48681446|NCT00423449|156682683|FG000|Overall Study|Laboratory Adverse Event|0|||
48681447|NCT00423449|156682684|FG001|Overall Study|Laboratory Adverse Event|1|||
48681448|NCT00423449|156682685|FG002|Overall Study|Laboratory Adverse Event|2|||
48681449|NCT00423449|156682686|FG003|Overall Study|Laboratory Adverse Event|0|||
48681450|NCT00423449|156682687|FG004|Overall Study|Laboratory Adverse Event|0|||
48681451|NCT00423449|156682683|FG000|Overall Study|Other|0|||
48681452|NCT00423449|156682684|FG001|Overall Study|Other|0|||
48681453|NCT00423449|156682685|FG002|Overall Study|Other|0|||
48681454|NCT00423449|156682686|FG003|Overall Study|Other|1|||
48681455|NCT00423449|156682687|FG004|Overall Study|Other|0|||
48681456|NCT00423449|156682683|FG000|Overall Study|Protocol Violation|0|||
49020877|NCT00162123|157912753|FG004|Overall Study|Deterioration without progression|1|||
49020878|NCT00162123|157912754|FG005|Overall Study|Deterioration without progression|0|||
49020879|NCT00162123|157912755|FG006|Overall Study|Deterioration without progression|0|||
49020880|NCT00162123|157912756|FG007|Overall Study|Deterioration without progression|0|||
49020881|NCT00162123|157912749|FG000|Overall Study|Adverse Event|1|||
49020882|NCT00162123|157912750|FG001|Overall Study|Adverse Event|2|||
49020883|NCT00162123|157912751|FG002|Overall Study|Adverse Event|0|||
49020884|NCT00162123|157912752|FG003|Overall Study|Adverse Event|2|||
49020885|NCT00162123|157912753|FG004|Overall Study|Adverse Event|1|||
49020886|NCT00162123|157912754|FG005|Overall Study|Adverse Event|0|||
49020887|NCT00162123|157912755|FG006|Overall Study|Adverse Event|0|||
48681457|NCT00423449|156682684|FG001|Overall Study|Protocol Violation|0|||
48681458|NCT00423449|156682685|FG002|Overall Study|Protocol Violation|2|||
48681459|NCT00423449|156682686|FG003|Overall Study|Protocol Violation|1|||
48681460|NCT00423449|156682687|FG004|Overall Study|Protocol Violation|0|||
48681461|NCT01153724|156682688|FG000|Treatment Period 1|Withdrawal by Subject|1|||
48681462|NCT01153724|156682688|FG000|Treatment Period 2|Adverse Event|1|||
48681463|NCT01153724|156682688|FG000|Treatment Period 2|Other reason not defined above|1|||
48681464|NCT01063153|156682689|FG000|Overall Study|Found Ineligible During Screening|2|||
48681465|NCT01063153|156682690|FG001|Overall Study|Found Ineligible During Screening|0|||
48681466|NCT01063153|156682689|FG000|Overall Study|Lost to Follow-up|0|||
48681467|NCT01063153|156682690|FG001|Overall Study|Lost to Follow-up|7|||
48681468|NCT01063153|156682689|FG000|Overall Study|Withdrawal by Subject|0|||
48681469|NCT01063153|156682690|FG001|Overall Study|Withdrawal by Subject|1|||
48681470|NCT01063153|156682689|FG000|Overall Study|Physician Decision|0|||
48681471|NCT01063153|156682690|FG001|Overall Study|Physician Decision|4|||
48681472|NCT00851786|156682691|FG000|Overall Study|Withdrawal by Subject|0|||
48681473|NCT00851786|156682692|FG001|Overall Study|Withdrawal by Subject|1|||
48681474|NCT00851786|156682691|FG000|Overall Study|Protocol Violation|0|||
48681475|NCT00851786|156682692|FG001|Overall Study|Protocol Violation|1|||
48681476|NCT00851786|156682691|FG000|Overall Study|Lost to Follow-up|1|||
48681477|NCT00851786|156682692|FG001|Overall Study|Lost to Follow-up|0|||
48681478|NCT00851786|156682691|FG000|Overall Study|Incarceration|1|||
48681479|NCT00851786|156682692|FG001|Overall Study|Incarceration|0|||
48681480|NCT00851786|156682691|FG000|Overall Study|Site Closure|1|||
48681481|NCT00851786|156682692|FG001|Overall Study|Site Closure|0|||
48681482|NCT00851786|156682691|FG000|Overall Study|Cannot Adhere to Protocol Requirement|2|||
48681483|NCT00851786|156682692|FG001|Overall Study|Cannot Adhere to Protocol Requirement|0|||
48681484|NCT01301833|156682693|FG000|Overall Study|Adverse Event|7|||
48681485|NCT01301833|156682694|FG001|Overall Study|Adverse Event|5|||
48681486|NCT01301833|156682695|FG002|Overall Study|Adverse Event|5|||
48681487|NCT01301833|156682696|FG003|Overall Study|Adverse Event|5|||
48681488|NCT01301833|156682693|FG000|Overall Study|Lack of Efficacy|1|||
48681489|NCT01301833|156682694|FG001|Overall Study|Lack of Efficacy|1|||
48681490|NCT01301833|156682695|FG002|Overall Study|Lack of Efficacy|0|||
48681491|NCT01301833|156682696|FG003|Overall Study|Lack of Efficacy|0|||
48681492|NCT01301833|156682693|FG000|Overall Study|Physician Decision|3|||
48681493|NCT01301833|156682694|FG001|Overall Study|Physician Decision|1|||
48681494|NCT01301833|156682695|FG002|Overall Study|Physician Decision|1|||
48681495|NCT01301833|156682696|FG003|Overall Study|Physician Decision|0|||
48681496|NCT01301833|156682693|FG000|Overall Study|Withdrawal by Subject|3|||
48681497|NCT01301833|156682694|FG001|Overall Study|Withdrawal by Subject|1|||
48681498|NCT01301833|156682695|FG002|Overall Study|Withdrawal by Subject|1|||
48681499|NCT01301833|156682696|FG003|Overall Study|Withdrawal by Subject|2|||
48681500|NCT01301833|156682693|FG000|Overall Study|Personal matter|1|||
48681501|NCT01301833|156682694|FG001|Overall Study|Personal matter|0|||
48681502|NCT01301833|156682695|FG002|Overall Study|Personal matter|0|||
48681503|NCT01301833|156682696|FG003|Overall Study|Personal matter|0|||
48681504|NCT02663622|156682704|FG000|Overall Study|Death|3|||
48681505|NCT02663622|156682705|FG001|Overall Study|Death|1|||
48681506|NCT02663622|156682706|FG002|Overall Study|Death|1|||
48681507|NCT02663622|156682707|FG003|Overall Study|Death|8|||
48681508|NCT02663622|156682704|FG000|Overall Study|Protocol Violation|0|||
48681509|NCT02663622|156682705|FG001|Overall Study|Protocol Violation|0|||
48681510|NCT02663622|156682706|FG002|Overall Study|Protocol Violation|0|||
48875115|NCT00583947|157379061|FG000|Cross-over Period|Adverse Event|2|||
48980981|NCT01809327|157762251|FG001|Overall Study|Pregnancy|0|||
48681511|NCT02663622|156682707|FG003|Overall Study|Protocol Violation|1|||
48681512|NCT00930930|156682708|FG000|Overall Study|Death|1|||
48681513|NCT00930930|156682709|FG001|Overall Study|Death|0|||
48681514|NCT00930930|156682708|FG000|Overall Study|Physician Decision|1|||
48681515|NCT00930930|156682709|FG001|Overall Study|Physician Decision|0|||
48681516|NCT00930930|156682708|FG000|Overall Study|Adverse Event|13|||
48681517|NCT00930930|156682709|FG001|Overall Study|Adverse Event|3|||
48681518|NCT00930930|156682708|FG000|Overall Study|Withdrawal by Subject|3|||
48681519|NCT00930930|156682709|FG001|Overall Study|Withdrawal by Subject|1|||
48681520|NCT00930930|156682708|FG000|Overall Study|Disease progression|2|||
48681521|NCT00930930|156682709|FG001|Overall Study|Disease progression|3|||
48681522|NCT00930930|156682708|FG000|Overall Study|excessive lapse btw txs, not eligible|0|||
48681523|NCT00930930|156682709|FG001|Overall Study|excessive lapse btw txs, not eligible|1|||
48681524|NCT00930930|156682708|FG000|Overall Study|patients not compliant|1|||
48681525|NCT00930930|156682709|FG001|Overall Study|patients not compliant|1|||
48681526|NCT02775916|156682712|FG000|Overall Study|Adverse Event|1|||
48681527|NCT02775916|156682713|FG001|Overall Study|Adverse Event|0|||
48681528|NCT02775916|156682712|FG000|Overall Study|Subject/Guardian Decision|2|||
48681529|NCT02775916|156682713|FG001|Overall Study|Subject/Guardian Decision|0|||
48681530|NCT00163020|156682714|FG000|Overall Study|Lost to Follow-up|0|||
48681531|NCT00163020|156682715|FG001|Overall Study|Lost to Follow-up|2|||
48681532|NCT02291419|156684170|FG000|Overall Study|Early study termination|1|||
48681533|NCT02291419|156684171|FG001|Overall Study|Early study termination|5|||
48681534|NCT02950480|156684172|FG000|Overall Study|Withdrawal by Subject|1|||
48681535|NCT02950480|156684173|FG001|Overall Study|Withdrawal by Subject|0|||
48681536|NCT01496469|156684174|FG000|Overall Study|Adverse Event|1|||
48681537|NCT01496469|156684175|FG001|Overall Study|Adverse Event|0|||
48681538|NCT01496469|156684174|FG000|Overall Study|Protocol Violation|2|||
48681539|NCT01496469|156684175|FG001|Overall Study|Protocol Violation|0|||
48681540|NCT01496469|156684174|FG000|Overall Study|Lost to Follow-up|1|||
48681541|NCT01496469|156684175|FG001|Overall Study|Lost to Follow-up|1|||
48681542|NCT01496469|156684174|FG000|Overall Study|Withdrawal by Subject|4|||
48681543|NCT01496469|156684175|FG001|Overall Study|Withdrawal by Subject|4|||
48681544|NCT01496469|156684174|FG000|Overall Study|BP exceeds protocol limits|1|||
48681545|NCT01496469|156684175|FG001|Overall Study|BP exceeds protocol limits|2|||
48681546|NCT01496469|156684174|FG000|Overall Study|Other|1|||
48681547|NCT01496469|156684175|FG001|Overall Study|Other|1|||
48681548|NCT00511134|156684176|FG000|Overall Study|Withdrawal by Subject|0|||
48681549|NCT00511134|156684177|FG001|Overall Study|Withdrawal by Subject|2|||
48681550|NCT00767806|156684178|FG000|Overall Study|Adverse Event|30|||
48681551|NCT00767806|156684179|FG001|Overall Study|Adverse Event|11|||
48681552|NCT00767806|156684178|FG000|Overall Study|Withdrawal by Subject|8|||
48681553|NCT00767806|156684179|FG001|Overall Study|Withdrawal by Subject|13|||
48681554|NCT00767806|156684178|FG000|Overall Study|Protocol Violation|6|||
48681555|NCT00767806|156684179|FG001|Overall Study|Protocol Violation|5|||
48681556|NCT00767806|156684178|FG000|Overall Study|Lack of Efficacy|1|||
48681557|NCT00767806|156684179|FG001|Overall Study|Lack of Efficacy|9|||
48681558|NCT00767806|156684178|FG000|Overall Study|Physician Decision|4|||
48681559|NCT00767806|156684179|FG001|Overall Study|Physician Decision|3|||
48681560|NCT00767806|156684178|FG000|Overall Study|Lost to Follow-up|1|||
48681561|NCT00767806|156684179|FG001|Overall Study|Lost to Follow-up|4|||
48681562|NCT00767806|156684178|FG000|Overall Study|Entry Criteria Not Met|1|||
48681563|NCT00767806|156684179|FG001|Overall Study|Entry Criteria Not Met|1|||
48681564|NCT00767806|156684178|FG000|Overall Study|Sponsor Decision|0|||
48681565|NCT00767806|156684179|FG001|Overall Study|Sponsor Decision|1|||
48681566|NCT01949090|156684180|FG000|Overall Study|Serious Adverse Event|0|||
48681567|NCT01949090|156684181|FG001|Overall Study|Serious Adverse Event|1|||
48681568|NCT01949090|156684182|FG002|Overall Study|Serious Adverse Event|2|||
48681569|NCT01949090|156684183|FG003|Overall Study|Serious Adverse Event|0|||
48681570|NCT01949090|156684184|FG004|Overall Study|Serious Adverse Event|1|||
48681571|NCT01949090|156684180|FG000|Overall Study|Withdrawal by Subject|2|||
48681572|NCT01949090|156684181|FG001|Overall Study|Withdrawal by Subject|0|||
48681573|NCT01949090|156684182|FG002|Overall Study|Withdrawal by Subject|0|||
48681574|NCT01949090|156684183|FG003|Overall Study|Withdrawal by Subject|0|||
48681575|NCT01949090|156684184|FG004|Overall Study|Withdrawal by Subject|1|||
48681576|NCT01949090|156684180|FG000|Overall Study|Protocol non-compliance|0|||
48681577|NCT01949090|156684181|FG001|Overall Study|Protocol non-compliance|0|||
48681578|NCT01949090|156684182|FG002|Overall Study|Protocol non-compliance|0|||
48681579|NCT01949090|156684183|FG003|Overall Study|Protocol non-compliance|0|||
48681580|NCT01949090|156684184|FG004|Overall Study|Protocol non-compliance|1|||
48681581|NCT01949090|156684180|FG000|Overall Study|Lost to Follow-up|2|||
48681582|NCT01949090|156684181|FG001|Overall Study|Lost to Follow-up|1|||
48681583|NCT01949090|156684182|FG002|Overall Study|Lost to Follow-up|0|||
48681584|NCT01949090|156684183|FG003|Overall Study|Lost to Follow-up|1|||
48681585|NCT01949090|156684184|FG004|Overall Study|Lost to Follow-up|1|||
48681586|NCT00742183|156684185|FG000|Overall Study|Adverse Event|2|||
48681587|NCT00742183|156684186|FG001|Overall Study|Adverse Event|2|||
48681588|NCT00742183|156684185|FG000|Overall Study|Death|1|||
48681589|NCT00742183|156684186|FG001|Overall Study|Death|0|||
48681590|NCT00742183|156684185|FG000|Overall Study|Physician Decision|0|||
48681591|NCT00742183|156684186|FG001|Overall Study|Physician Decision|2|||
48681592|NCT00742183|156684185|FG000|Overall Study|Lost to Follow-up|4|||
48681593|NCT00742183|156684186|FG001|Overall Study|Lost to Follow-up|4|||
48681594|NCT00742183|156684185|FG000|Overall Study|Required skin-graft|1|||
48681595|NCT00742183|156684186|FG001|Overall Study|Required skin-graft|1|||
48681596|NCT00742183|156684185|FG000|Overall Study|Withdrawal by Subject|1|||
48681597|NCT00742183|156684186|FG001|Overall Study|Withdrawal by Subject|0|||
48681598|NCT00742183|156684185|FG000|Overall Study|Lack of Efficacy|0|||
48681599|NCT00742183|156684186|FG001|Overall Study|Lack of Efficacy|3|||
48681600|NCT00787189|156684187|FG000|Overall Study|Lost to Follow-up|2|||
48681601|NCT00787189|156684188|FG001|Overall Study|Lost to Follow-up|2|||
48681602|NCT02292446|156684189|FG000|Overall Study|Adverse Event|12|||
48681603|NCT02292446|156684189|FG000|Overall Study|Death|1|||
48681604|NCT02292446|156684189|FG000|Overall Study|Disease progression|2|||
48681605|NCT02292446|156684189|FG000|Overall Study|Subject/guardian decision|2|||
48681606|NCT02292446|156684189|FG000|Overall Study|Withdrawal by Subject|3|||
48681607|NCT00381693|156684190|FG000|Overall Study|Death|1|||
48762867|NCT01367158|156980367|FG003|Overall Study|Protocol Violation|0|||
48681608|NCT00381693|156684190|FG000|Overall Study|Adverse Event|4|||
48681609|NCT00381693|156684190|FG000|Overall Study|Patient Choice|1|||
48681610|NCT00381693|156684190|FG000|Overall Study|Progression|2|||
48681611|NCT00570310|156684191|FG000|Overall Study|Adverse Event|1|||
48681612|NCT00570310|156684192|FG001|Overall Study|Adverse Event|2|||
48681613|NCT00570310|156684191|FG000|Overall Study|Lack of Efficacy|1|||
48681614|NCT00570310|156684192|FG001|Overall Study|Lack of Efficacy|4|||
48681615|NCT00203424|156684206|FG000|Treatment Period|Withdrawal by Subject|4|||
48681616|NCT00203424|156684206|FG000|Treatment Period|Adverse Event|5|||
48681617|NCT00203424|156684206|FG000|Treatment Period|progressive disease|2|||
48681618|NCT00203424|156684206|FG000|Follow-up Period|Withdrawal by Subject|1|||
48681619|NCT00203424|156684206|FG000|Follow-up Period|progressive disease|4|||
48681620|NCT00203424|156684206|FG000|Follow-up Period|Lost to Follow-up|1|||
48681621|NCT01010971|156684207|FG000|Overall Study|Adverse Event|2|||
48681622|NCT01010971|156684208|FG001|Overall Study|Adverse Event|4|||
48681623|NCT01010971|156684209|FG002|Overall Study|Adverse Event|3|||
48681624|NCT01010971|156684207|FG000|Overall Study|Withdrawal by Subject|0|||
48681625|NCT01010971|156684208|FG001|Overall Study|Withdrawal by Subject|2|||
48681626|NCT01010971|156684209|FG002|Overall Study|Withdrawal by Subject|5|||
48681627|NCT01010971|156684207|FG000|Overall Study|Lost to Follow-up|0|||
48681628|NCT01010971|156684208|FG001|Overall Study|Lost to Follow-up|2|||
48681629|NCT01010971|156684209|FG002|Overall Study|Lost to Follow-up|3|||
48681630|NCT01010971|156684207|FG000|Overall Study|Other|1|||
48681631|NCT01010971|156684208|FG001|Overall Study|Other|0|||
48681632|NCT01010971|156684209|FG002|Overall Study|Other|2|||
48681633|NCT00596752|156684214|FG000|Overall Study|Other Reason|44|||
48681634|NCT00596752|156684215|FG001|Overall Study|Other Reason|49|||
48681635|NCT00596752|156684214|FG000|Overall Study|Adverse Event|34|||
48681636|NCT00596752|156684215|FG001|Overall Study|Adverse Event|34|||
48681637|NCT00596752|156684214|FG000|Overall Study|Lost to Follow-up|22|||
48681638|NCT00596752|156684215|FG001|Overall Study|Lost to Follow-up|38|||
48681639|NCT00596752|156684214|FG000|Overall Study|Withdrawal by Subject|12|||
48681640|NCT00596752|156684215|FG001|Overall Study|Withdrawal by Subject|9|||
48681641|NCT00596752|156684214|FG000|Overall Study|Unsatisfactory Compliance|9|||
48681642|NCT00596752|156684215|FG001|Overall Study|Unsatisfactory Compliance|6|||
48762868|NCT01367158|156980368|FG004|Overall Study|Protocol Violation|0|||
48762869|NCT01367158|156980369|FG005|Overall Study|Protocol Violation|0|||
48762870|NCT01367158|156980370|FG006|Overall Study|Protocol Violation|0|||
48762871|NCT01367158|156980371|FG007|Overall Study|Protocol Violation|0|||
48762872|NCT01367158|156980372|FG008|Overall Study|Protocol Violation|0|||
48762873|NCT01367158|156980373|FG009|Overall Study|Protocol Violation|0|||
48762874|NCT01367158|156980374|FG010|Overall Study|Protocol Violation|0|||
48762875|NCT02113956|156980375|FG000|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5|||
48762876|NCT02113956|156980376|FG001|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1|||
48762877|NCT02113956|156980375|FG000|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4|||
48762878|NCT02113956|156980376|FG001|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3|||
48762879|NCT02113956|156980375|FG000|3 Month Post-intervention|Lost to Follow-up|4|||
48762880|NCT02113956|156980376|FG001|3 Month Post-intervention|Lost to Follow-up|2|||
48762881|NCT00851799|156980377|FG000|Overall Study|Death|1|||
48762882|NCT00851799|156980378|FG001|Overall Study|Death|0|||
48762883|NCT00851799|156980379|FG002|Overall Study|Death|1|||
48681643|NCT00596752|156684214|FG000|Overall Study|Lack of Efficacy|4|||
48681644|NCT00596752|156684215|FG001|Overall Study|Lack of Efficacy|7|||
48681645|NCT00596752|156684214|FG000|Overall Study|Protocol Violation|1|||
48681646|NCT00596752|156684215|FG001|Overall Study|Protocol Violation|0|||
48681647|NCT02586727|156684216|FG000|Overall Study|Lost to Follow-up|1|||
48681648|NCT02586727|156684217|FG001|Overall Study|Lost to Follow-up|0|||
48681649|NCT01856582|156684218|FG000|Overall Study|Died prior to Boost infusion|1|||
48681650|NCT01221350|156684221|FG000|Overall Study|Discontinued intervention (GERD)|1|||
48681651|NCT01221350|156684222|FG001|Overall Study|Discontinued intervention (GERD)|0|||
48681652|NCT01221350|156684221|FG000|Overall Study|Exclusion criteria, asthma exacerbation|0|||
48681653|NCT01221350|156684222|FG001|Overall Study|Exclusion criteria, asthma exacerbation|1|||
48681654|NCT01221350|156684221|FG000|Overall Study|Withdrawal by Subject|4|||
48681655|NCT01221350|156684222|FG001|Overall Study|Withdrawal by Subject|2|||
48681656|NCT00731679|156684223|FG000|Overall Study|Adverse Event|7|||
48681657|NCT00731679|156684224|FG001|Overall Study|Adverse Event|8|||
48681658|NCT00731679|156684223|FG000|Overall Study|Withdrawal by Subject|8|||
48681659|NCT00731679|156684224|FG001|Overall Study|Withdrawal by Subject|8|||
48681660|NCT00731679|156684223|FG000|Overall Study|Lost to Follow-up|7|||
48681661|NCT00731679|156684224|FG001|Overall Study|Lost to Follow-up|8|||
48762884|NCT00851799|156980377|FG000|Overall Study|Lost to Follow-up|5|||
48762885|NCT00851799|156980378|FG001|Overall Study|Lost to Follow-up|3|||
48762886|NCT00851799|156980379|FG002|Overall Study|Lost to Follow-up|10|||
48762887|NCT00851799|156980377|FG000|Overall Study|Not able to get to clinic|8|||
48762888|NCT00851799|156980378|FG001|Overall Study|Not able to get to clinic|5|||
49020888|NCT00162123|157912756|FG007|Overall Study|Adverse Event|0|||
49020889|NCT00162123|157912749|FG000|Overall Study|Not specified (before treatment)|2|||
48762889|NCT00851799|156980379|FG002|Overall Study|Not able to get to clinic|9|||
49020890|NCT00162123|157912750|FG001|Overall Study|Not specified (before treatment)|0|||
48681662|NCT00731679|156684223|FG000|Overall Study|Noncompliance|0|||
48681663|NCT00731679|156684224|FG001|Overall Study|Noncompliance|1|||
48681664|NCT00731679|156684223|FG000|Overall Study|Pregnancy|0|||
48681665|NCT00731679|156684224|FG001|Overall Study|Pregnancy|1|||
48681666|NCT02134925|156684225|FG000|Overall Study|Withdrawal by Subject|1|||
48681667|NCT02134925|156684226|FG001|Overall Study|Withdrawal by Subject|0|||
48762890|NCT00851799|156980377|FG000|Overall Study|Not willing to adhere to requirements|1|||
48762891|NCT00851799|156980378|FG001|Overall Study|Not willing to adhere to requirements|2|||
48762892|NCT00851799|156980379|FG002|Overall Study|Not willing to adhere to requirements|2|||
48762893|NCT00851799|156980377|FG000|Overall Study|Withdrew consent prior study completion|1|||
48681668|NCT02134925|156684225|FG000|Overall Study|Cancel|1|||
48681669|NCT02134925|156684226|FG001|Overall Study|Cancel|6|||
48681670|NCT01514201|156684229|FG000|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1|||
48681671|NCT01514201|156684230|FG001|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
48681672|NCT01514201|156684231|FG002|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
48681673|NCT01514201|156684232|FG003|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
48681674|NCT01514201|156684229|FG000|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
48681675|NCT01514201|156684230|FG001|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
48681676|NCT01514201|156684231|FG002|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
48681677|NCT01514201|156684232|FG003|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
48681678|NCT01514201|156684229|FG000|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
48681679|NCT01514201|156684230|FG001|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
48681680|NCT01514201|156684231|FG002|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5|||
48681681|NCT01514201|156684232|FG003|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
48681682|NCT01514201|156684229|FG000|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
48681683|NCT01514201|156684230|FG001|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
48681684|NCT01514201|156684231|FG002|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
48681685|NCT01514201|156684232|FG003|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
48681686|NCT01514201|156684229|FG000|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
48681687|NCT01514201|156684230|FG001|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
48681688|NCT01514201|156684231|FG002|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
48681689|NCT01514201|156684232|FG003|PHASE II: Veliparib + Radiation Therapy|Ineligible|1|||
48681690|NCT01514201|156684229|FG000|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
48681691|NCT01514201|156684230|FG001|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
48681692|NCT01514201|156684231|FG002|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
48681693|NCT01514201|156684232|FG003|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2|||
48681694|NCT01514201|156684229|FG000|PHASE II: Veliparib + Radiation Therapy|Death|0|||
48681695|NCT01514201|156684230|FG001|PHASE II: Veliparib + Radiation Therapy|Death|0|||
48681696|NCT01514201|156684231|FG002|PHASE II: Veliparib + Radiation Therapy|Death|0|||
48681697|NCT01514201|156684232|FG003|PHASE II: Veliparib + Radiation Therapy|Death|1|||
48681698|NCT01514201|156684229|FG000|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
48681699|NCT01514201|156684230|FG001|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
48681700|NCT01514201|156684231|FG002|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
48681701|NCT01514201|156684232|FG003|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2|||
48681702|NCT01514201|156684229|FG000|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
48681703|NCT01514201|156684230|FG001|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
48681704|NCT01514201|156684231|FG002|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
48681705|NCT01514201|156684232|FG003|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6|||
48681706|NCT01514201|156684229|FG000|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
48681707|NCT01514201|156684230|FG001|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
48681708|NCT01514201|156684231|FG002|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
48681709|NCT01514201|156684232|FG003|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4|||
48681710|NCT01514201|156684229|FG000|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
48681711|NCT01514201|156684230|FG001|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
48681712|NCT01514201|156684231|FG002|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
48681713|NCT01514201|156684232|FG003|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7|||
48681714|NCT01514201|156684229|FG000|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
48681715|NCT01514201|156684230|FG001|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
48681716|NCT01514201|156684231|FG002|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
48681717|NCT01514201|156684232|FG003|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22|||
48681718|NCT01147055|156684243|FG000|First Intervention Period|Lost to Follow-up|1|||
48681719|NCT01147055|156684244|FG001|First Intervention Period|Lost to Follow-up|0|||
48681720|NCT01636986|156684246|FG000|Overall Study|Withdrawal by Subject|0|||
48681721|NCT01636986|156684247|FG001|Overall Study|Withdrawal by Subject|1|||
48681722|NCT01636986|156684246|FG000|Overall Study|Corneal Staining|0|||
48681723|NCT01636986|156684247|FG001|Overall Study|Corneal Staining|1|||
48681724|NCT00286429|156684251|FG000|Overall Study|Adverse Event|4|||
48681725|NCT00286429|156684252|FG001|Overall Study|Adverse Event|1|||
48681726|NCT00286429|156684253|FG002|Overall Study|Adverse Event|6|||
48681727|NCT00286429|156684251|FG000|Overall Study|Lack of Efficacy|52|||
48681728|NCT00286429|156684252|FG001|Overall Study|Lack of Efficacy|27|||
48681729|NCT00286429|156684253|FG002|Overall Study|Lack of Efficacy|25|||
48681730|NCT00286429|156684251|FG000|Overall Study|Lost to Follow-up|2|||
48681731|NCT00286429|156684252|FG001|Overall Study|Lost to Follow-up|4|||
48681732|NCT00286429|156684253|FG002|Overall Study|Lost to Follow-up|3|||
48681733|NCT00286429|156684251|FG000|Overall Study|Physician Decision|10|||
48681734|NCT00286429|156684252|FG001|Overall Study|Physician Decision|7|||
48681735|NCT00286429|156684253|FG002|Overall Study|Physician Decision|7|||
48762894|NCT00851799|156980378|FG001|Overall Study|Withdrew consent prior study completion|2|||
48762895|NCT00851799|156980379|FG002|Overall Study|Withdrew consent prior study completion|1|||
48681736|NCT00286429|156684251|FG000|Overall Study|Protocol Violation|3|||
48681737|NCT00286429|156684252|FG001|Overall Study|Protocol Violation|5|||
48681738|NCT00286429|156684253|FG002|Overall Study|Protocol Violation|4|||
48681739|NCT00286429|156684251|FG000|Overall Study|Withdrawal by Subject|3|||
48681740|NCT00286429|156684252|FG001|Overall Study|Withdrawal by Subject|2|||
48681741|NCT00286429|156684253|FG002|Overall Study|Withdrawal by Subject|6|||
48681742|NCT00286429|156684251|FG000|Overall Study|Administrative Error|1|||
48681743|NCT00286429|156684252|FG001|Overall Study|Administrative Error|1|||
48681744|NCT00286429|156684253|FG002|Overall Study|Administrative Error|1|||
48681745|NCT00286429|156684251|FG000|Overall Study|Administrative Decision|0|||
48681746|NCT00286429|156684252|FG001|Overall Study|Administrative Decision|1|||
48681747|NCT00286429|156684253|FG002|Overall Study|Administrative Decision|0|||
48681748|NCT01746225|156684254|FG000|Overall Study|Death|1|||
48681749|NCT01746225|156684255|FG001|Overall Study|Death|0|||
48681750|NCT01746225|156684256|FG002|Overall Study|Death|1|||
48681751|NCT01746225|156684254|FG000|Overall Study|Withdrawal by Subject|5|||
48681752|NCT01746225|156684255|FG001|Overall Study|Withdrawal by Subject|15|||
48681753|NCT01746225|156684256|FG002|Overall Study|Withdrawal by Subject|19|||
48681754|NCT01746225|156684254|FG000|Overall Study|Physician Decision|14|||
48681755|NCT01746225|156684255|FG001|Overall Study|Physician Decision|11|||
48762896|NCT00851799|156980377|FG000|Overall Study|Severe Debilitation|0|||
48875116|NCT00583947|157379062|FG001|Cross-over Period|Adverse Event|0|||
48980982|NCT01809327|157762252|FG002|Overall Study|Pregnancy|0|||
48681756|NCT01746225|156684256|FG002|Overall Study|Physician Decision|3|||
48681757|NCT01746225|156684254|FG000|Overall Study|Adverse Event|15|||
48681758|NCT01746225|156684255|FG001|Overall Study|Adverse Event|12|||
48681759|NCT01746225|156684256|FG002|Overall Study|Adverse Event|17|||
48681760|NCT01746225|156684254|FG000|Overall Study|Continuing Treatment|5|||
48681761|NCT01746225|156684255|FG001|Overall Study|Continuing Treatment|8|||
48681762|NCT01746225|156684256|FG002|Overall Study|Continuing Treatment|3|||
48681763|NCT00434109|156684261|FG000|Overall Study|Physician Decision|9|||
48681764|NCT00434109|156684261|FG000|Overall Study|Adverse Event|5|||
48681765|NCT00434109|156684261|FG000|Overall Study|Protocol Violation|1|||
48681766|NCT00434109|156684261|FG000|Overall Study|had embolism, did not receive sunitinib|3|||
48681767|NCT00319254|156684262|FG000|Overall Study|Withdrawal by Subject|4|||
48681768|NCT00319254|156684262|FG000|Overall Study|Death|46|||
48681769|NCT00319254|156684262|FG000|Overall Study|Lost to Follow-up|2|||
48681770|NCT00319254|156684262|FG000|Overall Study|Enrolled, Not Treated|2|||
48681771|NCT01711645|156684263|FG000|Overall Study|Withdrawal by Subject|8|||
48681772|NCT01711645|156684263|FG000|Overall Study|Lost to Follow-up|6|||
48681773|NCT01711645|156684263|FG000|Overall Study|Physician Decision|5|||
48681774|NCT02452424|156684268|FG000|Overall Study|Death|2|||
48681775|NCT02452424|156684269|FG001|Overall Study|Death|2|||
48681776|NCT02452424|156684270|FG002|Overall Study|Death|2|||
48681777|NCT02452424|156684271|FG003|Overall Study|Death|6|||
48980983|NCT01809327|157762253|FG003|Overall Study|Pregnancy|0|||
48980984|NCT01809327|157762254|FG004|Overall Study|Pregnancy|0|||
48980985|NCT01809327|157762250|FG000|Overall Study|Other|14|||
48980986|NCT01809327|157762251|FG001|Overall Study|Other|15|||
48980987|NCT01809327|157762252|FG002|Overall Study|Other|7|||
48980988|NCT01809327|157762253|FG003|Overall Study|Other|4|||
48980989|NCT01809327|157762254|FG004|Overall Study|Other|9|||
48980990|NCT03196973|157762255|FG000|Overall Study|Adverse Event|1|||
48980991|NCT03196973|157762256|FG001|Overall Study|Adverse Event|1|||
48980992|NCT03196973|157762257|FG002|Overall Study|Adverse Event|2|||
48980993|NCT03196973|157762255|FG000|Overall Study|Lack of Efficacy|2|||
48980994|NCT03196973|157762256|FG001|Overall Study|Lack of Efficacy|6|||
48980995|NCT03196973|157762257|FG002|Overall Study|Lack of Efficacy|1|||
48980996|NCT03196973|157762255|FG000|Overall Study|Lost to Follow-up|4|||
48980997|NCT03196973|157762256|FG001|Overall Study|Lost to Follow-up|3|||
48980998|NCT03196973|157762257|FG002|Overall Study|Lost to Follow-up|2|||
48980999|NCT03196973|157762255|FG000|Overall Study|Consent withdrawn|2|||
48981000|NCT03196973|157762256|FG001|Overall Study|Consent withdrawn|1|||
48981001|NCT03196973|157762257|FG002|Overall Study|Consent withdrawn|0|||
48981002|NCT03196973|157762255|FG000|Overall Study|Administration of a wrong kit of study medication|0|||
48981003|NCT03196973|157762256|FG001|Overall Study|Administration of a wrong kit of study medication|1|||
48981004|NCT03196973|157762257|FG002|Overall Study|Administration of a wrong kit of study medication|0|||
48981005|NCT00374127|157762258|FG000|Overall Study|Did not inhale during smoking procedure.|3|||
48981006|NCT00374127|157762258|FG000|Overall Study|Blood could not be drawn.|2|||
48981007|NCT00374127|157762258|FG000|Overall Study|Protocol Violation|5|||
48981008|NCT00374127|157762258|FG000|Overall Study|Pregnancy|1|||
48981009|NCT03864627|157762259|FG000|Overall Study|Adverse Event|0|||
48981010|NCT03864627|157762260|FG001|Overall Study|Adverse Event|1|||
48981011|NCT03864627|157762259|FG000|Overall Study|Lack of Efficacy|0|||
48981012|NCT03864627|157762260|FG001|Overall Study|Lack of Efficacy|1|||
48981013|NCT03864627|157762259|FG000|Overall Study|Lost to Follow-up|0|||
48681778|NCT02452424|156684272|FG004|Overall Study|Death|2|||
48681779|NCT02452424|156684273|FG005|Overall Study|Death|0|||
48681780|NCT02452424|156684274|FG006|Overall Study|Death|5|||
48681781|NCT02452424|156684275|FG007|Overall Study|Death|1|||
49020891|NCT00162123|157912751|FG002|Overall Study|Not specified (before treatment)|0|||
49020892|NCT00162123|157912752|FG003|Overall Study|Not specified (before treatment)|0|||
49020893|NCT00162123|157912753|FG004|Overall Study|Not specified (before treatment)|12|||
49020894|NCT00162123|157912754|FG005|Overall Study|Not specified (before treatment)|1|||
49020895|NCT00162123|157912755|FG006|Overall Study|Not specified (before treatment)|0|||
49020896|NCT00162123|157912756|FG007|Overall Study|Not specified (before treatment)|0|||
49020897|NCT00162123|157912749|FG000|Overall Study|Not specified (after start of treatment)|0|||
49020898|NCT00162123|157912750|FG001|Overall Study|Not specified (after start of treatment)|0|||
49020899|NCT00162123|157912751|FG002|Overall Study|Not specified (after start of treatment)|0|||
49020900|NCT00162123|157912752|FG003|Overall Study|Not specified (after start of treatment)|0|||
49020901|NCT00162123|157912753|FG004|Overall Study|Not specified (after start of treatment)|3|||
49020902|NCT00162123|157912754|FG005|Overall Study|Not specified (after start of treatment)|0|||
49020903|NCT00162123|157912755|FG006|Overall Study|Not specified (after start of treatment)|0|||
49020904|NCT00162123|157912756|FG007|Overall Study|Not specified (after start of treatment)|0|||
49020905|NCT00162123|157912749|FG000|Overall Study|Physician Decision|1|||
49020906|NCT00162123|157912750|FG001|Overall Study|Physician Decision|2|||
49020907|NCT00162123|157912751|FG002|Overall Study|Physician Decision|0|||
49020908|NCT00162123|157912752|FG003|Overall Study|Physician Decision|0|||
49020909|NCT00162123|157912753|FG004|Overall Study|Physician Decision|0|||
49020910|NCT00162123|157912754|FG005|Overall Study|Physician Decision|1|||
49020911|NCT00162123|157912755|FG006|Overall Study|Physician Decision|1|||
49020912|NCT00162123|157912756|FG007|Overall Study|Physician Decision|0|||
49020913|NCT00162123|157912749|FG000|Overall Study|Tumor assessment only (not treated)|0|||
49020914|NCT00162123|157912750|FG001|Overall Study|Tumor assessment only (not treated)|0|||
49020915|NCT00162123|157912751|FG002|Overall Study|Tumor assessment only (not treated)|0|||
49020916|NCT00162123|157912752|FG003|Overall Study|Tumor assessment only (not treated)|0|||
49020917|NCT00162123|157912753|FG004|Overall Study|Tumor assessment only (not treated)|0|||
49020918|NCT00162123|157912754|FG005|Overall Study|Tumor assessment only (not treated)|0|||
49020919|NCT00162123|157912755|FG006|Overall Study|Tumor assessment only (not treated)|0|||
49020920|NCT00162123|157912756|FG007|Overall Study|Tumor assessment only (not treated)|1|||
49020921|NCT00162123|157912749|FG000|Overall Study|Follow-up only (not treated or assessed)|0|||
49020922|NCT00162123|157912750|FG001|Overall Study|Follow-up only (not treated or assessed)|0|||
49020923|NCT00162123|157912751|FG002|Overall Study|Follow-up only (not treated or assessed)|0|||
49020924|NCT00162123|157912752|FG003|Overall Study|Follow-up only (not treated or assessed)|0|||
49020925|NCT00162123|157912753|FG004|Overall Study|Follow-up only (not treated or assessed)|0|||
49020926|NCT00162123|157912754|FG005|Overall Study|Follow-up only (not treated or assessed)|0|||
49020927|NCT00162123|157912755|FG006|Overall Study|Follow-up only (not treated or assessed)|0|||
49020928|NCT00162123|157912756|FG007|Overall Study|Follow-up only (not treated or assessed)|57|||
49020929|NCT02626949|157912757|FG000|Randomization, Pre-Enrollment|did not attend the baseline interview|15|||
49020930|NCT02626949|157912758|FG001|Randomization, Pre-Enrollment|did not attend the baseline interview|11|||
49020931|NCT02626949|157912757|FG000|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|1|||
49020932|NCT02626949|157912758|FG001|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|3|||
49020933|NCT02626949|157912757|FG000|Enrolled|Lost to Follow-up|7|||
49020934|NCT02626949|157912758|FG001|Enrolled|Lost to Follow-up|6|||
49020935|NCT02626949|157912757|FG000|Enrolled|Withdrawal by Subject|3|||
49020936|NCT02626949|157912758|FG001|Enrolled|Withdrawal by Subject|2|||
49020937|NCT00950872|157912763|FG000|Overall Study|Withdrawal by Subject|1|||
49020938|NCT00950872|157912763|FG000|Overall Study|Did not have surgery|2|||
49020939|NCT00510510|157912766|FG000|Overall Study|Adverse Event|4|||
49020940|NCT00510510|157912767|FG001|Overall Study|Adverse Event|3|||
49020941|NCT00510510|157912768|FG002|Overall Study|Adverse Event|6|||
49020942|NCT00510510|157912766|FG000|Overall Study|Lack of Efficacy|0|||
49020943|NCT00510510|157912767|FG001|Overall Study|Lack of Efficacy|1|||
49020944|NCT00510510|157912768|FG002|Overall Study|Lack of Efficacy|1|||
49020945|NCT00510510|157912766|FG000|Overall Study|Subjects no longer requires study drug|0|||
49020946|NCT00510510|157912767|FG001|Overall Study|Subjects no longer requires study drug|0|||
49020947|NCT00510510|157912768|FG002|Overall Study|Subjects no longer requires study drug|2|||
49020948|NCT00510510|157912766|FG000|Overall Study|Withdrawal by Subject|1|||
49020949|NCT00510510|157912767|FG001|Overall Study|Withdrawal by Subject|2|||
49020950|NCT00510510|157912768|FG002|Overall Study|Withdrawal by Subject|3|||
49020951|NCT00510510|157912766|FG000|Overall Study|Lost to Follow-up|0|||
49020952|NCT00510510|157912767|FG001|Overall Study|Lost to Follow-up|0|||
49020953|NCT00510510|157912768|FG002|Overall Study|Lost to Follow-up|1|||
49020954|NCT00510510|157912766|FG000|Overall Study|Protocol Violation|0|||
49020955|NCT00510510|157912767|FG001|Overall Study|Protocol Violation|3|||
49020956|NCT00510510|157912768|FG002|Overall Study|Protocol Violation|4|||
49020957|NCT00970281|157912769|FG000|Overall Study|Lack of Efficacy|1|||
49020958|NCT00970281|157912770|FG001|Overall Study|Lack of Efficacy|14|||
49020959|NCT00970281|157912769|FG000|Overall Study|Withdrawal by Subject|0|||
48681782|NCT02452424|156684276|FG008|Overall Study|Death|3|||
48681783|NCT02452424|156684277|FG009|Overall Study|Death|1|||
48681784|NCT02452424|156684278|FG010|Overall Study|Death|0|||
48681785|NCT02452424|156684268|FG000|Overall Study|Lost to Follow-up|0|||
48681786|NCT02452424|156684269|FG001|Overall Study|Lost to Follow-up|1|||
48681787|NCT02452424|156684270|FG002|Overall Study|Lost to Follow-up|1|||
48681788|NCT02452424|156684271|FG003|Overall Study|Lost to Follow-up|0|||
48681789|NCT02452424|156684272|FG004|Overall Study|Lost to Follow-up|0|||
48681790|NCT02452424|156684273|FG005|Overall Study|Lost to Follow-up|0|||
48681791|NCT02452424|156684274|FG006|Overall Study|Lost to Follow-up|0|||
48681792|NCT02452424|156684275|FG007|Overall Study|Lost to Follow-up|0|||
48681793|NCT02452424|156684276|FG008|Overall Study|Lost to Follow-up|0|||
48681794|NCT02452424|156684277|FG009|Overall Study|Lost to Follow-up|0|||
48681795|NCT02452424|156684278|FG010|Overall Study|Lost to Follow-up|0|||
48681796|NCT02452424|156684268|FG000|Overall Study|Withdrawal by Subject|0|||
48681797|NCT02452424|156684269|FG001|Overall Study|Withdrawal by Subject|0|||
48681798|NCT02452424|156684270|FG002|Overall Study|Withdrawal by Subject|3|||
48681799|NCT02452424|156684271|FG003|Overall Study|Withdrawal by Subject|2|||
48681800|NCT02452424|156684272|FG004|Overall Study|Withdrawal by Subject|0|||
48681801|NCT02452424|156684273|FG005|Overall Study|Withdrawal by Subject|0|||
48681802|NCT02452424|156684274|FG006|Overall Study|Withdrawal by Subject|1|||
48681803|NCT02452424|156684275|FG007|Overall Study|Withdrawal by Subject|0|||
48681804|NCT02452424|156684276|FG008|Overall Study|Withdrawal by Subject|1|||
48681805|NCT02452424|156684277|FG009|Overall Study|Withdrawal by Subject|1|||
48681806|NCT02452424|156684278|FG010|Overall Study|Withdrawal by Subject|0|||
48681807|NCT02452424|156684268|FG000|Overall Study|Other|0|||
48681808|NCT02452424|156684269|FG001|Overall Study|Other|0|||
48681809|NCT02452424|156684270|FG002|Overall Study|Other|1|||
48681810|NCT02452424|156684271|FG003|Overall Study|Other|0|||
48681811|NCT02452424|156684272|FG004|Overall Study|Other|0|||
48681812|NCT02452424|156684273|FG005|Overall Study|Other|1|||
48681813|NCT02452424|156684274|FG006|Overall Study|Other|4|||
48681814|NCT02452424|156684275|FG007|Overall Study|Other|3|||
48681815|NCT02452424|156684276|FG008|Overall Study|Other|0|||
48681816|NCT02452424|156684277|FG009|Overall Study|Other|0|||
48681817|NCT02452424|156684278|FG010|Overall Study|Other|1|||
48681818|NCT02452424|156684268|FG000|Overall Study|Progressive disease (per RECIST)|0|||
48681819|NCT02452424|156684269|FG001|Overall Study|Progressive disease (per RECIST)|0|||
48681820|NCT02452424|156684270|FG002|Overall Study|Progressive disease (per RECIST)|0|||
48681821|NCT02452424|156684271|FG003|Overall Study|Progressive disease (per RECIST)|0|||
48681822|NCT02452424|156684272|FG004|Overall Study|Progressive disease (per RECIST)|0|||
48681823|NCT02452424|156684273|FG005|Overall Study|Progressive disease (per RECIST)|0|||
49020960|NCT00970281|157912770|FG001|Overall Study|Withdrawal by Subject|1|||
49020961|NCT00970281|157912769|FG000|Overall Study|Physician Decision|1|||
49020962|NCT00970281|157912770|FG001|Overall Study|Physician Decision|1|||
49020963|NCT00408902|157912771|FG000|Overall Study|Lack of Efficacy|7|||
49020964|NCT00408902|157912771|FG000|Overall Study|Adverse Event|3|||
49020965|NCT03295721|157912772|FG000|Overall Study|Adverse Event|1|||
49020966|NCT03295721|157912773|FG001|Overall Study|Adverse Event|0|||
49020967|NCT03295721|157912774|FG002|Overall Study|Adverse Event|0|||
49020968|NCT03295721|157912772|FG000|Overall Study|Lost to Follow-up|1|||
49020969|NCT03295721|157912773|FG001|Overall Study|Lost to Follow-up|1|||
49020970|NCT03295721|157912774|FG002|Overall Study|Lost to Follow-up|1|||
49020971|NCT03295721|157912772|FG000|Overall Study|Withdrawal by Subject|1|||
49020972|NCT03295721|157912773|FG001|Overall Study|Withdrawal by Subject|0|||
49020973|NCT03295721|157912774|FG002|Overall Study|Withdrawal by Subject|1|||
49020974|NCT03295721|157912772|FG000|Overall Study|Death|0|||
49020975|NCT03295721|157912773|FG001|Overall Study|Death|0|||
49020976|NCT03295721|157912774|FG002|Overall Study|Death|1|||
49020977|NCT02994056|157912778|FG000|Overall Study|Death|8|||
49020978|NCT02994056|157912778|FG000|Overall Study|Withdrew Consent|1|||
49020979|NCT03184441|157912786|FG000|Overall Study|Withdrawal by Subject|1|||
49020980|NCT02534493|157912787|FG000|Overall Study|Lost to Follow-up|1|||
49020981|NCT02534493|157912787|FG000|Overall Study|Withdrawal by Subject|1|||
49020982|NCT03125200|157912790|FG000|Overall Study|Study Termination|0|||
49020983|NCT03125200|157912791|FG001|Overall Study|Study Termination|0|||
49020984|NCT03125200|157912792|FG002|Overall Study|Study Termination|0|||
49020985|NCT03125200|157912793|FG003|Overall Study|Study Termination|1|||
49020986|NCT03125200|157912794|FG004|Overall Study|Study Termination|1|||
49020987|NCT03125200|157912795|FG005|Overall Study|Study Termination|2|||
49020988|NCT03125200|157912796|FG006|Overall Study|Study Termination|1|||
49020989|NCT03125200|157912790|FG000|Overall Study|Clinical Progression|0|||
49020990|NCT03125200|157912791|FG001|Overall Study|Clinical Progression|0|||
49020991|NCT03125200|157912792|FG002|Overall Study|Clinical Progression|0|||
49020992|NCT03125200|157912793|FG003|Overall Study|Clinical Progression|1|||
48681824|NCT02452424|156684274|FG006|Overall Study|Progressive disease (per RECIST)|0|||
48681825|NCT02452424|156684275|FG007|Overall Study|Progressive disease (per RECIST)|0|||
48681826|NCT02452424|156684276|FG008|Overall Study|Progressive disease (per RECIST)|2|||
48681827|NCT02452424|156684277|FG009|Overall Study|Progressive disease (per RECIST)|0|||
48681828|NCT02452424|156684278|FG010|Overall Study|Progressive disease (per RECIST)|0|||
49020993|NCT03125200|157912794|FG004|Overall Study|Clinical Progression|0|||
49020994|NCT03125200|157912795|FG005|Overall Study|Clinical Progression|1|||
49020995|NCT03125200|157912796|FG006|Overall Study|Clinical Progression|0|||
49020996|NCT03125200|157912790|FG000|Overall Study|Progressive Disease|2|||
49020997|NCT03125200|157912791|FG001|Overall Study|Progressive Disease|1|||
49020998|NCT03125200|157912792|FG002|Overall Study|Progressive Disease|2|||
49020999|NCT03125200|157912793|FG003|Overall Study|Progressive Disease|1|||
49021000|NCT03125200|157912794|FG004|Overall Study|Progressive Disease|2|||
49021001|NCT03125200|157912795|FG005|Overall Study|Progressive Disease|0|||
49021002|NCT03125200|157912796|FG006|Overall Study|Progressive Disease|1|||
49021003|NCT03125200|157912790|FG000|Overall Study|Lack of Efficacy|0|||
49021004|NCT03125200|157912791|FG001|Overall Study|Lack of Efficacy|0|||
49021005|NCT03125200|157912792|FG002|Overall Study|Lack of Efficacy|0|||
49021006|NCT03125200|157912793|FG003|Overall Study|Lack of Efficacy|1|||
49021007|NCT03125200|157912794|FG004|Overall Study|Lack of Efficacy|0|||
49021008|NCT03125200|157912795|FG005|Overall Study|Lack of Efficacy|0|||
49021009|NCT03125200|157912796|FG006|Overall Study|Lack of Efficacy|0|||
49021010|NCT03125200|157912790|FG000|Overall Study|Toxicity|0|||
49021011|NCT03125200|157912791|FG001|Overall Study|Toxicity|0|||
49021012|NCT03125200|157912792|FG002|Overall Study|Toxicity|0|||
49021013|NCT03125200|157912793|FG003|Overall Study|Toxicity|1|||
48681829|NCT02452424|156684268|FG000|Overall Study|Adverse Event|0|||
48681830|NCT02452424|156684269|FG001|Overall Study|Adverse Event|0|||
48681831|NCT02452424|156684270|FG002|Overall Study|Adverse Event|0|||
48681832|NCT02452424|156684271|FG003|Overall Study|Adverse Event|0|||
48681833|NCT02452424|156684272|FG004|Overall Study|Adverse Event|0|||
48681834|NCT02452424|156684273|FG005|Overall Study|Adverse Event|0|||
48681835|NCT02452424|156684274|FG006|Overall Study|Adverse Event|0|||
48681836|NCT02452424|156684275|FG007|Overall Study|Adverse Event|0|||
48681837|NCT02452424|156684276|FG008|Overall Study|Adverse Event|0|||
48681838|NCT02452424|156684277|FG009|Overall Study|Adverse Event|0|||
48681839|NCT02452424|156684278|FG010|Overall Study|Adverse Event|1|||
48681840|NCT00103740|156684279|FG000|Period 1 - Core|Adverse Event|1|||
48681841|NCT00103740|156684280|FG001|Period 1 - Core|Adverse Event|0|||
48681842|NCT00103740|156684279|FG000|Period 1 - Core|Protocol Violation|3|||
48681843|NCT00103740|156684280|FG001|Period 1 - Core|Protocol Violation|2|||
48681844|NCT00103740|156684279|FG000|Period 1 - Core|Patient withdrew consent|3|||
48681845|NCT00103740|156684280|FG001|Period 1 - Core|Patient withdrew consent|2|||
48681846|NCT00103740|156684279|FG000|Period 2 - Extended Observation Period|Lost to Follow-up|7|||
48681847|NCT00103740|156684280|FG001|Period 2 - Extended Observation Period|Lost to Follow-up|6|||
48681848|NCT00103740|156684279|FG000|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21|||
48681849|NCT00103740|156684280|FG001|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13|||
48681850|NCT00103740|156684279|FG000|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5|||
48681851|NCT00103740|156684280|FG001|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6|||
49021014|NCT03125200|157912794|FG004|Overall Study|Toxicity|0|||
49021015|NCT03125200|157912795|FG005|Overall Study|Toxicity|0|||
48681852|NCT00103740|156684279|FG000|Period 2 - Extended Observation Period|Death|6|||
48681853|NCT00103740|156684280|FG001|Period 2 - Extended Observation Period|Death|2|||
48681854|NCT00103740|156684279|FG000|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30|||
48681855|NCT00103740|156684280|FG001|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9|||
48681856|NCT00555217|156684281|FG000|Overall Study|Withdrawal by Subject|35|||
48681857|NCT00555217|156684282|FG001|Overall Study|Withdrawal by Subject|31|||
48681858|NCT00555217|156684281|FG000|Overall Study|Lost to Follow-up|19|||
48681859|NCT00555217|156684282|FG001|Overall Study|Lost to Follow-up|20|||
48681860|NCT00555217|156684281|FG000|Overall Study|close out sites|21|||
48681861|NCT00555217|156684282|FG001|Overall Study|close out sites|17|||
48681862|NCT00992459|156684285|FG000|Overall Study|Withdrawal by Subject|0|||
48681863|NCT00992459|156684286|FG001|Overall Study|Withdrawal by Subject|1|||
48681864|NCT00992459|156684285|FG000|Overall Study|Adverse Event|1|||
48681865|NCT00992459|156684286|FG001|Overall Study|Adverse Event|0|||
48681866|NCT00543387|156684292|FG000|Panel 1 + Panel 2|Adverse Event|0|||
48681867|NCT00543387|156684293|FG001|Panel 1 + Panel 2|Adverse Event|1|||
48762897|NCT00851799|156980378|FG001|Overall Study|Severe Debilitation|1|||
48762898|NCT00851799|156980379|FG002|Overall Study|Severe Debilitation|0|||
48762899|NCT00851799|156980377|FG000|Overall Study|Completed protocol due to pregnancy|0|||
49021016|NCT03125200|157912796|FG006|Overall Study|Toxicity|0|||
49021017|NCT03125200|157912790|FG000|Overall Study|Consent Withdrawn by Subject|0|||
48681868|NCT00543387|156684294|FG002|Panel 1 + Panel 2|Adverse Event|0|||
48681869|NCT00543387|156684295|FG003|Panel 1 + Panel 2|Adverse Event|0|||
48681870|NCT00543387|156684296|FG004|Panel 1 + Panel 2|Adverse Event|0|||
48681871|NCT00543387|156684297|FG005|Panel 1 + Panel 2|Adverse Event|0|||
48681872|NCT00543387|156684298|FG006|Panel 1 + Panel 2|Adverse Event|0|||
48681873|NCT00543387|156684299|FG007|Panel 1 + Panel 2|Adverse Event|1|||
48681874|NCT00543387|156684300|FG008|Panel 1 + Panel 2|Adverse Event|1|||
48681875|NCT00543387|156684301|FG009|Panel 1 + Panel 2|Adverse Event|0|||
48681876|NCT00543387|156684302|FG010|Panel 1 + Panel 2|Adverse Event|0|||
48762900|NCT00851799|156980378|FG001|Overall Study|Completed protocol due to pregnancy|0|||
49021018|NCT03125200|157912791|FG001|Overall Study|Consent Withdrawn by Subject|1|||
49021019|NCT03125200|157912792|FG002|Overall Study|Consent Withdrawn by Subject|0|||
48681877|NCT00543387|156684292|FG000|Panel 1 + Panel 2|Physician Decision|0|||
48681878|NCT00543387|156684293|FG001|Panel 1 + Panel 2|Physician Decision|0|||
48681879|NCT00543387|156684294|FG002|Panel 1 + Panel 2|Physician Decision|1|||
48681880|NCT00543387|156684295|FG003|Panel 1 + Panel 2|Physician Decision|0|||
48681881|NCT00543387|156684296|FG004|Panel 1 + Panel 2|Physician Decision|0|||
48681882|NCT00543387|156684297|FG005|Panel 1 + Panel 2|Physician Decision|0|||
48681883|NCT00543387|156684298|FG006|Panel 1 + Panel 2|Physician Decision|0|||
48681884|NCT00543387|156684299|FG007|Panel 1 + Panel 2|Physician Decision|1|||
48681885|NCT00543387|156684300|FG008|Panel 1 + Panel 2|Physician Decision|0|||
48681886|NCT00543387|156684301|FG009|Panel 1 + Panel 2|Physician Decision|0|||
48681887|NCT00543387|156684302|FG010|Panel 1 + Panel 2|Physician Decision|0|||
48681888|NCT00543387|156684292|FG000|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
48681889|NCT00543387|156684293|FG001|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
48681890|NCT00543387|156684294|FG002|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
48681891|NCT00543387|156684295|FG003|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
48681892|NCT00543387|156684296|FG004|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
48681893|NCT00543387|156684297|FG005|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
48681894|NCT00543387|156684298|FG006|Panel 1 + Panel 2|Progressive Disease (PD)|5|||
48681895|NCT00543387|156684299|FG007|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
48681896|NCT00543387|156684300|FG008|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
48681897|NCT00543387|156684301|FG009|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
48681898|NCT00543387|156684302|FG010|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
48681899|NCT00543387|156684292|FG000|Panel 1 + Panel 2|Withdrawal by Subject|0|||
48681900|NCT00543387|156684293|FG001|Panel 1 + Panel 2|Withdrawal by Subject|0|||
48681901|NCT00543387|156684294|FG002|Panel 1 + Panel 2|Withdrawal by Subject|0|||
48681902|NCT00543387|156684295|FG003|Panel 1 + Panel 2|Withdrawal by Subject|0|||
48681903|NCT00543387|156684296|FG004|Panel 1 + Panel 2|Withdrawal by Subject|0|||
48681904|NCT00543387|156684297|FG005|Panel 1 + Panel 2|Withdrawal by Subject|0|||
48681905|NCT00543387|156684298|FG006|Panel 1 + Panel 2|Withdrawal by Subject|1|||
48681906|NCT00543387|156684299|FG007|Panel 1 + Panel 2|Withdrawal by Subject|0|||
48681907|NCT00543387|156684300|FG008|Panel 1 + Panel 2|Withdrawal by Subject|0|||
48681908|NCT00543387|156684301|FG009|Panel 1 + Panel 2|Withdrawal by Subject|0|||
48681909|NCT00543387|156684302|FG010|Panel 1 + Panel 2|Withdrawal by Subject|0|||
48681910|NCT00543387|156684292|FG000|Crossover Participants|Progressive Disease|0|||
48681911|NCT00543387|156684293|FG001|Crossover Participants|Progressive Disease|0|||
48681912|NCT00543387|156684294|FG002|Crossover Participants|Progressive Disease|0|||
48681913|NCT00543387|156684295|FG003|Crossover Participants|Progressive Disease|0|||
48681914|NCT00543387|156684296|FG004|Crossover Participants|Progressive Disease|0|||
48681915|NCT00543387|156684297|FG005|Crossover Participants|Progressive Disease|0|||
48681916|NCT00543387|156684298|FG006|Crossover Participants|Progressive Disease|0|||
48681917|NCT00543387|156684299|FG007|Crossover Participants|Progressive Disease|0|||
48681918|NCT00543387|156684300|FG008|Crossover Participants|Progressive Disease|0|||
48681919|NCT00543387|156684301|FG009|Crossover Participants|Progressive Disease|1|||
48681920|NCT00543387|156684302|FG010|Crossover Participants|Progressive Disease|2|||
48681921|NCT00543387|156684292|FG000|Crossover Participants|Study Terminated by Sponsor|0|||
48681922|NCT00543387|156684293|FG001|Crossover Participants|Study Terminated by Sponsor|0|||
48681923|NCT00543387|156684294|FG002|Crossover Participants|Study Terminated by Sponsor|0|||
48681924|NCT00543387|156684295|FG003|Crossover Participants|Study Terminated by Sponsor|0|||
48681925|NCT00543387|156684296|FG004|Crossover Participants|Study Terminated by Sponsor|0|||
48681926|NCT00543387|156684297|FG005|Crossover Participants|Study Terminated by Sponsor|0|||
48681927|NCT00543387|156684298|FG006|Crossover Participants|Study Terminated by Sponsor|0|||
48681928|NCT00543387|156684299|FG007|Crossover Participants|Study Terminated by Sponsor|0|||
48681929|NCT00543387|156684300|FG008|Crossover Participants|Study Terminated by Sponsor|0|||
48681930|NCT00543387|156684301|FG009|Crossover Participants|Study Terminated by Sponsor|0|||
48681931|NCT00543387|156684302|FG010|Crossover Participants|Study Terminated by Sponsor|1|||
48681932|NCT00549445|156684303|FG000|Overall Study|Sputum & Blood Samples Not Available|15|||
48681933|NCT00549445|156684304|FG001|Overall Study|Sputum & Blood Samples Not Available|17|||
48681934|NCT04178720|156684305|FG000|Overall Study|Withdrawal by Subject|2|||
48681935|NCT04178720|156684306|FG001|Overall Study|Withdrawal by Subject|0|||
48681936|NCT04178720|156684305|FG000|Overall Study|Relocation|0|||
48681937|NCT04178720|156684306|FG001|Overall Study|Relocation|1|||
48681938|NCT03566082|156684307|FG000|Overall Study|Death|7|||
48681939|NCT03566082|156684307|FG000|Overall Study|Failures (revision required)|2|||
48681940|NCT03566082|156684307|FG000|Overall Study|Lost to Follow-up|8|||
48681941|NCT02100475|156686168|FG000|Overall Study|Unclassified|1|||
48681942|NCT02100475|156686169|FG001|Overall Study|Unclassified|2|||
48681943|NCT02100475|156686168|FG000|Overall Study|Withdrawal criteria|1|||
48681944|NCT02100475|156686169|FG001|Overall Study|Withdrawal criteria|0|||
48681945|NCT02475278|156686177|FG000|Overall Study|Lost to Follow-up|1|||
48681946|NCT02475278|156686177|FG000|Overall Study|Reason Not Specified|1|||
48762901|NCT00851799|156980379|FG002|Overall Study|Completed protocol due to pregnancy|1|||
48681947|NCT03831100|156686181|FG000|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|6|||
49021020|NCT03125200|157912793|FG003|Overall Study|Consent Withdrawn by Subject|0|||
49021021|NCT03125200|157912794|FG004|Overall Study|Consent Withdrawn by Subject|1|||
49021022|NCT03125200|157912795|FG005|Overall Study|Consent Withdrawn by Subject|0|||
49021023|NCT03125200|157912796|FG006|Overall Study|Consent Withdrawn by Subject|1|||
49021024|NCT01937390|157912799|FG000|Overall Study|Death|2|||
49021025|NCT01937390|157912799|FG000|Overall Study|Lost to Follow-up|7|||
49021026|NCT01937390|157912799|FG000|Overall Study|Withdrawal by Subject|5|||
49021027|NCT01937390|157912799|FG000|Overall Study|Fail to return|21|||
49021028|NCT00922779|157912803|FG000|Overall Study|Adverse Event|67|||
49021029|NCT00922779|157912803|FG000|Overall Study|Pregnancy|7|||
49021030|NCT00922779|157912803|FG000|Overall Study|Withdrawal by Subject|308|||
49021031|NCT00922779|157912803|FG000|Overall Study|Lost to Follow-up|44|||
49021032|NCT00922779|157912803|FG000|Overall Study|Other|27|||
49021033|NCT00922779|157912803|FG000|Overall Study|Missing|1874|||
49021034|NCT03544138|157912804|FG000|Overall Study|Lost to Follow-up|29|||
49021035|NCT03144687|157912805|FG000|Overall Study|Death|0|||
49021036|NCT03144687|157912806|FG001|Overall Study|Death|2|||
49021037|NCT03144687|157912805|FG000|Overall Study|Lost to Follow-up|0|||
49021038|NCT03144687|157912806|FG001|Overall Study|Lost to Follow-up|1|||
49021039|NCT03144687|157912805|FG000|Overall Study|Physician Decision|0|||
49021040|NCT03144687|157912806|FG001|Overall Study|Physician Decision|1|||
49021041|NCT03144687|157912805|FG000|Overall Study|Withdrawal by Subject|1|||
49021042|NCT03144687|157912806|FG001|Overall Study|Withdrawal by Subject|3|||
49021043|NCT03144687|157912805|FG000|Overall Study|Not Reported|2|||
49021044|NCT03144687|157912806|FG001|Overall Study|Not Reported|0|||
49021045|NCT04529109|157912807|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
49021046|NCT04529109|157912808|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
49021047|NCT03708211|157912809|FG000|Overall Study|Progressive Disease|10|||
49021048|NCT03708211|157912810|FG001|Overall Study|Progressive Disease|7|||
49021049|NCT03708211|157912809|FG000|Overall Study|Withdrawal by Subject|0|||
49021050|NCT03708211|157912810|FG001|Overall Study|Withdrawal by Subject|1|||
49021051|NCT03708211|157912809|FG000|Overall Study|Other|2|||
49021052|NCT03708211|157912810|FG001|Overall Study|Other|0|||
49021053|NCT00368277|157914307|FG000|Overall Study|Adverse Event|33|||
49021054|NCT00368277|157914308|FG001|Overall Study|Adverse Event|49|||
49021055|NCT00368277|157914307|FG000|Overall Study|Death|2|||
49021056|NCT00368277|157914308|FG001|Overall Study|Death|1|||
49021057|NCT00368277|157914307|FG000|Overall Study|Unsatisfactory therapeutic effect|31|||
49021058|NCT00368277|157914308|FG001|Overall Study|Unsatisfactory therapeutic effect|24|||
49021059|NCT00368277|157914307|FG000|Overall Study|Protocol deviation|7|||
49021060|NCT00368277|157914308|FG001|Overall Study|Protocol deviation|0|||
49021061|NCT00368277|157914307|FG000|Overall Study|Patient withdrew consent|32|||
49021062|NCT00368277|157914308|FG001|Overall Study|Patient withdrew consent|28|||
49021063|NCT00368277|157914307|FG000|Overall Study|Lost to Follow-up|8|||
49021064|NCT00368277|157914308|FG001|Overall Study|Lost to Follow-up|6|||
48681948|NCT03831100|156686182|FG001|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|4|||
48681949|NCT00826618|156686183|FG000|Overall Study|Withdrawal by Subject|1|||
48681950|NCT03495102|156686185|FG000|Overall Study|Adverse Event|5|||
48681951|NCT03495102|156686186|FG001|Overall Study|Adverse Event|7|||
48981014|NCT03864627|157762260|FG001|Overall Study|Lost to Follow-up|1|||
48981015|NCT03864627|157762259|FG000|Overall Study|Withdrawal by Subject|4|||
48981016|NCT03864627|157762260|FG001|Overall Study|Withdrawal by Subject|8|||
48981017|NCT03864627|157762259|FG000|Overall Study|Study terminated by sponsor|0|||
48981018|NCT03864627|157762260|FG001|Overall Study|Study terminated by sponsor|1|||
48981019|NCT01388491|157762265|FG000|Overall Study|Adverse Event|10|||
48981020|NCT01388491|157762266|FG001|Overall Study|Adverse Event|9|||
48981021|NCT01388491|157762265|FG000|Overall Study|Sponsor Request|9|||
48981022|NCT01388491|157762266|FG001|Overall Study|Sponsor Request|7|||
48981023|NCT01388491|157762265|FG000|Overall Study|Withdrawal by Subject|6|||
48981024|NCT01388491|157762266|FG001|Overall Study|Withdrawal by Subject|10|||
48981025|NCT01388491|157762265|FG000|Overall Study|Lost to Follow-up|4|||
48981026|NCT01388491|157762266|FG001|Overall Study|Lost to Follow-up|3|||
48981027|NCT01388491|157762265|FG000|Overall Study|Protocol Violation|2|||
48981028|NCT01388491|157762266|FG001|Overall Study|Protocol Violation|0|||
48981029|NCT01388491|157762265|FG000|Overall Study|Noncompliance|2|||
48981030|NCT01388491|157762266|FG001|Overall Study|Noncompliance|0|||
48981031|NCT01388491|157762265|FG000|Overall Study|Pregnancy|1|||
48981032|NCT01388491|157762266|FG001|Overall Study|Pregnancy|0|||
49021065|NCT01132118|157914309|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
49021066|NCT01132118|157914310|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
49021067|NCT01132118|157914309|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
49021068|NCT01132118|157914310|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|3|||
48981033|NCT04035473|157762268|FG000|Screening/Baseline|Death|0|||
48981034|NCT04035473|157762269|FG001|Screening/Baseline|Death|1|||
48981035|NCT04035473|157762268|FG000|Screening/Baseline|Adverse Event|0|||
49021069|NCT01132118|157914309|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
49021070|NCT01132118|157914310|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
48981036|NCT04035473|157762269|FG001|Screening/Baseline|Adverse Event|1|||
48681952|NCT03495102|156686187|FG002|Overall Study|Adverse Event|10|||
48681953|NCT03495102|156686185|FG000|Overall Study|Death|3|||
48681954|NCT03495102|156686186|FG001|Overall Study|Death|4|||
48681955|NCT03495102|156686187|FG002|Overall Study|Death|4|||
48681956|NCT03495102|156686185|FG000|Overall Study|Lost to Follow-up|15|||
48681957|NCT03495102|156686186|FG001|Overall Study|Lost to Follow-up|16|||
48681958|NCT03495102|156686187|FG002|Overall Study|Lost to Follow-up|17|||
48681959|NCT03495102|156686185|FG000|Overall Study|Physician Decision|2|||
48681960|NCT03495102|156686186|FG001|Overall Study|Physician Decision|0|||
48681961|NCT03495102|156686187|FG002|Overall Study|Physician Decision|2|||
48681962|NCT03495102|156686185|FG000|Overall Study|Withdrawal by Subject|25|||
48681963|NCT03495102|156686186|FG001|Overall Study|Withdrawal by Subject|36|||
48681964|NCT03495102|156686187|FG002|Overall Study|Withdrawal by Subject|18|||
48681965|NCT03495102|156686185|FG000|Overall Study|Protocol Violation|1|||
48681966|NCT03495102|156686186|FG001|Overall Study|Protocol Violation|1|||
48681967|NCT03495102|156686187|FG002|Overall Study|Protocol Violation|0|||
48681968|NCT03495102|156686185|FG000|Overall Study|Site Closure|3|||
48681969|NCT03495102|156686186|FG001|Overall Study|Site Closure|1|||
48681970|NCT03495102|156686187|FG002|Overall Study|Site Closure|2|||
48681971|NCT03495102|156686185|FG000|Overall Study|Non-compliance|1|||
48681972|NCT03495102|156686186|FG001|Overall Study|Non-compliance|0|||
48681973|NCT03495102|156686187|FG002|Overall Study|Non-compliance|0|||
48681974|NCT03495102|156686185|FG000|Overall Study|Participant Duplicated at Another Site|0|||
48681975|NCT03495102|156686186|FG001|Overall Study|Participant Duplicated at Another Site|0|||
48681976|NCT03495102|156686187|FG002|Overall Study|Participant Duplicated at Another Site|1|||
48681977|NCT03495102|156686185|FG000|Overall Study|Primary Care Physician Recommendation|0|||
48681978|NCT03495102|156686186|FG001|Overall Study|Primary Care Physician Recommendation|1|||
48681979|NCT03495102|156686187|FG002|Overall Study|Primary Care Physician Recommendation|0|||
48681980|NCT03495102|156686185|FG000|Overall Study|Relocated to Another Country|0|||
48681981|NCT03495102|156686186|FG001|Overall Study|Relocated to Another Country|1|||
48681982|NCT03495102|156686187|FG002|Overall Study|Relocated to Another Country|0|||
48681983|NCT03495102|156686185|FG000|Overall Study|Participant was in Rehabilitation|1|||
48681984|NCT03495102|156686186|FG001|Overall Study|Participant was in Rehabilitation|0|||
48681985|NCT03495102|156686187|FG002|Overall Study|Participant was in Rehabilitation|0|||
48681986|NCT00742417|156686195|FG000|Randomized|Withdrawal by legal representative|0|||
48681987|NCT00742417|156686196|FG001|Randomized|Withdrawal by legal representative|1|||
48681988|NCT00742417|156686195|FG000|Randomized|Withdrawal by Subject|1|||
48681989|NCT00742417|156686196|FG001|Randomized|Withdrawal by Subject|0|||
48681990|NCT00742417|156686195|FG000|Randomized|Physician Decision|1|||
48681991|NCT00742417|156686196|FG001|Randomized|Physician Decision|0|||
48681992|NCT00742417|156686195|FG000|Intensive Period|Withdrawal by Subject|1|||
48681993|NCT00742417|156686196|FG001|Intensive Period|Withdrawal by Subject|1|||
48681994|NCT00742417|156686195|FG000|Intensive Period|Adverse Event|2|||
48681995|NCT00742417|156686196|FG001|Intensive Period|Adverse Event|0|||
48681996|NCT01946152|156686197|FG000|Overall Study|Adverse Event|1|||
48681997|NCT01946152|156686198|FG001|Overall Study|Adverse Event|0|||
48681998|NCT01946152|156686199|FG002|Overall Study|Adverse Event|0|||
48681999|NCT01946152|156686200|FG003|Overall Study|Adverse Event|0|||
48682000|NCT01946152|156686197|FG000|Overall Study|Withdrawal by Subject|0|||
48682001|NCT01946152|156686198|FG001|Overall Study|Withdrawal by Subject|2|||
48682002|NCT01946152|156686199|FG002|Overall Study|Withdrawal by Subject|0|||
48682003|NCT01946152|156686200|FG003|Overall Study|Withdrawal by Subject|0|||
48682004|NCT01946152|156686197|FG000|Overall Study|Progression|0|||
48682005|NCT01946152|156686198|FG001|Overall Study|Progression|1|||
48682006|NCT01946152|156686199|FG002|Overall Study|Progression|4|||
48682007|NCT01946152|156686200|FG003|Overall Study|Progression|7|||
48682008|NCT01946152|156686197|FG000|Overall Study|Physician Decision|0|||
48682009|NCT01946152|156686198|FG001|Overall Study|Physician Decision|0|||
48682010|NCT01946152|156686199|FG002|Overall Study|Physician Decision|1|||
48682011|NCT01946152|156686200|FG003|Overall Study|Physician Decision|0|||
48682012|NCT01946152|156686197|FG000|Overall Study|Second malignancy|0|||
48682013|NCT01946152|156686198|FG001|Overall Study|Second malignancy|0|||
48682014|NCT01946152|156686199|FG002|Overall Study|Second malignancy|1|||
48682015|NCT01946152|156686200|FG003|Overall Study|Second malignancy|0|||
48682016|NCT01946152|156686197|FG000|Overall Study|Adverse Event|0|||
48682017|NCT01946152|156686198|FG001|Overall Study|Adverse Event|0|||
48682018|NCT01946152|156686199|FG002|Overall Study|Adverse Event|0|||
48682019|NCT01946152|156686200|FG003|Overall Study|Adverse Event|1|||
48682020|NCT01865448|156686201|FG000|Overall Study|Adverse Event|1|||
48682021|NCT01865448|156686202|FG001|Overall Study|Adverse Event|1|||
48682022|NCT01865448|156686201|FG000|Overall Study|Pregnancy|0|||
48682023|NCT01865448|156686202|FG001|Overall Study|Pregnancy|1|||
48682024|NCT01865448|156686201|FG000|Overall Study|dropout unrelated to study|1|||
48682025|NCT01865448|156686202|FG001|Overall Study|dropout unrelated to study|1|||
48682026|NCT02454478|156686205|FG000|Overall Study|Incomplete DLT Evaluation|1|||
48682027|NCT05128578|156686213|FG000|Overall Study|Withdrawal by Subject|9|||
48682028|NCT05128578|156686213|FG000|Overall Study|Lost to Follow-up|5|||
48682029|NCT01959841|156686214|FG000|Overall Study|Adverse Event|1|||
48682030|NCT01959841|156686215|FG001|Overall Study|Adverse Event|3|||
48682031|NCT01959841|156686216|FG002|Overall Study|Adverse Event|2|||
48682032|NCT01959841|156686214|FG000|Overall Study|Lack of Efficacy|5|||
48682033|NCT01959841|156686215|FG001|Overall Study|Lack of Efficacy|0|||
48682034|NCT01959841|156686216|FG002|Overall Study|Lack of Efficacy|0|||
48682035|NCT01959841|156686214|FG000|Overall Study|Lost to Follow-up|1|||
48682036|NCT01959841|156686215|FG001|Overall Study|Lost to Follow-up|1|||
48682037|NCT01959841|156686216|FG002|Overall Study|Lost to Follow-up|0|||
48682038|NCT01959841|156686214|FG000|Overall Study|Physician Decision|0|||
48682039|NCT01959841|156686215|FG001|Overall Study|Physician Decision|2|||
48682040|NCT01959841|156686216|FG002|Overall Study|Physician Decision|3|||
48682041|NCT01959841|156686214|FG000|Overall Study|Protocol Violation|16|||
48682042|NCT01959841|156686215|FG001|Overall Study|Protocol Violation|23|||
48682043|NCT01959841|156686216|FG002|Overall Study|Protocol Violation|16|||
48682044|NCT01959841|156686214|FG000|Overall Study|Withdrawal by Subject|7|||
48682045|NCT01959841|156686215|FG001|Overall Study|Withdrawal by Subject|7|||
48682046|NCT01959841|156686216|FG002|Overall Study|Withdrawal by Subject|5|||
48682047|NCT01959841|156686214|FG000|Overall Study|Clinical laboratory value|2|||
48682048|NCT01959841|156686215|FG001|Overall Study|Clinical laboratory value|6|||
48682049|NCT01959841|156686216|FG002|Overall Study|Clinical laboratory value|6|||
48682050|NCT01959841|156686214|FG000|Overall Study|Platelet count below on day1 or 4|11|||
48682051|NCT01959841|156686215|FG001|Overall Study|Platelet count below on day1 or 4|15|||
48682052|NCT01959841|156686216|FG002|Overall Study|Platelet count below on day1 or 4|11|||
48682053|NCT00871338|156686218|FG000|Prior to Booster|Withdrawal by Subject|1|||
48682054|NCT00871338|156686219|FG001|Prior to Booster|Withdrawal by Subject|3|||
48682055|NCT00871338|156686218|FG000|Prior to Booster|Lost to Follow-up|1|||
48682056|NCT00871338|156686219|FG001|Prior to Booster|Lost to Follow-up|0|||
48682057|NCT02391363|156686220|FG000|Overall Study|Lost to Follow-up|5|||
48682058|NCT02391363|156686221|FG001|Overall Study|Lost to Follow-up|5|||
48682059|NCT02391363|156686220|FG000|Overall Study|Withdrawal by Subject|6|||
48682060|NCT02391363|156686221|FG001|Overall Study|Withdrawal by Subject|3|||
48682061|NCT00265317|156686223|FG000|Lead-In|Objective progression or relapse|6|||
48682062|NCT00265317|156686224|FG001|Lead-In|Objective progression or relapse|11|||
48682063|NCT00265317|156686225|FG002|Lead-In|Objective progression or relapse|0|||
48682064|NCT00265317|156686226|FG003|Lead-In|Objective progression or relapse|0|||
48682065|NCT00265317|156686223|FG000|Lead-In|Adverse Event|2|||
48682066|NCT00265317|156686224|FG001|Lead-In|Adverse Event|1|||
48682067|NCT00265317|156686225|FG002|Lead-In|Adverse Event|0|||
48682068|NCT00265317|156686226|FG003|Lead-In|Adverse Event|0|||
48682069|NCT00265317|156686223|FG000|Lead-In|Death|3|||
48682070|NCT00265317|156686224|FG001|Lead-In|Death|5|||
48682071|NCT00265317|156686225|FG002|Lead-In|Death|0|||
48682072|NCT00265317|156686226|FG003|Lead-In|Death|0|||
48682073|NCT00265317|156686223|FG000|Lead-In|Withdrawal/other than adverse event|1|||
48682074|NCT00265317|156686224|FG001|Lead-In|Withdrawal/other than adverse event|0|||
48682075|NCT00265317|156686225|FG002|Lead-In|Withdrawal/other than adverse event|0|||
48682076|NCT00265317|156686226|FG003|Lead-In|Withdrawal/other than adverse event|0|||
48682077|NCT00265317|156686223|FG000|Phase 2|Objective progression or relapse|0|||
48682078|NCT00265317|156686224|FG001|Phase 2|Objective progression or relapse|0|||
48682079|NCT00265317|156686225|FG002|Phase 2|Objective progression or relapse|37|||
48682080|NCT00265317|156686226|FG003|Phase 2|Objective progression or relapse|38|||
48682081|NCT00265317|156686223|FG000|Phase 2|Global deterioration of health status|0|||
48682082|NCT00265317|156686224|FG001|Phase 2|Global deterioration of health status|0|||
48682083|NCT00265317|156686225|FG002|Phase 2|Global deterioration of health status|3|||
48682084|NCT00265317|156686226|FG003|Phase 2|Global deterioration of health status|0|||
48682085|NCT00265317|156686223|FG000|Phase 2|Adverse Event|0|||
48682086|NCT00265317|156686224|FG001|Phase 2|Adverse Event|0|||
48682087|NCT00265317|156686225|FG002|Phase 2|Adverse Event|7|||
48682088|NCT00265317|156686226|FG003|Phase 2|Adverse Event|5|||
48682089|NCT00265317|156686223|FG000|Phase 2|Death|0|||
48682090|NCT00265317|156686224|FG001|Phase 2|Death|0|||
48682091|NCT00265317|156686225|FG002|Phase 2|Death|12|||
48682092|NCT00265317|156686226|FG003|Phase 2|Death|15|||
48682093|NCT00265317|156686223|FG000|Phase 2|Protocol Violation|0|||
48682094|NCT00265317|156686224|FG001|Phase 2|Protocol Violation|0|||
48682095|NCT00265317|156686225|FG002|Phase 2|Protocol Violation|1|||
48682096|NCT00265317|156686226|FG003|Phase 2|Protocol Violation|4|||
48682097|NCT00265317|156686223|FG000|Phase 2|Lost to Follow-up|0|||
48682098|NCT00265317|156686224|FG001|Phase 2|Lost to Follow-up|0|||
48682099|NCT00265317|156686225|FG002|Phase 2|Lost to Follow-up|0|||
48682100|NCT00265317|156686226|FG003|Phase 2|Lost to Follow-up|1|||
48682101|NCT00265317|156686223|FG000|Phase 2|Withdrawal/other than adverse event|0|||
48682102|NCT00265317|156686224|FG001|Phase 2|Withdrawal/other than adverse event|0|||
48682103|NCT00265317|156686225|FG002|Phase 2|Withdrawal/other than adverse event|2|||
48682104|NCT00265317|156686226|FG003|Phase 2|Withdrawal/other than adverse event|1|||
48682105|NCT00265317|156686223|FG000|Phase 2|Study terminated by sponsor|0|||
48682106|NCT00265317|156686224|FG001|Phase 2|Study terminated by sponsor|0|||
48682107|NCT00265317|156686225|FG002|Phase 2|Study terminated by sponsor|1|||
48682108|NCT00265317|156686226|FG003|Phase 2|Study terminated by sponsor|0|||
48682109|NCT00265317|156686223|FG000|Phase 2|Other|0|||
48682110|NCT00265317|156686224|FG001|Phase 2|Other|0|||
48682111|NCT00265317|156686225|FG002|Phase 2|Other|1|||
48682112|NCT00265317|156686226|FG003|Phase 2|Other|1|||
48682113|NCT00801229|156686227|FG000|Signed Consent|Withdrawal by Subject|2|||
48682114|NCT00801229|156686228|FG001|Signed Consent|Withdrawal by Subject|2|||
48682115|NCT00801229|156686227|FG000|Signed Consent|Found Ineligible|1|||
48682116|NCT00801229|156686228|FG001|Signed Consent|Found Ineligible|1|||
48682117|NCT00801229|156686227|FG000|Received Study Drug/Placebo|Elevated SGOT level|1|||
48682118|NCT00801229|156686228|FG001|Received Study Drug/Placebo|Elevated SGOT level|0|||
48682119|NCT00801229|156686227|FG000|Received Study Drug/Placebo|Sub-threshold ADHD|0|||
48682120|NCT00801229|156686228|FG001|Received Study Drug/Placebo|Sub-threshold ADHD|1|||
48682121|NCT00801229|156686227|FG000|Received Study Drug/Placebo|Simulator sickness|1|||
48682122|NCT00801229|156686228|FG001|Received Study Drug/Placebo|Simulator sickness|1|||
48682123|NCT00801229|156686227|FG000|Received Study Drug/Placebo|Withdrawal by Subject|1|||
48682124|NCT00801229|156686228|FG001|Received Study Drug/Placebo|Withdrawal by Subject|0|||
48682125|NCT00801229|156686227|FG000|Received Study Drug/Placebo|Lost to Follow-up|0|||
48682126|NCT00801229|156686228|FG001|Received Study Drug/Placebo|Lost to Follow-up|1|||
48682127|NCT00801229|156686227|FG000|Received Study Drug/Placebo|Adverse Event|1|||
48682128|NCT00801229|156686228|FG001|Received Study Drug/Placebo|Adverse Event|1|||
48682129|NCT01959139|156686236|FG000|Phase II|Disease progression|0|||
48682130|NCT01959139|156686237|FG001|Phase II|Disease progression|0|||
48682131|NCT01959139|156686238|FG002|Phase II|Disease progression|26|||
48682132|NCT01959139|156686239|FG003|Phase II|Disease progression|34|||
48682133|NCT01959139|156686236|FG000|Phase II|Adverse Event|0|||
48682134|NCT01959139|156686237|FG001|Phase II|Adverse Event|0|||
48682135|NCT01959139|156686238|FG002|Phase II|Adverse Event|10|||
48682136|NCT01959139|156686239|FG003|Phase II|Adverse Event|11|||
48682137|NCT01959139|156686236|FG000|Phase II|Patient Refusal|0|||
48682138|NCT01959139|156686237|FG001|Phase II|Patient Refusal|0|||
48682139|NCT01959139|156686238|FG002|Phase II|Patient Refusal|5|||
48682140|NCT01959139|156686239|FG003|Phase II|Patient Refusal|4|||
48682141|NCT01959139|156686236|FG000|Phase II|Death|0|||
48682142|NCT01959139|156686237|FG001|Phase II|Death|0|||
48682143|NCT01959139|156686238|FG002|Phase II|Death|3|||
48682144|NCT01959139|156686239|FG003|Phase II|Death|1|||
48682145|NCT01959139|156686236|FG000|Phase II|Other/Unknown|0|||
48682146|NCT01959139|156686237|FG001|Phase II|Other/Unknown|0|||
48682147|NCT01959139|156686238|FG002|Phase II|Other/Unknown|8|||
48682148|NCT01959139|156686239|FG003|Phase II|Other/Unknown|5|||
48682149|NCT01959139|156686236|FG000|Phase II|On treatment|0|||
48682150|NCT01959139|156686237|FG001|Phase II|On treatment|0|||
48682151|NCT01959139|156686238|FG002|Phase II|On treatment|4|||
48682152|NCT01959139|156686239|FG003|Phase II|On treatment|0|||
48682153|NCT03679624|156686240|FG000|Overall Study|Adverse Event|1|||
48682154|NCT03679624|156686241|FG001|Overall Study|Adverse Event|0|||
48682155|NCT01504412|156686244|FG000|Overall Study|Adverse Event|1|||
48682156|NCT01504412|156686245|FG001|Overall Study|Adverse Event|8|||
48682157|NCT01504412|156686246|FG002|Overall Study|Adverse Event|1|||
48682158|NCT01504412|156686247|FG003|Overall Study|Adverse Event|7|||
48682159|NCT01504412|156686248|FG004|Overall Study|Adverse Event|10|||
48682160|NCT01504412|156686244|FG000|Overall Study|Withdrawal by Subject|2|||
48682161|NCT01504412|156686245|FG001|Overall Study|Withdrawal by Subject|1|||
48981037|NCT04035473|157762268|FG000|Follow-up Period|Adverse Event|2|||
48981038|NCT04035473|157762269|FG001|Follow-up Period|Adverse Event|0|||
48981039|NCT00112840|157762273|FG000|Overall Study|Physician Decision|1|||
48981040|NCT00112840|157762274|FG001|Overall Study|Physician Decision|0|||
48981041|NCT00112840|157762275|FG002|Overall Study|Physician Decision|0|||
48981042|NCT00112840|157762273|FG000|Overall Study|Withdrawal by Subject|1|||
48981043|NCT00112840|157762274|FG001|Overall Study|Withdrawal by Subject|0|||
48981044|NCT00112840|157762275|FG002|Overall Study|Withdrawal by Subject|1|||
48981045|NCT00112840|157762273|FG000|Overall Study|Protocol Violation|0|||
48981046|NCT00112840|157762274|FG001|Overall Study|Protocol Violation|0|||
48981047|NCT00112840|157762275|FG002|Overall Study|Protocol Violation|5|||
48981048|NCT00636506|157762277|FG000|Overall Study|Lost to Follow-up|8|||
48981049|NCT00636506|157762277|FG000|Overall Study|Explanted|1|||
48981050|NCT00636506|157762277|FG000|Overall Study|Withdrawal by Subject|6|||
48981051|NCT00636506|157762277|FG000|Overall Study|Procedure aborted|1|||
48981052|NCT02299206|157762278|FG000|Overall Study|Lost to Follow-up|1|||
48981053|NCT02299206|157762278|FG000|Overall Study|Withdrawal by Subject|1|||
48981054|NCT02736474|157762279|FG000|Overall Study|Lost to Follow-up|0|||
48981055|NCT02736474|157762280|FG001|Overall Study|Lost to Follow-up|1|||
48981056|NCT02705755|157762283|FG000|Part A (6 Days)|Adverse Event|1|||
48981057|NCT02705755|157762284|FG001|Part A (6 Days)|Adverse Event|0|||
48682162|NCT01504412|156686246|FG002|Overall Study|Withdrawal by Subject|1|||
48682163|NCT01504412|156686247|FG003|Overall Study|Withdrawal by Subject|5|||
48682164|NCT01504412|156686248|FG004|Overall Study|Withdrawal by Subject|1|||
48682165|NCT01504412|156686244|FG000|Overall Study|Other|2|||
48682166|NCT01504412|156686245|FG001|Overall Study|Other|1|||
48682167|NCT01504412|156686246|FG002|Overall Study|Other|1|||
48981058|NCT02705755|157762285|FG002|Part A (6 Days)|Adverse Event|0|||
49021071|NCT01644890|157914311|FG000|Overall Study|Adverse Event|7|||
49021072|NCT01644890|157914312|FG001|Overall Study|Adverse Event|20|||
49021073|NCT01644890|157914311|FG000|Overall Study|Death|1|||
48682168|NCT01504412|156686247|FG003|Overall Study|Other|6|||
48682169|NCT01504412|156686248|FG004|Overall Study|Other|1|||
48682170|NCT01504412|156686244|FG000|Overall Study|Lost to Follow-up|0|||
48682171|NCT01504412|156686245|FG001|Overall Study|Lost to Follow-up|2|||
48682172|NCT01504412|156686246|FG002|Overall Study|Lost to Follow-up|0|||
48682173|NCT01504412|156686247|FG003|Overall Study|Lost to Follow-up|0|||
49021074|NCT01644890|157914312|FG001|Overall Study|Death|3|||
49021075|NCT01644890|157914311|FG000|Overall Study|Physician Decision|3|||
49021076|NCT01644890|157914312|FG001|Overall Study|Physician Decision|9|||
48682174|NCT01504412|156686248|FG004|Overall Study|Lost to Follow-up|0|||
48682175|NCT01504412|156686244|FG000|Overall Study|Lack of Efficacy|0|||
48682176|NCT01504412|156686245|FG001|Overall Study|Lack of Efficacy|0|||
48682177|NCT01504412|156686246|FG002|Overall Study|Lack of Efficacy|1|||
48682178|NCT01504412|156686247|FG003|Overall Study|Lack of Efficacy|0|||
48682179|NCT01504412|156686248|FG004|Overall Study|Lack of Efficacy|1|||
48682180|NCT01504412|156686244|FG000|Overall Study|Death|0|||
48682181|NCT01504412|156686245|FG001|Overall Study|Death|0|||
48682182|NCT01504412|156686246|FG002|Overall Study|Death|0|||
48682183|NCT01504412|156686247|FG003|Overall Study|Death|1|||
48682184|NCT01504412|156686248|FG004|Overall Study|Death|0|||
48682185|NCT03350815|156686255|FG000|Period 1|Adverse Event|10|||
48682186|NCT03350815|156686256|FG001|Period 1|Adverse Event|0|||
48682187|NCT03350815|156686257|FG002|Period 1|Adverse Event|0|||
48682188|NCT03350815|156686258|FG003|Period 1|Adverse Event|0|||
48682189|NCT03350815|156686255|FG000|Period 1|Technical problems|1|||
48682190|NCT03350815|156686256|FG001|Period 1|Technical problems|0|||
48682191|NCT03350815|156686257|FG002|Period 1|Technical problems|0|||
48682192|NCT03350815|156686258|FG003|Period 1|Technical problems|0|||
48682193|NCT03350815|156686255|FG000|Period 1|Lost to Follow-up|3|||
48682194|NCT03350815|156686256|FG001|Period 1|Lost to Follow-up|0|||
48682195|NCT03350815|156686257|FG002|Period 1|Lost to Follow-up|0|||
48682196|NCT03350815|156686258|FG003|Period 1|Lost to Follow-up|0|||
48682197|NCT03350815|156686255|FG000|Period 1|Physician Decision|1|||
48682198|NCT03350815|156686256|FG001|Period 1|Physician Decision|0|||
48682199|NCT03350815|156686257|FG002|Period 1|Physician Decision|0|||
48682200|NCT03350815|156686258|FG003|Period 1|Physician Decision|0|||
48682201|NCT03350815|156686255|FG000|Period 1|Withdrawal by Subject|8|||
48682202|NCT03350815|156686256|FG001|Period 1|Withdrawal by Subject|0|||
48682203|NCT03350815|156686257|FG002|Period 1|Withdrawal by Subject|0|||
48682204|NCT03350815|156686258|FG003|Period 1|Withdrawal by Subject|0|||
48682205|NCT03350815|156686255|FG000|Period 1|Lack of Efficacy|15|||
48682206|NCT03350815|156686256|FG001|Period 1|Lack of Efficacy|0|||
48682207|NCT03350815|156686257|FG002|Period 1|Lack of Efficacy|0|||
48682208|NCT03350815|156686258|FG003|Period 1|Lack of Efficacy|0|||
48682209|NCT03350815|156686255|FG000|Period 1|Non-compliance with study treatment|2|||
48682210|NCT03350815|156686256|FG001|Period 1|Non-compliance with study treatment|0|||
48682211|NCT03350815|156686257|FG002|Period 1|Non-compliance with study treatment|0|||
48682212|NCT03350815|156686258|FG003|Period 1|Non-compliance with study treatment|0|||
48682213|NCT03350815|156686255|FG000|Period 1|Protocol Violation|3|||
48682214|NCT03350815|156686256|FG001|Period 1|Protocol Violation|0|||
48682215|NCT03350815|156686257|FG002|Period 1|Protocol Violation|0|||
48682216|NCT03350815|156686258|FG003|Period 1|Protocol Violation|0|||
48682217|NCT03350815|156686255|FG000|Period 2|Adverse Event|0|||
48682218|NCT03350815|156686256|FG001|Period 2|Adverse Event|3|||
48682219|NCT03350815|156686257|FG002|Period 2|Adverse Event|5|||
48682220|NCT03350815|156686258|FG003|Period 2|Adverse Event|0|||
48682221|NCT03350815|156686255|FG000|Period 2|Technical problem|0|||
48682222|NCT03350815|156686256|FG001|Period 2|Technical problem|1|||
48682223|NCT03350815|156686257|FG002|Period 2|Technical problem|0|||
48682224|NCT03350815|156686258|FG003|Period 2|Technical problem|0|||
48682225|NCT03350815|156686255|FG000|Period 2|Lost to Follow-up|0|||
48682226|NCT03350815|156686256|FG001|Period 2|Lost to Follow-up|3|||
48682227|NCT03350815|156686257|FG002|Period 2|Lost to Follow-up|3|||
48682228|NCT03350815|156686258|FG003|Period 2|Lost to Follow-up|0|||
48682229|NCT03350815|156686255|FG000|Period 2|Physician Decision|0|||
48682230|NCT03350815|156686256|FG001|Period 2|Physician Decision|0|||
48682231|NCT03350815|156686257|FG002|Period 2|Physician Decision|1|||
48682232|NCT03350815|156686258|FG003|Period 2|Physician Decision|0|||
48682233|NCT03350815|156686255|FG000|Period 2|Withdrawal by Subject|0|||
48682234|NCT03350815|156686256|FG001|Period 2|Withdrawal by Subject|3|||
48682235|NCT03350815|156686257|FG002|Period 2|Withdrawal by Subject|4|||
48682236|NCT03350815|156686258|FG003|Period 2|Withdrawal by Subject|0|||
48682237|NCT03350815|156686255|FG000|Period 2|Lack of Efficacy|0|||
48682238|NCT03350815|156686256|FG001|Period 2|Lack of Efficacy|6|||
48682239|NCT03350815|156686257|FG002|Period 2|Lack of Efficacy|2|||
48682240|NCT03350815|156686258|FG003|Period 2|Lack of Efficacy|0|||
48682241|NCT03350815|156686255|FG000|Period 2|Protocol Violation|0|||
48682242|NCT03350815|156686256|FG001|Period 2|Protocol Violation|0|||
48682243|NCT03350815|156686257|FG002|Period 2|Protocol Violation|1|||
49021077|NCT01644890|157914311|FG000|Overall Study|Protocol Violation|6|||
49021078|NCT01644890|157914312|FG001|Overall Study|Protocol Violation|7|||
49021079|NCT01644890|157914311|FG000|Overall Study|Withdrawal by Subject|19|||
49021080|NCT01644890|157914312|FG001|Overall Study|Withdrawal by Subject|27|||
49021081|NCT01644890|157914311|FG000|Overall Study|Progression Disease|160|||
49021082|NCT01644890|157914312|FG001|Overall Study|Progression Disease|131|||
49021083|NCT01644890|157914311|FG000|Overall Study|Clinical Progression|6|||
49021084|NCT01644890|157914312|FG001|Overall Study|Clinical Progression|6|||
49021085|NCT01644890|157914311|FG000|Overall Study|> 28 days since last dose of study drug|6|||
49021086|NCT01644890|157914312|FG001|Overall Study|> 28 days since last dose of study drug|3|||
49021087|NCT01644890|157914311|FG000|Overall Study|Other|8|||
49021088|NCT01644890|157914312|FG001|Overall Study|Other|9|||
49021089|NCT02785913|157914313|FG000|Overall Study|Adverse Event|5|||
49021090|NCT02785913|157914313|FG000|Overall Study|Death|2|||
49021091|NCT02785913|157914313|FG000|Overall Study|Progression|18|||
49021092|NCT02785913|157914313|FG000|Overall Study|Not protocol specified|1|||
49021093|NCT01335477|157914314|FG000|Overall Study|Adverse Event|30|||
49021094|NCT01335477|157914315|FG001|Overall Study|Adverse Event|42|||
49021095|NCT01335477|157914314|FG000|Overall Study|Non compliant with protocol|0|||
49021096|NCT01335477|157914315|FG001|Overall Study|Non compliant with protocol|2|||
49021097|NCT01335477|157914314|FG000|Overall Study|Lost to Follow-up|1|||
49021098|NCT01335477|157914315|FG001|Overall Study|Lost to Follow-up|2|||
49021099|NCT01335477|157914314|FG000|Overall Study|Consent withdrawn, not due to AE|7|||
49021100|NCT01335477|157914315|FG001|Overall Study|Consent withdrawn, not due to AE|9|||
49021101|NCT01335477|157914314|FG000|Overall Study|Not treated|1|||
49021102|NCT01335477|157914315|FG001|Overall Study|Not treated|2|||
49021103|NCT01335477|157914314|FG000|Overall Study|Reason other than those stated above|2|||
49021104|NCT01335477|157914315|FG001|Overall Study|Reason other than those stated above|2|||
49021105|NCT01060670|157914321|FG000|Run In|screen failure|0|||
49021106|NCT01060670|157914322|FG001|Run In|screen failure|238|||
49021107|NCT02841709|157914323|FG000|5th Intervention|Adverse Event|2|||
49021108|NCT02841709|157914324|FG001|5th Intervention|Adverse Event|0|||
49021109|NCT02841709|157914325|FG002|5th Intervention|Adverse Event|0|||
49021110|NCT02841709|157914326|FG003|5th Intervention|Adverse Event|0|||
48682244|NCT03350815|156686258|FG003|Period 2|Protocol Violation|0|||
48682245|NCT03350815|156686255|FG000|Period 2|New therapy for study indication|0|||
48682246|NCT03350815|156686256|FG001|Period 2|New therapy for study indication|0|||
49021111|NCT02841709|157914327|FG004|5th Intervention|Adverse Event|2|||
49021112|NCT01929109|157914328|FG000|Period 1 (All Groups)|Deviation from protocol|0|||
49021113|NCT01929109|157914329|FG001|Period 1 (All Groups)|Deviation from protocol|0|||
49021114|NCT01929109|157914330|FG002|Period 1 (All Groups)|Deviation from protocol|1|||
49021115|NCT01929109|157914331|FG003|Period 1 (All Groups)|Deviation from protocol|0|||
48682247|NCT03350815|156686257|FG002|Period 2|New therapy for study indication|1|||
48682248|NCT03350815|156686258|FG003|Period 2|New therapy for study indication|0|||
48682249|NCT01964963|156686259|FG000|Overall Study|Case Report Forms Uncollected|888|||
48682250|NCT01964963|156686259|FG000|Overall Study|Protocol Deviation|50|||
48682251|NCT01964963|156686259|FG000|Overall Study|Data Reliability was not Assured|5|||
48682252|NCT00930553|156686260|FG000|Overall Study|Adverse Event|1|||
48682253|NCT00930553|156686260|FG000|Overall Study|Lack of Efficacy|7|||
48682254|NCT00930553|156686260|FG000|Overall Study|Physician Decision|39|||
48682255|NCT00930553|156686260|FG000|Overall Study|Protocol Violation|1|||
48682256|NCT00930553|156686260|FG000|Overall Study|Pregnancy|1|||
48682257|NCT00930553|156686260|FG000|Overall Study|Withdrawal by Subject|88|||
48682258|NCT00930553|156686260|FG000|Overall Study|Lost to Follow-up|25|||
48682259|NCT00930553|156686260|FG000|Overall Study|Death|9|||
48682260|NCT00930553|156686260|FG000|Overall Study|Study terminated by sponsor|24|||
48682261|NCT00930553|156686260|FG000|Overall Study|Other than specified above|28|||
48682262|NCT00785980|156686261|FG000|7 Day Washout Period|Protocol Violation|3|||
48682263|NCT01136408|156686262|FG000|Overall Study|Adverse Event|4|||
48682264|NCT01136408|156686263|FG001|Overall Study|Adverse Event|8|||
48682265|NCT01136408|156686264|FG002|Overall Study|Adverse Event|4|||
48682266|NCT01136408|156686262|FG000|Overall Study|Protocol Violation|1|||
48682267|NCT01136408|156686263|FG001|Overall Study|Protocol Violation|1|||
48682268|NCT01136408|156686264|FG002|Overall Study|Protocol Violation|1|||
48682269|NCT01510158|156686265|FG000|Overall Study|Adverse Event|7|||
48682270|NCT01510158|156686266|FG001|Overall Study|Adverse Event|8|||
48682271|NCT01510158|156686267|FG002|Overall Study|Adverse Event|5|||
48682272|NCT01510158|156686265|FG000|Overall Study|Gout flare|1|||
48682273|NCT01510158|156686266|FG001|Overall Study|Gout flare|0|||
48682274|NCT01510158|156686267|FG002|Overall Study|Gout flare|0|||
48682275|NCT01510158|156686265|FG000|Overall Study|Protocol Violation|17|||
48682276|NCT01510158|156686266|FG001|Overall Study|Protocol Violation|16|||
48682277|NCT01510158|156686267|FG002|Overall Study|Protocol Violation|24|||
48682278|NCT01510158|156686265|FG000|Overall Study|Sponsor terminated study.|2|||
48682279|NCT01510158|156686266|FG001|Overall Study|Sponsor terminated study.|0|||
49021116|NCT01929109|157914332|FG004|Period 1 (All Groups)|Deviation from protocol|0|||
49021117|NCT02228382|157914333|FG000|Overall Study|Death|5|||
49021118|NCT02228382|157914334|FG001|Overall Study|Death|7|||
49021119|NCT02228382|157914335|FG002|Overall Study|Death|5|||
48682280|NCT01510158|156686267|FG002|Overall Study|Sponsor terminated study.|2|||
48682281|NCT01510158|156686265|FG000|Overall Study|Lost to Follow-up|13|||
48682282|NCT01510158|156686266|FG001|Overall Study|Lost to Follow-up|16|||
48682283|NCT01510158|156686267|FG002|Overall Study|Lost to Follow-up|9|||
48682284|NCT01510158|156686265|FG000|Overall Study|Withdrawal by Subject|10|||
48682285|NCT01510158|156686266|FG001|Overall Study|Withdrawal by Subject|13|||
48682286|NCT01510158|156686267|FG002|Overall Study|Withdrawal by Subject|10|||
48682287|NCT01510158|156686265|FG000|Overall Study|Death|1|||
48682288|NCT01510158|156686266|FG001|Overall Study|Death|0|||
48682289|NCT01510158|156686267|FG002|Overall Study|Death|0|||
48682290|NCT02644343|156686276|FG000|Overall Study|Withdrawal by Subject|1|||
48682291|NCT01442714|156686280|FG000|Overall Study|Death|11|||
48682292|NCT01442714|156686280|FG000|Overall Study|Withdrawal by Subject|1|||
48682293|NCT02588261|156686281|FG000|Overall Study|Study Terminated by Sponsor|157|||
48682294|NCT02588261|156686282|FG001|Overall Study|Study Terminated by Sponsor|142|||
48682295|NCT02588261|156686281|FG000|Overall Study|Protocol Deviation|1|||
48682296|NCT02588261|156686282|FG001|Overall Study|Protocol Deviation|0|||
48682297|NCT02588261|156686281|FG000|Overall Study|Death|1|||
48682298|NCT02588261|156686282|FG001|Overall Study|Death|2|||
48682299|NCT02588261|156686281|FG000|Overall Study|Withdrawal by Subject|12|||
48682300|NCT02588261|156686282|FG001|Overall Study|Withdrawal by Subject|8|||
48682301|NCT02588261|156686281|FG000|Overall Study|Noncompliance with Study Drug|0|||
48682302|NCT02588261|156686282|FG001|Overall Study|Noncompliance with Study Drug|1|||
48682303|NCT02588261|156686281|FG000|Overall Study|Miscellaneous|5|||
48682304|NCT02588261|156686282|FG001|Overall Study|Miscellaneous|4|||
48682305|NCT02588261|156686281|FG000|Overall Study|Progressive Disease|61|||
48682306|NCT02588261|156686282|FG001|Overall Study|Progressive Disease|82|||
48682307|NCT02588261|156686281|FG000|Overall Study|Adverse Event|29|||
48682308|NCT02588261|156686282|FG001|Overall Study|Adverse Event|24|||
48682309|NCT02588261|156686281|FG000|Overall Study|Lost to Follow-up|1|||
48682310|NCT02588261|156686282|FG001|Overall Study|Lost to Follow-up|0|||
48682311|NCT01456169|156686292|FG000|Overall Study|Adverse Event|1|||
48682312|NCT01456169|156686293|FG001|Overall Study|Adverse Event|2|||
48682313|NCT01456169|156686294|FG002|Overall Study|Adverse Event|7|||
48682314|NCT01456169|156686292|FG000|Overall Study|Major Protocol Deviation|3|||
48682315|NCT01456169|156686293|FG001|Overall Study|Major Protocol Deviation|2|||
48682316|NCT01456169|156686294|FG002|Overall Study|Major Protocol Deviation|3|||
48682317|NCT01456169|156686292|FG000|Overall Study|Voluntary Withdrawal|3|||
48682318|NCT01456169|156686293|FG001|Overall Study|Voluntary Withdrawal|0|||
48682319|NCT01456169|156686294|FG002|Overall Study|Voluntary Withdrawal|2|||
48682320|NCT01456169|156686292|FG000|Overall Study|Lack of Efficacy|2|||
48682321|NCT01456169|156686293|FG001|Overall Study|Lack of Efficacy|0|||
48682322|NCT01456169|156686294|FG002|Overall Study|Lack of Efficacy|0|||
48682323|NCT01456169|156686292|FG000|Overall Study|Other|1|||
48682324|NCT01456169|156686293|FG001|Overall Study|Other|1|||
48682325|NCT01456169|156686294|FG002|Overall Study|Other|0|||
48682326|NCT03461146|156686305|FG000|Overall Study|Adverse Event|2|||
48682327|NCT03461146|156686305|FG000|Overall Study|Physician Decision|1|||
48682328|NCT01067144|156686310|FG000|Treatment|Did not receive allocated intervention|4|||
48682329|NCT01067144|156686311|FG001|Treatment|Did not receive allocated intervention|7|||
48682330|NCT01067144|156686310|FG000|Follow-up|Lost to Follow-up|22|||
48682331|NCT01067144|156686311|FG001|Follow-up|Lost to Follow-up|12|||
48682332|NCT01067144|156686310|FG000|Follow-up|Censored owing to second surgery|19|||
48682333|NCT01067144|156686311|FG001|Follow-up|Censored owing to second surgery|28|||
48682334|NCT01067144|156686310|FG000|Follow-up|Withdrawal by Subject|18|||
48682335|NCT01067144|156686311|FG001|Follow-up|Withdrawal by Subject|14|||
48682336|NCT01067144|156686310|FG000|Follow-up|Surgery cancelled|0|||
48682337|NCT01067144|156686311|FG001|Follow-up|Surgery cancelled|1|||
48682338|NCT01067144|156686310|FG000|Follow-up|Death|0|||
48682339|NCT01067144|156686311|FG001|Follow-up|Death|1|||
48682340|NCT03710642|156686312|FG000|Overall Study|Adverse Event|5|||
48875117|NCT00583947|157379061|FG000|Cross-over Period|Withdrawal by Subject|2|||
48875118|NCT00583947|157379062|FG001|Cross-over Period|Withdrawal by Subject|0|||
48875119|NCT00583947|157379061|FG000|Cross-over Period|Did not meet-no longer met entry criteri|0|||
48875120|NCT00583947|157379062|FG001|Cross-over Period|Did not meet-no longer met entry criteri|1|||
48875121|NCT00583947|157379061|FG000|Cross-over Period|Other|1|||
48875122|NCT00583947|157379062|FG001|Cross-over Period|Other|1|||
49021120|NCT02228382|157914336|FG003|Overall Study|Death|0|||
48682341|NCT03710642|156686313|FG001|Overall Study|Adverse Event|1|||
48682342|NCT03710642|156686312|FG000|Overall Study|non-site physician recommendation|1|||
48682343|NCT03710642|156686313|FG001|Overall Study|non-site physician recommendation|0|||
48682344|NCT03710642|156686312|FG000|Overall Study|Participant unwilling or unable to participate|1|||
48682345|NCT03710642|156686313|FG001|Overall Study|Participant unwilling or unable to participate|1|||
48682346|NCT03710642|156686312|FG000|Overall Study|"other is selected as the reason for study termination"|1|||
48682347|NCT03710642|156686313|FG001|Overall Study|"other is selected as the reason for study termination"|3|||
48682348|NCT03710642|156686312|FG000|Overall Study|NA-no code provided|1|||
48762902|NCT01498458|156980380|FG000|Overall Study|Adverse Event|4|||
48682349|NCT03710642|156686313|FG001|Overall Study|NA-no code provided|0|||
48875123|NCT01261247|157379063|FG000|Overall Study|Ineligible|2|||
48682350|NCT03710642|156686312|FG000|Overall Study|Withdrawal by Subject|1|||
48682351|NCT03710642|156686313|FG001|Overall Study|Withdrawal by Subject|0|||
48682352|NCT03081884|156686315|FG000|Overall Study|deferred prostate cancer treatment|1|||
48682353|NCT03081884|156686315|FG000|Overall Study|metastasis managed with systemic therapy|3|||
48682354|NCT01397461|156686316|FG000|Overall Study|Withdrawal by Subject|2|||
48682355|NCT01397461|156686317|FG001|Overall Study|Withdrawal by Subject|1|||
48682356|NCT01397461|156686318|FG002|Overall Study|Withdrawal by Subject|0|||
48762903|NCT01498458|156980380|FG000|Overall Study|Physician Decision|3|||
48762904|NCT03274986|156980383|FG000|Overall Study|Withdrawal by Subject|0|||
48682357|NCT01397461|156686316|FG000|Overall Study|Lost to Follow-up|0|||
48682358|NCT01397461|156686317|FG001|Overall Study|Lost to Follow-up|2|||
48682359|NCT01397461|156686318|FG002|Overall Study|Lost to Follow-up|1|||
48682360|NCT01397461|156686316|FG000|Overall Study|Lack of Efficacy|0|||
48682361|NCT01397461|156686317|FG001|Overall Study|Lack of Efficacy|3|||
48682362|NCT01397461|156686318|FG002|Overall Study|Lack of Efficacy|0|||
48682363|NCT01397461|156686316|FG000|Overall Study|Not treated|0|||
48682364|NCT01397461|156686317|FG001|Overall Study|Not treated|0|||
48682365|NCT01397461|156686318|FG002|Overall Study|Not treated|1|||
48682366|NCT01369784|156686319|FG000|Overall Study|Protocol Violation|12|||
48682367|NCT01219985|156686320|FG000|Overall Study|Physician Decision|20|||
48682368|NCT02097030|156686322|FG000|First Intervention (3 Days)|Lost to Follow-up|1|||
48682369|NCT02097030|156686323|FG001|First Intervention (3 Days)|Lost to Follow-up|0|||
48682370|NCT02097030|156686322|FG000|First Intervention (3 Days)|Visual Acuity|0|||
48682371|NCT02097030|156686323|FG001|First Intervention (3 Days)|Visual Acuity|1|||
48682372|NCT02735343|156686325|FG000|Overall Study|screen fail|0|||
48682373|NCT02735343|156686326|FG001|Overall Study|screen fail|2|||
48682374|NCT01327599|156686327|FG000|Overall Study|Adverse Event|1|||
48682375|NCT01327599|156686327|FG000|Overall Study|Could Not Attend Visit|1|||
48682376|NCT01327599|156686327|FG000|Overall Study|Withdrawal of Consent|1|||
48682377|NCT03343626|156688323|FG000|Overall Study|Lost to Follow-up|4|||
48682378|NCT03343626|156688324|FG001|Overall Study|Lost to Follow-up|3|||
48682379|NCT03343626|156688325|FG002|Overall Study|Lost to Follow-up|2|||
48682380|NCT03343626|156688326|FG003|Overall Study|Lost to Follow-up|5|||
48682381|NCT03343626|156688327|FG004|Overall Study|Lost to Follow-up|4|||
48682382|NCT03343626|156688328|FG005|Overall Study|Lost to Follow-up|4|||
48682383|NCT03343626|156688329|FG006|Overall Study|Lost to Follow-up|4|||
48682384|NCT03343626|156688330|FG007|Overall Study|Lost to Follow-up|7|||
48682385|NCT03343626|156688323|FG000|Overall Study|Withdrawal of Consent|2|||
48682386|NCT03343626|156688324|FG001|Overall Study|Withdrawal of Consent|1|||
48682387|NCT03343626|156688325|FG002|Overall Study|Withdrawal of Consent|0|||
48682388|NCT03343626|156688326|FG003|Overall Study|Withdrawal of Consent|3|||
48682389|NCT03343626|156688327|FG004|Overall Study|Withdrawal of Consent|3|||
48682390|NCT03343626|156688328|FG005|Overall Study|Withdrawal of Consent|1|||
48682391|NCT03343626|156688329|FG006|Overall Study|Withdrawal of Consent|1|||
48682392|NCT03343626|156688330|FG007|Overall Study|Withdrawal of Consent|2|||
48682393|NCT03343626|156688323|FG000|Overall Study|Reason not Specified|0|||
48682394|NCT03343626|156688324|FG001|Overall Study|Reason not Specified|1|||
48682395|NCT03343626|156688325|FG002|Overall Study|Reason not Specified|0|||
48762905|NCT03274986|156980384|FG001|Overall Study|Withdrawal by Subject|1|||
49021121|NCT02228382|157914337|FG004|Overall Study|Death|2|||
49021122|NCT02228382|157914333|FG000|Overall Study|Participant refused further follow-up|0|||
49021123|NCT02228382|157914334|FG001|Overall Study|Participant refused further follow-up|0|||
49021124|NCT02228382|157914335|FG002|Overall Study|Participant refused further follow-up|1|||
49021125|NCT02228382|157914336|FG003|Overall Study|Participant refused further follow-up|0|||
49021126|NCT02228382|157914337|FG004|Overall Study|Participant refused further follow-up|0|||
49021127|NCT02228382|157914333|FG000|Overall Study|Study terminated by sponsor|3|||
49021128|NCT02228382|157914334|FG001|Overall Study|Study terminated by sponsor|5|||
49021129|NCT02228382|157914335|FG002|Overall Study|Study terminated by sponsor|7|||
49021130|NCT02228382|157914336|FG003|Overall Study|Study terminated by sponsor|0|||
49021131|NCT02228382|157914337|FG004|Overall Study|Study terminated by sponsor|0|||
49021132|NCT02228382|157914333|FG000|Overall Study|Lost to Follow-up|0|||
49021133|NCT02228382|157914334|FG001|Overall Study|Lost to Follow-up|0|||
49021134|NCT02228382|157914335|FG002|Overall Study|Lost to Follow-up|3|||
48682396|NCT03343626|156688326|FG003|Overall Study|Reason not Specified|0|||
48682397|NCT03343626|156688327|FG004|Overall Study|Reason not Specified|0|||
48682398|NCT03343626|156688328|FG005|Overall Study|Reason not Specified|0|||
48682399|NCT03343626|156688329|FG006|Overall Study|Reason not Specified|0|||
48682400|NCT03343626|156688330|FG007|Overall Study|Reason not Specified|1|||
48682401|NCT03343626|156688323|FG000|Overall Study|Data Entry Error|0|||
48682402|NCT03343626|156688324|FG001|Overall Study|Data Entry Error|0|||
48682403|NCT03343626|156688325|FG002|Overall Study|Data Entry Error|0|||
48682404|NCT03343626|156688326|FG003|Overall Study|Data Entry Error|0|||
48762906|NCT03274986|156980383|FG000|Overall Study|Lost to Follow-up|0|||
48682405|NCT03343626|156688327|FG004|Overall Study|Data Entry Error|0|||
48682406|NCT03343626|156688328|FG005|Overall Study|Data Entry Error|0|||
48682407|NCT03343626|156688329|FG006|Overall Study|Data Entry Error|0|||
48682408|NCT03343626|156688330|FG007|Overall Study|Data Entry Error|1|||
48762907|NCT03274986|156980384|FG001|Overall Study|Lost to Follow-up|1|||
48762908|NCT00718328|156980387|FG000|Overall Study|Lost to Follow-up|1|||
48762909|NCT00718328|156980388|FG001|Overall Study|Lost to Follow-up|0|||
49021135|NCT02228382|157914336|FG003|Overall Study|Lost to Follow-up|1|||
49021136|NCT02228382|157914337|FG004|Overall Study|Lost to Follow-up|0|||
49021137|NCT02228382|157914333|FG000|Overall Study|Withdrawal by Subject|0|||
49021138|NCT02228382|157914334|FG001|Overall Study|Withdrawal by Subject|3|||
49021139|NCT02228382|157914335|FG002|Overall Study|Withdrawal by Subject|2|||
49021140|NCT02228382|157914336|FG003|Overall Study|Withdrawal by Subject|1|||
49021141|NCT02228382|157914337|FG004|Overall Study|Withdrawal by Subject|0|||
49021142|NCT02228382|157914333|FG000|Overall Study|Other|2|||
49021143|NCT02228382|157914334|FG001|Overall Study|Other|3|||
49021144|NCT02228382|157914335|FG002|Overall Study|Other|3|||
49021145|NCT02228382|157914336|FG003|Overall Study|Other|0|||
49021146|NCT02228382|157914337|FG004|Overall Study|Other|0|||
49021147|NCT01238848|157914339|FG000|Overall Study|Physician Decision|13|||
49021148|NCT01238848|157914340|FG001|Overall Study|Physician Decision|5|||
49021149|NCT00275002|157914342|FG000|Overall Study|Death|1|||
49021150|NCT00275002|157914343|FG001|Overall Study|Death|0|||
49021151|NCT00275002|157914342|FG000|Overall Study|Disease progression|21|||
49021152|NCT00275002|157914343|FG001|Overall Study|Disease progression|15|||
49021153|NCT00275002|157914342|FG000|Overall Study|Adverse Event|0|||
49021154|NCT00275002|157914343|FG001|Overall Study|Adverse Event|1|||
49021155|NCT03882047|157914346|FG000|Overall Study|Adverse Event|0|||
49021156|NCT03882047|157914347|FG001|Overall Study|Adverse Event|2|||
49021157|NCT03882047|157914348|FG002|Overall Study|Adverse Event|2|||
49021158|NCT03882047|157914346|FG000|Overall Study|Treatment Failure|3|||
49021159|NCT03882047|157914347|FG001|Overall Study|Treatment Failure|3|||
49021160|NCT03882047|157914348|FG002|Overall Study|Treatment Failure|12|||
49021161|NCT03882047|157914346|FG000|Overall Study|Lost to Follow-up|0|||
49021162|NCT03882047|157914347|FG001|Overall Study|Lost to Follow-up|1|||
49021163|NCT03882047|157914348|FG002|Overall Study|Lost to Follow-up|0|||
49021164|NCT03882047|157914346|FG000|Overall Study|Did Not Wish to Continue|1|||
49021165|NCT03882047|157914347|FG001|Overall Study|Did Not Wish to Continue|4|||
49021166|NCT03882047|157914348|FG002|Overall Study|Did Not Wish to Continue|1|||
49021167|NCT03882047|157914346|FG000|Overall Study|Noncompliance With Protocol|2|||
49021168|NCT03882047|157914347|FG001|Overall Study|Noncompliance With Protocol|0|||
49021169|NCT03882047|157914348|FG002|Overall Study|Noncompliance With Protocol|0|||
49021170|NCT03882047|157914346|FG000|Overall Study|Did Not Meet Eligibility|0|||
49021171|NCT03882047|157914347|FG001|Overall Study|Did Not Meet Eligibility|0|||
49021172|NCT03882047|157914348|FG002|Overall Study|Did Not Meet Eligibility|1|||
49021173|NCT00812253|157914349|FG000|Overall Study|Withdrawal by Subject|3|||
49021174|NCT00812253|157914350|FG001|Overall Study|Withdrawal by Subject|2|||
49021175|NCT00812253|157914349|FG000|Overall Study|Protocol Violation|1|||
49021176|NCT00812253|157914350|FG001|Overall Study|Protocol Violation|1|||
49021177|NCT00812253|157914349|FG000|Overall Study|Lost to Follow-up|2|||
49021178|NCT00812253|157914350|FG001|Overall Study|Lost to Follow-up|0|||
49021179|NCT00379340|157914353|FG000|Overall Study|Death|0|||
49021180|NCT00379340|157914354|FG001|Overall Study|Death|0|||
49021181|NCT00379340|157914355|FG002|Overall Study|Death|0|||
49021182|NCT00379340|157914356|FG003|Overall Study|Death|2|||
49021183|NCT00379340|157914357|FG004|Overall Study|Death|0|||
49021184|NCT00379340|157914353|FG000|Overall Study|Lack of Efficacy|6|||
49021185|NCT00379340|157914354|FG001|Overall Study|Lack of Efficacy|1|||
49021186|NCT00379340|157914355|FG002|Overall Study|Lack of Efficacy|0|||
49021187|NCT00379340|157914356|FG003|Overall Study|Lack of Efficacy|4|||
49021188|NCT00379340|157914357|FG004|Overall Study|Lack of Efficacy|3|||
49021189|NCT00379340|157914353|FG000|Overall Study|Physician Decision|6|||
49021190|NCT00379340|157914354|FG001|Overall Study|Physician Decision|2|||
49021191|NCT00379340|157914355|FG002|Overall Study|Physician Decision|1|||
49021192|NCT00379340|157914356|FG003|Overall Study|Physician Decision|2|||
49021193|NCT00379340|157914357|FG004|Overall Study|Physician Decision|3|||
49021194|NCT00379340|157914353|FG000|Overall Study|Withdrawal by Subject|0|||
49021195|NCT00379340|157914354|FG001|Overall Study|Withdrawal by Subject|0|||
49021196|NCT00379340|157914355|FG002|Overall Study|Withdrawal by Subject|0|||
49021197|NCT00379340|157914356|FG003|Overall Study|Withdrawal by Subject|1|||
49021198|NCT00379340|157914357|FG004|Overall Study|Withdrawal by Subject|0|||
49021199|NCT00379340|157914353|FG000|Overall Study|Refusal of further protocol therapy|1|||
49021200|NCT00379340|157914354|FG001|Overall Study|Refusal of further protocol therapy|0|||
49021201|NCT00379340|157914355|FG002|Overall Study|Refusal of further protocol therapy|1|||
49021202|NCT00379340|157914356|FG003|Overall Study|Refusal of further protocol therapy|1|||
49021203|NCT00379340|157914357|FG004|Overall Study|Refusal of further protocol therapy|7|||
49021204|NCT00379340|157914353|FG000|Overall Study|On more than 1 tumor therapeutic study|0|||
49021205|NCT00379340|157914354|FG001|Overall Study|On more than 1 tumor therapeutic study|0|||
49021206|NCT00379340|157914355|FG002|Overall Study|On more than 1 tumor therapeutic study|0|||
49021207|NCT00379340|157914356|FG003|Overall Study|On more than 1 tumor therapeutic study|2|||
49021208|NCT00379340|157914357|FG004|Overall Study|On more than 1 tumor therapeutic study|0|||
49021209|NCT00379340|157914353|FG000|Overall Study|Delayed nephrectomy and anaplasia|0|||
49021210|NCT00379340|157914354|FG001|Overall Study|Delayed nephrectomy and anaplasia|0|||
49021211|NCT00379340|157914355|FG002|Overall Study|Delayed nephrectomy and anaplasia|0|||
49021212|NCT00379340|157914356|FG003|Overall Study|Delayed nephrectomy and anaplasia|1|||
49021213|NCT00379340|157914357|FG004|Overall Study|Delayed nephrectomy and anaplasia|1|||
49021214|NCT01545076|157914358|FG000|IgPro10 Restabilization Period|Adverse Event|4|||
49021215|NCT01545076|157914359|FG001|IgPro10 Restabilization Period|Adverse Event|0|||
49021216|NCT01545076|157914360|FG002|IgPro10 Restabilization Period|Adverse Event|0|||
49021217|NCT01545076|157914361|FG003|IgPro10 Restabilization Period|Adverse Event|0|||
49021218|NCT01545076|157914362|FG004|IgPro10 Restabilization Period|Adverse Event|0|||
49021219|NCT01545076|157914358|FG000|IgPro10 Restabilization Period|Physician Decision|2|||
49021220|NCT01545076|157914359|FG001|IgPro10 Restabilization Period|Physician Decision|0|||
49021221|NCT01545076|157914360|FG002|IgPro10 Restabilization Period|Physician Decision|0|||
49021222|NCT01545076|157914361|FG003|IgPro10 Restabilization Period|Physician Decision|0|||
49021223|NCT01545076|157914362|FG004|IgPro10 Restabilization Period|Physician Decision|0|||
49021224|NCT01545076|157914358|FG000|IgPro10 Restabilization Period|Protocol Violation|1|||
49021225|NCT01545076|157914359|FG001|IgPro10 Restabilization Period|Protocol Violation|0|||
49021226|NCT01545076|157914360|FG002|IgPro10 Restabilization Period|Protocol Violation|0|||
49021227|NCT01545076|157914361|FG003|IgPro10 Restabilization Period|Protocol Violation|0|||
49021228|NCT01545076|157914362|FG004|IgPro10 Restabilization Period|Protocol Violation|0|||
49021229|NCT01545076|157914358|FG000|IgPro10 Restabilization Period|Failure to meet randomization criteria|22|||
49021230|NCT01545076|157914359|FG001|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
49021231|NCT01545076|157914360|FG002|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
49021232|NCT01545076|157914361|FG003|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
49021233|NCT01545076|157914362|FG004|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
49021234|NCT01545076|157914358|FG000|IgPro10 Restabilization Period|Withdrawal by Subject|7|||
49021235|NCT01545076|157914359|FG001|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
49021236|NCT01545076|157914360|FG002|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
49021237|NCT01545076|157914361|FG003|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
49021238|NCT01545076|157914362|FG004|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
49021239|NCT01545076|157914358|FG000|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
49021240|NCT01545076|157914359|FG001|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
49021241|NCT01545076|157914360|FG002|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
49021242|NCT01545076|157914361|FG003|IgPro20 Subcutaneous Treatment Period|Physician Decision|1|||
49021243|NCT01545076|157914362|FG004|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
49021244|NCT01545076|157914358|FG000|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
49021245|NCT01545076|157914359|FG001|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10|||
49021246|NCT01545076|157914360|FG002|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18|||
49021247|NCT01545076|157914361|FG003|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32|||
49021248|NCT01545076|157914362|FG004|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
49021249|NCT01545076|157914358|FG000|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
49021250|NCT01545076|157914359|FG001|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
49021251|NCT01545076|157914360|FG002|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
49021252|NCT01545076|157914361|FG003|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
49021253|NCT01545076|157914362|FG004|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
49021254|NCT01545076|157914358|FG000|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
49021255|NCT01545076|157914359|FG001|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8|||
49021256|NCT01545076|157914360|FG002|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2|||
49021257|NCT01545076|157914361|FG003|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3|||
49021258|NCT01545076|157914362|FG004|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
48682409|NCT00703924|156688331|FG000|Overall Study|Withdrawal by Subject|1|||
48682410|NCT00703924|156688332|FG001|Overall Study|Withdrawal by Subject|1|||
48682411|NCT01525615|156688333|FG000|Overall Study|Adverse Event|11|||
48682412|NCT01525615|156688334|FG001|Overall Study|Adverse Event|7|||
48682413|NCT01525615|156688335|FG002|Overall Study|Adverse Event|5|||
48682414|NCT01525615|156688333|FG000|Overall Study|Lost to Follow-up|1|||
48682415|NCT01525615|156688334|FG001|Overall Study|Lost to Follow-up|0|||
48682416|NCT01525615|156688335|FG002|Overall Study|Lost to Follow-up|0|||
48682417|NCT01525615|156688333|FG000|Overall Study|Withdrawal by Subject|1|||
48682418|NCT01525615|156688334|FG001|Overall Study|Withdrawal by Subject|0|||
48682419|NCT01525615|156688335|FG002|Overall Study|Withdrawal by Subject|0|||
48682420|NCT01525615|156688333|FG000|Overall Study|Other reason not described above|1|||
48682421|NCT01525615|156688334|FG001|Overall Study|Other reason not described above|0|||
48682422|NCT01525615|156688335|FG002|Overall Study|Other reason not described above|1|||
48682423|NCT00649428|156688338|FG000|Overall Study|Adverse Event|2|||
48682424|NCT00649428|156688339|FG001|Overall Study|Adverse Event|2|||
48682425|NCT00649428|156688338|FG000|Overall Study|Withdrawal by Subject|6|||
48682426|NCT00649428|156688339|FG001|Overall Study|Withdrawal by Subject|6|||
48682427|NCT00649428|156688338|FG000|Overall Study|Lost to Follow-up|1|||
48682428|NCT00649428|156688339|FG001|Overall Study|Lost to Follow-up|3|||
48682429|NCT00649428|156688338|FG000|Overall Study|Insufficient manufacturing yield|5|||
48682430|NCT00649428|156688339|FG001|Overall Study|Insufficient manufacturing yield|1|||
48682431|NCT00649428|156688338|FG000|Overall Study|Protocol Violation|6|||
48682432|NCT00649428|156688339|FG001|Overall Study|Protocol Violation|2|||
48682433|NCT00649428|156688338|FG000|Overall Study|Physician Decision|0|||
48682434|NCT00649428|156688339|FG001|Overall Study|Physician Decision|1|||
48682435|NCT03712787|156688340|FG000|Overall Study|Adverse Event|2|||
48682436|NCT03712787|156688341|FG001|Overall Study|Adverse Event|3|||
48682437|NCT03712787|156688342|FG002|Overall Study|Adverse Event|0|||
48682438|NCT03712787|156688343|FG003|Overall Study|Adverse Event|4|||
48682439|NCT03712787|156688340|FG000|Overall Study|Withdrawal by Subject|4|||
48682440|NCT03712787|156688341|FG001|Overall Study|Withdrawal by Subject|14|||
48682441|NCT03712787|156688342|FG002|Overall Study|Withdrawal by Subject|12|||
48682442|NCT03712787|156688343|FG003|Overall Study|Withdrawal by Subject|8|||
48682443|NCT03712787|156688340|FG000|Overall Study|Lost to Follow-up|1|||
48682444|NCT03712787|156688341|FG001|Overall Study|Lost to Follow-up|1|||
48682445|NCT03712787|156688342|FG002|Overall Study|Lost to Follow-up|2|||
48682446|NCT03712787|156688343|FG003|Overall Study|Lost to Follow-up|1|||
48682447|NCT03712787|156688340|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
48682448|NCT03712787|156688341|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
48682449|NCT03712787|156688342|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
48682450|NCT03712787|156688343|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
48682451|NCT03712787|156688340|FG000|Overall Study|COVID-19 Infection|0|||
48682452|NCT03712787|156688341|FG001|Overall Study|COVID-19 Infection|1|||
48682453|NCT03712787|156688342|FG002|Overall Study|COVID-19 Infection|0|||
48682454|NCT03712787|156688343|FG003|Overall Study|COVID-19 Infection|0|||
48682455|NCT03712787|156688340|FG000|Overall Study|Other, Not Specified|79|||
48682456|NCT03712787|156688341|FG001|Overall Study|Other, Not Specified|77|||
48682457|NCT03712787|156688342|FG002|Overall Study|Other, Not Specified|74|||
48682458|NCT03712787|156688343|FG003|Overall Study|Other, Not Specified|78|||
48682459|NCT01698814|156688344|FG000|Overall Study|Adverse Event|0|||
48682460|NCT01698814|156688345|FG001|Overall Study|Adverse Event|2|||
48682461|NCT01698814|156688344|FG000|Overall Study|Lost to Follow-up|0|||
48682462|NCT01698814|156688345|FG001|Overall Study|Lost to Follow-up|1|||
48682463|NCT01698814|156688344|FG000|Overall Study|Pregnancy|1|||
48682464|NCT01698814|156688345|FG001|Overall Study|Pregnancy|0|||
48682465|NCT01698814|156688344|FG000|Overall Study|Randomized in error|1|||
48682466|NCT01698814|156688345|FG001|Overall Study|Randomized in error|0|||
48682467|NCT00872599|156688352|FG000|Second Washout Period|Adverse Event|1|||
48682468|NCT00872599|156688353|FG001|Second Washout Period|Adverse Event|1|||
48682469|NCT03354273|156688356|FG000|Overall Study|Adverse Event|5|||
48682470|NCT03354273|156688356|FG000|Overall Study|Screen Failure|21|||
48682471|NCT03354273|156688356|FG000|Overall Study|Withdrawal by Subject|34|||
48682472|NCT03354273|156688356|FG000|Overall Study|Technical Problems|30|||
48682473|NCT03354273|156688356|FG000|Overall Study|Lost to Follow-up|4|||
48682474|NCT03354273|156688356|FG000|Overall Study|Investigator Decision|3|||
48682475|NCT03354273|156688356|FG000|Overall Study|Investigational Medicinal Product (IMP) Supply Issues|21|||
48682476|NCT03354273|156688356|FG000|Overall Study|Issues With Performing Invasive Coronary Angiography (ICA)|20|||
48682477|NCT03354273|156688356|FG000|Overall Study|COVID-19 Restrictions|9|||
48682478|NCT03354273|156688356|FG000|Overall Study|Other|5|||
48682479|NCT02510001|156688359|FG000|Overall Study|Early disease progression|0|||
48682480|NCT02510001|156688360|FG001|Overall Study|Early disease progression|0|||
48682481|NCT02510001|156688361|FG002|Overall Study|Early disease progression|0|||
48682482|NCT02510001|156688362|FG003|Overall Study|Early disease progression|1|||
48682483|NCT02510001|156688363|FG004|Overall Study|Early disease progression|1|||
48682484|NCT02510001|156688364|FG005|Overall Study|Early disease progression|1|||
48682485|NCT02510001|156688365|FG006|Overall Study|Early disease progression|0|||
48682486|NCT02510001|156688366|FG007|Overall Study|Early disease progression|0|||
48762910|NCT01380184|156980389|FG000|Part 1 (19 Days)|Adverse Event|1|||
48762911|NCT01380184|156980389|FG000|Part 2|Adverse Event|5|||
48762912|NCT01380184|156980389|FG000|Part 2|Disease Progression|8|||
48762913|NCT01380184|156980389|FG000|Part 2|Lost to Follow-up|1|||
48762914|NCT01806896|156980391|FG000|Overall Study|Adverse Event|2|||
48762915|NCT01806896|156980392|FG001|Overall Study|Adverse Event|0|||
48762916|NCT01806896|156980391|FG000|Overall Study|Other|1|||
48682487|NCT02510001|156688359|FG000|Overall Study|Adverse Event|0|||
48682488|NCT02510001|156688360|FG001|Overall Study|Adverse Event|0|||
48682489|NCT02510001|156688361|FG002|Overall Study|Adverse Event|0|||
48682490|NCT02510001|156688362|FG003|Overall Study|Adverse Event|1|||
48682491|NCT02510001|156688363|FG004|Overall Study|Adverse Event|2|||
48682492|NCT02510001|156688364|FG005|Overall Study|Adverse Event|1|||
48682493|NCT02510001|156688365|FG006|Overall Study|Adverse Event|2|||
48682494|NCT02510001|156688366|FG007|Overall Study|Adverse Event|5|||
48981059|NCT02705755|157762286|FG003|Part A (6 Days)|Adverse Event|0|||
48981060|NCT02705755|157762283|FG000|Part A (6 Days)|Physician Decision|3|||
48981061|NCT02705755|157762284|FG001|Part A (6 Days)|Physician Decision|0|||
48981062|NCT02705755|157762285|FG002|Part A (6 Days)|Physician Decision|0|||
48682495|NCT02510001|156688359|FG000|Overall Study|Physician Decision|0|||
48682496|NCT02510001|156688360|FG001|Overall Study|Physician Decision|0|||
48682497|NCT02510001|156688361|FG002|Overall Study|Physician Decision|0|||
48682498|NCT02510001|156688362|FG003|Overall Study|Physician Decision|0|||
48682499|NCT02510001|156688363|FG004|Overall Study|Physician Decision|1|||
48682500|NCT02510001|156688364|FG005|Overall Study|Physician Decision|0|||
48682501|NCT02510001|156688365|FG006|Overall Study|Physician Decision|0|||
48682502|NCT02510001|156688366|FG007|Overall Study|Physician Decision|0|||
48682503|NCT02510001|156688359|FG000|Overall Study|Withdrawal by Subject|0|||
48682504|NCT02510001|156688360|FG001|Overall Study|Withdrawal by Subject|0|||
48682505|NCT02510001|156688361|FG002|Overall Study|Withdrawal by Subject|0|||
48682506|NCT02510001|156688362|FG003|Overall Study|Withdrawal by Subject|0|||
48682507|NCT02510001|156688363|FG004|Overall Study|Withdrawal by Subject|0|||
48682508|NCT02510001|156688364|FG005|Overall Study|Withdrawal by Subject|0|||
48682509|NCT02510001|156688365|FG006|Overall Study|Withdrawal by Subject|0|||
48682510|NCT02510001|156688366|FG007|Overall Study|Withdrawal by Subject|2|||
48682511|NCT02255461|156688385|FG000|Overall Study|Adverse Event|0|||
48682512|NCT02255461|156688386|FG001|Overall Study|Adverse Event|1|||
48682513|NCT02255461|156688387|FG002|Overall Study|Adverse Event|0|||
48682514|NCT02255461|156688388|FG003|Overall Study|Adverse Event|0|||
48682515|NCT02255461|156688389|FG004|Overall Study|Adverse Event|1|||
48682516|NCT02255461|156688385|FG000|Overall Study|Withdrawal by Subject|0|||
48682517|NCT02255461|156688386|FG001|Overall Study|Withdrawal by Subject|0|||
48762917|NCT01806896|156980392|FG001|Overall Study|Other|0|||
48981063|NCT02705755|157762286|FG003|Part A (6 Days)|Physician Decision|0|||
48981064|NCT02705755|157762283|FG000|Part A (6 Days)|Withdrawal by Subject|1|||
48981065|NCT02705755|157762284|FG001|Part A (6 Days)|Withdrawal by Subject|0|||
48981066|NCT02705755|157762285|FG002|Part A (6 Days)|Withdrawal by Subject|0|||
48981067|NCT02705755|157762286|FG003|Part A (6 Days)|Withdrawal by Subject|0|||
48981068|NCT02705755|157762283|FG000|Part C (20 Weeks)|Physician Decision|0|||
48981069|NCT02705755|157762284|FG001|Part C (20 Weeks)|Physician Decision|0|||
48981070|NCT02705755|157762285|FG002|Part C (20 Weeks)|Physician Decision|0|||
48981071|NCT02705755|157762286|FG003|Part C (20 Weeks)|Physician Decision|2|||
48981072|NCT02705755|157762283|FG000|Part C (20 Weeks)|Adverse Event|0|||
48981073|NCT02705755|157762284|FG001|Part C (20 Weeks)|Adverse Event|0|||
48981074|NCT02705755|157762285|FG002|Part C (20 Weeks)|Adverse Event|0|||
48981075|NCT02705755|157762286|FG003|Part C (20 Weeks)|Adverse Event|6|||
48981076|NCT02705755|157762283|FG000|Part C (20 Weeks)|Withdrawal by Subject|0|||
48981077|NCT02705755|157762284|FG001|Part C (20 Weeks)|Withdrawal by Subject|0|||
48981078|NCT02705755|157762285|FG002|Part C (20 Weeks)|Withdrawal by Subject|0|||
48981079|NCT02705755|157762286|FG003|Part C (20 Weeks)|Withdrawal by Subject|2|||
48981080|NCT02177786|157764167|FG000|Overall Study|Withdrew Consent|2|||
48981081|NCT02177786|157764168|FG001|Overall Study|Withdrew Consent|6|||
48981082|NCT02177786|157764169|FG002|Overall Study|Withdrew Consent|9|||
48981083|NCT02177786|157764170|FG003|Overall Study|Withdrew Consent|5|||
48981084|NCT02177786|157764167|FG000|Overall Study|Progression to End Stage Renal Disease|2|||
48981085|NCT02177786|157764168|FG001|Overall Study|Progression to End Stage Renal Disease|3|||
48981086|NCT02177786|157764169|FG002|Overall Study|Progression to End Stage Renal Disease|2|||
48981087|NCT02177786|157764170|FG003|Overall Study|Progression to End Stage Renal Disease|1|||
48981088|NCT02177786|157764167|FG000|Overall Study|Adverse Event|1|||
48981089|NCT02177786|157764168|FG001|Overall Study|Adverse Event|1|||
48981090|NCT02177786|157764169|FG002|Overall Study|Adverse Event|2|||
48981091|NCT02177786|157764170|FG003|Overall Study|Adverse Event|3|||
48981092|NCT02177786|157764167|FG000|Overall Study|Death|1|||
48981093|NCT02177786|157764168|FG001|Overall Study|Death|1|||
48981094|NCT02177786|157764169|FG002|Overall Study|Death|1|||
48981095|NCT02177786|157764170|FG003|Overall Study|Death|1|||
48981096|NCT02177786|157764167|FG000|Overall Study|Lost to Follow-up|0|||
48981097|NCT02177786|157764168|FG001|Overall Study|Lost to Follow-up|0|||
48981098|NCT02177786|157764169|FG002|Overall Study|Lost to Follow-up|2|||
48981099|NCT02177786|157764170|FG003|Overall Study|Lost to Follow-up|2|||
48981100|NCT02177786|157764167|FG000|Overall Study|Non-Compliance with Study Drug|0|||
48981101|NCT02177786|157764168|FG001|Overall Study|Non-Compliance with Study Drug|1|||
48981102|NCT02177786|157764169|FG002|Overall Study|Non-Compliance with Study Drug|0|||
48981103|NCT02177786|157764170|FG003|Overall Study|Non-Compliance with Study Drug|1|||
48981104|NCT02177786|157764167|FG000|Overall Study|Protocol Violation|0|||
48981105|NCT02177786|157764168|FG001|Overall Study|Protocol Violation|0|||
48981106|NCT02177786|157764169|FG002|Overall Study|Protocol Violation|2|||
48981107|NCT02177786|157764170|FG003|Overall Study|Protocol Violation|0|||
48981108|NCT02177786|157764167|FG000|Overall Study|Progressive Disease|0|||
48981109|NCT02177786|157764168|FG001|Overall Study|Progressive Disease|1|||
48981110|NCT02177786|157764169|FG002|Overall Study|Progressive Disease|0|||
48981111|NCT02177786|157764170|FG003|Overall Study|Progressive Disease|0|||
48981112|NCT02177786|157764167|FG000|Overall Study|Missing study completion status|0|||
48981113|NCT02177786|157764168|FG001|Overall Study|Missing study completion status|1|||
48981114|NCT02177786|157764169|FG002|Overall Study|Missing study completion status|0|||
48981115|NCT02177786|157764170|FG003|Overall Study|Missing study completion status|0|||
48981116|NCT03950440|157764171|FG000|Overall Study|Death|8|||
48682518|NCT02255461|156688387|FG002|Overall Study|Withdrawal by Subject|1|||
48682519|NCT02255461|156688388|FG003|Overall Study|Withdrawal by Subject|0|||
48682520|NCT02255461|156688389|FG004|Overall Study|Withdrawal by Subject|1|||
48682521|NCT02255461|156688385|FG000|Overall Study|Not meet dose reduction BSA requirement|0|||
48682522|NCT02255461|156688386|FG001|Overall Study|Not meet dose reduction BSA requirement|1|||
48682523|NCT02255461|156688387|FG002|Overall Study|Not meet dose reduction BSA requirement|0|||
49021259|NCT02918162|157914363|FG000|Overall Study|Withdrawal by Subject|1|||
49021260|NCT02918162|157914363|FG000|Overall Study|Omental Disease|1|||
49021261|NCT00395226|157914365|FG000|Overall Study|Adverse Event|4|||
49021262|NCT00395226|157914366|FG001|Overall Study|Adverse Event|3|||
49021263|NCT00395226|157914365|FG000|Overall Study|Withdrawal by Subject|0|||
49021264|NCT00395226|157914366|FG001|Overall Study|Withdrawal by Subject|1|||
49021265|NCT00395226|157914365|FG000|Overall Study|Lost to Follow-up|0|||
49021266|NCT00395226|157914366|FG001|Overall Study|Lost to Follow-up|1|||
49021267|NCT02563522|157914367|FG000|Overall Study|Adverse Event|2|||
49021268|NCT02563522|157914368|FG001|Overall Study|Adverse Event|3|||
49021269|NCT02563522|157914367|FG000|Overall Study|Lost to Follow-up|1|||
49021270|NCT02563522|157914368|FG001|Overall Study|Lost to Follow-up|0|||
48682524|NCT02255461|156688388|FG003|Overall Study|Not meet dose reduction BSA requirement|0|||
48682525|NCT02255461|156688389|FG004|Overall Study|Not meet dose reduction BSA requirement|0|||
48682526|NCT01559675|156688394|FG000|Overall Study|Protocol Violation|1|||
48682527|NCT01559675|156688395|FG001|Overall Study|Protocol Violation|2|||
48682528|NCT01559675|156688394|FG000|Overall Study|2nd operation on same patient excluded|14|||
48682529|NCT01559675|156688395|FG001|Overall Study|2nd operation on same patient excluded|12|||
48682530|NCT00853151|156688396|FG000|Overall Study|Adverse Event|1|||
48682531|NCT00853151|156688397|FG001|Overall Study|Adverse Event|4|||
48682532|NCT00853151|156688398|FG002|Overall Study|Adverse Event|2|||
48682533|NCT00853151|156688399|FG003|Overall Study|Adverse Event|0|||
48682534|NCT00853151|156688396|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
48682535|NCT00853151|156688397|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
48682536|NCT00853151|156688398|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
48682537|NCT00853151|156688399|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
48682538|NCT00853151|156688396|FG000|Overall Study|Lost to Follow-up|2|||
48682539|NCT00853151|156688397|FG001|Overall Study|Lost to Follow-up|0|||
48682540|NCT00853151|156688398|FG002|Overall Study|Lost to Follow-up|3|||
48682541|NCT00853151|156688399|FG003|Overall Study|Lost to Follow-up|0|||
48682542|NCT00853151|156688396|FG000|Overall Study|Death|1|||
48682543|NCT00853151|156688397|FG001|Overall Study|Death|0|||
48762918|NCT04568590|156981956|FG000|Overall Study|Subjects were not Vaccine-hesitant|437|||
48762919|NCT03220217|156981957|FG000|Overall Study|Withdrawal by Subject|0|||
48762920|NCT03220217|156981958|FG001|Overall Study|Withdrawal by Subject|1|||
48762921|NCT03220217|156981959|FG002|Overall Study|Withdrawal by Subject|0|||
48762922|NCT03220217|156981957|FG000|Overall Study|Subject Missed Procedure|0|||
48762923|NCT03220217|156981958|FG001|Overall Study|Subject Missed Procedure|0|||
49021271|NCT02563522|157914367|FG000|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|1|||
49021272|NCT02563522|157914368|FG001|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|2|||
49021273|NCT01259869|157914369|FG000|Overall Study|Duplicated registration|1|||
49021274|NCT00576381|157914377|FG000|Overall Study|Reoperation|3|||
49021275|NCT00576381|157914377|FG000|Overall Study|Adverse Event|4|||
49021276|NCT02518113|157914378|FG000|Overall Study|Adverse Event|1|||
49021277|NCT02518113|157914379|FG001|Overall Study|Adverse Event|0|||
49021278|NCT02518113|157914380|FG002|Overall Study|Adverse Event|1|||
49021279|NCT02518113|157914381|FG003|Overall Study|Adverse Event|0|||
49021280|NCT02518113|157914378|FG000|Overall Study|Death|1|||
49021281|NCT02518113|157914379|FG001|Overall Study|Death|2|||
49021282|NCT02518113|157914380|FG002|Overall Study|Death|0|||
49021283|NCT02518113|157914381|FG003|Overall Study|Death|0|||
49021284|NCT02518113|157914378|FG000|Overall Study|Physician Decision|0|||
49021285|NCT02518113|157914379|FG001|Overall Study|Physician Decision|1|||
49021286|NCT02518113|157914380|FG002|Overall Study|Physician Decision|0|||
49021287|NCT02518113|157914381|FG003|Overall Study|Physician Decision|0|||
49021288|NCT02518113|157914378|FG000|Overall Study|Progressive Disease|1|||
49021289|NCT02518113|157914379|FG001|Overall Study|Progressive Disease|2|||
49021290|NCT02518113|157914380|FG002|Overall Study|Progressive Disease|3|||
49021291|NCT02518113|157914381|FG003|Overall Study|Progressive Disease|0|||
49021292|NCT00797108|157914382|FG000|Overall Study|Adverse Event|1|||
48762924|NCT03220217|156981959|FG002|Overall Study|Subject Missed Procedure|1|||
48762925|NCT01104636|156981960|FG000|Overall Study|Lack of Efficacy|43|||
49021293|NCT00797108|157914383|FG001|Overall Study|Adverse Event|0|||
49021294|NCT00797108|157914384|FG002|Overall Study|Adverse Event|3|||
49021295|NCT00797108|157914382|FG000|Overall Study|Did Not Meet Entrance Criteria|0|||
49021296|NCT00797108|157914383|FG001|Overall Study|Did Not Meet Entrance Criteria|1|||
49021297|NCT00797108|157914384|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
49021298|NCT00797108|157914382|FG000|Overall Study|Global Deterioration of Health Status|0|||
48682544|NCT00853151|156688398|FG002|Overall Study|Death|0|||
48682545|NCT00853151|156688399|FG003|Overall Study|Death|1|||
48682546|NCT00853151|156688396|FG000|Overall Study|Protocol Violation|0|||
48682547|NCT00853151|156688397|FG001|Overall Study|Protocol Violation|0|||
48682548|NCT00853151|156688398|FG002|Overall Study|Protocol Violation|0|||
48682549|NCT00853151|156688399|FG003|Overall Study|Protocol Violation|1|||
48682550|NCT00853151|156688396|FG000|Overall Study|Withdrawal by Subject|5|||
48682551|NCT00853151|156688397|FG001|Overall Study|Withdrawal by Subject|4|||
48682552|NCT00853151|156688398|FG002|Overall Study|Withdrawal by Subject|2|||
48682553|NCT00853151|156688399|FG003|Overall Study|Withdrawal by Subject|1|||
48682554|NCT00853151|156688396|FG000|Overall Study|Physician Decision|0|||
48682555|NCT00853151|156688397|FG001|Overall Study|Physician Decision|2|||
48682556|NCT00853151|156688398|FG002|Overall Study|Physician Decision|1|||
48682557|NCT00853151|156688399|FG003|Overall Study|Physician Decision|0|||
48682558|NCT00853151|156688396|FG000|Overall Study|Sponsor Decision|0|||
48682559|NCT00853151|156688397|FG001|Overall Study|Sponsor Decision|3|||
48682560|NCT00853151|156688398|FG002|Overall Study|Sponsor Decision|0|||
48682561|NCT00853151|156688399|FG003|Overall Study|Sponsor Decision|0|||
48682562|NCT00291018|156688400|FG000|Overall Study|Not Consented or Declined PAS|12|||
48682563|NCT00291018|156688401|FG001|Overall Study|Not Consented or Declined PAS|15|||
48682564|NCT00291018|156688402|FG002|Overall Study|Not Consented or Declined PAS|15|||
48682565|NCT00291018|156688400|FG000|Overall Study|Death|3|||
48682566|NCT00291018|156688401|FG001|Overall Study|Death|3|||
48682567|NCT00291018|156688402|FG002|Overall Study|Death|4|||
48682568|NCT00291018|156688400|FG000|Overall Study|Withdrawal by Subject|2|||
48682569|NCT00291018|156688401|FG001|Overall Study|Withdrawal by Subject|8|||
48682570|NCT00291018|156688402|FG002|Overall Study|Withdrawal by Subject|1|||
48682571|NCT00291018|156688400|FG000|Overall Study|Failures|5|||
48682572|NCT00291018|156688401|FG001|Overall Study|Failures|12|||
48682573|NCT00291018|156688402|FG002|Overall Study|Failures|5|||
48682574|NCT00291018|156688400|FG000|Overall Study|Lost to Follow-up|3|||
48682575|NCT00291018|156688401|FG001|Overall Study|Lost to Follow-up|4|||
48682576|NCT00291018|156688402|FG002|Overall Study|Lost to Follow-up|18|||
48682577|NCT00713544|156688403|FG000|Overall Study|Adverse Event|5|||
48682578|NCT00713544|156688404|FG001|Overall Study|Adverse Event|3|||
48682579|NCT00713544|156688405|FG002|Overall Study|Adverse Event|7|||
48682580|NCT00713544|156688406|FG003|Overall Study|Adverse Event|7|||
48682581|NCT00713544|156688407|FG004|Overall Study|Adverse Event|3|||
48682582|NCT00713544|156688408|FG005|Overall Study|Adverse Event|5|||
48682583|NCT00713544|156688403|FG000|Overall Study|Withdrawal by Subject|2|||
48682584|NCT00713544|156688404|FG001|Overall Study|Withdrawal by Subject|0|||
48682585|NCT00713544|156688405|FG002|Overall Study|Withdrawal by Subject|3|||
48762926|NCT01104636|156981960|FG000|Overall Study|Lost to Follow-up|24|||
48762927|NCT01104636|156981960|FG000|Overall Study|Withdrawal by Subject|4|||
48762928|NCT01104636|156981960|FG000|Overall Study|Other|43|||
48762929|NCT01104636|156981960|FG000|Overall Study|Study terminated by sponsor|1|||
48762930|NCT01104636|156981960|FG000|Overall Study|Pregnancy|2|||
49021299|NCT00797108|157914383|FG001|Overall Study|Global Deterioration of Health Status|1|||
49021300|NCT00797108|157914384|FG002|Overall Study|Global Deterioration of Health Status|0|||
49021301|NCT00797108|157914382|FG000|Overall Study|Lack of Efficacy|1|||
49021302|NCT00797108|157914383|FG001|Overall Study|Lack of Efficacy|0|||
49021303|NCT00797108|157914384|FG002|Overall Study|Lack of Efficacy|1|||
49021304|NCT00797108|157914382|FG000|Overall Study|Other|0|||
49021305|NCT00797108|157914383|FG001|Overall Study|Other|0|||
49021306|NCT00797108|157914384|FG002|Overall Study|Other|2|||
49021307|NCT00797108|157914382|FG000|Overall Study|Randomized but not Treated|2|||
49021308|NCT00797108|157914383|FG001|Overall Study|Randomized but not Treated|0|||
49021309|NCT00797108|157914384|FG002|Overall Study|Randomized but not Treated|0|||
49021310|NCT00287118|157914385|FG000|Overall Study|Adverse Event|30|||
49021311|NCT00287118|157914385|FG000|Overall Study|Death|1|||
49021312|NCT00287118|157914385|FG000|Overall Study|Lack of Efficacy|11|||
49021313|NCT00287118|157914385|FG000|Overall Study|Lost to Follow-up|1|||
49021314|NCT00287118|157914385|FG000|Overall Study|Protocol Violation|2|||
49021315|NCT00287118|157914385|FG000|Overall Study|Other|7|||
49021316|NCT00262600|157914386|FG000|Overall Study|Lost to Follow-up|17|||
49021317|NCT00262600|157914387|FG001|Overall Study|Lost to Follow-up|31|||
48682586|NCT00713544|156688406|FG003|Overall Study|Withdrawal by Subject|2|||
48682587|NCT00713544|156688407|FG004|Overall Study|Withdrawal by Subject|3|||
49021318|NCT00262600|157914388|FG002|Overall Study|Lost to Follow-up|41|||
49021319|NCT00262600|157914386|FG000|Overall Study|Withdrawal by Subject|128|||
49021320|NCT00262600|157914387|FG001|Overall Study|Withdrawal by Subject|145|||
49021321|NCT00262600|157914388|FG002|Overall Study|Withdrawal by Subject|139|||
49021322|NCT00262600|157914386|FG000|Overall Study|Not Treated|32|||
49021323|NCT00262600|157914387|FG001|Overall Study|Not Treated|17|||
49021324|NCT00262600|157914388|FG002|Overall Study|Not Treated|24|||
48682588|NCT00713544|156688408|FG005|Overall Study|Withdrawal by Subject|1|||
48682589|NCT00713544|156688403|FG000|Overall Study|Protocol Violation|0|||
48682590|NCT00713544|156688404|FG001|Overall Study|Protocol Violation|0|||
48682591|NCT00713544|156688405|FG002|Overall Study|Protocol Violation|0|||
48682592|NCT00713544|156688406|FG003|Overall Study|Protocol Violation|0|||
48682593|NCT00713544|156688407|FG004|Overall Study|Protocol Violation|0|||
48762931|NCT01104636|156981960|FG000|Overall Study|Adverse Event|40|||
48682594|NCT00713544|156688408|FG005|Overall Study|Protocol Violation|1|||
48682595|NCT00713544|156688403|FG000|Overall Study|Physician Decision|0|||
48682596|NCT00713544|156688404|FG001|Overall Study|Physician Decision|0|||
48682597|NCT00713544|156688405|FG002|Overall Study|Physician Decision|0|||
48682598|NCT00713544|156688406|FG003|Overall Study|Physician Decision|0|||
48682599|NCT00713544|156688407|FG004|Overall Study|Physician Decision|0|||
48682600|NCT00713544|156688408|FG005|Overall Study|Physician Decision|2|||
48682601|NCT00713544|156688403|FG000|Overall Study|Lack of Efficacy|0|||
48682602|NCT00713544|156688404|FG001|Overall Study|Lack of Efficacy|1|||
48682603|NCT00713544|156688405|FG002|Overall Study|Lack of Efficacy|0|||
48682604|NCT00713544|156688406|FG003|Overall Study|Lack of Efficacy|1|||
48682605|NCT00713544|156688407|FG004|Overall Study|Lack of Efficacy|1|||
48682606|NCT00713544|156688408|FG005|Overall Study|Lack of Efficacy|0|||
48682607|NCT00713544|156688403|FG000|Overall Study|Lost to Follow-up|0|||
48682608|NCT00713544|156688404|FG001|Overall Study|Lost to Follow-up|0|||
48682609|NCT00713544|156688405|FG002|Overall Study|Lost to Follow-up|1|||
48682610|NCT00713544|156688406|FG003|Overall Study|Lost to Follow-up|0|||
48682611|NCT00713544|156688407|FG004|Overall Study|Lost to Follow-up|0|||
48682612|NCT00713544|156688408|FG005|Overall Study|Lost to Follow-up|0|||
48682613|NCT00713544|156688403|FG000|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
48682614|NCT00713544|156688404|FG001|Overall Study|AZ decision - Hepatitis C ab reactive|1|||
48682615|NCT00713544|156688405|FG002|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
48682616|NCT00713544|156688406|FG003|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
48682617|NCT00713544|156688407|FG004|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
48682618|NCT00713544|156688408|FG005|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
48682619|NCT00713544|156688403|FG000|Overall Study|Incorrect enrollment|0|||
48682620|NCT00713544|156688404|FG001|Overall Study|Incorrect enrollment|1|||
48682621|NCT00713544|156688405|FG002|Overall Study|Incorrect enrollment|0|||
48682622|NCT00713544|156688406|FG003|Overall Study|Incorrect enrollment|0|||
48682623|NCT00713544|156688407|FG004|Overall Study|Incorrect enrollment|0|||
48682624|NCT00713544|156688408|FG005|Overall Study|Incorrect enrollment|0|||
48682625|NCT00713544|156688403|FG000|Overall Study|Hepatotoxicity - not an AE|0|||
48682626|NCT00713544|156688404|FG001|Overall Study|Hepatotoxicity - not an AE|0|||
48682627|NCT00713544|156688405|FG002|Overall Study|Hepatotoxicity - not an AE|0|||
48682628|NCT00713544|156688406|FG003|Overall Study|Hepatotoxicity - not an AE|0|||
48682629|NCT00713544|156688407|FG004|Overall Study|Hepatotoxicity - not an AE|1|||
48682630|NCT00713544|156688408|FG005|Overall Study|Hepatotoxicity - not an AE|0|||
48682631|NCT00269919|156688409|FG000|Overall Study|Other|26|||
48682632|NCT00269919|156688409|FG000|Overall Study|Started but not treated|1|||
48682633|NCT02219334|156688410|FG000|Overall Study|Withdrawal by Subject|1|||
48682634|NCT02219334|156688411|FG001|Overall Study|Withdrawal by Subject|0|||
48682635|NCT02219334|156688410|FG000|Overall Study|Protocol Violation|7|||
48682636|NCT02219334|156688411|FG001|Overall Study|Protocol Violation|3|||
48682637|NCT01641601|156688412|FG000|Overall Study|Study discontinued.|3|||
48682638|NCT01641601|156688413|FG001|Overall Study|Study discontinued.|5|||
48682639|NCT02517541|156688418|FG000|Baseline Period (Own Product)|Protocol Violation|1|||
48682640|NCT02517541|156688418|FG000|Test Period (SenSura Mio Convex Soft)|Adverse Event|3|||
48682641|NCT02517541|156688418|FG000|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2|||
48682642|NCT02517541|156688418|FG000|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1|||
48682643|NCT02517541|156688418|FG000|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4|||
48682644|NCT02517541|156688418|FG000|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2|||
48682645|NCT00592904|156688419|FG000|Overall Study|Adverse Event|15|||
48682646|NCT00592904|156688420|FG001|Overall Study|Adverse Event|25|||
48682647|NCT00592904|156688421|FG002|Overall Study|Adverse Event|13|||
48682648|NCT00592904|156688422|FG003|Overall Study|Adverse Event|5|||
48682649|NCT00592904|156688419|FG000|Overall Study|Protocol Violation|1|||
48682650|NCT00592904|156688420|FG001|Overall Study|Protocol Violation|1|||
48682651|NCT00592904|156688421|FG002|Overall Study|Protocol Violation|0|||
48682652|NCT00592904|156688422|FG003|Overall Study|Protocol Violation|1|||
48682653|NCT00592904|156688419|FG000|Overall Study|Withdrawal by Subject|4|||
48682654|NCT00592904|156688420|FG001|Overall Study|Withdrawal by Subject|16|||
48682655|NCT00592904|156688421|FG002|Overall Study|Withdrawal by Subject|1|||
48682656|NCT00592904|156688422|FG003|Overall Study|Withdrawal by Subject|2|||
48682657|NCT00592904|156688419|FG000|Overall Study|Lack of Efficacy|2|||
48682658|NCT00592904|156688420|FG001|Overall Study|Lack of Efficacy|7|||
48682659|NCT00592904|156688421|FG002|Overall Study|Lack of Efficacy|2|||
48682660|NCT00592904|156688422|FG003|Overall Study|Lack of Efficacy|3|||
48682661|NCT00592904|156688419|FG000|Overall Study|Physician Decision|0|||
48682662|NCT00592904|156688420|FG001|Overall Study|Physician Decision|3|||
48682663|NCT00592904|156688421|FG002|Overall Study|Physician Decision|1|||
48682664|NCT00592904|156688422|FG003|Overall Study|Physician Decision|0|||
48682665|NCT00592904|156688419|FG000|Overall Study|Other|3|||
48682666|NCT00592904|156688420|FG001|Overall Study|Other|3|||
48682667|NCT00592904|156688421|FG002|Overall Study|Other|0|||
48682668|NCT00592904|156688422|FG003|Overall Study|Other|0|||
48682669|NCT00398567|156688425|FG000|Overall Study|Disease Progression|3|||
48682670|NCT00398567|156688426|FG001|Overall Study|Disease Progression|4|||
48682671|NCT00398567|156688427|FG002|Overall Study|Disease Progression|27|||
48682672|NCT00398567|156688425|FG000|Overall Study|Withdrawal by Subject|1|||
48682673|NCT00398567|156688426|FG001|Overall Study|Withdrawal by Subject|0|||
48682674|NCT00398567|156688427|FG002|Overall Study|Withdrawal by Subject|4|||
48682675|NCT00398567|156688425|FG000|Overall Study|Adverse Event|0|||
48682676|NCT00398567|156688426|FG001|Overall Study|Adverse Event|0|||
48682677|NCT00398567|156688427|FG002|Overall Study|Adverse Event|2|||
48682678|NCT00398567|156688425|FG000|Overall Study|Protocol Violation|0|||
48682679|NCT00398567|156688426|FG001|Overall Study|Protocol Violation|0|||
48682680|NCT00398567|156688427|FG002|Overall Study|Protocol Violation|1|||
48682681|NCT03078556|156688428|FG000|Treatment Period 1 (4 Days)|Adverse Event|0|||
48682682|NCT03078556|156688429|FG001|Treatment Period 1 (4 Days)|Adverse Event|1|||
48682683|NCT03078556|156688430|FG002|Treatment Period 1 (4 Days)|Adverse Event|0|||
48682684|NCT03078556|156688431|FG003|Treatment Period 1 (4 Days)|Adverse Event|0|||
48682685|NCT03078556|156688428|FG000|Washout Period 1 (7 Days)|Lost to Follow-up|2|||
48682686|NCT03078556|156688429|FG001|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
48682687|NCT03078556|156688430|FG002|Washout Period 1 (7 Days)|Lost to Follow-up|1|||
48682688|NCT03078556|156688431|FG003|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
48682689|NCT03078556|156688428|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
48682690|NCT03078556|156688429|FG001|Washout Period 1 (7 Days)|Adverse Event|1|||
48682691|NCT03078556|156688430|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
48682692|NCT03078556|156688431|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
48682693|NCT03078556|156688428|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
48682694|NCT03078556|156688429|FG001|Washout Period 1 (7 Days)|Physician Decision|1|||
48682695|NCT03078556|156688430|FG002|Washout Period 1 (7 Days)|Physician Decision|0|||
48682696|NCT03078556|156688431|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
48682697|NCT03329092|156688438|FG000|Overall Study|Other|2|||
48682698|NCT03329092|156688439|FG001|Overall Study|Other|2|||
48682699|NCT03329092|156688438|FG000|Overall Study|Withdrawal by Subject|16|||
48682700|NCT03329092|156688439|FG001|Overall Study|Withdrawal by Subject|3|||
48682701|NCT03329092|156688438|FG000|Overall Study|Physician Decision|1|||
48682702|NCT03329092|156688439|FG001|Overall Study|Physician Decision|0|||
48682703|NCT03329092|156688438|FG000|Overall Study|Death|17|||
48682704|NCT03329092|156688439|FG001|Overall Study|Death|11|||
48682705|NCT03329092|156688438|FG000|Overall Study|Adverse Event|3|||
48682706|NCT03329092|156688439|FG001|Overall Study|Adverse Event|1|||
48682707|NCT03329092|156688438|FG000|Overall Study|Lost to Follow-up|1|||
48682708|NCT03329092|156688439|FG001|Overall Study|Lost to Follow-up|1|||
48682709|NCT05786508|156688440|FG000|Overall Study|Withdrawal by Subject|2|||
48682710|NCT05786508|156688441|FG001|Overall Study|Withdrawal by Subject|0|||
48682711|NCT04273893|156688442|FG000|Overall Study|Withdrawal by Subject|0|||
48682712|NCT04273893|156688443|FG001|Overall Study|Withdrawal by Subject|2|||
48682713|NCT04273893|156688442|FG000|Overall Study|Treatment of Disease Progression|0|||
48682714|NCT04273893|156688443|FG001|Overall Study|Treatment of Disease Progression|2|||
48682715|NCT04273893|156688442|FG000|Overall Study|Death|1|||
48682716|NCT04273893|156688443|FG001|Overall Study|Death|2|||
48682717|NCT04273893|156688442|FG000|Overall Study|Lost to Follow-up|0|||
48682718|NCT04273893|156688443|FG001|Overall Study|Lost to Follow-up|2|||
48682719|NCT04273893|156688442|FG000|Overall Study|Physician Decision|1|||
48682720|NCT04273893|156688443|FG001|Overall Study|Physician Decision|0|||
48682721|NCT02287467|156688450|FG000|Overall Study|Protocol Violation|12|||
48682722|NCT02287467|156688451|FG001|Overall Study|Protocol Violation|9|||
48682723|NCT01036321|156688452|FG000|Overall Study|Ineligible after randomization|0|||
48682724|NCT01036321|156688453|FG001|Overall Study|Ineligible after randomization|1|||
48682725|NCT01036321|156688452|FG000|Overall Study|Withdrawal by Subject|3|||
48682726|NCT01036321|156688453|FG001|Overall Study|Withdrawal by Subject|2|||
48682727|NCT01036321|156688452|FG000|Overall Study|Adverse Event|2|||
48682728|NCT01036321|156688453|FG001|Overall Study|Adverse Event|1|||
48682729|NCT00394706|156688454|FG000|Overall Study|Withdrawal by Subject|2|||
49021325|NCT00262600|157914386|FG000|Overall Study|Other|58|||
48682730|NCT00394706|156688455|FG001|Overall Study|Withdrawal by Subject|0|||
49021326|NCT00262600|157914387|FG001|Overall Study|Other|59|||
49021327|NCT00262600|157914388|FG002|Overall Study|Other|62|||
49021328|NCT03209570|157914389|FG000|Overall Study|Death|1|||
49021329|NCT03209570|157914390|FG001|Overall Study|Death|0|||
49021330|NCT03209570|157914389|FG000|Overall Study|Incomplete Data|8|||
48682731|NCT00394706|156688456|FG002|Overall Study|Withdrawal by Subject|1|||
48682732|NCT00394706|156688457|FG003|Overall Study|Withdrawal by Subject|0|||
48682733|NCT00394706|156688458|FG004|Overall Study|Withdrawal by Subject|0|||
48682734|NCT00394706|156688459|FG005|Overall Study|Withdrawal by Subject|2|||
48682735|NCT00394706|156688460|FG006|Overall Study|Withdrawal by Subject|1|||
48682736|NCT00394706|156688461|FG007|Overall Study|Withdrawal by Subject|0|||
48682737|NCT00394706|156688454|FG000|Overall Study|Lost to Follow-up|2|||
48682738|NCT00394706|156688455|FG001|Overall Study|Lost to Follow-up|2|||
48682739|NCT00394706|156688456|FG002|Overall Study|Lost to Follow-up|8|||
48682740|NCT00394706|156688457|FG003|Overall Study|Lost to Follow-up|1|||
49021331|NCT03209570|157914390|FG001|Overall Study|Incomplete Data|10|||
49021332|NCT03209570|157914389|FG000|Overall Study|Protocol Violation|1|||
48682741|NCT00394706|156688458|FG004|Overall Study|Lost to Follow-up|2|||
48682742|NCT00394706|156688459|FG005|Overall Study|Lost to Follow-up|5|||
48682743|NCT00394706|156688460|FG006|Overall Study|Lost to Follow-up|2|||
48682744|NCT00394706|156688461|FG007|Overall Study|Lost to Follow-up|0|||
48682745|NCT03387020|156688463|FG000|Overall Study|Adverse Event|0|||
48682746|NCT03387020|156688464|FG001|Overall Study|Adverse Event|2|||
48682747|NCT03387020|156688465|FG002|Overall Study|Adverse Event|0|||
48682748|NCT03387020|156688463|FG000|Overall Study|Withdrawal by Subject|2|||
48682749|NCT03387020|156688464|FG001|Overall Study|Withdrawal by Subject|0|||
48682750|NCT03387020|156688465|FG002|Overall Study|Withdrawal by Subject|0|||
48682751|NCT04112303|156688467|FG000|Overall Study|Death|1|||
48682752|NCT00377858|156688469|FG000|Overall Study|Withdrawal by Subject|12|||
48682753|NCT00377858|156688470|FG001|Overall Study|Withdrawal by Subject|11|||
48682754|NCT00377858|156688469|FG000|Overall Study|Lost to Follow-up|6|||
48682755|NCT00377858|156688470|FG001|Overall Study|Lost to Follow-up|1|||
48682756|NCT00377858|156688469|FG000|Overall Study|Physician Decision|5|||
48682757|NCT00377858|156688470|FG001|Overall Study|Physician Decision|5|||
48682758|NCT00377858|156688469|FG000|Overall Study|Protocol Violation|3|||
48682759|NCT00377858|156688470|FG001|Overall Study|Protocol Violation|4|||
48682760|NCT00377858|156688469|FG000|Overall Study|Adverse Event|2|||
48682761|NCT00377858|156688470|FG001|Overall Study|Adverse Event|1|||
48682762|NCT00377858|156688469|FG000|Overall Study|Entry Criteria Not Met|2|||
48682763|NCT00377858|156688470|FG001|Overall Study|Entry Criteria Not Met|0|||
48682764|NCT00377858|156688469|FG000|Overall Study|Sponsor Decision|1|||
48682765|NCT00377858|156688470|FG001|Overall Study|Sponsor Decision|2|||
48682766|NCT00377858|156688469|FG000|Overall Study|Death|0|||
48682767|NCT00377858|156688470|FG001|Overall Study|Death|3|||
48682768|NCT01685697|156688471|FG000|Overall Study|Protocol Violation|3|||
48682769|NCT01685697|156688472|FG001|Overall Study|Protocol Violation|3|||
48682770|NCT01461707|156688473|FG000|Overall Study|Withdrawal by Subject|1|||
48682771|NCT01461707|156688474|FG001|Overall Study|Withdrawal by Subject|0|||
48682772|NCT00256724|156688485|FG000|Overall Study|Physician Decision|2|||
48682773|NCT00256724|156688486|FG001|Overall Study|Physician Decision|5|||
48682774|NCT00256724|156688485|FG000|Overall Study|Protocol Violation|3|||
48682775|NCT00256724|156688486|FG001|Overall Study|Protocol Violation|3|||
48682776|NCT01076036|156688487|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|2|||
48682777|NCT01965704|156688488|FG000|Overall Study|Withdrawal by Subject|2|||
48682778|NCT01965704|156688489|FG001|Overall Study|Withdrawal by Subject|2|||
48682779|NCT01965704|156688490|FG002|Overall Study|Withdrawal by Subject|1|||
48682780|NCT01965704|156688491|FG003|Overall Study|Withdrawal by Subject|1|||
48682781|NCT01965704|156688488|FG000|Overall Study|Delivered at home|1|||
48682782|NCT01965704|156688489|FG001|Overall Study|Delivered at home|1|||
48682783|NCT01965704|156688490|FG002|Overall Study|Delivered at home|0|||
48682784|NCT01965704|156688491|FG003|Overall Study|Delivered at home|0|||
48682785|NCT01965704|156688488|FG000|Overall Study|Experienced complications|0|||
48682786|NCT01965704|156688489|FG001|Overall Study|Experienced complications|0|||
48682787|NCT01965704|156688490|FG002|Overall Study|Experienced complications|2|||
48682788|NCT01965704|156688491|FG003|Overall Study|Experienced complications|2|||
48682789|NCT01965704|156688488|FG000|Overall Study|Adverse Event|0|||
48682790|NCT01965704|156688489|FG001|Overall Study|Adverse Event|0|||
48682791|NCT01965704|156688490|FG002|Overall Study|Adverse Event|1|||
48682792|NCT01965704|156688491|FG003|Overall Study|Adverse Event|1|||
48682793|NCT01965704|156688488|FG000|Overall Study|Did not meet inclusion criteria|0|||
48682794|NCT01965704|156688489|FG001|Overall Study|Did not meet inclusion criteria|0|||
48682795|NCT01965704|156688490|FG002|Overall Study|Did not meet inclusion criteria|1|||
48682796|NCT01965704|156688491|FG003|Overall Study|Did not meet inclusion criteria|1|||
48682797|NCT00687804|156688492|FG000|Core Study|Adverse Event|5|||
48682798|NCT00687804|156688493|FG001|Core Study|Adverse Event|3|||
48682799|NCT00687804|156688494|FG002|Core Study|Adverse Event|3|||
48682800|NCT00687804|156688492|FG000|Core Study|Abnormal laboratory value(s)|1|||
48682801|NCT00687804|156688493|FG001|Core Study|Abnormal laboratory value(s)|0|||
48682802|NCT00687804|156688494|FG002|Core Study|Abnormal laboratory value(s)|0|||
48682803|NCT00687804|156688492|FG000|Core Study|Lack of Efficacy|1|||
48762932|NCT01104636|156981960|FG000|Overall Study|Ongoing|21|||
48682804|NCT00687804|156688493|FG001|Core Study|Lack of Efficacy|1|||
48682805|NCT00687804|156688494|FG002|Core Study|Lack of Efficacy|1|||
48682806|NCT00687804|156688492|FG000|Core Study|Withdrawal by Subject|4|||
48682807|NCT00687804|156688493|FG001|Core Study|Withdrawal by Subject|7|||
48682808|NCT00687804|156688494|FG002|Core Study|Withdrawal by Subject|7|||
48682809|NCT00687804|156688492|FG000|Core Study|Lost to Follow-up|0|||
48682810|NCT00687804|156688493|FG001|Core Study|Lost to Follow-up|1|||
48682811|NCT00687804|156688494|FG002|Core Study|Lost to Follow-up|0|||
48682812|NCT00687804|156688492|FG000|Core Study|Death|2|||
48682813|NCT00687804|156688493|FG001|Core Study|Death|2|||
48682814|NCT00687804|156688494|FG002|Core Study|Death|2|||
48682815|NCT00687804|156688492|FG000|Core Study|Protocol Violation|1|||
48682816|NCT00687804|156688493|FG001|Core Study|Protocol Violation|1|||
48682817|NCT00687804|156688494|FG002|Core Study|Protocol Violation|0|||
48682818|NCT00687804|156688492|FG000|Open-Label Extension Study|Adverse Event|2|||
48762933|NCT02535741|156981965|FG000|Overall Study|Adverse Event|3|||
48682819|NCT00687804|156688493|FG001|Open-Label Extension Study|Adverse Event|2|||
48682820|NCT00687804|156688494|FG002|Open-Label Extension Study|Adverse Event|2|||
48682821|NCT00687804|156688492|FG000|Open-Label Extension Study|Subject withdrew consent|3|||
49021333|NCT03209570|157914390|FG001|Overall Study|Protocol Violation|0|||
49021334|NCT03209570|157914389|FG000|Overall Study|Withdrawal by Subject|0|||
49021335|NCT03209570|157914390|FG001|Overall Study|Withdrawal by Subject|3|||
48682822|NCT00687804|156688493|FG001|Open-Label Extension Study|Subject withdrew consent|4|||
48682823|NCT00687804|156688494|FG002|Open-Label Extension Study|Subject withdrew consent|4|||
48682824|NCT00687804|156688492|FG000|Open-Label Extension Study|Lost to Follow-up|2|||
48682825|NCT00687804|156688493|FG001|Open-Label Extension Study|Lost to Follow-up|1|||
48682826|NCT00687804|156688494|FG002|Open-Label Extension Study|Lost to Follow-up|2|||
48682827|NCT00687804|156688492|FG000|Open-Label Extension Study|Administrative problems|1|||
48682828|NCT00687804|156688493|FG001|Open-Label Extension Study|Administrative problems|1|||
48682829|NCT00687804|156688494|FG002|Open-Label Extension Study|Administrative problems|0|||
48682830|NCT00687804|156688492|FG000|Open-Label Extension Study|Death|2|||
48682831|NCT00687804|156688493|FG001|Open-Label Extension Study|Death|3|||
48682832|NCT00687804|156688494|FG002|Open-Label Extension Study|Death|3|||
48682833|NCT02754726|156688495|FG000|Overall Study|Progressive Disease by RECIST|13|||
48682834|NCT02754726|156688495|FG000|Overall Study|Achieved Best Response and converted to maintenance treatment off study|12|||
48682835|NCT02754726|156688495|FG000|Overall Study|Clinical Disease Progression|5|||
48682836|NCT02754726|156688495|FG000|Overall Study|Adverse Event|3|||
48682837|NCT02754726|156688495|FG000|Overall Study|Withdrawal by Subject|1|||
48682838|NCT02754726|156688495|FG000|Overall Study|Tolerability|1|||
48682839|NCT02915263|156688496|FG000|Overall Study|Covid|3|||
48682840|NCT02915263|156688497|FG001|Overall Study|Covid|2|||
48682841|NCT01345188|156688499|FG000|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2|||
48682842|NCT01345188|156688499|FG000|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1|||
48682843|NCT01807598|156688502|FG000|Overall Study|Withdrawal by Subject|4|||
48682844|NCT01807598|156688502|FG000|Overall Study|Adverse Event|1|||
48682845|NCT01807598|156688502|FG000|Overall Study|Other Physician Decision|1|||
48682846|NCT03852719|156688504|FG000|Overall Study|Still on study after Week 192|37|||
48682847|NCT03852719|156688505|FG001|Overall Study|Still on study after Week 192|35|||
48682848|NCT03852719|156688506|FG002|Overall Study|Still on study after Week 192|35|||
48682849|NCT03852719|156688504|FG000|Overall Study|Withdrawal of consent|5|||
48682850|NCT03852719|156688505|FG001|Overall Study|Withdrawal of consent|8|||
48682851|NCT03852719|156688506|FG002|Overall Study|Withdrawal of consent|7|||
48682852|NCT03852719|156688504|FG000|Overall Study|Physician Decision|0|||
48682853|NCT03852719|156688505|FG001|Overall Study|Physician Decision|1|||
48682854|NCT03852719|156688506|FG002|Overall Study|Physician Decision|1|||
48682855|NCT03852719|156688504|FG000|Overall Study|Pregnancy|2|||
48682856|NCT03852719|156688505|FG001|Overall Study|Pregnancy|1|||
48682857|NCT03852719|156688506|FG002|Overall Study|Pregnancy|0|||
48682858|NCT03852719|156688504|FG000|Overall Study|Death|1|||
48682859|NCT03852719|156688505|FG001|Overall Study|Death|0|||
48682860|NCT03852719|156688506|FG002|Overall Study|Death|0|||
48682861|NCT03852719|156688504|FG000|Overall Study|Reason not Specified|3|||
48682862|NCT03852719|156688505|FG001|Overall Study|Reason not Specified|2|||
48682863|NCT03852719|156688506|FG002|Overall Study|Reason not Specified|2|||
48682864|NCT03852719|156688504|FG000|Overall Study|Adverse Event|1|||
48682865|NCT03852719|156688505|FG001|Overall Study|Adverse Event|0|||
48682866|NCT03852719|156688506|FG002|Overall Study|Adverse Event|4|||
48682867|NCT03852719|156688504|FG000|Overall Study|Progressive disease|1|||
48682868|NCT03852719|156688505|FG001|Overall Study|Progressive disease|2|||
48682869|NCT03852719|156688506|FG002|Overall Study|Progressive disease|1|||
48682870|NCT03852719|156688504|FG000|Overall Study|Lost to Follow-up|1|||
48682871|NCT03852719|156688505|FG001|Overall Study|Lost to Follow-up|0|||
48682872|NCT03852719|156688506|FG002|Overall Study|Lost to Follow-up|0|||
48682873|NCT01587040|156688508|FG000|Overall Study|Protocol Violation|0|||
48682874|NCT01587040|156688509|FG001|Overall Study|Protocol Violation|0|||
48682875|NCT01587040|156688510|FG002|Overall Study|Protocol Violation|1|||
48682876|NCT01587040|156688511|FG003|Overall Study|Protocol Violation|0|||
48875124|NCT01740154|157379064|FG000|Overall Study|Adverse Event|1|||
48875125|NCT00469859|157379065|FG000|Overall Study|Inevaluable|0|||
48875126|NCT00469859|157379066|FG001|Overall Study|Inevaluable|2|||
48875127|NCT02520310|157379067|FG000|At 6 Months Clinical Follow-up|Death|1|||
48875128|NCT02520310|157379067|FG000|At 1 Year Clinical Follow-up|Withdrawal by Subject|1|||
48875129|NCT02520310|157379067|FG000|AT 3 Year Clinical Follow-up|Death|2|||
48875130|NCT02520310|157379067|FG000|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2|||
48875131|NCT02520310|157379067|FG000|AT 4 Year Clinical Follow-up|Death|1|||
48682877|NCT01587040|156688508|FG000|Overall Study|Adverse Event|0|||
48682878|NCT01587040|156688509|FG001|Overall Study|Adverse Event|1|||
48682879|NCT01587040|156688510|FG002|Overall Study|Adverse Event|10|||
48682880|NCT01587040|156688511|FG003|Overall Study|Adverse Event|0|||
48682881|NCT01587040|156688508|FG000|Overall Study|Disease progression|12|||
48682882|NCT01587040|156688509|FG001|Overall Study|Disease progression|1|||
48875132|NCT02520310|157379067|FG000|AT 4 Year Clinical Follow-up|missed visit|1|||
48682883|NCT01587040|156688510|FG002|Overall Study|Disease progression|15|||
48682884|NCT01587040|156688511|FG003|Overall Study|Disease progression|3|||
48682885|NCT01587040|156688508|FG000|Overall Study|Other than specified|5|||
48682886|NCT01587040|156688509|FG001|Overall Study|Other than specified|1|||
48682887|NCT01587040|156688510|FG002|Overall Study|Other than specified|11|||
48682888|NCT01587040|156688511|FG003|Overall Study|Other than specified|1|||
48682889|NCT01670721|156688512|FG000|Overall Study|Participant's decision|15|||
48682890|NCT01670721|156688512|FG000|Overall Study|Other than specified above|38|||
48682891|NCT00794950|156688513|FG000|BCG Induction|Withdrawal by Subject|2|||
48682892|NCT00794950|156688513|FG000|BCG Induction|ineligible|3|||
48682893|NCT00794950|156688513|FG000|BCG Induction|noncompliant w. BCG|1|||
48682894|NCT00794950|156688513|FG000|BCG Induction|Adverse Event|1|||
48682895|NCT00794950|156688513|FG000|Beginning Sunitinib Treatment|cystectomy|5|||
48682896|NCT00794950|156688513|FG000|Beginning Sunitinib Treatment|Physician Decision|5|||
48682897|NCT00794950|156688513|FG000|Beginning Sunitinib Treatment|Withdrawal by Subject|1|||
48682898|NCT00794950|156688513|FG000|Beginning Sunitinib Treatment|Lost to Follow-up|1|||
48682899|NCT01777776|156688514|FG000|Overall Study|Adverse Event|2|||
48682900|NCT01777776|156688515|FG001|Overall Study|Adverse Event|4|||
48682901|NCT01777776|156688516|FG002|Overall Study|Adverse Event|0|||
48682902|NCT01777776|156688517|FG003|Overall Study|Adverse Event|0|||
48682903|NCT01777776|156688514|FG000|Overall Study|Disease Progression|4|||
48682904|NCT01777776|156688515|FG001|Overall Study|Disease Progression|8|||
48682905|NCT01777776|156688516|FG002|Overall Study|Disease Progression|6|||
48682906|NCT01777776|156688517|FG003|Overall Study|Disease Progression|3|||
48682907|NCT01777776|156688514|FG000|Overall Study|Withdrawal by Subject|0|||
48682908|NCT01777776|156688515|FG001|Overall Study|Withdrawal by Subject|0|||
48682909|NCT01777776|156688516|FG002|Overall Study|Withdrawal by Subject|0|||
48682910|NCT01777776|156688517|FG003|Overall Study|Withdrawal by Subject|1|||
48682911|NCT00650845|156688518|FG000|Overall Study|Withdrawal by Subject|5|||
48682912|NCT00650845|156688519|FG001|Overall Study|Withdrawal by Subject|0|||
48682913|NCT00650845|156688518|FG000|Overall Study|Protocol Violation|0|||
48682914|NCT00650845|156688519|FG001|Overall Study|Protocol Violation|13|||
48682915|NCT00350844|156688520|FG000|Overall Study|Lost to Follow-up|1|||
48682916|NCT00264537|156688521|FG000|Overall Study|Death|0|||
48682917|NCT00264537|156688522|FG001|Overall Study|Death|3|||
48682918|NCT00264537|156688523|FG002|Overall Study|Death|3|||
48682919|NCT00264537|156688524|FG003|Overall Study|Death|2|||
48682920|NCT00264537|156688521|FG000|Overall Study|Lost to Follow-up|3|||
48682921|NCT00264537|156688522|FG001|Overall Study|Lost to Follow-up|4|||
48682922|NCT00264537|156688523|FG002|Overall Study|Lost to Follow-up|7|||
48682923|NCT00264537|156688524|FG003|Overall Study|Lost to Follow-up|6|||
48682924|NCT00264537|156688521|FG000|Overall Study|Adverse Event|21|||
48682925|NCT00264537|156688522|FG001|Overall Study|Adverse Event|32|||
48682926|NCT00264537|156688523|FG002|Overall Study|Adverse Event|24|||
48682927|NCT00264537|156688524|FG003|Overall Study|Adverse Event|34|||
48682928|NCT00264537|156688521|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
48682929|NCT00264537|156688522|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
48682930|NCT00264537|156688523|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
48682931|NCT00264537|156688524|FG003|Overall Study|Unsatisfactory therapeutic effect|7|||
48682932|NCT00264537|156688521|FG000|Overall Study|Other|21|||
48682933|NCT00264537|156688522|FG001|Overall Study|Other|11|||
48682934|NCT00264537|156688523|FG002|Overall Study|Other|10|||
48682935|NCT00264537|156688524|FG003|Overall Study|Other|11|||
48682936|NCT00264537|156688521|FG000|Overall Study|Not treated|0|||
48682937|NCT00264537|156688522|FG001|Overall Study|Not treated|2|||
48682938|NCT00264537|156688523|FG002|Overall Study|Not treated|1|||
48682939|NCT00264537|156688524|FG003|Overall Study|Not treated|0|||
48682940|NCT03210961|156690546|FG000|Overall Study|Adverse Event|0|||
48682941|NCT03210961|156690547|FG001|Overall Study|Adverse Event|0|||
48682942|NCT03210961|156690548|FG002|Overall Study|Adverse Event|0|||
48682943|NCT03210961|156690549|FG003|Overall Study|Adverse Event|0|||
48682944|NCT03210961|156690550|FG004|Overall Study|Adverse Event|0|||
48682945|NCT03210961|156690551|FG005|Overall Study|Adverse Event|0|||
48682946|NCT03210961|156690552|FG006|Overall Study|Adverse Event|0|||
48682947|NCT03210961|156690553|FG007|Overall Study|Adverse Event|0|||
48682948|NCT03210961|156690554|FG008|Overall Study|Adverse Event|0|||
48682949|NCT03210961|156690555|FG009|Overall Study|Adverse Event|0|||
48682950|NCT03210961|156690556|FG010|Overall Study|Adverse Event|0|||
48682951|NCT03210961|156690557|FG011|Overall Study|Adverse Event|0|||
48682952|NCT03210961|156690558|FG012|Overall Study|Adverse Event|0|||
48682953|NCT03210961|156690559|FG013|Overall Study|Adverse Event|1|||
48875133|NCT02575950|157379068|FG000|Overall Study|Withdrawal by Subject|0|||
48682954|NCT03210961|156690560|FG014|Overall Study|Adverse Event|0|||
48682955|NCT03210961|156690546|FG000|Overall Study|Lost to Follow-up|0|||
48682956|NCT03210961|156690547|FG001|Overall Study|Lost to Follow-up|0|||
48682957|NCT03210961|156690548|FG002|Overall Study|Lost to Follow-up|0|||
48682958|NCT03210961|156690549|FG003|Overall Study|Lost to Follow-up|0|||
48682959|NCT03210961|156690550|FG004|Overall Study|Lost to Follow-up|0|||
48682960|NCT03210961|156690551|FG005|Overall Study|Lost to Follow-up|0|||
48682961|NCT03210961|156690552|FG006|Overall Study|Lost to Follow-up|0|||
48682962|NCT03210961|156690553|FG007|Overall Study|Lost to Follow-up|0|||
48682963|NCT03210961|156690554|FG008|Overall Study|Lost to Follow-up|0|||
48682964|NCT03210961|156690555|FG009|Overall Study|Lost to Follow-up|0|||
48682965|NCT03210961|156690556|FG010|Overall Study|Lost to Follow-up|0|||
48682966|NCT03210961|156690557|FG011|Overall Study|Lost to Follow-up|0|||
48682967|NCT03210961|156690558|FG012|Overall Study|Lost to Follow-up|0|||
48682968|NCT03210961|156690559|FG013|Overall Study|Lost to Follow-up|0|||
48682969|NCT03210961|156690560|FG014|Overall Study|Lost to Follow-up|1|||
48682970|NCT03210961|156690546|FG000|Overall Study|Withdrawal by Subject|0|||
48682971|NCT03210961|156690547|FG001|Overall Study|Withdrawal by Subject|0|||
48682972|NCT03210961|156690548|FG002|Overall Study|Withdrawal by Subject|0|||
48682973|NCT03210961|156690549|FG003|Overall Study|Withdrawal by Subject|0|||
48682974|NCT03210961|156690550|FG004|Overall Study|Withdrawal by Subject|0|||
48682975|NCT03210961|156690551|FG005|Overall Study|Withdrawal by Subject|0|||
48682976|NCT03210961|156690552|FG006|Overall Study|Withdrawal by Subject|0|||
48682977|NCT03210961|156690553|FG007|Overall Study|Withdrawal by Subject|0|||
48682978|NCT03210961|156690554|FG008|Overall Study|Withdrawal by Subject|0|||
48682979|NCT03210961|156690555|FG009|Overall Study|Withdrawal by Subject|0|||
48682980|NCT03210961|156690556|FG010|Overall Study|Withdrawal by Subject|0|||
48682981|NCT03210961|156690557|FG011|Overall Study|Withdrawal by Subject|0|||
48682982|NCT03210961|156690558|FG012|Overall Study|Withdrawal by Subject|0|||
48682983|NCT03210961|156690559|FG013|Overall Study|Withdrawal by Subject|0|||
48682984|NCT03210961|156690560|FG014|Overall Study|Withdrawal by Subject|1|||
48682985|NCT03210961|156690546|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
48682986|NCT03210961|156690547|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
48682987|NCT03210961|156690548|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
48682988|NCT03210961|156690549|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
48682989|NCT03210961|156690550|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
48682990|NCT03210961|156690551|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
48682991|NCT03210961|156690552|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
48682992|NCT03210961|156690553|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
48682993|NCT03210961|156690554|FG008|Overall Study|No Longer Meets Eligibility Criteria|0|||
48682994|NCT03210961|156690555|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
48682995|NCT03210961|156690556|FG010|Overall Study|No Longer Meets Eligibility Criteria|0|||
48682996|NCT03210961|156690557|FG011|Overall Study|No Longer Meets Eligibility Criteria|0|||
48682997|NCT03210961|156690558|FG012|Overall Study|No Longer Meets Eligibility Criteria|0|||
48682998|NCT03210961|156690559|FG013|Overall Study|No Longer Meets Eligibility Criteria|1|||
48682999|NCT03210961|156690560|FG014|Overall Study|No Longer Meets Eligibility Criteria|0|||
48683000|NCT03210961|156690546|FG000|Overall Study|Other|0|||
48683001|NCT03210961|156690547|FG001|Overall Study|Other|0|||
48683002|NCT03210961|156690548|FG002|Overall Study|Other|0|||
48683003|NCT03210961|156690549|FG003|Overall Study|Other|1|||
48683004|NCT03210961|156690550|FG004|Overall Study|Other|0|||
48683005|NCT03210961|156690551|FG005|Overall Study|Other|0|||
48683006|NCT03210961|156690552|FG006|Overall Study|Other|1|||
48683007|NCT03210961|156690553|FG007|Overall Study|Other|0|||
48683008|NCT03210961|156690554|FG008|Overall Study|Other|0|||
48683009|NCT03210961|156690555|FG009|Overall Study|Other|0|||
48683010|NCT03210961|156690556|FG010|Overall Study|Other|1|||
48683011|NCT03210961|156690557|FG011|Overall Study|Other|0|||
48683012|NCT03210961|156690558|FG012|Overall Study|Other|2|||
48683013|NCT03210961|156690559|FG013|Overall Study|Other|2|||
48683014|NCT03210961|156690560|FG014|Overall Study|Other|0|||
48683015|NCT00602420|156690562|FG000|Overall Study|Death|1|||
48683016|NCT00602420|156690563|FG001|Overall Study|Death|4|||
48683017|NCT00602420|156690562|FG000|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5|||
48683018|NCT00602420|156690563|FG001|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3|||
48683019|NCT00602420|156690562|FG000|Overall Study|Withdrawal by Subject|18|||
48683020|NCT00602420|156690563|FG001|Overall Study|Withdrawal by Subject|17|||
48683021|NCT00602420|156690562|FG000|Overall Study|Adverse Event|1|||
48683022|NCT00602420|156690563|FG001|Overall Study|Adverse Event|0|||
48683023|NCT03077919|156690564|FG000|Overall Study|Lost to Follow-up|4|||
48683024|NCT03077919|156690565|FG001|Overall Study|Lost to Follow-up|1|||
48683025|NCT04566601|156690566|FG000|Overall Study|Other than listed|13|||
48683026|NCT04566601|156690567|FG001|Overall Study|Other than listed|4|||
48683027|NCT04566601|156690568|FG002|Overall Study|Other than listed|2|||
48683028|NCT04566601|156690569|FG003|Overall Study|Other than listed|1|||
48683029|NCT04566601|156690570|FG004|Overall Study|Other than listed|4|||
48683030|NCT04566601|156690566|FG000|Overall Study|Protocol deviation|3|||
48683031|NCT04566601|156690567|FG001|Overall Study|Protocol deviation|0|||
48683032|NCT04566601|156690568|FG002|Overall Study|Protocol deviation|1|||
48683033|NCT04566601|156690569|FG003|Overall Study|Protocol deviation|1|||
48683034|NCT04566601|156690570|FG004|Overall Study|Protocol deviation|1|||
48683035|NCT04566601|156690566|FG000|Overall Study|Technical problems|0|||
48683036|NCT04566601|156690567|FG001|Overall Study|Technical problems|0|||
48683037|NCT04566601|156690568|FG002|Overall Study|Technical problems|1|||
48683038|NCT04566601|156690569|FG003|Overall Study|Technical problems|0|||
48683039|NCT04566601|156690570|FG004|Overall Study|Technical problems|0|||
48683040|NCT04566601|156690566|FG000|Overall Study|No reason available|3|||
48683041|NCT04566601|156690567|FG001|Overall Study|No reason available|2|||
48683042|NCT04566601|156690568|FG002|Overall Study|No reason available|7|||
48683043|NCT04566601|156690569|FG003|Overall Study|No reason available|1|||
48683044|NCT04566601|156690570|FG004|Overall Study|No reason available|5|||
48683045|NCT04566601|156690566|FG000|Overall Study|Burden of study procedures|3|||
48683046|NCT04566601|156690567|FG001|Overall Study|Burden of study procedures|0|||
48683047|NCT04566601|156690568|FG002|Overall Study|Burden of study procedures|0|||
48683048|NCT04566601|156690569|FG003|Overall Study|Burden of study procedures|3|||
48683049|NCT04566601|156690570|FG004|Overall Study|Burden of study procedures|1|||
48683050|NCT04566601|156690566|FG000|Overall Study|Change of residence|2|||
48683051|NCT04566601|156690567|FG001|Overall Study|Change of residence|2|||
48683052|NCT04566601|156690568|FG002|Overall Study|Change of residence|0|||
48683053|NCT04566601|156690569|FG003|Overall Study|Change of residence|1|||
49021336|NCT01031537|157914391|FG000|Overall Study|medical reasons not related to study|3|||
49021337|NCT01031537|157914391|FG000|Overall Study|Lack of Efficacy|1|||
48683054|NCT04566601|156690570|FG004|Overall Study|Change of residence|2|||
48683055|NCT04566601|156690566|FG000|Overall Study|Perceived lack of efficacy|2|||
48683056|NCT04566601|156690567|FG001|Overall Study|Perceived lack of efficacy|0|||
48683057|NCT04566601|156690568|FG002|Overall Study|Perceived lack of efficacy|1|||
49021338|NCT01031537|157914391|FG000|Overall Study|retired from NIH, met exclusion criteria|1|||
49021339|NCT01031537|157914391|FG000|Overall Study|moved, met exclusion criteria|10|||
49021340|NCT01031537|157914391|FG000|Overall Study|Withdrawal by Subject|5|||
49021341|NCT01031537|157914391|FG000|Overall Study|PI removal, no longer met eligibility|12|||
49021342|NCT04471207|157914394|FG000|Overall Study|Lost to Follow-up|4|||
49021343|NCT04471207|157914395|FG001|Overall Study|Lost to Follow-up|1|||
49021344|NCT04471207|157914394|FG000|Overall Study|Medication Contraindication|0|||
49021345|NCT04471207|157914395|FG001|Overall Study|Medication Contraindication|1|||
49021346|NCT04471207|157914394|FG000|Overall Study|Loss of Interest|2|||
49021347|NCT04471207|157914395|FG001|Overall Study|Loss of Interest|1|||
49021348|NCT04471207|157914394|FG000|Overall Study|Unwilling to Discuss Trauma|1|||
49021349|NCT04471207|157914395|FG001|Overall Study|Unwilling to Discuss Trauma|1|||
49021350|NCT04471207|157914394|FG000|Overall Study|Scheduling Conflicts|3|||
49021351|NCT04471207|157914395|FG001|Overall Study|Scheduling Conflicts|1|||
49021352|NCT04471207|157914394|FG000|Overall Study|Physician Decision|1|||
49021353|NCT04471207|157914395|FG001|Overall Study|Physician Decision|0|||
49021354|NCT04471207|157914394|FG000|Overall Study|Unwilling to Use System|0|||
49021355|NCT04471207|157914395|FG001|Overall Study|Unwilling to Use System|1|||
48683058|NCT04566601|156690569|FG003|Overall Study|Perceived lack of efficacy|1|||
48683059|NCT04566601|156690570|FG004|Overall Study|Perceived lack of efficacy|2|||
48683060|NCT04566601|156690566|FG000|Overall Study|Adverse Event|7|||
48683061|NCT04566601|156690567|FG001|Overall Study|Adverse Event|4|||
48683062|NCT04566601|156690568|FG002|Overall Study|Adverse Event|6|||
48683063|NCT04566601|156690569|FG003|Overall Study|Adverse Event|5|||
48683064|NCT04566601|156690570|FG004|Overall Study|Adverse Event|12|||
48683065|NCT00931606|156690573|FG000|Overall Study|Death|1|||
48683066|NCT00931606|156690574|FG001|Overall Study|Death|3|||
48683067|NCT00931606|156690575|FG002|Overall Study|Death|2|||
48683068|NCT00931606|156690576|FG003|Overall Study|Death|0|||
48683069|NCT00931606|156690573|FG000|Overall Study|Lost to Follow-up|0|||
48683070|NCT00931606|156690574|FG001|Overall Study|Lost to Follow-up|1|||
48683071|NCT00931606|156690575|FG002|Overall Study|Lost to Follow-up|0|||
48683072|NCT00931606|156690576|FG003|Overall Study|Lost to Follow-up|0|||
48683073|NCT00931606|156690573|FG000|Overall Study|Physician Decision|0|||
48683074|NCT00931606|156690574|FG001|Overall Study|Physician Decision|0|||
48683075|NCT00931606|156690575|FG002|Overall Study|Physician Decision|3|||
48683076|NCT00931606|156690576|FG003|Overall Study|Physician Decision|0|||
48683077|NCT00931606|156690573|FG000|Overall Study|Sponsor Decision|1|||
48683078|NCT00931606|156690574|FG001|Overall Study|Sponsor Decision|4|||
48762934|NCT02535741|156981965|FG000|Overall Study|Withdrawal by Subject|9|||
48762935|NCT02535741|156981965|FG000|Overall Study|Lost to Follow-up|10|||
49021356|NCT02655237|157914396|FG000|Overall Study|Adverse Event|10|||
48683079|NCT00931606|156690575|FG002|Overall Study|Sponsor Decision|0|||
48683080|NCT00931606|156690576|FG003|Overall Study|Sponsor Decision|2|||
48683081|NCT00931606|156690573|FG000|Overall Study|Withdrawal by Subject|3|||
48683082|NCT00931606|156690574|FG001|Overall Study|Withdrawal by Subject|1|||
48683083|NCT00931606|156690575|FG002|Overall Study|Withdrawal by Subject|1|||
48683084|NCT00931606|156690576|FG003|Overall Study|Withdrawal by Subject|1|||
48683085|NCT03828617|156690585|FG000|Overall Study|Lost to Follow-up|22|||
48683086|NCT03828617|156690586|FG001|Overall Study|Lost to Follow-up|12|||
48683087|NCT03828617|156690587|FG002|Overall Study|Lost to Follow-up|23|||
48683088|NCT03828617|156690588|FG003|Overall Study|Lost to Follow-up|7|||
48683089|NCT03828617|156690585|FG000|Overall Study|No longer met eligibility criteria|0|||
48683090|NCT03828617|156690586|FG001|Overall Study|No longer met eligibility criteria|1|||
48683091|NCT03828617|156690587|FG002|Overall Study|No longer met eligibility criteria|1|||
48762936|NCT02535741|156981965|FG000|Overall Study|Exclusion criteria: Bilateral implant|4|||
49021357|NCT02655237|157914397|FG001|Overall Study|Adverse Event|7|||
49021358|NCT02655237|157914396|FG000|Overall Study|Protocol Deviation|2|||
49021359|NCT02655237|157914397|FG001|Overall Study|Protocol Deviation|0|||
49021360|NCT02655237|157914396|FG000|Overall Study|Withdrawal by Participant|1|||
49021361|NCT02655237|157914397|FG001|Overall Study|Withdrawal by Participant|2|||
49021362|NCT02655237|157914396|FG000|Overall Study|Lack of Efficacy|0|||
48683092|NCT03828617|156690588|FG003|Overall Study|No longer met eligibility criteria|3|||
48683093|NCT03828617|156690585|FG000|Overall Study|Protocol Violation|0|||
48683094|NCT03828617|156690586|FG001|Overall Study|Protocol Violation|2|||
48683095|NCT03828617|156690587|FG002|Overall Study|Protocol Violation|0|||
48683096|NCT03828617|156690588|FG003|Overall Study|Protocol Violation|0|||
48683097|NCT03828617|156690585|FG000|Overall Study|Withdrawal by Subject|2|||
48683098|NCT03828617|156690586|FG001|Overall Study|Withdrawal by Subject|0|||
48683099|NCT03828617|156690587|FG002|Overall Study|Withdrawal by Subject|2|||
48683100|NCT03828617|156690588|FG003|Overall Study|Withdrawal by Subject|0|||
48683101|NCT01016600|156690591|FG000|Overall Study|Did not start treatment|1|||
49021363|NCT02655237|157914397|FG001|Overall Study|Lack of Efficacy|1|||
49021364|NCT02655237|157914396|FG000|Overall Study|Recovery Leading to Surgery|2|||
49021365|NCT02655237|157914397|FG001|Overall Study|Recovery Leading to Surgery|1|||
49021366|NCT02655237|157914396|FG000|Overall Study|Reduction of Hemoglobin Concentration|1|||
49021367|NCT02655237|157914397|FG001|Overall Study|Reduction of Hemoglobin Concentration|0|||
48683102|NCT01016600|156690592|FG001|Overall Study|Did not start treatment|0|||
48683103|NCT01016600|156690593|FG002|Overall Study|Did not start treatment|0|||
49021368|NCT02655237|157914396|FG000|Overall Study|Randomized but Not Treated|1|||
49021369|NCT02655237|157914397|FG001|Overall Study|Randomized but Not Treated|0|||
49021370|NCT02132247|157914407|FG000|Overall Study|Protocol Violation|1|||
49021371|NCT02132247|157914408|FG001|Overall Study|Protocol Violation|0|||
49021372|NCT00561730|157914409|FG000|Overall Study|Adverse Event|2|||
49021373|NCT00561730|157914409|FG000|Overall Study|Handling of the drug|1|||
49021374|NCT00561730|157914409|FG000|Overall Study|Lost to Follow-up|5|||
49021375|NCT00561730|157914409|FG000|Overall Study|Not specified reasons|1|||
49021376|NCT00376220|157914410|FG000|Overall Study|Lost to Follow-up|7|||
49021377|NCT00376220|157914411|FG001|Overall Study|Lost to Follow-up|10|||
49021378|NCT00376220|157914410|FG000|Overall Study|Withdrawal by Subject|3|||
49021379|NCT00376220|157914411|FG001|Overall Study|Withdrawal by Subject|2|||
49021380|NCT00220701|157914414|FG000|Overall Study|Lost to Follow-up|5|||
49021381|NCT00220701|157914415|FG001|Overall Study|Lost to Follow-up|4|||
49021382|NCT00723554|157914416|FG000|Overall Study|Adverse Event|12|||
49021383|NCT00723554|157914416|FG000|Overall Study|Investigator's judgement|5|||
49021384|NCT00723554|157914416|FG000|Overall Study|Inhaled medication other than iloprost|4|||
49021385|NCT00723554|157914416|FG000|Overall Study|Withdrawal of consent|3|||
49021386|NCT00723554|157914416|FG000|Overall Study|Other|3|||
49021387|NCT00723554|157914416|FG000|Overall Study|Lost to Follow-up|1|||
48683104|NCT01016600|156690594|FG003|Overall Study|Did not start treatment|0|||
48683105|NCT03229109|156690595|FG000|Overall Study|Withdrawal by Subject|0|||
48683106|NCT03229109|156690596|FG001|Overall Study|Withdrawal by Subject|0|||
48683107|NCT03229109|156690597|FG002|Overall Study|Withdrawal by Subject|0|||
48683108|NCT03229109|156690598|FG003|Overall Study|Withdrawal by Subject|1|||
48683109|NCT01449006|156690603|FG000|Overall Study|Lost to Follow-up|1|||
48683110|NCT01449006|156690604|FG001|Overall Study|Lost to Follow-up|0|||
48683111|NCT01449006|156690603|FG000|Overall Study|Withdrawal by Subject|1|||
48683112|NCT01449006|156690604|FG001|Overall Study|Withdrawal by Subject|0|||
48683113|NCT01449006|156690603|FG000|Overall Study|Protocol Violation|1|||
48683114|NCT01449006|156690604|FG001|Overall Study|Protocol Violation|0|||
48683115|NCT02223715|156690605|FG000|Overall Study|Death|31|||
48683116|NCT02223715|156690605|FG000|Overall Study|Lost to Follow-up|73|||
48683117|NCT02630472|156690610|FG000|Overall Study|Physician Decision|10|||
48683118|NCT02630472|156690611|FG001|Overall Study|Physician Decision|0|||
48683119|NCT02598297|156690612|FG000|Overall Study|Study terminated by Sponsor|21|||
48683120|NCT02598297|156690613|FG001|Overall Study|Study terminated by Sponsor|23|||
48683121|NCT02598297|156690612|FG000|Overall Study|Adverse Event|1|||
48683122|NCT02598297|156690613|FG001|Overall Study|Adverse Event|1|||
48683123|NCT02598297|156690612|FG000|Overall Study|Physician Decision|1|||
48683124|NCT02598297|156690613|FG001|Overall Study|Physician Decision|0|||
48683125|NCT02598297|156690612|FG000|Overall Study|Subject/guardian decision|1|||
48683126|NCT02598297|156690613|FG001|Overall Study|Subject/guardian decision|0|||
48683127|NCT02598297|156690612|FG000|Overall Study|Followed for survival|1|||
48683128|NCT02598297|156690613|FG001|Overall Study|Followed for survival|0|||
48683129|NCT00413036|156690617|FG000|Overall Study|Adverse Event|44|||
48683130|NCT00413036|156690617|FG000|Overall Study|Lack of Efficacy|129|||
48683131|NCT00413036|156690617|FG000|Overall Study|Withdrawal by Subject|7|||
48683132|NCT00413036|156690617|FG000|Overall Study|Death|9|||
48683133|NCT00413036|156690617|FG000|Overall Study|Other|26|||
48683134|NCT00413036|156690617|FG000|Overall Study|Missing|2|||
49021388|NCT00723554|157914416|FG000|Overall Study|Non-compliance|1|||
49021389|NCT00436007|157914425|FG000|Overall Study|Withdrawal by Subject|5|||
49021390|NCT00436007|157914426|FG001|Overall Study|Withdrawal by Subject|3|||
49021391|NCT00436007|157914427|FG002|Overall Study|Withdrawal by Subject|4|||
49021392|NCT00436007|157914425|FG000|Overall Study|Lost to Follow-up|14|||
48683135|NCT02045095|156690620|FG000|Overall Study|Other|0|||
48683136|NCT02045095|156690621|FG001|Overall Study|Other|0|||
48683137|NCT02045095|156690622|FG002|Overall Study|Other|1|||
48683138|NCT02045095|156690623|FG003|Overall Study|Other|0|||
48683139|NCT02045095|156690624|FG004|Overall Study|Other|0|||
49021393|NCT00436007|157914426|FG001|Overall Study|Lost to Follow-up|10|||
49021394|NCT00436007|157914427|FG002|Overall Study|Lost to Follow-up|13|||
49021395|NCT00436007|157914425|FG000|Overall Study|Physician Decision|0|||
49021396|NCT00436007|157914426|FG001|Overall Study|Physician Decision|0|||
49021397|NCT00436007|157914427|FG002|Overall Study|Physician Decision|2|||
49021398|NCT00436007|157914425|FG000|Overall Study|Death|0|||
49021399|NCT00436007|157914426|FG001|Overall Study|Death|1|||
49021400|NCT00436007|157914427|FG002|Overall Study|Death|3|||
49021401|NCT00436007|157914425|FG000|Overall Study|Other|0|||
49021402|NCT00436007|157914426|FG001|Overall Study|Other|0|||
49021403|NCT00436007|157914427|FG002|Overall Study|Other|1|||
49021404|NCT04041570|157914431|FG000|Overall Study|Moved from Area|0|||
49021405|NCT04041570|157914432|FG001|Overall Study|Moved from Area|2|||
49021406|NCT01180244|157914433|FG000|Overall Study|Lack of Efficacy|0|||
49021407|NCT01180244|157914434|FG001|Overall Study|Lack of Efficacy|7|||
49021408|NCT01180244|157914433|FG000|Overall Study|Physician Decision|3|||
49021409|NCT01180244|157914434|FG001|Overall Study|Physician Decision|0|||
49021410|NCT01180244|157914433|FG000|Overall Study|Adverse Event|1|||
49021411|NCT01180244|157914434|FG001|Overall Study|Adverse Event|0|||
49021412|NCT01180244|157914433|FG000|Overall Study|Withdrawal by Subject|0|||
49021413|NCT01180244|157914434|FG001|Overall Study|Withdrawal by Subject|1|||
49021414|NCT01180244|157914433|FG000|Overall Study|Protocol Violation|1|||
49021415|NCT01180244|157914434|FG001|Overall Study|Protocol Violation|0|||
49021416|NCT01180244|157914433|FG000|Overall Study|Lost to Follow-up|1|||
49021417|NCT01180244|157914434|FG001|Overall Study|Lost to Follow-up|0|||
49021418|NCT03331042|157914441|FG000|Overall Study|Protocol Violation|1|||
49021419|NCT03331042|157914442|FG001|Overall Study|Protocol Violation|0|||
49021420|NCT03331042|157914443|FG002|Overall Study|Protocol Violation|0|||
49021421|NCT03331042|157914444|FG003|Overall Study|Protocol Violation|0|||
49021422|NCT03331042|157914441|FG000|Overall Study|Physician Decision|0|||
49021423|NCT03331042|157914442|FG001|Overall Study|Physician Decision|0|||
49021424|NCT03331042|157914443|FG002|Overall Study|Physician Decision|1|||
49021425|NCT03331042|157914444|FG003|Overall Study|Physician Decision|0|||
49021426|NCT03331042|157914441|FG000|Overall Study|Lost to Follow-up|0|||
49021427|NCT03331042|157914442|FG001|Overall Study|Lost to Follow-up|0|||
49021428|NCT03331042|157914443|FG002|Overall Study|Lost to Follow-up|0|||
49021429|NCT03331042|157914444|FG003|Overall Study|Lost to Follow-up|1|||
49021430|NCT01475838|157914445|FG000|Randomized Phase|Randomized but Not Treated|0|||
49021431|NCT01475838|157914446|FG001|Randomized Phase|Randomized but Not Treated|5|||
49021432|NCT01475838|157914445|FG000|Randomized Phase|Adverse Event|6|||
49021433|NCT01475838|157914446|FG001|Randomized Phase|Adverse Event|1|||
49021434|NCT01475838|157914445|FG000|Randomized Phase|Pregnancy|0|||
49021435|NCT01475838|157914446|FG001|Randomized Phase|Pregnancy|1|||
49021436|NCT01475838|157914445|FG000|Randomized Phase|Investigators Discretion|1|||
49021437|NCT01475838|157914446|FG001|Randomized Phase|Investigators Discretion|2|||
49021438|NCT01475838|157914445|FG000|Randomized Phase|Withdrew Consent|10|||
49021439|NCT01475838|157914446|FG001|Randomized Phase|Withdrew Consent|14|||
49021440|NCT01475838|157914445|FG000|Randomized Phase|Lost to Follow-up|3|||
49021441|NCT01475838|157914446|FG001|Randomized Phase|Lost to Follow-up|4|||
49021442|NCT01475838|157914445|FG000|Randomized Phase|Participant Noncompliance|1|||
49021443|NCT01475838|157914446|FG001|Randomized Phase|Participant Noncompliance|5|||
49021444|NCT01475838|157914445|FG000|Randomized Phase|Protocol Violation|9|||
49021445|NCT01475838|157914446|FG001|Randomized Phase|Protocol Violation|4|||
49021446|NCT01475838|157914445|FG000|Extension Phase|Participant Noncompliance|1|||
49021447|NCT01475838|157914446|FG001|Extension Phase|Participant Noncompliance|0|||
49021448|NCT01694485|157914450|FG000|Overall Study|Withdrawal by Subject|20|||
49021449|NCT01694485|157914451|FG001|Overall Study|Withdrawal by Subject|6|||
49021450|NCT01694485|157914452|FG002|Overall Study|Withdrawal by Subject|7|||
48683140|NCT02045095|156690625|FG005|Overall Study|Other|2|||
48875134|NCT02575950|157379069|FG001|Overall Study|Withdrawal by Subject|0|||
48875135|NCT02575950|157379070|FG002|Overall Study|Withdrawal by Subject|0|||
49021451|NCT01694485|157914453|FG003|Overall Study|Withdrawal by Subject|25|||
49021452|NCT01694485|157914454|FG004|Overall Study|Withdrawal by Subject|18|||
49021453|NCT01694485|157914450|FG000|Overall Study|Sponsor Decision|3|||
49021454|NCT01694485|157914451|FG001|Overall Study|Sponsor Decision|0|||
49021455|NCT01694485|157914452|FG002|Overall Study|Sponsor Decision|0|||
49021456|NCT01694485|157914453|FG003|Overall Study|Sponsor Decision|2|||
49021457|NCT01694485|157914454|FG004|Overall Study|Sponsor Decision|0|||
49021458|NCT01694485|157914450|FG000|Overall Study|Lost to Follow-up|9|||
48683141|NCT02045095|156690626|FG006|Overall Study|Other|0|||
49021459|NCT01694485|157914451|FG001|Overall Study|Lost to Follow-up|1|||
49021460|NCT01694485|157914452|FG002|Overall Study|Lost to Follow-up|6|||
49021461|NCT01694485|157914453|FG003|Overall Study|Lost to Follow-up|10|||
49021462|NCT01694485|157914454|FG004|Overall Study|Lost to Follow-up|7|||
48683142|NCT02045095|156690620|FG000|Overall Study|Progressive Disease|3|||
48683143|NCT02045095|156690621|FG001|Overall Study|Progressive Disease|3|||
48683144|NCT02045095|156690622|FG002|Overall Study|Progressive Disease|2|||
48683145|NCT02045095|156690623|FG003|Overall Study|Progressive Disease|4|||
48683146|NCT02045095|156690624|FG004|Overall Study|Progressive Disease|2|||
48683147|NCT02045095|156690625|FG005|Overall Study|Progressive Disease|4|||
49021463|NCT01694485|157914450|FG000|Overall Study|Death|1|||
49021464|NCT01694485|157914451|FG001|Overall Study|Death|0|||
49021465|NCT01694485|157914452|FG002|Overall Study|Death|0|||
49021466|NCT01694485|157914453|FG003|Overall Study|Death|1|||
49021467|NCT01694485|157914454|FG004|Overall Study|Death|0|||
49021468|NCT02907203|157914455|FG000|Overall Study|Death|1|||
49021469|NCT02907203|157914455|FG000|Overall Study|Lost to Follow-up|3|||
49021470|NCT02907203|157914455|FG000|Overall Study|Withdrawal by Subject|3|||
49021471|NCT02907203|157914455|FG000|Overall Study|Surgical bypass|1|||
49021472|NCT00662025|157914459|FG000|Overall Study|Objective progression or relapse|51|||
49021473|NCT00662025|157914459|FG000|Overall Study|Adverse Event|7|||
49021474|NCT00662025|157914459|FG000|Overall Study|Withdrawal by Subject|1|||
48683148|NCT02045095|156690626|FG006|Overall Study|Progressive Disease|1|||
48683149|NCT02045095|156690620|FG000|Overall Study|Withdrawal by Subject|0|||
48683150|NCT02045095|156690621|FG001|Overall Study|Withdrawal by Subject|0|||
48683151|NCT02045095|156690622|FG002|Overall Study|Withdrawal by Subject|0|||
48683152|NCT02045095|156690623|FG003|Overall Study|Withdrawal by Subject|0|||
48981117|NCT03950440|157764172|FG001|Overall Study|Death|2|||
48981118|NCT03950440|157764173|FG002|Overall Study|Death|1|||
48981119|NCT02892734|157764174|FG000|Treatment on Study|Progressive Disease|2|||
48981120|NCT02892734|157764174|FG000|Follow up for 2 Years|Death|2|||
48981121|NCT02892734|157764174|FG000|Follow up for 2 Years|Study closed early|1|||
48683153|NCT02045095|156690624|FG004|Overall Study|Withdrawal by Subject|3|||
48683154|NCT02045095|156690625|FG005|Overall Study|Withdrawal by Subject|0|||
48683155|NCT02045095|156690626|FG006|Overall Study|Withdrawal by Subject|0|||
48683156|NCT02045095|156690620|FG000|Overall Study|Adverse Event|0|||
48683157|NCT02045095|156690621|FG001|Overall Study|Adverse Event|1|||
48683158|NCT02045095|156690622|FG002|Overall Study|Adverse Event|1|||
48683159|NCT02045095|156690623|FG003|Overall Study|Adverse Event|0|||
48683160|NCT02045095|156690624|FG004|Overall Study|Adverse Event|0|||
48683161|NCT02045095|156690625|FG005|Overall Study|Adverse Event|2|||
48683162|NCT02045095|156690626|FG006|Overall Study|Adverse Event|0|||
48683163|NCT04098809|156690627|FG000|Overall Study|Withdrawal by Subject|1|||
48683164|NCT04098809|156690628|FG001|Overall Study|Withdrawal by Subject|3|||
48683165|NCT04098809|156690627|FG000|Overall Study|Physician Decision|2|||
48683166|NCT04098809|156690628|FG001|Overall Study|Physician Decision|1|||
48683167|NCT00080301|156690631|FG000|Overall Study|Randomized but Never Treated|5|||
48683168|NCT00080301|156690632|FG001|Overall Study|Randomized but Never Treated|10|||
48683169|NCT00080301|156690631|FG000|Overall Study|Still on Treatment as of CSR date|0|||
48683170|NCT00080301|156690632|FG001|Overall Study|Still on Treatment as of CSR date|1|||
48683171|NCT02506192|156690637|FG000|Overall Study|Withdrawal by Subject|1|||
48683172|NCT02506192|156690638|FG001|Overall Study|Withdrawal by Subject|1|||
48683173|NCT00740584|156690639|FG000|Overall Study|Withdrawal by Subject|1|||
48683174|NCT00337207|156690653|FG000|Overall Study|Withdrawal by Subject|3|||
48683175|NCT00837213|156690656|FG000|Overall Study|Lost to Follow-up|3|||
48683176|NCT00837213|156690657|FG001|Overall Study|Lost to Follow-up|2|||
48683177|NCT00837213|156690656|FG000|Overall Study|Withdrawal by Subject|2|||
48683178|NCT00837213|156690657|FG001|Overall Study|Withdrawal by Subject|2|||
48683179|NCT00837213|156690656|FG000|Overall Study|not stated|1|||
48683180|NCT00837213|156690657|FG001|Overall Study|not stated|1|||
48683181|NCT00687739|156690661|FG000|Overall Study|Lost to Follow-up|2|||
48762937|NCT02535741|156981965|FG000|Overall Study|Missing data|6|||
48981122|NCT01957215|157764179|FG000|Overall Study|Adverse Event|2|||
48981123|NCT01957215|157764180|FG001|Overall Study|Adverse Event|2|||
48981124|NCT01957215|157764179|FG000|Overall Study|Lost to Follow-up|3|||
48981125|NCT01957215|157764180|FG001|Overall Study|Lost to Follow-up|3|||
48981126|NCT01957215|157764179|FG000|Overall Study|Protocol Violation|1|||
48981127|NCT01957215|157764180|FG001|Overall Study|Protocol Violation|2|||
48683182|NCT00687739|156690662|FG001|Overall Study|Lost to Follow-up|2|||
48683183|NCT00687739|156690663|FG002|Overall Study|Lost to Follow-up|1|||
48981128|NCT01957215|157764179|FG000|Overall Study|Withdrawal by Subject|7|||
48981129|NCT01957215|157764180|FG001|Overall Study|Withdrawal by Subject|5|||
48981130|NCT00784459|157764183|FG000|Overall Study|Adverse Event|0|||
49021475|NCT00662025|157914459|FG000|Overall Study|Results of other clinical study|2|||
48683184|NCT00687739|156690664|FG003|Overall Study|Lost to Follow-up|2|||
48683185|NCT00687739|156690661|FG000|Overall Study|Adverse Event|0|||
48683186|NCT00687739|156690662|FG001|Overall Study|Adverse Event|1|||
48683187|NCT00687739|156690663|FG002|Overall Study|Adverse Event|1|||
48683188|NCT00687739|156690664|FG003|Overall Study|Adverse Event|0|||
48981131|NCT00784459|157764184|FG001|Overall Study|Adverse Event|2|||
49021476|NCT00662025|157914459|FG000|Overall Study|Target lesion cannot be evaluated|1|||
49021477|NCT00662025|157914459|FG000|Overall Study|Domestic circumstances|1|||
48981132|NCT00731666|157764185|FG000|Overall Study|Adverse Event|2|||
48981133|NCT00731666|157764185|FG000|Overall Study|Lost to Follow-up|8|||
48683189|NCT01012258|156690665|FG000|Overall Study|Death|14|||
48683190|NCT01012258|156690665|FG000|Overall Study|Lost to Follow-up|1|||
48683191|NCT01012258|156690665|FG000|Overall Study|Adverse Event|1|||
48683192|NCT01012258|156690665|FG000|Overall Study|Progressive Disease (PD)|18|||
48683193|NCT01012258|156690665|FG000|Overall Study|Symptomatic Deterioration|1|||
48683194|NCT01012258|156690665|FG000|Overall Study|Another Anti-cancer Drug Received|1|||
48683195|NCT01012258|156690665|FG000|Overall Study|Another Tumor Discovered|1|||
48683196|NCT01012258|156690665|FG000|Overall Study|Ongoing|29|||
48683197|NCT03600740|156690666|FG000|Overall Study|Surgical plan was altered-subject not eligible|1|||
48683198|NCT00799903|156690667|FG000|Overall Study|Investigator Site Closed|25|||
48683199|NCT00799903|156690668|FG001|Overall Study|Investigator Site Closed|23|||
48683200|NCT00799903|156690667|FG000|Overall Study|Withdrawal by Subject|179|||
48683201|NCT00799903|156690668|FG001|Overall Study|Withdrawal by Subject|175|||
48683202|NCT00799903|156690667|FG000|Overall Study|Lost to Follow-up|69|||
48683203|NCT00799903|156690668|FG001|Overall Study|Lost to Follow-up|80|||
48683204|NCT00239928|156690669|FG000|Overall Study|Lack of Efficacy|1|||
48683205|NCT00239928|156690669|FG000|Overall Study|Adverse Event|4|||
48683206|NCT00239928|156690669|FG000|Overall Study|Not need to continue study|3|||
48683207|NCT00239928|156690669|FG000|Overall Study|Withdrawal by Subject|2|||
48683208|NCT01684202|156690676|FG000|Dose-escalation Period|Adverse Event|0|||
48683209|NCT01684202|156690677|FG001|Dose-escalation Period|Adverse Event|1|||
48683210|NCT01684202|156690678|FG002|Dose-escalation Period|Adverse Event|0|||
48683211|NCT01684202|156690679|FG003|Dose-escalation Period|Adverse Event|0|||
48683212|NCT01684202|156690676|FG000|Dose-escalation Period|Withdrawal by Subject|1|||
48683213|NCT01684202|156690677|FG001|Dose-escalation Period|Withdrawal by Subject|0|||
48683214|NCT01684202|156690678|FG002|Dose-escalation Period|Withdrawal by Subject|0|||
48683215|NCT01684202|156690679|FG003|Dose-escalation Period|Withdrawal by Subject|0|||
48683216|NCT01684202|156690676|FG000|Maintenance Period|Adverse Event|1|||
48683217|NCT01684202|156690677|FG001|Maintenance Period|Adverse Event|1|||
48683218|NCT01684202|156690678|FG002|Maintenance Period|Adverse Event|1|||
48683219|NCT01684202|156690679|FG003|Maintenance Period|Adverse Event|1|||
48683220|NCT01684202|156690676|FG000|Maintenance Period|Physician Decision|0|||
48683221|NCT01684202|156690677|FG001|Maintenance Period|Physician Decision|1|||
48683222|NCT01684202|156690678|FG002|Maintenance Period|Physician Decision|0|||
48683223|NCT01684202|156690679|FG003|Maintenance Period|Physician Decision|0|||
48683224|NCT01684202|156690676|FG000|Maintenance Period|Withdrawal by Subject|0|||
49021478|NCT00525590|157914467|FG000|Overall Study|Adverse Event|3|||
49021479|NCT00525590|157914467|FG000|Overall Study|Physician Decision|3|||
49021480|NCT00525590|157914467|FG000|Overall Study|Withdrawal by Subject|16|||
49021481|NCT00525590|157914467|FG000|Overall Study|Lost to Follow-up|1|||
49021482|NCT00525590|157914467|FG000|Overall Study|Death|9|||
49021483|NCT00525590|157914467|FG000|Overall Study|Other|13|||
49021484|NCT01025037|157914471|FG000|Overall Study|Adverse Event|3|||
49021485|NCT01025037|157914471|FG000|Overall Study|Lost to Follow-up|7|||
49021486|NCT01025037|157914471|FG000|Overall Study|Withdrawal by Subject|1|||
49021487|NCT03500484|157914472|FG000|Overall Study|Adverse Event|2|||
48683225|NCT01684202|156690677|FG001|Maintenance Period|Withdrawal by Subject|1|||
48683226|NCT01684202|156690678|FG002|Maintenance Period|Withdrawal by Subject|0|||
48683227|NCT01684202|156690679|FG003|Maintenance Period|Withdrawal by Subject|0|||
48683228|NCT01843023|156690680|FG000|Overall Study|Death|1|||
48683229|NCT01843023|156690681|FG001|Overall Study|Death|0|||
48683230|NCT01843023|156690680|FG000|Overall Study|Lost to Follow-up|24|||
48683231|NCT01843023|156690681|FG001|Overall Study|Lost to Follow-up|29|||
48683232|NCT01843023|156690680|FG000|Overall Study|Withdrawal by Subject|8|||
48683233|NCT01843023|156690681|FG001|Overall Study|Withdrawal by Subject|6|||
48683234|NCT00779025|156690682|FG000|Overall Study|Withdrawal by Subject|1|||
48683235|NCT00226811|156690683|FG000|Overall Study|Death|8|||
48683236|NCT00226811|156690683|FG000|Overall Study|Adverse Event|11|||
48683237|NCT00226811|156690683|FG000|Overall Study|Lack of Efficacy|55|||
48683238|NCT00226811|156690683|FG000|Overall Study|Withdrawal by Subject|2|||
48683239|NCT00104650|156690687|FG000|Treatment Period (25 Weeks)|Physician Decision|0|||
48683240|NCT00104650|156690688|FG001|Treatment Period (25 Weeks)|Physician Decision|0|||
49021488|NCT03500484|157914473|FG001|Overall Study|Adverse Event|0|||
49021489|NCT03500484|157914472|FG000|Overall Study|Physician Decision|1|||
48683241|NCT00104650|156690689|FG002|Treatment Period (25 Weeks)|Physician Decision|1|||
48683242|NCT00104650|156690687|FG000|Treatment Period (25 Weeks)|Withdrawal by Subject|2|||
48762938|NCT00798369|156981966|FG000|Overall Study|Subject withdrew consent|0|||
48762939|NCT00798369|156981967|FG001|Overall Study|Subject withdrew consent|0|||
48683243|NCT00104650|156690688|FG001|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
48683244|NCT00104650|156690689|FG002|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
48683245|NCT00104650|156690687|FG000|Treatment Period (25 Weeks)|Death|7|||
48683246|NCT00104650|156690688|FG001|Treatment Period (25 Weeks)|Death|5|||
48683247|NCT00104650|156690689|FG002|Treatment Period (25 Weeks)|Death|6|||
48683248|NCT00104650|156690687|FG000|Treatment Period (25 Weeks)|Disease progression|2|||
48683249|NCT00104650|156690688|FG001|Treatment Period (25 Weeks)|Disease progression|3|||
49021490|NCT03500484|157914473|FG001|Overall Study|Physician Decision|0|||
49021491|NCT03500484|157914472|FG000|Overall Study|Could not be scanned or followed up due to COVID|1|||
48683250|NCT00104650|156690689|FG002|Treatment Period (25 Weeks)|Disease progression|2|||
48683251|NCT00104650|156690687|FG000|Treatment Period (25 Weeks)|Ineligibility determined|0|||
48683252|NCT00104650|156690688|FG001|Treatment Period (25 Weeks)|Ineligibility determined|1|||
48683253|NCT00104650|156690689|FG002|Treatment Period (25 Weeks)|Ineligibility determined|0|||
48683254|NCT00104650|156690687|FG000|Treatment Period (25 Weeks)|Other|1|||
48683255|NCT00104650|156690688|FG001|Treatment Period (25 Weeks)|Other|0|||
48683256|NCT00104650|156690689|FG002|Treatment Period (25 Weeks)|Other|0|||
48683257|NCT00104650|156690687|FG000|Treatment Period (25 Weeks)|Protocol deviation|0|||
48683258|NCT00104650|156690688|FG001|Treatment Period (25 Weeks)|Protocol deviation|1|||
48683259|NCT00104650|156690689|FG002|Treatment Period (25 Weeks)|Protocol deviation|0|||
48683260|NCT00104650|156690687|FG000|Follow-up Period|Physician Decision|1|||
48683261|NCT00104650|156690688|FG001|Follow-up Period|Physician Decision|1|||
48683262|NCT00104650|156690689|FG002|Follow-up Period|Physician Decision|0|||
48683263|NCT00104650|156690687|FG000|Follow-up Period|Adverse Event|1|||
48683264|NCT00104650|156690688|FG001|Follow-up Period|Adverse Event|0|||
48683265|NCT00104650|156690689|FG002|Follow-up Period|Adverse Event|1|||
48683266|NCT00104650|156690687|FG000|Follow-up Period|Withdrawal by Subject|0|||
48683267|NCT00104650|156690688|FG001|Follow-up Period|Withdrawal by Subject|3|||
48683268|NCT00104650|156690689|FG002|Follow-up Period|Withdrawal by Subject|3|||
48683269|NCT00104650|156690687|FG000|Follow-up Period|Death|6|||
48683270|NCT00104650|156690688|FG001|Follow-up Period|Death|6|||
48683271|NCT00104650|156690689|FG002|Follow-up Period|Death|4|||
48683272|NCT00104650|156690687|FG000|Follow-up Period|Disease progression|3|||
48683273|NCT00104650|156690688|FG001|Follow-up Period|Disease progression|1|||
48683274|NCT00104650|156690689|FG002|Follow-up Period|Disease progression|0|||
48683275|NCT00104650|156690687|FG000|Follow-up Period|Lost to Follow-up|0|||
48762940|NCT00798369|156981968|FG002|Overall Study|Subject withdrew consent|1|||
48762941|NCT00798369|156981969|FG003|Overall Study|Subject withdrew consent|1|||
48683276|NCT00104650|156690688|FG001|Follow-up Period|Lost to Follow-up|1|||
48683277|NCT00104650|156690689|FG002|Follow-up Period|Lost to Follow-up|2|||
48683278|NCT00104650|156690687|FG000|Follow-up Period|Other|0|||
48683279|NCT00104650|156690688|FG001|Follow-up Period|Other|1|||
48762942|NCT00798369|156981970|FG004|Overall Study|Subject withdrew consent|0|||
48762943|NCT00798369|156981971|FG005|Overall Study|Subject withdrew consent|2|||
48762944|NCT00798369|156981966|FG000|Overall Study|Lost to Follow-up|1|||
48762945|NCT00798369|156981967|FG001|Overall Study|Lost to Follow-up|1|||
48762946|NCT00798369|156981968|FG002|Overall Study|Lost to Follow-up|1|||
48762947|NCT00798369|156981969|FG003|Overall Study|Lost to Follow-up|0|||
48762948|NCT00798369|156981970|FG004|Overall Study|Lost to Follow-up|1|||
48762949|NCT00798369|156981971|FG005|Overall Study|Lost to Follow-up|0|||
48762950|NCT00798369|156981966|FG000|Overall Study|Adminstrative problems|0|||
48762951|NCT00798369|156981967|FG001|Overall Study|Adminstrative problems|0|||
48762952|NCT00798369|156981968|FG002|Overall Study|Adminstrative problems|0|||
48762953|NCT00798369|156981969|FG003|Overall Study|Adminstrative problems|0|||
48762954|NCT00798369|156981970|FG004|Overall Study|Adminstrative problems|0|||
48762955|NCT00798369|156981971|FG005|Overall Study|Adminstrative problems|1|||
48762956|NCT00218296|156981972|FG000|Overall Study|Lost to Follow-up|9|||
48762957|NCT00218296|156981973|FG001|Overall Study|Lost to Follow-up|7|||
48762958|NCT00218296|156981972|FG000|Overall Study|Withdrawal by Subject|36|||
48762959|NCT00218296|156981973|FG001|Overall Study|Withdrawal by Subject|47|||
48762960|NCT00218296|156981972|FG000|Overall Study|Randomized but did not enter treatment|66|||
48762961|NCT00218296|156981973|FG001|Overall Study|Randomized but did not enter treatment|67|||
48762962|NCT02596854|156981974|FG000|Overall Study|Withdrawn|8|||
48762963|NCT02046148|156981975|FG000|Overall Study|Lost to Follow-up|1|||
48762964|NCT02046148|156981976|FG001|Overall Study|Lost to Follow-up|1|||
48875136|NCT02575950|157379071|FG003|Overall Study|Withdrawal by Subject|2|||
48683280|NCT00104650|156690689|FG002|Follow-up Period|Other|0|||
48683281|NCT01633541|156690690|FG000|Overall Study|Death|1|||
48683282|NCT01633541|156690691|FG001|Overall Study|Death|0|||
48683283|NCT03472326|156690692|FG000|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
48683284|NCT03472326|156690693|FG001|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
48762965|NCT02046148|156981975|FG000|Overall Study|Withdrawal by Subject|0|||
48762966|NCT02046148|156981976|FG001|Overall Study|Withdrawal by Subject|2|||
48762967|NCT02211131|156981983|FG000|Overall Study|Death|26|||
48762968|NCT02211131|156981984|FG001|Overall Study|Death|16|||
48762969|NCT02211131|156981983|FG000|Overall Study|Lost to Follow-up|4|||
48875137|NCT02575950|157379068|FG000|Overall Study|Lost to Follow-up|0|||
48875138|NCT02575950|157379069|FG001|Overall Study|Lost to Follow-up|1|||
48875139|NCT02575950|157379070|FG002|Overall Study|Lost to Follow-up|0|||
48875140|NCT02575950|157379071|FG003|Overall Study|Lost to Follow-up|3|||
48683285|NCT03472326|156690694|FG002|Part 2: Combination Therapy|Study Terminated by Sponsor|1|||
48683286|NCT03472326|156690695|FG003|Part 2: Combination Therapy|Study Terminated by Sponsor|2|||
48875141|NCT01124838|157379076|FG000|Overall Study|Miscellaneous|4|||
48683287|NCT03472326|156690692|FG000|Part 2: Combination Therapy|Pregnancy|0|||
48683288|NCT03472326|156690693|FG001|Part 2: Combination Therapy|Pregnancy|0|||
48683289|NCT03472326|156690694|FG002|Part 2: Combination Therapy|Pregnancy|0|||
48683290|NCT03472326|156690695|FG003|Part 2: Combination Therapy|Pregnancy|1|||
48683291|NCT02292719|156690696|FG000|Overall Study|Withdrawal by Subject|0|||
48683292|NCT02292719|156690697|FG001|Overall Study|Withdrawal by Subject|0|||
48683293|NCT02292719|156690698|FG002|Overall Study|Withdrawal by Subject|0|||
48683294|NCT02292719|156690699|FG003|Overall Study|Withdrawal by Subject|1|||
48683295|NCT02292719|156690700|FG004|Overall Study|Withdrawal by Subject|1|||
48683296|NCT02292719|156690701|FG005|Overall Study|Withdrawal by Subject|0|||
48683297|NCT02292719|156690696|FG000|Overall Study|Subject enrolled in new study.|0|||
48683298|NCT02292719|156690697|FG001|Overall Study|Subject enrolled in new study.|0|||
48683299|NCT02292719|156690698|FG002|Overall Study|Subject enrolled in new study.|1|||
48683300|NCT02292719|156690699|FG003|Overall Study|Subject enrolled in new study.|0|||
48683301|NCT02292719|156690700|FG004|Overall Study|Subject enrolled in new study.|0|||
48683302|NCT02292719|156690701|FG005|Overall Study|Subject enrolled in new study.|0|||
48683303|NCT01824355|156690704|FG000|Overall Study|Adverse Event|2|||
48683304|NCT01824355|156690704|FG000|Overall Study|unevaluable reference method results per|1|||
48683305|NCT02326597|156690707|FG000|Overall Study|Lost to Follow-up|42|||
48683306|NCT02326597|156690708|FG001|Overall Study|Lost to Follow-up|32|||
48683307|NCT01132313|156690709|FG000|Overall Study|Lack of Efficacy|1|||
48683308|NCT01132313|156690710|FG001|Overall Study|Lack of Efficacy|0|||
48683309|NCT01132313|156690711|FG002|Overall Study|Lack of Efficacy|0|||
48683310|NCT01132313|156690712|FG003|Overall Study|Lack of Efficacy|0|||
48683311|NCT01132313|156690713|FG004|Overall Study|Lack of Efficacy|0|||
48683312|NCT01132313|156690714|FG005|Overall Study|Lack of Efficacy|0|||
48683313|NCT01132313|156690715|FG006|Overall Study|Lack of Efficacy|0|||
48683314|NCT01132313|156690716|FG007|Overall Study|Lack of Efficacy|3|||
48683315|NCT01132313|156690717|FG008|Overall Study|Lack of Efficacy|14|||
48683316|NCT01132313|156690718|FG009|Overall Study|Lack of Efficacy|16|||
48683317|NCT01132313|156690719|FG010|Overall Study|Lack of Efficacy|0|||
48683318|NCT01132313|156690720|FG011|Overall Study|Lack of Efficacy|0|||
48683319|NCT01132313|156690709|FG000|Overall Study|Not treated|2|||
48683320|NCT01132313|156690710|FG001|Overall Study|Not treated|0|||
48683321|NCT01132313|156690711|FG002|Overall Study|Not treated|0|||
48683322|NCT01132313|156690712|FG003|Overall Study|Not treated|0|||
48683323|NCT01132313|156690713|FG004|Overall Study|Not treated|2|||
48683324|NCT01132313|156690714|FG005|Overall Study|Not treated|1|||
48683325|NCT01132313|156690715|FG006|Overall Study|Not treated|3|||
48683326|NCT01132313|156690716|FG007|Overall Study|Not treated|0|||
48683327|NCT01132313|156690717|FG008|Overall Study|Not treated|0|||
48683328|NCT01132313|156690718|FG009|Overall Study|Not treated|0|||
48683329|NCT01132313|156690719|FG010|Overall Study|Not treated|0|||
48683330|NCT01132313|156690720|FG011|Overall Study|Not treated|0|||
48683331|NCT01132313|156690709|FG000|Overall Study|Adverse Event|0|||
48683332|NCT01132313|156690710|FG001|Overall Study|Adverse Event|0|||
48683333|NCT01132313|156690711|FG002|Overall Study|Adverse Event|4|||
48683334|NCT01132313|156690712|FG003|Overall Study|Adverse Event|10|||
48683335|NCT01132313|156690713|FG004|Overall Study|Adverse Event|19|||
48683336|NCT01132313|156690714|FG005|Overall Study|Adverse Event|6|||
48683337|NCT01132313|156690715|FG006|Overall Study|Adverse Event|5|||
48683338|NCT01132313|156690716|FG007|Overall Study|Adverse Event|3|||
48683339|NCT01132313|156690717|FG008|Overall Study|Adverse Event|7|||
48683340|NCT01132313|156690718|FG009|Overall Study|Adverse Event|2|||
48683341|NCT01132313|156690719|FG010|Overall Study|Adverse Event|0|||
48683342|NCT01132313|156690720|FG011|Overall Study|Adverse Event|0|||
48683343|NCT01132313|156690709|FG000|Overall Study|Protocol Violation|0|||
48683344|NCT01132313|156690710|FG001|Overall Study|Protocol Violation|0|||
48683345|NCT01132313|156690711|FG002|Overall Study|Protocol Violation|0|||
48683346|NCT01132313|156690712|FG003|Overall Study|Protocol Violation|1|||
48683347|NCT01132313|156690713|FG004|Overall Study|Protocol Violation|0|||
48683348|NCT01132313|156690714|FG005|Overall Study|Protocol Violation|0|||
48683349|NCT01132313|156690715|FG006|Overall Study|Protocol Violation|0|||
48683350|NCT01132313|156690716|FG007|Overall Study|Protocol Violation|0|||
48683351|NCT01132313|156690717|FG008|Overall Study|Protocol Violation|0|||
48683352|NCT01132313|156690718|FG009|Overall Study|Protocol Violation|0|||
48683353|NCT01132313|156690719|FG010|Overall Study|Protocol Violation|0|||
48683354|NCT01132313|156690720|FG011|Overall Study|Protocol Violation|0|||
48683355|NCT01132313|156690709|FG000|Overall Study|Lost to Follow-up|0|||
48683356|NCT01132313|156690710|FG001|Overall Study|Lost to Follow-up|0|||
48683357|NCT01132313|156690711|FG002|Overall Study|Lost to Follow-up|1|||
48683358|NCT01132313|156690712|FG003|Overall Study|Lost to Follow-up|0|||
48683359|NCT01132313|156690713|FG004|Overall Study|Lost to Follow-up|0|||
48683360|NCT01132313|156690714|FG005|Overall Study|Lost to Follow-up|0|||
48683361|NCT01132313|156690715|FG006|Overall Study|Lost to Follow-up|0|||
48683362|NCT01132313|156690716|FG007|Overall Study|Lost to Follow-up|1|||
48683363|NCT01132313|156690717|FG008|Overall Study|Lost to Follow-up|0|||
48683364|NCT01132313|156690718|FG009|Overall Study|Lost to Follow-up|0|||
48683365|NCT01132313|156690719|FG010|Overall Study|Lost to Follow-up|0|||
48683366|NCT01132313|156690720|FG011|Overall Study|Lost to Follow-up|0|||
48683367|NCT01132313|156690709|FG000|Overall Study|Withdrawal by Subject|0|||
48683368|NCT01132313|156690710|FG001|Overall Study|Withdrawal by Subject|0|||
48683369|NCT01132313|156690711|FG002|Overall Study|Withdrawal by Subject|3|||
48683370|NCT01132313|156690712|FG003|Overall Study|Withdrawal by Subject|3|||
48762970|NCT02211131|156981984|FG001|Overall Study|Lost to Follow-up|3|||
48762971|NCT02211131|156981983|FG000|Overall Study|Decision by Sponsor|1|||
48762972|NCT02211131|156981984|FG001|Overall Study|Decision by Sponsor|1|||
49021492|NCT03500484|157914473|FG001|Overall Study|Could not be scanned or followed up due to COVID|0|||
49021493|NCT01166568|157914474|FG000|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
48683371|NCT01132313|156690713|FG004|Overall Study|Withdrawal by Subject|6|||
48683372|NCT01132313|156690714|FG005|Overall Study|Withdrawal by Subject|0|||
48683373|NCT01132313|156690715|FG006|Overall Study|Withdrawal by Subject|1|||
48683374|NCT01132313|156690716|FG007|Overall Study|Withdrawal by Subject|0|||
48683375|NCT01132313|156690717|FG008|Overall Study|Withdrawal by Subject|0|||
48683376|NCT01132313|156690718|FG009|Overall Study|Withdrawal by Subject|2|||
48683377|NCT01132313|156690719|FG010|Overall Study|Withdrawal by Subject|0|||
48683378|NCT01132313|156690720|FG011|Overall Study|Withdrawal by Subject|0|||
48683379|NCT01132313|156690709|FG000|Overall Study|Lack of antiviral response|0|||
48683380|NCT01132313|156690710|FG001|Overall Study|Lack of antiviral response|0|||
48683381|NCT01132313|156690711|FG002|Overall Study|Lack of antiviral response|12|||
48683382|NCT01132313|156690712|FG003|Overall Study|Lack of antiviral response|18|||
48683383|NCT01132313|156690713|FG004|Overall Study|Lack of antiviral response|18|||
48683384|NCT01132313|156690714|FG005|Overall Study|Lack of antiviral response|18|||
48683385|NCT01132313|156690715|FG006|Overall Study|Lack of antiviral response|21|||
48683386|NCT01132313|156690716|FG007|Overall Study|Lack of antiviral response|0|||
48683387|NCT01132313|156690717|FG008|Overall Study|Lack of antiviral response|0|||
48683388|NCT01132313|156690718|FG009|Overall Study|Lack of antiviral response|0|||
48683389|NCT01132313|156690719|FG010|Overall Study|Lack of antiviral response|1|||
48683390|NCT01132313|156690720|FG011|Overall Study|Lack of antiviral response|0|||
48683391|NCT01132313|156690709|FG000|Overall Study|Other reason not defined above|0|||
48683392|NCT01132313|156690710|FG001|Overall Study|Other reason not defined above|0|||
48683393|NCT01132313|156690711|FG002|Overall Study|Other reason not defined above|0|||
48683394|NCT01132313|156690712|FG003|Overall Study|Other reason not defined above|0|||
48683395|NCT01132313|156690713|FG004|Overall Study|Other reason not defined above|0|||
48683396|NCT01132313|156690714|FG005|Overall Study|Other reason not defined above|0|||
48683397|NCT01132313|156690715|FG006|Overall Study|Other reason not defined above|0|||
48683398|NCT01132313|156690716|FG007|Overall Study|Other reason not defined above|1|||
48683399|NCT01132313|156690717|FG008|Overall Study|Other reason not defined above|0|||
48683400|NCT01132313|156690718|FG009|Overall Study|Other reason not defined above|0|||
48683401|NCT01132313|156690719|FG010|Overall Study|Other reason not defined above|0|||
48683402|NCT01132313|156690720|FG011|Overall Study|Other reason not defined above|0|||
48683403|NCT01156714|156690721|FG000|Overall Study|Withdrawal by Subject|9|||
48683404|NCT01156714|156690722|FG001|Overall Study|Withdrawal by Subject|4|||
48683405|NCT01156714|156690723|FG002|Overall Study|Withdrawal by Subject|3|||
48683406|NCT04970654|156690726|FG000|Overall Study|Withdrawal by parents/guardian|1|||
48683407|NCT04970654|156690727|FG001|Overall Study|Withdrawal by parents/guardian|2|||
48683408|NCT04970654|156690726|FG000|Overall Study|Unclassified|2|||
48683409|NCT04970654|156690727|FG001|Overall Study|Unclassified|1|||
48683410|NCT04970654|156690726|FG000|Overall Study|Lost to Follow-up|1|||
48683411|NCT04970654|156690727|FG001|Overall Study|Lost to Follow-up|0|||
48683412|NCT03915470|156690728|FG000|Overall Study|Death|3|||
48683413|NCT03915470|156690729|FG001|Overall Study|Death|1|||
48683414|NCT03915470|156690728|FG000|Overall Study|Adverse Event|1|||
48683415|NCT03915470|156690729|FG001|Overall Study|Adverse Event|0|||
48683416|NCT03915470|156690728|FG000|Overall Study|Physician Decision|1|||
48683417|NCT03915470|156690729|FG001|Overall Study|Physician Decision|0|||
48683418|NCT03915470|156690728|FG000|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
48683419|NCT03915470|156690729|FG001|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
48683420|NCT03160898|156690730|FG000|Overall Study|Adverse Event|4|||
48683421|NCT03160898|156690731|FG001|Overall Study|Adverse Event|8|||
48683422|NCT03160898|156690732|FG002|Overall Study|Adverse Event|7|||
48683423|NCT03160898|156690733|FG003|Overall Study|Adverse Event|10|||
48683424|NCT03160898|156690730|FG000|Overall Study|Death|1|||
48683425|NCT03160898|156690731|FG001|Overall Study|Death|0|||
48875142|NCT01124838|157379077|FG001|Overall Study|Miscellaneous|2|||
48683426|NCT03160898|156690732|FG002|Overall Study|Death|0|||
48683427|NCT03160898|156690733|FG003|Overall Study|Death|1|||
48875143|NCT01124838|157379076|FG000|Overall Study|Adverse Event|7|||
48875144|NCT01124838|157379077|FG001|Overall Study|Adverse Event|11|||
48683428|NCT03160898|156690730|FG000|Overall Study|Difficulty Traveling to Clinic Visits|3|||
48683429|NCT03160898|156690731|FG001|Overall Study|Difficulty Traveling to Clinic Visits|0|||
48683430|NCT03160898|156690732|FG002|Overall Study|Difficulty Traveling to Clinic Visits|0|||
48683431|NCT03160898|156690733|FG003|Overall Study|Difficulty Traveling to Clinic Visits|1|||
48683432|NCT03160898|156690730|FG000|Overall Study|Lost to Follow-up|1|||
48683433|NCT03160898|156690731|FG001|Overall Study|Lost to Follow-up|1|||
48683434|NCT03160898|156690732|FG002|Overall Study|Lost to Follow-up|1|||
48683435|NCT03160898|156690733|FG003|Overall Study|Lost to Follow-up|2|||
48683436|NCT03160898|156690730|FG000|Overall Study|Physician Decision|1|||
48683437|NCT03160898|156690731|FG001|Overall Study|Physician Decision|0|||
48683438|NCT03160898|156690732|FG002|Overall Study|Physician Decision|0|||
48683439|NCT03160898|156690733|FG003|Overall Study|Physician Decision|1|||
48683440|NCT03160898|156690730|FG000|Overall Study|Progressive Disease|4|||
48683441|NCT03160898|156690731|FG001|Overall Study|Progressive Disease|1|||
48875145|NCT01124838|157379076|FG000|Overall Study|Lack of Efficacy|2|||
48683442|NCT03160898|156690732|FG002|Overall Study|Progressive Disease|2|||
48683443|NCT03160898|156690733|FG003|Overall Study|Progressive Disease|1|||
48683444|NCT03160898|156690730|FG000|Overall Study|Protocol Violation|1|||
48683445|NCT03160898|156690731|FG001|Overall Study|Protocol Violation|0|||
48683446|NCT03160898|156690732|FG002|Overall Study|Protocol Violation|2|||
48683447|NCT03160898|156690733|FG003|Overall Study|Protocol Violation|0|||
48683448|NCT03160898|156690730|FG000|Overall Study|Sponsor Discretion|2|||
48683449|NCT03160898|156690731|FG001|Overall Study|Sponsor Discretion|0|||
48683450|NCT03160898|156690732|FG002|Overall Study|Sponsor Discretion|0|||
48683451|NCT03160898|156690733|FG003|Overall Study|Sponsor Discretion|0|||
48683452|NCT03160898|156690730|FG000|Overall Study|Withdrawal by Subject|1|||
48683453|NCT03160898|156690731|FG001|Overall Study|Withdrawal by Subject|3|||
48683454|NCT03160898|156690732|FG002|Overall Study|Withdrawal by Subject|2|||
48683455|NCT03160898|156690733|FG003|Overall Study|Withdrawal by Subject|1|||
48683456|NCT03160898|156690730|FG000|Overall Study|Other|2|||
48683457|NCT03160898|156690731|FG001|Overall Study|Other|0|||
48683458|NCT03160898|156690732|FG002|Overall Study|Other|2|||
48683459|NCT03160898|156690733|FG003|Overall Study|Other|2|||
48683460|NCT01505374|156690734|FG000|Overall Study|Lost to Follow-up|1|||
48683461|NCT01505374|156690735|FG001|Overall Study|Lost to Follow-up|0|||
48683462|NCT01150097|156690736|FG000|Months 24 to 36 Post-transplantation|Death|2|||
48683463|NCT01150097|156690737|FG001|Months 24 to 36 Post-transplantation|Death|0|||
48683464|NCT01150097|156690738|FG002|Months 24 to 36 Post-transplantation|Death|0|||
48683465|NCT01150097|156690736|FG000|Months 24 to 36 Post-transplantation|Administrative problems|5|||
48683466|NCT01150097|156690737|FG001|Months 24 to 36 Post-transplantation|Administrative problems|2|||
48683467|NCT01150097|156690738|FG002|Months 24 to 36 Post-transplantation|Administrative problems|2|||
48683468|NCT01150097|156690736|FG000|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
48683469|NCT01150097|156690737|FG001|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
48683470|NCT01150097|156690738|FG002|Months 24 to 36 Post-transplantation|Lost to Follow-up|3|||
48683471|NCT01150097|156690736|FG000|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
48683472|NCT01150097|156690737|FG001|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0|||
49021494|NCT01166568|157914475|FG001|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
49021495|NCT01166568|157914476|FG002|Deferred Implantation- Randomized|Withdrawal by Subject|1|||
49021496|NCT01166568|157914474|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7|||
49021497|NCT01166568|157914475|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
49021498|NCT01166568|157914476|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0|||
49021499|NCT01166568|157914474|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7|||
49021500|NCT01166568|157914475|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
49021501|NCT01166568|157914476|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
48683473|NCT01150097|156690738|FG002|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
48683474|NCT01150097|156690736|FG000|Months 24 to 48 Post-transplantation|Administrative problems|5|||
48683475|NCT01150097|156690737|FG001|Months 24 to 48 Post-transplantation|Administrative problems|4|||
48683476|NCT01150097|156690738|FG002|Months 24 to 48 Post-transplantation|Administrative problems|0|||
48683477|NCT01150097|156690736|FG000|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4|||
48683478|NCT01150097|156690737|FG001|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
48683479|NCT01150097|156690738|FG002|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
48683480|NCT01150097|156690736|FG000|Months 24 to 48 Post-transplantation|Death|2|||
48683481|NCT01150097|156690737|FG001|Months 24 to 48 Post-transplantation|Death|0|||
48683482|NCT01150097|156690738|FG002|Months 24 to 48 Post-transplantation|Death|0|||
48683483|NCT04158583|156690739|FG000|Overall Study|Withdrawal by Subject|1|||
48683484|NCT04158583|156690740|FG001|Overall Study|Withdrawal by Subject|1|||
48683485|NCT04158583|156690741|FG002|Overall Study|Withdrawal by Subject|0|||
48683486|NCT04158583|156690742|FG003|Overall Study|Withdrawal by Subject|0|||
48683487|NCT04158583|156690743|FG004|Overall Study|Withdrawal by Subject|1|||
48683488|NCT04158583|156690744|FG005|Overall Study|Withdrawal by Subject|0|||
48683489|NCT04158583|156690745|FG006|Overall Study|Withdrawal by Subject|0|||
48683490|NCT04158583|156690746|FG007|Overall Study|Withdrawal by Subject|0|||
48683491|NCT04158583|156690747|FG008|Overall Study|Withdrawal by Subject|2|||
48683492|NCT04158583|156690748|FG009|Overall Study|Withdrawal by Subject|0|||
48683493|NCT04158583|156690739|FG000|Overall Study|Study Terminated by Sponsor|0|||
48683494|NCT04158583|156690740|FG001|Overall Study|Study Terminated by Sponsor|0|||
48683495|NCT04158583|156690741|FG002|Overall Study|Study Terminated by Sponsor|0|||
48683496|NCT04158583|156690742|FG003|Overall Study|Study Terminated by Sponsor|1|||
48683497|NCT04158583|156690743|FG004|Overall Study|Study Terminated by Sponsor|0|||
48683498|NCT04158583|156690744|FG005|Overall Study|Study Terminated by Sponsor|0|||
48683499|NCT04158583|156690745|FG006|Overall Study|Study Terminated by Sponsor|0|||
48683500|NCT04158583|156690746|FG007|Overall Study|Study Terminated by Sponsor|0|||
48683501|NCT04158583|156690747|FG008|Overall Study|Study Terminated by Sponsor|0|||
48683502|NCT04158583|156690748|FG009|Overall Study|Study Terminated by Sponsor|0|||
48683503|NCT04158583|156690739|FG000|Overall Study|Progressive Disease|1|||
48683504|NCT04158583|156690740|FG001|Overall Study|Progressive Disease|0|||
48683505|NCT04158583|156690741|FG002|Overall Study|Progressive Disease|3|||
48683506|NCT04158583|156690742|FG003|Overall Study|Progressive Disease|5|||
48683507|NCT04158583|156690743|FG004|Overall Study|Progressive Disease|0|||
48683508|NCT04158583|156690744|FG005|Overall Study|Progressive Disease|1|||
48683509|NCT04158583|156690745|FG006|Overall Study|Progressive Disease|6|||
48683510|NCT04158583|156690746|FG007|Overall Study|Progressive Disease|2|||
48683511|NCT04158583|156690747|FG008|Overall Study|Progressive Disease|1|||
48683512|NCT04158583|156690748|FG009|Overall Study|Progressive Disease|2|||
48683513|NCT04158583|156690739|FG000|Overall Study|Lost to Follow-up|0|||
48683514|NCT04158583|156690740|FG001|Overall Study|Lost to Follow-up|0|||
48683515|NCT04158583|156690741|FG002|Overall Study|Lost to Follow-up|1|||
48683516|NCT04158583|156690742|FG003|Overall Study|Lost to Follow-up|1|||
48683517|NCT04158583|156690743|FG004|Overall Study|Lost to Follow-up|1|||
48683518|NCT04158583|156690744|FG005|Overall Study|Lost to Follow-up|0|||
48683519|NCT04158583|156690745|FG006|Overall Study|Lost to Follow-up|0|||
48683520|NCT04158583|156690746|FG007|Overall Study|Lost to Follow-up|0|||
48683521|NCT04158583|156690747|FG008|Overall Study|Lost to Follow-up|0|||
48683522|NCT04158583|156690748|FG009|Overall Study|Lost to Follow-up|0|||
48683523|NCT04158583|156690739|FG000|Overall Study|Due To Patient Status|0|||
48683524|NCT04158583|156690740|FG001|Overall Study|Due To Patient Status|0|||
48683525|NCT04158583|156690741|FG002|Overall Study|Due To Patient Status|0|||
48683526|NCT04158583|156690742|FG003|Overall Study|Due To Patient Status|0|||
48683527|NCT04158583|156690743|FG004|Overall Study|Due To Patient Status|0|||
48683528|NCT04158583|156690744|FG005|Overall Study|Due To Patient Status|0|||
48683529|NCT04158583|156690745|FG006|Overall Study|Due To Patient Status|0|||
48683530|NCT04158583|156690746|FG007|Overall Study|Due To Patient Status|0|||
48683531|NCT04158583|156690747|FG008|Overall Study|Due To Patient Status|1|||
48683532|NCT04158583|156690748|FG009|Overall Study|Due To Patient Status|0|||
48683533|NCT04158583|156690739|FG000|Overall Study|Death|3|||
48683534|NCT04158583|156690740|FG001|Overall Study|Death|4|||
48683535|NCT04158583|156690741|FG002|Overall Study|Death|2|||
48683536|NCT04158583|156690742|FG003|Overall Study|Death|2|||
48683537|NCT04158583|156690743|FG004|Overall Study|Death|4|||
48683538|NCT04158583|156690744|FG005|Overall Study|Death|3|||
48683539|NCT04158583|156690745|FG006|Overall Study|Death|5|||
48683540|NCT04158583|156690746|FG007|Overall Study|Death|2|||
48683541|NCT04158583|156690747|FG008|Overall Study|Death|0|||
48683542|NCT04158583|156690748|FG009|Overall Study|Death|1|||
48683543|NCT04158583|156690739|FG000|Overall Study|Clinical Progression Disease|0|||
48683544|NCT04158583|156690740|FG001|Overall Study|Clinical Progression Disease|0|||
48683545|NCT04158583|156690741|FG002|Overall Study|Clinical Progression Disease|0|||
48683546|NCT04158583|156690742|FG003|Overall Study|Clinical Progression Disease|1|||
48683547|NCT04158583|156690743|FG004|Overall Study|Clinical Progression Disease|0|||
48683548|NCT04158583|156690744|FG005|Overall Study|Clinical Progression Disease|0|||
48762973|NCT02211131|156981983|FG000|Overall Study|Withdrawal by Subject|3|||
48762974|NCT02211131|156981984|FG001|Overall Study|Withdrawal by Subject|8|||
48762975|NCT02939560|156981985|FG000|Overall Study|Withdrawal by Subject|2|||
48762976|NCT02939560|156981985|FG000|Overall Study|Protocol Violation|1|||
48683549|NCT04158583|156690745|FG006|Overall Study|Clinical Progression Disease|0|||
48683550|NCT04158583|156690746|FG007|Overall Study|Clinical Progression Disease|0|||
48683551|NCT04158583|156690747|FG008|Overall Study|Clinical Progression Disease|0|||
48683552|NCT04158583|156690748|FG009|Overall Study|Clinical Progression Disease|0|||
48762977|NCT02612428|156981998|FG000|VTL-308|Death|14|||
48762978|NCT02612428|156981999|FG001|VTL-308|Death|16|||
48762979|NCT02612428|156981998|FG000|VTL-308|Withdrawal by Subject|0|||
48762980|NCT02612428|156981999|FG001|VTL-308|Withdrawal by Subject|1|||
48762981|NCT02612428|156981998|FG000|VTL-308E|Death|9|||
48762982|NCT02612428|156981999|FG001|VTL-308E|Death|7|||
48762983|NCT02612428|156981998|FG000|VTL-308E|Lost to Follow-up|2|||
48762984|NCT02612428|156981999|FG001|VTL-308E|Lost to Follow-up|0|||
48762985|NCT01293240|156982005|FG000|Overall Study|Noncompliance|2|||
48762986|NCT01251380|156982009|FG000|Overall Study|Other (Not otherwise specified)|12|||
48762987|NCT01251380|156982009|FG000|Overall Study|Withdrawal by Subject|6|||
48762988|NCT01251380|156982009|FG000|Overall Study|Lack of Efficacy|1|||
48981134|NCT00731666|157764185|FG000|Overall Study|Withdrawal by Subject|2|||
48762989|NCT01251380|156982009|FG000|Overall Study|Adverse Event|1|||
48981135|NCT00608894|157764189|FG000|Overall Study|Withdrawal by Subject|0|||
48981136|NCT00608894|157764190|FG001|Overall Study|Withdrawal by Subject|2|||
48981137|NCT01308853|157764198|FG000|Overall Study|Adverse Event|1|||
48981138|NCT01308853|157764198|FG000|Overall Study|Lost to Follow-up|2|||
48981139|NCT01308853|157764198|FG000|Overall Study|Insertion of permanent implants|1|||
48981140|NCT00444951|157764199|FG000|Overall Study|Lost to Follow-up|1|||
48981141|NCT00444951|157764200|FG001|Overall Study|Lost to Follow-up|1|||
48981142|NCT00444951|157764201|FG002|Overall Study|Lost to Follow-up|0|||
48981143|NCT00444951|157764199|FG000|Overall Study|Withdrawal by Subject|4|||
48981144|NCT00444951|157764200|FG001|Overall Study|Withdrawal by Subject|5|||
48981145|NCT00444951|157764201|FG002|Overall Study|Withdrawal by Subject|3|||
48981146|NCT01784211|157764205|FG000|Part A (Days 1-15)|Adverse Event|1|||
48683553|NCT04158583|156690739|FG000|Overall Study|Clinical Progression|0|||
48683554|NCT04158583|156690740|FG001|Overall Study|Clinical Progression|0|||
49021502|NCT01508936|157914477|FG000|Overall Study|Adverse Event|11|||
49021503|NCT01508936|157914478|FG001|Overall Study|Adverse Event|32|||
49021504|NCT01508936|157914477|FG000|Overall Study|Lack of Efficacy|0|||
49021505|NCT01508936|157914478|FG001|Overall Study|Lack of Efficacy|1|||
49021506|NCT01508936|157914477|FG000|Overall Study|Withdrawal by Subject|4|||
49021507|NCT01508936|157914478|FG001|Overall Study|Withdrawal by Subject|18|||
49021508|NCT01508936|157914477|FG000|Overall Study|Protocol Violation|2|||
49021509|NCT01508936|157914478|FG001|Overall Study|Protocol Violation|3|||
49021510|NCT01508936|157914477|FG000|Overall Study|Lost to Follow-up|2|||
49021511|NCT01508936|157914478|FG001|Overall Study|Lost to Follow-up|9|||
49021512|NCT01508936|157914477|FG000|Overall Study|Other|0|||
49021513|NCT01508936|157914478|FG001|Overall Study|Other|5|||
49021514|NCT01508936|157914477|FG000|Overall Study|Data from 2 sites deemed invalid|4|||
49021515|NCT01508936|157914478|FG001|Overall Study|Data from 2 sites deemed invalid|11|||
49021516|NCT01531205|157914479|FG000|Overall Study|Did not proceed to surgery|1|||
49021517|NCT00948675|157914480|FG000|Overall Study|Lost to Follow-up|1|||
49021518|NCT00948675|157914481|FG001|Overall Study|Lost to Follow-up|0|||
49021519|NCT00669864|157914486|FG000|Overall Study|Lost to Follow-up|2|||
49021520|NCT00669864|157914486|FG000|Overall Study|Protocol Violation|2|||
48683555|NCT04158583|156690741|FG002|Overall Study|Clinical Progression|0|||
48683556|NCT04158583|156690742|FG003|Overall Study|Clinical Progression|0|||
48683557|NCT04158583|156690743|FG004|Overall Study|Clinical Progression|1|||
48683558|NCT04158583|156690744|FG005|Overall Study|Clinical Progression|0|||
48683559|NCT04158583|156690745|FG006|Overall Study|Clinical Progression|2|||
48683560|NCT04158583|156690746|FG007|Overall Study|Clinical Progression|0|||
48875146|NCT01124838|157379077|FG001|Overall Study|Lack of Efficacy|0|||
49021521|NCT00669864|157914486|FG000|Overall Study|Withdrawal by Subject|3|||
49021522|NCT00669864|157914486|FG000|Overall Study|Other|2|||
49021523|NCT03717064|157916754|FG000|Period 2|Adverse Event|1|||
49021524|NCT00313703|157916755|FG000|Overall Study|Lost to Follow-up|11|||
49021525|NCT00313703|157916756|FG001|Overall Study|Lost to Follow-up|2|||
49021526|NCT00313703|157916757|FG002|Overall Study|Lost to Follow-up|5|||
49021527|NCT00313703|157916758|FG003|Overall Study|Lost to Follow-up|12|||
49021528|NCT01298570|157916759|FG000|Overall Study|Disease progression, relapse during acti|64|||
49021529|NCT01298570|157916760|FG001|Overall Study|Disease progression, relapse during acti|40|||
49021530|NCT01298570|157916759|FG000|Overall Study|Adverse Event|20|||
49021531|NCT01298570|157916760|FG001|Overall Study|Adverse Event|2|||
49021532|NCT01298570|157916759|FG000|Overall Study|Withdrawal by Subject|21|||
49021533|NCT01298570|157916760|FG001|Overall Study|Withdrawal by Subject|6|||
49021534|NCT01298570|157916759|FG000|Overall Study|Treatment delay > 4 weeks|4|||
49021535|NCT01298570|157916760|FG001|Overall Study|Treatment delay > 4 weeks|5|||
49021536|NCT01298570|157916759|FG000|Overall Study|Physician Decision|4|||
49021537|NCT01298570|157916760|FG001|Overall Study|Physician Decision|2|||
49021538|NCT01298570|157916759|FG000|Overall Study|Other complicating disease|2|||
49021539|NCT01298570|157916760|FG001|Overall Study|Other complicating disease|1|||
49021540|NCT01298570|157916759|FG000|Overall Study|Surgery|2|||
49021541|NCT01298570|157916760|FG001|Overall Study|Surgery|1|||
49021542|NCT01298570|157916759|FG000|Overall Study|Symptomatic progression/deterioration|3|||
49021543|NCT01298570|157916760|FG001|Overall Study|Symptomatic progression/deterioration|2|||
49021544|NCT01298570|157916759|FG000|Overall Study|Death|0|||
49021545|NCT01298570|157916760|FG001|Overall Study|Death|1|||
49021546|NCT01298570|157916759|FG000|Overall Study|Ineligibility|0|||
49021547|NCT01298570|157916760|FG001|Overall Study|Ineligibility|1|||
49021548|NCT00527423|157916773|FG000|Overall Study|Protocol Violation|1|||
49021549|NCT00527423|157916773|FG000|Overall Study|Adverse Event|5|||
49021550|NCT00527423|157916773|FG000|Overall Study|Physician Decision|4|||
49021551|NCT00527423|157916773|FG000|Overall Study|Withdrawal by Subject|10|||
49021552|NCT00527423|157916773|FG000|Overall Study|Lost to Follow-up|4|||
49021553|NCT00527423|157916773|FG000|Overall Study|OTHER|4|||
49021554|NCT00527423|157916773|FG000|Overall Study|Death|9|||
49021555|NCT00883090|157916776|FG000|Overall Study|Sponsor's decision|1|||
49021556|NCT00883090|157916776|FG000|Overall Study|Withdrawal by Subject|1|||
49021557|NCT00531206|157916777|FG000|Overall Study|Adverse Event related|5|||
49021558|NCT00531206|157916777|FG000|Overall Study|Lack of Efficacy|2|||
48683561|NCT04158583|156690747|FG008|Overall Study|Clinical Progression|0|||
48875147|NCT01124838|157379076|FG000|Overall Study|Withdrawal by Subject|3|||
48875148|NCT01124838|157379077|FG001|Overall Study|Withdrawal by Subject|2|||
49021559|NCT00531206|157916777|FG000|Overall Study|Lost to Follow-up|5|||
49021560|NCT00531206|157916777|FG000|Overall Study|including non-related adverse events|8|||
48762990|NCT01251380|156982009|FG000|Overall Study|Lost to Follow-up|2|||
48875149|NCT01124838|157379076|FG000|Overall Study|Lost to Follow-up|2|||
49021561|NCT02750761|157916781|FG000|Overall Study|Lost to Follow-up|0|||
49021562|NCT02750761|157916782|FG001|Overall Study|Lost to Follow-up|0|||
49021563|NCT02750761|157916783|FG002|Overall Study|Lost to Follow-up|1|||
49021564|NCT02750761|157916784|FG003|Overall Study|Lost to Follow-up|0|||
49021565|NCT02750761|157916785|FG004|Overall Study|Lost to Follow-up|0|||
49021566|NCT02750761|157916786|FG005|Overall Study|Lost to Follow-up|0|||
49021567|NCT03527745|157916787|FG000|Overall Study|Lost to Follow-up|3|||
49021568|NCT03527745|157916788|FG001|Overall Study|Lost to Follow-up|6|||
49021569|NCT03527745|157916789|FG002|Overall Study|Lost to Follow-up|7|||
49021570|NCT03527745|157916790|FG003|Overall Study|Lost to Follow-up|9|||
49021571|NCT03527745|157916791|FG004|Overall Study|Lost to Follow-up|0|||
49021572|NCT03527745|157916792|FG005|Overall Study|Lost to Follow-up|2|||
49021573|NCT03527745|157916793|FG006|Overall Study|Lost to Follow-up|3|||
49021574|NCT03527745|157916794|FG007|Overall Study|Lost to Follow-up|2|||
48683562|NCT04158583|156690748|FG009|Overall Study|Clinical Progression|0|||
48683563|NCT04158583|156690739|FG000|Overall Study|Clinical Deterioration|0|||
48683564|NCT04158583|156690740|FG001|Overall Study|Clinical Deterioration|0|||
48683565|NCT04158583|156690741|FG002|Overall Study|Clinical Deterioration|0|||
48683566|NCT04158583|156690742|FG003|Overall Study|Clinical Deterioration|1|||
48683567|NCT04158583|156690743|FG004|Overall Study|Clinical Deterioration|0|||
48683568|NCT04158583|156690744|FG005|Overall Study|Clinical Deterioration|0|||
48683569|NCT04158583|156690745|FG006|Overall Study|Clinical Deterioration|0|||
48683570|NCT04158583|156690746|FG007|Overall Study|Clinical Deterioration|0|||
48683571|NCT04158583|156690747|FG008|Overall Study|Clinical Deterioration|0|||
48683572|NCT04158583|156690748|FG009|Overall Study|Clinical Deterioration|1|||
48683573|NCT04618744|156690749|FG000|Overall Study|Adverse Event|0|||
48683574|NCT04618744|156690750|FG001|Overall Study|Adverse Event|1|||
48683575|NCT04618744|156690749|FG000|Overall Study|Withdrawal by Subject|0|||
48683576|NCT04618744|156690750|FG001|Overall Study|Withdrawal by Subject|1|||
48683577|NCT02709330|156690751|FG000|Overall Study|Death|5|||
48683578|NCT02709330|156690752|FG001|Overall Study|Death|0|||
48683579|NCT02709330|156690751|FG000|Overall Study|Lost to Follow-up|2|||
49021575|NCT03527745|157916795|FG008|Overall Study|Lost to Follow-up|3|||
49021576|NCT03527745|157916796|FG009|Overall Study|Lost to Follow-up|2|||
49021577|NCT03527745|157916797|FG010|Overall Study|Lost to Follow-up|1|||
49021578|NCT03527745|157916798|FG011|Overall Study|Lost to Follow-up|1|||
49021579|NCT03527745|157916799|FG012|Overall Study|Lost to Follow-up|0|||
49021580|NCT03527745|157916800|FG013|Overall Study|Lost to Follow-up|0|||
48683580|NCT02709330|156690752|FG001|Overall Study|Lost to Follow-up|0|||
48683581|NCT02709330|156690751|FG000|Overall Study|Physician Decision|2|||
48683582|NCT02709330|156690752|FG001|Overall Study|Physician Decision|0|||
48683583|NCT02709330|156690751|FG000|Overall Study|Withdrawal by Subject|4|||
48683584|NCT02709330|156690752|FG001|Overall Study|Withdrawal by Subject|0|||
48683585|NCT01807299|156690753|FG000|Overall Study|Protocol Violation|3|||
48683586|NCT01807299|156690754|FG001|Overall Study|Protocol Violation|1|||
48683587|NCT01807299|156690755|FG002|Overall Study|Protocol Violation|0|||
48683588|NCT01807299|156690756|FG003|Overall Study|Protocol Violation|2|||
48683589|NCT01370265|156692600|FG000|First Intervention|Adverse Event|1|||
48683590|NCT01370265|156692601|FG001|First Intervention|Adverse Event|1|||
48683591|NCT03738618|156692606|FG000|Overall Study|Protocol deviation|23|||
48683592|NCT03738618|156692607|FG001|Overall Study|Protocol deviation|0|||
48683593|NCT03738618|156692606|FG000|Overall Study|Adverse Event|4|||
48683594|NCT03738618|156692607|FG001|Overall Study|Adverse Event|0|||
48683595|NCT03738618|156692606|FG000|Overall Study|Lost to Follow-up|2|||
48683596|NCT03738618|156692607|FG001|Overall Study|Lost to Follow-up|0|||
48683597|NCT03738618|156692606|FG000|Overall Study|Randomization failure|1|||
48683598|NCT03738618|156692607|FG001|Overall Study|Randomization failure|0|||
48683599|NCT03738618|156692606|FG000|Overall Study|Participant relocated, unable to continue in trial|1|||
48683600|NCT03738618|156692607|FG001|Overall Study|Participant relocated, unable to continue in trial|0|||
48683601|NCT03738618|156692606|FG000|Overall Study|Participant did not show to visit (stimulation day 12)|1|||
48683602|NCT03738618|156692607|FG001|Overall Study|Participant did not show to visit (stimulation day 12)|0|||
48683603|NCT01216683|156692608|FG000|Induction|Never started treatment|0|||
48683604|NCT01216683|156692609|FG001|Induction|Never started treatment|6|||
48683605|NCT01216683|156692610|FG002|Induction|Never started treatment|3|||
48683606|NCT01216683|156692608|FG000|Induction|Lack of Efficacy|4|||
48683607|NCT01216683|156692609|FG001|Induction|Lack of Efficacy|3|||
48683608|NCT01216683|156692610|FG002|Induction|Lack of Efficacy|7|||
49021581|NCT03527745|157916801|FG014|Overall Study|Lost to Follow-up|0|||
49021582|NCT03527745|157916802|FG015|Overall Study|Lost to Follow-up|0|||
48683609|NCT01216683|156692608|FG000|Induction|Adverse Event|0|||
48683610|NCT01216683|156692609|FG001|Induction|Adverse Event|5|||
48683611|NCT01216683|156692610|FG002|Induction|Adverse Event|5|||
48683612|NCT01216683|156692608|FG000|Induction|Death|0|||
48683613|NCT01216683|156692609|FG001|Induction|Death|0|||
48683614|NCT01216683|156692610|FG002|Induction|Death|2|||
48683615|NCT01216683|156692608|FG000|Induction|Withdrawal by Subject|0|||
48683616|NCT01216683|156692609|FG001|Induction|Withdrawal by Subject|4|||
48683617|NCT01216683|156692610|FG002|Induction|Withdrawal by Subject|2|||
48683618|NCT01216683|156692608|FG000|Induction|Other disease|0|||
48683619|NCT01216683|156692609|FG001|Induction|Other disease|1|||
48683620|NCT01216683|156692610|FG002|Induction|Other disease|2|||
48683621|NCT01216683|156692608|FG000|Continuation|Lack of Efficacy|3|||
48683622|NCT01216683|156692609|FG001|Continuation|Lack of Efficacy|2|||
49021583|NCT03527745|157916803|FG016|Overall Study|Lost to Follow-up|1|||
48683623|NCT01216683|156692610|FG002|Continuation|Lack of Efficacy|7|||
49021584|NCT03527745|157916804|FG017|Overall Study|Lost to Follow-up|0|||
49021585|NCT03527745|157916805|FG018|Overall Study|Lost to Follow-up|0|||
49021586|NCT03527745|157916806|FG019|Overall Study|Lost to Follow-up|1|||
48683624|NCT01216683|156692608|FG000|Continuation|Adverse Event|5|||
48683625|NCT01216683|156692609|FG001|Continuation|Adverse Event|3|||
48683626|NCT01216683|156692610|FG002|Continuation|Adverse Event|16|||
48683627|NCT01216683|156692608|FG000|Continuation|Death|1|||
48683628|NCT01216683|156692609|FG001|Continuation|Death|0|||
48683629|NCT01216683|156692610|FG002|Continuation|Death|2|||
48683630|NCT01216683|156692608|FG000|Continuation|Withdrawal by Subject|4|||
48683631|NCT01216683|156692609|FG001|Continuation|Withdrawal by Subject|5|||
48683632|NCT01216683|156692610|FG002|Continuation|Withdrawal by Subject|9|||
48683633|NCT01216683|156692608|FG000|Continuation|Other diseases|0|||
48683634|NCT01216683|156692609|FG001|Continuation|Other diseases|2|||
48683635|NCT01216683|156692610|FG002|Continuation|Other diseases|1|||
48683636|NCT01216683|156692608|FG000|Continuation|Physician Decision|1|||
48683637|NCT01216683|156692609|FG001|Continuation|Physician Decision|0|||
48683638|NCT01216683|156692610|FG002|Continuation|Physician Decision|1|||
48683639|NCT01216683|156692608|FG000|Continuation|Non-compliance|1|||
48683640|NCT01216683|156692609|FG001|Continuation|Non-compliance|0|||
48683641|NCT01216683|156692610|FG002|Continuation|Non-compliance|1|||
48683642|NCT01216683|156692608|FG000|Continuation|Insurance change|0|||
48683643|NCT01216683|156692609|FG001|Continuation|Insurance change|1|||
48683644|NCT01216683|156692610|FG002|Continuation|Insurance change|0|||
48683645|NCT01216683|156692608|FG000|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
48683646|NCT01216683|156692609|FG001|Continuation|Mistakenly stayed on treatment for longer than expected|1|||
48683647|NCT01216683|156692610|FG002|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
48683648|NCT01216683|156692608|FG000|Continuation|Not reported|0|||
48683649|NCT01216683|156692609|FG001|Continuation|Not reported|0|||
48683650|NCT01216683|156692610|FG002|Continuation|Not reported|1|||
48683651|NCT01216683|156692608|FG000|Continuation|Never started treatment|0|||
48683652|NCT01216683|156692609|FG001|Continuation|Never started treatment|1|||
48683653|NCT01216683|156692610|FG002|Continuation|Never started treatment|5|||
48683654|NCT00780416|156692611|FG000|Overall Study|Physician Decision|3|||
48683655|NCT00780416|156692612|FG001|Overall Study|Physician Decision|3|||
48683656|NCT00780416|156692611|FG000|Overall Study|Protocol Violation|1|||
48683657|NCT00780416|156692612|FG001|Overall Study|Protocol Violation|0|||
48683658|NCT00780416|156692611|FG000|Overall Study|Withdrawal by Subject|8|||
48683659|NCT00780416|156692612|FG001|Overall Study|Withdrawal by Subject|6|||
48683660|NCT02679755|156692615|FG000|Overall Study|Death|0|||
48683661|NCT02679755|156692616|FG001|Overall Study|Death|3|||
48683662|NCT02679755|156692615|FG000|Overall Study|Global deterioration of health status|1|||
48683663|NCT02679755|156692616|FG001|Overall Study|Global deterioration of health status|8|||
48683664|NCT02679755|156692615|FG000|Overall Study|Lost to Follow-up|1|||
48683665|NCT02679755|156692616|FG001|Overall Study|Lost to Follow-up|0|||
48683666|NCT02679755|156692615|FG000|Overall Study|Objective progression or relapse|24|||
48683667|NCT02679755|156692616|FG001|Overall Study|Objective progression or relapse|83|||
48683668|NCT02679755|156692615|FG000|Overall Study|Not defined|0|||
48683669|NCT02679755|156692616|FG001|Overall Study|Not defined|2|||
48683670|NCT02679755|156692615|FG000|Overall Study|Withdrawal by participant|6|||
48683671|NCT02679755|156692616|FG001|Overall Study|Withdrawal by participant|3|||
48683672|NCT02679755|156692615|FG000|Overall Study|Adverse Event|1|||
48683673|NCT02679755|156692616|FG001|Overall Study|Adverse Event|4|||
48683674|NCT02679755|156692615|FG000|Overall Study|Adverse events not related to study drug|1|||
48683675|NCT02679755|156692616|FG001|Overall Study|Adverse events not related to study drug|2|||
48683676|NCT01061359|156692617|FG000|Overall Study|Death|32|||
48683677|NCT01061359|156692617|FG000|Overall Study|Lost to Follow-up|1072|||
48683678|NCT01061359|156692617|FG000|Overall Study|Relapse|187|||
49021587|NCT03527745|157916807|FG020|Overall Study|Lost to Follow-up|1|||
48683679|NCT01061359|156692617|FG000|Overall Study|Secondary neoplasm|11|||
48683680|NCT00732875|156692618|FG000|Overall Study|Adverse Event|16|||
48875150|NCT01124838|157379077|FG001|Overall Study|Lost to Follow-up|0|||
48875151|NCT03020069|157381558|FG000|Overall Study|Lost to Follow-up|0|||
49021588|NCT03527745|157916808|FG021|Overall Study|Lost to Follow-up|5|||
48683681|NCT00732875|156692618|FG000|Overall Study|Withdrawal by Subject|6|||
48683682|NCT00732875|156692618|FG000|Overall Study|Lack of Efficacy|13|||
48683683|NCT03826186|156692619|FG000|Overall Study|Protocol Violation|2|||
48683684|NCT03826186|156692620|FG001|Overall Study|Protocol Violation|0|||
48683685|NCT03826186|156692619|FG000|Overall Study|Withdrawal by Subject|1|||
48683686|NCT03826186|156692620|FG001|Overall Study|Withdrawal by Subject|0|||
48683687|NCT00655629|156692621|FG000|Overall Study|Adverse Event|4|||
48683688|NCT00655629|156692622|FG001|Overall Study|Adverse Event|1|||
48683689|NCT00655629|156692621|FG000|Overall Study|Lack of Efficacy|2|||
48683690|NCT00655629|156692622|FG001|Overall Study|Lack of Efficacy|12|||
48683691|NCT00655629|156692621|FG000|Overall Study|Lost to Follow-up|4|||
48683692|NCT00655629|156692622|FG001|Overall Study|Lost to Follow-up|3|||
48683693|NCT00655629|156692621|FG000|Overall Study|Protocol Violation|5|||
48683694|NCT00655629|156692622|FG001|Overall Study|Protocol Violation|3|||
48683695|NCT00655629|156692621|FG000|Overall Study|consent withdrawn|6|||
49021589|NCT03527745|157916809|FG022|Overall Study|Lost to Follow-up|6|||
48683696|NCT00655629|156692622|FG001|Overall Study|consent withdrawn|4|||
48683697|NCT05258149|156692624|FG000|Period 1|Protocol Deviation|1|||
49021590|NCT03527745|157916810|FG023|Overall Study|Lost to Follow-up|8|||
48683698|NCT05258149|156692625|FG001|Period 1|Protocol Deviation|0|||
48683699|NCT05258149|156692624|FG000|Period 1|Adverse Event|0|||
48683700|NCT05258149|156692625|FG001|Period 1|Adverse Event|1|||
48683701|NCT05258149|156692624|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
48683702|NCT05258149|156692625|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
48683703|NCT05258149|156692624|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
48683704|NCT05258149|156692625|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
48683705|NCT05258149|156692624|FG000|Period 3|Subject Was Not Returning for More Than A Week|0|||
48683706|NCT05258149|156692625|FG001|Period 3|Subject Was Not Returning for More Than A Week|1|||
48762991|NCT02319031|156982016|FG000|Treatment Period|Death|1|||
48762992|NCT02319031|156982017|FG001|Treatment Period|Death|0|||
48762993|NCT02009046|156982018|FG000|Overall Study|Lost to Follow-up|256|||
48762994|NCT02009046|156982019|FG001|Overall Study|Lost to Follow-up|206|||
48762995|NCT01085097|156982022|FG000|Overall Study|Adverse Event|0|||
49021591|NCT03527745|157916811|FG024|Overall Study|Lost to Follow-up|1|||
49021592|NCT03527745|157916812|FG025|Overall Study|Lost to Follow-up|3|||
49021593|NCT01860976|157916813|FG000|Blinded Treatment|Adverse Event|1|||
49021594|NCT01860976|157916814|FG001|Blinded Treatment|Adverse Event|3|||
49021595|NCT01860976|157916813|FG000|Blinded Treatment|Lack of Efficacy|5|||
49021596|NCT01860976|157916814|FG001|Blinded Treatment|Lack of Efficacy|12|||
49021597|NCT01860976|157916813|FG000|Blinded Treatment|Subject request to discontinue treatment|2|||
49021598|NCT01860976|157916814|FG001|Blinded Treatment|Subject request to discontinue treatment|3|||
49021599|NCT01860976|157916813|FG000|Blinded Treatment|Withdrawal by Subject|3|||
49021600|NCT01860976|157916814|FG001|Blinded Treatment|Withdrawal by Subject|5|||
49021601|NCT01860976|157916813|FG000|Blinded Treatment|Subject no longer met criteria|1|||
49021602|NCT01860976|157916814|FG001|Blinded Treatment|Subject no longer met criteria|0|||
49021603|NCT01860976|157916813|FG000|Blinded Treatment|Entered Open-Label in error|0|||
49021604|NCT01860976|157916814|FG001|Blinded Treatment|Entered Open-Label in error|1|||
49021605|NCT01860976|157916813|FG000|Blinded Treatment|Early Escape: Transitioned to OL period|76|||
49021606|NCT01860976|157916814|FG001|Blinded Treatment|Early Escape: Transitioned to OL period|89|||
49021607|NCT01860976|157916813|FG000|Open-Label|Adverse Event|2|||
49021608|NCT01860976|157916814|FG001|Open-Label|Adverse Event|4|||
48762996|NCT01085097|156982023|FG001|Overall Study|Adverse Event|0|||
48762997|NCT01085097|156982024|FG002|Overall Study|Adverse Event|2|||
48762998|NCT01085097|156982022|FG000|Overall Study|Treatment failure|2|||
48762999|NCT01085097|156982023|FG001|Overall Study|Treatment failure|0|||
48763000|NCT01085097|156982024|FG002|Overall Study|Treatment failure|0|||
48763001|NCT03316885|156982025|FG000|Overall Study|Adverse Event|1|||
48763002|NCT03316885|156982025|FG000|Overall Study|Death|10|||
48763003|NCT03316885|156982025|FG000|Overall Study|Lost to Follow-up|4|||
48763004|NCT03316885|156982025|FG000|Overall Study|Withdrawal by Subject|9|||
48763005|NCT03316885|156982025|FG000|Overall Study|COVID related|8|||
48763006|NCT03338062|156982026|FG000|Overall Study|Alternative Therapy|1|||
48763007|NCT03338062|156982027|FG001|Overall Study|Alternative Therapy|0|||
48763008|NCT00537381|156982032|FG000|Overall Study|Adverse Event|13|||
48763009|NCT00537381|156982033|FG001|Overall Study|Adverse Event|9|||
48763010|NCT00537381|156982032|FG000|Overall Study|Death|3|||
48763011|NCT00537381|156982033|FG001|Overall Study|Death|3|||
48763012|NCT00537381|156982032|FG000|Overall Study|Withdrawal by Subject|5|||
48763013|NCT00537381|156982033|FG001|Overall Study|Withdrawal by Subject|14|||
48763014|NCT00537381|156982032|FG000|Overall Study|Physician Decision|7|||
48763015|NCT00537381|156982033|FG001|Overall Study|Physician Decision|6|||
48763016|NCT00537381|156982032|FG000|Overall Study|Disease Progression|9|||
48763017|NCT00537381|156982033|FG001|Overall Study|Disease Progression|18|||
48763018|NCT00537381|156982032|FG000|Overall Study|Sponsor decision|14|||
48763019|NCT00537381|156982033|FG001|Overall Study|Sponsor decision|9|||
48763020|NCT00537381|156982032|FG000|Overall Study|Other|5|||
48763021|NCT00537381|156982033|FG001|Overall Study|Other|3|||
48763022|NCT01708174|156982034|FG000|Treatment Period|Withdrawal by Subject|1|||
48763023|NCT01708174|156982035|FG001|Treatment Period|Withdrawal by Subject|0|||
48763024|NCT01708174|156982036|FG002|Treatment Period|Withdrawal by Subject|0|||
48763025|NCT01708174|156982034|FG000|Treatment Period|Progressive disease|0|||
48763026|NCT01708174|156982035|FG001|Treatment Period|Progressive disease|1|||
48763027|NCT01708174|156982036|FG002|Treatment Period|Progressive disease|0|||
49021609|NCT01860976|157916813|FG000|Open-Label|Lack of Efficacy|16|||
48683707|NCT00832416|156692626|FG000|Overall Study|Lack of Efficacy|17|||
48683708|NCT00832416|156692627|FG001|Overall Study|Lack of Efficacy|15|||
48683709|NCT00832416|156692628|FG002|Overall Study|Lack of Efficacy|13|||
48763028|NCT01708174|156982034|FG000|Treatment Period|Death|0|||
48763029|NCT01708174|156982035|FG001|Treatment Period|Death|0|||
48763030|NCT01708174|156982036|FG002|Treatment Period|Death|1|||
48763031|NCT01708174|156982034|FG000|Treatment Period|Adverse Event|0|||
48763032|NCT01708174|156982035|FG001|Treatment Period|Adverse Event|1|||
48763033|NCT01708174|156982036|FG002|Treatment Period|Adverse Event|0|||
48763034|NCT01062555|156982043|FG000|Phase 1|Death|10|||
48763035|NCT01062555|156982044|FG001|Phase 1|Death|17|||
49021610|NCT01860976|157916814|FG001|Open-Label|Lack of Efficacy|8|||
49021611|NCT01860976|157916813|FG000|Open-Label|Lost to Follow-up|1|||
49021612|NCT01860976|157916814|FG001|Open-Label|Lost to Follow-up|2|||
49021613|NCT01860976|157916813|FG000|Open-Label|Subject request discontinue treatment|4|||
49021614|NCT01860976|157916814|FG001|Open-Label|Subject request discontinue treatment|3|||
49021615|NCT01860976|157916813|FG000|Open-Label|Withdrawal by Subject|4|||
49021616|NCT01860976|157916814|FG001|Open-Label|Withdrawal by Subject|1|||
49021617|NCT01860976|157916813|FG000|Open-Label|Other Reasons|1|||
49021618|NCT01860976|157916814|FG001|Open-Label|Other Reasons|1|||
49021619|NCT01860976|157916813|FG000|Long Term Extension|Adverse Event|4|||
49021620|NCT01860976|157916814|FG001|Long Term Extension|Adverse Event|0|||
49021621|NCT01860976|157916813|FG000|Long Term Extension|Lack of Efficacy|2|||
49021622|NCT01860976|157916814|FG001|Long Term Extension|Lack of Efficacy|0|||
49021623|NCT01860976|157916813|FG000|Long Term Extension|Subject request to discontinue treatment|10|||
49021624|NCT01860976|157916814|FG001|Long Term Extension|Subject request to discontinue treatment|0|||
49021625|NCT01860976|157916813|FG000|Long Term Extension|Lost to Follow-up|2|||
49021626|NCT01860976|157916814|FG001|Long Term Extension|Lost to Follow-up|0|||
49021627|NCT01860976|157916813|FG000|Long Term Extension|subject withdrew consent|7|||
49021628|NCT01860976|157916814|FG001|Long Term Extension|subject withdrew consent|0|||
49021629|NCT00755326|157916815|FG000|Overall Study|Lost to Follow-up|2|||
49021630|NCT00755326|157916816|FG001|Overall Study|Lost to Follow-up|3|||
49021631|NCT01439165|157916823|FG000|Overall Study|Protocol Violation|3|||
49021632|NCT01439165|157916824|FG001|Overall Study|Protocol Violation|0|||
49021633|NCT01439165|157916823|FG000|Overall Study|Lost to Follow-up|11|||
49021634|NCT01439165|157916824|FG001|Overall Study|Lost to Follow-up|1|||
49021635|NCT01439165|157916823|FG000|Overall Study|Withdrawal by Subject|7|||
49021636|NCT01439165|157916824|FG001|Overall Study|Withdrawal by Subject|1|||
49021637|NCT01506947|157916830|FG000|Overall Study|Lost to Follow-up|7|||
49021638|NCT01506947|157916830|FG000|Overall Study|Adverse Event|5|||
49021639|NCT01506947|157916830|FG000|Overall Study|Death|1|||
49021640|NCT01506947|157916830|FG000|Overall Study|Did Not Meet Eligibility Criteria|3|||
49021641|NCT01513148|157916831|FG000|Overall Study|Protocol Violation|2|||
49021642|NCT01513148|157916832|FG001|Overall Study|Protocol Violation|2|||
49021643|NCT00424489|157916841|FG000|Overall Study|Death|3|||
49021644|NCT01654380|157916842|FG000|Part B, Period 1|Physician Decision|0|||
49021645|NCT01654380|157916843|FG001|Part B, Period 1|Physician Decision|0|||
49021646|NCT01654380|157916844|FG002|Part B, Period 1|Physician Decision|1|||
49021647|NCT01654380|157916845|FG003|Part B, Period 1|Physician Decision|0|||
49021648|NCT01984242|157916846|FG000|Overall Study|Death|52|||
49021649|NCT01984242|157916847|FG001|Overall Study|Death|50|||
49021650|NCT01984242|157916848|FG002|Overall Study|Death|52|||
49021651|NCT01984242|157916846|FG000|Overall Study|Withdrawal by Subject|5|||
49021652|NCT01984242|157916847|FG001|Overall Study|Withdrawal by Subject|3|||
49021653|NCT01984242|157916848|FG002|Overall Study|Withdrawal by Subject|10|||
49021654|NCT01984242|157916846|FG000|Overall Study|Physician Decision|0|||
49021655|NCT01984242|157916847|FG001|Overall Study|Physician Decision|0|||
49021656|NCT01984242|157916848|FG002|Overall Study|Physician Decision|1|||
49021657|NCT01984242|157916846|FG000|Overall Study|Lost to Follow-up|4|||
49021658|NCT01984242|157916847|FG001|Overall Study|Lost to Follow-up|0|||
49021659|NCT01984242|157916848|FG002|Overall Study|Lost to Follow-up|3|||
49021660|NCT01984242|157916846|FG000|Overall Study|Sponsor Decision|1|||
49021661|NCT01984242|157916847|FG001|Overall Study|Sponsor Decision|0|||
49021662|NCT01984242|157916848|FG002|Overall Study|Sponsor Decision|0|||
49021663|NCT01984242|157916846|FG000|Overall Study|Non-Compliance|1|||
49021664|NCT01984242|157916847|FG001|Overall Study|Non-Compliance|0|||
49021665|NCT01984242|157916848|FG002|Overall Study|Non-Compliance|0|||
49021666|NCT01984242|157916846|FG000|Overall Study|Study terminated by Sponsor|38|||
49021667|NCT01984242|157916847|FG001|Overall Study|Study terminated by Sponsor|50|||
49021668|NCT01984242|157916848|FG002|Overall Study|Study terminated by Sponsor|34|||
49021669|NCT01984242|157916846|FG000|Overall Study|Disease Progression|0|||
49021670|NCT01984242|157916847|FG001|Overall Study|Disease Progression|0|||
49021671|NCT01984242|157916848|FG002|Overall Study|Disease Progression|1|||
49021672|NCT02674334|157916856|FG000|Overall Study|Lost to Follow-up|5|||
49021673|NCT02674334|157916857|FG001|Overall Study|Lost to Follow-up|3|||
49021674|NCT02674334|157916856|FG000|Overall Study|participant difficulty breathing|1|||
49021675|NCT02674334|157916857|FG001|Overall Study|participant difficulty breathing|0|||
49021676|NCT02674334|157916856|FG000|Overall Study|NIRS not recording|1|||
49021677|NCT02674334|157916857|FG001|Overall Study|NIRS not recording|0|||
49021678|NCT01432171|157916858|FG000|Overall Study|Death|1|||
49021679|NCT01432171|157916859|FG001|Overall Study|Death|2|||
49021680|NCT01432171|157916858|FG000|Overall Study|Lost to Follow-up|6|||
49021681|NCT01432171|157916859|FG001|Overall Study|Lost to Follow-up|5|||
48683710|NCT00832416|156692629|FG003|Overall Study|Lack of Efficacy|52|||
49021682|NCT01432171|157916858|FG000|Overall Study|Withdrawal by Subject|3|||
49021683|NCT01432171|157916859|FG001|Overall Study|Withdrawal by Subject|1|||
49021684|NCT01432171|157916858|FG000|Overall Study|Noncompliance|2|||
49021685|NCT01432171|157916859|FG001|Overall Study|Noncompliance|3|||
49021686|NCT01432171|157916858|FG000|Overall Study|Insurance denial trial coverage|1|||
49021687|NCT01432171|157916859|FG001|Overall Study|Insurance denial trial coverage|0|||
48683711|NCT00832416|156692626|FG000|Overall Study|Withdrawal by Subject|5|||
48683712|NCT00832416|156692627|FG001|Overall Study|Withdrawal by Subject|7|||
48683713|NCT00832416|156692628|FG002|Overall Study|Withdrawal by Subject|2|||
48683714|NCT00832416|156692629|FG003|Overall Study|Withdrawal by Subject|10|||
48683715|NCT00832416|156692626|FG000|Overall Study|Physician Decision|2|||
48683716|NCT00832416|156692627|FG001|Overall Study|Physician Decision|12|||
48683717|NCT00832416|156692628|FG002|Overall Study|Physician Decision|5|||
48683718|NCT00832416|156692629|FG003|Overall Study|Physician Decision|10|||
48683719|NCT00832416|156692626|FG000|Overall Study|Administrative|0|||
48683720|NCT00832416|156692627|FG001|Overall Study|Administrative|0|||
48683721|NCT00832416|156692628|FG002|Overall Study|Administrative|0|||
48683722|NCT00832416|156692629|FG003|Overall Study|Administrative|1|||
48683723|NCT00832416|156692626|FG000|Overall Study|Adverse Event|21|||
48683724|NCT00832416|156692627|FG001|Overall Study|Adverse Event|19|||
48683725|NCT00832416|156692628|FG002|Overall Study|Adverse Event|41|||
48683726|NCT00832416|156692629|FG003|Overall Study|Adverse Event|10|||
48683727|NCT00832416|156692626|FG000|Overall Study|Death|1|||
48683728|NCT00832416|156692627|FG001|Overall Study|Death|0|||
48683729|NCT00832416|156692628|FG002|Overall Study|Death|0|||
48683730|NCT00832416|156692629|FG003|Overall Study|Death|0|||
48683731|NCT01388907|156692630|FG000|Overall Study|Adverse Event|2|||
48683732|NCT01388907|156692631|FG001|Overall Study|Adverse Event|0|||
48683733|NCT02034877|156692633|FG000|Overall Study|Lost to Follow-up|0|||
48683734|NCT02034877|156692634|FG001|Overall Study|Lost to Follow-up|3|||
48683735|NCT02034877|156692633|FG000|Overall Study|No Longer Willing to Participate|0|||
48683736|NCT02034877|156692634|FG001|Overall Study|No Longer Willing to Participate|3|||
48683737|NCT01910402|156692635|FG000|Randomized Phase (Up to 48 Weeks)|Adverse Event|10|||
48683738|NCT01910402|156692636|FG001|Randomized Phase (Up to 48 Weeks)|Adverse Event|18|||
48683739|NCT01910402|156692637|FG002|Randomized Phase (Up to 48 Weeks)|Adverse Event|0|||
48683740|NCT01910402|156692635|FG000|Randomized Phase (Up to 48 Weeks)|Physician Decision|1|||
48683741|NCT01910402|156692636|FG001|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
48683742|NCT01910402|156692637|FG002|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
48683743|NCT01910402|156692635|FG000|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|5|||
48683744|NCT01910402|156692636|FG001|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|4|||
48683745|NCT01910402|156692637|FG002|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|0|||
48683746|NCT01910402|156692635|FG000|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|11|||
48683747|NCT01910402|156692636|FG001|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|13|||
48683748|NCT01910402|156692637|FG002|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|0|||
48683749|NCT01910402|156692635|FG000|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|5|||
48683750|NCT01910402|156692636|FG001|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|7|||
48683751|NCT01910402|156692637|FG002|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|0|||
48683752|NCT01910402|156692635|FG000|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
48683753|NCT01910402|156692636|FG001|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
48683754|NCT01910402|156692637|FG002|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|0|||
48683755|NCT01910402|156692635|FG000|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|10|||
48683756|NCT01910402|156692636|FG001|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|13|||
48683757|NCT01910402|156692637|FG002|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|0|||
48683758|NCT01910402|156692635|FG000|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
48683759|NCT01910402|156692636|FG001|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
48683760|NCT01910402|156692637|FG002|Continuation Phase(From Weeks 48 to 432)|Physician Decision|1|||
48683761|NCT01910402|156692635|FG000|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
48683762|NCT01910402|156692636|FG001|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
48683763|NCT01910402|156692637|FG002|Continuation Phase(From Weeks 48 to 432)|Adverse Event|4|||
48683764|NCT01910402|156692635|FG000|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
48683765|NCT01910402|156692636|FG001|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
48683766|NCT01910402|156692637|FG002|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|7|||
48683767|NCT01910402|156692635|FG000|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
48683768|NCT01910402|156692636|FG001|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
48683769|NCT01910402|156692637|FG002|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|8|||
48683770|NCT01910402|156692635|FG000|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
48683771|NCT01910402|156692636|FG001|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
48683772|NCT01910402|156692637|FG002|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|1|||
48683773|NCT01910402|156692635|FG000|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
48683774|NCT01910402|156692636|FG001|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
48683775|NCT01910402|156692637|FG002|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|15|||
48683776|NCT02128724|156692640|FG000|Overall Study|Death|1|||
48683777|NCT02128724|156692641|FG001|Overall Study|Death|0|||
48683778|NCT02128724|156692642|FG002|Overall Study|Death|0|||
48683779|NCT02128724|156692643|FG003|Overall Study|Death|0|||
48683780|NCT02128724|156692640|FG000|Overall Study|Adverse Event|0|||
48683781|NCT02128724|156692641|FG001|Overall Study|Adverse Event|1|||
48683782|NCT02128724|156692642|FG002|Overall Study|Adverse Event|0|||
48683783|NCT02128724|156692643|FG003|Overall Study|Adverse Event|0|||
48683784|NCT02128724|156692640|FG000|Overall Study|Physician Decision|0|||
48683785|NCT02128724|156692641|FG001|Overall Study|Physician Decision|0|||
48683786|NCT02128724|156692642|FG002|Overall Study|Physician Decision|0|||
48683787|NCT02128724|156692643|FG003|Overall Study|Physician Decision|2|||
48683788|NCT02128724|156692640|FG000|Overall Study|Withdrawal by Subject|0|||
48683789|NCT02128724|156692641|FG001|Overall Study|Withdrawal by Subject|0|||
48683790|NCT02128724|156692642|FG002|Overall Study|Withdrawal by Subject|0|||
48683791|NCT02128724|156692643|FG003|Overall Study|Withdrawal by Subject|1|||
48683792|NCT00622505|156692646|FG000|Overall Study|Adverse Event|9|||
48683793|NCT00622505|156692647|FG001|Overall Study|Adverse Event|7|||
48683794|NCT00622505|156692646|FG000|Overall Study|Abnormal Laboratory Value(s)|3|||
48683795|NCT00622505|156692647|FG001|Overall Study|Abnormal Laboratory Value(s)|5|||
48683796|NCT00622505|156692646|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
48683797|NCT00622505|156692647|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
48683798|NCT00622505|156692646|FG000|Overall Study|Withdrawal by Subject|12|||
48683799|NCT00622505|156692647|FG001|Overall Study|Withdrawal by Subject|5|||
48683800|NCT00622505|156692646|FG000|Overall Study|Administrative Problems|2|||
48683801|NCT00622505|156692647|FG001|Overall Study|Administrative Problems|4|||
48683802|NCT00622505|156692646|FG000|Overall Study|Death|2|||
48683803|NCT00622505|156692647|FG001|Overall Study|Death|2|||
48683804|NCT01359904|156692650|FG000|Overall Study|Withdrawal by Subject|1|||
48683805|NCT01359904|156692651|FG001|Overall Study|Withdrawal by Subject|0|||
48683806|NCT02003534|156692652|FG000|Overall Study|Lost to Follow-up|47|||
48683807|NCT01818596|156692653|FG000|Overall Study|Enrolled but Not Treated|4|||
48683808|NCT01818596|156692654|FG001|Overall Study|Enrolled but Not Treated|0|||
48683809|NCT01818596|156692653|FG000|Overall Study|Adverse Event|7|||
48683810|NCT01818596|156692654|FG001|Overall Study|Adverse Event|0|||
48683811|NCT01818596|156692653|FG000|Overall Study|Death|3|||
48683812|NCT01818596|156692654|FG001|Overall Study|Death|0|||
48683813|NCT01818596|156692653|FG000|Overall Study|Investigator's Discretion|4|||
48683814|NCT01818596|156692654|FG001|Overall Study|Investigator's Discretion|0|||
48683815|NCT01818596|156692653|FG000|Overall Study|Protocol Violation|1|||
48683816|NCT01818596|156692654|FG001|Overall Study|Protocol Violation|0|||
48683817|NCT01818596|156692653|FG000|Overall Study|Withdrew Consent|5|||
48683818|NCT01818596|156692654|FG001|Overall Study|Withdrew Consent|0|||
48683819|NCT01818596|156692653|FG000|Overall Study|Lost to Follow-up|7|||
48683820|NCT01818596|156692654|FG001|Overall Study|Lost to Follow-up|0|||
48683821|NCT03801174|156692655|FG000|Overall Study|Withdrawal by Subject|14|||
48683822|NCT03801174|156692656|FG001|Overall Study|Withdrawal by Subject|15|||
48683823|NCT03801174|156692655|FG000|Overall Study|Death|1|||
48683824|NCT03801174|156692656|FG001|Overall Study|Death|0|||
48683825|NCT03801174|156692655|FG000|Overall Study|Pregnancy|2|||
48683826|NCT03801174|156692656|FG001|Overall Study|Pregnancy|2|||
48683827|NCT03801174|156692655|FG000|Overall Study|Lost to Follow-up|19|||
48683828|NCT03801174|156692656|FG001|Overall Study|Lost to Follow-up|10|||
48683829|NCT03801174|156692655|FG000|Overall Study|Other|4|||
48683830|NCT03801174|156692656|FG001|Overall Study|Other|3|||
48683831|NCT03801174|156692655|FG000|Overall Study|Lack of Efficacy|4|||
48683832|NCT03801174|156692656|FG001|Overall Study|Lack of Efficacy|0|||
48683833|NCT03801174|156692655|FG000|Overall Study|Unwilling to complete activities|5|||
48763036|NCT01062555|156982045|FG002|Phase 1|Death|0|||
48763037|NCT01062555|156982046|FG003|Phase 1|Death|0|||
48763038|NCT01062555|156982043|FG000|Phase 1|Graft Failure|12|||
48763039|NCT01062555|156982044|FG001|Phase 1|Graft Failure|8|||
48763040|NCT01062555|156982045|FG002|Phase 1|Graft Failure|0|||
48763041|NCT01062555|156982046|FG003|Phase 1|Graft Failure|0|||
48763042|NCT01062555|156982043|FG000|Phase 1|Withdrawal by Subject|1|||
48763043|NCT01062555|156982044|FG001|Phase 1|Withdrawal by Subject|1|||
48763044|NCT01062555|156982045|FG002|Phase 1|Withdrawal by Subject|0|||
48763045|NCT01062555|156982046|FG003|Phase 1|Withdrawal by Subject|0|||
48683834|NCT03801174|156692656|FG001|Overall Study|Unwilling to complete activities|6|||
48683835|NCT03801174|156692655|FG000|Overall Study|Moved out of area|3|||
48683836|NCT03801174|156692656|FG001|Overall Study|Moved out of area|0|||
48683837|NCT00855816|156692659|FG000|Overall Study|Withdrawal by Subject|22|||
48683838|NCT00855816|156692660|FG001|Overall Study|Withdrawal by Subject|15|||
48683839|NCT00855816|156692659|FG000|Overall Study|Lost to Follow-up|3|||
48683840|NCT00855816|156692660|FG001|Overall Study|Lost to Follow-up|5|||
48683841|NCT00855816|156692659|FG000|Overall Study|Death|1|||
48683842|NCT00855816|156692660|FG001|Overall Study|Death|0|||
48683843|NCT00855816|156692659|FG000|Overall Study|Became ineligible|0|||
48683844|NCT00855816|156692660|FG001|Overall Study|Became ineligible|1|||
48763046|NCT01062555|156982043|FG000|Phase 2|Death|0|||
49021688|NCT01432171|157916858|FG000|Overall Study|Patient moved to palliative care|1|||
48683845|NCT02221674|156692662|FG000|Overall Study|Lost to Follow-up|1|||
48683846|NCT02221674|156692663|FG001|Overall Study|Lost to Follow-up|0|||
48683847|NCT02221674|156692664|FG002|Overall Study|Lost to Follow-up|0|||
48763047|NCT01062555|156982044|FG001|Phase 2|Death|0|||
48763048|NCT01062555|156982045|FG002|Phase 2|Death|8|||
48683848|NCT01702558|156692671|FG000|Overall Study|Withdrawal by Subject|0|||
48683849|NCT01702558|156692672|FG001|Overall Study|Withdrawal by Subject|0|||
48683850|NCT01702558|156692673|FG002|Overall Study|Withdrawal by Subject|0|||
48683851|NCT01702558|156692674|FG003|Overall Study|Withdrawal by Subject|12|||
48683852|NCT01702558|156692675|FG004|Overall Study|Withdrawal by Subject|4|||
48683853|NCT01702558|156692671|FG000|Overall Study|Lost to Follow-up|0|||
48683854|NCT01702558|156692672|FG001|Overall Study|Lost to Follow-up|0|||
48683855|NCT01702558|156692673|FG002|Overall Study|Lost to Follow-up|0|||
49021689|NCT01432171|157916859|FG001|Overall Study|Patient moved to palliative care|0|||
48683856|NCT01702558|156692674|FG003|Overall Study|Lost to Follow-up|3|||
48683857|NCT01702558|156692675|FG004|Overall Study|Lost to Follow-up|0|||
48683858|NCT01702558|156692671|FG000|Overall Study|Death|4|||
48683859|NCT01702558|156692672|FG001|Overall Study|Death|3|||
48683860|NCT01702558|156692673|FG002|Overall Study|Death|3|||
48683861|NCT01702558|156692674|FG003|Overall Study|Death|16|||
48683862|NCT01702558|156692675|FG004|Overall Study|Death|20|||
48683863|NCT01702558|156692671|FG000|Overall Study|Safety Follow-Up less than 3 Months|0|||
48683864|NCT01702558|156692672|FG001|Overall Study|Safety Follow-Up less than 3 Months|0|||
48683865|NCT01702558|156692673|FG002|Overall Study|Safety Follow-Up less than 3 Months|2|||
48683866|NCT01702558|156692674|FG003|Overall Study|Safety Follow-Up less than 3 Months|0|||
48683867|NCT01702558|156692675|FG004|Overall Study|Safety Follow-Up less than 3 Months|0|||
48683868|NCT01702558|156692671|FG000|Overall Study|Study Terminated by Sponsor|0|||
48683869|NCT01702558|156692672|FG001|Overall Study|Study Terminated by Sponsor|1|||
48683870|NCT01702558|156692673|FG002|Overall Study|Study Terminated by Sponsor|0|||
48683871|NCT01702558|156692674|FG003|Overall Study|Study Terminated by Sponsor|0|||
48683872|NCT01702558|156692675|FG004|Overall Study|Study Terminated by Sponsor|1|||
48683873|NCT01702558|156692671|FG000|Overall Study|Other|0|||
48683874|NCT01702558|156692672|FG001|Overall Study|Other|0|||
48683875|NCT01702558|156692673|FG002|Overall Study|Other|0|||
48683876|NCT01702558|156692674|FG003|Overall Study|Other|16|||
48683877|NCT01702558|156692675|FG004|Overall Study|Other|17|||
48683878|NCT02396212|156692678|FG000|Overall Study|Adverse Event|1|||
48683879|NCT02396212|156692678|FG000|Overall Study|Lack of Efficacy|2|||
48683880|NCT03030417|156692681|FG000|Dose Expansion|Disease progression before treatment|0|||
48683881|NCT03030417|156692682|FG001|Dose Expansion|Disease progression before treatment|0|||
48683882|NCT03030417|156692683|FG002|Dose Expansion|Disease progression before treatment|0|||
48683883|NCT03030417|156692684|FG003|Dose Expansion|Disease progression before treatment|0|||
48683884|NCT03030417|156692685|FG004|Dose Expansion|Disease progression before treatment|0|||
48683885|NCT03030417|156692686|FG005|Dose Expansion|Disease progression before treatment|0|||
48683886|NCT03030417|156692687|FG006|Dose Expansion|Disease progression before treatment|0|||
48683887|NCT03030417|156692688|FG007|Dose Expansion|Disease progression before treatment|0|||
48683888|NCT03030417|156692689|FG008|Dose Expansion|Disease progression before treatment|0|||
48683889|NCT03030417|156692690|FG009|Dose Expansion|Disease progression before treatment|0|||
48683890|NCT03030417|156692691|FG010|Dose Expansion|Disease progression before treatment|0|||
48683891|NCT03030417|156692692|FG011|Dose Expansion|Disease progression before treatment|0|||
48683892|NCT03030417|156692693|FG012|Dose Expansion|Disease progression before treatment|1|||
48683893|NCT04915729|156692694|FG000|Overall Study|Lost to Follow-up|20|||
48683894|NCT04915729|156692695|FG001|Overall Study|Lost to Follow-up|10|||
48683895|NCT04915729|156692694|FG000|Overall Study|Withdrawal by Subject|12|||
48683896|NCT04915729|156692695|FG001|Overall Study|Withdrawal by Subject|5|||
48683897|NCT04915729|156692694|FG000|Overall Study|Death|34|||
48683898|NCT04915729|156692695|FG001|Overall Study|Death|44|||
49021690|NCT01939197|157916860|FG000|Overall Study|Withdrawal by Subject|1|||
49021691|NCT01939197|157916861|FG001|Overall Study|Withdrawal by Subject|0|||
49021692|NCT01939197|157916862|FG002|Overall Study|Withdrawal by Subject|0|||
49021693|NCT01939197|157916863|FG003|Overall Study|Withdrawal by Subject|0|||
49021694|NCT01939197|157916864|FG004|Overall Study|Withdrawal by Subject|1|||
49021695|NCT01939197|157916865|FG005|Overall Study|Withdrawal by Subject|0|||
48683899|NCT04915729|156692694|FG000|Overall Study|not treated|3|||
48683900|NCT04915729|156692695|FG001|Overall Study|not treated|6|||
48683901|NCT04915729|156692694|FG000|Overall Study|Investigator removed subject|1|||
48683902|NCT04915729|156692695|FG001|Overall Study|Investigator removed subject|2|||
48683903|NCT04915729|156692694|FG000|Overall Study|questionnaire result not evaluated|1|||
48683904|NCT04915729|156692695|FG001|Overall Study|questionnaire result not evaluated|0|||
49021696|NCT01939197|157916866|FG006|Overall Study|Withdrawal by Subject|0|||
48683905|NCT04915729|156692694|FG000|Overall Study|refuse of hospital visit|1|||
48683906|NCT04915729|156692695|FG001|Overall Study|refuse of hospital visit|3|||
48683907|NCT04915729|156692694|FG000|Overall Study|Subject withdrew|1|||
48683908|NCT04915729|156692695|FG001|Overall Study|Subject withdrew|0|||
49021697|NCT01939197|157916860|FG000|Overall Study|Lost to Follow-up|0|||
49021698|NCT01939197|157916861|FG001|Overall Study|Lost to Follow-up|1|||
49021699|NCT01939197|157916862|FG002|Overall Study|Lost to Follow-up|0|||
49021700|NCT01939197|157916863|FG003|Overall Study|Lost to Follow-up|1|||
48683909|NCT00191308|156692696|FG000|Overall Study|Adverse Event|1|||
48683910|NCT01433172|156692697|FG000|Overall Study|Withdrawal by Subject|0|||
48683911|NCT01433172|156692698|FG001|Overall Study|Withdrawal by Subject|1|||
49021701|NCT01939197|157916864|FG004|Overall Study|Lost to Follow-up|3|||
49021702|NCT01939197|157916865|FG005|Overall Study|Lost to Follow-up|1|||
49021703|NCT01939197|157916866|FG006|Overall Study|Lost to Follow-up|2|||
49021704|NCT02660242|157916872|FG000|Glucose Tabs|Lost to Follow-up|1|||
49021705|NCT02660242|157916872|FG000|Glucagon Injection|Lost to Follow-up|1|||
49021706|NCT00623779|157916877|FG000|Overall Study|Adverse Event|1|||
49021707|NCT00623779|157916878|FG001|Overall Study|Adverse Event|3|||
49021708|NCT00623779|157916879|FG002|Overall Study|Adverse Event|0|||
49021709|NCT00623779|157916877|FG000|Overall Study|Criteria from CSR|2|||
49021710|NCT00623779|157916878|FG001|Overall Study|Criteria from CSR|0|||
49021711|NCT00623779|157916879|FG002|Overall Study|Criteria from CSR|1|||
49021712|NCT03661528|157916880|FG000|Overall Study|Death|1|||
49021713|NCT03661528|157916881|FG001|Overall Study|Death|0|||
49021714|NCT03661528|157916880|FG000|Overall Study|Physician Decision|3|||
48763049|NCT01062555|156982046|FG003|Phase 2|Death|3|||
48763050|NCT01062555|156982043|FG000|Phase 2|Graft failure|0|||
48763051|NCT01062555|156982044|FG001|Phase 2|Graft failure|0|||
49021715|NCT03661528|157916881|FG001|Overall Study|Physician Decision|1|||
49021716|NCT03661528|157916880|FG000|Overall Study|Other than Specified|5|||
49021717|NCT03661528|157916881|FG001|Overall Study|Other than Specified|2|||
49021718|NCT03661528|157916880|FG000|Overall Study|Withdrawal by Subject|5|||
49021719|NCT03661528|157916881|FG001|Overall Study|Withdrawal by Subject|3|||
49021720|NCT03661528|157916880|FG000|Overall Study|Disease Progression|8|||
49021721|NCT03661528|157916881|FG001|Overall Study|Disease Progression|13|||
49021722|NCT03661528|157916880|FG000|Overall Study|Adverse Event|61|||
49021723|NCT03661528|157916881|FG001|Overall Study|Adverse Event|55|||
49021724|NCT00796822|157916882|FG000|Overall Study|Lost to Follow-up|2|||
49021725|NCT00796822|157916883|FG001|Overall Study|Lost to Follow-up|0|||
49021726|NCT00796822|157916882|FG000|Overall Study|Adverse Event|1|||
49021727|NCT00796822|157916883|FG001|Overall Study|Adverse Event|0|||
49021728|NCT01941030|157916886|FG000|Overall Study|Death|3|||
49021729|NCT01941030|157916887|FG001|Overall Study|Death|2|||
49021730|NCT01941030|157916886|FG000|Overall Study|Lost to Follow-up|6|||
49021731|NCT01941030|157916887|FG001|Overall Study|Lost to Follow-up|5|||
49021732|NCT01941030|157916886|FG000|Overall Study|Withdrawal by Subject|4|||
49021733|NCT01941030|157916887|FG001|Overall Study|Withdrawal by Subject|6|||
49021734|NCT04646109|157916888|FG000|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0|||
49021735|NCT04646109|157916889|FG001|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6|||
49021736|NCT01479439|157916890|FG000|Overall Study|Adverse Event|1|||
49021737|NCT01479439|157916891|FG001|Overall Study|Adverse Event|0|||
49021738|NCT01479439|157916892|FG002|Overall Study|Adverse Event|0|||
49021739|NCT01479439|157916890|FG000|Overall Study|Lost to Follow-up|0|||
49021740|NCT01479439|157916891|FG001|Overall Study|Lost to Follow-up|1|||
49021741|NCT01479439|157916892|FG002|Overall Study|Lost to Follow-up|0|||
49021742|NCT01479439|157916890|FG000|Overall Study|Protocol Violation|0|||
49021743|NCT01479439|157916891|FG001|Overall Study|Protocol Violation|0|||
49021744|NCT01479439|157916892|FG002|Overall Study|Protocol Violation|2|||
49021745|NCT01001208|157916893|FG000|Overall Study|Adverse Event|10|||
49021746|NCT01001208|157916894|FG001|Overall Study|Adverse Event|5|||
49021747|NCT01001208|157916893|FG000|Overall Study|Lost to Follow-up|5|||
49021748|NCT01001208|157916894|FG001|Overall Study|Lost to Follow-up|9|||
49021749|NCT01001208|157916893|FG000|Overall Study|Physician Decision|1|||
49021750|NCT01001208|157916894|FG001|Overall Study|Physician Decision|0|||
49021751|NCT01001208|157916893|FG000|Overall Study|Withdrawal by Subject|4|||
49021752|NCT01001208|157916894|FG001|Overall Study|Withdrawal by Subject|5|||
48763052|NCT01062555|156982045|FG002|Phase 2|Graft failure|7|||
48763053|NCT01062555|156982046|FG003|Phase 2|Graft failure|4|||
48763054|NCT01062555|156982043|FG000|Phase 2|Withdrawal by Subject|0|||
49021753|NCT01001208|157916893|FG000|Overall Study|Ineligibility Determined|4|||
49021754|NCT01001208|157916894|FG001|Overall Study|Ineligibility Determined|2|||
49021755|NCT01001208|157916893|FG000|Overall Study|Noncompliance|4|||
49021756|NCT01001208|157916894|FG001|Overall Study|Noncompliance|7|||
49021757|NCT01001208|157916893|FG000|Overall Study|Disease Progression|0|||
49021758|NCT01001208|157916894|FG001|Overall Study|Disease Progression|3|||
49021759|NCT01001208|157916893|FG000|Overall Study|Other|0|||
49021760|NCT01001208|157916894|FG001|Overall Study|Other|2|||
49021761|NCT01139164|157916897|FG000|Overall Study|Withdrawn prior to study start|0|||
49021762|NCT01139164|157916898|FG001|Overall Study|Withdrawn prior to study start|2|||
49021763|NCT01139164|157916899|FG002|Overall Study|Withdrawn prior to study start|0|||
49021764|NCT02003183|157916902|FG000|Overall Study|Lost to Follow-up|0|||
49021765|NCT02003183|157916903|FG001|Overall Study|Lost to Follow-up|2|||
49021766|NCT00878995|157916904|FG000|Baseline Study - Midpoint Study|Withdrawal by Subject|0|||
49021767|NCT00878995|157916905|FG001|Baseline Study - Midpoint Study|Withdrawal by Subject|2|||
49021768|NCT01417078|157916913|FG000|Overall Study|Withdrawal by Subject|1|||
48763055|NCT01062555|156982044|FG001|Phase 2|Withdrawal by Subject|0|||
49021769|NCT01030965|157916914|FG000|Overall Study|Lack of Efficacy|3|||
49021770|NCT01030965|157916915|FG001|Overall Study|Lack of Efficacy|2|||
49021771|NCT01030965|157916916|FG002|Overall Study|Lack of Efficacy|0|||
49021772|NCT01030965|157916917|FG003|Overall Study|Lack of Efficacy|3|||
48683912|NCT01433172|156692699|FG002|Overall Study|Withdrawal by Subject|0|||
48683913|NCT01433172|156692697|FG000|Overall Study|Disease Progression|0|||
48683914|NCT01433172|156692698|FG001|Overall Study|Disease Progression|0|||
48683915|NCT01433172|156692699|FG002|Overall Study|Disease Progression|1|||
48683916|NCT01433172|156692697|FG000|Overall Study|Death|0|||
48683917|NCT01433172|156692698|FG001|Overall Study|Death|2|||
48683918|NCT01433172|156692699|FG002|Overall Study|Death|0|||
48683919|NCT03305770|156692700|FG000|Overall Study|Physician Decision - prior to dispense|0|||
48683920|NCT03305770|156692701|FG001|Overall Study|Physician Decision - prior to dispense|1|||
48683921|NCT03305770|156692700|FG000|Overall Study|Subject moved|1|||
48683922|NCT03305770|156692701|FG001|Overall Study|Subject moved|0|||
48683923|NCT02741635|156692702|FG000|Overall Study|Withdrawal by Subject|1|||
48683924|NCT02680665|156692703|FG000|Overall Study|No visit after the first prescription|5|||
48683925|NCT03384940|156692708|FG000|Overall Study|Progressive disease|36|||
48683926|NCT03384940|156692709|FG001|Overall Study|Progressive disease|11|||
48683927|NCT03384940|156692710|FG002|Overall Study|Progressive disease|13|||
48683928|NCT03384940|156692708|FG000|Overall Study|Clinical progression|4|||
48683929|NCT03384940|156692709|FG001|Overall Study|Clinical progression|0|||
48683930|NCT03384940|156692710|FG002|Overall Study|Clinical progression|3|||
48683931|NCT03384940|156692708|FG000|Overall Study|Adverse Event|7|||
48683932|NCT03384940|156692709|FG001|Overall Study|Adverse Event|1|||
48683933|NCT03384940|156692710|FG002|Overall Study|Adverse Event|1|||
48683934|NCT03384940|156692708|FG000|Overall Study|Withdrawal by Subject|3|||
49021773|NCT01030965|157916914|FG000|Overall Study|Protocol Violation|1|||
49021774|NCT01030965|157916915|FG001|Overall Study|Protocol Violation|1|||
49021775|NCT01030965|157916916|FG002|Overall Study|Protocol Violation|1|||
49021776|NCT01030965|157916917|FG003|Overall Study|Protocol Violation|1|||
49021777|NCT01030965|157916914|FG000|Overall Study|Adverse Event|0|||
49021778|NCT01030965|157916915|FG001|Overall Study|Adverse Event|1|||
49021779|NCT01030965|157916916|FG002|Overall Study|Adverse Event|2|||
49021780|NCT01030965|157916917|FG003|Overall Study|Adverse Event|1|||
48683935|NCT03384940|156692709|FG001|Overall Study|Withdrawal by Subject|1|||
48683936|NCT03384940|156692710|FG002|Overall Study|Withdrawal by Subject|0|||
48683937|NCT03384940|156692708|FG000|Overall Study|Physician Decision|1|||
48683938|NCT03384940|156692709|FG001|Overall Study|Physician Decision|1|||
48683939|NCT03384940|156692710|FG002|Overall Study|Physician Decision|0|||
48683940|NCT03384940|156692708|FG000|Overall Study|Death|2|||
48683941|NCT03384940|156692709|FG001|Overall Study|Death|1|||
48683942|NCT03384940|156692710|FG002|Overall Study|Death|0|||
48683943|NCT03384940|156692708|FG000|Overall Study|Other|0|||
48683944|NCT03384940|156692709|FG001|Overall Study|Other|0|||
48683945|NCT03384940|156692710|FG002|Overall Study|Other|1|||
48683946|NCT03089580|156692711|FG000|Overall Study|Lost to Follow-up|2|||
48683947|NCT04303559|156692715|FG000|Overall Study|Study closed due to poor enrollment.|1|||
48683948|NCT01987102|156692716|FG000|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
48683949|NCT01987102|156692717|FG001|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
48683950|NCT01987102|156692716|FG000|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1|||
48683951|NCT01987102|156692717|FG001|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2|||
48683952|NCT01987102|156692716|FG000|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1|||
48683953|NCT01987102|156692717|FG001|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0|||
48683954|NCT01987102|156692716|FG000|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0|||
48683955|NCT01987102|156692717|FG001|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1|||
48683956|NCT01987102|156692716|FG000|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0|||
48683957|NCT01987102|156692717|FG001|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1|||
48683958|NCT01987102|156692716|FG000|2 Courses of HDMTX With MOD Rescue|Adverse Event|0|||
48683959|NCT01987102|156692717|FG001|2 Courses of HDMTX With MOD Rescue|Adverse Event|1|||
48683960|NCT01288989|156692718|FG000|Overall Study|Death|0|||
48683961|NCT01288989|156692719|FG001|Overall Study|Death|0|||
49021781|NCT01030965|157916914|FG000|Overall Study|Protocol-defined Stopping Criteria|0|||
49021782|NCT01030965|157916915|FG001|Overall Study|Protocol-defined Stopping Criteria|1|||
49021783|NCT01030965|157916916|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
49021784|NCT01030965|157916917|FG003|Overall Study|Protocol-defined Stopping Criteria|0|||
49021785|NCT01030965|157916914|FG000|Overall Study|Withdrawal by Subject|0|||
48683962|NCT01288989|156692720|FG002|Overall Study|Death|0|||
48683963|NCT01288989|156692721|FG003|Overall Study|Death|1|||
48683964|NCT01288989|156692722|FG004|Overall Study|Death|0|||
48683965|NCT01288989|156692718|FG000|Overall Study|Dose limiting toxicity|1|||
48683966|NCT01288989|156692719|FG001|Overall Study|Dose limiting toxicity|0|||
48683967|NCT01288989|156692720|FG002|Overall Study|Dose limiting toxicity|0|||
48683968|NCT01288989|156692721|FG003|Overall Study|Dose limiting toxicity|0|||
48683969|NCT01288989|156692722|FG004|Overall Study|Dose limiting toxicity|0|||
48683970|NCT01288989|156692718|FG000|Overall Study|Adverse Event|0|||
49021786|NCT01030965|157916915|FG001|Overall Study|Withdrawal by Subject|1|||
49021787|NCT01030965|157916916|FG002|Overall Study|Withdrawal by Subject|0|||
48683971|NCT01288989|156692719|FG001|Overall Study|Adverse Event|0|||
48683972|NCT01288989|156692720|FG002|Overall Study|Adverse Event|0|||
48683973|NCT01288989|156692721|FG003|Overall Study|Adverse Event|0|||
48683974|NCT01288989|156692722|FG004|Overall Study|Adverse Event|2|||
48683975|NCT01288989|156692718|FG000|Overall Study|Physician Decision|0|||
48683976|NCT01288989|156692719|FG001|Overall Study|Physician Decision|0|||
48683977|NCT01288989|156692720|FG002|Overall Study|Physician Decision|0|||
48683978|NCT01288989|156692721|FG003|Overall Study|Physician Decision|0|||
48683979|NCT01288989|156692722|FG004|Overall Study|Physician Decision|1|||
48683980|NCT01288989|156692718|FG000|Overall Study|Withdrawal by Subject|0|||
48683981|NCT01288989|156692719|FG001|Overall Study|Withdrawal by Subject|0|||
48683982|NCT01288989|156692720|FG002|Overall Study|Withdrawal by Subject|0|||
48683983|NCT01288989|156692721|FG003|Overall Study|Withdrawal by Subject|0|||
48683984|NCT01288989|156692722|FG004|Overall Study|Withdrawal by Subject|3|||
48683985|NCT03370718|156692723|FG000|Overall Study|Withdrawal by Subject|1|||
48683986|NCT03116685|156692727|FG000|Overall Study|Physician Decision|0|||
48683987|NCT03116685|156692728|FG001|Overall Study|Physician Decision|1|||
48683988|NCT06385483|156692729|FG000|Overall Study|Withdrawal by Subject|2|||
48683989|NCT06385483|156692729|FG000|Overall Study|Never start protocol therapy|2|||
48683990|NCT06385483|156692729|FG000|Overall Study|Disease progression|15|||
48683991|NCT02429830|156692732|FG000|Overall Study|Lost to Follow-up|1|||
48683992|NCT02429830|156692732|FG000|Overall Study|Device Explant|2|||
48683993|NCT03301350|156692733|FG000|Overall Study|Withdrawal by Subject|4|||
48683994|NCT03301350|156692733|FG000|Overall Study|Adverse Event|1|||
48683995|NCT03301350|156692733|FG000|Overall Study|Pt withdrawn per DSMC request|1|||
48683996|NCT03301350|156692733|FG000|Overall Study|completed all chemo cycles, however died prior to definitive surgery|1|||
48683997|NCT03301350|156692733|FG000|Overall Study|no detail provided|1|||
48683998|NCT02926638|156692735|FG000|Overall Study|Progression|2|||
48683999|NCT02926638|156692736|FG001|Overall Study|Progression|5|||
48684000|NCT02926638|156692735|FG000|Overall Study|Ineligible|1|||
48684001|NCT02926638|156692736|FG001|Overall Study|Ineligible|0|||
48684002|NCT02926638|156692735|FG000|Overall Study|Not protocol specified|1|||
48684003|NCT02926638|156692736|FG001|Overall Study|Not protocol specified|0|||
48684004|NCT01420926|156692739|FG000|Overall Study|Adverse Event|6|||
48684005|NCT01420926|156692740|FG001|Overall Study|Adverse Event|4|||
48684006|NCT01420926|156692739|FG000|Overall Study|Death|18|||
48684007|NCT01420926|156692740|FG001|Overall Study|Death|17|||
48684008|NCT01420926|156692739|FG000|Overall Study|Withdrawal by Subject|11|||
48684009|NCT01420926|156692740|FG001|Overall Study|Withdrawal by Subject|17|||
48684010|NCT01420926|156692739|FG000|Overall Study|Non-protocol treatment|17|||
48684011|NCT01420926|156692740|FG001|Overall Study|Non-protocol treatment|20|||
48684012|NCT01420926|156692739|FG000|Overall Study|Physician Decision|8|||
48684013|NCT01420926|156692740|FG001|Overall Study|Physician Decision|5|||
48684014|NCT05066165|156694815|FG000|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|0|||
48684015|NCT05066165|156694816|FG001|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|4|||
48684016|NCT05066165|156694815|FG000|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
48684017|NCT05066165|156694816|FG001|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
48684018|NCT03109184|156694817|FG000|Overall Study|Lost to Follow-up|6|||
48684019|NCT03109184|156694818|FG001|Overall Study|Lost to Follow-up|6|||
48684020|NCT03109184|156694817|FG000|Overall Study|Withdrawal by Subject|1|||
48684021|NCT03109184|156694818|FG001|Overall Study|Withdrawal by Subject|1|||
48684022|NCT00615017|156694819|FG000|Overall Study|Adverse Event|0|||
48684023|NCT00615017|156694820|FG001|Overall Study|Adverse Event|1|||
48684024|NCT00615017|156694821|FG002|Overall Study|Adverse Event|2|||
48684025|NCT00615017|156694822|FG003|Overall Study|Adverse Event|0|||
48684026|NCT00615017|156694823|FG004|Overall Study|Adverse Event|0|||
48684027|NCT00615017|156694824|FG005|Overall Study|Adverse Event|1|||
48684028|NCT00615017|156694819|FG000|Overall Study|Death|0|||
48684029|NCT00615017|156694820|FG001|Overall Study|Death|0|||
48684030|NCT00615017|156694821|FG002|Overall Study|Death|2|||
48684031|NCT00615017|156694822|FG003|Overall Study|Death|0|||
48684032|NCT00615017|156694823|FG004|Overall Study|Death|1|||
48684033|NCT00615017|156694824|FG005|Overall Study|Death|1|||
48684034|NCT00615017|156694819|FG000|Overall Study|Sepsis resolved|0|||
48684035|NCT00615017|156694820|FG001|Overall Study|Sepsis resolved|0|||
48684036|NCT00615017|156694821|FG002|Overall Study|Sepsis resolved|1|||
48684037|NCT00615017|156694822|FG003|Overall Study|Sepsis resolved|0|||
48684038|NCT00615017|156694823|FG004|Overall Study|Sepsis resolved|0|||
48684039|NCT00615017|156694824|FG005|Overall Study|Sepsis resolved|0|||
48684040|NCT00615017|156694819|FG000|Overall Study|Transferred out of Intensive Care Unit|0|||
48763056|NCT01062555|156982045|FG002|Phase 2|Withdrawal by Subject|0|||
48763057|NCT01062555|156982046|FG003|Phase 2|Withdrawal by Subject|7|||
48684041|NCT00615017|156694820|FG001|Overall Study|Transferred out of Intensive Care Unit|0|||
48684042|NCT00615017|156694821|FG002|Overall Study|Transferred out of Intensive Care Unit|0|||
48684043|NCT00615017|156694822|FG003|Overall Study|Transferred out of Intensive Care Unit|1|||
48684044|NCT00615017|156694823|FG004|Overall Study|Transferred out of Intensive Care Unit|0|||
48684045|NCT00615017|156694824|FG005|Overall Study|Transferred out of Intensive Care Unit|0|||
48684046|NCT00615017|156694819|FG000|Overall Study|Physician discontinued drug|0|||
48684047|NCT00615017|156694820|FG001|Overall Study|Physician discontinued drug|0|||
48763058|NCT01062555|156982043|FG000|Phase 2|Protocol Violation|0|||
48684048|NCT00615017|156694821|FG002|Overall Study|Physician discontinued drug|0|||
48684049|NCT00615017|156694822|FG003|Overall Study|Physician discontinued drug|0|||
48684050|NCT00615017|156694823|FG004|Overall Study|Physician discontinued drug|0|||
48684051|NCT00615017|156694824|FG005|Overall Study|Physician discontinued drug|1|||
48684052|NCT02333799|156694831|FG000|Treatment Period|Withdrawal by Subject|1|||
48684053|NCT02333799|156694831|FG000|Treatment Period|Death|6|||
48684054|NCT02333799|156694831|FG000|6 Month Follow Up Period|Physician Decision|1|||
48684055|NCT02333799|156694831|FG000|6 Month Follow Up Period|Death|1|||
48684056|NCT02333799|156694831|FG000|7 to 24 Month Follow Up Period|Lost to Follow-up|1|||
48684057|NCT02333799|156694831|FG000|7 to 24 Month Follow Up Period|Physician Decision|1|||
48684058|NCT03499314|156694832|FG000|Overall Study|Time Commitment|1|||
48684059|NCT03499314|156694833|FG001|Overall Study|Time Commitment|2|||
48684060|NCT03499314|156694832|FG000|Overall Study|Medical issue unrelated to research study|1|||
48684061|NCT03499314|156694833|FG001|Overall Study|Medical issue unrelated to research study|1|||
48684062|NCT01271725|156694834|FG000|Part A|Progressive disease according to RECIST|8|||
48684063|NCT01271725|156694835|FG001|Part A|Progressive disease according to RECIST|0|||
48684064|NCT01271725|156694834|FG000|Part A|Clinical signs/symptoms of progression|2|||
48684065|NCT01271725|156694835|FG001|Part A|Clinical signs/symptoms of progression|0|||
48684066|NCT01271725|156694834|FG000|Part A|Other Adverse Event|8|||
48684067|NCT01271725|156694835|FG001|Part A|Other Adverse Event|0|||
48684068|NCT01271725|156694834|FG000|Part A|Lost to Follow-up|1|||
48684069|NCT01271725|156694835|FG001|Part A|Lost to Follow-up|0|||
48684070|NCT01271725|156694834|FG000|Part A|Withdrawal by Subject|12|||
48684071|NCT01271725|156694835|FG001|Part A|Withdrawal by Subject|0|||
48684072|NCT01271725|156694834|FG000|Part A|Other than specified|3|||
48684073|NCT01271725|156694835|FG001|Part A|Other than specified|0|||
48684074|NCT01271725|156694834|FG000|Part A|Protocol Violation|1|||
48684075|NCT01271725|156694835|FG001|Part A|Protocol Violation|0|||
48684076|NCT01271725|156694834|FG000|Part B|Other than specified|0|||
48684077|NCT01271725|156694835|FG001|Part B|Other than specified|2|||
48684078|NCT01271725|156694834|FG000|Part B|Clinical signs/symptoms of progression|0|||
48684079|NCT01271725|156694835|FG001|Part B|Clinical signs/symptoms of progression|2|||
48684080|NCT01271725|156694834|FG000|Part B|Other Adverse Event|0|||
48684081|NCT01271725|156694835|FG001|Part B|Other Adverse Event|1|||
48684082|NCT01271725|156694834|FG000|Part B|Protocol Violation|0|||
48684083|NCT01271725|156694835|FG001|Part B|Protocol Violation|1|||
48684084|NCT01271725|156694834|FG000|Part B|Withdrawal by Subject|0|||
48684085|NCT01271725|156694835|FG001|Part B|Withdrawal by Subject|6|||
48684086|NCT01702025|156694836|FG000|Overall Study|Equipment failure|1|||
48684087|NCT01702025|156694837|FG001|Overall Study|Equipment failure|0|||
48684088|NCT01702025|156694838|FG002|Overall Study|Equipment failure|0|||
48684089|NCT01702025|156694839|FG003|Overall Study|Equipment failure|0|||
48684090|NCT01702025|156694836|FG000|Overall Study|Adverse Event|1|||
48684091|NCT01702025|156694837|FG001|Overall Study|Adverse Event|1|||
48684092|NCT01702025|156694838|FG002|Overall Study|Adverse Event|1|||
48684093|NCT01702025|156694839|FG003|Overall Study|Adverse Event|0|||
48684094|NCT04014062|156694840|FG000|Period I: Dosing|Medical Grounds|4|||
48684095|NCT04014062|156694841|FG001|Period I: Dosing|Medical Grounds|5|||
48684096|NCT04014062|156694840|FG000|Period I: Dosing|Withdrawal by Subject|3|||
48684097|NCT04014062|156694841|FG001|Period I: Dosing|Withdrawal by Subject|1|||
48684098|NCT02871635|156694844|FG000|Overall Study|Primary lack of efficacy|4|||
48684099|NCT02871635|156694845|FG001|Overall Study|Primary lack of efficacy|4|||
48684100|NCT02871635|156694844|FG000|Overall Study|Protocol Violation|3|||
48684101|NCT02871635|156694845|FG001|Overall Study|Protocol Violation|1|||
48684102|NCT02871635|156694844|FG000|Overall Study|Lost to Follow-up|1|||
48684103|NCT02871635|156694845|FG001|Overall Study|Lost to Follow-up|2|||
48684104|NCT02871635|156694844|FG000|Overall Study|Pregnancy|0|||
48684105|NCT02871635|156694845|FG001|Overall Study|Pregnancy|2|||
48684106|NCT02871635|156694844|FG000|Overall Study|Physician Decision|1|||
48684107|NCT02871635|156694845|FG001|Overall Study|Physician Decision|1|||
48684108|NCT02871635|156694844|FG000|Overall Study|Withdrawal by Subject|3|||
48684109|NCT02871635|156694845|FG001|Overall Study|Withdrawal by Subject|4|||
48684110|NCT02871635|156694844|FG000|Overall Study|Adverse Event|4|||
48875152|NCT03020069|157381559|FG001|Overall Study|Lost to Follow-up|1|||
48684111|NCT02871635|156694845|FG001|Overall Study|Adverse Event|4|||
48684112|NCT02871635|156694844|FG000|Overall Study|Secondary lack of efficacy|2|||
48684113|NCT02871635|156694845|FG001|Overall Study|Secondary lack of efficacy|1|||
48684114|NCT00082407|156694849|FG000|Overall Study|Adverse Event|20|||
48684115|NCT00082407|156694850|FG001|Overall Study|Adverse Event|0|||
48684116|NCT00082407|156694849|FG000|Overall Study|Protocol Violation|14|||
48684117|NCT00082407|156694850|FG001|Overall Study|Protocol Violation|12|||
48684118|NCT00082407|156694849|FG000|Overall Study|Patient Decision|13|||
48684119|NCT00082407|156694850|FG001|Overall Study|Patient Decision|6|||
48684120|NCT00082407|156694849|FG000|Overall Study|Physician Decision|5|||
48684121|NCT00082407|156694850|FG001|Overall Study|Physician Decision|3|||
48684122|NCT00082407|156694849|FG000|Overall Study|Loss of Glucose Control|2|||
48875153|NCT03596242|157381560|FG000|Overall Study|Lost to Follow-up|2|||
48684123|NCT00082407|156694850|FG001|Overall Study|Loss of Glucose Control|2|||
48684124|NCT00082407|156694849|FG000|Overall Study|Death|2|||
48684125|NCT00082407|156694850|FG001|Overall Study|Death|1|||
48684126|NCT00082407|156694849|FG000|Overall Study|Lost to Follow-up|0|||
48684127|NCT00082407|156694850|FG001|Overall Study|Lost to Follow-up|3|||
48684128|NCT04809285|156694854|FG000|Phase 1|Lost to Follow-up|6|||
48684129|NCT04809285|156694854|FG000|Phase 1|Protocol Violation|2|||
48684130|NCT04809285|156694854|FG000|Phase 1|Physician Decision|3|||
48684131|NCT04809285|156694854|FG000|Phase 1|Withdrawal by Subject|29|||
48684132|NCT04809285|156694854|FG000|Phase 2|Protocol Violation|3|||
48684133|NCT04809285|156694854|FG000|Phase 2|Withdrawal by Subject|4|||
48684134|NCT01745367|156694855|FG000|Overall Study|Death|1|||
48684135|NCT01745367|156694856|FG001|Overall Study|Death|0|||
48684136|NCT01745367|156694855|FG000|Overall Study|Withdrawal by Subject|1|||
48684137|NCT01745367|156694856|FG001|Overall Study|Withdrawal by Subject|2|||
48684138|NCT01745367|156694855|FG000|Overall Study|Termination of The Study by The Sponsor|6|||
48684139|NCT01745367|156694856|FG001|Overall Study|Termination of The Study by The Sponsor|18|||
48684140|NCT01745367|156694855|FG000|Overall Study|Other Reasons Unspecified|0|||
48684141|NCT01745367|156694856|FG001|Overall Study|Other Reasons Unspecified|2|||
48684142|NCT00699608|156694857|FG000|First Intervention|Withdrawal by Subject|0|||
48684143|NCT00699608|156694858|FG001|First Intervention|Withdrawal by Subject|0|||
48684144|NCT00699608|156694859|FG002|First Intervention|Withdrawal by Subject|1|||
48684145|NCT00699608|156694860|FG003|First Intervention|Withdrawal by Subject|0|||
48684146|NCT00699608|156694861|FG004|First Intervention|Withdrawal by Subject|0|||
48684147|NCT00699608|156694862|FG005|First Intervention|Withdrawal by Subject|0|||
48684148|NCT00699608|156694857|FG000|First Intervention|Protocol Violation|0|||
48684149|NCT00699608|156694858|FG001|First Intervention|Protocol Violation|0|||
48684150|NCT00699608|156694859|FG002|First Intervention|Protocol Violation|0|||
48684151|NCT00699608|156694860|FG003|First Intervention|Protocol Violation|0|||
48684152|NCT00699608|156694861|FG004|First Intervention|Protocol Violation|1|||
48684153|NCT00699608|156694862|FG005|First Intervention|Protocol Violation|0|||
48684154|NCT00699608|156694857|FG000|Second Intervention|Adverse Event|0|||
48684155|NCT00699608|156694858|FG001|Second Intervention|Adverse Event|0|||
48684156|NCT00699608|156694859|FG002|Second Intervention|Adverse Event|1|||
48684157|NCT00699608|156694860|FG003|Second Intervention|Adverse Event|0|||
48684158|NCT00699608|156694861|FG004|Second Intervention|Adverse Event|0|||
48684159|NCT00699608|156694862|FG005|Second Intervention|Adverse Event|0|||
48684160|NCT00699608|156694857|FG000|Second Intervention|Withdrawal by Subject|0|||
48684161|NCT00699608|156694858|FG001|Second Intervention|Withdrawal by Subject|0|||
48684162|NCT00699608|156694859|FG002|Second Intervention|Withdrawal by Subject|0|||
48684163|NCT00699608|156694860|FG003|Second Intervention|Withdrawal by Subject|1|||
48684164|NCT00699608|156694861|FG004|Second Intervention|Withdrawal by Subject|0|||
48684165|NCT00699608|156694862|FG005|Second Intervention|Withdrawal by Subject|0|||
48684166|NCT02837029|156694863|FG000|Screening|Failed to meet screening requirements.|7|||
48684167|NCT02837029|156694864|FG001|Screening|Failed to meet screening requirements.|3|||
48684168|NCT02837029|156694865|FG002|Screening|Failed to meet screening requirements.|0|||
48684169|NCT02837029|156694863|FG000|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2|||
48684170|NCT02837029|156694864|FG001|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
49021788|NCT01030965|157916917|FG003|Overall Study|Withdrawal by Subject|2|||
49021789|NCT02339909|157916924|FG000|Overall Study|Became ineligible after randomisation|89|||
49021790|NCT02339909|157916925|FG001|Overall Study|Became ineligible after randomisation|63|||
49021791|NCT02339909|157916926|FG002|Overall Study|Became ineligible after randomisation|71|||
49021792|NCT01469546|157916935|FG000|Received 5 mg Dose|Adverse Event|13|||
49021793|NCT01469546|157916935|FG000|Received 5 mg Dose|Death|2|||
49021794|NCT01469546|157916935|FG000|Received 5 mg Dose|Protocol Violation|2|||
48684171|NCT02837029|156694865|FG002|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
48684172|NCT02837029|156694863|FG000|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
48684173|NCT02837029|156694864|FG001|Cycle 1 (DLT Monitoring Period)|Adverse Event|2|||
48684174|NCT02837029|156694865|FG002|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
48684175|NCT02837029|156694863|FG000|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
48684176|NCT02837029|156694864|FG001|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1|||
48684177|NCT02837029|156694865|FG002|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
48684178|NCT02837029|156694863|FG000|Cycle 2 and Beyond|Adverse Event|1|||
48684179|NCT02837029|156694864|FG001|Cycle 2 and Beyond|Adverse Event|0|||
49021795|NCT01469546|157916935|FG000|Received 5 mg Dose|Progressive Disease|3|||
48684180|NCT02837029|156694865|FG002|Cycle 2 and Beyond|Adverse Event|0|||
48684181|NCT02837029|156694863|FG000|2 Year Follow-up|Death|6|||
48684182|NCT02837029|156694864|FG001|2 Year Follow-up|Death|7|||
48684183|NCT02837029|156694865|FG002|2 Year Follow-up|Death|0|||
48684184|NCT03920254|156694872|FG000|Overall Study|Adverse Event|1|||
48684185|NCT03920254|156694873|FG001|Overall Study|Adverse Event|0|||
48684186|NCT03920254|156694874|FG002|Overall Study|Adverse Event|0|||
48684187|NCT03920254|156694872|FG000|Overall Study|Physician Decision|0|||
49021796|NCT01469546|157916935|FG000|Received 5 mg Dose|Physician Decision|3|||
48684188|NCT03920254|156694873|FG001|Overall Study|Physician Decision|1|||
48684189|NCT03920254|156694874|FG002|Overall Study|Physician Decision|2|||
48684190|NCT03920254|156694872|FG000|Overall Study|Study Terminated By Sponsor|12|||
48684191|NCT03920254|156694873|FG001|Overall Study|Study Terminated By Sponsor|17|||
49021797|NCT03481309|157916936|FG000|Washout (at Least 3 Days)|Withdrawal by Subject|1|||
49021798|NCT03481309|157916937|FG001|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
48684192|NCT03920254|156694874|FG002|Overall Study|Study Terminated By Sponsor|12|||
48684193|NCT03920254|156694872|FG000|Overall Study|Withdrawal by Subject|0|||
48684194|NCT03920254|156694873|FG001|Overall Study|Withdrawal by Subject|0|||
48684195|NCT03920254|156694874|FG002|Overall Study|Withdrawal by Subject|1|||
48684196|NCT01797263|156694875|FG000|Overall Study|Withdrawal by Subject|21|||
48684197|NCT01797263|156694876|FG001|Overall Study|Withdrawal by Subject|25|||
48684198|NCT01797263|156694875|FG000|Overall Study|Death|1|||
49021799|NCT03481309|157916938|FG002|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
49021800|NCT03481309|157916939|FG003|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
49021801|NCT03481309|157916940|FG004|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
49021802|NCT03481309|157916941|FG005|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
49021803|NCT00154102|157916942|FG000|Overall Study|investigational study phase ongoing|7|||
49021804|NCT00154102|157916943|FG001|Overall Study|investigational study phase ongoing|2|||
48684199|NCT01797263|156694876|FG001|Overall Study|Death|0|||
48684200|NCT01797263|156694875|FG000|Overall Study|Lost to Follow-up|15|||
48684201|NCT01797263|156694876|FG001|Overall Study|Lost to Follow-up|15|||
48684202|NCT02342223|156694880|FG000|Overall Study|Lost to Follow-up|1|||
48684203|NCT03329846|156694884|FG000|Overall Study|Disease progression|4|||
48684204|NCT03329846|156694885|FG001|Overall Study|Disease progression|6|||
48684205|NCT03329846|156694884|FG000|Overall Study|Study drug toxicity|1|||
48684206|NCT03329846|156694885|FG001|Overall Study|Study drug toxicity|0|||
48684207|NCT03329846|156694884|FG000|Overall Study|Participant request to discontinue treatment|0|||
48684208|NCT03329846|156694885|FG001|Overall Study|Participant request to discontinue treatment|1|||
48684209|NCT03329846|156694884|FG000|Overall Study|Participant withdrew consent|1|||
48684210|NCT03329846|156694885|FG001|Overall Study|Participant withdrew consent|0|||
48684211|NCT03329846|156694884|FG000|Overall Study|Other reasons|2|||
48684212|NCT03329846|156694885|FG001|Overall Study|Other reasons|2|||
48684213|NCT02741596|156694886|FG000|Overall Study|Adverse Event|1|||
48684214|NCT02741596|156694887|FG001|Overall Study|Adverse Event|5|||
48684215|NCT02741596|156694886|FG000|Overall Study|Lost to Follow-up|1|||
48684216|NCT02741596|156694887|FG001|Overall Study|Lost to Follow-up|1|||
48684217|NCT02741596|156694886|FG000|Overall Study|Physician Decision|2|||
48684218|NCT02741596|156694887|FG001|Overall Study|Physician Decision|1|||
48684219|NCT02741596|156694886|FG000|Overall Study|Pregnancy|3|||
48684220|NCT02741596|156694887|FG001|Overall Study|Pregnancy|1|||
48684221|NCT02741596|156694886|FG000|Overall Study|Other (Unspecified)|0|||
48684222|NCT02741596|156694887|FG001|Overall Study|Other (Unspecified)|3|||
48684223|NCT02741596|156694886|FG000|Overall Study|Subject withdrawn-Other|17|||
48684224|NCT02741596|156694887|FG001|Overall Study|Subject withdrawn-Other|4|||
48684225|NCT02741596|156694886|FG000|Overall Study|Subject withdrawn-to commercial product|54|||
48684226|NCT02741596|156694887|FG001|Overall Study|Subject withdrawn-to commercial product|63|||
48684227|NCT00479336|156694888|FG000|Overall Study|Adverse Event|1|||
48684228|NCT00479336|156694889|FG001|Overall Study|Adverse Event|1|||
48684229|NCT00479336|156694890|FG002|Overall Study|Adverse Event|1|||
48684230|NCT00479336|156694891|FG003|Overall Study|Adverse Event|3|||
48684231|NCT00479336|156694888|FG000|Overall Study|Lack of Efficacy|1|||
48684232|NCT00479336|156694889|FG001|Overall Study|Lack of Efficacy|0|||
48684233|NCT00479336|156694890|FG002|Overall Study|Lack of Efficacy|0|||
48684234|NCT00479336|156694891|FG003|Overall Study|Lack of Efficacy|0|||
48684235|NCT00479336|156694888|FG000|Overall Study|Protocol Violation|0|||
48684236|NCT00479336|156694889|FG001|Overall Study|Protocol Violation|1|||
48684237|NCT00479336|156694890|FG002|Overall Study|Protocol Violation|0|||
48684238|NCT00479336|156694891|FG003|Overall Study|Protocol Violation|0|||
48684239|NCT00479336|156694888|FG000|Overall Study|Withdrawal by Subject|1|||
48684240|NCT00479336|156694889|FG001|Overall Study|Withdrawal by Subject|2|||
48684241|NCT00479336|156694890|FG002|Overall Study|Withdrawal by Subject|0|||
48684242|NCT00479336|156694891|FG003|Overall Study|Withdrawal by Subject|0|||
48684243|NCT00479336|156694888|FG000|Overall Study|Physician Decision|0|||
48684244|NCT00479336|156694889|FG001|Overall Study|Physician Decision|1|||
48684245|NCT00479336|156694890|FG002|Overall Study|Physician Decision|0|||
48684246|NCT00479336|156694891|FG003|Overall Study|Physician Decision|2|||
48684247|NCT00479336|156694888|FG000|Overall Study|Resolution of all hepatic edema findings|1|||
49021805|NCT01471522|157916945|FG000|Overall Study|Withdrawal by Subject|28|||
49021806|NCT01471522|157916946|FG001|Overall Study|Withdrawal by Subject|22|||
48684248|NCT00479336|156694889|FG001|Overall Study|Resolution of all hepatic edema findings|1|||
48684249|NCT00479336|156694890|FG002|Overall Study|Resolution of all hepatic edema findings|0|||
48684250|NCT00479336|156694891|FG003|Overall Study|Resolution of all hepatic edema findings|0|||
48684251|NCT03066193|156694892|FG000|Overall Study|Withdrawal by Subject|1|||
48684252|NCT02021643|156694893|FG000|Overall Study|Enrolled but Never Treated|1|||
48684253|NCT02021643|156694894|FG001|Overall Study|Enrolled but Never Treated|0|||
48684254|NCT02021643|156694895|FG002|Overall Study|Enrolled but Never Treated|0|||
49021807|NCT01471522|157916945|FG000|Overall Study|Lost to Follow-up|36|||
49021808|NCT01471522|157916946|FG001|Overall Study|Lost to Follow-up|26|||
48684255|NCT02021643|156694896|FG003|Overall Study|Enrolled but Never Treated|0|||
49021809|NCT00094302|157918582|FG000|Overall Study|Lost to Follow-up|43|||
49021810|NCT00094302|157918583|FG001|Overall Study|Lost to Follow-up|41|||
49021811|NCT00094302|157918582|FG000|Overall Study|Physician Decision|5|||
49021812|NCT00094302|157918583|FG001|Overall Study|Physician Decision|8|||
49021813|NCT00094302|157918582|FG000|Overall Study|Withdrawal by Subject|103|||
49021814|NCT00094302|157918583|FG001|Overall Study|Withdrawal by Subject|111|||
49021815|NCT00094302|157918582|FG000|Overall Study|Death|266|||
49021816|NCT00094302|157918583|FG001|Overall Study|Death|246|||
49021817|NCT01941095|157918586|FG000|Overall Study|Insufficient therapeutic response|13|||
49021818|NCT01941095|157918586|FG000|Overall Study|Anaphylaxis or serious hypersensitivity|2|||
49021819|NCT01941095|157918586|FG000|Overall Study|Adverse Event|11|||
49021820|NCT01941095|157918586|FG000|Overall Study|Physician Decision|3|||
49021821|NCT01941095|157918586|FG000|Overall Study|Withdrawal by Subject|17|||
49021822|NCT01941095|157918586|FG000|Overall Study|Lost to Follow-up|10|||
49021823|NCT01658943|157918587|FG000|Overall Study|Adverse Event|6|||
49021824|NCT01658943|157918588|FG001|Overall Study|Adverse Event|13|||
49021825|NCT01658943|157918587|FG000|Overall Study|Withdrawal by Subject|9|||
49021826|NCT01658943|157918588|FG001|Overall Study|Withdrawal by Subject|2|||
49021827|NCT01658943|157918587|FG000|Overall Study|Progression/Relapse|39|||
49021828|NCT01658943|157918588|FG001|Overall Study|Progression/Relapse|40|||
49021829|NCT01658943|157918587|FG000|Overall Study|Death|4|||
49021830|NCT01658943|157918588|FG001|Overall Study|Death|2|||
49021831|NCT01658943|157918587|FG000|Overall Study|not protocol specified|4|||
49021832|NCT01658943|157918588|FG001|Overall Study|not protocol specified|1|||
49021833|NCT01658943|157918587|FG000|Overall Study|Not eligible|7|||
49021834|NCT01658943|157918588|FG001|Overall Study|Not eligible|9|||
49021835|NCT01658943|157918587|FG000|Overall Study|Withdrew prior to beginning protocol Tx|1|||
49021836|NCT01658943|157918588|FG001|Overall Study|Withdrew prior to beginning protocol Tx|0|||
49021837|NCT02458638|157918589|FG000|Overall Study|Death|309|||
49021838|NCT02458638|157918589|FG000|Overall Study|End of Cohort/End of Study|67|||
49021839|NCT02458638|157918589|FG000|Overall Study|Lost to Follow-up|31|||
49021840|NCT02458638|157918589|FG000|Overall Study|Other Reasons|4|||
49021841|NCT02458638|157918589|FG000|Overall Study|Physician Decision|1|||
49021842|NCT02458638|157918589|FG000|Overall Study|Withdrawal by Subject|47|||
49021843|NCT01648166|157918590|FG000|Overall Study|inadequate toenail samples|53|||
49021844|NCT01648166|157918591|FG001|Overall Study|inadequate toenail samples|100|||
49021845|NCT02564263|157918607|FG000|Overall Study|Adverse Event|31|||
49021846|NCT02564263|157918608|FG001|Overall Study|Adverse Event|29|||
49021847|NCT02564263|157918607|FG000|Overall Study|Death|270|||
49021848|NCT02564263|157918608|FG001|Overall Study|Death|262|||
49021849|NCT02564263|157918607|FG000|Overall Study|Withdrawal by Subject|4|||
49021850|NCT02564263|157918608|FG001|Overall Study|Withdrawal by Subject|19|||
49021851|NCT02564263|157918607|FG000|Overall Study|Sponsor's decision|9|||
49021852|NCT02564263|157918608|FG001|Overall Study|Sponsor's decision|4|||
49021853|NCT00520741|157918609|FG000|Overall Study|Adverse Event|16|||
49021854|NCT00520741|157918610|FG001|Overall Study|Adverse Event|56|||
49021855|NCT00520741|157918609|FG000|Overall Study|Lack of Efficacy|11|||
49021856|NCT00520741|157918610|FG001|Overall Study|Lack of Efficacy|30|||
49021857|NCT00520741|157918609|FG000|Overall Study|Withdrawal by Subject|0|||
49021858|NCT00520741|157918610|FG001|Overall Study|Withdrawal by Subject|11|||
49021859|NCT00520741|157918609|FG000|Overall Study|Protocol Violation|2|||
49021860|NCT00520741|157918610|FG001|Overall Study|Protocol Violation|15|||
49021861|NCT00520741|157918609|FG000|Overall Study|Unsatisfactory compliance of subject|4|||
49021862|NCT00520741|157918610|FG001|Overall Study|Unsatisfactory compliance of subject|3|||
49021863|NCT00520741|157918609|FG000|Overall Study|Lost to Follow-up|4|||
49021864|NCT00520741|157918610|FG001|Overall Study|Lost to Follow-up|4|||
49021865|NCT00520741|157918609|FG000|Overall Study|Other reasons for premature termination|0|||
49021866|NCT00520741|157918610|FG001|Overall Study|Other reasons for premature termination|6|||
49021867|NCT03679741|157918611|FG000|Period 1|No longer meet eligibility criteria|1|||
49021868|NCT03679741|157918612|FG001|Period 1|No longer meet eligibility criteria|0|||
49021869|NCT03679741|157918611|FG000|Period 1|Lost to Follow-up|0|||
49021870|NCT03679741|157918612|FG001|Period 1|Lost to Follow-up|1|||
48875154|NCT03596242|157381561|FG001|Overall Study|Lost to Follow-up|2|||
49021871|NCT03679741|157918611|FG000|Period 1|Adverse Event|1|||
49021872|NCT03679741|157918612|FG001|Period 1|Adverse Event|1|||
49021873|NCT03679741|157918611|FG000|Period 1|Withdrawal by Subject|0|||
49021874|NCT03679741|157918612|FG001|Period 1|Withdrawal by Subject|1|||
49021875|NCT03679741|157918611|FG000|Period 2|Adverse Event|2|||
49021876|NCT03679741|157918612|FG001|Period 2|Adverse Event|1|||
49021877|NCT03679741|157918611|FG000|Period 2|Withdrawal by Subject|1|||
49021878|NCT03679741|157918612|FG001|Period 2|Withdrawal by Subject|1|||
49021879|NCT03311646|157918613|FG000|Overall Study|Physician Decision|1|||
49021880|NCT03311646|157918613|FG000|Overall Study|Withdrawal by Subject|5|||
49021881|NCT03311646|157918613|FG000|Overall Study|Lost to Follow-up|5|||
49021882|NCT03311646|157918613|FG000|Overall Study|PI Withdrawal for Positive Drug Screen|4|||
49021883|NCT03702621|157918614|FG000|Overall Study|Physician Decision|6|||
49021884|NCT03702621|157918615|FG001|Overall Study|Physician Decision|6|||
49021885|NCT03194464|157918618|FG000|Overall Study|data not usable|2|||
49021886|NCT03103100|157918619|FG000|Overall Study|Adverse Event|1|||
49021887|NCT03103100|157918620|FG001|Overall Study|Adverse Event|0|||
49021888|NCT03103100|157918621|FG002|Overall Study|Adverse Event|0|||
49021889|NCT03103100|157918619|FG000|Overall Study|Physician Decision|1|||
49021890|NCT03103100|157918620|FG001|Overall Study|Physician Decision|0|||
49021891|NCT03103100|157918621|FG002|Overall Study|Physician Decision|2|||
49021892|NCT01000337|157918622|FG000|Overall Study|Lost to Follow-up|4|||
49021893|NCT01000337|157918623|FG001|Overall Study|Lost to Follow-up|3|||
49021894|NCT01492361|157918630|FG000|Overall Study|Withdrawal by Subject|281|||
49021895|NCT01492361|157918631|FG001|Overall Study|Withdrawal by Subject|297|||
49021896|NCT01492361|157918630|FG000|Overall Study|Physician Decision|12|||
49021897|NCT01492361|157918631|FG001|Overall Study|Physician Decision|12|||
49021898|NCT01492361|157918630|FG000|Overall Study|Lost to Follow-up|6|||
49021899|NCT01492361|157918631|FG001|Overall Study|Lost to Follow-up|13|||
49021900|NCT01492361|157918630|FG000|Overall Study|Other than specified above|106|||
49021901|NCT01492361|157918631|FG001|Overall Study|Other than specified above|138|||
49021902|NCT02906709|157918632|FG000|Phase A (Week 0 to Week 16)|Adverse Event|1|||
49021903|NCT02906709|157918633|FG001|Phase A (Week 0 to Week 16)|Adverse Event|2|||
49021904|NCT02906709|157918632|FG000|Phase A (Week 0 to Week 16)|Death|0|||
49021905|NCT02906709|157918633|FG001|Phase A (Week 0 to Week 16)|Death|1|||
49021906|NCT02906709|157918632|FG000|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3|||
49021907|NCT02906709|157918633|FG001|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0|||
49021908|NCT02906709|157918632|FG000|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2|||
49021909|NCT02906709|157918633|FG001|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0|||
49021910|NCT02227862|157918634|FG000|Overall Study|Protocol Violation|7|||
49021911|NCT02227862|157918635|FG001|Overall Study|Protocol Violation|9|||
49021912|NCT02227862|157918634|FG000|Overall Study|Other|0|||
49021913|NCT02227862|157918635|FG001|Overall Study|Other|2|||
48684256|NCT02021643|156694893|FG000|Overall Study|Adverse Event|0|||
48684257|NCT02021643|156694894|FG001|Overall Study|Adverse Event|1|||
48684258|NCT02021643|156694895|FG002|Overall Study|Adverse Event|0|||
48684259|NCT02021643|156694896|FG003|Overall Study|Adverse Event|0|||
48684260|NCT02021643|156694893|FG000|Overall Study|Death|0|||
48684261|NCT02021643|156694894|FG001|Overall Study|Death|1|||
48684262|NCT02021643|156694895|FG002|Overall Study|Death|0|||
48684263|NCT02021643|156694896|FG003|Overall Study|Death|0|||
48684264|NCT02021643|156694893|FG000|Overall Study|Investigator's Discretion|1|||
48684265|NCT02021643|156694894|FG001|Overall Study|Investigator's Discretion|0|||
48684266|NCT02021643|156694895|FG002|Overall Study|Investigator's Discretion|0|||
48684267|NCT02021643|156694896|FG003|Overall Study|Investigator's Discretion|0|||
48684268|NCT02021643|156694893|FG000|Overall Study|Lack of Efficacy|7|||
48684269|NCT02021643|156694894|FG001|Overall Study|Lack of Efficacy|6|||
48684270|NCT02021643|156694895|FG002|Overall Study|Lack of Efficacy|0|||
48684271|NCT02021643|156694896|FG003|Overall Study|Lack of Efficacy|12|||
48684272|NCT02021643|156694893|FG000|Overall Study|Lost to Follow-up|0|||
48684273|NCT02021643|156694894|FG001|Overall Study|Lost to Follow-up|1|||
48684274|NCT02021643|156694895|FG002|Overall Study|Lost to Follow-up|0|||
48684275|NCT02021643|156694896|FG003|Overall Study|Lost to Follow-up|0|||
48684276|NCT02021643|156694893|FG000|Overall Study|Withdrew Consent|0|||
48684277|NCT02021643|156694894|FG001|Overall Study|Withdrew Consent|1|||
48684278|NCT02021643|156694895|FG002|Overall Study|Withdrew Consent|0|||
48684279|NCT02021643|156694896|FG003|Overall Study|Withdrew Consent|0|||
48684280|NCT04854551|156694899|FG000|Overall Study|Withdrawal by Subject|1|||
48684281|NCT04854551|156694900|FG001|Overall Study|Withdrawal by Subject|1|||
48684282|NCT00100789|156694902|FG000|Overall Study|Adverse Event|10|||
48684283|NCT00100789|156694902|FG000|Overall Study|Withdrawal by Subject|1|||
48684284|NCT00100789|156694902|FG000|Overall Study|Progression/relapse|42|||
48684285|NCT00100789|156694902|FG000|Overall Study|Death|2|||
48684286|NCT00100789|156694902|FG000|Overall Study|Not protocol specified|5|||
48684287|NCT00100789|156694902|FG000|Overall Study|Ineligible|3|||
48684288|NCT00100789|156694902|FG000|Overall Study|Never received treatment|1|||
48684289|NCT03472950|156694903|FG000|Overall Study|Lost to Follow-up|0|||
48684290|NCT03472950|156694904|FG001|Overall Study|Lost to Follow-up|1|||
48684291|NCT03472950|156694903|FG000|Overall Study|Adverse Event|0|||
49021914|NCT02227862|157918634|FG000|Overall Study|Adverse Event|4|||
49021915|NCT02227862|157918635|FG001|Overall Study|Adverse Event|3|||
48684292|NCT03472950|156694904|FG001|Overall Study|Adverse Event|3|||
48684293|NCT01450761|156694907|FG000|Randomization|Subject no longer meets study criteria|1|||
49021916|NCT02227862|157918634|FG000|Overall Study|Withdrawal by Subject|7|||
49021917|NCT02227862|157918635|FG001|Overall Study|Withdrawal by Subject|6|||
48684294|NCT01450761|156694908|FG001|Randomization|Subject no longer meets study criteria|2|||
48684295|NCT01450761|156694907|FG000|Randomization|Withdrawal by Subject|2|||
48684296|NCT01450761|156694908|FG001|Randomization|Withdrawal by Subject|0|||
48684297|NCT01450761|156694907|FG000|Randomization|Disease progression|0|||
48684298|NCT01450761|156694908|FG001|Randomization|Disease progression|2|||
49021918|NCT02227862|157918634|FG000|Overall Study|Lost to Follow-up|1|||
49021919|NCT02227862|157918635|FG001|Overall Study|Lost to Follow-up|2|||
49021920|NCT00680121|157918637|FG000|Overall Study|Lost to Follow-up|27|||
49021921|NCT00680121|157918638|FG001|Overall Study|Lost to Follow-up|23|||
49021922|NCT01124149|157918639|FG000|Acute Phase|Withdrawal by Subject|22|||
49021923|NCT01124149|157918639|FG000|Acute Phase|Adverse Event|21|||
49021924|NCT01124149|157918639|FG000|Acute Phase|Lack of Efficacy|17|||
49021925|NCT01124149|157918639|FG000|Acute Phase|Protocol Violation|14|||
49021926|NCT01124149|157918639|FG000|Acute Phase|Lost to Follow-up|2|||
49021927|NCT01124149|157918639|FG000|Acute Phase|Prolonged antibiotic therapy|1|||
49021928|NCT01124149|157918639|FG000|Acute Phase|Sponsor request|1|||
49021929|NCT01124149|157918639|FG000|Acute Phase|UC symptoms not ameliorated|1|||
49021930|NCT01124149|157918639|FG000|Acute Phase|Non-compliance|1|||
49021931|NCT01124149|157918639|FG000|Acute Phase|Low hemoglobin|1|||
49021932|NCT01124149|157918639|FG000|Acute Phase|Travelling to another country|1|||
49021933|NCT01124149|157918639|FG000|Acute Phase|Sponsor decision|1|||
49021934|NCT01124149|157918639|FG000|Maintenance Phase|Lack of Efficacy|40|||
49021935|NCT01124149|157918639|FG000|Maintenance Phase|Adverse Event|24|||
49021936|NCT01124149|157918639|FG000|Maintenance Phase|Lost to Follow-up|15|||
49021937|NCT01124149|157918639|FG000|Maintenance Phase|Withdrawal by Subject|10|||
49021938|NCT01124149|157918639|FG000|Maintenance Phase|Protocol Violation|5|||
49021939|NCT01124149|157918639|FG000|Maintenance Phase|Coordinator error|1|||
49021940|NCT01124149|157918639|FG000|Maintenance Phase|Non-compliance|1|||
49021955|NCT02153398|157918643|FG000|Overall Study|Withdrawal by Subject|1|||
49021956|NCT02153398|157918644|FG001|Overall Study|Withdrawal by Subject|0|||
49021957|NCT02153398|157918645|FG002|Overall Study|Withdrawal by Subject|0|||
49021958|NCT02153398|157918646|FG003|Overall Study|Withdrawal by Subject|0|||
49021959|NCT02153398|157918647|FG004|Overall Study|Withdrawal by Subject|0|||
49021960|NCT02153398|157918643|FG000|Overall Study|Adverse Event|0|||
49021961|NCT02153398|157918644|FG001|Overall Study|Adverse Event|0|||
49021962|NCT02153398|157918645|FG002|Overall Study|Adverse Event|1|||
49021963|NCT02153398|157918646|FG003|Overall Study|Adverse Event|1|||
49021964|NCT02153398|157918647|FG004|Overall Study|Adverse Event|0|||
49021965|NCT02402166|157918648|FG000|Overall Study|Adverse Event|2|||
49021966|NCT02402166|157918648|FG000|Overall Study|Withdrawal by Subject|2|||
48684299|NCT01450761|156694907|FG000|Randomization|Adverse Event unrelated to study drug|1|||
48684300|NCT01450761|156694908|FG001|Randomization|Adverse Event unrelated to study drug|0|||
48684301|NCT01450761|156694907|FG000|Randomization|Other|0|||
48684302|NCT01450761|156694908|FG001|Randomization|Other|1|||
48684303|NCT01450761|156694907|FG000|Lead-in Chemotherapy|Disease progression|33|||
48684304|NCT01450761|156694908|FG001|Lead-in Chemotherapy|Disease progression|32|||
48684305|NCT01450761|156694907|FG000|Lead-in Chemotherapy|Adverse event unrelated to study drug|21|||
48684306|NCT01450761|156694908|FG001|Lead-in Chemotherapy|Adverse event unrelated to study drug|19|||
48684307|NCT01450761|156694907|FG000|Lead-in Chemotherapy|Withdrawal by Subject|14|||
48684308|NCT01450761|156694908|FG001|Lead-in Chemotherapy|Withdrawal by Subject|12|||
48763059|NCT01062555|156982044|FG001|Phase 2|Protocol Violation|0|||
48763060|NCT01062555|156982045|FG002|Phase 2|Protocol Violation|0|||
48763061|NCT01062555|156982046|FG003|Phase 2|Protocol Violation|3|||
48763062|NCT01062555|156982043|FG000|Phase 2|Physician Decision|0|||
48763063|NCT01062555|156982044|FG001|Phase 2|Physician Decision|0|||
48763064|NCT01062555|156982045|FG002|Phase 2|Physician Decision|0|||
48763065|NCT01062555|156982046|FG003|Phase 2|Physician Decision|17|||
48763066|NCT00329407|156982049|FG000|Overall Study|Withdrawal by Subject|1|||
48763067|NCT02347189|156982050|FG000|Overall Study|No implant attempted of study device|9|||
48763068|NCT02347189|156982050|FG000|Overall Study|No primary outcome data available|2|||
48763069|NCT00698581|156982053|FG000|Overall Study|Lack of Efficacy|23|||
48763070|NCT00698581|156982054|FG001|Overall Study|Lack of Efficacy|11|||
48763071|NCT00698581|156982053|FG000|Overall Study|Withdrawal by Subject|6|||
48763072|NCT00698581|156982054|FG001|Overall Study|Withdrawal by Subject|0|||
49021967|NCT02402166|157918648|FG000|Overall Study|Lost to Follow-up|1|||
49021968|NCT01400425|157918655|FG000|Overall Study|Withdrawal by Subject|10|||
48684309|NCT01450761|156694907|FG000|Lead-in Chemotherapy|Study drug toxicity|6|||
49021969|NCT00688064|157918656|FG000|Overall Study|Protocol Violation|0|||
49021970|NCT00688064|157918657|FG001|Overall Study|Protocol Violation|1|||
49021971|NCT00688064|157918656|FG000|Overall Study|Adverse Event|2|||
48763073|NCT00698581|156982053|FG000|Overall Study|Other reason|9|||
48684310|NCT01450761|156694908|FG001|Lead-in Chemotherapy|Study drug toxicity|10|||
48684311|NCT01450761|156694907|FG000|Lead-in Chemotherapy|No longer meets study criteria|3|||
48684312|NCT01450761|156694908|FG001|Lead-in Chemotherapy|No longer meets study criteria|7|||
48684313|NCT01450761|156694907|FG000|Lead-in Chemotherapy|Death|3|||
48684314|NCT01450761|156694908|FG001|Lead-in Chemotherapy|Death|3|||
48684315|NCT01450761|156694907|FG000|Lead-in Chemotherapy|Other|2|||
48684316|NCT01450761|156694908|FG001|Lead-in Chemotherapy|Other|2|||
48684317|NCT01450761|156694907|FG000|Lead-in Chemotherapy|Lost to Follow-up|2|||
48684318|NCT01450761|156694908|FG001|Lead-in Chemotherapy|Lost to Follow-up|0|||
48684319|NCT01450761|156694907|FG000|Treatment With Blinded Study Therapy|Disease progression|318|||
48684320|NCT01450761|156694908|FG001|Treatment With Blinded Study Therapy|Disease progression|415|||
48684321|NCT01450761|156694907|FG000|Treatment With Blinded Study Therapy|Study drug toxicity|87|||
48684322|NCT01450761|156694908|FG001|Treatment With Blinded Study Therapy|Study drug toxicity|9|||
48684323|NCT01450761|156694907|FG000|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27|||
48684324|NCT01450761|156694908|FG001|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19|||
48684325|NCT01450761|156694907|FG000|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15|||
48684326|NCT01450761|156694908|FG001|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8|||
48684327|NCT01450761|156694907|FG000|Treatment With Blinded Study Therapy|Withdrawal by Subject|12|||
48684328|NCT01450761|156694908|FG001|Treatment With Blinded Study Therapy|Withdrawal by Subject|5|||
48684329|NCT01450761|156694907|FG000|Treatment With Blinded Study Therapy|Death|5|||
48684330|NCT01450761|156694908|FG001|Treatment With Blinded Study Therapy|Death|6|||
48684331|NCT01450761|156694907|FG000|Treatment With Blinded Study Therapy|Other/Unspecified|5|||
48684332|NCT01450761|156694908|FG001|Treatment With Blinded Study Therapy|Other/Unspecified|4|||
48684333|NCT01450761|156694907|FG000|Treatment With Blinded Study Therapy|Lost to Follow-up|2|||
48684334|NCT01450761|156694908|FG001|Treatment With Blinded Study Therapy|Lost to Follow-up|1|||
48684335|NCT01450761|156694907|FG000|Treatment With Blinded Study Therapy|Maximum clinical benefit|1|||
48684336|NCT01450761|156694908|FG001|Treatment With Blinded Study Therapy|Maximum clinical benefit|2|||
48684337|NCT01450761|156694907|FG000|Treatment With Blinded Study Therapy|No longer meets study criteria|1|||
48684338|NCT01450761|156694908|FG001|Treatment With Blinded Study Therapy|No longer meets study criteria|2|||
48684339|NCT01450761|156694907|FG000|Treatment With Blinded Study Therapy|Not reported|2|||
48684340|NCT01450761|156694908|FG001|Treatment With Blinded Study Therapy|Not reported|2|||
48684341|NCT01450761|156694907|FG000|Treatment With Blinded Study Therapy|Poor/non-compliance|1|||
48684342|NCT01450761|156694908|FG001|Treatment With Blinded Study Therapy|Poor/non-compliance|0|||
48684343|NCT01450761|156694907|FG000|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2|||
48684344|NCT01450761|156694908|FG001|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3|||
48684345|NCT01858363|156694911|FG000|Overall Study|Death|35|||
48684346|NCT01858363|156694912|FG001|Overall Study|Death|9|||
48684347|NCT01858363|156694911|FG000|Overall Study|Withdrawal by Subject|28|||
48684348|NCT01858363|156694912|FG001|Overall Study|Withdrawal by Subject|14|||
48684349|NCT01858363|156694911|FG000|Overall Study|Lost to Follow-up|13|||
48875155|NCT02438371|157381562|FG000|Overall Study|Lost to Follow-up|3|||
48875156|NCT02438371|157381563|FG001|Overall Study|Lost to Follow-up|2|||
48875157|NCT02438371|157381562|FG000|Overall Study|Withdrawal by Subject|1|||
48875158|NCT02438371|157381563|FG001|Overall Study|Withdrawal by Subject|1|||
48875159|NCT03546816|157381564|FG000|Overall Study|Adverse Event|5|||
48875160|NCT03546816|157381565|FG001|Overall Study|Adverse Event|3|||
48875161|NCT03546816|157381564|FG000|Overall Study|Lack of Efficacy|2|||
48875162|NCT03546816|157381565|FG001|Overall Study|Lack of Efficacy|4|||
48875163|NCT03546816|157381564|FG000|Overall Study|Pregnancy|1|||
48875164|NCT03546816|157381565|FG001|Overall Study|Pregnancy|0|||
48875165|NCT03546816|157381564|FG000|Overall Study|Physician Decision|2|||
48875166|NCT03546816|157381565|FG001|Overall Study|Physician Decision|0|||
48875167|NCT03546816|157381564|FG000|Overall Study|Withdrawal by Subject|8|||
48875168|NCT03546816|157381565|FG001|Overall Study|Withdrawal by Subject|10|||
48875169|NCT03546816|157381564|FG000|Overall Study|Lost to Follow-up|3|||
48875170|NCT03546816|157381565|FG001|Overall Study|Lost to Follow-up|2|||
48875171|NCT01161446|157381566|FG000|Overall Study|Lost to Follow-up|18|||
48875172|NCT01161446|157381567|FG001|Overall Study|Lost to Follow-up|14|||
48875173|NCT01161446|157381566|FG000|Overall Study|Withdrawal by Subject|0|||
48875174|NCT01161446|157381567|FG001|Overall Study|Withdrawal by Subject|1|||
48875175|NCT00810342|157381572|FG000|Month 1 Follow-up|Lost to Follow-up|4|||
48875176|NCT00810342|157381573|FG001|Month 1 Follow-up|Lost to Follow-up|2|||
48875177|NCT00810342|157381572|FG000|Month 1 Follow-up|Pregnancy|1|||
48875178|NCT00810342|157381573|FG001|Month 1 Follow-up|Pregnancy|0|||
48875179|NCT00810342|157381572|FG000|6-month Follow-up|Lost to Follow-up|18|||
48875180|NCT00810342|157381573|FG001|6-month Follow-up|Lost to Follow-up|6|||
48875181|NCT00810342|157381572|FG000|6-month Follow-up|Pregnancy|6|||
48875182|NCT00810342|157381573|FG001|6-month Follow-up|Pregnancy|2|||
48875183|NCT00810342|157381572|FG000|12-month Followup|Pregnancy|9|||
48875184|NCT00810342|157381573|FG001|12-month Followup|Pregnancy|10|||
48875185|NCT00810342|157381572|FG000|12-month Followup|Lost to Follow-up|3|||
48875186|NCT00810342|157381573|FG001|12-month Followup|Lost to Follow-up|1|||
49021972|NCT00688064|157918657|FG001|Overall Study|Adverse Event|4|||
49021973|NCT00688064|157918656|FG000|Overall Study|Withdrawal by Subject|7|||
49021974|NCT00688064|157918657|FG001|Overall Study|Withdrawal by Subject|7|||
49021975|NCT00688064|157918656|FG000|Overall Study|Lost to Follow-up|10|||
49021976|NCT00688064|157918657|FG001|Overall Study|Lost to Follow-up|10|||
49021977|NCT00688064|157918656|FG000|Overall Study|Lack of Efficacy|0|||
48684350|NCT01858363|156694912|FG001|Overall Study|Lost to Follow-up|3|||
48684351|NCT04390243|156694913|FG000|Overall Study|Death|1|||
48684352|NCT04390243|156694913|FG000|Overall Study|Disease Progression|4|||
48684353|NCT04390243|156694913|FG000|Overall Study|Patient was on treatment when study was terminated|1|||
48684354|NCT02478463|156694918|FG000|Treatment Period 1 (Up to Day 29)|Physician Decision|1|||
48684355|NCT02478463|156694918|FG000|Washout Period (Up to 42 Days)|Lost to Follow-up|1|||
48684356|NCT02478463|156694918|FG000|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1|||
49021978|NCT00688064|157918657|FG001|Overall Study|Lack of Efficacy|1|||
48684357|NCT03259087|156694927|FG000|Part 1 and Period 1 of Part 2|Adverse Event|0|||
48684358|NCT03259087|156694928|FG001|Part 1 and Period 1 of Part 2|Adverse Event|0|||
48684359|NCT03259087|156694929|FG002|Part 1 and Period 1 of Part 2|Adverse Event|0|||
48684360|NCT03259087|156694930|FG003|Part 1 and Period 1 of Part 2|Adverse Event|0|||
48684361|NCT03259087|156694931|FG004|Part 1 and Period 1 of Part 2|Adverse Event|1|||
48684362|NCT03259087|156694927|FG000|Period 2 of Part 2|Adverse Event|0|||
48684363|NCT03259087|156694928|FG001|Period 2 of Part 2|Adverse Event|0|||
48684364|NCT03259087|156694929|FG002|Period 2 of Part 2|Adverse Event|0|||
48684365|NCT03259087|156694930|FG003|Period 2 of Part 2|Adverse Event|0|||
48684366|NCT03259087|156694931|FG004|Period 2 of Part 2|Adverse Event|1|||
48684367|NCT02518971|156694932|FG000|Overall Study|Lost to Follow-up|0|||
48684368|NCT02518971|156694933|FG001|Overall Study|Lost to Follow-up|1|||
48684369|NCT02518971|156694932|FG000|Overall Study|Physician Decision|6|||
48684370|NCT02518971|156694933|FG001|Overall Study|Physician Decision|6|||
48684371|NCT02518971|156694932|FG000|Overall Study|Protocol Violation|6|||
48684372|NCT02518971|156694933|FG001|Overall Study|Protocol Violation|4|||
48684373|NCT02518971|156694932|FG000|Overall Study|Withdrawal by Subject|4|||
48684374|NCT02518971|156694933|FG001|Overall Study|Withdrawal by Subject|5|||
48684375|NCT02518971|156694932|FG000|Overall Study|Side effects|1|||
48684376|NCT02518971|156694933|FG001|Overall Study|Side effects|0|||
48684377|NCT02518971|156694932|FG000|Overall Study|medication lost in mail|0|||
48684378|NCT02518971|156694933|FG001|Overall Study|medication lost in mail|1|||
48684379|NCT02518971|156694932|FG000|Overall Study|eligibility criteria no longer met|6|||
48684380|NCT02518971|156694933|FG001|Overall Study|eligibility criteria no longer met|3|||
48684381|NCT03551626|156694934|FG000|Overall Study|Adverse Event|88|||
48684382|NCT03551626|156694934|FG000|Overall Study|Disease relapse|18|||
48684383|NCT03551626|156694934|FG000|Overall Study|Withdrawal of informed consent|6|||
48684384|NCT03551626|156694934|FG000|Overall Study|Patient decision|5|||
48684385|NCT03551626|156694934|FG000|Overall Study|Physician Decision|4|||
48684386|NCT03551626|156694934|FG000|Overall Study|Lost to Follow-up|3|||
48684387|NCT03551626|156694934|FG000|Overall Study|Pregnancy|1|||
48684388|NCT03551626|156694934|FG000|Overall Study|Protocol deviation|1|||
48684389|NCT03551626|156694934|FG000|Overall Study|Technical problems|1|||
48684390|NCT02336230|156694935|FG000|Overall Study|Adverse Event|1|||
48684391|NCT02336230|156694935|FG000|Overall Study|Withdrawal of consent|1|||
48684392|NCT02336230|156694935|FG000|Overall Study|Death|9|||
48684393|NCT02336230|156694935|FG000|Overall Study|Dose not received due to shipping delay|1|||
48684394|NCT02336230|156694935|FG000|Overall Study|Discontinuation of MSC infusion|1|||
48684395|NCT01362348|156694936|FG000|Overall Study|Protocol-defined stopping criteria|9|||
48684396|NCT01362348|156694936|FG000|Overall Study|Study closed/terminated|5|||
48684397|NCT00684996|156694937|FG000|Overall Study|Adverse Event|1|||
48684398|NCT00684996|156694937|FG000|Overall Study|Refusal unrelated to adverse event|1|||
48684399|NCT00684996|156694937|FG000|Overall Study|Progression/relapse|2|||
48684400|NCT00684996|156694937|FG000|Overall Study|Other reasons not protocol specified|1|||
48684401|NCT00556998|156694938|FG000|Voriconazole Intravenous (IV)|Adverse Event|1|||
48763074|NCT00698581|156982054|FG001|Overall Study|Other reason|1|||
48763075|NCT00698581|156982053|FG000|Overall Study|SAE, non-fatal|1|||
48763076|NCT00698581|156982054|FG001|Overall Study|SAE, non-fatal|0|||
49021979|NCT00688064|157918656|FG000|Overall Study|Pregnancy|1|||
49021980|NCT00688064|157918657|FG001|Overall Study|Pregnancy|0|||
49021981|NCT00688064|157918656|FG000|Overall Study|Any other reasons|1|||
49021982|NCT00688064|157918657|FG001|Overall Study|Any other reasons|3|||
49021983|NCT00620763|157918660|FG000|Period: First Intervention|Withdrawal by Subject|0|||
49021984|NCT00620763|157918661|FG001|Period: First Intervention|Withdrawal by Subject|2|||
48684402|NCT00556998|156694938|FG000|Voriconazole Intravenous (IV)|Other|4|||
48684403|NCT00556998|156694938|FG000|Voriconazole Oral|Adverse Event|1|||
48684404|NCT00556998|156694938|FG000|Voriconazole Oral|Intolerant of oral treatment|1|||
48763077|NCT00698581|156982053|FG000|Overall Study|AE, non-serious non-fatal|4|||
49021985|NCT00620763|157918660|FG000|Period: First Intervention|Protocol Violation|0|||
49021986|NCT00620763|157918661|FG001|Period: First Intervention|Protocol Violation|3|||
49021987|NCT00620763|157918660|FG000|Period: Second Intervention|Withdrawal by Subject|1|||
49021988|NCT00620763|157918661|FG001|Period: Second Intervention|Withdrawal by Subject|0|||
48684405|NCT00286494|156694943|FG000|Overall Study|Hyperglycemic rescue|12|||
48684406|NCT00286494|156694944|FG001|Overall Study|Hyperglycemic rescue|19|||
48875187|NCT04486313|157381576|FG000|Overall Study|Lost to Follow-up|7|||
48875188|NCT04486313|157381577|FG001|Overall Study|Lost to Follow-up|9|||
48875189|NCT04486313|157381576|FG000|Overall Study|Withdrawal by Subject|8|||
49021989|NCT00560235|157918662|FG000|Phase 1|Discontinued|8|||
49021990|NCT00560235|157918663|FG001|Phase 1|Discontinued|0|||
49021991|NCT00560235|157918664|FG002|Phase 1|Discontinued|0|||
49021992|NCT00560235|157918662|FG000|Phase 1B|Discontinued|0|||
49021993|NCT00560235|157918663|FG001|Phase 1B|Discontinued|19|||
49021994|NCT00560235|157918664|FG002|Phase 1B|Discontinued|0|||
49021995|NCT00560235|157918662|FG000|Phase 2|Discontinued|0|||
49021996|NCT00560235|157918663|FG001|Phase 2|Discontinued|0|||
49021997|NCT00560235|157918664|FG002|Phase 2|Discontinued|96|||
49021998|NCT00560235|157918662|FG000|Phase 2|Ongoing at Date of Cut-Off|0|||
49021999|NCT00560235|157918663|FG001|Phase 2|Ongoing at Date of Cut-Off|0|||
49022000|NCT00560235|157918664|FG002|Phase 2|Ongoing at Date of Cut-Off|1|||
49022001|NCT02428699|157918666|FG000|Washout Period 1|Screen Failure|1|||
49022002|NCT02428699|157918667|FG001|Washout Period 1|Screen Failure|2|||
49022003|NCT00728949|157918668|FG000|Overall Study|Adverse Event|8|||
49022004|NCT00728949|157918669|FG001|Overall Study|Adverse Event|0|||
49022005|NCT00728949|157918668|FG000|Overall Study|Withdrawal by Subject|2|||
49022006|NCT00728949|157918669|FG001|Overall Study|Withdrawal by Subject|2|||
49022007|NCT00728949|157918668|FG000|Overall Study|Abnormal Lab Results|0|||
49022008|NCT00728949|157918669|FG001|Overall Study|Abnormal Lab Results|2|||
49022009|NCT00728949|157918668|FG000|Overall Study|On treatment at cutoff date|1|||
49022010|NCT00728949|157918669|FG001|Overall Study|On treatment at cutoff date|0|||
49022011|NCT01996033|157918670|FG000|Overall Study|Death|1|||
49022012|NCT01996033|157918670|FG000|Overall Study|Physician Decision|1|||
49022013|NCT01996033|157918670|FG000|Overall Study|Withdrawal by Subject|4|||
49022014|NCT01996033|157918670|FG000|Overall Study|Lost to Follow-up|3|||
49022015|NCT03583606|157918671|FG000|Overall Study|Lost to Follow-up|0|||
49022016|NCT03583606|157918672|FG001|Overall Study|Lost to Follow-up|1|||
49022017|NCT03583606|157918673|FG002|Overall Study|Lost to Follow-up|0|||
49022018|NCT03583606|157918671|FG000|Overall Study|Ineligible at baseline|1|||
49022019|NCT03583606|157918672|FG001|Overall Study|Ineligible at baseline|0|||
49022020|NCT03583606|157918673|FG002|Overall Study|Ineligible at baseline|0|||
48684407|NCT00286494|156694945|FG002|Overall Study|Hyperglycemic rescue|18|||
48684408|NCT00286494|156694943|FG000|Overall Study|Withdrawal by Subject|2|||
48684409|NCT00286494|156694944|FG001|Overall Study|Withdrawal by Subject|10|||
48684410|NCT00286494|156694945|FG002|Overall Study|Withdrawal by Subject|9|||
48684411|NCT00286494|156694943|FG000|Overall Study|Adverse Event|3|||
48684412|NCT00286494|156694944|FG001|Overall Study|Adverse Event|8|||
48684413|NCT00286494|156694945|FG002|Overall Study|Adverse Event|6|||
48684414|NCT00286494|156694943|FG000|Overall Study|Physician Decision|5|||
48684415|NCT00286494|156694944|FG001|Overall Study|Physician Decision|5|||
48684416|NCT00286494|156694945|FG002|Overall Study|Physician Decision|1|||
48684417|NCT00286494|156694943|FG000|Overall Study|Lost to Follow-up|3|||
48684418|NCT00286494|156694944|FG001|Overall Study|Lost to Follow-up|1|||
48684419|NCT00286494|156694945|FG002|Overall Study|Lost to Follow-up|3|||
48684420|NCT00286494|156694943|FG000|Overall Study|Protocol Violation|1|||
48684421|NCT00286494|156694944|FG001|Overall Study|Protocol Violation|1|||
48684422|NCT00286494|156694945|FG002|Overall Study|Protocol Violation|2|||
48684423|NCT02175017|156694946|FG000|Overall Study|Did not receive the investigational product|1|||
48684424|NCT02175017|156694947|FG001|Overall Study|Did not receive the investigational product|2|||
48684425|NCT02175017|156694946|FG000|Overall Study|Withdrawal by Subject|6|||
48684426|NCT02175017|156694947|FG001|Overall Study|Withdrawal by Subject|3|||
48684427|NCT02175017|156694946|FG000|Overall Study|Met an exclusion criteria|0|||
48684428|NCT02175017|156694947|FG001|Overall Study|Met an exclusion criteria|1|||
48684429|NCT02175017|156694946|FG000|Overall Study|Adverse Event|3|||
48684430|NCT02175017|156694947|FG001|Overall Study|Adverse Event|10|||
48875190|NCT04486313|157381577|FG001|Overall Study|Withdrawal by Subject|6|||
48875191|NCT04486313|157381576|FG000|Overall Study|Physician Decision|1|||
49022021|NCT02143102|157918674|FG000|Overall Study|Lost to Follow-up|11|||
49022022|NCT02143102|157918675|FG001|Overall Study|Lost to Follow-up|0|||
49022023|NCT01725451|157918680|FG000|Period 1|Withdrawal by Subject|1|||
49022024|NCT01725451|157918681|FG001|Period 1|Withdrawal by Subject|0|||
49022025|NCT01725451|157918682|FG002|Period 1|Withdrawal by Subject|0|||
49022026|NCT01725451|157918683|FG003|Period 1|Withdrawal by Subject|0|||
49022027|NCT01725451|157918680|FG000|Washout From Period 3|Protocol Violation|0|||
49022028|NCT01725451|157918681|FG001|Washout From Period 3|Protocol Violation|0|||
48684431|NCT02175017|156694946|FG000|Overall Study|Disease progression|20|||
48684432|NCT02175017|156694947|FG001|Overall Study|Disease progression|27|||
48684433|NCT02175017|156694946|FG000|Overall Study|Other than above reasons|3|||
48684434|NCT02175017|156694947|FG001|Overall Study|Other than above reasons|0|||
49022029|NCT01725451|157918682|FG002|Washout From Period 3|Protocol Violation|1|||
48875192|NCT04486313|157381577|FG001|Overall Study|Physician Decision|1|||
48875193|NCT04486313|157381576|FG000|Overall Study|Death|2|||
49022030|NCT01725451|157918683|FG003|Washout From Period 3|Protocol Violation|0|||
49022031|NCT01725451|157918680|FG000|Washout From Period 3|Adverse Event|0|||
49022032|NCT01725451|157918681|FG001|Washout From Period 3|Adverse Event|1|||
49022033|NCT01725451|157918682|FG002|Washout From Period 3|Adverse Event|0|||
49022034|NCT01725451|157918683|FG003|Washout From Period 3|Adverse Event|0|||
49022035|NCT01725451|157918680|FG000|Period 4|Adverse Event|0|||
49022036|NCT01725451|157918681|FG001|Period 4|Adverse Event|0|||
49022037|NCT01725451|157918682|FG002|Period 4|Adverse Event|1|||
49022038|NCT01725451|157918683|FG003|Period 4|Adverse Event|0|||
49022039|NCT01345019|157918684|FG000|Blinded Treatment Phase|Death|147|||
49022040|NCT01345019|157918685|FG001|Blinded Treatment Phase|Death|137|||
49022041|NCT01345019|157918684|FG000|Blinded Treatment Phase|Withdrawal by Subject|103|||
49022042|NCT01345019|157918685|FG001|Blinded Treatment Phase|Withdrawal by Subject|112|||
49022043|NCT01345019|157918684|FG000|Blinded Treatment Phase|Completed Survival Follow-up|21|||
48684435|NCT01970306|156694952|FG000|Overall Study|Not eligible|3|||
48684436|NCT01970306|156694952|FG000|Overall Study|Not able to be treated|9|||
48684437|NCT02330055|156694958|FG000|Overall Study|technical issues|2|||
48684438|NCT02330055|156694959|FG001|Overall Study|technical issues|0|||
48684439|NCT02330055|156694958|FG000|Overall Study|participant forgot to wear device|5|||
48684440|NCT02330055|156694959|FG001|Overall Study|participant forgot to wear device|5|||
48684441|NCT02330055|156694958|FG000|Overall Study|data for less than 60 minutes|3|||
48684442|NCT02330055|156694959|FG001|Overall Study|data for less than 60 minutes|3|||
48684443|NCT02330055|156694958|FG000|Overall Study|participant did not sleep|0|||
48684444|NCT02330055|156694959|FG001|Overall Study|participant did not sleep|1|||
48684445|NCT02488005|156694960|FG000|Overall Study|Lost to Follow-up|2|||
48684446|NCT00650767|156694961|FG000|Overall Study|Adverse Event|0|||
48684447|NCT00650767|156694962|FG001|Overall Study|Adverse Event|3|||
48684448|NCT00650767|156694963|FG002|Overall Study|Adverse Event|10|||
48684449|NCT00650767|156694964|FG003|Overall Study|Adverse Event|8|||
48684450|NCT00650767|156694961|FG000|Overall Study|Death|1|||
48684451|NCT00650767|156694962|FG001|Overall Study|Death|0|||
48684452|NCT00650767|156694963|FG002|Overall Study|Death|0|||
49022044|NCT01345019|157918685|FG001|Blinded Treatment Phase|Completed Survival Follow-up|9|||
49022045|NCT01345019|157918684|FG000|Blinded Treatment Phase|Disease Progression|12|||
48684453|NCT00650767|156694964|FG003|Overall Study|Death|0|||
48684454|NCT00650767|156694961|FG000|Overall Study|Withdrawal by Subject|2|||
48684455|NCT00650767|156694962|FG001|Overall Study|Withdrawal by Subject|4|||
48684456|NCT00650767|156694963|FG002|Overall Study|Withdrawal by Subject|3|||
48684457|NCT00650767|156694964|FG003|Overall Study|Withdrawal by Subject|3|||
48684458|NCT00650767|156694961|FG000|Overall Study|Lost to Follow-up|1|||
48684459|NCT00650767|156694962|FG001|Overall Study|Lost to Follow-up|1|||
48684460|NCT00650767|156694963|FG002|Overall Study|Lost to Follow-up|1|||
48684461|NCT00650767|156694964|FG003|Overall Study|Lost to Follow-up|0|||
48684462|NCT00650767|156694961|FG000|Overall Study|Other|1|||
48684463|NCT00650767|156694962|FG001|Overall Study|Other|1|||
48684464|NCT00650767|156694963|FG002|Overall Study|Other|0|||
48684465|NCT00650767|156694964|FG003|Overall Study|Other|0|||
48684466|NCT00801216|156694968|FG000|Overall Study|Screening Failure|2|||
48684467|NCT01597635|156697746|FG000|Part A|Adverse Event|3|||
48684468|NCT01597635|156697747|FG001|Part A|Adverse Event|0|||
48684469|NCT01597635|156697748|FG002|Part A|Adverse Event|0|||
49022046|NCT01345019|157918685|FG001|Blinded Treatment Phase|Disease Progression|10|||
49022047|NCT01345019|157918684|FG000|Blinded Treatment Phase|Adverse Event|6|||
49022048|NCT01345019|157918685|FG001|Blinded Treatment Phase|Adverse Event|13|||
49022049|NCT01345019|157918684|FG000|Blinded Treatment Phase|Administrative Decision|10|||
48684470|NCT01597635|156697746|FG000|Part B|Adverse Event|0|||
48684471|NCT01597635|156697747|FG001|Part B|Adverse Event|0|||
48684472|NCT01597635|156697748|FG002|Part B|Adverse Event|1|||
48684473|NCT01597635|156697746|FG000|Part B|Protocol Violation|0|||
48684474|NCT01597635|156697747|FG001|Part B|Protocol Violation|1|||
48684475|NCT01597635|156697748|FG002|Part B|Protocol Violation|0|||
48875194|NCT04486313|157381577|FG001|Overall Study|Death|0|||
48875195|NCT04486313|157381576|FG000|Overall Study|Protocol Violation|1|||
48684476|NCT01597635|156697746|FG000|Part B|Protocol-defined stopping criteria|0|||
48875196|NCT04486313|157381577|FG001|Overall Study|Protocol Violation|1|||
48875197|NCT00916305|157381585|FG000|Overall Study|Lost to Follow-up|21|||
48875198|NCT00916305|157381586|FG001|Overall Study|Lost to Follow-up|27|||
48875199|NCT00916305|157381585|FG000|Overall Study|Withdrawal by Subject|0|||
48684477|NCT01597635|156697747|FG001|Part B|Protocol-defined stopping criteria|4|||
49022050|NCT01345019|157918685|FG001|Blinded Treatment Phase|Administrative Decision|8|||
49022051|NCT01345019|157918684|FG000|Blinded Treatment Phase|Noncompliance|5|||
49022052|NCT01345019|157918685|FG001|Blinded Treatment Phase|Noncompliance|3|||
49022053|NCT01345019|157918684|FG000|Blinded Treatment Phase|Ineligibility Determined|1|||
48684478|NCT01597635|156697748|FG002|Part B|Protocol-defined stopping criteria|3|||
48684479|NCT01597635|156697746|FG000|Part B|Withdrawal by Subject|0|||
48684480|NCT01597635|156697747|FG001|Part B|Withdrawal by Subject|1|||
48684481|NCT01597635|156697748|FG002|Part B|Withdrawal by Subject|0|||
48684482|NCT02300259|156697749|FG000|Period 1|Adverse Event|0|||
48875200|NCT00916305|157381586|FG001|Overall Study|Withdrawal by Subject|1|||
48875201|NCT00307164|157381587|FG000|Overall Study|Death|1|||
48684483|NCT02300259|156697750|FG001|Period 1|Adverse Event|0|||
48684484|NCT02300259|156697751|FG002|Period 1|Adverse Event|1|||
48684485|NCT02300259|156697749|FG000|Period 1|Withdrawal by Subject|0|||
48684486|NCT02300259|156697750|FG001|Period 1|Withdrawal by Subject|0|||
48684487|NCT02300259|156697751|FG002|Period 1|Withdrawal by Subject|1|||
48684488|NCT02300259|156697749|FG000|Period 2|Adverse Event|1|||
48684489|NCT02300259|156697750|FG001|Period 2|Adverse Event|0|||
48684490|NCT02300259|156697751|FG002|Period 2|Adverse Event|0|||
48684491|NCT02300259|156697749|FG000|Period 2|Withdrawal by Subject|0|||
48684492|NCT02300259|156697750|FG001|Period 2|Withdrawal by Subject|0|||
48684493|NCT02300259|156697751|FG002|Period 2|Withdrawal by Subject|1|||
48684494|NCT01980095|156697755|FG000|Overall Study|Lost to Follow-up|6|||
48684495|NCT01980095|156697756|FG001|Overall Study|Lost to Follow-up|7|||
48684496|NCT01980095|156697755|FG000|Overall Study|Withdrawal by Subject|2|||
48684497|NCT01980095|156697756|FG001|Overall Study|Withdrawal by Subject|3|||
48684498|NCT01980095|156697755|FG000|Overall Study|Poor compliance|5|||
48684499|NCT01980095|156697756|FG001|Overall Study|Poor compliance|0|||
48684500|NCT01980095|156697755|FG000|Overall Study|Safety issue|0|||
48684501|NCT01980095|156697756|FG001|Overall Study|Safety issue|1|||
48684502|NCT01980095|156697755|FG000|Overall Study|Study drug discontinued|1|||
48684503|NCT01980095|156697756|FG001|Overall Study|Study drug discontinued|0|||
48684504|NCT01980095|156697755|FG000|Overall Study|Randomized by mistake|1|||
48684505|NCT01980095|156697756|FG001|Overall Study|Randomized by mistake|0|||
48684506|NCT00412893|156697757|FG000|Overall Study|Adverse Event|31|||
48684507|NCT00412893|156697758|FG001|Overall Study|Adverse Event|53|||
48684508|NCT00412893|156697757|FG000|Overall Study|Death|17|||
48684509|NCT00412893|156697758|FG001|Overall Study|Death|21|||
48684510|NCT00412893|156697757|FG000|Overall Study|Insufficient Therapeutic Response|39|||
48684511|NCT00412893|156697758|FG001|Overall Study|Insufficient Therapeutic Response|23|||
48684512|NCT00412893|156697757|FG000|Overall Study|Lost to Follow-up|2|||
49022054|NCT01345019|157918685|FG001|Blinded Treatment Phase|Ineligibility Determined|6|||
49022055|NCT01345019|157918684|FG000|Blinded Treatment Phase|Protocol Deviation|5|||
49022056|NCT01345019|157918685|FG001|Blinded Treatment Phase|Protocol Deviation|0|||
49022057|NCT01345019|157918684|FG000|Blinded Treatment Phase|Other, Not Specified|2|||
49022058|NCT01345019|157918685|FG001|Blinded Treatment Phase|Other, Not Specified|3|||
49022059|NCT01345019|157918684|FG000|Blinded Treatment Phase|Lost to Follow-up|6|||
48684513|NCT00412893|156697758|FG001|Overall Study|Lost to Follow-up|1|||
48684514|NCT00412893|156697757|FG000|Overall Study|Violation of Selection at Entry|17|||
48684515|NCT00412893|156697758|FG001|Overall Study|Violation of Selection at Entry|10|||
48684516|NCT00412893|156697757|FG000|Overall Study|Other Protocol Violation|10|||
48684517|NCT00412893|156697758|FG001|Overall Study|Other Protocol Violation|6|||
48684518|NCT00412893|156697757|FG000|Overall Study|Did Not Cooperate|12|||
48684519|NCT00412893|156697758|FG001|Overall Study|Did Not Cooperate|9|||
48684520|NCT00412893|156697757|FG000|Overall Study|Administrative Reason|12|||
48684521|NCT00412893|156697758|FG001|Overall Study|Administrative Reason|15|||
48684522|NCT00412893|156697757|FG000|Overall Study|Randomized but Never Received Study Drug|5|||
48684523|NCT00412893|156697758|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
48684524|NCT02737475|156697759|FG000|Overall Study|Other reasons|0|||
48684525|NCT02737475|156697760|FG001|Overall Study|Other reasons|0|||
48684526|NCT02737475|156697761|FG002|Overall Study|Other reasons|0|||
48684527|NCT02737475|156697762|FG003|Overall Study|Other reasons|0|||
48684528|NCT02737475|156697763|FG004|Overall Study|Other reasons|1|||
48684529|NCT02737475|156697764|FG005|Overall Study|Other reasons|1|||
48684530|NCT02737475|156697765|FG006|Overall Study|Other reasons|0|||
48684531|NCT02737475|156697766|FG007|Overall Study|Other reasons|0|||
48684532|NCT02737475|156697767|FG008|Overall Study|Other reasons|1|||
48684533|NCT02737475|156697768|FG009|Overall Study|Other reasons|0|||
48684534|NCT02737475|156697769|FG010|Overall Study|Other reasons|1|||
48684535|NCT02737475|156697770|FG011|Overall Study|Other reasons|0|||
48684536|NCT02737475|156697771|FG012|Overall Study|Other reasons|0|||
48684537|NCT02737475|156697772|FG013|Overall Study|Other reasons|0|||
48684538|NCT02737475|156697773|FG014|Overall Study|Other reasons|0|||
48684539|NCT02737475|156697774|FG015|Overall Study|Other reasons|0|||
48684540|NCT02737475|156697775|FG016|Overall Study|Other reasons|0|||
48684541|NCT02737475|156697776|FG017|Overall Study|Other reasons|0|||
48684542|NCT02737475|156697777|FG018|Overall Study|Other reasons|0|||
48684543|NCT02737475|156697778|FG019|Overall Study|Other reasons|0|||
48684544|NCT02737475|156697779|FG020|Overall Study|Other reasons|0|||
48684545|NCT02737475|156697780|FG021|Overall Study|Other reasons|1|||
48684546|NCT02737475|156697781|FG022|Overall Study|Other reasons|0|||
48684547|NCT02737475|156697782|FG023|Overall Study|Other reasons|1|||
48684548|NCT02737475|156697783|FG024|Overall Study|Other reasons|1|||
48684549|NCT02737475|156697784|FG025|Overall Study|Other reasons|1|||
49022060|NCT01345019|157918685|FG001|Blinded Treatment Phase|Lost to Follow-up|3|||
49022061|NCT01345019|157918684|FG000|Open Label Treatment Phase|Death|49|||
48684550|NCT02737475|156697785|FG026|Overall Study|Other reasons|0|||
48684551|NCT02737475|156697759|FG000|Overall Study|Death|1|||
48684552|NCT02737475|156697760|FG001|Overall Study|Death|0|||
48684553|NCT02737475|156697761|FG002|Overall Study|Death|0|||
49022062|NCT01345019|157918685|FG001|Open Label Treatment Phase|Death|48|||
49022063|NCT01345019|157918684|FG000|Open Label Treatment Phase|Withdrawal by Subject|49|||
49022064|NCT01345019|157918685|FG001|Open Label Treatment Phase|Withdrawal by Subject|47|||
49022065|NCT01345019|157918684|FG000|Open Label Treatment Phase|Adverse Event|30|||
49022066|NCT01345019|157918685|FG001|Open Label Treatment Phase|Adverse Event|51|||
49022067|NCT01345019|157918684|FG000|Open Label Treatment Phase|Administrative Decision|30|||
48684554|NCT02737475|156697762|FG003|Overall Study|Death|1|||
48684555|NCT02737475|156697763|FG004|Overall Study|Death|0|||
48684556|NCT02737475|156697764|FG005|Overall Study|Death|0|||
48684557|NCT02737475|156697765|FG006|Overall Study|Death|0|||
48684558|NCT02737475|156697766|FG007|Overall Study|Death|2|||
48684559|NCT02737475|156697767|FG008|Overall Study|Death|0|||
48684560|NCT02737475|156697768|FG009|Overall Study|Death|0|||
48684561|NCT02737475|156697769|FG010|Overall Study|Death|0|||
48684562|NCT02737475|156697770|FG011|Overall Study|Death|4|||
48684563|NCT02737475|156697771|FG012|Overall Study|Death|2|||
48684564|NCT02737475|156697772|FG013|Overall Study|Death|2|||
48684565|NCT02737475|156697773|FG014|Overall Study|Death|0|||
48684566|NCT02737475|156697774|FG015|Overall Study|Death|2|||
48684567|NCT02737475|156697775|FG016|Overall Study|Death|2|||
48684568|NCT02737475|156697776|FG017|Overall Study|Death|2|||
48684569|NCT02737475|156697777|FG018|Overall Study|Death|1|||
48763078|NCT00698581|156982054|FG001|Overall Study|AE, non-serious non-fatal|0|||
48763079|NCT00698581|156982053|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
48763080|NCT00698581|156982054|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
48763081|NCT00698581|156982053|FG000|Overall Study|AE of unknown type|1|||
48763082|NCT00698581|156982054|FG001|Overall Study|AE of unknown type|0|||
49022068|NCT01345019|157918685|FG001|Open Label Treatment Phase|Administrative Decision|15|||
49022069|NCT01345019|157918684|FG000|Open Label Treatment Phase|Disease Progression|17|||
49022070|NCT01345019|157918685|FG001|Open Label Treatment Phase|Disease Progression|18|||
49022071|NCT01345019|157918684|FG000|Open Label Treatment Phase|Noncompliance|5|||
49022072|NCT01345019|157918685|FG001|Open Label Treatment Phase|Noncompliance|4|||
49022073|NCT01345019|157918684|FG000|Open Label Treatment Phase|Lost to Follow-up|1|||
49022074|NCT01345019|157918685|FG001|Open Label Treatment Phase|Lost to Follow-up|2|||
49022075|NCT01345019|157918684|FG000|Open Label Treatment Phase|Pregnancy|1|||
49022076|NCT01345019|157918685|FG001|Open Label Treatment Phase|Pregnancy|0|||
49022077|NCT01345019|157918684|FG000|Open Label Treatment Phase|Other, Not Specified|9|||
49022078|NCT01345019|157918685|FG001|Open Label Treatment Phase|Other, Not Specified|7|||
49022079|NCT01345019|157918684|FG000|Open Label Treatment Phase|Protocol Violation|0|||
49022080|NCT01345019|157918685|FG001|Open Label Treatment Phase|Protocol Violation|1|||
49022081|NCT03164772|157918686|FG000|Overall Study|Death|4|||
49022082|NCT03164772|157918687|FG001|Overall Study|Death|2|||
49022083|NCT03164772|157918686|FG000|Overall Study|Adverse Event|1|||
49022084|NCT03164772|157918687|FG001|Overall Study|Adverse Event|4|||
49022085|NCT03164772|157918686|FG000|Overall Study|Progressive Disease|11|||
49022086|NCT03164772|157918687|FG001|Overall Study|Progressive Disease|21|||
49022087|NCT03164772|157918686|FG000|Overall Study|Physician Decision|2|||
49022088|NCT03164772|157918687|FG001|Overall Study|Physician Decision|0|||
49022089|NCT03164772|157918686|FG000|Overall Study|Withdrawal by Subject|0|||
49022090|NCT03164772|157918687|FG001|Overall Study|Withdrawal by Subject|4|||
49022091|NCT00497796|157918694|FG000|Overall Study|Adverse event (not related)|9|||
49022092|NCT00497796|157918695|FG001|Overall Study|Adverse event (not related)|9|||
49022093|NCT00497796|157918694|FG000|Overall Study|Adverse event (related)|5|||
49022094|NCT00497796|157918695|FG001|Overall Study|Adverse event (related)|4|||
49022095|NCT00497796|157918694|FG000|Overall Study|CMV infection or disease treatment|30|||
49022096|NCT00497796|157918695|FG001|Overall Study|CMV infection or disease treatment|4|||
49022097|NCT00497796|157918694|FG000|Overall Study|Consent withdrawn|10|||
49022098|NCT00497796|157918695|FG001|Overall Study|Consent withdrawn|3|||
49022099|NCT00497796|157918694|FG000|Overall Study|Investigator/sponsor discretion|31|||
49022100|NCT00497796|157918695|FG001|Overall Study|Investigator/sponsor discretion|34|||
49022101|NCT00497796|157918694|FG000|Overall Study|Lost to Follow-up|0|||
48684570|NCT02737475|156697778|FG019|Overall Study|Death|0|||
48684571|NCT02737475|156697779|FG020|Overall Study|Death|0|||
48684572|NCT02737475|156697780|FG021|Overall Study|Death|0|||
48684573|NCT02737475|156697781|FG022|Overall Study|Death|0|||
49022102|NCT00497796|157918695|FG001|Overall Study|Lost to Follow-up|1|||
49022103|NCT00497796|157918694|FG000|Overall Study|Not applicable (randomized not treated)|0|||
49022104|NCT00497796|157918695|FG001|Overall Study|Not applicable (randomized not treated)|4|||
49022105|NCT01199861|157918696|FG000|Overall Study|Administrative problems|1|||
49022106|NCT01199861|157918697|FG001|Overall Study|Administrative problems|0|||
49022107|NCT01199861|157918696|FG000|Overall Study|Adverse Event|1|||
49022108|NCT01199861|157918697|FG001|Overall Study|Adverse Event|0|||
48684574|NCT02737475|156697782|FG023|Overall Study|Death|0|||
49022109|NCT02979353|157918705|FG000|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|24|||
48684575|NCT02737475|156697783|FG024|Overall Study|Death|0|||
48684576|NCT02737475|156697784|FG025|Overall Study|Death|0|||
48684577|NCT02737475|156697785|FG026|Overall Study|Death|0|||
48684578|NCT02737475|156697759|FG000|Overall Study|Participant withdrew consent|0|||
49022110|NCT02979353|157918706|FG001|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|29|||
49022111|NCT02979353|157918705|FG000|Overall Study|Withdrawal by Subject|16|||
49022112|NCT02979353|157918706|FG001|Overall Study|Withdrawal by Subject|12|||
49022113|NCT02979353|157918705|FG000|Overall Study|Death|10|||
49022114|NCT02979353|157918706|FG001|Overall Study|Death|11|||
49022115|NCT02979353|157918705|FG000|Overall Study|Transfer to Hospice Care|19|||
49022116|NCT02979353|157918706|FG001|Overall Study|Transfer to Hospice Care|14|||
48684579|NCT02737475|156697760|FG001|Overall Study|Participant withdrew consent|0|||
48684580|NCT02737475|156697761|FG002|Overall Study|Participant withdrew consent|0|||
48684581|NCT02737475|156697762|FG003|Overall Study|Participant withdrew consent|0|||
48684582|NCT02737475|156697763|FG004|Overall Study|Participant withdrew consent|0|||
48684583|NCT02737475|156697764|FG005|Overall Study|Participant withdrew consent|2|||
49022117|NCT02979353|157918705|FG000|Overall Study|Lost to Follow-up|1|||
49022118|NCT02979353|157918706|FG001|Overall Study|Lost to Follow-up|5|||
49022119|NCT03309956|157918711|FG000|Overall Study|Devices worn for <24 hrs or >72 hrs, device failing to record, or devices were lost|47|||
49022120|NCT04025879|157918712|FG000|Randomization|Participant withdrew consent|0|||
49022121|NCT04025879|157918713|FG001|Randomization|Participant withdrew consent|1|||
48684584|NCT02737475|156697765|FG006|Overall Study|Participant withdrew consent|0|||
48684585|NCT02737475|156697766|FG007|Overall Study|Participant withdrew consent|0|||
48684586|NCT02737475|156697767|FG008|Overall Study|Participant withdrew consent|0|||
49022122|NCT04025879|157918712|FG000|Randomization|Participant no longer met study criteria|1|||
49022123|NCT04025879|157918713|FG001|Randomization|Participant no longer met study criteria|1|||
49022124|NCT04025879|157918712|FG000|Treatment|Ongoing treatment|10|||
49022125|NCT04025879|157918713|FG001|Treatment|Ongoing treatment|8|||
49022126|NCT04025879|157918712|FG000|Treatment|Disease progression/recurrence|36|||
49022127|NCT04025879|157918713|FG001|Treatment|Disease progression/recurrence|72|||
49022128|NCT04025879|157918712|FG000|Treatment|Study drug toxicity|36|||
49022129|NCT04025879|157918713|FG001|Treatment|Study drug toxicity|13|||
49022130|NCT04025879|157918712|FG000|Treatment|Death|2|||
49022131|NCT04025879|157918713|FG001|Treatment|Death|0|||
49022132|NCT04025879|157918712|FG000|Treatment|Adverse event unrelated to study drug|21|||
49022133|NCT04025879|157918713|FG001|Treatment|Adverse event unrelated to study drug|14|||
49022134|NCT04025879|157918712|FG000|Treatment|Participant request to discontinue study treatment|16|||
49022135|NCT04025879|157918713|FG001|Treatment|Participant request to discontinue study treatment|8|||
49022136|NCT04025879|157918712|FG000|Treatment|Participant withdrew consent|1|||
49022137|NCT04025879|157918713|FG001|Treatment|Participant withdrew consent|3|||
49022138|NCT04025879|157918712|FG000|Treatment|Participant no longer meets study criteria|3|||
49022139|NCT04025879|157918713|FG001|Treatment|Participant no longer meets study criteria|2|||
49022140|NCT04025879|157918712|FG000|Treatment|Lost to Follow-up|1|||
49022141|NCT04025879|157918713|FG001|Treatment|Lost to Follow-up|0|||
49022142|NCT04025879|157918712|FG000|Treatment|Other reasons|15|||
49022143|NCT04025879|157918713|FG001|Treatment|Other reasons|17|||
49022144|NCT04025879|157918712|FG000|Treatment|Administrative reason by sponsor|0|||
49022145|NCT04025879|157918713|FG001|Treatment|Administrative reason by sponsor|1|||
49022146|NCT04025879|157918712|FG000|Treatment|Not reported|2|||
49022147|NCT04025879|157918713|FG001|Treatment|Not reported|0|||
49022148|NCT02170688|157918716|FG000|Overall Study|Exclusion Criteria: Fatty Liver|4|||
49022149|NCT02170688|157918717|FG001|Overall Study|Exclusion Criteria: Fatty Liver|2|||
49022150|NCT02170688|157918718|FG002|Overall Study|Exclusion Criteria: Fatty Liver|3|||
49022151|NCT02170688|157918719|FG003|Overall Study|Exclusion Criteria: Fatty Liver|2|||
49022152|NCT02170688|157918720|FG004|Overall Study|Exclusion Criteria: Fatty Liver|0|||
49022153|NCT02170688|157918716|FG000|Overall Study|Full dose not received|0|||
49022154|NCT02170688|157918717|FG001|Overall Study|Full dose not received|1|||
49022155|NCT02170688|157918718|FG002|Overall Study|Full dose not received|0|||
49022156|NCT02170688|157918719|FG003|Overall Study|Full dose not received|0|||
49022157|NCT02170688|157918720|FG004|Overall Study|Full dose not received|0|||
49022158|NCT02170688|157918716|FG000|Overall Study|Physician Decision|0|||
49022159|NCT02170688|157918717|FG001|Overall Study|Physician Decision|0|||
49022160|NCT02170688|157918718|FG002|Overall Study|Physician Decision|1|||
49022161|NCT02170688|157918719|FG003|Overall Study|Physician Decision|0|||
49022162|NCT02170688|157918720|FG004|Overall Study|Physician Decision|0|||
49022163|NCT03329027|157920641|FG000|Overall Study|Lost to Follow-up|1|||
49022164|NCT03329027|157920642|FG001|Overall Study|Lost to Follow-up|0|||
49022165|NCT03329027|157920643|FG002|Overall Study|Lost to Follow-up|1|||
48684587|NCT02737475|156697768|FG009|Overall Study|Participant withdrew consent|0|||
48684588|NCT02737475|156697769|FG010|Overall Study|Participant withdrew consent|0|||
48684589|NCT02737475|156697770|FG011|Overall Study|Participant withdrew consent|0|||
48684590|NCT02737475|156697771|FG012|Overall Study|Participant withdrew consent|0|||
49022166|NCT03329027|157920641|FG000|Overall Study|Protocol Violation|9|||
49022167|NCT03329027|157920642|FG001|Overall Study|Protocol Violation|5|||
49022168|NCT03329027|157920643|FG002|Overall Study|Protocol Violation|7|||
49022169|NCT00076102|157920644|FG000|Overall Study|Clinical progression|1|||
49022170|NCT00076102|157920644|FG000|Overall Study|Progression in pre-existing brain tumor|1|||
49022171|NCT00076102|157920644|FG000|Overall Study|plexiform neurofibroma surgery|1|||
49022172|NCT00076102|157920644|FG000|Overall Study|refusal of further therapy|2|||
48684591|NCT02737475|156697772|FG013|Overall Study|Participant withdrew consent|0|||
48684592|NCT02737475|156697773|FG014|Overall Study|Participant withdrew consent|1|||
48684593|NCT02737475|156697774|FG015|Overall Study|Participant withdrew consent|0|||
48684594|NCT02737475|156697775|FG016|Overall Study|Participant withdrew consent|0|||
48684595|NCT02737475|156697776|FG017|Overall Study|Participant withdrew consent|2|||
48684596|NCT02737475|156697777|FG018|Overall Study|Participant withdrew consent|1|||
48684597|NCT02737475|156697778|FG019|Overall Study|Participant withdrew consent|0|||
48684598|NCT02737475|156697779|FG020|Overall Study|Participant withdrew consent|2|||
48684599|NCT02737475|156697780|FG021|Overall Study|Participant withdrew consent|0|||
48684600|NCT02737475|156697781|FG022|Overall Study|Participant withdrew consent|0|||
48684601|NCT02737475|156697782|FG023|Overall Study|Participant withdrew consent|0|||
48684602|NCT02737475|156697783|FG024|Overall Study|Participant withdrew consent|0|||
48684603|NCT02737475|156697784|FG025|Overall Study|Participant withdrew consent|0|||
48684604|NCT02737475|156697785|FG026|Overall Study|Participant withdrew consent|0|||
48684605|NCT02737475|156697759|FG000|Overall Study|Lost to Follow-up|0|||
48684606|NCT02737475|156697760|FG001|Overall Study|Lost to Follow-up|0|||
48684607|NCT02737475|156697761|FG002|Overall Study|Lost to Follow-up|0|||
48684608|NCT02737475|156697762|FG003|Overall Study|Lost to Follow-up|0|||
48684609|NCT02737475|156697763|FG004|Overall Study|Lost to Follow-up|0|||
48684610|NCT02737475|156697764|FG005|Overall Study|Lost to Follow-up|0|||
48684611|NCT02737475|156697765|FG006|Overall Study|Lost to Follow-up|0|||
48684612|NCT02737475|156697766|FG007|Overall Study|Lost to Follow-up|0|||
48684613|NCT02737475|156697767|FG008|Overall Study|Lost to Follow-up|0|||
48684614|NCT02737475|156697768|FG009|Overall Study|Lost to Follow-up|0|||
48684615|NCT02737475|156697769|FG010|Overall Study|Lost to Follow-up|0|||
48684616|NCT02737475|156697770|FG011|Overall Study|Lost to Follow-up|0|||
48684617|NCT02737475|156697771|FG012|Overall Study|Lost to Follow-up|0|||
48684618|NCT02737475|156697772|FG013|Overall Study|Lost to Follow-up|0|||
48763083|NCT03642717|156982055|FG000|Overall Study|Lost to Follow-up|2|||
48763084|NCT03642717|156982055|FG000|Overall Study|Inclusion/exclusion criteria violation|33|||
48763085|NCT03642717|156982055|FG000|Overall Study|Taken study drug prior to contract date|3|||
48763086|NCT00642668|156982056|FG000|Overall Study|Lost to Follow-up|1|||
48763087|NCT00642668|156982056|FG000|Overall Study|Adverse Event|2|||
48763088|NCT00642668|156982056|FG000|Overall Study|Death|2|||
48763089|NCT00642668|156982056|FG000|Overall Study|Insufficient Therapeutic Response|1|||
48763090|NCT00642668|156982056|FG000|Overall Study|Failure to Return|1|||
48763091|NCT00642668|156982056|FG000|Overall Study|Dialysis Initiation|5|||
48763092|NCT00642668|156982056|FG000|Overall Study|Blood Transfusion|2|||
48763093|NCT01559012|156982057|FG000|Overall Study|Withdrawal by Subject|0|||
48875202|NCT00307164|157381588|FG001|Overall Study|Death|0|||
48763094|NCT01559012|156982058|FG001|Overall Study|Withdrawal by Subject|1|||
48875203|NCT00307164|157381587|FG000|Overall Study|Severe debilitation, unable to continue|1|||
48981147|NCT01784211|157764206|FG001|Part A (Days 1-15)|Adverse Event|1|||
48684619|NCT02737475|156697773|FG014|Overall Study|Lost to Follow-up|0|||
48684620|NCT02737475|156697774|FG015|Overall Study|Lost to Follow-up|1|||
48684621|NCT02737475|156697775|FG016|Overall Study|Lost to Follow-up|0|||
48684622|NCT02737475|156697776|FG017|Overall Study|Lost to Follow-up|0|||
48684623|NCT02737475|156697777|FG018|Overall Study|Lost to Follow-up|0|||
48684624|NCT02737475|156697778|FG019|Overall Study|Lost to Follow-up|0|||
48981148|NCT01784211|157764207|FG002|Part A (Days 1-15)|Adverse Event|0|||
48981149|NCT01784211|157764208|FG003|Part A (Days 1-15)|Adverse Event|0|||
48981150|NCT01784211|157764209|FG004|Part A (Days 1-15)|Adverse Event|0|||
48981151|NCT01784211|157764210|FG005|Part A (Days 1-15)|Adverse Event|0|||
48981152|NCT01784211|157764205|FG000|Part A (Days 1-15)|Withdrawal by Subject|2|||
48981153|NCT01784211|157764206|FG001|Part A (Days 1-15)|Withdrawal by Subject|1|||
48981154|NCT01784211|157764207|FG002|Part A (Days 1-15)|Withdrawal by Subject|0|||
48981155|NCT01784211|157764208|FG003|Part A (Days 1-15)|Withdrawal by Subject|0|||
48981156|NCT01784211|157764209|FG004|Part A (Days 1-15)|Withdrawal by Subject|0|||
48981157|NCT01784211|157764210|FG005|Part A (Days 1-15)|Withdrawal by Subject|0|||
48981158|NCT00939055|157764211|FG000|Overall Study|Discontinuation prior to procedure|4|||
48981159|NCT00939055|157764212|FG001|Overall Study|Discontinuation prior to procedure|0|||
48981160|NCT00809614|157764215|FG000|Overall Study|Lack of Efficacy|2|||
48981161|NCT00809614|157764216|FG001|Overall Study|Lack of Efficacy|3|||
48981162|NCT00809614|157764215|FG000|Overall Study|Withdrawal by Subject|1|||
48981163|NCT00809614|157764216|FG001|Overall Study|Withdrawal by Subject|1|||
48981164|NCT00584987|157764217|FG000|Overall Study|Protocol Violation|1|||
48981165|NCT00584987|157764218|FG001|Overall Study|Protocol Violation|1|||
48981166|NCT00584987|157764219|FG002|Overall Study|Protocol Violation|1|||
48981167|NCT00584987|157764220|FG003|Overall Study|Protocol Violation|0|||
48981168|NCT00584987|157764217|FG000|Overall Study|Adverse Event|0|||
48981169|NCT00584987|157764218|FG001|Overall Study|Adverse Event|0|||
48981170|NCT00584987|157764219|FG002|Overall Study|Adverse Event|0|||
48981171|NCT00584987|157764220|FG003|Overall Study|Adverse Event|1|||
48981172|NCT00589602|157764221|FG000|Overall Study|Did not collect enough CD34+ cells|1|||
48981173|NCT01263470|157764225|FG000|Overall Study|Adverse Event|2|||
48684625|NCT02737475|156697779|FG020|Overall Study|Lost to Follow-up|0|||
48684626|NCT02737475|156697780|FG021|Overall Study|Lost to Follow-up|0|||
48684627|NCT02737475|156697781|FG022|Overall Study|Lost to Follow-up|0|||
48684628|NCT02737475|156697782|FG023|Overall Study|Lost to Follow-up|0|||
48684629|NCT02737475|156697783|FG024|Overall Study|Lost to Follow-up|0|||
48684630|NCT02737475|156697784|FG025|Overall Study|Lost to Follow-up|0|||
48684631|NCT02737475|156697785|FG026|Overall Study|Lost to Follow-up|0|||
48684632|NCT02737475|156697759|FG000|Overall Study|Disease Progression|0|||
48684633|NCT02737475|156697760|FG001|Overall Study|Disease Progression|0|||
48684634|NCT02737475|156697761|FG002|Overall Study|Disease Progression|0|||
48684635|NCT02737475|156697762|FG003|Overall Study|Disease Progression|0|||
48684636|NCT02737475|156697763|FG004|Overall Study|Disease Progression|0|||
48684637|NCT02737475|156697764|FG005|Overall Study|Disease Progression|0|||
48684638|NCT02737475|156697765|FG006|Overall Study|Disease Progression|0|||
48684639|NCT02737475|156697766|FG007|Overall Study|Disease Progression|0|||
48684640|NCT02737475|156697767|FG008|Overall Study|Disease Progression|0|||
48684641|NCT02737475|156697768|FG009|Overall Study|Disease Progression|0|||
48684642|NCT02737475|156697769|FG010|Overall Study|Disease Progression|0|||
48684643|NCT02737475|156697770|FG011|Overall Study|Disease Progression|0|||
48684644|NCT02737475|156697771|FG012|Overall Study|Disease Progression|0|||
48684645|NCT02737475|156697772|FG013|Overall Study|Disease Progression|0|||
48684646|NCT02737475|156697773|FG014|Overall Study|Disease Progression|0|||
48684647|NCT02737475|156697774|FG015|Overall Study|Disease Progression|0|||
48684648|NCT02737475|156697775|FG016|Overall Study|Disease Progression|0|||
48684649|NCT02737475|156697776|FG017|Overall Study|Disease Progression|0|||
48684650|NCT02737475|156697777|FG018|Overall Study|Disease Progression|0|||
48684651|NCT02737475|156697778|FG019|Overall Study|Disease Progression|0|||
48684652|NCT02737475|156697779|FG020|Overall Study|Disease Progression|0|||
48684653|NCT02737475|156697780|FG021|Overall Study|Disease Progression|0|||
48684654|NCT02737475|156697781|FG022|Overall Study|Disease Progression|0|||
48684655|NCT02737475|156697782|FG023|Overall Study|Disease Progression|0|||
48684656|NCT02737475|156697783|FG024|Overall Study|Disease Progression|0|||
48684657|NCT02737475|156697784|FG025|Overall Study|Disease Progression|0|||
48684658|NCT02737475|156697785|FG026|Overall Study|Disease Progression|1|||
48684659|NCT02471014|156697790|FG000|Overall Study|Lost to Follow-up|2|||
48684660|NCT02471014|156697791|FG001|Overall Study|Lost to Follow-up|2|||
48684661|NCT00786799|156697792|FG000|Overall Study|Lost to Follow-up|1|||
48684662|NCT00786799|156697793|FG001|Overall Study|Lost to Follow-up|1|||
48684663|NCT00937937|156697794|FG000|Overall Study|Adverse Event|6|||
48684664|NCT00937937|156697794|FG000|Overall Study|Withdrawal by Subject|2|||
48684665|NCT00937937|156697794|FG000|Overall Study|Progression/relapse|61|||
48684666|NCT00937937|156697794|FG000|Overall Study|Death|1|||
48684667|NCT00937937|156697794|FG000|Overall Study|Other|2|||
48684668|NCT03956550|156697797|FG000|Overall Study|Sponsor decision|65|||
48684669|NCT03956550|156697798|FG001|Overall Study|Sponsor decision|66|||
48684670|NCT03956550|156697799|FG002|Overall Study|Sponsor decision|64|||
48684671|NCT03956550|156697797|FG000|Overall Study|Adverse Event|0|||
48684672|NCT03956550|156697798|FG001|Overall Study|Adverse Event|1|||
48684673|NCT03956550|156697799|FG002|Overall Study|Adverse Event|0|||
48684674|NCT03956550|156697797|FG000|Overall Study|Withdrawal by Subject|5|||
48684675|NCT03956550|156697798|FG001|Overall Study|Withdrawal by Subject|5|||
48684676|NCT03956550|156697799|FG002|Overall Study|Withdrawal by Subject|6|||
48684677|NCT00950846|156697803|FG000|Overall Study|Death|6|||
48684678|NCT00950846|156697803|FG000|Overall Study|Lost to Follow-up|3|||
48684679|NCT00950846|156697803|FG000|Overall Study|Possible undiagnosed AML at study entry|1|||
48684680|NCT02274792|156697806|FG000|Overall Study|Withdrawal by Subject|13|||
48684681|NCT02274792|156697806|FG000|Overall Study|Lost to Follow-up|8|||
48684682|NCT02274792|156697806|FG000|Overall Study|Protocol Specified Criteria|2|||
48684683|NCT02274792|156697806|FG000|Overall Study|Sponsor Decision|2|||
48684684|NCT02114606|156697809|FG000|Overall Study|Unable to swallow Cytosponge|6|||
48684685|NCT00981461|156697810|FG000|Overall Study|Lost to Follow-up|5|||
48684686|NCT00981461|156697811|FG001|Overall Study|Lost to Follow-up|2|||
48684687|NCT05192200|156697814|FG000|Treatment Period|Other|1|||
48684688|NCT05192200|156697814|FG000|Treatment Period|Lack of Efficacy|1|||
48684689|NCT05192200|156697814|FG000|Treatment Period|Withdrawal by Subject|1|||
48684690|NCT05192200|156697814|FG000|Follow-up|Withdrawal by Subject|1|||
48684691|NCT00601900|156697815|FG000|Overall Study|Withdrawal by Subject|0|||
48684692|NCT00601900|156697816|FG001|Overall Study|Withdrawal by Subject|3|||
48684693|NCT01176058|156697819|FG000|Overall Study|Adverse Event|1|||
48684694|NCT01176058|156697820|FG001|Overall Study|Adverse Event|0|||
48684695|NCT01176058|156697819|FG000|Overall Study|Insufficient clinical response|2|||
48684696|NCT01176058|156697820|FG001|Overall Study|Insufficient clinical response|2|||
48684697|NCT01176058|156697819|FG000|Overall Study|Insufficient mycological response|0|||
48684698|NCT01176058|156697820|FG001|Overall Study|Insufficient mycological response|1|||
48684699|NCT01176058|156697819|FG000|Overall Study|Withdrawal by Subject|1|||
48684700|NCT01176058|156697820|FG001|Overall Study|Withdrawal by Subject|0|||
48684701|NCT00181766|156697821|FG000|Overall Study|Lost to Follow-up|6|||
48684702|NCT00181766|156697821|FG000|Overall Study|Adverse Event|4|||
48684703|NCT00181766|156697821|FG000|Overall Study|non-compliance|2|||
48981174|NCT01263470|157764226|FG001|Overall Study|Adverse Event|2|||
48684704|NCT02079038|156697831|FG000|Modified Intent to Treat Population|Withdrawal by Subject|6|||
48684705|NCT02079038|156697832|FG001|Modified Intent to Treat Population|Withdrawal by Subject|5|||
48684706|NCT02079038|156697831|FG000|Modified Intent to Treat Population|Death|1|||
48684707|NCT02079038|156697832|FG001|Modified Intent to Treat Population|Death|0|||
48684708|NCT02079038|156697831|FG000|Completed 6 Months|Lost to Follow-up|2|||
48684709|NCT02079038|156697832|FG001|Completed 6 Months|Lost to Follow-up|1|||
48684710|NCT03573323|156697833|FG000|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
49022173|NCT01210001|157920647|FG000|Overall Study|Not treated|1|||
49022174|NCT01210001|157920648|FG001|Overall Study|Not treated|0|||
49022175|NCT01210001|157920649|FG002|Overall Study|Not treated|0|||
49022176|NCT01210001|157920647|FG000|Overall Study|Adverse Event|4|||
49022177|NCT01210001|157920648|FG001|Overall Study|Adverse Event|2|||
49022178|NCT01210001|157920649|FG002|Overall Study|Adverse Event|5|||
49022179|NCT01210001|157920647|FG000|Overall Study|Non compliant with protocol|2|||
49022180|NCT01210001|157920648|FG001|Overall Study|Non compliant with protocol|2|||
49022181|NCT01210001|157920649|FG002|Overall Study|Non compliant with protocol|3|||
49022182|NCT01210001|157920647|FG000|Overall Study|Lost to Follow-up|4|||
49022183|NCT01210001|157920648|FG001|Overall Study|Lost to Follow-up|3|||
48684711|NCT03573323|156697834|FG001|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
48684712|NCT03573323|156697833|FG000|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15|||
48684713|NCT03573323|156697834|FG001|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8|||
48684714|NCT03573323|156697833|FG000|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3|||
48684715|NCT03573323|156697834|FG001|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8|||
48684716|NCT03573323|156697833|FG000|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17|||
48763095|NCT01586819|156982059|FG000|Overall Study|Withdrawal by Subject|1|||
48763096|NCT01586819|156982060|FG001|Overall Study|Withdrawal by Subject|0|||
48763097|NCT00302458|156982061|FG000|Overall Study|Lost to Follow-up|1|||
48763098|NCT00302458|156982061|FG000|Overall Study|Ineligible after screening|1|||
48684717|NCT03573323|156697834|FG001|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9|||
48684718|NCT03573323|156697833|FG000|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2|||
48684719|NCT03573323|156697834|FG001|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3|||
48684720|NCT03573323|156697833|FG000|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1|||
48684721|NCT03573323|156697834|FG001|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2|||
48684722|NCT03573323|156697833|FG000|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1|||
48684723|NCT03573323|156697834|FG001|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0|||
48684724|NCT03573323|156697833|FG000|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14|||
48684725|NCT03573323|156697834|FG001|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13|||
48684726|NCT03573323|156697833|FG000|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0|||
48684727|NCT03573323|156697834|FG001|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1|||
48684728|NCT03573323|156697833|FG000|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0|||
48684729|NCT03573323|156697834|FG001|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1|||
48763099|NCT00302458|156982061|FG000|Overall Study|Withdrawal by Subject|1|||
48763100|NCT04248933|156982068|FG000|Overall Study|Lost to Follow-up|9|||
48763101|NCT04248933|156982068|FG000|Overall Study|Withdrawal by Subject|2|||
48763102|NCT01464346|156982081|FG000|Overall Study|Withdrawal by Subject|0|||
48763103|NCT01464346|156982082|FG001|Overall Study|Withdrawal by Subject|0|||
48763104|NCT01464346|156982083|FG002|Overall Study|Withdrawal by Subject|1|||
48763105|NCT00733746|156982084|FG000|Overall Study|Ineligible|5|||
48763106|NCT00747435|156982085|FG000|Overall Study|Lost to Follow-up|2|||
48763107|NCT00747435|156982085|FG000|Overall Study|Withdrawal by Subject|3|||
48763108|NCT00747435|156982085|FG000|Overall Study|Still undergoing follow up|1|||
48763109|NCT01712256|156982087|FG000|Overall Study|Lost to Follow-up|1|||
48763110|NCT02013167|156982088|FG000|Overall Study|Withdrawal by Subject|15|||
48763111|NCT02013167|156982089|FG001|Overall Study|Withdrawal by Subject|14|||
48763112|NCT02013167|156982088|FG000|Overall Study|Sponsor Decision|1|||
48763113|NCT02013167|156982089|FG001|Overall Study|Sponsor Decision|3|||
49022184|NCT01210001|157920649|FG002|Overall Study|Lost to Follow-up|2|||
49022185|NCT01210001|157920647|FG000|Overall Study|Patient refusal to continue,not due toAE|6|||
49022186|NCT01210001|157920648|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
48763114|NCT02013167|156982088|FG000|Overall Study|Lost to Follow-up|0|||
48684730|NCT03573323|156697833|FG000|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1|||
48684731|NCT03573323|156697834|FG001|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2|||
48684732|NCT03573323|156697833|FG000|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22|||
48684733|NCT03573323|156697834|FG001|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12|||
48763115|NCT02013167|156982089|FG001|Overall Study|Lost to Follow-up|1|||
48763116|NCT02013167|156982088|FG000|Overall Study|Death|85|||
48763117|NCT02013167|156982089|FG001|Overall Study|Death|160|||
48684734|NCT03573323|156697833|FG000|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8|||
49022187|NCT01210001|157920649|FG002|Overall Study|Patient refusal to continue,not due toAE|1|||
49022188|NCT01210001|157920647|FG000|Overall Study|Other reason not defined above|2|||
49022189|NCT01210001|157920648|FG001|Overall Study|Other reason not defined above|2|||
49022190|NCT01210001|157920649|FG002|Overall Study|Other reason not defined above|1|||
48684735|NCT03573323|156697834|FG001|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19|||
48684736|NCT03573323|156697833|FG000|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4|||
48684737|NCT03573323|156697834|FG001|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3|||
48763118|NCT03200899|156982090|FG000|Overall Study|Lost to Follow-up|10|||
48763119|NCT03200899|156982091|FG001|Overall Study|Lost to Follow-up|23|||
49022191|NCT02207231|157920655|FG000|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
48684738|NCT03573323|156697833|FG000|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3|||
48684739|NCT03573323|156697834|FG001|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2|||
48684740|NCT03573323|156697833|FG000|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14|||
48684741|NCT03573323|156697834|FG001|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8|||
48684742|NCT03573323|156697833|FG000|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8|||
48684743|NCT03573323|156697834|FG001|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11|||
48684744|NCT03573323|156697833|FG000|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0|||
48684745|NCT03573323|156697834|FG001|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1|||
48684746|NCT03573323|156697833|FG000|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0|||
48684747|NCT03573323|156697834|FG001|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1|||
48684748|NCT00972478|156697835|FG000|Overall Study|Adverse Event|3|||
48684749|NCT00972478|156697836|FG001|Overall Study|Adverse Event|16|||
48763120|NCT03465878|156982093|FG000|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
48763121|NCT03465878|156982094|FG001|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1|||
48763122|NCT03465878|156982095|FG002|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
48763123|NCT03465878|156982096|FG003|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
49022192|NCT02207231|157920656|FG001|Placebo Controlled Period: Week 0 - 16|Adverse Event|4|||
49022193|NCT02207231|157920657|FG002|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
49022194|NCT02207231|157920658|FG003|Placebo Controlled Period: Week 0 - 16|Adverse Event|0|||
49022195|NCT02207231|157920655|FG000|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2|||
49022196|NCT02207231|157920656|FG001|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
49022197|NCT02207231|157920657|FG002|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1|||
49022198|NCT02207231|157920658|FG003|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
49022199|NCT02207231|157920655|FG000|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
49022200|NCT02207231|157920656|FG001|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
49022201|NCT02207231|157920657|FG002|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
49022202|NCT02207231|157920658|FG003|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0|||
49022203|NCT02207231|157920655|FG000|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2|||
49022204|NCT02207231|157920656|FG001|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
49022205|NCT02207231|157920657|FG002|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4|||
49022206|NCT02207231|157920658|FG003|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
49022207|NCT02207231|157920655|FG000|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
49022208|NCT02207231|157920656|FG001|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
49022209|NCT02207231|157920657|FG002|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1|||
49022210|NCT02207231|157920658|FG003|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
49022211|NCT02207231|157920655|FG000|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
49022212|NCT02207231|157920656|FG001|Placebo Controlled Period: Week 0 - 16|Noncompliance|2|||
49022213|NCT02207231|157920657|FG002|Placebo Controlled Period: Week 0 - 16|Noncompliance|1|||
48684750|NCT00972478|156697835|FG000|Overall Study|Withdrawal by Subject|1|||
48684751|NCT00972478|156697836|FG001|Overall Study|Withdrawal by Subject|8|||
48763124|NCT03465878|156982093|FG000|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
48763125|NCT03465878|156982094|FG001|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
48763126|NCT03465878|156982095|FG002|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
48763127|NCT03465878|156982096|FG003|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1|||
48763128|NCT03465878|156982093|FG000|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
48763129|NCT03465878|156982094|FG001|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
48684752|NCT00972478|156697835|FG000|Overall Study|Progression/Relapse|0|||
48763130|NCT03465878|156982095|FG002|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
48763131|NCT03465878|156982096|FG003|Period 1-Part B First Intervention Day 1|Physician Decision|1|||
48763132|NCT01342510|156982097|FG000|Overall Study|Protocol Violation|12|||
48763133|NCT01342510|156982098|FG001|Overall Study|Protocol Violation|6|||
48763134|NCT01342510|156982099|FG002|Overall Study|Protocol Violation|13|||
48763135|NCT01342510|156982100|FG003|Overall Study|Protocol Violation|11|||
48763136|NCT00256698|156982103|FG000|Overall Study|Withdrawal by Subject|7|||
48763137|NCT00256698|156982104|FG001|Overall Study|Withdrawal by Subject|7|||
48763138|NCT00256698|156982103|FG000|Overall Study|Adverse Event|13|||
48763139|NCT00256698|156982104|FG001|Overall Study|Adverse Event|6|||
48763140|NCT00256698|156982103|FG000|Overall Study|Protocol Violation|6|||
48875204|NCT00307164|157381588|FG001|Overall Study|Severe debilitation, unable to continue|0|||
49022214|NCT02207231|157920658|FG003|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
49022215|NCT02207231|157920655|FG000|Active Controlled Period: Week 16 - 48|Adverse Event|1|||
49022216|NCT02207231|157920656|FG001|Active Controlled Period: Week 16 - 48|Adverse Event|6|||
49022217|NCT02207231|157920657|FG002|Active Controlled Period: Week 16 - 48|Adverse Event|10|||
48763141|NCT00256698|156982104|FG001|Overall Study|Protocol Violation|5|||
48763142|NCT00256698|156982103|FG000|Overall Study|Lost to Follow-up|1|||
48763143|NCT00256698|156982104|FG001|Overall Study|Lost to Follow-up|3|||
48763144|NCT00256698|156982103|FG000|Overall Study|disease progression|97|||
48763145|NCT00256698|156982104|FG001|Overall Study|disease progression|105|||
48763146|NCT00256698|156982103|FG000|Overall Study|still ongoing at data cut-off|41|||
48763147|NCT00256698|156982104|FG001|Overall Study|still ongoing at data cut-off|46|||
48763148|NCT00256698|156982103|FG000|Overall Study|withdrawn due to osteoporosis|1|||
48763149|NCT00256698|156982104|FG001|Overall Study|withdrawn due to osteoporosis|0|||
48763150|NCT00256698|156982103|FG000|Overall Study|Prematurely Discontinued|1|||
48763151|NCT00256698|156982104|FG001|Overall Study|Prematurely Discontinued|0|||
48763152|NCT00316199|156982106|FG000|Overall Study|Adverse Event|2|||
48763153|NCT00316199|156982106|FG000|Overall Study|Death|8|||
48763154|NCT00316199|156982106|FG000|Overall Study|Lost to Follow-up|2|||
48763155|NCT00560950|156982107|FG000|Overall Study|Lost to Follow-up|1|||
48763156|NCT00560950|156982108|FG001|Overall Study|Lost to Follow-up|0|||
48763157|NCT01921179|156983799|FG000|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
48763158|NCT01921179|156983800|FG001|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
48763159|NCT01921179|156983799|FG000|Long Term Follow-up After GOALS Training|Lost to Follow-up|2|||
48763160|NCT01921179|156983800|FG001|Long Term Follow-up After GOALS Training|Lost to Follow-up|0|||
48763161|NCT02558790|156983803|FG000|Overall Study|Lost to Follow-up|2|||
48763162|NCT02558790|156983803|FG000|Overall Study|Physician Decision|1|||
48763163|NCT02558790|156983803|FG000|Overall Study|Withdrawal by Subject|1|||
48763164|NCT02558790|156983803|FG000|Overall Study|Screen Fail|3|||
48763165|NCT04475588|156983804|FG000|Overall Study|Adverse Event|2|||
48763166|NCT04475588|156983805|FG001|Overall Study|Adverse Event|0|||
48763167|NCT03662542|156983806|FG000|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|3|||
48763168|NCT03662542|156983807|FG001|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
48763169|NCT03662542|156983808|FG002|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
48763170|NCT03662542|156983809|FG003|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
48763171|NCT03662542|156983810|FG004|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
48763172|NCT03662542|156983811|FG005|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
48763173|NCT03662542|156983812|FG006|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
48763174|NCT03662542|156983813|FG007|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
48763175|NCT03662542|156983814|FG008|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
48763176|NCT03662542|156983806|FG000|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
48763177|NCT03662542|156983807|FG001|Combination Phase ( Week 0- Week 12)|Adverse Event|1|||
48763178|NCT03662542|156983808|FG002|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
48763179|NCT03662542|156983809|FG003|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
48763180|NCT03662542|156983810|FG004|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
48763181|NCT03662542|156983811|FG005|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
48763182|NCT03662542|156983812|FG006|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
48763183|NCT03662542|156983813|FG007|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
48763184|NCT03662542|156983814|FG008|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
48763185|NCT03662542|156983806|FG000|Combination Phase ( Week 0- Week 12)|Other|1|||
48763186|NCT03662542|156983807|FG001|Combination Phase ( Week 0- Week 12)|Other|0|||
48763187|NCT03662542|156983808|FG002|Combination Phase ( Week 0- Week 12)|Other|0|||
48763188|NCT03662542|156983809|FG003|Combination Phase ( Week 0- Week 12)|Other|0|||
48763189|NCT03662542|156983810|FG004|Combination Phase ( Week 0- Week 12)|Other|0|||
48763190|NCT03662542|156983811|FG005|Combination Phase ( Week 0- Week 12)|Other|0|||
48763191|NCT03662542|156983812|FG006|Combination Phase ( Week 0- Week 12)|Other|0|||
48763192|NCT03662542|156983813|FG007|Combination Phase ( Week 0- Week 12)|Other|0|||
48763193|NCT03662542|156983814|FG008|Combination Phase ( Week 0- Week 12)|Other|0|||
48763194|NCT03662542|156983806|FG000|Combination Phase ( Week 0- Week 12)|COVID-19|1|||
48763195|NCT03662542|156983807|FG001|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
48763196|NCT03662542|156983808|FG002|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
48763197|NCT03662542|156983809|FG003|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
48763198|NCT03662542|156983810|FG004|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
48763199|NCT03662542|156983811|FG005|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
48763200|NCT03662542|156983812|FG006|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
49022218|NCT02207231|157920658|FG003|Active Controlled Period: Week 16 - 48|Adverse Event|0|||
49022219|NCT02207231|157920655|FG000|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
48763201|NCT03662542|156983813|FG007|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
48763202|NCT03662542|156983814|FG008|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
48763203|NCT03662542|156983806|FG000|Monotherapy Phase (Week 12-Week 38)|Death|0|||
48763204|NCT03662542|156983807|FG001|Monotherapy Phase (Week 12-Week 38)|Death|0|||
48763205|NCT03662542|156983808|FG002|Monotherapy Phase (Week 12-Week 38)|Death|0|||
48684753|NCT00972478|156697836|FG001|Overall Study|Progression/Relapse|2|||
48684754|NCT00972478|156697835|FG000|Overall Study|Death|0|||
48684755|NCT00972478|156697836|FG001|Overall Study|Death|2|||
48684756|NCT00972478|156697835|FG000|Overall Study|Not protocol specified|1|||
48684757|NCT00972478|156697836|FG001|Overall Study|Not protocol specified|1|||
48684758|NCT00972478|156697835|FG000|Overall Study|Ineligible|1|||
48684759|NCT00972478|156697836|FG001|Overall Study|Ineligible|7|||
48684760|NCT00972478|156697835|FG000|Overall Study|Not start protocol treatment|1|||
48684761|NCT00972478|156697836|FG001|Overall Study|Not start protocol treatment|2|||
48684762|NCT01196026|156697839|FG000|Overall Study|Withdrawal by Subject|1|||
48684763|NCT01196026|156697840|FG001|Overall Study|Withdrawal by Subject|4|||
48684764|NCT01196026|156697841|FG002|Overall Study|Withdrawal by Subject|0|||
48684765|NCT01196026|156697842|FG003|Overall Study|Withdrawal by Subject|0|||
48684766|NCT01196026|156697843|FG004|Overall Study|Withdrawal by Subject|0|||
48684767|NCT01196026|156697844|FG005|Overall Study|Withdrawal by Subject|0|||
48684768|NCT01196026|156697839|FG000|Overall Study|Lost to Follow-up|0|||
48684769|NCT01196026|156697840|FG001|Overall Study|Lost to Follow-up|3|||
48684770|NCT01196026|156697841|FG002|Overall Study|Lost to Follow-up|0|||
48684771|NCT01196026|156697842|FG003|Overall Study|Lost to Follow-up|0|||
48684772|NCT01196026|156697843|FG004|Overall Study|Lost to Follow-up|1|||
48684773|NCT01196026|156697844|FG005|Overall Study|Lost to Follow-up|0|||
48684774|NCT01196026|156697839|FG000|Overall Study|Other|0|||
48684775|NCT01196026|156697840|FG001|Overall Study|Other|1|||
48684776|NCT01196026|156697841|FG002|Overall Study|Other|0|||
48684777|NCT01196026|156697842|FG003|Overall Study|Other|0|||
48684778|NCT01196026|156697843|FG004|Overall Study|Other|0|||
48684779|NCT01196026|156697844|FG005|Overall Study|Other|0|||
48684780|NCT02855268|156697845|FG000|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
48684781|NCT02855268|156697846|FG001|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
48684782|NCT02855268|156697845|FG000|DB Period (up to 48 Weeks)|Adverse Event|0|||
48684783|NCT02855268|156697846|FG001|DB Period (up to 48 Weeks)|Adverse Event|2|||
48684784|NCT02855268|156697845|FG000|DB Period (up to 48 Weeks)|Sponsor Decision|4|||
48684785|NCT02855268|156697846|FG001|DB Period (up to 48 Weeks)|Sponsor Decision|7|||
48684786|NCT02855268|156697845|FG000|OLE Period (up to 96 Weeks)|Adverse Event|0|||
48684787|NCT02855268|156697846|FG001|OLE Period (up to 96 Weeks)|Adverse Event|2|||
48684788|NCT02855268|156697845|FG000|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
48684789|NCT02855268|156697846|FG001|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
48684790|NCT02855268|156697845|FG000|OLE Period (up to 96 Weeks)|Early study termination by sponsor|7|||
48684791|NCT02855268|156697846|FG001|OLE Period (up to 96 Weeks)|Early study termination by sponsor|16|||
48684792|NCT01687296|156697847|FG000|Overall Study|Lack of Efficacy|1|||
48684793|NCT01687296|156697848|FG001|Overall Study|Lack of Efficacy|1|||
48684794|NCT01687296|156697847|FG000|Overall Study|Protocol Violation|0|||
48684795|NCT01687296|156697848|FG001|Overall Study|Protocol Violation|1|||
48684796|NCT01687296|156697847|FG000|Overall Study|Withdrawal by Subject|6|||
48684797|NCT01687296|156697848|FG001|Overall Study|Withdrawal by Subject|3|||
48684798|NCT03500640|156697854|FG000|DPP Core Program (0-6 Months)|Lost to Follow-up|26|||
48684799|NCT03500640|156697855|FG001|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
48684800|NCT03500640|156697856|FG002|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
48684801|NCT03500640|156697854|FG000|DPP Core Program (0-6 Months)|Withdrawal by Subject|21|||
48684802|NCT03500640|156697855|FG001|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
48684803|NCT03500640|156697856|FG002|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
48684804|NCT03500640|156697854|FG000|DPP Core Program (0-6 Months)|No Exercise Clearance|3|||
48684805|NCT03500640|156697855|FG001|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
48684806|NCT03500640|156697856|FG002|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
48684807|NCT03500640|156697854|FG000|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|6|||
48684808|NCT03500640|156697855|FG001|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
48684809|NCT03500640|156697856|FG002|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
49022220|NCT02207231|157920656|FG001|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
48684810|NCT03500640|156697854|FG000|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|0|||
48763206|NCT03662542|156983809|FG003|Monotherapy Phase (Week 12-Week 38)|Death|0|||
48763207|NCT03662542|156983810|FG004|Monotherapy Phase (Week 12-Week 38)|Death|0|||
48684811|NCT03500640|156697855|FG001|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|33|||
48684812|NCT03500640|156697856|FG002|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|41|||
48763208|NCT03662542|156983811|FG005|Monotherapy Phase (Week 12-Week 38)|Death|1|||
48875205|NCT00307164|157381587|FG000|Overall Study|Subject/parent not able to get to clinic|2|||
48684813|NCT03500640|156697854|FG000|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|0|||
48684814|NCT03500640|156697855|FG001|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|1|||
48684815|NCT03500640|156697856|FG002|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|4|||
48684816|NCT03500640|156697854|FG000|Follow-up Contacts (13-18 Months)|Lost to Follow-up|0|||
48684817|NCT03500640|156697855|FG001|Follow-up Contacts (13-18 Months)|Lost to Follow-up|1|||
48684818|NCT03500640|156697856|FG002|Follow-up Contacts (13-18 Months)|Lost to Follow-up|9|||
48684819|NCT03500640|156697854|FG000|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|0|||
48763209|NCT03662542|156983812|FG006|Monotherapy Phase (Week 12-Week 38)|Death|0|||
48684820|NCT03500640|156697855|FG001|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
48684821|NCT03500640|156697856|FG002|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
48684822|NCT03500640|156697854|FG000|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|0|||
48684823|NCT03500640|156697855|FG001|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|2|||
48684824|NCT03500640|156697856|FG002|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|1|||
48684825|NCT03500640|156697854|FG000|Follow-Up Contacts (19-24 Months)|Death|0|||
48684826|NCT03500640|156697855|FG001|Follow-Up Contacts (19-24 Months)|Death|1|||
48684827|NCT03500640|156697856|FG002|Follow-Up Contacts (19-24 Months)|Death|0|||
48684828|NCT03571204|156697857|FG000|Overall Study|Stopped due to COVID-19 pandemic|1|||
48684829|NCT03571204|156697858|FG001|Overall Study|Stopped due to COVID-19 pandemic|1|||
48684830|NCT03571204|156697859|FG002|Overall Study|Stopped due to COVID-19 pandemic|0|||
48684831|NCT03571204|156697857|FG000|Overall Study|Physician Decision|0|||
48684832|NCT03571204|156697858|FG001|Overall Study|Physician Decision|1|||
48684833|NCT03571204|156697859|FG002|Overall Study|Physician Decision|0|||
48684834|NCT02562716|156697860|FG000|Overall Study|Adverse Event|7|||
48684835|NCT02562716|156697861|FG001|Overall Study|Adverse Event|14|||
48684836|NCT02562716|156697860|FG000|Overall Study|Withdrawal unrelated to AE|7|||
48684837|NCT02562716|156697861|FG001|Overall Study|Withdrawal unrelated to AE|1|||
48684838|NCT02562716|156697860|FG000|Overall Study|Progression|8|||
48684839|NCT02562716|156697861|FG001|Overall Study|Progression|10|||
48684840|NCT02562716|156697860|FG000|Overall Study|Death|2|||
48684841|NCT02562716|156697861|FG001|Overall Study|Death|1|||
48684842|NCT02562716|156697860|FG000|Overall Study|Not protocol specified|4|||
48684843|NCT02562716|156697861|FG001|Overall Study|Not protocol specified|2|||
48684844|NCT02491983|156697862|FG000|Overall Study|Physician Decision|1|||
48684845|NCT02491983|156697863|FG001|Overall Study|Physician Decision|0|||
48684846|NCT02491983|156697862|FG000|Overall Study|Not meet selection criteria|1|||
48684847|NCT02491983|156697863|FG001|Overall Study|Not meet selection criteria|0|||
48684848|NCT02491983|156697862|FG000|Overall Study|Withdrawal by Subject|0|||
48684849|NCT02491983|156697863|FG001|Overall Study|Withdrawal by Subject|1|||
48684850|NCT00369577|156697864|FG000|Overall Study|Withdrawal by Subject|0|||
48684851|NCT00369577|156697865|FG001|Overall Study|Withdrawal by Subject|0|||
48684852|NCT00369577|156697866|FG002|Overall Study|Withdrawal by Subject|1|||
48684853|NCT03386721|156697867|FG000|Overall Study|Death|12|||
48684854|NCT03386721|156697868|FG001|Overall Study|Death|21|||
48684855|NCT03386721|156697869|FG002|Overall Study|Death|2|||
48684856|NCT03386721|156697870|FG003|Overall Study|Death|5|||
48684857|NCT03386721|156697871|FG004|Overall Study|Death|1|||
48684858|NCT03386721|156697872|FG005|Overall Study|Death|12|||
48684859|NCT03386721|156697873|FG006|Overall Study|Death|1|||
48684860|NCT03386721|156697874|FG007|Overall Study|Death|1|||
48684861|NCT03386721|156697875|FG008|Overall Study|Death|12|||
48684862|NCT03386721|156697876|FG009|Overall Study|Death|20|||
48684863|NCT03386721|156697877|FG010|Overall Study|Death|21|||
48684864|NCT03386721|156697878|FG011|Overall Study|Death|21|||
48684865|NCT03386721|156697879|FG012|Overall Study|Death|14|||
48684866|NCT03386721|156697880|FG013|Overall Study|Death|2|||
48684867|NCT03386721|156697881|FG014|Overall Study|Death|1|||
48684868|NCT03386721|156697867|FG000|Overall Study|Lost to Follow-up|1|||
48684869|NCT03386721|156697868|FG001|Overall Study|Lost to Follow-up|3|||
48684870|NCT03386721|156697869|FG002|Overall Study|Lost to Follow-up|0|||
48684871|NCT03386721|156697870|FG003|Overall Study|Lost to Follow-up|0|||
48763210|NCT03662542|156983813|FG007|Monotherapy Phase (Week 12-Week 38)|Death|0|||
49022221|NCT02207231|157920657|FG002|Active Controlled Period: Week 16 - 48|Pregnancy|1|||
49022222|NCT02207231|157920658|FG003|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
49022223|NCT02207231|157920655|FG000|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
49022224|NCT02207231|157920656|FG001|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3|||
49022225|NCT02207231|157920657|FG002|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11|||
49022226|NCT02207231|157920658|FG003|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
49022227|NCT02207231|157920655|FG000|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1|||
49022228|NCT02207231|157920656|FG001|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2|||
48684872|NCT03386721|156697871|FG004|Overall Study|Lost to Follow-up|0|||
48684873|NCT03386721|156697872|FG005|Overall Study|Lost to Follow-up|2|||
48684874|NCT03386721|156697873|FG006|Overall Study|Lost to Follow-up|1|||
48684875|NCT03386721|156697874|FG007|Overall Study|Lost to Follow-up|0|||
48684876|NCT03386721|156697875|FG008|Overall Study|Lost to Follow-up|1|||
48684877|NCT03386721|156697876|FG009|Overall Study|Lost to Follow-up|2|||
48684878|NCT03386721|156697877|FG010|Overall Study|Lost to Follow-up|1|||
48684879|NCT03386721|156697878|FG011|Overall Study|Lost to Follow-up|0|||
48684880|NCT03386721|156697879|FG012|Overall Study|Lost to Follow-up|0|||
48684881|NCT03386721|156697880|FG013|Overall Study|Lost to Follow-up|0|||
48684882|NCT03386721|156697881|FG014|Overall Study|Lost to Follow-up|0|||
48684883|NCT03386721|156697867|FG000|Overall Study|Reason not specified|3|||
48684884|NCT03386721|156697868|FG001|Overall Study|Reason not specified|0|||
48684885|NCT03386721|156697869|FG002|Overall Study|Reason not specified|0|||
48684886|NCT03386721|156697870|FG003|Overall Study|Reason not specified|0|||
48684887|NCT03386721|156697871|FG004|Overall Study|Reason not specified|0|||
48684888|NCT03386721|156697872|FG005|Overall Study|Reason not specified|3|||
48684889|NCT03386721|156697873|FG006|Overall Study|Reason not specified|1|||
48684890|NCT03386721|156697874|FG007|Overall Study|Reason not specified|0|||
48684891|NCT03386721|156697875|FG008|Overall Study|Reason not specified|0|||
48684892|NCT03386721|156697876|FG009|Overall Study|Reason not specified|1|||
48684893|NCT03386721|156697877|FG010|Overall Study|Reason not specified|2|||
48684894|NCT03386721|156697878|FG011|Overall Study|Reason not specified|6|||
48684895|NCT03386721|156697879|FG012|Overall Study|Reason not specified|1|||
48684896|NCT03386721|156697880|FG013|Overall Study|Reason not specified|0|||
48684897|NCT03386721|156697881|FG014|Overall Study|Reason not specified|0|||
48684898|NCT03386721|156697867|FG000|Overall Study|Progressive Disease|0|||
48684899|NCT03386721|156697868|FG001|Overall Study|Progressive Disease|0|||
48684900|NCT03386721|156697869|FG002|Overall Study|Progressive Disease|1|||
48684901|NCT03386721|156697870|FG003|Overall Study|Progressive Disease|0|||
48684902|NCT03386721|156697871|FG004|Overall Study|Progressive Disease|0|||
48684903|NCT03386721|156697872|FG005|Overall Study|Progressive Disease|1|||
48684904|NCT03386721|156697873|FG006|Overall Study|Progressive Disease|0|||
48684905|NCT03386721|156697874|FG007|Overall Study|Progressive Disease|0|||
48684906|NCT03386721|156697875|FG008|Overall Study|Progressive Disease|2|||
48684907|NCT03386721|156697876|FG009|Overall Study|Progressive Disease|1|||
48684908|NCT03386721|156697877|FG010|Overall Study|Progressive Disease|1|||
48684909|NCT03386721|156697878|FG011|Overall Study|Progressive Disease|0|||
48684910|NCT03386721|156697879|FG012|Overall Study|Progressive Disease|1|||
48684911|NCT03386721|156697880|FG013|Overall Study|Progressive Disease|0|||
48684912|NCT03386721|156697881|FG014|Overall Study|Progressive Disease|0|||
48684913|NCT03386721|156697867|FG000|Overall Study|Site Terminated by Sponsor|5|||
48684914|NCT03386721|156697868|FG001|Overall Study|Site Terminated by Sponsor|5|||
48684915|NCT03386721|156697869|FG002|Overall Study|Site Terminated by Sponsor|0|||
48684916|NCT03386721|156697870|FG003|Overall Study|Site Terminated by Sponsor|0|||
48684917|NCT03386721|156697871|FG004|Overall Study|Site Terminated by Sponsor|1|||
48684918|NCT03386721|156697872|FG005|Overall Study|Site Terminated by Sponsor|3|||
48684919|NCT03386721|156697873|FG006|Overall Study|Site Terminated by Sponsor|0|||
48684920|NCT03386721|156697874|FG007|Overall Study|Site Terminated by Sponsor|1|||
48684921|NCT03386721|156697875|FG008|Overall Study|Site Terminated by Sponsor|4|||
48684922|NCT03386721|156697876|FG009|Overall Study|Site Terminated by Sponsor|5|||
48684923|NCT03386721|156697877|FG010|Overall Study|Site Terminated by Sponsor|3|||
48684924|NCT03386721|156697878|FG011|Overall Study|Site Terminated by Sponsor|11|||
48684925|NCT03386721|156697879|FG012|Overall Study|Site Terminated by Sponsor|6|||
48684926|NCT03386721|156697880|FG013|Overall Study|Site Terminated by Sponsor|0|||
48684927|NCT03386721|156697881|FG014|Overall Study|Site Terminated by Sponsor|0|||
48684928|NCT03386721|156697867|FG000|Overall Study|Symptomatic Deterioration|0|||
48684929|NCT03386721|156697868|FG001|Overall Study|Symptomatic Deterioration|0|||
48684930|NCT03386721|156697869|FG002|Overall Study|Symptomatic Deterioration|0|||
48684931|NCT03386721|156697870|FG003|Overall Study|Symptomatic Deterioration|0|||
48684932|NCT03386721|156697871|FG004|Overall Study|Symptomatic Deterioration|0|||
48684933|NCT03386721|156697872|FG005|Overall Study|Symptomatic Deterioration|0|||
48684934|NCT03386721|156697873|FG006|Overall Study|Symptomatic Deterioration|0|||
48684935|NCT03386721|156697874|FG007|Overall Study|Symptomatic Deterioration|0|||
48684936|NCT03386721|156697875|FG008|Overall Study|Symptomatic Deterioration|1|||
48684937|NCT03386721|156697876|FG009|Overall Study|Symptomatic Deterioration|0|||
48684938|NCT03386721|156697877|FG010|Overall Study|Symptomatic Deterioration|0|||
48684939|NCT03386721|156697878|FG011|Overall Study|Symptomatic Deterioration|1|||
48684940|NCT03386721|156697879|FG012|Overall Study|Symptomatic Deterioration|0|||
48684941|NCT03386721|156697880|FG013|Overall Study|Symptomatic Deterioration|0|||
48684942|NCT03386721|156697881|FG014|Overall Study|Symptomatic Deterioration|0|||
48684943|NCT03386721|156697867|FG000|Overall Study|Withdrawal by Subject|1|||
48684944|NCT03386721|156697868|FG001|Overall Study|Withdrawal by Subject|2|||
48684945|NCT03386721|156697869|FG002|Overall Study|Withdrawal by Subject|0|||
49022229|NCT02207231|157920657|FG002|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5|||
49022230|NCT02207231|157920658|FG003|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0|||
48684946|NCT03386721|156697870|FG003|Overall Study|Withdrawal by Subject|0|||
48684947|NCT03386721|156697871|FG004|Overall Study|Withdrawal by Subject|0|||
48684948|NCT03386721|156697872|FG005|Overall Study|Withdrawal by Subject|0|||
48684949|NCT03386721|156697873|FG006|Overall Study|Withdrawal by Subject|0|||
48684950|NCT03386721|156697874|FG007|Overall Study|Withdrawal by Subject|0|||
48684951|NCT03386721|156697875|FG008|Overall Study|Withdrawal by Subject|2|||
48684952|NCT03386721|156697876|FG009|Overall Study|Withdrawal by Subject|1|||
48684953|NCT03386721|156697877|FG010|Overall Study|Withdrawal by Subject|3|||
48684954|NCT03386721|156697878|FG011|Overall Study|Withdrawal by Subject|2|||
48684955|NCT03386721|156697879|FG012|Overall Study|Withdrawal by Subject|3|||
48684956|NCT03386721|156697880|FG013|Overall Study|Withdrawal by Subject|0|||
48684957|NCT03386721|156697881|FG014|Overall Study|Withdrawal by Subject|0|||
48684958|NCT03948334|156697883|FG000|Overall Study|Adverse Event|1|||
48684959|NCT03948334|156697884|FG001|Overall Study|Adverse Event|4|||
48684960|NCT03948334|156697883|FG000|Overall Study|Lack of Efficacy|2|||
48684961|NCT03948334|156697884|FG001|Overall Study|Lack of Efficacy|0|||
48684962|NCT03948334|156697883|FG000|Overall Study|Lost to Follow-up|1|||
48684963|NCT03948334|156697884|FG001|Overall Study|Lost to Follow-up|0|||
48684964|NCT03948334|156697883|FG000|Overall Study|Physician Decision|1|||
48684965|NCT03948334|156697884|FG001|Overall Study|Physician Decision|0|||
48684966|NCT03948334|156697883|FG000|Overall Study|Pregnancy|0|||
48684967|NCT03948334|156697884|FG001|Overall Study|Pregnancy|1|||
48684968|NCT03948334|156697883|FG000|Overall Study|Protocol Deviation|1|||
48684969|NCT03948334|156697884|FG001|Overall Study|Protocol Deviation|0|||
48684970|NCT03948334|156697883|FG000|Overall Study|Study terminated by Sponsor|50|||
48684971|NCT03948334|156697884|FG001|Overall Study|Study terminated by Sponsor|51|||
48684972|NCT03948334|156697883|FG000|Overall Study|Subject Decision /Guardian Decision|4|||
48684973|NCT03948334|156697884|FG001|Overall Study|Subject Decision /Guardian Decision|7|||
48684974|NCT01391663|156697885|FG000|Overall Study|Withdrawal by Subject|0|||
48684975|NCT01391663|156697886|FG001|Overall Study|Withdrawal by Subject|0|||
48684976|NCT01391663|156697887|FG002|Overall Study|Withdrawal by Subject|1|||
48684977|NCT01391663|156697888|FG003|Overall Study|Withdrawal by Subject|0|||
48684978|NCT02294058|156697889|FG000|Overall Study|Adverse Event|16|||
48684979|NCT02294058|156697890|FG001|Overall Study|Adverse Event|7|||
48684980|NCT02294058|156697891|FG002|Overall Study|Adverse Event|13|||
48684981|NCT02294058|156697889|FG000|Overall Study|Lack of Efficacy|3|||
48684982|NCT02294058|156697890|FG001|Overall Study|Lack of Efficacy|3|||
48684983|NCT02294058|156697891|FG002|Overall Study|Lack of Efficacy|0|||
48684984|NCT02294058|156697889|FG000|Overall Study|Lost to Follow-up|1|||
48684985|NCT02294058|156697890|FG001|Overall Study|Lost to Follow-up|0|||
48684986|NCT02294058|156697891|FG002|Overall Study|Lost to Follow-up|2|||
48684987|NCT02294058|156697889|FG000|Overall Study|Withdrawal by Subject|10|||
48684988|NCT02294058|156697890|FG001|Overall Study|Withdrawal by Subject|14|||
48684989|NCT02294058|156697891|FG002|Overall Study|Withdrawal by Subject|13|||
48684990|NCT02294058|156697889|FG000|Overall Study|Physician Decision|2|||
48684991|NCT02294058|156697890|FG001|Overall Study|Physician Decision|1|||
48684992|NCT02294058|156697891|FG002|Overall Study|Physician Decision|0|||
48684993|NCT02294058|156697889|FG000|Overall Study|Miscellaneous|4|||
48684994|NCT02294058|156697890|FG001|Overall Study|Miscellaneous|1|||
48684995|NCT02294058|156697891|FG002|Overall Study|Miscellaneous|1|||
48684996|NCT02728089|156697892|FG000|Overall Study|Physician Decision|2|||
48684997|NCT02728089|156697892|FG000|Overall Study|Withdrawal by Subject|1|||
48684998|NCT00782717|156697894|FG000|Overall Study|Adverse Event|2|||
48684999|NCT00782717|156697895|FG001|Overall Study|Adverse Event|5|||
48685000|NCT00782717|156697894|FG000|Overall Study|Patient decision unrelated to AE|6|||
48685001|NCT00782717|156697895|FG001|Overall Study|Patient decision unrelated to AE|3|||
48685002|NCT00782717|156697894|FG000|Overall Study|Noncompliance|2|||
48685003|NCT00782717|156697895|FG001|Overall Study|Noncompliance|1|||
48685004|NCT00782717|156697894|FG000|Overall Study|Treatment failure|3|||
48685005|NCT00782717|156697895|FG001|Overall Study|Treatment failure|14|||
48685006|NCT00782717|156697894|FG000|Overall Study|Enrollment close prior to surgery|1|||
48685007|NCT00782717|156697895|FG001|Overall Study|Enrollment close prior to surgery|0|||
48685008|NCT00782717|156697894|FG000|Overall Study|Did not meet entrance criteria|1|||
48685009|NCT00782717|156697895|FG001|Overall Study|Did not meet entrance criteria|3|||
48685010|NCT00782717|156697894|FG000|Overall Study|Exited in error|0|||
48685011|NCT00782717|156697895|FG001|Overall Study|Exited in error|2|||
48685012|NCT00607087|156697896|FG000|Overall Study|Withdrawal by Subject|9|||
48685013|NCT00607087|156697897|FG001|Overall Study|Withdrawal by Subject|4|||
48685014|NCT00607087|156697898|FG002|Overall Study|Withdrawal by Subject|4|||
48685015|NCT00607087|156697896|FG000|Overall Study|Adverse Event|3|||
48685016|NCT00607087|156697897|FG001|Overall Study|Adverse Event|2|||
48685017|NCT00607087|156697898|FG002|Overall Study|Adverse Event|3|||
48685018|NCT00607087|156697896|FG000|Overall Study|Other reason|1|||
48685019|NCT00607087|156697897|FG001|Overall Study|Other reason|5|||
48685020|NCT00607087|156697898|FG002|Overall Study|Other reason|2|||
48685021|NCT00607087|156697896|FG000|Overall Study|Poor compliance to protocol|1|||
48685022|NCT00607087|156697897|FG001|Overall Study|Poor compliance to protocol|0|||
48685023|NCT00607087|156697898|FG002|Overall Study|Poor compliance to protocol|1|||
48685024|NCT00607087|156697896|FG000|Overall Study|Lost to Follow-up|1|||
48875206|NCT00307164|157381588|FG001|Overall Study|Subject/parent not able to get to clinic|1|||
48875207|NCT00307164|157381587|FG000|Overall Study|Withdrawal by Subject|1|||
48875208|NCT00307164|157381588|FG001|Overall Study|Withdrawal by Subject|8|||
48685025|NCT00607087|156697897|FG001|Overall Study|Lost to Follow-up|0|||
48685026|NCT00607087|156697898|FG002|Overall Study|Lost to Follow-up|0|||
48685027|NCT00607087|156697896|FG000|Period 1|Withdrawal by Subject|7|||
48685028|NCT00607087|156697897|FG001|Period 1|Withdrawal by Subject|2|||
48685029|NCT00607087|156697898|FG002|Period 1|Withdrawal by Subject|3|||
48685030|NCT00607087|156697896|FG000|Period 1|Adverse Event|3|||
48685031|NCT00607087|156697897|FG001|Period 1|Adverse Event|0|||
48685032|NCT00607087|156697898|FG002|Period 1|Adverse Event|0|||
48685033|NCT00607087|156697896|FG000|Period 1|Poor compliance to protocol|1|||
48685034|NCT00607087|156697897|FG001|Period 1|Poor compliance to protocol|0|||
48685035|NCT00607087|156697898|FG002|Period 1|Poor compliance to protocol|0|||
48685036|NCT00607087|156697896|FG000|Period 1|Lost to Follow-up|1|||
48685037|NCT00607087|156697897|FG001|Period 1|Lost to Follow-up|0|||
48685038|NCT00607087|156697898|FG002|Period 1|Lost to Follow-up|0|||
48685039|NCT00607087|156697896|FG000|Period 1|Other reason|0|||
48685040|NCT00607087|156697897|FG001|Period 1|Other reason|4|||
48685041|NCT00607087|156697898|FG002|Period 1|Other reason|2|||
48685042|NCT00607087|156697896|FG000|Period 2|Withdrawal by Subject|0|||
48685043|NCT00607087|156697897|FG001|Period 2|Withdrawal by Subject|1|||
48685044|NCT00607087|156697898|FG002|Period 2|Withdrawal by Subject|1|||
48685045|NCT00607087|156697896|FG000|Period 2|Other reason|1|||
48685046|NCT00607087|156697897|FG001|Period 2|Other reason|1|||
48685047|NCT00607087|156697898|FG002|Period 2|Other reason|0|||
48685048|NCT00607087|156697896|FG000|Period 2|Adverse Event|0|||
48685049|NCT00607087|156697897|FG001|Period 2|Adverse Event|1|||
48685050|NCT00607087|156697898|FG002|Period 2|Adverse Event|3|||
48685051|NCT00607087|156697896|FG000|Period 2|Poor compliance to protocol|0|||
48685052|NCT00607087|156697897|FG001|Period 2|Poor compliance to protocol|0|||
48685053|NCT00607087|156697898|FG002|Period 2|Poor compliance to protocol|1|||
48685054|NCT00607087|156697896|FG000|Period 3|Withdrawal by Subject|2|||
48685055|NCT00607087|156697897|FG001|Period 3|Withdrawal by Subject|1|||
48685056|NCT00607087|156697898|FG002|Period 3|Withdrawal by Subject|0|||
48685057|NCT00607087|156697896|FG000|Period 3|Adverse Event|0|||
48685058|NCT00607087|156697897|FG001|Period 3|Adverse Event|1|||
48685059|NCT00607087|156697898|FG002|Period 3|Adverse Event|0|||
48685060|NCT00550407|156697899|FG000|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55|||
48685061|NCT00550407|156697900|FG001|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
48685062|NCT00550407|156697901|FG002|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
48685063|NCT00550407|156697899|FG000|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39|||
48685064|NCT00550407|156697900|FG001|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
48685065|NCT00550407|156697901|FG002|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
48685066|NCT00550407|156697899|FG000|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1|||
48685067|NCT00550407|156697900|FG001|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
48685068|NCT00550407|156697901|FG002|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
48685069|NCT00550407|156697899|FG000|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1|||
48685070|NCT00550407|156697900|FG001|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
48685071|NCT00550407|156697901|FG002|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
48685072|NCT00550407|156697899|FG000|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1|||
48685073|NCT00550407|156697900|FG001|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
48685074|NCT00550407|156697901|FG002|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
48685075|NCT00550407|156697899|FG000|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8|||
48685076|NCT00550407|156697900|FG001|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
48685077|NCT00550407|156697901|FG002|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
48685078|NCT00550407|156697899|FG000|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6|||
48685079|NCT00550407|156697900|FG001|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
48685080|NCT00550407|156697901|FG002|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
48685081|NCT00550407|156697899|FG000|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1|||
48685082|NCT00550407|156697900|FG001|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
48685083|NCT00550407|156697901|FG002|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
48685084|NCT00550407|156697899|FG000|26-Week Randomized Phase|Adverse Event|0|||
48685085|NCT00550407|156697900|FG001|26-Week Randomized Phase|Adverse Event|5|||
48685086|NCT00550407|156697901|FG002|26-Week Randomized Phase|Adverse Event|2|||
48685087|NCT00550407|156697899|FG000|26-Week Randomized Phase|Lack of Efficacy|0|||
48685088|NCT00550407|156697900|FG001|26-Week Randomized Phase|Lack of Efficacy|36|||
48685089|NCT00550407|156697901|FG002|26-Week Randomized Phase|Lack of Efficacy|19|||
48685090|NCT00550407|156697899|FG000|26-Week Randomized Phase|Investigator Discretion|0|||
48685091|NCT00550407|156697900|FG001|26-Week Randomized Phase|Investigator Discretion|1|||
48685092|NCT00550407|156697901|FG002|26-Week Randomized Phase|Investigator Discretion|0|||
48685093|NCT00550407|156697899|FG000|26-Week Randomized Phase|Withdrawal by Subject|0|||
48685094|NCT00550407|156697900|FG001|26-Week Randomized Phase|Withdrawal by Subject|1|||
48685095|NCT00550407|156697901|FG002|26-Week Randomized Phase|Withdrawal by Subject|3|||
48685096|NCT02487095|156697904|FG000|Dose Expansion|Unable to scan/restage participant|0|||
48685097|NCT02487095|156697905|FG001|Dose Expansion|Unable to scan/restage participant|0|||
48685098|NCT02487095|156697906|FG002|Dose Expansion|Unable to scan/restage participant|0|||
48685099|NCT02487095|156697907|FG003|Dose Expansion|Unable to scan/restage participant|0|||
48685100|NCT02487095|156697908|FG004|Dose Expansion|Unable to scan/restage participant|1|||
48685101|NCT03201419|156697925|FG000|Overall Study|Adverse Event|3|||
48685102|NCT03201419|156697926|FG001|Overall Study|Adverse Event|1|||
48685103|NCT03201419|156697927|FG002|Overall Study|Adverse Event|0|||
48685104|NCT03201419|156697928|FG003|Overall Study|Adverse Event|0|||
48685105|NCT03201419|156697929|FG004|Overall Study|Adverse Event|1|||
48685106|NCT03201419|156697930|FG005|Overall Study|Adverse Event|1|||
48685107|NCT03201419|156697931|FG006|Overall Study|Adverse Event|5|||
48685108|NCT03201419|156697932|FG007|Overall Study|Adverse Event|0|||
48685109|NCT03201419|156697933|FG008|Overall Study|Adverse Event|0|||
48685110|NCT03201419|156697925|FG000|Overall Study|Lost to Follow-up|1|||
48685111|NCT03201419|156697926|FG001|Overall Study|Lost to Follow-up|0|||
48685112|NCT03201419|156697927|FG002|Overall Study|Lost to Follow-up|0|||
48685113|NCT03201419|156697928|FG003|Overall Study|Lost to Follow-up|0|||
48685114|NCT03201419|156697929|FG004|Overall Study|Lost to Follow-up|0|||
48685115|NCT03201419|156697930|FG005|Overall Study|Lost to Follow-up|0|||
49022231|NCT02207231|157920655|FG000|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1|||
49022232|NCT02207231|157920656|FG001|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4|||
49022233|NCT02207231|157920657|FG002|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10|||
49022234|NCT02207231|157920658|FG003|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0|||
48685116|NCT03201419|156697931|FG006|Overall Study|Lost to Follow-up|0|||
48685117|NCT03201419|156697932|FG007|Overall Study|Lost to Follow-up|0|||
48685118|NCT03201419|156697933|FG008|Overall Study|Lost to Follow-up|0|||
48685119|NCT03201419|156697925|FG000|Overall Study|Protocol Deviation|0|||
48685120|NCT03201419|156697926|FG001|Overall Study|Protocol Deviation|0|||
48685121|NCT03201419|156697927|FG002|Overall Study|Protocol Deviation|0|||
48685122|NCT03201419|156697928|FG003|Overall Study|Protocol Deviation|0|||
48685123|NCT03201419|156697929|FG004|Overall Study|Protocol Deviation|0|||
48685124|NCT03201419|156697930|FG005|Overall Study|Protocol Deviation|0|||
48685125|NCT03201419|156697931|FG006|Overall Study|Protocol Deviation|1|||
48685126|NCT03201419|156697932|FG007|Overall Study|Protocol Deviation|0|||
48685127|NCT03201419|156697933|FG008|Overall Study|Protocol Deviation|0|||
48685128|NCT03201419|156697925|FG000|Overall Study|Withdrawal by Subject|4|||
48685129|NCT03201419|156697926|FG001|Overall Study|Withdrawal by Subject|2|||
48685130|NCT03201419|156697927|FG002|Overall Study|Withdrawal by Subject|1|||
48685131|NCT03201419|156697928|FG003|Overall Study|Withdrawal by Subject|0|||
48685132|NCT03201419|156697929|FG004|Overall Study|Withdrawal by Subject|0|||
48685133|NCT03201419|156697930|FG005|Overall Study|Withdrawal by Subject|0|||
48685134|NCT03201419|156697931|FG006|Overall Study|Withdrawal by Subject|0|||
48685135|NCT03201419|156697932|FG007|Overall Study|Withdrawal by Subject|1|||
48685136|NCT03201419|156697933|FG008|Overall Study|Withdrawal by Subject|2|||
48685137|NCT03201419|156697925|FG000|Overall Study|Other|0|||
48685138|NCT03201419|156697926|FG001|Overall Study|Other|0|||
48685139|NCT03201419|156697927|FG002|Overall Study|Other|1|||
48685140|NCT03201419|156697928|FG003|Overall Study|Other|0|||
48685141|NCT03201419|156697929|FG004|Overall Study|Other|0|||
48685142|NCT03201419|156697930|FG005|Overall Study|Other|0|||
48685143|NCT03201419|156697931|FG006|Overall Study|Other|0|||
48685144|NCT03201419|156697932|FG007|Overall Study|Other|0|||
48685145|NCT03201419|156697933|FG008|Overall Study|Other|0|||
48685146|NCT04842500|156699138|FG000|Overall Study|Withdrawal by Subject|4|||
48685147|NCT04842500|156699139|FG001|Overall Study|Withdrawal by Subject|1|||
48685148|NCT04842500|156699140|FG002|Overall Study|Withdrawal by Subject|2|||
48685149|NCT04842500|156699141|FG003|Overall Study|Withdrawal by Subject|3|||
48685150|NCT04842500|156699138|FG000|Overall Study|Protocol Violation|1|||
48685151|NCT04842500|156699139|FG001|Overall Study|Protocol Violation|0|||
48685152|NCT04842500|156699140|FG002|Overall Study|Protocol Violation|0|||
48685153|NCT04842500|156699141|FG003|Overall Study|Protocol Violation|1|||
48685154|NCT03038126|156699142|FG000|Overall Study|Death|1|||
48685155|NCT03038126|156699143|FG001|Overall Study|Death|1|||
48685156|NCT03038126|156699142|FG000|Overall Study|Withdrawal by Subject|5|||
48685157|NCT03038126|156699143|FG001|Overall Study|Withdrawal by Subject|0|||
48685158|NCT03038126|156699142|FG000|Overall Study|Lost to Follow-up|0|||
48685159|NCT03038126|156699143|FG001|Overall Study|Lost to Follow-up|1|||
48685160|NCT03038126|156699142|FG000|Overall Study|Long Term Hospitalization|2|||
48685161|NCT03038126|156699143|FG001|Overall Study|Long Term Hospitalization|0|||
48685162|NCT03038126|156699142|FG000|Overall Study|Too Ill to Participate|1|||
48685163|NCT03038126|156699143|FG001|Overall Study|Too Ill to Participate|2|||
48685164|NCT02610777|156699144|FG000|Overall Study|Lost to Follow-up|1|||
48685165|NCT02610777|156699145|FG001|Overall Study|Lost to Follow-up|0|||
48685166|NCT02610777|156699144|FG000|Overall Study|Site Terminated by Sponsor|9|||
48685167|NCT02610777|156699145|FG001|Overall Study|Site Terminated by Sponsor|8|||
48685168|NCT02610777|156699144|FG000|Overall Study|Withdrawal by Subject|2|||
48685169|NCT02610777|156699145|FG001|Overall Study|Withdrawal by Subject|2|||
48875209|NCT00307164|157381587|FG000|Overall Study|Not compliant with requirements|4|||
49022235|NCT02207231|157920655|FG000|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
49022236|NCT02207231|157920656|FG001|Active Controlled Period: Week 16 - 48|Protocol Violation|1|||
48685170|NCT02610777|156699144|FG000|Overall Study|Reason not Specified|0|||
48685171|NCT02610777|156699145|FG001|Overall Study|Reason not Specified|1|||
48685172|NCT02610777|156699144|FG000|Overall Study|Death|50|||
48685173|NCT02610777|156699145|FG001|Overall Study|Death|47|||
48685174|NCT01362608|156699151|FG000|Overall Study|Protocol Violation|0|||
48685175|NCT01362608|156699152|FG001|Overall Study|Protocol Violation|1|||
48685176|NCT01362608|156699151|FG000|Overall Study|Lost to Follow-up|3|||
48685177|NCT01362608|156699152|FG001|Overall Study|Lost to Follow-up|1|||
48685178|NCT01362608|156699151|FG000|Overall Study|Withdrawal by Subject|1|||
48685179|NCT01362608|156699152|FG001|Overall Study|Withdrawal by Subject|2|||
48685180|NCT01362608|156699151|FG000|Overall Study|Lack of Efficacy|0|||
48685181|NCT01362608|156699152|FG001|Overall Study|Lack of Efficacy|2|||
48685182|NCT01362608|156699151|FG000|Overall Study|Adverse Event|0|||
48685183|NCT01362608|156699152|FG001|Overall Study|Adverse Event|2|||
48685184|NCT01395901|156699154|FG000|Overall Study|Lost to Follow-up|4|||
48685185|NCT01395901|156699155|FG001|Overall Study|Lost to Follow-up|0|||
48685186|NCT01395901|156699154|FG000|Overall Study|Randomized but not received study drug|5|||
48685187|NCT01395901|156699155|FG001|Overall Study|Randomized but not received study drug|4|||
48685188|NCT01395901|156699154|FG000|Overall Study|Adverse Event|0|||
48685189|NCT01395901|156699155|FG001|Overall Study|Adverse Event|1|||
48685190|NCT01395901|156699154|FG000|Overall Study|Withdrawal of consent|1|||
48685191|NCT01395901|156699155|FG001|Overall Study|Withdrawal of consent|0|||
48685192|NCT01380769|156699156|FG000|Overall Study|Withdrawal by Subject|7|||
48685193|NCT01380769|156699157|FG001|Overall Study|Withdrawal by Subject|11|||
48685194|NCT01380769|156699156|FG000|Overall Study|Physician Decision|1|||
48685195|NCT01380769|156699157|FG001|Overall Study|Physician Decision|1|||
48685196|NCT01380769|156699156|FG000|Overall Study|Adverse Event|1|||
48685197|NCT01380769|156699157|FG001|Overall Study|Adverse Event|1|||
48685198|NCT01380769|156699156|FG000|Overall Study|Protocol Violation|0|||
49022237|NCT02207231|157920657|FG002|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
48685199|NCT01380769|156699157|FG001|Overall Study|Protocol Violation|1|||
48685200|NCT04337372|156699158|FG000|Day 1: Eye-tracking Measures|Protocol Violation|1|||
48685201|NCT04337372|156699159|FG001|Day 1: Eye-tracking Measures|Protocol Violation|3|||
48685202|NCT04337372|156699160|FG002|Day 1: Eye-tracking Measures|Protocol Violation|7|||
48685203|NCT04337372|156699161|FG003|Day 1: Eye-tracking Measures|Protocol Violation|11|||
48685204|NCT04337372|156699158|FG000|Day 1: Eye-tracking Measures|Equipment Failure|0|||
48685205|NCT04337372|156699159|FG001|Day 1: Eye-tracking Measures|Equipment Failure|0|||
48685206|NCT04337372|156699160|FG002|Day 1: Eye-tracking Measures|Equipment Failure|2|||
48685207|NCT04337372|156699161|FG003|Day 1: Eye-tracking Measures|Equipment Failure|2|||
48685208|NCT04337372|156699158|FG000|Day 2: EEG Measures|Lost to Follow-up|0|||
48685209|NCT04337372|156699159|FG001|Day 2: EEG Measures|Lost to Follow-up|3|||
48685210|NCT04337372|156699160|FG002|Day 2: EEG Measures|Lost to Follow-up|2|||
48685211|NCT04337372|156699161|FG003|Day 2: EEG Measures|Lost to Follow-up|5|||
48685212|NCT04337372|156699158|FG000|Day 2: EEG Measures|Protocol Violation|6|||
48685213|NCT04337372|156699159|FG001|Day 2: EEG Measures|Protocol Violation|6|||
48685214|NCT04337372|156699160|FG002|Day 2: EEG Measures|Protocol Violation|5|||
48685215|NCT04337372|156699161|FG003|Day 2: EEG Measures|Protocol Violation|17|||
48981175|NCT01263470|157764227|FG002|Overall Study|Adverse Event|1|||
48981176|NCT01263470|157764228|FG003|Overall Study|Adverse Event|1|||
48981177|NCT01263470|157764229|FG004|Overall Study|Adverse Event|2|||
48981178|NCT01263470|157764230|FG005|Overall Study|Adverse Event|2|||
48981179|NCT01263470|157764225|FG000|Overall Study|Protocol Violation|0|||
48981180|NCT01263470|157764226|FG001|Overall Study|Protocol Violation|1|||
48981181|NCT01263470|157764227|FG002|Overall Study|Protocol Violation|0|||
48981182|NCT01263470|157764228|FG003|Overall Study|Protocol Violation|0|||
48981183|NCT01263470|157764229|FG004|Overall Study|Protocol Violation|0|||
48981184|NCT01263470|157764230|FG005|Overall Study|Protocol Violation|1|||
48981185|NCT01263470|157764225|FG000|Overall Study|Withdrawal by Subject|0|||
48981186|NCT01263470|157764226|FG001|Overall Study|Withdrawal by Subject|1|||
48981187|NCT01263470|157764227|FG002|Overall Study|Withdrawal by Subject|1|||
48981188|NCT01263470|157764228|FG003|Overall Study|Withdrawal by Subject|2|||
48981189|NCT01263470|157764229|FG004|Overall Study|Withdrawal by Subject|0|||
48981190|NCT01263470|157764230|FG005|Overall Study|Withdrawal by Subject|2|||
48981191|NCT01263470|157764225|FG000|Overall Study|Lack of Efficacy|0|||
48981192|NCT01263470|157764226|FG001|Overall Study|Lack of Efficacy|0|||
48981193|NCT01263470|157764227|FG002|Overall Study|Lack of Efficacy|2|||
48981194|NCT01263470|157764228|FG003|Overall Study|Lack of Efficacy|0|||
48981195|NCT01263470|157764229|FG004|Overall Study|Lack of Efficacy|0|||
48981196|NCT01263470|157764230|FG005|Overall Study|Lack of Efficacy|0|||
48981197|NCT01263470|157764225|FG000|Overall Study|Participant Unavailability|0|||
48981198|NCT01263470|157764226|FG001|Overall Study|Participant Unavailability|1|||
48981199|NCT01263470|157764227|FG002|Overall Study|Participant Unavailability|0|||
48981200|NCT01263470|157764228|FG003|Overall Study|Participant Unavailability|0|||
48981201|NCT01263470|157764229|FG004|Overall Study|Participant Unavailability|0|||
48685244|NCT02201108|156699164|FG000|Double-blind Period (up to Week 96)|Adverse Event|0|||
48685245|NCT02201108|156699165|FG001|Double-blind Period (up to Week 96)|Adverse Event|6|||
48685246|NCT02201108|156699166|FG002|Double-blind Period (up to Week 96)|Adverse Event|0|||
48685247|NCT02201108|156699164|FG000|Double-blind Period (up to Week 96)|Lack of Efficacy|2|||
48685248|NCT02201108|156699165|FG001|Double-blind Period (up to Week 96)|Lack of Efficacy|1|||
48685249|NCT02201108|156699166|FG002|Double-blind Period (up to Week 96)|Lack of Efficacy|0|||
48685250|NCT02201108|156699164|FG000|Double-blind Period (up to Week 96)|Withdrawal by Subject|2|||
48685251|NCT02201108|156699165|FG001|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
48685252|NCT02201108|156699166|FG002|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
48685253|NCT02201108|156699164|FG000|Open Label Period (up to Week 192)|Lack of Efficacy|10|||
48685254|NCT02201108|156699165|FG001|Open Label Period (up to Week 192)|Lack of Efficacy|14|||
48875210|NCT00307164|157381588|FG001|Overall Study|Not compliant with requirements|4|||
48875211|NCT00307164|157381587|FG000|Overall Study|Lost to Follow-up|6|||
48875212|NCT00307164|157381588|FG001|Overall Study|Lost to Follow-up|1|||
48875213|NCT00490945|157381589|FG000|Overall Study|Adverse Event|0|||
48875214|NCT00490945|157381590|FG001|Overall Study|Adverse Event|1|||
48875215|NCT00490945|157381591|FG002|Overall Study|Adverse Event|0|||
48875216|NCT00490945|157381592|FG003|Overall Study|Adverse Event|0|||
48875217|NCT00490945|157381593|FG004|Overall Study|Adverse Event|0|||
49022238|NCT02207231|157920658|FG003|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
48685255|NCT02201108|156699166|FG002|Open Label Period (up to Week 192)|Lack of Efficacy|0|||
48685256|NCT02201108|156699164|FG000|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
48685257|NCT02201108|156699165|FG001|Open Label Period (up to Week 192)|Poor compliance to protocol|1|||
48685258|NCT02201108|156699166|FG002|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
48685259|NCT02201108|156699164|FG000|Open Label Period (up to Week 192)|Other reason|4|||
48685260|NCT02201108|156699165|FG001|Open Label Period (up to Week 192)|Other reason|7|||
48685261|NCT02201108|156699166|FG002|Open Label Period (up to Week 192)|Other reason|0|||
48685262|NCT02201108|156699164|FG000|Open Label Period (up to Week 192)|Adverse Event|7|||
48685263|NCT02201108|156699165|FG001|Open Label Period (up to Week 192)|Adverse Event|5|||
48685264|NCT02201108|156699166|FG002|Open Label Period (up to Week 192)|Adverse Event|0|||
48685265|NCT02201108|156699164|FG000|Extension Period (Up to Week 492)|Adverse Event|0|||
48685266|NCT02201108|156699165|FG001|Extension Period (Up to Week 492)|Adverse Event|0|||
48685267|NCT02201108|156699166|FG002|Extension Period (Up to Week 492)|Adverse Event|2|||
48685268|NCT02201108|156699164|FG000|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
48685269|NCT02201108|156699165|FG001|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
48685270|NCT02201108|156699166|FG002|Extension Period (Up to Week 492)|Poor compliance to protocol|1|||
48685271|NCT04205812|156699167|FG000|Randomized Treatment Period|Ongoing|28|||
48685272|NCT04205812|156699168|FG001|Randomized Treatment Period|Ongoing|138|||
49022239|NCT02207231|157920655|FG000|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
49022240|NCT02207231|157920656|FG001|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
49022241|NCT02207231|157920657|FG002|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
49022242|NCT02207231|157920658|FG003|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
49022243|NCT02207231|157920655|FG000|Active Controlled Period: Week 16 - 48|Other|0|||
49022244|NCT02207231|157920656|FG001|Active Controlled Period: Week 16 - 48|Other|2|||
49022245|NCT02207231|157920657|FG002|Active Controlled Period: Week 16 - 48|Other|3|||
49022246|NCT02207231|157920658|FG003|Active Controlled Period: Week 16 - 48|Other|0|||
49022247|NCT02207231|157920655|FG000|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
49022248|NCT02207231|157920656|FG001|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
49022249|NCT02207231|157920657|FG002|Open-label Guselkumab: Week 48 - 264|Adverse Event|12|||
49022250|NCT02207231|157920658|FG003|Open-label Guselkumab: Week 48 - 264|Adverse Event|19|||
49022251|NCT02207231|157920655|FG000|Open-label Guselkumab: Week 48 - 264|Death|0|||
49022252|NCT02207231|157920656|FG001|Open-label Guselkumab: Week 48 - 264|Death|0|||
49022253|NCT02207231|157920657|FG002|Open-label Guselkumab: Week 48 - 264|Death|1|||
49022254|NCT02207231|157920658|FG003|Open-label Guselkumab: Week 48 - 264|Death|3|||
49022255|NCT02207231|157920655|FG000|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
49022256|NCT02207231|157920656|FG001|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
49022257|NCT02207231|157920657|FG002|Open-label Guselkumab: Week 48 - 264|Pregnancy|3|||
49022258|NCT02207231|157920658|FG003|Open-label Guselkumab: Week 48 - 264|Pregnancy|7|||
49022259|NCT02207231|157920655|FG000|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
49022260|NCT02207231|157920656|FG001|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
49022261|NCT02207231|157920657|FG002|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2|||
49022262|NCT02207231|157920658|FG003|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4|||
49022263|NCT02207231|157920655|FG000|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
49022264|NCT02207231|157920656|FG001|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
49022265|NCT02207231|157920657|FG002|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6|||
49022266|NCT02207231|157920658|FG003|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11|||
49022267|NCT02207231|157920655|FG000|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
49022268|NCT02207231|157920656|FG001|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
49022269|NCT02207231|157920657|FG002|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10|||
49022270|NCT02207231|157920658|FG003|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28|||
48685273|NCT04205812|156699167|FG000|Randomized Treatment Period|Death|94|||
48685274|NCT04205812|156699168|FG001|Randomized Treatment Period|Death|226|||
48685275|NCT04205812|156699167|FG000|Randomized Treatment Period|Lost to Follow-up|5|||
48685276|NCT04205812|156699168|FG001|Randomized Treatment Period|Lost to Follow-up|11|||
48685277|NCT04205812|156699167|FG000|Randomized Treatment Period|Physician Decision|1|||
48875218|NCT01496365|157381594|FG000|Overall Study|Adverse Event|2|||
48875219|NCT01496365|157381595|FG001|Overall Study|Adverse Event|3|||
49022271|NCT02207231|157920655|FG000|Open-label Guselkumab: Week 48 - 264|Other|0|||
49022272|NCT02207231|157920656|FG001|Open-label Guselkumab: Week 48 - 264|Other|0|||
49022273|NCT02207231|157920657|FG002|Open-label Guselkumab: Week 48 - 264|Other|4|||
49022274|NCT02207231|157920658|FG003|Open-label Guselkumab: Week 48 - 264|Other|11|||
49022275|NCT02532764|157920659|FG000|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
49022276|NCT02532764|157920660|FG001|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
49022277|NCT02532764|157920661|FG002|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
49022278|NCT02532764|157920662|FG003|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
49022279|NCT02532764|157920663|FG004|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
48763211|NCT03662542|156983814|FG008|Monotherapy Phase (Week 12-Week 38)|Death|0|||
48763212|NCT03662542|156983806|FG000|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
48763213|NCT03662542|156983807|FG001|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
49022280|NCT02532764|157920664|FG005|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
49022281|NCT02532764|157920665|FG006|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
49022282|NCT02532764|157920666|FG007|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
49022283|NCT02532764|157920667|FG008|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
49022284|NCT02532764|157920668|FG009|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
49022285|NCT00920140|157920669|FG000|Phase 1 (Dose Escalation)|Adverse Event|3|||
49022286|NCT00920140|157920670|FG001|Phase 1 (Dose Escalation)|Adverse Event|3|||
49022287|NCT00920140|157920671|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
49022288|NCT00920140|157920672|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
49022289|NCT00920140|157920673|FG004|Phase 1 (Dose Escalation)|Adverse Event|0|||
49022290|NCT00920140|157920669|FG000|Phase 1 (Dose Escalation)|Lack of Efficacy|2|||
49022291|NCT00920140|157920670|FG001|Phase 1 (Dose Escalation)|Lack of Efficacy|4|||
49022292|NCT00920140|157920671|FG002|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
49022293|NCT00920140|157920672|FG003|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
49022294|NCT00920140|157920673|FG004|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
48685278|NCT04205812|156699168|FG001|Randomized Treatment Period|Physician Decision|4|||
48685279|NCT04205812|156699167|FG000|Randomized Treatment Period|Withdrawal by Subject|4|||
48685280|NCT04205812|156699168|FG001|Randomized Treatment Period|Withdrawal by Subject|11|||
48685281|NCT04205812|156699167|FG000|Randomized Treatment Period|Progressive Disease|0|||
48685282|NCT04205812|156699168|FG001|Randomized Treatment Period|Progressive Disease|1|||
48685283|NCT04205812|156699167|FG000|Randomized Treatment Period|Met Exclusion Criteria|1|||
48685284|NCT04205812|156699168|FG001|Randomized Treatment Period|Met Exclusion Criteria|0|||
48685285|NCT04205812|156699167|FG000|Monotherapy Treatment Period|Ongoing|17|||
48685286|NCT04205812|156699168|FG001|Monotherapy Treatment Period|Ongoing|0|||
48685287|NCT04205812|156699167|FG000|Monotherapy Treatment Period|Death|39|||
48685288|NCT04205812|156699168|FG001|Monotherapy Treatment Period|Death|0|||
48685289|NCT04205812|156699167|FG000|Monotherapy Treatment Period|Lost to Follow-up|2|||
48685290|NCT04205812|156699168|FG001|Monotherapy Treatment Period|Lost to Follow-up|0|||
48685291|NCT04205812|156699167|FG000|Monotherapy Treatment Period|Withdrawal by Subject|1|||
48685292|NCT04205812|156699168|FG001|Monotherapy Treatment Period|Withdrawal by Subject|0|||
48685293|NCT00413218|156699172|FG000|Overall Study|Randomized but didn't receive study drug|2|||
48685294|NCT00413218|156699173|FG001|Overall Study|Randomized but didn't receive study drug|8|||
48685295|NCT00413218|156699172|FG000|Overall Study|Death|57|||
48685296|NCT00413218|156699173|FG001|Overall Study|Death|56|||
48685297|NCT00413218|156699172|FG000|Overall Study|Lost to Follow-up|14|||
48685298|NCT00413218|156699173|FG001|Overall Study|Lost to Follow-up|17|||
48685299|NCT00413218|156699172|FG000|Overall Study|Admin|20|||
48685300|NCT00413218|156699173|FG001|Overall Study|Admin|14|||
48685301|NCT00413218|156699172|FG000|Overall Study|Missing|1|||
48685302|NCT00413218|156699173|FG001|Overall Study|Missing|0|||
48685303|NCT00413218|156699172|FG000|Overall Study|Withdrawal by Subject|9|||
48685304|NCT00413218|156699173|FG001|Overall Study|Withdrawal by Subject|1|||
48763214|NCT03662542|156983808|FG002|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
48763215|NCT03662542|156983809|FG003|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
48763216|NCT03662542|156983810|FG004|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
48875220|NCT01496365|157381596|FG002|Overall Study|Adverse Event|3|||
48875221|NCT01496365|157381597|FG003|Overall Study|Adverse Event|2|||
48875222|NCT01496365|157381598|FG004|Overall Study|Adverse Event|5|||
48875223|NCT01496365|157381599|FG005|Overall Study|Adverse Event|6|||
48875224|NCT01496365|157381600|FG006|Overall Study|Adverse Event|4|||
48875225|NCT01496365|157381594|FG000|Overall Study|Withdrawal by Subject|6|||
48875226|NCT01496365|157381595|FG001|Overall Study|Withdrawal by Subject|6|||
48875227|NCT01496365|157381596|FG002|Overall Study|Withdrawal by Subject|0|||
49022295|NCT00920140|157920669|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
48685305|NCT01824875|156699174|FG000|Overall Study|Disease progression|22|||
48685306|NCT01824875|156699175|FG001|Overall Study|Disease progression|15|||
48685307|NCT01824875|156699174|FG000|Overall Study|Withdrawal by Subject|5|||
48685308|NCT01824875|156699175|FG001|Overall Study|Withdrawal by Subject|4|||
48685309|NCT01824875|156699174|FG000|Overall Study|Adverse Event|4|||
48763217|NCT03662542|156983811|FG005|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
48763218|NCT03662542|156983812|FG006|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
48875228|NCT01496365|157381597|FG003|Overall Study|Withdrawal by Subject|1|||
48685310|NCT01824875|156699175|FG001|Overall Study|Adverse Event|10|||
48685311|NCT01824875|156699174|FG000|Overall Study|Alternative therapy|3|||
48685312|NCT01824875|156699175|FG001|Overall Study|Alternative therapy|0|||
48685313|NCT01824875|156699174|FG000|Overall Study|Complicating disease|1|||
48685314|NCT01824875|156699175|FG001|Overall Study|Complicating disease|0|||
48685315|NCT01824875|156699174|FG000|Overall Study|Physician Decision|0|||
48685316|NCT01824875|156699175|FG001|Overall Study|Physician Decision|1|||
48685317|NCT01824875|156699174|FG000|Overall Study|Non-compliance|1|||
48685318|NCT01824875|156699175|FG001|Overall Study|Non-compliance|1|||
48685319|NCT01824875|156699174|FG000|Overall Study|Treatment ended early due to mis-interpretation of protocol|1|||
48685320|NCT01824875|156699175|FG001|Overall Study|Treatment ended early due to mis-interpretation of protocol|0|||
49022296|NCT00920140|157920670|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|2|||
49022297|NCT00920140|157920671|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
49022298|NCT00920140|157920672|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
49022299|NCT00920140|157920673|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
49022300|NCT00920140|157920669|FG000|Phase 2|Adverse Event|0|||
49022301|NCT00920140|157920670|FG001|Phase 2|Adverse Event|0|||
49022302|NCT00920140|157920671|FG002|Phase 2|Adverse Event|14|||
49022303|NCT00920140|157920672|FG003|Phase 2|Adverse Event|2|||
49022304|NCT00920140|157920673|FG004|Phase 2|Adverse Event|3|||
49022305|NCT00920140|157920669|FG000|Phase 2|Lack of Efficacy|0|||
49022306|NCT00920140|157920670|FG001|Phase 2|Lack of Efficacy|0|||
49022307|NCT00920140|157920671|FG002|Phase 2|Lack of Efficacy|29|||
49022308|NCT00920140|157920672|FG003|Phase 2|Lack of Efficacy|14|||
49022309|NCT00920140|157920673|FG004|Phase 2|Lack of Efficacy|5|||
49022310|NCT00920140|157920669|FG000|Phase 2|Lost to Follow-up|0|||
49022311|NCT00920140|157920670|FG001|Phase 2|Lost to Follow-up|0|||
49022312|NCT00920140|157920671|FG002|Phase 2|Lost to Follow-up|0|||
49022313|NCT00920140|157920672|FG003|Phase 2|Lost to Follow-up|1|||
49022314|NCT00920140|157920673|FG004|Phase 2|Lost to Follow-up|0|||
49022315|NCT00920140|157920669|FG000|Phase 2|Physician Decision|0|||
49022316|NCT00920140|157920670|FG001|Phase 2|Physician Decision|0|||
49022317|NCT00920140|157920671|FG002|Phase 2|Physician Decision|3|||
49022318|NCT00920140|157920672|FG003|Phase 2|Physician Decision|3|||
49022319|NCT00920140|157920673|FG004|Phase 2|Physician Decision|2|||
49022320|NCT00920140|157920669|FG000|Phase 2|Withdrawal by Subject|0|||
49022321|NCT00920140|157920670|FG001|Phase 2|Withdrawal by Subject|0|||
49022322|NCT00920140|157920671|FG002|Phase 2|Withdrawal by Subject|4|||
49022323|NCT00920140|157920672|FG003|Phase 2|Withdrawal by Subject|2|||
49022324|NCT00920140|157920673|FG004|Phase 2|Withdrawal by Subject|1|||
49022325|NCT03444038|157920678|FG000|Overall Study|Adverse Event|12|||
49022326|NCT03444038|157920678|FG000|Overall Study|Withdrawal by Subject|7|||
49022327|NCT03444038|157920678|FG000|Overall Study|Lost to Follow-up|1|||
49022328|NCT03444038|157920678|FG000|Overall Study|Physician Decision|2|||
49022329|NCT03444038|157920678|FG000|Overall Study|Lack of Efficacy|7|||
49022330|NCT00977106|157920679|FG000|Overall Study|Adverse Event|5|||
48685321|NCT01824875|156699174|FG000|Overall Study|Administrative issues|0|||
48685322|NCT01824875|156699175|FG001|Overall Study|Administrative issues|2|||
48685323|NCT01824875|156699174|FG000|Overall Study|Ineligible or never started treatment|9|||
48685324|NCT01824875|156699175|FG001|Overall Study|Ineligible or never started treatment|5|||
48685325|NCT01824875|156699174|FG000|Overall Study|Other|0|||
48763219|NCT03662542|156983813|FG007|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
48763220|NCT03662542|156983814|FG008|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
48763221|NCT03662542|156983806|FG000|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
48763222|NCT03662542|156983807|FG001|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
48875229|NCT01496365|157381598|FG004|Overall Study|Withdrawal by Subject|3|||
48875230|NCT01496365|157381599|FG005|Overall Study|Withdrawal by Subject|2|||
49022331|NCT00977106|157920680|FG001|Overall Study|Adverse Event|6|||
49022332|NCT00977106|157920679|FG000|Overall Study|Withdrawal by Subject|2|||
49022333|NCT00977106|157920680|FG001|Overall Study|Withdrawal by Subject|2|||
49022334|NCT00977106|157920679|FG000|Overall Study|Lack of Efficacy|2|||
49022335|NCT00977106|157920680|FG001|Overall Study|Lack of Efficacy|2|||
49022336|NCT00977106|157920679|FG000|Overall Study|Protocol Violation|0|||
49022337|NCT00977106|157920680|FG001|Overall Study|Protocol Violation|1|||
49022338|NCT00977106|157920679|FG000|Overall Study|Other|1|||
49022339|NCT00977106|157920680|FG001|Overall Study|Other|0|||
49022340|NCT01644500|157920685|FG000|Overall Study|Adverse Event|6|||
49022341|NCT01644500|157920686|FG001|Overall Study|Adverse Event|1|||
49022342|NCT01644500|157920687|FG002|Overall Study|Adverse Event|2|||
49022343|NCT01644500|157920685|FG000|Overall Study|Death|0|||
48685326|NCT01824875|156699175|FG001|Overall Study|Other|2|||
48685327|NCT04810650|156699176|FG000|Overall Study|Disenrolled in error|0|||
48685328|NCT04810650|156699177|FG001|Overall Study|Disenrolled in error|0|||
48685329|NCT04810650|156699178|FG002|Overall Study|Disenrolled in error|0|||
48763223|NCT03662542|156983808|FG002|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
49022344|NCT01644500|157920686|FG001|Overall Study|Death|1|||
49022345|NCT01644500|157920687|FG002|Overall Study|Death|0|||
49022346|NCT01644500|157920685|FG000|Overall Study|Lost to Follow-up|3|||
49022347|NCT01644500|157920686|FG001|Overall Study|Lost to Follow-up|8|||
48685330|NCT04810650|156699179|FG003|Overall Study|Disenrolled in error|0|||
48685331|NCT04810650|156699180|FG004|Overall Study|Disenrolled in error|0|||
48685332|NCT04810650|156699181|FG005|Overall Study|Disenrolled in error|0|||
48685333|NCT04810650|156699182|FG006|Overall Study|Disenrolled in error|0|||
48685334|NCT04810650|156699183|FG007|Overall Study|Disenrolled in error|0|||
48685335|NCT04810650|156699184|FG008|Overall Study|Disenrolled in error|1|||
48685336|NCT04810650|156699185|FG009|Overall Study|Disenrolled in error|0|||
48685337|NCT04810650|156699186|FG010|Overall Study|Disenrolled in error|0|||
48685338|NCT04810650|156699187|FG011|Overall Study|Disenrolled in error|0|||
48685339|NCT04810650|156699188|FG012|Overall Study|Disenrolled in error|0|||
48685340|NCT04810650|156699189|FG013|Overall Study|Disenrolled in error|0|||
48685341|NCT04810650|156699176|FG000|Overall Study|Death|0|||
48685342|NCT04810650|156699177|FG001|Overall Study|Death|0|||
48685343|NCT04810650|156699178|FG002|Overall Study|Death|0|||
48685344|NCT04810650|156699179|FG003|Overall Study|Death|0|||
48685345|NCT04810650|156699180|FG004|Overall Study|Death|0|||
48685346|NCT04810650|156699181|FG005|Overall Study|Death|0|||
48685347|NCT04810650|156699182|FG006|Overall Study|Death|2|||
48685348|NCT04810650|156699183|FG007|Overall Study|Death|2|||
48685349|NCT04810650|156699184|FG008|Overall Study|Death|0|||
48685350|NCT04810650|156699185|FG009|Overall Study|Death|1|||
48685351|NCT04810650|156699186|FG010|Overall Study|Death|0|||
48685352|NCT04810650|156699187|FG011|Overall Study|Death|0|||
48685353|NCT04810650|156699188|FG012|Overall Study|Death|2|||
48685354|NCT04810650|156699189|FG013|Overall Study|Death|1|||
48685355|NCT04810650|156699176|FG000|Overall Study|Moved/transferred care|0|||
48685356|NCT04810650|156699177|FG001|Overall Study|Moved/transferred care|0|||
48685357|NCT04810650|156699178|FG002|Overall Study|Moved/transferred care|0|||
48685358|NCT04810650|156699179|FG003|Overall Study|Moved/transferred care|0|||
48685359|NCT04810650|156699180|FG004|Overall Study|Moved/transferred care|0|||
48685360|NCT04810650|156699181|FG005|Overall Study|Moved/transferred care|0|||
48685361|NCT04810650|156699182|FG006|Overall Study|Moved/transferred care|0|||
48685362|NCT04810650|156699183|FG007|Overall Study|Moved/transferred care|1|||
48685363|NCT04810650|156699184|FG008|Overall Study|Moved/transferred care|12|||
48685364|NCT04810650|156699185|FG009|Overall Study|Moved/transferred care|10|||
48685365|NCT04810650|156699186|FG010|Overall Study|Moved/transferred care|0|||
48685366|NCT04810650|156699187|FG011|Overall Study|Moved/transferred care|0|||
48685367|NCT04810650|156699188|FG012|Overall Study|Moved/transferred care|0|||
48685368|NCT04810650|156699189|FG013|Overall Study|Moved/transferred care|0|||
48685369|NCT04810650|156699176|FG000|Overall Study|Lost to Follow-up|15|||
48685370|NCT04810650|156699177|FG001|Overall Study|Lost to Follow-up|12|||
48685371|NCT04810650|156699178|FG002|Overall Study|Lost to Follow-up|7|||
49022348|NCT01644500|157920687|FG002|Overall Study|Lost to Follow-up|0|||
49022349|NCT01644500|157920685|FG000|Overall Study|Protocol Violation|1|||
48685372|NCT04810650|156699179|FG003|Overall Study|Lost to Follow-up|9|||
49022350|NCT01644500|157920686|FG001|Overall Study|Protocol Violation|1|||
49022351|NCT01644500|157920687|FG002|Overall Study|Protocol Violation|0|||
49022352|NCT01644500|157920685|FG000|Overall Study|Withdrawal by Subject|11|||
49022353|NCT01644500|157920686|FG001|Overall Study|Withdrawal by Subject|12|||
49022354|NCT01644500|157920687|FG002|Overall Study|Withdrawal by Subject|12|||
49022355|NCT01644500|157920685|FG000|Overall Study|Physician Decision|1|||
49022356|NCT01644500|157920686|FG001|Overall Study|Physician Decision|1|||
49022357|NCT01644500|157920687|FG002|Overall Study|Physician Decision|1|||
49022358|NCT00634907|157920688|FG000|Overall Study|Withdrawal by Subject|3|||
49022359|NCT00634907|157920689|FG001|Overall Study|Withdrawal by Subject|0|||
49022360|NCT00634907|157920688|FG000|Overall Study|Physician Decision|3|||
49022361|NCT00634907|157920689|FG001|Overall Study|Physician Decision|9|||
49022362|NCT00634907|157920688|FG000|Overall Study|Withdrawal by Subject|11|||
49022363|NCT00634907|157920689|FG001|Overall Study|Withdrawal by Subject|8|||
49022364|NCT02863575|157920690|FG000|Overall Study|Participants Unable To Swallow Capsule|1|||
49022365|NCT02863575|157920691|FG001|Overall Study|Participants Unable To Swallow Capsule|0|||
49022366|NCT02863575|157920692|FG002|Overall Study|Participants Unable To Swallow Capsule|0|||
49022367|NCT02863575|157920690|FG000|Overall Study|Withdrawal by Subject|0|||
48685373|NCT04810650|156699180|FG004|Overall Study|Lost to Follow-up|10|||
48685374|NCT04810650|156699181|FG005|Overall Study|Lost to Follow-up|6|||
48685375|NCT04810650|156699182|FG006|Overall Study|Lost to Follow-up|0|||
48685376|NCT04810650|156699183|FG007|Overall Study|Lost to Follow-up|0|||
48685377|NCT04810650|156699184|FG008|Overall Study|Lost to Follow-up|0|||
48685378|NCT04810650|156699185|FG009|Overall Study|Lost to Follow-up|0|||
48685379|NCT04810650|156699186|FG010|Overall Study|Lost to Follow-up|1|||
48685380|NCT04810650|156699187|FG011|Overall Study|Lost to Follow-up|0|||
48685381|NCT04810650|156699188|FG012|Overall Study|Lost to Follow-up|3|||
48685382|NCT04810650|156699189|FG013|Overall Study|Lost to Follow-up|9|||
48685383|NCT04810650|156699176|FG000|Overall Study|Participant declined|0|||
48685384|NCT04810650|156699177|FG001|Overall Study|Participant declined|0|||
48685385|NCT04810650|156699178|FG002|Overall Study|Participant declined|0|||
48685386|NCT04810650|156699179|FG003|Overall Study|Participant declined|0|||
48685387|NCT04810650|156699180|FG004|Overall Study|Participant declined|0|||
48685388|NCT04810650|156699181|FG005|Overall Study|Participant declined|0|||
48685389|NCT04810650|156699182|FG006|Overall Study|Participant declined|0|||
48685390|NCT04810650|156699183|FG007|Overall Study|Participant declined|0|||
48685391|NCT04810650|156699184|FG008|Overall Study|Participant declined|0|||
48685392|NCT04810650|156699185|FG009|Overall Study|Participant declined|0|||
48685393|NCT04810650|156699186|FG010|Overall Study|Participant declined|2|||
48685394|NCT04810650|156699187|FG011|Overall Study|Participant declined|0|||
48685395|NCT04810650|156699188|FG012|Overall Study|Participant declined|0|||
48685396|NCT04810650|156699189|FG013|Overall Study|Participant declined|0|||
48685397|NCT01358825|156699190|FG000|Overall Study|Blood sample not drawn|0|||
48685398|NCT01358825|156699191|FG001|Overall Study|Blood sample not drawn|1|||
48685399|NCT02524171|156699194|FG000|6-month Follow-up|Lost to Follow-up|53|||
48685400|NCT02524171|156699195|FG001|6-month Follow-up|Lost to Follow-up|45|||
48685401|NCT02524171|156699194|FG000|12-month Follow-up Interview|Lost to Follow-up|45|||
48685402|NCT02524171|156699195|FG001|12-month Follow-up Interview|Lost to Follow-up|41|||
48981202|NCT01263470|157764230|FG005|Overall Study|Participant Unavailability|0|||
48981203|NCT01263470|157764225|FG000|Overall Study|Study Drug Non-compliance|0|||
48981204|NCT01263470|157764226|FG001|Overall Study|Study Drug Non-compliance|0|||
48981205|NCT01263470|157764227|FG002|Overall Study|Study Drug Non-compliance|0|||
48981206|NCT01263470|157764228|FG003|Overall Study|Study Drug Non-compliance|0|||
48981207|NCT01263470|157764229|FG004|Overall Study|Study Drug Non-compliance|1|||
48981208|NCT01263470|157764230|FG005|Overall Study|Study Drug Non-compliance|0|||
48981209|NCT00413777|157764233|FG000|Fixed-dose Period|Lost to Follow-up|1|||
48981210|NCT00413777|157764234|FG001|Fixed-dose Period|Lost to Follow-up|1|||
48981211|NCT00413777|157764233|FG000|Fixed-dose Period|Adverse Event|2|||
48981212|NCT00413777|157764234|FG001|Fixed-dose Period|Adverse Event|1|||
48981213|NCT00413777|157764233|FG000|Fixed-dose Period|Met Withdrawal Criteria|1|||
48981214|NCT00413777|157764234|FG001|Fixed-dose Period|Met Withdrawal Criteria|0|||
48981215|NCT00413777|157764233|FG000|Fixed-dose Period|Withdrew Consent|0|||
48981216|NCT00413777|157764234|FG001|Fixed-dose Period|Withdrew Consent|1|||
48981217|NCT02565576|157764235|FG000|Overall Study|abnormal lab value|2|||
48685419|NCT00773513|156699200|FG000|Overall Study|Renal Transplant|254|||
48685420|NCT00773513|156699201|FG001|Overall Study|Renal Transplant|263|||
48685421|NCT00773513|156699200|FG000|Overall Study|Adverse Event / Intercurrent Illness|40|||
48685422|NCT00773513|156699201|FG001|Overall Study|Adverse Event / Intercurrent Illness|48|||
48685423|NCT00773513|156699200|FG000|Overall Study|Withdrew Consent|68|||
48685424|NCT00773513|156699201|FG001|Overall Study|Withdrew Consent|69|||
48685425|NCT00773513|156699200|FG000|Overall Study|Refused Treatment / Did not Cooperate|26|||
48685426|NCT00773513|156699201|FG001|Overall Study|Refused Treatment / Did not Cooperate|32|||
48685427|NCT00773513|156699200|FG000|Overall Study|Failure to Return|22|||
48685428|NCT00773513|156699201|FG001|Overall Study|Failure to Return|8|||
48685429|NCT00773513|156699200|FG000|Overall Study|Insufficient Therapeutic Response|1|||
48685430|NCT00773513|156699201|FG001|Overall Study|Insufficient Therapeutic Response|18|||
49022368|NCT02863575|157920691|FG001|Overall Study|Withdrawal by Subject|1|||
49022369|NCT02863575|157920692|FG002|Overall Study|Withdrawal by Subject|1|||
49022370|NCT02863575|157920690|FG000|Overall Study|Adverse Event|0|||
49022371|NCT02863575|157920691|FG001|Overall Study|Adverse Event|1|||
49022372|NCT02863575|157920692|FG002|Overall Study|Adverse Event|0|||
49022373|NCT03831048|157920694|FG000|Overall Study|Protocol Violation|9|||
49022374|NCT03831048|157920695|FG001|Overall Study|Protocol Violation|3|||
49022375|NCT03831048|157920694|FG000|Overall Study|Death|4|||
49022376|NCT03831048|157920695|FG001|Overall Study|Death|9|||
49022377|NCT03831048|157920694|FG000|Overall Study|Re-transplant|0|||
49022378|NCT03831048|157920695|FG001|Overall Study|Re-transplant|2|||
49022379|NCT03831048|157920694|FG000|Overall Study|Protocol violation and death|1|||
49022380|NCT03831048|157920695|FG001|Overall Study|Protocol violation and death|1|||
49022381|NCT00322491|157920696|FG000|Overall Study|Adverse Event|1|||
48685431|NCT00773513|156699200|FG000|Overall Study|Reason Not Specified|159|||
48685432|NCT00773513|156699201|FG001|Overall Study|Reason Not Specified|126|||
48685433|NCT00773513|156699200|FG000|Overall Study|Death|531|||
48685434|NCT00773513|156699201|FG001|Overall Study|Death|545|||
48981218|NCT02565576|157764236|FG001|Overall Study|abnormal lab value|0|||
49022382|NCT00322491|157920697|FG001|Overall Study|Adverse Event|0|||
49022383|NCT00322491|157920696|FG000|Overall Study|Death|1|||
49022384|NCT00322491|157920697|FG001|Overall Study|Death|2|||
49022385|NCT04015232|157920703|FG000|Overall Study|Withdrawal by Subject|7|||
48685435|NCT00700713|156699202|FG000|Overall Study|Protocol Violation|1|||
48685436|NCT00700713|156699203|FG001|Overall Study|Protocol Violation|0|||
48685437|NCT00700713|156699204|FG002|Overall Study|Protocol Violation|1|||
48685438|NCT00700713|156699202|FG000|Overall Study|Withdrawal by Subject|0|||
48685439|NCT00700713|156699203|FG001|Overall Study|Withdrawal by Subject|0|||
48685440|NCT00700713|156699204|FG002|Overall Study|Withdrawal by Subject|1|||
48685441|NCT01922271|156699205|FG000|WASHOUT Period|Withdrawal by Subject|1|||
48685442|NCT01922271|156699206|FG001|WASHOUT Period|Withdrawal by Subject|0|||
48981219|NCT02565576|157764235|FG000|Overall Study|subject / guardian decision|1|||
49022386|NCT04015232|157920704|FG001|Overall Study|Withdrawal by Subject|4|||
49022387|NCT04015232|157920703|FG000|Overall Study|Protocol Violation|1|||
48981220|NCT02565576|157764236|FG001|Overall Study|subject / guardian decision|3|||
48981221|NCT02565576|157764235|FG000|Overall Study|Lost to Follow-up|1|||
48981222|NCT02565576|157764236|FG001|Overall Study|Lost to Follow-up|0|||
48981223|NCT02565576|157764235|FG000|Overall Study|Death|0|||
48981224|NCT02565576|157764236|FG001|Overall Study|Death|2|||
48981225|NCT02565576|157764235|FG000|Overall Study|Adverse Event|1|||
48981226|NCT02565576|157764236|FG001|Overall Study|Adverse Event|0|||
48981227|NCT00981292|157764237|FG000|Day 1|Protocol Violation|1|||
48981228|NCT00981292|157764238|FG001|Day 1|Protocol Violation|0|||
48981229|NCT00981292|157764239|FG002|Day 1|Protocol Violation|0|||
49022388|NCT04015232|157920704|FG001|Overall Study|Protocol Violation|0|||
49022389|NCT04015232|157920703|FG000|Overall Study|Medical Grounds|3|||
49022390|NCT04015232|157920704|FG001|Overall Study|Medical Grounds|3|||
49022391|NCT03127137|157920705|FG000|Overall Study|Requested sedation after consent|1|||
49022392|NCT03127137|157920706|FG001|Overall Study|Requested sedation after consent|0|||
49022393|NCT03127137|157920705|FG000|Overall Study|Malfunction in electronic data collection|1|||
49022394|NCT03127137|157920706|FG001|Overall Study|Malfunction in electronic data collection|0|||
49022395|NCT03127137|157920705|FG000|Overall Study|Post procedure testing could not be obtained|0|||
49022396|NCT03127137|157920706|FG001|Overall Study|Post procedure testing could not be obtained|1|||
48981230|NCT00981292|157764240|FG003|Day 1|Protocol Violation|0|||
48981231|NCT00981292|157764241|FG004|Day 1|Protocol Violation|0|||
48981232|NCT00981292|157764242|FG005|Day 1|Protocol Violation|2|||
48981233|NCT00981292|157764237|FG000|Day 2|Protocol Violation|2|||
48981234|NCT00981292|157764238|FG001|Day 2|Protocol Violation|0|||
48981235|NCT00981292|157764239|FG002|Day 2|Protocol Violation|0|||
48981236|NCT00981292|157764240|FG003|Day 2|Protocol Violation|0|||
48981237|NCT00981292|157764241|FG004|Day 2|Protocol Violation|0|||
48981238|NCT00981292|157764242|FG005|Day 2|Protocol Violation|0|||
48981239|NCT00981292|157764237|FG000|Day 3|Protocol Violation|0|||
48981240|NCT00981292|157764238|FG001|Day 3|Protocol Violation|0|||
48685467|NCT02446717|156699213|FG000|Overall Study|Adverse Event|0|||
48685468|NCT02446717|156699214|FG001|Overall Study|Adverse Event|0|||
48685469|NCT02446717|156699215|FG002|Overall Study|Adverse Event|1|||
49022397|NCT02433678|157920708|FG000|Overall Study|Lost to Follow-up|1|||
49022398|NCT02433678|157920709|FG001|Overall Study|Lost to Follow-up|2|||
49022399|NCT03787680|157920717|FG000|Overall Study|Physician Decision|2|||
49022400|NCT03787680|157920718|FG001|Overall Study|Physician Decision|3|||
49022401|NCT03787680|157920717|FG000|Overall Study|Adverse Event|7|||
49022402|NCT03787680|157920718|FG001|Overall Study|Adverse Event|3|||
49022403|NCT03787680|157920717|FG000|Overall Study|Withdrawal by Subject|2|||
49022404|NCT03787680|157920718|FG001|Overall Study|Withdrawal by Subject|1|||
48685470|NCT02446717|156699216|FG003|Overall Study|Adverse Event|0|||
48685471|NCT02446717|156699217|FG004|Overall Study|Adverse Event|0|||
48685472|NCT02446717|156699213|FG000|Overall Study|Lost to Follow-up|0|||
48685473|NCT02446717|156699214|FG001|Overall Study|Lost to Follow-up|1|||
48685474|NCT02446717|156699215|FG002|Overall Study|Lost to Follow-up|1|||
48685475|NCT02446717|156699216|FG003|Overall Study|Lost to Follow-up|0|||
48685476|NCT02446717|156699217|FG004|Overall Study|Lost to Follow-up|1|||
48685477|NCT02446717|156699213|FG000|Overall Study|Withdrew consent|0|||
48685478|NCT02446717|156699214|FG001|Overall Study|Withdrew consent|0|||
48685479|NCT02446717|156699215|FG002|Overall Study|Withdrew consent|0|||
48685480|NCT02446717|156699216|FG003|Overall Study|Withdrew consent|1|||
48685481|NCT02446717|156699217|FG004|Overall Study|Withdrew consent|0|||
48685482|NCT00279916|156699223|FG000|Overall Study|Withdrawal by Subject|4|||
48685483|NCT00279916|156699224|FG001|Overall Study|Withdrawal by Subject|3|||
48685484|NCT00279916|156699223|FG000|Overall Study|Lost to Follow-up|3|||
48685485|NCT00279916|156699224|FG001|Overall Study|Lost to Follow-up|2|||
48685486|NCT01774799|156699227|FG000|Overall Study|Lost to Follow-up|1|||
48685487|NCT01774799|156699228|FG001|Overall Study|Lost to Follow-up|1|||
48685488|NCT01774799|156699229|FG002|Overall Study|Lost to Follow-up|0|||
48685489|NCT01774799|156699230|FG003|Overall Study|Lost to Follow-up|0|||
49022405|NCT00995410|157920721|FG000|Overall Study|Adverse Event|51|||
49022406|NCT00995410|157920721|FG000|Overall Study|Withdrawal by Subject|7|||
49022407|NCT00995410|157920721|FG000|Overall Study|Lost to Follow-up|2|||
49022408|NCT00995410|157920721|FG000|Overall Study|Misc|28|||
48685490|NCT04089761|156699231|FG000|"Run In Phase"|Not eligible to proceed to the treatment phase|14|||
48685491|NCT04089761|156699231|FG000|"Run In Phase"|Lost to Follow-up|1|||
48685492|NCT04089761|156699231|FG000|"Treatment Phase"|No evaluable data|5|||
48685493|NCT04089761|156699231|FG000|"Treatment Phase"|Lost to Follow-up|1|||
48685494|NCT00556894|156699236|FG000|Overall Study|Adverse Event|2|||
48685495|NCT00556894|156699237|FG001|Overall Study|Adverse Event|3|||
48685496|NCT00556894|156699238|FG002|Overall Study|Adverse Event|3|||
48685497|NCT00556894|156699236|FG000|Overall Study|Death|1|||
48685498|NCT00556894|156699237|FG001|Overall Study|Death|0|||
48685499|NCT00556894|156699238|FG002|Overall Study|Death|0|||
48685500|NCT00556894|156699236|FG000|Overall Study|regulatory decision in Bulgaria|10|||
48685501|NCT00556894|156699237|FG001|Overall Study|regulatory decision in Bulgaria|14|||
48981241|NCT00981292|157764239|FG002|Day 3|Protocol Violation|0|||
48981242|NCT00981292|157764240|FG003|Day 3|Protocol Violation|0|||
49022409|NCT01700621|157920722|FG000|Analyzed for Immunogenicity|Lost to Follow-up|7|||
49022410|NCT01700621|157920723|FG001|Analyzed for Immunogenicity|Lost to Follow-up|4|||
49022411|NCT01700621|157920722|FG000|Analyzed for Immunogenicity|Protocol Violation|5|||
49022412|NCT01700621|157920723|FG001|Analyzed for Immunogenicity|Protocol Violation|1|||
49022413|NCT01700621|157920722|FG000|Analyzed for Immunogenicity|Baseline measles measure high|1|||
49022414|NCT01700621|157920723|FG001|Analyzed for Immunogenicity|Baseline measles measure high|2|||
49022415|NCT00543309|157920724|FG000|Overall Study|Physician Decision|0|||
49022416|NCT00543309|157920725|FG001|Overall Study|Physician Decision|1|||
49022417|NCT00543309|157920726|FG002|Overall Study|Physician Decision|0|||
49022418|NCT03552757|157920733|FG000|Overall Study|Withdrawal by Subject|10|||
49022419|NCT03552757|157920734|FG001|Overall Study|Withdrawal by Subject|5|||
49022420|NCT03552757|157920735|FG002|Overall Study|Withdrawal by Subject|12|||
49022421|NCT03552757|157920733|FG000|Overall Study|Lost to Follow-up|2|||
49022422|NCT03552757|157920734|FG001|Overall Study|Lost to Follow-up|7|||
49022423|NCT03552757|157920735|FG002|Overall Study|Lost to Follow-up|7|||
48685502|NCT00556894|156699238|FG002|Overall Study|regulatory decision in Bulgaria|13|||
48763224|NCT03662542|156983809|FG003|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|4|||
48763225|NCT03662542|156983810|FG004|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
48763226|NCT03662542|156983811|FG005|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
48763227|NCT03662542|156983812|FG006|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
48763228|NCT03662542|156983813|FG007|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
48763229|NCT03662542|156983814|FG008|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
48763230|NCT03662542|156983806|FG000|Monotherapy Phase (Week 12-Week 38)|Other|0|||
48763231|NCT03662542|156983807|FG001|Monotherapy Phase (Week 12-Week 38)|Other|0|||
48763232|NCT03662542|156983808|FG002|Monotherapy Phase (Week 12-Week 38)|Other|0|||
48763233|NCT03662542|156983809|FG003|Monotherapy Phase (Week 12-Week 38)|Other|0|||
48763234|NCT03662542|156983810|FG004|Monotherapy Phase (Week 12-Week 38)|Other|1|||
48875231|NCT01496365|157381600|FG006|Overall Study|Withdrawal by Subject|1|||
48875232|NCT01496365|157381594|FG000|Overall Study|Protocol Violation|2|||
48685503|NCT00556894|156699236|FG000|Overall Study|Change in therapy|2|||
48685504|NCT00556894|156699237|FG001|Overall Study|Change in therapy|1|||
48685505|NCT00556894|156699238|FG002|Overall Study|Change in therapy|2|||
48685506|NCT00556894|156699236|FG000|Overall Study|Withdrawal by Subject|1|||
48685507|NCT00556894|156699237|FG001|Overall Study|Withdrawal by Subject|1|||
48685508|NCT00556894|156699238|FG002|Overall Study|Withdrawal by Subject|1|||
48685509|NCT04417361|156699239|FG000|Overall Study|Withdrawal by Subject|1|||
48685510|NCT04417361|156699240|FG001|Overall Study|Withdrawal by Subject|0|||
48685511|NCT04417361|156699239|FG000|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|0|||
48685512|NCT04417361|156699240|FG001|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|1|||
48685513|NCT01236521|156699246|FG000|Overall Study|Withdrawal by Subject|12|||
48685514|NCT01236521|156699247|FG001|Overall Study|Withdrawal by Subject|17|||
48685515|NCT01236521|156699246|FG000|Overall Study|Death|2|||
48685516|NCT01236521|156699247|FG001|Overall Study|Death|1|||
48685517|NCT01236521|156699246|FG000|Overall Study|Lost to Follow-up|9|||
48685518|NCT01236521|156699247|FG001|Overall Study|Lost to Follow-up|7|||
48685519|NCT04531241|156699248|FG000|Period 1|Withdrawal by Subject|2|||
48685520|NCT04531241|156699249|FG001|Period 1|Withdrawal by Subject|0|||
48685521|NCT04531241|156699248|FG000|Period 1|Dispesed incorrect lens power|1|||
48685522|NCT04531241|156699249|FG001|Period 1|Dispesed incorrect lens power|0|||
48685523|NCT04531241|156699248|FG000|Period 1|Protocol Violation|1|||
48685524|NCT04531241|156699249|FG001|Period 1|Protocol Violation|0|||
48685525|NCT04531241|156699248|FG000|Period 1|No longer eligible|0|||
48685526|NCT04531241|156699249|FG001|Period 1|No longer eligible|1|||
48685527|NCT04531241|156699248|FG000|Period 1|Lens Discomfort|0|||
48685528|NCT04531241|156699249|FG001|Period 1|Lens Discomfort|1|||
48685529|NCT04531241|156699248|FG000|Period 2|Covid-19 Related|1|||
48685530|NCT04531241|156699249|FG001|Period 2|Covid-19 Related|1|||
48685531|NCT04332107|156699257|FG000|Day 3|Lost to Follow-up|23|||
48685532|NCT04332107|156699258|FG001|Day 3|Lost to Follow-up|14|||
48685533|NCT04332107|156699257|FG000|Day 3|Missing outcome data|3|||
49022424|NCT03552757|157920733|FG000|Overall Study|Death|1|||
49022425|NCT03552757|157920734|FG001|Overall Study|Death|1|||
49022426|NCT03552757|157920735|FG002|Overall Study|Death|1|||
49022427|NCT00449150|157920736|FG000|Overall Study|Adverse Event|11|||
49022428|NCT00449150|157920737|FG001|Overall Study|Adverse Event|18|||
48685534|NCT04332107|156699258|FG001|Day 3|Missing outcome data|6|||
48685535|NCT04332107|156699257|FG000|Day 14|Lost to Follow-up|13|||
48685536|NCT04332107|156699258|FG001|Day 14|Lost to Follow-up|4|||
48685537|NCT04332107|156699257|FG000|Day 14|Missing outcome data|4|||
48685538|NCT04332107|156699258|FG001|Day 14|Missing outcome data|4|||
48685539|NCT04332107|156699257|FG000|Day 21|Lost to Follow-up|10|||
48685540|NCT04332107|156699258|FG001|Day 21|Lost to Follow-up|2|||
48685541|NCT03734679|156699261|FG000|Overall Study|Missed Visit|1|||
48763235|NCT03662542|156983811|FG005|Monotherapy Phase (Week 12-Week 38)|Other|2|||
48763236|NCT03662542|156983812|FG006|Monotherapy Phase (Week 12-Week 38)|Other|0|||
48763237|NCT03662542|156983813|FG007|Monotherapy Phase (Week 12-Week 38)|Other|0|||
48763238|NCT03662542|156983814|FG008|Monotherapy Phase (Week 12-Week 38)|Other|0|||
49022429|NCT00449150|157920738|FG002|Overall Study|Adverse Event|9|||
48685542|NCT00479713|156699264|FG000|Overall Study|Adverse Event|8|||
48685543|NCT00479713|156699265|FG001|Overall Study|Adverse Event|6|||
48685544|NCT00479713|156699264|FG000|Overall Study|Death|1|||
48685545|NCT00479713|156699265|FG001|Overall Study|Death|0|||
48685546|NCT00479713|156699264|FG000|Overall Study|Lost to Follow-up|0|||
49022430|NCT00449150|157920736|FG000|Overall Study|Lack of Efficacy|1|||
49022431|NCT00449150|157920737|FG001|Overall Study|Lack of Efficacy|2|||
49022432|NCT00449150|157920738|FG002|Overall Study|Lack of Efficacy|2|||
49022433|NCT00449150|157920736|FG000|Overall Study|Other|16|||
49022434|NCT00449150|157920737|FG001|Overall Study|Other|13|||
49022435|NCT00449150|157920738|FG002|Overall Study|Other|14|||
49022436|NCT00449150|157920736|FG000|Overall Study|Withdrawal by Subject|17|||
49022437|NCT00449150|157920737|FG001|Overall Study|Withdrawal by Subject|18|||
49022438|NCT00449150|157920738|FG002|Overall Study|Withdrawal by Subject|21|||
49022439|NCT00449150|157920736|FG000|Overall Study|Protocol Violation|1|||
49022440|NCT00449150|157920737|FG001|Overall Study|Protocol Violation|2|||
49022441|NCT00449150|157920738|FG002|Overall Study|Protocol Violation|1|||
49022442|NCT04652453|157920739|FG000|Overall Study|Death|8|||
49022443|NCT04652453|157920740|FG001|Overall Study|Death|2|||
49022444|NCT04652453|157920741|FG002|Overall Study|Death|0|||
49022445|NCT04652453|157920739|FG000|Overall Study|Hospice|5|||
49022446|NCT04652453|157920740|FG001|Overall Study|Hospice|5|||
49022447|NCT04652453|157920741|FG002|Overall Study|Hospice|0|||
49022448|NCT04652453|157920739|FG000|Overall Study|Withdrawal by Subject|2|||
49022449|NCT04652453|157920740|FG001|Overall Study|Withdrawal by Subject|0|||
49022450|NCT04652453|157920741|FG002|Overall Study|Withdrawal by Subject|0|||
49022451|NCT00984295|157920751|FG000|Overall Study|Lost to Follow-up|31|||
49022452|NCT00984295|157920752|FG001|Overall Study|Lost to Follow-up|12|||
49022453|NCT00984295|157920753|FG002|Overall Study|Lost to Follow-up|13|||
49022454|NCT00984295|157920751|FG000|Overall Study|Protocol Violation|2|||
49022455|NCT00984295|157920752|FG001|Overall Study|Protocol Violation|1|||
49022456|NCT00984295|157920753|FG002|Overall Study|Protocol Violation|4|||
49022457|NCT00984295|157920751|FG000|Overall Study|Withdrawal by Subject|18|||
49022458|NCT00984295|157920752|FG001|Overall Study|Withdrawal by Subject|9|||
49022459|NCT00984295|157920753|FG002|Overall Study|Withdrawal by Subject|12|||
49022460|NCT00984295|157920751|FG000|Overall Study|CAE - discontinued test vaccine|0|||
49022461|NCT00984295|157920752|FG001|Overall Study|CAE - discontinued test vaccine|1|||
49022462|NCT00984295|157920753|FG002|Overall Study|CAE - discontinued test vaccine|3|||
49022463|NCT00984295|157920751|FG000|Overall Study|Missed one or more blood samplings|3|||
49022464|NCT00984295|157920752|FG001|Overall Study|Missed one or more blood samplings|7|||
49022465|NCT00984295|157920753|FG002|Overall Study|Missed one or more blood samplings|2|||
49022466|NCT00984295|157920751|FG000|Overall Study|Incomplete safety follow-up|11|||
49022467|NCT00984295|157920752|FG001|Overall Study|Incomplete safety follow-up|2|||
49022468|NCT00984295|157920753|FG002|Overall Study|Incomplete safety follow-up|3|||
49022469|NCT00770510|157920754|FG000|Overall Study|Lost to Follow-up|2|||
49022470|NCT00770510|157920754|FG000|Overall Study|Pregnancy|1|||
49022471|NCT00770510|157920754|FG000|Overall Study|Withdrawal by Subject|2|||
49022472|NCT00881621|157920756|FG000|Overall Study|Physician Decision|34|||
49022473|NCT02636907|157920761|FG000|Autoinjector Assessment Period|Adverse Event|2|||
49022474|NCT02636907|157920761|FG000|Autoinjector Assessment Period|Withdrawal by Subject|2|||
49022475|NCT02636907|157920761|FG000|Extension Phase|Adverse Event|2|||
49022476|NCT02636907|157920761|FG000|Extension Phase|Withdrawal by Subject|4|||
49022477|NCT02636907|157920761|FG000|Extension Phase|Physician Decision|1|||
49022478|NCT02636907|157920761|FG000|Extension Phase|Lost to Follow-up|2|||
49022479|NCT02636907|157920761|FG000|Extension Phase|Lack of Efficacy|1|||
49022480|NCT00727571|157920762|FG000|Overall Study|Ineligibility determined|1|||
49022481|NCT00727571|157920763|FG001|Overall Study|Ineligibility determined|1|||
49022482|NCT00727571|157920764|FG002|Overall Study|Ineligibility determined|1|||
49022483|NCT00727571|157920765|FG003|Overall Study|Ineligibility determined|0|||
49022484|NCT00727571|157920762|FG000|Overall Study|Death|0|||
49022485|NCT00727571|157920763|FG001|Overall Study|Death|19|||
48685547|NCT00479713|156699265|FG001|Overall Study|Lost to Follow-up|1|||
48685548|NCT00479713|156699264|FG000|Overall Study|Protocol Violation|0|||
49022486|NCT00727571|157920764|FG002|Overall Study|Death|5|||
49022487|NCT00727571|157920765|FG003|Overall Study|Death|1|||
49022488|NCT00727571|157920762|FG000|Overall Study|Physician Decision|0|||
49022489|NCT00727571|157920763|FG001|Overall Study|Physician Decision|5|||
49022490|NCT00727571|157920764|FG002|Overall Study|Physician Decision|0|||
48685549|NCT00479713|156699265|FG001|Overall Study|Protocol Violation|1|||
48685550|NCT00479713|156699264|FG000|Overall Study|Withdrawal by Subject|4|||
49022491|NCT00727571|157920765|FG003|Overall Study|Physician Decision|0|||
49022492|NCT00727571|157920762|FG000|Overall Study|Withdrawal by Subject|0|||
49022493|NCT00727571|157920763|FG001|Overall Study|Withdrawal by Subject|10|||
49022494|NCT00727571|157920764|FG002|Overall Study|Withdrawal by Subject|11|||
49022495|NCT00727571|157920765|FG003|Overall Study|Withdrawal by Subject|0|||
49022496|NCT00727571|157920762|FG000|Overall Study|Subject Non Compliance|0|||
49022497|NCT00727571|157920763|FG001|Overall Study|Subject Non Compliance|6|||
49022498|NCT00727571|157920764|FG002|Overall Study|Subject Non Compliance|0|||
49022499|NCT00727571|157920765|FG003|Overall Study|Subject Non Compliance|4|||
49022500|NCT00727571|157920762|FG000|Overall Study|Dismissed from nursing home|0|||
49022501|NCT00727571|157920763|FG001|Overall Study|Dismissed from nursing home|9|||
49022502|NCT00727571|157920764|FG002|Overall Study|Dismissed from nursing home|5|||
49022503|NCT00727571|157920765|FG003|Overall Study|Dismissed from nursing home|0|||
49022504|NCT00727571|157920762|FG000|Overall Study|Hospitalization|0|||
49022505|NCT00727571|157920763|FG001|Overall Study|Hospitalization|1|||
49022506|NCT00727571|157920764|FG002|Overall Study|Hospitalization|0|||
49022507|NCT00727571|157920765|FG003|Overall Study|Hospitalization|1|||
49022508|NCT00727571|157920762|FG000|Overall Study|AE not leading to hospitalization|0|||
49022509|NCT00727571|157920763|FG001|Overall Study|AE not leading to hospitalization|0|||
49022510|NCT00727571|157920764|FG002|Overall Study|AE not leading to hospitalization|2|||
49022511|NCT00727571|157920765|FG003|Overall Study|AE not leading to hospitalization|0|||
49022512|NCT00727571|157920762|FG000|Overall Study|Other|0|||
49022513|NCT00727571|157920763|FG001|Overall Study|Other|4|||
49022514|NCT00727571|157920764|FG002|Overall Study|Other|6|||
49022515|NCT00727571|157920765|FG003|Overall Study|Other|0|||
49022516|NCT01706926|157920766|FG000|Overall Study|Lost to Follow-up|0|||
49022517|NCT01706926|157920767|FG001|Overall Study|Lost to Follow-up|0|||
49022518|NCT01706926|157920768|FG002|Overall Study|Lost to Follow-up|1|||
49022519|NCT01706926|157920769|FG003|Overall Study|Lost to Follow-up|0|||
49022520|NCT01706926|157920766|FG000|Overall Study|Withdrawal by Subject|2|||
49022521|NCT01706926|157920767|FG001|Overall Study|Withdrawal by Subject|0|||
49022522|NCT01706926|157920768|FG002|Overall Study|Withdrawal by Subject|1|||
49022523|NCT01706926|157920769|FG003|Overall Study|Withdrawal by Subject|2|||
49022524|NCT01706926|157920766|FG000|Overall Study|Other|4|||
49022525|NCT01706926|157920767|FG001|Overall Study|Other|4|||
49022526|NCT01706926|157920768|FG002|Overall Study|Other|4|||
49022527|NCT01706926|157920769|FG003|Overall Study|Other|3|||
49022528|NCT00762086|157920770|FG000|Overall Study|Adverse Event|2|||
49022529|NCT00762086|157920771|FG001|Overall Study|Adverse Event|0|||
49022530|NCT00762086|157920770|FG000|Overall Study|Lost to Follow-up|0|||
49022531|NCT00762086|157920771|FG001|Overall Study|Lost to Follow-up|2|||
49022532|NCT00762086|157920770|FG000|Overall Study|Non compliance|1|||
49022533|NCT00762086|157920771|FG001|Overall Study|Non compliance|0|||
49022534|NCT00762086|157920770|FG000|Overall Study|Withdrawal by Subject|2|||
49022535|NCT00762086|157920771|FG001|Overall Study|Withdrawal by Subject|2|||
49022536|NCT00762086|157920770|FG000|Overall Study|Ineligible to participate in the study|1|||
49022537|NCT00762086|157920771|FG001|Overall Study|Ineligible to participate in the study|0|||
49022538|NCT01029353|157920773|FG000|Overall Study|Lost to Follow-up|4|||
49022539|NCT01029353|157920774|FG001|Overall Study|Lost to Follow-up|5|||
49022540|NCT01029353|157920775|FG002|Overall Study|Lost to Follow-up|5|||
49022541|NCT01029353|157920776|FG003|Overall Study|Lost to Follow-up|4|||
49022542|NCT01029353|157920773|FG000|Overall Study|Consent Withdrawn|2|||
49022543|NCT01029353|157920774|FG001|Overall Study|Consent Withdrawn|0|||
49022544|NCT01029353|157920775|FG002|Overall Study|Consent Withdrawn|0|||
49022545|NCT01029353|157920776|FG003|Overall Study|Consent Withdrawn|0|||
48685551|NCT00479713|156699265|FG001|Overall Study|Withdrawal by Subject|1|||
48685552|NCT04661150|156699266|FG000|Overall Study|Ongoing in study|19|||
48685553|NCT04661150|156699267|FG001|Overall Study|Ongoing in study|20|||
48685554|NCT04661150|156699266|FG000|Overall Study|Refused surgery and for personal reasons.|0|||
48685555|NCT04661150|156699267|FG001|Overall Study|Refused surgery and for personal reasons.|1|||
48685556|NCT04661150|156699266|FG000|Overall Study|Death|2|||
48685557|NCT04661150|156699267|FG001|Overall Study|Death|0|||
48685558|NCT00191334|156699268|FG000|Overall Study|Adverse Event|4|||
48685559|NCT00191334|156699268|FG000|Overall Study|Disease Progression or Relapse|8|||
48685560|NCT00191334|156699268|FG000|Overall Study|Physician Decision|1|||
48685561|NCT00191334|156699268|FG000|Overall Study|Withdrawal by Subject|4|||
48685562|NCT02257528|156699271|FG000|Overall Study|Never received study treatment|1|||
48685563|NCT01871519|156699281|FG000|Overall Study|Death|26|||
48685564|NCT01871519|156699281|FG000|Overall Study|Lost to Follow-up|15|||
48685565|NCT01871519|156699281|FG000|Overall Study|Withdrawal by Subject|49|||
49022546|NCT01029353|157920773|FG000|Overall Study|Primary Outcome Indeterminate|1|||
49022547|NCT01029353|157920774|FG001|Overall Study|Primary Outcome Indeterminate|3|||
49022548|NCT01029353|157920775|FG002|Overall Study|Primary Outcome Indeterminate|2|||
49022549|NCT01029353|157920776|FG003|Overall Study|Primary Outcome Indeterminate|0|||
49022550|NCT01287013|157920777|FG000|Overall Study|Non-evaluable|3|||
49022551|NCT01287013|157920778|FG001|Overall Study|Non-evaluable|5|||
49022552|NCT01287013|157920779|FG002|Overall Study|Non-evaluable|21|||
49022553|NCT03830164|157920780|FG000|Overall Study|Adverse Event|0|||
49022554|NCT03830164|157920781|FG001|Overall Study|Adverse Event|2|||
49022555|NCT03830164|157920782|FG002|Overall Study|Adverse Event|0|||
49022556|NCT03830164|157920780|FG000|Overall Study|Lack of Efficacy|1|||
48685566|NCT02611817|156700445|FG000|Open-label Induction Phase|Reason not Specified|9|||
48685567|NCT02611817|156700446|FG001|Open-label Induction Phase|Reason not Specified|0|||
48685568|NCT02611817|156700447|FG002|Open-label Induction Phase|Reason not Specified|0|||
48685569|NCT02611817|156700445|FG000|Open-label Induction Phase|Lack of Efficacy|8|||
49022557|NCT03830164|157920781|FG001|Overall Study|Lack of Efficacy|5|||
49022558|NCT03830164|157920782|FG002|Overall Study|Lack of Efficacy|0|||
48685570|NCT02611817|156700446|FG001|Open-label Induction Phase|Lack of Efficacy|0|||
48685571|NCT02611817|156700447|FG002|Open-label Induction Phase|Lack of Efficacy|0|||
48685572|NCT02611817|156700445|FG000|Open-label Induction Phase|Pregnancy|1|||
48685573|NCT02611817|156700446|FG001|Open-label Induction Phase|Pregnancy|0|||
48685574|NCT02611817|156700447|FG002|Open-label Induction Phase|Pregnancy|0|||
48685575|NCT02611817|156700445|FG000|Open-label Induction Phase|Withdrawal by Subject|9|||
49022559|NCT03830164|157920780|FG000|Overall Study|Lost to Follow-up|0|||
49022560|NCT03830164|157920781|FG001|Overall Study|Lost to Follow-up|1|||
49022561|NCT03830164|157920782|FG002|Overall Study|Lost to Follow-up|0|||
48685576|NCT02611817|156700446|FG001|Open-label Induction Phase|Withdrawal by Subject|0|||
48685577|NCT02611817|156700447|FG002|Open-label Induction Phase|Withdrawal by Subject|0|||
48685578|NCT02611817|156700445|FG000|Open-label Induction Phase|Lost to Follow-up|2|||
48685579|NCT02611817|156700446|FG001|Open-label Induction Phase|Lost to Follow-up|0|||
48685580|NCT02611817|156700447|FG002|Open-label Induction Phase|Lost to Follow-up|0|||
48685581|NCT02611817|156700445|FG000|Open-label Induction Phase|Protocol Violation|5|||
48685582|NCT02611817|156700446|FG001|Open-label Induction Phase|Protocol Violation|0|||
48685583|NCT02611817|156700447|FG002|Open-label Induction Phase|Protocol Violation|0|||
48685584|NCT02611817|156700445|FG000|Open-label Induction Phase|Adverse Event|16|||
48685585|NCT02611817|156700446|FG001|Open-label Induction Phase|Adverse Event|0|||
48685586|NCT02611817|156700447|FG002|Open-label Induction Phase|Adverse Event|0|||
48685587|NCT02611817|156700445|FG000|Double-blind Maintenance Phase|Adverse Event|0|||
48685588|NCT02611817|156700446|FG001|Double-blind Maintenance Phase|Adverse Event|12|||
48685589|NCT02611817|156700447|FG002|Double-blind Maintenance Phase|Adverse Event|11|||
48685590|NCT02611817|156700445|FG000|Double-blind Maintenance Phase|Randomized but not Treated|0|||
48685591|NCT02611817|156700446|FG001|Double-blind Maintenance Phase|Randomized but not Treated|1|||
48685592|NCT02611817|156700447|FG002|Double-blind Maintenance Phase|Randomized but not Treated|0|||
48685593|NCT02611817|156700445|FG000|Double-blind Maintenance Phase|Reason not Specified|0|||
48685594|NCT02611817|156700446|FG001|Double-blind Maintenance Phase|Reason not Specified|1|||
48685595|NCT02611817|156700447|FG002|Double-blind Maintenance Phase|Reason not Specified|2|||
48685596|NCT02611817|156700445|FG000|Double-blind Maintenance Phase|Lack of Efficacy|0|||
48685597|NCT02611817|156700446|FG001|Double-blind Maintenance Phase|Lack of Efficacy|43|||
48685598|NCT02611817|156700447|FG002|Double-blind Maintenance Phase|Lack of Efficacy|78|||
48685599|NCT02611817|156700445|FG000|Double-blind Maintenance Phase|Pregnancy|0|||
48685600|NCT02611817|156700446|FG001|Double-blind Maintenance Phase|Pregnancy|0|||
48685601|NCT02611817|156700447|FG002|Double-blind Maintenance Phase|Pregnancy|1|||
48685602|NCT02611817|156700445|FG000|Double-blind Maintenance Phase|Withdrawal by Subject|0|||
48685603|NCT02611817|156700446|FG001|Double-blind Maintenance Phase|Withdrawal by Subject|5|||
48685604|NCT02611817|156700447|FG002|Double-blind Maintenance Phase|Withdrawal by Subject|14|||
48685605|NCT02611817|156700445|FG000|Double-blind Maintenance Phase|Lost to Follow-up|0|||
48685606|NCT02611817|156700446|FG001|Double-blind Maintenance Phase|Lost to Follow-up|0|||
48685607|NCT02611817|156700447|FG002|Double-blind Maintenance Phase|Lost to Follow-up|1|||
48685608|NCT00584012|156700448|FG000|Overall Study|Withdrawal by Subject|1|||
48685609|NCT04050618|156700449|FG000|First Intervention|Withdrawal by Subject|2|||
48685610|NCT04050618|156700450|FG001|First Intervention|Withdrawal by Subject|0|||
48685611|NCT04050618|156700449|FG000|Second Intervention|Withdrawal by Subject|1|||
48685612|NCT04050618|156700450|FG001|Second Intervention|Withdrawal by Subject|0|||
48685613|NCT02229539|156700455|FG000|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
48685614|NCT02229539|156700456|FG001|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1|||
48685615|NCT02229539|156700457|FG002|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
48685616|NCT02229539|156700455|FG000|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
48685617|NCT02229539|156700456|FG001|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
48685618|NCT02229539|156700457|FG002|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1|||
48685619|NCT02229539|156700455|FG000|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
48685620|NCT02229539|156700456|FG001|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
48685621|NCT02229539|156700457|FG002|Cycle 1 (Treatment Per Protocol)|Medical Problems|1|||
48875233|NCT01496365|157381595|FG001|Overall Study|Protocol Violation|1|||
48685622|NCT02229539|156700455|FG000|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|3|||
48685623|NCT02229539|156700456|FG001|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|4|||
48685624|NCT02229539|156700457|FG002|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|1|||
48685625|NCT02229539|156700455|FG000|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
48685626|NCT02229539|156700456|FG001|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
48685627|NCT02229539|156700457|FG002|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6|||
48685628|NCT02229539|156700455|FG000|Cycle 2 (Optional Continuation Phase)|Adverse Event|2|||
48685629|NCT02229539|156700456|FG001|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
48685630|NCT02229539|156700457|FG002|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
49022562|NCT03830164|157920780|FG000|Overall Study|Withdrawal by Subject|1|||
48875234|NCT01496365|157381596|FG002|Overall Study|Protocol Violation|1|||
49022563|NCT03830164|157920781|FG001|Overall Study|Withdrawal by Subject|0|||
49022564|NCT03830164|157920782|FG002|Overall Study|Withdrawal by Subject|0|||
49022565|NCT04099888|157920783|FG000|Overall Study|Study terminated by sponsor|9|||
49022566|NCT04099888|157920784|FG001|Overall Study|Study terminated by sponsor|11|||
49022567|NCT04099888|157920783|FG000|Overall Study|Lost to Follow-up|1|||
49022568|NCT04099888|157920784|FG001|Overall Study|Lost to Follow-up|1|||
49022569|NCT04099888|157920783|FG000|Overall Study|Withdrawal by Subject|5|||
49022570|NCT04099888|157920784|FG001|Overall Study|Withdrawal by Subject|6|||
49022571|NCT04099888|157920783|FG000|Overall Study|Death|5|||
49022572|NCT04099888|157920784|FG001|Overall Study|Death|2|||
49022573|NCT04099888|157920783|FG000|Overall Study|Other|1|||
49022574|NCT04099888|157920784|FG001|Overall Study|Other|0|||
49022575|NCT04538170|157920787|FG000|Overall Study|Withdrawal by Subject|104|||
49022576|NCT04538170|157920788|FG001|Overall Study|Withdrawal by Subject|210|||
49022577|NCT01074554|157920789|FG000|Overall Study|Adverse Event|3|||
49022578|NCT01074554|157920790|FG001|Overall Study|Adverse Event|3|||
49022579|NCT01074554|157920789|FG000|Overall Study|Lost to Follow-up|0|||
49022580|NCT01074554|157920790|FG001|Overall Study|Lost to Follow-up|1|||
49022581|NCT00220337|157920791|FG000|Overall Study|Adverse Event|70|||
49022582|NCT00220337|157920791|FG000|Overall Study|Lack of Efficacy|17|||
49022583|NCT00220337|157920791|FG000|Overall Study|Withdrawal by Subject|68|||
49022584|NCT00220337|157920791|FG000|Overall Study|Protocol Violation|2|||
49022585|NCT00220337|157920791|FG000|Overall Study|Lost to Follow-up|5|||
49022586|NCT00220337|157920791|FG000|Overall Study|Other|12|||
49022587|NCT00220337|157920791|FG000|Overall Study|Unsatisfactory compliance|5|||
49022588|NCT01265784|157920792|FG000|Overall Study|Lost to Follow-up|5|||
49022589|NCT01265784|157920793|FG001|Overall Study|Lost to Follow-up|3|||
49022590|NCT01265784|157920794|FG002|Overall Study|Lost to Follow-up|2|||
49022591|NCT01265784|157920792|FG000|Overall Study|Withdrawal by Subject|0|||
49022592|NCT01265784|157920793|FG001|Overall Study|Withdrawal by Subject|5|||
49022593|NCT01265784|157920794|FG002|Overall Study|Withdrawal by Subject|0|||
49022594|NCT01265784|157920792|FG000|Overall Study|Physician Decision|1|||
49022595|NCT01265784|157920793|FG001|Overall Study|Physician Decision|0|||
49022596|NCT01265784|157920794|FG002|Overall Study|Physician Decision|1|||
49022597|NCT01265784|157920792|FG000|Overall Study|Adverse Event|1|||
49022598|NCT01265784|157920793|FG001|Overall Study|Adverse Event|0|||
49022599|NCT01265784|157920794|FG002|Overall Study|Adverse Event|0|||
49022600|NCT01265784|157920792|FG000|Overall Study|Death|3|||
49022601|NCT01265784|157920793|FG001|Overall Study|Death|0|||
49022602|NCT01265784|157920794|FG002|Overall Study|Death|0|||
49022603|NCT01265784|157920792|FG000|Overall Study|Protocol Violation|2|||
49022604|NCT01265784|157920793|FG001|Overall Study|Protocol Violation|0|||
49022605|NCT01265784|157920794|FG002|Overall Study|Protocol Violation|0|||
49022606|NCT01265784|157920792|FG000|Overall Study|Incorrectly Randomized|0|||
49022607|NCT01265784|157920793|FG001|Overall Study|Incorrectly Randomized|0|||
49022608|NCT01265784|157920794|FG002|Overall Study|Incorrectly Randomized|1|||
49022609|NCT04849988|157922565|FG000|Overall Study|Lack of Efficacy|3|||
49022610|NCT04849988|157922566|FG001|Overall Study|Lack of Efficacy|4|||
49022611|NCT04849988|157922567|FG002|Overall Study|Lack of Efficacy|1|||
49022612|NCT04849988|157922568|FG003|Overall Study|Lack of Efficacy|4|||
49022613|NCT04849988|157922565|FG000|Overall Study|Other reasons|1|||
49022614|NCT04849988|157922566|FG001|Overall Study|Other reasons|2|||
49022615|NCT04849988|157922567|FG002|Overall Study|Other reasons|2|||
49022616|NCT04849988|157922568|FG003|Overall Study|Other reasons|1|||
49022617|NCT02173704|157922580|FG000|Overall Study|Adverse Event|1|||
49022618|NCT02173704|157922581|FG001|Overall Study|Adverse Event|0|||
49022619|NCT02173704|157922580|FG000|Overall Study|Lost to Follow-up|1|||
49022620|NCT02173704|157922581|FG001|Overall Study|Lost to Follow-up|0|||
49022621|NCT02173704|157922580|FG000|Overall Study|Other|1|||
49022622|NCT02173704|157922581|FG001|Overall Study|Other|0|||
48685631|NCT02229539|156700455|FG000|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0|||
48685632|NCT02229539|156700456|FG001|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
48685633|NCT02229539|156700457|FG002|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
48685634|NCT02229539|156700455|FG000|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0|||
48685635|NCT02229539|156700456|FG001|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0|||
48875235|NCT01496365|157381597|FG003|Overall Study|Protocol Violation|0|||
49022623|NCT02173704|157922580|FG000|Overall Study|Protocol Violation|1|||
49022624|NCT02173704|157922581|FG001|Overall Study|Protocol Violation|0|||
49022625|NCT02173704|157922580|FG000|Overall Study|Withdrawal by Subject|9|||
49022626|NCT02173704|157922581|FG001|Overall Study|Withdrawal by Subject|4|||
49022627|NCT01717976|157922586|FG000|Overall Study|Protocol Violation|0|||
49022628|NCT01717976|157922587|FG001|Overall Study|Protocol Violation|1|||
49022629|NCT00048568|157922588|FG000|Double-Blind Period Days 1 to 169|Adverse Event|11|||
49022630|NCT00048568|157922589|FG001|Double-Blind Period Days 1 to 169|Adverse Event|3|||
49022631|NCT00048568|157922590|FG002|Double-Blind Period Days 1 to 169|Adverse Event|0|||
49022632|NCT00048568|157922588|FG000|Double-Blind Period Days 1 to 169|Lack of Efficacy|11|||
49022633|NCT00048568|157922589|FG001|Double-Blind Period Days 1 to 169|Lack of Efficacy|33|||
49022634|NCT00048568|157922590|FG002|Double-Blind Period Days 1 to 169|Lack of Efficacy|0|||
49022635|NCT00048568|157922588|FG000|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
49022636|NCT00048568|157922589|FG001|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
49022637|NCT00048568|157922590|FG002|Double-Blind Period Days 1 to 169|Lost to Follow-up|0|||
48685636|NCT02229539|156700457|FG002|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|3|||
48685637|NCT02229539|156700455|FG000|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|2|||
48685638|NCT02229539|156700456|FG001|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|1|||
48685639|NCT02229539|156700457|FG002|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|0|||
48685640|NCT00770809|156700458|FG000|Overall Study|Adverse Event|9|||
48685641|NCT00770809|156700459|FG001|Overall Study|Adverse Event|1|||
48685642|NCT00770809|156700460|FG002|Overall Study|Adverse Event|12|||
48685643|NCT00770809|156700458|FG000|Overall Study|Death|1|||
48685644|NCT00770809|156700459|FG001|Overall Study|Death|0|||
48685645|NCT00770809|156700460|FG002|Overall Study|Death|0|||
48685646|NCT00770809|156700458|FG000|Overall Study|Withdrawal by Subject|3|||
48685647|NCT00770809|156700459|FG001|Overall Study|Withdrawal by Subject|3|||
48685648|NCT00770809|156700460|FG002|Overall Study|Withdrawal by Subject|7|||
48685649|NCT00770809|156700458|FG000|Overall Study|Progression|2|||
48685650|NCT00770809|156700459|FG001|Overall Study|Progression|2|||
48685651|NCT00770809|156700460|FG002|Overall Study|Progression|0|||
48685652|NCT00770809|156700458|FG000|Overall Study|Complicating illness|0|||
48685653|NCT00770809|156700459|FG001|Overall Study|Complicating illness|0|||
48685654|NCT00770809|156700460|FG002|Overall Study|Complicating illness|1|||
48685655|NCT00770809|156700458|FG000|Overall Study|Other Medical Reasons|2|||
48685656|NCT00770809|156700459|FG001|Overall Study|Other Medical Reasons|4|||
48685657|NCT00770809|156700460|FG002|Overall Study|Other Medical Reasons|3|||
48685658|NCT02763644|156700473|FG000|Overall Study|Patient/guardian decision|1|||
48685659|NCT02763644|156700474|FG001|Overall Study|Patient/guardian decision|0|||
48685660|NCT02763644|156700473|FG000|Overall Study|Death|1|||
48685661|NCT02763644|156700474|FG001|Overall Study|Death|1|||
48685662|NCT02763644|156700473|FG000|Overall Study|Adverse Event|1|||
48685663|NCT02763644|156700474|FG001|Overall Study|Adverse Event|1|||
48685664|NCT00483405|156700479|FG000|Overall Study|Adverse Event|8|||
48685665|NCT00483405|156700479|FG000|Overall Study|Lack of Efficacy|14|||
48685666|NCT00483405|156700479|FG000|Overall Study|Death|3|||
48685667|NCT00483405|156700479|FG000|Overall Study|Withdrawal by Subject|2|||
48685668|NCT00483405|156700479|FG000|Overall Study|Other complicating disease|1|||
48685669|NCT05215314|156700490|FG000|Overall Study|Lost to Follow-up|2|||
48685670|NCT05215314|156700491|FG001|Overall Study|Lost to Follow-up|2|||
48685671|NCT05215314|156700490|FG000|Overall Study|Withdrawal by Subject|2|||
48685672|NCT05215314|156700491|FG001|Overall Study|Withdrawal by Subject|0|||
48685673|NCT05215314|156700490|FG000|Overall Study|Physician Decision|1|||
48685674|NCT05215314|156700491|FG001|Overall Study|Physician Decision|0|||
48981243|NCT00981292|157764241|FG004|Day 3|Protocol Violation|0|||
48981244|NCT00981292|157764242|FG005|Day 3|Protocol Violation|1|||
48981245|NCT03377452|157764247|FG000|Overall Study|Refused assessment|0|||
48981246|NCT03377452|157764248|FG001|Overall Study|Refused assessment|2|||
48981247|NCT03377452|157764247|FG000|Overall Study|Lost to Follow-up|5|||
48981248|NCT03377452|157764248|FG001|Overall Study|Lost to Follow-up|4|||
48981249|NCT00424099|157764249|FG000|Overall Study|Adverse Event|0|||
48981250|NCT00424099|157764250|FG001|Overall Study|Adverse Event|1|||
48685683|NCT00108862|156700494|FG000|Overall Study|Death|31|||
48685684|NCT00108862|156700495|FG001|Overall Study|Death|37|||
48685685|NCT00108862|156700494|FG000|Overall Study|Withdrawal by Subject|10|||
48685686|NCT00108862|156700495|FG001|Overall Study|Withdrawal by Subject|6|||
48685687|NCT00108862|156700494|FG000|Overall Study|Lost to Follow-up|27|||
48685688|NCT00108862|156700495|FG001|Overall Study|Lost to Follow-up|19|||
48685689|NCT01134614|156700496|FG000|Overall Study|Still on treatment as of March 2013|21|||
48685690|NCT01134614|156700497|FG001|Overall Study|Still on treatment as of March 2013|13|||
48685691|NCT01134614|156700496|FG000|Overall Study|Progressive disease|60|||
48685692|NCT01134614|156700497|FG001|Overall Study|Progressive disease|54|||
48685693|NCT01134614|156700496|FG000|Overall Study|Adverse Event|26|||
48685694|NCT01134614|156700497|FG001|Overall Study|Adverse Event|39|||
48685695|NCT01134614|156700496|FG000|Overall Study|Death|5|||
49022638|NCT00048568|157922588|FG000|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7|||
49022639|NCT00048568|157922589|FG001|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4|||
49022640|NCT00048568|157922590|FG002|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0|||
49022641|NCT00048568|157922588|FG000|Double-Blind Period Days 1 to 169|Unknown Reasons|2|||
49022642|NCT00048568|157922589|FG001|Double-Blind Period Days 1 to 169|Unknown Reasons|4|||
49022643|NCT00048568|157922590|FG002|Double-Blind Period Days 1 to 169|Unknown Reasons|0|||
48685696|NCT01134614|156700497|FG001|Overall Study|Death|8|||
48685697|NCT01134614|156700496|FG000|Overall Study|Withdrawal by Subject|3|||
48685698|NCT01134614|156700497|FG001|Overall Study|Withdrawal by Subject|2|||
48685699|NCT01134614|156700496|FG000|Overall Study|Alternative therapy|2|||
48685700|NCT01134614|156700497|FG001|Overall Study|Alternative therapy|0|||
49022644|NCT00048568|157922588|FG000|Double-Blind Period Days 170 to 365|Death|1|||
49022645|NCT00048568|157922589|FG001|Double-Blind Period Days 170 to 365|Death|1|||
48685701|NCT01134614|156700496|FG000|Overall Study|Complicating disease|2|||
48685702|NCT01134614|156700497|FG001|Overall Study|Complicating disease|1|||
48685703|NCT01134614|156700496|FG000|Overall Study|Physician's decision|0|||
48981251|NCT00424099|157764251|FG002|Overall Study|Adverse Event|1|||
49022646|NCT00048568|157922590|FG002|Double-Blind Period Days 170 to 365|Death|0|||
49022647|NCT00048568|157922588|FG000|Double-Blind Period Days 170 to 365|Adverse Event|7|||
49022648|NCT00048568|157922589|FG001|Double-Blind Period Days 170 to 365|Adverse Event|1|||
49022649|NCT00048568|157922590|FG002|Double-Blind Period Days 170 to 365|Adverse Event|0|||
49022650|NCT00048568|157922588|FG000|Double-Blind Period Days 170 to 365|Lack of Efficacy|2|||
49022651|NCT00048568|157922589|FG001|Double-Blind Period Days 170 to 365|Lack of Efficacy|7|||
49022652|NCT00048568|157922590|FG002|Double-Blind Period Days 170 to 365|Lack of Efficacy|0|||
49022653|NCT00048568|157922588|FG000|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3|||
49022654|NCT00048568|157922589|FG001|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1|||
49022655|NCT00048568|157922590|FG002|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0|||
49022656|NCT00048568|157922588|FG000|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
49022657|NCT00048568|157922589|FG001|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1|||
49022658|NCT00048568|157922590|FG002|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
49022659|NCT00048568|157922588|FG000|Double-Blind Period Days 170 to 365|Pregnancy|2|||
49022660|NCT00048568|157922589|FG001|Double-Blind Period Days 170 to 365|Pregnancy|0|||
49022661|NCT00048568|157922590|FG002|Double-Blind Period Days 170 to 365|Pregnancy|0|||
49022662|NCT00048568|157922588|FG000|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
49022663|NCT00048568|157922589|FG001|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
48685704|NCT01134614|156700497|FG001|Overall Study|Physician's decision|1|||
48685705|NCT01134614|156700496|FG000|Overall Study|Never started treatment|4|||
48685706|NCT01134614|156700497|FG001|Overall Study|Never started treatment|1|||
48685707|NCT01134614|156700496|FG000|Overall Study|Pt received tx not allowed on study|0|||
48685708|NCT01134614|156700497|FG001|Overall Study|Pt received tx not allowed on study|1|||
48685709|NCT01134614|156700496|FG000|Overall Study|Symptomatic deterioration|0|||
48685710|NCT01134614|156700497|FG001|Overall Study|Symptomatic deterioration|1|||
48685711|NCT01134614|156700496|FG000|Overall Study|Patient in hospice care|0|||
48685712|NCT01134614|156700497|FG001|Overall Study|Patient in hospice care|1|||
48685723|NCT04276233|156700502|FG000|Overall Study|Adverse Event|1|||
48685724|NCT04276233|156700502|FG000|Overall Study|Lost to Follow-up|3|||
48685725|NCT04276233|156700502|FG000|Overall Study|Physician Decision|4|||
48685726|NCT04276233|156700502|FG000|Overall Study|Withdrawal by Subject|2|||
48685727|NCT04456517|156700503|FG000|First Intervention:Baseline to 12 Weeks|Adverse Event|0|||
48685728|NCT04456517|156700504|FG001|First Intervention:Baseline to 12 Weeks|Adverse Event|1|||
48685729|NCT03106779|156700505|FG000|Overall Study|Lack of Efficacy|33|||
48685730|NCT03106779|156700506|FG001|Overall Study|Lack of Efficacy|24|||
48685731|NCT03106779|156700505|FG000|Overall Study|Adverse Event|8|||
48685732|NCT03106779|156700506|FG001|Overall Study|Adverse Event|16|||
48685733|NCT03106779|156700505|FG000|Overall Study|Physician Decision|10|||
48685734|NCT03106779|156700506|FG001|Overall Study|Physician Decision|6|||
48685735|NCT03106779|156700505|FG000|Overall Study|Patient/guardian decision|4|||
48685736|NCT03106779|156700506|FG001|Overall Study|Patient/guardian decision|3|||
48685737|NCT03106779|156700505|FG000|Overall Study|Progressive disease|1|||
48685738|NCT03106779|156700506|FG001|Overall Study|Progressive disease|3|||
48685739|NCT03106779|156700505|FG000|Overall Study|Lost to Follow-up|1|||
48685740|NCT03106779|156700506|FG001|Overall Study|Lost to Follow-up|2|||
48685741|NCT03106779|156700505|FG000|Overall Study|Death|1|||
48685742|NCT03106779|156700506|FG001|Overall Study|Death|0|||
48685743|NCT03106779|156700505|FG000|Overall Study|Protocol Violation|1|||
48685744|NCT03106779|156700506|FG001|Overall Study|Protocol Violation|0|||
48685745|NCT03106779|156700505|FG000|Overall Study|Not treated|1|||
48685746|NCT03106779|156700506|FG001|Overall Study|Not treated|0|||
48685747|NCT01575548|156700507|FG000|Overall Study|Adverse Event|15|||
48685748|NCT01575548|156700508|FG001|Overall Study|Adverse Event|2|||
48685749|NCT01575548|156700507|FG000|Overall Study|Disease progression|12|||
48685750|NCT01575548|156700508|FG001|Overall Study|Disease progression|25|||
48685751|NCT01575548|156700507|FG000|Overall Study|Death|1|||
48685752|NCT01575548|156700508|FG001|Overall Study|Death|0|||
48685753|NCT01575548|156700507|FG000|Overall Study|Other complicating disease|1|||
48685754|NCT01575548|156700508|FG001|Overall Study|Other complicating disease|0|||
48685755|NCT01575548|156700507|FG000|Overall Study|Withdrawal by Subject|7|||
48685756|NCT01575548|156700508|FG001|Overall Study|Withdrawal by Subject|3|||
48685757|NCT01575548|156700507|FG000|Overall Study|Noncompliance|1|||
48685758|NCT01575548|156700508|FG001|Overall Study|Noncompliance|0|||
48685759|NCT01575548|156700507|FG000|Overall Study|Anticipated surgery|0|||
48685760|NCT01575548|156700508|FG001|Overall Study|Anticipated surgery|1|||
48875236|NCT01496365|157381598|FG004|Overall Study|Protocol Violation|0|||
48875237|NCT01496365|157381599|FG005|Overall Study|Protocol Violation|1|||
48875238|NCT01496365|157381600|FG006|Overall Study|Protocol Violation|0|||
48875239|NCT01496365|157381594|FG000|Overall Study|Lack of Efficacy|1|||
48875240|NCT01496365|157381595|FG001|Overall Study|Lack of Efficacy|0|||
48875241|NCT01496365|157381596|FG002|Overall Study|Lack of Efficacy|0|||
48875242|NCT01496365|157381597|FG003|Overall Study|Lack of Efficacy|0|||
48875243|NCT01496365|157381598|FG004|Overall Study|Lack of Efficacy|0|||
48875244|NCT01496365|157381599|FG005|Overall Study|Lack of Efficacy|1|||
48875245|NCT01496365|157381600|FG006|Overall Study|Lack of Efficacy|0|||
48685761|NCT01575548|156700507|FG000|Overall Study|Never started protocol therapy|3|||
49022664|NCT00048568|157922590|FG002|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0|||
49022665|NCT00048568|157922588|FG000|Open-Label Period|Death|0|||
49022666|NCT00048568|157922589|FG001|Open-Label Period|Death|0|||
49022667|NCT00048568|157922590|FG002|Open-Label Period|Death|13|||
49022668|NCT00048568|157922588|FG000|Open-Label Period|Adverse Event|0|||
49022669|NCT00048568|157922589|FG001|Open-Label Period|Adverse Event|0|||
49022670|NCT00048568|157922590|FG002|Open-Label Period|Adverse Event|49|||
49022671|NCT00048568|157922588|FG000|Open-Label Period|Lack of Efficacy|0|||
49022672|NCT00048568|157922589|FG001|Open-Label Period|Lack of Efficacy|0|||
49022673|NCT00048568|157922590|FG002|Open-Label Period|Lack of Efficacy|32|||
49022674|NCT00048568|157922588|FG000|Open-Label Period|Withdrawal by Subject|0|||
49022675|NCT00048568|157922589|FG001|Open-Label Period|Withdrawal by Subject|0|||
49022676|NCT00048568|157922590|FG002|Open-Label Period|Withdrawal by Subject|26|||
49022677|NCT00048568|157922588|FG000|Open-Label Period|Pregnancy|0|||
49022678|NCT00048568|157922589|FG001|Open-Label Period|Pregnancy|0|||
49022679|NCT00048568|157922590|FG002|Open-Label Period|Pregnancy|5|||
49022680|NCT00048568|157922588|FG000|Open-Label Period|No Longer Met Study Criteria|0|||
49022681|NCT00048568|157922589|FG001|Open-Label Period|No Longer Met Study Criteria|0|||
48685762|NCT01575548|156700508|FG001|Overall Study|Never started protocol therapy|2|||
48685763|NCT01708954|156700509|FG000|Step 1|Disease progression|26|||
49022682|NCT00048568|157922590|FG002|Open-Label Period|No Longer Met Study Criteria|2|||
49022683|NCT00048568|157922588|FG000|Open-Label Period|Administrative Decision By Sponsor|0|||
49022684|NCT00048568|157922589|FG001|Open-Label Period|Administrative Decision By Sponsor|0|||
49022685|NCT00048568|157922590|FG002|Open-Label Period|Administrative Decision By Sponsor|1|||
49022686|NCT00048568|157922588|FG000|Open-Label Period|Unknown Reasons|0|||
49022687|NCT00048568|157922589|FG001|Open-Label Period|Unknown Reasons|0|||
49022688|NCT00048568|157922590|FG002|Open-Label Period|Unknown Reasons|25|||
49022689|NCT00048568|157922588|FG000|Open-Label Period|Lost to Follow-up|0|||
49022690|NCT00048568|157922589|FG001|Open-Label Period|Lost to Follow-up|0|||
49022691|NCT00048568|157922590|FG002|Open-Label Period|Lost to Follow-up|7|||
49022692|NCT00720096|157922591|FG000|Overall Study|Withdrawal by Subject|0|||
49022693|NCT00720096|157922592|FG001|Overall Study|Withdrawal by Subject|2|||
49022694|NCT00001849|157922594|FG000|Overall Study|Death|4|||
49022695|NCT00001849|157922594|FG000|Overall Study|Lost to Follow-up|2|||
49022696|NCT00001849|157922594|FG000|Overall Study|Withdrawal by Subject|2|||
49022697|NCT00001849|157922594|FG000|Overall Study|tumor remained occult|6|||
49022698|NCT00442936|157922595|FG000|Overall Study|Protocol Violation|1|||
49022699|NCT00442936|157922596|FG001|Overall Study|Protocol Violation|0|||
49022700|NCT00442936|157922597|FG002|Overall Study|Protocol Violation|1|||
49022701|NCT00442936|157922598|FG003|Overall Study|Protocol Violation|1|||
49022702|NCT02319148|157922600|FG000|Second Intervention Period|Adverse event (AE) related to study drug|0|||
49022703|NCT02319148|157922601|FG001|Second Intervention Period|Adverse event (AE) related to study drug|0|||
49022704|NCT02319148|157922602|FG002|Second Intervention Period|Adverse event (AE) related to study drug|1|||
49022705|NCT02319148|157922603|FG003|Second Intervention Period|Adverse event (AE) related to study drug|1|||
48685764|NCT01708954|156700510|FG001|Step 1|Disease progression|17|||
48685765|NCT01708954|156700511|FG002|Step 1|Disease progression|14|||
48685766|NCT01708954|156700509|FG000|Step 1|Adverse Event|3|||
48685767|NCT01708954|156700510|FG001|Step 1|Adverse Event|11|||
48685768|NCT01708954|156700511|FG002|Step 1|Adverse Event|13|||
48685769|NCT01708954|156700509|FG000|Step 1|Death|3|||
48685770|NCT01708954|156700510|FG001|Step 1|Death|2|||
48685771|NCT01708954|156700511|FG002|Step 1|Death|3|||
48685772|NCT01708954|156700509|FG000|Step 1|Withdrawal by Subject|2|||
48685773|NCT01708954|156700510|FG001|Step 1|Withdrawal by Subject|5|||
48685774|NCT01708954|156700511|FG002|Step 1|Withdrawal by Subject|3|||
48685775|NCT01708954|156700509|FG000|Step 1|Other complicating disease|0|||
48685776|NCT01708954|156700510|FG001|Step 1|Other complicating disease|2|||
48685777|NCT01708954|156700511|FG002|Step 1|Other complicating disease|0|||
48685778|NCT01708954|156700509|FG000|Step 1|Crossed over to Step 2|2|||
48685779|NCT01708954|156700510|FG001|Step 1|Crossed over to Step 2|0|||
48685780|NCT01708954|156700511|FG002|Step 1|Crossed over to Step 2|0|||
48685781|NCT01708954|156700509|FG000|Step 1|Symptomatic deterioration|1|||
48685782|NCT01708954|156700510|FG001|Step 1|Symptomatic deterioration|0|||
48685783|NCT01708954|156700511|FG002|Step 1|Symptomatic deterioration|1|||
48685784|NCT01708954|156700509|FG000|Step 1|Off-treatment reason not submitted|1|||
49022706|NCT02319148|157922600|FG000|Second Intervention Period|No longer willing to participate|0|||
49022707|NCT02319148|157922601|FG001|Second Intervention Period|No longer willing to participate|1|||
49022708|NCT02319148|157922602|FG002|Second Intervention Period|No longer willing to participate|0|||
49022709|NCT02319148|157922603|FG003|Second Intervention Period|No longer willing to participate|0|||
49022710|NCT02319148|157922600|FG000|Second Intervention Period|Other|0|||
48685785|NCT01708954|156700510|FG001|Step 1|Off-treatment reason not submitted|1|||
48685786|NCT01708954|156700511|FG002|Step 1|Off-treatment reason not submitted|1|||
48685787|NCT01708954|156700509|FG000|Step 1|Ineligible or never received treatment|4|||
49022711|NCT02319148|157922601|FG001|Second Intervention Period|Other|0|||
49022712|NCT02319148|157922602|FG002|Second Intervention Period|Other|0|||
49022713|NCT02319148|157922603|FG003|Second Intervention Period|Other|1|||
49022714|NCT01574248|157922604|FG000|Overall Study|Withdrawal by Subject|2|||
49022715|NCT01574248|157922605|FG001|Overall Study|Withdrawal by Subject|0|||
49022716|NCT01574248|157922604|FG000|Overall Study|Missing primary endpoint data|1|||
49022717|NCT01574248|157922605|FG001|Overall Study|Missing primary endpoint data|0|||
49022718|NCT04109222|157922606|FG000|Overall Study|Adverse Event|1|||
49022719|NCT04109222|157922607|FG001|Overall Study|Adverse Event|0|||
48875246|NCT01496365|157381594|FG000|Overall Study|Lost to Follow-up|0|||
48875247|NCT01496365|157381595|FG001|Overall Study|Lost to Follow-up|1|||
49022720|NCT04109222|157922608|FG002|Overall Study|Adverse Event|0|||
49022721|NCT01424722|157922609|FG000|Overall Study|Sponsor terminated investigation|2258|||
49022722|NCT01781286|157922614|FG000|Overall Study|Lost to Follow-up|0|||
49022723|NCT01781286|157922615|FG001|Overall Study|Lost to Follow-up|0|||
49022724|NCT01781286|157922616|FG002|Overall Study|Lost to Follow-up|0|||
49022725|NCT01781286|157922617|FG003|Overall Study|Lost to Follow-up|0|||
49022726|NCT01781286|157922618|FG004|Overall Study|Lost to Follow-up|0|||
49022727|NCT01781286|157922619|FG005|Overall Study|Lost to Follow-up|1|||
49022728|NCT01781286|157922614|FG000|Overall Study|Time Constraints|2|||
49022729|NCT01781286|157922615|FG001|Overall Study|Time Constraints|0|||
49022730|NCT01781286|157922616|FG002|Overall Study|Time Constraints|2|||
49022731|NCT01781286|157922617|FG003|Overall Study|Time Constraints|0|||
49022732|NCT01781286|157922618|FG004|Overall Study|Time Constraints|0|||
49022733|NCT01781286|157922619|FG005|Overall Study|Time Constraints|0|||
49022734|NCT01781286|157922614|FG000|Overall Study|Noncompliance|0|||
49022735|NCT01781286|157922615|FG001|Overall Study|Noncompliance|0|||
49022736|NCT01781286|157922616|FG002|Overall Study|Noncompliance|0|||
49022737|NCT01781286|157922617|FG003|Overall Study|Noncompliance|1|||
49022738|NCT01781286|157922618|FG004|Overall Study|Noncompliance|0|||
49022739|NCT01781286|157922619|FG005|Overall Study|Noncompliance|0|||
49022740|NCT03594123|157922620|FG000|Overall Study|Lost to Follow-up|0|||
49022741|NCT03594123|157922621|FG001|Overall Study|Lost to Follow-up|1|||
49022742|NCT03594123|157922620|FG000|Overall Study|Adverse Event|8|||
49022743|NCT03594123|157922621|FG001|Overall Study|Adverse Event|5|||
49022744|NCT03594123|157922620|FG000|Overall Study|Site Terminated by Sponsor|4|||
49022745|NCT03594123|157922621|FG001|Overall Study|Site Terminated by Sponsor|1|||
49022746|NCT03594123|157922620|FG000|Overall Study|Subject Withdrew Consent to Participate|7|||
49022747|NCT03594123|157922621|FG001|Overall Study|Subject Withdrew Consent to Participate|1|||
49022748|NCT03594123|157922620|FG000|Overall Study|Lack of Efficacy|1|||
49022749|NCT03594123|157922621|FG001|Overall Study|Lack of Efficacy|0|||
49022750|NCT03594123|157922620|FG000|Overall Study|Other (Not Related to COVID-19)|1|||
49022751|NCT03594123|157922621|FG001|Overall Study|Other (Not Related to COVID-19)|1|||
49022752|NCT01315249|157922622|FG000|Overall Study|Adverse Event|22|||
49022753|NCT01315249|157922623|FG001|Overall Study|Adverse Event|26|||
49022754|NCT01315249|157922622|FG000|Overall Study|Withdrawal by Subject|11|||
49022755|NCT01315249|157922623|FG001|Overall Study|Withdrawal by Subject|10|||
49022756|NCT01315249|157922622|FG000|Overall Study|Protocol Violation|8|||
49022757|NCT01315249|157922623|FG001|Overall Study|Protocol Violation|5|||
49022758|NCT01315249|157922622|FG000|Overall Study|Abnormal test results|1|||
49022759|NCT01315249|157922623|FG001|Overall Study|Abnormal test results|2|||
49022760|NCT01315249|157922622|FG000|Overall Study|Administrative problems|1|||
49022761|NCT01315249|157922623|FG001|Overall Study|Administrative problems|0|||
49022762|NCT01315249|157922622|FG000|Overall Study|inability to use device|1|||
49022763|NCT01315249|157922623|FG001|Overall Study|inability to use device|0|||
49022764|NCT01315249|157922622|FG000|Overall Study|Lack of Efficacy|0|||
49022765|NCT01315249|157922623|FG001|Overall Study|Lack of Efficacy|1|||
49022766|NCT01315249|157922622|FG000|Overall Study|Lost to Follow-up|0|||
49022767|NCT01315249|157922623|FG001|Overall Study|Lost to Follow-up|2|||
49022768|NCT01315249|157922622|FG000|Overall Study|Death|0|||
49022769|NCT01315249|157922623|FG001|Overall Study|Death|1|||
49022770|NCT03365375|157922624|FG000|Overall Study|Withdrawal by Subject|0|||
49022771|NCT03365375|157922625|FG001|Overall Study|Withdrawal by Subject|1|||
49022772|NCT03365375|157922624|FG000|Overall Study|Lost to Follow-up|0|||
49022773|NCT03365375|157922625|FG001|Overall Study|Lost to Follow-up|4|||
48685788|NCT01708954|156700510|FG001|Step 1|Ineligible or never received treatment|2|||
48685789|NCT01708954|156700511|FG002|Step 1|Ineligible or never received treatment|8|||
48685790|NCT01708954|156700509|FG000|Step 2|Disease progression|9|||
48685791|NCT01708954|156700510|FG001|Step 2|Disease progression|4|||
48685792|NCT01708954|156700511|FG002|Step 2|Disease progression|0|||
48685793|NCT01708954|156700509|FG000|Step 2|Adverse Event|3|||
48685794|NCT01708954|156700510|FG001|Step 2|Adverse Event|2|||
48685795|NCT01708954|156700511|FG002|Step 2|Adverse Event|0|||
48685796|NCT01708954|156700509|FG000|Step 2|Withdrawal by Subject|1|||
48685797|NCT01708954|156700510|FG001|Step 2|Withdrawal by Subject|1|||
48685798|NCT01708954|156700511|FG002|Step 2|Withdrawal by Subject|0|||
48685799|NCT01013649|156700513|FG000|First Step|Withdrawal by Subject|36|||
49022774|NCT02483975|157922626|FG000|Overall Study|Adverse Event|0|||
49022775|NCT02483975|157922627|FG001|Overall Study|Adverse Event|1|||
49022776|NCT02483975|157922626|FG000|Overall Study|Lost to Follow-up|0|||
49022777|NCT02483975|157922627|FG001|Overall Study|Lost to Follow-up|1|||
49022778|NCT02483975|157922626|FG000|Overall Study|Physician Decision|2|||
49022779|NCT02483975|157922627|FG001|Overall Study|Physician Decision|0|||
49022780|NCT01087970|157922630|FG000|Overall Study|Protocol Violation|2|||
49022781|NCT03655106|157922631|FG000|Overall Study|Withdrawal by Subject|3|||
49022782|NCT03655106|157922632|FG001|Overall Study|Withdrawal by Subject|2|||
49022783|NCT03655106|157922631|FG000|Overall Study|Lost to Follow-up|2|||
49022784|NCT03655106|157922632|FG001|Overall Study|Lost to Follow-up|1|||
49022785|NCT03655106|157922631|FG000|Overall Study|Duplicate Enrollment|1|||
49022786|NCT03655106|157922632|FG001|Overall Study|Duplicate Enrollment|1|||
49022787|NCT03655106|157922631|FG000|Overall Study|Protocol Violation|3|||
49022788|NCT03655106|157922632|FG001|Overall Study|Protocol Violation|0|||
49022789|NCT00818883|157922633|FG000|Overall Study|Adverse Event|28|||
48685800|NCT01013649|156700514|FG001|First Step|Withdrawal by Subject|19|||
48685801|NCT01013649|156700515|FG002|First Step|Withdrawal by Subject|0|||
48685802|NCT01013649|156700516|FG003|First Step|Withdrawal by Subject|0|||
48685803|NCT01013649|156700513|FG000|First Step|Progression|58|||
48685804|NCT01013649|156700514|FG001|First Step|Progression|23|||
48685805|NCT01013649|156700515|FG002|First Step|Progression|0|||
48685806|NCT01013649|156700516|FG003|First Step|Progression|0|||
48685807|NCT01013649|156700513|FG000|First Step|Did not start 5th cycle of first step treatment|15|||
48685808|NCT01013649|156700514|FG001|First Step|Did not start 5th cycle of first step treatment|10|||
48685809|NCT01013649|156700515|FG002|First Step|Did not start 5th cycle of first step treatment|0|||
48685810|NCT01013649|156700516|FG003|First Step|Did not start 5th cycle of first step treatment|0|||
48685811|NCT01013649|156700513|FG000|First Step|Death|3|||
48685812|NCT01013649|156700514|FG001|First Step|Death|4|||
48685813|NCT01013649|156700515|FG002|First Step|Death|0|||
48685814|NCT01013649|156700516|FG003|First Step|Death|0|||
48763239|NCT03662542|156983806|FG000|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
48763240|NCT03662542|156983807|FG001|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
49022790|NCT00818883|157922634|FG001|Overall Study|Adverse Event|19|||
49022791|NCT00818883|157922633|FG000|Overall Study|Protocol Violation|2|||
49022792|NCT00818883|157922634|FG001|Overall Study|Protocol Violation|2|||
49022793|NCT00818883|157922633|FG000|Overall Study|Lost to Follow-up|3|||
49022794|NCT00818883|157922634|FG001|Overall Study|Lost to Follow-up|2|||
49022795|NCT00818883|157922633|FG000|Overall Study|Withdrawal by Subject|16|||
49022796|NCT00818883|157922634|FG001|Overall Study|Withdrawal by Subject|14|||
49022797|NCT00818883|157922633|FG000|Overall Study|Lack of Efficacy|0|||
49022798|NCT00818883|157922634|FG001|Overall Study|Lack of Efficacy|2|||
49022799|NCT00818883|157922633|FG000|Overall Study|Other|2|||
48685815|NCT01013649|156700513|FG000|First Step|Adverse Event|9|||
48685816|NCT01013649|156700514|FG001|First Step|Adverse Event|5|||
48685817|NCT01013649|156700515|FG002|First Step|Adverse Event|0|||
48685818|NCT01013649|156700516|FG003|First Step|Adverse Event|0|||
48685819|NCT01013649|156700513|FG000|First Step|Other|4|||
48685820|NCT01013649|156700514|FG001|First Step|Other|6|||
48685821|NCT01013649|156700515|FG002|First Step|Other|0|||
48685822|NCT01013649|156700516|FG003|First Step|Other|0|||
48685823|NCT00985465|156700524|FG000|Overall Study|Withdrawal by Subject|1|||
48685824|NCT00985465|156700525|FG001|Overall Study|Withdrawal by Subject|2|||
48685825|NCT00985465|156700524|FG000|Overall Study|Considered to be part of the other group|0|||
48685826|NCT00985465|156700525|FG001|Overall Study|Considered to be part of the other group|1|||
48685827|NCT01177007|156700526|FG000|Overall Study|Lost to Follow-up|2|||
48685828|NCT01177007|156700526|FG000|Overall Study|Death|4|||
48685829|NCT01177007|156700526|FG000|Overall Study|Entered hospice care|5|||
48685830|NCT01177007|156700526|FG000|Overall Study|Required additional Y90 treatment|6|||
49022800|NCT00818883|157922634|FG001|Overall Study|Other|7|||
49022801|NCT02166697|157922635|FG000|Overall Study|Protocol Violation|347|||
49022802|NCT00264797|157922639|FG000|Overall Study|Withdrawal by Subject|11|||
49022803|NCT00264797|157922640|FG001|Overall Study|Withdrawal by Subject|11|||
49022804|NCT00264797|157922639|FG000|Overall Study|Lost to Follow-up|9|||
49022805|NCT00264797|157922640|FG001|Overall Study|Lost to Follow-up|17|||
48685831|NCT01177007|156700526|FG000|Overall Study|Change in treatment modality|21|||
48763241|NCT03662542|156983808|FG002|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
49022806|NCT00264797|157922639|FG000|Overall Study|Moved from area|3|||
49022807|NCT00264797|157922640|FG001|Overall Study|Moved from area|1|||
49022808|NCT00264797|157922639|FG000|Overall Study|Practical Problems|2|||
49022809|NCT00264797|157922640|FG001|Overall Study|Practical Problems|3|||
48685832|NCT01292187|156700527|FG000|Overall Study|Adverse Event|10|||
48685833|NCT01292187|156700528|FG001|Overall Study|Adverse Event|5|||
48685834|NCT01292187|156700527|FG000|Overall Study|Withdrawal by Subject|6|||
48685835|NCT01292187|156700528|FG001|Overall Study|Withdrawal by Subject|5|||
48685836|NCT01292187|156700527|FG000|Overall Study|All other reasons|1|||
48685837|NCT01292187|156700528|FG001|Overall Study|All other reasons|3|||
48875248|NCT01496365|157381596|FG002|Overall Study|Lost to Follow-up|0|||
49022810|NCT00264797|157922639|FG000|Overall Study|Incarceration|4|||
49022811|NCT00264797|157922640|FG001|Overall Study|Incarceration|5|||
49022812|NCT00264797|157922639|FG000|Overall Study|Pressure/advice from Outsiders|1|||
49022813|NCT00264797|157922640|FG001|Overall Study|Pressure/advice from Outsiders|1|||
49022814|NCT00264797|157922639|FG000|Overall Study|Feels treatment not necessary, not worki|0|||
49022815|NCT00264797|157922640|FG001|Overall Study|Feels treatment not necessary, not worki|1|||
49022816|NCT00264797|157922639|FG000|Overall Study|Other|3|||
49022817|NCT00264797|157922640|FG001|Overall Study|Other|4|||
49022818|NCT03227445|157922641|FG000|Period 1 (28 Days)|Adverse Event|1|||
49022819|NCT03227445|157922642|FG001|Period 1 (28 Days)|Adverse Event|2|||
49022820|NCT03227445|157922643|FG002|Period 1 (28 Days)|Adverse Event|0|||
49022821|NCT03227445|157922644|FG003|Period 1 (28 Days)|Adverse Event|1|||
49022822|NCT03227445|157922641|FG000|Period 1 (28 Days)|Protocol Violation|1|||
49022823|NCT03227445|157922642|FG001|Period 1 (28 Days)|Protocol Violation|0|||
49022824|NCT03227445|157922643|FG002|Period 1 (28 Days)|Protocol Violation|0|||
49022825|NCT03227445|157922644|FG003|Period 1 (28 Days)|Protocol Violation|0|||
49022826|NCT03227445|157922641|FG000|Period 1 (28 Days)|Withdrawal by Subject|0|||
49022827|NCT03227445|157922642|FG001|Period 1 (28 Days)|Withdrawal by Subject|0|||
49022828|NCT03227445|157922643|FG002|Period 1 (28 Days)|Withdrawal by Subject|1|||
49022829|NCT03227445|157922644|FG003|Period 1 (28 Days)|Withdrawal by Subject|1|||
48685838|NCT04950465|156700529|FG000|Overall Study|Lost to Follow-up|1|||
48685839|NCT04950465|156700530|FG001|Overall Study|Lost to Follow-up|0|||
48685840|NCT04950465|156700531|FG002|Overall Study|Lost to Follow-up|0|||
48685841|NCT01620086|156700538|FG000|Overall Study|Withdrawal by Subject|3|||
48685842|NCT01620086|156700539|FG001|Overall Study|Withdrawal by Subject|3|||
48685843|NCT01620086|156700540|FG002|Overall Study|Withdrawal by Subject|0|||
48685844|NCT01620086|156700538|FG000|Overall Study|failed study criteria|1|||
48685845|NCT01620086|156700539|FG001|Overall Study|failed study criteria|4|||
48685846|NCT01620086|156700540|FG002|Overall Study|failed study criteria|0|||
48685847|NCT01620086|156700538|FG000|Overall Study|Physician Decision|1|||
48685848|NCT01620086|156700539|FG001|Overall Study|Physician Decision|0|||
48685849|NCT01620086|156700540|FG002|Overall Study|Physician Decision|0|||
48685850|NCT01695135|156700541|FG000|Double-blind Treatment Phase|Progressive disease|50|||
48685851|NCT01695135|156700542|FG001|Double-blind Treatment Phase|Progressive disease|110|||
48685852|NCT01695135|156700543|FG002|Double-blind Treatment Phase|Progressive disease|0|||
48685853|NCT01695135|156700544|FG003|Double-blind Treatment Phase|Progressive disease|0|||
48685854|NCT01695135|156700541|FG000|Double-blind Treatment Phase|Withdrawal by Subject|6|||
48685855|NCT01695135|156700542|FG001|Double-blind Treatment Phase|Withdrawal by Subject|14|||
48685856|NCT01695135|156700543|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
48685857|NCT01695135|156700544|FG003|Double-blind Treatment Phase|Withdrawal by Subject|0|||
48685858|NCT01695135|156700541|FG000|Double-blind Treatment Phase|Adverse Event|7|||
48685859|NCT01695135|156700542|FG001|Double-blind Treatment Phase|Adverse Event|7|||
48685860|NCT01695135|156700543|FG002|Double-blind Treatment Phase|Adverse Event|0|||
48685861|NCT01695135|156700544|FG003|Double-blind Treatment Phase|Adverse Event|0|||
48685862|NCT01695135|156700541|FG000|Double-blind Treatment Phase|Other|1|||
48685863|NCT01695135|156700542|FG001|Double-blind Treatment Phase|Other|3|||
48685864|NCT01695135|156700543|FG002|Double-blind Treatment Phase|Other|0|||
48685865|NCT01695135|156700544|FG003|Double-blind Treatment Phase|Other|0|||
48685866|NCT01695135|156700541|FG000|Double-blind Treatment Phase|Physician Decision|6|||
48685867|NCT01695135|156700542|FG001|Double-blind Treatment Phase|Physician Decision|3|||
48685868|NCT01695135|156700543|FG002|Double-blind Treatment Phase|Physician Decision|0|||
48685869|NCT01695135|156700544|FG003|Double-blind Treatment Phase|Physician Decision|0|||
48685870|NCT01695135|156700541|FG000|Double-blind Treatment Phase|Death|1|||
48685871|NCT01695135|156700542|FG001|Double-blind Treatment Phase|Death|1|||
48685872|NCT01695135|156700543|FG002|Double-blind Treatment Phase|Death|0|||
48685873|NCT01695135|156700544|FG003|Double-blind Treatment Phase|Death|0|||
48685874|NCT01695135|156700541|FG000|Double-blind Treatment Phase|Noncompliance with study drug|0|||
48685875|NCT01695135|156700542|FG001|Double-blind Treatment Phase|Noncompliance with study drug|1|||
48685876|NCT01695135|156700543|FG002|Double-blind Treatment Phase|Noncompliance with study drug|0|||
48685877|NCT01695135|156700544|FG003|Double-blind Treatment Phase|Noncompliance with study drug|0|||
48685878|NCT01695135|156700541|FG000|Open Label Extension Treatment Phase|Progressive disease|0|||
48685879|NCT01695135|156700542|FG001|Open Label Extension Treatment Phase|Progressive disease|0|||
48685880|NCT01695135|156700543|FG002|Open Label Extension Treatment Phase|Progressive disease|13|||
48685881|NCT01695135|156700544|FG003|Open Label Extension Treatment Phase|Progressive disease|22|||
48685882|NCT01695135|156700541|FG000|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
48685883|NCT01695135|156700542|FG001|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
49022830|NCT03227445|157922641|FG000|Period 2 (28 Days)|Adverse Event|1|||
48685884|NCT01695135|156700543|FG002|Open Label Extension Treatment Phase|Withdrawal by Subject|6|||
48685885|NCT01695135|156700544|FG003|Open Label Extension Treatment Phase|Withdrawal by Subject|16|||
48685886|NCT01695135|156700541|FG000|Open Label Extension Treatment Phase|Adverse Event|0|||
48685887|NCT01695135|156700542|FG001|Open Label Extension Treatment Phase|Adverse Event|0|||
48685888|NCT01695135|156700543|FG002|Open Label Extension Treatment Phase|Adverse Event|11|||
48685889|NCT01695135|156700544|FG003|Open Label Extension Treatment Phase|Adverse Event|16|||
48763242|NCT03662542|156983809|FG003|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
49022831|NCT03227445|157922642|FG001|Period 2 (28 Days)|Adverse Event|0|||
49022832|NCT03227445|157922643|FG002|Period 2 (28 Days)|Adverse Event|2|||
49022833|NCT03227445|157922644|FG003|Period 2 (28 Days)|Adverse Event|1|||
48685890|NCT01695135|156700541|FG000|Open Label Extension Treatment Phase|Other|0|||
48685891|NCT01695135|156700542|FG001|Open Label Extension Treatment Phase|Other|0|||
48685892|NCT01695135|156700543|FG002|Open Label Extension Treatment Phase|Other|4|||
48685893|NCT01695135|156700544|FG003|Open Label Extension Treatment Phase|Other|7|||
48685894|NCT01695135|156700541|FG000|Open Label Extension Treatment Phase|Physician Decision|0|||
48685895|NCT01695135|156700542|FG001|Open Label Extension Treatment Phase|Physician Decision|0|||
48685896|NCT01695135|156700543|FG002|Open Label Extension Treatment Phase|Physician Decision|4|||
48685897|NCT01695135|156700544|FG003|Open Label Extension Treatment Phase|Physician Decision|1|||
48685898|NCT01695135|156700541|FG000|Open Label Extension Treatment Phase|Death|0|||
48685899|NCT01695135|156700542|FG001|Open Label Extension Treatment Phase|Death|0|||
48685900|NCT01695135|156700543|FG002|Open Label Extension Treatment Phase|Death|2|||
48685901|NCT01695135|156700544|FG003|Open Label Extension Treatment Phase|Death|7|||
48685902|NCT01695135|156700541|FG000|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
48685903|NCT01695135|156700542|FG001|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
48685904|NCT01695135|156700543|FG002|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
48685905|NCT01695135|156700544|FG003|Open Label Extension Treatment Phase|Noncompliance with study drug|1|||
48685906|NCT00880698|156700545|FG000|Overall Study|Death|0|||
48685907|NCT00880698|156700546|FG001|Overall Study|Death|0|||
48685908|NCT00880698|156700547|FG002|Overall Study|Death|1|||
48685909|NCT00880698|156700548|FG003|Overall Study|Death|2|||
48685910|NCT00880698|156700545|FG000|Overall Study|Lost to Follow-up|1|||
48685911|NCT00880698|156700546|FG001|Overall Study|Lost to Follow-up|3|||
48685912|NCT00880698|156700547|FG002|Overall Study|Lost to Follow-up|0|||
48685913|NCT00880698|156700548|FG003|Overall Study|Lost to Follow-up|1|||
48685914|NCT04307355|156700553|FG000|Overall Study|Non-Compliance|3|||
48685915|NCT04307355|156700554|FG001|Overall Study|Non-Compliance|3|||
48685916|NCT04307355|156700555|FG002|Overall Study|Non-Compliance|0|||
48685917|NCT00920855|156700556|FG000|Overall Study|Adverse Event|1|||
48685918|NCT00920855|156700557|FG001|Overall Study|Adverse Event|1|||
48685919|NCT00920855|156700558|FG002|Overall Study|Adverse Event|4|||
48685920|NCT00920855|156700556|FG000|Overall Study|Withdrawal by Subject|2|||
48685921|NCT00920855|156700557|FG001|Overall Study|Withdrawal by Subject|1|||
48685922|NCT00920855|156700558|FG002|Overall Study|Withdrawal by Subject|6|||
48685923|NCT00920855|156700556|FG000|Overall Study|Disease progression|2|||
48685924|NCT00920855|156700557|FG001|Overall Study|Disease progression|1|||
48685925|NCT00920855|156700558|FG002|Overall Study|Disease progression|10|||
48685926|NCT00920855|156700556|FG000|Overall Study|Noncompliance to study medication|0|||
48685927|NCT00920855|156700557|FG001|Overall Study|Noncompliance to study medication|0|||
48685928|NCT00920855|156700558|FG002|Overall Study|Noncompliance to study medication|1|||
48685929|NCT00920855|156700556|FG000|Overall Study|Response plateau; started maintenance|0|||
48685930|NCT00920855|156700557|FG001|Overall Study|Response plateau; started maintenance|0|||
48685931|NCT00920855|156700558|FG002|Overall Study|Response plateau; started maintenance|1|||
48685932|NCT01100320|156700559|FG000|Period 1|Withdrawal by Subject|2|||
48685933|NCT01100320|156700560|FG001|Period 1|Withdrawal by Subject|4|||
48685934|NCT01100320|156700559|FG000|Period 1|Positive Drug Screen|1|||
48685935|NCT01100320|156700560|FG001|Period 1|Positive Drug Screen|1|||
48685936|NCT01100320|156700559|FG000|Period 1|Adverse Event|2|||
48685937|NCT01100320|156700560|FG001|Period 1|Adverse Event|2|||
48685938|NCT01100320|156700559|FG000|Period 2|Withdrawal by Subject|1|||
48685939|NCT01100320|156700560|FG001|Period 2|Withdrawal by Subject|1|||
48685940|NCT00104676|156700561|FG000|Overall Study|Death|3|||
48685941|NCT00104676|156700562|FG001|Overall Study|Death|2|||
48685942|NCT00104676|156700561|FG000|Overall Study|Withdrawal by Subject|0|||
48685943|NCT00104676|156700562|FG001|Overall Study|Withdrawal by Subject|2|||
48685944|NCT00104676|156700561|FG000|Overall Study|treatment interruption|4|||
48685945|NCT00104676|156700562|FG001|Overall Study|treatment interruption|10|||
48685946|NCT00569127|156700563|FG000|Overall Study|Adverse Event|57|||
48685947|NCT00569127|156700564|FG001|Overall Study|Adverse Event|47|||
48685948|NCT00569127|156700563|FG000|Overall Study|Withdrawal by Subject|13|||
48685949|NCT00569127|156700564|FG001|Overall Study|Withdrawal by Subject|27|||
48685950|NCT00569127|156700563|FG000|Overall Study|Progression|99|||
48685951|NCT00569127|156700564|FG001|Overall Study|Progression|100|||
48685952|NCT00569127|156700563|FG000|Overall Study|Death|4|||
48685953|NCT00569127|156700564|FG001|Overall Study|Death|3|||
48685954|NCT00569127|156700563|FG000|Overall Study|Other|20|||
48685955|NCT00569127|156700564|FG001|Overall Study|Other|19|||
48685956|NCT00569127|156700563|FG000|Overall Study|Lost to Follow-up|0|||
48685957|NCT00569127|156700564|FG001|Overall Study|Lost to Follow-up|3|||
48685958|NCT00569127|156700563|FG000|Overall Study|Not Eligible|14|||
48685959|NCT00569127|156700564|FG001|Overall Study|Not Eligible|11|||
48685960|NCT00569127|156700563|FG000|Overall Study|Still on Treatment|7|||
48685961|NCT00569127|156700564|FG001|Overall Study|Still on Treatment|3|||
48685962|NCT02936635|156701884|FG000|Overall Study|Adverse Event|43|||
48685963|NCT02936635|156701885|FG001|Overall Study|Adverse Event|25|||
48685964|NCT02936635|156701884|FG000|Overall Study|Progressive Disease|10|||
48685965|NCT02936635|156701885|FG001|Overall Study|Progressive Disease|18|||
48685966|NCT02936635|156701884|FG000|Overall Study|Sponsor Discretion|10|||
48685967|NCT02936635|156701885|FG001|Overall Study|Sponsor Discretion|16|||
48685968|NCT02936635|156701884|FG000|Overall Study|Death|9|||
48685969|NCT02936635|156701885|FG001|Overall Study|Death|15|||
48685970|NCT02936635|156701884|FG000|Overall Study|Withdrawal by Subject|8|||
48685971|NCT02936635|156701885|FG001|Overall Study|Withdrawal by Subject|15|||
48685972|NCT02936635|156701884|FG000|Overall Study|Physician Decision|2|||
48685973|NCT02936635|156701885|FG001|Overall Study|Physician Decision|9|||
48685974|NCT02936635|156701884|FG000|Overall Study|Lost to Follow-up|1|||
48685975|NCT02936635|156701885|FG001|Overall Study|Lost to Follow-up|2|||
48685976|NCT02936635|156701884|FG000|Overall Study|Protocol Violation|1|||
48685977|NCT02936635|156701885|FG001|Overall Study|Protocol Violation|0|||
48685978|NCT02936635|156701884|FG000|Overall Study|Lack of effect/Entry into other study|31|||
48685979|NCT02936635|156701885|FG001|Overall Study|Lack of effect/Entry into other study|65|||
48685980|NCT01633788|156701886|FG000|Overall Study|Adverse Event|1|||
48685981|NCT01633788|156701887|FG001|Overall Study|Adverse Event|3|||
48685982|NCT01633788|156701888|FG002|Overall Study|Adverse Event|3|||
48685983|NCT01633788|156701889|FG003|Overall Study|Adverse Event|3|||
48685984|NCT01633788|156701886|FG000|Overall Study|Lost to Follow-up|2|||
48685985|NCT01633788|156701887|FG001|Overall Study|Lost to Follow-up|2|||
48685986|NCT01633788|156701888|FG002|Overall Study|Lost to Follow-up|2|||
48685987|NCT01633788|156701889|FG003|Overall Study|Lost to Follow-up|0|||
48685988|NCT01633788|156701886|FG000|Overall Study|Personal Reasons|3|||
48685989|NCT01633788|156701887|FG001|Overall Study|Personal Reasons|1|||
48685990|NCT01633788|156701888|FG002|Overall Study|Personal Reasons|1|||
48685991|NCT01633788|156701889|FG003|Overall Study|Personal Reasons|3|||
48685992|NCT01633788|156701886|FG000|Overall Study|Protocol Violation|1|||
48685993|NCT01633788|156701887|FG001|Overall Study|Protocol Violation|0|||
48685994|NCT01633788|156701888|FG002|Overall Study|Protocol Violation|1|||
48685995|NCT01633788|156701889|FG003|Overall Study|Protocol Violation|0|||
48685996|NCT01633788|156701886|FG000|Overall Study|Other Reasons|0|||
48685997|NCT01633788|156701887|FG001|Overall Study|Other Reasons|2|||
48685998|NCT01633788|156701888|FG002|Overall Study|Other Reasons|3|||
48685999|NCT01633788|156701889|FG003|Overall Study|Other Reasons|7|||
48686000|NCT01929226|156701890|FG000|Overall Study|Lost to Follow-up|4|||
48686001|NCT01929226|156701891|FG001|Overall Study|Lost to Follow-up|0|||
48686002|NCT01929226|156701890|FG000|Overall Study|Withdrawal by Subject|1|||
48686003|NCT01929226|156701891|FG001|Overall Study|Withdrawal by Subject|1|||
48686004|NCT00806988|156701892|FG000|Overall Study|Death|15|||
48686005|NCT00806988|156701893|FG001|Overall Study|Death|16|||
48686006|NCT00806988|156701892|FG000|Overall Study|Withdrawal by Subject|8|||
48686007|NCT00806988|156701893|FG001|Overall Study|Withdrawal by Subject|8|||
48686008|NCT00806988|156701892|FG000|Overall Study|Lost to Follow-up|4|||
48686009|NCT00806988|156701893|FG001|Overall Study|Lost to Follow-up|19|||
48686010|NCT01142388|156701901|FG000|Overall Study|Lack of Efficacy|21|||
48686011|NCT01142388|156701902|FG001|Overall Study|Lack of Efficacy|31|||
48686012|NCT01142388|156701901|FG000|Overall Study|Adverse Event|9|||
48686013|NCT01142388|156701902|FG001|Overall Study|Adverse Event|5|||
48686014|NCT01142388|156701901|FG000|Overall Study|Death|3|||
48686015|NCT01142388|156701902|FG001|Overall Study|Death|2|||
48686016|NCT01142388|156701901|FG000|Overall Study|Withdrawal by Subject|5|||
48686017|NCT01142388|156701902|FG001|Overall Study|Withdrawal by Subject|3|||
48686018|NCT01142388|156701901|FG000|Overall Study|Alternative therapy|1|||
48686019|NCT01142388|156701902|FG001|Overall Study|Alternative therapy|0|||
48686020|NCT01142388|156701901|FG000|Overall Study|Other complications|0|||
48763243|NCT03662542|156983810|FG004|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
48763244|NCT03662542|156983811|FG005|Monotherapy Phase (Week 12-Week 38)|Adverse Event|2|||
48763245|NCT03662542|156983812|FG006|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
48763246|NCT03662542|156983813|FG007|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
48763247|NCT03662542|156983814|FG008|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
49022834|NCT03227445|157922641|FG000|Period 2 (28 Days)|Protocol Violation|0|||
48686021|NCT01142388|156701902|FG001|Overall Study|Other complications|2|||
48686022|NCT01142388|156701901|FG000|Overall Study|Other|1|||
48686023|NCT01142388|156701902|FG001|Overall Study|Other|1|||
48686024|NCT01142388|156701901|FG000|Overall Study|Never started therapy|7|||
48686025|NCT01142388|156701902|FG001|Overall Study|Never started therapy|3|||
48981252|NCT00424099|157764252|FG003|Overall Study|Adverse Event|0|||
48981253|NCT00424099|157764249|FG000|Overall Study|Death|0|||
48981254|NCT00424099|157764250|FG001|Overall Study|Death|1|||
48981255|NCT00424099|157764251|FG002|Overall Study|Death|0|||
48981256|NCT00424099|157764252|FG003|Overall Study|Death|0|||
48981257|NCT00424099|157764249|FG000|Overall Study|Illness|2|||
48981258|NCT00424099|157764250|FG001|Overall Study|Illness|0|||
48981259|NCT00424099|157764251|FG002|Overall Study|Illness|1|||
48981260|NCT00424099|157764252|FG003|Overall Study|Illness|4|||
48981261|NCT00424099|157764249|FG000|Overall Study|Lost to Follow-up|0|||
48981262|NCT00424099|157764250|FG001|Overall Study|Lost to Follow-up|0|||
48981263|NCT00424099|157764251|FG002|Overall Study|Lost to Follow-up|3|||
48981264|NCT00424099|157764252|FG003|Overall Study|Lost to Follow-up|0|||
48981265|NCT00424099|157764249|FG000|Overall Study|Hospitalized|1|||
48763248|NCT03662542|156983806|FG000|Safety Follow-up (Week 38- Week 50)|Death|0|||
48981266|NCT00424099|157764250|FG001|Overall Study|Hospitalized|2|||
48981267|NCT00424099|157764251|FG002|Overall Study|Hospitalized|1|||
48981268|NCT00424099|157764252|FG003|Overall Study|Hospitalized|3|||
48981269|NCT00424099|157764249|FG000|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
48981270|NCT00424099|157764250|FG001|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
48981271|NCT00424099|157764251|FG002|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
48981272|NCT00424099|157764252|FG003|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
48981273|NCT00424099|157764249|FG000|Overall Study|Withdrawal by Subject|1|||
48981274|NCT00424099|157764250|FG001|Overall Study|Withdrawal by Subject|9|||
48981275|NCT00424099|157764251|FG002|Overall Study|Withdrawal by Subject|4|||
48981276|NCT00424099|157764252|FG003|Overall Study|Withdrawal by Subject|6|||
49022835|NCT03227445|157922642|FG001|Period 2 (28 Days)|Protocol Violation|0|||
49022836|NCT03227445|157922643|FG002|Period 2 (28 Days)|Protocol Violation|0|||
49022837|NCT03227445|157922644|FG003|Period 2 (28 Days)|Protocol Violation|1|||
48981277|NCT00424099|157764249|FG000|Overall Study|Physician Decision|0|||
48981278|NCT00424099|157764250|FG001|Overall Study|Physician Decision|0|||
48981279|NCT00424099|157764251|FG002|Overall Study|Physician Decision|1|||
48981280|NCT00424099|157764252|FG003|Overall Study|Physician Decision|0|||
48981281|NCT00424099|157764249|FG000|Overall Study|Missing|0|||
48981282|NCT00424099|157764250|FG001|Overall Study|Missing|0|||
48981283|NCT00424099|157764251|FG002|Overall Study|Missing|1|||
48981284|NCT00424099|157764252|FG003|Overall Study|Missing|0|||
48981285|NCT02155712|157764253|FG000|Overall Study|Death|12|||
48981286|NCT02155712|157764254|FG001|Overall Study|Death|0|||
48981287|NCT02155712|157764253|FG000|Overall Study|Lost to Follow-up|37|||
48981288|NCT02155712|157764254|FG001|Overall Study|Lost to Follow-up|22|||
48981289|NCT02155712|157764253|FG000|Overall Study|Revision of device|4|||
48981290|NCT02155712|157764254|FG001|Overall Study|Revision of device|3|||
48981291|NCT02155712|157764253|FG000|Overall Study|Withdrawal by Subject|39|||
48981292|NCT02155712|157764254|FG001|Overall Study|Withdrawal by Subject|21|||
48981293|NCT02155712|157764253|FG000|Overall Study|Site termination|77|||
48981294|NCT02155712|157764254|FG001|Overall Study|Site termination|19|||
48981295|NCT02155712|157764253|FG000|Overall Study|Sponsor terminated study early|150|||
48981296|NCT02155712|157764254|FG001|Overall Study|Sponsor terminated study early|0|||
49022838|NCT03227445|157922641|FG000|Period 2 (28 Days)|Withdrawal by Subject|0|||
49022839|NCT03227445|157922642|FG001|Period 2 (28 Days)|Withdrawal by Subject|1|||
49022840|NCT03227445|157922643|FG002|Period 2 (28 Days)|Withdrawal by Subject|0|||
49022841|NCT03227445|157922644|FG003|Period 2 (28 Days)|Withdrawal by Subject|1|||
49022842|NCT00048048|157922645|FG000|Core Treatment|Withdrawal by Subject|0|||
49022843|NCT00048048|157922646|FG001|Core Treatment|Withdrawal by Subject|0|||
49022844|NCT00048048|157922647|FG002|Core Treatment|Withdrawal by Subject|1|||
49022845|NCT00048048|157922648|FG003|Core Treatment|Withdrawal by Subject|0|||
49022846|NCT00048048|157922649|FG004|Core Treatment|Withdrawal by Subject|0|||
49022847|NCT00048048|157922650|FG005|Core Treatment|Withdrawal by Subject|0|||
49022848|NCT00048048|157922651|FG006|Core Treatment|Withdrawal by Subject|0|||
49022849|NCT00048048|157922652|FG007|Core Treatment|Withdrawal by Subject|0|||
49022850|NCT00048048|157922653|FG008|Core Treatment|Withdrawal by Subject|0|||
49022851|NCT00048048|157922654|FG009|Core Treatment|Withdrawal by Subject|0|||
49022852|NCT00048048|157922655|FG010|Core Treatment|Withdrawal by Subject|0|||
49022853|NCT00048048|157922656|FG011|Core Treatment|Withdrawal by Subject|0|||
49022854|NCT00048048|157922645|FG000|Core Treatment|Adverse Event|0|||
49022855|NCT00048048|157922646|FG001|Core Treatment|Adverse Event|0|||
49022856|NCT00048048|157922647|FG002|Core Treatment|Adverse Event|0|||
49022857|NCT00048048|157922648|FG003|Core Treatment|Adverse Event|0|||
49022858|NCT00048048|157922649|FG004|Core Treatment|Adverse Event|0|||
49022859|NCT00048048|157922650|FG005|Core Treatment|Adverse Event|0|||
48981297|NCT02155712|157764253|FG000|Overall Study|Missed final 5-year protocol visit|0|||
48981298|NCT02155712|157764254|FG001|Overall Study|Missed final 5-year protocol visit|32|||
48981299|NCT02155712|157764253|FG000|Overall Study|Censored because surgery cancelled|6|||
48981300|NCT02155712|157764254|FG001|Overall Study|Censored because surgery cancelled|10|||
48981301|NCT02155712|157764253|FG000|Overall Study|Censored because study device was not implanted|61|||
48981302|NCT02155712|157764254|FG001|Overall Study|Censored because study device was not implanted|66|||
48981303|NCT02155712|157764253|FG000|Overall Study|Censored because of inclusion/exclusion violation|11|||
48981304|NCT02155712|157764254|FG001|Overall Study|Censored because of inclusion/exclusion violation|6|||
49022860|NCT00048048|157922651|FG006|Core Treatment|Adverse Event|0|||
49022861|NCT00048048|157922652|FG007|Core Treatment|Adverse Event|1|||
49022862|NCT00048048|157922653|FG008|Core Treatment|Adverse Event|0|||
49022863|NCT00048048|157922654|FG009|Core Treatment|Adverse Event|0|||
49022864|NCT00048048|157922655|FG010|Core Treatment|Adverse Event|0|||
49022865|NCT00048048|157922656|FG011|Core Treatment|Adverse Event|0|||
49022866|NCT00048048|157922645|FG000|Extension Year 1|Early withdrawals|0|||
49022867|NCT00048048|157922646|FG001|Extension Year 1|Early withdrawals|0|||
48981305|NCT02559115|157764255|FG000|Overall Study|Withdrawal by Subject|3|||
48981306|NCT03605836|157764256|FG000|OL Placebo Run-in Period [1 Week]|Adverse Event|2|||
48981307|NCT03605836|157764257|FG001|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
48981308|NCT03605836|157764258|FG002|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
48981309|NCT03605836|157764259|FG003|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
48686086|NCT00799266|156701915|FG000|Overall Study|Adverse Event|0|||
48686087|NCT00799266|156701916|FG001|Overall Study|Adverse Event|1|||
48686088|NCT00799266|156701915|FG000|Overall Study|Subject withdrew consent|3|||
48686089|NCT00799266|156701916|FG001|Overall Study|Subject withdrew consent|0|||
48686090|NCT01276639|156701917|FG000|Week 0 to 16|Death|1|||
48686091|NCT01276639|156701918|FG001|Week 0 to 16|Death|0|||
48686092|NCT01276639|156701919|FG002|Week 0 to 16|Death|0|||
48686093|NCT01276639|156701920|FG003|Week 0 to 16|Death|0|||
48686094|NCT01276639|156701921|FG004|Week 0 to 16|Death|0|||
48686095|NCT01276639|156701917|FG000|Week 0 to 16|Adverse Event|11|||
48686096|NCT01276639|156701918|FG001|Week 0 to 16|Adverse Event|8|||
48686097|NCT01276639|156701919|FG002|Week 0 to 16|Adverse Event|11|||
48686098|NCT01276639|156701920|FG003|Week 0 to 16|Adverse Event|0|||
48686099|NCT01276639|156701921|FG004|Week 0 to 16|Adverse Event|0|||
48686100|NCT01276639|156701917|FG000|Week 0 to 16|Lack of Efficacy|20|||
48686101|NCT01276639|156701918|FG001|Week 0 to 16|Lack of Efficacy|15|||
48686102|NCT01276639|156701919|FG002|Week 0 to 16|Lack of Efficacy|25|||
48686103|NCT01276639|156701920|FG003|Week 0 to 16|Lack of Efficacy|0|||
48686104|NCT01276639|156701921|FG004|Week 0 to 16|Lack of Efficacy|0|||
48686105|NCT01276639|156701917|FG000|Week 0 to 16|Lost to Follow-up|3|||
48686106|NCT01276639|156701918|FG001|Week 0 to 16|Lost to Follow-up|5|||
48686107|NCT01276639|156701919|FG002|Week 0 to 16|Lost to Follow-up|3|||
48686108|NCT01276639|156701920|FG003|Week 0 to 16|Lost to Follow-up|0|||
48686109|NCT01276639|156701921|FG004|Week 0 to 16|Lost to Follow-up|0|||
48686110|NCT01276639|156701917|FG000|Week 0 to 16|Withdrawal by Subject|8|||
48686111|NCT01276639|156701918|FG001|Week 0 to 16|Withdrawal by Subject|5|||
48686112|NCT01276639|156701919|FG002|Week 0 to 16|Withdrawal by Subject|4|||
48686113|NCT01276639|156701920|FG003|Week 0 to 16|Withdrawal by Subject|0|||
48686114|NCT01276639|156701921|FG004|Week 0 to 16|Withdrawal by Subject|0|||
48686115|NCT01276639|156701917|FG000|Week 0 to 16|Other|7|||
48686116|NCT01276639|156701918|FG001|Week 0 to 16|Other|7|||
48686117|NCT01276639|156701919|FG002|Week 0 to 16|Other|2|||
48686118|NCT01276639|156701920|FG003|Week 0 to 16|Other|0|||
48686119|NCT01276639|156701921|FG004|Week 0 to 16|Other|0|||
48686120|NCT01276639|156701917|FG000|Week 0 to 16|Randomized, But Not Treated|0|||
48686121|NCT01276639|156701918|FG001|Week 0 to 16|Randomized, But Not Treated|1|||
48686122|NCT01276639|156701919|FG002|Week 0 to 16|Randomized, But Not Treated|0|||
48686123|NCT01276639|156701920|FG003|Week 0 to 16|Randomized, But Not Treated|0|||
48763249|NCT03662542|156983807|FG001|Safety Follow-up (Week 38- Week 50)|Death|0|||
48686124|NCT01276639|156701921|FG004|Week 0 to 16|Randomized, But Not Treated|0|||
48686125|NCT01276639|156701917|FG000|Week 16 to 52|Death|1|||
48686126|NCT01276639|156701918|FG001|Week 16 to 52|Death|0|||
48763250|NCT03662542|156983808|FG002|Safety Follow-up (Week 38- Week 50)|Death|0|||
48686127|NCT01276639|156701919|FG002|Week 16 to 52|Death|0|||
48686128|NCT01276639|156701920|FG003|Week 16 to 52|Death|0|||
48686129|NCT01276639|156701921|FG004|Week 16 to 52|Death|0|||
48686130|NCT01276639|156701917|FG000|Week 16 to 52|Adverse Event|10|||
48686131|NCT01276639|156701918|FG001|Week 16 to 52|Adverse Event|13|||
48686132|NCT01276639|156701919|FG002|Week 16 to 52|Adverse Event|0|||
48686133|NCT01276639|156701920|FG003|Week 16 to 52|Adverse Event|1|||
48686134|NCT01276639|156701921|FG004|Week 16 to 52|Adverse Event|3|||
48981310|NCT03605836|157764256|FG000|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2|||
48981311|NCT03605836|157764257|FG001|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
48981312|NCT03605836|157764258|FG002|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
48981313|NCT03605836|157764259|FG003|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
48981314|NCT03605836|157764256|FG000|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8|||
48981315|NCT03605836|157764257|FG001|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
48981316|NCT03605836|157764258|FG002|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
48981317|NCT03605836|157764259|FG003|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
48981318|NCT03605836|157764256|FG000|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4|||
48981319|NCT03605836|157764257|FG001|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
48981320|NCT03605836|157764258|FG002|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
48981321|NCT03605836|157764259|FG003|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
48981322|NCT03605836|157764256|FG000|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4|||
48981323|NCT03605836|157764257|FG001|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
48981324|NCT03605836|157764258|FG002|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
48981325|NCT03605836|157764259|FG003|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
48981326|NCT03605836|157764256|FG000|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17|||
48981327|NCT03605836|157764257|FG001|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
48981328|NCT03605836|157764258|FG002|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
48981329|NCT03605836|157764259|FG003|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
48981330|NCT03605836|157764256|FG000|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5|||
48686135|NCT01276639|156701917|FG000|Week 16 to 52|Lack of Efficacy|99|||
48686136|NCT01276639|156701918|FG001|Week 16 to 52|Lack of Efficacy|71|||
48686137|NCT01276639|156701919|FG002|Week 16 to 52|Lack of Efficacy|0|||
48686138|NCT01276639|156701920|FG003|Week 16 to 52|Lack of Efficacy|14|||
48686139|NCT01276639|156701921|FG004|Week 16 to 52|Lack of Efficacy|13|||
48686140|NCT01276639|156701917|FG000|Week 16 to 52|Lost to Follow-up|3|||
48686141|NCT01276639|156701918|FG001|Week 16 to 52|Lost to Follow-up|1|||
48686142|NCT01276639|156701919|FG002|Week 16 to 52|Lost to Follow-up|0|||
48686143|NCT01276639|156701920|FG003|Week 16 to 52|Lost to Follow-up|0|||
48686144|NCT01276639|156701921|FG004|Week 16 to 52|Lost to Follow-up|1|||
48686145|NCT01276639|156701917|FG000|Week 16 to 52|Withdrawal by Subject|4|||
48686146|NCT01276639|156701918|FG001|Week 16 to 52|Withdrawal by Subject|4|||
48686147|NCT01276639|156701919|FG002|Week 16 to 52|Withdrawal by Subject|0|||
48686148|NCT01276639|156701920|FG003|Week 16 to 52|Withdrawal by Subject|0|||
48686149|NCT01276639|156701921|FG004|Week 16 to 52|Withdrawal by Subject|1|||
48686150|NCT01276639|156701917|FG000|Week 16 to 52|Other|10|||
48686151|NCT01276639|156701918|FG001|Week 16 to 52|Other|12|||
48686152|NCT01276639|156701919|FG002|Week 16 to 52|Other|0|||
48686153|NCT01276639|156701920|FG003|Week 16 to 52|Other|1|||
48686154|NCT01276639|156701921|FG004|Week 16 to 52|Other|3|||
48686155|NCT00086047|156701922|FG000|Overall Study|Lost to Follow-up|7|||
48686156|NCT00086047|156701923|FG001|Overall Study|Lost to Follow-up|6|||
48686157|NCT00086047|156701922|FG000|Overall Study|Physician Decision|0|||
48686158|NCT00086047|156701923|FG001|Overall Study|Physician Decision|1|||
48686159|NCT01473732|156701926|FG000|Overall Study|Adverse Event|1|||
48686160|NCT01473732|156701927|FG001|Overall Study|Adverse Event|0|||
48686161|NCT01473732|156701926|FG000|Overall Study|Death|1|||
48686162|NCT01473732|156701927|FG001|Overall Study|Death|0|||
48686163|NCT02544503|156701928|FG000|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|24|||
48686164|NCT02544503|156701929|FG001|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|3|||
48686165|NCT02544503|156701928|FG000|Overall Study|Lost to Follow-up|9|||
48686166|NCT02544503|156701929|FG001|Overall Study|Lost to Follow-up|0|||
48686167|NCT02544503|156701928|FG000|Overall Study|Withdrawal by Subject|1|||
48686168|NCT02544503|156701929|FG001|Overall Study|Withdrawal by Subject|0|||
48686169|NCT02380287|156701933|FG000|Overall Study|Adverse Event|0|||
48686170|NCT02380287|156701934|FG001|Overall Study|Adverse Event|0|||
48686171|NCT02380287|156701935|FG002|Overall Study|Adverse Event|1|||
48686172|NCT02380287|156701936|FG003|Overall Study|Adverse Event|0|||
48686173|NCT02380287|156701937|FG004|Overall Study|Adverse Event|0|||
48686174|NCT02380287|156701938|FG005|Overall Study|Adverse Event|0|||
48686175|NCT02380287|156701939|FG006|Overall Study|Adverse Event|0|||
48686176|NCT02380287|156701940|FG007|Overall Study|Adverse Event|0|||
48686177|NCT03400852|156701941|FG000|Blinded Treatment Period|Physician Decision|0|||
48686178|NCT03400852|156701942|FG001|Blinded Treatment Period|Physician Decision|1|||
48686179|NCT03400852|156701943|FG002|Blinded Treatment Period|Physician Decision|0|||
48686180|NCT03400852|156701941|FG000|Blinded Treatment Period|Adverse Event|1|||
48686181|NCT03400852|156701942|FG001|Blinded Treatment Period|Adverse Event|1|||
48686182|NCT03400852|156701943|FG002|Blinded Treatment Period|Adverse Event|0|||
48686183|NCT03400852|156701941|FG000|Blinded Treatment Period|Study terminated by sponsor|8|||
48686184|NCT03400852|156701942|FG001|Blinded Treatment Period|Study terminated by sponsor|4|||
48686185|NCT03400852|156701943|FG002|Blinded Treatment Period|Study terminated by sponsor|0|||
48686186|NCT03400852|156701941|FG000|Open Label Period|Physician Decision|0|||
48686187|NCT03400852|156701942|FG001|Open Label Period|Physician Decision|0|||
48686188|NCT03400852|156701943|FG002|Open Label Period|Physician Decision|1|||
48686189|NCT03400852|156701941|FG000|Open Label Period|Study terminated by sponsor|0|||
48686190|NCT03400852|156701942|FG001|Open Label Period|Study terminated by sponsor|0|||
48686191|NCT03400852|156701943|FG002|Open Label Period|Study terminated by sponsor|21|||
48686192|NCT00587158|156701944|FG000|Overall Study|Did not want to do 24 hr urine collect.|4|||
48686193|NCT00587158|156701945|FG001|Overall Study|Did not want to do 24 hr urine collect.|3|||
48686194|NCT00587158|156701944|FG000|Overall Study|Physician Decision|0|||
48686195|NCT00587158|156701945|FG001|Overall Study|Physician Decision|1|||
48686196|NCT00587158|156701944|FG000|Overall Study|Lost to Follow-up|1|||
48686197|NCT00587158|156701945|FG001|Overall Study|Lost to Follow-up|2|||
48875249|NCT01496365|157381597|FG003|Overall Study|Lost to Follow-up|0|||
48875250|NCT01496365|157381598|FG004|Overall Study|Lost to Follow-up|2|||
48875251|NCT01496365|157381599|FG005|Overall Study|Lost to Follow-up|0|||
48686198|NCT00587158|156701944|FG000|Overall Study|Death|0|||
48686199|NCT00587158|156701945|FG001|Overall Study|Death|1|||
48686200|NCT00587158|156701944|FG000|Overall Study|Subject did not want to take study med|0|||
48686201|NCT00587158|156701945|FG001|Overall Study|Subject did not want to take study med|1|||
48686202|NCT03010319|156701948|FG000|Overall Study|Adverse Event|15|||
48686203|NCT03010319|156701949|FG001|Overall Study|Adverse Event|9|||
48686204|NCT03010319|156701948|FG000|Overall Study|Withdrawal by Subject|1|||
48686205|NCT03010319|156701949|FG001|Overall Study|Withdrawal by Subject|6|||
48686206|NCT03010319|156701948|FG000|Overall Study|Physician Decision|2|||
48686207|NCT03010319|156701949|FG001|Overall Study|Physician Decision|4|||
48875252|NCT01496365|157381600|FG006|Overall Study|Lost to Follow-up|0|||
48686208|NCT03010319|156701948|FG000|Overall Study|Sponsor requested withdrawal|2|||
48686209|NCT03010319|156701949|FG001|Overall Study|Sponsor requested withdrawal|2|||
48686210|NCT03010319|156701948|FG000|Overall Study|Death|1|||
48686211|NCT03010319|156701949|FG001|Overall Study|Death|0|||
48686212|NCT03010319|156701948|FG000|Overall Study|Lost to Follow-up|0|||
48686213|NCT03010319|156701949|FG001|Overall Study|Lost to Follow-up|1|||
48686214|NCT03010319|156701948|FG000|Overall Study|Other Reason|5|||
48686215|NCT03010319|156701949|FG001|Overall Study|Other Reason|7|||
48686216|NCT02532465|156701950|FG000|Overall Study|Protocol Violation|1|||
48686217|NCT02532465|156701951|FG001|Overall Study|Protocol Violation|0|||
48686218|NCT02532465|156701950|FG000|Overall Study|Lack of Efficacy|0|||
48686219|NCT02532465|156701951|FG001|Overall Study|Lack of Efficacy|1|||
48686220|NCT00718510|156701958|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
48686221|NCT00718510|156701959|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
48686222|NCT00718510|156701958|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
48686223|NCT00718510|156701959|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
48686224|NCT01217463|156701967|FG000|Overall Study|Adverse Event|8|||
48686225|NCT01217463|156701968|FG001|Overall Study|Adverse Event|5|||
48686226|NCT01217463|156701967|FG000|Overall Study|Physician Decision|0|||
48686227|NCT01217463|156701968|FG001|Overall Study|Physician Decision|1|||
48686228|NCT01217463|156701967|FG000|Overall Study|Withdrawal by Subject|3|||
48686229|NCT01217463|156701968|FG001|Overall Study|Withdrawal by Subject|0|||
48686230|NCT01217463|156701967|FG000|Overall Study|Surgery on the Target Limb|0|||
48686231|NCT01217463|156701968|FG001|Overall Study|Surgery on the Target Limb|1|||
48686232|NCT01217463|156701967|FG000|Overall Study|Patient Non-compliant|1|||
48686233|NCT01217463|156701968|FG001|Overall Study|Patient Non-compliant|0|||
48686234|NCT01217463|156701967|FG000|Overall Study|Other|1|||
48686235|NCT01217463|156701968|FG001|Overall Study|Other|1|||
48686236|NCT01521507|156701969|FG000|Stage 1: Randomized Design|Device did not fit, No Treatment|2|||
48686237|NCT01521507|156701970|FG001|Stage 1: Randomized Design|Device did not fit, No Treatment|0|||
48686238|NCT01521507|156701969|FG000|Stage 1: Randomized Design|Withdrawal by Subject|1|||
48686239|NCT01521507|156701970|FG001|Stage 1: Randomized Design|Withdrawal by Subject|3|||
48686240|NCT01521507|156701969|FG000|Stage 1: Randomized Design|Lost to Follow-up|0|||
48686241|NCT01521507|156701970|FG001|Stage 1: Randomized Design|Lost to Follow-up|2|||
48686242|NCT01521507|156701969|FG000|Stage 2: Observational Design|Device did not fit, No Treatment|0|||
48686243|NCT01521507|156701970|FG001|Stage 2: Observational Design|Device did not fit, No Treatment|1|||
48686244|NCT01521507|156701969|FG000|Stage 2: Observational Design|Withdrawal by Subject|3|||
48686245|NCT01521507|156701970|FG001|Stage 2: Observational Design|Withdrawal by Subject|1|||
48686246|NCT01521507|156701969|FG000|Stage 2: Observational Design|Physician Decision|1|||
48686247|NCT01521507|156701970|FG001|Stage 2: Observational Design|Physician Decision|0|||
48981331|NCT03605836|157764257|FG001|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
48981332|NCT03605836|157764258|FG002|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
48981333|NCT03605836|157764259|FG003|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
48981334|NCT03605836|157764256|FG000|OL Placebo Run-in Period [1 Week]|Physician Decision|7|||
48981335|NCT03605836|157764257|FG001|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
48981336|NCT03605836|157764258|FG002|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
48981337|NCT03605836|157764259|FG003|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
48686256|NCT00580723|156701974|FG000|Overall Study|Did not want to participate in extension|3|||
48686257|NCT00580723|156701974|FG000|Overall Study|Lost to Follow-up|5|||
48686258|NCT02642042|156701977|FG000|Overall Study|Adverse Event|22|||
48686259|NCT02642042|156701977|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
48686260|NCT02642042|156701977|FG000|Overall Study|Progression/Relapse|28|||
48686261|NCT02642042|156701977|FG000|Overall Study|Death|1|||
48686262|NCT02642042|156701977|FG000|Overall Study|Not Protocol Specified|2|||
48686263|NCT05962814|156701978|FG000|Overall Study|failed eligibility|1|||
48686264|NCT00362648|156701979|FG000|Overall Study|Adverse Event|12|||
48686265|NCT00362648|156701980|FG001|Overall Study|Adverse Event|21|||
48686266|NCT00362648|156701981|FG002|Overall Study|Adverse Event|1|||
48686267|NCT00362648|156701982|FG003|Overall Study|Adverse Event|0|||
48686268|NCT00362648|156701979|FG000|Overall Study|Lost to Follow-up|62|||
48686269|NCT00362648|156701980|FG001|Overall Study|Lost to Follow-up|69|||
48686270|NCT00362648|156701981|FG002|Overall Study|Lost to Follow-up|4|||
48686271|NCT00362648|156701982|FG003|Overall Study|Lost to Follow-up|3|||
48686272|NCT00362648|156701979|FG000|Overall Study|Protocol Violation|4|||
48686273|NCT00362648|156701980|FG001|Overall Study|Protocol Violation|2|||
48686274|NCT00362648|156701981|FG002|Overall Study|Protocol Violation|2|||
48686275|NCT00362648|156701982|FG003|Overall Study|Protocol Violation|2|||
48686276|NCT00362648|156701979|FG000|Overall Study|Withdrawal by Subject|48|||
48686277|NCT00362648|156701980|FG001|Overall Study|Withdrawal by Subject|42|||
48686278|NCT00362648|156701981|FG002|Overall Study|Withdrawal by Subject|2|||
48686279|NCT00362648|156701982|FG003|Overall Study|Withdrawal by Subject|6|||
48686280|NCT00165672|156701984|FG000|Overall Study|Adverse Event|0|||
48686281|NCT00165672|156701985|FG001|Overall Study|Adverse Event|1|||
48686282|NCT05318937|156701986|FG000|Overall Study|Non-Compliance with Study Drug|1|||
48686283|NCT05318937|156701987|FG001|Overall Study|Non-Compliance with Study Drug|0|||
48686284|NCT05318937|156701986|FG000|Overall Study|Lost to Follow-up|0|||
48686285|NCT05318937|156701987|FG001|Overall Study|Lost to Follow-up|1|||
48686286|NCT05318937|156701986|FG000|Overall Study|Withdrawal by Subject|0|||
48686287|NCT05318937|156701987|FG001|Overall Study|Withdrawal by Subject|2|||
48686288|NCT05318937|156701986|FG000|Overall Study|Protocol Violation|0|||
48686289|NCT05318937|156701987|FG001|Overall Study|Protocol Violation|1|||
48686290|NCT02532621|156701988|FG000|Overall Study|Death|3|||
48686291|NCT02532621|156701988|FG000|Overall Study|Lost to Follow-up|3|||
48686292|NCT02532621|156701988|FG000|Overall Study|Withdrawal by Subject|6|||
48686293|NCT02532621|156701988|FG000|Overall Study|implanted graft abandoned before 6 months|12|||
48686294|NCT02532621|156701988|FG000|Overall Study|last follow up performed outside window (<166 days) -censored|2|||
48981338|NCT03605836|157764256|FG000|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85|||
48981339|NCT03605836|157764257|FG001|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
48981340|NCT03605836|157764258|FG002|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
48981341|NCT03605836|157764259|FG003|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
49022868|NCT00048048|157922647|FG002|Extension Year 1|Early withdrawals|0|||
48981342|NCT03605836|157764256|FG000|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15|||
48981343|NCT03605836|157764257|FG001|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
48981344|NCT03605836|157764258|FG002|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
48981345|NCT03605836|157764259|FG003|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
48981346|NCT03605836|157764256|FG000|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1|||
49022869|NCT00048048|157922648|FG003|Extension Year 1|Early withdrawals|0|||
49022870|NCT00048048|157922649|FG004|Extension Year 1|Early withdrawals|0|||
49022871|NCT00048048|157922650|FG005|Extension Year 1|Early withdrawals|0|||
49022872|NCT00048048|157922651|FG006|Extension Year 1|Early withdrawals|0|||
49022873|NCT00048048|157922652|FG007|Extension Year 1|Early withdrawals|0|||
49022874|NCT00048048|157922653|FG008|Extension Year 1|Early withdrawals|0|||
49022875|NCT00048048|157922654|FG009|Extension Year 1|Early withdrawals|2|||
49022876|NCT00048048|157922655|FG010|Extension Year 1|Early withdrawals|2|||
49022877|NCT00048048|157922656|FG011|Extension Year 1|Early withdrawals|4|||
49022878|NCT00048048|157922645|FG000|Extension Year 2|Early withdrawals|0|||
49022879|NCT00048048|157922646|FG001|Extension Year 2|Early withdrawals|0|||
49022880|NCT00048048|157922647|FG002|Extension Year 2|Early withdrawals|0|||
49022881|NCT00048048|157922648|FG003|Extension Year 2|Early withdrawals|0|||
49022882|NCT00048048|157922649|FG004|Extension Year 2|Early withdrawals|0|||
49022883|NCT00048048|157922650|FG005|Extension Year 2|Early withdrawals|0|||
49022884|NCT00048048|157922651|FG006|Extension Year 2|Early withdrawals|0|||
49022885|NCT00048048|157922652|FG007|Extension Year 2|Early withdrawals|0|||
49022886|NCT00048048|157922653|FG008|Extension Year 2|Early withdrawals|0|||
49022887|NCT00048048|157922654|FG009|Extension Year 2|Early withdrawals|0|||
49022888|NCT00048048|157922655|FG010|Extension Year 2|Early withdrawals|4|||
49022889|NCT00048048|157922656|FG011|Extension Year 2|Early withdrawals|2|||
49022890|NCT03992196|157922657|FG000|Enrollment|lost to follow-up prior dosing|1|||
49022891|NCT03992196|157922658|FG001|Enrollment|lost to follow-up prior dosing|0|||
49022892|NCT03992196|157922659|FG002|Enrollment|lost to follow-up prior dosing|0|||
49022893|NCT03992196|157922657|FG000|Treatment|Protocol Violation|0|||
49022894|NCT03992196|157922658|FG001|Treatment|Protocol Violation|0|||
49022895|NCT03992196|157922659|FG002|Treatment|Protocol Violation|1|||
49022896|NCT03992196|157922657|FG000|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
49022897|NCT03992196|157922658|FG001|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
49022898|NCT03992196|157922659|FG002|Treatment|Poor drug compliance withdrawn by team and sponsor|1|||
49022899|NCT03992196|157922657|FG000|Treatment|Withdrawal due to non-compliance|0|||
49022900|NCT03992196|157922658|FG001|Treatment|Withdrawal due to non-compliance|0|||
49022901|NCT03992196|157922659|FG002|Treatment|Withdrawal due to non-compliance|1|||
49022902|NCT03992196|157922657|FG000|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
49022903|NCT03992196|157922658|FG001|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
49022904|NCT03992196|157922659|FG002|Treatment|PI's decision due to investigational medicinal product non-compliance|1|||
49022905|NCT03992196|157922657|FG000|Treatment|Withdrawal by parent/guardian|0|||
48981347|NCT03605836|157764257|FG001|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
48981348|NCT03605836|157764258|FG002|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
48981349|NCT03605836|157764259|FG003|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
48981350|NCT03605836|157764256|FG000|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0|||
48981351|NCT03605836|157764257|FG001|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2|||
49022906|NCT03992196|157922658|FG001|Treatment|Withdrawal by parent/guardian|0|||
49022907|NCT03992196|157922659|FG002|Treatment|Withdrawal by parent/guardian|2|||
49022908|NCT02684578|157922662|FG000|Overall Study|Withdrawal by Subject|10|||
49022909|NCT02684578|157922663|FG001|Overall Study|Withdrawal by Subject|7|||
49022910|NCT02684578|157922662|FG000|Overall Study|Lost to Follow-up|0|||
49022911|NCT02684578|157922663|FG001|Overall Study|Lost to Follow-up|3|||
48981352|NCT03605836|157764258|FG002|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
48981353|NCT03605836|157764259|FG003|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
48981354|NCT03605836|157764256|FG000|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
48981355|NCT03605836|157764257|FG001|Double-blind Treatment Period [6 Weeks]|Adverse Event|5|||
48981356|NCT03605836|157764258|FG002|Double-blind Treatment Period [6 Weeks]|Adverse Event|8|||
48981357|NCT03605836|157764259|FG003|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
48981358|NCT03605836|157764256|FG000|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
48981359|NCT03605836|157764257|FG001|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
48981360|NCT03605836|157764258|FG002|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2|||
48981361|NCT03605836|157764259|FG003|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1|||
48981362|NCT03605836|157764256|FG000|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0|||
48981363|NCT03605836|157764257|FG001|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3|||
48981364|NCT03605836|157764258|FG002|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5|||
48981365|NCT03605836|157764259|FG003|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1|||
48981366|NCT03605836|157764256|FG000|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
48981367|NCT03605836|157764257|FG001|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1|||
48981368|NCT03605836|157764258|FG002|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
48981369|NCT03605836|157764259|FG003|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4|||
48981370|NCT03605836|157764256|FG000|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
48981371|NCT03605836|157764257|FG001|Double-blind Treatment Period [6 Weeks]|Pregnancy|1|||
48981372|NCT03605836|157764258|FG002|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
48981373|NCT03605836|157764259|FG003|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
48981374|NCT03605836|157764256|FG000|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0|||
48981375|NCT03605836|157764257|FG001|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5|||
48981376|NCT03605836|157764258|FG002|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
48981377|NCT03605836|157764259|FG003|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
48981378|NCT03605836|157764256|FG000|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0|||
48981379|NCT03605836|157764257|FG001|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10|||
49022912|NCT02684578|157922662|FG000|Overall Study|Ineligible after reviewing baseline imaging|1|||
49022913|NCT02684578|157922663|FG001|Overall Study|Ineligible after reviewing baseline imaging|0|||
49022914|NCT02684578|157922662|FG000|Overall Study|Missing follow-up data|0|||
49022915|NCT02684578|157922663|FG001|Overall Study|Missing follow-up data|1|||
49022916|NCT01505530|157922665|FG000|Overall Study|Progressive Disease|19|||
49022917|NCT01505530|157922666|FG001|Overall Study|Progressive Disease|17|||
49022918|NCT01505530|157922667|FG002|Overall Study|Progressive Disease|18|||
48686351|NCT01251861|156701998|FG000|Overall Study|Disease progression|6|||
48686352|NCT01251861|156701999|FG001|Overall Study|Disease progression|6|||
48686353|NCT01251861|156701998|FG000|Overall Study|Adverse Event|2|||
48686354|NCT01251861|156701999|FG001|Overall Study|Adverse Event|17|||
48686355|NCT01251861|156701998|FG000|Overall Study|Withdrawal by Subject|2|||
49022919|NCT01505530|157922665|FG000|Overall Study|Adverse Event|1|||
49022920|NCT01505530|157922666|FG001|Overall Study|Adverse Event|1|||
49022921|NCT01505530|157922667|FG002|Overall Study|Adverse Event|0|||
49022922|NCT01505530|157922665|FG000|Overall Study|Withdrawal by Subject|7|||
49022923|NCT01505530|157922666|FG001|Overall Study|Withdrawal by Subject|8|||
48686356|NCT01251861|156701999|FG001|Overall Study|Withdrawal by Subject|2|||
48686357|NCT01251861|156701998|FG000|Overall Study|Alternative therapy|1|||
48686358|NCT01251861|156701999|FG001|Overall Study|Alternative therapy|0|||
48686359|NCT01251861|156701998|FG000|Overall Study|Other complicating disease|0|||
48686360|NCT01251861|156701999|FG001|Overall Study|Other complicating disease|1|||
48686361|NCT01251861|156701998|FG000|Overall Study|Physician Decision|1|||
48686362|NCT01251861|156701999|FG001|Overall Study|Physician Decision|0|||
48686363|NCT01251861|156701998|FG000|Overall Study|Continued treatment beyond 18 cycles|1|||
48686364|NCT01251861|156701999|FG001|Overall Study|Continued treatment beyond 18 cycles|0|||
48686365|NCT01251861|156701998|FG000|Overall Study|Other|1|||
48686366|NCT01251861|156701999|FG001|Overall Study|Other|0|||
48686367|NCT01251861|156701998|FG000|Overall Study|Never started therapy|4|||
48686368|NCT01251861|156701999|FG001|Overall Study|Never started therapy|1|||
48686369|NCT01251861|156701998|FG000|Overall Study|Potential interaction of drugs|0|||
48686370|NCT01251861|156701999|FG001|Overall Study|Potential interaction of drugs|1|||
48686371|NCT03976323|156702002|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|251|||
48686372|NCT03976323|156702003|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
48686373|NCT03976323|156702004|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
48686374|NCT03976323|156702002|FG000|Induction Phase|Death|80|||
48686375|NCT03976323|156702003|FG001|Induction Phase|Death|0|||
48686376|NCT03976323|156702004|FG002|Induction Phase|Death|0|||
48686377|NCT03976323|156702002|FG000|Maintenance Phase|Participant Ongoing in Study|0|||
48686378|NCT03976323|156702003|FG001|Maintenance Phase|Participant Ongoing in Study|100|||
48686379|NCT03976323|156702004|FG002|Maintenance Phase|Participant Ongoing in Study|97|||
48686380|NCT03976323|156702002|FG000|Maintenance Phase|Withdrawal by Subject|0|||
48686381|NCT03976323|156702003|FG001|Maintenance Phase|Withdrawal by Subject|9|||
48686382|NCT03976323|156702004|FG002|Maintenance Phase|Withdrawal by Subject|3|||
48686383|NCT03976323|156702002|FG000|Maintenance Phase|Physician Decision|0|||
48686384|NCT03976323|156702003|FG001|Maintenance Phase|Physician Decision|0|||
48686385|NCT03976323|156702004|FG002|Maintenance Phase|Physician Decision|1|||
48686386|NCT03976323|156702002|FG000|Maintenance Phase|Death|0|||
48686387|NCT03976323|156702003|FG001|Maintenance Phase|Death|228|||
48686388|NCT03976323|156702004|FG002|Maintenance Phase|Death|234|||
48686389|NCT01928927|156702005|FG000|Overall Study|Lost to Follow-up|1|||
48686390|NCT01928927|156702006|FG001|Overall Study|Lost to Follow-up|0|||
48686391|NCT01928927|156702005|FG000|Overall Study|Withdrawal by Subject|1|||
48686392|NCT01928927|156702006|FG001|Overall Study|Withdrawal by Subject|1|||
48686393|NCT03058692|156703590|FG000|Overall Study|Lost to Follow-up|2|||
48686394|NCT03058692|156703591|FG001|Overall Study|Lost to Follow-up|1|||
48686395|NCT03058692|156703590|FG000|Overall Study|Withdrawal by Subject|1|||
48686396|NCT03058692|156703591|FG001|Overall Study|Withdrawal by Subject|1|||
48686397|NCT04775953|156703592|FG000|Overall Study|Lost to Follow-up|6|||
48686398|NCT04775953|156703593|FG001|Overall Study|Lost to Follow-up|11|||
48686399|NCT04775953|156703592|FG000|Overall Study|Death|5|||
48686400|NCT04775953|156703593|FG001|Overall Study|Death|4|||
48686401|NCT04775953|156703592|FG000|Overall Study|Withdrawal by Subject|3|||
48686402|NCT04775953|156703593|FG001|Overall Study|Withdrawal by Subject|3|||
48686403|NCT04775953|156703592|FG000|Overall Study|Protocol Violation|2|||
48686404|NCT04775953|156703593|FG001|Overall Study|Protocol Violation|0|||
48686405|NCT04775953|156703592|FG000|Overall Study|Participant non-compliance|0|||
48686406|NCT04775953|156703593|FG001|Overall Study|Participant non-compliance|1|||
48686407|NCT03777059|156703594|FG000|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
48686408|NCT03777059|156703595|FG001|DB Treatment Period (Up to Week 12)|Adverse Event|9|||
48686409|NCT03777059|156703596|FG002|DB Treatment Period (Up to Week 12)|Adverse Event|4|||
48686410|NCT03777059|156703597|FG003|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
48686411|NCT03777059|156703594|FG000|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
48686412|NCT03777059|156703595|FG001|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
48686413|NCT03777059|156703596|FG002|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
48686414|NCT03777059|156703597|FG003|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
48686415|NCT03777059|156703594|FG000|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
48686416|NCT03777059|156703595|FG001|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9|||
48686417|NCT03777059|156703596|FG002|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
48686418|NCT03777059|156703597|FG003|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10|||
48686419|NCT03777059|156703594|FG000|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
48686420|NCT03777059|156703595|FG001|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
48686421|NCT03777059|156703596|FG002|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4|||
48686422|NCT03777059|156703597|FG003|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5|||
48686423|NCT03777059|156703594|FG000|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
48686424|NCT03777059|156703595|FG001|DB Treatment Period (Up to Week 12)|Pregnancy|1|||
48686425|NCT03777059|156703596|FG002|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
48686426|NCT03777059|156703597|FG003|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
48686427|NCT03777059|156703594|FG000|DB Treatment Period (Up to Week 12)|Protocol Deviation|4|||
48686428|NCT03777059|156703595|FG001|DB Treatment Period (Up to Week 12)|Protocol Deviation|5|||
48686429|NCT03777059|156703596|FG002|DB Treatment Period (Up to Week 12)|Protocol Deviation|7|||
48686430|NCT03777059|156703597|FG003|DB Treatment Period (Up to Week 12)|Protocol Deviation|8|||
48686431|NCT03777059|156703594|FG000|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
48686432|NCT03777059|156703595|FG001|DB Treatment Period (Up to Week 12)|Reason Not Specified|2|||
48686433|NCT03777059|156703596|FG002|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
48686434|NCT03777059|156703597|FG003|DB Treatment Period (Up to Week 12)|Reason Not Specified|1|||
48686435|NCT03777059|156703594|FG000|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
48686436|NCT03777059|156703595|FG001|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3|||
48686437|NCT03777059|156703596|FG002|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4|||
48686438|NCT03777059|156703597|FG003|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
48686439|NCT03777059|156703594|FG000|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
48686440|NCT03777059|156703595|FG001|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1|||
48686441|NCT03777059|156703596|FG002|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
48686442|NCT03777059|156703597|FG003|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3|||
48686443|NCT03777059|156703594|FG000|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
48686444|NCT03777059|156703595|FG001|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
48686445|NCT03777059|156703596|FG002|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
48686446|NCT03777059|156703597|FG003|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
48686447|NCT03777059|156703594|FG000|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
48686448|NCT03777059|156703595|FG001|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
48686449|NCT03777059|156703596|FG002|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
48686450|NCT03777059|156703597|FG003|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
48686451|NCT04426318|156703603|FG000|Overall Study|failed attention checks and had their data removed from analyses|2|||
48686452|NCT04426318|156703604|FG001|Overall Study|failed attention checks and had their data removed from analyses|2|||
48686453|NCT03294590|156703610|FG000|Overall Study|Lost to Follow-up|105|||
48686454|NCT03294590|156703611|FG001|Overall Study|Lost to Follow-up|107|||
49022924|NCT01505530|157922667|FG002|Overall Study|Withdrawal by Subject|6|||
49022925|NCT01505530|157922665|FG000|Overall Study|Physician Decision|6|||
49022926|NCT01505530|157922666|FG001|Overall Study|Physician Decision|2|||
49022927|NCT01505530|157922667|FG002|Overall Study|Physician Decision|5|||
49022928|NCT01505530|157922665|FG000|Overall Study|Sponsor Decision|1|||
49022929|NCT01505530|157922666|FG001|Overall Study|Sponsor Decision|8|||
49022930|NCT01505530|157922667|FG002|Overall Study|Sponsor Decision|7|||
49022931|NCT01505530|157922665|FG000|Overall Study|Death|7|||
49022932|NCT01505530|157922666|FG001|Overall Study|Death|6|||
49022933|NCT01505530|157922667|FG002|Overall Study|Death|5|||
49022934|NCT01505530|157922665|FG000|Overall Study|entry criteria not met|0|||
49022935|NCT01505530|157922666|FG001|Overall Study|entry criteria not met|1|||
49022936|NCT01505530|157922667|FG002|Overall Study|entry criteria not met|0|||
49022937|NCT02388763|157922668|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
49022938|NCT02388763|157922669|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
49022939|NCT02388763|157922668|FG000|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
49022940|NCT02388763|157922669|FG001|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
49022941|NCT00365300|157922676|FG000|Open-label Phase|Adverse Event|4|||
48686455|NCT03187132|156703612|FG000|Inpatient Trauma Only|Lost to Follow-up|3|||
48686456|NCT03187132|156703613|FG001|Inpatient Trauma Only|Lost to Follow-up|12|||
48686457|NCT03187132|156703612|FG000|Inpatient Trauma Only|socioeconomic burden|1|||
48686458|NCT03187132|156703613|FG001|Inpatient Trauma Only|socioeconomic burden|0|||
48686459|NCT03187132|156703612|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0|||
48686460|NCT03187132|156703613|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5|||
48686461|NCT03187132|156703612|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1|||
48686462|NCT03187132|156703613|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0|||
48686463|NCT03187132|156703612|FG000|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2|||
48686464|NCT03187132|156703613|FG001|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5|||
48686465|NCT03187132|156703612|FG000|Inpatient Trauma+Pain Clinic|Disease burden|1|||
48686466|NCT03187132|156703613|FG001|Inpatient Trauma+Pain Clinic|Disease burden|0|||
48686467|NCT03187132|156703612|FG000|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0|||
48686468|NCT03187132|156703613|FG001|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2|||
48686469|NCT03187132|156703612|FG000|Pain Clinic Only, Fully Remote|Lost to Follow-up|27|||
48686470|NCT03187132|156703613|FG001|Pain Clinic Only, Fully Remote|Lost to Follow-up|47|||
48686471|NCT03187132|156703612|FG000|Pain Clinic Only, Fully Remote|Disease burden|6|||
48686472|NCT03187132|156703613|FG001|Pain Clinic Only, Fully Remote|Disease burden|5|||
48686473|NCT03187132|156703612|FG000|Pain Clinic Only, Fully Remote|Language barrier|0|||
48686474|NCT03187132|156703613|FG001|Pain Clinic Only, Fully Remote|Language barrier|1|||
48686475|NCT03187132|156703612|FG000|Pain Clinic Only, Fully Remote|EMR|0|||
48686476|NCT03187132|156703613|FG001|Pain Clinic Only, Fully Remote|EMR|1|||
48686477|NCT03191630|156703614|FG000|Overall Study|Lost to Follow-up|7|||
48686478|NCT03191630|156703615|FG001|Overall Study|Lost to Follow-up|7|||
48686479|NCT02525588|156703616|FG000|Overall Study|Death|3|||
48686480|NCT02525588|156703617|FG001|Overall Study|Death|1|||
48686481|NCT02525588|156703616|FG000|Overall Study|Lost to Follow-up|2|||
48686482|NCT02525588|156703617|FG001|Overall Study|Lost to Follow-up|0|||
48686483|NCT02525588|156703616|FG000|Overall Study|Withdrawal by Subject|1|||
48686484|NCT02525588|156703617|FG001|Overall Study|Withdrawal by Subject|1|||
48686485|NCT02525588|156703616|FG000|Overall Study|Adverse Event|0|||
48686486|NCT02525588|156703617|FG001|Overall Study|Adverse Event|1|||
48686487|NCT03018691|156703618|FG000|Overall Study|Adverse Event|1|||
48686488|NCT03018691|156703619|FG001|Overall Study|Adverse Event|1|||
48686489|NCT03018691|156703620|FG002|Overall Study|Adverse Event|4|||
48686490|NCT03018691|156703618|FG000|Overall Study|Lack of Efficacy|0|||
48686491|NCT03018691|156703619|FG001|Overall Study|Lack of Efficacy|0|||
49022942|NCT00365300|157922677|FG001|Open-label Phase|Adverse Event|0|||
49022943|NCT00365300|157922676|FG000|Open-label Phase|Failed to Return|1|||
49022944|NCT00365300|157922677|FG001|Open-label Phase|Failed to Return|0|||
49022945|NCT00365300|157922676|FG000|Open-label Phase|Physician Decision|1|||
49022946|NCT00365300|157922677|FG001|Open-label Phase|Physician Decision|0|||
49022947|NCT00365300|157922676|FG000|Open-label Phase|Noncompliance|9|||
49022948|NCT00365300|157922677|FG001|Open-label Phase|Noncompliance|0|||
48686492|NCT03018691|156703620|FG002|Overall Study|Lack of Efficacy|1|||
48686493|NCT03018691|156703618|FG000|Overall Study|Withdrawal by Subject|0|||
48686494|NCT03018691|156703619|FG001|Overall Study|Withdrawal by Subject|0|||
48686495|NCT03018691|156703620|FG002|Overall Study|Withdrawal by Subject|1|||
48686496|NCT03018691|156703618|FG000|Overall Study|Withdrawal by parent/guardian|1|||
48686497|NCT03018691|156703619|FG001|Overall Study|Withdrawal by parent/guardian|0|||
48686498|NCT03018691|156703620|FG002|Overall Study|Withdrawal by parent/guardian|1|||
49022949|NCT00365300|157922676|FG000|Open-label Phase|Parent/Legal Guardian Request|4|||
49022950|NCT00365300|157922677|FG001|Open-label Phase|Parent/Legal Guardian Request|0|||
49022951|NCT00365300|157922676|FG000|Open-label Phase|Protocol Violation|1|||
49022952|NCT00365300|157922677|FG001|Open-label Phase|Protocol Violation|0|||
49022953|NCT00365300|157922676|FG000|Open-label Phase|Lack of Efficacy|1|||
49022954|NCT00365300|157922677|FG001|Open-label Phase|Lack of Efficacy|0|||
49022955|NCT00365300|157922676|FG000|Open-label Phase|Patient skipped open label phase|1|||
49022956|NCT00365300|157922677|FG001|Open-label Phase|Patient skipped open label phase|0|||
49022957|NCT00365300|157922676|FG000|Double-blind Phase|Failed to return|1|||
49022958|NCT00365300|157922677|FG001|Double-blind Phase|Failed to return|0|||
49022959|NCT00365300|157922676|FG000|Double-blind Phase|Noncompliance|1|||
49022960|NCT00365300|157922677|FG001|Double-blind Phase|Noncompliance|1|||
49022961|NCT00365300|157922676|FG000|Double-blind Phase|Withdrawal by Subject|0|||
49022962|NCT00365300|157922677|FG001|Double-blind Phase|Withdrawal by Subject|1|||
49022963|NCT00365300|157922676|FG000|Double-blind Phase|Protocol Violation|3|||
49022964|NCT00365300|157922677|FG001|Double-blind Phase|Protocol Violation|1|||
49022965|NCT00365300|157922676|FG000|Double-blind Phase|Lack of Efficacy|6|||
49022966|NCT00365300|157922677|FG001|Double-blind Phase|Lack of Efficacy|6|||
49022967|NCT01991470|157922678|FG000|Enlite 1 Period|Withdrawal by Subject|18|||
49022968|NCT01991470|157922678|FG000|Enlite 1 Period|Adverse Event|1|||
49022969|NCT01991470|157922678|FG000|Enlite 1 Period|Inclusion/Exclusion not met|1|||
49022970|NCT01991470|157922678|FG000|Enlite 3 Period|Lost to Follow-up|1|||
49022971|NCT01991470|157922678|FG000|Enlite 3 Period|Physician Decision|2|||
48686499|NCT02611479|156703624|FG000|Baseline Enrollment|Exited study|13|||
48686500|NCT02611479|156703624|FG000|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2|||
48686501|NCT02611479|156703624|FG000|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18|||
48686502|NCT02611479|156703624|FG000|Data Cleaning|No baseline function or pain metrics|2|||
48981380|NCT03605836|157764258|FG002|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6|||
48981381|NCT03605836|157764259|FG003|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4|||
48981382|NCT03605836|157764256|FG000|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
48981383|NCT03605836|157764257|FG001|Double-blind Treatment Period [6 Weeks]|Physician Decision|3|||
48981384|NCT03605836|157764258|FG002|Double-blind Treatment Period [6 Weeks]|Physician Decision|1|||
48981385|NCT03605836|157764259|FG003|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
48981386|NCT03605836|157764256|FG000|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0|||
48981387|NCT03605836|157764257|FG001|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6|||
48981388|NCT03605836|157764258|FG002|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16|||
48981389|NCT03605836|157764259|FG003|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7|||
48981390|NCT03605836|157764256|FG000|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
48981391|NCT03605836|157764257|FG001|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
48981392|NCT03605836|157764258|FG002|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2|||
48981393|NCT03605836|157764259|FG003|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1|||
48981394|NCT01642004|157764265|FG000|Randomization|Adverse Event unrelated to study drug|1|||
48981395|NCT01642004|157764266|FG001|Randomization|Adverse Event unrelated to study drug|0|||
48981396|NCT01642004|157764265|FG000|Randomization|Participant withdrew consent|1|||
48981397|NCT01642004|157764266|FG001|Randomization|Participant withdrew consent|6|||
48981398|NCT01642004|157764265|FG000|Randomization|No longer meets study criteria|2|||
48981399|NCT01642004|157764266|FG001|Randomization|No longer meets study criteria|2|||
48981400|NCT01642004|157764265|FG000|Treatment|Disease progression|95|||
48981401|NCT01642004|157764266|FG001|Treatment|Disease progression|79|||
48981402|NCT01642004|157764265|FG000|Treatment|Study drug toxicity|10|||
48981403|NCT01642004|157764266|FG001|Treatment|Study drug toxicity|13|||
48981404|NCT01642004|157764265|FG000|Treatment|Death|1|||
48981405|NCT01642004|157764266|FG001|Treatment|Death|1|||
48981406|NCT01642004|157764265|FG000|Treatment|Adverse event unrelated to study drug|9|||
48981407|NCT01642004|157764266|FG001|Treatment|Adverse event unrelated to study drug|13|||
48981408|NCT01642004|157764265|FG000|Treatment|Maximum clinical benefit|1|||
48981409|NCT01642004|157764266|FG001|Treatment|Maximum clinical benefit|9|||
48981410|NCT01642004|157764265|FG000|Treatment|Poor/non-compliance|1|||
49022972|NCT01991470|157922678|FG000|Enlite 3 Period|Physician Decision|8|||
49022973|NCT01991470|157922678|FG000|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1|||
49022974|NCT00243932|157922679|FG000|Stage 1: Dose Selection|Lost to Follow-up|2|||
49022975|NCT00243932|157922680|FG001|Stage 1: Dose Selection|Lost to Follow-up|0|||
49022976|NCT00243932|157922681|FG002|Stage 1: Dose Selection|Lost to Follow-up|0|||
48686539|NCT01708941|156703630|FG000|Overall Study|Adverse Event|4|||
49022977|NCT02194998|157922682|FG000|On-HCV Treatment|Did not pick up study medication|0|||
49022978|NCT02194998|157922683|FG001|On-HCV Treatment|Did not pick up study medication|1|||
48686540|NCT01708941|156703631|FG001|Overall Study|Adverse Event|6|||
48686541|NCT01708941|156703632|FG002|Overall Study|Adverse Event|1|||
48686542|NCT01708941|156703633|FG003|Overall Study|Adverse Event|0|||
48686543|NCT01708941|156703630|FG000|Overall Study|Death|1|||
48686544|NCT01708941|156703631|FG001|Overall Study|Death|1|||
48686545|NCT01708941|156703632|FG002|Overall Study|Death|2|||
48686546|NCT01708941|156703633|FG003|Overall Study|Death|14|||
48686547|NCT01708941|156703630|FG000|Overall Study|Withdrawal by Subject|1|||
48686548|NCT01708941|156703631|FG001|Overall Study|Withdrawal by Subject|0|||
49022979|NCT02194998|157922684|FG002|On-HCV Treatment|Did not pick up study medication|0|||
49022980|NCT02194998|157922685|FG003|On-HCV Treatment|Did not pick up study medication|0|||
49022981|NCT02194998|157922682|FG000|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
49022982|NCT02194998|157922683|FG001|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
49022983|NCT02194998|157922684|FG002|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
49022984|NCT02194998|157922685|FG003|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
49022985|NCT05150964|157922690|FG000|Overall Study|Lost to Follow-up|2|||
49022986|NCT01273181|157922691|FG000|Phase I, Dose 1|Study termination|1|||
49022987|NCT01273181|157922692|FG001|Phase I, Dose 1|Study termination|0|||
49022988|NCT01273181|157922693|FG002|Phase I, Dose 1|Study termination|0|||
49022989|NCT01273181|157922694|FG003|Phase I, Dose 1|Study termination|0|||
49022990|NCT01273181|157922691|FG000|Phase I, Dose 2|Death during treatment|0|||
49022991|NCT01273181|157922692|FG001|Phase I, Dose 2|Death during treatment|1|||
49022992|NCT01273181|157922693|FG002|Phase I, Dose 2|Death during treatment|0|||
48686549|NCT01708941|156703632|FG002|Overall Study|Withdrawal by Subject|3|||
48686550|NCT01708941|156703633|FG003|Overall Study|Withdrawal by Subject|4|||
48686551|NCT01708941|156703630|FG000|Overall Study|Disease progression|9|||
48686552|NCT01708941|156703631|FG001|Overall Study|Disease progression|10|||
48686553|NCT01708941|156703632|FG002|Overall Study|Disease progression|8|||
48875253|NCT01496365|157381594|FG000|Overall Study|Other|4|||
49022993|NCT01273181|157922694|FG003|Phase I, Dose 2|Death during treatment|0|||
48686554|NCT01708941|156703633|FG003|Overall Study|Disease progression|0|||
48686555|NCT01708941|156703630|FG000|Overall Study|Alternative therapy|0|||
48686556|NCT01708941|156703631|FG001|Overall Study|Alternative therapy|0|||
48686557|NCT01708941|156703632|FG002|Overall Study|Alternative therapy|2|||
48686558|NCT01708941|156703633|FG003|Overall Study|Alternative therapy|0|||
48686559|NCT01708941|156703630|FG000|Overall Study|Ineligible and never started treatment|1|||
48686560|NCT01708941|156703631|FG001|Overall Study|Ineligible and never started treatment|0|||
48686561|NCT01708941|156703632|FG002|Overall Study|Ineligible and never started treatment|1|||
48686562|NCT01708941|156703633|FG003|Overall Study|Ineligible and never started treatment|0|||
48686563|NCT01708941|156703630|FG000|Overall Study|Never started treatment|2|||
48686564|NCT01708941|156703631|FG001|Overall Study|Never started treatment|1|||
48686565|NCT01708941|156703632|FG002|Overall Study|Never started treatment|0|||
48686566|NCT01708941|156703633|FG003|Overall Study|Never started treatment|0|||
48763251|NCT03662542|156983809|FG003|Safety Follow-up (Week 38- Week 50)|Death|0|||
48763252|NCT03662542|156983810|FG004|Safety Follow-up (Week 38- Week 50)|Death|0|||
48763253|NCT03662542|156983811|FG005|Safety Follow-up (Week 38- Week 50)|Death|0|||
48763254|NCT03662542|156983812|FG006|Safety Follow-up (Week 38- Week 50)|Death|0|||
48763255|NCT03662542|156983813|FG007|Safety Follow-up (Week 38- Week 50)|Death|1|||
48763256|NCT03662542|156983814|FG008|Safety Follow-up (Week 38- Week 50)|Death|0|||
49022994|NCT01273181|157922691|FG000|Phase 2, Dose 1|Study termination|0|||
49022995|NCT01273181|157922692|FG001|Phase 2, Dose 1|Study termination|0|||
49022996|NCT01273181|157922693|FG002|Phase 2, Dose 1|Study termination|1|||
49022997|NCT01273181|157922694|FG003|Phase 2, Dose 1|Study termination|0|||
49022998|NCT01273181|157922691|FG000|Phase 2, Dose 2|Death during treatment|0|||
49022999|NCT01273181|157922692|FG001|Phase 2, Dose 2|Death during treatment|0|||
49023000|NCT01273181|157922693|FG002|Phase 2, Dose 2|Death during treatment|0|||
49023001|NCT01273181|157922694|FG003|Phase 2, Dose 2|Death during treatment|1|||
49023002|NCT03361228|157922711|FG000|Overall Study|Other|1|||
49023003|NCT03361228|157922712|FG001|Overall Study|Other|1|||
49023004|NCT03361228|157922711|FG000|Overall Study|Death|3|||
49023005|NCT03361228|157922712|FG001|Overall Study|Death|0|||
49023006|NCT02016170|157922713|FG000|Overall Study|Adverse Event|1|||
49023007|NCT02016170|157922714|FG001|Overall Study|Adverse Event|1|||
49023008|NCT02016170|157922715|FG002|Overall Study|Adverse Event|0|||
49023009|NCT02016170|157922713|FG000|Overall Study|Protocol Violation|1|||
49023010|NCT02016170|157922714|FG001|Overall Study|Protocol Violation|0|||
48763257|NCT03662542|156983806|FG000|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
48763258|NCT03662542|156983807|FG001|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
48763259|NCT03662542|156983808|FG002|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
48875254|NCT01496365|157381595|FG001|Overall Study|Other|4|||
48875255|NCT01496365|157381596|FG002|Overall Study|Other|2|||
48875256|NCT01496365|157381597|FG003|Overall Study|Other|1|||
48875257|NCT01496365|157381598|FG004|Overall Study|Other|3|||
49023011|NCT02016170|157922715|FG002|Overall Study|Protocol Violation|0|||
49023012|NCT02930005|157922721|FG000|Overall Study|Lost to Follow-up|1|||
49023013|NCT02930005|157922722|FG001|Overall Study|Lost to Follow-up|5|||
49023014|NCT05067647|157922723|FG000|Overall Study|Lost to Follow-up|1|||
49023015|NCT01759290|157922724|FG000|Overall Study|Subjects withdrawn consent|5|||
48686567|NCT01708941|156703630|FG000|Overall Study|Ineligible|0|||
49023016|NCT01759290|157922724|FG000|Overall Study|Physician Decision|2|||
49023017|NCT01759290|157922724|FG000|Overall Study|Death|17|||
48686568|NCT01708941|156703631|FG001|Overall Study|Ineligible|0|||
48686569|NCT01708941|156703632|FG002|Overall Study|Ineligible|2|||
48686570|NCT01708941|156703633|FG003|Overall Study|Ineligible|0|||
48686571|NCT02698826|156703634|FG000|Overall Study|Death|13|||
48875258|NCT01496365|157381599|FG005|Overall Study|Other|0|||
49023018|NCT01759290|157922724|FG000|Overall Study|Lost to Follow-up|53|||
49023019|NCT01759290|157922724|FG000|Overall Study|Unknown reason|4|||
49023020|NCT03897088|157922727|FG000|Overall Study|Withdrawal by Subject|12|||
49023021|NCT03897088|157922728|FG001|Overall Study|Withdrawal by Subject|12|||
48686572|NCT02698826|156703634|FG000|Overall Study|Adverse Event|1|||
48686573|NCT00867165|156703635|FG000|Overall Study|Adverse Event|3|||
48686574|NCT00867165|156703636|FG001|Overall Study|Adverse Event|0|||
48686575|NCT00867165|156703635|FG000|Overall Study|Withdrawal by Subject|1|||
48686576|NCT00867165|156703636|FG001|Overall Study|Withdrawal by Subject|0|||
48686577|NCT03275740|156703637|FG000|Overall Study|Adverse Event|0|||
48686578|NCT03275740|156703638|FG001|Overall Study|Adverse Event|0|||
48686579|NCT03275740|156703639|FG002|Overall Study|Adverse Event|0|||
48686580|NCT03275740|156703640|FG003|Overall Study|Adverse Event|0|||
48686581|NCT03275740|156703641|FG004|Overall Study|Adverse Event|1|||
48686582|NCT03275740|156703642|FG005|Overall Study|Adverse Event|0|||
48686583|NCT03275740|156703643|FG006|Overall Study|Adverse Event|0|||
48686584|NCT03275740|156703644|FG007|Overall Study|Adverse Event|0|||
48686585|NCT03275740|156703645|FG008|Overall Study|Adverse Event|0|||
48686586|NCT03275740|156703646|FG009|Overall Study|Adverse Event|0|||
48686587|NCT03275740|156703647|FG010|Overall Study|Adverse Event|0|||
48686588|NCT03275740|156703648|FG011|Overall Study|Adverse Event|0|||
48686589|NCT03275740|156703637|FG000|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
48686590|NCT03275740|156703638|FG001|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
48686591|NCT03275740|156703639|FG002|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
48686592|NCT03275740|156703640|FG003|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
48686593|NCT03275740|156703641|FG004|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
48686594|NCT03275740|156703642|FG005|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|1|||
48686595|NCT03275740|156703643|FG006|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
48686596|NCT03275740|156703644|FG007|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
48686597|NCT03275740|156703645|FG008|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
48686598|NCT03275740|156703646|FG009|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
48686599|NCT03275740|156703647|FG010|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
48686600|NCT03275740|156703648|FG011|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
48686601|NCT03275740|156703637|FG000|Overall Study|Withdrawal by Subject|0|||
48686602|NCT03275740|156703638|FG001|Overall Study|Withdrawal by Subject|0|||
48686603|NCT03275740|156703639|FG002|Overall Study|Withdrawal by Subject|0|||
48686604|NCT03275740|156703640|FG003|Overall Study|Withdrawal by Subject|0|||
48686605|NCT03275740|156703641|FG004|Overall Study|Withdrawal by Subject|0|||
48686606|NCT03275740|156703642|FG005|Overall Study|Withdrawal by Subject|0|||
48686607|NCT03275740|156703643|FG006|Overall Study|Withdrawal by Subject|0|||
48686608|NCT03275740|156703644|FG007|Overall Study|Withdrawal by Subject|0|||
48686609|NCT03275740|156703645|FG008|Overall Study|Withdrawal by Subject|1|||
48686610|NCT03275740|156703646|FG009|Overall Study|Withdrawal by Subject|1|||
48686611|NCT03275740|156703647|FG010|Overall Study|Withdrawal by Subject|0|||
48686612|NCT03275740|156703648|FG011|Overall Study|Withdrawal by Subject|0|||
48686613|NCT01479868|156703651|FG000|Overall Study|Adverse Event|1|||
48686614|NCT01479868|156703651|FG000|Overall Study|Lost to Follow-up|4|||
48686615|NCT01479868|156703651|FG000|Overall Study|Protocol Violation|1|||
48686616|NCT01479868|156703651|FG000|Overall Study|Withdrawal by Subject|1|||
48686617|NCT01479868|156703651|FG000|Overall Study|Sponsor's Decision|1|||
48686618|NCT01479868|156703651|FG000|Overall Study|Initiation of new HCV Therapy|1|||
48686619|NCT01618669|156703652|FG000|Overall Study|Lost to Follow-up|1|||
48763260|NCT03662542|156983809|FG003|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
48763261|NCT03662542|156983810|FG004|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
49023022|NCT03897088|157922727|FG000|Overall Study|Lost to Follow-up|7|||
49023023|NCT03897088|157922728|FG001|Overall Study|Lost to Follow-up|15|||
49023024|NCT03897088|157922727|FG000|Overall Study|Sponsor Decision|1|||
49023025|NCT03897088|157922728|FG001|Overall Study|Sponsor Decision|2|||
49023026|NCT03897088|157922727|FG000|Overall Study|COVID-19|2|||
49023027|NCT03897088|157922728|FG001|Overall Study|COVID-19|0|||
49023028|NCT03897088|157922727|FG000|Overall Study|Other|3|||
49023029|NCT03897088|157922728|FG001|Overall Study|Other|0|||
49023030|NCT03897088|157922727|FG000|Overall Study|Non-compliance with Study Drug|1|||
48686620|NCT01618669|156703653|FG001|Overall Study|Lost to Follow-up|1|||
48686621|NCT01618669|156703652|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
48686622|NCT01618669|156703653|FG001|Overall Study|Randomized but Never Received Study Drug|2|||
48686623|NCT01618669|156703652|FG000|Overall Study|Adverse Event|16|||
48686624|NCT01618669|156703653|FG001|Overall Study|Adverse Event|7|||
49023031|NCT03897088|157922728|FG001|Overall Study|Non-compliance with Study Drug|1|||
49023032|NCT03897088|157922727|FG000|Overall Study|Pregnancy|0|||
49023033|NCT03897088|157922728|FG001|Overall Study|Pregnancy|1|||
48686625|NCT01618669|156703652|FG000|Overall Study|Protocol Violation|5|||
48763262|NCT03662542|156983811|FG005|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
49023034|NCT02079532|157922734|FG000|Overall Study|Adverse Event|7|||
49023035|NCT02079532|157922734|FG000|Overall Study|Additional or changed therapy|2|||
49023036|NCT02079532|157922734|FG000|Overall Study|Lack of Efficacy|9|||
48686626|NCT01618669|156703653|FG001|Overall Study|Protocol Violation|3|||
48686627|NCT01618669|156703652|FG000|Overall Study|Withdrawal by Subject|9|||
48686628|NCT01618669|156703653|FG001|Overall Study|Withdrawal by Subject|9|||
48686629|NCT01618669|156703652|FG000|Overall Study|Miscellaneous Reason|0|||
48686630|NCT01618669|156703653|FG001|Overall Study|Miscellaneous Reason|1|||
48686631|NCT04317040|156703654|FG000|Overall Study|Lost to Follow-up|2|||
48686632|NCT04317040|156703655|FG001|Overall Study|Lost to Follow-up|0|||
48686633|NCT04317040|156703654|FG000|Overall Study|Death|16|||
48686634|NCT04317040|156703655|FG001|Overall Study|Death|18|||
48686635|NCT04317040|156703654|FG000|Overall Study|Withdrawal by Subject|0|||
48686636|NCT04317040|156703655|FG001|Overall Study|Withdrawal by Subject|1|||
48686637|NCT04317040|156703654|FG000|Overall Study|Incomplete assessments|0|||
48686638|NCT04317040|156703655|FG001|Overall Study|Incomplete assessments|1|||
48686639|NCT01632020|156703656|FG000|Overall Study|Withdrawal by Subject|1|||
48686640|NCT01632020|156703657|FG001|Overall Study|Withdrawal by Subject|0|||
48686641|NCT01632020|156703656|FG000|Overall Study|Adverse Event|1|||
48686642|NCT01632020|156703657|FG001|Overall Study|Adverse Event|0|||
48686643|NCT01076959|156703668|FG000|Overall Study|Adverse Event|767|||
48686644|NCT01076959|156703668|FG000|Overall Study|Lack of Efficacy|849|||
48686645|NCT01076959|156703668|FG000|Overall Study|Non-compliance|274|||
48686646|NCT01076959|156703668|FG000|Overall Study|Lost to Follow-up|241|||
48686647|NCT01076959|156703668|FG000|Overall Study|Other|119|||
48686648|NCT02868554|156703672|FG000|Overall Study|Lost to Follow-up|3|||
48686649|NCT02868554|156703673|FG001|Overall Study|Lost to Follow-up|0|||
48686650|NCT02868554|156703674|FG002|Overall Study|Lost to Follow-up|1|||
48686651|NCT00216671|156703675|FG000|Overall Study|Adverse Event|4|||
48686652|NCT00216671|156703676|FG001|Overall Study|Adverse Event|9|||
48686653|NCT00216671|156703675|FG000|Overall Study|Pregnancy|0|||
48686654|NCT00216671|156703676|FG001|Overall Study|Pregnancy|1|||
48686655|NCT00216671|156703675|FG000|Overall Study|Withdrawal by Subject|4|||
48686656|NCT00216671|156703676|FG001|Overall Study|Withdrawal by Subject|2|||
48686657|NCT00216671|156703675|FG000|Overall Study|Refused Injections|3|||
48686658|NCT00216671|156703676|FG001|Overall Study|Refused Injections|13|||
48686659|NCT00216671|156703675|FG000|Overall Study|No Need to Continue Medication|1|||
48686660|NCT00216671|156703676|FG001|Overall Study|No Need to Continue Medication|1|||
48686661|NCT00216671|156703675|FG000|Overall Study|Insufficient Response|9|||
48686662|NCT00216671|156703676|FG001|Overall Study|Insufficient Response|4|||
48686663|NCT00216671|156703675|FG000|Overall Study|Lost to Follow-up|3|||
48686664|NCT00216671|156703676|FG001|Overall Study|Lost to Follow-up|5|||
48686665|NCT00216671|156703675|FG000|Overall Study|Non compliant|2|||
48686666|NCT00216671|156703676|FG001|Overall Study|Non compliant|2|||
48686667|NCT00216671|156703675|FG000|Overall Study|Ineligible|0|||
48686668|NCT00216671|156703676|FG001|Overall Study|Ineligible|2|||
48686669|NCT00216671|156703675|FG000|Overall Study|Physician Decision|1|||
48686670|NCT00216671|156703676|FG001|Overall Study|Physician Decision|1|||
48686671|NCT00216671|156703675|FG000|Overall Study|Protocol Violation|3|||
48686672|NCT00216671|156703676|FG001|Overall Study|Protocol Violation|5|||
48686673|NCT00216671|156703675|FG000|Overall Study|Relapse|1|||
48686674|NCT00216671|156703676|FG001|Overall Study|Relapse|0|||
48686675|NCT00216671|156703675|FG000|Overall Study|Investigator Illness|0|||
48686676|NCT00216671|156703676|FG001|Overall Study|Investigator Illness|1|||
48686677|NCT00216671|156703675|FG000|Overall Study|Patient Moved|0|||
49023037|NCT02079532|157922734|FG000|Overall Study|Protocol Violation|3|||
49023038|NCT02079532|157922734|FG000|Overall Study|Withdrawal by Subject|1|||
49023039|NCT02079532|157922734|FG000|Overall Study|Administrative problems|1|||
49023040|NCT02079532|157922734|FG000|Overall Study|Inclusion into ReFIRST|3|||
49023041|NCT02079532|157922734|FG000|Overall Study|Other|3|||
49023042|NCT02920996|157922735|FG000|Overall Study|Adverse Event|8|||
49023043|NCT02920996|157922736|FG001|Overall Study|Adverse Event|0|||
48686678|NCT00216671|156703676|FG001|Overall Study|Patient Moved|1|||
48686679|NCT00216671|156703675|FG000|Overall Study|Ineligible, no efficacy data|2|||
48686680|NCT00216671|156703676|FG001|Overall Study|Ineligible, no efficacy data|2|||
48686681|NCT00216671|156703675|FG000|Overall Study|Insufficient Response Adverse Event|2|||
48686682|NCT00216671|156703676|FG001|Overall Study|Insufficient Response Adverse Event|1|||
49023044|NCT02920996|157922735|FG000|Overall Study|Physician Decision|1|||
49023045|NCT02920996|157922736|FG001|Overall Study|Physician Decision|0|||
48686683|NCT04119843|156703679|FG000|Overall Study|Adverse Event|3|||
48686684|NCT04119843|156703679|FG000|Overall Study|Death|1|||
48686685|NCT02910466|156703689|FG000|Overall Study|Adverse Event|1|||
48686686|NCT02910466|156703689|FG000|Overall Study|Withdrawal by Subject|3|||
48686687|NCT02910466|156703689|FG000|Overall Study|Lost to Follow-up|5|||
48686688|NCT02910466|156703689|FG000|Overall Study|Due to Food and Drug Administration (FDA) recall|29|||
48686689|NCT02910466|156703689|FG000|Overall Study|Participant didn't meet inclusion criteria|1|||
48686690|NCT02516241|156703690|FG000|Overall Study|Death|255|||
48686691|NCT02516241|156703691|FG001|Overall Study|Death|262|||
48686692|NCT02516241|156703692|FG002|Overall Study|Death|270|||
48686693|NCT02516241|156703690|FG000|Overall Study|Lost to Follow-up|1|||
48686694|NCT02516241|156703691|FG001|Overall Study|Lost to Follow-up|1|||
48686695|NCT02516241|156703692|FG002|Overall Study|Lost to Follow-up|3|||
49023046|NCT02920996|157922735|FG000|Overall Study|Death|1|||
49023047|NCT02920996|157922736|FG001|Overall Study|Death|0|||
49023048|NCT02920996|157922735|FG000|Overall Study|Missing|1|||
49023049|NCT02920996|157922736|FG001|Overall Study|Missing|0|||
49023050|NCT02920996|157922735|FG000|Overall Study|Subject Non-Compliance|1|||
49023051|NCT02920996|157922736|FG001|Overall Study|Subject Non-Compliance|0|||
49023052|NCT02682602|157922737|FG000|Pre-operative Diseased & Normal Hips|Unusable images|1|||
49023053|NCT02682602|157922738|FG001|Pre-operative Diseased & Normal Hips|Unusable images|0|||
49023054|NCT02682602|157922737|FG000|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3|||
49023055|NCT02682602|157922738|FG001|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0|||
49023056|NCT02761980|157924044|FG000|Overall Study|Adverse Event|4|||
49023057|NCT02761980|157924045|FG001|Overall Study|Adverse Event|6|||
49023058|NCT02761980|157924046|FG002|Overall Study|Adverse Event|5|||
49023059|NCT02761980|157924047|FG003|Overall Study|Adverse Event|6|||
49023060|NCT02761980|157924044|FG000|Overall Study|Withdrawal by Subject|0|||
48686696|NCT02516241|156703690|FG000|Overall Study|Withdrawal by Subject|2|||
49023061|NCT02761980|157924045|FG001|Overall Study|Withdrawal by Subject|1|||
49023062|NCT02761980|157924046|FG002|Overall Study|Withdrawal by Subject|0|||
49023063|NCT02761980|157924047|FG003|Overall Study|Withdrawal by Subject|0|||
49023064|NCT02761980|157924044|FG000|Overall Study|Other|0|||
49023065|NCT02761980|157924045|FG001|Overall Study|Other|0|||
49023066|NCT02761980|157924046|FG002|Overall Study|Other|1|||
49023067|NCT02761980|157924047|FG003|Overall Study|Other|0|||
49023068|NCT00788125|157924048|FG000|Overall Study|Death|6|||
49023072|NCT01052116|157924052|FG000|Overall Study|Lost to Follow-up|11|||
49023073|NCT01052116|157924053|FG001|Overall Study|Lost to Follow-up|17|||
49023074|NCT01052116|157924052|FG000|Overall Study|Withdrawal by Subject|3|||
49023075|NCT01052116|157924053|FG001|Overall Study|Withdrawal by Subject|6|||
49023076|NCT01052116|157924052|FG000|Overall Study|Spirometry not performed|0|||
49023077|NCT01052116|157924053|FG001|Overall Study|Spirometry not performed|4|||
49023078|NCT00101582|157924061|FG000|Overall Study|Ineligibility determined|0|||
49023079|NCT00101582|157924062|FG001|Overall Study|Ineligibility determined|1|||
49023080|NCT00101582|157924061|FG000|Overall Study|Adverse Event|1|||
49023081|NCT00101582|157924062|FG001|Overall Study|Adverse Event|4|||
49023082|NCT00101582|157924061|FG000|Overall Study|Withdrawal by Subject|6|||
49023083|NCT00101582|157924062|FG001|Overall Study|Withdrawal by Subject|4|||
49023084|NCT00101582|157924061|FG000|Overall Study|Physician Decision|1|||
49023085|NCT00101582|157924062|FG001|Overall Study|Physician Decision|0|||
49023086|NCT00101582|157924061|FG000|Overall Study|Death|3|||
49023087|NCT00101582|157924062|FG001|Overall Study|Death|5|||
49023088|NCT00101582|157924061|FG000|Overall Study|Other|0|||
49023089|NCT00101582|157924062|FG001|Overall Study|Other|1|||
49023090|NCT00056160|157924063|FG000|Up to Unblinding (07 Jun 2005)|Adverse Event|35|||
48686697|NCT02516241|156703691|FG001|Overall Study|Withdrawal by Subject|7|||
48686698|NCT02516241|156703692|FG002|Overall Study|Withdrawal by Subject|12|||
48686699|NCT02516241|156703690|FG000|Overall Study|participants ongoing at data cut-off|84|||
48686700|NCT02516241|156703691|FG001|Overall Study|participants ongoing at data cut-off|76|||
48686701|NCT02516241|156703692|FG002|Overall Study|participants ongoing at data cut-off|59|||
48686702|NCT06473662|156703693|FG000|Overall Study|Withdrawal by Subject|1|||
48686703|NCT06473662|156703694|FG001|Overall Study|Withdrawal by Subject|6|||
48686704|NCT06473662|156703695|FG002|Overall Study|Withdrawal by Subject|5|||
48686705|NCT06473662|156703693|FG000|Overall Study|Uncontrolled hyperglycaemia|1|||
48686706|NCT06473662|156703694|FG001|Overall Study|Uncontrolled hyperglycaemia|2|||
48686707|NCT06473662|156703695|FG002|Overall Study|Uncontrolled hyperglycaemia|2|||
48686708|NCT06473662|156703693|FG000|Overall Study|Starting HbA1c below 7%|0|||
48686709|NCT06473662|156703694|FG001|Overall Study|Starting HbA1c below 7%|1|||
48686710|NCT06473662|156703695|FG002|Overall Study|Starting HbA1c below 7%|1|||
48686711|NCT06473662|156703693|FG000|Overall Study|No data from Central lab (protocol violation)|14|||
49023091|NCT00056160|157924064|FG001|Up to Unblinding (07 Jun 2005)|Adverse Event|18|||
49023092|NCT00056160|157924063|FG000|Up to Unblinding (07 Jun 2005)|Progression of disease|57|||
49023093|NCT00056160|157924064|FG001|Up to Unblinding (07 Jun 2005)|Progression of disease|124|||
49023094|NCT00056160|157924063|FG000|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3|||
49023095|NCT00056160|157924064|FG001|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5|||
49023096|NCT00056160|157924063|FG000|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
49023097|NCT00056160|157924064|FG001|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
49023098|NCT00056160|157924063|FG000|Up to Unblinding (07 Jun 2005)|Death|2|||
49023099|NCT00056160|157924064|FG001|Up to Unblinding (07 Jun 2005)|Death|1|||
49023100|NCT00056160|157924063|FG000|Up to Unblinding (07 Jun 2005)|Other|8|||
49023101|NCT00056160|157924064|FG001|Up to Unblinding (07 Jun 2005)|Other|7|||
49023102|NCT00056160|157924063|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44|||
49023103|NCT00056160|157924064|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0|||
49023104|NCT00056160|157924063|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87|||
48686712|NCT06473662|156703694|FG001|Overall Study|No data from Central lab (protocol violation)|9|||
48686713|NCT06473662|156703695|FG002|Overall Study|No data from Central lab (protocol violation)|4|||
48686714|NCT06473662|156703693|FG000|Overall Study|Did not take medication|2|||
48686715|NCT06473662|156703694|FG001|Overall Study|Did not take medication|3|||
48686716|NCT06473662|156703695|FG002|Overall Study|Did not take medication|2|||
48686717|NCT00843882|156703696|FG000|Step 1|Lack of Efficacy|14|||
48686718|NCT00843882|156703697|FG001|Step 1|Lack of Efficacy|10|||
48686719|NCT00843882|156703698|FG002|Step 1|Lack of Efficacy|21|||
48686720|NCT00843882|156703696|FG000|Step 1|Adverse Event|8|||
48686721|NCT00843882|156703697|FG001|Step 1|Adverse Event|17|||
48686722|NCT00843882|156703698|FG002|Step 1|Adverse Event|20|||
48686723|NCT00843882|156703696|FG000|Step 1|Death|1|||
48686724|NCT00843882|156703697|FG001|Step 1|Death|2|||
48686725|NCT00843882|156703698|FG002|Step 1|Death|4|||
48686726|NCT00843882|156703696|FG000|Step 1|Withdrawal by Subject|6|||
48686727|NCT00843882|156703697|FG001|Step 1|Withdrawal by Subject|12|||
48686728|NCT00843882|156703698|FG002|Step 1|Withdrawal by Subject|9|||
48686729|NCT00843882|156703696|FG000|Step 1|Physician Decision|0|||
48686730|NCT00843882|156703697|FG001|Step 1|Physician Decision|5|||
48686731|NCT00843882|156703698|FG002|Step 1|Physician Decision|1|||
48686732|NCT00843882|156703696|FG000|Step 1|Patient and physician's decision|0|||
48686733|NCT00843882|156703697|FG001|Step 1|Patient and physician's decision|0|||
48686734|NCT00843882|156703698|FG002|Step 1|Patient and physician's decision|1|||
48686735|NCT00843882|156703696|FG000|Step 1|Other complicating disease|1|||
48686736|NCT00843882|156703697|FG001|Step 1|Other complicating disease|3|||
48686737|NCT00843882|156703698|FG002|Step 1|Other complicating disease|4|||
48686738|NCT00843882|156703696|FG000|Step 1|Alternative therapy|0|||
48686739|NCT00843882|156703697|FG001|Step 1|Alternative therapy|1|||
48686740|NCT00843882|156703698|FG002|Step 1|Alternative therapy|1|||
48686741|NCT00843882|156703696|FG000|Step 1|Patient switched treatment early due to DSMC announcement|0|||
48686742|NCT00843882|156703697|FG001|Step 1|Patient switched treatment early due to DSMC announcement|4|||
48686743|NCT00843882|156703698|FG002|Step 1|Patient switched treatment early due to DSMC announcement|0|||
48763263|NCT03662542|156983812|FG006|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
48763264|NCT03662542|156983813|FG007|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
48763265|NCT03662542|156983814|FG008|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
48763266|NCT03662542|156983806|FG000|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
48763267|NCT03662542|156983807|FG001|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
48763268|NCT03662542|156983808|FG002|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
48763269|NCT03662542|156983809|FG003|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
48763270|NCT03662542|156983810|FG004|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
48763271|NCT03662542|156983811|FG005|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
48763272|NCT03662542|156983812|FG006|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|1|||
48763273|NCT03662542|156983813|FG007|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
48763274|NCT03662542|156983814|FG008|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|2|||
48763275|NCT03662542|156983806|FG000|Safety Follow-up (Week 38- Week 50)|Other|0|||
48763276|NCT03662542|156983807|FG001|Safety Follow-up (Week 38- Week 50)|Other|0|||
48763277|NCT03662542|156983808|FG002|Safety Follow-up (Week 38- Week 50)|Other|0|||
48763278|NCT03662542|156983809|FG003|Safety Follow-up (Week 38- Week 50)|Other|0|||
48763279|NCT03662542|156983810|FG004|Safety Follow-up (Week 38- Week 50)|Other|0|||
48763280|NCT03662542|156983811|FG005|Safety Follow-up (Week 38- Week 50)|Other|0|||
48763281|NCT03662542|156983812|FG006|Safety Follow-up (Week 38- Week 50)|Other|1|||
48763282|NCT03662542|156983813|FG007|Safety Follow-up (Week 38- Week 50)|Other|6|||
48763283|NCT03662542|156983814|FG008|Safety Follow-up (Week 38- Week 50)|Other|2|||
48763284|NCT00588822|156983817|FG000|Overall Study|progression of disease|8|||
48763285|NCT04014075|156983818|FG000|Overall Study|Progressive Disease|48|||
48763286|NCT04014075|156983818|FG000|Overall Study|Adverse Event|11|||
48763287|NCT04014075|156983818|FG000|Overall Study|Clinical Progression|4|||
48763288|NCT04014075|156983818|FG000|Overall Study|Death|2|||
48763289|NCT04014075|156983818|FG000|Overall Study|Withdrawal by Subject|2|||
48763290|NCT04014075|156983818|FG000|Overall Study|Miscellaneous|1|||
48686744|NCT00843882|156703696|FG000|Step 1|Off treatment reason unknown|0|||
48686745|NCT00843882|156703697|FG001|Step 1|Off treatment reason unknown|1|||
48686746|NCT00843882|156703698|FG002|Step 1|Off treatment reason unknown|4|||
48686747|NCT00843882|156703696|FG000|Step 1|Never started treatment|2|||
48686748|NCT00843882|156703697|FG001|Step 1|Never started treatment|0|||
48763291|NCT04014075|156983818|FG000|Overall Study|Physician Decision|1|||
48763292|NCT02945410|156983819|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
48875259|NCT01496365|157381600|FG006|Overall Study|Other|1|||
48875260|NCT03712449|157381604|FG000|Overall Study|Withdraw Consent|0|||
48875261|NCT03712449|157381605|FG001|Overall Study|Withdraw Consent|1|||
48686749|NCT00843882|156703698|FG002|Step 1|Never started treatment|0|||
48686750|NCT00843882|156703696|FG000|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1|||
48763293|NCT02945410|156983820|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|3|||
48875262|NCT02706951|157381606|FG000|Period 1|Adverse Event|1|||
48686751|NCT00843882|156703697|FG001|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9|||
48686752|NCT00843882|156703698|FG002|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0|||
48686753|NCT00843882|156703696|FG000|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
48686754|NCT00843882|156703697|FG001|Step 2 (Cross-over to Arm B)|Adverse Event|6|||
48686755|NCT00843882|156703698|FG002|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
48686756|NCT00843882|156703696|FG000|Step 2 (Cross-over to Arm B)|Death|0|||
48686757|NCT00843882|156703697|FG001|Step 2 (Cross-over to Arm B)|Death|3|||
48686758|NCT00843882|156703698|FG002|Step 2 (Cross-over to Arm B)|Death|0|||
48686759|NCT00843882|156703696|FG000|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2|||
48686760|NCT00843882|156703697|FG001|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5|||
48686761|NCT00843882|156703698|FG002|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0|||
48686762|NCT00843882|156703696|FG000|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
48686763|NCT00843882|156703697|FG001|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
48686764|NCT00843882|156703698|FG002|Step 2 (Cross-over to Arm B)|Physician Decision|0|||
48686765|NCT00843882|156703696|FG000|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
48686766|NCT00843882|156703697|FG001|Step 2 (Cross-over to Arm B)|Alternative treatment|1|||
48686767|NCT00843882|156703698|FG002|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
48686768|NCT00843882|156703696|FG000|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
48686769|NCT00843882|156703697|FG001|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1|||
48686770|NCT00843882|156703698|FG002|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
48981411|NCT01642004|157764266|FG001|Treatment|Poor/non-compliance|0|||
48981412|NCT01642004|157764265|FG000|Treatment|No longer meets study criteria|1|||
48981413|NCT01642004|157764266|FG001|Treatment|No longer meets study criteria|2|||
48981414|NCT01642004|157764265|FG000|Treatment|Other reasons|2|||
48981415|NCT01642004|157764266|FG001|Treatment|Other reasons|0|||
48981416|NCT01642004|157764265|FG000|Treatment|Not reported|0|||
48981417|NCT01642004|157764266|FG001|Treatment|Not reported|3|||
48981418|NCT01642004|157764265|FG000|Treatment|Participant request to discontinue study treatment|6|||
48981419|NCT01642004|157764266|FG001|Treatment|Participant request to discontinue study treatment|4|||
48981420|NCT01642004|157764265|FG000|Treatment|Participant withdrew consent|5|||
48981421|NCT01642004|157764266|FG001|Treatment|Participant withdrew consent|5|||
48981422|NCT05333289|157764267|FG000|Overall Study|Other|1|||
48981423|NCT05333289|157764268|FG001|Overall Study|Other|0|||
48981424|NCT05333289|157764269|FG002|Overall Study|Other|0|||
48981425|NCT05333289|157764270|FG003|Overall Study|Other|1|||
48981426|NCT05333289|157764271|FG004|Overall Study|Other|1|||
48981427|NCT05333289|157764272|FG005|Overall Study|Other|2|||
48981428|NCT05333289|157764273|FG006|Overall Study|Other|2|||
48981429|NCT05333289|157764274|FG007|Overall Study|Other|0|||
48981430|NCT05333289|157764267|FG000|Overall Study|Withdrawal by Subject|1|||
48981431|NCT05333289|157764268|FG001|Overall Study|Withdrawal by Subject|2|||
48981432|NCT05333289|157764269|FG002|Overall Study|Withdrawal by Subject|2|||
48686793|NCT00644228|156703701|FG000|Randomization & Eligibility|Ineligible|31|||
48686794|NCT00644228|156703702|FG001|Randomization & Eligibility|Ineligible|21|||
48686795|NCT00644228|156703701|FG000|Randomization & Eligibility|Withdrew Consent prior to therapy start|1|||
48686796|NCT00644228|156703702|FG001|Randomization & Eligibility|Withdrew Consent prior to therapy start|0|||
48686797|NCT00644228|156703701|FG000|Randomization & Eligibility|Invalid Consent|0|||
48686798|NCT00644228|156703702|FG001|Randomization & Eligibility|Invalid Consent|1|||
48686799|NCT00644228|156703701|FG000|Induction Therapy|Adverse Event|22|||
48686800|NCT00644228|156703702|FG001|Induction Therapy|Adverse Event|55|||
48686801|NCT00644228|156703701|FG000|Induction Therapy|Withdrawal by Subject|10|||
48686802|NCT00644228|156703702|FG001|Induction Therapy|Withdrawal by Subject|3|||
48686803|NCT00644228|156703701|FG000|Induction Therapy|Progression/Relapse|24|||
48686804|NCT00644228|156703702|FG001|Induction Therapy|Progression/Relapse|12|||
48686805|NCT00644228|156703701|FG000|Induction Therapy|Death|3|||
48686806|NCT00644228|156703702|FG001|Induction Therapy|Death|7|||
48686807|NCT00644228|156703701|FG000|Induction Therapy|Not Protocol-Specified|24|||
48686808|NCT00644228|156703702|FG001|Induction Therapy|Not Protocol-Specified|28|||
49023105|NCT00056160|157924064|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0|||
49023106|NCT00056160|157924063|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3|||
49023107|NCT00056160|157924064|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0|||
49023108|NCT00056160|157924063|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11|||
49023109|NCT00056160|157924064|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0|||
49023110|NCT00056160|157924063|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Death|5|||
48686809|NCT00644228|156703701|FG000|Maintenance|Adverse Event|27|||
48686810|NCT00644228|156703702|FG001|Maintenance|Adverse Event|31|||
48686811|NCT00644228|156703701|FG000|Maintenance|Withdrawal by Subject|6|||
48686812|NCT00644228|156703702|FG001|Maintenance|Withdrawal by Subject|4|||
48686813|NCT00644228|156703701|FG000|Maintenance|Progression/Relapse|67|||
48686814|NCT00644228|156703702|FG001|Maintenance|Progression/Relapse|42|||
49023111|NCT00056160|157924064|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Death|0|||
48686815|NCT00644228|156703701|FG000|Maintenance|Death|3|||
48686816|NCT00644228|156703702|FG001|Maintenance|Death|3|||
48686817|NCT00644228|156703701|FG000|Maintenance|Not Protocol-Specified|14|||
48981433|NCT05333289|157764270|FG003|Overall Study|Withdrawal by Subject|1|||
48981434|NCT05333289|157764271|FG004|Overall Study|Withdrawal by Subject|1|||
49023112|NCT00056160|157924063|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Other|21|||
49023113|NCT00056160|157924064|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Other|0|||
49023114|NCT00056160|157924063|FG000|Final Follow-up|Transferred into expanded access study.|3|||
49023115|NCT00056160|157924064|FG001|Final Follow-up|Transferred into expanded access study.|0|||
49023116|NCT00056160|157924063|FG000|Final Follow-up|Transferred into RevAssist Program|2|||
49023117|NCT00056160|157924064|FG001|Final Follow-up|Transferred into RevAssist Program|0|||
49023118|NCT00056160|157924063|FG000|Final Follow-up|Adverse Event|1|||
49023119|NCT00056160|157924064|FG001|Final Follow-up|Adverse Event|0|||
49023120|NCT01402908|157924072|FG000|Overall Study|Withdrawal by Subject|30|||
49023121|NCT01402908|157924073|FG001|Overall Study|Withdrawal by Subject|17|||
49023122|NCT01402908|157924072|FG000|Overall Study|Lost to Follow-up|3|||
49023123|NCT01402908|157924073|FG001|Overall Study|Lost to Follow-up|1|||
49023124|NCT01402908|157924072|FG000|Overall Study|Physician Decision|1|||
49023125|NCT01402908|157924073|FG001|Overall Study|Physician Decision|0|||
49023126|NCT01919190|157924075|FG000|Overall Study|Intra-op findings, etc.|3|||
49023127|NCT01919190|157924076|FG001|Overall Study|Intra-op findings, etc.|0|||
49023128|NCT01739790|157924077|FG000|Overall Study|Early Trial Termination|2|||
49023129|NCT01739790|157924078|FG001|Overall Study|Early Trial Termination|4|||
49023130|NCT00444145|157924079|FG000|Overall Study|Withdrawal by Subject|2|||
49023131|NCT00444145|157924079|FG000|Overall Study|Lost to Follow-up|1|||
49023132|NCT00444145|157924079|FG000|Overall Study|non-compliant|11|||
49023133|NCT00444145|157924079|FG000|Overall Study|Screen Failures|5|||
49023134|NCT01153984|157924091|FG000|Overall Study|Withdrawal by Subject|1|||
49023135|NCT01153984|157924091|FG000|Overall Study|Adverse Event|1|||
49023136|NCT02896361|157924092|FG000|Third Intervention (2 Weeks)|Protocol Violation|1|||
49023137|NCT02896361|157924093|FG001|Third Intervention (2 Weeks)|Protocol Violation|0|||
49023138|NCT02896361|157924094|FG002|Third Intervention (2 Weeks)|Protocol Violation|0|||
49023139|NCT02896361|157924092|FG000|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
49023140|NCT02896361|157924093|FG001|Third Intervention (2 Weeks)|emergenge of several new painful regions|1|||
48686818|NCT00644228|156703702|FG001|Maintenance|Not Protocol-Specified|15|||
48686819|NCT00644228|156703701|FG000|Maintenance|On Treatment|26|||
48686820|NCT00644228|156703702|FG001|Maintenance|On Treatment|40|||
48686821|NCT04378270|156703705|FG000|Overall Study|Lack of Efficacy|1|||
48686822|NCT04378270|156703705|FG000|Overall Study|Withdrawal by Subject|1|||
48686823|NCT04378270|156703705|FG000|Overall Study|Screen Failure|1|||
48686824|NCT04378270|156703705|FG000|Overall Study|University Required, Research Covid Shut Down|2|||
48686825|NCT00717249|156703716|FG000|Overall Study|Lens Discomfort|4|||
48686826|NCT00717249|156703717|FG001|Overall Study|Lens Discomfort|1|||
48686827|NCT00717249|156703716|FG000|Overall Study|Unsatisfactory visual Response|0|||
48686828|NCT00717249|156703717|FG001|Overall Study|Unsatisfactory visual Response|2|||
48686829|NCT00717249|156703716|FG000|Overall Study|Adverse Event|4|||
48686830|NCT00717249|156703717|FG001|Overall Study|Adverse Event|2|||
48686831|NCT00717249|156703716|FG000|Overall Study|Lost to Follow-up|2|||
48686832|NCT00717249|156703717|FG001|Overall Study|Lost to Follow-up|0|||
48686833|NCT00717249|156703716|FG000|Overall Study|Withdrawal by Subject|1|||
48686834|NCT00717249|156703717|FG001|Overall Study|Withdrawal by Subject|2|||
48686835|NCT00717249|156703716|FG000|Overall Study|Pregnancy|6|||
48686836|NCT00717249|156703717|FG001|Overall Study|Pregnancy|3|||
48686837|NCT00717249|156703716|FG000|Overall Study|Protocol Violation|0|||
48686838|NCT00717249|156703717|FG001|Overall Study|Protocol Violation|2|||
49023141|NCT02896361|157924094|FG002|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
49023142|NCT01458405|157924101|FG000|Phase 1 (up to 12 Months)|Other|0|||
49023143|NCT01458405|157924102|FG001|Phase 1 (up to 12 Months)|Other|1|||
49023144|NCT01458405|157924103|FG002|Phase 1 (up to 12 Months)|Other|0|||
49023145|NCT01458405|157924104|FG003|Phase 1 (up to 12 Months)|Other|0|||
49023146|NCT01458405|157924101|FG000|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
49023147|NCT01458405|157924102|FG001|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
49023148|NCT01458405|157924103|FG002|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|11|||
49023149|NCT01458405|157924104|FG003|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|20|||
49023150|NCT01458405|157924101|FG000|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
48686839|NCT00717249|156703716|FG000|Overall Study|Subject became Ineligible|1|||
48875263|NCT02706951|157381607|FG001|Period 1|Adverse Event|5|||
48875264|NCT02706951|157381608|FG002|Period 1|Adverse Event|3|||
49023151|NCT01458405|157924102|FG001|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
49023152|NCT01458405|157924103|FG002|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
49023153|NCT01458405|157924104|FG003|Phase 2 (up to 12 Months)|Lost to Follow-up|2|||
49023154|NCT01458405|157924101|FG000|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
49023155|NCT01458405|157924102|FG001|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
48686840|NCT00717249|156703717|FG001|Overall Study|Subject became Ineligible|1|||
48686841|NCT00717249|156703716|FG000|Overall Study|Unsatisfactory Physiological Response|0|||
48686842|NCT00717249|156703717|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
48686843|NCT00717249|156703716|FG000|Overall Study|Gastric Surgery|0|||
48686844|NCT00717249|156703717|FG001|Overall Study|Gastric Surgery|1|||
48875265|NCT02706951|157381609|FG003|Period 1|Adverse Event|0|||
49023156|NCT01458405|157924103|FG002|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
49023157|NCT01458405|157924104|FG003|Phase 2 (up to 12 Months)|Withdrawal by Subject|1|||
49023158|NCT02192099|157924112|FG000|Overall Study|Adverse Event|1|||
49023159|NCT02192099|157924112|FG000|Overall Study|Lost to Follow-up|2|||
49023160|NCT02192099|157924112|FG000|Overall Study|Physician Decision|1|||
49023161|NCT02192099|157924112|FG000|Overall Study|Pregnancy|1|||
49023162|NCT02192099|157924112|FG000|Overall Study|Protocol Violation|8|||
49023163|NCT02192099|157924112|FG000|Overall Study|Study Terminated by Sponsor|32|||
49023164|NCT02192099|157924112|FG000|Overall Study|Withdrawal by Subject|11|||
49023165|NCT02192099|157924112|FG000|Overall Study|Miscellaneous Reasons|5|||
49023166|NCT02796664|157924115|FG000|Overall Study|Withdrawal by Subject|0|||
49023167|NCT02796664|157924116|FG001|Overall Study|Withdrawal by Subject|3|||
49023168|NCT02796664|157924115|FG000|Overall Study|Noncompliance|1|||
49023169|NCT02796664|157924116|FG001|Overall Study|Noncompliance|1|||
49023170|NCT02796664|157924115|FG000|Overall Study|Death|0|||
49023171|NCT02796664|157924116|FG001|Overall Study|Death|1|||
49023172|NCT01045096|157924117|FG000|Overall Study|Withdrawal by Subject|2|||
49023173|NCT01045096|157924118|FG001|Overall Study|Withdrawal by Subject|0|||
49023174|NCT01045096|157924119|FG002|Overall Study|Withdrawal by Subject|0|||
49023175|NCT01045096|157924117|FG000|Overall Study|Other|1|||
49023176|NCT01045096|157924118|FG001|Overall Study|Other|0|||
49023177|NCT01045096|157924119|FG002|Overall Study|Other|0|||
49023178|NCT02731157|157924124|FG000|First Rejuvenated RCE|Withdrawal by Subject|1|||
49023179|NCT02465567|157924125|FG000|Overall Study|Adverse Event|118|||
49023180|NCT02465567|157924126|FG001|Overall Study|Adverse Event|113|||
49023181|NCT02465567|157924127|FG002|Overall Study|Adverse Event|147|||
49023182|NCT02465567|157924128|FG003|Overall Study|Adverse Event|138|||
49023183|NCT02465567|157924125|FG000|Overall Study|Lack of Efficacy|103|||
49023184|NCT02465567|157924126|FG001|Overall Study|Lack of Efficacy|102|||
49023185|NCT02465567|157924127|FG002|Overall Study|Lack of Efficacy|171|||
49023186|NCT02465567|157924128|FG003|Overall Study|Lack of Efficacy|135|||
49023187|NCT02465567|157924125|FG000|Overall Study|Withdrawal by Subject|104|||
49023188|NCT02465567|157924126|FG001|Overall Study|Withdrawal by Subject|94|||
49023189|NCT02465567|157924127|FG002|Overall Study|Withdrawal by Subject|123|||
49023190|NCT02465567|157924128|FG003|Overall Study|Withdrawal by Subject|130|||
49023191|NCT02465567|157924125|FG000|Overall Study|Physician Decision|23|||
49023192|NCT02465567|157924126|FG001|Overall Study|Physician Decision|33|||
48686845|NCT00717249|156703716|FG000|Overall Study|Diagnosed with Diabetes|1|||
48686846|NCT00717249|156703717|FG001|Overall Study|Diagnosed with Diabetes|0|||
48686847|NCT00717249|156703716|FG000|Overall Study|Diagnosed with Multiple Scletosis|1|||
48686848|NCT00717249|156703717|FG001|Overall Study|Diagnosed with Multiple Scletosis|0|||
48686849|NCT00717249|156703716|FG000|Overall Study|Subject relocated|1|||
48763294|NCT02945410|156983821|FG002|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
48763295|NCT02945410|156983822|FG003|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
48763296|NCT02945410|156983823|FG004|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
48763297|NCT02945410|156983824|FG005|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
48763298|NCT02945410|156983819|FG000|Intervention 1 (5 Days)|Adverse Event|1|||
48763299|NCT02945410|156983820|FG001|Intervention 1 (5 Days)|Adverse Event|0|||
48763300|NCT02945410|156983821|FG002|Intervention 1 (5 Days)|Adverse Event|0|||
48763301|NCT02945410|156983822|FG003|Intervention 1 (5 Days)|Adverse Event|0|||
48763302|NCT02945410|156983823|FG004|Intervention 1 (5 Days)|Adverse Event|0|||
48763303|NCT02945410|156983824|FG005|Intervention 1 (5 Days)|Adverse Event|1|||
48763304|NCT02945410|156983819|FG000|Washout 1 (14 Days)|Withdrawal by Subject|0|||
48763305|NCT02945410|156983820|FG001|Washout 1 (14 Days)|Withdrawal by Subject|0|||
48763306|NCT02945410|156983821|FG002|Washout 1 (14 Days)|Withdrawal by Subject|2|||
48763307|NCT02945410|156983822|FG003|Washout 1 (14 Days)|Withdrawal by Subject|0|||
48763308|NCT02945410|156983823|FG004|Washout 1 (14 Days)|Withdrawal by Subject|1|||
48763309|NCT02945410|156983824|FG005|Washout 1 (14 Days)|Withdrawal by Subject|0|||
48763310|NCT00923559|156983827|FG000|Overall Study|Lost to Follow-up|2|||
48763311|NCT00923559|156983828|FG001|Overall Study|Lost to Follow-up|3|||
49023193|NCT02465567|157924127|FG002|Overall Study|Physician Decision|38|||
49023194|NCT02465567|157924128|FG003|Overall Study|Physician Decision|28|||
49023195|NCT02465567|157924125|FG000|Overall Study|Major Protocol Deviation|24|||
49023196|NCT02465567|157924126|FG001|Overall Study|Major Protocol Deviation|26|||
48686850|NCT00717249|156703717|FG001|Overall Study|Subject relocated|0|||
48686851|NCT00717249|156703716|FG000|Overall Study|Headaches|1|||
48686852|NCT00717249|156703717|FG001|Overall Study|Headaches|0|||
48686853|NCT03228537|156703718|FG000|Neoadjuvant|Adverse Event|2|||
48686854|NCT03228537|156703718|FG000|Neoadjuvant|Progression/Relapse|4|||
48763312|NCT00811577|156983829|FG000|Overall Study|Lost to Follow-up|7|||
48763313|NCT00811577|156983830|FG001|Overall Study|Lost to Follow-up|1|||
48763314|NCT00811577|156983829|FG000|Overall Study|Withdrawal by Subject|3|||
49023197|NCT02465567|157924127|FG002|Overall Study|Major Protocol Deviation|22|||
49023198|NCT02465567|157924128|FG003|Overall Study|Major Protocol Deviation|25|||
49023199|NCT02465567|157924125|FG000|Overall Study|Lost to Follow-up|25|||
49023200|NCT02465567|157924126|FG001|Overall Study|Lost to Follow-up|21|||
49023201|NCT02465567|157924127|FG002|Overall Study|Lost to Follow-up|19|||
49023202|NCT02465567|157924128|FG003|Overall Study|Lost to Follow-up|15|||
48763315|NCT00811577|156983830|FG001|Overall Study|Withdrawal by Subject|0|||
48763316|NCT02385084|156983831|FG000|Period 2|Protocol Violation|0|||
48763317|NCT02385084|156983832|FG001|Period 2|Protocol Violation|0|||
48763318|NCT02385084|156983833|FG002|Period 2|Protocol Violation|1|||
48763319|NCT02385084|156983834|FG003|Period 2|Protocol Violation|0|||
48763320|NCT02385084|156983835|FG004|Period 2|Protocol Violation|0|||
48763321|NCT02385084|156983836|FG005|Period 2|Protocol Violation|0|||
49023203|NCT02465567|157924125|FG000|Overall Study|Protocol Specified Criteria|20|||
49023204|NCT02465567|157924126|FG001|Overall Study|Protocol Specified Criteria|10|||
49023205|NCT02465567|157924127|FG002|Overall Study|Protocol Specified Criteria|9|||
49023206|NCT02465567|157924128|FG003|Overall Study|Protocol Specified Criteria|12|||
49023207|NCT02465567|157924125|FG000|Overall Study|Administrative Reasons|12|||
49023208|NCT02465567|157924126|FG001|Overall Study|Administrative Reasons|9|||
49023209|NCT02465567|157924127|FG002|Overall Study|Administrative Reasons|11|||
49023210|NCT02465567|157924128|FG003|Overall Study|Administrative Reasons|5|||
49023211|NCT02465567|157924125|FG000|Overall Study|Randomized but not treated|1|||
49023212|NCT02465567|157924126|FG001|Overall Study|Randomized but not treated|5|||
49023213|NCT02465567|157924127|FG002|Overall Study|Randomized but not treated|4|||
49023214|NCT02465567|157924128|FG003|Overall Study|Randomized but not treated|5|||
49023215|NCT02465567|157924125|FG000|Overall Study|enrolled in >1 studies|18|||
49023216|NCT02465567|157924126|FG001|Overall Study|enrolled in >1 studies|11|||
49023217|NCT02465567|157924127|FG002|Overall Study|enrolled in >1 studies|19|||
49023218|NCT02465567|157924128|FG003|Overall Study|enrolled in >1 studies|15|||
49023219|NCT02465567|157924125|FG000|Overall Study|missing PI Signature|1|||
49023220|NCT02465567|157924126|FG001|Overall Study|missing PI Signature|0|||
49023221|NCT02465567|157924127|FG002|Overall Study|missing PI Signature|0|||
49023222|NCT02465567|157924128|FG003|Overall Study|missing PI Signature|0|||
49023223|NCT00944697|157924135|FG000|Overall Study|Withdrawal by Subject|1|||
49023224|NCT00944697|157924136|FG001|Overall Study|Withdrawal by Subject|1|||
49023225|NCT00944697|157924135|FG000|Overall Study|Adverse Event|0|||
49023226|NCT00944697|157924136|FG001|Overall Study|Adverse Event|3|||
49023227|NCT00944697|157924135|FG000|Overall Study|Administrative|1|||
49023228|NCT00944697|157924136|FG001|Overall Study|Administrative|1|||
49023229|NCT00337077|157924137|FG000|Overall Study|Progressive disease|25|||
49023230|NCT00337077|157924138|FG001|Overall Study|Progressive disease|37|||
49023231|NCT00337077|157924139|FG002|Overall Study|Progressive disease|19|||
49023232|NCT00337077|157924137|FG000|Overall Study|Adverse Event|7|||
49023233|NCT00337077|157924138|FG001|Overall Study|Adverse Event|7|||
49023234|NCT00337077|157924139|FG002|Overall Study|Adverse Event|1|||
49023235|NCT00337077|157924137|FG000|Overall Study|Death|0|||
49023236|NCT00337077|157924138|FG001|Overall Study|Death|1|||
49023237|NCT00337077|157924139|FG002|Overall Study|Death|0|||
49023238|NCT00337077|157924137|FG000|Overall Study|Withdrawal by Subject|7|||
49023239|NCT00337077|157924138|FG001|Overall Study|Withdrawal by Subject|2|||
49023240|NCT00337077|157924139|FG002|Overall Study|Withdrawal by Subject|2|||
49023241|NCT00337077|157924137|FG000|Overall Study|Alternative therapy|1|||
49023242|NCT00337077|157924138|FG001|Overall Study|Alternative therapy|0|||
49023243|NCT00337077|157924139|FG002|Overall Study|Alternative therapy|0|||
49023244|NCT00337077|157924137|FG000|Overall Study|Physician Decision|1|||
49023245|NCT00337077|157924138|FG001|Overall Study|Physician Decision|4|||
49023246|NCT00337077|157924139|FG002|Overall Study|Physician Decision|2|||
49023247|NCT00337077|157924137|FG000|Overall Study|Never started treatment|1|||
48875266|NCT02706951|157381610|FG004|Period 1|Adverse Event|0|||
48875267|NCT02706951|157381606|FG000|Period 1|Withdrawal by Subject|10|||
49023248|NCT00337077|157924138|FG001|Overall Study|Never started treatment|1|||
49023249|NCT00337077|157924139|FG002|Overall Study|Never started treatment|0|||
49023250|NCT00337077|157924137|FG000|Overall Study|Ineligible|1|||
49023251|NCT00337077|157924138|FG001|Overall Study|Ineligible|1|||
49023252|NCT00337077|157924139|FG002|Overall Study|Ineligible|1|||
49023253|NCT03657160|157924140|FG000|Overall Study|Adverse Event|5|||
49023254|NCT03657160|157924141|FG001|Overall Study|Adverse Event|6|||
48686855|NCT03228537|156703718|FG000|Neoadjuvant|Death|1|||
48686856|NCT03228537|156703718|FG000|Surgery|Death|1|||
48686857|NCT03228537|156703718|FG000|Surgery|Other - Not Protocol Specified|2|||
48686858|NCT03228537|156703718|FG000|Maintenance|Refusal Unrelated to Adverse Event|1|||
48686859|NCT03228537|156703718|FG000|Maintenance|Progression/Relapse|10|||
48686860|NCT02038153|156705231|FG000|Overall Study|Withdrawal by Subject|1|||
48686861|NCT01101035|156705232|FG000|Overall Study|Adverse Event|191|||
48686862|NCT01101035|156705233|FG001|Overall Study|Adverse Event|172|||
48686863|NCT01101035|156705232|FG000|Overall Study|Major Protocol Deviation|52|||
48686864|NCT01101035|156705233|FG001|Overall Study|Major Protocol Deviation|46|||
48686865|NCT01101035|156705232|FG000|Overall Study|Lost to Follow-up|226|||
48686866|NCT01101035|156705233|FG001|Overall Study|Lost to Follow-up|223|||
48686867|NCT01101035|156705232|FG000|Overall Study|Voluntary Withdrawal|595|||
48686868|NCT01101035|156705233|FG001|Overall Study|Voluntary Withdrawal|587|||
48686869|NCT01101035|156705232|FG000|Overall Study|Reason not Specified|333|||
48875268|NCT02706951|157381607|FG001|Period 1|Withdrawal by Subject|6|||
48875269|NCT02706951|157381608|FG002|Period 1|Withdrawal by Subject|6|||
48875270|NCT02706951|157381609|FG003|Period 1|Withdrawal by Subject|0|||
48981435|NCT05333289|157764272|FG005|Overall Study|Withdrawal by Subject|2|||
48981436|NCT05333289|157764273|FG006|Overall Study|Withdrawal by Subject|1|||
48981437|NCT05333289|157764274|FG007|Overall Study|Withdrawal by Subject|3|||
48981438|NCT05333289|157764267|FG000|Overall Study|Protocol Violation|1|||
48981439|NCT05333289|157764268|FG001|Overall Study|Protocol Violation|0|||
48763330|NCT01150123|156983843|FG000|Overall Study|Withdrawal by Subject|1|||
48763331|NCT01150123|156983844|FG001|Overall Study|Withdrawal by Subject|1|||
48763332|NCT01150123|156983845|FG002|Overall Study|Withdrawal by Subject|2|||
48763333|NCT01150123|156983846|FG003|Overall Study|Withdrawal by Subject|1|||
48763334|NCT01150123|156983847|FG004|Overall Study|Withdrawal by Subject|1|||
48763335|NCT01150123|156983848|FG005|Overall Study|Withdrawal by Subject|1|||
48763336|NCT01150123|156983849|FG006|Overall Study|Withdrawal by Subject|0|||
48763337|NCT01150123|156983850|FG007|Overall Study|Withdrawal by Subject|3|||
48763338|NCT01150123|156983851|FG008|Overall Study|Withdrawal by Subject|2|||
49023255|NCT03657160|157924140|FG000|Overall Study|Protocol Deviation|3|||
49023256|NCT03657160|157924141|FG001|Overall Study|Protocol Deviation|0|||
49023257|NCT03657160|157924140|FG000|Overall Study|Withdrawal by Subject|18|||
49023258|NCT03657160|157924141|FG001|Overall Study|Withdrawal by Subject|16|||
49023259|NCT03657160|157924140|FG000|Overall Study|Site Termination|1|||
48686870|NCT01101035|156705233|FG001|Overall Study|Reason not Specified|363|||
48686871|NCT00410761|156705234|FG000|Overall Study|Adverse Event|29|||
48686872|NCT00410761|156705235|FG001|Overall Study|Adverse Event|3|||
48686873|NCT00410761|156705234|FG000|Overall Study|objective disease progression|71|||
48686874|NCT00410761|156705235|FG001|Overall Study|objective disease progression|55|||
48686875|NCT00410761|156705234|FG000|Overall Study|Withdrawal by Subject|8|||
48686876|NCT00410761|156705235|FG001|Overall Study|Withdrawal by Subject|4|||
48686877|NCT00410761|156705234|FG000|Overall Study|Other|12|||
48686878|NCT00410761|156705235|FG001|Overall Study|Other|9|||
48686879|NCT00410761|156705234|FG000|Overall Study|Never received randomised treatment|0|||
48686880|NCT00410761|156705235|FG001|Overall Study|Never received randomised treatment|1|||
48686881|NCT00411671|156705240|FG000|Overall Study|Adverse Event|15|||
48686882|NCT00411671|156705240|FG000|Overall Study|Death|2|||
48686883|NCT00411671|156705240|FG000|Overall Study|Lost to Follow-up|3|||
48686884|NCT01080807|156705245|FG000|Overall Study|Adverse Event|9|||
48686885|NCT01080807|156705246|FG001|Overall Study|Adverse Event|1|||
48686886|NCT01080807|156705245|FG000|Overall Study|Lack of Efficacy|0|||
48686887|NCT01080807|156705246|FG001|Overall Study|Lack of Efficacy|1|||
48686888|NCT01080807|156705245|FG000|Overall Study|Withdrawal by Subject|7|||
48686889|NCT01080807|156705246|FG001|Overall Study|Withdrawal by Subject|2|||
48686890|NCT01080807|156705245|FG000|Overall Study|Protocol Violation|7|||
48686891|NCT01080807|156705246|FG001|Overall Study|Protocol Violation|6|||
48686892|NCT01080807|156705245|FG000|Overall Study|Lost to Follow-up|6|||
48686893|NCT01080807|156705246|FG001|Overall Study|Lost to Follow-up|4|||
48686894|NCT01080807|156705245|FG000|Overall Study|Noncompliance with drug administration|1|||
48686895|NCT01080807|156705246|FG001|Overall Study|Noncompliance with drug administration|1|||
48686896|NCT01080807|156705245|FG000|Overall Study|Noncompliance to study procedures|1|||
48686897|NCT01080807|156705246|FG001|Overall Study|Noncompliance to study procedures|1|||
48686898|NCT01080807|156705245|FG000|Overall Study|Began working day shift|0|||
48686899|NCT01080807|156705246|FG001|Overall Study|Began working day shift|2|||
48686900|NCT01080807|156705245|FG000|Overall Study|Laid off or terminated from job|1|||
48686901|NCT01080807|156705246|FG001|Overall Study|Laid off or terminated from job|2|||
48686902|NCT01080807|156705245|FG000|Overall Study|Stopped working consistent night shifts|0|||
48686903|NCT01080807|156705246|FG001|Overall Study|Stopped working consistent night shifts|1|||
48686904|NCT01080807|156705245|FG000|Overall Study|Work schedule changing|1|||
48686905|NCT01080807|156705246|FG001|Overall Study|Work schedule changing|1|||
48686906|NCT01080807|156705245|FG000|Overall Study|Work schedule and travel|0|||
48686907|NCT01080807|156705246|FG001|Overall Study|Work schedule and travel|1|||
48686908|NCT01080807|156705245|FG000|Overall Study|Switched to first shift|1|||
48686909|NCT01080807|156705246|FG001|Overall Study|Switched to first shift|0|||
48686910|NCT01080807|156705245|FG000|Overall Study|Moved away without notifying center|1|||
48686911|NCT01080807|156705246|FG001|Overall Study|Moved away without notifying center|0|||
48686912|NCT02836652|156705247|FG000|Overall Study|Death|3|||
48686913|NCT02836652|156705248|FG001|Overall Study|Death|3|||
48763339|NCT01150123|156983852|FG009|Overall Study|Withdrawal by Subject|0|||
48763340|NCT01150123|156983853|FG010|Overall Study|Withdrawal by Subject|1|||
48763341|NCT01150123|156983854|FG011|Overall Study|Withdrawal by Subject|0|||
48981440|NCT05333289|157764269|FG002|Overall Study|Protocol Violation|0|||
48686914|NCT02836652|156705247|FG000|Overall Study|Transplant/Explant|3|||
48981441|NCT05333289|157764270|FG003|Overall Study|Protocol Violation|0|||
48686915|NCT02836652|156705248|FG001|Overall Study|Transplant/Explant|4|||
48686916|NCT02836652|156705247|FG000|Overall Study|Withdrawn|9|||
48981442|NCT05333289|157764271|FG004|Overall Study|Protocol Violation|0|||
48981443|NCT05333289|157764272|FG005|Overall Study|Protocol Violation|0|||
48981444|NCT05333289|157764273|FG006|Overall Study|Protocol Violation|0|||
48981445|NCT05333289|157764274|FG007|Overall Study|Protocol Violation|0|||
48981446|NCT05333289|157764267|FG000|Overall Study|Physician Decision|0|||
49023260|NCT03657160|157924141|FG001|Overall Study|Site Termination|0|||
49023261|NCT03657160|157924140|FG000|Overall Study|Unsatisfactory Therapeutic Response|5|||
49023262|NCT03657160|157924141|FG001|Overall Study|Unsatisfactory Therapeutic Response|3|||
49023263|NCT03657160|157924140|FG000|Overall Study|Death|33|||
49023264|NCT03657160|157924141|FG001|Overall Study|Death|26|||
49023265|NCT03657160|157924140|FG000|Overall Study|Death (COVID-19-Related)|1|||
49023266|NCT03657160|157924141|FG001|Overall Study|Death (COVID-19-Related)|0|||
49023267|NCT03657160|157924140|FG000|Overall Study|Reason Not Specified|5|||
49023268|NCT03657160|157924141|FG001|Overall Study|Reason Not Specified|5|||
49023269|NCT03657160|157924140|FG000|Overall Study|Other (COVID-19-Related)|0|||
49023270|NCT03657160|157924141|FG001|Overall Study|Other (COVID-19-Related)|1|||
49023271|NCT00302952|157924148|FG000|Overall Study|Physician Decision|1|||
49023272|NCT00302952|157924149|FG001|Overall Study|Physician Decision|1|||
49023273|NCT00302952|157924148|FG000|Overall Study|Withdrawal by Subject|2|||
49023274|NCT00302952|157924149|FG001|Overall Study|Withdrawal by Subject|3|||
49023275|NCT00302952|157924148|FG000|Overall Study|Elevated SGOT (AST) lab value|0|||
49023276|NCT00302952|157924149|FG001|Overall Study|Elevated SGOT (AST) lab value|1|||
49023277|NCT01936948|157924150|FG000|Overall Study|no 30-day follow-up data|0|||
49023278|NCT01936948|157924151|FG001|Overall Study|no 30-day follow-up data|3|||
49023279|NCT01936948|157924152|FG002|Overall Study|no 30-day follow-up data|3|||
49023280|NCT01936948|157924153|FG003|Overall Study|no 30-day follow-up data|3|||
49023281|NCT02365207|157924154|FG000|Overall Study|Withdrawal by Subject|1|||
49023282|NCT02365207|157924154|FG000|Overall Study|Physician Decision|1|||
49023283|NCT00406848|157924160|FG000|Overall Study|Withdrawal by Subject|27|||
49023284|NCT00406848|157924161|FG001|Overall Study|Withdrawal by Subject|22|||
49023285|NCT00406848|157924160|FG000|Overall Study|Adverse Event|38|||
49023286|NCT00406848|157924161|FG001|Overall Study|Adverse Event|7|||
49023287|NCT00406848|157924160|FG000|Overall Study|Lack of Efficacy|9|||
49023288|NCT00406848|157924161|FG001|Overall Study|Lack of Efficacy|14|||
49023289|NCT00406848|157924160|FG000|Overall Study|Protocol Violation|10|||
49023290|NCT00406848|157924161|FG001|Overall Study|Protocol Violation|6|||
49023291|NCT00406848|157924160|FG000|Overall Study|Lost to Follow-up|6|||
49023292|NCT00406848|157924161|FG001|Overall Study|Lost to Follow-up|2|||
49023293|NCT00406848|157924160|FG000|Overall Study|Physician Decision|2|||
49023294|NCT00406848|157924161|FG001|Overall Study|Physician Decision|2|||
49023295|NCT00406848|157924160|FG000|Overall Study|Sponsor Decision|1|||
49023296|NCT00406848|157924161|FG001|Overall Study|Sponsor Decision|1|||
49023297|NCT00626548|157924162|FG000|Overall Study|Adverse Event|164|||
49023298|NCT00626548|157924163|FG001|Overall Study|Adverse Event|44|||
49023299|NCT00626548|157924162|FG000|Overall Study|Withdrawal by Subject|42|||
49023300|NCT00626548|157924163|FG001|Overall Study|Withdrawal by Subject|46|||
49023301|NCT00626548|157924162|FG000|Overall Study|Protocol Violation|4|||
49023302|NCT00626548|157924163|FG001|Overall Study|Protocol Violation|11|||
49023303|NCT00626548|157924162|FG000|Overall Study|Lost to Follow-up|2|||
49023304|NCT00626548|157924163|FG001|Overall Study|Lost to Follow-up|2|||
49023305|NCT00626548|157924162|FG000|Overall Study|Other termination reason|493|||
49023306|NCT00626548|157924163|FG001|Overall Study|Other termination reason|613|||
49023307|NCT00048581|157924164|FG000|Double-Blind Period|Adverse Event|9|||
49023308|NCT00048581|157924165|FG001|Double-Blind Period|Adverse Event|5|||
49023309|NCT00048581|157924166|FG002|Double-Blind Period|Adverse Event|0|||
49023310|NCT00048581|157924164|FG000|Double-Blind Period|Lack of Efficacy|14|||
49023311|NCT00048581|157924165|FG001|Double-Blind Period|Lack of Efficacy|27|||
49023312|NCT00048581|157924166|FG002|Double-Blind Period|Lack of Efficacy|0|||
49023313|NCT00048581|157924164|FG000|Double-Blind Period|Lost to Follow-up|5|||
49023314|NCT00048581|157924165|FG001|Double-Blind Period|Lost to Follow-up|0|||
49023315|NCT00048581|157924166|FG002|Double-Blind Period|Lost to Follow-up|0|||
49023316|NCT00048581|157924164|FG000|Double-Blind Period|Withdrawal by Subject|5|||
49023317|NCT00048581|157924165|FG001|Double-Blind Period|Withdrawal by Subject|2|||
49023318|NCT00048581|157924166|FG002|Double-Blind Period|Withdrawal by Subject|0|||
49023319|NCT00048581|157924164|FG000|Double-Blind Period|Participant Has History of Lymphopenia|1|||
49023320|NCT00048581|157924165|FG001|Double-Blind Period|Participant Has History of Lymphopenia|0|||
49023321|NCT00048581|157924166|FG002|Double-Blind Period|Participant Has History of Lymphopenia|0|||
49023322|NCT00048581|157924164|FG000|Double-Blind Period|Investigator Decision|1|||
49023323|NCT00048581|157924165|FG001|Double-Blind Period|Investigator Decision|0|||
49023324|NCT00048581|157924166|FG002|Double-Blind Period|Investigator Decision|0|||
49023325|NCT00048581|157924164|FG000|Open-Label Period|Death|0|||
49023326|NCT00048581|157924165|FG001|Open-Label Period|Death|0|||
49023327|NCT00048581|157924166|FG002|Open-Label Period|Death|4|||
49023328|NCT00048581|157924164|FG000|Open-Label Period|Adverse Event|0|||
49023329|NCT00048581|157924165|FG001|Open-Label Period|Adverse Event|0|||
49023330|NCT00048581|157924166|FG002|Open-Label Period|Adverse Event|37|||
49023331|NCT00048581|157924164|FG000|Open-Label Period|Lack of Efficacy|0|||
49023332|NCT00048581|157924165|FG001|Open-Label Period|Lack of Efficacy|0|||
49023333|NCT00048581|157924166|FG002|Open-Label Period|Lack of Efficacy|69|||
49023334|NCT00048581|157924164|FG000|Open-Label Period|Lost to Follow-up|0|||
49023335|NCT00048581|157924165|FG001|Open-Label Period|Lost to Follow-up|0|||
49023336|NCT00048581|157924166|FG002|Open-Label Period|Lost to Follow-up|14|||
48686917|NCT02836652|156705248|FG001|Overall Study|Withdrawn|9|||
48686918|NCT02836652|156705247|FG000|Overall Study|Not on treatment regimen post-op day 15|3|||
48686919|NCT02836652|156705248|FG001|Overall Study|Not on treatment regimen post-op day 15|3|||
48686920|NCT01220167|156705250|FG000|Period 3|Urine positive for substance abuse|0|||
48686921|NCT01220167|156705251|FG001|Period 3|Urine positive for substance abuse|1|||
48686922|NCT01220167|156705252|FG002|Period 3|Urine positive for substance abuse|0|||
48686923|NCT02366312|156705253|FG000|Overall Study|Lost to Follow-up|0|||
48686924|NCT02366312|156705254|FG001|Overall Study|Lost to Follow-up|1|||
48686925|NCT03594773|156705255|FG000|Overall Study|Withdrawal by Subject|3|||
48686926|NCT03594773|156705256|FG001|Overall Study|Withdrawal by Subject|2|||
48686927|NCT03594773|156705255|FG000|Overall Study|Lost to Follow-up|3|||
48686928|NCT03594773|156705256|FG001|Overall Study|Lost to Follow-up|4|||
48686929|NCT01290757|156705257|FG000|Overall Study|Adverse Event|1|||
48686930|NCT01290757|156705258|FG001|Overall Study|Adverse Event|0|||
48686931|NCT01290757|156705257|FG000|Overall Study|Protocol Violation|1|||
48686932|NCT01290757|156705258|FG001|Overall Study|Protocol Violation|1|||
48686933|NCT01290757|156705257|FG000|Overall Study|Other|0|||
48686934|NCT01290757|156705258|FG001|Overall Study|Other|1|||
49023337|NCT00048581|157924164|FG000|Open-Label Period|Withdrawal by Subject|0|||
49023338|NCT00048581|157924165|FG001|Open-Label Period|Withdrawal by Subject|0|||
49023339|NCT00048581|157924166|FG002|Open-Label Period|Withdrawal by Subject|20|||
49023340|NCT00048581|157924164|FG000|Open-Label Period|No Longer Meets Study Criteria|0|||
49023341|NCT00048581|157924165|FG001|Open-Label Period|No Longer Meets Study Criteria|0|||
49023342|NCT00048581|157924166|FG002|Open-Label Period|No Longer Meets Study Criteria|2|||
48686935|NCT02634333|156705260|FG000|Overall Study|Completed out of Window|3|||
48686936|NCT02634333|156705261|FG001|Overall Study|Completed out of Window|2|||
48686937|NCT02634333|156705260|FG000|Overall Study|Missed Visit|5|||
48686938|NCT02634333|156705261|FG001|Overall Study|Missed Visit|2|||
48686939|NCT02634333|156705260|FG000|Overall Study|Lost to Follow-up|12|||
48686940|NCT02634333|156705261|FG001|Overall Study|Lost to Follow-up|7|||
48686941|NCT02634333|156705260|FG000|Overall Study|Withdrawal by Subject|9|||
48686942|NCT02634333|156705261|FG001|Overall Study|Withdrawal by Subject|13|||
48686943|NCT02634333|156705260|FG000|Overall Study|Death|11|||
48686944|NCT02634333|156705261|FG001|Overall Study|Death|8|||
48686945|NCT01426958|156705262|FG000|Overall Study|Adverse Event|2|||
48686946|NCT02631551|156705263|FG000|Overall Study|Adverse Event|1|||
48686947|NCT02631551|156705264|FG001|Overall Study|Adverse Event|2|||
48686948|NCT02631551|156705265|FG002|Overall Study|Adverse Event|4|||
48686949|NCT02631551|156705266|FG003|Overall Study|Adverse Event|0|||
48686950|NCT02631551|156705263|FG000|Overall Study|Lack of Efficacy|0|||
49023343|NCT00048581|157924164|FG000|Open-Label Period|Poor/Non-compliance|0|||
49023344|NCT00048581|157924165|FG001|Open-Label Period|Poor/Non-compliance|0|||
49023345|NCT00048581|157924166|FG002|Open-Label Period|Poor/Non-compliance|5|||
49023346|NCT00048581|157924164|FG000|Open-Label Period|Pregnancy|0|||
49023347|NCT00048581|157924165|FG001|Open-Label Period|Pregnancy|0|||
49023348|NCT00048581|157924166|FG002|Open-Label Period|Pregnancy|7|||
49023349|NCT00048581|157924164|FG000|Open-Label Period|Study Site Closure|0|||
49023350|NCT00048581|157924165|FG001|Open-Label Period|Study Site Closure|0|||
48686951|NCT02631551|156705264|FG001|Overall Study|Lack of Efficacy|0|||
48686952|NCT02631551|156705265|FG002|Overall Study|Lack of Efficacy|1|||
48686953|NCT02631551|156705266|FG003|Overall Study|Lack of Efficacy|0|||
48686954|NCT02631551|156705263|FG000|Overall Study|Lost to Follow-up|1|||
48686955|NCT02631551|156705264|FG001|Overall Study|Lost to Follow-up|2|||
48686956|NCT02631551|156705265|FG002|Overall Study|Lost to Follow-up|0|||
48686957|NCT02631551|156705266|FG003|Overall Study|Lost to Follow-up|3|||
48686958|NCT02631551|156705263|FG000|Overall Study|Withdrawal by Subject|2|||
48686959|NCT02631551|156705264|FG001|Overall Study|Withdrawal by Subject|2|||
48686960|NCT02631551|156705265|FG002|Overall Study|Withdrawal by Subject|0|||
48686961|NCT02631551|156705266|FG003|Overall Study|Withdrawal by Subject|5|||
49023351|NCT00048581|157924166|FG002|Open-Label Period|Study Site Closure|2|||
49023352|NCT00048581|157924164|FG000|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
49023353|NCT00048581|157924165|FG001|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
49023354|NCT00048581|157924166|FG002|Open-Label Period|Continue ABA With Primary Rheumatologist|3|||
49023355|NCT00048581|157924164|FG000|Open-Label Period|Problem With Transportation To Site|0|||
48686962|NCT02631551|156705263|FG000|Overall Study|Protocol deviation|3|||
48686963|NCT02631551|156705264|FG001|Overall Study|Protocol deviation|6|||
48686964|NCT02631551|156705265|FG002|Overall Study|Protocol deviation|3|||
48686965|NCT02631551|156705266|FG003|Overall Study|Protocol deviation|0|||
49023356|NCT00048581|157924165|FG001|Open-Label Period|Problem With Transportation To Site|0|||
48686966|NCT02631551|156705263|FG000|Overall Study|Non-compliance with study procedures|0|||
48686967|NCT02631551|156705264|FG001|Overall Study|Non-compliance with study procedures|0|||
48686968|NCT02631551|156705265|FG002|Overall Study|Non-compliance with study procedures|1|||
48686969|NCT02631551|156705266|FG003|Overall Study|Non-compliance with study procedures|1|||
48686970|NCT02631551|156705263|FG000|Overall Study|Non-compliance with study drug|1|||
48686971|NCT02631551|156705264|FG001|Overall Study|Non-compliance with study drug|0|||
48686972|NCT02631551|156705265|FG002|Overall Study|Non-compliance with study drug|0|||
49023357|NCT00048581|157924166|FG002|Open-Label Period|Problem With Transportation To Site|1|||
49023358|NCT00048581|157924164|FG000|Open-Label Period|Primary Investigator Retired|0|||
49023359|NCT00048581|157924165|FG001|Open-Label Period|Primary Investigator Retired|0|||
49023360|NCT00048581|157924166|FG002|Open-Label Period|Primary Investigator Retired|2|||
49023361|NCT00048581|157924164|FG000|Open-Label Period|Study Ended By Sponsor|0|||
49023362|NCT00048581|157924165|FG001|Open-Label Period|Study Ended By Sponsor|0|||
49023363|NCT00048581|157924166|FG002|Open-Label Period|Study Ended By Sponsor|1|||
49023364|NCT00841100|157924171|FG000|Phase 1 (28 Days)|Adverse Event|1|||
49023365|NCT00841100|157924171|FG000|Phase 1 (28 Days)|Participant non-compliance|2|||
49023366|NCT00870870|157924174|FG000|Overall Study|Withdrawal by Subject|0|||
49023367|NCT00870870|157924175|FG001|Overall Study|Withdrawal by Subject|1|||
49023368|NCT00870870|157924176|FG002|Overall Study|Withdrawal by Subject|1|||
49023369|NCT00870870|157924177|FG003|Overall Study|Withdrawal by Subject|3|||
49023370|NCT00870870|157924174|FG000|Overall Study|Adverse Event|0|||
49023371|NCT00870870|157924175|FG001|Overall Study|Adverse Event|0|||
49023372|NCT00870870|157924176|FG002|Overall Study|Adverse Event|2|||
49023373|NCT00870870|157924177|FG003|Overall Study|Adverse Event|2|||
49023374|NCT03420300|157924178|FG000|Overall Study|Death|2|||
49023375|NCT02658084|157924183|FG000|Overall Study|Withdrawal by Subject|1|||
49023376|NCT02658084|157924184|FG001|Overall Study|Withdrawal by Subject|0|||
49023377|NCT02658084|157924183|FG000|Overall Study|Study Termination|1|||
48686973|NCT02631551|156705266|FG003|Overall Study|Non-compliance with study drug|0|||
48686974|NCT02631551|156705263|FG000|Overall Study|Other, specific reasons not collected|5|||
48686975|NCT02631551|156705264|FG001|Overall Study|Other, specific reasons not collected|7|||
48686976|NCT02631551|156705265|FG002|Overall Study|Other, specific reasons not collected|2|||
48686977|NCT02631551|156705266|FG003|Overall Study|Other, specific reasons not collected|2|||
48686978|NCT01367834|156705267|FG000|Overall Study|Withdrawal by Subject|2|||
48686979|NCT01367834|156705268|FG001|Overall Study|Withdrawal by Subject|2|||
48686980|NCT01367834|156705267|FG000|Overall Study|Study was ended.|0|||
48686981|NCT01367834|156705268|FG001|Overall Study|Study was ended.|1|||
48686982|NCT01011673|156705273|FG000|Randomized|Secondary headache|2|||
48686983|NCT01011673|156705274|FG001|Randomized|Secondary headache|1|||
48686984|NCT01011673|156705273|FG000|24 Hour Follow-up|Lost to Follow-up|3|||
48686985|NCT01011673|156705274|FG001|24 Hour Follow-up|Lost to Follow-up|3|||
48686986|NCT00539994|156705280|FG000|Overall Study|Lost to Follow-up|2|||
48686987|NCT00539994|156705281|FG001|Overall Study|Lost to Follow-up|1|||
48686988|NCT00539994|156705282|FG002|Overall Study|Lost to Follow-up|0|||
49023378|NCT02658084|157924184|FG001|Overall Study|Study Termination|0|||
49023379|NCT04149964|157924187|FG000|Overall Study|Lost to Follow-up|19|||
49023380|NCT04149964|157924188|FG001|Overall Study|Lost to Follow-up|18|||
49023381|NCT01411332|157924189|FG000|Enrollment|Protocol Violation|0|||
49023382|NCT01411332|157924190|FG001|Enrollment|Protocol Violation|1|||
49023383|NCT01411332|157924189|FG000|Enrollment|Withdrawal by Subject|0|||
49023384|NCT01411332|157924190|FG001|Enrollment|Withdrawal by Subject|1|||
49023385|NCT01411332|157924189|FG000|Treatment|Lost to Follow-up|1|||
49023386|NCT01411332|157924190|FG001|Treatment|Lost to Follow-up|0|||
49023387|NCT00679367|157924191|FG000|Overall Study|Adverse Event|7|||
49023388|NCT00679367|157924191|FG000|Overall Study|inability to swallow oral drugs|1|||
49023389|NCT00679367|157924191|FG000|Overall Study|Lack of Efficacy|3|||
49023390|NCT00679367|157924191|FG000|Overall Study|Withdrawal by Subject|1|||
49023391|NCT02146430|157925656|FG000|Overall Study|Protocol Violation|5|||
49023392|NCT02146430|157925657|FG001|Overall Study|Protocol Violation|4|||
49023393|NCT02146430|157925658|FG002|Overall Study|Protocol Violation|8|||
49023394|NCT02146430|157925659|FG003|Overall Study|Protocol Violation|6|||
49023395|NCT02146430|157925656|FG000|Overall Study|Lack of Efficacy|13|||
49023396|NCT02146430|157925657|FG001|Overall Study|Lack of Efficacy|11|||
48686989|NCT00539994|156705280|FG000|Overall Study|Withdrawal by Subject|1|||
48686990|NCT00539994|156705281|FG001|Overall Study|Withdrawal by Subject|0|||
48686991|NCT00539994|156705282|FG002|Overall Study|Withdrawal by Subject|1|||
49023397|NCT02146430|157925658|FG002|Overall Study|Lack of Efficacy|8|||
49023398|NCT02146430|157925659|FG003|Overall Study|Lack of Efficacy|5|||
49023399|NCT02146430|157925656|FG000|Overall Study|Adverse Event|20|||
49023400|NCT02146430|157925657|FG001|Overall Study|Adverse Event|40|||
49023401|NCT02146430|157925658|FG002|Overall Study|Adverse Event|32|||
49023402|NCT02146430|157925659|FG003|Overall Study|Adverse Event|49|||
48686992|NCT00539994|156705280|FG000|Overall Study|Physician Decision|0|||
48686993|NCT00539994|156705281|FG001|Overall Study|Physician Decision|0|||
48686994|NCT00539994|156705282|FG002|Overall Study|Physician Decision|1|||
48686995|NCT01917747|156705284|FG000|Overall Study|Withdrawal by Subject|1|||
48686996|NCT01917747|156705285|FG001|Overall Study|Withdrawal by Subject|2|||
48686997|NCT01917747|156705284|FG000|Overall Study|Lost to Follow-up|18|||
48686998|NCT01917747|156705285|FG001|Overall Study|Lost to Follow-up|9|||
48686999|NCT03359174|156705292|FG000|Overall Study|Adverse Event|1|||
48687000|NCT02905266|156705295|FG000|Treatment Phase Part 1|Participant Withdrew Consent|1|||
49023403|NCT02146430|157925656|FG000|Overall Study|Reason missing or not reported|2|||
49023404|NCT02146430|157925657|FG001|Overall Study|Reason missing or not reported|3|||
49023405|NCT02146430|157925658|FG002|Overall Study|Reason missing or not reported|4|||
48687001|NCT02905266|156705296|FG001|Treatment Phase Part 1|Participant Withdrew Consent|0|||
48687002|NCT02905266|156705295|FG000|Treatment Phase Part 1|Disease Progression|6|||
48687003|NCT02905266|156705296|FG001|Treatment Phase Part 1|Disease Progression|7|||
48687004|NCT02905266|156705295|FG000|Treatment Phase Part 1|Study Drug Toxicity|22|||
48687005|NCT02905266|156705296|FG001|Treatment Phase Part 1|Study Drug Toxicity|16|||
48687006|NCT02905266|156705295|FG000|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1|||
48687007|NCT02905266|156705296|FG001|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0|||
48687008|NCT02905266|156705295|FG000|Transition From Part 1 to Part 2|Disease progression|2|||
48687009|NCT02905266|156705296|FG001|Transition From Part 1 to Part 2|Disease progression|1|||
48687010|NCT02905266|156705295|FG000|Transition From Part 1 to Part 2|Study drug toxicity|0|||
48687011|NCT02905266|156705296|FG001|Transition From Part 1 to Part 2|Study drug toxicity|4|||
48687012|NCT02905266|156705295|FG000|Transition From Part 1 to Part 2|Death|0|||
48687013|NCT02905266|156705296|FG001|Transition From Part 1 to Part 2|Death|1|||
48687014|NCT02905266|156705295|FG000|Transition From Part 1 to Part 2|Participant withdrew consent|0|||
48687015|NCT02905266|156705296|FG001|Transition From Part 1 to Part 2|Participant withdrew consent|1|||
48687016|NCT02905266|156705295|FG000|Transition From Part 1 to Part 2|Adverse Event|1|||
48687017|NCT02905266|156705296|FG001|Transition From Part 1 to Part 2|Adverse Event|1|||
48687018|NCT02905266|156705295|FG000|Maintenance Phase Part 2|Disease Progression|9|||
48687019|NCT02905266|156705296|FG001|Maintenance Phase Part 2|Disease Progression|2|||
48687020|NCT02905266|156705295|FG000|Maintenance Phase Part 2|Study Drug Toxicity|3|||
48687021|NCT02905266|156705296|FG001|Maintenance Phase Part 2|Study Drug Toxicity|4|||
48687022|NCT02905266|156705295|FG000|Maintenance Phase Part 2|Maximum Clinical Benefit|0|||
48687023|NCT02905266|156705296|FG001|Maintenance Phase Part 2|Maximum Clinical Benefit|2|||
48687024|NCT00402168|156705297|FG000|Randomized|Lost to Follow-up|1|||
48687025|NCT00402168|156705298|FG001|Randomized|Lost to Follow-up|0|||
48687026|NCT00402168|156705297|FG000|Randomized|Withdrawal by Subject|0|||
48687027|NCT00402168|156705298|FG001|Randomized|Withdrawal by Subject|1|||
48687028|NCT00402168|156705297|FG000|Treatment (up to 12 Months)|Death|0|||
48687029|NCT00402168|156705298|FG001|Treatment (up to 12 Months)|Death|1|||
48687030|NCT00402168|156705297|FG000|Treatment (up to 12 Months)|Lack of Efficacy|2|||
48687031|NCT00402168|156705298|FG001|Treatment (up to 12 Months)|Lack of Efficacy|0|||
48687032|NCT00402168|156705297|FG000|Treatment (up to 12 Months)|non-specified|0|||
48687033|NCT00402168|156705298|FG001|Treatment (up to 12 Months)|non-specified|1|||
48687034|NCT00402168|156705297|FG000|Long Term (LT)|Adverse Event|1|||
48687035|NCT00402168|156705298|FG001|Long Term (LT)|Adverse Event|5|||
48687036|NCT00402168|156705297|FG000|Long Term (LT)|Withdrawal by Subject|4|||
48687037|NCT00402168|156705298|FG001|Long Term (LT)|Withdrawal by Subject|7|||
48687038|NCT00402168|156705297|FG000|Long Term (LT)|Pregnancy|0|||
48687039|NCT00402168|156705298|FG001|Long Term (LT)|Pregnancy|1|||
48687040|NCT00402168|156705297|FG000|Long Term (LT)|Lost to Follow-up|1|||
48687041|NCT00402168|156705298|FG001|Long Term (LT)|Lost to Follow-up|0|||
48687042|NCT00402168|156705297|FG000|Long Term (LT)|Death|4|||
48687043|NCT00402168|156705298|FG001|Long Term (LT)|Death|0|||
48687044|NCT00402168|156705297|FG000|Long Term (LT)|Lack of Efficacy|0|||
48687045|NCT00402168|156705298|FG001|Long Term (LT)|Lack of Efficacy|2|||
48687046|NCT00402168|156705297|FG000|Long Term (LT)|non-specified|1|||
48687047|NCT00402168|156705298|FG001|Long Term (LT)|non-specified|2|||
48687048|NCT00402168|156705297|FG000|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2|||
48687049|NCT00402168|156705298|FG001|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0|||
48687050|NCT00402168|156705297|FG000|Switched From CNI to Belatacept in LT|Adverse Event|4|||
48687051|NCT00402168|156705298|FG001|Switched From CNI to Belatacept in LT|Adverse Event|0|||
48687052|NCT02362724|156705299|FG000|Overall Study|Withdrawal by Subject|3|||
48687053|NCT02362724|156705300|FG001|Overall Study|Withdrawal by Subject|1|||
48687054|NCT02362724|156705299|FG000|Overall Study|Adverse Event|3|||
48687055|NCT02362724|156705300|FG001|Overall Study|Adverse Event|0|||
49023406|NCT02146430|157925659|FG003|Overall Study|Reason missing or not reported|5|||
49023407|NCT02146430|157925656|FG000|Overall Study|Withdrawal by Subject|27|||
49023408|NCT02146430|157925657|FG001|Overall Study|Withdrawal by Subject|29|||
49023409|NCT02146430|157925658|FG002|Overall Study|Withdrawal by Subject|30|||
49023410|NCT02146430|157925659|FG003|Overall Study|Withdrawal by Subject|34|||
49023411|NCT01469364|157925660|FG000|Overall Study|Adverse Event|1|||
49023412|NCT01469364|157925660|FG000|Overall Study|Withdrawal by Subject|1|||
48763342|NCT01150123|156983855|FG012|Overall Study|Withdrawal by Subject|1|||
48763343|NCT01150123|156983856|FG013|Overall Study|Withdrawal by Subject|0|||
49023413|NCT06066541|157925661|FG000|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|107|||
49023414|NCT06066541|157925662|FG001|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|122|||
48687056|NCT01332994|156705304|FG000|Overall Study|Adverse Event|34|||
48687057|NCT01332994|156705304|FG000|Overall Study|Death|1|||
48687058|NCT01332994|156705304|FG000|Overall Study|Lack of Efficacy|1|||
48687059|NCT01332994|156705304|FG000|Overall Study|Lost to Follow-up|4|||
49023415|NCT06066541|157925663|FG002|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|128|||
48687060|NCT01332994|156705304|FG000|Overall Study|Protocol Violation|6|||
48687061|NCT01332994|156705304|FG000|Overall Study|Withdrawal by Subject|15|||
48687062|NCT01332994|156705304|FG000|Overall Study|Administrative Problem|2|||
48687063|NCT01332994|156705304|FG000|Overall Study|Other|8|||
48687064|NCT02800863|156705305|FG000|Overall Study|Adverse Event|14|||
48687065|NCT02800863|156705305|FG000|Overall Study|Another Device Implanted|1|||
48687066|NCT02800863|156705305|FG000|Overall Study|Device Explanted|1|||
48687067|NCT02800863|156705305|FG000|Overall Study|Device Has Been Turned Off Since Jan 2019|1|||
48687068|NCT02800863|156705305|FG000|Overall Study|Health Issues|1|||
48687069|NCT02800863|156705305|FG000|Overall Study|Insurance Denial|8|||
48687070|NCT02800863|156705305|FG000|Overall Study|No Perm Implant, Active Pain Pump Implanted|1|||
48687071|NCT02800863|156705305|FG000|Overall Study|Patient Did not Obtain at Least 50% Pain Relief|1|||
48687072|NCT02800863|156705305|FG000|Overall Study|Screen Failure|1|||
48687073|NCT02800863|156705305|FG000|Overall Study|Sponsor Request|6|||
48687074|NCT02800863|156705305|FG000|Overall Study|Death|3|||
48687075|NCT02800863|156705305|FG000|Overall Study|Subject Implant at Another Facility|1|||
48687076|NCT02800863|156705305|FG000|Overall Study|Lost to Follow-up|26|||
48687077|NCT02800863|156705305|FG000|Overall Study|Subject Participation Terminated by Investigator|17|||
48687078|NCT02800863|156705305|FG000|Overall Study|Subject and/or Family Request|64|||
48687079|NCT02800863|156705305|FG000|Overall Study|Trial Failure|81|||
48687080|NCT02800863|156705305|FG000|Overall Study|Used Different Battery not Approved for Study at Time of Perm|1|||
48687081|NCT02966873|156705306|FG000|Overall Study|Lost to Follow-up|16|||
48687082|NCT02966873|156705307|FG001|Overall Study|Lost to Follow-up|15|||
48687083|NCT04816214|156705312|FG000|Overall Study|Progressive Disease|4|||
48687084|NCT04816214|156705313|FG001|Overall Study|Progressive Disease|0|||
48687085|NCT04816214|156705314|FG002|Overall Study|Progressive Disease|0|||
48687086|NCT04816214|156705312|FG000|Overall Study|Death|1|||
48687087|NCT04816214|156705313|FG001|Overall Study|Death|0|||
48687088|NCT04816214|156705314|FG002|Overall Study|Death|0|||
48687089|NCT04816214|156705312|FG000|Overall Study|Study Terminated by Sponsor|1|||
48687090|NCT04816214|156705313|FG001|Overall Study|Study Terminated by Sponsor|0|||
48687091|NCT04816214|156705314|FG002|Overall Study|Study Terminated by Sponsor|0|||
48687092|NCT00584415|156705320|FG000|Overall Study|Adverse Event|7|||
48687093|NCT04170543|156705321|FG000|Overall Study|Death|1|||
48687094|NCT04170543|156705322|FG001|Overall Study|Death|1|||
48687095|NCT04170543|156705323|FG002|Overall Study|Death|1|||
48687096|NCT04170543|156705324|FG003|Overall Study|Death|1|||
48687097|NCT04170543|156705325|FG004|Overall Study|Death|1|||
48763344|NCT01150123|156983857|FG014|Overall Study|Withdrawal by Subject|0|||
48763345|NCT01150123|156983858|FG015|Overall Study|Withdrawal by Subject|1|||
48763346|NCT01150123|156983859|FG016|Overall Study|Withdrawal by Subject|0|||
49023416|NCT06066541|157925664|FG003|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|110|||
49023417|NCT06066541|157925665|FG004|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|125|||
49023418|NCT06066541|157925666|FG005|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
49023419|NCT06066541|157925667|FG006|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
49023420|NCT06066541|157925661|FG000|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|6|||
49023421|NCT06066541|157925662|FG001|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|9|||
49023422|NCT06066541|157925663|FG002|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|3|||
49023423|NCT06066541|157925664|FG003|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|8|||
49023424|NCT06066541|157925665|FG004|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|7|||
49023425|NCT06066541|157925666|FG005|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|11|||
49023426|NCT06066541|157925667|FG006|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|5|||
49023427|NCT02581345|157925668|FG000|Part 1: up to Week 16|Adverse Event|3|||
49023428|NCT02581345|157925669|FG001|Part 1: up to Week 16|Adverse Event|8|||
49023429|NCT02581345|157925670|FG002|Part 1: up to Week 16|Adverse Event|0|||
49023430|NCT02581345|157925671|FG003|Part 1: up to Week 16|Adverse Event|0|||
49023431|NCT02581345|157925668|FG000|Part 1: up to Week 16|Physician Decision|2|||
49023432|NCT02581345|157925669|FG001|Part 1: up to Week 16|Physician Decision|4|||
49023433|NCT02581345|157925670|FG002|Part 1: up to Week 16|Physician Decision|0|||
49023434|NCT02581345|157925671|FG003|Part 1: up to Week 16|Physician Decision|0|||
49023435|NCT02581345|157925668|FG000|Part 1: up to Week 16|Withdrawal by Subject|4|||
49023436|NCT02581345|157925669|FG001|Part 1: up to Week 16|Withdrawal by Subject|7|||
49023437|NCT02581345|157925670|FG002|Part 1: up to Week 16|Withdrawal by Subject|0|||
49023438|NCT02581345|157925671|FG003|Part 1: up to Week 16|Withdrawal by Subject|0|||
49023439|NCT02581345|157925668|FG000|Part 1: up to Week 16|Lost to Follow-up|2|||
49023440|NCT02581345|157925669|FG001|Part 1: up to Week 16|Lost to Follow-up|0|||
49023441|NCT02581345|157925670|FG002|Part 1: up to Week 16|Lost to Follow-up|0|||
48687098|NCT04170543|156705321|FG000|Overall Study|Lost to Follow-up|3|||
48687099|NCT04170543|156705322|FG001|Overall Study|Lost to Follow-up|3|||
48687100|NCT04170543|156705323|FG002|Overall Study|Lost to Follow-up|0|||
48687101|NCT04170543|156705324|FG003|Overall Study|Lost to Follow-up|3|||
48687102|NCT04170543|156705325|FG004|Overall Study|Lost to Follow-up|1|||
48687103|NCT04170543|156705321|FG000|Overall Study|Withdrawal by Subject|13|||
48687104|NCT04170543|156705322|FG001|Overall Study|Withdrawal by Subject|6|||
48687105|NCT04170543|156705323|FG002|Overall Study|Withdrawal by Subject|5|||
49023442|NCT02581345|157925671|FG003|Part 1: up to Week 16|Lost to Follow-up|0|||
48687106|NCT04170543|156705324|FG003|Overall Study|Withdrawal by Subject|4|||
48687107|NCT04170543|156705325|FG004|Overall Study|Withdrawal by Subject|9|||
48687108|NCT04170543|156705321|FG000|Overall Study|Not able to transition to phase 2b|8|||
48687109|NCT04170543|156705322|FG001|Overall Study|Not able to transition to phase 2b|0|||
48687110|NCT04170543|156705323|FG002|Overall Study|Not able to transition to phase 2b|10|||
48687111|NCT04170543|156705324|FG003|Overall Study|Not able to transition to phase 2b|0|||
48687112|NCT04170543|156705325|FG004|Overall Study|Not able to transition to phase 2b|6|||
48687113|NCT04170543|156705321|FG000|Overall Study|Enrolled in Site with GCP Breach|6|||
48687114|NCT04170543|156705322|FG001|Overall Study|Enrolled in Site with GCP Breach|1|||
48687115|NCT04170543|156705323|FG002|Overall Study|Enrolled in Site with GCP Breach|2|||
48687116|NCT04170543|156705324|FG003|Overall Study|Enrolled in Site with GCP Breach|2|||
48687117|NCT04170543|156705325|FG004|Overall Study|Enrolled in Site with GCP Breach|4|||
48687118|NCT04170543|156705321|FG000|Overall Study|Not Treated|0|||
48687119|NCT04170543|156705322|FG001|Overall Study|Not Treated|0|||
48687120|NCT04170543|156705323|FG002|Overall Study|Not Treated|0|||
48687121|NCT04170543|156705324|FG003|Overall Study|Not Treated|0|||
48687122|NCT04170543|156705325|FG004|Overall Study|Not Treated|2|||
48687123|NCT04170543|156705321|FG000|Overall Study|(CRF)|16|||
48687124|NCT04170543|156705322|FG001|Overall Study|(CRF)|15|||
48687125|NCT04170543|156705323|FG002|Overall Study|(CRF)|12|||
48687126|NCT04170543|156705324|FG003|Overall Study|(CRF)|17|||
48687127|NCT04170543|156705325|FG004|Overall Study|(CRF)|17|||
48687128|NCT04170543|156705321|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
48687129|NCT04170543|156705322|FG001|Overall Study|Due to COVID-19 Pandemic|0|||
48687130|NCT04170543|156705323|FG002|Overall Study|Due to COVID-19 Pandemic|1|||
48687131|NCT04170543|156705324|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
48687132|NCT04170543|156705325|FG004|Overall Study|Due to COVID-19 Pandemic|0|||
48687133|NCT02586623|156705326|FG000|Open-Label (Up to 16 Weeks)|Adverse Event|53|||
48687134|NCT02586623|156705327|FG001|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
48687135|NCT02586623|156705328|FG002|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
48687136|NCT02586623|156705326|FG000|Open-Label (Up to 16 Weeks)|Lost to Follow-up|4|||
48687137|NCT02586623|156705327|FG001|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
48687138|NCT02586623|156705328|FG002|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
48687139|NCT02586623|156705326|FG000|Open-Label (Up to 16 Weeks)|Non-Compliance|6|||
48687140|NCT02586623|156705327|FG001|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
48687141|NCT02586623|156705328|FG002|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
48687142|NCT02586623|156705326|FG000|Open-Label (Up to 16 Weeks)|Physician Decision|11|||
48687143|NCT02586623|156705327|FG001|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
48687144|NCT02586623|156705328|FG002|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
48687145|NCT02586623|156705326|FG000|Open-Label (Up to 16 Weeks)|Protocol Violation|9|||
48687146|NCT02586623|156705327|FG001|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
48687147|NCT02586623|156705328|FG002|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
48687148|NCT02586623|156705326|FG000|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|56|||
48687149|NCT02586623|156705327|FG001|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
48687150|NCT02586623|156705328|FG002|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
48687151|NCT02586623|156705326|FG000|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|30|||
48687152|NCT02586623|156705327|FG001|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
48687153|NCT02586623|156705328|FG002|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
48687154|NCT02586623|156705326|FG000|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|17|||
48687155|NCT02586623|156705327|FG001|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
48687156|NCT02586623|156705328|FG002|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
48687157|NCT02586623|156705326|FG000|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|2|||
48687158|NCT02586623|156705327|FG001|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
48687159|NCT02586623|156705328|FG002|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
48687160|NCT02586623|156705326|FG000|Open-Label (Up to 16 Weeks)|Met stopping criteria|4|||
48687161|NCT02586623|156705327|FG001|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
48687162|NCT02586623|156705328|FG002|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
48687163|NCT02586623|156705326|FG000|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|3|||
48687164|NCT02586623|156705327|FG001|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
48687165|NCT02586623|156705328|FG002|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
48687166|NCT02586623|156705326|FG000|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|2|||
48687167|NCT02586623|156705327|FG001|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
48687168|NCT02586623|156705328|FG002|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
49023443|NCT02581345|157925668|FG000|Part 1: up to Week 16|Unspecified Reason|3|||
48687169|NCT02586623|156705326|FG000|Open-Label (Up to 16 Weeks)|Site closing|3|||
48687170|NCT02586623|156705327|FG001|Open-Label (Up to 16 Weeks)|Site closing|0|||
48687171|NCT02586623|156705328|FG002|Open-Label (Up to 16 Weeks)|Site closing|0|||
48687172|NCT02586623|156705326|FG000|Double-Blind (Up to 12 Weeks)|Adverse Event|0|||
48763347|NCT01150123|156983860|FG017|Overall Study|Withdrawal by Subject|1|||
49023444|NCT02581345|157925669|FG001|Part 1: up to Week 16|Unspecified Reason|3|||
48687173|NCT02586623|156705327|FG001|Double-Blind (Up to 12 Weeks)|Adverse Event|6|||
48687174|NCT02586623|156705328|FG002|Double-Blind (Up to 12 Weeks)|Adverse Event|4|||
48687175|NCT02586623|156705326|FG000|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|0|||
48687176|NCT02586623|156705327|FG001|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|1|||
48687177|NCT02586623|156705328|FG002|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|2|||
48687178|NCT02586623|156705326|FG000|Double-Blind (Up to 12 Weeks)|Non-compliance|0|||
48687179|NCT02586623|156705327|FG001|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
48687180|NCT02586623|156705328|FG002|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
48687181|NCT02586623|156705326|FG000|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
48687182|NCT02586623|156705327|FG001|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
48687183|NCT02586623|156705328|FG002|Double-Blind (Up to 12 Weeks)|Physician Decision|1|||
48687184|NCT02586623|156705326|FG000|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
48687185|NCT02586623|156705327|FG001|Double-Blind (Up to 12 Weeks)|Protocol Violation|3|||
48687186|NCT02586623|156705328|FG002|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
48687187|NCT02586623|156705326|FG000|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|0|||
48687188|NCT02586623|156705327|FG001|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|6|||
48687189|NCT02586623|156705328|FG002|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|5|||
48687190|NCT02586623|156705326|FG000|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|0|||
48687191|NCT02586623|156705327|FG001|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|31|||
48687192|NCT02586623|156705328|FG002|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|27|||
48687193|NCT02586623|156705326|FG000|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
48687194|NCT02586623|156705327|FG001|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|1|||
48687195|NCT02586623|156705328|FG002|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
48687196|NCT02370420|156705329|FG000|Overall Study|Physician Decision|3|||
48687197|NCT02370420|156705330|FG001|Overall Study|Physician Decision|3|||
48687198|NCT02370420|156705329|FG000|Overall Study|Lost to Follow-up|11|||
48687199|NCT02370420|156705330|FG001|Overall Study|Lost to Follow-up|9|||
48687200|NCT04628780|156705331|FG000|Overall Study|Death|0|||
48687201|NCT04628780|156705332|FG001|Overall Study|Death|1|||
48687202|NCT04628780|156705333|FG002|Overall Study|Death|0|||
48687203|NCT04628780|156705334|FG003|Overall Study|Death|0|||
48687204|NCT04628780|156705335|FG004|Overall Study|Death|1|||
48687205|NCT04628780|156705336|FG005|Overall Study|Death|0|||
48687206|NCT04628780|156705331|FG000|Overall Study|Physician Decision|2|||
48687207|NCT04628780|156705332|FG001|Overall Study|Physician Decision|0|||
48687208|NCT04628780|156705333|FG002|Overall Study|Physician Decision|0|||
48687209|NCT04628780|156705334|FG003|Overall Study|Physician Decision|0|||
48687210|NCT04628780|156705335|FG004|Overall Study|Physician Decision|2|||
48687211|NCT04628780|156705336|FG005|Overall Study|Physician Decision|0|||
48687212|NCT04628780|156705331|FG000|Overall Study|Progressive disease|2|||
48687213|NCT04628780|156705332|FG001|Overall Study|Progressive disease|2|||
48687214|NCT04628780|156705333|FG002|Overall Study|Progressive disease|2|||
48687215|NCT04628780|156705334|FG003|Overall Study|Progressive disease|3|||
48687216|NCT04628780|156705335|FG004|Overall Study|Progressive disease|9|||
48687217|NCT04628780|156705336|FG005|Overall Study|Progressive disease|4|||
48687218|NCT04628780|156705331|FG000|Overall Study|Withdrawal by Subject|0|||
48687219|NCT04628780|156705332|FG001|Overall Study|Withdrawal by Subject|1|||
48687220|NCT04628780|156705333|FG002|Overall Study|Withdrawal by Subject|2|||
48687221|NCT04628780|156705334|FG003|Overall Study|Withdrawal by Subject|0|||
48687222|NCT04628780|156705335|FG004|Overall Study|Withdrawal by Subject|3|||
48687223|NCT04628780|156705336|FG005|Overall Study|Withdrawal by Subject|1|||
48687224|NCT04628780|156705331|FG000|Overall Study|Global deterioration of health status|0|||
48687225|NCT04628780|156705332|FG001|Overall Study|Global deterioration of health status|0|||
48687226|NCT04628780|156705333|FG002|Overall Study|Global deterioration of health status|0|||
48687227|NCT04628780|156705334|FG003|Overall Study|Global deterioration of health status|0|||
48687228|NCT04628780|156705335|FG004|Overall Study|Global deterioration of health status|1|||
48687229|NCT04628780|156705336|FG005|Overall Study|Global deterioration of health status|1|||
48687230|NCT00795704|156705338|FG000|Overall Study|Withdrawal by Subject|3|||
48687231|NCT00795704|156705339|FG001|Overall Study|Withdrawal by Subject|2|||
48687232|NCT00795704|156705338|FG000|Overall Study|Adverse Event|1|||
48687233|NCT00795704|156705339|FG001|Overall Study|Adverse Event|1|||
48687234|NCT03980730|156705340|FG000|Overall Study|Study Terminated by Sponsor|0|||
48687235|NCT03980730|156705341|FG001|Overall Study|Study Terminated by Sponsor|3|||
48687236|NCT03980730|156705340|FG000|Overall Study|Adverse Event|2|||
48687237|NCT03980730|156705341|FG001|Overall Study|Adverse Event|0|||
48687238|NCT03980730|156705340|FG000|Overall Study|Sponsor Request|0|||
48687239|NCT03980730|156705341|FG001|Overall Study|Sponsor Request|1|||
48687240|NCT00428948|156705342|FG000|Overall Study|Lost to Follow-up|15|||
48687241|NCT00428948|156705343|FG001|Overall Study|Lost to Follow-up|8|||
48687242|NCT00428948|156705342|FG000|Overall Study|Adverse Event|148|||
48763348|NCT01150123|156983843|FG000|Overall Study|Lost to Follow-up|2|||
48763349|NCT01150123|156983844|FG001|Overall Study|Lost to Follow-up|1|||
48763350|NCT01150123|156983845|FG002|Overall Study|Lost to Follow-up|2|||
48763351|NCT01150123|156983846|FG003|Overall Study|Lost to Follow-up|2|||
48687243|NCT00428948|156705343|FG001|Overall Study|Adverse Event|24|||
48763352|NCT01150123|156983847|FG004|Overall Study|Lost to Follow-up|2|||
48763353|NCT01150123|156983848|FG005|Overall Study|Lost to Follow-up|5|||
48687244|NCT00428948|156705342|FG000|Overall Study|Subject Met Withdrawal Criteria|4|||
48687245|NCT00428948|156705343|FG001|Overall Study|Subject Met Withdrawal Criteria|0|||
48687246|NCT00428948|156705342|FG000|Overall Study|Investigator Withdrew Subject|3|||
48687247|NCT00428948|156705343|FG001|Overall Study|Investigator Withdrew Subject|4|||
48687248|NCT00428948|156705342|FG000|Overall Study|Subject Withdrew Consent|50|||
48687249|NCT00428948|156705343|FG001|Overall Study|Subject Withdrew Consent|30|||
48687250|NCT00428948|156705342|FG000|Overall Study|Protocol Deviation|1|||
48687251|NCT00428948|156705343|FG001|Overall Study|Protocol Deviation|1|||
48687252|NCT04076618|156705344|FG000|Overall Study|Lost to Follow-up|2|||
48687253|NCT04076618|156705345|FG001|Overall Study|Lost to Follow-up|1|||
48687254|NCT04076618|156705346|FG002|Overall Study|Lost to Follow-up|3|||
48687255|NCT04076618|156705344|FG000|Overall Study|Withdrawal by Subject|3|||
48687256|NCT04076618|156705345|FG001|Overall Study|Withdrawal by Subject|1|||
48687257|NCT04076618|156705346|FG002|Overall Study|Withdrawal by Subject|2|||
48687258|NCT04076618|156705344|FG000|Overall Study|Relocated out of state|0|||
48687259|NCT04076618|156705345|FG001|Overall Study|Relocated out of state|2|||
48687260|NCT04076618|156705346|FG002|Overall Study|Relocated out of state|0|||
48687261|NCT04076618|156705344|FG000|Overall Study|COVID concerns|0|||
48687262|NCT04076618|156705345|FG001|Overall Study|COVID concerns|1|||
48687263|NCT04076618|156705346|FG002|Overall Study|COVID concerns|0|||
48687264|NCT04076618|156705344|FG000|Overall Study|Adverse Event|0|||
48687265|NCT04076618|156705345|FG001|Overall Study|Adverse Event|0|||
48687266|NCT04076618|156705346|FG002|Overall Study|Adverse Event|2|||
48687267|NCT00658814|156705350|FG000|Remission Induction Chemotherapy|Adverse Event|1|||
48687268|NCT00658814|156705351|FG001|Remission Induction Chemotherapy|Adverse Event|3|||
48687269|NCT00658814|156705350|FG000|Remission Induction Chemotherapy|Withdrawal by Subject|3|||
48687270|NCT00658814|156705351|FG001|Remission Induction Chemotherapy|Withdrawal by Subject|4|||
48687271|NCT00658814|156705350|FG000|Remission Induction Chemotherapy|Progression/Relapse|0|||
48687272|NCT00658814|156705351|FG001|Remission Induction Chemotherapy|Progression/Relapse|1|||
48687273|NCT00658814|156705350|FG000|Remission Induction Chemotherapy|Death|1|||
48687274|NCT00658814|156705351|FG001|Remission Induction Chemotherapy|Death|4|||
48687275|NCT00658814|156705350|FG000|Remission Induction Chemotherapy|Not protocol specified|2|||
48687276|NCT00658814|156705351|FG001|Remission Induction Chemotherapy|Not protocol specified|4|||
48687277|NCT00658814|156705350|FG000|Remission Induction Chemotherapy|Not eligible|1|||
48687278|NCT00658814|156705351|FG001|Remission Induction Chemotherapy|Not eligible|2|||
48687279|NCT00658814|156705350|FG000|Consolidation Therapy|Not protocol specified|0|||
48687280|NCT00658814|156705351|FG001|Consolidation Therapy|Not protocol specified|1|||
48687281|NCT00658814|156705350|FG000|Consolidation Therapy|Not eligible|2|||
48687282|NCT00658814|156705351|FG001|Consolidation Therapy|Not eligible|2|||
48687283|NCT00658814|156705350|FG000|Maintenance Therapy|Adverse Event|1|||
48687284|NCT00658814|156705351|FG001|Maintenance Therapy|Adverse Event|1|||
48687285|NCT00658814|156705350|FG000|Maintenance Therapy|Not protocol specified|1|||
48687286|NCT00658814|156705351|FG001|Maintenance Therapy|Not protocol specified|0|||
48687287|NCT00658814|156705350|FG000|Maintenance Therapy|Not eligible|1|||
48687288|NCT00658814|156705351|FG001|Maintenance Therapy|Not eligible|0|||
48687289|NCT03863509|156705352|FG000|Overall Study|COVID-19 shutdown period|0|||
48687290|NCT03863509|156705353|FG001|Overall Study|COVID-19 shutdown period|4|||
48687291|NCT03863509|156705354|FG002|Overall Study|COVID-19 shutdown period|0|||
48687292|NCT03863509|156705352|FG000|Overall Study|Missed V2 visit- outside protocol window|4|||
48687293|NCT03863509|156705353|FG001|Overall Study|Missed V2 visit- outside protocol window|3|||
48687294|NCT03863509|156705354|FG002|Overall Study|Missed V2 visit- outside protocol window|1|||
48687295|NCT03863509|156705352|FG000|Overall Study|Lost to Follow-up|8|||
48687296|NCT03863509|156705353|FG001|Overall Study|Lost to Follow-up|0|||
48687297|NCT03863509|156705354|FG002|Overall Study|Lost to Follow-up|2|||
48687298|NCT03863509|156705352|FG000|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|10|||
48687299|NCT03863509|156705353|FG001|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|20|||
48687300|NCT03863509|156705354|FG002|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|2|||
48687301|NCT03863509|156705352|FG000|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
48687302|NCT03863509|156705353|FG001|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|1|||
48687303|NCT03863509|156705354|FG002|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
48981447|NCT05333289|157764268|FG001|Overall Study|Physician Decision|0|||
48981448|NCT05333289|157764269|FG002|Overall Study|Physician Decision|1|||
48981449|NCT05333289|157764270|FG003|Overall Study|Physician Decision|0|||
48981450|NCT05333289|157764271|FG004|Overall Study|Physician Decision|0|||
48981451|NCT05333289|157764272|FG005|Overall Study|Physician Decision|2|||
48763354|NCT01150123|156983849|FG006|Overall Study|Lost to Follow-up|0|||
48763355|NCT01150123|156983850|FG007|Overall Study|Lost to Follow-up|0|||
48763356|NCT01150123|156983851|FG008|Overall Study|Lost to Follow-up|3|||
48981452|NCT05333289|157764273|FG006|Overall Study|Physician Decision|0|||
48981453|NCT05333289|157764274|FG007|Overall Study|Physician Decision|0|||
48981454|NCT05333289|157764267|FG000|Overall Study|Lost to Follow-up|6|||
48981455|NCT05333289|157764268|FG001|Overall Study|Lost to Follow-up|0|||
48687312|NCT05736458|156705358|FG000|Baseline MRI and Assessments|Lost to Follow-up|0|||
48687313|NCT05736458|156705359|FG001|Baseline MRI and Assessments|Lost to Follow-up|0|||
48687314|NCT05736458|156705360|FG002|Baseline MRI and Assessments|Lost to Follow-up|4|||
48687315|NCT05736458|156705358|FG000|Baseline MRI and Assessments|Withdrawal by Subject|2|||
48687316|NCT05736458|156705359|FG001|Baseline MRI and Assessments|Withdrawal by Subject|0|||
48687317|NCT05736458|156705360|FG002|Baseline MRI and Assessments|Withdrawal by Subject|0|||
48687318|NCT05736458|156705358|FG000|TMS/fMRI #1|Physician Decision|0|||
48687319|NCT05736458|156705359|FG001|TMS/fMRI #1|Physician Decision|0|||
48687320|NCT05736458|156705360|FG002|TMS/fMRI #1|Physician Decision|2|||
48687321|NCT05736458|156705358|FG000|Washout (at Least 7 Days)|Lost to Follow-up|0|||
48687322|NCT05736458|156705359|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
48687323|NCT05736458|156705360|FG002|Washout (at Least 7 Days)|Lost to Follow-up|0|||
48687324|NCT05274958|156705361|FG000|Overall Study|Only completed 1 set of PROMs|22|||
48687325|NCT05274958|156705362|FG001|Overall Study|Only completed 1 set of PROMs|35|||
48687326|NCT00855959|156706820|FG000|Overall Study|Adverse Event|2|||
48687327|NCT00855959|156706820|FG000|Overall Study|Lost to Follow-up|2|||
48687328|NCT00855959|156706820|FG000|Overall Study|Withdrawal by Subject|3|||
48687329|NCT00855959|156706820|FG000|Overall Study|Pregnancy|1|||
48687330|NCT00855959|156706820|FG000|Overall Study|Incorrect enrolment|1|||
48687331|NCT04794270|156706822|FG000|Period 1|Non Compliance|1|||
48687332|NCT04794270|156706823|FG001|Period 1|Non Compliance|0|||
48687333|NCT04794270|156706822|FG000|Period 1|Adverse Event|1|||
48687334|NCT04794270|156706823|FG001|Period 1|Adverse Event|0|||
48687335|NCT04794270|156706822|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
48687336|NCT04794270|156706823|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
48687337|NCT02178995|156706836|FG000|Double Blind|Adverse Event|0|||
48687338|NCT02178995|156706837|FG001|Double Blind|Adverse Event|0|||
48687339|NCT02178995|156706838|FG002|Double Blind|Adverse Event|0|||
48687340|NCT02178995|156706839|FG003|Double Blind|Adverse Event|0|||
48687341|NCT02178995|156706840|FG004|Double Blind|Adverse Event|0|||
48687342|NCT02178995|156706841|FG005|Double Blind|Adverse Event|1|||
48687343|NCT02178995|156706842|FG006|Double Blind|Adverse Event|0|||
48687344|NCT02178995|156706843|FG007|Double Blind|Adverse Event|1|||
48687345|NCT02178995|156706844|FG008|Double Blind|Adverse Event|1|||
48687346|NCT02178995|156706836|FG000|Double Blind|Lost to Follow-up|0|||
48687347|NCT02178995|156706837|FG001|Double Blind|Lost to Follow-up|1|||
48687348|NCT02178995|156706838|FG002|Double Blind|Lost to Follow-up|0|||
48687349|NCT02178995|156706839|FG003|Double Blind|Lost to Follow-up|0|||
48687350|NCT02178995|156706840|FG004|Double Blind|Lost to Follow-up|0|||
48687351|NCT02178995|156706841|FG005|Double Blind|Lost to Follow-up|0|||
48687352|NCT02178995|156706842|FG006|Double Blind|Lost to Follow-up|0|||
48687353|NCT02178995|156706843|FG007|Double Blind|Lost to Follow-up|1|||
48687354|NCT02178995|156706844|FG008|Double Blind|Lost to Follow-up|0|||
48687355|NCT02178995|156706836|FG000|Open Label|Adverse Event|2|||
48687356|NCT02178995|156706837|FG001|Open Label|Adverse Event|0|||
48687357|NCT02178995|156706838|FG002|Open Label|Adverse Event|0|||
48687358|NCT02178995|156706839|FG003|Open Label|Adverse Event|0|||
48687359|NCT02178995|156706840|FG004|Open Label|Adverse Event|0|||
48687360|NCT02178995|156706841|FG005|Open Label|Adverse Event|0|||
48687361|NCT02178995|156706842|FG006|Open Label|Adverse Event|0|||
48687362|NCT02178995|156706843|FG007|Open Label|Adverse Event|0|||
48687363|NCT02178995|156706844|FG008|Open Label|Adverse Event|0|||
48687364|NCT01008943|156706846|FG000|Overall Study|Withdrawal by Subject|1|||
48687365|NCT00824473|156706847|FG000|Overall Study|Adverse Event|4|||
48687366|NCT00824473|156706848|FG001|Overall Study|Adverse Event|5|||
48687367|NCT00824473|156706847|FG000|Overall Study|Lack of Efficacy|2|||
48687368|NCT00824473|156706848|FG001|Overall Study|Lack of Efficacy|2|||
48687369|NCT00824473|156706847|FG000|Overall Study|Protocol Violation|2|||
48687370|NCT00824473|156706848|FG001|Overall Study|Protocol Violation|0|||
48687371|NCT00824473|156706847|FG000|Overall Study|Non-Compliance|4|||
48687372|NCT00824473|156706848|FG001|Overall Study|Non-Compliance|2|||
48687373|NCT00824473|156706847|FG000|Overall Study|Withdrawal by Subject|2|||
48687374|NCT00824473|156706848|FG001|Overall Study|Withdrawal by Subject|3|||
48687375|NCT00824473|156706847|FG000|Overall Study|Other|1|||
48687376|NCT00824473|156706848|FG001|Overall Study|Other|1|||
48687377|NCT00466440|156706849|FG000|Overall Study|Adverse Event|0|||
48687378|NCT00466440|156706850|FG001|Overall Study|Adverse Event|3|||
48687379|NCT00466440|156706851|FG002|Overall Study|Adverse Event|1|||
48687380|NCT00466440|156706849|FG000|Overall Study|Death|1|||
48981456|NCT05333289|157764269|FG002|Overall Study|Lost to Follow-up|1|||
48687381|NCT00466440|156706850|FG001|Overall Study|Death|1|||
48687382|NCT00466440|156706851|FG002|Overall Study|Death|0|||
48687383|NCT00466440|156706849|FG000|Overall Study|Progressive disease|13|||
48687384|NCT00466440|156706850|FG001|Overall Study|Progressive disease|5|||
48687385|NCT00466440|156706851|FG002|Overall Study|Progressive disease|4|||
48687386|NCT00466440|156706849|FG000|Overall Study|Lost to Follow-up|0|||
48687387|NCT00466440|156706850|FG001|Overall Study|Lost to Follow-up|1|||
48687388|NCT00466440|156706851|FG002|Overall Study|Lost to Follow-up|0|||
48687389|NCT00466440|156706849|FG000|Overall Study|Physician Decision|0|||
48687390|NCT00466440|156706850|FG001|Overall Study|Physician Decision|1|||
48687391|NCT00466440|156706851|FG002|Overall Study|Physician Decision|2|||
48687392|NCT00466440|156706849|FG000|Overall Study|Protocol entry criteria not met|0|||
48687393|NCT00466440|156706850|FG001|Overall Study|Protocol entry criteria not met|0|||
48687394|NCT00466440|156706851|FG002|Overall Study|Protocol entry criteria not met|4|||
48687395|NCT00466440|156706849|FG000|Overall Study|Withdrawal by Subject|0|||
48687396|NCT00466440|156706850|FG001|Overall Study|Withdrawal by Subject|1|||
48687397|NCT00466440|156706851|FG002|Overall Study|Withdrawal by Subject|0|||
48687398|NCT00466440|156706849|FG000|Overall Study|Sponsor decision|0|||
48687399|NCT00466440|156706850|FG001|Overall Study|Sponsor decision|0|||
48687400|NCT00466440|156706851|FG002|Overall Study|Sponsor decision|1|||
48687401|NCT02420093|156706854|FG000|Overall Study|Withdrawal by Subject|1|||
48687402|NCT02420093|156706855|FG001|Overall Study|Withdrawal by Subject|1|||
48687403|NCT01550757|156706858|FG000|Overall Study|Lost to Follow-up|21|||
48687404|NCT01550757|156706859|FG001|Overall Study|Lost to Follow-up|14|||
48687405|NCT01550757|156706860|FG002|Overall Study|Lost to Follow-up|42|||
48687406|NCT01550757|156706861|FG003|Overall Study|Lost to Follow-up|53|||
48687407|NCT01550757|156706858|FG000|Overall Study|Withdrawal by Subject|2|||
48687408|NCT01550757|156706859|FG001|Overall Study|Withdrawal by Subject|0|||
48687409|NCT01550757|156706860|FG002|Overall Study|Withdrawal by Subject|3|||
48763357|NCT01150123|156983852|FG009|Overall Study|Lost to Follow-up|1|||
48763358|NCT01150123|156983853|FG010|Overall Study|Lost to Follow-up|1|||
48763359|NCT01150123|156983854|FG011|Overall Study|Lost to Follow-up|1|||
48763360|NCT01150123|156983855|FG012|Overall Study|Lost to Follow-up|2|||
48763361|NCT01150123|156983856|FG013|Overall Study|Lost to Follow-up|0|||
48763362|NCT01150123|156983857|FG014|Overall Study|Lost to Follow-up|0|||
48763363|NCT01150123|156983858|FG015|Overall Study|Lost to Follow-up|0|||
48763364|NCT01150123|156983859|FG016|Overall Study|Lost to Follow-up|0|||
48763365|NCT01150123|156983860|FG017|Overall Study|Lost to Follow-up|0|||
48763366|NCT04809220|156983868|FG000|Overall Study|Adverse Event|4|||
48763367|NCT04809220|156983869|FG001|Overall Study|Adverse Event|0|||
48763368|NCT04809220|156983868|FG000|Overall Study|Death|1|||
48763369|NCT04809220|156983869|FG001|Overall Study|Death|0|||
48763370|NCT04809220|156983868|FG000|Overall Study|Lost to Follow-up|3|||
48763371|NCT04809220|156983869|FG001|Overall Study|Lost to Follow-up|0|||
48763372|NCT04809220|156983868|FG000|Overall Study|Physician Decision|0|||
48763373|NCT04809220|156983869|FG001|Overall Study|Physician Decision|1|||
49023445|NCT02581345|157925670|FG002|Part 1: up to Week 16|Unspecified Reason|0|||
48687410|NCT01550757|156706861|FG003|Overall Study|Withdrawal by Subject|1|||
48687411|NCT00496080|156706864|FG000|Overall Study|Lost to Follow-up|9|||
48687412|NCT00496080|156706864|FG000|Overall Study|Surgical re-intervention|7|||
48687413|NCT00496080|156706864|FG000|Overall Study|Withdrawal by Subject|5|||
48687414|NCT00496080|156706864|FG000|Overall Study|Physician Decision|6|||
48687415|NCT00764361|156706874|FG000|Overall Study|Withdrawal by Subject|2|||
48687416|NCT00764361|156706875|FG001|Overall Study|Withdrawal by Subject|3|||
48687417|NCT00764361|156706874|FG000|Overall Study|Adverse Event|0|||
48687418|NCT00764361|156706875|FG001|Overall Study|Adverse Event|1|||
48687419|NCT01141712|156706879|FG000|Overall Study|Disease progression|3|||
48687420|NCT01168349|156706881|FG000|Overall Study|Death|157|||
48687421|NCT01168349|156706881|FG000|Overall Study|Lost to Follow-up|34|||
48687422|NCT01168349|156706881|FG000|Overall Study|Withdrawal by Subject|9|||
48687423|NCT01168349|156706881|FG000|Overall Study|Kidney transplantation|3|||
48687424|NCT01168349|156706881|FG000|Overall Study|Other|22|||
48687425|NCT01168349|156706881|FG000|Overall Study|Protocol Violation|76|||
48687426|NCT00890825|156706882|FG000|Overall Study|Withdrawal by Subject|1|||
48687427|NCT00890825|156706883|FG001|Overall Study|Withdrawal by Subject|0|||
48687428|NCT00890825|156706882|FG000|Overall Study|Alive at data cut off (DCO)|13|||
48687429|NCT00890825|156706883|FG001|Overall Study|Alive at data cut off (DCO)|14|||
48687430|NCT02678351|156706887|FG000|Overall Study|Withdrawal by Subject|1|||
48687431|NCT01919229|156706888|FG000|Overall Study|Subject/guardian decision|0|||
48687432|NCT01919229|156706889|FG001|Overall Study|Subject/guardian decision|0|||
48687433|NCT01919229|156706890|FG002|Overall Study|Subject/guardian decision|1|||
48687434|NCT04524858|156706891|FG000|Overall Study|Adverse Event|1|||
48687435|NCT02366195|156706894|FG000|Overall Study|Protocol-specified criteria|3|||
48687436|NCT02366195|156706894|FG000|Overall Study|Withdrawal by Subject|9|||
48875271|NCT02706951|157381610|FG004|Period 1|Withdrawal by Subject|0|||
48687437|NCT02366195|156706894|FG000|Overall Study|Lost to Follow-up|1|||
48763374|NCT04809220|156983868|FG000|Overall Study|Withdrawal by Subject|9|||
48763375|NCT04809220|156983869|FG001|Overall Study|Withdrawal by Subject|5|||
48687438|NCT02366195|156706894|FG000|Overall Study|Death|41|||
48687439|NCT01338818|156706895|FG000|Overall Study|Adverse Event|8|||
48687440|NCT01338818|156706895|FG000|Overall Study|Lack of Efficacy|5|||
48687441|NCT01338818|156706895|FG000|Overall Study|no longer require study drug|1|||
48687442|NCT01338818|156706895|FG000|Overall Study|Withdrawal by Subject|11|||
48687443|NCT01338818|156706895|FG000|Overall Study|Lost to Follow-up|4|||
49023446|NCT02581345|157925671|FG003|Part 1: up to Week 16|Unspecified Reason|0|||
48875272|NCT02706951|157381606|FG000|Period 1|Lost to Follow-up|0|||
48687444|NCT01338818|156706895|FG000|Overall Study|Administrative problems|3|||
48687445|NCT01338818|156706895|FG000|Overall Study|Protocol Deviation|4|||
48687446|NCT01078441|156706899|FG000|Overall Study|Withdrawal by Subject|1|||
48687447|NCT02714569|156706900|FG000|Part A Second Intervention|Withdrawal by Subject|0|||
48687448|NCT02714569|156706901|FG001|Part A Second Intervention|Withdrawal by Subject|1|||
48687449|NCT02714569|156706902|FG002|Part A Second Intervention|Withdrawal by Subject|0|||
48687450|NCT02714569|156706903|FG003|Part A Second Intervention|Withdrawal by Subject|0|||
48687451|NCT02714569|156706904|FG004|Part A Second Intervention|Withdrawal by Subject|0|||
48687452|NCT02714569|156706905|FG005|Part A Second Intervention|Withdrawal by Subject|0|||
48687453|NCT02714569|156706906|FG006|Part A Second Intervention|Withdrawal by Subject|0|||
48687454|NCT02714569|156706907|FG007|Part A Second Intervention|Withdrawal by Subject|0|||
48687455|NCT02714569|156706908|FG008|Part A Second Intervention|Withdrawal by Subject|0|||
48687456|NCT02714569|156706909|FG009|Part A Second Intervention|Withdrawal by Subject|0|||
48687457|NCT02714569|156706910|FG010|Part A Second Intervention|Withdrawal by Subject|0|||
48687458|NCT02714569|156706900|FG000|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
48687459|NCT02714569|156706901|FG001|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
48687460|NCT02714569|156706902|FG002|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
48687461|NCT02714569|156706903|FG003|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1|||
48687462|NCT02714569|156706904|FG004|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
48687463|NCT02714569|156706905|FG005|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
48687464|NCT02714569|156706906|FG006|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
48687465|NCT02714569|156706907|FG007|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
48687466|NCT02714569|156706908|FG008|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
48687467|NCT02714569|156706909|FG009|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
48687468|NCT02714569|156706910|FG010|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
48687469|NCT02714569|156706900|FG000|Part A Third Intervention|Adverse Event|0|||
48687470|NCT02714569|156706901|FG001|Part A Third Intervention|Adverse Event|0|||
48687471|NCT02714569|156706902|FG002|Part A Third Intervention|Adverse Event|1|||
48687472|NCT02714569|156706903|FG003|Part A Third Intervention|Adverse Event|0|||
48687473|NCT02714569|156706904|FG004|Part A Third Intervention|Adverse Event|0|||
48687474|NCT02714569|156706905|FG005|Part A Third Intervention|Adverse Event|0|||
48687475|NCT02714569|156706906|FG006|Part A Third Intervention|Adverse Event|0|||
48687476|NCT02714569|156706907|FG007|Part A Third Intervention|Adverse Event|0|||
48687477|NCT02714569|156706908|FG008|Part A Third Intervention|Adverse Event|0|||
48687478|NCT02714569|156706909|FG009|Part A Third Intervention|Adverse Event|0|||
48687479|NCT02714569|156706910|FG010|Part A Third Intervention|Adverse Event|0|||
48687480|NCT02714569|156706900|FG000|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
48687481|NCT02714569|156706901|FG001|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
48687482|NCT02714569|156706902|FG002|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
48687483|NCT02714569|156706903|FG003|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
49023447|NCT02581345|157925668|FG000|Part 1: up to Week 16|Did Not Receive Treatment|1|||
49023448|NCT02581345|157925669|FG001|Part 1: up to Week 16|Did Not Receive Treatment|1|||
49023449|NCT02581345|157925670|FG002|Part 1: up to Week 16|Did Not Receive Treatment|0|||
49023450|NCT02581345|157925671|FG003|Part 1: up to Week 16|Did Not Receive Treatment|0|||
49023451|NCT02581345|157925668|FG000|Part 2: Week 17 to Week 47|Adverse Event|5|||
49023452|NCT02581345|157925669|FG001|Part 2: Week 17 to Week 47|Adverse Event|0|||
49023453|NCT02581345|157925670|FG002|Part 2: Week 17 to Week 47|Adverse Event|2|||
49023454|NCT02581345|157925671|FG003|Part 2: Week 17 to Week 47|Adverse Event|2|||
49023455|NCT02581345|157925668|FG000|Part 2: Week 17 to Week 47|Physician Decision|3|||
49023456|NCT02581345|157925669|FG001|Part 2: Week 17 to Week 47|Physician Decision|0|||
49023457|NCT02581345|157925670|FG002|Part 2: Week 17 to Week 47|Physician Decision|2|||
49023458|NCT02581345|157925671|FG003|Part 2: Week 17 to Week 47|Physician Decision|1|||
49023459|NCT02581345|157925668|FG000|Part 2: Week 17 to Week 47|Withdrawal by Subject|9|||
49023460|NCT02581345|157925669|FG001|Part 2: Week 17 to Week 47|Withdrawal by Subject|0|||
49023461|NCT02581345|157925670|FG002|Part 2: Week 17 to Week 47|Withdrawal by Subject|7|||
49023462|NCT02581345|157925671|FG003|Part 2: Week 17 to Week 47|Withdrawal by Subject|5|||
49023463|NCT02581345|157925668|FG000|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8|||
49023464|NCT02581345|157925669|FG001|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0|||
49023465|NCT02581345|157925670|FG002|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3|||
49023466|NCT02581345|157925671|FG003|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2|||
48687484|NCT02714569|156706904|FG004|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
48687485|NCT02714569|156706905|FG005|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
48687486|NCT02714569|156706906|FG006|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
48687487|NCT02714569|156706907|FG007|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
48687488|NCT02714569|156706908|FG008|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
48875273|NCT02706951|157381607|FG001|Period 1|Lost to Follow-up|4|||
48687489|NCT02714569|156706909|FG009|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
48687490|NCT02714569|156706910|FG010|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
49023467|NCT02581345|157925668|FG000|Part 2: Week 17 to Week 47|Lost to Follow-up|2|||
49023468|NCT02581345|157925669|FG001|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
49023469|NCT02581345|157925670|FG002|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
49023470|NCT02581345|157925671|FG003|Part 2: Week 17 to Week 47|Lost to Follow-up|1|||
49023471|NCT02581345|157925668|FG000|Part 2: Week 17 to Week 47|Unspecified Reason|2|||
49023472|NCT02581345|157925669|FG001|Part 2: Week 17 to Week 47|Unspecified Reason|0|||
49023473|NCT02581345|157925670|FG002|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
49023474|NCT02581345|157925671|FG003|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
49023475|NCT01893905|157925672|FG000|Overall Study|Withdrawal by Subject|1|||
49023476|NCT01893905|157925673|FG001|Overall Study|Withdrawal by Subject|0|||
49023477|NCT01893905|157925672|FG000|Overall Study|Adverse Event|9|||
49023478|NCT01893905|157925673|FG001|Overall Study|Adverse Event|3|||
49023479|NCT01893905|157925672|FG000|Overall Study|Lack of Efficacy|5|||
49023480|NCT01893905|157925673|FG001|Overall Study|Lack of Efficacy|7|||
49023481|NCT01893905|157925672|FG000|Overall Study|Lost to Follow-up|1|||
49023482|NCT01893905|157925673|FG001|Overall Study|Lost to Follow-up|0|||
49023483|NCT01893905|157925672|FG000|Overall Study|Protocol Violation|6|||
49023484|NCT01893905|157925673|FG001|Overall Study|Protocol Violation|1|||
49023485|NCT01893905|157925672|FG000|Overall Study|Lack of adherence to treatment|2|||
49023486|NCT01893905|157925673|FG001|Overall Study|Lack of adherence to treatment|0|||
49023487|NCT01893905|157925672|FG000|Overall Study|Other reason|1|||
49023488|NCT01893905|157925673|FG001|Overall Study|Other reason|3|||
49023489|NCT03289039|157925674|FG000|Overall Study|Withdrawal by Subject|0|||
49023490|NCT03289039|157925675|FG001|Overall Study|Withdrawal by Subject|1|||
49023491|NCT03289039|157925674|FG000|Overall Study|Became ineligible prior to treatment start|0|||
49023492|NCT03289039|157925675|FG001|Overall Study|Became ineligible prior to treatment start|1|||
49023493|NCT03289039|157925674|FG000|Overall Study|progressed before treatment start|1|||
49023494|NCT03289039|157925675|FG001|Overall Study|progressed before treatment start|0|||
49023495|NCT01768858|157925678|FG000|Overall Study|Lost to Follow-up|9|||
49023496|NCT01768858|157925678|FG000|Overall Study|Lack of Efficacy|8|||
49023497|NCT01768858|157925678|FG000|Overall Study|Serious Adverse Event|1|||
49023498|NCT01768858|157925678|FG000|Overall Study|Participant moved to Germany|1|||
49023499|NCT01768858|157925678|FG000|Overall Study|Aggravation of NY Heart Assoc 3 status|1|||
49023500|NCT01768858|157925678|FG000|Overall Study|Exanthema|1|||
49023501|NCT01768858|157925678|FG000|Overall Study|Withdrawal by Subject|1|||
49023502|NCT01374919|157925679|FG000|Overall Study|Withdrawal by Subject|2|||
49023503|NCT03312530|157925680|FG000|Overall Study|Death|5|||
49023504|NCT03312530|157925681|FG001|Overall Study|Death|5|||
49023505|NCT03312530|157925682|FG002|Overall Study|Death|4|||
49023506|NCT03312530|157925683|FG003|Overall Study|Death|10|||
49023507|NCT03312530|157925684|FG004|Overall Study|Death|8|||
49023508|NCT03312530|157925680|FG000|Overall Study|Lost to Follow-up|0|||
49023509|NCT03312530|157925681|FG001|Overall Study|Lost to Follow-up|0|||
49023510|NCT03312530|157925682|FG002|Overall Study|Lost to Follow-up|0|||
49023511|NCT03312530|157925683|FG003|Overall Study|Lost to Follow-up|1|||
49023512|NCT03312530|157925684|FG004|Overall Study|Lost to Follow-up|0|||
49023513|NCT03312530|157925680|FG000|Overall Study|Participant in another sponsor study.|0|||
49023514|NCT03312530|157925681|FG001|Overall Study|Participant in another sponsor study.|0|||
49023515|NCT03312530|157925682|FG002|Overall Study|Participant in another sponsor study.|0|||
49023516|NCT03312530|157925683|FG003|Overall Study|Participant in another sponsor study.|1|||
49023517|NCT03312530|157925684|FG004|Overall Study|Participant in another sponsor study.|0|||
49023518|NCT03312530|157925680|FG000|Overall Study|Study terminated by sponsor|1|||
49023519|NCT03312530|157925681|FG001|Overall Study|Study terminated by sponsor|0|||
49023520|NCT03312530|157925682|FG002|Overall Study|Study terminated by sponsor|2|||
49023521|NCT03312530|157925683|FG003|Overall Study|Study terminated by sponsor|3|||
49023522|NCT03312530|157925684|FG004|Overall Study|Study terminated by sponsor|7|||
49023523|NCT03312530|157925680|FG000|Overall Study|Withdrawal by Subject|0|||
49023524|NCT03312530|157925681|FG001|Overall Study|Withdrawal by Subject|1|||
49023525|NCT03312530|157925682|FG002|Overall Study|Withdrawal by Subject|0|||
49023526|NCT03312530|157925683|FG003|Overall Study|Withdrawal by Subject|0|||
48687491|NCT02714569|156706900|FG000|Part B (Overall)|Lost to Follow-up|0|||
48687492|NCT02714569|156706901|FG001|Part B (Overall)|Lost to Follow-up|0|||
49023527|NCT03312530|157925684|FG004|Overall Study|Withdrawal by Subject|0|||
49023528|NCT03312530|157925680|FG000|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
49023529|NCT03312530|157925681|FG001|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
49023530|NCT03312530|157925682|FG002|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
48687493|NCT02714569|156706902|FG002|Part B (Overall)|Lost to Follow-up|0|||
49023531|NCT03312530|157925683|FG003|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|1|||
49023532|NCT03312530|157925684|FG004|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
49023533|NCT02819843|157925685|FG000|Overall Study|Disease progression before RT|0|||
49023534|NCT02819843|157925686|FG001|Overall Study|Disease progression before RT|1|||
48687494|NCT02714569|156706903|FG003|Part B (Overall)|Lost to Follow-up|0|||
48687495|NCT02714569|156706904|FG004|Part B (Overall)|Lost to Follow-up|0|||
48687496|NCT02714569|156706905|FG005|Part B (Overall)|Lost to Follow-up|0|||
48687497|NCT02714569|156706906|FG006|Part B (Overall)|Lost to Follow-up|1|||
48687498|NCT02714569|156706907|FG007|Part B (Overall)|Lost to Follow-up|0|||
48687499|NCT02714569|156706908|FG008|Part B (Overall)|Lost to Follow-up|0|||
48687500|NCT02714569|156706909|FG009|Part B (Overall)|Lost to Follow-up|0|||
48687501|NCT02714569|156706910|FG010|Part B (Overall)|Lost to Follow-up|0|||
48687502|NCT02714569|156706900|FG000|Part B (Overall)|Withdrawal by Subject|0|||
48687503|NCT02714569|156706901|FG001|Part B (Overall)|Withdrawal by Subject|0|||
48687504|NCT02714569|156706902|FG002|Part B (Overall)|Withdrawal by Subject|0|||
48687505|NCT02714569|156706903|FG003|Part B (Overall)|Withdrawal by Subject|0|||
48687506|NCT02714569|156706904|FG004|Part B (Overall)|Withdrawal by Subject|0|||
48687507|NCT02714569|156706905|FG005|Part B (Overall)|Withdrawal by Subject|0|||
48687508|NCT02714569|156706906|FG006|Part B (Overall)|Withdrawal by Subject|0|||
48687509|NCT02714569|156706907|FG007|Part B (Overall)|Withdrawal by Subject|1|||
48687510|NCT02714569|156706908|FG008|Part B (Overall)|Withdrawal by Subject|0|||
48687511|NCT02714569|156706909|FG009|Part B (Overall)|Withdrawal by Subject|1|||
48687512|NCT02714569|156706910|FG010|Part B (Overall)|Withdrawal by Subject|0|||
48687513|NCT02714569|156706900|FG000|Part B (Overall)|Adverse Event|0|||
48687514|NCT02714569|156706901|FG001|Part B (Overall)|Adverse Event|0|||
48687515|NCT02714569|156706902|FG002|Part B (Overall)|Adverse Event|0|||
48687516|NCT02714569|156706903|FG003|Part B (Overall)|Adverse Event|0|||
48687517|NCT02714569|156706904|FG004|Part B (Overall)|Adverse Event|0|||
48687518|NCT02714569|156706905|FG005|Part B (Overall)|Adverse Event|0|||
48687519|NCT02714569|156706906|FG006|Part B (Overall)|Adverse Event|0|||
48687520|NCT02714569|156706907|FG007|Part B (Overall)|Adverse Event|0|||
48763376|NCT04809220|156983868|FG000|Overall Study|Due to long-term overseas business trips|1|||
48763377|NCT04809220|156983869|FG001|Overall Study|Due to long-term overseas business trips|0|||
49023535|NCT00366899|157925687|FG000|Infant Series|Withdrawal by Subject|4|||
49023536|NCT00366899|157925688|FG001|Infant Series|Withdrawal by Subject|7|||
49023537|NCT00366899|157925687|FG000|Infant Series|Protocol Violation|2|||
49023538|NCT00366899|157925688|FG001|Infant Series|Protocol Violation|1|||
49023539|NCT00366899|157925687|FG000|Infant Series|Failed to return|1|||
49023540|NCT00366899|157925688|FG001|Infant Series|Failed to return|1|||
49023541|NCT00366899|157925687|FG000|Infant Series|Lost to Follow-up|0|||
49023542|NCT00366899|157925688|FG001|Infant Series|Lost to Follow-up|2|||
49023543|NCT00366899|157925687|FG000|Infant Series|Adverse Event|0|||
49023544|NCT00366899|157925688|FG001|Infant Series|Adverse Event|1|||
49023545|NCT00366899|157925687|FG000|Infant Series|Physician Decision|1|||
49023546|NCT00366899|157925688|FG001|Infant Series|Physician Decision|0|||
49023547|NCT00366899|157925687|FG000|Infant Series|Randomized but not consented|1|||
49023548|NCT00366899|157925688|FG001|Infant Series|Randomized but not consented|0|||
49023549|NCT00366899|157925687|FG000|After Infant Series|Lost to Follow-up|4|||
49023550|NCT00366899|157925688|FG001|After Infant Series|Lost to Follow-up|3|||
49023551|NCT00366899|157925687|FG000|After Infant Series|Withdrawal by Subject|1|||
49023552|NCT00366899|157925688|FG001|After Infant Series|Withdrawal by Subject|4|||
49023553|NCT00366899|157925687|FG000|After Infant Series|Adverse Event|1|||
49023554|NCT00366899|157925688|FG001|After Infant Series|Adverse Event|2|||
49023555|NCT00366899|157925687|FG000|After Infant Series|Protocol Violation|1|||
49023556|NCT00366899|157925688|FG001|After Infant Series|Protocol Violation|0|||
49023557|NCT00366899|157925687|FG000|Toddler Dose|Withdrawal by Subject|1|||
49023558|NCT00366899|157925688|FG001|Toddler Dose|Withdrawal by Subject|1|||
49023559|NCT00366899|157925687|FG000|Toddler Dose|Protocol Violation|1|||
49023560|NCT00366899|157925688|FG001|Toddler Dose|Protocol Violation|0|||
49023561|NCT01619800|157925689|FG000|Overall Study|study terminated|2|||
49023562|NCT01619800|157925690|FG001|Overall Study|study terminated|0|||
49023563|NCT00755196|157925698|FG000|Overall Study|Lost to Follow-up|1|||
49023564|NCT00755196|157925698|FG000|Overall Study|Lack of Efficiency|1|||
49023565|NCT02720510|157925701|FG000|Overall Study|Study Terminated by the sponsor|2|||
49023566|NCT02720510|157925702|FG001|Overall Study|Study Terminated by the sponsor|0|||
49023567|NCT02720510|157925701|FG000|Overall Study|Adverse Event|0|||
49023568|NCT02720510|157925702|FG001|Overall Study|Adverse Event|1|||
49023569|NCT02720510|157925701|FG000|Overall Study|Physician Decision|1|||
49023570|NCT02720510|157925702|FG001|Overall Study|Physician Decision|2|||
49023571|NCT01604850|157925703|FG000|Overall Study|Enrolled but never treated|0|||
48763378|NCT02515045|156983870|FG000|Overall Study|Adverse Event|0|||
49023572|NCT01604850|157925704|FG001|Overall Study|Enrolled but never treated|1|||
48687521|NCT02714569|156706908|FG008|Part B (Overall)|Adverse Event|0|||
48687522|NCT02714569|156706909|FG009|Part B (Overall)|Adverse Event|1|||
48687523|NCT02714569|156706910|FG010|Part B (Overall)|Adverse Event|0|||
48687524|NCT00462306|156706911|FG000|Overall Study|insufficient data|0|||
49023573|NCT01604850|157925703|FG000|Overall Study|Efficacy Failure|50|||
49023574|NCT01604850|157925704|FG001|Overall Study|Efficacy Failure|29|||
49023575|NCT01604850|157925703|FG000|Overall Study|Lost to Follow-up|1|||
49023576|NCT01604850|157925704|FG001|Overall Study|Lost to Follow-up|0|||
49023577|NCT01604850|157925703|FG000|Overall Study|Subject withdrew consent|1|||
49023578|NCT01604850|157925704|FG001|Overall Study|Subject withdrew consent|0|||
49023579|NCT02460159|157925705|FG000|Overall Study|Adverse Event|4|||
49023580|NCT02460159|157925706|FG001|Overall Study|Adverse Event|1|||
49023581|NCT02460159|157925705|FG000|Overall Study|Withdrawal by Subject|2|||
49023582|NCT02460159|157925706|FG001|Overall Study|Withdrawal by Subject|0|||
49023583|NCT00973700|157925707|FG000|Overall Study|Withdrawal by Subject|2|||
49023584|NCT00973700|157925708|FG001|Overall Study|Withdrawal by Subject|2|||
49023585|NCT00973700|157925709|FG002|Overall Study|Withdrawal by Subject|8|||
49023586|NCT00973700|157925710|FG003|Overall Study|Withdrawal by Subject|4|||
48687525|NCT00462306|156706912|FG001|Overall Study|insufficient data|13|||
48687526|NCT03155724|156706913|FG000|Overall Study|Death|3|||
48687527|NCT03155724|156706913|FG000|Overall Study|Physician Decision|1|||
48687528|NCT03155724|156706913|FG000|Overall Study|Study closure|7|||
48687529|NCT03515824|156706914|FG000|Overall Study|Death|3|||
48687530|NCT03515824|156706915|FG001|Overall Study|Death|2|||
48687531|NCT03515824|156706916|FG002|Overall Study|Death|6|||
48687532|NCT03515824|156706917|FG003|Overall Study|Death|0|||
48687533|NCT03515824|156706914|FG000|Overall Study|Lost to Follow-up|0|||
48687534|NCT03515824|156706915|FG001|Overall Study|Lost to Follow-up|1|||
48687535|NCT03515824|156706916|FG002|Overall Study|Lost to Follow-up|1|||
48687536|NCT03515824|156706917|FG003|Overall Study|Lost to Follow-up|0|||
48687537|NCT03515824|156706914|FG000|Overall Study|Study terminated by sponsor|0|||
48687538|NCT03515824|156706915|FG001|Overall Study|Study terminated by sponsor|1|||
48687539|NCT03515824|156706916|FG002|Overall Study|Study terminated by sponsor|6|||
48687540|NCT03515824|156706917|FG003|Overall Study|Study terminated by sponsor|0|||
48687541|NCT03515824|156706914|FG000|Overall Study|Status not recorded|0|||
48687542|NCT03515824|156706915|FG001|Overall Study|Status not recorded|0|||
48687543|NCT03515824|156706916|FG002|Overall Study|Status not recorded|2|||
49023587|NCT00973700|157925711|FG004|Overall Study|Withdrawal by Subject|4|||
49023588|NCT00973700|157925707|FG000|Overall Study|Lost to Follow-up|5|||
49023589|NCT00973700|157925708|FG001|Overall Study|Lost to Follow-up|0|||
49023590|NCT00973700|157925709|FG002|Overall Study|Lost to Follow-up|1|||
49023591|NCT00973700|157925710|FG003|Overall Study|Lost to Follow-up|8|||
49023592|NCT00973700|157925711|FG004|Overall Study|Lost to Follow-up|5|||
49023593|NCT00973700|157925707|FG000|Overall Study|Inappropriate enrolment|0|||
49023594|NCT00973700|157925708|FG001|Overall Study|Inappropriate enrolment|0|||
49023595|NCT00973700|157925709|FG002|Overall Study|Inappropriate enrolment|0|||
49023596|NCT00973700|157925710|FG003|Overall Study|Inappropriate enrolment|4|||
49023597|NCT00973700|157925711|FG004|Overall Study|Inappropriate enrolment|0|||
49023598|NCT00973700|157925707|FG000|Overall Study|Unable to Classify|0|||
49023599|NCT00973700|157925708|FG001|Overall Study|Unable to Classify|0|||
49023600|NCT00973700|157925709|FG002|Overall Study|Unable to Classify|1|||
49023601|NCT00973700|157925710|FG003|Overall Study|Unable to Classify|2|||
49023602|NCT00973700|157925711|FG004|Overall Study|Unable to Classify|1|||
49023603|NCT01703832|157925712|FG000|Overall Study|Withdrawal by Subject|1|||
49023604|NCT01703832|157925713|FG001|Overall Study|Withdrawal by Subject|0|||
49023605|NCT02849652|157925732|FG000|Overall Study|Lost to Follow-up|104|||
49023606|NCT02849652|157925733|FG001|Overall Study|Lost to Follow-up|35|||
49023607|NCT02849652|157925734|FG002|Overall Study|Lost to Follow-up|116|||
49023608|NCT02849652|157925735|FG003|Overall Study|Lost to Follow-up|22|||
49023609|NCT02849652|157925732|FG000|Overall Study|Withdrawal by Subject|10|||
48687544|NCT03515824|156706917|FG003|Overall Study|Status not recorded|0|||
48687545|NCT00550953|156706925|FG000|Overall Study|Adverse Event|4|||
48687546|NCT00550953|156706926|FG001|Overall Study|Adverse Event|3|||
48687547|NCT00550953|156706925|FG000|Overall Study|Not able to visit the site|2|||
48687548|NCT00550953|156706926|FG001|Overall Study|Not able to visit the site|3|||
48687549|NCT02741245|156706927|FG000|Overall Study|Adverse Event|0|||
48687550|NCT02741245|156706928|FG001|Overall Study|Adverse Event|0|||
49023610|NCT02849652|157925733|FG001|Overall Study|Withdrawal by Subject|2|||
49023611|NCT02849652|157925734|FG002|Overall Study|Withdrawal by Subject|8|||
49023612|NCT02849652|157925735|FG003|Overall Study|Withdrawal by Subject|4|||
49023613|NCT03247556|157925736|FG000|Overall Study|Adverse Event|1|||
48687551|NCT02741245|156706929|FG002|Overall Study|Adverse Event|0|||
48687552|NCT02741245|156706930|FG003|Overall Study|Adverse Event|2|||
48687553|NCT02741245|156706931|FG004|Overall Study|Adverse Event|2|||
48687554|NCT02741245|156706927|FG000|Overall Study|Protocol Violation|0|||
48687555|NCT02741245|156706928|FG001|Overall Study|Protocol Violation|1|||
48687556|NCT02741245|156706929|FG002|Overall Study|Protocol Violation|0|||
48687557|NCT02741245|156706930|FG003|Overall Study|Protocol Violation|1|||
48687558|NCT02741245|156706931|FG004|Overall Study|Protocol Violation|0|||
48687559|NCT02741245|156706927|FG000|Overall Study|Withdrawal by Subject|0|||
48687560|NCT02741245|156706928|FG001|Overall Study|Withdrawal by Subject|0|||
48687561|NCT02741245|156706929|FG002|Overall Study|Withdrawal by Subject|0|||
48687562|NCT02741245|156706930|FG003|Overall Study|Withdrawal by Subject|1|||
49023614|NCT03247556|157925737|FG001|Overall Study|Adverse Event|4|||
49023615|NCT03247556|157925738|FG002|Overall Study|Adverse Event|5|||
49023616|NCT03247556|157925736|FG000|Overall Study|Lost to Follow-up|5|||
49023617|NCT03247556|157925737|FG001|Overall Study|Lost to Follow-up|5|||
49023618|NCT03247556|157925738|FG002|Overall Study|Lost to Follow-up|4|||
48687563|NCT02741245|156706931|FG004|Overall Study|Withdrawal by Subject|0|||
48687564|NCT02025179|156706932|FG000|Overall Study|Lost to Follow-up|0|||
48687565|NCT02025179|156706933|FG001|Overall Study|Lost to Follow-up|0|||
48687566|NCT02025179|156706934|FG002|Overall Study|Lost to Follow-up|1|||
48687567|NCT04393493|156706940|FG000|First 4 Days of Intervention|Early improvement|5|||
48687568|NCT04393493|156706941|FG001|First 4 Days of Intervention|Early improvement|7|||
48687569|NCT01125800|156706942|FG000|Phase I|Protocol Violation|0|||
48687570|NCT01125800|156706943|FG001|Phase I|Protocol Violation|3|||
48687571|NCT01125800|156706944|FG002|Phase I|Protocol Violation|1|||
48687572|NCT01125800|156706945|FG003|Phase I|Protocol Violation|1|||
48687573|NCT01125800|156706946|FG004|Phase I|Protocol Violation|0|||
48687574|NCT01125800|156706942|FG000|Phase I|Adverse Event|2|||
48687575|NCT01125800|156706943|FG001|Phase I|Adverse Event|2|||
48687576|NCT01125800|156706944|FG002|Phase I|Adverse Event|1|||
48687577|NCT01125800|156706945|FG003|Phase I|Adverse Event|7|||
48687578|NCT01125800|156706946|FG004|Phase I|Adverse Event|0|||
48687579|NCT01125800|156706942|FG000|Phase I|Administrative problems|1|||
48687580|NCT01125800|156706943|FG001|Phase I|Administrative problems|0|||
48687581|NCT01125800|156706944|FG002|Phase I|Administrative problems|0|||
48687582|NCT01125800|156706945|FG003|Phase I|Administrative problems|0|||
48687583|NCT01125800|156706946|FG004|Phase I|Administrative problems|0|||
48687584|NCT01125800|156706942|FG000|Phase I|Withdrawal by Subject|0|||
48687585|NCT01125800|156706943|FG001|Phase I|Withdrawal by Subject|0|||
48687586|NCT01125800|156706944|FG002|Phase I|Withdrawal by Subject|1|||
48687587|NCT01125800|156706945|FG003|Phase I|Withdrawal by Subject|0|||
48687588|NCT01125800|156706946|FG004|Phase I|Withdrawal by Subject|0|||
48687589|NCT01125800|156706942|FG000|Phase I|Disease progression|5|||
48687590|NCT01125800|156706943|FG001|Phase I|Disease progression|4|||
48687591|NCT01125800|156706944|FG002|Phase I|Disease progression|1|||
48687592|NCT01125800|156706945|FG003|Phase I|Disease progression|3|||
48687593|NCT01125800|156706946|FG004|Phase I|Disease progression|0|||
48687594|NCT01125800|156706942|FG000|Phase II|Protocol Violation|0|||
48687595|NCT01125800|156706943|FG001|Phase II|Protocol Violation|0|||
48687596|NCT01125800|156706944|FG002|Phase II|Protocol Violation|0|||
48687597|NCT01125800|156706945|FG003|Phase II|Protocol Violation|0|||
48687598|NCT01125800|156706946|FG004|Phase II|Protocol Violation|1|||
48687599|NCT01125800|156706942|FG000|Phase II|Adverse Event|0|||
48687600|NCT01125800|156706943|FG001|Phase II|Adverse Event|0|||
48687601|NCT01125800|156706944|FG002|Phase II|Adverse Event|0|||
48687602|NCT01125800|156706945|FG003|Phase II|Adverse Event|0|||
48687603|NCT01125800|156706946|FG004|Phase II|Adverse Event|2|||
48687604|NCT01125800|156706942|FG000|Phase II|Disease progression|0|||
48687605|NCT01125800|156706943|FG001|Phase II|Disease progression|0|||
48687606|NCT01125800|156706944|FG002|Phase II|Disease progression|0|||
48687607|NCT01125800|156706945|FG003|Phase II|Disease progression|1|||
48687608|NCT01125800|156706946|FG004|Phase II|Disease progression|8|||
48687609|NCT02919761|156706951|FG000|Part 1: Open Label|Withdrawal by Subject|12|||
48687610|NCT02919761|156706952|FG001|Part 1: Open Label|Withdrawal by Subject|0|||
48687611|NCT02919761|156706953|FG002|Part 1: Open Label|Withdrawal by Subject|0|||
48687612|NCT02919761|156706951|FG000|Part 1: Open Label|Adverse Event|1|||
48687613|NCT02919761|156706952|FG001|Part 1: Open Label|Adverse Event|0|||
48687614|NCT02919761|156706953|FG002|Part 1: Open Label|Adverse Event|0|||
48687615|NCT02919761|156706951|FG000|Part 1: Open Label|Lost to Follow-up|1|||
48687616|NCT02919761|156706952|FG001|Part 1: Open Label|Lost to Follow-up|0|||
48687617|NCT02919761|156706953|FG002|Part 1: Open Label|Lost to Follow-up|0|||
48687618|NCT02919761|156706951|FG000|Part 1: Open Label|Met withdrawal criteria|5|||
48687619|NCT02919761|156706952|FG001|Part 1: Open Label|Met withdrawal criteria|0|||
48687620|NCT02919761|156706953|FG002|Part 1: Open Label|Met withdrawal criteria|0|||
48687621|NCT02919761|156706951|FG000|Part 1: Open Label|Did Not Achieve Lda At Week 12|2|||
48687622|NCT02919761|156706952|FG001|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
48687623|NCT02919761|156706953|FG002|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
48687624|NCT02919761|156706951|FG000|Part 1: Open Label|Dose Greater Than 20mg/Week|1|||
48687625|NCT02919761|156706952|FG001|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
48687626|NCT02919761|156706953|FG002|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
48687627|NCT02919761|156706951|FG000|Part 1: Open Label|did not meet inclusion criteria 8|1|||
48687628|NCT02919761|156706952|FG001|Part 1: Open Label|did not meet inclusion criteria 8|0|||
48687629|NCT02919761|156706953|FG002|Part 1: Open Label|did not meet inclusion criteria 8|0|||
48687630|NCT02919761|156706951|FG000|Part 1: Open Label|Termination by Sponsor|1|||
48687631|NCT02919761|156706952|FG001|Part 1: Open Label|Termination by Sponsor|0|||
48687632|NCT02919761|156706953|FG002|Part 1: Open Label|Termination by Sponsor|0|||
48687633|NCT02919761|156706951|FG000|Part 2: Double-blind|Withdrawal by Subject|0|||
49023619|NCT03247556|157925736|FG000|Overall Study|Consent Withdrawn by Caregiver|4|||
48687634|NCT02919761|156706952|FG001|Part 2: Double-blind|Withdrawal by Subject|0|||
48687635|NCT02919761|156706953|FG002|Part 2: Double-blind|Withdrawal by Subject|2|||
48687636|NCT02919761|156706951|FG000|Part 2: Double-blind|Adverse Event|0|||
48687637|NCT02919761|156706952|FG001|Part 2: Double-blind|Adverse Event|1|||
48687638|NCT02919761|156706953|FG002|Part 2: Double-blind|Adverse Event|0|||
48687639|NCT02919761|156706951|FG000|Part 2: Double-blind|Lost to Follow-up|0|||
48687640|NCT02919761|156706952|FG001|Part 2: Double-blind|Lost to Follow-up|0|||
48687641|NCT02919761|156706953|FG002|Part 2: Double-blind|Lost to Follow-up|3|||
48687642|NCT02919761|156706951|FG000|Part 2: Double-blind|Met withdrawal criteria|0|||
48687643|NCT02919761|156706952|FG001|Part 2: Double-blind|Met withdrawal criteria|1|||
48763379|NCT02515045|156983871|FG001|Overall Study|Adverse Event|3|||
48763380|NCT02515045|156983872|FG002|Overall Study|Adverse Event|3|||
48763381|NCT02515045|156983870|FG000|Overall Study|Lost to Follow-up|0|||
48763382|NCT02515045|156983871|FG001|Overall Study|Lost to Follow-up|1|||
48763383|NCT02515045|156983872|FG002|Overall Study|Lost to Follow-up|1|||
48763384|NCT00323492|156983873|FG000|Study Phase 1|Adverse Event|2|||
48763385|NCT00323492|156983874|FG001|Study Phase 1|Adverse Event|0|||
48763386|NCT00323492|156983875|FG002|Study Phase 1|Adverse Event|0|||
48763387|NCT00323492|156983873|FG000|Study Phase 2|Adverse Event|1|||
48763388|NCT00323492|156983874|FG001|Study Phase 2|Adverse Event|0|||
48763389|NCT00323492|156983875|FG002|Study Phase 2|Adverse Event|0|||
48763390|NCT00323492|156983873|FG000|Study Phase 2|Physician Decision|1|||
48763391|NCT00323492|156983874|FG001|Study Phase 2|Physician Decision|0|||
48763392|NCT00323492|156983875|FG002|Study Phase 2|Physician Decision|0|||
48763393|NCT00323492|156983873|FG000|Study Phase 2|Lost to Follow-up|1|||
48763394|NCT00323492|156983874|FG001|Study Phase 2|Lost to Follow-up|0|||
48763395|NCT00323492|156983875|FG002|Study Phase 2|Lost to Follow-up|0|||
48763396|NCT00323492|156983873|FG000|Study Phase 2|Withdrawal by Subject|0|||
48763397|NCT00323492|156983874|FG001|Study Phase 2|Withdrawal by Subject|1|||
48763398|NCT00323492|156983875|FG002|Study Phase 2|Withdrawal by Subject|0|||
48763399|NCT00323492|156983873|FG000|Study Phase 2|Noncompliance with study schedule|0|||
48763400|NCT00323492|156983874|FG001|Study Phase 2|Noncompliance with study schedule|0|||
48763401|NCT00323492|156983875|FG002|Study Phase 2|Noncompliance with study schedule|1|||
48763402|NCT00323492|156983873|FG000|Study Phase 2|Protocol Violation|1|||
48763403|NCT00323492|156983874|FG001|Study Phase 2|Protocol Violation|0|||
48763404|NCT00323492|156983875|FG002|Study Phase 2|Protocol Violation|0|||
48763405|NCT03082599|156983877|FG000|Overall Study|Lost to Follow-up|1|||
48763406|NCT03082599|156983878|FG001|Overall Study|Lost to Follow-up|0|||
48763407|NCT01319877|156983879|FG000|Overall Study|Lost to Follow-up|100|||
48763408|NCT01319877|156983880|FG001|Overall Study|Lost to Follow-up|37|||
48763409|NCT01319877|156983879|FG000|Overall Study|Physician Decision|2|||
48763410|NCT01319877|156983880|FG001|Overall Study|Physician Decision|0|||
48763411|NCT01319877|156983879|FG000|Overall Study|Disease Progression|2|||
48763412|NCT01319877|156983880|FG001|Overall Study|Disease Progression|2|||
48763413|NCT01319877|156983879|FG000|Overall Study|Withdrawal by Subject|0|||
48687644|NCT02919761|156706953|FG002|Part 2: Double-blind|Met withdrawal criteria|2|||
48687645|NCT02919761|156706951|FG000|Part 2: Double-blind|Worsening of disease activity|0|||
48687646|NCT02919761|156706952|FG001|Part 2: Double-blind|Worsening of disease activity|4|||
48687647|NCT02919761|156706953|FG002|Part 2: Double-blind|Worsening of disease activity|10|||
48687648|NCT02919761|156706951|FG000|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
48687649|NCT02919761|156706952|FG001|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
48687650|NCT02919761|156706953|FG002|Part 2: Double-blind|Did not meet LDA at Week 16|1|||
48687651|NCT02919761|156706951|FG000|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
48687652|NCT02919761|156706952|FG001|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
48687653|NCT02919761|156706953|FG002|Part 2: Double-blind|Did not meet LDA at Week 20|1|||
48687654|NCT02919761|156706951|FG000|Part 2: Double-blind|Discontinued exclusion 16|0|||
48687655|NCT02919761|156706952|FG001|Part 2: Double-blind|Discontinued exclusion 16|0|||
48687656|NCT02919761|156706953|FG002|Part 2: Double-blind|Discontinued exclusion 16|2|||
48687657|NCT00452790|156706955|FG000|Infant Series|Clinical hold - consent withdrawn|118|||
48687658|NCT00452790|156706956|FG001|Infant Series|Clinical hold - consent withdrawn|123|||
48687659|NCT00452790|156706955|FG000|Infant Series|Parent/legal guardian request|8|||
48687660|NCT00452790|156706956|FG001|Infant Series|Parent/legal guardian request|6|||
48687661|NCT00452790|156706955|FG000|Infant Series|Failed to return|4|||
48687662|NCT00452790|156706956|FG001|Infant Series|Failed to return|1|||
48687663|NCT00452790|156706955|FG000|Infant Series|Protocol Violation|1|||
48687664|NCT00452790|156706956|FG001|Infant Series|Protocol Violation|3|||
48687665|NCT00452790|156706955|FG000|Infant Series|Lost to Follow-up|2|||
48687666|NCT00452790|156706956|FG001|Infant Series|Lost to Follow-up|2|||
48687667|NCT00452790|156706955|FG000|Infant Series|Adverse Event|1|||
48687668|NCT00452790|156706956|FG001|Infant Series|Adverse Event|2|||
48687669|NCT00452790|156706955|FG000|Infant Series|Other reasons|1|||
48687670|NCT00452790|156706956|FG001|Infant Series|Other reasons|2|||
48763414|NCT01319877|156983880|FG001|Overall Study|Withdrawal by Subject|1|||
48687671|NCT00452790|156706955|FG000|Infant Series|Investigator request|0|||
48687672|NCT00452790|156706956|FG001|Infant Series|Investigator request|1|||
48763415|NCT01319877|156983879|FG000|Overall Study|Reason Not Specified|4|||
48763416|NCT01319877|156983880|FG001|Overall Study|Reason Not Specified|5|||
48763417|NCT00978068|156983883|FG000|Overall Study|Were Awaiting Initiation of ART|2|||
48763418|NCT00978068|156983884|FG001|Overall Study|Were Awaiting Initiation of ART|2|||
48763419|NCT00978068|156983883|FG000|Overall Study|Death|1|||
48763420|NCT00978068|156983884|FG001|Overall Study|Death|2|||
48763421|NCT00978068|156983883|FG000|Overall Study|Lost to Follow-up|1|||
48687673|NCT00452790|156706955|FG000|Infant Series|Death|0|||
48687674|NCT00452790|156706956|FG001|Infant Series|Death|1|||
48687675|NCT00452790|156706955|FG000|After Infant Series|Investigator request|10|||
48687676|NCT00452790|156706956|FG001|After Infant Series|Investigator request|10|||
48687677|NCT00452790|156706955|FG000|After Infant Series|Adverse Event|4|||
48687678|NCT00452790|156706956|FG001|After Infant Series|Adverse Event|1|||
48687679|NCT00452790|156706955|FG000|After Infant Series|Parent/legal guardian request|1|||
48687680|NCT00452790|156706956|FG001|After Infant Series|Parent/legal guardian request|3|||
48687681|NCT00452790|156706955|FG000|After Infant Series|Lost to Follow-up|4|||
48687682|NCT00452790|156706956|FG001|After Infant Series|Lost to Follow-up|0|||
48687683|NCT00452790|156706955|FG000|After Infant Series|Failed to return|1|||
48687684|NCT00452790|156706956|FG001|After Infant Series|Failed to return|0|||
48687685|NCT00452790|156706955|FG000|After Infant Series|Other reasons|1|||
48687686|NCT00452790|156706956|FG001|After Infant Series|Other reasons|0|||
48687687|NCT00452790|156706955|FG000|Toddler Dose|Failed to return|0|||
48687688|NCT00452790|156706956|FG001|Toddler Dose|Failed to return|1|||
48687689|NCT00452790|156706955|FG000|Toddler Dose|Parent/legal guardian request|0|||
48687690|NCT00452790|156706956|FG001|Toddler Dose|Parent/legal guardian request|1|||
48687691|NCT01478971|156708224|FG000|Standard of Care Period|Adverse Event|1|||
48687692|NCT01478971|156708224|FG000|Standard of Care Period|Withdrawal by Subject|3|||
48687693|NCT01478971|156708224|FG000|Standard of Care Period|Death|8|||
48687694|NCT01478971|156708224|FG000|Standard of Care Period|Lost to Follow-up|9|||
48687695|NCT01478971|156708224|FG000|Standard of Care Period|Other|4|||
48687696|NCT01478971|156708224|FG000|Peginesatide Treatment Period|Adverse Event|1|||
48687697|NCT01478971|156708224|FG000|Peginesatide Treatment Period|Withdrawal by Subject|1|||
48687698|NCT01478971|156708224|FG000|Peginesatide Treatment Period|Death|4|||
48687699|NCT01478971|156708224|FG000|Peginesatide Treatment Period|Lost to Follow-up|4|||
48687700|NCT01478971|156708224|FG000|Peginesatide Treatment Period|Other|4|||
48687701|NCT01535807|156708230|FG000|Overall Study|Withdrawal by Subject|1|||
48687702|NCT01535807|156708231|FG001|Overall Study|Withdrawal by Subject|1|||
48687703|NCT01535807|156708230|FG000|Overall Study|Data collection error|1|||
48687704|NCT01535807|156708231|FG001|Overall Study|Data collection error|1|||
49023620|NCT03247556|157925737|FG001|Overall Study|Consent Withdrawn by Caregiver|1|||
49023621|NCT03247556|157925738|FG002|Overall Study|Consent Withdrawn by Caregiver|5|||
49023622|NCT03247556|157925736|FG000|Overall Study|Assent/consent Withdrawn by Subject|0|||
49023623|NCT03247556|157925737|FG001|Overall Study|Assent/consent Withdrawn by Subject|2|||
49023624|NCT03247556|157925738|FG002|Overall Study|Assent/consent Withdrawn by Subject|2|||
49023625|NCT03247556|157925736|FG000|Overall Study|Protocol Violation|2|||
49023626|NCT03247556|157925737|FG001|Overall Study|Protocol Violation|0|||
49023627|NCT03247556|157925738|FG002|Overall Study|Protocol Violation|1|||
49023628|NCT03247556|157925736|FG000|Overall Study|Subject did not meet inclusion criteria|0|||
49023629|NCT03247556|157925737|FG001|Overall Study|Subject did not meet inclusion criteria|0|||
49023630|NCT03247556|157925738|FG002|Overall Study|Subject did not meet inclusion criteria|1|||
49023631|NCT00760266|157925741|FG000|Overall Study|Adverse Event|13|||
49023632|NCT00760266|157925742|FG001|Overall Study|Adverse Event|7|||
49023633|NCT00760266|157925741|FG000|Overall Study|Abnormal laboratory value(s)|1|||
49023634|NCT00760266|157925742|FG001|Overall Study|Abnormal laboratory value(s)|0|||
49023635|NCT00760266|157925741|FG000|Overall Study|Abnormal test procedure result(s)|1|||
49023636|NCT00760266|157925742|FG001|Overall Study|Abnormal test procedure result(s)|0|||
49023637|NCT00760266|157925741|FG000|Overall Study|Lack of Efficacy|2|||
49023638|NCT00760266|157925742|FG001|Overall Study|Lack of Efficacy|2|||
49023639|NCT00760266|157925741|FG000|Overall Study|Protocol deviation|2|||
49023640|NCT00760266|157925742|FG001|Overall Study|Protocol deviation|4|||
49023641|NCT00760266|157925741|FG000|Overall Study|Patient withdrew consent|3|||
49023642|NCT00760266|157925742|FG001|Overall Study|Patient withdrew consent|3|||
49023643|NCT00760266|157925741|FG000|Overall Study|Lost to Follow-up|2|||
49023644|NCT00760266|157925742|FG001|Overall Study|Lost to Follow-up|1|||
49023645|NCT00760266|157925741|FG000|Overall Study|Administrative Problems|0|||
49023646|NCT00760266|157925742|FG001|Overall Study|Administrative Problems|1|||
49023647|NCT01856309|157925752|FG000|Overall Study|Death|4|||
49023648|NCT01856309|157925753|FG001|Overall Study|Death|6|||
49023649|NCT01856309|157925754|FG002|Overall Study|Death|11|||
49023650|NCT01856309|157925755|FG003|Overall Study|Death|6|||
49023651|NCT01856309|157925752|FG000|Overall Study|Lost to Follow-up|6|||
49023652|NCT01856309|157925753|FG001|Overall Study|Lost to Follow-up|2|||
49023653|NCT01856309|157925754|FG002|Overall Study|Lost to Follow-up|4|||
48687705|NCT02451917|156708232|FG000|First Intervention (24 Weeks)|Lost to Follow-up|2|||
48687706|NCT02451917|156708233|FG001|First Intervention (24 Weeks)|Lost to Follow-up|0|||
48687707|NCT02451917|156708232|FG000|First Intervention (24 Weeks)|Death|0|||
48687708|NCT02451917|156708233|FG001|First Intervention (24 Weeks)|Death|1|||
49023654|NCT01856309|157925755|FG003|Overall Study|Lost to Follow-up|8|||
49023655|NCT01856309|157925752|FG000|Overall Study|Withdrawal by Subject|11|||
49023656|NCT01856309|157925753|FG001|Overall Study|Withdrawal by Subject|13|||
49023657|NCT01856309|157925754|FG002|Overall Study|Withdrawal by Subject|28|||
49023658|NCT01856309|157925755|FG003|Overall Study|Withdrawal by Subject|26|||
48763422|NCT00978068|156983884|FG001|Overall Study|Lost to Follow-up|2|||
48687709|NCT02451917|156708232|FG000|First Intervention (24 Weeks)|Adverse Event|0|||
48687710|NCT02451917|156708233|FG001|First Intervention (24 Weeks)|Adverse Event|2|||
48687711|NCT01724866|156708234|FG000|Overall Study|Adverse Event|0|||
48687712|NCT01724866|156708235|FG001|Overall Study|Adverse Event|0|||
48687713|NCT01724866|156708236|FG002|Overall Study|Adverse Event|1|||
48687714|NCT01724866|156708237|FG003|Overall Study|Adverse Event|1|||
48687715|NCT01724866|156708234|FG000|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
48687716|NCT01724866|156708235|FG001|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|2|||
48687717|NCT01724866|156708236|FG002|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
48687718|NCT01724866|156708237|FG003|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
48687719|NCT01724866|156708234|FG000|Overall Study|Investigator's Discretion|0|||
48687720|NCT01724866|156708235|FG001|Overall Study|Investigator's Discretion|1|||
48687721|NCT01724866|156708236|FG002|Overall Study|Investigator's Discretion|1|||
48687722|NCT01724866|156708237|FG003|Overall Study|Investigator's Discretion|0|||
48687723|NCT01724866|156708234|FG000|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|1|||
48687724|NCT01724866|156708235|FG001|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
48687725|NCT01724866|156708236|FG002|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
48687726|NCT01724866|156708237|FG003|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
48687727|NCT01724866|156708234|FG000|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
48687728|NCT01724866|156708235|FG001|Overall Study|Participant Refused Further Treatment or Withdrew Consent|2|||
48687729|NCT01724866|156708236|FG002|Overall Study|Participant Refused Further Treatment or Withdrew Consent|1|||
48687730|NCT01724866|156708237|FG003|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
48687731|NCT02420379|156708238|FG000|Overall Study|Withdrawal by Subject|0|||
48687732|NCT02420379|156708239|FG001|Overall Study|Withdrawal by Subject|3|||
48687733|NCT02420379|156708238|FG000|Overall Study|Unable to complete due to schooling|0|||
48687734|NCT02420379|156708239|FG001|Overall Study|Unable to complete due to schooling|1|||
48687735|NCT02420379|156708238|FG000|Overall Study|Transitioned to commercial drug|1|||
48687736|NCT02420379|156708239|FG001|Overall Study|Transitioned to commercial drug|0|||
48687737|NCT01402817|156708240|FG000|Overall Study|Withdrawal by Subject|3|||
48687738|NCT01402817|156708240|FG000|Overall Study|Study Suspended by FDA|8|||
48687739|NCT00502671|156708241|FG000|Overall Study|Disease Progression|13|||
48687740|NCT00502671|156708241|FG000|Overall Study|Personal Reasons|22|||
48687741|NCT00502671|156708241|FG000|Overall Study|Lost to Follow-up|7|||
48687742|NCT00502671|156708241|FG000|Overall Study|Protocol Violation|16|||
48687743|NCT00502671|156708241|FG000|Overall Study|Adverse Event|19|||
48687744|NCT00681629|156708250|FG000|Overall Study|Study termination|4|||
48687745|NCT00681629|156708251|FG001|Overall Study|Study termination|2|||
48687746|NCT00681629|156708250|FG000|Overall Study|Adverse Event|1|||
48687747|NCT00681629|156708251|FG001|Overall Study|Adverse Event|0|||
48687748|NCT02098746|156708261|FG000|Overall Study|Changes of Investigator|2|||
48687749|NCT02098746|156708261|FG000|Overall Study|Other Miscellaneous Reasons|1|||
48687750|NCT02098746|156708261|FG000|Overall Study|Enrolled 15 Days After the First Dose|1|||
48687751|NCT02098746|156708261|FG000|Overall Study|Data Not Available After Treatment|1|||
48687752|NCT01217944|156708266|FG000|Overall Study|Protocol Violation|1|||
48687753|NCT01217944|156708267|FG001|Overall Study|Protocol Violation|1|||
48687754|NCT01217944|156708268|FG002|Overall Study|Protocol Violation|0|||
48687755|NCT01217944|156708266|FG000|Overall Study|Lost to Follow-up|3|||
48687756|NCT01217944|156708267|FG001|Overall Study|Lost to Follow-up|1|||
48687757|NCT01217944|156708268|FG002|Overall Study|Lost to Follow-up|0|||
48687758|NCT01217944|156708266|FG000|Overall Study|Withdrawal by Subject|1|||
48687759|NCT01217944|156708267|FG001|Overall Study|Withdrawal by Subject|2|||
48687760|NCT01217944|156708268|FG002|Overall Study|Withdrawal by Subject|0|||
48687761|NCT01217944|156708266|FG000|Overall Study|Lack of Efficacy|1|||
48687762|NCT01217944|156708267|FG001|Overall Study|Lack of Efficacy|0|||
48687763|NCT01217944|156708268|FG002|Overall Study|Lack of Efficacy|0|||
49023659|NCT01856309|157925752|FG000|Overall Study|Other|227|||
48687764|NCT03579940|156708269|FG000|Period 2|Withdrawal by Subject|0|||
48687765|NCT03579940|156708270|FG001|Period 2|Withdrawal by Subject|0|||
48687766|NCT03579940|156708271|FG002|Period 2|Withdrawal by Subject|1|||
48687767|NCT03579940|156708272|FG003|Period 2|Withdrawal by Subject|0|||
48687768|NCT03579940|156708273|FG004|Period 2|Withdrawal by Subject|0|||
48687769|NCT03579940|156708274|FG005|Period 2|Withdrawal by Subject|0|||
48687770|NCT03579940|156708275|FG006|Period 2|Withdrawal by Subject|0|||
48687771|NCT03579940|156708276|FG007|Period 2|Withdrawal by Subject|0|||
48687772|NCT03579940|156708277|FG008|Period 2|Withdrawal by Subject|0|||
48763423|NCT00978068|156983883|FG000|Overall Study|Physician Decision|0|||
48763424|NCT00978068|156983884|FG001|Overall Study|Physician Decision|1|||
48763425|NCT00978068|156983883|FG000|Overall Study|Unable to Comply with Study|0|||
48687773|NCT03579940|156708278|FG009|Period 2|Withdrawal by Subject|0|||
48763426|NCT00978068|156983884|FG001|Overall Study|Unable to Comply with Study|2|||
48763427|NCT01165138|156983885|FG000|Overall Study|Adverse Event|0|||
48687774|NCT03579940|156708279|FG010|Period 2|Withdrawal by Subject|0|||
48687775|NCT01751984|156708280|FG000|Overall Study|Adverse Event|5|||
48687776|NCT01751984|156708281|FG001|Overall Study|Adverse Event|3|||
48687777|NCT01751984|156708280|FG000|Overall Study|Withdrawal by Subject|0|||
48687778|NCT01751984|156708281|FG001|Overall Study|Withdrawal by Subject|1|||
48687779|NCT01751984|156708280|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
48687780|NCT01751984|156708281|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
48687781|NCT02469623|156708287|FG000|Overall Study|Not consented for long-term follow-up|4|||
48687782|NCT02469623|156708287|FG000|Overall Study|Lost to Follow-up|4|||
48687783|NCT02469623|156708287|FG000|Overall Study|Withdrawal by Subject|2|||
48687784|NCT02469623|156708287|FG000|Overall Study|Death|3|||
48687785|NCT01799226|156708288|FG000|Overall Study|Withdrawal by Subject|1|||
48687786|NCT01799226|156708289|FG001|Overall Study|Withdrawal by Subject|0|||
48687787|NCT01799226|156708288|FG000|Overall Study|Disqualified at Day 14|1|||
48687788|NCT01799226|156708289|FG001|Overall Study|Disqualified at Day 14|0|||
48687789|NCT03361293|156708292|FG000|Overall Study|Lost to Follow-up|0|||
48687790|NCT03361293|156708293|FG001|Overall Study|Lost to Follow-up|2|||
48687791|NCT03361293|156708292|FG000|Overall Study|Withdrawal by Subject|1|||
48687792|NCT03361293|156708293|FG001|Overall Study|Withdrawal by Subject|3|||
48687793|NCT00936702|156708297|FG000|Overall Study|Disease progression|34|||
48687794|NCT00936702|156708297|FG000|Overall Study|Adverse Event|8|||
48687795|NCT00936702|156708297|FG000|Overall Study|Withdrawal by Subject|2|||
48687796|NCT00936702|156708297|FG000|Overall Study|Alternative Treatment|1|||
48687797|NCT00936702|156708297|FG000|Overall Study|Other|1|||
48687798|NCT01544920|156708299|FG000|Overall Study|Adverse Event|0|||
48687799|NCT01544920|156708300|FG001|Overall Study|Adverse Event|3|||
48687800|NCT01544920|156708299|FG000|Overall Study|Death|0|||
48687801|NCT01544920|156708300|FG001|Overall Study|Death|1|||
48687802|NCT01544920|156708299|FG000|Overall Study|Lost to Follow-up|11|||
48687803|NCT01544920|156708300|FG001|Overall Study|Lost to Follow-up|12|||
48981457|NCT05333289|157764270|FG003|Overall Study|Lost to Follow-up|6|||
48981458|NCT05333289|157764271|FG004|Overall Study|Lost to Follow-up|3|||
48981459|NCT05333289|157764272|FG005|Overall Study|Lost to Follow-up|3|||
48981460|NCT05333289|157764273|FG006|Overall Study|Lost to Follow-up|2|||
48981461|NCT05333289|157764274|FG007|Overall Study|Lost to Follow-up|1|||
48981462|NCT05333289|157764267|FG000|Overall Study|Death|1|||
48981463|NCT05333289|157764268|FG001|Overall Study|Death|0|||
48981464|NCT05333289|157764269|FG002|Overall Study|Death|0|||
48981465|NCT05333289|157764270|FG003|Overall Study|Death|0|||
48981466|NCT05333289|157764271|FG004|Overall Study|Death|0|||
48981467|NCT05333289|157764272|FG005|Overall Study|Death|0|||
48981468|NCT05333289|157764273|FG006|Overall Study|Death|0|||
48981469|NCT05333289|157764274|FG007|Overall Study|Death|0|||
48981470|NCT00621244|157764275|FG000|Overall Study|Withdrawal by Subject|7|||
48981471|NCT00621244|157764276|FG001|Overall Study|Withdrawal by Subject|3|||
48981472|NCT00621244|157764277|FG002|Overall Study|Withdrawal by Subject|3|||
48981473|NCT00621244|157764278|FG003|Overall Study|Withdrawal by Subject|3|||
48981474|NCT00621244|157764275|FG000|Overall Study|Disease progression|44|||
48981475|NCT00621244|157764276|FG001|Overall Study|Disease progression|20|||
48981476|NCT00621244|157764277|FG002|Overall Study|Disease progression|20|||
48981477|NCT00621244|157764278|FG003|Overall Study|Disease progression|15|||
48981478|NCT00621244|157764275|FG000|Overall Study|Death|3|||
48981479|NCT00621244|157764276|FG001|Overall Study|Death|3|||
48981480|NCT00621244|157764277|FG002|Overall Study|Death|1|||
48981481|NCT00621244|157764278|FG003|Overall Study|Death|1|||
48981482|NCT00621244|157764275|FG000|Overall Study|Adverse Event|27|||
48981483|NCT00621244|157764276|FG001|Overall Study|Adverse Event|7|||
48981484|NCT00621244|157764277|FG002|Overall Study|Adverse Event|9|||
48981485|NCT00621244|157764278|FG003|Overall Study|Adverse Event|2|||
48981486|NCT00621244|157764275|FG000|Overall Study|Administrative problems|5|||
48981487|NCT00621244|157764276|FG001|Overall Study|Administrative problems|1|||
48981488|NCT00621244|157764277|FG002|Overall Study|Administrative problems|0|||
48981489|NCT00621244|157764278|FG003|Overall Study|Administrative problems|2|||
48981490|NCT03733249|157764279|FG000|Overall Study|Death|7|||
48981491|NCT03733249|157764279|FG000|Overall Study|Disease relapse|16|||
48981492|NCT03733249|157764279|FG000|Overall Study|Lost to Follow-up|4|||
48981493|NCT03733249|157764279|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
48981494|NCT03733249|157764279|FG000|Overall Study|Withdrawal by Subject|1|||
48981495|NCT02447952|157764280|FG000|Overall Study|Adverse Event|2|||
48981496|NCT02447952|157764280|FG000|Overall Study|Physician Decision|1|||
48981497|NCT02447952|157764280|FG000|Overall Study|Withdrawal by Subject|4|||
48981498|NCT01756833|157764288|FG000|Overall Study|Withdrawal by Subject|4|||
48981499|NCT01756833|157764289|FG001|Overall Study|Withdrawal by Subject|3|||
48981500|NCT00550615|157764290|FG000|Overall Study|Withdrawal by Subject|0|||
48981501|NCT00550615|157764291|FG001|Overall Study|Withdrawal by Subject|0|||
48981502|NCT00550615|157764292|FG002|Overall Study|Withdrawal by Subject|2|||
48981503|NCT00550615|157764293|FG003|Overall Study|Withdrawal by Subject|3|||
48687804|NCT01544920|156708299|FG000|Overall Study|Protocol Violation|0|||
48981504|NCT00550615|157764290|FG000|Overall Study|Not evaluable|0|||
49023660|NCT01856309|157925753|FG001|Overall Study|Other|225|||
49023661|NCT01856309|157925754|FG002|Overall Study|Other|447|||
49023662|NCT01856309|157925755|FG003|Overall Study|Other|469|||
49023663|NCT01856309|157925752|FG000|Overall Study|Lack of Efficacy|14|||
49023664|NCT01856309|157925753|FG001|Overall Study|Lack of Efficacy|9|||
49023665|NCT01856309|157925754|FG002|Overall Study|Lack of Efficacy|40|||
49023666|NCT01856309|157925755|FG003|Overall Study|Lack of Efficacy|25|||
49023667|NCT01856309|157925752|FG000|Overall Study|Adverse Event|31|||
49023668|NCT01856309|157925753|FG001|Overall Study|Adverse Event|31|||
49023669|NCT01856309|157925754|FG002|Overall Study|Adverse Event|55|||
49023670|NCT01856309|157925755|FG003|Overall Study|Adverse Event|65|||
49023671|NCT01856309|157925752|FG000|Overall Study|Pregnancy|0|||
49023672|NCT01856309|157925753|FG001|Overall Study|Pregnancy|0|||
49023673|NCT01856309|157925754|FG002|Overall Study|Pregnancy|0|||
49023674|NCT01856309|157925755|FG003|Overall Study|Pregnancy|1|||
49023675|NCT01856309|157925752|FG000|Overall Study|Physician Decision|6|||
49023676|NCT01856309|157925753|FG001|Overall Study|Physician Decision|1|||
49023677|NCT01856309|157925754|FG002|Overall Study|Physician Decision|6|||
49023678|NCT01856309|157925755|FG003|Overall Study|Physician Decision|8|||
49023679|NCT01856309|157925752|FG000|Overall Study|Noncompliance With Study Drug|0|||
49023680|NCT01856309|157925753|FG001|Overall Study|Noncompliance With Study Drug|1|||
48687805|NCT01544920|156708300|FG001|Overall Study|Protocol Violation|2|||
48687806|NCT01544920|156708299|FG000|Overall Study|Physician Decision|4|||
48687807|NCT01544920|156708300|FG001|Overall Study|Physician Decision|1|||
48687808|NCT01544920|156708299|FG000|Overall Study|Withdrawal by Subject|4|||
48687809|NCT01544920|156708300|FG001|Overall Study|Withdrawal by Subject|4|||
48687810|NCT03244917|156708302|FG000|Overall Study|Lost to Follow-up|2|||
48687811|NCT03244917|156708303|FG001|Overall Study|Lost to Follow-up|2|||
48687812|NCT01135134|156708310|FG000|Overall Study|Adverse Event|1|||
48687813|NCT01135134|156708311|FG001|Overall Study|Adverse Event|1|||
48687814|NCT01135134|156708310|FG000|Overall Study|Did not meet protocol eligibility|1|||
48687815|NCT01135134|156708311|FG001|Overall Study|Did not meet protocol eligibility|0|||
48687816|NCT00988598|156708315|FG000|Overall Study|Withdrawal by Subject|2|||
48687817|NCT00988598|156708316|FG001|Overall Study|Withdrawal by Subject|0|||
48687818|NCT01569841|156708327|FG000|Period A (6 Weeks)|Withdrawal by Subject|0|||
48687819|NCT01569841|156708328|FG001|Period A (6 Weeks)|Withdrawal by Subject|1|||
48687820|NCT00300755|156708329|FG000|Overall Study|Adverse Event|1|||
48687821|NCT00300755|156708330|FG001|Overall Study|Adverse Event|2|||
48687822|NCT00300755|156708331|FG002|Overall Study|Adverse Event|1|||
48687823|NCT00300755|156708329|FG000|Overall Study|Withdrawal by Subject|0|||
48687824|NCT00300755|156708330|FG001|Overall Study|Withdrawal by Subject|2|||
48687825|NCT00300755|156708331|FG002|Overall Study|Withdrawal by Subject|0|||
48687826|NCT00300755|156708329|FG000|Overall Study|Protocol Violation|0|||
48687827|NCT00300755|156708330|FG001|Overall Study|Protocol Violation|0|||
48687828|NCT00300755|156708331|FG002|Overall Study|Protocol Violation|1|||
48687829|NCT03634085|156708332|FG000|Overall Study|Adverse Event|1|||
48687830|NCT03634085|156708333|FG001|Overall Study|Adverse Event|0|||
48687831|NCT03634085|156708332|FG000|Overall Study|Withdrawal by Subject|0|||
49023681|NCT01856309|157925754|FG002|Overall Study|Noncompliance With Study Drug|4|||
49023682|NCT01856309|157925755|FG003|Overall Study|Noncompliance With Study Drug|1|||
49023683|NCT00832377|157925758|FG000|Overall Study|Protocol Violation|1|||
49023684|NCT01617668|157925760|FG000|Overall Study|Adverse Event|7|||
49023685|NCT01617668|157925761|FG001|Overall Study|Adverse Event|0|||
49023686|NCT01617668|157925762|FG002|Overall Study|Adverse Event|12|||
49023687|NCT01617668|157925763|FG003|Overall Study|Adverse Event|5|||
49023688|NCT01617668|157925760|FG000|Overall Study|Physician Decision|1|||
49023689|NCT01617668|157925761|FG001|Overall Study|Physician Decision|2|||
49023690|NCT01617668|157925762|FG002|Overall Study|Physician Decision|3|||
49023691|NCT01617668|157925763|FG003|Overall Study|Physician Decision|0|||
49023692|NCT01617668|157925760|FG000|Overall Study|Progressive Disease|4|||
49023693|NCT01617668|157925761|FG001|Overall Study|Progressive Disease|4|||
49023694|NCT01617668|157925762|FG002|Overall Study|Progressive Disease|6|||
49023695|NCT01617668|157925763|FG003|Overall Study|Progressive Disease|9|||
48687832|NCT03634085|156708333|FG001|Overall Study|Withdrawal by Subject|2|||
48687833|NCT01946139|156708339|FG000|Overall Study|Withdrawal by Subject|8|||
48687834|NCT01946139|156708339|FG000|Overall Study|ineligible|8|||
48687835|NCT01946139|156708339|FG000|Overall Study|Specimens not available|4|||
48687836|NCT00296816|156708340|FG000|Overall Study|Disease Progression|37|||
48687837|NCT00296816|156708340|FG000|Overall Study|Adverse Event|18|||
48875274|NCT02706951|157381608|FG002|Period 1|Lost to Follow-up|1|||
49023696|NCT01617668|157925760|FG000|Overall Study|Subject/guardian decision|1|||
49023697|NCT01617668|157925761|FG001|Overall Study|Subject/guardian decision|3|||
49023698|NCT01617668|157925762|FG002|Overall Study|Subject/guardian decision|2|||
49023699|NCT01617668|157925763|FG003|Overall Study|Subject/guardian decision|1|||
49023700|NCT02017964|157925764|FG000|Overall Study|Patient deemed ineligible|1|||
49023701|NCT01038856|157925768|FG000|Overall Study|Adverse Event|2|||
49023702|NCT01492400|157925769|FG000|Overall Study|Miscellaneous Reasons|2|||
48687838|NCT00296816|156708340|FG000|Overall Study|Investigator/Participant request|5|||
49023703|NCT01492400|157925770|FG001|Overall Study|Miscellaneous Reasons|3|||
49023704|NCT01492400|157925769|FG000|Overall Study|Personal Reasons|0|||
49023705|NCT01492400|157925770|FG001|Overall Study|Personal Reasons|5|||
49023706|NCT01492400|157925769|FG000|Overall Study|Lost to Follow-up|3|||
49023707|NCT01492400|157925770|FG001|Overall Study|Lost to Follow-up|1|||
49023708|NCT01492400|157925769|FG000|Overall Study|Pregnancy|0|||
49023709|NCT01492400|157925770|FG001|Overall Study|Pregnancy|1|||
49023710|NCT01492400|157925769|FG000|Overall Study|Lack of Efficacy|1|||
49023711|NCT01492400|157925770|FG001|Overall Study|Lack of Efficacy|1|||
49023712|NCT01492400|157925769|FG000|Overall Study|Adverse Event|10|||
49023713|NCT01492400|157925770|FG001|Overall Study|Adverse Event|5|||
49023714|NCT00604500|157925773|FG000|Overall Study|Adverse Event|2|||
49023715|NCT00604500|157925773|FG000|Overall Study|Protocol Violation|2|||
49023716|NCT00604500|157925773|FG000|Overall Study|Treatment Failure|1|||
49023717|NCT00604500|157925773|FG000|Overall Study|Withdrawal by Subject|4|||
49023718|NCT00604500|157925773|FG000|Overall Study|Administrative|1|||
49023719|NCT00604500|157925773|FG000|Overall Study|Did not meet protocol eligibility|1|||
49023720|NCT00659607|157925775|FG000|Overall Study|No blood pressure recorded|147|||
49023721|NCT00659607|157925775|FG000|Overall Study|Unknown measuring date of blood pressure|85|||
49023722|NCT00659607|157925775|FG000|Overall Study|'Unable to evaluate' for the final asses|67|||
49023723|NCT00659607|157925775|FG000|Overall Study|No recorded efficacy data|15|||
49023724|NCT00659607|157925775|FG000|Overall Study|Inconsistent BP measuring date|2|||
49023725|NCT04091971|157925778|FG000|Overall Study|Withdrawal by Subject|1|||
49023726|NCT04091971|157925778|FG000|Overall Study|No longer met eligibility criteria after enrollment.|2|||
49023727|NCT04091971|157925778|FG000|Overall Study|Panic attack during MRI; no MRI or PET but completed ketamine and other procedures|1|||
49023728|NCT00472290|157925779|FG000|Overall Study|Progression of Therapy-Related MDS|1|||
49023729|NCT00472290|157925779|FG000|Overall Study|Protocol Specified Criteria|7|||
49023730|NCT00472290|157925779|FG000|Overall Study|Administrative Decision|37|||
49023731|NCT00472290|157925779|FG000|Overall Study|Death|3|||
49023732|NCT00472290|157925779|FG000|Overall Study|Lost to Follow-up|1|||
49023733|NCT00472290|157925779|FG000|Overall Study|Lack of Efficacy|1|||
49023734|NCT00472290|157925779|FG000|Overall Study|Disease Progression|4|||
49023735|NCT00472290|157925779|FG000|Overall Study|Withdrawal by Subject|5|||
49023736|NCT00472290|157925779|FG000|Overall Study|Adverse Event|6|||
49023737|NCT00472290|157925779|FG000|Overall Study|Requirement for alternative therapy|7|||
49023738|NCT00193609|157925780|FG000|Overall Study|Lack of Efficacy|2|||
49023739|NCT00193609|157925780|FG000|Overall Study|Adverse Event|2|||
49023740|NCT01722877|157925787|FG000|Overall Study|Death|1|||
49023741|NCT01722877|157925787|FG000|Overall Study|Lost to Follow-up|1|||
49023742|NCT03693430|157925788|FG000|Overall Study|Lost to Follow-up|3|||
48687839|NCT00296816|156708340|FG000|Overall Study|Non-compliance|1|||
48687840|NCT00296816|156708340|FG000|Overall Study|Missing for end of treatment|4|||
48687841|NCT00296816|156708340|FG000|Overall Study|Progression based on CA-125 (biomarker)|2|||
48687842|NCT00296816|156708340|FG000|Overall Study|Poor performance status|1|||
48687843|NCT00296816|156708340|FG000|Overall Study|Relocation to Florida|1|||
48687844|NCT00296816|156708340|FG000|Overall Study|Noncompliance/decision to discontinue|1|||
48687845|NCT00296816|156708340|FG000|Overall Study|Urine protein/creatinine ratio delay|1|||
48687846|NCT00296816|156708340|FG000|Overall Study|Neuropathy/patient preference|1|||
48687847|NCT00296816|156708340|FG000|Overall Study|Proteinuria|1|||
48687848|NCT00296816|156708340|FG000|Overall Study|ineligibility due to radiation treatment|1|||
48687849|NCT01664910|156708341|FG000|Overall Study|Adverse Event|0|||
48687850|NCT01664910|156708342|FG001|Overall Study|Adverse Event|0|||
48687851|NCT01664910|156708343|FG002|Overall Study|Adverse Event|1|||
48687852|NCT01879683|156708344|FG000|Overall Study|Did not Complete 4-week Follow-up Visit|1|||
48687853|NCT01054456|156708348|FG000|Overall Study|Other|1|||
48687854|NCT04701333|156708349|FG000|Overall Study|Lost to Follow-up|3|||
48687855|NCT04701333|156708350|FG001|Overall Study|Lost to Follow-up|7|||
48687856|NCT04701333|156708349|FG000|Overall Study|Withdrawal by Subject|0|||
48687857|NCT04701333|156708350|FG001|Overall Study|Withdrawal by Subject|1|||
48687858|NCT01363700|156708351|FG000|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
48687859|NCT01363700|156708352|FG001|Epinastine vs Placebo Period1|Withdrawal by Subject|1|||
48687860|NCT01363700|156708353|FG002|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
48763428|NCT01165138|156983886|FG001|Overall Study|Adverse Event|1|||
49023743|NCT03693430|157925789|FG001|Overall Study|Lost to Follow-up|14|||
49023744|NCT03693430|157925788|FG000|Overall Study|Death|1|||
49023745|NCT03693430|157925789|FG001|Overall Study|Death|0|||
48763429|NCT01165138|156983887|FG002|Overall Study|Adverse Event|0|||
49023746|NCT03693430|157925788|FG000|Overall Study|Withdrawal by Subject|0|||
49023747|NCT03693430|157925789|FG001|Overall Study|Withdrawal by Subject|4|||
49023748|NCT03338972|157925790|FG000|Overall Study|Death|1|||
49023749|NCT03338972|157925791|FG001|Overall Study|Death|1|||
48687861|NCT01363700|156708354|FG003|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
49023750|NCT03338972|157925792|FG002|Overall Study|Death|0|||
49023751|NCT03338972|157925793|FG003|Overall Study|Death|0|||
49023752|NCT03338972|157925790|FG000|Overall Study|Withdrawal by Subject|1|||
49023753|NCT03338972|157925791|FG001|Overall Study|Withdrawal by Subject|0|||
48687862|NCT01363700|156708355|FG004|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
48687863|NCT00148759|156708356|FG000|Overall Study|Withdrawal by Subject|1|||
48687864|NCT00148759|156708357|FG001|Overall Study|Withdrawal by Subject|1|||
48687865|NCT00148759|156708356|FG000|Overall Study|Lost to Follow-up|1|||
48687866|NCT00148759|156708357|FG001|Overall Study|Lost to Follow-up|0|||
48687867|NCT01454596|156708358|FG000|Overall Study|Death|0|||
48687868|NCT01454596|156708359|FG001|Overall Study|Death|0|||
48687869|NCT01454596|156708360|FG002|Overall Study|Death|0|||
48687870|NCT01454596|156708361|FG003|Overall Study|Death|0|||
48687871|NCT01454596|156708362|FG004|Overall Study|Death|0|||
48763430|NCT01165138|156983888|FG003|Overall Study|Adverse Event|2|||
48763431|NCT01165138|156983885|FG000|Overall Study|Lack of Efficacy|0|||
48763432|NCT01165138|156983886|FG001|Overall Study|Lack of Efficacy|32|||
48763433|NCT01165138|156983887|FG002|Overall Study|Lack of Efficacy|6|||
48763434|NCT01165138|156983888|FG003|Overall Study|Lack of Efficacy|7|||
48763435|NCT01165138|156983885|FG000|Overall Study|Protocol Violation|0|||
48763436|NCT01165138|156983886|FG001|Overall Study|Protocol Violation|7|||
48763437|NCT01165138|156983887|FG002|Overall Study|Protocol Violation|0|||
48763438|NCT01165138|156983888|FG003|Overall Study|Protocol Violation|2|||
48763439|NCT01165138|156983885|FG000|Overall Study|Lost to Follow-up|0|||
48763440|NCT01165138|156983886|FG001|Overall Study|Lost to Follow-up|0|||
49023754|NCT03338972|157925792|FG002|Overall Study|Withdrawal by Subject|0|||
49023755|NCT03338972|157925793|FG003|Overall Study|Withdrawal by Subject|0|||
49023756|NCT01355081|157925794|FG000|Overall Study|Pretreatment Event or Adverse Event|3|||
49023757|NCT01355081|157925795|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
49023758|NCT01355081|157925796|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
49023759|NCT01355081|157925794|FG000|Overall Study|Major Protocol Deviation|0|||
49023760|NCT01355081|157925795|FG001|Overall Study|Major Protocol Deviation|1|||
49023761|NCT01355081|157925796|FG002|Overall Study|Major Protocol Deviation|0|||
49023762|NCT01355081|157925794|FG000|Overall Study|Lost to Follow-up|0|||
49023763|NCT01355081|157925795|FG001|Overall Study|Lost to Follow-up|0|||
49023764|NCT01355081|157925796|FG002|Overall Study|Lost to Follow-up|1|||
49023765|NCT01355081|157925794|FG000|Overall Study|Withdrawal of Consent|2|||
49023766|NCT01355081|157925795|FG001|Overall Study|Withdrawal of Consent|3|||
49023767|NCT01355081|157925796|FG002|Overall Study|Withdrawal of Consent|3|||
48687872|NCT01454596|156708363|FG005|Overall Study|Death|0|||
48687873|NCT01454596|156708364|FG006|Overall Study|Death|0|||
48687874|NCT01454596|156708365|FG007|Overall Study|Death|0|||
48687875|NCT01454596|156708366|FG008|Overall Study|Death|0|||
48687876|NCT01454596|156708367|FG009|Overall Study|Death|1|||
48687877|NCT01454596|156708368|FG010|Overall Study|Death|1|||
48687878|NCT01454596|156708369|FG011|Overall Study|Death|0|||
48687879|NCT00614380|156708371|FG000|Overall Study|Adverse Event|14|||
48687880|NCT00614380|156708372|FG001|Overall Study|Adverse Event|4|||
48687881|NCT00614380|156708373|FG002|Overall Study|Adverse Event|0|||
48687882|NCT00614380|156708374|FG003|Overall Study|Adverse Event|0|||
48687883|NCT00614380|156708371|FG000|Overall Study|Lost to Follow-up|6|||
48687884|NCT00614380|156708372|FG001|Overall Study|Lost to Follow-up|1|||
48687885|NCT00614380|156708373|FG002|Overall Study|Lost to Follow-up|0|||
48687886|NCT00614380|156708374|FG003|Overall Study|Lost to Follow-up|0|||
48687887|NCT00614380|156708371|FG000|Overall Study|Non compliant with the protocol|12|||
48687888|NCT00614380|156708372|FG001|Overall Study|Non compliant with the protocol|2|||
48687889|NCT00614380|156708373|FG002|Overall Study|Non compliant with the protocol|1|||
48687890|NCT00614380|156708374|FG003|Overall Study|Non compliant with the protocol|2|||
48687891|NCT00614380|156708371|FG000|Overall Study|Consent withdrawn|3|||
48687892|NCT00614380|156708372|FG001|Overall Study|Consent withdrawn|1|||
48687893|NCT00614380|156708373|FG002|Overall Study|Consent withdrawn|0|||
48687894|NCT00614380|156708374|FG003|Overall Study|Consent withdrawn|0|||
48763441|NCT01165138|156983887|FG002|Overall Study|Lost to Follow-up|1|||
48763442|NCT01165138|156983888|FG003|Overall Study|Lost to Follow-up|2|||
48763443|NCT01165138|156983885|FG000|Overall Study|Physician Decision|0|||
48763444|NCT01165138|156983886|FG001|Overall Study|Physician Decision|6|||
48875275|NCT02706951|157381609|FG003|Period 1|Lost to Follow-up|0|||
49023768|NCT01355081|157925794|FG000|Overall Study|Lack of Efficacy|2|||
49023769|NCT01355081|157925795|FG001|Overall Study|Lack of Efficacy|1|||
49023770|NCT01355081|157925796|FG002|Overall Study|Lack of Efficacy|1|||
49023771|NCT01355081|157925794|FG000|Overall Study|Non Compliance with Study Medication|0|||
49023772|NCT01355081|157925795|FG001|Overall Study|Non Compliance with Study Medication|1|||
49023773|NCT01355081|157925796|FG002|Overall Study|Non Compliance with Study Medication|0|||
48687895|NCT00857285|156708375|FG000|Overall Study|Adverse Event|4|||
48687896|NCT00857285|156708376|FG001|Overall Study|Adverse Event|2|||
48687897|NCT00857285|156708375|FG000|Overall Study|Lack of Efficacy|0|||
48687898|NCT00857285|156708376|FG001|Overall Study|Lack of Efficacy|2|||
48875276|NCT02706951|157381610|FG004|Period 1|Lost to Follow-up|0|||
48687899|NCT00857285|156708375|FG000|Overall Study|Protocol Violation|3|||
48687900|NCT00857285|156708376|FG001|Overall Study|Protocol Violation|1|||
48687901|NCT00857285|156708375|FG000|Overall Study|Withdrawal by Subject|4|||
48687902|NCT00857285|156708376|FG001|Overall Study|Withdrawal by Subject|0|||
48763445|NCT01165138|156983887|FG002|Overall Study|Physician Decision|7|||
48763446|NCT01165138|156983888|FG003|Overall Study|Physician Decision|6|||
48687903|NCT00857285|156708375|FG000|Overall Study|Randomization criteria not met|1|||
48687904|NCT00857285|156708376|FG001|Overall Study|Randomization criteria not met|1|||
48687905|NCT02675907|156708381|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
48687906|NCT02675907|156708382|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
48687907|NCT02675907|156708381|FG000|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
48687908|NCT02675907|156708382|FG001|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
48687909|NCT02675907|156708381|FG000|Study Overall|Lack of Efficacy|1|||
48687910|NCT02675907|156708382|FG001|Study Overall|Lack of Efficacy|0|||
49023774|NCT02480764|157925797|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
49023775|NCT02480764|157925798|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
49023776|NCT02480764|157925799|FG002|Overall Study|Pretreatment Event/Adverse Event|3|||
49023777|NCT02480764|157925797|FG000|Overall Study|Major Protocol Deviation|1|||
49023778|NCT02480764|157925798|FG001|Overall Study|Major Protocol Deviation|4|||
49023779|NCT02480764|157925799|FG002|Overall Study|Major Protocol Deviation|3|||
49023780|NCT02480764|157925797|FG000|Overall Study|Lost to Follow-up|0|||
49023781|NCT02480764|157925798|FG001|Overall Study|Lost to Follow-up|1|||
49023782|NCT02480764|157925799|FG002|Overall Study|Lost to Follow-up|2|||
49023783|NCT02480764|157925797|FG000|Overall Study|Voluntary Withdrawal|6|||
49023784|NCT02480764|157925798|FG001|Overall Study|Voluntary Withdrawal|5|||
48687911|NCT02675907|156708381|FG000|Study Overall|Withdrawal by Subject|2|||
48687912|NCT02675907|156708382|FG001|Study Overall|Withdrawal by Subject|2|||
48687913|NCT02675907|156708381|FG000|Study Overall|Lost to Follow-up|0|||
48687914|NCT02675907|156708382|FG001|Study Overall|Lost to Follow-up|2|||
48687915|NCT01594931|156709932|FG000|Overall Study|Adverse Event|3|||
48687916|NCT01594931|156709933|FG001|Overall Study|Adverse Event|1|||
48687917|NCT01594931|156709934|FG002|Overall Study|Adverse Event|1|||
48687918|NCT01594931|156709932|FG000|Overall Study|Withdrawal by Subject|2|||
48687919|NCT01594931|156709933|FG001|Overall Study|Withdrawal by Subject|1|||
48687920|NCT01594931|156709934|FG002|Overall Study|Withdrawal by Subject|1|||
48687921|NCT01594931|156709932|FG000|Overall Study|Lack of Efficacy|7|||
48687922|NCT01594931|156709933|FG001|Overall Study|Lack of Efficacy|2|||
48687923|NCT01594931|156709934|FG002|Overall Study|Lack of Efficacy|2|||
48687924|NCT01594931|156709932|FG000|Overall Study|Lost to Follow-up|4|||
48687925|NCT01594931|156709933|FG001|Overall Study|Lost to Follow-up|3|||
48687926|NCT01594931|156709934|FG002|Overall Study|Lost to Follow-up|3|||
48687927|NCT01594931|156709932|FG000|Overall Study|Protocol Violation|2|||
48687928|NCT01594931|156709933|FG001|Overall Study|Protocol Violation|1|||
48687929|NCT01594931|156709934|FG002|Overall Study|Protocol Violation|0|||
48687930|NCT01594931|156709932|FG000|Overall Study|No defiined|11|||
48687931|NCT01594931|156709933|FG001|Overall Study|No defiined|4|||
48687932|NCT01594931|156709934|FG002|Overall Study|No defiined|7|||
48687933|NCT04549545|156709935|FG000|Initial Period|Withdrawal by Subject|4|||
48687934|NCT04549545|156709936|FG001|Initial Period|Withdrawal by Subject|0|||
48687935|NCT04549545|156709935|FG000|Initial Period|Additional ENT Procedure|3|||
48687936|NCT04549545|156709936|FG001|Initial Period|Additional ENT Procedure|0|||
48687937|NCT04549545|156709935|FG000|Initial Period|Lost to Follow-up|3|||
48687938|NCT04549545|156709936|FG001|Initial Period|Lost to Follow-up|1|||
48687939|NCT04549545|156709935|FG000|Initial Period|Ineligible for Crossover and Exited as study complete|0|||
48687940|NCT04549545|156709936|FG001|Initial Period|Ineligible for Crossover and Exited as study complete|9|||
48687941|NCT04549545|156709935|FG000|Crossover Period|Additional ENT Procedure|0|||
48687942|NCT04549545|156709936|FG001|Crossover Period|Additional ENT Procedure|6|||
48687943|NCT04549545|156709935|FG000|Crossover Period|Lost to Follow-up|0|||
48687944|NCT04549545|156709936|FG001|Crossover Period|Lost to Follow-up|1|||
49023785|NCT02480764|157925799|FG002|Overall Study|Voluntary Withdrawal|10|||
48687945|NCT04549545|156709935|FG000|Crossover Period|Withdrawal by Subject|0|||
48687946|NCT04549545|156709936|FG001|Crossover Period|Withdrawal by Subject|4|||
48687947|NCT01467505|156709944|FG000|Overall Study|Adverse Event|1|||
48687948|NCT01467505|156709945|FG001|Overall Study|Adverse Event|0|||
48687949|NCT01467505|156709944|FG000|Overall Study|Withdrawal by Subject|4|||
48687950|NCT01467505|156709945|FG001|Overall Study|Withdrawal by Subject|0|||
48687951|NCT01467505|156709944|FG000|Overall Study|Study Terminated by Sponsor|28|||
48687952|NCT01467505|156709945|FG001|Overall Study|Study Terminated by Sponsor|3|||
48687953|NCT02614729|156709946|FG000|Overall Study|Withdrawal by Subject|1|||
48687954|NCT02614729|156709947|FG001|Overall Study|Withdrawal by Subject|0|||
48687955|NCT00227721|156709948|FG000|Overall Study|On study, but never treated.|1|||
48687956|NCT02539797|156709949|FG000|Overall Study|Lost to Follow-up|0|||
48687957|NCT02539797|156709950|FG001|Overall Study|Lost to Follow-up|1|||
48687958|NCT02539797|156709951|FG002|Overall Study|Lost to Follow-up|0|||
48687959|NCT00961181|156709952|FG000|Overall Study|Death|2|||
48687960|NCT00961181|156709952|FG000|Overall Study|Withdrawal by Subject|2|||
48687961|NCT00961181|156709952|FG000|Overall Study|Lost to Follow-up|1|||
48687962|NCT02252146|156709956|FG000|Overall Study|Lack of Efficacy|4|||
49023786|NCT02480764|157925797|FG000|Overall Study|Lack of Efficacy|0|||
49023787|NCT02480764|157925798|FG001|Overall Study|Lack of Efficacy|3|||
49023788|NCT02480764|157925799|FG002|Overall Study|Lack of Efficacy|3|||
49023789|NCT02480764|157925797|FG000|Overall Study|Reason not Specified|0|||
48687963|NCT02252146|156709956|FG000|Overall Study|Entered hospice care|1|||
48687964|NCT02252146|156709956|FG000|Overall Study|Inability to travel to study site|1|||
48687965|NCT00763386|156709961|FG000|Overall Study|Adverse Event|43|||
48687966|NCT00763386|156709962|FG001|Overall Study|Adverse Event|33|||
48687967|NCT00763386|156709961|FG000|Overall Study|Death|1|||
48687968|NCT00763386|156709962|FG001|Overall Study|Death|2|||
48687969|NCT00763386|156709961|FG000|Overall Study|Lost to Follow-up|3|||
48687970|NCT00763386|156709962|FG001|Overall Study|Lost to Follow-up|3|||
48687971|NCT00763386|156709961|FG000|Overall Study|Withdrawal by Subject|0|||
48687972|NCT00763386|156709962|FG001|Overall Study|Withdrawal by Subject|1|||
48687973|NCT00763386|156709961|FG000|Overall Study|CRF missing|0|||
48687974|NCT00763386|156709962|FG001|Overall Study|CRF missing|1|||
48687975|NCT00763386|156709961|FG000|Overall Study|Study Prosthesis Removed|1|||
48687976|NCT00763386|156709962|FG001|Overall Study|Study Prosthesis Removed|0|||
48687977|NCT01132807|156709963|FG000|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9|||
48687978|NCT01132807|156709964|FG001|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
48687979|NCT01132807|156709965|FG002|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
48687980|NCT01132807|156709963|FG000|Initial ABVD Treatment (2 Cycles)|Ineligible|6|||
48687981|NCT01132807|156709964|FG001|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
48687982|NCT01132807|156709965|FG002|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
48687983|NCT03010527|156709966|FG000|Overall Study|Death|0|||
48687984|NCT03010527|156709967|FG001|Overall Study|Death|0|||
48687985|NCT03010527|156709968|FG002|Overall Study|Death|1|||
48687986|NCT03010527|156709966|FG000|Overall Study|Adverse Event|0|||
48687987|NCT03010527|156709967|FG001|Overall Study|Adverse Event|4|||
48687988|NCT03010527|156709968|FG002|Overall Study|Adverse Event|2|||
48687989|NCT03010527|156709966|FG000|Overall Study|Protocol Violation|0|||
48687990|NCT03010527|156709967|FG001|Overall Study|Protocol Violation|1|||
48687991|NCT03010527|156709968|FG002|Overall Study|Protocol Violation|0|||
48687992|NCT03010527|156709966|FG000|Overall Study|Lost to Follow-up|0|||
48687993|NCT03010527|156709967|FG001|Overall Study|Lost to Follow-up|2|||
48687994|NCT03010527|156709968|FG002|Overall Study|Lost to Follow-up|1|||
48687995|NCT03010527|156709966|FG000|Overall Study|Withdrawal by Subject|0|||
48687996|NCT03010527|156709967|FG001|Overall Study|Withdrawal by Subject|3|||
48687997|NCT03010527|156709968|FG002|Overall Study|Withdrawal by Subject|4|||
48763447|NCT01165138|156983885|FG000|Overall Study|Withdrawal by Subject|0|||
48687998|NCT03010527|156709966|FG000|Overall Study|WITHDRAWAL CRITERIA #9|0|||
48687999|NCT03010527|156709967|FG001|Overall Study|WITHDRAWAL CRITERIA #9|4|||
48688000|NCT03010527|156709968|FG002|Overall Study|WITHDRAWAL CRITERIA #9|6|||
48688001|NCT03010527|156709966|FG000|Overall Study|WITHDRAWAL CRITERIA #12|0|||
48688002|NCT03010527|156709967|FG001|Overall Study|WITHDRAWAL CRITERIA #12|4|||
48688003|NCT03010527|156709968|FG002|Overall Study|WITHDRAWAL CRITERIA #12|2|||
48688004|NCT03010527|156709966|FG000|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
48688005|NCT03010527|156709967|FG001|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1|||
48688006|NCT03010527|156709968|FG002|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
48688007|NCT01458639|156709969|FG000|Overall Study|Physician Decision|4|||
48688008|NCT01458639|156709969|FG000|Overall Study|Equipment issue|1|||
48688009|NCT01458639|156709969|FG000|Overall Study|Inability to obtain subject blood sample|1|||
48688010|NCT04439136|156709973|FG000|Overall Study|Ineligible|1|||
48688011|NCT04439136|156709973|FG000|Overall Study|Never Started Treatment|2|||
48688012|NCT04439136|156709973|FG000|Overall Study|Adverse Event|4|||
48688013|NCT04439136|156709973|FG000|Overall Study|Death|3|||
48688014|NCT04439136|156709973|FG000|Overall Study|Disease Progression|27|||
48688015|NCT04439136|156709973|FG000|Overall Study|Alternative Therapy|1|||
48688016|NCT04439136|156709973|FG000|Overall Study|Increased Tumor Burden|1|||
48688017|NCT04439136|156709973|FG000|Overall Study|Symptomatic Detrioration|1|||
48688018|NCT02222558|156709974|FG000|Period 1: Single Dose|Withdrawal by Subject|4|||
48688019|NCT02222558|156709975|FG001|Period 1: Single Dose|Withdrawal by Subject|0|||
48688020|NCT02222558|156709976|FG002|Period 1: Single Dose|Withdrawal by Subject|0|||
48688021|NCT02222558|156709977|FG003|Period 1: Single Dose|Withdrawal by Subject|0|||
48763448|NCT01165138|156983886|FG001|Overall Study|Withdrawal by Subject|6|||
48763449|NCT01165138|156983887|FG002|Overall Study|Withdrawal by Subject|6|||
48688022|NCT02222558|156709978|FG004|Period 1: Single Dose|Withdrawal by Subject|0|||
48688023|NCT02222558|156709979|FG005|Period 1: Single Dose|Withdrawal by Subject|0|||
48688024|NCT02222558|156709974|FG000|Period 3|Withdrawal by Subject|0|||
48763450|NCT01165138|156983888|FG003|Overall Study|Withdrawal by Subject|3|||
48763451|NCT03526458|156983889|FG000|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
48688025|NCT02222558|156709975|FG001|Period 3|Withdrawal by Subject|0|||
48688026|NCT02222558|156709976|FG002|Period 3|Withdrawal by Subject|0|||
48688027|NCT02222558|156709977|FG003|Period 3|Withdrawal by Subject|0|||
48763452|NCT03526458|156983890|FG001|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
48763453|NCT03526458|156983889|FG000|Overall Study|Stone passed, surgery cancelled|2|||
48763454|NCT03526458|156983890|FG001|Overall Study|Stone passed, surgery cancelled|1|||
48763455|NCT03526458|156983889|FG000|Overall Study|Withdrawal by Subject|1|||
48688028|NCT02222558|156709978|FG004|Period 3|Withdrawal by Subject|0|||
48688029|NCT02222558|156709979|FG005|Period 3|Withdrawal by Subject|1|||
48688030|NCT04073186|156709980|FG000|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1|||
48688031|NCT04073186|156709980|FG000|First Wearing Cycle|Withdrawal by Subject|1|||
48688032|NCT04073186|156709980|FG000|First Wearing Cycle|Protocol Violation|1|||
48688033|NCT04073186|156709980|FG000|First Wearing Cycle|Lens Discomfort|2|||
48688034|NCT04073186|156709980|FG000|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1|||
48688035|NCT04073186|156709980|FG000|Second Wearing Cycle|Adverse Event|1|||
48688036|NCT00981149|156709981|FG000|Overall Study|Lost to Follow-up|1|||
48688037|NCT00981149|156709982|FG001|Overall Study|Lost to Follow-up|2|||
48688038|NCT00981149|156709981|FG000|Overall Study|Withdrawal by Subject|1|||
48688039|NCT00981149|156709982|FG001|Overall Study|Withdrawal by Subject|1|||
48688040|NCT00354679|156709985|FG000|Overall Study|Patient Not Treated|1|||
48688041|NCT02640547|156709986|FG000|Overall Study|Failure to Return|1|||
48688042|NCT02640547|156709986|FG000|Overall Study|Withdrawal by Subject|1|||
48688043|NCT02640547|156709986|FG000|Overall Study|Death|6|||
48688044|NCT02640547|156709986|FG000|Overall Study|Miscellaneous|3|||
48688045|NCT01453140|156709988|FG000|Overall Study|Adverse Event|3|||
48688046|NCT00887549|156709989|FG000|Induction Therapy|Adverse Event|8|||
48688047|NCT00887549|156709989|FG000|Induction Therapy|Physician Decision|1|||
48688048|NCT00887549|156709989|FG000|Induction Therapy|Progressive Disease|13|||
48688049|NCT00887549|156709989|FG000|Induction Therapy|Death due to Study Disease|4|||
48688050|NCT00887549|156709989|FG000|Induction Therapy|Death due to Study Drug Toxicity|1|||
48688051|NCT00887549|156709989|FG000|Maintenance Therapy|Adverse Event|16|||
48688052|NCT00887549|156709989|FG000|Maintenance Therapy|Physician Decision|1|||
48688053|NCT00887549|156709989|FG000|Maintenance Therapy|Progressive Disease|25|||
48688054|NCT00887549|156709989|FG000|Maintenance Therapy|Death due to adverse event|1|||
48688055|NCT01485094|156709991|FG000|Overall Study|Adverse Event|1|||
48688056|NCT01485094|156709992|FG001|Overall Study|Adverse Event|1|||
48688057|NCT01485094|156709993|FG002|Overall Study|Adverse Event|1|||
48688058|NCT01485094|156709991|FG000|Overall Study|Lost to Follow-up|1|||
48688059|NCT01485094|156709992|FG001|Overall Study|Lost to Follow-up|0|||
48688060|NCT01485094|156709993|FG002|Overall Study|Lost to Follow-up|0|||
48688061|NCT01485094|156709991|FG000|Overall Study|Withdrawal by Subject|1|||
48688062|NCT01485094|156709992|FG001|Overall Study|Withdrawal by Subject|1|||
48688063|NCT01485094|156709993|FG002|Overall Study|Withdrawal by Subject|0|||
48688064|NCT00688259|156709994|FG000|Overall Study|Lost to Follow-up|2|||
48688065|NCT00688259|156709995|FG001|Overall Study|Lost to Follow-up|4|||
48688066|NCT00688259|156709994|FG000|Overall Study|Physician Decision|1|||
48688067|NCT00688259|156709995|FG001|Overall Study|Physician Decision|0|||
48688068|NCT00688259|156709994|FG000|Overall Study|Withdrawal by Subject|2|||
48688069|NCT00688259|156709995|FG001|Overall Study|Withdrawal by Subject|0|||
48688070|NCT00688259|156709994|FG000|Overall Study|Declined Interview|2|||
48688071|NCT00688259|156709995|FG001|Overall Study|Declined Interview|3|||
48688072|NCT00688259|156709994|FG000|Overall Study|Hospitalized at Follow-up|0|||
48688073|NCT00688259|156709995|FG001|Overall Study|Hospitalized at Follow-up|1|||
48688074|NCT01272232|156709999|FG000|Weeks 0-56|Adverse Event|39|||
48688075|NCT01272232|156710000|FG001|Weeks 0-56|Adverse Event|18|||
48688076|NCT01272232|156710001|FG002|Weeks 0-56|Adverse Event|7|||
48688077|NCT01272232|156709999|FG000|Weeks 0-56|Lack of Efficacy|0|||
48688078|NCT01272232|156710000|FG001|Weeks 0-56|Lack of Efficacy|0|||
48688079|NCT01272232|156710001|FG002|Weeks 0-56|Lack of Efficacy|3|||
48688080|NCT01272232|156709999|FG000|Weeks 0-56|Protocol Violation|12|||
48688081|NCT01272232|156710000|FG001|Weeks 0-56|Protocol Violation|8|||
48688082|NCT01272232|156710001|FG002|Weeks 0-56|Protocol Violation|13|||
48688083|NCT01272232|156709999|FG000|Weeks 0-56|Withdrawal criteria|32|||
48688084|NCT01272232|156710000|FG001|Weeks 0-56|Withdrawal criteria|14|||
48688085|NCT01272232|156710001|FG002|Weeks 0-56|Withdrawal criteria|37|||
48688086|NCT01272232|156709999|FG000|Weeks 0-56|Unclassified|16|||
49023790|NCT02480764|157925798|FG001|Overall Study|Reason not Specified|1|||
49023791|NCT02480764|157925799|FG002|Overall Study|Reason not Specified|0|||
49023792|NCT03629249|157925802|FG000|Overall Study|Study terminated by sponsor|197|||
49023793|NCT03629249|157925803|FG001|Overall Study|Study terminated by sponsor|197|||
49023794|NCT03629249|157925804|FG002|Overall Study|Study terminated by sponsor|194|||
48688087|NCT01272232|156710000|FG001|Weeks 0-56|Unclassified|7|||
48688088|NCT01272232|156710001|FG002|Weeks 0-56|Unclassified|12|||
48688089|NCT01272232|156709999|FG000|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
48688090|NCT01272232|156710000|FG001|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
48688091|NCT01272232|156710001|FG002|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0|||
48688092|NCT01272232|156709999|FG000|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1|||
48688093|NCT01272232|156710000|FG001|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
48688094|NCT01272232|156710001|FG002|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
48688095|NCT01272232|156709999|FG000|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
48688096|NCT01272232|156710000|FG001|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0|||
48688097|NCT01272232|156710001|FG002|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
48688098|NCT01272232|156709999|FG000|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9|||
49023795|NCT03629249|157925802|FG000|Overall Study|Protocol deviation|0|||
49023796|NCT03629249|157925803|FG001|Overall Study|Protocol deviation|2|||
48688099|NCT01272232|156710000|FG001|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7|||
48688100|NCT01272232|156710001|FG002|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4|||
48688101|NCT01272232|156709999|FG000|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
48688102|NCT01272232|156710000|FG001|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
48688103|NCT01272232|156710001|FG002|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0|||
48688104|NCT01147666|156710002|FG000|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
48688105|NCT01147666|156710003|FG001|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
48688106|NCT01147666|156710004|FG002|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
48688107|NCT01147666|156710005|FG003|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
48688108|NCT01147666|156710006|FG004|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
48688109|NCT01147666|156710007|FG005|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
48688110|NCT01147666|156710008|FG006|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
48688111|NCT01147666|156710009|FG007|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
48688112|NCT01147666|156710010|FG008|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
48688113|NCT01147666|156710011|FG009|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
48688114|NCT01147666|156710012|FG010|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
48688115|NCT01147666|156710013|FG011|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
48688116|NCT01147666|156710014|FG012|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
48688117|NCT01147666|156710015|FG013|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
48688118|NCT01147666|156710016|FG014|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
48688119|NCT01147666|156710002|FG000|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
48688120|NCT01147666|156710003|FG001|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
48688121|NCT01147666|156710004|FG002|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
48688122|NCT01147666|156710005|FG003|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
48688123|NCT01147666|156710006|FG004|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
48688124|NCT01147666|156710007|FG005|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
48688125|NCT01147666|156710008|FG006|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
48688126|NCT01147666|156710009|FG007|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
48688127|NCT01147666|156710010|FG008|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
48688128|NCT01147666|156710011|FG009|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
48688129|NCT01147666|156710012|FG010|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
48688130|NCT01147666|156710013|FG011|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
48688131|NCT01147666|156710014|FG012|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
48688132|NCT01147666|156710015|FG013|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
48688133|NCT01147666|156710016|FG014|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
48688134|NCT01147666|156710002|FG000|Dosing Period 1: 6-Week Treatment|Death|0|||
48688135|NCT01147666|156710003|FG001|Dosing Period 1: 6-Week Treatment|Death|0|||
48688136|NCT01147666|156710004|FG002|Dosing Period 1: 6-Week Treatment|Death|0|||
48688137|NCT01147666|156710005|FG003|Dosing Period 1: 6-Week Treatment|Death|0|||
48688138|NCT01147666|156710006|FG004|Dosing Period 1: 6-Week Treatment|Death|1|||
48688139|NCT01147666|156710007|FG005|Dosing Period 1: 6-Week Treatment|Death|1|||
48688140|NCT01147666|156710008|FG006|Dosing Period 1: 6-Week Treatment|Death|1|||
48688141|NCT01147666|156710009|FG007|Dosing Period 1: 6-Week Treatment|Death|0|||
48688142|NCT01147666|156710010|FG008|Dosing Period 1: 6-Week Treatment|Death|0|||
48688143|NCT01147666|156710011|FG009|Dosing Period 1: 6-Week Treatment|Death|0|||
48688144|NCT01147666|156710012|FG010|Dosing Period 1: 6-Week Treatment|Death|0|||
48688145|NCT01147666|156710013|FG011|Dosing Period 1: 6-Week Treatment|Death|0|||
48688146|NCT01147666|156710014|FG012|Dosing Period 1: 6-Week Treatment|Death|1|||
48688147|NCT01147666|156710015|FG013|Dosing Period 1: 6-Week Treatment|Death|0|||
48688148|NCT01147666|156710016|FG014|Dosing Period 1: 6-Week Treatment|Death|0|||
48688149|NCT01147666|156710002|FG000|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
48688150|NCT01147666|156710003|FG001|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
48688151|NCT01147666|156710004|FG002|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
48688152|NCT01147666|156710005|FG003|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
48688153|NCT01147666|156710006|FG004|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
48688154|NCT01147666|156710007|FG005|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
48688155|NCT01147666|156710008|FG006|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
48688156|NCT01147666|156710009|FG007|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
48688157|NCT01147666|156710010|FG008|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
49023797|NCT03629249|157925804|FG002|Overall Study|Protocol deviation|5|||
49023798|NCT03629249|157925802|FG000|Overall Study|Subject decision|1|||
48688158|NCT01147666|156710011|FG009|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
48688159|NCT01147666|156710012|FG010|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
48688160|NCT01147666|156710013|FG011|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
48688161|NCT01147666|156710014|FG012|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
48875277|NCT02706951|157381606|FG000|Period 1|Other|2|||
49023799|NCT03629249|157925803|FG001|Overall Study|Subject decision|1|||
49023800|NCT03629249|157925804|FG002|Overall Study|Subject decision|3|||
49023801|NCT03629249|157925802|FG000|Overall Study|Adverse Event|1|||
49023802|NCT03629249|157925803|FG001|Overall Study|Adverse Event|1|||
48688162|NCT01147666|156710015|FG013|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
48688163|NCT01147666|156710016|FG014|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
48688164|NCT01147666|156710002|FG000|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
48688165|NCT01147666|156710003|FG001|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
48688166|NCT01147666|156710004|FG002|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
48688167|NCT01147666|156710005|FG003|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
48688168|NCT01147666|156710006|FG004|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
48688169|NCT01147666|156710007|FG005|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
48688170|NCT01147666|156710008|FG006|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
48763456|NCT03526458|156983890|FG001|Overall Study|Withdrawal by Subject|0|||
48763457|NCT03526458|156983889|FG000|Overall Study|Physician Decision|2|||
48763458|NCT03526458|156983890|FG001|Overall Study|Physician Decision|1|||
48763459|NCT03526458|156983889|FG000|Overall Study|Lack of equipment|1|||
48763460|NCT03526458|156983890|FG001|Overall Study|Lack of equipment|1|||
48763461|NCT04964128|156983891|FG000|Phase 1 (Software Release Tag 1.0)|Withdrawal by Subject|1|||
48763462|NCT04964128|156983891|FG000|Phase 2 (Software Release Tag 2.0)|Physician Decision|1|||
48763463|NCT01471379|156983892|FG000|Overall Study|Adverse Event|1|||
48763464|NCT01471379|156983893|FG001|Overall Study|Adverse Event|0|||
48763465|NCT01471379|156983894|FG002|Overall Study|Adverse Event|0|||
48763466|NCT01471379|156983892|FG000|Overall Study|Study terminated|0|||
48763467|NCT01471379|156983893|FG001|Overall Study|Study terminated|1|||
48763468|NCT01471379|156983894|FG002|Overall Study|Study terminated|0|||
48763469|NCT02275481|156983895|FG000|Overall Study|Death|2|||
48763470|NCT02275481|156983896|FG001|Overall Study|Death|1|||
48763471|NCT02275481|156983895|FG000|Overall Study|Lost to Follow-up|2|||
48763472|NCT02275481|156983896|FG001|Overall Study|Lost to Follow-up|0|||
48763473|NCT02275481|156983895|FG000|Overall Study|Withdrawal by Subject|3|||
48763474|NCT02275481|156983896|FG001|Overall Study|Withdrawal by Subject|0|||
48763475|NCT02275481|156983895|FG000|Overall Study|all other reasons combined|2|||
48875278|NCT02706951|157381607|FG001|Period 1|Other|1|||
48875279|NCT02706951|157381608|FG002|Period 1|Other|0|||
48875280|NCT02706951|157381609|FG003|Period 1|Other|0|||
48875281|NCT02706951|157381610|FG004|Period 1|Other|0|||
48875282|NCT02706951|157381606|FG000|Period 2|Adverse Event|0|||
48875283|NCT02706951|157381607|FG001|Period 2|Adverse Event|0|||
48875284|NCT02706951|157381608|FG002|Period 2|Adverse Event|0|||
48875285|NCT02706951|157381609|FG003|Period 2|Adverse Event|25|||
48875286|NCT02706951|157381610|FG004|Period 2|Adverse Event|34|||
48875287|NCT02706951|157381606|FG000|Period 2|Withdrawal by Subject|0|||
48875288|NCT02706951|157381607|FG001|Period 2|Withdrawal by Subject|0|||
48875289|NCT02706951|157381608|FG002|Period 2|Withdrawal by Subject|0|||
48875290|NCT02706951|157381609|FG003|Period 2|Withdrawal by Subject|38|||
48875291|NCT02706951|157381610|FG004|Period 2|Withdrawal by Subject|44|||
48875292|NCT02706951|157381606|FG000|Period 2|Lost to Follow-up|0|||
48875293|NCT02706951|157381607|FG001|Period 2|Lost to Follow-up|0|||
48875294|NCT02706951|157381608|FG002|Period 2|Lost to Follow-up|0|||
48875295|NCT02706951|157381609|FG003|Period 2|Lost to Follow-up|17|||
48875296|NCT02706951|157381610|FG004|Period 2|Lost to Follow-up|9|||
48875297|NCT02706951|157381606|FG000|Period 2|COVID-19 Related|0|||
48875298|NCT02706951|157381607|FG001|Period 2|COVID-19 Related|0|||
48875299|NCT02706951|157381608|FG002|Period 2|COVID-19 Related|0|||
48875300|NCT02706951|157381609|FG003|Period 2|COVID-19 Related|1|||
48875301|NCT02706951|157381610|FG004|Period 2|COVID-19 Related|2|||
48875302|NCT02706951|157381606|FG000|Period 2|Other|0|||
48875303|NCT02706951|157381607|FG001|Period 2|Other|0|||
48875304|NCT02706951|157381608|FG002|Period 2|Other|0|||
48688171|NCT01147666|156710009|FG007|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
48688172|NCT01147666|156710010|FG008|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
48688173|NCT01147666|156710011|FG009|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
48688174|NCT01147666|156710012|FG010|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
48688175|NCT01147666|156710013|FG011|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
48688176|NCT01147666|156710014|FG012|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
48688177|NCT01147666|156710015|FG013|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
48688178|NCT01147666|156710016|FG014|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
48688179|NCT01147666|156710002|FG000|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
48688180|NCT01147666|156710003|FG001|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
48688181|NCT01147666|156710004|FG002|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
48875305|NCT02706951|157381609|FG003|Period 2|Other|37|||
48875306|NCT02706951|157381610|FG004|Period 2|Other|31|||
48875307|NCT00666198|157381613|FG000|Overall Study|Protocol Violation|10|||
48688182|NCT01147666|156710005|FG003|Dosing Period 1: 6-Week Treatment|Other than specified|1|||
48763476|NCT02275481|156983896|FG001|Overall Study|all other reasons combined|1|||
48763477|NCT02275481|156983895|FG000|Overall Study|Physician Decision|0|||
48875308|NCT00666198|157381613|FG000|Overall Study|No Visit After First Day of Treatment|13|||
48875309|NCT00666198|157381613|FG000|Overall Study|Safety Not Assessable|6|||
48875310|NCT00666198|157381613|FG000|Overall Study|No Drug Administration|4|||
48875311|NCT02165397|157381614|FG000|Overall Study|Death|7|||
48688183|NCT01147666|156710006|FG004|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
48688184|NCT01147666|156710007|FG005|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
48688185|NCT01147666|156710008|FG006|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
48688186|NCT01147666|156710009|FG007|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
48688187|NCT01147666|156710010|FG008|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
48688188|NCT01147666|156710011|FG009|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
48688189|NCT01147666|156710012|FG010|Dosing Period 1: 6-Week Treatment|Other than specified|2|||
48688190|NCT01147666|156710013|FG011|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
48688191|NCT01147666|156710014|FG012|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
48688192|NCT01147666|156710015|FG013|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
48688193|NCT01147666|156710016|FG014|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
48688194|NCT01147666|156710002|FG000|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
48688195|NCT01147666|156710003|FG001|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
48688196|NCT01147666|156710004|FG002|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
48688197|NCT01147666|156710005|FG003|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
48688198|NCT01147666|156710006|FG004|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
48688199|NCT01147666|156710007|FG005|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
48688200|NCT01147666|156710008|FG006|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
48688201|NCT01147666|156710009|FG007|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
48688202|NCT01147666|156710010|FG008|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
48688203|NCT01147666|156710011|FG009|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
48688204|NCT01147666|156710012|FG010|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
48688205|NCT01147666|156710013|FG011|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
48688206|NCT01147666|156710014|FG012|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
48688207|NCT01147666|156710015|FG013|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
48688208|NCT01147666|156710016|FG014|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
48688209|NCT01147666|156710002|FG000|Dosing Period 2: 19-Week Treatment|Death|0|||
48688210|NCT01147666|156710003|FG001|Dosing Period 2: 19-Week Treatment|Death|0|||
48688211|NCT01147666|156710004|FG002|Dosing Period 2: 19-Week Treatment|Death|0|||
48688212|NCT01147666|156710005|FG003|Dosing Period 2: 19-Week Treatment|Death|0|||
48688213|NCT01147666|156710006|FG004|Dosing Period 2: 19-Week Treatment|Death|1|||
48688214|NCT01147666|156710007|FG005|Dosing Period 2: 19-Week Treatment|Death|1|||
48688215|NCT01147666|156710008|FG006|Dosing Period 2: 19-Week Treatment|Death|1|||
48688216|NCT01147666|156710009|FG007|Dosing Period 2: 19-Week Treatment|Death|0|||
48688217|NCT01147666|156710010|FG008|Dosing Period 2: 19-Week Treatment|Death|0|||
48688218|NCT01147666|156710011|FG009|Dosing Period 2: 19-Week Treatment|Death|0|||
48688219|NCT01147666|156710012|FG010|Dosing Period 2: 19-Week Treatment|Death|0|||
48688220|NCT01147666|156710013|FG011|Dosing Period 2: 19-Week Treatment|Death|0|||
48688221|NCT01147666|156710014|FG012|Dosing Period 2: 19-Week Treatment|Death|1|||
48688222|NCT01147666|156710015|FG013|Dosing Period 2: 19-Week Treatment|Death|0|||
48688223|NCT01147666|156710016|FG014|Dosing Period 2: 19-Week Treatment|Death|0|||
48688224|NCT01147666|156710002|FG000|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
48688225|NCT01147666|156710003|FG001|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
48688226|NCT01147666|156710004|FG002|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
48688227|NCT01147666|156710005|FG003|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
48688228|NCT01147666|156710006|FG004|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|3|||
48688229|NCT01147666|156710007|FG005|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
48688230|NCT01147666|156710008|FG006|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
48688231|NCT01147666|156710009|FG007|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
48688232|NCT01147666|156710010|FG008|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
48688233|NCT01147666|156710011|FG009|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
48688234|NCT01147666|156710012|FG010|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
48688235|NCT01147666|156710013|FG011|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
48688236|NCT01147666|156710014|FG012|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
48688237|NCT01147666|156710015|FG013|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
48688238|NCT01147666|156710016|FG014|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
48688239|NCT01147666|156710002|FG000|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
48688240|NCT01147666|156710003|FG001|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
48688241|NCT01147666|156710004|FG002|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
48688242|NCT01147666|156710005|FG003|Dosing Period 2: 19-Week Treatment|Protocol Violation|1|||
48688243|NCT01147666|156710006|FG004|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
48688244|NCT01147666|156710007|FG005|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
48688245|NCT01147666|156710008|FG006|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
48688246|NCT01147666|156710009|FG007|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
48763478|NCT02275481|156983896|FG001|Overall Study|Physician Decision|1|||
48875312|NCT02165397|157381615|FG001|Overall Study|Death|10|||
48875313|NCT02165397|157381616|FG002|Overall Study|Death|8|||
48688247|NCT01147666|156710010|FG008|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
48688248|NCT01147666|156710011|FG009|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
48688249|NCT01147666|156710012|FG010|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
48688250|NCT01147666|156710013|FG011|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
48763479|NCT04404855|156983898|FG000|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|69|||
48763480|NCT04404855|156983899|FG001|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|35|||
48763481|NCT00352846|156983901|FG000|Overall Study|Disease progression|0|||
49023803|NCT03629249|157925804|FG002|Overall Study|Adverse Event|0|||
49023804|NCT03629249|157925802|FG000|Overall Study|Death|1|||
49023805|NCT03629249|157925803|FG001|Overall Study|Death|0|||
49023806|NCT03629249|157925804|FG002|Overall Study|Death|0|||
49023807|NCT03629249|157925802|FG000|Overall Study|Physician Decision|1|||
49023808|NCT03629249|157925803|FG001|Overall Study|Physician Decision|0|||
49023809|NCT03629249|157925804|FG002|Overall Study|Physician Decision|0|||
49023810|NCT01706536|157925805|FG000|Overall Study|Withdrawal by Subject|1|||
49023811|NCT01706536|157925806|FG001|Overall Study|Withdrawal by Subject|0|||
49023812|NCT01706536|157925807|FG002|Overall Study|Withdrawal by Subject|1|||
49023813|NCT01706536|157925808|FG003|Overall Study|Withdrawal by Subject|0|||
49023814|NCT01706536|157925809|FG004|Overall Study|Withdrawal by Subject|0|||
49023815|NCT01706536|157925805|FG000|Overall Study|Adverse Event|2|||
49023816|NCT01706536|157925806|FG001|Overall Study|Adverse Event|3|||
49023817|NCT01706536|157925807|FG002|Overall Study|Adverse Event|4|||
49023818|NCT01706536|157925808|FG003|Overall Study|Adverse Event|3|||
49023819|NCT01706536|157925809|FG004|Overall Study|Adverse Event|2|||
49023820|NCT01706536|157925805|FG000|Overall Study|Lack of Efficacy|1|||
49023821|NCT01706536|157925806|FG001|Overall Study|Lack of Efficacy|0|||
49023822|NCT01706536|157925807|FG002|Overall Study|Lack of Efficacy|0|||
49023823|NCT01706536|157925808|FG003|Overall Study|Lack of Efficacy|1|||
49023824|NCT01706536|157925809|FG004|Overall Study|Lack of Efficacy|0|||
49023825|NCT01706536|157925805|FG000|Overall Study|non compliance|0|||
49023826|NCT01706536|157925806|FG001|Overall Study|non compliance|1|||
49023827|NCT01706536|157925807|FG002|Overall Study|non compliance|0|||
49023828|NCT01706536|157925808|FG003|Overall Study|non compliance|0|||
49023829|NCT01706536|157925809|FG004|Overall Study|non compliance|0|||
49023830|NCT01697696|157925815|FG000|Overall Study|Study terminated by sponsor|0|||
49023831|NCT01697696|157925816|FG001|Overall Study|Study terminated by sponsor|3|||
49023832|NCT01697696|157925815|FG000|Overall Study|Protocol deviation|1|||
49023833|NCT01697696|157925816|FG001|Overall Study|Protocol deviation|0|||
49023834|NCT01697696|157925815|FG000|Overall Study|Physician Decision|1|||
49023835|NCT01697696|157925816|FG001|Overall Study|Physician Decision|0|||
49023836|NCT01697696|157925815|FG000|Overall Study|Death|4|||
49023837|NCT01697696|157925816|FG001|Overall Study|Death|2|||
49023838|NCT01697696|157925815|FG000|Overall Study|Lost to Follow-up|10|||
49023839|NCT01697696|157925816|FG001|Overall Study|Lost to Follow-up|7|||
48688251|NCT01147666|156710014|FG012|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
48688252|NCT01147666|156710015|FG013|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
48688253|NCT01147666|156710016|FG014|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
48688254|NCT01147666|156710002|FG000|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
48688255|NCT01147666|156710003|FG001|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
48688256|NCT01147666|156710004|FG002|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
48688257|NCT01147666|156710005|FG003|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
48688258|NCT01147666|156710006|FG004|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
48688259|NCT01147666|156710007|FG005|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
48688260|NCT01147666|156710008|FG006|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
48688261|NCT01147666|156710009|FG007|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
48688262|NCT01147666|156710010|FG008|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
48688263|NCT01147666|156710011|FG009|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
48688264|NCT01147666|156710012|FG010|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
48688265|NCT01147666|156710013|FG011|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
48763482|NCT00352846|156983902|FG001|Overall Study|Disease progression|2|||
49023840|NCT01697696|157925815|FG000|Overall Study|Subject/guardian decision|31|||
49023841|NCT01697696|157925816|FG001|Overall Study|Subject/guardian decision|35|||
49023842|NCT01402947|157925817|FG000|First Intervention|Adverse Event|0|||
49023843|NCT01402947|157925818|FG001|First Intervention|Adverse Event|1|||
49023844|NCT05593965|157925819|FG000|1st Intervention (1 Day)|Technical error|1|||
49023845|NCT05593965|157925820|FG001|1st Intervention (1 Day)|Technical error|0|||
49023846|NCT00591630|157925821|FG000|Overall Study|Death|0|||
49023847|NCT00591630|157925822|FG001|Overall Study|Death|0|||
49023848|NCT00591630|157925823|FG002|Overall Study|Death|1|||
49023849|NCT00591630|157925824|FG003|Overall Study|Death|0|||
49023850|NCT03805438|157927463|FG000|Overall Study|Lack of Efficacy|1|||
49023851|NCT03805438|157927463|FG000|Overall Study|Protocol Violation|1|||
49023852|NCT00419770|157927464|FG000|Overall Study|Withdrawal by Subject|5|||
49023853|NCT00419770|157927465|FG001|Overall Study|Withdrawal by Subject|1|||
49023854|NCT01494506|157927466|FG000|Overall Study|Lack of Efficacy|77|||
48688266|NCT01147666|156710014|FG012|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
48763483|NCT00352846|156983901|FG000|Overall Study|Withdrawal by Subject|3|||
48763484|NCT00352846|156983902|FG001|Overall Study|Withdrawal by Subject|8|||
48688267|NCT01147666|156710015|FG013|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
48688268|NCT01147666|156710016|FG014|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
48688269|NCT01147666|156710002|FG000|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
48688270|NCT01147666|156710003|FG001|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
48688271|NCT01147666|156710004|FG002|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
48688272|NCT01147666|156710005|FG003|Dosing Period 2: 19-Week Treatment|Other than specified|1|||
48688273|NCT01147666|156710006|FG004|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
48688274|NCT01147666|156710007|FG005|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
48688275|NCT01147666|156710008|FG006|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
48763485|NCT00352846|156983901|FG000|Overall Study|Ineligible|3|||
48763486|NCT00352846|156983902|FG001|Overall Study|Ineligible|2|||
48763487|NCT00352846|156983901|FG000|Overall Study|Non-compliance|2|||
48763488|NCT00352846|156983902|FG001|Overall Study|Non-compliance|0|||
48763489|NCT00352846|156983901|FG000|Overall Study|Death|0|||
48763490|NCT00352846|156983902|FG001|Overall Study|Death|1|||
48763491|NCT03571581|156983903|FG000|Overall Study|Death|2|||
48763492|NCT03571581|156983903|FG000|Overall Study|Withdrawal by Subject|2|||
48763493|NCT00729183|156983904|FG000|Overall Study|Adverse Event|11|||
48763494|NCT00729183|156983905|FG001|Overall Study|Adverse Event|5|||
48763495|NCT00729183|156983904|FG000|Overall Study|Lack of Efficacy|0|||
48763496|NCT00729183|156983905|FG001|Overall Study|Lack of Efficacy|1|||
48763497|NCT00729183|156983904|FG000|Overall Study|Lost to Follow-up|3|||
48763498|NCT00729183|156983905|FG001|Overall Study|Lost to Follow-up|1|||
48763499|NCT00729183|156983904|FG000|Overall Study|Physician Decision|1|||
48763500|NCT00729183|156983905|FG001|Overall Study|Physician Decision|1|||
48763501|NCT00729183|156983904|FG000|Overall Study|Protocol Violation|1|||
48763502|NCT00729183|156983905|FG001|Overall Study|Protocol Violation|0|||
48763503|NCT00729183|156983904|FG000|Overall Study|Withdrawal by Subject|9|||
48763504|NCT00729183|156983905|FG001|Overall Study|Withdrawal by Subject|7|||
48763505|NCT01120756|156983906|FG000|Overall Study|Withdrawal by Subject|1|||
48763506|NCT01120756|156983907|FG001|Overall Study|Withdrawal by Subject|1|||
48763507|NCT00449644|156983908|FG000|Overall Study|Adverse Event|0|||
48763508|NCT00449644|156983909|FG001|Overall Study|Adverse Event|0|||
48763509|NCT00449644|156983910|FG002|Overall Study|Adverse Event|3|||
48763510|NCT00449644|156983911|FG003|Overall Study|Adverse Event|5|||
48763511|NCT00449644|156983908|FG000|Overall Study|Death|1|||
48763512|NCT00449644|156983909|FG001|Overall Study|Death|0|||
48763513|NCT00449644|156983910|FG002|Overall Study|Death|6|||
48763514|NCT00449644|156983911|FG003|Overall Study|Death|1|||
48763515|NCT00449644|156983908|FG000|Overall Study|Lost to Follow-up|1|||
48763516|NCT00449644|156983909|FG001|Overall Study|Lost to Follow-up|1|||
48763517|NCT00449644|156983910|FG002|Overall Study|Lost to Follow-up|5|||
48763518|NCT00449644|156983911|FG003|Overall Study|Lost to Follow-up|3|||
48763519|NCT00449644|156983908|FG000|Overall Study|Pregnancy|0|||
49023855|NCT01494506|157927467|FG001|Overall Study|Lack of Efficacy|83|||
49023856|NCT01494506|157927468|FG002|Overall Study|Lack of Efficacy|57|||
49023857|NCT01494506|157927466|FG000|Overall Study|Adverse Event|17|||
49023858|NCT01494506|157927467|FG001|Overall Study|Adverse Event|10|||
49023859|NCT01494506|157927468|FG002|Overall Study|Adverse Event|11|||
49023860|NCT01494506|157927466|FG000|Overall Study|Death|9|||
49023861|NCT01494506|157927467|FG001|Overall Study|Death|5|||
49023862|NCT01494506|157927468|FG002|Overall Study|Death|2|||
49023863|NCT01494506|157927466|FG000|Overall Study|Physician Decision|7|||
49023864|NCT01494506|157927467|FG001|Overall Study|Physician Decision|5|||
49023865|NCT01494506|157927468|FG002|Overall Study|Physician Decision|4|||
48763520|NCT00449644|156983909|FG001|Overall Study|Pregnancy|0|||
48763521|NCT00449644|156983910|FG002|Overall Study|Pregnancy|3|||
48763522|NCT00449644|156983911|FG003|Overall Study|Pregnancy|2|||
48763523|NCT00449644|156983908|FG000|Overall Study|Protocol Violation|4|||
49023866|NCT01494506|157927466|FG000|Overall Study|Withdrawal by Subject|17|||
48688276|NCT01147666|156710009|FG007|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
48688277|NCT01147666|156710010|FG008|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
48688278|NCT01147666|156710011|FG009|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
49023867|NCT01494506|157927467|FG001|Overall Study|Withdrawal by Subject|20|||
48688279|NCT01147666|156710012|FG010|Dosing Period 2: 19-Week Treatment|Other than specified|2|||
48688280|NCT01147666|156710013|FG011|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
48763524|NCT00449644|156983909|FG001|Overall Study|Protocol Violation|4|||
48763525|NCT00449644|156983910|FG002|Overall Study|Protocol Violation|3|||
48763526|NCT00449644|156983911|FG003|Overall Study|Protocol Violation|7|||
48763527|NCT00449644|156983908|FG000|Overall Study|Withdrawal by Subject|3|||
48763528|NCT00449644|156983909|FG001|Overall Study|Withdrawal by Subject|4|||
48763529|NCT00449644|156983910|FG002|Overall Study|Withdrawal by Subject|6|||
48763530|NCT00449644|156983911|FG003|Overall Study|Withdrawal by Subject|7|||
48875314|NCT02165397|157381614|FG000|Overall Study|Lost to Follow-up|1|||
49023868|NCT01494506|157927468|FG002|Overall Study|Withdrawal by Subject|14|||
48688281|NCT01147666|156710014|FG012|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
48688282|NCT01147666|156710015|FG013|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
48688283|NCT01147666|156710016|FG014|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
48688284|NCT01147666|156710002|FG000|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
48688285|NCT01147666|156710003|FG001|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
48688286|NCT01147666|156710004|FG002|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
48688287|NCT01147666|156710005|FG003|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
48688288|NCT01147666|156710006|FG004|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
48688289|NCT01147666|156710007|FG005|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
48688290|NCT01147666|156710008|FG006|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
48688291|NCT01147666|156710009|FG007|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
48875315|NCT02165397|157381615|FG001|Overall Study|Lost to Follow-up|3|||
48875316|NCT02165397|157381616|FG002|Overall Study|Lost to Follow-up|0|||
48875317|NCT02165397|157381614|FG000|Overall Study|Withdrawal by Subject|6|||
48875318|NCT02165397|157381615|FG001|Overall Study|Withdrawal by Subject|6|||
48875319|NCT02165397|157381616|FG002|Overall Study|Withdrawal by Subject|1|||
48875320|NCT02165397|157381614|FG000|Overall Study|Other, Not Specified|0|||
48875321|NCT02165397|157381615|FG001|Overall Study|Other, Not Specified|0|||
48875322|NCT02165397|157381616|FG002|Overall Study|Other, Not Specified|1|||
48875323|NCT03297398|157381617|FG000|Overall Study|Sponsor's decision|6|||
48875324|NCT03297398|157381618|FG001|Overall Study|Sponsor's decision|9|||
48875325|NCT03297398|157381619|FG002|Overall Study|Sponsor's decision|7|||
48875326|NCT03297398|157381617|FG000|Overall Study|Adverse Event|1|||
48875327|NCT03297398|157381618|FG001|Overall Study|Adverse Event|4|||
48875328|NCT03297398|157381619|FG002|Overall Study|Adverse Event|4|||
49023869|NCT01494506|157927466|FG000|Overall Study|Clinical Deterioration|21|||
49023870|NCT01494506|157927467|FG001|Overall Study|Clinical Deterioration|17|||
49023871|NCT01494506|157927468|FG002|Overall Study|Clinical Deterioration|13|||
49023872|NCT01494506|157927466|FG000|Overall Study|Sponsor Decision|0|||
49023873|NCT01494506|157927467|FG001|Overall Study|Sponsor Decision|0|||
49023874|NCT01494506|157927468|FG002|Overall Study|Sponsor Decision|1|||
49023875|NCT01494506|157927466|FG000|Overall Study|Other|0|||
49023876|NCT01494506|157927467|FG001|Overall Study|Other|3|||
49023877|NCT01494506|157927468|FG002|Overall Study|Other|1|||
49023878|NCT02848326|157927469|FG000|Treatment Period|Adverse Event|5|||
49023879|NCT02848326|157927470|FG001|Treatment Period|Adverse Event|4|||
49023880|NCT02848326|157927471|FG002|Treatment Period|Adverse Event|11|||
49023881|NCT02848326|157927472|FG003|Treatment Period|Adverse Event|6|||
49023882|NCT02848326|157927473|FG004|Treatment Period|Adverse Event|5|||
49023883|NCT02848326|157927474|FG005|Treatment Period|Adverse Event|7|||
49023884|NCT02848326|157927469|FG000|Treatment Period|Withdrawal of Consent|20|||
49023885|NCT02848326|157927470|FG001|Treatment Period|Withdrawal of Consent|6|||
49023886|NCT02848326|157927471|FG002|Treatment Period|Withdrawal of Consent|9|||
49023887|NCT02848326|157927472|FG003|Treatment Period|Withdrawal of Consent|6|||
49023888|NCT02848326|157927473|FG004|Treatment Period|Withdrawal of Consent|9|||
48875329|NCT03297398|157381617|FG000|Overall Study|Withdrawal by Subject|1|||
48875330|NCT03297398|157381618|FG001|Overall Study|Withdrawal by Subject|2|||
48875331|NCT03297398|157381619|FG002|Overall Study|Withdrawal by Subject|2|||
48875332|NCT03297398|157381617|FG000|Overall Study|Protocol Violation|0|||
48875333|NCT03297398|157381618|FG001|Overall Study|Protocol Violation|2|||
48875334|NCT03297398|157381619|FG002|Overall Study|Protocol Violation|0|||
48875335|NCT03297398|157381617|FG000|Overall Study|Physician Decision|0|||
49023889|NCT02848326|157927474|FG005|Treatment Period|Withdrawal of Consent|6|||
49023890|NCT02848326|157927469|FG000|Treatment Period|Lost to Follow-up|5|||
49023891|NCT02848326|157927470|FG001|Treatment Period|Lost to Follow-up|1|||
49023892|NCT02848326|157927471|FG002|Treatment Period|Lost to Follow-up|11|||
48688292|NCT01147666|156710010|FG008|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
48688293|NCT01147666|156710011|FG009|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
48688294|NCT01147666|156710012|FG010|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
48688295|NCT01147666|156710013|FG011|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
48688296|NCT01147666|156710014|FG012|Dosing Period 2: 19-Week Treatment|Adverse Event|1|||
48688297|NCT01147666|156710015|FG013|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
48688298|NCT01147666|156710016|FG014|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
48688299|NCT01147666|156710002|FG000|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
48688300|NCT01147666|156710003|FG001|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
48688301|NCT01147666|156710004|FG002|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
48688302|NCT01147666|156710005|FG003|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
48688303|NCT01147666|156710006|FG004|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
48688304|NCT01147666|156710007|FG005|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
48688305|NCT01147666|156710008|FG006|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
48688306|NCT01147666|156710009|FG007|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
48875336|NCT03297398|157381618|FG001|Overall Study|Physician Decision|0|||
48875337|NCT03297398|157381619|FG002|Overall Study|Physician Decision|1|||
48875338|NCT03297398|157381617|FG000|Overall Study|Lost to Follow-up|0|||
48688307|NCT01147666|156710010|FG008|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
48688308|NCT01147666|156710011|FG009|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
48688309|NCT01147666|156710012|FG010|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
48688310|NCT01147666|156710013|FG011|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
48688311|NCT01147666|156710014|FG012|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
48688312|NCT01147666|156710015|FG013|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
48688313|NCT01147666|156710016|FG014|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
48688314|NCT00796666|156710017|FG000|Overall Study|Death|2|||
48688315|NCT00796666|156710018|FG001|Overall Study|Death|4|||
48688316|NCT00796666|156710017|FG000|Overall Study|Withdrawal by Subject|2|||
48688317|NCT00796666|156710018|FG001|Overall Study|Withdrawal by Subject|0|||
48688318|NCT00796666|156710017|FG000|Overall Study|Adverse Event|7|||
48688319|NCT00796666|156710018|FG001|Overall Study|Adverse Event|5|||
48688320|NCT00796666|156710017|FG000|Overall Study|Protocol Violation|1|||
48688321|NCT00796666|156710018|FG001|Overall Study|Protocol Violation|0|||
48688322|NCT00796666|156710017|FG000|Overall Study|Other|1|||
48688323|NCT00796666|156710018|FG001|Overall Study|Other|0|||
48688324|NCT00796666|156710017|FG000|Overall Study|Terminated by sponsor|53|||
48688325|NCT00796666|156710018|FG001|Overall Study|Terminated by sponsor|55|||
48688326|NCT00796666|156710017|FG000|Overall Study|Randomized and not treated|1|||
48688327|NCT00796666|156710018|FG001|Overall Study|Randomized and not treated|0|||
48688328|NCT00117637|156710019|FG000|First Intervention (Period 1)|Adverse Event|11|||
48688329|NCT00117637|156710020|FG001|First Intervention (Period 1)|Adverse Event|16|||
48688330|NCT00117637|156710019|FG000|First Intervention (Period 1)|Lost to Follow-up|0|||
48688331|NCT00117637|156710020|FG001|First Intervention (Period 1)|Lost to Follow-up|2|||
48688332|NCT00117637|156710019|FG000|First Intervention (Period 1)|Protocol Violation|1|||
48763531|NCT00449644|156983908|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
48763532|NCT00449644|156983909|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
48763533|NCT00449644|156983910|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
48763534|NCT00449644|156983911|FG003|Overall Study|Inclusion/exclusion criteria not met|6|||
48763535|NCT00449644|156983908|FG000|Overall Study|Other|1|||
48763536|NCT00449644|156983909|FG001|Overall Study|Other|4|||
48763537|NCT00449644|156983910|FG002|Overall Study|Other|1|||
48763538|NCT00449644|156983911|FG003|Overall Study|Other|0|||
48763539|NCT00449644|156983908|FG000|Overall Study|Rolled-over to treatment with TMC207|0|||
48763540|NCT00449644|156983909|FG001|Overall Study|Rolled-over to treatment with TMC207|0|||
48763541|NCT00449644|156983910|FG002|Overall Study|Rolled-over to treatment with TMC207|0|||
48763542|NCT00449644|156983911|FG003|Overall Study|Rolled-over to treatment with TMC207|1|||
48763543|NCT03608774|156983912|FG000|Overall Study|Lost to Follow-up|5|||
48763544|NCT03608774|156983913|FG001|Overall Study|Lost to Follow-up|5|||
48763545|NCT03608774|156983912|FG000|Overall Study|Withdrawal by Subject|1|||
48763546|NCT03608774|156983913|FG001|Overall Study|Withdrawal by Subject|0|||
48763547|NCT03608774|156983912|FG000|Overall Study|Protocol Violation|1|||
48763548|NCT03608774|156983913|FG001|Overall Study|Protocol Violation|0|||
48763549|NCT03608774|156983912|FG000|Overall Study|Not eligible at enrollment|0|||
48763550|NCT03608774|156983913|FG001|Overall Study|Not eligible at enrollment|1|||
48763551|NCT03608774|156983912|FG000|Overall Study|Health related event|0|||
48763552|NCT03608774|156983913|FG001|Overall Study|Health related event|1|||
48763553|NCT01177540|156983914|FG000|Overall Study|Adverse Event|1|||
48763554|NCT01177540|156983915|FG001|Overall Study|Adverse Event|0|||
48763555|NCT02028988|156983928|FG000|Overall Study|Withdrawal by Subject|2|||
48763556|NCT02680639|156983933|FG000|Screening Period|Screen Failure|7|||
48763557|NCT02680639|156983934|FG001|Screening Period|Screen Failure|0|||
48763558|NCT02680639|156983935|FG002|Screening Period|Screen Failure|0|||
48763559|NCT00451035|156983936|FG000|Overall Study|Disease progression|11|||
48763560|NCT00451035|156983936|FG000|Overall Study|Death|3|||
48763561|NCT00451035|156983936|FG000|Overall Study|New anti-neoplastic therapy|3|||
48763562|NCT01623596|156983937|FG000|Overall Study|Abnormal laboratory values|2|||
48763563|NCT01623596|156983938|FG001|Overall Study|Abnormal laboratory values|0|||
48763564|NCT01623596|156983937|FG000|Overall Study|Administrative problems|9|||
48763565|NCT01623596|156983938|FG001|Overall Study|Administrative problems|13|||
48763566|NCT01623596|156983937|FG000|Overall Study|Adverse Event|20|||
48763567|NCT01623596|156983938|FG001|Overall Study|Adverse Event|29|||
48763568|NCT01623596|156983937|FG000|Overall Study|Death|0|||
48763569|NCT01623596|156983938|FG001|Overall Study|Death|2|||
48763570|NCT01623596|156983937|FG000|Overall Study|Lost to Follow-up|12|||
48763571|NCT01623596|156983938|FG001|Overall Study|Lost to Follow-up|16|||
48763572|NCT01623596|156983937|FG000|Overall Study|Withdrawal by Subject|13|||
48981505|NCT00550615|157764291|FG001|Overall Study|Not evaluable|0|||
48688333|NCT00117637|156710020|FG001|First Intervention (Period 1)|Protocol Violation|0|||
48763573|NCT01623596|156983938|FG001|Overall Study|Withdrawal by Subject|31|||
48763574|NCT01623596|156983937|FG000|Overall Study|Patient no longer requires study drug|1|||
48763575|NCT01623596|156983938|FG001|Overall Study|Patient no longer requires study drug|0|||
48688334|NCT00117637|156710019|FG000|First Intervention (Period 1)|Withdrawal by Subject|2|||
48763576|NCT01623596|156983937|FG000|Overall Study|Protocol Violation|0|||
49023893|NCT02848326|157927472|FG003|Treatment Period|Lost to Follow-up|7|||
49023894|NCT02848326|157927473|FG004|Treatment Period|Lost to Follow-up|2|||
49023895|NCT02848326|157927474|FG005|Treatment Period|Lost to Follow-up|3|||
49023896|NCT02848326|157927469|FG000|Treatment Period|Pregnancy|0|||
49023897|NCT02848326|157927470|FG001|Treatment Period|Pregnancy|0|||
49023898|NCT02848326|157927471|FG002|Treatment Period|Pregnancy|1|||
48688335|NCT00117637|156710020|FG001|First Intervention (Period 1)|Withdrawal by Subject|4|||
48688336|NCT00117637|156710019|FG000|First Intervention (Period 1)|study terminated by the sponsor|3|||
48688337|NCT00117637|156710020|FG001|First Intervention (Period 1)|study terminated by the sponsor|1|||
48688338|NCT00117637|156710019|FG000|First Intervention (Period 1)|protocol driven decision point|1|||
48688339|NCT00117637|156710020|FG001|First Intervention (Period 1)|protocol driven decision point|0|||
48688340|NCT00117637|156710019|FG000|First Intervention (Period 1)|investig. decision, not protocol driven|0|||
48688341|NCT00117637|156710020|FG001|First Intervention (Period 1)|investig. decision, not protocol driven|1|||
48688342|NCT00117637|156710019|FG000|First Intervention (Period 1)|reason not reported|0|||
48688343|NCT00117637|156710020|FG001|First Intervention (Period 1)|reason not reported|1|||
48688344|NCT00117637|156710019|FG000|Second Intervention (Period 2)|Adverse Event|0|||
48688345|NCT00117637|156710020|FG001|Second Intervention (Period 2)|Adverse Event|9|||
48688346|NCT00117637|156710019|FG000|Second Intervention (Period 2)|Lost to Follow-up|1|||
48688347|NCT00117637|156710020|FG001|Second Intervention (Period 2)|Lost to Follow-up|0|||
48688348|NCT00117637|156710019|FG000|Second Intervention (Period 2)|Protocol Violation|1|||
48688349|NCT00117637|156710020|FG001|Second Intervention (Period 2)|Protocol Violation|0|||
48688350|NCT00117637|156710019|FG000|Second Intervention (Period 2)|Withdrawal by Subject|4|||
48688351|NCT00117637|156710020|FG001|Second Intervention (Period 2)|Withdrawal by Subject|3|||
48688352|NCT00117637|156710019|FG000|Second Intervention (Period 2)|study terminated by the sponsor|2|||
48688353|NCT00117637|156710020|FG001|Second Intervention (Period 2)|study terminated by the sponsor|9|||
48688354|NCT00117637|156710019|FG000|Second Intervention (Period 2)|non compliant with study medication|1|||
48688355|NCT00117637|156710020|FG001|Second Intervention (Period 2)|non compliant with study medication|1|||
48688356|NCT00117637|156710019|FG000|Second Intervention (Period 2)|reason not reported|1|||
48688357|NCT00117637|156710020|FG001|Second Intervention (Period 2)|reason not reported|0|||
48688358|NCT02576639|156710021|FG000|Overall Study|Withdrawal by Subject|1|||
48688359|NCT02576639|156710022|FG001|Overall Study|Withdrawal by Subject|2|||
48688360|NCT02576639|156710023|FG002|Overall Study|Withdrawal by Subject|1|||
48688361|NCT02576639|156710024|FG003|Overall Study|Withdrawal by Subject|0|||
48688362|NCT02576639|156710025|FG004|Overall Study|Withdrawal by Subject|1|||
48688363|NCT02576639|156710021|FG000|Overall Study|Adverse Event|1|||
48688364|NCT02576639|156710022|FG001|Overall Study|Adverse Event|0|||
48688365|NCT02576639|156710023|FG002|Overall Study|Adverse Event|1|||
48688366|NCT02576639|156710024|FG003|Overall Study|Adverse Event|1|||
48688367|NCT02576639|156710025|FG004|Overall Study|Adverse Event|2|||
48688368|NCT02576639|156710021|FG000|Overall Study|Physician Decision|0|||
48688369|NCT02576639|156710022|FG001|Overall Study|Physician Decision|0|||
48688370|NCT02576639|156710023|FG002|Overall Study|Physician Decision|0|||
48688371|NCT02576639|156710024|FG003|Overall Study|Physician Decision|0|||
48688372|NCT02576639|156710025|FG004|Overall Study|Physician Decision|1|||
48688373|NCT01020786|156710026|FG000|Induction Period|Entry Criteria Not Met|2|||
48688374|NCT01020786|156710026|FG000|Induction Period|Adverse Event|10|||
48688375|NCT01020786|156710026|FG000|Induction Period|Progressive Disease|31|||
48688376|NCT01020786|156710026|FG000|Induction Period|Investigator Decision|3|||
48688377|NCT01020786|156710026|FG000|Induction Period|Withdrawal by Subject|3|||
48688378|NCT01020786|156710026|FG000|Maintenance Period|Adverse Event|8|||
48688379|NCT01020786|156710026|FG000|Maintenance Period|Progressive Disease|43|||
48688380|NCT01020786|156710026|FG000|Maintenance Period|Withdrawal by Subject|8|||
48688381|NCT01020786|156710026|FG000|Maintenance Period|Sponsor Decision|1|||
48688382|NCT03367858|156710027|FG000|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
48688383|NCT03367858|156710028|FG001|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
49023899|NCT02848326|157927472|FG003|Treatment Period|Pregnancy|1|||
49023900|NCT02848326|157927473|FG004|Treatment Period|Pregnancy|0|||
49023901|NCT02848326|157927474|FG005|Treatment Period|Pregnancy|1|||
49023902|NCT02848326|157927469|FG000|Treatment Period|Protocol Violation|4|||
49023903|NCT02848326|157927470|FG001|Treatment Period|Protocol Violation|3|||
49023904|NCT02848326|157927471|FG002|Treatment Period|Protocol Violation|4|||
49023905|NCT02848326|157927472|FG003|Treatment Period|Protocol Violation|2|||
49023906|NCT02848326|157927473|FG004|Treatment Period|Protocol Violation|3|||
49023907|NCT02848326|157927474|FG005|Treatment Period|Protocol Violation|3|||
48688384|NCT03367858|156710027|FG000|Intervention + Baseline Scan|Withdrawal by Subject|2|||
48688385|NCT03367858|156710028|FG001|Intervention + Baseline Scan|Withdrawal by Subject|0|||
48688386|NCT03367858|156710027|FG000|3 Month Follow Up|Lost to Follow-up|8|||
49023908|NCT02848326|157927469|FG000|Treatment Period|Non-compliance with Study Drug|4|||
49023909|NCT02848326|157927470|FG001|Treatment Period|Non-compliance with Study Drug|0|||
48688387|NCT03367858|156710028|FG001|3 Month Follow Up|Lost to Follow-up|3|||
48763577|NCT01623596|156983938|FG001|Overall Study|Protocol Violation|6|||
49023910|NCT02848326|157927471|FG002|Treatment Period|Non-compliance with Study Drug|0|||
48688388|NCT03367858|156710027|FG000|3 Month Follow Up|Moved out of study area|2|||
48688389|NCT03367858|156710028|FG001|3 Month Follow Up|Moved out of study area|6|||
48688390|NCT03367858|156710027|FG000|3 Month Follow Up|Unable to adhere to session timeline|1|||
48688391|NCT03367858|156710028|FG001|3 Month Follow Up|Unable to adhere to session timeline|3|||
48688392|NCT03367858|156710027|FG000|3 Month Follow Up|MRI contraindication|2|||
48688393|NCT03367858|156710028|FG001|3 Month Follow Up|MRI contraindication|1|||
48688394|NCT03367858|156710027|FG000|3 Month Follow Up|Incarcerated|0|||
48688395|NCT03367858|156710028|FG001|3 Month Follow Up|Incarcerated|1|||
48688396|NCT03367858|156710027|FG000|3 Month Follow Up|Withdrawal by Subject|3|||
48688397|NCT03367858|156710028|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
48688398|NCT03367858|156710027|FG000|6 Month Follow Up|Lost to Follow-up|5|||
48688399|NCT03367858|156710028|FG001|6 Month Follow Up|Lost to Follow-up|2|||
48688400|NCT03367858|156710027|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
48688401|NCT03367858|156710028|FG001|6 Month Follow Up|Withdrawal by Subject|1|||
48688402|NCT03367858|156710027|FG000|12 Month Follow Up|Lost to Follow-up|3|||
48688403|NCT03367858|156710028|FG001|12 Month Follow Up|Lost to Follow-up|3|||
48688404|NCT03367858|156710027|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
48688405|NCT03367858|156710028|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
48688406|NCT00088530|156710029|FG000|Overall Study|Progressive/Relapsed Disease|28|||
48688407|NCT00088530|156710030|FG001|Overall Study|Progressive/Relapsed Disease|39|||
48763578|NCT01623596|156983937|FG000|Overall Study|Lack of Efficacy|5|||
48763579|NCT01623596|156983938|FG001|Overall Study|Lack of Efficacy|3|||
48763580|NCT01070316|156983942|FG000|Extension Phase|Lack of Efficacy|3|||
49023911|NCT02848326|157927472|FG003|Treatment Period|Non-compliance with Study Drug|1|||
49023912|NCT02848326|157927473|FG004|Treatment Period|Non-compliance with Study Drug|0|||
49023913|NCT02848326|157927474|FG005|Treatment Period|Non-compliance with Study Drug|0|||
49023914|NCT02848326|157927469|FG000|Safety Follow-up Period|Withdrawal of Consent|0|||
49023915|NCT02848326|157927470|FG001|Safety Follow-up Period|Withdrawal of Consent|1|||
48763581|NCT01070316|156983942|FG000|Extension Phase|Withdrawal by Subject|1|||
48763582|NCT04151290|156983950|FG000|Overall Study|The COVID-19 Pandemic made it hard for subjects to complete the study.|286|||
48763583|NCT01524627|156983951|FG000|Overall Study|Physician Decision|0|||
48763584|NCT01524627|156983952|FG001|Overall Study|Physician Decision|1|||
48875339|NCT03297398|157381618|FG001|Overall Study|Lost to Follow-up|0|||
48875340|NCT03297398|157381619|FG002|Overall Study|Lost to Follow-up|1|||
48875341|NCT00236184|157381620|FG000|Overall Study|Adverse Event|5|||
48875342|NCT00236184|157381621|FG001|Overall Study|Adverse Event|2|||
48875343|NCT00236184|157381620|FG000|Overall Study|Lack of Efficacy|0|||
48875344|NCT00236184|157381621|FG001|Overall Study|Lack of Efficacy|1|||
48875345|NCT00236184|157381620|FG000|Overall Study|Lost to Follow-up|3|||
49023916|NCT02848326|157927471|FG002|Safety Follow-up Period|Withdrawal of Consent|1|||
49023917|NCT02848326|157927472|FG003|Safety Follow-up Period|Withdrawal of Consent|0|||
49023918|NCT02848326|157927473|FG004|Safety Follow-up Period|Withdrawal of Consent|0|||
49023919|NCT02848326|157927474|FG005|Safety Follow-up Period|Withdrawal of Consent|2|||
49023920|NCT02848326|157927469|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
49023921|NCT02848326|157927470|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
49023922|NCT02848326|157927471|FG002|Safety Follow-up Period|Lost to Follow-up|2|||
49023923|NCT02848326|157927472|FG003|Safety Follow-up Period|Lost to Follow-up|0|||
49023924|NCT02848326|157927473|FG004|Safety Follow-up Period|Lost to Follow-up|1|||
49023925|NCT02848326|157927474|FG005|Safety Follow-up Period|Lost to Follow-up|3|||
49023926|NCT04473963|157927476|FG000|Overall Study|Withdrawal by Subject|1|||
49023927|NCT04473963|157927477|FG001|Overall Study|Withdrawal by Subject|1|||
49023928|NCT04473963|157927478|FG002|Overall Study|Withdrawal by Subject|0|||
49023929|NCT04473963|157927476|FG000|Overall Study|Not inducible in AF|0|||
49023930|NCT04473963|157927477|FG001|Overall Study|Not inducible in AF|0|||
49023931|NCT04473963|157927478|FG002|Overall Study|Not inducible in AF|2|||
49023932|NCT03093324|157927479|FG000|Overall Study|Adverse Event|4|||
49023933|NCT03093324|157927480|FG001|Overall Study|Adverse Event|15|||
49023934|NCT03093324|157927479|FG000|Overall Study|Lost to Follow-up|1|||
49023935|NCT03093324|157927480|FG001|Overall Study|Lost to Follow-up|0|||
49023936|NCT03093324|157927479|FG000|Overall Study|Protocol Deviation|2|||
49023937|NCT03093324|157927480|FG001|Overall Study|Protocol Deviation|2|||
49023938|NCT03093324|157927479|FG000|Overall Study|Withdrawal by Subject|2|||
49023939|NCT03093324|157927480|FG001|Overall Study|Withdrawal by Subject|2|||
49023940|NCT00414466|157927481|FG000|Overall Study|Adverse Event|0|||
49023941|NCT00414466|157927482|FG001|Overall Study|Adverse Event|0|||
49023942|NCT00414466|157927483|FG002|Overall Study|Adverse Event|1|||
49023943|NCT00414466|157927484|FG003|Overall Study|Adverse Event|1|||
49023944|NCT00414466|157927481|FG000|Overall Study|Lack of Efficacy|1|||
48688408|NCT00088530|156710029|FG000|Overall Study|Adverse Event|15|||
48688409|NCT00088530|156710030|FG001|Overall Study|Adverse Event|9|||
48875346|NCT00236184|157381621|FG001|Overall Study|Lost to Follow-up|4|||
48688410|NCT00088530|156710029|FG000|Overall Study|Withdrawal by Subject|2|||
48688411|NCT00088530|156710030|FG001|Overall Study|Withdrawal by Subject|5|||
49023945|NCT00414466|157927482|FG001|Overall Study|Lack of Efficacy|0|||
49023946|NCT00414466|157927483|FG002|Overall Study|Lack of Efficacy|0|||
49023947|NCT00414466|157927484|FG003|Overall Study|Lack of Efficacy|0|||
48688412|NCT00088530|156710029|FG000|Overall Study|Lost to Follow-up|2|||
48688413|NCT00088530|156710030|FG001|Overall Study|Lost to Follow-up|0|||
48688414|NCT00088530|156710029|FG000|Overall Study|Physician Decision|2|||
48688415|NCT00088530|156710030|FG001|Overall Study|Physician Decision|0|||
48688416|NCT00088530|156710029|FG000|Overall Study|Sponsor decision|0|||
48688417|NCT00088530|156710030|FG001|Overall Study|Sponsor decision|1|||
48688418|NCT00088530|156710029|FG000|Overall Study|Patient never treated|1|||
48688419|NCT00088530|156710030|FG001|Overall Study|Patient never treated|0|||
48688420|NCT01508169|156710031|FG000|Overall Study|Adverse Event|1|||
48688421|NCT01508169|156710032|FG001|Overall Study|Adverse Event|0|||
48688422|NCT01508169|156710031|FG000|Overall Study|Withdrawal by Subject|1|||
48688423|NCT01508169|156710032|FG001|Overall Study|Withdrawal by Subject|0|||
48688424|NCT01508169|156710031|FG000|Overall Study|Lost to Follow-up|1|||
48688425|NCT01508169|156710032|FG001|Overall Study|Lost to Follow-up|2|||
48688426|NCT02336607|156710037|FG000|Overall Study|Physician Decision|1|||
48688427|NCT02336607|156710038|FG001|Overall Study|Physician Decision|4|||
48688428|NCT02336607|156710039|FG002|Overall Study|Physician Decision|3|||
48688429|NCT02336607|156710040|FG003|Overall Study|Physician Decision|15|||
48688430|NCT02336607|156710037|FG000|Overall Study|Lack of Efficacy|1|||
48688431|NCT02336607|156710038|FG001|Overall Study|Lack of Efficacy|0|||
48688432|NCT02336607|156710039|FG002|Overall Study|Lack of Efficacy|0|||
48688433|NCT02336607|156710040|FG003|Overall Study|Lack of Efficacy|2|||
48688434|NCT02336607|156710037|FG000|Overall Study|Lost to Follow-up|2|||
48688435|NCT02336607|156710038|FG001|Overall Study|Lost to Follow-up|1|||
48688436|NCT02336607|156710039|FG002|Overall Study|Lost to Follow-up|0|||
48688437|NCT02336607|156710040|FG003|Overall Study|Lost to Follow-up|21|||
48688438|NCT02336607|156710037|FG000|Overall Study|Protocol Violation|0|||
48688439|NCT02336607|156710038|FG001|Overall Study|Protocol Violation|1|||
48688440|NCT02336607|156710039|FG002|Overall Study|Protocol Violation|1|||
48688441|NCT02336607|156710040|FG003|Overall Study|Protocol Violation|3|||
48688442|NCT02336607|156710037|FG000|Overall Study|Adverse Event|0|||
48763585|NCT01524627|156983951|FG000|Overall Study|Lost to Follow-up|1|||
48763586|NCT01524627|156983952|FG001|Overall Study|Lost to Follow-up|1|||
48763587|NCT01449526|156983953|FG000|Overall Study|Lost to Follow-up|1|||
49023948|NCT00414466|157927481|FG000|Overall Study|Withdrawn by Sponsor|1|||
49023949|NCT00414466|157927482|FG001|Overall Study|Withdrawn by Sponsor|0|||
49023950|NCT00414466|157927483|FG002|Overall Study|Withdrawn by Sponsor|0|||
49023951|NCT00414466|157927484|FG003|Overall Study|Withdrawn by Sponsor|0|||
49023952|NCT04526210|157927485|FG000|Overall Study|Sponsor decision|7|||
49023953|NCT04526210|157927486|FG001|Overall Study|Sponsor decision|5|||
49023954|NCT04526210|157927485|FG000|Overall Study|Withdrawal by Subject|3|||
49023955|NCT04526210|157927486|FG001|Overall Study|Withdrawal by Subject|2|||
49023956|NCT02999178|157927487|FG000|Overall Study|Adverse Event|85|||
49023957|NCT02999178|157927488|FG001|Overall Study|Adverse Event|62|||
48688443|NCT02336607|156710038|FG001|Overall Study|Adverse Event|2|||
48688444|NCT02336607|156710039|FG002|Overall Study|Adverse Event|2|||
48688445|NCT02336607|156710040|FG003|Overall Study|Adverse Event|26|||
48688446|NCT02336607|156710037|FG000|Overall Study|Withdrawal by Subject|0|||
48688447|NCT02336607|156710038|FG001|Overall Study|Withdrawal by Subject|2|||
48688448|NCT02336607|156710039|FG002|Overall Study|Withdrawal by Subject|0|||
48688449|NCT02336607|156710040|FG003|Overall Study|Withdrawal by Subject|20|||
48688450|NCT00430716|156710048|FG000|Double Blind Phase|Death|1|||
48688451|NCT00430716|156710049|FG001|Double Blind Phase|Death|0|||
48688452|NCT00430716|156710050|FG002|Double Blind Phase|Death|0|||
48688453|NCT00430716|156710048|FG000|Double Blind Phase|No longer willing to participate|2|||
48688454|NCT00430716|156710049|FG001|Double Blind Phase|No longer willing to participate|1|||
48688455|NCT00430716|156710050|FG002|Double Blind Phase|No longer willing to participate|1|||
48688456|NCT00430716|156710048|FG000|Double Blind Phase|Other|0|||
48688457|NCT00430716|156710049|FG001|Double Blind Phase|Other|2|||
48688458|NCT00430716|156710050|FG002|Double Blind Phase|Other|0|||
48688459|NCT00430716|156710048|FG000|Double Blind Phase|Study terminated by sponsor|1|||
48688460|NCT00430716|156710049|FG001|Double Blind Phase|Study terminated by sponsor|1|||
48688461|NCT00430716|156710050|FG002|Double Blind Phase|Study terminated by sponsor|2|||
48688462|NCT00430716|156710048|FG000|Double Blind Phase|Adverse Event|1|||
48688463|NCT00430716|156710049|FG001|Double Blind Phase|Adverse Event|1|||
48763588|NCT01449526|156983954|FG001|Overall Study|Lost to Follow-up|2|||
48763589|NCT01449526|156983953|FG000|Overall Study|Withdrawal by Subject|1|||
49023958|NCT02999178|157927487|FG000|Overall Study|Protocol Violation|1|||
49023959|NCT02999178|157927488|FG001|Overall Study|Protocol Violation|2|||
49023960|NCT02999178|157927487|FG000|Overall Study|Lost to Follow-up|0|||
48688464|NCT00430716|156710050|FG002|Double Blind Phase|Adverse Event|3|||
48688465|NCT00430716|156710048|FG000|Double Blind Phase|Not treated|1|||
48688466|NCT00430716|156710049|FG001|Double Blind Phase|Not treated|0|||
48688467|NCT00430716|156710050|FG002|Double Blind Phase|Not treated|0|||
48688468|NCT00430716|156710048|FG000|Open Label Phase|Lost to Follow-up|1|||
48688469|NCT00430716|156710049|FG001|Open Label Phase|Lost to Follow-up|0|||
48688470|NCT00430716|156710050|FG002|Open Label Phase|Lost to Follow-up|1|||
49023961|NCT02999178|157927488|FG001|Overall Study|Lost to Follow-up|2|||
48688471|NCT00430716|156710048|FG000|Open Label Phase|No longer willing to participate|0|||
48688472|NCT00430716|156710049|FG001|Open Label Phase|No longer willing to participate|1|||
48688473|NCT00430716|156710050|FG002|Open Label Phase|No longer willing to participate|1|||
48688474|NCT00430716|156710048|FG000|Open Label Phase|Other|3|||
48688475|NCT00430716|156710049|FG001|Open Label Phase|Other|1|||
48688476|NCT00430716|156710050|FG002|Open Label Phase|Other|1|||
48688477|NCT00430716|156710048|FG000|Open Label Phase|Protocol Violation|1|||
48688478|NCT00430716|156710049|FG001|Open Label Phase|Protocol Violation|0|||
48688479|NCT00430716|156710050|FG002|Open Label Phase|Protocol Violation|0|||
48688480|NCT00430716|156710048|FG000|Open Label Phase|Study terminated by sponsor|4|||
48688481|NCT00430716|156710049|FG001|Open Label Phase|Study terminated by sponsor|5|||
48688482|NCT00430716|156710050|FG002|Open Label Phase|Study terminated by sponsor|4|||
48688483|NCT01384734|156710056|FG000|Overall Study|Adverse Event|0|||
48688484|NCT01384734|156710057|FG001|Overall Study|Adverse Event|3|||
48688485|NCT01384734|156710058|FG002|Overall Study|Adverse Event|0|||
48688486|NCT01384734|156710059|FG003|Overall Study|Adverse Event|2|||
49023962|NCT02999178|157927487|FG000|Overall Study|Withdrawal by Subject|21|||
49023963|NCT02999178|157927488|FG001|Overall Study|Withdrawal by Subject|21|||
49023964|NCT02999178|157927487|FG000|Overall Study|Other reason not defined above|7|||
49023965|NCT02999178|157927488|FG001|Overall Study|Other reason not defined above|13|||
49023966|NCT01179048|157927490|FG000|Overall Study|Withdrawn - does not allow contact|4|||
49023967|NCT01179048|157927491|FG001|Overall Study|Withdrawn - does not allow contact|8|||
49023968|NCT01179048|157927490|FG000|Overall Study|Lost to Follow-up|8|||
49023969|NCT01179048|157927491|FG001|Overall Study|Lost to Follow-up|9|||
49023970|NCT01179048|157927490|FG000|Overall Study|Alive|127|||
49023971|NCT01179048|157927491|FG001|Overall Study|Alive|142|||
49023972|NCT01626079|157927493|FG000|Overall Study|Death|167|||
49023973|NCT01626079|157927494|FG001|Overall Study|Death|192|||
49023974|NCT01626079|157927495|FG002|Overall Study|Death|39|||
49023975|NCT01626079|157927493|FG000|Overall Study|Withdrawal by Subject|23|||
49023976|NCT01626079|157927494|FG001|Overall Study|Withdrawal by Subject|37|||
49023977|NCT01626079|157927495|FG002|Overall Study|Withdrawal by Subject|5|||
49023978|NCT01626079|157927493|FG000|Overall Study|Lost to Follow-up|7|||
49023979|NCT01626079|157927494|FG001|Overall Study|Lost to Follow-up|4|||
49023980|NCT01626079|157927495|FG002|Overall Study|Lost to Follow-up|2|||
49023981|NCT01626079|157927493|FG000|Overall Study|Missed Visits|1|||
49023982|NCT01626079|157927494|FG001|Overall Study|Missed Visits|4|||
49023983|NCT01626079|157927495|FG002|Overall Study|Missed Visits|6|||
49023984|NCT03364647|157927497|FG000|Overall Study|Withdrawal by Subject|3|||
49023985|NCT03364647|157927498|FG001|Overall Study|Withdrawal by Subject|1|||
49023986|NCT00320112|157927499|FG000|Overall Study|Lost to Follow-up|3|||
49023987|NCT00320112|157927500|FG001|Overall Study|Lost to Follow-up|4|||
49023988|NCT00320112|157927499|FG000|Overall Study|Withdrawal by Subject|3|||
49023989|NCT00320112|157927500|FG001|Overall Study|Withdrawal by Subject|0|||
49023990|NCT00320112|157927499|FG000|Overall Study|Death|2|||
49023991|NCT00320112|157927500|FG001|Overall Study|Death|1|||
49023992|NCT00569374|157927501|FG000|Overall Study|Withdrawal by Subject|4|||
49023993|NCT02899338|157927505|FG000|Overall Study|Adverse Event|1|||
49023994|NCT02899338|157927506|FG001|Overall Study|Adverse Event|2|||
49023995|NCT02899338|157927505|FG000|Overall Study|Withdrawal by Subject|2|||
49023996|NCT02899338|157927506|FG001|Overall Study|Withdrawal by Subject|0|||
49023997|NCT04292223|157927507|FG000|Overall Study|Adverse Event|1|||
49023998|NCT04292223|157927507|FG000|Overall Study|Lost to Follow-up|1|||
49023999|NCT04292223|157927507|FG000|Overall Study|Noncompliance with study drug|2|||
49024000|NCT04292223|157927507|FG000|Overall Study|Patient moved out of the state|1|||
49024001|NCT04719390|157927508|FG000|Overall Study|Withdrawal by Subject|1|||
49024002|NCT00814463|157927510|FG000|Overall Study|Lost to Follow-up|1|||
49024003|NCT03023410|157927511|FG000|Overall Study|study termination|0|||
49024004|NCT03023410|157927512|FG001|Overall Study|study termination|1|||
49024005|NCT01370408|157927513|FG000|Overall Study|treatment failure|9|||
48688487|NCT01384734|156710060|FG004|Overall Study|Adverse Event|7|||
48688488|NCT01384734|156710056|FG000|Overall Study|Death|1|||
48688489|NCT01384734|156710057|FG001|Overall Study|Death|0|||
48688490|NCT01384734|156710058|FG002|Overall Study|Death|1|||
48688491|NCT01384734|156710059|FG003|Overall Study|Death|0|||
48688492|NCT01384734|156710060|FG004|Overall Study|Death|0|||
49024006|NCT01434693|157927514|FG000|Overall Study|Adverse Event|1|||
49024007|NCT01434693|157927515|FG001|Overall Study|Adverse Event|0|||
49024008|NCT01434693|157927516|FG002|Overall Study|Adverse Event|0|||
49024009|NCT01434693|157927517|FG003|Overall Study|Adverse Event|0|||
49024010|NCT01434693|157927514|FG000|Overall Study|Withdrawal by Subject|1|||
49024011|NCT01434693|157927515|FG001|Overall Study|Withdrawal by Subject|0|||
49024012|NCT01434693|157927516|FG002|Overall Study|Withdrawal by Subject|1|||
49024013|NCT01434693|157927517|FG003|Overall Study|Withdrawal by Subject|1|||
48688493|NCT01384734|156710056|FG000|Overall Study|Continuation criteria not met|0|||
48688494|NCT01384734|156710057|FG001|Overall Study|Continuation criteria not met|0|||
49024014|NCT01434693|157927514|FG000|Overall Study|Lost to Follow-up|1|||
49024015|NCT01434693|157927515|FG001|Overall Study|Lost to Follow-up|0|||
49024016|NCT01434693|157927516|FG002|Overall Study|Lost to Follow-up|0|||
49024017|NCT01434693|157927517|FG003|Overall Study|Lost to Follow-up|0|||
48688495|NCT01384734|156710058|FG002|Overall Study|Continuation criteria not met|1|||
48688496|NCT01384734|156710059|FG003|Overall Study|Continuation criteria not met|1|||
48688497|NCT01384734|156710060|FG004|Overall Study|Continuation criteria not met|0|||
48688498|NCT01384734|156710056|FG000|Overall Study|Lack of Efficacy|3|||
48688499|NCT01384734|156710057|FG001|Overall Study|Lack of Efficacy|7|||
48688500|NCT01384734|156710058|FG002|Overall Study|Lack of Efficacy|4|||
48688501|NCT01384734|156710059|FG003|Overall Study|Lack of Efficacy|4|||
48688502|NCT01384734|156710060|FG004|Overall Study|Lack of Efficacy|2|||
48688503|NCT01384734|156710056|FG000|Overall Study|Lost to Follow-up|5|||
48688504|NCT01384734|156710057|FG001|Overall Study|Lost to Follow-up|3|||
48688505|NCT01384734|156710058|FG002|Overall Study|Lost to Follow-up|3|||
48688506|NCT01384734|156710059|FG003|Overall Study|Lost to Follow-up|8|||
48688507|NCT01384734|156710060|FG004|Overall Study|Lost to Follow-up|5|||
48688508|NCT01384734|156710056|FG000|Overall Study|Non-compliance with study drug|1|||
49024018|NCT00854308|157927521|FG000|Overall Study|Disease progression|42|||
49024019|NCT00854308|157927522|FG001|Overall Study|Disease progression|50|||
49024020|NCT00854308|157927521|FG000|Overall Study|Adverse Event|8|||
48688509|NCT01384734|156710057|FG001|Overall Study|Non-compliance with study drug|2|||
48688510|NCT01384734|156710058|FG002|Overall Study|Non-compliance with study drug|6|||
48688511|NCT01384734|156710059|FG003|Overall Study|Non-compliance with study drug|0|||
48688512|NCT01384734|156710060|FG004|Overall Study|Non-compliance with study drug|2|||
48688513|NCT01384734|156710056|FG000|Overall Study|Pregnancy|0|||
48688514|NCT01384734|156710057|FG001|Overall Study|Pregnancy|1|||
48688515|NCT01384734|156710058|FG002|Overall Study|Pregnancy|0|||
48688516|NCT01384734|156710059|FG003|Overall Study|Pregnancy|0|||
48688517|NCT01384734|156710060|FG004|Overall Study|Pregnancy|1|||
48688518|NCT01384734|156710056|FG000|Overall Study|Sponsor terminated|0|||
48688519|NCT01384734|156710057|FG001|Overall Study|Sponsor terminated|0|||
48688520|NCT01384734|156710058|FG002|Overall Study|Sponsor terminated|0|||
48688521|NCT01384734|156710059|FG003|Overall Study|Sponsor terminated|0|||
48688522|NCT01384734|156710060|FG004|Overall Study|Sponsor terminated|1|||
48688523|NCT01384734|156710056|FG000|Overall Study|Withdrawal by Subject|5|||
48688524|NCT01384734|156710057|FG001|Overall Study|Withdrawal by Subject|5|||
48688525|NCT01384734|156710058|FG002|Overall Study|Withdrawal by Subject|6|||
48688526|NCT01384734|156710059|FG003|Overall Study|Withdrawal by Subject|7|||
48688527|NCT01384734|156710060|FG004|Overall Study|Withdrawal by Subject|9|||
48688528|NCT01384734|156710056|FG000|Overall Study|Investigator relocating|0|||
48688529|NCT01384734|156710057|FG001|Overall Study|Investigator relocating|2|||
48688530|NCT01384734|156710058|FG002|Overall Study|Investigator relocating|0|||
48688531|NCT01384734|156710059|FG003|Overall Study|Investigator relocating|3|||
48688532|NCT01384734|156710060|FG004|Overall Study|Investigator relocating|1|||
48688533|NCT01384734|156710056|FG000|Overall Study|Unable to come back for visit|1|||
48688534|NCT01384734|156710057|FG001|Overall Study|Unable to come back for visit|0|||
48688535|NCT01384734|156710058|FG002|Overall Study|Unable to come back for visit|1|||
48688536|NCT01384734|156710059|FG003|Overall Study|Unable to come back for visit|1|||
48688537|NCT01384734|156710060|FG004|Overall Study|Unable to come back for visit|0|||
48688538|NCT01384734|156710056|FG000|Overall Study|Prison|0|||
48688539|NCT01384734|156710057|FG001|Overall Study|Prison|0|||
48688540|NCT01384734|156710058|FG002|Overall Study|Prison|1|||
48688541|NCT01384734|156710059|FG003|Overall Study|Prison|0|||
48688542|NCT01384734|156710060|FG004|Overall Study|Prison|0|||
48688543|NCT01384734|156710056|FG000|Overall Study|As per Exclusion criteria|0|||
48688544|NCT01384734|156710057|FG001|Overall Study|As per Exclusion criteria|1|||
48688545|NCT01384734|156710058|FG002|Overall Study|As per Exclusion criteria|0|||
48688546|NCT01384734|156710059|FG003|Overall Study|As per Exclusion criteria|0|||
48688547|NCT01384734|156710060|FG004|Overall Study|As per Exclusion criteria|0|||
48688548|NCT01384734|156710056|FG000|Overall Study|Missed End of treatment visit|0|||
48688549|NCT01384734|156710057|FG001|Overall Study|Missed End of treatment visit|0|||
49024021|NCT00854308|157927522|FG001|Overall Study|Adverse Event|3|||
49024022|NCT00854308|157927521|FG000|Overall Study|Death|2|||
49024023|NCT00854308|157927522|FG001|Overall Study|Death|5|||
49024024|NCT00854308|157927521|FG000|Overall Study|Physician Decision|6|||
48688550|NCT01384734|156710058|FG002|Overall Study|Missed End of treatment visit|0|||
48688551|NCT01384734|156710059|FG003|Overall Study|Missed End of treatment visit|1|||
48688552|NCT01384734|156710060|FG004|Overall Study|Missed End of treatment visit|0|||
48688553|NCT01384734|156710056|FG000|Overall Study|Adhesion problem|0|||
48688554|NCT01384734|156710057|FG001|Overall Study|Adhesion problem|0|||
48688555|NCT01384734|156710058|FG002|Overall Study|Adhesion problem|0|||
48688556|NCT01384734|156710059|FG003|Overall Study|Adhesion problem|1|||
48688557|NCT01384734|156710060|FG004|Overall Study|Adhesion problem|0|||
48688558|NCT01384734|156710056|FG000|Overall Study|Early termination|0|||
48688559|NCT01384734|156710057|FG001|Overall Study|Early termination|0|||
48688560|NCT01384734|156710058|FG002|Overall Study|Early termination|0|||
48688561|NCT01384734|156710059|FG003|Overall Study|Early termination|0|||
48688562|NCT01384734|156710060|FG004|Overall Study|Early termination|1|||
48688563|NCT01384734|156710056|FG000|Overall Study|Physician Decision|1|||
48688564|NCT01384734|156710057|FG001|Overall Study|Physician Decision|0|||
49024025|NCT00854308|157927522|FG001|Overall Study|Physician Decision|6|||
48688565|NCT01384734|156710058|FG002|Overall Study|Physician Decision|0|||
48688566|NCT01384734|156710059|FG003|Overall Study|Physician Decision|0|||
48688567|NCT01384734|156710060|FG004|Overall Study|Physician Decision|0|||
48688568|NCT00795535|156710061|FG000|Overall Study|incomplete data and technical problems|20|||
48688569|NCT01787461|156710071|FG000|Overall Study|Adverse Event|4|||
48688570|NCT01787461|156710072|FG001|Overall Study|Adverse Event|3|||
48688571|NCT01787461|156710071|FG000|Overall Study|Lost to Follow-up|3|||
48688572|NCT01787461|156710072|FG001|Overall Study|Lost to Follow-up|2|||
48688573|NCT01787461|156710071|FG000|Overall Study|No longer met eligibility criteria|1|||
48688574|NCT01787461|156710072|FG001|Overall Study|No longer met eligibility criteria|0|||
48688575|NCT01787461|156710071|FG000|Overall Study|Withdrawal by Subject|3|||
48688576|NCT01787461|156710072|FG001|Overall Study|Withdrawal by Subject|4|||
48688577|NCT01787461|156710071|FG000|Overall Study|Protocol Violation|3|||
48688578|NCT01787461|156710072|FG001|Overall Study|Protocol Violation|0|||
48688579|NCT00360412|156710078|FG000|Overall Study|Adverse Event|37|||
48688580|NCT00360412|156710079|FG001|Overall Study|Adverse Event|65|||
48688581|NCT00360412|156710078|FG000|Overall Study|Protocol Violation|2|||
48688582|NCT00360412|156710079|FG001|Overall Study|Protocol Violation|5|||
48688583|NCT00360412|156710078|FG000|Overall Study|Patient withdrew consent|27|||
48688584|NCT00360412|156710079|FG001|Overall Study|Patient withdrew consent|52|||
48688585|NCT00360412|156710078|FG000|Overall Study|Lack of therapeutic efficacy|46|||
48688586|NCT00360412|156710079|FG001|Overall Study|Lack of therapeutic efficacy|61|||
48688587|NCT00360412|156710078|FG000|Overall Study|Physician Decision|2|||
48688588|NCT00360412|156710079|FG001|Overall Study|Physician Decision|4|||
48688589|NCT00360412|156710078|FG000|Overall Study|Other|5|||
48688590|NCT00360412|156710079|FG001|Overall Study|Other|6|||
48688591|NCT00360412|156710078|FG000|Overall Study|Study termination by Sponsor|214|||
48688592|NCT00360412|156710079|FG001|Overall Study|Study termination by Sponsor|469|||
48688593|NCT00999544|156711591|FG000|Overall Study|Withdrawal by Subject|1|||
48688594|NCT02813889|156711606|FG000|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|7|||
48688595|NCT02813889|156711607|FG001|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|0|||
48688596|NCT04737278|156711609|FG000|Overall Study|Lost to Follow-up|1|||
48688597|NCT04737278|156711610|FG001|Overall Study|Lost to Follow-up|1|||
48688598|NCT04737278|156711609|FG000|Overall Study|Withdrawal by Subject|1|||
48688599|NCT04737278|156711610|FG001|Overall Study|Withdrawal by Subject|0|||
48688600|NCT04737278|156711609|FG000|Overall Study|Protocol Violation|1|||
48688601|NCT04737278|156711610|FG001|Overall Study|Protocol Violation|1|||
48688602|NCT04737278|156711609|FG000|Overall Study|failure to complete questionnaire|1|||
48688603|NCT04737278|156711610|FG001|Overall Study|failure to complete questionnaire|1|||
48688604|NCT03951077|156711611|FG000|Overall Study|Adverse Event|1|||
48688605|NCT03951077|156711612|FG001|Overall Study|Adverse Event|0|||
48688606|NCT03951077|156711613|FG002|Overall Study|Adverse Event|0|||
48688607|NCT03951077|156711614|FG003|Overall Study|Adverse Event|0|||
48688608|NCT03951077|156711615|FG004|Overall Study|Adverse Event|0|||
48688609|NCT03951077|156711616|FG005|Overall Study|Adverse Event|0|||
48688610|NCT03951077|156711611|FG000|Overall Study|Withdrawal by Subject|3|||
48688611|NCT03951077|156711612|FG001|Overall Study|Withdrawal by Subject|3|||
48688612|NCT03951077|156711613|FG002|Overall Study|Withdrawal by Subject|0|||
48688613|NCT03951077|156711614|FG003|Overall Study|Withdrawal by Subject|3|||
48688614|NCT03951077|156711615|FG004|Overall Study|Withdrawal by Subject|3|||
48688615|NCT03951077|156711616|FG005|Overall Study|Withdrawal by Subject|2|||
48688616|NCT03951077|156711611|FG000|Overall Study|Lost to Follow-up|1|||
48688617|NCT03951077|156711612|FG001|Overall Study|Lost to Follow-up|1|||
48688618|NCT03951077|156711613|FG002|Overall Study|Lost to Follow-up|2|||
48688619|NCT03951077|156711614|FG003|Overall Study|Lost to Follow-up|3|||
48688620|NCT03951077|156711615|FG004|Overall Study|Lost to Follow-up|2|||
48688621|NCT03951077|156711616|FG005|Overall Study|Lost to Follow-up|3|||
48688622|NCT03951077|156711611|FG000|Overall Study|Non-Compliance With Study Procedures|0|||
48688623|NCT03951077|156711612|FG001|Overall Study|Non-Compliance With Study Procedures|0|||
48688624|NCT03951077|156711613|FG002|Overall Study|Non-Compliance With Study Procedures|0|||
48688625|NCT03951077|156711614|FG003|Overall Study|Non-Compliance With Study Procedures|0|||
48688626|NCT03951077|156711615|FG004|Overall Study|Non-Compliance With Study Procedures|1|||
48688627|NCT03951077|156711616|FG005|Overall Study|Non-Compliance With Study Procedures|0|||
48688628|NCT03951077|156711611|FG000|Overall Study|Other, Not Specified|12|||
48763590|NCT01449526|156983954|FG001|Overall Study|Withdrawal by Subject|1|||
48763591|NCT01449526|156983953|FG000|Overall Study|Symptoms/complaints|0|||
48688629|NCT03951077|156711612|FG001|Overall Study|Other, Not Specified|10|||
48688630|NCT03951077|156711613|FG002|Overall Study|Other, Not Specified|10|||
48688631|NCT03951077|156711614|FG003|Overall Study|Other, Not Specified|5|||
48688632|NCT03951077|156711615|FG004|Overall Study|Other, Not Specified|9|||
48688633|NCT03951077|156711616|FG005|Overall Study|Other, Not Specified|6|||
48688634|NCT03951077|156711611|FG000|Overall Study|Did Not Receive Any Study Drug|1|||
48688635|NCT03951077|156711612|FG001|Overall Study|Did Not Receive Any Study Drug|0|||
48688636|NCT03951077|156711613|FG002|Overall Study|Did Not Receive Any Study Drug|1|||
48688637|NCT03951077|156711614|FG003|Overall Study|Did Not Receive Any Study Drug|1|||
48688638|NCT03951077|156711615|FG004|Overall Study|Did Not Receive Any Study Drug|1|||
48688639|NCT03951077|156711616|FG005|Overall Study|Did Not Receive Any Study Drug|0|||
48688640|NCT00743249|156711617|FG000|Overall Study|Adverse Event|0|||
48688641|NCT00743249|156711618|FG001|Overall Study|Adverse Event|4|||
48688642|NCT00743249|156711617|FG000|Overall Study|Patient Decision Unrelated to Ad Event|0|||
48688643|NCT00743249|156711618|FG001|Overall Study|Patient Decision Unrelated to Ad Event|1|||
48688644|NCT00743249|156711617|FG000|Overall Study|Unsuccessful insertion of stent|2|||
48688645|NCT00743249|156711618|FG001|Overall Study|Unsuccessful insertion of stent|1|||
48688646|NCT00965081|156711619|FG000|Overall Study|Adverse Event|14|||
48688647|NCT00965081|156711620|FG001|Overall Study|Adverse Event|9|||
48688648|NCT00965081|156711619|FG000|Overall Study|Lack of Efficacy|2|||
48688649|NCT00965081|156711620|FG001|Overall Study|Lack of Efficacy|5|||
48688650|NCT00965081|156711619|FG000|Overall Study|Lost to Follow-up|4|||
48688651|NCT00965081|156711620|FG001|Overall Study|Lost to Follow-up|5|||
48688652|NCT00965081|156711619|FG000|Overall Study|Physician Decision|2|||
48688653|NCT00965081|156711620|FG001|Overall Study|Physician Decision|0|||
48688654|NCT00965081|156711619|FG000|Overall Study|Protocol Violation|2|||
48688655|NCT00965081|156711620|FG001|Overall Study|Protocol Violation|5|||
48688656|NCT00965081|156711619|FG000|Overall Study|Sponsor Decision|1|||
48688657|NCT00965081|156711620|FG001|Overall Study|Sponsor Decision|0|||
48688658|NCT00965081|156711619|FG000|Overall Study|Withdrawal by Subject|4|||
48688659|NCT00965081|156711620|FG001|Overall Study|Withdrawal by Subject|7|||
48688660|NCT00965081|156711619|FG000|Overall Study|Switched to Rescue Arm|5|||
48688661|NCT00965081|156711620|FG001|Overall Study|Switched to Rescue Arm|12|||
48688662|NCT00474955|156711622|FG000|Overall Study|Adverse Event|2|||
48688663|NCT00474955|156711622|FG000|Overall Study|Drug unavailability|1|||
48688664|NCT00474955|156711622|FG000|Overall Study|Personal reasons|5|||
48688665|NCT00255190|156711623|FG000|Overall Study|Adverse Event|17|||
48688666|NCT00255190|156711624|FG001|Overall Study|Adverse Event|36|||
48688667|NCT00255190|156711623|FG000|Overall Study|Protocol Violation|2|||
48688668|NCT00255190|156711624|FG001|Overall Study|Protocol Violation|2|||
48688669|NCT00255190|156711623|FG000|Overall Study|Lost to Follow-up|10|||
48688670|NCT00255190|156711624|FG001|Overall Study|Lost to Follow-up|27|||
48688671|NCT00255190|156711623|FG000|Overall Study|Withdrew Consent|17|||
48688672|NCT00255190|156711624|FG001|Overall Study|Withdrew Consent|48|||
48688673|NCT00255190|156711623|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
48688674|NCT00255190|156711624|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
48688675|NCT00255190|156711623|FG000|Overall Study|Erosive esophagitis not healed|0|||
48688676|NCT00255190|156711624|FG001|Overall Study|Erosive esophagitis not healed|20|||
48688677|NCT00255190|156711623|FG000|Overall Study|Various|4|||
48688678|NCT00255190|156711624|FG001|Overall Study|Various|23|||
48688679|NCT00628030|156711625|FG000|Baseline to Post-Assessment|Lost to Follow-up|28|||
48688680|NCT00628030|156711626|FG001|Baseline to Post-Assessment|Lost to Follow-up|29|||
48688681|NCT00628030|156711625|FG000|Baseline to Post-Assessment|Withdrawal by Subject|5|||
48688682|NCT00628030|156711626|FG001|Baseline to Post-Assessment|Withdrawal by Subject|0|||
48688683|NCT00628030|156711625|FG000|Post to 6 Month Follow-up|Lost to Follow-up|32|||
48688684|NCT00628030|156711626|FG001|Post to 6 Month Follow-up|Lost to Follow-up|30|||
48688685|NCT01172535|156711627|FG000|Overall Study|Death|3|||
48688686|NCT01172535|156711627|FG000|Overall Study|Withdrawal by Subject|2|||
48688687|NCT01172535|156711627|FG000|Overall Study|Lost to Follow-up|1|||
48688688|NCT01172535|156711627|FG000|Overall Study|Ineligible at study entry|1|||
48688689|NCT01172535|156711627|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
48688690|NCT01156480|156711628|FG000|Overall Study|change in diagnosis|0|||
48688691|NCT01156480|156711629|FG001|Overall Study|change in diagnosis|1|||
48688692|NCT01582061|156711630|FG000|Overall Study|Lack of Efficacy|3|||
48688693|NCT01582061|156711631|FG001|Overall Study|Lack of Efficacy|23|||
48688694|NCT01582061|156711630|FG000|Overall Study|Adverse Event|12|||
48688695|NCT01582061|156711631|FG001|Overall Study|Adverse Event|8|||
48688696|NCT01582061|156711630|FG000|Overall Study|Withdrawal by Subject|10|||
48688697|NCT01582061|156711631|FG001|Overall Study|Withdrawal by Subject|4|||
48688698|NCT01582061|156711630|FG000|Overall Study|Abnormal laboratory value(s)|1|||
48688699|NCT01582061|156711631|FG001|Overall Study|Abnormal laboratory value(s)|0|||
48688700|NCT01582061|156711630|FG000|Overall Study|Death|0|||
48688701|NCT01582061|156711631|FG001|Overall Study|Death|1|||
48688702|NCT01582061|156711630|FG000|Overall Study|condition no longer requires study drug|1|||
48688703|NCT01582061|156711631|FG001|Overall Study|condition no longer requires study drug|0|||
48688704|NCT01582061|156711630|FG000|Overall Study|Lost to Follow-up|1|||
48688705|NCT01582061|156711631|FG001|Overall Study|Lost to Follow-up|0|||
48688706|NCT02859246|156711632|FG000|Overall Study|Screen fails|3|||
48688707|NCT02859246|156711632|FG000|Overall Study|Adverse Event|1|||
48688708|NCT02859246|156711632|FG000|Overall Study|Withdrawal by Subject|1|||
48688709|NCT01746368|156711635|FG000|Overall Study|Lost to Follow-up|2|||
48763592|NCT01449526|156983954|FG001|Overall Study|Symptoms/complaints|1|||
48763593|NCT01449526|156983953|FG000|Overall Study|Lack of Motivation|0|||
48688710|NCT01746368|156711636|FG001|Overall Study|Lost to Follow-up|0|||
48688711|NCT01746368|156711635|FG000|Overall Study|Withdrawal by Subject|0|||
48763594|NCT01449526|156983954|FG001|Overall Study|Lack of Motivation|1|||
48688712|NCT01746368|156711636|FG001|Overall Study|Withdrawal by Subject|1|||
48688713|NCT00499681|156711640|FG000|Overall Study|toxicity|0|||
48688714|NCT00499681|156711641|FG001|Overall Study|toxicity|1|||
48688715|NCT00499681|156711640|FG000|Overall Study|disease progression|0|||
48688716|NCT00499681|156711641|FG001|Overall Study|disease progression|1|||
48688717|NCT00659061|156711642|FG000|Overall Study|Migration due to political unrest|21|||
48688718|NCT00659061|156711643|FG001|Overall Study|Migration due to political unrest|15|||
48688719|NCT03480152|156711644|FG000|Phase I|Signed consent. Died before treatment.|1|||
48688720|NCT03480152|156711645|FG001|Phase I|Signed consent. Died before treatment.|0|||
48688721|NCT03480152|156711646|FG002|Phase I|Signed consent. Died before treatment.|0|||
48688722|NCT03535974|156711647|FG000|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
48688723|NCT03535974|156711648|FG001|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1|||
48688724|NCT03535974|156711649|FG002|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
48688725|NCT03535974|156711647|FG000|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2|||
48688726|NCT03535974|156711648|FG001|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1|||
48688727|NCT03535974|156711649|FG002|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0|||
48688728|NCT02913482|156711650|FG000|Overall Study|Death|0|||
48688729|NCT02913482|156711651|FG001|Overall Study|Death|2|||
48688730|NCT02913482|156711652|FG002|Overall Study|Death|2|||
48688731|NCT02913482|156711650|FG000|Overall Study|Progressive Disease|1|||
48688732|NCT02913482|156711651|FG001|Overall Study|Progressive Disease|1|||
48688733|NCT02913482|156711652|FG002|Overall Study|Progressive Disease|1|||
48688734|NCT02913482|156711650|FG000|Overall Study|Reason not specified|0|||
48688735|NCT02913482|156711651|FG001|Overall Study|Reason not specified|0|||
48688736|NCT02913482|156711652|FG002|Overall Study|Reason not specified|1|||
48688737|NCT02913482|156711650|FG000|Overall Study|Withdrawal by Subject|0|||
48688738|NCT02913482|156711651|FG001|Overall Study|Withdrawal by Subject|1|||
48688739|NCT02913482|156711652|FG002|Overall Study|Withdrawal by Subject|1|||
48688740|NCT00988884|156711653|FG000|Overall Study|Adverse Event|0|||
48688741|NCT00988884|156711654|FG001|Overall Study|Adverse Event|1|||
48688742|NCT00988884|156711653|FG000|Overall Study|Lost to Follow-up|20|||
48688743|NCT00988884|156711654|FG001|Overall Study|Lost to Follow-up|16|||
48688744|NCT00988884|156711653|FG000|Overall Study|Protocol Violation|0|||
48688745|NCT00988884|156711654|FG001|Overall Study|Protocol Violation|1|||
48688746|NCT00988884|156711653|FG000|Overall Study|Withdrawal by Subject|15|||
48688747|NCT00988884|156711654|FG001|Overall Study|Withdrawal by Subject|18|||
48688748|NCT01623115|156711655|FG000|Overall Study|Randomized but not treated|0|||
48688749|NCT01623115|156711656|FG001|Overall Study|Randomized but not treated|1|||
48688750|NCT01623115|156711655|FG000|Overall Study|Physician Decision|1|||
48688751|NCT01623115|156711656|FG001|Overall Study|Physician Decision|0|||
48688752|NCT01623115|156711655|FG000|Overall Study|Participants moved|1|||
48688753|NCT01623115|156711656|FG001|Overall Study|Participants moved|5|||
48688754|NCT01623115|156711655|FG000|Overall Study|Adverse Event|10|||
48688755|NCT01623115|156711656|FG001|Overall Study|Adverse Event|13|||
48688756|NCT01623115|156711655|FG000|Overall Study|Poor compliance to protocol|4|||
48688757|NCT01623115|156711656|FG001|Overall Study|Poor compliance to protocol|10|||
48688758|NCT01623115|156711655|FG000|Overall Study|Consent withdrawn by participant|2|||
48688759|NCT01623115|156711656|FG001|Overall Study|Consent withdrawn by participant|6|||
48688760|NCT01623115|156711655|FG000|Overall Study|Related to study drug administration|0|||
48688761|NCT01623115|156711656|FG001|Overall Study|Related to study drug administration|2|||
48688762|NCT01623115|156711655|FG000|Overall Study|Last visit outside protocol visit window|14|||
48688763|NCT01623115|156711656|FG001|Overall Study|Last visit outside protocol visit window|26|||
48688764|NCT01623115|156711655|FG000|Overall Study|Site closure|1|||
48688765|NCT01623115|156711656|FG001|Overall Study|Site closure|7|||
48688766|NCT01623115|156711655|FG000|Overall Study|Death|0|||
48688767|NCT01623115|156711656|FG001|Overall Study|Death|4|||
48688768|NCT01623115|156711655|FG000|Overall Study|Other than specified above|0|||
48688769|NCT01623115|156711656|FG001|Overall Study|Other than specified above|3|||
48688770|NCT00687401|156711663|FG000|Overall Study|Protocol Violation|7|||
48688771|NCT00687401|156711663|FG000|Overall Study|Adverse Event|6|||
48688772|NCT00687401|156711663|FG000|Overall Study|Lack of Efficacy|6|||
48688773|NCT00687401|156711663|FG000|Overall Study|Withdrawal by Subject|4|||
48688774|NCT00687401|156711663|FG000|Overall Study|Did not return for visit|3|||
48688775|NCT00687401|156711663|FG000|Overall Study|For reasons different from those above|4|||
48688776|NCT00626275|156711664|FG000|Part A - Treatment Period 1|Adverse Event|1|||
48688777|NCT00626275|156711665|FG001|Part A - Treatment Period 1|Adverse Event|0|||
48688778|NCT00626275|156711666|FG002|Part A - Treatment Period 1|Adverse Event|0|||
48688779|NCT00626275|156711667|FG003|Part A - Treatment Period 1|Adverse Event|0|||
48688780|NCT00626275|156711668|FG004|Part A - Treatment Period 1|Adverse Event|0|||
48688781|NCT00626275|156711669|FG005|Part A - Treatment Period 1|Adverse Event|0|||
48688782|NCT00626275|156711670|FG006|Part A - Treatment Period 1|Adverse Event|0|||
48688783|NCT00626275|156711671|FG007|Part A - Treatment Period 1|Adverse Event|0|||
48688784|NCT00626275|156711664|FG000|Part A - Treatment Period 1|Withdrawal by Subject|0|||
48688785|NCT00626275|156711665|FG001|Part A - Treatment Period 1|Withdrawal by Subject|0|||
48875347|NCT00236184|157381620|FG000|Overall Study|Physician Decision|1|||
48688786|NCT00626275|156711666|FG002|Part A - Treatment Period 1|Withdrawal by Subject|1|||
48688787|NCT00626275|156711667|FG003|Part A - Treatment Period 1|Withdrawal by Subject|0|||
48688788|NCT00626275|156711668|FG004|Part A - Treatment Period 1|Withdrawal by Subject|0|||
48688789|NCT00626275|156711669|FG005|Part A - Treatment Period 1|Withdrawal by Subject|0|||
48688790|NCT00626275|156711670|FG006|Part A - Treatment Period 1|Withdrawal by Subject|0|||
48688791|NCT00626275|156711671|FG007|Part A - Treatment Period 1|Withdrawal by Subject|0|||
48688792|NCT00626275|156711664|FG000|Part B|Lost to Follow-up|0|||
48688793|NCT00626275|156711665|FG001|Part B|Lost to Follow-up|0|||
48688794|NCT00626275|156711666|FG002|Part B|Lost to Follow-up|0|||
48688795|NCT00626275|156711667|FG003|Part B|Lost to Follow-up|0|||
48688796|NCT00626275|156711668|FG004|Part B|Lost to Follow-up|0|||
48688797|NCT00626275|156711669|FG005|Part B|Lost to Follow-up|0|||
48688798|NCT00626275|156711670|FG006|Part B|Lost to Follow-up|1|||
48688799|NCT00626275|156711671|FG007|Part B|Lost to Follow-up|0|||
48688800|NCT00626275|156711664|FG000|Part B|Withdrawal by Subject|0|||
48688801|NCT00626275|156711665|FG001|Part B|Withdrawal by Subject|0|||
48688802|NCT00626275|156711666|FG002|Part B|Withdrawal by Subject|0|||
48688803|NCT00626275|156711667|FG003|Part B|Withdrawal by Subject|0|||
48688804|NCT00626275|156711668|FG004|Part B|Withdrawal by Subject|0|||
48688805|NCT00626275|156711669|FG005|Part B|Withdrawal by Subject|0|||
48688806|NCT00626275|156711670|FG006|Part B|Withdrawal by Subject|0|||
48688807|NCT00626275|156711671|FG007|Part B|Withdrawal by Subject|1|||
48688808|NCT00468299|156711674|FG000|Overall Study|Withdrawal by Subject|0|||
48688809|NCT00468299|156711675|FG001|Overall Study|Withdrawal by Subject|1|||
48688810|NCT03649217|156711676|FG000|Overall Study|subject had severe ataxia not initially found|1|||
48688811|NCT03649217|156711676|FG000|Overall Study|subject had cognitive issues not initially found|1|||
48688812|NCT01092728|156711677|FG000|Overall Study|Withdrawal by Subject|2|||
48688813|NCT01092728|156711678|FG001|Overall Study|Withdrawal by Subject|0|||
48688814|NCT01092728|156711677|FG000|Overall Study|Adverse Event|0|||
48688815|NCT01092728|156711678|FG001|Overall Study|Adverse Event|1|||
48688816|NCT01092728|156711677|FG000|Overall Study|Disease Progression|1|||
48688817|NCT01092728|156711678|FG001|Overall Study|Disease Progression|13|||
48688818|NCT01092728|156711677|FG000|Overall Study|Prohibited Concomitant Medications|1|||
48688819|NCT01092728|156711678|FG001|Overall Study|Prohibited Concomitant Medications|0|||
49024026|NCT00854308|157927521|FG000|Overall Study|Withdrawal by Subject|4|||
48688820|NCT01788566|156711679|FG000|Overall Study|Death|4|||
48688821|NCT01788566|156711679|FG000|Overall Study|Adverse Event|1|||
48688822|NCT01788566|156711679|FG000|Overall Study|Clinical Progressive Disease|3|||
48688823|NCT00721396|156711684|FG000|Overall Study|Adverse Event|4|||
48688824|NCT00721396|156711685|FG001|Overall Study|Adverse Event|7|||
48688825|NCT00721396|156711686|FG002|Overall Study|Adverse Event|2|||
48688826|NCT00721396|156711687|FG003|Overall Study|Adverse Event|0|||
48688827|NCT00721396|156711684|FG000|Overall Study|Withdrawal by Subject|12|||
48688828|NCT00721396|156711685|FG001|Overall Study|Withdrawal by Subject|15|||
48688829|NCT00721396|156711686|FG002|Overall Study|Withdrawal by Subject|3|||
48688830|NCT00721396|156711687|FG003|Overall Study|Withdrawal by Subject|7|||
48688831|NCT00721396|156711684|FG000|Overall Study|Lost to Follow-up|7|||
48688832|NCT00721396|156711685|FG001|Overall Study|Lost to Follow-up|9|||
48688833|NCT00721396|156711686|FG002|Overall Study|Lost to Follow-up|3|||
48688834|NCT00721396|156711687|FG003|Overall Study|Lost to Follow-up|3|||
48688835|NCT00721396|156711684|FG000|Overall Study|Protocol Violation|4|||
48688836|NCT00721396|156711685|FG001|Overall Study|Protocol Violation|3|||
48688837|NCT00721396|156711686|FG002|Overall Study|Protocol Violation|1|||
49024027|NCT00854308|157927522|FG001|Overall Study|Withdrawal by Subject|2|||
49024028|NCT00854308|157927521|FG000|Overall Study|Sponsor's decision to terminate study|0|||
49024029|NCT00854308|157927522|FG001|Overall Study|Sponsor's decision to terminate study|1|||
49024030|NCT02781727|157927525|FG000|Pre-dosing Period|Withdrawal by Subject|1|||
49024031|NCT02781727|157927526|FG001|Pre-dosing Period|Withdrawal by Subject|0|||
49024032|NCT02781727|157927525|FG000|Treatment Period|Withdrawal by Subject|1|||
49024033|NCT02781727|157927526|FG001|Treatment Period|Withdrawal by Subject|0|||
49024034|NCT02781727|157927525|FG000|Treatment Period|Lost to Follow-up|0|||
49024035|NCT02781727|157927526|FG001|Treatment Period|Lost to Follow-up|1|||
49024036|NCT02193178|157927527|FG000|Overall Study|Lost to Follow-up|1|||
49024037|NCT02193178|157927527|FG000|Overall Study|Dry eyes|1|||
49024038|NCT01406795|157927528|FG000|Overall Study|Withdrawal by Subject|1|||
49024039|NCT05090683|157927530|FG000|Overall Study|Lost to Follow-up|10|||
49024040|NCT05090683|157927531|FG001|Overall Study|Lost to Follow-up|2|||
48688838|NCT00721396|156711687|FG003|Overall Study|Protocol Violation|0|||
48688839|NCT00721396|156711684|FG000|Overall Study|Inappropriate enrollment|0|||
48688840|NCT00721396|156711685|FG001|Overall Study|Inappropriate enrollment|2|||
48688841|NCT00721396|156711686|FG002|Overall Study|Inappropriate enrollment|0|||
48688842|NCT00721396|156711687|FG003|Overall Study|Inappropriate enrollment|0|||
48688843|NCT00721396|156711684|FG000|Overall Study|Administrative reason|3|||
48688844|NCT00721396|156711685|FG001|Overall Study|Administrative reason|0|||
48688845|NCT00721396|156711686|FG002|Overall Study|Administrative reason|1|||
48688846|NCT00721396|156711687|FG003|Overall Study|Administrative reason|0|||
48688847|NCT00757237|156711688|FG000|Overall Study|Lost to Follow-up|0|||
48688848|NCT00757237|156711689|FG001|Overall Study|Lost to Follow-up|1|||
48688849|NCT00757237|156711688|FG000|Overall Study|Protocol Violation|0|||
48688850|NCT00757237|156711689|FG001|Overall Study|Protocol Violation|2|||
48688851|NCT00757237|156711688|FG000|Overall Study|Physician Decision|2|||
48688852|NCT00757237|156711689|FG001|Overall Study|Physician Decision|3|||
48688853|NCT00757237|156711688|FG000|Overall Study|Withdrawal by Subject|8|||
49024041|NCT05090683|157927530|FG000|Overall Study|Withdrawal by Subject|15|||
49024042|NCT05090683|157927531|FG001|Overall Study|Withdrawal by Subject|0|||
49024043|NCT01790568|157927535|FG000|Overall Study|Progression prior to transplant|0|||
49024044|NCT01790568|157927536|FG001|Overall Study|Progression prior to transplant|1|||
48688854|NCT00757237|156711689|FG001|Overall Study|Withdrawal by Subject|12|||
48688855|NCT00757237|156711688|FG000|Overall Study|Safety or Tolerability|3|||
48688856|NCT00757237|156711689|FG001|Overall Study|Safety or Tolerability|5|||
48688857|NCT00757237|156711688|FG000|Overall Study|Other|0|||
48688858|NCT00757237|156711689|FG001|Overall Study|Other|2|||
48688859|NCT01721161|156711690|FG000|Overall Study|Adverse Event|2|||
48688860|NCT01721161|156711691|FG001|Overall Study|Adverse Event|3|||
48688861|NCT01721161|156711690|FG000|Overall Study|Lost to Follow-up|1|||
48688862|NCT01721161|156711691|FG001|Overall Study|Lost to Follow-up|2|||
48688863|NCT01721161|156711690|FG000|Overall Study|Withdrawal by Subject|1|||
48688864|NCT01721161|156711691|FG001|Overall Study|Withdrawal by Subject|1|||
48688865|NCT01721161|156711690|FG000|Overall Study|Other|0|||
48688866|NCT01721161|156711691|FG001|Overall Study|Other|1|||
48688867|NCT02753946|156711695|FG000|Overall Study|Adverse Event|7|||
48688868|NCT02753946|156711696|FG001|Overall Study|Adverse Event|6|||
48688869|NCT02753946|156711695|FG000|Overall Study|Withdrawal by Subject|6|||
48688870|NCT02753946|156711696|FG001|Overall Study|Withdrawal by Subject|1|||
48688871|NCT02753946|156711695|FG000|Overall Study|Lack of Efficacy|1|||
48688872|NCT02753946|156711696|FG001|Overall Study|Lack of Efficacy|0|||
48688873|NCT02753946|156711695|FG000|Overall Study|Physician Decision|0|||
48688874|NCT02753946|156711696|FG001|Overall Study|Physician Decision|2|||
48688875|NCT03546621|156711699|FG000|Overall Study|Withdrawal by Subject|0|||
48688876|NCT03546621|156711700|FG001|Overall Study|Withdrawal by Subject|1|||
48688877|NCT03546621|156711701|FG002|Overall Study|Withdrawal by Subject|2|||
48688878|NCT03546621|156711702|FG003|Overall Study|Withdrawal by Subject|1|||
48688879|NCT03546621|156711699|FG000|Overall Study|Lost to Follow-up|0|||
48688880|NCT03546621|156711700|FG001|Overall Study|Lost to Follow-up|1|||
48688881|NCT03546621|156711701|FG002|Overall Study|Lost to Follow-up|0|||
48688882|NCT03546621|156711702|FG003|Overall Study|Lost to Follow-up|0|||
48688883|NCT03546621|156711699|FG000|Overall Study|Adverse Event|0|||
48688884|NCT03546621|156711700|FG001|Overall Study|Adverse Event|1|||
48688885|NCT03546621|156711701|FG002|Overall Study|Adverse Event|0|||
48688886|NCT03546621|156711702|FG003|Overall Study|Adverse Event|1|||
48688887|NCT03546621|156711699|FG000|Overall Study|Progressive disease|0|||
48688888|NCT03546621|156711700|FG001|Overall Study|Progressive disease|0|||
48688889|NCT03546621|156711701|FG002|Overall Study|Progressive disease|0|||
48688890|NCT03546621|156711702|FG003|Overall Study|Progressive disease|1|||
48688891|NCT02721875|156711707|FG000|Overall Study|Progressive disease/relapse|1|||
48688892|NCT02721875|156711708|FG001|Overall Study|Progressive disease/relapse|0|||
48688893|NCT01290523|156711709|FG000|Overall Study|Death|3|||
48688894|NCT03914417|156711710|FG000|Overall Study|Withdrawal by Subject|2|||
48688895|NCT03259555|156711713|FG000|Overall Study|Adverse Event|6|||
48688896|NCT03259555|156711714|FG001|Overall Study|Adverse Event|4|||
48688897|NCT03259555|156711713|FG000|Overall Study|Lack of Efficacy|6|||
48688898|NCT03259555|156711714|FG001|Overall Study|Lack of Efficacy|4|||
48688899|NCT03259555|156711713|FG000|Overall Study|Lost to Follow-up|0|||
48688900|NCT03259555|156711714|FG001|Overall Study|Lost to Follow-up|2|||
48688901|NCT03259555|156711713|FG000|Overall Study|Non-Compliance With Study Drug|1|||
48688902|NCT03259555|156711714|FG001|Overall Study|Non-Compliance With Study Drug|0|||
48688903|NCT03259555|156711713|FG000|Overall Study|Progressive Disease|0|||
48688904|NCT03259555|156711714|FG001|Overall Study|Progressive Disease|2|||
49024045|NCT01059903|157927537|FG000|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
49024046|NCT01059903|157927538|FG001|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
49024047|NCT00352690|157927539|FG000|Overall Study|Determined to be ineligible|2|||
48688905|NCT03259555|156711713|FG000|Overall Study|Withdrawal by Subject|19|||
48688906|NCT03259555|156711714|FG001|Overall Study|Withdrawal by Subject|16|||
49024048|NCT00352690|157927540|FG001|Overall Study|Determined to be ineligible|0|||
48688907|NCT03259555|156711713|FG000|Overall Study|Physician Decision|1|||
48688908|NCT03259555|156711714|FG001|Overall Study|Physician Decision|2|||
48688909|NCT03259555|156711713|FG000|Overall Study|Other|1|||
48688910|NCT03259555|156711714|FG001|Overall Study|Other|0|||
48688911|NCT00154297|156711715|FG000|Overall Study|Death|5|||
48688912|NCT00154297|156711716|FG001|Overall Study|Death|2|||
48688913|NCT00154297|156711715|FG000|Overall Study|Withdrawal by Subject|0|||
48688914|NCT00154297|156711716|FG001|Overall Study|Withdrawal by Subject|5|||
48688915|NCT00154297|156711715|FG000|Overall Study|Lost to Follow-up|3|||
48688916|NCT00154297|156711716|FG001|Overall Study|Lost to Follow-up|0|||
48688917|NCT03087513|156711717|FG000|Second Intervention After 3 hr Washout|Equipment malfunction|2|||
48688918|NCT03077542|156711721|FG000|Overall Study|Death|4|||
48688919|NCT03077542|156711722|FG001|Overall Study|Death|0|||
48688920|NCT03077542|156711721|FG000|Overall Study|Physician Decision|6|||
48688921|NCT03077542|156711722|FG001|Overall Study|Physician Decision|1|||
48688922|NCT03077542|156711721|FG000|Overall Study|Withdrawal by Subject|0|||
48688923|NCT03077542|156711722|FG001|Overall Study|Withdrawal by Subject|1|||
48688924|NCT01486966|156711724|FG000|Overall Study|Adverse Event|0|||
48688925|NCT01486966|156711725|FG001|Overall Study|Adverse Event|1|||
48688926|NCT01486966|156711724|FG000|Overall Study|Withdrawal by Subject|0|||
48688927|NCT01486966|156711725|FG001|Overall Study|Withdrawal by Subject|1|||
48688928|NCT02532517|156711726|FG000|Overall Study|Did not complete 24-Month visit|4|||
48688929|NCT02532517|156711726|FG000|Overall Study|Failed Angiographic eligibility|1|||
48688930|NCT02532517|156711726|FG000|Overall Study|Lost to Follow-up|4|||
48688931|NCT02532517|156711726|FG000|Overall Study|Withdrawal by Subject|4|||
48688932|NCT02532517|156711726|FG000|Overall Study|Death|4|||
48688933|NCT05051579|156711728|FG000|Overall Study|Withdrawal by Subject|3|||
48688934|NCT05051579|156711729|FG001|Overall Study|Withdrawal by Subject|5|||
48688935|NCT05051579|156711730|FG002|Overall Study|Withdrawal by Subject|2|||
48688936|NCT05051579|156711731|FG003|Overall Study|Withdrawal by Subject|1|||
48688937|NCT05051579|156711732|FG004|Overall Study|Withdrawal by Subject|4|||
48688938|NCT05051579|156711733|FG005|Overall Study|Withdrawal by Subject|0|||
48688939|NCT05051579|156711734|FG006|Overall Study|Withdrawal by Subject|4|||
48688940|NCT05051579|156711728|FG000|Overall Study|Lost to Follow-up|1|||
48688941|NCT05051579|156711729|FG001|Overall Study|Lost to Follow-up|0|||
48688942|NCT05051579|156711730|FG002|Overall Study|Lost to Follow-up|0|||
48688943|NCT05051579|156711731|FG003|Overall Study|Lost to Follow-up|0|||
48688944|NCT05051579|156711732|FG004|Overall Study|Lost to Follow-up|1|||
48688945|NCT05051579|156711733|FG005|Overall Study|Lost to Follow-up|0|||
48688946|NCT05051579|156711734|FG006|Overall Study|Lost to Follow-up|1|||
48688947|NCT05051579|156711728|FG000|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
48688948|NCT05051579|156711729|FG001|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
48688949|NCT05051579|156711730|FG002|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
48688950|NCT05051579|156711731|FG003|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
48688951|NCT05051579|156711732|FG004|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
48688952|NCT05051579|156711733|FG005|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
48688953|NCT05051579|156711734|FG006|Overall Study|Subject Unable to Visit Due to Working Out of Town|1|||
48688954|NCT05051579|156711728|FG000|Overall Study|Adverse Event|2|||
48688955|NCT05051579|156711729|FG001|Overall Study|Adverse Event|1|||
48688956|NCT05051579|156711730|FG002|Overall Study|Adverse Event|0|||
48688957|NCT05051579|156711731|FG003|Overall Study|Adverse Event|4|||
48688958|NCT05051579|156711732|FG004|Overall Study|Adverse Event|1|||
48688959|NCT05051579|156711733|FG005|Overall Study|Adverse Event|2|||
48688960|NCT05051579|156711734|FG006|Overall Study|Adverse Event|0|||
48688961|NCT05051579|156711728|FG000|Overall Study|Inadvertent Enrollment|0|||
48688962|NCT05051579|156711729|FG001|Overall Study|Inadvertent Enrollment|0|||
48688963|NCT05051579|156711730|FG002|Overall Study|Inadvertent Enrollment|0|||
48688964|NCT05051579|156711731|FG003|Overall Study|Inadvertent Enrollment|0|||
48688965|NCT05051579|156711732|FG004|Overall Study|Inadvertent Enrollment|0|||
48688966|NCT05051579|156711733|FG005|Overall Study|Inadvertent Enrollment|0|||
48688967|NCT05051579|156711734|FG006|Overall Study|Inadvertent Enrollment|1|||
48688968|NCT05051579|156711728|FG000|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
48688969|NCT05051579|156711729|FG001|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|1|||
48688970|NCT05051579|156711730|FG002|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
48688971|NCT05051579|156711731|FG003|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
48688972|NCT05051579|156711732|FG004|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
48688973|NCT05051579|156711733|FG005|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
48688974|NCT05051579|156711734|FG006|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
48688975|NCT05051579|156711728|FG000|Overall Study|Sponsor Decision|0|||
48688976|NCT05051579|156711729|FG001|Overall Study|Sponsor Decision|0|||
48688977|NCT05051579|156711730|FG002|Overall Study|Sponsor Decision|0|||
48688978|NCT05051579|156711731|FG003|Overall Study|Sponsor Decision|0|||
48875348|NCT00236184|157381621|FG001|Overall Study|Physician Decision|1|||
48688979|NCT05051579|156711732|FG004|Overall Study|Sponsor Decision|1|||
48688980|NCT05051579|156711733|FG005|Overall Study|Sponsor Decision|0|||
48688981|NCT05051579|156711734|FG006|Overall Study|Sponsor Decision|0|||
48688982|NCT05051579|156711728|FG000|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
48688983|NCT05051579|156711729|FG001|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
48692814|NCT01188772|156724610|FG000|Overall Study|Withdrawal by Subject|0|||
48692815|NCT01188772|156724611|FG001|Overall Study|Withdrawal by Subject|0|||
48692816|NCT01188772|156724612|FG002|Overall Study|Withdrawal by Subject|2|||
48692817|NCT01188772|156724613|FG003|Overall Study|Withdrawal by Subject|0|||
48692818|NCT03040141|156724614|FG000|Overall Study|Death|1|||
48692819|NCT03040141|156724615|FG001|Overall Study|Death|2|||
48688984|NCT05051579|156711730|FG002|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
48688985|NCT05051579|156711731|FG003|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
48688986|NCT05051579|156711732|FG004|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|1|||
48688987|NCT05051579|156711733|FG005|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
48688988|NCT05051579|156711734|FG006|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
48688989|NCT00880620|156711735|FG000|Overall Study|Adverse Event|4|||
48688990|NCT00880620|156711736|FG001|Overall Study|Adverse Event|5|||
48688991|NCT00880620|156711737|FG002|Overall Study|Adverse Event|15|||
48688992|NCT00880620|156711738|FG003|Overall Study|Adverse Event|15|||
48688993|NCT00880620|156711735|FG000|Overall Study|Death|0|||
48688994|NCT00880620|156711736|FG001|Overall Study|Death|0|||
48688995|NCT00880620|156711737|FG002|Overall Study|Death|1|||
48688996|NCT00880620|156711738|FG003|Overall Study|Death|0|||
48688997|NCT00880620|156711735|FG000|Overall Study|Lack of Efficacy|12|||
48688998|NCT00880620|156711736|FG001|Overall Study|Lack of Efficacy|4|||
48688999|NCT00880620|156711737|FG002|Overall Study|Lack of Efficacy|0|||
48689000|NCT00880620|156711738|FG003|Overall Study|Lack of Efficacy|1|||
48689001|NCT00880620|156711735|FG000|Overall Study|Lost to Follow-up|0|||
48689002|NCT00880620|156711736|FG001|Overall Study|Lost to Follow-up|1|||
48689003|NCT00880620|156711737|FG002|Overall Study|Lost to Follow-up|1|||
48689004|NCT00880620|156711738|FG003|Overall Study|Lost to Follow-up|0|||
48689005|NCT00880620|156711735|FG000|Overall Study|Protocol Violation|0|||
48689006|NCT00880620|156711736|FG001|Overall Study|Protocol Violation|1|||
48689007|NCT00880620|156711737|FG002|Overall Study|Protocol Violation|0|||
48689008|NCT00880620|156711738|FG003|Overall Study|Protocol Violation|2|||
48689009|NCT00880620|156711735|FG000|Overall Study|Withdrawal by Subject|4|||
48689010|NCT00880620|156711736|FG001|Overall Study|Withdrawal by Subject|3|||
48689011|NCT00880620|156711737|FG002|Overall Study|Withdrawal by Subject|1|||
48689012|NCT00880620|156711738|FG003|Overall Study|Withdrawal by Subject|3|||
48689013|NCT00880620|156711735|FG000|Overall Study|Noncompliance|0|||
48689014|NCT00880620|156711736|FG001|Overall Study|Noncompliance|0|||
48689015|NCT00880620|156711737|FG002|Overall Study|Noncompliance|1|||
48689016|NCT00880620|156711738|FG003|Overall Study|Noncompliance|1|||
48689017|NCT00880620|156711735|FG000|Overall Study|Other|1|||
48689018|NCT00880620|156711736|FG001|Overall Study|Other|1|||
48689019|NCT00880620|156711737|FG002|Overall Study|Other|2|||
48689020|NCT00880620|156711738|FG003|Overall Study|Other|2|||
48689021|NCT00871871|156711745|FG000|Part I|Adverse Event|0|||
48689022|NCT00871871|156711746|FG001|Part I|Adverse Event|2|||
48689023|NCT00871871|156711747|FG002|Part I|Adverse Event|0|||
48689024|NCT00871871|156711748|FG003|Part I|Adverse Event|0|||
48689025|NCT00871871|156711745|FG000|Part I|Withdrawal by Subject|3|||
48689026|NCT00871871|156711746|FG001|Part I|Withdrawal by Subject|0|||
48689027|NCT00871871|156711747|FG002|Part I|Withdrawal by Subject|0|||
48689028|NCT00871871|156711748|FG003|Part I|Withdrawal by Subject|0|||
48689029|NCT00871871|156711745|FG000|Part I|Laboratory abnormality|0|||
48689030|NCT00871871|156711746|FG001|Part I|Laboratory abnormality|1|||
48689031|NCT00871871|156711747|FG002|Part I|Laboratory abnormality|0|||
48689032|NCT00871871|156711748|FG003|Part I|Laboratory abnormality|0|||
48689033|NCT00871871|156711745|FG000|Part II|Lack of Efficacy|0|||
48689034|NCT00871871|156711746|FG001|Part II|Lack of Efficacy|0|||
48689035|NCT00871871|156711747|FG002|Part II|Lack of Efficacy|1|||
48689036|NCT00871871|156711748|FG003|Part II|Lack of Efficacy|0|||
48689037|NCT00871871|156711745|FG000|Part II|Withdrawal by Subject|0|||
48689038|NCT00871871|156711746|FG001|Part II|Withdrawal by Subject|0|||
48689039|NCT00871871|156711747|FG002|Part II|Withdrawal by Subject|2|||
48689040|NCT00871871|156711748|FG003|Part II|Withdrawal by Subject|1|||
48689041|NCT00871871|156711745|FG000|Part II|Adverse Event|0|||
48689042|NCT00871871|156711746|FG001|Part II|Adverse Event|0|||
48689043|NCT00871871|156711747|FG002|Part II|Adverse Event|1|||
48689044|NCT00871871|156711748|FG003|Part II|Adverse Event|2|||
48689045|NCT00871871|156711745|FG000|Part II|Protocol Violation|0|||
48689046|NCT00871871|156711746|FG001|Part II|Protocol Violation|0|||
48689047|NCT00871871|156711747|FG002|Part II|Protocol Violation|0|||
48689048|NCT00871871|156711748|FG003|Part II|Protocol Violation|1|||
48689049|NCT02354235|156711749|FG000|Overall Study|Adverse Event|2|||
48689050|NCT02354235|156711750|FG001|Overall Study|Adverse Event|2|||
48689051|NCT02354235|156711749|FG000|Overall Study|Physician Decision|0|||
48689052|NCT02354235|156711750|FG001|Overall Study|Physician Decision|1|||
48689053|NCT02354235|156711749|FG000|Overall Study|Withdrawal by Subject|1|||
48689054|NCT02354235|156711750|FG001|Overall Study|Withdrawal by Subject|3|||
48689055|NCT02354235|156711749|FG000|Overall Study|Conflict with the stopping criteria|0|||
48689056|NCT02354235|156711750|FG001|Overall Study|Conflict with the stopping criteria|1|||
48689057|NCT00410956|156711755|FG000|Overall Study|Adverse Event|1|||
48689058|NCT00410956|156711755|FG000|Overall Study|Death|2|||
48689059|NCT00410956|156711755|FG000|Overall Study|Lack of Efficacy|10|||
48763595|NCT01449526|156983953|FG000|Overall Study|Cannot maintain visits|0|||
48689060|NCT00410956|156711755|FG000|Overall Study|Physician Decision|6|||
48689061|NCT01650194|156711756|FG000|Overall Study|Progressive Disease (PD)|35|||
48689062|NCT01650194|156711756|FG000|Overall Study|Withdrawal by Subject|2|||
48689063|NCT01650194|156711756|FG000|Overall Study|Miscellaneous|10|||
48689064|NCT02407223|156713430|FG000|Overall Study|Adverse Event|1|||
48689065|NCT02407223|156713431|FG001|Overall Study|Adverse Event|0|||
48689066|NCT02407223|156713432|FG002|Overall Study|Adverse Event|1|||
48689067|NCT02407223|156713430|FG000|Overall Study|Lack of Efficacy|6|||
48689068|NCT02407223|156713431|FG001|Overall Study|Lack of Efficacy|6|||
48689069|NCT02407223|156713432|FG002|Overall Study|Lack of Efficacy|4|||
48689070|NCT02407223|156713430|FG000|Overall Study|Lost to Follow-up|1|||
48689071|NCT02407223|156713431|FG001|Overall Study|Lost to Follow-up|0|||
48689072|NCT02407223|156713432|FG002|Overall Study|Lost to Follow-up|2|||
48689073|NCT02407223|156713430|FG000|Overall Study|Withdrawal by Subject|2|||
48689074|NCT02407223|156713431|FG001|Overall Study|Withdrawal by Subject|4|||
48689075|NCT02407223|156713432|FG002|Overall Study|Withdrawal by Subject|4|||
48689076|NCT02407223|156713430|FG000|Overall Study|Study Terminated by Sponsor|77|||
48689077|NCT02407223|156713431|FG001|Overall Study|Study Terminated by Sponsor|80|||
48689078|NCT02407223|156713432|FG002|Overall Study|Study Terminated by Sponsor|86|||
48689079|NCT02407223|156713430|FG000|Overall Study|Subject Refused Further Study Treatment|0|||
48689080|NCT02407223|156713431|FG001|Overall Study|Subject Refused Further Study Treatment|1|||
48689081|NCT02407223|156713432|FG002|Overall Study|Subject Refused Further Study Treatment|0|||
48689082|NCT02407223|156713430|FG000|Overall Study|Other|29|||
48689083|NCT02407223|156713431|FG001|Overall Study|Other|27|||
48689084|NCT02407223|156713432|FG002|Overall Study|Other|25|||
48689085|NCT03553758|156713433|FG000|Overall Study|Lost to Follow-up|1|||
48689086|NCT04864639|156713434|FG000|Overall Study|Death|1|||
48689087|NCT04864639|156713434|FG000|Overall Study|Lost to Follow-up|1|||
48689088|NCT02719171|156713435|FG000|Overall Study|Adverse Event|1|||
48689089|NCT02719171|156713436|FG001|Overall Study|Adverse Event|2|||
48689090|NCT02719171|156713437|FG002|Overall Study|Adverse Event|0|||
48689091|NCT02719171|156713438|FG003|Overall Study|Adverse Event|0|||
48689092|NCT02719171|156713439|FG004|Overall Study|Adverse Event|2|||
48689093|NCT02719171|156713435|FG000|Overall Study|Lost to Follow-up|0|||
48689094|NCT02719171|156713436|FG001|Overall Study|Lost to Follow-up|0|||
48689095|NCT02719171|156713437|FG002|Overall Study|Lost to Follow-up|1|||
48689096|NCT02719171|156713438|FG003|Overall Study|Lost to Follow-up|0|||
48689097|NCT02719171|156713439|FG004|Overall Study|Lost to Follow-up|0|||
48689098|NCT02719171|156713435|FG000|Overall Study|Subject Withdrawal|0|||
48689099|NCT02719171|156713436|FG001|Overall Study|Subject Withdrawal|2|||
48689100|NCT02719171|156713437|FG002|Overall Study|Subject Withdrawal|2|||
48689101|NCT02719171|156713438|FG003|Overall Study|Subject Withdrawal|1|||
48689102|NCT02719171|156713439|FG004|Overall Study|Subject Withdrawal|0|||
48689103|NCT02719171|156713435|FG000|Overall Study|Other|0|||
48689104|NCT02719171|156713436|FG001|Overall Study|Other|0|||
48689105|NCT02719171|156713437|FG002|Overall Study|Other|0|||
48689106|NCT02719171|156713438|FG003|Overall Study|Other|1|||
48689107|NCT02719171|156713439|FG004|Overall Study|Other|0|||
48689108|NCT02807623|156713440|FG000|Overall Study|Lost to Follow-up|23|||
48689109|NCT02807623|156713441|FG001|Overall Study|Lost to Follow-up|18|||
48689110|NCT02807623|156713442|FG002|Overall Study|Lost to Follow-up|22|||
48689111|NCT02807623|156713440|FG000|Overall Study|Drug intolerance|0|||
48689112|NCT02807623|156713441|FG001|Overall Study|Drug intolerance|1|||
48689113|NCT02807623|156713442|FG002|Overall Study|Drug intolerance|0|||
48689114|NCT02807623|156713440|FG000|Overall Study|incomplete blood draw|0|||
48689115|NCT02807623|156713441|FG001|Overall Study|incomplete blood draw|2|||
48763596|NCT01449526|156983954|FG001|Overall Study|Cannot maintain visits|1|||
48763597|NCT02865915|156983955|FG000|Overall Study|Pregnancy|1|||
48763598|NCT02865915|156983956|FG001|Overall Study|Pregnancy|0|||
48763599|NCT02865915|156983955|FG000|Overall Study|Withdrawal by Subject|1|||
48763600|NCT02865915|156983956|FG001|Overall Study|Withdrawal by Subject|1|||
48763601|NCT02865915|156983955|FG000|Overall Study|Adverse Event|0|||
48689116|NCT02807623|156713442|FG002|Overall Study|incomplete blood draw|1|||
48689117|NCT01389882|156713450|FG000|Overall Study|Respiratory rate > 80/min during study|1|||
48689118|NCT01389882|156713451|FG001|Overall Study|Respiratory rate > 80/min during study|3|||
48689119|NCT01389882|156713450|FG000|Overall Study|Withdrawal by Subject|0|||
48689120|NCT01389882|156713451|FG001|Overall Study|Withdrawal by Subject|1|||
48689121|NCT03449758|156713452|FG000|Overall Study|Major protocol deviation|1|||
48689122|NCT03449758|156713452|FG000|Overall Study|Treatment inefficacy|5|||
48689123|NCT03449758|156713452|FG000|Overall Study|Adverse Event|9|||
48689124|NCT03449758|156713452|FG000|Overall Study|Consent withdrawal|1|||
48689125|NCT03449758|156713452|FG000|Overall Study|Other unspecified reason|3|||
48689126|NCT02796677|156713453|FG000|Overall Study|Adverse Event|11|||
48763602|NCT02865915|156983956|FG001|Overall Study|Adverse Event|4|||
48763603|NCT02865915|156983955|FG000|Overall Study|Lost to Follow-up|0|||
48763604|NCT02865915|156983956|FG001|Overall Study|Lost to Follow-up|1|||
48689127|NCT02796677|156713454|FG001|Overall Study|Adverse Event|22|||
48689128|NCT02796677|156713455|FG002|Overall Study|Adverse Event|14|||
48689129|NCT02796677|156713456|FG003|Overall Study|Adverse Event|14|||
48689130|NCT02796677|156713453|FG000|Overall Study|Protocol Violation|7|||
48689131|NCT02796677|156713454|FG001|Overall Study|Protocol Violation|5|||
48689132|NCT02796677|156713455|FG002|Overall Study|Protocol Violation|4|||
48689133|NCT02796677|156713456|FG003|Overall Study|Protocol Violation|8|||
48689134|NCT02796677|156713453|FG000|Overall Study|Lost to Follow-up|1|||
48689135|NCT02796677|156713454|FG001|Overall Study|Lost to Follow-up|5|||
48689136|NCT02796677|156713455|FG002|Overall Study|Lost to Follow-up|2|||
48689137|NCT02796677|156713456|FG003|Overall Study|Lost to Follow-up|2|||
48689138|NCT02796677|156713453|FG000|Overall Study|Lack of Efficacy|7|||
48689139|NCT02796677|156713454|FG001|Overall Study|Lack of Efficacy|9|||
48689140|NCT02796677|156713455|FG002|Overall Study|Lack of Efficacy|14|||
48689141|NCT02796677|156713456|FG003|Overall Study|Lack of Efficacy|20|||
48689142|NCT02796677|156713453|FG000|Overall Study|Withdrawal by Subject|4|||
48689143|NCT02796677|156713454|FG001|Overall Study|Withdrawal by Subject|14|||
48689144|NCT02796677|156713455|FG002|Overall Study|Withdrawal by Subject|6|||
48689145|NCT02796677|156713456|FG003|Overall Study|Withdrawal by Subject|7|||
48689146|NCT02796677|156713453|FG000|Overall Study|Progressive disease|6|||
48689147|NCT02796677|156713454|FG001|Overall Study|Progressive disease|15|||
48689148|NCT02796677|156713455|FG002|Overall Study|Progressive disease|13|||
48689149|NCT02796677|156713456|FG003|Overall Study|Progressive disease|18|||
48689150|NCT02796677|156713453|FG000|Overall Study|Reason not mentioned|2|||
48689151|NCT02796677|156713454|FG001|Overall Study|Reason not mentioned|3|||
48689152|NCT02796677|156713455|FG002|Overall Study|Reason not mentioned|0|||
48689153|NCT02796677|156713456|FG003|Overall Study|Reason not mentioned|5|||
48689154|NCT04024891|156713462|FG000|Overall Study|Pregnancy|0|||
48689155|NCT04024891|156713463|FG001|Overall Study|Pregnancy|1|||
48689156|NCT00496015|156713464|FG000|Overall Study|Other|1|||
48689157|NCT00496015|156713465|FG001|Overall Study|Other|0|||
48689158|NCT00496015|156713466|FG002|Overall Study|Other|0|||
48689159|NCT00496015|156713467|FG003|Overall Study|Other|1|||
48689160|NCT00496015|156713468|FG004|Overall Study|Other|0|||
48689161|NCT02587520|156713469|FG000|Overall Study|Protocol Violation|2|||
48689162|NCT02587520|156713470|FG001|Overall Study|Protocol Violation|0|||
48689163|NCT02587520|156713471|FG002|Overall Study|Protocol Violation|0|||
48689164|NCT02587520|156713472|FG003|Overall Study|Protocol Violation|2|||
48689165|NCT02587520|156713473|FG004|Overall Study|Protocol Violation|0|||
48689166|NCT02587520|156713474|FG005|Overall Study|Protocol Violation|1|||
48689167|NCT02587520|156713475|FG006|Overall Study|Protocol Violation|1|||
48689168|NCT02587520|156713476|FG007|Overall Study|Protocol Violation|1|||
48689169|NCT02587520|156713477|FG008|Overall Study|Protocol Violation|3|||
48689170|NCT02587520|156713478|FG009|Overall Study|Protocol Violation|3|||
48689171|NCT02587520|156713479|FG010|Overall Study|Protocol Violation|1|||
48689172|NCT02587520|156713480|FG011|Overall Study|Protocol Violation|2|||
48689173|NCT02587520|156713481|FG012|Overall Study|Protocol Violation|0|||
48689174|NCT02587520|156713482|FG013|Overall Study|Protocol Violation|0|||
48689175|NCT02587520|156713483|FG014|Overall Study|Protocol Violation|0|||
48689176|NCT02587520|156713484|FG015|Overall Study|Protocol Violation|0|||
48689177|NCT02587520|156713485|FG016|Overall Study|Protocol Violation|0|||
48689178|NCT02587520|156713486|FG017|Overall Study|Protocol Violation|0|||
48689179|NCT02587520|156713469|FG000|Overall Study|Adverse Event|0|||
48689180|NCT02587520|156713470|FG001|Overall Study|Adverse Event|0|||
48689181|NCT02587520|156713471|FG002|Overall Study|Adverse Event|0|||
48689182|NCT02587520|156713472|FG003|Overall Study|Adverse Event|0|||
48689183|NCT02587520|156713473|FG004|Overall Study|Adverse Event|0|||
48689184|NCT02587520|156713474|FG005|Overall Study|Adverse Event|0|||
48689185|NCT02587520|156713475|FG006|Overall Study|Adverse Event|0|||
48689186|NCT02587520|156713476|FG007|Overall Study|Adverse Event|0|||
48689187|NCT02587520|156713477|FG008|Overall Study|Adverse Event|0|||
48689188|NCT02587520|156713478|FG009|Overall Study|Adverse Event|0|||
48689189|NCT02587520|156713479|FG010|Overall Study|Adverse Event|0|||
48763605|NCT02865915|156983955|FG000|Overall Study|Protocol Violation|0|||
48763606|NCT02865915|156983956|FG001|Overall Study|Protocol Violation|1|||
48763607|NCT02865915|156983955|FG000|Overall Study|Study terminated by sponsor|23|||
48763608|NCT02865915|156983956|FG001|Overall Study|Study terminated by sponsor|18|||
48763609|NCT02865915|156983955|FG000|Overall Study|Dosing group discontinued|0|||
48763610|NCT02865915|156983956|FG001|Overall Study|Dosing group discontinued|5|||
48689190|NCT02587520|156713480|FG011|Overall Study|Adverse Event|1|||
48689191|NCT02587520|156713481|FG012|Overall Study|Adverse Event|0|||
48689192|NCT02587520|156713482|FG013|Overall Study|Adverse Event|0|||
48689193|NCT02587520|156713483|FG014|Overall Study|Adverse Event|0|||
48689194|NCT02587520|156713484|FG015|Overall Study|Adverse Event|0|||
48689195|NCT02587520|156713485|FG016|Overall Study|Adverse Event|0|||
48689196|NCT02587520|156713486|FG017|Overall Study|Adverse Event|0|||
48689197|NCT02587520|156713469|FG000|Overall Study|Withdrawal by Subject|0|||
48689198|NCT02587520|156713470|FG001|Overall Study|Withdrawal by Subject|0|||
48689199|NCT02587520|156713471|FG002|Overall Study|Withdrawal by Subject|1|||
48689200|NCT02587520|156713472|FG003|Overall Study|Withdrawal by Subject|1|||
48689201|NCT02587520|156713473|FG004|Overall Study|Withdrawal by Subject|0|||
48763611|NCT00615056|156983960|FG000|Overall Study|Death|31|||
48763612|NCT00615056|156983961|FG001|Overall Study|Death|31|||
48689202|NCT02587520|156713474|FG005|Overall Study|Withdrawal by Subject|1|||
48763613|NCT00615056|156983962|FG002|Overall Study|Death|21|||
48689203|NCT02587520|156713475|FG006|Overall Study|Withdrawal by Subject|1|||
48689204|NCT02587520|156713476|FG007|Overall Study|Withdrawal by Subject|0|||
48689205|NCT02587520|156713477|FG008|Overall Study|Withdrawal by Subject|0|||
48689206|NCT02587520|156713478|FG009|Overall Study|Withdrawal by Subject|0|||
48689207|NCT02587520|156713479|FG010|Overall Study|Withdrawal by Subject|0|||
48689208|NCT02587520|156713480|FG011|Overall Study|Withdrawal by Subject|0|||
48689209|NCT02587520|156713481|FG012|Overall Study|Withdrawal by Subject|0|||
48689210|NCT02587520|156713482|FG013|Overall Study|Withdrawal by Subject|1|||
48689211|NCT02587520|156713483|FG014|Overall Study|Withdrawal by Subject|0|||
48689212|NCT02587520|156713484|FG015|Overall Study|Withdrawal by Subject|0|||
48689213|NCT02587520|156713485|FG016|Overall Study|Withdrawal by Subject|0|||
48689214|NCT02587520|156713486|FG017|Overall Study|Withdrawal by Subject|0|||
48689215|NCT02587520|156713469|FG000|Overall Study|Lost to Follow-up|0|||
48689216|NCT02587520|156713470|FG001|Overall Study|Lost to Follow-up|2|||
48689217|NCT02587520|156713471|FG002|Overall Study|Lost to Follow-up|0|||
48689218|NCT02587520|156713472|FG003|Overall Study|Lost to Follow-up|2|||
48689219|NCT02587520|156713473|FG004|Overall Study|Lost to Follow-up|0|||
48689220|NCT02587520|156713474|FG005|Overall Study|Lost to Follow-up|1|||
48689221|NCT02587520|156713475|FG006|Overall Study|Lost to Follow-up|1|||
48689222|NCT02587520|156713476|FG007|Overall Study|Lost to Follow-up|1|||
48689223|NCT02587520|156713477|FG008|Overall Study|Lost to Follow-up|0|||
48689224|NCT02587520|156713478|FG009|Overall Study|Lost to Follow-up|2|||
48689225|NCT02587520|156713479|FG010|Overall Study|Lost to Follow-up|2|||
48689226|NCT02587520|156713480|FG011|Overall Study|Lost to Follow-up|1|||
48689227|NCT02587520|156713481|FG012|Overall Study|Lost to Follow-up|0|||
48689228|NCT02587520|156713482|FG013|Overall Study|Lost to Follow-up|0|||
48689229|NCT02587520|156713483|FG014|Overall Study|Lost to Follow-up|0|||
48689230|NCT02587520|156713484|FG015|Overall Study|Lost to Follow-up|0|||
48689231|NCT02587520|156713485|FG016|Overall Study|Lost to Follow-up|0|||
48689232|NCT02587520|156713486|FG017|Overall Study|Lost to Follow-up|0|||
48689233|NCT00527735|156713487|FG000|Overall Study|Disease progression|47|||
48689234|NCT00527735|156713488|FG001|Overall Study|Disease progression|61|||
48689235|NCT00527735|156713489|FG002|Overall Study|Disease progression|53|||
48689236|NCT00527735|156713487|FG000|Overall Study|Death|23|||
48689237|NCT00527735|156713488|FG001|Overall Study|Death|13|||
48689238|NCT00527735|156713489|FG002|Overall Study|Death|15|||
48689239|NCT00527735|156713487|FG000|Overall Study|Completed treatment in treatment phase|14|||
48689240|NCT00527735|156713488|FG001|Overall Study|Completed treatment in treatment phase|13|||
48689241|NCT00527735|156713489|FG002|Overall Study|Completed treatment in treatment phase|18|||
48689242|NCT00527735|156713487|FG000|Overall Study|Adverse Event|10|||
48689243|NCT00527735|156713488|FG001|Overall Study|Adverse Event|6|||
48689244|NCT00527735|156713489|FG002|Overall Study|Adverse Event|7|||
48689245|NCT00527735|156713487|FG000|Overall Study|Not identified|5|||
48689246|NCT00527735|156713488|FG001|Overall Study|Not identified|5|||
48689247|NCT00527735|156713489|FG002|Overall Study|Not identified|5|||
48689248|NCT00527735|156713487|FG000|Overall Study|Withdrawal by Subject|5|||
48689249|NCT00527735|156713488|FG001|Overall Study|Withdrawal by Subject|4|||
48689250|NCT00527735|156713489|FG002|Overall Study|Withdrawal by Subject|3|||
48689251|NCT00527735|156713487|FG000|Overall Study|No longer met study criteria|2|||
48689252|NCT00527735|156713488|FG001|Overall Study|No longer met study criteria|2|||
48689253|NCT00527735|156713489|FG002|Overall Study|No longer met study criteria|1|||
48689254|NCT00527735|156713487|FG000|Overall Study|Lost to Follow-up|0|||
48689255|NCT00527735|156713488|FG001|Overall Study|Lost to Follow-up|0|||
48689256|NCT00527735|156713489|FG002|Overall Study|Lost to Follow-up|3|||
48689257|NCT00527735|156713487|FG000|Overall Study|Poor compliance or noncompliance|0|||
48689258|NCT00527735|156713488|FG001|Overall Study|Poor compliance or noncompliance|1|||
48689259|NCT00527735|156713489|FG002|Overall Study|Poor compliance or noncompliance|1|||
48689260|NCT00527735|156713487|FG000|Overall Study|Completed treatment during maintenance|2|||
48689261|NCT00527735|156713488|FG001|Overall Study|Completed treatment during maintenance|2|||
48689262|NCT00527735|156713489|FG002|Overall Study|Completed treatment during maintenance|1|||
48689263|NCT02210000|156713490|FG000|Overall Study|Study Terminated|11|||
48689264|NCT02210000|156713491|FG001|Overall Study|Study Terminated|12|||
48689265|NCT02210000|156713490|FG000|Overall Study|Withdrawal by Subject|7|||
48689266|NCT02210000|156713491|FG001|Overall Study|Withdrawal by Subject|1|||
48689267|NCT02210000|156713490|FG000|Overall Study|Adverse Event|1|||
48689268|NCT02210000|156713491|FG001|Overall Study|Adverse Event|5|||
48689269|NCT02210000|156713490|FG000|Overall Study|Lost to Follow-up|0|||
48689270|NCT02210000|156713491|FG001|Overall Study|Lost to Follow-up|2|||
48689271|NCT02210000|156713490|FG000|Overall Study|Physician Decision|0|||
48689272|NCT02210000|156713491|FG001|Overall Study|Physician Decision|1|||
48689273|NCT01173601|156713494|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23|||
48689274|NCT01173601|156713495|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
48689275|NCT01173601|156713496|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
48689276|NCT01173601|156713497|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
48689277|NCT01173601|156713498|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
48689278|NCT01173601|156713494|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9|||
48689279|NCT01173601|156713495|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
48689280|NCT01173601|156713496|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
48689281|NCT01173601|156713497|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
48981506|NCT00550615|157764292|FG002|Overall Study|Not evaluable|2|||
48981507|NCT00550615|157764293|FG003|Overall Study|Not evaluable|7|||
48981508|NCT00398086|157764296|FG000|Overall Study|Unacceptable Toxicity|2|||
48689282|NCT01173601|156713498|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
48689283|NCT01173601|156713494|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7|||
48689284|NCT01173601|156713495|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
48689285|NCT01173601|156713496|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
48689286|NCT01173601|156713497|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
48689287|NCT01173601|156713498|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
48689288|NCT01173601|156713494|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3|||
48689289|NCT01173601|156713495|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
48689290|NCT01173601|156713496|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
48689291|NCT01173601|156713497|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
48689292|NCT01173601|156713498|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
48689293|NCT01173601|156713494|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15|||
48689294|NCT01173601|156713495|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
48689295|NCT01173601|156713496|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
48689296|NCT01173601|156713497|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
48689297|NCT01173601|156713498|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
48689298|NCT01173601|156713494|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25|||
48689299|NCT01173601|156713495|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
48689300|NCT01173601|156713496|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
48689301|NCT01173601|156713497|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
48689302|NCT01173601|156713498|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
48689303|NCT01173601|156713494|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6|||
48689304|NCT01173601|156713495|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
48689305|NCT01173601|156713496|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
48689306|NCT01173601|156713497|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
48689307|NCT01173601|156713498|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
48689308|NCT01173601|156713494|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
48689309|NCT01173601|156713495|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10|||
48689310|NCT01173601|156713496|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15|||
48689311|NCT01173601|156713497|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7|||
48689312|NCT01173601|156713498|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14|||
48689313|NCT01173601|156713494|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
48981509|NCT00398086|157764297|FG001|Overall Study|Unacceptable Toxicity|8|||
48981510|NCT00398086|157764298|FG002|Overall Study|Unacceptable Toxicity|2|||
48981511|NCT00398086|157764296|FG000|Overall Study|Adverse Event|1|||
48981512|NCT00398086|157764297|FG001|Overall Study|Adverse Event|4|||
48689314|NCT01173601|156713495|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10|||
48689315|NCT01173601|156713496|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6|||
48689316|NCT01173601|156713497|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
48689317|NCT01173601|156713498|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9|||
48689318|NCT01173601|156713494|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
48689319|NCT01173601|156713495|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
48689320|NCT01173601|156713496|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
48689321|NCT01173601|156713497|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
48689322|NCT01173601|156713498|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
48689323|NCT01173601|156713494|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
48689324|NCT01173601|156713495|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
48689325|NCT01173601|156713496|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
48689326|NCT01173601|156713497|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
48689327|NCT01173601|156713498|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
48689328|NCT01173601|156713494|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
48689329|NCT01173601|156713495|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1|||
48689330|NCT01173601|156713496|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
48689331|NCT01173601|156713497|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4|||
48689332|NCT01173601|156713498|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
48689333|NCT01173601|156713494|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
48689334|NCT01173601|156713495|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
48689335|NCT01173601|156713496|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7|||
48689336|NCT01173601|156713497|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5|||
48692820|NCT03040141|156724616|FG002|Overall Study|Death|3|||
48875349|NCT00236184|157381620|FG000|Overall Study|Withdrawal by Subject|3|||
49024049|NCT03482882|157927543|FG000|Overall Study|Adverse Event|3|||
49024050|NCT03482882|157927543|FG000|Overall Study|Lost to Follow-up|1|||
49024051|NCT03482882|157927543|FG000|Overall Study|Protocol Violation|2|||
49024052|NCT03482882|157927543|FG000|Overall Study|Not further specified|1|||
49024053|NCT02216071|157927544|FG000|Overall Study|Withdrawal by Subject|7|||
49024054|NCT02216071|157927545|FG001|Overall Study|Withdrawal by Subject|2|||
49024055|NCT02216071|157927544|FG000|Overall Study|Lost to Follow-up|3|||
49024056|NCT02216071|157927545|FG001|Overall Study|Lost to Follow-up|3|||
49024057|NCT02216071|157927544|FG000|Overall Study|Protocol Violation|3|||
49024058|NCT02216071|157927545|FG001|Overall Study|Protocol Violation|5|||
49024059|NCT02216071|157927544|FG000|Overall Study|Other|2|||
49024060|NCT02216071|157927545|FG001|Overall Study|Other|2|||
48689337|NCT01173601|156713498|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
48689338|NCT01173601|156713494|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
48689339|NCT01173601|156713495|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
48689340|NCT01173601|156713496|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
48689341|NCT01173601|156713497|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
48689342|NCT01173601|156713498|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6|||
48689343|NCT01410890|156713499|FG000|Overall Study|Withdrawal by Subject|0|||
48689344|NCT01410890|156713500|FG001|Overall Study|Withdrawal by Subject|1|||
48689345|NCT00217425|156713502|FG000|Overall Study|Never started treatment|2|||
48689346|NCT00217425|156713502|FG000|Overall Study|Patient ineligible|5|||
48689347|NCT00217425|156713502|FG000|Overall Study|Lack of Efficacy|13|||
48689348|NCT00217425|156713502|FG000|Overall Study|Adverse Event|8|||
48689349|NCT00217425|156713502|FG000|Overall Study|Withdrawal by Subject|4|||
48689350|NCT00217425|156713502|FG000|Overall Study|Other complicating disease|1|||
48689351|NCT00217425|156713502|FG000|Overall Study|Other|4|||
48689352|NCT01121146|156713503|FG000|Overall Study|Death|17|||
48689353|NCT01121146|156713504|FG001|Overall Study|Death|15|||
48689354|NCT01121146|156713503|FG000|Overall Study|Adverse Event|2|||
48689355|NCT01121146|156713504|FG001|Overall Study|Adverse Event|11|||
48689356|NCT01121146|156713503|FG000|Overall Study|Lost to Follow-up|7|||
48689357|NCT01121146|156713504|FG001|Overall Study|Lost to Follow-up|16|||
48689358|NCT00791388|156713505|FG000|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
48689359|NCT00791388|156713506|FG001|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1|||
48689360|NCT00791388|156713507|FG002|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
48689361|NCT00791388|156713508|FG003|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
48689362|NCT00791388|156713509|FG004|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
48689363|NCT00791388|156713505|FG000|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1|||
48689364|NCT00791388|156713506|FG001|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
48689365|NCT00791388|156713507|FG002|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
48689366|NCT00791388|156713508|FG003|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
48689367|NCT00791388|156713509|FG004|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
48689368|NCT00791388|156713505|FG000|Period 4 - 400 mg Dose Group|Adverse Event|0|||
49024061|NCT03262012|157927548|FG000|Overall Study|Withdrawal by Subject|15|||
49024062|NCT03262012|157927549|FG001|Overall Study|Withdrawal by Subject|13|||
49024063|NCT03262012|157927550|FG002|Overall Study|Withdrawal by Subject|8|||
49024064|NCT03262012|157927551|FG003|Overall Study|Withdrawal by Subject|7|||
49024065|NCT03262012|157927548|FG000|Overall Study|Adverse Event|10|||
49024066|NCT03262012|157927549|FG001|Overall Study|Adverse Event|12|||
49024067|NCT03262012|157927550|FG002|Overall Study|Adverse Event|4|||
49024068|NCT03262012|157927551|FG003|Overall Study|Adverse Event|6|||
49024069|NCT03262012|157927548|FG000|Overall Study|Physician Decision|2|||
49024070|NCT03262012|157927549|FG001|Overall Study|Physician Decision|5|||
49024071|NCT03262012|157927550|FG002|Overall Study|Physician Decision|1|||
49024072|NCT03262012|157927551|FG003|Overall Study|Physician Decision|0|||
48689369|NCT00791388|156713506|FG001|Period 4 - 400 mg Dose Group|Adverse Event|0|||
48689370|NCT00791388|156713507|FG002|Period 4 - 400 mg Dose Group|Adverse Event|0|||
48689371|NCT00791388|156713508|FG003|Period 4 - 400 mg Dose Group|Adverse Event|0|||
48689372|NCT00791388|156713509|FG004|Period 4 - 400 mg Dose Group|Adverse Event|4|||
48689373|NCT03431441|156713510|FG000|Overall Study|Withdrawal by Subject|2|||
48689374|NCT03431441|156713510|FG000|Overall Study|Adverse Event|2|||
48689375|NCT03431441|156713510|FG000|Overall Study|Dispensed Incorrect Replacement Lens|1|||
48689376|NCT00330759|156713511|FG000|Overall Study|Death|316|||
48689377|NCT00330759|156713512|FG001|Overall Study|Death|310|||
48689378|NCT00330759|156713511|FG000|Overall Study|Disease progression|104|||
48689379|NCT00330759|156713512|FG001|Overall Study|Disease progression|126|||
49024073|NCT03262012|157927548|FG000|Overall Study|Lack of Efficacy|0|||
49024074|NCT03262012|157927549|FG001|Overall Study|Lack of Efficacy|5|||
49024075|NCT03262012|157927550|FG002|Overall Study|Lack of Efficacy|1|||
48875350|NCT00236184|157381621|FG001|Overall Study|Withdrawal by Subject|0|||
49024076|NCT03262012|157927551|FG003|Overall Study|Lack of Efficacy|2|||
49024077|NCT03262012|157927548|FG000|Overall Study|Protocol Discontinuation Criteria|0|||
49024078|NCT03262012|157927549|FG001|Overall Study|Protocol Discontinuation Criteria|1|||
49024079|NCT03262012|157927550|FG002|Overall Study|Protocol Discontinuation Criteria|0|||
49024080|NCT03262012|157927551|FG003|Overall Study|Protocol Discontinuation Criteria|0|||
49024081|NCT03500692|157927552|FG000|Overall Study|Death|163|||
49024082|NCT03500692|157927552|FG000|Overall Study|Lost to Follow-up|75|||
49024083|NCT03500692|157927552|FG000|Overall Study|Termination Reasons|3|||
49024084|NCT02305758|157927553|FG000|Overall Study|Death|27|||
49024085|NCT02305758|157927554|FG001|Overall Study|Death|27|||
49024086|NCT02305758|157927553|FG000|Overall Study|Withdrew consent|9|||
49024087|NCT02305758|157927554|FG001|Overall Study|Withdrew consent|2|||
49024088|NCT02305758|157927553|FG000|Overall Study|Lost to Follow-up|6|||
49024089|NCT02305758|157927554|FG001|Overall Study|Lost to Follow-up|1|||
49024090|NCT02305758|157927553|FG000|Overall Study|Study Terminated by Sponsor|21|||
49024091|NCT02305758|157927554|FG001|Overall Study|Study Terminated by Sponsor|34|||
49024092|NCT02305758|157927553|FG000|Overall Study|Other, not specified|2|||
49024093|NCT02305758|157927554|FG001|Overall Study|Other, not specified|1|||
49024094|NCT00824265|157927555|FG000|Treatment Phase|Adverse Event,non-fatal|50|||
49024095|NCT00824265|157927556|FG001|Treatment Phase|Adverse Event,non-fatal|52|||
49024096|NCT00824265|157927555|FG000|Treatment Phase|Protocol Violation|1|||
49024097|NCT00824265|157927556|FG001|Treatment Phase|Protocol Violation|0|||
49024098|NCT00824265|157927555|FG000|Treatment Phase|Lost to Follow-up|1|||
49024099|NCT00824265|157927556|FG001|Treatment Phase|Lost to Follow-up|1|||
49024100|NCT00824265|157927555|FG000|Treatment Phase|Physician Decision|6|||
49024101|NCT00824265|157927556|FG001|Treatment Phase|Physician Decision|12|||
49024102|NCT00824265|157927555|FG000|Treatment Phase|Withdrawal by Subject|6|||
49024103|NCT00824265|157927556|FG001|Treatment Phase|Withdrawal by Subject|15|||
49024104|NCT00824265|157927555|FG000|Follow-up Phase|w/drew consent, no f/u, or MD choice|18|||
49024105|NCT00824265|157927556|FG001|Follow-up Phase|w/drew consent, no f/u, or MD choice|31|||
49024106|NCT00824265|157927555|FG000|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9|||
49024107|NCT00824265|157927556|FG001|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16|||
49024108|NCT00463606|157927559|FG000|Overall Study|Adverse Event|21|||
49024109|NCT00463606|157927560|FG001|Overall Study|Adverse Event|18|||
49024110|NCT00463606|157927561|FG002|Overall Study|Adverse Event|11|||
49024111|NCT00463606|157927559|FG000|Overall Study|Withdrawal by Subject|11|||
49024112|NCT00463606|157927560|FG001|Overall Study|Withdrawal by Subject|11|||
49024113|NCT00463606|157927561|FG002|Overall Study|Withdrawal by Subject|5|||
49024114|NCT00463606|157927559|FG000|Overall Study|Lost to Follow-up|2|||
49024115|NCT00463606|157927560|FG001|Overall Study|Lost to Follow-up|2|||
49024116|NCT00463606|157927561|FG002|Overall Study|Lost to Follow-up|3|||
49024117|NCT00463606|157927559|FG000|Overall Study|Subject noncompliance|1|||
49024118|NCT00463606|157927560|FG001|Overall Study|Subject noncompliance|1|||
49024119|NCT00463606|157927561|FG002|Overall Study|Subject noncompliance|0|||
49024120|NCT00463606|157927559|FG000|Overall Study|Subject moved out of town|1|||
49024121|NCT00463606|157927560|FG001|Overall Study|Subject moved out of town|0|||
49024122|NCT00463606|157927561|FG002|Overall Study|Subject moved out of town|0|||
49024123|NCT00463606|157927559|FG000|Overall Study|Physician Decision|0|||
49024124|NCT00463606|157927560|FG001|Overall Study|Physician Decision|1|||
49024125|NCT00463606|157927561|FG002|Overall Study|Physician Decision|0|||
49024126|NCT00463606|157927559|FG000|Overall Study|Sponsor request|0|||
49024127|NCT00463606|157927560|FG001|Overall Study|Sponsor request|1|||
49024128|NCT00463606|157927561|FG002|Overall Study|Sponsor request|0|||
49024129|NCT00463606|157927559|FG000|Overall Study|Exclusion criteria violation|2|||
49024130|NCT00463606|157927560|FG001|Overall Study|Exclusion criteria violation|0|||
49024131|NCT00463606|157927561|FG002|Overall Study|Exclusion criteria violation|0|||
49024132|NCT00463606|157927559|FG000|Overall Study|Coordinator error|1|||
49024133|NCT00463606|157927560|FG001|Overall Study|Coordinator error|0|||
49024134|NCT00463606|157927561|FG002|Overall Study|Coordinator error|0|||
49024135|NCT00463606|157927559|FG000|Overall Study|Patient randomized in error|1|||
49024136|NCT00463606|157927560|FG001|Overall Study|Patient randomized in error|0|||
48689380|NCT00330759|156713511|FG000|Overall Study|Withdrawal by Subject|143|||
49024137|NCT00463606|157927561|FG002|Overall Study|Patient randomized in error|0|||
49024138|NCT00463606|157927559|FG000|Overall Study|Participation in another ABT-335 trial|1|||
49024139|NCT00463606|157927560|FG001|Overall Study|Participation in another ABT-335 trial|0|||
49024140|NCT00463606|157927561|FG002|Overall Study|Participation in another ABT-335 trial|0|||
49024141|NCT00463606|157927559|FG000|Overall Study|Protocol Violation|0|||
48689381|NCT00330759|156713512|FG001|Overall Study|Withdrawal by Subject|124|||
48689382|NCT00330759|156713511|FG000|Overall Study|Adverse Event|48|||
48689383|NCT00330759|156713512|FG001|Overall Study|Adverse Event|36|||
48689384|NCT00330759|156713511|FG000|Overall Study|Participant request|31|||
48689385|NCT00330759|156713512|FG001|Overall Study|Participant request|22|||
48689386|NCT00330759|156713511|FG000|Overall Study|Lost to Follow-up|16|||
48689387|NCT00330759|156713512|FG001|Overall Study|Lost to Follow-up|22|||
48689388|NCT00330759|156713511|FG000|Overall Study|Noncompliance|15|||
48689389|NCT00330759|156713512|FG001|Overall Study|Noncompliance|17|||
48689390|NCT00330759|156713511|FG000|Overall Study|Physician Decision|1|||
49024142|NCT00463606|157927560|FG001|Overall Study|Protocol Violation|0|||
49024143|NCT00463606|157927561|FG002|Overall Study|Protocol Violation|1|||
49024144|NCT01223365|157927563|FG000|Open-label Titration Period|Enrolled but not treated|1|||
48689391|NCT00330759|156713512|FG001|Overall Study|Physician Decision|2|||
48689392|NCT00330759|156713511|FG000|Overall Study|Protocol deviation|0|||
48689393|NCT00330759|156713512|FG001|Overall Study|Protocol deviation|2|||
48689394|NCT00330759|156713511|FG000|Overall Study|Ineligibility determined|2|||
48689395|NCT00330759|156713512|FG001|Overall Study|Ineligibility determined|1|||
48689396|NCT00330759|156713511|FG000|Overall Study|Other|36|||
48689397|NCT00330759|156713512|FG001|Overall Study|Other|44|||
48689398|NCT00997035|156713518|FG000|3-week Followup Visit|Lost to Follow-up|9|||
48689399|NCT00997035|156713519|FG001|3-week Followup Visit|Lost to Follow-up|6|||
48689400|NCT00997035|156713518|FG000|3-month Follow-up Visit|Lost to Follow-up|12|||
48689401|NCT00997035|156713519|FG001|3-month Follow-up Visit|Lost to Follow-up|6|||
48689402|NCT02995980|156713526|FG000|Overall Study|Lost to Follow-up|14|||
48689403|NCT02792231|156713534|FG000|Overall Study|Patient/guardian decision|32|||
48689404|NCT02792231|156713535|FG001|Overall Study|Patient/guardian decision|42|||
48689405|NCT02792231|156713534|FG000|Overall Study|Adverse Event|15|||
48689406|NCT02792231|156713535|FG001|Overall Study|Adverse Event|11|||
48689407|NCT02792231|156713534|FG000|Overall Study|Physician Decision|14|||
48689408|NCT02792231|156713535|FG001|Overall Study|Physician Decision|12|||
48689409|NCT02792231|156713534|FG000|Overall Study|Lack of Efficacy|7|||
48689410|NCT02792231|156713535|FG001|Overall Study|Lack of Efficacy|9|||
48689411|NCT02792231|156713534|FG000|Overall Study|Lost to Follow-up|9|||
48689412|NCT02792231|156713535|FG001|Overall Study|Lost to Follow-up|5|||
48689413|NCT02792231|156713534|FG000|Overall Study|Pregnancy|1|||
48689414|NCT02792231|156713535|FG001|Overall Study|Pregnancy|3|||
48689415|NCT02792231|156713534|FG000|Overall Study|Non-compliance with study treatment|2|||
48689416|NCT02792231|156713535|FG001|Overall Study|Non-compliance with study treatment|1|||
48689417|NCT02792231|156713534|FG000|Overall Study|Protocol deviation|2|||
48689418|NCT02792231|156713535|FG001|Overall Study|Protocol deviation|0|||
48689419|NCT02792231|156713534|FG000|Overall Study|Technical problems|0|||
48689420|NCT02792231|156713535|FG001|Overall Study|Technical problems|1|||
48689421|NCT03309878|156713536|FG000|Overall Study|Adverse Event|1|||
48689422|NCT03309878|156713537|FG001|Overall Study|Adverse Event|0|||
48689423|NCT03309878|156713538|FG002|Overall Study|Adverse Event|0|||
48689424|NCT03309878|156713539|FG003|Overall Study|Adverse Event|0|||
48689425|NCT03309878|156713536|FG000|Overall Study|Did not maintain eligibility|2|||
48689426|NCT03309878|156713537|FG001|Overall Study|Did not maintain eligibility|1|||
48689427|NCT03309878|156713538|FG002|Overall Study|Did not maintain eligibility|0|||
48689428|NCT03309878|156713539|FG003|Overall Study|Did not maintain eligibility|0|||
48689429|NCT03309878|156713536|FG000|Overall Study|Withdrawal by Subject|0|||
48689430|NCT03309878|156713537|FG001|Overall Study|Withdrawal by Subject|1|||
48689431|NCT03309878|156713538|FG002|Overall Study|Withdrawal by Subject|0|||
48689432|NCT03309878|156713539|FG003|Overall Study|Withdrawal by Subject|0|||
48689433|NCT01096316|156713540|FG000|Overall Study|Lost to Follow-up|15|||
48689434|NCT01096316|156713541|FG001|Overall Study|Lost to Follow-up|9|||
48763614|NCT00615056|156983963|FG003|Overall Study|Death|23|||
48763615|NCT00615056|156983960|FG000|Overall Study|Lost to Follow-up|1|||
48763616|NCT00615056|156983961|FG001|Overall Study|Lost to Follow-up|2|||
49024145|NCT01223365|157927563|FG000|Open-label Titration Period|Adverse Event|23|||
49024146|NCT01223365|157927563|FG000|Open-label Titration Period|Lack of Efficacy|3|||
49024147|NCT01223365|157927563|FG000|Open-label Titration Period|Withdrawal by Subject|5|||
49024148|NCT01223365|157927563|FG000|Open-label Titration Period|Protocol Violation|1|||
49024149|NCT01223365|157927563|FG000|Open-label Titration Period|Lost to Follow-up|2|||
49024150|NCT01223365|157927563|FG000|Open-label Titration Period|Noncompliance with study drug admin|1|||
49024151|NCT01223365|157927563|FG000|Open-label Titration Period|Noncompliance with study procedures|2|||
49024152|NCT01223365|157927563|FG000|Open-label Titration Period|Starting physical therapy|1|||
49024153|NCT01223365|157927563|FG000|Open-label Treatment Period|Adverse Event|39|||
49024154|NCT01223365|157927563|FG000|Open-label Treatment Period|Lack of Efficacy|2|||
49024155|NCT01223365|157927563|FG000|Open-label Treatment Period|Withdrawal by Subject|19|||
49024156|NCT01223365|157927563|FG000|Open-label Treatment Period|Protocol Violation|15|||
48689435|NCT00248495|156713543|FG000|Overall Study|Withdrawal by Subject|1|||
48689436|NCT00619515|156713545|FG000|Overall Study|Study Termination by IRB|73|||
48689437|NCT00836589|156713550|FG000|Overall Study|Lost to Follow-up|246|||
48689438|NCT00836589|156713550|FG000|Overall Study|Death|429|||
48689439|NCT00836589|156713550|FG000|Overall Study|Withdrawal by Subject or Physician|591|||
48689440|NCT01794000|156713551|FG000|Double-Blind Phase (DBP)|Adverse Event|5|||
49024157|NCT01223365|157927563|FG000|Open-label Treatment Period|Lost to Follow-up|7|||
48689441|NCT01794000|156713552|FG001|Double-Blind Phase (DBP)|Adverse Event|2|||
48689442|NCT01794000|156713551|FG000|Double-Blind Phase (DBP)|Death|1|||
48689443|NCT01794000|156713552|FG001|Double-Blind Phase (DBP)|Death|2|||
48689444|NCT01794000|156713551|FG000|Double-Blind Phase (DBP)|Entry Criteria Not Met|2|||
48689445|NCT01794000|156713552|FG001|Double-Blind Phase (DBP)|Entry Criteria Not Met|0|||
48689446|NCT01794000|156713551|FG000|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5|||
48689447|NCT01794000|156713552|FG001|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2|||
48689448|NCT01794000|156713551|FG000|Double-Blind Phase (DBP)|Physician Decision|2|||
48763617|NCT00615056|156983962|FG002|Overall Study|Lost to Follow-up|4|||
48763618|NCT00615056|156983963|FG003|Overall Study|Lost to Follow-up|5|||
48689449|NCT01794000|156713552|FG001|Double-Blind Phase (DBP)|Physician Decision|0|||
48689450|NCT01794000|156713551|FG000|Double-Blind Phase (DBP)|Sponsor Decision|148|||
48689451|NCT01794000|156713552|FG001|Double-Blind Phase (DBP)|Sponsor Decision|149|||
48689452|NCT01794000|156713551|FG000|Double-Blind Phase (DBP)|Withdrawal by Subject|6|||
48689453|NCT01794000|156713552|FG001|Double-Blind Phase (DBP)|Withdrawal by Subject|11|||
48689454|NCT01794000|156713551|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|3|||
48689455|NCT01794000|156713552|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
48689456|NCT04033367|156713555|FG000|DB Period (Up to Week 12)|Adverse Event|1|||
48689457|NCT04033367|156713556|FG001|DB Period (Up to Week 12)|Adverse Event|1|||
48689458|NCT04033367|156713555|FG000|DB Period (Up to Week 12)|Withdrawal by Subject|4|||
48689459|NCT04033367|156713556|FG001|DB Period (Up to Week 12)|Withdrawal by Subject|0|||
48689460|NCT04033367|156713555|FG000|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|4|||
48689461|NCT04033367|156713556|FG001|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|1|||
48689462|NCT04033367|156713555|FG000|OLE Period (Week 12 to Week 24)|Other-unspecified|1|||
48689463|NCT04033367|156713556|FG001|OLE Period (Week 12 to Week 24)|Other-unspecified|0|||
48689464|NCT04537793|156713557|FG000|Part B (24 Weeks)|Adverse Event|0|||
48689465|NCT04537793|156713558|FG001|Part B (24 Weeks)|Adverse Event|1|||
48689466|NCT01255423|156713559|FG000|Overall Study|Abnormal Laboratory value|3|||
48689467|NCT01255423|156713560|FG001|Overall Study|Abnormal Laboratory value|2|||
48689468|NCT01255423|156713559|FG000|Overall Study|Use of prohibited medications|0|||
48689469|NCT01255423|156713560|FG001|Overall Study|Use of prohibited medications|1|||
48689470|NCT05470387|156713561|FG000|Overall Study|Protocol Violation|0|||
48689471|NCT05470387|156713562|FG001|Overall Study|Protocol Violation|3|||
48689472|NCT00231777|156713563|FG000|Overall Study|Lost to Follow-up|3|||
48689473|NCT00231777|156713564|FG001|Overall Study|Lost to Follow-up|0|||
48689474|NCT00231777|156713563|FG000|Overall Study|Other|3|||
48689475|NCT00231777|156713564|FG001|Overall Study|Other|2|||
48689476|NCT05280717|156713566|FG000|Part A (Up to Week 35)|Withdrawal by Subject|1|||
48689477|NCT05280717|156713567|FG001|Part A (Up to Week 35)|Withdrawal by Subject|3|||
48689478|NCT05280717|156713568|FG002|Part A (Up to Week 35)|Withdrawal by Subject|2|||
48689479|NCT05280717|156713569|FG003|Part A (Up to Week 35)|Withdrawal by Subject|0|||
48689480|NCT05280717|156713570|FG004|Part A (Up to Week 35)|Withdrawal by Subject|0|||
48689481|NCT05280717|156713571|FG005|Part A (Up to Week 35)|Withdrawal by Subject|0|||
48689482|NCT05280717|156713572|FG006|Part A (Up to Week 35)|Withdrawal by Subject|0|||
48689483|NCT05280717|156713566|FG000|Part A (Up to Week 35)|Randomized but not received treatment|1|||
48689484|NCT05280717|156713567|FG001|Part A (Up to Week 35)|Randomized but not received treatment|0|||
48689485|NCT05280717|156713568|FG002|Part A (Up to Week 35)|Randomized but not received treatment|0|||
48689486|NCT05280717|156713569|FG003|Part A (Up to Week 35)|Randomized but not received treatment|0|||
48689487|NCT05280717|156713570|FG004|Part A (Up to Week 35)|Randomized but not received treatment|0|||
48689488|NCT05280717|156713571|FG005|Part A (Up to Week 35)|Randomized but not received treatment|0|||
48689489|NCT05280717|156713572|FG006|Part A (Up to Week 35)|Randomized but not received treatment|0|||
48689490|NCT05280717|156713566|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
48689491|NCT05280717|156713567|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|1|||
48689492|NCT05280717|156713568|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
48689493|NCT05280717|156713569|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
48689494|NCT05280717|156713570|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
48689495|NCT05280717|156713571|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
48689496|NCT05280717|156713572|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
48689497|NCT05280717|156713566|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
48689498|NCT05280717|156713567|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
48689499|NCT05280717|156713568|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|1|||
48689500|NCT05280717|156713569|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
48689501|NCT05280717|156713570|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
48689502|NCT05280717|156713571|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
48689503|NCT05280717|156713572|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
48689504|NCT05280717|156713566|FG000|Part C (Up to Week 35)|Withdrawal by Subject|0|||
48689505|NCT05280717|156713567|FG001|Part C (Up to Week 35)|Withdrawal by Subject|0|||
48689506|NCT05280717|156713568|FG002|Part C (Up to Week 35)|Withdrawal by Subject|0|||
48689507|NCT05280717|156713569|FG003|Part C (Up to Week 35)|Withdrawal by Subject|0|||
48689508|NCT05280717|156713570|FG004|Part C (Up to Week 35)|Withdrawal by Subject|0|||
48689509|NCT05280717|156713571|FG005|Part C (Up to Week 35)|Withdrawal by Subject|2|||
48689510|NCT05280717|156713572|FG006|Part C (Up to Week 35)|Withdrawal by Subject|0|||
48689511|NCT05280717|156713566|FG000|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
48689512|NCT05280717|156713567|FG001|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
48763619|NCT00615056|156983960|FG000|Overall Study|Other|13|||
49024158|NCT01223365|157927563|FG000|Open-label Treatment Period|Noncompliance with study drug admin|7|||
49024159|NCT01223365|157927563|FG000|Open-label Treatment Period|Noncompliance with study procedures|6|||
49024160|NCT01223365|157927563|FG000|Open-label Treatment Period|Moved out of area|2|||
49024161|NCT01223365|157927563|FG000|Open-label Treatment Period|Negative urine drug screen when on treat|1|||
49024162|NCT01223365|157927563|FG000|Open-label Treatment Period|"Out of window"|1|||
49024163|NCT01223365|157927563|FG000|Open-label Treatment Period|Starting physical therapy|1|||
49024164|NCT01223365|157927563|FG000|Open-label Treatment Period|Physician Decision|2|||
48689513|NCT05280717|156713568|FG002|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
48689514|NCT05280717|156713569|FG003|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
48689515|NCT05280717|156713570|FG004|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
48689516|NCT05280717|156713571|FG005|Part C (Up to Week 35)|Enrolled but not received treatment|2|||
48689517|NCT05280717|156713572|FG006|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
48689518|NCT00657046|156713573|FG000|Overall Study|Adverse Event|1|||
49024165|NCT01949662|157927564|FG000|Overall Study|Death|9|||
48689519|NCT00657046|156713574|FG001|Overall Study|Adverse Event|1|||
48689520|NCT00657046|156713575|FG002|Overall Study|Adverse Event|0|||
48689521|NCT00657046|156713573|FG000|Overall Study|Protocol Violation|2|||
48689522|NCT00657046|156713574|FG001|Overall Study|Protocol Violation|2|||
48689523|NCT00657046|156713575|FG002|Overall Study|Protocol Violation|0|||
48689524|NCT00657046|156713573|FG000|Overall Study|Withdrawal by Subject|1|||
48689525|NCT00657046|156713574|FG001|Overall Study|Withdrawal by Subject|0|||
48689526|NCT00657046|156713575|FG002|Overall Study|Withdrawal by Subject|0|||
48689527|NCT00657046|156713573|FG000|Overall Study|Death|0|||
48689528|NCT00657046|156713574|FG001|Overall Study|Death|0|||
48689529|NCT00657046|156713575|FG002|Overall Study|Death|1|||
48689530|NCT00657046|156713573|FG000|Overall Study|Surgery|0|||
48689531|NCT00657046|156713574|FG001|Overall Study|Surgery|0|||
48689532|NCT00657046|156713575|FG002|Overall Study|Surgery|1|||
48689533|NCT02525471|156713585|FG000|Overall Study|Screen Failure|6|||
48689534|NCT02525471|156713585|FG000|Overall Study|Withdrawal by Subject|4|||
48689535|NCT02525471|156713585|FG000|Overall Study|Death|1|||
48689536|NCT00844376|156713590|FG000|Period 1: First Intervention|Withdrawal by Subject|1|||
48689537|NCT00844376|156713591|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
48689538|NCT01392547|156715481|FG000|Overall Study|Adverse Event|2|||
48689539|NCT01392547|156715481|FG000|Overall Study|Non-compliance|2|||
48689540|NCT01392547|156715481|FG000|Overall Study|Withdrawal criteria|3|||
48689541|NCT01392547|156715481|FG000|Overall Study|Unclassified|1|||
48689542|NCT02831764|156715482|FG000|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
48689543|NCT02831764|156715483|FG001|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|2|||
48689544|NCT02831764|156715484|FG002|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
48689545|NCT02831764|156715485|FG003|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
48689546|NCT02831764|156715486|FG004|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
48689547|NCT02831764|156715482|FG000|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
48689548|NCT02831764|156715483|FG001|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
48689549|NCT02831764|156715484|FG002|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
48689550|NCT02831764|156715485|FG003|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
48689551|NCT02831764|156715486|FG004|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
48689552|NCT02831764|156715482|FG000|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
48689553|NCT02831764|156715483|FG001|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
48689554|NCT02831764|156715484|FG002|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
48689555|NCT02831764|156715485|FG003|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
48689556|NCT02831764|156715486|FG004|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
48689557|NCT02831764|156715482|FG000|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|9|||
48689558|NCT02831764|156715483|FG001|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|7|||
48689559|NCT02831764|156715484|FG002|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
48689560|NCT02831764|156715485|FG003|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
48689561|NCT02831764|156715486|FG004|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
48689562|NCT02831764|156715482|FG000|Double-blind Phase (Day1 to Week 96)|Adverse Event|10|||
48689563|NCT02831764|156715483|FG001|Double-blind Phase (Day1 to Week 96)|Adverse Event|6|||
48689564|NCT02831764|156715484|FG002|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
48689565|NCT02831764|156715485|FG003|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
48689566|NCT02831764|156715486|FG004|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
48689567|NCT02831764|156715482|FG000|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|5|||
48689568|NCT02831764|156715483|FG001|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|2|||
48689569|NCT02831764|156715484|FG002|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
48689570|NCT02831764|156715485|FG003|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
48689571|NCT02831764|156715486|FG004|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
48689572|NCT02831764|156715482|FG000|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|5|||
49024166|NCT01949662|157927565|FG001|Overall Study|Death|7|||
48689573|NCT02831764|156715483|FG001|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|3|||
48689574|NCT02831764|156715484|FG002|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
48689575|NCT02831764|156715485|FG003|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
48689576|NCT02831764|156715486|FG004|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
48689577|NCT02831764|156715482|FG000|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
48689578|NCT02831764|156715483|FG001|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|3|||
48689579|NCT02831764|156715484|FG002|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
48763620|NCT00615056|156983961|FG001|Overall Study|Other|15|||
48763621|NCT00615056|156983962|FG002|Overall Study|Other|10|||
48763622|NCT00615056|156983963|FG003|Overall Study|Other|7|||
48763623|NCT00615056|156983960|FG000|Overall Study|Objective progression or relapse|0|||
48763624|NCT00615056|156983961|FG001|Overall Study|Objective progression or relapse|2|||
48763625|NCT00615056|156983962|FG002|Overall Study|Objective progression or relapse|0|||
48763626|NCT00615056|156983963|FG003|Overall Study|Objective progression or relapse|0|||
48763627|NCT00615056|156983960|FG000|Overall Study|Withdrawal by Subject|0|||
48763628|NCT00615056|156983961|FG001|Overall Study|Withdrawal by Subject|1|||
48763629|NCT00615056|156983962|FG002|Overall Study|Withdrawal by Subject|1|||
48763630|NCT00615056|156983963|FG003|Overall Study|Withdrawal by Subject|0|||
48763631|NCT00615056|156983960|FG000|Overall Study|Discontinued by Sponsor|1|||
48763632|NCT00615056|156983961|FG001|Overall Study|Discontinued by Sponsor|0|||
48763633|NCT00615056|156983962|FG002|Overall Study|Discontinued by Sponsor|0|||
48763634|NCT00615056|156983963|FG003|Overall Study|Discontinued by Sponsor|0|||
48763635|NCT00615056|156983960|FG000|Overall Study|Randomized but not treated|3|||
48763636|NCT00615056|156983961|FG001|Overall Study|Randomized but not treated|0|||
48763637|NCT00615056|156983962|FG002|Overall Study|Randomized but not treated|0|||
48763638|NCT00615056|156983963|FG003|Overall Study|Randomized but not treated|0|||
48763639|NCT02276612|156983966|FG000|Overall Study|Death|1|||
48763640|NCT02276612|156983967|FG001|Overall Study|Death|0|||
48763641|NCT02276612|156983966|FG000|Overall Study|Pregnancy|1|||
48763642|NCT02276612|156983967|FG001|Overall Study|Pregnancy|0|||
48763643|NCT02276612|156983966|FG000|Overall Study|Withdrew Consent|1|||
48763644|NCT02276612|156983967|FG001|Overall Study|Withdrew Consent|0|||
48875351|NCT00236184|157381620|FG000|Overall Study|Protocol Violation|3|||
48875352|NCT00236184|157381621|FG001|Overall Study|Protocol Violation|0|||
48875353|NCT00236184|157381620|FG000|Overall Study|non-compliance with study drug|2|||
48875354|NCT00236184|157381621|FG001|Overall Study|non-compliance with study drug|1|||
48875355|NCT00236184|157381620|FG000|Overall Study|other|1|||
48875356|NCT00236184|157381621|FG001|Overall Study|other|2|||
48875357|NCT00233389|157381624|FG000|Overall Study|Adverse Event|5|||
48875358|NCT00233389|157381625|FG001|Overall Study|Adverse Event|5|||
48875359|NCT00233389|157381624|FG000|Overall Study|Lack of Efficacy|11|||
48875360|NCT00233389|157381625|FG001|Overall Study|Lack of Efficacy|8|||
48875361|NCT00233389|157381624|FG000|Overall Study|Lost to Follow-up|1|||
48875362|NCT00233389|157381625|FG001|Overall Study|Lost to Follow-up|1|||
48875363|NCT00233389|157381624|FG000|Overall Study|Physician Decision|1|||
48875364|NCT00233389|157381625|FG001|Overall Study|Physician Decision|0|||
48875365|NCT00233389|157381624|FG000|Overall Study|Protocol Violation|0|||
48875366|NCT00233389|157381625|FG001|Overall Study|Protocol Violation|1|||
48875367|NCT00233389|157381624|FG000|Overall Study|Withdrawal by Subject|0|||
48875368|NCT00233389|157381625|FG001|Overall Study|Withdrawal by Subject|1|||
48875369|NCT04962698|157381633|FG000|Motor Imagery|Technical difficulty|1|||
48875370|NCT04962698|157381634|FG001|Motor Imagery|Technical difficulty|0|||
48875371|NCT04962698|157381633|FG000|Motor Imagery|Exclusion criteria met after enrollment|0|||
48875372|NCT04962698|157381634|FG001|Motor Imagery|Exclusion criteria met after enrollment|2|||
48689580|NCT02831764|156715485|FG003|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
48689581|NCT02831764|156715486|FG004|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
48689582|NCT02831764|156715482|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
48689583|NCT02831764|156715483|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
48689584|NCT02831764|156715484|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|1|||
48689585|NCT02831764|156715485|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
48689586|NCT02831764|156715486|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
48689587|NCT02831764|156715482|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
48689588|NCT02831764|156715483|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
48875373|NCT04962698|157381633|FG000|Kinesthetic MI|Technical difficulty|1|||
48875374|NCT04962698|157381634|FG001|Kinesthetic MI|Technical difficulty|0|||
48689589|NCT02831764|156715484|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
48763645|NCT02276612|156983966|FG000|Overall Study|Lost to Follow-up|1|||
48763646|NCT02276612|156983967|FG001|Overall Study|Lost to Follow-up|0|||
48763647|NCT04327986|156983968|FG000|Overall Study|Physician Decision|2|||
48763648|NCT04327986|156983969|FG001|Overall Study|Physician Decision|0|||
48763649|NCT04327986|156983970|FG002|Overall Study|Physician Decision|0|||
48763650|NCT04327986|156983968|FG000|Overall Study|Death|1|||
48875375|NCT04962698|157381633|FG000|Robotic-hand Interaction With MI|Technical difficulty|1|||
48981513|NCT00398086|157764298|FG002|Overall Study|Adverse Event|0|||
48689590|NCT02831764|156715485|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
48689591|NCT02831764|156715486|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
48689592|NCT02831764|156715482|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
48689593|NCT02831764|156715483|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
48689594|NCT02831764|156715484|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
48689595|NCT02831764|156715485|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
48689596|NCT02831764|156715486|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
48689597|NCT02831764|156715482|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
48689598|NCT02831764|156715483|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
48689599|NCT02831764|156715484|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|1|||
48689600|NCT02831764|156715485|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
48689601|NCT02831764|156715486|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
48689602|NCT02831764|156715482|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
48689603|NCT02831764|156715483|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
48689604|NCT02831764|156715484|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|4|||
48689605|NCT02831764|156715485|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
48689606|NCT02831764|156715486|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
48689607|NCT02831764|156715482|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
48689608|NCT02831764|156715483|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
48689609|NCT02831764|156715484|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
48689610|NCT02831764|156715485|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|3|||
48689611|NCT02831764|156715486|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
48689612|NCT02831764|156715482|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
48689613|NCT02831764|156715483|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
48689614|NCT02831764|156715484|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|7|||
48689615|NCT02831764|156715485|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|9|||
48689616|NCT02831764|156715486|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
48689617|NCT02831764|156715482|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
48689618|NCT02831764|156715483|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
48689619|NCT02831764|156715484|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
48689620|NCT02831764|156715485|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
48689621|NCT02831764|156715486|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
48689622|NCT02831764|156715482|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
48689623|NCT02831764|156715483|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
48689624|NCT02831764|156715484|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
48689625|NCT02831764|156715485|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
48689626|NCT02831764|156715486|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|2|||
48689627|NCT02831764|156715482|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
48689628|NCT02831764|156715483|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
48689629|NCT02831764|156715484|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
48689630|NCT02831764|156715485|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
48689631|NCT02831764|156715486|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|5|||
48689632|NCT02831764|156715482|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
48689633|NCT02831764|156715483|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
48689634|NCT02831764|156715484|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
48689635|NCT02831764|156715485|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
48689636|NCT02831764|156715486|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|5|||
48689637|NCT01045967|156715487|FG000|Second Intervention|Protocol Violation|0|||
48689638|NCT01045967|156715488|FG001|Second Intervention|Protocol Violation|1|||
48689639|NCT06308822|156715491|FG000|Overall Study|Mutation Status Not Confirmed|17|||
48689640|NCT06308822|156715491|FG000|Overall Study|Adverse Event|1|||
48689641|NCT06308822|156715491|FG000|Overall Study|Death|5|||
48689642|NCT06308822|156715491|FG000|Overall Study|Disease progression|8|||
48689643|NCT06308822|156715491|FG000|Overall Study|Withdrawal by Subject|1|||
48689644|NCT06308822|156715491|FG000|Overall Study|Physician Decision|3|||
48689645|NCT03007966|156715492|FG000|Overall Study|Did not meeting inclusion/exclusion|1|||
48763651|NCT04327986|156983969|FG001|Overall Study|Death|0|||
48763652|NCT04327986|156983970|FG002|Overall Study|Death|0|||
48763653|NCT00834912|156983971|FG000|Treatment Period 1|Adverse Event|0|||
48763654|NCT00834912|156983972|FG001|Treatment Period 1|Adverse Event|1|||
48763655|NCT00834912|156983973|FG002|Treatment Period 1|Adverse Event|0|||
48763656|NCT00834912|156983974|FG003|Treatment Period 1|Adverse Event|1|||
48763657|NCT00834912|156983975|FG004|Treatment Period 1|Adverse Event|0|||
48763658|NCT00834912|156983976|FG005|Treatment Period 1|Adverse Event|0|||
48763659|NCT00834912|156983971|FG000|Treatment Period 2|Withdrawal by Subject|0|||
48763660|NCT00834912|156983972|FG001|Treatment Period 2|Withdrawal by Subject|0|||
48689646|NCT03007966|156715493|FG001|Overall Study|Did not meeting inclusion/exclusion|0|||
48689647|NCT01421017|156715494|FG000|Overall Study|Withdrawal by Subject|2|||
48689648|NCT01421017|156715495|FG001|Overall Study|Withdrawal by Subject|0|||
48689649|NCT01421017|156715496|FG002|Overall Study|Withdrawal by Subject|0|||
48689650|NCT01421017|156715494|FG000|Overall Study|POD|0|||
48763661|NCT00834912|156983973|FG002|Treatment Period 2|Withdrawal by Subject|1|||
48763662|NCT00834912|156983974|FG003|Treatment Period 2|Withdrawal by Subject|0|||
48763663|NCT00834912|156983975|FG004|Treatment Period 2|Withdrawal by Subject|1|||
48763664|NCT00834912|156983976|FG005|Treatment Period 2|Withdrawal by Subject|0|||
48763665|NCT04536727|156983977|FG000|Overall Study|Lost to Follow-up|1|||
48763666|NCT04536727|156983978|FG001|Overall Study|Lost to Follow-up|1|||
48763667|NCT04536727|156983977|FG000|Overall Study|Death|0|||
48763668|NCT04536727|156983978|FG001|Overall Study|Death|1|||
48763669|NCT00344773|156983979|FG000|Overall Study|Adverse Event|2|||
48763670|NCT00344773|156983979|FG000|Overall Study|Objective Disease Progression|16|||
48763671|NCT00344773|156983979|FG000|Overall Study|Withdrawal by Subject|1|||
48763672|NCT00344773|156983979|FG000|Overall Study|Not Eligible for the study|2|||
48763673|NCT00244712|156983980|FG000|Overall Study|Adverse Event|20|||
48763674|NCT00244712|156983981|FG001|Overall Study|Adverse Event|21|||
48763675|NCT00244712|156983980|FG000|Overall Study|Protocol-Defined Virologic Failure|8|||
48689651|NCT01421017|156715495|FG001|Overall Study|POD|6|||
48689652|NCT01421017|156715496|FG002|Overall Study|POD|3|||
48689653|NCT00859547|156715499|FG000|Overall Study|Lost to Follow-up|1|||
48689654|NCT00859547|156715499|FG000|Overall Study|Parent withdrew consent|1|||
48689655|NCT03310723|156715502|FG000|Overall Study|Withdrawal by Subject|0|||
48689656|NCT03310723|156715503|FG001|Overall Study|Withdrawal by Subject|1|||
48689657|NCT03310723|156715502|FG000|Overall Study|Protocol Violation|0|||
48689658|NCT03310723|156715503|FG001|Overall Study|Protocol Violation|2|||
48689659|NCT05579977|156715504|FG000|Treatment Phase|Other|0|||
48689660|NCT05579977|156715505|FG001|Treatment Phase|Other|0|||
48689661|NCT05579977|156715506|FG002|Treatment Phase|Other|0|||
48689662|NCT05579977|156715507|FG003|Treatment Phase|Other|2|||
48689663|NCT05579977|156715508|FG004|Treatment Phase|Other|1|||
48689664|NCT05579977|156715509|FG005|Treatment Phase|Other|2|||
48689665|NCT05579977|156715510|FG006|Treatment Phase|Other|1|||
48689666|NCT05579977|156715511|FG007|Treatment Phase|Other|2|||
48689667|NCT05579977|156715512|FG008|Treatment Phase|Other|2|||
48689668|NCT05579977|156715513|FG009|Treatment Phase|Other|1|||
48689669|NCT05579977|156715514|FG010|Treatment Phase|Other|0|||
48689670|NCT05579977|156715515|FG011|Treatment Phase|Other|0|||
48689671|NCT05579977|156715516|FG012|Treatment Phase|Other|3|||
48689672|NCT05579977|156715504|FG000|Treatment Phase|Treatment with restricted medication needed|2|||
48689673|NCT05579977|156715505|FG001|Treatment Phase|Treatment with restricted medication needed|0|||
48689674|NCT05579977|156715506|FG002|Treatment Phase|Treatment with restricted medication needed|0|||
48689675|NCT05579977|156715507|FG003|Treatment Phase|Treatment with restricted medication needed|0|||
48689676|NCT05579977|156715508|FG004|Treatment Phase|Treatment with restricted medication needed|0|||
48689677|NCT05579977|156715509|FG005|Treatment Phase|Treatment with restricted medication needed|1|||
48689678|NCT05579977|156715510|FG006|Treatment Phase|Treatment with restricted medication needed|0|||
48763676|NCT00244712|156983981|FG001|Overall Study|Protocol-Defined Virologic Failure|6|||
48763677|NCT00244712|156983980|FG000|Overall Study|Lack of Compliance|10|||
48763678|NCT00244712|156983981|FG001|Overall Study|Lack of Compliance|11|||
48763679|NCT00244712|156983980|FG000|Overall Study|Lost to Follow-up|45|||
48763680|NCT00244712|156983981|FG001|Overall Study|Lost to Follow-up|52|||
48763681|NCT00244712|156983980|FG000|Overall Study|Withdrawal by Subject|13|||
48763682|NCT00244712|156983981|FG001|Overall Study|Withdrawal by Subject|23|||
48763683|NCT00244712|156983980|FG000|Overall Study|Protocol Violation, disease progression|13|||
48763684|NCT00244712|156983981|FG001|Overall Study|Protocol Violation, disease progression|11|||
48763685|NCT00500370|156983984|FG000|Overall Study|Adverse Event|9|||
48689679|NCT05579977|156715511|FG007|Treatment Phase|Treatment with restricted medication needed|0|||
48689680|NCT05579977|156715512|FG008|Treatment Phase|Treatment with restricted medication needed|0|||
48689681|NCT05579977|156715513|FG009|Treatment Phase|Treatment with restricted medication needed|0|||
48689682|NCT05579977|156715514|FG010|Treatment Phase|Treatment with restricted medication needed|0|||
48689683|NCT05579977|156715515|FG011|Treatment Phase|Treatment with restricted medication needed|0|||
48689684|NCT05579977|156715516|FG012|Treatment Phase|Treatment with restricted medication needed|0|||
48763686|NCT00500370|156983985|FG001|Overall Study|Adverse Event|3|||
48763687|NCT00500370|156983984|FG000|Overall Study|Lost to Follow-up|10|||
48689685|NCT05579977|156715504|FG000|Treatment Phase|Withdrawal by Subject|2|||
48689686|NCT05579977|156715505|FG001|Treatment Phase|Withdrawal by Subject|0|||
48763688|NCT00500370|156983985|FG001|Overall Study|Lost to Follow-up|10|||
48763689|NCT00500370|156983984|FG000|Overall Study|Protocol Violation|2|||
48763690|NCT00500370|156983985|FG001|Overall Study|Protocol Violation|4|||
48763691|NCT00500370|156983984|FG000|Overall Study|Sponsor Decision|2|||
48689687|NCT05579977|156715506|FG002|Treatment Phase|Withdrawal by Subject|0|||
48689688|NCT05579977|156715507|FG003|Treatment Phase|Withdrawal by Subject|1|||
48689689|NCT05579977|156715508|FG004|Treatment Phase|Withdrawal by Subject|2|||
48763692|NCT00500370|156983985|FG001|Overall Study|Sponsor Decision|0|||
48689690|NCT05579977|156715509|FG005|Treatment Phase|Withdrawal by Subject|0|||
48689691|NCT05579977|156715510|FG006|Treatment Phase|Withdrawal by Subject|1|||
48689692|NCT05579977|156715511|FG007|Treatment Phase|Withdrawal by Subject|8|||
48689693|NCT05579977|156715512|FG008|Treatment Phase|Withdrawal by Subject|3|||
48689694|NCT05579977|156715513|FG009|Treatment Phase|Withdrawal by Subject|3|||
48689695|NCT05579977|156715514|FG010|Treatment Phase|Withdrawal by Subject|5|||
48689696|NCT05579977|156715515|FG011|Treatment Phase|Withdrawal by Subject|1|||
48689697|NCT05579977|156715516|FG012|Treatment Phase|Withdrawal by Subject|3|||
48689698|NCT05579977|156715504|FG000|Treatment Phase|Study terminated by sponsor|70|||
48689699|NCT05579977|156715505|FG001|Treatment Phase|Study terminated by sponsor|70|||
48689700|NCT05579977|156715506|FG002|Treatment Phase|Study terminated by sponsor|61|||
48689701|NCT05579977|156715507|FG003|Treatment Phase|Study terminated by sponsor|59|||
48689702|NCT05579977|156715508|FG004|Treatment Phase|Study terminated by sponsor|63|||
48689703|NCT05579977|156715509|FG005|Treatment Phase|Study terminated by sponsor|53|||
48689704|NCT05579977|156715510|FG006|Treatment Phase|Study terminated by sponsor|66|||
48689705|NCT05579977|156715511|FG007|Treatment Phase|Study terminated by sponsor|48|||
48689706|NCT05579977|156715512|FG008|Treatment Phase|Study terminated by sponsor|47|||
48689707|NCT05579977|156715513|FG009|Treatment Phase|Study terminated by sponsor|37|||
48689708|NCT05579977|156715514|FG010|Treatment Phase|Study terminated by sponsor|44|||
48689709|NCT05579977|156715515|FG011|Treatment Phase|Study terminated by sponsor|36|||
48689710|NCT05579977|156715516|FG012|Treatment Phase|Study terminated by sponsor|32|||
48689711|NCT05579977|156715504|FG000|Treatment Phase|Pregnancy|0|||
48689712|NCT05579977|156715505|FG001|Treatment Phase|Pregnancy|0|||
48689713|NCT05579977|156715506|FG002|Treatment Phase|Pregnancy|0|||
48689714|NCT05579977|156715507|FG003|Treatment Phase|Pregnancy|0|||
48689715|NCT05579977|156715508|FG004|Treatment Phase|Pregnancy|0|||
48689716|NCT05579977|156715509|FG005|Treatment Phase|Pregnancy|0|||
48689717|NCT05579977|156715510|FG006|Treatment Phase|Pregnancy|0|||
48689718|NCT05579977|156715511|FG007|Treatment Phase|Pregnancy|0|||
48689719|NCT05579977|156715512|FG008|Treatment Phase|Pregnancy|0|||
48689720|NCT05579977|156715513|FG009|Treatment Phase|Pregnancy|1|||
48689721|NCT05579977|156715514|FG010|Treatment Phase|Pregnancy|0|||
48689722|NCT05579977|156715515|FG011|Treatment Phase|Pregnancy|0|||
48689723|NCT05579977|156715516|FG012|Treatment Phase|Pregnancy|0|||
48689724|NCT05579977|156715504|FG000|Treatment Phase|Physician Decision|0|||
48689725|NCT05579977|156715505|FG001|Treatment Phase|Physician Decision|0|||
48689726|NCT05579977|156715506|FG002|Treatment Phase|Physician Decision|0|||
48689727|NCT05579977|156715507|FG003|Treatment Phase|Physician Decision|0|||
48689728|NCT05579977|156715508|FG004|Treatment Phase|Physician Decision|0|||
48689729|NCT05579977|156715509|FG005|Treatment Phase|Physician Decision|0|||
48689730|NCT05579977|156715510|FG006|Treatment Phase|Physician Decision|0|||
48689731|NCT05579977|156715511|FG007|Treatment Phase|Physician Decision|0|||
48689732|NCT05579977|156715512|FG008|Treatment Phase|Physician Decision|0|||
48689733|NCT05579977|156715513|FG009|Treatment Phase|Physician Decision|0|||
48689734|NCT05579977|156715514|FG010|Treatment Phase|Physician Decision|0|||
48689735|NCT05579977|156715515|FG011|Treatment Phase|Physician Decision|1|||
48689736|NCT05579977|156715516|FG012|Treatment Phase|Physician Decision|0|||
48689737|NCT05579977|156715504|FG000|Treatment Phase|Lost to Follow-up|0|||
48689738|NCT05579977|156715505|FG001|Treatment Phase|Lost to Follow-up|0|||
48689739|NCT05579977|156715506|FG002|Treatment Phase|Lost to Follow-up|0|||
48689740|NCT05579977|156715507|FG003|Treatment Phase|Lost to Follow-up|1|||
48689741|NCT05579977|156715508|FG004|Treatment Phase|Lost to Follow-up|1|||
48689742|NCT05579977|156715509|FG005|Treatment Phase|Lost to Follow-up|1|||
48689743|NCT05579977|156715510|FG006|Treatment Phase|Lost to Follow-up|0|||
48689744|NCT05579977|156715511|FG007|Treatment Phase|Lost to Follow-up|1|||
48689745|NCT05579977|156715512|FG008|Treatment Phase|Lost to Follow-up|2|||
48689746|NCT05579977|156715513|FG009|Treatment Phase|Lost to Follow-up|2|||
48689747|NCT05579977|156715514|FG010|Treatment Phase|Lost to Follow-up|1|||
48689748|NCT05579977|156715515|FG011|Treatment Phase|Lost to Follow-up|4|||
48689749|NCT05579977|156715516|FG012|Treatment Phase|Lost to Follow-up|3|||
48689750|NCT05579977|156715504|FG000|Treatment Phase|Death|1|||
48763693|NCT00500370|156983984|FG000|Overall Study|Subject Decision|10|||
48875376|NCT04962698|157381634|FG001|Robotic-hand Interaction With MI|Technical difficulty|0|||
48689751|NCT05579977|156715505|FG001|Treatment Phase|Death|0|||
48689752|NCT05579977|156715506|FG002|Treatment Phase|Death|0|||
48689753|NCT05579977|156715507|FG003|Treatment Phase|Death|0|||
48689754|NCT05579977|156715508|FG004|Treatment Phase|Death|0|||
48689755|NCT05579977|156715509|FG005|Treatment Phase|Death|0|||
48689756|NCT05579977|156715510|FG006|Treatment Phase|Death|0|||
48689757|NCT05579977|156715511|FG007|Treatment Phase|Death|0|||
48689758|NCT05579977|156715512|FG008|Treatment Phase|Death|0|||
48689759|NCT05579977|156715513|FG009|Treatment Phase|Death|0|||
48689760|NCT05579977|156715514|FG010|Treatment Phase|Death|0|||
48689761|NCT05579977|156715515|FG011|Treatment Phase|Death|0|||
48689762|NCT05579977|156715516|FG012|Treatment Phase|Death|0|||
48689763|NCT05579977|156715504|FG000|Treatment Phase|Adverse Event|0|||
48689764|NCT05579977|156715505|FG001|Treatment Phase|Adverse Event|3|||
48689765|NCT05579977|156715506|FG002|Treatment Phase|Adverse Event|11|||
48689766|NCT05579977|156715507|FG003|Treatment Phase|Adverse Event|10|||
48763694|NCT00500370|156983985|FG001|Overall Study|Subject Decision|17|||
48763695|NCT00714259|156983987|FG000|Overall Study|Death|2|||
48763696|NCT02016625|156985706|FG000|Cyclo or Tac (Single Dose, Day 1)|not treated|0|||
48763697|NCT02016625|156985707|FG001|Cyclo or Tac (Single Dose, Day 1)|not treated|1|||
48763698|NCT02016625|156985706|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1|||
48763699|NCT02016625|156985707|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0|||
48763700|NCT02016625|156985706|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2|||
49024167|NCT01949662|157927564|FG000|Overall Study|Discharged before an agitation event|8|||
49024168|NCT01949662|157927565|FG001|Overall Study|Discharged before an agitation event|3|||
49024169|NCT01949662|157927564|FG000|Overall Study|Dropped out|1|||
49024170|NCT01949662|157927565|FG001|Overall Study|Dropped out|3|||
49024171|NCT01949662|157927564|FG000|Overall Study|Ineligible|0|||
49024172|NCT01949662|157927565|FG001|Overall Study|Ineligible|1|||
49024173|NCT02637232|157928743|FG000|Overall Study|Lost to Follow-up|42|||
49024174|NCT02637232|157928743|FG000|Overall Study|Adverse Event|11|||
49024175|NCT02637232|157928743|FG000|Overall Study|patient 's decision|2|||
49024176|NCT01781637|157928744|FG000|Overall Study|Adverse Event|1|||
49024177|NCT01781637|157928745|FG001|Overall Study|Adverse Event|0|||
49024178|NCT01781637|157928744|FG000|Overall Study|Lack of Efficacy|2|||
49024179|NCT01781637|157928745|FG001|Overall Study|Lack of Efficacy|6|||
49024180|NCT01781637|157928744|FG000|Overall Study|Withdrawal by Subject|1|||
49024181|NCT01781637|157928745|FG001|Overall Study|Withdrawal by Subject|0|||
49024182|NCT00683293|157928746|FG000|Overall Study|Withdrawal by Subject|2|||
49024183|NCT00683293|157928747|FG001|Overall Study|Withdrawal by Subject|3|||
49024184|NCT00090857|157928749|FG000|Overall Study|Lost to Follow-up|0|||
49024185|NCT00090857|157928750|FG001|Overall Study|Lost to Follow-up|1|||
49024186|NCT00090857|157928749|FG000|Overall Study|Withdrawal by Subject|2|||
49024187|NCT00090857|157928750|FG001|Overall Study|Withdrawal by Subject|0|||
49024188|NCT00090857|157928749|FG000|Overall Study|Adverse Event|2|||
49024189|NCT00090857|157928750|FG001|Overall Study|Adverse Event|2|||
49024190|NCT05097326|157928751|FG000|Overall Study|Spontaneous labor prior to medication administration|1|||
49024191|NCT05097326|157928752|FG001|Overall Study|Spontaneous labor prior to medication administration|0|||
49024194|NCT02684344|157928756|FG000|Overall Study|Withdrawal by Subject|0|||
49024195|NCT02684344|157928757|FG001|Overall Study|Withdrawal by Subject|1|||
49024196|NCT01244126|157928758|FG000|Overall Study|Protocol Violation|3|||
49024197|NCT01244126|157928759|FG001|Overall Study|Protocol Violation|3|||
49024198|NCT01244126|157928760|FG002|Overall Study|Protocol Violation|9|||
49024199|NCT02246478|157928763|FG000|Multiple-dose Phase|Protocol Violation|1|||
49024200|NCT02246478|157928764|FG001|Multiple-dose Phase|Protocol Violation|0|||
49024201|NCT02246478|157928765|FG002|Multiple-dose Phase|Protocol Violation|0|||
49024202|NCT02246478|157928766|FG003|Multiple-dose Phase|Protocol Violation|1|||
49024203|NCT04176965|157928767|FG000|Overall Study|Death|1|||
49024204|NCT04176965|157928768|FG001|Overall Study|Death|2|||
49024205|NCT04176965|157928767|FG000|Overall Study|Lost to Follow-up|10|||
49024206|NCT04176965|157928768|FG001|Overall Study|Lost to Follow-up|2|||
49024207|NCT04176965|157928767|FG000|Overall Study|Withdrawal by Subject|6|||
49024208|NCT04176965|157928768|FG001|Overall Study|Withdrawal by Subject|1|||
49024209|NCT03903146|157928769|FG000|Overall Study|Lost to Follow-up|6|||
49024210|NCT03903146|157928770|FG001|Overall Study|Lost to Follow-up|4|||
49024211|NCT03903146|157928769|FG000|Overall Study|Withdrawal by Subject|0|||
49024212|NCT03903146|157928770|FG001|Overall Study|Withdrawal by Subject|1|||
49024213|NCT01900730|157928771|FG000|Overall Study|Withdrawal by Subject|1|||
49024214|NCT01900730|157928772|FG001|Overall Study|Withdrawal by Subject|0|||
49024215|NCT01900730|157928771|FG000|Overall Study|Screen Failure|1|||
49024216|NCT01900730|157928772|FG001|Overall Study|Screen Failure|0|||
49024217|NCT00051025|157928773|FG000|Overall Study|Progressive Disease|1|||
49024218|NCT00051025|157928774|FG001|Overall Study|Progressive Disease|1|||
49024219|NCT00051025|157928773|FG000|Overall Study|Adverse Event|1|||
49024220|NCT00051025|157928774|FG001|Overall Study|Adverse Event|1|||
49024221|NCT00051025|157928773|FG000|Overall Study|Withdrawal by Subject|0|||
49024222|NCT00051025|157928774|FG001|Overall Study|Withdrawal by Subject|1|||
49024223|NCT00051025|157928773|FG000|Overall Study|Death|0|||
49024224|NCT00051025|157928774|FG001|Overall Study|Death|1|||
48763701|NCT02016625|156985707|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0|||
48763702|NCT02155738|156985708|FG000|Overall Study|Missing critical information|1|||
49024225|NCT00386009|157928777|FG000|Overall Study|Adverse Event|0|||
49024226|NCT00386009|157928778|FG001|Overall Study|Adverse Event|2|||
49024227|NCT00386009|157928777|FG000|Overall Study|Death|1|||
49024228|NCT00386009|157928778|FG001|Overall Study|Death|0|||
49024229|NCT00386009|157928777|FG000|Overall Study|Entry Criteria Not Met|0|||
49024230|NCT00386009|157928778|FG001|Overall Study|Entry Criteria Not Met|2|||
49024231|NCT00386009|157928777|FG000|Overall Study|Lost to Follow-up|1|||
49024232|NCT00386009|157928778|FG001|Overall Study|Lost to Follow-up|1|||
49024233|NCT00386009|157928777|FG000|Overall Study|Protocol Violation|1|||
49024234|NCT00386009|157928778|FG001|Overall Study|Protocol Violation|0|||
48689767|NCT05579977|156715508|FG004|Treatment Phase|Adverse Event|5|||
48689768|NCT05579977|156715509|FG005|Treatment Phase|Adverse Event|17|||
48689769|NCT05579977|156715510|FG006|Treatment Phase|Adverse Event|5|||
48689770|NCT05579977|156715511|FG007|Treatment Phase|Adverse Event|5|||
48689771|NCT05579977|156715512|FG008|Treatment Phase|Adverse Event|12|||
48689772|NCT05579977|156715513|FG009|Treatment Phase|Adverse Event|20|||
48689773|NCT05579977|156715514|FG010|Treatment Phase|Adverse Event|15|||
48689774|NCT05579977|156715515|FG011|Treatment Phase|Adverse Event|24|||
48689775|NCT05579977|156715516|FG012|Treatment Phase|Adverse Event|23|||
48689776|NCT05579977|156715504|FG000|Treatment Phase|Randomized not treated|0|||
48689777|NCT05579977|156715505|FG001|Treatment Phase|Randomized not treated|0|||
48689778|NCT05579977|156715506|FG002|Treatment Phase|Randomized not treated|0|||
48689779|NCT05579977|156715507|FG003|Treatment Phase|Randomized not treated|0|||
48689780|NCT05579977|156715508|FG004|Treatment Phase|Randomized not treated|1|||
48689781|NCT05579977|156715509|FG005|Treatment Phase|Randomized not treated|0|||
48689782|NCT05579977|156715510|FG006|Treatment Phase|Randomized not treated|0|||
48689783|NCT05579977|156715511|FG007|Treatment Phase|Randomized not treated|0|||
48689784|NCT05579977|156715512|FG008|Treatment Phase|Randomized not treated|0|||
48689785|NCT05579977|156715513|FG009|Treatment Phase|Randomized not treated|0|||
48689786|NCT05579977|156715514|FG010|Treatment Phase|Randomized not treated|0|||
48689787|NCT05579977|156715515|FG011|Treatment Phase|Randomized not treated|0|||
48689788|NCT05579977|156715516|FG012|Treatment Phase|Randomized not treated|0|||
48689789|NCT05579977|156715504|FG000|Follow up|Death|1|||
48689790|NCT05579977|156715505|FG001|Follow up|Death|0|||
48689791|NCT05579977|156715506|FG002|Follow up|Death|0|||
48689792|NCT05579977|156715507|FG003|Follow up|Death|0|||
48689793|NCT05579977|156715508|FG004|Follow up|Death|0|||
48689794|NCT05579977|156715509|FG005|Follow up|Death|0|||
48689795|NCT05579977|156715510|FG006|Follow up|Death|0|||
48689796|NCT05579977|156715511|FG007|Follow up|Death|0|||
48689797|NCT05579977|156715512|FG008|Follow up|Death|0|||
48689798|NCT05579977|156715513|FG009|Follow up|Death|0|||
48689799|NCT05579977|156715514|FG010|Follow up|Death|0|||
48689800|NCT05579977|156715515|FG011|Follow up|Death|0|||
49024235|NCT00386009|157928777|FG000|Overall Study|Sponsor Decision|1|||
49024236|NCT00386009|157928778|FG001|Overall Study|Sponsor Decision|1|||
49024237|NCT00386009|157928777|FG000|Overall Study|Withdrawal by Subject|5|||
49024238|NCT00386009|157928778|FG001|Overall Study|Withdrawal by Subject|4|||
49024239|NCT00418184|157928781|FG000|Double-blind Phase|Withdrawal by Subject|22|||
49024240|NCT00418184|157928782|FG001|Double-blind Phase|Withdrawal by Subject|9|||
49024241|NCT00418184|157928781|FG000|Double-blind Phase|Adverse Event|2|||
49024242|NCT00418184|157928782|FG001|Double-blind Phase|Adverse Event|1|||
49024243|NCT00418184|157928781|FG000|Double-blind Phase|Poor compliance|3|||
49024244|NCT00418184|157928782|FG001|Double-blind Phase|Poor compliance|1|||
49024245|NCT01239121|157928783|FG000|Overall Study|Withdrawal by Subject|2|||
49024246|NCT01239121|157928784|FG001|Overall Study|Withdrawal by Subject|4|||
49024247|NCT01239121|157928785|FG002|Overall Study|Withdrawal by Subject|0|||
49024248|NCT04088760|157928786|FG000|Overall Study|Physician Decision|1|||
49024249|NCT02732210|157928790|FG000|Overall Study|Site Closed|0|||
49024250|NCT02732210|157928791|FG001|Overall Study|Site Closed|11|||
49024251|NCT02732210|157928790|FG000|Overall Study|Study Ended|13|||
49024252|NCT02732210|157928791|FG001|Overall Study|Study Ended|13|||
49024253|NCT02732210|157928790|FG000|Overall Study|Withdrawal by Subject|28|||
49024254|NCT02732210|157928791|FG001|Overall Study|Withdrawal by Subject|87|||
49024255|NCT02732210|157928790|FG000|Overall Study|Lost to Follow-up|5|||
49024256|NCT02732210|157928791|FG001|Overall Study|Lost to Follow-up|57|||
49024257|NCT02732210|157928790|FG000|Overall Study|Death|4|||
49024258|NCT02732210|157928791|FG001|Overall Study|Death|15|||
48689801|NCT05579977|156715516|FG012|Follow up|Death|0|||
48689802|NCT05579977|156715504|FG000|Follow up|Lost to Follow-up|0|||
48689803|NCT05579977|156715505|FG001|Follow up|Lost to Follow-up|0|||
48763703|NCT02155738|156985709|FG001|Overall Study|Missing critical information|0|||
49024259|NCT02732210|157928790|FG000|Overall Study|Other|35|||
49024260|NCT02732210|157928791|FG001|Overall Study|Other|103|||
49024261|NCT02732210|157928790|FG000|Overall Study|Missing|0|||
49024262|NCT02732210|157928791|FG001|Overall Study|Missing|8|||
49024263|NCT00925769|157928792|FG000|Overall Study|Major toxicity|1|||
49024264|NCT00925769|157928793|FG001|Overall Study|Major toxicity|0|||
49024265|NCT00925769|157928794|FG002|Overall Study|Major toxicity|1|||
48689804|NCT05579977|156715506|FG002|Follow up|Lost to Follow-up|0|||
48689805|NCT05579977|156715507|FG003|Follow up|Lost to Follow-up|1|||
48689806|NCT05579977|156715508|FG004|Follow up|Lost to Follow-up|1|||
48689807|NCT05579977|156715509|FG005|Follow up|Lost to Follow-up|2|||
48689808|NCT05579977|156715510|FG006|Follow up|Lost to Follow-up|1|||
48689809|NCT05579977|156715511|FG007|Follow up|Lost to Follow-up|1|||
48689810|NCT05579977|156715512|FG008|Follow up|Lost to Follow-up|3|||
48689811|NCT05579977|156715513|FG009|Follow up|Lost to Follow-up|2|||
48689812|NCT05579977|156715514|FG010|Follow up|Lost to Follow-up|2|||
48689813|NCT05579977|156715515|FG011|Follow up|Lost to Follow-up|4|||
48689814|NCT05579977|156715516|FG012|Follow up|Lost to Follow-up|4|||
48689815|NCT05579977|156715504|FG000|Follow up|Withdrawal by Subject|2|||
49024266|NCT00925769|157928795|FG003|Overall Study|Major toxicity|1|||
48689816|NCT05579977|156715505|FG001|Follow up|Withdrawal by Subject|0|||
48689817|NCT05579977|156715506|FG002|Follow up|Withdrawal by Subject|0|||
48689818|NCT05579977|156715507|FG003|Follow up|Withdrawal by Subject|0|||
48689819|NCT05579977|156715508|FG004|Follow up|Withdrawal by Subject|1|||
48689820|NCT05579977|156715509|FG005|Follow up|Withdrawal by Subject|0|||
48689821|NCT05579977|156715510|FG006|Follow up|Withdrawal by Subject|1|||
48689822|NCT05579977|156715511|FG007|Follow up|Withdrawal by Subject|4|||
48689823|NCT05579977|156715512|FG008|Follow up|Withdrawal by Subject|2|||
48689824|NCT05579977|156715513|FG009|Follow up|Withdrawal by Subject|3|||
48689825|NCT05579977|156715514|FG010|Follow up|Withdrawal by Subject|3|||
48689826|NCT05579977|156715515|FG011|Follow up|Withdrawal by Subject|1|||
48689827|NCT05579977|156715516|FG012|Follow up|Withdrawal by Subject|3|||
48689828|NCT00671034|156715519|FG000|Overall Study|Adverse Event|5|||
48689829|NCT00671034|156715520|FG001|Overall Study|Adverse Event|7|||
48689830|NCT00671034|156715521|FG002|Overall Study|Adverse Event|1|||
48689831|NCT00671034|156715519|FG000|Overall Study|Death|3|||
48689832|NCT00671034|156715520|FG001|Overall Study|Death|2|||
48689833|NCT00671034|156715521|FG002|Overall Study|Death|1|||
48689834|NCT00671034|156715519|FG000|Overall Study|Physician Decision|12|||
48689835|NCT00671034|156715520|FG001|Overall Study|Physician Decision|4|||
48689836|NCT00671034|156715521|FG002|Overall Study|Physician Decision|5|||
48689837|NCT00671034|156715519|FG000|Overall Study|VHR ALL feature|8|||
48689838|NCT00671034|156715520|FG001|Overall Study|VHR ALL feature|3|||
48689839|NCT00671034|156715521|FG002|Overall Study|VHR ALL feature|5|||
49024267|NCT00925769|157928796|FG004|Overall Study|Major toxicity|0|||
49024268|NCT00925769|157928797|FG005|Overall Study|Major toxicity|0|||
49024269|NCT00925769|157928792|FG000|Overall Study|Disease progression|4|||
49024270|NCT00925769|157928793|FG001|Overall Study|Disease progression|5|||
49024271|NCT00925769|157928794|FG002|Overall Study|Disease progression|3|||
49024272|NCT00925769|157928795|FG003|Overall Study|Disease progression|4|||
49024273|NCT00925769|157928796|FG004|Overall Study|Disease progression|2|||
49024274|NCT00925769|157928797|FG005|Overall Study|Disease progression|3|||
49024275|NCT00925769|157928792|FG000|Overall Study|Death|0|||
49024276|NCT00925769|157928793|FG001|Overall Study|Death|0|||
49024277|NCT00925769|157928794|FG002|Overall Study|Death|1|||
49024278|NCT00925769|157928795|FG003|Overall Study|Death|0|||
49024279|NCT00925769|157928796|FG004|Overall Study|Death|0|||
49024280|NCT00925769|157928797|FG005|Overall Study|Death|0|||
49024281|NCT00925769|157928792|FG000|Overall Study|Physician Decision|1|||
49024282|NCT00925769|157928793|FG001|Overall Study|Physician Decision|0|||
49024283|NCT00925769|157928794|FG002|Overall Study|Physician Decision|0|||
49024284|NCT00925769|157928795|FG003|Overall Study|Physician Decision|0|||
49024285|NCT00925769|157928796|FG004|Overall Study|Physician Decision|0|||
49024286|NCT00925769|157928797|FG005|Overall Study|Physician Decision|0|||
49024287|NCT00925769|157928792|FG000|Overall Study|Missing documentation|0|||
49024288|NCT00925769|157928793|FG001|Overall Study|Missing documentation|1|||
49024289|NCT00925769|157928794|FG002|Overall Study|Missing documentation|0|||
49024290|NCT00925769|157928795|FG003|Overall Study|Missing documentation|0|||
49024291|NCT00925769|157928796|FG004|Overall Study|Missing documentation|0|||
49024292|NCT00925769|157928797|FG005|Overall Study|Missing documentation|0|||
49024293|NCT00925769|157928792|FG000|Overall Study|End of study visit not done|0|||
49024294|NCT00925769|157928793|FG001|Overall Study|End of study visit not done|0|||
49024295|NCT00925769|157928794|FG002|Overall Study|End of study visit not done|1|||
49024296|NCT00925769|157928795|FG003|Overall Study|End of study visit not done|0|||
49024297|NCT00925769|157928796|FG004|Overall Study|End of study visit not done|0|||
49024298|NCT00925769|157928797|FG005|Overall Study|End of study visit not done|0|||
49024299|NCT00925769|157928792|FG000|Overall Study|Participant is unable to swallow drug|0|||
49024300|NCT00925769|157928793|FG001|Overall Study|Participant is unable to swallow drug|0|||
49024301|NCT00925769|157928794|FG002|Overall Study|Participant is unable to swallow drug|0|||
48689840|NCT00671034|156715519|FG000|Overall Study|Refusal|5|||
48689841|NCT00671034|156715520|FG001|Overall Study|Refusal|3|||
48689842|NCT00671034|156715521|FG002|Overall Study|Refusal|5|||
48689843|NCT00671034|156715519|FG000|Overall Study|includes Alternative therapy, etc.|6|||
48689844|NCT00671034|156715520|FG001|Overall Study|includes Alternative therapy, etc.|1|||
48689845|NCT00671034|156715521|FG002|Overall Study|includes Alternative therapy, etc.|7|||
48689846|NCT02043938|156715522|FG000|Overall Study|Withdrawal by Subject|7|||
49024302|NCT00925769|157928795|FG003|Overall Study|Participant is unable to swallow drug|1|||
49024303|NCT00925769|157928796|FG004|Overall Study|Participant is unable to swallow drug|0|||
48689847|NCT02043938|156715522|FG000|Overall Study|Unable to place EEG sensors on patient|1|||
48689848|NCT02043938|156715522|FG000|Overall Study|No show by subject|1|||
49024304|NCT00925769|157928797|FG005|Overall Study|Participant is unable to swallow drug|0|||
48689849|NCT02043938|156715522|FG000|Overall Study|Investigator decision|1|||
48689850|NCT00443040|156715523|FG000|Overall Study|Withdrawal by Subject|1|||
48689851|NCT00443040|156715524|FG001|Overall Study|Withdrawal by Subject|0|||
48689852|NCT00443040|156715525|FG002|Overall Study|Withdrawal by Subject|0|||
48689853|NCT00443040|156715523|FG000|Overall Study|Converted to an open laparotomy|3|||
48689854|NCT00443040|156715524|FG001|Overall Study|Converted to an open laparotomy|0|||
48689855|NCT00443040|156715525|FG002|Overall Study|Converted to an open laparotomy|1|||
49024305|NCT00925769|157928792|FG000|Overall Study|Adverse Event|0|||
49024306|NCT00925769|157928793|FG001|Overall Study|Adverse Event|0|||
49024307|NCT00925769|157928794|FG002|Overall Study|Adverse Event|0|||
49024308|NCT00925769|157928795|FG003|Overall Study|Adverse Event|0|||
49024309|NCT00925769|157928796|FG004|Overall Study|Adverse Event|1|||
49024310|NCT00925769|157928797|FG005|Overall Study|Adverse Event|0|||
49024311|NCT03401112|157928798|FG000|Overall Study|Adverse Event|1|||
49024312|NCT03401112|157928799|FG001|Overall Study|Adverse Event|2|||
49024313|NCT03401112|157928800|FG002|Overall Study|Adverse Event|3|||
48689856|NCT03922581|156715526|FG000|Overall Study|Lost to Follow-up|20|||
48689857|NCT03922581|156715527|FG001|Overall Study|Lost to Follow-up|9|||
48689858|NCT03922581|156715526|FG000|Overall Study|Physician Decision|1|||
48689859|NCT03922581|156715527|FG001|Overall Study|Physician Decision|1|||
48689860|NCT03922581|156715526|FG000|Overall Study|Withdrawal by Subject|1|||
48689861|NCT03922581|156715527|FG001|Overall Study|Withdrawal by Subject|0|||
48689862|NCT03369418|156715528|FG000|Overall Study|Withdrawal by Subject|3|||
48689863|NCT03369418|156715529|FG001|Overall Study|Withdrawal by Subject|3|||
48689864|NCT02756338|156715534|FG000|Overall Study|Withdrawn by Investigator|1|||
48689865|NCT02756338|156715534|FG000|Overall Study|Device Replaced with Pacemaker|4|||
48689866|NCT01176032|156715540|FG000|Overall Study|Adverse Event|1|||
48689867|NCT01176032|156715541|FG001|Overall Study|Adverse Event|0|||
48689868|NCT01176032|156715540|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
48689869|NCT01176032|156715541|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
48689870|NCT01176032|156715540|FG000|Overall Study|Protocol Violation|1|||
48689871|NCT01176032|156715541|FG001|Overall Study|Protocol Violation|0|||
48689872|NCT01176032|156715540|FG000|Overall Study|Informed consent withdrawn|3|||
48689873|NCT01176032|156715541|FG001|Overall Study|Informed consent withdrawn|0|||
48689874|NCT01176032|156715540|FG000|Overall Study|Other|1|||
48689875|NCT01176032|156715541|FG001|Overall Study|Other|0|||
48689876|NCT00667888|156715542|FG000|Overall Study|Death|1|||
48689877|NCT00667888|156715543|FG001|Overall Study|Death|1|||
48689878|NCT00667888|156715542|FG000|Overall Study|Withdrawal by Subject|6|||
48689879|NCT00667888|156715543|FG001|Overall Study|Withdrawal by Subject|3|||
48689880|NCT00667888|156715542|FG000|Overall Study|Proceed with other treatment|3|||
48689881|NCT00667888|156715543|FG001|Overall Study|Proceed with other treatment|3|||
48689882|NCT00667888|156715542|FG000|Overall Study|Ineligible after SIM|0|||
48689883|NCT00667888|156715543|FG001|Overall Study|Ineligible after SIM|2|||
48689884|NCT01945021|156715544|FG000|Overall Study|Adverse Event|1|||
48689885|NCT01945021|156715544|FG000|Overall Study|Withdrawal of consent|12|||
48689886|NCT01945021|156715544|FG000|Overall Study|Lost to Follow-up|5|||
48689887|NCT01945021|156715544|FG000|Overall Study|Death|65|||
49024314|NCT03401112|157928801|FG003|Overall Study|Adverse Event|2|||
49024315|NCT03401112|157928802|FG004|Overall Study|Adverse Event|0|||
49024316|NCT03401112|157928798|FG000|Overall Study|Lost to Follow-up|1|||
49024317|NCT03401112|157928799|FG001|Overall Study|Lost to Follow-up|0|||
49024318|NCT03401112|157928800|FG002|Overall Study|Lost to Follow-up|0|||
49024319|NCT03401112|157928801|FG003|Overall Study|Lost to Follow-up|0|||
49024320|NCT03401112|157928802|FG004|Overall Study|Lost to Follow-up|0|||
49024321|NCT03401112|157928798|FG000|Overall Study|Noncompliance|1|||
49024322|NCT03401112|157928799|FG001|Overall Study|Noncompliance|2|||
49024323|NCT03401112|157928800|FG002|Overall Study|Noncompliance|3|||
49024324|NCT03401112|157928801|FG003|Overall Study|Noncompliance|0|||
49024325|NCT03401112|157928802|FG004|Overall Study|Noncompliance|0|||
48689888|NCT00079040|156715545|FG000|Overall Study|Withdrew before treatment|1|||
48689889|NCT00079040|156715545|FG000|Overall Study|Ineligible|1|||
48689890|NCT01308736|156715546|FG000|Overall Study|Did not attend a single session|6|||
48689891|NCT01308736|156715547|FG001|Overall Study|Did not attend a single session|5|||
48689892|NCT00467740|156715554|FG000|Overall Study|Adverse Event|0|||
48689893|NCT00467740|156715555|FG001|Overall Study|Adverse Event|0|||
48689894|NCT00467740|156715556|FG002|Overall Study|Adverse Event|1|||
48689895|NCT00467740|156715557|FG003|Overall Study|Adverse Event|0|||
48689896|NCT00467740|156715558|FG004|Overall Study|Adverse Event|0|||
48689897|NCT00467740|156715554|FG000|Overall Study|Protocol Violation|0|||
48689898|NCT00467740|156715555|FG001|Overall Study|Protocol Violation|0|||
48689899|NCT00467740|156715556|FG002|Overall Study|Protocol Violation|1|||
48689900|NCT00467740|156715557|FG003|Overall Study|Protocol Violation|0|||
49024326|NCT03401112|157928798|FG000|Overall Study|Did not Meet Inclusion Criteria|1|||
49024327|NCT03401112|157928799|FG001|Overall Study|Did not Meet Inclusion Criteria|0|||
49024328|NCT03401112|157928800|FG002|Overall Study|Did not Meet Inclusion Criteria|0|||
49024329|NCT03401112|157928801|FG003|Overall Study|Did not Meet Inclusion Criteria|0|||
48689901|NCT00467740|156715558|FG004|Overall Study|Protocol Violation|0|||
48689902|NCT00467740|156715554|FG000|Overall Study|Lost to Follow-up|0|||
48689903|NCT00467740|156715555|FG001|Overall Study|Lost to Follow-up|1|||
48689904|NCT00467740|156715556|FG002|Overall Study|Lost to Follow-up|0|||
48689905|NCT00467740|156715557|FG003|Overall Study|Lost to Follow-up|0|||
49024330|NCT03401112|157928802|FG004|Overall Study|Did not Meet Inclusion Criteria|0|||
49024331|NCT03401112|157928798|FG000|Overall Study|Withdrawal by Subject|0|||
48689906|NCT00467740|156715558|FG004|Overall Study|Lost to Follow-up|0|||
48689907|NCT00467740|156715554|FG000|Overall Study|Withdrawal by Subject|1|||
48689908|NCT00467740|156715555|FG001|Overall Study|Withdrawal by Subject|1|||
48689909|NCT00467740|156715556|FG002|Overall Study|Withdrawal by Subject|0|||
48689910|NCT00467740|156715557|FG003|Overall Study|Withdrawal by Subject|1|||
48689911|NCT00467740|156715558|FG004|Overall Study|Withdrawal by Subject|0|||
48689912|NCT00467740|156715554|FG000|Overall Study|Lack of Efficacy|0|||
48689913|NCT00467740|156715555|FG001|Overall Study|Lack of Efficacy|1|||
48689914|NCT00467740|156715556|FG002|Overall Study|Lack of Efficacy|0|||
48689915|NCT00467740|156715557|FG003|Overall Study|Lack of Efficacy|0|||
48689916|NCT00467740|156715558|FG004|Overall Study|Lack of Efficacy|0|||
48689917|NCT02903160|156715559|FG000|Overall Study|Adverse Event|2|||
48689918|NCT02903160|156715559|FG000|Overall Study|Death|1|||
48689919|NCT02903160|156715559|FG000|Overall Study|Lost to Follow-up|2|||
48689920|NCT02903160|156715559|FG000|Overall Study|Withdrawal by Subject|1|||
48689921|NCT02903160|156715559|FG000|Overall Study|Medical Insurance Barriers|1|||
48689922|NCT00101686|156715560|FG000|Overall Study|Progressive Disease|37|||
48689923|NCT00101686|156715561|FG001|Overall Study|Progressive Disease|28|||
48689924|NCT00101686|156715562|FG002|Overall Study|Progressive Disease|37|||
48689925|NCT00101686|156715563|FG003|Overall Study|Progressive Disease|38|||
48689926|NCT00101686|156715564|FG004|Overall Study|Progressive Disease|28|||
48689927|NCT00101686|156715565|FG005|Overall Study|Progressive Disease|25|||
48689928|NCT00101686|156715566|FG006|Overall Study|Progressive Disease|5|||
48689929|NCT00101686|156715567|FG007|Overall Study|Progressive Disease|7|||
48689930|NCT00101686|156715568|FG008|Overall Study|Progressive Disease|10|||
48689931|NCT00101686|156715569|FG009|Overall Study|Progressive Disease|8|||
48689932|NCT00101686|156715560|FG000|Overall Study|initiation other anti-cancer treatment|4|||
48689933|NCT00101686|156715561|FG001|Overall Study|initiation other anti-cancer treatment|3|||
48689934|NCT00101686|156715562|FG002|Overall Study|initiation other anti-cancer treatment|4|||
48689935|NCT00101686|156715563|FG003|Overall Study|initiation other anti-cancer treatment|3|||
48689936|NCT00101686|156715564|FG004|Overall Study|initiation other anti-cancer treatment|1|||
48689937|NCT00101686|156715565|FG005|Overall Study|initiation other anti-cancer treatment|1|||
48689938|NCT00101686|156715566|FG006|Overall Study|initiation other anti-cancer treatment|2|||
48689939|NCT00101686|156715567|FG007|Overall Study|initiation other anti-cancer treatment|2|||
48981514|NCT00398086|157764296|FG000|Overall Study|Physician Decision|1|||
48689940|NCT00101686|156715568|FG008|Overall Study|initiation other anti-cancer treatment|3|||
48981515|NCT00398086|157764297|FG001|Overall Study|Physician Decision|4|||
48981516|NCT00398086|157764298|FG002|Overall Study|Physician Decision|0|||
48981517|NCT00398086|157764296|FG000|Overall Study|Withdrawal by Subject|5|||
48981518|NCT00398086|157764297|FG001|Overall Study|Withdrawal by Subject|7|||
48981519|NCT00398086|157764298|FG002|Overall Study|Withdrawal by Subject|0|||
48981520|NCT01950364|157764301|FG000|Overall Study|Adverse Event|3|||
48981521|NCT01950364|157764302|FG001|Overall Study|Adverse Event|0|||
48981522|NCT01950364|157764301|FG000|Overall Study|Stem Cell Transplant|2|||
48981523|NCT01950364|157764302|FG001|Overall Study|Stem Cell Transplant|6|||
48981524|NCT01950364|157764301|FG000|Overall Study|Disease Progression|5|||
48981525|NCT01950364|157764302|FG001|Overall Study|Disease Progression|2|||
48981526|NCT01950364|157764301|FG000|Overall Study|Withdrawal by Subject|0|||
48981527|NCT01950364|157764302|FG001|Overall Study|Withdrawal by Subject|1|||
48981528|NCT01950364|157764301|FG000|Overall Study|Protocol Violation|0|||
48981529|NCT01950364|157764302|FG001|Overall Study|Protocol Violation|1|||
48981530|NCT00033293|157764304|FG000|Overall Study|Death|0|||
48981531|NCT00033293|157764305|FG001|Overall Study|Death|1|||
48981532|NCT00033293|157764304|FG000|Overall Study|Lack of Efficacy|5|||
48981533|NCT00033293|157764305|FG001|Overall Study|Lack of Efficacy|8|||
48981534|NCT00033293|157764304|FG000|Overall Study|Lost to Follow-up|0|||
48981535|NCT00033293|157764305|FG001|Overall Study|Lost to Follow-up|1|||
48981536|NCT00033293|157764304|FG000|Overall Study|Physician Decision|3|||
48981537|NCT00033293|157764305|FG001|Overall Study|Physician Decision|1|||
48981538|NCT00033293|157764304|FG000|Overall Study|Withdrawal by Subject|1|||
48981539|NCT00033293|157764305|FG001|Overall Study|Withdrawal by Subject|0|||
48981540|NCT00033293|157764304|FG000|Overall Study|Could not be weaned from steroid therapy|1|||
48981541|NCT00033293|157764305|FG001|Overall Study|Could not be weaned from steroid therapy|1|||
48981542|NCT00033293|157764304|FG000|Overall Study|Treatment refused|0|||
48981543|NCT00033293|157764305|FG001|Overall Study|Treatment refused|6|||
48981544|NCT02087241|157764306|FG000|Overall Study|Death|2|||
48981545|NCT02087241|157764307|FG001|Overall Study|Death|1|||
48981546|NCT02087241|157764308|FG002|Overall Study|Death|1|||
48981547|NCT02087241|157764309|FG003|Overall Study|Death|1|||
48981548|NCT02087241|157764306|FG000|Overall Study|Withdrawal by Subject|1|||
48981549|NCT02087241|157764307|FG001|Overall Study|Withdrawal by Subject|0|||
48981550|NCT02087241|157764308|FG002|Overall Study|Withdrawal by Subject|0|||
48981551|NCT02087241|157764309|FG003|Overall Study|Withdrawal by Subject|1|||
48981552|NCT02087241|157764306|FG000|Overall Study|Progressive Disease|0|||
48981553|NCT02087241|157764307|FG001|Overall Study|Progressive Disease|0|||
48981554|NCT02087241|157764308|FG002|Overall Study|Progressive Disease|0|||
48981555|NCT02087241|157764309|FG003|Overall Study|Progressive Disease|1|||
48981556|NCT02087241|157764306|FG000|Overall Study|Study Terminated by Sponsor|0|||
49024332|NCT03401112|157928799|FG001|Overall Study|Withdrawal by Subject|3|||
49024333|NCT03401112|157928800|FG002|Overall Study|Withdrawal by Subject|2|||
49024334|NCT03401112|157928801|FG003|Overall Study|Withdrawal by Subject|1|||
49024335|NCT03401112|157928802|FG004|Overall Study|Withdrawal by Subject|0|||
49024336|NCT03401112|157928798|FG000|Overall Study|Physician Decision|0|||
49024337|NCT03401112|157928799|FG001|Overall Study|Physician Decision|0|||
49024338|NCT03401112|157928800|FG002|Overall Study|Physician Decision|0|||
49024339|NCT03401112|157928801|FG003|Overall Study|Physician Decision|2|||
49024340|NCT03401112|157928802|FG004|Overall Study|Physician Decision|0|||
49024341|NCT03401112|157928798|FG000|Overall Study|Study was Terminated by Sponsor|0|||
49024342|NCT03401112|157928799|FG001|Overall Study|Study was Terminated by Sponsor|0|||
49024343|NCT03401112|157928800|FG002|Overall Study|Study was Terminated by Sponsor|0|||
49024344|NCT03401112|157928801|FG003|Overall Study|Study was Terminated by Sponsor|1|||
49024345|NCT03401112|157928802|FG004|Overall Study|Study was Terminated by Sponsor|0|||
49024346|NCT03401112|157928798|FG000|Overall Study|Day 1 Assessment not Done|1|||
49024347|NCT03401112|157928799|FG001|Overall Study|Day 1 Assessment not Done|0|||
49024348|NCT03401112|157928800|FG002|Overall Study|Day 1 Assessment not Done|0|||
49024349|NCT03401112|157928801|FG003|Overall Study|Day 1 Assessment not Done|0|||
49024350|NCT03401112|157928802|FG004|Overall Study|Day 1 Assessment not Done|0|||
49024351|NCT03401112|157928798|FG000|Overall Study|Not Dosed|0|||
49024352|NCT03401112|157928799|FG001|Overall Study|Not Dosed|0|||
49024353|NCT03401112|157928800|FG002|Overall Study|Not Dosed|1|||
49024354|NCT03401112|157928801|FG003|Overall Study|Not Dosed|0|||
49024355|NCT03401112|157928802|FG004|Overall Study|Not Dosed|0|||
49024356|NCT03401112|157928798|FG000|Overall Study|Missed Clinical Visit|0|||
49024357|NCT03401112|157928799|FG001|Overall Study|Missed Clinical Visit|0|||
48689941|NCT00101686|156715569|FG009|Overall Study|initiation other anti-cancer treatment|3|||
48689942|NCT00101686|156715560|FG000|Overall Study|>3 week delay treatment due toxicity|6|||
48689943|NCT00101686|156715561|FG001|Overall Study|>3 week delay treatment due toxicity|2|||
48689944|NCT00101686|156715562|FG002|Overall Study|>3 week delay treatment due toxicity|1|||
48689945|NCT00101686|156715563|FG003|Overall Study|>3 week delay treatment due toxicity|2|||
48689946|NCT00101686|156715564|FG004|Overall Study|>3 week delay treatment due toxicity|7|||
48689947|NCT00101686|156715565|FG005|Overall Study|>3 week delay treatment due toxicity|3|||
48689948|NCT00101686|156715566|FG006|Overall Study|>3 week delay treatment due toxicity|2|||
48689949|NCT00101686|156715567|FG007|Overall Study|>3 week delay treatment due toxicity|1|||
48689950|NCT00101686|156715568|FG008|Overall Study|>3 week delay treatment due toxicity|3|||
48689951|NCT00101686|156715569|FG009|Overall Study|>3 week delay treatment due toxicity|0|||
48689952|NCT00101686|156715560|FG000|Overall Study|unacceptable toxicity|3|||
48689953|NCT00101686|156715561|FG001|Overall Study|unacceptable toxicity|9|||
48689954|NCT00101686|156715562|FG002|Overall Study|unacceptable toxicity|10|||
48689955|NCT00101686|156715563|FG003|Overall Study|unacceptable toxicity|6|||
48689956|NCT00101686|156715564|FG004|Overall Study|unacceptable toxicity|16|||
48689957|NCT00101686|156715565|FG005|Overall Study|unacceptable toxicity|10|||
48689958|NCT00101686|156715566|FG006|Overall Study|unacceptable toxicity|4|||
48689959|NCT00101686|156715567|FG007|Overall Study|unacceptable toxicity|2|||
48689960|NCT00101686|156715568|FG008|Overall Study|unacceptable toxicity|1|||
48689961|NCT00101686|156715569|FG009|Overall Study|unacceptable toxicity|4|||
48689962|NCT00101686|156715560|FG000|Overall Study|Randomized but did not receive treament|1|||
48689963|NCT00101686|156715561|FG001|Overall Study|Randomized but did not receive treament|6|||
48689964|NCT00101686|156715562|FG002|Overall Study|Randomized but did not receive treament|2|||
48689965|NCT00101686|156715563|FG003|Overall Study|Randomized but did not receive treament|2|||
48689966|NCT00101686|156715564|FG004|Overall Study|Randomized but did not receive treament|2|||
48689967|NCT00101686|156715565|FG005|Overall Study|Randomized but did not receive treament|2|||
48689968|NCT00101686|156715566|FG006|Overall Study|Randomized but did not receive treament|0|||
48689969|NCT00101686|156715567|FG007|Overall Study|Randomized but did not receive treament|1|||
48689970|NCT00101686|156715568|FG008|Overall Study|Randomized but did not receive treament|0|||
48689971|NCT00101686|156715569|FG009|Overall Study|Randomized but did not receive treament|1|||
48689972|NCT00101686|156715560|FG000|Overall Study|intercurrent non-cancer related illness|0|||
48689973|NCT00101686|156715561|FG001|Overall Study|intercurrent non-cancer related illness|0|||
48689974|NCT00101686|156715562|FG002|Overall Study|intercurrent non-cancer related illness|2|||
48689975|NCT00101686|156715563|FG003|Overall Study|intercurrent non-cancer related illness|0|||
48689976|NCT00101686|156715564|FG004|Overall Study|intercurrent non-cancer related illness|1|||
48689977|NCT00101686|156715565|FG005|Overall Study|intercurrent non-cancer related illness|3|||
48689978|NCT00101686|156715566|FG006|Overall Study|intercurrent non-cancer related illness|1|||
48689979|NCT00101686|156715567|FG007|Overall Study|intercurrent non-cancer related illness|0|||
49024358|NCT03401112|157928800|FG002|Overall Study|Missed Clinical Visit|1|||
49024359|NCT03401112|157928801|FG003|Overall Study|Missed Clinical Visit|0|||
49024360|NCT03401112|157928802|FG004|Overall Study|Missed Clinical Visit|0|||
49024361|NCT03401112|157928798|FG000|Overall Study|Missed Doses|0|||
49024362|NCT03401112|157928799|FG001|Overall Study|Missed Doses|0|||
49024363|NCT03401112|157928800|FG002|Overall Study|Missed Doses|1|||
49024364|NCT03401112|157928801|FG003|Overall Study|Missed Doses|0|||
48689980|NCT00101686|156715568|FG008|Overall Study|intercurrent non-cancer related illness|1|||
48689981|NCT00101686|156715569|FG009|Overall Study|intercurrent non-cancer related illness|1|||
48689982|NCT00101686|156715560|FG000|Overall Study|Physician Decision|10|||
48689983|NCT00101686|156715561|FG001|Overall Study|Physician Decision|13|||
48689984|NCT00101686|156715562|FG002|Overall Study|Physician Decision|6|||
48689985|NCT00101686|156715563|FG003|Overall Study|Physician Decision|7|||
48689986|NCT00101686|156715564|FG004|Overall Study|Physician Decision|8|||
48689987|NCT00101686|156715565|FG005|Overall Study|Physician Decision|9|||
48689988|NCT00101686|156715566|FG006|Overall Study|Physician Decision|5|||
48689989|NCT00101686|156715567|FG007|Overall Study|Physician Decision|5|||
48689990|NCT00101686|156715568|FG008|Overall Study|Physician Decision|1|||
48689991|NCT00101686|156715569|FG009|Overall Study|Physician Decision|1|||
48689992|NCT00101686|156715560|FG000|Overall Study|Other|1|||
48689993|NCT00101686|156715561|FG001|Overall Study|Other|4|||
48689994|NCT00101686|156715562|FG002|Overall Study|Other|1|||
48689995|NCT00101686|156715563|FG003|Overall Study|Other|6|||
48689996|NCT00101686|156715564|FG004|Overall Study|Other|2|||
48689997|NCT00101686|156715565|FG005|Overall Study|Other|12|||
48689998|NCT00101686|156715566|FG006|Overall Study|Other|1|||
48689999|NCT00101686|156715567|FG007|Overall Study|Other|5|||
48690000|NCT00101686|156715568|FG008|Overall Study|Other|3|||
48690001|NCT00101686|156715569|FG009|Overall Study|Other|3|||
48690002|NCT00101686|156715560|FG000|Overall Study|Withdrawal by Subject|9|||
48690003|NCT00101686|156715561|FG001|Overall Study|Withdrawal by Subject|8|||
48690004|NCT00101686|156715562|FG002|Overall Study|Withdrawal by Subject|6|||
48690005|NCT00101686|156715563|FG003|Overall Study|Withdrawal by Subject|8|||
48690006|NCT00101686|156715564|FG004|Overall Study|Withdrawal by Subject|8|||
48690007|NCT00101686|156715565|FG005|Overall Study|Withdrawal by Subject|7|||
48690008|NCT00101686|156715566|FG006|Overall Study|Withdrawal by Subject|7|||
48690009|NCT00101686|156715567|FG007|Overall Study|Withdrawal by Subject|7|||
48690010|NCT00101686|156715568|FG008|Overall Study|Withdrawal by Subject|8|||
48981557|NCT02087241|157764307|FG001|Overall Study|Study Terminated by Sponsor|2|||
48981558|NCT02087241|157764308|FG002|Overall Study|Study Terminated by Sponsor|0|||
48981559|NCT02087241|157764309|FG003|Overall Study|Study Terminated by Sponsor|4|||
48981560|NCT01708915|157764314|FG000|Overall Study|Adverse Event|1|||
48981561|NCT01708915|157764315|FG001|Overall Study|Adverse Event|0|||
48981562|NCT01708915|157764316|FG002|Overall Study|Adverse Event|9|||
48981563|NCT01708915|157764317|FG003|Overall Study|Adverse Event|13|||
48981564|NCT01708915|157764314|FG000|Overall Study|Lack of Efficacy|84|||
48981565|NCT01708915|157764315|FG001|Overall Study|Lack of Efficacy|60|||
48981566|NCT01708915|157764316|FG002|Overall Study|Lack of Efficacy|35|||
48981567|NCT01708915|157764317|FG003|Overall Study|Lack of Efficacy|15|||
48981568|NCT01708915|157764314|FG000|Overall Study|Protocol Violation|0|||
48690011|NCT00101686|156715569|FG009|Overall Study|Withdrawal by Subject|9|||
48690012|NCT00702702|156715570|FG000|Overall Study|Study prematurely terminated|56|||
48690013|NCT01814527|156715573|FG000|Overall Study|RTP greater than 30 days|6|||
48690014|NCT01814527|156715574|FG001|Overall Study|RTP greater than 30 days|1|||
48690015|NCT00549640|156715575|FG000|Overall Study|Withdrawal by Subject|6|||
49024365|NCT03401112|157928802|FG004|Overall Study|Missed Doses|0|||
49024366|NCT00686959|157928805|FG000|Overall Study|Participants censored (no death events)|124|||
49024367|NCT00686959|157928806|FG001|Overall Study|Participants censored (no death events)|117|||
49024368|NCT01876706|157928807|FG000|Overall Study|BPH Intervention|9|||
49024369|NCT01876706|157928807|FG000|Overall Study|Lost to Follow-up|7|||
49024370|NCT01876706|157928807|FG000|Overall Study|Withdrawals|6|||
49024371|NCT01876706|157928807|FG000|Overall Study|Death|3|||
48690016|NCT00549640|156715576|FG001|Overall Study|Withdrawal by Subject|12|||
48690017|NCT00549640|156715575|FG000|Overall Study|Adverse Event|5|||
48690018|NCT00549640|156715576|FG001|Overall Study|Adverse Event|0|||
48690019|NCT00549640|156715575|FG000|Overall Study|Lost to Follow-up|7|||
48690020|NCT00549640|156715576|FG001|Overall Study|Lost to Follow-up|4|||
48690021|NCT02920892|156715579|FG000|Placebo Lead-In Period|Withdrawal by Subject|1|||
48690022|NCT02920892|156715580|FG001|Placebo Lead-In Period|Withdrawal by Subject|0|||
48690023|NCT02920892|156715581|FG002|Placebo Lead-In Period|Withdrawal by Subject|0|||
48690024|NCT02920892|156715579|FG000|Placebo Lead-In Period|Subject Ineligible|6|||
48690025|NCT02920892|156715580|FG001|Placebo Lead-In Period|Subject Ineligible|0|||
48690026|NCT02920892|156715581|FG002|Placebo Lead-In Period|Subject Ineligible|0|||
48690027|NCT02920892|156715579|FG000|Placebo Lead-In Period|Subject Screen Fail|4|||
48690028|NCT02920892|156715580|FG001|Placebo Lead-In Period|Subject Screen Fail|0|||
48690029|NCT02920892|156715581|FG002|Placebo Lead-In Period|Subject Screen Fail|0|||
48690030|NCT02920892|156715579|FG000|Placebo-Controlled Period|Withdrawal by Subject|0|||
48690031|NCT02920892|156715580|FG001|Placebo-Controlled Period|Withdrawal by Subject|3|||
48690032|NCT02920892|156715581|FG002|Placebo-Controlled Period|Withdrawal by Subject|5|||
48690033|NCT02920892|156715579|FG000|Placebo-Controlled Period|Physician Decision|0|||
48690034|NCT02920892|156715580|FG001|Placebo-Controlled Period|Physician Decision|0|||
48690035|NCT02920892|156715581|FG002|Placebo-Controlled Period|Physician Decision|1|||
48690036|NCT02920892|156715579|FG000|Placebo-Controlled Period|Lost to Follow-up|0|||
48690037|NCT02920892|156715580|FG001|Placebo-Controlled Period|Lost to Follow-up|0|||
48690038|NCT02920892|156715581|FG002|Placebo-Controlled Period|Lost to Follow-up|1|||
48690039|NCT02920892|156715579|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
48690040|NCT02920892|156715580|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
48690041|NCT02920892|156715581|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
48690042|NCT02920892|156715579|FG000|Open-Label Extension (OLE) Period|Study Drug Expiration|0|||
48690043|NCT02920892|156715580|FG001|Open-Label Extension (OLE) Period|Study Drug Expiration|4|||
48690044|NCT02920892|156715581|FG002|Open-Label Extension (OLE) Period|Study Drug Expiration|2|||
48690045|NCT03827655|156715586|FG000|Overall Study|Death|0|||
48690046|NCT03827655|156715587|FG001|Overall Study|Death|0|||
48690047|NCT03827655|156715588|FG002|Overall Study|Death|0|||
48690048|NCT03827655|156715589|FG003|Overall Study|Death|0|||
48690049|NCT03827655|156715590|FG004|Overall Study|Death|1|||
48690050|NCT03827655|156715586|FG000|Overall Study|Protocol Deviation|1|||
48690051|NCT03827655|156715587|FG001|Overall Study|Protocol Deviation|0|||
48690052|NCT03827655|156715588|FG002|Overall Study|Protocol Deviation|1|||
48690053|NCT03827655|156715589|FG003|Overall Study|Protocol Deviation|1|||
48690054|NCT03827655|156715590|FG004|Overall Study|Protocol Deviation|0|||
48690055|NCT03827655|156715586|FG000|Overall Study|Withdrawal by Subject|3|||
48690056|NCT03827655|156715587|FG001|Overall Study|Withdrawal by Subject|2|||
48690057|NCT03827655|156715588|FG002|Overall Study|Withdrawal by Subject|2|||
48690058|NCT03827655|156715589|FG003|Overall Study|Withdrawal by Subject|0|||
48690059|NCT03827655|156715590|FG004|Overall Study|Withdrawal by Subject|1|||
48690060|NCT03827655|156715586|FG000|Overall Study|Reason not Specified|3|||
48690061|NCT03827655|156715587|FG001|Overall Study|Reason not Specified|1|||
48690062|NCT03827655|156715588|FG002|Overall Study|Reason not Specified|1|||
48690063|NCT03827655|156715589|FG003|Overall Study|Reason not Specified|1|||
48690064|NCT03827655|156715590|FG004|Overall Study|Reason not Specified|1|||
48690065|NCT04486235|156715591|FG000|Overall Study|Pregnancy|1|||
48690066|NCT04486235|156715592|FG001|Overall Study|Pregnancy|0|||
48690067|NCT04486235|156715591|FG000|Overall Study|Lost to Follow-up|1|||
48690068|NCT04486235|156715592|FG001|Overall Study|Lost to Follow-up|0|||
48690069|NCT00644358|156715603|FG000|Overall Study|Adverse Event|124|||
49024372|NCT01391793|157928809|FG000|Overall Study|Ineligible|3|||
48690070|NCT00644358|156715603|FG000|Overall Study|Lost to Follow-up|105|||
48690071|NCT00644358|156715603|FG000|Overall Study|Consent Withdrawal|64|||
48690072|NCT00644358|156715603|FG000|Overall Study|Lack of Effectiveness|39|||
48690073|NCT00644358|156715603|FG000|Overall Study|Protocol Violation|5|||
48690074|NCT00644358|156715603|FG000|Overall Study|Noncompliance|14|||
49024373|NCT01391793|157928810|FG001|Overall Study|Ineligible|0|||
49024374|NCT01391793|157928809|FG000|Overall Study|Urine Culture Negative or Indeterminate|71|||
49024375|NCT01391793|157928810|FG001|Overall Study|Urine Culture Negative or Indeterminate|87|||
49024376|NCT01391793|157928809|FG000|Overall Study|No DMSA|73|||
49024377|NCT01391793|157928810|FG001|Overall Study|No DMSA|57|||
49024378|NCT00150462|157928811|FG000|Overall Study|Disease Progression or Relapse|3|||
49024379|NCT00150462|157928812|FG001|Overall Study|Disease Progression or Relapse|1|||
48690075|NCT00644358|156715603|FG000|Overall Study|Other Unspecified|11|||
48690076|NCT00651924|156715605|FG000|Overall Study|Withdrawal by PI|0|||
48690077|NCT00651924|156715606|FG001|Overall Study|Withdrawal by PI|2|||
48690078|NCT00651924|156715605|FG000|Overall Study|Withdrawal by Subject|0|||
48690079|NCT00651924|156715606|FG001|Overall Study|Withdrawal by Subject|5|||
48690080|NCT00960063|156715607|FG000|Overall Study|Adverse Event|1|||
48690081|NCT00960063|156715608|FG001|Overall Study|Adverse Event|0|||
48690082|NCT00960063|156715609|FG002|Overall Study|Adverse Event|0|||
48690083|NCT00960063|156715607|FG000|Overall Study|Progression of Disease|0|||
48690084|NCT00960063|156715608|FG001|Overall Study|Progression of Disease|0|||
48690085|NCT00960063|156715609|FG002|Overall Study|Progression of Disease|3|||
48690086|NCT00317473|156715612|FG000|Overall Study|Withdrawal by Subject|2|||
48690087|NCT00317473|156715613|FG001|Overall Study|Withdrawal by Subject|1|||
48690088|NCT00317473|156715614|FG002|Overall Study|Withdrawal by Subject|2|||
48690089|NCT00317473|156715615|FG003|Overall Study|Withdrawal by Subject|1|||
48690090|NCT00317473|156715616|FG004|Overall Study|Withdrawal by Subject|3|||
48690091|NCT00317473|156715617|FG005|Overall Study|Withdrawal by Subject|1|||
48690092|NCT00317473|156715612|FG000|Overall Study|Relocation|1|||
48690093|NCT00317473|156715613|FG001|Overall Study|Relocation|0|||
48690094|NCT00317473|156715614|FG002|Overall Study|Relocation|1|||
48690095|NCT00317473|156715615|FG003|Overall Study|Relocation|1|||
48690096|NCT00317473|156715616|FG004|Overall Study|Relocation|5|||
48690097|NCT00317473|156715617|FG005|Overall Study|Relocation|2|||
48690098|NCT00317473|156715612|FG000|Overall Study|Death|1|||
48690099|NCT00317473|156715613|FG001|Overall Study|Death|0|||
48690100|NCT00317473|156715614|FG002|Overall Study|Death|0|||
48690101|NCT00317473|156715615|FG003|Overall Study|Death|0|||
48690102|NCT00317473|156715616|FG004|Overall Study|Death|0|||
48690103|NCT00317473|156715617|FG005|Overall Study|Death|0|||
48690104|NCT00317473|156715612|FG000|Overall Study|Other|0|||
48690105|NCT00317473|156715613|FG001|Overall Study|Other|2|||
48690106|NCT00317473|156715614|FG002|Overall Study|Other|0|||
48690107|NCT00317473|156715615|FG003|Overall Study|Other|0|||
48690108|NCT00317473|156715616|FG004|Overall Study|Other|0|||
48690109|NCT00317473|156715617|FG005|Overall Study|Other|0|||
48690110|NCT01611792|156715618|FG000|Initial Period: Time 0|unable to schedule 10 consecutive appts|12|||
48763704|NCT02155738|156985710|FG002|Overall Study|Missing critical information|0|||
48763705|NCT02155738|156985711|FG003|Overall Study|Missing critical information|1|||
48690111|NCT01611792|156715619|FG001|Initial Period: Time 0|unable to schedule 10 consecutive appts|9|||
48690112|NCT01611792|156715618|FG000|Followup: at 6 Months|Lost to Follow-up|6|||
48690113|NCT01611792|156715619|FG001|Followup: at 6 Months|Lost to Follow-up|13|||
48690114|NCT01759420|156715620|FG000|Overall Study|Screen failure|5|||
48690115|NCT01759420|156715620|FG000|Overall Study|Inaccurate EKG machine readings|1|||
48763706|NCT00112502|156985712|FG000|Overall Study|Withdrawal by Subject|0|||
48763707|NCT00112502|156985713|FG001|Overall Study|Withdrawal by Subject|1|||
48763708|NCT00112502|156985714|FG002|Overall Study|Withdrawal by Subject|1|||
48763709|NCT00112502|156985715|FG003|Overall Study|Withdrawal by Subject|4|||
48763710|NCT00112502|156985716|FG004|Overall Study|Withdrawal by Subject|2|||
48763711|NCT00112502|156985717|FG005|Overall Study|Withdrawal by Subject|5|||
48763712|NCT00112502|156985718|FG006|Overall Study|Withdrawal by Subject|3|||
48763713|NCT00112502|156985719|FG007|Overall Study|Withdrawal by Subject|7|||
48763714|NCT00914810|156985722|FG000|Overall Study|Withdrawal by Subject|1|||
48763715|NCT00914810|156985723|FG001|Overall Study|Withdrawal by Subject|0|||
48763716|NCT00914810|156985722|FG000|Overall Study|Relocated out of state|1|||
48875377|NCT04962698|157381633|FG000|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|0|||
49024380|NCT00150462|157928813|FG002|Overall Study|Disease Progression or Relapse|2|||
48690116|NCT01329978|156715621|FG000|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1|||
48690117|NCT01329978|156715622|FG001|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2|||
48690118|NCT01329978|156715623|FG002|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
48690119|NCT01329978|156715624|FG003|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
48690120|NCT01329978|156715625|FG004|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
48690121|NCT01329978|156715621|FG000|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
48690122|NCT01329978|156715622|FG001|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8|||
48690123|NCT01329978|156715623|FG002|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
48690124|NCT01329978|156715624|FG003|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
48690125|NCT01329978|156715625|FG004|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
48690126|NCT01329978|156715621|FG000|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
48875378|NCT04962698|157381634|FG001|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|2|||
48690127|NCT01329978|156715622|FG001|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
48690128|NCT01329978|156715623|FG002|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3|||
49024381|NCT00150462|157928814|FG003|Overall Study|Disease Progression or Relapse|1|||
49024382|NCT00150462|157928815|FG004|Overall Study|Disease Progression or Relapse|2|||
48690129|NCT01329978|156715624|FG003|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
48690130|NCT01329978|156715625|FG004|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
48690131|NCT01329978|156715621|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
48690132|NCT01329978|156715622|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1|||
48690133|NCT01329978|156715623|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
48690134|NCT01329978|156715624|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
48690135|NCT01329978|156715625|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
48690136|NCT01329978|156715621|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
48690137|NCT01329978|156715622|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1|||
48690138|NCT01329978|156715623|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
48690139|NCT01329978|156715624|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
48690140|NCT01329978|156715625|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
48690141|NCT01329978|156715621|FG000|Rerandomization Treatment Period|Lost to Follow-up|0|||
48690142|NCT01329978|156715622|FG001|Rerandomization Treatment Period|Lost to Follow-up|0|||
48690143|NCT01329978|156715623|FG002|Rerandomization Treatment Period|Lost to Follow-up|0|||
48690144|NCT01329978|156715624|FG003|Rerandomization Treatment Period|Lost to Follow-up|5|||
48690145|NCT01329978|156715625|FG004|Rerandomization Treatment Period|Lost to Follow-up|3|||
48690146|NCT01329978|156715621|FG000|Rerandomization Treatment Period|Withdrawal by Subject|0|||
48690147|NCT01329978|156715622|FG001|Rerandomization Treatment Period|Withdrawal by Subject|0|||
48690148|NCT01329978|156715623|FG002|Rerandomization Treatment Period|Withdrawal by Subject|0|||
48690149|NCT01329978|156715624|FG003|Rerandomization Treatment Period|Withdrawal by Subject|0|||
48690150|NCT01329978|156715625|FG004|Rerandomization Treatment Period|Withdrawal by Subject|1|||
48690151|NCT00960375|156715626|FG000|Overall Study|Lost to Follow-up|20|||
48690152|NCT00960375|156715627|FG001|Overall Study|Lost to Follow-up|22|||
48690153|NCT00689390|156715628|FG000|Overall Study|Adverse Event|19|||
48690154|NCT00689390|156715629|FG001|Overall Study|Adverse Event|0|||
48690155|NCT00689390|156715628|FG000|Overall Study|Lost to Follow-up|179|||
48690156|NCT00689390|156715629|FG001|Overall Study|Lost to Follow-up|7|||
48690157|NCT00689390|156715628|FG000|Overall Study|Withdrawal by Subject|117|||
48690158|NCT00689390|156715629|FG001|Overall Study|Withdrawal by Subject|3|||
48690159|NCT00689390|156715628|FG000|Overall Study|Withdrew Consent-Retreatment Opportunity|52|||
48690160|NCT00689390|156715629|FG001|Overall Study|Withdrew Consent-Retreatment Opportunity|0|||
48690161|NCT00689390|156715628|FG000|Overall Study|Non-Compliance With Protocol|21|||
48690162|NCT00689390|156715629|FG001|Overall Study|Non-Compliance With Protocol|0|||
48690163|NCT00689390|156715628|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
48690164|NCT00689390|156715629|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
48690165|NCT00689390|156715628|FG000|Overall Study|Administrative|37|||
48690166|NCT00689390|156715629|FG001|Overall Study|Administrative|0|||
48690167|NCT03557970|156715630|FG000|Overall Study|Study closure|1|||
48690168|NCT03557970|156715631|FG001|Overall Study|Study closure|0|||
48690169|NCT03557970|156715630|FG000|Overall Study|Physician Decision|0|||
48690170|NCT03557970|156715631|FG001|Overall Study|Physician Decision|1|||
48690171|NCT03557970|156715630|FG000|Overall Study|Death|0|||
48690172|NCT03557970|156715631|FG001|Overall Study|Death|1|||
48690173|NCT03071263|156715632|FG000|Overall Study|Adverse Event|1|||
48690174|NCT03071263|156715633|FG001|Overall Study|Adverse Event|3|||
48690175|NCT03071263|156715632|FG000|Overall Study|Withdrawal by Subject|1|||
48690176|NCT03071263|156715633|FG001|Overall Study|Withdrawal by Subject|3|||
48690177|NCT03071263|156715632|FG000|Overall Study|Physician Decision|1|||
48690178|NCT03071263|156715633|FG001|Overall Study|Physician Decision|0|||
48690179|NCT03071263|156715632|FG000|Overall Study|Participant moved to another city|0|||
48690180|NCT03071263|156715633|FG001|Overall Study|Participant moved to another city|1|||
48690181|NCT04258423|156715638|FG000|Overall Study|Study Closure|2|||
48690182|NCT04258423|156715639|FG001|Overall Study|Study Closure|2|||
48690183|NCT01601535|156715640|FG000|Phase 1|Adverse Event|1|||
48690184|NCT01601535|156715641|FG001|Phase 1|Adverse Event|0|||
48690185|NCT01601535|156715642|FG002|Phase 1|Adverse Event|2|||
48690186|NCT01601535|156715643|FG003|Phase 1|Adverse Event|1|||
48690187|NCT01601535|156715644|FG004|Phase 1|Adverse Event|0|||
48690188|NCT01601535|156715645|FG005|Phase 1|Adverse Event|0|||
48690189|NCT01601535|156715640|FG000|Phase 1|Withdrawal by Subject|2|||
48875379|NCT04962698|157381633|FG000|Robotic-hand Interaction Without MI|Technical difficulty|1|||
48875380|NCT04962698|157381634|FG001|Robotic-hand Interaction Without MI|Technical difficulty|0|||
48875381|NCT04962698|157381633|FG000|Virtual-hand Interaction|Technical difficulty|1|||
48875382|NCT04962698|157381634|FG001|Virtual-hand Interaction|Technical difficulty|0|||
48690190|NCT01601535|156715641|FG001|Phase 1|Withdrawal by Subject|1|||
48690191|NCT01601535|156715642|FG002|Phase 1|Withdrawal by Subject|1|||
48690192|NCT01601535|156715643|FG003|Phase 1|Withdrawal by Subject|2|||
48690193|NCT01601535|156715644|FG004|Phase 1|Withdrawal by Subject|0|||
48690194|NCT01601535|156715645|FG005|Phase 1|Withdrawal by Subject|0|||
48690195|NCT01601535|156715640|FG000|Phase 1|Progressive Disease|2|||
48690196|NCT01601535|156715641|FG001|Phase 1|Progressive Disease|3|||
48875383|NCT04962698|157381633|FG000|Robotic Action Observation|Technical difficulty|1|||
48690197|NCT01601535|156715642|FG002|Phase 1|Progressive Disease|2|||
48690198|NCT01601535|156715643|FG003|Phase 1|Progressive Disease|1|||
48690199|NCT01601535|156715644|FG004|Phase 1|Progressive Disease|0|||
48690200|NCT01601535|156715645|FG005|Phase 1|Progressive Disease|0|||
48690201|NCT01601535|156715640|FG000|Phase 1|Started Another Treatment|1|||
48690202|NCT01601535|156715641|FG001|Phase 1|Started Another Treatment|2|||
48690203|NCT01601535|156715642|FG002|Phase 1|Started Another Treatment|0|||
48690204|NCT01601535|156715643|FG003|Phase 1|Started Another Treatment|0|||
48690205|NCT01601535|156715644|FG004|Phase 1|Started Another Treatment|0|||
48690206|NCT01601535|156715645|FG005|Phase 1|Started Another Treatment|0|||
48690207|NCT01601535|156715640|FG000|Phase 2|Adverse Event|0|||
48690208|NCT01601535|156715641|FG001|Phase 2|Adverse Event|0|||
48690209|NCT01601535|156715642|FG002|Phase 2|Adverse Event|0|||
48690210|NCT01601535|156715643|FG003|Phase 2|Adverse Event|0|||
48690211|NCT01601535|156715644|FG004|Phase 2|Adverse Event|5|||
48690212|NCT01601535|156715645|FG005|Phase 2|Adverse Event|1|||
48690213|NCT01601535|156715640|FG000|Phase 2|Withdrawal by Subject|0|||
48690214|NCT01601535|156715641|FG001|Phase 2|Withdrawal by Subject|0|||
48690215|NCT01601535|156715642|FG002|Phase 2|Withdrawal by Subject|0|||
48690216|NCT01601535|156715643|FG003|Phase 2|Withdrawal by Subject|0|||
48690217|NCT01601535|156715644|FG004|Phase 2|Withdrawal by Subject|8|||
48690218|NCT01601535|156715645|FG005|Phase 2|Withdrawal by Subject|2|||
48690219|NCT01601535|156715640|FG000|Phase 2|Progressive Disease|0|||
48690220|NCT01601535|156715641|FG001|Phase 2|Progressive Disease|0|||
48690221|NCT01601535|156715642|FG002|Phase 2|Progressive Disease|0|||
48690222|NCT01601535|156715643|FG003|Phase 2|Progressive Disease|0|||
48690223|NCT01601535|156715644|FG004|Phase 2|Progressive Disease|5|||
48690224|NCT01601535|156715645|FG005|Phase 2|Progressive Disease|7|||
48690225|NCT01601535|156715640|FG000|Phase 2|Started Another Treatment|0|||
48690226|NCT01601535|156715641|FG001|Phase 2|Started Another Treatment|0|||
48690227|NCT01601535|156715642|FG002|Phase 2|Started Another Treatment|0|||
48690228|NCT01601535|156715643|FG003|Phase 2|Started Another Treatment|0|||
48690229|NCT01601535|156715644|FG004|Phase 2|Started Another Treatment|1|||
48690230|NCT01601535|156715645|FG005|Phase 2|Started Another Treatment|2|||
48690231|NCT03084796|156715646|FG000|Overall Study|Adverse Event|4|||
48690232|NCT03084796|156715647|FG001|Overall Study|Adverse Event|5|||
48690233|NCT03084796|156715648|FG002|Overall Study|Adverse Event|6|||
48690234|NCT03084796|156715649|FG003|Overall Study|Adverse Event|2|||
48690235|NCT03084796|156715650|FG004|Overall Study|Adverse Event|3|||
48690236|NCT03084796|156715651|FG005|Overall Study|Adverse Event|5|||
48690237|NCT03084796|156715646|FG000|Overall Study|Withdrawal by Subject|3|||
48690238|NCT03084796|156715647|FG001|Overall Study|Withdrawal by Subject|5|||
48690239|NCT03084796|156715648|FG002|Overall Study|Withdrawal by Subject|2|||
48690240|NCT03084796|156715649|FG003|Overall Study|Withdrawal by Subject|1|||
48690241|NCT03084796|156715650|FG004|Overall Study|Withdrawal by Subject|3|||
48690242|NCT03084796|156715651|FG005|Overall Study|Withdrawal by Subject|0|||
48690243|NCT03084796|156715646|FG000|Overall Study|Protocol Violation|0|||
48690244|NCT03084796|156715647|FG001|Overall Study|Protocol Violation|0|||
48690245|NCT03084796|156715648|FG002|Overall Study|Protocol Violation|1|||
48690246|NCT03084796|156715649|FG003|Overall Study|Protocol Violation|0|||
48690247|NCT03084796|156715650|FG004|Overall Study|Protocol Violation|1|||
48690248|NCT03084796|156715651|FG005|Overall Study|Protocol Violation|1|||
48690249|NCT03084796|156715646|FG000|Overall Study|Lack of Efficacy|0|||
48690250|NCT03084796|156715647|FG001|Overall Study|Lack of Efficacy|0|||
48690251|NCT03084796|156715648|FG002|Overall Study|Lack of Efficacy|1|||
48690252|NCT03084796|156715649|FG003|Overall Study|Lack of Efficacy|0|||
48763717|NCT00914810|156985723|FG001|Overall Study|Relocated out of state|0|||
48690253|NCT03084796|156715650|FG004|Overall Study|Lack of Efficacy|1|||
48690254|NCT03084796|156715651|FG005|Overall Study|Lack of Efficacy|0|||
48690255|NCT03084796|156715646|FG000|Overall Study|Lost to Follow-up|0|||
48690256|NCT03084796|156715647|FG001|Overall Study|Lost to Follow-up|0|||
48690257|NCT03084796|156715648|FG002|Overall Study|Lost to Follow-up|1|||
48690258|NCT03084796|156715649|FG003|Overall Study|Lost to Follow-up|1|||
48690259|NCT03084796|156715650|FG004|Overall Study|Lost to Follow-up|3|||
48690260|NCT03084796|156715651|FG005|Overall Study|Lost to Follow-up|1|||
48763718|NCT00914810|156985722|FG000|Overall Study|Hospitalized and unable to follow up.|0|||
48981569|NCT01708915|157764315|FG001|Overall Study|Protocol Violation|0|||
48690261|NCT03084796|156715646|FG000|Overall Study|Randomization error|0|||
48690262|NCT03084796|156715647|FG001|Overall Study|Randomization error|0|||
48690263|NCT03084796|156715648|FG002|Overall Study|Randomization error|1|||
48690264|NCT03084796|156715649|FG003|Overall Study|Randomization error|0|||
48690265|NCT03084796|156715650|FG004|Overall Study|Randomization error|0|||
48690266|NCT03084796|156715651|FG005|Overall Study|Randomization error|0|||
48690267|NCT00141102|156715657|FG000|Overall Study|Adverse Event|233|||
48690268|NCT00141102|156715658|FG001|Overall Study|Adverse Event|305|||
48690269|NCT00141102|156715657|FG000|Overall Study|Laboratory Abnormality|9|||
48981570|NCT01708915|157764316|FG002|Overall Study|Protocol Violation|0|||
48690270|NCT00141102|156715658|FG001|Overall Study|Laboratory Abnormality|33|||
48690271|NCT00141102|156715657|FG000|Overall Study|Lack of Efficacy|21|||
48690272|NCT00141102|156715658|FG001|Overall Study|Lack of Efficacy|26|||
48690273|NCT00141102|156715657|FG000|Overall Study|Lost to Follow-up|29|||
48875384|NCT04962698|157381634|FG001|Robotic Action Observation|Technical difficulty|0|||
48875385|NCT04962698|157381633|FG000|Rest|Technical difficulty|1|||
48690274|NCT00141102|156715658|FG001|Overall Study|Lost to Follow-up|32|||
48690275|NCT00141102|156715657|FG000|Overall Study|Other|87|||
48690276|NCT00141102|156715658|FG001|Overall Study|Other|76|||
48690277|NCT00141102|156715657|FG000|Overall Study|Withdrawal by Subject|112|||
48690278|NCT00141102|156715658|FG001|Overall Study|Withdrawal by Subject|142|||
48690279|NCT00141102|156715657|FG000|Overall Study|Randomized But Did Not Receive Treatment|15|||
48690280|NCT00141102|156715658|FG001|Overall Study|Randomized But Did Not Receive Treatment|9|||
48690281|NCT00141102|156715657|FG000|Overall Study|Death|2|||
48690282|NCT00141102|156715658|FG001|Overall Study|Death|2|||
48690283|NCT04388111|156717557|FG000|Overall Study|Lost to Follow-up|5|||
48690284|NCT04388111|156717558|FG001|Overall Study|Lost to Follow-up|3|||
48690285|NCT04388111|156717557|FG000|Overall Study|Adverse Event|1|||
48690286|NCT04388111|156717558|FG001|Overall Study|Adverse Event|1|||
48690287|NCT04388111|156717557|FG000|Overall Study|Protocol Violation|2|||
48690288|NCT04388111|156717558|FG001|Overall Study|Protocol Violation|4|||
48690289|NCT04388111|156717557|FG000|Overall Study|Withdrawal by Subject|1|||
48690290|NCT04388111|156717558|FG001|Overall Study|Withdrawal by Subject|0|||
48690291|NCT01790594|156717566|FG000|Overall Study|Death|1|||
48690292|NCT01790594|156717567|FG001|Overall Study|Death|0|||
48690293|NCT01790594|156717568|FG002|Overall Study|Death|0|||
48690294|NCT01790594|156717566|FG000|Overall Study|Physician Decision|2|||
48690295|NCT01790594|156717567|FG001|Overall Study|Physician Decision|1|||
48690296|NCT01790594|156717568|FG002|Overall Study|Physician Decision|0|||
48690297|NCT01790594|156717566|FG000|Overall Study|Withdrawal by Subject|2|||
48690298|NCT01790594|156717567|FG001|Overall Study|Withdrawal by Subject|0|||
48690299|NCT01790594|156717568|FG002|Overall Study|Withdrawal by Subject|0|||
48690300|NCT01790594|156717566|FG000|Overall Study|Transplant was not done|0|||
48690301|NCT01790594|156717567|FG001|Overall Study|Transplant was not done|0|||
48690302|NCT01790594|156717568|FG002|Overall Study|Transplant was not done|3|||
48690303|NCT01790594|156717566|FG000|Overall Study|Terminated prior to week 76|0|||
48690304|NCT01790594|156717567|FG001|Overall Study|Terminated prior to week 76|2|||
48690305|NCT01790594|156717568|FG002|Overall Study|Terminated prior to week 76|0|||
48690306|NCT03683173|156717577|FG000|Completed Follow-up|Unavailable|235|||
48690307|NCT03683173|156717578|FG001|Completed Follow-up|Unavailable|217|||
48690308|NCT03683173|156717577|FG000|Completed Follow-up|Refused|69|||
48690309|NCT03683173|156717578|FG001|Completed Follow-up|Refused|59|||
48690310|NCT03683173|156717577|FG000|Completed Follow-up|Disconnected phone|65|||
48690311|NCT03683173|156717578|FG001|Completed Follow-up|Disconnected phone|95|||
48690312|NCT03683173|156717577|FG000|Completed Follow-up|Health issue/deceased|10|||
48690313|NCT03683173|156717578|FG001|Completed Follow-up|Health issue/deceased|4|||
48690314|NCT03683173|156717577|FG000|Completed Follow-up|Moved away|8|||
48690315|NCT03683173|156717578|FG001|Completed Follow-up|Moved away|1|||
48690316|NCT03016312|156717579|FG000|Overall Study|discontinued before the treatment started|0|||
48690317|NCT03016312|156717580|FG001|Overall Study|discontinued before the treatment started|1|||
48690318|NCT03016312|156717579|FG000|Overall Study|Withdrawal by Subject|37|||
48690319|NCT03016312|156717580|FG001|Overall Study|Withdrawal by Subject|44|||
48690320|NCT03016312|156717579|FG000|Overall Study|Terminated by the Sponsor's decision|100|||
48690321|NCT03016312|156717580|FG001|Overall Study|Terminated by the Sponsor's decision|126|||
48690322|NCT03016312|156717579|FG000|Overall Study|Physician Decision|1|||
48690323|NCT03016312|156717580|FG001|Overall Study|Physician Decision|3|||
48690324|NCT03016312|156717579|FG000|Overall Study|Lost to Follow-up|12|||
48690325|NCT03016312|156717580|FG001|Overall Study|Lost to Follow-up|12|||
48690326|NCT03016312|156717579|FG000|Overall Study|Death|210|||
48690327|NCT03016312|156717580|FG001|Overall Study|Death|184|||
48690328|NCT03016312|156717579|FG000|Overall Study|loss to contact|1|||
48690329|NCT03016312|156717580|FG001|Overall Study|loss to contact|0|||
48690330|NCT03016312|156717579|FG000|Overall Study|started a new cancer therapy|1|||
48690331|NCT03016312|156717580|FG001|Overall Study|started a new cancer therapy|0|||
48690332|NCT01050634|156717581|FG000|Overall Study|Enrolled, but Not Treated|56|||
48875386|NCT04962698|157381634|FG001|Rest|Technical difficulty|0|||
48690333|NCT01050634|156717581|FG000|Overall Study|Death|2|||
48690334|NCT01050634|156717581|FG000|Overall Study|Adverse Event|42|||
48690335|NCT01050634|156717581|FG000|Overall Study|Lost to Follow-up|2|||
48690336|NCT01050634|156717581|FG000|Overall Study|Other|21|||
48690337|NCT01050634|156717581|FG000|Overall Study|Ongoing at Date of Cut-Off|5|||
48690338|NCT01855412|156717584|FG000|Overall Study|Death|77|||
48690339|NCT01855412|156717585|FG001|Overall Study|Death|123|||
48690340|NCT01855412|156717586|FG002|Overall Study|Death|30|||
48690341|NCT01855412|156717584|FG000|Overall Study|Lost to Follow-up|28|||
48690342|NCT01855412|156717585|FG001|Overall Study|Lost to Follow-up|46|||
48690343|NCT01855412|156717586|FG002|Overall Study|Lost to Follow-up|15|||
48690344|NCT01855412|156717584|FG000|Overall Study|Withdrawal by Subject|77|||
48690345|NCT01855412|156717585|FG001|Overall Study|Withdrawal by Subject|123|||
48690346|NCT01855412|156717586|FG002|Overall Study|Withdrawal by Subject|24|||
48690347|NCT01855412|156717584|FG000|Overall Study|Physician Decision|25|||
48981571|NCT01708915|157764317|FG003|Overall Study|Protocol Violation|1|||
48981572|NCT01708915|157764314|FG000|Overall Study|Withdrawal by Subject|0|||
48690348|NCT01855412|156717585|FG001|Overall Study|Physician Decision|31|||
48690349|NCT01855412|156717586|FG002|Overall Study|Physician Decision|3|||
48690350|NCT01855412|156717584|FG000|Overall Study|Site Closure|4|||
48690351|NCT01855412|156717585|FG001|Overall Study|Site Closure|18|||
48690352|NCT01855412|156717586|FG002|Overall Study|Site Closure|1|||
48690353|NCT01855412|156717584|FG000|Overall Study|Reason not Specified|1|||
48690354|NCT01855412|156717585|FG001|Overall Study|Reason not Specified|2|||
48690355|NCT01855412|156717586|FG002|Overall Study|Reason not Specified|3|||
48690356|NCT00423657|156717592|FG000|Overall Study|Withdrew consent|10|||
48690357|NCT00423657|156717593|FG001|Overall Study|Withdrew consent|8|||
48690358|NCT00423657|156717592|FG000|Overall Study|Non-compliance|0|||
48690359|NCT00423657|156717593|FG001|Overall Study|Non-compliance|1|||
48690360|NCT00423657|156717592|FG000|Overall Study|Other|15|||
48690361|NCT00423657|156717593|FG001|Overall Study|Other|16|||
48690362|NCT00423657|156717592|FG000|Overall Study|Request of sponsor/investigator|1|||
48690363|NCT00423657|156717593|FG001|Overall Study|Request of sponsor/investigator|0|||
48690364|NCT03206216|156717594|FG000|Overall Study|Withdrawal by Subject|0|||
48690365|NCT03206216|156717595|FG001|Overall Study|Withdrawal by Subject|1|||
48690366|NCT00286442|156717598|FG000|Overall Study|Hyperglycemic Rescue|19|||
48690367|NCT00286442|156717599|FG001|Overall Study|Hyperglycemic Rescue|17|||
48690368|NCT00286442|156717600|FG002|Overall Study|Hyperglycemic Rescue|25|||
49024383|NCT00150462|157928816|FG005|Overall Study|Disease Progression or Relapse|2|||
49024384|NCT00150462|157928817|FG006|Overall Study|Disease Progression or Relapse|3|||
49024385|NCT00150462|157928818|FG007|Overall Study|Disease Progression or Relapse|5|||
49024386|NCT00150462|157928819|FG008|Overall Study|Disease Progression or Relapse|5|||
49024387|NCT00150462|157928820|FG009|Overall Study|Disease Progression or Relapse|3|||
49024388|NCT00150462|157928821|FG010|Overall Study|Disease Progression or Relapse|2|||
49024389|NCT00150462|157928811|FG000|Overall Study|Withdrawal by Subject|0|||
49024390|NCT00150462|157928812|FG001|Overall Study|Withdrawal by Subject|1|||
49024391|NCT00150462|157928813|FG002|Overall Study|Withdrawal by Subject|1|||
49024392|NCT00150462|157928814|FG003|Overall Study|Withdrawal by Subject|0|||
49024393|NCT00150462|157928815|FG004|Overall Study|Withdrawal by Subject|1|||
49024394|NCT00150462|157928816|FG005|Overall Study|Withdrawal by Subject|2|||
49024395|NCT00150462|157928817|FG006|Overall Study|Withdrawal by Subject|0|||
48690369|NCT00286442|156717598|FG000|Overall Study|Adverse Event|7|||
48690370|NCT00286442|156717599|FG001|Overall Study|Adverse Event|6|||
48690371|NCT00286442|156717600|FG002|Overall Study|Adverse Event|1|||
48690372|NCT00286442|156717598|FG000|Overall Study|Protocol Violation|2|||
48690373|NCT00286442|156717599|FG001|Overall Study|Protocol Violation|4|||
48690374|NCT00286442|156717600|FG002|Overall Study|Protocol Violation|2|||
48690375|NCT00286442|156717598|FG000|Overall Study|Lost to Follow-up|5|||
48690376|NCT00286442|156717599|FG001|Overall Study|Lost to Follow-up|2|||
48690377|NCT00286442|156717600|FG002|Overall Study|Lost to Follow-up|1|||
48690378|NCT00286442|156717598|FG000|Overall Study|Physician Decision|1|||
48690379|NCT00286442|156717599|FG001|Overall Study|Physician Decision|1|||
48690380|NCT00286442|156717600|FG002|Overall Study|Physician Decision|1|||
48690381|NCT00286442|156717598|FG000|Overall Study|Administrative Error|1|||
49024396|NCT00150462|157928818|FG007|Overall Study|Withdrawal by Subject|1|||
48690382|NCT00286442|156717599|FG001|Overall Study|Administrative Error|1|||
48690383|NCT00286442|156717600|FG002|Overall Study|Administrative Error|0|||
48690384|NCT00286442|156717598|FG000|Overall Study|Withdrawal by Subject|2|||
48690385|NCT00286442|156717599|FG001|Overall Study|Withdrawal by Subject|14|||
48690386|NCT00286442|156717600|FG002|Overall Study|Withdrawal by Subject|2|||
48690387|NCT01546857|156717601|FG000|Overall Study|Withdrawal by Subject|2|||
48690388|NCT01546857|156717602|FG001|Overall Study|Withdrawal by Subject|3|||
48690389|NCT01859923|156717603|FG000|Overall Study|Adverse Event|0|||
48690390|NCT01859923|156717604|FG001|Overall Study|Adverse Event|0|||
48690391|NCT01859923|156717605|FG002|Overall Study|Adverse Event|1|||
48690392|NCT01859923|156717606|FG003|Overall Study|Adverse Event|1|||
48690393|NCT00883779|156717610|FG000|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
48690394|NCT00883779|156717611|FG001|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
48690395|NCT00883779|156717610|FG000|Primary Study Treatment Phase|Disease progression|75|||
48690396|NCT00883779|156717611|FG001|Primary Study Treatment Phase|Disease progression|59|||
48690397|NCT00883779|156717610|FG000|Primary Study Treatment Phase|Adverse Event|16|||
48690398|NCT00883779|156717611|FG001|Primary Study Treatment Phase|Adverse Event|16|||
48690399|NCT00883779|156717610|FG000|Primary Study Treatment Phase|Death|2|||
48690400|NCT00883779|156717611|FG001|Primary Study Treatment Phase|Death|3|||
48690401|NCT00883779|156717610|FG000|Primary Study Treatment Phase|Refused Treatment|5|||
48690402|NCT00883779|156717611|FG001|Primary Study Treatment Phase|Refused Treatment|4|||
48690403|NCT00883779|156717610|FG000|Primary Study Treatment Phase|Other|3|||
48690404|NCT00883779|156717611|FG001|Primary Study Treatment Phase|Other|0|||
49024397|NCT00150462|157928819|FG008|Overall Study|Withdrawal by Subject|0|||
49024398|NCT00150462|157928820|FG009|Overall Study|Withdrawal by Subject|1|||
49024399|NCT00150462|157928821|FG010|Overall Study|Withdrawal by Subject|0|||
49024400|NCT00150462|157928811|FG000|Overall Study|Death|0|||
49024401|NCT00150462|157928812|FG001|Overall Study|Death|1|||
48690405|NCT00883779|156717610|FG000|Post-Study Treatment Phase|Adverse Event|2|||
48690406|NCT00883779|156717611|FG001|Post-Study Treatment Phase|Adverse Event|3|||
48690407|NCT00883779|156717610|FG000|Post-Study Treatment Phase|Death|1|||
48690408|NCT00883779|156717611|FG001|Post-Study Treatment Phase|Death|3|||
48690409|NCT00883779|156717610|FG000|Post-Study Treatment Phase|Protocol Violation|0|||
48690410|NCT00883779|156717611|FG001|Post-Study Treatment Phase|Protocol Violation|1|||
48690411|NCT00883779|156717610|FG000|Post-Study Treatment Phase|Refused Treatment|3|||
48690412|NCT00883779|156717611|FG001|Post-Study Treatment Phase|Refused Treatment|0|||
48690413|NCT00883779|156717610|FG000|Post-Study Treatment Phase|Disease progression|103|||
48690414|NCT00883779|156717611|FG001|Post-Study Treatment Phase|Disease progression|122|||
48690415|NCT00883779|156717610|FG000|Post-Study Treatment Phase|Other|3|||
48690416|NCT00883779|156717611|FG001|Post-Study Treatment Phase|Other|0|||
48690417|NCT00883779|156717610|FG000|Post-Study Treatment Phase|Ongoing in the study|0|||
48690418|NCT00883779|156717611|FG001|Post-Study Treatment Phase|Ongoing in the study|6|||
48690419|NCT00883779|156717610|FG000|Off-study Phase|Death|185|||
48690420|NCT00883779|156717611|FG001|Off-study Phase|Death|174|||
48690421|NCT00883779|156717610|FG000|Off-study Phase|Refused treatment|1|||
48690422|NCT00883779|156717611|FG001|Off-study Phase|Refused treatment|1|||
48690423|NCT00883779|156717610|FG000|Off-study Phase|Failure to return|5|||
48690424|NCT00883779|156717611|FG001|Off-study Phase|Failure to return|6|||
48690425|NCT00883779|156717610|FG000|Off-study Phase|Other|18|||
48690426|NCT00883779|156717611|FG001|Off-study Phase|Other|21|||
48690427|NCT00475670|156717614|FG000|Overall Study|Death|0|||
48690428|NCT00475670|156717615|FG001|Overall Study|Death|1|||
48690429|NCT00475670|156717614|FG000|Overall Study|Lack of Efficacy|3|||
48690430|NCT00475670|156717615|FG001|Overall Study|Lack of Efficacy|34|||
48690431|NCT00475670|156717614|FG000|Overall Study|Refused treatment|0|||
48690432|NCT00475670|156717615|FG001|Overall Study|Refused treatment|2|||
48690433|NCT00475670|156717614|FG000|Overall Study|Failure to Return|0|||
48690434|NCT00475670|156717615|FG001|Overall Study|Failure to Return|1|||
48690435|NCT00475670|156717614|FG000|Overall Study|Other|0|||
48690436|NCT00475670|156717615|FG001|Overall Study|Other|3|||
48690437|NCT04590014|156717616|FG000|Overall Study|Withdrawal by Subject|1|||
48690438|NCT04590014|156717617|FG001|Overall Study|Withdrawal by Subject|0|||
48690439|NCT00399516|156717620|FG000|Overall Study|Lost to Follow-up|2|||
48690440|NCT01216202|156717621|FG000|Overall Study|Withdrawal by Subject|8|||
48690441|NCT01216202|156717622|FG001|Overall Study|Withdrawal by Subject|0|||
48690442|NCT01216202|156717621|FG000|Overall Study|Death|0|||
48690443|NCT01216202|156717622|FG001|Overall Study|Death|2|||
48690444|NCT01216202|156717621|FG000|Overall Study|Lost to Follow-up|14|||
48690445|NCT01216202|156717622|FG001|Overall Study|Lost to Follow-up|0|||
48690446|NCT01650558|156717623|FG000|Overall Study|Migration out of study area|61|||
48690447|NCT01650558|156717624|FG001|Overall Study|Migration out of study area|71|||
48690448|NCT01650558|156717625|FG002|Overall Study|Migration out of study area|56|||
48690449|NCT01650558|156717623|FG000|Overall Study|Lost to Follow-up|10|||
48690450|NCT01650558|156717624|FG001|Overall Study|Lost to Follow-up|13|||
48690451|NCT01650558|156717625|FG002|Overall Study|Lost to Follow-up|6|||
49024402|NCT00150462|157928813|FG002|Overall Study|Death|0|||
49024403|NCT00150462|157928814|FG003|Overall Study|Death|0|||
49024404|NCT00150462|157928815|FG004|Overall Study|Death|0|||
49024405|NCT00150462|157928816|FG005|Overall Study|Death|0|||
48690452|NCT01650558|156717623|FG000|Overall Study|Death|10|||
48690453|NCT01650558|156717624|FG001|Overall Study|Death|6|||
48690454|NCT01650558|156717625|FG002|Overall Study|Death|8|||
48690455|NCT01650558|156717623|FG000|Overall Study|Withdrawal by Subject|1|||
48690456|NCT01650558|156717624|FG001|Overall Study|Withdrawal by Subject|1|||
48690457|NCT01650558|156717625|FG002|Overall Study|Withdrawal by Subject|3|||
48690458|NCT01650558|156717623|FG000|Overall Study|Non-compliant participant|1|||
48690459|NCT01650558|156717624|FG001|Overall Study|Non-compliant participant|0|||
48690460|NCT01650558|156717625|FG002|Overall Study|Non-compliant participant|2|||
48690461|NCT01650558|156717623|FG000|Overall Study|Physician Decision|0|||
48690462|NCT01650558|156717624|FG001|Overall Study|Physician Decision|1|||
48690463|NCT01650558|156717625|FG002|Overall Study|Physician Decision|0|||
48690464|NCT02960217|156717626|FG000|Maintenance Phase: Treatment Period 1|Adverse Event|1|||
48690465|NCT02960217|156717627|FG001|Maintenance Phase: Treatment Period 1|Adverse Event|0|||
48690466|NCT02960217|156717626|FG000|Maintenance Phase: Treatment Period 2|Adverse Event|0|||
48690467|NCT02960217|156717627|FG001|Maintenance Phase: Treatment Period 2|Adverse Event|1|||
48690468|NCT02960217|156717626|FG000|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0|||
48690469|NCT02960217|156717627|FG001|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1|||
48875387|NCT04962698|157381633|FG000|Rest|Exclusion criteria met after enrollment|0|||
49024406|NCT00150462|157928817|FG006|Overall Study|Death|0|||
49024407|NCT00150462|157928818|FG007|Overall Study|Death|0|||
48690470|NCT02960217|156717626|FG000|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1|||
48690471|NCT02960217|156717627|FG001|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0|||
48690472|NCT02960217|156717626|FG000|Maintenance Phase: Treatment Period 2|Other, Not Specified|0|||
48690473|NCT02960217|156717627|FG001|Maintenance Phase: Treatment Period 2|Other, Not Specified|1|||
49024408|NCT00150462|157928819|FG008|Overall Study|Death|1|||
49024409|NCT00150462|157928820|FG009|Overall Study|Death|0|||
48690474|NCT02960217|156717626|FG000|Open-Label Extension Phase|Adverse Event|1|||
48690475|NCT02960217|156717627|FG001|Open-Label Extension Phase|Adverse Event|0|||
48690476|NCT02960217|156717626|FG000|Open-Label Extension Phase|Sponsor Decision|18|||
48690477|NCT02960217|156717627|FG001|Open-Label Extension Phase|Sponsor Decision|11|||
48690478|NCT02960217|156717626|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
48690479|NCT02960217|156717627|FG001|Open-Label Extension Phase|Lack of Efficacy|1|||
48690480|NCT02960217|156717626|FG000|Open-Label Extension Phase|Other, Not Specified|0|||
48690481|NCT02960217|156717627|FG001|Open-Label Extension Phase|Other, Not Specified|1|||
48690482|NCT02519439|156717630|FG000|Overall Study|Study Termination|19|||
48690483|NCT02519439|156717630|FG000|Overall Study|Withdrawal by Subject|1|||
48690484|NCT02519439|156717630|FG000|Overall Study|Adverse Event|1|||
48690485|NCT01091675|156717631|FG000|Overall Study|Adverse Event|7|||
48690486|NCT01091675|156717631|FG000|Overall Study|Lack of Efficacy|27|||
48690487|NCT00528957|156717636|FG000|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2|||
48690488|NCT00528957|156717637|FG001|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1|||
48690489|NCT00528957|156717636|FG000|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2|||
48690490|NCT00528957|156717637|FG001|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0|||
48690491|NCT00528957|156717636|FG000|First Extension (Week 48 to Week 144)|Investigator's Discretion|2|||
48690492|NCT00528957|156717637|FG001|First Extension (Week 48 to Week 144)|Investigator's Discretion|0|||
48690493|NCT00528957|156717636|FG000|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1|||
48690494|NCT00528957|156717637|FG001|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0|||
48690495|NCT00528957|156717636|FG000|First Extension (Week 48 to Week 144)|Withdrew Consent|0|||
48690496|NCT00528957|156717637|FG001|First Extension (Week 48 to Week 144)|Withdrew Consent|1|||
48690497|NCT00528957|156717636|FG000|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4|||
48690498|NCT00528957|156717637|FG001|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3|||
48690499|NCT00528957|156717636|FG000|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3|||
48690500|NCT00528957|156717637|FG001|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0|||
48690501|NCT00528957|156717636|FG000|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5|||
48690502|NCT00528957|156717637|FG001|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4|||
48690503|NCT00528957|156717636|FG000|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0|||
48690504|NCT00528957|156717637|FG001|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3|||
48690505|NCT00528957|156717636|FG000|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
48690506|NCT00528957|156717637|FG001|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
48690507|NCT00528957|156717636|FG000|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0|||
48690508|NCT00528957|156717637|FG001|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1|||
48690509|NCT00528957|156717636|FG000|Third Extension (Week 240 to Week 336)|Withdrew Consent|0|||
48690510|NCT00528957|156717637|FG001|Third Extension (Week 240 to Week 336)|Withdrew Consent|1|||
48690511|NCT00528957|156717636|FG000|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4|||
48690512|NCT00528957|156717637|FG001|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10|||
48690513|NCT00528957|156717636|FG000|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3|||
48690514|NCT00528957|156717637|FG001|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5|||
48690515|NCT00528957|156717636|FG000|Long-Term Extension (Week 336 and On)|Withdrew Consent|2|||
48690516|NCT00528957|156717637|FG001|Long-Term Extension (Week 336 and On)|Withdrew Consent|1|||
48690517|NCT00528957|156717636|FG000|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
48981573|NCT01708915|157764315|FG001|Overall Study|Withdrawal by Subject|1|||
48981574|NCT01708915|157764316|FG002|Overall Study|Withdrawal by Subject|2|||
48981575|NCT01708915|157764317|FG003|Overall Study|Withdrawal by Subject|2|||
48981576|NCT01708915|157764314|FG000|Overall Study|Other reasons than stated above|1|||
48981577|NCT01708915|157764315|FG001|Overall Study|Other reasons than stated above|1|||
48981578|NCT01708915|157764316|FG002|Overall Study|Other reasons than stated above|0|||
48981579|NCT01708915|157764317|FG003|Overall Study|Other reasons than stated above|2|||
48981580|NCT01369069|157764318|FG000|Overall Study|Lost to Follow-up|8|||
48981581|NCT01369069|157764319|FG001|Overall Study|Lost to Follow-up|9|||
48981582|NCT01369069|157764318|FG000|Overall Study|Withdrawal by Subject|9|||
48981583|NCT01369069|157764319|FG001|Overall Study|Withdrawal by Subject|7|||
48981584|NCT03858686|157764320|FG000|Period 1|Adverse Event|1|||
48981585|NCT03858686|157764321|FG001|Period 1|Adverse Event|1|||
48981586|NCT03858686|157764320|FG000|Period 1|Lack of compliance|0|||
48981587|NCT03858686|157764321|FG001|Period 1|Lack of compliance|1|||
48981588|NCT03858686|157764320|FG000|Period 1|Adverse Event|0|||
48981589|NCT03858686|157764321|FG001|Period 1|Adverse Event|1|||
48981590|NCT03858686|157764320|FG000|Period 2|Adverse Event|0|||
48981591|NCT03858686|157764321|FG001|Period 2|Adverse Event|1|||
48981592|NCT02573012|157764322|FG000|Overall Study|Adverse Event|5|||
48981593|NCT02573012|157764323|FG001|Overall Study|Adverse Event|5|||
48981594|NCT02573012|157764322|FG000|Overall Study|Lack of Efficacy|5|||
48981595|NCT02573012|157764323|FG001|Overall Study|Lack of Efficacy|4|||
48981596|NCT02573012|157764322|FG000|Overall Study|Non-compliance|1|||
48690518|NCT00528957|156717637|FG001|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
48690519|NCT01539759|156717638|FG000|Overall Study|Lost to Follow-up|6|||
48690520|NCT01539759|156717639|FG001|Overall Study|Lost to Follow-up|8|||
48690521|NCT02872116|156717640|FG000|Pre-Treatment|Disease Progression|0|||
48690522|NCT02872116|156717641|FG001|Pre-Treatment|Disease Progression|1|||
48690523|NCT02872116|156717642|FG002|Pre-Treatment|Disease Progression|0|||
48690524|NCT02872116|156717640|FG000|Pre-Treatment|Adverse event unrelated to study drug|0|||
48690525|NCT02872116|156717641|FG001|Pre-Treatment|Adverse event unrelated to study drug|2|||
48690526|NCT02872116|156717642|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
48690527|NCT02872116|156717640|FG000|Pre-Treatment|Participants request to discontinue study treatment|0|||
48690528|NCT02872116|156717641|FG001|Pre-Treatment|Participants request to discontinue study treatment|2|||
48690529|NCT02872116|156717642|FG002|Pre-Treatment|Participants request to discontinue study treatment|0|||
48690530|NCT02872116|156717640|FG000|Pre-Treatment|Participant withdrew consent|2|||
48690531|NCT02872116|156717641|FG001|Pre-Treatment|Participant withdrew consent|20|||
48690532|NCT02872116|156717642|FG002|Pre-Treatment|Participant withdrew consent|3|||
48690533|NCT02872116|156717640|FG000|Pre-Treatment|Participant no longer meets study criteria|4|||
48690534|NCT02872116|156717641|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
48690535|NCT02872116|156717642|FG002|Pre-Treatment|Participant no longer meets study criteria|0|||
48690536|NCT02872116|156717640|FG000|Pre-Treatment|Other reasons|1|||
48690537|NCT02872116|156717641|FG001|Pre-Treatment|Other reasons|2|||
48690538|NCT02872116|156717642|FG002|Pre-Treatment|Other reasons|2|||
48690539|NCT02872116|156717640|FG000|Treatment|Death|122|||
48690540|NCT02872116|156717641|FG001|Treatment|Death|94|||
48690541|NCT02872116|156717642|FG002|Treatment|Death|68|||
48690542|NCT02872116|156717640|FG000|Treatment|Lost to Follow-up|5|||
48690543|NCT02872116|156717641|FG001|Treatment|Lost to Follow-up|7|||
48690544|NCT02872116|156717642|FG002|Treatment|Lost to Follow-up|3|||
48690545|NCT02872116|156717640|FG000|Treatment|Participant withdrew consent|20|||
48690546|NCT02872116|156717641|FG001|Treatment|Participant withdrew consent|40|||
48690547|NCT02872116|156717642|FG002|Treatment|Participant withdrew consent|8|||
48690548|NCT02872116|156717640|FG000|Treatment|Other reasons|12|||
48690549|NCT02872116|156717641|FG001|Treatment|Other reasons|12|||
48690550|NCT02872116|156717642|FG002|Treatment|Other reasons|5|||
48690551|NCT04349072|156717643|FG000|Randomization Period|Found ineligible post enrollment|0|||
48690552|NCT04349072|156717644|FG001|Randomization Period|Found ineligible post enrollment|1|||
48690553|NCT04349072|156717643|FG000|Treatment Period|Permanent Stopping Criteria Met|0|||
48690554|NCT04349072|156717644|FG001|Treatment Period|Permanent Stopping Criteria Met|2|||
48690555|NCT04349072|156717643|FG000|Treatment Period|Proceeding With Septal Reduction Therapy (SRT)|3|||
48690556|NCT04349072|156717644|FG001|Treatment Period|Proceeding With Septal Reduction Therapy (SRT)|5|||
48690557|NCT04349072|156717643|FG000|Treatment Period|Physician Decision|0|||
48690558|NCT04349072|156717644|FG001|Treatment Period|Physician Decision|1|||
48690559|NCT04349072|156717643|FG000|Treatment Period|Protocol Violation|0|||
48690560|NCT04349072|156717644|FG001|Treatment Period|Protocol Violation|1|||
48690561|NCT04349072|156717643|FG000|Treatment Period|Withdrawal by Subject|1|||
48690562|NCT04349072|156717644|FG001|Treatment Period|Withdrawal by Subject|1|||
48690563|NCT03901144|156717647|FG000|Overall Study|Lost to Follow-up|1|||
48690564|NCT03901144|156717648|FG001|Overall Study|Lost to Follow-up|1|||
48690565|NCT03901144|156717649|FG002|Overall Study|Lost to Follow-up|1|||
48690566|NCT03901144|156717650|FG003|Overall Study|Lost to Follow-up|1|||
48690567|NCT00990106|156717651|FG000|Overall Study|"too busy to continue"|1|||
48690568|NCT00990106|156717652|FG001|Overall Study|"too busy to continue"|2|||
48690569|NCT00990106|156717651|FG000|Overall Study|Lost to Follow-up|1|||
48690570|NCT00990106|156717652|FG001|Overall Study|Lost to Follow-up|3|||
48690571|NCT00990106|156717651|FG000|Overall Study|Withdrawal by Subject|2|||
48690572|NCT00990106|156717652|FG001|Overall Study|Withdrawal by Subject|1|||
48690573|NCT00990106|156717651|FG000|Overall Study|opted for open label prazosin|1|||
48690574|NCT00990106|156717652|FG001|Overall Study|opted for open label prazosin|1|||
48690575|NCT00990106|156717651|FG000|Overall Study|relocation/deployment|4|||
48690576|NCT00990106|156717652|FG001|Overall Study|relocation/deployment|1|||
48690577|NCT00990106|156717651|FG000|Overall Study|started exclusionary medication|0|||
48690578|NCT00990106|156717652|FG001|Overall Study|started exclusionary medication|1|||
48690579|NCT00990106|156717651|FG000|Overall Study|planned major surgery|0|||
48690580|NCT00990106|156717652|FG001|Overall Study|planned major surgery|1|||
48690581|NCT00990106|156717651|FG000|Overall Study|scheduling conflicts|0|||
48690582|NCT00990106|156717652|FG001|Overall Study|scheduling conflicts|2|||
48690583|NCT02138890|156717653|FG000|Overall Study|Adverse Event|1|||
48690584|NCT02138890|156717654|FG001|Overall Study|Adverse Event|0|||
48690585|NCT03318549|156717657|FG000|Overall Study|Withdrawal by Subject|5|||
48763719|NCT00914810|156985723|FG001|Overall Study|Hospitalized and unable to follow up.|1|||
48690586|NCT03318549|156717658|FG001|Overall Study|Withdrawal by Subject|19|||
48690587|NCT03318549|156717659|FG002|Overall Study|Withdrawal by Subject|2|||
48690588|NCT03318549|156717660|FG003|Overall Study|Withdrawal by Subject|0|||
48690589|NCT03318549|156717661|FG004|Overall Study|Withdrawal by Subject|0|||
48690590|NCT03318549|156717662|FG005|Overall Study|Withdrawal by Subject|0|||
48690591|NCT03318549|156717663|FG006|Overall Study|Withdrawal by Subject|0|||
48690592|NCT03318549|156717657|FG000|Overall Study|Physician Decision|0|||
48690593|NCT03318549|156717658|FG001|Overall Study|Physician Decision|4|||
48690594|NCT03318549|156717659|FG002|Overall Study|Physician Decision|1|||
48690595|NCT03318549|156717660|FG003|Overall Study|Physician Decision|0|||
48690596|NCT03318549|156717661|FG004|Overall Study|Physician Decision|0|||
48690597|NCT03318549|156717662|FG005|Overall Study|Physician Decision|0|||
48690598|NCT03318549|156717663|FG006|Overall Study|Physician Decision|0|||
48690599|NCT03318549|156717657|FG000|Overall Study|Lost to Follow-up|0|||
48690600|NCT03318549|156717658|FG001|Overall Study|Lost to Follow-up|3|||
48690601|NCT03318549|156717659|FG002|Overall Study|Lost to Follow-up|3|||
48690602|NCT03318549|156717660|FG003|Overall Study|Lost to Follow-up|0|||
48690603|NCT03318549|156717661|FG004|Overall Study|Lost to Follow-up|0|||
48690604|NCT03318549|156717662|FG005|Overall Study|Lost to Follow-up|0|||
48690605|NCT03318549|156717663|FG006|Overall Study|Lost to Follow-up|0|||
48690606|NCT02657889|156717664|FG000|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
48690607|NCT02657889|156717665|FG001|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
48690608|NCT02657889|156717666|FG002|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
48690609|NCT02657889|156717667|FG003|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
48690610|NCT02657889|156717664|FG000|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|2|||
48690611|NCT02657889|156717665|FG001|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
48690612|NCT02657889|156717666|FG002|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
48690613|NCT02657889|156717667|FG003|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
48690614|NCT02657889|156717664|FG000|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
48690615|NCT02657889|156717665|FG001|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|1|||
48690616|NCT02657889|156717666|FG002|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
48690617|NCT02657889|156717667|FG003|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
48690618|NCT02657889|156717664|FG000|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
48690619|NCT02657889|156717665|FG001|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|1|||
48690620|NCT02657889|156717666|FG002|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
48690621|NCT02657889|156717667|FG003|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
48690622|NCT02657889|156717664|FG000|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
48690623|NCT02657889|156717665|FG001|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
48690624|NCT02657889|156717666|FG002|Phase 2: (Up to a Maximum of 54 Months)|Death|30|||
48690625|NCT02657889|156717667|FG003|Phase 2: (Up to a Maximum of 54 Months)|Death|42|||
48690626|NCT02657889|156717664|FG000|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
48690627|NCT02657889|156717665|FG001|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
48690628|NCT02657889|156717666|FG002|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|5|||
48690629|NCT02657889|156717667|FG003|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|2|||
48690630|NCT02657889|156717664|FG000|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
48690631|NCT02657889|156717665|FG001|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
48690632|NCT02657889|156717666|FG002|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|8|||
48690633|NCT02657889|156717667|FG003|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|2|||
48763720|NCT01816893|156985724|FG000|Washout Period|Withdrawal by Subject|2|||
48763721|NCT01816893|156985725|FG001|Washout Period|Withdrawal by Subject|0|||
48763722|NCT00004888|156985726|FG000|Overall Study|Adverse Event|5|||
48763723|NCT00004888|156985727|FG001|Overall Study|Adverse Event|10|||
48763724|NCT00004888|156985726|FG000|Overall Study|Withdrawal by Subject|0|||
48763725|NCT00004888|156985727|FG001|Overall Study|Withdrawal by Subject|3|||
48763726|NCT00004888|156985726|FG000|Overall Study|Physician Decision|1|||
48763727|NCT00004888|156985727|FG001|Overall Study|Physician Decision|1|||
48763728|NCT00004888|156985726|FG000|Overall Study|Progressive Disease|4|||
48763729|NCT00004888|156985727|FG001|Overall Study|Progressive Disease|9|||
48763730|NCT00004888|156985726|FG000|Overall Study|Death without progressive disease|0|||
48763731|NCT00004888|156985727|FG001|Overall Study|Death without progressive disease|1|||
48690634|NCT02657889|156717664|FG000|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
48690635|NCT02657889|156717665|FG001|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
48690636|NCT02657889|156717666|FG002|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
48690637|NCT02657889|156717667|FG003|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
48690638|NCT02657889|156717664|FG000|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
48763732|NCT00004888|156985726|FG000|Overall Study|Toxic death|1|||
48763733|NCT00004888|156985727|FG001|Overall Study|Toxic death|0|||
48763734|NCT02082210|156985735|FG000|Overall Study|Death|0|||
48763735|NCT02082210|156985736|FG001|Overall Study|Death|0|||
48763736|NCT02082210|156985737|FG002|Overall Study|Death|1|||
48763737|NCT02082210|156985738|FG003|Overall Study|Death|1|||
48763738|NCT02082210|156985739|FG004|Overall Study|Death|1|||
48763739|NCT02082210|156985740|FG005|Overall Study|Death|0|||
48763740|NCT02082210|156985735|FG000|Overall Study|Withdrawal by Subject|0|||
48763741|NCT02082210|156985736|FG001|Overall Study|Withdrawal by Subject|0|||
48763742|NCT02082210|156985737|FG002|Overall Study|Withdrawal by Subject|0|||
48763743|NCT02082210|156985738|FG003|Overall Study|Withdrawal by Subject|1|||
48690639|NCT02657889|156717665|FG001|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
48690640|NCT02657889|156717666|FG002|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|6|||
48690641|NCT02657889|156717667|FG003|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|1|||
48690642|NCT02657889|156717664|FG000|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
48690643|NCT02657889|156717665|FG001|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
48690644|NCT02657889|156717666|FG002|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
49024410|NCT00150462|157928821|FG010|Overall Study|Death|0|||
48690645|NCT02657889|156717667|FG003|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|1|||
48690646|NCT02657889|156717664|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
48690647|NCT02657889|156717665|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
48690648|NCT02657889|156717666|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participant request|2|||
48690649|NCT02657889|156717667|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participant request|1|||
48690650|NCT02657889|156717664|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
48690651|NCT02657889|156717665|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
48690652|NCT02657889|156717666|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
48690653|NCT02657889|156717667|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|4|||
48690654|NCT00685165|156717668|FG000|Washout Period of 14 Days|Adverse Event|1|||
48690655|NCT00685165|156717669|FG001|Washout Period of 14 Days|Adverse Event|0|||
48690656|NCT01894607|156717679|FG000|Overall Study|Ineligible|1|||
48690657|NCT00849940|156717680|FG000|Overall Study|Physician Decision|4|||
48690658|NCT05135871|156717681|FG000|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|1|||
48690659|NCT05135871|156717682|FG001|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
48690660|NCT05135871|156717683|FG002|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
48690661|NCT05135871|156717684|FG003|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
48690662|NCT00556075|156717685|FG000|Overall Study|Lost to Follow-up|3|||
48690663|NCT00556075|156717686|FG001|Overall Study|Lost to Follow-up|0|||
48690664|NCT00556075|156717687|FG002|Overall Study|Lost to Follow-up|3|||
48690665|NCT00556075|156717685|FG000|Overall Study|Withdrawal by Subject|3|||
48690666|NCT00556075|156717686|FG001|Overall Study|Withdrawal by Subject|3|||
48690667|NCT00556075|156717687|FG002|Overall Study|Withdrawal by Subject|0|||
48690668|NCT00556075|156717685|FG000|Overall Study|Protocol Violation|1|||
48690669|NCT00556075|156717686|FG001|Overall Study|Protocol Violation|1|||
48690670|NCT00556075|156717687|FG002|Overall Study|Protocol Violation|3|||
48690671|NCT00556075|156717685|FG000|Overall Study|Not eligible|1|||
48690672|NCT00556075|156717686|FG001|Overall Study|Not eligible|1|||
48690673|NCT00556075|156717687|FG002|Overall Study|Not eligible|2|||
48690674|NCT00556075|156717685|FG000|Overall Study|Adverse Event|1|||
48690675|NCT00556075|156717686|FG001|Overall Study|Adverse Event|2|||
48690676|NCT00556075|156717687|FG002|Overall Study|Adverse Event|0|||
48690677|NCT00556075|156717685|FG000|Overall Study|Personal issues|4|||
48690678|NCT00556075|156717686|FG001|Overall Study|Personal issues|1|||
48690679|NCT00556075|156717687|FG002|Overall Study|Personal issues|0|||
48690680|NCT00556075|156717685|FG000|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
48690681|NCT00556075|156717686|FG001|Overall Study|Endometrial stripe not viewed on 2 tvu|1|||
48690682|NCT00556075|156717687|FG002|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
48690683|NCT02922725|156717688|FG000|Overall Study|Withdrawal by Subject|1|||
48690684|NCT02922725|156717689|FG001|Overall Study|Withdrawal by Subject|0|||
48690685|NCT02922725|156717690|FG002|Overall Study|Withdrawal by Subject|0|||
48690686|NCT03649074|156717693|FG000|Overall Study|Lost to Follow-up|2|||
48690687|NCT03649074|156717694|FG001|Overall Study|Lost to Follow-up|1|||
48690688|NCT03649074|156717693|FG000|Overall Study|Adverse Event|1|||
48690689|NCT03649074|156717694|FG001|Overall Study|Adverse Event|0|||
48690690|NCT03649074|156717693|FG000|Overall Study|Physician Decision|1|||
48690691|NCT03649074|156717694|FG001|Overall Study|Physician Decision|0|||
48690692|NCT03649074|156717693|FG000|Overall Study|Withdrawal by Subject|0|||
48690693|NCT03649074|156717694|FG001|Overall Study|Withdrawal by Subject|2|||
48690694|NCT03649074|156717693|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
48690695|NCT03649074|156717694|FG001|Overall Study|Withdrawn by Parent/Guardian|2|||
48690696|NCT03649074|156717693|FG000|Overall Study|Other|1|||
48690697|NCT03649074|156717694|FG001|Overall Study|Other|0|||
48690698|NCT01300728|156717695|FG000|Overall Study|Withdrawal by Subject|1|||
48690699|NCT01300728|156717696|FG001|Overall Study|Withdrawal by Subject|1|||
48690700|NCT01300728|156717695|FG000|Overall Study|Physician Decision|1|||
48690701|NCT01300728|156717696|FG001|Overall Study|Physician Decision|0|||
48690702|NCT01253291|156717697|FG000|Overall Study|Withdrawal by Subject|1|||
48690703|NCT01253291|156717698|FG001|Overall Study|Withdrawal by Subject|1|||
48690704|NCT01253291|156717699|FG002|Overall Study|Withdrawal by Subject|0|||
48690705|NCT01253291|156717700|FG003|Overall Study|Withdrawal by Subject|0|||
48690706|NCT01253291|156717701|FG004|Overall Study|Withdrawal by Subject|0|||
49024411|NCT00150462|157928811|FG000|Overall Study|Adverse Event|0|||
48763744|NCT02082210|156985739|FG004|Overall Study|Withdrawal by Subject|2|||
48690707|NCT01253291|156717697|FG000|Overall Study|Adverse Event|0|||
48690708|NCT01253291|156717698|FG001|Overall Study|Adverse Event|1|||
48690709|NCT01253291|156717699|FG002|Overall Study|Adverse Event|0|||
48690710|NCT01253291|156717700|FG003|Overall Study|Adverse Event|0|||
48690711|NCT01253291|156717701|FG004|Overall Study|Adverse Event|0|||
48690712|NCT01253291|156717697|FG000|Overall Study|Lack of Efficacy|1|||
48690713|NCT01253291|156717698|FG001|Overall Study|Lack of Efficacy|0|||
48690714|NCT01253291|156717699|FG002|Overall Study|Lack of Efficacy|0|||
48690715|NCT01253291|156717700|FG003|Overall Study|Lack of Efficacy|0|||
48690716|NCT01253291|156717701|FG004|Overall Study|Lack of Efficacy|0|||
48690717|NCT01253291|156717697|FG000|Overall Study|Physician Decision|2|||
48690718|NCT01253291|156717698|FG001|Overall Study|Physician Decision|0|||
48690719|NCT01253291|156717699|FG002|Overall Study|Physician Decision|0|||
48690720|NCT01253291|156717700|FG003|Overall Study|Physician Decision|0|||
48690721|NCT01253291|156717701|FG004|Overall Study|Physician Decision|2|||
48690722|NCT03883581|156717702|FG000|Overall Study|Withdrawal by Subject|4|||
48690723|NCT01808196|156717706|FG000|Overall Study|Lost to Follow-up|1|||
48690724|NCT04612725|156717707|FG000|Overall Study|Adverse Event|1|||
48690725|NCT04612725|156717708|FG001|Overall Study|Adverse Event|3|||
48690726|NCT04612725|156717709|FG002|Overall Study|Adverse Event|1|||
48690727|NCT04612725|156717710|FG003|Overall Study|Adverse Event|0|||
48690728|NCT04612725|156717711|FG004|Overall Study|Adverse Event|1|||
48690729|NCT04612725|156717707|FG000|Overall Study|Lost to Follow-up|0|||
48690730|NCT04612725|156717708|FG001|Overall Study|Lost to Follow-up|1|||
48690731|NCT04612725|156717709|FG002|Overall Study|Lost to Follow-up|0|||
48690732|NCT04612725|156717710|FG003|Overall Study|Lost to Follow-up|0|||
48690733|NCT04612725|156717711|FG004|Overall Study|Lost to Follow-up|0|||
48690734|NCT04612725|156717707|FG000|Overall Study|Physician Decision|2|||
48690735|NCT04612725|156717708|FG001|Overall Study|Physician Decision|0|||
48690736|NCT04612725|156717709|FG002|Overall Study|Physician Decision|0|||
48690737|NCT04612725|156717710|FG003|Overall Study|Physician Decision|0|||
48690738|NCT04612725|156717711|FG004|Overall Study|Physician Decision|0|||
48690739|NCT04612725|156717707|FG000|Overall Study|Study terminated by sponsor|3|||
48690740|NCT04612725|156717708|FG001|Overall Study|Study terminated by sponsor|1|||
48690741|NCT04612725|156717709|FG002|Overall Study|Study terminated by sponsor|2|||
48690742|NCT04612725|156717710|FG003|Overall Study|Study terminated by sponsor|4|||
48690743|NCT04612725|156717711|FG004|Overall Study|Study terminated by sponsor|5|||
48690744|NCT04612725|156717707|FG000|Overall Study|Withdrawal by Subject|8|||
48690745|NCT04612725|156717708|FG001|Overall Study|Withdrawal by Subject|3|||
48690746|NCT04612725|156717709|FG002|Overall Study|Withdrawal by Subject|5|||
48690747|NCT04612725|156717710|FG003|Overall Study|Withdrawal by Subject|1|||
48690748|NCT04612725|156717711|FG004|Overall Study|Withdrawal by Subject|9|||
48690749|NCT04612725|156717707|FG000|Overall Study|Other|0|||
48690750|NCT04612725|156717708|FG001|Overall Study|Other|0|||
48690751|NCT04612725|156717709|FG002|Overall Study|Other|0|||
48690752|NCT04612725|156717710|FG003|Overall Study|Other|0|||
48690753|NCT04612725|156717711|FG004|Overall Study|Other|1|||
48690754|NCT00506350|156717712|FG000|Overall Study|Serious Adverse Event|1|||
48690755|NCT00506350|156717713|FG001|Overall Study|Serious Adverse Event|0|||
48690756|NCT00506350|156717714|FG002|Overall Study|Serious Adverse Event|0|||
48690757|NCT00506350|156717715|FG003|Overall Study|Serious Adverse Event|0|||
48690758|NCT00506350|156717716|FG004|Overall Study|Serious Adverse Event|0|||
48690759|NCT00506350|156717717|FG005|Overall Study|Serious Adverse Event|0|||
48690760|NCT00506350|156717718|FG006|Overall Study|Serious Adverse Event|0|||
48690761|NCT00506350|156717719|FG007|Overall Study|Serious Adverse Event|0|||
48690762|NCT00506350|156717720|FG008|Overall Study|Serious Adverse Event|0|||
48690763|NCT00506350|156717712|FG000|Overall Study|Adverse Event|0|||
48690764|NCT00506350|156717713|FG001|Overall Study|Adverse Event|0|||
48690765|NCT00506350|156717714|FG002|Overall Study|Adverse Event|0|||
48690766|NCT00506350|156717715|FG003|Overall Study|Adverse Event|0|||
48690767|NCT00506350|156717716|FG004|Overall Study|Adverse Event|0|||
48981597|NCT02573012|157764323|FG001|Overall Study|Non-compliance|2|||
48690768|NCT00506350|156717717|FG005|Overall Study|Adverse Event|0|||
48690769|NCT00506350|156717718|FG006|Overall Study|Adverse Event|0|||
48690770|NCT00506350|156717719|FG007|Overall Study|Adverse Event|1|||
48690771|NCT00506350|156717720|FG008|Overall Study|Adverse Event|1|||
48690772|NCT00506350|156717712|FG000|Overall Study|Protocol Violation|0|||
48690773|NCT00506350|156717713|FG001|Overall Study|Protocol Violation|0|||
48690774|NCT00506350|156717714|FG002|Overall Study|Protocol Violation|1|||
48690775|NCT00506350|156717715|FG003|Overall Study|Protocol Violation|0|||
48690776|NCT00506350|156717716|FG004|Overall Study|Protocol Violation|0|||
48690777|NCT00506350|156717717|FG005|Overall Study|Protocol Violation|0|||
48690778|NCT00506350|156717718|FG006|Overall Study|Protocol Violation|1|||
48690779|NCT00506350|156717719|FG007|Overall Study|Protocol Violation|0|||
48690780|NCT00506350|156717720|FG008|Overall Study|Protocol Violation|0|||
48690781|NCT00506350|156717712|FG000|Overall Study|Withdrawal by Subject|0|||
48690782|NCT00506350|156717713|FG001|Overall Study|Withdrawal by Subject|1|||
48690783|NCT00506350|156717714|FG002|Overall Study|Withdrawal by Subject|1|||
48690784|NCT00506350|156717715|FG003|Overall Study|Withdrawal by Subject|1|||
49024412|NCT00150462|157928812|FG001|Overall Study|Adverse Event|0|||
49024413|NCT00150462|157928813|FG002|Overall Study|Adverse Event|0|||
49024414|NCT00150462|157928814|FG003|Overall Study|Adverse Event|1|||
49024415|NCT00150462|157928815|FG004|Overall Study|Adverse Event|0|||
49024416|NCT00150462|157928816|FG005|Overall Study|Adverse Event|0|||
49024417|NCT00150462|157928817|FG006|Overall Study|Adverse Event|0|||
49024418|NCT00150462|157928818|FG007|Overall Study|Adverse Event|2|||
49024419|NCT00150462|157928819|FG008|Overall Study|Adverse Event|0|||
49024420|NCT00150462|157928820|FG009|Overall Study|Adverse Event|1|||
49024421|NCT00150462|157928821|FG010|Overall Study|Adverse Event|0|||
49024422|NCT00150462|157928811|FG000|Overall Study|Physician Decision|0|||
49024423|NCT00150462|157928812|FG001|Overall Study|Physician Decision|0|||
49024424|NCT00150462|157928813|FG002|Overall Study|Physician Decision|1|||
49024425|NCT00150462|157928814|FG003|Overall Study|Physician Decision|1|||
49024426|NCT00150462|157928815|FG004|Overall Study|Physician Decision|0|||
49024427|NCT00150462|157928816|FG005|Overall Study|Physician Decision|0|||
49024428|NCT00150462|157928817|FG006|Overall Study|Physician Decision|0|||
48690785|NCT00506350|156717716|FG004|Overall Study|Withdrawal by Subject|4|||
48690786|NCT00506350|156717717|FG005|Overall Study|Withdrawal by Subject|1|||
48690787|NCT00506350|156717718|FG006|Overall Study|Withdrawal by Subject|1|||
48690788|NCT00506350|156717719|FG007|Overall Study|Withdrawal by Subject|2|||
48690789|NCT00506350|156717720|FG008|Overall Study|Withdrawal by Subject|0|||
48690790|NCT00506350|156717712|FG000|Overall Study|Lost to Follow-up|1|||
48690791|NCT00506350|156717713|FG001|Overall Study|Lost to Follow-up|1|||
48690792|NCT00506350|156717714|FG002|Overall Study|Lost to Follow-up|1|||
48690793|NCT00506350|156717715|FG003|Overall Study|Lost to Follow-up|1|||
48690794|NCT00506350|156717716|FG004|Overall Study|Lost to Follow-up|2|||
48690795|NCT00506350|156717717|FG005|Overall Study|Lost to Follow-up|1|||
48690796|NCT00506350|156717718|FG006|Overall Study|Lost to Follow-up|0|||
48690797|NCT00506350|156717719|FG007|Overall Study|Lost to Follow-up|0|||
48690798|NCT00506350|156717720|FG008|Overall Study|Lost to Follow-up|2|||
48690799|NCT00506350|156717712|FG000|Overall Study|Medical Reason|0|||
48690800|NCT00506350|156717713|FG001|Overall Study|Medical Reason|0|||
48690801|NCT00506350|156717714|FG002|Overall Study|Medical Reason|0|||
48690802|NCT00506350|156717715|FG003|Overall Study|Medical Reason|0|||
48690803|NCT00506350|156717716|FG004|Overall Study|Medical Reason|1|||
48690804|NCT00506350|156717717|FG005|Overall Study|Medical Reason|0|||
48690805|NCT00506350|156717718|FG006|Overall Study|Medical Reason|0|||
48690806|NCT00506350|156717719|FG007|Overall Study|Medical Reason|0|||
48690807|NCT00506350|156717720|FG008|Overall Study|Medical Reason|0|||
48690808|NCT00506350|156717712|FG000|Overall Study|Other|1|||
48690809|NCT00506350|156717713|FG001|Overall Study|Other|1|||
48690810|NCT00506350|156717714|FG002|Overall Study|Other|3|||
48690811|NCT00506350|156717715|FG003|Overall Study|Other|0|||
48690812|NCT00506350|156717716|FG004|Overall Study|Other|3|||
48690813|NCT00506350|156717717|FG005|Overall Study|Other|0|||
48690814|NCT00506350|156717718|FG006|Overall Study|Other|0|||
48690815|NCT00506350|156717719|FG007|Overall Study|Other|2|||
48690816|NCT00506350|156717720|FG008|Overall Study|Other|2|||
48690817|NCT00301808|156717721|FG000|Overall Study|Adverse Event|5|||
48690818|NCT00301808|156717721|FG000|Overall Study|Death|3|||
48690819|NCT00301808|156717721|FG000|Overall Study|Lack of Efficacy|4|||
48690820|NCT00668148|156717722|FG000|Overall Study|Adverse Event|5|||
48690821|NCT00668148|156717722|FG000|Overall Study|Subject Non-compliance|1|||
48690822|NCT00668148|156717722|FG000|Overall Study|Progressive Disease Before Treatment|2|||
48690823|NCT00668148|156717722|FG000|Overall Study|Withdrawal of Consent|2|||
48690824|NCT04801420|156717723|FG000|Overall Study|Other|1|||
48690825|NCT04801420|156717724|FG001|Overall Study|Other|2|||
48690826|NCT04801420|156717725|FG002|Overall Study|Other|1|||
48690827|NCT04801420|156717723|FG000|Overall Study|Lost to Follow-up|7|||
48690828|NCT04801420|156717724|FG001|Overall Study|Lost to Follow-up|9|||
48690829|NCT04801420|156717725|FG002|Overall Study|Lost to Follow-up|10|||
48690830|NCT04801420|156717723|FG000|Overall Study|Moved from study area|0|||
48690831|NCT04801420|156717724|FG001|Overall Study|Moved from study area|1|||
48690832|NCT04801420|156717725|FG002|Overall Study|Moved from study area|1|||
48690833|NCT04801420|156717723|FG000|Overall Study|Withdrawal by Subject|5|||
48690834|NCT04801420|156717724|FG001|Overall Study|Withdrawal by Subject|1|||
48690835|NCT04801420|156717725|FG002|Overall Study|Withdrawal by Subject|4|||
48690836|NCT04801420|156717723|FG000|Overall Study|Individual stopping criteria reached|0|||
48690837|NCT04801420|156717724|FG001|Overall Study|Individual stopping criteria reached|1|||
48690838|NCT04801420|156717725|FG002|Overall Study|Individual stopping criteria reached|0|||
48690839|NCT04801420|156717723|FG000|Overall Study|Ongoing in the study|195|||
49024429|NCT00150462|157928818|FG007|Overall Study|Physician Decision|0|||
48690840|NCT04801420|156717724|FG001|Overall Study|Ongoing in the study|195|||
48690841|NCT04801420|156717725|FG002|Overall Study|Ongoing in the study|192|||
48690842|NCT03790111|156720092|FG000|Overall Study|Study did not meet its primary endpoint.|53|||
48690843|NCT03798717|156720096|FG000|Overall Study|Failed Screening|0|||
48690844|NCT03798717|156720097|FG001|Overall Study|Failed Screening|0|||
49024430|NCT00150462|157928819|FG008|Overall Study|Physician Decision|0|||
49024431|NCT00150462|157928820|FG009|Overall Study|Physician Decision|0|||
48763745|NCT02082210|156985740|FG005|Overall Study|Withdrawal by Subject|2|||
48763746|NCT02082210|156985735|FG000|Overall Study|Clinical Progression|0|||
48763747|NCT02082210|156985736|FG001|Overall Study|Clinical Progression|0|||
48763748|NCT02082210|156985737|FG002|Overall Study|Clinical Progression|0|||
48763749|NCT02082210|156985738|FG003|Overall Study|Clinical Progression|1|||
48763750|NCT02082210|156985739|FG004|Overall Study|Clinical Progression|0|||
48763751|NCT02082210|156985740|FG005|Overall Study|Clinical Progression|0|||
48763752|NCT02082210|156985735|FG000|Overall Study|No Post-Baseline Tumor Assesment|0|||
48763753|NCT02082210|156985736|FG001|Overall Study|No Post-Baseline Tumor Assesment|0|||
48763754|NCT02082210|156985737|FG002|Overall Study|No Post-Baseline Tumor Assesment|1|||
48763755|NCT02082210|156985738|FG003|Overall Study|No Post-Baseline Tumor Assesment|2|||
48763756|NCT02082210|156985739|FG004|Overall Study|No Post-Baseline Tumor Assesment|0|||
48763757|NCT02082210|156985740|FG005|Overall Study|No Post-Baseline Tumor Assesment|0|||
48763758|NCT02082210|156985735|FG000|Overall Study|Physician Decision|0|||
48763759|NCT02082210|156985736|FG001|Overall Study|Physician Decision|0|||
48981598|NCT02573012|157764322|FG000|Overall Study|Withdrawal by Subject|2|||
48981599|NCT02573012|157764323|FG001|Overall Study|Withdrawal by Subject|2|||
48981600|NCT02573012|157764322|FG000|Overall Study|Study Ended per Protocol|1|||
48981601|NCT02573012|157764323|FG001|Overall Study|Study Ended per Protocol|0|||
48981602|NCT02573012|157764322|FG000|Overall Study|Physician Decision|1|||
48981603|NCT02573012|157764323|FG001|Overall Study|Physician Decision|2|||
48981604|NCT00882362|157764325|FG000|Overall Study|Adverse Event|13|||
48981605|NCT00882362|157764326|FG001|Overall Study|Adverse Event|10|||
48981606|NCT00882362|157764325|FG000|Overall Study|Withdrawal by Subject|13|||
48981607|NCT00882362|157764326|FG001|Overall Study|Withdrawal by Subject|10|||
48981608|NCT00882362|157764325|FG000|Overall Study|Lack of Efficacy|3|||
48981609|NCT00882362|157764326|FG001|Overall Study|Lack of Efficacy|0|||
48981610|NCT00882362|157764325|FG000|Overall Study|Protocol Violation|7|||
48981611|NCT00882362|157764326|FG001|Overall Study|Protocol Violation|2|||
48981612|NCT00882362|157764325|FG000|Overall Study|Pregnancy|1|||
48981613|NCT00882362|157764326|FG001|Overall Study|Pregnancy|0|||
48981614|NCT00882362|157764325|FG000|Overall Study|Physician Decision|5|||
48981615|NCT00882362|157764326|FG001|Overall Study|Physician Decision|1|||
48981616|NCT00882362|157764325|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2|||
48981617|NCT00882362|157764326|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
48981618|NCT00882362|157764325|FG000|Overall Study|change of residence or other commitments|5|||
48981619|NCT00882362|157764326|FG001|Overall Study|change of residence or other commitments|0|||
48981620|NCT02545049|157764328|FG000|Overall Study|Withdrawal by Subject|1|||
48981621|NCT02545049|157764329|FG001|Overall Study|Withdrawal by Subject|7|||
48981622|NCT02545049|157764328|FG000|Overall Study|Lost to Follow-up|4|||
48981623|NCT02545049|157764329|FG001|Overall Study|Lost to Follow-up|6|||
48981624|NCT02545049|157764328|FG000|Overall Study|GCP violations|37|||
48981625|NCT02545049|157764329|FG001|Overall Study|GCP violations|48|||
48981626|NCT00984009|157764330|FG000|Grapefruit Juice Alone|missed serving of grapefruit juice|1|||
48981627|NCT03922711|157764333|FG000|Overall Study|Adverse Event|3|||
48981628|NCT03922711|157764334|FG001|Overall Study|Adverse Event|2|||
48981629|NCT03922711|157764335|FG002|Overall Study|Adverse Event|2|||
48981630|NCT03922711|157764333|FG000|Overall Study|Protocol Violation|1|||
48981631|NCT03922711|157764334|FG001|Overall Study|Protocol Violation|0|||
48981632|NCT03922711|157764335|FG002|Overall Study|Protocol Violation|0|||
48981633|NCT03922711|157764333|FG000|Overall Study|Withdrawal by Subject|0|||
48981634|NCT03922711|157764334|FG001|Overall Study|Withdrawal by Subject|3|||
48981635|NCT03922711|157764335|FG002|Overall Study|Withdrawal by Subject|1|||
48981636|NCT03922711|157764333|FG000|Overall Study|Not further specified|0|||
48981637|NCT03922711|157764334|FG001|Overall Study|Not further specified|0|||
48981638|NCT03922711|157764335|FG002|Overall Study|Not further specified|1|||
48981639|NCT01080625|157765471|FG000|Overall Study|Physician Decision|0|||
48981640|NCT01080625|157765472|FG001|Overall Study|Physician Decision|2|||
48981641|NCT01080625|157765473|FG002|Overall Study|Physician Decision|1|||
48981642|NCT02100813|157765474|FG000|Overall Study|Adverse Event|0|||
48981643|NCT02100813|157765475|FG001|Overall Study|Adverse Event|0|||
48981644|NCT02100813|157765476|FG002|Overall Study|Adverse Event|0|||
48981645|NCT02100813|157765477|FG003|Overall Study|Adverse Event|0|||
48981646|NCT02100813|157765478|FG004|Overall Study|Adverse Event|0|||
48981647|NCT02100813|157765479|FG005|Overall Study|Adverse Event|0|||
48981648|NCT02100813|157765480|FG006|Overall Study|Adverse Event|0|||
48981649|NCT02100813|157765481|FG007|Overall Study|Adverse Event|1|||
48981650|NCT02274311|157765482|FG000|Three Months of Clomiphene Wash-out|Lost to Follow-up|1|||
48981651|NCT01536418|157765483|FG000|Overall Study|Protocol Violation|2|||
48981652|NCT01536418|157765484|FG001|Overall Study|Protocol Violation|3|||
48981653|NCT01536418|157765483|FG000|Overall Study|Physician Decision|1|||
48981654|NCT01536418|157765484|FG001|Overall Study|Physician Decision|3|||
48981655|NCT01536418|157765483|FG000|Overall Study|Study closed/terminated|41|||
48981656|NCT01536418|157765484|FG001|Overall Study|Study closed/terminated|37|||
48981657|NCT01536418|157765483|FG000|Overall Study|Lack of Efficacy|10|||
48981658|NCT01536418|157765484|FG001|Overall Study|Lack of Efficacy|16|||
48981659|NCT01536418|157765483|FG000|Overall Study|Adverse Event|9|||
49024432|NCT00150462|157928821|FG010|Overall Study|Physician Decision|0|||
49024433|NCT00150462|157928811|FG000|Overall Study|Other|0|||
49024434|NCT00150462|157928812|FG001|Overall Study|Other|0|||
49024435|NCT00150462|157928813|FG002|Overall Study|Other|0|||
49024436|NCT00150462|157928814|FG003|Overall Study|Other|0|||
49024437|NCT00150462|157928815|FG004|Overall Study|Other|0|||
49024438|NCT00150462|157928816|FG005|Overall Study|Other|0|||
49024439|NCT00150462|157928817|FG006|Overall Study|Other|0|||
49024440|NCT00150462|157928818|FG007|Overall Study|Other|0|||
49024441|NCT00150462|157928819|FG008|Overall Study|Other|0|||
49024442|NCT00150462|157928820|FG009|Overall Study|Other|1|||
49024443|NCT00150462|157928821|FG010|Overall Study|Other|1|||
49024444|NCT01666730|157928824|FG000|Overall Study|Adverse Event|16|||
49024445|NCT01666730|157928824|FG000|Overall Study|Death|2|||
49024446|NCT01666730|157928824|FG000|Overall Study|Physician Decision|5|||
49024447|NCT01666730|157928824|FG000|Overall Study|Withdrawal by Subject|9|||
49024448|NCT01666730|157928824|FG000|Overall Study|Disease progression/relapse|18|||
49024449|NCT04638153|157928825|FG000|Overall Study|Withdrawal by parent/guardian|0|||
49024450|NCT04638153|157928826|FG001|Overall Study|Withdrawal by parent/guardian|0|||
49024451|NCT04638153|157928827|FG002|Overall Study|Withdrawal by parent/guardian|1|||
49024452|NCT04638153|157928825|FG000|Overall Study|Study terminated by sponsor|4|||
49024453|NCT04638153|157928826|FG001|Overall Study|Study terminated by sponsor|2|||
49024454|NCT04638153|157928827|FG002|Overall Study|Study terminated by sponsor|14|||
49024455|NCT01457053|157928828|FG000|Overall Study|Unable to undergo selected treatment|1|||
49024456|NCT01457053|157928829|FG001|Overall Study|Unable to undergo selected treatment|1|||
48690845|NCT03798717|156720098|FG002|Overall Study|Failed Screening|0|||
48690846|NCT03798717|156720099|FG003|Overall Study|Failed Screening|0|||
49024457|NCT01874353|157928830|FG000|Overall Study|One patient was unblinded and one patient was randomised in error|2|||
49024458|NCT01874353|157928831|FG001|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
49024459|NCT01874353|157928832|FG002|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
49024460|NCT01874353|157928833|FG003|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
48690847|NCT03798717|156720100|FG004|Overall Study|Failed Screening|0|||
48690848|NCT03798717|156720101|FG005|Overall Study|Failed Screening|1|||
48690849|NCT03798717|156720096|FG000|Overall Study|Physician Decision|1|||
48690850|NCT03798717|156720097|FG001|Overall Study|Physician Decision|0|||
48690851|NCT03798717|156720098|FG002|Overall Study|Physician Decision|1|||
48690852|NCT03798717|156720099|FG003|Overall Study|Physician Decision|0|||
48690853|NCT03798717|156720100|FG004|Overall Study|Physician Decision|0|||
48690854|NCT03798717|156720101|FG005|Overall Study|Physician Decision|0|||
48690855|NCT03798717|156720096|FG000|Overall Study|Withdrawal by Subject|0|||
48690856|NCT03798717|156720097|FG001|Overall Study|Withdrawal by Subject|0|||
48690857|NCT03798717|156720098|FG002|Overall Study|Withdrawal by Subject|0|||
48690858|NCT03798717|156720099|FG003|Overall Study|Withdrawal by Subject|1|||
48690859|NCT03798717|156720100|FG004|Overall Study|Withdrawal by Subject|0|||
48690860|NCT03798717|156720101|FG005|Overall Study|Withdrawal by Subject|0|||
48690861|NCT03798717|156720096|FG000|Overall Study|Lost to Follow-up|1|||
48690862|NCT03798717|156720097|FG001|Overall Study|Lost to Follow-up|0|||
48690863|NCT03798717|156720098|FG002|Overall Study|Lost to Follow-up|0|||
48690864|NCT03798717|156720099|FG003|Overall Study|Lost to Follow-up|1|||
48690865|NCT03798717|156720100|FG004|Overall Study|Lost to Follow-up|0|||
48690866|NCT03798717|156720101|FG005|Overall Study|Lost to Follow-up|0|||
48690867|NCT03798717|156720096|FG000|Overall Study|Adverse Event|0|||
48690868|NCT03798717|156720097|FG001|Overall Study|Adverse Event|1|||
48690869|NCT03798717|156720098|FG002|Overall Study|Adverse Event|0|||
48690870|NCT03798717|156720099|FG003|Overall Study|Adverse Event|0|||
48763760|NCT02082210|156985737|FG002|Overall Study|Physician Decision|1|||
48763761|NCT02082210|156985738|FG003|Overall Study|Physician Decision|1|||
48763762|NCT02082210|156985739|FG004|Overall Study|Physician Decision|0|||
48763763|NCT02082210|156985740|FG005|Overall Study|Physician Decision|0|||
48690871|NCT03798717|156720100|FG004|Overall Study|Adverse Event|0|||
48690872|NCT03798717|156720101|FG005|Overall Study|Adverse Event|0|||
48690873|NCT03798717|156720096|FG000|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
48690874|NCT03798717|156720097|FG001|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
48690875|NCT03798717|156720098|FG002|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
48763764|NCT02579265|156985743|FG000|Overall Study|Weaned off earlier than 28 days|44|||
48763765|NCT02579265|156985744|FG001|Overall Study|Weaned off earlier than 28 days|43|||
49024461|NCT01874353|157928830|FG000|Overall Study|Lost to Follow-up|2|||
49024462|NCT01874353|157928831|FG001|Overall Study|Lost to Follow-up|2|||
49024463|NCT01874353|157928832|FG002|Overall Study|Lost to Follow-up|2|||
49024464|NCT01874353|157928833|FG003|Overall Study|Lost to Follow-up|0|||
49024465|NCT01874353|157928830|FG000|Overall Study|Death|110|||
49024466|NCT01874353|157928831|FG001|Overall Study|Death|60|||
49024467|NCT01874353|157928832|FG002|Overall Study|Death|13|||
48690876|NCT03798717|156720099|FG003|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
48763766|NCT02579265|156985743|FG000|Overall Study|Adverse Event|2|||
48763767|NCT02579265|156985744|FG001|Overall Study|Adverse Event|0|||
49024468|NCT01874353|157928833|FG003|Overall Study|Death|7|||
48690877|NCT03798717|156720100|FG004|Overall Study|COVID-19 (coronavirus disease) Lockdown|1|||
48690878|NCT03798717|156720101|FG005|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
48690879|NCT03057496|156720103|FG000|Overall Study|Withdrawal by Subject|8|||
48690880|NCT03057496|156720103|FG000|Overall Study|Lost to Follow-up|5|||
48690881|NCT03057496|156720103|FG000|Overall Study|Did not use device during home trial|3|||
48690882|NCT03057496|156720103|FG000|Overall Study|Device failure|2|||
48690883|NCT01307319|156720104|FG000|Overall Study|Adverse Event|2|||
48690884|NCT01307319|156720105|FG001|Overall Study|Adverse Event|2|||
48690885|NCT01307319|156720106|FG002|Overall Study|Adverse Event|1|||
48690886|NCT01307319|156720104|FG000|Overall Study|Lost to Follow-up|1|||
49024469|NCT01874353|157928830|FG000|Overall Study|Withdrawal by Subject|13|||
49024470|NCT01874353|157928831|FG001|Overall Study|Withdrawal by Subject|11|||
49024471|NCT01874353|157928832|FG002|Overall Study|Withdrawal by Subject|0|||
49024472|NCT01874353|157928833|FG003|Overall Study|Withdrawal by Subject|0|||
49024473|NCT03839940|157928835|FG000|Overall Study|Withdrawal by Subject|3|||
49024474|NCT03839940|157928836|FG001|Overall Study|Withdrawal by Subject|0|||
49024475|NCT03839940|157928835|FG000|Overall Study|Protocol Violation|0|||
49024476|NCT03839940|157928836|FG001|Overall Study|Protocol Violation|1|||
49024477|NCT03839940|157928835|FG000|Overall Study|No Post-Baseline Pain Score Data|1|||
49024478|NCT03839940|157928836|FG001|Overall Study|No Post-Baseline Pain Score Data|1|||
49024479|NCT02073643|157928839|FG000|Overall Study|Lost to Follow-up|24|||
49024480|NCT01062256|157928840|FG000|Overall Study|Adverse Event|1|||
49024481|NCT01062256|157928841|FG001|Overall Study|Adverse Event|0|||
49024482|NCT01062256|157928842|FG002|Overall Study|Adverse Event|0|||
49024483|NCT01062256|157928840|FG000|Overall Study|Withdrawal by Subject|1|||
49024484|NCT01062256|157928841|FG001|Overall Study|Withdrawal by Subject|1|||
49024485|NCT01062256|157928842|FG002|Overall Study|Withdrawal by Subject|1|||
49024486|NCT01062256|157928840|FG000|Overall Study|Ineligible|1|||
49024487|NCT01062256|157928841|FG001|Overall Study|Ineligible|4|||
49024488|NCT01062256|157928842|FG002|Overall Study|Ineligible|3|||
49024489|NCT01062256|157928840|FG000|Overall Study|Administrative|0|||
49024490|NCT01062256|157928841|FG001|Overall Study|Administrative|2|||
48690887|NCT01307319|156720105|FG001|Overall Study|Lost to Follow-up|0|||
48690888|NCT01307319|156720106|FG002|Overall Study|Lost to Follow-up|1|||
48690889|NCT01307319|156720104|FG000|Overall Study|Protocol Violation|1|||
48690890|NCT01307319|156720105|FG001|Overall Study|Protocol Violation|1|||
48690891|NCT01307319|156720106|FG002|Overall Study|Protocol Violation|0|||
48690892|NCT01307319|156720104|FG000|Overall Study|Withdrawal by Subject|0|||
48690893|NCT01307319|156720105|FG001|Overall Study|Withdrawal by Subject|1|||
48690894|NCT01307319|156720106|FG002|Overall Study|Withdrawal by Subject|2|||
48690895|NCT01307319|156720104|FG000|Overall Study|Other|0|||
48690896|NCT01307319|156720105|FG001|Overall Study|Other|4|||
48690897|NCT01307319|156720106|FG002|Overall Study|Other|3|||
48690898|NCT04924062|156720108|FG000|Overall Study|Death|49|||
48690899|NCT04924062|156720109|FG001|Overall Study|Death|63|||
48690900|NCT04924062|156720108|FG000|Overall Study|Participant On-going|26|||
48690901|NCT04924062|156720109|FG001|Overall Study|Participant On-going|20|||
48690902|NCT02730728|156720110|FG000|Overall Study|Withdrawal by Subject|0|||
48690903|NCT02730728|156720111|FG001|Overall Study|Withdrawal by Subject|1|||
48690904|NCT02730728|156720112|FG002|Overall Study|Withdrawal by Subject|0|||
48690905|NCT02730728|156720110|FG000|Overall Study|Lack of Efficacy|0|||
48690906|NCT02730728|156720111|FG001|Overall Study|Lack of Efficacy|1|||
48690907|NCT02730728|156720112|FG002|Overall Study|Lack of Efficacy|1|||
48690908|NCT03623243|156720113|FG000|Overall Study|Adverse Event|15|||
48690909|NCT03623243|156720113|FG000|Overall Study|Guardian Decision|1|||
48690910|NCT03623243|156720113|FG000|Overall Study|New Therapy for Study Indication|1|||
48690911|NCT03623243|156720113|FG000|Overall Study|Protocol Deviation|3|||
48690912|NCT03623243|156720113|FG000|Overall Study|Physician Decision|4|||
48690913|NCT03623243|156720113|FG000|Overall Study|Patient Decision|15|||
48690914|NCT01329263|156720116|FG000|Overall Study|Lost to Follow-up|4|||
48690915|NCT01329263|156720117|FG001|Overall Study|Lost to Follow-up|21|||
48690916|NCT01329263|156720116|FG000|Overall Study|Withdrawal by Subject|1|||
48690917|NCT01329263|156720117|FG001|Overall Study|Withdrawal by Subject|2|||
48763768|NCT02579265|156985743|FG000|Overall Study|Any other reason not specified|0|||
48763769|NCT02579265|156985744|FG001|Overall Study|Any other reason not specified|2|||
49024491|NCT01062256|157928842|FG002|Overall Study|Administrative|0|||
49024492|NCT02780687|157928843|FG000|Overall Study|Adverse Event|1|||
48690918|NCT01631435|156720119|FG000|Overall Study|Adverse Event|2|||
48690919|NCT01631435|156720119|FG000|Overall Study|Withdrawal by Subject|2|||
48690920|NCT01631435|156720119|FG000|Overall Study|incomplete study procedure|5|||
49024493|NCT02780687|157928844|FG001|Overall Study|Adverse Event|1|||
49024494|NCT02780687|157928843|FG000|Overall Study|Withdrawal by Subject|2|||
49024495|NCT02780687|157928844|FG001|Overall Study|Withdrawal by Subject|1|||
49024496|NCT02780687|157928843|FG000|Overall Study|Switched to commercial program (in CTP)|2|||
49024497|NCT02780687|157928844|FG001|Overall Study|Switched to commercial program (in CTP)|0|||
49024498|NCT02780687|157928843|FG000|Overall Study|progressive disease|29|||
49024499|NCT02780687|157928844|FG001|Overall Study|progressive disease|6|||
49024500|NCT05213390|157928845|FG000|Overall Study|Withdrawal by Subject|2|||
49024501|NCT05213390|157928845|FG000|Overall Study|Lost to Follow-up|12|||
49024502|NCT05213390|157928845|FG000|Overall Study|Protocol Violation|9|||
49024503|NCT01395030|157928849|FG000|Overall Study|Did not complete FCH PET/CT|7|||
49024504|NCT04625114|157928850|FG000|Overall Study|Adverse Event|3|||
49024505|NCT04625114|157928851|FG001|Overall Study|Adverse Event|1|||
49024506|NCT04625114|157928850|FG000|Overall Study|Withdrawal by Subject|2|||
49024507|NCT04625114|157928851|FG001|Overall Study|Withdrawal by Subject|0|||
49024508|NCT03819049|157928859|FG000|Overall Study|Lost to Follow-up|1|||
49024509|NCT03819049|157928860|FG001|Overall Study|Lost to Follow-up|2|||
49024510|NCT03819049|157928861|FG002|Overall Study|Lost to Follow-up|9|||
49024511|NCT03819049|157928862|FG003|Overall Study|Lost to Follow-up|0|||
49024512|NCT03819049|157928863|FG004|Overall Study|Lost to Follow-up|3|||
49024513|NCT03819049|157928864|FG005|Overall Study|Lost to Follow-up|1|||
49024514|NCT03819049|157928865|FG006|Overall Study|Lost to Follow-up|0|||
49024515|NCT03819049|157928859|FG000|Overall Study|Withdrawal by Subject|0|||
49024516|NCT03819049|157928860|FG001|Overall Study|Withdrawal by Subject|0|||
49024517|NCT03819049|157928861|FG002|Overall Study|Withdrawal by Subject|18|||
49024518|NCT03819049|157928862|FG003|Overall Study|Withdrawal by Subject|0|||
49024519|NCT03819049|157928863|FG004|Overall Study|Withdrawal by Subject|10|||
49024520|NCT03819049|157928864|FG005|Overall Study|Withdrawal by Subject|9|||
49024521|NCT03819049|157928865|FG006|Overall Study|Withdrawal by Subject|1|||
49024522|NCT03819049|157928859|FG000|Overall Study|Ongoing|0|||
49024523|NCT03819049|157928860|FG001|Overall Study|Ongoing|0|||
49024524|NCT03819049|157928861|FG002|Overall Study|Ongoing|75|||
49024525|NCT03819049|157928862|FG003|Overall Study|Ongoing|0|||
49024526|NCT03819049|157928863|FG004|Overall Study|Ongoing|41|||
49024527|NCT03819049|157928864|FG005|Overall Study|Ongoing|0|||
49024528|NCT03819049|157928865|FG006|Overall Study|Ongoing|0|||
49024529|NCT03819049|157928859|FG000|Overall Study|Other|0|||
49024530|NCT03819049|157928860|FG001|Overall Study|Other|0|||
49024531|NCT03819049|157928861|FG002|Overall Study|Other|2|||
49024532|NCT03819049|157928862|FG003|Overall Study|Other|0|||
49024533|NCT03819049|157928863|FG004|Overall Study|Other|0|||
49024534|NCT03819049|157928864|FG005|Overall Study|Other|0|||
49024535|NCT03819049|157928865|FG006|Overall Study|Other|0|||
49024536|NCT03819049|157928859|FG000|Overall Study|Randomized but not vaccinated|0|||
49024537|NCT03819049|157928860|FG001|Overall Study|Randomized but not vaccinated|0|||
49024538|NCT03819049|157928861|FG002|Overall Study|Randomized but not vaccinated|0|||
49024539|NCT03819049|157928862|FG003|Overall Study|Randomized but not vaccinated|1|||
49024540|NCT03819049|157928863|FG004|Overall Study|Randomized but not vaccinated|0|||
49024541|NCT03819049|157928864|FG005|Overall Study|Randomized but not vaccinated|2|||
49024542|NCT03819049|157928865|FG006|Overall Study|Randomized but not vaccinated|1|||
49024543|NCT03819049|157928859|FG000|Overall Study|Physician Decision|0|||
49024544|NCT03819049|157928860|FG001|Overall Study|Physician Decision|0|||
49024545|NCT03819049|157928861|FG002|Overall Study|Physician Decision|0|||
49024546|NCT03819049|157928862|FG003|Overall Study|Physician Decision|0|||
49024547|NCT03819049|157928863|FG004|Overall Study|Physician Decision|0|||
49024548|NCT03819049|157928864|FG005|Overall Study|Physician Decision|0|||
49024549|NCT03819049|157928865|FG006|Overall Study|Physician Decision|1|||
49024550|NCT01044732|157928866|FG000|Overall Study|Lost to Follow-up|2|||
49024551|NCT01044732|157928867|FG001|Overall Study|Lost to Follow-up|1|||
49024552|NCT01044732|157928866|FG000|Overall Study|Physician Decision|5|||
49024553|NCT01044732|157928867|FG001|Overall Study|Physician Decision|3|||
49024554|NCT01044732|157928866|FG000|Overall Study|Protocol Violation|11|||
49024555|NCT01044732|157928867|FG001|Overall Study|Protocol Violation|12|||
49024556|NCT01044732|157928866|FG000|Overall Study|Withdrawal by Subject|0|||
49024557|NCT01044732|157928867|FG001|Overall Study|Withdrawal by Subject|1|||
49024558|NCT01044732|157928866|FG000|Overall Study|Inadequate bowel preparation|11|||
49024559|NCT01044732|157928867|FG001|Overall Study|Inadequate bowel preparation|17|||
49024560|NCT01044732|157928866|FG000|Overall Study|Inability to reach cecum|5|||
49024561|NCT01044732|157928867|FG001|Overall Study|Inability to reach cecum|2|||
49024562|NCT01044732|157928866|FG000|Overall Study|Technical error or malfunction|15|||
48690925|NCT00768989|156720126|FG000|Prior to Week 24|Withdrawal by Subject|1|||
48690926|NCT00768989|156720127|FG001|Prior to Week 24|Withdrawal by Subject|0|||
48690927|NCT00768989|156720126|FG000|Prior to Week 24|Adverse Event|3|||
49024563|NCT01044732|157928867|FG001|Overall Study|Technical error or malfunction|14|||
49024564|NCT03492177|157928870|FG000|Overall Study|Adverse Event|1|||
48690928|NCT00768989|156720127|FG001|Prior to Week 24|Adverse Event|0|||
48690929|NCT00768989|156720126|FG000|Prior to Week 24|Lost to Follow-up|0|||
49024565|NCT03492177|157928871|FG001|Overall Study|Adverse Event|0|||
49024566|NCT03492177|157928872|FG002|Overall Study|Adverse Event|0|||
49024567|NCT03492177|157928870|FG000|Overall Study|Death|3|||
49024568|NCT03492177|157928871|FG001|Overall Study|Death|0|||
49024569|NCT03492177|157928872|FG002|Overall Study|Death|3|||
49024570|NCT03492177|157928870|FG000|Overall Study|Lack of Efficacy|1|||
48690930|NCT00768989|156720127|FG001|Prior to Week 24|Lost to Follow-up|1|||
48690931|NCT00768989|156720126|FG000|Prior to Week 24|Protocol Violation|0|||
48690932|NCT00768989|156720127|FG001|Prior to Week 24|Protocol Violation|2|||
48690933|NCT00768989|156720126|FG000|Week 24 to Prior to Week 36|Adverse Event|1|||
48690934|NCT00768989|156720127|FG001|Week 24 to Prior to Week 36|Adverse Event|0|||
48690935|NCT00768989|156720126|FG000|Week 24 to Prior to Week 36|Lack of Efficacy|6|||
48690936|NCT00768989|156720127|FG001|Week 24 to Prior to Week 36|Lack of Efficacy|0|||
48690937|NCT00768989|156720126|FG000|Week 24 to Prior to Week 36|Withdrawal by Subject|1|||
48690938|NCT00768989|156720127|FG001|Week 24 to Prior to Week 36|Withdrawal by Subject|0|||
48690939|NCT00768989|156720126|FG000|On or After Week 36|Lack of Efficacy|1|||
48690940|NCT00768989|156720127|FG001|On or After Week 36|Lack of Efficacy|0|||
48690941|NCT00768989|156720126|FG000|On or After Week 36|Adverse Event|0|||
48690942|NCT00768989|156720127|FG001|On or After Week 36|Adverse Event|1|||
48690943|NCT00768989|156720126|FG000|On or After Week 36|Lost to Follow-up|1|||
48690944|NCT00768989|156720127|FG001|On or After Week 36|Lost to Follow-up|0|||
48690945|NCT00768989|156720126|FG000|On or After Week 36|Poor Compliance|1|||
48690946|NCT00768989|156720127|FG001|On or After Week 36|Poor Compliance|0|||
48690947|NCT00768989|156720126|FG000|On or After Week 36|Protocol Violation|1|||
48690948|NCT00768989|156720127|FG001|On or After Week 36|Protocol Violation|0|||
48690949|NCT00768989|156720126|FG000|On or After Week 36|Did not attend termination visit|2|||
48690950|NCT00768989|156720127|FG001|On or After Week 36|Did not attend termination visit|0|||
49024571|NCT03492177|157928871|FG001|Overall Study|Lack of Efficacy|2|||
49024572|NCT03492177|157928872|FG002|Overall Study|Lack of Efficacy|0|||
49024573|NCT03492177|157928870|FG000|Overall Study|Other|1|||
49024574|NCT03492177|157928871|FG001|Overall Study|Other|0|||
49024575|NCT03492177|157928872|FG002|Overall Study|Other|0|||
49024576|NCT03492177|157928870|FG000|Overall Study|Ongoing|16|||
49024577|NCT03492177|157928871|FG001|Overall Study|Ongoing|19|||
49024578|NCT03492177|157928872|FG002|Overall Study|Ongoing|17|||
49024579|NCT02242201|157928875|FG000|Overall Study|preoperative identified neuropathy|2|||
49024580|NCT02242201|157928876|FG001|Overall Study|preoperative identified neuropathy|0|||
49024581|NCT02242201|157928877|FG002|Overall Study|preoperative identified neuropathy|0|||
49024582|NCT02242201|157928875|FG000|Overall Study|planned post-op anticoagulation|1|||
49024583|NCT02242201|157928876|FG001|Overall Study|planned post-op anticoagulation|0|||
49024584|NCT02242201|157928877|FG002|Overall Study|planned post-op anticoagulation|0|||
49024585|NCT02242201|157928875|FG000|Overall Study|changed surgical procedure|1|||
49024586|NCT02242201|157928876|FG001|Overall Study|changed surgical procedure|0|||
49024587|NCT02242201|157928877|FG002|Overall Study|changed surgical procedure|0|||
49024588|NCT02242201|157928875|FG000|Overall Study|postponed surgery|0|||
49024589|NCT02242201|157928876|FG001|Overall Study|postponed surgery|0|||
48690951|NCT00768989|156720126|FG000|On or After Week 36|Sponsor Termination|45|||
48690952|NCT00768989|156720127|FG001|On or After Week 36|Sponsor Termination|26|||
48690953|NCT00866177|156720129|FG000|Overall Study|Withdrawal by Subject|1|||
48690954|NCT00866177|156720129|FG000|Overall Study|Not Treated|151|||
48690955|NCT03585660|156720130|FG000|Overall Study|operator error|1|||
48690956|NCT03585660|156720130|FG000|Overall Study|technical error|2|||
48690957|NCT03585660|156720130|FG000|Overall Study|hip prosthesis|2|||
48690958|NCT03585660|156720130|FG000|Overall Study|did not undergo biopsy|8|||
48690959|NCT03585660|156720130|FG000|Overall Study|scanner problem|2|||
48690960|NCT04143061|156720131|FG000|Overall Study|Protocol Deviation|0|||
48690961|NCT04143061|156720132|FG001|Overall Study|Protocol Deviation|0|||
48690962|NCT04143061|156720133|FG002|Overall Study|Protocol Deviation|0|||
48690963|NCT04143061|156720134|FG003|Overall Study|Protocol Deviation|0|||
48690964|NCT04143061|156720135|FG004|Overall Study|Protocol Deviation|0|||
48690965|NCT04143061|156720136|FG005|Overall Study|Protocol Deviation|0|||
48690966|NCT04143061|156720137|FG006|Overall Study|Protocol Deviation|5|||
48875388|NCT04962698|157381634|FG001|Rest|Exclusion criteria met after enrollment|2|||
49024590|NCT02242201|157928877|FG002|Overall Study|postponed surgery|1|||
49024591|NCT02242201|157928875|FG000|Overall Study|preoperative opioid consumption|0|||
49024592|NCT02242201|157928876|FG001|Overall Study|preoperative opioid consumption|1|||
49024593|NCT02242201|157928877|FG002|Overall Study|preoperative opioid consumption|0|||
49024594|NCT03480425|157930084|FG000|Overall Study|Force transducer technical failure|1|||
49024595|NCT05113966|157930085|FG000|Overall Study|Death|21|||
49024596|NCT05113966|157930085|FG000|Overall Study|Study Terminated by Sponsor|9|||
49024597|NCT01451762|157930086|FG000|Overall Study|Lost to Follow-up|3|||
49024598|NCT01451762|157930087|FG001|Overall Study|Lost to Follow-up|6|||
49024599|NCT01451762|157930088|FG002|Overall Study|Lost to Follow-up|6|||
49024600|NCT04006171|157930092|FG000|Overall Study|Withdrawal by Subject|8|||
49024601|NCT04006171|157930093|FG001|Overall Study|Withdrawal by Subject|7|||
48690967|NCT04143061|156720138|FG007|Overall Study|Protocol Deviation|5|||
48690968|NCT04143061|156720131|FG000|Overall Study|Withdrawal by Subject|2|||
48690969|NCT04143061|156720132|FG001|Overall Study|Withdrawal by Subject|0|||
48690970|NCT04143061|156720133|FG002|Overall Study|Withdrawal by Subject|0|||
48690971|NCT04143061|156720134|FG003|Overall Study|Withdrawal by Subject|0|||
48690972|NCT04143061|156720135|FG004|Overall Study|Withdrawal by Subject|0|||
49024602|NCT04006171|157930092|FG000|Overall Study|missing serum samples|2|||
49024603|NCT04006171|157930093|FG001|Overall Study|missing serum samples|2|||
48763770|NCT02579265|156985743|FG000|Overall Study|Withdrawal by Subject|2|||
48763771|NCT02579265|156985744|FG001|Overall Study|Withdrawal by Subject|0|||
48763772|NCT02579265|156985743|FG000|Overall Study|Physician Decision|1|||
48690973|NCT04143061|156720136|FG005|Overall Study|Withdrawal by Subject|1|||
48690974|NCT04143061|156720137|FG006|Overall Study|Withdrawal by Subject|0|||
48690975|NCT04143061|156720138|FG007|Overall Study|Withdrawal by Subject|0|||
48690976|NCT04143061|156720131|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
48690977|NCT04143061|156720132|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
48690978|NCT04143061|156720133|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
48690979|NCT04143061|156720134|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
48690980|NCT04143061|156720135|FG004|Overall Study|Withdrawal by Parent/Guardian|8|||
48690981|NCT04143061|156720136|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
48690982|NCT04143061|156720137|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
48690983|NCT04143061|156720138|FG007|Overall Study|Withdrawal by Parent/Guardian|7|||
48690984|NCT05288283|156720139|FG000|Overall Study|Study Terminated Early|1|||
48690985|NCT05288283|156720140|FG001|Overall Study|Study Terminated Early|1|||
48690986|NCT04685798|156720141|FG000|Overall Study|Did not have standard of care FDG PET/CT|2|||
48690987|NCT03812380|156720142|FG000|Overall Study|Protocol Violation|3|||
48690988|NCT03812380|156720143|FG001|Overall Study|Protocol Violation|3|||
48690989|NCT03812380|156720142|FG000|Overall Study|Withdrawal by Subject|5|||
48690990|NCT03812380|156720143|FG001|Overall Study|Withdrawal by Subject|4|||
48690991|NCT03812380|156720142|FG000|Overall Study|Early termination of study|14|||
48690992|NCT03812380|156720143|FG001|Overall Study|Early termination of study|14|||
48690993|NCT03303625|156720144|FG000|Overall Study|Withdrawal by Subject|2|||
48690994|NCT03303625|156720145|FG001|Overall Study|Withdrawal by Subject|0|||
48690995|NCT03303625|156720146|FG002|Overall Study|Withdrawal by Subject|0|||
48690996|NCT03303625|156720147|FG003|Overall Study|Withdrawal by Subject|0|||
48690997|NCT01962441|156720148|FG000|Randomized Period|Randomized but Never Treated|4|||
48690998|NCT01962441|156720149|FG001|Randomized Period|Randomized but Never Treated|2|||
48690999|NCT01962441|156720150|FG002|Randomized Period|Randomized but Never Treated|3|||
48691000|NCT01962441|156720148|FG000|Randomized Period|Lost to Follow-up|2|||
48691001|NCT01962441|156720149|FG001|Randomized Period|Lost to Follow-up|4|||
48691002|NCT01962441|156720150|FG002|Randomized Period|Lost to Follow-up|4|||
48691003|NCT01962441|156720148|FG000|Randomized Period|Withdrew Consent|3|||
48691004|NCT01962441|156720149|FG001|Randomized Period|Withdrew Consent|3|||
48691005|NCT01962441|156720150|FG002|Randomized Period|Withdrew Consent|2|||
48691006|NCT01962441|156720148|FG000|Randomized Period|Adverse Event|1|||
48691007|NCT01962441|156720149|FG001|Randomized Period|Adverse Event|1|||
48691008|NCT01962441|156720150|FG002|Randomized Period|Adverse Event|0|||
48691009|NCT01962441|156720148|FG000|Randomized Period|Death|0|||
48691010|NCT01962441|156720149|FG001|Randomized Period|Death|0|||
48691011|NCT01962441|156720150|FG002|Randomized Period|Death|2|||
48691012|NCT01962441|156720148|FG000|Randomized Period|Protocol Violation|0|||
48691013|NCT01962441|156720149|FG001|Randomized Period|Protocol Violation|1|||
48691014|NCT01962441|156720150|FG002|Randomized Period|Protocol Violation|0|||
48691015|NCT01962441|156720148|FG000|Retreatment Substudy|Lack of Efficacy|1|||
48691016|NCT01962441|156720149|FG001|Retreatment Substudy|Lack of Efficacy|0|||
48691017|NCT01962441|156720150|FG002|Retreatment Substudy|Lack of Efficacy|0|||
48691018|NCT01962441|156720148|FG000|Retreatment Substudy|Lost to Follow-up|1|||
48691019|NCT01962441|156720149|FG001|Retreatment Substudy|Lost to Follow-up|0|||
48691020|NCT01962441|156720150|FG002|Retreatment Substudy|Lost to Follow-up|0|||
48691021|NCT04862065|156720151|FG000|Screening|Protocol Violation|54|||
48691022|NCT04862065|156720152|FG001|Screening|Protocol Violation|0|||
48691023|NCT04862065|156720153|FG002|Screening|Protocol Violation|0|||
48691024|NCT04862065|156720151|FG000|Screening|Insufficient Sample|1|||
48691025|NCT04862065|156720152|FG001|Screening|Insufficient Sample|0|||
48691026|NCT04862065|156720153|FG002|Screening|Insufficient Sample|0|||
48691027|NCT04862065|156720151|FG000|Follow-Up|Lost to Follow-up|3|||
48691028|NCT04862065|156720152|FG001|Follow-Up|Lost to Follow-up|0|||
48691029|NCT04862065|156720153|FG002|Follow-Up|Lost to Follow-up|0|||
48691030|NCT02055898|156720154|FG000|First Intervention (5 Days)|Physician Decision|2|||
48691031|NCT02055898|156720155|FG001|First Intervention (5 Days)|Physician Decision|0|||
48691032|NCT02055898|156720154|FG000|First Intervention (5 Days)|Withdrawal by Subject|0|||
48691033|NCT02055898|156720155|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
48691034|NCT01488045|156720157|FG000|Overall Study|Withdrawal by Subject|6|||
48691035|NCT01488045|156720158|FG001|Overall Study|Withdrawal by Subject|11|||
48691036|NCT01488045|156720157|FG000|Overall Study|Failure to present for colonoscopy|3|||
48691037|NCT01488045|156720158|FG001|Overall Study|Failure to present for colonoscopy|6|||
48691038|NCT01488045|156720157|FG000|Overall Study|Failure to report exclusion criteria|0|||
48763773|NCT02579265|156985744|FG001|Overall Study|Physician Decision|0|||
48763774|NCT02579265|156985743|FG000|Overall Study|Withdrawal due to increased conjugated bilirubin|1|||
49024604|NCT04006171|157930092|FG000|Overall Study|insufficient sample volume|2|||
48691039|NCT01488045|156720158|FG001|Overall Study|Failure to report exclusion criteria|1|||
48691040|NCT02159066|156720159|FG000|Part I|Adverse Event|7|||
49024605|NCT04006171|157930093|FG001|Overall Study|insufficient sample volume|3|||
48691041|NCT02159066|156720160|FG001|Part I|Adverse Event|5|||
48691042|NCT02159066|156720161|FG002|Part I|Adverse Event|0|||
48691043|NCT02159066|156720162|FG003|Part I|Adverse Event|0|||
48691044|NCT02159066|156720163|FG004|Part I|Adverse Event|0|||
48691045|NCT02159066|156720164|FG005|Part I|Adverse Event|0|||
48691046|NCT02159066|156720159|FG000|Part I|Death|11|||
48691047|NCT02159066|156720160|FG001|Part I|Death|9|||
48691048|NCT02159066|156720161|FG002|Part I|Death|0|||
48691049|NCT02159066|156720162|FG003|Part I|Death|0|||
48691050|NCT02159066|156720163|FG004|Part I|Death|0|||
48691051|NCT02159066|156720164|FG005|Part I|Death|0|||
48691052|NCT02159066|156720159|FG000|Part I|Progressive Disease|37|||
48691053|NCT02159066|156720160|FG001|Part I|Progressive Disease|46|||
48691054|NCT02159066|156720161|FG002|Part I|Progressive Disease|0|||
48691055|NCT02159066|156720162|FG003|Part I|Progressive Disease|0|||
48691056|NCT02159066|156720163|FG004|Part I|Progressive Disease|0|||
48691057|NCT02159066|156720164|FG005|Part I|Progressive Disease|0|||
48691058|NCT02159066|156720159|FG000|Part I|New Therapy for Study Indication|5|||
48691059|NCT02159066|156720160|FG001|Part I|New Therapy for Study Indication|4|||
48691060|NCT02159066|156720161|FG002|Part I|New Therapy for Study Indication|0|||
48691061|NCT02159066|156720162|FG003|Part I|New Therapy for Study Indication|0|||
48691062|NCT02159066|156720163|FG004|Part I|New Therapy for Study Indication|0|||
48691063|NCT02159066|156720164|FG005|Part I|New Therapy for Study Indication|0|||
48691064|NCT02159066|156720159|FG000|Part I|Termination of participants from the study|3|||
48691065|NCT02159066|156720160|FG001|Part I|Termination of participants from the study|3|||
48691066|NCT02159066|156720161|FG002|Part I|Termination of participants from the study|0|||
48691067|NCT02159066|156720162|FG003|Part I|Termination of participants from the study|0|||
48691068|NCT02159066|156720163|FG004|Part I|Termination of participants from the study|0|||
48691069|NCT02159066|156720164|FG005|Part I|Termination of participants from the study|0|||
48691070|NCT02159066|156720159|FG000|Part I|Physician Decision|2|||
48691071|NCT02159066|156720160|FG001|Part I|Physician Decision|9|||
48691072|NCT02159066|156720161|FG002|Part I|Physician Decision|0|||
48691073|NCT02159066|156720162|FG003|Part I|Physician Decision|0|||
48691074|NCT02159066|156720163|FG004|Part I|Physician Decision|0|||
48691075|NCT02159066|156720164|FG005|Part I|Physician Decision|0|||
48691076|NCT02159066|156720159|FG000|Part I|Participant/Guardian Decision|9|||
48691077|NCT02159066|156720160|FG001|Part I|Participant/Guardian Decision|3|||
48691078|NCT02159066|156720161|FG002|Part I|Participant/Guardian Decision|0|||
48691079|NCT02159066|156720162|FG003|Part I|Participant/Guardian Decision|0|||
48691080|NCT02159066|156720163|FG004|Part I|Participant/Guardian Decision|0|||
48691081|NCT02159066|156720164|FG005|Part I|Participant/Guardian Decision|0|||
48691082|NCT02159066|156720159|FG000|Part I|Missing Data|1|||
48691083|NCT02159066|156720160|FG001|Part I|Missing Data|0|||
48691084|NCT02159066|156720161|FG002|Part I|Missing Data|0|||
48691085|NCT02159066|156720162|FG003|Part I|Missing Data|0|||
48691086|NCT02159066|156720163|FG004|Part I|Missing Data|0|||
48691087|NCT02159066|156720164|FG005|Part I|Missing Data|0|||
48691088|NCT02159066|156720159|FG000|Part II|Adverse Event|0|||
48691089|NCT02159066|156720160|FG001|Part II|Adverse Event|0|||
48691090|NCT02159066|156720161|FG002|Part II|Adverse Event|1|||
48691091|NCT02159066|156720162|FG003|Part II|Adverse Event|0|||
48691092|NCT02159066|156720163|FG004|Part II|Adverse Event|1|||
48691093|NCT02159066|156720164|FG005|Part II|Adverse Event|1|||
48691094|NCT02159066|156720159|FG000|Part II|Death|0|||
48691095|NCT02159066|156720160|FG001|Part II|Death|0|||
48691096|NCT02159066|156720161|FG002|Part II|Death|1|||
48691097|NCT02159066|156720162|FG003|Part II|Death|0|||
48691098|NCT02159066|156720163|FG004|Part II|Death|2|||
48691099|NCT02159066|156720164|FG005|Part II|Death|1|||
48691100|NCT02159066|156720159|FG000|Part II|Progressive Disease|0|||
48763775|NCT02579265|156985744|FG001|Overall Study|Withdrawal due to increased conjugated bilirubin|0|||
49024606|NCT02430870|157930099|FG000|Part 2|Voluntary Withdrawal|0|||
49024607|NCT02430870|157930100|FG001|Part 2|Voluntary Withdrawal|0|||
49024608|NCT02430870|157930101|FG002|Part 2|Voluntary Withdrawal|0|||
49024609|NCT02430870|157930102|FG003|Part 2|Voluntary Withdrawal|0|||
48691101|NCT02159066|156720160|FG001|Part II|Progressive Disease|0|||
48691102|NCT02159066|156720161|FG002|Part II|Progressive Disease|35|||
48691103|NCT02159066|156720162|FG003|Part II|Progressive Disease|1|||
48691104|NCT02159066|156720163|FG004|Part II|Progressive Disease|7|||
48691105|NCT02159066|156720164|FG005|Part II|Progressive Disease|4|||
48691106|NCT02159066|156720159|FG000|Part II|New Therapy for Study Indication|0|||
48691107|NCT02159066|156720160|FG001|Part II|New Therapy for Study Indication|0|||
48691108|NCT02159066|156720161|FG002|Part II|New Therapy for Study Indication|0|||
48691109|NCT02159066|156720162|FG003|Part II|New Therapy for Study Indication|0|||
48691110|NCT02159066|156720163|FG004|Part II|New Therapy for Study Indication|1|||
48691111|NCT02159066|156720164|FG005|Part II|New Therapy for Study Indication|0|||
48691112|NCT02159066|156720159|FG000|Part II|Physician Decision|0|||
48691113|NCT02159066|156720160|FG001|Part II|Physician Decision|0|||
48763776|NCT02174848|156985745|FG000|Overall Study|Adverse Event|2|||
48691114|NCT02159066|156720161|FG002|Part II|Physician Decision|1|||
48691115|NCT02159066|156720162|FG003|Part II|Physician Decision|0|||
48691116|NCT02159066|156720163|FG004|Part II|Physician Decision|0|||
48691117|NCT02159066|156720164|FG005|Part II|Physician Decision|0|||
48691118|NCT02159066|156720159|FG000|Part II|Participant/Guardian Decision|0|||
48691119|NCT02159066|156720160|FG001|Part II|Participant/Guardian Decision|0|||
48691120|NCT02159066|156720161|FG002|Part II|Participant/Guardian Decision|0|||
48691121|NCT02159066|156720162|FG003|Part II|Participant/Guardian Decision|0|||
48691122|NCT02159066|156720163|FG004|Part II|Participant/Guardian Decision|2|||
48691123|NCT02159066|156720164|FG005|Part II|Participant/Guardian Decision|0|||
48691124|NCT02314052|156720165|FG000|Cycle One|Adverse Event|0|||
48691125|NCT02314052|156720166|FG001|Cycle One|Adverse Event|0|||
48691126|NCT02314052|156720167|FG002|Cycle One|Adverse Event|0|||
48691127|NCT02314052|156720168|FG003|Cycle One|Adverse Event|1|||
48691128|NCT02314052|156720169|FG004|Cycle One|Adverse Event|0|||
48691129|NCT02314052|156720170|FG005|Cycle One|Adverse Event|0|||
48691130|NCT02748863|156720171|FG000|Treatment Period 1|Adverse Event|0|||
48691131|NCT02748863|156720172|FG001|Treatment Period 1|Adverse Event|1|||
48691132|NCT02748863|156720173|FG002|Treatment Period 1|Adverse Event|0|||
48691133|NCT02748863|156720174|FG003|Treatment Period 1|Adverse Event|0|||
48691134|NCT02748863|156720175|FG004|Treatment Period 1|Adverse Event|0|||
48691135|NCT02748863|156720171|FG000|Treatment Period 1|Lack of Efficacy|0|||
48691136|NCT02748863|156720172|FG001|Treatment Period 1|Lack of Efficacy|0|||
48691137|NCT02748863|156720173|FG002|Treatment Period 1|Lack of Efficacy|1|||
48691138|NCT02748863|156720174|FG003|Treatment Period 1|Lack of Efficacy|0|||
48691139|NCT02748863|156720175|FG004|Treatment Period 1|Lack of Efficacy|0|||
48691140|NCT02748863|156720171|FG000|Treatment Period 1|Withdrawal by Subject|0|||
48691141|NCT02748863|156720172|FG001|Treatment Period 1|Withdrawal by Subject|1|||
48691142|NCT02748863|156720173|FG002|Treatment Period 1|Withdrawal by Subject|1|||
48691143|NCT02748863|156720174|FG003|Treatment Period 1|Withdrawal by Subject|0|||
48691144|NCT02748863|156720175|FG004|Treatment Period 1|Withdrawal by Subject|0|||
48691145|NCT02748863|156720171|FG000|Treatment Period 2|Lost to Follow-up|2|||
48691146|NCT02748863|156720172|FG001|Treatment Period 2|Lost to Follow-up|0|||
48691147|NCT02748863|156720173|FG002|Treatment Period 2|Lost to Follow-up|0|||
48691148|NCT02748863|156720174|FG003|Treatment Period 2|Lost to Follow-up|0|||
48691149|NCT02748863|156720175|FG004|Treatment Period 2|Lost to Follow-up|0|||
48691150|NCT02748863|156720171|FG000|Treatment Period 2|Adverse Event|3|||
48691151|NCT02748863|156720172|FG001|Treatment Period 2|Adverse Event|2|||
48691152|NCT02748863|156720173|FG002|Treatment Period 2|Adverse Event|0|||
48691153|NCT02748863|156720174|FG003|Treatment Period 2|Adverse Event|2|||
48691154|NCT02748863|156720175|FG004|Treatment Period 2|Adverse Event|0|||
48691155|NCT02748863|156720171|FG000|Treatment Period 2|Lack of Efficacy|0|||
48691156|NCT02748863|156720172|FG001|Treatment Period 2|Lack of Efficacy|1|||
48691157|NCT02748863|156720173|FG002|Treatment Period 2|Lack of Efficacy|0|||
48691158|NCT02748863|156720174|FG003|Treatment Period 2|Lack of Efficacy|0|||
48691159|NCT02748863|156720175|FG004|Treatment Period 2|Lack of Efficacy|0|||
48691160|NCT02748863|156720171|FG000|Treatment Period 2|Pregnancy|0|||
48691161|NCT02748863|156720172|FG001|Treatment Period 2|Pregnancy|0|||
48691162|NCT02748863|156720173|FG002|Treatment Period 2|Pregnancy|0|||
48691163|NCT02748863|156720174|FG003|Treatment Period 2|Pregnancy|0|||
48691164|NCT02748863|156720175|FG004|Treatment Period 2|Pregnancy|1|||
48691165|NCT02653326|156720177|FG000|Overall Study|Lost to Follow-up|10|||
48691166|NCT02653326|156720178|FG001|Overall Study|Lost to Follow-up|7|||
48691167|NCT02422498|156720179|FG000|Overall Study|Inevaluable|4|||
48691168|NCT02914639|156720180|FG000|Overall Study|Withdrawal by Subject|0|||
48691169|NCT02914639|156720181|FG001|Overall Study|Withdrawal by Subject|2|||
48691170|NCT01960140|156720182|FG000|Period 2 (Days 3-18)|Adverse Event|2|||
48691171|NCT01046565|156720186|FG000|Overall Study|Adverse Event|2|||
48691172|NCT01046565|156720186|FG000|Overall Study|Withdrawal by Subject|7|||
48691173|NCT00660192|156720187|FG000|Overall Study|Lost to Follow-up|2|||
48691174|NCT00660192|156720188|FG001|Overall Study|Lost to Follow-up|3|||
48691175|NCT02734693|156720189|FG000|Overall Study|Adverse Event|1|||
48691176|NCT02734693|156720190|FG001|Overall Study|Adverse Event|3|||
48691177|NCT02734693|156720191|FG002|Overall Study|Adverse Event|3|||
48691178|NCT02734693|156720189|FG000|Overall Study|Lack of Efficacy|1|||
48691179|NCT02734693|156720190|FG001|Overall Study|Lack of Efficacy|0|||
48691180|NCT02734693|156720191|FG002|Overall Study|Lack of Efficacy|0|||
48691181|NCT02734693|156720189|FG000|Overall Study|Lost to Follow-up|2|||
48691182|NCT02734693|156720190|FG001|Overall Study|Lost to Follow-up|0|||
48691183|NCT02734693|156720191|FG002|Overall Study|Lost to Follow-up|0|||
48691184|NCT02734693|156720189|FG000|Overall Study|Protocol Violation|1|||
48691185|NCT02734693|156720190|FG001|Overall Study|Protocol Violation|0|||
48691186|NCT02734693|156720191|FG002|Overall Study|Protocol Violation|0|||
48691187|NCT02734693|156720189|FG000|Overall Study|Withdrawal by Subject|1|||
48691188|NCT02734693|156720190|FG001|Overall Study|Withdrawal by Subject|0|||
48691189|NCT02734693|156720191|FG002|Overall Study|Withdrawal by Subject|0|||
48691190|NCT01069484|156720199|FG000|Overall Study|Death-in-near-family|1|||
48691191|NCT01069484|156720200|FG001|Overall Study|Death-in-near-family|0|||
48691192|NCT01069484|156720199|FG000|Overall Study|No specific reason|8|||
48691193|NCT01069484|156720200|FG001|Overall Study|No specific reason|2|||
48691194|NCT01069484|156720199|FG000|Overall Study|Illness mother or child|3|||
48763777|NCT02174848|156985746|FG001|Overall Study|Adverse Event|1|||
48763778|NCT02174848|156985745|FG000|Overall Study|Withdrawal by Subject|3|||
48763779|NCT02174848|156985746|FG001|Overall Study|Withdrawal by Subject|3|||
48763780|NCT02174848|156985745|FG000|Overall Study|Lost to Follow-up|0|||
48763781|NCT02174848|156985746|FG001|Overall Study|Lost to Follow-up|1|||
48763782|NCT02174848|156985745|FG000|Overall Study|Worsening of disease|1|||
48763783|NCT02174848|156985746|FG001|Overall Study|Worsening of disease|1|||
48763784|NCT02174848|156985745|FG000|Overall Study|Unable to comply with study requirements|1|||
48763785|NCT02174848|156985746|FG001|Overall Study|Unable to comply with study requirements|0|||
48763786|NCT03257631|156985752|FG000|Overall Study|Death|1|||
48875389|NCT02560389|157381638|FG000|Overall Study|Lost to Follow-up|1|||
48875390|NCT02560389|157381639|FG001|Overall Study|Lost to Follow-up|2|||
48875391|NCT02560389|157381640|FG002|Overall Study|Lost to Follow-up|2|||
48875392|NCT02560389|157381638|FG000|Overall Study|Tested positive for illicit substance|0|||
48875393|NCT02560389|157381639|FG001|Overall Study|Tested positive for illicit substance|1|||
48875394|NCT02560389|157381640|FG002|Overall Study|Tested positive for illicit substance|0|||
48875395|NCT00550446|157381641|FG000|Up To Week 12|Adverse Event|2|||
48875396|NCT00550446|157381642|FG001|Up To Week 12|Adverse Event|2|||
48875397|NCT00550446|157381643|FG002|Up To Week 12|Adverse Event|0|||
48875398|NCT00550446|157381644|FG003|Up To Week 12|Adverse Event|0|||
48875399|NCT00550446|157381645|FG004|Up To Week 12|Adverse Event|2|||
48875400|NCT00550446|157381646|FG005|Up To Week 12|Adverse Event|2|||
48875401|NCT00550446|157381647|FG006|Up To Week 12|Adverse Event|1|||
48875402|NCT00550446|157381648|FG007|Up To Week 12|Adverse Event|0|||
48875403|NCT00550446|157381649|FG008|Up To Week 12|Adverse Event|0|||
48875404|NCT00550446|157381650|FG009|Up To Week 12|Adverse Event|0|||
48875405|NCT00550446|157381651|FG010|Up To Week 12|Adverse Event|0|||
48875406|NCT00550446|157381641|FG000|Up To Week 12|Lack of Efficacy|3|||
48875407|NCT00550446|157381642|FG001|Up To Week 12|Lack of Efficacy|1|||
48875408|NCT00550446|157381643|FG002|Up To Week 12|Lack of Efficacy|0|||
48875409|NCT00550446|157381644|FG003|Up To Week 12|Lack of Efficacy|1|||
48875410|NCT00550446|157381645|FG004|Up To Week 12|Lack of Efficacy|0|||
48875411|NCT00550446|157381646|FG005|Up To Week 12|Lack of Efficacy|3|||
48875412|NCT00550446|157381647|FG006|Up To Week 12|Lack of Efficacy|3|||
48875413|NCT00550446|157381648|FG007|Up To Week 12|Lack of Efficacy|0|||
48875414|NCT00550446|157381649|FG008|Up To Week 12|Lack of Efficacy|0|||
48875415|NCT00550446|157381650|FG009|Up To Week 12|Lack of Efficacy|0|||
48875416|NCT00550446|157381651|FG010|Up To Week 12|Lack of Efficacy|0|||
48875417|NCT00550446|157381641|FG000|Up To Week 12|Lost to Follow-up|0|||
48875418|NCT00550446|157381642|FG001|Up To Week 12|Lost to Follow-up|1|||
48875419|NCT00550446|157381643|FG002|Up To Week 12|Lost to Follow-up|0|||
49024610|NCT02430870|157930103|FG004|Part 2|Voluntary Withdrawal|0|||
48691195|NCT01069484|156720200|FG001|Overall Study|Illness mother or child|1|||
48691196|NCT01506271|156720201|FG000|Overall Study|Progressive disease|0|||
48691197|NCT01506271|156720202|FG001|Overall Study|Progressive disease|1|||
48691198|NCT01506271|156720203|FG002|Overall Study|Progressive disease|0|||
48691199|NCT01506271|156720201|FG000|Overall Study|Protocol Violation|3|||
48691200|NCT01506271|156720202|FG001|Overall Study|Protocol Violation|1|||
48691201|NCT01506271|156720203|FG002|Overall Study|Protocol Violation|0|||
48691202|NCT01506271|156720201|FG000|Overall Study|Death|0|||
48691203|NCT01506271|156720202|FG001|Overall Study|Death|1|||
48691204|NCT01506271|156720203|FG002|Overall Study|Death|0|||
48691205|NCT01506271|156720201|FG000|Overall Study|Adverse Event|0|||
48691206|NCT01506271|156720202|FG001|Overall Study|Adverse Event|2|||
48691207|NCT01506271|156720203|FG002|Overall Study|Adverse Event|0|||
48691208|NCT01506271|156720201|FG000|Overall Study|Insufficient supply of study drug|1|||
48691209|NCT01506271|156720202|FG001|Overall Study|Insufficient supply of study drug|0|||
48691210|NCT01506271|156720203|FG002|Overall Study|Insufficient supply of study drug|0|||
48691211|NCT01506271|156720201|FG000|Overall Study|Withdrawal by Subject|0|||
48691212|NCT01506271|156720202|FG001|Overall Study|Withdrawal by Subject|1|||
48691213|NCT01506271|156720203|FG002|Overall Study|Withdrawal by Subject|1|||
48691214|NCT01506271|156720201|FG000|Overall Study|Lost to Follow-up|0|||
48691215|NCT01506271|156720202|FG001|Overall Study|Lost to Follow-up|1|||
48763787|NCT03257631|156985753|FG001|Overall Study|Death|0|||
48763788|NCT03257631|156985754|FG002|Overall Study|Death|1|||
48763789|NCT03257631|156985755|FG003|Overall Study|Death|1|||
48763790|NCT03257631|156985752|FG000|Overall Study|Progressive Disease|10|||
48875420|NCT00550446|157381644|FG003|Up To Week 12|Lost to Follow-up|0|||
48875421|NCT00550446|157381645|FG004|Up To Week 12|Lost to Follow-up|1|||
49024611|NCT02430870|157930104|FG005|Part 2|Voluntary Withdrawal|0|||
48875422|NCT00550446|157381646|FG005|Up To Week 12|Lost to Follow-up|1|||
48875423|NCT00550446|157381647|FG006|Up To Week 12|Lost to Follow-up|2|||
48875424|NCT00550446|157381648|FG007|Up To Week 12|Lost to Follow-up|0|||
48763791|NCT03257631|156985753|FG001|Overall Study|Progressive Disease|9|||
49024612|NCT02430870|157930105|FG006|Part 2|Voluntary Withdrawal|1|||
48691216|NCT01506271|156720203|FG002|Overall Study|Lost to Follow-up|2|||
48691217|NCT01129622|156720209|FG000|Overall Study|Withdrawal by Subject|2|||
48691218|NCT01425801|156720210|FG000|Period 1|Withdrawal by Subject|0|||
48875425|NCT00550446|157381649|FG008|Up To Week 12|Lost to Follow-up|0|||
48875426|NCT00550446|157381650|FG009|Up To Week 12|Lost to Follow-up|0|||
48763792|NCT03257631|156985754|FG002|Overall Study|Progressive Disease|17|||
48763793|NCT03257631|156985755|FG003|Overall Study|Progressive Disease|8|||
48763794|NCT03257631|156985752|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
48763795|NCT03257631|156985753|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
48763796|NCT03257631|156985754|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
48763797|NCT03257631|156985755|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
48763798|NCT03257631|156985752|FG000|Overall Study|Adverse Event|0|||
48763799|NCT03257631|156985753|FG001|Overall Study|Adverse Event|0|||
48763800|NCT03257631|156985754|FG002|Overall Study|Adverse Event|2|||
48875427|NCT00550446|157381651|FG010|Up To Week 12|Lost to Follow-up|0|||
48875428|NCT00550446|157381641|FG000|Up To Week 12|Withdrawal by Subject|2|||
48875429|NCT00550446|157381642|FG001|Up To Week 12|Withdrawal by Subject|0|||
48875430|NCT00550446|157381643|FG002|Up To Week 12|Withdrawal by Subject|3|||
48875431|NCT00550446|157381644|FG003|Up To Week 12|Withdrawal by Subject|2|||
48875432|NCT00550446|157381645|FG004|Up To Week 12|Withdrawal by Subject|0|||
48875433|NCT00550446|157381646|FG005|Up To Week 12|Withdrawal by Subject|1|||
48875434|NCT00550446|157381647|FG006|Up To Week 12|Withdrawal by Subject|3|||
48875435|NCT00550446|157381648|FG007|Up To Week 12|Withdrawal by Subject|0|||
48875436|NCT00550446|157381649|FG008|Up To Week 12|Withdrawal by Subject|0|||
48875437|NCT00550446|157381650|FG009|Up To Week 12|Withdrawal by Subject|0|||
48875438|NCT00550446|157381651|FG010|Up To Week 12|Withdrawal by Subject|0|||
48875439|NCT00550446|157381641|FG000|Up To Week 12|Other|3|||
48875440|NCT00550446|157381642|FG001|Up To Week 12|Other|0|||
48875441|NCT00550446|157381643|FG002|Up To Week 12|Other|0|||
48875442|NCT00550446|157381644|FG003|Up To Week 12|Other|0|||
48875443|NCT00550446|157381645|FG004|Up To Week 12|Other|0|||
48875444|NCT00550446|157381646|FG005|Up To Week 12|Other|1|||
48875445|NCT00550446|157381647|FG006|Up To Week 12|Other|4|||
48875446|NCT00550446|157381648|FG007|Up To Week 12|Other|0|||
48875447|NCT00550446|157381649|FG008|Up To Week 12|Other|0|||
48875448|NCT00550446|157381650|FG009|Up To Week 12|Other|0|||
48875449|NCT00550446|157381651|FG010|Up To Week 12|Other|0|||
48875450|NCT00550446|157381641|FG000|Up To Week 12|Randomized not treated|0|||
48875451|NCT00550446|157381642|FG001|Up To Week 12|Randomized not treated|1|||
48875452|NCT00550446|157381643|FG002|Up To Week 12|Randomized not treated|1|||
48875453|NCT00550446|157381644|FG003|Up To Week 12|Randomized not treated|0|||
48875454|NCT00550446|157381645|FG004|Up To Week 12|Randomized not treated|0|||
49024613|NCT02430870|157930106|FG007|Part 2|Voluntary Withdrawal|0|||
49024614|NCT02430870|157930099|FG000|Part 2|Other Reason Not Specified|0|||
48691219|NCT01425801|156720211|FG001|Period 1|Withdrawal by Subject|0|||
48691220|NCT01425801|156720212|FG002|Period 1|Withdrawal by Subject|0|||
48691221|NCT01425801|156720213|FG003|Period 1|Withdrawal by Subject|0|||
48763801|NCT03257631|156985755|FG003|Overall Study|Adverse Event|0|||
48763802|NCT01063764|156985756|FG000|1st Period (From Week 8 to Week 22)|Adverse Event|4|||
48763803|NCT01063764|156985756|FG000|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6|||
48763804|NCT01063764|156985756|FG000|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1|||
48691222|NCT01425801|156720214|FG004|Period 1|Withdrawal by Subject|1|||
48691223|NCT01425801|156720215|FG005|Period 1|Withdrawal by Subject|0|||
48691224|NCT01425801|156720210|FG000|Period 2|Withdrawal by Subject|0|||
48691225|NCT01425801|156720211|FG001|Period 2|Withdrawal by Subject|0|||
48691226|NCT01425801|156720212|FG002|Period 2|Withdrawal by Subject|0|||
48691227|NCT01425801|156720213|FG003|Period 2|Withdrawal by Subject|0|||
48691228|NCT01425801|156720214|FG004|Period 2|Withdrawal by Subject|1|||
48691229|NCT01425801|156720215|FG005|Period 2|Withdrawal by Subject|0|||
48691230|NCT01425801|156720210|FG000|Period 3|Stability criteria not fullfilled|0|||
48691231|NCT01425801|156720211|FG001|Period 3|Stability criteria not fullfilled|0|||
48691232|NCT01425801|156720212|FG002|Period 3|Stability criteria not fullfilled|1|||
48691233|NCT01425801|156720213|FG003|Period 3|Stability criteria not fullfilled|0|||
48691234|NCT01425801|156720214|FG004|Period 3|Stability criteria not fullfilled|0|||
48691235|NCT01425801|156720215|FG005|Period 3|Stability criteria not fullfilled|0|||
48691236|NCT01425801|156720210|FG000|Period 4|Not able to maintain visit schedule|0|||
48691237|NCT01425801|156720211|FG001|Period 4|Not able to maintain visit schedule|0|||
48691238|NCT01425801|156720212|FG002|Period 4|Not able to maintain visit schedule|1|||
48763805|NCT01063764|156985756|FG000|2nd Period (Week 22 to the End of Study)|Adverse Event|3|||
48875455|NCT00550446|157381646|FG005|Up To Week 12|Randomized not treated|0|||
48875456|NCT00550446|157381647|FG006|Up To Week 12|Randomized not treated|0|||
48875457|NCT00550446|157381648|FG007|Up To Week 12|Randomized not treated|0|||
48875458|NCT00550446|157381649|FG008|Up To Week 12|Randomized not treated|0|||
48875459|NCT00550446|157381650|FG009|Up To Week 12|Randomized not treated|0|||
48875460|NCT00550446|157381651|FG010|Up To Week 12|Randomized not treated|0|||
48875461|NCT00550446|157381641|FG000|Post Week 12|Adverse Event|2|||
48875462|NCT00550446|157381642|FG001|Post Week 12|Adverse Event|1|||
48875463|NCT00550446|157381643|FG002|Post Week 12|Adverse Event|1|||
48875464|NCT00550446|157381644|FG003|Post Week 12|Adverse Event|1|||
49024615|NCT02430870|157930100|FG001|Part 2|Other Reason Not Specified|0|||
48691239|NCT01425801|156720213|FG003|Period 4|Not able to maintain visit schedule|0|||
48763806|NCT01063764|156985756|FG000|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9|||
48691240|NCT01425801|156720214|FG004|Period 4|Not able to maintain visit schedule|0|||
49024616|NCT02430870|157930101|FG002|Part 2|Other Reason Not Specified|0|||
49024617|NCT02430870|157930102|FG003|Part 2|Other Reason Not Specified|0|||
49024618|NCT02430870|157930103|FG004|Part 2|Other Reason Not Specified|0|||
49024619|NCT02430870|157930104|FG005|Part 2|Other Reason Not Specified|0|||
48691241|NCT01425801|156720215|FG005|Period 4|Not able to maintain visit schedule|0|||
48691242|NCT02898454|156720216|FG000|Overall Study|Adverse Event|4|||
48691243|NCT02898454|156720217|FG001|Overall Study|Adverse Event|1|||
48691244|NCT02898454|156720218|FG002|Overall Study|Adverse Event|2|||
48691245|NCT02898454|156720216|FG000|Overall Study|Protocol Violation|1|||
48691246|NCT02898454|156720217|FG001|Overall Study|Protocol Violation|0|||
48691247|NCT02898454|156720218|FG002|Overall Study|Protocol Violation|1|||
48691248|NCT02898454|156720216|FG000|Overall Study|Lack of Efficacy|4|||
48691249|NCT02898454|156720217|FG001|Overall Study|Lack of Efficacy|1|||
48691250|NCT02898454|156720218|FG002|Overall Study|Lack of Efficacy|0|||
48691251|NCT02898454|156720216|FG000|Overall Study|Withdrawal by Subject|6|||
48691252|NCT02898454|156720217|FG001|Overall Study|Withdrawal by Subject|3|||
48691253|NCT02898454|156720218|FG002|Overall Study|Withdrawal by Subject|3|||
48691254|NCT02898454|156720216|FG000|Overall Study|Lost to Follow-up|1|||
48691255|NCT02898454|156720217|FG001|Overall Study|Lost to Follow-up|0|||
48691256|NCT02898454|156720218|FG002|Overall Study|Lost to Follow-up|0|||
48691257|NCT02898454|156720216|FG000|Overall Study|Did Not Met Eligibility Criteria|1|||
48691258|NCT02898454|156720217|FG001|Overall Study|Did Not Met Eligibility Criteria|0|||
48691259|NCT02898454|156720218|FG002|Overall Study|Did Not Met Eligibility Criteria|0|||
48691260|NCT00525512|156720220|FG000|Double-Blind Phase|Adverse Event|48|||
48691261|NCT00525512|156720221|FG001|Double-Blind Phase|Adverse Event|28|||
48691262|NCT00525512|156720222|FG002|Double-Blind Phase|Adverse Event|0|||
48691263|NCT00525512|156720223|FG003|Double-Blind Phase|Adverse Event|0|||
48691264|NCT00525512|156720220|FG000|Double-Blind Phase|Protocol Violation|3|||
48691265|NCT00525512|156720221|FG001|Double-Blind Phase|Protocol Violation|1|||
48691266|NCT00525512|156720222|FG002|Double-Blind Phase|Protocol Violation|0|||
48691267|NCT00525512|156720223|FG003|Double-Blind Phase|Protocol Violation|0|||
48691268|NCT00525512|156720220|FG000|Double-Blind Phase|Lost to Follow-up|3|||
48691269|NCT00525512|156720221|FG001|Double-Blind Phase|Lost to Follow-up|7|||
48691270|NCT00525512|156720222|FG002|Double-Blind Phase|Lost to Follow-up|0|||
48691271|NCT00525512|156720223|FG003|Double-Blind Phase|Lost to Follow-up|0|||
48691272|NCT00525512|156720220|FG000|Double-Blind Phase|Withdrawal by Subject|17|||
48691273|NCT00525512|156720221|FG001|Double-Blind Phase|Withdrawal by Subject|12|||
48691274|NCT00525512|156720222|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
48691275|NCT00525512|156720223|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
48691276|NCT00525512|156720220|FG000|Double-Blind Phase|Lack of Efficacy|13|||
48691277|NCT00525512|156720221|FG001|Double-Blind Phase|Lack of Efficacy|5|||
48691278|NCT00525512|156720222|FG002|Double-Blind Phase|Lack of Efficacy|0|||
48691279|NCT00525512|156720223|FG003|Double-Blind Phase|Lack of Efficacy|0|||
48691280|NCT00525512|156720220|FG000|Double-Blind Phase|Other reason (not specified)|12|||
48691281|NCT00525512|156720221|FG001|Double-Blind Phase|Other reason (not specified)|13|||
48691282|NCT00525512|156720222|FG002|Double-Blind Phase|Other reason (not specified)|0|||
48691283|NCT00525512|156720223|FG003|Double-Blind Phase|Other reason (not specified)|0|||
48691284|NCT00525512|156720220|FG000|Open-Label Phase|Adverse Event|0|||
48691285|NCT00525512|156720221|FG001|Open-Label Phase|Adverse Event|0|||
48691286|NCT00525512|156720222|FG002|Open-Label Phase|Adverse Event|1|||
48691287|NCT00525512|156720223|FG003|Open-Label Phase|Adverse Event|0|||
48691288|NCT00525512|156720220|FG000|Open-Label Phase|Lost to Follow-up|0|||
48691289|NCT00525512|156720221|FG001|Open-Label Phase|Lost to Follow-up|0|||
48691290|NCT00525512|156720222|FG002|Open-Label Phase|Lost to Follow-up|1|||
48691291|NCT00525512|156720223|FG003|Open-Label Phase|Lost to Follow-up|0|||
48691292|NCT00525512|156720220|FG000|Open-Label Phase|Other reason (not specified)|0|||
48691293|NCT00525512|156720221|FG001|Open-Label Phase|Other reason (not specified)|0|||
48875465|NCT00550446|157381645|FG004|Post Week 12|Adverse Event|1|||
48875466|NCT00550446|157381646|FG005|Post Week 12|Adverse Event|1|||
48875467|NCT00550446|157381647|FG006|Post Week 12|Adverse Event|0|||
48875468|NCT00550446|157381648|FG007|Post Week 12|Adverse Event|0|||
48875469|NCT00550446|157381649|FG008|Post Week 12|Adverse Event|0|||
48875470|NCT00550446|157381650|FG009|Post Week 12|Adverse Event|4|||
48875471|NCT00550446|157381651|FG010|Post Week 12|Adverse Event|0|||
48875472|NCT00550446|157381641|FG000|Post Week 12|Lack of Efficacy|0|||
48875473|NCT00550446|157381642|FG001|Post Week 12|Lack of Efficacy|0|||
48691294|NCT00525512|156720222|FG002|Open-Label Phase|Other reason (not specified)|4|||
48691295|NCT00525512|156720223|FG003|Open-Label Phase|Other reason (not specified)|5|||
48763807|NCT01063764|156985756|FG000|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7|||
48875474|NCT00550446|157381643|FG002|Post Week 12|Lack of Efficacy|1|||
48875475|NCT00550446|157381644|FG003|Post Week 12|Lack of Efficacy|0|||
48875476|NCT00550446|157381645|FG004|Post Week 12|Lack of Efficacy|0|||
48875477|NCT00550446|157381646|FG005|Post Week 12|Lack of Efficacy|0|||
48691296|NCT01903460|156720224|FG000|Overall Study|Adverse Event|0|||
48691297|NCT01903460|156720225|FG001|Overall Study|Adverse Event|0|||
48691298|NCT01903460|156720226|FG002|Overall Study|Adverse Event|0|||
48763808|NCT01063764|156985756|FG000|2nd Period (Week 22 to the End of Study)|Protocol Violation|1|||
48763809|NCT03240133|156985764|FG000|Overall Study|Withdrawal by Subject|0|||
48763810|NCT03240133|156985765|FG001|Overall Study|Withdrawal by Subject|1|||
48763811|NCT03240133|156985766|FG002|Overall Study|Withdrawal by Subject|0|||
48763812|NCT03240133|156985764|FG000|Overall Study|Adverse Event|1|||
49024620|NCT02430870|157930105|FG006|Part 2|Other Reason Not Specified|0|||
49024621|NCT02430870|157930106|FG007|Part 2|Other Reason Not Specified|1|||
49024622|NCT03447470|157930107|FG000|Overall Study|Death|0|||
48691299|NCT01903460|156720227|FG003|Overall Study|Adverse Event|1|||
48691300|NCT00321789|156720230|FG000|Overall Study|Lost to Follow-up|4|||
48691301|NCT00321789|156720231|FG001|Overall Study|Lost to Follow-up|7|||
48691302|NCT00321789|156720230|FG000|Overall Study|Withdrawal by Subject|6|||
48691303|NCT00321789|156720231|FG001|Overall Study|Withdrawal by Subject|6|||
48691304|NCT00321789|156720230|FG000|Overall Study|Protocol Violation|5|||
48691305|NCT00321789|156720231|FG001|Overall Study|Protocol Violation|3|||
48691306|NCT00647296|156720232|FG000|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
48691307|NCT00647296|156720233|FG001|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
48691308|NCT00647296|156720234|FG002|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
48691309|NCT00647296|156720235|FG003|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1|||
48691310|NCT00647296|156720232|FG000|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
48691311|NCT00647296|156720233|FG001|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
48691312|NCT00647296|156720234|FG002|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
48691313|NCT00647296|156720235|FG003|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
48691314|NCT00647296|156720232|FG000|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
48691315|NCT00647296|156720233|FG001|Part 1: 12-week Double-Blind Treatment|Physician Decision|1|||
48691316|NCT00647296|156720234|FG002|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
48691317|NCT00647296|156720235|FG003|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
48691318|NCT00647296|156720232|FG000|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1|||
48691319|NCT00647296|156720233|FG001|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
48691320|NCT00647296|156720234|FG002|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
48691321|NCT00647296|156720235|FG003|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
48691322|NCT00647296|156720232|FG000|Part 2: 4-week Placebo Washout|Lost to Follow-up|1|||
48691323|NCT00647296|156720233|FG001|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
48691324|NCT00647296|156720234|FG002|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
48691325|NCT00647296|156720235|FG003|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
48691326|NCT00647296|156720232|FG000|Part 2: 4-week Placebo Washout|Death|3|||
48691327|NCT00647296|156720233|FG001|Part 2: 4-week Placebo Washout|Death|0|||
48691328|NCT00647296|156720234|FG002|Part 2: 4-week Placebo Washout|Death|0|||
48691329|NCT00647296|156720235|FG003|Part 2: 4-week Placebo Washout|Death|0|||
48691330|NCT00647296|156720232|FG000|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
48691331|NCT00647296|156720233|FG001|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5|||
48691332|NCT00647296|156720234|FG002|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
48691333|NCT00647296|156720235|FG003|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4|||
48691334|NCT00647296|156720232|FG000|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
48691335|NCT00647296|156720233|FG001|Part 2: 76-week Double-Blind Treatment|Adverse Event|1|||
48691336|NCT00647296|156720234|FG002|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
48691337|NCT00647296|156720235|FG003|Part 2: 76-week Double-Blind Treatment|Adverse Event|4|||
48691338|NCT00647296|156720232|FG000|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
48691339|NCT00647296|156720233|FG001|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1|||
48691340|NCT00647296|156720234|FG002|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
48691341|NCT00647296|156720235|FG003|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
48691342|NCT00647296|156720232|FG000|Part 2: 76-week Double-Blind Treatment|Death|0|||
48691343|NCT00647296|156720233|FG001|Part 2: 76-week Double-Blind Treatment|Death|7|||
48691344|NCT00647296|156720234|FG002|Part 2: 76-week Double-Blind Treatment|Death|0|||
48691345|NCT00647296|156720235|FG003|Part 2: 76-week Double-Blind Treatment|Death|5|||
48691346|NCT00647296|156720232|FG000|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
48691347|NCT00647296|156720233|FG001|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
48691348|NCT00647296|156720234|FG002|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
48691349|NCT00647296|156720235|FG003|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
48691350|NCT02485691|156720236|FG000|Overall Study|Adverse Event|25|||
48691351|NCT02485691|156720237|FG001|Overall Study|Adverse Event|11|||
48691352|NCT02485691|156720236|FG000|Overall Study|Poor compliance to protocol|0|||
48763813|NCT03240133|156985765|FG001|Overall Study|Adverse Event|1|||
48691353|NCT02485691|156720237|FG001|Overall Study|Poor compliance to protocol|1|||
48691354|NCT02485691|156720236|FG000|Overall Study|Disease progression|57|||
48691355|NCT02485691|156720237|FG001|Overall Study|Disease progression|92|||
48691356|NCT02485691|156720236|FG000|Overall Study|Investigator's decision|23|||
48763814|NCT03240133|156985766|FG002|Overall Study|Adverse Event|0|||
48763815|NCT03240133|156985764|FG000|Overall Study|Rash|1|||
49024623|NCT03447470|157930108|FG001|Overall Study|Death|1|||
48763816|NCT03240133|156985765|FG001|Overall Study|Rash|0|||
48763817|NCT03240133|156985766|FG002|Overall Study|Rash|0|||
48763818|NCT03240133|156985764|FG000|Overall Study|sponsor closure/completion of Part 1 of the study|1|||
49024624|NCT03447470|157930109|FG002|Overall Study|Death|3|||
49024625|NCT03447470|157930110|FG003|Overall Study|Death|0|||
49024626|NCT03447470|157930111|FG004|Overall Study|Death|1|||
48691357|NCT02485691|156720237|FG001|Overall Study|Investigator's decision|5|||
48691358|NCT02485691|156720236|FG000|Overall Study|Participant's request|13|||
48691359|NCT02485691|156720237|FG001|Overall Study|Participant's request|6|||
48691360|NCT02485691|156720236|FG000|Overall Study|Other reason|8|||
48691361|NCT02485691|156720237|FG001|Overall Study|Other reason|9|||
48691362|NCT02485691|156720236|FG000|Overall Study|Randomized and not treated|3|||
48691363|NCT02485691|156720237|FG001|Overall Study|Randomized and not treated|2|||
49024627|NCT03447470|157930112|FG005|Overall Study|Death|0|||
49024628|NCT03447470|157930113|FG006|Overall Study|Death|3|||
49024629|NCT03447470|157930114|FG007|Overall Study|Death|3|||
49024630|NCT03447470|157930115|FG008|Overall Study|Death|1|||
49024631|NCT03447470|157930107|FG000|Overall Study|Withdrawal by Subject|1|||
49024632|NCT03447470|157930108|FG001|Overall Study|Withdrawal by Subject|0|||
49024633|NCT03447470|157930109|FG002|Overall Study|Withdrawal by Subject|0|||
49024634|NCT03447470|157930110|FG003|Overall Study|Withdrawal by Subject|0|||
49024635|NCT03447470|157930111|FG004|Overall Study|Withdrawal by Subject|1|||
49024636|NCT03447470|157930112|FG005|Overall Study|Withdrawal by Subject|0|||
49024637|NCT03447470|157930113|FG006|Overall Study|Withdrawal by Subject|1|||
49024638|NCT03447470|157930114|FG007|Overall Study|Withdrawal by Subject|1|||
49024639|NCT03447470|157930115|FG008|Overall Study|Withdrawal by Subject|3|||
49024640|NCT03447470|157930107|FG000|Overall Study|Treatment discontinued|3|||
49024641|NCT03447470|157930108|FG001|Overall Study|Treatment discontinued|2|||
49024642|NCT03447470|157930109|FG002|Overall Study|Treatment discontinued|4|||
49024643|NCT03447470|157930110|FG003|Overall Study|Treatment discontinued|6|||
49024644|NCT03447470|157930111|FG004|Overall Study|Treatment discontinued|2|||
49024645|NCT03447470|157930112|FG005|Overall Study|Treatment discontinued|1|||
49024646|NCT03447470|157930113|FG006|Overall Study|Treatment discontinued|2|||
49024647|NCT03447470|157930114|FG007|Overall Study|Treatment discontinued|4|||
49024648|NCT03447470|157930115|FG008|Overall Study|Treatment discontinued|3|||
49024649|NCT01606215|157930121|FG000|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
49024650|NCT01606215|157930122|FG001|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
49024651|NCT03049488|157930123|FG000|Overall Study|Lost to Follow-up|1|||
49024652|NCT03049488|157930124|FG001|Overall Study|Lost to Follow-up|1|||
49024653|NCT03049488|157930125|FG002|Overall Study|Lost to Follow-up|0|||
49024654|NCT03049488|157930126|FG003|Overall Study|Lost to Follow-up|0|||
48691364|NCT02260934|156720239|FG000|Overall Study|Lost to Follow-up|2|||
48691365|NCT02260934|156720240|FG001|Overall Study|Lost to Follow-up|1|||
48691366|NCT02260934|156720239|FG000|Overall Study|Withdrawal by Subject|0|||
48691367|NCT02260934|156720240|FG001|Overall Study|Withdrawal by Subject|2|||
48691368|NCT02260934|156720239|FG000|Overall Study|Participant Relocated|1|||
48691369|NCT02260934|156720240|FG001|Overall Study|Participant Relocated|0|||
48691370|NCT02260934|156720239|FG000|Overall Study|Site error|0|||
48691371|NCT02260934|156720240|FG001|Overall Study|Site error|1|||
48691372|NCT04292535|156720241|FG000|Overall Study|Withdrawal by Subject|0|||
48691373|NCT04292535|156720242|FG001|Overall Study|Withdrawal by Subject|0|||
48691374|NCT04292535|156720243|FG002|Overall Study|Withdrawal by Subject|0|||
48691375|NCT04292535|156720244|FG003|Overall Study|Withdrawal by Subject|0|||
48691376|NCT04292535|156720245|FG004|Overall Study|Withdrawal by Subject|0|||
48691377|NCT04292535|156720246|FG005|Overall Study|Withdrawal by Subject|0|||
48691378|NCT04292535|156720247|FG006|Overall Study|Withdrawal by Subject|0|||
48691379|NCT04292535|156720248|FG007|Overall Study|Withdrawal by Subject|1|||
48691380|NCT04292535|156720249|FG008|Overall Study|Withdrawal by Subject|0|||
48691381|NCT04292535|156720250|FG009|Overall Study|Withdrawal by Subject|0|||
48691382|NCT04292535|156720251|FG010|Overall Study|Withdrawal by Subject|0|||
48763819|NCT03240133|156985765|FG001|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
49024655|NCT03049488|157930127|FG004|Overall Study|Lost to Follow-up|0|||
49024656|NCT03049488|157930128|FG005|Overall Study|Lost to Follow-up|0|||
49024657|NCT03049488|157930123|FG000|Overall Study|Moved from Area|1|||
49024658|NCT03049488|157930124|FG001|Overall Study|Moved from Area|0|||
49024659|NCT03049488|157930125|FG002|Overall Study|Moved from Area|0|||
49024660|NCT03049488|157930126|FG003|Overall Study|Moved from Area|1|||
48691383|NCT04292535|156720252|FG011|Overall Study|Withdrawal by Subject|0|||
48691384|NCT04292535|156720253|FG012|Overall Study|Withdrawal by Subject|0|||
48691385|NCT04292535|156720254|FG013|Overall Study|Withdrawal by Subject|0|||
48691386|NCT04292535|156720241|FG000|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
48691387|NCT04292535|156720242|FG001|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
48691388|NCT04292535|156720243|FG002|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
48875478|NCT00550446|157381647|FG006|Post Week 12|Lack of Efficacy|0|||
49024661|NCT03049488|157930127|FG004|Overall Study|Moved from Area|1|||
48691389|NCT04292535|156720244|FG003|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
48691390|NCT04292535|156720245|FG004|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
48691391|NCT04292535|156720246|FG005|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
48691392|NCT04292535|156720247|FG006|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
48691393|NCT04292535|156720248|FG007|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
48691394|NCT04292535|156720249|FG008|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
48691395|NCT04292535|156720250|FG009|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
48691396|NCT04292535|156720251|FG010|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
48691397|NCT04292535|156720252|FG011|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
48691398|NCT04292535|156720253|FG012|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
48691399|NCT04292535|156720254|FG013|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
48691400|NCT04292535|156720241|FG000|Overall Study|Report of Dizziness|0|||
48691401|NCT04292535|156720242|FG001|Overall Study|Report of Dizziness|0|||
48691402|NCT04292535|156720243|FG002|Overall Study|Report of Dizziness|0|||
48691403|NCT04292535|156720244|FG003|Overall Study|Report of Dizziness|0|||
48691404|NCT04292535|156720245|FG004|Overall Study|Report of Dizziness|0|||
48691405|NCT04292535|156720246|FG005|Overall Study|Report of Dizziness|0|||
48691406|NCT04292535|156720247|FG006|Overall Study|Report of Dizziness|0|||
48691407|NCT04292535|156720248|FG007|Overall Study|Report of Dizziness|0|||
48691408|NCT04292535|156720249|FG008|Overall Study|Report of Dizziness|0|||
48691409|NCT04292535|156720250|FG009|Overall Study|Report of Dizziness|0|||
48691410|NCT04292535|156720251|FG010|Overall Study|Report of Dizziness|0|||
48691411|NCT04292535|156720252|FG011|Overall Study|Report of Dizziness|0|||
48691412|NCT04292535|156720253|FG012|Overall Study|Report of Dizziness|0|||
48691413|NCT04292535|156720254|FG013|Overall Study|Report of Dizziness|1|||
48691414|NCT04292535|156720241|FG000|Overall Study|Equipment Failure|0|||
48691415|NCT04292535|156720242|FG001|Overall Study|Equipment Failure|0|||
48691416|NCT04292535|156720243|FG002|Overall Study|Equipment Failure|0|||
48691417|NCT04292535|156720244|FG003|Overall Study|Equipment Failure|0|||
48691418|NCT04292535|156720245|FG004|Overall Study|Equipment Failure|0|||
48691419|NCT04292535|156720246|FG005|Overall Study|Equipment Failure|0|||
48691420|NCT04292535|156720247|FG006|Overall Study|Equipment Failure|0|||
48691421|NCT04292535|156720248|FG007|Overall Study|Equipment Failure|0|||
48691422|NCT04292535|156720249|FG008|Overall Study|Equipment Failure|0|||
48691423|NCT04292535|156720250|FG009|Overall Study|Equipment Failure|0|||
48691424|NCT04292535|156720251|FG010|Overall Study|Equipment Failure|0|||
48691425|NCT04292535|156720252|FG011|Overall Study|Equipment Failure|1|||
48691426|NCT04292535|156720253|FG012|Overall Study|Equipment Failure|0|||
48691427|NCT04292535|156720254|FG013|Overall Study|Equipment Failure|0|||
48691428|NCT04528641|156720257|FG000|Overall Study|Withdrawal by Subject|0|||
48691429|NCT04528641|156720258|FG001|Overall Study|Withdrawal by Subject|0|||
48691430|NCT04528641|156720259|FG002|Overall Study|Withdrawal by Subject|0|||
48691431|NCT04528641|156720260|FG003|Overall Study|Withdrawal by Subject|1|||
48691432|NCT04528641|156720261|FG004|Overall Study|Withdrawal by Subject|0|||
48691433|NCT04528641|156720262|FG005|Overall Study|Withdrawal by Subject|1|||
48691434|NCT04972786|156720265|FG000|First Intervention (1 Day)|Adverse Event|1|||
48981660|NCT01536418|157765484|FG001|Overall Study|Adverse Event|4|||
48981661|NCT01536418|157765483|FG000|Overall Study|Met Liver Chemistry Stopping criteria|1|||
48981662|NCT01536418|157765484|FG001|Overall Study|Met Liver Chemistry Stopping criteria|0|||
48981663|NCT01536418|157765483|FG000|Overall Study|Withdrawal by Subject|5|||
48981664|NCT01536418|157765484|FG001|Overall Study|Withdrawal by Subject|3|||
48981665|NCT00735072|157765490|FG000|Overall Study|interrupted study med during ARV change|1|||
48981666|NCT00735072|157765491|FG001|Overall Study|interrupted study med during ARV change|0|||
48981667|NCT00735072|157765490|FG000|Overall Study|Subject interrupted ARVs (non-adherence)|0|||
48981668|NCT00735072|157765491|FG001|Overall Study|Subject interrupted ARVs (non-adherence)|1|||
48981669|NCT00911144|157765492|FG000|Overall Study|Withdrawal by Subject|16|||
48981670|NCT00911144|157765493|FG001|Overall Study|Withdrawal by Subject|5|||
48981671|NCT03598140|157765495|FG000|Overall Study|enrolled but didn't start|1|||
48981672|NCT03598140|157765496|FG001|Overall Study|enrolled but didn't start|0|||
48981673|NCT01131130|157765497|FG000|Period 1 - Baseline|Pregnancy|1|||
48981674|NCT01131130|157765497|FG000|Period 3- Crossover|+ Slit lamp finding|1|||
48981675|NCT00939094|157765498|FG000|Overall Study|Adverse Event|9|||
48981676|NCT00939094|157765499|FG001|Overall Study|Adverse Event|0|||
48981677|NCT00939094|157765498|FG000|Overall Study|Withdrawal by Subject|1|||
48981678|NCT00939094|157765499|FG001|Overall Study|Withdrawal by Subject|6|||
48981679|NCT00939094|157765498|FG000|Overall Study|Lost to Follow-up|1|||
48981680|NCT00939094|157765499|FG001|Overall Study|Lost to Follow-up|1|||
48981681|NCT00939094|157765498|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
48981682|NCT00939094|157765499|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
48981683|NCT00939094|157765498|FG000|Overall Study|Severe non-compliance to protocol|0|||
48981684|NCT00939094|157765499|FG001|Overall Study|Severe non-compliance to protocol|1|||
48981685|NCT00939094|157765498|FG000|Overall Study|Study stopped by sponsor|0|||
48981686|NCT00939094|157765499|FG001|Overall Study|Study stopped by sponsor|2|||
48691435|NCT04972786|156720266|FG001|First Intervention (1 Day)|Adverse Event|0|||
48981687|NCT00939094|157765498|FG000|Overall Study|Abnormal ECG findings|1|||
48981688|NCT00939094|157765499|FG001|Overall Study|Abnormal ECG findings|0|||
48981689|NCT02148952|157765500|FG000|Assessing Eligibility and Consent|Were not eligible for inclusion|1241|||
48981690|NCT02148952|157765501|FG001|Assessing Eligibility and Consent|Were not eligible for inclusion|1591|||
48981691|NCT02148952|157765500|FG000|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862|||
48981692|NCT02148952|157765501|FG001|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556|||
48981693|NCT02148952|157765500|FG000|Follow-Up|Lost to Follow-up|219|||
48981694|NCT02148952|157765501|FG001|Follow-Up|Lost to Follow-up|231|||
48981695|NCT02148952|157765500|FG000|Follow-Up|Withdrawal by Subject|46|||
48981696|NCT02148952|157765501|FG001|Follow-Up|Withdrawal by Subject|48|||
48981697|NCT02010567|157765504|FG000|Overall Study|Adverse Event|0|||
49024662|NCT03049488|157930128|FG005|Overall Study|Moved from Area|0|||
49024663|NCT03049488|157930123|FG000|Overall Study|Physician Decision|0|||
49024664|NCT03049488|157930124|FG001|Overall Study|Physician Decision|1|||
49024665|NCT03049488|157930125|FG002|Overall Study|Physician Decision|0|||
49024666|NCT03049488|157930126|FG003|Overall Study|Physician Decision|0|||
48691436|NCT02016781|156720269|FG000|Interim Look for Primary Analysis|Alive and on study|71|||
48691437|NCT02016781|156720270|FG001|Interim Look for Primary Analysis|Alive and on study|23|||
48691438|NCT02016781|156720269|FG000|Interim Look for Primary Analysis|Withdrawal by Subject|2|||
48691439|NCT02016781|156720270|FG001|Interim Look for Primary Analysis|Withdrawal by Subject|1|||
48691440|NCT02016781|156720269|FG000|Final Database Lock|Withdrawal by Subject|2|||
48691441|NCT02016781|156720270|FG001|Final Database Lock|Withdrawal by Subject|1|||
48691442|NCT02016781|156720269|FG000|Final Database Lock|Lost to Follow-up|11|||
48691443|NCT02016781|156720270|FG001|Final Database Lock|Lost to Follow-up|4|||
48691444|NCT02016781|156720269|FG000|Final Database Lock|Missing data|0|||
48691445|NCT02016781|156720270|FG001|Final Database Lock|Missing data|3|||
48691446|NCT00447226|156722418|FG000|12-Week Open-label Phase|Adverse Event|0|||
48691447|NCT00447226|156722419|FG001|12-Week Open-label Phase|Adverse Event|3|||
48691448|NCT00447226|156722418|FG000|12-Week Open-label Phase|Protocol Violation|0|||
48691449|NCT00447226|156722419|FG001|12-Week Open-label Phase|Protocol Violation|1|||
48691450|NCT00447226|156722418|FG000|12-Week Open-label Phase|Disease Progression|0|||
48691451|NCT00447226|156722419|FG001|12-Week Open-label Phase|Disease Progression|20|||
48691452|NCT00447226|156722418|FG000|12-Week Open-label Phase|Physician Decision|0|||
48691453|NCT00447226|156722419|FG001|12-Week Open-label Phase|Physician Decision|1|||
48691454|NCT00447226|156722418|FG000|Double-blind Phase|Disease Progression|4|||
48691455|NCT00447226|156722419|FG001|Double-blind Phase|Disease Progression|3|||
48691456|NCT01232868|156722422|FG000|Overall Study|Lost to Follow-up|2|||
48691457|NCT01232868|156722423|FG001|Overall Study|Lost to Follow-up|4|||
48691458|NCT01853748|156722429|FG000|Allocation|Withdrawal by Subject|1|||
48691459|NCT01853748|156722430|FG001|Allocation|Withdrawal by Subject|13|||
48691460|NCT01853748|156722429|FG000|Allocation|not sufficient to receive intervention|0|||
48691461|NCT01853748|156722430|FG001|Allocation|not sufficient to receive intervention|1|||
48691462|NCT01853748|156722429|FG000|Follow-Up|Withdrawal by Subject|7|||
48691463|NCT01853748|156722430|FG001|Follow-Up|Withdrawal by Subject|6|||
48691464|NCT01853748|156722429|FG000|Follow-Up|Adverse Event|67|||
48691465|NCT01853748|156722430|FG001|Follow-Up|Adverse Event|7|||
49024667|NCT03049488|157930127|FG004|Overall Study|Physician Decision|0|||
49024668|NCT03049488|157930128|FG005|Overall Study|Physician Decision|0|||
49024669|NCT03049488|157930123|FG000|Overall Study|Withdrawal by Subject|0|||
49024670|NCT03049488|157930124|FG001|Overall Study|Withdrawal by Subject|0|||
49024671|NCT03049488|157930125|FG002|Overall Study|Withdrawal by Subject|0|||
49024672|NCT03049488|157930126|FG003|Overall Study|Withdrawal by Subject|1|||
49024673|NCT03049488|157930127|FG004|Overall Study|Withdrawal by Subject|1|||
49024674|NCT03049488|157930128|FG005|Overall Study|Withdrawal by Subject|0|||
49024675|NCT02362503|157930129|FG000|Double-blind Period-Up to 8 Days|Adverse Event|0|||
49024676|NCT02362503|157930130|FG001|Double-blind Period-Up to 8 Days|Adverse Event|2|||
49024677|NCT02362503|157930131|FG002|Double-blind Period-Up to 8 Days|Adverse Event|0|||
48691466|NCT01853748|156722429|FG000|Follow-Up|not available for data collection|16|||
48691467|NCT01853748|156722430|FG001|Follow-Up|not available for data collection|4|||
48691468|NCT00985673|156722431|FG000|Overall Study|Lost to Follow-up|6|||
48691469|NCT00985673|156722432|FG001|Overall Study|Lost to Follow-up|7|||
48691470|NCT00985673|156722433|FG002|Overall Study|Lost to Follow-up|6|||
48691471|NCT00985673|156722434|FG003|Overall Study|Lost to Follow-up|10|||
48691472|NCT00985673|156722435|FG004|Overall Study|Lost to Follow-up|5|||
48691473|NCT00985673|156722436|FG005|Overall Study|Lost to Follow-up|3|||
48691474|NCT00985673|156722431|FG000|Overall Study|Withdrawal by Subject|0|||
48691475|NCT00985673|156722432|FG001|Overall Study|Withdrawal by Subject|4|||
48691476|NCT00985673|156722433|FG002|Overall Study|Withdrawal by Subject|5|||
48981698|NCT02010567|157765505|FG001|Overall Study|Adverse Event|0|||
48981699|NCT02010567|157765506|FG002|Overall Study|Adverse Event|1|||
48981700|NCT02010567|157765507|FG003|Overall Study|Adverse Event|0|||
48981701|NCT02010567|157765508|FG004|Overall Study|Adverse Event|1|||
48981702|NCT03330106|157765509|FG000|Part A|Withdrawal by Subject|1|||
48981703|NCT03330106|157765510|FG001|Part A|Withdrawal by Subject|1|||
49024678|NCT02362503|157930129|FG000|Double-blind Period-Up to 8 Days|Death|1|||
48763820|NCT03240133|156985766|FG002|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
48763821|NCT03240133|156985764|FG000|Overall Study|Intercurrent illness.|0|||
48763822|NCT03240133|156985765|FG001|Overall Study|Intercurrent illness.|1|||
49024679|NCT02362503|157930130|FG001|Double-blind Period-Up to 8 Days|Death|0|||
49024680|NCT02362503|157930131|FG002|Double-blind Period-Up to 8 Days|Death|0|||
49024681|NCT02362503|157930129|FG000|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
49024682|NCT02362503|157930130|FG001|Double-blind Period-Up to 8 Days|Lost to Follow-up|1|||
49024683|NCT02362503|157930131|FG002|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
49024684|NCT02362503|157930129|FG000|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
49024685|NCT02362503|157930130|FG001|Double-blind Period-Up to 8 Days|No longer meets study criteria|1|||
49024686|NCT02362503|157930131|FG002|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
49024687|NCT02362503|157930129|FG000|Open Label Period-Up to 96 Weeks|Other|0|||
48691477|NCT00985673|156722434|FG003|Overall Study|Withdrawal by Subject|2|||
48691478|NCT00985673|156722435|FG004|Overall Study|Withdrawal by Subject|2|||
48763823|NCT03240133|156985766|FG002|Overall Study|Intercurrent illness.|0|||
48763824|NCT03240133|156985764|FG000|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
48763825|NCT03240133|156985765|FG001|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
48763826|NCT03240133|156985766|FG002|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1|||
48763827|NCT01023581|156985767|FG000|Overall Study|Adverse Event|4|||
48763828|NCT01023581|156985768|FG001|Overall Study|Adverse Event|4|||
48763829|NCT01023581|156985769|FG002|Overall Study|Adverse Event|7|||
48763830|NCT01023581|156985770|FG003|Overall Study|Adverse Event|3|||
48763831|NCT01023581|156985771|FG004|Overall Study|Adverse Event|2|||
48763832|NCT01023581|156985772|FG005|Overall Study|Adverse Event|5|||
48763833|NCT01023581|156985773|FG006|Overall Study|Adverse Event|11|||
48763834|NCT01023581|156985767|FG000|Overall Study|Major protocol deviation|2|||
48763835|NCT01023581|156985768|FG001|Overall Study|Major protocol deviation|0|||
48763836|NCT01023581|156985769|FG002|Overall Study|Major protocol deviation|3|||
48691479|NCT00985673|156722436|FG005|Overall Study|Withdrawal by Subject|3|||
48763837|NCT01023581|156985770|FG003|Overall Study|Major protocol deviation|0|||
48763838|NCT01023581|156985771|FG004|Overall Study|Major protocol deviation|0|||
48763839|NCT01023581|156985772|FG005|Overall Study|Major protocol deviation|0|||
48763840|NCT01023581|156985773|FG006|Overall Study|Major protocol deviation|0|||
48763841|NCT01023581|156985767|FG000|Overall Study|Lost to Follow-up|4|||
48763842|NCT01023581|156985768|FG001|Overall Study|Lost to Follow-up|8|||
48691480|NCT00985673|156722431|FG000|Overall Study|Other|1|||
48691481|NCT00985673|156722432|FG001|Overall Study|Other|0|||
48691482|NCT00985673|156722433|FG002|Overall Study|Other|1|||
48691483|NCT00985673|156722434|FG003|Overall Study|Other|0|||
48691484|NCT00985673|156722435|FG004|Overall Study|Other|1|||
48691485|NCT00985673|156722436|FG005|Overall Study|Other|0|||
48691486|NCT00531284|156722437|FG000|Overall Study|Progressive Disease|1|||
48691487|NCT00531284|156722438|FG001|Overall Study|Progressive Disease|3|||
48691488|NCT00531284|156722439|FG002|Overall Study|Progressive Disease|5|||
48691489|NCT00531284|156722440|FG003|Overall Study|Progressive Disease|42|||
48691490|NCT00531284|156722441|FG004|Overall Study|Progressive Disease|4|||
48691491|NCT00531284|156722442|FG005|Overall Study|Progressive Disease|4|||
48691492|NCT00531284|156722443|FG006|Overall Study|Progressive Disease|3|||
48691493|NCT00531284|156722444|FG007|Overall Study|Progressive Disease|8|||
48691494|NCT00531284|156722445|FG008|Overall Study|Progressive Disease|6|||
48691495|NCT00531284|156722446|FG009|Overall Study|Progressive Disease|3|||
48691496|NCT00531284|156722447|FG010|Overall Study|Progressive Disease|3|||
48691497|NCT00531284|156722448|FG011|Overall Study|Progressive Disease|14|||
48691498|NCT00531284|156722449|FG012|Overall Study|Progressive Disease|2|||
48691499|NCT00531284|156722450|FG013|Overall Study|Progressive Disease|1|||
48691500|NCT00531284|156722451|FG014|Overall Study|Progressive Disease|2|||
48691501|NCT00531284|156722452|FG015|Overall Study|Progressive Disease|11|||
48691502|NCT00531284|156722453|FG016|Overall Study|Progressive Disease|5|||
48691503|NCT00531284|156722437|FG000|Overall Study|Adverse Event|0|||
48691504|NCT00531284|156722438|FG001|Overall Study|Adverse Event|1|||
48691505|NCT00531284|156722439|FG002|Overall Study|Adverse Event|1|||
48691506|NCT00531284|156722440|FG003|Overall Study|Adverse Event|7|||
48691507|NCT00531284|156722441|FG004|Overall Study|Adverse Event|0|||
48763843|NCT01023581|156985769|FG002|Overall Study|Lost to Follow-up|7|||
48763844|NCT01023581|156985770|FG003|Overall Study|Lost to Follow-up|2|||
48875479|NCT00550446|157381648|FG007|Post Week 12|Lack of Efficacy|1|||
48875480|NCT00550446|157381649|FG008|Post Week 12|Lack of Efficacy|1|||
48875481|NCT00550446|157381650|FG009|Post Week 12|Lack of Efficacy|2|||
48691508|NCT00531284|156722442|FG005|Overall Study|Adverse Event|2|||
48691509|NCT00531284|156722443|FG006|Overall Study|Adverse Event|3|||
48691510|NCT00531284|156722444|FG007|Overall Study|Adverse Event|2|||
48691511|NCT00531284|156722445|FG008|Overall Study|Adverse Event|3|||
48691512|NCT00531284|156722446|FG009|Overall Study|Adverse Event|0|||
48691513|NCT00531284|156722447|FG010|Overall Study|Adverse Event|0|||
48691514|NCT00531284|156722448|FG011|Overall Study|Adverse Event|5|||
48763845|NCT01023581|156985771|FG004|Overall Study|Lost to Follow-up|5|||
48875482|NCT00550446|157381651|FG010|Post Week 12|Lack of Efficacy|1|||
48691515|NCT00531284|156722449|FG012|Overall Study|Adverse Event|0|||
48691516|NCT00531284|156722450|FG013|Overall Study|Adverse Event|1|||
48691517|NCT00531284|156722451|FG014|Overall Study|Adverse Event|1|||
48691518|NCT00531284|156722452|FG015|Overall Study|Adverse Event|0|||
48691519|NCT00531284|156722453|FG016|Overall Study|Adverse Event|2|||
48691520|NCT00531284|156722437|FG000|Overall Study|Withdrawal by Subject|1|||
48691521|NCT00531284|156722438|FG001|Overall Study|Withdrawal by Subject|0|||
48691522|NCT00531284|156722439|FG002|Overall Study|Withdrawal by Subject|0|||
48691523|NCT00531284|156722440|FG003|Overall Study|Withdrawal by Subject|4|||
48691524|NCT00531284|156722441|FG004|Overall Study|Withdrawal by Subject|0|||
48691525|NCT00531284|156722442|FG005|Overall Study|Withdrawal by Subject|0|||
48691526|NCT00531284|156722443|FG006|Overall Study|Withdrawal by Subject|0|||
48691527|NCT00531284|156722444|FG007|Overall Study|Withdrawal by Subject|0|||
48691528|NCT00531284|156722445|FG008|Overall Study|Withdrawal by Subject|0|||
48691529|NCT00531284|156722446|FG009|Overall Study|Withdrawal by Subject|0|||
48691530|NCT00531284|156722447|FG010|Overall Study|Withdrawal by Subject|0|||
48691531|NCT00531284|156722448|FG011|Overall Study|Withdrawal by Subject|3|||
48691532|NCT00531284|156722449|FG012|Overall Study|Withdrawal by Subject|0|||
48691533|NCT00531284|156722450|FG013|Overall Study|Withdrawal by Subject|1|||
48691534|NCT00531284|156722451|FG014|Overall Study|Withdrawal by Subject|0|||
48691535|NCT00531284|156722452|FG015|Overall Study|Withdrawal by Subject|1|||
48691536|NCT00531284|156722453|FG016|Overall Study|Withdrawal by Subject|1|||
48691537|NCT00531284|156722437|FG000|Overall Study|Other|1|||
48691538|NCT00531284|156722438|FG001|Overall Study|Other|0|||
48691539|NCT00531284|156722439|FG002|Overall Study|Other|0|||
48691540|NCT00531284|156722440|FG003|Overall Study|Other|10|||
48691541|NCT00531284|156722441|FG004|Overall Study|Other|2|||
48691542|NCT00531284|156722442|FG005|Overall Study|Other|1|||
48691543|NCT00531284|156722443|FG006|Overall Study|Other|0|||
48691544|NCT00531284|156722444|FG007|Overall Study|Other|0|||
48691545|NCT00531284|156722445|FG008|Overall Study|Other|2|||
48691546|NCT00531284|156722446|FG009|Overall Study|Other|1|||
48691547|NCT00531284|156722447|FG010|Overall Study|Other|0|||
48691548|NCT00531284|156722448|FG011|Overall Study|Other|2|||
48691549|NCT00531284|156722449|FG012|Overall Study|Other|0|||
48691550|NCT00531284|156722450|FG013|Overall Study|Other|0|||
48691551|NCT00531284|156722451|FG014|Overall Study|Other|1|||
48691552|NCT00531284|156722452|FG015|Overall Study|Other|0|||
48691553|NCT00531284|156722453|FG016|Overall Study|Other|0|||
48691554|NCT02219464|156722454|FG000|Overall Study|Withdrawal by Subject|1|||
48691555|NCT02219464|156722455|FG001|Overall Study|Withdrawal by Subject|0|||
48691556|NCT02219464|156722454|FG000|Overall Study|case cancelled|1|||
48691557|NCT02219464|156722455|FG001|Overall Study|case cancelled|0|||
48691558|NCT02219464|156722454|FG000|Overall Study|catheter malfunction|1|||
48691559|NCT02219464|156722455|FG001|Overall Study|catheter malfunction|0|||
48691560|NCT01519323|156722456|FG000|Overall Study|Death|3|||
48691561|NCT01519323|156722457|FG001|Overall Study|Death|2|||
48691562|NCT01519323|156722456|FG000|Overall Study|Study terminated by sponsor|0|||
48691563|NCT01519323|156722457|FG001|Overall Study|Study terminated by sponsor|1|||
48691564|NCT01419769|156722458|FG000|Overall Study|Did not receive the AXIOS stent|3|||
48691565|NCT01419769|156722458|FG000|Overall Study|Not evaluable due to pigtail stents|1|||
48691566|NCT02544321|156722461|FG000|Overall Study|Withdrawal by Subject|1|||
48691567|NCT02544321|156722462|FG001|Overall Study|Withdrawal by Subject|2|||
48691568|NCT02544321|156722461|FG000|Overall Study|Adverse Event|1|||
48691569|NCT02544321|156722462|FG001|Overall Study|Adverse Event|1|||
48691570|NCT02544321|156722461|FG000|Overall Study|Protocol Violation|0|||
48691571|NCT02544321|156722462|FG001|Overall Study|Protocol Violation|1|||
48691572|NCT05568615|156722463|FG000|Overall Study|Death|1|||
48691573|NCT05568615|156722463|FG000|Overall Study|Physician Decision|1|||
48691574|NCT04617782|156722468|FG000|Treatment A - 5 mg TDS|Physician Decision|2|||
48691575|NCT04617782|156722468|FG000|Treatment A - 5 mg TDS|failure to follow site rules|1|||
48691576|NCT04617782|156722468|FG000|Treatment B - 10 mg TDS|Protocol Violation|1|||
48691577|NCT04617782|156722468|FG000|Treatment B - 10 mg TDS|Withdrawal by Subject|1|||
48691578|NCT04617782|156722468|FG000|Treatment C - 10 mg Oral|Protocol Violation|2|||
48691579|NCT04617782|156722468|FG000|Treatment C - 10 mg Oral|failure to follow site rules|1|||
48691580|NCT01453049|156722474|FG000|Overall Study|Protocol Violation|2|||
48691581|NCT01453049|156722475|FG001|Overall Study|Protocol Violation|5|||
48691582|NCT01453049|156722474|FG000|Overall Study|Lost to Follow-up|2|||
48691583|NCT01453049|156722475|FG001|Overall Study|Lost to Follow-up|1|||
48691584|NCT01453049|156722474|FG000|Overall Study|Withdrawn When Sponsor Terminated Study|35|||
48691585|NCT01453049|156722475|FG001|Overall Study|Withdrawn When Sponsor Terminated Study|36|||
48691586|NCT01453049|156722474|FG000|Overall Study|Withdrawal by Subject|1|||
48691587|NCT01453049|156722475|FG001|Overall Study|Withdrawal by Subject|0|||
48691588|NCT01453049|156722474|FG000|Overall Study|Randomized in Error|1|||
48763846|NCT01023581|156985772|FG005|Overall Study|Lost to Follow-up|2|||
48691589|NCT01453049|156722475|FG001|Overall Study|Randomized in Error|0|||
48691590|NCT01342913|156722476|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66|||
48691591|NCT01342913|156722477|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
48763847|NCT01023581|156985773|FG006|Overall Study|Lost to Follow-up|2|||
48691592|NCT01342913|156722478|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
48691593|NCT01342913|156722476|FG000|2-week Run-in Period|Physician Decision|6|||
48691594|NCT01342913|156722477|FG001|2-week Run-in Period|Physician Decision|0|||
48691595|NCT01342913|156722478|FG002|2-week Run-in Period|Physician Decision|0|||
48691596|NCT01342913|156722476|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
48691597|NCT01342913|156722477|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
48691598|NCT01342913|156722478|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
48691599|NCT01342913|156722476|FG000|2-week Run-in Period|Adverse Event|2|||
48691600|NCT01342913|156722477|FG001|2-week Run-in Period|Adverse Event|0|||
48691601|NCT01342913|156722478|FG002|2-week Run-in Period|Adverse Event|0|||
48691602|NCT01342913|156722476|FG000|2-week Run-in Period|Protocol Violation|5|||
48691603|NCT01342913|156722477|FG001|2-week Run-in Period|Protocol Violation|0|||
48691604|NCT01342913|156722478|FG002|2-week Run-in Period|Protocol Violation|0|||
48691605|NCT01342913|156722476|FG000|2-week Run-in Period|Continuation Criteria Not Met|88|||
48691606|NCT01342913|156722477|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
48691607|NCT01342913|156722478|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
48691608|NCT01342913|156722476|FG000|Double-Blind Treatment Period|Adverse Event|0|||
48691609|NCT01342913|156722477|FG001|Double-Blind Treatment Period|Adverse Event|3|||
48691610|NCT01342913|156722478|FG002|Double-Blind Treatment Period|Adverse Event|6|||
48691611|NCT01342913|156722476|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
48691612|NCT01342913|156722477|FG001|Double-Blind Treatment Period|Lack of Efficacy|2|||
48691613|NCT01342913|156722478|FG002|Double-Blind Treatment Period|Lack of Efficacy|3|||
48691614|NCT01342913|156722476|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
48691615|NCT01342913|156722477|FG001|Double-Blind Treatment Period|Protocol Violation|6|||
48691616|NCT01342913|156722478|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
48691617|NCT01342913|156722476|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
48691618|NCT01342913|156722477|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
48691619|NCT01342913|156722478|FG002|Double-Blind Treatment Period|Lost to Follow-up|3|||
48691620|NCT01342913|156722476|FG000|Double-Blind Treatment Period|Physician Decision|0|||
48691621|NCT01342913|156722477|FG001|Double-Blind Treatment Period|Physician Decision|2|||
48691622|NCT01342913|156722478|FG002|Double-Blind Treatment Period|Physician Decision|0|||
48691623|NCT01342913|156722476|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
48691624|NCT01342913|156722477|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
48691625|NCT01342913|156722478|FG002|Double-Blind Treatment Period|Withdrawal by Subject|2|||
48691626|NCT00683878|156722479|FG000|Overall Study|Lack of Efficacy|3|||
48691627|NCT00683878|156722480|FG001|Overall Study|Lack of Efficacy|0|||
48691628|NCT00683878|156722481|FG002|Overall Study|Lack of Efficacy|1|||
48691629|NCT00683878|156722479|FG000|Overall Study|Adverse Event|4|||
48691630|NCT00683878|156722480|FG001|Overall Study|Adverse Event|3|||
48691631|NCT00683878|156722481|FG002|Overall Study|Adverse Event|3|||
48691632|NCT00683878|156722479|FG000|Overall Study|Withdrawal by Subject|9|||
48691633|NCT00683878|156722480|FG001|Overall Study|Withdrawal by Subject|8|||
48763848|NCT01023581|156985767|FG000|Overall Study|Withdrawal by Subject|13|||
48763849|NCT01023581|156985768|FG001|Overall Study|Withdrawal by Subject|8|||
48763850|NCT01023581|156985769|FG002|Overall Study|Withdrawal by Subject|16|||
48763851|NCT01023581|156985770|FG003|Overall Study|Withdrawal by Subject|10|||
48763852|NCT01023581|156985771|FG004|Overall Study|Withdrawal by Subject|6|||
48763853|NCT01023581|156985772|FG005|Overall Study|Withdrawal by Subject|8|||
49024688|NCT02362503|157930130|FG001|Open Label Period-Up to 96 Weeks|Other|1|||
49024689|NCT02362503|157930131|FG002|Open Label Period-Up to 96 Weeks|Other|1|||
49024690|NCT02362503|157930129|FG000|Open Label Period-Up to 96 Weeks|No longer meets criteria|0|||
49024691|NCT02362503|157930130|FG001|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
49024692|NCT02362503|157930131|FG002|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
49024693|NCT02362503|157930129|FG000|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
49024694|NCT02362503|157930130|FG001|Open Label Period-Up to 96 Weeks|Pregnancy|1|||
49024695|NCT02362503|157930131|FG002|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
49024696|NCT02362503|157930129|FG000|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3|||
49024697|NCT02362503|157930130|FG001|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8|||
49024698|NCT02362503|157930131|FG002|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6|||
49024699|NCT02362503|157930129|FG000|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4|||
49024700|NCT02362503|157930130|FG001|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3|||
49024701|NCT02362503|157930131|FG002|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1|||
49024702|NCT02362503|157930129|FG000|Open Label Period-Up to 96 Weeks|Death|1|||
48691634|NCT00683878|156722481|FG002|Overall Study|Withdrawal by Subject|6|||
48763854|NCT01023581|156985773|FG006|Overall Study|Withdrawal by Subject|5|||
49024703|NCT02362503|157930130|FG001|Open Label Period-Up to 96 Weeks|Death|7|||
48691635|NCT00683878|156722479|FG000|Overall Study|Death|0|||
48691636|NCT00683878|156722480|FG001|Overall Study|Death|1|||
48691637|NCT00683878|156722481|FG002|Overall Study|Death|0|||
48691638|NCT00683878|156722479|FG000|Overall Study|Lost to Follow-up|4|||
48763855|NCT01023581|156985767|FG000|Overall Study|Pregnancy|0|||
48763856|NCT01023581|156985768|FG001|Overall Study|Pregnancy|0|||
48763857|NCT01023581|156985769|FG002|Overall Study|Pregnancy|0|||
48763858|NCT01023581|156985770|FG003|Overall Study|Pregnancy|2|||
48763859|NCT01023581|156985771|FG004|Overall Study|Pregnancy|0|||
48763860|NCT01023581|156985772|FG005|Overall Study|Pregnancy|1|||
48763861|NCT01023581|156985773|FG006|Overall Study|Pregnancy|0|||
48763862|NCT01023581|156985767|FG000|Overall Study|Lack of Efficacy|9|||
48763863|NCT01023581|156985768|FG001|Overall Study|Lack of Efficacy|3|||
48763864|NCT01023581|156985769|FG002|Overall Study|Lack of Efficacy|6|||
48763865|NCT01023581|156985770|FG003|Overall Study|Lack of Efficacy|2|||
48763866|NCT01023581|156985771|FG004|Overall Study|Lack of Efficacy|1|||
48763867|NCT01023581|156985772|FG005|Overall Study|Lack of Efficacy|2|||
48763868|NCT01023581|156985773|FG006|Overall Study|Lack of Efficacy|1|||
48763869|NCT01023581|156985767|FG000|Overall Study|Physician Decision|2|||
48763870|NCT01023581|156985768|FG001|Overall Study|Physician Decision|0|||
48763871|NCT01023581|156985769|FG002|Overall Study|Physician Decision|2|||
48763872|NCT01023581|156985770|FG003|Overall Study|Physician Decision|1|||
48763873|NCT01023581|156985771|FG004|Overall Study|Physician Decision|1|||
48763874|NCT01023581|156985772|FG005|Overall Study|Physician Decision|1|||
48763875|NCT01023581|156985773|FG006|Overall Study|Physician Decision|1|||
48763876|NCT01023581|156985767|FG000|Overall Study|Other|1|||
48763877|NCT01023581|156985768|FG001|Overall Study|Other|0|||
48763878|NCT01023581|156985769|FG002|Overall Study|Other|1|||
48763879|NCT01023581|156985770|FG003|Overall Study|Other|0|||
48763880|NCT01023581|156985771|FG004|Overall Study|Other|1|||
48763881|NCT01023581|156985772|FG005|Overall Study|Other|0|||
48763882|NCT01023581|156985773|FG006|Overall Study|Other|0|||
48763883|NCT00922766|156985774|FG000|Overall Study|Death|3|||
48763884|NCT00922766|156985774|FG000|Overall Study|Withdrawal by Subject|2|||
48763885|NCT00922766|156985774|FG000|Overall Study|Other|1|||
48763886|NCT00922766|156985774|FG000|Overall Study|Adverse Event|1|||
48763887|NCT02603432|156985775|FG000|Overall Study|Adverse Event|1|||
48763888|NCT02603432|156985776|FG001|Overall Study|Adverse Event|0|||
48763889|NCT02603432|156985775|FG000|Overall Study|Death|221|||
48763890|NCT02603432|156985776|FG001|Overall Study|Death|242|||
48763891|NCT02603432|156985775|FG000|Overall Study|Lost to Follow-up|3|||
48763892|NCT02603432|156985776|FG001|Overall Study|Lost to Follow-up|9|||
48763893|NCT02603432|156985775|FG000|Overall Study|Progressive Disease|7|||
48763894|NCT02603432|156985776|FG001|Overall Study|Progressive Disease|5|||
48763895|NCT02603432|156985775|FG000|Overall Study|Withdrawal by Subject|12|||
48763896|NCT02603432|156985776|FG001|Overall Study|Withdrawal by Subject|18|||
48763897|NCT02603432|156985775|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
48763898|NCT02603432|156985776|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
48763899|NCT02603432|156985775|FG000|Overall Study|Study terminated by sponsor|74|||
48763900|NCT02603432|156985776|FG001|Overall Study|Study terminated by sponsor|75|||
49024704|NCT02362503|157930131|FG002|Open Label Period-Up to 96 Weeks|Death|15|||
49024705|NCT02362503|157930129|FG000|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0|||
49024706|NCT02362503|157930130|FG001|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5|||
49024707|NCT02362503|157930131|FG002|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1|||
49024708|NCT02362503|157930129|FG000|Open Label Period-Up to 96 Weeks|Adverse Event|3|||
49024709|NCT02362503|157930130|FG001|Open Label Period-Up to 96 Weeks|Adverse Event|2|||
49024710|NCT02362503|157930131|FG002|Open Label Period-Up to 96 Weeks|Adverse Event|4|||
49024711|NCT02362503|157930129|FG000|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3|||
49024712|NCT02362503|157930130|FG001|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9|||
49024713|NCT02362503|157930131|FG002|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6|||
49024714|NCT02362503|157930129|FG000|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54|||
49024715|NCT02362503|157930130|FG001|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159|||
49024716|NCT02362503|157930131|FG002|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61|||
49024717|NCT04692077|157930132|FG000|Cabotegravir Long Acting Injection Phase|Withdrawal by Subject|1|||
49024718|NCT04044768|157930133|FG000|Overall Study|Ongoing in Interventional phase at data cut-off|8|||
49024719|NCT04044768|157930134|FG001|Overall Study|Ongoing in Interventional phase at data cut-off|0|||
49024720|NCT05447663|157930138|FG000|Overall Study|Study terminated by Sponsor|5|||
49024721|NCT05447663|157930138|FG000|Overall Study|Death|2|||
49024722|NCT05447663|157930138|FG000|Overall Study|Withdrawal by Subject|1|||
49024723|NCT04338061|157930139|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|59|||
48875483|NCT00550446|157381641|FG000|Post Week 12|Lost to Follow-up|0|||
48875484|NCT00550446|157381642|FG001|Post Week 12|Lost to Follow-up|0|||
49024724|NCT04338061|157930140|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|52|||
48763901|NCT02603432|156985775|FG000|Overall Study|Other|13|||
48763902|NCT02603432|156985776|FG001|Overall Study|Other|0|||
48763903|NCT00297037|156985780|FG000|Overall Study|Withdrawal by Subject|2|||
48763904|NCT00297037|156985781|FG001|Overall Study|Withdrawal by Subject|0|||
48763905|NCT03340025|156985782|FG000|Overall Study|Lost to Follow-up|2|||
48763906|NCT03340025|156985783|FG001|Overall Study|Lost to Follow-up|2|||
48763907|NCT01413360|156985786|FG000|Overall Study|Lost to Follow-up|2|||
48763908|NCT01413360|156985786|FG000|Overall Study|Adverse Event|1|||
48875485|NCT00550446|157381643|FG002|Post Week 12|Lost to Follow-up|1|||
49024725|NCT04338061|157930139|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|11|||
49024726|NCT04338061|157930140|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|16|||
49024727|NCT04338061|157930139|FG000|Double-blind Treatment Period: 156 Weeks|Other Reasons|17|||
49024728|NCT04338061|157930140|FG001|Double-blind Treatment Period: 156 Weeks|Other Reasons|22|||
49024729|NCT04338061|157930139|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|67|||
49024730|NCT04338061|157930140|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|70|||
49024731|NCT04338061|157930139|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|9|||
49024732|NCT04338061|157930140|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|8|||
49024733|NCT04338061|157930139|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|11|||
49024734|NCT04338061|157930140|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|3|||
49024735|NCT04338061|157930139|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|0|||
49024736|NCT04338061|157930140|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|2|||
49024737|NCT04338061|157930139|FG000|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|2|||
49024738|NCT04338061|157930140|FG001|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|1|||
49024739|NCT04338061|157930139|FG000|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|1|||
49024740|NCT04338061|157930140|FG001|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|2|||
49024741|NCT04338061|157930139|FG000|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
49024742|NCT04338061|157930140|FG001|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
49024743|NCT04338061|157930139|FG000|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|1|||
49024744|NCT04338061|157930140|FG001|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|0|||
49024745|NCT04338061|157930139|FG000|Double-blind Extension Period: 96 Weeks|Other Reasons|4|||
49024746|NCT04338061|157930140|FG001|Double-blind Extension Period: 96 Weeks|Other Reasons|8|||
49024747|NCT01698905|157930141|FG000|Overall Study|Adverse Event|4|||
49024748|NCT01698905|157930141|FG000|Overall Study|Physician Decision|2|||
49024749|NCT01698905|157930141|FG000|Overall Study|Pregnancy|1|||
49024750|NCT01698905|157930141|FG000|Overall Study|Protocol Violation|1|||
49024751|NCT01698905|157930141|FG000|Overall Study|Subject/guardian decision|2|||
49024752|NCT01698905|157930141|FG000|Overall Study|Death|1|||
49024753|NCT03048500|157930144|FG000|2 Cycles of Treatment|Withdrawal by Subject|1|||
49024754|NCT03048500|157930144|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|4|||
49024755|NCT03048500|157930144|FG000|Reached 1st Response/Continued Treatment|Death|1|||
49024756|NCT03048500|157930144|FG000|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1|||
49024757|NCT03048500|157930144|FG000|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1|||
49024758|NCT03048500|157930144|FG000|Follow up for 3 Years|Currently in Follow-up|4|||
49024759|NCT03048500|157930144|FG000|Follow up for 3 Years|Death|12|||
49024760|NCT02079766|157930147|FG000|Overall Study|Physician Decision|1|||
49024761|NCT02079766|157930148|FG001|Overall Study|Physician Decision|0|||
49024762|NCT02079766|157930147|FG000|Overall Study|Withdrawal by Subject|1|||
49024763|NCT02079766|157930148|FG001|Overall Study|Withdrawal by Subject|0|||
49024764|NCT01079988|157930149|FG000|Overall Study|Lost to Follow-up|0|||
49024765|NCT01079988|157930150|FG001|Overall Study|Lost to Follow-up|0|||
49024766|NCT01079988|157930151|FG002|Overall Study|Lost to Follow-up|0|||
49024767|NCT01079988|157930152|FG003|Overall Study|Lost to Follow-up|1|||
49024768|NCT01079988|157930153|FG004|Overall Study|Lost to Follow-up|0|||
49024769|NCT01079988|157930149|FG000|Overall Study|Lack of Efficacy|1|||
49024770|NCT01079988|157930150|FG001|Overall Study|Lack of Efficacy|0|||
49024771|NCT01079988|157930151|FG002|Overall Study|Lack of Efficacy|0|||
49024772|NCT01079988|157930152|FG003|Overall Study|Lack of Efficacy|0|||
49024773|NCT01079988|157930153|FG004|Overall Study|Lack of Efficacy|0|||
49024774|NCT01079988|157930149|FG000|Overall Study|Other|0|||
49024775|NCT01079988|157930150|FG001|Overall Study|Other|0|||
49024776|NCT01079988|157930151|FG002|Overall Study|Other|0|||
49024777|NCT01079988|157930152|FG003|Overall Study|Other|2|||
49024778|NCT01079988|157930153|FG004|Overall Study|Other|1|||
49024779|NCT04510285|157930154|FG000|Overall Study|Death|1|||
48691639|NCT00683878|156722480|FG001|Overall Study|Lost to Follow-up|2|||
48691640|NCT00683878|156722481|FG002|Overall Study|Lost to Follow-up|4|||
48691641|NCT00683878|156722479|FG000|Overall Study|Non-compliance, not met criteria etc.|3|||
48691642|NCT00683878|156722480|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
48691643|NCT00683878|156722481|FG002|Overall Study|Non-compliance, not met criteria etc.|0|||
48691644|NCT02869633|156722482|FG000|Overall Study|Death|2|||
49024780|NCT03595657|157930157|FG000|Overall Study|Adverse Event|14|||
49024781|NCT03595657|157930157|FG000|Overall Study|Death|1|||
49024782|NCT03595657|157930157|FG000|Overall Study|Lack of Efficacy|40|||
49024783|NCT03595657|157930157|FG000|Overall Study|Withdrawal by Subject|10|||
49024784|NCT03595657|157930157|FG000|Overall Study|Dosing delayed over 9 weeks|1|||
49024785|NCT03595657|157930157|FG000|Overall Study|Achieved CR and completed 2 years of treatment|1|||
49024786|NCT03929393|157930164|FG000|Overall Study|Death|1|||
49024787|NCT03929393|157930165|FG001|Overall Study|Death|0|||
49024788|NCT03929393|157930164|FG000|Overall Study|Time Commitment|2|||
48691645|NCT02869633|156722483|FG001|Overall Study|Death|1|||
48691646|NCT02869633|156722482|FG000|Overall Study|Patient refused follow-up|1|||
48691647|NCT02869633|156722483|FG001|Overall Study|Patient refused follow-up|0|||
48763909|NCT01928862|156985787|FG000|Overall Study|Lost to Follow-up|1|||
48763910|NCT01928862|156985788|FG001|Overall Study|Lost to Follow-up|0|||
48763911|NCT01928862|156985789|FG002|Overall Study|Lost to Follow-up|0|||
48763912|NCT01928862|156985790|FG003|Overall Study|Lost to Follow-up|0|||
48763913|NCT01928862|156985791|FG004|Overall Study|Lost to Follow-up|1|||
48763914|NCT01549964|156985795|FG000|24-Week Treatment Period|Study Terminated by Sponsor|50|||
48763915|NCT01549964|156985796|FG001|24-Week Treatment Period|Study Terminated by Sponsor|104|||
48763916|NCT01549964|156985797|FG002|24-Week Treatment Period|Study Terminated by Sponsor|104|||
48763917|NCT01549964|156985798|FG003|24-Week Treatment Period|Study Terminated by Sponsor|105|||
48763918|NCT01549964|156985795|FG000|24-Week Treatment Period|Voluntary Withdrawal|6|||
48763919|NCT01549964|156985796|FG001|24-Week Treatment Period|Voluntary Withdrawal|3|||
48763920|NCT01549964|156985797|FG002|24-Week Treatment Period|Voluntary Withdrawal|3|||
48763921|NCT01549964|156985798|FG003|24-Week Treatment Period|Voluntary Withdrawal|8|||
48763922|NCT01549964|156985795|FG000|24-Week Treatment Period|Pretreatment Event/Adverse Event|1|||
48763923|NCT01549964|156985796|FG001|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
48763924|NCT01549964|156985797|FG002|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
48763925|NCT01549964|156985798|FG003|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
48763926|NCT01549964|156985795|FG000|24-Week Treatment Period|Lost to Follow-up|1|||
48763927|NCT01549964|156985796|FG001|24-Week Treatment Period|Lost to Follow-up|0|||
48763928|NCT01549964|156985797|FG002|24-Week Treatment Period|Lost to Follow-up|1|||
48763929|NCT01549964|156985798|FG003|24-Week Treatment Period|Lost to Follow-up|2|||
48763930|NCT01549964|156985795|FG000|24-Week Treatment Period|Lack of Efficacy|1|||
48763931|NCT01549964|156985796|FG001|24-Week Treatment Period|Lack of Efficacy|0|||
48763932|NCT01549964|156985797|FG002|24-Week Treatment Period|Lack of Efficacy|1|||
48763933|NCT01549964|156985798|FG003|24-Week Treatment Period|Lack of Efficacy|1|||
48763934|NCT01549964|156985795|FG000|24-Week Treatment Period|Other|1|||
48763935|NCT01549964|156985796|FG001|24-Week Treatment Period|Other|0|||
48763936|NCT01549964|156985797|FG002|24-Week Treatment Period|Other|1|||
48763937|NCT01549964|156985798|FG003|24-Week Treatment Period|Other|0|||
48763938|NCT01549964|156985795|FG000|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
48763939|NCT01549964|156985796|FG001|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
48763940|NCT01549964|156985797|FG002|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1|||
48763941|NCT01549964|156985798|FG003|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
48763942|NCT01549964|156985795|FG000|24-Week Treatment Period|Randomized but Not Treated|0|||
48763943|NCT01549964|156985796|FG001|24-Week Treatment Period|Randomized but Not Treated|0|||
48763944|NCT01549964|156985797|FG002|24-Week Treatment Period|Randomized but Not Treated|0|||
48763945|NCT01549964|156985798|FG003|24-Week Treatment Period|Randomized but Not Treated|1|||
48763946|NCT01549964|156985795|FG000|24-Week Treatment Period|Completion Status Unknown|1|||
49024789|NCT03929393|157930165|FG001|Overall Study|Time Commitment|5|||
49024790|NCT03929393|157930164|FG000|Overall Study|Motor Vehicle Accident|0|||
49024791|NCT03929393|157930165|FG001|Overall Study|Motor Vehicle Accident|1|||
49024792|NCT03929393|157930164|FG000|Overall Study|Difficulty Using Videoconferencing Technology|0|||
49024793|NCT03929393|157930165|FG001|Overall Study|Difficulty Using Videoconferencing Technology|1|||
49024794|NCT03929393|157930164|FG000|Overall Study|Other|1|||
49024795|NCT03929393|157930165|FG001|Overall Study|Other|3|||
49024796|NCT00980538|157930166|FG000|Overall Study|Lost to Follow-up|20|||
49024797|NCT00980538|157930166|FG000|Overall Study|Sponsor's Decision|4|||
49024798|NCT00980538|157930166|FG000|Overall Study|Participant/Legal Representative Withdrew Consent/Assent|34|||
48691648|NCT02869633|156722482|FG000|Overall Study|Provider discretion|1|||
48691649|NCT02869633|156722483|FG001|Overall Study|Provider discretion|0|||
48691650|NCT02869633|156722482|FG000|Overall Study|Investigator decision|1|||
48691651|NCT02869633|156722483|FG001|Overall Study|Investigator decision|0|||
48691652|NCT02869633|156722482|FG000|Overall Study|Lost to Follow-up|0|||
48691653|NCT02869633|156722483|FG001|Overall Study|Lost to Follow-up|1|||
48691654|NCT02869633|156722482|FG000|Overall Study|Not eligible|6|||
48691655|NCT02869633|156722483|FG001|Overall Study|Not eligible|1|||
48691656|NCT02869633|156722482|FG000|Overall Study|Protocol-defined follow-up period completed|2|||
48691657|NCT02869633|156722483|FG001|Overall Study|Protocol-defined follow-up period completed|1|||
48691658|NCT02869633|156722482|FG000|Overall Study|Withdrawal by Subject|0|||
48691659|NCT02869633|156722483|FG001|Overall Study|Withdrawal by Subject|1|||
48691660|NCT01381016|156722484|FG000|Overall Study|Lost to Follow-up|1|||
48691661|NCT01381016|156722485|FG001|Overall Study|Lost to Follow-up|1|||
48691662|NCT01381016|156722484|FG000|Overall Study|Screen Failure|2|||
48691663|NCT01381016|156722485|FG001|Overall Study|Screen Failure|2|||
48691664|NCT01381016|156722484|FG000|Overall Study|Withdrawal by Subject|0|||
48691665|NCT01381016|156722485|FG001|Overall Study|Withdrawal by Subject|1|||
48691666|NCT01381016|156722484|FG000|Overall Study|Physician Decision|0|||
48691667|NCT01381016|156722485|FG001|Overall Study|Physician Decision|2|||
48763947|NCT01549964|156985796|FG001|24-Week Treatment Period|Completion Status Unknown|0|||
48763948|NCT01549964|156985797|FG002|24-Week Treatment Period|Completion Status Unknown|1|||
48691668|NCT01693029|156722490|FG000|Overall Study|Withdrawal by Subject|15|||
48691669|NCT01693029|156722491|FG001|Overall Study|Withdrawal by Subject|22|||
48691670|NCT01693029|156722490|FG000|Overall Study|Kidney transplantation|7|||
48691671|NCT01693029|156722491|FG001|Overall Study|Kidney transplantation|7|||
49024799|NCT00980538|157930166|FG000|Overall Study|Adverse Event/HIV-Related Event/Cutaneous Event/Rash|12|||
49024800|NCT00980538|157930166|FG000|Overall Study|Switch to Commercially Available Medication|25|||
49024801|NCT00980538|157930166|FG000|Overall Study|Participant Non-Compliant|9|||
49024802|NCT00980538|157930166|FG000|Overall Study|Investigator no Longer Thinks Participant Benefits from the ETR Treatment|9|||
48691672|NCT01693029|156722490|FG000|Overall Study|Bindinging anti-EPO antibodies|6|||
48691673|NCT01693029|156722491|FG001|Overall Study|Bindinging anti-EPO antibodies|2|||
48691674|NCT01693029|156722490|FG000|Overall Study|Protocol Violation|6|||
48691675|NCT01693029|156722491|FG001|Overall Study|Protocol Violation|7|||
48691676|NCT01693029|156722490|FG000|Overall Study|Change in dialysis modality|2|||
48691677|NCT01693029|156722491|FG001|Overall Study|Change in dialysis modality|1|||
48691678|NCT01693029|156722490|FG000|Overall Study|Physician Decision|0|||
48691679|NCT01693029|156722491|FG001|Overall Study|Physician Decision|2|||
48691680|NCT01693029|156722490|FG000|Overall Study|Lost to Follow-up|0|||
48691681|NCT01693029|156722491|FG001|Overall Study|Lost to Follow-up|1|||
48691682|NCT01693029|156722490|FG000|Overall Study|Adverse Event|1|||
48691683|NCT01693029|156722491|FG001|Overall Study|Adverse Event|6|||
48691684|NCT01693029|156722490|FG000|Overall Study|Death|5|||
48691685|NCT01693029|156722491|FG001|Overall Study|Death|8|||
48691686|NCT01693029|156722490|FG000|Overall Study|Non-compliance|2|||
48691687|NCT01693029|156722491|FG001|Overall Study|Non-compliance|1|||
48691688|NCT03190330|156722493|FG000|Overall Study|Adverse Event|2|||
48691689|NCT03190330|156722493|FG000|Overall Study|Death|10|||
48691690|NCT03190330|156722493|FG000|Overall Study|Lost to Follow-up|1|||
48691691|NCT03190330|156722493|FG000|Overall Study|Withdrawal by Subject|6|||
48691692|NCT03190330|156722493|FG000|Overall Study|Progressive Disease|1|||
48691693|NCT00922623|156722494|FG000|Overall Study|Other|4|||
48691694|NCT00922623|156722494|FG000|Overall Study|Lost to Follow-up|1|||
48691695|NCT00404651|156722495|FG000|Overall Study|Serious Adverse Event|0|||
48691696|NCT00404651|156722496|FG001|Overall Study|Serious Adverse Event|0|||
48691697|NCT00404651|156722497|FG002|Overall Study|Serious Adverse Event|2|||
48691698|NCT00404651|156722498|FG003|Overall Study|Serious Adverse Event|0|||
48691699|NCT00404651|156722495|FG000|Overall Study|Protocol Violation|10|||
48691700|NCT00404651|156722496|FG001|Overall Study|Protocol Violation|5|||
48691701|NCT00404651|156722497|FG002|Overall Study|Protocol Violation|14|||
48691702|NCT00404651|156722498|FG003|Overall Study|Protocol Violation|5|||
48691703|NCT00404651|156722495|FG000|Overall Study|Lost to Follow-up|15|||
48691704|NCT00404651|156722496|FG001|Overall Study|Lost to Follow-up|11|||
48691705|NCT00404651|156722497|FG002|Overall Study|Lost to Follow-up|13|||
48691706|NCT00404651|156722498|FG003|Overall Study|Lost to Follow-up|10|||
48691707|NCT00404651|156722495|FG000|Overall Study|Withdrawal by Subject|14|||
48691708|NCT00404651|156722496|FG001|Overall Study|Withdrawal by Subject|12|||
49024803|NCT00980538|157930166|FG000|Overall Study|Participant Ineligible to Continue the Trial|6|||
49024804|NCT00980538|157930166|FG000|Overall Study|Other|60|||
49024805|NCT00980538|157930166|FG000|Overall Study|Other|1|||
49024806|NCT00694551|157930172|FG000|Overall Study|Disease Progression|1|||
49024807|NCT00694551|157930173|FG001|Overall Study|Disease Progression|0|||
49024808|NCT00694551|157930174|FG002|Overall Study|Disease Progression|1|||
49024809|NCT01424644|157930179|FG000|Overall Study|Adverse Event|2|||
49024810|NCT01424644|157930180|FG001|Overall Study|Adverse Event|0|||
49024811|NCT01424644|157930179|FG000|Overall Study|Withdrawal by Subject|9|||
49024812|NCT01424644|157930180|FG001|Overall Study|Withdrawal by Subject|12|||
49024813|NCT01424644|157930179|FG000|Overall Study|Lost to Follow-up|16|||
49024814|NCT01424644|157930180|FG001|Overall Study|Lost to Follow-up|12|||
49024815|NCT01424644|157930179|FG000|Overall Study|Protocol Violation|4|||
49024816|NCT01424644|157930180|FG001|Overall Study|Protocol Violation|3|||
49024817|NCT01424644|157930179|FG000|Overall Study|Administrative Reason|1|||
49024818|NCT01424644|157930180|FG001|Overall Study|Administrative Reason|0|||
48691709|NCT00404651|156722497|FG002|Overall Study|Withdrawal by Subject|16|||
48691710|NCT00404651|156722498|FG003|Overall Study|Withdrawal by Subject|6|||
48691711|NCT01428258|156722499|FG000|Intervention 1|Withdrawal by Subject|2|||
48691712|NCT01428258|156722500|FG001|Intervention 1|Withdrawal by Subject|0|||
48691713|NCT00833040|156722501|FG000|Overall Study|Adverse Event|0|||
48691714|NCT00833040|156722502|FG001|Overall Study|Adverse Event|0|||
49024819|NCT01424644|157930179|FG000|Overall Study|Unable to Classify|1|||
49024820|NCT01424644|157930180|FG001|Overall Study|Unable to Classify|0|||
48691715|NCT00833040|156722503|FG002|Overall Study|Adverse Event|0|||
49024821|NCT02272777|157930181|FG000|Overall Study|Adverse Event|0|||
49024822|NCT02272777|157930182|FG001|Overall Study|Adverse Event|1|||
48691716|NCT00833040|156722504|FG003|Overall Study|Adverse Event|0|||
48691717|NCT00833040|156722505|FG004|Overall Study|Adverse Event|0|||
48691718|NCT00833040|156722506|FG005|Overall Study|Adverse Event|1|||
48691719|NCT03347123|156722507|FG000|Overall Study|Death|1|||
48691720|NCT03347123|156722508|FG001|Overall Study|Death|2|||
48691721|NCT03347123|156722509|FG002|Overall Study|Death|0|||
48691722|NCT03347123|156722510|FG003|Overall Study|Death|0|||
48691723|NCT03347123|156722511|FG004|Overall Study|Death|0|||
48875486|NCT00550446|157381644|FG003|Post Week 12|Lost to Follow-up|1|||
48981704|NCT03330106|157765511|FG002|Part A|Withdrawal by Subject|0|||
48691724|NCT03347123|156722512|FG005|Overall Study|Death|0|||
48691725|NCT03347123|156722513|FG006|Overall Study|Death|0|||
48691726|NCT03347123|156722507|FG000|Overall Study|Withdrawal by Subject|1|||
48691727|NCT03347123|156722508|FG001|Overall Study|Withdrawal by Subject|0|||
48691728|NCT03347123|156722509|FG002|Overall Study|Withdrawal by Subject|0|||
48691729|NCT03347123|156722510|FG003|Overall Study|Withdrawal by Subject|0|||
48691730|NCT03347123|156722511|FG004|Overall Study|Withdrawal by Subject|0|||
48691731|NCT03347123|156722512|FG005|Overall Study|Withdrawal by Subject|0|||
48691732|NCT03347123|156722513|FG006|Overall Study|Withdrawal by Subject|0|||
48691733|NCT03347123|156722507|FG000|Overall Study|Reason not Specified|3|||
48691734|NCT03347123|156722508|FG001|Overall Study|Reason not Specified|4|||
48691735|NCT03347123|156722509|FG002|Overall Study|Reason not Specified|0|||
48691736|NCT03347123|156722510|FG003|Overall Study|Reason not Specified|0|||
48691737|NCT03347123|156722511|FG004|Overall Study|Reason not Specified|0|||
48691738|NCT03347123|156722512|FG005|Overall Study|Reason not Specified|0|||
48691739|NCT03347123|156722513|FG006|Overall Study|Reason not Specified|0|||
48691740|NCT00416624|156722521|FG000|Overall Study|Withdrawal by Subject|1|||
48691741|NCT00416624|156722522|FG001|Overall Study|Withdrawal by Subject|6|||
48691742|NCT00416624|156722523|FG002|Overall Study|Withdrawal by Subject|4|||
48691743|NCT00416624|156722524|FG003|Overall Study|Withdrawal by Subject|9|||
48691744|NCT00416624|156722521|FG000|Overall Study|Death|4|||
48691745|NCT00416624|156722522|FG001|Overall Study|Death|7|||
48691746|NCT00416624|156722523|FG002|Overall Study|Death|7|||
48691747|NCT00416624|156722524|FG003|Overall Study|Death|1|||
48691748|NCT00416624|156722521|FG000|Overall Study|Adverse Event|8|||
48691749|NCT00416624|156722522|FG001|Overall Study|Adverse Event|3|||
48691750|NCT00416624|156722523|FG002|Overall Study|Adverse Event|2|||
48691751|NCT00416624|156722524|FG003|Overall Study|Adverse Event|2|||
48691752|NCT00416624|156722521|FG000|Overall Study|Other|8|||
48691753|NCT00416624|156722522|FG001|Overall Study|Other|11|||
48691754|NCT00416624|156722523|FG002|Overall Study|Other|5|||
48691755|NCT00416624|156722524|FG003|Overall Study|Other|5|||
48691756|NCT00416624|156722521|FG000|Overall Study|Cancel|1|||
48691757|NCT00416624|156722522|FG001|Overall Study|Cancel|0|||
48691758|NCT00416624|156722523|FG002|Overall Study|Cancel|0|||
48691759|NCT00416624|156722524|FG003|Overall Study|Cancel|0|||
48691760|NCT02123134|156722528|FG000|Overall Study|Withdrawal of consent|3|||
48691761|NCT02123134|156722529|FG001|Overall Study|Withdrawal of consent|2|||
48691762|NCT02123134|156722528|FG000|Overall Study|Administrative decision|0|||
48691763|NCT02123134|156722529|FG001|Overall Study|Administrative decision|1|||
48691764|NCT00657540|156722536|FG000|Overall Study|Lost to Follow-up|1|||
48691765|NCT00657540|156722537|FG001|Overall Study|Lost to Follow-up|4|||
48691766|NCT03149055|156722542|FG000|Overall Study|Not treated|4|||
48691767|NCT02349633|156722544|FG000|Overall Study|Death|0|||
48691768|NCT02349633|156722545|FG001|Overall Study|Death|1|||
48691769|NCT02349633|156722546|FG002|Overall Study|Death|0|||
48691770|NCT02349633|156722547|FG003|Overall Study|Death|0|||
48691771|NCT02349633|156722548|FG004|Overall Study|Death|0|||
48691772|NCT02349633|156722549|FG005|Overall Study|Death|1|||
48691773|NCT02349633|156722550|FG006|Overall Study|Death|1|||
48691774|NCT02349633|156722551|FG007|Overall Study|Death|1|||
48691775|NCT02349633|156722552|FG008|Overall Study|Death|0|||
48691776|NCT02349633|156722553|FG009|Overall Study|Death|1|||
48691777|NCT02349633|156722554|FG010|Overall Study|Death|0|||
48691778|NCT02349633|156722555|FG011|Overall Study|Death|0|||
48691779|NCT02349633|156722556|FG012|Overall Study|Death|0|||
48691780|NCT02349633|156722557|FG013|Overall Study|Death|0|||
48691781|NCT02349633|156722544|FG000|Overall Study|Withdrawal by Subject|0|||
48691782|NCT02349633|156722545|FG001|Overall Study|Withdrawal by Subject|0|||
48691783|NCT02349633|156722546|FG002|Overall Study|Withdrawal by Subject|0|||
48691784|NCT02349633|156722547|FG003|Overall Study|Withdrawal by Subject|1|||
48691785|NCT02349633|156722548|FG004|Overall Study|Withdrawal by Subject|0|||
48691786|NCT02349633|156722549|FG005|Overall Study|Withdrawal by Subject|0|||
48691787|NCT02349633|156722550|FG006|Overall Study|Withdrawal by Subject|0|||
48875487|NCT00550446|157381645|FG004|Post Week 12|Lost to Follow-up|0|||
48981705|NCT03330106|157765512|FG003|Part A|Withdrawal by Subject|0|||
48691788|NCT02349633|156722551|FG007|Overall Study|Withdrawal by Subject|2|||
48691789|NCT02349633|156722552|FG008|Overall Study|Withdrawal by Subject|2|||
48691790|NCT02349633|156722553|FG009|Overall Study|Withdrawal by Subject|1|||
48691791|NCT02349633|156722554|FG010|Overall Study|Withdrawal by Subject|0|||
48691792|NCT02349633|156722555|FG011|Overall Study|Withdrawal by Subject|0|||
48691793|NCT02349633|156722556|FG012|Overall Study|Withdrawal by Subject|0|||
48691794|NCT02349633|156722557|FG013|Overall Study|Withdrawal by Subject|0|||
48691795|NCT02349633|156722544|FG000|Overall Study|Withdrawal of informed consent|0|||
48691796|NCT02349633|156722545|FG001|Overall Study|Withdrawal of informed consent|0|||
48691797|NCT02349633|156722546|FG002|Overall Study|Withdrawal of informed consent|0|||
48691798|NCT02349633|156722547|FG003|Overall Study|Withdrawal of informed consent|1|||
48691799|NCT02349633|156722548|FG004|Overall Study|Withdrawal of informed consent|1|||
48763949|NCT01549964|156985798|FG003|24-Week Treatment Period|Completion Status Unknown|0|||
48763950|NCT01549964|156985795|FG000|80-Week Extension Period|Pregnancy|0|||
48763951|NCT01549964|156985796|FG001|80-Week Extension Period|Pregnancy|0|||
48763952|NCT01549964|156985797|FG002|80-Week Extension Period|Pregnancy|1|||
48763953|NCT01549964|156985798|FG003|80-Week Extension Period|Pregnancy|0|||
48763954|NCT01549964|156985795|FG000|80-Week Extension Period|Study Terminated by Sponsor|65|||
48763955|NCT01549964|156985796|FG001|80-Week Extension Period|Study Terminated by Sponsor|137|||
48763956|NCT01549964|156985797|FG002|80-Week Extension Period|Study Terminated by Sponsor|132|||
48763957|NCT01549964|156985798|FG003|80-Week Extension Period|Study Terminated by Sponsor|132|||
48763958|NCT01549964|156985795|FG000|80-Week Extension Period|Voluntary Withdrawal|0|||
48763959|NCT01549964|156985796|FG001|80-Week Extension Period|Voluntary Withdrawal|1|||
48763960|NCT01549964|156985797|FG002|80-Week Extension Period|Voluntary Withdrawal|4|||
48763961|NCT01549964|156985798|FG003|80-Week Extension Period|Voluntary Withdrawal|2|||
48763962|NCT01549964|156985795|FG000|80-Week Extension Period|Lost to Follow-up|1|||
48763963|NCT01549964|156985796|FG001|80-Week Extension Period|Lost to Follow-up|0|||
48691800|NCT02349633|156722549|FG005|Overall Study|Withdrawal of informed consent|0|||
48691801|NCT02349633|156722550|FG006|Overall Study|Withdrawal of informed consent|0|||
48691802|NCT02349633|156722551|FG007|Overall Study|Withdrawal of informed consent|3|||
48691803|NCT02349633|156722552|FG008|Overall Study|Withdrawal of informed consent|0|||
48691804|NCT02349633|156722553|FG009|Overall Study|Withdrawal of informed consent|0|||
48691805|NCT02349633|156722554|FG010|Overall Study|Withdrawal of informed consent|0|||
48691806|NCT02349633|156722555|FG011|Overall Study|Withdrawal of informed consent|0|||
48691807|NCT02349633|156722556|FG012|Overall Study|Withdrawal of informed consent|0|||
48691808|NCT02349633|156722557|FG013|Overall Study|Withdrawal of informed consent|0|||
48691809|NCT02349633|156722544|FG000|Overall Study|Transition to compassionate use|0|||
48691810|NCT02349633|156722545|FG001|Overall Study|Transition to compassionate use|0|||
48691811|NCT02349633|156722546|FG002|Overall Study|Transition to compassionate use|0|||
48691812|NCT02349633|156722547|FG003|Overall Study|Transition to compassionate use|0|||
48691813|NCT02349633|156722548|FG004|Overall Study|Transition to compassionate use|1|||
48691814|NCT02349633|156722549|FG005|Overall Study|Transition to compassionate use|0|||
48691815|NCT02349633|156722550|FG006|Overall Study|Transition to compassionate use|0|||
48763964|NCT01549964|156985797|FG002|80-Week Extension Period|Lost to Follow-up|2|||
48691816|NCT02349633|156722551|FG007|Overall Study|Transition to compassionate use|3|||
48691817|NCT02349633|156722552|FG008|Overall Study|Transition to compassionate use|0|||
48691818|NCT02349633|156722553|FG009|Overall Study|Transition to compassionate use|1|||
48691819|NCT02349633|156722554|FG010|Overall Study|Transition to compassionate use|0|||
48691820|NCT02349633|156722555|FG011|Overall Study|Transition to compassionate use|0|||
48691821|NCT02349633|156722556|FG012|Overall Study|Transition to compassionate use|0|||
48691822|NCT02349633|156722557|FG013|Overall Study|Transition to compassionate use|0|||
48691823|NCT02349633|156722544|FG000|Overall Study|Early termination of survival follow-up|0|||
48691824|NCT02349633|156722545|FG001|Overall Study|Early termination of survival follow-up|0|||
48691825|NCT02349633|156722546|FG002|Overall Study|Early termination of survival follow-up|0|||
48691826|NCT02349633|156722547|FG003|Overall Study|Early termination of survival follow-up|0|||
48691827|NCT02349633|156722548|FG004|Overall Study|Early termination of survival follow-up|0|||
48691828|NCT02349633|156722549|FG005|Overall Study|Early termination of survival follow-up|0|||
48691829|NCT02349633|156722550|FG006|Overall Study|Early termination of survival follow-up|0|||
48691830|NCT02349633|156722551|FG007|Overall Study|Early termination of survival follow-up|4|||
48691831|NCT02349633|156722552|FG008|Overall Study|Early termination of survival follow-up|0|||
48691832|NCT02349633|156722553|FG009|Overall Study|Early termination of survival follow-up|0|||
48691833|NCT02349633|156722554|FG010|Overall Study|Early termination of survival follow-up|0|||
48691834|NCT02349633|156722555|FG011|Overall Study|Early termination of survival follow-up|0|||
48691835|NCT02349633|156722556|FG012|Overall Study|Early termination of survival follow-up|0|||
48691836|NCT02349633|156722557|FG013|Overall Study|Early termination of survival follow-up|0|||
48763965|NCT01549964|156985798|FG003|80-Week Extension Period|Lost to Follow-up|1|||
48763966|NCT01549964|156985795|FG000|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
48763967|NCT01549964|156985796|FG001|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
48763968|NCT01549964|156985797|FG002|80-Week Extension Period|Pretreatment Event/Adverse Event|1|||
48763969|NCT01549964|156985798|FG003|80-Week Extension Period|Pretreatment Event/Adverse Event|2|||
48763970|NCT01232296|156985799|FG000|Overall Study|Adverse Event|24|||
48763971|NCT01232296|156985800|FG001|Overall Study|Adverse Event|12|||
48763972|NCT01232296|156985799|FG000|Overall Study|Physician Decision|1|||
48763973|NCT01232296|156985800|FG001|Overall Study|Physician Decision|1|||
48763974|NCT01232296|156985799|FG000|Overall Study|Progressive disease|43|||
48691837|NCT02349633|156722544|FG000|Overall Study|Termination by sponsor|0|||
48691838|NCT02349633|156722545|FG001|Overall Study|Termination by sponsor|0|||
48691839|NCT02349633|156722546|FG002|Overall Study|Termination by sponsor|0|||
48763975|NCT01232296|156985800|FG001|Overall Study|Progressive disease|61|||
48763976|NCT01232296|156985799|FG000|Overall Study|Study terminated by sponsor|0|||
48763977|NCT01232296|156985800|FG001|Overall Study|Study terminated by sponsor|1|||
48981706|NCT03330106|157765509|FG000|Part A|Death|2|||
48691840|NCT02349633|156722547|FG003|Overall Study|Termination by sponsor|0|||
48691841|NCT02349633|156722548|FG004|Overall Study|Termination by sponsor|0|||
48691842|NCT02349633|156722549|FG005|Overall Study|Termination by sponsor|0|||
48691843|NCT02349633|156722550|FG006|Overall Study|Termination by sponsor|0|||
48691844|NCT02349633|156722551|FG007|Overall Study|Termination by sponsor|1|||
48691845|NCT02349633|156722552|FG008|Overall Study|Termination by sponsor|0|||
48691846|NCT02349633|156722553|FG009|Overall Study|Termination by sponsor|2|||
48691847|NCT02349633|156722554|FG010|Overall Study|Termination by sponsor|0|||
48691848|NCT02349633|156722555|FG011|Overall Study|Termination by sponsor|0|||
49024823|NCT02272777|157930181|FG000|Overall Study|Withdrawal by Subject|0|||
49024824|NCT02272777|157930182|FG001|Overall Study|Withdrawal by Subject|3|||
49024825|NCT02272777|157930181|FG000|Overall Study|Lost to Follow-up|2|||
49024826|NCT02272777|157930182|FG001|Overall Study|Lost to Follow-up|0|||
49024827|NCT02272777|157930181|FG000|Overall Study|Other|2|||
49024828|NCT02272777|157930182|FG001|Overall Study|Other|0|||
49024829|NCT02066922|157930185|FG000|Overall Study|Adverse Event|1|||
49024830|NCT03020641|157930187|FG000|Overall Study|Lost to Follow-up|0|||
49024831|NCT03020641|157930188|FG001|Overall Study|Lost to Follow-up|1|||
49024832|NCT03020641|157930187|FG000|Overall Study|Converted to open surgery|2|||
49024833|NCT03020641|157930188|FG001|Overall Study|Converted to open surgery|1|||
49024834|NCT03020641|157930187|FG000|Overall Study|for surgery not performed|0|||
49024835|NCT03020641|157930188|FG001|Overall Study|for surgery not performed|1|||
49024836|NCT03978637|157930189|FG000|Overall Study|Death|0|||
49024837|NCT03978637|157930190|FG001|Overall Study|Death|2|||
48691849|NCT02349633|156722556|FG012|Overall Study|Termination by sponsor|0|||
48691850|NCT02349633|156722557|FG013|Overall Study|Termination by sponsor|0|||
48981707|NCT03330106|157765510|FG001|Part A|Death|1|||
48981708|NCT03330106|157765511|FG002|Part A|Death|0|||
48981709|NCT03330106|157765512|FG003|Part A|Death|0|||
48981710|NCT03330106|157765509|FG000|Part A|Adverse Event|0|||
48981711|NCT03330106|157765510|FG001|Part A|Adverse Event|1|||
48981712|NCT03330106|157765511|FG002|Part A|Adverse Event|0|||
48981713|NCT03330106|157765512|FG003|Part A|Adverse Event|0|||
48981714|NCT03330106|157765509|FG000|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
48981715|NCT03330106|157765510|FG001|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|1|||
48981716|NCT03330106|157765511|FG002|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
48981717|NCT03330106|157765512|FG003|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
48981718|NCT03330106|157765509|FG000|Part A|Worsening Creatinine Clearance and Thrombocytopenia|1|||
48981719|NCT03330106|157765510|FG001|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
48981720|NCT03330106|157765511|FG002|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
48981721|NCT03330106|157765512|FG003|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
48981722|NCT03330106|157765509|FG000|Part A|Progressive Disease|0|||
48981723|NCT03330106|157765510|FG001|Part A|Progressive Disease|1|||
48981724|NCT03330106|157765511|FG002|Part A|Progressive Disease|0|||
48981725|NCT03330106|157765512|FG003|Part A|Progressive Disease|0|||
48981726|NCT03330106|157765509|FG000|Part B|Lost to Follow-up|0|||
48981727|NCT03330106|157765510|FG001|Part B|Lost to Follow-up|0|||
48981728|NCT03330106|157765511|FG002|Part B|Lost to Follow-up|0|||
48981729|NCT03330106|157765512|FG003|Part B|Lost to Follow-up|1|||
48981730|NCT03330106|157765509|FG000|Part B|Withdrawal by Subject|0|||
48981731|NCT03330106|157765510|FG001|Part B|Withdrawal by Subject|0|||
48981732|NCT03330106|157765511|FG002|Part B|Withdrawal by Subject|4|||
48981733|NCT03330106|157765512|FG003|Part B|Withdrawal by Subject|0|||
48981734|NCT03330106|157765509|FG000|Part B|Death|0|||
48981735|NCT03330106|157765510|FG001|Part B|Death|0|||
48981736|NCT03330106|157765511|FG002|Part B|Death|2|||
48981737|NCT03330106|157765512|FG003|Part B|Death|0|||
48981738|NCT03330106|157765509|FG000|Part B|Clinical Progression|0|||
48981739|NCT03330106|157765510|FG001|Part B|Clinical Progression|0|||
48981740|NCT03330106|157765511|FG002|Part B|Clinical Progression|1|||
48981741|NCT03330106|157765512|FG003|Part B|Clinical Progression|1|||
48981742|NCT03330106|157765509|FG000|Part B|Symptomatic Deterioration|0|||
48981743|NCT03330106|157765510|FG001|Part B|Symptomatic Deterioration|0|||
48981744|NCT03330106|157765511|FG002|Part B|Symptomatic Deterioration|0|||
48981745|NCT03330106|157765512|FG003|Part B|Symptomatic Deterioration|1|||
48981746|NCT03330106|157765509|FG000|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
48981747|NCT03330106|157765510|FG001|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
48981748|NCT03330106|157765511|FG002|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
48981749|NCT03330106|157765512|FG003|Part B|Symptomatic Deterioration, Participant Placed on Hospice|1|||
48981750|NCT03330106|157765509|FG000|Part B|Progressive Disease|0|||
48981751|NCT03330106|157765510|FG001|Part B|Progressive Disease|0|||
48981752|NCT03330106|157765511|FG002|Part B|Progressive Disease|11|||
48981753|NCT03330106|157765512|FG003|Part B|Progressive Disease|4|||
48981754|NCT04247828|157765513|FG000|Overall Study|covid-19 mandated patient recruitment restrictions|9|||
48981755|NCT04051944|157765514|FG000|Overall Study|Study ending|1|||
48981756|NCT04051944|157765515|FG001|Overall Study|Study ending|1|||
49024838|NCT03978637|157930191|FG002|Overall Study|Death|2|||
48691851|NCT02349633|156722544|FG000|Overall Study|Other|0|||
48691852|NCT02349633|156722545|FG001|Overall Study|Other|0|||
48691853|NCT02349633|156722546|FG002|Overall Study|Other|0|||
48691854|NCT02349633|156722547|FG003|Overall Study|Other|0|||
48691855|NCT02349633|156722548|FG004|Overall Study|Other|0|||
48691856|NCT02349633|156722549|FG005|Overall Study|Other|0|||
48691857|NCT02349633|156722550|FG006|Overall Study|Other|0|||
48691858|NCT02349633|156722551|FG007|Overall Study|Other|2|||
48691859|NCT02349633|156722552|FG008|Overall Study|Other|0|||
48691860|NCT02349633|156722553|FG009|Overall Study|Other|0|||
48691861|NCT02349633|156722554|FG010|Overall Study|Other|0|||
48691862|NCT02349633|156722555|FG011|Overall Study|Other|0|||
48691863|NCT02349633|156722556|FG012|Overall Study|Other|0|||
48691864|NCT02349633|156722557|FG013|Overall Study|Other|0|||
48691865|NCT02788045|156722560|FG000|Main Study (Up to Week 72)|Adverse Event|0|||
48691866|NCT02788045|156722561|FG001|Main Study (Up to Week 72)|Adverse Event|1|||
48691867|NCT02788045|156722562|FG002|Main Study (Up to Week 72)|Adverse Event|1|||
48691868|NCT02788045|156722560|FG000|Main Study (Up to Week 72)|Lost to Follow-up|5|||
48691869|NCT02788045|156722561|FG001|Main Study (Up to Week 72)|Lost to Follow-up|4|||
48691870|NCT02788045|156722562|FG002|Main Study (Up to Week 72)|Lost to Follow-up|3|||
48691871|NCT02788045|156722560|FG000|Main Study (Up to Week 72)|Pregnancy|1|||
48691872|NCT02788045|156722561|FG001|Main Study (Up to Week 72)|Pregnancy|1|||
48691873|NCT02788045|156722562|FG002|Main Study (Up to Week 72)|Pregnancy|0|||
48691874|NCT02788045|156722560|FG000|Main Study (Up to Week 72)|Protocol Violation|1|||
48691875|NCT02788045|156722561|FG001|Main Study (Up to Week 72)|Protocol Violation|0|||
48691876|NCT02788045|156722562|FG002|Main Study (Up to Week 72)|Protocol Violation|0|||
48691877|NCT02788045|156722560|FG000|Main Study (Up to Week 72)|Withdrawal by Subject|6|||
48691878|NCT02788045|156722561|FG001|Main Study (Up to Week 72)|Withdrawal by Subject|4|||
48691879|NCT02788045|156722562|FG002|Main Study (Up to Week 72)|Withdrawal by Subject|1|||
48691880|NCT02788045|156722560|FG000|Main Study (Up to Week 72)|Other|3|||
48691881|NCT02788045|156722561|FG001|Main Study (Up to Week 72)|Other|0|||
48691882|NCT02788045|156722562|FG002|Main Study (Up to Week 72)|Other|0|||
48691883|NCT02788045|156722560|FG000|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|8|||
48691884|NCT02788045|156722561|FG001|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
48691885|NCT02788045|156722562|FG002|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
48691886|NCT02788045|156722560|FG000|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|8|||
48691887|NCT02788045|156722561|FG001|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
48691888|NCT02788045|156722562|FG002|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
48691889|NCT02788045|156722560|FG000|Long Term Extension (From Wk 72 to 264)|Other|1|||
48691890|NCT02788045|156722561|FG001|Long Term Extension (From Wk 72 to 264)|Other|0|||
48691891|NCT02788045|156722562|FG002|Long Term Extension (From Wk 72 to 264)|Other|0|||
48691892|NCT05789745|156722563|FG000|Overall Study|Withdrawal by Subject|0|||
48691893|NCT05789745|156722564|FG001|Overall Study|Withdrawal by Subject|0|||
48691894|NCT05789745|156722565|FG002|Overall Study|Withdrawal by Subject|0|||
48691895|NCT05789745|156722566|FG003|Overall Study|Withdrawal by Subject|0|||
48691896|NCT05789745|156722567|FG004|Overall Study|Withdrawal by Subject|1|||
48691897|NCT03982199|156722568|FG000|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|152|||
48691898|NCT03982199|156722569|FG001|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|159|||
48691899|NCT03982199|156722570|FG002|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
48691900|NCT03982199|156722571|FG003|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
48691901|NCT03982199|156722572|FG004|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
48691902|NCT03982199|156722573|FG005|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
48691903|NCT03982199|156722574|FG006|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
48691904|NCT03982199|156722575|FG007|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
48691905|NCT03982199|156722576|FG008|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
48691906|NCT03982199|156722577|FG009|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
48691907|NCT03982199|156722578|FG010|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
48691908|NCT03982199|156722579|FG011|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
48691909|NCT03982199|156722580|FG012|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
48691910|NCT03982199|156722581|FG013|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
48691911|NCT03982199|156722568|FG000|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|39|||
48691912|NCT03982199|156722569|FG001|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|33|||
48691913|NCT03982199|156722570|FG002|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
48691914|NCT03982199|156722571|FG003|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
48691915|NCT03982199|156722572|FG004|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
48691916|NCT03982199|156722573|FG005|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
48691917|NCT03982199|156722574|FG006|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
48691918|NCT03982199|156722575|FG007|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
48691919|NCT03982199|156722576|FG008|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
48691920|NCT03982199|156722577|FG009|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
48691921|NCT03982199|156722578|FG010|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
48691922|NCT03982199|156722579|FG011|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
48691923|NCT03982199|156722580|FG012|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
48691924|NCT03982199|156722581|FG013|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
48691925|NCT03982199|156722568|FG000|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|514|||
48691926|NCT03982199|156722569|FG001|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|503|||
48691927|NCT03982199|156722570|FG002|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
48763978|NCT01232296|156985799|FG000|Overall Study|Technical problems|3|||
48763979|NCT01232296|156985800|FG001|Overall Study|Technical problems|0|||
48763980|NCT01232296|156985799|FG000|Overall Study|Subject/guardian decision|10|||
48763981|NCT01232296|156985800|FG001|Overall Study|Subject/guardian decision|2|||
48763982|NCT01232296|156985799|FG000|Overall Study|Death|1|||
48763983|NCT01232296|156985800|FG001|Overall Study|Death|6|||
48763984|NCT02932904|156985803|FG000|Overall Study|Reason not Specified|1|||
48763985|NCT02932904|156985804|FG001|Overall Study|Reason not Specified|0|||
48763986|NCT02932904|156985805|FG002|Overall Study|Reason not Specified|2|||
48763987|NCT02932904|156985806|FG003|Overall Study|Reason not Specified|2|||
48763988|NCT02932904|156985803|FG000|Overall Study|Noncompliance with Study Drug|2|||
48763989|NCT02932904|156985804|FG001|Overall Study|Noncompliance with Study Drug|3|||
48763990|NCT02932904|156985805|FG002|Overall Study|Noncompliance with Study Drug|3|||
48763991|NCT02932904|156985806|FG003|Overall Study|Noncompliance with Study Drug|4|||
48763992|NCT02932904|156985803|FG000|Overall Study|Pregnancy|0|||
48763993|NCT02932904|156985804|FG001|Overall Study|Pregnancy|1|||
48763994|NCT02932904|156985805|FG002|Overall Study|Pregnancy|1|||
48763995|NCT02932904|156985806|FG003|Overall Study|Pregnancy|0|||
48763996|NCT02932904|156985803|FG000|Overall Study|Study Termination|0|||
48763997|NCT02932904|156985804|FG001|Overall Study|Study Termination|1|||
48763998|NCT02932904|156985805|FG002|Overall Study|Study Termination|0|||
48763999|NCT02932904|156985806|FG003|Overall Study|Study Termination|0|||
48764000|NCT02932904|156985803|FG000|Overall Study|Voluntary Withdrawal|2|||
48691928|NCT03982199|156722571|FG003|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
48691929|NCT03982199|156722572|FG004|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
48691930|NCT03982199|156722573|FG005|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
48691931|NCT03982199|156722574|FG006|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
48691932|NCT03982199|156722575|FG007|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
48691933|NCT03982199|156722576|FG008|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
48691934|NCT03982199|156722577|FG009|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
48691935|NCT03982199|156722578|FG010|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
48691936|NCT03982199|156722579|FG011|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
48691937|NCT03982199|156722580|FG012|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
48691938|NCT03982199|156722581|FG013|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
48691939|NCT03982199|156722568|FG000|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|12|||
48691940|NCT03982199|156722569|FG001|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|14|||
48691941|NCT03982199|156722570|FG002|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
48691942|NCT03982199|156722571|FG003|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
48691943|NCT03982199|156722572|FG004|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
48691944|NCT03982199|156722573|FG005|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
48691945|NCT03982199|156722574|FG006|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
48691946|NCT03982199|156722575|FG007|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
48691947|NCT03982199|156722576|FG008|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
48691948|NCT03982199|156722577|FG009|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
48691949|NCT03982199|156722578|FG010|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
48691950|NCT03982199|156722579|FG011|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
48691951|NCT03982199|156722580|FG012|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
48691952|NCT03982199|156722581|FG013|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
48691953|NCT03982199|156722568|FG000|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|10|||
48691954|NCT03982199|156722569|FG001|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|8|||
48691955|NCT03982199|156722570|FG002|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
48691956|NCT03982199|156722571|FG003|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
48691957|NCT03982199|156722572|FG004|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
48691958|NCT03982199|156722573|FG005|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
48691959|NCT03982199|156722574|FG006|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
48691960|NCT03982199|156722575|FG007|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
48691961|NCT03982199|156722576|FG008|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
48691962|NCT03982199|156722577|FG009|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
48764001|NCT02932904|156985804|FG001|Overall Study|Voluntary Withdrawal|1|||
48764002|NCT02932904|156985805|FG002|Overall Study|Voluntary Withdrawal|4|||
48764003|NCT02932904|156985806|FG003|Overall Study|Voluntary Withdrawal|2|||
48764004|NCT02932904|156985803|FG000|Overall Study|Lost to Follow-up|5|||
48764005|NCT02932904|156985804|FG001|Overall Study|Lost to Follow-up|3|||
48764006|NCT02932904|156985805|FG002|Overall Study|Lost to Follow-up|6|||
48691963|NCT03982199|156722578|FG010|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
48691964|NCT03982199|156722579|FG011|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
48691965|NCT03982199|156722580|FG012|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
48691966|NCT03982199|156722581|FG013|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
48691967|NCT03982199|156722568|FG000|Main Cohorts (Day 1 up to Day 1095)|Death|39|||
48691968|NCT03982199|156722569|FG001|Main Cohorts (Day 1 up to Day 1095)|Death|38|||
48691969|NCT03982199|156722570|FG002|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
48691970|NCT03982199|156722571|FG003|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
48691971|NCT03982199|156722572|FG004|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
48691972|NCT03982199|156722573|FG005|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
48691973|NCT03982199|156722574|FG006|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
48691974|NCT03982199|156722575|FG007|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
48691975|NCT03982199|156722576|FG008|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
48691976|NCT03982199|156722577|FG009|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
48691977|NCT03982199|156722578|FG010|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
48691978|NCT03982199|156722579|FG011|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
48691979|NCT03982199|156722580|FG012|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
48691980|NCT03982199|156722581|FG013|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
48691981|NCT03982199|156722568|FG000|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|26|||
48691982|NCT03982199|156722569|FG001|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|21|||
48691983|NCT03982199|156722570|FG002|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
48691984|NCT03982199|156722571|FG003|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
48691985|NCT03982199|156722572|FG004|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
48691986|NCT03982199|156722573|FG005|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
48691987|NCT03982199|156722574|FG006|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
48691988|NCT03982199|156722575|FG007|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
48691989|NCT03982199|156722576|FG008|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
48691990|NCT03982199|156722577|FG009|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
48691991|NCT03982199|156722578|FG010|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
48691992|NCT03982199|156722579|FG011|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
48691993|NCT03982199|156722580|FG012|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
48691994|NCT03982199|156722581|FG013|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
48691995|NCT03982199|156722568|FG000|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|129|||
48691996|NCT03982199|156722569|FG001|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|117|||
48875488|NCT00550446|157381646|FG005|Post Week 12|Lost to Follow-up|0|||
48875489|NCT00550446|157381647|FG006|Post Week 12|Lost to Follow-up|1|||
48691997|NCT03982199|156722570|FG002|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
48691998|NCT03982199|156722571|FG003|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
48691999|NCT03982199|156722572|FG004|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
48692000|NCT03982199|156722573|FG005|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
48692001|NCT03982199|156722574|FG006|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
48692002|NCT03982199|156722575|FG007|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
48692003|NCT03982199|156722576|FG008|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
48692004|NCT03982199|156722577|FG009|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
48692005|NCT03982199|156722578|FG010|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
48692006|NCT03982199|156722579|FG011|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
48692007|NCT03982199|156722580|FG012|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
48692008|NCT03982199|156722581|FG013|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
48692009|NCT03982199|156722568|FG000|Main Cohorts (Day 1 up to Day 1095)|Other|80|||
48692010|NCT03982199|156722569|FG001|Main Cohorts (Day 1 up to Day 1095)|Other|83|||
48692011|NCT03982199|156722570|FG002|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
48692012|NCT03982199|156722571|FG003|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
48692013|NCT03982199|156722572|FG004|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
48692014|NCT03982199|156722573|FG005|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
48692015|NCT03982199|156722574|FG006|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
48692016|NCT03982199|156722575|FG007|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
48692017|NCT03982199|156722576|FG008|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
48692018|NCT03982199|156722577|FG009|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
48692019|NCT03982199|156722578|FG010|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
48692020|NCT03982199|156722579|FG011|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
48692021|NCT03982199|156722580|FG012|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
48692022|NCT03982199|156722581|FG013|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
48692023|NCT03982199|156722568|FG000|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|18|||
48875490|NCT00550446|157381648|FG007|Post Week 12|Lost to Follow-up|0|||
48875491|NCT00550446|157381649|FG008|Post Week 12|Lost to Follow-up|0|||
48692024|NCT03982199|156722569|FG001|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|15|||
48692025|NCT03982199|156722570|FG002|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
48692026|NCT03982199|156722571|FG003|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
48692027|NCT03982199|156722572|FG004|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
48692028|NCT03982199|156722573|FG005|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
48764007|NCT02932904|156985806|FG003|Overall Study|Lost to Follow-up|0|||
48764008|NCT02932904|156985803|FG000|Overall Study|Significant Protocol Deviation|2|||
48764009|NCT02932904|156985804|FG001|Overall Study|Significant Protocol Deviation|3|||
48764010|NCT02932904|156985805|FG002|Overall Study|Significant Protocol Deviation|6|||
48764011|NCT02932904|156985806|FG003|Overall Study|Significant Protocol Deviation|1|||
48764012|NCT02932904|156985803|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
48764013|NCT02932904|156985804|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
48764014|NCT02932904|156985805|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
48764015|NCT02932904|156985806|FG003|Overall Study|Pretreatment Event/Adverse Event|3|||
48764016|NCT02932904|156985803|FG000|Overall Study|Randomized But Not Treated|1|||
48764017|NCT02932904|156985804|FG001|Overall Study|Randomized But Not Treated|1|||
48764018|NCT02932904|156985805|FG002|Overall Study|Randomized But Not Treated|0|||
48764019|NCT02932904|156985806|FG003|Overall Study|Randomized But Not Treated|2|||
48764020|NCT00909779|156985807|FG000|Overall Study|Adverse Event|53|||
48692029|NCT03982199|156722574|FG006|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
48692030|NCT03982199|156722575|FG007|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
48692031|NCT03982199|156722576|FG008|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
48692032|NCT03982199|156722577|FG009|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
48692033|NCT03982199|156722578|FG010|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
48692034|NCT03982199|156722579|FG011|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
48692035|NCT03982199|156722580|FG012|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
48692036|NCT03982199|156722581|FG013|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
48692037|NCT03982199|156722568|FG000|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|4|||
48764021|NCT00909779|156985808|FG001|Overall Study|Adverse Event|55|||
48764022|NCT00909779|156985807|FG000|Overall Study|Lack of Efficacy|7|||
48764023|NCT00909779|156985808|FG001|Overall Study|Lack of Efficacy|4|||
49024839|NCT03978637|157930192|FG003|Overall Study|Death|0|||
49024840|NCT03978637|157930189|FG000|Overall Study|Withdrawal by Subject|0|||
48692038|NCT03982199|156722569|FG001|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|7|||
48692039|NCT03982199|156722570|FG002|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
48692040|NCT03982199|156722571|FG003|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
48692041|NCT03982199|156722572|FG004|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
48692042|NCT03982199|156722573|FG005|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
48692043|NCT03982199|156722574|FG006|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
48692044|NCT03982199|156722575|FG007|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
48692045|NCT03982199|156722576|FG008|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
48692046|NCT03982199|156722577|FG009|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
48692047|NCT03982199|156722578|FG010|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
48692048|NCT03982199|156722579|FG011|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
48692049|NCT03982199|156722580|FG012|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
48692050|NCT03982199|156722581|FG013|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
48692051|NCT03982199|156722568|FG000|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
48692052|NCT03982199|156722569|FG001|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
48692053|NCT03982199|156722570|FG002|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
48692054|NCT03982199|156722571|FG003|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
48692055|NCT03982199|156722572|FG004|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
48692056|NCT03982199|156722573|FG005|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
48692057|NCT03982199|156722574|FG006|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
48692058|NCT03982199|156722575|FG007|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
48692059|NCT03982199|156722576|FG008|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
48692060|NCT03982199|156722577|FG009|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
48692061|NCT03982199|156722578|FG010|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
48692062|NCT03982199|156722579|FG011|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
48764024|NCT00909779|156985807|FG000|Overall Study|Lost to Follow-up|19|||
48764025|NCT00909779|156985808|FG001|Overall Study|Lost to Follow-up|15|||
48764026|NCT00909779|156985807|FG000|Overall Study|Physician Decision|8|||
49024841|NCT03978637|157930190|FG001|Overall Study|Withdrawal by Subject|0|||
49024842|NCT03978637|157930191|FG002|Overall Study|Withdrawal by Subject|1|||
49024843|NCT03978637|157930192|FG003|Overall Study|Withdrawal by Subject|0|||
49024844|NCT03978637|157930189|FG000|Overall Study|Transitioned to Itacitinib Rollover Trial|1|||
49024845|NCT03978637|157930190|FG001|Overall Study|Transitioned to Itacitinib Rollover Trial|3|||
49024846|NCT03978637|157930191|FG002|Overall Study|Transitioned to Itacitinib Rollover Trial|2|||
48764027|NCT00909779|156985808|FG001|Overall Study|Physician Decision|2|||
48764028|NCT00909779|156985807|FG000|Overall Study|Protocol Violation|2|||
48764029|NCT00909779|156985808|FG001|Overall Study|Protocol Violation|5|||
48764030|NCT00909779|156985807|FG000|Overall Study|Withdrawal by Subject|116|||
49024847|NCT03978637|157930192|FG003|Overall Study|Transitioned to Itacitinib Rollover Trial|0|||
48764031|NCT00909779|156985808|FG001|Overall Study|Withdrawal by Subject|80|||
48764032|NCT00909779|156985807|FG000|Overall Study|Site Ceasing Operation|2|||
48764033|NCT00909779|156985808|FG001|Overall Study|Site Ceasing Operation|2|||
48764034|NCT00909779|156985807|FG000|Overall Study|Medical Monitor Decision|1|||
48764035|NCT00909779|156985808|FG001|Overall Study|Medical Monitor Decision|0|||
48764036|NCT00909779|156985807|FG000|Overall Study|Noncompliance|1|||
48764037|NCT00909779|156985808|FG001|Overall Study|Noncompliance|1|||
48764038|NCT00909779|156985807|FG000|Overall Study|Randomized in error|1|||
48764039|NCT00909779|156985808|FG001|Overall Study|Randomized in error|1|||
48764040|NCT03792672|156985811|FG000|Washout Period 3 (10 Days)|Withdrawal by Subject|1|||
48764041|NCT03792672|156985812|FG001|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
48764042|NCT03792672|156985813|FG002|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
48764043|NCT03792672|156985814|FG003|Washout Period 3 (10 Days)|Withdrawal by Subject|2|||
48764044|NCT03792672|156985815|FG004|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
48764045|NCT03792672|156985816|FG005|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
48764046|NCT03792672|156985811|FG000|Washout Period 3 (10 Days)|Physician Decision|0|||
48764047|NCT03792672|156985812|FG001|Washout Period 3 (10 Days)|Physician Decision|0|||
48764048|NCT03792672|156985813|FG002|Washout Period 3 (10 Days)|Physician Decision|1|||
48764049|NCT03792672|156985814|FG003|Washout Period 3 (10 Days)|Physician Decision|0|||
48764050|NCT03792672|156985815|FG004|Washout Period 3 (10 Days)|Physician Decision|0|||
49024848|NCT03365882|157931334|FG000|Randomization|Still Receiving Protocol Treatment|2|||
49024849|NCT03365882|157931335|FG001|Randomization|Still Receiving Protocol Treatment|0|||
49024850|NCT03365882|157931334|FG000|Randomization|Adverse Event|1|||
49024851|NCT03365882|157931335|FG001|Randomization|Adverse Event|2|||
49024852|NCT03365882|157931334|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
49024853|NCT03365882|157931335|FG001|Randomization|Refusal Unrelated to Adverse Event|1|||
49024854|NCT03365882|157931334|FG000|Randomization|Progression/Relapse|21|||
49024855|NCT03365882|157931335|FG001|Randomization|Progression/Relapse|3|||
48692063|NCT03982199|156722580|FG012|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
48692064|NCT03982199|156722581|FG013|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
48692065|NCT03982199|156722568|FG000|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
48692066|NCT03982199|156722569|FG001|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
48692067|NCT03982199|156722570|FG002|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
48692068|NCT03982199|156722571|FG003|Revacc Subcohorts (From Day 365 to 730)|Other|3|||
48692069|NCT03982199|156722572|FG004|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
49024856|NCT03365882|157931334|FG000|Randomization|Death|1|||
49024857|NCT03365882|157931335|FG001|Randomization|Death|0|||
48692070|NCT03982199|156722573|FG005|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
48692071|NCT03982199|156722574|FG006|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
48692072|NCT03982199|156722575|FG007|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
48692073|NCT03982199|156722576|FG008|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
48692074|NCT03982199|156722577|FG009|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
48692075|NCT03982199|156722578|FG010|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
48692076|NCT03982199|156722579|FG011|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
48692077|NCT03982199|156722580|FG012|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
48692078|NCT03982199|156722581|FG013|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
48692079|NCT03982199|156722568|FG000|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
48692080|NCT03982199|156722569|FG001|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
48692081|NCT03982199|156722570|FG002|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|1|||
48692082|NCT03982199|156722571|FG003|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
48692083|NCT03982199|156722572|FG004|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
48692084|NCT03982199|156722573|FG005|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
48692085|NCT03982199|156722574|FG006|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
48692086|NCT03982199|156722575|FG007|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
48764051|NCT03792672|156985816|FG005|Washout Period 3 (10 Days)|Physician Decision|0|||
49024858|NCT03365882|157931334|FG000|Randomization|Other - Not Protocol Specified|1|||
49024859|NCT03365882|157931335|FG001|Randomization|Other - Not Protocol Specified|1|||
49024860|NCT03365882|157931334|FG000|Randomization|Major Protocol Deviation|0|||
49024861|NCT03365882|157931335|FG001|Randomization|Major Protocol Deviation|1|||
49024862|NCT03365882|157931334|FG000|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|0|||
49024863|NCT03365882|157931335|FG001|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|1|||
48692087|NCT03982199|156722576|FG008|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
48875492|NCT00550446|157381650|FG009|Post Week 12|Lost to Follow-up|0|||
49024864|NCT03365882|157931334|FG000|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|0|||
48764052|NCT03792672|156985811|FG000|Treatment Period 4 (2 Days)|Other|1|||
48764053|NCT03792672|156985812|FG001|Treatment Period 4 (2 Days)|Other|0|||
48764054|NCT03792672|156985813|FG002|Treatment Period 4 (2 Days)|Other|0|||
48764055|NCT03792672|156985814|FG003|Treatment Period 4 (2 Days)|Other|0|||
49024865|NCT03365882|157931335|FG001|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|13|||
49024866|NCT03365882|157931334|FG000|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|0|||
48692088|NCT03982199|156722577|FG009|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
48692089|NCT03982199|156722578|FG010|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
48692090|NCT03982199|156722579|FG011|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
48692091|NCT03982199|156722580|FG012|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
48692092|NCT03982199|156722581|FG013|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
48692093|NCT03982199|156722568|FG000|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
49024867|NCT03365882|157931335|FG001|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|4|||
49024868|NCT03365882|157931334|FG000|Crossover: Trastuzumab + Pertuzumab|Adverse Event|0|||
49024869|NCT03365882|157931335|FG001|Crossover: Trastuzumab + Pertuzumab|Adverse Event|2|||
49024870|NCT01704079|157931336|FG000|Overall Study|Withdrawal by Subject|5|||
48764056|NCT03792672|156985815|FG004|Treatment Period 4 (2 Days)|Other|0|||
48764057|NCT03792672|156985816|FG005|Treatment Period 4 (2 Days)|Other|0|||
48764058|NCT01256593|156985822|FG000|Overall Study|Protocol Violation|26|||
48764059|NCT01256593|156985822|FG000|Overall Study|No Drug Administration Information|2|||
49024871|NCT01704079|157931337|FG001|Overall Study|Withdrawal by Subject|7|||
49024872|NCT01704079|157931336|FG000|Overall Study|Lost to Follow-up|2|||
49024873|NCT01704079|157931337|FG001|Overall Study|Lost to Follow-up|5|||
49024874|NCT01704079|157931336|FG000|Overall Study|Adverse Event|4|||
49024875|NCT01704079|157931337|FG001|Overall Study|Adverse Event|7|||
49024876|NCT01704079|157931336|FG000|Overall Study|Protocol Violation|1|||
49024877|NCT01704079|157931337|FG001|Overall Study|Protocol Violation|0|||
49024878|NCT01704079|157931336|FG000|Overall Study|Subject noncompliance|2|||
49024879|NCT01704079|157931337|FG001|Overall Study|Subject noncompliance|3|||
48692094|NCT03982199|156722569|FG001|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
48692095|NCT03982199|156722570|FG002|Revacc Subcohorts (From Day 365 to 730)|Death|1|||
48692096|NCT03982199|156722571|FG003|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
48692097|NCT03982199|156722572|FG004|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
48692098|NCT03982199|156722573|FG005|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
48692099|NCT03982199|156722574|FG006|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
48692100|NCT03982199|156722575|FG007|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
48692101|NCT03982199|156722576|FG008|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
48692102|NCT03982199|156722577|FG009|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
48692103|NCT03982199|156722578|FG010|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
48692104|NCT03982199|156722579|FG011|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
48692105|NCT03982199|156722580|FG012|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
48692106|NCT03982199|156722581|FG013|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
48692107|NCT03982199|156722568|FG000|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
48692108|NCT03982199|156722569|FG001|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
48692109|NCT03982199|156722570|FG002|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|21|||
48692110|NCT03982199|156722571|FG003|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|18|||
48692111|NCT03982199|156722572|FG004|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
48692112|NCT03982199|156722573|FG005|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
48692113|NCT03982199|156722574|FG006|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
48692114|NCT03982199|156722575|FG007|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
48692115|NCT03982199|156722576|FG008|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
48764060|NCT01256593|156985822|FG000|Overall Study|No Visit After Treatment|186|||
48764061|NCT02689258|156985823|FG000|Overall Study|Subject Non-Compliance|0|||
48764062|NCT02689258|156985824|FG001|Overall Study|Subject Non-Compliance|1|||
48764063|NCT02689258|156985825|FG002|Overall Study|Subject Non-Compliance|0|||
48875493|NCT00550446|157381651|FG010|Post Week 12|Lost to Follow-up|0|||
48875494|NCT00550446|157381641|FG000|Post Week 12|Withdrawal by Subject|0|||
48875495|NCT00550446|157381642|FG001|Post Week 12|Withdrawal by Subject|0|||
48875496|NCT00550446|157381643|FG002|Post Week 12|Withdrawal by Subject|0|||
48875497|NCT00550446|157381644|FG003|Post Week 12|Withdrawal by Subject|0|||
48875498|NCT00550446|157381645|FG004|Post Week 12|Withdrawal by Subject|1|||
49024880|NCT01704079|157931336|FG000|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0|||
49024881|NCT01704079|157931337|FG001|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1|||
49024882|NCT00630305|157931342|FG000|Overall Study|Withdrawal by Subject|1|||
49024883|NCT00630305|157931342|FG000|Overall Study|Inability to insert contact lens|1|||
49024884|NCT01085045|157931343|FG000|Part A|Withdrawal by Subject|4|||
49024885|NCT01085045|157931343|FG000|Part A|Adverse Event|6|||
49024886|NCT01085045|157931343|FG000|Part A|Protocol Violation|1|||
49024887|NCT01085045|157931343|FG000|Part A|Protocol Specified Criteria|7|||
48692116|NCT03982199|156722577|FG009|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
48692117|NCT03982199|156722578|FG010|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
48764064|NCT02689258|156985826|FG003|Overall Study|Subject Non-Compliance|0|||
48764065|NCT02689258|156985827|FG004|Overall Study|Subject Non-Compliance|0|||
48875499|NCT00550446|157381646|FG005|Post Week 12|Withdrawal by Subject|0|||
49024888|NCT01085045|157931343|FG000|Part B|Withdrawal by Subject|2|||
49024889|NCT01085045|157931343|FG000|Part B|Protocol Specified Criteria|6|||
49024890|NCT01085045|157931343|FG000|Part B|Lost to Follow-up|1|||
48692118|NCT03982199|156722579|FG011|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
48692119|NCT03982199|156722580|FG012|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
48692120|NCT03982199|156722581|FG013|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
48692121|NCT03982199|156722568|FG000|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
48692122|NCT03982199|156722569|FG001|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
48692123|NCT03982199|156722570|FG002|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
48692124|NCT03982199|156722571|FG003|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|1|||
48692125|NCT03982199|156722572|FG004|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
48692126|NCT03982199|156722573|FG005|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
48692127|NCT03982199|156722574|FG006|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
48692128|NCT03982199|156722575|FG007|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
48692129|NCT03982199|156722576|FG008|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
48692130|NCT03982199|156722577|FG009|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
48692131|NCT03982199|156722578|FG010|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
48692132|NCT03982199|156722579|FG011|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
48692133|NCT03982199|156722580|FG012|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
48692134|NCT03982199|156722581|FG013|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
48692135|NCT03982199|156722568|FG000|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
48692136|NCT03982199|156722569|FG001|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
48692137|NCT03982199|156722570|FG002|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|3|||
48692138|NCT03982199|156722571|FG003|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|2|||
48692139|NCT03982199|156722572|FG004|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
48692140|NCT03982199|156722573|FG005|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
48692141|NCT03982199|156722574|FG006|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
48692142|NCT03982199|156722575|FG007|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
48692143|NCT03982199|156722576|FG008|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
48692144|NCT03982199|156722577|FG009|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
48692145|NCT03982199|156722578|FG010|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
48692146|NCT03982199|156722579|FG011|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
48692147|NCT03982199|156722580|FG012|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
48692148|NCT03982199|156722581|FG013|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
48692149|NCT03982199|156722568|FG000|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
48692150|NCT03982199|156722569|FG001|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
48692151|NCT03982199|156722570|FG002|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
48692152|NCT03982199|156722571|FG003|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
48692153|NCT03982199|156722572|FG004|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
48692154|NCT03982199|156722573|FG005|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
48692155|NCT03982199|156722574|FG006|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
48692156|NCT03982199|156722575|FG007|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
48692157|NCT03982199|156722576|FG008|Revacc Subcohorts (From Day 730 to 1095)|Other|5|||
48692158|NCT03982199|156722577|FG009|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
48692159|NCT03982199|156722578|FG010|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
48692160|NCT03982199|156722579|FG011|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
48692161|NCT03982199|156722580|FG012|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
48692162|NCT03982199|156722581|FG013|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
48692163|NCT03982199|156722568|FG000|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
48692164|NCT03982199|156722569|FG001|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
48692165|NCT03982199|156722570|FG002|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
48692166|NCT03982199|156722571|FG003|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
48692167|NCT03982199|156722572|FG004|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
48692168|NCT03982199|156722573|FG005|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
48692169|NCT03982199|156722574|FG006|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
48692170|NCT03982199|156722575|FG007|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
48692171|NCT03982199|156722576|FG008|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|107|||
48692172|NCT03982199|156722577|FG009|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
48692173|NCT03982199|156722578|FG010|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
48692174|NCT03982199|156722579|FG011|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
48692175|NCT03982199|156722580|FG012|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
48692176|NCT03982199|156722581|FG013|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
48692177|NCT03982199|156722568|FG000|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
48692178|NCT03982199|156722569|FG001|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
48692179|NCT03982199|156722570|FG002|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
48692180|NCT03982199|156722571|FG003|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
48764066|NCT02689258|156985828|FG005|Overall Study|Subject Non-Compliance|0|||
48764067|NCT02689258|156985829|FG006|Overall Study|Subject Non-Compliance|0|||
48764068|NCT02689258|156985830|FG007|Overall Study|Subject Non-Compliance|0|||
48764069|NCT02689258|156985831|FG008|Overall Study|Subject Non-Compliance|0|||
48764070|NCT02689258|156985832|FG009|Overall Study|Subject Non-Compliance|0|||
48764071|NCT02689258|156985833|FG010|Overall Study|Subject Non-Compliance|0|||
48764072|NCT02689258|156985834|FG011|Overall Study|Subject Non-Compliance|0|||
48764073|NCT02689258|156985823|FG000|Overall Study|Subject Refusal to Continue|0|||
48764074|NCT02689258|156985824|FG001|Overall Study|Subject Refusal to Continue|1|||
48764075|NCT02689258|156985825|FG002|Overall Study|Subject Refusal to Continue|0|||
48764076|NCT02689258|156985826|FG003|Overall Study|Subject Refusal to Continue|0|||
48764077|NCT02689258|156985827|FG004|Overall Study|Subject Refusal to Continue|0|||
48764078|NCT02689258|156985828|FG005|Overall Study|Subject Refusal to Continue|0|||
48764079|NCT02689258|156985829|FG006|Overall Study|Subject Refusal to Continue|0|||
48764080|NCT02689258|156985830|FG007|Overall Study|Subject Refusal to Continue|0|||
48764081|NCT02689258|156985831|FG008|Overall Study|Subject Refusal to Continue|1|||
48764082|NCT02689258|156985832|FG009|Overall Study|Subject Refusal to Continue|0|||
48764083|NCT02689258|156985833|FG010|Overall Study|Subject Refusal to Continue|0|||
48764084|NCT02689258|156985834|FG011|Overall Study|Subject Refusal to Continue|1|||
48764085|NCT02689258|156985823|FG000|Overall Study|Other|0|||
48764086|NCT02689258|156985824|FG001|Overall Study|Other|2|||
48764087|NCT02689258|156985825|FG002|Overall Study|Other|0|||
48764088|NCT02689258|156985826|FG003|Overall Study|Other|0|||
48764089|NCT02689258|156985827|FG004|Overall Study|Other|1|||
48764090|NCT02689258|156985828|FG005|Overall Study|Other|0|||
48764091|NCT02689258|156985829|FG006|Overall Study|Other|0|||
48764092|NCT02689258|156985830|FG007|Overall Study|Other|0|||
48764093|NCT02689258|156985831|FG008|Overall Study|Other|1|||
48764094|NCT02689258|156985832|FG009|Overall Study|Other|0|||
48764095|NCT02689258|156985833|FG010|Overall Study|Other|0|||
48764096|NCT02689258|156985834|FG011|Overall Study|Other|0|||
48764097|NCT00405548|156985843|FG000|Overall Study|Cognitive Memory problems on study day|1|||
48764098|NCT00405548|156985844|FG001|Overall Study|Cognitive Memory problems on study day|0|||
48764099|NCT00405548|156985843|FG000|Overall Study|Amyloidosis on study echo-exclusionary|0|||
48764100|NCT00405548|156985844|FG001|Overall Study|Amyloidosis on study echo-exclusionary|1|||
48764101|NCT00405548|156985843|FG000|Overall Study|Unable to self-administer shots|1|||
48764102|NCT00405548|156985844|FG001|Overall Study|Unable to self-administer shots|0|||
48764103|NCT00405548|156985843|FG000|Overall Study|Venous access failed during study day|1|||
48764104|NCT00405548|156985844|FG001|Overall Study|Venous access failed during study day|0|||
48764105|NCT00405548|156985843|FG000|Overall Study|Withdrawal by Subject|1|||
48764106|NCT00405548|156985844|FG001|Overall Study|Withdrawal by Subject|0|||
48764107|NCT01894152|156985845|FG000|Overall Study|No DMR and no Stent thrombosis|151|||
48764108|NCT02486042|156985848|FG000|Overall Study|Physician Decision|1|||
48764109|NCT02486042|156985849|FG001|Overall Study|Physician Decision|7|||
48764110|NCT02486042|156985848|FG000|Overall Study|Hospital transfer|2|||
48764111|NCT02486042|156985849|FG001|Overall Study|Hospital transfer|2|||
48764112|NCT02486042|156985848|FG000|Overall Study|Withdrawal by Subject|0|||
48764113|NCT02486042|156985849|FG001|Overall Study|Withdrawal by Subject|2|||
48764114|NCT02120794|156985850|FG000|Overall Study|Withdrawal by Subject|43|||
48764115|NCT02120794|156985850|FG000|Overall Study|Adverse Event|10|||
48764116|NCT02120794|156985850|FG000|Overall Study|Physician Decision|4|||
48764117|NCT02120794|156985850|FG000|Overall Study|Due to insurance coverage|1|||
48764118|NCT00735878|156985851|FG000|Phase I- Dose Determination|Withdrawal by Subject|0|||
48764119|NCT00735878|156985852|FG001|Phase I- Dose Determination|Withdrawal by Subject|0|||
48764120|NCT00735878|156985853|FG002|Phase I- Dose Determination|Withdrawal by Subject|1|||
48764121|NCT03320564|156985854|FG000|Overall Study|Protocol Violation|1|||
48764122|NCT01148511|156985855|FG000|Exposed to Study Drug|Protocol Violation|2|||
48764123|NCT01148511|156985856|FG001|Exposed to Study Drug|Protocol Violation|0|||
48764124|NCT01148511|156985857|FG002|Exposed to Study Drug|Protocol Violation|0|||
48764125|NCT01148511|156985855|FG000|Exposed to Study Drug|Lost to Follow-up|4|||
48764126|NCT01148511|156985856|FG001|Exposed to Study Drug|Lost to Follow-up|0|||
48764127|NCT01148511|156985857|FG002|Exposed to Study Drug|Lost to Follow-up|0|||
49024891|NCT01085045|157931343|FG000|Part B|Adverse Event|6|||
49024892|NCT05986565|157931344|FG000|Overall Study|Lost to Follow-up|8|||
49024893|NCT05986565|157931345|FG001|Overall Study|Lost to Follow-up|3|||
48764128|NCT01148511|156985855|FG000|Randomized|Adverse Event|0|||
48764129|NCT01148511|156985856|FG001|Randomized|Adverse Event|1|||
48764130|NCT01148511|156985857|FG002|Randomized|Adverse Event|0|||
48764131|NCT01148511|156985855|FG000|Randomized|Protocol Violation|0|||
48764132|NCT01148511|156985856|FG001|Randomized|Protocol Violation|2|||
49024894|NCT05986565|157931344|FG000|Overall Study|Withdrawal by Subject|0|||
48764133|NCT01148511|156985857|FG002|Randomized|Protocol Violation|1|||
48764134|NCT01148511|156985855|FG000|Randomized|Lost to Follow-up|0|||
49024895|NCT05986565|157931345|FG001|Overall Study|Withdrawal by Subject|1|||
48764135|NCT01148511|156985856|FG001|Randomized|Lost to Follow-up|1|||
48764136|NCT01148511|156985857|FG002|Randomized|Lost to Follow-up|1|||
48764137|NCT01148511|156985855|FG000|Randomized|Consent withdrawal|0|||
49024896|NCT04755595|157931348|FG000|Overall Study|Lost to Follow-up|1|||
49024897|NCT02919683|157931355|FG000|Post-Surgery Follow-Up|Death|2|||
49024898|NCT02919683|157931356|FG001|Post-Surgery Follow-Up|Death|2|||
49024899|NCT02919683|157931355|FG000|Post-Surgery Follow-Up|Patient is still completing follow-ups|1|||
49024900|NCT02919683|157931356|FG001|Post-Surgery Follow-Up|Patient is still completing follow-ups|0|||
49024901|NCT00324168|157931362|FG000|Overall Study|Lost to Follow-up|19|||
49024902|NCT00324168|157931363|FG001|Overall Study|Lost to Follow-up|18|||
49024903|NCT00324168|157931362|FG000|Overall Study|Death|3|||
49024904|NCT00324168|157931363|FG001|Overall Study|Death|3|||
49024905|NCT00324168|157931362|FG000|Overall Study|Patient did not visit in f/u window|6|||
49024906|NCT00324168|157931363|FG001|Overall Study|Patient did not visit in f/u window|9|||
49024907|NCT01203878|157931364|FG000|Overall Study|Withdrawal by Subject|0|||
49024908|NCT01203878|157931365|FG001|Overall Study|Withdrawal by Subject|0|||
49024909|NCT01203878|157931366|FG002|Overall Study|Withdrawal by Subject|1|||
49024910|NCT01203878|157931364|FG000|Overall Study|Adverse Event|0|||
49024911|NCT01203878|157931365|FG001|Overall Study|Adverse Event|0|||
49024912|NCT01203878|157931366|FG002|Overall Study|Adverse Event|2|||
49024913|NCT04799899|157931372|FG000|Overall Study|Lost to Follow-up|2|||
49024914|NCT04799899|157931373|FG001|Overall Study|Lost to Follow-up|4|||
49024915|NCT00912288|157931378|FG000|Overall Study|Death|0|||
48692181|NCT03982199|156722572|FG004|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
48692182|NCT03982199|156722573|FG005|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
48692183|NCT03982199|156722574|FG006|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
48692184|NCT03982199|156722575|FG007|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
48692185|NCT03982199|156722576|FG008|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|3|||
48692186|NCT03982199|156722577|FG009|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
48692187|NCT03982199|156722578|FG010|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
48692188|NCT03982199|156722579|FG011|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
48692189|NCT03982199|156722580|FG012|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
48692190|NCT03982199|156722581|FG013|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
48692191|NCT03982199|156722568|FG000|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
48692192|NCT03982199|156722569|FG001|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
48692193|NCT03982199|156722570|FG002|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
48692194|NCT03982199|156722571|FG003|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
48692195|NCT03982199|156722572|FG004|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
48692196|NCT03982199|156722573|FG005|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
48692197|NCT03982199|156722574|FG006|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
48692198|NCT03982199|156722575|FG007|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
48692199|NCT03982199|156722576|FG008|Revacc Subcohorts (From Day 730 to 1095)|Death|2|||
48692200|NCT03982199|156722577|FG009|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
48692201|NCT03982199|156722578|FG010|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
48692202|NCT03982199|156722579|FG011|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
48692203|NCT03982199|156722580|FG012|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
48692204|NCT03982199|156722581|FG013|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
48692205|NCT03982199|156722568|FG000|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
48692206|NCT03982199|156722569|FG001|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
48692207|NCT03982199|156722570|FG002|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
48692208|NCT03982199|156722571|FG003|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
48692209|NCT03982199|156722572|FG004|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
48692210|NCT03982199|156722573|FG005|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
48692211|NCT03982199|156722574|FG006|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
48692212|NCT03982199|156722575|FG007|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
48692213|NCT03982199|156722576|FG008|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|2|||
48692214|NCT03982199|156722577|FG009|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
48692215|NCT03982199|156722578|FG010|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
48692216|NCT03982199|156722579|FG011|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
48692217|NCT03982199|156722580|FG012|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
48692218|NCT03982199|156722581|FG013|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
48692219|NCT03982199|156722568|FG000|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
48692220|NCT03982199|156722569|FG001|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
48692221|NCT03982199|156722570|FG002|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
48692222|NCT03982199|156722571|FG003|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
48692223|NCT03982199|156722572|FG004|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
48764138|NCT01148511|156985856|FG001|Randomized|Consent withdrawal|5|||
49024916|NCT00912288|157931379|FG001|Overall Study|Death|1|||
49024917|NCT00912288|157931378|FG000|Overall Study|Adverse Event|1|||
49024918|NCT00912288|157931379|FG001|Overall Study|Adverse Event|1|||
49024919|NCT00912288|157931378|FG000|Overall Study|Lost to Follow-up|1|||
49024920|NCT00912288|157931379|FG001|Overall Study|Lost to Follow-up|0|||
48764139|NCT01148511|156985857|FG002|Randomized|Consent withdrawal|3|||
48764140|NCT01148511|156985855|FG000|Randomized|Other|0|||
48764141|NCT01148511|156985856|FG001|Randomized|Other|1|||
48764142|NCT01148511|156985857|FG002|Randomized|Other|1|||
48764143|NCT01200797|156985860|FG000|Overall Study|symptomatic deterioration|2|||
48764144|NCT01200797|156985860|FG000|Overall Study|Adverse Event|4|||
48764145|NCT01200797|156985860|FG000|Overall Study|Disease Progression|13|||
48764146|NCT03979638|156985866|FG000|Period 1|Physician Decision|1|||
48764147|NCT03979638|156985867|FG001|Period 1|Physician Decision|1|||
48764148|NCT03979638|156985866|FG000|Period 1|Withdrawal by Subject|4|||
48692224|NCT03982199|156722573|FG005|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|3|||
48692225|NCT03982199|156722574|FG006|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
48692226|NCT03982199|156722575|FG007|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|7|||
48692227|NCT03982199|156722576|FG008|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|20|||
48692228|NCT03982199|156722577|FG009|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
48692229|NCT03982199|156722578|FG010|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
48692230|NCT03982199|156722579|FG011|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
48692231|NCT03982199|156722580|FG012|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
48764149|NCT03979638|156985867|FG001|Period 1|Withdrawal by Subject|3|||
48764150|NCT03979638|156985866|FG000|Period 1|Study terminated by Sponsor|1|||
48764151|NCT03979638|156985867|FG001|Period 1|Study terminated by Sponsor|3|||
48764152|NCT03979638|156985866|FG000|Period 1|Protocol Violation|1|||
48764153|NCT03979638|156985867|FG001|Period 1|Protocol Violation|0|||
48764154|NCT03979638|156985866|FG000|Period 2|Study terminated by Sponsor|1|||
48764155|NCT03979638|156985867|FG001|Period 2|Study terminated by Sponsor|1|||
48764156|NCT01531387|156985868|FG000|Overall Study|Early termination of study|11|||
48764157|NCT01531387|156985869|FG001|Overall Study|Early termination of study|11|||
48764158|NCT02910167|156985872|FG000|Overall Study|Adverse Event|1|||
48764159|NCT02910167|156985872|FG000|Overall Study|Lost to Follow-up|18|||
48764160|NCT02642432|156985873|FG000|Overall Study|Adverse Event|2|||
48764161|NCT02642432|156985873|FG000|Overall Study|Withdrew Consent|1|||
48764162|NCT02642432|156985873|FG000|Overall Study|Lost to Follow-up|2|||
48764163|NCT02642432|156985873|FG000|Overall Study|Other|3|||
48764164|NCT03999892|156985874|FG000|Overall Study|Lost to Follow-up|1|||
48764165|NCT00856908|156985875|FG000|Overall Study|Lost to Follow-up|1|||
48764166|NCT00856908|156985876|FG001|Overall Study|Lost to Follow-up|0|||
48764167|NCT01063595|156985877|FG000|Enrolled in Study and Randomized|Reason not Specified|1|||
48764168|NCT01063595|156985878|FG001|Enrolled in Study and Randomized|Reason not Specified|0|||
48764169|NCT01063595|156985877|FG000|Enrolled in Study and Randomized|Adverse Event|0|||
48764170|NCT01063595|156985878|FG001|Enrolled in Study and Randomized|Adverse Event|1|||
48764171|NCT01063595|156985877|FG000|Enrolled in Study and Randomized|Withdrawn by the Investigator|0|||
48764172|NCT01063595|156985878|FG001|Enrolled in Study and Randomized|Withdrawn by the Investigator|1|||
48764173|NCT01063595|156985877|FG000|First Intervention|Adverse Event|1|||
48764174|NCT01063595|156985878|FG001|First Intervention|Adverse Event|4|||
48764175|NCT01063595|156985877|FG000|First Intervention|Withdrawal by Subject|1|||
48764176|NCT01063595|156985878|FG001|First Intervention|Withdrawal by Subject|0|||
48764177|NCT01063595|156985877|FG000|First Intervention|Reason not Specified|0|||
48764178|NCT01063595|156985878|FG001|First Intervention|Reason not Specified|1|||
48764179|NCT00748215|156985879|FG000|Overall Study|Withdrawal by Subject|7|||
48764180|NCT00748215|156985880|FG001|Overall Study|Withdrawal by Subject|7|||
48764181|NCT00748215|156985879|FG000|Overall Study|Treatment change|2|||
48764182|NCT00748215|156985880|FG001|Overall Study|Treatment change|1|||
48764183|NCT00748215|156985879|FG000|Overall Study|Change in patient condition|0|||
48764184|NCT00748215|156985880|FG001|Overall Study|Change in patient condition|3|||
48764185|NCT00748215|156985879|FG000|Overall Study|Non-compliant|0|||
49024921|NCT00912288|157931378|FG000|Overall Study|Protocol Violation|1|||
49024922|NCT00912288|157931379|FG001|Overall Study|Protocol Violation|0|||
48764186|NCT00748215|156985880|FG001|Overall Study|Non-compliant|2|||
48764187|NCT00748215|156985879|FG000|Overall Study|Adverse Event|0|||
49024923|NCT00912288|157931378|FG000|Overall Study|Withdrawal by Subject|3|||
49024924|NCT00912288|157931379|FG001|Overall Study|Withdrawal by Subject|3|||
49024925|NCT00912288|157931378|FG000|Overall Study|Study terminated by sponsor|34|||
49024926|NCT00912288|157931379|FG001|Overall Study|Study terminated by sponsor|35|||
49024927|NCT00912288|157931378|FG000|Overall Study|Other|1|||
49024928|NCT00912288|157931379|FG001|Overall Study|Other|0|||
49024929|NCT01440283|157931380|FG000|Overall Study|Death|3|||
49024930|NCT01440283|157931380|FG000|Overall Study|Withdrawal by Subject|4|||
49024931|NCT01440283|157931380|FG000|Overall Study|Physician Decision|3|||
49024932|NCT03896789|157931383|FG000|Baseline|Lost to Follow-up|1|||
48764188|NCT00748215|156985880|FG001|Overall Study|Adverse Event|5|||
48764189|NCT00962104|156985881|FG000|Overall Study|Adverse Event|10|||
48764190|NCT00962104|156985882|FG001|Overall Study|Adverse Event|3|||
48764191|NCT00962104|156985881|FG000|Overall Study|Entry Criteria Not Met|1|||
49024933|NCT03896789|157931384|FG001|Baseline|Lost to Follow-up|2|||
49024934|NCT03896789|157931383|FG000|Baseline|Death|3|||
49024935|NCT03896789|157931384|FG001|Baseline|Death|6|||
49024936|NCT03896789|157931383|FG000|Post-Randomization|Lost to Follow-up|12|||
48764192|NCT00962104|156985882|FG001|Overall Study|Entry Criteria Not Met|2|||
48764193|NCT00962104|156985881|FG000|Overall Study|Lack of Efficacy|0|||
48764194|NCT00962104|156985882|FG001|Overall Study|Lack of Efficacy|1|||
48764195|NCT00962104|156985881|FG000|Overall Study|Lost to Follow-up|10|||
48764196|NCT00962104|156985882|FG001|Overall Study|Lost to Follow-up|4|||
48764197|NCT00962104|156985881|FG000|Overall Study|Physician Decision|1|||
48764198|NCT00962104|156985882|FG001|Overall Study|Physician Decision|0|||
48764199|NCT00962104|156985881|FG000|Overall Study|Protocol Violation|6|||
48764200|NCT00962104|156985882|FG001|Overall Study|Protocol Violation|8|||
48764201|NCT00962104|156985881|FG000|Overall Study|Sponsor Decision|0|||
48764202|NCT00962104|156985882|FG001|Overall Study|Sponsor Decision|1|||
48764203|NCT00962104|156985881|FG000|Overall Study|Withdrawal by Subject|10|||
48764204|NCT00962104|156985882|FG001|Overall Study|Withdrawal by Subject|6|||
48764205|NCT00962104|156985881|FG000|Overall Study|Other|2|||
48764206|NCT00962104|156985882|FG001|Overall Study|Other|0|||
48764207|NCT04056195|156985883|FG000|Overall Study|Adverse Event|1|||
48764208|NCT04056195|156985884|FG001|Overall Study|Adverse Event|0|||
48764209|NCT04056195|156985885|FG002|Overall Study|Adverse Event|0|||
48764210|NCT04056195|156985883|FG000|Overall Study|Withdrawal by Subject|0|||
48764211|NCT04056195|156985884|FG001|Overall Study|Withdrawal by Subject|1|||
48764212|NCT04056195|156985885|FG002|Overall Study|Withdrawal by Subject|1|||
48764213|NCT04056195|156985883|FG000|Overall Study|Physician Decision|1|||
48764214|NCT04056195|156985884|FG001|Overall Study|Physician Decision|1|||
48764215|NCT04056195|156985885|FG002|Overall Study|Physician Decision|1|||
48764216|NCT00603746|156985888|FG000|Overall Study|Adverse Event|2|||
48764217|NCT00603746|156985889|FG001|Overall Study|Adverse Event|3|||
48764218|NCT00603746|156985890|FG002|Overall Study|Adverse Event|0|||
48764219|NCT00603746|156985891|FG003|Overall Study|Adverse Event|1|||
48764220|NCT00603746|156985892|FG004|Overall Study|Adverse Event|0|||
48764221|NCT00603746|156985893|FG005|Overall Study|Adverse Event|4|||
48764222|NCT00603746|156985888|FG000|Overall Study|Lack of Efficacy|34|||
48764223|NCT00603746|156985889|FG001|Overall Study|Lack of Efficacy|11|||
48764224|NCT00603746|156985890|FG002|Overall Study|Lack of Efficacy|6|||
48764225|NCT00603746|156985891|FG003|Overall Study|Lack of Efficacy|11|||
48764226|NCT00603746|156985892|FG004|Overall Study|Lack of Efficacy|12|||
49024937|NCT03896789|157931384|FG001|Post-Randomization|Lost to Follow-up|11|||
49024938|NCT03896789|157931383|FG000|Post-Randomization|Death|12|||
49024939|NCT03896789|157931384|FG001|Post-Randomization|Death|13|||
49024940|NCT01449630|157931385|FG000|Period 1|Physician Decision|1|||
49024941|NCT01449630|157931386|FG001|Period 1|Physician Decision|0|||
49024942|NCT01449630|157931387|FG002|Period 1|Physician Decision|0|||
49024943|NCT01449630|157931388|FG003|Period 1|Physician Decision|1|||
49024944|NCT01449630|157931389|FG004|Period 1|Physician Decision|0|||
49024945|NCT01449630|157931390|FG005|Period 1|Physician Decision|0|||
49024946|NCT01449630|157931391|FG006|Period 1|Physician Decision|0|||
49024947|NCT01449630|157931392|FG007|Period 1|Physician Decision|0|||
49024948|NCT01449630|157931393|FG008|Period 1|Physician Decision|0|||
49024949|NCT01449630|157931385|FG000|Period 1|Sponsor Decision|0|||
49024950|NCT01449630|157931386|FG001|Period 1|Sponsor Decision|0|||
49024951|NCT01449630|157931387|FG002|Period 1|Sponsor Decision|0|||
48692232|NCT03982199|156722581|FG013|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
48692233|NCT03982199|156722568|FG000|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
48692234|NCT03982199|156722569|FG001|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
48692235|NCT03982199|156722570|FG002|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
48692236|NCT03982199|156722571|FG003|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
48692237|NCT03982199|156722572|FG004|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
48692238|NCT03982199|156722573|FG005|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
48692239|NCT03982199|156722574|FG006|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
48692240|NCT03982199|156722575|FG007|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
48692241|NCT03982199|156722576|FG008|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|3|||
48764227|NCT00603746|156985893|FG005|Overall Study|Lack of Efficacy|8|||
48764228|NCT00603746|156985888|FG000|Overall Study|Protocol Violation|0|||
48764229|NCT00603746|156985889|FG001|Overall Study|Protocol Violation|3|||
48764230|NCT00603746|156985890|FG002|Overall Study|Protocol Violation|1|||
48764231|NCT00603746|156985891|FG003|Overall Study|Protocol Violation|0|||
48764232|NCT00603746|156985892|FG004|Overall Study|Protocol Violation|1|||
48764233|NCT00603746|156985893|FG005|Overall Study|Protocol Violation|0|||
48764234|NCT00603746|156985888|FG000|Overall Study|Lost to Follow-up|0|||
48764235|NCT00603746|156985889|FG001|Overall Study|Lost to Follow-up|1|||
48764236|NCT00603746|156985890|FG002|Overall Study|Lost to Follow-up|1|||
48764237|NCT00603746|156985891|FG003|Overall Study|Lost to Follow-up|0|||
48764238|NCT00603746|156985892|FG004|Overall Study|Lost to Follow-up|0|||
48764239|NCT00603746|156985893|FG005|Overall Study|Lost to Follow-up|0|||
48764240|NCT00603746|156985888|FG000|Overall Study|Physician Decision|1|||
49024952|NCT01449630|157931388|FG003|Period 1|Sponsor Decision|0|||
49024953|NCT01449630|157931389|FG004|Period 1|Sponsor Decision|0|||
49024954|NCT01449630|157931390|FG005|Period 1|Sponsor Decision|1|||
49024955|NCT01449630|157931391|FG006|Period 1|Sponsor Decision|0|||
49024956|NCT01449630|157931392|FG007|Period 1|Sponsor Decision|0|||
49024957|NCT01449630|157931393|FG008|Period 1|Sponsor Decision|0|||
48692242|NCT03982199|156722577|FG009|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
48692243|NCT03982199|156722578|FG010|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
48692244|NCT03982199|156722579|FG011|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
48692245|NCT03982199|156722580|FG012|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
48692246|NCT03982199|156722581|FG013|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
48692247|NCT03982199|156722568|FG000|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
48692248|NCT03982199|156722569|FG001|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
48692249|NCT03982199|156722570|FG002|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
48692250|NCT03982199|156722571|FG003|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
48692251|NCT03982199|156722572|FG004|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
48692252|NCT03982199|156722573|FG005|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|1|||
48692253|NCT03982199|156722574|FG006|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
48692254|NCT03982199|156722575|FG007|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|3|||
48692255|NCT03982199|156722576|FG008|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|4|||
48692256|NCT03982199|156722577|FG009|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
48692257|NCT03982199|156722578|FG010|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
48692258|NCT03982199|156722579|FG011|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
49024958|NCT01449630|157931385|FG000|Period 2|Sponsor Decision|0|||
49024959|NCT01449630|157931386|FG001|Period 2|Sponsor Decision|0|||
49024960|NCT01449630|157931387|FG002|Period 2|Sponsor Decision|0|||
49024961|NCT01449630|157931388|FG003|Period 2|Sponsor Decision|0|||
49024962|NCT01449630|157931389|FG004|Period 2|Sponsor Decision|0|||
48692259|NCT03982199|156722580|FG012|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
48692260|NCT03982199|156722581|FG013|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
48692261|NCT03982199|156722568|FG000|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
48692262|NCT03982199|156722569|FG001|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
48692263|NCT03982199|156722570|FG002|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
48692264|NCT03982199|156722571|FG003|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
48692265|NCT03982199|156722572|FG004|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
48692266|NCT03982199|156722573|FG005|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
48692267|NCT03982199|156722574|FG006|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
48692268|NCT03982199|156722575|FG007|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
48692269|NCT03982199|156722576|FG008|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
48692270|NCT03982199|156722577|FG009|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
48692271|NCT03982199|156722578|FG010|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
48692272|NCT03982199|156722579|FG011|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|35|||
48692273|NCT03982199|156722580|FG012|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|125|||
48692274|NCT03982199|156722581|FG013|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|114|||
48692275|NCT03982199|156722568|FG000|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
48764241|NCT00603746|156985889|FG001|Overall Study|Physician Decision|0|||
48764242|NCT00603746|156985890|FG002|Overall Study|Physician Decision|0|||
48764243|NCT00603746|156985891|FG003|Overall Study|Physician Decision|0|||
48764244|NCT00603746|156985892|FG004|Overall Study|Physician Decision|1|||
48764245|NCT00603746|156985893|FG005|Overall Study|Physician Decision|0|||
49024963|NCT01449630|157931390|FG005|Period 2|Sponsor Decision|0|||
49024964|NCT01449630|157931391|FG006|Period 2|Sponsor Decision|1|||
49024965|NCT01449630|157931392|FG007|Period 2|Sponsor Decision|0|||
49024966|NCT01449630|157931393|FG008|Period 2|Sponsor Decision|0|||
49024967|NCT01735630|157931399|FG000|Overall Study|Adverse Event|8|||
49024968|NCT01735630|157931400|FG001|Overall Study|Adverse Event|7|||
49024969|NCT01735630|157931399|FG000|Overall Study|Lost to Follow-up|1|||
49024970|NCT01735630|157931400|FG001|Overall Study|Lost to Follow-up|0|||
49024971|NCT01735630|157931399|FG000|Overall Study|Physician Decision|0|||
49024972|NCT01735630|157931400|FG001|Overall Study|Physician Decision|1|||
49024973|NCT01735630|157931399|FG000|Overall Study|Sponsor Decision|2|||
49024974|NCT01735630|157931400|FG001|Overall Study|Sponsor Decision|1|||
49024975|NCT01735630|157931399|FG000|Overall Study|Withdrawal by Subject|7|||
49024976|NCT01735630|157931400|FG001|Overall Study|Withdrawal by Subject|9|||
49024977|NCT03603314|157931401|FG000|Overall Study|Lost to Follow-up|0|||
49024978|NCT03603314|157931402|FG001|Overall Study|Lost to Follow-up|3|||
49024979|NCT03603314|157931403|FG002|Overall Study|Lost to Follow-up|0|||
48764246|NCT00603746|156985888|FG000|Overall Study|Withdrawal by Subject|1|||
49024980|NCT03603314|157931401|FG000|Overall Study|Protocol Violation|0|||
49024981|NCT03603314|157931402|FG001|Overall Study|Protocol Violation|1|||
49024982|NCT03603314|157931403|FG002|Overall Study|Protocol Violation|0|||
49024983|NCT03603314|157931401|FG000|Overall Study|Adverse Event|2|||
49024984|NCT03603314|157931402|FG001|Overall Study|Adverse Event|0|||
49024985|NCT03603314|157931403|FG002|Overall Study|Adverse Event|0|||
48764247|NCT00603746|156985889|FG001|Overall Study|Withdrawal by Subject|0|||
48764248|NCT00603746|156985890|FG002|Overall Study|Withdrawal by Subject|0|||
48764249|NCT00603746|156985891|FG003|Overall Study|Withdrawal by Subject|1|||
48764250|NCT00603746|156985892|FG004|Overall Study|Withdrawal by Subject|3|||
48764251|NCT00603746|156985893|FG005|Overall Study|Withdrawal by Subject|1|||
48764252|NCT01113879|156985896|FG000|Period 1: Block 1|Withdrawal by Subject|2|||
48764253|NCT01113879|156985897|FG001|Period 1: Block 1|Withdrawal by Subject|0|||
48764254|NCT03350503|156985904|FG000|Overall Study|Adverse Event|5|||
48764255|NCT03350503|156985904|FG000|Overall Study|Withdrawal by Subject|5|||
48764256|NCT03350503|156985904|FG000|Overall Study|Continuation impossible due to move|4|||
48764257|NCT03350503|156985904|FG000|Overall Study|Physician Decision|3|||
48764258|NCT03873987|156988122|FG000|Overall Study|Adverse Event|1|||
48764259|NCT03873987|156988123|FG001|Overall Study|Adverse Event|0|||
48764260|NCT03873987|156988122|FG000|Overall Study|staff was unable to start a new IV line|1|||
48764261|NCT03873987|156988123|FG001|Overall Study|staff was unable to start a new IV line|0|||
48764262|NCT03873987|156988122|FG000|Overall Study|Lost to Follow-up|0|||
48764263|NCT03873987|156988123|FG001|Overall Study|Lost to Follow-up|1|||
48764264|NCT01904604|156988124|FG000|Overall Study|Withdrew before receiving dosing|0|||
48764265|NCT01904604|156988125|FG001|Overall Study|Withdrew before receiving dosing|1|||
48764266|NCT01904604|156988126|FG002|Overall Study|Withdrew before receiving dosing|0|||
48764267|NCT01904604|156988124|FG000|Overall Study|Non-compliance|1|||
48764268|NCT01904604|156988125|FG001|Overall Study|Non-compliance|0|||
48764269|NCT01904604|156988126|FG002|Overall Study|Non-compliance|0|||
48764270|NCT01904604|156988124|FG000|Overall Study|Anxiety about OFC/Refused OFC|2|||
48764271|NCT01904604|156988125|FG001|Overall Study|Anxiety about OFC/Refused OFC|0|||
48764272|NCT01904604|156988126|FG002|Overall Study|Anxiety about OFC/Refused OFC|0|||
48764273|NCT01904604|156988124|FG000|Overall Study|Patch site reactions|1|||
48764274|NCT01904604|156988125|FG001|Overall Study|Patch site reactions|1|||
48764275|NCT01904604|156988126|FG002|Overall Study|Patch site reactions|0|||
48764276|NCT01904604|156988124|FG000|Overall Study|Increased syncope|0|||
48764277|NCT01904604|156988125|FG001|Overall Study|Increased syncope|1|||
48764278|NCT01904604|156988126|FG002|Overall Study|Increased syncope|0|||
48764279|NCT01904604|156988124|FG000|Overall Study|Unrelated illness|0|||
48764280|NCT01904604|156988125|FG001|Overall Study|Unrelated illness|1|||
48764281|NCT01904604|156988126|FG002|Overall Study|Unrelated illness|0|||
48764282|NCT01904604|156988124|FG000|Overall Study|Passed Week 52 OFC|1|||
49024986|NCT03603314|157931401|FG000|Overall Study|Physician Decision|1|||
48764283|NCT01904604|156988125|FG001|Overall Study|Passed Week 52 OFC|0|||
48764284|NCT01904604|156988126|FG002|Overall Study|Passed Week 52 OFC|0|||
48764285|NCT01904604|156988124|FG000|Overall Study|Withdrawal by Subject|1|||
48764286|NCT01904604|156988125|FG001|Overall Study|Withdrawal by Subject|2|||
48764287|NCT01904604|156988126|FG002|Overall Study|Withdrawal by Subject|0|||
48764288|NCT01904604|156988124|FG000|Overall Study|Participant Relocated|1|||
48764289|NCT01904604|156988125|FG001|Overall Study|Participant Relocated|1|||
48764290|NCT01904604|156988126|FG002|Overall Study|Participant Relocated|1|||
48764291|NCT01904604|156988124|FG000|Overall Study|Lost to Follow-up|0|||
48764292|NCT01904604|156988125|FG001|Overall Study|Lost to Follow-up|0|||
48764293|NCT01904604|156988126|FG002|Overall Study|Lost to Follow-up|1|||
48764294|NCT00666757|156988130|FG000|Overall Study|Lost to Follow-up|39|||
48764295|NCT00666757|156988131|FG001|Overall Study|Lost to Follow-up|35|||
48764296|NCT00666757|156988130|FG000|Overall Study|Protocol Violation|23|||
48764297|NCT00666757|156988131|FG001|Overall Study|Protocol Violation|24|||
48764298|NCT00666757|156988130|FG000|Overall Study|Adverse Event|22|||
48764299|NCT00666757|156988131|FG001|Overall Study|Adverse Event|12|||
48764300|NCT00666757|156988130|FG000|Overall Study|Withdrawal by Subject|13|||
48764301|NCT00666757|156988131|FG001|Overall Study|Withdrawal by Subject|17|||
48764302|NCT00666757|156988130|FG000|Overall Study|Lack of Efficacy|3|||
48764303|NCT00666757|156988131|FG001|Overall Study|Lack of Efficacy|6|||
48764304|NCT00666757|156988130|FG000|Overall Study|Physician Decision|0|||
48764305|NCT00666757|156988131|FG001|Overall Study|Physician Decision|2|||
48764306|NCT00666757|156988130|FG000|Overall Study|Sponsor decision|0|||
48764307|NCT00666757|156988131|FG001|Overall Study|Sponsor decision|1|||
48764308|NCT04145895|156988132|FG000|Overall Study|Physician Decision|2|||
48764309|NCT04145895|156988133|FG001|Overall Study|Physician Decision|0|||
48764310|NCT04145895|156988132|FG000|Overall Study|Withdrawal by Subject|0|||
48764311|NCT04145895|156988133|FG001|Overall Study|Withdrawal by Subject|2|||
48764312|NCT03616912|156988134|FG000|Overall Study|Adverse Event|17|||
48764313|NCT03616912|156988135|FG001|Overall Study|Adverse Event|21|||
48764314|NCT03616912|156988136|FG002|Overall Study|Adverse Event|9|||
48764315|NCT03616912|156988137|FG003|Overall Study|Adverse Event|0|||
48764316|NCT03616912|156988138|FG004|Overall Study|Adverse Event|0|||
48764317|NCT03616912|156988139|FG005|Overall Study|Adverse Event|0|||
48764318|NCT03616912|156988134|FG000|Overall Study|Death|1|||
48764319|NCT03616912|156988135|FG001|Overall Study|Death|1|||
48764320|NCT03616912|156988136|FG002|Overall Study|Death|0|||
48764321|NCT03616912|156988137|FG003|Overall Study|Death|0|||
48764322|NCT03616912|156988138|FG004|Overall Study|Death|0|||
48764323|NCT03616912|156988139|FG005|Overall Study|Death|0|||
48764324|NCT03616912|156988134|FG000|Overall Study|Lack of Efficacy|13|||
48764325|NCT03616912|156988135|FG001|Overall Study|Lack of Efficacy|6|||
48764326|NCT03616912|156988136|FG002|Overall Study|Lack of Efficacy|8|||
49024987|NCT03603314|157931402|FG001|Overall Study|Physician Decision|1|||
49024988|NCT03603314|157931403|FG002|Overall Study|Physician Decision|0|||
49024989|NCT03603314|157931401|FG000|Overall Study|Withdrawal by Subject|4|||
49024990|NCT03603314|157931402|FG001|Overall Study|Withdrawal by Subject|5|||
49024991|NCT03603314|157931403|FG002|Overall Study|Withdrawal by Subject|3|||
49024992|NCT03603314|157931401|FG000|Overall Study|Other|0|||
49024993|NCT03603314|157931402|FG001|Overall Study|Other|1|||
49024994|NCT03603314|157931403|FG002|Overall Study|Other|0|||
49024995|NCT01784068|157931405|FG000|NTCS Phase|Adverse Event|5|||
49024996|NCT01784068|157931406|FG001|NTCS Phase|Adverse Event|0|||
49024997|NCT01784068|157931405|FG000|NTCS Phase|Physician Decision|2|||
49024998|NCT01784068|157931406|FG001|NTCS Phase|Physician Decision|0|||
49024999|NCT01784068|157931405|FG000|NTCS Phase|Patient/guardian decision|3|||
49025000|NCT01784068|157931406|FG001|NTCS Phase|Patient/guardian decision|0|||
49025001|NCT01784068|157931405|FG000|NTCS Phase|Death|2|||
49025002|NCT01784068|157931406|FG001|NTCS Phase|Death|0|||
49025003|NCT01784068|157931405|FG000|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203|||
49025004|NCT01784068|157931406|FG001|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0|||
49025005|NCT01784068|157931405|FG000|TFR Phase|Physician Decision|0|||
49025006|NCT01784068|157931406|FG001|TFR Phase|Physician Decision|1|||
49025007|NCT01784068|157931405|FG000|TFR Phase|Patient/guardian decision|0|||
49025008|NCT01784068|157931406|FG001|TFR Phase|Patient/guardian decision|3|||
49025009|NCT01784068|157931405|FG000|TFR Phase|Death|0|||
49025010|NCT01784068|157931406|FG001|TFR Phase|Death|1|||
49025011|NCT01784068|157931405|FG000|TFR Phase|Lack of Efficacy|0|||
49025012|NCT01784068|157931406|FG001|TFR Phase|Lack of Efficacy|88|||
48764327|NCT03616912|156988137|FG003|Overall Study|Lack of Efficacy|4|||
48764328|NCT03616912|156988138|FG004|Overall Study|Lack of Efficacy|5|||
48764329|NCT03616912|156988139|FG005|Overall Study|Lack of Efficacy|1|||
48764330|NCT03616912|156988134|FG000|Overall Study|Lost to Follow-up|1|||
48764331|NCT03616912|156988135|FG001|Overall Study|Lost to Follow-up|2|||
48764332|NCT03616912|156988136|FG002|Overall Study|Lost to Follow-up|3|||
48764333|NCT03616912|156988137|FG003|Overall Study|Lost to Follow-up|0|||
48764334|NCT03616912|156988138|FG004|Overall Study|Lost to Follow-up|0|||
48764335|NCT03616912|156988139|FG005|Overall Study|Lost to Follow-up|0|||
48764336|NCT03616912|156988134|FG000|Overall Study|Due to Epidemic/Pandemic|4|||
48764337|NCT03616912|156988135|FG001|Overall Study|Due to Epidemic/Pandemic|2|||
48764338|NCT03616912|156988136|FG002|Overall Study|Due to Epidemic/Pandemic|5|||
48764339|NCT03616912|156988137|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
48764340|NCT03616912|156988138|FG004|Overall Study|Due to Epidemic/Pandemic|0|||
48764341|NCT03616912|156988139|FG005|Overall Study|Due to Epidemic/Pandemic|0|||
48764342|NCT03616912|156988134|FG000|Overall Study|Withdrawal by Subject|12|||
48764343|NCT03616912|156988135|FG001|Overall Study|Withdrawal by Subject|12|||
48764344|NCT03616912|156988136|FG002|Overall Study|Withdrawal by Subject|15|||
48764345|NCT03616912|156988137|FG003|Overall Study|Withdrawal by Subject|2|||
48764346|NCT03616912|156988138|FG004|Overall Study|Withdrawal by Subject|0|||
48764347|NCT03616912|156988139|FG005|Overall Study|Withdrawal by Subject|2|||
48764348|NCT03616912|156988134|FG000|Overall Study|Study Terminated by Sponsor|0|||
48764349|NCT03616912|156988135|FG001|Overall Study|Study Terminated by Sponsor|0|||
48764350|NCT03616912|156988136|FG002|Overall Study|Study Terminated by Sponsor|0|||
49025013|NCT05808257|157931407|FG000|Overall Study|Lost to Follow-up|8|||
49025014|NCT05808257|157931408|FG001|Overall Study|Lost to Follow-up|8|||
49025015|NCT04185909|157931409|FG000|Overall Study|Lost to Follow-up|1|||
49025016|NCT03639311|157931410|FG000|Maintenance Phase|Lost to Follow-up|1|||
48764351|NCT03616912|156988137|FG003|Overall Study|Study Terminated by Sponsor|10|||
48764352|NCT03616912|156988138|FG004|Overall Study|Study Terminated by Sponsor|9|||
48764353|NCT03616912|156988139|FG005|Overall Study|Study Terminated by Sponsor|11|||
48764354|NCT03616912|156988134|FG000|Overall Study|Protocol Deviation|1|||
48764355|NCT03616912|156988135|FG001|Overall Study|Protocol Deviation|1|||
48764356|NCT03616912|156988136|FG002|Overall Study|Protocol Deviation|0|||
48764357|NCT03616912|156988137|FG003|Overall Study|Protocol Deviation|0|||
48764358|NCT03616912|156988138|FG004|Overall Study|Protocol Deviation|0|||
48764359|NCT03616912|156988139|FG005|Overall Study|Protocol Deviation|0|||
48764360|NCT03616912|156988134|FG000|Overall Study|Pregnancy|1|||
48764361|NCT03616912|156988135|FG001|Overall Study|Pregnancy|0|||
48764362|NCT03616912|156988136|FG002|Overall Study|Pregnancy|4|||
48764363|NCT03616912|156988137|FG003|Overall Study|Pregnancy|0|||
48764364|NCT03616912|156988138|FG004|Overall Study|Pregnancy|0|||
48764365|NCT03616912|156988139|FG005|Overall Study|Pregnancy|0|||
48764366|NCT03616912|156988134|FG000|Overall Study|Protocol Violation|1|||
48764367|NCT03616912|156988135|FG001|Overall Study|Protocol Violation|0|||
48764368|NCT03616912|156988136|FG002|Overall Study|Protocol Violation|2|||
49025017|NCT03639311|157931411|FG001|Maintenance Phase|Lost to Follow-up|0|||
49025018|NCT03639311|157931412|FG002|Maintenance Phase|Lost to Follow-up|0|||
49025019|NCT03639311|157931410|FG000|Maintenance Phase|Adverse Event|1|||
49025020|NCT03639311|157931411|FG001|Maintenance Phase|Adverse Event|0|||
48764369|NCT03616912|156988137|FG003|Overall Study|Protocol Violation|0|||
48764370|NCT03616912|156988138|FG004|Overall Study|Protocol Violation|0|||
48764371|NCT03616912|156988139|FG005|Overall Study|Protocol Violation|0|||
48764372|NCT03616912|156988134|FG000|Overall Study|Physician Decision|2|||
48764373|NCT03616912|156988135|FG001|Overall Study|Physician Decision|0|||
48764374|NCT03616912|156988136|FG002|Overall Study|Physician Decision|0|||
48764375|NCT03616912|156988137|FG003|Overall Study|Physician Decision|0|||
48764376|NCT03616912|156988138|FG004|Overall Study|Physician Decision|1|||
48764377|NCT03616912|156988139|FG005|Overall Study|Physician Decision|0|||
48764378|NCT03616912|156988134|FG000|Overall Study|Randomized But Never Treated|0|||
48764379|NCT03616912|156988135|FG001|Overall Study|Randomized But Never Treated|2|||
48764380|NCT03616912|156988136|FG002|Overall Study|Randomized But Never Treated|0|||
48764381|NCT03616912|156988137|FG003|Overall Study|Randomized But Never Treated|0|||
48764382|NCT03616912|156988138|FG004|Overall Study|Randomized But Never Treated|0|||
48764383|NCT03616912|156988139|FG005|Overall Study|Randomized But Never Treated|0|||
48764384|NCT02780804|156988140|FG000|Overall Study|Death|1|||
48764385|NCT02780804|156988141|FG001|Overall Study|Death|0|||
48764386|NCT02780804|156988142|FG002|Overall Study|Death|0|||
48764387|NCT02780804|156988140|FG000|Overall Study|Lack of Efficacy|5|||
48764388|NCT02780804|156988141|FG001|Overall Study|Lack of Efficacy|8|||
48764389|NCT02780804|156988142|FG002|Overall Study|Lack of Efficacy|4|||
48764390|NCT02780804|156988140|FG000|Overall Study|Physician Decision|0|||
48764391|NCT02780804|156988141|FG001|Overall Study|Physician Decision|0|||
48764392|NCT02780804|156988142|FG002|Overall Study|Physician Decision|2|||
48764393|NCT02780804|156988140|FG000|Overall Study|Withdrawal by Subject|0|||
48764394|NCT02780804|156988141|FG001|Overall Study|Withdrawal by Subject|1|||
48764395|NCT02780804|156988142|FG002|Overall Study|Withdrawal by Subject|0|||
48764396|NCT01124604|156988143|FG000|Overall Study|Adverse Event|10|||
48764397|NCT01124604|156988144|FG001|Overall Study|Adverse Event|1|||
48764398|NCT01124604|156988143|FG000|Overall Study|Lack of Efficacy|1|||
48764399|NCT01124604|156988144|FG001|Overall Study|Lack of Efficacy|0|||
48764400|NCT01124604|156988143|FG000|Overall Study|Withdrawal by Subject|4|||
48764401|NCT01124604|156988144|FG001|Overall Study|Withdrawal by Subject|0|||
48764402|NCT01124604|156988143|FG000|Overall Study|Disease Progression|0|||
48764403|NCT01124604|156988144|FG001|Overall Study|Disease Progression|1|||
48764404|NCT02584504|156988145|FG000|Double-blind Treatment|Participant withdrew consent|0|||
48764405|NCT02584504|156988146|FG001|Double-blind Treatment|Participant withdrew consent|0|||
48764406|NCT02584504|156988147|FG002|Double-blind Treatment|Participant withdrew consent|1|||
48764407|NCT02584504|156988145|FG000|Double-blind Treatment|Adverse Event|0|||
48764408|NCT02584504|156988146|FG001|Double-blind Treatment|Adverse Event|1|||
48764409|NCT02584504|156988147|FG002|Double-blind Treatment|Adverse Event|0|||
48764410|NCT02584504|156988145|FG000|Double-blind Treatment|Family Matter|0|||
48764411|NCT02584504|156988146|FG001|Double-blind Treatment|Family Matter|1|||
48764412|NCT02584504|156988147|FG002|Double-blind Treatment|Family Matter|0|||
48764413|NCT02584504|156988145|FG000|Open-label Treatment|Participant withdrew consent|0|||
48764414|NCT02584504|156988146|FG001|Open-label Treatment|Participant withdrew consent|0|||
48764415|NCT02584504|156988147|FG002|Open-label Treatment|Participant withdrew consent|4|||
48764416|NCT02584504|156988145|FG000|Open-label Treatment|Adverse Event|2|||
48764417|NCT02584504|156988146|FG001|Open-label Treatment|Adverse Event|2|||
48764418|NCT02584504|156988147|FG002|Open-label Treatment|Adverse Event|3|||
48764419|NCT02584504|156988145|FG000|Open-label Treatment|Physician Decision|0|||
48764420|NCT02584504|156988146|FG001|Open-label Treatment|Physician Decision|1|||
48764421|NCT02584504|156988147|FG002|Open-label Treatment|Physician Decision|0|||
48764422|NCT02584504|156988145|FG000|Open-label Treatment|Entered but not treated|0|||
49025021|NCT03639311|157931412|FG002|Maintenance Phase|Adverse Event|0|||
48764423|NCT02584504|156988146|FG001|Open-label Treatment|Entered but not treated|1|||
48764424|NCT02584504|156988147|FG002|Open-label Treatment|Entered but not treated|1|||
48764425|NCT00539838|156988151|FG000|Overall Study|Fail to return|2|||
48764426|NCT00539838|156988152|FG001|Overall Study|Fail to return|0|||
48764427|NCT00539838|156988153|FG002|Overall Study|Fail to return|0|||
48764428|NCT00539838|156988151|FG000|Overall Study|Withdrawal by Subject|0|||
48764429|NCT00539838|156988152|FG001|Overall Study|Withdrawal by Subject|4|||
48764430|NCT00539838|156988153|FG002|Overall Study|Withdrawal by Subject|0|||
48764431|NCT00539838|156988151|FG000|Overall Study|Death|0|||
48764432|NCT00539838|156988152|FG001|Overall Study|Death|2|||
48764433|NCT00539838|156988153|FG002|Overall Study|Death|0|||
48764434|NCT00539838|156988151|FG000|Overall Study|Did not cooperate|1|||
48764435|NCT00539838|156988152|FG001|Overall Study|Did not cooperate|0|||
48764436|NCT00539838|156988153|FG002|Overall Study|Did not cooperate|1|||
48764437|NCT00539838|156988151|FG000|Overall Study|Administrative|4|||
48764438|NCT00539838|156988152|FG001|Overall Study|Administrative|0|||
48764439|NCT00539838|156988153|FG002|Overall Study|Administrative|8|||
48764440|NCT03090100|156988156|FG000|Overall Study|Adverse Event|9|||
48764441|NCT03090100|156988157|FG001|Overall Study|Adverse Event|11|||
48764442|NCT03090100|156988156|FG000|Overall Study|Pregnancy|1|||
48764443|NCT03090100|156988157|FG001|Overall Study|Pregnancy|1|||
48764444|NCT03090100|156988156|FG000|Overall Study|Lack of Efficacy|2|||
48764445|NCT03090100|156988157|FG001|Overall Study|Lack of Efficacy|7|||
48764446|NCT03090100|156988156|FG000|Overall Study|Lost to Follow-up|2|||
48764447|NCT03090100|156988157|FG001|Overall Study|Lost to Follow-up|2|||
48764448|NCT03090100|156988156|FG000|Overall Study|Withdrawal by Subject|7|||
48764449|NCT03090100|156988157|FG001|Overall Study|Withdrawal by Subject|19|||
48764450|NCT03090100|156988156|FG000|Overall Study|Protocol Violation|2|||
48764451|NCT03090100|156988157|FG001|Overall Study|Protocol Violation|6|||
48764452|NCT03090100|156988156|FG000|Overall Study|Non-compliance|2|||
48764453|NCT03090100|156988157|FG001|Overall Study|Non-compliance|0|||
48764454|NCT03090100|156988156|FG000|Overall Study|Other|2|||
48764455|NCT03090100|156988157|FG001|Overall Study|Other|2|||
48764456|NCT02506816|156988158|FG000|Overall Study|Adverse Event|3|||
48764457|NCT01316276|156988159|FG000|Overall Study|Death|1|||
48764458|NCT01316276|156988159|FG000|Overall Study|Adverse Event|19|||
48764459|NCT01316276|156988159|FG000|Overall Study|Withdrawal of consent|24|||
48764460|NCT01316276|156988159|FG000|Overall Study|Lost to Follow-up|1|||
48764461|NCT01316276|156988159|FG000|Overall Study|Other|22|||
48764462|NCT01652664|156988160|FG000|Overall Study|Treatment Failure|5|||
48764463|NCT01652664|156988161|FG001|Overall Study|Treatment Failure|1|||
48764464|NCT01652664|156988160|FG000|Overall Study|Inadequate IOP control|1|||
48764465|NCT01652664|156988161|FG001|Overall Study|Inadequate IOP control|0|||
48764466|NCT00581776|156988162|FG000|Overall Study|Disease progression or no response|3|||
48764467|NCT02120950|156988167|FG000|Overall Study|Adverse Event|5|||
48764468|NCT02120950|156988168|FG001|Overall Study|Adverse Event|4|||
48764469|NCT02120950|156988169|FG002|Overall Study|Adverse Event|3|||
48764470|NCT02120950|156988167|FG000|Overall Study|Death|3|||
48764471|NCT02120950|156988168|FG001|Overall Study|Death|0|||
48764472|NCT02120950|156988169|FG002|Overall Study|Death|1|||
48764473|NCT02120950|156988167|FG000|Overall Study|Withdrawal by Subject|6|||
48764474|NCT02120950|156988168|FG001|Overall Study|Withdrawal by Subject|3|||
48764475|NCT02120950|156988169|FG002|Overall Study|Withdrawal by Subject|2|||
48764476|NCT02120950|156988167|FG000|Overall Study|Protocol Violation|1|||
48764477|NCT02120950|156988168|FG001|Overall Study|Protocol Violation|1|||
48764478|NCT02120950|156988169|FG002|Overall Study|Protocol Violation|7|||
48764479|NCT02120950|156988167|FG000|Overall Study|Other reasons|5|||
48764480|NCT02120950|156988168|FG001|Overall Study|Other reasons|4|||
48764481|NCT02120950|156988169|FG002|Overall Study|Other reasons|1|||
48764482|NCT02120950|156988167|FG000|Overall Study|Lost to Follow-up|0|||
48764483|NCT02120950|156988168|FG001|Overall Study|Lost to Follow-up|2|||
48764484|NCT02120950|156988169|FG002|Overall Study|Lost to Follow-up|1|||
48764485|NCT03329690|156988170|FG000|Overall Study|Progressive disease per RECIST|85|||
48764486|NCT03329690|156988171|FG001|Overall Study|Progressive disease per RECIST|44|||
48764487|NCT03329690|156988172|FG002|Overall Study|Progressive disease per RECIST|6|||
48764488|NCT03329690|156988173|FG003|Overall Study|Progressive disease per RECIST|16|||
48764489|NCT03329690|156988174|FG004|Overall Study|Progressive disease per RECIST|20|||
48764490|NCT03329690|156988170|FG000|Overall Study|Clinical progression|7|||
48764491|NCT03329690|156988171|FG001|Overall Study|Clinical progression|4|||
48764492|NCT03329690|156988172|FG002|Overall Study|Clinical progression|1|||
48764493|NCT03329690|156988173|FG003|Overall Study|Clinical progression|1|||
48764494|NCT03329690|156988174|FG004|Overall Study|Clinical progression|1|||
48764495|NCT03329690|156988170|FG000|Overall Study|Adverse Event|22|||
48764496|NCT03329690|156988171|FG001|Overall Study|Adverse Event|4|||
48764497|NCT03329690|156988172|FG002|Overall Study|Adverse Event|0|||
48764498|NCT03329690|156988173|FG003|Overall Study|Adverse Event|1|||
48764499|NCT03329690|156988174|FG004|Overall Study|Adverse Event|2|||
48764500|NCT03329690|156988170|FG000|Overall Study|Death|2|||
48764501|NCT03329690|156988171|FG001|Overall Study|Death|0|||
48764502|NCT03329690|156988172|FG002|Overall Study|Death|0|||
48764503|NCT03329690|156988173|FG003|Overall Study|Death|1|||
48764504|NCT03329690|156988174|FG004|Overall Study|Death|0|||
48764505|NCT03329690|156988170|FG000|Overall Study|Withdrawal by Subject|2|||
48764506|NCT03329690|156988171|FG001|Overall Study|Withdrawal by Subject|3|||
48764507|NCT03329690|156988172|FG002|Overall Study|Withdrawal by Subject|0|||
48764508|NCT03329690|156988173|FG003|Overall Study|Withdrawal by Subject|1|||
48764509|NCT03329690|156988174|FG004|Overall Study|Withdrawal by Subject|0|||
48764510|NCT03329690|156988170|FG000|Overall Study|Physician Decision|1|||
48764511|NCT03329690|156988171|FG001|Overall Study|Physician Decision|0|||
48764512|NCT03329690|156988172|FG002|Overall Study|Physician Decision|0|||
48764513|NCT03329690|156988173|FG003|Overall Study|Physician Decision|0|||
48764514|NCT03329690|156988174|FG004|Overall Study|Physician Decision|1|||
48764515|NCT03329690|156988170|FG000|Overall Study|Miscellaneous|6|||
48764516|NCT03329690|156988171|FG001|Overall Study|Miscellaneous|0|||
48764517|NCT03329690|156988172|FG002|Overall Study|Miscellaneous|0|||
48764518|NCT03329690|156988173|FG003|Overall Study|Miscellaneous|0|||
48764519|NCT03329690|156988174|FG004|Overall Study|Miscellaneous|0|||
48764520|NCT03329690|156988170|FG000|Overall Study|Did not receive treatment|1|||
48764521|NCT03329690|156988171|FG001|Overall Study|Did not receive treatment|0|||
48764522|NCT03329690|156988172|FG002|Overall Study|Did not receive treatment|0|||
48764523|NCT03329690|156988173|FG003|Overall Study|Did not receive treatment|1|||
48764524|NCT03329690|156988174|FG004|Overall Study|Did not receive treatment|0|||
48764525|NCT02018458|156988175|FG000|Overall Study|Death|4|||
48764526|NCT01752855|156988176|FG000|Overall Study|Adverse Event|1|||
49025022|NCT03639311|157931410|FG000|Maintenance Phase|DECISION BY SUBJECT OR PROXY|7|||
49025023|NCT03639311|157931411|FG001|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
49025024|NCT03639311|157931412|FG002|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
49025025|NCT03639311|157931410|FG000|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|3|||
49025026|NCT03639311|157931411|FG001|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
49025027|NCT03639311|157931412|FG002|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
49025028|NCT03639311|157931410|FG000|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
49025029|NCT03639311|157931411|FG001|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
48764527|NCT01752855|156988177|FG001|Overall Study|Adverse Event|0|||
48764528|NCT01752855|156988176|FG000|Overall Study|Withdrew Consent|0|||
48764529|NCT01752855|156988177|FG001|Overall Study|Withdrew Consent|2|||
48764530|NCT01752855|156988176|FG000|Overall Study|Lack of Efficacy|0|||
48764531|NCT01752855|156988177|FG001|Overall Study|Lack of Efficacy|2|||
48764532|NCT04649164|156988181|FG000|Overall Study|Withdrawal by Subject|1|||
48764533|NCT04649164|156988182|FG001|Overall Study|Withdrawal by Subject|1|||
48764534|NCT04649164|156988183|FG002|Overall Study|Withdrawal by Subject|2|||
48764535|NCT04649164|156988181|FG000|Overall Study|Participant's care recipient expired|0|||
48764536|NCT04649164|156988182|FG001|Overall Study|Participant's care recipient expired|0|||
48764537|NCT04649164|156988183|FG002|Overall Study|Participant's care recipient expired|2|||
48764538|NCT02053753|156988184|FG000|Overall Study|Withdrawal by Subject|2|||
48764539|NCT02053753|156988185|FG001|Overall Study|Withdrawal by Subject|4|||
48764540|NCT02053753|156988184|FG000|Overall Study|Decision by Sponsor|1|||
48764541|NCT02053753|156988185|FG001|Overall Study|Decision by Sponsor|1|||
48764542|NCT02053753|156988184|FG000|Overall Study|Lost to Follow-up|4|||
48764543|NCT02053753|156988185|FG001|Overall Study|Lost to Follow-up|3|||
48764544|NCT02439320|156988186|FG000|Overall Study|Adverse Event|0|||
48764545|NCT02439320|156988187|FG001|Overall Study|Adverse Event|2|||
48764546|NCT02439320|156988188|FG002|Overall Study|Adverse Event|0|||
48764547|NCT02439320|156988186|FG000|Overall Study|Lost to Follow-up|37|||
48764548|NCT02439320|156988187|FG001|Overall Study|Lost to Follow-up|34|||
48764549|NCT02439320|156988188|FG002|Overall Study|Lost to Follow-up|42|||
48764550|NCT02439320|156988186|FG000|Overall Study|Death|0|||
48764551|NCT02439320|156988187|FG001|Overall Study|Death|1|||
48764552|NCT02439320|156988188|FG002|Overall Study|Death|0|||
48764553|NCT02439320|156988186|FG000|Overall Study|Noncompliance with Protocol|10|||
48764554|NCT02439320|156988187|FG001|Overall Study|Noncompliance with Protocol|11|||
48764555|NCT02439320|156988188|FG002|Overall Study|Noncompliance with Protocol|7|||
48764556|NCT02439320|156988186|FG000|Overall Study|Pregnancy|0|||
48764557|NCT02439320|156988187|FG001|Overall Study|Pregnancy|1|||
48764558|NCT02439320|156988188|FG002|Overall Study|Pregnancy|1|||
48764559|NCT02439320|156988186|FG000|Overall Study|Withdrawal by Subject|12|||
48764560|NCT02439320|156988187|FG001|Overall Study|Withdrawal by Subject|16|||
48764561|NCT02439320|156988188|FG002|Overall Study|Withdrawal by Subject|14|||
48764562|NCT02439320|156988186|FG000|Overall Study|Physician Decision|2|||
48764563|NCT02439320|156988187|FG001|Overall Study|Physician Decision|1|||
49025030|NCT03639311|157931412|FG002|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
49025031|NCT03639311|157931410|FG000|Maintenance Phase|Lack of Efficacy|1|||
48764564|NCT02439320|156988188|FG002|Overall Study|Physician Decision|0|||
48764565|NCT02439320|156988186|FG000|Overall Study|Sponsor Request|0|||
48764566|NCT02439320|156988187|FG001|Overall Study|Sponsor Request|2|||
48764567|NCT02439320|156988188|FG002|Overall Study|Sponsor Request|1|||
48764568|NCT02439320|156988186|FG000|Overall Study|Randomization Failure|35|||
48764569|NCT02439320|156988187|FG001|Overall Study|Randomization Failure|46|||
48764570|NCT02439320|156988188|FG002|Overall Study|Randomization Failure|34|||
49025032|NCT03639311|157931411|FG001|Maintenance Phase|Lack of Efficacy|0|||
48764571|NCT00116558|156988189|FG000|Overall Study|Death|11|||
48764572|NCT00116558|156988190|FG001|Overall Study|Death|5|||
48764573|NCT00116558|156988191|FG002|Overall Study|Death|3|||
48764574|NCT00116558|156988189|FG000|Overall Study|Withdrawal by Subject|17|||
48764575|NCT00116558|156988190|FG001|Overall Study|Withdrawal by Subject|3|||
48764576|NCT00116558|156988191|FG002|Overall Study|Withdrawal by Subject|12|||
48764577|NCT00116558|156988189|FG000|Overall Study|disease progression|3|||
48764578|NCT00116558|156988190|FG001|Overall Study|disease progression|7|||
48764579|NCT00116558|156988191|FG002|Overall Study|disease progression|18|||
48764580|NCT02972632|156988192|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
48764581|NCT02972632|156988192|FG000|Overall Study|Lost to Follow-up|4|||
48764582|NCT02972632|156988192|FG000|Overall Study|Voluntary Withdrawal|10|||
48764583|NCT03450707|156988193|FG000|Overall Study|Outside enrollment window|4|||
48764584|NCT03450707|156988194|FG001|Overall Study|Outside enrollment window|1|||
48764585|NCT03450707|156988193|FG000|Overall Study|Death|1|||
48764586|NCT03450707|156988194|FG001|Overall Study|Death|0|||
48764587|NCT03450707|156988193|FG000|Overall Study|Indication for thiamine|1|||
48764588|NCT03450707|156988194|FG001|Overall Study|Indication for thiamine|1|||
48764589|NCT03450707|156988193|FG000|Overall Study|Evidence of traumatic brain injury|1|||
48764590|NCT03450707|156988194|FG001|Overall Study|Evidence of traumatic brain injury|0|||
48764591|NCT03450707|156988193|FG000|Overall Study|Following commands|0|||
48764592|NCT03450707|156988194|FG001|Overall Study|Following commands|3|||
48764593|NCT03450707|156988193|FG000|Overall Study|Lactate < 3.5|0|||
48764594|NCT03450707|156988194|FG001|Overall Study|Lactate < 3.5|2|||
48764595|NCT03450707|156988193|FG000|Overall Study|Rearrest with ECMO|0|||
48764596|NCT03450707|156988194|FG001|Overall Study|Rearrest with ECMO|1|||
48764597|NCT03450707|156988193|FG000|Overall Study|Indication for thiamine + head CT results|0|||
48764598|NCT03450707|156988194|FG001|Overall Study|Indication for thiamine + head CT results|1|||
48764599|NCT03450707|156988193|FG000|Overall Study|Family/patient goals of care|0|||
48764600|NCT03450707|156988194|FG001|Overall Study|Family/patient goals of care|1|||
48764601|NCT03343483|156988195|FG000|Overall Study|Death|0|||
48764602|NCT03343483|156988196|FG001|Overall Study|Death|3|||
48764603|NCT03343483|156988195|FG000|Overall Study|Lost to Follow-up|9|||
48764604|NCT03343483|156988196|FG001|Overall Study|Lost to Follow-up|13|||
48764605|NCT03343483|156988195|FG000|Overall Study|Withdrawal by Subject|8|||
48764606|NCT03343483|156988196|FG001|Overall Study|Withdrawal by Subject|17|||
48764607|NCT01452412|156988202|FG000|Overall Study|Withdrawal by Subject|15|||
48764608|NCT01452412|156988203|FG001|Overall Study|Withdrawal by Subject|11|||
48764609|NCT01452412|156988202|FG000|Overall Study|Adverse Event|4|||
48764610|NCT01452412|156988203|FG001|Overall Study|Adverse Event|3|||
48764611|NCT01452412|156988202|FG000|Overall Study|Lost to Follow-up|5|||
48764612|NCT01452412|156988203|FG001|Overall Study|Lost to Follow-up|3|||
48764613|NCT01452412|156988202|FG000|Overall Study|Death|1|||
48764614|NCT01452412|156988203|FG001|Overall Study|Death|0|||
48764615|NCT01452412|156988202|FG000|Overall Study|Initiated dialysis|1|||
48764616|NCT01452412|156988203|FG001|Overall Study|Initiated dialysis|0|||
48764617|NCT01452412|156988202|FG000|Overall Study|Other|2|||
48764618|NCT01452412|156988203|FG001|Overall Study|Other|0|||
48764619|NCT00453999|156988204|FG000|Overall Study|Adverse Event|1|||
48764620|NCT00453999|156988205|FG001|Overall Study|Adverse Event|2|||
48764621|NCT00453999|156988206|FG002|Overall Study|Adverse Event|1|||
48764622|NCT00453999|156988204|FG000|Overall Study|Lost to Follow-up|0|||
48764623|NCT00453999|156988205|FG001|Overall Study|Lost to Follow-up|1|||
48764624|NCT00453999|156988206|FG002|Overall Study|Lost to Follow-up|1|||
48764625|NCT00453999|156988204|FG000|Overall Study|Withdrawal by Subject|2|||
48764626|NCT00453999|156988205|FG001|Overall Study|Withdrawal by Subject|1|||
48764627|NCT00453999|156988206|FG002|Overall Study|Withdrawal by Subject|1|||
48764628|NCT00453999|156988204|FG000|Overall Study|Subject Request|2|||
48764629|NCT00453999|156988205|FG001|Overall Study|Subject Request|1|||
48764630|NCT00453999|156988206|FG002|Overall Study|Subject Request|0|||
48764631|NCT00579826|156988208|FG000|Overall Study|Withdrawal by Subject|5|||
48764632|NCT00579826|156988209|FG001|Overall Study|Withdrawal by Subject|3|||
48875500|NCT00550446|157381647|FG006|Post Week 12|Withdrawal by Subject|0|||
48692276|NCT03982199|156722569|FG001|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
48692277|NCT03982199|156722570|FG002|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
48692278|NCT03982199|156722571|FG003|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
48692279|NCT03982199|156722572|FG004|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
48692280|NCT03982199|156722573|FG005|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
48692281|NCT03982199|156722574|FG006|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
48692282|NCT03982199|156722575|FG007|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
48692283|NCT03982199|156722576|FG008|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
48692284|NCT03982199|156722577|FG009|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|1|||
48692285|NCT03982199|156722578|FG010|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
48764633|NCT02659020|156988212|FG000|Overall Study|Adverse Event|0|||
48764634|NCT02659020|156988213|FG001|Overall Study|Adverse Event|0|||
48764635|NCT02659020|156988214|FG002|Overall Study|Adverse Event|0|||
48764636|NCT02659020|156988215|FG003|Overall Study|Adverse Event|2|||
48764637|NCT02659020|156988216|FG004|Overall Study|Adverse Event|0|||
48764638|NCT02659020|156988217|FG005|Overall Study|Adverse Event|0|||
48764639|NCT02659020|156988218|FG006|Overall Study|Adverse Event|2|||
48764640|NCT02659020|156988212|FG000|Overall Study|Lost to Follow-up|1|||
48764641|NCT02659020|156988213|FG001|Overall Study|Lost to Follow-up|2|||
48764642|NCT02659020|156988214|FG002|Overall Study|Lost to Follow-up|1|||
48764643|NCT02659020|156988215|FG003|Overall Study|Lost to Follow-up|6|||
48764644|NCT02659020|156988216|FG004|Overall Study|Lost to Follow-up|1|||
48764645|NCT02659020|156988217|FG005|Overall Study|Lost to Follow-up|5|||
48764646|NCT02659020|156988218|FG006|Overall Study|Lost to Follow-up|0|||
48764647|NCT02659020|156988212|FG000|Overall Study|Physician Decision|0|||
48764648|NCT02659020|156988213|FG001|Overall Study|Physician Decision|0|||
48764649|NCT02659020|156988214|FG002|Overall Study|Physician Decision|0|||
48764650|NCT02659020|156988215|FG003|Overall Study|Physician Decision|1|||
48764651|NCT02659020|156988216|FG004|Overall Study|Physician Decision|1|||
48764652|NCT02659020|156988217|FG005|Overall Study|Physician Decision|0|||
48764653|NCT02659020|156988218|FG006|Overall Study|Physician Decision|1|||
48764654|NCT02659020|156988212|FG000|Overall Study|Withdrawal by Subject|2|||
48764655|NCT02659020|156988213|FG001|Overall Study|Withdrawal by Subject|1|||
48764656|NCT02659020|156988214|FG002|Overall Study|Withdrawal by Subject|0|||
48764657|NCT02659020|156988215|FG003|Overall Study|Withdrawal by Subject|3|||
48764658|NCT02659020|156988216|FG004|Overall Study|Withdrawal by Subject|3|||
48764659|NCT02659020|156988217|FG005|Overall Study|Withdrawal by Subject|6|||
48764660|NCT02659020|156988218|FG006|Overall Study|Withdrawal by Subject|3|||
48764661|NCT02659020|156988212|FG000|Overall Study|Progressive Disease|0|||
48764662|NCT02659020|156988213|FG001|Overall Study|Progressive Disease|0|||
48764663|NCT02659020|156988214|FG002|Overall Study|Progressive Disease|0|||
48764664|NCT02659020|156988215|FG003|Overall Study|Progressive Disease|4|||
48764665|NCT02659020|156988216|FG004|Overall Study|Progressive Disease|1|||
48764666|NCT02659020|156988217|FG005|Overall Study|Progressive Disease|0|||
48764667|NCT02659020|156988218|FG006|Overall Study|Progressive Disease|2|||
48764668|NCT02404350|156988219|FG000|Overall Study|Adverse Event|2|||
48764669|NCT02404350|156988220|FG001|Overall Study|Adverse Event|2|||
48764670|NCT02404350|156988221|FG002|Overall Study|Adverse Event|3|||
48764671|NCT02404350|156988222|FG003|Overall Study|Adverse Event|9|||
48764672|NCT02404350|156988219|FG000|Overall Study|Lack of Efficacy|3|||
48875501|NCT00550446|157381648|FG007|Post Week 12|Withdrawal by Subject|0|||
48875502|NCT00550446|157381649|FG008|Post Week 12|Withdrawal by Subject|0|||
48875503|NCT00550446|157381650|FG009|Post Week 12|Withdrawal by Subject|0|||
48875504|NCT00550446|157381651|FG010|Post Week 12|Withdrawal by Subject|0|||
48875505|NCT00550446|157381641|FG000|Post Week 12|Other|1|||
49025033|NCT03639311|157931412|FG002|Maintenance Phase|Lack of Efficacy|0|||
48875506|NCT00550446|157381642|FG001|Post Week 12|Other|1|||
49025034|NCT00565448|157931415|FG000|Overall Study|Adverse Event|1|||
48764673|NCT02404350|156988220|FG001|Overall Study|Lack of Efficacy|1|||
48764674|NCT02404350|156988221|FG002|Overall Study|Lack of Efficacy|0|||
48764675|NCT02404350|156988222|FG003|Overall Study|Lack of Efficacy|3|||
48764676|NCT02404350|156988219|FG000|Overall Study|Lost to Follow-up|2|||
48764677|NCT02404350|156988220|FG001|Overall Study|Lost to Follow-up|0|||
48764678|NCT02404350|156988221|FG002|Overall Study|Lost to Follow-up|0|||
48764679|NCT02404350|156988222|FG003|Overall Study|Lost to Follow-up|1|||
48764680|NCT02404350|156988219|FG000|Overall Study|Physician Decision|1|||
48764681|NCT02404350|156988220|FG001|Overall Study|Physician Decision|0|||
48764682|NCT02404350|156988221|FG002|Overall Study|Physician Decision|0|||
48764683|NCT02404350|156988222|FG003|Overall Study|Physician Decision|2|||
48764684|NCT02404350|156988219|FG000|Overall Study|Pregnancy|0|||
48764685|NCT02404350|156988220|FG001|Overall Study|Pregnancy|0|||
48764686|NCT02404350|156988221|FG002|Overall Study|Pregnancy|0|||
48764687|NCT02404350|156988222|FG003|Overall Study|Pregnancy|1|||
48764688|NCT02404350|156988219|FG000|Overall Study|Withdrawal by Subject|7|||
48764689|NCT02404350|156988220|FG001|Overall Study|Withdrawal by Subject|3|||
48764690|NCT02404350|156988221|FG002|Overall Study|Withdrawal by Subject|3|||
48764691|NCT02404350|156988222|FG003|Overall Study|Withdrawal by Subject|19|||
48764692|NCT02404350|156988219|FG000|Overall Study|Due to Non-compliance with treatment|0|||
48764693|NCT02404350|156988220|FG001|Overall Study|Due to Non-compliance with treatment|0|||
48764694|NCT02404350|156988221|FG002|Overall Study|Due to Non-compliance with treatment|0|||
48764695|NCT02404350|156988222|FG003|Overall Study|Due to Non-compliance with treatment|1|||
48764696|NCT02404350|156988219|FG000|Overall Study|Due to Technical problems|0|||
48764697|NCT02404350|156988220|FG001|Overall Study|Due to Technical problems|0|||
48764698|NCT02404350|156988221|FG002|Overall Study|Due to Technical problems|0|||
48764699|NCT02404350|156988222|FG003|Overall Study|Due to Technical problems|1|||
48764700|NCT01417481|156988225|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
48764701|NCT01417481|156988226|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
48764702|NCT01364428|156988227|FG000|Overall Study|Adverse Event|1|||
48764703|NCT01364428|156988228|FG001|Overall Study|Adverse Event|2|||
48764704|NCT01364428|156988227|FG000|Overall Study|Protocol Violation|2|||
48764705|NCT01364428|156988228|FG001|Overall Study|Protocol Violation|0|||
48764706|NCT01364428|156988227|FG000|Overall Study|Withdrawal Criteria|14|||
48764707|NCT01364428|156988228|FG001|Overall Study|Withdrawal Criteria|10|||
48764708|NCT01364428|156988227|FG000|Overall Study|Other|3|||
48764709|NCT01364428|156988228|FG001|Overall Study|Other|3|||
48764710|NCT00600756|156988229|FG000|Analysis After 6 Months|Adverse Event|43|||
48764711|NCT00600756|156988230|FG001|Analysis After 6 Months|Adverse Event|33|||
48764712|NCT00600756|156988229|FG000|Analysis After 6 Months|Withdrawal by Subject|38|||
48764713|NCT00600756|156988230|FG001|Analysis After 6 Months|Withdrawal by Subject|30|||
48764714|NCT00600756|156988229|FG000|Analysis After 6 Months|Incorrect Enrollment|12|||
48764715|NCT00600756|156988230|FG001|Analysis After 6 Months|Incorrect Enrollment|21|||
48764716|NCT00600756|156988229|FG000|Analysis After 6 Months|worsening symptom, lack of efficacy|11|||
48764717|NCT00600756|156988230|FG001|Analysis After 6 Months|worsening symptom, lack of efficacy|14|||
48764718|NCT00600756|156988229|FG000|Analysis After 6 Months|Severe non-compliance to protocol|11|||
48764719|NCT00600756|156988230|FG001|Analysis After 6 Months|Severe non-compliance to protocol|11|||
48764720|NCT00600756|156988229|FG000|Analysis After 6 Months|Lost to Follow-up|10|||
48764721|NCT00600756|156988230|FG001|Analysis After 6 Months|Lost to Follow-up|8|||
48764722|NCT00600756|156988229|FG000|Analysis After 6 Months|Study-specific discontinuation criteria|6|||
48764723|NCT00600756|156988230|FG001|Analysis After 6 Months|Study-specific discontinuation criteria|3|||
48764724|NCT00600756|156988229|FG000|Overall Study Analysis After 12 Months|Adverse Event|53|||
48764725|NCT00600756|156988230|FG001|Overall Study Analysis After 12 Months|Adverse Event|44|||
48764726|NCT00600756|156988229|FG000|Overall Study Analysis After 12 Months|Withdrawal by Subject|51|||
48764727|NCT00600756|156988230|FG001|Overall Study Analysis After 12 Months|Withdrawal by Subject|41|||
48764728|NCT00600756|156988229|FG000|Overall Study Analysis After 12 Months|Incorrect enrollment|21|||
48764729|NCT00600756|156988230|FG001|Overall Study Analysis After 12 Months|Incorrect enrollment|29|||
48764730|NCT00600756|156988229|FG000|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17|||
48764731|NCT00600756|156988230|FG001|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20|||
48764732|NCT00600756|156988229|FG000|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16|||
48764733|NCT00600756|156988230|FG001|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20|||
48764734|NCT00600756|156988229|FG000|Overall Study Analysis After 12 Months|Lost to Follow-up|16|||
48764735|NCT00600756|156988230|FG001|Overall Study Analysis After 12 Months|Lost to Follow-up|13|||
48764736|NCT00600756|156988229|FG000|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
48764737|NCT00600756|156988230|FG001|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
48764738|NCT02063737|156988232|FG000|Overall Study|Lost to Follow-up|11|||
48764739|NCT02063737|156988233|FG001|Overall Study|Lost to Follow-up|4|||
48764740|NCT01526889|156988234|FG000|Treatment Period|Adverse Event|2|||
48875507|NCT00550446|157381643|FG002|Post Week 12|Other|0|||
48692286|NCT03982199|156722579|FG011|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
48764741|NCT01526889|156988235|FG001|Treatment Period|Adverse Event|0|||
48764742|NCT01526889|156988234|FG000|Treatment Extension Period|Administrative problems|1|||
48692287|NCT03982199|156722580|FG012|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
48692288|NCT03982199|156722581|FG013|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
48692289|NCT03982199|156722568|FG000|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
48692290|NCT03982199|156722569|FG001|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
48692291|NCT03982199|156722570|FG002|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
48692292|NCT03982199|156722571|FG003|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
48692293|NCT03982199|156722572|FG004|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
48692294|NCT03982199|156722573|FG005|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
48692295|NCT03982199|156722574|FG006|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
48692296|NCT03982199|156722575|FG007|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
48692297|NCT03982199|156722576|FG008|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
48692298|NCT03982199|156722577|FG009|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
48692299|NCT03982199|156722578|FG010|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
48692300|NCT03982199|156722579|FG011|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
48692301|NCT03982199|156722580|FG012|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
48692302|NCT03982199|156722581|FG013|Revacc Subcohort (From Day 1095 to 1460)|Death|1|||
48692303|NCT03982199|156722568|FG000|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
48692304|NCT03982199|156722569|FG001|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
48692305|NCT03982199|156722570|FG002|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
48692306|NCT03982199|156722571|FG003|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
48692307|NCT03982199|156722572|FG004|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
48692308|NCT03982199|156722573|FG005|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
48692309|NCT03982199|156722574|FG006|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
48692310|NCT03982199|156722575|FG007|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
48692311|NCT03982199|156722576|FG008|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
48692312|NCT03982199|156722577|FG009|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
48692313|NCT03982199|156722578|FG010|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|1|||
48692314|NCT03982199|156722579|FG011|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|2|||
48692315|NCT03982199|156722580|FG012|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|4|||
48692316|NCT03982199|156722581|FG013|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
48692317|NCT03982199|156722568|FG000|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
48692318|NCT03982199|156722569|FG001|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
48692319|NCT03982199|156722570|FG002|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
48692320|NCT03982199|156722571|FG003|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
48692321|NCT03982199|156722572|FG004|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
48692322|NCT03982199|156722573|FG005|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
48692323|NCT03982199|156722574|FG006|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
48692324|NCT03982199|156722575|FG007|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
48692325|NCT03982199|156722576|FG008|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
48692326|NCT03982199|156722577|FG009|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
48692327|NCT03982199|156722578|FG010|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
48692328|NCT03982199|156722579|FG011|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
48692329|NCT03982199|156722580|FG012|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
48764743|NCT01526889|156988235|FG001|Treatment Extension Period|Administrative problems|0|||
48764744|NCT00694369|156988236|FG000|Overall Study|Adverse Event|0|||
48764745|NCT00694369|156988237|FG001|Overall Study|Adverse Event|1|||
48764746|NCT00694369|156988238|FG002|Overall Study|Adverse Event|0|||
48764747|NCT00694369|156988239|FG003|Overall Study|Adverse Event|1|||
48764748|NCT00694369|156988240|FG004|Overall Study|Adverse Event|3|||
48764749|NCT00694369|156988236|FG000|Overall Study|Lost to Follow-up|0|||
48764750|NCT00694369|156988237|FG001|Overall Study|Lost to Follow-up|0|||
48764751|NCT00694369|156988238|FG002|Overall Study|Lost to Follow-up|1|||
48764752|NCT00694369|156988239|FG003|Overall Study|Lost to Follow-up|1|||
48764753|NCT00694369|156988240|FG004|Overall Study|Lost to Follow-up|0|||
48764754|NCT00694369|156988236|FG000|Overall Study|Physician Decision|0|||
48764755|NCT00694369|156988237|FG001|Overall Study|Physician Decision|0|||
48764756|NCT00694369|156988238|FG002|Overall Study|Physician Decision|0|||
48764757|NCT00694369|156988239|FG003|Overall Study|Physician Decision|0|||
48764758|NCT00694369|156988240|FG004|Overall Study|Physician Decision|1|||
48764759|NCT00694369|156988236|FG000|Overall Study|Protocol Violation|0|||
48764760|NCT00694369|156988237|FG001|Overall Study|Protocol Violation|1|||
48764761|NCT00694369|156988238|FG002|Overall Study|Protocol Violation|0|||
48764762|NCT00694369|156988239|FG003|Overall Study|Protocol Violation|0|||
48764763|NCT00694369|156988240|FG004|Overall Study|Protocol Violation|0|||
48764764|NCT00694369|156988236|FG000|Overall Study|Withdrawal by Subject|1|||
48764765|NCT00694369|156988237|FG001|Overall Study|Withdrawal by Subject|1|||
48764766|NCT00694369|156988238|FG002|Overall Study|Withdrawal by Subject|1|||
48764767|NCT00694369|156988239|FG003|Overall Study|Withdrawal by Subject|1|||
48764768|NCT00694369|156988240|FG004|Overall Study|Withdrawal by Subject|2|||
48764769|NCT02871739|156988245|FG000|Overall Study|Lost to Follow-up|3|||
48764770|NCT02871739|156988246|FG001|Overall Study|Lost to Follow-up|2|||
48764771|NCT02871739|156988247|FG002|Overall Study|Lost to Follow-up|0|||
48764772|NCT02871739|156988248|FG003|Overall Study|Lost to Follow-up|2|||
48764773|NCT03131440|156988249|FG000|Overall Study|Withdrawal by Subject|1|||
48764774|NCT03131440|156988250|FG001|Overall Study|Withdrawal by Subject|3|||
48764775|NCT03131440|156988251|FG002|Overall Study|Withdrawal by Subject|0|||
48764776|NCT03131440|156988252|FG003|Overall Study|Withdrawal by Subject|0|||
48764777|NCT03131440|156988253|FG004|Overall Study|Withdrawal by Subject|1|||
48764778|NCT03131440|156988254|FG005|Overall Study|Withdrawal by Subject|0|||
48764779|NCT03131440|156988255|FG006|Overall Study|Withdrawal by Subject|0|||
48764780|NCT03131440|156988256|FG007|Overall Study|Withdrawal by Subject|1|||
48764781|NCT03131440|156988257|FG008|Overall Study|Withdrawal by Subject|1|||
48764782|NCT03131440|156988258|FG009|Overall Study|Withdrawal by Subject|1|||
48764783|NCT03131440|156988259|FG010|Overall Study|Withdrawal by Subject|0|||
48764784|NCT03131440|156988260|FG011|Overall Study|Withdrawal by Subject|1|||
48764785|NCT03131440|156988261|FG012|Overall Study|Withdrawal by Subject|1|||
48764786|NCT03131440|156988262|FG013|Overall Study|Withdrawal by Subject|0|||
48764787|NCT03131440|156988263|FG014|Overall Study|Withdrawal by Subject|1|||
48764788|NCT03131440|156988264|FG015|Overall Study|Withdrawal by Subject|0|||
48764789|NCT03131440|156988265|FG016|Overall Study|Withdrawal by Subject|0|||
48764790|NCT03131440|156988266|FG017|Overall Study|Withdrawal by Subject|0|||
48764791|NCT03131440|156988267|FG018|Overall Study|Withdrawal by Subject|1|||
48764792|NCT03131440|156988268|FG019|Overall Study|Withdrawal by Subject|0|||
48764793|NCT03131440|156988269|FG020|Overall Study|Withdrawal by Subject|1|||
48764794|NCT03131440|156988270|FG021|Overall Study|Withdrawal by Subject|1|||
48764795|NCT03131440|156988271|FG022|Overall Study|Withdrawal by Subject|1|||
48764796|NCT03131440|156988272|FG023|Overall Study|Withdrawal by Subject|0|||
48764797|NCT03131440|156988273|FG024|Overall Study|Withdrawal by Subject|0|||
48764798|NCT03131440|156988274|FG025|Overall Study|Withdrawal by Subject|0|||
48764799|NCT03131440|156988275|FG026|Overall Study|Withdrawal by Subject|0|||
48764800|NCT03131440|156988276|FG027|Overall Study|Withdrawal by Subject|0|||
48764801|NCT03131440|156988277|FG028|Overall Study|Withdrawal by Subject|0|||
48764802|NCT03131440|156988278|FG029|Overall Study|Withdrawal by Subject|0|||
48764803|NCT03131440|156988279|FG030|Overall Study|Withdrawal by Subject|1|||
49025035|NCT00565448|157931416|FG001|Overall Study|Adverse Event|2|||
48764804|NCT03131440|156988280|FG031|Overall Study|Withdrawal by Subject|0|||
48764805|NCT03131440|156988249|FG000|Overall Study|Lost to Follow-up|0|||
48764806|NCT03131440|156988250|FG001|Overall Study|Lost to Follow-up|0|||
48764807|NCT03131440|156988251|FG002|Overall Study|Lost to Follow-up|0|||
48764808|NCT03131440|156988252|FG003|Overall Study|Lost to Follow-up|0|||
48764809|NCT03131440|156988253|FG004|Overall Study|Lost to Follow-up|0|||
48764810|NCT03131440|156988254|FG005|Overall Study|Lost to Follow-up|1|||
48764811|NCT03131440|156988255|FG006|Overall Study|Lost to Follow-up|0|||
48764812|NCT03131440|156988256|FG007|Overall Study|Lost to Follow-up|0|||
48764813|NCT03131440|156988257|FG008|Overall Study|Lost to Follow-up|0|||
48764814|NCT03131440|156988258|FG009|Overall Study|Lost to Follow-up|0|||
48764815|NCT03131440|156988259|FG010|Overall Study|Lost to Follow-up|0|||
48764816|NCT03131440|156988260|FG011|Overall Study|Lost to Follow-up|0|||
48764817|NCT03131440|156988261|FG012|Overall Study|Lost to Follow-up|0|||
48764818|NCT03131440|156988262|FG013|Overall Study|Lost to Follow-up|0|||
48764819|NCT03131440|156988263|FG014|Overall Study|Lost to Follow-up|0|||
48764820|NCT03131440|156988264|FG015|Overall Study|Lost to Follow-up|0|||
48764821|NCT03131440|156988265|FG016|Overall Study|Lost to Follow-up|0|||
48764822|NCT03131440|156988266|FG017|Overall Study|Lost to Follow-up|0|||
48764823|NCT03131440|156988267|FG018|Overall Study|Lost to Follow-up|0|||
48764824|NCT03131440|156988268|FG019|Overall Study|Lost to Follow-up|2|||
48764825|NCT03131440|156988269|FG020|Overall Study|Lost to Follow-up|1|||
48764826|NCT03131440|156988270|FG021|Overall Study|Lost to Follow-up|0|||
48764827|NCT03131440|156988271|FG022|Overall Study|Lost to Follow-up|1|||
48764828|NCT03131440|156988272|FG023|Overall Study|Lost to Follow-up|0|||
48764829|NCT03131440|156988273|FG024|Overall Study|Lost to Follow-up|1|||
48764830|NCT03131440|156988274|FG025|Overall Study|Lost to Follow-up|0|||
48764831|NCT03131440|156988275|FG026|Overall Study|Lost to Follow-up|0|||
48764832|NCT03131440|156988276|FG027|Overall Study|Lost to Follow-up|2|||
48764833|NCT03131440|156988277|FG028|Overall Study|Lost to Follow-up|0|||
48764834|NCT03131440|156988278|FG029|Overall Study|Lost to Follow-up|2|||
48764835|NCT03131440|156988279|FG030|Overall Study|Lost to Follow-up|0|||
48764836|NCT03131440|156988280|FG031|Overall Study|Lost to Follow-up|0|||
48764837|NCT03131440|156988249|FG000|Overall Study|Death|0|||
48764838|NCT03131440|156988250|FG001|Overall Study|Death|0|||
48764839|NCT03131440|156988251|FG002|Overall Study|Death|0|||
48764840|NCT03131440|156988252|FG003|Overall Study|Death|0|||
48764841|NCT03131440|156988253|FG004|Overall Study|Death|0|||
48764842|NCT03131440|156988254|FG005|Overall Study|Death|0|||
48764843|NCT03131440|156988255|FG006|Overall Study|Death|0|||
48764844|NCT03131440|156988256|FG007|Overall Study|Death|0|||
48764845|NCT03131440|156988257|FG008|Overall Study|Death|0|||
48764846|NCT03131440|156988258|FG009|Overall Study|Death|0|||
48764847|NCT03131440|156988259|FG010|Overall Study|Death|0|||
48764848|NCT03131440|156988260|FG011|Overall Study|Death|0|||
48764849|NCT03131440|156988261|FG012|Overall Study|Death|0|||
48764850|NCT03131440|156988262|FG013|Overall Study|Death|0|||
48764851|NCT03131440|156988263|FG014|Overall Study|Death|0|||
48764852|NCT03131440|156988264|FG015|Overall Study|Death|0|||
48764853|NCT03131440|156988265|FG016|Overall Study|Death|0|||
48764854|NCT03131440|156988266|FG017|Overall Study|Death|0|||
48764855|NCT03131440|156988267|FG018|Overall Study|Death|0|||
48764856|NCT03131440|156988268|FG019|Overall Study|Death|0|||
48764857|NCT03131440|156988269|FG020|Overall Study|Death|0|||
48764858|NCT03131440|156988270|FG021|Overall Study|Death|0|||
48764859|NCT03131440|156988271|FG022|Overall Study|Death|0|||
48764860|NCT03131440|156988272|FG023|Overall Study|Death|0|||
48764861|NCT03131440|156988273|FG024|Overall Study|Death|0|||
48764862|NCT03131440|156988274|FG025|Overall Study|Death|1|||
48764863|NCT03131440|156988275|FG026|Overall Study|Death|0|||
48764864|NCT03131440|156988276|FG027|Overall Study|Death|0|||
48764865|NCT03131440|156988277|FG028|Overall Study|Death|0|||
48764866|NCT03131440|156988278|FG029|Overall Study|Death|0|||
48764867|NCT03131440|156988279|FG030|Overall Study|Death|0|||
48764868|NCT03131440|156988280|FG031|Overall Study|Death|0|||
48764869|NCT00746941|156988281|FG000|Overall Study|Death|2|||
48764870|NCT00746941|156988282|FG001|Overall Study|Death|0|||
48764871|NCT00746941|156988283|FG002|Overall Study|Death|0|||
48764872|NCT00746941|156988284|FG003|Overall Study|Death|6|||
48764873|NCT00746941|156988281|FG000|Overall Study|Physician Decision|0|||
48764874|NCT00746941|156988282|FG001|Overall Study|Physician Decision|0|||
48764875|NCT00746941|156988283|FG002|Overall Study|Physician Decision|2|||
48764876|NCT00746941|156988284|FG003|Overall Study|Physician Decision|0|||
48764877|NCT00746941|156988281|FG000|Overall Study|Withdrawal by Subject|3|||
48764878|NCT00746941|156988282|FG001|Overall Study|Withdrawal by Subject|0|||
48764879|NCT00746941|156988283|FG002|Overall Study|Withdrawal by Subject|0|||
48764880|NCT00746941|156988284|FG003|Overall Study|Withdrawal by Subject|2|||
48764881|NCT00746941|156988281|FG000|Overall Study|Other, reason not provided|2|||
48764882|NCT00746941|156988282|FG001|Overall Study|Other, reason not provided|4|||
48764883|NCT00746941|156988283|FG002|Overall Study|Other, reason not provided|0|||
48764884|NCT00746941|156988284|FG003|Overall Study|Other, reason not provided|4|||
48764885|NCT00746941|156988281|FG000|Overall Study|Adverse Event|0|||
48764886|NCT00746941|156988282|FG001|Overall Study|Adverse Event|0|||
48764887|NCT00746941|156988283|FG002|Overall Study|Adverse Event|0|||
48764888|NCT00746941|156988284|FG003|Overall Study|Adverse Event|1|||
48764889|NCT00973479|156988287|FG000|Overall Study|Lost to Follow-up|0|||
48764890|NCT00973479|156988288|FG001|Overall Study|Lost to Follow-up|3|||
48764891|NCT00973479|156988287|FG000|Overall Study|Death|2|||
48764892|NCT00973479|156988288|FG001|Overall Study|Death|2|||
48764893|NCT00973479|156988287|FG000|Overall Study|Withdrawal by Subject|15|||
48764894|NCT00973479|156988288|FG001|Overall Study|Withdrawal by Subject|16|||
48764895|NCT00973479|156988287|FG000|Overall Study|Lack of Efficacy|5|||
48764896|NCT00973479|156988288|FG001|Overall Study|Lack of Efficacy|7|||
48764897|NCT00973479|156988287|FG000|Overall Study|Adverse Event|12|||
48764898|NCT00973479|156988288|FG001|Overall Study|Adverse Event|32|||
48764899|NCT00973479|156988287|FG000|Overall Study|Protocol Violation|2|||
48764900|NCT00973479|156988288|FG001|Overall Study|Protocol Violation|2|||
48764901|NCT00973479|156988287|FG000|Overall Study|Other|1|||
48764902|NCT00973479|156988288|FG001|Overall Study|Other|7|||
48764903|NCT00129129|156988289|FG000|Primary Phase|Adverse Event|2|||
48764904|NCT00129129|156988290|FG001|Primary Phase|Adverse Event|1|||
48764905|NCT00129129|156988291|FG002|Primary Phase|Adverse Event|0|||
49025036|NCT00565448|157931415|FG000|Overall Study|Disease progression|1|||
49025037|NCT00565448|157931416|FG001|Overall Study|Disease progression|0|||
49025038|NCT00565448|157931415|FG000|Overall Study|Withdrawal by Subject|1|||
49025039|NCT00565448|157931416|FG001|Overall Study|Withdrawal by Subject|0|||
49025040|NCT00822926|157931417|FG000|Second Injection Visit|Lost to Follow-up|1|||
49025041|NCT00822926|157931418|FG001|Second Injection Visit|Lost to Follow-up|0|||
49025042|NCT00822926|157931417|FG000|Second Injection Visit|Withdrawal by Subject|0|||
49025043|NCT00822926|157931418|FG001|Second Injection Visit|Withdrawal by Subject|1|||
49025044|NCT00429364|157931421|FG000|Overall Study|Withdrawal by Subject|11|||
49025045|NCT00429364|157931422|FG001|Overall Study|Withdrawal by Subject|5|||
49025046|NCT00429364|157931421|FG000|Overall Study|Physician Decision|4|||
49025047|NCT00429364|157931422|FG001|Overall Study|Physician Decision|2|||
49025048|NCT00429364|157931421|FG000|Overall Study|Lost to Follow-up|7|||
49025049|NCT00429364|157931422|FG001|Overall Study|Lost to Follow-up|6|||
49025050|NCT00429364|157931421|FG000|Overall Study|Death|0|||
49025051|NCT00429364|157931422|FG001|Overall Study|Death|1|||
49025052|NCT00429364|157931421|FG000|Overall Study|Underwent aortic root surgery|10|||
49025053|NCT00429364|157931422|FG001|Overall Study|Underwent aortic root surgery|18|||
49025054|NCT00429364|157931421|FG000|Overall Study|Pregnancy|0|||
49025055|NCT00429364|157931422|FG001|Overall Study|Pregnancy|1|||
49025056|NCT05089734|157931431|FG000|Overall Study|Still on study|122|||
49025057|NCT05089734|157931432|FG001|Overall Study|Still on study|101|||
49025058|NCT05089734|157931431|FG000|Overall Study|Death|161|||
49025059|NCT05089734|157931432|FG001|Overall Study|Death|179|||
49025060|NCT05089734|157931431|FG000|Overall Study|Withdrew consent|11|||
49025061|NCT05089734|157931432|FG001|Overall Study|Withdrew consent|24|||
49025062|NCT05089734|157931431|FG000|Overall Study|Lost to Follow-up|5|||
49025063|NCT05089734|157931432|FG001|Overall Study|Lost to Follow-up|0|||
49025064|NCT03991494|157931433|FG000|Overall Study|Progressive Disease|4|||
49025065|NCT00319735|157931434|FG000|Overall Study|Death|2|||
49025066|NCT04451772|157931438|FG000|Overall Study|Adverse Event|1|||
49025067|NCT04451772|157931439|FG001|Overall Study|Adverse Event|0|||
49025068|NCT04451772|157931440|FG002|Overall Study|Adverse Event|1|||
49025069|NCT04451772|157931441|FG003|Overall Study|Adverse Event|1|||
49025070|NCT04451772|157931442|FG004|Overall Study|Adverse Event|0|||
49025071|NCT04451772|157931443|FG005|Overall Study|Adverse Event|3|||
49025072|NCT04451772|157931438|FG000|Overall Study|Withdrawal by Subject|2|||
49025073|NCT04451772|157931439|FG001|Overall Study|Withdrawal by Subject|7|||
49025074|NCT04451772|157931440|FG002|Overall Study|Withdrawal by Subject|2|||
49025075|NCT04451772|157931441|FG003|Overall Study|Withdrawal by Subject|1|||
49025076|NCT04451772|157931442|FG004|Overall Study|Withdrawal by Subject|1|||
49025077|NCT04451772|157931443|FG005|Overall Study|Withdrawal by Subject|0|||
49025078|NCT04451772|157931438|FG000|Overall Study|Other, not specified|1|||
49025079|NCT04451772|157931439|FG001|Overall Study|Other, not specified|2|||
49025080|NCT04451772|157931440|FG002|Overall Study|Other, not specified|1|||
49025081|NCT04451772|157931441|FG003|Overall Study|Other, not specified|0|||
48764906|NCT00129129|156988292|FG003|Primary Phase|Adverse Event|0|||
48764907|NCT00129129|156988293|FG004|Primary Phase|Adverse Event|0|||
48764908|NCT00129129|156988289|FG000|Primary Phase|Withdrawal by Subject|12|||
48764909|NCT00129129|156988290|FG001|Primary Phase|Withdrawal by Subject|10|||
48764910|NCT00129129|156988291|FG002|Primary Phase|Withdrawal by Subject|0|||
48764911|NCT00129129|156988292|FG003|Primary Phase|Withdrawal by Subject|0|||
49025082|NCT04451772|157931442|FG004|Overall Study|Other, not specified|0|||
49025083|NCT04451772|157931443|FG005|Overall Study|Other, not specified|1|||
48764912|NCT00129129|156988293|FG004|Primary Phase|Withdrawal by Subject|0|||
48764913|NCT00129129|156988289|FG000|Primary Phase|Migration from study area|1|||
48764914|NCT00129129|156988290|FG001|Primary Phase|Migration from study area|3|||
48764915|NCT00129129|156988291|FG002|Primary Phase|Migration from study area|0|||
48764916|NCT00129129|156988292|FG003|Primary Phase|Migration from study area|0|||
48764917|NCT00129129|156988293|FG004|Primary Phase|Migration from study area|0|||
48764918|NCT00129129|156988289|FG000|Primary Phase|Lost to Follow-up|8|||
48764919|NCT00129129|156988290|FG001|Primary Phase|Lost to Follow-up|6|||
48764920|NCT00129129|156988291|FG002|Primary Phase|Lost to Follow-up|0|||
48764921|NCT00129129|156988292|FG003|Primary Phase|Lost to Follow-up|0|||
48764922|NCT00129129|156988293|FG004|Primary Phase|Lost to Follow-up|0|||
48764923|NCT00129129|156988289|FG000|Primary Phase|Other|2|||
48764924|NCT00129129|156988290|FG001|Primary Phase|Other|5|||
48764925|NCT00129129|156988291|FG002|Primary Phase|Other|0|||
48764926|NCT00129129|156988292|FG003|Primary Phase|Other|0|||
49025084|NCT04451772|157931438|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
49025085|NCT04451772|157931439|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
49025086|NCT04451772|157931440|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
49025087|NCT04451772|157931441|FG003|Overall Study|Sponsor decision based on interim analysis data review|11|||
49025088|NCT04451772|157931442|FG004|Overall Study|Sponsor decision based on interim analysis data review|23|||
49025089|NCT04451772|157931443|FG005|Overall Study|Sponsor decision based on interim analysis data review|9|||
48764927|NCT00129129|156988293|FG004|Primary Phase|Other|0|||
48764928|NCT00129129|156988289|FG000|Fourth Dose Phase|Lost to Follow-up|4|||
49025090|NCT03773107|157931444|FG000|Overall Study|Participant currently on study and in follow up status.|1|||
49025091|NCT03773107|157931445|FG001|Overall Study|Participant currently on study and in follow up status.|0|||
49025092|NCT03773107|157931446|FG002|Overall Study|Participant currently on study and in follow up status.|0|||
49025093|NCT03773107|157931447|FG003|Overall Study|Participant currently on study and in follow up status.|1|||
49025094|NCT02109042|157932911|FG000|Overall Study|Sponsor Decision|15|||
49025095|NCT01511939|157932914|FG000|Overall Study|Withdrawal by Subject|2|||
49025096|NCT01511939|157932915|FG001|Overall Study|Withdrawal by Subject|1|||
49025097|NCT01511939|157932916|FG002|Overall Study|Withdrawal by Subject|0|||
49025098|NCT03203447|157932917|FG000|Overall Study|Withdrawal by Subject|2|||
48764929|NCT00129129|156988290|FG001|Fourth Dose Phase|Lost to Follow-up|0|||
48764930|NCT00129129|156988291|FG002|Fourth Dose Phase|Lost to Follow-up|0|||
48764931|NCT00129129|156988292|FG003|Fourth Dose Phase|Lost to Follow-up|2|||
48764932|NCT00129129|156988293|FG004|Fourth Dose Phase|Lost to Follow-up|2|||
48764933|NCT00129129|156988289|FG000|Fourth Dose Phase|Withdrawal by Subject|0|||
48764934|NCT00129129|156988290|FG001|Fourth Dose Phase|Withdrawal by Subject|0|||
48764935|NCT00129129|156988291|FG002|Fourth Dose Phase|Withdrawal by Subject|0|||
48764936|NCT00129129|156988292|FG003|Fourth Dose Phase|Withdrawal by Subject|0|||
48764937|NCT00129129|156988293|FG004|Fourth Dose Phase|Withdrawal by Subject|1|||
48764938|NCT00129129|156988289|FG000|Fourth Dose Phase|Migration from study area|0|||
48764939|NCT00129129|156988290|FG001|Fourth Dose Phase|Migration from study area|0|||
48764940|NCT00129129|156988291|FG002|Fourth Dose Phase|Migration from study area|0|||
48764941|NCT00129129|156988292|FG003|Fourth Dose Phase|Migration from study area|0|||
48764942|NCT00129129|156988293|FG004|Fourth Dose Phase|Migration from study area|2|||
48764943|NCT00129129|156988289|FG000|Fourth Dose Phase|Other|0|||
49025099|NCT03203447|157932918|FG001|Overall Study|Withdrawal by Subject|1|||
49025100|NCT03203447|157932917|FG000|Overall Study|Lost to Follow-up|1|||
49025101|NCT03203447|157932918|FG001|Overall Study|Lost to Follow-up|10|||
49025102|NCT03203447|157932917|FG000|Overall Study|Includes premature discontinuation due to study termination and unknown|159|||
49025103|NCT03203447|157932918|FG001|Overall Study|Includes premature discontinuation due to study termination and unknown|152|||
49025104|NCT03652688|157932919|FG000|Baseline|Withdrawal by Subject|0|||
49025105|NCT03652688|157932920|FG001|Baseline|Withdrawal by Subject|3|||
49025106|NCT03652688|157932919|FG000|Follow-up|Lost to Follow-up|56|||
49025107|NCT03652688|157932920|FG001|Follow-up|Lost to Follow-up|54|||
49025108|NCT00105196|157932925|FG000|Overall Study|Lack of Efficacy|2|||
49025109|NCT00105196|157932926|FG001|Overall Study|Lack of Efficacy|3|||
49025110|NCT00105196|157932925|FG000|Overall Study|Adverse Event|11|||
49025111|NCT00105196|157932926|FG001|Overall Study|Adverse Event|3|||
49025112|NCT00105196|157932925|FG000|Overall Study|Withdrawal by Subject|6|||
49025113|NCT00105196|157932926|FG001|Overall Study|Withdrawal by Subject|6|||
49025114|NCT00105196|157932925|FG000|Overall Study|Lost to Follow-up|3|||
49025115|NCT00105196|157932926|FG001|Overall Study|Lost to Follow-up|2|||
49025116|NCT00105196|157932925|FG000|Overall Study|Poor/noncompliance|3|||
49025117|NCT00105196|157932926|FG001|Overall Study|Poor/noncompliance|4|||
49025118|NCT00105196|157932925|FG000|Overall Study|Protocol Violation|5|||
49025119|NCT00105196|157932926|FG001|Overall Study|Protocol Violation|2|||
49025120|NCT00105196|157932925|FG000|Overall Study|pending surgery|0|||
49025121|NCT00105196|157932926|FG001|Overall Study|pending surgery|1|||
49025122|NCT00105196|157932925|FG000|Overall Study|marijuana use|0|||
49025123|NCT00105196|157932926|FG001|Overall Study|marijuana use|1|||
49025124|NCT00105196|157932925|FG000|Overall Study|Subject became unblinded|0|||
49025125|NCT00105196|157932926|FG001|Overall Study|Subject became unblinded|1|||
48764944|NCT00129129|156988290|FG001|Fourth Dose Phase|Other|0|||
48764945|NCT00129129|156988291|FG002|Fourth Dose Phase|Other|0|||
48764946|NCT00129129|156988292|FG003|Fourth Dose Phase|Other|1|||
48764947|NCT00129129|156988293|FG004|Fourth Dose Phase|Other|1|||
48764948|NCT00129129|156988289|FG000|Fourth Dose Phase|Protocol Violation|0|||
48764949|NCT00129129|156988290|FG001|Fourth Dose Phase|Protocol Violation|0|||
48764950|NCT00129129|156988291|FG002|Fourth Dose Phase|Protocol Violation|0|||
48764951|NCT00129129|156988292|FG003|Fourth Dose Phase|Protocol Violation|1|||
48764952|NCT00129129|156988293|FG004|Fourth Dose Phase|Protocol Violation|0|||
48764953|NCT02098109|156988298|FG000|Overall Study|Protocol Violation|3|||
48764954|NCT02098109|156988299|FG001|Overall Study|Protocol Violation|0|||
48764955|NCT01709695|156988300|FG000|Overall Study|Withdrawal by Subject|1|||
48764956|NCT01709695|156988301|FG001|Overall Study|Withdrawal by Subject|1|||
48764957|NCT00500292|156988305|FG000|Overall Study|Adverse Event|3|||
48764958|NCT00500292|156988306|FG001|Overall Study|Adverse Event|6|||
48764959|NCT00500292|156988307|FG002|Overall Study|Adverse Event|4|||
48764960|NCT00500292|156988305|FG000|Overall Study|Condition under investigation worsened|21|||
48875508|NCT00550446|157381644|FG003|Post Week 12|Other|1|||
48875509|NCT00550446|157381645|FG004|Post Week 12|Other|0|||
49025126|NCT03959423|157932928|FG000|Overall Study|Withdrawal by Subject|2|||
49025127|NCT03959423|157932929|FG001|Overall Study|Withdrawal by Subject|3|||
49025128|NCT03959423|157932928|FG000|Overall Study|Physician Decision|0|||
49025129|NCT03959423|157932929|FG001|Overall Study|Physician Decision|1|||
48764961|NCT00500292|156988306|FG001|Overall Study|Condition under investigation worsened|23|||
48764962|NCT00500292|156988307|FG002|Overall Study|Condition under investigation worsened|19|||
48764963|NCT00500292|156988305|FG000|Overall Study|Withdrawal by Subject|0|||
48764964|NCT00500292|156988306|FG001|Overall Study|Withdrawal by Subject|1|||
48764965|NCT00500292|156988307|FG002|Overall Study|Withdrawal by Subject|0|||
48764966|NCT00500292|156988305|FG000|Overall Study|Other|1|||
48764967|NCT00500292|156988306|FG001|Overall Study|Other|1|||
48764968|NCT00500292|156988307|FG002|Overall Study|Other|4|||
48764969|NCT02741700|156988308|FG000|Overall Study|Lost to Follow-up|17|||
48764970|NCT02741700|156988309|FG001|Overall Study|Lost to Follow-up|8|||
48764971|NCT02741700|156988308|FG000|Overall Study|Withdrawal by Subject|2|||
48764972|NCT02741700|156988309|FG001|Overall Study|Withdrawal by Subject|5|||
48764973|NCT02741700|156988308|FG000|Overall Study|Physician Decision|3|||
48764974|NCT02741700|156988309|FG001|Overall Study|Physician Decision|0|||
48764975|NCT02741700|156988308|FG000|Overall Study|Moved out of State|0|||
48764976|NCT02741700|156988309|FG001|Overall Study|Moved out of State|1|||
48764977|NCT02741700|156988308|FG000|Overall Study|Death|4|||
48764978|NCT02741700|156988309|FG001|Overall Study|Death|5|||
48764979|NCT02641379|156988312|FG000|Overall Study|Exclusion criterion during screening|1|||
48764980|NCT02641379|156988313|FG001|Overall Study|Exclusion criterion during screening|0|||
48764981|NCT02641379|156988314|FG002|Overall Study|Exclusion criterion during screening|0|||
49025130|NCT03959423|157932928|FG000|Overall Study|Lost to Follow-up|1|||
49025131|NCT03959423|157932929|FG001|Overall Study|Lost to Follow-up|0|||
49025132|NCT03959423|157932928|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
49025133|NCT03959423|157932929|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
49025134|NCT03473223|157932930|FG000|Overall Study|Lost to Follow-up|1|||
49025135|NCT03473223|157932931|FG001|Overall Study|Lost to Follow-up|1|||
49025136|NCT03473223|157932930|FG000|Overall Study|Withdrawal by Subject|47|||
49025137|NCT03473223|157932931|FG001|Overall Study|Withdrawal by Subject|42|||
49025138|NCT03473223|157932930|FG000|Overall Study|Indirect contact|32|||
49025139|NCT03473223|157932931|FG001|Overall Study|Indirect contact|29|||
49025140|NCT03473223|157932930|FG000|Overall Study|Other (Not specified)|32|||
49025141|NCT03473223|157932931|FG001|Overall Study|Other (Not specified)|20|||
49025142|NCT03524118|157932932|FG000|Overall Study|Lost to Follow-up|0|||
49025143|NCT03524118|157932933|FG001|Overall Study|Lost to Follow-up|0|||
49025144|NCT03524118|157932934|FG002|Overall Study|Lost to Follow-up|0|||
49025145|NCT03524118|157932935|FG003|Overall Study|Lost to Follow-up|0|||
49025146|NCT03524118|157932936|FG004|Overall Study|Lost to Follow-up|1|||
49025147|NCT03524118|157932937|FG005|Overall Study|Lost to Follow-up|0|||
49025148|NCT03524118|157932932|FG000|Overall Study|Other|0|||
49025149|NCT03524118|157932933|FG001|Overall Study|Other|1|||
49025150|NCT03524118|157932934|FG002|Overall Study|Other|0|||
49025151|NCT03524118|157932935|FG003|Overall Study|Other|0|||
49025152|NCT03524118|157932936|FG004|Overall Study|Other|1|||
49025153|NCT03524118|157932937|FG005|Overall Study|Other|1|||
49025154|NCT03524118|157932932|FG000|Overall Study|Physician Decision|0|||
49025155|NCT03524118|157932933|FG001|Overall Study|Physician Decision|0|||
49025156|NCT03524118|157932934|FG002|Overall Study|Physician Decision|0|||
49025157|NCT03524118|157932935|FG003|Overall Study|Physician Decision|0|||
49025158|NCT03524118|157932936|FG004|Overall Study|Physician Decision|1|||
49025159|NCT03524118|157932937|FG005|Overall Study|Physician Decision|0|||
49025160|NCT03524118|157932932|FG000|Overall Study|Protocol Violation|0|||
49025161|NCT03524118|157932933|FG001|Overall Study|Protocol Violation|0|||
49025162|NCT03524118|157932934|FG002|Overall Study|Protocol Violation|1|||
49025163|NCT03524118|157932935|FG003|Overall Study|Protocol Violation|0|||
49025164|NCT03524118|157932936|FG004|Overall Study|Protocol Violation|1|||
49025165|NCT03524118|157932937|FG005|Overall Study|Protocol Violation|0|||
49025166|NCT03524118|157932932|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
49025167|NCT03524118|157932933|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
49025168|NCT03524118|157932934|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
49025169|NCT03524118|157932935|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
49025170|NCT03524118|157932936|FG004|Overall Study|Withdrawal by Parent/Guardian|3|||
49025171|NCT03524118|157932937|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
49025172|NCT03099538|157932938|FG000|Overall Study|Lack of Efficacy|3|||
49025173|NCT01196052|157932939|FG000|Overall Study|Adverse Event|9|||
48764982|NCT02641379|156988315|FG003|Overall Study|Exclusion criterion during screening|1|||
48764983|NCT02641379|156988316|FG004|Overall Study|Exclusion criterion during screening|2|||
48764984|NCT02641379|156988317|FG005|Overall Study|Exclusion criterion during screening|0|||
48764985|NCT02641379|156988318|FG006|Overall Study|Exclusion criterion during screening|0|||
48764986|NCT02641379|156988319|FG007|Overall Study|Exclusion criterion during screening|0|||
48764987|NCT02641379|156988320|FG008|Overall Study|Exclusion criterion during screening|0|||
48764988|NCT02641379|156988321|FG009|Overall Study|Exclusion criterion during screening|0|||
49025174|NCT01196052|157932939|FG000|Overall Study|Lost to Follow-up|1|||
49025175|NCT01196052|157932939|FG000|Overall Study|Noncompliance to Protocol Requirements|2|||
49025176|NCT01196052|157932939|FG000|Overall Study|Reason not Specified|5|||
49025177|NCT01196052|157932939|FG000|Overall Study|Withdrawal by Subject|6|||
49025178|NCT02353169|157932940|FG000|Overall Study|QTc > 450 msec|1|||
49025179|NCT02353169|157932941|FG001|Overall Study|QTc > 450 msec|1|||
49025180|NCT02353169|157932942|FG002|Overall Study|QTc > 450 msec|1|||
49025181|NCT02353169|157932943|FG003|Overall Study|QTc > 450 msec|1|||
49025182|NCT02353169|157932940|FG000|Overall Study|OR team declined|2|||
48764989|NCT02641379|156988322|FG010|Overall Study|Exclusion criterion during screening|0|||
48764990|NCT02641379|156988312|FG000|Overall Study|Withdrawal of informed consent|0|||
48764991|NCT02641379|156988313|FG001|Overall Study|Withdrawal of informed consent|1|||
48764992|NCT02641379|156988314|FG002|Overall Study|Withdrawal of informed consent|0|||
48764993|NCT02641379|156988315|FG003|Overall Study|Withdrawal of informed consent|0|||
48764994|NCT02641379|156988316|FG004|Overall Study|Withdrawal of informed consent|0|||
48764995|NCT02641379|156988317|FG005|Overall Study|Withdrawal of informed consent|0|||
48764996|NCT02641379|156988318|FG006|Overall Study|Withdrawal of informed consent|0|||
48764997|NCT02641379|156988319|FG007|Overall Study|Withdrawal of informed consent|1|||
48764998|NCT02641379|156988320|FG008|Overall Study|Withdrawal of informed consent|0|||
48764999|NCT02641379|156988321|FG009|Overall Study|Withdrawal of informed consent|0|||
48765000|NCT02641379|156988322|FG010|Overall Study|Withdrawal of informed consent|0|||
48765001|NCT02641379|156988312|FG000|Overall Study|Adverse Event|7|||
48765002|NCT02641379|156988313|FG001|Overall Study|Adverse Event|8|||
48765003|NCT02641379|156988314|FG002|Overall Study|Adverse Event|2|||
48765004|NCT02641379|156988315|FG003|Overall Study|Adverse Event|2|||
48765005|NCT02641379|156988316|FG004|Overall Study|Adverse Event|5|||
48765006|NCT02641379|156988317|FG005|Overall Study|Adverse Event|1|||
48765007|NCT02641379|156988318|FG006|Overall Study|Adverse Event|5|||
49025183|NCT02353169|157932941|FG001|Overall Study|OR team declined|0|||
49025184|NCT02353169|157932942|FG002|Overall Study|OR team declined|0|||
49025185|NCT02353169|157932943|FG003|Overall Study|OR team declined|0|||
49025186|NCT02353169|157932940|FG000|Overall Study|Inhalational induction|0|||
49025187|NCT02353169|157932941|FG001|Overall Study|Inhalational induction|2|||
49025188|NCT02353169|157932942|FG002|Overall Study|Inhalational induction|0|||
49025189|NCT02353169|157932943|FG003|Overall Study|Inhalational induction|0|||
49025190|NCT02353169|157932940|FG000|Overall Study|ECG data error|0|||
49025191|NCT02353169|157932941|FG001|Overall Study|ECG data error|3|||
49025192|NCT02353169|157932942|FG002|Overall Study|ECG data error|2|||
49025193|NCT02353169|157932943|FG003|Overall Study|ECG data error|2|||
49025194|NCT02353169|157932940|FG000|Overall Study|Pre-op medication|0|||
49025195|NCT02353169|157932941|FG001|Overall Study|Pre-op medication|0|||
49025196|NCT02353169|157932942|FG002|Overall Study|Pre-op medication|1|||
49025197|NCT02353169|157932943|FG003|Overall Study|Pre-op medication|0|||
49025198|NCT04338269|157932944|FG000|Overall Study|Death|86|||
49025199|NCT04338269|157932945|FG001|Overall Study|Death|89|||
49025200|NCT04338269|157932944|FG000|Overall Study|Lost to Follow-up|1|||
49025201|NCT04338269|157932945|FG001|Overall Study|Lost to Follow-up|2|||
49025202|NCT04338269|157932944|FG000|Overall Study|Physician Decision|1|||
49025203|NCT04338269|157932945|FG001|Overall Study|Physician Decision|0|||
49025204|NCT04338269|157932944|FG000|Overall Study|Withdrawal by Subject|14|||
49025205|NCT04338269|157932945|FG001|Overall Study|Withdrawal by Subject|11|||
49025206|NCT00085735|157932946|FG000|Overall Study|Adverse Event|1|||
49025207|NCT00085735|157932947|FG001|Overall Study|Adverse Event|0|||
49025208|NCT00085735|157932948|FG002|Overall Study|Adverse Event|0|||
49025209|NCT00085735|157932949|FG003|Overall Study|Adverse Event|0|||
49025210|NCT00085735|157932950|FG004|Overall Study|Adverse Event|0|||
49025211|NCT00085735|157932951|FG005|Overall Study|Adverse Event|0|||
49025212|NCT00085735|157932946|FG000|Overall Study|Lack of Efficacy|2|||
49025213|NCT00085735|157932947|FG001|Overall Study|Lack of Efficacy|4|||
49025214|NCT00085735|157932948|FG002|Overall Study|Lack of Efficacy|6|||
49025215|NCT00085735|157932949|FG003|Overall Study|Lack of Efficacy|3|||
49025216|NCT00085735|157932950|FG004|Overall Study|Lack of Efficacy|4|||
49025217|NCT00085735|157932951|FG005|Overall Study|Lack of Efficacy|3|||
48765008|NCT02641379|156988319|FG007|Overall Study|Adverse Event|0|||
48765009|NCT02641379|156988320|FG008|Overall Study|Adverse Event|1|||
48765010|NCT02641379|156988321|FG009|Overall Study|Adverse Event|1|||
48875510|NCT00550446|157381646|FG005|Post Week 12|Other|0|||
49025218|NCT00085735|157932946|FG000|Overall Study|Lost to Follow-up|0|||
49025219|NCT00085735|157932947|FG001|Overall Study|Lost to Follow-up|1|||
48765011|NCT02641379|156988322|FG010|Overall Study|Adverse Event|5|||
48765012|NCT02641379|156988312|FG000|Overall Study|Lack of Efficacy|0|||
48765013|NCT02641379|156988313|FG001|Overall Study|Lack of Efficacy|0|||
48765014|NCT02641379|156988314|FG002|Overall Study|Lack of Efficacy|2|||
48765015|NCT02641379|156988315|FG003|Overall Study|Lack of Efficacy|0|||
48875511|NCT00550446|157381647|FG006|Post Week 12|Other|1|||
48875512|NCT00550446|157381648|FG007|Post Week 12|Other|0|||
49025220|NCT00085735|157932948|FG002|Overall Study|Lost to Follow-up|0|||
49025221|NCT00085735|157932949|FG003|Overall Study|Lost to Follow-up|0|||
49025222|NCT00085735|157932950|FG004|Overall Study|Lost to Follow-up|1|||
49025223|NCT00085735|157932951|FG005|Overall Study|Lost to Follow-up|0|||
49025224|NCT00085735|157932946|FG000|Overall Study|Physician Decision|2|||
49025225|NCT00085735|157932947|FG001|Overall Study|Physician Decision|3|||
49025226|NCT00085735|157932948|FG002|Overall Study|Physician Decision|2|||
49025227|NCT00085735|157932949|FG003|Overall Study|Physician Decision|3|||
49025228|NCT00085735|157932950|FG004|Overall Study|Physician Decision|11|||
49025229|NCT00085735|157932951|FG005|Overall Study|Physician Decision|8|||
49025230|NCT00085735|157932946|FG000|Overall Study|Protocol Violation|1|||
49025231|NCT00085735|157932947|FG001|Overall Study|Protocol Violation|0|||
49025232|NCT00085735|157932948|FG002|Overall Study|Protocol Violation|0|||
49025233|NCT00085735|157932949|FG003|Overall Study|Protocol Violation|0|||
49025234|NCT00085735|157932950|FG004|Overall Study|Protocol Violation|0|||
49025235|NCT00085735|157932951|FG005|Overall Study|Protocol Violation|0|||
49025236|NCT00085735|157932946|FG000|Overall Study|Withdrawal by Subject|1|||
49025237|NCT00085735|157932947|FG001|Overall Study|Withdrawal by Subject|0|||
49025238|NCT00085735|157932948|FG002|Overall Study|Withdrawal by Subject|4|||
49025239|NCT00085735|157932949|FG003|Overall Study|Withdrawal by Subject|5|||
49025240|NCT00085735|157932950|FG004|Overall Study|Withdrawal by Subject|7|||
49025241|NCT00085735|157932951|FG005|Overall Study|Withdrawal by Subject|8|||
49025242|NCT00085735|157932946|FG000|Overall Study|Patient ineligible|1|||
49025243|NCT00085735|157932947|FG001|Overall Study|Patient ineligible|0|||
49025244|NCT00085735|157932948|FG002|Overall Study|Patient ineligible|3|||
49025245|NCT00085735|157932949|FG003|Overall Study|Patient ineligible|7|||
48765016|NCT02641379|156988316|FG004|Overall Study|Lack of Efficacy|0|||
48765017|NCT02641379|156988317|FG005|Overall Study|Lack of Efficacy|2|||
48765018|NCT02641379|156988318|FG006|Overall Study|Lack of Efficacy|0|||
48765019|NCT02641379|156988319|FG007|Overall Study|Lack of Efficacy|5|||
48765020|NCT02641379|156988320|FG008|Overall Study|Lack of Efficacy|0|||
48765021|NCT02641379|156988321|FG009|Overall Study|Lack of Efficacy|0|||
48765022|NCT02641379|156988322|FG010|Overall Study|Lack of Efficacy|0|||
48765023|NCT02641379|156988312|FG000|Overall Study|Participant unable to attend study visit|4|||
48765024|NCT02641379|156988313|FG001|Overall Study|Participant unable to attend study visit|10|||
48765025|NCT02641379|156988314|FG002|Overall Study|Participant unable to attend study visit|1|||
48765026|NCT02641379|156988315|FG003|Overall Study|Participant unable to attend study visit|2|||
48765027|NCT02641379|156988316|FG004|Overall Study|Participant unable to attend study visit|5|||
48765028|NCT02641379|156988317|FG005|Overall Study|Participant unable to attend study visit|1|||
48765029|NCT02641379|156988318|FG006|Overall Study|Participant unable to attend study visit|1|||
48765030|NCT02641379|156988319|FG007|Overall Study|Participant unable to attend study visit|1|||
48765031|NCT02641379|156988320|FG008|Overall Study|Participant unable to attend study visit|0|||
49025246|NCT00085735|157932950|FG004|Overall Study|Patient ineligible|17|||
49025247|NCT00085735|157932951|FG005|Overall Study|Patient ineligible|8|||
49025248|NCT00085735|157932946|FG000|Overall Study|Excess residual disease|2|||
49025249|NCT00085735|157932947|FG001|Overall Study|Excess residual disease|2|||
49025250|NCT00085735|157932948|FG002|Overall Study|Excess residual disease|1|||
49025251|NCT00085735|157932949|FG003|Overall Study|Excess residual disease|1|||
49025252|NCT00085735|157932950|FG004|Overall Study|Excess residual disease|1|||
48692330|NCT03982199|156722581|FG013|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|1|||
48692331|NCT03982199|156722568|FG000|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
48692332|NCT03982199|156722569|FG001|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
48692333|NCT03982199|156722570|FG002|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
48692334|NCT03982199|156722571|FG003|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
48692335|NCT03982199|156722572|FG004|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
48692336|NCT03982199|156722573|FG005|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
48692337|NCT03982199|156722574|FG006|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
48692338|NCT03982199|156722575|FG007|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
48692339|NCT03982199|156722576|FG008|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
48692340|NCT03982199|156722577|FG009|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
48692341|NCT03982199|156722578|FG010|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
48692342|NCT03982199|156722579|FG011|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
48692343|NCT03982199|156722580|FG012|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|1|||
48692344|NCT03982199|156722581|FG013|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|3|||
48692345|NCT03982199|156722568|FG000|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
48692346|NCT03982199|156722569|FG001|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
48692347|NCT03982199|156722570|FG002|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
48692348|NCT03982199|156722571|FG003|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
48692349|NCT03982199|156722572|FG004|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
48692350|NCT03982199|156722573|FG005|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
48692351|NCT03982199|156722574|FG006|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
48692352|NCT03982199|156722575|FG007|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
48692353|NCT03982199|156722576|FG008|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
48692354|NCT03982199|156722577|FG009|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
48692355|NCT03982199|156722578|FG010|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
48692356|NCT03982199|156722579|FG011|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
48692357|NCT03982199|156722580|FG012|Revacc Subcohort (From Day 1095 to 1460)|Other|1|||
49025253|NCT00085735|157932951|FG005|Overall Study|Excess residual disease|4|||
49025254|NCT00085735|157932946|FG000|Overall Study|Reason not documented|1|||
48765032|NCT02641379|156988321|FG009|Overall Study|Participant unable to attend study visit|2|||
48765033|NCT02641379|156988322|FG010|Overall Study|Participant unable to attend study visit|0|||
48765034|NCT02641379|156988312|FG000|Overall Study|Participant's compliance|0|||
48765035|NCT02641379|156988313|FG001|Overall Study|Participant's compliance|1|||
48765036|NCT02641379|156988314|FG002|Overall Study|Participant's compliance|0|||
48765037|NCT02641379|156988315|FG003|Overall Study|Participant's compliance|1|||
48765038|NCT02641379|156988316|FG004|Overall Study|Participant's compliance|0|||
48765039|NCT02641379|156988317|FG005|Overall Study|Participant's compliance|2|||
48765040|NCT02641379|156988318|FG006|Overall Study|Participant's compliance|0|||
48765041|NCT02641379|156988319|FG007|Overall Study|Participant's compliance|0|||
48765042|NCT02641379|156988320|FG008|Overall Study|Participant's compliance|1|||
48765043|NCT02641379|156988321|FG009|Overall Study|Participant's compliance|1|||
48765044|NCT02641379|156988322|FG010|Overall Study|Participant's compliance|1|||
48765045|NCT02641379|156988312|FG000|Overall Study|Participant cannot be reached|4|||
48765046|NCT02641379|156988313|FG001|Overall Study|Participant cannot be reached|4|||
48765047|NCT02641379|156988314|FG002|Overall Study|Participant cannot be reached|0|||
48765048|NCT02641379|156988315|FG003|Overall Study|Participant cannot be reached|8|||
48765049|NCT02641379|156988316|FG004|Overall Study|Participant cannot be reached|2|||
48765050|NCT02641379|156988317|FG005|Overall Study|Participant cannot be reached|1|||
48765051|NCT02641379|156988318|FG006|Overall Study|Participant cannot be reached|0|||
48765052|NCT02641379|156988319|FG007|Overall Study|Participant cannot be reached|1|||
48765053|NCT02641379|156988320|FG008|Overall Study|Participant cannot be reached|0|||
48765054|NCT02641379|156988321|FG009|Overall Study|Participant cannot be reached|2|||
48765055|NCT02641379|156988322|FG010|Overall Study|Participant cannot be reached|1|||
48765056|NCT02641379|156988312|FG000|Overall Study|PCR positive at Week 24|15|||
48765057|NCT02641379|156988313|FG001|Overall Study|PCR positive at Week 24|21|||
48765058|NCT02641379|156988314|FG002|Overall Study|PCR positive at Week 24|62|||
48765059|NCT02641379|156988315|FG003|Overall Study|PCR positive at Week 24|0|||
48765060|NCT02641379|156988316|FG004|Overall Study|PCR positive at Week 24|0|||
48765061|NCT02641379|156988317|FG005|Overall Study|PCR positive at Week 24|6|||
48765062|NCT02641379|156988318|FG006|Overall Study|PCR positive at Week 24|3|||
48765063|NCT02641379|156988319|FG007|Overall Study|PCR positive at Week 24|8|||
48765064|NCT02641379|156988320|FG008|Overall Study|PCR positive at Week 24|0|||
48765065|NCT02641379|156988321|FG009|Overall Study|PCR positive at Week 24|1|||
48765066|NCT02641379|156988322|FG010|Overall Study|PCR positive at Week 24|0|||
48765067|NCT02641379|156988312|FG000|Overall Study|PCR positive at follow up 2|1|||
48765068|NCT02641379|156988313|FG001|Overall Study|PCR positive at follow up 2|0|||
48765069|NCT02641379|156988314|FG002|Overall Study|PCR positive at follow up 2|0|||
48765070|NCT02641379|156988315|FG003|Overall Study|PCR positive at follow up 2|0|||
48765071|NCT02641379|156988316|FG004|Overall Study|PCR positive at follow up 2|0|||
48765072|NCT02641379|156988317|FG005|Overall Study|PCR positive at follow up 2|0|||
48765073|NCT02641379|156988318|FG006|Overall Study|PCR positive at follow up 2|0|||
48765074|NCT02641379|156988319|FG007|Overall Study|PCR positive at follow up 2|0|||
48765075|NCT02641379|156988320|FG008|Overall Study|PCR positive at follow up 2|0|||
48765076|NCT02641379|156988321|FG009|Overall Study|PCR positive at follow up 2|0|||
48765077|NCT02641379|156988322|FG010|Overall Study|PCR positive at follow up 2|0|||
48765078|NCT02641379|156988312|FG000|Overall Study|Participant showed relapse|1|||
48765079|NCT02641379|156988313|FG001|Overall Study|Participant showed relapse|0|||
48765080|NCT02641379|156988314|FG002|Overall Study|Participant showed relapse|0|||
48765081|NCT02641379|156988315|FG003|Overall Study|Participant showed relapse|0|||
48765082|NCT02641379|156988316|FG004|Overall Study|Participant showed relapse|0|||
48765083|NCT02641379|156988317|FG005|Overall Study|Participant showed relapse|0|||
48765084|NCT02641379|156988318|FG006|Overall Study|Participant showed relapse|1|||
48765085|NCT02641379|156988319|FG007|Overall Study|Participant showed relapse|0|||
48765086|NCT02641379|156988320|FG008|Overall Study|Participant showed relapse|0|||
48765087|NCT02641379|156988321|FG009|Overall Study|Participant showed relapse|0|||
48765088|NCT02641379|156988322|FG010|Overall Study|Participant showed relapse|0|||
48765089|NCT02641379|156988312|FG000|Overall Study|Participant stopped study/treatment|1|||
48765090|NCT02641379|156988313|FG001|Overall Study|Participant stopped study/treatment|3|||
48765091|NCT02641379|156988314|FG002|Overall Study|Participant stopped study/treatment|1|||
48875513|NCT00550446|157381649|FG008|Post Week 12|Other|1|||
48875514|NCT00550446|157381650|FG009|Post Week 12|Other|1|||
49025255|NCT00085735|157932947|FG001|Overall Study|Reason not documented|0|||
49025256|NCT00085735|157932948|FG002|Overall Study|Reason not documented|1|||
49025257|NCT00085735|157932949|FG003|Overall Study|Reason not documented|0|||
48765092|NCT02641379|156988315|FG003|Overall Study|Participant stopped study/treatment|0|||
48765093|NCT02641379|156988316|FG004|Overall Study|Participant stopped study/treatment|0|||
48765094|NCT02641379|156988317|FG005|Overall Study|Participant stopped study/treatment|1|||
48765095|NCT02641379|156988318|FG006|Overall Study|Participant stopped study/treatment|2|||
48765096|NCT02641379|156988319|FG007|Overall Study|Participant stopped study/treatment|0|||
48765097|NCT02641379|156988320|FG008|Overall Study|Participant stopped study/treatment|1|||
48765098|NCT02641379|156988321|FG009|Overall Study|Participant stopped study/treatment|0|||
48765099|NCT02641379|156988322|FG010|Overall Study|Participant stopped study/treatment|0|||
49025258|NCT00085735|157932950|FG004|Overall Study|Reason not documented|1|||
48765100|NCT02641379|156988312|FG000|Overall Study|Therapy stopped due to misunderstanding|1|||
48765101|NCT02641379|156988313|FG001|Overall Study|Therapy stopped due to misunderstanding|0|||
48765102|NCT02641379|156988314|FG002|Overall Study|Therapy stopped due to misunderstanding|0|||
48765103|NCT02641379|156988315|FG003|Overall Study|Therapy stopped due to misunderstanding|0|||
48765104|NCT02641379|156988316|FG004|Overall Study|Therapy stopped due to misunderstanding|0|||
48765105|NCT02641379|156988317|FG005|Overall Study|Therapy stopped due to misunderstanding|0|||
48765106|NCT02641379|156988318|FG006|Overall Study|Therapy stopped due to misunderstanding|0|||
48765107|NCT02641379|156988319|FG007|Overall Study|Therapy stopped due to misunderstanding|0|||
48765108|NCT02641379|156988320|FG008|Overall Study|Therapy stopped due to misunderstanding|0|||
48765109|NCT02641379|156988321|FG009|Overall Study|Therapy stopped due to misunderstanding|0|||
48765110|NCT02641379|156988322|FG010|Overall Study|Therapy stopped due to misunderstanding|0|||
48765111|NCT02641379|156988312|FG000|Overall Study|Financial problems|0|||
48765112|NCT02641379|156988313|FG001|Overall Study|Financial problems|1|||
48765113|NCT02641379|156988314|FG002|Overall Study|Financial problems|0|||
48765114|NCT02641379|156988315|FG003|Overall Study|Financial problems|0|||
48765115|NCT02641379|156988316|FG004|Overall Study|Financial problems|0|||
48765116|NCT02641379|156988317|FG005|Overall Study|Financial problems|0|||
48765117|NCT02641379|156988318|FG006|Overall Study|Financial problems|0|||
48765118|NCT02641379|156988319|FG007|Overall Study|Financial problems|0|||
48765119|NCT02641379|156988320|FG008|Overall Study|Financial problems|0|||
48765120|NCT02641379|156988321|FG009|Overall Study|Financial problems|0|||
48765121|NCT02641379|156988322|FG010|Overall Study|Financial problems|0|||
48765122|NCT02641379|156988312|FG000|Overall Study|PCR positive at Week 68|0|||
48765123|NCT02641379|156988313|FG001|Overall Study|PCR positive at Week 68|1|||
48765124|NCT02641379|156988314|FG002|Overall Study|PCR positive at Week 68|0|||
48765125|NCT02641379|156988315|FG003|Overall Study|PCR positive at Week 68|0|||
48765126|NCT02641379|156988316|FG004|Overall Study|PCR positive at Week 68|0|||
48765127|NCT02641379|156988317|FG005|Overall Study|PCR positive at Week 68|0|||
48765128|NCT02641379|156988318|FG006|Overall Study|PCR positive at Week 68|0|||
48765129|NCT02641379|156988319|FG007|Overall Study|PCR positive at Week 68|0|||
48765130|NCT02641379|156988320|FG008|Overall Study|PCR positive at Week 68|0|||
48765131|NCT02641379|156988321|FG009|Overall Study|PCR positive at Week 68|0|||
48765132|NCT02641379|156988322|FG010|Overall Study|PCR positive at Week 68|0|||
48765133|NCT02641379|156988312|FG000|Overall Study|PCR positive at Week 48|0|||
48765134|NCT02641379|156988313|FG001|Overall Study|PCR positive at Week 48|1|||
48765135|NCT02641379|156988314|FG002|Overall Study|PCR positive at Week 48|0|||
48765136|NCT02641379|156988315|FG003|Overall Study|PCR positive at Week 48|0|||
48765137|NCT02641379|156988316|FG004|Overall Study|PCR positive at Week 48|0|||
48765138|NCT02641379|156988317|FG005|Overall Study|PCR positive at Week 48|0|||
48765139|NCT02641379|156988318|FG006|Overall Study|PCR positive at Week 48|0|||
48765140|NCT02641379|156988319|FG007|Overall Study|PCR positive at Week 48|0|||
48765141|NCT02641379|156988320|FG008|Overall Study|PCR positive at Week 48|0|||
48765142|NCT02641379|156988321|FG009|Overall Study|PCR positive at Week 48|0|||
48765143|NCT02641379|156988322|FG010|Overall Study|PCR positive at Week 48|0|||
48765144|NCT02641379|156988312|FG000|Overall Study|PCR not performed at Week 12|0|||
48765145|NCT02641379|156988313|FG001|Overall Study|PCR not performed at Week 12|0|||
48765146|NCT02641379|156988314|FG002|Overall Study|PCR not performed at Week 12|1|||
48765147|NCT02641379|156988315|FG003|Overall Study|PCR not performed at Week 12|0|||
48765148|NCT02641379|156988316|FG004|Overall Study|PCR not performed at Week 12|0|||
48765149|NCT02641379|156988317|FG005|Overall Study|PCR not performed at Week 12|0|||
48765150|NCT02641379|156988318|FG006|Overall Study|PCR not performed at Week 12|0|||
48765151|NCT02641379|156988319|FG007|Overall Study|PCR not performed at Week 12|0|||
48765152|NCT02641379|156988320|FG008|Overall Study|PCR not performed at Week 12|0|||
48765153|NCT02641379|156988321|FG009|Overall Study|PCR not performed at Week 12|0|||
48765154|NCT02641379|156988322|FG010|Overall Study|PCR not performed at Week 12|0|||
48765155|NCT02641379|156988312|FG000|Overall Study|No PCR at baseline|0|||
48765156|NCT02641379|156988313|FG001|Overall Study|No PCR at baseline|0|||
48765157|NCT02641379|156988314|FG002|Overall Study|No PCR at baseline|1|||
48765158|NCT02641379|156988315|FG003|Overall Study|No PCR at baseline|0|||
48765159|NCT02641379|156988316|FG004|Overall Study|No PCR at baseline|0|||
48765160|NCT02641379|156988317|FG005|Overall Study|No PCR at baseline|0|||
48765161|NCT02641379|156988318|FG006|Overall Study|No PCR at baseline|0|||
48765162|NCT02641379|156988319|FG007|Overall Study|No PCR at baseline|0|||
48765163|NCT02641379|156988320|FG008|Overall Study|No PCR at baseline|0|||
48765164|NCT02641379|156988321|FG009|Overall Study|No PCR at baseline|0|||
48765165|NCT02641379|156988322|FG010|Overall Study|No PCR at baseline|0|||
48765166|NCT02641379|156988312|FG000|Overall Study|PCR positive at Week 28|0|||
48765167|NCT02641379|156988313|FG001|Overall Study|PCR positive at Week 28|0|||
48765168|NCT02641379|156988314|FG002|Overall Study|PCR positive at Week 28|1|||
48765169|NCT02641379|156988315|FG003|Overall Study|PCR positive at Week 28|0|||
48765170|NCT02641379|156988316|FG004|Overall Study|PCR positive at Week 28|0|||
48765171|NCT02641379|156988317|FG005|Overall Study|PCR positive at Week 28|0|||
48765172|NCT02641379|156988318|FG006|Overall Study|PCR positive at Week 28|0|||
48765173|NCT02641379|156988319|FG007|Overall Study|PCR positive at Week 28|0|||
48765174|NCT02641379|156988320|FG008|Overall Study|PCR positive at Week 28|0|||
48765175|NCT02641379|156988321|FG009|Overall Study|PCR positive at Week 28|0|||
48765176|NCT02641379|156988322|FG010|Overall Study|PCR positive at Week 28|0|||
48765177|NCT02641379|156988312|FG000|Overall Study|PCR sample for Week 4 not drawn|0|||
48765178|NCT02641379|156988313|FG001|Overall Study|PCR sample for Week 4 not drawn|0|||
48765179|NCT02641379|156988314|FG002|Overall Study|PCR sample for Week 4 not drawn|0|||
48765180|NCT02641379|156988315|FG003|Overall Study|PCR sample for Week 4 not drawn|1|||
48765181|NCT02641379|156988316|FG004|Overall Study|PCR sample for Week 4 not drawn|0|||
48765182|NCT02641379|156988317|FG005|Overall Study|PCR sample for Week 4 not drawn|0|||
48765183|NCT02641379|156988318|FG006|Overall Study|PCR sample for Week 4 not drawn|0|||
48765184|NCT02641379|156988319|FG007|Overall Study|PCR sample for Week 4 not drawn|0|||
48765185|NCT02641379|156988320|FG008|Overall Study|PCR sample for Week 4 not drawn|0|||
48765186|NCT02641379|156988321|FG009|Overall Study|PCR sample for Week 4 not drawn|0|||
48765187|NCT02641379|156988322|FG010|Overall Study|PCR sample for Week 4 not drawn|0|||
48765188|NCT02641379|156988312|FG000|Overall Study|Inclusion criteria not fulfilled|0|||
48765189|NCT02641379|156988313|FG001|Overall Study|Inclusion criteria not fulfilled|0|||
48765190|NCT02641379|156988314|FG002|Overall Study|Inclusion criteria not fulfilled|0|||
48765191|NCT02641379|156988315|FG003|Overall Study|Inclusion criteria not fulfilled|1|||
48765192|NCT02641379|156988316|FG004|Overall Study|Inclusion criteria not fulfilled|0|||
48765193|NCT02641379|156988317|FG005|Overall Study|Inclusion criteria not fulfilled|0|||
48765194|NCT02641379|156988318|FG006|Overall Study|Inclusion criteria not fulfilled|0|||
48765195|NCT02641379|156988319|FG007|Overall Study|Inclusion criteria not fulfilled|0|||
48765196|NCT02641379|156988320|FG008|Overall Study|Inclusion criteria not fulfilled|0|||
48765197|NCT02641379|156988321|FG009|Overall Study|Inclusion criteria not fulfilled|0|||
48765198|NCT02641379|156988322|FG010|Overall Study|Inclusion criteria not fulfilled|0|||
48765199|NCT02641379|156988312|FG000|Overall Study|Baseline viral load unavailable|0|||
48765200|NCT02641379|156988313|FG001|Overall Study|Baseline viral load unavailable|0|||
48765201|NCT02641379|156988314|FG002|Overall Study|Baseline viral load unavailable|0|||
48765202|NCT02641379|156988315|FG003|Overall Study|Baseline viral load unavailable|1|||
48765203|NCT02641379|156988316|FG004|Overall Study|Baseline viral load unavailable|0|||
48765204|NCT02641379|156988317|FG005|Overall Study|Baseline viral load unavailable|0|||
48765205|NCT02641379|156988318|FG006|Overall Study|Baseline viral load unavailable|0|||
48765206|NCT02641379|156988319|FG007|Overall Study|Baseline viral load unavailable|0|||
48765207|NCT02641379|156988320|FG008|Overall Study|Baseline viral load unavailable|0|||
48765208|NCT02641379|156988321|FG009|Overall Study|Baseline viral load unavailable|0|||
48765209|NCT02641379|156988322|FG010|Overall Study|Baseline viral load unavailable|0|||
48765210|NCT02641379|156988312|FG000|Overall Study|Blood could not be drawn|0|||
48765211|NCT02641379|156988313|FG001|Overall Study|Blood could not be drawn|0|||
48765212|NCT02641379|156988314|FG002|Overall Study|Blood could not be drawn|0|||
48765213|NCT02641379|156988315|FG003|Overall Study|Blood could not be drawn|0|||
48765214|NCT02641379|156988316|FG004|Overall Study|Blood could not be drawn|1|||
48765215|NCT02641379|156988317|FG005|Overall Study|Blood could not be drawn|0|||
48765216|NCT02641379|156988318|FG006|Overall Study|Blood could not be drawn|0|||
48765217|NCT02641379|156988319|FG007|Overall Study|Blood could not be drawn|0|||
48765218|NCT02641379|156988320|FG008|Overall Study|Blood could not be drawn|0|||
48765219|NCT02641379|156988321|FG009|Overall Study|Blood could not be drawn|0|||
48765220|NCT02641379|156988322|FG010|Overall Study|Blood could not be drawn|0|||
48765221|NCT02641379|156988312|FG000|Overall Study|Protocol Violation|0|||
48765222|NCT02641379|156988313|FG001|Overall Study|Protocol Violation|0|||
48765223|NCT02641379|156988314|FG002|Overall Study|Protocol Violation|0|||
48765224|NCT02641379|156988315|FG003|Overall Study|Protocol Violation|0|||
48765225|NCT02641379|156988316|FG004|Overall Study|Protocol Violation|2|||
48765226|NCT02641379|156988317|FG005|Overall Study|Protocol Violation|0|||
48765227|NCT02641379|156988318|FG006|Overall Study|Protocol Violation|0|||
48765228|NCT02641379|156988319|FG007|Overall Study|Protocol Violation|0|||
48765229|NCT02641379|156988320|FG008|Overall Study|Protocol Violation|1|||
48765230|NCT02641379|156988321|FG009|Overall Study|Protocol Violation|0|||
48765231|NCT02641379|156988322|FG010|Overall Study|Protocol Violation|0|||
48765232|NCT02641379|156988312|FG000|Overall Study|Participation in sili rescue study|0|||
48765233|NCT02641379|156988313|FG001|Overall Study|Participation in sili rescue study|0|||
48765234|NCT02641379|156988314|FG002|Overall Study|Participation in sili rescue study|0|||
48765235|NCT02641379|156988315|FG003|Overall Study|Participation in sili rescue study|0|||
48765236|NCT02641379|156988316|FG004|Overall Study|Participation in sili rescue study|0|||
48765237|NCT02641379|156988317|FG005|Overall Study|Participation in sili rescue study|1|||
48765238|NCT02641379|156988318|FG006|Overall Study|Participation in sili rescue study|0|||
48765239|NCT02641379|156988319|FG007|Overall Study|Participation in sili rescue study|0|||
48765240|NCT02641379|156988320|FG008|Overall Study|Participation in sili rescue study|0|||
48765241|NCT02641379|156988321|FG009|Overall Study|Participation in sili rescue study|0|||
48765242|NCT02641379|156988322|FG010|Overall Study|Participation in sili rescue study|0|||
49025259|NCT00085735|157932951|FG005|Overall Study|Reason not documented|0|||
48765243|NCT02641379|156988312|FG000|Overall Study|Lost to Follow-up|0|||
48765244|NCT02641379|156988313|FG001|Overall Study|Lost to Follow-up|0|||
48765245|NCT02641379|156988314|FG002|Overall Study|Lost to Follow-up|0|||
48875515|NCT00550446|157381651|FG010|Post Week 12|Other|0|||
48875516|NCT01192776|157381652|FG000|Overall Study|Death|8|||
48875517|NCT01192776|157381653|FG001|Overall Study|Death|15|||
48875518|NCT01192776|157381654|FG002|Overall Study|Death|18|||
48875519|NCT01192776|157381655|FG003|Overall Study|Death|15|||
48875520|NCT01192776|157381652|FG000|Overall Study|Lost to Follow-up|3|||
48875521|NCT01192776|157381653|FG001|Overall Study|Lost to Follow-up|6|||
48875522|NCT01192776|157381654|FG002|Overall Study|Lost to Follow-up|3|||
48875523|NCT01192776|157381655|FG003|Overall Study|Lost to Follow-up|5|||
48875524|NCT02872311|157381660|FG000|Overall Study|Death|2|||
48875525|NCT02872311|157381661|FG001|Overall Study|Death|0|||
48875526|NCT02872311|157381662|FG002|Overall Study|Death|0|||
48875527|NCT02872311|157381663|FG003|Overall Study|Death|0|||
48875528|NCT02872311|157381664|FG004|Overall Study|Death|0|||
48875529|NCT02872311|157381660|FG000|Overall Study|Lost to Follow-up|2|||
48875530|NCT02872311|157381661|FG001|Overall Study|Lost to Follow-up|0|||
48875531|NCT02872311|157381662|FG002|Overall Study|Lost to Follow-up|0|||
48875532|NCT02872311|157381663|FG003|Overall Study|Lost to Follow-up|0|||
48875533|NCT02872311|157381664|FG004|Overall Study|Lost to Follow-up|0|||
48875534|NCT02872311|157381660|FG000|Overall Study|Protocol Violation|0|||
48875535|NCT02872311|157381661|FG001|Overall Study|Protocol Violation|2|||
48875536|NCT02872311|157381662|FG002|Overall Study|Protocol Violation|1|||
48875537|NCT02872311|157381663|FG003|Overall Study|Protocol Violation|0|||
48875538|NCT02872311|157381664|FG004|Overall Study|Protocol Violation|0|||
48875539|NCT00263575|157381671|FG000|Titration Period|Adverse Event|14|||
48875540|NCT00263575|157381671|FG000|Titration Period|Withdrawal by Subject|10|||
48875541|NCT00263575|157381671|FG000|Titration Period|Protocol Violation|9|||
48875542|NCT00263575|157381671|FG000|Titration Period|Sponsor Decision|2|||
48875543|NCT00263575|157381671|FG000|Titration Period|Other|2|||
48875544|NCT00263575|157381671|FG000|Titration Period|Lack of Efficacy|6|||
48875545|NCT00263575|157381671|FG000|Maintence Period|Adverse Event|23|||
48875546|NCT00263575|157381671|FG000|Maintence Period|Withdrawal by Subject|8|||
48765246|NCT02641379|156988315|FG003|Overall Study|Lost to Follow-up|0|||
48765247|NCT02641379|156988316|FG004|Overall Study|Lost to Follow-up|0|||
48765248|NCT02641379|156988317|FG005|Overall Study|Lost to Follow-up|0|||
48765249|NCT02641379|156988318|FG006|Overall Study|Lost to Follow-up|0|||
48765250|NCT02641379|156988319|FG007|Overall Study|Lost to Follow-up|0|||
48765251|NCT02641379|156988320|FG008|Overall Study|Lost to Follow-up|1|||
48765252|NCT02641379|156988321|FG009|Overall Study|Lost to Follow-up|0|||
48765253|NCT02641379|156988322|FG010|Overall Study|Lost to Follow-up|0|||
48765254|NCT02641379|156988312|FG000|Overall Study|Source data not found|0|||
48765255|NCT02641379|156988313|FG001|Overall Study|Source data not found|0|||
48765256|NCT02641379|156988314|FG002|Overall Study|Source data not found|0|||
48765257|NCT02641379|156988315|FG003|Overall Study|Source data not found|0|||
48765258|NCT02641379|156988316|FG004|Overall Study|Source data not found|0|||
48765259|NCT02641379|156988317|FG005|Overall Study|Source data not found|1|||
48765260|NCT02641379|156988318|FG006|Overall Study|Source data not found|0|||
48765261|NCT02641379|156988319|FG007|Overall Study|Source data not found|0|||
48765262|NCT02641379|156988320|FG008|Overall Study|Source data not found|0|||
48765263|NCT02641379|156988321|FG009|Overall Study|Source data not found|0|||
48765264|NCT02641379|156988322|FG010|Overall Study|Source data not found|0|||
48765265|NCT02641379|156988312|FG000|Overall Study|Participant showed weight reduction|0|||
48765266|NCT02641379|156988313|FG001|Overall Study|Participant showed weight reduction|0|||
48765267|NCT02641379|156988314|FG002|Overall Study|Participant showed weight reduction|0|||
48765268|NCT02641379|156988315|FG003|Overall Study|Participant showed weight reduction|0|||
48875547|NCT00263575|157381671|FG000|Maintence Period|Protocol Violation|4|||
48875548|NCT00263575|157381671|FG000|Maintence Period|Lack of Efficacy|4|||
48875549|NCT00263575|157381671|FG000|Maintence Period|Physician Decision|6|||
48765269|NCT02641379|156988316|FG004|Overall Study|Participant showed weight reduction|0|||
48765270|NCT02641379|156988317|FG005|Overall Study|Participant showed weight reduction|0|||
48765271|NCT02641379|156988318|FG006|Overall Study|Participant showed weight reduction|0|||
48765272|NCT02641379|156988319|FG007|Overall Study|Participant showed weight reduction|1|||
48765273|NCT02641379|156988320|FG008|Overall Study|Participant showed weight reduction|0|||
48875550|NCT00263575|157381671|FG000|Maintence Period|Lost to Follow-up|1|||
48875551|NCT00263575|157381671|FG000|Maintence Period|Sponsor Decision|24|||
48875552|NCT00263575|157381671|FG000|Maintence Period|Other|7|||
48875553|NCT02447718|157381672|FG000|Overall Study|Lost to Follow-up|8|||
48875554|NCT02447718|157381673|FG001|Overall Study|Lost to Follow-up|0|||
48875555|NCT02447718|157381672|FG000|Overall Study|Withdrawal by Subject|3|||
48875556|NCT02447718|157381673|FG001|Overall Study|Withdrawal by Subject|0|||
48875557|NCT02447718|157381672|FG000|Overall Study|Screen Failure|1|||
48765274|NCT02641379|156988321|FG009|Overall Study|Participant showed weight reduction|0|||
48765275|NCT02641379|156988322|FG010|Overall Study|Participant showed weight reduction|0|||
48765276|NCT02641379|156988312|FG000|Overall Study|Non-response Week 12|0|||
48875558|NCT02447718|157381673|FG001|Overall Study|Screen Failure|0|||
48875559|NCT01728623|157381679|FG000|Overall Study|Disease progression|26|||
48875560|NCT01728623|157381679|FG000|Overall Study|Adverse Event|1|||
48875561|NCT01728623|157381679|FG000|Overall Study|Withdrawal by Subject|1|||
48875562|NCT01099579|157381680|FG000|Stage 1 (ATV Powder Formulation)|Adverse Event|4|||
48875563|NCT01099579|157381681|FG001|Stage 1 (ATV Powder Formulation)|Adverse Event|1|||
48875564|NCT01099579|157381682|FG002|Stage 1 (ATV Powder Formulation)|Adverse Event|0|||
48875565|NCT01099579|157381680|FG000|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
48875566|NCT01099579|157381681|FG001|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
48875567|NCT01099579|157381682|FG002|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1|||
48875568|NCT01099579|157381680|FG000|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
48875569|NCT01099579|157381681|FG001|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2|||
48875570|NCT01099579|157381682|FG002|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
48875571|NCT01099579|157381680|FG000|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
48875572|NCT01099579|157381681|FG001|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2|||
48875573|NCT01099579|157381682|FG002|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
48875574|NCT01099579|157381680|FG000|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
48875575|NCT01099579|157381681|FG001|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
48875576|NCT01099579|157381682|FG002|Stage 2 (ATV Capsule)|No longer met study criteria|1|||
48875577|NCT01099579|157381680|FG000|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
48875578|NCT01099579|157381681|FG001|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
48875579|NCT01099579|157381682|FG002|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
48875580|NCT01099579|157381680|FG000|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
48875581|NCT01099579|157381681|FG001|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
48875582|NCT01099579|157381682|FG002|Stage 2 (ATV Capsule)|Lack of Efficacy|2|||
48875583|NCT01099579|157381680|FG000|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
48875584|NCT01099579|157381681|FG001|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
48765277|NCT02641379|156988313|FG001|Overall Study|Non-response Week 12|0|||
48765278|NCT02641379|156988314|FG002|Overall Study|Non-response Week 12|0|||
48765279|NCT02641379|156988315|FG003|Overall Study|Non-response Week 12|0|||
48765280|NCT02641379|156988316|FG004|Overall Study|Non-response Week 12|0|||
48765281|NCT02641379|156988317|FG005|Overall Study|Non-response Week 12|0|||
48765282|NCT02641379|156988318|FG006|Overall Study|Non-response Week 12|0|||
48765283|NCT02641379|156988319|FG007|Overall Study|Non-response Week 12|1|||
48765284|NCT02641379|156988320|FG008|Overall Study|Non-response Week 12|0|||
48765285|NCT02641379|156988321|FG009|Overall Study|Non-response Week 12|0|||
48765286|NCT02641379|156988322|FG010|Overall Study|Non-response Week 12|0|||
48765287|NCT02641379|156988312|FG000|Overall Study|No 2 Log drop at Week 12|0|||
48765288|NCT02641379|156988313|FG001|Overall Study|No 2 Log drop at Week 12|0|||
48765289|NCT02641379|156988314|FG002|Overall Study|No 2 Log drop at Week 12|0|||
48765290|NCT02641379|156988315|FG003|Overall Study|No 2 Log drop at Week 12|0|||
48765291|NCT02641379|156988316|FG004|Overall Study|No 2 Log drop at Week 12|0|||
48765292|NCT02641379|156988317|FG005|Overall Study|No 2 Log drop at Week 12|0|||
48765293|NCT02641379|156988318|FG006|Overall Study|No 2 Log drop at Week 12|0|||
48765294|NCT02641379|156988319|FG007|Overall Study|No 2 Log drop at Week 12|0|||
48765295|NCT02641379|156988320|FG008|Overall Study|No 2 Log drop at Week 12|0|||
48765296|NCT02641379|156988321|FG009|Overall Study|No 2 Log drop at Week 12|0|||
48765297|NCT02641379|156988322|FG010|Overall Study|No 2 Log drop at Week 12|1|||
48765298|NCT02641379|156988312|FG000|Overall Study|Negative PCR result|0|||
48765299|NCT02641379|156988313|FG001|Overall Study|Negative PCR result|0|||
48765300|NCT02641379|156988314|FG002|Overall Study|Negative PCR result|0|||
48765301|NCT02641379|156988315|FG003|Overall Study|Negative PCR result|0|||
48765302|NCT02641379|156988316|FG004|Overall Study|Negative PCR result|0|||
48765303|NCT02641379|156988317|FG005|Overall Study|Negative PCR result|0|||
48765304|NCT02641379|156988318|FG006|Overall Study|Negative PCR result|0|||
48765305|NCT02641379|156988319|FG007|Overall Study|Negative PCR result|0|||
48765306|NCT02641379|156988320|FG008|Overall Study|Negative PCR result|0|||
48765307|NCT02641379|156988321|FG009|Overall Study|Negative PCR result|1|||
48765308|NCT02641379|156988322|FG010|Overall Study|Negative PCR result|0|||
48765309|NCT02641379|156988312|FG000|Overall Study|Participant's PCR high|0|||
48765310|NCT02641379|156988313|FG001|Overall Study|Participant's PCR high|0|||
48765311|NCT02641379|156988314|FG002|Overall Study|Participant's PCR high|0|||
48765312|NCT02641379|156988315|FG003|Overall Study|Participant's PCR high|0|||
48765313|NCT02641379|156988316|FG004|Overall Study|Participant's PCR high|0|||
48765314|NCT02641379|156988317|FG005|Overall Study|Participant's PCR high|0|||
48765315|NCT02641379|156988318|FG006|Overall Study|Participant's PCR high|0|||
48875585|NCT01099579|157381682|FG002|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
48875586|NCT01099579|157381680|FG000|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2|||
48875587|NCT01099579|157381681|FG001|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0|||
48765316|NCT02641379|156988319|FG007|Overall Study|Participant's PCR high|1|||
48765317|NCT02641379|156988320|FG008|Overall Study|Participant's PCR high|0|||
48765318|NCT02641379|156988321|FG009|Overall Study|Participant's PCR high|0|||
48765319|NCT02641379|156988322|FG010|Overall Study|Participant's PCR high|0|||
48765320|NCT02641379|156988312|FG000|Overall Study|Participant treated after Week 24|0|||
48765321|NCT02641379|156988313|FG001|Overall Study|Participant treated after Week 24|0|||
48765322|NCT02641379|156988314|FG002|Overall Study|Participant treated after Week 24|0|||
48765323|NCT02641379|156988315|FG003|Overall Study|Participant treated after Week 24|0|||
48765324|NCT02641379|156988316|FG004|Overall Study|Participant treated after Week 24|0|||
49025260|NCT00085735|157932946|FG000|Overall Study|Pt transferred to inst w/out study open|1|||
49025261|NCT00085735|157932947|FG001|Overall Study|Pt transferred to inst w/out study open|0|||
49025262|NCT00085735|157932948|FG002|Overall Study|Pt transferred to inst w/out study open|0|||
49025263|NCT00085735|157932949|FG003|Overall Study|Pt transferred to inst w/out study open|0|||
49025264|NCT00085735|157932950|FG004|Overall Study|Pt transferred to inst w/out study open|0|||
49025265|NCT00085735|157932951|FG005|Overall Study|Pt transferred to inst w/out study open|0|||
49025266|NCT04567186|157932952|FG000|Period 1|COVID-19 related|1|||
49025267|NCT04567186|157932953|FG001|Period 1|COVID-19 related|0|||
49025268|NCT04567186|157932952|FG000|Period 1|Protocol Violation|0|||
49025269|NCT04567186|157932953|FG001|Period 1|Protocol Violation|1|||
49025270|NCT04567186|157932952|FG000|Period 1|Adverse Event|0|||
49025271|NCT04567186|157932953|FG001|Period 1|Adverse Event|2|||
49025272|NCT04567186|157932952|FG000|Period 2|COVID-19 Related|0|||
49025273|NCT04567186|157932953|FG001|Period 2|COVID-19 Related|1|||
49025274|NCT04567186|157932952|FG000|Period 2|Protocol Violation|0|||
49025275|NCT04567186|157932953|FG001|Period 2|Protocol Violation|1|||
49025276|NCT04567186|157932952|FG000|Period 2|Lost to Follow-up|0|||
49025277|NCT04567186|157932953|FG001|Period 2|Lost to Follow-up|1|||
49025278|NCT04567186|157932952|FG000|Period 3|Subject no longer meets eligibilty criteria|1|||
49025279|NCT04567186|157932953|FG001|Period 3|Subject no longer meets eligibilty criteria|0|||
49025280|NCT00440557|157932954|FG000|Overall Study|Withdrawal by Subject|10|||
49025281|NCT00440557|157932955|FG001|Overall Study|Withdrawal by Subject|5|||
49025282|NCT00440557|157932956|FG002|Overall Study|Withdrawal by Subject|11|||
49025283|NCT00440557|157932954|FG000|Overall Study|Lost to Follow-up|1|||
48765325|NCT02641379|156988317|FG005|Overall Study|Participant treated after Week 24|0|||
48765326|NCT02641379|156988318|FG006|Overall Study|Participant treated after Week 24|0|||
48765327|NCT02641379|156988319|FG007|Overall Study|Participant treated after Week 24|0|||
48765328|NCT02641379|156988320|FG008|Overall Study|Participant treated after Week 24|1|||
48765329|NCT02641379|156988321|FG009|Overall Study|Participant treated after Week 24|0|||
48765330|NCT02641379|156988322|FG010|Overall Study|Participant treated after Week 24|0|||
48765331|NCT02641379|156988312|FG000|Overall Study|Missing PCR result at Week 8|0|||
48765332|NCT02641379|156988313|FG001|Overall Study|Missing PCR result at Week 8|0|||
48765333|NCT02641379|156988314|FG002|Overall Study|Missing PCR result at Week 8|0|||
48765334|NCT02641379|156988315|FG003|Overall Study|Missing PCR result at Week 8|0|||
48765335|NCT02641379|156988316|FG004|Overall Study|Missing PCR result at Week 8|0|||
48765336|NCT02641379|156988317|FG005|Overall Study|Missing PCR result at Week 8|0|||
48765337|NCT02641379|156988318|FG006|Overall Study|Missing PCR result at Week 8|0|||
48765338|NCT02641379|156988319|FG007|Overall Study|Missing PCR result at Week 8|0|||
48765339|NCT02641379|156988320|FG008|Overall Study|Missing PCR result at Week 8|0|||
48765340|NCT02641379|156988321|FG009|Overall Study|Missing PCR result at Week 8|1|||
48765341|NCT02641379|156988322|FG010|Overall Study|Missing PCR result at Week 8|0|||
48765342|NCT02641379|156988312|FG000|Overall Study|PCR positive|0|||
48765343|NCT02641379|156988313|FG001|Overall Study|PCR positive|0|||
48765344|NCT02641379|156988314|FG002|Overall Study|PCR positive|0|||
48765345|NCT02641379|156988315|FG003|Overall Study|PCR positive|0|||
48765346|NCT02641379|156988316|FG004|Overall Study|PCR positive|0|||
48765347|NCT02641379|156988317|FG005|Overall Study|PCR positive|0|||
48765348|NCT02641379|156988318|FG006|Overall Study|PCR positive|1|||
48765349|NCT02641379|156988319|FG007|Overall Study|PCR positive|0|||
48765350|NCT02641379|156988320|FG008|Overall Study|PCR positive|0|||
48765351|NCT02641379|156988321|FG009|Overall Study|PCR positive|0|||
48765352|NCT02641379|156988322|FG010|Overall Study|PCR positive|0|||
48765353|NCT00271947|156988323|FG000|Overall Study|Lost to Follow-up|1|||
48765354|NCT02818777|156988332|FG000|Overall Study|Adverse Event|3|||
48765355|NCT04220411|156988333|FG000|Overall Study|Adverse Event|0|||
48765356|NCT04220411|156988334|FG001|Overall Study|Adverse Event|0|||
48765357|NCT04220411|156988335|FG002|Overall Study|Adverse Event|0|||
48765358|NCT04220411|156988336|FG003|Overall Study|Adverse Event|1|||
48765359|NCT01398956|156988337|FG000|Overall Study|Withdrawal by Subject|4|||
48765360|NCT01398956|156988337|FG000|Overall Study|AE, non-serious non-fatal|4|||
48765361|NCT01398956|156988337|FG000|Overall Study|Withdrawal Criteria No.3|1|||
48765362|NCT01398956|156988337|FG000|Overall Study|Subject moved a long distance|1|||
48765363|NCT01132495|156988340|FG000|Overall Study|Various reasons|40|||
48765364|NCT01132495|156988341|FG001|Overall Study|Various reasons|38|||
49025284|NCT00440557|157932955|FG001|Overall Study|Lost to Follow-up|2|||
49025285|NCT00440557|157932956|FG002|Overall Study|Lost to Follow-up|6|||
48765365|NCT01132495|156988342|FG002|Overall Study|Various reasons|20|||
48765366|NCT01132495|156988343|FG003|Overall Study|Various reasons|12|||
48765367|NCT00663052|156988344|FG000|Overall Study|Adverse Event|6|||
48765368|NCT00663052|156988345|FG001|Overall Study|Adverse Event|3|||
48765369|NCT00663052|156988344|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
48765370|NCT00663052|156988345|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
48765371|NCT00663052|156988344|FG000|Overall Study|Protocol Violation|1|||
49025286|NCT00440557|157932954|FG000|Overall Study|Adverse Event|3|||
49025287|NCT00440557|157932955|FG001|Overall Study|Adverse Event|3|||
49025288|NCT00440557|157932956|FG002|Overall Study|Adverse Event|5|||
48875588|NCT01099579|157381682|FG002|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1|||
48875589|NCT01099579|157381680|FG000|Stage 2 (ATV Capsule)|Adverse Event|0|||
48875590|NCT01099579|157381681|FG001|Stage 2 (ATV Capsule)|Adverse Event|1|||
48875591|NCT01099579|157381682|FG002|Stage 2 (ATV Capsule)|Adverse Event|0|||
48875592|NCT02635386|157381685|FG000|Overall Study|Pregnancy|2|||
48875593|NCT02635386|157381686|FG001|Overall Study|Pregnancy|0|||
49025289|NCT00440557|157932954|FG000|Overall Study|Death|2|||
49025290|NCT00440557|157932955|FG001|Overall Study|Death|6|||
49025291|NCT00440557|157932956|FG002|Overall Study|Death|3|||
48765372|NCT00663052|156988345|FG001|Overall Study|Protocol Violation|0|||
49025292|NCT00440557|157932954|FG000|Overall Study|Began Dialysis|4|||
48765373|NCT00663052|156988344|FG000|Overall Study|Withdrawal by Subject|2|||
48765374|NCT00663052|156988345|FG001|Overall Study|Withdrawal by Subject|5|||
48765375|NCT00663052|156988344|FG000|Overall Study|Unsatisfactory Response - Efficacy|1|||
48765376|NCT00663052|156988345|FG001|Overall Study|Unsatisfactory Response - Efficacy|1|||
48765377|NCT00663052|156988344|FG000|Overall Study|Other|0|||
48765378|NCT00663052|156988345|FG001|Overall Study|Other|1|||
48765379|NCT01786629|156990224|FG000|Overall Study|Lack of Efficacy|0|||
48765380|NCT01786629|156990225|FG001|Overall Study|Lack of Efficacy|4|||
48765381|NCT01786629|156990224|FG000|Overall Study|Adverse Event|0|||
48765382|NCT01786629|156990225|FG001|Overall Study|Adverse Event|1|||
48765383|NCT00397982|156990228|FG000|Overall Study|Withdrawal by Subject|1|||
48765384|NCT00397982|156990228|FG000|Overall Study|Adverse Event|1|||
48765385|NCT00397982|156990228|FG000|Overall Study|noncompliance|1|||
48765386|NCT00397982|156990228|FG000|Overall Study|Unrelated health issues|1|||
48765387|NCT04244786|156990229|FG000|Overall Study|Adverse Event|0|||
48765388|NCT04244786|156990230|FG001|Overall Study|Adverse Event|0|||
48765389|NCT04244786|156990231|FG002|Overall Study|Adverse Event|2|||
48765390|NCT04244786|156990229|FG000|Overall Study|Withdrawal by Subject|0|||
48765391|NCT04244786|156990230|FG001|Overall Study|Withdrawal by Subject|0|||
48765392|NCT04244786|156990231|FG002|Overall Study|Withdrawal by Subject|5|||
48765393|NCT00720941|156990232|FG000|Overall Study|Death|334|||
48765394|NCT00720941|156990233|FG001|Overall Study|Death|335|||
48765395|NCT00720941|156990232|FG000|Overall Study|Protocol Violation|0|||
48765396|NCT00720941|156990233|FG001|Overall Study|Protocol Violation|2|||
48765397|NCT00720941|156990232|FG000|Overall Study|Lost to Follow-up|17|||
48765398|NCT00720941|156990233|FG001|Overall Study|Lost to Follow-up|15|||
48765399|NCT00720941|156990232|FG000|Overall Study|Physician Decision|1|||
48765400|NCT00720941|156990233|FG001|Overall Study|Physician Decision|5|||
48765401|NCT00720941|156990232|FG000|Overall Study|Withdrawal by Subject|27|||
49025293|NCT00440557|157932955|FG001|Overall Study|Began Dialysis|1|||
49025294|NCT00440557|157932956|FG002|Overall Study|Began Dialysis|4|||
49025295|NCT00440557|157932954|FG000|Overall Study|Principal Investigator decision|0|||
49025296|NCT00440557|157932955|FG001|Overall Study|Principal Investigator decision|3|||
49025297|NCT00440557|157932956|FG002|Overall Study|Principal Investigator decision|1|||
49025298|NCT00440557|157932954|FG000|Overall Study|Patient moved|1|||
48765402|NCT00720941|156990233|FG001|Overall Study|Withdrawal by Subject|35|||
48765403|NCT00720941|156990232|FG000|Overall Study|Ongoing|34|||
48765404|NCT00720941|156990233|FG001|Overall Study|Ongoing|23|||
48765405|NCT00066066|156990237|FG000|Overall Study|Lost to Follow-up|6|||
48765406|NCT00066066|156990238|FG001|Overall Study|Lost to Follow-up|4|||
48765407|NCT00066066|156990239|FG002|Overall Study|Lost to Follow-up|7|||
48765408|NCT00066066|156990240|FG003|Overall Study|Lost to Follow-up|4|||
48765409|NCT00066066|156990241|FG004|Overall Study|Lost to Follow-up|3|||
48765410|NCT00066066|156990242|FG005|Overall Study|Lost to Follow-up|5|||
48765411|NCT01572038|156990247|FG000|Overall Study|Death|648|||
48765412|NCT01572038|156990247|FG000|Overall Study|Withdrawal by Subject|204|||
48765413|NCT01572038|156990247|FG000|Overall Study|Lost to Follow-up|81|||
48765414|NCT01572038|156990247|FG000|Overall Study|Physician Decision|20|||
48765415|NCT01572038|156990247|FG000|Overall Study|Patient Decision|14|||
48765416|NCT01572038|156990247|FG000|Overall Study|Progressive Disease|8|||
48765417|NCT01572038|156990247|FG000|Overall Study|Site Closed Before Completing Form|6|||
48765418|NCT01572038|156990247|FG000|Overall Study|Enrolled into Another Trial|3|||
48765419|NCT01572038|156990247|FG000|Overall Study|Participated in Another Trial|3|||
48765420|NCT01572038|156990247|FG000|Overall Study|Termination by Sponsor|2|||
48765421|NCT01572038|156990247|FG000|Overall Study|Patient Deterioration|1|||
48765422|NCT01572038|156990247|FG000|Overall Study|Sponsor Decision|1|||
48765423|NCT00489853|156990248|FG000|Wash-out Period 1|Withdrawal by Subject|1|||
48765424|NCT00489853|156990249|FG001|Wash-out Period 1|Withdrawal by Subject|0|||
48765425|NCT00489853|156990250|FG002|Wash-out Period 1|Withdrawal by Subject|0|||
48765426|NCT00489853|156990248|FG000|Wash-out Period 1|Adverse Event|0|||
48765427|NCT00489853|156990249|FG001|Wash-out Period 1|Adverse Event|1|||
48765428|NCT00489853|156990250|FG002|Wash-out Period 1|Adverse Event|1|||
48765429|NCT00489853|156990248|FG000|Wash-out Period 1|Protocol Violation|0|||
48765430|NCT00489853|156990249|FG001|Wash-out Period 1|Protocol Violation|1|||
48765431|NCT00489853|156990250|FG002|Wash-out Period 1|Protocol Violation|1|||
48765432|NCT00489853|156990248|FG000|Wash-out Period 1|Study-specific discontinuation criteria|0|||
48875594|NCT02635386|157381687|FG002|Overall Study|Pregnancy|0|||
49025299|NCT00440557|157932955|FG001|Overall Study|Patient moved|2|||
48765433|NCT00489853|156990249|FG001|Wash-out Period 1|Study-specific discontinuation criteria|1|||
48765434|NCT00489853|156990250|FG002|Wash-out Period 1|Study-specific discontinuation criteria|4|||
48765435|NCT00489853|156990248|FG000|Wash-out Period 2|Adverse Event|1|||
48765436|NCT00489853|156990249|FG001|Wash-out Period 2|Adverse Event|1|||
48765437|NCT00489853|156990250|FG002|Wash-out Period 2|Adverse Event|0|||
48765438|NCT00489853|156990248|FG000|Wash-out Period 2|Study specific discontinuation criteria|3|||
48765439|NCT00489853|156990249|FG001|Wash-out Period 2|Study specific discontinuation criteria|2|||
48765440|NCT00489853|156990250|FG002|Wash-out Period 2|Study specific discontinuation criteria|2|||
48765441|NCT00489853|156990248|FG000|Treatment Period 3|Study specific discontinuation criteria|0|||
48765442|NCT00489853|156990249|FG001|Treatment Period 3|Study specific discontinuation criteria|1|||
48765443|NCT00489853|156990250|FG002|Treatment Period 3|Study specific discontinuation criteria|0|||
48765444|NCT02603809|156990251|FG000|Overall Study|Withdrawal by Subject|4|||
48765445|NCT02603809|156990252|FG001|Overall Study|Withdrawal by Subject|1|||
48765446|NCT02603809|156990253|FG002|Overall Study|Withdrawal by Subject|2|||
48765447|NCT02603809|156990254|FG003|Overall Study|Withdrawal by Subject|3|||
48765448|NCT02603809|156990255|FG004|Overall Study|Withdrawal by Subject|3|||
48765449|NCT02603809|156990256|FG005|Overall Study|Withdrawal by Subject|4|||
48765450|NCT02603809|156990251|FG000|Overall Study|Lost to Follow-up|2|||
48765451|NCT02603809|156990252|FG001|Overall Study|Lost to Follow-up|3|||
48765452|NCT02603809|156990253|FG002|Overall Study|Lost to Follow-up|1|||
48765453|NCT02603809|156990254|FG003|Overall Study|Lost to Follow-up|4|||
48765454|NCT02603809|156990255|FG004|Overall Study|Lost to Follow-up|2|||
48765455|NCT02603809|156990256|FG005|Overall Study|Lost to Follow-up|2|||
48765456|NCT02603809|156990251|FG000|Overall Study|Pre-specified discontinuation criteria|3|||
48765457|NCT02603809|156990252|FG001|Overall Study|Pre-specified discontinuation criteria|3|||
48765458|NCT02603809|156990253|FG002|Overall Study|Pre-specified discontinuation criteria|2|||
48765459|NCT02603809|156990254|FG003|Overall Study|Pre-specified discontinuation criteria|2|||
48765460|NCT02603809|156990255|FG004|Overall Study|Pre-specified discontinuation criteria|3|||
48765461|NCT02603809|156990256|FG005|Overall Study|Pre-specified discontinuation criteria|1|||
48765462|NCT02603809|156990251|FG000|Overall Study|Physician Decision|0|||
48765463|NCT02603809|156990252|FG001|Overall Study|Physician Decision|0|||
48765464|NCT02603809|156990253|FG002|Overall Study|Physician Decision|0|||
48765465|NCT02603809|156990254|FG003|Overall Study|Physician Decision|1|||
48765466|NCT02603809|156990255|FG004|Overall Study|Physician Decision|2|||
48765467|NCT02603809|156990256|FG005|Overall Study|Physician Decision|1|||
48765468|NCT02603809|156990251|FG000|Overall Study|Adverse Event|3|||
48765469|NCT02603809|156990252|FG001|Overall Study|Adverse Event|0|||
48765470|NCT02603809|156990253|FG002|Overall Study|Adverse Event|2|||
48765471|NCT02603809|156990254|FG003|Overall Study|Adverse Event|2|||
48765472|NCT02603809|156990255|FG004|Overall Study|Adverse Event|1|||
48765473|NCT02603809|156990256|FG005|Overall Study|Adverse Event|1|||
48765474|NCT02603809|156990251|FG000|Overall Study|Lack of Efficacy|0|||
48765475|NCT02603809|156990252|FG001|Overall Study|Lack of Efficacy|1|||
48765476|NCT02603809|156990253|FG002|Overall Study|Lack of Efficacy|0|||
48765477|NCT02603809|156990254|FG003|Overall Study|Lack of Efficacy|0|||
48765478|NCT02603809|156990255|FG004|Overall Study|Lack of Efficacy|0|||
48765479|NCT02603809|156990256|FG005|Overall Study|Lack of Efficacy|1|||
48765480|NCT00542919|156990258|FG000|Overall Study|Adverse Event|1|||
48765481|NCT00542919|156990259|FG001|Overall Study|Adverse Event|5|||
48765482|NCT00542919|156990260|FG002|Overall Study|Adverse Event|1|||
48765483|NCT00542919|156990258|FG000|Overall Study|Withdrawal by Subject|1|||
48765484|NCT00542919|156990259|FG001|Overall Study|Withdrawal by Subject|0|||
48765485|NCT00542919|156990260|FG002|Overall Study|Withdrawal by Subject|3|||
48765486|NCT00542919|156990258|FG000|Overall Study|Physician Decision|2|||
48765487|NCT00542919|156990259|FG001|Overall Study|Physician Decision|2|||
48765488|NCT00542919|156990260|FG002|Overall Study|Physician Decision|1|||
48765489|NCT00542919|156990258|FG000|Overall Study|Sponsor Decision|1|||
48765490|NCT00542919|156990259|FG001|Overall Study|Sponsor Decision|0|||
48765491|NCT00542919|156990260|FG002|Overall Study|Sponsor Decision|0|||
48765492|NCT00542919|156990258|FG000|Overall Study|Lost to Follow-up|2|||
48765493|NCT00542919|156990259|FG001|Overall Study|Lost to Follow-up|0|||
48765494|NCT00542919|156990260|FG002|Overall Study|Lost to Follow-up|1|||
48765495|NCT00706641|156990261|FG000|Dasatinib Administration|Withdrawal by Subject|1|||
48765496|NCT00706641|156990261|FG000|Dasatinib Administration|Ineligible after start of therapy|1|||
48765497|NCT00706641|156990261|FG000|Radical Cystectomy|Deemed unresectable upon exploration|1|||
48765498|NCT01851720|156990262|FG000|Overall Study|Lost to Follow-up|0|||
48981757|NCT04051944|157765514|FG000|Overall Study|Early study termination by participant|1|||
48981758|NCT04051944|157765515|FG001|Overall Study|Early study termination by participant|0|||
48981759|NCT04051944|157765514|FG000|Overall Study|Withdrawal by Subject|2|||
48981760|NCT04051944|157765515|FG001|Overall Study|Withdrawal by Subject|2|||
48981761|NCT04051944|157765514|FG000|Overall Study|Lack of Efficacy|3|||
48981762|NCT04051944|157765515|FG001|Overall Study|Lack of Efficacy|0|||
48981763|NCT04051944|157765514|FG000|Overall Study|Adverse event, non- fatal|1|||
48981764|NCT04051944|157765515|FG001|Overall Study|Adverse event, non- fatal|1|||
48981765|NCT03344562|157765520|FG000|Overall Study|Withdrawal by Subject|2|||
49025300|NCT00440557|157932956|FG002|Overall Study|Patient moved|1|||
48765499|NCT01851720|156990263|FG001|Overall Study|Lost to Follow-up|1|||
48765500|NCT02515942|156990264|FG000|Overall Study|Adverse Event|5|||
48765501|NCT02515942|156990265|FG001|Overall Study|Adverse Event|0|||
48765502|NCT02515942|156990266|FG002|Overall Study|Adverse Event|0|||
48765503|NCT02515942|156990264|FG000|Overall Study|Death|0|||
48765504|NCT02515942|156990265|FG001|Overall Study|Death|0|||
48765505|NCT02515942|156990266|FG002|Overall Study|Death|1|||
48765506|NCT02515942|156990264|FG000|Overall Study|Lack of Efficacy|0|||
48765507|NCT02515942|156990265|FG001|Overall Study|Lack of Efficacy|0|||
48765508|NCT02515942|156990266|FG002|Overall Study|Lack of Efficacy|1|||
48765509|NCT02515942|156990264|FG000|Overall Study|Lost to Follow-up|2|||
48765510|NCT02515942|156990265|FG001|Overall Study|Lost to Follow-up|0|||
48765511|NCT02515942|156990266|FG002|Overall Study|Lost to Follow-up|0|||
48765512|NCT02515942|156990264|FG000|Overall Study|Withdrawal by Subject|0|||
48765513|NCT02515942|156990265|FG001|Overall Study|Withdrawal by Subject|3|||
48765514|NCT02515942|156990266|FG002|Overall Study|Withdrawal by Subject|2|||
48765515|NCT00394212|156990269|FG000|Overall Study|Lost to Follow-up|3|||
48765516|NCT00394212|156990270|FG001|Overall Study|Lost to Follow-up|0|||
48875595|NCT02635386|157381688|FG003|Overall Study|Pregnancy|0|||
48875596|NCT02635386|157381689|FG004|Overall Study|Pregnancy|2|||
48875597|NCT02635386|157381685|FG000|Overall Study|Withdrawal by Subject|1|||
48875598|NCT02635386|157381686|FG001|Overall Study|Withdrawal by Subject|1|||
48875599|NCT02635386|157381687|FG002|Overall Study|Withdrawal by Subject|0|||
48875600|NCT02635386|157381688|FG003|Overall Study|Withdrawal by Subject|1|||
48875601|NCT02635386|157381689|FG004|Overall Study|Withdrawal by Subject|0|||
48875602|NCT02635386|157381685|FG000|Overall Study|Physician Decision|0|||
48875603|NCT02635386|157381686|FG001|Overall Study|Physician Decision|1|||
48875604|NCT02635386|157381687|FG002|Overall Study|Physician Decision|0|||
48875605|NCT02635386|157381688|FG003|Overall Study|Physician Decision|0|||
48875606|NCT02635386|157381689|FG004|Overall Study|Physician Decision|0|||
48875607|NCT02635386|157381685|FG000|Overall Study|Moved Out of State|0|||
48875608|NCT02635386|157381686|FG001|Overall Study|Moved Out of State|1|||
48875609|NCT02635386|157381687|FG002|Overall Study|Moved Out of State|0|||
48875610|NCT02635386|157381688|FG003|Overall Study|Moved Out of State|0|||
48875611|NCT02635386|157381689|FG004|Overall Study|Moved Out of State|0|||
48875612|NCT02635386|157381685|FG000|Overall Study|Noncompliant|0|||
48875613|NCT02635386|157381686|FG001|Overall Study|Noncompliant|2|||
48875614|NCT02635386|157381687|FG002|Overall Study|Noncompliant|1|||
49025301|NCT00440557|157932954|FG000|Overall Study|Principal Investigator's office closed|3|||
49025302|NCT00440557|157932955|FG001|Overall Study|Principal Investigator's office closed|6|||
49025303|NCT00440557|157932956|FG002|Overall Study|Principal Investigator's office closed|4|||
49025304|NCT00440557|157932954|FG000|Overall Study|Patient transferred to nursing home|0|||
49025305|NCT00440557|157932955|FG001|Overall Study|Patient transferred to nursing home|1|||
49025306|NCT00440557|157932956|FG002|Overall Study|Patient transferred to nursing home|0|||
49025307|NCT00440557|157932954|FG000|Overall Study|Patient had surgery|1|||
49025308|NCT00440557|157932955|FG001|Overall Study|Patient had surgery|0|||
49025309|NCT00440557|157932956|FG002|Overall Study|Patient had surgery|0|||
49025310|NCT01448057|157932957|FG000|Overall Study|Protocol Violation|3|||
49025311|NCT01448057|157932958|FG001|Overall Study|Protocol Violation|2|||
49025312|NCT01448057|157932957|FG000|Overall Study|Lost to Follow-up|3|||
49025313|NCT01448057|157932958|FG001|Overall Study|Lost to Follow-up|0|||
49025314|NCT01448057|157932957|FG000|Overall Study|Adverse Event|0|||
49025315|NCT01448057|157932958|FG001|Overall Study|Adverse Event|2|||
49025316|NCT01448057|157932957|FG000|Overall Study|Withdrawal by Subject|2|||
49025317|NCT01448057|157932958|FG001|Overall Study|Withdrawal by Subject|0|||
49025318|NCT03553823|157932959|FG000|Overall Study|Physician Decision|0|||
49025319|NCT03553823|157932960|FG001|Overall Study|Physician Decision|1|||
49025320|NCT03450070|157932961|FG000|Overall Study|Withdrawal by Subject|8|||
49025321|NCT00050778|157932962|FG000|Overall Study|Adverse Event|13|||
48765517|NCT00394212|156990269|FG000|Overall Study|Withdrawal by Subject|4|||
48765518|NCT00394212|156990270|FG001|Overall Study|Withdrawal by Subject|1|||
48765519|NCT00277212|156990271|FG000|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61|||
48765520|NCT00277212|156990272|FG001|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
48765521|NCT00277212|156990273|FG002|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
49025322|NCT00050778|157932963|FG001|Overall Study|Adverse Event|3|||
49025323|NCT00050778|157932964|FG002|Overall Study|Adverse Event|2|||
49025324|NCT00050778|157932962|FG000|Overall Study|Death|0|||
49025325|NCT00050778|157932963|FG001|Overall Study|Death|1|||
49025326|NCT00050778|157932964|FG002|Overall Study|Death|1|||
49025327|NCT00050778|157932962|FG000|Overall Study|Lack of Efficacy|16|||
48765522|NCT00277212|156990271|FG000|Phase 1 - Single-Blind Treatment|Adverse Event|93|||
48875615|NCT02635386|157381688|FG003|Overall Study|Noncompliant|1|||
48875616|NCT02635386|157381689|FG004|Overall Study|Noncompliant|1|||
48875617|NCT02635386|157381685|FG000|Overall Study|side effects|0|||
48875618|NCT02635386|157381686|FG001|Overall Study|side effects|0|||
48875619|NCT02635386|157381687|FG002|Overall Study|side effects|1|||
48875620|NCT02635386|157381688|FG003|Overall Study|side effects|4|||
49025328|NCT00050778|157932963|FG001|Overall Study|Lack of Efficacy|2|||
48765523|NCT00277212|156990272|FG001|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
48765524|NCT00277212|156990273|FG002|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
48765525|NCT00277212|156990271|FG000|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96|||
48765526|NCT00277212|156990272|FG001|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
48765527|NCT00277212|156990273|FG002|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
48765528|NCT00277212|156990271|FG000|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87|||
48765529|NCT00277212|156990272|FG001|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
48765530|NCT00277212|156990273|FG002|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
48765531|NCT00277212|156990271|FG000|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35|||
48765532|NCT00277212|156990272|FG001|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
48765533|NCT00277212|156990273|FG002|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
48765534|NCT00277212|156990271|FG000|Phase 1 - Single-Blind Treatment|Pregnancy|6|||
48765535|NCT00277212|156990272|FG001|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
48765536|NCT00277212|156990273|FG002|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
48765537|NCT00277212|156990271|FG000|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44|||
48765538|NCT00277212|156990272|FG001|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
48765539|NCT00277212|156990273|FG002|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
49025329|NCT00050778|157932964|FG002|Overall Study|Lack of Efficacy|2|||
49025330|NCT00050778|157932962|FG000|Overall Study|Lost to Follow-up|0|||
49025331|NCT00050778|157932963|FG001|Overall Study|Lost to Follow-up|2|||
49025332|NCT00050778|157932964|FG002|Overall Study|Lost to Follow-up|4|||
49025333|NCT00050778|157932962|FG000|Overall Study|Physician Decision|3|||
49025334|NCT00050778|157932963|FG001|Overall Study|Physician Decision|0|||
49025335|NCT00050778|157932964|FG002|Overall Study|Physician Decision|2|||
49025336|NCT00050778|157932962|FG000|Overall Study|Protocol Violation|2|||
49025337|NCT00050778|157932963|FG001|Overall Study|Protocol Violation|0|||
48765540|NCT00277212|156990271|FG000|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1|||
48765541|NCT00277212|156990272|FG001|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
48765542|NCT00277212|156990273|FG002|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
48765543|NCT00277212|156990271|FG000|Phase 1 - Single-Blind Treatment|Other Reasons|12|||
48765544|NCT00277212|156990272|FG001|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
48765545|NCT00277212|156990273|FG002|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
48765546|NCT00277212|156990271|FG000|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0|||
48765547|NCT00277212|156990272|FG001|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54|||
48765548|NCT00277212|156990273|FG002|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39|||
48765549|NCT00277212|156990271|FG000|Phase 2 - Double-Blind Treatment|Adverse Event|0|||
48765550|NCT00277212|156990272|FG001|Phase 2 - Double-Blind Treatment|Adverse Event|10|||
48765551|NCT00277212|156990273|FG002|Phase 2 - Double-Blind Treatment|Adverse Event|16|||
48765552|NCT00277212|156990271|FG000|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0|||
48765553|NCT00277212|156990272|FG001|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17|||
48765554|NCT00277212|156990273|FG002|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16|||
48765555|NCT00277212|156990271|FG000|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0|||
48765556|NCT00277212|156990272|FG001|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
48765557|NCT00277212|156990273|FG002|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
48765558|NCT00277212|156990271|FG000|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0|||
48765559|NCT00277212|156990272|FG001|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7|||
48765560|NCT00277212|156990273|FG002|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8|||
48765561|NCT00277212|156990271|FG000|Phase 2 - Double-Blind Treatment|Pregnancy|0|||
48765562|NCT00277212|156990272|FG001|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
48765563|NCT00277212|156990273|FG002|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
48765564|NCT00277212|156990271|FG000|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0|||
48765565|NCT00277212|156990272|FG001|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4|||
48765566|NCT00277212|156990273|FG002|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6|||
48765567|NCT00277212|156990271|FG000|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0|||
48765568|NCT00277212|156990272|FG001|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1|||
48765569|NCT00277212|156990273|FG002|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3|||
48765570|NCT00277212|156990271|FG000|Phase 2 - Double-Blind Treatment|Other reasons|0|||
48765571|NCT00277212|156990272|FG001|Phase 2 - Double-Blind Treatment|Other reasons|7|||
48765572|NCT00277212|156990273|FG002|Phase 2 - Double-Blind Treatment|Other reasons|5|||
48765573|NCT00902564|156990274|FG000|Overall Study|Withdrawal by Subject|2|||
48765574|NCT01727141|156990277|FG000|Overall Study|Physician Decision|0|||
48765575|NCT01727141|156990278|FG001|Overall Study|Physician Decision|1|||
48765576|NCT01727141|156990279|FG002|Overall Study|Physician Decision|0|||
48765577|NCT01727141|156990280|FG003|Overall Study|Physician Decision|2|||
48765578|NCT01727141|156990277|FG000|Overall Study|Lost to Follow-up|0|||
48765579|NCT01727141|156990278|FG001|Overall Study|Lost to Follow-up|2|||
48765580|NCT01727141|156990279|FG002|Overall Study|Lost to Follow-up|0|||
49025338|NCT00050778|157932964|FG002|Overall Study|Protocol Violation|1|||
49025339|NCT00050778|157932962|FG000|Overall Study|Withdrawal by Subject|6|||
49025340|NCT00050778|157932963|FG001|Overall Study|Withdrawal by Subject|8|||
49025341|NCT00050778|157932964|FG002|Overall Study|Withdrawal by Subject|4|||
49025342|NCT00050778|157932962|FG000|Overall Study|Randomized but not treated|4|||
49025343|NCT00050778|157932963|FG001|Overall Study|Randomized but not treated|5|||
49025344|NCT00050778|157932964|FG002|Overall Study|Randomized but not treated|2|||
49025345|NCT00050778|157932962|FG000|Overall Study|Familial and personal reasons|1|||
49025346|NCT00050778|157932963|FG001|Overall Study|Familial and personal reasons|0|||
49025347|NCT00050778|157932964|FG002|Overall Study|Familial and personal reasons|0|||
49025348|NCT00436553|157932978|FG000|Overall Study|Adverse Event|4|||
49025349|NCT00436553|157932979|FG001|Overall Study|Adverse Event|3|||
49025350|NCT00436553|157932980|FG002|Overall Study|Adverse Event|4|||
49025351|NCT00436553|157932978|FG000|Overall Study|Death|3|||
49025352|NCT00436553|157932979|FG001|Overall Study|Death|1|||
49025353|NCT00436553|157932980|FG002|Overall Study|Death|3|||
49025354|NCT00436553|157932978|FG000|Overall Study|Lost to Follow-up|0|||
49025355|NCT00436553|157932979|FG001|Overall Study|Lost to Follow-up|2|||
49025356|NCT00436553|157932980|FG002|Overall Study|Lost to Follow-up|0|||
49025357|NCT00436553|157932978|FG000|Overall Study|Protocol Violation|1|||
49025358|NCT00436553|157932979|FG001|Overall Study|Protocol Violation|0|||
49025359|NCT00436553|157932980|FG002|Overall Study|Protocol Violation|0|||
49025360|NCT00436553|157932978|FG000|Overall Study|Withdrawal by Subject|5|||
49025361|NCT00436553|157932979|FG001|Overall Study|Withdrawal by Subject|6|||
49025362|NCT00436553|157932980|FG002|Overall Study|Withdrawal by Subject|3|||
49025363|NCT02468778|157932983|FG000|Overall Study|Death|2|||
49025364|NCT02468778|157932984|FG001|Overall Study|Death|1|||
49025365|NCT02468778|157932985|FG002|Overall Study|Death|0|||
49025366|NCT02468778|157932983|FG000|Overall Study|Lost to Follow-up|1|||
49025367|NCT02468778|157932984|FG001|Overall Study|Lost to Follow-up|2|||
49025368|NCT02468778|157932985|FG002|Overall Study|Lost to Follow-up|2|||
49025369|NCT02468778|157932983|FG000|Overall Study|Withdrawal by Subject|0|||
49025370|NCT02468778|157932984|FG001|Overall Study|Withdrawal by Subject|1|||
49025371|NCT02468778|157932985|FG002|Overall Study|Withdrawal by Subject|1|||
49025372|NCT02206828|157932986|FG000|Overall Study|Lost to Follow-up|7|||
49025373|NCT06132282|157932992|FG000|Overall Study|Lost to Follow-up|31|||
49025374|NCT05052996|157932993|FG000|Overall Study|Still on study|0|||
49025375|NCT05052996|157932994|FG001|Overall Study|Still on study|0|||
48765581|NCT01727141|156990280|FG003|Overall Study|Lost to Follow-up|0|||
48765582|NCT01727141|156990277|FG000|Overall Study|Death|0|||
48765583|NCT01727141|156990278|FG001|Overall Study|Death|1|||
48765584|NCT01727141|156990279|FG002|Overall Study|Death|1|||
48765585|NCT01727141|156990280|FG003|Overall Study|Death|1|||
48765586|NCT01727141|156990277|FG000|Overall Study|Protocol deviation|1|||
48765587|NCT01727141|156990278|FG001|Overall Study|Protocol deviation|1|||
48765588|NCT01727141|156990279|FG002|Overall Study|Protocol deviation|0|||
48765589|NCT01727141|156990280|FG003|Overall Study|Protocol deviation|1|||
48765590|NCT01727141|156990277|FG000|Overall Study|Withdrawal by Subject|4|||
48765591|NCT01727141|156990278|FG001|Overall Study|Withdrawal by Subject|4|||
48765592|NCT01727141|156990279|FG002|Overall Study|Withdrawal by Subject|2|||
48765593|NCT01727141|156990280|FG003|Overall Study|Withdrawal by Subject|11|||
48765594|NCT05620576|156990282|FG000|Overall Study|Adverse Event|1|||
48765595|NCT05620576|156990283|FG001|Overall Study|Adverse Event|1|||
48765596|NCT05620576|156990282|FG000|Overall Study|Lost to Follow-up|3|||
48765597|NCT05620576|156990283|FG001|Overall Study|Lost to Follow-up|1|||
48765598|NCT05620576|156990282|FG000|Overall Study|Physician Decision|0|||
48765599|NCT05620576|156990283|FG001|Overall Study|Physician Decision|1|||
49025376|NCT05052996|157932995|FG002|Overall Study|Still on study|47|||
49025377|NCT05052996|157932996|FG003|Overall Study|Still on study|44|||
49025378|NCT05052996|157932993|FG000|Overall Study|Cohort terminated by sponsor|21|||
49025379|NCT05052996|157932994|FG001|Overall Study|Cohort terminated by sponsor|12|||
49025380|NCT05052996|157932995|FG002|Overall Study|Cohort terminated by sponsor|0|||
49025381|NCT05052996|157932996|FG003|Overall Study|Cohort terminated by sponsor|0|||
49025382|NCT05052996|157932993|FG000|Overall Study|Withdrew consent|1|||
49025383|NCT05052996|157932994|FG001|Overall Study|Withdrew consent|0|||
49025384|NCT05052996|157932995|FG002|Overall Study|Withdrew consent|1|||
49025385|NCT05052996|157932996|FG003|Overall Study|Withdrew consent|2|||
49025386|NCT05052996|157932993|FG000|Overall Study|Lost to Follow-up|1|||
49025387|NCT05052996|157932994|FG001|Overall Study|Lost to Follow-up|0|||
49025388|NCT05052996|157932995|FG002|Overall Study|Lost to Follow-up|0|||
49025389|NCT05052996|157932996|FG003|Overall Study|Lost to Follow-up|2|||
49025390|NCT05052996|157932993|FG000|Overall Study|Adverse Event|0|||
49025391|NCT05052996|157932994|FG001|Overall Study|Adverse Event|0|||
49025392|NCT05052996|157932995|FG002|Overall Study|Adverse Event|2|||
48765600|NCT05620576|156990282|FG000|Overall Study|Protocol Deviation|1|||
48765601|NCT05620576|156990283|FG001|Overall Study|Protocol Deviation|1|||
48765602|NCT05620576|156990282|FG000|Overall Study|Withdrawal by Subject|2|||
48765603|NCT05620576|156990283|FG001|Overall Study|Withdrawal by Subject|3|||
48765604|NCT03239470|156990284|FG000|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|1|||
48875621|NCT02635386|157381689|FG004|Overall Study|side effects|6|||
49025393|NCT05052996|157932996|FG003|Overall Study|Adverse Event|0|||
48765605|NCT03239470|156990285|FG001|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|0|||
48765606|NCT02622828|156990286|FG000|Overall Study|participant withdrew|3|||
48765607|NCT00116831|156990290|FG000|Overall Study|Adverse Event|14|||
48765608|NCT00116831|156990291|FG001|Overall Study|Adverse Event|16|||
48765609|NCT00116831|156990290|FG000|Overall Study|Baseline IVUS determined unevaluable|12|||
49025394|NCT05052996|157932993|FG000|Overall Study|Randomized but never treated|0|||
49025395|NCT05052996|157932994|FG001|Overall Study|Randomized but never treated|0|||
49025396|NCT05052996|157932995|FG002|Overall Study|Randomized but never treated|1|||
49025397|NCT05052996|157932996|FG003|Overall Study|Randomized but never treated|1|||
49025398|NCT05052996|157932993|FG000|Overall Study|Protocol Violation|1|||
48765610|NCT00116831|156990291|FG001|Overall Study|Baseline IVUS determined unevaluable|11|||
48765611|NCT00116831|156990290|FG000|Overall Study|Lost to Follow-up|8|||
48765612|NCT00116831|156990291|FG001|Overall Study|Lost to Follow-up|6|||
48765613|NCT00116831|156990290|FG000|Overall Study|Protocol Violation|3|||
49025399|NCT05052996|157932994|FG001|Overall Study|Protocol Violation|0|||
49025400|NCT05052996|157932995|FG002|Overall Study|Protocol Violation|0|||
49025401|NCT05052996|157932996|FG003|Overall Study|Protocol Violation|0|||
49025402|NCT05672069|157932997|FG000|Overall Study|Implant removal|1|||
48765614|NCT00116831|156990291|FG001|Overall Study|Protocol Violation|6|||
48765615|NCT00116831|156990290|FG000|Overall Study|Hypoglycaemic events|1|||
48765616|NCT00116831|156990291|FG001|Overall Study|Hypoglycaemic events|0|||
48765617|NCT00116831|156990290|FG000|Overall Study|Low haemoglobin on screening|1|||
48765618|NCT00116831|156990291|FG001|Overall Study|Low haemoglobin on screening|0|||
48765619|NCT00116831|156990290|FG000|Overall Study|Withdrawn investigational product|1|||
48765620|NCT00116831|156990291|FG001|Overall Study|Withdrawn investigational product|0|||
48765621|NCT00116831|156990290|FG000|Overall Study|Withdrawal by Subject|32|||
48765622|NCT00116831|156990291|FG001|Overall Study|Withdrawal by Subject|32|||
48765623|NCT00116831|156990290|FG000|Overall Study|Insufficient therapeutic effect|0|||
48765624|NCT00116831|156990291|FG001|Overall Study|Insufficient therapeutic effect|1|||
48765625|NCT00116831|156990290|FG000|Overall Study|Missing data for participant|1|||
48765626|NCT00116831|156990291|FG001|Overall Study|Missing data for participant|0|||
48765627|NCT01649375|156990292|FG000|Up to Week 16|Adverse Event|2|||
48765628|NCT01649375|156990293|FG001|Up to Week 16|Adverse Event|5|||
48765629|NCT01649375|156990294|FG002|Up to Week 16|Adverse Event|4|||
48765630|NCT01649375|156990295|FG003|Up to Week 16|Adverse Event|0|||
48765631|NCT01649375|156990296|FG004|Up to Week 16|Adverse Event|0|||
48765632|NCT01649375|156990292|FG000|Up to Week 16|Lack of Efficacy|0|||
48765633|NCT01649375|156990293|FG001|Up to Week 16|Lack of Efficacy|0|||
48765634|NCT01649375|156990294|FG002|Up to Week 16|Lack of Efficacy|1|||
48765635|NCT01649375|156990295|FG003|Up to Week 16|Lack of Efficacy|0|||
48765636|NCT01649375|156990296|FG004|Up to Week 16|Lack of Efficacy|0|||
48765637|NCT01649375|156990292|FG000|Up to Week 16|Physician Decision|0|||
48765638|NCT01649375|156990293|FG001|Up to Week 16|Physician Decision|0|||
48765639|NCT01649375|156990294|FG002|Up to Week 16|Physician Decision|1|||
48765640|NCT01649375|156990295|FG003|Up to Week 16|Physician Decision|0|||
48765641|NCT01649375|156990296|FG004|Up to Week 16|Physician Decision|0|||
48765642|NCT01649375|156990292|FG000|Up to Week 16|Withdrawal by Subject|2|||
48765643|NCT01649375|156990293|FG001|Up to Week 16|Withdrawal by Subject|1|||
48765644|NCT01649375|156990294|FG002|Up to Week 16|Withdrawal by Subject|2|||
48765645|NCT01649375|156990295|FG003|Up to Week 16|Withdrawal by Subject|0|||
48765646|NCT01649375|156990296|FG004|Up to Week 16|Withdrawal by Subject|0|||
48765647|NCT01649375|156990292|FG000|Up to Week 16|Death|1|||
48765648|NCT01649375|156990293|FG001|Up to Week 16|Death|0|||
48765649|NCT01649375|156990294|FG002|Up to Week 16|Death|0|||
48765650|NCT01649375|156990295|FG003|Up to Week 16|Death|0|||
48765651|NCT01649375|156990296|FG004|Up to Week 16|Death|0|||
48765652|NCT01649375|156990292|FG000|Week 16 up to Week 260|Lack of Efficacy|7|||
48765653|NCT01649375|156990293|FG001|Week 16 up to Week 260|Lack of Efficacy|4|||
48765654|NCT01649375|156990294|FG002|Week 16 up to Week 260|Lack of Efficacy|0|||
48765655|NCT01649375|156990295|FG003|Week 16 up to Week 260|Lack of Efficacy|4|||
48765656|NCT01649375|156990296|FG004|Week 16 up to Week 260|Lack of Efficacy|2|||
48765657|NCT01649375|156990292|FG000|Week 16 up to Week 260|Non-compliance|0|||
48765658|NCT01649375|156990293|FG001|Week 16 up to Week 260|Non-compliance|1|||
48765659|NCT01649375|156990294|FG002|Week 16 up to Week 260|Non-compliance|0|||
48765660|NCT01649375|156990295|FG003|Week 16 up to Week 260|Non-compliance|1|||
48765661|NCT01649375|156990296|FG004|Week 16 up to Week 260|Non-compliance|0|||
48765662|NCT01649375|156990292|FG000|Week 16 up to Week 260|Physician Decision|0|||
49025403|NCT05672069|157932997|FG000|Overall Study|Lost to Follow-up|2|||
48765663|NCT01649375|156990293|FG001|Week 16 up to Week 260|Physician Decision|2|||
48765664|NCT01649375|156990294|FG002|Week 16 up to Week 260|Physician Decision|0|||
48765665|NCT01649375|156990295|FG003|Week 16 up to Week 260|Physician Decision|0|||
48765666|NCT01649375|156990296|FG004|Week 16 up to Week 260|Physician Decision|0|||
48765667|NCT01649375|156990292|FG000|Week 16 up to Week 260|Technical issues|0|||
48765668|NCT01649375|156990293|FG001|Week 16 up to Week 260|Technical issues|1|||
48765669|NCT01649375|156990294|FG002|Week 16 up to Week 260|Technical issues|0|||
48765670|NCT01649375|156990295|FG003|Week 16 up to Week 260|Technical issues|1|||
49025404|NCT05257486|157932998|FG000|Overall Study|Protocol Violation|3|||
49025405|NCT00248287|157932999|FG000|Overall Study|Adverse Event|11|||
49025406|NCT00248287|157933000|FG001|Overall Study|Adverse Event|10|||
49025407|NCT00248287|157932999|FG000|Overall Study|Death|1|||
49025408|NCT00248287|157933000|FG001|Overall Study|Death|0|||
49025409|NCT00248287|157932999|FG000|Overall Study|Lost to Follow-up|0|||
49025410|NCT00248287|157933000|FG001|Overall Study|Lost to Follow-up|1|||
49025411|NCT00248287|157932999|FG000|Overall Study|Investigator Request|4|||
49025412|NCT00248287|157933000|FG001|Overall Study|Investigator Request|3|||
49025413|NCT00248287|157932999|FG000|Overall Study|Patient Request|5|||
49025414|NCT00248287|157933000|FG001|Overall Study|Patient Request|3|||
49025415|NCT00248287|157932999|FG000|Overall Study|Other|3|||
49025416|NCT00248287|157933000|FG001|Overall Study|Other|2|||
49025417|NCT00857623|157933004|FG000|Overall Study|Adverse Event|5|||
49025418|NCT00857623|157933005|FG001|Overall Study|Adverse Event|2|||
49025419|NCT00857623|157933004|FG000|Overall Study|Study-specific discontinuation criteria|5|||
49025420|NCT00857623|157933005|FG001|Overall Study|Study-specific discontinuation criteria|3|||
49025421|NCT00857623|157933004|FG000|Overall Study|Withdrawal by Subject|2|||
49025422|NCT00857623|157933005|FG001|Overall Study|Withdrawal by Subject|1|||
49025423|NCT00857623|157933004|FG000|Overall Study|Lack of Efficacy|1|||
49025424|NCT00857623|157933005|FG001|Overall Study|Lack of Efficacy|1|||
49025425|NCT00857623|157933004|FG000|Overall Study|Severe non-compliance to protocol|1|||
49025426|NCT00857623|157933005|FG001|Overall Study|Severe non-compliance to protocol|1|||
49025427|NCT00857623|157933004|FG000|Overall Study|Intake of prohibited medication|0|||
49025428|NCT00857623|157933005|FG001|Overall Study|Intake of prohibited medication|1|||
49025429|NCT00857623|157933004|FG000|Overall Study|Positive for HEP C|0|||
49025430|NCT00857623|157933005|FG001|Overall Study|Positive for HEP C|1|||
49025431|NCT03435081|157933006|FG000|Week 0 to Week 16|Lack of Efficacy|6|||
49025432|NCT03435081|157933007|FG001|Week 0 to Week 16|Lack of Efficacy|5|||
49025433|NCT03435081|157933008|FG002|Week 0 to Week 16|Lack of Efficacy|0|||
49025434|NCT03435081|157933006|FG000|Week 0 to Week 16|Adverse Event|2|||
49025435|NCT03435081|157933007|FG001|Week 0 to Week 16|Adverse Event|2|||
49025436|NCT03435081|157933008|FG002|Week 0 to Week 16|Adverse Event|2|||
49025437|NCT03435081|157933006|FG000|Week 0 to Week 16|Withdrawal by Subject|8|||
48765671|NCT01649375|156990296|FG004|Week 16 up to Week 260|Technical issues|0|||
48765672|NCT01649375|156990292|FG000|Week 16 up to Week 260|Withdrawal by Subject|7|||
48765673|NCT01649375|156990293|FG001|Week 16 up to Week 260|Withdrawal by Subject|2|||
48765674|NCT01649375|156990294|FG002|Week 16 up to Week 260|Withdrawal by Subject|0|||
48765675|NCT01649375|156990295|FG003|Week 16 up to Week 260|Withdrawal by Subject|3|||
48765676|NCT01649375|156990296|FG004|Week 16 up to Week 260|Withdrawal by Subject|1|||
48765677|NCT01649375|156990292|FG000|Week 16 up to Week 260|Death|1|||
48765678|NCT01649375|156990293|FG001|Week 16 up to Week 260|Death|1|||
48765679|NCT01649375|156990294|FG002|Week 16 up to Week 260|Death|0|||
48765680|NCT01649375|156990295|FG003|Week 16 up to Week 260|Death|0|||
48765681|NCT01649375|156990296|FG004|Week 16 up to Week 260|Death|0|||
48765682|NCT01649375|156990292|FG000|Week 16 up to Week 260|Adverse Event|5|||
48765683|NCT01649375|156990293|FG001|Week 16 up to Week 260|Adverse Event|2|||
48765684|NCT01649375|156990294|FG002|Week 16 up to Week 260|Adverse Event|0|||
48765685|NCT01649375|156990295|FG003|Week 16 up to Week 260|Adverse Event|3|||
48765686|NCT01649375|156990296|FG004|Week 16 up to Week 260|Adverse Event|2|||
48765687|NCT01856790|156990299|FG000|Closed Loop Control|Withdrawal by Subject|2|||
48765688|NCT01856790|156990299|FG000|Closed Loop Control + Liraglutide|Withdrawal by Subject|2|||
48765689|NCT04765358|156990300|FG000|Overall Study|Withdrawal by Subject|1|||
48765690|NCT01802775|156990303|FG000|Overall Study|Death|0|||
48765691|NCT01802775|156990304|FG001|Overall Study|Death|3|||
48765692|NCT01802775|156990303|FG000|Overall Study|Reason not provided|0|||
48765693|NCT01802775|156990304|FG001|Overall Study|Reason not provided|1|||
48765694|NCT01802775|156990303|FG000|Overall Study|Physician Decision|1|||
48765695|NCT01802775|156990304|FG001|Overall Study|Physician Decision|0|||
48765696|NCT01802775|156990303|FG000|Overall Study|Adverse Event|1|||
48765697|NCT01802775|156990304|FG001|Overall Study|Adverse Event|1|||
48765698|NCT01802775|156990303|FG000|Overall Study|Withdrawal by Subject|3|||
48765699|NCT01802775|156990304|FG001|Overall Study|Withdrawal by Subject|5|||
48765700|NCT01802775|156990303|FG000|Overall Study|Lost to Follow-up|1|||
48765701|NCT01802775|156990304|FG001|Overall Study|Lost to Follow-up|2|||
48765702|NCT01096784|156990305|FG000|Overall Study|Withdrawal by Subject|2|||
49025438|NCT03435081|157933007|FG001|Week 0 to Week 16|Withdrawal by Subject|7|||
49025439|NCT03435081|157933008|FG002|Week 0 to Week 16|Withdrawal by Subject|10|||
49025440|NCT03435081|157933006|FG000|Week 0 to Week 16|Lost to Follow-up|3|||
49025441|NCT03435081|157933007|FG001|Week 0 to Week 16|Lost to Follow-up|1|||
49025442|NCT03435081|157933008|FG002|Week 0 to Week 16|Lost to Follow-up|4|||
49025443|NCT03435081|157933006|FG000|Week 0 to Week 16|Pregnancy|1|||
49025444|NCT03435081|157933007|FG001|Week 0 to Week 16|Pregnancy|0|||
49025445|NCT03435081|157933008|FG002|Week 0 to Week 16|Pregnancy|0|||
48765703|NCT01096784|156990306|FG001|Overall Study|Withdrawal by Subject|1|||
48765704|NCT01096784|156990305|FG000|Overall Study|Adverse Event|11|||
49025446|NCT03435081|157933006|FG000|Week 0 to Week 16|Non-compliance|1|||
49025447|NCT03435081|157933007|FG001|Week 0 to Week 16|Non-compliance|0|||
49025448|NCT03435081|157933008|FG002|Week 0 to Week 16|Non-compliance|2|||
49025449|NCT03435081|157933006|FG000|Week 0 to Week 16|Inadequate Response|0|||
49025450|NCT03435081|157933007|FG001|Week 0 to Week 16|Inadequate Response|1|||
49025451|NCT03435081|157933008|FG002|Week 0 to Week 16|Inadequate Response|0|||
49025452|NCT03435081|157933006|FG000|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
49025453|NCT03435081|157933007|FG001|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
49025454|NCT03435081|157933008|FG002|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|1|||
49025455|NCT03435081|157933006|FG000|Week 16 to Week 104|Lack of Efficacy|2|||
49025456|NCT03435081|157933007|FG001|Week 16 to Week 104|Lack of Efficacy|11|||
49025457|NCT03435081|157933008|FG002|Week 16 to Week 104|Lack of Efficacy|10|||
49025458|NCT03435081|157933006|FG000|Week 16 to Week 104|Adverse Event|1|||
49025459|NCT03435081|157933007|FG001|Week 16 to Week 104|Adverse Event|0|||
49025460|NCT03435081|157933008|FG002|Week 16 to Week 104|Adverse Event|2|||
49025461|NCT03435081|157933006|FG000|Week 16 to Week 104|Withdrawal by Subject|0|||
49025462|NCT03435081|157933007|FG001|Week 16 to Week 104|Withdrawal by Subject|1|||
49025463|NCT03435081|157933008|FG002|Week 16 to Week 104|Withdrawal by Subject|2|||
49025464|NCT03435081|157933006|FG000|Week 16 to Week 104|Lost to Follow-up|0|||
49025465|NCT03435081|157933007|FG001|Week 16 to Week 104|Lost to Follow-up|1|||
49025466|NCT03435081|157933008|FG002|Week 16 to Week 104|Lost to Follow-up|4|||
49025467|NCT03435081|157933006|FG000|Week 16 to Week 104|Non--Compliance|0|||
49025468|NCT03435081|157933007|FG001|Week 16 to Week 104|Non--Compliance|0|||
49025469|NCT03435081|157933008|FG002|Week 16 to Week 104|Non--Compliance|1|||
48765705|NCT01096784|156990306|FG001|Overall Study|Adverse Event|9|||
48765706|NCT01096784|156990305|FG000|Overall Study|Protocol Deviation|2|||
48765707|NCT01096784|156990306|FG001|Overall Study|Protocol Deviation|2|||
48765708|NCT01096784|156990305|FG000|Overall Study|Administrative Decision|0|||
48765709|NCT01096784|156990306|FG001|Overall Study|Administrative Decision|1|||
48765710|NCT01096784|156990305|FG000|Overall Study|Other Unspecified|0|||
48765711|NCT01096784|156990306|FG001|Overall Study|Other Unspecified|1|||
48765712|NCT02418468|156990315|FG000|Overall Study|Adverse Event|1|||
48765713|NCT02418468|156990316|FG001|Overall Study|Adverse Event|0|||
48765714|NCT02418468|156990315|FG000|Overall Study|Withdrawal of informed consent|1|||
48765715|NCT02418468|156990316|FG001|Overall Study|Withdrawal of informed consent|1|||
48765716|NCT01488097|156990326|FG000|Overall Study|Lost to Follow-up|1|||
48765717|NCT01577758|156990330|FG000|Dose Escalation Phase|Adverse Event|0|||
48765718|NCT01577758|156990331|FG001|Dose Escalation Phase|Adverse Event|0|||
48765719|NCT01577758|156990332|FG002|Dose Escalation Phase|Adverse Event|0|||
48765720|NCT01577758|156990333|FG003|Dose Escalation Phase|Adverse Event|0|||
48765721|NCT01577758|156990334|FG004|Dose Escalation Phase|Adverse Event|0|||
48765722|NCT01577758|156990335|FG005|Dose Escalation Phase|Adverse Event|2|||
48765723|NCT01577758|156990336|FG006|Dose Escalation Phase|Adverse Event|1|||
48765724|NCT01577758|156990337|FG007|Dose Escalation Phase|Adverse Event|0|||
48765725|NCT01577758|156990330|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
48765726|NCT01577758|156990331|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
48765727|NCT01577758|156990332|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
48765728|NCT01577758|156990333|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
48765729|NCT01577758|156990334|FG004|Dose Escalation Phase|Symptomatic Deterioration|1|||
48765730|NCT01577758|156990335|FG005|Dose Escalation Phase|Symptomatic Deterioration|1|||
48765731|NCT01577758|156990336|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
48765732|NCT01577758|156990337|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
48765733|NCT01577758|156990330|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
48765734|NCT01577758|156990331|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
48765735|NCT01577758|156990332|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
48765736|NCT01577758|156990333|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
48765737|NCT01577758|156990334|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
48765738|NCT01577758|156990335|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
48765739|NCT01577758|156990336|FG006|Dose Escalation Phase|Withdrawal by Subject|0|||
48765740|NCT01577758|156990337|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
48765741|NCT01577758|156990330|FG000|Dose Escalation Phase|Progression Disease|2|||
48765742|NCT01577758|156990331|FG001|Dose Escalation Phase|Progression Disease|2|||
48765743|NCT01577758|156990332|FG002|Dose Escalation Phase|Progression Disease|1|||
48765744|NCT01577758|156990333|FG003|Dose Escalation Phase|Progression Disease|2|||
48765745|NCT01577758|156990334|FG004|Dose Escalation Phase|Progression Disease|5|||
49025470|NCT05586490|157933009|FG000|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
48765746|NCT01577758|156990335|FG005|Dose Escalation Phase|Progression Disease|0|||
48765747|NCT01577758|156990336|FG006|Dose Escalation Phase|Progression Disease|0|||
48765748|NCT01577758|156990337|FG007|Dose Escalation Phase|Progression Disease|0|||
49025471|NCT05586490|157933010|FG001|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
49025472|NCT05586490|157933011|FG002|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|1|||
49025473|NCT05586490|157933012|FG003|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
48765749|NCT01577758|156990330|FG000|mCRC Expansion Phase|Symptomatic Deterioration|0|||
48765750|NCT01577758|156990331|FG001|mCRC Expansion Phase|Symptomatic Deterioration|0|||
48765751|NCT01577758|156990332|FG002|mCRC Expansion Phase|Symptomatic Deterioration|0|||
48765752|NCT01577758|156990333|FG003|mCRC Expansion Phase|Symptomatic Deterioration|0|||
48765753|NCT01577758|156990334|FG004|mCRC Expansion Phase|Symptomatic Deterioration|0|||
48765754|NCT01577758|156990335|FG005|mCRC Expansion Phase|Symptomatic Deterioration|0|||
48765755|NCT01577758|156990336|FG006|mCRC Expansion Phase|Symptomatic Deterioration|0|||
48765756|NCT01577758|156990337|FG007|mCRC Expansion Phase|Symptomatic Deterioration|4|||
48765757|NCT01577758|156990330|FG000|mCRC Expansion Phase|Withdrawal by Subject|0|||
48765758|NCT01577758|156990331|FG001|mCRC Expansion Phase|Withdrawal by Subject|0|||
48765759|NCT01577758|156990332|FG002|mCRC Expansion Phase|Withdrawal by Subject|0|||
48765760|NCT01577758|156990333|FG003|mCRC Expansion Phase|Withdrawal by Subject|0|||
48765761|NCT01577758|156990334|FG004|mCRC Expansion Phase|Withdrawal by Subject|0|||
48765762|NCT01577758|156990335|FG005|mCRC Expansion Phase|Withdrawal by Subject|0|||
48765763|NCT01577758|156990336|FG006|mCRC Expansion Phase|Withdrawal by Subject|0|||
48765764|NCT01577758|156990337|FG007|mCRC Expansion Phase|Withdrawal by Subject|2|||
48765765|NCT01577758|156990330|FG000|mCRC Expansion Phase|Progression Disease|0|||
48765766|NCT01577758|156990331|FG001|mCRC Expansion Phase|Progression Disease|0|||
48765767|NCT01577758|156990332|FG002|mCRC Expansion Phase|Progression Disease|0|||
48765768|NCT01577758|156990333|FG003|mCRC Expansion Phase|Progression Disease|0|||
48765769|NCT01577758|156990334|FG004|mCRC Expansion Phase|Progression Disease|0|||
48765770|NCT01577758|156990335|FG005|mCRC Expansion Phase|Progression Disease|0|||
48765771|NCT01577758|156990336|FG006|mCRC Expansion Phase|Progression Disease|0|||
48765772|NCT01577758|156990337|FG007|mCRC Expansion Phase|Progression Disease|19|||
48765773|NCT04327999|156990342|FG000|Overall Study|Protocol Violation|1|||
48765774|NCT00486265|156990347|FG000|Overall Study|Adverse Event|1|||
48765775|NCT00486265|156990347|FG000|Overall Study|Lack of Efficacy|8|||
48765776|NCT01907828|156990352|FG000|Overall Study|Exclusion criteria not met|0|||
48765777|NCT01907828|156990353|FG001|Overall Study|Exclusion criteria not met|1|||
48765778|NCT01907828|156990352|FG000|Overall Study|Withdrawal by Subject|3|||
48765779|NCT01907828|156990353|FG001|Overall Study|Withdrawal by Subject|4|||
48765780|NCT01907828|156990352|FG000|Overall Study|Lost to Follow-up|3|||
48765781|NCT01907828|156990353|FG001|Overall Study|Lost to Follow-up|0|||
48765782|NCT01907828|156990352|FG000|Overall Study|Participant refused 24-month follow-up|1|||
48765783|NCT01907828|156990353|FG001|Overall Study|Participant refused 24-month follow-up|0|||
48765784|NCT01907828|156990352|FG000|Overall Study|Participant met exclusion criteria|0|||
48765785|NCT01907828|156990353|FG001|Overall Study|Participant met exclusion criteria|1|||
48765786|NCT00805766|156990354|FG000|Screening Period|Adverse Event|1|||
48765787|NCT00805766|156990354|FG000|Screening Period|Lack of Efficacy|2|||
48765788|NCT00805766|156990354|FG000|Screening Period|Pregnancy|1|||
48765789|NCT00805766|156990354|FG000|Screening Period|Responder|2|||
48765790|NCT00805766|156990354|FG000|Increased Dose Period|Adverse Event|4|||
48765791|NCT00805766|156990354|FG000|Increased Dose Period|Lack of Efficacy|7|||
48765792|NCT00805766|156990354|FG000|Increased Dose Period|Pregnancy|1|||
48765793|NCT00805766|156990354|FG000|Increased Dose Period|Withdrawal by Subject|1|||
48765794|NCT00696137|156990355|FG000|Overall Study|Withdrawal by Subject|2|||
48765795|NCT02073279|156990356|FG000|Double-blind Period|Adverse Event|1|||
48765796|NCT02073279|156990357|FG001|Double-blind Period|Adverse Event|1|||
48765797|NCT02073279|156990356|FG000|Double-blind Period|Switched to another treatment|1|||
48765798|NCT02073279|156990357|FG001|Double-blind Period|Switched to another treatment|2|||
48765799|NCT02073279|156990356|FG000|Double-blind Period|Protocol Violation|0|||
48765800|NCT02073279|156990357|FG001|Double-blind Period|Protocol Violation|1|||
48765801|NCT02073279|156990356|FG000|Double-blind Period|Refused Treatment/Did Not Cooperate|0|||
48765802|NCT02073279|156990357|FG001|Double-blind Period|Refused Treatment/Did Not Cooperate|1|||
48765803|NCT02073279|156990356|FG000|Double-blind Period|Withdrawal by Subject|2|||
48765804|NCT02073279|156990357|FG001|Double-blind Period|Withdrawal by Subject|2|||
48765805|NCT02073279|156990356|FG000|Open-label Extension Period|Adverse Event|1|||
48765806|NCT02073279|156990357|FG001|Open-label Extension Period|Adverse Event|0|||
48765807|NCT02073279|156990356|FG000|Open-label Extension Period|Lack of Efficacy|1|||
48981766|NCT03344562|157765521|FG001|Overall Study|Withdrawal by Subject|0|||
48981767|NCT03742271|157765530|FG000|Overall Study|Unsatisfactory Visual Response|1|||
48981768|NCT03742271|157765530|FG000|Overall Study|Withdrawal by Subject|3|||
48981769|NCT03742271|157765530|FG000|Overall Study|Lost to Follow-up|4|||
48981770|NCT03742271|157765530|FG000|Overall Study|Failed Insertion & removal|3|||
48981771|NCT03742271|157765530|FG000|Overall Study|Protocol Violation|1|||
48765808|NCT02073279|156990357|FG001|Open-label Extension Period|Lack of Efficacy|0|||
48765809|NCT02073279|156990356|FG000|Open-label Extension Period|Lost to Follow-up|0|||
48765810|NCT02073279|156990357|FG001|Open-label Extension Period|Lost to Follow-up|4|||
49025474|NCT05586490|157933013|FG004|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
48765811|NCT02073279|156990356|FG000|Open-label Extension Period|Switched to another treatment|1|||
48981772|NCT03619902|157765531|FG000|Overall Study|Termination of Study by Investigator|1|||
48981773|NCT03619902|157765531|FG000|Overall Study|Use of Excluded/Prohibited Medication|1|||
48981774|NCT00472043|157765532|FG000|Overall Study|Withdrawal by Subject|1|||
48765812|NCT02073279|156990357|FG001|Open-label Extension Period|Switched to another treatment|4|||
48765813|NCT02073279|156990356|FG000|Open-label Extension Period|Protocol Violation|0|||
48981775|NCT00472043|157765533|FG001|Overall Study|Withdrawal by Subject|0|||
48981776|NCT00472043|157765532|FG000|Overall Study|Death|1|||
48981777|NCT00472043|157765533|FG001|Overall Study|Death|0|||
48981778|NCT04048876|157765539|FG000|Placebo Controlled Phase|Withdrawal by Subject|1|||
48981779|NCT04048876|157765540|FG001|Placebo Controlled Phase|Withdrawal by Subject|2|||
48981780|NCT04048876|157765541|FG002|Placebo Controlled Phase|Withdrawal by Subject|0|||
48981781|NCT04048876|157765542|FG003|Placebo Controlled Phase|Withdrawal by Subject|1|||
48981782|NCT04048876|157765539|FG000|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
48981783|NCT04048876|157765540|FG001|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
48981784|NCT04048876|157765541|FG002|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
48981785|NCT04048876|157765542|FG003|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
48981786|NCT04048876|157765539|FG000|Placebo Controlled Phase|Adverse Event|0|||
48981787|NCT04048876|157765540|FG001|Placebo Controlled Phase|Adverse Event|1|||
48981788|NCT04048876|157765541|FG002|Placebo Controlled Phase|Adverse Event|0|||
48981789|NCT04048876|157765542|FG003|Placebo Controlled Phase|Adverse Event|0|||
48981790|NCT04048876|157765539|FG000|Active Treatment Phase|Study Terminated by Sponsor|2|||
48981791|NCT04048876|157765540|FG001|Active Treatment Phase|Study Terminated by Sponsor|0|||
48981792|NCT04048876|157765541|FG002|Active Treatment Phase|Study Terminated by Sponsor|3|||
48981793|NCT04048876|157765542|FG003|Active Treatment Phase|Study Terminated by Sponsor|2|||
48981794|NCT02875366|157765544|FG000|Overall Study|Adverse Event|0|||
48981795|NCT02875366|157765545|FG001|Overall Study|Adverse Event|2|||
48981796|NCT02875366|157765544|FG000|Overall Study|Noncompliance|0|||
48981797|NCT02875366|157765545|FG001|Overall Study|Noncompliance|1|||
48981798|NCT00683774|157765546|FG000|Overall Study|Withdrawal by Subject|0|||
48981799|NCT00683774|157765547|FG001|Overall Study|Withdrawal by Subject|1|||
48981800|NCT00683774|157765546|FG000|Overall Study|Physician Decision|3|||
48981801|NCT00683774|157765547|FG001|Overall Study|Physician Decision|0|||
48981802|NCT01624974|157765548|FG000|Period III of Treatment (4 Weeks)|Lack of Efficacy|0|||
48981803|NCT01624974|157765549|FG001|Period III of Treatment (4 Weeks)|Lack of Efficacy|2|||
48981804|NCT01624974|157765548|FG000|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1|||
48981805|NCT01624974|157765549|FG001|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2|||
48981806|NCT01624974|157765548|FG000|Period III of Treatment (4 Weeks)|Physician Decision|5|||
48981807|NCT01624974|157765549|FG001|Period III of Treatment (4 Weeks)|Physician Decision|3|||
48981808|NCT01624974|157765548|FG000|Period III of Treatment (4 Weeks)|Protocol Violation|1|||
48981809|NCT01624974|157765549|FG001|Period III of Treatment (4 Weeks)|Protocol Violation|0|||
48981810|NCT01624974|157765548|FG000|Period III of Treatment (4 Weeks)|Adverse Event|0|||
48981811|NCT01624974|157765549|FG001|Period III of Treatment (4 Weeks)|Adverse Event|1|||
48981812|NCT01624974|157765548|FG000|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
48981813|NCT01624974|157765549|FG001|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
48981814|NCT01624974|157765548|FG000|Period IV Washout (4 Weeks)|Withdrawal by Subject|0|||
48981815|NCT01624974|157765549|FG001|Period IV Washout (4 Weeks)|Withdrawal by Subject|1|||
48981816|NCT01624974|157765548|FG000|Period IV Washout (4 Weeks)|Adverse Event|2|||
48981817|NCT01624974|157765549|FG001|Period IV Washout (4 Weeks)|Adverse Event|0|||
48765814|NCT02073279|156990357|FG001|Open-label Extension Period|Protocol Violation|1|||
48765815|NCT02073279|156990356|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
48765816|NCT02073279|156990357|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
48765817|NCT02073279|156990356|FG000|Open-label Extension Period|Withdrawal by Subject|4|||
48765818|NCT02073279|156990357|FG001|Open-label Extension Period|Withdrawal by Subject|5|||
48765819|NCT01116232|156990359|FG000|Overall Study|Progressive diease|4|||
48765820|NCT02519712|156990361|FG000|Overall Study|Disease Relapse|1|||
48765821|NCT02519712|156990361|FG000|Overall Study|Disease Progression|1|||
48765822|NCT02519712|156990361|FG000|Overall Study|Accruals are donors|2|||
48765823|NCT01124643|156990362|FG000|Overall Study|Death|1|||
48765824|NCT00291668|156990363|FG000|Overall Study|Lack of Efficacy|1|||
48765825|NCT00291668|156990364|FG001|Overall Study|Lack of Efficacy|0|||
48765826|NCT00291668|156990365|FG002|Overall Study|Lack of Efficacy|0|||
48765827|NCT00291668|156990363|FG000|Overall Study|SAE, non-fatal|1|||
48765828|NCT00291668|156990364|FG001|Overall Study|SAE, non-fatal|1|||
48765829|NCT00291668|156990365|FG002|Overall Study|SAE, non-fatal|1|||
48765830|NCT00291668|156990363|FG000|Overall Study|AE, non-serious non-fatal|1|||
48765831|NCT00291668|156990364|FG001|Overall Study|AE, non-serious non-fatal|0|||
48765832|NCT00291668|156990365|FG002|Overall Study|AE, non-serious non-fatal|0|||
48765833|NCT00291668|156990363|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
48765834|NCT00291668|156990364|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
48765835|NCT00291668|156990365|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
48765836|NCT04059146|156990366|FG000|Overall Study|Withdrawal by Subject|0|||
48765837|NCT04059146|156990367|FG001|Overall Study|Withdrawal by Subject|1|||
48765838|NCT03323658|156990372|FG000|Overall Study|Adverse Event|0|||
48765839|NCT03323658|156990373|FG001|Overall Study|Adverse Event|1|||
48765840|NCT03323658|156990374|FG002|Overall Study|Adverse Event|0|||
48765841|NCT03913091|156990379|FG000|Overall Study|Lost to Follow-up|18|||
48765842|NCT03913091|156990380|FG001|Overall Study|Lost to Follow-up|11|||
48765843|NCT03913091|156990379|FG000|Overall Study|Required additional meds/surgery|1|||
48875622|NCT02635386|157381685|FG000|Overall Study|needed other major surgery|0|||
48875623|NCT02635386|157381686|FG001|Overall Study|needed other major surgery|1|||
48875624|NCT02635386|157381687|FG002|Overall Study|needed other major surgery|0|||
48875625|NCT02635386|157381688|FG003|Overall Study|needed other major surgery|0|||
48875626|NCT02635386|157381689|FG004|Overall Study|needed other major surgery|0|||
48875627|NCT02635386|157381685|FG000|Overall Study|Other medical problems not drug related|0|||
48765844|NCT03913091|156990380|FG001|Overall Study|Required additional meds/surgery|2|||
48765845|NCT03913091|156990379|FG000|Overall Study|Chronic pain/history of substance abuse|1|||
48765846|NCT03913091|156990380|FG001|Overall Study|Chronic pain/history of substance abuse|1|||
48765847|NCT00082433|156990381|FG000|Overall Study|Adverse Event|12|||
48765848|NCT00082433|156990382|FG001|Overall Study|Adverse Event|17|||
48765849|NCT00082433|156990381|FG000|Overall Study|Death|8|||
48765850|NCT00082433|156990382|FG001|Overall Study|Death|18|||
48875628|NCT02635386|157381686|FG001|Overall Study|Other medical problems not drug related|0|||
48981818|NCT01624974|157765548|FG000|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0|||
48981819|NCT01624974|157765549|FG001|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1|||
48765851|NCT00082433|156990381|FG000|Overall Study|Disease Progression/Relapse|270|||
48765852|NCT00082433|156990382|FG001|Overall Study|Disease Progression/Relapse|388|||
48765853|NCT00082433|156990381|FG000|Overall Study|Physician Decision|50|||
48765854|NCT00082433|156990382|FG001|Overall Study|Physician Decision|61|||
48765855|NCT00082433|156990381|FG000|Overall Study|Lost to Follow-up|1|||
48765856|NCT00082433|156990382|FG001|Overall Study|Lost to Follow-up|2|||
48765857|NCT00082433|156990381|FG000|Overall Study|Study Drug Toxicity|179|||
48765858|NCT00082433|156990382|FG001|Overall Study|Study Drug Toxicity|66|||
48765859|NCT00082433|156990381|FG000|Overall Study|Withdrawal by Subject|55|||
48765860|NCT00082433|156990382|FG001|Overall Study|Withdrawal by Subject|30|||
48765861|NCT00082433|156990381|FG000|Overall Study|Still On Treatment|2|||
48765862|NCT00082433|156990382|FG001|Overall Study|Still On Treatment|1|||
48765863|NCT00082433|156990381|FG000|Overall Study|Not Treated|12|||
48765864|NCT00082433|156990382|FG001|Overall Study|Not Treated|11|||
48765865|NCT00082433|156990381|FG000|Overall Study|Ineligible|2|||
48765866|NCT00082433|156990382|FG001|Overall Study|Ineligible|1|||
48765867|NCT00082433|156990381|FG000|Overall Study|Noncompliance|2|||
48765868|NCT00082433|156990382|FG001|Overall Study|Noncompliance|1|||
48765869|NCT00082433|156990381|FG000|Overall Study|New primary cancer|1|||
48765870|NCT00082433|156990382|FG001|Overall Study|New primary cancer|0|||
48765871|NCT00082433|156990381|FG000|Overall Study|Impending surgery|0|||
48765872|NCT00082433|156990382|FG001|Overall Study|Impending surgery|1|||
48765873|NCT00558103|156990384|FG000|Randomized Treatment Phase|Lost to Follow-up|2|||
48765874|NCT00558103|156990385|FG001|Randomized Treatment Phase|Lost to Follow-up|2|||
48765875|NCT00558103|156990386|FG002|Randomized Treatment Phase|Lost to Follow-up|2|||
48765876|NCT00558103|156990387|FG003|Randomized Treatment Phase|Lost to Follow-up|1|||
48765877|NCT00558103|156990388|FG004|Randomized Treatment Phase|Lost to Follow-up|3|||
48765878|NCT00558103|156990389|FG005|Randomized Treatment Phase|Lost to Follow-up|0|||
48765879|NCT00558103|156990384|FG000|Randomized Treatment Phase|Withdrawal by Subject|2|||
48765880|NCT00558103|156990385|FG001|Randomized Treatment Phase|Withdrawal by Subject|2|||
48765881|NCT00558103|156990386|FG002|Randomized Treatment Phase|Withdrawal by Subject|0|||
48765882|NCT00558103|156990387|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
48765883|NCT00558103|156990388|FG004|Randomized Treatment Phase|Withdrawal by Subject|1|||
48765884|NCT00558103|156990389|FG005|Randomized Treatment Phase|Withdrawal by Subject|0|||
48765885|NCT00558103|156990384|FG000|Randomized Treatment Phase|Disease Progression|1|||
48765886|NCT00558103|156990385|FG001|Randomized Treatment Phase|Disease Progression|0|||
48765887|NCT00558103|156990386|FG002|Randomized Treatment Phase|Disease Progression|1|||
48765888|NCT00558103|156990387|FG003|Randomized Treatment Phase|Disease Progression|0|||
48765889|NCT00558103|156990388|FG004|Randomized Treatment Phase|Disease Progression|0|||
48765890|NCT00558103|156990389|FG005|Randomized Treatment Phase|Disease Progression|0|||
48765891|NCT00558103|156990384|FG000|Randomized Treatment Phase|Adverse Event|0|||
48765892|NCT00558103|156990385|FG001|Randomized Treatment Phase|Adverse Event|0|||
48765893|NCT00558103|156990386|FG002|Randomized Treatment Phase|Adverse Event|0|||
48765894|NCT00558103|156990387|FG003|Randomized Treatment Phase|Adverse Event|1|||
48765895|NCT00558103|156990388|FG004|Randomized Treatment Phase|Adverse Event|1|||
48765896|NCT00558103|156990389|FG005|Randomized Treatment Phase|Adverse Event|0|||
48765897|NCT00558103|156990384|FG000|Monotherapy Extension Phase|Protocol Violation|0|||
48765898|NCT00558103|156990385|FG001|Monotherapy Extension Phase|Protocol Violation|0|||
48765899|NCT00558103|156990386|FG002|Monotherapy Extension Phase|Protocol Violation|0|||
48765900|NCT00558103|156990387|FG003|Monotherapy Extension Phase|Protocol Violation|0|||
48765901|NCT00558103|156990388|FG004|Monotherapy Extension Phase|Protocol Violation|0|||
48875629|NCT02635386|157381687|FG002|Overall Study|Other medical problems not drug related|0|||
48981820|NCT01624974|157765548|FG000|Period V of Treatment (4 Weeks)|Lack of Efficacy|1|||
48981821|NCT01624974|157765549|FG001|Period V of Treatment (4 Weeks)|Lack of Efficacy|0|||
48981822|NCT01624974|157765548|FG000|Period V of Treatment (4 Weeks)|Physician Decision|3|||
48981823|NCT01624974|157765549|FG001|Period V of Treatment (4 Weeks)|Physician Decision|0|||
48981824|NCT01624974|157765548|FG000|Period V of Treatment (4 Weeks)|Adverse Event|1|||
48981825|NCT01624974|157765549|FG001|Period V of Treatment (4 Weeks)|Adverse Event|0|||
48765902|NCT00558103|156990389|FG005|Monotherapy Extension Phase|Protocol Violation|1|||
48765903|NCT00558103|156990384|FG000|Monotherapy Extension Phase|Disease Progression|0|||
48765904|NCT00558103|156990385|FG001|Monotherapy Extension Phase|Disease Progression|0|||
48765905|NCT00558103|156990386|FG002|Monotherapy Extension Phase|Disease Progression|0|||
48765906|NCT00558103|156990387|FG003|Monotherapy Extension Phase|Disease Progression|0|||
48765907|NCT00558103|156990388|FG004|Monotherapy Extension Phase|Disease Progression|0|||
48765908|NCT00558103|156990389|FG005|Monotherapy Extension Phase|Disease Progression|8|||
48765909|NCT03388138|156992426|FG000|Overall Study|Protocol Violation|1|||
48765910|NCT03388138|156992427|FG001|Overall Study|Protocol Violation|0|||
48765911|NCT03336216|156992428|FG000|Randomization|Not reported|2|||
48765912|NCT03336216|156992429|FG001|Randomization|Not reported|0|||
48765913|NCT03336216|156992430|FG002|Randomization|Not reported|1|||
48765914|NCT03336216|156992431|FG003|Randomization|Not reported|0|||
48765915|NCT03336216|156992428|FG000|Randomization|Other reasons|1|||
48765916|NCT03336216|156992429|FG001|Randomization|Other reasons|1|||
48765917|NCT03336216|156992430|FG002|Randomization|Other reasons|1|||
48765918|NCT03336216|156992431|FG003|Randomization|Other reasons|0|||
48765919|NCT03336216|156992428|FG000|Randomization|Participant no longer meets study criteria|0|||
48765920|NCT03336216|156992429|FG001|Randomization|Participant no longer meets study criteria|2|||
48765921|NCT03336216|156992430|FG002|Randomization|Participant no longer meets study criteria|4|||
48765922|NCT03336216|156992431|FG003|Randomization|Participant no longer meets study criteria|1|||
48765923|NCT03336216|156992428|FG000|Randomization|Lost to Follow-up|1|||
48765924|NCT03336216|156992429|FG001|Randomization|Lost to Follow-up|0|||
48765925|NCT03336216|156992430|FG002|Randomization|Lost to Follow-up|0|||
48765926|NCT03336216|156992431|FG003|Randomization|Lost to Follow-up|0|||
48765927|NCT03336216|156992428|FG000|Randomization|Participant withdrew consent|9|||
48765928|NCT03336216|156992429|FG001|Randomization|Participant withdrew consent|1|||
48765929|NCT03336216|156992430|FG002|Randomization|Participant withdrew consent|0|||
48765930|NCT03336216|156992431|FG003|Randomization|Participant withdrew consent|0|||
48765931|NCT03336216|156992428|FG000|Randomization|Adverse Event|1|||
48765932|NCT03336216|156992429|FG001|Randomization|Adverse Event|1|||
48765933|NCT03336216|156992430|FG002|Randomization|Adverse Event|0|||
48765934|NCT03336216|156992431|FG003|Randomization|Adverse Event|0|||
48765935|NCT03336216|156992428|FG000|Treatment|Adverse Event|2|||
48765936|NCT03336216|156992429|FG001|Treatment|Adverse Event|3|||
48765937|NCT03336216|156992430|FG002|Treatment|Adverse Event|4|||
48765938|NCT03336216|156992431|FG003|Treatment|Adverse Event|4|||
48765939|NCT03336216|156992428|FG000|Treatment|Participant request to discontinue treatment|2|||
48765940|NCT03336216|156992429|FG001|Treatment|Participant request to discontinue treatment|1|||
48765941|NCT03336216|156992430|FG002|Treatment|Participant request to discontinue treatment|2|||
48765942|NCT03336216|156992431|FG003|Treatment|Participant request to discontinue treatment|2|||
48765943|NCT03336216|156992428|FG000|Treatment|Participant withdrew consent|7|||
48765944|NCT03336216|156992429|FG001|Treatment|Participant withdrew consent|2|||
48765945|NCT03336216|156992430|FG002|Treatment|Participant withdrew consent|3|||
48765946|NCT03336216|156992431|FG003|Treatment|Participant withdrew consent|2|||
48765947|NCT03336216|156992428|FG000|Treatment|Death|2|||
48765948|NCT03336216|156992429|FG001|Treatment|Death|3|||
48765949|NCT03336216|156992430|FG002|Treatment|Death|3|||
48765950|NCT03336216|156992431|FG003|Treatment|Death|4|||
48765951|NCT03336216|156992428|FG000|Treatment|Participant no longer meets study criteria|0|||
48765952|NCT03336216|156992429|FG001|Treatment|Participant no longer meets study criteria|1|||
48765953|NCT03336216|156992430|FG002|Treatment|Participant no longer meets study criteria|0|||
48765954|NCT03336216|156992431|FG003|Treatment|Participant no longer meets study criteria|0|||
48765955|NCT03336216|156992428|FG000|Treatment|Other reasons|2|||
48765956|NCT03336216|156992429|FG001|Treatment|Other reasons|0|||
48765957|NCT03336216|156992430|FG002|Treatment|Other reasons|0|||
48765958|NCT03336216|156992431|FG003|Treatment|Other reasons|3|||
48765959|NCT03336216|156992428|FG000|Treatment|Disease progression|23|||
48765960|NCT03336216|156992429|FG001|Treatment|Disease progression|34|||
48765961|NCT03336216|156992430|FG002|Treatment|Disease progression|33|||
48765962|NCT03336216|156992431|FG003|Treatment|Disease progression|26|||
48765963|NCT03336216|156992428|FG000|Treatment|Study drug toxicity|0|||
48765964|NCT03336216|156992429|FG001|Treatment|Study drug toxicity|3|||
48765965|NCT03336216|156992430|FG002|Treatment|Study drug toxicity|2|||
48765966|NCT03336216|156992431|FG003|Treatment|Study drug toxicity|0|||
48981826|NCT02463331|157765551|FG000|Overall Study|Adverse Event|4|||
48765967|NCT03336216|156992428|FG000|Treatment|Adverse Event unrelated to study drug|1|||
48765968|NCT03336216|156992429|FG001|Treatment|Adverse Event unrelated to study drug|1|||
48765969|NCT03336216|156992430|FG002|Treatment|Adverse Event unrelated to study drug|1|||
48765970|NCT03336216|156992431|FG003|Treatment|Adverse Event unrelated to study drug|0|||
48765971|NCT03336216|156992428|FG000|Treatment|Disease Recurrence|1|||
48765972|NCT03336216|156992429|FG001|Treatment|Disease Recurrence|0|||
48765973|NCT03336216|156992430|FG002|Treatment|Disease Recurrence|0|||
48765974|NCT03336216|156992431|FG003|Treatment|Disease Recurrence|0|||
48765975|NCT03238911|156992432|FG000|Overall Study|Withdrawal by Subject|1|||
48765976|NCT03238911|156992433|FG001|Overall Study|Withdrawal by Subject|2|||
48765977|NCT03238911|156992432|FG000|Overall Study|Lost to Follow-up|2|||
48765978|NCT03238911|156992433|FG001|Overall Study|Lost to Follow-up|1|||
48765979|NCT01641367|156992439|FG000|Cohorts|Death|18|||
48765980|NCT01641367|156992440|FG001|Cohorts|Death|1|||
48765981|NCT01641367|156992441|FG002|Cohorts|Death|2|||
48765982|NCT01641367|156992442|FG003|Cohorts|Death|0|||
48765983|NCT01641367|156992443|FG004|Cohorts|Death|1|||
48765984|NCT01641367|156992444|FG005|Cohorts|Death|1|||
48765985|NCT01641367|156992445|FG006|Cohorts|Death|0|||
48765986|NCT01641367|156992446|FG007|Cohorts|Death|0|||
48765987|NCT01641367|156992439|FG000|Cohorts|Lost to Follow-up|16|||
48765988|NCT01641367|156992440|FG001|Cohorts|Lost to Follow-up|0|||
48765989|NCT01641367|156992441|FG002|Cohorts|Lost to Follow-up|2|||
48765990|NCT01641367|156992442|FG003|Cohorts|Lost to Follow-up|0|||
48765991|NCT01641367|156992443|FG004|Cohorts|Lost to Follow-up|2|||
48765992|NCT01641367|156992444|FG005|Cohorts|Lost to Follow-up|0|||
48765993|NCT01641367|156992445|FG006|Cohorts|Lost to Follow-up|0|||
48765994|NCT01641367|156992446|FG007|Cohorts|Lost to Follow-up|0|||
48765995|NCT01641367|156992439|FG000|Randomized Adherence Intervention|Death|0|||
48765996|NCT01641367|156992440|FG001|Randomized Adherence Intervention|Death|0|||
48765997|NCT01641367|156992441|FG002|Randomized Adherence Intervention|Death|0|||
48765998|NCT01641367|156992442|FG003|Randomized Adherence Intervention|Death|0|||
48765999|NCT01641367|156992443|FG004|Randomized Adherence Intervention|Death|0|||
48766000|NCT01641367|156992444|FG005|Randomized Adherence Intervention|Death|0|||
48766001|NCT01641367|156992445|FG006|Randomized Adherence Intervention|Death|11|||
48766002|NCT01641367|156992446|FG007|Randomized Adherence Intervention|Death|12|||
48766003|NCT01641367|156992439|FG000|Randomized Adherence Intervention|Lost to Follow-up|0|||
48766004|NCT01641367|156992440|FG001|Randomized Adherence Intervention|Lost to Follow-up|0|||
48766005|NCT01641367|156992441|FG002|Randomized Adherence Intervention|Lost to Follow-up|0|||
48766006|NCT01641367|156992442|FG003|Randomized Adherence Intervention|Lost to Follow-up|0|||
48766007|NCT01641367|156992443|FG004|Randomized Adherence Intervention|Lost to Follow-up|0|||
48766008|NCT01641367|156992444|FG005|Randomized Adherence Intervention|Lost to Follow-up|0|||
48766009|NCT01641367|156992445|FG006|Randomized Adherence Intervention|Lost to Follow-up|8|||
48766010|NCT01641367|156992446|FG007|Randomized Adherence Intervention|Lost to Follow-up|12|||
48766011|NCT02586493|156992453|FG000|Overall Study|Adverse Event|4|||
48766012|NCT02586493|156992453|FG000|Overall Study|Protocol Violation|6|||
48766013|NCT02586493|156992453|FG000|Overall Study|Lost to Follow-up|1|||
48766014|NCT02586493|156992453|FG000|Overall Study|Withdrawal by Subject|1|||
48766015|NCT01675882|156992455|FG000|Overall Study|Adverse Event|0|||
48766016|NCT01675882|156992456|FG001|Overall Study|Adverse Event|2|||
48766017|NCT01675882|156992457|FG002|Overall Study|Adverse Event|1|||
48766018|NCT01675882|156992458|FG003|Overall Study|Adverse Event|0|||
48766019|NCT01675882|156992455|FG000|Overall Study|Participant unwilling to continue|2|||
48766020|NCT01675882|156992456|FG001|Overall Study|Participant unwilling to continue|4|||
48766021|NCT01675882|156992457|FG002|Overall Study|Participant unwilling to continue|2|||
48981827|NCT02463331|157765552|FG001|Overall Study|Adverse Event|2|||
48981828|NCT02463331|157765551|FG000|Overall Study|Lost to Follow-up|1|||
48981829|NCT02463331|157765552|FG001|Overall Study|Lost to Follow-up|1|||
48981830|NCT02463331|157765551|FG000|Overall Study|Pregnancy|2|||
48981831|NCT02463331|157765552|FG001|Overall Study|Pregnancy|3|||
48981832|NCT02463331|157765551|FG000|Overall Study|Lack of Efficacy|6|||
48981833|NCT02463331|157765552|FG001|Overall Study|Lack of Efficacy|0|||
48981834|NCT02463331|157765551|FG000|Overall Study|Physician Decision|3|||
48981835|NCT02463331|157765552|FG001|Overall Study|Physician Decision|0|||
48981836|NCT00826540|157765553|FG000|Overall Study|ineligible|3|||
48981837|NCT00826540|157765553|FG000|Overall Study|Withdrawal by Subject|1|||
48981838|NCT01166386|157765554|FG000|Overall Study|Withdrawal by Subject|3|||
48981839|NCT01166386|157765555|FG001|Overall Study|Withdrawal by Subject|5|||
48981840|NCT02802735|157765556|FG000|Overall Study|Withdrawal by Subject|0|||
48981841|NCT02802735|157765557|FG001|Overall Study|Withdrawal by Subject|1|||
48981842|NCT02802735|157765558|FG002|Overall Study|Withdrawal by Subject|0|||
48981843|NCT02802735|157765559|FG003|Overall Study|Withdrawal by Subject|0|||
48981844|NCT02802735|157765560|FG004|Overall Study|Withdrawal by Subject|0|||
48981845|NCT00715949|157765561|FG000|Overall Study|could not finish first test|4|||
48981846|NCT00420212|157765564|FG000|Overall Study|Adverse Event|22|||
48981847|NCT00420212|157765565|FG001|Overall Study|Adverse Event|40|||
48981848|NCT00420212|157765566|FG002|Overall Study|Adverse Event|36|||
48981849|NCT00420212|157765564|FG000|Overall Study|Lost to Follow-up|9|||
48981850|NCT00420212|157765565|FG001|Overall Study|Lost to Follow-up|11|||
48981851|NCT00420212|157765566|FG002|Overall Study|Lost to Follow-up|11|||
48981852|NCT00420212|157765564|FG000|Overall Study|Withdrawal by Subject|31|||
48981853|NCT00420212|157765565|FG001|Overall Study|Withdrawal by Subject|22|||
48981854|NCT00420212|157765566|FG002|Overall Study|Withdrawal by Subject|19|||
48981855|NCT00420212|157765564|FG000|Overall Study|Physician Decision|4|||
48981856|NCT00420212|157765565|FG001|Overall Study|Physician Decision|4|||
48981857|NCT00420212|157765566|FG002|Overall Study|Physician Decision|3|||
48981858|NCT00420212|157765564|FG000|Overall Study|Protocol Violation|4|||
48981859|NCT00420212|157765565|FG001|Overall Study|Protocol Violation|4|||
48981860|NCT00420212|157765566|FG002|Overall Study|Protocol Violation|8|||
48981861|NCT00420212|157765564|FG000|Overall Study|Death|0|||
49025475|NCT05586490|157933009|FG000|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|1|||
48766022|NCT01675882|156992458|FG003|Overall Study|Participant unwilling to continue|1|||
48766023|NCT01675882|156992455|FG000|Overall Study|Lost to Follow-up|0|||
48766024|NCT01675882|156992456|FG001|Overall Study|Lost to Follow-up|1|||
48766025|NCT01675882|156992457|FG002|Overall Study|Lost to Follow-up|0|||
48766026|NCT01675882|156992458|FG003|Overall Study|Lost to Follow-up|0|||
49025476|NCT05586490|157933010|FG001|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
49025477|NCT05586490|157933011|FG002|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
49025478|NCT05586490|157933012|FG003|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
49025479|NCT05586490|157933013|FG004|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
49025480|NCT05586490|157933009|FG000|Completed Aim 3 - No Device Arm|Withdrawal by Subject|1|||
49025481|NCT05586490|157933010|FG001|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
49025482|NCT05586490|157933011|FG002|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
49025483|NCT05586490|157933012|FG003|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
49025484|NCT05586490|157933013|FG004|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
49025485|NCT04786119|157933014|FG000|Overall Study|Withdrawal by Subject|2|||
49025486|NCT00855738|157933015|FG000|Overall Study|Lost to Follow-up|2|||
49025487|NCT00855738|157933015|FG000|Overall Study|Adverse Event|1|||
49025488|NCT00855738|157933015|FG000|Overall Study|Subject Defaulted|1|||
49025489|NCT00855738|157933015|FG000|Overall Study|Death|1|||
49025490|NCT02323880|157933018|FG000|Overall Study|Adverse Event|2|||
49025491|NCT02323880|157933019|FG001|Overall Study|Adverse Event|0|||
49025492|NCT02323880|157933020|FG002|Overall Study|Adverse Event|1|||
49025493|NCT02323880|157933021|FG003|Overall Study|Adverse Event|1|||
49025494|NCT02323880|157933022|FG004|Overall Study|Adverse Event|1|||
49025495|NCT02323880|157933023|FG005|Overall Study|Adverse Event|0|||
49025496|NCT02323880|157933024|FG006|Overall Study|Adverse Event|1|||
49025497|NCT02323880|157933025|FG007|Overall Study|Adverse Event|0|||
49025498|NCT02323880|157933018|FG000|Overall Study|Death|0|||
49025499|NCT02323880|157933019|FG001|Overall Study|Death|0|||
49025500|NCT02323880|157933020|FG002|Overall Study|Death|0|||
49025501|NCT02323880|157933021|FG003|Overall Study|Death|0|||
49025502|NCT02323880|157933022|FG004|Overall Study|Death|0|||
49025503|NCT02323880|157933023|FG005|Overall Study|Death|1|||
49025504|NCT02323880|157933024|FG006|Overall Study|Death|0|||
49025505|NCT02323880|157933025|FG007|Overall Study|Death|0|||
49025506|NCT02323880|157933018|FG000|Overall Study|Lack of Efficacy|4|||
49025507|NCT02323880|157933019|FG001|Overall Study|Lack of Efficacy|11|||
49025508|NCT02323880|157933020|FG002|Overall Study|Lack of Efficacy|5|||
49025509|NCT02323880|157933021|FG003|Overall Study|Lack of Efficacy|5|||
49025510|NCT02323880|157933022|FG004|Overall Study|Lack of Efficacy|4|||
49025511|NCT02323880|157933023|FG005|Overall Study|Lack of Efficacy|8|||
49025512|NCT02323880|157933024|FG006|Overall Study|Lack of Efficacy|4|||
49025513|NCT02323880|157933025|FG007|Overall Study|Lack of Efficacy|6|||
49025514|NCT02323880|157933018|FG000|Overall Study|Physician Decision|0|||
49025515|NCT02323880|157933019|FG001|Overall Study|Physician Decision|0|||
49025516|NCT02323880|157933020|FG002|Overall Study|Physician Decision|0|||
49025517|NCT02323880|157933021|FG003|Overall Study|Physician Decision|0|||
49025518|NCT02323880|157933022|FG004|Overall Study|Physician Decision|1|||
49025519|NCT02323880|157933023|FG005|Overall Study|Physician Decision|1|||
48766027|NCT01675882|156992455|FG000|Overall Study|Non-compliance|0|||
48766028|NCT01675882|156992456|FG001|Overall Study|Non-compliance|0|||
48766029|NCT01675882|156992457|FG002|Overall Study|Non-compliance|0|||
48766030|NCT01675882|156992458|FG003|Overall Study|Non-compliance|1|||
48766031|NCT02759120|156992459|FG000|Overall Study|Death|34|||
48766032|NCT02759120|156992460|FG001|Overall Study|Death|36|||
48766033|NCT02759120|156992459|FG000|Overall Study|Lost to Follow-up|4|||
48766034|NCT02759120|156992460|FG001|Overall Study|Lost to Follow-up|7|||
48766035|NCT02759120|156992459|FG000|Overall Study|Physician Decision|3|||
48766036|NCT02759120|156992460|FG001|Overall Study|Physician Decision|0|||
48766037|NCT02759120|156992459|FG000|Overall Study|Withdrawal by Subject|28|||
48766038|NCT02759120|156992460|FG001|Overall Study|Withdrawal by Subject|15|||
49025520|NCT02323880|157933024|FG006|Overall Study|Physician Decision|1|||
49025521|NCT02323880|157933025|FG007|Overall Study|Physician Decision|0|||
48766039|NCT02759120|156992459|FG000|Overall Study|Moved out of area|3|||
48766040|NCT02759120|156992460|FG001|Overall Study|Moved out of area|4|||
48766041|NCT02759120|156992459|FG000|Overall Study|Lung transplant|3|||
48766042|NCT02759120|156992460|FG001|Overall Study|Lung transplant|5|||
48766043|NCT02759120|156992459|FG000|Overall Study|Other reason not completed|10|||
49025522|NCT02323880|157933018|FG000|Overall Study|Withdrawal by Subject|0|||
49025523|NCT02323880|157933019|FG001|Overall Study|Withdrawal by Subject|2|||
49025524|NCT02323880|157933020|FG002|Overall Study|Withdrawal by Subject|0|||
49025525|NCT02323880|157933021|FG003|Overall Study|Withdrawal by Subject|0|||
49025526|NCT02323880|157933022|FG004|Overall Study|Withdrawal by Subject|0|||
48766044|NCT02759120|156992460|FG001|Overall Study|Other reason not completed|12|||
48766045|NCT00048542|156992462|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
49025527|NCT02323880|157933023|FG005|Overall Study|Withdrawal by Subject|0|||
49025528|NCT02323880|157933024|FG006|Overall Study|Withdrawal by Subject|0|||
48766046|NCT00048542|156992463|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
48766047|NCT00048542|156992464|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
48766048|NCT00048542|156992465|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
48766049|NCT00048542|156992466|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
48766050|NCT00048542|156992467|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
49025529|NCT02323880|157933025|FG007|Overall Study|Withdrawal by Subject|0|||
49025530|NCT04218851|157933026|FG000|Overall Study|Death|1|||
49025531|NCT04218851|157933027|FG001|Overall Study|Death|3|||
49025532|NCT00119379|157933028|FG000|Overall Study|Adverse Event|4|||
48766051|NCT00048542|156992468|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
48766052|NCT00048542|156992469|FG007|Double-Blind Phase|Withdrawal by Subject|0|||
48766053|NCT00048542|156992462|FG000|Double-Blind Phase|Protocol Violation|0|||
48766054|NCT00048542|156992463|FG001|Double-Blind Phase|Protocol Violation|0|||
48766055|NCT00048542|156992464|FG002|Double-Blind Phase|Protocol Violation|1|||
48766056|NCT00048542|156992465|FG003|Double-Blind Phase|Protocol Violation|0|||
48766057|NCT00048542|156992466|FG004|Double-Blind Phase|Protocol Violation|0|||
48766058|NCT00048542|156992467|FG005|Double-Blind Phase|Protocol Violation|0|||
48766059|NCT00048542|156992468|FG006|Double-Blind Phase|Protocol Violation|0|||
48766060|NCT00048542|156992469|FG007|Double-Blind Phase|Protocol Violation|0|||
48766061|NCT00048542|156992462|FG000|Double-Blind Phase|Sponsor request or decision|2|||
48766062|NCT00048542|156992463|FG001|Double-Blind Phase|Sponsor request or decision|0|||
48766063|NCT00048542|156992464|FG002|Double-Blind Phase|Sponsor request or decision|0|||
48766064|NCT00048542|156992465|FG003|Double-Blind Phase|Sponsor request or decision|0|||
48766065|NCT00048542|156992466|FG004|Double-Blind Phase|Sponsor request or decision|0|||
48766066|NCT00048542|156992467|FG005|Double-Blind Phase|Sponsor request or decision|0|||
48766067|NCT00048542|156992468|FG006|Double-Blind Phase|Sponsor request or decision|0|||
48766068|NCT00048542|156992469|FG007|Double-Blind Phase|Sponsor request or decision|0|||
48766069|NCT00048542|156992462|FG000|Double-Blind Phase|Randomized in error|1|||
48766070|NCT00048542|156992463|FG001|Double-Blind Phase|Randomized in error|0|||
48766071|NCT00048542|156992464|FG002|Double-Blind Phase|Randomized in error|0|||
48766072|NCT00048542|156992465|FG003|Double-Blind Phase|Randomized in error|0|||
48766073|NCT00048542|156992466|FG004|Double-Blind Phase|Randomized in error|0|||
48766074|NCT00048542|156992467|FG005|Double-Blind Phase|Randomized in error|0|||
48766075|NCT00048542|156992468|FG006|Double-Blind Phase|Randomized in error|0|||
48766076|NCT00048542|156992469|FG007|Double-Blind Phase|Randomized in error|0|||
48766077|NCT00048542|156992462|FG000|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
48766078|NCT00048542|156992463|FG001|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
48766079|NCT00048542|156992464|FG002|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
49025533|NCT00119379|157933029|FG001|Overall Study|Adverse Event|1|||
48766080|NCT00048542|156992465|FG003|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
48766081|NCT00048542|156992466|FG004|Open-Label Extension BSA Phase|Withdrawal by Subject|3|||
48766082|NCT00048542|156992467|FG005|Open-Label Extension BSA Phase|Withdrawal by Subject|6|||
48766083|NCT00048542|156992468|FG006|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
48766084|NCT00048542|156992469|FG007|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
48766085|NCT00048542|156992462|FG000|Open-Label Extension BSA Phase|Protocol Violation|0|||
48766086|NCT00048542|156992463|FG001|Open-Label Extension BSA Phase|Protocol Violation|0|||
48766087|NCT00048542|156992464|FG002|Open-Label Extension BSA Phase|Protocol Violation|0|||
48766088|NCT00048542|156992465|FG003|Open-Label Extension BSA Phase|Protocol Violation|0|||
48766089|NCT00048542|156992466|FG004|Open-Label Extension BSA Phase|Protocol Violation|0|||
48766090|NCT00048542|156992467|FG005|Open-Label Extension BSA Phase|Protocol Violation|1|||
48766091|NCT00048542|156992468|FG006|Open-Label Extension BSA Phase|Protocol Violation|0|||
48766092|NCT00048542|156992469|FG007|Open-Label Extension BSA Phase|Protocol Violation|0|||
48766093|NCT00048542|156992462|FG000|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
48766094|NCT00048542|156992463|FG001|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
48766095|NCT00048542|156992464|FG002|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
48766096|NCT00048542|156992465|FG003|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
48766097|NCT00048542|156992466|FG004|Open-Label Extension BSA Phase|Sponsor request or decision|5|||
48766098|NCT00048542|156992467|FG005|Open-Label Extension BSA Phase|Sponsor request or decision|1|||
48766099|NCT00048542|156992468|FG006|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
49025534|NCT04753437|157933042|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
49025535|NCT04753437|157933043|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
49025536|NCT04753437|157933042|FG000|Overall Study|Liver Function Test Abnormalities|2|||
48766100|NCT00048542|156992469|FG007|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
48766101|NCT00048542|156992462|FG000|Open-Label Extension BSA Phase|Adverse Event|0|||
48766102|NCT00048542|156992463|FG001|Open-Label Extension BSA Phase|Adverse Event|0|||
48766103|NCT00048542|156992464|FG002|Open-Label Extension BSA Phase|Adverse Event|0|||
48766104|NCT00048542|156992465|FG003|Open-Label Extension BSA Phase|Adverse Event|0|||
48766105|NCT00048542|156992466|FG004|Open-Label Extension BSA Phase|Adverse Event|1|||
48766106|NCT00048542|156992467|FG005|Open-Label Extension BSA Phase|Adverse Event|1|||
49025537|NCT04753437|157933043|FG001|Overall Study|Liver Function Test Abnormalities|4|||
49025538|NCT02032888|157933044|FG000|Treatment Period|Poor compliance/noncompliance|1|||
48766107|NCT00048542|156992468|FG006|Open-Label Extension BSA Phase|Adverse Event|0|||
48766108|NCT00048542|156992469|FG007|Open-Label Extension BSA Phase|Adverse Event|0|||
48766109|NCT00048542|156992462|FG000|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
48766110|NCT00048542|156992463|FG001|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
48766111|NCT00048542|156992464|FG002|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
48766112|NCT00048542|156992465|FG003|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
48766113|NCT00048542|156992466|FG004|Open-Label Extension BSA Phase|Lack of Efficacy|3|||
48766114|NCT00048542|156992467|FG005|Open-Label Extension BSA Phase|Lack of Efficacy|1|||
48766115|NCT00048542|156992468|FG006|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
48766116|NCT00048542|156992469|FG007|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
48766117|NCT00048542|156992462|FG000|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
48766118|NCT00048542|156992463|FG001|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
48766119|NCT00048542|156992464|FG002|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
48766120|NCT00048542|156992465|FG003|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
48766121|NCT00048542|156992466|FG004|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
48766122|NCT00048542|156992467|FG005|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
48766123|NCT00048542|156992468|FG006|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6|||
48766124|NCT00048542|156992469|FG007|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3|||
48766125|NCT00048542|156992462|FG000|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
48766126|NCT00048542|156992463|FG001|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
48766127|NCT00048542|156992464|FG002|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
48766128|NCT00048542|156992465|FG003|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
48766129|NCT00048542|156992466|FG004|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
48766130|NCT00048542|156992467|FG005|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
48766131|NCT00048542|156992468|FG006|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
48766132|NCT00048542|156992469|FG007|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
48766133|NCT00048542|156992462|FG000|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
48766134|NCT00048542|156992463|FG001|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
48766135|NCT00048542|156992464|FG002|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
48766136|NCT00048542|156992465|FG003|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
48766137|NCT00048542|156992466|FG004|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
48766138|NCT00048542|156992467|FG005|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
48766139|NCT00048542|156992468|FG006|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6|||
48766140|NCT00048542|156992469|FG007|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7|||
48766141|NCT00048542|156992462|FG000|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
48766142|NCT00048542|156992463|FG001|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
48766143|NCT00048542|156992464|FG002|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
48766144|NCT00048542|156992465|FG003|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
48766145|NCT00048542|156992466|FG004|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
48766146|NCT00048542|156992467|FG005|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
48766147|NCT00048542|156992468|FG006|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
48766148|NCT00048542|156992469|FG007|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
48766149|NCT00048542|156992462|FG000|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
48766150|NCT00048542|156992463|FG001|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
48766151|NCT00048542|156992464|FG002|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
48766152|NCT00048542|156992465|FG003|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
48766153|NCT00048542|156992466|FG004|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
48766154|NCT00048542|156992467|FG005|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
48766155|NCT00048542|156992468|FG006|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2|||
48766156|NCT00048542|156992469|FG007|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1|||
48766157|NCT00048542|156992462|FG000|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
48981862|NCT00420212|157765565|FG001|Overall Study|Death|0|||
48981863|NCT00420212|157765566|FG002|Overall Study|Death|1|||
48981864|NCT00420212|157765564|FG000|Overall Study|Other-Unspecified|21|||
48981865|NCT00420212|157765565|FG001|Overall Study|Other-Unspecified|14|||
48981866|NCT00420212|157765566|FG002|Overall Study|Other-Unspecified|18|||
48981867|NCT02390362|157765567|FG000|Overall Study|Withdrawal by Subject|0|||
48981868|NCT02390362|157765568|FG001|Overall Study|Withdrawal by Subject|1|||
48981869|NCT04009824|157765569|FG000|Overall Study|COVID-19 pandemic restriction/closure|2|||
48981870|NCT04009824|157765570|FG001|Overall Study|COVID-19 pandemic restriction/closure|3|||
48981871|NCT04009824|157765571|FG002|Overall Study|COVID-19 pandemic restriction/closure|5|||
48981872|NCT04009824|157765572|FG003|Overall Study|COVID-19 pandemic restriction/closure|2|||
48981873|NCT04009824|157765573|FG004|Overall Study|COVID-19 pandemic restriction/closure|3|||
48981874|NCT00957034|157765574|FG000|Overall Study|Adverse Event|0|||
48981875|NCT00957034|157765575|FG001|Overall Study|Adverse Event|1|||
48981876|NCT00957034|157765576|FG002|Overall Study|Adverse Event|1|||
48981877|NCT00957034|157765574|FG000|Overall Study|Sponsor Terminated Study|6|||
48766158|NCT00048542|156992463|FG001|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
48766159|NCT00048542|156992464|FG002|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
48766160|NCT00048542|156992465|FG003|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
48766161|NCT00048542|156992466|FG004|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
48766162|NCT00048542|156992467|FG005|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
48766163|NCT00048542|156992468|FG006|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5|||
48766164|NCT00048542|156992469|FG007|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8|||
48766165|NCT01350128|156992470|FG000|Overall Study|Withdrawal by Subject|3|||
48766166|NCT01350128|156992470|FG000|Overall Study|Protocol discontinuation criteria|8|||
48766167|NCT01350128|156992470|FG000|Overall Study|Physician Decision|1|||
48766168|NCT01350128|156992470|FG000|Overall Study|Lost to Follow-up|2|||
48766169|NCT01817725|156992471|FG000|Overall Study|Withdrawal by Subject|1|||
48766170|NCT00314574|156992473|FG000|Overall Study|Death|3|||
48766171|NCT00314574|156992474|FG001|Overall Study|Death|0|||
48766172|NCT00314574|156992473|FG000|Overall Study|Adverse Event|11|||
48766173|NCT00314574|156992474|FG001|Overall Study|Adverse Event|16|||
48766174|NCT00314574|156992473|FG000|Overall Study|Lost to Follow-up|19|||
48766175|NCT00314574|156992474|FG001|Overall Study|Lost to Follow-up|25|||
48766176|NCT00314574|156992473|FG000|Overall Study|Withdrawal by Subject|33|||
48766177|NCT00314574|156992474|FG001|Overall Study|Withdrawal by Subject|22|||
48766178|NCT00314574|156992473|FG000|Overall Study|Physician Decision|22|||
48766179|NCT00314574|156992474|FG001|Overall Study|Physician Decision|15|||
48766180|NCT00314574|156992473|FG000|Overall Study|Pregnancy|6|||
48766181|NCT00314574|156992474|FG001|Overall Study|Pregnancy|4|||
48766182|NCT00314574|156992473|FG000|Overall Study|Data unknown at database lock|0|||
48766183|NCT00314574|156992474|FG001|Overall Study|Data unknown at database lock|1|||
48766184|NCT00006489|156992475|FG000|Overall Study|Adverse Event|3|||
48766185|NCT00006489|156992476|FG001|Overall Study|Adverse Event|2|||
48766186|NCT00006489|156992477|FG002|Overall Study|Adverse Event|4|||
48766187|NCT00006489|156992478|FG003|Overall Study|Adverse Event|3|||
48766188|NCT00006489|156992475|FG000|Overall Study|Withdrawal by Subject|10|||
48766189|NCT00006489|156992476|FG001|Overall Study|Withdrawal by Subject|9|||
48766190|NCT00006489|156992477|FG002|Overall Study|Withdrawal by Subject|9|||
48766191|NCT00006489|156992478|FG003|Overall Study|Withdrawal by Subject|6|||
48766192|NCT00006489|156992475|FG000|Overall Study|Scheduling Conflict|0|||
48766193|NCT00006489|156992476|FG001|Overall Study|Scheduling Conflict|3|||
48766194|NCT00006489|156992477|FG002|Overall Study|Scheduling Conflict|2|||
48766195|NCT00006489|156992478|FG003|Overall Study|Scheduling Conflict|1|||
48766196|NCT00006489|156992475|FG000|Overall Study|Death|0|||
48766197|NCT00006489|156992476|FG001|Overall Study|Death|0|||
48766198|NCT00006489|156992477|FG002|Overall Study|Death|0|||
48766199|NCT00006489|156992478|FG003|Overall Study|Death|1|||
48766200|NCT02086110|156992479|FG000|Overall Study|Withdrawal by Subject|1|||
48766201|NCT02086110|156992480|FG001|Overall Study|Withdrawal by Subject|1|||
48766202|NCT02286193|156992481|FG000|Overall Study|Referred: CRS unable to make contact|62|||
48766203|NCT02286193|156992481|FG000|Overall Study|Referred: unable to reach/resource sent|104|||
48766204|NCT02286193|156992481|FG000|Overall Study|Referred: Declined service|38|||
48766205|NCT01289847|156992482|FG000|Overall Study|Patient could not comply with visits|1|||
48766206|NCT03373383|156992486|FG000|Treatment Period: Wk0-16|Adverse Event|7|||
48766207|NCT03373383|156992487|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
48766208|NCT03373383|156992488|FG002|Treatment Period: Wk0-16|Adverse Event|11|||
48766209|NCT03373383|156992489|FG003|Treatment Period: Wk0-16|Adverse Event|15|||
48766210|NCT03373383|156992490|FG004|Treatment Period: Wk0-16|Adverse Event|21|||
48766211|NCT03373383|156992486|FG000|Treatment Period: Wk0-16|Lack of Efficacy|2|||
48766212|NCT03373383|156992487|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
48766213|NCT03373383|156992488|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
48766214|NCT03373383|156992489|FG003|Treatment Period: Wk0-16|Lack of Efficacy|0|||
48766215|NCT03373383|156992490|FG004|Treatment Period: Wk0-16|Lack of Efficacy|0|||
48766216|NCT03373383|156992486|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
48766217|NCT03373383|156992487|FG001|Treatment Period: Wk0-16|Protocol Violation|4|||
48766218|NCT03373383|156992488|FG002|Treatment Period: Wk0-16|Protocol Violation|2|||
48766219|NCT03373383|156992489|FG003|Treatment Period: Wk0-16|Protocol Violation|1|||
48766220|NCT03373383|156992490|FG004|Treatment Period: Wk0-16|Protocol Violation|0|||
48766221|NCT03373383|156992486|FG000|Treatment Period: Wk0-16|Lost to Follow-up|2|||
48766222|NCT03373383|156992487|FG001|Treatment Period: Wk0-16|Lost to Follow-up|0|||
48766223|NCT03373383|156992488|FG002|Treatment Period: Wk0-16|Lost to Follow-up|0|||
48766224|NCT03373383|156992489|FG003|Treatment Period: Wk0-16|Lost to Follow-up|0|||
48766225|NCT03373383|156992490|FG004|Treatment Period: Wk0-16|Lost to Follow-up|0|||
48981878|NCT00957034|157765575|FG001|Overall Study|Sponsor Terminated Study|1|||
48766226|NCT03373383|156992486|FG000|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
48766227|NCT03373383|156992487|FG001|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
48766228|NCT03373383|156992488|FG002|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
48766229|NCT03373383|156992489|FG003|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
48766230|NCT03373383|156992490|FG004|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
48981879|NCT00957034|157765576|FG002|Overall Study|Sponsor Terminated Study|5|||
48766231|NCT03373383|156992486|FG000|Treatment Period: Wk0-16|As advised by the sponsor|0|||
48766232|NCT03373383|156992487|FG001|Treatment Period: Wk0-16|As advised by the sponsor|1|||
48766233|NCT03373383|156992488|FG002|Treatment Period: Wk0-16|As advised by the sponsor|0|||
48766234|NCT03373383|156992489|FG003|Treatment Period: Wk0-16|As advised by the sponsor|0|||
48766235|NCT03373383|156992490|FG004|Treatment Period: Wk0-16|As advised by the sponsor|0|||
48766236|NCT03373383|156992486|FG000|Treatment Period: Wk0-16|By opinion of investigator|0|||
48766237|NCT03373383|156992487|FG001|Treatment Period: Wk0-16|By opinion of investigator|0|||
48766238|NCT03373383|156992488|FG002|Treatment Period: Wk0-16|By opinion of investigator|0|||
48766239|NCT03373383|156992489|FG003|Treatment Period: Wk0-16|By opinion of investigator|1|||
49025539|NCT02032888|157933045|FG001|Treatment Period|Poor compliance/noncompliance|1|||
49025540|NCT02032888|157933046|FG002|Treatment Period|Poor compliance/noncompliance|0|||
49025541|NCT02032888|157933044|FG000|Treatment Period|Other|1|||
49025542|NCT02032888|157933045|FG001|Treatment Period|Other|1|||
49025543|NCT02032888|157933046|FG002|Treatment Period|Other|0|||
49025544|NCT02032888|157933044|FG000|Follow-up Period|Lost to Follow-up|1|||
48766240|NCT03373383|156992490|FG004|Treatment Period: Wk0-16|By opinion of investigator|0|||
48766241|NCT03373383|156992486|FG000|Treatment Period: Wk0-16|Sponsor decision|0|||
48766242|NCT03373383|156992487|FG001|Treatment Period: Wk0-16|Sponsor decision|0|||
48766243|NCT03373383|156992488|FG002|Treatment Period: Wk0-16|Sponsor decision|0|||
48766244|NCT03373383|156992489|FG003|Treatment Period: Wk0-16|Sponsor decision|1|||
48766245|NCT03373383|156992490|FG004|Treatment Period: Wk0-16|Sponsor decision|0|||
48766246|NCT03373383|156992486|FG000|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1|||
48766247|NCT03373383|156992487|FG001|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
48766248|NCT03373383|156992488|FG002|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
48766249|NCT03373383|156992489|FG003|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
48766250|NCT03373383|156992490|FG004|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
48766251|NCT01498640|156992495|FG000|Overall Study|Lost to Follow-up|1|||
48766252|NCT01498640|156992495|FG000|Overall Study|Death|1|||
48766253|NCT01498640|156992495|FG000|Overall Study|Other|3|||
48766254|NCT00850395|156992500|FG000|Overall Study|Death|1|||
48766255|NCT00850395|156992500|FG000|Overall Study|Adverse Event|1|||
48766256|NCT00850395|156992500|FG000|Overall Study|Insufficient clinical response|3|||
48766257|NCT00850395|156992500|FG000|Overall Study|Other|5|||
48766258|NCT00477672|156992503|FG000|Overall Study|Adverse Event|3|||
48766259|NCT00477672|156992504|FG001|Overall Study|Adverse Event|5|||
48766260|NCT00477672|156992505|FG002|Overall Study|Adverse Event|6|||
48766261|NCT00477672|156992503|FG000|Overall Study|Death|0|||
48766262|NCT00477672|156992504|FG001|Overall Study|Death|1|||
48766263|NCT00477672|156992505|FG002|Overall Study|Death|0|||
48766264|NCT00477672|156992503|FG000|Overall Study|Disease progression|0|||
48766265|NCT00477672|156992504|FG001|Overall Study|Disease progression|1|||
48766266|NCT00477672|156992505|FG002|Overall Study|Disease progression|0|||
48766267|NCT00477672|156992503|FG000|Overall Study|Physician Decision|1|||
48766268|NCT00477672|156992504|FG001|Overall Study|Physician Decision|0|||
48766269|NCT00477672|156992505|FG002|Overall Study|Physician Decision|0|||
48766270|NCT00477672|156992503|FG000|Overall Study|Protocol noncompliance|0|||
48766271|NCT00477672|156992504|FG001|Overall Study|Protocol noncompliance|2|||
48766272|NCT00477672|156992505|FG002|Overall Study|Protocol noncompliance|0|||
48766273|NCT00477672|156992503|FG000|Overall Study|Consent withdrawn|2|||
48766274|NCT00477672|156992504|FG001|Overall Study|Consent withdrawn|5|||
48766275|NCT00477672|156992505|FG002|Overall Study|Consent withdrawn|10|||
48766276|NCT00477672|156992503|FG000|Overall Study|Discretion of Sponsor|1|||
48766277|NCT00477672|156992504|FG001|Overall Study|Discretion of Sponsor|2|||
48766278|NCT00477672|156992505|FG002|Overall Study|Discretion of Sponsor|0|||
48766279|NCT02739269|156992506|FG000|Overall Study|Protocol Violation|5|||
48766280|NCT02739269|156992507|FG001|Overall Study|Protocol Violation|0|||
48766281|NCT02739269|156992506|FG000|Overall Study|Cycle cancellation|2|||
48766282|NCT02739269|156992507|FG001|Overall Study|Cycle cancellation|2|||
48766283|NCT02739269|156992506|FG000|Overall Study|Withdrawal by Subject|0|||
48766284|NCT02739269|156992507|FG001|Overall Study|Withdrawal by Subject|2|||
48766285|NCT02244580|156992508|FG000|Overall Study|No cancer tissues available|241|||
48766286|NCT01736696|156992509|FG000|Overall Study|Withdrawal by Subject|0|||
48766287|NCT01736696|156992510|FG001|Overall Study|Withdrawal by Subject|0|||
48766288|NCT01736696|156992511|FG002|Overall Study|Withdrawal by Subject|1|||
48766289|NCT01736696|156992512|FG003|Overall Study|Withdrawal by Subject|0|||
48766290|NCT01736696|156992513|FG004|Overall Study|Withdrawal by Subject|0|||
48766291|NCT01736696|156992514|FG005|Overall Study|Withdrawal by Subject|0|||
49025545|NCT02032888|157933045|FG001|Follow-up Period|Lost to Follow-up|1|||
48766292|NCT01736696|156992515|FG006|Overall Study|Withdrawal by Subject|0|||
48766293|NCT02114879|156992516|FG000|Overall Study|Withdrawal by Subject|9|||
49025546|NCT02032888|157933046|FG002|Follow-up Period|Lost to Follow-up|0|||
48766294|NCT02114879|156992517|FG001|Overall Study|Withdrawal by Subject|5|||
48766295|NCT02114879|156992516|FG000|Overall Study|Death|6|||
48766296|NCT02114879|156992517|FG001|Overall Study|Death|11|||
48766297|NCT02114879|156992516|FG000|Overall Study|Lost to Follow-up|4|||
48766298|NCT02114879|156992517|FG001|Overall Study|Lost to Follow-up|6|||
48766299|NCT02114879|156992516|FG000|Overall Study|Physician Decision|0|||
48766300|NCT02114879|156992517|FG001|Overall Study|Physician Decision|2|||
48766301|NCT01068509|156992521|FG000|Overall Study|Death|0|||
48766302|NCT01068509|156992522|FG001|Overall Study|Death|0|||
48766303|NCT01068509|156992523|FG002|Overall Study|Death|1|||
48766304|NCT01068509|156992521|FG000|Overall Study|Disease Progression|5|||
48766305|NCT01068509|156992522|FG001|Overall Study|Disease Progression|20|||
48766306|NCT01068509|156992523|FG002|Overall Study|Disease Progression|18|||
48766307|NCT01068509|156992521|FG000|Overall Study|Lost to Follow-up|1|||
48766308|NCT01068509|156992522|FG001|Overall Study|Lost to Follow-up|0|||
48766309|NCT01068509|156992523|FG002|Overall Study|Lost to Follow-up|0|||
48766310|NCT01068509|156992521|FG000|Overall Study|Withdrew Consent|0|||
48766311|NCT01068509|156992522|FG001|Overall Study|Withdrew Consent|1|||
48766312|NCT01068509|156992523|FG002|Overall Study|Withdrew Consent|2|||
48766313|NCT01068509|156992521|FG000|Overall Study|Reason Not Specified|0|||
48766314|NCT01068509|156992522|FG001|Overall Study|Reason Not Specified|1|||
48766315|NCT01068509|156992523|FG002|Overall Study|Reason Not Specified|0|||
48766316|NCT02357940|156992524|FG000|Overall Study|Adverse Event|0|||
48766317|NCT02357940|156992525|FG001|Overall Study|Adverse Event|1|||
48766318|NCT02357940|156992524|FG000|Overall Study|Investigator's judgement|0|||
48766319|NCT02357940|156992525|FG001|Overall Study|Investigator's judgement|1|||
48766320|NCT00788827|156992526|FG000|Overall Study|Lack of Efficacy|2|||
48766321|NCT01644175|156992529|FG000|Overall Study|Randomized But Not Treated|0|||
48766322|NCT01644175|156992530|FG001|Overall Study|Randomized But Not Treated|2|||
48766323|NCT01644175|156992529|FG000|Overall Study|Adverse Event|8|||
48766324|NCT01644175|156992530|FG001|Overall Study|Adverse Event|13|||
48766325|NCT01644175|156992529|FG000|Overall Study|Death|1|||
48766326|NCT01644175|156992530|FG001|Overall Study|Death|2|||
48766327|NCT01644175|156992529|FG000|Overall Study|Poor compliance to protocol|9|||
48766328|NCT01644175|156992530|FG001|Overall Study|Poor compliance to protocol|10|||
48766329|NCT01644175|156992529|FG000|Overall Study|Physician Decision|1|||
48766330|NCT01644175|156992530|FG001|Overall Study|Physician Decision|2|||
48766331|NCT01644175|156992529|FG000|Overall Study|Participant Moved|1|||
49025547|NCT02032888|157933044|FG000|Follow-up Period|Death|1|||
49025548|NCT02032888|157933045|FG001|Follow-up Period|Death|1|||
49025549|NCT02032888|157933046|FG002|Follow-up Period|Death|0|||
49025550|NCT02032888|157933044|FG000|Follow-up Period|Other|1|||
49025551|NCT02032888|157933045|FG001|Follow-up Period|Other|0|||
49025552|NCT02032888|157933046|FG002|Follow-up Period|Other|0|||
49025553|NCT05275205|157933049|FG000|Overall Study|Adverse Event|1|||
49025554|NCT05275205|157933050|FG001|Overall Study|Adverse Event|2|||
49025555|NCT05275205|157933049|FG000|Overall Study|Physician Decision|1|||
49025556|NCT05275205|157933050|FG001|Overall Study|Physician Decision|1|||
49025557|NCT05275205|157933049|FG000|Overall Study|Withdrawal by Subject|2|||
49025558|NCT05275205|157933050|FG001|Overall Study|Withdrawal by Subject|3|||
49025559|NCT05275205|157933049|FG000|Overall Study|Death|1|||
49025560|NCT05275205|157933050|FG001|Overall Study|Death|0|||
49025561|NCT05275205|157933049|FG000|Overall Study|Patient unable to attend visits|1|||
49025562|NCT05275205|157933050|FG001|Overall Study|Patient unable to attend visits|0|||
49025563|NCT00440297|157933051|FG000|Overall Study|Adverse Event|8|||
48766332|NCT01644175|156992530|FG001|Overall Study|Participant Moved|2|||
48766333|NCT01644175|156992529|FG000|Overall Study|Consent withdrawn by participant|3|||
48766334|NCT01644175|156992530|FG001|Overall Study|Consent withdrawn by participant|4|||
48766335|NCT01644175|156992529|FG000|Overall Study|Related to Autoinjector Administration|2|||
48766336|NCT01644175|156992530|FG001|Overall Study|Related to Autoinjector Administration|1|||
48766337|NCT01644175|156992529|FG000|Overall Study|Last visit outside protocol visit window|4|||
48766338|NCT01644175|156992530|FG001|Overall Study|Last visit outside protocol visit window|11|||
48766339|NCT01644175|156992529|FG000|Overall Study|Selection criteria finally not met|0|||
48766340|NCT01644175|156992530|FG001|Overall Study|Selection criteria finally not met|1|||
48766341|NCT01644175|156992529|FG000|Overall Study|Site closure|2|||
48766342|NCT01644175|156992530|FG001|Overall Study|Site closure|2|||
48766343|NCT01644175|156992529|FG000|Overall Study|Lost to Follow-up|1|||
48766344|NCT01644175|156992530|FG001|Overall Study|Lost to Follow-up|0|||
48766345|NCT01644175|156992529|FG000|Overall Study|Other than specified above|0|||
48766346|NCT01644175|156992530|FG001|Overall Study|Other than specified above|3|||
49025564|NCT00440297|157933052|FG001|Overall Study|Adverse Event|5|||
49025565|NCT00440297|157933051|FG000|Overall Study|Lost to Follow-up|1|||
49025566|NCT00440297|157933052|FG001|Overall Study|Lost to Follow-up|0|||
49025567|NCT00440297|157933051|FG000|Overall Study|Physician Decision|1|||
48766347|NCT01838642|156992533|FG000|Overall Study|Died on study|1|||
49025568|NCT00440297|157933052|FG001|Overall Study|Physician Decision|0|||
48766348|NCT00578942|156992536|FG000|Overall Study|Lost to Follow-up|1|||
48766349|NCT00313612|156992537|FG000|Overall Study|Patient never received treatment|0|||
48766350|NCT00313612|156992538|FG001|Overall Study|Patient never received treatment|1|||
48766351|NCT00842348|156992540|FG000|Patients Randomised in Study 726|Did not enter Study 729|59|||
48766352|NCT00842348|156992541|FG001|Patients Randomised in Study 726|Did not enter Study 729|56|||
49025569|NCT00440297|157933051|FG000|Overall Study|Protocol Violation|11|||
48766353|NCT00842348|156992540|FG000|Study 729|Disease progression/death|19|||
48766354|NCT00842348|156992541|FG001|Study 729|Disease progression/death|30|||
48766355|NCT00842348|156992540|FG000|Study 729|Adverse Event|1|||
48766356|NCT00842348|156992541|FG001|Study 729|Adverse Event|1|||
48766357|NCT00842348|156992540|FG000|Study 729|Protocol Violation|1|||
48766358|NCT00842348|156992541|FG001|Study 729|Protocol Violation|1|||
48766359|NCT00842348|156992540|FG000|Study 729|Withdrawal by Subject|2|||
48766360|NCT00842348|156992541|FG001|Study 729|Withdrawal by Subject|4|||
48766361|NCT00842348|156992540|FG000|Study 729|Due to Sponsor stopping the study|1|||
48981880|NCT00957034|157765574|FG000|Overall Study|Withdrawal by Subject|0|||
48981881|NCT00957034|157765575|FG001|Overall Study|Withdrawal by Subject|2|||
48981882|NCT00957034|157765576|FG002|Overall Study|Withdrawal by Subject|0|||
48981883|NCT01326910|157765577|FG000|Overall Study|Withdrawal by Subject|3|||
48981884|NCT01326910|157765578|FG001|Overall Study|Withdrawal by Subject|2|||
48981885|NCT01326910|157765577|FG000|Overall Study|Protocol Violation|1|||
48981886|NCT01326910|157765578|FG001|Overall Study|Protocol Violation|1|||
48981887|NCT03147495|157765579|FG000|Overall Study|Physician Decision|0|||
48981888|NCT03147495|157765580|FG001|Overall Study|Physician Decision|6|||
48981889|NCT01024946|157765581|FG000|Overall Study|Screen Failure|3|||
48981890|NCT01024946|157765581|FG000|Overall Study|Withdrawal by Subject|1|||
48981891|NCT01024946|157765581|FG000|Overall Study|Adverse Event|1|||
48981892|NCT02483611|157765582|FG000|Overall Study|Protocol Violation|0|||
48981893|NCT02483611|157765583|FG001|Overall Study|Protocol Violation|0|||
48981894|NCT02483611|157765584|FG002|Overall Study|Protocol Violation|1|||
48981895|NCT02274766|157765585|FG000|Overall Study|Withdrawal by Subject|3|||
48981896|NCT02274766|157765586|FG001|Overall Study|Withdrawal by Subject|6|||
48981897|NCT02274766|157765585|FG000|Overall Study|Did Not Receive Study Drug|1|||
48981898|NCT02274766|157765586|FG001|Overall Study|Did Not Receive Study Drug|1|||
48981899|NCT02274766|157765585|FG000|Overall Study|Subject Unwilling to Proceed|0|||
48981900|NCT02274766|157765586|FG001|Overall Study|Subject Unwilling to Proceed|1|||
48981901|NCT02274766|157765585|FG000|Overall Study|Adverse Event|0|||
48981902|NCT02274766|157765586|FG001|Overall Study|Adverse Event|1|||
48981903|NCT02607735|157765587|FG000|Primary Study|Randomized but Never Treated|1|||
48981904|NCT02607735|157765588|FG001|Primary Study|Randomized but Never Treated|0|||
48981905|NCT02607735|157765589|FG002|Primary Study|Randomized but Never Treated|0|||
48981906|NCT02607735|157765587|FG000|Primary Study|Lost to Follow-up|4|||
48981907|NCT02607735|157765588|FG001|Primary Study|Lost to Follow-up|0|||
48981908|NCT02607735|157765589|FG002|Primary Study|Lost to Follow-up|0|||
48981909|NCT02607735|157765587|FG000|Primary Study|Withdrew Consent|2|||
48981910|NCT02607735|157765588|FG001|Primary Study|Withdrew Consent|0|||
48981911|NCT02607735|157765589|FG002|Primary Study|Withdrew Consent|0|||
48981912|NCT02607735|157765587|FG000|Deferred Treatment Substudy|Lost to Follow-up|0|||
48981913|NCT02607735|157765588|FG001|Deferred Treatment Substudy|Lost to Follow-up|0|||
48981914|NCT02607735|157765589|FG002|Deferred Treatment Substudy|Lost to Follow-up|4|||
48981915|NCT02607735|157765587|FG000|Deferred Treatment Substudy|Withdrew Consent|0|||
48981916|NCT02607735|157765588|FG001|Deferred Treatment Substudy|Withdrew Consent|0|||
48981917|NCT02607735|157765589|FG002|Deferred Treatment Substudy|Withdrew Consent|1|||
48981918|NCT01222416|157765590|FG000|Overall Study|ineligible;metastasis|3|||
48981919|NCT01222416|157765591|FG001|Overall Study|ineligible;metastasis|0|||
48981920|NCT01222416|157765590|FG000|Overall Study|Adverse Event|4|||
48981921|NCT01222416|157765591|FG001|Overall Study|Adverse Event|0|||
48981922|NCT01222416|157765590|FG000|Overall Study|Withdrawal by Subject|5|||
48981923|NCT01222416|157765591|FG001|Overall Study|Withdrawal by Subject|0|||
48981924|NCT01222416|157765590|FG000|Overall Study|scheduling|6|||
48981925|NCT01222416|157765591|FG001|Overall Study|scheduling|0|||
48981926|NCT01222416|157765590|FG000|Overall Study|missed view/scan|1|||
48981927|NCT01222416|157765591|FG001|Overall Study|missed view/scan|0|||
48981928|NCT01222416|157765590|FG000|Overall Study|Death|1|||
48981929|NCT01222416|157765591|FG001|Overall Study|Death|0|||
48981930|NCT04921969|157765592|FG000|VC Period (Day 1 to Week 8)|Adverse Event|0|||
48981931|NCT04921969|157765593|FG001|VC Period (Day 1 to Week 8)|Adverse Event|1|||
48981932|NCT04921969|157765594|FG002|VC Period (Day 1 to Week 8)|Adverse Event|1|||
48981933|NCT04921969|157765595|FG003|VC Period (Day 1 to Week 8)|Adverse Event|0|||
48981934|NCT04921969|157765596|FG004|VC Period (Day 1 to Week 8)|Adverse Event|0|||
48981935|NCT04921969|157765597|FG005|VC Period (Day 1 to Week 8)|Adverse Event|0|||
48981936|NCT04921969|157765598|FG006|VC Period (Day 1 to Week 8)|Adverse Event|0|||
48981937|NCT04921969|157765592|FG000|VC Period (Day 1 to Week 8)|Lack of Efficacy|2|||
48981938|NCT04921969|157765593|FG001|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
48981939|NCT04921969|157765594|FG002|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
48981940|NCT04921969|157765595|FG003|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
48981941|NCT04921969|157765596|FG004|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
48981942|NCT04921969|157765597|FG005|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
48981943|NCT04921969|157765598|FG006|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
48981944|NCT04921969|157765592|FG000|VC Period (Day 1 to Week 8)|Lost to Follow-up|2|||
48981945|NCT04921969|157765593|FG001|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
48981946|NCT04921969|157765594|FG002|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
48766362|NCT00842348|156992541|FG001|Study 729|Due to Sponsor stopping the study|1|||
48766363|NCT00842348|156992540|FG000|Study 729|Due to non-availability of IP|0|||
48766364|NCT00842348|156992541|FG001|Study 729|Due to non-availability of IP|1|||
48766365|NCT00842348|156992540|FG000|Study 729|Sponsor's decision|1|||
48766366|NCT00842348|156992541|FG001|Study 729|Sponsor's decision|0|||
48766367|NCT00842348|156992540|FG000|Study 729|Surgical resection|1|||
48766368|NCT00842348|156992541|FG001|Study 729|Surgical resection|0|||
48766369|NCT04656132|156992550|FG000|Overall Study|Lost to Follow-up|4|||
48766370|NCT04656132|156992550|FG000|Overall Study|Lost to Follow-Up Prior to Baseline Data Collection|4|||
48766371|NCT02321462|156992554|FG000|Overall Study|Withdrawal by Subject|5|||
48766372|NCT02321462|156992555|FG001|Overall Study|Withdrawal by Subject|2|||
48766373|NCT02321462|156992554|FG000|Overall Study|Subject withdrawn before any treatment|1|||
48766374|NCT02321462|156992555|FG001|Overall Study|Subject withdrawn before any treatment|1|||
48766375|NCT02196324|156992556|FG000|Overall Study|Withdrawal by Subject|8|||
48766376|NCT02196324|156992557|FG001|Overall Study|Withdrawal by Subject|4|||
48766377|NCT02196324|156992556|FG000|Overall Study|Adverse Event or Serious Adverse Event|6|||
48766378|NCT02196324|156992557|FG001|Overall Study|Adverse Event or Serious Adverse Event|3|||
48766379|NCT02196324|156992556|FG000|Overall Study|Occurrence of an Exclusion Criterion|0|||
48766380|NCT02196324|156992557|FG001|Overall Study|Occurrence of an Exclusion Criterion|1|||
48766381|NCT02196324|156992556|FG000|Overall Study|Other|1|||
48766382|NCT02196324|156992557|FG001|Overall Study|Other|0|||
48766383|NCT00692770|156992566|FG000|Overall Study|Protocol Violation|2|||
48766384|NCT00692770|156992567|FG001|Overall Study|Protocol Violation|7|||
48766385|NCT00692770|156992566|FG000|Overall Study|Withdrawal by Subject|97|||
48766386|NCT00692770|156992567|FG001|Overall Study|Withdrawal by Subject|36|||
48766387|NCT00692770|156992566|FG000|Overall Study|Adverse Event|136|||
48766388|NCT00692770|156992567|FG001|Overall Study|Adverse Event|41|||
48766389|NCT00692770|156992566|FG000|Overall Study|Death|10|||
48766390|NCT00692770|156992567|FG001|Overall Study|Death|5|||
48766391|NCT00692770|156992566|FG000|Overall Study|Lost to Follow-up|7|||
48766392|NCT00692770|156992567|FG001|Overall Study|Lost to Follow-up|3|||
48766393|NCT00692770|156992566|FG000|Overall Study|Non-compliant with study medication|11|||
48766394|NCT00692770|156992567|FG001|Overall Study|Non-compliant with study medication|5|||
48766395|NCT00692770|156992566|FG000|Overall Study|Progression by clinical judgment|2|||
48766396|NCT00692770|156992567|FG001|Overall Study|Progression by clinical judgment|3|||
48766397|NCT00692770|156992566|FG000|Overall Study|Physician decision not protocol driven|10|||
48766398|NCT00692770|156992567|FG001|Overall Study|Physician decision not protocol driven|14|||
48766399|NCT00692770|156992566|FG000|Overall Study|Disease progression, recurrence/relapse|170|||
48766400|NCT00692770|156992567|FG001|Overall Study|Disease progression, recurrence/relapse|279|||
48766401|NCT00692770|156992566|FG000|Overall Study|Protocol driven decision point|3|||
48766402|NCT00692770|156992567|FG001|Overall Study|Protocol driven decision point|7|||
48766403|NCT00692770|156992566|FG000|Overall Study|Completed all planned assessments|79|||
48766404|NCT00692770|156992567|FG001|Overall Study|Completed all planned assessments|101|||
48766405|NCT00692770|156992566|FG000|Overall Study|Radiological and clinical progression|8|||
48766406|NCT00692770|156992567|FG001|Overall Study|Radiological and clinical progression|8|||
48766407|NCT00692770|156992566|FG000|Overall Study|Clinical endpoint reached|16|||
48766408|NCT00692770|156992567|FG001|Overall Study|Clinical endpoint reached|43|||
48766409|NCT00692770|156992566|FG000|Overall Study|Study terminated by sponsor|2|||
48766410|NCT00692770|156992567|FG001|Overall Study|Study terminated by sponsor|2|||
48766411|NCT00692770|156992566|FG000|Overall Study|Randomized but not treated|3|||
48766412|NCT00692770|156992567|FG001|Overall Study|Randomized but not treated|4|||
48766413|NCT04248816|156992568|FG000|Overall Study|Ineligible post-randomization|7|||
48766414|NCT04248816|156992569|FG001|Overall Study|Ineligible post-randomization|21|||
48766415|NCT04248816|156992570|FG002|Overall Study|Ineligible post-randomization|25|||
48766416|NCT00660348|156992579|FG000|Overall Study|Withdrawal by Subject|1|||
48766417|NCT00660348|156992580|FG001|Overall Study|Withdrawal by Subject|0|||
48766418|NCT02849548|156992581|FG000|Overall Study|Lost to Follow-up|1|||
48766419|NCT02849548|156992582|FG001|Overall Study|Lost to Follow-up|2|||
48766420|NCT02849548|156992581|FG000|Overall Study|Protocol Violation|1|||
48766421|NCT02849548|156992582|FG001|Overall Study|Protocol Violation|0|||
48766422|NCT01239368|156994671|FG000|Overall Study|Principal investigator discretion|1|||
48766423|NCT01239368|156994672|FG001|Overall Study|Principal investigator discretion|0|||
48766424|NCT01239368|156994673|FG002|Overall Study|Principal investigator discretion|0|||
48766425|NCT01239368|156994674|FG003|Overall Study|Principal investigator discretion|0|||
48766426|NCT01239368|156994675|FG004|Overall Study|Principal investigator discretion|1|||
49025570|NCT00440297|157933052|FG001|Overall Study|Protocol Violation|7|||
48766427|NCT01239368|156994676|FG005|Overall Study|Principal investigator discretion|2|||
48766428|NCT01239368|156994677|FG006|Overall Study|Principal investigator discretion|0|||
48766429|NCT01239368|156994678|FG007|Overall Study|Principal investigator discretion|0|||
48766430|NCT01239368|156994679|FG008|Overall Study|Principal investigator discretion|0|||
48766431|NCT01239368|156994680|FG009|Overall Study|Principal investigator discretion|1|||
48766432|NCT01239368|156994671|FG000|Overall Study|Disease progression on study|1|||
48766433|NCT01239368|156994672|FG001|Overall Study|Disease progression on study|1|||
48766434|NCT01239368|156994673|FG002|Overall Study|Disease progression on study|1|||
48766435|NCT01239368|156994674|FG003|Overall Study|Disease progression on study|1|||
48766436|NCT01239368|156994675|FG004|Overall Study|Disease progression on study|4|||
48766437|NCT01239368|156994676|FG005|Overall Study|Disease progression on study|2|||
48766438|NCT01239368|156994677|FG006|Overall Study|Disease progression on study|5|||
48766439|NCT01239368|156994678|FG007|Overall Study|Disease progression on study|0|||
48766440|NCT01239368|156994679|FG008|Overall Study|Disease progression on study|0|||
48766441|NCT01239368|156994680|FG009|Overall Study|Disease progression on study|2|||
48766442|NCT01239368|156994671|FG000|Overall Study|Refused further treatment|0|||
48766443|NCT01239368|156994672|FG001|Overall Study|Refused further treatment|0|||
48766444|NCT01239368|156994673|FG002|Overall Study|Refused further treatment|0|||
48766445|NCT01239368|156994674|FG003|Overall Study|Refused further treatment|0|||
48766446|NCT01239368|156994675|FG004|Overall Study|Refused further treatment|0|||
48766447|NCT01239368|156994676|FG005|Overall Study|Refused further treatment|0|||
48766448|NCT01239368|156994677|FG006|Overall Study|Refused further treatment|0|||
48766449|NCT01239368|156994678|FG007|Overall Study|Refused further treatment|0|||
48766450|NCT01239368|156994679|FG008|Overall Study|Refused further treatment|0|||
48766451|NCT01239368|156994680|FG009|Overall Study|Refused further treatment|1|||
48766452|NCT01239368|156994671|FG000|Overall Study|Death|0|||
48766453|NCT01239368|156994672|FG001|Overall Study|Death|0|||
48766454|NCT01239368|156994673|FG002|Overall Study|Death|0|||
48766455|NCT01239368|156994674|FG003|Overall Study|Death|0|||
48766456|NCT01239368|156994675|FG004|Overall Study|Death|0|||
48766457|NCT01239368|156994676|FG005|Overall Study|Death|0|||
48766458|NCT01239368|156994677|FG006|Overall Study|Death|1|||
48766459|NCT01239368|156994678|FG007|Overall Study|Death|0|||
48766460|NCT01239368|156994679|FG008|Overall Study|Death|0|||
48766461|NCT01239368|156994680|FG009|Overall Study|Death|0|||
48766462|NCT00670800|156994682|FG000|Overall Study|2 controls were insulin resistant|0|||
48766463|NCT00670800|156994683|FG001|Overall Study|2 controls were insulin resistant|2|||
48766464|NCT02268409|156994686|FG000|Overall Study|Reason for discontinuation not reported by the investigator|2|||
48766465|NCT02268409|156994686|FG000|Overall Study|Death|1|||
48766466|NCT02268409|156994686|FG000|Overall Study|Lost to Follow-up|1|||
48766467|NCT02268409|156994686|FG000|Overall Study|Protocol Violation|3|||
48766468|NCT02268409|156994686|FG000|Overall Study|Participation in study terminated by Sponsor|25|||
48766469|NCT02268409|156994686|FG000|Overall Study|Withdrawal by Subject|5|||
48766470|NCT03026257|156994687|FG000|Overall Study|Adverse Event|3|||
48766471|NCT03026257|156994688|FG001|Overall Study|Adverse Event|0|||
48766472|NCT03026257|156994689|FG002|Overall Study|Adverse Event|0|||
48766473|NCT03026257|156994690|FG003|Overall Study|Adverse Event|0|||
48766474|NCT03026257|156994691|FG004|Overall Study|Adverse Event|0|||
48766475|NCT03026257|156994692|FG005|Overall Study|Adverse Event|0|||
48766476|NCT03026257|156994687|FG000|Overall Study|Lost to Follow-up|1|||
48766477|NCT03026257|156994688|FG001|Overall Study|Lost to Follow-up|0|||
48766478|NCT03026257|156994689|FG002|Overall Study|Lost to Follow-up|0|||
48766479|NCT03026257|156994690|FG003|Overall Study|Lost to Follow-up|0|||
48766480|NCT03026257|156994691|FG004|Overall Study|Lost to Follow-up|0|||
48766481|NCT03026257|156994692|FG005|Overall Study|Lost to Follow-up|0|||
48766482|NCT03026257|156994687|FG000|Overall Study|Protocol Violation|1|||
48766483|NCT03026257|156994688|FG001|Overall Study|Protocol Violation|0|||
48766484|NCT03026257|156994689|FG002|Overall Study|Protocol Violation|0|||
48766485|NCT03026257|156994690|FG003|Overall Study|Protocol Violation|1|||
48766486|NCT03026257|156994691|FG004|Overall Study|Protocol Violation|1|||
48766487|NCT03026257|156994692|FG005|Overall Study|Protocol Violation|0|||
48766488|NCT03026257|156994687|FG000|Overall Study|Withdrawal by Subject|1|||
48766489|NCT03026257|156994688|FG001|Overall Study|Withdrawal by Subject|1|||
48766490|NCT03026257|156994689|FG002|Overall Study|Withdrawal by Subject|0|||
48766491|NCT03026257|156994690|FG003|Overall Study|Withdrawal by Subject|0|||
48766492|NCT03026257|156994691|FG004|Overall Study|Withdrawal by Subject|0|||
48766493|NCT03026257|156994692|FG005|Overall Study|Withdrawal by Subject|0|||
48766494|NCT02181556|156994693|FG000|Overall Study|Withdrawal by Subject|1|||
48766495|NCT01190254|156994694|FG000|Overall Study|Adverse Event|3|||
48766496|NCT01190254|156994695|FG001|Overall Study|Adverse Event|6|||
48766497|NCT01190254|156994696|FG002|Overall Study|Adverse Event|8|||
48766498|NCT01190254|156994694|FG000|Overall Study|Lack of Efficacy|7|||
48766499|NCT01190254|156994695|FG001|Overall Study|Lack of Efficacy|4|||
48766500|NCT01190254|156994696|FG002|Overall Study|Lack of Efficacy|5|||
48766501|NCT01190254|156994694|FG000|Overall Study|Lost to Follow-up|4|||
48766502|NCT01190254|156994695|FG001|Overall Study|Lost to Follow-up|2|||
48766503|NCT01190254|156994696|FG002|Overall Study|Lost to Follow-up|0|||
49025571|NCT00440297|157933051|FG000|Overall Study|Withdrawal by Subject|1|||
48766504|NCT01190254|156994694|FG000|Overall Study|Withdrawal by Subject|4|||
48766505|NCT01190254|156994695|FG001|Overall Study|Withdrawal by Subject|5|||
48766506|NCT01190254|156994696|FG002|Overall Study|Withdrawal by Subject|7|||
48766507|NCT01190254|156994694|FG000|Overall Study|Protocol Violation|2|||
48766508|NCT01190254|156994695|FG001|Overall Study|Protocol Violation|0|||
48766509|NCT01190254|156994696|FG002|Overall Study|Protocol Violation|2|||
48766510|NCT01190254|156994694|FG000|Overall Study|Did not meet protocol eligibility|1|||
48766511|NCT01190254|156994695|FG001|Overall Study|Did not meet protocol eligibility|0|||
48766512|NCT01190254|156994696|FG002|Overall Study|Did not meet protocol eligibility|0|||
48766513|NCT04013191|156994699|FG000|Overall Study|Adverse Event|1|||
48766514|NCT04013191|156994700|FG001|Overall Study|Adverse Event|0|||
48766515|NCT01217060|156994707|FG000|Overall Study|Withdrawal by Subject|1|||
48766516|NCT00136084|156994708|FG000|Overall Study|Death|12|||
48766517|NCT00136084|156994709|FG001|Overall Study|Death|5|||
48766518|NCT00136084|156994708|FG000|Overall Study|Unacceptable toxicity|8|||
48766519|NCT00136084|156994709|FG001|Overall Study|Unacceptable toxicity|11|||
48766520|NCT00136084|156994708|FG000|Overall Study|Relapse|20|||
48766521|NCT00136084|156994709|FG001|Overall Study|Relapse|23|||
48766522|NCT00136084|156994708|FG000|Overall Study|Lost to Follow-up|2|||
48766523|NCT00136084|156994709|FG001|Overall Study|Lost to Follow-up|0|||
48766524|NCT00136084|156994708|FG000|Overall Study|No Response|1|||
48766525|NCT00136084|156994709|FG001|Overall Study|No Response|2|||
48766526|NCT00136084|156994708|FG000|Overall Study|Withdrawal by Subject|5|||
48766527|NCT00136084|156994709|FG001|Overall Study|Withdrawal by Subject|1|||
48766528|NCT00588445|156994710|FG000|Overall Study|Protocol Violation|1|||
48766529|NCT00588445|156994710|FG000|Overall Study|Withdrawal by Subject|3|||
48766530|NCT00588445|156994710|FG000|Overall Study|Disease Progression|1|||
48766531|NCT00588445|156994710|FG000|Overall Study|Not Treated|10|||
48766532|NCT03569371|156994714|FG000|Overall Study|Lack of Efficacy|1|||
48766533|NCT03569371|156994714|FG000|Overall Study|Lost to Follow-up|1|||
48766534|NCT03569371|156994714|FG000|Overall Study|Adverse Event|1|||
48766535|NCT01982253|156994719|FG000|Overall Study|Withdrawal by Subject|1|||
48766536|NCT01982253|156994720|FG001|Overall Study|Withdrawal by Subject|0|||
48766537|NCT01982253|156994721|FG002|Overall Study|Withdrawal by Subject|0|||
48766538|NCT01982253|156994719|FG000|Overall Study|Study terminated by sponsor|1|||
48766539|NCT01982253|156994720|FG001|Overall Study|Study terminated by sponsor|4|||
48766540|NCT01982253|156994721|FG002|Overall Study|Study terminated by sponsor|4|||
48766541|NCT01231581|156994722|FG000|Overall Study|Lost to Follow-up|2|||
48766542|NCT01231581|156994723|FG001|Overall Study|Lost to Follow-up|2|||
48766543|NCT01231581|156994722|FG000|Overall Study|Withdrawal by Subject|6|||
48766544|NCT01231581|156994723|FG001|Overall Study|Withdrawal by Subject|9|||
48766545|NCT01231581|156994722|FG000|Overall Study|Study Closed/Terminated|6|||
48766546|NCT01231581|156994723|FG001|Overall Study|Study Closed/Terminated|5|||
48766547|NCT01231581|156994722|FG000|Overall Study|Death|65|||
48766548|NCT01231581|156994723|FG001|Overall Study|Death|64|||
48766549|NCT01231581|156994722|FG000|Overall Study|Ongoing|1|||
48766550|NCT01231581|156994723|FG001|Overall Study|Ongoing|0|||
48766551|NCT01176292|156994724|FG000|Overall Study|Lost to Follow-up|2|||
48766552|NCT01176292|156994725|FG001|Overall Study|Lost to Follow-up|4|||
48766553|NCT01176292|156994724|FG000|Overall Study|Adverse Event|1|||
48766554|NCT01176292|156994725|FG001|Overall Study|Adverse Event|1|||
48766555|NCT01176292|156994724|FG000|Overall Study|Physician Decision|0|||
48766556|NCT01176292|156994725|FG001|Overall Study|Physician Decision|2|||
48766557|NCT01176292|156994724|FG000|Overall Study|Has not scheduled one-year visit yet|2|||
48766558|NCT01176292|156994725|FG001|Overall Study|Has not scheduled one-year visit yet|2|||
48766559|NCT00913744|156994728|FG000|Overall Study|Adverse Event|2|||
48766560|NCT00913744|156994729|FG001|Overall Study|Adverse Event|0|||
48766561|NCT00913744|156994728|FG000|Overall Study|Withdrawal by Subject|2|||
48766562|NCT00913744|156994729|FG001|Overall Study|Withdrawal by Subject|1|||
48766563|NCT00913744|156994728|FG000|Overall Study|Death|1|||
48766564|NCT00913744|156994729|FG001|Overall Study|Death|0|||
48766565|NCT00380393|156994732|FG000|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6|||
48766566|NCT00380393|156994733|FG001|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5|||
48766567|NCT00380393|156994732|FG000|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0|||
48766568|NCT00380393|156994733|FG001|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1|||
48766569|NCT00380393|156994732|FG000|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37|||
48766570|NCT00380393|156994733|FG001|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29|||
48766571|NCT00380393|156994732|FG000|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
48766572|NCT00380393|156994733|FG001|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
48766573|NCT00380393|156994732|FG000|Month 8 (Cross-sectional Visit)|Others|5|||
48766574|NCT00380393|156994733|FG001|Month 8 (Cross-sectional Visit)|Others|4|||
48766575|NCT00380393|156994732|FG000|Month 14|Withdrawal by Subject|9|||
48766576|NCT00380393|156994733|FG001|Month 14|Withdrawal by Subject|7|||
48766577|NCT00380393|156994732|FG000|Month 14|Death|1|||
48875630|NCT02635386|157381688|FG003|Overall Study|Other medical problems not drug related|1|||
48766578|NCT00380393|156994733|FG001|Month 14|Death|0|||
48766579|NCT00380393|156994732|FG000|Month 14|Lost to Follow-up|0|||
48766580|NCT00380393|156994733|FG001|Month 14|Lost to Follow-up|1|||
48766581|NCT00380393|156994732|FG000|Month 14|Migrated/moved from study area|39|||
48766582|NCT00380393|156994733|FG001|Month 14|Migrated/moved from study area|42|||
48766583|NCT00380393|156994732|FG000|Month 14|Protocol Violation|2|||
48766584|NCT00380393|156994733|FG001|Month 14|Protocol Violation|0|||
48766585|NCT00380393|156994732|FG000|Month 14|Others|6|||
48766586|NCT00380393|156994733|FG001|Month 14|Others|6|||
48766587|NCT02510794|156994734|FG000|Overall Study|Adverse Event|0|||
49025572|NCT00440297|157933052|FG001|Overall Study|Withdrawal by Subject|6|||
49025573|NCT00440297|157933051|FG000|Overall Study|Randomized by mistake|1|||
49025574|NCT00440297|157933052|FG001|Overall Study|Randomized by mistake|0|||
49025575|NCT02024932|157933053|FG000|Overall Study|Adverse Event|2|||
49025576|NCT02024932|157933054|FG001|Overall Study|Adverse Event|3|||
49025577|NCT02024932|157933055|FG002|Overall Study|Adverse Event|0|||
49025578|NCT02024932|157933056|FG003|Overall Study|Adverse Event|0|||
49025579|NCT02024932|157933057|FG004|Overall Study|Adverse Event|2|||
49025580|NCT02024932|157933058|FG005|Overall Study|Adverse Event|0|||
49025581|NCT02024932|157933053|FG000|Overall Study|Abnormal laboratory value|0|||
49025582|NCT02024932|157933054|FG001|Overall Study|Abnormal laboratory value|0|||
49025583|NCT02024932|157933055|FG002|Overall Study|Abnormal laboratory value|0|||
49025584|NCT02024932|157933056|FG003|Overall Study|Abnormal laboratory value|2|||
49025585|NCT02024932|157933057|FG004|Overall Study|Abnormal laboratory value|0|||
49025586|NCT02024932|157933058|FG005|Overall Study|Abnormal laboratory value|0|||
49025587|NCT00096265|157934778|FG000|Overall Study|Ineligible|1|||
49025588|NCT00096265|157934779|FG001|Overall Study|Ineligible|0|||
49025589|NCT00096265|157934780|FG002|Overall Study|Ineligible|0|||
49025590|NCT00863746|157934781|FG000|Treatment|Not treated|4|||
49025591|NCT00863746|157934782|FG001|Treatment|Not treated|2|||
49025592|NCT00863746|157934781|FG000|Treatment|Adverse Event|41|||
49025593|NCT00863746|157934782|FG001|Treatment|Adverse Event|16|||
48766588|NCT02510794|156994735|FG001|Overall Study|Adverse Event|1|||
48875631|NCT02635386|157381689|FG004|Overall Study|Other medical problems not drug related|0|||
48875632|NCT01781832|157381691|FG000|Overall Study|Withdrawal by Subject|1|||
48875633|NCT01266161|157381692|FG000|Overall Study|Ineligible|1|||
48875634|NCT01266161|157381693|FG001|Overall Study|Ineligible|0|||
48875635|NCT01266161|157381692|FG000|Overall Study|Lack of Efficacy|0|||
48875636|NCT01266161|157381693|FG001|Overall Study|Lack of Efficacy|1|||
48875637|NCT01266161|157381692|FG000|Overall Study|Vomited within 4 hours of dosing|3|||
48875638|NCT01266161|157381693|FG001|Overall Study|Vomited within 4 hours of dosing|0|||
48875639|NCT02990468|157381694|FG000|Phase 2: MTD|Change in treatment|0|||
48875640|NCT02990468|157381695|FG001|Phase 2: MTD|Change in treatment|0|||
48875641|NCT02990468|157381696|FG002|Phase 2: MTD|Change in treatment|1|||
48875642|NCT00085566|157381697|FG000|Overall Study|Adverse Event|0|||
48875643|NCT00085566|157381698|FG001|Overall Study|Adverse Event|0|||
48875644|NCT00085566|157381699|FG002|Overall Study|Adverse Event|10|||
48875645|NCT00085566|157381697|FG000|Overall Study|Patient Not treated|0|||
48766589|NCT02510794|156994736|FG002|Overall Study|Adverse Event|0|||
48766590|NCT02510794|156994737|FG003|Overall Study|Adverse Event|0|||
48875646|NCT00085566|157381698|FG001|Overall Study|Patient Not treated|0|||
48875647|NCT00085566|157381699|FG002|Overall Study|Patient Not treated|3|||
48875648|NCT00085566|157381697|FG000|Overall Study|Clinical progression|0|||
48875649|NCT00085566|157381698|FG001|Overall Study|Clinical progression|0|||
48875650|NCT00085566|157381699|FG002|Overall Study|Clinical progression|1|||
48875651|NCT04092452|157381700|FG000|Overall Study|Adverse Event|1|||
48875652|NCT04092452|157381701|FG001|Overall Study|Adverse Event|3|||
49025594|NCT00863746|157934781|FG000|Treatment|non-compliant with study medication|4|||
48766591|NCT02510794|156994734|FG000|Overall Study|Death|1|||
48766592|NCT02510794|156994735|FG001|Overall Study|Death|2|||
48766593|NCT02510794|156994736|FG002|Overall Study|Death|1|||
48766594|NCT02510794|156994737|FG003|Overall Study|Death|1|||
48766595|NCT02510794|156994734|FG000|Overall Study|Lack of Efficacy|3|||
48766596|NCT02510794|156994735|FG001|Overall Study|Lack of Efficacy|1|||
48766597|NCT02510794|156994736|FG002|Overall Study|Lack of Efficacy|1|||
48766598|NCT02510794|156994737|FG003|Overall Study|Lack of Efficacy|0|||
48766599|NCT02510794|156994734|FG000|Overall Study|Participant moved out of the area|0|||
48875653|NCT04092452|157381702|FG002|Overall Study|Adverse Event|3|||
48875654|NCT04092452|157381703|FG003|Overall Study|Adverse Event|7|||
48875655|NCT04092452|157381700|FG000|Overall Study|Lack of Efficacy|1|||
49025595|NCT00863746|157934782|FG001|Treatment|non-compliant with study medication|0|||
49025596|NCT00863746|157934781|FG000|Treatment|Consent withdrawn|15|||
49025597|NCT00863746|157934782|FG001|Treatment|Consent withdrawn|14|||
49025598|NCT00863746|157934781|FG000|Treatment|Lost to Follow-up|1|||
49025599|NCT00863746|157934782|FG001|Treatment|Lost to Follow-up|0|||
49025600|NCT00863746|157934781|FG000|Treatment|Protocol Violation|5|||
49025601|NCT00863746|157934782|FG001|Treatment|Protocol Violation|3|||
48766600|NCT02510794|156994735|FG001|Overall Study|Participant moved out of the area|0|||
49025602|NCT00863746|157934781|FG000|Treatment|Other|1|||
49025603|NCT00863746|157934782|FG001|Treatment|Other|0|||
48766601|NCT02510794|156994736|FG002|Overall Study|Participant moved out of the area|0|||
48875656|NCT04092452|157381701|FG001|Overall Study|Lack of Efficacy|1|||
48875657|NCT04092452|157381702|FG002|Overall Study|Lack of Efficacy|1|||
48875658|NCT04092452|157381703|FG003|Overall Study|Lack of Efficacy|0|||
48875659|NCT04092452|157381700|FG000|Overall Study|Lost to Follow-up|4|||
48875660|NCT04092452|157381701|FG001|Overall Study|Lost to Follow-up|3|||
48875661|NCT04092452|157381702|FG002|Overall Study|Lost to Follow-up|5|||
48875662|NCT04092452|157381703|FG003|Overall Study|Lost to Follow-up|1|||
48875663|NCT04092452|157381700|FG000|Overall Study|Non-Compliance With Study Drug|0|||
49025604|NCT00863746|157934781|FG000|Survival Follow up|Death|244|||
48766602|NCT02510794|156994737|FG003|Overall Study|Participant moved out of the area|1|||
48766603|NCT02510794|156994734|FG000|Overall Study|Physician Decision|3|||
48766604|NCT02510794|156994735|FG001|Overall Study|Physician Decision|0|||
48766605|NCT02510794|156994736|FG002|Overall Study|Physician Decision|0|||
48766606|NCT02510794|156994737|FG003|Overall Study|Physician Decision|0|||
48766607|NCT02510794|156994734|FG000|Overall Study|Protocol Violation|0|||
48766608|NCT02510794|156994735|FG001|Overall Study|Protocol Violation|0|||
48766609|NCT02510794|156994736|FG002|Overall Study|Protocol Violation|1|||
48766610|NCT02510794|156994737|FG003|Overall Study|Protocol Violation|0|||
48766611|NCT02510794|156994734|FG000|Overall Study|Withdrawal by Subject|1|||
48766612|NCT02510794|156994735|FG001|Overall Study|Withdrawal by Subject|2|||
48766613|NCT02510794|156994736|FG002|Overall Study|Withdrawal by Subject|4|||
48766614|NCT02510794|156994737|FG003|Overall Study|Withdrawal by Subject|3|||
48766615|NCT04200248|156994738|FG000|Overall Study|Personal reasons|0|||
48766616|NCT04200248|156994739|FG001|Overall Study|Personal reasons|0|||
48766617|NCT04200248|156994740|FG002|Overall Study|Personal reasons|1|||
48766618|NCT04200248|156994738|FG000|Overall Study|Discontinued prior to treatment|3|||
48766619|NCT04200248|156994739|FG001|Overall Study|Discontinued prior to treatment|3|||
48766620|NCT04200248|156994740|FG002|Overall Study|Discontinued prior to treatment|2|||
48766621|NCT03848845|156994741|FG000|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
48766622|NCT03848845|156994742|FG001|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|1|||
48766623|NCT03848845|156994743|FG002|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
48766624|NCT03848845|156994744|FG003|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
48766625|NCT03848845|156994741|FG000|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
48766626|NCT03848845|156994742|FG001|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
48766627|NCT03848845|156994743|FG002|Main Study Phase (Day 1 to Week 178)|Physician Decision|1|||
48766628|NCT03848845|156994744|FG003|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
48766629|NCT03848845|156994741|FG000|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|3|||
48766630|NCT03848845|156994742|FG001|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|2|||
48766631|NCT03848845|156994743|FG002|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|8|||
48766632|NCT03848845|156994744|FG003|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|0|||
48766633|NCT03848845|156994741|FG000|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
48766634|NCT03848845|156994742|FG001|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
48766635|NCT03848845|156994743|FG002|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
48766636|NCT03848845|156994744|FG003|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|1|||
48766637|NCT01859507|156994745|FG000|Overall Study|left the country|4|||
48766638|NCT04091646|156994746|FG000|Overall Study|Adverse Event|2|||
48766639|NCT04091646|156994747|FG001|Overall Study|Adverse Event|1|||
49025605|NCT00863746|157934782|FG001|Survival Follow up|Death|271|||
49025606|NCT00863746|157934781|FG000|Survival Follow up|Lost to Follow-up|2|||
48766640|NCT04091646|156994746|FG000|Overall Study|Lost to Follow-up|6|||
48766641|NCT04091646|156994747|FG001|Overall Study|Lost to Follow-up|2|||
48766642|NCT04091646|156994746|FG000|Overall Study|Protocol Violation|0|||
48766643|NCT04091646|156994747|FG001|Overall Study|Protocol Violation|1|||
48766644|NCT04091646|156994746|FG000|Overall Study|Withdrawal by Subject|4|||
48766645|NCT04091646|156994747|FG001|Overall Study|Withdrawal by Subject|1|||
48766646|NCT04091646|156994746|FG000|Overall Study|Participant Incarcerated|1|||
48766647|NCT04091646|156994747|FG001|Overall Study|Participant Incarcerated|0|||
48766648|NCT02658890|156994748|FG000|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766649|NCT02658890|156994749|FG001|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766650|NCT02658890|156994750|FG002|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766651|NCT02658890|156994751|FG003|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766652|NCT02658890|156994752|FG004|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766653|NCT02658890|156994753|FG005|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766654|NCT02658890|156994754|FG006|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766655|NCT02658890|156994755|FG007|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766656|NCT02658890|156994756|FG008|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|1|||
48766657|NCT02658890|156994757|FG009|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766658|NCT02658890|156994758|FG010|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766659|NCT02658890|156994759|FG011|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766660|NCT02658890|156994760|FG012|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766661|NCT02658890|156994761|FG013|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766662|NCT02658890|156994762|FG014|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766663|NCT02658890|156994763|FG015|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766664|NCT02658890|156994764|FG016|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766665|NCT02658890|156994765|FG017|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766666|NCT02658890|156994766|FG018|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766667|NCT02658890|156994767|FG019|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766668|NCT02658890|156994768|FG020|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766669|NCT02658890|156994769|FG021|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766670|NCT02658890|156994770|FG022|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766671|NCT02658890|156994771|FG023|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766672|NCT02658890|156994772|FG024|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766673|NCT02658890|156994773|FG025|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766674|NCT02658890|156994774|FG026|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766675|NCT02658890|156994748|FG000|Treatment Phase|Adverse Event|0|||
48875664|NCT04092452|157381701|FG001|Overall Study|Non-Compliance With Study Drug|0|||
48875665|NCT04092452|157381702|FG002|Overall Study|Non-Compliance With Study Drug|1|||
48875666|NCT04092452|157381703|FG003|Overall Study|Non-Compliance With Study Drug|1|||
48875667|NCT04092452|157381700|FG000|Overall Study|Physician Decision|1|||
48875668|NCT04092452|157381701|FG001|Overall Study|Physician Decision|0|||
48875669|NCT04092452|157381702|FG002|Overall Study|Physician Decision|1|||
48875670|NCT04092452|157381703|FG003|Overall Study|Physician Decision|0|||
48766676|NCT02658890|156994749|FG001|Treatment Phase|Adverse Event|1|||
48766677|NCT02658890|156994750|FG002|Treatment Phase|Adverse Event|2|||
48766678|NCT02658890|156994751|FG003|Treatment Phase|Adverse Event|2|||
48766679|NCT02658890|156994752|FG004|Treatment Phase|Adverse Event|1|||
48766680|NCT02658890|156994753|FG005|Treatment Phase|Adverse Event|0|||
48766681|NCT02658890|156994754|FG006|Treatment Phase|Adverse Event|0|||
48766682|NCT02658890|156994755|FG007|Treatment Phase|Adverse Event|2|||
48766683|NCT02658890|156994756|FG008|Treatment Phase|Adverse Event|1|||
48766684|NCT02658890|156994757|FG009|Treatment Phase|Adverse Event|2|||
48766685|NCT02658890|156994758|FG010|Treatment Phase|Adverse Event|3|||
48766686|NCT02658890|156994759|FG011|Treatment Phase|Adverse Event|0|||
48766687|NCT02658890|156994760|FG012|Treatment Phase|Adverse Event|1|||
48766688|NCT02658890|156994761|FG013|Treatment Phase|Adverse Event|4|||
48766689|NCT02658890|156994762|FG014|Treatment Phase|Adverse Event|0|||
48766690|NCT02658890|156994763|FG015|Treatment Phase|Adverse Event|0|||
48766691|NCT02658890|156994764|FG016|Treatment Phase|Adverse Event|0|||
48766692|NCT02658890|156994765|FG017|Treatment Phase|Adverse Event|0|||
48766693|NCT02658890|156994766|FG018|Treatment Phase|Adverse Event|5|||
48766694|NCT02658890|156994767|FG019|Treatment Phase|Adverse Event|1|||
48766695|NCT02658890|156994768|FG020|Treatment Phase|Adverse Event|3|||
48766696|NCT02658890|156994769|FG021|Treatment Phase|Adverse Event|0|||
48766697|NCT02658890|156994770|FG022|Treatment Phase|Adverse Event|5|||
48766698|NCT02658890|156994771|FG023|Treatment Phase|Adverse Event|0|||
48766699|NCT02658890|156994772|FG024|Treatment Phase|Adverse Event|0|||
48766700|NCT02658890|156994773|FG025|Treatment Phase|Adverse Event|2|||
48766701|NCT02658890|156994774|FG026|Treatment Phase|Adverse Event|1|||
48766702|NCT02658890|156994748|FG000|Treatment Phase|Death|0|||
48766703|NCT02658890|156994749|FG001|Treatment Phase|Death|0|||
48766704|NCT02658890|156994750|FG002|Treatment Phase|Death|0|||
48766705|NCT02658890|156994751|FG003|Treatment Phase|Death|0|||
48766706|NCT02658890|156994752|FG004|Treatment Phase|Death|0|||
48766707|NCT02658890|156994753|FG005|Treatment Phase|Death|0|||
48766708|NCT02658890|156994754|FG006|Treatment Phase|Death|0|||
48766709|NCT02658890|156994755|FG007|Treatment Phase|Death|0|||
48766710|NCT02658890|156994756|FG008|Treatment Phase|Death|0|||
48766711|NCT02658890|156994757|FG009|Treatment Phase|Death|0|||
48875671|NCT04092452|157381700|FG000|Overall Study|Pregnancy|2|||
48875672|NCT04092452|157381701|FG001|Overall Study|Pregnancy|0|||
48875673|NCT04092452|157381702|FG002|Overall Study|Pregnancy|0|||
48766712|NCT02658890|156994758|FG010|Treatment Phase|Death|0|||
48766713|NCT02658890|156994759|FG011|Treatment Phase|Death|0|||
48875674|NCT04092452|157381703|FG003|Overall Study|Pregnancy|0|||
48875675|NCT04092452|157381700|FG000|Overall Study|Protocol Deviation|1|||
48766714|NCT02658890|156994760|FG012|Treatment Phase|Death|0|||
48766715|NCT02658890|156994761|FG013|Treatment Phase|Death|0|||
48766716|NCT02658890|156994762|FG014|Treatment Phase|Death|0|||
48766717|NCT02658890|156994763|FG015|Treatment Phase|Death|0|||
48766718|NCT02658890|156994764|FG016|Treatment Phase|Death|0|||
48766719|NCT02658890|156994765|FG017|Treatment Phase|Death|0|||
48766720|NCT02658890|156994766|FG018|Treatment Phase|Death|1|||
48766721|NCT02658890|156994767|FG019|Treatment Phase|Death|0|||
48766722|NCT02658890|156994768|FG020|Treatment Phase|Death|0|||
48766723|NCT02658890|156994769|FG021|Treatment Phase|Death|0|||
48875676|NCT04092452|157381701|FG001|Overall Study|Protocol Deviation|0|||
48981947|NCT04921969|157765595|FG003|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
48766724|NCT02658890|156994770|FG022|Treatment Phase|Death|0|||
48766725|NCT02658890|156994771|FG023|Treatment Phase|Death|0|||
48766726|NCT02658890|156994772|FG024|Treatment Phase|Death|0|||
48766727|NCT02658890|156994773|FG025|Treatment Phase|Death|0|||
48766728|NCT02658890|156994774|FG026|Treatment Phase|Death|0|||
48766729|NCT02658890|156994748|FG000|Treatment Phase|Lost to Follow-up|0|||
48766730|NCT02658890|156994749|FG001|Treatment Phase|Lost to Follow-up|0|||
48766731|NCT02658890|156994750|FG002|Treatment Phase|Lost to Follow-up|0|||
48875677|NCT04092452|157381702|FG002|Overall Study|Protocol Deviation|0|||
48875678|NCT04092452|157381703|FG003|Overall Study|Protocol Deviation|0|||
48875679|NCT04092452|157381700|FG000|Overall Study|Withdrawal by Subject|3|||
48875680|NCT04092452|157381701|FG001|Overall Study|Withdrawal by Subject|10|||
48875681|NCT04092452|157381702|FG002|Overall Study|Withdrawal by Subject|3|||
48875682|NCT04092452|157381703|FG003|Overall Study|Withdrawal by Subject|5|||
48875683|NCT04092452|157381700|FG000|Overall Study|Other|0|||
48875684|NCT04092452|157381701|FG001|Overall Study|Other|0|||
48875685|NCT04092452|157381702|FG002|Overall Study|Other|1|||
48875686|NCT04092452|157381703|FG003|Overall Study|Other|2|||
48875687|NCT00745498|157381704|FG000|Overall Study|Lost to Follow-up|1|||
48875688|NCT00745498|157381705|FG001|Overall Study|Lost to Follow-up|1|||
48875689|NCT00745498|157381706|FG002|Overall Study|Lost to Follow-up|3|||
48875690|NCT00745498|157381704|FG000|Overall Study|Injection of intravitreal silicone oil o|3|||
48875691|NCT00745498|157381705|FG001|Overall Study|Injection of intravitreal silicone oil o|4|||
48875692|NCT00745498|157381706|FG002|Overall Study|Injection of intravitreal silicone oil o|4|||
48875693|NCT00745498|157381704|FG000|Overall Study|Non-PDR related VH|0|||
48875694|NCT00745498|157381705|FG001|Overall Study|Non-PDR related VH|1|||
48875695|NCT00745498|157381706|FG002|Overall Study|Non-PDR related VH|1|||
48875696|NCT00745498|157381704|FG000|Overall Study|Edophthalmitis after preoperative IVB|1|||
48875697|NCT00745498|157381705|FG001|Overall Study|Edophthalmitis after preoperative IVB|0|||
48875698|NCT00745498|157381706|FG002|Overall Study|Edophthalmitis after preoperative IVB|0|||
48875699|NCT03174782|157381707|FG000|Overall Study|Protocol Violation|1|||
48875700|NCT03174782|157381708|FG001|Overall Study|Protocol Violation|0|||
48875701|NCT03174782|157381707|FG000|Overall Study|Unable to perform procedure by medical staff|0|||
48875702|NCT03174782|157381708|FG001|Overall Study|Unable to perform procedure by medical staff|1|||
48875703|NCT03636373|157381718|FG000|Overall Study|Study closure due to Covid-19|1|||
48875704|NCT03636373|157381719|FG001|Overall Study|Study closure due to Covid-19|0|||
48875705|NCT01103232|157381720|FG000|Overall Study|Withdrawal by Subject|1|||
49025607|NCT00863746|157934782|FG001|Survival Follow up|Lost to Follow-up|1|||
48875706|NCT01103232|157381721|FG001|Overall Study|Withdrawal by Subject|1|||
48875707|NCT01103232|157381720|FG000|Overall Study|Protocol Violation|0|||
48875708|NCT01103232|157381721|FG001|Overall Study|Protocol Violation|1|||
48875709|NCT00936598|157381722|FG000|Overall Study|Withdrawal by Subject|1|||
48875710|NCT00936598|157381723|FG001|Overall Study|Withdrawal by Subject|0|||
48875711|NCT00936598|157381722|FG000|Overall Study|Ineligible after consent|1|||
48875712|NCT00936598|157381723|FG001|Overall Study|Ineligible after consent|0|||
48875713|NCT04156399|157383268|FG000|Overall Study|hospitalization unrelated to acupuncture|1|||
48875714|NCT04156399|157383268|FG000|Overall Study|study suspension due to COVID pandemic|3|||
48875715|NCT01929876|157383272|FG000|Period 2|Non-Compliance|1|||
48875716|NCT03616964|157383273|FG000|Overall Study|Adverse Event|15|||
49025608|NCT00863746|157934781|FG000|Survival Follow up|Consent Withdrawn|7|||
49025609|NCT00863746|157934782|FG001|Survival Follow up|Consent Withdrawn|8|||
49025610|NCT02924038|157934783|FG000|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
49025611|NCT02924038|157934784|FG001|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
49025612|NCT03538041|157934788|FG000|12-Week Treatment Period|Adverse Event|1|||
49025613|NCT03538041|157934789|FG001|12-Week Treatment Period|Adverse Event|1|||
49025614|NCT03538041|157934788|FG000|12-Week Treatment Period|Withdrawal by Subject|0|||
49025615|NCT03538041|157934789|FG001|12-Week Treatment Period|Withdrawal by Subject|1|||
49025616|NCT03538041|157934788|FG000|Treatment Extension Period|Adverse Event|4|||
49025617|NCT03538041|157934789|FG001|Treatment Extension Period|Adverse Event|1|||
49025618|NCT03538041|157934788|FG000|Treatment Extension Period|Physician Decision|1|||
49025619|NCT03538041|157934789|FG001|Treatment Extension Period|Physician Decision|1|||
49025620|NCT03538041|157934788|FG000|Treatment Extension Period|Lack of Efficacy|1|||
49025621|NCT03538041|157934789|FG001|Treatment Extension Period|Lack of Efficacy|4|||
49025622|NCT03538041|157934788|FG000|Treatment Extension Period|Transitioned to Rollover Study|1|||
49025623|NCT03538041|157934789|FG001|Treatment Extension Period|Transitioned to Rollover Study|4|||
49025624|NCT03538041|157934788|FG000|Treatment Extension Period|Death|0|||
49025625|NCT03538041|157934789|FG001|Treatment Extension Period|Death|1|||
49025626|NCT03471078|157934790|FG000|Overall Study|Withdrawal by Subject|9|||
49025627|NCT03471078|157934791|FG001|Overall Study|Withdrawal by Subject|1|||
49025628|NCT03471078|157934790|FG000|Overall Study|Adverse Event|4|||
49025629|NCT03471078|157934791|FG001|Overall Study|Adverse Event|1|||
49025630|NCT03471078|157934790|FG000|Overall Study|Physician Decision|3|||
49025631|NCT03471078|157934791|FG001|Overall Study|Physician Decision|2|||
48875717|NCT03616964|157383274|FG001|Overall Study|Adverse Event|10|||
48875718|NCT03616964|157383275|FG002|Overall Study|Adverse Event|16|||
48875719|NCT03616964|157383273|FG000|Overall Study|Death|3|||
48875720|NCT03616964|157383274|FG001|Overall Study|Death|0|||
48875721|NCT03616964|157383275|FG002|Overall Study|Death|4|||
48875722|NCT03616964|157383273|FG000|Overall Study|Lack of Efficacy|4|||
48875723|NCT03616964|157383274|FG001|Overall Study|Lack of Efficacy|8|||
48875724|NCT03616964|157383275|FG002|Overall Study|Lack of Efficacy|8|||
49025632|NCT03471078|157934790|FG000|Overall Study|Death|2|||
49025633|NCT03471078|157934791|FG001|Overall Study|Death|0|||
49025634|NCT03471078|157934790|FG000|Overall Study|Other|3|||
48875725|NCT03616964|157383273|FG000|Overall Study|Lost to Follow-up|2|||
48875726|NCT03616964|157383274|FG001|Overall Study|Lost to Follow-up|1|||
48875727|NCT03616964|157383275|FG002|Overall Study|Lost to Follow-up|3|||
49025635|NCT03471078|157934791|FG001|Overall Study|Other|2|||
49025636|NCT04072380|157934805|FG000|Overall Study|Adverse Event|4|||
49025637|NCT04072380|157934806|FG001|Overall Study|Adverse Event|6|||
49025638|NCT04072380|157934807|FG002|Overall Study|Adverse Event|0|||
49025639|NCT04072380|157934805|FG000|Overall Study|Withdrawal by Subject|3|||
49025640|NCT04072380|157934806|FG001|Overall Study|Withdrawal by Subject|1|||
49025641|NCT04072380|157934807|FG002|Overall Study|Withdrawal by Subject|1|||
49025642|NCT04072380|157934805|FG000|Overall Study|Physician Decision|2|||
49025643|NCT04072380|157934806|FG001|Overall Study|Physician Decision|0|||
49025644|NCT04072380|157934807|FG002|Overall Study|Physician Decision|0|||
49025645|NCT04072380|157934805|FG000|Overall Study|Protocol Violation|0|||
49025646|NCT04072380|157934806|FG001|Overall Study|Protocol Violation|2|||
49025647|NCT04072380|157934807|FG002|Overall Study|Protocol Violation|3|||
49025648|NCT04072380|157934805|FG000|Overall Study|Intercurrent Illness and Others|3|||
49025649|NCT04072380|157934806|FG001|Overall Study|Intercurrent Illness and Others|5|||
49025650|NCT04072380|157934807|FG002|Overall Study|Intercurrent Illness and Others|6|||
49025651|NCT00274937|157934808|FG000|Overall Study|Physician Decision|10|||
49025652|NCT00274937|157934808|FG000|Overall Study|Withdrawal by Subject|6|||
49025653|NCT00274937|157934808|FG000|Overall Study|Progressive Disease|4|||
49025654|NCT00445003|157934812|FG000|Overall Study|Death|1|||
49025655|NCT00445003|157934813|FG001|Overall Study|Death|2|||
49025656|NCT00445003|157934814|FG002|Overall Study|Death|1|||
49025657|NCT00445003|157934812|FG000|Overall Study|Missed Visit|3|||
49025658|NCT00445003|157934813|FG001|Overall Study|Missed Visit|5|||
49025659|NCT00445003|157934814|FG002|Overall Study|Missed Visit|1|||
49025660|NCT00445003|157934812|FG000|Overall Study|Dropped|1|||
49025661|NCT00445003|157934813|FG001|Overall Study|Dropped|3|||
49025662|NCT00445003|157934814|FG002|Overall Study|Dropped|2|||
49025663|NCT02087904|157934815|FG000|Overall Study|Did Not Receive Study Drug|0|||
49025664|NCT02087904|157934816|FG001|Overall Study|Did Not Receive Study Drug|0|||
49025665|NCT02087904|157934817|FG002|Overall Study|Did Not Receive Study Drug|2|||
49025666|NCT02087904|157934818|FG003|Overall Study|Did Not Receive Study Drug|1|||
49025667|NCT02087904|157934815|FG000|Overall Study|Adverse Event|8|||
49025668|NCT02087904|157934816|FG001|Overall Study|Adverse Event|4|||
49025669|NCT02087904|157934817|FG002|Overall Study|Adverse Event|4|||
49025670|NCT02087904|157934818|FG003|Overall Study|Adverse Event|12|||
49025671|NCT02087904|157934815|FG000|Overall Study|Lack of Efficacy|3|||
49025672|NCT02087904|157934816|FG001|Overall Study|Lack of Efficacy|6|||
49025673|NCT02087904|157934817|FG002|Overall Study|Lack of Efficacy|3|||
49025674|NCT02087904|157934818|FG003|Overall Study|Lack of Efficacy|2|||
49025675|NCT02087904|157934815|FG000|Overall Study|Other|6|||
49025676|NCT02087904|157934816|FG001|Overall Study|Other|2|||
49025677|NCT02087904|157934817|FG002|Overall Study|Other|4|||
49025678|NCT02087904|157934818|FG003|Overall Study|Other|4|||
49025679|NCT02087904|157934815|FG000|Overall Study|Withdrawal by Subject|8|||
49025680|NCT02087904|157934816|FG001|Overall Study|Withdrawal by Subject|3|||
49025681|NCT02087904|157934817|FG002|Overall Study|Withdrawal by Subject|7|||
49025682|NCT02087904|157934818|FG003|Overall Study|Withdrawal by Subject|4|||
49025683|NCT02087904|157934815|FG000|Overall Study|Lost to Follow-up|0|||
49025684|NCT02087904|157934816|FG001|Overall Study|Lost to Follow-up|4|||
49025685|NCT02087904|157934817|FG002|Overall Study|Lost to Follow-up|2|||
49025686|NCT02087904|157934818|FG003|Overall Study|Lost to Follow-up|2|||
49025687|NCT03945292|157934819|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
49025688|NCT03945292|157934820|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
49025689|NCT03945292|157934821|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
49025690|NCT03945292|157934822|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
49025691|NCT03945292|157934823|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
49025692|NCT03945292|157934824|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
49025693|NCT03945292|157934825|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
49025694|NCT03945292|157934826|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
49025695|NCT03945292|157934819|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
49025696|NCT03945292|157934820|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
49025697|NCT03945292|157934821|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|1|||
49025698|NCT03945292|157934822|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
49025699|NCT03945292|157934823|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
49025700|NCT03945292|157934824|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
49025701|NCT03945292|157934825|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
49025702|NCT03945292|157934826|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
49025703|NCT03945292|157934819|FG000|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
49025704|NCT03945292|157934820|FG001|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
49025705|NCT03945292|157934821|FG002|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
48875728|NCT03616964|157383273|FG000|Overall Study|Withdrawal by Subject|18|||
49025706|NCT03945292|157934822|FG003|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
49025707|NCT03945292|157934823|FG004|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
49025708|NCT03945292|157934824|FG005|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
48766732|NCT02658890|156994751|FG003|Treatment Phase|Lost to Follow-up|0|||
48766733|NCT02658890|156994752|FG004|Treatment Phase|Lost to Follow-up|0|||
48766734|NCT02658890|156994753|FG005|Treatment Phase|Lost to Follow-up|0|||
48766735|NCT02658890|156994754|FG006|Treatment Phase|Lost to Follow-up|1|||
48766736|NCT02658890|156994755|FG007|Treatment Phase|Lost to Follow-up|0|||
48766737|NCT02658890|156994756|FG008|Treatment Phase|Lost to Follow-up|0|||
48766738|NCT02658890|156994757|FG009|Treatment Phase|Lost to Follow-up|0|||
48766739|NCT02658890|156994758|FG010|Treatment Phase|Lost to Follow-up|0|||
48766740|NCT02658890|156994759|FG011|Treatment Phase|Lost to Follow-up|0|||
48766741|NCT02658890|156994760|FG012|Treatment Phase|Lost to Follow-up|0|||
48766742|NCT02658890|156994761|FG013|Treatment Phase|Lost to Follow-up|0|||
48766743|NCT02658890|156994762|FG014|Treatment Phase|Lost to Follow-up|0|||
48766744|NCT02658890|156994763|FG015|Treatment Phase|Lost to Follow-up|0|||
48766745|NCT02658890|156994764|FG016|Treatment Phase|Lost to Follow-up|0|||
48766746|NCT02658890|156994765|FG017|Treatment Phase|Lost to Follow-up|0|||
48766747|NCT02658890|156994766|FG018|Treatment Phase|Lost to Follow-up|0|||
48766748|NCT02658890|156994767|FG019|Treatment Phase|Lost to Follow-up|0|||
48766749|NCT02658890|156994768|FG020|Treatment Phase|Lost to Follow-up|0|||
48766750|NCT02658890|156994769|FG021|Treatment Phase|Lost to Follow-up|0|||
48766751|NCT02658890|156994770|FG022|Treatment Phase|Lost to Follow-up|0|||
48766752|NCT02658890|156994771|FG023|Treatment Phase|Lost to Follow-up|0|||
48766753|NCT02658890|156994772|FG024|Treatment Phase|Lost to Follow-up|0|||
48766754|NCT02658890|156994773|FG025|Treatment Phase|Lost to Follow-up|0|||
48766755|NCT02658890|156994774|FG026|Treatment Phase|Lost to Follow-up|0|||
48875729|NCT03616964|157383274|FG001|Overall Study|Withdrawal by Subject|14|||
48875730|NCT03616964|157383275|FG002|Overall Study|Withdrawal by Subject|21|||
48875731|NCT03616964|157383273|FG000|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
48875732|NCT03616964|157383274|FG001|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
48875733|NCT03616964|157383275|FG002|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
48875734|NCT03616964|157383273|FG000|Overall Study|Sponsor's Decision|1|||
48875735|NCT03616964|157383274|FG001|Overall Study|Sponsor's Decision|0|||
48875736|NCT03616964|157383275|FG002|Overall Study|Sponsor's Decision|0|||
48875737|NCT03616964|157383273|FG000|Overall Study|Physician Decision|0|||
48875738|NCT03616964|157383274|FG001|Overall Study|Physician Decision|2|||
48875739|NCT03616964|157383275|FG002|Overall Study|Physician Decision|0|||
48875740|NCT03616964|157383273|FG000|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
48875741|NCT03616964|157383274|FG001|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|1|||
48875742|NCT03616964|157383275|FG002|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
48875743|NCT03616964|157383273|FG000|Overall Study|Protocol Violation|0|||
48875744|NCT03616964|157383274|FG001|Overall Study|Protocol Violation|1|||
48875745|NCT03616964|157383275|FG002|Overall Study|Protocol Violation|0|||
48875746|NCT03616964|157383273|FG000|Overall Study|Due to Epidemic/Pandemic|0|||
48875747|NCT03616964|157383274|FG001|Overall Study|Due to Epidemic/Pandemic|1|||
48875748|NCT03616964|157383275|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
48875749|NCT03616964|157383273|FG000|Overall Study|Randomized but Never Treated|1|||
48875750|NCT03616964|157383274|FG001|Overall Study|Randomized but Never Treated|1|||
48875751|NCT03616964|157383275|FG002|Overall Study|Randomized but Never Treated|1|||
48875752|NCT01266018|157383277|FG000|Overall Study|Physician Decision|1|||
48875753|NCT01266018|157383278|FG001|Overall Study|Physician Decision|0|||
48875754|NCT01266018|157383277|FG000|Overall Study|Progressive disease|0|||
48875755|NCT01266018|157383278|FG001|Overall Study|Progressive disease|1|||
48875756|NCT02684123|157383279|FG000|Phase 1|Lack of Efficacy|5|||
48875757|NCT02684123|157383280|FG001|Phase 1|Lack of Efficacy|0|||
48875758|NCT02684123|157383279|FG000|Phase 1|Adverse Event|3|||
48875759|NCT02684123|157383280|FG001|Phase 1|Adverse Event|0|||
48875760|NCT02684123|157383279|FG000|Phase 1|Lost to Follow-up|0|||
48875761|NCT02684123|157383280|FG001|Phase 1|Lost to Follow-up|1|||
48875762|NCT02684123|157383279|FG000|Phase 2|Lack of Efficacy|1|||
48875763|NCT02684123|157383280|FG001|Phase 2|Lack of Efficacy|8|||
48875764|NCT00966979|157383281|FG000|Overall Study|Death|1|||
48875765|NCT00966979|157383281|FG000|Overall Study|Lost to Follow-up|6|||
48875766|NCT00966979|157383281|FG000|Overall Study|Withdrawal by Subject|14|||
48875767|NCT00966979|157383281|FG000|Overall Study|Adverse Event|5|||
48875768|NCT00966979|157383281|FG000|Overall Study|Sponsor terminated early|49|||
48875769|NCT00966979|157383281|FG000|Overall Study|Censored because surgery not done|2|||
48875770|NCT00966979|157383281|FG000|Overall Study|Censored because study device was not implanted|14|||
48875771|NCT00966979|157383281|FG000|Overall Study|Censored because of Inclusion/exclusion violation|7|||
48875772|NCT00511836|157383282|FG000|Double-blind Period|Lost to Follow-up|1|||
48766756|NCT02658890|156994748|FG000|Treatment Phase|Maximum Clinical Benefit|0|||
48875773|NCT00511836|157383283|FG001|Double-blind Period|Lost to Follow-up|0|||
48766757|NCT02658890|156994749|FG001|Treatment Phase|Maximum Clinical Benefit|0|||
48766758|NCT02658890|156994750|FG002|Treatment Phase|Maximum Clinical Benefit|0|||
48766759|NCT02658890|156994751|FG003|Treatment Phase|Maximum Clinical Benefit|0|||
48766760|NCT02658890|156994752|FG004|Treatment Phase|Maximum Clinical Benefit|0|||
48766761|NCT02658890|156994753|FG005|Treatment Phase|Maximum Clinical Benefit|0|||
48875774|NCT00030823|157383284|FG000|Overall Study|Withdrawal by Subject|1|||
48875775|NCT00891046|157383292|FG000|Overall Study|Protocol Violation|1|||
49025709|NCT03945292|157934825|FG006|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
49025710|NCT03945292|157934826|FG007|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|1|||
49025711|NCT01572948|157934828|FG000|Overall Study|Lost to Follow-up|1|||
49025712|NCT01572948|157934829|FG001|Overall Study|Lost to Follow-up|0|||
48766762|NCT02658890|156994754|FG006|Treatment Phase|Maximum Clinical Benefit|0|||
48766763|NCT02658890|156994755|FG007|Treatment Phase|Maximum Clinical Benefit|0|||
48766764|NCT02658890|156994756|FG008|Treatment Phase|Maximum Clinical Benefit|0|||
48766765|NCT02658890|156994757|FG009|Treatment Phase|Maximum Clinical Benefit|0|||
48766766|NCT02658890|156994758|FG010|Treatment Phase|Maximum Clinical Benefit|0|||
48766767|NCT02658890|156994759|FG011|Treatment Phase|Maximum Clinical Benefit|0|||
48766768|NCT02658890|156994760|FG012|Treatment Phase|Maximum Clinical Benefit|0|||
48766769|NCT02658890|156994761|FG013|Treatment Phase|Maximum Clinical Benefit|1|||
48766770|NCT02658890|156994762|FG014|Treatment Phase|Maximum Clinical Benefit|0|||
48766771|NCT02658890|156994763|FG015|Treatment Phase|Maximum Clinical Benefit|0|||
48766772|NCT02658890|156994764|FG016|Treatment Phase|Maximum Clinical Benefit|0|||
48766773|NCT02658890|156994765|FG017|Treatment Phase|Maximum Clinical Benefit|0|||
48766774|NCT02658890|156994766|FG018|Treatment Phase|Maximum Clinical Benefit|1|||
48766775|NCT02658890|156994767|FG019|Treatment Phase|Maximum Clinical Benefit|0|||
49025713|NCT01572948|157934828|FG000|Overall Study|unable to contact|0|||
49025714|NCT01572948|157934829|FG001|Overall Study|unable to contact|1|||
49025715|NCT00893464|157934831|FG000|Overall Study|Did not complete therapy/experience PD|0|||
49025716|NCT00893464|157934832|FG001|Overall Study|Did not complete therapy/experience PD|0|||
49025717|NCT00893464|157934833|FG002|Overall Study|Did not complete therapy/experience PD|0|||
49025718|NCT00893464|157934834|FG003|Overall Study|Did not complete therapy/experience PD|0|||
49025719|NCT00893464|157934835|FG004|Overall Study|Did not complete therapy/experience PD|0|||
49025720|NCT00893464|157934836|FG005|Overall Study|Did not complete therapy/experience PD|0|||
49025721|NCT00893464|157934837|FG006|Overall Study|Did not complete therapy/experience PD|2|||
49025722|NCT00893464|157934838|FG007|Overall Study|Did not complete therapy/experience PD|2|||
49025723|NCT03560609|157934839|FG000|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|3|||
49025724|NCT03560609|157934840|FG001|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|0|||
49025725|NCT00486837|157934843|FG000|Overall Study|Withdrawal by Subject|1|||
49025726|NCT00486837|157934844|FG001|Overall Study|Withdrawal by Subject|0|||
49025727|NCT00486837|157934843|FG000|Overall Study|Adverse Event|1|||
49025728|NCT00486837|157934844|FG001|Overall Study|Adverse Event|1|||
49025729|NCT00486837|157934843|FG000|Overall Study|Protocol Violation|4|||
49025730|NCT00486837|157934844|FG001|Overall Study|Protocol Violation|2|||
48766776|NCT02658890|156994768|FG020|Treatment Phase|Maximum Clinical Benefit|0|||
48766777|NCT02658890|156994769|FG021|Treatment Phase|Maximum Clinical Benefit|0|||
48766778|NCT02658890|156994770|FG022|Treatment Phase|Maximum Clinical Benefit|2|||
48766779|NCT02658890|156994771|FG023|Treatment Phase|Maximum Clinical Benefit|0|||
48766780|NCT02658890|156994772|FG024|Treatment Phase|Maximum Clinical Benefit|0|||
48766781|NCT02658890|156994773|FG025|Treatment Phase|Maximum Clinical Benefit|0|||
48766782|NCT02658890|156994774|FG026|Treatment Phase|Maximum Clinical Benefit|0|||
48766783|NCT02658890|156994748|FG000|Treatment Phase|Non-compliance With Study Drug|0|||
48766784|NCT02658890|156994749|FG001|Treatment Phase|Non-compliance With Study Drug|0|||
48766785|NCT02658890|156994750|FG002|Treatment Phase|Non-compliance With Study Drug|1|||
48766786|NCT02658890|156994751|FG003|Treatment Phase|Non-compliance With Study Drug|0|||
48766787|NCT02658890|156994752|FG004|Treatment Phase|Non-compliance With Study Drug|0|||
48766788|NCT02658890|156994753|FG005|Treatment Phase|Non-compliance With Study Drug|0|||
48766789|NCT02658890|156994754|FG006|Treatment Phase|Non-compliance With Study Drug|0|||
48766790|NCT02658890|156994755|FG007|Treatment Phase|Non-compliance With Study Drug|0|||
48766791|NCT02658890|156994756|FG008|Treatment Phase|Non-compliance With Study Drug|0|||
48766792|NCT02658890|156994757|FG009|Treatment Phase|Non-compliance With Study Drug|0|||
48766793|NCT02658890|156994758|FG010|Treatment Phase|Non-compliance With Study Drug|0|||
48766794|NCT02658890|156994759|FG011|Treatment Phase|Non-compliance With Study Drug|0|||
48766795|NCT02658890|156994760|FG012|Treatment Phase|Non-compliance With Study Drug|0|||
48766796|NCT02658890|156994761|FG013|Treatment Phase|Non-compliance With Study Drug|0|||
48766797|NCT02658890|156994762|FG014|Treatment Phase|Non-compliance With Study Drug|0|||
48766798|NCT02658890|156994763|FG015|Treatment Phase|Non-compliance With Study Drug|0|||
48766799|NCT02658890|156994764|FG016|Treatment Phase|Non-compliance With Study Drug|0|||
48766800|NCT02658890|156994765|FG017|Treatment Phase|Non-compliance With Study Drug|0|||
48766801|NCT02658890|156994766|FG018|Treatment Phase|Non-compliance With Study Drug|1|||
48766802|NCT02658890|156994767|FG019|Treatment Phase|Non-compliance With Study Drug|0|||
48766803|NCT02658890|156994768|FG020|Treatment Phase|Non-compliance With Study Drug|0|||
48766804|NCT02658890|156994769|FG021|Treatment Phase|Non-compliance With Study Drug|0|||
48766805|NCT02658890|156994770|FG022|Treatment Phase|Non-compliance With Study Drug|0|||
48766806|NCT02658890|156994771|FG023|Treatment Phase|Non-compliance With Study Drug|0|||
48766807|NCT02658890|156994772|FG024|Treatment Phase|Non-compliance With Study Drug|0|||
49025731|NCT00486837|157934843|FG000|Overall Study|No sputum, devise issues, exacerbation|3|||
49025732|NCT00486837|157934844|FG001|Overall Study|No sputum, devise issues, exacerbation|4|||
49025733|NCT00874237|157934845|FG000|Overall Study|Physician Decision|0|||
48875776|NCT00891046|157383293|FG001|Overall Study|Protocol Violation|1|||
48875777|NCT00891046|157383294|FG002|Overall Study|Protocol Violation|0|||
48875778|NCT00891046|157383295|FG003|Overall Study|Protocol Violation|0|||
48875779|NCT00891046|157383296|FG004|Overall Study|Protocol Violation|1|||
48875780|NCT00891046|157383292|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
48875781|NCT00891046|157383293|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
48875782|NCT00891046|157383294|FG002|Overall Study|Unsatisfactory therapeutic effect|19|||
48875783|NCT00891046|157383295|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
48875784|NCT00891046|157383296|FG004|Overall Study|Unsatisfactory therapeutic effect|20|||
48875785|NCT00891046|157383292|FG000|Overall Study|Administrative problems|0|||
48875786|NCT00891046|157383293|FG001|Overall Study|Administrative problems|0|||
48875787|NCT00891046|157383294|FG002|Overall Study|Administrative problems|0|||
48875788|NCT00891046|157383295|FG003|Overall Study|Administrative problems|0|||
48875789|NCT00891046|157383296|FG004|Overall Study|Administrative problems|1|||
48875790|NCT00891046|157383292|FG000|Overall Study|Participant no longer required drug|0|||
48875791|NCT00891046|157383293|FG001|Overall Study|Participant no longer required drug|2|||
48875792|NCT00891046|157383294|FG002|Overall Study|Participant no longer required drug|0|||
48875793|NCT00891046|157383295|FG003|Overall Study|Participant no longer required drug|0|||
48875794|NCT00891046|157383296|FG004|Overall Study|Participant no longer required drug|1|||
48875795|NCT00891046|157383292|FG000|Overall Study|Adverse Event|4|||
48875796|NCT00891046|157383293|FG001|Overall Study|Adverse Event|3|||
48875797|NCT00891046|157383294|FG002|Overall Study|Adverse Event|2|||
48875798|NCT00891046|157383295|FG003|Overall Study|Adverse Event|0|||
48875799|NCT00891046|157383296|FG004|Overall Study|Adverse Event|14|||
48875800|NCT00891046|157383292|FG000|Overall Study|Withdrawal by Subject|2|||
48875801|NCT00891046|157383293|FG001|Overall Study|Withdrawal by Subject|1|||
48875802|NCT00891046|157383294|FG002|Overall Study|Withdrawal by Subject|2|||
48875803|NCT00891046|157383295|FG003|Overall Study|Withdrawal by Subject|1|||
48875804|NCT00891046|157383296|FG004|Overall Study|Withdrawal by Subject|1|||
48875805|NCT00891046|157383292|FG000|Overall Study|Lost to Follow-up|0|||
48875806|NCT00891046|157383293|FG001|Overall Study|Lost to Follow-up|0|||
48875807|NCT00891046|157383294|FG002|Overall Study|Lost to Follow-up|0|||
48875808|NCT00891046|157383295|FG003|Overall Study|Lost to Follow-up|0|||
48875809|NCT00891046|157383296|FG004|Overall Study|Lost to Follow-up|1|||
48875810|NCT01606319|157383297|FG000|Overall Study|Lost to Follow-up|17|||
49025734|NCT00874237|157934846|FG001|Overall Study|Physician Decision|1|||
49025735|NCT00874237|157934847|FG002|Overall Study|Physician Decision|0|||
49025736|NCT00874237|157934848|FG003|Overall Study|Physician Decision|0|||
49025737|NCT00874237|157934849|FG004|Overall Study|Physician Decision|0|||
49025738|NCT00874237|157934850|FG005|Overall Study|Physician Decision|0|||
49025739|NCT00874237|157934845|FG000|Overall Study|Withdrawal by Subject|0|||
49025740|NCT00874237|157934846|FG001|Overall Study|Withdrawal by Subject|0|||
49025741|NCT00874237|157934847|FG002|Overall Study|Withdrawal by Subject|1|||
49025742|NCT00874237|157934848|FG003|Overall Study|Withdrawal by Subject|0|||
49025743|NCT00874237|157934849|FG004|Overall Study|Withdrawal by Subject|0|||
49025744|NCT00874237|157934850|FG005|Overall Study|Withdrawal by Subject|0|||
49025745|NCT02728102|157934855|FG000|Overall Study|Death|3|||
49025746|NCT02728102|157934856|FG001|Overall Study|Death|0|||
48766808|NCT02658890|156994773|FG025|Treatment Phase|Non-compliance With Study Drug|0|||
48766809|NCT02658890|156994774|FG026|Treatment Phase|Non-compliance With Study Drug|0|||
48766810|NCT02658890|156994748|FG000|Treatment Phase|Other Reasons|0|||
48766811|NCT02658890|156994749|FG001|Treatment Phase|Other Reasons|0|||
48766812|NCT02658890|156994750|FG002|Treatment Phase|Other Reasons|0|||
48766813|NCT02658890|156994751|FG003|Treatment Phase|Other Reasons|0|||
48766814|NCT02658890|156994752|FG004|Treatment Phase|Other Reasons|0|||
48766815|NCT02658890|156994753|FG005|Treatment Phase|Other Reasons|0|||
48766816|NCT02658890|156994754|FG006|Treatment Phase|Other Reasons|1|||
48766817|NCT02658890|156994755|FG007|Treatment Phase|Other Reasons|0|||
48766818|NCT02658890|156994756|FG008|Treatment Phase|Other Reasons|1|||
48766819|NCT02658890|156994757|FG009|Treatment Phase|Other Reasons|0|||
48766820|NCT02658890|156994758|FG010|Treatment Phase|Other Reasons|0|||
48766821|NCT02658890|156994759|FG011|Treatment Phase|Other Reasons|0|||
48766822|NCT02658890|156994760|FG012|Treatment Phase|Other Reasons|0|||
48875811|NCT01606319|157383298|FG001|Overall Study|Lost to Follow-up|14|||
48875812|NCT01606319|157383297|FG000|Overall Study|Withdrawal by Subject|9|||
48875813|NCT01606319|157383298|FG001|Overall Study|Withdrawal by Subject|12|||
48766823|NCT02658890|156994761|FG013|Treatment Phase|Other Reasons|2|||
48766824|NCT02658890|156994762|FG014|Treatment Phase|Other Reasons|0|||
48875814|NCT01606319|157383297|FG000|Overall Study|Physician Decision|1|||
49025747|NCT02728102|157934857|FG002|Overall Study|Death|1|||
49025748|NCT02728102|157934855|FG000|Overall Study|Withdrawal by Subject|0|||
49025749|NCT02728102|157934856|FG001|Overall Study|Withdrawal by Subject|2|||
48766825|NCT02658890|156994763|FG015|Treatment Phase|Other Reasons|0|||
48766826|NCT02658890|156994764|FG016|Treatment Phase|Other Reasons|0|||
48766827|NCT02658890|156994765|FG017|Treatment Phase|Other Reasons|0|||
48766828|NCT02658890|156994766|FG018|Treatment Phase|Other Reasons|1|||
48766829|NCT02658890|156994767|FG019|Treatment Phase|Other Reasons|0|||
48875815|NCT01606319|157383298|FG001|Overall Study|Physician Decision|2|||
48766830|NCT02658890|156994768|FG020|Treatment Phase|Other Reasons|0|||
48766831|NCT02658890|156994769|FG021|Treatment Phase|Other Reasons|0|||
48766832|NCT02658890|156994770|FG022|Treatment Phase|Other Reasons|0|||
48766833|NCT02658890|156994771|FG023|Treatment Phase|Other Reasons|0|||
48766834|NCT02658890|156994772|FG024|Treatment Phase|Other Reasons|1|||
48766835|NCT02658890|156994773|FG025|Treatment Phase|Other Reasons|0|||
48766836|NCT02658890|156994774|FG026|Treatment Phase|Other Reasons|1|||
48766837|NCT02658890|156994748|FG000|Treatment Phase|Progressive Disease|6|||
49025750|NCT02728102|157934857|FG002|Overall Study|Withdrawal by Subject|3|||
49025751|NCT02728102|157934855|FG000|Overall Study|Physician Decision|1|||
49025752|NCT02728102|157934856|FG001|Overall Study|Physician Decision|1|||
49025753|NCT02728102|157934857|FG002|Overall Study|Physician Decision|0|||
49025754|NCT02728102|157934855|FG000|Overall Study|Investigational study drug permanently discontinued|3|||
49025755|NCT02728102|157934856|FG001|Overall Study|Investigational study drug permanently discontinued|1|||
49025756|NCT02728102|157934857|FG002|Overall Study|Investigational study drug permanently discontinued|0|||
49025757|NCT02728102|157934855|FG000|Overall Study|Covid|0|||
49025758|NCT02728102|157934856|FG001|Overall Study|Covid|0|||
49025759|NCT02728102|157934857|FG002|Overall Study|Covid|1|||
49025760|NCT04869787|157934858|FG000|Screening|Physician Decision|1|||
49025761|NCT04869787|157934858|FG000|SCD Treatment Period (up to 10 Days)|Death|1|||
49025762|NCT00877032|157934860|FG000|Overall Study|Did not meet entrance criteria|0|||
49025763|NCT00877032|157934861|FG001|Overall Study|Did not meet entrance criteria|0|||
49025764|NCT00877032|157934862|FG002|Overall Study|Did not meet entrance criteria|0|||
49025765|NCT00877032|157934863|FG003|Overall Study|Did not meet entrance criteria|1|||
49025766|NCT00877032|157934864|FG004|Overall Study|Did not meet entrance criteria|0|||
49025767|NCT00877032|157934865|FG005|Overall Study|Did not meet entrance criteria|0|||
49025768|NCT00877032|157934866|FG006|Overall Study|Did not meet entrance criteria|2|||
48766838|NCT02658890|156994749|FG001|Treatment Phase|Progressive Disease|7|||
48766839|NCT02658890|156994750|FG002|Treatment Phase|Progressive Disease|6|||
48766840|NCT02658890|156994751|FG003|Treatment Phase|Progressive Disease|12|||
48766841|NCT02658890|156994752|FG004|Treatment Phase|Progressive Disease|6|||
48766842|NCT02658890|156994753|FG005|Treatment Phase|Progressive Disease|18|||
48766843|NCT02658890|156994754|FG006|Treatment Phase|Progressive Disease|12|||
48766844|NCT02658890|156994755|FG007|Treatment Phase|Progressive Disease|19|||
48766845|NCT02658890|156994756|FG008|Treatment Phase|Progressive Disease|26|||
48766846|NCT02658890|156994757|FG009|Treatment Phase|Progressive Disease|8|||
48766847|NCT02658890|156994758|FG010|Treatment Phase|Progressive Disease|7|||
48766848|NCT02658890|156994759|FG011|Treatment Phase|Progressive Disease|9|||
48766849|NCT02658890|156994760|FG012|Treatment Phase|Progressive Disease|8|||
48766850|NCT02658890|156994761|FG013|Treatment Phase|Progressive Disease|29|||
48766851|NCT02658890|156994762|FG014|Treatment Phase|Progressive Disease|6|||
49025795|NCT04585789|157934870|FG000|Overall Study|Withdrawal by Subject|1|||
49025796|NCT04585789|157934871|FG001|Overall Study|Withdrawal by Subject|0|||
49025797|NCT04585789|157934870|FG000|Overall Study|Ongoing|9|||
49025798|NCT04585789|157934871|FG001|Overall Study|Ongoing|10|||
49025799|NCT02601313|157934876|FG000|Overall Study|Death|2|||
49025800|NCT02601313|157934877|FG001|Overall Study|Death|41|||
48766852|NCT02658890|156994763|FG015|Treatment Phase|Progressive Disease|2|||
48766853|NCT02658890|156994764|FG016|Treatment Phase|Progressive Disease|32|||
48766854|NCT02658890|156994765|FG017|Treatment Phase|Progressive Disease|14|||
48766855|NCT02658890|156994766|FG018|Treatment Phase|Progressive Disease|40|||
48766856|NCT02658890|156994767|FG019|Treatment Phase|Progressive Disease|32|||
48766857|NCT02658890|156994768|FG020|Treatment Phase|Progressive Disease|19|||
48766858|NCT02658890|156994769|FG021|Treatment Phase|Progressive Disease|30|||
48766859|NCT02658890|156994770|FG022|Treatment Phase|Progressive Disease|15|||
48766860|NCT02658890|156994771|FG023|Treatment Phase|Progressive Disease|0|||
48766861|NCT02658890|156994772|FG024|Treatment Phase|Progressive Disease|0|||
48766862|NCT02658890|156994773|FG025|Treatment Phase|Progressive Disease|14|||
48766863|NCT02658890|156994774|FG026|Treatment Phase|Progressive Disease|11|||
48766864|NCT02658890|156994748|FG000|Treatment Phase|Study Drug Toxicity|0|||
48766865|NCT02658890|156994749|FG001|Treatment Phase|Study Drug Toxicity|0|||
48766866|NCT02658890|156994750|FG002|Treatment Phase|Study Drug Toxicity|2|||
48766867|NCT02658890|156994751|FG003|Treatment Phase|Study Drug Toxicity|0|||
48766868|NCT02658890|156994752|FG004|Treatment Phase|Study Drug Toxicity|0|||
48766869|NCT02658890|156994753|FG005|Treatment Phase|Study Drug Toxicity|0|||
48766870|NCT02658890|156994754|FG006|Treatment Phase|Study Drug Toxicity|0|||
48766871|NCT02658890|156994755|FG007|Treatment Phase|Study Drug Toxicity|0|||
48766872|NCT02658890|156994756|FG008|Treatment Phase|Study Drug Toxicity|3|||
48766873|NCT02658890|156994757|FG009|Treatment Phase|Study Drug Toxicity|0|||
49025801|NCT02601313|157934878|FG002|Overall Study|Death|6|||
49025802|NCT02601313|157934876|FG000|Overall Study|Enrolled but never treated|0|||
49025803|NCT02601313|157934877|FG001|Overall Study|Enrolled but never treated|6|||
49025804|NCT02601313|157934878|FG002|Overall Study|Enrolled but never treated|3|||
49025805|NCT02601313|157934876|FG000|Overall Study|Enrolled, did not initiate AC|4|||
49025806|NCT02601313|157934877|FG001|Overall Study|Enrolled, did not initiate AC|0|||
49025807|NCT02601313|157934878|FG002|Overall Study|Enrolled, did not initiate AC|0|||
49025808|NCT02601313|157934876|FG000|Overall Study|Full consent withdrawal|0|||
49025809|NCT02601313|157934877|FG001|Overall Study|Full consent withdrawal|3|||
49025810|NCT02601313|157934878|FG002|Overall Study|Full consent withdrawal|2|||
49025811|NCT02601313|157934876|FG000|Overall Study|Lost to Follow-up|0|||
49025812|NCT02601313|157934877|FG001|Overall Study|Lost to Follow-up|1|||
49025813|NCT02601313|157934878|FG002|Overall Study|Lost to Follow-up|1|||
49025814|NCT01390844|157934882|FG000|Treatment Phase|Adverse Event|12|||
49025815|NCT01390844|157934883|FG001|Treatment Phase|Adverse Event|2|||
49025816|NCT01390844|157934884|FG002|Treatment Phase|Adverse Event|3|||
48766874|NCT02658890|156994758|FG010|Treatment Phase|Study Drug Toxicity|1|||
48766875|NCT02658890|156994759|FG011|Treatment Phase|Study Drug Toxicity|1|||
49025817|NCT01390844|157934885|FG003|Treatment Phase|Adverse Event|2|||
49025818|NCT01390844|157934882|FG000|Treatment Phase|Treatment Failure|23|||
49025819|NCT01390844|157934883|FG001|Treatment Phase|Treatment Failure|25|||
49025820|NCT01390844|157934884|FG002|Treatment Phase|Treatment Failure|10|||
49025821|NCT01390844|157934885|FG003|Treatment Phase|Treatment Failure|13|||
49025822|NCT01390844|157934882|FG000|Treatment Phase|Non-Medical Reasons|5|||
49025823|NCT01390844|157934883|FG001|Treatment Phase|Non-Medical Reasons|1|||
49025824|NCT01390844|157934884|FG002|Treatment Phase|Non-Medical Reasons|8|||
49025825|NCT01390844|157934885|FG003|Treatment Phase|Non-Medical Reasons|1|||
49025826|NCT01390844|157934882|FG000|Treatment Phase|Non-GCP Compliant|0|||
49025827|NCT01390844|157934883|FG001|Treatment Phase|Non-GCP Compliant|0|||
49025828|NCT01390844|157934884|FG002|Treatment Phase|Non-GCP Compliant|10|||
49025829|NCT01390844|157934885|FG003|Treatment Phase|Non-GCP Compliant|3|||
49025830|NCT01390844|157934882|FG000|Follow-Up Phase|Non-Medical Reasons|1|||
49025831|NCT01390844|157934883|FG001|Follow-Up Phase|Non-Medical Reasons|1|||
49025832|NCT01390844|157934884|FG002|Follow-Up Phase|Non-Medical Reasons|1|||
49025833|NCT01390844|157934885|FG003|Follow-Up Phase|Non-Medical Reasons|0|||
49025834|NCT01318499|157934888|FG000|Overall Study|Adverse Event|16|||
49025835|NCT01318499|157934889|FG001|Overall Study|Adverse Event|11|||
49025836|NCT01318499|157934890|FG002|Overall Study|Adverse Event|6|||
48766876|NCT02658890|156994760|FG012|Treatment Phase|Study Drug Toxicity|2|||
48766877|NCT02658890|156994761|FG013|Treatment Phase|Study Drug Toxicity|9|||
48766878|NCT02658890|156994762|FG014|Treatment Phase|Study Drug Toxicity|0|||
48766879|NCT02658890|156994763|FG015|Treatment Phase|Study Drug Toxicity|1|||
48766880|NCT02658890|156994764|FG016|Treatment Phase|Study Drug Toxicity|1|||
48766881|NCT02658890|156994765|FG017|Treatment Phase|Study Drug Toxicity|0|||
49025837|NCT01318499|157934888|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
49025838|NCT01318499|157934889|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
48766882|NCT02658890|156994766|FG018|Treatment Phase|Study Drug Toxicity|8|||
48766883|NCT02658890|156994767|FG019|Treatment Phase|Study Drug Toxicity|3|||
48766884|NCT02658890|156994768|FG020|Treatment Phase|Study Drug Toxicity|2|||
49025839|NCT01318499|157934890|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|2|||
49025840|NCT01318499|157934888|FG000|Overall Study|Noncompliance|2|||
49025841|NCT01318499|157934889|FG001|Overall Study|Noncompliance|3|||
49025842|NCT01318499|157934890|FG002|Overall Study|Noncompliance|0|||
49025843|NCT01318499|157934888|FG000|Overall Study|Treatment Failure|19|||
48766885|NCT02658890|156994769|FG021|Treatment Phase|Study Drug Toxicity|0|||
48766886|NCT02658890|156994770|FG022|Treatment Phase|Study Drug Toxicity|8|||
48766887|NCT02658890|156994771|FG023|Treatment Phase|Study Drug Toxicity|0|||
48766888|NCT02658890|156994772|FG024|Treatment Phase|Study Drug Toxicity|0|||
48766889|NCT02658890|156994773|FG025|Treatment Phase|Study Drug Toxicity|2|||
48766890|NCT02658890|156994774|FG026|Treatment Phase|Study Drug Toxicity|0|||
48766891|NCT02658890|156994748|FG000|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766892|NCT02658890|156994749|FG001|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766893|NCT02658890|156994750|FG002|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766894|NCT02658890|156994751|FG003|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
48766895|NCT02658890|156994752|FG004|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766896|NCT02658890|156994753|FG005|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766897|NCT02658890|156994754|FG006|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766898|NCT02658890|156994755|FG007|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766899|NCT02658890|156994756|FG008|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766900|NCT02658890|156994757|FG009|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
48766901|NCT02658890|156994758|FG010|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766902|NCT02658890|156994759|FG011|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766903|NCT02658890|156994760|FG012|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766904|NCT02658890|156994761|FG013|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766905|NCT02658890|156994762|FG014|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766906|NCT02658890|156994763|FG015|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766907|NCT02658890|156994764|FG016|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766908|NCT02658890|156994765|FG017|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766909|NCT02658890|156994766|FG018|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
48766910|NCT02658890|156994767|FG019|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766911|NCT02658890|156994768|FG020|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766912|NCT02658890|156994769|FG021|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766913|NCT02658890|156994770|FG022|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
48766914|NCT02658890|156994771|FG023|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766915|NCT02658890|156994772|FG024|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766916|NCT02658890|156994773|FG025|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766917|NCT02658890|156994774|FG026|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766918|NCT02658890|156994748|FG000|Treatment Phase|Withdrawal by Subject|0|||
48766919|NCT02658890|156994749|FG001|Treatment Phase|Withdrawal by Subject|1|||
48766920|NCT02658890|156994750|FG002|Treatment Phase|Withdrawal by Subject|0|||
48766921|NCT02658890|156994751|FG003|Treatment Phase|Withdrawal by Subject|0|||
48766922|NCT02658890|156994752|FG004|Treatment Phase|Withdrawal by Subject|0|||
48766923|NCT02658890|156994753|FG005|Treatment Phase|Withdrawal by Subject|0|||
48766924|NCT02658890|156994754|FG006|Treatment Phase|Withdrawal by Subject|1|||
48766925|NCT02658890|156994755|FG007|Treatment Phase|Withdrawal by Subject|0|||
48766926|NCT02658890|156994756|FG008|Treatment Phase|Withdrawal by Subject|0|||
48766927|NCT02658890|156994757|FG009|Treatment Phase|Withdrawal by Subject|1|||
48766928|NCT02658890|156994758|FG010|Treatment Phase|Withdrawal by Subject|0|||
48766929|NCT02658890|156994759|FG011|Treatment Phase|Withdrawal by Subject|0|||
48766930|NCT02658890|156994760|FG012|Treatment Phase|Withdrawal by Subject|1|||
48766931|NCT02658890|156994761|FG013|Treatment Phase|Withdrawal by Subject|3|||
48766932|NCT02658890|156994762|FG014|Treatment Phase|Withdrawal by Subject|0|||
48766933|NCT02658890|156994763|FG015|Treatment Phase|Withdrawal by Subject|0|||
48766934|NCT02658890|156994764|FG016|Treatment Phase|Withdrawal by Subject|1|||
48766935|NCT02658890|156994765|FG017|Treatment Phase|Withdrawal by Subject|0|||
48766936|NCT02658890|156994766|FG018|Treatment Phase|Withdrawal by Subject|4|||
48766937|NCT02658890|156994767|FG019|Treatment Phase|Withdrawal by Subject|3|||
48766938|NCT02658890|156994768|FG020|Treatment Phase|Withdrawal by Subject|0|||
48766939|NCT02658890|156994769|FG021|Treatment Phase|Withdrawal by Subject|4|||
48766940|NCT02658890|156994770|FG022|Treatment Phase|Withdrawal by Subject|1|||
48766941|NCT02658890|156994771|FG023|Treatment Phase|Withdrawal by Subject|1|||
48766942|NCT02658890|156994772|FG024|Treatment Phase|Withdrawal by Subject|0|||
48766943|NCT02658890|156994773|FG025|Treatment Phase|Withdrawal by Subject|0|||
48766944|NCT02658890|156994774|FG026|Treatment Phase|Withdrawal by Subject|0|||
48766945|NCT02342704|156994776|FG000|Overall Study|Physician Decision|0|||
48766946|NCT02342704|156994777|FG001|Overall Study|Physician Decision|3|||
48766947|NCT02342704|156994776|FG000|Overall Study|Sponsor Termination|49|||
48766948|NCT02342704|156994777|FG001|Overall Study|Sponsor Termination|43|||
48766949|NCT02342704|156994776|FG000|Overall Study|Other|0|||
48766950|NCT02342704|156994777|FG001|Overall Study|Other|1|||
48766951|NCT02342704|156994776|FG000|Overall Study|Withdrawal by Subject|1|||
48766952|NCT02342704|156994777|FG001|Overall Study|Withdrawal by Subject|0|||
48766953|NCT02342704|156994776|FG000|Overall Study|Lost to Follow-up|2|||
48766954|NCT02342704|156994777|FG001|Overall Study|Lost to Follow-up|1|||
48766955|NCT02342704|156994776|FG000|Overall Study|Adverse Event|1|||
48766956|NCT02342704|156994777|FG001|Overall Study|Adverse Event|3|||
48766957|NCT02347527|156994778|FG000|Overall Study|MRI not completed due to technical difficulties|1|||
48766958|NCT02347527|156994779|FG001|Overall Study|MRI not completed due to technical difficulties|0|||
48766959|NCT02347527|156994780|FG002|Overall Study|MRI not completed due to technical difficulties|0|||
48766960|NCT02347527|156994781|FG003|Overall Study|MRI not completed due to technical difficulties|0|||
48766961|NCT02347527|156994778|FG000|Overall Study|MRI stopped due to participant anxiety|0|||
48766962|NCT02347527|156994779|FG001|Overall Study|MRI stopped due to participant anxiety|1|||
48766963|NCT02347527|156994780|FG002|Overall Study|MRI stopped due to participant anxiety|0|||
48766964|NCT02347527|156994781|FG003|Overall Study|MRI stopped due to participant anxiety|0|||
48766965|NCT02347527|156994778|FG000|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
48766966|NCT02347527|156994779|FG001|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
48766967|NCT02347527|156994780|FG002|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
48766968|NCT02347527|156994781|FG003|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
48766969|NCT02347527|156994778|FG000|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
48766970|NCT02347527|156994779|FG001|Overall Study|Excluded from analyses due to technical difficulties during the study visit|0|||
48766971|NCT02347527|156994780|FG002|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
48766972|NCT02347527|156994781|FG003|Overall Study|Excluded from analyses due to technical difficulties during the study visit|2|||
48766973|NCT02347527|156994778|FG000|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
48766974|NCT02347527|156994779|FG001|Overall Study|Excluded from analyses due to non-compliance with study procedures|1|||
48766975|NCT02347527|156994780|FG002|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
48766976|NCT02347527|156994781|FG003|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
48766977|NCT00302003|156994785|FG000|Overall Study|Lack of Efficacy|62|||
48766978|NCT00302003|156994785|FG000|Overall Study|Lost to Follow-up|1|||
48766979|NCT00302003|156994785|FG000|Overall Study|Physician Decision|2|||
48766980|NCT00302003|156994785|FG000|Overall Study|Withdrawal by Subject|5|||
48766981|NCT00302003|156994785|FG000|Overall Study|Ineligible|9|||
48766982|NCT00302003|156994785|FG000|Overall Study|Protocol Violation|1|||
48766983|NCT00283439|156994786|FG000|Overall Study|Adverse Event|0|||
48766984|NCT00283439|156994787|FG001|Overall Study|Adverse Event|0|||
48766985|NCT00283439|156994788|FG002|Overall Study|Adverse Event|0|||
48766986|NCT00283439|156994789|FG003|Overall Study|Adverse Event|1|||
48766987|NCT00283439|156994786|FG000|Overall Study|Death|0|||
48766988|NCT00283439|156994787|FG001|Overall Study|Death|0|||
48766989|NCT00283439|156994788|FG002|Overall Study|Death|1|||
48766990|NCT00283439|156994789|FG003|Overall Study|Death|0|||
48766991|NCT00283439|156994786|FG000|Overall Study|Disease progression|0|||
48766992|NCT00283439|156994787|FG001|Overall Study|Disease progression|1|||
48766993|NCT00283439|156994788|FG002|Overall Study|Disease progression|0|||
48766994|NCT00283439|156994789|FG003|Overall Study|Disease progression|0|||
48766995|NCT00283439|156994786|FG000|Overall Study|Requirement for alternative therapy|1|||
48766996|NCT00283439|156994787|FG001|Overall Study|Requirement for alternative therapy|2|||
48766997|NCT00283439|156994788|FG002|Overall Study|Requirement for alternative therapy|5|||
48766998|NCT00283439|156994789|FG003|Overall Study|Requirement for alternative therapy|2|||
48766999|NCT00283439|156994786|FG000|Overall Study|Stem cell transplant|6|||
48767000|NCT00283439|156994787|FG001|Overall Study|Stem cell transplant|6|||
48767001|NCT00283439|156994788|FG002|Overall Study|Stem cell transplant|4|||
48767002|NCT00283439|156994789|FG003|Overall Study|Stem cell transplant|3|||
48767003|NCT00283439|156994786|FG000|Overall Study|Treatment discontinued|0|||
48767004|NCT00283439|156994787|FG001|Overall Study|Treatment discontinued|2|||
48767005|NCT00283439|156994788|FG002|Overall Study|Treatment discontinued|1|||
48767006|NCT00283439|156994789|FG003|Overall Study|Treatment discontinued|3|||
48767007|NCT00283439|156994786|FG000|Overall Study|Other|1|||
48767008|NCT00283439|156994787|FG001|Overall Study|Other|0|||
48767009|NCT00283439|156994788|FG002|Overall Study|Other|0|||
48767010|NCT00283439|156994789|FG003|Overall Study|Other|0|||
48767011|NCT02042924|156994790|FG000|Overall Study|Early Death|1|||
48767012|NCT00348556|156994791|FG000|Overall Study|Adverse Event|1|||
48767013|NCT02731729|156994792|FG000|Overall Study|Death|2|||
48767014|NCT02731729|156994793|FG001|Overall Study|Death|2|||
48767015|NCT02731729|156994792|FG000|Overall Study|Study terminated by Sponsor|6|||
48767016|NCT02731729|156994793|FG001|Overall Study|Study terminated by Sponsor|6|||
48767017|NCT02731729|156994792|FG000|Overall Study|Withdrawal by Subject|1|||
49025844|NCT01318499|157934889|FG001|Overall Study|Treatment Failure|19|||
48767018|NCT02731729|156994793|FG001|Overall Study|Withdrawal by Subject|0|||
48767019|NCT00159588|156994794|FG000|5 Month Follow-up|Withdrawal by Subject|2|||
48767020|NCT00159588|156994795|FG001|5 Month Follow-up|Withdrawal by Subject|4|||
48767021|NCT00159588|156994796|FG002|5 Month Follow-up|Withdrawal by Subject|2|||
48767022|NCT04206293|156994801|FG000|Overall Study|Consent withdrawal|1|||
48767023|NCT00430092|156994805|FG000|Overall Study|Adverse Event|0|||
48767024|NCT00430092|156994806|FG001|Overall Study|Adverse Event|0|||
49025845|NCT01318499|157934890|FG002|Overall Study|Treatment Failure|101|||
48767025|NCT00430092|156994807|FG002|Overall Study|Adverse Event|1|||
48767026|NCT00430092|156994805|FG000|Overall Study|Lack of Efficacy|5|||
48767027|NCT00430092|156994806|FG001|Overall Study|Lack of Efficacy|2|||
48767028|NCT00430092|156994807|FG002|Overall Study|Lack of Efficacy|54|||
48767029|NCT00430092|156994805|FG000|Overall Study|Lost to Follow-up|1|||
48767030|NCT00430092|156994806|FG001|Overall Study|Lost to Follow-up|0|||
48767031|NCT00430092|156994807|FG002|Overall Study|Lost to Follow-up|0|||
48767032|NCT00430092|156994805|FG000|Overall Study|Protocol Violation|0|||
48767033|NCT00430092|156994806|FG001|Overall Study|Protocol Violation|1|||
48767034|NCT00430092|156994807|FG002|Overall Study|Protocol Violation|1|||
48767035|NCT00430092|156994805|FG000|Overall Study|Withdrawal by Subject|0|||
48767036|NCT00430092|156994806|FG001|Overall Study|Withdrawal by Subject|1|||
48767037|NCT00430092|156994807|FG002|Overall Study|Withdrawal by Subject|1|||
48767038|NCT03325166|156994808|FG000|Overall Study|Adverse Event|1|||
48767039|NCT00952341|156994812|FG000|Cycle 1|Adverse Event|4|||
48767040|NCT00952341|156994813|FG001|Cycle 1|Adverse Event|1|||
48767041|NCT00952341|156994812|FG000|Cycle 1|Withdrawal by Subject|3|||
48767042|NCT00952341|156994813|FG001|Cycle 1|Withdrawal by Subject|8|||
48767043|NCT00952341|156994812|FG000|Cycle 1|Protocol Violation|2|||
48767044|NCT00952341|156994813|FG001|Cycle 1|Protocol Violation|1|||
48767045|NCT00952341|156994812|FG000|Cycle 1|Lost to Follow-up|11|||
48767046|NCT00952341|156994813|FG001|Cycle 1|Lost to Follow-up|2|||
48767047|NCT00952341|156994812|FG000|Cycle 1|Physician Decision|0|||
48767048|NCT00952341|156994813|FG001|Cycle 1|Physician Decision|1|||
48767049|NCT00952341|156994812|FG000|Cycle 2|Withdrawal by Subject|1|||
48767050|NCT00952341|156994813|FG001|Cycle 2|Withdrawal by Subject|1|||
48767051|NCT00952341|156994812|FG000|Cycle 2|Protocol Violation|1|||
48767052|NCT00952341|156994813|FG001|Cycle 2|Protocol Violation|0|||
48767053|NCT00952341|156994812|FG000|Cycle 2|Lost to Follow-up|6|||
48767054|NCT00952341|156994813|FG001|Cycle 2|Lost to Follow-up|9|||
48767055|NCT00952341|156994812|FG000|Cycle 2|Physician Decision|1|||
48767056|NCT00952341|156994813|FG001|Cycle 2|Physician Decision|1|||
48767057|NCT00952341|156994812|FG000|Cycle 2|Progressive Disease|0|||
48767058|NCT00952341|156994813|FG001|Cycle 2|Progressive Disease|1|||
48767059|NCT01467076|156994814|FG000|Overall Study|Lost to Follow-up|1|||
48767060|NCT01467076|156994815|FG001|Overall Study|Lost to Follow-up|0|||
48767061|NCT01467076|156994816|FG002|Overall Study|Lost to Follow-up|0|||
48767062|NCT00994448|156994820|FG000|Overall Study|Adverse Event|1|||
48767063|NCT00994448|156994821|FG001|Overall Study|Adverse Event|0|||
48767064|NCT00994448|156994820|FG000|Overall Study|Lost to Follow-up|5|||
48767065|NCT00994448|156994821|FG001|Overall Study|Lost to Follow-up|1|||
48767066|NCT00994448|156994820|FG000|Overall Study|Withdrawal by Subject|1|||
48767067|NCT00994448|156994821|FG001|Overall Study|Withdrawal by Subject|1|||
48767068|NCT00994448|156994820|FG000|Overall Study|Physician Decision|1|||
48767069|NCT00994448|156994821|FG001|Overall Study|Physician Decision|0|||
48767070|NCT00578175|156994828|FG000|Overall Study|Adverse Event|0|||
48767071|NCT00578175|156994829|FG001|Overall Study|Adverse Event|1|||
48767072|NCT00578175|156994830|FG002|Overall Study|Adverse Event|1|||
48767073|NCT00578175|156994828|FG000|Overall Study|Other reasons|70|||
48767074|NCT00578175|156994829|FG001|Overall Study|Other reasons|42|||
48767075|NCT00578175|156994830|FG002|Overall Study|Other reasons|23|||
48767076|NCT01203072|156994831|FG000|Overall Study|Adverse Event|5|||
48767077|NCT01203072|156994832|FG001|Overall Study|Adverse Event|3|||
48767078|NCT01203072|156994833|FG002|Overall Study|Adverse Event|2|||
48767079|NCT01203072|156994834|FG003|Overall Study|Adverse Event|4|||
48767080|NCT01203072|156994835|FG004|Overall Study|Adverse Event|2|||
48767081|NCT01203072|156994831|FG000|Overall Study|Lack of Efficacy|1|||
48767082|NCT01203072|156994832|FG001|Overall Study|Lack of Efficacy|0|||
48767083|NCT01203072|156994833|FG002|Overall Study|Lack of Efficacy|0|||
48767084|NCT01203072|156994834|FG003|Overall Study|Lack of Efficacy|0|||
48767085|NCT01203072|156994835|FG004|Overall Study|Lack of Efficacy|0|||
48767086|NCT01203072|156994831|FG000|Overall Study|Lost to Follow-up|0|||
49025846|NCT01318499|157934888|FG000|Overall Study|Protocol Violation|2|||
49025847|NCT01318499|157934889|FG001|Overall Study|Protocol Violation|4|||
48767087|NCT01203072|156994832|FG001|Overall Study|Lost to Follow-up|1|||
48767088|NCT01203072|156994833|FG002|Overall Study|Lost to Follow-up|0|||
48767089|NCT01203072|156994834|FG003|Overall Study|Lost to Follow-up|0|||
48767090|NCT01203072|156994835|FG004|Overall Study|Lost to Follow-up|0|||
48767091|NCT01203072|156994831|FG000|Overall Study|Protocol Violation|2|||
48767092|NCT01203072|156994832|FG001|Overall Study|Protocol Violation|0|||
49025848|NCT01318499|157934890|FG002|Overall Study|Protocol Violation|2|||
49025849|NCT01318499|157934888|FG000|Overall Study|Patient Did Not Use Study Medication|18|||
48767093|NCT01203072|156994833|FG002|Overall Study|Protocol Violation|0|||
48767094|NCT01203072|156994834|FG003|Overall Study|Protocol Violation|0|||
48767095|NCT01203072|156994835|FG004|Overall Study|Protocol Violation|1|||
48767096|NCT01203072|156994831|FG000|Overall Study|Withdrawal by Subject|2|||
48767097|NCT01203072|156994832|FG001|Overall Study|Withdrawal by Subject|2|||
48767098|NCT01203072|156994833|FG002|Overall Study|Withdrawal by Subject|1|||
48767099|NCT01203072|156994834|FG003|Overall Study|Withdrawal by Subject|2|||
48767100|NCT01203072|156994835|FG004|Overall Study|Withdrawal by Subject|3|||
48875816|NCT01606319|157383297|FG000|Overall Study|Lack of Efficacy|6|||
48875817|NCT01606319|157383298|FG001|Overall Study|Lack of Efficacy|8|||
48875818|NCT01606319|157383297|FG000|Overall Study|Adverse Event|1|||
49025850|NCT01318499|157934889|FG001|Overall Study|Patient Did Not Use Study Medication|28|||
48767101|NCT00235872|156994836|FG000|Overall Study|Adverse Event|34|||
48767102|NCT00235872|156994836|FG000|Overall Study|Death|1|||
48767103|NCT00235872|156994836|FG000|Overall Study|Lost to Follow-up|1|||
48767104|NCT00235872|156994836|FG000|Overall Study|Withdrawal by Subject|50|||
48767105|NCT00235872|156994836|FG000|Overall Study|Administrative reason|61|||
48767106|NCT02027844|156994837|FG000|Overall Study|Withdrawal by Subject|3|||
48767107|NCT02027844|156994838|FG001|Overall Study|Withdrawal by Subject|2|||
48767108|NCT02027844|156994839|FG002|Overall Study|Withdrawal by Subject|1|||
48767109|NCT02027844|156994837|FG000|Overall Study|Lost to Follow-up|0|||
48767110|NCT02027844|156994838|FG001|Overall Study|Lost to Follow-up|2|||
48767111|NCT02027844|156994839|FG002|Overall Study|Lost to Follow-up|1|||
48767112|NCT02027844|156994837|FG000|Overall Study|Protocol Violation|0|||
48767113|NCT02027844|156994838|FG001|Overall Study|Protocol Violation|2|||
48767114|NCT02027844|156994839|FG002|Overall Study|Protocol Violation|0|||
48767115|NCT02027844|156994837|FG000|Overall Study|Incomlete data|2|||
48767116|NCT02027844|156994838|FG001|Overall Study|Incomlete data|0|||
48767117|NCT02027844|156994839|FG002|Overall Study|Incomlete data|0|||
48767118|NCT04889625|156994847|FG000|Period 1|Subject did not meet eligibility criteria and was enrolled by error|2|||
48767119|NCT04889625|156994848|FG001|Period 1|Subject did not meet eligibility criteria and was enrolled by error|1|||
48767120|NCT04889625|156994847|FG000|Period 1|Subject out of window|0|||
48767121|NCT04889625|156994848|FG001|Period 1|Subject out of window|1|||
48767122|NCT04889625|156994847|FG000|Period 1|Wrong add power dispensed|0|||
48767123|NCT04889625|156994848|FG001|Period 1|Wrong add power dispensed|1|||
48767124|NCT04889625|156994847|FG000|Period 1|Discontinued due to fitting guide error|1|||
48875819|NCT01606319|157383298|FG001|Overall Study|Adverse Event|4|||
48875820|NCT04120376|157383299|FG000|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|9|||
48875821|NCT04120376|157383300|FG001|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|0|||
48875822|NCT01519778|157383307|FG000|Overall Study|Withdrawal by Subject|3|||
48875823|NCT01519778|157383307|FG000|Overall Study|Lost to Follow-up|10|||
48875824|NCT01519778|157383307|FG000|Overall Study|Physician Decision|1|||
48875825|NCT03021551|157383312|FG000|Overall Study|Equipment Issues|2|||
48875826|NCT03021551|157383312|FG000|Overall Study|Protocol Violation|1|||
48875827|NCT01841697|157383321|FG000|Overall Study|Death|0|||
48875828|NCT01841697|157383322|FG001|Overall Study|Death|1|||
49025851|NCT01318499|157934890|FG002|Overall Study|Patient Did Not Use Study Medication|14|||
49025852|NCT01318499|157934888|FG000|Overall Study|Other|7|||
49025853|NCT01318499|157934889|FG001|Overall Study|Other|10|||
49025854|NCT01318499|157934890|FG002|Overall Study|Other|22|||
49025855|NCT01974141|157934891|FG000|Overall Study|Other Reasons|28|||
49025856|NCT01974141|157934892|FG001|Overall Study|Other Reasons|18|||
49025857|NCT01974141|157934891|FG000|Overall Study|Protocol Violation|2|||
49025858|NCT01974141|157934892|FG001|Overall Study|Protocol Violation|6|||
49025859|NCT01974141|157934891|FG000|Overall Study|Personal Reasons|21|||
49025860|NCT01974141|157934892|FG001|Overall Study|Personal Reasons|20|||
49025861|NCT01974141|157934891|FG000|Overall Study|Lost to Follow-up|38|||
49025862|NCT01974141|157934892|FG001|Overall Study|Lost to Follow-up|29|||
49025863|NCT01974141|157934891|FG000|Overall Study|Pregnancy|3|||
49025864|NCT01974141|157934892|FG001|Overall Study|Pregnancy|3|||
49025865|NCT01974141|157934891|FG000|Overall Study|Lack of Efficacy|0|||
49025866|NCT01974141|157934892|FG001|Overall Study|Lack of Efficacy|1|||
49025867|NCT01974141|157934891|FG000|Overall Study|Adverse Event|4|||
49025868|NCT01974141|157934892|FG001|Overall Study|Adverse Event|5|||
49025869|NCT02719522|157934897|FG000|Overall Study|Implant Failure|4|||
49025870|NCT02719522|157934897|FG000|Overall Study|Death|2|||
49025871|NCT02719522|157934897|FG000|Overall Study|Lost to Follow-up|5|||
49025872|NCT03583333|157934912|FG000|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|8|||
49025873|NCT03583333|157934913|FG001|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|6|||
49025874|NCT03583333|157934912|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
49025875|NCT03583333|157934913|FG001|Overall Study|Withdrawal by Parent/Guardian|10|||
48767125|NCT04889625|156994848|FG001|Period 1|Discontinued due to fitting guide error|1|||
48767126|NCT04889625|156994847|FG000|Period 2|Test article no longer available|1|||
48767127|NCT04889625|156994848|FG001|Period 2|Test article no longer available|0|||
48767128|NCT04889625|156994847|FG000|Period 2|Incorrect lens dispensed|1|||
48767129|NCT04889625|156994848|FG001|Period 2|Incorrect lens dispensed|0|||
48767130|NCT04889625|156994847|FG000|Period 2|Wrong add power dispensed|0|||
49025876|NCT03583333|157934912|FG000|Overall Study|Withdrawal by Subject|9|||
48767131|NCT04889625|156994848|FG001|Period 2|Wrong add power dispensed|1|||
49025877|NCT03583333|157934913|FG001|Overall Study|Withdrawal by Subject|5|||
49025878|NCT03583333|157934912|FG000|Overall Study|Physician Decision|3|||
49025879|NCT03583333|157934913|FG001|Overall Study|Physician Decision|2|||
49025880|NCT03583333|157934912|FG000|Overall Study|Death|12|||
49025881|NCT03583333|157934913|FG001|Overall Study|Death|7|||
48767132|NCT03690388|156994852|FG000|Overall Study|Adverse Event|8|||
48767133|NCT03690388|156994853|FG001|Overall Study|Adverse Event|1|||
48767134|NCT03690388|156994852|FG000|Overall Study|Radiographic Progression|14|||
48767135|NCT03690388|156994853|FG001|Overall Study|Radiographic Progression|29|||
48767136|NCT03690388|156994852|FG000|Overall Study|Clinical deterioration|10|||
48767137|NCT03690388|156994853|FG001|Overall Study|Clinical deterioration|6|||
48767138|NCT03690388|156994852|FG000|Overall Study|Withdrawal by Subject|2|||
48767139|NCT03690388|156994853|FG001|Overall Study|Withdrawal by Subject|0|||
48767140|NCT03690388|156994852|FG000|Overall Study|Lack of Efficacy|1|||
48767141|NCT03690388|156994853|FG001|Overall Study|Lack of Efficacy|0|||
48767142|NCT03690388|156994852|FG000|Overall Study|Lost to Follow-up|1|||
48767143|NCT03690388|156994853|FG001|Overall Study|Lost to Follow-up|0|||
48767144|NCT02308735|156994857|FG000|Overall Study|Physician Decision|2|||
48767145|NCT02308735|156994858|FG001|Overall Study|Physician Decision|0|||
48875829|NCT01841697|157383321|FG000|Overall Study|Lost to Follow-up|4|||
49025882|NCT03536884|157934914|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|8|||
49025883|NCT03536884|157934915|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|6|||
49025884|NCT03536884|157934916|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
49025885|NCT03536884|157934917|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
49025886|NCT03536884|157934918|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
49025887|NCT03536884|157934919|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
49025888|NCT03536884|157934920|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
49025889|NCT03536884|157934921|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
48767146|NCT02308735|156994859|FG002|Overall Study|Physician Decision|0|||
48767147|NCT02308735|156994860|FG003|Overall Study|Physician Decision|2|||
48767148|NCT04372602|156994869|FG000|Overall Study|Withdrawal by Subject|1|||
48767149|NCT04372602|156994870|FG001|Overall Study|Withdrawal by Subject|1|||
48767150|NCT04372602|156994869|FG000|Overall Study|Adverse Event|0|||
48767151|NCT04372602|156994870|FG001|Overall Study|Adverse Event|1|||
48767152|NCT04372602|156994869|FG000|Overall Study|Transitioned to comfort care|0|||
48767153|NCT04372602|156994870|FG001|Overall Study|Transitioned to comfort care|1|||
48767154|NCT04334460|156994871|FG000|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|4|||
48767155|NCT04334460|156994872|FG001|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|1|||
48767156|NCT04334460|156994871|FG000|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|4|||
48767157|NCT04334460|156994872|FG001|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|1|||
48767158|NCT02357147|156994873|FG000|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
48767159|NCT02357147|156994874|FG001|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
48767160|NCT02357147|156994873|FG000|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0|||
48767161|NCT02357147|156994874|FG001|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1|||
48767162|NCT02357147|156994873|FG000|Combination Treatment Phase|Investigator Discretion|1|||
48767163|NCT02357147|156994874|FG001|Combination Treatment Phase|Investigator Discretion|1|||
48767164|NCT02357147|156994873|FG000|Combination Treatment Phase|Withdrawal by Subject|4|||
48767165|NCT02357147|156994874|FG001|Combination Treatment Phase|Withdrawal by Subject|2|||
48767166|NCT02357147|156994873|FG000|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4|||
48767167|NCT02357147|156994874|FG001|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1|||
48767168|NCT02357147|156994873|FG000|Combination Treatment Phase|Adverse Event|12|||
48767169|NCT02357147|156994874|FG001|Combination Treatment Phase|Adverse Event|4|||
48767170|NCT02357147|156994873|FG000|Combination Treatment Phase|Death|1|||
48767171|NCT02357147|156994874|FG001|Combination Treatment Phase|Death|1|||
48767172|NCT02357147|156994873|FG000|Combination Treatment Phase|Sponsor Decision|0|||
48767173|NCT02357147|156994874|FG001|Combination Treatment Phase|Sponsor Decision|12|||
48767174|NCT02357147|156994873|FG000|Combination Treatment Phase|Other|1|||
48767175|NCT02357147|156994874|FG001|Combination Treatment Phase|Other|0|||
48767176|NCT02357147|156994873|FG000|Combination Treatment Phase|Not treated|0|||
48767177|NCT02357147|156994874|FG001|Combination Treatment Phase|Not treated|2|||
49025890|NCT03536884|157934922|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
49025891|NCT03536884|157934923|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
48767178|NCT02357147|156994873|FG000|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15|||
48767179|NCT02357147|156994874|FG001|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10|||
48767180|NCT02357147|156994873|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
48767181|NCT02357147|156994874|FG001|Maintenance Treatment Phase|Withdrawal by Subject|1|||
48875830|NCT01841697|157383322|FG001|Overall Study|Lost to Follow-up|1|||
48875831|NCT01841697|157383321|FG000|Overall Study|Withdrawal by Subject|16|||
49025892|NCT03536884|157934924|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
49025893|NCT03536884|157934925|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
49025894|NCT03536884|157934914|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
49025895|NCT03536884|157934915|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|3|||
49025896|NCT03536884|157934916|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
48767182|NCT02357147|156994873|FG000|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10|||
48767183|NCT02357147|156994874|FG001|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0|||
48767184|NCT02357147|156994873|FG000|Maintenance Treatment Phase|Adverse Event|0|||
48767185|NCT02357147|156994874|FG001|Maintenance Treatment Phase|Adverse Event|3|||
48767186|NCT02357147|156994873|FG000|Maintenance Treatment Phase|Sponsor Decision|0|||
48767187|NCT02357147|156994874|FG001|Maintenance Treatment Phase|Sponsor Decision|15|||
48767188|NCT02357147|156994873|FG000|Maintenance Treatment Phase|Not Treated|1|||
48767189|NCT02357147|156994874|FG001|Maintenance Treatment Phase|Not Treated|0|||
48767190|NCT03299842|156996849|FG000|Overall Study|Caregiver withdrew consent|2|||
48767191|NCT03299842|156996849|FG000|Overall Study|Child would not keep the watch on|3|||
48767192|NCT01940120|156996850|FG000|Overall Study|Death|40|||
48767193|NCT01940120|156996850|FG000|Overall Study|Withdrawal by Subject|8|||
48767194|NCT00997503|156996854|FG000|Overall Study|Death|53|||
48767195|NCT00997503|156996854|FG000|Overall Study|Withdrawal by Subject|76|||
48767196|NCT00997503|156996854|FG000|Overall Study|Lost to Follow-up|33|||
48767197|NCT00997503|156996854|FG000|Overall Study|Adverse Event|3|||
48767198|NCT00997503|156996854|FG000|Overall Study|Physician Decision|10|||
48767199|NCT00997503|156996854|FG000|Overall Study|Missed 12-month follow-up|85|||
48767200|NCT00997503|156996854|FG000|Overall Study|Other reason|13|||
48767201|NCT00805935|156996855|FG000|Overall Study|Stimulation Failure|1|||
48767202|NCT00805935|156996856|FG001|Overall Study|Stimulation Failure|5|||
48767203|NCT00805935|156996857|FG002|Overall Study|Stimulation Failure|2|||
48767204|NCT00805935|156996858|FG003|Overall Study|Stimulation Failure|2|||
48767205|NCT00805935|156996855|FG000|Overall Study|Cycle cancelled|0|||
48767206|NCT00805935|156996856|FG001|Overall Study|Cycle cancelled|0|||
48767207|NCT00805935|156996857|FG002|Overall Study|Cycle cancelled|2|||
48767208|NCT00805935|156996858|FG003|Overall Study|Cycle cancelled|0|||
48767209|NCT00805935|156996855|FG000|Overall Study|Cycle cancellation for risk of OHSS|1|||
48767210|NCT00805935|156996856|FG001|Overall Study|Cycle cancellation for risk of OHSS|0|||
48767211|NCT00805935|156996857|FG002|Overall Study|Cycle cancellation for risk of OHSS|1|||
48767212|NCT00805935|156996858|FG003|Overall Study|Cycle cancellation for risk of OHSS|0|||
48767213|NCT00805935|156996855|FG000|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
48767214|NCT00805935|156996856|FG001|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
48767215|NCT00805935|156996857|FG002|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
48875832|NCT01841697|157383322|FG001|Overall Study|Withdrawal by Subject|16|||
48875833|NCT00302159|157383323|FG000|Overall Study|pt declined before treatment started|1|||
48875834|NCT00302159|157383323|FG000|Overall Study|pt started Avastin|1|||
48875835|NCT00813098|157383324|FG000|Overall Study|Adverse Event|2|||
48875836|NCT00813098|157383325|FG001|Overall Study|Adverse Event|4|||
48875837|NCT00813098|157383326|FG002|Overall Study|Adverse Event|1|||
48875838|NCT00813098|157383324|FG000|Overall Study|Withdrawal by Subject|0|||
48875839|NCT00813098|157383325|FG001|Overall Study|Withdrawal by Subject|1|||
48875840|NCT00813098|157383326|FG002|Overall Study|Withdrawal by Subject|0|||
48767216|NCT00805935|156996858|FG003|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1|||
48767217|NCT00805935|156996855|FG000|Overall Study|Lost to Follow-up|1|||
48767218|NCT00805935|156996856|FG001|Overall Study|Lost to Follow-up|0|||
48767219|NCT00805935|156996857|FG002|Overall Study|Lost to Follow-up|0|||
48767220|NCT00805935|156996858|FG003|Overall Study|Lost to Follow-up|0|||
48767221|NCT00805935|156996855|FG000|Overall Study|No positive serum pregnancy|8|||
48767222|NCT00805935|156996856|FG001|Overall Study|No positive serum pregnancy|7|||
48767223|NCT00805935|156996857|FG002|Overall Study|No positive serum pregnancy|6|||
48875841|NCT00813098|157383324|FG000|Overall Study|Inability to complete study procedures|1|||
48875842|NCT00813098|157383325|FG001|Overall Study|Inability to complete study procedures|0|||
48981948|NCT04921969|157765596|FG004|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
48981949|NCT04921969|157765597|FG005|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
48981950|NCT04921969|157765598|FG006|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
48981951|NCT04921969|157765592|FG000|VC Period (Day 1 to Week 8)|Physician Decision|0|||
48981952|NCT04921969|157765593|FG001|VC Period (Day 1 to Week 8)|Physician Decision|1|||
48981953|NCT04921969|157765594|FG002|VC Period (Day 1 to Week 8)|Physician Decision|1|||
48981954|NCT04921969|157765595|FG003|VC Period (Day 1 to Week 8)|Physician Decision|0|||
48981955|NCT04921969|157765596|FG004|VC Period (Day 1 to Week 8)|Physician Decision|0|||
48981956|NCT04921969|157765597|FG005|VC Period (Day 1 to Week 8)|Physician Decision|0|||
48981957|NCT04921969|157765598|FG006|VC Period (Day 1 to Week 8)|Physician Decision|0|||
48981958|NCT04921969|157765592|FG000|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
48981959|NCT04921969|157765593|FG001|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
48981960|NCT04921969|157765594|FG002|VC Period (Day 1 to Week 8)|Protocol Violation|1|||
48981961|NCT04921969|157765595|FG003|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
48981962|NCT04921969|157765596|FG004|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
48981963|NCT04921969|157765597|FG005|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
48981964|NCT04921969|157765598|FG006|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
48981965|NCT04921969|157765592|FG000|VC Period (Day 1 to Week 8)|Withdrawal by Subject|9|||
48981966|NCT04921969|157765593|FG001|VC Period (Day 1 to Week 8)|Withdrawal by Subject|5|||
48981967|NCT04921969|157765594|FG002|VC Period (Day 1 to Week 8)|Withdrawal by Subject|8|||
48767224|NCT00805935|156996858|FG003|Overall Study|No positive serum pregnancy|5|||
48767225|NCT00805935|156996855|FG000|Overall Study|Pregnancy not confirmed by ultrasound|0|||
48767226|NCT00805935|156996856|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
48767227|NCT00805935|156996857|FG002|Overall Study|Pregnancy not confirmed by ultrasound|0|||
48767228|NCT00805935|156996858|FG003|Overall Study|Pregnancy not confirmed by ultrasound|1|||
48767229|NCT00805935|156996855|FG000|Overall Study|Pregnancy loss/miscarriage|2|||
48767230|NCT00805935|156996856|FG001|Overall Study|Pregnancy loss/miscarriage|0|||
48767231|NCT00805935|156996857|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
48767232|NCT00805935|156996858|FG003|Overall Study|Pregnancy loss/miscarriage|0|||
48767233|NCT00805935|156996855|FG000|Overall Study|Biochemical pregnancy|0|||
48767234|NCT00805935|156996856|FG001|Overall Study|Biochemical pregnancy|1|||
48767235|NCT00805935|156996857|FG002|Overall Study|Biochemical pregnancy|0|||
48767236|NCT00805935|156996858|FG003|Overall Study|Biochemical pregnancy|0|||
48767237|NCT00805935|156996855|FG000|Overall Study|Chemical pregnancy|0|||
48767238|NCT00805935|156996856|FG001|Overall Study|Chemical pregnancy|5|||
48767239|NCT00805935|156996857|FG002|Overall Study|Chemical pregnancy|3|||
48767240|NCT00805935|156996858|FG003|Overall Study|Chemical pregnancy|2|||
48767241|NCT00805935|156996855|FG000|Overall Study|Ectopic pregnancy|0|||
48767242|NCT00805935|156996856|FG001|Overall Study|Ectopic pregnancy|0|||
48767243|NCT00805935|156996857|FG002|Overall Study|Ectopic pregnancy|1|||
48767244|NCT00805935|156996858|FG003|Overall Study|Ectopic pregnancy|0|||
48767245|NCT00805935|156996855|FG000|Overall Study|Serious Adverse Event-congenital anomaly|0|||
48767246|NCT00805935|156996856|FG001|Overall Study|Serious Adverse Event-congenital anomaly|1|||
48767247|NCT00805935|156996857|FG002|Overall Study|Serious Adverse Event-congenital anomaly|0|||
48767248|NCT00805935|156996858|FG003|Overall Study|Serious Adverse Event-congenital anomaly|0|||
48767249|NCT01344369|156996859|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
48767250|NCT01344369|156996860|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
48767251|NCT01344369|156996859|FG000|Washout of 28 Days|Physician Decision|0|||
48767252|NCT01344369|156996860|FG001|Washout of 28 Days|Physician Decision|1|||
48767253|NCT01344369|156996859|FG000|Second Intervention|Emesis within 2 x Tmax|0|||
48767254|NCT01344369|156996860|FG001|Second Intervention|Emesis within 2 x Tmax|1|||
48767255|NCT01762943|156996868|FG000|Overall Study|Physician Decision|1|||
49025897|NCT03536884|157934917|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
49025898|NCT03536884|157934918|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
49025899|NCT03536884|157934919|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
49025900|NCT03536884|157934920|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
49025901|NCT03536884|157934921|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
49025902|NCT03536884|157934922|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
49025903|NCT03536884|157934923|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
49025904|NCT03536884|157934924|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
49025905|NCT03536884|157934925|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
49025906|NCT03536884|157934914|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|3|||
49025907|NCT03536884|157934915|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|4|||
49025908|NCT03536884|157934916|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
49025909|NCT03536884|157934917|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
49025910|NCT03536884|157934918|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
49025911|NCT03536884|157934919|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
49025912|NCT03536884|157934920|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
49025913|NCT03536884|157934921|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
49025914|NCT03536884|157934922|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
49025915|NCT03536884|157934923|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
49025916|NCT03536884|157934924|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
49025917|NCT03536884|157934925|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
49025918|NCT03536884|157934914|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
49025919|NCT03536884|157934915|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|1|||
48767256|NCT01762943|156996869|FG001|Overall Study|Physician Decision|1|||
48767257|NCT01762943|156996868|FG000|Overall Study|Protocol Violation|1|||
48767258|NCT01762943|156996869|FG001|Overall Study|Protocol Violation|0|||
48767259|NCT01762943|156996868|FG000|Overall Study|Withdrawal by Subject|2|||
48767260|NCT01762943|156996869|FG001|Overall Study|Withdrawal by Subject|1|||
48767261|NCT02487394|156996870|FG000|Phase 1|Withdrawal by Subject|0|||
48767262|NCT02487394|156996871|FG001|Phase 1|Withdrawal by Subject|1|||
48767263|NCT03670810|156996875|FG000|Main Study|Adverse Event|37|||
48767264|NCT03670810|156996876|FG001|Main Study|Adverse Event|38|||
48767265|NCT03670810|156996877|FG002|Main Study|Adverse Event|3|||
48767266|NCT03670810|156996878|FG003|Main Study|Adverse Event|4|||
48767267|NCT03670810|156996879|FG004|Main Study|Adverse Event|4|||
48767268|NCT03670810|156996880|FG005|Main Study|Adverse Event|5|||
48767269|NCT03670810|156996881|FG006|Main Study|Adverse Event|0|||
48767270|NCT03670810|156996882|FG007|Main Study|Adverse Event|0|||
48767271|NCT03670810|156996883|FG008|Main Study|Adverse Event|0|||
48767272|NCT03670810|156996875|FG000|Main Study|Lack of Efficacy|8|||
48767273|NCT03670810|156996876|FG001|Main Study|Lack of Efficacy|9|||
48767274|NCT03670810|156996877|FG002|Main Study|Lack of Efficacy|3|||
48767275|NCT03670810|156996878|FG003|Main Study|Lack of Efficacy|4|||
48767276|NCT03670810|156996879|FG004|Main Study|Lack of Efficacy|0|||
48767277|NCT03670810|156996880|FG005|Main Study|Lack of Efficacy|0|||
48767278|NCT03670810|156996881|FG006|Main Study|Lack of Efficacy|0|||
48767279|NCT03670810|156996882|FG007|Main Study|Lack of Efficacy|0|||
48767280|NCT03670810|156996883|FG008|Main Study|Lack of Efficacy|0|||
48767281|NCT03670810|156996875|FG000|Main Study|Lost to Follow-up|9|||
48767282|NCT03670810|156996876|FG001|Main Study|Lost to Follow-up|7|||
49025920|NCT03536884|157934916|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
48767283|NCT03670810|156996877|FG002|Main Study|Lost to Follow-up|4|||
48767284|NCT03670810|156996878|FG003|Main Study|Lost to Follow-up|6|||
48767285|NCT03670810|156996879|FG004|Main Study|Lost to Follow-up|1|||
48767286|NCT03670810|156996880|FG005|Main Study|Lost to Follow-up|0|||
48767287|NCT03670810|156996881|FG006|Main Study|Lost to Follow-up|0|||
48767288|NCT03670810|156996882|FG007|Main Study|Lost to Follow-up|0|||
48767289|NCT03670810|156996883|FG008|Main Study|Lost to Follow-up|0|||
48767290|NCT03670810|156996875|FG000|Main Study|Non-compliance with Study Drug|0|||
48767291|NCT03670810|156996876|FG001|Main Study|Non-compliance with Study Drug|2|||
48767292|NCT03670810|156996877|FG002|Main Study|Non-compliance with Study Drug|3|||
48767293|NCT03670810|156996878|FG003|Main Study|Non-compliance with Study Drug|0|||
48767294|NCT03670810|156996879|FG004|Main Study|Non-compliance with Study Drug|0|||
48767295|NCT03670810|156996880|FG005|Main Study|Non-compliance with Study Drug|0|||
48767296|NCT03670810|156996881|FG006|Main Study|Non-compliance with Study Drug|0|||
48767297|NCT03670810|156996882|FG007|Main Study|Non-compliance with Study Drug|1|||
48767298|NCT03670810|156996883|FG008|Main Study|Non-compliance with Study Drug|0|||
48767299|NCT03670810|156996875|FG000|Main Study|Physician Decision|3|||
48767300|NCT03670810|156996876|FG001|Main Study|Physician Decision|0|||
48767301|NCT03670810|156996877|FG002|Main Study|Physician Decision|1|||
48767302|NCT03670810|156996878|FG003|Main Study|Physician Decision|0|||
48767303|NCT03670810|156996879|FG004|Main Study|Physician Decision|0|||
48767304|NCT03670810|156996880|FG005|Main Study|Physician Decision|0|||
48767305|NCT03670810|156996881|FG006|Main Study|Physician Decision|1|||
48767306|NCT03670810|156996882|FG007|Main Study|Physician Decision|1|||
49025921|NCT03536884|157934917|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
49025922|NCT03536884|157934918|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
49025923|NCT03536884|157934919|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
48767307|NCT03670810|156996883|FG008|Main Study|Physician Decision|0|||
48767308|NCT03670810|156996875|FG000|Main Study|Pregnancy|1|||
48767309|NCT03670810|156996876|FG001|Main Study|Pregnancy|2|||
48767310|NCT03670810|156996877|FG002|Main Study|Pregnancy|0|||
48767311|NCT03670810|156996878|FG003|Main Study|Pregnancy|0|||
48767312|NCT03670810|156996879|FG004|Main Study|Pregnancy|0|||
48767313|NCT03670810|156996880|FG005|Main Study|Pregnancy|0|||
48767314|NCT03670810|156996881|FG006|Main Study|Pregnancy|0|||
48767315|NCT03670810|156996882|FG007|Main Study|Pregnancy|0|||
48767316|NCT03670810|156996883|FG008|Main Study|Pregnancy|0|||
48767317|NCT03670810|156996875|FG000|Main Study|Protocol Deviation|2|||
48767318|NCT03670810|156996876|FG001|Main Study|Protocol Deviation|12|||
48767319|NCT03670810|156996877|FG002|Main Study|Protocol Deviation|8|||
48767320|NCT03670810|156996878|FG003|Main Study|Protocol Deviation|4|||
48767321|NCT03670810|156996879|FG004|Main Study|Protocol Deviation|0|||
48767322|NCT03670810|156996880|FG005|Main Study|Protocol Deviation|0|||
48767323|NCT03670810|156996881|FG006|Main Study|Protocol Deviation|0|||
48767324|NCT03670810|156996882|FG007|Main Study|Protocol Deviation|0|||
48767325|NCT03670810|156996883|FG008|Main Study|Protocol Deviation|0|||
48767326|NCT03670810|156996875|FG000|Main Study|Withdrawal by Subject|21|||
48767327|NCT03670810|156996876|FG001|Main Study|Withdrawal by Subject|21|||
48767328|NCT03670810|156996877|FG002|Main Study|Withdrawal by Subject|8|||
48767329|NCT03670810|156996878|FG003|Main Study|Withdrawal by Subject|9|||
48767330|NCT03670810|156996879|FG004|Main Study|Withdrawal by Subject|5|||
48767331|NCT03670810|156996880|FG005|Main Study|Withdrawal by Subject|2|||
48767332|NCT03670810|156996881|FG006|Main Study|Withdrawal by Subject|1|||
48767333|NCT03670810|156996882|FG007|Main Study|Withdrawal by Subject|1|||
48767334|NCT03670810|156996883|FG008|Main Study|Withdrawal by Subject|0|||
48767335|NCT03670810|156996875|FG000|Main Study|Participant did not want to take the three other treatments|1|||
48767336|NCT03670810|156996876|FG001|Main Study|Participant did not want to take the three other treatments|0|||
48767337|NCT03670810|156996877|FG002|Main Study|Participant did not want to take the three other treatments|0|||
48767338|NCT03670810|156996878|FG003|Main Study|Participant did not want to take the three other treatments|0|||
48767339|NCT03670810|156996879|FG004|Main Study|Participant did not want to take the three other treatments|0|||
48767340|NCT03670810|156996880|FG005|Main Study|Participant did not want to take the three other treatments|0|||
48767341|NCT03670810|156996881|FG006|Main Study|Participant did not want to take the three other treatments|0|||
48767342|NCT03670810|156996882|FG007|Main Study|Participant did not want to take the three other treatments|0|||
48767343|NCT03670810|156996883|FG008|Main Study|Participant did not want to take the three other treatments|0|||
48767344|NCT03670810|156996875|FG000|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
48767345|NCT03670810|156996876|FG001|Main Study|Migraines more frequent-GP advised to re-start Topiramate|1|||
48767346|NCT03670810|156996877|FG002|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
48767347|NCT03670810|156996878|FG003|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
48767348|NCT03670810|156996879|FG004|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
48767349|NCT03670810|156996880|FG005|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
48767350|NCT03670810|156996881|FG006|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
48767351|NCT03670810|156996882|FG007|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
48767352|NCT03670810|156996883|FG008|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
48767353|NCT03670810|156996875|FG000|Main Study|Travel and Coronavirus issues|0|||
48767354|NCT03670810|156996876|FG001|Main Study|Travel and Coronavirus issues|0|||
48767355|NCT03670810|156996877|FG002|Main Study|Travel and Coronavirus issues|0|||
48767356|NCT03670810|156996878|FG003|Main Study|Travel and Coronavirus issues|1|||
48767357|NCT03670810|156996879|FG004|Main Study|Travel and Coronavirus issues|0|||
48767358|NCT03670810|156996880|FG005|Main Study|Travel and Coronavirus issues|0|||
48767359|NCT03670810|156996881|FG006|Main Study|Travel and Coronavirus issues|0|||
48767360|NCT03670810|156996882|FG007|Main Study|Travel and Coronavirus issues|0|||
48767361|NCT03670810|156996883|FG008|Main Study|Travel and Coronavirus issues|0|||
48767362|NCT03670810|156996875|FG000|Open Label Extension|Protocol Deviation|0|||
48767363|NCT03670810|156996876|FG001|Open Label Extension|Protocol Deviation|0|||
48767364|NCT03670810|156996877|FG002|Open Label Extension|Protocol Deviation|0|||
48767365|NCT03670810|156996878|FG003|Open Label Extension|Protocol Deviation|0|||
48767366|NCT03670810|156996879|FG004|Open Label Extension|Protocol Deviation|0|||
48767367|NCT03670810|156996880|FG005|Open Label Extension|Protocol Deviation|0|||
48767368|NCT03670810|156996881|FG006|Open Label Extension|Protocol Deviation|0|||
48767369|NCT03670810|156996882|FG007|Open Label Extension|Protocol Deviation|0|||
48767370|NCT03670810|156996883|FG008|Open Label Extension|Protocol Deviation|5|||
48767371|NCT03670810|156996875|FG000|Open Label Extension|Death|0|||
48767372|NCT03670810|156996876|FG001|Open Label Extension|Death|0|||
48767373|NCT03670810|156996877|FG002|Open Label Extension|Death|0|||
48767374|NCT03670810|156996878|FG003|Open Label Extension|Death|0|||
48767375|NCT03670810|156996879|FG004|Open Label Extension|Death|0|||
48767376|NCT03670810|156996880|FG005|Open Label Extension|Death|0|||
48767377|NCT03670810|156996881|FG006|Open Label Extension|Death|0|||
48875843|NCT00813098|157383326|FG002|Overall Study|Inability to complete study procedures|0|||
49025924|NCT03536884|157934920|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
49025925|NCT03536884|157934921|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
49025926|NCT03536884|157934922|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
49025927|NCT03536884|157934923|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
49025928|NCT03536884|157934924|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
49025929|NCT03536884|157934925|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
49025930|NCT03536884|157934914|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
49025931|NCT03536884|157934915|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|1|||
49025932|NCT03536884|157934916|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
49025933|NCT03536884|157934917|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
49025934|NCT03536884|157934918|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
49025935|NCT03536884|157934919|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
49025936|NCT03536884|157934920|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
49025937|NCT03536884|157934921|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
48875844|NCT00813098|157383324|FG000|Overall Study|Lost to Follow-up|0|||
48875845|NCT00813098|157383325|FG001|Overall Study|Lost to Follow-up|1|||
48875846|NCT00813098|157383326|FG002|Overall Study|Lost to Follow-up|0|||
48875847|NCT00813098|157383324|FG000|Overall Study|Protocol Violation|0|||
49025938|NCT03536884|157934922|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
49025939|NCT03536884|157934923|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
49025940|NCT03536884|157934924|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
49025941|NCT03536884|157934925|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
49025942|NCT03536884|157934914|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
49025943|NCT03536884|157934915|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|1|||
49025944|NCT03536884|157934916|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
48875848|NCT00813098|157383325|FG001|Overall Study|Protocol Violation|0|||
48767378|NCT03670810|156996882|FG007|Open Label Extension|Death|0|||
48767379|NCT03670810|156996883|FG008|Open Label Extension|Death|1|||
48767380|NCT03670810|156996875|FG000|Open Label Extension|COVID-19|0|||
48767381|NCT03670810|156996876|FG001|Open Label Extension|COVID-19|0|||
48875849|NCT00813098|157383326|FG002|Overall Study|Protocol Violation|1|||
48767382|NCT03670810|156996877|FG002|Open Label Extension|COVID-19|0|||
48767383|NCT03670810|156996878|FG003|Open Label Extension|COVID-19|0|||
48767384|NCT03670810|156996879|FG004|Open Label Extension|COVID-19|0|||
48767385|NCT03670810|156996880|FG005|Open Label Extension|COVID-19|0|||
48767386|NCT03670810|156996881|FG006|Open Label Extension|COVID-19|0|||
48767387|NCT03670810|156996882|FG007|Open Label Extension|COVID-19|0|||
48767388|NCT03670810|156996883|FG008|Open Label Extension|COVID-19|1|||
48981968|NCT04921969|157765595|FG003|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
48981969|NCT04921969|157765596|FG004|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
48981970|NCT04921969|157765597|FG005|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
48981971|NCT04921969|157765598|FG006|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
48981972|NCT04921969|157765592|FG000|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|3|||
48981973|NCT04921969|157765593|FG001|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|2|||
48981974|NCT04921969|157765594|FG002|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
48981975|NCT04921969|157765595|FG003|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
48981976|NCT04921969|157765596|FG004|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
48981977|NCT04921969|157765597|FG005|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
48981978|NCT04921969|157765598|FG006|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
48981979|NCT04921969|157765592|FG000|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
48981980|NCT04921969|157765593|FG001|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
48981981|NCT04921969|157765594|FG002|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
48981982|NCT04921969|157765595|FG003|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
48981983|NCT04921969|157765596|FG004|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
48981984|NCT04921969|157765597|FG005|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
48981985|NCT04921969|157765598|FG006|LTS Period (Weeks 8 to 52)|Adverse Event|1|||
48981986|NCT04921969|157765592|FG000|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
48981987|NCT04921969|157765593|FG001|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
48981988|NCT04921969|157765594|FG002|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
48981989|NCT04921969|157765595|FG003|LTS Period (Weeks 8 to 52)|Lack of Efficacy|1|||
48981990|NCT04921969|157765596|FG004|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
48981991|NCT04921969|157765597|FG005|LTS Period (Weeks 8 to 52)|Lack of Efficacy|3|||
48981992|NCT04921969|157765598|FG006|LTS Period (Weeks 8 to 52)|Lack of Efficacy|2|||
48981993|NCT04921969|157765592|FG000|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
48981994|NCT04921969|157765593|FG001|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
48981995|NCT04921969|157765594|FG002|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
48981996|NCT04921969|157765595|FG003|LTS Period (Weeks 8 to 52)|Lost to Follow-up|1|||
48981997|NCT04921969|157765596|FG004|LTS Period (Weeks 8 to 52)|Lost to Follow-up|3|||
48981998|NCT04921969|157765597|FG005|LTS Period (Weeks 8 to 52)|Lost to Follow-up|13|||
48981999|NCT04921969|157765598|FG006|LTS Period (Weeks 8 to 52)|Lost to Follow-up|6|||
48982000|NCT04921969|157765592|FG000|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
48982001|NCT04921969|157765593|FG001|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
48982002|NCT04921969|157765594|FG002|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
48982003|NCT04921969|157765595|FG003|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
48982004|NCT04921969|157765596|FG004|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
48982005|NCT04921969|157765597|FG005|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
48982006|NCT04921969|157765598|FG006|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
48982007|NCT04921969|157765592|FG000|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
48982008|NCT04921969|157765593|FG001|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
48982009|NCT04921969|157765594|FG002|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
48982010|NCT04921969|157765595|FG003|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|1|||
48982011|NCT04921969|157765596|FG004|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|1|||
48982012|NCT04921969|157765597|FG005|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|18|||
48982013|NCT04921969|157765598|FG006|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|13|||
48982014|NCT04921969|157765592|FG000|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
48982015|NCT04921969|157765593|FG001|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
48982016|NCT04921969|157765594|FG002|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
48982017|NCT04921969|157765595|FG003|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
48982018|NCT04921969|157765596|FG004|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
48982019|NCT04921969|157765597|FG005|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
48982020|NCT04921969|157765598|FG006|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|2|||
48982021|NCT04921969|157765592|FG000|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
48982022|NCT04921969|157765593|FG001|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
48982023|NCT04921969|157765594|FG002|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
48982024|NCT04921969|157765595|FG003|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
48982025|NCT04921969|157765596|FG004|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
49025945|NCT03536884|157934917|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
49025946|NCT03536884|157934918|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
48767389|NCT03670810|156996875|FG000|Open Label Extension|Lack of Efficacy|0|||
49025947|NCT03536884|157934919|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
49025948|NCT03536884|157934920|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
49025949|NCT03536884|157934921|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
49025950|NCT03536884|157934922|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
49025951|NCT03536884|157934923|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
49025952|NCT03536884|157934924|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
49025953|NCT03536884|157934925|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
49025954|NCT03536884|157934914|FG000|Double-Blind Period: MTP Wk 16-48|Death|0|||
49025955|NCT03536884|157934915|FG001|Double-Blind Period: MTP Wk 16-48|Death|0|||
49025956|NCT03536884|157934916|FG002|Double-Blind Period: MTP Wk 16-48|Death|1|||
49025957|NCT03536884|157934917|FG003|Double-Blind Period: MTP Wk 16-48|Death|0|||
48875850|NCT00813098|157383324|FG000|Overall Study|Principal Investigator decision|0|||
49025958|NCT03536884|157934918|FG004|Double-Blind Period: MTP Wk 16-48|Death|1|||
49025959|NCT03536884|157934919|FG005|Double-Blind Period: MTP Wk 16-48|Death|0|||
49025960|NCT03536884|157934920|FG006|Double-Blind Period: MTP Wk 16-48|Death|0|||
49025961|NCT03536884|157934921|FG007|Double-Blind Period: MTP Wk 16-48|Death|0|||
49025962|NCT03536884|157934922|FG008|Double-Blind Period: MTP Wk 16-48|Death|0|||
49025963|NCT03536884|157934923|FG009|Double-Blind Period: MTP Wk 16-48|Death|0|||
49025964|NCT03536884|157934924|FG010|Double-Blind Period: MTP Wk 16-48|Death|0|||
49025965|NCT03536884|157934925|FG011|Double-Blind Period: MTP Wk 16-48|Death|0|||
49025966|NCT03536884|157934914|FG000|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
49025967|NCT03536884|157934915|FG001|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
49025968|NCT03536884|157934916|FG002|Double-Blind Period: MTP Wk 16-48|Adverse Event|1|||
49025969|NCT03536884|157934917|FG003|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
49025970|NCT03536884|157934918|FG004|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
49025971|NCT03536884|157934919|FG005|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
49025972|NCT03536884|157934920|FG006|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
49025973|NCT03536884|157934921|FG007|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
49025974|NCT03536884|157934922|FG008|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
49025975|NCT03536884|157934923|FG009|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
49025976|NCT03536884|157934924|FG010|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
49025977|NCT03536884|157934925|FG011|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
49025978|NCT03536884|157934914|FG000|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
49025979|NCT03536884|157934915|FG001|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
49025980|NCT03536884|157934916|FG002|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
49025981|NCT03536884|157934917|FG003|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|1|||
49025982|NCT03536884|157934918|FG004|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|4|||
49025983|NCT03536884|157934919|FG005|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
49025984|NCT03536884|157934920|FG006|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
49025985|NCT03536884|157934921|FG007|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
49025986|NCT03536884|157934922|FG008|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
49025987|NCT03536884|157934923|FG009|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
49025988|NCT03536884|157934924|FG010|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
48767390|NCT03670810|156996876|FG001|Open Label Extension|Lack of Efficacy|0|||
48767391|NCT03670810|156996877|FG002|Open Label Extension|Lack of Efficacy|0|||
48767392|NCT03670810|156996878|FG003|Open Label Extension|Lack of Efficacy|0|||
48767393|NCT03670810|156996879|FG004|Open Label Extension|Lack of Efficacy|0|||
48767394|NCT03670810|156996880|FG005|Open Label Extension|Lack of Efficacy|0|||
48767395|NCT03670810|156996881|FG006|Open Label Extension|Lack of Efficacy|0|||
48767396|NCT03670810|156996882|FG007|Open Label Extension|Lack of Efficacy|0|||
48767397|NCT03670810|156996883|FG008|Open Label Extension|Lack of Efficacy|39|||
48767398|NCT03670810|156996875|FG000|Open Label Extension|Participant refused to comply with face mask use|0|||
48767399|NCT03670810|156996876|FG001|Open Label Extension|Participant refused to comply with face mask use|0|||
48767400|NCT03670810|156996877|FG002|Open Label Extension|Participant refused to comply with face mask use|0|||
48767401|NCT03670810|156996878|FG003|Open Label Extension|Participant refused to comply with face mask use|0|||
48767402|NCT03670810|156996879|FG004|Open Label Extension|Participant refused to comply with face mask use|0|||
48767403|NCT03670810|156996880|FG005|Open Label Extension|Participant refused to comply with face mask use|0|||
48767404|NCT03670810|156996881|FG006|Open Label Extension|Participant refused to comply with face mask use|0|||
48767405|NCT03670810|156996882|FG007|Open Label Extension|Participant refused to comply with face mask use|0|||
48767406|NCT03670810|156996883|FG008|Open Label Extension|Participant refused to comply with face mask use|1|||
49025989|NCT03536884|157934925|FG011|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
49025990|NCT03536884|157934914|FG000|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
49025991|NCT03536884|157934915|FG001|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
49025992|NCT03536884|157934916|FG002|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|1|||
49025993|NCT03536884|157934917|FG003|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|2|||
49025994|NCT03536884|157934918|FG004|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|9|||
49025995|NCT03536884|157934919|FG005|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
49025996|NCT03536884|157934920|FG006|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
49025997|NCT03536884|157934921|FG007|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
49025998|NCT03536884|157934922|FG008|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
49025999|NCT03536884|157934923|FG009|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
49026000|NCT03536884|157934924|FG010|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
48767407|NCT03670810|156996875|FG000|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
48767408|NCT03670810|156996876|FG001|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
49026001|NCT03536884|157934925|FG011|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
48767409|NCT03670810|156996877|FG002|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
48767410|NCT03670810|156996878|FG003|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
48767411|NCT03670810|156996879|FG004|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
48767412|NCT03670810|156996880|FG005|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
48767413|NCT03670810|156996881|FG006|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
48767414|NCT03670810|156996882|FG007|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
48767415|NCT03670810|156996883|FG008|Open Label Extension|Taking medication too restrictive for lifestyle|1|||
48767416|NCT03670810|156996875|FG000|Open Label Extension|Withdrawal by Subject|0|||
48767417|NCT03670810|156996876|FG001|Open Label Extension|Withdrawal by Subject|0|||
48767418|NCT03670810|156996877|FG002|Open Label Extension|Withdrawal by Subject|0|||
48767419|NCT03670810|156996878|FG003|Open Label Extension|Withdrawal by Subject|0|||
48767420|NCT03670810|156996879|FG004|Open Label Extension|Withdrawal by Subject|0|||
48767421|NCT03670810|156996880|FG005|Open Label Extension|Withdrawal by Subject|0|||
48767422|NCT03670810|156996881|FG006|Open Label Extension|Withdrawal by Subject|0|||
48767423|NCT03670810|156996882|FG007|Open Label Extension|Withdrawal by Subject|0|||
48767424|NCT03670810|156996883|FG008|Open Label Extension|Withdrawal by Subject|46|||
48767425|NCT03670810|156996875|FG000|Open Label Extension|Participant didn't have disposition for OLE period|0|||
48767426|NCT03670810|156996876|FG001|Open Label Extension|Participant didn't have disposition for OLE period|0|||
48767427|NCT03670810|156996877|FG002|Open Label Extension|Participant didn't have disposition for OLE period|0|||
48767428|NCT03670810|156996878|FG003|Open Label Extension|Participant didn't have disposition for OLE period|0|||
48875851|NCT00813098|157383325|FG001|Overall Study|Principal Investigator decision|1|||
48875852|NCT00813098|157383326|FG002|Overall Study|Principal Investigator decision|0|||
48875853|NCT00813098|157383324|FG000|Overall Study|Withdrew Consent|0|||
48875854|NCT00813098|157383325|FG001|Overall Study|Withdrew Consent|1|||
48875855|NCT00813098|157383326|FG002|Overall Study|Withdrew Consent|0|||
48875856|NCT03201900|157383327|FG000|Treatment Phase (Up to 62 Weeks)|Adverse Event|9|||
48875857|NCT03201900|157383327|FG000|Treatment Phase (Up to 62 Weeks)|Subject Choice|1|||
48875858|NCT03201900|157383327|FG000|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6|||
48875859|NCT03201900|157383327|FG000|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2|||
48875860|NCT03201900|157383327|FG000|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6|||
48875861|NCT03201900|157383327|FG000|Treatment Phase (Up to 62 Weeks)|Other than specified|11|||
48875862|NCT03201900|157383327|FG000|Treatment Phase (Up to 62 Weeks)|Not treated|2|||
48875863|NCT03201900|157383327|FG000|Extension Phase (From Week 63 to 156)|Subject choice|1|||
48875864|NCT03201900|157383327|FG000|Extension Phase (From Week 63 to 156)|Pregnancy|1|||
48875865|NCT03201900|157383327|FG000|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1|||
48875866|NCT03201900|157383327|FG000|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1|||
48875867|NCT03201900|157383327|FG000|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3|||
48875868|NCT03201900|157383327|FG000|Extension Phase (From Week 63 to 156)|Other|1|||
48875869|NCT03470545|157383328|FG000|Overall Study|Death|0|||
48875870|NCT03470545|157383329|FG001|Overall Study|Death|1|||
48875871|NCT03470545|157383328|FG000|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1|||
48875872|NCT03470545|157383329|FG001|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0|||
48875873|NCT03470545|157383328|FG000|Overall Study|Adverse Event|2|||
48875874|NCT03470545|157383329|FG001|Overall Study|Adverse Event|0|||
48875875|NCT03470545|157383328|FG000|Overall Study|Withdrawal by Subject|1|||
48875876|NCT03470545|157383329|FG001|Overall Study|Withdrawal by Subject|1|||
48875877|NCT03470545|157383328|FG000|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0|||
48875878|NCT03470545|157383329|FG001|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1|||
48875879|NCT01233999|157383330|FG000|Overall Study|Withdrawal by Subject|1|||
48875880|NCT01233999|157383330|FG000|Overall Study|Lost to Follow-up|1|||
48875881|NCT02835092|157383335|FG000|Overall Study|Withdrawal by Subject|3|||
48875882|NCT02835092|157383336|FG001|Overall Study|Withdrawal by Subject|6|||
48875883|NCT02835092|157383337|FG002|Overall Study|Withdrawal by Subject|3|||
48875884|NCT02835092|157383335|FG000|Overall Study|Lost to Follow-up|0|||
48875885|NCT02835092|157383336|FG001|Overall Study|Lost to Follow-up|2|||
48875886|NCT02835092|157383337|FG002|Overall Study|Lost to Follow-up|0|||
49026002|NCT03536884|157934914|FG000|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
49026003|NCT03536884|157934915|FG001|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
48767429|NCT03670810|156996879|FG004|Open Label Extension|Participant didn't have disposition for OLE period|0|||
48767430|NCT03670810|156996880|FG005|Open Label Extension|Participant didn't have disposition for OLE period|0|||
48767431|NCT03670810|156996881|FG006|Open Label Extension|Participant didn't have disposition for OLE period|0|||
48767432|NCT03670810|156996882|FG007|Open Label Extension|Participant didn't have disposition for OLE period|0|||
49026004|NCT03536884|157934916|FG002|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|7|||
49026005|NCT03536884|157934917|FG003|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|3|||
49026006|NCT03536884|157934918|FG004|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|12|||
49026007|NCT03536884|157934919|FG005|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
49026008|NCT03536884|157934920|FG006|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
49026009|NCT03536884|157934921|FG007|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
49026010|NCT03536884|157934922|FG008|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
49026011|NCT03536884|157934923|FG009|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
49026012|NCT03536884|157934924|FG010|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
49026013|NCT03536884|157934925|FG011|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
49026014|NCT03536884|157934914|FG000|OLE Period: Wk48-Wk144|Adverse Event|0|||
49026015|NCT03536884|157934915|FG001|OLE Period: Wk48-Wk144|Adverse Event|0|||
49026016|NCT03536884|157934916|FG002|OLE Period: Wk48-Wk144|Adverse Event|0|||
49026017|NCT03536884|157934917|FG003|OLE Period: Wk48-Wk144|Adverse Event|0|||
49026018|NCT03536884|157934918|FG004|OLE Period: Wk48-Wk144|Adverse Event|0|||
49026019|NCT03536884|157934919|FG005|OLE Period: Wk48-Wk144|Adverse Event|10|||
49026020|NCT03536884|157934920|FG006|OLE Period: Wk48-Wk144|Adverse Event|8|||
49026021|NCT03536884|157934921|FG007|OLE Period: Wk48-Wk144|Adverse Event|6|||
49026022|NCT03536884|157934922|FG008|OLE Period: Wk48-Wk144|Adverse Event|13|||
49026023|NCT03536884|157934923|FG009|OLE Period: Wk48-Wk144|Adverse Event|0|||
49026024|NCT03536884|157934924|FG010|OLE Period: Wk48-Wk144|Adverse Event|0|||
49026025|NCT03536884|157934925|FG011|OLE Period: Wk48-Wk144|Adverse Event|0|||
49026026|NCT03536884|157934914|FG000|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
49026027|NCT03536884|157934915|FG001|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
49026028|NCT03536884|157934916|FG002|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
49026029|NCT03536884|157934917|FG003|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
49026030|NCT03536884|157934918|FG004|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
49026031|NCT03536884|157934919|FG005|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
49026032|NCT03536884|157934920|FG006|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
49026033|NCT03536884|157934921|FG007|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
49026034|NCT03536884|157934922|FG008|OLE Period: Wk48-Wk144|Lack of Efficacy|4|||
49026035|NCT03536884|157934923|FG009|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
49026036|NCT03536884|157934924|FG010|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
49026037|NCT03536884|157934925|FG011|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
49026038|NCT03536884|157934914|FG000|OLE Period: Wk48-Wk144|Protocol Violation|0|||
49026039|NCT03536884|157934915|FG001|OLE Period: Wk48-Wk144|Protocol Violation|0|||
49026040|NCT03536884|157934916|FG002|OLE Period: Wk48-Wk144|Protocol Violation|0|||
49026041|NCT03536884|157934917|FG003|OLE Period: Wk48-Wk144|Protocol Violation|0|||
49026042|NCT03536884|157934918|FG004|OLE Period: Wk48-Wk144|Protocol Violation|0|||
49026043|NCT03536884|157934919|FG005|OLE Period: Wk48-Wk144|Protocol Violation|1|||
49026044|NCT03536884|157934920|FG006|OLE Period: Wk48-Wk144|Protocol Violation|0|||
49026045|NCT03536884|157934921|FG007|OLE Period: Wk48-Wk144|Protocol Violation|2|||
49026046|NCT03536884|157934922|FG008|OLE Period: Wk48-Wk144|Protocol Violation|0|||
49026047|NCT03536884|157934923|FG009|OLE Period: Wk48-Wk144|Protocol Violation|0|||
49026048|NCT03536884|157934924|FG010|OLE Period: Wk48-Wk144|Protocol Violation|0|||
49026049|NCT03536884|157934925|FG011|OLE Period: Wk48-Wk144|Protocol Violation|0|||
49026050|NCT03536884|157934914|FG000|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
48767433|NCT03670810|156996883|FG008|Open Label Extension|Participant didn't have disposition for OLE period|1|||
48767434|NCT03670810|156996875|FG000|Open Label Extension|Physician Decision|0|||
48767435|NCT03670810|156996876|FG001|Open Label Extension|Physician Decision|0|||
48767436|NCT03670810|156996877|FG002|Open Label Extension|Physician Decision|0|||
48767437|NCT03670810|156996878|FG003|Open Label Extension|Physician Decision|0|||
48767438|NCT03670810|156996879|FG004|Open Label Extension|Physician Decision|0|||
48767439|NCT03670810|156996880|FG005|Open Label Extension|Physician Decision|0|||
48767440|NCT03670810|156996881|FG006|Open Label Extension|Physician Decision|0|||
48767441|NCT03670810|156996882|FG007|Open Label Extension|Physician Decision|0|||
48767442|NCT03670810|156996883|FG008|Open Label Extension|Physician Decision|2|||
48767443|NCT03670810|156996875|FG000|Open Label Extension|Non-compliance with study drug|0|||
48767444|NCT03670810|156996876|FG001|Open Label Extension|Non-compliance with study drug|0|||
48767445|NCT03670810|156996877|FG002|Open Label Extension|Non-compliance with study drug|0|||
48767446|NCT03670810|156996878|FG003|Open Label Extension|Non-compliance with study drug|0|||
48875887|NCT01918371|157383343|FG000|Overall Study|Missing Data|1|||
49026051|NCT03536884|157934915|FG001|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
49026052|NCT03536884|157934916|FG002|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
49026053|NCT03536884|157934917|FG003|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
49026054|NCT03536884|157934918|FG004|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
49026055|NCT03536884|157934919|FG005|OLE Period: Wk48-Wk144|Lost to Follow-up|7|||
49026056|NCT03536884|157934920|FG006|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
49026057|NCT03536884|157934921|FG007|OLE Period: Wk48-Wk144|Lost to Follow-up|1|||
49026058|NCT03536884|157934922|FG008|OLE Period: Wk48-Wk144|Lost to Follow-up|5|||
49026059|NCT03536884|157934923|FG009|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
49026060|NCT03536884|157934924|FG010|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
49026061|NCT03536884|157934925|FG011|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
49026062|NCT03536884|157934914|FG000|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
49026063|NCT03536884|157934915|FG001|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
49026064|NCT03536884|157934916|FG002|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
49026065|NCT03536884|157934917|FG003|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
49026066|NCT03536884|157934918|FG004|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
49026067|NCT03536884|157934919|FG005|OLE Period: Wk48-Wk144|Withdrawal by Subject|12|||
49026068|NCT03536884|157934920|FG006|OLE Period: Wk48-Wk144|Withdrawal by Subject|7|||
49026069|NCT03536884|157934921|FG007|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
49026070|NCT03536884|157934922|FG008|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
49026071|NCT03536884|157934923|FG009|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
49026072|NCT03536884|157934924|FG010|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
49026073|NCT03536884|157934925|FG011|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
49026074|NCT03536884|157934914|FG000|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
49026075|NCT03536884|157934915|FG001|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
49026076|NCT03536884|157934916|FG002|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
49026077|NCT03536884|157934917|FG003|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
49026078|NCT03536884|157934918|FG004|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
49026079|NCT03536884|157934919|FG005|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|1|||
49026080|NCT03536884|157934920|FG006|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
49026081|NCT03536884|157934921|FG007|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
49026082|NCT03536884|157934922|FG008|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
49026083|NCT03536884|157934923|FG009|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
49026084|NCT03536884|157934924|FG010|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
49026085|NCT03536884|157934925|FG011|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
49026086|NCT03536884|157934914|FG000|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
49026087|NCT03536884|157934915|FG001|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
49026088|NCT03536884|157934916|FG002|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
49026089|NCT03536884|157934917|FG003|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
49026090|NCT03536884|157934918|FG004|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
49026091|NCT03536884|157934919|FG005|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
49026092|NCT03536884|157934920|FG006|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|1|||
49026093|NCT03536884|157934921|FG007|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
49026094|NCT03536884|157934922|FG008|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
49026095|NCT03536884|157934923|FG009|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
49026096|NCT03536884|157934924|FG010|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
49026097|NCT03536884|157934925|FG011|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
49026098|NCT03536884|157934914|FG000|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
49026099|NCT03536884|157934915|FG001|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
49026100|NCT03536884|157934916|FG002|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
49026101|NCT03536884|157934917|FG003|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
49026102|NCT03536884|157934918|FG004|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
49026103|NCT03536884|157934919|FG005|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
49026104|NCT03536884|157934920|FG006|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|1|||
49026105|NCT03536884|157934921|FG007|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
49026106|NCT03536884|157934922|FG008|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
49026107|NCT03536884|157934923|FG009|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
49026108|NCT03536884|157934924|FG010|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
48767447|NCT03670810|156996879|FG004|Open Label Extension|Non-compliance with study drug|0|||
48767448|NCT03670810|156996880|FG005|Open Label Extension|Non-compliance with study drug|0|||
48767449|NCT03670810|156996881|FG006|Open Label Extension|Non-compliance with study drug|0|||
48767450|NCT03670810|156996882|FG007|Open Label Extension|Non-compliance with study drug|0|||
48767451|NCT03670810|156996883|FG008|Open Label Extension|Non-compliance with study drug|5|||
48767452|NCT03670810|156996875|FG000|Open Label Extension|Pregnancy|0|||
48767453|NCT03670810|156996876|FG001|Open Label Extension|Pregnancy|0|||
48767454|NCT03670810|156996877|FG002|Open Label Extension|Pregnancy|0|||
48767455|NCT03670810|156996878|FG003|Open Label Extension|Pregnancy|0|||
48767456|NCT03670810|156996879|FG004|Open Label Extension|Pregnancy|0|||
48767457|NCT03670810|156996880|FG005|Open Label Extension|Pregnancy|0|||
48767458|NCT03670810|156996881|FG006|Open Label Extension|Pregnancy|0|||
49026109|NCT03536884|157934925|FG011|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
49026110|NCT03536884|157934914|FG000|OLE Period: Wk48-Wk144|Non-compliance|0|||
49026111|NCT03536884|157934915|FG001|OLE Period: Wk48-Wk144|Non-compliance|0|||
49026112|NCT03536884|157934916|FG002|OLE Period: Wk48-Wk144|Non-compliance|0|||
49026113|NCT03536884|157934917|FG003|OLE Period: Wk48-Wk144|Non-compliance|0|||
49026114|NCT03536884|157934918|FG004|OLE Period: Wk48-Wk144|Non-compliance|0|||
49026115|NCT03536884|157934919|FG005|OLE Period: Wk48-Wk144|Non-compliance|1|||
49026116|NCT03536884|157934920|FG006|OLE Period: Wk48-Wk144|Non-compliance|0|||
49026117|NCT03536884|157934921|FG007|OLE Period: Wk48-Wk144|Non-compliance|0|||
49026118|NCT03536884|157934922|FG008|OLE Period: Wk48-Wk144|Non-compliance|0|||
49026119|NCT03536884|157934923|FG009|OLE Period: Wk48-Wk144|Non-compliance|0|||
49026120|NCT03536884|157934924|FG010|OLE Period: Wk48-Wk144|Non-compliance|0|||
49026121|NCT03536884|157934925|FG011|OLE Period: Wk48-Wk144|Non-compliance|0|||
49026122|NCT03536884|157934914|FG000|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
49026123|NCT03536884|157934915|FG001|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
49026124|NCT03536884|157934916|FG002|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
49026125|NCT03536884|157934917|FG003|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
49026126|NCT03536884|157934918|FG004|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
49026127|NCT03536884|157934919|FG005|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
49026128|NCT03536884|157934920|FG006|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
49026129|NCT03536884|157934921|FG007|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
49026130|NCT03536884|157934922|FG008|OLE Period: Wk48-Wk144|She wants to be pregnant|1|||
49026131|NCT03536884|157934923|FG009|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
49026132|NCT03536884|157934924|FG010|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
49026133|NCT03536884|157934925|FG011|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
49026134|NCT03536884|157934914|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
49026135|NCT03536884|157934915|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
49026136|NCT03536884|157934916|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
49026137|NCT03536884|157934917|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
49026138|NCT03536884|157934918|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
49026139|NCT03536884|157934919|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
49026140|NCT03536884|157934920|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
49026141|NCT03536884|157934921|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
49026142|NCT03536884|157934922|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
49026143|NCT03536884|157934923|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
49026144|NCT03536884|157934924|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
49026145|NCT03536884|157934925|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
49026146|NCT03536884|157934914|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
49026147|NCT03536884|157934915|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
49026148|NCT03536884|157934916|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
49026149|NCT03536884|157934917|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
49026150|NCT03536884|157934918|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
49026151|NCT03536884|157934919|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
49026152|NCT03536884|157934920|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
48767459|NCT03670810|156996882|FG007|Open Label Extension|Pregnancy|0|||
48767460|NCT03670810|156996883|FG008|Open Label Extension|Pregnancy|3|||
48767461|NCT03670810|156996875|FG000|Open Label Extension|Adverse Event|0|||
48767462|NCT03670810|156996876|FG001|Open Label Extension|Adverse Event|0|||
48767463|NCT03670810|156996877|FG002|Open Label Extension|Adverse Event|0|||
48767464|NCT03670810|156996878|FG003|Open Label Extension|Adverse Event|0|||
48767465|NCT03670810|156996879|FG004|Open Label Extension|Adverse Event|0|||
48767466|NCT03670810|156996880|FG005|Open Label Extension|Adverse Event|0|||
48767467|NCT03670810|156996881|FG006|Open Label Extension|Adverse Event|0|||
48767468|NCT03670810|156996882|FG007|Open Label Extension|Adverse Event|0|||
48767469|NCT03670810|156996883|FG008|Open Label Extension|Adverse Event|24|||
48767470|NCT03670810|156996875|FG000|Open Label Extension|Participant wanted to become pregnant|0|||
48767471|NCT03670810|156996876|FG001|Open Label Extension|Participant wanted to become pregnant|0|||
48767472|NCT03670810|156996877|FG002|Open Label Extension|Participant wanted to become pregnant|0|||
48767473|NCT03670810|156996878|FG003|Open Label Extension|Participant wanted to become pregnant|0|||
48767474|NCT03670810|156996879|FG004|Open Label Extension|Participant wanted to become pregnant|0|||
48767475|NCT03670810|156996880|FG005|Open Label Extension|Participant wanted to become pregnant|0|||
48767476|NCT03670810|156996881|FG006|Open Label Extension|Participant wanted to become pregnant|0|||
48767477|NCT03670810|156996882|FG007|Open Label Extension|Participant wanted to become pregnant|0|||
48767478|NCT03670810|156996883|FG008|Open Label Extension|Participant wanted to become pregnant|1|||
48767479|NCT03670810|156996875|FG000|Open Label Extension|Lost to Follow-up|0|||
48767480|NCT03670810|156996876|FG001|Open Label Extension|Lost to Follow-up|0|||
48767481|NCT03670810|156996877|FG002|Open Label Extension|Lost to Follow-up|0|||
49026153|NCT03536884|157934921|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
48767482|NCT03670810|156996878|FG003|Open Label Extension|Lost to Follow-up|0|||
49026154|NCT03536884|157934922|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
49026155|NCT03536884|157934923|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
49026156|NCT03536884|157934924|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
49026157|NCT03536884|157934925|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
49026158|NCT03536884|157934914|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
49026159|NCT03536884|157934915|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
49026160|NCT03536884|157934916|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
49026161|NCT03536884|157934917|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
49026162|NCT03536884|157934918|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
49026163|NCT03536884|157934919|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
49026164|NCT03536884|157934920|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
49026165|NCT03536884|157934921|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
49026166|NCT03536884|157934922|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
48767483|NCT03670810|156996879|FG004|Open Label Extension|Lost to Follow-up|0|||
48767484|NCT03670810|156996880|FG005|Open Label Extension|Lost to Follow-up|0|||
48767485|NCT03670810|156996881|FG006|Open Label Extension|Lost to Follow-up|0|||
48767486|NCT03670810|156996882|FG007|Open Label Extension|Lost to Follow-up|0|||
49026167|NCT03536884|157934923|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
49026168|NCT03536884|157934924|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|1|||
49026169|NCT03536884|157934925|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
49026170|NCT03536884|157934914|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
49026171|NCT03536884|157934915|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
49026172|NCT03536884|157934916|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
49026173|NCT03536884|157934917|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
48767487|NCT03670810|156996883|FG008|Open Label Extension|Lost to Follow-up|23|||
48767488|NCT02775344|156996887|FG000|Overall Study|No ovarian cyst identified|3|||
48767489|NCT02775344|156996888|FG001|Overall Study|No ovarian cyst identified|2|||
48767490|NCT04098458|156996912|FG000|Overall Study|Death|1|||
48767491|NCT04098458|156996912|FG000|Overall Study|did not meet study inclusion criteria|3|||
48767492|NCT04033159|156996913|FG000|Washout Period|Physician Decision|0|||
48767493|NCT04033159|156996914|FG001|Washout Period|Physician Decision|1|||
48767494|NCT04033159|156996915|FG002|Washout Period|Physician Decision|0|||
48767495|NCT04033159|156996913|FG000|Washout Period|Study terminated by Sponsor|0|||
48767496|NCT04033159|156996914|FG001|Washout Period|Study terminated by Sponsor|7|||
48767497|NCT04033159|156996915|FG002|Washout Period|Study terminated by Sponsor|0|||
48767498|NCT04033159|156996913|FG000|Multiple Ascending Dose Period|Study terminated by Sponsor|6|||
48767499|NCT04033159|156996914|FG001|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
48767500|NCT04033159|156996915|FG002|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
48767501|NCT00449956|156996918|FG000|Overall Study|Adverse Event|7|||
48767502|NCT00449956|156996919|FG001|Overall Study|Adverse Event|1|||
48767503|NCT00449956|156996920|FG002|Overall Study|Adverse Event|6|||
48767504|NCT00449956|156996918|FG000|Overall Study|Lack of Efficacy|0|||
48767505|NCT00449956|156996919|FG001|Overall Study|Lack of Efficacy|0|||
48767506|NCT00449956|156996920|FG002|Overall Study|Lack of Efficacy|1|||
48767507|NCT00449956|156996918|FG000|Overall Study|Protocol Violation|1|||
48767508|NCT00449956|156996919|FG001|Overall Study|Protocol Violation|1|||
48767509|NCT00449956|156996920|FG002|Overall Study|Protocol Violation|1|||
48767510|NCT00449956|156996918|FG000|Overall Study|Withdrawal by Subject|0|||
48767511|NCT00449956|156996919|FG001|Overall Study|Withdrawal by Subject|1|||
48767512|NCT00449956|156996920|FG002|Overall Study|Withdrawal by Subject|0|||
48767513|NCT00449956|156996918|FG000|Overall Study|Physician Decision|2|||
48767514|NCT00449956|156996919|FG001|Overall Study|Physician Decision|1|||
48767515|NCT00449956|156996920|FG002|Overall Study|Physician Decision|1|||
48767516|NCT04074317|156996933|FG000|Third Period|Withdrawal by Subject|0|||
48767517|NCT04074317|156996934|FG001|Third Period|Withdrawal by Subject|0|||
48767518|NCT04074317|156996935|FG002|Third Period|Withdrawal by Subject|0|||
48767519|NCT04074317|156996936|FG003|Third Period|Withdrawal by Subject|1|||
48767520|NCT04074317|156996937|FG004|Third Period|Withdrawal by Subject|0|||
48767521|NCT04074317|156996938|FG005|Third Period|Withdrawal by Subject|0|||
48767522|NCT00423891|156996939|FG000|Enrolled|Withdrawal by Subject|0|||
48767523|NCT00423891|156996940|FG001|Enrolled|Withdrawal by Subject|0|||
48767524|NCT00423891|156996941|FG002|Enrolled|Withdrawal by Subject|1|||
48767525|NCT00423891|156996939|FG000|Enrolled|Lost to Follow-up|0|||
48767526|NCT00423891|156996940|FG001|Enrolled|Lost to Follow-up|0|||
48767527|NCT00423891|156996941|FG002|Enrolled|Lost to Follow-up|1|||
48767528|NCT00423891|156996939|FG000|Enrolled|No longer met criteria|11|||
48767529|NCT00423891|156996940|FG001|Enrolled|No longer met criteria|2|||
48767530|NCT00423891|156996941|FG002|Enrolled|No longer met criteria|1|||
48767531|NCT00423891|156996939|FG000|Treatment|Withdrawal by Subject|1|||
48767532|NCT00423891|156996940|FG001|Treatment|Withdrawal by Subject|0|||
48767533|NCT00423891|156996941|FG002|Treatment|Withdrawal by Subject|0|||
48767534|NCT00423891|156996939|FG000|Treatment|Lost to Follow-up|1|||
48767535|NCT00423891|156996940|FG001|Treatment|Lost to Follow-up|0|||
48767536|NCT00423891|156996941|FG002|Treatment|Lost to Follow-up|0|||
48767537|NCT00423891|156996939|FG000|Post-Dosing Follow Up|Withdrawal by Subject|0|||
48767538|NCT00423891|156996940|FG001|Post-Dosing Follow Up|Withdrawal by Subject|3|||
48767539|NCT00423891|156996941|FG002|Post-Dosing Follow Up|Withdrawal by Subject|2|||
48767540|NCT00423891|156996939|FG000|Post-Dosing Follow Up|Lost to Follow-up|2|||
48767541|NCT00423891|156996940|FG001|Post-Dosing Follow Up|Lost to Follow-up|0|||
48767542|NCT00423891|156996941|FG002|Post-Dosing Follow Up|Lost to Follow-up|0|||
48767543|NCT02023151|156996945|FG000|Overall Study|Lost to Follow-up|4|||
48767544|NCT05179421|156996946|FG000|First Infusion Day|Adverse Event|1|||
48767545|NCT05179421|156996947|FG001|First Infusion Day|Adverse Event|0|||
48767546|NCT03013543|156996953|FG000|Overall Study|Withdrawal by Subject|0|||
48767547|NCT03013543|156996954|FG001|Overall Study|Withdrawal by Subject|2|||
48767548|NCT03013543|156996955|FG002|Overall Study|Withdrawal by Subject|0|||
48767549|NCT03013543|156996956|FG003|Overall Study|Withdrawal by Subject|5|||
48767550|NCT03013543|156996957|FG004|Overall Study|Withdrawal by Subject|6|||
48767551|NCT03013543|156996958|FG005|Overall Study|Withdrawal by Subject|2|||
48767552|NCT03013543|156996959|FG006|Overall Study|Withdrawal by Subject|3|||
48767553|NCT03013543|156996960|FG007|Overall Study|Withdrawal by Subject|1|||
48767554|NCT03013543|156996961|FG008|Overall Study|Withdrawal by Subject|0|||
48767555|NCT03013543|156996962|FG009|Overall Study|Withdrawal by Subject|4|||
48767556|NCT03013543|156996953|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
48767557|NCT03013543|156996954|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
48767558|NCT03013543|156996955|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
48767559|NCT03013543|156996956|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
48767560|NCT03013543|156996957|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
48767561|NCT03013543|156996958|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
48767562|NCT03013543|156996959|FG006|Overall Study|Withdrawal By Parent/Guardian|0|||
48767563|NCT03013543|156996960|FG007|Overall Study|Withdrawal By Parent/Guardian|0|||
48767564|NCT03013543|156996961|FG008|Overall Study|Withdrawal By Parent/Guardian|1|||
48767565|NCT03013543|156996962|FG009|Overall Study|Withdrawal By Parent/Guardian|1|||
48767566|NCT03013543|156996953|FG000|Overall Study|Other|0|||
48767567|NCT03013543|156996954|FG001|Overall Study|Other|0|||
48767568|NCT03013543|156996955|FG002|Overall Study|Other|2|||
48767569|NCT03013543|156996956|FG003|Overall Study|Other|0|||
48767570|NCT03013543|156996957|FG004|Overall Study|Other|2|||
48767571|NCT03013543|156996958|FG005|Overall Study|Other|0|||
48767572|NCT03013543|156996959|FG006|Overall Study|Other|0|||
48767573|NCT03013543|156996960|FG007|Overall Study|Other|0|||
48767574|NCT03013543|156996961|FG008|Overall Study|Other|1|||
48767575|NCT03013543|156996962|FG009|Overall Study|Other|0|||
48767576|NCT03013543|156996953|FG000|Overall Study|Adverse Event|0|||
48767577|NCT03013543|156996954|FG001|Overall Study|Adverse Event|0|||
48767578|NCT03013543|156996955|FG002|Overall Study|Adverse Event|0|||
48767579|NCT03013543|156996956|FG003|Overall Study|Adverse Event|3|||
48767580|NCT03013543|156996957|FG004|Overall Study|Adverse Event|2|||
48767581|NCT03013543|156996958|FG005|Overall Study|Adverse Event|1|||
48767582|NCT03013543|156996959|FG006|Overall Study|Adverse Event|3|||
48767583|NCT03013543|156996960|FG007|Overall Study|Adverse Event|8|||
48767584|NCT03013543|156996961|FG008|Overall Study|Adverse Event|0|||
48767585|NCT03013543|156996962|FG009|Overall Study|Adverse Event|2|||
48767586|NCT03013543|156996953|FG000|Overall Study|Death|0|||
48767587|NCT03013543|156996954|FG001|Overall Study|Death|0|||
48767588|NCT03013543|156996955|FG002|Overall Study|Death|0|||
48767589|NCT03013543|156996956|FG003|Overall Study|Death|1|||
48767590|NCT03013543|156996957|FG004|Overall Study|Death|0|||
48767591|NCT03013543|156996958|FG005|Overall Study|Death|0|||
48767592|NCT03013543|156996959|FG006|Overall Study|Death|0|||
48767593|NCT03013543|156996960|FG007|Overall Study|Death|0|||
48767594|NCT03013543|156996961|FG008|Overall Study|Death|0|||
48767595|NCT03013543|156996962|FG009|Overall Study|Death|0|||
48767596|NCT03013543|156996953|FG000|Overall Study|Lack of Efficacy|0|||
48767597|NCT03013543|156996954|FG001|Overall Study|Lack of Efficacy|0|||
48982026|NCT04921969|157765597|FG005|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
48982027|NCT04921969|157765598|FG006|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
48982028|NCT04921969|157765592|FG000|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
48982029|NCT04921969|157765593|FG001|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
48982030|NCT04921969|157765594|FG002|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
48982031|NCT04921969|157765595|FG003|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
48982032|NCT04921969|157765596|FG004|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
48982033|NCT04921969|157765597|FG005|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|1|||
48982034|NCT04921969|157765598|FG006|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|2|||
48982035|NCT04921969|157765592|FG000|LTS Period (Weeks 8 to 52)|Ongoing|0|||
48982036|NCT04921969|157765593|FG001|LTS Period (Weeks 8 to 52)|Ongoing|0|||
48767598|NCT03013543|156996955|FG002|Overall Study|Lack of Efficacy|0|||
48767599|NCT03013543|156996956|FG003|Overall Study|Lack of Efficacy|1|||
48767600|NCT03013543|156996957|FG004|Overall Study|Lack of Efficacy|0|||
48767601|NCT03013543|156996958|FG005|Overall Study|Lack of Efficacy|0|||
48767602|NCT03013543|156996959|FG006|Overall Study|Lack of Efficacy|0|||
48767603|NCT03013543|156996960|FG007|Overall Study|Lack of Efficacy|0|||
48767604|NCT03013543|156996961|FG008|Overall Study|Lack of Efficacy|0|||
48767605|NCT03013543|156996962|FG009|Overall Study|Lack of Efficacy|0|||
48767606|NCT03013543|156996953|FG000|Overall Study|Lost to Follow-up|0|||
48767607|NCT03013543|156996954|FG001|Overall Study|Lost to Follow-up|0|||
48767608|NCT03013543|156996955|FG002|Overall Study|Lost to Follow-up|0|||
48767609|NCT03013543|156996956|FG003|Overall Study|Lost to Follow-up|1|||
48767610|NCT03013543|156996957|FG004|Overall Study|Lost to Follow-up|0|||
48767611|NCT03013543|156996958|FG005|Overall Study|Lost to Follow-up|0|||
48767612|NCT03013543|156996959|FG006|Overall Study|Lost to Follow-up|1|||
48767613|NCT03013543|156996960|FG007|Overall Study|Lost to Follow-up|0|||
48767614|NCT03013543|156996961|FG008|Overall Study|Lost to Follow-up|0|||
48767615|NCT03013543|156996962|FG009|Overall Study|Lost to Follow-up|2|||
48767616|NCT03013543|156996953|FG000|Overall Study|Non-Compliance With Study Drug|0|||
48767617|NCT03013543|156996954|FG001|Overall Study|Non-Compliance With Study Drug|0|||
48767618|NCT03013543|156996955|FG002|Overall Study|Non-Compliance With Study Drug|0|||
48767619|NCT03013543|156996956|FG003|Overall Study|Non-Compliance With Study Drug|0|||
48767620|NCT03013543|156996957|FG004|Overall Study|Non-Compliance With Study Drug|0|||
48767621|NCT03013543|156996958|FG005|Overall Study|Non-Compliance With Study Drug|0|||
48767622|NCT03013543|156996959|FG006|Overall Study|Non-Compliance With Study Drug|0|||
48767623|NCT03013543|156996960|FG007|Overall Study|Non-Compliance With Study Drug|0|||
48767624|NCT03013543|156996961|FG008|Overall Study|Non-Compliance With Study Drug|1|||
48767625|NCT03013543|156996962|FG009|Overall Study|Non-Compliance With Study Drug|0|||
48767626|NCT03013543|156996953|FG000|Overall Study|Physician Decision|0|||
48767627|NCT03013543|156996954|FG001|Overall Study|Physician Decision|0|||
48767628|NCT03013543|156996955|FG002|Overall Study|Physician Decision|0|||
48767629|NCT03013543|156996956|FG003|Overall Study|Physician Decision|0|||
48767630|NCT03013543|156996957|FG004|Overall Study|Physician Decision|1|||
48767631|NCT03013543|156996958|FG005|Overall Study|Physician Decision|0|||
48767632|NCT03013543|156996959|FG006|Overall Study|Physician Decision|0|||
48767633|NCT03013543|156996960|FG007|Overall Study|Physician Decision|0|||
48767634|NCT03013543|156996961|FG008|Overall Study|Physician Decision|0|||
48767635|NCT03013543|156996962|FG009|Overall Study|Physician Decision|0|||
48767636|NCT03013543|156996953|FG000|Overall Study|Protocol Violation|0|||
48767637|NCT03013543|156996954|FG001|Overall Study|Protocol Violation|0|||
48767638|NCT03013543|156996955|FG002|Overall Study|Protocol Violation|0|||
48767639|NCT03013543|156996956|FG003|Overall Study|Protocol Violation|0|||
48767640|NCT03013543|156996957|FG004|Overall Study|Protocol Violation|0|||
48767641|NCT03013543|156996958|FG005|Overall Study|Protocol Violation|0|||
48767642|NCT03013543|156996959|FG006|Overall Study|Protocol Violation|0|||
48767643|NCT03013543|156996960|FG007|Overall Study|Protocol Violation|0|||
48767644|NCT03013543|156996961|FG008|Overall Study|Protocol Violation|0|||
48767645|NCT03013543|156996962|FG009|Overall Study|Protocol Violation|1|||
48767646|NCT00323414|156996963|FG000|Overall Study|Withdrawal by Subject|0|||
48767647|NCT00323414|156996964|FG001|Overall Study|Withdrawal by Subject|1|||
48767648|NCT03161483|156996965|FG000|Placebo Controlled Phase|Participant Withdrew Consent|0|||
48767649|NCT03161483|156996966|FG001|Placebo Controlled Phase|Participant Withdrew Consent|1|||
48767650|NCT03161483|156996967|FG002|Placebo Controlled Phase|Participant Withdrew Consent|0|||
48767651|NCT03161483|156996968|FG003|Placebo Controlled Phase|Participant Withdrew Consent|0|||
48767652|NCT03161483|156996965|FG000|Treatment Period|Death|1|||
48767653|NCT03161483|156996966|FG001|Treatment Period|Death|0|||
48767654|NCT03161483|156996967|FG002|Treatment Period|Death|0|||
48767655|NCT03161483|156996968|FG003|Treatment Period|Death|0|||
48767656|NCT03161483|156996965|FG000|Treatment Period|Adverse Event|5|||
48767657|NCT03161483|156996966|FG001|Treatment Period|Adverse Event|2|||
48767658|NCT03161483|156996967|FG002|Treatment Period|Adverse Event|1|||
48767659|NCT03161483|156996968|FG003|Treatment Period|Adverse Event|11|||
48767660|NCT03161483|156996965|FG000|Treatment Period|Pregnancy|1|||
48767661|NCT03161483|156996966|FG001|Treatment Period|Pregnancy|0|||
48875888|NCT01918371|157383344|FG001|Overall Study|Missing Data|1|||
48875889|NCT00243022|157383345|FG000|Overall Study|Withdrawal by Subject|1|||
48767662|NCT03161483|156996967|FG002|Treatment Period|Pregnancy|0|||
48767663|NCT03161483|156996968|FG003|Treatment Period|Pregnancy|0|||
48767664|NCT03161483|156996965|FG000|Treatment Period|Lack of Efficacy|0|||
48767665|NCT03161483|156996966|FG001|Treatment Period|Lack of Efficacy|0|||
48767666|NCT03161483|156996967|FG002|Treatment Period|Lack of Efficacy|0|||
48767667|NCT03161483|156996968|FG003|Treatment Period|Lack of Efficacy|1|||
48767668|NCT03161483|156996965|FG000|Treatment Period|Withdrawal by Subject|2|||
48767669|NCT03161483|156996966|FG001|Treatment Period|Withdrawal by Subject|5|||
48767670|NCT03161483|156996967|FG002|Treatment Period|Withdrawal by Subject|2|||
48875890|NCT00243022|157383346|FG001|Overall Study|Withdrawal by Subject|0|||
48875891|NCT00243022|157383345|FG000|Overall Study|Death|1|||
48767671|NCT03161483|156996968|FG003|Treatment Period|Withdrawal by Subject|6|||
48767672|NCT03161483|156996965|FG000|Treatment Period|Lost to Follow-up|0|||
48767673|NCT03161483|156996966|FG001|Treatment Period|Lost to Follow-up|0|||
48875892|NCT00243022|157383346|FG001|Overall Study|Death|0|||
48875893|NCT00243022|157383345|FG000|Overall Study|Difficult Travel Distance|0|||
48875894|NCT00243022|157383346|FG001|Overall Study|Difficult Travel Distance|1|||
48875895|NCT00621192|157383347|FG000|Overall Study|Withdrawal by Subject|0|||
48875896|NCT00621192|157383348|FG001|Overall Study|Withdrawal by Subject|0|||
48875897|NCT00621192|157383349|FG002|Overall Study|Withdrawal by Subject|2|||
48875898|NCT00621192|157383350|FG003|Overall Study|Withdrawal by Subject|0|||
48875899|NCT00621192|157383347|FG000|Overall Study|Physician Decision|1|||
48875900|NCT00621192|157383348|FG001|Overall Study|Physician Decision|3|||
48875901|NCT00621192|157383349|FG002|Overall Study|Physician Decision|0|||
48875902|NCT00621192|157383350|FG003|Overall Study|Physician Decision|0|||
48875903|NCT00621192|157383347|FG000|Overall Study|Protocol Violation|1|||
48875904|NCT00621192|157383348|FG001|Overall Study|Protocol Violation|0|||
48875905|NCT00621192|157383349|FG002|Overall Study|Protocol Violation|0|||
48875906|NCT00621192|157383350|FG003|Overall Study|Protocol Violation|1|||
48875907|NCT00621192|157383347|FG000|Overall Study|Adverse Event|0|||
48875908|NCT00621192|157383348|FG001|Overall Study|Adverse Event|1|||
48875909|NCT00621192|157383349|FG002|Overall Study|Adverse Event|0|||
48875910|NCT00621192|157383350|FG003|Overall Study|Adverse Event|1|||
48875911|NCT00621192|157383347|FG000|Overall Study|Death|2|||
48875912|NCT00621192|157383348|FG001|Overall Study|Death|5|||
48875913|NCT00621192|157383349|FG002|Overall Study|Death|0|||
48875914|NCT00621192|157383350|FG003|Overall Study|Death|0|||
48875915|NCT00621192|157383347|FG000|Overall Study|Final Assessments not Completed|0|||
48875916|NCT00621192|157383348|FG001|Overall Study|Final Assessments not Completed|0|||
48875917|NCT00621192|157383349|FG002|Overall Study|Final Assessments not Completed|3|||
48875918|NCT00621192|157383350|FG003|Overall Study|Final Assessments not Completed|1|||
48875919|NCT03713320|157383351|FG000|Randomized Period|Adverse Event|1|||
48875920|NCT03713320|157383352|FG001|Randomized Period|Adverse Event|5|||
48875921|NCT03713320|157383353|FG002|Randomized Period|Adverse Event|0|||
48875922|NCT03713320|157383351|FG000|Randomized Period|Physician Decision|1|||
48875923|NCT03713320|157383352|FG001|Randomized Period|Physician Decision|1|||
48875924|NCT03713320|157383353|FG002|Randomized Period|Physician Decision|0|||
48875925|NCT03713320|157383351|FG000|Randomized Period|Withdrawal by Subject|4|||
48875926|NCT03713320|157383352|FG001|Randomized Period|Withdrawal by Subject|0|||
48875927|NCT03713320|157383353|FG002|Randomized Period|Withdrawal by Subject|0|||
48875928|NCT03713320|157383351|FG000|Randomized Period|Participant decision|3|||
49026174|NCT03536884|157934918|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
49026175|NCT03536884|157934919|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
49026176|NCT03536884|157934920|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
49026177|NCT03536884|157934921|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
49026178|NCT03536884|157934922|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
49026179|NCT03536884|157934923|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
49026180|NCT03536884|157934924|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
49026181|NCT03536884|157934925|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|3|||
49026182|NCT03536884|157934914|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
49026183|NCT03536884|157934915|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
49026184|NCT03536884|157934916|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
49026185|NCT03536884|157934917|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
49026186|NCT03536884|157934918|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
49026187|NCT03536884|157934919|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
48767674|NCT03161483|156996967|FG002|Treatment Period|Lost to Follow-up|0|||
48767675|NCT03161483|156996968|FG003|Treatment Period|Lost to Follow-up|1|||
48767676|NCT03161483|156996965|FG000|Treatment Period|Protocol Violation|0|||
48767677|NCT03161483|156996966|FG001|Treatment Period|Protocol Violation|0|||
48875929|NCT03713320|157383352|FG001|Randomized Period|Participant decision|1|||
48875930|NCT03713320|157383353|FG002|Randomized Period|Participant decision|0|||
48875931|NCT03713320|157383351|FG000|Randomized Period|Study terminated by sponsor|6|||
48875932|NCT03713320|157383352|FG001|Randomized Period|Study terminated by sponsor|3|||
48875933|NCT03713320|157383353|FG002|Randomized Period|Study terminated by sponsor|0|||
48875934|NCT03713320|157383351|FG000|Cobomarsen Crossover Period|Physician Decision|0|||
48767678|NCT03161483|156996967|FG002|Treatment Period|Protocol Violation|0|||
48767679|NCT03161483|156996968|FG003|Treatment Period|Protocol Violation|1|||
48875935|NCT03713320|157383352|FG001|Cobomarsen Crossover Period|Physician Decision|0|||
48875936|NCT03713320|157383353|FG002|Cobomarsen Crossover Period|Physician Decision|2|||
48875937|NCT03713320|157383351|FG000|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
48875938|NCT03713320|157383352|FG001|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
48875939|NCT03713320|157383353|FG002|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|5|||
48875940|NCT02719743|157383354|FG000|Overall Study|Consent withdrawal|0|||
48875941|NCT02719743|157383355|FG001|Overall Study|Consent withdrawal|2|||
48875942|NCT02719743|157383356|FG002|Overall Study|Consent withdrawal|0|||
48875943|NCT02719743|157383357|FG003|Overall Study|Consent withdrawal|1|||
48875944|NCT02719743|157383358|FG004|Overall Study|Consent withdrawal|0|||
48875945|NCT02719743|157383354|FG000|Overall Study|Migrated/moved from study area|0|||
48875946|NCT02719743|157383355|FG001|Overall Study|Migrated/moved from study area|0|||
48875947|NCT02719743|157383356|FG002|Overall Study|Migrated/moved from study area|0|||
48875948|NCT02719743|157383357|FG003|Overall Study|Migrated/moved from study area|0|||
48875949|NCT02719743|157383358|FG004|Overall Study|Migrated/moved from study area|2|||
48875950|NCT02719743|157383354|FG000|Overall Study|Lost to Follow-up|1|||
48875951|NCT02719743|157383355|FG001|Overall Study|Lost to Follow-up|1|||
49026188|NCT03536884|157934920|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
49026189|NCT03536884|157934921|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
48767680|NCT03161483|156996965|FG000|Treatment Period|Other reasons|1|||
48767681|NCT03161483|156996966|FG001|Treatment Period|Other reasons|1|||
48767682|NCT03161483|156996967|FG002|Treatment Period|Other reasons|0|||
48767683|NCT03161483|156996968|FG003|Treatment Period|Other reasons|0|||
48767684|NCT01073865|156996971|FG000|Overall Study|Reasons other than below|19|||
48767685|NCT01073865|156996972|FG001|Overall Study|Reasons other than below|31|||
48767686|NCT01073865|156996971|FG000|Overall Study|Lost to Follow-up|1|||
48767687|NCT01073865|156996972|FG001|Overall Study|Lost to Follow-up|1|||
48767688|NCT01073865|156996971|FG000|Overall Study|Death|3|||
48767689|NCT01073865|156996972|FG001|Overall Study|Death|2|||
48767690|NCT01073865|156996971|FG000|Overall Study|Withdrawal by Subject|5|||
48767691|NCT01073865|156996972|FG001|Overall Study|Withdrawal by Subject|5|||
48767692|NCT00743652|156996973|FG000|Overall Study|Parent/Legal Guardian Request|3|||
48767693|NCT00743652|156996974|FG001|Overall Study|Parent/Legal Guardian Request|2|||
48767694|NCT00743652|156996975|FG002|Overall Study|Parent/Legal Guardian Request|2|||
48767695|NCT00743652|156996976|FG003|Overall Study|Parent/Legal Guardian Request|2|||
48767696|NCT00743652|156996977|FG004|Overall Study|Parent/Legal Guardian Request|0|||
48767697|NCT00743652|156996973|FG000|Overall Study|Adverse Event|3|||
48767698|NCT00743652|156996974|FG001|Overall Study|Adverse Event|0|||
48767699|NCT00743652|156996975|FG002|Overall Study|Adverse Event|0|||
48767700|NCT00743652|156996976|FG003|Overall Study|Adverse Event|0|||
48767701|NCT00743652|156996977|FG004|Overall Study|Adverse Event|0|||
48767702|NCT00743652|156996973|FG000|Overall Study|Death|2|||
48767703|NCT00743652|156996974|FG001|Overall Study|Death|0|||
48767704|NCT00743652|156996975|FG002|Overall Study|Death|0|||
48767705|NCT00743652|156996976|FG003|Overall Study|Death|0|||
48767706|NCT00743652|156996977|FG004|Overall Study|Death|0|||
48767707|NCT00743652|156996973|FG000|Overall Study|Investigator Request|0|||
48767708|NCT00743652|156996974|FG001|Overall Study|Investigator Request|0|||
48767709|NCT00743652|156996975|FG002|Overall Study|Investigator Request|0|||
48767710|NCT00743652|156996976|FG003|Overall Study|Investigator Request|2|||
48767711|NCT00743652|156996977|FG004|Overall Study|Investigator Request|0|||
48767712|NCT00743652|156996973|FG000|Overall Study|Other|1|||
48767713|NCT00743652|156996974|FG001|Overall Study|Other|1|||
48767714|NCT00743652|156996975|FG002|Overall Study|Other|0|||
48767715|NCT00743652|156996976|FG003|Overall Study|Other|0|||
48767716|NCT00743652|156996977|FG004|Overall Study|Other|0|||
48767717|NCT00743652|156996973|FG000|Overall Study|Lost to Follow-up|1|||
48767718|NCT00743652|156996974|FG001|Overall Study|Lost to Follow-up|0|||
48767719|NCT00743652|156996975|FG002|Overall Study|Lost to Follow-up|0|||
48767720|NCT00743652|156996976|FG003|Overall Study|Lost to Follow-up|0|||
48767721|NCT00743652|156996977|FG004|Overall Study|Lost to Follow-up|0|||
48767722|NCT02547129|156996978|FG000|Overall Study|Difficulty with ongoing infection|1|||
48767723|NCT02547129|156996979|FG001|Overall Study|Difficulty with ongoing infection|0|||
48875952|NCT02719743|157383356|FG002|Overall Study|Lost to Follow-up|0|||
48875953|NCT02719743|157383357|FG003|Overall Study|Lost to Follow-up|0|||
48875954|NCT02719743|157383358|FG004|Overall Study|Lost to Follow-up|0|||
48875955|NCT01209598|157383359|FG000|Overall Study|Withdrawal by Subject|1|||
48767724|NCT02129803|156996983|FG000|Overall Study|Protocol Violation|4|||
48767725|NCT02129803|156996984|FG001|Overall Study|Protocol Violation|0|||
48767726|NCT02129803|156996983|FG000|Overall Study|Physician Decision|0|||
48767727|NCT02129803|156996984|FG001|Overall Study|Physician Decision|1|||
48767728|NCT02129803|156996983|FG000|Overall Study|Difficulty sleeping|1|||
48767729|NCT02129803|156996984|FG001|Overall Study|Difficulty sleeping|0|||
48767730|NCT02129803|156996983|FG000|Overall Study|Morning headache|0|||
48767731|NCT02129803|156996984|FG001|Overall Study|Morning headache|1|||
48767732|NCT02129803|156996983|FG000|Overall Study|Withdrawal by Subject|1|||
48767733|NCT02129803|156996984|FG001|Overall Study|Withdrawal by Subject|1|||
48767734|NCT01537783|156996994|FG000|Overall Study|Lost to Follow-up|11|||
48767735|NCT01537783|156996995|FG001|Overall Study|Lost to Follow-up|2|||
48767736|NCT03025828|156996996|FG000|Overall Study|Lost to Follow-up|1|||
48767737|NCT01554618|156996997|FG000|Randomized Through Start of Treatment|Adverse Event|1|||
48875956|NCT01209598|157383360|FG001|Overall Study|Withdrawal by Subject|0|||
48875957|NCT04016272|157383372|FG000|Overall Study|Withdrawal by Subject|1|||
48875958|NCT04016272|157383373|FG001|Overall Study|Withdrawal by Subject|2|||
48875959|NCT01078922|157383374|FG000|Overall Study|Adverse Event|1|||
48875960|NCT03432390|157383379|FG000|Apnea Period|Protocol Violation|2|||
48875961|NCT03432390|157383380|FG001|Apnea Period|Protocol Violation|2|||
48875962|NCT00003477|157383381|FG000|Overall Study|Not evalauable|4|||
48875963|NCT01236352|157383382|FG000|Overall Study|Death|0|||
48875964|NCT01236352|157383383|FG001|Overall Study|Death|0|||
48875965|NCT01236352|157383384|FG002|Overall Study|Death|0|||
48875966|NCT01236352|157383385|FG003|Overall Study|Death|0|||
48875967|NCT01236352|157383386|FG004|Overall Study|Death|0|||
48875968|NCT01236352|157383387|FG005|Overall Study|Death|0|||
48875969|NCT01236352|157383388|FG006|Overall Study|Death|0|||
48875970|NCT01236352|157383389|FG007|Overall Study|Death|1|||
48875971|NCT01236352|157383390|FG008|Overall Study|Death|0|||
48875972|NCT01236352|157383391|FG009|Overall Study|Death|0|||
48875973|NCT01236352|157383392|FG010|Overall Study|Death|0|||
48875974|NCT01236352|157383382|FG000|Overall Study|Withdrawal by Subject|0|||
48875975|NCT01236352|157383383|FG001|Overall Study|Withdrawal by Subject|0|||
48875976|NCT01236352|157383384|FG002|Overall Study|Withdrawal by Subject|0|||
48875977|NCT01236352|157383385|FG003|Overall Study|Withdrawal by Subject|0|||
48875978|NCT01236352|157383386|FG004|Overall Study|Withdrawal by Subject|0|||
48875979|NCT01236352|157383387|FG005|Overall Study|Withdrawal by Subject|0|||
48875980|NCT01236352|157383388|FG006|Overall Study|Withdrawal by Subject|0|||
48875981|NCT01236352|157383389|FG007|Overall Study|Withdrawal by Subject|0|||
48875982|NCT01236352|157383390|FG008|Overall Study|Withdrawal by Subject|0|||
48875983|NCT01236352|157383391|FG009|Overall Study|Withdrawal by Subject|2|||
48875984|NCT01236352|157383392|FG010|Overall Study|Withdrawal by Subject|1|||
48875985|NCT01236352|157383382|FG000|Overall Study|Adverse Event|0|||
48875986|NCT01236352|157383383|FG001|Overall Study|Adverse Event|0|||
48875987|NCT01236352|157383384|FG002|Overall Study|Adverse Event|0|||
48875988|NCT01236352|157383385|FG003|Overall Study|Adverse Event|0|||
48875989|NCT01236352|157383386|FG004|Overall Study|Adverse Event|0|||
48875990|NCT01236352|157383387|FG005|Overall Study|Adverse Event|0|||
48875991|NCT01236352|157383388|FG006|Overall Study|Adverse Event|2|||
48875992|NCT01236352|157383389|FG007|Overall Study|Adverse Event|0|||
48875993|NCT01236352|157383390|FG008|Overall Study|Adverse Event|0|||
48875994|NCT01236352|157383391|FG009|Overall Study|Adverse Event|4|||
48875995|NCT01236352|157383392|FG010|Overall Study|Adverse Event|1|||
48875996|NCT01236352|157383382|FG000|Overall Study|Study drug toxicity|0|||
48875997|NCT01236352|157383383|FG001|Overall Study|Study drug toxicity|0|||
48875998|NCT01236352|157383384|FG002|Overall Study|Study drug toxicity|0|||
48875999|NCT01236352|157383385|FG003|Overall Study|Study drug toxicity|0|||
48876000|NCT01236352|157383386|FG004|Overall Study|Study drug toxicity|0|||
48876001|NCT01236352|157383387|FG005|Overall Study|Study drug toxicity|1|||
48876002|NCT01236352|157383388|FG006|Overall Study|Study drug toxicity|1|||
48876003|NCT01236352|157383389|FG007|Overall Study|Study drug toxicity|0|||
48876004|NCT01236352|157383390|FG008|Overall Study|Study drug toxicity|0|||
48876005|NCT01236352|157383391|FG009|Overall Study|Study drug toxicity|2|||
48876006|NCT01236352|157383392|FG010|Overall Study|Study drug toxicity|2|||
48876007|NCT01236352|157383382|FG000|Overall Study|Disease progression|1|||
48876008|NCT01236352|157383383|FG001|Overall Study|Disease progression|2|||
48876009|NCT01236352|157383384|FG002|Overall Study|Disease progression|1|||
48876010|NCT01236352|157383385|FG003|Overall Study|Disease progression|2|||
48876011|NCT01236352|157383386|FG004|Overall Study|Disease progression|2|||
49026190|NCT03536884|157934922|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
49026191|NCT03536884|157934923|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
49026192|NCT03536884|157934924|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
49098990|NCT04064411|158197011|FG001|Overall Study|Other than Specified|1|||
48876012|NCT01236352|157383387|FG005|Overall Study|Disease progression|2|||
48876013|NCT01236352|157383388|FG006|Overall Study|Disease progression|1|||
48876014|NCT01236352|157383389|FG007|Overall Study|Disease progression|3|||
48876015|NCT01236352|157383390|FG008|Overall Study|Disease progression|2|||
48876016|NCT01236352|157383391|FG009|Overall Study|Disease progression|2|||
48876017|NCT01236352|157383392|FG010|Overall Study|Disease progression|2|||
48876018|NCT01236352|157383382|FG000|Overall Study|Poor/Non-compliance|1|||
48876019|NCT01236352|157383383|FG001|Overall Study|Poor/Non-compliance|0|||
48876020|NCT01236352|157383384|FG002|Overall Study|Poor/Non-compliance|0|||
48876021|NCT01236352|157383385|FG003|Overall Study|Poor/Non-compliance|0|||
48876022|NCT01236352|157383386|FG004|Overall Study|Poor/Non-compliance|0|||
48876023|NCT01236352|157383387|FG005|Overall Study|Poor/Non-compliance|0|||
48876024|NCT01236352|157383388|FG006|Overall Study|Poor/Non-compliance|0|||
48876025|NCT01236352|157383389|FG007|Overall Study|Poor/Non-compliance|0|||
48876026|NCT01236352|157383390|FG008|Overall Study|Poor/Non-compliance|0|||
48876027|NCT01236352|157383391|FG009|Overall Study|Poor/Non-compliance|0|||
48876028|NCT01236352|157383392|FG010|Overall Study|Poor/Non-compliance|0|||
48876029|NCT01236352|157383382|FG000|Overall Study|Maximum clinical benefit|1|||
48876030|NCT01236352|157383383|FG001|Overall Study|Maximum clinical benefit|1|||
49026193|NCT03536884|157934925|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|1|||
49026194|NCT00385684|157934926|FG000|FIRST INTERVENTION OF PHASE A|Death|1|||
49026195|NCT00385684|157934927|FG001|FIRST INTERVENTION OF PHASE A|Death|0|||
49026196|NCT00385684|157934926|FG000|SECOND INTERVENTION OF PHASE A|Adverse Event|0|||
49026197|NCT00385684|157934927|FG001|SECOND INTERVENTION OF PHASE A|Adverse Event|1|||
49026198|NCT00385684|157934926|FG000|SECOND INTERVENTION OF PHASE A|study drug recall|0|||
49026199|NCT00385684|157934927|FG001|SECOND INTERVENTION OF PHASE A|study drug recall|1|||
49026200|NCT03616106|157934928|FG000|Overall Study|Removed by PI|6|||
49026201|NCT03616106|157934929|FG001|Overall Study|Removed by PI|0|||
48767738|NCT01554618|156996998|FG001|Randomized Through Start of Treatment|Adverse Event|0|||
48767739|NCT01554618|156996997|FG000|Controlled Assessment Period|Lost to Follow-up|2|||
48767740|NCT01554618|156996998|FG001|Controlled Assessment Period|Lost to Follow-up|1|||
48767741|NCT01554618|156996997|FG000|Controlled Assessment Period|Withdrawal by Subject|6|||
48767742|NCT01554618|156996998|FG001|Controlled Assessment Period|Withdrawal by Subject|0|||
48767743|NCT01554618|156996997|FG000|Open-Label Extension Period|Withdrawal by Subject|2|||
49026202|NCT03616106|157934928|FG000|Overall Study|Withdrawal by Subject|1|||
49026203|NCT03616106|157934929|FG001|Overall Study|Withdrawal by Subject|1|||
49026204|NCT03616106|157934928|FG000|Overall Study|Lost to Follow-up|7|||
49026205|NCT03616106|157934929|FG001|Overall Study|Lost to Follow-up|0|||
49026206|NCT03567174|157934932|FG000|Overall Study|Death|24|||
49026207|NCT03567174|157934933|FG001|Overall Study|Death|31|||
49026208|NCT03567174|157934932|FG000|Overall Study|Lost to Follow-up|165|||
49026209|NCT03567174|157934933|FG001|Overall Study|Lost to Follow-up|174|||
49026210|NCT02131129|157934934|FG000|Overall Study|Withdrawal by Subject|1|||
49026211|NCT02131129|157934935|FG001|Overall Study|Withdrawal by Subject|0|||
49026212|NCT04439539|157935838|FG000|IP:W0-36(Post-PA5)/W52(Prior-PA5)|Withdrawal by Subject|1|||
49026213|NCT04439539|157935839|FG001|IP:W0-36(Post-PA5)/W52(Prior-PA5)|Withdrawal by Subject|0|||
49026214|NCT04439539|157935840|FG002|IP:W0-36(Post-PA5)/W52(Prior-PA5)|Withdrawal by Subject|2|||
49026215|NCT04439539|157935838|FG000|Follow-up (FU): FU Week 0 to 48|Ongoing|0|||
49026216|NCT04439539|157935839|FG001|Follow-up (FU): FU Week 0 to 48|Ongoing|5|||
49026217|NCT04439539|157935840|FG002|Follow-up (FU): FU Week 0 to 48|Ongoing|17|||
49026218|NCT04439539|157935838|FG000|Follow-up (FU): FU Week 0 to 48|Other|0|||
49026219|NCT04439539|157935839|FG001|Follow-up (FU): FU Week 0 to 48|Other|1|||
49026220|NCT04439539|157935840|FG002|Follow-up (FU): FU Week 0 to 48|Other|0|||
49026221|NCT01691508|157935841|FG000|Overall Study|Adverse Event|3|||
49026222|NCT01691508|157935842|FG001|Overall Study|Adverse Event|3|||
49026223|NCT01691508|157935841|FG000|Overall Study|Withdrawal by Subject|1|||
49026224|NCT01691508|157935842|FG001|Overall Study|Withdrawal by Subject|0|||
49026225|NCT02127281|157935843|FG000|Overall Study|Lost to Follow-up|1|||
49026226|NCT02127281|157935844|FG001|Overall Study|Lost to Follow-up|0|||
49026227|NCT04885296|157935845|FG000|Period 1|Covid-19 Related|1|||
48767744|NCT01554618|156996998|FG001|Open-Label Extension Period|Withdrawal by Subject|3|||
48767745|NCT01554618|156996997|FG000|Open-Label Extension Period|Physician Decision|0|||
48767746|NCT01554618|156996998|FG001|Open-Label Extension Period|Physician Decision|1|||
48767747|NCT01554618|156996997|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
48767748|NCT01554618|156996998|FG001|Open-Label Extension Period|Lost to Follow-up|1|||
48767749|NCT02442778|156997004|FG000|Overall Study|Adverse Event|2|||
48767750|NCT02442778|156997005|FG001|Overall Study|Adverse Event|6|||
48767751|NCT02442778|156997006|FG002|Overall Study|Adverse Event|6|||
48767752|NCT02442778|156997004|FG000|Overall Study|Death|0|||
48767753|NCT02442778|156997005|FG001|Overall Study|Death|2|||
48767754|NCT02442778|156997006|FG002|Overall Study|Death|0|||
48767755|NCT02442778|156997004|FG000|Overall Study|Lack of Efficacy|1|||
48767756|NCT02442778|156997005|FG001|Overall Study|Lack of Efficacy|0|||
48767757|NCT02442778|156997006|FG002|Overall Study|Lack of Efficacy|0|||
48767758|NCT02442778|156997004|FG000|Overall Study|Lost to Follow-up|1|||
48767759|NCT02442778|156997005|FG001|Overall Study|Lost to Follow-up|1|||
48767760|NCT02442778|156997006|FG002|Overall Study|Lost to Follow-up|1|||
49026228|NCT04885296|157935846|FG001|Period 1|Covid-19 Related|0|||
49026229|NCT04885296|157935845|FG000|Period 1|Adverse Event|0|||
49026230|NCT04885296|157935846|FG001|Period 1|Adverse Event|1|||
49026231|NCT04885296|157935845|FG000|Period 1|Withdrawal by Subject|1|||
49026232|NCT04885296|157935846|FG001|Period 1|Withdrawal by Subject|1|||
49026233|NCT04885296|157935845|FG000|Period 1|Test Article No Longer Available|1|||
49026234|NCT04885296|157935846|FG001|Period 1|Test Article No Longer Available|0|||
49026235|NCT04885296|157935845|FG000|Period 1|Dispensed Study lens in Error|1|||
49026236|NCT04885296|157935846|FG001|Period 1|Dispensed Study lens in Error|0|||
49026237|NCT04885296|157935845|FG000|Period 1|Lost to Follow-up|1|||
49026238|NCT04885296|157935846|FG001|Period 1|Lost to Follow-up|0|||
48767761|NCT02442778|156997004|FG000|Overall Study|Non-compliance with study drug|2|||
48767762|NCT02442778|156997005|FG001|Overall Study|Non-compliance with study drug|0|||
48767763|NCT02442778|156997006|FG002|Overall Study|Non-compliance with study drug|1|||
48767764|NCT02442778|156997004|FG000|Overall Study|Physician Decision|1|||
49026239|NCT04885296|157935845|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
49026240|NCT04885296|157935846|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
49026241|NCT00862979|157935849|FG000|Overall Study|Adverse Event|6|||
49026242|NCT00862979|157935850|FG001|Overall Study|Adverse Event|3|||
49026243|NCT00862979|157935849|FG000|Overall Study|Protocol Violation|0|||
49026244|NCT00862979|157935850|FG001|Overall Study|Protocol Violation|1|||
49026245|NCT00862979|157935849|FG000|Overall Study|Patient withdrew consent|2|||
49026246|NCT00862979|157935850|FG001|Overall Study|Patient withdrew consent|1|||
49026247|NCT00862979|157935849|FG000|Overall Study|Administrative problems|0|||
49026248|NCT00862979|157935850|FG001|Overall Study|Administrative problems|1|||
49026249|NCT00862979|157935849|FG000|Overall Study|Death|0|||
49026250|NCT00862979|157935850|FG001|Overall Study|Death|1|||
49026251|NCT05551637|157935851|FG000|Overall Study|Lack of Efficacy|0|||
49026252|NCT05551637|157935852|FG001|Overall Study|Lack of Efficacy|6|||
49026253|NCT05551637|157935851|FG000|Overall Study|Lost to Follow-up|1|||
49026254|NCT05551637|157935852|FG001|Overall Study|Lost to Follow-up|1|||
49026255|NCT01682083|157935853|FG000|Overall Study|Lost to Follow-up|11|||
49026256|NCT01682083|157935854|FG001|Overall Study|Lost to Follow-up|18|||
49026257|NCT01682083|157935853|FG000|Overall Study|Withdrawal by Subject|31|||
49026258|NCT01682083|157935854|FG001|Overall Study|Withdrawal by Subject|40|||
49026259|NCT01682083|157935853|FG000|Overall Study|Death|60|||
49026260|NCT01682083|157935854|FG001|Overall Study|Death|93|||
49026261|NCT01682083|157935853|FG000|Overall Study|Physician Decision|5|||
49026262|NCT01682083|157935854|FG001|Overall Study|Physician Decision|4|||
49026263|NCT03497897|157935856|FG000|Overall Study|Adverse Event|1|||
49026264|NCT03497897|157935857|FG001|Overall Study|Adverse Event|1|||
49026265|NCT03497897|157935858|FG002|Overall Study|Adverse Event|1|||
49026266|NCT03497897|157935856|FG000|Overall Study|Lost to Follow-up|2|||
49026267|NCT03497897|157935857|FG001|Overall Study|Lost to Follow-up|0|||
49026268|NCT03497897|157935858|FG002|Overall Study|Lost to Follow-up|2|||
49026269|NCT03497897|157935856|FG000|Overall Study|Physician Decision|1|||
49026270|NCT03497897|157935857|FG001|Overall Study|Physician Decision|0|||
49026271|NCT03497897|157935858|FG002|Overall Study|Physician Decision|0|||
49026272|NCT03497897|157935856|FG000|Overall Study|Subject/Guardian Decision|2|||
49026273|NCT03497897|157935857|FG001|Overall Study|Subject/Guardian Decision|1|||
48767765|NCT02442778|156997005|FG001|Overall Study|Physician Decision|1|||
48767766|NCT02442778|156997006|FG002|Overall Study|Physician Decision|1|||
48767767|NCT02442778|156997004|FG000|Overall Study|Protocol Deviation|3|||
48767768|NCT02442778|156997005|FG001|Overall Study|Protocol Deviation|0|||
48767769|NCT02442778|156997006|FG002|Overall Study|Protocol Deviation|1|||
48767770|NCT02442778|156997004|FG000|Overall Study|Study participant withdrawal by parent or guardian|3|||
48767771|NCT02442778|156997005|FG001|Overall Study|Study participant withdrawal by parent or guardian|12|||
48767772|NCT02442778|156997006|FG002|Overall Study|Study participant withdrawal by parent or guardian|2|||
48767773|NCT02442778|156997004|FG000|Overall Study|Withdrawal by Subject|4|||
48767774|NCT02442778|156997005|FG001|Overall Study|Withdrawal by Subject|4|||
48767775|NCT02442778|156997006|FG002|Overall Study|Withdrawal by Subject|3|||
48767776|NCT02442778|156997004|FG000|Overall Study|Reason not specified|1|||
48767777|NCT02442778|156997005|FG001|Overall Study|Reason not specified|4|||
48767778|NCT02442778|156997006|FG002|Overall Study|Reason not specified|0|||
48767779|NCT01455012|156997007|FG000|Overall Study|Adverse Event|0|||
48767780|NCT01455012|156997008|FG001|Overall Study|Adverse Event|2|||
48767781|NCT01455012|156997007|FG000|Overall Study|Lack of Efficacy|6|||
48767782|NCT01455012|156997008|FG001|Overall Study|Lack of Efficacy|1|||
48767783|NCT01455012|156997007|FG000|Overall Study|Withdrawal by Subject|3|||
48767784|NCT01455012|156997008|FG001|Overall Study|Withdrawal by Subject|1|||
48767785|NCT01455012|156997007|FG000|Overall Study|Unknown reason|2|||
48767786|NCT01455012|156997008|FG001|Overall Study|Unknown reason|0|||
48767787|NCT04552587|156997009|FG000|Overall Study|Lost to Follow-up|4|||
48767788|NCT01822132|156997010|FG000|Overall Study|Lost to Follow-up|4|||
48767789|NCT01822132|156997011|FG001|Overall Study|Lost to Follow-up|2|||
48767790|NCT01215227|156997013|FG000|Overall Study|Adverse Event|11|||
48767791|NCT01215227|156997014|FG001|Overall Study|Adverse Event|11|||
48767792|NCT01215227|156997015|FG002|Overall Study|Adverse Event|4|||
48767793|NCT01215227|156997016|FG003|Overall Study|Adverse Event|8|||
48767794|NCT01215227|156997017|FG004|Overall Study|Adverse Event|7|||
48767795|NCT01215227|156997018|FG005|Overall Study|Adverse Event|6|||
48767796|NCT01215227|156997013|FG000|Overall Study|Treatment Failure|8|||
48767797|NCT01215227|156997014|FG001|Overall Study|Treatment Failure|4|||
48767798|NCT01215227|156997015|FG002|Overall Study|Treatment Failure|1|||
48767799|NCT01215227|156997016|FG003|Overall Study|Treatment Failure|5|||
48767800|NCT01215227|156997017|FG004|Overall Study|Treatment Failure|1|||
48767801|NCT01215227|156997018|FG005|Overall Study|Treatment Failure|1|||
49026274|NCT03497897|157935858|FG002|Overall Study|Subject/Guardian Decision|3|||
49026275|NCT00860405|157935859|FG000|Overall Study|Main reason: Follow-up data not complete|5|||
49026276|NCT00860405|157935860|FG001|Overall Study|Main reason: Follow-up data not complete|4|||
49026277|NCT01710657|157935865|FG000|Overall Study|Lost to Follow-up|2|||
48767802|NCT01215227|156997013|FG000|Overall Study|Lost to Follow-up|1|||
48767803|NCT01215227|156997014|FG001|Overall Study|Lost to Follow-up|4|||
48767804|NCT01215227|156997015|FG002|Overall Study|Lost to Follow-up|1|||
48767805|NCT01215227|156997016|FG003|Overall Study|Lost to Follow-up|1|||
48767806|NCT01215227|156997017|FG004|Overall Study|Lost to Follow-up|1|||
49026278|NCT01710657|157935866|FG001|Overall Study|Lost to Follow-up|0|||
49026279|NCT01710657|157935867|FG002|Overall Study|Lost to Follow-up|1|||
49026280|NCT01710657|157935865|FG000|Overall Study|Protocol Violation|2|||
49026281|NCT01710657|157935866|FG001|Overall Study|Protocol Violation|2|||
49026282|NCT01710657|157935867|FG002|Overall Study|Protocol Violation|0|||
48767807|NCT01215227|156997018|FG005|Overall Study|Lost to Follow-up|2|||
48767808|NCT01215227|156997013|FG000|Overall Study|Subject Withdrew Consent|16|||
48767809|NCT01215227|156997014|FG001|Overall Study|Subject Withdrew Consent|20|||
48767810|NCT01215227|156997015|FG002|Overall Study|Subject Withdrew Consent|7|||
48767811|NCT01215227|156997016|FG003|Overall Study|Subject Withdrew Consent|10|||
48767812|NCT01215227|156997017|FG004|Overall Study|Subject Withdrew Consent|11|||
48767813|NCT01215227|156997018|FG005|Overall Study|Subject Withdrew Consent|8|||
48767814|NCT01215227|156997013|FG000|Overall Study|Non-Compliance With Protocol|2|||
48767815|NCT01215227|156997014|FG001|Overall Study|Non-Compliance With Protocol|6|||
48767816|NCT01215227|156997015|FG002|Overall Study|Non-Compliance With Protocol|1|||
48767817|NCT01215227|156997016|FG003|Overall Study|Non-Compliance With Protocol|0|||
48767818|NCT01215227|156997017|FG004|Overall Study|Non-Compliance With Protocol|0|||
48767819|NCT01215227|156997018|FG005|Overall Study|Non-Compliance With Protocol|0|||
48767820|NCT01215227|156997013|FG000|Overall Study|Administrative|83|||
48767821|NCT01215227|156997014|FG001|Overall Study|Administrative|73|||
48767822|NCT01215227|156997015|FG002|Overall Study|Administrative|42|||
48767823|NCT01215227|156997016|FG003|Overall Study|Administrative|24|||
48767824|NCT01215227|156997017|FG004|Overall Study|Administrative|28|||
48767825|NCT01215227|156997018|FG005|Overall Study|Administrative|40|||
48767826|NCT01215227|156997013|FG000|Overall Study|Missing Status|0|||
48767827|NCT01215227|156997014|FG001|Overall Study|Missing Status|1|||
48767828|NCT01215227|156997015|FG002|Overall Study|Missing Status|0|||
48767829|NCT01215227|156997016|FG003|Overall Study|Missing Status|0|||
48767830|NCT01215227|156997017|FG004|Overall Study|Missing Status|0|||
48767831|NCT01215227|156997018|FG005|Overall Study|Missing Status|0|||
48767832|NCT01215227|156997013|FG000|Overall Study|Randomized but not treated|0|||
48767833|NCT01215227|156997014|FG001|Overall Study|Randomized but not treated|0|||
48767834|NCT01215227|156997015|FG002|Overall Study|Randomized but not treated|1|||
48767835|NCT01215227|156997016|FG003|Overall Study|Randomized but not treated|1|||
48767836|NCT01215227|156997017|FG004|Overall Study|Randomized but not treated|0|||
48767837|NCT01215227|156997018|FG005|Overall Study|Randomized but not treated|1|||
48767838|NCT02678676|156997020|FG000|Overall Study|Death|619|||
48767839|NCT02678676|156997021|FG001|Overall Study|Death|649|||
48767840|NCT02678676|156997020|FG000|Overall Study|Withdrawal by Subject|13|||
48767841|NCT02678676|156997021|FG001|Overall Study|Withdrawal by Subject|5|||
48767842|NCT02678676|156997020|FG000|Overall Study|Lost to Follow-up|171|||
48767843|NCT02678676|156997021|FG001|Overall Study|Lost to Follow-up|151|||
48767844|NCT02678676|156997020|FG000|Overall Study|Unconfirmed for lost to follow-up|85|||
48767845|NCT02678676|156997021|FG001|Overall Study|Unconfirmed for lost to follow-up|67|||
48767846|NCT00989833|156997022|FG000|Overall Study|Lost to Follow-up|0|||
48767847|NCT00989833|156997023|FG001|Overall Study|Lost to Follow-up|1|||
48767848|NCT00989833|156997024|FG002|Overall Study|Lost to Follow-up|0|||
48767849|NCT00989833|156997022|FG000|Overall Study|Protocol Violation|1|||
48767850|NCT00989833|156997023|FG001|Overall Study|Protocol Violation|2|||
48767851|NCT00989833|156997024|FG002|Overall Study|Protocol Violation|1|||
48767852|NCT00989833|156997022|FG000|Overall Study|Withdrawal by Subject|0|||
48767853|NCT00989833|156997023|FG001|Overall Study|Withdrawal by Subject|0|||
48767854|NCT00989833|156997024|FG002|Overall Study|Withdrawal by Subject|1|||
48767855|NCT00989833|156997022|FG000|Overall Study|Incorrectly randomized|1|||
48767856|NCT00989833|156997023|FG001|Overall Study|Incorrectly randomized|0|||
48767857|NCT00989833|156997024|FG002|Overall Study|Incorrectly randomized|0|||
48767858|NCT00308711|156997026|FG000|Overall Study|Withdrawal by Subject|1|||
48767859|NCT00308711|156997027|FG001|Overall Study|Withdrawal by Subject|0|||
48767860|NCT00308711|156997028|FG002|Overall Study|Withdrawal by Subject|1|||
48767861|NCT00308711|156997026|FG000|Overall Study|Protocol Violation|0|||
48767862|NCT00308711|156997027|FG001|Overall Study|Protocol Violation|1|||
48767863|NCT00308711|156997028|FG002|Overall Study|Protocol Violation|1|||
48767864|NCT00308711|156997026|FG000|Overall Study|Lost to Follow-up|0|||
48767865|NCT00308711|156997027|FG001|Overall Study|Lost to Follow-up|1|||
48767866|NCT00308711|156997028|FG002|Overall Study|Lost to Follow-up|0|||
48767867|NCT00308711|156997026|FG000|Overall Study|Baby not born within 7 days of treatment|1|||
48767868|NCT00308711|156997027|FG001|Overall Study|Baby not born within 7 days of treatment|2|||
48767869|NCT00308711|156997028|FG002|Overall Study|Baby not born within 7 days of treatment|2|||
48767870|NCT00308711|156997026|FG000|Overall Study|Subject incarcerated, data not allowed|0|||
48767871|NCT00308711|156997027|FG001|Overall Study|Subject incarcerated, data not allowed|0|||
48767872|NCT00308711|156997028|FG002|Overall Study|Subject incarcerated, data not allowed|1|||
48767873|NCT03149237|156997029|FG000|Overall Study|Withdrawal by Subject|4|||
48767874|NCT03149237|156997030|FG001|Overall Study|Withdrawal by Subject|5|||
48767875|NCT02167256|156997031|FG000|Overall Study|Adverse Event|13|||
48767876|NCT02167256|156997032|FG001|Overall Study|Adverse Event|6|||
48876031|NCT01236352|157383384|FG002|Overall Study|Maximum clinical benefit|1|||
48876032|NCT01236352|157383385|FG003|Overall Study|Maximum clinical benefit|0|||
48876033|NCT01236352|157383386|FG004|Overall Study|Maximum clinical benefit|2|||
48876034|NCT01236352|157383387|FG005|Overall Study|Maximum clinical benefit|0|||
48876035|NCT01236352|157383388|FG006|Overall Study|Maximum clinical benefit|3|||
48876036|NCT01236352|157383389|FG007|Overall Study|Maximum clinical benefit|1|||
48876037|NCT01236352|157383390|FG008|Overall Study|Maximum clinical benefit|1|||
48876038|NCT01236352|157383391|FG009|Overall Study|Maximum clinical benefit|4|||
48876039|NCT01236352|157383392|FG010|Overall Study|Maximum clinical benefit|2|||
48876040|NCT01236352|157383382|FG000|Overall Study|Subject request to discontinue treatment|0|||
48876041|NCT01236352|157383383|FG001|Overall Study|Subject request to discontinue treatment|0|||
48767877|NCT02167256|156997031|FG000|Overall Study|Withdrawal by Subject|4|||
48767878|NCT02167256|156997032|FG001|Overall Study|Withdrawal by Subject|4|||
48767879|NCT02167256|156997031|FG000|Overall Study|non-compliance|3|||
48767880|NCT02167256|156997032|FG001|Overall Study|non-compliance|0|||
48767881|NCT02167256|156997031|FG000|Overall Study|Study partner unable to participate|1|||
48767882|NCT02167256|156997032|FG001|Overall Study|Study partner unable to participate|0|||
48767883|NCT01466192|156997033|FG000|Overall Study|Physician Decision|1|||
48767884|NCT01466192|156997033|FG000|Overall Study|Withdrawal by Subject|3|||
48767885|NCT00414388|156997034|FG000|Overall Study|Adverse Event|1|||
48876042|NCT01236352|157383384|FG002|Overall Study|Subject request to discontinue treatment|1|||
48876043|NCT01236352|157383385|FG003|Overall Study|Subject request to discontinue treatment|1|||
48876044|NCT01236352|157383386|FG004|Overall Study|Subject request to discontinue treatment|0|||
48876045|NCT01236352|157383387|FG005|Overall Study|Subject request to discontinue treatment|1|||
48876046|NCT01236352|157383388|FG006|Overall Study|Subject request to discontinue treatment|0|||
48876047|NCT01236352|157383389|FG007|Overall Study|Subject request to discontinue treatment|0|||
48876048|NCT01236352|157383390|FG008|Overall Study|Subject request to discontinue treatment|0|||
48876049|NCT01236352|157383391|FG009|Overall Study|Subject request to discontinue treatment|1|||
48876050|NCT01236352|157383392|FG010|Overall Study|Subject request to discontinue treatment|4|||
48876051|NCT01236352|157383382|FG000|Overall Study|Subject to receive drug via EAP|1|||
48876052|NCT01236352|157383383|FG001|Overall Study|Subject to receive drug via EAP|1|||
48876053|NCT01236352|157383384|FG002|Overall Study|Subject to receive drug via EAP|1|||
48876054|NCT01236352|157383385|FG003|Overall Study|Subject to receive drug via EAP|0|||
48876055|NCT01236352|157383386|FG004|Overall Study|Subject to receive drug via EAP|0|||
48876056|NCT01236352|157383387|FG005|Overall Study|Subject to receive drug via EAP|0|||
48876057|NCT01236352|157383388|FG006|Overall Study|Subject to receive drug via EAP|0|||
48876058|NCT01236352|157383389|FG007|Overall Study|Subject to receive drug via EAP|2|||
48876059|NCT01236352|157383390|FG008|Overall Study|Subject to receive drug via EAP|0|||
48876060|NCT01236352|157383391|FG009|Overall Study|Subject to receive drug via EAP|4|||
48876061|NCT01236352|157383392|FG010|Overall Study|Subject to receive drug via EAP|0|||
48876062|NCT01236352|157383382|FG000|Overall Study|Patient moving to allogeneic transplant|0|||
48876063|NCT01236352|157383383|FG001|Overall Study|Patient moving to allogeneic transplant|0|||
48767886|NCT03467425|156997035|FG000|Overall Study|Adverse Event|9|||
48767887|NCT03467425|156997036|FG001|Overall Study|Adverse Event|9|||
48767888|NCT03467425|156997035|FG000|Overall Study|Lack of Efficacy|3|||
48767889|NCT03467425|156997036|FG001|Overall Study|Lack of Efficacy|1|||
48767890|NCT03467425|156997035|FG000|Overall Study|Protocol Violation|0|||
48767891|NCT03467425|156997036|FG001|Overall Study|Protocol Violation|1|||
48767892|NCT03467425|156997035|FG000|Overall Study|Lost to Follow-up|18|||
48767893|NCT03467425|156997036|FG001|Overall Study|Lost to Follow-up|25|||
48767894|NCT03467425|156997035|FG000|Overall Study|Physician Decision|2|||
48767895|NCT03467425|156997036|FG001|Overall Study|Physician Decision|1|||
48767896|NCT03467425|156997035|FG000|Overall Study|Withdrawal by Subject|15|||
48767897|NCT03467425|156997036|FG001|Overall Study|Withdrawal by Subject|17|||
48767898|NCT00813358|156997037|FG000|Overall Study|Death|32|||
48767899|NCT00813358|156997037|FG000|Overall Study|Lost to Follow-up|12|||
48767900|NCT00813358|156997037|FG000|Overall Study|other endpoints|5|||
48767901|NCT00813358|156997037|FG000|Overall Study|Withdrawal by Subject|20|||
48767902|NCT01660412|156997050|FG000|Overall Study|Protocol Violation|0|||
48767903|NCT01660412|156997051|FG001|Overall Study|Protocol Violation|3|||
48767904|NCT00403273|156998878|FG000|Overall Study|Lost to Follow-up|3|||
48767905|NCT00403273|156998879|FG001|Overall Study|Lost to Follow-up|2|||
48767906|NCT00403273|156998878|FG000|Overall Study|Physician Decision|0|||
48767907|NCT00403273|156998879|FG001|Overall Study|Physician Decision|1|||
48767908|NCT00403273|156998878|FG000|Overall Study|pt. wanted to have a surgical procedure|0|||
48767909|NCT00403273|156998879|FG001|Overall Study|pt. wanted to have a surgical procedure|1|||
48767910|NCT04709575|156998880|FG000|Overall Study|Withdrawal by Subject|6|||
48767911|NCT04709575|156998881|FG001|Overall Study|Withdrawal by Subject|2|||
48767912|NCT04709575|156998880|FG000|Overall Study|Lost to Follow-up|2|||
48876064|NCT01236352|157383384|FG002|Overall Study|Patient moving to allogeneic transplant|0|||
48876065|NCT01236352|157383385|FG003|Overall Study|Patient moving to allogeneic transplant|0|||
48876066|NCT01236352|157383386|FG004|Overall Study|Patient moving to allogeneic transplant|0|||
48876067|NCT01236352|157383387|FG005|Overall Study|Patient moving to allogeneic transplant|0|||
48767913|NCT04709575|156998881|FG001|Overall Study|Lost to Follow-up|2|||
48767914|NCT04709575|156998880|FG000|Overall Study|Adverse Event|1|||
48876068|NCT01236352|157383388|FG006|Overall Study|Patient moving to allogeneic transplant|1|||
48876069|NCT01236352|157383389|FG007|Overall Study|Patient moving to allogeneic transplant|0|||
48876070|NCT01236352|157383390|FG008|Overall Study|Patient moving to allogeneic transplant|0|||
48876071|NCT01236352|157383391|FG009|Overall Study|Patient moving to allogeneic transplant|0|||
48876072|NCT01236352|157383392|FG010|Overall Study|Patient moving to allogeneic transplant|0|||
48876073|NCT01236352|157383382|FG000|Overall Study|Relapse of Splenomegaly and symptoms|0|||
48876074|NCT01236352|157383383|FG001|Overall Study|Relapse of Splenomegaly and symptoms|0|||
48876075|NCT01236352|157383384|FG002|Overall Study|Relapse of Splenomegaly and symptoms|0|||
48876076|NCT01236352|157383385|FG003|Overall Study|Relapse of Splenomegaly and symptoms|0|||
48876077|NCT01236352|157383386|FG004|Overall Study|Relapse of Splenomegaly and symptoms|0|||
48876078|NCT01236352|157383387|FG005|Overall Study|Relapse of Splenomegaly and symptoms|0|||
48876079|NCT01236352|157383388|FG006|Overall Study|Relapse of Splenomegaly and symptoms|0|||
48876080|NCT01236352|157383389|FG007|Overall Study|Relapse of Splenomegaly and symptoms|0|||
48876081|NCT01236352|157383390|FG008|Overall Study|Relapse of Splenomegaly and symptoms|0|||
48876082|NCT01236352|157383391|FG009|Overall Study|Relapse of Splenomegaly and symptoms|0|||
48876083|NCT01236352|157383392|FG010|Overall Study|Relapse of Splenomegaly and symptoms|1|||
48876084|NCT01236352|157383382|FG000|Overall Study|Lack of response to drug|0|||
48876085|NCT01236352|157383383|FG001|Overall Study|Lack of response to drug|0|||
48876086|NCT01236352|157383384|FG002|Overall Study|Lack of response to drug|0|||
48876087|NCT01236352|157383385|FG003|Overall Study|Lack of response to drug|0|||
48876088|NCT01236352|157383386|FG004|Overall Study|Lack of response to drug|0|||
48876089|NCT01236352|157383387|FG005|Overall Study|Lack of response to drug|0|||
48876090|NCT01236352|157383388|FG006|Overall Study|Lack of response to drug|0|||
48876091|NCT01236352|157383389|FG007|Overall Study|Lack of response to drug|0|||
48876092|NCT01236352|157383390|FG008|Overall Study|Lack of response to drug|0|||
48876093|NCT01236352|157383391|FG009|Overall Study|Lack of response to drug|1|||
48876094|NCT01236352|157383392|FG010|Overall Study|Lack of response to drug|1|||
48876095|NCT01236352|157383382|FG000|Overall Study|Patient transferred to IST|0|||
48876096|NCT01236352|157383383|FG001|Overall Study|Patient transferred to IST|0|||
48876097|NCT01236352|157383384|FG002|Overall Study|Patient transferred to IST|0|||
48767915|NCT04709575|156998881|FG001|Overall Study|Adverse Event|0|||
48767916|NCT04709575|156998880|FG000|Overall Study|Protocol Violation|1|||
48767917|NCT04709575|156998881|FG001|Overall Study|Protocol Violation|1|||
48767918|NCT01852292|156998886|FG000|Overall Study|Untreated - did not receive study drug|3|||
48767919|NCT01852292|156998887|FG001|Overall Study|Untreated - did not receive study drug|1|||
48767920|NCT01852292|156998886|FG000|Overall Study|Death|9|||
48767921|NCT01852292|156998887|FG001|Overall Study|Death|8|||
48767922|NCT01852292|156998886|FG000|Overall Study|Patient/guardian decision|8|||
48767923|NCT01852292|156998887|FG001|Overall Study|Patient/guardian decision|4|||
48876098|NCT01236352|157383385|FG003|Overall Study|Patient transferred to IST|0|||
48767924|NCT01852292|156998886|FG000|Overall Study|Adverse Event|8|||
48767925|NCT01852292|156998887|FG001|Overall Study|Adverse Event|11|||
48767926|NCT01852292|156998886|FG000|Overall Study|Physician Decision|6|||
48767927|NCT01852292|156998887|FG001|Overall Study|Physician Decision|2|||
48767928|NCT01852292|156998886|FG000|Overall Study|Protocol Violation|2|||
48767929|NCT01852292|156998887|FG001|Overall Study|Protocol Violation|0|||
48767930|NCT01852292|156998886|FG000|Overall Study|Non-compliance with study treatment|1|||
48767931|NCT01852292|156998887|FG001|Overall Study|Non-compliance with study treatment|0|||
48767932|NCT01852292|156998886|FG000|Overall Study|Study terminated by Sponsor|0|||
48767933|NCT01852292|156998887|FG001|Overall Study|Study terminated by Sponsor|1|||
48767934|NCT01852292|156998886|FG000|Overall Study|Progressive disease|42|||
48767935|NCT01852292|156998887|FG001|Overall Study|Progressive disease|52|||
48767936|NCT01914666|156998888|FG000|Treatment Period|Lack of Efficacy|0|||
48767937|NCT01914666|156998889|FG001|Treatment Period|Lack of Efficacy|0|||
48767938|NCT01914666|156998890|FG002|Treatment Period|Lack of Efficacy|2|||
48767939|NCT01914666|156998888|FG000|Treatment Period|Adverse Event|10|||
48767940|NCT01914666|156998889|FG001|Treatment Period|Adverse Event|4|||
48767941|NCT01914666|156998890|FG002|Treatment Period|Adverse Event|2|||
48767942|NCT01914666|156998888|FG000|Treatment Period|Withdrawal by Subject|3|||
48876099|NCT01236352|157383386|FG004|Overall Study|Patient transferred to IST|0|||
49026283|NCT01710657|157935865|FG000|Overall Study|Adverse Event|14|||
48767943|NCT01914666|156998889|FG001|Treatment Period|Withdrawal by Subject|2|||
48876100|NCT01236352|157383387|FG005|Overall Study|Patient transferred to IST|0|||
48876101|NCT01236352|157383388|FG006|Overall Study|Patient transferred to IST|0|||
48876102|NCT01236352|157383389|FG007|Overall Study|Patient transferred to IST|0|||
49026284|NCT01710657|157935866|FG001|Overall Study|Adverse Event|8|||
49026285|NCT01710657|157935867|FG002|Overall Study|Adverse Event|28|||
49026286|NCT01710657|157935865|FG000|Overall Study|Withdrawal by Subject|0|||
49026287|NCT01710657|157935866|FG001|Overall Study|Withdrawal by Subject|1|||
48767944|NCT01914666|156998890|FG002|Treatment Period|Withdrawal by Subject|2|||
48767945|NCT01914666|156998888|FG000|Treatment Period|Physician Decision|0|||
48767946|NCT01914666|156998889|FG001|Treatment Period|Physician Decision|0|||
48767947|NCT01914666|156998890|FG002|Treatment Period|Physician Decision|2|||
48767948|NCT02586012|156998891|FG000|Overall Study|Withdrawal by Subject|1|||
48767949|NCT02586012|156998892|FG001|Overall Study|Withdrawal by Subject|1|||
48767950|NCT02586012|156998893|FG002|Overall Study|Withdrawal by Subject|0|||
48767951|NCT02586012|156998894|FG003|Overall Study|Withdrawal by Subject|1|||
48767952|NCT02586012|156998895|FG004|Overall Study|Withdrawal by Subject|0|||
48767953|NCT02586012|156998896|FG005|Overall Study|Withdrawal by Subject|2|||
48767954|NCT02586012|156998891|FG000|Overall Study|Protocol Violation|0|||
48767955|NCT02586012|156998892|FG001|Overall Study|Protocol Violation|0|||
48767956|NCT02586012|156998893|FG002|Overall Study|Protocol Violation|0|||
48767957|NCT02586012|156998894|FG003|Overall Study|Protocol Violation|0|||
48767958|NCT02586012|156998895|FG004|Overall Study|Protocol Violation|0|||
48767959|NCT02586012|156998896|FG005|Overall Study|Protocol Violation|1|||
48767960|NCT02586012|156998891|FG000|Overall Study|study terminated|0|||
48767961|NCT02586012|156998892|FG001|Overall Study|study terminated|2|||
48767962|NCT02586012|156998893|FG002|Overall Study|study terminated|1|||
48767963|NCT02586012|156998894|FG003|Overall Study|study terminated|1|||
48767964|NCT02586012|156998895|FG004|Overall Study|study terminated|1|||
48767965|NCT02586012|156998896|FG005|Overall Study|study terminated|0|||
48767966|NCT02388737|156998897|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
48767967|NCT02388737|156998898|FG001|Overall Study|Pretreatment Event/Adverse Event|11|||
48767968|NCT02388737|156998899|FG002|Overall Study|Pretreatment Event/Adverse Event|12|||
48767969|NCT02388737|156998897|FG000|Overall Study|Major Protocol Deviation|18|||
48767970|NCT02388737|156998898|FG001|Overall Study|Major Protocol Deviation|25|||
48767971|NCT02388737|156998899|FG002|Overall Study|Major Protocol Deviation|22|||
48767972|NCT02388737|156998897|FG000|Overall Study|Lost to Follow-up|5|||
48767973|NCT02388737|156998898|FG001|Overall Study|Lost to Follow-up|1|||
48767974|NCT02388737|156998899|FG002|Overall Study|Lost to Follow-up|4|||
48767975|NCT02388737|156998897|FG000|Overall Study|Voluntary Withdrawal|10|||
48767976|NCT02388737|156998898|FG001|Overall Study|Voluntary Withdrawal|18|||
48767977|NCT02388737|156998899|FG002|Overall Study|Voluntary Withdrawal|17|||
48767978|NCT02388737|156998897|FG000|Overall Study|Lack of Efficacy|3|||
48767979|NCT02388737|156998898|FG001|Overall Study|Lack of Efficacy|0|||
48767980|NCT02388737|156998899|FG002|Overall Study|Lack of Efficacy|3|||
48767981|NCT02388737|156998897|FG000|Overall Study|Reason Not Specified|5|||
48767982|NCT02388737|156998898|FG001|Overall Study|Reason Not Specified|5|||
48767983|NCT02388737|156998899|FG002|Overall Study|Reason Not Specified|4|||
48767984|NCT03711162|156998901|FG000|Overall Study|Adverse Event|5|||
48767985|NCT03711162|156998902|FG001|Overall Study|Adverse Event|2|||
48767986|NCT03711162|156998903|FG002|Overall Study|Adverse Event|4|||
48767987|NCT03711162|156998901|FG000|Overall Study|Death|11|||
48767988|NCT03711162|156998902|FG001|Overall Study|Death|7|||
48767989|NCT03711162|156998903|FG002|Overall Study|Death|8|||
48767990|NCT03711162|156998901|FG000|Overall Study|Lost to Follow-up|1|||
48767991|NCT03711162|156998902|FG001|Overall Study|Lost to Follow-up|0|||
48767992|NCT03711162|156998903|FG002|Overall Study|Lost to Follow-up|1|||
48767993|NCT03711162|156998901|FG000|Overall Study|Study Terminated by Sponsor|139|||
48767994|NCT03711162|156998902|FG001|Overall Study|Study Terminated by Sponsor|152|||
48767995|NCT03711162|156998903|FG002|Overall Study|Study Terminated by Sponsor|146|||
48767996|NCT03711162|156998901|FG000|Overall Study|Withdrawal by Subject|17|||
48767997|NCT03711162|156998902|FG001|Overall Study|Withdrawal by Subject|10|||
48767998|NCT03711162|156998903|FG002|Overall Study|Withdrawal by Subject|10|||
48767999|NCT03711162|156998901|FG000|Overall Study|Miscellaneous|1|||
48768000|NCT03711162|156998902|FG001|Overall Study|Miscellaneous|2|||
48768001|NCT03711162|156998903|FG002|Overall Study|Miscellaneous|2|||
48768002|NCT03711162|156998901|FG000|Overall Study|Not Treated|1|||
48768003|NCT03711162|156998902|FG001|Overall Study|Not Treated|0|||
48768004|NCT03711162|156998903|FG002|Overall Study|Not Treated|1|||
48768005|NCT03711162|156998901|FG000|Overall Study|Physician Decision|0|||
48768006|NCT03711162|156998902|FG001|Overall Study|Physician Decision|2|||
48768007|NCT03711162|156998903|FG002|Overall Study|Physician Decision|0|||
48768008|NCT03711162|156998901|FG000|Overall Study|Lack of Efficacy|0|||
48876103|NCT01236352|157383390|FG008|Overall Study|Patient transferred to IST|0|||
48876104|NCT01236352|157383391|FG009|Overall Study|Patient transferred to IST|2|||
48876105|NCT01236352|157383392|FG010|Overall Study|Patient transferred to IST|6|||
48876106|NCT01774305|157383393|FG000|Overall Study|Physician Decision|1|||
48876107|NCT01774305|157383394|FG001|Overall Study|Physician Decision|0|||
48768009|NCT03711162|156998902|FG001|Overall Study|Lack of Efficacy|0|||
48768010|NCT03711162|156998903|FG002|Overall Study|Lack of Efficacy|2|||
48876108|NCT04211389|157383395|FG000|Overall Study|Adverse Event|1|||
48768011|NCT03711162|156998901|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
48768012|NCT03711162|156998902|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
48768013|NCT03711162|156998903|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
48768014|NCT03102918|156998907|FG000|Overall Study|Protocol Violation|1|||
48768015|NCT03102918|156998908|FG001|Overall Study|Protocol Violation|0|||
48768016|NCT00953329|156998911|FG000|Overall Study|Lack of Efficacy|1|||
48768017|NCT00097721|156998918|FG000|Overall Study|Adverse Event|8|||
48768018|NCT00097721|156998919|FG001|Overall Study|Adverse Event|1|||
48768019|NCT00097721|156998918|FG000|Overall Study|Withdrawal by Subject|6|||
48768020|NCT00097721|156998919|FG001|Overall Study|Withdrawal by Subject|1|||
48768021|NCT00097721|156998918|FG000|Overall Study|Progressive Disease|55|||
48768022|NCT00097721|156998919|FG001|Overall Study|Progressive Disease|27|||
48768023|NCT00097721|156998918|FG000|Overall Study|Physician Decision|1|||
48768024|NCT00097721|156998919|FG001|Overall Study|Physician Decision|3|||
48768025|NCT00097721|156998918|FG000|Overall Study|Reason not given|1|||
48768026|NCT00097721|156998919|FG001|Overall Study|Reason not given|1|||
48768027|NCT03168464|156998920|FG000|Overall Study|Death|9|||
48768028|NCT03168464|156998920|FG000|Overall Study|Progression of disease|6|||
48768029|NCT01869192|156998923|FG000|Preoperative Chemotherapy to Surgery|patient choice|2|||
48768030|NCT01869192|156998924|FG001|Preoperative Chemotherapy to Surgery|patient choice|1|||
48768031|NCT01869192|156998923|FG000|Postoperative Chemotherapy|Physician Decision|0|||
48768032|NCT01869192|156998924|FG001|Postoperative Chemotherapy|Physician Decision|2|||
48768033|NCT01533246|156998925|FG000|Overall Study|Adverse Event|1|||
48768034|NCT01533246|156998925|FG000|Overall Study|Withdrawal by Subject|1|||
48768035|NCT01446965|156998926|FG000|Randominization|One site was dismissed due to IRB irregularity|30|||
48768036|NCT01446965|156998927|FG001|Randominization|One site was dismissed due to IRB irregularity|16|||
48768037|NCT01446965|156998926|FG000|Participants Followed and Analyzed|Lost to Follow-up|10|||
48768038|NCT01446965|156998927|FG001|Participants Followed and Analyzed|Lost to Follow-up|12|||
48768039|NCT01143090|156998928|FG000|Overall Study|Lack of Efficacy|2|||
48768040|NCT01143090|156998928|FG000|Overall Study|Adverse Event|17|||
48768041|NCT01143090|156998928|FG000|Overall Study|Lost to Follow-up|9|||
48768042|NCT01143090|156998928|FG000|Overall Study|Protocol Violation|2|||
48768043|NCT01143090|156998928|FG000|Overall Study|Withdrawal by Subject|18|||
48768044|NCT01143090|156998928|FG000|Overall Study|Non-compliance with study drug|1|||
48768045|NCT01143090|156998928|FG000|Overall Study|Failure to meet eligibility criteria|1|||
48768046|NCT01143090|156998928|FG000|Overall Study|Administrative|1|||
48768047|NCT00337103|156998929|FG000|Overall Study|Progressive Disease|414|||
48768048|NCT00337103|156998930|FG001|Overall Study|Progressive Disease|410|||
48768049|NCT00337103|156998929|FG000|Overall Study|Adverse Event|45|||
48768050|NCT00337103|156998930|FG001|Overall Study|Adverse Event|59|||
48768051|NCT00337103|156998929|FG000|Overall Study|Subject Choice|34|||
48768052|NCT00337103|156998930|FG001|Overall Study|Subject Choice|27|||
48768053|NCT00337103|156998929|FG000|Overall Study|Clinical Progression|27|||
48768054|NCT00337103|156998930|FG001|Overall Study|Clinical Progression|24|||
48768055|NCT00337103|156998929|FG000|Overall Study|Physician Decision|15|||
48768056|NCT00337103|156998930|FG001|Overall Study|Physician Decision|14|||
48768057|NCT00337103|156998929|FG000|Overall Study|Withdrawal by Subject|8|||
48768058|NCT00337103|156998930|FG001|Overall Study|Withdrawal by Subject|5|||
48768059|NCT00337103|156998929|FG000|Overall Study|Other|5|||
48768060|NCT00337103|156998930|FG001|Overall Study|Other|6|||
48768061|NCT00337103|156998929|FG000|Overall Study|Entry Criteria Not Met|4|||
48768062|NCT00337103|156998930|FG001|Overall Study|Entry Criteria Not Met|1|||
48768063|NCT00337103|156998929|FG000|Overall Study|Lost to Follow-up|1|||
48768064|NCT00337103|156998930|FG001|Overall Study|Lost to Follow-up|2|||
48768065|NCT00337103|156998929|FG000|Overall Study|Death|1|||
48768066|NCT00337103|156998930|FG001|Overall Study|Death|0|||
48768067|NCT00404352|156998931|FG000|Double Blind (up to 24 Month)|Adverse Event|5|||
48768068|NCT00404352|156998932|FG001|Double Blind (up to 24 Month)|Adverse Event|4|||
48768069|NCT00404352|156998933|FG002|Double Blind (up to 24 Month)|Adverse Event|6|||
48768070|NCT00404352|156998934|FG003|Double Blind (up to 24 Month)|Adverse Event|0|||
48768071|NCT00404352|156998935|FG004|Double Blind (up to 24 Month)|Adverse Event|0|||
48768072|NCT00404352|156998936|FG005|Double Blind (up to 24 Month)|Adverse Event|0|||
48768073|NCT00404352|156998937|FG006|Double Blind (up to 24 Month)|Adverse Event|0|||
48768074|NCT00404352|156998938|FG007|Double Blind (up to 24 Month)|Adverse Event|0|||
48768075|NCT00404352|156998939|FG008|Double Blind (up to 24 Month)|Adverse Event|0|||
48768076|NCT00404352|156998931|FG000|Double Blind (up to 24 Month)|Pregnancy|0|||
48768077|NCT00404352|156998932|FG001|Double Blind (up to 24 Month)|Pregnancy|0|||
48768078|NCT00404352|156998933|FG002|Double Blind (up to 24 Month)|Pregnancy|2|||
48768079|NCT00404352|156998934|FG003|Double Blind (up to 24 Month)|Pregnancy|0|||
48768080|NCT00404352|156998935|FG004|Double Blind (up to 24 Month)|Pregnancy|0|||
48768081|NCT00404352|156998936|FG005|Double Blind (up to 24 Month)|Pregnancy|0|||
48768082|NCT00404352|156998937|FG006|Double Blind (up to 24 Month)|Pregnancy|0|||
48768083|NCT00404352|156998938|FG007|Double Blind (up to 24 Month)|Pregnancy|0|||
48768084|NCT00404352|156998939|FG008|Double Blind (up to 24 Month)|Pregnancy|0|||
48768085|NCT00404352|156998931|FG000|Double Blind (up to 24 Month)|Death|0|||
48768086|NCT00404352|156998932|FG001|Double Blind (up to 24 Month)|Death|0|||
48768087|NCT00404352|156998933|FG002|Double Blind (up to 24 Month)|Death|1|||
48768088|NCT00404352|156998934|FG003|Double Blind (up to 24 Month)|Death|0|||
48768089|NCT00404352|156998935|FG004|Double Blind (up to 24 Month)|Death|0|||
48768090|NCT00404352|156998936|FG005|Double Blind (up to 24 Month)|Death|0|||
48768091|NCT00404352|156998937|FG006|Double Blind (up to 24 Month)|Death|0|||
48768092|NCT00404352|156998938|FG007|Double Blind (up to 24 Month)|Death|0|||
48768093|NCT00404352|156998939|FG008|Double Blind (up to 24 Month)|Death|0|||
48768094|NCT00404352|156998931|FG000|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
48768095|NCT00404352|156998932|FG001|Double Blind (up to 24 Month)|Lost to Follow-up|2|||
48768096|NCT00404352|156998933|FG002|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
48768097|NCT00404352|156998934|FG003|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
48768098|NCT00404352|156998935|FG004|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
48768099|NCT00404352|156998936|FG005|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
48768100|NCT00404352|156998937|FG006|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
48768101|NCT00404352|156998938|FG007|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
48768102|NCT00404352|156998939|FG008|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
48768103|NCT00404352|156998931|FG000|Double Blind (up to 24 Month)|Withdrawal by Subject|11|||
48768104|NCT00404352|156998932|FG001|Double Blind (up to 24 Month)|Withdrawal by Subject|8|||
48768105|NCT00404352|156998933|FG002|Double Blind (up to 24 Month)|Withdrawal by Subject|7|||
48768106|NCT00404352|156998934|FG003|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
48768107|NCT00404352|156998935|FG004|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
48768108|NCT00404352|156998936|FG005|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
48768109|NCT00404352|156998937|FG006|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
48768110|NCT00404352|156998938|FG007|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
48768111|NCT00404352|156998939|FG008|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
48768112|NCT00404352|156998931|FG000|Double Blind (up to 24 Month)|Disease progression|3|||
48768113|NCT00404352|156998932|FG001|Double Blind (up to 24 Month)|Disease progression|0|||
48768114|NCT00404352|156998933|FG002|Double Blind (up to 24 Month)|Disease progression|2|||
48768115|NCT00404352|156998934|FG003|Double Blind (up to 24 Month)|Disease progression|0|||
48768116|NCT00404352|156998935|FG004|Double Blind (up to 24 Month)|Disease progression|0|||
48768117|NCT00404352|156998936|FG005|Double Blind (up to 24 Month)|Disease progression|0|||
48768118|NCT00404352|156998937|FG006|Double Blind (up to 24 Month)|Disease progression|0|||
48768119|NCT00404352|156998938|FG007|Double Blind (up to 24 Month)|Disease progression|0|||
48768120|NCT00404352|156998939|FG008|Double Blind (up to 24 Month)|Disease progression|0|||
48768121|NCT00404352|156998931|FG000|Double Blind (up to 24 Month)|Poor compliance|1|||
48768122|NCT00404352|156998932|FG001|Double Blind (up to 24 Month)|Poor compliance|0|||
48768123|NCT00404352|156998933|FG002|Double Blind (up to 24 Month)|Poor compliance|0|||
48768124|NCT00404352|156998934|FG003|Double Blind (up to 24 Month)|Poor compliance|0|||
48768125|NCT00404352|156998935|FG004|Double Blind (up to 24 Month)|Poor compliance|0|||
48768126|NCT00404352|156998936|FG005|Double Blind (up to 24 Month)|Poor compliance|0|||
48768127|NCT00404352|156998937|FG006|Double Blind (up to 24 Month)|Poor compliance|0|||
48768128|NCT00404352|156998938|FG007|Double Blind (up to 24 Month)|Poor compliance|0|||
48768129|NCT00404352|156998939|FG008|Double Blind (up to 24 Month)|Poor compliance|0|||
48768130|NCT00404352|156998931|FG000|Double Blind (up to 24 Month)|Switched to open label phase|31|||
48768131|NCT00404352|156998932|FG001|Double Blind (up to 24 Month)|Switched to open label phase|30|||
48768132|NCT00404352|156998933|FG002|Double Blind (up to 24 Month)|Switched to open label phase|59|||
48768133|NCT00404352|156998934|FG003|Double Blind (up to 24 Month)|Switched to open label phase|0|||
48768134|NCT00404352|156998935|FG004|Double Blind (up to 24 Month)|Switched to open label phase|0|||
48768135|NCT00404352|156998936|FG005|Double Blind (up to 24 Month)|Switched to open label phase|0|||
48768136|NCT00404352|156998937|FG006|Double Blind (up to 24 Month)|Switched to open label phase|0|||
48768137|NCT00404352|156998938|FG007|Double Blind (up to 24 Month)|Switched to open label phase|0|||
48768138|NCT00404352|156998939|FG008|Double Blind (up to 24 Month)|Switched to open label phase|0|||
48768139|NCT00404352|156998931|FG000|Double Blind (up to 24 Month)|Randomized but not treated|0|||
48768140|NCT00404352|156998932|FG001|Double Blind (up to 24 Month)|Randomized but not treated|2|||
48768141|NCT00404352|156998933|FG002|Double Blind (up to 24 Month)|Randomized but not treated|0|||
48768142|NCT00404352|156998934|FG003|Double Blind (up to 24 Month)|Randomized but not treated|0|||
48768143|NCT00404352|156998935|FG004|Double Blind (up to 24 Month)|Randomized but not treated|0|||
48768144|NCT00404352|156998936|FG005|Double Blind (up to 24 Month)|Randomized but not treated|0|||
48768145|NCT00404352|156998937|FG006|Double Blind (up to 24 Month)|Randomized but not treated|0|||
48768146|NCT00404352|156998938|FG007|Double Blind (up to 24 Month)|Randomized but not treated|0|||
48768147|NCT00404352|156998939|FG008|Double Blind (up to 24 Month)|Randomized but not treated|0|||
48768148|NCT00404352|156998931|FG000|Double Blind (up to 24 Month)|Physician Decision|0|||
48768149|NCT00404352|156998932|FG001|Double Blind (up to 24 Month)|Physician Decision|0|||
48768150|NCT00404352|156998933|FG002|Double Blind (up to 24 Month)|Physician Decision|1|||
48768151|NCT00404352|156998934|FG003|Double Blind (up to 24 Month)|Physician Decision|0|||
48768152|NCT00404352|156998935|FG004|Double Blind (up to 24 Month)|Physician Decision|0|||
48768153|NCT00404352|156998936|FG005|Double Blind (up to 24 Month)|Physician Decision|0|||
49026288|NCT01710657|157935867|FG002|Overall Study|Withdrawal by Subject|2|||
49026289|NCT01710657|157935865|FG000|Overall Study|Lack of Efficacy|0|||
49026290|NCT01710657|157935866|FG001|Overall Study|Lack of Efficacy|1|||
49026291|NCT01710657|157935867|FG002|Overall Study|Lack of Efficacy|1|||
49026292|NCT02178722|157935868|FG000|Overall Study|Withdrawal by Subject|0|||
49026293|NCT02178722|157935869|FG001|Overall Study|Withdrawal by Subject|0|||
49026294|NCT02178722|157935870|FG002|Overall Study|Withdrawal by Subject|0|||
49026295|NCT02178722|157935871|FG003|Overall Study|Withdrawal by Subject|2|||
49026296|NCT02178722|157935872|FG004|Overall Study|Withdrawal by Subject|33|||
49026297|NCT02178722|157935868|FG000|Overall Study|Death|2|||
49026298|NCT02178722|157935869|FG001|Overall Study|Death|13|||
48768154|NCT00404352|156998937|FG006|Double Blind (up to 24 Month)|Physician Decision|0|||
48768155|NCT00404352|156998938|FG007|Double Blind (up to 24 Month)|Physician Decision|0|||
48768156|NCT00404352|156998939|FG008|Double Blind (up to 24 Month)|Physician Decision|0|||
48768157|NCT00404352|156998931|FG000|Double Blind (up to 24 Month)|Other|0|||
48768158|NCT00404352|156998932|FG001|Double Blind (up to 24 Month)|Other|1|||
48768159|NCT00404352|156998933|FG002|Double Blind (up to 24 Month)|Other|0|||
48768160|NCT00404352|156998934|FG003|Double Blind (up to 24 Month)|Other|0|||
48768161|NCT00404352|156998935|FG004|Double Blind (up to 24 Month)|Other|0|||
48768162|NCT00404352|156998936|FG005|Double Blind (up to 24 Month)|Other|0|||
48768163|NCT00404352|156998937|FG006|Double Blind (up to 24 Month)|Other|0|||
48768164|NCT00404352|156998938|FG007|Double Blind (up to 24 Month)|Other|0|||
48768165|NCT00404352|156998939|FG008|Double Blind (up to 24 Month)|Other|0|||
48768166|NCT00404352|156998931|FG000|Open Label (up to 24 Month)|Adverse Event|0|||
48768167|NCT00404352|156998932|FG001|Open Label (up to 24 Month)|Adverse Event|0|||
48768168|NCT00404352|156998933|FG002|Open Label (up to 24 Month)|Adverse Event|0|||
48768169|NCT00404352|156998934|FG003|Open Label (up to 24 Month)|Adverse Event|2|||
49026299|NCT02178722|157935870|FG002|Overall Study|Death|12|||
49026300|NCT02178722|157935871|FG003|Overall Study|Death|12|||
49026301|NCT02178722|157935872|FG004|Overall Study|Death|205|||
49026302|NCT02178722|157935868|FG000|Overall Study|Lost to Follow-up|0|||
49026303|NCT02178722|157935869|FG001|Overall Study|Lost to Follow-up|0|||
48768170|NCT00404352|156998935|FG004|Open Label (up to 24 Month)|Adverse Event|1|||
48768171|NCT00404352|156998936|FG005|Open Label (up to 24 Month)|Adverse Event|1|||
48768172|NCT00404352|156998937|FG006|Open Label (up to 24 Month)|Adverse Event|0|||
48768173|NCT00404352|156998938|FG007|Open Label (up to 24 Month)|Adverse Event|0|||
48768174|NCT00404352|156998939|FG008|Open Label (up to 24 Month)|Adverse Event|0|||
48768175|NCT00404352|156998931|FG000|Open Label (up to 24 Month)|Pregnancy|0|||
48768176|NCT00404352|156998932|FG001|Open Label (up to 24 Month)|Pregnancy|0|||
48768177|NCT00404352|156998933|FG002|Open Label (up to 24 Month)|Pregnancy|0|||
48768178|NCT00404352|156998934|FG003|Open Label (up to 24 Month)|Pregnancy|0|||
48768179|NCT00404352|156998935|FG004|Open Label (up to 24 Month)|Pregnancy|0|||
48768180|NCT00404352|156998936|FG005|Open Label (up to 24 Month)|Pregnancy|1|||
48768181|NCT00404352|156998937|FG006|Open Label (up to 24 Month)|Pregnancy|0|||
48768182|NCT00404352|156998938|FG007|Open Label (up to 24 Month)|Pregnancy|0|||
48768183|NCT00404352|156998939|FG008|Open Label (up to 24 Month)|Pregnancy|0|||
48768184|NCT00404352|156998931|FG000|Open Label (up to 24 Month)|Lost to Follow-up|0|||
48768185|NCT00404352|156998932|FG001|Open Label (up to 24 Month)|Lost to Follow-up|0|||
48768186|NCT00404352|156998933|FG002|Open Label (up to 24 Month)|Lost to Follow-up|0|||
48768187|NCT00404352|156998934|FG003|Open Label (up to 24 Month)|Lost to Follow-up|0|||
48768188|NCT00404352|156998935|FG004|Open Label (up to 24 Month)|Lost to Follow-up|1|||
48768189|NCT00404352|156998936|FG005|Open Label (up to 24 Month)|Lost to Follow-up|0|||
48768190|NCT00404352|156998937|FG006|Open Label (up to 24 Month)|Lost to Follow-up|0|||
48768191|NCT00404352|156998938|FG007|Open Label (up to 24 Month)|Lost to Follow-up|0|||
48768192|NCT00404352|156998939|FG008|Open Label (up to 24 Month)|Lost to Follow-up|0|||
48768193|NCT00404352|156998931|FG000|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
48768194|NCT00404352|156998932|FG001|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
48768195|NCT00404352|156998933|FG002|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
48768196|NCT00404352|156998934|FG003|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
48768197|NCT00404352|156998935|FG004|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
48768198|NCT00404352|156998936|FG005|Open Label (up to 24 Month)|Withdrawal by Subject|5|||
48768199|NCT00404352|156998937|FG006|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
48768200|NCT00404352|156998938|FG007|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
48768201|NCT00404352|156998939|FG008|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
48768202|NCT00404352|156998931|FG000|Open Label (up to 24 Month)|Disease progression|0|||
48768203|NCT00404352|156998932|FG001|Open Label (up to 24 Month)|Disease progression|0|||
48768204|NCT00404352|156998933|FG002|Open Label (up to 24 Month)|Disease progression|0|||
48768205|NCT00404352|156998934|FG003|Open Label (up to 24 Month)|Disease progression|1|||
48768206|NCT00404352|156998935|FG004|Open Label (up to 24 Month)|Disease progression|0|||
48768207|NCT00404352|156998936|FG005|Open Label (up to 24 Month)|Disease progression|0|||
48768208|NCT00404352|156998937|FG006|Open Label (up to 24 Month)|Disease progression|0|||
48768209|NCT00404352|156998938|FG007|Open Label (up to 24 Month)|Disease progression|0|||
48768210|NCT00404352|156998939|FG008|Open Label (up to 24 Month)|Disease progression|0|||
48768211|NCT00404352|156998931|FG000|Open Label Extension (up to 36 Months)|Adverse Event|0|||
48768212|NCT00404352|156998932|FG001|Open Label Extension (up to 36 Months)|Adverse Event|0|||
48768213|NCT00404352|156998933|FG002|Open Label Extension (up to 36 Months)|Adverse Event|0|||
48768214|NCT00404352|156998934|FG003|Open Label Extension (up to 36 Months)|Adverse Event|0|||
48768215|NCT00404352|156998935|FG004|Open Label Extension (up to 36 Months)|Adverse Event|0|||
48768216|NCT00404352|156998936|FG005|Open Label Extension (up to 36 Months)|Adverse Event|0|||
48768217|NCT00404352|156998937|FG006|Open Label Extension (up to 36 Months)|Adverse Event|1|||
48876109|NCT04211389|157383396|FG001|Overall Study|Adverse Event|2|||
49026304|NCT02178722|157935870|FG002|Overall Study|Lost to Follow-up|0|||
48876110|NCT04211389|157383395|FG000|Overall Study|Lost to Follow-up|15|||
49026305|NCT02178722|157935871|FG003|Overall Study|Lost to Follow-up|2|||
48768218|NCT00404352|156998938|FG007|Open Label Extension (up to 36 Months)|Adverse Event|1|||
48768219|NCT00404352|156998939|FG008|Open Label Extension (up to 36 Months)|Adverse Event|0|||
48768220|NCT00404352|156998931|FG000|Open Label Extension (up to 36 Months)|Other|0|||
48768221|NCT00404352|156998932|FG001|Open Label Extension (up to 36 Months)|Other|0|||
48768222|NCT00404352|156998933|FG002|Open Label Extension (up to 36 Months)|Other|0|||
48768223|NCT00404352|156998934|FG003|Open Label Extension (up to 36 Months)|Other|0|||
48768224|NCT00404352|156998935|FG004|Open Label Extension (up to 36 Months)|Other|0|||
48768225|NCT00404352|156998936|FG005|Open Label Extension (up to 36 Months)|Other|0|||
48768226|NCT00404352|156998937|FG006|Open Label Extension (up to 36 Months)|Other|0|||
48768227|NCT00404352|156998938|FG007|Open Label Extension (up to 36 Months)|Other|0|||
48768228|NCT00404352|156998939|FG008|Open Label Extension (up to 36 Months)|Other|2|||
48768229|NCT01520363|156998940|FG000|Overall Study|Withdrawal by Subject|2|||
48768230|NCT01520363|156998941|FG001|Overall Study|Withdrawal by Subject|0|||
48768231|NCT00606892|156998942|FG000|First Intervention|Protocol Violation|1|||
48768232|NCT00606892|156998943|FG001|First Intervention|Protocol Violation|4|||
48768233|NCT00829296|156998951|FG000|Overall Study|Adverse Event|5|||
48768234|NCT00829296|156998952|FG001|Overall Study|Adverse Event|4|||
48768235|NCT00582933|156998955|FG000|Overall Study|Physician Decision|3|||
48768236|NCT01494610|156998959|FG000|Period 1|Withdrawal by Subject|1|||
48768237|NCT01494610|156998960|FG001|Period 1|Withdrawal by Subject|1|||
48768238|NCT01494610|156998959|FG000|Period 3|Adverse Event|1|||
48768239|NCT01494610|156998960|FG001|Period 3|Adverse Event|0|||
48768240|NCT01494610|156998959|FG000|Period 3|Withdrawal by Subject|1|||
48768241|NCT01494610|156998960|FG001|Period 3|Withdrawal by Subject|0|||
48768242|NCT01494610|156998959|FG000|Period 4|Protocol Violation|1|||
48768243|NCT01494610|156998960|FG001|Period 4|Protocol Violation|0|||
48768244|NCT00594464|156998961|FG000|Overall Study|Withdrawal by Subject|1|||
48768245|NCT00594464|156998961|FG000|Overall Study|Delay in operation|2|||
48768246|NCT02385799|156998965|FG000|Overall Study|Lost to Follow-up|1|||
48768247|NCT02385799|156998966|FG001|Overall Study|Lost to Follow-up|2|||
48768248|NCT02385799|156998965|FG000|Overall Study|Adverse Event|4|||
48768249|NCT02385799|156998966|FG001|Overall Study|Adverse Event|2|||
48768250|NCT02385799|156998965|FG000|Overall Study|Withdrawal by Subject|0|||
48768251|NCT02385799|156998966|FG001|Overall Study|Withdrawal by Subject|4|||
48768252|NCT00547703|156998967|FG000|Overall Study|Lost to Follow-up|1|||
48768253|NCT00547703|156998968|FG001|Overall Study|Lost to Follow-up|0|||
48768254|NCT02350309|156998969|FG000|Treatment Period 1 (2 Days)|Physician Decision|0|||
48768255|NCT02350309|156998970|FG001|Treatment Period 1 (2 Days)|Physician Decision|0|||
48768256|NCT02350309|156998971|FG002|Treatment Period 1 (2 Days)|Physician Decision|1|||
48768257|NCT02350309|156998972|FG003|Treatment Period 1 (2 Days)|Physician Decision|0|||
48768258|NCT02350309|156998973|FG004|Treatment Period 1 (2 Days)|Physician Decision|0|||
48768259|NCT02350309|156998974|FG005|Treatment Period 1 (2 Days)|Physician Decision|0|||
48768260|NCT02350309|156998969|FG000|Treatment Period 4 (2 Days)|Death in the Family|0|||
48768261|NCT02350309|156998970|FG001|Treatment Period 4 (2 Days)|Death in the Family|0|||
48768262|NCT02350309|156998971|FG002|Treatment Period 4 (2 Days)|Death in the Family|0|||
48768263|NCT02350309|156998972|FG003|Treatment Period 4 (2 Days)|Death in the Family|0|||
48768264|NCT02350309|156998973|FG004|Treatment Period 4 (2 Days)|Death in the Family|0|||
48768265|NCT02350309|156998974|FG005|Treatment Period 4 (2 Days)|Death in the Family|1|||
48768266|NCT00207142|156998975|FG000|Induction Phase|Adverse Event|9|||
48768267|NCT00207142|156998976|FG001|Induction Phase|Adverse Event|0|||
48768268|NCT00207142|156998977|FG002|Induction Phase|Adverse Event|0|||
48768269|NCT00207142|156998978|FG003|Induction Phase|Adverse Event|0|||
48768270|NCT00207142|156998975|FG000|Induction Phase|Death|1|||
48768271|NCT00207142|156998976|FG001|Induction Phase|Death|0|||
48768272|NCT00207142|156998977|FG002|Induction Phase|Death|0|||
48768273|NCT00207142|156998978|FG003|Induction Phase|Death|0|||
48768274|NCT00207142|156998975|FG000|Induction Phase|Lack of Efficacy|1|||
48768275|NCT00207142|156998976|FG001|Induction Phase|Lack of Efficacy|0|||
48768276|NCT00207142|156998977|FG002|Induction Phase|Lack of Efficacy|0|||
48768277|NCT00207142|156998978|FG003|Induction Phase|Lack of Efficacy|0|||
48768278|NCT00207142|156998975|FG000|Induction Phase|Lost to Follow-up|5|||
48768279|NCT00207142|156998976|FG001|Induction Phase|Lost to Follow-up|0|||
48768280|NCT00207142|156998977|FG002|Induction Phase|Lost to Follow-up|0|||
48768281|NCT00207142|156998978|FG003|Induction Phase|Lost to Follow-up|0|||
48768282|NCT00207142|156998975|FG000|Induction Phase|Physician Decision|2|||
48768283|NCT00207142|156998976|FG001|Induction Phase|Physician Decision|0|||
48768284|NCT00207142|156998977|FG002|Induction Phase|Physician Decision|0|||
48768285|NCT00207142|156998978|FG003|Induction Phase|Physician Decision|0|||
48768286|NCT00207142|156998975|FG000|Induction Phase|Poor/noncompliance|2|||
48768287|NCT00207142|156998976|FG001|Induction Phase|Poor/noncompliance|0|||
48768288|NCT00207142|156998977|FG002|Induction Phase|Poor/noncompliance|0|||
48768289|NCT00207142|156998978|FG003|Induction Phase|Poor/noncompliance|0|||
48768290|NCT00207142|156998975|FG000|Induction Phase|Pregnancy|1|||
48768291|NCT00207142|156998976|FG001|Induction Phase|Pregnancy|0|||
48768292|NCT00207142|156998977|FG002|Induction Phase|Pregnancy|0|||
48768293|NCT00207142|156998978|FG003|Induction Phase|Pregnancy|0|||
48768294|NCT00207142|156998975|FG000|Induction Phase|Subject no longer meets study criteria|3|||
48768295|NCT00207142|156998976|FG001|Induction Phase|Subject no longer meets study criteria|0|||
48768296|NCT00207142|156998977|FG002|Induction Phase|Subject no longer meets study criteria|0|||
48768297|NCT00207142|156998978|FG003|Induction Phase|Subject no longer meets study criteria|0|||
48768298|NCT00207142|156998975|FG000|Induction Phase|Withdrawal by Subject|4|||
48768299|NCT00207142|156998976|FG001|Induction Phase|Withdrawal by Subject|0|||
48768300|NCT00207142|156998977|FG002|Induction Phase|Withdrawal by Subject|0|||
48768301|NCT00207142|156998978|FG003|Induction Phase|Withdrawal by Subject|0|||
48768302|NCT00207142|156998975|FG000|Induction Phase|Incarceration|1|||
48768303|NCT00207142|156998976|FG001|Induction Phase|Incarceration|0|||
48768304|NCT00207142|156998977|FG002|Induction Phase|Incarceration|0|||
48768305|NCT00207142|156998978|FG003|Induction Phase|Incarceration|0|||
48768306|NCT00207142|156998975|FG000|Induction Phase|Missing lab data|1|||
48768307|NCT00207142|156998976|FG001|Induction Phase|Missing lab data|0|||
48768308|NCT00207142|156998977|FG002|Induction Phase|Missing lab data|0|||
48768309|NCT00207142|156998978|FG003|Induction Phase|Missing lab data|0|||
48768310|NCT00207142|156998975|FG000|Maintenance Phase/Rescue Phase|Adverse Event|0|||
48768311|NCT00207142|156998976|FG001|Maintenance Phase/Rescue Phase|Adverse Event|1|||
48768312|NCT00207142|156998977|FG002|Maintenance Phase/Rescue Phase|Adverse Event|4|||
48768313|NCT00207142|156998978|FG003|Maintenance Phase/Rescue Phase|Adverse Event|1|||
48768314|NCT00207142|156998975|FG000|Maintenance Phase/Rescue Phase|Lost to Follow-up|0|||
48768315|NCT00207142|156998976|FG001|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
49026306|NCT02178722|157935872|FG004|Overall Study|Lost to Follow-up|11|||
49026307|NCT02178722|157935868|FG000|Overall Study|Study terminated by Sponsor|2|||
48768316|NCT00207142|156998977|FG002|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
48768317|NCT00207142|156998978|FG003|Maintenance Phase/Rescue Phase|Lost to Follow-up|2|||
48768318|NCT00207142|156998975|FG000|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
48768319|NCT00207142|156998976|FG001|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
48768320|NCT00207142|156998977|FG002|Maintenance Phase/Rescue Phase|RTV intake impossible|1|||
48768321|NCT00207142|156998978|FG003|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
48768322|NCT00207142|156998975|FG000|Maintenance Phase/Rescue Phase|Poor/noncompliance|0|||
48768323|NCT00207142|156998976|FG001|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
48768324|NCT00207142|156998977|FG002|Maintenance Phase/Rescue Phase|Poor/noncompliance|2|||
48768325|NCT00207142|156998978|FG003|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
48768326|NCT00207142|156998975|FG000|Maintenance Phase/Rescue Phase|Pregnancy|0|||
48768327|NCT00207142|156998976|FG001|Maintenance Phase/Rescue Phase|Pregnancy|2|||
48768328|NCT00207142|156998977|FG002|Maintenance Phase/Rescue Phase|Pregnancy|2|||
48768329|NCT00207142|156998978|FG003|Maintenance Phase/Rescue Phase|Pregnancy|0|||
48768330|NCT00207142|156998975|FG000|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
48768331|NCT00207142|156998976|FG001|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
48768332|NCT00207142|156998977|FG002|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1|||
48768333|NCT00207142|156998978|FG003|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
48768334|NCT00207142|156998975|FG000|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0|||
48768335|NCT00207142|156998976|FG001|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
48768336|NCT00207142|156998977|FG002|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
48768337|NCT00207142|156998978|FG003|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1|||
48768338|NCT00207142|156998975|FG000|Maintenance Phase/Rescue Phase|Death|0|||
48768339|NCT00207142|156998976|FG001|Maintenance Phase/Rescue Phase|Death|0|||
48768340|NCT00207142|156998977|FG002|Maintenance Phase/Rescue Phase|Death|0|||
48768341|NCT00207142|156998978|FG003|Maintenance Phase/Rescue Phase|Death|1|||
48768342|NCT00207142|156998975|FG000|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
48768343|NCT00207142|156998976|FG001|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
48768344|NCT00207142|156998977|FG002|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
48768345|NCT00207142|156998978|FG003|Maintenance Phase/Rescue Phase|Lack of Efficacy|1|||
48768346|NCT02214121|156998979|FG000|Part A|Patient decision|2|||
48768347|NCT02214121|156998980|FG001|Part A|Patient decision|0|||
48768348|NCT02214121|156998981|FG002|Part A|Patient decision|0|||
48768349|NCT02214121|156998979|FG000|Part A|Dev. of study-specific withdrawal crit.|4|||
48768350|NCT02214121|156998980|FG001|Part A|Dev. of study-specific withdrawal crit.|0|||
48768351|NCT02214121|156998981|FG002|Part A|Dev. of study-specific withdrawal crit.|0|||
48876111|NCT04211389|157383396|FG001|Overall Study|Lost to Follow-up|7|||
48876112|NCT04211389|157383395|FG000|Overall Study|Protocol Violation|0|||
48768352|NCT02214121|156998979|FG000|Part A|Other|1|||
48768353|NCT02214121|156998980|FG001|Part A|Other|0|||
48768354|NCT02214121|156998981|FG002|Part A|Other|0|||
48768355|NCT02214121|156998979|FG000|Part B|Patient decision|0|||
48768356|NCT02214121|156998980|FG001|Part B|Patient decision|1|||
48768357|NCT02214121|156998981|FG002|Part B|Patient decision|0|||
48768358|NCT02214121|156998979|FG000|Part B|Dev. of study-specific withdrawal crit.|0|||
48768359|NCT02214121|156998980|FG001|Part B|Dev. of study-specific withdrawal crit.|2|||
48768360|NCT02214121|156998981|FG002|Part B|Dev. of study-specific withdrawal crit.|0|||
48768361|NCT02214121|156998979|FG000|Part B|Lost to Follow-up|0|||
48768362|NCT02214121|156998980|FG001|Part B|Lost to Follow-up|0|||
48768363|NCT02214121|156998981|FG002|Part B|Lost to Follow-up|1|||
48768364|NCT01256710|156998982|FG000|Overall Study|Death|449|||
48768365|NCT01256710|156998982|FG000|Overall Study|System Explant|67|||
48768366|NCT01256710|156998982|FG000|Overall Study|Transcatheter Aortic Valve-in-Valve Intervention|28|||
48768367|NCT01256710|156998982|FG000|Overall Study|Lost to Follow-up|67|||
48768368|NCT01256710|156998982|FG000|Overall Study|Withdrawal by Subject|29|||
48768369|NCT01256710|156998982|FG000|Overall Study|Physician Decision|9|||
48768370|NCT01256710|156998982|FG000|Overall Study|Subject Noncompliance|2|||
48768371|NCT01256710|156998982|FG000|Overall Study|Study Terminated by Sponsor|273|||
48768372|NCT01573624|156998983|FG000|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
48768373|NCT01573624|156998984|FG001|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
48768374|NCT01573624|156998985|FG002|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
48768375|NCT01573624|156998986|FG003|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
48768376|NCT01573624|156998987|FG004|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
48768377|NCT01573624|156998988|FG005|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
48768378|NCT01573624|156998989|FG006|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
48768379|NCT01573624|156998983|FG000|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4|||
48768380|NCT01573624|156998984|FG001|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3|||
48768381|NCT01573624|156998985|FG002|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6|||
48768382|NCT01573624|156998986|FG003|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
48768383|NCT01573624|156998987|FG004|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2|||
48768384|NCT01573624|156998988|FG005|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
48768385|NCT01573624|156998989|FG006|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
48768386|NCT01573624|156998983|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1|||
48768387|NCT01573624|156998984|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
48768388|NCT01573624|156998985|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
48768389|NCT01573624|156998986|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
48768390|NCT01573624|156998987|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
48768391|NCT01573624|156998988|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
48768392|NCT01573624|156998989|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
48768393|NCT01573624|156998983|FG000|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
48768394|NCT01573624|156998984|FG001|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
48768395|NCT01573624|156998985|FG002|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
48768396|NCT01573624|156998986|FG003|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
48768397|NCT01573624|156998987|FG004|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
48768398|NCT01573624|156998988|FG005|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
49026308|NCT02178722|157935869|FG001|Overall Study|Study terminated by Sponsor|7|||
49026309|NCT02178722|157935870|FG002|Overall Study|Study terminated by Sponsor|6|||
49026310|NCT02178722|157935871|FG003|Overall Study|Study terminated by Sponsor|4|||
49026311|NCT02178722|157935872|FG004|Overall Study|Study terminated by Sponsor|128|||
48768399|NCT01573624|156998989|FG006|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
48768400|NCT01573624|156998983|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
48768401|NCT01573624|156998984|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
48768402|NCT01573624|156998985|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
48768403|NCT01573624|156998986|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
48768404|NCT01573624|156998987|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
48768405|NCT01573624|156998988|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
48768406|NCT01573624|156998989|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
48768407|NCT01573624|156998983|FG000|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
48768408|NCT01573624|156998984|FG001|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
48768409|NCT01573624|156998985|FG002|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
48768410|NCT01573624|156998986|FG003|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
48768411|NCT01573624|156998987|FG004|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
48768412|NCT01573624|156998988|FG005|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1|||
48768413|NCT01573624|156998989|FG006|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
48768414|NCT01573624|156998983|FG000|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
48768415|NCT01573624|156998984|FG001|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
49026312|NCT02178722|157935868|FG000|Overall Study|Physician Decision|0|||
49026313|NCT02178722|157935869|FG001|Overall Study|Physician Decision|0|||
49026314|NCT02178722|157935870|FG002|Overall Study|Physician Decision|0|||
49026315|NCT02178722|157935871|FG003|Overall Study|Physician Decision|0|||
49026316|NCT02178722|157935872|FG004|Overall Study|Physician Decision|3|||
48768416|NCT01573624|156998985|FG002|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
48768417|NCT01573624|156998986|FG003|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
48768418|NCT01573624|156998987|FG004|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
48768419|NCT01573624|156998988|FG005|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
48768420|NCT01573624|156998989|FG006|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
49026317|NCT02178722|157935868|FG000|Overall Study|Other|0|||
48768421|NCT01573624|156998983|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
49026318|NCT02178722|157935869|FG001|Overall Study|Other|0|||
49026319|NCT02178722|157935870|FG002|Overall Study|Other|0|||
49026320|NCT02178722|157935871|FG003|Overall Study|Other|0|||
49026321|NCT02178722|157935872|FG004|Overall Study|Other|2|||
49026322|NCT03025880|157935873|FG000|Overall Study|Adverse Event|1|||
49026323|NCT03025880|157935874|FG001|Overall Study|Adverse Event|0|||
48768422|NCT01573624|156998984|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
48768423|NCT01573624|156998985|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2|||
48768424|NCT01573624|156998986|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
48768425|NCT01573624|156998987|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
48768426|NCT01573624|156998988|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
48768427|NCT01573624|156998989|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
48768428|NCT01573624|156998983|FG000|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
48768429|NCT01573624|156998984|FG001|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
48768430|NCT01573624|156998985|FG002|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
48768431|NCT01573624|156998986|FG003|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
48768432|NCT01573624|156998987|FG004|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
48768433|NCT01573624|156998988|FG005|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1|||
48768434|NCT01573624|156998989|FG006|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
48768435|NCT01573624|156998983|FG000|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
48768436|NCT01573624|156998984|FG001|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
48768437|NCT01573624|156998985|FG002|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
48768438|NCT01573624|156998986|FG003|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2|||
48768439|NCT01573624|156998987|FG004|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
48768440|NCT01573624|156998988|FG005|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
48768441|NCT01573624|156998989|FG006|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
48768442|NCT01573624|156998983|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
48768443|NCT01573624|156998984|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
48768444|NCT01573624|156998985|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
48768445|NCT01573624|156998986|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
48768446|NCT01573624|156998987|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
48768447|NCT01573624|156998988|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
48768448|NCT01573624|156998989|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
48768449|NCT01573624|156998983|FG000|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5|||
48768450|NCT01573624|156998984|FG001|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4|||
48768451|NCT01573624|156998985|FG002|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
48768452|NCT01573624|156998986|FG003|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1|||
48768453|NCT01573624|156998987|FG004|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3|||
48768454|NCT01573624|156998988|FG005|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
48768455|NCT01573624|156998989|FG006|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0|||
48768456|NCT01573624|156998983|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
48768457|NCT01573624|156998984|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1|||
48768458|NCT01573624|156998985|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
48768459|NCT01573624|156998986|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
48768460|NCT01573624|156998987|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
48768461|NCT01573624|156998988|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2|||
48768462|NCT01573624|156998989|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
48768463|NCT01573624|156998983|FG000|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1|||
48768464|NCT01573624|156998984|FG001|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
48768465|NCT01573624|156998985|FG002|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
48768466|NCT01573624|156998986|FG003|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
48768467|NCT01573624|156998987|FG004|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
48768468|NCT01573624|156998988|FG005|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
48768469|NCT01573624|156998989|FG006|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
48768470|NCT01573624|156998983|FG000|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
48768471|NCT01573624|156998984|FG001|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
48768472|NCT01573624|156998985|FG002|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
48768473|NCT01573624|156998986|FG003|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
49026324|NCT03025880|157935873|FG000|Overall Study|Death|1|||
49026325|NCT03025880|157935874|FG001|Overall Study|Death|1|||
49026326|NCT03025880|157935873|FG000|Overall Study|Withdrawal by Subject|0|||
49026327|NCT03025880|157935874|FG001|Overall Study|Withdrawal by Subject|1|||
49026328|NCT03025880|157935873|FG000|Overall Study|Physician Decision|0|||
48768474|NCT01573624|156998987|FG004|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
48768475|NCT01573624|156998988|FG005|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
48768476|NCT01573624|156998989|FG006|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
48768477|NCT01573624|156998983|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1|||
48768478|NCT01573624|156998984|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
48768479|NCT01573624|156998985|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
48768480|NCT01573624|156998986|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
48768481|NCT01573624|156998987|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
48768482|NCT01573624|156998988|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
48768483|NCT01573624|156998989|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
48768484|NCT01573624|156998983|FG000|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
48768485|NCT01573624|156998984|FG001|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
48768486|NCT01573624|156998985|FG002|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
48768487|NCT01573624|156998986|FG003|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
48768488|NCT01573624|156998987|FG004|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
48768489|NCT01573624|156998988|FG005|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
48768490|NCT01573624|156998989|FG006|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
48768491|NCT01573624|156998983|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
48768492|NCT01573624|156998984|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
49026329|NCT03025880|157935874|FG001|Overall Study|Physician Decision|1|||
49026330|NCT03025880|157935873|FG000|Overall Study|Progressive Disease|12|||
48768493|NCT01573624|156998985|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
48768494|NCT01573624|156998986|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
48768495|NCT01573624|156998987|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
48768496|NCT01573624|156998988|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
48768497|NCT01573624|156998989|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
48768498|NCT01573624|156998983|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
49026331|NCT03025880|157935874|FG001|Overall Study|Progressive Disease|19|||
49026332|NCT01389102|157935875|FG000|Overall Study|Adverse Event|1|||
49026333|NCT01389102|157935876|FG001|Overall Study|Adverse Event|3|||
49026334|NCT01389102|157935877|FG002|Overall Study|Adverse Event|2|||
48768499|NCT01573624|156998984|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1|||
48768500|NCT01573624|156998985|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
48768501|NCT01573624|156998986|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
48768502|NCT01573624|156998987|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
48768503|NCT01573624|156998988|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
48768504|NCT01573624|156998989|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
48768505|NCT01573624|156998983|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
48768506|NCT01573624|156998984|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1|||
49026335|NCT01389102|157935878|FG003|Overall Study|Adverse Event|2|||
49026336|NCT01389102|157935879|FG004|Overall Study|Adverse Event|2|||
48768507|NCT01573624|156998985|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
48768508|NCT01573624|156998986|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
48768509|NCT01573624|156998987|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
48768510|NCT01573624|156998988|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
48768511|NCT01573624|156998989|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
48768512|NCT01573624|156998983|FG000|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
48768513|NCT01573624|156998984|FG001|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
48768514|NCT01573624|156998985|FG002|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
48768515|NCT01573624|156998986|FG003|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
48768516|NCT01573624|156998987|FG004|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
48768517|NCT01573624|156998988|FG005|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
48768518|NCT01573624|156998989|FG006|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
48768519|NCT01573624|156998983|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
48768520|NCT01573624|156998984|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
48768521|NCT01573624|156998985|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
48768522|NCT01573624|156998986|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
48768523|NCT01573624|156998987|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
48768524|NCT01573624|156998988|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
48797681|NCT00828984|157097046|FG000|Overall Study|Withdrawal by Subject|4|||
48797682|NCT00828984|157097047|FG001|Overall Study|Withdrawal by Subject|4|||
49026337|NCT01389102|157935880|FG005|Overall Study|Adverse Event|2|||
49026338|NCT01389102|157935875|FG000|Overall Study|Hurricane Katrina|4|||
49026339|NCT01389102|157935876|FG001|Overall Study|Hurricane Katrina|2|||
48768525|NCT01573624|156998989|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
48768526|NCT01573624|156998983|FG000|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
48768527|NCT01573624|156998984|FG001|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
48768528|NCT01573624|156998985|FG002|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
48768529|NCT01573624|156998986|FG003|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
48768530|NCT01573624|156998987|FG004|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
48768531|NCT01573624|156998988|FG005|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
48768532|NCT01573624|156998989|FG006|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4|||
48768533|NCT01573624|156998983|FG000|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
48768534|NCT01573624|156998984|FG001|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
48768535|NCT01573624|156998985|FG002|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
48768536|NCT01573624|156998986|FG003|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
48768537|NCT01573624|156998987|FG004|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
48768538|NCT01573624|156998988|FG005|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
48768539|NCT01573624|156998989|FG006|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
48768540|NCT01573624|156998983|FG000|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1|||
48768541|NCT01573624|156998984|FG001|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
48768542|NCT01573624|156998985|FG002|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
48768543|NCT01573624|156998986|FG003|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
48768544|NCT01573624|156998987|FG004|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
48768545|NCT01573624|156998988|FG005|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
48768546|NCT01573624|156998989|FG006|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
48768547|NCT01573624|156998983|FG000|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
48768548|NCT01573624|156998984|FG001|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
48768549|NCT01573624|156998985|FG002|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
48768550|NCT01573624|156998986|FG003|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
48768551|NCT01573624|156998987|FG004|Period 6 : Follow-up Period (7 Days)|Adverse Event|2|||
48768552|NCT01573624|156998988|FG005|Period 6 : Follow-up Period (7 Days)|Adverse Event|1|||
48768553|NCT01573624|156998989|FG006|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
48768554|NCT01573624|156998983|FG000|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1|||
48768555|NCT01573624|156998984|FG001|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
48768556|NCT01573624|156998985|FG002|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
48768557|NCT01573624|156998986|FG003|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
48768558|NCT01573624|156998987|FG004|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
48768559|NCT01573624|156998988|FG005|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
48768560|NCT01573624|156998989|FG006|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
48768561|NCT03216850|156998992|FG000|Overall Study|Pre-analytical error|6|||
48768562|NCT03554291|156998993|FG000|Overall Study|Death|2|||
48768563|NCT03554291|156998994|FG001|Overall Study|Death|1|||
48768564|NCT03554291|156998993|FG000|Overall Study|Lost to Follow-up|1|||
48768565|NCT03554291|156998994|FG001|Overall Study|Lost to Follow-up|0|||
48768566|NCT03554291|156998993|FG000|Overall Study|Withdrawal by Subject|1|||
48768567|NCT03554291|156998994|FG001|Overall Study|Withdrawal by Subject|0|||
48768568|NCT03554291|156998993|FG000|Overall Study|COVID Travel Restriction- Partial Data Collected|3|||
48768569|NCT03554291|156998994|FG001|Overall Study|COVID Travel Restriction- Partial Data Collected|0|||
48768570|NCT01418937|156999003|FG000|Overall Study|Lost to Follow-up|5|||
48768571|NCT01418937|156999003|FG000|Overall Study|Protocol Violation|1|||
48768572|NCT01418937|156999003|FG000|Overall Study|Pregnancy|1|||
48768573|NCT01418937|156999003|FG000|Overall Study|Withdrawal by Subject|1|||
48768574|NCT01462357|156999021|FG000|Overall Study|Death|0|||
48768575|NCT01462357|156999022|FG001|Overall Study|Death|0|||
48768576|NCT01462357|156999023|FG002|Overall Study|Death|1|||
48768577|NCT01462357|156999021|FG000|Overall Study|Withdrawal by Subject|3|||
48768578|NCT01462357|156999022|FG001|Overall Study|Withdrawal by Subject|11|||
48768579|NCT01462357|156999023|FG002|Overall Study|Withdrawal by Subject|3|||
48768580|NCT01462357|156999021|FG000|Overall Study|Migrated/moved from study area|2|||
48768581|NCT01462357|156999022|FG001|Overall Study|Migrated/moved from study area|3|||
48768582|NCT01462357|156999023|FG002|Overall Study|Migrated/moved from study area|1|||
48768583|NCT01462357|156999021|FG000|Overall Study|Lost to Follow-up|3|||
48768584|NCT01462357|156999022|FG001|Overall Study|Lost to Follow-up|5|||
48768585|NCT01462357|156999023|FG002|Overall Study|Lost to Follow-up|7|||
49026340|NCT01389102|157935877|FG002|Overall Study|Hurricane Katrina|3|||
48768586|NCT01334866|156999029|FG000|Overall Study|Withdrawal by Subject|10|||
48768587|NCT01334866|156999029|FG000|Overall Study|Lost to Follow-up|3|||
48768588|NCT01334866|156999029|FG000|Overall Study|Physician Decision|3|||
48768589|NCT01334866|156999029|FG000|Overall Study|medically necessary prior to procedure|2|||
48768590|NCT01334866|156999029|FG000|Overall Study|medically necessary post-procedure|1|||
48768591|NCT00677807|156999031|FG000|Overall Study|Adverse Event|4|||
48768592|NCT00677807|156999032|FG001|Overall Study|Adverse Event|1|||
48768593|NCT00677807|156999033|FG002|Overall Study|Adverse Event|6|||
48768594|NCT00677807|156999031|FG000|Overall Study|Lack of Efficacy|0|||
48768595|NCT00677807|156999032|FG001|Overall Study|Lack of Efficacy|0|||
48768596|NCT00677807|156999033|FG002|Overall Study|Lack of Efficacy|2|||
48768597|NCT00677807|156999031|FG000|Overall Study|Participant no longer needs study drug|0|||
48768598|NCT00677807|156999032|FG001|Overall Study|Participant no longer needs study drug|0|||
48768599|NCT00677807|156999033|FG002|Overall Study|Participant no longer needs study drug|1|||
48768600|NCT00677807|156999031|FG000|Overall Study|Withdrawal by Subject|10|||
48768601|NCT00677807|156999032|FG001|Overall Study|Withdrawal by Subject|3|||
48768602|NCT00677807|156999033|FG002|Overall Study|Withdrawal by Subject|6|||
48768603|NCT00677807|156999031|FG000|Overall Study|Lost to Follow-up|2|||
48768604|NCT00677807|156999032|FG001|Overall Study|Lost to Follow-up|2|||
48768605|NCT00677807|156999033|FG002|Overall Study|Lost to Follow-up|2|||
48768606|NCT00677807|156999031|FG000|Overall Study|Administrative problems|1|||
48768607|NCT00677807|156999032|FG001|Overall Study|Administrative problems|1|||
48768608|NCT00677807|156999033|FG002|Overall Study|Administrative problems|2|||
48768609|NCT00677807|156999031|FG000|Overall Study|Death|0|||
48768610|NCT00677807|156999032|FG001|Overall Study|Death|1|||
48768611|NCT00677807|156999033|FG002|Overall Study|Death|1|||
48768612|NCT00677807|156999031|FG000|Overall Study|Protocol Deviation|1|||
48768613|NCT00677807|156999032|FG001|Overall Study|Protocol Deviation|3|||
48768614|NCT00677807|156999033|FG002|Overall Study|Protocol Deviation|0|||
48768615|NCT02540954|156999036|FG000|Overall Study|Physician Decision|3|||
48768616|NCT02540954|156999037|FG001|Overall Study|Physician Decision|1|||
48768617|NCT02540954|156999036|FG000|Overall Study|Withdrawal by Subject|6|||
48768618|NCT02540954|156999037|FG001|Overall Study|Withdrawal by Subject|5|||
48768619|NCT02540954|156999036|FG000|Overall Study|Lost to Follow-up|1|||
48768620|NCT02540954|156999037|FG001|Overall Study|Lost to Follow-up|1|||
48768621|NCT02540954|156999036|FG000|Overall Study|Adverse Event|4|||
48768622|NCT02540954|156999037|FG001|Overall Study|Adverse Event|2|||
48768623|NCT02540954|156999036|FG000|Overall Study|Death|0|||
48768624|NCT02540954|156999037|FG001|Overall Study|Death|3|||
48768625|NCT02540954|156999036|FG000|Overall Study|Treatment failure|1|||
48768626|NCT02540954|156999037|FG001|Overall Study|Treatment failure|0|||
48768627|NCT02540954|156999036|FG000|Overall Study|Other reason|4|||
48876113|NCT04211389|157383396|FG001|Overall Study|Protocol Violation|1|||
48876114|NCT04211389|157383395|FG000|Overall Study|Withdrawal by Subject|10|||
48876115|NCT04211389|157383396|FG001|Overall Study|Withdrawal by Subject|11|||
48876116|NCT02689453|157383403|FG000|Overall Study|Progressive disease|0|||
48876117|NCT02689453|157383404|FG001|Overall Study|Progressive disease|1|||
48876118|NCT02689453|157383405|FG002|Overall Study|Progressive disease|1|||
48876119|NCT03327831|157383407|FG000|Overall Study|Lost to Follow-up|2|||
48876120|NCT00725543|157383411|FG000|Overall Study|Adverse Event|10|||
48876121|NCT00725543|157383411|FG000|Overall Study|Lack of Efficacy|3|||
48768628|NCT02540954|156999037|FG001|Overall Study|Other reason|2|||
48876122|NCT00725543|157383411|FG000|Overall Study|Withdrawal by Subject|10|||
48876123|NCT00725543|157383411|FG000|Overall Study|Physician Decision|5|||
48876124|NCT00725543|157383411|FG000|Overall Study|Lost to Follow-up|4|||
48876125|NCT00725543|157383411|FG000|Overall Study|Non-compliance|2|||
48876126|NCT00725543|157383411|FG000|Overall Study|Other|119|||
48768629|NCT01527292|156999038|FG000|Overall Study|Physician Decision|0|||
48768630|NCT01527292|156999039|FG001|Overall Study|Physician Decision|3|||
48768631|NCT00983580|156999040|FG000|Overall Study|Cancel Prior to treatment|1|||
48768632|NCT00983580|156999041|FG001|Overall Study|Cancel Prior to treatment|3|||
48768633|NCT00983580|156999040|FG000|Overall Study|Protocol Violation|1|||
48768634|NCT00983580|156999041|FG001|Overall Study|Protocol Violation|1|||
48768635|NCT00983580|156999040|FG000|Overall Study|Ineligible|3|||
48768636|NCT00983580|156999041|FG001|Overall Study|Ineligible|0|||
48768637|NCT01482767|156999042|FG000|Overall Study|Death|1|||
48768638|NCT01482767|156999043|FG001|Overall Study|Death|1|||
48768639|NCT01482767|156999042|FG000|Overall Study|Withdrawal by Subject|7|||
48768640|NCT01482767|156999043|FG001|Overall Study|Withdrawal by Subject|5|||
48768641|NCT01482767|156999042|FG000|Overall Study|Lost to Follow-up|12|||
48768642|NCT01482767|156999043|FG001|Overall Study|Lost to Follow-up|6|||
48768643|NCT01482767|156999042|FG000|Overall Study|Adverse Event|0|||
48768644|NCT01482767|156999043|FG001|Overall Study|Adverse Event|3|||
48768645|NCT01482767|156999042|FG000|Overall Study|Site closure|22|||
48768646|NCT01482767|156999043|FG001|Overall Study|Site closure|14|||
48768647|NCT01482767|156999042|FG000|Overall Study|Non-adherence to study requirements|4|||
48768648|NCT01482767|156999043|FG001|Overall Study|Non-adherence to study requirements|7|||
48768649|NCT01482767|156999042|FG000|Overall Study|Alternate HCV treatment|7|||
48876127|NCT01214421|157383412|FG000|Overall Study|Lost to Follow-up|7|||
48876128|NCT01214421|157383413|FG001|Overall Study|Lost to Follow-up|3|||
48768650|NCT01482767|156999043|FG001|Overall Study|Alternate HCV treatment|8|||
48768651|NCT01482767|156999042|FG000|Overall Study|Ineligible|0|||
48876129|NCT01214421|157383414|FG002|Overall Study|Lost to Follow-up|7|||
48768652|NCT01482767|156999043|FG001|Overall Study|Ineligible|5|||
48768653|NCT01482767|156999042|FG000|Overall Study|Nurse error|1|||
48768654|NCT01482767|156999043|FG001|Overall Study|Nurse error|0|||
48768655|NCT00314366|156999046|FG000|Overall Study|not treated due to patient medical condi|1|||
48876130|NCT01214421|157383415|FG003|Overall Study|Lost to Follow-up|3|||
48876131|NCT01214421|157383412|FG000|Overall Study|Adverse Event|16|||
48876132|NCT01214421|157383413|FG001|Overall Study|Adverse Event|35|||
48876133|NCT01214421|157383414|FG002|Overall Study|Adverse Event|14|||
48876134|NCT01214421|157383415|FG003|Overall Study|Adverse Event|3|||
48876135|NCT01214421|157383412|FG000|Overall Study|Sponsor Discontinued Site|1|||
48876136|NCT01214421|157383413|FG001|Overall Study|Sponsor Discontinued Site|2|||
48876137|NCT01214421|157383414|FG002|Overall Study|Sponsor Discontinued Site|0|||
48876138|NCT01214421|157383415|FG003|Overall Study|Sponsor Discontinued Site|0|||
48876139|NCT01214421|157383412|FG000|Overall Study|Withdrawal Criteria Met|3|||
48768656|NCT00314366|156999047|FG001|Overall Study|not treated due to patient medical condi|0|||
48768657|NCT00806546|156999048|FG000|Overall Study|Enrolled, not treated|35|||
48768658|NCT00806546|156999048|FG000|Overall Study|Lost to Follow-up|32|||
48768659|NCT00806546|156999048|FG000|Overall Study|Adverse Event|74|||
48768660|NCT00806546|156999048|FG000|Overall Study|Withdrawal by Subject|75|||
48768661|NCT00806546|156999048|FG000|Overall Study|Protocol Violation|49|||
48768662|NCT00806546|156999048|FG000|Overall Study|Various|42|||
48768663|NCT00006916|156999049|FG000|Overall Study|Device not inserted|4|||
48768664|NCT00006916|156999049|FG000|Overall Study|Complication of device insertion|1|||
48768665|NCT03829046|156999054|FG000|Overall Study|Withdrawal by Subject|1|||
48768666|NCT03829046|156999055|FG001|Overall Study|Withdrawal by Subject|0|||
48768667|NCT02296112|156999057|FG000|Overall Study|Disease progression|7|||
48768668|NCT02296112|156999057|FG000|Overall Study|Toxicity|1|||
48768669|NCT02296112|156999057|FG000|Overall Study|Began an alternate therapy|1|||
48768670|NCT04568122|156999060|FG000|Overall Study|Lost to Follow-up|48|||
48768671|NCT04568122|156999061|FG001|Overall Study|Lost to Follow-up|44|||
48768672|NCT04568122|156999062|FG002|Overall Study|Lost to Follow-up|4|||
48768673|NCT04568122|156999063|FG003|Overall Study|Lost to Follow-up|0|||
48768674|NCT04568122|156999064|FG004|Overall Study|Lost to Follow-up|0|||
48768675|NCT00245765|156999066|FG000|Overall Study|Adverse Event|1|||
48768676|NCT00245765|156999067|FG001|Overall Study|Adverse Event|1|||
48768677|NCT00245765|156999068|FG002|Overall Study|Adverse Event|0|||
48768678|NCT00245765|156999066|FG000|Overall Study|Lack of Efficacy|14|||
48768679|NCT00245765|156999067|FG001|Overall Study|Lack of Efficacy|7|||
48768680|NCT00245765|156999068|FG002|Overall Study|Lack of Efficacy|0|||
48768681|NCT00245765|156999066|FG000|Overall Study|Lost to Follow-up|1|||
48768682|NCT00245765|156999067|FG001|Overall Study|Lost to Follow-up|2|||
48768683|NCT00245765|156999068|FG002|Overall Study|Lost to Follow-up|0|||
48768684|NCT00245765|156999066|FG000|Overall Study|Withdrawal by Subject|1|||
48768685|NCT00245765|156999067|FG001|Overall Study|Withdrawal by Subject|0|||
48768686|NCT00245765|156999068|FG002|Overall Study|Withdrawal by Subject|3|||
48768687|NCT00245765|156999066|FG000|Overall Study|Other reason|2|||
48768688|NCT00245765|156999067|FG001|Overall Study|Other reason|0|||
48768689|NCT00245765|156999068|FG002|Overall Study|Other reason|1|||
48768690|NCT00245765|156999066|FG000|Overall Study|Other|13|||
48768691|NCT00245765|156999067|FG001|Overall Study|Other|4|||
48768692|NCT00245765|156999068|FG002|Overall Study|Other|4|||
48768693|NCT03080961|156999069|FG000|Overall Study|Withdrawal by Subject|3|||
48768694|NCT03945981|156999070|FG000|Overall Study|Lost to Follow-up|12|||
48768695|NCT03945981|156999070|FG000|Overall Study|Physician Decision|4|||
48768696|NCT03945981|156999070|FG000|Overall Study|Withdrawal by Subject|6|||
48768697|NCT03945981|156999070|FG000|Overall Study|Protocol Violation|1|||
48768698|NCT00590954|156999072|FG000|Overall Study|Inevaluable|2|||
48768699|NCT03551210|156999073|FG000|Overall Study|Adverse Event|5|||
48768700|NCT03551210|156999074|FG001|Overall Study|Adverse Event|6|||
48768701|NCT03551210|156999073|FG000|Overall Study|Withdrawal by Subject|1|||
48768702|NCT03551210|156999074|FG001|Overall Study|Withdrawal by Subject|7|||
48768703|NCT03551210|156999073|FG000|Overall Study|Needed in other antibiotic treatment|2|||
48876140|NCT01214421|157383413|FG001|Overall Study|Withdrawal Criteria Met|0|||
48876141|NCT01214421|157383414|FG002|Overall Study|Withdrawal Criteria Met|2|||
48876142|NCT01214421|157383415|FG003|Overall Study|Withdrawal Criteria Met|1|||
48876143|NCT01214421|157383412|FG000|Overall Study|Physician Decision|2|||
48876144|NCT01214421|157383413|FG001|Overall Study|Physician Decision|0|||
48982037|NCT04921969|157765594|FG002|LTS Period (Weeks 8 to 52)|Ongoing|0|||
48982038|NCT04921969|157765595|FG003|LTS Period (Weeks 8 to 52)|Ongoing|14|||
48982039|NCT04921969|157765596|FG004|LTS Period (Weeks 8 to 52)|Ongoing|12|||
48982040|NCT04921969|157765597|FG005|LTS Period (Weeks 8 to 52)|Ongoing|55|||
48982041|NCT04921969|157765598|FG006|LTS Period (Weeks 8 to 52)|Ongoing|54|||
48982042|NCT03032523|157765599|FG000|Overall Study|Withdrawal by Subject|2|||
48982043|NCT03032523|157765600|FG001|Overall Study|Withdrawal by Subject|2|||
48982044|NCT03032523|157765599|FG000|Overall Study|Physician Decision|1|||
48982045|NCT03032523|157765600|FG001|Overall Study|Physician Decision|0|||
49026341|NCT01389102|157935878|FG003|Overall Study|Hurricane Katrina|0|||
49026342|NCT01389102|157935879|FG004|Overall Study|Hurricane Katrina|3|||
49026343|NCT01389102|157935880|FG005|Overall Study|Hurricane Katrina|1|||
49026344|NCT01389102|157935875|FG000|Overall Study|Lost to Follow-up|4|||
49026345|NCT01389102|157935876|FG001|Overall Study|Lost to Follow-up|1|||
48768704|NCT03551210|156999074|FG001|Overall Study|Needed in other antibiotic treatment|5|||
48768705|NCT03551210|156999073|FG000|Overall Study|Lost to Follow-up|1|||
48768706|NCT03551210|156999074|FG001|Overall Study|Lost to Follow-up|1|||
48876145|NCT01214421|157383414|FG002|Overall Study|Physician Decision|4|||
48876146|NCT01214421|157383415|FG003|Overall Study|Physician Decision|0|||
48876147|NCT01214421|157383412|FG000|Overall Study|Withdrawal by Subject|21|||
48876148|NCT01214421|157383413|FG001|Overall Study|Withdrawal by Subject|18|||
48876149|NCT01214421|157383414|FG002|Overall Study|Withdrawal by Subject|11|||
48876150|NCT01214421|157383415|FG003|Overall Study|Withdrawal by Subject|2|||
48876151|NCT00844597|157383418|FG000|Overall Study|Adverse Event|0|||
48876152|NCT00844597|157383419|FG001|Overall Study|Adverse Event|0|||
48876153|NCT00844597|157383420|FG002|Overall Study|Adverse Event|0|||
48876154|NCT00844597|157383421|FG003|Overall Study|Adverse Event|1|||
48876155|NCT00844597|157383422|FG004|Overall Study|Adverse Event|0|||
48876156|NCT00844597|157383423|FG005|Overall Study|Adverse Event|0|||
48876157|NCT02581059|157383424|FG000|Study Treatment|Disease Progression|1|||
48876158|NCT02581059|157383425|FG001|Study Treatment|Disease Progression|1|||
48876159|NCT02581059|157383424|FG000|Study Treatment|Adverse Event|2|||
48876160|NCT02581059|157383425|FG001|Study Treatment|Adverse Event|1|||
48876161|NCT02581059|157383424|FG000|Study Treatment|Death|1|||
48876162|NCT02581059|157383425|FG001|Study Treatment|Death|1|||
48876163|NCT02581059|157383424|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
48876164|NCT02581059|157383425|FG001|Study Treatment|Patient Withdrawal After Therapy Start|1|||
48876165|NCT02581059|157383424|FG000|Study Treatment|Screen Failure Before Therapy Start|0|||
48876166|NCT02581059|157383425|FG001|Study Treatment|Screen Failure Before Therapy Start|1|||
48876167|NCT02581059|157383424|FG000|Follow up|Death|1|||
48876168|NCT02581059|157383425|FG001|Follow up|Death|3|||
48876169|NCT02581059|157383424|FG000|Follow up|study terminated|1|||
48876170|NCT02581059|157383425|FG001|Follow up|study terminated|1|||
48876171|NCT02581059|157383424|FG000|Follow up|screen failure|0|||
48876172|NCT02581059|157383425|FG001|Follow up|screen failure|1|||
48876173|NCT02581059|157383424|FG000|Follow up|Patient started new clinical trial|1|||
48876174|NCT02581059|157383425|FG001|Follow up|Patient started new clinical trial|0|||
48876175|NCT01056263|157383428|FG000|Overall Study|Adverse Event|12|||
48876176|NCT01056263|157383428|FG000|Overall Study|Death|1|||
48876177|NCT01056263|157383428|FG000|Overall Study|Withdrawal by Subject|1|||
48876178|NCT01056263|157383428|FG000|Overall Study|Lack of Efficacy|29|||
48876179|NCT01056263|157383428|FG000|Overall Study|Progressive disease|2|||
48876180|NCT01056263|157383428|FG000|Overall Study|Neoplasm progression|1|||
48876181|NCT01056263|157383428|FG000|Overall Study|Objective progression or relapse|1|||
48876182|NCT01056263|157383428|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|5|||
48876183|NCT02636608|157383429|FG000|Overall Study|Failure to Return|4|||
48876184|NCT02636608|157383429|FG000|Overall Study|Insufficient Virological Response|1|||
48876185|NCT02636608|157383429|FG000|Overall Study|Death|3|||
48876186|NCT02636608|157383429|FG000|Overall Study|Other|2|||
48876187|NCT02636608|157383429|FG000|Overall Study|Did Not Receive Treatment|1|||
48876188|NCT01256671|157384589|FG000|Overall Study|Adverse Event|29|||
48876189|NCT01256671|157384589|FG000|Overall Study|Lost to Follow-up|16|||
48876190|NCT01256671|157384589|FG000|Overall Study|Withdrawal by Subject|31|||
48876191|NCT01256671|157384589|FG000|Overall Study|Physician Decision|3|||
48876192|NCT01256671|157384589|FG000|Overall Study|Lack of Efficacy|4|||
48876193|NCT01256671|157384589|FG000|Overall Study|Non-compliance/Sponsor Decision/Other|12|||
48876194|NCT00908349|157384592|FG000|Overall Study|Adverse Event|10|||
48876195|NCT00908349|157384592|FG000|Overall Study|Withdrawal by Subject|9|||
48876196|NCT00908349|157384592|FG000|Overall Study|Physician Decision|5|||
48876197|NCT00908349|157384592|FG000|Overall Study|Lost to Follow-up|5|||
48876198|NCT00908349|157384592|FG000|Overall Study|Various|6|||
48876199|NCT01468077|157384595|FG000|Overall Study|Adverse Event|2|||
48876200|NCT01468077|157384596|FG001|Overall Study|Adverse Event|2|||
48876201|NCT01468077|157384595|FG000|Overall Study|Lack of Efficacy|1|||
48876202|NCT01468077|157384596|FG001|Overall Study|Lack of Efficacy|1|||
48876203|NCT01468077|157384595|FG000|Overall Study|Physician Decision|1|||
48876204|NCT01468077|157384596|FG001|Overall Study|Physician Decision|0|||
48876205|NCT04009629|157384597|FG000|Overall Study|Withdrawal by Subject|2|||
48876206|NCT04009629|157384598|FG001|Overall Study|Withdrawal by Subject|0|||
48876207|NCT00761956|157384599|FG000|Overall Study|Lost to Follow-up|6|||
48876208|NCT00761956|157384600|FG001|Overall Study|Lost to Follow-up|11|||
48876209|NCT00761956|157384599|FG000|Overall Study|Withdrawal by Subject|3|||
48876210|NCT00761956|157384600|FG001|Overall Study|Withdrawal by Subject|8|||
48876211|NCT00761956|157384599|FG000|Overall Study|Death|0|||
48876212|NCT00761956|157384600|FG001|Overall Study|Death|1|||
48876213|NCT00761956|157384599|FG000|Overall Study|Adverse Event|26|||
48876214|NCT00761956|157384600|FG001|Overall Study|Adverse Event|34|||
48876215|NCT00958711|157384601|FG000|Overall Study|Withdrawal by Subject|0|||
48876216|NCT00958711|157384602|FG001|Overall Study|Withdrawal by Subject|4|||
48876217|NCT00958711|157384601|FG000|Overall Study|Physician Decision|5|||
48876218|NCT00958711|157384602|FG001|Overall Study|Physician Decision|7|||
48876219|NCT00958711|157384601|FG000|Overall Study|Lost to Follow-up|4|||
48876220|NCT00958711|157384602|FG001|Overall Study|Lost to Follow-up|1|||
48876221|NCT00958711|157384601|FG000|Overall Study|Other|2|||
48876222|NCT00958711|157384602|FG001|Overall Study|Other|5|||
48876223|NCT00958711|157384601|FG000|Overall Study|Death|1|||
49026346|NCT01389102|157935877|FG002|Overall Study|Lost to Follow-up|1|||
49026347|NCT01389102|157935878|FG003|Overall Study|Lost to Follow-up|2|||
49026348|NCT01389102|157935879|FG004|Overall Study|Lost to Follow-up|4|||
49026349|NCT01389102|157935880|FG005|Overall Study|Lost to Follow-up|1|||
49026350|NCT01389102|157935875|FG000|Overall Study|Protocol Violation|0|||
49026351|NCT01389102|157935876|FG001|Overall Study|Protocol Violation|0|||
49026352|NCT01389102|157935877|FG002|Overall Study|Protocol Violation|3|||
49026353|NCT01389102|157935878|FG003|Overall Study|Protocol Violation|0|||
49026354|NCT01389102|157935879|FG004|Overall Study|Protocol Violation|1|||
49026355|NCT01389102|157935880|FG005|Overall Study|Protocol Violation|1|||
48768707|NCT03551210|156999073|FG000|Overall Study|Absence of visit 4 and 5|1|||
48768708|NCT03551210|156999074|FG001|Overall Study|Absence of visit 4 and 5|0|||
48768709|NCT03551210|156999073|FG000|Overall Study|No drug for dispensing|0|||
48768710|NCT03551210|156999074|FG001|Overall Study|No drug for dispensing|1|||
48768711|NCT02382016|157000435|FG000|Double-blind (DB) Treatment Period|Physician Decision|3|||
48768712|NCT02382016|157000436|FG001|Double-blind (DB) Treatment Period|Physician Decision|0|||
48768713|NCT02382016|157000435|FG000|Double-blind (DB) Treatment Period|Lack of Efficacy|1|||
48768714|NCT02382016|157000436|FG001|Double-blind (DB) Treatment Period|Lack of Efficacy|0|||
48768715|NCT02382016|157000435|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|0|||
48768716|NCT02382016|157000436|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|1|||
48768717|NCT02382016|157000435|FG000|Open-label (OL) Treatment Period|Physician Decision|3|||
48768718|NCT02382016|157000436|FG001|Open-label (OL) Treatment Period|Physician Decision|0|||
48768719|NCT02382016|157000435|FG000|Open-label (OL) Treatment Period|Withdrawal by Subject|2|||
48768720|NCT02382016|157000436|FG001|Open-label (OL) Treatment Period|Withdrawal by Subject|0|||
48768721|NCT02382016|157000435|FG000|Open-label (OL) Treatment Period|Death|4|||
48768722|NCT02382016|157000436|FG001|Open-label (OL) Treatment Period|Death|0|||
48768723|NCT02382016|157000435|FG000|OL Extension Period|Physician Decision|3|||
48768724|NCT02382016|157000436|FG001|OL Extension Period|Physician Decision|0|||
48768725|NCT02382016|157000435|FG000|OL Extension Period|Death|2|||
48768726|NCT02382016|157000436|FG001|OL Extension Period|Death|0|||
48768727|NCT02382016|157000435|FG000|OL Extension Period|Withdrawal by Subject|1|||
48768728|NCT02382016|157000436|FG001|OL Extension Period|Withdrawal by Subject|0|||
48768729|NCT03034954|157000439|FG000|Overall Study|Machine malfunction; did not reach 3 mA|1|||
48768730|NCT03034954|157000440|FG001|Overall Study|Machine malfunction; did not reach 3 mA|0|||
48768731|NCT03925324|157000443|FG000|Overall Study|Death|1|||
48768732|NCT03925324|157000444|FG001|Overall Study|Death|1|||
48768733|NCT00794196|157000445|FG000|Overall Study|Lost to Follow-up|5|||
48768734|NCT00794196|157000446|FG001|Overall Study|Lost to Follow-up|23|||
48768735|NCT01077960|157000447|FG000|Overall Study|Adverse Event|6|||
48768736|NCT01077960|157000447|FG000|Overall Study|Protocol Violation|3|||
48768737|NCT01077960|157000447|FG000|Overall Study|Lost to Follow-up|5|||
48768738|NCT01077960|157000447|FG000|Overall Study|Subject decision|1|||
48768739|NCT01077960|157000447|FG000|Overall Study|Reason unspecified|1|||
48768740|NCT04753164|157000448|FG000|Overall Study|Adverse Event|0|||
48768741|NCT04753164|157000449|FG001|Overall Study|Adverse Event|2|||
48768742|NCT04753164|157000448|FG000|Overall Study|Withdrawal by Subject|9|||
48768743|NCT04753164|157000449|FG001|Overall Study|Withdrawal by Subject|7|||
48768744|NCT04753164|157000448|FG000|Overall Study|Lost to Follow-up|6|||
48768745|NCT04753164|157000449|FG001|Overall Study|Lost to Follow-up|6|||
48768746|NCT04753164|157000448|FG000|Overall Study|Other|12|||
48768747|NCT04753164|157000449|FG001|Overall Study|Other|5|||
48768748|NCT00907374|157000459|FG000|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
48768749|NCT00907374|157000460|FG001|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
48768750|NCT00439556|157000461|FG000|Overall Study|Patient was taken off study for non-comp|0|||
48768751|NCT00439556|157000462|FG001|Overall Study|Patient was taken off study for non-comp|1|||
48768752|NCT00439556|157000463|FG002|Overall Study|Patient was taken off study for non-comp|0|||
48768753|NCT03818516|157000464|FG000|Overall Study|Exclusion due to positive UDS (THC) test|1|||
48768754|NCT02703636|157000465|FG000|Overall Study|Adverse Event|14|||
48768755|NCT02703636|157000465|FG000|Overall Study|Study stopped by sponsor|1|||
48768756|NCT02703636|157000465|FG000|Overall Study|Withdrawal by Subject|1|||
48768757|NCT01465464|157000472|FG000|Overall Study|Adverse Event|96|||
49026356|NCT01389102|157935875|FG000|Overall Study|Withdrawal by Subject|7|||
48768758|NCT01465464|157000473|FG001|Overall Study|Adverse Event|49|||
48768759|NCT01465464|157000472|FG000|Overall Study|Lack of Efficacy|139|||
48768760|NCT01465464|157000473|FG001|Overall Study|Lack of Efficacy|190|||
48768761|NCT01465464|157000472|FG000|Overall Study|Physician Decision|13|||
48768762|NCT01465464|157000473|FG001|Overall Study|Physician Decision|5|||
49026357|NCT01389102|157935876|FG001|Overall Study|Withdrawal by Subject|4|||
48768763|NCT01465464|157000472|FG000|Overall Study|Protocol Violation|1|||
48768764|NCT01465464|157000473|FG001|Overall Study|Protocol Violation|1|||
48768765|NCT01465464|157000472|FG000|Overall Study|Withdrawal by Subject|46|||
49026358|NCT01389102|157935877|FG002|Overall Study|Withdrawal by Subject|9|||
48768766|NCT01465464|157000473|FG001|Overall Study|Withdrawal by Subject|30|||
48768767|NCT01465464|157000472|FG000|Overall Study|Other|9|||
48768768|NCT01465464|157000473|FG001|Overall Study|Other|3|||
49026359|NCT01389102|157935878|FG003|Overall Study|Withdrawal by Subject|2|||
48768769|NCT01465464|157000472|FG000|Overall Study|Ongoing treatment at cutoff date|140|||
48768770|NCT01465464|157000473|FG001|Overall Study|Ongoing treatment at cutoff date|166|||
48768771|NCT02907359|157000476|FG000|Overall Study|Death|234|||
48768772|NCT02907359|157000477|FG001|Overall Study|Death|117|||
48768773|NCT02907359|157000476|FG000|Overall Study|Withdrawal by Subject|6|||
48768774|NCT02907359|157000477|FG001|Overall Study|Withdrawal by Subject|11|||
48768775|NCT02907359|157000476|FG000|Overall Study|Lost to Follow-up|1|||
48768776|NCT02907359|157000477|FG001|Overall Study|Lost to Follow-up|0|||
48768777|NCT05091528|157000478|FG000|Overall Study|Study Termination by Sponsor|0|||
48768778|NCT05091528|157000479|FG001|Overall Study|Study Termination by Sponsor|1|||
48768779|NCT05091528|157000480|FG002|Overall Study|Study Termination by Sponsor|0|||
48768780|NCT05091528|157000481|FG003|Overall Study|Study Termination by Sponsor|1|||
48768781|NCT03742141|157000482|FG000|Overall Study|no surgery or post-operative laryngoscopy|50|||
48768782|NCT00058825|157000483|FG000|Overall Study|Relapse|9|||
48768783|NCT00058825|157000483|FG000|Overall Study|Progressive Disease|5|||
48768784|NCT00058825|157000483|FG000|Overall Study|Graft Failure|5|||
48768785|NCT00058825|157000483|FG000|Overall Study|Death|3|||
48768786|NCT04371380|157000484|FG000|Oral Lead-in Phase (Up to Day 28)|Physician Decision|1|||
48768787|NCT04371380|157000485|FG001|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
48768788|NCT04371380|157000486|FG002|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
48768789|NCT02376166|157000488|FG000|Overall Study|Adverse Event|1|||
48768790|NCT02376166|157000488|FG000|Overall Study|Discontinued metformin early|2|||
48768791|NCT01640366|157000489|FG000|Overall Study|Withdrawal by Subject|1|||
48768792|NCT01640366|157000489|FG000|Overall Study|Protocol Violation|16|||
48768793|NCT01640366|157000489|FG000|Overall Study|Lost to Follow-up|5|||
48768794|NCT01354496|157000494|FG000|Period 1|Adverse Event|0|||
48768795|NCT01354496|157000495|FG001|Period 1|Adverse Event|0|||
48768796|NCT01354496|157000496|FG002|Period 1|Adverse Event|1|||
48768797|NCT01354496|157000497|FG003|Period 1|Adverse Event|0|||
48768798|NCT01354496|157000498|FG004|Period 1|Adverse Event|0|||
48768799|NCT01354496|157000499|FG005|Period 1|Adverse Event|0|||
48768800|NCT01354496|157000494|FG000|Period 1|Physician Decision|0|||
48768801|NCT01354496|157000495|FG001|Period 1|Physician Decision|0|||
48768802|NCT01354496|157000496|FG002|Period 1|Physician Decision|1|||
48768803|NCT01354496|157000497|FG003|Period 1|Physician Decision|0|||
48768804|NCT01354496|157000498|FG004|Period 1|Physician Decision|0|||
48768805|NCT01354496|157000499|FG005|Period 1|Physician Decision|0|||
48768806|NCT01354496|157000494|FG000|Period 2|Adverse Event|0|||
48768807|NCT01354496|157000495|FG001|Period 2|Adverse Event|0|||
48768808|NCT01354496|157000496|FG002|Period 2|Adverse Event|0|||
48768809|NCT01354496|157000497|FG003|Period 2|Adverse Event|1|||
48768810|NCT01354496|157000498|FG004|Period 2|Adverse Event|0|||
48768811|NCT01354496|157000499|FG005|Period 2|Adverse Event|0|||
48768812|NCT01354496|157000494|FG000|Washout (at Least 14 Days)|Scheduling Conflict|0|||
48768813|NCT01354496|157000495|FG001|Washout (at Least 14 Days)|Scheduling Conflict|1|||
48768814|NCT01354496|157000496|FG002|Washout (at Least 14 Days)|Scheduling Conflict|0|||
48768815|NCT01354496|157000497|FG003|Washout (at Least 14 Days)|Scheduling Conflict|1|||
48768816|NCT01354496|157000498|FG004|Washout (at Least 14 Days)|Scheduling Conflict|0|||
48768817|NCT01354496|157000499|FG005|Washout (at Least 14 Days)|Scheduling Conflict|0|||
48768818|NCT00838565|157000500|FG000|Overall Study|Withdrawal by Subject|0|||
48768819|NCT00838565|157000501|FG001|Overall Study|Withdrawal by Subject|0|||
48768820|NCT00838565|157000502|FG002|Overall Study|Withdrawal by Subject|1|||
48768821|NCT00838565|157000503|FG003|Overall Study|Withdrawal by Subject|0|||
48768822|NCT00838565|157000504|FG004|Overall Study|Withdrawal by Subject|0|||
48768823|NCT00838565|157000505|FG005|Overall Study|Withdrawal by Subject|2|||
48768824|NCT00838565|157000500|FG000|Overall Study|Other|0|||
48768825|NCT00838565|157000501|FG001|Overall Study|Other|2|||
48768826|NCT00838565|157000502|FG002|Overall Study|Other|0|||
48768827|NCT00838565|157000503|FG003|Overall Study|Other|0|||
48768828|NCT00838565|157000504|FG004|Overall Study|Other|0|||
48768829|NCT00838565|157000505|FG005|Overall Study|Other|0|||
48768830|NCT00838565|157000500|FG000|Overall Study|Randomized but not Treated|0|||
48768831|NCT00838565|157000501|FG001|Overall Study|Randomized but not Treated|1|||
48768832|NCT00838565|157000502|FG002|Overall Study|Randomized but not Treated|0|||
48768833|NCT00838565|157000503|FG003|Overall Study|Randomized but not Treated|0|||
48768834|NCT00838565|157000504|FG004|Overall Study|Randomized but not Treated|0|||
48768835|NCT00838565|157000505|FG005|Overall Study|Randomized but not Treated|0|||
48768836|NCT00480779|157000507|FG000|Overall Study|Other|2|||
48768837|NCT00480779|157000508|FG001|Overall Study|Other|0|||
48768838|NCT00480779|157000507|FG000|Overall Study|Job and Health-related|0|||
48768839|NCT00480779|157000508|FG001|Overall Study|Job and Health-related|3|||
48768840|NCT04907032|157000511|FG000|Overall Study|Withdrawal by Subject|7|||
48768841|NCT04907032|157000512|FG001|Overall Study|Withdrawal by Subject|1|||
48768842|NCT00613509|157000515|FG000|Cycle 1|Adverse Event|2|||
48768843|NCT00613509|157000516|FG001|Cycle 1|Adverse Event|1|||
48768844|NCT00613509|157000515|FG000|Cycle 1|Disease Progression|2|||
48768845|NCT00613509|157000516|FG001|Cycle 1|Disease Progression|6|||
48768846|NCT00613509|157000515|FG000|Cycle 1|Unacceptable Toxicity|1|||
48768847|NCT00613509|157000516|FG001|Cycle 1|Unacceptable Toxicity|0|||
48768848|NCT00613509|157000515|FG000|Cycle 1|Other administrative reason|0|||
48768849|NCT00613509|157000516|FG001|Cycle 1|Other administrative reason|1|||
48768850|NCT02563028|157000519|FG000|Overall Study|Lack of equipment|1|||
48768851|NCT02563028|157000519|FG000|Overall Study|Unable to elicit VEP post induction|1|||
48768852|NCT02281552|157000520|FG000|Overall Study|Medication error|1|||
48768853|NCT02281552|157000521|FG001|Overall Study|Medication error|0|||
48768854|NCT02281552|157000520|FG000|Overall Study|Insufficient clinical response|0|||
48768855|NCT02281552|157000521|FG001|Overall Study|Insufficient clinical response|1|||
48768856|NCT02281552|157000520|FG000|Overall Study|Adverse Event|3|||
48768857|NCT02281552|157000521|FG001|Overall Study|Adverse Event|9|||
48768858|NCT01009099|157000522|FG000|Overall Study|Lost to Follow-up|1|||
48768859|NCT01009099|157000523|FG001|Overall Study|Lost to Follow-up|0|||
48768860|NCT01009099|157000522|FG000|Overall Study|Physician Decision|3|||
48768861|NCT01009099|157000523|FG001|Overall Study|Physician Decision|2|||
48768862|NCT01009099|157000522|FG000|Overall Study|Withdrawal by Subject|1|||
48768863|NCT01009099|157000523|FG001|Overall Study|Withdrawal by Subject|1|||
48768864|NCT01009099|157000522|FG000|Overall Study|Death|0|||
48768865|NCT01009099|157000523|FG001|Overall Study|Death|1|||
48768866|NCT03925727|157000527|FG000|Overall Study|Adverse Event|4|||
48768867|NCT03925727|157000528|FG001|Overall Study|Adverse Event|0|||
48768868|NCT03925727|157000529|FG002|Overall Study|Adverse Event|3|||
48768869|NCT03925727|157000527|FG000|Overall Study|Protocol Violation|1|||
48768870|NCT03925727|157000528|FG001|Overall Study|Protocol Violation|2|||
48768871|NCT03925727|157000529|FG002|Overall Study|Protocol Violation|2|||
48768872|NCT03925727|157000527|FG000|Overall Study|Withdrawal by Subject|3|||
48768873|NCT03925727|157000528|FG001|Overall Study|Withdrawal by Subject|2|||
48768874|NCT03925727|157000529|FG002|Overall Study|Withdrawal by Subject|4|||
48768875|NCT03925727|157000527|FG000|Overall Study|Administrative Reasons|3|||
48768876|NCT03925727|157000528|FG001|Overall Study|Administrative Reasons|1|||
48768877|NCT03925727|157000529|FG002|Overall Study|Administrative Reasons|2|||
48768878|NCT03925727|157000527|FG000|Overall Study|Randomized in error or Disqualified|8|||
48768879|NCT03925727|157000528|FG001|Overall Study|Randomized in error or Disqualified|1|||
48768880|NCT03925727|157000529|FG002|Overall Study|Randomized in error or Disqualified|7|||
48768881|NCT01393743|157000530|FG000|Core Study|Adverse Event|5|||
48768882|NCT01393743|157000531|FG001|Core Study|Adverse Event|9|||
48768883|NCT01393743|157000532|FG002|Core Study|Adverse Event|0|||
48768884|NCT01393743|157000530|FG000|Core Study|Lost to Follow-up|1|||
48768885|NCT01393743|157000531|FG001|Core Study|Lost to Follow-up|1|||
48768886|NCT01393743|157000532|FG002|Core Study|Lost to Follow-up|0|||
48768887|NCT01393743|157000530|FG000|Core Study|Participant's Choice|2|||
48768888|NCT01393743|157000531|FG001|Core Study|Participant's Choice|3|||
48768889|NCT01393743|157000532|FG002|Core Study|Participant's Choice|0|||
48768890|NCT01393743|157000530|FG000|Core Study|Inadequate therapeutic effect|2|||
48768891|NCT01393743|157000531|FG001|Core Study|Inadequate therapeutic effect|0|||
48768892|NCT01393743|157000532|FG002|Core Study|Inadequate therapeutic effect|0|||
48768893|NCT01393743|157000530|FG000|Extension Phase|Adverse Event|0|||
48768894|NCT01393743|157000531|FG001|Extension Phase|Adverse Event|0|||
48768895|NCT01393743|157000532|FG002|Extension Phase|Adverse Event|12|||
48768896|NCT01393743|157000530|FG000|Extension Phase|Lost to Follow-up|0|||
48768897|NCT01393743|157000531|FG001|Extension Phase|Lost to Follow-up|0|||
48768898|NCT01393743|157000532|FG002|Extension Phase|Lost to Follow-up|2|||
48768899|NCT01393743|157000530|FG000|Extension Phase|Participant choice|0|||
48768900|NCT01393743|157000531|FG001|Extension Phase|Participant choice|0|||
48768901|NCT01393743|157000532|FG002|Extension Phase|Participant choice|16|||
48768902|NCT01393743|157000530|FG000|Extension Phase|Inadequate therapeutic effect|0|||
48768903|NCT01393743|157000531|FG001|Extension Phase|Inadequate therapeutic effect|0|||
48768904|NCT01393743|157000532|FG002|Extension Phase|Inadequate therapeutic effect|7|||
48768905|NCT01393743|157000530|FG000|Extension Phase|Withdrawal by Subject|0|||
48768906|NCT01393743|157000531|FG001|Extension Phase|Withdrawal by Subject|0|||
48768907|NCT01393743|157000532|FG002|Extension Phase|Withdrawal by Subject|8|||
48768908|NCT01393743|157000530|FG000|Extension Phase|Pregnancy|0|||
48768909|NCT01393743|157000531|FG001|Extension Phase|Pregnancy|0|||
48768910|NCT01393743|157000532|FG002|Extension Phase|Pregnancy|1|||
48768911|NCT01393743|157000530|FG000|Extension Phase|Other|0|||
48768912|NCT01393743|157000531|FG001|Extension Phase|Other|0|||
48768913|NCT01393743|157000532|FG002|Extension Phase|Other|14|||
48768914|NCT00213148|157000533|FG000|Cycle 1 (1 Month)|Lost to Follow-up|1|||
48768915|NCT00213148|157000534|FG001|Cycle 1 (1 Month)|Lost to Follow-up|0|||
48768916|NCT00213148|157000535|FG002|Cycle 1 (1 Month)|Lost to Follow-up|2|||
48768917|NCT00213148|157000536|FG003|Cycle 1 (1 Month)|Lost to Follow-up|2|||
48768918|NCT00213148|157000537|FG004|Cycle 1 (1 Month)|Lost to Follow-up|1|||
48768919|NCT00213148|157000533|FG000|Cycle 1 (1 Month)|Adverse Event|0|||
48768920|NCT00213148|157000534|FG001|Cycle 1 (1 Month)|Adverse Event|0|||
48768921|NCT00213148|157000535|FG002|Cycle 1 (1 Month)|Adverse Event|1|||
48768922|NCT00213148|157000536|FG003|Cycle 1 (1 Month)|Adverse Event|0|||
48768923|NCT00213148|157000537|FG004|Cycle 1 (1 Month)|Adverse Event|0|||
48768924|NCT00213148|157000533|FG000|Cycle 1 (1 Month)|Lack of Efficacy|4|||
48768925|NCT00213148|157000534|FG001|Cycle 1 (1 Month)|Lack of Efficacy|0|||
48876224|NCT00958711|157384602|FG001|Overall Study|Death|2|||
48768926|NCT00213148|157000535|FG002|Cycle 1 (1 Month)|Lack of Efficacy|8|||
48768927|NCT00213148|157000536|FG003|Cycle 1 (1 Month)|Lack of Efficacy|5|||
48768928|NCT00213148|157000537|FG004|Cycle 1 (1 Month)|Lack of Efficacy|8|||
48768929|NCT00213148|157000533|FG000|Cycle 1 (1 Month)|Protocol Violation|1|||
48768930|NCT00213148|157000534|FG001|Cycle 1 (1 Month)|Protocol Violation|0|||
48768931|NCT00213148|157000535|FG002|Cycle 1 (1 Month)|Protocol Violation|1|||
48768932|NCT00213148|157000536|FG003|Cycle 1 (1 Month)|Protocol Violation|0|||
48768933|NCT00213148|157000537|FG004|Cycle 1 (1 Month)|Protocol Violation|0|||
48768934|NCT00213148|157000533|FG000|Cycle 1 (1 Month)|Other|3|||
48768935|NCT00213148|157000534|FG001|Cycle 1 (1 Month)|Other|0|||
48768936|NCT00213148|157000535|FG002|Cycle 1 (1 Month)|Other|2|||
48768937|NCT00213148|157000536|FG003|Cycle 1 (1 Month)|Other|2|||
48768938|NCT00213148|157000537|FG004|Cycle 1 (1 Month)|Other|7|||
48768939|NCT00213148|157000533|FG000|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
48768940|NCT00213148|157000534|FG001|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
48768941|NCT00213148|157000535|FG002|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
48768942|NCT00213148|157000536|FG003|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1|||
48768943|NCT00213148|157000537|FG004|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
48768944|NCT00213148|157000533|FG000|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
48768945|NCT00213148|157000534|FG001|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
48768946|NCT00213148|157000535|FG002|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
48768947|NCT00213148|157000536|FG003|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
48768948|NCT00213148|157000537|FG004|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1|||
48768949|NCT00213148|157000533|FG000|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15|||
48768950|NCT00213148|157000534|FG001|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0|||
48768951|NCT00213148|157000535|FG002|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
48768952|NCT00213148|157000536|FG003|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8|||
48768953|NCT00213148|157000537|FG004|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
48768954|NCT00213148|157000533|FG000|Cycle 2 (1 Month)|Lost to Follow-up|0|||
48768955|NCT00213148|157000534|FG001|Cycle 2 (1 Month)|Lost to Follow-up|0|||
48768956|NCT00213148|157000535|FG002|Cycle 2 (1 Month)|Lost to Follow-up|2|||
48768957|NCT00213148|157000536|FG003|Cycle 2 (1 Month)|Lost to Follow-up|2|||
48768958|NCT00213148|157000537|FG004|Cycle 2 (1 Month)|Lost to Follow-up|1|||
48768959|NCT00213148|157000533|FG000|Cycle 2 (1 Month)|Lack of Efficacy|1|||
48768960|NCT00213148|157000534|FG001|Cycle 2 (1 Month)|Lack of Efficacy|3|||
48768961|NCT00213148|157000535|FG002|Cycle 2 (1 Month)|Lack of Efficacy|7|||
48768962|NCT00213148|157000536|FG003|Cycle 2 (1 Month)|Lack of Efficacy|6|||
48768963|NCT00213148|157000537|FG004|Cycle 2 (1 Month)|Lack of Efficacy|16|||
48768964|NCT00213148|157000533|FG000|Cycle 2 (1 Month)|Other|2|||
48768965|NCT00213148|157000534|FG001|Cycle 2 (1 Month)|Other|1|||
48768966|NCT00213148|157000535|FG002|Cycle 2 (1 Month)|Other|2|||
48768967|NCT00213148|157000536|FG003|Cycle 2 (1 Month)|Other|8|||
48768968|NCT00213148|157000537|FG004|Cycle 2 (1 Month)|Other|7|||
48768969|NCT00213148|157000533|FG000|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
48768970|NCT00213148|157000534|FG001|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1|||
48768971|NCT00213148|157000535|FG002|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
48768972|NCT00213148|157000536|FG003|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
48768973|NCT00213148|157000537|FG004|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
48768974|NCT00213148|157000533|FG000|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1|||
48768975|NCT00213148|157000534|FG001|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
48768976|NCT00213148|157000535|FG002|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
48768977|NCT00213148|157000536|FG003|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
48768978|NCT00213148|157000537|FG004|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
48768979|NCT00213148|157000533|FG000|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10|||
48768980|NCT00213148|157000534|FG001|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1|||
48768981|NCT00213148|157000535|FG002|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
48876225|NCT00958711|157384601|FG000|Overall Study|Adverse Event|1|||
48876226|NCT00958711|157384602|FG001|Overall Study|Adverse Event|2|||
48876227|NCT03834623|157384603|FG000|Overall Study|Progression|0|||
49026360|NCT01389102|157935879|FG004|Overall Study|Withdrawal by Subject|3|||
49026361|NCT01389102|157935880|FG005|Overall Study|Withdrawal by Subject|3|||
49026362|NCT01389102|157935875|FG000|Overall Study|Subject Traveling Out of Country|0|||
49026363|NCT01389102|157935876|FG001|Overall Study|Subject Traveling Out of Country|0|||
49026364|NCT01389102|157935877|FG002|Overall Study|Subject Traveling Out of Country|0|||
48768982|NCT00213148|157000536|FG003|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
48768983|NCT00213148|157000537|FG004|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6|||
48768984|NCT00213148|157000533|FG000|Cycle 3 (1 Month)|Lost to Follow-up|0|||
48768985|NCT00213148|157000534|FG001|Cycle 3 (1 Month)|Lost to Follow-up|2|||
48768986|NCT00213148|157000535|FG002|Cycle 3 (1 Month)|Lost to Follow-up|0|||
48768987|NCT00213148|157000536|FG003|Cycle 3 (1 Month)|Lost to Follow-up|0|||
49026365|NCT01389102|157935878|FG003|Overall Study|Subject Traveling Out of Country|1|||
48768988|NCT00213148|157000537|FG004|Cycle 3 (1 Month)|Lost to Follow-up|1|||
48768989|NCT00213148|157000533|FG000|Cycle 3 (1 Month)|Other|0|||
48876228|NCT03834623|157384604|FG001|Overall Study|Progression|1|||
48876229|NCT01375751|157384609|FG000|Overall Study|Other|0|||
48876230|NCT01375751|157384610|FG001|Overall Study|Other|1|||
48768990|NCT00213148|157000534|FG001|Cycle 3 (1 Month)|Other|0|||
48768991|NCT00213148|157000535|FG002|Cycle 3 (1 Month)|Other|1|||
48768992|NCT00213148|157000536|FG003|Cycle 3 (1 Month)|Other|1|||
48768993|NCT00213148|157000537|FG004|Cycle 3 (1 Month)|Other|0|||
48768994|NCT00717769|157000538|FG000|Overall Study|Adverse Event|9|||
48768995|NCT00717769|157000539|FG001|Overall Study|Adverse Event|6|||
48768996|NCT00717769|157000540|FG002|Overall Study|Adverse Event|1|||
48768997|NCT00717769|157000538|FG000|Overall Study|Lack of compliance|0|||
48768998|NCT00717769|157000539|FG001|Overall Study|Lack of compliance|2|||
48768999|NCT00717769|157000540|FG002|Overall Study|Lack of compliance|0|||
48769000|NCT00717769|157000538|FG000|Overall Study|Lost to Follow-up|3|||
48769001|NCT00717769|157000539|FG001|Overall Study|Lost to Follow-up|4|||
48769002|NCT00717769|157000540|FG002|Overall Study|Lost to Follow-up|0|||
48769003|NCT00717769|157000538|FG000|Overall Study|Lack of Efficacy|1|||
48769004|NCT00717769|157000539|FG001|Overall Study|Lack of Efficacy|2|||
48769005|NCT00717769|157000540|FG002|Overall Study|Lack of Efficacy|0|||
48769006|NCT00717769|157000538|FG000|Overall Study|Protocol Violation|0|||
48769007|NCT00717769|157000539|FG001|Overall Study|Protocol Violation|2|||
48769008|NCT00717769|157000540|FG002|Overall Study|Protocol Violation|0|||
48769009|NCT00717769|157000538|FG000|Overall Study|Sponsor decision|1|||
48769010|NCT00717769|157000539|FG001|Overall Study|Sponsor decision|0|||
48769011|NCT00717769|157000540|FG002|Overall Study|Sponsor decision|10|||
48769012|NCT00717769|157000538|FG000|Overall Study|Withdrew consent|2|||
48769013|NCT00717769|157000539|FG001|Overall Study|Withdrew consent|2|||
48769014|NCT00717769|157000540|FG002|Overall Study|Withdrew consent|0|||
48769015|NCT01071512|157000552|FG000|Overall Study|Adverse Event|1|||
48769016|NCT01071512|157000552|FG000|Overall Study|Development of antibodies to drug|2|||
48769017|NCT01071512|157000552|FG000|Overall Study|positive anti-JC virus antibody test|2|||
48769018|NCT01541930|157000555|FG000|Overall Study|Withdrawal by Subject|1|||
48769019|NCT00262067|157000556|FG000|Overall Study|Death|190|||
48769020|NCT00262067|157000557|FG001|Overall Study|Death|89|||
48769021|NCT00262067|157000558|FG002|Overall Study|Death|186|||
48769022|NCT00262067|157000559|FG003|Overall Study|Death|99|||
48769023|NCT00262067|157000556|FG000|Overall Study|Lost to Follow-up|5|||
48769024|NCT00262067|157000557|FG001|Overall Study|Lost to Follow-up|4|||
48769025|NCT00262067|157000558|FG002|Overall Study|Lost to Follow-up|7|||
48769026|NCT00262067|157000559|FG003|Overall Study|Lost to Follow-up|5|||
48769027|NCT00262067|157000556|FG000|Overall Study|Sponsor's Decision to Terminate Study|1|||
48769028|NCT00262067|157000557|FG001|Overall Study|Sponsor's Decision to Terminate Study|0|||
48769029|NCT00262067|157000558|FG002|Overall Study|Sponsor's Decision to Terminate Study|0|||
48769030|NCT00262067|157000559|FG003|Overall Study|Sponsor's Decision to Terminate Study|0|||
48769031|NCT00262067|157000556|FG000|Overall Study|Patient Withdrew for Survival Follow-up|23|||
48769032|NCT00262067|157000557|FG001|Overall Study|Patient Withdrew for Survival Follow-up|7|||
48769033|NCT00262067|157000558|FG002|Overall Study|Patient Withdrew for Survival Follow-up|23|||
48769034|NCT00262067|157000559|FG003|Overall Study|Patient Withdrew for Survival Follow-up|9|||
48769035|NCT00586469|157000563|FG000|Overall Study|Adverse Event|0|||
48769036|NCT00586469|157000564|FG001|Overall Study|Adverse Event|1|||
48769037|NCT01755416|157000567|FG000|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1|||
48769038|NCT01755416|157000568|FG001|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2|||
48769039|NCT02449239|157001915|FG000|Induction Phase|Lack of Efficacy|64|||
48769040|NCT02449239|157001915|FG000|Induction Phase|Adverse Event|1|||
48769041|NCT02449239|157001915|FG000|Induction Phase|Lost to Follow-up|1|||
48769042|NCT02449239|157001915|FG000|Induction Phase|Protocol Violation|1|||
48769043|NCT02449239|157001915|FG000|Induction Phase|Physician Decision|1|||
48769044|NCT02449239|157001915|FG000|Induction Phase|Patient was determined by the sponsor to be ineligible for enrollment|1|||
48769045|NCT02449239|157001915|FG000|Induction Phase|Withdrawal by Subject|1|||
48769046|NCT02449239|157001915|FG000|Maintenance Month 3|Lack of Efficacy|14|||
48769047|NCT02449239|157001915|FG000|Maintenance Month 6|Lack of Efficacy|10|||
48769048|NCT02449239|157001915|FG000|Maintenance Month 6|Adverse Event|2|||
48769049|NCT02449239|157001915|FG000|Maintenance Month 6|Physician Decision|1|||
48769050|NCT02449239|157001915|FG000|Maintenance Month 9|Lack of Efficacy|2|||
48876231|NCT01375751|157384611|FG002|Overall Study|Other|0|||
48876232|NCT00559377|157384619|FG000|Overall Study|Withdrawal by Subject|9|||
48982046|NCT02371980|157767518|FG000|Open-label Period|Pretreatment Event/Adverse Event|63|||
48769051|NCT02449239|157001915|FG000|Maintenance Month 9|Started ibrutinib for CLL|1|||
48769052|NCT02449239|157001915|FG000|Maintenance Month 12|Lack of Efficacy|5|||
48769053|NCT02449239|157001915|FG000|Maintenance Month 12|Withdrawal by Subject|1|||
48769054|NCT02449239|157001915|FG000|Maintenance Month 12|Subject moved from area|1|||
48769055|NCT02449239|157001915|FG000|Maintenance Month 15|Lack of Efficacy|1|||
48769056|NCT02449239|157001915|FG000|Maintenance Month 21|Lack of Efficacy|1|||
48769057|NCT02449239|157001915|FG000|Maintenance Month 21|Sponsor decision|1|||
48769058|NCT01275066|157001916|FG000|Overall Study|Withdrawal by Subject|0|||
48769059|NCT01275066|157001917|FG001|Overall Study|Withdrawal by Subject|0|||
48876233|NCT03672175|157384622|FG000|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
49098991|NCT04064411|158197010|FG000|Overall Study|Death|1|||
48769060|NCT01275066|157001918|FG002|Overall Study|Withdrawal by Subject|1|||
48769061|NCT01275066|157001916|FG000|Overall Study|Not Diagnosed w/ Disease|1|||
48769062|NCT01275066|157001917|FG001|Overall Study|Not Diagnosed w/ Disease|0|||
48769063|NCT01275066|157001918|FG002|Overall Study|Not Diagnosed w/ Disease|0|||
48769064|NCT03509675|157001921|FG000|First Intervention (7 Days)|Lost to Follow-up|3|||
48769065|NCT03509675|157001922|FG001|First Intervention (7 Days)|Lost to Follow-up|3|||
48769066|NCT03509675|157001921|FG000|First Intervention (7 Days)|Lack of Efficacy|2|||
48769067|NCT03509675|157001922|FG001|First Intervention (7 Days)|Lack of Efficacy|1|||
48769068|NCT03509675|157001921|FG000|Second Intervention )7 Days)|Withdrawal by Subject|1|||
48769069|NCT03509675|157001922|FG001|Second Intervention )7 Days)|Withdrawal by Subject|0|||
48769070|NCT03509675|157001921|FG000|Second Intervention )7 Days)|Lost Rinse B|1|||
48769071|NCT03509675|157001922|FG001|Second Intervention )7 Days)|Lost Rinse B|0|||
48769072|NCT00326612|157001927|FG000|Overall Study|They did not have a seizure requiring tx|129|||
48769073|NCT00326612|157001928|FG001|Overall Study|They did not have a seizure requiring tx|137|||
48769074|NCT01236755|157001929|FG000|Spectacles Wearing Phase|Withdrawal by Subject|8|||
48769075|NCT01236755|157001929|FG000|Spectacles Wearing Phase|Lost to Follow-up|9|||
48769076|NCT01236755|157001929|FG000|Orthokeratology Wearing Phase|Withdrawal by Subject|5|||
48769077|NCT01236755|157001929|FG000|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3|||
48769078|NCT00110812|157001930|FG000|Main Study|Death|0|||
48769079|NCT00110812|157001931|FG001|Main Study|Death|0|||
48769080|NCT00110812|157001932|FG002|Main Study|Death|2|||
48769081|NCT00110812|157001930|FG000|Main Study|Withdrawal by Subject|0|||
48769082|NCT00110812|157001931|FG001|Main Study|Withdrawal by Subject|0|||
48769083|NCT00110812|157001932|FG002|Main Study|Withdrawal by Subject|1|||
48769084|NCT00110812|157001930|FG000|Main Study|Lost to Follow-up|8|||
48769085|NCT00110812|157001931|FG001|Main Study|Lost to Follow-up|11|||
48769086|NCT00110812|157001932|FG002|Main Study|Lost to Follow-up|10|||
48769087|NCT00110812|157001930|FG000|Extended Follow-up|Death|1|||
48769088|NCT00110812|157001931|FG001|Extended Follow-up|Death|0|||
48769089|NCT00110812|157001932|FG002|Extended Follow-up|Death|3|||
48769090|NCT00110812|157001930|FG000|Extended Follow-up|Withdrawal by Subject|0|||
48769091|NCT00110812|157001931|FG001|Extended Follow-up|Withdrawal by Subject|1|||
48769092|NCT00110812|157001932|FG002|Extended Follow-up|Withdrawal by Subject|0|||
48769093|NCT00110812|157001930|FG000|Extended Follow-up|Lost to Follow-up|1|||
48769094|NCT00110812|157001931|FG001|Extended Follow-up|Lost to Follow-up|3|||
48769095|NCT00110812|157001932|FG002|Extended Follow-up|Lost to Follow-up|1|||
48769096|NCT01933048|157001933|FG000|Overall Study|Lost to Follow-up|15|||
48769097|NCT01933048|157001934|FG001|Overall Study|Lost to Follow-up|18|||
48769098|NCT01933048|157001933|FG000|Overall Study|personal reasons|1|||
48769099|NCT01933048|157001934|FG001|Overall Study|personal reasons|1|||
48769100|NCT01933048|157001933|FG000|Overall Study|Protocol Violation|7|||
48769101|NCT01933048|157001934|FG001|Overall Study|Protocol Violation|8|||
48769102|NCT01933048|157001933|FG000|Overall Study|Physician Decision|1|||
48769103|NCT01933048|157001934|FG001|Overall Study|Physician Decision|0|||
48769104|NCT01933048|157001933|FG000|Overall Study|unknown reasons|1|||
48769105|NCT01933048|157001934|FG001|Overall Study|unknown reasons|1|||
48769106|NCT01454726|157001937|FG000|Overall Study|Withdrawal by Subject|0|||
48769107|NCT01454726|157001938|FG001|Overall Study|Withdrawal by Subject|1|||
48769108|NCT02821962|157001945|FG000|Overall Study|Lost to Follow-up|2|||
48769109|NCT02821962|157001946|FG001|Overall Study|Lost to Follow-up|0|||
48769110|NCT01344447|157001947|FG000|Overall Study|Adverse Event|1|||
48769111|NCT01344447|157001947|FG000|Overall Study|Protocol Violation|1|||
48769112|NCT01344447|157001947|FG000|Overall Study|Withdrawal by Subject|1|||
48769113|NCT01344447|157001947|FG000|Overall Study|The contrast was not seen|1|||
48769114|NCT01344447|157001947|FG000|Overall Study|Physician Decision|1|||
48769115|NCT01344447|157001947|FG000|Overall Study|MRA unsuccessful|1|||
48769116|NCT01344447|157001947|FG000|Overall Study|Bolus tracking failed|1|||
48769117|NCT01344447|157001947|FG000|Overall Study|Error of power injector|1|||
48769118|NCT00355238|157001951|FG000|Overall Study|Adverse event unrelated to study drug|2|||
48769119|NCT00355238|157001952|FG001|Overall Study|Adverse event unrelated to study drug|2|||
48769120|NCT00355238|157001953|FG002|Overall Study|Adverse event unrelated to study drug|0|||
48769121|NCT00355238|157001954|FG003|Overall Study|Adverse event unrelated to study drug|1|||
48769122|NCT00355238|157001951|FG000|Overall Study|Death|1|||
48769123|NCT00355238|157001952|FG001|Overall Study|Death|0|||
48769124|NCT00355238|157001953|FG002|Overall Study|Death|0|||
48769125|NCT00355238|157001954|FG003|Overall Study|Death|0|||
48769126|NCT00355238|157001951|FG000|Overall Study|Disease progression|37|||
48769127|NCT00355238|157001952|FG001|Overall Study|Disease progression|36|||
48769128|NCT00355238|157001953|FG002|Overall Study|Disease progression|16|||
48982047|NCT02371980|157767519|FG001|Open-label Period|Pretreatment Event/Adverse Event|0|||
48769129|NCT00355238|157001954|FG003|Overall Study|Disease progression|11|||
48769130|NCT00355238|157001951|FG000|Overall Study|Study drug toxicity|11|||
48769131|NCT00355238|157001952|FG001|Overall Study|Study drug toxicity|7|||
48769132|NCT00355238|157001953|FG002|Overall Study|Study drug toxicity|5|||
48769133|NCT00355238|157001954|FG003|Overall Study|Study drug toxicity|2|||
48769134|NCT00355238|157001951|FG000|Overall Study|Participant withdrew consent|3|||
48982048|NCT02371980|157767520|FG002|Open-label Period|Pretreatment Event/Adverse Event|0|||
48769135|NCT00355238|157001952|FG001|Overall Study|Participant withdrew consent|1|||
48769136|NCT00355238|157001953|FG002|Overall Study|Participant withdrew consent|0|||
48769137|NCT00355238|157001954|FG003|Overall Study|Participant withdrew consent|0|||
48769138|NCT00355238|157001951|FG000|Overall Study|Participant request to discontinue study treatment|1|||
48769139|NCT00355238|157001952|FG001|Overall Study|Participant request to discontinue study treatment|0|||
48769140|NCT00355238|157001953|FG002|Overall Study|Participant request to discontinue study treatment|1|||
48769141|NCT00355238|157001954|FG003|Overall Study|Participant request to discontinue study treatment|0|||
49026366|NCT01389102|157935879|FG004|Overall Study|Subject Traveling Out of Country|0|||
49026367|NCT01389102|157935880|FG005|Overall Study|Subject Traveling Out of Country|0|||
49026368|NCT01389102|157935875|FG000|Overall Study|Subject Moved|2|||
49026369|NCT01389102|157935876|FG001|Overall Study|Subject Moved|0|||
49026370|NCT01389102|157935877|FG002|Overall Study|Subject Moved|1|||
49026371|NCT01389102|157935878|FG003|Overall Study|Subject Moved|0|||
49026372|NCT01389102|157935879|FG004|Overall Study|Subject Moved|0|||
49026373|NCT01389102|157935880|FG005|Overall Study|Subject Moved|0|||
49026374|NCT01389102|157935875|FG000|Overall Study|Unavailable due to husband's illness|0|||
49026375|NCT01389102|157935876|FG001|Overall Study|Unavailable due to husband's illness|1|||
49026376|NCT01389102|157935877|FG002|Overall Study|Unavailable due to husband's illness|0|||
49026377|NCT01389102|157935878|FG003|Overall Study|Unavailable due to husband's illness|0|||
49026378|NCT01389102|157935879|FG004|Overall Study|Unavailable due to husband's illness|0|||
49026379|NCT01389102|157935880|FG005|Overall Study|Unavailable due to husband's illness|0|||
49026380|NCT01389102|157935875|FG000|Overall Study|Investigator Judgement|0|||
48769142|NCT00749775|157001960|FG000|Overall Study|Protocol Violation|24|||
48769143|NCT00749775|157001960|FG000|Overall Study|Lost to Follow-up|36|||
48769144|NCT00749775|157001960|FG000|Overall Study|No visit after first day of treatment|44|||
48769145|NCT00749775|157001960|FG000|Overall Study|No drug administration|3|||
48769146|NCT01714310|157001967|FG000|Open Lisdexamfetamine Titration|Protocol Violation|0|||
48769147|NCT01714310|157001968|FG001|Open Lisdexamfetamine Titration|Protocol Violation|0|||
48769148|NCT01714310|157001969|FG002|Open Lisdexamfetamine Titration|Protocol Violation|1|||
48769149|NCT01714310|157001967|FG000|Open Lisdexamfetamine Titration|Adverse Event|0|||
48769150|NCT01714310|157001968|FG001|Open Lisdexamfetamine Titration|Adverse Event|0|||
48769151|NCT01714310|157001969|FG002|Open Lisdexamfetamine Titration|Adverse Event|3|||
48769152|NCT01714310|157001967|FG000|Double Blind Adjunctive Treatment|Adverse Event|1|||
48769153|NCT01714310|157001968|FG001|Double Blind Adjunctive Treatment|Adverse Event|1|||
48769154|NCT01714310|157001969|FG002|Double Blind Adjunctive Treatment|Adverse Event|0|||
48769155|NCT01714310|157001967|FG000|Double Blind Adjunctive Treatment|Protocol Violation|1|||
48769156|NCT01714310|157001968|FG001|Double Blind Adjunctive Treatment|Protocol Violation|2|||
48769157|NCT01714310|157001969|FG002|Double Blind Adjunctive Treatment|Protocol Violation|0|||
48769158|NCT00908960|157001972|FG000|Overall Study|Presence VTE dx or Absent VTE eval|1|||
48769159|NCT00908960|157001973|FG001|Overall Study|Presence VTE dx or Absent VTE eval|1|||
48769160|NCT00908960|157001974|FG002|Overall Study|Presence VTE dx or Absent VTE eval|2|||
48769161|NCT00378014|157001975|FG000|Core (Randomization to Month 11)|Adverse Event|1|||
48769162|NCT00378014|157001976|FG001|Core (Randomization to Month 11)|Adverse Event|0|||
48769163|NCT00378014|157001975|FG000|Core (Randomization to Month 11)|Graft loss|1|||
48769164|NCT00378014|157001976|FG001|Core (Randomization to Month 11)|Graft loss|2|||
48769165|NCT00378014|157001975|FG000|Core (Randomization to Month 11)|Death|5|||
48769166|NCT00378014|157001976|FG001|Core (Randomization to Month 11)|Death|3|||
48769167|NCT00378014|157001975|FG000|Core (Randomization to Month 11)|Administrative Problems|2|||
48769168|NCT00378014|157001976|FG001|Core (Randomization to Month 11)|Administrative Problems|2|||
48769169|NCT00378014|157001975|FG000|Core (Randomization to Month 11)|Lost to Follow-up|0|||
48769170|NCT00378014|157001976|FG001|Core (Randomization to Month 11)|Lost to Follow-up|1|||
48769171|NCT00378014|157001975|FG000|Core (Randomization to Month 11)|Withdrawal by Subject|5|||
48769172|NCT00378014|157001976|FG001|Core (Randomization to Month 11)|Withdrawal by Subject|2|||
48769173|NCT00378014|157001975|FG000|Core (Randomization to Month 11)|Protocol deviation|0|||
48769174|NCT00378014|157001976|FG001|Core (Randomization to Month 11)|Protocol deviation|1|||
48769175|NCT00378014|157001975|FG000|Core (Randomization to Month 11)|Lack of Efficacy|0|||
48769176|NCT00378014|157001976|FG001|Core (Randomization to Month 11)|Lack of Efficacy|1|||
48769177|NCT00378014|157001975|FG000|Extension (Month 12 to Month 59)|Adverse Event|8|||
48769178|NCT00378014|157001976|FG001|Extension (Month 12 to Month 59)|Adverse Event|7|||
48769179|NCT00378014|157001975|FG000|Extension (Month 12 to Month 59)|Death|1|||
48769180|NCT00378014|157001976|FG001|Extension (Month 12 to Month 59)|Death|2|||
48769181|NCT00378014|157001975|FG000|Extension (Month 12 to Month 59)|Administrative problems|1|||
48769182|NCT00378014|157001976|FG001|Extension (Month 12 to Month 59)|Administrative problems|0|||
48769183|NCT00378014|157001975|FG000|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
48769184|NCT00378014|157001976|FG001|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
49026381|NCT01389102|157935876|FG001|Overall Study|Investigator Judgement|1|||
49026382|NCT01389102|157935877|FG002|Overall Study|Investigator Judgement|0|||
48769185|NCT00378014|157001975|FG000|Extension (Month 12 to Month 59)|Withdrawal by Subject|0|||
48769186|NCT00378014|157001976|FG001|Extension (Month 12 to Month 59)|Withdrawal by Subject|3|||
48769187|NCT00378014|157001975|FG000|Extension (Month 12 to Month 59)|Lack of Efficacy|3|||
48769188|NCT00378014|157001976|FG001|Extension (Month 12 to Month 59)|Lack of Efficacy|1|||
48769189|NCT02777125|157001982|FG000|Overall Study|Consent form violation|14|||
48769190|NCT02777125|157001983|FG001|Overall Study|Consent form violation|12|||
48769191|NCT02777125|157001982|FG000|Overall Study|Assent form violation|21|||
48769192|NCT02777125|157001983|FG001|Overall Study|Assent form violation|23|||
48769193|NCT02777125|157001982|FG000|Overall Study|Protocol Violation|8|||
48769194|NCT02777125|157001983|FG001|Overall Study|Protocol Violation|12|||
48769195|NCT01828034|157001984|FG000|Overall Study|Withdrawal by Subject|0|||
48769196|NCT01828034|157001985|FG001|Overall Study|Withdrawal by Subject|0|||
48769197|NCT01828034|157001986|FG002|Overall Study|Withdrawal by Subject|0|||
48769198|NCT01828034|157001987|FG003|Overall Study|Withdrawal by Subject|1|||
48769199|NCT00499603|157001989|FG000|Overall Study|Adverse Event|0|||
48769200|NCT00499603|157001990|FG001|Overall Study|Adverse Event|1|||
48769201|NCT01639040|157001993|FG000|Overall Study|Adverse Event|1|||
48769202|NCT01639040|157001994|FG001|Overall Study|Adverse Event|0|||
48769203|NCT04238728|157001999|FG000|Overall Study|Withdrawal by Subject|1|||
48769204|NCT04238728|157001999|FG000|Overall Study|Lost to Follow-up|2|||
48769205|NCT04382911|157002000|FG000|Overall Study|unable to be imaged prior to surgery|2|||
48769206|NCT00974571|157002005|FG000|Overall Study|Adverse Event|31|||
48769207|NCT00974571|157002006|FG001|Overall Study|Adverse Event|4|||
48769208|NCT00974571|157002007|FG002|Overall Study|Adverse Event|27|||
48769209|NCT00974571|157002005|FG000|Overall Study|Lack of Efficacy|3|||
48769210|NCT00974571|157002006|FG001|Overall Study|Lack of Efficacy|2|||
48769211|NCT00974571|157002007|FG002|Overall Study|Lack of Efficacy|9|||
48769212|NCT00974571|157002005|FG000|Overall Study|Lost to Follow-up|2|||
48769213|NCT00974571|157002006|FG001|Overall Study|Lost to Follow-up|1|||
48769214|NCT00974571|157002007|FG002|Overall Study|Lost to Follow-up|2|||
48769215|NCT00974571|157002005|FG000|Overall Study|Protocol Violation|13|||
48769216|NCT00974571|157002006|FG001|Overall Study|Protocol Violation|4|||
48769217|NCT00974571|157002007|FG002|Overall Study|Protocol Violation|18|||
48769218|NCT00974571|157002005|FG000|Overall Study|Withdrawal by Subject|14|||
48769219|NCT00974571|157002006|FG001|Overall Study|Withdrawal by Subject|5|||
48769220|NCT00974571|157002007|FG002|Overall Study|Withdrawal by Subject|16|||
48769221|NCT00974571|157002005|FG000|Overall Study|Patient Moved|1|||
48769222|NCT00974571|157002006|FG001|Overall Study|Patient Moved|0|||
48769223|NCT00974571|157002007|FG002|Overall Study|Patient Moved|1|||
48769224|NCT00974571|157002005|FG000|Overall Study|Other|4|||
48769225|NCT00974571|157002006|FG001|Overall Study|Other|0|||
48769226|NCT00974571|157002007|FG002|Overall Study|Other|10|||
48769227|NCT01183975|157002010|FG000|Overall Study|Lost to Follow-up|73|||
48769228|NCT00376168|157002011|FG000|Overall Study|Adverse Event|1|||
48769229|NCT00376168|157002012|FG001|Overall Study|Adverse Event|1|||
48769230|NCT00376168|157002011|FG000|Overall Study|Pregnancy|1|||
48769231|NCT00376168|157002012|FG001|Overall Study|Pregnancy|0|||
48769232|NCT02722928|157002013|FG000|Overall Study|Standard CT was not as required per prot|5|||
48769233|NCT02722928|157002014|FG001|Overall Study|Standard CT was not as required per prot|13|||
48769234|NCT02722928|157002013|FG000|Overall Study|Required Intraoperative MRI|5|||
48769235|NCT02722928|157002014|FG001|Overall Study|Required Intraoperative MRI|7|||
48769236|NCT00515827|157002015|FG000|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
48769237|NCT00515827|157002016|FG001|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
48769238|NCT00515827|157002015|FG000|Second Intervention (12 Weeks)|Consent withdraw|1|||
48769239|NCT00515827|157002016|FG001|Second Intervention (12 Weeks)|Consent withdraw|0|||
48769240|NCT02253810|157002020|FG000|Overall Study|Withdrawal by Subject|2|||
48769241|NCT02253810|157002021|FG001|Overall Study|Withdrawal by Subject|1|||
48769242|NCT02253810|157002020|FG000|Overall Study|Unknown concomitant procedure|3|||
48769243|NCT02253810|157002021|FG001|Overall Study|Unknown concomitant procedure|2|||
48769244|NCT01339390|157002022|FG000|Overall Study|Death|32|||
48769245|NCT01339390|157002023|FG001|Overall Study|Death|29|||
48769246|NCT01339390|157002022|FG000|Overall Study|Lost to Follow-up|125|||
48769247|NCT01339390|157002023|FG001|Overall Study|Lost to Follow-up|127|||
48769248|NCT03254134|157002024|FG000|Overall Study|Not eligible patients|599|||
48769249|NCT03254134|157002025|FG001|Overall Study|Not eligible patients|3630|||
48769250|NCT01224639|157002039|FG000|Overall Study|Withdrawal by Subject|0|||
48769251|NCT01224639|157002040|FG001|Overall Study|Withdrawal by Subject|0|||
48769252|NCT01224639|157002041|FG002|Overall Study|Withdrawal by Subject|0|||
48769253|NCT01224639|157002042|FG003|Overall Study|Withdrawal by Subject|0|||
48769254|NCT01224639|157002043|FG004|Overall Study|Withdrawal by Subject|2|||
48769255|NCT01224639|157002044|FG005|Overall Study|Withdrawal by Subject|0|||
48769256|NCT01224639|157002045|FG006|Overall Study|Withdrawal by Subject|1|||
48769257|NCT01224639|157002046|FG007|Overall Study|Withdrawal by Subject|1|||
48769258|NCT01224639|157002039|FG000|Overall Study|Adverse Event|0|||
48769259|NCT01224639|157002040|FG001|Overall Study|Adverse Event|0|||
48769260|NCT01224639|157002041|FG002|Overall Study|Adverse Event|0|||
48769261|NCT01224639|157002042|FG003|Overall Study|Adverse Event|0|||
48769262|NCT01224639|157002043|FG004|Overall Study|Adverse Event|0|||
48769263|NCT01224639|157002044|FG005|Overall Study|Adverse Event|0|||
49026383|NCT01389102|157935878|FG003|Overall Study|Investigator Judgement|0|||
49026384|NCT01389102|157935879|FG004|Overall Study|Investigator Judgement|0|||
49026385|NCT01389102|157935880|FG005|Overall Study|Investigator Judgement|0|||
49026386|NCT02910037|157935883|FG000|Overall Study|Withdrawal by Subject|4|||
49026387|NCT02910037|157935883|FG000|Overall Study|Lost to Follow-up|6|||
49026388|NCT01035060|157935888|FG000|Overall Study|Lost to Follow-up|0|||
49026389|NCT01035060|157935889|FG001|Overall Study|Lost to Follow-up|7|||
49026390|NCT01035060|157935888|FG000|Overall Study|Did not quality after 2nd screening|14|||
49026391|NCT01035060|157935889|FG001|Overall Study|Did not quality after 2nd screening|1|||
48769264|NCT01224639|157002045|FG006|Overall Study|Adverse Event|0|||
48769265|NCT01224639|157002046|FG007|Overall Study|Adverse Event|1|||
48769266|NCT02702401|157002049|FG000|Overall Study|Death|242|||
48769267|NCT02702401|157002050|FG001|Overall Study|Death|125|||
48769268|NCT02702401|157002049|FG000|Overall Study|Withdrawal by Subject|15|||
48769269|NCT02702401|157002050|FG001|Overall Study|Withdrawal by Subject|5|||
48769270|NCT02702401|157002049|FG000|Overall Study|Sponsor Decision|19|||
48769271|NCT02702401|157002050|FG001|Overall Study|Sponsor Decision|3|||
48769272|NCT02702401|157002049|FG000|Overall Study|Physician Decision|1|||
48769273|NCT02702401|157002050|FG001|Overall Study|Physician Decision|2|||
48769274|NCT02702401|157002049|FG000|Overall Study|Lost to Follow-up|1|||
48769275|NCT02702401|157002050|FG001|Overall Study|Lost to Follow-up|0|||
48769276|NCT04019041|157002063|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|3|||
48769277|NCT04019041|157002064|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|5|||
48769278|NCT04019041|157002065|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
48769279|NCT04019041|157002066|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
48769280|NCT04019041|157002067|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
48769281|NCT04019041|157002068|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
48769282|NCT04019041|157002063|FG000|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
48769283|NCT04019041|157002064|FG001|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
48769284|NCT04019041|157002065|FG002|Placebo Controlled Period (Weeks 0-16)|Adverse Event|2|||
48769285|NCT04019041|157002066|FG003|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
48769286|NCT04019041|157002067|FG004|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
48769287|NCT04019041|157002068|FG005|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
48769288|NCT04019041|157002063|FG000|Placebo Controlled Period (Weeks 0-16)|Other|1|||
48769289|NCT04019041|157002064|FG001|Placebo Controlled Period (Weeks 0-16)|Other|2|||
48769290|NCT04019041|157002065|FG002|Placebo Controlled Period (Weeks 0-16)|Other|1|||
48769291|NCT04019041|157002066|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
48769292|NCT04019041|157002067|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
48769293|NCT04019041|157002068|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
48769294|NCT04019041|157002063|FG000|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
48769295|NCT04019041|157002064|FG001|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
48769296|NCT04019041|157002065|FG002|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|1|||
48769297|NCT04019041|157002066|FG003|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
48769298|NCT04019041|157002067|FG004|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
48769299|NCT04019041|157002068|FG005|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
48769300|NCT04019041|157002063|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
48769301|NCT04019041|157002064|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
48769302|NCT04019041|157002065|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
48769303|NCT04019041|157002066|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|4|||
48769304|NCT04019041|157002067|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
48769305|NCT04019041|157002068|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
48769306|NCT04019041|157002063|FG000|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
48769307|NCT04019041|157002064|FG001|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
48769308|NCT04019041|157002065|FG002|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
48769309|NCT04019041|157002066|FG003|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|1|||
48769310|NCT04019041|157002067|FG004|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
48769311|NCT04019041|157002068|FG005|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
48769312|NCT04019041|157002063|FG000|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
48769313|NCT04019041|157002064|FG001|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
48769314|NCT04019041|157002065|FG002|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
48769315|NCT04019041|157002066|FG003|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
48769316|NCT04019041|157002067|FG004|Active Treatment+Safety F-U (Week 17-36)|Death|1|||
48769317|NCT04019041|157002068|FG005|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
49026392|NCT01035060|157935888|FG000|Overall Study|Withdrawal by Subject|8|||
49026393|NCT01035060|157935889|FG001|Overall Study|Withdrawal by Subject|6|||
48769318|NCT04019041|157002063|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
48769319|NCT04019041|157002064|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
48769320|NCT04019041|157002065|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
49026394|NCT01035060|157935888|FG000|Overall Study|Physician Decision|2|||
48769321|NCT04019041|157002066|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
48769322|NCT04019041|157002067|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|2|||
48769323|NCT04019041|157002068|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
48769324|NCT04019041|157002063|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
48769325|NCT04019041|157002064|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
48769326|NCT04019041|157002065|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
48769327|NCT04019041|157002066|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
48769328|NCT04019041|157002067|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|3|||
48769329|NCT04019041|157002068|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|1|||
48769330|NCT04365699|157002069|FG000|Overall Study|Death|2|||
48769331|NCT04365699|157002070|FG001|Overall Study|Death|5|||
48769332|NCT04365699|157002071|FG002|Overall Study|Death|15|||
48769333|NCT04292730|157002073|FG000|Overall Study|Lost to Follow-up|8|||
48769334|NCT04292730|157002074|FG001|Overall Study|Lost to Follow-up|12|||
48769335|NCT04292730|157002075|FG002|Overall Study|Lost to Follow-up|12|||
48769336|NCT04292730|157002076|FG003|Overall Study|Lost to Follow-up|48|||
48769337|NCT04292730|157002073|FG000|Overall Study|Death|2|||
48769338|NCT04292730|157002074|FG001|Overall Study|Death|2|||
48769339|NCT04292730|157002075|FG002|Overall Study|Death|4|||
48769340|NCT04292730|157002076|FG003|Overall Study|Death|12|||
48769341|NCT04292730|157002073|FG000|Overall Study|Withdrew Consent|2|||
48769342|NCT04292730|157002074|FG001|Overall Study|Withdrew Consent|2|||
48769343|NCT04292730|157002075|FG002|Overall Study|Withdrew Consent|5|||
48769344|NCT04292730|157002076|FG003|Overall Study|Withdrew Consent|6|||
48769345|NCT04292730|157002073|FG000|Overall Study|Non-Compliance with Study Drug|0|||
48769346|NCT04292730|157002074|FG001|Overall Study|Non-Compliance with Study Drug|1|||
48769347|NCT04292730|157002075|FG002|Overall Study|Non-Compliance with Study Drug|0|||
48769348|NCT04292730|157002076|FG003|Overall Study|Non-Compliance with Study Drug|0|||
48769349|NCT04292730|157002073|FG000|Overall Study|Protocol Violation|0|||
48769350|NCT04292730|157002074|FG001|Overall Study|Protocol Violation|0|||
48769351|NCT04292730|157002075|FG002|Overall Study|Protocol Violation|1|||
48769352|NCT04292730|157002076|FG003|Overall Study|Protocol Violation|0|||
48769353|NCT04292730|157002073|FG000|Overall Study|Randomized but not Treated|8|||
48769354|NCT04292730|157002074|FG001|Overall Study|Randomized but not Treated|4|||
48769355|NCT04292730|157002075|FG002|Overall Study|Randomized but not Treated|0|||
48769356|NCT04292730|157002076|FG003|Overall Study|Randomized but not Treated|14|||
48769357|NCT01247090|157002078|FG000|Overall Study|Physician Decision|1|||
48769358|NCT01247090|157002079|FG001|Overall Study|Physician Decision|0|||
48769359|NCT01247090|157002080|FG002|Overall Study|Physician Decision|0|||
48769360|NCT01247090|157002078|FG000|Overall Study|Withdrawal by Subject|0|||
48769361|NCT01247090|157002079|FG001|Overall Study|Withdrawal by Subject|1|||
48769362|NCT01247090|157002080|FG002|Overall Study|Withdrawal by Subject|0|||
48769363|NCT01574703|157002083|FG000|Overall Study|Adverse Event|0|||
48769364|NCT01574703|157002084|FG001|Overall Study|Adverse Event|2|||
48769365|NCT01574703|157002085|FG002|Overall Study|Adverse Event|1|||
48769366|NCT01574703|157002086|FG003|Overall Study|Adverse Event|1|||
48769367|NCT01574703|157002083|FG000|Overall Study|Protocol Violation|0|||
48769368|NCT01574703|157002084|FG001|Overall Study|Protocol Violation|0|||
48769369|NCT01574703|157002085|FG002|Overall Study|Protocol Violation|0|||
48769370|NCT01574703|157002086|FG003|Overall Study|Protocol Violation|1|||
48769371|NCT01574703|157002083|FG000|Overall Study|Unspecified Reason|27|||
48769372|NCT01574703|157002084|FG001|Overall Study|Unspecified Reason|15|||
48769373|NCT01574703|157002085|FG002|Overall Study|Unspecified Reason|20|||
48769374|NCT01574703|157002086|FG003|Overall Study|Unspecified Reason|16|||
48769375|NCT01574703|157002083|FG000|Overall Study|Withdrawal by Subject|53|||
48769376|NCT01574703|157002084|FG001|Overall Study|Withdrawal by Subject|52|||
48769377|NCT01574703|157002085|FG002|Overall Study|Withdrawal by Subject|36|||
48769378|NCT01574703|157002086|FG003|Overall Study|Withdrawal by Subject|61|||
48769379|NCT01574703|157002083|FG000|Overall Study|Met Withdrawal Criteria|0|||
48769380|NCT01574703|157002084|FG001|Overall Study|Met Withdrawal Criteria|1|||
48982049|NCT02371980|157767521|FG003|Open-label Period|Pretreatment Event/Adverse Event|0|||
48982050|NCT02371980|157767522|FG004|Open-label Period|Pretreatment Event/Adverse Event|0|||
48982051|NCT02371980|157767518|FG000|Open-label Period|Significant Protocol Deviation|19|||
48982052|NCT02371980|157767519|FG001|Open-label Period|Significant Protocol Deviation|0|||
48982053|NCT02371980|157767520|FG002|Open-label Period|Significant Protocol Deviation|0|||
48982054|NCT02371980|157767521|FG003|Open-label Period|Significant Protocol Deviation|0|||
48982055|NCT02371980|157767522|FG004|Open-label Period|Significant Protocol Deviation|0|||
48982056|NCT02371980|157767518|FG000|Open-label Period|Noncompliance with Study Drug|10|||
48769381|NCT01574703|157002085|FG002|Overall Study|Met Withdrawal Criteria|1|||
48769382|NCT01574703|157002086|FG003|Overall Study|Met Withdrawal Criteria|0|||
48769383|NCT01574703|157002083|FG000|Overall Study|Lost to Follow-up|43|||
48769384|NCT01574703|157002084|FG001|Overall Study|Lost to Follow-up|41|||
48769385|NCT01574703|157002085|FG002|Overall Study|Lost to Follow-up|46|||
48769386|NCT01574703|157002086|FG003|Overall Study|Lost to Follow-up|35|||
48769387|NCT01574703|157002083|FG000|Overall Study|Death|2|||
48769388|NCT01574703|157002084|FG001|Overall Study|Death|1|||
48769389|NCT01574703|157002085|FG002|Overall Study|Death|1|||
48769390|NCT01574703|157002086|FG003|Overall Study|Death|0|||
48769391|NCT01524770|157002087|FG000|First Intervention|Withdrawal by Subject|1|||
48769392|NCT01524770|157002088|FG001|First Intervention|Withdrawal by Subject|0|||
48769393|NCT01524770|157002087|FG000|First Intervention|Adverse Event|1|||
48769394|NCT01524770|157002088|FG001|First Intervention|Adverse Event|1|||
48769395|NCT01524770|157002087|FG000|First Intervention|Protocol Violation|1|||
48769396|NCT01524770|157002088|FG001|First Intervention|Protocol Violation|0|||
48769397|NCT00508742|157002089|FG000|Period 1: Infant Series|Adverse Event|5|||
48769398|NCT00508742|157002090|FG001|Period 1: Infant Series|Adverse Event|4|||
48769399|NCT00508742|157002089|FG000|Period 1: Infant Series|Protocol Violation|1|||
48769400|NCT00508742|157002090|FG001|Period 1: Infant Series|Protocol Violation|0|||
48769401|NCT00508742|157002089|FG000|Period 1: Infant Series|Parent/Legal Guardian Request|31|||
48769402|NCT00508742|157002090|FG001|Period 1: Infant Series|Parent/Legal Guardian Request|40|||
49026395|NCT01035060|157935889|FG001|Overall Study|Physician Decision|0|||
48769403|NCT00508742|157002089|FG000|Period 1: Infant Series|Physician Decision|1|||
48769404|NCT00508742|157002090|FG001|Period 1: Infant Series|Physician Decision|0|||
48769405|NCT00508742|157002089|FG000|Period 1: Infant Series|Other|4|||
48769406|NCT00508742|157002090|FG001|Period 1: Infant Series|Other|1|||
48769407|NCT00508742|157002089|FG000|Period 2: After Infant Series|Adverse Event|2|||
48769408|NCT00508742|157002090|FG001|Period 2: After Infant Series|Adverse Event|6|||
48769409|NCT00508742|157002089|FG000|Period 2: After Infant Series|Lost to Follow-up|1|||
48769410|NCT00508742|157002090|FG001|Period 2: After Infant Series|Lost to Follow-up|1|||
48769411|NCT00508742|157002089|FG000|Period 2: After Infant Series|Protocol Violation|1|||
48769412|NCT00508742|157002090|FG001|Period 2: After Infant Series|Protocol Violation|0|||
48769413|NCT00508742|157002089|FG000|Period 2: After Infant Series|Parent/Legal Guardian Request|0|||
48769414|NCT00508742|157002090|FG001|Period 2: After Infant Series|Parent/Legal Guardian Request|3|||
48769415|NCT00508742|157002089|FG000|Period 2: After Infant Series|Failed to Return|1|||
48769416|NCT00508742|157002090|FG001|Period 2: After Infant Series|Failed to Return|0|||
48769417|NCT00508742|157002089|FG000|Period 2: After Infant Series|Other|2|||
48769418|NCT00508742|157002090|FG001|Period 2: After Infant Series|Other|1|||
48769419|NCT00508742|157002089|FG000|Period 3: Toddler Dose|Adverse Event|1|||
48769420|NCT00508742|157002090|FG001|Period 3: Toddler Dose|Adverse Event|0|||
48769421|NCT00508742|157002089|FG000|Period 3: Toddler Dose|Lost to Follow-up|2|||
48769422|NCT00508742|157002090|FG001|Period 3: Toddler Dose|Lost to Follow-up|3|||
48769423|NCT00508742|157002089|FG000|Period 3: Toddler Dose|Parent/Legal Guardian Request|17|||
48769424|NCT00508742|157002090|FG001|Period 3: Toddler Dose|Parent/Legal Guardian Request|8|||
48769425|NCT00508742|157002089|FG000|Period 3: Toddler Dose|Other|5|||
48769426|NCT00508742|157002090|FG001|Period 3: Toddler Dose|Other|4|||
48769427|NCT01574352|157002094|FG000|Overall Study|Withdrawal by Subject|6|||
48769428|NCT01574352|157002095|FG001|Overall Study|Withdrawal by Subject|13|||
48769429|NCT01574352|157002094|FG000|Overall Study|Injury in non-camp related sport|1|||
48769430|NCT01574352|157002095|FG001|Overall Study|Injury in non-camp related sport|0|||
48769431|NCT00528528|157002101|FG000|Overall Study|Lost to Follow-up|0|||
48769432|NCT00528528|157002102|FG001|Overall Study|Lost to Follow-up|0|||
48769433|NCT00528528|157002103|FG002|Overall Study|Lost to Follow-up|1|||
48769434|NCT00528528|157002104|FG003|Overall Study|Lost to Follow-up|1|||
48769435|NCT00528528|157002101|FG000|Overall Study|Ineligible to continue the trial|0|||
48769436|NCT00528528|157002102|FG001|Overall Study|Ineligible to continue the trial|0|||
48769437|NCT00528528|157002103|FG002|Overall Study|Ineligible to continue the trial|0|||
48769438|NCT00528528|157002104|FG003|Overall Study|Ineligible to continue the trial|1|||
48769439|NCT00528528|157002101|FG000|Overall Study|Other|0|||
48769440|NCT00528528|157002102|FG001|Overall Study|Other|1|||
48769441|NCT00528528|157002103|FG002|Overall Study|Other|0|||
48769442|NCT00528528|157002104|FG003|Overall Study|Other|0|||
48769443|NCT00528528|157002101|FG000|Overall Study|Withdrawal by Subject|3|||
48769444|NCT00528528|157002102|FG001|Overall Study|Withdrawal by Subject|2|||
48769445|NCT00528528|157002103|FG002|Overall Study|Withdrawal by Subject|1|||
48769446|NCT00528528|157002104|FG003|Overall Study|Withdrawal by Subject|1|||
48769447|NCT00528528|157002101|FG000|Overall Study|Ongoing participant|0|||
48769448|NCT00528528|157002102|FG001|Overall Study|Ongoing participant|0|||
48769449|NCT00528528|157002103|FG002|Overall Study|Ongoing participant|1|||
48769450|NCT00528528|157002104|FG003|Overall Study|Ongoing participant|0|||
48769451|NCT01545817|157003894|FG000|Pazopanib|Disease progression|51|||
48769452|NCT01545817|157003895|FG001|Pazopanib|Disease progression|0|||
48769453|NCT01545817|157003894|FG000|Pazopanib|Adverse Event|19|||
48769454|NCT01545817|157003895|FG001|Pazopanib|Adverse Event|0|||
48769455|NCT01545817|157003894|FG000|Pazopanib|Other reason|4|||
48769456|NCT01545817|157003895|FG001|Pazopanib|Other reason|0|||
48769457|NCT01545817|157003894|FG000|Everolimus|Other reason|0|||
48769458|NCT01545817|157003895|FG001|Everolimus|Other reason|7|||
48769459|NCT01545817|157003894|FG000|Everolimus|Disease progression|0|||
48769460|NCT01545817|157003895|FG001|Everolimus|Disease progression|25|||
48769461|NCT01545817|157003894|FG000|Everolimus|Adverse Event|0|||
48769462|NCT01545817|157003895|FG001|Everolimus|Adverse Event|6|||
48769463|NCT03252522|157003899|FG000|Phase 1: Intervention & Placebo|Adverse Event|3|||
48769464|NCT03252522|157003900|FG001|Phase 1: Intervention & Placebo|Adverse Event|1|||
48769465|NCT03252522|157003901|FG002|Phase 1: Intervention & Placebo|Adverse Event|0|||
48769466|NCT03252522|157003899|FG000|Phase 1: Intervention & Placebo|Unable to swallow pills|4|||
48769467|NCT03252522|157003900|FG001|Phase 1: Intervention & Placebo|Unable to swallow pills|1|||
48769468|NCT03252522|157003901|FG002|Phase 1: Intervention & Placebo|Unable to swallow pills|0|||
48769469|NCT03252522|157003899|FG000|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
48769470|NCT03252522|157003900|FG001|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
48769471|NCT03252522|157003901|FG002|Phase 1: Intervention & Placebo|Commenced stimulant medication|0|||
48769472|NCT03252522|157003899|FG000|Phase 1: Intervention & Placebo|Protocol Violation|1|||
48769473|NCT03252522|157003900|FG001|Phase 1: Intervention & Placebo|Protocol Violation|0|||
48769474|NCT03252522|157003901|FG002|Phase 1: Intervention & Placebo|Protocol Violation|0|||
48769475|NCT03252522|157003899|FG000|Phase 2: Open Label|Commenced stimulant medication|0|||
48769476|NCT03252522|157003900|FG001|Phase 2: Open Label|Commenced stimulant medication|0|||
48769477|NCT03252522|157003901|FG002|Phase 2: Open Label|Commenced stimulant medication|3|||
48769478|NCT03252522|157003899|FG000|Phase 2: Open Label|Lack of Efficacy|0|||
48769479|NCT03252522|157003900|FG001|Phase 2: Open Label|Lack of Efficacy|0|||
48769480|NCT03252522|157003901|FG002|Phase 2: Open Label|Lack of Efficacy|3|||
48769481|NCT03252522|157003899|FG000|Phase 2: Open Label|Adverse Event|0|||
48769482|NCT03252522|157003900|FG001|Phase 2: Open Label|Adverse Event|0|||
48769483|NCT03252522|157003901|FG002|Phase 2: Open Label|Adverse Event|2|||
48769484|NCT03252522|157003899|FG000|Phase 2: Open Label|Lost to Follow-up|0|||
48769485|NCT03252522|157003900|FG001|Phase 2: Open Label|Lost to Follow-up|0|||
48769486|NCT03252522|157003901|FG002|Phase 2: Open Label|Lost to Follow-up|16|||
48769487|NCT02239536|157003903|FG000|Overall Study|Non-neoplastic polyp|23|||
48769488|NCT02239536|157003904|FG001|Overall Study|Non-neoplastic polyp|17|||
48769489|NCT00838201|157003905|FG000|Overall Study|Investigator decision, or other reasons|2|||
48769490|NCT00838201|157003906|FG001|Overall Study|Investigator decision, or other reasons|3|||
48769491|NCT00838201|157003905|FG000|Overall Study|Noncompliance|0|||
48769492|NCT00838201|157003906|FG001|Overall Study|Noncompliance|1|||
48769493|NCT00838201|157003905|FG000|Overall Study|Administrative decision|1|||
48769494|NCT00838201|157003906|FG001|Overall Study|Administrative decision|2|||
48769495|NCT00838201|157003905|FG000|Overall Study|Disease progression|3|||
48769496|NCT00838201|157003906|FG001|Overall Study|Disease progression|3|||
48769497|NCT00838201|157003905|FG000|Overall Study|Consent withdrawn|16|||
48769498|NCT00838201|157003906|FG001|Overall Study|Consent withdrawn|19|||
48769499|NCT00838201|157003905|FG000|Overall Study|Lost to Follow-up|4|||
48769500|NCT00838201|157003906|FG001|Overall Study|Lost to Follow-up|3|||
48769501|NCT00838201|157003905|FG000|Overall Study|Adverse Event|5|||
48769502|NCT00838201|157003906|FG001|Overall Study|Adverse Event|9|||
48769503|NCT00838201|157003905|FG000|Overall Study|Death|11|||
48769504|NCT00838201|157003906|FG001|Overall Study|Death|13|||
48769505|NCT01140477|157003907|FG000|Overall Study|Lost to Follow-up|4|||
48769506|NCT01140477|157003908|FG001|Overall Study|Lost to Follow-up|0|||
48769507|NCT01140477|157003907|FG000|Overall Study|Withdrawal by Subject|1|||
48769508|NCT01140477|157003908|FG001|Overall Study|Withdrawal by Subject|4|||
49026396|NCT02979327|157935895|FG000|First Intervention|Protocol Violation|1|||
49026397|NCT02979327|157935896|FG001|First Intervention|Protocol Violation|0|||
48769509|NCT01140477|157003907|FG000|Overall Study|Surgical complication preventing implant|2|||
48769510|NCT01140477|157003908|FG001|Overall Study|Surgical complication preventing implant|0|||
48769511|NCT01140477|157003907|FG000|Overall Study|Death|1|||
48769512|NCT01140477|157003908|FG001|Overall Study|Death|1|||
48769513|NCT01140477|157003907|FG000|Overall Study|Subject explanted|0|||
48769514|NCT01140477|157003908|FG001|Overall Study|Subject explanted|1|||
48769515|NCT05439603|157003923|FG000|Overall Study|met withdrawal criteria|2|||
48769516|NCT01945489|157003924|FG000|Cycle 1|Adverse Event|2|||
48769517|NCT01945489|157003925|FG001|Cycle 1|Adverse Event|0|||
48769518|NCT01945489|157003924|FG000|Cycle 1|Lost to Follow-up|4|||
48769519|NCT01945489|157003925|FG001|Cycle 1|Lost to Follow-up|0|||
48769520|NCT01945489|157003924|FG000|Cycle 1|Personal Reasons|4|||
48769521|NCT01945489|157003925|FG001|Cycle 1|Personal Reasons|2|||
48769522|NCT01945489|157003924|FG000|Cycle 1|Protocol Violation|0|||
48769523|NCT01945489|157003925|FG001|Cycle 1|Protocol Violation|1|||
48769524|NCT01945489|157003924|FG000|Cycle 1|Other Miscellaneous Reasons|3|||
48769525|NCT01945489|157003925|FG001|Cycle 1|Other Miscellaneous Reasons|1|||
48769526|NCT01945489|157003924|FG000|Cycle 2|Adverse Event|1|||
48769527|NCT01945489|157003925|FG001|Cycle 2|Adverse Event|0|||
48769528|NCT01945489|157003924|FG000|Cycle 2|Lost to Follow-up|0|||
48769529|NCT01945489|157003925|FG001|Cycle 2|Lost to Follow-up|1|||
48769530|NCT00358527|157003929|FG000|Overall Study|Adverse Event|4|||
48769531|NCT00358527|157003930|FG001|Overall Study|Adverse Event|0|||
48769532|NCT00358527|157003929|FG000|Overall Study|Withdrawal by Subject|1|||
48769533|NCT00358527|157003930|FG001|Overall Study|Withdrawal by Subject|1|||
48769534|NCT00358527|157003929|FG000|Overall Study|Non-compliance with protocol|6|||
49026398|NCT02193880|157935897|FG000|Overall Study|patients did not collect enough HPC|3|||
48769535|NCT00358527|157003930|FG001|Overall Study|Non-compliance with protocol|1|||
48769536|NCT00358527|157003929|FG000|Overall Study|Administrative|2|||
48769537|NCT00358527|157003930|FG001|Overall Study|Administrative|1|||
48769538|NCT04144166|157003931|FG000|Overall Study|Discharged before study start|1|||
48769539|NCT04144166|157003931|FG000|Overall Study|Pregnancy|1|||
48769540|NCT04144166|157003931|FG000|Overall Study|Nail polish could not be removed from finger|1|||
48769541|NCT00749463|157003932|FG000|Overall Study|Adverse Event|0|||
48769542|NCT00749463|157003933|FG001|Overall Study|Adverse Event|4|||
48769543|NCT00749463|157003934|FG002|Overall Study|Adverse Event|1|||
48769544|NCT00749463|157003932|FG000|Overall Study|Withdrawal by Subject|1|||
48769545|NCT00749463|157003933|FG001|Overall Study|Withdrawal by Subject|0|||
48769546|NCT00749463|157003934|FG002|Overall Study|Withdrawal by Subject|0|||
48769547|NCT00697346|157003943|FG000|Overall Study|Adverse Event|4|||
48769548|NCT00697346|157003944|FG001|Overall Study|Adverse Event|5|||
48769549|NCT00697346|157003945|FG002|Overall Study|Adverse Event|0|||
48769550|NCT00697346|157003943|FG000|Overall Study|Progressive Disease|19|||
48769551|NCT00697346|157003944|FG001|Overall Study|Progressive Disease|18|||
48769552|NCT00697346|157003945|FG002|Overall Study|Progressive Disease|0|||
48769553|NCT00697346|157003943|FG000|Overall Study|Symptomatic Deterioration|0|||
48769554|NCT00697346|157003944|FG001|Overall Study|Symptomatic Deterioration|1|||
48769555|NCT00697346|157003945|FG002|Overall Study|Symptomatic Deterioration|0|||
48769556|NCT00697346|157003943|FG000|Overall Study|Withdrawal by Subject|2|||
48769557|NCT00697346|157003944|FG001|Overall Study|Withdrawal by Subject|2|||
48769558|NCT00697346|157003945|FG002|Overall Study|Withdrawal by Subject|0|||
48769559|NCT00697346|157003943|FG000|Overall Study|Reason not Specified|3|||
48769560|NCT00697346|157003944|FG001|Overall Study|Reason not Specified|0|||
48769561|NCT00697346|157003945|FG002|Overall Study|Reason not Specified|1|||
48769562|NCT03643562|157003946|FG000|Overall Study|Adverse Event|1|||
48769563|NCT03643562|157003947|FG001|Overall Study|Adverse Event|0|||
48769564|NCT03643562|157003946|FG000|Overall Study|Lack of Efficacy|0|||
48769565|NCT03643562|157003947|FG001|Overall Study|Lack of Efficacy|1|||
48769566|NCT03643562|157003946|FG000|Overall Study|Physician Decision|0|||
48769567|NCT03643562|157003947|FG001|Overall Study|Physician Decision|1|||
48769568|NCT03643562|157003946|FG000|Overall Study|Study Terminated by Sponsor|2|||
48769569|NCT03643562|157003947|FG001|Overall Study|Study Terminated by Sponsor|10|||
48769570|NCT03643562|157003946|FG000|Overall Study|Withdrawal by Subject|2|||
48769571|NCT03643562|157003947|FG001|Overall Study|Withdrawal by Subject|2|||
48769572|NCT03643562|157003946|FG000|Overall Study|Other than specified|3|||
48769573|NCT03643562|157003947|FG001|Overall Study|Other than specified|2|||
48769574|NCT00419562|157003949|FG000|Overall Study|Lost to Follow-up|12|||
48769575|NCT00419562|157003950|FG001|Overall Study|Lost to Follow-up|13|||
48769576|NCT00419562|157003949|FG000|Overall Study|Withdrawal by Subject|20|||
48769577|NCT00419562|157003950|FG001|Overall Study|Withdrawal by Subject|18|||
48769578|NCT00419562|157003949|FG000|Overall Study|Participant Institutionalized|1|||
48769579|NCT00419562|157003950|FG001|Overall Study|Participant Institutionalized|0|||
48769580|NCT01723163|157003951|FG000|Treatment Phase|Withdrawal by Subject|14|||
48769581|NCT01723163|157003952|FG001|Treatment Phase|Withdrawal by Subject|6|||
48769582|NCT01723163|157003951|FG000|Treatment Phase|Withdrawal by PI|5|||
48769583|NCT01723163|157003952|FG001|Treatment Phase|Withdrawal by PI|1|||
48769584|NCT01723163|157003951|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
48769585|NCT01723163|157003952|FG001|3-Month Follow-up|Withdrawal by Subject|0|||
48769586|NCT01723163|157003951|FG000|3-Month Follow-up|Unable to Contact|12|||
48769587|NCT01723163|157003952|FG001|3-Month Follow-up|Unable to Contact|19|||
48769588|NCT01723163|157003951|FG000|6-Month Follow-up|Death|1|||
48982057|NCT02371980|157767519|FG001|Open-label Period|Noncompliance with Study Drug|0|||
48982058|NCT02371980|157767520|FG002|Open-label Period|Noncompliance with Study Drug|0|||
48982059|NCT02371980|157767521|FG003|Open-label Period|Noncompliance with Study Drug|0|||
48982060|NCT02371980|157767522|FG004|Open-label Period|Noncompliance with Study Drug|0|||
48982061|NCT02371980|157767518|FG000|Open-label Period|Lost to Follow-up|55|||
48982062|NCT02371980|157767519|FG001|Open-label Period|Lost to Follow-up|0|||
48982063|NCT02371980|157767520|FG002|Open-label Period|Lost to Follow-up|0|||
48982064|NCT02371980|157767521|FG003|Open-label Period|Lost to Follow-up|0|||
48982065|NCT02371980|157767522|FG004|Open-label Period|Lost to Follow-up|0|||
48982066|NCT02371980|157767518|FG000|Open-label Period|Voluntary Withdrawal|91|||
48982067|NCT02371980|157767519|FG001|Open-label Period|Voluntary Withdrawal|0|||
48982068|NCT02371980|157767520|FG002|Open-label Period|Voluntary Withdrawal|0|||
48982069|NCT02371980|157767521|FG003|Open-label Period|Voluntary Withdrawal|0|||
48982070|NCT02371980|157767522|FG004|Open-label Period|Voluntary Withdrawal|0|||
48982071|NCT02371980|157767518|FG000|Open-label Period|Pregnancy|1|||
48982072|NCT02371980|157767519|FG001|Open-label Period|Pregnancy|0|||
48982073|NCT02371980|157767520|FG002|Open-label Period|Pregnancy|0|||
48982074|NCT02371980|157767521|FG003|Open-label Period|Pregnancy|0|||
48982075|NCT02371980|157767522|FG004|Open-label Period|Pregnancy|0|||
48982076|NCT02371980|157767518|FG000|Open-label Period|Lack of Efficacy|116|||
48982077|NCT02371980|157767519|FG001|Open-label Period|Lack of Efficacy|0|||
48982078|NCT02371980|157767520|FG002|Open-label Period|Lack of Efficacy|0|||
48982079|NCT02371980|157767521|FG003|Open-label Period|Lack of Efficacy|0|||
48982080|NCT02371980|157767522|FG004|Open-label Period|Lack of Efficacy|0|||
49026399|NCT01873586|157935908|FG000|Overall Study|Lost to Follow-up|3|||
48769589|NCT01723163|157003952|FG001|6-Month Follow-up|Death|0|||
48769590|NCT01723163|157003951|FG000|6-Month Follow-up|Unable to Contact|17|||
48769591|NCT01723163|157003952|FG001|6-Month Follow-up|Unable to Contact|15|||
48769592|NCT01723163|157003951|FG000|12-Month Follow-up|Death|1|||
48769593|NCT01723163|157003952|FG001|12-Month Follow-up|Death|0|||
48769594|NCT01723163|157003951|FG000|12-Month Follow-up|Unable to Contact|23|||
48769595|NCT01723163|157003952|FG001|12-Month Follow-up|Unable to Contact|28|||
48769596|NCT00640510|157003958|FG000|Overall Study|Lack of Efficacy|0|||
48769597|NCT00640510|157003959|FG001|Overall Study|Lack of Efficacy|1|||
48769598|NCT00640510|157003958|FG000|Overall Study|Protocol Violation|1|||
48769599|NCT00640510|157003959|FG001|Overall Study|Protocol Violation|0|||
48769600|NCT00640510|157003958|FG000|Overall Study|Physician Decision|0|||
48769601|NCT00640510|157003959|FG001|Overall Study|Physician Decision|1|||
48769602|NCT02474199|157003960|FG000|Overall Study|Lost to Follow-up|1|||
48769603|NCT02474199|157003961|FG001|Overall Study|Lost to Follow-up|0|||
48769604|NCT02474199|157003962|FG002|Overall Study|Lost to Follow-up|0|||
48769605|NCT02474199|157003963|FG003|Overall Study|Lost to Follow-up|0|||
48769606|NCT02474199|157003960|FG000|Overall Study|Withdrawal by Subject|1|||
48876234|NCT03672175|157384623|FG001|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
48876235|NCT03672175|157384624|FG002|Treatment Period (Days 1 to 14)|Withdrawal by Subject|4|||
48982081|NCT02371980|157767518|FG000|Open-label Period|Did not Meet Randomization Criteria|162|||
48982082|NCT02371980|157767519|FG001|Open-label Period|Did not Meet Randomization Criteria|0|||
48982083|NCT02371980|157767520|FG002|Open-label Period|Did not Meet Randomization Criteria|0|||
48982084|NCT02371980|157767521|FG003|Open-label Period|Did not Meet Randomization Criteria|0|||
48982085|NCT02371980|157767522|FG004|Open-label Period|Did not Meet Randomization Criteria|0|||
48982086|NCT02371980|157767518|FG000|Open-label Period|Reason not Specified|9|||
48982087|NCT02371980|157767519|FG001|Open-label Period|Reason not Specified|0|||
48982088|NCT02371980|157767520|FG002|Open-label Period|Reason not Specified|0|||
48982089|NCT02371980|157767521|FG003|Open-label Period|Reason not Specified|0|||
48982090|NCT02371980|157767522|FG004|Open-label Period|Reason not Specified|0|||
48982091|NCT02371980|157767518|FG000|Double-blind Period|Pretreatment Event/Adverse Event|0|||
48982092|NCT02371980|157767519|FG001|Double-blind Period|Pretreatment Event/Adverse Event|4|||
48982093|NCT02371980|157767520|FG002|Double-blind Period|Pretreatment Event/Adverse Event|3|||
48982094|NCT02371980|157767521|FG003|Double-blind Period|Pretreatment Event/Adverse Event|2|||
48982095|NCT02371980|157767522|FG004|Double-blind Period|Pretreatment Event/Adverse Event|9|||
48982096|NCT02371980|157767518|FG000|Double-blind Period|Significant Protocol Deviation|0|||
48982097|NCT02371980|157767519|FG001|Double-blind Period|Significant Protocol Deviation|2|||
48982098|NCT02371980|157767520|FG002|Double-blind Period|Significant Protocol Deviation|7|||
48982099|NCT02371980|157767521|FG003|Double-blind Period|Significant Protocol Deviation|3|||
48982100|NCT02371980|157767522|FG004|Double-blind Period|Significant Protocol Deviation|3|||
48982101|NCT02371980|157767518|FG000|Double-blind Period|Noncompliance with Study Drug|0|||
48982102|NCT02371980|157767519|FG001|Double-blind Period|Noncompliance with Study Drug|1|||
48982103|NCT02371980|157767520|FG002|Double-blind Period|Noncompliance with Study Drug|2|||
48982104|NCT02371980|157767521|FG003|Double-blind Period|Noncompliance with Study Drug|2|||
48982105|NCT02371980|157767522|FG004|Double-blind Period|Noncompliance with Study Drug|3|||
48982106|NCT02371980|157767518|FG000|Double-blind Period|Lost to Follow-up|0|||
48982107|NCT02371980|157767519|FG001|Double-blind Period|Lost to Follow-up|8|||
48982108|NCT02371980|157767520|FG002|Double-blind Period|Lost to Follow-up|8|||
48982109|NCT02371980|157767521|FG003|Double-blind Period|Lost to Follow-up|6|||
48982110|NCT02371980|157767522|FG004|Double-blind Period|Lost to Follow-up|5|||
48982111|NCT02371980|157767518|FG000|Double-blind Period|Voluntary Withdrawal|0|||
48982112|NCT02371980|157767519|FG001|Double-blind Period|Voluntary Withdrawal|12|||
48982113|NCT02371980|157767520|FG002|Double-blind Period|Voluntary Withdrawal|8|||
48982114|NCT02371980|157767521|FG003|Double-blind Period|Voluntary Withdrawal|9|||
48982115|NCT02371980|157767522|FG004|Double-blind Period|Voluntary Withdrawal|11|||
48982116|NCT02371980|157767518|FG000|Double-blind Period|Relapse|0|||
48982117|NCT02371980|157767519|FG001|Double-blind Period|Relapse|50|||
48982118|NCT02371980|157767520|FG002|Double-blind Period|Relapse|25|||
48982119|NCT02371980|157767521|FG003|Double-blind Period|Relapse|25|||
48982120|NCT02371980|157767522|FG004|Double-blind Period|Relapse|26|||
48982121|NCT02371980|157767518|FG000|Double-blind Period|Reason not Specified|0|||
48982122|NCT02371980|157767519|FG001|Double-blind Period|Reason not Specified|3|||
48982123|NCT02371980|157767520|FG002|Double-blind Period|Reason not Specified|3|||
48982124|NCT02371980|157767521|FG003|Double-blind Period|Reason not Specified|2|||
48982125|NCT02371980|157767522|FG004|Double-blind Period|Reason not Specified|1|||
48982126|NCT02371980|157767518|FG000|Double-blind Period|Missing|0|||
48982127|NCT02371980|157767519|FG001|Double-blind Period|Missing|1|||
48982128|NCT02371980|157767520|FG002|Double-blind Period|Missing|0|||
48982129|NCT02371980|157767521|FG003|Double-blind Period|Missing|0|||
48982130|NCT02371980|157767522|FG004|Double-blind Period|Missing|0|||
48982131|NCT02712008|157767523|FG000|Baseline (Day 1) up to Week 12|Death|3|||
48982132|NCT02712008|157767524|FG001|Baseline (Day 1) up to Week 12|Death|0|||
48982133|NCT02712008|157767525|FG002|Baseline (Day 1) up to Week 12|Death|0|||
48982134|NCT02712008|157767526|FG003|Baseline (Day 1) up to Week 12|Death|0|||
49026400|NCT02421952|157935912|FG000|Overall Study|Diary Not Returned|93|||
49026401|NCT02421952|157935912|FG000|Overall Study|Failed seriation task|13|||
49026402|NCT02421952|157935912|FG000|Overall Study|Subject uncooperative for baseline test|2|||
49026403|NCT02421952|157935912|FG000|Overall Study|Surgery cancelled|1|||
49026404|NCT00119015|157935914|FG000|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48|||
49026405|NCT00119015|157935915|FG001|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
49026406|NCT00119015|157935916|FG002|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
49026407|NCT00669942|157935917|FG000|Parts 2 and 3|Adverse Event|0|||
49026408|NCT00669942|157935918|FG001|Parts 2 and 3|Adverse Event|0|||
49026409|NCT00669942|157935919|FG002|Parts 2 and 3|Adverse Event|0|||
49026410|NCT00669942|157935920|FG003|Parts 2 and 3|Adverse Event|0|||
49026411|NCT00669942|157935921|FG004|Parts 2 and 3|Adverse Event|0|||
49026412|NCT00669942|157935922|FG005|Parts 2 and 3|Adverse Event|0|||
49026413|NCT00669942|157935923|FG006|Parts 2 and 3|Adverse Event|0|||
49026414|NCT00669942|157935924|FG007|Parts 2 and 3|Adverse Event|2|||
49026415|NCT00669942|157935925|FG008|Parts 2 and 3|Adverse Event|1|||
49026416|NCT00669942|157935926|FG009|Parts 2 and 3|Adverse Event|0|||
49026417|NCT00669942|157935927|FG010|Parts 2 and 3|Adverse Event|0|||
48769607|NCT02474199|157003961|FG001|Overall Study|Withdrawal by Subject|2|||
48769608|NCT02474199|157003962|FG002|Overall Study|Withdrawal by Subject|0|||
48769609|NCT02474199|157003963|FG003|Overall Study|Withdrawal by Subject|1|||
48769610|NCT02474199|157003960|FG000|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
48769611|NCT02474199|157003961|FG001|Overall Study|Did not receive Tregs due to insufficient manufacture|1|||
48769612|NCT02474199|157003962|FG002|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
48769613|NCT02474199|157003963|FG003|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
48769614|NCT02474199|157003960|FG000|Overall Study|Did not meet eligibility criteria|0|||
48769615|NCT02474199|157003961|FG001|Overall Study|Did not meet eligibility criteria|0|||
48769616|NCT02474199|157003962|FG002|Overall Study|Did not meet eligibility criteria|2|||
48769617|NCT02474199|157003963|FG003|Overall Study|Did not meet eligibility criteria|2|||
48769618|NCT02404311|157003964|FG000|Part A: Month 0-18|Death|2|||
48769619|NCT02404311|157003965|FG001|Part A: Month 0-18|Death|0|||
49026418|NCT00669942|157935928|FG011|Parts 2 and 3|Adverse Event|0|||
49026419|NCT00669942|157935917|FG000|Parts 2 and 3|Withdrawal by Subject|0|||
49026420|NCT00669942|157935918|FG001|Parts 2 and 3|Withdrawal by Subject|0|||
49026421|NCT00669942|157935919|FG002|Parts 2 and 3|Withdrawal by Subject|0|||
49026422|NCT00669942|157935920|FG003|Parts 2 and 3|Withdrawal by Subject|0|||
49026423|NCT00669942|157935921|FG004|Parts 2 and 3|Withdrawal by Subject|0|||
49026424|NCT00669942|157935922|FG005|Parts 2 and 3|Withdrawal by Subject|1|||
49026425|NCT00669942|157935923|FG006|Parts 2 and 3|Withdrawal by Subject|0|||
49026426|NCT00669942|157935924|FG007|Parts 2 and 3|Withdrawal by Subject|0|||
49026427|NCT00669942|157935925|FG008|Parts 2 and 3|Withdrawal by Subject|2|||
49026428|NCT00669942|157935926|FG009|Parts 2 and 3|Withdrawal by Subject|0|||
49026429|NCT00669942|157935927|FG010|Parts 2 and 3|Withdrawal by Subject|0|||
49026430|NCT00669942|157935928|FG011|Parts 2 and 3|Withdrawal by Subject|0|||
49026431|NCT00669942|157935917|FG000|Parts 2 and 3|Protocol Violation|0|||
49026432|NCT00669942|157935918|FG001|Parts 2 and 3|Protocol Violation|0|||
49026433|NCT00669942|157935919|FG002|Parts 2 and 3|Protocol Violation|0|||
49026434|NCT00669942|157935920|FG003|Parts 2 and 3|Protocol Violation|0|||
49026435|NCT00669942|157935921|FG004|Parts 2 and 3|Protocol Violation|0|||
49026436|NCT00669942|157935922|FG005|Parts 2 and 3|Protocol Violation|1|||
48769620|NCT02404311|157003966|FG002|Part A: Month 0-18|Death|0|||
49026437|NCT00669942|157935923|FG006|Parts 2 and 3|Protocol Violation|0|||
49026438|NCT00669942|157935924|FG007|Parts 2 and 3|Protocol Violation|0|||
48769621|NCT02404311|157003967|FG003|Part A: Month 0-18|Death|0|||
48769622|NCT02404311|157003968|FG004|Part A: Month 0-18|Death|0|||
48769623|NCT02404311|157003964|FG000|Part A: Month 0-18|Physician Decision|1|||
48769624|NCT02404311|157003965|FG001|Part A: Month 0-18|Physician Decision|0|||
48769625|NCT02404311|157003966|FG002|Part A: Month 0-18|Physician Decision|0|||
48769626|NCT02404311|157003967|FG003|Part A: Month 0-18|Physician Decision|0|||
48769627|NCT02404311|157003968|FG004|Part A: Month 0-18|Physician Decision|0|||
48769628|NCT02404311|157003964|FG000|Part A: Month 0-18|Lost to Follow-up|4|||
48769629|NCT02404311|157003965|FG001|Part A: Month 0-18|Lost to Follow-up|2|||
48769630|NCT02404311|157003966|FG002|Part A: Month 0-18|Lost to Follow-up|0|||
48769631|NCT02404311|157003967|FG003|Part A: Month 0-18|Lost to Follow-up|0|||
48769632|NCT02404311|157003968|FG004|Part A: Month 0-18|Lost to Follow-up|0|||
48769633|NCT02404311|157003964|FG000|Part A: Month 0-18|Withdrawal by Subject|6|||
48769634|NCT02404311|157003965|FG001|Part A: Month 0-18|Withdrawal by Subject|2|||
48769635|NCT02404311|157003966|FG002|Part A: Month 0-18|Withdrawal by Subject|0|||
48769636|NCT02404311|157003967|FG003|Part A: Month 0-18|Withdrawal by Subject|0|||
48769637|NCT02404311|157003968|FG004|Part A: Month 0-18|Withdrawal by Subject|0|||
48769638|NCT02404311|157003964|FG000|Part A: Month 0-18|HIV Infection|6|||
48769639|NCT02404311|157003965|FG001|Part A: Month 0-18|HIV Infection|2|||
48876236|NCT03672175|157384622|FG000|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
49026439|NCT00669942|157935925|FG008|Parts 2 and 3|Protocol Violation|0|||
49026440|NCT00669942|157935926|FG009|Parts 2 and 3|Protocol Violation|0|||
49026441|NCT00669942|157935927|FG010|Parts 2 and 3|Protocol Violation|0|||
48769640|NCT02404311|157003966|FG002|Part A: Month 0-18|HIV Infection|0|||
48769641|NCT02404311|157003967|FG003|Part A: Month 0-18|HIV Infection|0|||
48769642|NCT02404311|157003968|FG004|Part A: Month 0-18|HIV Infection|0|||
48769643|NCT02404311|157003964|FG000|Part A: Month 0-18|Participant unable to adhere|7|||
48769644|NCT02404311|157003965|FG001|Part A: Month 0-18|Participant unable to adhere|0|||
48769645|NCT02404311|157003966|FG002|Part A: Month 0-18|Participant unable to adhere|0|||
48769646|NCT02404311|157003967|FG003|Part A: Month 0-18|Participant unable to adhere|0|||
48769647|NCT02404311|157003968|FG004|Part A: Month 0-18|Participant unable to adhere|0|||
48769648|NCT00934544|157003969|FG000|Primary Endpoint Analysis (Interim)|Adverse Event|12|||
48769649|NCT00934544|157003970|FG001|Primary Endpoint Analysis (Interim)|Adverse Event|4|||
48769650|NCT00934544|157003971|FG002|Primary Endpoint Analysis (Interim)|Adverse Event|0|||
48769651|NCT00934544|157003969|FG000|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2|||
48769652|NCT00934544|157003970|FG001|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9|||
48769653|NCT00934544|157003971|FG002|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0|||
48769654|NCT00934544|157003969|FG000|Primary Endpoint Analysis (Interim)|Protocol Violation|2|||
48769655|NCT00934544|157003970|FG001|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
48769656|NCT00934544|157003971|FG002|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
48769657|NCT00934544|157003969|FG000|Primary Endpoint Analysis (Interim)|Disease Progression|1|||
48769658|NCT00934544|157003970|FG001|Primary Endpoint Analysis (Interim)|Disease Progression|3|||
48769659|NCT00934544|157003971|FG002|Primary Endpoint Analysis (Interim)|Disease Progression|0|||
48769660|NCT00934544|157003969|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2|||
48769661|NCT00934544|157003970|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
48769662|NCT00934544|157003971|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
48769663|NCT00934544|157003969|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
48769664|NCT00934544|157003970|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1|||
48769665|NCT00934544|157003971|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
48769666|NCT00934544|157003969|FG000|Primary Endpoint Analysis (Interim)|Other reasons|7|||
48769667|NCT00934544|157003970|FG001|Primary Endpoint Analysis (Interim)|Other reasons|7|||
48769668|NCT00934544|157003971|FG002|Primary Endpoint Analysis (Interim)|Other reasons|0|||
48769669|NCT00934544|157003969|FG000|Primary Endpoint Analysis (Interim)|Entered extension phase|29|||
48769670|NCT00934544|157003970|FG001|Primary Endpoint Analysis (Interim)|Entered extension phase|18|||
48769671|NCT00934544|157003971|FG002|Primary Endpoint Analysis (Interim)|Entered extension phase|0|||
48769672|NCT00934544|157003969|FG000|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16|||
48769673|NCT00934544|157003970|FG001|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9|||
48769674|NCT00934544|157003971|FG002|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6|||
48769675|NCT00934544|157003969|FG000|Overall Disposition at 5 Year Follow-up|Adverse Event|35|||
48769676|NCT00934544|157003970|FG001|Overall Disposition at 5 Year Follow-up|Adverse Event|5|||
48769677|NCT00934544|157003971|FG002|Overall Disposition at 5 Year Follow-up|Adverse Event|10|||
48769678|NCT00934544|157003969|FG000|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10|||
48769679|NCT00934544|157003970|FG001|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9|||
48769680|NCT00934544|157003971|FG002|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0|||
48769681|NCT00934544|157003969|FG000|Overall Disposition at 5 Year Follow-up|Protocol Violation|2|||
48769682|NCT00934544|157003970|FG001|Overall Disposition at 5 Year Follow-up|Protocol Violation|0|||
48769683|NCT00934544|157003971|FG002|Overall Disposition at 5 Year Follow-up|Protocol Violation|5|||
48769684|NCT00934544|157003969|FG000|Overall Disposition at 5 Year Follow-up|Disease progression|32|||
48769685|NCT00934544|157003970|FG001|Overall Disposition at 5 Year Follow-up|Disease progression|4|||
48769686|NCT00934544|157003971|FG002|Overall Disposition at 5 Year Follow-up|Disease progression|7|||
48769687|NCT00934544|157003969|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4|||
48769688|NCT00934544|157003970|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0|||
48769689|NCT00934544|157003971|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1|||
48769690|NCT00934544|157003969|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
48769691|NCT00934544|157003970|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1|||
48769692|NCT00934544|157003971|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
48769693|NCT00934544|157003969|FG000|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8|||
48769694|NCT00934544|157003970|FG001|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0|||
48769695|NCT00934544|157003971|FG002|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5|||
48769696|NCT01539226|157003972|FG000|Overall Study|Withdrawal by Subject|24|||
48769697|NCT01539226|157003973|FG001|Overall Study|Withdrawal by Subject|54|||
48769698|NCT01539226|157003972|FG000|Overall Study|Lost to Follow-up|20|||
48769699|NCT01539226|157003973|FG001|Overall Study|Lost to Follow-up|54|||
48769700|NCT01539226|157003972|FG000|Overall Study|Death|1|||
48769701|NCT01539226|157003973|FG001|Overall Study|Death|2|||
48769702|NCT01539226|157003972|FG000|Overall Study|Adverse Event|2|||
48769703|NCT01539226|157003973|FG001|Overall Study|Adverse Event|0|||
48769704|NCT01539226|157003972|FG000|Overall Study|Pregnancy|13|||
48769705|NCT01539226|157003973|FG001|Overall Study|Pregnancy|29|||
48769706|NCT01539226|157003972|FG000|Overall Study|inappropriate enrollment|0|||
48769707|NCT01539226|157003973|FG001|Overall Study|inappropriate enrollment|1|||
48769708|NCT01539226|157003972|FG000|Overall Study|Multiple Reasons|3|||
48769709|NCT01539226|157003973|FG001|Overall Study|Multiple Reasons|1|||
48769710|NCT01539226|157003972|FG000|Overall Study|not HIV seroconversion-related|93|||
48769711|NCT01539226|157003973|FG001|Overall Study|not HIV seroconversion-related|176|||
48769712|NCT01539226|157003972|FG000|Overall Study|HIV seroconversion-related|55|||
48769713|NCT01539226|157003973|FG001|Overall Study|HIV seroconversion-related|80|||
48769714|NCT01539226|157003972|FG000|Overall Study|Non-compliance|6|||
48769715|NCT01539226|157003973|FG001|Overall Study|Non-compliance|8|||
48769716|NCT01218516|157003974|FG000|Combination Therapy (up to 4.5 Months)|Death|2|||
48769717|NCT01218516|157003975|FG001|Combination Therapy (up to 4.5 Months)|Death|1|||
48769718|NCT01218516|157003976|FG002|Combination Therapy (up to 4.5 Months)|Death|0|||
48769719|NCT01218516|157003977|FG003|Combination Therapy (up to 4.5 Months)|Death|0|||
48769720|NCT01218516|157003974|FG000|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
48769721|NCT01218516|157003975|FG001|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3|||
48769722|NCT01218516|157003976|FG002|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
48769723|NCT01218516|157003977|FG003|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
48769724|NCT01218516|157003974|FG000|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
48769725|NCT01218516|157003975|FG001|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
48769726|NCT01218516|157003976|FG002|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
48769727|NCT01218516|157003977|FG003|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
48769728|NCT01218516|157003974|FG000|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2|||
48769729|NCT01218516|157003975|FG001|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
48769730|NCT01218516|157003976|FG002|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
48769731|NCT01218516|157003977|FG003|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
48769732|NCT01218516|157003974|FG000|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17|||
48769733|NCT01218516|157003975|FG001|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15|||
48769734|NCT01218516|157003976|FG002|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
48769735|NCT01218516|157003977|FG003|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
48769736|NCT01218516|157003974|FG000|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
48769737|NCT01218516|157003975|FG001|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1|||
48769738|NCT01218516|157003976|FG002|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
48769739|NCT01218516|157003977|FG003|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
48769740|NCT01218516|157003974|FG000|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
48769741|NCT01218516|157003975|FG001|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1|||
48769742|NCT01218516|157003976|FG002|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
48769743|NCT01218516|157003977|FG003|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
48769744|NCT01218516|157003974|FG000|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
48769745|NCT01218516|157003975|FG001|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3|||
48769746|NCT01218516|157003976|FG002|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
48769747|NCT01218516|157003977|FG003|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
48769748|NCT01218516|157003974|FG000|Combination Therapy (up to 4.5 Months)|Other|3|||
48769749|NCT01218516|157003975|FG001|Combination Therapy (up to 4.5 Months)|Other|4|||
48769750|NCT01218516|157003976|FG002|Combination Therapy (up to 4.5 Months)|Other|0|||
48769751|NCT01218516|157003977|FG003|Combination Therapy (up to 4.5 Months)|Other|0|||
48769752|NCT01218516|157003974|FG000|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
48769753|NCT01218516|157003975|FG001|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1|||
48769754|NCT01218516|157003976|FG002|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
48769755|NCT01218516|157003977|FG003|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
48769756|NCT01218516|157003974|FG000|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2|||
48769757|NCT01218516|157003975|FG001|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3|||
48769758|NCT01218516|157003976|FG002|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
48769759|NCT01218516|157003977|FG003|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
48769760|NCT01218516|157003974|FG000|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
48797683|NCT00828984|157097048|FG002|Overall Study|Withdrawal by Subject|4|||
48797684|NCT00828984|157097046|FG000|Overall Study|Ineligable|1|||
48797685|NCT00828984|157097047|FG001|Overall Study|Ineligable|2|||
48797686|NCT00828984|157097048|FG002|Overall Study|Ineligable|0|||
48797687|NCT00828984|157097046|FG000|Overall Study|Medical Contraindication|0|||
48797688|NCT00828984|157097047|FG001|Overall Study|Medical Contraindication|1|||
48797689|NCT00828984|157097048|FG002|Overall Study|Medical Contraindication|0|||
48797690|NCT00828984|157097046|FG000|Overall Study|Noncompliant|1|||
48797691|NCT00828984|157097047|FG001|Overall Study|Noncompliant|2|||
48797692|NCT00828984|157097048|FG002|Overall Study|Noncompliant|3|||
48769761|NCT01218516|157003975|FG001|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
48769762|NCT01218516|157003976|FG002|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
48769763|NCT01218516|157003977|FG003|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
48769764|NCT02643251|157003978|FG000|Overall Study|Adverse Event|3|||
48769765|NCT02643251|157003979|FG001|Overall Study|Adverse Event|1|||
48769766|NCT02643251|157003978|FG000|Overall Study|Withdrawal by Subject|2|||
48769767|NCT02643251|157003979|FG001|Overall Study|Withdrawal by Subject|0|||
48769768|NCT02643251|157003978|FG000|Overall Study|Lost to Follow-up|4|||
48769769|NCT02643251|157003979|FG001|Overall Study|Lost to Follow-up|1|||
48876237|NCT03672175|157384623|FG001|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
48876238|NCT03672175|157384624|FG002|Treatment Period (Days 1 to 14)|Lost to Follow-up|3|||
48876239|NCT03672175|157384622|FG000|Treatment Period (Days 1 to 14)|Randomized but not Treated|3|||
48769770|NCT02643251|157003978|FG000|Overall Study|Protocol Violation|1|||
48769771|NCT02643251|157003979|FG001|Overall Study|Protocol Violation|0|||
48769772|NCT02643251|157003978|FG000|Overall Study|PI Decision to terminate patient|1|||
48769773|NCT02643251|157003979|FG001|Overall Study|PI Decision to terminate patient|0|||
48769774|NCT01632891|157003980|FG000|Overall Study|Lost to Follow-up|0|||
48769775|NCT01632891|157003981|FG001|Overall Study|Lost to Follow-up|1|||
48769776|NCT01632891|157003980|FG000|Overall Study|Withdrawal by Subject|1|||
48769777|NCT01632891|157003981|FG001|Overall Study|Withdrawal by Subject|0|||
48769778|NCT04033003|157003985|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|113|||
48769779|NCT04033003|157003986|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|190|||
48982135|NCT02712008|157767527|FG004|Baseline (Day 1) up to Week 12|Death|0|||
48982136|NCT02712008|157767528|FG005|Baseline (Day 1) up to Week 12|Death|0|||
48769780|NCT04033003|157003985|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|115|||
48769781|NCT04033003|157003986|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|0|||
48769782|NCT04033003|157003985|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|2|||
48769783|NCT04033003|157003986|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|6|||
48769784|NCT04033003|157003985|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|30|||
48769785|NCT04033003|157003986|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|19|||
48769786|NCT04033003|157003985|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|0|||
48769787|NCT04033003|157003986|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|1|||
48769788|NCT04033003|157003985|FG000|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|133|||
48769789|NCT04033003|157003986|FG001|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|247|||
48769790|NCT04033003|157003985|FG000|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|4|||
48769791|NCT04033003|157003986|FG001|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|0|||
48769792|NCT04033003|157003985|FG000|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|5|||
48769793|NCT04033003|157003986|FG001|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|3|||
48769794|NCT04033003|157003985|FG000|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|1|||
48769795|NCT04033003|157003986|FG001|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|10|||
48769796|NCT04033003|157003985|FG000|T2 (6 - 12 Weeks Postpartum)|Death|2|||
48769797|NCT04033003|157003986|FG001|T2 (6 - 12 Weeks Postpartum)|Death|2|||
48769798|NCT04033003|157003985|FG000|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|96|||
48769799|NCT04033003|157003986|FG001|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|165|||
48769800|NCT04033003|157003985|FG000|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|3|||
48769801|NCT04033003|157003986|FG001|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|5|||
48769802|NCT04033003|157003985|FG000|T4 (11 -14 Months Postpartum)|Lost to Follow-up|89|||
48769803|NCT04033003|157003986|FG001|T4 (11 -14 Months Postpartum)|Lost to Follow-up|150|||
48769804|NCT00240071|157003987|FG000|Overall Study|Withdrawal by Subject|3|||
48769805|NCT02256891|157003988|FG000|Overall Study|Death|0|||
48769806|NCT02256891|157003989|FG001|Overall Study|Death|2|||
48769807|NCT02256891|157003988|FG000|Overall Study|Lost to Follow-up|0|||
48769808|NCT02256891|157003989|FG001|Overall Study|Lost to Follow-up|3|||
48769809|NCT02256891|157003988|FG000|Overall Study|Physician Decision|7|||
48769810|NCT02256891|157003989|FG001|Overall Study|Physician Decision|3|||
48769811|NCT02256891|157003988|FG000|Overall Study|Screen Fail|5|||
48769812|NCT02256891|157003989|FG001|Overall Study|Screen Fail|4|||
48769813|NCT02256891|157003988|FG000|Overall Study|Equipment Malfunction|0|||
48769814|NCT02256891|157003989|FG001|Overall Study|Equipment Malfunction|1|||
48769815|NCT01660711|157003993|FG000|Overall Study|Adverse Event|7|||
48769816|NCT01660711|157003993|FG000|Overall Study|Withdrawal by Subject|1|||
48769817|NCT04171414|157003994|FG000|Overall Study|Death|1|||
48769818|NCT04171414|157003994|FG000|Overall Study|Withdrawal by Subject|1|||
48769819|NCT00463060|157003995|FG000|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5|||
48769820|NCT00463060|157003995|FG000|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1|||
48769821|NCT03907683|157004002|FG000|Overall Study|Pregnancy|1|||
48769822|NCT03907683|157004002|FG000|Overall Study|Withdrawal by Subject|1|||
48769823|NCT02272413|157004005|FG000|Randomized Through Treatment Start|Not treated|3|||
48769824|NCT02272413|157004006|FG001|Randomized Through Treatment Start|Not treated|5|||
48769825|NCT02272413|157004005|FG000|Pre-switch Period|Adverse Event|38|||
48982137|NCT02712008|157767529|FG006|Baseline (Day 1) up to Week 12|Death|0|||
48982138|NCT02712008|157767530|FG007|Baseline (Day 1) up to Week 12|Death|0|||
48769826|NCT02272413|157004006|FG001|Pre-switch Period|Adverse Event|37|||
48769827|NCT02272413|157004005|FG000|Pre-switch Period|Death|26|||
48769828|NCT02272413|157004006|FG001|Pre-switch Period|Death|26|||
48769829|NCT02272413|157004005|FG000|Pre-switch Period|Withdrawal by Subject|27|||
48769830|NCT02272413|157004006|FG001|Pre-switch Period|Withdrawal by Subject|15|||
48769831|NCT02272413|157004005|FG000|Pre-switch Period|Physician Decision|6|||
48769832|NCT02272413|157004006|FG001|Pre-switch Period|Physician Decision|18|||
48769833|NCT02272413|157004005|FG000|Pre-switch Period|Progressive disease|185|||
48769834|NCT02272413|157004006|FG001|Pre-switch Period|Progressive disease|173|||
48769835|NCT02272413|157004005|FG000|Pre-switch Period|Lost to Follow-up|0|||
48769836|NCT02272413|157004006|FG001|Pre-switch Period|Lost to Follow-up|2|||
48769837|NCT02272413|157004005|FG000|Pre-switch Period|Protocol Violation|1|||
48769838|NCT02272413|157004006|FG001|Pre-switch Period|Protocol Violation|0|||
48769839|NCT02272413|157004005|FG000|Pre-switch Period|Other than listed|10|||
48769840|NCT02272413|157004006|FG001|Pre-switch Period|Other than listed|11|||
48769841|NCT02272413|157004005|FG000|Post-switch Period|Adverse Event|4|||
48876240|NCT03672175|157384623|FG001|Treatment Period (Days 1 to 14)|Randomized but not Treated|6|||
48769842|NCT02272413|157004006|FG001|Post-switch Period|Adverse Event|4|||
48769843|NCT02272413|157004005|FG000|Post-switch Period|Death|3|||
48769844|NCT02272413|157004006|FG001|Post-switch Period|Death|2|||
48769845|NCT02272413|157004005|FG000|Post-switch Period|Withdrawal by Subject|1|||
48769846|NCT02272413|157004006|FG001|Post-switch Period|Withdrawal by Subject|2|||
48769847|NCT02272413|157004005|FG000|Post-switch Period|Physician Decision|1|||
48769848|NCT02272413|157004006|FG001|Post-switch Period|Physician Decision|1|||
48769849|NCT02272413|157004005|FG000|Post-switch Period|Progressive disease|21|||
48769850|NCT02272413|157004006|FG001|Post-switch Period|Progressive disease|21|||
48769851|NCT02272413|157004005|FG000|Post-switch Period|Study terminated by sponsor|8|||
48769852|NCT02272413|157004006|FG001|Post-switch Period|Study terminated by sponsor|11|||
48769853|NCT02272413|157004005|FG000|Post-switch Period|Other than listed|4|||
48769854|NCT02272413|157004006|FG001|Post-switch Period|Other than listed|5|||
48769855|NCT02852265|157004007|FG000|3-month Follow-up|Lost to Follow-up|1|||
48769856|NCT02852265|157004008|FG001|3-month Follow-up|Lost to Follow-up|1|||
48876241|NCT03672175|157384624|FG002|Treatment Period (Days 1 to 14)|Randomized but not Treated|2|||
48876242|NCT03672175|157384622|FG000|FU Period (Days 15 to 42)|Adverse Event|0|||
48876243|NCT03672175|157384623|FG001|FU Period (Days 15 to 42)|Adverse Event|0|||
48876244|NCT03672175|157384624|FG002|FU Period (Days 15 to 42)|Adverse Event|1|||
48876245|NCT03672175|157384622|FG000|FU Period (Days 15 to 42)|Lost to Follow-up|3|||
48876246|NCT03672175|157384623|FG001|FU Period (Days 15 to 42)|Lost to Follow-up|6|||
48876247|NCT03672175|157384624|FG002|FU Period (Days 15 to 42)|Lost to Follow-up|2|||
48876248|NCT03672175|157384622|FG000|FU Period (Days 15 to 42)|Withdrawal by Subject|1|||
48876249|NCT03672175|157384623|FG001|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
48769857|NCT02287896|157004011|FG000|Second Injection Visit|Withdrawal by Subject|0|||
48769858|NCT02287896|157004012|FG001|Second Injection Visit|Withdrawal by Subject|1|||
48769859|NCT03029624|157004013|FG000|Overall Study|Adverse Event|1|||
48769860|NCT03029624|157004013|FG000|Overall Study|Withdrawal by Subject|1|||
48769861|NCT03029624|157004013|FG000|Overall Study|Lack of Efficacy|1|||
48769862|NCT03029624|157004013|FG000|Overall Study|MRI need|2|||
48876250|NCT03672175|157384624|FG002|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
48876251|NCT03672175|157384622|FG000|Extended FU Period (Days 43 to 182)|Adverse Event|5|||
48876252|NCT03672175|157384623|FG001|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
48876253|NCT03672175|157384624|FG002|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
48876254|NCT03672175|157384622|FG000|Extended FU Period (Days 43 to 182)|Lost to Follow-up|6|||
48769863|NCT00854581|157004014|FG000|Induction (Up to Day 21)|Lack of Efficacy|4|||
48769864|NCT00854581|157004014|FG000|Induction (Up to Day 21)|Death|1|||
48769865|NCT00854581|157004014|FG000|Induction (Up to Day 21)|Physician Decision|1|||
48769866|NCT00854581|157004014|FG000|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3|||
48769867|NCT04847674|157004015|FG000|Overall Study|Withdrawal by Subject|0|||
48769868|NCT04847674|157004016|FG001|Overall Study|Withdrawal by Subject|1|||
48769869|NCT04847674|157004017|FG002|Overall Study|Withdrawal by Subject|0|||
48769870|NCT04847674|157004015|FG000|Overall Study|Lost to Follow-up|0|||
48769871|NCT04847674|157004016|FG001|Overall Study|Lost to Follow-up|0|||
48769872|NCT04847674|157004017|FG002|Overall Study|Lost to Follow-up|2|||
48876255|NCT03672175|157384623|FG001|Extended FU Period (Days 43 to 182)|Lost to Follow-up|8|||
48876256|NCT03672175|157384624|FG002|Extended FU Period (Days 43 to 182)|Lost to Follow-up|7|||
48876257|NCT03672175|157384622|FG000|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
48769873|NCT04847674|157004015|FG000|Overall Study|Other than specified|21|||
48769874|NCT04847674|157004016|FG001|Overall Study|Other than specified|20|||
48769875|NCT04847674|157004017|FG002|Overall Study|Other than specified|20|||
48769876|NCT01557400|157004018|FG000|Overall Study|Transitioned to Commercial Drug Product|40|||
48769877|NCT01557400|157004018|FG000|Overall Study|Adverse Event|3|||
48769878|NCT01557400|157004018|FG000|Overall Study|Lost to Follow-up|5|||
48769879|NCT01557400|157004018|FG000|Overall Study|Withdrawal by Subject|9|||
48769880|NCT01434290|157004021|FG000|Overall Study|Protocol Violation|6|||
48769881|NCT01434290|157004022|FG001|Overall Study|Protocol Violation|3|||
48769882|NCT01434290|157004021|FG000|Overall Study|No protocol treatment|2|||
48769883|NCT01434290|157004022|FG001|Overall Study|No protocol treatment|4|||
48769884|NCT00235989|157004023|FG000|Core Treatment Period (CT)|Lost to Follow-up|0|||
48769885|NCT00235989|157004024|FG001|Core Treatment Period (CT)|Lost to Follow-up|0|||
48769886|NCT00235989|157004025|FG002|Core Treatment Period (CT)|Lost to Follow-up|0|||
48769887|NCT00235989|157004026|FG003|Core Treatment Period (CT)|Lost to Follow-up|0|||
48769888|NCT00235989|157004027|FG004|Core Treatment Period (CT)|Lost to Follow-up|0|||
48769889|NCT00235989|157004028|FG005|Core Treatment Period (CT)|Lost to Follow-up|2|||
48769890|NCT00235989|157004023|FG000|Extension Treatment Period (ET)|Adverse Event|3|||
48769891|NCT00235989|157004024|FG001|Extension Treatment Period (ET)|Adverse Event|0|||
48769892|NCT00235989|157004025|FG002|Extension Treatment Period (ET)|Adverse Event|2|||
48769893|NCT00235989|157004026|FG003|Extension Treatment Period (ET)|Adverse Event|0|||
48769894|NCT00235989|157004027|FG004|Extension Treatment Period (ET)|Adverse Event|0|||
48769895|NCT00235989|157004028|FG005|Extension Treatment Period (ET)|Adverse Event|0|||
48769896|NCT00235989|157004023|FG000|Extension Treatment Period (ET)|Lost to Follow-up|2|||
48769897|NCT00235989|157004024|FG001|Extension Treatment Period (ET)|Lost to Follow-up|0|||
48769898|NCT00235989|157004025|FG002|Extension Treatment Period (ET)|Lost to Follow-up|1|||
48769899|NCT00235989|157004026|FG003|Extension Treatment Period (ET)|Lost to Follow-up|0|||
48769900|NCT00235989|157004027|FG004|Extension Treatment Period (ET)|Lost to Follow-up|0|||
48769901|NCT00235989|157004028|FG005|Extension Treatment Period (ET)|Lost to Follow-up|0|||
48769902|NCT00235989|157004023|FG000|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
48769903|NCT00235989|157004024|FG001|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
48769904|NCT00235989|157004025|FG002|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
48769905|NCT00235989|157004026|FG003|Extension Treatment Period (ET)|Withdrawal by Subject|4|||
48769906|NCT00235989|157004027|FG004|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
48769907|NCT00235989|157004028|FG005|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
48769908|NCT00235989|157004023|FG000|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
48769909|NCT00235989|157004024|FG001|Extension Treatment Period (ET)|´Other´ not further itemized|3|||
48769910|NCT00235989|157004025|FG002|Extension Treatment Period (ET)|´Other´ not further itemized|1|||
48769911|NCT00235989|157004026|FG003|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
48769912|NCT00235989|157004027|FG004|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
48769913|NCT00235989|157004028|FG005|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
48769914|NCT03181542|157004029|FG000|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|1|||
48769915|NCT03181542|157004030|FG001|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|0|||
48769916|NCT00969553|157004035|FG000|Overall Study|Progressive disease (PD)|2|||
48769917|NCT00969553|157004036|FG001|Overall Study|Progressive disease (PD)|2|||
48769918|NCT00969553|157004037|FG002|Overall Study|Progressive disease (PD)|6|||
48769919|NCT00969553|157004038|FG003|Overall Study|Progressive disease (PD)|9|||
48769920|NCT00969553|157004039|FG004|Overall Study|Progressive disease (PD)|2|||
48769921|NCT00969553|157004040|FG005|Overall Study|Progressive disease (PD)|4|||
48769922|NCT00969553|157004041|FG006|Overall Study|Progressive disease (PD)|2|||
48769923|NCT00969553|157004042|FG007|Overall Study|Progressive disease (PD)|12|||
48769924|NCT00969553|157004043|FG008|Overall Study|Progressive disease (PD)|3|||
48769925|NCT00969553|157004035|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
48769926|NCT00969553|157004036|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
48769927|NCT00969553|157004037|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
48769928|NCT00969553|157004038|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
48769929|NCT00969553|157004039|FG004|Overall Study|Dose limiting Toxicity (DLT)|1|||
48769930|NCT00969553|157004040|FG005|Overall Study|Dose limiting Toxicity (DLT)|0|||
48769931|NCT00969553|157004041|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
48769932|NCT00969553|157004042|FG007|Overall Study|Dose limiting Toxicity (DLT)|0|||
48769933|NCT00969553|157004043|FG008|Overall Study|Dose limiting Toxicity (DLT)|0|||
48769934|NCT00969553|157004035|FG000|Overall Study|Other Adverse Event|0|||
48769935|NCT00969553|157004036|FG001|Overall Study|Other Adverse Event|0|||
48769936|NCT00969553|157004037|FG002|Overall Study|Other Adverse Event|0|||
48769937|NCT00969553|157004038|FG003|Overall Study|Other Adverse Event|1|||
48769938|NCT00969553|157004039|FG004|Overall Study|Other Adverse Event|0|||
48769939|NCT00969553|157004040|FG005|Overall Study|Other Adverse Event|0|||
48769940|NCT00969553|157004041|FG006|Overall Study|Other Adverse Event|1|||
48769941|NCT00969553|157004042|FG007|Overall Study|Other Adverse Event|0|||
48769942|NCT00969553|157004043|FG008|Overall Study|Other Adverse Event|0|||
48769943|NCT00969553|157004035|FG000|Overall Study|Refused cont. medication|1|||
48769944|NCT00969553|157004036|FG001|Overall Study|Refused cont. medication|1|||
48769945|NCT00969553|157004037|FG002|Overall Study|Refused cont. medication|0|||
48769946|NCT00969553|157004038|FG003|Overall Study|Refused cont. medication|2|||
48769947|NCT00969553|157004039|FG004|Overall Study|Refused cont. medication|0|||
48769948|NCT00969553|157004040|FG005|Overall Study|Refused cont. medication|0|||
48769949|NCT00969553|157004041|FG006|Overall Study|Refused cont. medication|0|||
48982139|NCT02712008|157767523|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
48797693|NCT00828984|157097046|FG000|Overall Study|ConMed|1|||
48797694|NCT00828984|157097047|FG001|Overall Study|ConMed|1|||
48769950|NCT00969553|157004042|FG007|Overall Study|Refused cont. medication|1|||
48769951|NCT00969553|157004043|FG008|Overall Study|Refused cont. medication|0|||
48769952|NCT00969553|157004035|FG000|Overall Study|Not specified above|0|||
48769953|NCT00969553|157004036|FG001|Overall Study|Not specified above|0|||
48769954|NCT00969553|157004037|FG002|Overall Study|Not specified above|0|||
48769955|NCT00969553|157004038|FG003|Overall Study|Not specified above|4|||
48769956|NCT00969553|157004039|FG004|Overall Study|Not specified above|0|||
48769957|NCT00969553|157004040|FG005|Overall Study|Not specified above|0|||
48769958|NCT00969553|157004041|FG006|Overall Study|Not specified above|1|||
48769959|NCT00969553|157004042|FG007|Overall Study|Not specified above|1|||
48769960|NCT00969553|157004043|FG008|Overall Study|Not specified above|0|||
48769961|NCT03400033|157004044|FG000|Overall Study|Withdrawal by Subject|1|||
48769962|NCT03400033|157004045|FG001|Overall Study|Withdrawal by Subject|2|||
48769963|NCT02457325|157004048|FG000|First Intervention (1 Day)|Lost to Follow-up|2|||
48769964|NCT02457325|157004049|FG001|First Intervention (1 Day)|Lost to Follow-up|2|||
48769965|NCT01399593|157004051|FG000|Overall Study|Physician Decision|1|||
48769966|NCT01399593|157004052|FG001|Overall Study|Physician Decision|0|||
48769967|NCT01399593|157004051|FG000|Overall Study|Adverse Event|1|||
48769968|NCT01399593|157004052|FG001|Overall Study|Adverse Event|0|||
48769969|NCT01399593|157004051|FG000|Overall Study|Death|1|||
48769970|NCT01399593|157004052|FG001|Overall Study|Death|1|||
48769971|NCT01399593|157004051|FG000|Overall Study|Transplantectomy|0|||
48769972|NCT01399593|157004052|FG001|Overall Study|Transplantectomy|1|||
48769973|NCT00096044|157004055|FG000|Overall Study|Withdrawal by Subject|9|||
48769974|NCT00096044|157004055|FG000|Overall Study|Adverse Event|21|||
48769975|NCT00096044|157004055|FG000|Overall Study|Disease Progression|4|||
48769976|NCT03595878|157004056|FG000|Overall Study|Death|2|||
48769977|NCT03595878|157004057|FG001|Overall Study|Death|1|||
48769978|NCT03595878|157004058|FG002|Overall Study|Death|0|||
48769979|NCT03595878|157004056|FG000|Overall Study|Disease progression|2|||
48769980|NCT03595878|157004057|FG001|Overall Study|Disease progression|1|||
48769981|NCT03595878|157004058|FG002|Overall Study|Disease progression|2|||
48769982|NCT01552772|157004059|FG000|Overall Study|Lost to Follow-up|2|||
48769983|NCT01552772|157004059|FG000|Overall Study|Adverse Event|1|||
48769984|NCT01552772|157004059|FG000|Overall Study|Protocol Deviation|1|||
48769985|NCT01420081|157004060|FG000|Overall Study|Death|1|||
48769986|NCT01420081|157004061|FG001|Overall Study|Death|0|||
48769987|NCT01420081|157004062|FG002|Overall Study|Death|8|||
48769988|NCT01420081|157004063|FG003|Overall Study|Death|0|||
48769989|NCT01420081|157004064|FG004|Overall Study|Death|7|||
48769990|NCT01420081|157004065|FG005|Overall Study|Death|12|||
48769991|NCT01420081|157004066|FG006|Overall Study|Death|0|||
48769992|NCT01420081|157004067|FG007|Overall Study|Death|1|||
48769993|NCT01420081|157004068|FG008|Overall Study|Death|1|||
48769994|NCT01420081|157004060|FG000|Overall Study|Lost to Follow-up|0|||
48769995|NCT01420081|157004061|FG001|Overall Study|Lost to Follow-up|0|||
48769996|NCT01420081|157004062|FG002|Overall Study|Lost to Follow-up|0|||
48769997|NCT01420081|157004063|FG003|Overall Study|Lost to Follow-up|0|||
48769998|NCT01420081|157004064|FG004|Overall Study|Lost to Follow-up|1|||
48769999|NCT01420081|157004065|FG005|Overall Study|Lost to Follow-up|1|||
48770000|NCT01420081|157004066|FG006|Overall Study|Lost to Follow-up|0|||
48770001|NCT01420081|157004067|FG007|Overall Study|Lost to Follow-up|0|||
48770002|NCT01420081|157004068|FG008|Overall Study|Lost to Follow-up|0|||
48770003|NCT01420081|157004060|FG000|Overall Study|Study Terminated by Sponsor|2|||
48770004|NCT01420081|157004061|FG001|Overall Study|Study Terminated by Sponsor|1|||
48770005|NCT01420081|157004062|FG002|Overall Study|Study Terminated by Sponsor|1|||
48770006|NCT01420081|157004063|FG003|Overall Study|Study Terminated by Sponsor|3|||
48770007|NCT01420081|157004064|FG004|Overall Study|Study Terminated by Sponsor|11|||
48770008|NCT01420081|157004065|FG005|Overall Study|Study Terminated by Sponsor|7|||
48770009|NCT01420081|157004066|FG006|Overall Study|Study Terminated by Sponsor|3|||
48770010|NCT01420081|157004067|FG007|Overall Study|Study Terminated by Sponsor|2|||
48770011|NCT01420081|157004068|FG008|Overall Study|Study Terminated by Sponsor|2|||
48770012|NCT01420081|157004060|FG000|Overall Study|Subject Refused Futher Follow-up|0|||
48770013|NCT01420081|157004061|FG001|Overall Study|Subject Refused Futher Follow-up|0|||
48770014|NCT01420081|157004062|FG002|Overall Study|Subject Refused Futher Follow-up|1|||
48770015|NCT01420081|157004063|FG003|Overall Study|Subject Refused Futher Follow-up|0|||
48770016|NCT01420081|157004064|FG004|Overall Study|Subject Refused Futher Follow-up|1|||
48770017|NCT01420081|157004065|FG005|Overall Study|Subject Refused Futher Follow-up|0|||
48770018|NCT01420081|157004066|FG006|Overall Study|Subject Refused Futher Follow-up|0|||
48770019|NCT01420081|157004067|FG007|Overall Study|Subject Refused Futher Follow-up|0|||
48770020|NCT01420081|157004068|FG008|Overall Study|Subject Refused Futher Follow-up|0|||
48770021|NCT01420081|157004060|FG000|Overall Study|Other Reasons|0|||
48770022|NCT01420081|157004061|FG001|Overall Study|Other Reasons|0|||
48770023|NCT01420081|157004062|FG002|Overall Study|Other Reasons|1|||
48770024|NCT01420081|157004063|FG003|Overall Study|Other Reasons|0|||
48770025|NCT01420081|157004064|FG004|Overall Study|Other Reasons|0|||
48770026|NCT01420081|157004065|FG005|Overall Study|Other Reasons|0|||
48770027|NCT01420081|157004066|FG006|Overall Study|Other Reasons|0|||
48770028|NCT01420081|157004067|FG007|Overall Study|Other Reasons|0|||
48770029|NCT01420081|157004068|FG008|Overall Study|Other Reasons|0|||
48770030|NCT00360334|157004069|FG000|Overall Study|Adverse Event|7|||
48770031|NCT00360334|157004070|FG001|Overall Study|Adverse Event|4|||
48770032|NCT00360334|157004069|FG000|Overall Study|Protocol Violation|1|||
48770033|NCT00360334|157004070|FG001|Overall Study|Protocol Violation|1|||
48770034|NCT00360334|157004069|FG000|Overall Study|Physician Decision|2|||
48770035|NCT00360334|157004070|FG001|Overall Study|Physician Decision|3|||
48770036|NCT00360334|157004069|FG000|Overall Study|Lack of Efficacy|0|||
48770037|NCT00360334|157004070|FG001|Overall Study|Lack of Efficacy|1|||
48770038|NCT00360334|157004069|FG000|Overall Study|Entry criterion not met|1|||
48770039|NCT00360334|157004070|FG001|Overall Study|Entry criterion not met|2|||
48770040|NCT00360334|157004069|FG000|Overall Study|Subject decision|8|||
48770041|NCT00360334|157004070|FG001|Overall Study|Subject decision|2|||
48770042|NCT01451424|157004072|FG000|Overall Study|Withdrawal by Subject|1|||
48770043|NCT01451424|157004073|FG001|Overall Study|Withdrawal by Subject|1|||
48770044|NCT01451424|157004074|FG002|Overall Study|Withdrawal by Subject|0|||
48770045|NCT01451424|157004075|FG003|Overall Study|Withdrawal by Subject|2|||
48770046|NCT01451424|157004072|FG000|Overall Study|Lost to Follow-up|0|||
48770047|NCT01451424|157004073|FG001|Overall Study|Lost to Follow-up|1|||
48770048|NCT01451424|157004074|FG002|Overall Study|Lost to Follow-up|0|||
48770049|NCT01451424|157004075|FG003|Overall Study|Lost to Follow-up|1|||
48770050|NCT01451424|157004072|FG000|Overall Study|Physician Decision|0|||
48770051|NCT01451424|157004073|FG001|Overall Study|Physician Decision|0|||
48770052|NCT01451424|157004074|FG002|Overall Study|Physician Decision|1|||
48770053|NCT01451424|157004075|FG003|Overall Study|Physician Decision|1|||
48770054|NCT01451424|157004072|FG000|Overall Study|Adverse Event|0|||
48770055|NCT01451424|157004073|FG001|Overall Study|Adverse Event|0|||
48770056|NCT01451424|157004074|FG002|Overall Study|Adverse Event|0|||
48770057|NCT01451424|157004075|FG003|Overall Study|Adverse Event|1|||
48770058|NCT04476030|157005717|FG000|Overall Study|Withdrawal by Subject|20|||
48770059|NCT04476030|157005718|FG001|Overall Study|Withdrawal by Subject|16|||
48770060|NCT04476030|157005717|FG000|Overall Study|Adverse Event|10|||
48876258|NCT03672175|157384623|FG001|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|0|||
49026442|NCT00669942|157935928|FG011|Parts 2 and 3|Protocol Violation|0|||
48770061|NCT04476030|157005718|FG001|Overall Study|Adverse Event|11|||
48770062|NCT04476030|157005717|FG000|Overall Study|Lost to Follow-up|7|||
48770063|NCT04476030|157005718|FG001|Overall Study|Lost to Follow-up|4|||
48770064|NCT04476030|157005717|FG000|Overall Study|Physician Decision|1|||
48770065|NCT04476030|157005718|FG001|Overall Study|Physician Decision|1|||
48770066|NCT04476030|157005717|FG000|Overall Study|Protocol Deviation|2|||
48770067|NCT04476030|157005718|FG001|Overall Study|Protocol Deviation|0|||
48770068|NCT04476030|157005717|FG000|Overall Study|Non-compliance with Investigational Product (IP)|1|||
48770069|NCT04476030|157005718|FG001|Overall Study|Non-compliance with Investigational Product (IP)|0|||
48770070|NCT04476030|157005717|FG000|Overall Study|Randomized but not Dosed|2|||
48770071|NCT04476030|157005718|FG001|Overall Study|Randomized but not Dosed|8|||
48770072|NCT02884089|157005719|FG000|Period 1|Dosing error|2|||
48770073|NCT02884089|157005720|FG001|Period 1|Dosing error|2|||
48770074|NCT02884089|157005721|FG002|Period 1|Dosing error|0|||
48770075|NCT02884089|157005722|FG003|Period 1|Dosing error|0|||
48770076|NCT02884089|157005719|FG000|Washout Period 1|Lost to Follow-up|0|||
48770077|NCT02884089|157005720|FG001|Washout Period 1|Lost to Follow-up|1|||
48770078|NCT02884089|157005721|FG002|Washout Period 1|Lost to Follow-up|0|||
48770079|NCT02884089|157005722|FG003|Washout Period 1|Lost to Follow-up|1|||
48770080|NCT02884089|157005719|FG000|Washout Period 1|Withdrawal by Subject|0|||
48770081|NCT02884089|157005720|FG001|Washout Period 1|Withdrawal by Subject|1|||
48770082|NCT02884089|157005721|FG002|Washout Period 1|Withdrawal by Subject|0|||
48770083|NCT02884089|157005722|FG003|Washout Period 1|Withdrawal by Subject|0|||
48770084|NCT02884089|157005719|FG000|Period 2|Adverse Event|1|||
48770085|NCT02884089|157005720|FG001|Period 2|Adverse Event|0|||
48770086|NCT02884089|157005721|FG002|Period 2|Adverse Event|0|||
48770087|NCT02884089|157005722|FG003|Period 2|Adverse Event|0|||
48770088|NCT02884089|157005719|FG000|Period 3|Withdrawal by Subject|0|||
48770089|NCT02884089|157005720|FG001|Period 3|Withdrawal by Subject|0|||
48770090|NCT02884089|157005721|FG002|Period 3|Withdrawal by Subject|1|||
48770091|NCT02884089|157005722|FG003|Period 3|Withdrawal by Subject|0|||
48770092|NCT02884089|157005719|FG000|Washout Period 3|Withdrawal by Subject|0|||
48770093|NCT02884089|157005720|FG001|Washout Period 3|Withdrawal by Subject|0|||
48770094|NCT02884089|157005721|FG002|Washout Period 3|Withdrawal by Subject|1|||
48770095|NCT02884089|157005722|FG003|Washout Period 3|Withdrawal by Subject|0|||
48770096|NCT02884089|157005719|FG000|Washout Period 3|Lost to Follow-up|0|||
48770097|NCT02884089|157005720|FG001|Washout Period 3|Lost to Follow-up|0|||
48770098|NCT02884089|157005721|FG002|Washout Period 3|Lost to Follow-up|0|||
48770099|NCT02884089|157005722|FG003|Washout Period 3|Lost to Follow-up|1|||
48770100|NCT02884089|157005719|FG000|Period 4|Withdrawal by Subject|0|||
48770101|NCT02884089|157005720|FG001|Period 4|Withdrawal by Subject|1|||
48770102|NCT02884089|157005721|FG002|Period 4|Withdrawal by Subject|0|||
48770103|NCT02884089|157005722|FG003|Period 4|Withdrawal by Subject|0|||
48770104|NCT02884089|157005719|FG000|Period 4|Lost to Follow-up|1|||
48770105|NCT02884089|157005720|FG001|Period 4|Lost to Follow-up|0|||
48770106|NCT02884089|157005721|FG002|Period 4|Lost to Follow-up|0|||
48770107|NCT02884089|157005722|FG003|Period 4|Lost to Follow-up|0|||
48770108|NCT02884089|157005719|FG000|Follow-up Visit|Withdrawal by Subject|1|||
48770109|NCT02884089|157005720|FG001|Follow-up Visit|Withdrawal by Subject|0|||
48770110|NCT02884089|157005721|FG002|Follow-up Visit|Withdrawal by Subject|0|||
48770111|NCT02884089|157005722|FG003|Follow-up Visit|Withdrawal by Subject|1|||
48770112|NCT02624284|157005723|FG000|Overall Study|Withdrawal by Subject|3|||
48770113|NCT02624284|157005724|FG001|Overall Study|Withdrawal by Subject|6|||
48770114|NCT02624284|157005725|FG002|Overall Study|Withdrawal by Subject|3|||
48770115|NCT02624284|157005723|FG000|Overall Study|Protocol Violation|9|||
48770116|NCT02624284|157005724|FG001|Overall Study|Protocol Violation|10|||
48770117|NCT02624284|157005725|FG002|Overall Study|Protocol Violation|7|||
49026443|NCT02914600|157935929|FG000|Overall Study|Adverse Event|298|||
49026444|NCT02914600|157935930|FG001|Overall Study|Adverse Event|35|||
49026445|NCT02914600|157935931|FG002|Overall Study|Adverse Event|25|||
49026446|NCT02914600|157935929|FG000|Overall Study|Sponsors decision|287|||
49026447|NCT02914600|157935930|FG001|Overall Study|Sponsors decision|41|||
49026448|NCT02914600|157935931|FG002|Overall Study|Sponsors decision|12|||
49026449|NCT02914600|157935929|FG000|Overall Study|Withdrawal by Subject|158|||
49026450|NCT02914600|157935930|FG001|Overall Study|Withdrawal by Subject|20|||
49026451|NCT02914600|157935931|FG002|Overall Study|Withdrawal by Subject|18|||
49026452|NCT02914600|157935929|FG000|Overall Study|Investigators discretion|169|||
49026453|NCT02914600|157935930|FG001|Overall Study|Investigators discretion|14|||
49026454|NCT02914600|157935931|FG002|Overall Study|Investigators discretion|13|||
49026455|NCT02914600|157935929|FG000|Overall Study|Lost to Follow-up|10|||
49026456|NCT02914600|157935930|FG001|Overall Study|Lost to Follow-up|4|||
49026457|NCT02914600|157935931|FG002|Overall Study|Lost to Follow-up|0|||
49026458|NCT02914600|157935929|FG000|Overall Study|Pregnancy|8|||
49026459|NCT02914600|157935930|FG001|Overall Study|Pregnancy|0|||
49026460|NCT02914600|157935931|FG002|Overall Study|Pregnancy|0|||
49026461|NCT02914600|157935929|FG000|Overall Study|Protocol Violation|5|||
49026462|NCT02914600|157935930|FG001|Overall Study|Protocol Violation|3|||
48770118|NCT02624284|157005723|FG000|Overall Study|Revealed exclusionary condition|2|||
49026463|NCT02914600|157935931|FG002|Overall Study|Protocol Violation|0|||
49026464|NCT02914600|157935929|FG000|Overall Study|Non-compliance with study drug|6|||
48770119|NCT02624284|157005724|FG001|Overall Study|Revealed exclusionary condition|2|||
48770120|NCT02624284|157005725|FG002|Overall Study|Revealed exclusionary condition|0|||
48770121|NCT02624284|157005723|FG000|Overall Study|Adverse Event|0|||
48770122|NCT02624284|157005724|FG001|Overall Study|Adverse Event|0|||
48770123|NCT02624284|157005725|FG002|Overall Study|Adverse Event|1|||
48770124|NCT00418691|157005727|FG000|Overall Study|Lost to Follow-up|1|||
48770125|NCT00418691|157005728|FG001|Overall Study|Lost to Follow-up|2|||
48770126|NCT00418691|157005729|FG002|Overall Study|Lost to Follow-up|3|||
48770127|NCT00418691|157005727|FG000|Overall Study|Started new medication voiding entry|0|||
48770128|NCT00418691|157005728|FG001|Overall Study|Started new medication voiding entry|0|||
48770129|NCT00418691|157005729|FG002|Overall Study|Started new medication voiding entry|1|||
48770130|NCT00418691|157005727|FG000|Overall Study|Progressive Disease|1|||
48770131|NCT00418691|157005728|FG001|Overall Study|Progressive Disease|0|||
48770132|NCT00418691|157005729|FG002|Overall Study|Progressive Disease|1|||
48770133|NCT00519649|157005734|FG000|Overall Study|Withdrawal by Subject|1|||
48770134|NCT01067352|157005739|FG000|Overall Study|Withdrawal by Subject|1|||
48770135|NCT01067352|157005740|FG001|Overall Study|Withdrawal by Subject|2|||
48770136|NCT01067352|157005741|FG002|Overall Study|Withdrawal by Subject|1|||
48770137|NCT01067352|157005739|FG000|Overall Study|Physician Decision|0|||
48770138|NCT01067352|157005740|FG001|Overall Study|Physician Decision|1|||
48770139|NCT01067352|157005741|FG002|Overall Study|Physician Decision|0|||
48770140|NCT00723606|157005743|FG000|Overall Study|Adverse Event|2|||
48770141|NCT00723606|157005744|FG001|Overall Study|Adverse Event|5|||
48770142|NCT00723606|157005743|FG000|Overall Study|Other|2|||
48770143|NCT00723606|157005744|FG001|Overall Study|Other|0|||
48770144|NCT00723606|157005743|FG000|Overall Study|Withdrawal by Subject|0|||
48770145|NCT00723606|157005744|FG001|Overall Study|Withdrawal by Subject|2|||
48770146|NCT00735371|157005751|FG000|Overall Study|Adverse Event|3|||
48770147|NCT00735371|157005752|FG001|Overall Study|Adverse Event|3|||
48770148|NCT00735371|157005753|FG002|Overall Study|Adverse Event|4|||
48770149|NCT00735371|157005754|FG003|Overall Study|Adverse Event|1|||
48770150|NCT00735371|157005751|FG000|Overall Study|Protocol Violation|2|||
48770151|NCT00735371|157005752|FG001|Overall Study|Protocol Violation|2|||
48770152|NCT00735371|157005753|FG002|Overall Study|Protocol Violation|0|||
48770153|NCT00735371|157005754|FG003|Overall Study|Protocol Violation|3|||
48770154|NCT00735371|157005751|FG000|Overall Study|Withdrawal by Subject|0|||
48770155|NCT00735371|157005752|FG001|Overall Study|Withdrawal by Subject|2|||
49026465|NCT02914600|157935930|FG001|Overall Study|Non-compliance with study drug|1|||
49026466|NCT02914600|157935931|FG002|Overall Study|Non-compliance with study drug|0|||
49026467|NCT02914600|157935929|FG000|Overall Study|Death|3|||
49026468|NCT02914600|157935930|FG001|Overall Study|Death|1|||
49026469|NCT02914600|157935931|FG002|Overall Study|Death|1|||
48770156|NCT00735371|157005753|FG002|Overall Study|Withdrawal by Subject|2|||
48770157|NCT00735371|157005754|FG003|Overall Study|Withdrawal by Subject|0|||
48770158|NCT00735371|157005751|FG000|Overall Study|Lost to Follow-up|1|||
48770159|NCT00735371|157005752|FG001|Overall Study|Lost to Follow-up|1|||
48770160|NCT00735371|157005753|FG002|Overall Study|Lost to Follow-up|3|||
48770161|NCT00735371|157005754|FG003|Overall Study|Lost to Follow-up|1|||
48770162|NCT00735371|157005751|FG000|Overall Study|Lack of Efficacy|4|||
48770163|NCT00735371|157005752|FG001|Overall Study|Lack of Efficacy|2|||
48770164|NCT00735371|157005753|FG002|Overall Study|Lack of Efficacy|0|||
48770165|NCT00735371|157005754|FG003|Overall Study|Lack of Efficacy|4|||
48770166|NCT00735371|157005751|FG000|Overall Study|Sponsor Decision|3|||
48770167|NCT00735371|157005752|FG001|Overall Study|Sponsor Decision|1|||
48770168|NCT00735371|157005753|FG002|Overall Study|Sponsor Decision|0|||
48770169|NCT00735371|157005754|FG003|Overall Study|Sponsor Decision|1|||
48770170|NCT00735371|157005751|FG000|Overall Study|Protocol Violation|0|||
48770171|NCT00735371|157005752|FG001|Overall Study|Protocol Violation|1|||
48770172|NCT00735371|157005753|FG002|Overall Study|Protocol Violation|2|||
48770173|NCT00735371|157005754|FG003|Overall Study|Protocol Violation|0|||
48770174|NCT00735371|157005751|FG000|Overall Study|Prior Vyvanse Exposure|1|||
48770175|NCT00735371|157005752|FG001|Overall Study|Prior Vyvanse Exposure|1|||
48770176|NCT00735371|157005753|FG002|Overall Study|Prior Vyvanse Exposure|0|||
48770177|NCT00735371|157005754|FG003|Overall Study|Prior Vyvanse Exposure|0|||
48770178|NCT00735371|157005751|FG000|Overall Study|Exclusion criteria|1|||
48770179|NCT00735371|157005752|FG001|Overall Study|Exclusion criteria|0|||
48770180|NCT00735371|157005753|FG002|Overall Study|Exclusion criteria|0|||
48770181|NCT00735371|157005754|FG003|Overall Study|Exclusion criteria|0|||
48770182|NCT00436748|157005757|FG000|Overall Study|Ineligibility Determined|1|||
48770183|NCT00436748|157005758|FG001|Overall Study|Ineligibility Determined|1|||
48770184|NCT00436748|157005757|FG000|Overall Study|Adverse Event|0|||
48770185|NCT00436748|157005758|FG001|Overall Study|Adverse Event|2|||
48770186|NCT00436748|157005757|FG000|Overall Study|Consent Withdrawn|1|||
48770187|NCT00436748|157005758|FG001|Overall Study|Consent Withdrawn|4|||
48770188|NCT00436748|157005757|FG000|Overall Study|Administrative Decision|1|||
48770189|NCT00436748|157005758|FG001|Overall Study|Administrative Decision|0|||
48770190|NCT00436748|157005757|FG000|Overall Study|Lost to Follow-up|0|||
48770191|NCT00436748|157005758|FG001|Overall Study|Lost to Follow-up|1|||
48770192|NCT00436748|157005757|FG000|Overall Study|Protocol-specified Criteria|5|||
48770193|NCT00436748|157005758|FG001|Overall Study|Protocol-specified Criteria|4|||
48770194|NCT00436748|157005757|FG000|Overall Study|Other|3|||
48770195|NCT00436748|157005758|FG001|Overall Study|Other|0|||
48770196|NCT01610791|157005759|FG000|Overall Study|Lost to Follow-up|7|||
48770197|NCT01610791|157005759|FG000|Overall Study|Adverse Event|6|||
48770198|NCT01610791|157005759|FG000|Overall Study|Physician Decision|1|||
48770199|NCT01610791|157005759|FG000|Overall Study|Adverse event and Investigator decision|1|||
48770200|NCT01610791|157005759|FG000|Overall Study|Death|1|||
48770201|NCT01610791|157005759|FG000|Overall Study|Not determined|5|||
48770202|NCT00482391|157005760|FG000|Overall Study|Withdrawal by Subject|1|||
48770203|NCT00482391|157005760|FG000|Overall Study|Adverse Event|1|||
48770204|NCT00482391|157005760|FG000|Overall Study|Death|1|||
48770205|NCT02711800|157005761|FG000|Overall Study|Lost to Follow-up|1|||
48770206|NCT02711800|157005761|FG000|Overall Study|Withdrawal by Subject|1|||
48770207|NCT01428193|157005762|FG000|Overall Study|Physician Decision|1|||
48770208|NCT01428193|157005762|FG000|Overall Study|Elevated screening liver enzymes|1|||
48770209|NCT02871375|157005763|FG000|Period 1, First 14 Days of Wear|Inclusion criteria not met|0|||
48770210|NCT02871375|157005764|FG001|Period 1, First 14 Days of Wear|Inclusion criteria not met|1|||
48770211|NCT00004412|157005767|FG000|Randomized Period|Moved to Crossover Period|3|||
48770212|NCT00004412|157005768|FG001|Randomized Period|Moved to Crossover Period|0|||
48770213|NCT00004412|157005769|FG002|Randomized Period|Moved to Crossover Period|0|||
48982140|NCT02712008|157767524|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2|||
48982141|NCT02712008|157767525|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
48982142|NCT02712008|157767526|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
48982143|NCT02712008|157767527|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
48982144|NCT02712008|157767528|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
48982145|NCT02712008|157767529|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
48982146|NCT02712008|157767530|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
48982147|NCT02712008|157767523|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
48982148|NCT02712008|157767524|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
48982149|NCT02712008|157767525|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|2|||
48982150|NCT02712008|157767526|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
48770214|NCT00727714|157005774|FG000|Overall Study|Lost to Follow-up|2|||
48770215|NCT02346136|157005776|FG000|Overall Study|Withdrawal by Subject|7|||
48770216|NCT02346136|157005777|FG001|Overall Study|Withdrawal by Subject|5|||
48770217|NCT02346136|157005776|FG000|Overall Study|Death|1|||
48770218|NCT02346136|157005777|FG001|Overall Study|Death|0|||
48770219|NCT02346136|157005776|FG000|Overall Study|Study termination|14|||
48770220|NCT02346136|157005777|FG001|Overall Study|Study termination|18|||
48770221|NCT02075320|157005780|FG000|Overall Study|Withdrawal by Subject|2|||
48770222|NCT00855309|157005784|FG000|Overall Study|patient never recieved drug|1|||
48770223|NCT00855309|157005785|FG001|Overall Study|patient never recieved drug|0|||
48770224|NCT01987427|157005790|FG000|Overall Study|Adverse Event|4|||
48770225|NCT01987427|157005791|FG001|Overall Study|Adverse Event|2|||
48770226|NCT01987427|157005792|FG002|Overall Study|Adverse Event|8|||
48770227|NCT01987427|157005790|FG000|Overall Study|Lost to Follow-up|6|||
48770228|NCT01987427|157005791|FG001|Overall Study|Lost to Follow-up|6|||
48770229|NCT01987427|157005792|FG002|Overall Study|Lost to Follow-up|9|||
48770230|NCT01987427|157005790|FG000|Overall Study|Withdrawal by Subject|2|||
48770231|NCT01987427|157005791|FG001|Overall Study|Withdrawal by Subject|1|||
48770232|NCT01987427|157005792|FG002|Overall Study|Withdrawal by Subject|3|||
48770233|NCT01987427|157005790|FG000|Overall Study|Lack of Efficacy|1|||
48770234|NCT01987427|157005791|FG001|Overall Study|Lack of Efficacy|0|||
48770235|NCT01987427|157005792|FG002|Overall Study|Lack of Efficacy|0|||
48770236|NCT01987427|157005790|FG000|Overall Study|Other|1|||
48770237|NCT01987427|157005791|FG001|Overall Study|Other|1|||
48770238|NCT01987427|157005792|FG002|Overall Study|Other|0|||
48770239|NCT01857063|157005794|FG000|Period 1 (7 Days)|Adverse Event|0|||
48770240|NCT01857063|157005795|FG001|Period 1 (7 Days)|Adverse Event|1|||
48770241|NCT01857063|157005794|FG000|Period 1 (7 Days)|Physician Decision|1|||
48770242|NCT01857063|157005795|FG001|Period 1 (7 Days)|Physician Decision|0|||
48770243|NCT01857063|157005794|FG000|Period 1 (7 Days)|Withdrawal by Subject|1|||
49026470|NCT02914600|157935929|FG000|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
49026471|NCT02914600|157935930|FG001|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
49026472|NCT02914600|157935931|FG002|Overall Study|Current Study Unblinded and participant confirmed on Placebo|55|||
49026473|NCT02914600|157935929|FG000|Overall Study|Enrolled but not treated|1|||
49026474|NCT02914600|157935930|FG001|Overall Study|Enrolled but not treated|0|||
48770244|NCT01857063|157005795|FG001|Period 1 (7 Days)|Withdrawal by Subject|3|||
48770245|NCT01857063|157005794|FG000|Period 2 (7 Days)|Adverse Event|2|||
48770246|NCT01857063|157005795|FG001|Period 2 (7 Days)|Adverse Event|1|||
48770247|NCT01857063|157005794|FG000|Period 2 (7 Days)|Physician Decision|1|||
48770248|NCT01857063|157005795|FG001|Period 2 (7 Days)|Physician Decision|1|||
48770249|NCT01857063|157005794|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
48770250|NCT01857063|157005795|FG001|Period 2 (7 Days)|Withdrawal by Subject|0|||
48770251|NCT01192152|157005796|FG000|Period 1|left prematurely (while on treatment B)|0|||
48770252|NCT01192152|157005797|FG001|Period 1|left prematurely (while on treatment B)|1|||
48770253|NCT01192152|157005796|FG000|Period 3|family emergency|1|||
48770254|NCT01192152|157005797|FG001|Period 3|family emergency|0|||
48770255|NCT02375672|157005798|FG000|Overall Study|remain on follow up|20|||
48770256|NCT02346240|157005803|FG000|Initial Period (Baseline to Week 16)|Adverse Event|0|||
48770257|NCT02346240|157005804|FG001|Initial Period (Baseline to Week 16)|Adverse Event|4|||
48770258|NCT02346240|157005805|FG002|Initial Period (Baseline to Week 16)|Adverse Event|1|||
48770259|NCT02346240|157005806|FG003|Initial Period (Baseline to Week 16)|Adverse Event|1|||
48770260|NCT02346240|157005807|FG004|Initial Period (Baseline to Week 16)|Adverse Event|0|||
48770261|NCT02346240|157005808|FG005|Initial Period (Baseline to Week 16)|Adverse Event|0|||
48770262|NCT02346240|157005809|FG006|Initial Period (Baseline to Week 16)|Adverse Event|0|||
48770263|NCT02346240|157005810|FG007|Initial Period (Baseline to Week 16)|Adverse Event|0|||
48770264|NCT02346240|157005811|FG008|Initial Period (Baseline to Week 16)|Adverse Event|0|||
48770265|NCT02346240|157005812|FG009|Initial Period (Baseline to Week 16)|Adverse Event|0|||
48770266|NCT02346240|157005813|FG010|Initial Period (Baseline to Week 16)|Adverse Event|0|||
48770267|NCT02346240|157005814|FG011|Initial Period (Baseline to Week 16)|Adverse Event|0|||
48770268|NCT02346240|157005815|FG012|Initial Period (Baseline to Week 16)|Adverse Event|0|||
48770269|NCT02346240|157005816|FG013|Initial Period (Baseline to Week 16)|Adverse Event|0|||
48770270|NCT02346240|157005817|FG014|Initial Period (Baseline to Week 16)|Adverse Event|0|||
48770271|NCT02346240|157005818|FG015|Initial Period (Baseline to Week 16)|Adverse Event|0|||
48770272|NCT02346240|157005819|FG016|Initial Period (Baseline to Week 16)|Adverse Event|0|||
48770273|NCT02346240|157005820|FG017|Initial Period (Baseline to Week 16)|Adverse Event|0|||
48770274|NCT02346240|157005821|FG018|Initial Period (Baseline to Week 16)|Adverse Event|0|||
48770275|NCT02346240|157005822|FG019|Initial Period (Baseline to Week 16)|Adverse Event|0|||
48770276|NCT02346240|157005823|FG020|Initial Period (Baseline to Week 16)|Adverse Event|0|||
48770277|NCT02346240|157005824|FG021|Initial Period (Baseline to Week 16)|Adverse Event|0|||
48770278|NCT02346240|157005825|FG022|Initial Period (Baseline to Week 16)|Adverse Event|0|||
48770279|NCT02346240|157005826|FG023|Initial Period (Baseline to Week 16)|Adverse Event|0|||
48770280|NCT02346240|157005803|FG000|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
48770281|NCT02346240|157005804|FG001|Initial Period (Baseline to Week 16)|Lack of Efficacy|1|||
48770282|NCT02346240|157005805|FG002|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
48770283|NCT02346240|157005806|FG003|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
48770284|NCT02346240|157005807|FG004|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
48770285|NCT02346240|157005808|FG005|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
48770286|NCT02346240|157005809|FG006|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
48770287|NCT02346240|157005810|FG007|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
48770288|NCT02346240|157005811|FG008|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
48770289|NCT02346240|157005812|FG009|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
48770290|NCT02346240|157005813|FG010|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
48770291|NCT02346240|157005814|FG011|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
48770292|NCT02346240|157005815|FG012|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
48770293|NCT02346240|157005816|FG013|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
48770294|NCT02346240|157005817|FG014|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
48770295|NCT02346240|157005818|FG015|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
48770296|NCT02346240|157005819|FG016|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
48770297|NCT02346240|157005820|FG017|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
48770298|NCT02346240|157005821|FG018|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
48770299|NCT02346240|157005822|FG019|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
48770300|NCT02346240|157005823|FG020|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
48770301|NCT02346240|157005824|FG021|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
48770302|NCT02346240|157005825|FG022|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
48770303|NCT02346240|157005826|FG023|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
48770304|NCT02346240|157005803|FG000|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
48770305|NCT02346240|157005804|FG001|Initial Period (Baseline to Week 16)|Protocol Violation|1|||
48770306|NCT02346240|157005805|FG002|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
48770307|NCT02346240|157005806|FG003|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
48770308|NCT02346240|157005807|FG004|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
48770309|NCT02346240|157005808|FG005|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
48770310|NCT02346240|157005809|FG006|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
48770311|NCT02346240|157005810|FG007|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
48770312|NCT02346240|157005811|FG008|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
48770313|NCT02346240|157005812|FG009|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
48770314|NCT02346240|157005813|FG010|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
48770315|NCT02346240|157005814|FG011|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
48770316|NCT02346240|157005815|FG012|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
48770317|NCT02346240|157005816|FG013|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
48770318|NCT02346240|157005817|FG014|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
48770319|NCT02346240|157005818|FG015|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
48770320|NCT02346240|157005819|FG016|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
48770321|NCT02346240|157005820|FG017|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
48770322|NCT02346240|157005821|FG018|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
48770323|NCT02346240|157005822|FG019|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
48770324|NCT02346240|157005823|FG020|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
48770325|NCT02346240|157005824|FG021|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
48770326|NCT02346240|157005825|FG022|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
48770327|NCT02346240|157005826|FG023|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
48770328|NCT02346240|157005803|FG000|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
48770329|NCT02346240|157005804|FG001|Initial Period (Baseline to Week 16)|Lost to Follow-up|2|||
48770330|NCT02346240|157005805|FG002|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
48770331|NCT02346240|157005806|FG003|Initial Period (Baseline to Week 16)|Lost to Follow-up|3|||
48770332|NCT02346240|157005807|FG004|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
48770333|NCT02346240|157005808|FG005|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
48770334|NCT02346240|157005809|FG006|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
48770335|NCT02346240|157005810|FG007|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
48770336|NCT02346240|157005811|FG008|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
48770337|NCT02346240|157005812|FG009|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
48770338|NCT02346240|157005813|FG010|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
48770339|NCT02346240|157005814|FG011|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
48770340|NCT02346240|157005815|FG012|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
48770341|NCT02346240|157005816|FG013|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
48770342|NCT02346240|157005817|FG014|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
48770343|NCT02346240|157005818|FG015|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
49026475|NCT02914600|157935931|FG002|Overall Study|Enrolled but not treated|0|||
49026476|NCT00454909|157935932|FG000|Overall Study|Withdrawal by Subject|1|||
49026477|NCT00454909|157935933|FG001|Overall Study|Withdrawal by Subject|0|||
49026478|NCT00454909|157935934|FG002|Overall Study|Withdrawal by Subject|0|||
49026479|NCT00454909|157935932|FG000|Overall Study|Migrated/moved from study area|0|||
49026480|NCT00454909|157935933|FG001|Overall Study|Migrated/moved from study area|0|||
48770344|NCT02346240|157005819|FG016|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
48770345|NCT02346240|157005820|FG017|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
48770346|NCT02346240|157005821|FG018|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
49026481|NCT00454909|157935934|FG002|Overall Study|Migrated/moved from study area|1|||
49026482|NCT00454909|157935932|FG000|Overall Study|Lost to follow-up (complete vaccination)|5|||
49026483|NCT00454909|157935933|FG001|Overall Study|Lost to follow-up (complete vaccination)|3|||
49026484|NCT00454909|157935934|FG002|Overall Study|Lost to follow-up (complete vaccination)|1|||
49026485|NCT00454909|157935932|FG000|Overall Study|Others|1|||
49026486|NCT00454909|157935933|FG001|Overall Study|Others|0|||
49026487|NCT00454909|157935934|FG002|Overall Study|Others|0|||
49026488|NCT03912337|157935935|FG000|Overall Study|Withdrawal of Consent From Study|1|||
49026489|NCT03912337|157935936|FG001|Overall Study|Withdrawal of Consent From Study|0|||
49026490|NCT03912337|157935935|FG000|Overall Study|Lost to Follow-up|1|||
49026491|NCT03912337|157935936|FG001|Overall Study|Lost to Follow-up|1|||
49026492|NCT03752528|157935937|FG000|Part A|Lost to Follow-up|1|||
49026493|NCT03752528|157935937|FG000|Part A|Protocol Violation|1|||
49026494|NCT03752528|157935937|FG000|Part B|Protocol Violation|1|||
49026495|NCT03752528|157935937|FG000|Part B|Study terminated by sponsor|3|||
49026496|NCT02465268|157935938|FG000|Overall Study|Withdrawal by Subject|4|||
49026497|NCT02465268|157935939|FG001|Overall Study|Withdrawal by Subject|3|||
49026498|NCT02465268|157935940|FG002|Overall Study|Withdrawal by Subject|1|||
49026499|NCT02465268|157935938|FG000|Overall Study|Not evaluable per protocol criteria|3|||
49026500|NCT02465268|157935939|FG001|Overall Study|Not evaluable per protocol criteria|2|||
49026501|NCT02465268|157935940|FG002|Overall Study|Not evaluable per protocol criteria|1|||
49026502|NCT02465268|157935938|FG000|Overall Study|did not meet eligibility prior to Cycle #1|8|||
49026503|NCT02465268|157935939|FG001|Overall Study|did not meet eligibility prior to Cycle #1|9|||
48770347|NCT02346240|157005822|FG019|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
48770348|NCT02346240|157005823|FG020|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
48770349|NCT02346240|157005824|FG021|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
48770350|NCT02346240|157005825|FG022|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
48770351|NCT02346240|157005826|FG023|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
48770352|NCT02346240|157005803|FG000|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1|||
48770353|NCT02346240|157005804|FG001|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
48770354|NCT02346240|157005805|FG002|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3|||
48770355|NCT02346240|157005806|FG003|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
48770356|NCT02346240|157005807|FG004|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
48770357|NCT02346240|157005808|FG005|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
48770358|NCT02346240|157005809|FG006|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
48770359|NCT02346240|157005810|FG007|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
48770360|NCT02346240|157005811|FG008|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
48770361|NCT02346240|157005812|FG009|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
48770362|NCT02346240|157005813|FG010|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
48770363|NCT02346240|157005814|FG011|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
48770364|NCT02346240|157005815|FG012|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
48770365|NCT02346240|157005816|FG013|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
48770366|NCT02346240|157005817|FG014|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
48770367|NCT02346240|157005818|FG015|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
48770368|NCT02346240|157005819|FG016|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
48770369|NCT02346240|157005820|FG017|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
48770370|NCT02346240|157005821|FG018|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
48770371|NCT02346240|157005822|FG019|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
48770372|NCT02346240|157005823|FG020|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
48770373|NCT02346240|157005824|FG021|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
48770374|NCT02346240|157005825|FG022|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
48770375|NCT02346240|157005826|FG023|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
48770376|NCT02346240|157005803|FG000|Initial Period (Baseline to Week 16)|Non-compliance|0|||
48770377|NCT02346240|157005804|FG001|Initial Period (Baseline to Week 16)|Non-compliance|1|||
48770378|NCT02346240|157005805|FG002|Initial Period (Baseline to Week 16)|Non-compliance|0|||
48770379|NCT02346240|157005806|FG003|Initial Period (Baseline to Week 16)|Non-compliance|1|||
48770380|NCT02346240|157005807|FG004|Initial Period (Baseline to Week 16)|Non-compliance|0|||
48770381|NCT02346240|157005808|FG005|Initial Period (Baseline to Week 16)|Non-compliance|0|||
48770382|NCT02346240|157005809|FG006|Initial Period (Baseline to Week 16)|Non-compliance|0|||
48770383|NCT02346240|157005810|FG007|Initial Period (Baseline to Week 16)|Non-compliance|0|||
48770384|NCT02346240|157005811|FG008|Initial Period (Baseline to Week 16)|Non-compliance|0|||
48770385|NCT02346240|157005812|FG009|Initial Period (Baseline to Week 16)|Non-compliance|0|||
48770386|NCT02346240|157005813|FG010|Initial Period (Baseline to Week 16)|Non-compliance|0|||
48770387|NCT02346240|157005814|FG011|Initial Period (Baseline to Week 16)|Non-compliance|0|||
49026504|NCT02465268|157935940|FG002|Overall Study|did not meet eligibility prior to Cycle #1|9|||
49026505|NCT02465268|157935938|FG000|Overall Study|Study drug did not pass QA/QC|1|||
48770388|NCT02346240|157005815|FG012|Initial Period (Baseline to Week 16)|Non-compliance|0|||
49026506|NCT02465268|157935939|FG001|Overall Study|Study drug did not pass QA/QC|0|||
48770389|NCT02346240|157005816|FG013|Initial Period (Baseline to Week 16)|Non-compliance|0|||
48770390|NCT02346240|157005817|FG014|Initial Period (Baseline to Week 16)|Non-compliance|0|||
48770391|NCT02346240|157005818|FG015|Initial Period (Baseline to Week 16)|Non-compliance|0|||
48770392|NCT02346240|157005819|FG016|Initial Period (Baseline to Week 16)|Non-compliance|0|||
48770393|NCT02346240|157005820|FG017|Initial Period (Baseline to Week 16)|Non-compliance|0|||
48770394|NCT02346240|157005821|FG018|Initial Period (Baseline to Week 16)|Non-compliance|0|||
48770395|NCT02346240|157005822|FG019|Initial Period (Baseline to Week 16)|Non-compliance|0|||
48770396|NCT02346240|157005823|FG020|Initial Period (Baseline to Week 16)|Non-compliance|0|||
48770397|NCT02346240|157005824|FG021|Initial Period (Baseline to Week 16)|Non-compliance|0|||
48770398|NCT02346240|157005825|FG022|Initial Period (Baseline to Week 16)|Non-compliance|0|||
48770399|NCT02346240|157005826|FG023|Initial Period (Baseline to Week 16)|Non-compliance|0|||
48770400|NCT02346240|157005803|FG000|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
48770401|NCT02346240|157005804|FG001|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
48770402|NCT02346240|157005805|FG002|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1|||
48770403|NCT02346240|157005806|FG003|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
48770404|NCT02346240|157005807|FG004|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
48770405|NCT02346240|157005808|FG005|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
48770406|NCT02346240|157005809|FG006|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
48770407|NCT02346240|157005810|FG007|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
48770408|NCT02346240|157005811|FG008|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
48770409|NCT02346240|157005812|FG009|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
48770410|NCT02346240|157005813|FG010|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
48770411|NCT02346240|157005814|FG011|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
48770412|NCT02346240|157005815|FG012|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
48770413|NCT02346240|157005816|FG013|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
48770414|NCT02346240|157005817|FG014|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
48770415|NCT02346240|157005818|FG015|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
48770416|NCT02346240|157005819|FG016|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
48770417|NCT02346240|157005820|FG017|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
48770418|NCT02346240|157005821|FG018|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
48770419|NCT02346240|157005822|FG019|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
48770420|NCT02346240|157005823|FG020|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
48770421|NCT02346240|157005824|FG021|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
48770422|NCT02346240|157005825|FG022|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
48770423|NCT02346240|157005826|FG023|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
48770424|NCT02346240|157005803|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48770425|NCT02346240|157005804|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48770426|NCT02346240|157005805|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48770427|NCT02346240|157005806|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48770428|NCT02346240|157005807|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48770429|NCT02346240|157005808|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48770430|NCT02346240|157005809|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48770431|NCT02346240|157005810|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
48770432|NCT02346240|157005811|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
48770433|NCT02346240|157005812|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48770434|NCT02346240|157005813|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48770435|NCT02346240|157005814|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48770436|NCT02346240|157005815|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48770437|NCT02346240|157005816|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
48770438|NCT02346240|157005817|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
48770439|NCT02346240|157005818|FG015|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
48770440|NCT02346240|157005819|FG016|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
48770441|NCT02346240|157005820|FG017|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48770442|NCT02346240|157005821|FG018|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48770443|NCT02346240|157005822|FG019|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48770444|NCT02346240|157005823|FG020|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48770445|NCT02346240|157005824|FG021|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48770446|NCT02346240|157005825|FG022|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48770447|NCT02346240|157005826|FG023|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48770448|NCT02346240|157005803|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
48770449|NCT02346240|157005804|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
48770450|NCT02346240|157005805|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
49026507|NCT02465268|157935940|FG002|Overall Study|Study drug did not pass QA/QC|0|||
48770451|NCT02346240|157005806|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
48770452|NCT02346240|157005807|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
48770453|NCT02346240|157005808|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
48770454|NCT02346240|157005809|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
48770455|NCT02346240|157005810|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
48770456|NCT02346240|157005811|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
48770457|NCT02346240|157005812|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
48770458|NCT02346240|157005813|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
48770459|NCT02346240|157005814|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
48770460|NCT02346240|157005815|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
48770461|NCT02346240|157005816|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
48770462|NCT02346240|157005817|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
48770463|NCT02346240|157005818|FG015|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3|||
48770464|NCT02346240|157005819|FG016|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
48770465|NCT02346240|157005820|FG017|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
48770466|NCT02346240|157005821|FG018|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
48770467|NCT02346240|157005822|FG019|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
48770468|NCT02346240|157005823|FG020|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
48770469|NCT02346240|157005824|FG021|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
48770470|NCT02346240|157005825|FG022|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
48770471|NCT02346240|157005826|FG023|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
48770472|NCT02346240|157005803|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48770473|NCT02346240|157005804|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48770474|NCT02346240|157005805|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48770475|NCT02346240|157005806|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48770476|NCT02346240|157005807|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48770477|NCT02346240|157005808|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48770478|NCT02346240|157005809|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48770479|NCT02346240|157005810|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
49026508|NCT02465268|157935938|FG000|Overall Study|Adverse Event|0|||
49026509|NCT02465268|157935939|FG001|Overall Study|Adverse Event|1|||
48770480|NCT02346240|157005811|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48770481|NCT02346240|157005812|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48770482|NCT02346240|157005813|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48770483|NCT02346240|157005814|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48770484|NCT02346240|157005815|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48770485|NCT02346240|157005816|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48770486|NCT02346240|157005817|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
48770487|NCT02346240|157005818|FG015|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48770488|NCT02346240|157005819|FG016|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48770489|NCT02346240|157005820|FG017|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48770490|NCT02346240|157005821|FG018|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48770491|NCT02346240|157005822|FG019|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
49026510|NCT02465268|157935940|FG002|Overall Study|Adverse Event|0|||
48770492|NCT02346240|157005823|FG020|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48770493|NCT02346240|157005824|FG021|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48770494|NCT02346240|157005825|FG022|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48770495|NCT02346240|157005826|FG023|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48770496|NCT02346240|157005803|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
48770497|NCT02346240|157005804|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
48770498|NCT02346240|157005805|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
48770499|NCT02346240|157005806|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
48770500|NCT02346240|157005807|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
49026511|NCT02465268|157935938|FG000|Overall Study|Physician Decision|0|||
49026512|NCT02465268|157935939|FG001|Overall Study|Physician Decision|1|||
49026513|NCT02465268|157935940|FG002|Overall Study|Physician Decision|0|||
49026514|NCT04320849|157935943|FG000|Overall Study|Withdrawal by Subject|4|||
49026515|NCT04320849|157935943|FG000|Overall Study|Imaging data unavailable|2|||
49026516|NCT04320849|157935943|FG000|Overall Study|Incomplete imaging|2|||
49026517|NCT03100149|157935944|FG000|Overall Study|Adverse Event|0|||
49026518|NCT03100149|157935945|FG001|Overall Study|Adverse Event|1|||
48770501|NCT02346240|157005808|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
48770502|NCT02346240|157005809|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
48797695|NCT00828984|157097048|FG002|Overall Study|ConMed|1|||
48797696|NCT01733732|157097049|FG000|Overall Study|Adverse Event|1|||
48797697|NCT01733732|157097050|FG001|Overall Study|Adverse Event|0|||
48797698|NCT01733732|157097049|FG000|Overall Study|Did not attend all study visits|1|||
49026519|NCT03100149|157935946|FG002|Overall Study|Adverse Event|0|||
49026520|NCT03100149|157935944|FG000|Overall Study|Participant Moved out of Country|0|||
48770503|NCT02346240|157005810|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
48770504|NCT02346240|157005811|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
48770505|NCT02346240|157005812|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
48770506|NCT02346240|157005813|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
48770507|NCT02346240|157005814|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
48770508|NCT02346240|157005815|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
48770509|NCT02346240|157005816|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
48770510|NCT02346240|157005817|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5|||
48770511|NCT02346240|157005818|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
48770512|NCT02346240|157005819|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
48770513|NCT02346240|157005820|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
48770514|NCT02346240|157005821|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
48770515|NCT02346240|157005822|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
48770516|NCT02346240|157005823|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
48770517|NCT02346240|157005824|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
48770518|NCT02346240|157005825|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
48770519|NCT02346240|157005826|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
48770520|NCT02346240|157005803|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
48770521|NCT02346240|157005804|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
48770522|NCT02346240|157005805|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
48770523|NCT02346240|157005806|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
48770524|NCT02346240|157005807|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
48770525|NCT02346240|157005808|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
48770526|NCT02346240|157005809|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
48770527|NCT02346240|157005810|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
48770528|NCT02346240|157005811|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
48770529|NCT02346240|157005812|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
48770530|NCT02346240|157005813|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
48770531|NCT02346240|157005814|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
48770532|NCT02346240|157005815|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
48770533|NCT02346240|157005816|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
48770534|NCT02346240|157005817|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
48770535|NCT02346240|157005818|FG015|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8|||
48770536|NCT02346240|157005819|FG016|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4|||
48770537|NCT02346240|157005820|FG017|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
48770538|NCT02346240|157005821|FG018|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
48770539|NCT02346240|157005822|FG019|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
48770540|NCT02346240|157005823|FG020|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
48770541|NCT02346240|157005824|FG021|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
48770542|NCT02346240|157005825|FG022|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
48770543|NCT02346240|157005826|FG023|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
48770544|NCT02346240|157005803|FG000|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
48770545|NCT02346240|157005804|FG001|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
48770546|NCT02346240|157005805|FG002|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
48770547|NCT02346240|157005806|FG003|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
48770548|NCT02346240|157005807|FG004|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
48770549|NCT02346240|157005808|FG005|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
48770550|NCT02346240|157005809|FG006|Maintenance Period (Week 16 to Week 48)|Moved out of state|1|||
48770551|NCT02346240|157005810|FG007|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
48770552|NCT02346240|157005811|FG008|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
48770553|NCT02346240|157005812|FG009|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
48770554|NCT02346240|157005813|FG010|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
48770555|NCT02346240|157005814|FG011|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
49026521|NCT03100149|157935945|FG001|Overall Study|Participant Moved out of Country|0|||
49026522|NCT03100149|157935946|FG002|Overall Study|Participant Moved out of Country|1|||
49026523|NCT03100149|157935944|FG000|Overall Study|Withdrawal by Subject|0|||
49026524|NCT03100149|157935945|FG001|Overall Study|Withdrawal by Subject|3|||
49026525|NCT03100149|157935946|FG002|Overall Study|Withdrawal by Subject|1|||
49026526|NCT03018249|157935947|FG000|Overall Study|Withdrawal by Subject|2|||
49026527|NCT03018249|157935948|FG001|Overall Study|Withdrawal by Subject|2|||
49026528|NCT00939003|157935950|FG000|Double-blind Treatment Period|Adverse Event|1|||
49026529|NCT00939003|157935951|FG001|Double-blind Treatment Period|Adverse Event|1|||
49026530|NCT00939003|157935950|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
48770556|NCT02346240|157005815|FG012|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
48770557|NCT02346240|157005816|FG013|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
48770558|NCT02346240|157005817|FG014|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
48770559|NCT02346240|157005818|FG015|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
48770560|NCT02346240|157005819|FG016|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
48770561|NCT02346240|157005820|FG017|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
48770562|NCT02346240|157005821|FG018|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
48770563|NCT02346240|157005822|FG019|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
48770564|NCT02346240|157005823|FG020|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
48770565|NCT02346240|157005824|FG021|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
48770566|NCT02346240|157005825|FG022|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
48770567|NCT02346240|157005826|FG023|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
48770568|NCT02346240|157005803|FG000|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
48770569|NCT02346240|157005804|FG001|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
48770570|NCT02346240|157005805|FG002|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
48770571|NCT02346240|157005806|FG003|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
48770572|NCT02346240|157005807|FG004|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
48770573|NCT02346240|157005808|FG005|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
48770574|NCT02346240|157005809|FG006|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
48770575|NCT02346240|157005810|FG007|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
48770576|NCT02346240|157005811|FG008|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
48770577|NCT02346240|157005812|FG009|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
48770578|NCT02346240|157005813|FG010|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
48770579|NCT02346240|157005814|FG011|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
48770580|NCT02346240|157005815|FG012|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
48770581|NCT02346240|157005816|FG013|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
48770582|NCT02346240|157005817|FG014|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
48770583|NCT02346240|157005818|FG015|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
48770584|NCT02346240|157005819|FG016|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
48770585|NCT02346240|157005820|FG017|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
48770586|NCT02346240|157005821|FG018|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
48770587|NCT02346240|157005822|FG019|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
48770588|NCT02346240|157005823|FG020|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
48770589|NCT02346240|157005824|FG021|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
48770590|NCT02346240|157005825|FG022|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
48770591|NCT02346240|157005826|FG023|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
48770592|NCT02346240|157005803|FG000|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
48770593|NCT02346240|157005804|FG001|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
48770594|NCT02346240|157005805|FG002|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
48770595|NCT02346240|157005806|FG003|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
48770596|NCT02346240|157005807|FG004|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
48770597|NCT02346240|157005808|FG005|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
48770598|NCT02346240|157005809|FG006|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
48770599|NCT02346240|157005810|FG007|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
48770600|NCT02346240|157005811|FG008|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
48770601|NCT02346240|157005812|FG009|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1|||
48770602|NCT02346240|157005813|FG010|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
48770603|NCT02346240|157005814|FG011|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
48770604|NCT02346240|157005815|FG012|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
48770605|NCT02346240|157005816|FG013|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
48770606|NCT02346240|157005817|FG014|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
48770607|NCT02346240|157005818|FG015|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
48770608|NCT02346240|157005819|FG016|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
48770609|NCT02346240|157005820|FG017|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
48770610|NCT02346240|157005821|FG018|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
48876259|NCT03672175|157384624|FG002|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
48770611|NCT02346240|157005822|FG019|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
48770612|NCT02346240|157005823|FG020|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
48770613|NCT02346240|157005824|FG021|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
48770614|NCT02346240|157005825|FG022|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
48770615|NCT02346240|157005826|FG023|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
48770616|NCT02346240|157005803|FG000|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
48770617|NCT02346240|157005804|FG001|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
48770618|NCT02346240|157005805|FG002|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
48770619|NCT02346240|157005806|FG003|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
48770620|NCT02346240|157005807|FG004|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
48770621|NCT02346240|157005808|FG005|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
48770622|NCT02346240|157005809|FG006|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
48770623|NCT02346240|157005810|FG007|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
48770624|NCT02346240|157005811|FG008|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
48770625|NCT02346240|157005812|FG009|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
48770626|NCT02346240|157005813|FG010|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1|||
48770627|NCT02346240|157005814|FG011|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
48770628|NCT02346240|157005815|FG012|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
48770629|NCT02346240|157005816|FG013|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
48770630|NCT02346240|157005817|FG014|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
48770631|NCT02346240|157005818|FG015|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
48770632|NCT02346240|157005819|FG016|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
48770633|NCT02346240|157005820|FG017|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
48770634|NCT02346240|157005821|FG018|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
48770635|NCT02346240|157005822|FG019|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
48770636|NCT02346240|157005823|FG020|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
48770637|NCT02346240|157005824|FG021|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
48770638|NCT02346240|157005825|FG022|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
48770639|NCT02346240|157005826|FG023|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
48770640|NCT02346240|157005803|FG000|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
48770641|NCT02346240|157005804|FG001|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
48770642|NCT02346240|157005805|FG002|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
48770643|NCT02346240|157005806|FG003|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
48770644|NCT02346240|157005807|FG004|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
48770645|NCT02346240|157005808|FG005|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
48770646|NCT02346240|157005809|FG006|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
48770647|NCT02346240|157005810|FG007|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
48770648|NCT02346240|157005811|FG008|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
48770649|NCT02346240|157005812|FG009|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
48770650|NCT02346240|157005813|FG010|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
48770651|NCT02346240|157005814|FG011|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
48770652|NCT02346240|157005815|FG012|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
48770653|NCT02346240|157005816|FG013|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
48770654|NCT02346240|157005817|FG014|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1|||
48770655|NCT02346240|157005818|FG015|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
48770656|NCT02346240|157005819|FG016|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
48770657|NCT02346240|157005820|FG017|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
48770658|NCT02346240|157005821|FG018|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
48770659|NCT02346240|157005822|FG019|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
48770660|NCT02346240|157005823|FG020|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
48770661|NCT02346240|157005824|FG021|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
48770662|NCT02346240|157005825|FG022|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
48770663|NCT02346240|157005826|FG023|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
48770664|NCT02346240|157005803|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
48770665|NCT02346240|157005804|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
49026531|NCT00939003|157935951|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
49026532|NCT00939003|157935950|FG000|Double-blind Treatment Period|Pregnancy|0|||
49026533|NCT00939003|157935951|FG001|Double-blind Treatment Period|Pregnancy|1|||
49098992|NCT04064411|158197011|FG001|Overall Study|Death|0|||
48770666|NCT02346240|157005805|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
48770667|NCT02346240|157005806|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
48770668|NCT02346240|157005807|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
48770669|NCT02346240|157005808|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
48770670|NCT02346240|157005809|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
48770671|NCT02346240|157005810|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
48770672|NCT02346240|157005811|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
48770673|NCT02346240|157005812|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
48770674|NCT02346240|157005813|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
48770675|NCT02346240|157005814|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
48770676|NCT02346240|157005815|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
48770677|NCT02346240|157005816|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
48770678|NCT02346240|157005817|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1|||
48770679|NCT02346240|157005818|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
48770680|NCT02346240|157005819|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
48770681|NCT02346240|157005820|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
48770682|NCT02346240|157005821|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
48770683|NCT02346240|157005822|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
48770684|NCT02346240|157005823|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
48770685|NCT02346240|157005824|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
48770686|NCT02346240|157005825|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
48770687|NCT02346240|157005826|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
48770688|NCT02346240|157005803|FG000|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
48770689|NCT02346240|157005804|FG001|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
48770690|NCT02346240|157005805|FG002|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
48770691|NCT02346240|157005806|FG003|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
48770692|NCT02346240|157005807|FG004|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
48770693|NCT02346240|157005808|FG005|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
48770694|NCT02346240|157005809|FG006|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
48770695|NCT02346240|157005810|FG007|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
49026534|NCT00939003|157935950|FG000|Double-blind Treatment Period|MRI Not Diagnostic|1|||
48770696|NCT02346240|157005811|FG008|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
48770697|NCT02346240|157005812|FG009|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
48770698|NCT02346240|157005813|FG010|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
48770699|NCT02346240|157005814|FG011|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
48770700|NCT02346240|157005815|FG012|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
48797699|NCT01733732|157097050|FG001|Overall Study|Did not attend all study visits|0|||
48982151|NCT02712008|157767527|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
48982152|NCT02712008|157767528|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
49026535|NCT00939003|157935951|FG001|Double-blind Treatment Period|MRI Not Diagnostic|1|||
49026536|NCT00939003|157935950|FG000|Open-label Treatment Period|Adverse Event|4|||
49026537|NCT00939003|157935951|FG001|Open-label Treatment Period|Adverse Event|8|||
48982153|NCT02712008|157767529|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
48982154|NCT02712008|157767530|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
48982155|NCT02712008|157767523|FG000|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
48982156|NCT02712008|157767524|FG001|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
48982157|NCT02712008|157767525|FG002|Baseline (Day 1) up to Week 12|Protocol Violation|1|||
48982158|NCT02712008|157767526|FG003|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
48982159|NCT02712008|157767527|FG004|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
48982160|NCT02712008|157767528|FG005|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
48982161|NCT02712008|157767529|FG006|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
48982162|NCT02712008|157767530|FG007|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
48982163|NCT02712008|157767523|FG000|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
48982164|NCT02712008|157767524|FG001|Baseline (Day 1) up to Week 12|Other Unspecified|1|||
48982165|NCT02712008|157767525|FG002|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
48982166|NCT02712008|157767526|FG003|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
48982167|NCT02712008|157767527|FG004|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
48982168|NCT02712008|157767528|FG005|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
48982169|NCT02712008|157767529|FG006|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
48982170|NCT02712008|157767530|FG007|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
48982171|NCT02712008|157767523|FG000|From Week 12 up to Week 36|Adverse Event|0|||
48982172|NCT02712008|157767524|FG001|From Week 12 up to Week 36|Adverse Event|0|||
48982173|NCT02712008|157767525|FG002|From Week 12 up to Week 36|Adverse Event|0|||
48982174|NCT02712008|157767526|FG003|From Week 12 up to Week 36|Adverse Event|0|||
48770701|NCT02346240|157005816|FG013|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
48770702|NCT02346240|157005817|FG014|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1|||
49026538|NCT00939003|157935950|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
49026539|NCT00939003|157935951|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
48770703|NCT02346240|157005818|FG015|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
48770704|NCT02346240|157005819|FG016|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
48770705|NCT02346240|157005820|FG017|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
48770706|NCT02346240|157005821|FG018|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
48770707|NCT02346240|157005822|FG019|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
48770708|NCT02346240|157005823|FG020|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
48770709|NCT02346240|157005824|FG021|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
48770710|NCT02346240|157005825|FG022|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
48770711|NCT02346240|157005826|FG023|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
48770712|NCT02346240|157005803|FG000|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
48770713|NCT02346240|157005804|FG001|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
48770714|NCT02346240|157005805|FG002|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
48770715|NCT02346240|157005806|FG003|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
48770716|NCT02346240|157005807|FG004|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
48770717|NCT02346240|157005808|FG005|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
48770718|NCT02346240|157005809|FG006|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
48770719|NCT02346240|157005810|FG007|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
48770720|NCT02346240|157005811|FG008|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
48770721|NCT02346240|157005812|FG009|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
48770722|NCT02346240|157005813|FG010|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
48770723|NCT02346240|157005814|FG011|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
48770724|NCT02346240|157005815|FG012|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
48770725|NCT02346240|157005816|FG013|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
48770726|NCT02346240|157005817|FG014|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
48770727|NCT02346240|157005818|FG015|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
48770728|NCT02346240|157005819|FG016|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
48770729|NCT02346240|157005820|FG017|Open-Label Period (Week 48 to Week 144)|Adverse Event|1|||
48770730|NCT02346240|157005821|FG018|Open-Label Period (Week 48 to Week 144)|Adverse Event|6|||
48770731|NCT02346240|157005822|FG019|Open-Label Period (Week 48 to Week 144)|Adverse Event|2|||
48770732|NCT02346240|157005823|FG020|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
48770733|NCT02346240|157005824|FG021|Open-Label Period (Week 48 to Week 144)|Adverse Event|13|||
48770734|NCT02346240|157005825|FG022|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
48770735|NCT02346240|157005826|FG023|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
48770736|NCT02346240|157005803|FG000|Open-Label Period (Week 48 to Week 144)|Death|0|||
48770737|NCT02346240|157005804|FG001|Open-Label Period (Week 48 to Week 144)|Death|0|||
48770738|NCT02346240|157005805|FG002|Open-Label Period (Week 48 to Week 144)|Death|0|||
48770739|NCT02346240|157005806|FG003|Open-Label Period (Week 48 to Week 144)|Death|0|||
48770740|NCT02346240|157005807|FG004|Open-Label Period (Week 48 to Week 144)|Death|0|||
48770741|NCT02346240|157005808|FG005|Open-Label Period (Week 48 to Week 144)|Death|0|||
48770742|NCT02346240|157005809|FG006|Open-Label Period (Week 48 to Week 144)|Death|0|||
48770743|NCT02346240|157005810|FG007|Open-Label Period (Week 48 to Week 144)|Death|0|||
48770744|NCT02346240|157005811|FG008|Open-Label Period (Week 48 to Week 144)|Death|0|||
48770745|NCT02346240|157005812|FG009|Open-Label Period (Week 48 to Week 144)|Death|0|||
48770746|NCT02346240|157005813|FG010|Open-Label Period (Week 48 to Week 144)|Death|0|||
48770747|NCT02346240|157005814|FG011|Open-Label Period (Week 48 to Week 144)|Death|0|||
48770748|NCT02346240|157005815|FG012|Open-Label Period (Week 48 to Week 144)|Death|0|||
48770749|NCT02346240|157005816|FG013|Open-Label Period (Week 48 to Week 144)|Death|0|||
48770750|NCT02346240|157005817|FG014|Open-Label Period (Week 48 to Week 144)|Death|0|||
48770751|NCT02346240|157005818|FG015|Open-Label Period (Week 48 to Week 144)|Death|0|||
48770752|NCT02346240|157005819|FG016|Open-Label Period (Week 48 to Week 144)|Death|0|||
48770753|NCT02346240|157005820|FG017|Open-Label Period (Week 48 to Week 144)|Death|0|||
48770754|NCT02346240|157005821|FG018|Open-Label Period (Week 48 to Week 144)|Death|1|||
48770755|NCT02346240|157005822|FG019|Open-Label Period (Week 48 to Week 144)|Death|1|||
48770756|NCT02346240|157005823|FG020|Open-Label Period (Week 48 to Week 144)|Death|0|||
48770757|NCT02346240|157005824|FG021|Open-Label Period (Week 48 to Week 144)|Death|1|||
48770758|NCT02346240|157005825|FG022|Open-Label Period (Week 48 to Week 144)|Death|0|||
48770759|NCT02346240|157005826|FG023|Open-Label Period (Week 48 to Week 144)|Death|0|||
48770760|NCT02346240|157005803|FG000|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48770761|NCT02346240|157005804|FG001|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48876260|NCT03672175|157384622|FG000|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
49026540|NCT00939003|157935950|FG000|Open-label Treatment Period|Lack of Efficacy|6|||
48876261|NCT03672175|157384623|FG001|Extended FU Period (Days 43 to 182)|Reason not Specified|4|||
48876262|NCT03672175|157384624|FG002|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
48876263|NCT03672175|157384622|FG000|Extended FU Period (Days 43 to 182)|Physician Decision|4|||
48876264|NCT03672175|157384623|FG001|Extended FU Period (Days 43 to 182)|Physician Decision|0|||
48876265|NCT03672175|157384624|FG002|Extended FU Period (Days 43 to 182)|Physician Decision|2|||
48770762|NCT02346240|157005805|FG002|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48770763|NCT02346240|157005806|FG003|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48770764|NCT02346240|157005807|FG004|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48770765|NCT02346240|157005808|FG005|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48770766|NCT02346240|157005809|FG006|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48770767|NCT02346240|157005810|FG007|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48770768|NCT02346240|157005811|FG008|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48770769|NCT02346240|157005812|FG009|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48770770|NCT02346240|157005813|FG010|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48876266|NCT03672175|157384622|FG000|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|18|||
48876267|NCT03672175|157384623|FG001|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|24|||
48876268|NCT03672175|157384624|FG002|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|21|||
48876269|NCT02818998|157384627|FG000|Overall Study|Adverse Event|3|||
48876270|NCT02818998|157384628|FG001|Overall Study|Adverse Event|2|||
48876271|NCT02818998|157384629|FG002|Overall Study|Adverse Event|1|||
48876272|NCT02818998|157384627|FG000|Overall Study|Lost to Follow-up|4|||
48876273|NCT02818998|157384628|FG001|Overall Study|Lost to Follow-up|1|||
48876274|NCT02818998|157384629|FG002|Overall Study|Lost to Follow-up|2|||
48770771|NCT02346240|157005814|FG011|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48770772|NCT02346240|157005815|FG012|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48770773|NCT02346240|157005816|FG013|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48770774|NCT02346240|157005817|FG014|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48770775|NCT02346240|157005818|FG015|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48770776|NCT02346240|157005819|FG016|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48770777|NCT02346240|157005820|FG017|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48770778|NCT02346240|157005821|FG018|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
48770779|NCT02346240|157005822|FG019|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48770780|NCT02346240|157005823|FG020|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48770781|NCT02346240|157005824|FG021|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
48770782|NCT02346240|157005825|FG022|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48770783|NCT02346240|157005826|FG023|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48770784|NCT02346240|157005803|FG000|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
48770785|NCT02346240|157005804|FG001|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
48770786|NCT02346240|157005805|FG002|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
48770787|NCT02346240|157005806|FG003|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
48770788|NCT02346240|157005807|FG004|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
48770789|NCT02346240|157005808|FG005|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
48876275|NCT02818998|157384627|FG000|Overall Study|Withdrawal by sponsor|0|||
48876276|NCT02818998|157384628|FG001|Overall Study|Withdrawal by sponsor|1|||
48876277|NCT02818998|157384629|FG002|Overall Study|Withdrawal by sponsor|1|||
48876278|NCT02818998|157384627|FG000|Overall Study|Death|3|||
48876279|NCT02818998|157384628|FG001|Overall Study|Death|6|||
48982175|NCT02712008|157767527|FG004|From Week 12 up to Week 36|Adverse Event|1|||
48982176|NCT02712008|157767528|FG005|From Week 12 up to Week 36|Adverse Event|0|||
48982177|NCT02712008|157767529|FG006|From Week 12 up to Week 36|Adverse Event|0|||
48982178|NCT02712008|157767530|FG007|From Week 12 up to Week 36|Adverse Event|2|||
48982179|NCT02712008|157767523|FG000|From Week 12 up to Week 36|Death|1|||
48982180|NCT02712008|157767524|FG001|From Week 12 up to Week 36|Death|0|||
48982181|NCT02712008|157767525|FG002|From Week 12 up to Week 36|Death|0|||
48982182|NCT02712008|157767526|FG003|From Week 12 up to Week 36|Death|0|||
48982183|NCT02712008|157767527|FG004|From Week 12 up to Week 36|Death|0|||
48982184|NCT02712008|157767528|FG005|From Week 12 up to Week 36|Death|0|||
48982185|NCT02712008|157767529|FG006|From Week 12 up to Week 36|Death|1|||
48982186|NCT02712008|157767530|FG007|From Week 12 up to Week 36|Death|0|||
48982187|NCT02712008|157767523|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
48982188|NCT02712008|157767524|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
48982189|NCT02712008|157767525|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
48982190|NCT02712008|157767526|FG003|From Week 12 up to Week 36|Lost to Follow-up|1|||
48982191|NCT02712008|157767527|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
48982192|NCT02712008|157767528|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
48982193|NCT02712008|157767529|FG006|From Week 12 up to Week 36|Lost to Follow-up|1|||
48982194|NCT02712008|157767530|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
48982195|NCT02712008|157767523|FG000|From Week 12 up to Week 36|Physician Decision|0|||
48982196|NCT02712008|157767524|FG001|From Week 12 up to Week 36|Physician Decision|0|||
48982197|NCT02712008|157767525|FG002|From Week 12 up to Week 36|Physician Decision|0|||
49026541|NCT00939003|157935951|FG001|Open-label Treatment Period|Lack of Efficacy|9|||
49026542|NCT00939003|157935950|FG000|Open-label Treatment Period|Pregnancy|1|||
49026543|NCT00939003|157935951|FG001|Open-label Treatment Period|Pregnancy|1|||
49026544|NCT00939003|157935950|FG000|Open-label Treatment Period|Exclusion Criteria|1|||
49026545|NCT00939003|157935951|FG001|Open-label Treatment Period|Exclusion Criteria|0|||
49026546|NCT00939003|157935950|FG000|Open-label Treatment Period|Site Closure|3|||
49026547|NCT00939003|157935951|FG001|Open-label Treatment Period|Site Closure|4|||
49026548|NCT00727961|157935952|FG000|Overall Study|Lost to Follow-up|1|||
49026549|NCT00727961|157935952|FG000|Overall Study|Adverse Event|4|||
49026550|NCT00727961|157935952|FG000|Overall Study|Patient's refusal|2|||
48770790|NCT02346240|157005809|FG006|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
48770791|NCT02346240|157005810|FG007|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
48770792|NCT02346240|157005811|FG008|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
48770793|NCT02346240|157005812|FG009|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
48770794|NCT02346240|157005813|FG010|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
48770795|NCT02346240|157005814|FG011|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
48770796|NCT02346240|157005815|FG012|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
48770797|NCT02346240|157005816|FG013|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
48770798|NCT02346240|157005817|FG014|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
48770799|NCT02346240|157005818|FG015|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
48770800|NCT02346240|157005819|FG016|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
48770801|NCT02346240|157005820|FG017|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
48770802|NCT02346240|157005821|FG018|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
48770803|NCT02346240|157005822|FG019|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
48770804|NCT02346240|157005823|FG020|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
48770805|NCT02346240|157005824|FG021|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1|||
48770806|NCT02346240|157005825|FG022|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
48770807|NCT02346240|157005826|FG023|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
48770808|NCT02346240|157005803|FG000|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48770809|NCT02346240|157005804|FG001|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48770810|NCT02346240|157005805|FG002|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48770811|NCT02346240|157005806|FG003|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48770812|NCT02346240|157005807|FG004|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48770813|NCT02346240|157005808|FG005|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48770814|NCT02346240|157005809|FG006|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48770815|NCT02346240|157005810|FG007|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48770816|NCT02346240|157005811|FG008|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48770817|NCT02346240|157005812|FG009|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48770818|NCT02346240|157005813|FG010|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48770819|NCT02346240|157005814|FG011|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48770820|NCT02346240|157005815|FG012|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48770821|NCT02346240|157005816|FG013|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48770822|NCT02346240|157005817|FG014|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48770823|NCT02346240|157005818|FG015|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48770824|NCT02346240|157005819|FG016|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48770825|NCT02346240|157005820|FG017|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
48770826|NCT02346240|157005821|FG018|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
48770827|NCT02346240|157005822|FG019|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
48770828|NCT02346240|157005823|FG020|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48770829|NCT02346240|157005824|FG021|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
48770830|NCT02346240|157005825|FG022|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
48770831|NCT02346240|157005826|FG023|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
48770832|NCT02346240|157005803|FG000|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
49026551|NCT00727961|157935952|FG000|Overall Study|Progression|30|||
48770833|NCT02346240|157005804|FG001|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48770834|NCT02346240|157005805|FG002|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48770835|NCT02346240|157005806|FG003|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48770836|NCT02346240|157005807|FG004|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48770837|NCT02346240|157005808|FG005|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48770838|NCT02346240|157005809|FG006|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48770839|NCT02346240|157005810|FG007|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48770840|NCT02346240|157005811|FG008|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48770841|NCT02346240|157005812|FG009|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48770842|NCT02346240|157005813|FG010|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
49026552|NCT02865122|157935953|FG000|Overall Study|Adverse Event|1|||
49026553|NCT02865122|157935954|FG001|Overall Study|Adverse Event|0|||
49026554|NCT02865122|157935955|FG002|Overall Study|Adverse Event|0|||
49026555|NCT01651000|157935956|FG000|Overall Study|Adverse Event|2|||
49026556|NCT01651000|157935957|FG001|Overall Study|Adverse Event|8|||
49026557|NCT01651000|157935956|FG000|Overall Study|Lost to Follow-up|3|||
49026558|NCT01651000|157935957|FG001|Overall Study|Lost to Follow-up|2|||
49026559|NCT01651000|157935956|FG000|Overall Study|Protocol Violation|0|||
49026560|NCT01651000|157935957|FG001|Overall Study|Protocol Violation|3|||
49026561|NCT01651000|157935956|FG000|Overall Study|Withdrawal by Subject|2|||
48876280|NCT02818998|157384629|FG002|Overall Study|Death|8|||
49026562|NCT01651000|157935957|FG001|Overall Study|Withdrawal by Subject|10|||
49026563|NCT01651000|157935956|FG000|Overall Study|Subject noncompliance|0|||
49026564|NCT01651000|157935957|FG001|Overall Study|Subject noncompliance|3|||
49026565|NCT01651000|157935956|FG000|Overall Study|Lack of Efficacy|1|||
49026566|NCT01651000|157935957|FG001|Overall Study|Lack of Efficacy|1|||
49026567|NCT01651000|157935956|FG000|Overall Study|Physician Decision|1|||
49026568|NCT01651000|157935957|FG001|Overall Study|Physician Decision|0|||
49026569|NCT01651000|157935956|FG000|Overall Study|Administrative reason|1|||
49026570|NCT01651000|157935957|FG001|Overall Study|Administrative reason|0|||
48770843|NCT02346240|157005814|FG011|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48770844|NCT02346240|157005815|FG012|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48770845|NCT02346240|157005816|FG013|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48770846|NCT02346240|157005817|FG014|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48770847|NCT02346240|157005818|FG015|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48770848|NCT02346240|157005819|FG016|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48770849|NCT02346240|157005820|FG017|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48770850|NCT02346240|157005821|FG018|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
48770851|NCT02346240|157005822|FG019|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
48770852|NCT02346240|157005823|FG020|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48770853|NCT02346240|157005824|FG021|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10|||
48770854|NCT02346240|157005825|FG022|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
48770855|NCT02346240|157005826|FG023|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
48770856|NCT02346240|157005803|FG000|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
48770857|NCT02346240|157005804|FG001|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
48770858|NCT02346240|157005805|FG002|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
48770859|NCT02346240|157005806|FG003|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
48770860|NCT02346240|157005807|FG004|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
48770861|NCT02346240|157005808|FG005|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
48770862|NCT02346240|157005809|FG006|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
48770863|NCT02346240|157005810|FG007|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
48770864|NCT02346240|157005811|FG008|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
48770865|NCT02346240|157005812|FG009|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
48770866|NCT02346240|157005813|FG010|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
48770867|NCT02346240|157005814|FG011|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
48770868|NCT02346240|157005815|FG012|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
48770869|NCT02346240|157005816|FG013|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
48770870|NCT02346240|157005817|FG014|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
48770871|NCT02346240|157005818|FG015|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
48770872|NCT02346240|157005819|FG016|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
48770873|NCT02346240|157005820|FG017|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
48770874|NCT02346240|157005821|FG018|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
48770875|NCT02346240|157005822|FG019|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
48770876|NCT02346240|157005823|FG020|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
48770877|NCT02346240|157005824|FG021|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4|||
48770878|NCT02346240|157005825|FG022|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
48770879|NCT02346240|157005826|FG023|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3|||
48770880|NCT02346240|157005803|FG000|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
48770881|NCT02346240|157005804|FG001|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
48770882|NCT02346240|157005805|FG002|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
48770883|NCT02346240|157005806|FG003|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
48770884|NCT02346240|157005807|FG004|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
48770885|NCT02346240|157005808|FG005|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
48770886|NCT02346240|157005809|FG006|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
49026571|NCT01651000|157935956|FG000|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0|||
49026572|NCT01651000|157935957|FG001|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1|||
49026573|NCT02473640|157937465|FG000|Treatment Period 1|Adverse Event|1|||
48770887|NCT02346240|157005810|FG007|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
48770888|NCT02346240|157005811|FG008|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
48770889|NCT02346240|157005812|FG009|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
48770890|NCT02346240|157005813|FG010|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
48770891|NCT02346240|157005814|FG011|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
48770892|NCT02346240|157005815|FG012|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
48770893|NCT02346240|157005816|FG013|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
48770894|NCT02346240|157005817|FG014|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
48770895|NCT02346240|157005818|FG015|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
48770896|NCT02346240|157005819|FG016|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
48770897|NCT02346240|157005820|FG017|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
48770898|NCT02346240|157005821|FG018|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1|||
48770899|NCT02346240|157005822|FG019|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
48770900|NCT02346240|157005823|FG020|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
48770901|NCT02346240|157005824|FG021|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
48770902|NCT02346240|157005825|FG022|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
48770903|NCT02346240|157005826|FG023|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
48770904|NCT01849588|157005827|FG000|Overall Study|Lack of Efficacy|3|||
48770905|NCT04399161|157005828|FG000|Overall Study|Withdrawal by Subject|1|||
48770906|NCT04399161|157005829|FG001|Overall Study|Withdrawal by Subject|0|||
48770907|NCT04399161|157005830|FG002|Overall Study|Withdrawal by Subject|2|||
48770908|NCT04399161|157005828|FG000|Overall Study|Protocol Violation|1|||
48770909|NCT04399161|157005829|FG001|Overall Study|Protocol Violation|2|||
48770910|NCT04399161|157005830|FG002|Overall Study|Protocol Violation|0|||
48770911|NCT03571516|157005833|FG000|Overall Study|Severe diarrhea|1|||
49026574|NCT00453362|157937466|FG000|Overall Study|Adverse Event|5|||
49026575|NCT00453362|157937466|FG000|Overall Study|Death|7|||
49026576|NCT00453362|157937466|FG000|Overall Study|Physician Decision|2|||
49026577|NCT00453362|157937466|FG000|Overall Study|Withdrawal by Subject|3|||
49026578|NCT00453362|157937466|FG000|Overall Study|Progression of disease|56|||
49026579|NCT00453362|157937466|FG000|Overall Study|Screening Failure|14|||
49026580|NCT03100903|157937469|FG000|Overall Study|Withdrawal by Subject|0|||
49026581|NCT03100903|157937470|FG001|Overall Study|Withdrawal by Subject|0|||
49026582|NCT03100903|157937471|FG002|Overall Study|Withdrawal by Subject|1|||
49026583|NCT00433147|157937472|FG000|Overall Study|Adverse Event|0|||
49026584|NCT00433147|157937473|FG001|Overall Study|Adverse Event|1|||
49026585|NCT00433147|157937474|FG002|Overall Study|Adverse Event|0|||
49026586|NCT00433147|157937475|FG003|Overall Study|Adverse Event|0|||
49026587|NCT01882647|157937476|FG000|Overall Study|Lost to Follow-up|2|||
49026588|NCT01882647|157937477|FG001|Overall Study|Lost to Follow-up|2|||
49026589|NCT01882647|157937476|FG000|Overall Study|Withdrawal by Subject|0|||
49026590|NCT01882647|157937477|FG001|Overall Study|Withdrawal by Subject|4|||
49026591|NCT02937701|157937478|FG000|Day 1 to Week 22|Adverse Event|11|||
49026592|NCT02937701|157937479|FG001|Day 1 to Week 22|Adverse Event|14|||
49026593|NCT02937701|157937480|FG002|Day 1 to Week 22|Adverse Event|0|||
49026594|NCT02937701|157937481|FG003|Day 1 to Week 22|Adverse Event|0|||
49026595|NCT02937701|157937482|FG004|Day 1 to Week 22|Adverse Event|0|||
49026596|NCT02937701|157937478|FG000|Day 1 to Week 22|Protocol Specified Criteria|7|||
48770912|NCT03571516|157005834|FG001|Overall Study|Severe diarrhea|0|||
49026597|NCT02937701|157937479|FG001|Day 1 to Week 22|Protocol Specified Criteria|7|||
49026598|NCT02937701|157937480|FG002|Day 1 to Week 22|Protocol Specified Criteria|0|||
49026599|NCT02937701|157937481|FG003|Day 1 to Week 22|Protocol Specified Criteria|0|||
49026600|NCT02937701|157937482|FG004|Day 1 to Week 22|Protocol Specified Criteria|0|||
49026601|NCT02937701|157937478|FG000|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5|||
49026602|NCT02937701|157937479|FG001|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9|||
49026603|NCT02937701|157937480|FG002|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
49026604|NCT02937701|157937481|FG003|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
49026605|NCT02937701|157937482|FG004|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
48770913|NCT03571516|157005833|FG000|Overall Study|Withdrawal by Subject|0|||
48770914|NCT03571516|157005834|FG001|Overall Study|Withdrawal by Subject|1|||
48770915|NCT01541826|157005835|FG000|Overall Study|Lost to Follow-up|2|||
48770916|NCT01541826|157005836|FG001|Overall Study|Lost to Follow-up|3|||
48770917|NCT01541826|157005837|FG002|Overall Study|Lost to Follow-up|0|||
49026606|NCT02937701|157937478|FG000|Day 1 to Week 22|Withdrawal by Subject|6|||
49026607|NCT02937701|157937479|FG001|Day 1 to Week 22|Withdrawal by Subject|6|||
49026608|NCT02937701|157937480|FG002|Day 1 to Week 22|Withdrawal by Subject|0|||
49026609|NCT02937701|157937481|FG003|Day 1 to Week 22|Withdrawal by Subject|0|||
49026610|NCT02937701|157937482|FG004|Day 1 to Week 22|Withdrawal by Subject|0|||
49026611|NCT02937701|157937478|FG000|Day 1 to Week 22|Death|1|||
49026612|NCT02937701|157937479|FG001|Day 1 to Week 22|Death|1|||
49026613|NCT02937701|157937480|FG002|Day 1 to Week 22|Death|0|||
48770918|NCT01541826|157005835|FG000|Overall Study|Withdrawal by Subject|2|||
48770919|NCT01541826|157005836|FG001|Overall Study|Withdrawal by Subject|0|||
48770920|NCT01541826|157005837|FG002|Overall Study|Withdrawal by Subject|0|||
48770921|NCT02673775|157005838|FG000|Washout (at Least 2 Weeks)|Lost to Follow-up|1|||
48770922|NCT02673775|157005839|FG001|Washout (at Least 2 Weeks)|Lost to Follow-up|0|||
48770923|NCT02673775|157005838|FG000|Washout (at Least 2 Weeks)|Physician Decision|1|||
48770924|NCT02673775|157005839|FG001|Washout (at Least 2 Weeks)|Physician Decision|0|||
48770925|NCT02673775|157005838|FG000|Washout (at Least 2 Weeks)|Withdrawal by Subject|0|||
48770926|NCT02673775|157005839|FG001|Washout (at Least 2 Weeks)|Withdrawal by Subject|2|||
48770927|NCT02673775|157005838|FG000|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
48770928|NCT02673775|157005839|FG001|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
48770929|NCT03299192|157005845|FG000|Overall Study|Fell before classes started|1|||
48770930|NCT03299192|157005846|FG001|Overall Study|Fell before classes started|0|||
48770931|NCT03299192|157005847|FG002|Overall Study|Fell before classes started|0|||
48770932|NCT03299192|157005845|FG000|Overall Study|Other|0|||
48770933|NCT03299192|157005846|FG001|Overall Study|Other|2|||
48770934|NCT03299192|157005847|FG002|Overall Study|Other|1|||
48770935|NCT01365273|157005848|FG000|Overall Study|Lost to Follow-up|1|||
48770936|NCT01365273|157005849|FG001|Overall Study|Lost to Follow-up|0|||
48770937|NCT01365273|157005848|FG000|Overall Study|Protocol Violation|0|||
48770938|NCT01365273|157005849|FG001|Overall Study|Protocol Violation|1|||
48770939|NCT01365273|157005848|FG000|Overall Study|Physician Decision|1|||
48770940|NCT01365273|157005849|FG001|Overall Study|Physician Decision|0|||
48770941|NCT00378703|157005852|FG000|Overall Study|Disease progression|59|||
48770942|NCT00378703|157005853|FG001|Overall Study|Disease progression|43|||
48770943|NCT00378703|157005854|FG002|Overall Study|Disease progression|48|||
48770944|NCT00378703|157005855|FG003|Overall Study|Disease progression|49|||
48770945|NCT00378703|157005852|FG000|Overall Study|Adverse Event|11|||
48770946|NCT00378703|157005853|FG001|Overall Study|Adverse Event|17|||
48770947|NCT00378703|157005854|FG002|Overall Study|Adverse Event|20|||
48770948|NCT00378703|157005855|FG003|Overall Study|Adverse Event|18|||
48770949|NCT00378703|157005852|FG000|Overall Study|Death|2|||
48770950|NCT00378703|157005853|FG001|Overall Study|Death|2|||
48770951|NCT00378703|157005854|FG002|Overall Study|Death|4|||
48770952|NCT00378703|157005855|FG003|Overall Study|Death|3|||
48770953|NCT00378703|157005852|FG000|Overall Study|Withdrawal by Subject|4|||
48770954|NCT00378703|157005853|FG001|Overall Study|Withdrawal by Subject|8|||
48770955|NCT00378703|157005854|FG002|Overall Study|Withdrawal by Subject|5|||
48770956|NCT00378703|157005855|FG003|Overall Study|Withdrawal by Subject|7|||
48770957|NCT00378703|157005852|FG000|Overall Study|Physician Decision|1|||
48770958|NCT00378703|157005853|FG001|Overall Study|Physician Decision|4|||
48770959|NCT00378703|157005854|FG002|Overall Study|Physician Decision|1|||
48770960|NCT00378703|157005855|FG003|Overall Study|Physician Decision|0|||
48770961|NCT00378703|157005852|FG000|Overall Study|Alternative therapy|4|||
48770962|NCT00378703|157005853|FG001|Overall Study|Alternative therapy|2|||
48770963|NCT00378703|157005854|FG002|Overall Study|Alternative therapy|0|||
48770964|NCT00378703|157005855|FG003|Overall Study|Alternative therapy|0|||
48770965|NCT00378703|157005852|FG000|Overall Study|Other complicated disease|0|||
48770966|NCT00378703|157005853|FG001|Overall Study|Other complicated disease|2|||
48770967|NCT00378703|157005854|FG002|Overall Study|Other complicated disease|2|||
48770968|NCT00378703|157005855|FG003|Overall Study|Other complicated disease|0|||
48770969|NCT00378703|157005852|FG000|Overall Study|Symptomatic deterioration|0|||
48770970|NCT00378703|157005853|FG001|Overall Study|Symptomatic deterioration|1|||
48770971|NCT00378703|157005854|FG002|Overall Study|Symptomatic deterioration|0|||
48770972|NCT00378703|157005855|FG003|Overall Study|Symptomatic deterioration|2|||
48770973|NCT00378703|157005852|FG000|Overall Study|Surgery|1|||
48770974|NCT00378703|157005853|FG001|Overall Study|Surgery|0|||
48770975|NCT00378703|157005854|FG002|Overall Study|Surgery|0|||
48770976|NCT00378703|157005855|FG003|Overall Study|Surgery|1|||
48770977|NCT00378703|157005852|FG000|Overall Study|Joint decision of physician and patient|1|||
48770978|NCT00378703|157005853|FG001|Overall Study|Joint decision of physician and patient|0|||
48770979|NCT00378703|157005854|FG002|Overall Study|Joint decision of physician and patient|0|||
48770980|NCT00378703|157005855|FG003|Overall Study|Joint decision of physician and patient|0|||
48770981|NCT00378703|157005852|FG000|Overall Study|Adverse events and progressive disease|0|||
49026614|NCT02937701|157937481|FG003|Day 1 to Week 22|Death|0|||
49026615|NCT02937701|157937482|FG004|Day 1 to Week 22|Death|0|||
48876281|NCT02818998|157384627|FG000|Overall Study|Withdrawal by Subject|7|||
48876282|NCT02818998|157384628|FG001|Overall Study|Withdrawal by Subject|6|||
48876283|NCT02818998|157384629|FG002|Overall Study|Withdrawal by Subject|6|||
48770982|NCT00378703|157005853|FG001|Overall Study|Adverse events and progressive disease|0|||
48770983|NCT00378703|157005854|FG002|Overall Study|Adverse events and progressive disease|0|||
48770984|NCT00378703|157005855|FG003|Overall Study|Adverse events and progressive disease|1|||
48770985|NCT00378703|157005852|FG000|Overall Study|Relocation|0|||
48770986|NCT00378703|157005853|FG001|Overall Study|Relocation|0|||
48876284|NCT02818998|157384627|FG000|Overall Study|Physician Decision|1|||
48876285|NCT02818998|157384628|FG001|Overall Study|Physician Decision|0|||
49026616|NCT02937701|157937478|FG000|Day 1 to Week 22|Protocol Violation|1|||
48770987|NCT00378703|157005854|FG002|Overall Study|Relocation|1|||
48770988|NCT00378703|157005855|FG003|Overall Study|Relocation|0|||
48770989|NCT00378703|157005852|FG000|Overall Study|Ineligible|4|||
48770990|NCT00378703|157005853|FG001|Overall Study|Ineligible|7|||
48770991|NCT00378703|157005854|FG002|Overall Study|Ineligible|7|||
48770992|NCT00378703|157005855|FG003|Overall Study|Ineligible|7|||
48770993|NCT00378703|157005852|FG000|Overall Study|Never started treatment|1|||
48770994|NCT00378703|157005853|FG001|Overall Study|Never started treatment|4|||
48770995|NCT00378703|157005854|FG002|Overall Study|Never started treatment|0|||
48770996|NCT00378703|157005855|FG003|Overall Study|Never started treatment|0|||
48770997|NCT00378703|157005852|FG000|Overall Study|Other|1|||
48770998|NCT00378703|157005853|FG001|Overall Study|Other|1|||
48770999|NCT00378703|157005854|FG002|Overall Study|Other|2|||
48771000|NCT00378703|157005855|FG003|Overall Study|Other|3|||
48771001|NCT05402995|157005856|FG000|Overall Study|Study terminated due to lack of enrollment and followup.|0|||
48771002|NCT05402995|157005857|FG001|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
48771003|NCT05402995|157005858|FG002|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
48771004|NCT05402995|157005859|FG003|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
48771005|NCT00205712|157005860|FG000|Overall Study|Lost to Follow-up|0|||
48771006|NCT00205712|157005861|FG001|Overall Study|Lost to Follow-up|1|||
48771007|NCT03385239|157005866|FG000|Overall Study|Voluntary Withdrawal|2|||
48771008|NCT03385239|157005867|FG001|Overall Study|Voluntary Withdrawal|3|||
48771009|NCT03385239|157005868|FG002|Overall Study|Voluntary Withdrawal|2|||
48771010|NCT03385239|157005869|FG003|Overall Study|Voluntary Withdrawal|3|||
48771011|NCT03385239|157005870|FG004|Overall Study|Voluntary Withdrawal|0|||
48771012|NCT03385239|157005866|FG000|Overall Study|Adverse Event|0|||
48771013|NCT03385239|157005867|FG001|Overall Study|Adverse Event|0|||
48771014|NCT03385239|157005868|FG002|Overall Study|Adverse Event|1|||
48771015|NCT03385239|157005869|FG003|Overall Study|Adverse Event|0|||
48771016|NCT03385239|157005870|FG004|Overall Study|Adverse Event|0|||
48771017|NCT03385239|157005866|FG000|Overall Study|Other|0|||
48771018|NCT03385239|157005867|FG001|Overall Study|Other|0|||
48771019|NCT03385239|157005868|FG002|Overall Study|Other|0|||
48771020|NCT03385239|157005869|FG003|Overall Study|Other|1|||
48771021|NCT03385239|157005870|FG004|Overall Study|Other|0|||
48771022|NCT02501096|157005871|FG000|Overall Study|Lost to Follow-up|0|||
48771023|NCT02501096|157005872|FG001|Overall Study|Lost to Follow-up|0|||
48771024|NCT02501096|157005873|FG002|Overall Study|Lost to Follow-up|0|||
48771025|NCT02501096|157005874|FG003|Overall Study|Lost to Follow-up|0|||
48771026|NCT02501096|157005875|FG004|Overall Study|Lost to Follow-up|1|||
48771027|NCT02501096|157005876|FG005|Overall Study|Lost to Follow-up|1|||
48771028|NCT02501096|157005877|FG006|Overall Study|Lost to Follow-up|3|||
48771029|NCT02501096|157005878|FG007|Overall Study|Lost to Follow-up|0|||
48771030|NCT02501096|157005879|FG008|Overall Study|Lost to Follow-up|0|||
48771031|NCT02501096|157005871|FG000|Overall Study|Withdrawal by Subject|1|||
48771032|NCT02501096|157005872|FG001|Overall Study|Withdrawal by Subject|0|||
48771033|NCT02501096|157005873|FG002|Overall Study|Withdrawal by Subject|7|||
48771034|NCT02501096|157005874|FG003|Overall Study|Withdrawal by Subject|13|||
48771035|NCT02501096|157005875|FG004|Overall Study|Withdrawal by Subject|2|||
48771036|NCT02501096|157005876|FG005|Overall Study|Withdrawal by Subject|2|||
48771037|NCT02501096|157005877|FG006|Overall Study|Withdrawal by Subject|2|||
48771038|NCT02501096|157005878|FG007|Overall Study|Withdrawal by Subject|3|||
48771039|NCT02501096|157005879|FG008|Overall Study|Withdrawal by Subject|0|||
48771040|NCT02501096|157005871|FG000|Overall Study|Survival follow-up discontinued by sponsor|0|||
48771041|NCT02501096|157005872|FG001|Overall Study|Survival follow-up discontinued by sponsor|0|||
48771042|NCT02501096|157005873|FG002|Overall Study|Survival follow-up discontinued by sponsor|29|||
48771043|NCT02501096|157005874|FG003|Overall Study|Survival follow-up discontinued by sponsor|58|||
48771044|NCT02501096|157005875|FG004|Overall Study|Survival follow-up discontinued by sponsor|3|||
48771045|NCT02501096|157005876|FG005|Overall Study|Survival follow-up discontinued by sponsor|2|||
48771046|NCT02501096|157005877|FG006|Overall Study|Survival follow-up discontinued by sponsor|2|||
48771047|NCT02501096|157005878|FG007|Overall Study|Survival follow-up discontinued by sponsor|1|||
48771048|NCT02501096|157005879|FG008|Overall Study|Survival follow-up discontinued by sponsor|0|||
48771049|NCT02501096|157005871|FG000|Overall Study|Death|1|||
48771050|NCT02501096|157005872|FG001|Overall Study|Death|1|||
49026617|NCT02937701|157937479|FG001|Day 1 to Week 22|Protocol Violation|1|||
49026618|NCT02937701|157937480|FG002|Day 1 to Week 22|Protocol Violation|0|||
48771051|NCT02501096|157005873|FG002|Overall Study|Death|88|||
48771052|NCT02501096|157005874|FG003|Overall Study|Death|74|||
48771053|NCT02501096|157005875|FG004|Overall Study|Death|15|||
48771054|NCT02501096|157005876|FG005|Overall Study|Death|16|||
48771055|NCT02501096|157005877|FG006|Overall Study|Death|15|||
48771056|NCT02501096|157005878|FG007|Overall Study|Death|16|||
48771057|NCT02501096|157005879|FG008|Overall Study|Death|1|||
48771058|NCT00655564|157005881|FG000|Overall Study|Adverse Event|1|||
48771059|NCT00655564|157005881|FG000|Overall Study|Lost to Follow-up|1|||
48771060|NCT00655564|157005881|FG000|Overall Study|Desired Alternate Therapy|1|||
48771061|NCT02755831|157005887|FG000|Overall Study|Lost to Follow-up|3|||
49026619|NCT02937701|157937481|FG003|Day 1 to Week 22|Protocol Violation|0|||
48771062|NCT02755831|157005888|FG001|Overall Study|Lost to Follow-up|3|||
48771063|NCT01516879|157005889|FG000|Overall Study|Withdrawal by Subject|9|||
48771064|NCT01516879|157005890|FG001|Overall Study|Withdrawal by Subject|11|||
48771065|NCT01516879|157005889|FG000|Overall Study|Death|0|||
48771066|NCT01516879|157005890|FG001|Overall Study|Death|2|||
48771067|NCT01516879|157005889|FG000|Overall Study|Lost to Follow-up|2|||
48771068|NCT01516879|157005890|FG001|Overall Study|Lost to Follow-up|11|||
48771069|NCT01516879|157005889|FG000|Overall Study|Other|5|||
48771070|NCT01516879|157005890|FG001|Overall Study|Other|10|||
48771071|NCT03591575|157005893|FG000|Overall Study|Adverse Event|2|||
48771072|NCT03591575|157005894|FG001|Overall Study|Adverse Event|0|||
48771073|NCT03591575|157005893|FG000|Overall Study|Withdrawal by Subject|4|||
48771074|NCT03591575|157005894|FG001|Overall Study|Withdrawal by Subject|1|||
48771075|NCT00025883|157005895|FG000|Overall Study|had atypical progeriod lipodystrophy|4|||
48771076|NCT00025883|157005895|FG000|Overall Study|no baseline data|1|||
48771077|NCT00025883|157005895|FG000|Overall Study|Death|1|||
48771078|NCT00025883|157005895|FG000|Overall Study|Adverse Event|1|||
48771079|NCT00025883|157005895|FG000|Overall Study|didn't reach 6 months of Metreleptin|10|||
48771080|NCT02448875|157005896|FG000|Overall Study|Adverse Event|2|||
48771081|NCT02448875|157005897|FG001|Overall Study|Adverse Event|1|||
48771082|NCT02448875|157005898|FG002|Overall Study|Adverse Event|0|||
48771083|NCT02448875|157005896|FG000|Overall Study|Lost to Follow-up|1|||
48771084|NCT02448875|157005897|FG001|Overall Study|Lost to Follow-up|0|||
48771085|NCT02448875|157005898|FG002|Overall Study|Lost to Follow-up|0|||
48771086|NCT02448875|157005896|FG000|Overall Study|Investigator Decision|3|||
48771087|NCT02448875|157005897|FG001|Overall Study|Investigator Decision|0|||
48771088|NCT02448875|157005898|FG002|Overall Study|Investigator Decision|1|||
48771089|NCT02448875|157005896|FG000|Overall Study|Withdrawal by Subject|1|||
48771090|NCT02448875|157005897|FG001|Overall Study|Withdrawal by Subject|0|||
48771091|NCT02448875|157005898|FG002|Overall Study|Withdrawal by Subject|0|||
48771092|NCT02434770|157005899|FG000|Week 1 to Week 18|Lost to Follow-up|0|||
48771093|NCT02434770|157005900|FG001|Week 1 to Week 18|Lost to Follow-up|0|||
48771094|NCT02434770|157005901|FG002|Week 1 to Week 18|Lost to Follow-up|2|||
48771095|NCT02434770|157005899|FG000|Week 1 to Week 18|Withdrawal by Subject|6|||
48771096|NCT02434770|157005900|FG001|Week 1 to Week 18|Withdrawal by Subject|12|||
48771097|NCT02434770|157005901|FG002|Week 1 to Week 18|Withdrawal by Subject|5|||
48771098|NCT02434770|157005899|FG000|Week 1 to Week 18|Received Non-study Polio Vaccine|8|||
48771099|NCT02434770|157005900|FG001|Week 1 to Week 18|Received Non-study Polio Vaccine|10|||
48771100|NCT02434770|157005901|FG002|Week 1 to Week 18|Received Non-study Polio Vaccine|9|||
48771101|NCT02434770|157005899|FG000|Week 1 to Week 18|Relocated Out of Study Area|0|||
48771102|NCT02434770|157005900|FG001|Week 1 to Week 18|Relocated Out of Study Area|0|||
48771103|NCT02434770|157005901|FG002|Week 1 to Week 18|Relocated Out of Study Area|1|||
48771104|NCT02434770|157005899|FG000|Week 1 to Week 18|Death|1|||
48771105|NCT02434770|157005900|FG001|Week 1 to Week 18|Death|0|||
48771106|NCT02434770|157005901|FG002|Week 1 to Week 18|Death|0|||
48771107|NCT02434770|157005899|FG000|Week 18 to Week|Lost to Follow-up|2|||
48771108|NCT02434770|157005900|FG001|Week 18 to Week|Lost to Follow-up|2|||
49026620|NCT02937701|157937482|FG004|Day 1 to Week 22|Protocol Violation|0|||
49026621|NCT02937701|157937478|FG000|Day 1 to Week 22|Lost to Follow-up|1|||
49026622|NCT02937701|157937479|FG001|Day 1 to Week 22|Lost to Follow-up|1|||
49026623|NCT02937701|157937480|FG002|Day 1 to Week 22|Lost to Follow-up|0|||
49026624|NCT02937701|157937481|FG003|Day 1 to Week 22|Lost to Follow-up|0|||
49026625|NCT02937701|157937482|FG004|Day 1 to Week 22|Lost to Follow-up|0|||
49026626|NCT02937701|157937478|FG000|Day 1 to Week 22|Physician Decision|2|||
49026627|NCT02937701|157937479|FG001|Day 1 to Week 22|Physician Decision|0|||
49026628|NCT02937701|157937480|FG002|Day 1 to Week 22|Physician Decision|0|||
49026629|NCT02937701|157937481|FG003|Day 1 to Week 22|Physician Decision|0|||
49026630|NCT02937701|157937482|FG004|Day 1 to Week 22|Physician Decision|0|||
49026631|NCT02937701|157937478|FG000|Day 1 to Week 22|Other|1|||
48771109|NCT02434770|157005901|FG002|Week 18 to Week|Lost to Follow-up|1|||
48771110|NCT02434770|157005899|FG000|Week 18 to Week|Withdrawal by Subject|0|||
48771111|NCT02434770|157005900|FG001|Week 18 to Week|Withdrawal by Subject|0|||
48771112|NCT02434770|157005901|FG002|Week 18 to Week|Withdrawal by Subject|2|||
48771113|NCT02434770|157005899|FG000|Week 18 to Week|Received Non-study Polio Vaccine|6|||
48771114|NCT02434770|157005900|FG001|Week 18 to Week|Received Non-study Polio Vaccine|6|||
48771115|NCT02434770|157005901|FG002|Week 18 to Week|Received Non-study Polio Vaccine|3|||
48771116|NCT01227512|157005903|FG000|Overall Study|Physician Decision|6|||
48771117|NCT01227512|157005904|FG001|Overall Study|Physician Decision|6|||
48771118|NCT01227512|157005903|FG000|Overall Study|Adverse Event|4|||
48771119|NCT01227512|157005904|FG001|Overall Study|Adverse Event|3|||
48771120|NCT01227512|157005903|FG000|Overall Study|Withdrawal by Subject|3|||
48771121|NCT01227512|157005904|FG001|Overall Study|Withdrawal by Subject|0|||
48771122|NCT01227512|157005903|FG000|Overall Study|Participant met withdrawal criteria|0|||
48771123|NCT01227512|157005904|FG001|Overall Study|Participant met withdrawal criteria|1|||
49026632|NCT02937701|157937479|FG001|Day 1 to Week 22|Other|0|||
49026633|NCT02937701|157937480|FG002|Day 1 to Week 22|Other|0|||
49026634|NCT02937701|157937481|FG003|Day 1 to Week 22|Other|0|||
48771124|NCT02774681|157005905|FG000|Treatment on Study|Progressive Disease|7|||
48771125|NCT02774681|157005905|FG000|Follow-Up for 3 Years|Death|11|||
48771126|NCT02774681|157005905|FG000|Follow-Up for 3 Years|Withdrawal by Subject|1|||
48771127|NCT04497987|157005906|FG000|Overall Study|Adverse Event|1|||
48771128|NCT04497987|157005907|FG001|Overall Study|Adverse Event|0|||
48771129|NCT04497987|157005906|FG000|Overall Study|Death|21|||
48771130|NCT04497987|157005907|FG001|Overall Study|Death|13|||
48771131|NCT04497987|157005906|FG000|Overall Study|Lost to Follow-up|19|||
48771132|NCT04497987|157005907|FG001|Overall Study|Lost to Follow-up|17|||
48771133|NCT04497987|157005906|FG000|Overall Study|Other - as reported by the investigator|22|||
48771134|NCT04497987|157005907|FG001|Overall Study|Other - as reported by the investigator|16|||
48771135|NCT04497987|157005906|FG000|Overall Study|Physician Decision|1|||
48771136|NCT04497987|157005907|FG001|Overall Study|Physician Decision|0|||
48771137|NCT04497987|157005906|FG000|Overall Study|Withdrawal by Subject|35|||
48771138|NCT04497987|157005907|FG001|Overall Study|Withdrawal by Subject|21|||
48771139|NCT02696096|157005908|FG000|Overall Study|ruled out at screening|1|||
48771140|NCT02696096|157005908|FG000|Overall Study|did not attend second fMRI|1|||
48771141|NCT00445328|157005911|FG000|Overall Study|Death|0|||
48771142|NCT00445328|157005912|FG001|Overall Study|Death|1|||
48771143|NCT00445328|157005911|FG000|Overall Study|Adverse Event|0|||
48771144|NCT00445328|157005912|FG001|Overall Study|Adverse Event|3|||
48771145|NCT00445328|157005911|FG000|Overall Study|Other|0|||
48771146|NCT00445328|157005912|FG001|Overall Study|Other|2|||
48771147|NCT00445328|157005911|FG000|Overall Study|Withdrawal by Subject|2|||
48771148|NCT00445328|157005912|FG001|Overall Study|Withdrawal by Subject|0|||
48771149|NCT00445328|157005911|FG000|Overall Study|Protocol Violation|1|||
48771150|NCT00445328|157005912|FG001|Overall Study|Protocol Violation|0|||
48771151|NCT00699972|157007686|FG000|Overall Study|Adverse Event|7|||
48771152|NCT00699972|157007687|FG001|Overall Study|Adverse Event|9|||
48771153|NCT00699972|157007688|FG002|Overall Study|Adverse Event|24|||
48771154|NCT00699972|157007686|FG000|Overall Study|Lost to Follow-up|0|||
48771155|NCT00699972|157007687|FG001|Overall Study|Lost to Follow-up|2|||
48771156|NCT00699972|157007688|FG002|Overall Study|Lost to Follow-up|0|||
48771157|NCT00699972|157007686|FG000|Overall Study|Withdrawal by Subject|3|||
48771158|NCT00699972|157007687|FG001|Overall Study|Withdrawal by Subject|7|||
48771159|NCT00699972|157007688|FG002|Overall Study|Withdrawal by Subject|4|||
48771160|NCT00699972|157007686|FG000|Overall Study|Lack of Efficacy|2|||
48771161|NCT00699972|157007687|FG001|Overall Study|Lack of Efficacy|0|||
48771162|NCT00699972|157007688|FG002|Overall Study|Lack of Efficacy|2|||
48771163|NCT00699972|157007686|FG000|Overall Study|Administrative/Other|3|||
48771164|NCT00699972|157007687|FG001|Overall Study|Administrative/Other|1|||
48771165|NCT00699972|157007688|FG002|Overall Study|Administrative/Other|4|||
48771166|NCT00699972|157007686|FG000|Overall Study|Randomized, Not Treated|1|||
48771167|NCT00699972|157007687|FG001|Overall Study|Randomized, Not Treated|0|||
48771168|NCT00699972|157007688|FG002|Overall Study|Randomized, Not Treated|1|||
48771169|NCT00502697|157007689|FG000|Overall Study|Withdrawal by Subject|3|||
48771170|NCT00502697|157007690|FG001|Overall Study|Withdrawal by Subject|1|||
48771171|NCT00502697|157007689|FG000|Overall Study|disenrolled due to pregnancy loss|3|||
48771172|NCT00502697|157007690|FG001|Overall Study|disenrolled due to pregnancy loss|5|||
48771173|NCT00502697|157007689|FG000|Overall Study|found not to meet eligibility criteria|3|||
48771174|NCT00502697|157007690|FG001|Overall Study|found not to meet eligibility criteria|4|||
48771175|NCT00502697|157007689|FG000|Overall Study|did not meet assignment criteria|4|||
49026635|NCT02937701|157937482|FG004|Day 1 to Week 22|Other|0|||
49026636|NCT02937701|157937478|FG000|Week 22 to Week 50|Adverse Event|0|||
49026637|NCT02937701|157937479|FG001|Week 22 to Week 50|Adverse Event|0|||
49026638|NCT02937701|157937480|FG002|Week 22 to Week 50|Adverse Event|10|||
48771176|NCT00502697|157007690|FG001|Overall Study|did not meet assignment criteria|2|||
48771177|NCT03459196|157007691|FG000|Overall Study|Subject didn't receive study catheter|2|||
48771178|NCT01888497|157007699|FG000|Washout Period 1|Withdrawal by Subject|0|||
48771179|NCT01888497|157007700|FG001|Washout Period 1|Withdrawal by Subject|0|||
48771180|NCT01888497|157007701|FG002|Washout Period 1|Withdrawal by Subject|1|||
48771181|NCT01888497|157007702|FG003|Washout Period 1|Withdrawal by Subject|1|||
48771182|NCT01888497|157007699|FG000|Washout Period 2|Adverse Event|0|||
48771183|NCT01888497|157007700|FG001|Washout Period 2|Adverse Event|0|||
48771184|NCT01888497|157007701|FG002|Washout Period 2|Adverse Event|0|||
48771185|NCT01888497|157007702|FG003|Washout Period 2|Adverse Event|1|||
48771186|NCT01888497|157007699|FG000|Washout Period 2|Withdrawal by Subject|0|||
48982198|NCT02712008|157767526|FG003|From Week 12 up to Week 36|Physician Decision|1|||
48982199|NCT02712008|157767527|FG004|From Week 12 up to Week 36|Physician Decision|1|||
48982200|NCT02712008|157767528|FG005|From Week 12 up to Week 36|Physician Decision|0|||
48982201|NCT02712008|157767529|FG006|From Week 12 up to Week 36|Physician Decision|0|||
48982202|NCT02712008|157767530|FG007|From Week 12 up to Week 36|Physician Decision|0|||
48982203|NCT02712008|157767523|FG000|From Week 12 up to Week 36|Withdrawal by Subject|0|||
48982204|NCT02712008|157767524|FG001|From Week 12 up to Week 36|Withdrawal by Subject|0|||
48982205|NCT02712008|157767525|FG002|From Week 12 up to Week 36|Withdrawal by Subject|0|||
49026639|NCT02937701|157937481|FG003|Week 22 to Week 50|Adverse Event|3|||
49026640|NCT02937701|157937482|FG004|Week 22 to Week 50|Adverse Event|3|||
48876286|NCT02818998|157384629|FG002|Overall Study|Physician Decision|0|||
48876287|NCT02547441|157384630|FG000|Double-Blind Study Period|Adverse Event|4|||
48876288|NCT02547441|157384631|FG001|Double-Blind Study Period|Adverse Event|9|||
48876289|NCT02547441|157384630|FG000|Double-Blind Study Period|Lost to Follow-up|2|||
48876290|NCT02547441|157384631|FG001|Double-Blind Study Period|Lost to Follow-up|4|||
48876291|NCT02547441|157384630|FG000|Double-Blind Study Period|Physician Decision|1|||
48876292|NCT02547441|157384631|FG001|Double-Blind Study Period|Physician Decision|0|||
49026641|NCT02937701|157937478|FG000|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
49026642|NCT02937701|157937479|FG001|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
49026643|NCT02937701|157937480|FG002|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10|||
49026644|NCT02937701|157937481|FG003|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3|||
49026645|NCT02937701|157937482|FG004|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2|||
49026646|NCT02937701|157937478|FG000|Week 22 to Week 50|Withdrawal by Subject|0|||
49026647|NCT02937701|157937479|FG001|Week 22 to Week 50|Withdrawal by Subject|0|||
49026648|NCT02937701|157937480|FG002|Week 22 to Week 50|Withdrawal by Subject|8|||
49026649|NCT02937701|157937481|FG003|Week 22 to Week 50|Withdrawal by Subject|2|||
49026650|NCT02937701|157937482|FG004|Week 22 to Week 50|Withdrawal by Subject|1|||
49026651|NCT02937701|157937478|FG000|Week 22 to Week 50|Lost to Follow-up|0|||
49026652|NCT02937701|157937479|FG001|Week 22 to Week 50|Lost to Follow-up|0|||
49026653|NCT02937701|157937480|FG002|Week 22 to Week 50|Lost to Follow-up|2|||
49026654|NCT02937701|157937481|FG003|Week 22 to Week 50|Lost to Follow-up|0|||
49026655|NCT02937701|157937482|FG004|Week 22 to Week 50|Lost to Follow-up|1|||
49026656|NCT02937701|157937478|FG000|Week 22 to Week 50|Physician Decision|0|||
49026657|NCT02937701|157937479|FG001|Week 22 to Week 50|Physician Decision|0|||
49026658|NCT02937701|157937480|FG002|Week 22 to Week 50|Physician Decision|2|||
49026659|NCT02937701|157937481|FG003|Week 22 to Week 50|Physician Decision|0|||
49026660|NCT02937701|157937482|FG004|Week 22 to Week 50|Physician Decision|1|||
49026661|NCT02937701|157937478|FG000|Week 22 to Week 50|Other|0|||
49026662|NCT02937701|157937479|FG001|Week 22 to Week 50|Other|0|||
49026663|NCT02937701|157937480|FG002|Week 22 to Week 50|Other|0|||
49026664|NCT02937701|157937481|FG003|Week 22 to Week 50|Other|0|||
49026665|NCT02937701|157937482|FG004|Week 22 to Week 50|Other|1|||
49026666|NCT03601637|157937484|FG000|Overall Study|Withdrawal of Consent (not due to adverse event)|0|||
49026667|NCT03601637|157937485|FG001|Overall Study|Withdrawal of Consent (not due to adverse event)|1|||
49026668|NCT03601637|157937484|FG000|Overall Study|Adverse Event|1|||
49026669|NCT03601637|157937485|FG001|Overall Study|Adverse Event|1|||
49026670|NCT03601637|157937484|FG000|Overall Study|Other|0|||
49026671|NCT03601637|157937485|FG001|Overall Study|Other|1|||
49026672|NCT01387737|157937486|FG000|Overall Study|Adverse Event|20|||
49026673|NCT01387737|157937487|FG001|Overall Study|Adverse Event|30|||
49026674|NCT01387737|157937486|FG000|Overall Study|Lack of Efficacy|1|||
49026675|NCT01387737|157937487|FG001|Overall Study|Lack of Efficacy|0|||
49026676|NCT01387737|157937486|FG000|Overall Study|Physician Decision|3|||
49026677|NCT01387737|157937487|FG001|Overall Study|Physician Decision|10|||
49026678|NCT01387737|157937486|FG000|Overall Study|Withdrawal by Subject|27|||
49026679|NCT01387737|157937487|FG001|Overall Study|Withdrawal by Subject|31|||
49026680|NCT01387737|157937486|FG000|Overall Study|Clearly not eligible for the study|1|||
49026681|NCT01387737|157937487|FG001|Overall Study|Clearly not eligible for the study|3|||
49026682|NCT02189941|157937489|FG000|Overall Study|Non-compliance|0|||
49026683|NCT02189941|157937490|FG001|Overall Study|Non-compliance|0|||
49026684|NCT02189941|157937491|FG002|Overall Study|Non-compliance|1|||
49026685|NCT03817983|157937492|FG000|ProSpA-CD Assess Phase|MRI not performed|0|||
49026686|NCT03817983|157937493|FG001|ProSpA-CD Assess Phase|MRI not performed|0|||
49026687|NCT03817983|157937494|FG002|ProSpA-CD Assess Phase|MRI not performed|7|||
49026688|NCT00723528|157937497|FG000|Period 1: Controlled Period (CP)|Adverse Event|0|||
49026689|NCT00723528|157937498|FG001|Period 1: Controlled Period (CP)|Adverse Event|0|||
49026690|NCT00723528|157937499|FG002|Period 1: Controlled Period (CP)|Adverse Event|1|||
49026691|NCT00723528|157937500|FG003|Period 1: Controlled Period (CP)|Adverse Event|0|||
49026692|NCT00723528|157937501|FG004|Period 1: Controlled Period (CP)|Adverse Event|0|||
49026693|NCT00723528|157937502|FG005|Period 1: Controlled Period (CP)|Adverse Event|0|||
48876293|NCT02547441|157384630|FG000|Double-Blind Study Period|Protocol Violation|1|||
48876294|NCT02547441|157384631|FG001|Double-Blind Study Period|Protocol Violation|2|||
49026694|NCT00723528|157937503|FG006|Period 1: Controlled Period (CP)|Adverse Event|0|||
49026695|NCT00723528|157937497|FG000|Period 1: Controlled Period (CP)|Withdrawal by Subject|2|||
49026696|NCT00723528|157937498|FG001|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
49026697|NCT00723528|157937499|FG002|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
49026698|NCT00723528|157937500|FG003|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
49026699|NCT00723528|157937501|FG004|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
49026700|NCT00723528|157937502|FG005|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
49026701|NCT00723528|157937503|FG006|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
49026702|NCT00723528|157937497|FG000|Period 1: Controlled Period (CP)|Physician Decision|0|||
49026703|NCT00723528|157937498|FG001|Period 1: Controlled Period (CP)|Physician Decision|0|||
48876295|NCT02547441|157384630|FG000|Double-Blind Study Period|Withdrawal by Subject|15|||
49026704|NCT00723528|157937499|FG002|Period 1: Controlled Period (CP)|Physician Decision|1|||
49026705|NCT00723528|157937500|FG003|Period 1: Controlled Period (CP)|Physician Decision|0|||
49026706|NCT00723528|157937501|FG004|Period 1: Controlled Period (CP)|Physician Decision|0|||
49026707|NCT00723528|157937502|FG005|Period 1: Controlled Period (CP)|Physician Decision|0|||
49026708|NCT00723528|157937503|FG006|Period 1: Controlled Period (CP)|Physician Decision|0|||
49026709|NCT00723528|157937497|FG000|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
49026710|NCT00723528|157937498|FG001|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
49026711|NCT00723528|157937499|FG002|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1|||
49026712|NCT00723528|157937500|FG003|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
49026713|NCT00723528|157937501|FG004|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
49026714|NCT00723528|157937502|FG005|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
49026715|NCT00723528|157937503|FG006|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
49026716|NCT00723528|157937497|FG000|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2|||
49026717|NCT00723528|157937498|FG001|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
48771187|NCT01888497|157007700|FG001|Washout Period 2|Withdrawal by Subject|0|||
48771188|NCT01888497|157007701|FG002|Washout Period 2|Withdrawal by Subject|0|||
48771189|NCT01888497|157007702|FG003|Washout Period 2|Withdrawal by Subject|1|||
48771190|NCT04152447|157007703|FG000|Overall Study|Lost to Follow-up|1|||
49026718|NCT00723528|157937499|FG002|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1|||
49026719|NCT00723528|157937500|FG003|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
48771191|NCT04152447|157007704|FG001|Overall Study|Lost to Follow-up|0|||
48771192|NCT04152447|157007703|FG000|Overall Study|Treatment plan switched to an ineligible criteria|1|||
48771193|NCT04152447|157007704|FG001|Overall Study|Treatment plan switched to an ineligible criteria|1|||
48771194|NCT04152447|157007703|FG000|Overall Study|Withdrawal by Subject|0|||
48771195|NCT04152447|157007704|FG001|Overall Study|Withdrawal by Subject|1|||
48771196|NCT04152447|157007703|FG000|Overall Study|Found ineligible after enrolling|1|||
48771197|NCT04152447|157007704|FG001|Overall Study|Found ineligible after enrolling|1|||
48771198|NCT04152447|157007703|FG000|Overall Study|Did not receive VR headset in time.|0|||
48771199|NCT04152447|157007704|FG001|Overall Study|Did not receive VR headset in time.|2|||
48771200|NCT01921829|157007705|FG000|Overall Study|Withdrawal by Subject|0|||
48771201|NCT01921829|157007706|FG001|Overall Study|Withdrawal by Subject|1|||
48771202|NCT02789176|157007707|FG000|Overall Study|Death|0|||
48771203|NCT02789176|157007708|FG001|Overall Study|Death|0|||
48771204|NCT02789176|157007709|FG002|Overall Study|Death|3|||
48771205|NCT02789176|157007710|FG003|Overall Study|Death|0|||
48771206|NCT02789176|157007707|FG000|Overall Study|Withdrawal by Subject|0|||
48771207|NCT02789176|157007708|FG001|Overall Study|Withdrawal by Subject|0|||
48771208|NCT02789176|157007709|FG002|Overall Study|Withdrawal by Subject|1|||
48771209|NCT02789176|157007710|FG003|Overall Study|Withdrawal by Subject|0|||
48771210|NCT02789176|157007707|FG000|Overall Study|Lost to Follow-up|8|||
48771211|NCT02789176|157007708|FG001|Overall Study|Lost to Follow-up|2|||
48771212|NCT02789176|157007709|FG002|Overall Study|Lost to Follow-up|6|||
48771213|NCT02789176|157007710|FG003|Overall Study|Lost to Follow-up|1|||
48771214|NCT02223767|157007711|FG000|Overall Study|Withdrawal by Subject|4|||
48771215|NCT02223767|157007712|FG001|Overall Study|Withdrawal by Subject|4|||
48771216|NCT01466270|157007715|FG000|Overall Study|Withdrawal by Subject|4|||
48771217|NCT01466270|157007716|FG001|Overall Study|Withdrawal by Subject|1|||
48771218|NCT01466270|157007715|FG000|Overall Study|Physician Decision|1|||
48771219|NCT01466270|157007716|FG001|Overall Study|Physician Decision|0|||
48771220|NCT01466270|157007715|FG000|Overall Study|Lost to Follow-up|1|||
48771221|NCT01466270|157007716|FG001|Overall Study|Lost to Follow-up|3|||
48771222|NCT01466270|157007715|FG000|Overall Study|Progression|1|||
48771223|NCT01466270|157007716|FG001|Overall Study|Progression|0|||
48771224|NCT01466270|157007715|FG000|Overall Study|Toxicity|4|||
48771225|NCT01466270|157007716|FG001|Overall Study|Toxicity|1|||
48771226|NCT01466270|157007715|FG000|Overall Study|Multiple|1|||
48771227|NCT01466270|157007716|FG001|Overall Study|Multiple|1|||
48771228|NCT01944059|157007717|FG000|Overall Study|Lost to Follow-up|1|||
48771229|NCT01944059|157007717|FG000|Overall Study|Physician Decision|3|||
48771230|NCT01944059|157007717|FG000|Overall Study|Withdrawal by Subject|1|||
48771231|NCT01944059|157007717|FG000|Overall Study|Adverse Event|2|||
48771232|NCT02365636|157007729|FG000|Overall Study|Adverse Event|3|||
48771233|NCT02365636|157007730|FG001|Overall Study|Adverse Event|3|||
48771234|NCT02365636|157007731|FG002|Overall Study|Adverse Event|2|||
48771235|NCT02365636|157007729|FG000|Overall Study|Protocol Violation|1|||
48771236|NCT02365636|157007730|FG001|Overall Study|Protocol Violation|4|||
48771237|NCT02365636|157007731|FG002|Overall Study|Protocol Violation|0|||
48771238|NCT02365636|157007729|FG000|Overall Study|Lost to Follow-up|0|||
48771239|NCT02365636|157007730|FG001|Overall Study|Lost to Follow-up|0|||
48771240|NCT02365636|157007731|FG002|Overall Study|Lost to Follow-up|1|||
48771241|NCT02365636|157007729|FG000|Overall Study|Other|2|||
48771242|NCT02365636|157007730|FG001|Overall Study|Other|0|||
48771243|NCT02365636|157007731|FG002|Overall Study|Other|0|||
48771244|NCT01454934|157007735|FG000|Overall Study|Clinical progression|28|||
48771245|NCT01454934|157007736|FG001|Overall Study|Clinical progression|25|||
48771246|NCT01454934|157007735|FG000|Overall Study|Other|6|||
48771247|NCT01454934|157007736|FG001|Overall Study|Other|17|||
48771248|NCT01454934|157007735|FG000|Overall Study|Adverse Event|28|||
48771249|NCT01454934|157007736|FG001|Overall Study|Adverse Event|24|||
48771250|NCT01454934|157007735|FG000|Overall Study|Withdrawn consent|2|||
48771251|NCT01454934|157007736|FG001|Overall Study|Withdrawn consent|5|||
48771252|NCT01454934|157007735|FG000|Overall Study|Withdrawal by Subject|11|||
48771253|NCT01454934|157007736|FG001|Overall Study|Withdrawal by Subject|15|||
48771254|NCT01454934|157007735|FG000|Overall Study|Disease progression|194|||
48771255|NCT01454934|157007736|FG001|Overall Study|Disease progression|181|||
48771256|NCT01454934|157007735|FG000|Overall Study|Lost to Follow-up|0|||
48771257|NCT01454934|157007736|FG001|Overall Study|Lost to Follow-up|1|||
48771258|NCT01454934|157007735|FG000|Overall Study|Not treated|1|||
48771259|NCT01454934|157007736|FG001|Overall Study|Not treated|2|||
48771260|NCT01956110|157007737|FG000|Overall Study|Protocol Violation|25|||
48771261|NCT01956110|157007738|FG001|Overall Study|Protocol Violation|11|||
48771262|NCT01956110|157007737|FG000|Overall Study|Adverse Event|9|||
48771263|NCT01956110|157007738|FG001|Overall Study|Adverse Event|10|||
48771264|NCT01956110|157007737|FG000|Overall Study|Personal reasons|1|||
48771265|NCT01956110|157007738|FG001|Overall Study|Personal reasons|1|||
48771266|NCT00701129|157007746|FG000|Overall Study|Death|2|||
48771267|NCT01782313|157007748|FG000|Reached First Response/Completed 2 Cycle|Adverse Event|3|||
48771268|NCT01782313|157007748|FG000|Reached First Response/Completed 2 Cycle|Progressive Disease|3|||
48771269|NCT01782313|157007748|FG000|Treated Cycle 3|Progressive Disease|21|||
48771270|NCT01782313|157007748|FG000|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5|||
48771271|NCT01782313|157007748|FG000|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1|||
48771272|NCT01782313|157007748|FG000|Continued Treatment After 16 Weeks|Progressive Disease|6|||
48771273|NCT01782313|157007748|FG000|Continued Treatment After 16 Weeks|Withdrawal by Subject|1|||
48771274|NCT01782313|157007748|FG000|Survival Follow up|Lost to Follow-up|1|||
48771275|NCT02932891|157007749|FG000|Overall Study|Lost to Follow-up|2|||
48771276|NCT02932891|157007749|FG000|Overall Study|HPA Suppress|2|||
48771277|NCT02583256|157007750|FG000|Overall Study|Withdrawal by Subject|0|||
48771278|NCT02583256|157007751|FG001|Overall Study|Withdrawal by Subject|1|||
48771279|NCT02583256|157007752|FG002|Overall Study|Withdrawal by Subject|1|||
48771280|NCT02583256|157007753|FG003|Overall Study|Withdrawal by Subject|0|||
48771281|NCT02583256|157007750|FG000|Overall Study|Lost to Follow-up|1|||
48771282|NCT02583256|157007751|FG001|Overall Study|Lost to Follow-up|1|||
48771283|NCT02583256|157007752|FG002|Overall Study|Lost to Follow-up|0|||
48771284|NCT02583256|157007753|FG003|Overall Study|Lost to Follow-up|1|||
48771285|NCT02583256|157007750|FG000|Overall Study|Administrative/Other|2|||
48771286|NCT02583256|157007751|FG001|Overall Study|Administrative/Other|0|||
48771287|NCT02583256|157007752|FG002|Overall Study|Administrative/Other|1|||
48771288|NCT02583256|157007753|FG003|Overall Study|Administrative/Other|2|||
48771289|NCT03019627|157007754|FG000|Overall Study|Adverse Event|8|||
48771290|NCT03019627|157007755|FG001|Overall Study|Adverse Event|0|||
48771291|NCT03019627|157007754|FG000|Overall Study|Unrelated to adverse event|1|||
48771292|NCT03019627|157007755|FG001|Overall Study|Unrelated to adverse event|3|||
48771293|NCT03019627|157007754|FG000|Overall Study|Lost to Follow-up|2|||
48771294|NCT03019627|157007755|FG001|Overall Study|Lost to Follow-up|1|||
48771295|NCT03019627|157007754|FG000|Overall Study|not compliance|2|||
48771296|NCT03019627|157007755|FG001|Overall Study|not compliance|2|||
48771297|NCT03019627|157007754|FG000|Overall Study|Other|2|||
48771298|NCT03019627|157007755|FG001|Overall Study|Other|2|||
48771299|NCT00546715|157007756|FG000|Overall Study|Withdrawal by Subject|0|||
48771300|NCT00546715|157007757|FG001|Overall Study|Withdrawal by Subject|1|||
48771301|NCT00546715|157007758|FG002|Overall Study|Withdrawal by Subject|0|||
48771302|NCT00546715|157007759|FG003|Overall Study|Withdrawal by Subject|0|||
48771303|NCT00782210|157007760|FG000|Overall Study|Adverse Event|21|||
48771304|NCT00782210|157007761|FG001|Overall Study|Adverse Event|17|||
48771305|NCT00782210|157007762|FG002|Overall Study|Adverse Event|16|||
48771306|NCT00782210|157007760|FG000|Overall Study|Lost to Follow-up|2|||
48771307|NCT00782210|157007761|FG001|Overall Study|Lost to Follow-up|1|||
48771308|NCT00782210|157007762|FG002|Overall Study|Lost to Follow-up|2|||
48771309|NCT00782210|157007760|FG000|Overall Study|Withdrawal by Subject|11|||
48771310|NCT00782210|157007761|FG001|Overall Study|Withdrawal by Subject|8|||
48771311|NCT00782210|157007762|FG002|Overall Study|Withdrawal by Subject|11|||
48876296|NCT02547441|157384631|FG001|Double-Blind Study Period|Withdrawal by Subject|17|||
48771312|NCT00782210|157007760|FG000|Overall Study|Non compliance with protocol|0|||
48771313|NCT00782210|157007761|FG001|Overall Study|Non compliance with protocol|3|||
48771314|NCT00782210|157007762|FG002|Overall Study|Non compliance with protocol|2|||
48771315|NCT00782210|157007760|FG000|Overall Study|Lack of Efficacy|13|||
48771316|NCT00782210|157007761|FG001|Overall Study|Lack of Efficacy|4|||
48771317|NCT00782210|157007762|FG002|Overall Study|Lack of Efficacy|1|||
48771318|NCT00782210|157007760|FG000|Overall Study|Other reason not described above|3|||
48771319|NCT00782210|157007761|FG001|Overall Study|Other reason not described above|2|||
48771320|NCT00782210|157007762|FG002|Overall Study|Other reason not described above|3|||
48771321|NCT00654381|157007763|FG000|1st Stage|Adverse Event|3|||
48771322|NCT00654381|157007764|FG001|1st Stage|Adverse Event|3|||
48771323|NCT00654381|157007765|FG002|1st Stage|Adverse Event|3|||
48771324|NCT00654381|157007766|FG003|1st Stage|Adverse Event|3|||
48771325|NCT00654381|157007767|FG004|1st Stage|Adverse Event|2|||
48771326|NCT00654381|157007768|FG005|1st Stage|Adverse Event|1|||
48771327|NCT00654381|157007763|FG000|1st Stage|Withdrawal by Subject|0|||
48771328|NCT00654381|157007764|FG001|1st Stage|Withdrawal by Subject|0|||
48771329|NCT00654381|157007765|FG002|1st Stage|Withdrawal by Subject|0|||
48771330|NCT00654381|157007766|FG003|1st Stage|Withdrawal by Subject|1|||
48771331|NCT00654381|157007767|FG004|1st Stage|Withdrawal by Subject|0|||
48771332|NCT00654381|157007768|FG005|1st Stage|Withdrawal by Subject|1|||
48771333|NCT00654381|157007763|FG000|1st Stage|Investigator's decision|0|||
48771334|NCT00654381|157007764|FG001|1st Stage|Investigator's decision|0|||
48771335|NCT00654381|157007765|FG002|1st Stage|Investigator's decision|0|||
48771336|NCT00654381|157007766|FG003|1st Stage|Investigator's decision|1|||
48771337|NCT00654381|157007767|FG004|1st Stage|Investigator's decision|0|||
48771338|NCT00654381|157007768|FG005|1st Stage|Investigator's decision|0|||
48771339|NCT00654381|157007763|FG000|2nd Stage|Adverse Event|2|||
48771340|NCT00654381|157007764|FG001|2nd Stage|Adverse Event|0|||
48771341|NCT00654381|157007765|FG002|2nd Stage|Adverse Event|2|||
48771342|NCT00654381|157007766|FG003|2nd Stage|Adverse Event|3|||
48771343|NCT00654381|157007767|FG004|2nd Stage|Adverse Event|7|||
48771344|NCT00654381|157007768|FG005|2nd Stage|Adverse Event|2|||
48771345|NCT00654381|157007763|FG000|2nd Stage|Withdrawal by Subject|0|||
48771346|NCT00654381|157007764|FG001|2nd Stage|Withdrawal by Subject|0|||
48771347|NCT00654381|157007765|FG002|2nd Stage|Withdrawal by Subject|0|||
48771348|NCT00654381|157007766|FG003|2nd Stage|Withdrawal by Subject|0|||
48771349|NCT00654381|157007767|FG004|2nd Stage|Withdrawal by Subject|1|||
48771350|NCT00654381|157007768|FG005|2nd Stage|Withdrawal by Subject|1|||
48771351|NCT00654381|157007763|FG000|2nd Stage|Investigator's decision|0|||
48771352|NCT00654381|157007764|FG001|2nd Stage|Investigator's decision|0|||
48771353|NCT00654381|157007765|FG002|2nd Stage|Investigator's decision|1|||
48771354|NCT00654381|157007766|FG003|2nd Stage|Investigator's decision|1|||
48771355|NCT00654381|157007767|FG004|2nd Stage|Investigator's decision|0|||
48771356|NCT00654381|157007768|FG005|2nd Stage|Investigator's decision|0|||
48771357|NCT00654381|157007763|FG000|Extension Stage|Adverse Event|1|||
48771358|NCT00654381|157007764|FG001|Extension Stage|Adverse Event|2|||
48771359|NCT00654381|157007765|FG002|Extension Stage|Adverse Event|9|||
48771360|NCT00654381|157007766|FG003|Extension Stage|Adverse Event|7|||
48771361|NCT00654381|157007767|FG004|Extension Stage|Adverse Event|1|||
48771362|NCT00654381|157007768|FG005|Extension Stage|Adverse Event|1|||
48771363|NCT00654381|157007763|FG000|Extension Stage|Protocol Violation|0|||
48771364|NCT00654381|157007764|FG001|Extension Stage|Protocol Violation|0|||
48771365|NCT00654381|157007765|FG002|Extension Stage|Protocol Violation|0|||
48876297|NCT02547441|157384630|FG000|Double-Blind Study Period|Sponsor Decision|1|||
48876298|NCT02547441|157384631|FG001|Double-Blind Study Period|Sponsor Decision|0|||
48876299|NCT02547441|157384630|FG000|Open-Label Study Period|Adverse Event|10|||
49026720|NCT00723528|157937501|FG004|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
49026721|NCT00723528|157937502|FG005|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
49026722|NCT00723528|157937503|FG006|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
49026723|NCT00723528|157937497|FG000|Period 2: After Controlled Period|Withdrawal by Subject|0|||
49026724|NCT00723528|157937498|FG001|Period 2: After Controlled Period|Withdrawal by Subject|0|||
49026725|NCT00723528|157937499|FG002|Period 2: After Controlled Period|Withdrawal by Subject|0|||
49026726|NCT00723528|157937500|FG003|Period 2: After Controlled Period|Withdrawal by Subject|1|||
49026727|NCT00723528|157937501|FG004|Period 2: After Controlled Period|Withdrawal by Subject|0|||
49026728|NCT00723528|157937502|FG005|Period 2: After Controlled Period|Withdrawal by Subject|1|||
49026729|NCT00723528|157937503|FG006|Period 2: After Controlled Period|Withdrawal by Subject|1|||
49026730|NCT00723528|157937497|FG000|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
49026731|NCT00723528|157937498|FG001|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
48771366|NCT00654381|157007766|FG003|Extension Stage|Protocol Violation|1|||
48771367|NCT00654381|157007767|FG004|Extension Stage|Protocol Violation|0|||
48771368|NCT00654381|157007768|FG005|Extension Stage|Protocol Violation|0|||
48771369|NCT00654381|157007763|FG000|Extension Stage|Lack of Efficacy|0|||
48771370|NCT00654381|157007764|FG001|Extension Stage|Lack of Efficacy|0|||
48771371|NCT00654381|157007765|FG002|Extension Stage|Lack of Efficacy|1|||
48771372|NCT00654381|157007766|FG003|Extension Stage|Lack of Efficacy|0|||
48771373|NCT00654381|157007767|FG004|Extension Stage|Lack of Efficacy|0|||
48771374|NCT00654381|157007768|FG005|Extension Stage|Lack of Efficacy|0|||
48771375|NCT00654381|157007763|FG000|Extension Stage|Withdrawal by Subject|0|||
48771376|NCT00654381|157007764|FG001|Extension Stage|Withdrawal by Subject|0|||
48771377|NCT00654381|157007765|FG002|Extension Stage|Withdrawal by Subject|1|||
48771378|NCT00654381|157007766|FG003|Extension Stage|Withdrawal by Subject|1|||
48771379|NCT00654381|157007767|FG004|Extension Stage|Withdrawal by Subject|1|||
48771380|NCT00654381|157007768|FG005|Extension Stage|Withdrawal by Subject|1|||
48771381|NCT00654381|157007763|FG000|Extension Stage|Closure of the trial site|0|||
48771382|NCT00654381|157007764|FG001|Extension Stage|Closure of the trial site|0|||
48771383|NCT00654381|157007765|FG002|Extension Stage|Closure of the trial site|0|||
48771384|NCT00654381|157007766|FG003|Extension Stage|Closure of the trial site|0|||
48771385|NCT00654381|157007767|FG004|Extension Stage|Closure of the trial site|1|||
48771386|NCT00654381|157007768|FG005|Extension Stage|Closure of the trial site|1|||
48771387|NCT03852316|157007769|FG000|Overall Study|Protocol Violation|1|||
48771388|NCT03852316|157007769|FG000|Overall Study|Withdrawal by Subject|2|||
48771389|NCT03852316|157007769|FG000|Overall Study|Enrolled but Device not Utilized|1|||
49026732|NCT00723528|157937499|FG002|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
49026733|NCT00723528|157937500|FG003|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
49026734|NCT00723528|157937501|FG004|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
49026735|NCT00723528|157937502|FG005|Period 2: After Controlled Period|Onset of tuberculosis infection|1|||
49026736|NCT00723528|157937503|FG006|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
49026737|NCT00723528|157937497|FG000|Period 2: After Controlled Period|Other|0|||
49026738|NCT00723528|157937498|FG001|Period 2: After Controlled Period|Other|0|||
49026739|NCT00723528|157937499|FG002|Period 2: After Controlled Period|Other|0|||
48771390|NCT01430585|157007770|FG000|Overall Study|Death|1|||
48771391|NCT01430585|157007770|FG000|Overall Study|Objective Progression or Relapse|3|||
48771392|NCT01430585|157007770|FG000|Overall Study|Study Terminated by Sponsor|3|||
48771393|NCT01430585|157007770|FG000|Overall Study|Other|7|||
48771394|NCT00850200|157007771|FG000|Overall Study|Physician Decision|2|||
48771395|NCT00850200|157007771|FG000|Overall Study|Did not recieve treatment|2|||
48771396|NCT00850200|157007771|FG000|Overall Study|Withdrawal by Subject|1|||
48771397|NCT03277261|157007782|FG000|Overall Study|Adverse Event|17|||
48771398|NCT03277261|157007783|FG001|Overall Study|Adverse Event|1|||
49026740|NCT00723528|157937500|FG003|Period 2: After Controlled Period|Other|0|||
49026741|NCT00723528|157937501|FG004|Period 2: After Controlled Period|Other|1|||
49026742|NCT00723528|157937502|FG005|Period 2: After Controlled Period|Other|4|||
49026743|NCT00723528|157937503|FG006|Period 2: After Controlled Period|Other|0|||
49026744|NCT00723528|157937497|FG000|Period 2: After Controlled Period|Adverse Event|0|||
49026745|NCT00723528|157937498|FG001|Period 2: After Controlled Period|Adverse Event|0|||
49026746|NCT00723528|157937499|FG002|Period 2: After Controlled Period|Adverse Event|0|||
49026747|NCT00723528|157937500|FG003|Period 2: After Controlled Period|Adverse Event|0|||
49026748|NCT00723528|157937501|FG004|Period 2: After Controlled Period|Adverse Event|1|||
49026749|NCT00723528|157937502|FG005|Period 2: After Controlled Period|Adverse Event|0|||
49026750|NCT00723528|157937503|FG006|Period 2: After Controlled Period|Adverse Event|1|||
49026751|NCT00723528|157937497|FG000|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
49026752|NCT00723528|157937498|FG001|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
48771399|NCT03277261|157007782|FG000|Overall Study|Participant Withdrawal of Consent|6|||
48771400|NCT03277261|157007783|FG001|Overall Study|Participant Withdrawal of Consent|15|||
48771401|NCT03277261|157007782|FG000|Overall Study|Investigator / Sponsor Decision|4|||
48771402|NCT03277261|157007783|FG001|Overall Study|Investigator / Sponsor Decision|2|||
48771403|NCT03277261|157007782|FG000|Overall Study|Pregnancy|2|||
48771404|NCT03277261|157007783|FG001|Overall Study|Pregnancy|0|||
48771405|NCT03277261|157007782|FG000|Overall Study|Lost to Follow-up|2|||
48771406|NCT03277261|157007783|FG001|Overall Study|Lost to Follow-up|2|||
48771407|NCT03277261|157007782|FG000|Overall Study|Lack of Efficacy|2|||
48771408|NCT03277261|157007783|FG001|Overall Study|Lack of Efficacy|2|||
48771409|NCT03277261|157007782|FG000|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
48771410|NCT03277261|157007783|FG001|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
48771411|NCT01252290|157007784|FG000|Overall Study|Withdrawal by Subject|1|||
48771412|NCT00354172|157007787|FG000|Overall Study|Did not receive transplant|1|||
48771413|NCT01800916|157007788|FG000|Test Period 1 (1 Week)|Convex product user|0|||
48771414|NCT01800916|157007789|FG001|Test Period 1 (1 Week)|Convex product user|0|||
48771415|NCT01800916|157007790|FG002|Test Period 1 (1 Week)|Convex product user|0|||
48771416|NCT01800916|157007791|FG003|Test Period 1 (1 Week)|Convex product user|1|||
48771417|NCT01800916|157007792|FG004|Test Period 1 (1 Week)|Convex product user|0|||
48771418|NCT01800916|157007793|FG005|Test Period 1 (1 Week)|Convex product user|0|||
48771419|NCT01800916|157007794|FG006|Test Period 1 (1 Week)|Convex product user|0|||
48771420|NCT01800916|157007795|FG007|Test Period 1 (1 Week)|Convex product user|0|||
48771421|NCT01800916|157007796|FG008|Test Period 1 (1 Week)|Convex product user|0|||
48771422|NCT01800916|157007788|FG000|Test Period 1 (1 Week)|Adverse Event|0|||
48771423|NCT01800916|157007789|FG001|Test Period 1 (1 Week)|Adverse Event|0|||
48771424|NCT01800916|157007790|FG002|Test Period 1 (1 Week)|Adverse Event|0|||
48771425|NCT01800916|157007791|FG003|Test Period 1 (1 Week)|Adverse Event|0|||
48771426|NCT01800916|157007792|FG004|Test Period 1 (1 Week)|Adverse Event|1|||
48771427|NCT01800916|157007793|FG005|Test Period 1 (1 Week)|Adverse Event|0|||
48771428|NCT01800916|157007794|FG006|Test Period 1 (1 Week)|Adverse Event|0|||
48771429|NCT01800916|157007795|FG007|Test Period 1 (1 Week)|Adverse Event|0|||
48771430|NCT01800916|157007796|FG008|Test Period 1 (1 Week)|Adverse Event|0|||
48771431|NCT03144180|157007798|FG000|Overall Study|STAT Delivery|1|||
48771432|NCT03144180|157007799|FG001|Overall Study|STAT Delivery|1|||
48771433|NCT03144180|157007798|FG000|Overall Study|Provider forgot to fill out forms|1|||
48771434|NCT03144180|157007799|FG001|Overall Study|Provider forgot to fill out forms|3|||
49026753|NCT00723528|157937499|FG002|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
49026754|NCT00723528|157937500|FG003|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
49026755|NCT00723528|157937501|FG004|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
49026756|NCT00723528|157937502|FG005|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
49026757|NCT00723528|157937503|FG006|Period 2: After Controlled Period|Use of prohibited concomitant medication|1|||
49026758|NCT00723528|157937497|FG000|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
49026759|NCT00723528|157937498|FG001|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
49026760|NCT00723528|157937499|FG002|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
49026761|NCT00723528|157937500|FG003|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
49026762|NCT00723528|157937501|FG004|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
49026763|NCT00723528|157937502|FG005|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
49026764|NCT00723528|157937503|FG006|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1|||
49026765|NCT00528606|157937509|FG000|Overall Study|Withdrew consent|4|||
49026766|NCT00528606|157937510|FG001|Overall Study|Withdrew consent|3|||
49026767|NCT00528606|157937509|FG000|Overall Study|Lost to Follow-up|4|||
49026768|NCT00528606|157937510|FG001|Overall Study|Lost to Follow-up|1|||
49026769|NCT00528606|157937509|FG000|Overall Study|Adverse Event|3|||
49026770|NCT00528606|157937510|FG001|Overall Study|Adverse Event|0|||
49026771|NCT00528606|157937509|FG000|Overall Study|Other|2|||
49026772|NCT00528606|157937510|FG001|Overall Study|Other|0|||
49026773|NCT01471093|157937511|FG000|Overall Study|Adverse Event|1|||
49026774|NCT01471093|157937512|FG001|Overall Study|Adverse Event|0|||
49026775|NCT01471093|157937513|FG002|Overall Study|Adverse Event|0|||
48771435|NCT03144180|157007798|FG000|Overall Study|Provider forgot to use the Q-cup|0|||
48771436|NCT03144180|157007799|FG001|Overall Study|Provider forgot to use the Q-cup|1|||
49026776|NCT01471093|157937514|FG003|Overall Study|Adverse Event|0|||
49026777|NCT02475954|157937515|FG000|Overall Study|Withdrawal by Subject|2|||
49026778|NCT02475954|157937516|FG001|Overall Study|Withdrawal by Subject|2|||
49026779|NCT02475954|157937515|FG000|Overall Study|Lost to Follow-up|11|||
49026780|NCT02475954|157937516|FG001|Overall Study|Lost to Follow-up|9|||
49026781|NCT02475954|157937515|FG000|Overall Study|Death|1|||
49026782|NCT02475954|157937516|FG001|Overall Study|Death|1|||
49026783|NCT02932878|157937518|FG000|Overall Study|Due to Lab Results|2|||
49026784|NCT02932878|157937519|FG001|Overall Study|Due to Lab Results|1|||
49026785|NCT01993030|157937520|FG000|Overall Study|Adverse Event|0|||
49026786|NCT01993030|157937521|FG001|Overall Study|Adverse Event|4|||
49026787|NCT00620022|157937522|FG000|Treatment Period 1|Adverse Event|4|||
49026788|NCT00620022|157937523|FG001|Treatment Period 1|Adverse Event|6|||
49026789|NCT00620022|157937522|FG000|Treatment Period 1|Subject withdrew consent|1|||
49026790|NCT00620022|157937523|FG001|Treatment Period 1|Subject withdrew consent|0|||
49026791|NCT00620022|157937522|FG000|Treatment Period 2|Adverse Event|2|||
49026792|NCT00620022|157937523|FG001|Treatment Period 2|Adverse Event|2|||
49026793|NCT03340727|157937526|FG000|Overall Study|Death|1|||
49026794|NCT03340727|157937527|FG001|Overall Study|Death|0|||
48771437|NCT03144180|157007798|FG000|Overall Study|Scrub tech removed tube cap|0|||
48771438|NCT03144180|157007799|FG001|Overall Study|Scrub tech removed tube cap|1|||
48771439|NCT03746522|157007800|FG000|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
48771440|NCT03746522|157007801|FG001|Period 1: Double-Blind (14 Weeks)|Adverse Event|1|||
48771441|NCT03746522|157007802|FG002|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
48771442|NCT03746522|157007800|FG000|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
48771443|NCT03746522|157007801|FG001|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|1|||
48771444|NCT03746522|157007802|FG002|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
48771445|NCT03746522|157007800|FG000|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
48771446|NCT03746522|157007801|FG001|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
48771447|NCT03746522|157007802|FG002|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|3|||
48771448|NCT03746522|157007800|FG000|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
48771449|NCT03746522|157007801|FG001|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
48771450|NCT03746522|157007802|FG002|Period 2: Open-Label (38 Weeks)|Adverse Event|4|||
48771451|NCT03746522|157007800|FG000|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
48771452|NCT03746522|157007801|FG001|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
48771453|NCT03746522|157007802|FG002|Period 2: Open-Label (38 Weeks)|Other than specified|2|||
48771454|NCT02552316|157007806|FG000|Overall Study|Withdrawal by Subject|1|||
48771455|NCT02552316|157007806|FG000|Overall Study|Withdrawal due to non-compliance|1|||
49026795|NCT03340727|157937526|FG000|Overall Study|Lost to Follow-up|31|||
49026796|NCT03340727|157937527|FG001|Overall Study|Lost to Follow-up|35|||
49026797|NCT03340727|157937526|FG000|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
48771456|NCT00684424|157007807|FG000|Overall Study|Adverse Event|1|||
48771457|NCT00684424|157007807|FG000|Overall Study|Lost to Follow-up|2|||
49026798|NCT03340727|157937527|FG001|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
49026799|NCT03340727|157937526|FG000|Overall Study|Transferred to another facility|10|||
49026800|NCT03340727|157937527|FG001|Overall Study|Transferred to another facility|7|||
49026801|NCT03340727|157937526|FG000|Overall Study|Withdrawal by Subject|28|||
49026802|NCT03340727|157937527|FG001|Overall Study|Withdrawal by Subject|17|||
49026803|NCT01902173|157937528|FG000|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1|||
48771458|NCT00684424|157007807|FG000|Overall Study|Other|2|||
49026804|NCT01902173|157937529|FG001|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
49026805|NCT01902173|157937530|FG002|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
49026806|NCT01902173|157937531|FG003|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
49026807|NCT01902173|157937532|FG004|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
49026808|NCT01902173|157937533|FG005|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
49026809|NCT01902173|157937528|FG000|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2|||
49026810|NCT01902173|157937529|FG001|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
49026811|NCT01902173|157937530|FG002|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
49026812|NCT01902173|157937531|FG003|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
49026813|NCT01902173|157937532|FG004|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
48771459|NCT00353366|157007809|FG000|Overall Study|Adverse Event|8|||
48771460|NCT00353366|157007809|FG000|Overall Study|Protocol Violation|12|||
48771461|NCT00353366|157007809|FG000|Overall Study|Withdrawal by Subject|12|||
48771462|NCT00353366|157007809|FG000|Overall Study|Lost to Follow-up|92|||
48771463|NCT00353366|157007809|FG000|Overall Study|Other|19|||
48771464|NCT04116710|157007810|FG000|Overall Study|Death|4|||
48771465|NCT04116710|157007811|FG001|Overall Study|Death|6|||
48771466|NCT04116710|157007812|FG002|Overall Study|Death|3|||
48771467|NCT04116710|157007813|FG003|Overall Study|Death|1|||
48771468|NCT04116710|157007810|FG000|Overall Study|Withdrawal by Subject|0|||
48771469|NCT04116710|157007811|FG001|Overall Study|Withdrawal by Subject|0|||
48771470|NCT04116710|157007812|FG002|Overall Study|Withdrawal by Subject|0|||
48771471|NCT04116710|157007813|FG003|Overall Study|Withdrawal by Subject|1|||
48771472|NCT01109316|157007814|FG000|Study Period 1|Adverse Event|0|||
48771473|NCT01109316|157007815|FG001|Study Period 1|Adverse Event|0|||
48771474|NCT01109316|157007816|FG002|Study Period 1|Adverse Event|1|||
48771475|NCT01109316|157007817|FG003|Study Period 1|Adverse Event|0|||
48771476|NCT01109316|157007818|FG004|Study Period 1|Adverse Event|0|||
48771477|NCT01109316|157007819|FG005|Study Period 1|Adverse Event|0|||
48771478|NCT01109316|157007814|FG000|Study Period 1|Lost to Follow-up|0|||
48771479|NCT01109316|157007815|FG001|Study Period 1|Lost to Follow-up|0|||
48771480|NCT01109316|157007816|FG002|Study Period 1|Lost to Follow-up|1|||
48771481|NCT01109316|157007817|FG003|Study Period 1|Lost to Follow-up|1|||
48771482|NCT01109316|157007818|FG004|Study Period 1|Lost to Follow-up|0|||
48771483|NCT01109316|157007819|FG005|Study Period 1|Lost to Follow-up|0|||
48771484|NCT01109316|157007814|FG000|Study Period 1|Withdrawal by Subject|0|||
48771485|NCT01109316|157007815|FG001|Study Period 1|Withdrawal by Subject|0|||
48771486|NCT01109316|157007816|FG002|Study Period 1|Withdrawal by Subject|1|||
48771487|NCT01109316|157007817|FG003|Study Period 1|Withdrawal by Subject|0|||
48771488|NCT01109316|157007818|FG004|Study Period 1|Withdrawal by Subject|2|||
48771489|NCT01109316|157007819|FG005|Study Period 1|Withdrawal by Subject|0|||
48771490|NCT01109316|157007814|FG000|Study Period 1|Sponsor Decision|0|||
48771491|NCT01109316|157007815|FG001|Study Period 1|Sponsor Decision|0|||
48771492|NCT01109316|157007816|FG002|Study Period 1|Sponsor Decision|0|||
48771493|NCT01109316|157007817|FG003|Study Period 1|Sponsor Decision|0|||
48771494|NCT01109316|157007818|FG004|Study Period 1|Sponsor Decision|0|||
48771495|NCT01109316|157007819|FG005|Study Period 1|Sponsor Decision|2|||
48771496|NCT01109316|157007814|FG000|Study Period 2|Entry Criteria Not Met|0|||
48771497|NCT01109316|157007815|FG001|Study Period 2|Entry Criteria Not Met|1|||
48771498|NCT01109316|157007816|FG002|Study Period 2|Entry Criteria Not Met|0|||
48771499|NCT01109316|157007817|FG003|Study Period 2|Entry Criteria Not Met|0|||
48771500|NCT01109316|157007818|FG004|Study Period 2|Entry Criteria Not Met|0|||
48771501|NCT01109316|157007819|FG005|Study Period 2|Entry Criteria Not Met|0|||
48771502|NCT01109316|157007814|FG000|Study Period 2|Physician Decision|0|||
48771503|NCT01109316|157007815|FG001|Study Period 2|Physician Decision|0|||
48771504|NCT01109316|157007816|FG002|Study Period 2|Physician Decision|0|||
48771505|NCT01109316|157007817|FG003|Study Period 2|Physician Decision|1|||
48771506|NCT01109316|157007818|FG004|Study Period 2|Physician Decision|0|||
48771507|NCT01109316|157007819|FG005|Study Period 2|Physician Decision|0|||
48771508|NCT01109316|157007814|FG000|Study Period 2|Protocol Violation|1|||
48771509|NCT01109316|157007815|FG001|Study Period 2|Protocol Violation|0|||
48771510|NCT01109316|157007816|FG002|Study Period 2|Protocol Violation|0|||
48771511|NCT01109316|157007817|FG003|Study Period 2|Protocol Violation|0|||
48771512|NCT01109316|157007818|FG004|Study Period 2|Protocol Violation|0|||
48771513|NCT01109316|157007819|FG005|Study Period 2|Protocol Violation|0|||
49026814|NCT01902173|157937533|FG005|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
49026815|NCT01902173|157937528|FG000|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
49026816|NCT01902173|157937529|FG001|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5|||
48771514|NCT01109316|157007814|FG000|Study Period 2|Withdrawal by Subject|0|||
48771515|NCT01109316|157007815|FG001|Study Period 2|Withdrawal by Subject|0|||
48771516|NCT01109316|157007816|FG002|Study Period 2|Withdrawal by Subject|1|||
48771517|NCT01109316|157007817|FG003|Study Period 2|Withdrawal by Subject|0|||
48876300|NCT02547441|157384631|FG001|Open-Label Study Period|Adverse Event|11|||
48876301|NCT02547441|157384630|FG000|Open-Label Study Period|Lack of Efficacy|3|||
48876302|NCT02547441|157384631|FG001|Open-Label Study Period|Lack of Efficacy|2|||
48876303|NCT02547441|157384630|FG000|Open-Label Study Period|Lost to Follow-up|7|||
48876304|NCT02547441|157384631|FG001|Open-Label Study Period|Lost to Follow-up|8|||
48876305|NCT02547441|157384630|FG000|Open-Label Study Period|Physician Decision|1|||
48876306|NCT02547441|157384631|FG001|Open-Label Study Period|Physician Decision|0|||
48876307|NCT02547441|157384630|FG000|Open-Label Study Period|Protocol Violation|2|||
48876308|NCT02547441|157384631|FG001|Open-Label Study Period|Protocol Violation|0|||
48876309|NCT02547441|157384630|FG000|Open-Label Study Period|Withdrawal by Subject|33|||
48876310|NCT02547441|157384631|FG001|Open-Label Study Period|Withdrawal by Subject|37|||
48876311|NCT02547441|157384630|FG000|Open-Label Study Period|Terminated by Sponsor|66|||
48876312|NCT02547441|157384631|FG001|Open-Label Study Period|Terminated by Sponsor|69|||
48876313|NCT01322009|157384632|FG000|Overall Study|Death|0|||
48876314|NCT01322009|157384633|FG001|Overall Study|Death|1|||
48876315|NCT01322009|157384632|FG000|Overall Study|Adverse Event|0|||
48876316|NCT01322009|157384633|FG001|Overall Study|Adverse Event|1|||
48876317|NCT01322009|157384632|FG000|Overall Study|ng tube discontinued|0|||
48876318|NCT01322009|157384633|FG001|Overall Study|ng tube discontinued|1|||
48876319|NCT02586415|157384638|FG000|Overall Study|Death|13|||
48876320|NCT02586415|157384639|FG001|Overall Study|Death|23|||
48876321|NCT02586415|157384638|FG000|Overall Study|Lost to Follow-up|1|||
48876322|NCT02586415|157384639|FG001|Overall Study|Lost to Follow-up|2|||
48876323|NCT02250534|157384640|FG000|Overall Study|Lost to Follow-up|18|||
48876324|NCT02250534|157384641|FG001|Overall Study|Lost to Follow-up|28|||
48876325|NCT02250534|157384642|FG002|Overall Study|Lost to Follow-up|33|||
48876326|NCT02250534|157384640|FG000|Overall Study|Personal reasons|7|||
48876327|NCT02250534|157384641|FG001|Overall Study|Personal reasons|8|||
48876328|NCT02250534|157384642|FG002|Overall Study|Personal reasons|14|||
48876329|NCT02250534|157384640|FG000|Overall Study|Adverse Event|6|||
48876330|NCT02250534|157384641|FG001|Overall Study|Adverse Event|3|||
48876331|NCT02250534|157384642|FG002|Overall Study|Adverse Event|8|||
48876332|NCT02250534|157384640|FG000|Overall Study|incarcerated|2|||
48876333|NCT02250534|157384641|FG001|Overall Study|incarcerated|1|||
48876334|NCT02250534|157384642|FG002|Overall Study|incarcerated|2|||
48876335|NCT02250534|157384640|FG000|Overall Study|Withdrawal by Subject|0|||
48876336|NCT02250534|157384641|FG001|Overall Study|Withdrawal by Subject|1|||
48876337|NCT02250534|157384642|FG002|Overall Study|Withdrawal by Subject|2|||
48876338|NCT02250534|157384640|FG000|Overall Study|Death|0|||
48876339|NCT02250534|157384641|FG001|Overall Study|Death|1|||
48876340|NCT02250534|157384642|FG002|Overall Study|Death|1|||
48876341|NCT02250534|157384640|FG000|Overall Study|Physician Decision|1|||
48876342|NCT02250534|157384641|FG001|Overall Study|Physician Decision|3|||
48982206|NCT02712008|157767526|FG003|From Week 12 up to Week 36|Withdrawal by Subject|0|||
48982207|NCT02712008|157767527|FG004|From Week 12 up to Week 36|Withdrawal by Subject|0|||
48771518|NCT01109316|157007818|FG004|Study Period 2|Withdrawal by Subject|0|||
48771519|NCT01109316|157007819|FG005|Study Period 2|Withdrawal by Subject|1|||
48771520|NCT01109316|157007814|FG000|Study Period 3|Lost to Follow-up|0|||
48771521|NCT01109316|157007815|FG001|Study Period 3|Lost to Follow-up|0|||
48771522|NCT01109316|157007816|FG002|Study Period 3|Lost to Follow-up|0|||
48771523|NCT01109316|157007817|FG003|Study Period 3|Lost to Follow-up|0|||
48771524|NCT01109316|157007818|FG004|Study Period 3|Lost to Follow-up|1|||
48771525|NCT01109316|157007819|FG005|Study Period 3|Lost to Follow-up|0|||
48771526|NCT01109316|157007814|FG000|Study Period 3|Withdrawal by Subject|1|||
48771527|NCT01109316|157007815|FG001|Study Period 3|Withdrawal by Subject|0|||
48771528|NCT01109316|157007816|FG002|Study Period 3|Withdrawal by Subject|0|||
48771529|NCT01109316|157007817|FG003|Study Period 3|Withdrawal by Subject|0|||
48771530|NCT01109316|157007818|FG004|Study Period 3|Withdrawal by Subject|1|||
48771531|NCT01109316|157007819|FG005|Study Period 3|Withdrawal by Subject|0|||
48982208|NCT02712008|157767528|FG005|From Week 12 up to Week 36|Withdrawal by Subject|0|||
48982209|NCT02712008|157767529|FG006|From Week 12 up to Week 36|Withdrawal by Subject|3|||
48982210|NCT02712008|157767530|FG007|From Week 12 up to Week 36|Withdrawal by Subject|2|||
48982211|NCT04315298|157767531|FG000|Overall Study|Withdrawal by Subject|0|||
48771532|NCT01120210|157007820|FG000|MAIN INFUSION|Adverse Event|1|||
48771533|NCT01120210|157007821|FG001|MAIN INFUSION|Adverse Event|0|||
48771534|NCT01120210|157007820|FG000|MAIN INFUSION|Withdrawal by Subject|0|||
48771535|NCT01120210|157007821|FG001|MAIN INFUSION|Withdrawal by Subject|1|||
48876343|NCT02250534|157384642|FG002|Overall Study|Physician Decision|1|||
48876344|NCT02250534|157384640|FG000|Overall Study|Protocol Violation|1|||
48876345|NCT02250534|157384641|FG001|Overall Study|Protocol Violation|0|||
48876346|NCT02250534|157384642|FG002|Overall Study|Protocol Violation|1|||
48876347|NCT02250534|157384640|FG000|Overall Study|Reason unknown|1|||
48876348|NCT02250534|157384641|FG001|Overall Study|Reason unknown|0|||
48876349|NCT02250534|157384642|FG002|Overall Study|Reason unknown|0|||
48876350|NCT00832000|157384643|FG000|Overall Study|Adverse Event|2|||
48876351|NCT00832000|157384644|FG001|Overall Study|Adverse Event|0|||
48876352|NCT00832000|157384643|FG000|Overall Study|Withdrawal by Subject|1|||
48876353|NCT00832000|157384644|FG001|Overall Study|Withdrawal by Subject|0|||
49026817|NCT01902173|157937530|FG002|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
49026818|NCT01902173|157937531|FG003|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
49026819|NCT01902173|157937532|FG004|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
49026820|NCT01902173|157937533|FG005|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
49026821|NCT01902173|157937528|FG000|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
48771536|NCT02043015|157007822|FG000|Overall Study|Lost to Follow-up|4|||
48771537|NCT02043015|157007822|FG000|Overall Study|Withdrawal by Subject|4|||
48771538|NCT02043015|157007822|FG000|Overall Study|Removed once target enrollment reached|15|||
48771539|NCT02043015|157007822|FG000|Overall Study|Participant moved away from study city|4|||
48771540|NCT02043015|157007822|FG000|Overall Study|Incarceration|1|||
48771541|NCT00775437|157007823|FG000|Overall Study|Loss of efficacy|2|||
48771542|NCT00775437|157007823|FG000|Overall Study|Withdrawal by Subject|3|||
48771543|NCT00775437|157007823|FG000|Overall Study|Lost to Follow-up|1|||
48771544|NCT03075644|157007827|FG000|Overall Study|Withdrawal by Subject|1|||
48771545|NCT03075644|157007828|FG001|Overall Study|Withdrawal by Subject|1|||
48771546|NCT01205165|157007829|FG000|Overall Study|Lost to Follow-up|2|||
48771547|NCT03306264|157007830|FG000|Overall Study|Death|33|||
48771548|NCT03306264|157007831|FG001|Overall Study|Death|25|||
48771549|NCT03306264|157007832|FG002|Overall Study|Death|34|||
48771550|NCT03306264|157007833|FG003|Overall Study|Death|34|||
48771551|NCT03306264|157007830|FG000|Overall Study|Complete Consent Withdrawal|4|||
48771552|NCT03306264|157007831|FG001|Overall Study|Complete Consent Withdrawal|4|||
48771553|NCT03306264|157007832|FG002|Overall Study|Complete Consent Withdrawal|1|||
48771554|NCT03306264|157007833|FG003|Overall Study|Complete Consent Withdrawal|8|||
48771555|NCT03306264|157007830|FG000|Overall Study|Lost to Follow-up|1|||
48771556|NCT03306264|157007831|FG001|Overall Study|Lost to Follow-up|0|||
48771557|NCT03306264|157007832|FG002|Overall Study|Lost to Follow-up|1|||
48771558|NCT03306264|157007833|FG003|Overall Study|Lost to Follow-up|0|||
48771559|NCT03306264|157007830|FG000|Overall Study|Rollover to ASTX727-06|10|||
48771560|NCT03306264|157007831|FG001|Overall Study|Rollover to ASTX727-06|18|||
48771561|NCT03306264|157007832|FG002|Overall Study|Rollover to ASTX727-06|4|||
48771562|NCT03306264|157007833|FG003|Overall Study|Rollover to ASTX727-06|2|||
48771563|NCT03306264|157007830|FG000|Overall Study|Study Centre Terminated by Sponsor|21|||
48771564|NCT03306264|157007831|FG001|Overall Study|Study Centre Terminated by Sponsor|22|||
48771565|NCT03306264|157007832|FG002|Overall Study|Study Centre Terminated by Sponsor|4|||
48771566|NCT03306264|157007833|FG003|Overall Study|Study Centre Terminated by Sponsor|1|||
48771567|NCT01706250|157007838|FG000|Overall Study|Lost to Follow-up|2|||
48771568|NCT02143843|157007839|FG000|Overall Study|Adverse Event|8|||
48771569|NCT02143843|157007839|FG000|Overall Study|Lack of Efficacy|2|||
48771570|NCT02143843|157007839|FG000|Overall Study|Withdrawal by Subject|2|||
48771571|NCT03044197|157007842|FG000|Overall Study|Withdrawal by Subject|3|||
48771572|NCT03044197|157007843|FG001|Overall Study|Withdrawal by Subject|1|||
48771573|NCT01720069|157007844|FG000|Overall Study|Could not use e-diary correctly|0|||
48771574|NCT01720069|157007845|FG001|Overall Study|Could not use e-diary correctly|1|||
48771575|NCT01720069|157007846|FG002|Overall Study|Could not use e-diary correctly|1|||
48771576|NCT01720069|157007844|FG000|Overall Study|Randomised without baseline values|0|||
48771577|NCT01720069|157007845|FG001|Overall Study|Randomised without baseline values|0|||
48771578|NCT01720069|157007846|FG002|Overall Study|Randomised without baseline values|1|||
48771579|NCT01720069|157007844|FG000|Overall Study|Adverse Event|0|||
48771580|NCT01720069|157007845|FG001|Overall Study|Adverse Event|0|||
48771581|NCT01720069|157007846|FG002|Overall Study|Adverse Event|1|||
48771582|NCT01720069|157007844|FG000|Overall Study|Lack of Efficacy|0|||
48771583|NCT01720069|157007845|FG001|Overall Study|Lack of Efficacy|4|||
48771584|NCT01720069|157007846|FG002|Overall Study|Lack of Efficacy|0|||
48771585|NCT01720069|157007844|FG000|Overall Study|Treatment period withdrawal criteria met|4|||
48771586|NCT01720069|157007845|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
48771587|NCT01720069|157007846|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
48771588|NCT01720069|157007844|FG000|Overall Study|Withdrawal by Subject|0|||
48771589|NCT01720069|157007845|FG001|Overall Study|Withdrawal by Subject|2|||
49026822|NCT01902173|157937529|FG001|Phase 1 Doublet Regimen Cohort 2|Ineligible|1|||
49026823|NCT01902173|157937530|FG002|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
49026824|NCT01902173|157937531|FG003|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
49026825|NCT01902173|157937532|FG004|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
48771590|NCT01720069|157007846|FG002|Overall Study|Withdrawal by Subject|1|||
48771591|NCT01720069|157007844|FG000|Overall Study|OCS bursts occured, discontinued in line|1|||
48771592|NCT01720069|157007845|FG001|Overall Study|OCS bursts occured, discontinued in line|0|||
48771593|NCT01720069|157007846|FG002|Overall Study|OCS bursts occured, discontinued in line|0|||
48771594|NCT01720069|157007844|FG000|Overall Study|Non-compliance on using e-diary|0|||
48771595|NCT01720069|157007845|FG001|Overall Study|Non-compliance on using e-diary|0|||
48771596|NCT01720069|157007846|FG002|Overall Study|Non-compliance on using e-diary|1|||
48771597|NCT01720069|157007844|FG000|Overall Study|Lost to Follow-up|0|||
48771598|NCT01720069|157007845|FG001|Overall Study|Lost to Follow-up|0|||
48771599|NCT01720069|157007846|FG002|Overall Study|Lost to Follow-up|1|||
48771600|NCT02318693|157007847|FG000|Overall Study|Protocol Violation|0|||
48771601|NCT02318693|157007848|FG001|Overall Study|Protocol Violation|1|||
48771602|NCT00218543|157007850|FG000|Overall Study|Lost to Follow-up|8|||
48771603|NCT00218543|157007850|FG000|Overall Study|relocated|1|||
48771604|NCT00218543|157007850|FG000|Overall Study|Withdrawal by Subject|1|||
48771605|NCT00218543|157007850|FG000|Overall Study|Physician Decision|3|||
48771606|NCT00218543|157007850|FG000|Overall Study|Adverse Event|2|||
48771607|NCT01864291|157007851|FG000|Overall Study|need for revision surgery|2|||
48771608|NCT02920983|157007852|FG000|Dispense 1|Unacceptable Lens Fit|0|||
48771609|NCT02920983|157007853|FG001|Dispense 1|Unacceptable Lens Fit|0|||
48771610|NCT02920983|157007854|FG002|Dispense 1|Unacceptable Lens Fit|0|||
48771611|NCT02920983|157007855|FG003|Dispense 1|Unacceptable Lens Fit|0|||
48771612|NCT02920983|157007856|FG004|Dispense 1|Unacceptable Lens Fit|1|||
48771613|NCT02920983|157007857|FG005|Dispense 1|Unacceptable Lens Fit|0|||
48771614|NCT02920983|157007852|FG000|Dispense 2|Unscceptable lens fit|1|||
48771615|NCT02920983|157007853|FG001|Dispense 2|Unscceptable lens fit|0|||
48771616|NCT02920983|157007854|FG002|Dispense 2|Unscceptable lens fit|0|||
48771617|NCT02920983|157007855|FG003|Dispense 2|Unscceptable lens fit|0|||
48771618|NCT02920983|157007856|FG004|Dispense 2|Unscceptable lens fit|1|||
48771619|NCT02920983|157007857|FG005|Dispense 2|Unscceptable lens fit|0|||
48771620|NCT02920983|157007852|FG000|Dispense 3|Unacceptable Lens Fit|1|||
48771621|NCT02920983|157007853|FG001|Dispense 3|Unacceptable Lens Fit|1|||
48771622|NCT02920983|157007854|FG002|Dispense 3|Unacceptable Lens Fit|0|||
48771623|NCT02920983|157007855|FG003|Dispense 3|Unacceptable Lens Fit|0|||
48771624|NCT02920983|157007856|FG004|Dispense 3|Unacceptable Lens Fit|1|||
48771625|NCT02920983|157007857|FG005|Dispense 3|Unacceptable Lens Fit|0|||
48771626|NCT03256552|157009830|FG000|Overall Study|Protocol Violation|1|||
48771627|NCT03256552|157009830|FG000|Overall Study|Physician Decision|1|||
48771628|NCT03256552|157009830|FG000|Overall Study|Adverse Event|1|||
48771629|NCT03256552|157009830|FG000|Overall Study|Withdrawal by Subject|2|||
48771630|NCT04380857|157009839|FG000|Overall Study|Lost to Follow-up|3|||
48771631|NCT04380857|157009840|FG001|Overall Study|Lost to Follow-up|3|||
48771632|NCT00427635|157009841|FG000|Treatment Phase|Withdrawal by Subject|1|||
48771633|NCT00427635|157009842|FG001|Treatment Phase|Withdrawal by Subject|0|||
48771634|NCT00427635|157009841|FG000|Study Completion to Safety Follow-up|Lost to Follow-up|0|||
48771635|NCT00427635|157009842|FG001|Study Completion to Safety Follow-up|Lost to Follow-up|1|||
48771636|NCT03277846|157009843|FG000|Overall Study|Inpatient stay too brief|12|||
48771637|NCT03277846|157009844|FG001|Overall Study|Inpatient stay too brief|11|||
48771638|NCT02554656|157009845|FG000|Overall Study|Protocol Violation|3|||
48771639|NCT03240575|157009846|FG000|Overall Study|Adverse Event|0|||
48771640|NCT03240575|157009847|FG001|Overall Study|Adverse Event|2|||
48771641|NCT03240575|157009848|FG002|Overall Study|Adverse Event|0|||
48771642|NCT03240575|157009849|FG003|Overall Study|Adverse Event|1|||
48771643|NCT03240575|157009846|FG000|Overall Study|Withdrawal by Subject|2|||
48771644|NCT03240575|157009847|FG001|Overall Study|Withdrawal by Subject|11|||
48771645|NCT03240575|157009848|FG002|Overall Study|Withdrawal by Subject|0|||
48771646|NCT03240575|157009849|FG003|Overall Study|Withdrawal by Subject|1|||
48771647|NCT03240575|157009846|FG000|Overall Study|Other|0|||
48982212|NCT04315298|157767532|FG001|Overall Study|Withdrawal by Subject|0|||
48982213|NCT04315298|157767533|FG002|Overall Study|Withdrawal by Subject|0|||
48982214|NCT04315298|157767534|FG003|Overall Study|Withdrawal by Subject|2|||
48982215|NCT04315298|157767535|FG004|Overall Study|Withdrawal by Subject|2|||
48982216|NCT04315298|157767536|FG005|Overall Study|Withdrawal by Subject|2|||
48982217|NCT04315298|157767537|FG006|Overall Study|Withdrawal by Subject|0|||
48982218|NCT04315298|157767538|FG007|Overall Study|Withdrawal by Subject|1|||
48982219|NCT04315298|157767539|FG008|Overall Study|Withdrawal by Subject|1|||
48982220|NCT04315298|157767540|FG009|Overall Study|Withdrawal by Subject|1|||
48982221|NCT04315298|157767541|FG010|Overall Study|Withdrawal by Subject|0|||
48982222|NCT04315298|157767542|FG011|Overall Study|Withdrawal by Subject|0|||
48982223|NCT04315298|157767543|FG012|Overall Study|Withdrawal by Subject|0|||
48982224|NCT04315298|157767544|FG013|Overall Study|Withdrawal by Subject|0|||
48982225|NCT04315298|157767545|FG014|Overall Study|Withdrawal by Subject|0|||
48982226|NCT04315298|157767546|FG015|Overall Study|Withdrawal by Subject|0|||
48982227|NCT04315298|157767547|FG016|Overall Study|Withdrawal by Subject|0|||
48771648|NCT03240575|157009847|FG001|Overall Study|Other|1|||
48771649|NCT03240575|157009848|FG002|Overall Study|Other|0|||
48771650|NCT03240575|157009849|FG003|Overall Study|Other|0|||
48771651|NCT03568942|157009850|FG000|Overall Study|Family emergency|1|||
48771652|NCT03568942|157009850|FG000|Overall Study|Lost to Follow-up|1|||
48771653|NCT02118428|157009856|FG000|Overall Study|Physician Decision|0|||
48771654|NCT02118428|157009857|FG001|Overall Study|Physician Decision|1|||
48771655|NCT02118428|157009858|FG002|Overall Study|Physician Decision|0|||
48771656|NCT02118428|157009856|FG000|Overall Study|Withdrawal by Subject|2|||
48771657|NCT02118428|157009857|FG001|Overall Study|Withdrawal by Subject|2|||
48771658|NCT02118428|157009858|FG002|Overall Study|Withdrawal by Subject|0|||
48771659|NCT02118428|157009856|FG000|Overall Study|Death|7|||
48771660|NCT02118428|157009857|FG001|Overall Study|Death|5|||
48771661|NCT02118428|157009858|FG002|Overall Study|Death|0|||
48982228|NCT04315298|157767548|FG017|Overall Study|Withdrawal by Subject|0|||
48982229|NCT04315298|157767549|FG018|Overall Study|Withdrawal by Subject|0|||
49026826|NCT01902173|157937533|FG005|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
49026827|NCT01902173|157937528|FG000|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
49026828|NCT01902173|157937529|FG001|Phase 1 Doublet Regimen Cohort 2|No treated|3|||
49026829|NCT01902173|157937530|FG002|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
49026830|NCT01902173|157937531|FG003|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
49026831|NCT01902173|157937532|FG004|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
49026832|NCT01902173|157937533|FG005|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
49026833|NCT01902173|157937528|FG000|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
49026834|NCT01902173|157937529|FG001|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
49026835|NCT01902173|157937530|FG002|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3|||
49026836|NCT01902173|157937531|FG003|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
49026837|NCT01902173|157937532|FG004|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
49026838|NCT01902173|157937533|FG005|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
49026839|NCT01902173|157937528|FG000|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
49026840|NCT01902173|157937529|FG001|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
49026841|NCT01902173|157937530|FG002|Phase 1 Triplet Regimen Cohort 1|Ineligible|1|||
49026842|NCT01902173|157937531|FG003|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
49026843|NCT01902173|157937532|FG004|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
49026844|NCT01902173|157937533|FG005|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
49026845|NCT01902173|157937528|FG000|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
49026846|NCT01902173|157937529|FG001|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
49026847|NCT01902173|157937530|FG002|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
49026848|NCT01902173|157937531|FG003|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1|||
49026849|NCT01902173|157937532|FG004|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
49026850|NCT01902173|157937533|FG005|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
49026851|NCT01902173|157937528|FG000|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
49026852|NCT01902173|157937529|FG001|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
49026853|NCT01902173|157937530|FG002|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
49026854|NCT01902173|157937531|FG003|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2|||
49026855|NCT01902173|157937532|FG004|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
49026856|NCT01902173|157937533|FG005|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
49026857|NCT01902173|157937528|FG000|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
49026858|NCT01902173|157937529|FG001|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
49026859|NCT01902173|157937530|FG002|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
49026860|NCT01902173|157937531|FG003|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
49026861|NCT01902173|157937532|FG004|Phase 1 Triplet Regimen Cohort 3|Ongoing|1|||
49026862|NCT01902173|157937533|FG005|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
49026863|NCT01902173|157937528|FG000|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
49026864|NCT01902173|157937529|FG001|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
49026865|NCT01902173|157937530|FG002|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
49026866|NCT01902173|157937531|FG003|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
49026867|NCT01902173|157937532|FG004|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2|||
49026868|NCT01902173|157937533|FG005|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
49026869|NCT01902173|157937528|FG000|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
49026870|NCT01902173|157937529|FG001|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
49026871|NCT01902173|157937530|FG002|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
49026872|NCT01902173|157937531|FG003|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
49026873|NCT01902173|157937532|FG004|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
49026874|NCT01902173|157937533|FG005|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1|||
49026875|NCT01902173|157937528|FG000|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
49026876|NCT01902173|157937529|FG001|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
49026877|NCT01902173|157937530|FG002|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
49026878|NCT01902173|157937531|FG003|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
49026879|NCT01902173|157937532|FG004|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
49026880|NCT01902173|157937533|FG005|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3|||
49026881|NCT01902173|157937528|FG000|Phase 1 Triplet Regimen Cohort 4|Death|0|||
49026882|NCT01902173|157937529|FG001|Phase 1 Triplet Regimen Cohort 4|Death|0|||
49026883|NCT01902173|157937530|FG002|Phase 1 Triplet Regimen Cohort 4|Death|0|||
49026884|NCT01902173|157937531|FG003|Phase 1 Triplet Regimen Cohort 4|Death|0|||
49026885|NCT01902173|157937532|FG004|Phase 1 Triplet Regimen Cohort 4|Death|0|||
48876354|NCT00832000|157384643|FG000|Overall Study|No calls to IVR in either period|1|||
49026886|NCT01902173|157937533|FG005|Phase 1 Triplet Regimen Cohort 4|Death|1|||
49026893|NCT04477486|157937543|FG000|Overall Study|Death|2|||
49026894|NCT04477486|157937543|FG000|Overall Study|Ongoing at Time of Analysis|11|||
49026895|NCT00625443|157937550|FG000|Overall Study|Adverse Event|1|||
49026896|NCT00625443|157937551|FG001|Overall Study|Adverse Event|4|||
49026897|NCT00625443|157937552|FG002|Overall Study|Adverse Event|0|||
49026898|NCT00625443|157937550|FG000|Overall Study|Non-compliance with protocol|0|||
49026899|NCT00625443|157937551|FG001|Overall Study|Non-compliance with protocol|1|||
49026900|NCT00625443|157937552|FG002|Overall Study|Non-compliance with protocol|0|||
49026901|NCT00625443|157937550|FG000|Overall Study|Platelet count increase >=500,000/mm3|1|||
49026902|NCT00625443|157937551|FG001|Overall Study|Platelet count increase >=500,000/mm3|0|||
49026903|NCT00625443|157937552|FG002|Overall Study|Platelet count increase >=500,000/mm3|0|||
49026904|NCT00625443|157937550|FG000|Overall Study|Withdrawal by Subject|0|||
49026905|NCT00625443|157937551|FG001|Overall Study|Withdrawal by Subject|1|||
49026906|NCT00625443|157937552|FG002|Overall Study|Withdrawal by Subject|2|||
49026907|NCT00625443|157937550|FG000|Overall Study|Physician Decision|0|||
49026908|NCT00625443|157937551|FG001|Overall Study|Physician Decision|4|||
49026909|NCT00625443|157937552|FG002|Overall Study|Physician Decision|2|||
49026910|NCT00625443|157937550|FG000|Overall Study|Other|0|||
49026911|NCT00625443|157937551|FG001|Overall Study|Other|1|||
49026912|NCT00625443|157937552|FG002|Overall Study|Other|1|||
49026913|NCT03883906|157937553|FG000|Overall Study|Withdrawal by Subject|2|||
49026914|NCT03883906|157937553|FG000|Overall Study|Physician Decision|5|||
49026915|NCT01126736|157937554|FG000|Overall Study|Death|2|||
48982230|NCT04315298|157767531|FG000|Overall Study|Physician Decision|0|||
48982231|NCT04315298|157767532|FG001|Overall Study|Physician Decision|0|||
48982232|NCT04315298|157767533|FG002|Overall Study|Physician Decision|0|||
48982233|NCT04315298|157767534|FG003|Overall Study|Physician Decision|0|||
48982234|NCT04315298|157767535|FG004|Overall Study|Physician Decision|1|||
48982235|NCT04315298|157767536|FG005|Overall Study|Physician Decision|0|||
48982236|NCT04315298|157767537|FG006|Overall Study|Physician Decision|0|||
48982237|NCT04315298|157767538|FG007|Overall Study|Physician Decision|0|||
48982238|NCT04315298|157767539|FG008|Overall Study|Physician Decision|0|||
48982239|NCT04315298|157767540|FG009|Overall Study|Physician Decision|0|||
48982240|NCT04315298|157767541|FG010|Overall Study|Physician Decision|0|||
48982241|NCT04315298|157767542|FG011|Overall Study|Physician Decision|0|||
48982242|NCT04315298|157767543|FG012|Overall Study|Physician Decision|0|||
48982243|NCT04315298|157767544|FG013|Overall Study|Physician Decision|0|||
48982244|NCT04315298|157767545|FG014|Overall Study|Physician Decision|0|||
48982245|NCT04315298|157767546|FG015|Overall Study|Physician Decision|0|||
48982246|NCT04315298|157767547|FG016|Overall Study|Physician Decision|0|||
48982247|NCT04315298|157767548|FG017|Overall Study|Physician Decision|0|||
48982248|NCT04315298|157767549|FG018|Overall Study|Physician Decision|0|||
48982249|NCT04315298|157767531|FG000|Overall Study|Lost to Follow-up|5|||
48982250|NCT04315298|157767532|FG001|Overall Study|Lost to Follow-up|10|||
48982251|NCT04315298|157767533|FG002|Overall Study|Lost to Follow-up|6|||
48982252|NCT04315298|157767534|FG003|Overall Study|Lost to Follow-up|8|||
48982253|NCT04315298|157767535|FG004|Overall Study|Lost to Follow-up|12|||
48982254|NCT04315298|157767536|FG005|Overall Study|Lost to Follow-up|13|||
48982255|NCT04315298|157767537|FG006|Overall Study|Lost to Follow-up|9|||
48982256|NCT04315298|157767538|FG007|Overall Study|Lost to Follow-up|16|||
48982257|NCT04315298|157767539|FG008|Overall Study|Lost to Follow-up|14|||
48982258|NCT04315298|157767540|FG009|Overall Study|Lost to Follow-up|0|||
48982259|NCT04315298|157767541|FG010|Overall Study|Lost to Follow-up|2|||
48982260|NCT04315298|157767542|FG011|Overall Study|Lost to Follow-up|1|||
48982261|NCT04315298|157767543|FG012|Overall Study|Lost to Follow-up|0|||
48982262|NCT04315298|157767544|FG013|Overall Study|Lost to Follow-up|0|||
48982263|NCT04315298|157767545|FG014|Overall Study|Lost to Follow-up|0|||
48982264|NCT04315298|157767546|FG015|Overall Study|Lost to Follow-up|2|||
48982265|NCT04315298|157767547|FG016|Overall Study|Lost to Follow-up|0|||
48982266|NCT04315298|157767548|FG017|Overall Study|Lost to Follow-up|0|||
48982267|NCT04315298|157767549|FG018|Overall Study|Lost to Follow-up|0|||
48982268|NCT04315298|157767531|FG000|Overall Study|Death|24|||
48982269|NCT04315298|157767532|FG001|Overall Study|Death|60|||
48982270|NCT04315298|157767533|FG002|Overall Study|Death|49|||
48982271|NCT04315298|157767534|FG003|Overall Study|Death|59|||
48982272|NCT04315298|157767535|FG004|Overall Study|Death|70|||
48982273|NCT04315298|157767536|FG005|Overall Study|Death|114|||
48982274|NCT04315298|157767537|FG006|Overall Study|Death|9|||
48982275|NCT04315298|157767538|FG007|Overall Study|Death|12|||
48982276|NCT04315298|157767539|FG008|Overall Study|Death|21|||
49026916|NCT01126736|157937555|FG001|Overall Study|Death|2|||
49026917|NCT01126736|157937556|FG002|Overall Study|Death|1|||
48982277|NCT04315298|157767540|FG009|Overall Study|Death|16|||
48982278|NCT04315298|157767541|FG010|Overall Study|Death|40|||
48982279|NCT04315298|157767542|FG011|Overall Study|Death|40|||
48982280|NCT04315298|157767543|FG012|Overall Study|Death|3|||
48982281|NCT04315298|157767544|FG013|Overall Study|Death|4|||
48982282|NCT04315298|157767545|FG014|Overall Study|Death|6|||
48982283|NCT04315298|157767546|FG015|Overall Study|Death|4|||
48982284|NCT04315298|157767547|FG016|Overall Study|Death|3|||
48982285|NCT04315298|157767548|FG017|Overall Study|Death|1|||
48982286|NCT04315298|157767549|FG018|Overall Study|Death|0|||
48982287|NCT01199198|157767550|FG000|Overall Study|Adverse Event|3|||
49026918|NCT01126736|157937557|FG003|Overall Study|Death|19|||
49026919|NCT01126736|157937558|FG004|Overall Study|Death|19|||
48771662|NCT02118428|157009856|FG000|Overall Study|Lost to Follow-up|3|||
48771663|NCT02118428|157009857|FG001|Overall Study|Lost to Follow-up|1|||
48771664|NCT02118428|157009858|FG002|Overall Study|Lost to Follow-up|0|||
48771665|NCT02118428|157009856|FG000|Overall Study|Screen Failure or Became Inelegible|1|||
48771666|NCT02118428|157009857|FG001|Overall Study|Screen Failure or Became Inelegible|0|||
48771667|NCT02118428|157009858|FG002|Overall Study|Screen Failure or Became Inelegible|1|||
48771668|NCT04300296|157009859|FG000|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|1|||
48771669|NCT04300296|157009860|FG001|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
48771670|NCT04300296|157009861|FG002|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
48771671|NCT04300296|157009862|FG003|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
48771672|NCT04300296|157009863|FG004|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
48771673|NCT04300296|157009864|FG005|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
48771674|NCT04300296|157009859|FG000|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
48771675|NCT04300296|157009860|FG001|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
48771676|NCT04300296|157009861|FG002|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
48771677|NCT04300296|157009862|FG003|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
48771678|NCT04300296|157009863|FG004|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|1|||
48771679|NCT04300296|157009864|FG005|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
48771680|NCT04300296|157009859|FG000|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
48771681|NCT04300296|157009860|FG001|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|2|||
48771682|NCT04300296|157009861|FG002|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
48771683|NCT04300296|157009862|FG003|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
48771684|NCT04300296|157009863|FG004|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
48771685|NCT04300296|157009864|FG005|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
48771686|NCT04300296|157009859|FG000|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
48771687|NCT04300296|157009860|FG001|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
48771688|NCT04300296|157009861|FG002|Treatment Period 2: 16 to 32 Weeks|Adverse Event|2|||
48771689|NCT04300296|157009862|FG003|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
48771690|NCT04300296|157009863|FG004|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
48771691|NCT04300296|157009864|FG005|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
48771692|NCT04300296|157009859|FG000|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
48771693|NCT04300296|157009860|FG001|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
48771694|NCT04300296|157009861|FG002|Treatment Period 2: 16 to 32 Weeks|Progressive disease|1|||
48771695|NCT04300296|157009862|FG003|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
48771696|NCT04300296|157009863|FG004|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
48771697|NCT04300296|157009864|FG005|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
48771698|NCT04300296|157009859|FG000|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
48771699|NCT04300296|157009860|FG001|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|1|||
48771700|NCT04300296|157009861|FG002|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
48771701|NCT04300296|157009862|FG003|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
48771702|NCT04300296|157009863|FG004|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
48771703|NCT04300296|157009864|FG005|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
48771704|NCT04300296|157009859|FG000|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|2|||
48771705|NCT04300296|157009860|FG001|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
48771706|NCT04300296|157009861|FG002|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
48771707|NCT04300296|157009862|FG003|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
48771708|NCT04300296|157009863|FG004|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|3|||
48771709|NCT04300296|157009864|FG005|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
48771710|NCT00424372|157009867|FG000|Overall Study|Death|1|||
49026920|NCT01126736|157937554|FG000|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
49026921|NCT01126736|157937555|FG001|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
49026922|NCT01126736|157937556|FG002|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
49026923|NCT01126736|157937557|FG003|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
49026924|NCT01126736|157937558|FG004|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
49026925|NCT01126736|157937554|FG000|Overall Study|Lost to Follow-up|0|||
49026926|NCT01126736|157937555|FG001|Overall Study|Lost to Follow-up|0|||
48771711|NCT00424372|157009867|FG000|Overall Study|Adverse Event|18|||
48771712|NCT00424372|157009867|FG000|Overall Study|Lack of Efficacy|6|||
48771713|NCT00424372|157009867|FG000|Overall Study|Withdrawal by Subject|4|||
48771714|NCT00424372|157009867|FG000|Overall Study|Protocol Violation|1|||
48771715|NCT00424372|157009867|FG000|Overall Study|Health deterioration|1|||
48771716|NCT02412631|157009870|FG000|Overall Study|Adverse Event|1|||
48771717|NCT02412631|157009871|FG001|Overall Study|Adverse Event|2|||
48771718|NCT02412631|157009870|FG000|Overall Study|Lost to Follow-up|5|||
48771719|NCT02412631|157009871|FG001|Overall Study|Lost to Follow-up|9|||
48771720|NCT02412631|157009870|FG000|Overall Study|Withdrawal by Subject|9|||
48771721|NCT02412631|157009871|FG001|Overall Study|Withdrawal by Subject|3|||
48771722|NCT02412631|157009870|FG000|Overall Study|Early stop by FDA|5|||
48771723|NCT02412631|157009871|FG001|Overall Study|Early stop by FDA|2|||
48771724|NCT02412631|157009870|FG000|Overall Study|Unspecified reason|6|||
48771725|NCT02412631|157009871|FG001|Overall Study|Unspecified reason|8|||
48771726|NCT02940691|157009872|FG000|Overall Study|Lost to Follow-up|5|||
48771727|NCT02940691|157009872|FG000|Overall Study|Incarceration|1|||
48771728|NCT02177266|157009873|FG000|Overall Study|Adverse Event|0|||
48771729|NCT02177266|157009874|FG001|Overall Study|Adverse Event|1|||
48771730|NCT02177266|157009873|FG000|Overall Study|Withdrawal by Subject|1|||
48771731|NCT02177266|157009874|FG001|Overall Study|Withdrawal by Subject|0|||
48771732|NCT03364049|157009875|FG000|Overall Study|Death|6|||
48771733|NCT03364049|157009876|FG001|Overall Study|Death|4|||
48771734|NCT03364049|157009877|FG002|Overall Study|Death|5|||
48771735|NCT03364049|157009878|FG003|Overall Study|Death|14|||
48771736|NCT03364049|157009875|FG000|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
48771737|NCT03364049|157009876|FG001|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|1|||
48771738|NCT03364049|157009877|FG002|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
48771739|NCT03364049|157009878|FG003|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
48771740|NCT03364049|157009875|FG000|Overall Study|Withdrawal by Subject|0|||
48771741|NCT03364049|157009876|FG001|Overall Study|Withdrawal by Subject|1|||
48771742|NCT03364049|157009877|FG002|Overall Study|Withdrawal by Subject|1|||
48771743|NCT03364049|157009878|FG003|Overall Study|Withdrawal by Subject|1|||
48771744|NCT00577122|157009883|FG000|Overall Study|Adverse Event|0|||
48771745|NCT00577122|157009884|FG001|Overall Study|Adverse Event|2|||
48771746|NCT00577122|157009883|FG000|Overall Study|Progression, relapse during active trt|6|||
48771747|NCT00577122|157009884|FG001|Overall Study|Progression, relapse during active trt|8|||
48771748|NCT00577122|157009883|FG000|Overall Study|Prog, refract disease during active trt|8|||
48771749|NCT00577122|157009884|FG001|Overall Study|Prog, refract disease during active trt|5|||
48771750|NCT00577122|157009883|FG000|Overall Study|Alternative Therapy|0|||
48771751|NCT00577122|157009884|FG001|Overall Study|Alternative Therapy|1|||
48771752|NCT01340976|157009885|FG000|Overall Study|Physician Decision|2|||
48771753|NCT01340976|157009886|FG001|Overall Study|Physician Decision|0|||
48771754|NCT01340976|157009887|FG002|Overall Study|Physician Decision|1|||
48771755|NCT01340976|157009888|FG003|Overall Study|Physician Decision|1|||
48771756|NCT01340976|157009889|FG004|Overall Study|Physician Decision|1|||
48771757|NCT01340976|157009890|FG005|Overall Study|Physician Decision|0|||
48771758|NCT01340976|157009885|FG000|Overall Study|Death|0|||
48771759|NCT01340976|157009886|FG001|Overall Study|Death|1|||
48771760|NCT01340976|157009887|FG002|Overall Study|Death|0|||
48771761|NCT01340976|157009888|FG003|Overall Study|Death|0|||
48771762|NCT01340976|157009889|FG004|Overall Study|Death|0|||
48771763|NCT01340976|157009890|FG005|Overall Study|Death|0|||
48771764|NCT01340976|157009885|FG000|Overall Study|Dose Limiting Toxicity Stopping Rule|1|||
48771765|NCT01340976|157009886|FG001|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
48771766|NCT01340976|157009887|FG002|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
48771767|NCT01340976|157009888|FG003|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
48771768|NCT01340976|157009889|FG004|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
48771769|NCT01340976|157009890|FG005|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
48771770|NCT01340976|157009885|FG000|Overall Study|Withdrawal by Subject|0|||
48771771|NCT01340976|157009886|FG001|Overall Study|Withdrawal by Subject|0|||
48771772|NCT01340976|157009887|FG002|Overall Study|Withdrawal by Subject|0|||
48771773|NCT01340976|157009888|FG003|Overall Study|Withdrawal by Subject|1|||
48771774|NCT01340976|157009889|FG004|Overall Study|Withdrawal by Subject|1|||
48771775|NCT01340976|157009890|FG005|Overall Study|Withdrawal by Subject|0|||
48771776|NCT01340976|157009885|FG000|Overall Study|Other anemia treatment|1|||
48771777|NCT01340976|157009886|FG001|Overall Study|Other anemia treatment|0|||
48771778|NCT01340976|157009887|FG002|Overall Study|Other anemia treatment|2|||
48771779|NCT01340976|157009888|FG003|Overall Study|Other anemia treatment|1|||
48771780|NCT01340976|157009889|FG004|Overall Study|Other anemia treatment|0|||
48771781|NCT01340976|157009890|FG005|Overall Study|Other anemia treatment|1|||
48771782|NCT01340976|157009885|FG000|Overall Study|Adverse Event|0|||
48771783|NCT01340976|157009886|FG001|Overall Study|Adverse Event|1|||
48771784|NCT01340976|157009887|FG002|Overall Study|Adverse Event|0|||
48771785|NCT01340976|157009888|FG003|Overall Study|Adverse Event|0|||
48771786|NCT01340976|157009889|FG004|Overall Study|Adverse Event|0|||
48771787|NCT01340976|157009890|FG005|Overall Study|Adverse Event|0|||
48771788|NCT02953821|157009894|FG000|Overall Study|Adverse Event|0|||
48771789|NCT02953821|157009895|FG001|Overall Study|Adverse Event|4|||
48771790|NCT02953821|157009894|FG000|Overall Study|Death|1|||
48771791|NCT02953821|157009895|FG001|Overall Study|Death|0|||
48771792|NCT02953821|157009894|FG000|Overall Study|Progressive Disease|5|||
48771793|NCT02953821|157009895|FG001|Overall Study|Progressive Disease|1|||
48771794|NCT02953821|157009894|FG000|Overall Study|Lost to Follow-up|2|||
48771795|NCT02953821|157009895|FG001|Overall Study|Lost to Follow-up|0|||
49026927|NCT01126736|157937556|FG002|Overall Study|Lost to Follow-up|0|||
48771796|NCT02953821|157009894|FG000|Overall Study|Physician Decision|1|||
48771797|NCT02953821|157009895|FG001|Overall Study|Physician Decision|1|||
48771798|NCT02953821|157009894|FG000|Overall Study|Withdrawal by Subject|3|||
48771799|NCT02953821|157009895|FG001|Overall Study|Withdrawal by Subject|3|||
48771800|NCT02953821|157009894|FG000|Overall Study|Change of address|0|||
48771801|NCT02953821|157009895|FG001|Overall Study|Change of address|1|||
48771802|NCT02953821|157009894|FG000|Overall Study|Lack of Efficacy|1|||
48771803|NCT02953821|157009895|FG001|Overall Study|Lack of Efficacy|0|||
48771804|NCT02953821|157009894|FG000|Overall Study|Out of state for indeterminate time|0|||
48771805|NCT02953821|157009895|FG001|Overall Study|Out of state for indeterminate time|1|||
48771806|NCT02953821|157009894|FG000|Overall Study|No improvement|0|||
48771807|NCT02953821|157009895|FG001|Overall Study|No improvement|1|||
48771808|NCT02953821|157009894|FG000|Overall Study|Refused follow-up visit|2|||
48771809|NCT02953821|157009895|FG001|Overall Study|Refused follow-up visit|1|||
48771810|NCT02840877|157009900|FG000|Baseline to 12 Weeks|Withdrawal by Subject|11|||
48771811|NCT02840877|157009900|FG000|Baseline to 12 Weeks|Moved/Transferred out|5|||
48771812|NCT02840877|157009900|FG000|Baseline to 12 Weeks|Lost to Follow-up|2|||
48771813|NCT02840877|157009900|FG000|Baseline to 12 Weeks|Death|1|||
48771814|NCT02840877|157009900|FG000|Baseline to 12 Weeks|Changed treatment regimen, no longer on first line drugs.|1|||
48771815|NCT02840877|157009900|FG000|Baseline to 12 Weeks|Treatment extended due to bacterial meningitis.|1|||
48771816|NCT02840877|157009900|FG000|12 Weeks to 6 Months|Withdrawal by Subject|4|||
48771817|NCT02840877|157009900|FG000|12 Weeks to 6 Months|Treatment failure|1|||
48771818|NCT02840877|157009900|FG000|12 Weeks to 6 Months|Moved/transferred out|1|||
48771819|NCT02840877|157009900|FG000|12 Weeks to 6 Months|Lost to Follow-up|4|||
48771820|NCT02840877|157009900|FG000|12 Weeks to 6 Months|Death|1|||
48771821|NCT02840877|157009900|FG000|6 Months to 18 Months|Withdrawal by Subject|1|||
48771822|NCT02840877|157009900|FG000|6 Months to 18 Months|Treatment failure|7|||
48771823|NCT02840877|157009900|FG000|6 Months to 18 Months|Relapse/recurrence of TB|8|||
48771824|NCT02840877|157009900|FG000|6 Months to 18 Months|Moved/transferred out|6|||
48771825|NCT02840877|157009900|FG000|6 Months to 18 Months|Lost to Follow-up|24|||
48771826|NCT02840877|157009900|FG000|6 Months to 18 Months|Death|4|||
48771827|NCT02840877|157009900|FG000|6 Months to 18 Months|Diagnosed with multi-drug resistant tuberculosis.|1|||
48771828|NCT02840877|157009900|FG000|6 Months to 18 Months|Treatment stopped due to liver injury.|1|||
48771829|NCT02840877|157009900|FG000|6 Months to 18 Months|Still in study.|14|||
48771830|NCT01743092|157009904|FG000|Overall Study|Lost to Follow-up|14|||
48771831|NCT01743092|157009905|FG001|Overall Study|Lost to Follow-up|15|||
48771832|NCT00826267|157009906|FG000|Overall Study|Other Adverse Event|1|||
48771833|NCT00826267|157009907|FG001|Overall Study|Other Adverse Event|0|||
48771834|NCT00826267|157009908|FG002|Overall Study|Other Adverse Event|0|||
48771835|NCT00414661|157009918|FG000|Overall Study|Death|2|||
48771836|NCT00414661|157009919|FG001|Overall Study|Death|5|||
48771837|NCT00414661|157009920|FG002|Overall Study|Death|0|||
48771838|NCT00414661|157009921|FG003|Overall Study|Death|0|||
48771839|NCT00414661|157009918|FG000|Overall Study|Lost to Follow-up|1|||
48771840|NCT00414661|157009919|FG001|Overall Study|Lost to Follow-up|4|||
48771841|NCT00414661|157009920|FG002|Overall Study|Lost to Follow-up|0|||
48771842|NCT00414661|157009921|FG003|Overall Study|Lost to Follow-up|1|||
48771843|NCT00414661|157009918|FG000|Overall Study|Withdrawal by Subject|5|||
48771844|NCT00414661|157009919|FG001|Overall Study|Withdrawal by Subject|2|||
48771845|NCT00414661|157009920|FG002|Overall Study|Withdrawal by Subject|2|||
48771846|NCT00414661|157009921|FG003|Overall Study|Withdrawal by Subject|2|||
48771847|NCT00414661|157009918|FG000|Overall Study|Other|6|||
48771848|NCT00414661|157009919|FG001|Overall Study|Other|3|||
48771849|NCT00414661|157009920|FG002|Overall Study|Other|0|||
48771850|NCT00414661|157009921|FG003|Overall Study|Other|0|||
48771851|NCT00357370|157009922|FG000|Cohort 2|Lack of Efficacy|0|||
48771852|NCT00357370|157009923|FG001|Cohort 2|Lack of Efficacy|2|||
48771853|NCT00357370|157009924|FG002|Cohort 2|Lack of Efficacy|1|||
48771854|NCT00357370|157009922|FG000|Cohort 2|Adverse Event|1|||
48771855|NCT00357370|157009923|FG001|Cohort 2|Adverse Event|1|||
48771856|NCT00357370|157009924|FG002|Cohort 2|Adverse Event|1|||
48771857|NCT00357370|157009922|FG000|Cohort 2|Lost to Follow-up|0|||
48771858|NCT00357370|157009923|FG001|Cohort 2|Lost to Follow-up|1|||
48771859|NCT00357370|157009924|FG002|Cohort 2|Lost to Follow-up|0|||
48771860|NCT00357370|157009922|FG000|Cohort 2|non-compliance, not met criteria, etc|1|||
48771861|NCT00357370|157009923|FG001|Cohort 2|non-compliance, not met criteria, etc|1|||
48771862|NCT00357370|157009924|FG002|Cohort 2|non-compliance, not met criteria, etc|0|||
48771863|NCT00357370|157009922|FG000|Cohort 2|Withdrawal by Subject|0|||
48771864|NCT00357370|157009923|FG001|Cohort 2|Withdrawal by Subject|2|||
48771865|NCT00357370|157009924|FG002|Cohort 2|Withdrawal by Subject|0|||
48771866|NCT03491150|157009925|FG000|Overall Study|Adverse Event|1|||
48771867|NCT03491150|157009926|FG001|Overall Study|Adverse Event|0|||
48771868|NCT03491150|157009925|FG000|Overall Study|Study Terminated by Sponsor|74|||
48771869|NCT03491150|157009926|FG001|Overall Study|Study Terminated by Sponsor|70|||
48771870|NCT03491150|157009925|FG000|Overall Study|Other|0|||
48771871|NCT03491150|157009926|FG001|Overall Study|Other|1|||
48771872|NCT03491150|157009925|FG000|Overall Study|Withdrawal by Subject|1|||
48771873|NCT03491150|157009926|FG001|Overall Study|Withdrawal by Subject|2|||
48876355|NCT00832000|157384644|FG001|Overall Study|No calls to IVR in either period|1|||
48876356|NCT00832000|157384643|FG000|Overall Study|No calls to IVR in period 2|2|||
48876357|NCT00832000|157384644|FG001|Overall Study|No calls to IVR in period 2|0|||
48876358|NCT01253447|157384646|FG000|Overall Study|Adverse Event|2|||
48876359|NCT01017263|157384647|FG000|Overall Study|not eligible|12|||
48876360|NCT00909532|157384648|FG000|Overall Study|Adverse Event|4|||
48876361|NCT00909532|157384649|FG001|Overall Study|Adverse Event|1|||
48771874|NCT01147653|157009927|FG000|Year 2|Withdrawal by Subject|2|||
48771875|NCT01147653|157009928|FG001|Year 2|Withdrawal by Subject|3|||
48771876|NCT01302392|157009931|FG000|Overall Study|Lost to Follow-up|1|||
48771877|NCT01302392|157009932|FG001|Overall Study|Lost to Follow-up|0|||
48771878|NCT01302392|157009931|FG000|Overall Study|Withdrawal by Subject|6|||
48771879|NCT01302392|157009932|FG001|Overall Study|Withdrawal by Subject|1|||
48771880|NCT02388997|157009933|FG000|Overall Study|Adverse Event|1|||
48771881|NCT02388997|157009934|FG001|Overall Study|Adverse Event|2|||
48771882|NCT02388997|157009933|FG000|Overall Study|Withdrawal by Subject|2|||
48771883|NCT02388997|157009934|FG001|Overall Study|Withdrawal by Subject|1|||
48771884|NCT02388997|157009933|FG000|Overall Study|Lung function exclusion criteria|0|||
48771885|NCT02388997|157009934|FG001|Overall Study|Lung function exclusion criteria|2|||
48771886|NCT02388997|157009933|FG000|Overall Study|Tested positive for virus during run-in|0|||
48771887|NCT02388997|157009934|FG001|Overall Study|Tested positive for virus during run-in|1|||
48771888|NCT01565291|157009935|FG000|Overall Study|Withdrawal by Subject|1|||
48771889|NCT01565291|157009936|FG001|Overall Study|Withdrawal by Subject|0|||
48771890|NCT01856543|157009943|FG000|Overall Study|Treatment discontinued|6|||
48771891|NCT01856543|157009944|FG001|Overall Study|Treatment discontinued|3|||
48771892|NCT01856543|157009943|FG000|Overall Study|Withdrawn before start|7|||
48771893|NCT01856543|157009944|FG001|Overall Study|Withdrawn before start|3|||
48771894|NCT00298831|157009947|FG000|Overall Study|Adverse Event|1|||
48771895|NCT00298831|157009947|FG000|Overall Study|Lost to Follow-up|3|||
48771896|NCT00298831|157009947|FG000|Overall Study|Withdrawal by Subject|1|||
48771897|NCT00298831|157009947|FG000|Overall Study|Participants did not receive treatment|27|||
48771898|NCT03139916|157009948|FG000|Overall Study|Withdrawal by Subject|2|||
48771899|NCT03139916|157009948|FG000|Overall Study|Clinical progression prior to start of study treatment|1|||
48771900|NCT01957475|157009949|FG000|Test Period 1|Withdrawal by Subject|1|||
48771901|NCT01957475|157009950|FG001|Test Period 1|Withdrawal by Subject|0|||
48771902|NCT01957475|157009949|FG000|Test Period 1|Other|1|||
48771903|NCT01957475|157009950|FG001|Test Period 1|Other|0|||
48771904|NCT01957475|157009949|FG000|Test Period 1|Lack of Efficacy|0|||
48771905|NCT01957475|157009950|FG001|Test Period 1|Lack of Efficacy|1|||
48771906|NCT01957475|157009949|FG000|Test Period 2|Adverse Event|1|||
48771907|NCT01957475|157009950|FG001|Test Period 2|Adverse Event|0|||
48771908|NCT00183872|157009951|FG000|Overall Study|Death|3|||
48771909|NCT00183872|157009951|FG000|Overall Study|Adverse Event|9|||
48771910|NCT00183872|157009951|FG000|Overall Study|Withdrawal by Subject|2|||
48771911|NCT00183872|157009951|FG000|Overall Study|Drug delayed more than 28 days|2|||
48771912|NCT04587193|157009952|FG000|Overall Study|Screen failure after consent|3|||
48771913|NCT04587193|157009953|FG001|Overall Study|Screen failure after consent|0|||
48771914|NCT04587193|157009952|FG000|Overall Study|Device broke during study|3|||
48771915|NCT04587193|157009953|FG001|Overall Study|Device broke during study|2|||
48771916|NCT02469610|157009954|FG000|Overall Study|Death|1|||
48771917|NCT02469610|157009955|FG001|Overall Study|Death|0|||
48771918|NCT02469610|157009954|FG000|Overall Study|Lost to Follow-up|1|||
48771919|NCT02469610|157009955|FG001|Overall Study|Lost to Follow-up|0|||
48771920|NCT02469610|157009954|FG000|Overall Study|exclusion criteria|2|||
48771921|NCT02469610|157009955|FG001|Overall Study|exclusion criteria|1|||
48771922|NCT01387607|157009956|FG000|Overall Study|Adverse Event|23|||
48771923|NCT01387607|157009957|FG001|Overall Study|Adverse Event|11|||
48771924|NCT01387607|157009956|FG000|Overall Study|Lack of Efficacy|8|||
48771925|NCT01387607|157009957|FG001|Overall Study|Lack of Efficacy|6|||
48771926|NCT01387607|157009956|FG000|Overall Study|Lost to Follow-up|2|||
48771927|NCT01387607|157009957|FG001|Overall Study|Lost to Follow-up|1|||
48771928|NCT01387607|157009956|FG000|Overall Study|No longer meets eligibility criteria|0|||
48771929|NCT01387607|157009957|FG001|Overall Study|No longer meets eligibility criteria|1|||
48771930|NCT01387607|157009956|FG000|Overall Study|Protocol Violation|1|||
48982288|NCT01199198|157767551|FG001|Overall Study|Adverse Event|0|||
48982289|NCT01199198|157767550|FG000|Overall Study|Lost to Follow-up|1|||
48982290|NCT01199198|157767551|FG001|Overall Study|Lost to Follow-up|5|||
48771931|NCT01387607|157009957|FG001|Overall Study|Protocol Violation|5|||
48771932|NCT01387607|157009956|FG000|Overall Study|Withdrawal by Subject|13|||
48876362|NCT00909532|157384648|FG000|Overall Study|Pregnancy|0|||
48982291|NCT01199198|157767550|FG000|Overall Study|Withdrawal by Subject|1|||
48982292|NCT01199198|157767551|FG001|Overall Study|Withdrawal by Subject|2|||
48982293|NCT01199198|157767550|FG000|Overall Study|ICU Transfer|1|||
48982294|NCT01199198|157767551|FG001|Overall Study|ICU Transfer|2|||
48982295|NCT01199198|157767550|FG000|Overall Study|Hospice-care transfer|1|||
48982296|NCT01199198|157767551|FG001|Overall Study|Hospice-care transfer|2|||
48982297|NCT00088595|157767552|FG000|Overall Study|Adverse Event|11|||
48876363|NCT00909532|157384649|FG001|Overall Study|Pregnancy|1|||
49026928|NCT01126736|157937557|FG003|Overall Study|Lost to Follow-up|1|||
49026929|NCT01126736|157937558|FG004|Overall Study|Lost to Follow-up|1|||
49026930|NCT01126736|157937554|FG000|Overall Study|Administrative reasons|0|||
49026931|NCT01126736|157937555|FG001|Overall Study|Administrative reasons|0|||
49026932|NCT01126736|157937556|FG002|Overall Study|Administrative reasons|0|||
49026933|NCT01126736|157937557|FG003|Overall Study|Administrative reasons|0|||
49026934|NCT01126736|157937558|FG004|Overall Study|Administrative reasons|1|||
48771933|NCT01387607|157009957|FG001|Overall Study|Withdrawal by Subject|14|||
48771934|NCT01387607|157009956|FG000|Overall Study|Other|1|||
48771935|NCT01387607|157009957|FG001|Overall Study|Other|1|||
48771936|NCT01387607|157009956|FG000|Overall Study|Randomized, not treated|3|||
48771937|NCT01387607|157009957|FG001|Overall Study|Randomized, not treated|6|||
48771938|NCT03878134|157009959|FG000|Overall Study|Scanner downtime or scheduling conflict|11|||
48771939|NCT03851016|157009960|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
48771940|NCT03851016|157009961|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
48876364|NCT00909532|157384648|FG000|Overall Study|Prohibited Medication|2|||
48876365|NCT00909532|157384649|FG001|Overall Study|Prohibited Medication|1|||
48876366|NCT00909532|157384648|FG000|Overall Study|Withdrawal of Consent|1|||
48876367|NCT00909532|157384649|FG001|Overall Study|Withdrawal of Consent|1|||
48876368|NCT00909532|157384648|FG000|Overall Study|Noncompliance with Study Requirements|0|||
48876369|NCT00909532|157384649|FG001|Overall Study|Noncompliance with Study Requirements|2|||
48876370|NCT00909532|157384648|FG000|Overall Study|Physician Decision|1|||
48876371|NCT00909532|157384649|FG001|Overall Study|Physician Decision|0|||
48876372|NCT00909532|157384648|FG000|Overall Study|Wrong Genotype|1|||
48876373|NCT00909532|157384649|FG001|Overall Study|Wrong Genotype|0|||
48876374|NCT00909532|157384648|FG000|Overall Study|Increased Lab Draws, Difficult Lab Stick|1|||
48876375|NCT00909532|157384649|FG001|Overall Study|Increased Lab Draws, Difficult Lab Stick|0|||
48876376|NCT02058836|157384651|FG000|Overall Study|Withdrawal by Subject|1|||
48876377|NCT02058836|157384652|FG001|Overall Study|Withdrawal by Subject|1|||
48876378|NCT02031536|157384656|FG000|Overall Study|ineligible|1|||
48876379|NCT02031536|157384657|FG001|Overall Study|ineligible|0|||
48876380|NCT01850030|157384658|FG000|Overall Study|Adverse Event|64|||
48876381|NCT01850030|157384659|FG001|Overall Study|Adverse Event|82|||
48876382|NCT01850030|157384658|FG000|Overall Study|Lack of Efficacy|3|||
48876383|NCT01850030|157384659|FG001|Overall Study|Lack of Efficacy|1|||
48876384|NCT01850030|157384658|FG000|Overall Study|Lost to Follow-up|5|||
48876385|NCT01850030|157384659|FG001|Overall Study|Lost to Follow-up|5|||
48876386|NCT01850030|157384658|FG000|Overall Study|Withdrawal by Subject|3|||
48876387|NCT01850030|157384659|FG001|Overall Study|Withdrawal by Subject|4|||
48876388|NCT01850030|157384658|FG000|Overall Study|Protocol Violation|24|||
48876389|NCT01850030|157384659|FG001|Overall Study|Protocol Violation|28|||
48876390|NCT01850030|157384658|FG000|Overall Study|pregnancy not confirmed at visit 4|248|||
48876391|NCT01850030|157384659|FG001|Overall Study|pregnancy not confirmed at visit 4|249|||
48876392|NCT01658020|157384667|FG000|Overall Study|Adverse Event|3|||
48876393|NCT01658020|157384668|FG001|Overall Study|Adverse Event|3|||
48876394|NCT01658020|157384667|FG000|Overall Study|Lost to Follow-up|1|||
48876395|NCT01658020|157384668|FG001|Overall Study|Lost to Follow-up|0|||
48876396|NCT01658020|157384667|FG000|Overall Study|Withdrawal by Subject|4|||
48876397|NCT01658020|157384668|FG001|Overall Study|Withdrawal by Subject|5|||
48876398|NCT01658020|157384667|FG000|Overall Study|Protocol Violation|0|||
48876399|NCT01658020|157384668|FG001|Overall Study|Protocol Violation|1|||
48876400|NCT00927901|157384669|FG000|Treatment Period 1|Subject withdrew consent|0|||
48876401|NCT00927901|157384670|FG001|Treatment Period 1|Subject withdrew consent|0|||
48876402|NCT00927901|157384671|FG002|Treatment Period 1|Subject withdrew consent|1|||
48876403|NCT00927901|157384672|FG003|Treatment Period 1|Subject withdrew consent|0|||
48876404|NCT00927901|157384669|FG000|Treatment Period 4|Adverse Event|0|||
48876405|NCT00927901|157384670|FG001|Treatment Period 4|Adverse Event|0|||
48876406|NCT00927901|157384671|FG002|Treatment Period 4|Adverse Event|0|||
48876407|NCT00927901|157384672|FG003|Treatment Period 4|Adverse Event|1|||
48876408|NCT00927901|157384669|FG000|Treatment Period 4|Subject withdrew consent|0|||
48876409|NCT00927901|157384670|FG001|Treatment Period 4|Subject withdrew consent|0|||
49026935|NCT01126736|157937554|FG000|Overall Study|Progressive disease|0|||
49026936|NCT01126736|157937555|FG001|Overall Study|Progressive disease|0|||
48771941|NCT02460224|157009962|FG000|Overall Study|Adverse Event|0|||
48771942|NCT02460224|157009963|FG001|Overall Study|Adverse Event|0|||
48876410|NCT00927901|157384671|FG002|Treatment Period 4|Subject withdrew consent|1|||
48876411|NCT00927901|157384672|FG003|Treatment Period 4|Subject withdrew consent|0|||
48876412|NCT01128114|157384673|FG000|Overall Study|Treatment Withdrawn|6|||
48876413|NCT01128114|157384673|FG000|Overall Study|Screening Failed|2|||
48876414|NCT01461005|157384679|FG000|Overall Study|FDA reclassified Dynamic Stabilization D|1|||
48876415|NCT02165826|157384685|FG000|Main Treatment Period|Pre-treatment Event/Adverse Event|44|||
48876416|NCT02165826|157384686|FG001|Main Treatment Period|Pre-treatment Event/Adverse Event|57|||
48876417|NCT02165826|157384687|FG002|Main Treatment Period|Pre-treatment Event/Adverse Event|68|||
48876418|NCT02165826|157384685|FG000|Main Treatment Period|Major/Significant Protocol Deviation|0|||
49026937|NCT01126736|157937556|FG002|Overall Study|Progressive disease|0|||
48876419|NCT02165826|157384686|FG001|Main Treatment Period|Major/Significant Protocol Deviation|1|||
48876420|NCT02165826|157384687|FG002|Main Treatment Period|Major/Significant Protocol Deviation|3|||
48876421|NCT02165826|157384685|FG000|Main Treatment Period|Lost to Follow-up|4|||
48876422|NCT02165826|157384686|FG001|Main Treatment Period|Lost to Follow-up|2|||
48876423|NCT02165826|157384687|FG002|Main Treatment Period|Lost to Follow-up|1|||
48876424|NCT02165826|157384685|FG000|Main Treatment Period|Voluntary Withdrawal|23|||
48876425|NCT02165826|157384686|FG001|Main Treatment Period|Voluntary Withdrawal|23|||
48876426|NCT02165826|157384687|FG002|Main Treatment Period|Voluntary Withdrawal|21|||
48876427|NCT02165826|157384685|FG000|Main Treatment Period|Lack of Efficacy|2|||
48876428|NCT02165826|157384686|FG001|Main Treatment Period|Lack of Efficacy|0|||
48876429|NCT02165826|157384687|FG002|Main Treatment Period|Lack of Efficacy|0|||
48876430|NCT02165826|157384685|FG000|Main Treatment Period|Reason Not Specified|8|||
49026938|NCT01126736|157937557|FG003|Overall Study|Progressive disease|2|||
49026939|NCT01126736|157937558|FG004|Overall Study|Progressive disease|1|||
49026940|NCT01126736|157937554|FG000|Overall Study|Withdrawal by Subject|0|||
49026941|NCT01126736|157937555|FG001|Overall Study|Withdrawal by Subject|0|||
48771943|NCT02460224|157009964|FG002|Overall Study|Adverse Event|0|||
48771944|NCT02460224|157009965|FG003|Overall Study|Adverse Event|0|||
48771945|NCT02460224|157009966|FG004|Overall Study|Adverse Event|0|||
48771946|NCT02460224|157009967|FG005|Overall Study|Adverse Event|0|||
48771947|NCT02460224|157009968|FG006|Overall Study|Adverse Event|1|||
48771948|NCT02460224|157009969|FG007|Overall Study|Adverse Event|0|||
48771949|NCT02460224|157009970|FG008|Overall Study|Adverse Event|0|||
48771950|NCT02460224|157009971|FG009|Overall Study|Adverse Event|0|||
48771951|NCT02460224|157009972|FG010|Overall Study|Adverse Event|0|||
48771952|NCT02460224|157009973|FG011|Overall Study|Adverse Event|0|||
48771953|NCT02460224|157009974|FG012|Overall Study|Adverse Event|1|||
48771954|NCT02460224|157009975|FG013|Overall Study|Adverse Event|0|||
48771955|NCT02460224|157009976|FG014|Overall Study|Adverse Event|0|||
48771956|NCT02460224|157009977|FG015|Overall Study|Adverse Event|0|||
48771957|NCT02460224|157009978|FG016|Overall Study|Adverse Event|1|||
48771958|NCT02460224|157009979|FG017|Overall Study|Adverse Event|0|||
48771959|NCT02460224|157009980|FG018|Overall Study|Adverse Event|1|||
48771960|NCT02460224|157009981|FG019|Overall Study|Adverse Event|0|||
48771961|NCT02460224|157009982|FG020|Overall Study|Adverse Event|1|||
48771962|NCT02460224|157009983|FG021|Overall Study|Adverse Event|1|||
48771963|NCT02460224|157009984|FG022|Overall Study|Adverse Event|1|||
48771964|NCT02460224|157009985|FG023|Overall Study|Adverse Event|0|||
48771965|NCT02460224|157009986|FG024|Overall Study|Adverse Event|0|||
48771966|NCT02460224|157009987|FG025|Overall Study|Adverse Event|0|||
48771967|NCT02460224|157009988|FG026|Overall Study|Adverse Event|11|||
48771968|NCT02460224|157009989|FG027|Overall Study|Adverse Event|1|||
48771969|NCT02460224|157009990|FG028|Overall Study|Adverse Event|6|||
48771970|NCT02460224|157009962|FG000|Overall Study|Death|0|||
48771971|NCT02460224|157009963|FG001|Overall Study|Death|0|||
48771972|NCT02460224|157009964|FG002|Overall Study|Death|0|||
48771973|NCT02460224|157009965|FG003|Overall Study|Death|0|||
48771974|NCT02460224|157009966|FG004|Overall Study|Death|0|||
48771975|NCT02460224|157009967|FG005|Overall Study|Death|2|||
48771976|NCT02460224|157009968|FG006|Overall Study|Death|1|||
48771977|NCT02460224|157009969|FG007|Overall Study|Death|0|||
48771978|NCT02460224|157009970|FG008|Overall Study|Death|0|||
48771979|NCT02460224|157009971|FG009|Overall Study|Death|1|||
48771980|NCT02460224|157009972|FG010|Overall Study|Death|0|||
48771981|NCT02460224|157009973|FG011|Overall Study|Death|0|||
48771982|NCT02460224|157009974|FG012|Overall Study|Death|0|||
48771983|NCT02460224|157009975|FG013|Overall Study|Death|1|||
48771984|NCT02460224|157009976|FG014|Overall Study|Death|0|||
48771985|NCT02460224|157009977|FG015|Overall Study|Death|0|||
48771986|NCT02460224|157009978|FG016|Overall Study|Death|2|||
48876431|NCT02165826|157384686|FG001|Main Treatment Period|Reason Not Specified|5|||
49026942|NCT01126736|157937556|FG002|Overall Study|Withdrawal by Subject|0|||
48771987|NCT02460224|157009979|FG017|Overall Study|Death|1|||
48771988|NCT02460224|157009980|FG018|Overall Study|Death|0|||
48771989|NCT02460224|157009981|FG019|Overall Study|Death|2|||
48771990|NCT02460224|157009982|FG020|Overall Study|Death|0|||
48771991|NCT02460224|157009983|FG021|Overall Study|Death|0|||
48771992|NCT02460224|157009984|FG022|Overall Study|Death|0|||
48771993|NCT02460224|157009985|FG023|Overall Study|Death|0|||
48771994|NCT02460224|157009986|FG024|Overall Study|Death|1|||
48771995|NCT02460224|157009987|FG025|Overall Study|Death|1|||
48771996|NCT02460224|157009988|FG026|Overall Study|Death|5|||
48771997|NCT02460224|157009989|FG027|Overall Study|Death|0|||
48771998|NCT02460224|157009990|FG028|Overall Study|Death|1|||
48771999|NCT02460224|157009962|FG000|Overall Study|Lost to Follow-up|0|||
48772000|NCT02460224|157009963|FG001|Overall Study|Lost to Follow-up|0|||
48772001|NCT02460224|157009964|FG002|Overall Study|Lost to Follow-up|0|||
48772002|NCT02460224|157009965|FG003|Overall Study|Lost to Follow-up|0|||
48772003|NCT02460224|157009966|FG004|Overall Study|Lost to Follow-up|0|||
48876432|NCT02165826|157384687|FG002|Main Treatment Period|Reason Not Specified|16|||
49026943|NCT01126736|157937557|FG003|Overall Study|Withdrawal by Subject|1|||
48772004|NCT02460224|157009967|FG005|Overall Study|Lost to Follow-up|0|||
48772005|NCT02460224|157009968|FG006|Overall Study|Lost to Follow-up|0|||
48772006|NCT02460224|157009969|FG007|Overall Study|Lost to Follow-up|0|||
48772007|NCT02460224|157009970|FG008|Overall Study|Lost to Follow-up|0|||
48772008|NCT02460224|157009971|FG009|Overall Study|Lost to Follow-up|0|||
48772009|NCT02460224|157009972|FG010|Overall Study|Lost to Follow-up|0|||
48772010|NCT02460224|157009973|FG011|Overall Study|Lost to Follow-up|0|||
48772011|NCT02460224|157009974|FG012|Overall Study|Lost to Follow-up|0|||
48772012|NCT02460224|157009975|FG013|Overall Study|Lost to Follow-up|0|||
48772013|NCT02460224|157009976|FG014|Overall Study|Lost to Follow-up|0|||
48772014|NCT02460224|157009977|FG015|Overall Study|Lost to Follow-up|0|||
48772015|NCT02460224|157009978|FG016|Overall Study|Lost to Follow-up|0|||
48772016|NCT02460224|157009979|FG017|Overall Study|Lost to Follow-up|0|||
48772017|NCT02460224|157009980|FG018|Overall Study|Lost to Follow-up|0|||
48772018|NCT02460224|157009981|FG019|Overall Study|Lost to Follow-up|0|||
48772019|NCT02460224|157009982|FG020|Overall Study|Lost to Follow-up|0|||
48772020|NCT02460224|157009983|FG021|Overall Study|Lost to Follow-up|0|||
48772021|NCT02460224|157009984|FG022|Overall Study|Lost to Follow-up|1|||
48772022|NCT02460224|157009985|FG023|Overall Study|Lost to Follow-up|0|||
48772023|NCT02460224|157009986|FG024|Overall Study|Lost to Follow-up|0|||
48772024|NCT02460224|157009987|FG025|Overall Study|Lost to Follow-up|0|||
48772025|NCT02460224|157009988|FG026|Overall Study|Lost to Follow-up|0|||
48772026|NCT02460224|157009989|FG027|Overall Study|Lost to Follow-up|0|||
48772027|NCT02460224|157009990|FG028|Overall Study|Lost to Follow-up|0|||
48772028|NCT02460224|157009962|FG000|Overall Study|Physician Decision|0|||
48772029|NCT02460224|157009963|FG001|Overall Study|Physician Decision|1|||
48772030|NCT02460224|157009964|FG002|Overall Study|Physician Decision|0|||
48772031|NCT02460224|157009965|FG003|Overall Study|Physician Decision|0|||
48772032|NCT02460224|157009966|FG004|Overall Study|Physician Decision|1|||
48772033|NCT02460224|157009967|FG005|Overall Study|Physician Decision|0|||
48772034|NCT02460224|157009968|FG006|Overall Study|Physician Decision|0|||
48772035|NCT02460224|157009969|FG007|Overall Study|Physician Decision|1|||
48772036|NCT02460224|157009970|FG008|Overall Study|Physician Decision|0|||
48772037|NCT02460224|157009971|FG009|Overall Study|Physician Decision|0|||
48772038|NCT02460224|157009972|FG010|Overall Study|Physician Decision|0|||
48772039|NCT02460224|157009973|FG011|Overall Study|Physician Decision|1|||
48772040|NCT02460224|157009974|FG012|Overall Study|Physician Decision|0|||
48772041|NCT02460224|157009975|FG013|Overall Study|Physician Decision|1|||
48772042|NCT02460224|157009976|FG014|Overall Study|Physician Decision|0|||
48772043|NCT02460224|157009977|FG015|Overall Study|Physician Decision|0|||
48772044|NCT02460224|157009978|FG016|Overall Study|Physician Decision|2|||
48772045|NCT02460224|157009979|FG017|Overall Study|Physician Decision|1|||
48772046|NCT02460224|157009980|FG018|Overall Study|Physician Decision|1|||
48772047|NCT02460224|157009981|FG019|Overall Study|Physician Decision|2|||
48772048|NCT02460224|157009982|FG020|Overall Study|Physician Decision|1|||
48772049|NCT02460224|157009983|FG021|Overall Study|Physician Decision|1|||
48772050|NCT02460224|157009984|FG022|Overall Study|Physician Decision|0|||
48772051|NCT02460224|157009985|FG023|Overall Study|Physician Decision|0|||
48772052|NCT02460224|157009986|FG024|Overall Study|Physician Decision|1|||
48772053|NCT02460224|157009987|FG025|Overall Study|Physician Decision|0|||
48772054|NCT02460224|157009988|FG026|Overall Study|Physician Decision|14|||
48772055|NCT02460224|157009989|FG027|Overall Study|Physician Decision|1|||
48772056|NCT02460224|157009990|FG028|Overall Study|Physician Decision|6|||
48772057|NCT02460224|157009962|FG000|Overall Study|Progressive disease|15|||
48772058|NCT02460224|157009963|FG001|Overall Study|Progressive disease|11|||
48772059|NCT02460224|157009964|FG002|Overall Study|Progressive disease|5|||
48772060|NCT02460224|157009965|FG003|Overall Study|Progressive disease|6|||
48772061|NCT02460224|157009966|FG004|Overall Study|Progressive disease|3|||
48772062|NCT02460224|157009967|FG005|Overall Study|Progressive disease|26|||
48772063|NCT02460224|157009968|FG006|Overall Study|Progressive disease|28|||
48772064|NCT02460224|157009969|FG007|Overall Study|Progressive disease|4|||
48772065|NCT02460224|157009970|FG008|Overall Study|Progressive disease|5|||
48772066|NCT02460224|157009971|FG009|Overall Study|Progressive disease|9|||
48772067|NCT02460224|157009972|FG010|Overall Study|Progressive disease|5|||
48772068|NCT02460224|157009973|FG011|Overall Study|Progressive disease|4|||
48772069|NCT02460224|157009974|FG012|Overall Study|Progressive disease|5|||
48772070|NCT02460224|157009975|FG013|Overall Study|Progressive disease|4|||
48772071|NCT02460224|157009976|FG014|Overall Study|Progressive disease|5|||
48772072|NCT02460224|157009977|FG015|Overall Study|Progressive disease|5|||
48772073|NCT02460224|157009978|FG016|Overall Study|Progressive disease|15|||
48772074|NCT02460224|157009979|FG017|Overall Study|Progressive disease|3|||
48772075|NCT02460224|157009980|FG018|Overall Study|Progressive disease|8|||
48772076|NCT02460224|157009981|FG019|Overall Study|Progressive disease|3|||
48772077|NCT02460224|157009982|FG020|Overall Study|Progressive disease|4|||
48772078|NCT02460224|157009983|FG021|Overall Study|Progressive disease|9|||
48772079|NCT02460224|157009984|FG022|Overall Study|Progressive disease|4|||
48772080|NCT02460224|157009985|FG023|Overall Study|Progressive disease|11|||
48772081|NCT02460224|157009986|FG024|Overall Study|Progressive disease|4|||
48772082|NCT02460224|157009987|FG025|Overall Study|Progressive disease|5|||
48772083|NCT02460224|157009988|FG026|Overall Study|Progressive disease|85|||
48772084|NCT02460224|157009989|FG027|Overall Study|Progressive disease|17|||
48772085|NCT02460224|157009990|FG028|Overall Study|Progressive disease|77|||
48772086|NCT02460224|157009962|FG000|Overall Study|Subject/guardian decision|2|||
48772087|NCT02460224|157009963|FG001|Overall Study|Subject/guardian decision|0|||
48772088|NCT02460224|157009964|FG002|Overall Study|Subject/guardian decision|1|||
49026944|NCT01126736|157937558|FG004|Overall Study|Withdrawal by Subject|1|||
49026945|NCT01126736|157937554|FG000|Overall Study|Other|2|||
49026946|NCT01126736|157937555|FG001|Overall Study|Other|4|||
49026947|NCT01126736|157937556|FG002|Overall Study|Other|4|||
49026948|NCT01126736|157937557|FG003|Overall Study|Other|16|||
49026949|NCT01126736|157937558|FG004|Overall Study|Other|15|||
49026950|NCT00389064|157937559|FG000|Overall Study|Adverse Event|11|||
49026951|NCT00389064|157937560|FG001|Overall Study|Adverse Event|3|||
49026952|NCT00389064|157937559|FG000|Overall Study|Lack of Efficacy|3|||
49026953|NCT00389064|157937560|FG001|Overall Study|Lack of Efficacy|14|||
49026954|NCT00389064|157937559|FG000|Overall Study|Withdrawal by Subject|17|||
49026955|NCT00389064|157937560|FG001|Overall Study|Withdrawal by Subject|27|||
49026956|NCT00389064|157937559|FG000|Overall Study|Physician Decision|2|||
49026957|NCT00389064|157937560|FG001|Overall Study|Physician Decision|2|||
49026958|NCT00389064|157937559|FG000|Overall Study|Lost to Follow-up|1|||
49026959|NCT00389064|157937560|FG001|Overall Study|Lost to Follow-up|2|||
49026960|NCT00389064|157937559|FG000|Overall Study|Protocol Violation|2|||
49026961|NCT00389064|157937560|FG001|Overall Study|Protocol Violation|0|||
49026962|NCT00389064|157937559|FG000|Overall Study|Multiple Reasons|9|||
49026963|NCT00389064|157937560|FG001|Overall Study|Multiple Reasons|11|||
49026964|NCT02015390|157937562|FG000|Overall Study|Lost to Follow-up|1|||
49026965|NCT02015390|157937563|FG001|Overall Study|Lost to Follow-up|0|||
49026966|NCT02015390|157937562|FG000|Overall Study|Adverse Event|0|||
49026967|NCT02015390|157937563|FG001|Overall Study|Adverse Event|3|||
49026968|NCT02015390|157937562|FG000|Overall Study|Physician Decision|0|||
49026969|NCT02015390|157937563|FG001|Overall Study|Physician Decision|1|||
49026970|NCT01358877|157937564|FG000|Overall Study|Death|80|||
49026971|NCT01358877|157937565|FG001|Overall Study|Death|89|||
49026972|NCT01358877|157937564|FG000|Overall Study|Ongoing follow-up for post-recurrence|87|||
49026973|NCT01358877|157937565|FG001|Overall Study|Ongoing follow-up for post-recurrence|108|||
49026974|NCT01358877|157937564|FG000|Overall Study|Ongoing follow-up for IDFS event|2084|||
49026975|NCT01358877|157937565|FG001|Overall Study|Ongoing follow-up for IDFS event|2073|||
49026976|NCT01358877|157937564|FG000|Overall Study|Ongoing follow-up for overall survival|7|||
49026977|NCT01358877|157937565|FG001|Overall Study|Ongoing follow-up for overall survival|5|||
49026978|NCT01358877|157937564|FG000|Overall Study|Other|142|||
49026979|NCT01358877|157937565|FG001|Overall Study|Other|129|||
49026980|NCT00064753|157937566|FG000|Overall Study|Death|251|||
49026981|NCT00064753|157937567|FG001|Overall Study|Death|242|||
49026982|NCT00064753|157937566|FG000|Overall Study|Withdrawal by Subject|198|||
49026983|NCT00064753|157937567|FG001|Overall Study|Withdrawal by Subject|171|||
49026984|NCT00064753|157937566|FG000|Overall Study|Lost to Follow-up|225|||
49026985|NCT00064753|157937567|FG001|Overall Study|Lost to Follow-up|235|||
49026986|NCT03136380|157937568|FG000|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
49026987|NCT03136380|157937569|FG001|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
49026988|NCT03136380|157937570|FG002|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
49026989|NCT03136380|157937571|FG003|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
49026990|NCT03136380|157937572|FG004|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
48772089|NCT02460224|157009965|FG003|Overall Study|Subject/guardian decision|0|||
48772090|NCT02460224|157009966|FG004|Overall Study|Subject/guardian decision|2|||
48772091|NCT02460224|157009967|FG005|Overall Study|Subject/guardian decision|2|||
48772092|NCT02460224|157009968|FG006|Overall Study|Subject/guardian decision|0|||
48772093|NCT02460224|157009969|FG007|Overall Study|Subject/guardian decision|0|||
48772094|NCT02460224|157009970|FG008|Overall Study|Subject/guardian decision|1|||
48772095|NCT02460224|157009971|FG009|Overall Study|Subject/guardian decision|1|||
48772096|NCT02460224|157009972|FG010|Overall Study|Subject/guardian decision|0|||
48772097|NCT02460224|157009973|FG011|Overall Study|Subject/guardian decision|1|||
48772098|NCT02460224|157009974|FG012|Overall Study|Subject/guardian decision|0|||
48772099|NCT02460224|157009975|FG013|Overall Study|Subject/guardian decision|0|||
48772100|NCT02460224|157009976|FG014|Overall Study|Subject/guardian decision|0|||
48772101|NCT02460224|157009977|FG015|Overall Study|Subject/guardian decision|1|||
49026991|NCT05341622|157937577|FG000|Overall Study|Death|0|||
49026992|NCT05341622|157937578|FG001|Overall Study|Death|0|||
49026993|NCT05341622|157937579|FG002|Overall Study|Death|0|||
49026994|NCT05341622|157937580|FG003|Overall Study|Death|0|||
49026995|NCT05341622|157937581|FG004|Overall Study|Death|1|||
49026996|NCT05341622|157937582|FG005|Overall Study|Death|0|||
49026997|NCT05341622|157937583|FG006|Overall Study|Death|0|||
49026998|NCT05341622|157937584|FG007|Overall Study|Death|1|||
48772102|NCT02460224|157009978|FG016|Overall Study|Subject/guardian decision|0|||
48772103|NCT02460224|157009979|FG017|Overall Study|Subject/guardian decision|1|||
48772104|NCT02460224|157009980|FG018|Overall Study|Subject/guardian decision|2|||
48772105|NCT02460224|157009981|FG019|Overall Study|Subject/guardian decision|0|||
49026999|NCT05341622|157937577|FG000|Overall Study|Invalid Address|0|||
49027000|NCT05341622|157937578|FG001|Overall Study|Invalid Address|1|||
48772106|NCT02460224|157009982|FG020|Overall Study|Subject/guardian decision|0|||
48772107|NCT02460224|157009983|FG021|Overall Study|Subject/guardian decision|1|||
48772108|NCT02460224|157009984|FG022|Overall Study|Subject/guardian decision|0|||
48772109|NCT02460224|157009985|FG023|Overall Study|Subject/guardian decision|0|||
48772110|NCT02460224|157009986|FG024|Overall Study|Subject/guardian decision|0|||
48772111|NCT02460224|157009987|FG025|Overall Study|Subject/guardian decision|0|||
48772112|NCT02460224|157009988|FG026|Overall Study|Subject/guardian decision|6|||
48772113|NCT02460224|157009989|FG027|Overall Study|Subject/guardian decision|2|||
48772114|NCT02460224|157009990|FG028|Overall Study|Subject/guardian decision|3|||
48772115|NCT01600586|157009992|FG000|Overall Study|Physician Decision|3|||
48772116|NCT01600586|157009993|FG001|Overall Study|Physician Decision|3|||
48772117|NCT04055116|157009995|FG000|First Intervention|Physician Decision|2|||
49027001|NCT05341622|157937579|FG002|Overall Study|Invalid Address|0|||
49027002|NCT05341622|157937580|FG003|Overall Study|Invalid Address|0|||
49027003|NCT05341622|157937581|FG004|Overall Study|Invalid Address|0|||
49027004|NCT05341622|157937582|FG005|Overall Study|Invalid Address|0|||
49027005|NCT05341622|157937583|FG006|Overall Study|Invalid Address|0|||
49027006|NCT05341622|157937584|FG007|Overall Study|Invalid Address|0|||
49027007|NCT05341622|157937577|FG000|Overall Study|Ineligible|26|||
49027008|NCT05341622|157937578|FG001|Overall Study|Ineligible|21|||
49027009|NCT05341622|157937579|FG002|Overall Study|Ineligible|28|||
49027010|NCT05341622|157937580|FG003|Overall Study|Ineligible|24|||
49027011|NCT05341622|157937581|FG004|Overall Study|Ineligible|29|||
49027012|NCT05341622|157937582|FG005|Overall Study|Ineligible|31|||
49027013|NCT05341622|157937583|FG006|Overall Study|Ineligible|28|||
48772118|NCT04055116|157009996|FG001|First Intervention|Physician Decision|7|||
48772119|NCT01898793|157009997|FG000|Overall Study|Death|2|||
48772120|NCT01898793|157009998|FG001|Overall Study|Death|1|||
48772121|NCT01898793|157009999|FG002|Overall Study|Death|4|||
48772122|NCT01898793|157010000|FG003|Overall Study|Death|0|||
48772123|NCT01898793|157010001|FG004|Overall Study|Death|0|||
48772124|NCT01898793|157010002|FG005|Overall Study|Death|0|||
48772125|NCT01898793|157010003|FG006|Overall Study|Death|0|||
48772126|NCT02908529|157010004|FG000|Overall Study|Lost to Follow-up|0|||
48772127|NCT02908529|157010005|FG001|Overall Study|Lost to Follow-up|2|||
48772128|NCT00689481|157010007|FG000|Overall Study|Adverse Event|7|||
48772129|NCT00689481|157010008|FG001|Overall Study|Adverse Event|1|||
48772130|NCT00689481|157010007|FG000|Overall Study|Lost to Follow-up|4|||
48772131|NCT00689481|157010008|FG001|Overall Study|Lost to Follow-up|3|||
48772132|NCT00689481|157010007|FG000|Overall Study|Lack of Efficacy|4|||
48772133|NCT00689481|157010008|FG001|Overall Study|Lack of Efficacy|3|||
48772134|NCT00689481|157010007|FG000|Overall Study|Non-compliance with study treatment|1|||
48772135|NCT00689481|157010008|FG001|Overall Study|Non-compliance with study treatment|1|||
48772136|NCT00689481|157010007|FG000|Overall Study|Withdrawal by Subject|8|||
48772137|NCT00689481|157010008|FG001|Overall Study|Withdrawal by Subject|4|||
48772138|NCT00689481|157010007|FG000|Overall Study|Excluded medication started during study|0|||
48772139|NCT00689481|157010008|FG001|Overall Study|Excluded medication started during study|1|||
48772140|NCT00689481|157010007|FG000|Overall Study|Subject early term, left on vacation|0|||
48772141|NCT00689481|157010008|FG001|Overall Study|Subject early term, left on vacation|1|||
48772142|NCT00512096|157010009|FG000|Overall Study|Adverse Event|2|||
48772143|NCT00512096|157010009|FG000|Overall Study|Withdrawal by Subject|2|||
48772144|NCT00512096|157010009|FG000|Overall Study|Lack of Efficacy|3|||
48772145|NCT00931307|157010013|FG000|Overall Study|Lack of Efficacy|12|||
48772146|NCT00931307|157010013|FG000|Overall Study|Biomicroscopy|1|||
48772147|NCT01069289|157010014|FG000|Overall Study|Withdrawal by Subject|15|||
48772148|NCT01069289|157010015|FG001|Overall Study|Withdrawal by Subject|26|||
48772149|NCT01069289|157010014|FG000|Overall Study|Adverse Event|21|||
48982298|NCT00088595|157767552|FG000|Overall Study|Withdrawal by Subject|8|||
48982299|NCT00088595|157767552|FG000|Overall Study|Ongoing (After Core)|7|||
48982300|NCT00088595|157767552|FG000|Overall Study|New Cancer Therapy|2|||
48982301|NCT01998906|157767553|FG000|Overall Study|Participants ongoing in follow-up|77|||
48982302|NCT01998906|157767554|FG001|Overall Study|Participants ongoing in follow-up|60|||
48982303|NCT01998906|157767555|FG002|Overall Study|Participants ongoing in follow-up|58|||
48982304|NCT01998906|157767553|FG000|Overall Study|Death|21|||
48982305|NCT01998906|157767554|FG001|Overall Study|Death|30|||
48982306|NCT01998906|157767555|FG002|Overall Study|Death|17|||
48772150|NCT01069289|157010015|FG001|Overall Study|Adverse Event|28|||
48772151|NCT01069289|157010014|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
48772152|NCT01069289|157010015|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
48772153|NCT01069289|157010014|FG000|Overall Study|Severe non-compliance to protocol|3|||
48772154|NCT01069289|157010015|FG001|Overall Study|Severe non-compliance to protocol|2|||
48772155|NCT01069289|157010014|FG000|Overall Study|Due to deteriorating health condition|1|||
48772156|NCT01069289|157010015|FG001|Overall Study|Due to deteriorating health condition|0|||
48772157|NCT01797536|157011391|FG000|Overall Study|Adverse Event|0|||
48772158|NCT01797536|157011392|FG001|Overall Study|Adverse Event|1|||
48772159|NCT01797536|157011393|FG002|Overall Study|Adverse Event|0|||
48982307|NCT01998906|157767553|FG000|Overall Study|Lack of Efficacy|10|||
48982308|NCT01998906|157767554|FG001|Overall Study|Lack of Efficacy|9|||
49027014|NCT05341622|157937584|FG007|Overall Study|Ineligible|26|||
49027015|NCT01661686|157937587|FG000|Overall Study|Lost to Follow-up|2|||
49027016|NCT01661686|157937588|FG001|Overall Study|Lost to Follow-up|1|||
49027017|NCT01661686|157937587|FG000|Overall Study|did not receive allocated intervention|0|||
49027018|NCT01661686|157937588|FG001|Overall Study|did not receive allocated intervention|1|||
49027019|NCT02935686|157937589|FG000|Main Study (Week 0 up to Week 72)|Adverse Event|1|||
49027020|NCT02935686|157937590|FG001|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
49027021|NCT02935686|157937591|FG002|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
49027022|NCT02935686|157937592|FG003|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
49027023|NCT02935686|157937593|FG004|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
49027024|NCT02935686|157937589|FG000|Main Study (Week 0 up to Week 72)|Lost to Follow-up|4|||
49027025|NCT02935686|157937590|FG001|Main Study (Week 0 up to Week 72)|Lost to Follow-up|1|||
49027026|NCT02935686|157937591|FG002|Main Study (Week 0 up to Week 72)|Lost to Follow-up|2|||
49027027|NCT02935686|157937592|FG003|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
49027028|NCT02935686|157937593|FG004|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
49027029|NCT02935686|157937589|FG000|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
49027030|NCT02935686|157937590|FG001|Main Study (Week 0 up to Week 72)|Pregnancy|2|||
49027031|NCT02935686|157937591|FG002|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
49027032|NCT02935686|157937592|FG003|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
49027033|NCT02935686|157937593|FG004|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
49027034|NCT02935686|157937589|FG000|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|2|||
49027035|NCT02935686|157937590|FG001|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|9|||
49027036|NCT02935686|157937591|FG002|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
49027037|NCT02935686|157937592|FG003|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
49027038|NCT02935686|157937593|FG004|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
49027039|NCT02935686|157937589|FG000|Main Study (Week 0 up to Week 72)|Other|0|||
49027040|NCT02935686|157937590|FG001|Main Study (Week 0 up to Week 72)|Other|1|||
49027041|NCT02935686|157937591|FG002|Main Study (Week 0 up to Week 72)|Other|0|||
49027042|NCT02935686|157937592|FG003|Main Study (Week 0 up to Week 72)|Other|0|||
49027043|NCT02935686|157937593|FG004|Main Study (Week 0 up to Week 72)|Other|0|||
49027044|NCT02935686|157937589|FG000|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
49027045|NCT02935686|157937590|FG001|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|3|||
49027046|NCT02935686|157937591|FG002|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
49027047|NCT02935686|157937592|FG003|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
49027048|NCT02935686|157937593|FG004|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
49027049|NCT02935686|157937589|FG000|Long-term Extension (Week 72 - 216)|Lost to Follow-up|2|||
49027050|NCT02935686|157937590|FG001|Long-term Extension (Week 72 - 216)|Lost to Follow-up|8|||
49027051|NCT02935686|157937591|FG002|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
49027052|NCT02935686|157937592|FG003|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
49027053|NCT02935686|157937593|FG004|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
49027054|NCT02935686|157937589|FG000|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
49027055|NCT02935686|157937590|FG001|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|4|||
49027056|NCT02935686|157937591|FG002|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
49027057|NCT02935686|157937592|FG003|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
49027058|NCT02935686|157937593|FG004|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
49027059|NCT02935686|157937589|FG000|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
48772160|NCT01797536|157011394|FG003|Overall Study|Adverse Event|0|||
48772161|NCT01158222|157011395|FG000|Overall Study|Not eligible for intermediate phase|17|||
48772162|NCT01470469|157011396|FG000|Overall Study|Withdrawal by Subject|4|||
48772163|NCT01470469|157011397|FG001|Overall Study|Withdrawal by Subject|6|||
48772164|NCT01470469|157011396|FG000|Overall Study|Lack of Efficacy|1|||
48772165|NCT01470469|157011397|FG001|Overall Study|Lack of Efficacy|7|||
48772166|NCT01470469|157011396|FG000|Overall Study|Adverse Event|0|||
48772167|NCT01470469|157011397|FG001|Overall Study|Adverse Event|7|||
48772168|NCT01470469|157011396|FG000|Overall Study|Lost to Follow-up|2|||
48772169|NCT01470469|157011397|FG001|Overall Study|Lost to Follow-up|2|||
48772170|NCT01470469|157011396|FG000|Overall Study|Protocol Violation|1|||
48772171|NCT01470469|157011397|FG001|Overall Study|Protocol Violation|1|||
49027060|NCT02935686|157937590|FG001|Long-term Extension (Week 72 - 216)|Adverse Event|1|||
49027061|NCT02935686|157937591|FG002|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
49027062|NCT02935686|157937592|FG003|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
49027063|NCT02935686|157937593|FG004|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
49027064|NCT02935686|157937589|FG000|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
49027065|NCT02935686|157937590|FG001|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
49027066|NCT02935686|157937591|FG002|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
49027067|NCT02935686|157937592|FG003|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
48772172|NCT01470469|157011396|FG000|Overall Study|Other|2|||
49027068|NCT02935686|157937593|FG004|Late Boost Vaccination (Week 192 - 288)|Adverse Event|1|||
48772173|NCT01470469|157011397|FG001|Overall Study|Other|1|||
48772174|NCT01604343|157011398|FG000|Prior to W52 Administration(Through W52)|Lost to Follow-up|5|||
48772175|NCT01604343|157011399|FG001|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
48772176|NCT01604343|157011400|FG002|Prior to W52 Administration(Through W52)|Lost to Follow-up|4|||
48772177|NCT01604343|157011401|FG003|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
48772178|NCT01604343|157011402|FG004|Prior to W52 Administration(Through W52)|Lost to Follow-up|3|||
48772179|NCT01604343|157011398|FG000|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19|||
48772180|NCT01604343|157011399|FG001|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
48772181|NCT01604343|157011400|FG002|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12|||
48772182|NCT01604343|157011401|FG003|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
48772183|NCT01604343|157011402|FG004|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16|||
48772184|NCT01604343|157011398|FG000|Prior to W52 Administration(Through W52)|Adverse Event|25|||
48772185|NCT01604343|157011399|FG001|Prior to W52 Administration(Through W52)|Adverse Event|0|||
48772186|NCT01604343|157011400|FG002|Prior to W52 Administration(Through W52)|Adverse Event|41|||
48772187|NCT01604343|157011401|FG003|Prior to W52 Administration(Through W52)|Adverse Event|0|||
48772188|NCT01604343|157011402|FG004|Prior to W52 Administration(Through W52)|Adverse Event|42|||
48772189|NCT01604343|157011398|FG000|Prior to W52 Administration(Through W52)|Death|5|||
48772190|NCT01604343|157011399|FG001|Prior to W52 Administration(Through W52)|Death|0|||
48772191|NCT01604343|157011400|FG002|Prior to W52 Administration(Through W52)|Death|2|||
48772192|NCT01604343|157011401|FG003|Prior to W52 Administration(Through W52)|Death|0|||
48772193|NCT01604343|157011402|FG004|Prior to W52 Administration(Through W52)|Death|4|||
48772194|NCT01604343|157011398|FG000|Prior to W52 Administration(Through W52)|Lack of Efficacy|24|||
48772195|NCT01604343|157011399|FG001|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
48772196|NCT01604343|157011400|FG002|Prior to W52 Administration(Through W52)|Lack of Efficacy|5|||
48772197|NCT01604343|157011401|FG003|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
48772198|NCT01604343|157011402|FG004|Prior to W52 Administration(Through W52)|Lack of Efficacy|14|||
48772199|NCT01604343|157011398|FG000|Prior to W52 Administration(Through W52)|Physician Decision|4|||
48772200|NCT01604343|157011399|FG001|Prior to W52 Administration(Through W52)|Physician Decision|0|||
48772201|NCT01604343|157011400|FG002|Prior to W52 Administration(Through W52)|Physician Decision|1|||
48772202|NCT01604343|157011401|FG003|Prior to W52 Administration(Through W52)|Physician Decision|0|||
48772203|NCT01604343|157011402|FG004|Prior to W52 Administration(Through W52)|Physician Decision|2|||
48772204|NCT01604343|157011398|FG000|Prior to W52 Administration(Through W52)|Pregnancy|1|||
48772205|NCT01604343|157011399|FG001|Prior to W52 Administration(Through W52)|Pregnancy|0|||
48772206|NCT01604343|157011400|FG002|Prior to W52 Administration(Through W52)|Pregnancy|1|||
48772207|NCT01604343|157011401|FG003|Prior to W52 Administration(Through W52)|Pregnancy|0|||
48772208|NCT01604343|157011402|FG004|Prior to W52 Administration(Through W52)|Pregnancy|0|||
48772209|NCT01604343|157011398|FG000|Prior to W52 Administration(Through W52)|Other|15|||
48772210|NCT01604343|157011399|FG001|Prior to W52 Administration(Through W52)|Other|0|||
48772211|NCT01604343|157011400|FG002|Prior to W52 Administration(Through W52)|Other|10|||
48772212|NCT01604343|157011401|FG003|Prior to W52 Administration(Through W52)|Other|0|||
48772213|NCT01604343|157011402|FG004|Prior to W52 Administration(Through W52)|Other|6|||
48772214|NCT01604343|157011398|FG000|Week 52 to Week 104|Lost to Follow-up|0|||
48772215|NCT01604343|157011399|FG001|Week 52 to Week 104|Lost to Follow-up|2|||
48772216|NCT01604343|157011400|FG002|Week 52 to Week 104|Lost to Follow-up|4|||
48772217|NCT01604343|157011401|FG003|Week 52 to Week 104|Lost to Follow-up|2|||
48772218|NCT01604343|157011402|FG004|Week 52 to Week 104|Lost to Follow-up|1|||
48772219|NCT01604343|157011398|FG000|Week 52 to Week 104|Withdrawal by Subject|0|||
48876433|NCT02165826|157384685|FG000|Main Treatment Period|Did Not Receive Study Drug|0|||
48982309|NCT01998906|157767555|FG002|Overall Study|Lack of Efficacy|8|||
48982310|NCT01998906|157767553|FG000|Overall Study|Failure to return|0|||
48982311|NCT01998906|157767554|FG001|Overall Study|Failure to return|2|||
48982312|NCT01998906|157767555|FG002|Overall Study|Failure to return|4|||
48982313|NCT01998906|157767553|FG000|Overall Study|Violation of Selection Criteria|0|||
48982314|NCT01998906|157767554|FG001|Overall Study|Violation of Selection Criteria|0|||
48982315|NCT01998906|157767555|FG002|Overall Study|Violation of Selection Criteria|1|||
48982316|NCT01998906|157767553|FG000|Overall Study|Withdrawal by Subject|1|||
48982317|NCT01998906|157767554|FG001|Overall Study|Withdrawal by Subject|4|||
48982318|NCT01998906|157767555|FG002|Overall Study|Withdrawal by Subject|3|||
48982319|NCT01998906|157767553|FG000|Overall Study|Administrative/Other|2|||
48982320|NCT01998906|157767554|FG001|Overall Study|Administrative/Other|1|||
48982321|NCT01998906|157767555|FG002|Overall Study|Administrative/Other|3|||
48982322|NCT01998906|157767553|FG000|Overall Study|Other|3|||
48982323|NCT01998906|157767554|FG001|Overall Study|Other|8|||
48982324|NCT01998906|157767555|FG002|Overall Study|Other|4|||
48982325|NCT02903966|157767558|FG000|Part A (Day 1 to 43)|Adverse Event|1|||
48982326|NCT02903966|157767559|FG001|Part A (Day 1 to 43)|Adverse Event|0|||
48982327|NCT02903966|157767558|FG000|Part B (Day 44 to 112)|Lack of Efficacy|0|||
48982328|NCT02903966|157767559|FG001|Part B (Day 44 to 112)|Lack of Efficacy|1|||
48982329|NCT02903966|157767558|FG000|Part B (Day 44 to 112)|Withdrawal by Subject|0|||
48982330|NCT02903966|157767559|FG001|Part B (Day 44 to 112)|Withdrawal by Subject|1|||
48982331|NCT02828644|157767562|FG000|Overall Study|Lost to Follow-up|23|||
48772220|NCT01604343|157011399|FG001|Week 52 to Week 104|Withdrawal by Subject|7|||
48772221|NCT01604343|157011400|FG002|Week 52 to Week 104|Withdrawal by Subject|12|||
48772222|NCT01604343|157011401|FG003|Week 52 to Week 104|Withdrawal by Subject|8|||
48772223|NCT01604343|157011402|FG004|Week 52 to Week 104|Withdrawal by Subject|4|||
48772224|NCT01604343|157011398|FG000|Week 52 to Week 104|Adverse Event|0|||
48772225|NCT01604343|157011399|FG001|Week 52 to Week 104|Adverse Event|12|||
48772226|NCT01604343|157011400|FG002|Week 52 to Week 104|Adverse Event|26|||
48772227|NCT01604343|157011401|FG003|Week 52 to Week 104|Adverse Event|21|||
48772228|NCT01604343|157011402|FG004|Week 52 to Week 104|Adverse Event|27|||
48772229|NCT01604343|157011398|FG000|Week 52 to Week 104|Death|0|||
48772230|NCT01604343|157011399|FG001|Week 52 to Week 104|Death|4|||
48772231|NCT01604343|157011400|FG002|Week 52 to Week 104|Death|2|||
48772232|NCT01604343|157011401|FG003|Week 52 to Week 104|Death|5|||
48772233|NCT01604343|157011402|FG004|Week 52 to Week 104|Death|0|||
48772234|NCT01604343|157011398|FG000|Week 52 to Week 104|Lack of Efficacy|0|||
48772235|NCT01604343|157011399|FG001|Week 52 to Week 104|Lack of Efficacy|6|||
48772236|NCT01604343|157011400|FG002|Week 52 to Week 104|Lack of Efficacy|11|||
48772237|NCT01604343|157011401|FG003|Week 52 to Week 104|Lack of Efficacy|2|||
48772238|NCT01604343|157011402|FG004|Week 52 to Week 104|Lack of Efficacy|3|||
48772239|NCT01604343|157011398|FG000|Week 52 to Week 104|Physician Decision|0|||
48772240|NCT01604343|157011399|FG001|Week 52 to Week 104|Physician Decision|1|||
48772241|NCT01604343|157011400|FG002|Week 52 to Week 104|Physician Decision|0|||
48772242|NCT01604343|157011401|FG003|Week 52 to Week 104|Physician Decision|0|||
48772243|NCT01604343|157011402|FG004|Week 52 to Week 104|Physician Decision|2|||
48772244|NCT01604343|157011398|FG000|Week 52 to Week 104|Pregnancy|0|||
48772245|NCT01604343|157011399|FG001|Week 52 to Week 104|Pregnancy|0|||
48772246|NCT01604343|157011400|FG002|Week 52 to Week 104|Pregnancy|1|||
48772247|NCT01604343|157011401|FG003|Week 52 to Week 104|Pregnancy|2|||
48772248|NCT01604343|157011402|FG004|Week 52 to Week 104|Pregnancy|1|||
48772249|NCT01604343|157011398|FG000|Week 52 to Week 104|Other|0|||
48772250|NCT01604343|157011399|FG001|Week 52 to Week 104|Other|11|||
48772251|NCT01604343|157011400|FG002|Week 52 to Week 104|Other|11|||
48772252|NCT01604343|157011401|FG003|Week 52 to Week 104|Other|6|||
48772253|NCT01604343|157011402|FG004|Week 52 to Week 104|Other|3|||
48772254|NCT01604343|157011398|FG000|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3|||
48772255|NCT01604343|157011399|FG001|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
48772256|NCT01604343|157011400|FG002|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2|||
48772257|NCT01604343|157011401|FG003|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
48772258|NCT01604343|157011402|FG004|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
48772259|NCT01604343|157011398|FG000|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12|||
48772260|NCT01604343|157011399|FG001|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4|||
48772261|NCT01604343|157011400|FG002|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11|||
48772262|NCT01604343|157011401|FG003|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3|||
48772263|NCT01604343|157011402|FG004|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14|||
48772264|NCT01604343|157011398|FG000|Safety Follow-up Period (Week 104-120)|Other|15|||
48772265|NCT01604343|157011399|FG001|Safety Follow-up Period (Week 104-120)|Other|2|||
48772266|NCT01604343|157011400|FG002|Safety Follow-up Period (Week 104-120)|Other|20|||
48772267|NCT01604343|157011401|FG003|Safety Follow-up Period (Week 104-120)|Other|6|||
48772268|NCT01604343|157011402|FG004|Safety Follow-up Period (Week 104-120)|Other|14|||
48772269|NCT00111228|157011403|FG000|Overall Study|Withdrawal by Subject|5|||
48772270|NCT00111228|157011404|FG001|Overall Study|Withdrawal by Subject|1|||
48772271|NCT00111228|157011405|FG002|Overall Study|Withdrawal by Subject|0|||
48772272|NCT02579616|157011408|FG000|Overall Study|Participants did not receive treatment|3|||
48772273|NCT01448850|157011410|FG000|Overall Study|Death|3|||
48772274|NCT01448850|157011411|FG001|Overall Study|Death|6|||
48772275|NCT01448850|157011410|FG000|Overall Study|Withdrawal by Subject|13|||
48876434|NCT02165826|157384686|FG001|Main Treatment Period|Did Not Receive Study Drug|2|||
48876435|NCT02165826|157384687|FG002|Main Treatment Period|Did Not Receive Study Drug|0|||
48876436|NCT02165826|157384685|FG000|Down-Titration Period|Pre-treatment Event/Adverse Event|4|||
48876437|NCT02165826|157384686|FG001|Down-Titration Period|Pre-treatment Event/Adverse Event|10|||
49027069|NCT02935686|157937589|FG000|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
49027070|NCT02935686|157937590|FG001|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
48772276|NCT01448850|157011411|FG001|Overall Study|Withdrawal by Subject|21|||
48772277|NCT01448850|157011410|FG000|Overall Study|Lost to Follow-up|3|||
48772278|NCT01448850|157011411|FG001|Overall Study|Lost to Follow-up|1|||
48772279|NCT01448850|157011410|FG000|Overall Study|Other|15|||
48876438|NCT02165826|157384687|FG002|Down-Titration Period|Pre-treatment Event/Adverse Event|3|||
48876439|NCT02165826|157384685|FG000|Down-Titration Period|Voluntary Withdrawal|2|||
48876440|NCT02165826|157384686|FG001|Down-Titration Period|Voluntary Withdrawal|1|||
48876441|NCT02165826|157384687|FG002|Down-Titration Period|Voluntary Withdrawal|2|||
48876442|NCT02165826|157384685|FG000|Down-Titration Period|Reason Not Specified|1|||
48772280|NCT01448850|157011411|FG001|Overall Study|Other|12|||
48772281|NCT02465528|157011412|FG000|Overall Study|Progressive disease|0|||
48772282|NCT02465528|157011413|FG001|Overall Study|Progressive disease|2|||
48772283|NCT02465528|157011414|FG002|Overall Study|Progressive disease|9|||
48876443|NCT02165826|157384686|FG001|Down-Titration Period|Reason Not Specified|0|||
48876444|NCT02165826|157384687|FG002|Down-Titration Period|Reason Not Specified|2|||
48876445|NCT02670122|157384688|FG000|Overall Study|Lost to Follow-up|4|||
48876446|NCT02762903|157384692|FG000|Overall Study|Lost to Follow-up|0|||
48876447|NCT02762903|157384693|FG001|Overall Study|Lost to Follow-up|1|||
48876448|NCT01262092|157384697|FG000|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2|||
48876449|NCT01262092|157384698|FG001|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1|||
48876450|NCT01262092|157384697|FG000|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1|||
48876451|NCT01262092|157384698|FG001|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0|||
48876452|NCT01262092|157384697|FG000|Buprenorphine Taper|noncompliance - missed medication|1|||
48876453|NCT01262092|157384698|FG001|Buprenorphine Taper|noncompliance - missed medication|1|||
48876454|NCT01262092|157384697|FG000|Gabapentin Taper|noncompliance - missed medications|1|||
48876455|NCT01262092|157384698|FG001|Gabapentin Taper|noncompliance - missed medications|0|||
48876456|NCT01806389|157384703|FG000|Overall Study|Withdrawal by Subject|4|||
48876457|NCT02579772|157384704|FG000|Overall Study|Withdrawal by Subject|0|||
48876458|NCT02579772|157384705|FG001|Overall Study|Withdrawal by Subject|1|||
48876459|NCT02579772|157384704|FG000|Overall Study|Usage of additional antioxidants|1|||
48876460|NCT02579772|157384705|FG001|Overall Study|Usage of additional antioxidants|0|||
48876461|NCT02579772|157384704|FG000|Overall Study|flu-like illness, orthopedic trauma|1|||
48876462|NCT02579772|157384705|FG001|Overall Study|flu-like illness, orthopedic trauma|1|||
48876463|NCT01210651|157384708|FG000|Overall Study|Lost to Follow-up|1|||
48876464|NCT01210651|157384709|FG001|Overall Study|Lost to Follow-up|1|||
48876465|NCT01210651|157384708|FG000|Overall Study|schedule conflicts|1|||
48876466|NCT01210651|157384709|FG001|Overall Study|schedule conflicts|5|||
48772284|NCT02465528|157011415|FG003|Overall Study|Progressive disease|4|||
48772285|NCT02465528|157011412|FG000|Overall Study|Study terminated by sponsor|1|||
48772286|NCT02465528|157011413|FG001|Overall Study|Study terminated by sponsor|2|||
48772287|NCT02465528|157011414|FG002|Overall Study|Study terminated by sponsor|0|||
48772288|NCT02465528|157011415|FG003|Overall Study|Study terminated by sponsor|0|||
48772289|NCT02465528|157011412|FG000|Overall Study|Withdrawal by Subject|0|||
48772290|NCT02465528|157011413|FG001|Overall Study|Withdrawal by Subject|0|||
48772291|NCT02465528|157011414|FG002|Overall Study|Withdrawal by Subject|2|||
48772292|NCT02465528|157011415|FG003|Overall Study|Withdrawal by Subject|0|||
48772293|NCT02465528|157011412|FG000|Overall Study|Adverse Event|0|||
48772294|NCT02465528|157011413|FG001|Overall Study|Adverse Event|0|||
48772295|NCT02465528|157011414|FG002|Overall Study|Adverse Event|0|||
48772296|NCT02465528|157011415|FG003|Overall Study|Adverse Event|1|||
48772297|NCT02465528|157011412|FG000|Overall Study|Physician Decision|0|||
48772298|NCT02465528|157011413|FG001|Overall Study|Physician Decision|0|||
48772299|NCT02465528|157011414|FG002|Overall Study|Physician Decision|1|||
48772300|NCT02465528|157011415|FG003|Overall Study|Physician Decision|0|||
48772301|NCT00086580|157011424|FG000|Treatment Period|Disease progression|9|||
48772302|NCT00086580|157011425|FG001|Treatment Period|Disease progression|8|||
48772303|NCT00086580|157011424|FG000|Treatment Period|Unable to comply with protocol|3|||
48772304|NCT00086580|157011425|FG001|Treatment Period|Unable to comply with protocol|1|||
48772305|NCT00086580|157011424|FG000|Treatment Period|Withdrawal by Subject|7|||
48772306|NCT00086580|157011425|FG001|Treatment Period|Withdrawal by Subject|8|||
48772307|NCT00086580|157011424|FG000|Treatment Period|Physician Decision|13|||
48772308|NCT00086580|157011425|FG001|Treatment Period|Physician Decision|7|||
48772309|NCT00086580|157011424|FG000|Treatment Period|AE - not treatment related|7|||
48772310|NCT00086580|157011425|FG001|Treatment Period|AE - not treatment related|7|||
48772311|NCT00086580|157011424|FG000|Treatment Period|Toxicity - treatment related|15|||
48772312|NCT00086580|157011425|FG001|Treatment Period|Toxicity - treatment related|15|||
48772313|NCT00086580|157011424|FG000|Treatment Period|Anemia or thrombocytopenia|1|||
48772314|NCT00086580|157011425|FG001|Treatment Period|Anemia or thrombocytopenia|4|||
48772315|NCT00086580|157011424|FG000|Treatment Period|Death|5|||
48876467|NCT01210651|157384708|FG000|Overall Study|Withdrawn by PI for disruptive behavior|0|||
48876468|NCT01210651|157384709|FG001|Overall Study|Withdrawn by PI for disruptive behavior|1|||
48876469|NCT01210651|157384708|FG000|Overall Study|Withdrawal by Subject|1|||
48876470|NCT01210651|157384709|FG001|Overall Study|Withdrawal by Subject|1|||
48876471|NCT01210651|157384708|FG000|Overall Study|Injury outside study|2|||
48876472|NCT01210651|157384709|FG001|Overall Study|Injury outside study|0|||
48876473|NCT04043455|157386523|FG000|Main Study Double-Blind Treatment Period|Adverse Event|2|||
48772316|NCT00086580|157011425|FG001|Treatment Period|Death|7|||
48772317|NCT00086580|157011424|FG000|Treatment Period|Other|5|||
48772318|NCT00086580|157011425|FG001|Treatment Period|Other|3|||
48772319|NCT00086580|157011424|FG000|Follow-up Period|Disease progression|72|||
48772320|NCT00086580|157011425|FG001|Follow-up Period|Disease progression|99|||
48772321|NCT00086580|157011424|FG000|Follow-up Period|Unable to comply with protocol|5|||
48772322|NCT00086580|157011425|FG001|Follow-up Period|Unable to comply with protocol|0|||
48772323|NCT00086580|157011424|FG000|Follow-up Period|Withdrawal by Subject|6|||
48876474|NCT04043455|157386524|FG001|Main Study Double-Blind Treatment Period|Adverse Event|3|||
48876475|NCT04043455|157386525|FG002|Main Study Double-Blind Treatment Period|Adverse Event|2|||
48876476|NCT04043455|157386526|FG003|Main Study Double-Blind Treatment Period|Adverse Event|3|||
48772324|NCT00086580|157011425|FG001|Follow-up Period|Withdrawal by Subject|6|||
48876477|NCT04043455|157386527|FG004|Main Study Double-Blind Treatment Period|Adverse Event|0|||
48876478|NCT04043455|157386528|FG005|Main Study Double-Blind Treatment Period|Adverse Event|0|||
48876479|NCT04043455|157386523|FG000|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
48876480|NCT04043455|157386524|FG001|Main Study Double-Blind Treatment Period|Withdrawal by Subject|5|||
48876481|NCT04043455|157386525|FG002|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
48876482|NCT04043455|157386526|FG003|Main Study Double-Blind Treatment Period|Withdrawal by Subject|9|||
48876483|NCT04043455|157386527|FG004|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
48772325|NCT00086580|157011424|FG000|Follow-up Period|Physician Decision|0|||
48772326|NCT00086580|157011425|FG001|Follow-up Period|Physician Decision|1|||
48772327|NCT00086580|157011424|FG000|Follow-up Period|AE - not related|1|||
48772328|NCT00086580|157011425|FG001|Follow-up Period|AE - not related|0|||
48876484|NCT04043455|157386528|FG005|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
48876485|NCT04043455|157386523|FG000|Main Study Double-Blind Treatment Period|Physician Decision|0|||
48876486|NCT04043455|157386524|FG001|Main Study Double-Blind Treatment Period|Physician Decision|2|||
48772329|NCT00086580|157011424|FG000|Follow-up Period|Death|13|||
48772330|NCT00086580|157011425|FG001|Follow-up Period|Death|7|||
48772331|NCT00086580|157011424|FG000|Follow-up Period|Other|7|||
48772332|NCT00086580|157011425|FG001|Follow-up Period|Other|6|||
48772333|NCT00086580|157011424|FG000|Observation Period|Unable to comply with protocol|1|||
48772334|NCT00086580|157011425|FG001|Observation Period|Unable to comply with protocol|1|||
48772335|NCT00086580|157011424|FG000|Observation Period|Withdrawal by Subject|4|||
48772336|NCT00086580|157011425|FG001|Observation Period|Withdrawal by Subject|2|||
48772337|NCT00086580|157011424|FG000|Observation Period|Death|33|||
48772338|NCT00086580|157011425|FG001|Observation Period|Death|55|||
48772339|NCT00086580|157011424|FG000|Observation Period|Other|8|||
48772340|NCT00086580|157011425|FG001|Observation Period|Other|7|||
48772341|NCT02126969|157011426|FG000|Overall Study|Withdrawal by Subject|1|||
48772342|NCT02126969|157011427|FG001|Overall Study|Withdrawal by Subject|2|||
48772343|NCT00767676|157011430|FG000|Overall Study|Investigator error|54|||
48772344|NCT01371656|157011431|FG000|Overall Study|Death|7|||
48772345|NCT01371656|157011432|FG001|Overall Study|Death|4|||
48772346|NCT01371656|157011431|FG000|Overall Study|Physician Decision|46|||
48772347|NCT01371656|157011432|FG001|Overall Study|Physician Decision|7|||
48772348|NCT01371656|157011431|FG000|Overall Study|Withdrawal by Subject|7|||
48772349|NCT01371656|157011432|FG001|Overall Study|Withdrawal by Subject|0|||
48772350|NCT01371656|157011431|FG000|Overall Study|Ineligible|4|||
48772351|NCT01371656|157011432|FG001|Overall Study|Ineligible|3|||
48772352|NCT02141516|157011438|FG000|Overall Study|Adverse Event|0|||
48876487|NCT04043455|157386525|FG002|Main Study Double-Blind Treatment Period|Physician Decision|1|||
48876488|NCT04043455|157386526|FG003|Main Study Double-Blind Treatment Period|Physician Decision|0|||
48876489|NCT04043455|157386527|FG004|Main Study Double-Blind Treatment Period|Physician Decision|0|||
48876490|NCT04043455|157386528|FG005|Main Study Double-Blind Treatment Period|Physician Decision|0|||
48876491|NCT04043455|157386523|FG000|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
48876492|NCT04043455|157386524|FG001|Main Study Double-Blind Treatment Period|Lost to Follow-up|2|||
48876493|NCT04043455|157386525|FG002|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
48876494|NCT04043455|157386526|FG003|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
48876495|NCT04043455|157386527|FG004|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
48876496|NCT04043455|157386528|FG005|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
48876497|NCT04043455|157386523|FG000|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
48876498|NCT04043455|157386524|FG001|Main Study Double-Blind Treatment Period|Protocol Violation|1|||
48876499|NCT04043455|157386525|FG002|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
48876500|NCT04043455|157386526|FG003|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
48876501|NCT04043455|157386527|FG004|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
48876502|NCT04043455|157386528|FG005|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
48876503|NCT04043455|157386523|FG000|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|1|||
48982332|NCT02828644|157767563|FG001|Overall Study|Lost to Follow-up|22|||
48772353|NCT02141516|157011439|FG001|Overall Study|Adverse Event|1|||
48772354|NCT02141516|157011440|FG002|Overall Study|Adverse Event|0|||
48772355|NCT02141516|157011438|FG000|Overall Study|Lost to Follow-up|0|||
48772356|NCT02141516|157011439|FG001|Overall Study|Lost to Follow-up|1|||
48772357|NCT02141516|157011440|FG002|Overall Study|Lost to Follow-up|0|||
48772358|NCT02141516|157011438|FG000|Overall Study|Other|0|||
48772359|NCT02141516|157011439|FG001|Overall Study|Other|3|||
48772360|NCT02141516|157011440|FG002|Overall Study|Other|0|||
48772361|NCT01559311|157011445|FG000|Overall Study|Protocol Violation|0|||
48772362|NCT01559311|157011446|FG001|Overall Study|Protocol Violation|0|||
48982333|NCT02996110|157767565|FG000|Pre-Treatment|Other Reasons|0|||
48982334|NCT02996110|157767566|FG001|Pre-Treatment|Other Reasons|1|||
48982335|NCT02996110|157767567|FG002|Pre-Treatment|Other Reasons|0|||
48982336|NCT02996110|157767568|FG003|Pre-Treatment|Other Reasons|0|||
48982337|NCT02996110|157767569|FG004|Pre-Treatment|Other Reasons|1|||
48876504|NCT04043455|157386524|FG001|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
48876505|NCT04043455|157386525|FG002|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
48876506|NCT04043455|157386526|FG003|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
48876507|NCT04043455|157386527|FG004|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
48876508|NCT04043455|157386528|FG005|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
48876509|NCT04043455|157386523|FG000|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
48876510|NCT04043455|157386524|FG001|Main Study Double-Blind Treatment Period|Did not receive treatment|1|||
48876511|NCT04043455|157386525|FG002|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
48876512|NCT04043455|157386526|FG003|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
48876513|NCT04043455|157386527|FG004|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
48876514|NCT04043455|157386528|FG005|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
48876515|NCT04043455|157386523|FG000|Double-Blind LTE Treatment Period|Adverse Event|0|||
48876516|NCT04043455|157386524|FG001|Double-Blind LTE Treatment Period|Adverse Event|0|||
48876517|NCT04043455|157386525|FG002|Double-Blind LTE Treatment Period|Adverse Event|0|||
48876518|NCT04043455|157386526|FG003|Double-Blind LTE Treatment Period|Adverse Event|0|||
48876519|NCT04043455|157386527|FG004|Double-Blind LTE Treatment Period|Adverse Event|0|||
48876520|NCT04043455|157386528|FG005|Double-Blind LTE Treatment Period|Adverse Event|2|||
48876521|NCT04043455|157386523|FG000|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
48876522|NCT04043455|157386524|FG001|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
48876523|NCT04043455|157386525|FG002|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
48876524|NCT04043455|157386526|FG003|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
48876525|NCT04043455|157386527|FG004|Double-Blind LTE Treatment Period|Withdrawal by Subject|5|||
48876526|NCT04043455|157386528|FG005|Double-Blind LTE Treatment Period|Withdrawal by Subject|6|||
48876527|NCT04043455|157386523|FG000|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
48876528|NCT04043455|157386524|FG001|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
48876529|NCT04043455|157386525|FG002|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
48876530|NCT04043455|157386526|FG003|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
48876531|NCT04043455|157386527|FG004|Double-Blind LTE Treatment Period|Lost to Follow-up|1|||
48876532|NCT04043455|157386528|FG005|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
48876533|NCT04043455|157386523|FG000|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
48876534|NCT04043455|157386524|FG001|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
48876535|NCT04043455|157386525|FG002|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
48876536|NCT04043455|157386526|FG003|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
48876537|NCT04043455|157386527|FG004|Double-Blind LTE Treatment Period|Study termination by Sponsor|47|||
48876538|NCT04043455|157386528|FG005|Double-Blind LTE Treatment Period|Study termination by Sponsor|44|||
48876539|NCT00966264|157386529|FG000|Overall Study|Lost to Follow-up|4|||
48876540|NCT00966264|157386530|FG001|Overall Study|Lost to Follow-up|3|||
48876541|NCT02859064|157386531|FG000|Overall Study|Progressive Disease|3|||
48876542|NCT02859064|157386531|FG000|Overall Study|Physician Decision|1|||
48876543|NCT02859064|157386531|FG000|Overall Study|Withdrawal by Subject|1|||
48876544|NCT02859064|157386531|FG000|Overall Study|Death|1|||
48876545|NCT04411186|157386532|FG000|Overall Study|Withdrawn due to protocol violation|0|||
48876546|NCT04411186|157386533|FG001|Overall Study|Withdrawn due to protocol violation|1|||
48876547|NCT04398368|157386535|FG000|Overall Study|Withdrawal by Subject|2|||
48876548|NCT02106195|157386537|FG000|Overall Study|Adverse Event|2|||
48876549|NCT02106195|157386537|FG000|Overall Study|Protocol Violation|1|||
48876550|NCT00753090|157386540|FG000|Overall Study|Withdrawal by Subject|10|||
48876551|NCT00753090|157386541|FG001|Overall Study|Withdrawal by Subject|10|||
48876552|NCT00753090|157386540|FG000|Overall Study|Death|17|||
48876553|NCT00753090|157386541|FG001|Overall Study|Death|6|||
49027071|NCT02935686|157937591|FG002|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
49027072|NCT02935686|157937592|FG003|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|2|||
49027073|NCT02935686|157937593|FG004|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|1|||
49027074|NCT02419937|157937596|FG000|Overall Study|Lost to Follow-up|1|||
49027075|NCT02419937|157937597|FG001|Overall Study|Lost to Follow-up|0|||
49027076|NCT02924883|157937598|FG000|Overall Study|Death|39|||
49027077|NCT02924883|157937599|FG001|Overall Study|Death|20|||
49027078|NCT02924883|157937598|FG000|Overall Study|Lost to Follow-up|1|||
49027079|NCT02924883|157937599|FG001|Overall Study|Lost to Follow-up|0|||
49027080|NCT02924883|157937598|FG000|Overall Study|Symptomatic Deterioration/ Clinical Progression|0|||
49027081|NCT02924883|157937599|FG001|Overall Study|Symptomatic Deterioration/ Clinical Progression|1|||
49027082|NCT02924883|157937598|FG000|Overall Study|Protocol Violation|1|||
49027083|NCT02924883|157937599|FG001|Overall Study|Protocol Violation|0|||
48876554|NCT00753090|157386540|FG000|Overall Study|Study Prosthesis Removed|12|||
48876555|NCT00753090|157386541|FG001|Overall Study|Study Prosthesis Removed|3|||
48876556|NCT00753090|157386540|FG000|Overall Study|Lost to Follow-up|2|||
48876557|NCT00753090|157386541|FG001|Overall Study|Lost to Follow-up|2|||
48876558|NCT00753090|157386540|FG000|Overall Study|Other|127|||
48876559|NCT00753090|157386541|FG001|Overall Study|Other|75|||
48876560|NCT04292470|157386546|FG000|Overall Study|Withdrawal by Subject|0|||
48876561|NCT04292470|157386547|FG001|Overall Study|Withdrawal by Subject|1|||
48876562|NCT02057575|157386553|FG000|Overall Study|Adverse Event|0|||
48876563|NCT02057575|157386554|FG001|Overall Study|Adverse Event|2|||
48876564|NCT02057575|157386555|FG002|Overall Study|Adverse Event|0|||
48876565|NCT02057575|157386556|FG003|Overall Study|Adverse Event|1|||
48876566|NCT02057575|157386553|FG000|Overall Study|Withdrawal by Subject|1|||
48876567|NCT02057575|157386554|FG001|Overall Study|Withdrawal by Subject|0|||
48876568|NCT02057575|157386555|FG002|Overall Study|Withdrawal by Subject|0|||
48876569|NCT02057575|157386556|FG003|Overall Study|Withdrawal by Subject|0|||
48876570|NCT02057575|157386553|FG000|Overall Study|Dissallowed Concurrent Medication|0|||
48876571|NCT02057575|157386554|FG001|Overall Study|Dissallowed Concurrent Medication|1|||
48876572|NCT02057575|157386555|FG002|Overall Study|Dissallowed Concurrent Medication|0|||
48876573|NCT02057575|157386556|FG003|Overall Study|Dissallowed Concurrent Medication|0|||
49027084|NCT02924883|157937598|FG000|Overall Study|Withdrawal by Subject|22|||
49027085|NCT02924883|157937599|FG001|Overall Study|Withdrawal by Subject|16|||
49027086|NCT02924883|157937598|FG000|Overall Study|Progressive Disease|1|||
49027087|NCT02924883|157937599|FG001|Overall Study|Progressive Disease|0|||
49027088|NCT02924883|157937598|FG000|Overall Study|Study Terminated by Sponsor|69|||
49027089|NCT02924883|157937599|FG001|Overall Study|Study Terminated by Sponsor|32|||
49027090|NCT01182415|157937600|FG000|Overall Study|Lost to Follow-up|1|||
49027091|NCT01544127|157937601|FG000|Overall Study|Lost to Follow-up|4|||
48772363|NCT01559311|157011447|FG002|Overall Study|Protocol Violation|2|||
48772364|NCT01559311|157011445|FG000|Overall Study|Difficulty in cannulating the lateral ve|1|||
48772365|NCT01559311|157011446|FG001|Overall Study|Difficulty in cannulating the lateral ve|0|||
48772366|NCT01559311|157011447|FG002|Overall Study|Difficulty in cannulating the lateral ve|0|||
48772367|NCT01559311|157011445|FG000|Overall Study|Withdrawal by Subject|2|||
48772368|NCT01559311|157011446|FG001|Overall Study|Withdrawal by Subject|1|||
48772369|NCT01559311|157011447|FG002|Overall Study|Withdrawal by Subject|0|||
48772370|NCT01559311|157011445|FG000|Overall Study|Death|0|||
48772371|NCT01559311|157011446|FG001|Overall Study|Death|2|||
48772372|NCT01559311|157011447|FG002|Overall Study|Death|3|||
48772373|NCT01559311|157011445|FG000|Overall Study|Lost to Follow-up|0|||
48772374|NCT01559311|157011446|FG001|Overall Study|Lost to Follow-up|3|||
48772375|NCT01559311|157011447|FG002|Overall Study|Lost to Follow-up|2|||
48772376|NCT01559311|157011445|FG000|Overall Study|Adverse Event|0|||
48772377|NCT01559311|157011446|FG001|Overall Study|Adverse Event|0|||
48772378|NCT01559311|157011447|FG002|Overall Study|Adverse Event|1|||
48772379|NCT01418209|157011453|FG000|Overall Study|Withdrawal by Subject|1|||
48772380|NCT01418209|157011454|FG001|Overall Study|Withdrawal by Subject|0|||
48772381|NCT01418209|157011455|FG002|Overall Study|Withdrawal by Subject|1|||
48772382|NCT01418209|157011453|FG000|Overall Study|Did not provide hot flash diary data|1|||
48772383|NCT01418209|157011454|FG001|Overall Study|Did not provide hot flash diary data|3|||
48772384|NCT01418209|157011455|FG002|Overall Study|Did not provide hot flash diary data|3|||
48772385|NCT01603875|157011460|FG000|Overall Study|Preexisting rabies antibody|3|||
48772386|NCT01603875|157011461|FG001|Overall Study|Preexisting rabies antibody|4|||
48772387|NCT01603875|157011462|FG002|Overall Study|Preexisting rabies antibody|3|||
48772388|NCT01603875|157011460|FG000|Overall Study|Lost to Follow-up|4|||
48772389|NCT01603875|157011461|FG001|Overall Study|Lost to Follow-up|3|||
48772390|NCT01603875|157011462|FG002|Overall Study|Lost to Follow-up|6|||
48772391|NCT01603875|157011460|FG000|Overall Study|Protocol Violation|0|||
48772392|NCT01603875|157011461|FG001|Overall Study|Protocol Violation|1|||
48772393|NCT01603875|157011462|FG002|Overall Study|Protocol Violation|0|||
48772394|NCT02188485|157011469|FG000|Overall Study|Withdrawal by Subject|2|||
48772395|NCT02188485|157011470|FG001|Overall Study|Withdrawal by Subject|1|||
48772396|NCT02188485|157011469|FG000|Overall Study|PI withdrew, lack of capacity|0|||
48772397|NCT02188485|157011470|FG001|Overall Study|PI withdrew, lack of capacity|2|||
48772398|NCT00799617|157011471|FG000|Main Testosterone Trial|Randomized in error|1|||
48772399|NCT00799617|157011472|FG001|Main Testosterone Trial|Randomized in error|1|||
48772400|NCT00799617|157011471|FG000|Main Testosterone Trial|Lost to Follow-up|18|||
48772401|NCT00799617|157011472|FG001|Main Testosterone Trial|Lost to Follow-up|20|||
48772402|NCT00799617|157011471|FG000|Sexual Funtion Trial|Lost to Follow-up|12|||
48772403|NCT00799617|157011472|FG001|Sexual Funtion Trial|Lost to Follow-up|14|||
48772404|NCT00799617|157011471|FG000|Sexual Funtion Trial|No Baseline Data|4|||
48772405|NCT00799617|157011472|FG001|Sexual Funtion Trial|No Baseline Data|7|||
48772406|NCT00799617|157011471|FG000|Physical Function Trial|Lost to Follow-up|6|||
48772407|NCT00799617|157011472|FG001|Physical Function Trial|Lost to Follow-up|11|||
48772408|NCT00799617|157011471|FG000|Vitality Trial|Lost to Follow-up|7|||
48772409|NCT00799617|157011472|FG001|Vitality Trial|Lost to Follow-up|22|||
48772410|NCT00799617|157011471|FG000|Cardiovascular Trial|Month 12 scan not available|15|||
48876574|NCT02057575|157386553|FG000|Overall Study|Protocol Violation|0|||
48876575|NCT02057575|157386554|FG001|Overall Study|Protocol Violation|1|||
48876576|NCT02057575|157386555|FG002|Overall Study|Protocol Violation|0|||
48876577|NCT02057575|157386556|FG003|Overall Study|Protocol Violation|0|||
48876578|NCT01006616|157386572|FG000|Period 1 (6 Months)|Adverse Event|10|||
48876579|NCT01006616|157386573|FG001|Period 1 (6 Months)|Adverse Event|31|||
48876580|NCT01006616|157386574|FG002|Period 1 (6 Months)|Adverse Event|37|||
48876581|NCT01006616|157386575|FG003|Period 1 (6 Months)|Adverse Event|9|||
48876582|NCT01006616|157386572|FG000|Period 1 (6 Months)|Lack of Efficacy|3|||
48876583|NCT01006616|157386573|FG001|Period 1 (6 Months)|Lack of Efficacy|4|||
48876584|NCT01006616|157386574|FG002|Period 1 (6 Months)|Lack of Efficacy|0|||
48876585|NCT01006616|157386575|FG003|Period 1 (6 Months)|Lack of Efficacy|4|||
48876586|NCT01006616|157386572|FG000|Period 1 (6 Months)|Lost to Follow-up|0|||
48876587|NCT01006616|157386573|FG001|Period 1 (6 Months)|Lost to Follow-up|0|||
48876588|NCT01006616|157386574|FG002|Period 1 (6 Months)|Lost to Follow-up|1|||
48876589|NCT01006616|157386575|FG003|Period 1 (6 Months)|Lost to Follow-up|0|||
48876590|NCT01006616|157386572|FG000|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6|||
48876591|NCT01006616|157386573|FG001|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5|||
48876592|NCT01006616|157386574|FG002|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2|||
48876593|NCT01006616|157386575|FG003|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3|||
48876594|NCT01006616|157386572|FG000|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0|||
48876595|NCT01006616|157386573|FG001|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3|||
48876596|NCT01006616|157386574|FG002|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1|||
48876597|NCT01006616|157386575|FG003|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2|||
48876598|NCT01006616|157386572|FG000|Period 1 (6 Months)|Withdrawal by Subject|2|||
48876599|NCT01006616|157386573|FG001|Period 1 (6 Months)|Withdrawal by Subject|2|||
48876600|NCT01006616|157386574|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
48876601|NCT01006616|157386575|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
48876602|NCT01006616|157386572|FG000|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
48876603|NCT01006616|157386573|FG001|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7|||
48876604|NCT01006616|157386574|FG002|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
48876605|NCT01006616|157386575|FG003|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
48876606|NCT01006616|157386572|FG000|Period 1 (6 Months)|Noncompliance With Protocol|0|||
48876607|NCT01006616|157386573|FG001|Period 1 (6 Months)|Noncompliance With Protocol|2|||
48876608|NCT01006616|157386574|FG002|Period 1 (6 Months)|Noncompliance With Protocol|2|||
48876609|NCT01006616|157386575|FG003|Period 1 (6 Months)|Noncompliance With Protocol|3|||
48876610|NCT01006616|157386572|FG000|Period 1 (6 Months)|Not Treated|0|||
48876611|NCT01006616|157386573|FG001|Period 1 (6 Months)|Not Treated|0|||
48876612|NCT01006616|157386574|FG002|Period 1 (6 Months)|Not Treated|1|||
48876613|NCT01006616|157386575|FG003|Period 1 (6 Months)|Not Treated|1|||
48876614|NCT01006616|157386572|FG000|Period 2 (18 Months)|Adverse Event|6|||
48876615|NCT01006616|157386573|FG001|Period 2 (18 Months)|Adverse Event|6|||
48876616|NCT01006616|157386574|FG002|Period 2 (18 Months)|Adverse Event|6|||
48772411|NCT00799617|157011472|FG001|Cardiovascular Trial|Month 12 scan not available|15|||
48772412|NCT00799617|157011471|FG000|Cardiovascular Trial|Baseline scan not analyzable|0|||
48772413|NCT00799617|157011472|FG001|Cardiovascular Trial|Baseline scan not analyzable|2|||
48772414|NCT00799617|157011471|FG000|Bone Trial|Month 12 scan not available|6|||
48772415|NCT00799617|157011472|FG001|Bone Trial|Month 12 scan not available|16|||
48772416|NCT00799617|157011471|FG000|Cognitive Function Trial|Lost to Follow-up|0|||
48772417|NCT00799617|157011472|FG001|Cognitive Function Trial|Lost to Follow-up|1|||
48772418|NCT00799617|157011471|FG000|Anemia Trial|Withdrawal by Subject|3|||
48772419|NCT00799617|157011472|FG001|Anemia Trial|Withdrawal by Subject|3|||
48772420|NCT04545515|157011473|FG000|Overall Study|Adverse Event|1|||
48772421|NCT04545515|157011473|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
48772422|NCT04545515|157011473|FG000|Overall Study|Commercial drug is available for participant|7|||
48772423|NCT01652716|157011474|FG000|Overall Study|Loss of glucose control|1|||
48772424|NCT01652716|157011475|FG001|Overall Study|Loss of glucose control|0|||
48772425|NCT01652716|157011474|FG000|Overall Study|Administrative|0|||
48772426|NCT01652716|157011475|FG001|Overall Study|Administrative|2|||
48772427|NCT01652716|157011474|FG000|Overall Study|Investigator decision|1|||
48772428|NCT01652716|157011475|FG001|Overall Study|Investigator decision|4|||
48772429|NCT01652716|157011474|FG000|Overall Study|Lost to Follow-up|12|||
48772430|NCT01652716|157011475|FG001|Overall Study|Lost to Follow-up|11|||
48772431|NCT01652716|157011474|FG000|Overall Study|Protocol Violation|2|||
48772432|NCT01652716|157011475|FG001|Overall Study|Protocol Violation|1|||
48772433|NCT01652716|157011474|FG000|Overall Study|Adverse Event|7|||
48772434|NCT01652716|157011475|FG001|Overall Study|Adverse Event|10|||
48772435|NCT01652716|157011474|FG000|Overall Study|Withdrawal by Subject|33|||
48772436|NCT01652716|157011475|FG001|Overall Study|Withdrawal by Subject|18|||
48876617|NCT01006616|157386575|FG003|Period 2 (18 Months)|Adverse Event|4|||
48876618|NCT01006616|157386572|FG000|Period 2 (18 Months)|Lack of Efficacy|0|||
48876619|NCT01006616|157386573|FG001|Period 2 (18 Months)|Lack of Efficacy|0|||
48876620|NCT01006616|157386574|FG002|Period 2 (18 Months)|Lack of Efficacy|1|||
48876621|NCT01006616|157386575|FG003|Period 2 (18 Months)|Lack of Efficacy|2|||
48876622|NCT01006616|157386572|FG000|Period 2 (18 Months)|Lost to Follow-up|2|||
48876623|NCT01006616|157386573|FG001|Period 2 (18 Months)|Lost to Follow-up|0|||
48876624|NCT01006616|157386574|FG002|Period 2 (18 Months)|Lost to Follow-up|0|||
48876625|NCT01006616|157386575|FG003|Period 2 (18 Months)|Lost to Follow-up|0|||
48876626|NCT01006616|157386572|FG000|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
48772437|NCT02751983|157011476|FG000|Treatment|Stopped ACT, but Remained in study|2|||
48772438|NCT02751983|157011477|FG001|Treatment|Stopped ACT, but Remained in study|0|||
48772439|NCT02751983|157011476|FG000|Treatment|Discharged prior to beginning ACT|2|||
48772440|NCT02751983|157011477|FG001|Treatment|Discharged prior to beginning ACT|0|||
48772441|NCT02751983|157011476|FG000|Post-Treatment Assessment|Lost to Follow-up|5|||
48772442|NCT02751983|157011477|FG001|Post-Treatment Assessment|Lost to Follow-up|0|||
48772443|NCT02751983|157011476|FG000|One-Month Follow-Up Assessments|Lost to Follow-up|14|||
48772444|NCT02751983|157011477|FG001|One-Month Follow-Up Assessments|Lost to Follow-up|12|||
48772445|NCT02751983|157011476|FG000|Three-Month Follow-Up Assessments|Lost to Follow-up|12|||
48772446|NCT02751983|157011477|FG001|Three-Month Follow-Up Assessments|Lost to Follow-up|16|||
48772447|NCT04187196|157011478|FG000|Overall Study|Screen Failure|2|||
48772448|NCT04187196|157011479|FG001|Overall Study|Screen Failure|0|||
48772449|NCT01723228|157011480|FG000|Overall Study|Adverse Event|2|||
48772450|NCT01723228|157011481|FG001|Overall Study|Adverse Event|6|||
48772451|NCT01723228|157011480|FG000|Overall Study|Withdrawal by Subject|2|||
48772452|NCT01723228|157011481|FG001|Overall Study|Withdrawal by Subject|1|||
48772453|NCT01723228|157011480|FG000|Overall Study|Protocol Violation|0|||
48772454|NCT01723228|157011481|FG001|Overall Study|Protocol Violation|2|||
48772455|NCT01723228|157011480|FG000|Overall Study|Lost to Follow-up|2|||
48772456|NCT01723228|157011481|FG001|Overall Study|Lost to Follow-up|1|||
48772457|NCT01723228|157011480|FG000|Overall Study|Other|2|||
48772458|NCT01723228|157011481|FG001|Overall Study|Other|1|||
48772459|NCT01282216|157011482|FG000|Overall Study|Graft failure|0|||
48772460|NCT01282216|157011483|FG001|Overall Study|Graft failure|0|||
48772461|NCT01282216|157011484|FG002|Overall Study|Graft failure|3|||
48772462|NCT01282216|157011485|FG003|Overall Study|Graft failure|2|||
48772463|NCT01282216|157011482|FG000|Overall Study|Physician Decision|0|||
48772464|NCT01282216|157011483|FG001|Overall Study|Physician Decision|0|||
48772465|NCT01282216|157011484|FG002|Overall Study|Physician Decision|11|||
48772466|NCT01282216|157011485|FG003|Overall Study|Physician Decision|0|||
48772467|NCT01282216|157011482|FG000|Overall Study|Relapse|0|||
48772468|NCT01282216|157011483|FG001|Overall Study|Relapse|0|||
48772469|NCT01282216|157011484|FG002|Overall Study|Relapse|17|||
48772470|NCT01282216|157011485|FG003|Overall Study|Relapse|6|||
48772471|NCT01282216|157011482|FG000|Overall Study|Death|0|||
48772472|NCT01282216|157011483|FG001|Overall Study|Death|0|||
48772473|NCT01282216|157011484|FG002|Overall Study|Death|2|||
48772474|NCT01282216|157011485|FG003|Overall Study|Death|0|||
48772475|NCT00437034|157011486|FG000|Overall Study|Adverse Event|1|||
48772476|NCT00437034|157011486|FG000|Overall Study|Disease progression during treatment|5|||
48772477|NCT02797262|157011487|FG000|Overall Study|Withdrawal by Subject|5|||
48772478|NCT02797262|157011488|FG001|Overall Study|Withdrawal by Subject|1|||
48876627|NCT01006616|157386573|FG001|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0|||
48876628|NCT01006616|157386574|FG002|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
48876629|NCT01006616|157386575|FG003|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2|||
48876630|NCT01006616|157386572|FG000|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0|||
48876631|NCT01006616|157386573|FG001|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6|||
48876632|NCT01006616|157386574|FG002|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1|||
48876633|NCT01006616|157386575|FG003|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2|||
48876634|NCT01006616|157386572|FG000|Period 2 (18 Months)|Withdrawal by Subject|1|||
48876635|NCT01006616|157386573|FG001|Period 2 (18 Months)|Withdrawal by Subject|4|||
48876636|NCT01006616|157386574|FG002|Period 2 (18 Months)|Withdrawal by Subject|0|||
48876637|NCT01006616|157386575|FG003|Period 2 (18 Months)|Withdrawal by Subject|1|||
48876638|NCT01006616|157386572|FG000|Period 2 (18 Months)|Noncompliance With Protocol|0|||
48876639|NCT01006616|157386573|FG001|Period 2 (18 Months)|Noncompliance With Protocol|1|||
48876640|NCT01006616|157386574|FG002|Period 2 (18 Months)|Noncompliance With Protocol|0|||
48876641|NCT01006616|157386575|FG003|Period 2 (18 Months)|Noncompliance With Protocol|1|||
48876642|NCT01006616|157386572|FG000|Period 2 (18 Months)|Study Terminated|63|||
48876643|NCT01006616|157386573|FG001|Period 2 (18 Months)|Study Terminated|46|||
48876644|NCT01006616|157386574|FG002|Period 2 (18 Months)|Study Terminated|44|||
48982338|NCT02996110|157767565|FG000|Pre-Treatment|Participant Withdrew Consent|0|||
48982339|NCT02996110|157767566|FG001|Pre-Treatment|Participant Withdrew Consent|0|||
48982340|NCT02996110|157767567|FG002|Pre-Treatment|Participant Withdrew Consent|1|||
48982341|NCT02996110|157767568|FG003|Pre-Treatment|Participant Withdrew Consent|0|||
48982342|NCT02996110|157767569|FG004|Pre-Treatment|Participant Withdrew Consent|1|||
48982343|NCT02996110|157767565|FG000|Track 1|Disease Progression|15|||
48982344|NCT02996110|157767566|FG001|Track 1|Disease Progression|17|||
48982345|NCT02996110|157767567|FG002|Track 1|Disease Progression|0|||
48982346|NCT02996110|157767568|FG003|Track 1|Disease Progression|0|||
48982347|NCT02996110|157767569|FG004|Track 1|Disease Progression|0|||
48982348|NCT02996110|157767565|FG000|Track 1|Adverse Event Unrelated to Study Drug|1|||
48982349|NCT02996110|157767566|FG001|Track 1|Adverse Event Unrelated to Study Drug|1|||
48982350|NCT02996110|157767567|FG002|Track 1|Adverse Event Unrelated to Study Drug|0|||
48982351|NCT02996110|157767568|FG003|Track 1|Adverse Event Unrelated to Study Drug|0|||
49027092|NCT01544127|157937602|FG001|Overall Study|Lost to Follow-up|2|||
49027093|NCT01544127|157937603|FG002|Overall Study|Lost to Follow-up|9|||
49027094|NCT01544127|157937601|FG000|Overall Study|Withdrawal by Subject|2|||
49027095|NCT01544127|157937602|FG001|Overall Study|Withdrawal by Subject|2|||
49027096|NCT01544127|157937603|FG002|Overall Study|Withdrawal by Subject|1|||
49027097|NCT01544127|157937601|FG000|Overall Study|Discharged out of catchment area|1|||
49027098|NCT01544127|157937602|FG001|Overall Study|Discharged out of catchment area|1|||
48772479|NCT02797262|157011487|FG000|Overall Study|Lost to Follow-up|10|||
48772480|NCT02797262|157011488|FG001|Overall Study|Lost to Follow-up|7|||
48772481|NCT02797262|157011487|FG000|Overall Study|Death|1|||
48772482|NCT02797262|157011488|FG001|Overall Study|Death|2|||
48772483|NCT02797262|157011487|FG000|Overall Study|Adverse Event|1|||
48772484|NCT02797262|157011488|FG001|Overall Study|Adverse Event|0|||
48772485|NCT02797262|157011487|FG000|Overall Study|COVID-19|2|||
48772486|NCT02797262|157011488|FG001|Overall Study|COVID-19|1|||
48772487|NCT02797262|157011487|FG000|Overall Study|Out-of-country|1|||
48772488|NCT02797262|157011488|FG001|Overall Study|Out-of-country|0|||
48772489|NCT01916304|157011489|FG000|Overall Study|Screening failure|17|||
48772490|NCT01282424|157011490|FG000|Treatment Period (TP) (81 Months)|Adverse Event|30|||
48772491|NCT01282424|157011490|FG000|Treatment Period (TP) (81 Months)|Withdrew Consent|6|||
48772492|NCT01282424|157011490|FG000|Treatment Period (TP) (81 Months)|Investigator Request|7|||
48772493|NCT01282424|157011490|FG000|Treatment Period (TP) (81 Months)|Other (Unknown)|3|||
48772494|NCT01282424|157011490|FG000|Long-term Follow-up Period (5 Years)|Withdrew Consent|2|||
48772495|NCT01282424|157011490|FG000|Long-term Follow-up Period (5 Years)|Death|40|||
48772496|NCT01282424|157011490|FG000|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1|||
48772497|NCT01282424|157011490|FG000|Long-term Follow-up Period (5 Years)|Other (Unknown)|21|||
48772498|NCT02553421|157011493|FG000|Overall Study|Lost to Follow-up|21|||
48772499|NCT02553421|157011494|FG001|Overall Study|Lost to Follow-up|1|||
48772500|NCT02553421|157011493|FG000|Overall Study|Incomplete or Insufficient Data Collecte|5|||
48772501|NCT02553421|157011494|FG001|Overall Study|Incomplete or Insufficient Data Collecte|0|||
48772502|NCT02553421|157011493|FG000|Overall Study|Improper Device Placement|3|||
48772503|NCT02553421|157011494|FG001|Overall Study|Improper Device Placement|0|||
48772504|NCT03337724|157011500|FG000|Overall Study|Reason not Specified|12|||
48772505|NCT03337724|157011501|FG001|Overall Study|Reason not Specified|21|||
48772506|NCT03337724|157011502|FG002|Overall Study|Reason not Specified|9|||
48772507|NCT03337724|157011503|FG003|Overall Study|Reason not Specified|9|||
48772508|NCT03337724|157011504|FG004|Overall Study|Reason not Specified|29|||
48772509|NCT03337724|157011500|FG000|Overall Study|Withdrawal by Subject|13|||
48772510|NCT03337724|157011501|FG001|Overall Study|Withdrawal by Subject|15|||
48772511|NCT03337724|157011502|FG002|Overall Study|Withdrawal by Subject|4|||
48772512|NCT03337724|157011503|FG003|Overall Study|Withdrawal by Subject|15|||
48772513|NCT03337724|157011504|FG004|Overall Study|Withdrawal by Subject|6|||
48772514|NCT03337724|157011500|FG000|Overall Study|Protocol Deviation|0|||
48772515|NCT03337724|157011501|FG001|Overall Study|Protocol Deviation|1|||
48772516|NCT03337724|157011502|FG002|Overall Study|Protocol Deviation|1|||
48772517|NCT03337724|157011503|FG003|Overall Study|Protocol Deviation|1|||
48772518|NCT03337724|157011504|FG004|Overall Study|Protocol Deviation|0|||
48772519|NCT03337724|157011500|FG000|Overall Study|Adverse Event|1|||
48772520|NCT03337724|157011501|FG001|Overall Study|Adverse Event|1|||
48772521|NCT03337724|157011502|FG002|Overall Study|Adverse Event|0|||
48772522|NCT03337724|157011503|FG003|Overall Study|Adverse Event|1|||
48772523|NCT03337724|157011504|FG004|Overall Study|Adverse Event|0|||
48772524|NCT03337724|157011500|FG000|Overall Study|Death|40|||
48772525|NCT03337724|157011501|FG001|Overall Study|Death|89|||
48772526|NCT03337724|157011502|FG002|Overall Study|Death|43|||
48772527|NCT03337724|157011503|FG003|Overall Study|Death|76|||
48772528|NCT03337724|157011504|FG004|Overall Study|Death|50|||
48772529|NCT03337724|157011500|FG000|Overall Study|Lost to Follow-up|5|||
48772530|NCT03337724|157011501|FG001|Overall Study|Lost to Follow-up|5|||
48772531|NCT03337724|157011502|FG002|Overall Study|Lost to Follow-up|4|||
48772532|NCT03337724|157011503|FG003|Overall Study|Lost to Follow-up|7|||
48772533|NCT03337724|157011504|FG004|Overall Study|Lost to Follow-up|4|||
48772534|NCT03337724|157011500|FG000|Overall Study|Physician Decision|16|||
48772535|NCT03337724|157011501|FG001|Overall Study|Physician Decision|34|||
48772536|NCT03337724|157011502|FG002|Overall Study|Physician Decision|14|||
48772537|NCT03337724|157011503|FG003|Overall Study|Physician Decision|34|||
48772538|NCT03337724|157011504|FG004|Overall Study|Physician Decision|13|||
48772539|NCT03337724|157011500|FG000|Overall Study|Progressive Disease|0|||
48772540|NCT03337724|157011501|FG001|Overall Study|Progressive Disease|2|||
48772541|NCT03337724|157011502|FG002|Overall Study|Progressive Disease|1|||
48772542|NCT03337724|157011503|FG003|Overall Study|Progressive Disease|2|||
48772543|NCT03337724|157011504|FG004|Overall Study|Progressive Disease|0|||
48772544|NCT03337724|157011500|FG000|Overall Study|Symptomatic Deterioration|0|||
49027099|NCT01544127|157937603|FG002|Overall Study|Discharged out of catchment area|1|||
48772545|NCT03337724|157011501|FG001|Overall Study|Symptomatic Deterioration|0|||
48772546|NCT03337724|157011502|FG002|Overall Study|Symptomatic Deterioration|0|||
48772547|NCT03337724|157011503|FG003|Overall Study|Symptomatic Deterioration|1|||
49027100|NCT01544127|157937601|FG000|Overall Study|Death|1|||
48772548|NCT03337724|157011504|FG004|Overall Study|Symptomatic Deterioration|0|||
48772549|NCT00773097|157011505|FG000|Overall Study|Withdrawal by Subject|1|||
48772550|NCT00773097|157011505|FG000|Overall Study|Physician Decision|6|||
48772551|NCT00080223|157011512|FG000|Overall Study|Adverse Event|23|||
48772552|NCT00080223|157011512|FG000|Overall Study|Death|21|||
48772553|NCT00080223|157011512|FG000|Overall Study|Withdrawal by Subject|13|||
48772554|NCT00080223|157011512|FG000|Overall Study|Lung Transplantation|9|||
48772555|NCT00080223|157011512|FG000|Overall Study|Non-compliance With Study Treatment|7|||
48772556|NCT00080223|157011512|FG000|Overall Study|Participant unwilling to continue|2|||
48772557|NCT00080223|157011512|FG000|Overall Study|Physician Decision|1|||
48772558|NCT02517905|157011515|FG000|Overall Study|Lost to Follow-up|4|||
48772559|NCT02517905|157011516|FG001|Overall Study|Lost to Follow-up|0|||
48772560|NCT02517905|157011515|FG000|Overall Study|Withdrawal by Subject|4|||
48772561|NCT02517905|157011516|FG001|Overall Study|Withdrawal by Subject|0|||
48772562|NCT02517905|157011515|FG000|Overall Study|Screen failure|2|||
48772563|NCT02517905|157011516|FG001|Overall Study|Screen failure|2|||
48772564|NCT01114516|157011520|FG000|Overall Study|Lost to Follow-up|2|||
48772565|NCT01114516|157011521|FG001|Overall Study|Lost to Follow-up|1|||
48772566|NCT00836875|157011523|FG000|Overall Study|Death|3|||
48772567|NCT00836875|157011524|FG001|Overall Study|Death|2|||
48772568|NCT00836875|157011523|FG000|Overall Study|Withdrawal by Subject|0|||
48772569|NCT00836875|157011524|FG001|Overall Study|Withdrawal by Subject|1|||
48772570|NCT00774995|157011525|FG000|Overall Study|Protocol Violation|0|||
48772571|NCT00774995|157011526|FG001|Overall Study|Protocol Violation|0|||
48772572|NCT00774995|157011527|FG002|Overall Study|Protocol Violation|1|||
48772573|NCT00774995|157011528|FG003|Overall Study|Protocol Violation|0|||
48772574|NCT01209624|157011529|FG000|Overall Study|Death|2|||
48772575|NCT01209624|157011529|FG000|Overall Study|Adverse Event|13|||
48772576|NCT01209624|157011529|FG000|Overall Study|Lack of Efficacy|17|||
48772577|NCT01209624|157011529|FG000|Overall Study|Lost to Follow-up|290|||
48772578|NCT01209624|157011529|FG000|Overall Study|Other|4|||
48772579|NCT03265119|157011530|FG000|Overall Study|Adverse Event|2|||
48772580|NCT03265119|157011531|FG001|Overall Study|Adverse Event|1|||
48772581|NCT03265119|157011530|FG000|Overall Study|Lack of Efficacy|3|||
48772582|NCT03265119|157011531|FG001|Overall Study|Lack of Efficacy|0|||
48772583|NCT03265119|157011530|FG000|Overall Study|Protocol Violation|1|||
48772584|NCT03265119|157011531|FG001|Overall Study|Protocol Violation|2|||
48772585|NCT03265119|157011530|FG000|Overall Study|Withdrawal by Subject|2|||
48772586|NCT03265119|157011531|FG001|Overall Study|Withdrawal by Subject|4|||
48772587|NCT03265119|157011530|FG000|Overall Study|Lost to Follow-up|1|||
48772588|NCT03265119|157011531|FG001|Overall Study|Lost to Follow-up|0|||
48772589|NCT03265119|157011530|FG000|Overall Study|Lack of Compliance|1|||
48772590|NCT03265119|157011531|FG001|Overall Study|Lack of Compliance|0|||
48797700|NCT03508843|157097052|FG000|Overall Study|Withdrawal by Subject|1|||
48797701|NCT03508843|157097052|FG000|Overall Study|technical difficulties|2|||
48797702|NCT00765843|157097054|FG000|Overall Study|Lost to Follow-up|1|||
48797703|NCT00765843|157097055|FG001|Overall Study|Lost to Follow-up|3|||
48797704|NCT00765843|157097056|FG002|Overall Study|Lost to Follow-up|2|||
48797705|NCT00765843|157097054|FG000|Overall Study|did not return to receive intervention|0|||
48797706|NCT00765843|157097055|FG001|Overall Study|did not return to receive intervention|1|||
48797707|NCT00765843|157097056|FG002|Overall Study|did not return to receive intervention|0|||
48797708|NCT00765843|157097054|FG000|Overall Study|Adverse Event|0|||
48797709|NCT00765843|157097055|FG001|Overall Study|Adverse Event|0|||
48797710|NCT00765843|157097056|FG002|Overall Study|Adverse Event|1|||
48797711|NCT00293267|157097059|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
48982352|NCT02996110|157767569|FG004|Track 1|Adverse Event Unrelated to Study Drug|0|||
48982353|NCT02996110|157767565|FG000|Track 1|Study Drug Toxicity|5|||
48982354|NCT02996110|157767566|FG001|Track 1|Study Drug Toxicity|3|||
48982355|NCT02996110|157767567|FG002|Track 1|Study Drug Toxicity|0|||
48982356|NCT02996110|157767568|FG003|Track 1|Study Drug Toxicity|0|||
48982357|NCT02996110|157767569|FG004|Track 1|Study Drug Toxicity|0|||
48982358|NCT02996110|157767565|FG000|Track 1|Participant Requested to Discontinue Study Treatment|1|||
48982359|NCT02996110|157767566|FG001|Track 1|Participant Requested to Discontinue Study Treatment|0|||
48982360|NCT02996110|157767567|FG002|Track 1|Participant Requested to Discontinue Study Treatment|0|||
48982361|NCT02996110|157767568|FG003|Track 1|Participant Requested to Discontinue Study Treatment|0|||
48982362|NCT02996110|157767569|FG004|Track 1|Participant Requested to Discontinue Study Treatment|0|||
48982363|NCT02996110|157767565|FG000|Track 1|Administrative Reason by Sponsor|0|||
48982364|NCT02996110|157767566|FG001|Track 1|Administrative Reason by Sponsor|1|||
48982365|NCT02996110|157767567|FG002|Track 1|Administrative Reason by Sponsor|0|||
48982366|NCT02996110|157767568|FG003|Track 1|Administrative Reason by Sponsor|0|||
48982367|NCT02996110|157767569|FG004|Track 1|Administrative Reason by Sponsor|0|||
48982368|NCT02996110|157767565|FG000|Track 1|Participant no Longer Met Study Criteria|1|||
48982369|NCT02996110|157767566|FG001|Track 1|Participant no Longer Met Study Criteria|0|||
48982370|NCT02996110|157767567|FG002|Track 1|Participant no Longer Met Study Criteria|0|||
48982371|NCT02996110|157767568|FG003|Track 1|Participant no Longer Met Study Criteria|0|||
48982372|NCT02996110|157767569|FG004|Track 1|Participant no Longer Met Study Criteria|0|||
48772591|NCT00574405|157013098|FG000|Overall Study|Withdrawal by Subject|3|||
48772592|NCT00574405|157013099|FG001|Overall Study|Withdrawal by Subject|2|||
48772593|NCT01101841|157013102|FG000|Overall Study|Adverse Event|15|||
48772594|NCT01101841|157013103|FG001|Overall Study|Adverse Event|15|||
48772595|NCT01101841|157013102|FG000|Overall Study|Lost to Follow-up|9|||
48772596|NCT01101841|157013103|FG001|Overall Study|Lost to Follow-up|3|||
48772597|NCT01101841|157013102|FG000|Overall Study|Withdrawal by Subject|21|||
48772598|NCT01101841|157013103|FG001|Overall Study|Withdrawal by Subject|40|||
48772599|NCT01101841|157013102|FG000|Overall Study|Protocol Violation|1|||
48772600|NCT01101841|157013103|FG001|Overall Study|Protocol Violation|1|||
48772601|NCT01101841|157013102|FG000|Overall Study|Physician Decision|0|||
48772602|NCT01101841|157013103|FG001|Overall Study|Physician Decision|2|||
48772603|NCT01101841|157013102|FG000|Overall Study|Lack of Efficacy|0|||
48772604|NCT01101841|157013103|FG001|Overall Study|Lack of Efficacy|2|||
48772605|NCT01101841|157013102|FG000|Overall Study|Other|0|||
48772606|NCT01101841|157013103|FG001|Overall Study|Other|1|||
48772607|NCT01101841|157013102|FG000|Overall Study|Suicidality Tracking Scale|3|||
48772608|NCT01101841|157013103|FG001|Overall Study|Suicidality Tracking Scale|1|||
48772609|NCT01101841|157013102|FG000|Overall Study|Eligibility Criteria|1|||
48772610|NCT01101841|157013103|FG001|Overall Study|Eligibility Criteria|2|||
48772611|NCT01700179|157013107|FG000|Overall Study|Physician Decision|2|||
48772612|NCT00679341|157013108|FG000|Overall Study|Disease progression|42|||
48772613|NCT00679341|157013109|FG001|Overall Study|Disease progression|36|||
48772614|NCT00679341|157013108|FG000|Overall Study|Adverse Event|5|||
48772615|NCT00679341|157013109|FG001|Overall Study|Adverse Event|6|||
48772616|NCT00679341|157013108|FG000|Overall Study|Subject/guardian decision to discontinue|3|||
48772617|NCT00679341|157013109|FG001|Overall Study|Subject/guardian decision to discontinue|0|||
48772618|NCT00679341|157013108|FG000|Overall Study|Death|1|||
48772619|NCT00679341|157013109|FG001|Overall Study|Death|1|||
48772620|NCT00679341|157013108|FG000|Overall Study|Other|1|||
48772621|NCT00679341|157013109|FG001|Overall Study|Other|0|||
48772622|NCT00679341|157013108|FG000|Overall Study|Physician Decision|1|||
48772623|NCT00679341|157013109|FG001|Overall Study|Physician Decision|0|||
48772624|NCT00679341|157013108|FG000|Overall Study|Not treated|0|||
48772625|NCT00679341|157013109|FG001|Overall Study|Not treated|2|||
48772626|NCT00679341|157013108|FG000|Overall Study|Physician/patient decision to withdraw|0|||
48772627|NCT00679341|157013109|FG001|Overall Study|Physician/patient decision to withdraw|6|||
48772628|NCT01207778|157013110|FG000|Overall Study|Lost to Follow-up|0|||
48772629|NCT01207778|157013111|FG001|Overall Study|Lost to Follow-up|3|||
48772630|NCT01207778|157013112|FG002|Overall Study|Lost to Follow-up|3|||
48772631|NCT01433263|157013115|FG000|Overall Study|Adverse Event|3|||
48772632|NCT01433263|157013116|FG001|Overall Study|Adverse Event|1|||
48772633|NCT01433263|157013115|FG000|Overall Study|Death|5|||
48772634|NCT01433263|157013116|FG001|Overall Study|Death|3|||
48772635|NCT01433263|157013115|FG000|Overall Study|Lost to Follow-up|0|||
48772636|NCT01433263|157013116|FG001|Overall Study|Lost to Follow-up|1|||
48772637|NCT01433263|157013115|FG000|Overall Study|Protocol Deviation|1|||
48772638|NCT01433263|157013116|FG001|Overall Study|Protocol Deviation|0|||
48772639|NCT01433263|157013115|FG000|Overall Study|Withdrawal by Subject|10|||
48772640|NCT01433263|157013116|FG001|Overall Study|Withdrawal by Subject|7|||
48772641|NCT00646204|157013117|FG000|Overall Study|Adverse Event|3|||
48772642|NCT00646204|157013118|FG001|Overall Study|Adverse Event|0|||
48772643|NCT00646204|157013117|FG000|Overall Study|Withdrawal by Subject|1|||
48772644|NCT00646204|157013118|FG001|Overall Study|Withdrawal by Subject|0|||
48772645|NCT02919670|157013124|FG000|Overall Study|Only 17 participants met compliance|43|||
48772646|NCT02919670|157013125|FG001|Overall Study|Only 17 participants met compliance|39|||
48772647|NCT00706966|157013126|FG000|Overall Study|Adverse Event|1|||
48772648|NCT01631474|157013127|FG000|Overall Study|Lost to Follow-up|8|||
48772649|NCT01631474|157013128|FG001|Overall Study|Lost to Follow-up|5|||
48772650|NCT01631474|157013129|FG002|Overall Study|Lost to Follow-up|7|||
48772651|NCT01631474|157013130|FG003|Overall Study|Lost to Follow-up|5|||
48772652|NCT01631474|157013131|FG004|Overall Study|Lost to Follow-up|5|||
48772653|NCT01631474|157013127|FG000|Overall Study|Withdrawal by Subject|4|||
48772654|NCT01631474|157013128|FG001|Overall Study|Withdrawal by Subject|4|||
48772655|NCT01631474|157013129|FG002|Overall Study|Withdrawal by Subject|2|||
48772656|NCT01631474|157013130|FG003|Overall Study|Withdrawal by Subject|6|||
48772657|NCT01631474|157013131|FG004|Overall Study|Withdrawal by Subject|5|||
48772658|NCT01631474|157013127|FG000|Overall Study|Lack of Efficacy|2|||
48772659|NCT01631474|157013128|FG001|Overall Study|Lack of Efficacy|2|||
48772660|NCT01631474|157013129|FG002|Overall Study|Lack of Efficacy|0|||
48772661|NCT01631474|157013130|FG003|Overall Study|Lack of Efficacy|0|||
48772662|NCT01631474|157013131|FG004|Overall Study|Lack of Efficacy|2|||
48772663|NCT01631474|157013127|FG000|Overall Study|Noncompliance with Study Drug|0|||
48772664|NCT01631474|157013128|FG001|Overall Study|Noncompliance with Study Drug|0|||
48772665|NCT01631474|157013129|FG002|Overall Study|Noncompliance with Study Drug|0|||
48772666|NCT01631474|157013130|FG003|Overall Study|Noncompliance with Study Drug|0|||
48772667|NCT01631474|157013131|FG004|Overall Study|Noncompliance with Study Drug|1|||
48772668|NCT01631474|157013127|FG000|Overall Study|Adverse Event|0|||
48772669|NCT01631474|157013128|FG001|Overall Study|Adverse Event|1|||
48772670|NCT01631474|157013129|FG002|Overall Study|Adverse Event|0|||
48772671|NCT01631474|157013130|FG003|Overall Study|Adverse Event|0|||
48772672|NCT01631474|157013131|FG004|Overall Study|Adverse Event|0|||
48772673|NCT00958776|157013132|FG000|Overall Study|Adverse Event|0|||
48772674|NCT00958776|157013133|FG001|Overall Study|Adverse Event|1|||
48772675|NCT00958776|157013132|FG000|Overall Study|Physician Decision|1|||
48772676|NCT00958776|157013133|FG001|Overall Study|Physician Decision|0|||
48772677|NCT00958776|157013132|FG000|Overall Study|Lost to Follow-up|2|||
48772678|NCT00958776|157013133|FG001|Overall Study|Lost to Follow-up|6|||
48772679|NCT00958776|157013132|FG000|Overall Study|Withdrawal by Subject|7|||
48772680|NCT00958776|157013133|FG001|Overall Study|Withdrawal by Subject|16|||
48772681|NCT00958776|157013132|FG000|Overall Study|Protocol Violation|1|||
48772682|NCT00958776|157013133|FG001|Overall Study|Protocol Violation|1|||
48772683|NCT00958776|157013132|FG000|Overall Study|Death|2|||
48772684|NCT00958776|157013133|FG001|Overall Study|Death|1|||
48772685|NCT00958776|157013132|FG000|Overall Study|Noncompliance; Protocol Deviations|2|||
48772686|NCT00958776|157013133|FG001|Overall Study|Noncompliance; Protocol Deviations|3|||
48772687|NCT00958776|157013132|FG000|Overall Study|Missing|1|||
48772688|NCT00958776|157013133|FG001|Overall Study|Missing|1|||
48772689|NCT00480636|157013134|FG000|Overall Study|Death|12|||
48772690|NCT00480636|157013134|FG000|Overall Study|Lost to Follow-up|4|||
48772691|NCT00480636|157013134|FG000|Overall Study|Other|2|||
48772692|NCT00480636|157013134|FG000|Overall Study|Lost to follow-up; subsequently died|1|||
48772693|NCT00326911|157013137|FG000|Overall Study|Hospitalization prior to treatment|0|||
48772694|NCT00326911|157013138|FG001|Overall Study|Hospitalization prior to treatment|1|||
48772695|NCT00326911|157013137|FG000|Overall Study|Physician decision prior to treatment|1|||
48772696|NCT00326911|157013138|FG001|Overall Study|Physician decision prior to treatment|0|||
48772697|NCT00326911|157013137|FG000|Overall Study|Withdrawal by subject prior to treatment|0|||
48772698|NCT00326911|157013138|FG001|Overall Study|Withdrawal by subject prior to treatment|1|||
48772699|NCT00654628|157013149|FG000|6-week Active Treatment Period|Adverse Event|9|||
48772700|NCT00654628|157013149|FG000|6-week Active Treatment Period|Lost to Follow-up|10|||
48772701|NCT00654628|157013149|FG000|6-week Active Treatment Period|Transferred to branch hospital|1|||
48772702|NCT00654628|157013149|FG000|6-week Active Treatment Period|Out of window period|1|||
48772703|NCT00654628|157013149|FG000|6 -Week Extension Period (Single Site)|Adverse Event|4|||
48772704|NCT00654628|157013149|FG000|6 -Week Extension Period (Single Site)|Lost to Follow-up|1|||
48772705|NCT02684006|157013150|FG000|Overall Study|Ongoing|31|||
48772706|NCT02684006|157013151|FG001|Overall Study|Ongoing|10|||
48772707|NCT02684006|157013150|FG000|Overall Study|Other|7|||
48772708|NCT02684006|157013151|FG001|Overall Study|Other|6|||
48772709|NCT02684006|157013150|FG000|Overall Study|Protocol Violation|2|||
48772710|NCT02684006|157013151|FG001|Overall Study|Protocol Violation|1|||
48772711|NCT02684006|157013150|FG000|Overall Study|Non-compliance with study drug|1|||
48772712|NCT02684006|157013151|FG001|Overall Study|Non-compliance with study drug|1|||
48772713|NCT02684006|157013150|FG000|Overall Study|No longer meets eligibility criteria|6|||
48772714|NCT02684006|157013151|FG001|Overall Study|No longer meets eligibility criteria|2|||
48772715|NCT02684006|157013150|FG000|Overall Study|Lost to Follow-up|0|||
48772716|NCT02684006|157013151|FG001|Overall Study|Lost to Follow-up|1|||
48876645|NCT01006616|157386575|FG003|Period 2 (18 Months)|Study Terminated|70|||
48876646|NCT04952701|157386578|FG000|Control Lens|Physician Decision|4|||
48772717|NCT02684006|157013150|FG000|Overall Study|Death|24|||
48772718|NCT02684006|157013151|FG001|Overall Study|Death|22|||
48772719|NCT02684006|157013150|FG000|Overall Study|Global deterioration of health status|18|||
48772720|NCT02684006|157013151|FG001|Overall Study|Global deterioration of health status|20|||
48772721|NCT02684006|157013150|FG000|Overall Study|Physician Decision|14|||
48772722|NCT02684006|157013151|FG001|Overall Study|Physician Decision|9|||
48772723|NCT02684006|157013150|FG000|Overall Study|Adverse Event|74|||
48772724|NCT02684006|157013151|FG001|Overall Study|Adverse Event|65|||
48772725|NCT02684006|157013150|FG000|Overall Study|Withdrawal by Subject|29|||
48772726|NCT02684006|157013151|FG001|Overall Study|Withdrawal by Subject|41|||
48772727|NCT02684006|157013150|FG000|Overall Study|Progressive disease|236|||
48772728|NCT02684006|157013151|FG001|Overall Study|Progressive disease|266|||
48772729|NCT02399085|157013152|FG000|Overall Study|Adverse Event|16|||
48772730|NCT02399085|157013152|FG000|Overall Study|Death|2|||
48772731|NCT02399085|157013152|FG000|Overall Study|Withdrawal by Subject|8|||
48772732|NCT02399085|157013152|FG000|Overall Study|Progressive disease/ Disease relapse|42|||
48982373|NCT02996110|157767565|FG000|Track 2|Disease Progression|33|||
48772733|NCT02399085|157013152|FG000|Overall Study|Physician Decision|5|||
48772734|NCT03235024|157013153|FG000|Overall Study|Adverse Event|2|||
48772735|NCT03235024|157013154|FG001|Overall Study|Adverse Event|2|||
48772736|NCT03235024|157013153|FG000|Overall Study|Death|1|||
48772737|NCT03235024|157013154|FG001|Overall Study|Death|0|||
48772738|NCT03235024|157013153|FG000|Overall Study|Lost to Follow-up|2|||
48772739|NCT03235024|157013154|FG001|Overall Study|Lost to Follow-up|5|||
48772740|NCT03235024|157013153|FG000|Overall Study|Protocol Violation|1|||
48772741|NCT03235024|157013154|FG001|Overall Study|Protocol Violation|0|||
48772742|NCT03235024|157013153|FG000|Overall Study|Withdrawal by Subject|0|||
48876647|NCT04952701|157386578|FG000|Test Lens|Physician Decision|1|||
48772743|NCT03235024|157013154|FG001|Overall Study|Withdrawal by Subject|3|||
48772744|NCT02357576|157013157|FG000|Treatment Period|Withdrawal by Subject|0|||
48772745|NCT02357576|157013158|FG001|Treatment Period|Withdrawal by Subject|1|||
48772746|NCT02357576|157013157|FG000|Treatment Period|Physician Decision|0|||
48772747|NCT02357576|157013158|FG001|Treatment Period|Physician Decision|1|||
48772748|NCT02357576|157013157|FG000|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
48772749|NCT02357576|157013158|FG001|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
48772750|NCT02357576|157013157|FG000|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1|||
48772751|NCT02357576|157013158|FG001|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0|||
48772752|NCT02357576|157013157|FG000|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1|||
48772753|NCT02357576|157013158|FG001|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4|||
48772754|NCT02357576|157013157|FG000|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2|||
48772755|NCT02357576|157013158|FG001|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0|||
48772756|NCT00261716|157013159|FG000|Overall Study|Withdrawal by Subject|6|||
48772757|NCT00261716|157013160|FG001|Overall Study|Withdrawal by Subject|8|||
48772758|NCT00261716|157013159|FG000|Overall Study|Lost to Follow-up|0|||
48772759|NCT00261716|157013160|FG001|Overall Study|Lost to Follow-up|2|||
48772760|NCT01988571|157013163|FG000|Overall Study|Death|3|||
48772761|NCT01988571|157013164|FG001|Overall Study|Death|1|||
48772762|NCT01988571|157013163|FG000|Overall Study|Physician Decision|2|||
48772763|NCT01988571|157013164|FG001|Overall Study|Physician Decision|1|||
48772764|NCT01988571|157013163|FG000|Overall Study|Lost to Follow-up|3|||
48772765|NCT01988571|157013164|FG001|Overall Study|Lost to Follow-up|0|||
48772766|NCT01988571|157013163|FG000|Overall Study|Withdrawal by Subject|31|||
48772767|NCT01988571|157013164|FG001|Overall Study|Withdrawal by Subject|33|||
48772768|NCT00937547|157013168|FG000|Overall Study|misdiagnosis|1|||
48772769|NCT00937547|157013169|FG001|Overall Study|misdiagnosis|6|||
48772770|NCT00937547|157013170|FG002|Overall Study|misdiagnosis|7|||
48772771|NCT00325234|157013171|FG000|Overall Study|Adverse Event|10|||
48772772|NCT00325234|157013172|FG001|Overall Study|Adverse Event|7|||
48772773|NCT00325234|157013171|FG000|Overall Study|Death due to Study Disease|1|||
48772774|NCT00325234|157013172|FG001|Overall Study|Death due to Study Disease|0|||
48772775|NCT00325234|157013171|FG000|Overall Study|Entry Criteria Not Met|1|||
48772776|NCT00325234|157013172|FG001|Overall Study|Entry Criteria Not Met|2|||
48772777|NCT00325234|157013171|FG000|Overall Study|Subject Decision|6|||
48772778|NCT00325234|157013172|FG001|Overall Study|Subject Decision|8|||
48772779|NCT00325234|157013171|FG000|Overall Study|Physician Decision|17|||
48772780|NCT00325234|157013172|FG001|Overall Study|Physician Decision|12|||
48772781|NCT00325234|157013171|FG000|Overall Study|Progressive Disease|34|||
48772782|NCT00325234|157013172|FG001|Overall Study|Progressive Disease|37|||
48772783|NCT01234467|157013173|FG000|Overall Study|Adverse Event|3|||
48772784|NCT01234467|157013173|FG000|Overall Study|Death|2|||
48772785|NCT01234467|157013173|FG000|Overall Study|Withdrawal by Subject|2|||
48772786|NCT01234467|157013173|FG000|Overall Study|Disease Progression|2|||
48772787|NCT01234467|157013173|FG000|Overall Study|Clinical deterioration|1|||
48772788|NCT01234467|157013173|FG000|Overall Study|Physician Decision|1|||
48772789|NCT01234467|157013173|FG000|Overall Study|Other complicating disease (stroke)|1|||
48772790|NCT01461096|157013174|FG000|Overall Study|Death|3|||
48772791|NCT01461096|157013175|FG001|Overall Study|Death|6|||
48772792|NCT01461096|157013174|FG000|Overall Study|Severe debilitation, unable to continue|1|||
48772793|NCT01461096|157013175|FG001|Overall Study|Severe debilitation, unable to continue|1|||
48772794|NCT01461096|157013174|FG000|Overall Study|Subj not able to get to clinic|15|||
48772795|NCT01461096|157013175|FG001|Overall Study|Subj not able to get to clinic|13|||
48772796|NCT01461096|157013174|FG000|Overall Study|Site is closing|27|||
48772797|NCT01461096|157013175|FG001|Overall Study|Site is closing|30|||
48772798|NCT01461096|157013174|FG000|Overall Study|Withdrawal by Subject|5|||
48772799|NCT01461096|157013175|FG001|Overall Study|Withdrawal by Subject|3|||
48772800|NCT01461096|157013174|FG000|Overall Study|Subj not willing to adhere to reqs|3|||
48772801|NCT01461096|157013175|FG001|Overall Study|Subj not willing to adhere to reqs|4|||
48772802|NCT01461096|157013174|FG000|Overall Study|Lost to Follow-up|8|||
48772803|NCT01461096|157013175|FG001|Overall Study|Lost to Follow-up|4|||
48772804|NCT02059148|157013176|FG000|Treatment 1|Protocol Violation|0|||
48772805|NCT02059148|157013177|FG001|Treatment 1|Protocol Violation|0|||
48772806|NCT02059148|157013178|FG002|Treatment 1|Protocol Violation|0|||
48772807|NCT02059148|157013179|FG003|Treatment 1|Protocol Violation|0|||
48772808|NCT02059148|157013180|FG004|Treatment 1|Protocol Violation|0|||
48772809|NCT02059148|157013181|FG005|Treatment 1|Protocol Violation|1|||
48772810|NCT00414050|157013182|FG000|Overall Study|Adverse Event|1|||
48772811|NCT00414050|157013183|FG001|Overall Study|Adverse Event|1|||
48772812|NCT00414050|157013184|FG002|Overall Study|Adverse Event|1|||
48772813|NCT00414050|157013185|FG003|Overall Study|Adverse Event|1|||
48772814|NCT00414050|157013182|FG000|Overall Study|Lost to Follow-up|2|||
48772815|NCT00414050|157013183|FG001|Overall Study|Lost to Follow-up|2|||
48772816|NCT00414050|157013184|FG002|Overall Study|Lost to Follow-up|1|||
48772817|NCT00414050|157013185|FG003|Overall Study|Lost to Follow-up|1|||
48772818|NCT00414050|157013182|FG000|Overall Study|Withdrawal by Subject|5|||
48772819|NCT00414050|157013183|FG001|Overall Study|Withdrawal by Subject|3|||
48772820|NCT00414050|157013184|FG002|Overall Study|Withdrawal by Subject|2|||
48772821|NCT00414050|157013185|FG003|Overall Study|Withdrawal by Subject|4|||
48772822|NCT00414050|157013182|FG000|Overall Study|Subject discontinued for other reason|1|||
48772823|NCT00414050|157013183|FG001|Overall Study|Subject discontinued for other reason|2|||
48772824|NCT00414050|157013184|FG002|Overall Study|Subject discontinued for other reason|2|||
48772825|NCT00414050|157013185|FG003|Overall Study|Subject discontinued for other reason|1|||
48772826|NCT00414050|157013182|FG000|Overall Study|Subject Moved|0|||
48772827|NCT00414050|157013183|FG001|Overall Study|Subject Moved|0|||
48772828|NCT00414050|157013184|FG002|Overall Study|Subject Moved|0|||
48772829|NCT00414050|157013185|FG003|Overall Study|Subject Moved|1|||
48772830|NCT00720876|157013186|FG000|Overall Study|found to be ineligible after starting tx|2|||
48772831|NCT00079274|157013187|FG000|Overall Study|Withdrawal by Subject|111|||
48772832|NCT00079274|157013188|FG001|Overall Study|Withdrawal by Subject|10|||
48772833|NCT00079274|157013189|FG002|Overall Study|Withdrawal by Subject|12|||
48772834|NCT00079274|157013190|FG003|Overall Study|Withdrawal by Subject|163|||
48772835|NCT00079274|157013191|FG004|Overall Study|Withdrawal by Subject|7|||
48772836|NCT00079274|157013192|FG005|Overall Study|Withdrawal by Subject|8|||
48772837|NCT00079274|157013193|FG006|Overall Study|Withdrawal by Subject|0|||
48772838|NCT00079274|157013187|FG000|Overall Study|Adverse Event|130|||
48772839|NCT00079274|157013188|FG001|Overall Study|Adverse Event|8|||
48772840|NCT00079274|157013189|FG002|Overall Study|Adverse Event|8|||
48772841|NCT00079274|157013190|FG003|Overall Study|Adverse Event|184|||
48772842|NCT00079274|157013191|FG004|Overall Study|Adverse Event|7|||
48772843|NCT00079274|157013192|FG005|Overall Study|Adverse Event|8|||
48772844|NCT00079274|157013193|FG006|Overall Study|Adverse Event|0|||
48772845|NCT00079274|157013187|FG000|Overall Study|Recurrence|21|||
48772846|NCT00079274|157013188|FG001|Overall Study|Recurrence|0|||
48772847|NCT00079274|157013189|FG002|Overall Study|Recurrence|1|||
48772848|NCT00079274|157013190|FG003|Overall Study|Recurrence|15|||
48772849|NCT00079274|157013191|FG004|Overall Study|Recurrence|0|||
48772850|NCT00079274|157013192|FG005|Overall Study|Recurrence|2|||
48772851|NCT00079274|157013193|FG006|Overall Study|Recurrence|0|||
48772852|NCT00079274|157013187|FG000|Overall Study|Alternate Treatment|6|||
48772853|NCT00079274|157013188|FG001|Overall Study|Alternate Treatment|1|||
48772854|NCT00079274|157013189|FG002|Overall Study|Alternate Treatment|0|||
48772855|NCT00079274|157013190|FG003|Overall Study|Alternate Treatment|3|||
48772856|NCT00079274|157013191|FG004|Overall Study|Alternate Treatment|0|||
48772857|NCT00079274|157013192|FG005|Overall Study|Alternate Treatment|0|||
48772858|NCT00079274|157013193|FG006|Overall Study|Alternate Treatment|0|||
48772859|NCT00079274|157013187|FG000|Overall Study|Other Medical Problems|6|||
48772860|NCT00079274|157013188|FG001|Overall Study|Other Medical Problems|1|||
48772861|NCT00079274|157013189|FG002|Overall Study|Other Medical Problems|0|||
48772862|NCT00079274|157013190|FG003|Overall Study|Other Medical Problems|7|||
48772863|NCT00079274|157013191|FG004|Overall Study|Other Medical Problems|0|||
48772864|NCT00079274|157013192|FG005|Overall Study|Other Medical Problems|0|||
48772865|NCT00079274|157013193|FG006|Overall Study|Other Medical Problems|0|||
48982374|NCT02996110|157767566|FG001|Track 2|Disease Progression|26|||
48982375|NCT02996110|157767567|FG002|Track 2|Disease Progression|19|||
48982376|NCT02996110|157767568|FG003|Track 2|Disease Progression|16|||
48982377|NCT02996110|157767569|FG004|Track 2|Disease Progression|15|||
48982378|NCT02996110|157767565|FG000|Track 2|Adverse Event Unrelated to Study Drug|4|||
48772866|NCT00079274|157013187|FG000|Overall Study|Death|4|||
48772867|NCT00079274|157013188|FG001|Overall Study|Death|0|||
48772868|NCT00079274|157013189|FG002|Overall Study|Death|1|||
48772869|NCT00079274|157013190|FG003|Overall Study|Death|15|||
48772870|NCT00079274|157013191|FG004|Overall Study|Death|0|||
48772871|NCT00079274|157013192|FG005|Overall Study|Death|0|||
48772872|NCT00079274|157013193|FG006|Overall Study|Death|0|||
48772873|NCT00079274|157013187|FG000|Overall Study|Cytogenetic resistance|0|||
48772874|NCT00079274|157013188|FG001|Overall Study|Cytogenetic resistance|0|||
48772875|NCT00079274|157013189|FG002|Overall Study|Cytogenetic resistance|0|||
48772876|NCT00079274|157013190|FG003|Overall Study|Cytogenetic resistance|2|||
48772877|NCT00079274|157013191|FG004|Overall Study|Cytogenetic resistance|0|||
48772878|NCT00079274|157013192|FG005|Overall Study|Cytogenetic resistance|0|||
48772879|NCT00079274|157013193|FG006|Overall Study|Cytogenetic resistance|0|||
48772880|NCT00079274|157013187|FG000|Overall Study|Other|43|||
48772881|NCT00079274|157013188|FG001|Overall Study|Other|7|||
48772882|NCT00079274|157013189|FG002|Overall Study|Other|5|||
48772883|NCT00079274|157013190|FG003|Overall Study|Other|55|||
48772884|NCT00079274|157013191|FG004|Overall Study|Other|1|||
48982379|NCT02996110|157767566|FG001|Track 2|Adverse Event Unrelated to Study Drug|0|||
48982380|NCT02996110|157767567|FG002|Track 2|Adverse Event Unrelated to Study Drug|0|||
48772885|NCT00079274|157013192|FG005|Overall Study|Other|2|||
48772886|NCT00079274|157013193|FG006|Overall Study|Other|0|||
48772887|NCT01479621|157013198|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93|||
48772888|NCT01479621|157013199|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
48772889|NCT01479621|157013200|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
48772890|NCT01479621|157013201|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
48772891|NCT01479621|157013202|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
48772892|NCT01479621|157013203|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
48772893|NCT01479621|157013204|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
48772894|NCT01479621|157013198|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19|||
48772895|NCT01479621|157013199|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
48772896|NCT01479621|157013200|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
48772897|NCT01479621|157013201|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
48772898|NCT01479621|157013202|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
48772899|NCT01479621|157013203|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
48772900|NCT01479621|157013204|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
48772901|NCT01479621|157013198|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153|||
48772902|NCT01479621|157013199|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
48772903|NCT01479621|157013200|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
48772904|NCT01479621|157013201|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
48772905|NCT01479621|157013202|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
48772906|NCT01479621|157013203|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
48772907|NCT01479621|157013204|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
48772908|NCT01479621|157013198|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7|||
48772909|NCT01479621|157013199|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
48772910|NCT01479621|157013200|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
48772911|NCT01479621|157013201|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
48772912|NCT01479621|157013202|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
48772913|NCT01479621|157013203|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
48772914|NCT01479621|157013204|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
48772915|NCT01479621|157013198|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
48772916|NCT01479621|157013199|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
48772917|NCT01479621|157013200|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
48772918|NCT01479621|157013201|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
48772919|NCT01479621|157013202|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
48772920|NCT01479621|157013203|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
48772921|NCT01479621|157013204|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
48772922|NCT01479621|157013198|FG000|Treatment Period|Adverse Event|0|||
48772923|NCT01479621|157013199|FG001|Treatment Period|Adverse Event|0|||
48772924|NCT01479621|157013200|FG002|Treatment Period|Adverse Event|0|||
48772925|NCT01479621|157013201|FG003|Treatment Period|Adverse Event|0|||
48772926|NCT01479621|157013202|FG004|Treatment Period|Adverse Event|1|||
48772927|NCT01479621|157013203|FG005|Treatment Period|Adverse Event|2|||
48772928|NCT01479621|157013204|FG006|Treatment Period|Adverse Event|2|||
48772929|NCT01479621|157013198|FG000|Treatment Period|Withdrawal by Subject|0|||
48772930|NCT01479621|157013199|FG001|Treatment Period|Withdrawal by Subject|4|||
48772931|NCT01479621|157013200|FG002|Treatment Period|Withdrawal by Subject|2|||
48772932|NCT01479621|157013201|FG003|Treatment Period|Withdrawal by Subject|2|||
48772933|NCT01479621|157013202|FG004|Treatment Period|Withdrawal by Subject|5|||
48772934|NCT01479621|157013203|FG005|Treatment Period|Withdrawal by Subject|5|||
48772935|NCT01479621|157013204|FG006|Treatment Period|Withdrawal by Subject|1|||
48772936|NCT01479621|157013198|FG000|Treatment Period|Physician Decision|0|||
48772937|NCT01479621|157013199|FG001|Treatment Period|Physician Decision|0|||
48772938|NCT01479621|157013200|FG002|Treatment Period|Physician Decision|0|||
48772939|NCT01479621|157013201|FG003|Treatment Period|Physician Decision|0|||
48772940|NCT01479621|157013202|FG004|Treatment Period|Physician Decision|1|||
48772941|NCT01479621|157013203|FG005|Treatment Period|Physician Decision|1|||
48772942|NCT01479621|157013204|FG006|Treatment Period|Physician Decision|0|||
48772943|NCT01479621|157013198|FG000|Treatment Period|Non-compliance to study drug|0|||
48772944|NCT01479621|157013199|FG001|Treatment Period|Non-compliance to study drug|1|||
48772945|NCT01479621|157013200|FG002|Treatment Period|Non-compliance to study drug|0|||
48772946|NCT01479621|157013201|FG003|Treatment Period|Non-compliance to study drug|0|||
48772947|NCT01479621|157013202|FG004|Treatment Period|Non-compliance to study drug|0|||
48772948|NCT01479621|157013203|FG005|Treatment Period|Non-compliance to study drug|0|||
48772949|NCT01479621|157013204|FG006|Treatment Period|Non-compliance to study drug|1|||
48772950|NCT01479621|157013198|FG000|Treatment Period|Protocol Violation|0|||
48772951|NCT01479621|157013199|FG001|Treatment Period|Protocol Violation|9|||
48772952|NCT01479621|157013200|FG002|Treatment Period|Protocol Violation|6|||
48772953|NCT01479621|157013201|FG003|Treatment Period|Protocol Violation|5|||
48772954|NCT01479621|157013202|FG004|Treatment Period|Protocol Violation|2|||
48772955|NCT01479621|157013203|FG005|Treatment Period|Protocol Violation|10|||
48772956|NCT01479621|157013204|FG006|Treatment Period|Protocol Violation|6|||
48772957|NCT01479621|157013198|FG000|Treatment Period|Pregnancy|0|||
48772958|NCT01479621|157013199|FG001|Treatment Period|Pregnancy|0|||
49027101|NCT01544127|157937602|FG001|Overall Study|Death|0|||
49027102|NCT01544127|157937603|FG002|Overall Study|Death|0|||
49027103|NCT01544127|157937601|FG000|Overall Study|Jail or Prison|1|||
49027104|NCT01544127|157937602|FG001|Overall Study|Jail or Prison|1|||
49027105|NCT01544127|157937603|FG002|Overall Study|Jail or Prison|2|||
49027106|NCT01544127|157937601|FG000|Overall Study|Became Psychotic|1|||
49027107|NCT01544127|157937602|FG001|Overall Study|Became Psychotic|0|||
49027108|NCT01544127|157937603|FG002|Overall Study|Became Psychotic|0|||
49027109|NCT01544127|157937601|FG000|Overall Study|Researcher withdrew|1|||
49027110|NCT01544127|157937602|FG001|Overall Study|Researcher withdrew|0|||
49027111|NCT01544127|157937603|FG002|Overall Study|Researcher withdrew|0|||
49027112|NCT01544127|157937601|FG000|Overall Study|Went active duty|0|||
49027113|NCT01544127|157937602|FG001|Overall Study|Went active duty|0|||
49027114|NCT01544127|157937603|FG002|Overall Study|Went active duty|1|||
49027115|NCT03699020|157937604|FG000|Overall Study|Withdrawal by Subject|3|||
49027116|NCT03699020|157937605|FG001|Overall Study|Withdrawal by Subject|2|||
49027117|NCT01256684|157937606|FG000|Overall Study|Adverse Event|1|||
49027118|NCT01256684|157937607|FG001|Overall Study|Adverse Event|4|||
49027119|NCT01256684|157937608|FG002|Overall Study|Adverse Event|2|||
49027120|NCT01256684|157937606|FG000|Overall Study|Withdrawal by Subject|4|||
49027121|NCT01256684|157937607|FG001|Overall Study|Withdrawal by Subject|0|||
49027122|NCT01256684|157937608|FG002|Overall Study|Withdrawal by Subject|2|||
49027123|NCT01256684|157937606|FG000|Overall Study|Physician Decision|0|||
49027124|NCT01256684|157937607|FG001|Overall Study|Physician Decision|1|||
49027125|NCT01256684|157937608|FG002|Overall Study|Physician Decision|0|||
49027126|NCT01256684|157937606|FG000|Overall Study|Lack of Efficacy|0|||
49027127|NCT01256684|157937607|FG001|Overall Study|Lack of Efficacy|1|||
49027128|NCT01256684|157937608|FG002|Overall Study|Lack of Efficacy|1|||
49027129|NCT01256684|157937606|FG000|Overall Study|Entry criteria not met/non-compliance|4|||
49027130|NCT01256684|157937607|FG001|Overall Study|Entry criteria not met/non-compliance|7|||
49027131|NCT01256684|157937608|FG002|Overall Study|Entry criteria not met/non-compliance|6|||
49027132|NCT02246920|157937610|FG000|Overall Study|Adverse Event|3|||
48772959|NCT01479621|157013200|FG002|Treatment Period|Pregnancy|2|||
48772960|NCT01479621|157013201|FG003|Treatment Period|Pregnancy|0|||
48772961|NCT01479621|157013202|FG004|Treatment Period|Pregnancy|0|||
48772962|NCT01479621|157013203|FG005|Treatment Period|Pregnancy|0|||
48772963|NCT01479621|157013204|FG006|Treatment Period|Pregnancy|0|||
48772964|NCT01479621|157013198|FG000|Treatment Period|Sponsor request subject to be withdrawn|0|||
48772965|NCT01479621|157013199|FG001|Treatment Period|Sponsor request subject to be withdrawn|2|||
48772966|NCT01479621|157013200|FG002|Treatment Period|Sponsor request subject to be withdrawn|3|||
48772967|NCT01479621|157013201|FG003|Treatment Period|Sponsor request subject to be withdrawn|1|||
48772968|NCT01479621|157013202|FG004|Treatment Period|Sponsor request subject to be withdrawn|1|||
48772969|NCT01479621|157013203|FG005|Treatment Period|Sponsor request subject to be withdrawn|1|||
48772970|NCT01479621|157013204|FG006|Treatment Period|Sponsor request subject to be withdrawn|3|||
48772971|NCT01479621|157013198|FG000|Treatment Period|Lost to Follow-up|0|||
48772972|NCT01479621|157013199|FG001|Treatment Period|Lost to Follow-up|0|||
48772973|NCT01479621|157013200|FG002|Treatment Period|Lost to Follow-up|1|||
48876648|NCT02019641|157386581|FG000|10-Week Follow up|Withdrawal by investigator|2|||
48876649|NCT02019641|157386582|FG001|10-Week Follow up|Withdrawal by investigator|0|||
48876650|NCT02019641|157386583|FG002|10-Week Follow up|Withdrawal by investigator|0|||
48876651|NCT02019641|157386581|FG000|10-Week Follow up|Withdrawal by Subject|1|||
48876652|NCT02019641|157386582|FG001|10-Week Follow up|Withdrawal by Subject|1|||
49027133|NCT02246920|157937611|FG001|Overall Study|Adverse Event|1|||
49027134|NCT02246920|157937612|FG002|Overall Study|Adverse Event|1|||
49027135|NCT02246920|157937610|FG000|Overall Study|Lost to Follow-up|2|||
49027136|NCT02246920|157937611|FG001|Overall Study|Lost to Follow-up|1|||
49027137|NCT02246920|157937612|FG002|Overall Study|Lost to Follow-up|0|||
49027138|NCT02246920|157937610|FG000|Overall Study|Protocol Violation|2|||
49027139|NCT02246920|157937611|FG001|Overall Study|Protocol Violation|5|||
49027140|NCT02246920|157937612|FG002|Overall Study|Protocol Violation|1|||
49027141|NCT02246920|157937610|FG000|Overall Study|Withdrawal by Subject|0|||
49027142|NCT02246920|157937611|FG001|Overall Study|Withdrawal by Subject|0|||
49027143|NCT02246920|157937612|FG002|Overall Study|Withdrawal by Subject|1|||
49027144|NCT02107092|157937613|FG000|Overall Study|Miscellaneous|3|||
49027145|NCT02107092|157937613|FG000|Overall Study|Subject compliance|3|||
49027146|NCT02107092|157937613|FG000|Overall Study|Hypo-or hyperkalemia|2|||
49027147|NCT02107092|157937613|FG000|Overall Study|Met ECG withdrawal criteria|3|||
49027148|NCT02107092|157937613|FG000|Overall Study|Physician Decision|3|||
49027149|NCT02107092|157937613|FG000|Overall Study|Lost to Follow-up|2|||
48772974|NCT01479621|157013201|FG003|Treatment Period|Lost to Follow-up|0|||
48772975|NCT01479621|157013202|FG004|Treatment Period|Lost to Follow-up|2|||
48876653|NCT02019641|157386583|FG002|10-Week Follow up|Withdrawal by Subject|0|||
49027150|NCT02107092|157937613|FG000|Overall Study|Withdrawal by Subject|9|||
49027151|NCT02107092|157937613|FG000|Overall Study|Adverse Event|7|||
49027152|NCT02107092|157937613|FG000|Overall Study|Expected progression of CKD|12|||
49027153|NCT03522675|157937614|FG000|Overall Study|Screen fail|1|||
49027154|NCT03522675|157937614|FG000|Overall Study|Non-reactive to histamine|1|||
49027155|NCT02674477|157937617|FG000|Overall Study|Protocol Violation|8|||
49027156|NCT02674477|157937618|FG001|Overall Study|Protocol Violation|2|||
49027157|NCT01185821|157937620|FG000|Overall Study|Abnormal laboratory value(s)|1|||
49027158|NCT01185821|157937621|FG001|Overall Study|Abnormal laboratory value(s)|2|||
49027159|NCT01185821|157937622|FG002|Overall Study|Abnormal laboratory value(s)|1|||
49027160|NCT01185821|157937623|FG003|Overall Study|Abnormal laboratory value(s)|0|||
49027161|NCT01185821|157937624|FG004|Overall Study|Abnormal laboratory value(s)|0|||
49027162|NCT01185821|157937620|FG000|Overall Study|Protocol Violation|0|||
49027163|NCT01185821|157937621|FG001|Overall Study|Protocol Violation|0|||
48772976|NCT01479621|157013203|FG005|Treatment Period|Lost to Follow-up|2|||
48772977|NCT01479621|157013204|FG006|Treatment Period|Lost to Follow-up|1|||
48772978|NCT01479621|157013198|FG000|Treatment Period|Met stopping criteria|0|||
48772979|NCT01479621|157013199|FG001|Treatment Period|Met stopping criteria|8|||
48772980|NCT01479621|157013200|FG002|Treatment Period|Met stopping criteria|7|||
48772981|NCT01479621|157013201|FG003|Treatment Period|Met stopping criteria|4|||
48772982|NCT01479621|157013202|FG004|Treatment Period|Met stopping criteria|9|||
48772983|NCT01479621|157013203|FG005|Treatment Period|Met stopping criteria|20|||
48772984|NCT01479621|157013204|FG006|Treatment Period|Met stopping criteria|6|||
48772985|NCT03304379|157013205|FG000|Overall Study|Protocol Violation|8|||
48772986|NCT03304379|157013206|FG001|Overall Study|Protocol Violation|10|||
48772987|NCT03304379|157013207|FG002|Overall Study|Protocol Violation|5|||
48772988|NCT03304379|157013208|FG003|Overall Study|Protocol Violation|0|||
48772989|NCT03304379|157013209|FG004|Overall Study|Protocol Violation|2|||
48772990|NCT03304379|157013205|FG000|Overall Study|Adverse Event|4|||
48772991|NCT03304379|157013206|FG001|Overall Study|Adverse Event|20|||
48772992|NCT03304379|157013207|FG002|Overall Study|Adverse Event|17|||
48772993|NCT03304379|157013208|FG003|Overall Study|Adverse Event|1|||
48772994|NCT03304379|157013209|FG004|Overall Study|Adverse Event|0|||
48772995|NCT03304379|157013205|FG000|Overall Study|Lack of Efficacy|17|||
48772996|NCT03304379|157013206|FG001|Overall Study|Lack of Efficacy|16|||
48772997|NCT03304379|157013207|FG002|Overall Study|Lack of Efficacy|20|||
48772998|NCT03304379|157013208|FG003|Overall Study|Lack of Efficacy|0|||
48772999|NCT03304379|157013209|FG004|Overall Study|Lack of Efficacy|0|||
48773000|NCT03304379|157013205|FG000|Overall Study|Physician Decision|6|||
48773001|NCT03304379|157013206|FG001|Overall Study|Physician Decision|10|||
48773002|NCT03304379|157013207|FG002|Overall Study|Physician Decision|6|||
48982381|NCT02996110|157767568|FG003|Track 2|Adverse Event Unrelated to Study Drug|1|||
48982382|NCT02996110|157767569|FG004|Track 2|Adverse Event Unrelated to Study Drug|1|||
48982383|NCT02996110|157767565|FG000|Track 2|Death|0|||
48982384|NCT02996110|157767566|FG001|Track 2|Death|0|||
48982385|NCT02996110|157767567|FG002|Track 2|Death|1|||
48982386|NCT02996110|157767568|FG003|Track 2|Death|0|||
48982387|NCT02996110|157767569|FG004|Track 2|Death|1|||
48982388|NCT02996110|157767565|FG000|Track 2|Study Drug Toxicity|4|||
48982389|NCT02996110|157767566|FG001|Track 2|Study Drug Toxicity|1|||
48982390|NCT02996110|157767567|FG002|Track 2|Study Drug Toxicity|4|||
48982391|NCT02996110|157767568|FG003|Track 2|Study Drug Toxicity|1|||
48982392|NCT02996110|157767569|FG004|Track 2|Study Drug Toxicity|0|||
48982393|NCT02996110|157767565|FG000|Track 2|Participant Requested to Discontinue Study Treatment|0|||
48982394|NCT02996110|157767566|FG001|Track 2|Participant Requested to Discontinue Study Treatment|0|||
48982395|NCT02996110|157767567|FG002|Track 2|Participant Requested to Discontinue Study Treatment|2|||
48982396|NCT02996110|157767568|FG003|Track 2|Participant Requested to Discontinue Study Treatment|1|||
48982397|NCT02996110|157767569|FG004|Track 2|Participant Requested to Discontinue Study Treatment|2|||
48982398|NCT02996110|157767565|FG000|Track 2|Participant Withdrew Consent|1|||
48982399|NCT02996110|157767566|FG001|Track 2|Participant Withdrew Consent|2|||
48982400|NCT02996110|157767567|FG002|Track 2|Participant Withdrew Consent|3|||
48982401|NCT02996110|157767568|FG003|Track 2|Participant Withdrew Consent|1|||
48982402|NCT02996110|157767569|FG004|Track 2|Participant Withdrew Consent|1|||
48982403|NCT02996110|157767565|FG000|Track 2|Other Reasons|0|||
48982404|NCT02996110|157767566|FG001|Track 2|Other Reasons|0|||
48982405|NCT02996110|157767567|FG002|Track 2|Other Reasons|1|||
48982406|NCT02996110|157767568|FG003|Track 2|Other Reasons|0|||
48982407|NCT02996110|157767569|FG004|Track 2|Other Reasons|1|||
48982408|NCT02471586|157767570|FG000|Overall Study|Lost to Follow-up|3|||
48982409|NCT02471586|157767571|FG001|Overall Study|Lost to Follow-up|8|||
48982410|NCT02471586|157767572|FG002|Overall Study|Lost to Follow-up|4|||
48982411|NCT02471586|157767570|FG000|Overall Study|Death|2|||
48982412|NCT02471586|157767571|FG001|Overall Study|Death|2|||
48982413|NCT02471586|157767572|FG002|Overall Study|Death|0|||
48982414|NCT02045979|157767573|FG000|Overall Study|Informed Consent Withdrawn|2|||
48982415|NCT02045979|157767574|FG001|Overall Study|Informed Consent Withdrawn|0|||
48982416|NCT02045979|157767575|FG002|Overall Study|Informed Consent Withdrawn|1|||
48982417|NCT02045979|157767573|FG000|Overall Study|not specified above|0|||
48773003|NCT03304379|157013208|FG003|Overall Study|Physician Decision|9|||
48773004|NCT03304379|157013209|FG004|Overall Study|Physician Decision|10|||
48773005|NCT03304379|157013205|FG000|Overall Study|Withdrawal by Subject|26|||
48773006|NCT03304379|157013206|FG001|Overall Study|Withdrawal by Subject|58|||
48773007|NCT03304379|157013207|FG002|Overall Study|Withdrawal by Subject|66|||
48773008|NCT03304379|157013208|FG003|Overall Study|Withdrawal by Subject|3|||
48773009|NCT03304379|157013209|FG004|Overall Study|Withdrawal by Subject|5|||
48773010|NCT03304379|157013205|FG000|Overall Study|Lost to Follow-up|8|||
48773011|NCT03304379|157013206|FG001|Overall Study|Lost to Follow-up|24|||
48773012|NCT03304379|157013207|FG002|Overall Study|Lost to Follow-up|35|||
48773013|NCT03304379|157013208|FG003|Overall Study|Lost to Follow-up|4|||
48773014|NCT03304379|157013209|FG004|Overall Study|Lost to Follow-up|0|||
48773015|NCT03304379|157013205|FG000|Overall Study|Death|1|||
48773016|NCT03304379|157013206|FG001|Overall Study|Death|2|||
48773017|NCT03304379|157013207|FG002|Overall Study|Death|0|||
48773018|NCT03304379|157013208|FG003|Overall Study|Death|0|||
48773019|NCT03304379|157013209|FG004|Overall Study|Death|0|||
48773020|NCT03304379|157013205|FG000|Overall Study|Other|0|||
48773021|NCT03304379|157013206|FG001|Overall Study|Other|1|||
48773022|NCT03304379|157013207|FG002|Overall Study|Other|0|||
48773023|NCT03304379|157013208|FG003|Overall Study|Other|0|||
48773024|NCT03304379|157013209|FG004|Overall Study|Other|0|||
48773025|NCT00179413|157013216|FG000|Overall Study|Adverse Event|38|||
48773026|NCT00179413|157013217|FG001|Overall Study|Adverse Event|20|||
48773027|NCT00179413|157013216|FG000|Overall Study|Withdrawal by Subject|87|||
48773028|NCT00179413|157013217|FG001|Overall Study|Withdrawal by Subject|95|||
48773029|NCT03027466|157013224|FG000|Overall Study|Opting out of the app|1869|||
48773030|NCT03027466|157013225|FG001|Overall Study|Opting out of the app|1819|||
48773031|NCT03027466|157013226|FG002|Overall Study|Opting out of the app|1743|||
48773032|NCT03027466|157013227|FG003|Overall Study|Opting out of the app|1821|||
48773033|NCT00094653|157013229|FG000|Overall Study|Death|306|||
48773034|NCT00094653|157013230|FG001|Overall Study|Death|100|||
48773035|NCT00094653|157013231|FG002|Overall Study|Death|119|||
48773036|NCT00094653|157013229|FG000|Overall Study|Subject Withdrew Consent|10|||
48773037|NCT00094653|157013230|FG001|Overall Study|Subject Withdrew Consent|2|||
48773038|NCT00094653|157013231|FG002|Overall Study|Subject Withdrew Consent|3|||
48773039|NCT00094653|157013229|FG000|Overall Study|Other|2|||
48773040|NCT00094653|157013230|FG001|Overall Study|Other|2|||
48773041|NCT00094653|157013231|FG002|Overall Study|Other|2|||
48773042|NCT00094653|157013229|FG000|Overall Study|Lost to Follow-up|3|||
48773043|NCT00094653|157013230|FG001|Overall Study|Lost to Follow-up|2|||
48773044|NCT00094653|157013231|FG002|Overall Study|Lost to Follow-up|1|||
48773045|NCT00094653|157013229|FG000|Overall Study|Protocol Violation|0|||
48773046|NCT00094653|157013230|FG001|Overall Study|Protocol Violation|0|||
48773047|NCT00094653|157013231|FG002|Overall Study|Protocol Violation|1|||
48773048|NCT00458484|157013232|FG000|Overall Study|Not eligible b/c prior radiation history|0|||
48773049|NCT00458484|157013233|FG001|Overall Study|Not eligible b/c prior radiation history|0|||
48982418|NCT02045979|157767574|FG001|Overall Study|not specified above|1|||
48982419|NCT02045979|157767575|FG002|Overall Study|not specified above|0|||
48982420|NCT01320033|157767576|FG000|Overall Study|Lack of Efficacy|0|||
48982421|NCT01320033|157767577|FG001|Overall Study|Lack of Efficacy|0|||
48982422|NCT01320033|157767578|FG002|Overall Study|Lack of Efficacy|1|||
48982423|NCT01320033|157767576|FG000|Overall Study|Adverse Event|9|||
48982424|NCT01320033|157767577|FG001|Overall Study|Adverse Event|7|||
48982425|NCT01320033|157767578|FG002|Overall Study|Adverse Event|8|||
48982426|NCT01320033|157767576|FG000|Overall Study|Withdrawal by Subject|22|||
48982427|NCT01320033|157767577|FG001|Overall Study|Withdrawal by Subject|23|||
48982428|NCT01320033|157767578|FG002|Overall Study|Withdrawal by Subject|23|||
48982429|NCT01320033|157767576|FG000|Overall Study|Protocol Violation|3|||
48982430|NCT01320033|157767577|FG001|Overall Study|Protocol Violation|5|||
48982431|NCT01320033|157767578|FG002|Overall Study|Protocol Violation|3|||
48982432|NCT01320033|157767576|FG000|Overall Study|Lost to Follow-up|22|||
48982433|NCT01320033|157767577|FG001|Overall Study|Lost to Follow-up|26|||
48982434|NCT01320033|157767578|FG002|Overall Study|Lost to Follow-up|17|||
48982435|NCT01320033|157767576|FG000|Overall Study|Other|2|||
48982436|NCT01320033|157767577|FG001|Overall Study|Other|3|||
48982437|NCT01320033|157767578|FG002|Overall Study|Other|1|||
48982438|NCT01938391|157767584|FG000|6 Month Follow up|Withdrawal by Subject|1|||
48982439|NCT01938391|157767584|FG000|12 Month Follow up|Physician Decision|1|||
48982440|NCT01938391|157767584|FG000|12 Month Follow up|Withdrawal by Subject|1|||
48982441|NCT02094612|157767596|FG000|Overall Study|Lost to Follow-up|47|||
48982442|NCT02094612|157767597|FG001|Overall Study|Lost to Follow-up|47|||
48982443|NCT02094612|157767596|FG000|Overall Study|Never started ADHD medication|32|||
48982444|NCT02094612|157767597|FG001|Overall Study|Never started ADHD medication|23|||
48982445|NCT00378534|157767598|FG000|Overall Study|Participants did not receive transplant|3|||
48982446|NCT00378534|157767599|FG001|Overall Study|Participants did not receive transplant|0|||
48982447|NCT03345849|157767600|FG000|Part 1: Induction Period (Weeks 1-12)|Adverse Event|8|||
48982448|NCT03345849|157767601|FG001|Part 1: Induction Period (Weeks 1-12)|Adverse Event|12|||
48982449|NCT03345849|157767602|FG002|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
48982450|NCT03345849|157767603|FG003|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
48982451|NCT03345849|157767600|FG000|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|6|||
48982452|NCT03345849|157767601|FG001|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|3|||
48773050|NCT00458484|157013234|FG002|Overall Study|Not eligible b/c prior radiation history|0|||
48773051|NCT00458484|157013235|FG003|Overall Study|Not eligible b/c prior radiation history|0|||
48773052|NCT00458484|157013236|FG004|Overall Study|Not eligible b/c prior radiation history|0|||
48773053|NCT00458484|157013237|FG005|Overall Study|Not eligible b/c prior radiation history|1|||
48773054|NCT00458484|157013238|FG006|Overall Study|Not eligible b/c prior radiation history|0|||
48773055|NCT01337297|157013239|FG000|Overall Study|They entered to single anodal tDCS|4|||
48773056|NCT01337297|157013240|FG001|Overall Study|They entered to single anodal tDCS|3|||
48773057|NCT01337297|157013239|FG000|Overall Study|Lost to Follow-up|1|||
48773058|NCT01337297|157013240|FG001|Overall Study|Lost to Follow-up|3|||
48773059|NCT02316717|157013241|FG000|Overall Study|Adverse Event|2|||
48773060|NCT02316717|157013242|FG001|Overall Study|Adverse Event|2|||
48773061|NCT02316717|157013243|FG002|Overall Study|Adverse Event|0|||
48773062|NCT02316717|157013241|FG000|Overall Study|Lost to Follow-up|1|||
48773063|NCT02316717|157013242|FG001|Overall Study|Lost to Follow-up|2|||
48773064|NCT02316717|157013243|FG002|Overall Study|Lost to Follow-up|1|||
48773065|NCT02316717|157013241|FG000|Overall Study|Non compliance|3|||
48773066|NCT02316717|157013242|FG001|Overall Study|Non compliance|1|||
48773067|NCT02316717|157013243|FG002|Overall Study|Non compliance|0|||
48876654|NCT02019641|157386581|FG000|20-Week Follow up|Withdrawal by investigator|0|||
48876655|NCT02019641|157386582|FG001|20-Week Follow up|Withdrawal by investigator|0|||
48773068|NCT02316717|157013241|FG000|Overall Study|Protocol Violation|2|||
48773069|NCT02316717|157013242|FG001|Overall Study|Protocol Violation|0|||
48773070|NCT02316717|157013243|FG002|Overall Study|Protocol Violation|0|||
48773071|NCT02316717|157013241|FG000|Overall Study|Withdrawal by Subject|2|||
48773072|NCT02316717|157013242|FG001|Overall Study|Withdrawal by Subject|1|||
48773073|NCT02316717|157013243|FG002|Overall Study|Withdrawal by Subject|1|||
48773074|NCT02316717|157013241|FG000|Overall Study|Death|0|||
48876656|NCT02019641|157386583|FG002|20-Week Follow up|Withdrawal by investigator|1|||
48876657|NCT03856047|157386584|FG000|Overall Study|Withdrawal by Subject|0|||
48876658|NCT03856047|157386585|FG001|Overall Study|Withdrawal by Subject|1|||
48876659|NCT03856047|157386586|FG002|Overall Study|Withdrawal by Subject|1|||
48876660|NCT03856047|157386587|FG003|Overall Study|Withdrawal by Subject|0|||
48876661|NCT03856047|157386588|FG004|Overall Study|Withdrawal by Subject|3|||
48876662|NCT03856047|157386589|FG005|Overall Study|Withdrawal by Subject|0|||
48876663|NCT03856047|157386590|FG006|Overall Study|Withdrawal by Subject|2|||
48876664|NCT03856047|157386584|FG000|Overall Study|Lost to Follow-up|4|||
48876665|NCT03856047|157386585|FG001|Overall Study|Lost to Follow-up|2|||
48876666|NCT03856047|157386586|FG002|Overall Study|Lost to Follow-up|3|||
48876667|NCT03856047|157386587|FG003|Overall Study|Lost to Follow-up|1|||
48982453|NCT03345849|157767602|FG002|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
48982454|NCT03345849|157767603|FG003|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
48773075|NCT02316717|157013242|FG001|Overall Study|Death|0|||
48773076|NCT02316717|157013243|FG002|Overall Study|Death|1|||
48773077|NCT02316717|157013241|FG000|Overall Study|Physician Decision|0|||
48773078|NCT02316717|157013242|FG001|Overall Study|Physician Decision|1|||
48773079|NCT02316717|157013243|FG002|Overall Study|Physician Decision|0|||
48773080|NCT02316717|157013241|FG000|Overall Study|TBC|1|||
48773081|NCT02316717|157013242|FG001|Overall Study|TBC|0|||
48982455|NCT03345849|157767600|FG000|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
48982456|NCT03345849|157767601|FG001|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|1|||
48982457|NCT03345849|157767602|FG002|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
48982458|NCT03345849|157767603|FG003|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
48982459|NCT03345849|157767600|FG000|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|8|||
48982460|NCT03345849|157767601|FG001|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|3|||
48982461|NCT03345849|157767602|FG002|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
48982462|NCT03345849|157767603|FG003|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
48982463|NCT03345849|157767600|FG000|Part 1: Induction Period (Weeks 1-12)|Other|0|||
48982464|NCT03345849|157767601|FG001|Part 1: Induction Period (Weeks 1-12)|Other|1|||
48982465|NCT03345849|157767602|FG002|Part 1: Induction Period (Weeks 1-12)|Other|0|||
48982466|NCT03345849|157767603|FG003|Part 1: Induction Period (Weeks 1-12)|Other|0|||
48982467|NCT03345849|157767600|FG000|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
48982468|NCT03345849|157767601|FG001|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
48982469|NCT03345849|157767602|FG002|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
48982470|NCT03345849|157767603|FG003|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
48982471|NCT03345849|157767600|FG000|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
48982472|NCT03345849|157767601|FG001|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
48982473|NCT03345849|157767602|FG002|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|3|||
49027164|NCT01185821|157937622|FG002|Overall Study|Protocol Violation|0|||
48773082|NCT02316717|157013243|FG002|Overall Study|TBC|0|||
48876668|NCT03856047|157386588|FG004|Overall Study|Lost to Follow-up|4|||
48876669|NCT03856047|157386589|FG005|Overall Study|Lost to Follow-up|4|||
48876670|NCT03856047|157386590|FG006|Overall Study|Lost to Follow-up|4|||
48876671|NCT04016805|157386591|FG000|Overall Study|Sponsor's Discretion|30|||
48876672|NCT04016805|157386592|FG001|Overall Study|Sponsor's Discretion|6|||
48773083|NCT00004031|157013246|FG000|Overall Study|Adverse Event|5|||
48773084|NCT00004031|157013247|FG001|Overall Study|Adverse Event|0|||
48773085|NCT00004031|157013246|FG000|Overall Study|Refusal unrelated to adverse events|2|||
48773086|NCT00004031|157013247|FG001|Overall Study|Refusal unrelated to adverse events|11|||
49027165|NCT01185821|157937623|FG003|Overall Study|Protocol Violation|1|||
49027166|NCT01185821|157937624|FG004|Overall Study|Protocol Violation|1|||
49027167|NCT01185821|157937620|FG000|Overall Study|Abnormal test procedure result|0|||
49027168|NCT01185821|157937621|FG001|Overall Study|Abnormal test procedure result|0|||
49027169|NCT01185821|157937622|FG002|Overall Study|Abnormal test procedure result|0|||
48773087|NCT00004031|157013246|FG000|Overall Study|Progression/relapse|9|||
49027170|NCT01185821|157937623|FG003|Overall Study|Abnormal test procedure result|0|||
49027171|NCT01185821|157937624|FG004|Overall Study|Abnormal test procedure result|1|||
49027172|NCT01185821|157937620|FG000|Overall Study|Death|0|||
49027173|NCT01185821|157937621|FG001|Overall Study|Death|1|||
49027174|NCT01185821|157937622|FG002|Overall Study|Death|0|||
49027175|NCT01185821|157937623|FG003|Overall Study|Death|0|||
49027176|NCT01185821|157937624|FG004|Overall Study|Death|0|||
49027177|NCT01185821|157937620|FG000|Overall Study|Condition no longer required study drug|0|||
49027178|NCT01185821|157937621|FG001|Overall Study|Condition no longer required study drug|0|||
49027179|NCT01185821|157937622|FG002|Overall Study|Condition no longer required study drug|0|||
49027180|NCT01185821|157937623|FG003|Overall Study|Condition no longer required study drug|0|||
49027181|NCT01185821|157937624|FG004|Overall Study|Condition no longer required study drug|1|||
49027182|NCT01185821|157937620|FG000|Overall Study|Adverse Event|2|||
49027183|NCT01185821|157937621|FG001|Overall Study|Adverse Event|3|||
49027184|NCT01185821|157937622|FG002|Overall Study|Adverse Event|1|||
49027185|NCT01185821|157937623|FG003|Overall Study|Adverse Event|2|||
49027186|NCT01185821|157937624|FG004|Overall Study|Adverse Event|5|||
49027187|NCT01185821|157937620|FG000|Overall Study|Lack of Efficacy|0|||
49027188|NCT01185821|157937621|FG001|Overall Study|Lack of Efficacy|0|||
49027189|NCT01185821|157937622|FG002|Overall Study|Lack of Efficacy|3|||
48773088|NCT00004031|157013247|FG001|Overall Study|Progression/relapse|4|||
48773089|NCT00004031|157013246|FG000|Overall Study|Death|3|||
48773090|NCT00004031|157013247|FG001|Overall Study|Death|1|||
48773091|NCT00004031|157013246|FG000|Overall Study|Other- not protocol specified|3|||
48773092|NCT00004031|157013247|FG001|Overall Study|Other- not protocol specified|3|||
49027190|NCT01185821|157937623|FG003|Overall Study|Lack of Efficacy|0|||
49027191|NCT01185821|157937624|FG004|Overall Study|Lack of Efficacy|9|||
49027192|NCT01185821|157937620|FG000|Overall Study|Withdrawal by Subject|3|||
49027193|NCT01185821|157937621|FG001|Overall Study|Withdrawal by Subject|2|||
49027194|NCT01185821|157937622|FG002|Overall Study|Withdrawal by Subject|2|||
49027195|NCT01185821|157937623|FG003|Overall Study|Withdrawal by Subject|1|||
49027196|NCT01185821|157937624|FG004|Overall Study|Withdrawal by Subject|3|||
49027197|NCT01185821|157937620|FG000|Overall Study|Lost to Follow-up|1|||
49027198|NCT01185821|157937621|FG001|Overall Study|Lost to Follow-up|1|||
49027199|NCT01185821|157937622|FG002|Overall Study|Lost to Follow-up|2|||
49027200|NCT01185821|157937623|FG003|Overall Study|Lost to Follow-up|1|||
49027201|NCT01185821|157937624|FG004|Overall Study|Lost to Follow-up|2|||
49027202|NCT01185821|157937620|FG000|Overall Study|Administrative problems|0|||
49027203|NCT01185821|157937621|FG001|Overall Study|Administrative problems|0|||
49027204|NCT01185821|157937622|FG002|Overall Study|Administrative problems|1|||
49027205|NCT01185821|157937623|FG003|Overall Study|Administrative problems|1|||
49027206|NCT01185821|157937624|FG004|Overall Study|Administrative problems|2|||
49027207|NCT00735904|157937625|FG000|Overall Study|Adverse Event|3|||
49027208|NCT00735904|157937625|FG000|Overall Study|Death|20|||
49027209|NCT00735904|157937625|FG000|Overall Study|Protocol Violation|1|||
49027210|NCT00735904|157937625|FG000|Overall Study|Withdrawal by Subject|1|||
49027211|NCT00735904|157937625|FG000|Overall Study|Study Terminated by Sponsor|5|||
49027212|NCT00735904|157937625|FG000|Overall Study|Other|8|||
49027213|NCT04625413|157937626|FG000|Overall Study|Hospice|2|||
49027214|NCT04625413|157937626|FG000|Overall Study|Distress|1|||
49027215|NCT04625413|157937626|FG000|Overall Study|Not feeling well|1|||
49027216|NCT02612337|157937629|FG000|Overall Study|Lack of Efficacy|1|||
48773093|NCT00004031|157013246|FG000|Overall Study|Reason under review|3|||
48773094|NCT00004031|157013247|FG001|Overall Study|Reason under review|2|||
48773095|NCT00853658|157013248|FG000|Overall Study|Death|713|||
49027217|NCT02612337|157937630|FG001|Overall Study|Lack of Efficacy|0|||
49027218|NCT02612337|157937629|FG000|Overall Study|Withdrawal by Subject|2|||
49027219|NCT02612337|157937630|FG001|Overall Study|Withdrawal by Subject|2|||
48773096|NCT00853658|157013249|FG001|Overall Study|Death|768|||
48773097|NCT00853658|157013250|FG002|Overall Study|Death|753|||
49027220|NCT02612337|157937629|FG000|Overall Study|Did not receive study drug|0|||
48773098|NCT00853658|157013248|FG000|Overall Study|Lost to Follow-up|11|||
49027221|NCT02612337|157937630|FG001|Overall Study|Did not receive study drug|1|||
49027222|NCT02441309|157937631|FG000|Overall Study|Disease progression|2|||
49027223|NCT02441309|157937632|FG001|Overall Study|Disease progression|1|||
49027224|NCT02441309|157937633|FG002|Overall Study|Disease progression|2|||
49027225|NCT02441309|157937631|FG000|Overall Study|Adverse Event|0|||
49027226|NCT02441309|157937632|FG001|Overall Study|Adverse Event|1|||
48773099|NCT00853658|157013249|FG001|Overall Study|Lost to Follow-up|6|||
48773100|NCT00853658|157013250|FG002|Overall Study|Lost to Follow-up|11|||
48773101|NCT00853658|157013248|FG000|Overall Study|H.A. Request|26|||
48773102|NCT00853658|157013249|FG001|Overall Study|H.A. Request|23|||
48773103|NCT00853658|157013250|FG002|Overall Study|H.A. Request|19|||
48773104|NCT00853658|157013248|FG000|Overall Study|IRB request|0|||
48773105|NCT00853658|157013249|FG001|Overall Study|IRB request|0|||
48773106|NCT00853658|157013250|FG002|Overall Study|IRB request|2|||
48876673|NCT04016805|157386593|FG002|Overall Study|Sponsor's Discretion|5|||
48876674|NCT01101061|157386594|FG000|Overall Study|Adverse Event|0|||
48876675|NCT01101061|157386595|FG001|Overall Study|Adverse Event|0|||
48876676|NCT01101061|157386596|FG002|Overall Study|Adverse Event|1|||
48773107|NCT00853658|157013248|FG000|Overall Study|Vital Status known (alive) at study end|2|||
48773108|NCT00853658|157013249|FG001|Overall Study|Vital Status known (alive) at study end|3|||
48773109|NCT00853658|157013250|FG002|Overall Study|Vital Status known (alive) at study end|3|||
48773110|NCT00853658|157013248|FG000|Overall Study|Vital Status unknown at study end|1|||
48773111|NCT00853658|157013249|FG001|Overall Study|Vital Status unknown at study end|1|||
48773112|NCT00853658|157013250|FG002|Overall Study|Vital Status unknown at study end|0|||
48773113|NCT00853658|157013248|FG000|Overall Study|Vital Status at study end N/A|8|||
48773114|NCT00853658|157013249|FG001|Overall Study|Vital Status at study end N/A|10|||
48773115|NCT00853658|157013250|FG002|Overall Study|Vital Status at study end N/A|10|||
48773116|NCT00853658|157013248|FG000|Overall Study|Patient's request|21|||
48773117|NCT00853658|157013249|FG001|Overall Study|Patient's request|17|||
48773118|NCT00853658|157013250|FG002|Overall Study|Patient's request|11|||
48773119|NCT00853658|157013248|FG000|Overall Study|Missing study completion information|5|||
48773120|NCT00853658|157013249|FG001|Overall Study|Missing study completion information|4|||
48773121|NCT00853658|157013250|FG002|Overall Study|Missing study completion information|6|||
48773122|NCT03146650|157013251|FG000|Registered for Study|Did not continue to meet protocol eligibility criteria after registration.|1|||
48773123|NCT03146650|157013251|FG000|Completed Cycle 1 of Treatment(Nivo+Ipi)|Adverse Event|1|||
48773124|NCT03146650|157013251|FG000|Continued to Cycle 2 and Beyond|Still on treatment|2|||
48773125|NCT03146650|157013251|FG000|Continued to Cycle 2 and Beyond|Progressive Disease|2|||
48773126|NCT03146650|157013251|FG000|2 Year Follow-up|Death|11|||
48773127|NCT03146650|157013251|FG000|2 Year Follow-up|Still in follow-up|7|||
48773128|NCT03146650|157013251|FG000|2 Year Follow-up|Lost to Follow-up|1|||
48773129|NCT03548584|157014763|FG000|Overall Study|Lost to Follow-up|0|||
48773130|NCT03548584|157014764|FG001|Overall Study|Lost to Follow-up|0|||
48773131|NCT03548584|157014765|FG002|Overall Study|Lost to Follow-up|1|||
48773132|NCT03548584|157014763|FG000|Overall Study|Adverse Event|1|||
48773133|NCT03548584|157014764|FG001|Overall Study|Adverse Event|11|||
48876677|NCT01101061|157386597|FG003|Overall Study|Adverse Event|0|||
48876678|NCT01101061|157386598|FG004|Overall Study|Adverse Event|0|||
48876679|NCT01101061|157386599|FG005|Overall Study|Adverse Event|0|||
48876680|NCT00770588|157386608|FG000|Overall Study|Adverse Event|9|||
48876681|NCT00770588|157386609|FG001|Overall Study|Adverse Event|2|||
48876682|NCT00770588|157386608|FG000|Overall Study|Death caused by progression of disease|70|||
48876683|NCT00770588|157386609|FG001|Overall Study|Death caused by progression of disease|91|||
48876684|NCT00770588|157386608|FG000|Overall Study|Lost to Follow-up|1|||
48876685|NCT00770588|157386609|FG001|Overall Study|Lost to Follow-up|1|||
48876686|NCT00770588|157386608|FG000|Overall Study|Withdrawal by Subject|1|||
48876687|NCT00770588|157386609|FG001|Overall Study|Withdrawal by Subject|1|||
48876688|NCT01426113|157386610|FG000|Overall Study|Study Discontinued|1|||
48876689|NCT01426113|157386611|FG001|Overall Study|Study Discontinued|1|||
48876690|NCT01426113|157386610|FG000|Overall Study|Adverse Event|0|||
48876691|NCT01426113|157386611|FG001|Overall Study|Adverse Event|1|||
48876692|NCT02485899|157386612|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
48876693|NCT02485899|157386613|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
48876694|NCT02485899|157386612|FG000|Overall Study|Withdrawal by Subject|1|||
48876695|NCT02485899|157386613|FG001|Overall Study|Withdrawal by Subject|0|||
48876696|NCT02485899|157386612|FG000|Overall Study|Withdrawal by Parent/ Guardian|4|||
48876697|NCT02485899|157386613|FG001|Overall Study|Withdrawal by Parent/ Guardian|0|||
48876698|NCT01834586|157386614|FG000|Overall Study|Adverse Event|1|||
48876699|NCT00732992|157386615|FG000|Overall Study|Adverse Event|1|||
48773134|NCT03548584|157014765|FG002|Overall Study|Adverse Event|5|||
48773135|NCT03548584|157014763|FG000|Overall Study|Site Terminated by Sponsor|1|||
48773136|NCT03548584|157014764|FG001|Overall Study|Site Terminated by Sponsor|3|||
48773137|NCT03548584|157014765|FG002|Overall Study|Site Terminated by Sponsor|2|||
48773138|NCT03548584|157014763|FG000|Overall Study|Subject Withdrew Consent to Participate|5|||
48876700|NCT00732992|157386616|FG001|Overall Study|Adverse Event|1|||
48876701|NCT00732992|157386615|FG000|Overall Study|Objective Progression or Relapse|3|||
48876702|NCT00732992|157386616|FG001|Overall Study|Objective Progression or Relapse|5|||
48876703|NCT00732992|157386615|FG000|Overall Study|Global Deterioration of Health Status|1|||
48876704|NCT00732992|157386616|FG001|Overall Study|Global Deterioration of Health Status|0|||
48876705|NCT00732992|157386615|FG000|Overall Study|Withdrawal by Subject|1|||
48876706|NCT00732992|157386616|FG001|Overall Study|Withdrawal by Subject|0|||
48773139|NCT03548584|157014764|FG001|Overall Study|Subject Withdrew Consent to Participate|5|||
48773140|NCT03548584|157014765|FG002|Overall Study|Subject Withdrew Consent to Participate|3|||
48773141|NCT03548584|157014763|FG000|Overall Study|Lack of Efficacy|0|||
48773142|NCT03548584|157014764|FG001|Overall Study|Lack of Efficacy|1|||
48773143|NCT03548584|157014765|FG002|Overall Study|Lack of Efficacy|0|||
48773144|NCT03548584|157014763|FG000|Overall Study|Non-compliance with Study Drug|0|||
48773145|NCT03548584|157014764|FG001|Overall Study|Non-compliance with Study Drug|1|||
48773146|NCT03548584|157014765|FG002|Overall Study|Non-compliance with Study Drug|0|||
48773147|NCT03548584|157014763|FG000|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|0|||
48773148|NCT03548584|157014764|FG001|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
48773149|NCT03548584|157014765|FG002|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
48773150|NCT04524403|157014766|FG000|Overall Study|Withdrawal by Subject|10|||
48773151|NCT04524403|157014767|FG001|Overall Study|Withdrawal by Subject|3|||
48773152|NCT04524403|157014768|FG002|Overall Study|Withdrawal by Subject|8|||
48773153|NCT04524403|157014766|FG000|Overall Study|Lost to Follow-up|3|||
48773154|NCT04524403|157014767|FG001|Overall Study|Lost to Follow-up|4|||
48773155|NCT04524403|157014768|FG002|Overall Study|Lost to Follow-up|3|||
48773156|NCT04524403|157014766|FG000|Overall Study|Adverse Event|3|||
48773157|NCT04524403|157014767|FG001|Overall Study|Adverse Event|1|||
49027227|NCT02441309|157937633|FG002|Overall Study|Adverse Event|0|||
49027228|NCT02441309|157937631|FG000|Overall Study|Withdrawal by Subject|1|||
49027229|NCT02441309|157937632|FG001|Overall Study|Withdrawal by Subject|0|||
49027230|NCT02441309|157937633|FG002|Overall Study|Withdrawal by Subject|1|||
49027231|NCT00854100|157937634|FG000|Overall Study|Inability to complete the study visits|0|||
49027232|NCT00854100|157937635|FG001|Overall Study|Inability to complete the study visits|0|||
49027233|NCT00854100|157937636|FG002|Overall Study|Inability to complete the study visits|1|||
49027234|NCT00854100|157937634|FG000|Overall Study|Lost to Follow-up|2|||
49027235|NCT00854100|157937635|FG001|Overall Study|Lost to Follow-up|0|||
49027236|NCT00854100|157937636|FG002|Overall Study|Lost to Follow-up|3|||
49027237|NCT00854100|157937634|FG000|Overall Study|Withdrawal by Subject|3|||
49027238|NCT00854100|157937635|FG001|Overall Study|Withdrawal by Subject|1|||
49027239|NCT00854100|157937636|FG002|Overall Study|Withdrawal by Subject|2|||
49027240|NCT00854100|157937634|FG000|Overall Study|Protocol Violation|2|||
49027241|NCT00854100|157937635|FG001|Overall Study|Protocol Violation|4|||
49027242|NCT00854100|157937636|FG002|Overall Study|Protocol Violation|3|||
49027243|NCT00854100|157937634|FG000|Overall Study|Adverse Event|2|||
49027244|NCT00854100|157937635|FG001|Overall Study|Adverse Event|1|||
48773158|NCT04524403|157014768|FG002|Overall Study|Adverse Event|4|||
48773159|NCT04524403|157014766|FG000|Overall Study|Non-compliant with study drug|1|||
49027245|NCT00854100|157937636|FG002|Overall Study|Adverse Event|2|||
48773160|NCT04524403|157014767|FG001|Overall Study|Non-compliant with study drug|2|||
48773161|NCT04524403|157014768|FG002|Overall Study|Non-compliant with study drug|3|||
48773162|NCT04524403|157014766|FG000|Overall Study|Moved|0|||
48773163|NCT04524403|157014767|FG001|Overall Study|Moved|1|||
48773164|NCT04524403|157014768|FG002|Overall Study|Moved|0|||
48773165|NCT01707004|157014770|FG000|Overall Study|Physician Decision|3|||
48773166|NCT00589108|157014771|FG000|Overall Study|Lost to Follow-up|1|||
48773167|NCT00589108|157014772|FG001|Overall Study|Lost to Follow-up|1|||
48773168|NCT00589108|157014773|FG002|Overall Study|Lost to Follow-up|1|||
48773169|NCT00589108|157014771|FG000|Overall Study|Death|3|||
48773170|NCT00589108|157014772|FG001|Overall Study|Death|3|||
48773171|NCT00589108|157014773|FG002|Overall Study|Death|4|||
48773172|NCT00727194|157014774|FG000|Screening Period|Low QMG scores|0|||
48773173|NCT00727194|157014775|FG001|Screening Period|Low QMG scores|0|||
48773174|NCT00727194|157014776|FG002|Screening Period|Low QMG scores|6|||
48773175|NCT00727194|157014774|FG000|Screening Period|Lacked AChR antibodies|0|||
48773176|NCT00727194|157014775|FG001|Screening Period|Lacked AChR antibodies|0|||
48773177|NCT00727194|157014776|FG002|Screening Period|Lacked AChR antibodies|5|||
48773178|NCT00727194|157014774|FG000|Screening Period|Not stable on concomitant MG therapy|0|||
48773179|NCT00727194|157014775|FG001|Screening Period|Not stable on concomitant MG therapy|0|||
48773180|NCT00727194|157014776|FG002|Screening Period|Not stable on concomitant MG therapy|2|||
48773181|NCT00727194|157014774|FG000|Screening Period|Severe infections|0|||
48773182|NCT00727194|157014775|FG001|Screening Period|Severe infections|0|||
48773183|NCT00727194|157014776|FG002|Screening Period|Severe infections|2|||
48773184|NCT00727194|157014774|FG000|Screening Period|History of thymoma|0|||
48773185|NCT00727194|157014775|FG001|Screening Period|History of thymoma|0|||
48773186|NCT00727194|157014776|FG002|Screening Period|History of thymoma|1|||
48773187|NCT00727194|157014774|FG000|Treatment Period 2|Lack of Efficacy|0|||
48773188|NCT00727194|157014775|FG001|Treatment Period 2|Lack of Efficacy|1|||
48773189|NCT00727194|157014776|FG002|Treatment Period 2|Lack of Efficacy|0|||
48773190|NCT02472756|157014777|FG000|Induction (Approximately 6 Months)|Adverse Event|1|||
49027246|NCT02395822|157939060|FG000|Overall Study|Withdrawal by Subject|1|||
49027247|NCT02395822|157939060|FG000|Overall Study|Death|1|||
49027248|NCT01248247|157939067|FG000|Overall Study|Adverse Event|2|||
48773191|NCT02472756|157014777|FG000|Induction (Approximately 6 Months)|Enrolled But Not Treated|1|||
48773192|NCT02472756|157014777|FG000|Maintenance (Approximately 2 Years)|Lack of Drug|7|||
48773193|NCT02472756|157014777|FG000|Maintenance (Approximately 2 Years)|Progression Disease|2|||
48773194|NCT02472756|157014777|FG000|Maintenance (Approximately 2 Years)|Adverse Event|1|||
48773195|NCT00978731|157014779|FG000|Overall Study|Death|4|||
48773196|NCT00978731|157014780|FG001|Overall Study|Death|1|||
48773197|NCT00978731|157014781|FG002|Overall Study|Death|1|||
48773198|NCT00978731|157014782|FG003|Overall Study|Death|0|||
48773199|NCT00978731|157014779|FG000|Overall Study|Lost to Follow-up|0|||
48773200|NCT00978731|157014780|FG001|Overall Study|Lost to Follow-up|0|||
48773201|NCT00978731|157014781|FG002|Overall Study|Lost to Follow-up|0|||
48773202|NCT00978731|157014782|FG003|Overall Study|Lost to Follow-up|1|||
48773203|NCT00978731|157014779|FG000|Overall Study|Adverse Event|5|||
49027249|NCT01248247|157939068|FG001|Overall Study|Adverse Event|4|||
49027250|NCT01248247|157939069|FG002|Overall Study|Adverse Event|4|||
49027251|NCT01248247|157939070|FG003|Overall Study|Adverse Event|2|||
49027252|NCT01248247|157939067|FG000|Overall Study|Death|0|||
49027253|NCT01248247|157939068|FG001|Overall Study|Death|1|||
49027254|NCT01248247|157939069|FG002|Overall Study|Death|4|||
49027255|NCT01248247|157939070|FG003|Overall Study|Death|7|||
49027256|NCT01248247|157939067|FG000|Overall Study|Lost to Follow-up|0|||
49027257|NCT01248247|157939068|FG001|Overall Study|Lost to Follow-up|1|||
49027258|NCT01248247|157939069|FG002|Overall Study|Lost to Follow-up|1|||
49027259|NCT01248247|157939070|FG003|Overall Study|Lost to Follow-up|0|||
49027260|NCT01248247|157939067|FG000|Overall Study|Alternative treatment|0|||
49027261|NCT01248247|157939068|FG001|Overall Study|Alternative treatment|1|||
49027262|NCT01248247|157939069|FG002|Overall Study|Alternative treatment|0|||
49027263|NCT01248247|157939070|FG003|Overall Study|Alternative treatment|0|||
49027264|NCT01248247|157939067|FG000|Overall Study|Other|2|||
49027265|NCT01248247|157939068|FG001|Overall Study|Other|8|||
49027266|NCT01248247|157939069|FG002|Overall Study|Other|8|||
49027267|NCT01248247|157939070|FG003|Overall Study|Other|5|||
49027268|NCT01248247|157939067|FG000|Overall Study|Progression|18|||
49027269|NCT01248247|157939068|FG001|Overall Study|Progression|27|||
49027270|NCT01248247|157939069|FG002|Overall Study|Progression|56|||
49027271|NCT01248247|157939070|FG003|Overall Study|Progression|44|||
49027272|NCT01248247|157939067|FG000|Overall Study|Refuse further treatment|0|||
49027273|NCT01248247|157939068|FG001|Overall Study|Refuse further treatment|0|||
49027274|NCT01248247|157939069|FG002|Overall Study|Refuse further treatment|1|||
49027275|NCT01248247|157939070|FG003|Overall Study|Refuse further treatment|2|||
49027276|NCT01248247|157939067|FG000|Overall Study|Complicating disease|0|||
49027277|NCT01248247|157939068|FG001|Overall Study|Complicating disease|0|||
49027278|NCT01248247|157939069|FG002|Overall Study|Complicating disease|1|||
49027279|NCT01248247|157939070|FG003|Overall Study|Complicating disease|1|||
49027280|NCT00880568|157939073|FG000|Overall Study|Disease progression|3|||
49027281|NCT00880568|157939074|FG001|Overall Study|Disease progression|3|||
49027282|NCT00880568|157939075|FG002|Overall Study|Disease progression|3|||
49027283|NCT00880568|157939076|FG003|Overall Study|Disease progression|1|||
49027284|NCT00880568|157939077|FG004|Overall Study|Disease progression|3|||
49027285|NCT00880568|157939078|FG005|Overall Study|Disease progression|3|||
49027286|NCT00880568|157939079|FG006|Overall Study|Disease progression|5|||
49027287|NCT00880568|157939080|FG007|Overall Study|Disease progression|0|||
49027288|NCT00880568|157939081|FG008|Overall Study|Disease progression|3|||
49027289|NCT00880568|157939073|FG000|Overall Study|Adverse Event|0|||
49027290|NCT00880568|157939074|FG001|Overall Study|Adverse Event|0|||
49027291|NCT00880568|157939075|FG002|Overall Study|Adverse Event|0|||
49027292|NCT00880568|157939076|FG003|Overall Study|Adverse Event|0|||
49027293|NCT00880568|157939077|FG004|Overall Study|Adverse Event|0|||
49027294|NCT00880568|157939078|FG005|Overall Study|Adverse Event|0|||
49027295|NCT00880568|157939079|FG006|Overall Study|Adverse Event|1|||
49027296|NCT00880568|157939080|FG007|Overall Study|Adverse Event|1|||
49027297|NCT00880568|157939081|FG008|Overall Study|Adverse Event|0|||
49027298|NCT00880568|157939073|FG000|Overall Study|Withdrawal by Subject|0|||
49027299|NCT00880568|157939074|FG001|Overall Study|Withdrawal by Subject|0|||
49027300|NCT00880568|157939075|FG002|Overall Study|Withdrawal by Subject|0|||
49027301|NCT00880568|157939076|FG003|Overall Study|Withdrawal by Subject|0|||
49027302|NCT00880568|157939077|FG004|Overall Study|Withdrawal by Subject|0|||
49027303|NCT00880568|157939078|FG005|Overall Study|Withdrawal by Subject|0|||
49027304|NCT00880568|157939079|FG006|Overall Study|Withdrawal by Subject|0|||
49027305|NCT00880568|157939080|FG007|Overall Study|Withdrawal by Subject|1|||
49027306|NCT00880568|157939081|FG008|Overall Study|Withdrawal by Subject|0|||
48773204|NCT00978731|157014780|FG001|Overall Study|Adverse Event|2|||
48773205|NCT00978731|157014781|FG002|Overall Study|Adverse Event|0|||
48773206|NCT00978731|157014782|FG003|Overall Study|Adverse Event|0|||
48773207|NCT00978731|157014779|FG000|Overall Study|Participant's request|1|||
48773208|NCT00978731|157014780|FG001|Overall Study|Participant's request|0|||
49027307|NCT01720264|157939085|FG000|Transplant With Sitagliptin for 15 Days|Adverse Event|1|||
48773209|NCT00978731|157014781|FG002|Overall Study|Participant's request|0|||
49027308|NCT01720264|157939085|FG000|Post-transplant (Day 16) to 1 Year|Death|8|||
49027309|NCT01720264|157939085|FG000|Post-transplant (Day 16) to 1 Year|Disease Progression|4|||
48773210|NCT00978731|157014782|FG003|Overall Study|Participant's request|0|||
48773211|NCT00978731|157014779|FG000|Overall Study|Administrative reason|3|||
48773212|NCT00978731|157014780|FG001|Overall Study|Administrative reason|3|||
48773213|NCT00978731|157014781|FG002|Overall Study|Administrative reason|1|||
48773214|NCT00978731|157014782|FG003|Overall Study|Administrative reason|0|||
48773215|NCT00978731|157014779|FG000|Overall Study|Deterioration without progression|0|||
48773216|NCT00978731|157014780|FG001|Overall Study|Deterioration without progression|1|||
48773217|NCT00978731|157014781|FG002|Overall Study|Deterioration without progression|0|||
48773218|NCT00978731|157014782|FG003|Overall Study|Deterioration without progression|0|||
48773219|NCT00978731|157014779|FG000|Overall Study|Disease progression/relapse|5|||
48773220|NCT00978731|157014780|FG001|Overall Study|Disease progression/relapse|4|||
48773221|NCT00978731|157014781|FG002|Overall Study|Disease progression/relapse|2|||
48773222|NCT00978731|157014782|FG003|Overall Study|Disease progression/relapse|2|||
48773223|NCT00978731|157014779|FG000|Overall Study|Study closure|3|||
48773224|NCT00978731|157014780|FG001|Overall Study|Study closure|4|||
48773225|NCT00978731|157014781|FG002|Overall Study|Study closure|1|||
48773226|NCT00978731|157014782|FG003|Overall Study|Study closure|1|||
48773227|NCT00978731|157014779|FG000|Overall Study|No response|1|||
48773228|NCT00978731|157014780|FG001|Overall Study|No response|0|||
48773229|NCT00978731|157014781|FG002|Overall Study|No response|0|||
48773230|NCT00978731|157014782|FG003|Overall Study|No response|0|||
48773231|NCT00110266|157014783|FG000|Overall Study|Adverse Event|27|||
48773232|NCT00110266|157014783|FG000|Overall Study|Abnormal laboratory value|15|||
48773233|NCT00110266|157014783|FG000|Overall Study|Withdrawal by Subject|16|||
48773234|NCT00110266|157014783|FG000|Overall Study|Death|17|||
48773235|NCT00110266|157014783|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
48773236|NCT00110266|157014783|FG000|Overall Study|Participant condition no longer requires study drug|1|||
48773237|NCT02097134|157014784|FG000|Overall Study|Physician Decision|4|||
48773238|NCT02097134|157014784|FG000|Overall Study|Non-Protocol Therapy|1|||
48773239|NCT02097134|157014784|FG000|Overall Study|Progressive Disease|3|||
48773240|NCT02097134|157014784|FG000|Overall Study|Refusal of Further Protocol Therapy|1|||
48773241|NCT02896400|157014785|FG000|1 Month Follow-up|Lost to Follow-up|7|||
48773242|NCT02896400|157014786|FG001|1 Month Follow-up|Lost to Follow-up|7|||
48773243|NCT02896400|157014787|FG002|1 Month Follow-up|Lost to Follow-up|5|||
48773244|NCT02896400|157014788|FG003|1 Month Follow-up|Lost to Follow-up|8|||
48773245|NCT02896400|157014789|FG004|1 Month Follow-up|Lost to Follow-up|9|||
48773246|NCT02896400|157014790|FG005|1 Month Follow-up|Lost to Follow-up|6|||
48773247|NCT02896400|157014791|FG006|1 Month Follow-up|Lost to Follow-up|5|||
48773248|NCT02896400|157014792|FG007|1 Month Follow-up|Lost to Follow-up|6|||
48773249|NCT02896400|157014793|FG008|1 Month Follow-up|Lost to Follow-up|4|||
48773250|NCT02896400|157014794|FG009|1 Month Follow-up|Lost to Follow-up|7|||
48773251|NCT02896400|157014795|FG010|1 Month Follow-up|Lost to Follow-up|5|||
48773252|NCT02896400|157014796|FG011|1 Month Follow-up|Lost to Follow-up|5|||
48876707|NCT01667549|157386621|FG000|Overall Study|Withdrawal by Subject|3|||
48876708|NCT01667549|157386622|FG001|Overall Study|Withdrawal by Subject|5|||
48876709|NCT01667549|157386623|FG002|Overall Study|Withdrawal by Subject|7|||
48876710|NCT01667549|157386624|FG003|Overall Study|Withdrawal by Subject|6|||
48876711|NCT01667549|157386625|FG004|Overall Study|Withdrawal by Subject|1|||
48876712|NCT01130168|157386626|FG000|Period 1|Withdrawal by Subject|0|||
48773253|NCT02896400|157014797|FG012|1 Month Follow-up|Lost to Follow-up|3|||
48773254|NCT02896400|157014798|FG013|1 Month Follow-up|Lost to Follow-up|4|||
48773255|NCT02896400|157014799|FG014|1 Month Follow-up|Lost to Follow-up|1|||
48773256|NCT02896400|157014800|FG015|1 Month Follow-up|Lost to Follow-up|2|||
48773257|NCT02896400|157014785|FG000|1 Month Follow-up|Death|0|||
48773258|NCT02896400|157014786|FG001|1 Month Follow-up|Death|0|||
48773259|NCT02896400|157014787|FG002|1 Month Follow-up|Death|0|||
48773260|NCT02896400|157014788|FG003|1 Month Follow-up|Death|0|||
48773261|NCT02896400|157014789|FG004|1 Month Follow-up|Death|0|||
48773262|NCT02896400|157014790|FG005|1 Month Follow-up|Death|0|||
48773263|NCT02896400|157014791|FG006|1 Month Follow-up|Death|0|||
48773264|NCT02896400|157014792|FG007|1 Month Follow-up|Death|0|||
48773265|NCT02896400|157014793|FG008|1 Month Follow-up|Death|0|||
48773266|NCT02896400|157014794|FG009|1 Month Follow-up|Death|0|||
48773267|NCT02896400|157014795|FG010|1 Month Follow-up|Death|0|||
48773268|NCT02896400|157014796|FG011|1 Month Follow-up|Death|0|||
48773269|NCT02896400|157014797|FG012|1 Month Follow-up|Death|0|||
48773270|NCT02896400|157014798|FG013|1 Month Follow-up|Death|0|||
48773271|NCT02896400|157014799|FG014|1 Month Follow-up|Death|0|||
48773272|NCT02896400|157014800|FG015|1 Month Follow-up|Death|1|||
48773273|NCT02896400|157014785|FG000|3 Month Follow-up|Lost to Follow-up|6|||
48773274|NCT02896400|157014786|FG001|3 Month Follow-up|Lost to Follow-up|3|||
48773275|NCT02896400|157014787|FG002|3 Month Follow-up|Lost to Follow-up|6|||
48773276|NCT02896400|157014788|FG003|3 Month Follow-up|Lost to Follow-up|11|||
48773277|NCT02896400|157014789|FG004|3 Month Follow-up|Lost to Follow-up|12|||
48773278|NCT02896400|157014790|FG005|3 Month Follow-up|Lost to Follow-up|6|||
48773279|NCT02896400|157014791|FG006|3 Month Follow-up|Lost to Follow-up|4|||
48876713|NCT01130168|157386627|FG001|Period 1|Withdrawal by Subject|1|||
48876714|NCT01130168|157386628|FG002|Period 1|Withdrawal by Subject|0|||
48773280|NCT02896400|157014792|FG007|3 Month Follow-up|Lost to Follow-up|3|||
48773281|NCT02896400|157014793|FG008|3 Month Follow-up|Lost to Follow-up|6|||
48773282|NCT02896400|157014794|FG009|3 Month Follow-up|Lost to Follow-up|5|||
48773283|NCT02896400|157014795|FG010|3 Month Follow-up|Lost to Follow-up|6|||
48773284|NCT02896400|157014796|FG011|3 Month Follow-up|Lost to Follow-up|6|||
48773285|NCT02896400|157014797|FG012|3 Month Follow-up|Lost to Follow-up|3|||
48773286|NCT02896400|157014798|FG013|3 Month Follow-up|Lost to Follow-up|5|||
48773287|NCT02896400|157014799|FG014|3 Month Follow-up|Lost to Follow-up|3|||
48773288|NCT02896400|157014800|FG015|3 Month Follow-up|Lost to Follow-up|2|||
48773289|NCT02896400|157014785|FG000|3 Month Follow-up|Death|0|||
48773290|NCT02896400|157014786|FG001|3 Month Follow-up|Death|0|||
48773291|NCT02896400|157014787|FG002|3 Month Follow-up|Death|0|||
48773292|NCT02896400|157014788|FG003|3 Month Follow-up|Death|0|||
48773293|NCT02896400|157014789|FG004|3 Month Follow-up|Death|0|||
48773294|NCT02896400|157014790|FG005|3 Month Follow-up|Death|0|||
48773295|NCT02896400|157014791|FG006|3 Month Follow-up|Death|0|||
48773296|NCT02896400|157014792|FG007|3 Month Follow-up|Death|0|||
48773297|NCT02896400|157014793|FG008|3 Month Follow-up|Death|0|||
48773298|NCT02896400|157014794|FG009|3 Month Follow-up|Death|0|||
48773299|NCT02896400|157014795|FG010|3 Month Follow-up|Death|0|||
48773300|NCT02896400|157014796|FG011|3 Month Follow-up|Death|0|||
48773301|NCT02896400|157014797|FG012|3 Month Follow-up|Death|0|||
48773302|NCT02896400|157014798|FG013|3 Month Follow-up|Death|1|||
48773303|NCT02896400|157014799|FG014|3 Month Follow-up|Death|1|||
48773304|NCT02896400|157014800|FG015|3 Month Follow-up|Death|0|||
48773305|NCT02896400|157014785|FG000|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
48773306|NCT02896400|157014786|FG001|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
48773307|NCT02896400|157014787|FG002|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
48773308|NCT02896400|157014788|FG003|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
48773309|NCT02896400|157014789|FG004|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
48773310|NCT02896400|157014790|FG005|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
48773311|NCT02896400|157014791|FG006|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
48773312|NCT02896400|157014792|FG007|Biochemical Verification at 3 Months|Lost to Follow-up|2|||
48773313|NCT02896400|157014793|FG008|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
48773314|NCT02896400|157014794|FG009|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
48773315|NCT02896400|157014795|FG010|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
48773316|NCT02896400|157014796|FG011|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
48773317|NCT02896400|157014797|FG012|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
48773318|NCT02896400|157014798|FG013|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
48773319|NCT02896400|157014799|FG014|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
48773320|NCT02896400|157014800|FG015|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
48773321|NCT02896400|157014785|FG000|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
48773322|NCT02896400|157014786|FG001|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
48773323|NCT02896400|157014787|FG002|Biochemical Verification at 3 Months|participant was not eligible for biochem|46|||
48773324|NCT02896400|157014788|FG003|Biochemical Verification at 3 Months|participant was not eligible for biochem|40|||
48773325|NCT02896400|157014789|FG004|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
48773326|NCT02896400|157014790|FG005|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
48773327|NCT02896400|157014791|FG006|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
48773328|NCT02896400|157014792|FG007|Biochemical Verification at 3 Months|participant was not eligible for biochem|47|||
48773329|NCT02896400|157014793|FG008|Biochemical Verification at 3 Months|participant was not eligible for biochem|44|||
48773330|NCT02896400|157014794|FG009|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
48773331|NCT02896400|157014795|FG010|Biochemical Verification at 3 Months|participant was not eligible for biochem|55|||
48773332|NCT02896400|157014796|FG011|Biochemical Verification at 3 Months|participant was not eligible for biochem|41|||
48773333|NCT02896400|157014797|FG012|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
48773334|NCT02896400|157014798|FG013|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
48773335|NCT02896400|157014799|FG014|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
48773336|NCT02896400|157014800|FG015|Biochemical Verification at 3 Months|participant was not eligible for biochem|56|||
48773337|NCT00071812|157014803|FG000|24-Week Double-Blind Period|Adverse Event|2|||
48773338|NCT00071812|157014804|FG001|24-Week Double-Blind Period|Adverse Event|3|||
48773339|NCT00071812|157014805|FG002|24-Week Double-Blind Period|Adverse Event|4|||
48773340|NCT00071812|157014806|FG003|24-Week Double-Blind Period|Adverse Event|4|||
48773341|NCT00071812|157014803|FG000|24-Week Double-Blind Period|Lack of Efficacy|3|||
48773342|NCT00071812|157014804|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
48773343|NCT00071812|157014805|FG002|24-Week Double-Blind Period|Lack of Efficacy|2|||
48773344|NCT00071812|157014806|FG003|24-Week Double-Blind Period|Lack of Efficacy|1|||
48773345|NCT00071812|157014803|FG000|24-Week Double-Blind Period|Lost to Follow-up|0|||
48773346|NCT00071812|157014804|FG001|24-Week Double-Blind Period|Lost to Follow-up|1|||
48773347|NCT00071812|157014805|FG002|24-Week Double-Blind Period|Lost to Follow-up|1|||
48773348|NCT00071812|157014806|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
49027310|NCT02472366|157939086|FG000|Overall Study|Lost to Follow-up|1|||
49027311|NCT02472366|157939087|FG001|Overall Study|Lost to Follow-up|0|||
49027312|NCT00813293|157939090|FG000|Overall Study|Intercurrent illness|1|||
49027313|NCT00813293|157939091|FG001|Overall Study|Intercurrent illness|0|||
48773349|NCT00071812|157014803|FG000|24-Week Double-Blind Period|Withdrawal by Subject|5|||
49027314|NCT00813293|157939090|FG000|Overall Study|Adverse Event|0|||
49027315|NCT00813293|157939091|FG001|Overall Study|Adverse Event|1|||
49027316|NCT00615069|157939096|FG000|Overall Study|Death|10|||
49027317|NCT00615069|157939096|FG000|Overall Study|Physician Decision|2|||
49027318|NCT00615069|157939096|FG000|Overall Study|Withdrawal by Subject|4|||
49027319|NCT02996682|157939098|FG000|Overall Study|Death|0|||
49027320|NCT02996682|157939099|FG001|Overall Study|Death|3|||
49027321|NCT00282048|157939101|FG000|Overall Study|Lack of Efficacy|30|||
49027322|NCT00282048|157939101|FG000|Overall Study|Adverse Event|22|||
49027323|NCT00282048|157939101|FG000|Overall Study|Withdrawal by Subject|1|||
49027324|NCT00282048|157939101|FG000|Overall Study|Other|8|||
48773350|NCT00071812|157014804|FG001|24-Week Double-Blind Period|Withdrawal by Subject|1|||
48773351|NCT00071812|157014805|FG002|24-Week Double-Blind Period|Withdrawal by Subject|1|||
48773352|NCT00071812|157014806|FG003|24-Week Double-Blind Period|Withdrawal by Subject|5|||
48773353|NCT00071812|157014803|FG000|24-Week Double-Blind Period|Protocol Violation|0|||
48773354|NCT00071812|157014804|FG001|24-Week Double-Blind Period|Protocol Violation|0|||
48773355|NCT00071812|157014805|FG002|24-Week Double-Blind Period|Protocol Violation|0|||
48773356|NCT00071812|157014806|FG003|24-Week Double-Blind Period|Protocol Violation|1|||
48773357|NCT00071812|157014803|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
48773358|NCT00071812|157014804|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
48773359|NCT00071812|157014805|FG002|24-Week Open-Label Extension Period|Adverse Event|0|||
48773360|NCT00071812|157014806|FG003|24-Week Open-Label Extension Period|Adverse Event|7|||
48773361|NCT00071812|157014803|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
48773362|NCT00071812|157014804|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
48773363|NCT00071812|157014805|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
48773364|NCT00071812|157014806|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|17|||
48773365|NCT00071812|157014803|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
48773366|NCT00071812|157014804|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
48773367|NCT00071812|157014805|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
48773368|NCT00071812|157014806|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
48773369|NCT00071812|157014803|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
48773370|NCT00071812|157014804|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
48773371|NCT00071812|157014805|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
48773372|NCT00071812|157014806|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|12|||
48773373|NCT00071812|157014803|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
48773374|NCT00071812|157014804|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
48773375|NCT00071812|157014805|FG002|24-Week Open-Label Extension Period|Lack of Compliance|1|||
48773376|NCT00071812|157014806|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
48773377|NCT01896895|157014807|FG000|Double-blind MP|Physician Decision|0|||
48773378|NCT01896895|157014808|FG001|Double-blind MP|Physician Decision|0|||
48773379|NCT01896895|157014809|FG002|Double-blind MP|Physician Decision|1|||
48773380|NCT01896895|157014810|FG003|Double-blind MP|Physician Decision|0|||
48773381|NCT01896895|157014807|FG000|Double-blind MP|Withdrawal by Subject|0|||
48773382|NCT01896895|157014808|FG001|Double-blind MP|Withdrawal by Subject|2|||
48773383|NCT01896895|157014809|FG002|Double-blind MP|Withdrawal by Subject|1|||
48773384|NCT01896895|157014810|FG003|Double-blind MP|Withdrawal by Subject|0|||
48773385|NCT01896895|157014807|FG000|Double-blind MP|Lost to Follow-up|1|||
48773386|NCT01896895|157014808|FG001|Double-blind MP|Lost to Follow-up|0|||
48773387|NCT01896895|157014809|FG002|Double-blind MP|Lost to Follow-up|1|||
48773388|NCT01896895|157014810|FG003|Double-blind MP|Lost to Follow-up|0|||
49027325|NCT00282048|157939101|FG000|Overall Study|Ongoing|1|||
48773389|NCT01589822|157014811|FG000|Overall Study|Withdrawal by Subject|1|||
48773390|NCT01589822|157014812|FG001|Overall Study|Withdrawal by Subject|2|||
48773391|NCT01589822|157014813|FG002|Overall Study|Withdrawal by Subject|0|||
48773392|NCT01589822|157014811|FG000|Overall Study|Death|1|||
48773393|NCT01589822|157014812|FG001|Overall Study|Death|0|||
48773394|NCT01589822|157014813|FG002|Overall Study|Death|0|||
49027326|NCT01185548|157939103|FG000|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2|||
49027327|NCT00537030|157939104|FG000|Overall Study|Physician Decision|2|||
49027328|NCT00537030|157939104|FG000|Overall Study|Withdrawal by Subject|2|||
48773395|NCT01589822|157014811|FG000|Overall Study|Missed 90 day visit|2|||
48773396|NCT01589822|157014812|FG001|Overall Study|Missed 90 day visit|1|||
48773397|NCT01589822|157014813|FG002|Overall Study|Missed 90 day visit|1|||
48773398|NCT00596011|157014816|FG000|Overall Study|Withdrawal by Subject|2|||
49027329|NCT00537030|157939104|FG000|Overall Study|≥ Grade 2 allergy|7|||
48773399|NCT00596011|157014817|FG001|Overall Study|Withdrawal by Subject|3|||
48773400|NCT00596011|157014816|FG000|Overall Study|Adverse Event|11|||
49027330|NCT00537030|157939104|FG000|Overall Study|Disease progression/ relapse during Tx|1|||
49027331|NCT00537030|157939104|FG000|Overall Study|Ineligible|2|||
49027332|NCT00537030|157939104|FG000|Overall Study|Inevaluable|2|||
49027333|NCT00414765|157939105|FG000|Overall Study|Adverse Event|5|||
48773401|NCT00596011|157014817|FG001|Overall Study|Adverse Event|7|||
48773402|NCT01633944|157014822|FG000|Open-label Titration Phase|Adverse Event|109|||
48773403|NCT01633944|157014823|FG001|Open-label Titration Phase|Adverse Event|0|||
48773404|NCT01633944|157014824|FG002|Open-label Titration Phase|Adverse Event|0|||
48773405|NCT01633944|157014822|FG000|Open-label Titration Phase|Lack of Efficacy|33|||
49027334|NCT00414765|157939106|FG001|Overall Study|Adverse Event|9|||
49027335|NCT00414765|157939105|FG000|Overall Study|Withdrawal by Subject|1|||
48773406|NCT01633944|157014823|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
48773407|NCT01633944|157014824|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
48773408|NCT01633944|157014822|FG000|Open-label Titration Phase|Withdrawal by Subject|34|||
48773409|NCT01633944|157014823|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
48773410|NCT01633944|157014824|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
48773411|NCT01633944|157014822|FG000|Open-label Titration Phase|Protocol Violation|24|||
48773412|NCT01633944|157014823|FG001|Open-label Titration Phase|Protocol Violation|0|||
48773413|NCT01633944|157014824|FG002|Open-label Titration Phase|Protocol Violation|0|||
48773414|NCT01633944|157014822|FG000|Open-label Titration Phase|Lost to Follow-up|22|||
48773415|NCT01633944|157014823|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
48773416|NCT01633944|157014824|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
48773417|NCT01633944|157014822|FG000|Open-label Titration Phase|Other|68|||
48773418|NCT01633944|157014823|FG001|Open-label Titration Phase|Other|0|||
48773419|NCT01633944|157014824|FG002|Open-label Titration Phase|Other|0|||
48773420|NCT01633944|157014822|FG000|Double-blind Treatment Phase|Adverse Event|0|||
48773421|NCT01633944|157014823|FG001|Double-blind Treatment Phase|Adverse Event|13|||
48773422|NCT01633944|157014824|FG002|Double-blind Treatment Phase|Adverse Event|7|||
48773423|NCT01633944|157014822|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
48773424|NCT01633944|157014823|FG001|Double-blind Treatment Phase|Lack of Efficacy|8|||
48773425|NCT01633944|157014824|FG002|Double-blind Treatment Phase|Lack of Efficacy|23|||
49027336|NCT00414765|157939106|FG001|Overall Study|Withdrawal by Subject|1|||
49027337|NCT00414765|157939105|FG000|Overall Study|Disease Progression|0|||
49027338|NCT00414765|157939106|FG001|Overall Study|Disease Progression|1|||
49027339|NCT02678286|157939107|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2|||
49027340|NCT02678286|157939108|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1|||
49027341|NCT02678286|157939107|FG000|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0|||
49027342|NCT02678286|157939108|FG001|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1|||
48773426|NCT01633944|157014822|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
48773427|NCT01633944|157014823|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
48773428|NCT01633944|157014824|FG002|Double-blind Treatment Phase|Withdrawal by Subject|8|||
48773429|NCT01633944|157014822|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
48773430|NCT01633944|157014823|FG001|Double-blind Treatment Phase|Protocol Violation|7|||
48773431|NCT01633944|157014824|FG002|Double-blind Treatment Phase|Protocol Violation|10|||
48773432|NCT01633944|157014822|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
48773433|NCT01633944|157014823|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
48773434|NCT01633944|157014824|FG002|Double-blind Treatment Phase|Lost to Follow-up|9|||
48773435|NCT01633944|157014822|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
48773436|NCT01633944|157014823|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3|||
48773437|NCT01633944|157014824|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
48773438|NCT01633944|157014822|FG000|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
48773439|NCT01633944|157014823|FG001|Double-blind Treatment Phase|Not exposed to DB study medication|1|||
48773440|NCT01633944|157014824|FG002|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
48773441|NCT01633944|157014822|FG000|Double-blind Treatment Phase|Other|0|||
49027343|NCT02678286|157939107|FG000|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1|||
49027344|NCT02678286|157939108|FG001|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0|||
48773442|NCT01633944|157014823|FG001|Double-blind Treatment Phase|Other|7|||
48773443|NCT01633944|157014824|FG002|Double-blind Treatment Phase|Other|0|||
48773444|NCT02488629|157014825|FG000|Overall Study|Lack of Efficacy|3|||
48773445|NCT02488629|157014826|FG001|Overall Study|Lack of Efficacy|1|||
48773446|NCT02488629|157014827|FG002|Overall Study|Lack of Efficacy|0|||
48773447|NCT02488629|157014828|FG003|Overall Study|Lack of Efficacy|0|||
48773448|NCT02488629|157014825|FG000|Overall Study|Withdrawal by Subject|0|||
48773449|NCT02488629|157014826|FG001|Overall Study|Withdrawal by Subject|1|||
48773450|NCT02488629|157014827|FG002|Overall Study|Withdrawal by Subject|0|||
48773451|NCT02488629|157014828|FG003|Overall Study|Withdrawal by Subject|0|||
48773452|NCT03912233|157014829|FG000|Overall Study|Adverse Event|1|||
48773453|NCT03912233|157014830|FG001|Overall Study|Adverse Event|0|||
48876715|NCT01130168|157386629|FG003|Period 1|Withdrawal by Subject|1|||
49027345|NCT02678286|157939107|FG000|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3|||
48773454|NCT03912233|157014831|FG002|Overall Study|Adverse Event|0|||
48773455|NCT03912233|157014832|FG003|Overall Study|Adverse Event|0|||
48773456|NCT03912233|157014833|FG004|Overall Study|Adverse Event|0|||
49027346|NCT02678286|157939108|FG001|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2|||
48773457|NCT03912233|157014834|FG005|Overall Study|Adverse Event|0|||
48773458|NCT03912233|157014829|FG000|Overall Study|Physician Decision|1|||
48773459|NCT03912233|157014830|FG001|Overall Study|Physician Decision|0|||
48876716|NCT01130168|157386630|FG004|Period 1|Withdrawal by Subject|0|||
48876717|NCT01130168|157386631|FG005|Period 1|Withdrawal by Subject|0|||
48876718|NCT01130168|157386626|FG000|Period 1|Discontinued For Other Reason|0|||
48876719|NCT01130168|157386627|FG001|Period 1|Discontinued For Other Reason|0|||
48876720|NCT01130168|157386628|FG002|Period 1|Discontinued For Other Reason|1|||
48876721|NCT01130168|157386629|FG003|Period 1|Discontinued For Other Reason|1|||
48876722|NCT01130168|157386630|FG004|Period 1|Discontinued For Other Reason|0|||
48876723|NCT01130168|157386631|FG005|Period 1|Discontinued For Other Reason|0|||
48876724|NCT01130168|157386626|FG000|Period 1|Adverse Event|0|||
48876725|NCT01130168|157386627|FG001|Period 1|Adverse Event|0|||
48876726|NCT01130168|157386628|FG002|Period 1|Adverse Event|0|||
48876727|NCT01130168|157386629|FG003|Period 1|Adverse Event|1|||
48876728|NCT01130168|157386630|FG004|Period 1|Adverse Event|0|||
48876729|NCT01130168|157386631|FG005|Period 1|Adverse Event|0|||
48876730|NCT03513068|157386633|FG000|Overall Study|Death|1|||
48876731|NCT03513068|157386634|FG001|Overall Study|Death|0|||
48876732|NCT03513068|157386633|FG000|Overall Study|Withdrawal by Subject|4|||
48876733|NCT03513068|157386634|FG001|Overall Study|Withdrawal by Subject|6|||
48876734|NCT02706847|157386638|FG000|Period 1: Day 1 to Week 12|Adverse Event|2|||
48876735|NCT02706847|157386639|FG001|Period 1: Day 1 to Week 12|Adverse Event|2|||
48876736|NCT02706847|157386640|FG002|Period 1: Day 1 to Week 12|Adverse Event|1|||
48876737|NCT02706847|157386641|FG003|Period 1: Day 1 to Week 12|Adverse Event|12|||
48876738|NCT02706847|157386638|FG000|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
48876739|NCT02706847|157386639|FG001|Period 1: Day 1 to Week 12|Withdrawal by Subject|1|||
48876740|NCT02706847|157386640|FG002|Period 1: Day 1 to Week 12|Withdrawal by Subject|4|||
48876741|NCT02706847|157386641|FG003|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
48876742|NCT02706847|157386638|FG000|Period 1: Day 1 to Week 12|Lost to Follow-up|2|||
48876743|NCT02706847|157386639|FG001|Period 1: Day 1 to Week 12|Lost to Follow-up|1|||
48773460|NCT03912233|157014831|FG002|Overall Study|Physician Decision|0|||
48773461|NCT03912233|157014832|FG003|Overall Study|Physician Decision|0|||
48773462|NCT03912233|157014833|FG004|Overall Study|Physician Decision|0|||
48773463|NCT03912233|157014834|FG005|Overall Study|Physician Decision|0|||
48773464|NCT03912233|157014829|FG000|Overall Study|Other|0|||
48773465|NCT03912233|157014830|FG001|Overall Study|Other|0|||
48876744|NCT02706847|157386640|FG002|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
48876745|NCT02706847|157386641|FG003|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
48876746|NCT02706847|157386638|FG000|Period 1: Day 1 to Week 12|Other|4|||
48876747|NCT02706847|157386639|FG001|Period 1: Day 1 to Week 12|Other|4|||
49027347|NCT02678286|157939107|FG000|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
49027348|NCT02678286|157939108|FG001|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
49027349|NCT00086996|157939111|FG000|Overall Study|Adverse Event|29|||
49027350|NCT00086996|157939111|FG000|Overall Study|Death|4|||
49027351|NCT00086996|157939111|FG000|Overall Study|progression/relapse|7|||
49027352|NCT00086996|157939111|FG000|Overall Study|Withdrawal by Subject|13|||
49027353|NCT00086996|157939111|FG000|Overall Study|Other|6|||
49027354|NCT00086996|157939111|FG000|Overall Study|not eligible|5|||
49027355|NCT00259012|157939113|FG000|Overall Study|Adverse Event|0|||
49027356|NCT00259012|157939114|FG001|Overall Study|Adverse Event|1|||
49027357|NCT00259012|157939113|FG000|Overall Study|Withdrawal by Subject|1|||
49027358|NCT00259012|157939114|FG001|Overall Study|Withdrawal by Subject|0|||
48773466|NCT03912233|157014831|FG002|Overall Study|Other|0|||
48773467|NCT03912233|157014832|FG003|Overall Study|Other|0|||
48773468|NCT03912233|157014833|FG004|Overall Study|Other|7|||
48773469|NCT03912233|157014834|FG005|Overall Study|Other|12|||
48773470|NCT01434823|157014835|FG000|Overall Study|Incomplete data in medical record|4|||
48773471|NCT01434823|157014836|FG001|Overall Study|Incomplete data in medical record|7|||
48773472|NCT00098839|157014839|FG000|Overall Study|Adverse Event|5|||
48773473|NCT00098839|157014840|FG001|Overall Study|Adverse Event|2|||
49027359|NCT00259012|157939113|FG000|Overall Study|Physician Decision|0|||
49027360|NCT00259012|157939114|FG001|Overall Study|Physician Decision|1|||
49027361|NCT00259012|157939113|FG000|Overall Study|Lost to Follow-up|0|||
48773474|NCT00098839|157014839|FG000|Overall Study|Death|1|||
48773475|NCT00098839|157014840|FG001|Overall Study|Death|2|||
48773476|NCT00098839|157014839|FG000|Overall Study|Physician Decision|4|||
48773477|NCT00098839|157014840|FG001|Overall Study|Physician Decision|14|||
48773478|NCT00098839|157014839|FG000|Overall Study|Withdrawal by Subject|1|||
48773479|NCT00098839|157014840|FG001|Overall Study|Withdrawal by Subject|0|||
48876748|NCT02706847|157386640|FG002|Period 1: Day 1 to Week 12|Other|2|||
48876749|NCT02706847|157386641|FG003|Period 1: Day 1 to Week 12|Other|2|||
48876750|NCT02706847|157386638|FG000|Period 1: Day 1 to Week 12|Randomized in Error|0|||
48876751|NCT02706847|157386639|FG001|Period 1: Day 1 to Week 12|Randomized in Error|0|||
48876752|NCT02706847|157386640|FG002|Period 1: Day 1 to Week 12|Randomized in Error|1|||
48876753|NCT02706847|157386641|FG003|Period 1: Day 1 to Week 12|Randomized in Error|0|||
48876754|NCT02706847|157386638|FG000|Period 1: Week 12 to Week 24|Adverse Event|1|||
48876755|NCT02706847|157386639|FG001|Period 1: Week 12 to Week 24|Adverse Event|2|||
48876756|NCT02706847|157386640|FG002|Period 1: Week 12 to Week 24|Adverse Event|2|||
48876757|NCT02706847|157386641|FG003|Period 1: Week 12 to Week 24|Adverse Event|5|||
48876758|NCT02706847|157386638|FG000|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
48876759|NCT02706847|157386639|FG001|Period 1: Week 12 to Week 24|Withdrawal by Subject|0|||
48876760|NCT02706847|157386640|FG002|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
48876761|NCT02706847|157386641|FG003|Period 1: Week 12 to Week 24|Withdrawal by Subject|4|||
48876762|NCT02706847|157386638|FG000|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
48876763|NCT02706847|157386639|FG001|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
48876764|NCT02706847|157386640|FG002|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
48876765|NCT02706847|157386641|FG003|Period 1: Week 12 to Week 24|Lost to Follow-up|1|||
48876766|NCT02706847|157386638|FG000|Period 1: Week 12 to Week 24|Other|1|||
48876767|NCT02706847|157386639|FG001|Period 1: Week 12 to Week 24|Other|0|||
48876768|NCT02706847|157386640|FG002|Period 1: Week 12 to Week 24|Other|1|||
48876769|NCT02706847|157386641|FG003|Period 1: Week 12 to Week 24|Other|4|||
48876770|NCT02706847|157386638|FG000|Period 2: Week 24 to Week 260|Adverse Event|11|||
48876771|NCT02706847|157386639|FG001|Period 2: Week 24 to Week 260|Adverse Event|9|||
48876772|NCT02706847|157386640|FG002|Period 2: Week 24 to Week 260|Adverse Event|21|||
48876773|NCT02706847|157386641|FG003|Period 2: Week 24 to Week 260|Adverse Event|11|||
48876774|NCT02706847|157386638|FG000|Period 2: Week 24 to Week 260|Withdrawal by Subject|11|||
48876775|NCT02706847|157386639|FG001|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
48876776|NCT02706847|157386640|FG002|Period 2: Week 24 to Week 260|Withdrawal by Subject|17|||
48876777|NCT02706847|157386641|FG003|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
48876778|NCT02706847|157386638|FG000|Period 2: Week 24 to Week 260|Lost to Follow-up|1|||
48876779|NCT02706847|157386639|FG001|Period 2: Week 24 to Week 260|Lost to Follow-up|5|||
48876780|NCT02706847|157386640|FG002|Period 2: Week 24 to Week 260|Lost to Follow-up|9|||
49027362|NCT00259012|157939114|FG001|Overall Study|Lost to Follow-up|1|||
49027363|NCT00259012|157939113|FG000|Overall Study|Protocol Violation|1|||
49027364|NCT00259012|157939114|FG001|Overall Study|Protocol Violation|1|||
49027365|NCT00184600|157939117|FG000|Overall Study|Adverse Event|9|||
49027366|NCT00184600|157939118|FG001|Overall Study|Adverse Event|0|||
49027367|NCT00184600|157939119|FG002|Overall Study|Adverse Event|5|||
49027368|NCT00184600|157939117|FG000|Overall Study|Death|3|||
49027369|NCT00184600|157939118|FG001|Overall Study|Death|9|||
49027370|NCT00184600|157939119|FG002|Overall Study|Death|7|||
49027371|NCT00184600|157939117|FG000|Overall Study|Lack of Efficacy|3|||
49027372|NCT00184600|157939118|FG001|Overall Study|Lack of Efficacy|1|||
49027373|NCT00184600|157939119|FG002|Overall Study|Lack of Efficacy|3|||
49027374|NCT00184600|157939117|FG000|Overall Study|Lost to Follow-up|4|||
49027375|NCT00184600|157939118|FG001|Overall Study|Lost to Follow-up|6|||
49027376|NCT00184600|157939119|FG002|Overall Study|Lost to Follow-up|1|||
49027377|NCT00184600|157939117|FG000|Overall Study|Protocol Violation|2|||
49027378|NCT00184600|157939118|FG001|Overall Study|Protocol Violation|2|||
49027379|NCT00184600|157939119|FG002|Overall Study|Protocol Violation|3|||
49027380|NCT00184600|157939117|FG000|Overall Study|Withdrawal by Subject|20|||
49027381|NCT00184600|157939118|FG001|Overall Study|Withdrawal by Subject|28|||
49027382|NCT00184600|157939119|FG002|Overall Study|Withdrawal by Subject|12|||
49027383|NCT00184600|157939117|FG000|Overall Study|Unclassified|4|||
49027384|NCT00184600|157939118|FG001|Overall Study|Unclassified|5|||
49027385|NCT00184600|157939119|FG002|Overall Study|Unclassified|3|||
49027386|NCT02231749|157939120|FG000|Overall Study|Disease progression|229|||
49027387|NCT02231749|157939121|FG001|Overall Study|Disease progression|297|||
49027388|NCT02231749|157939120|FG000|Overall Study|Study Drug Toxicity|134|||
49027389|NCT02231749|157939121|FG001|Overall Study|Study Drug Toxicity|63|||
49027390|NCT02231749|157939120|FG000|Overall Study|Death|1|||
49027391|NCT02231749|157939121|FG001|Overall Study|Death|1|||
48773480|NCT00098839|157014839|FG000|Overall Study|Refusal of further protocol therapy|3|||
48773481|NCT00098839|157014840|FG001|Overall Study|Refusal of further protocol therapy|1|||
48773482|NCT00098839|157014839|FG000|Overall Study|Relapse|6|||
48773483|NCT00098839|157014840|FG001|Overall Study|Relapse|3|||
48773484|NCT00098839|157014839|FG000|Overall Study|M2/M3 marrow on Day 15 of Block 2|10|||
48773485|NCT00098839|157014840|FG001|Overall Study|M2/M3 marrow on Day 15 of Block 2|11|||
48773486|NCT00098839|157014839|FG000|Overall Study|Ineligible|2|||
48773487|NCT00098839|157014840|FG001|Overall Study|Ineligible|0|||
48773488|NCT04879745|157014842|FG000|Overall Study|Lost to Follow-up|4|||
48773489|NCT04879745|157014843|FG001|Overall Study|Lost to Follow-up|1|||
48773490|NCT02148003|157014844|FG000|Overall Study|Failed inclusion criteria|1|||
48876781|NCT02706847|157386641|FG003|Period 2: Week 24 to Week 260|Lost to Follow-up|6|||
48876782|NCT02706847|157386638|FG000|Period 2: Week 24 to Week 260|Lack of Efficacy|5|||
48876783|NCT02706847|157386639|FG001|Period 2: Week 24 to Week 260|Lack of Efficacy|3|||
49027392|NCT02231749|157939120|FG000|Overall Study|AE unrelated to Study drug|32|||
49027393|NCT02231749|157939121|FG001|Overall Study|AE unrelated to Study drug|31|||
49027394|NCT02231749|157939120|FG000|Overall Study|Participant's request to discontinue|10|||
49027395|NCT02231749|157939121|FG001|Overall Study|Participant's request to discontinue|21|||
49027396|NCT02231749|157939120|FG000|Overall Study|Participant withdrew Consent|8|||
48773491|NCT02148003|157014845|FG001|Overall Study|Failed inclusion criteria|0|||
49027397|NCT02231749|157939121|FG001|Overall Study|Participant withdrew Consent|15|||
49027398|NCT02231749|157939120|FG000|Overall Study|Lost to Follow-up|1|||
49027399|NCT02231749|157939121|FG001|Overall Study|Lost to Follow-up|2|||
49027400|NCT02231749|157939120|FG000|Overall Study|Maximum Clinical Benefit|5|||
49027401|NCT02231749|157939121|FG001|Overall Study|Maximum Clinical Benefit|8|||
48773492|NCT02148003|157014844|FG000|Overall Study|Met exclusion criteria|0|||
48773493|NCT02148003|157014845|FG001|Overall Study|Met exclusion criteria|1|||
48773494|NCT02148003|157014844|FG000|Overall Study|Withdrawal by Subject|0|||
48773495|NCT02148003|157014845|FG001|Overall Study|Withdrawal by Subject|1|||
48773496|NCT03192150|157014848|FG000|Overall Study|Adverse Event|14|||
48773497|NCT03192150|157014849|FG001|Overall Study|Adverse Event|12|||
48773498|NCT03192150|157014848|FG000|Overall Study|Lack of Efficacy|23|||
48773499|NCT03192150|157014849|FG001|Overall Study|Lack of Efficacy|30|||
48773500|NCT03192150|157014848|FG000|Overall Study|Lost to Follow-up|1|||
48773501|NCT03192150|157014849|FG001|Overall Study|Lost to Follow-up|1|||
48773502|NCT03192150|157014848|FG000|Overall Study|Withdrawal by Subject|4|||
48773503|NCT03192150|157014849|FG001|Overall Study|Withdrawal by Subject|2|||
48773504|NCT03192150|157014848|FG000|Overall Study|Protocol Violation|5|||
48773505|NCT03192150|157014849|FG001|Overall Study|Protocol Violation|2|||
48773506|NCT03192150|157014848|FG000|Overall Study|Surgery Canceled|6|||
48773507|NCT03192150|157014849|FG001|Overall Study|Surgery Canceled|2|||
48773508|NCT03192150|157014848|FG000|Overall Study|Other-Various Administrative Reasons|2|||
48773509|NCT03192150|157014849|FG001|Overall Study|Other-Various Administrative Reasons|5|||
48773510|NCT02178475|157014850|FG000|Overall Study|Withdrawal by Subject|7|||
48773511|NCT02178475|157014850|FG000|Overall Study|Lost to Follow-up|10|||
48773512|NCT02178475|157014850|FG000|Overall Study|Death|13|||
48773513|NCT02178475|157014850|FG000|Overall Study|Protocol-specified Criteria|99|||
48773514|NCT00779766|157014851|FG000|Month 24|Serious Adverse Event|2|||
48773515|NCT00779766|157014852|FG001|Month 24|Serious Adverse Event|3|||
48773516|NCT00779766|157014851|FG000|Month 24|Adverse Event|3|||
48773517|NCT00779766|157014852|FG001|Month 24|Adverse Event|3|||
48773518|NCT00779766|157014851|FG000|Month 24|Protocol Violation|3|||
48773519|NCT00779766|157014852|FG001|Month 24|Protocol Violation|1|||
48773520|NCT00779766|157014851|FG000|Month 24|Withdrawal by Subject|159|||
48773521|NCT00779766|157014852|FG001|Month 24|Withdrawal by Subject|127|||
48773522|NCT00779766|157014851|FG000|Month 24|Migrated/moved from study area|138|||
48773523|NCT00779766|157014852|FG001|Month 24|Migrated/moved from study area|162|||
48773524|NCT00779766|157014851|FG000|Month 24|Lost to Follow-up|9|||
48773525|NCT00779766|157014852|FG001|Month 24|Lost to Follow-up|9|||
48773526|NCT00779766|157014851|FG000|Month 24|Other|18|||
48773527|NCT00779766|157014852|FG001|Month 24|Other|27|||
48773528|NCT00779766|157014851|FG000|Month 48|Withdrawal by Subject|68|||
48773529|NCT00779766|157014852|FG001|Month 48|Withdrawal by Subject|63|||
48773530|NCT00779766|157014851|FG000|Month 48|Migrated/moved from study area|76|||
48773531|NCT00779766|157014852|FG001|Month 48|Migrated/moved from study area|75|||
48773532|NCT00779766|157014851|FG000|Month 48|Lost to Follow-up|29|||
48773533|NCT00779766|157014852|FG001|Month 48|Lost to Follow-up|30|||
48773534|NCT00779766|157014851|FG000|Month 48|Other|1|||
48773535|NCT00779766|157014852|FG001|Month 48|Other|0|||
48773536|NCT00779766|157014851|FG000|Month 72|Withdrawal by Subject|55|||
48773537|NCT00779766|157014852|FG001|Month 72|Withdrawal by Subject|71|||
48773538|NCT00779766|157014851|FG000|Month 72|Migrated/moved from study area|124|||
48773539|NCT00779766|157014852|FG001|Month 72|Migrated/moved from study area|109|||
48773540|NCT00779766|157014851|FG000|Month 72|Lost to Follow-up|6|||
48773541|NCT00779766|157014852|FG001|Month 72|Lost to Follow-up|8|||
48773542|NCT00779766|157014851|FG000|Month 72|Other|0|||
48773543|NCT00779766|157014852|FG001|Month 72|Other|1|||
48773544|NCT00617240|157014858|FG000|Overall Study|Lack of Efficacy|1|||
48773545|NCT00617240|157014859|FG001|Overall Study|Lack of Efficacy|0|||
48773546|NCT02410811|157014860|FG000|Overall Study|Withdrawal by Subject|0|||
48773547|NCT02410811|157014861|FG001|Overall Study|Withdrawal by Subject|0|||
48773548|NCT02410811|157014862|FG002|Overall Study|Withdrawal by Subject|1|||
48773549|NCT02410811|157014863|FG003|Overall Study|Withdrawal by Subject|0|||
48773550|NCT04960228|157014864|FG000|Overall Study|Withdrawal by Subject|216|||
48773551|NCT04960228|157014865|FG001|Overall Study|Withdrawal by Subject|35|||
48773552|NCT04960228|157014864|FG000|Overall Study|Failed attention check|69|||
48773553|NCT04960228|157014865|FG001|Overall Study|Failed attention check|148|||
48773554|NCT04960228|157014864|FG000|Overall Study|Flagged for response quality by Dynata|3|||
48773555|NCT04960228|157014865|FG001|Overall Study|Flagged for response quality by Dynata|3|||
48773556|NCT00280566|157014866|FG000|Period 1 Open Label Ziprasidone|Lack of Efficacy|31|||
49027402|NCT02231749|157939120|FG000|Overall Study|Poor/Non-Compliance|0|||
48773557|NCT00280566|157014867|FG001|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
48773558|NCT00280566|157014868|FG002|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
48773559|NCT00280566|157014866|FG000|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3|||
48773560|NCT00280566|157014867|FG001|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
48773561|NCT00280566|157014868|FG002|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
48773562|NCT00280566|157014866|FG000|Period 1 Open Label Ziprasidone|Adverse Event|148|||
48773563|NCT00280566|157014867|FG001|Period 1 Open Label Ziprasidone|Adverse Event|0|||
48773564|NCT00280566|157014868|FG002|Period 1 Open Label Ziprasidone|Adverse Event|0|||
48773565|NCT00280566|157014866|FG000|Period 1 Open Label Ziprasidone|Lost to Follow-up|35|||
49027403|NCT02231749|157939121|FG001|Overall Study|Poor/Non-Compliance|3|||
49027404|NCT02231749|157939120|FG000|Overall Study|Pregnancy|1|||
49027405|NCT02231749|157939121|FG001|Overall Study|Pregnancy|0|||
49027406|NCT02231749|157939120|FG000|Overall Study|other|0|||
49027407|NCT02231749|157939121|FG001|Overall Study|other|8|||
49027408|NCT02231749|157939120|FG000|Overall Study|No longer meets Study Criteria|1|||
49027409|NCT02231749|157939121|FG001|Overall Study|No longer meets Study Criteria|0|||
49027410|NCT00707161|157939122|FG000|Overall Study|Physician Decision|6|||
49027411|NCT00610363|157939126|FG000|Overall Study|Non-compliance with protocol|0|||
49027412|NCT00610363|157939127|FG001|Overall Study|Non-compliance with protocol|1|||
49027413|NCT00610363|157939126|FG000|Overall Study|Adverse Event|3|||
49027414|NCT00610363|157939127|FG001|Overall Study|Adverse Event|1|||
49027415|NCT00610363|157939126|FG000|Overall Study|Lack of Efficacy|2|||
49027416|NCT00610363|157939127|FG001|Overall Study|Lack of Efficacy|0|||
49027417|NCT00610363|157939126|FG000|Overall Study|Lost to Follow-up|4|||
49027418|NCT00610363|157939127|FG001|Overall Study|Lost to Follow-up|0|||
49027419|NCT00610363|157939126|FG000|Overall Study|Withdrawal by Subject|1|||
49027420|NCT00610363|157939127|FG001|Overall Study|Withdrawal by Subject|0|||
49027421|NCT00610363|157939126|FG000|Overall Study|Other than specified above|1|||
49027422|NCT00610363|157939127|FG001|Overall Study|Other than specified above|1|||
49027423|NCT03204539|157939128|FG000|Overall Study|Loss of funding|0|||
49027424|NCT03204539|157939129|FG001|Overall Study|Loss of funding|1|||
49027425|NCT00336479|157939130|FG000|Overall Study|Adverse Event|8|||
49027426|NCT00336479|157939131|FG001|Overall Study|Adverse Event|11|||
48773566|NCT00280566|157014867|FG001|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
48773567|NCT00280566|157014868|FG002|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
48773568|NCT00280566|157014866|FG000|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76|||
48773569|NCT00280566|157014867|FG001|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
48773570|NCT00280566|157014868|FG002|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
48773571|NCT00280566|157014866|FG000|Period 1 Open Label Ziprasidone|Miscellaneous|50|||
48773572|NCT00280566|157014867|FG001|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
48773573|NCT00280566|157014868|FG002|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
48773574|NCT00280566|157014866|FG000|Period 2 Double Blind|Lack of Efficacy|0|||
48773575|NCT00280566|157014867|FG001|Period 2 Double Blind|Lack of Efficacy|9|||
48773576|NCT00280566|157014868|FG002|Period 2 Double Blind|Lack of Efficacy|22|||
48773577|NCT00280566|157014866|FG000|Period 2 Double Blind|Laboratory Abnormality|0|||
48773578|NCT00280566|157014867|FG001|Period 2 Double Blind|Laboratory Abnormality|1|||
48773579|NCT00280566|157014868|FG002|Period 2 Double Blind|Laboratory Abnormality|0|||
48773580|NCT00280566|157014866|FG000|Period 2 Double Blind|Adverse Event|0|||
48773581|NCT00280566|157014867|FG001|Period 2 Double Blind|Adverse Event|11|||
48773582|NCT00280566|157014868|FG002|Period 2 Double Blind|Adverse Event|15|||
48773583|NCT00280566|157014866|FG000|Period 2 Double Blind|Lost to Follow-up|0|||
48773584|NCT00280566|157014867|FG001|Period 2 Double Blind|Lost to Follow-up|3|||
48773585|NCT00280566|157014868|FG002|Period 2 Double Blind|Lost to Follow-up|6|||
48773586|NCT00280566|157014866|FG000|Period 2 Double Blind|Withdrawal by Subject|0|||
48773587|NCT00280566|157014867|FG001|Period 2 Double Blind|Withdrawal by Subject|9|||
48773588|NCT00280566|157014868|FG002|Period 2 Double Blind|Withdrawal by Subject|9|||
48773589|NCT00280566|157014866|FG000|Period 2 Double Blind|miscellaneous|0|||
48773590|NCT00280566|157014867|FG001|Period 2 Double Blind|miscellaneous|10|||
48773591|NCT00280566|157014868|FG002|Period 2 Double Blind|miscellaneous|5|||
48773592|NCT01502644|157014869|FG000|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1|||
48773593|NCT01502644|157014870|FG001|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
48773594|NCT01502644|157014871|FG002|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
48773595|NCT01502644|157014872|FG003|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
48773596|NCT01502644|157014869|FG000|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2|||
48773597|NCT01502644|157014870|FG001|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
48773598|NCT01502644|157014871|FG002|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
48773599|NCT01502644|157014872|FG003|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
48773600|NCT01502644|157014869|FG000|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6|||
48876784|NCT02706847|157386640|FG002|Period 2: Week 24 to Week 260|Lack of Efficacy|9|||
48876785|NCT02706847|157386641|FG003|Period 2: Week 24 to Week 260|Lack of Efficacy|8|||
48876786|NCT02706847|157386638|FG000|Period 2: Week 24 to Week 260|Other|8|||
48876787|NCT02706847|157386639|FG001|Period 2: Week 24 to Week 260|Other|5|||
49027427|NCT00336479|157939132|FG002|Overall Study|Adverse Event|18|||
49027428|NCT00336479|157939133|FG003|Overall Study|Adverse Event|4|||
49027429|NCT00336479|157939130|FG000|Overall Study|Noncompliant|1|||
49027430|NCT00336479|157939131|FG001|Overall Study|Noncompliant|7|||
49027431|NCT00336479|157939132|FG002|Overall Study|Noncompliant|3|||
49027432|NCT00336479|157939133|FG003|Overall Study|Noncompliant|0|||
49027433|NCT00336479|157939130|FG000|Overall Study|Physician Decision|2|||
48773601|NCT01502644|157014870|FG001|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
48773602|NCT01502644|157014871|FG002|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
48773603|NCT01502644|157014872|FG003|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
48773604|NCT01502644|157014869|FG000|Assigned to NA Groups|Drop Out due to Side Effects|0|||
48773605|NCT01502644|157014870|FG001|Assigned to NA Groups|Drop Out due to Side Effects|6|||
48773606|NCT01502644|157014871|FG002|Assigned to NA Groups|Drop Out due to Side Effects|2|||
48773607|NCT01502644|157014872|FG003|Assigned to NA Groups|Drop Out due to Side Effects|7|||
48773608|NCT01502644|157014869|FG000|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
48773609|NCT01502644|157014870|FG001|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
48773610|NCT01502644|157014871|FG002|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
48773611|NCT01502644|157014872|FG003|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
48773612|NCT00057746|157014875|FG000|Overall Study|Withdrawal by Subject|0|||
48773613|NCT00057746|157014876|FG001|Overall Study|Withdrawal by Subject|0|||
48773614|NCT00057746|157014877|FG002|Overall Study|Withdrawal by Subject|1|||
48773615|NCT00670228|157014880|FG000|Overall Study|Adverse Event|1|||
48773616|NCT00670228|157014881|FG001|Overall Study|Adverse Event|0|||
48773617|NCT00670228|157014880|FG000|Overall Study|Death or MACE|0|||
48773618|NCT00670228|157014881|FG001|Overall Study|Death or MACE|1|||
48773619|NCT00670228|157014880|FG000|Overall Study|Not treated|2|||
48773620|NCT00670228|157014881|FG001|Overall Study|Not treated|2|||
48773621|NCT00670228|157014880|FG000|Overall Study|Not meeting the selection criteria|2|||
48773622|NCT00670228|157014881|FG001|Overall Study|Not meeting the selection criteria|0|||
48773623|NCT01469065|157014885|FG000|Overall Study|Lack of Efficacy|0|||
48773624|NCT01469065|157014886|FG001|Overall Study|Lack of Efficacy|0|||
48773625|NCT01469065|157014887|FG002|Overall Study|Lack of Efficacy|0|||
48773626|NCT01469065|157014888|FG003|Overall Study|Lack of Efficacy|0|||
48773627|NCT01469065|157014889|FG004|Overall Study|Lack of Efficacy|1|||
48773628|NCT01469065|157014885|FG000|Overall Study|Other|0|||
48773629|NCT01469065|157014886|FG001|Overall Study|Other|1|||
48773630|NCT01469065|157014887|FG002|Overall Study|Other|0|||
48773631|NCT01469065|157014888|FG003|Overall Study|Other|0|||
48773632|NCT01469065|157014889|FG004|Overall Study|Other|0|||
48773633|NCT00785486|157014892|FG000|Midazolam Alone|Withdrawal by Subject|1|||
48773634|NCT02130765|157014895|FG000|Overall Study|Did not receive treatment|4|||
48773635|NCT02130765|157014896|FG001|Overall Study|Did not receive treatment|0|||
48773636|NCT02130765|157014897|FG002|Overall Study|Did not receive treatment|0|||
48773637|NCT02130765|157014898|FG003|Overall Study|Did not receive treatment|0|||
48773638|NCT00006184|157014899|FG000|Overall Study|Death|1|||
48773639|NCT00006184|157014900|FG001|Overall Study|Death|0|||
48773640|NCT01020019|157014913|FG000|Overall Study|Lost to Follow-up|21|||
48773641|NCT01020019|157014914|FG001|Overall Study|Lost to Follow-up|18|||
48773642|NCT01020019|157014913|FG000|Overall Study|Adverse Event|1|||
48773643|NCT01020019|157014914|FG001|Overall Study|Adverse Event|5|||
48773644|NCT01020019|157014913|FG000|Overall Study|not interested in treatment|4|||
48773645|NCT01020019|157014914|FG001|Overall Study|not interested in treatment|4|||
48773646|NCT01020019|157014913|FG000|Overall Study|moving|0|||
48773647|NCT01020019|157014914|FG001|Overall Study|moving|2|||
48773648|NCT04115358|157014915|FG000|Overall Study|exfoliation|0|||
48773649|NCT04115358|157014916|FG001|Overall Study|exfoliation|0|||
48773650|NCT04115358|157014917|FG002|Overall Study|exfoliation|1|||
48773651|NCT01440946|157014922|FG000|Overall Study|Lost to Follow-up|1|||
49027434|NCT00336479|157939131|FG001|Overall Study|Physician Decision|3|||
49027435|NCT00336479|157939132|FG002|Overall Study|Physician Decision|1|||
49027436|NCT00336479|157939133|FG003|Overall Study|Physician Decision|0|||
49027437|NCT00336479|157939130|FG000|Overall Study|Lost to Follow-up|3|||
49027438|NCT00336479|157939131|FG001|Overall Study|Lost to Follow-up|2|||
49027439|NCT00336479|157939132|FG002|Overall Study|Lost to Follow-up|0|||
49027440|NCT00336479|157939133|FG003|Overall Study|Lost to Follow-up|0|||
49027441|NCT00336479|157939130|FG000|Overall Study|Withdrawal by Subject|3|||
49027442|NCT00336479|157939131|FG001|Overall Study|Withdrawal by Subject|2|||
49027443|NCT00336479|157939132|FG002|Overall Study|Withdrawal by Subject|3|||
49027444|NCT00336479|157939133|FG003|Overall Study|Withdrawal by Subject|0|||
49027445|NCT00336479|157939130|FG000|Overall Study|Other|0|||
49027446|NCT00336479|157939131|FG001|Overall Study|Other|0|||
48773652|NCT01440946|157014923|FG001|Overall Study|Lost to Follow-up|1|||
49027447|NCT00336479|157939132|FG002|Overall Study|Other|1|||
49027448|NCT00336479|157939133|FG003|Overall Study|Other|0|||
49027449|NCT00336479|157939130|FG000|Overall Study|Virologic Stopping Rule|20|||
48773653|NCT01440946|157014922|FG000|Overall Study|Physician Decision|1|||
48773654|NCT01440946|157014923|FG001|Overall Study|Physician Decision|0|||
48773655|NCT00101101|157014928|FG000|Overall Study|never received vaccine|20|||
48773656|NCT01848990|157014933|FG000|Overall Study|Adverse Event|6|||
48773657|NCT01848990|157014934|FG001|Overall Study|Adverse Event|2|||
48773658|NCT01848990|157014935|FG002|Overall Study|Adverse Event|0|||
48773659|NCT01848990|157014933|FG000|Overall Study|Lost to Follow-up|6|||
48773660|NCT01848990|157014934|FG001|Overall Study|Lost to Follow-up|2|||
48773661|NCT01848990|157014935|FG002|Overall Study|Lost to Follow-up|2|||
48773662|NCT01848990|157014933|FG000|Overall Study|Protocol Violation|1|||
48773663|NCT01848990|157014934|FG001|Overall Study|Protocol Violation|1|||
48773664|NCT01848990|157014935|FG002|Overall Study|Protocol Violation|0|||
48773665|NCT01848990|157014933|FG000|Overall Study|Withdrawal by Subject|29|||
48876788|NCT02706847|157386640|FG002|Period 2: Week 24 to Week 260|Other|15|||
48876789|NCT02706847|157386641|FG003|Period 2: Week 24 to Week 260|Other|15|||
48876790|NCT01174264|157386642|FG000|Single Dose Pharmacokinetics|Early progressive disease|1|||
48876791|NCT01174264|157386643|FG001|Single Dose Pharmacokinetics|Early progressive disease|0|||
48876792|NCT01174264|157386644|FG002|Single Dose Pharmacokinetics|Early progressive disease|1|||
48876793|NCT01174264|157386642|FG000|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
48876794|NCT01174264|157386643|FG001|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
48876795|NCT01174264|157386644|FG002|Single Dose Pharmacokinetics|Patient entered hospice care|1|||
48876796|NCT01174264|157386642|FG000|Steady-state Pharmacokinetics|Not evaluable|6|||
48876797|NCT01174264|157386643|FG001|Steady-state Pharmacokinetics|Not evaluable|0|||
48876798|NCT01174264|157386644|FG002|Steady-state Pharmacokinetics|Not evaluable|2|||
48876799|NCT04206085|157386645|FG000|Overall Study|Lost to Follow-up|0|||
48876800|NCT04206085|157386646|FG001|Overall Study|Lost to Follow-up|1|||
48876801|NCT04206085|157386647|FG002|Overall Study|Lost to Follow-up|0|||
48876802|NCT04206085|157386645|FG000|Overall Study|Lost to Follow-up|0|||
48876803|NCT04206085|157386646|FG001|Overall Study|Lost to Follow-up|0|||
48773666|NCT01848990|157014934|FG001|Overall Study|Withdrawal by Subject|10|||
48773667|NCT01848990|157014935|FG002|Overall Study|Withdrawal by Subject|11|||
48773668|NCT01848990|157014933|FG000|Overall Study|Physician Decision|1|||
48773669|NCT01848990|157014934|FG001|Overall Study|Physician Decision|1|||
48773670|NCT01848990|157014935|FG002|Overall Study|Physician Decision|0|||
48876804|NCT04206085|157386647|FG002|Overall Study|Lost to Follow-up|1|||
48876805|NCT02392104|157386656|FG000|Overall Study|discontinuation of warfarin|3|||
48876806|NCT02392104|157386656|FG000|Overall Study|bleeding event|1|||
48876807|NCT02392104|157386656|FG000|Overall Study|transferred care to another doctor|2|||
48876808|NCT02392104|157386656|FG000|Overall Study|INR goal range changed|1|||
48876809|NCT02392104|157386656|FG000|Overall Study|admitted to skilled nursing facility|3|||
48876810|NCT02392104|157386656|FG000|Overall Study|INRs drawn by visiting nurse services|1|||
48876811|NCT01889069|157386657|FG000|Overall Study|Death|18|||
48876812|NCT01889069|157386657|FG000|Overall Study|Progression of Disease|14|||
48876813|NCT01889069|157386657|FG000|Overall Study|Lost to Follow-up|6|||
49027450|NCT00336479|157939131|FG001|Overall Study|Virologic Stopping Rule|0|||
49027451|NCT00336479|157939132|FG002|Overall Study|Virologic Stopping Rule|0|||
49027452|NCT00336479|157939133|FG003|Overall Study|Virologic Stopping Rule|0|||
49027453|NCT00585689|157939137|FG000|Overall Study|Received different ABI-007 schedule|3|||
49027454|NCT00585689|157939137|FG000|Overall Study|Adverse Event|1|||
48773671|NCT01848990|157014933|FG000|Overall Study|Non Compliance|1|||
48773672|NCT01848990|157014934|FG001|Overall Study|Non Compliance|0|||
48773673|NCT01848990|157014935|FG002|Overall Study|Non Compliance|0|||
48773674|NCT01848990|157014933|FG000|Overall Study|Death|1|||
48773675|NCT01848990|157014934|FG001|Overall Study|Death|0|||
48773676|NCT01848990|157014935|FG002|Overall Study|Death|1|||
48773677|NCT01848990|157014933|FG000|Overall Study|Other|1|||
48773678|NCT01848990|157014934|FG001|Overall Study|Other|4|||
48773679|NCT01848990|157014935|FG002|Overall Study|Other|2|||
48773680|NCT01971346|157014936|FG000|Overall Study|Protocol Violation|3|||
48773681|NCT01971346|157014936|FG000|Overall Study|Lost to Follow-up|2|||
48773682|NCT01971346|157014936|FG000|Overall Study|Withdrawal by Subject|2|||
48773683|NCT01971346|157014936|FG000|Overall Study|Physician Decision|1|||
48773684|NCT01687166|157014945|FG000|Overall Study|Attempt subject|2|||
48773685|NCT01687166|157014946|FG001|Overall Study|Attempt subject|3|||
48773686|NCT01687166|157014947|FG002|Overall Study|Attempt subject|2|||
48773687|NCT01687166|157014948|FG003|Overall Study|Attempt subject|0|||
48773688|NCT01687166|157014945|FG000|Overall Study|Did not meet eligibility criteria|4|||
48773689|NCT01687166|157014946|FG001|Overall Study|Did not meet eligibility criteria|6|||
48876814|NCT01889069|157386657|FG000|Overall Study|Other|4|||
48876815|NCT01889069|157386657|FG000|Overall Study|Consent Withdrawal|3|||
49027455|NCT00585689|157939137|FG000|Overall Study|Patient Declined Surgery|1|||
48773690|NCT01687166|157014947|FG002|Overall Study|Did not meet eligibility criteria|1|||
48773691|NCT01687166|157014948|FG003|Overall Study|Did not meet eligibility criteria|1|||
48773692|NCT01687166|157014945|FG000|Overall Study|Adverse Event|2|||
48773693|NCT01687166|157014946|FG001|Overall Study|Adverse Event|1|||
48773694|NCT01687166|157014947|FG002|Overall Study|Adverse Event|0|||
48773695|NCT01687166|157014948|FG003|Overall Study|Adverse Event|0|||
48773696|NCT01687166|157014945|FG000|Overall Study|Physician Decision|3|||
48773697|NCT01687166|157014946|FG001|Overall Study|Physician Decision|2|||
48773698|NCT01687166|157014947|FG002|Overall Study|Physician Decision|1|||
48773699|NCT01687166|157014948|FG003|Overall Study|Physician Decision|0|||
48773700|NCT01687166|157014945|FG000|Overall Study|Withdrawal by Subject|11|||
48773701|NCT01687166|157014946|FG001|Overall Study|Withdrawal by Subject|4|||
48876816|NCT01426347|157386658|FG000|Overall Study|Lost to Follow-up|0|||
48876817|NCT01426347|157386659|FG001|Overall Study|Lost to Follow-up|3|||
48876818|NCT01426347|157386658|FG000|Overall Study|Protocol Violation|2|||
48876819|NCT01426347|157386659|FG001|Overall Study|Protocol Violation|0|||
48876820|NCT01426347|157386658|FG000|Overall Study|Withdrawal by Subject|5|||
48876821|NCT01426347|157386659|FG001|Overall Study|Withdrawal by Subject|0|||
48876822|NCT04147858|157386664|FG000|Overall Study|Adverse Event|6|||
48773702|NCT01687166|157014947|FG002|Overall Study|Withdrawal by Subject|3|||
48773703|NCT01687166|157014948|FG003|Overall Study|Withdrawal by Subject|0|||
48773704|NCT01687166|157014945|FG000|Overall Study|Lost to Follow-up|2|||
48773705|NCT01687166|157014946|FG001|Overall Study|Lost to Follow-up|5|||
48773706|NCT01687166|157014947|FG002|Overall Study|Lost to Follow-up|1|||
48773707|NCT01687166|157014948|FG003|Overall Study|Lost to Follow-up|0|||
48773708|NCT01687166|157014945|FG000|Overall Study|Equipment/Device Availability|0|||
48773709|NCT01687166|157014946|FG001|Overall Study|Equipment/Device Availability|1|||
48876823|NCT04147858|157386665|FG001|Overall Study|Adverse Event|6|||
48876824|NCT04147858|157386666|FG002|Overall Study|Adverse Event|6|||
48876825|NCT04147858|157386664|FG000|Overall Study|Lack of Efficacy|3|||
48876826|NCT04147858|157386665|FG001|Overall Study|Lack of Efficacy|3|||
48876827|NCT04147858|157386666|FG002|Overall Study|Lack of Efficacy|1|||
48876828|NCT04147858|157386664|FG000|Overall Study|Lost to Follow-up|1|||
48876829|NCT04147858|157386665|FG001|Overall Study|Lost to Follow-up|6|||
48876830|NCT04147858|157386666|FG002|Overall Study|Lost to Follow-up|2|||
48876831|NCT04147858|157386664|FG000|Overall Study|Withdrawal by Subject|3|||
48876832|NCT04147858|157386665|FG001|Overall Study|Withdrawal by Subject|4|||
48876833|NCT04147858|157386666|FG002|Overall Study|Withdrawal by Subject|10|||
48876834|NCT04147858|157386664|FG000|Overall Study|Subject Noncompliance, Other|4|||
48876835|NCT04147858|157386665|FG001|Overall Study|Subject Noncompliance, Other|3|||
48876836|NCT04147858|157386666|FG002|Overall Study|Subject Noncompliance, Other|1|||
48876837|NCT00975676|157386672|FG000|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6|||
48876838|NCT00975676|157386673|FG001|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8|||
48876839|NCT02201901|157386674|FG000|Overall Study|Randomized but never treated|0|||
48876840|NCT02201901|157386675|FG001|Overall Study|Randomized but never treated|1|||
48876841|NCT02201901|157386676|FG002|Overall Study|Randomized but never treated|0|||
48876842|NCT02201901|157386674|FG000|Overall Study|Lack of Efficacy|7|||
48876843|NCT02201901|157386675|FG001|Overall Study|Lack of Efficacy|1|||
48876844|NCT02201901|157386676|FG002|Overall Study|Lack of Efficacy|6|||
48876845|NCT02201901|157386674|FG000|Overall Study|Death|3|||
48876846|NCT02201901|157386675|FG001|Overall Study|Death|3|||
48876847|NCT02201901|157386676|FG002|Overall Study|Death|3|||
48876848|NCT02201901|157386674|FG000|Overall Study|Lost to Follow-up|2|||
48876849|NCT02201901|157386675|FG001|Overall Study|Lost to Follow-up|3|||
48876850|NCT02201901|157386676|FG002|Overall Study|Lost to Follow-up|2|||
48876851|NCT02201901|157386674|FG000|Overall Study|Withdrew Consent|2|||
48876852|NCT02201901|157386675|FG001|Overall Study|Withdrew Consent|0|||
48876853|NCT02201901|157386676|FG002|Overall Study|Withdrew Consent|2|||
48876854|NCT02201901|157386674|FG000|Overall Study|Adverse Event|1|||
48876855|NCT02201901|157386675|FG001|Overall Study|Adverse Event|1|||
48876856|NCT02201901|157386676|FG002|Overall Study|Adverse Event|0|||
48876857|NCT02548078|157386677|FG000|Overall Study|Serious adverse event/Adverse event|1|||
48876858|NCT02548078|157386678|FG001|Overall Study|Serious adverse event/Adverse event|0|||
48876859|NCT02548078|157386677|FG000|Overall Study|Moved from study area|3|||
48876860|NCT02548078|157386678|FG001|Overall Study|Moved from study area|3|||
48773710|NCT01687166|157014947|FG002|Overall Study|Equipment/Device Availability|0|||
48773711|NCT01687166|157014948|FG003|Overall Study|Equipment/Device Availability|0|||
48773712|NCT01687166|157014945|FG000|Overall Study|Death|1|||
48773713|NCT01687166|157014946|FG001|Overall Study|Death|1|||
48773714|NCT01687166|157014947|FG002|Overall Study|Death|0|||
48773715|NCT01687166|157014948|FG003|Overall Study|Death|0|||
48773716|NCT01687166|157014945|FG000|Overall Study|Protocol Violation|1|||
48773717|NCT01687166|157014946|FG001|Overall Study|Protocol Violation|1|||
48773718|NCT01687166|157014947|FG002|Overall Study|Protocol Violation|1|||
48773719|NCT01687166|157014948|FG003|Overall Study|Protocol Violation|0|||
48773720|NCT01687166|157014945|FG000|Overall Study|Subject moved out of state|0|||
48876861|NCT02548078|157386677|FG000|Overall Study|Lost to Follow-up|1|||
48773721|NCT01687166|157014946|FG001|Overall Study|Subject moved out of state|1|||
48773722|NCT01687166|157014947|FG002|Overall Study|Subject moved out of state|0|||
48773723|NCT01687166|157014948|FG003|Overall Study|Subject moved out of state|0|||
48773724|NCT01687166|157014945|FG000|Overall Study|Patient unable to be compliant|1|||
48773725|NCT01687166|157014946|FG001|Overall Study|Patient unable to be compliant|0|||
48773726|NCT01687166|157014947|FG002|Overall Study|Patient unable to be compliant|0|||
48773727|NCT01687166|157014948|FG003|Overall Study|Patient unable to be compliant|0|||
48876862|NCT02548078|157386678|FG001|Overall Study|Lost to Follow-up|3|||
48876863|NCT03358238|157386679|FG000|Overall Study|Withdrawal by Subject|0|||
48876864|NCT03358238|157386680|FG001|Overall Study|Withdrawal by Subject|1|||
48876865|NCT02242643|157386681|FG000|Overall Study|Protocol Violation|1|||
48876866|NCT02242643|157386682|FG001|Overall Study|Protocol Violation|2|||
48876867|NCT02242643|157386681|FG000|Overall Study|Withdrawal by Subject|15|||
48876868|NCT02242643|157386682|FG001|Overall Study|Withdrawal by Subject|10|||
48876869|NCT02242643|157386681|FG000|Overall Study|Migrated/moved from study area|1|||
49098993|NCT01744184|158197013|FG000|Overall Study|Adverse Event|1|||
48773728|NCT01687166|157014945|FG000|Overall Study|Physician choice to use different device|1|||
48773729|NCT01687166|157014946|FG001|Overall Study|Physician choice to use different device|2|||
48773730|NCT01687166|157014947|FG002|Overall Study|Physician choice to use different device|4|||
48773731|NCT01687166|157014948|FG003|Overall Study|Physician choice to use different device|0|||
48773732|NCT01687166|157014945|FG000|Overall Study|Insurance|0|||
48773733|NCT01687166|157014946|FG001|Overall Study|Insurance|0|||
48773734|NCT01687166|157014947|FG002|Overall Study|Insurance|1|||
48773735|NCT01687166|157014948|FG003|Overall Study|Insurance|1|||
48773736|NCT04122443|157014949|FG000|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
48773737|NCT04122443|157014950|FG001|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
48773738|NCT04122443|157014951|FG002|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|234|||
48773739|NCT04122443|157014949|FG000|Stage 1 - Open Label|Withdrawal by Subject|0|||
48773740|NCT04122443|157014950|FG001|Stage 1 - Open Label|Withdrawal by Subject|0|||
48773741|NCT04122443|157014951|FG002|Stage 1 - Open Label|Withdrawal by Subject|5|||
48773742|NCT01072201|157014952|FG000|Overall Study|Lost to Follow-up|0|||
48773743|NCT01072201|157014953|FG001|Overall Study|Lost to Follow-up|1|||
48773744|NCT00700011|157014954|FG000|Overall Study|Death|0|||
48773745|NCT00700011|157014955|FG001|Overall Study|Death|1|||
48773746|NCT00678561|157014956|FG000|Overall Study|Adverse Event|0|||
48773747|NCT00678561|157014957|FG001|Overall Study|Adverse Event|1|||
48773748|NCT00678561|157014958|FG002|Overall Study|Adverse Event|1|||
48773749|NCT00678561|157014959|FG003|Overall Study|Adverse Event|0|||
48773750|NCT00678561|157014960|FG004|Overall Study|Adverse Event|1|||
48773751|NCT00678561|157014961|FG005|Overall Study|Adverse Event|0|||
48773752|NCT00678561|157014962|FG006|Overall Study|Adverse Event|0|||
48773753|NCT00678561|157014963|FG007|Overall Study|Adverse Event|0|||
48773754|NCT00678561|157014956|FG000|Overall Study|Protocol Violation|0|||
48773755|NCT00678561|157014957|FG001|Overall Study|Protocol Violation|0|||
48773756|NCT00678561|157014958|FG002|Overall Study|Protocol Violation|0|||
48773757|NCT00678561|157014959|FG003|Overall Study|Protocol Violation|0|||
48773758|NCT00678561|157014960|FG004|Overall Study|Protocol Violation|1|||
48773759|NCT00678561|157014961|FG005|Overall Study|Protocol Violation|1|||
48773760|NCT00678561|157014962|FG006|Overall Study|Protocol Violation|0|||
48773761|NCT00678561|157014963|FG007|Overall Study|Protocol Violation|0|||
48773762|NCT00678561|157014956|FG000|Overall Study|Withdrawal by Subject|0|||
48773763|NCT00678561|157014957|FG001|Overall Study|Withdrawal by Subject|0|||
48773764|NCT00678561|157014958|FG002|Overall Study|Withdrawal by Subject|0|||
48773765|NCT00678561|157014959|FG003|Overall Study|Withdrawal by Subject|0|||
48773766|NCT00678561|157014960|FG004|Overall Study|Withdrawal by Subject|0|||
48773767|NCT00678561|157014961|FG005|Overall Study|Withdrawal by Subject|0|||
48773768|NCT00678561|157014962|FG006|Overall Study|Withdrawal by Subject|0|||
48773769|NCT00678561|157014963|FG007|Overall Study|Withdrawal by Subject|1|||
48773770|NCT00667342|157016648|FG000|Overall Study|Protocol Violation|1|||
48773771|NCT00667342|157016649|FG001|Overall Study|Protocol Violation|0|||
48773772|NCT00667342|157016650|FG002|Overall Study|Protocol Violation|0|||
48773773|NCT00667342|157016648|FG000|Overall Study|Withdrawal by Subject|1|||
48773774|NCT00667342|157016649|FG001|Overall Study|Withdrawal by Subject|0|||
48773775|NCT00667342|157016650|FG002|Overall Study|Withdrawal by Subject|0|||
48773776|NCT00667342|157016648|FG000|Overall Study|Physician Decision|3|||
48773777|NCT00667342|157016649|FG001|Overall Study|Physician Decision|0|||
48773778|NCT00667342|157016650|FG002|Overall Study|Physician Decision|0|||
48773779|NCT00667342|157016648|FG000|Overall Study|Relapse or tumor progression|9|||
48773780|NCT00667342|157016649|FG001|Overall Study|Relapse or tumor progression|0|||
48773781|NCT00667342|157016650|FG002|Overall Study|Relapse or tumor progression|7|||
48773782|NCT00667342|157016648|FG000|Overall Study|Adverse Event|0|||
48773783|NCT00667342|157016649|FG001|Overall Study|Adverse Event|0|||
48773784|NCT00667342|157016650|FG002|Overall Study|Adverse Event|1|||
48773785|NCT00667342|157016648|FG000|Overall Study|Ineligible|0|||
48876870|NCT02242643|157386682|FG001|Overall Study|Migrated/moved from study area|3|||
48773786|NCT00667342|157016649|FG001|Overall Study|Ineligible|0|||
48773787|NCT00667342|157016650|FG002|Overall Study|Ineligible|1|||
48773788|NCT00293384|157016651|FG000|Overall Study|Non-compliance|2|||
48773789|NCT00293384|157016651|FG000|Overall Study|Missed dosage/study drug|1|||
48773790|NCT00293384|157016651|FG000|Overall Study|Ineligible|2|||
48773791|NCT01886833|157016658|FG000|Overall Study|IgA not available from both periods|204|||
48773792|NCT01440322|157016659|FG000|Overall Study|Discomfort|2|||
48773793|NCT01440322|157016660|FG001|Overall Study|Discomfort|0|||
48773794|NCT01440322|157016659|FG000|Overall Study|Biomicroscopy|1|||
48773795|NCT01440322|157016660|FG001|Overall Study|Biomicroscopy|0|||
48773796|NCT01440322|157016659|FG000|Overall Study|Symptoms and Problems|1|||
48773797|NCT01440322|157016660|FG001|Overall Study|Symptoms and Problems|0|||
48773798|NCT01440322|157016659|FG000|Overall Study|Unacceptable Subjective Vision|1|||
48773799|NCT01440322|157016660|FG001|Overall Study|Unacceptable Subjective Vision|0|||
48773800|NCT01440322|157016659|FG000|Overall Study|Other Product Related|1|||
48773801|NCT01440322|157016660|FG001|Overall Study|Other Product Related|0|||
48773802|NCT01440322|157016659|FG000|Overall Study|Unrelated Medical Problem|0|||
48876871|NCT02242643|157386681|FG000|Overall Study|Lost to Follow-up|54|||
48773803|NCT01440322|157016660|FG001|Overall Study|Unrelated Medical Problem|1|||
48773804|NCT01440322|157016659|FG000|Overall Study|Other Non-Product Related|1|||
48876872|NCT02242643|157386682|FG001|Overall Study|Lost to Follow-up|61|||
48773805|NCT01440322|157016660|FG001|Overall Study|Other Non-Product Related|0|||
48773806|NCT00770120|157016668|FG000|Overall Study|Progression|31|||
48773807|NCT00770120|157016668|FG000|Overall Study|Adverse Event|11|||
48773808|NCT00770120|157016668|FG000|Overall Study|Not Protocol Specified|11|||
48773809|NCT00770120|157016668|FG000|Overall Study|Death|3|||
48773810|NCT00770120|157016668|FG000|Overall Study|Withdrawal by Subject|2|||
48773811|NCT00770120|157016668|FG000|Overall Study|Ineligible|1|||
48773812|NCT00770120|157016668|FG000|Overall Study|Never Received Treatment/Not Analyzable|1|||
48773813|NCT00770120|157016668|FG000|Overall Study|Reason under Review|1|||
48773814|NCT00279708|157016669|FG000|Overall Study|Withdrawal by Subject|2|||
48773815|NCT00279708|157016670|FG001|Overall Study|Withdrawal by Subject|3|||
48773816|NCT00279708|157016669|FG000|Overall Study|Adverse Event|1|||
48773817|NCT00279708|157016670|FG001|Overall Study|Adverse Event|1|||
48773818|NCT02652624|157016671|FG000|Randomized Phase|Pregnancy|3|||
48773819|NCT02652624|157016672|FG001|Randomized Phase|Pregnancy|1|||
48773820|NCT02652624|157016671|FG000|Randomized Phase|Investigator's Discretion|0|||
48773821|NCT02652624|157016672|FG001|Randomized Phase|Investigator's Discretion|2|||
48773822|NCT02652624|157016671|FG000|Randomized Phase|Death|0|||
48773823|NCT02652624|157016672|FG001|Randomized Phase|Death|1|||
48773824|NCT02652624|157016671|FG000|Randomized Phase|Lost to Follow-up|0|||
48773825|NCT02652624|157016672|FG001|Randomized Phase|Lost to Follow-up|1|||
48773826|NCT02652624|157016671|FG000|Extension Phase|Lost to Follow-up|3|||
48773827|NCT02652624|157016672|FG001|Extension Phase|Lost to Follow-up|1|||
48773828|NCT02652624|157016671|FG000|Extension Phase|Pregnancy|1|||
48773829|NCT02652624|157016672|FG001|Extension Phase|Pregnancy|1|||
48773830|NCT02652624|157016671|FG000|Extension Phase|Adverse Event|0|||
48773831|NCT02652624|157016672|FG001|Extension Phase|Adverse Event|1|||
48773832|NCT02652624|157016671|FG000|Extension Phase|Withdrew Consent|0|||
48773833|NCT02652624|157016672|FG001|Extension Phase|Withdrew Consent|1|||
48773834|NCT00501540|157016677|FG000|Overall Study|Death|5|||
48773835|NCT03228680|157016678|FG000|Overall Study|Adverse Event|13|||
48773836|NCT03228680|157016679|FG001|Overall Study|Adverse Event|18|||
48773837|NCT03228680|157016678|FG000|Overall Study|Randomization failure|0|||
48773838|NCT03228680|157016679|FG001|Overall Study|Randomization failure|1|||
48773839|NCT03228680|157016678|FG000|Overall Study|Withdrawal by Subject|1|||
48773840|NCT03228680|157016679|FG001|Overall Study|Withdrawal by Subject|0|||
48773841|NCT03228680|157016678|FG000|Overall Study|Other|9|||
48773842|NCT03228680|157016679|FG001|Overall Study|Other|16|||
48773843|NCT01018264|157016690|FG000|Overall Study|Withdrawal by Subject|1|||
48773844|NCT01018264|157016691|FG001|Overall Study|Withdrawal by Subject|0|||
48773845|NCT01018264|157016690|FG000|Overall Study|Lost to Follow-up|0|||
48876873|NCT02242643|157386681|FG000|Overall Study|Child placed in foster care by family|0|||
48876874|NCT02242643|157386682|FG001|Overall Study|Child placed in foster care by family|1|||
48876875|NCT02242643|157386681|FG000|Overall Study|Non-compliance|1|||
48876876|NCT02242643|157386682|FG001|Overall Study|Non-compliance|0|||
48876877|NCT02242643|157386681|FG000|Overall Study|Consent withdrawal by parent|1|||
48876878|NCT02242643|157386682|FG001|Overall Study|Consent withdrawal by parent|0|||
48876879|NCT02242643|157386681|FG000|Overall Study|Protocol requirements not followed|1|||
48876880|NCT02242643|157386682|FG001|Overall Study|Protocol requirements not followed|0|||
48876881|NCT02242643|157386681|FG000|Overall Study|Language barrier|1|||
49027456|NCT00585689|157939137|FG000|Overall Study|Patient had unresectable disease|1|||
49027457|NCT00585689|157939137|FG000|Overall Study|Death|1|||
49027458|NCT00984126|157939138|FG000|Overall Study|Protocol Violation|0|||
48773846|NCT01018264|157016691|FG001|Overall Study|Lost to Follow-up|1|||
48773847|NCT00211081|157016692|FG000|Overall Study|Withdrawal by Subject|2|||
48773848|NCT00678691|157016693|FG000|Overall Study|Adverse Event|6|||
48773849|NCT00678691|157016694|FG001|Overall Study|Adverse Event|4|||
48773850|NCT03698773|157016701|FG000|Overall Study|Lost to Follow-up|2|||
48773851|NCT03698773|157016702|FG001|Overall Study|Lost to Follow-up|1|||
48773852|NCT02047110|157016703|FG000|DB Treatment Period up to Week 24|Adverse Event|1|||
48773853|NCT02047110|157016704|FG001|DB Treatment Period up to Week 24|Adverse Event|0|||
48773854|NCT02047110|157016705|FG002|DB Treatment Period up to Week 24|Adverse Event|0|||
48773855|NCT02047110|157016706|FG003|DB Treatment Period up to Week 24|Adverse Event|0|||
48773856|NCT02047110|157016703|FG000|DB Treatment Period up to Week 24|Lost to Follow-up|1|||
48773857|NCT02047110|157016704|FG001|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
48773858|NCT02047110|157016705|FG002|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
48773859|NCT02047110|157016706|FG003|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
48773860|NCT02047110|157016703|FG000|DB Treatment Period up to Week 24|Protocol Violation|1|||
48773861|NCT02047110|157016704|FG001|DB Treatment Period up to Week 24|Protocol Violation|0|||
48773862|NCT02047110|157016705|FG002|DB Treatment Period up to Week 24|Protocol Violation|0|||
48773863|NCT02047110|157016706|FG003|DB Treatment Period up to Week 24|Protocol Violation|0|||
48876882|NCT02242643|157386682|FG001|Overall Study|Language barrier|0|||
48876883|NCT02242643|157386681|FG000|Overall Study|Withdrawal by subject at Visit 2|0|||
48773864|NCT02047110|157016703|FG000|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
48773865|NCT02047110|157016704|FG001|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
48773866|NCT02047110|157016705|FG002|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
48773867|NCT02047110|157016706|FG003|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
48773868|NCT02047110|157016703|FG000|DB Treatment Period up to Week 24|Other than specified|1|||
48773869|NCT02047110|157016704|FG001|DB Treatment Period up to Week 24|Other than specified|2|||
48773870|NCT02047110|157016705|FG002|DB Treatment Period up to Week 24|Other than specified|3|||
48773871|NCT02047110|157016706|FG003|DB Treatment Period up to Week 24|Other than specified|1|||
48773872|NCT02047110|157016703|FG000|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
48773873|NCT02047110|157016704|FG001|DB (Week 12 up to Week 24)|Withdrawal by Subject|1|||
48773874|NCT02047110|157016705|FG002|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
48773875|NCT02047110|157016706|FG003|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
48773876|NCT02047110|157016703|FG000|DB (Week 12 up to Week 24)|Other than specified|0|||
48773877|NCT02047110|157016704|FG001|DB (Week 12 up to Week 24)|Other than specified|1|||
48773878|NCT02047110|157016705|FG002|DB (Week 12 up to Week 24)|Other than specified|1|||
48773879|NCT02047110|157016706|FG003|DB (Week 12 up to Week 24)|Other than specified|0|||
48773880|NCT02047110|157016703|FG000|Escape Treatment Period|Withdrawal by Subject|1|||
48773881|NCT02047110|157016704|FG001|Escape Treatment Period|Withdrawal by Subject|2|||
48773882|NCT02047110|157016705|FG002|Escape Treatment Period|Withdrawal by Subject|1|||
48773883|NCT02047110|157016706|FG003|Escape Treatment Period|Withdrawal by Subject|1|||
48773884|NCT02047110|157016703|FG000|Escape Treatment Period|Adverse Event|1|||
48773885|NCT02047110|157016704|FG001|Escape Treatment Period|Adverse Event|2|||
48773886|NCT02047110|157016705|FG002|Escape Treatment Period|Adverse Event|2|||
48773887|NCT02047110|157016706|FG003|Escape Treatment Period|Adverse Event|0|||
48773888|NCT02047110|157016703|FG000|Escape Treatment Period|Other than specified|1|||
48773889|NCT02047110|157016704|FG001|Escape Treatment Period|Other than specified|2|||
48773890|NCT02047110|157016705|FG002|Escape Treatment Period|Other than specified|0|||
48773891|NCT02047110|157016706|FG003|Escape Treatment Period|Other than specified|1|||
48773892|NCT02047110|157016703|FG000|OLE Treatment Period|Other than specified|0|||
48773893|NCT02047110|157016704|FG001|OLE Treatment Period|Other than specified|0|||
48773894|NCT02047110|157016705|FG002|OLE Treatment Period|Other than specified|1|||
48773895|NCT02047110|157016706|FG003|OLE Treatment Period|Other than specified|0|||
48773896|NCT02247349|157016707|FG000|Overall Study|Disease Progression|7|||
48773897|NCT02247349|157016708|FG001|Overall Study|Disease Progression|4|||
48773898|NCT02247349|157016709|FG002|Overall Study|Disease Progression|26|||
48773899|NCT02247349|157016710|FG003|Overall Study|Disease Progression|31|||
48773900|NCT02247349|157016711|FG004|Overall Study|Disease Progression|16|||
48773901|NCT02247349|157016712|FG005|Overall Study|Disease Progression|6|||
48773902|NCT02247349|157016707|FG000|Overall Study|Study drug toxicity|0|||
48773903|NCT02247349|157016708|FG001|Overall Study|Study drug toxicity|1|||
48773904|NCT02247349|157016709|FG002|Overall Study|Study drug toxicity|1|||
48773905|NCT02247349|157016710|FG003|Overall Study|Study drug toxicity|1|||
48773906|NCT02247349|157016711|FG004|Overall Study|Study drug toxicity|2|||
48773907|NCT02247349|157016712|FG005|Overall Study|Study drug toxicity|2|||
48773908|NCT02247349|157016707|FG000|Overall Study|Death|0|||
48773909|NCT02247349|157016708|FG001|Overall Study|Death|0|||
48773910|NCT02247349|157016709|FG002|Overall Study|Death|0|||
48773911|NCT02247349|157016710|FG003|Overall Study|Death|1|||
48773912|NCT02247349|157016711|FG004|Overall Study|Death|0|||
48773913|NCT02247349|157016712|FG005|Overall Study|Death|0|||
48773914|NCT02247349|157016707|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
48773915|NCT02247349|157016708|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
48773916|NCT02247349|157016709|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
48773917|NCT02247349|157016710|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
48773918|NCT02247349|157016711|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
48773919|NCT02247349|157016712|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
48773920|NCT02247349|157016707|FG000|Overall Study|Participant request to discontinue study treatment|0|||
48773921|NCT02247349|157016708|FG001|Overall Study|Participant request to discontinue study treatment|0|||
48773922|NCT02247349|157016709|FG002|Overall Study|Participant request to discontinue study treatment|1|||
48773923|NCT02247349|157016710|FG003|Overall Study|Participant request to discontinue study treatment|2|||
48773924|NCT02247349|157016711|FG004|Overall Study|Participant request to discontinue study treatment|1|||
48773925|NCT02247349|157016712|FG005|Overall Study|Participant request to discontinue study treatment|0|||
48773926|NCT02247349|157016707|FG000|Overall Study|Withdrawal by Subject|0|||
48773927|NCT02247349|157016708|FG001|Overall Study|Withdrawal by Subject|1|||
48773928|NCT02247349|157016709|FG002|Overall Study|Withdrawal by Subject|0|||
48773929|NCT02247349|157016710|FG003|Overall Study|Withdrawal by Subject|0|||
48773930|NCT02247349|157016711|FG004|Overall Study|Withdrawal by Subject|0|||
48773931|NCT02247349|157016712|FG005|Overall Study|Withdrawal by Subject|0|||
48773932|NCT02247349|157016707|FG000|Overall Study|Administrative reason by sponsor|0|||
48876884|NCT02242643|157386682|FG001|Overall Study|Withdrawal by subject at Visit 2|1|||
48773933|NCT02247349|157016708|FG001|Overall Study|Administrative reason by sponsor|0|||
48773934|NCT02247349|157016709|FG002|Overall Study|Administrative reason by sponsor|0|||
48773935|NCT02247349|157016710|FG003|Overall Study|Administrative reason by sponsor|0|||
48773936|NCT02247349|157016711|FG004|Overall Study|Administrative reason by sponsor|1|||
48773937|NCT02247349|157016712|FG005|Overall Study|Administrative reason by sponsor|0|||
48773938|NCT02247349|157016707|FG000|Overall Study|Other reasons|0|||
48773939|NCT02247349|157016708|FG001|Overall Study|Other reasons|0|||
48773940|NCT02247349|157016709|FG002|Overall Study|Other reasons|1|||
48773941|NCT02247349|157016710|FG003|Overall Study|Other reasons|0|||
48773942|NCT02247349|157016711|FG004|Overall Study|Other reasons|0|||
48773943|NCT02247349|157016712|FG005|Overall Study|Other reasons|0|||
48773944|NCT02644967|157016713|FG000|Overall Study|Death|26|||
48773945|NCT02644967|157016713|FG000|Overall Study|Physician Decision|1|||
48773946|NCT02644967|157016713|FG000|Overall Study|Withdrawal by Subject|2|||
48773947|NCT02644967|157016713|FG000|Overall Study|Protocol Violation|1|||
48773948|NCT02644967|157016713|FG000|Overall Study|Progressive Disease|1|||
48773949|NCT02644967|157016713|FG000|Overall Study|Study Terminated by Sponsor|4|||
48773950|NCT00559962|157016714|FG000|Overall Study|Adverse Event|1|||
48773951|NCT00559962|157016715|FG001|Overall Study|Adverse Event|7|||
48773952|NCT00559962|157016716|FG002|Overall Study|Adverse Event|8|||
48773953|NCT00559962|157016717|FG003|Overall Study|Adverse Event|5|||
48773954|NCT00559962|157016718|FG004|Overall Study|Adverse Event|11|||
48773955|NCT00559962|157016719|FG005|Overall Study|Adverse Event|4|||
48773956|NCT00559962|157016720|FG006|Overall Study|Adverse Event|4|||
48773957|NCT00559962|157016721|FG007|Overall Study|Adverse Event|2|||
48773958|NCT00559962|157016714|FG000|Overall Study|Lost to Follow-up|0|||
48773959|NCT00559962|157016715|FG001|Overall Study|Lost to Follow-up|1|||
48773960|NCT00559962|157016716|FG002|Overall Study|Lost to Follow-up|0|||
48773961|NCT00559962|157016717|FG003|Overall Study|Lost to Follow-up|0|||
48773962|NCT00559962|157016718|FG004|Overall Study|Lost to Follow-up|0|||
48773963|NCT00559962|157016719|FG005|Overall Study|Lost to Follow-up|0|||
48773964|NCT00559962|157016720|FG006|Overall Study|Lost to Follow-up|0|||
48773965|NCT00559962|157016721|FG007|Overall Study|Lost to Follow-up|0|||
48773966|NCT00559962|157016714|FG000|Overall Study|Withdrawal by Subject|1|||
48773967|NCT00559962|157016715|FG001|Overall Study|Withdrawal by Subject|1|||
48773968|NCT00559962|157016716|FG002|Overall Study|Withdrawal by Subject|2|||
48773969|NCT00559962|157016717|FG003|Overall Study|Withdrawal by Subject|0|||
48773970|NCT00559962|157016718|FG004|Overall Study|Withdrawal by Subject|3|||
48876885|NCT02080403|157388453|FG000|Overall Study|Adverse Event|5|||
48876886|NCT02080403|157388454|FG001|Overall Study|Adverse Event|1|||
48876887|NCT02080403|157388453|FG000|Overall Study|Death|0|||
48876888|NCT02080403|157388454|FG001|Overall Study|Death|2|||
48876889|NCT02080403|157388453|FG000|Overall Study|Lost to Follow-up|2|||
48876890|NCT02080403|157388454|FG001|Overall Study|Lost to Follow-up|0|||
48876891|NCT02080403|157388453|FG000|Overall Study|Pregnancy|0|||
48876892|NCT02080403|157388454|FG001|Overall Study|Pregnancy|1|||
49027459|NCT00984126|157939139|FG001|Overall Study|Protocol Violation|0|||
49027460|NCT00984126|157939140|FG002|Overall Study|Protocol Violation|1|||
49027461|NCT00984126|157939141|FG003|Overall Study|Protocol Violation|2|||
49027462|NCT00984126|157939138|FG000|Overall Study|Adverse Event|0|||
49027463|NCT00984126|157939139|FG001|Overall Study|Adverse Event|0|||
49027464|NCT00984126|157939140|FG002|Overall Study|Adverse Event|0|||
49027465|NCT00984126|157939141|FG003|Overall Study|Adverse Event|2|||
49027466|NCT00984126|157939138|FG000|Overall Study|Choose to join Pathfinder trial™ + other|7|||
49027467|NCT00984126|157939139|FG001|Overall Study|Choose to join Pathfinder trial™ + other|7|||
49027468|NCT00984126|157939140|FG002|Overall Study|Choose to join Pathfinder trial™ + other|3|||
48876893|NCT02080403|157388453|FG000|Overall Study|Protocol Violation|3|||
48876894|NCT02080403|157388454|FG001|Overall Study|Protocol Violation|7|||
48876895|NCT02080403|157388453|FG000|Overall Study|Withdrawal by Subject|5|||
48876896|NCT02080403|157388454|FG001|Overall Study|Withdrawal by Subject|1|||
48876897|NCT00368641|157388455|FG000|Overall Study|Adverse Event|2|||
49027469|NCT00984126|157939141|FG003|Overall Study|Choose to join Pathfinder trial™ + other|46|||
48876898|NCT00368641|157388456|FG001|Overall Study|Adverse Event|1|||
48876899|NCT00368641|157388455|FG000|Overall Study|Death|1|||
48876900|NCT00368641|157388456|FG001|Overall Study|Death|0|||
48876901|NCT00368641|157388455|FG000|Overall Study|Withdrawal by Subject|1|||
49027470|NCT00984126|157939138|FG000|Overall Study|Withdrawal criteria|0|||
49027471|NCT00984126|157939139|FG001|Overall Study|Withdrawal criteria|1|||
48773971|NCT00559962|157016719|FG005|Overall Study|Withdrawal by Subject|1|||
48773972|NCT00559962|157016720|FG006|Overall Study|Withdrawal by Subject|0|||
48773973|NCT00559962|157016721|FG007|Overall Study|Withdrawal by Subject|2|||
48773974|NCT00559962|157016714|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
48773975|NCT00559962|157016715|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
48773976|NCT00559962|157016716|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
48773977|NCT00559962|157016717|FG003|Overall Study|Inclusion/exclusion criteria not met|0|||
48876902|NCT00368641|157388456|FG001|Overall Study|Withdrawal by Subject|0|||
48876903|NCT00368641|157388455|FG000|Overall Study|Sponsor decision to terminate study|2|||
48876904|NCT00368641|157388456|FG001|Overall Study|Sponsor decision to terminate study|5|||
48876905|NCT02820597|157388457|FG000|Overall Study|Lost to Follow-up|12|||
48876906|NCT00362375|157388458|FG000|Overall Study|Lost to Follow-up|40|||
48773978|NCT00559962|157016718|FG004|Overall Study|Inclusion/exclusion criteria not met|0|||
48773979|NCT00559962|157016719|FG005|Overall Study|Inclusion/exclusion criteria not met|0|||
48773980|NCT00559962|157016720|FG006|Overall Study|Inclusion/exclusion criteria not met|1|||
48773981|NCT00559962|157016721|FG007|Overall Study|Inclusion/exclusion criteria not met|0|||
48773982|NCT00259857|157016723|FG000|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1|||
48773983|NCT00259857|157016724|FG001|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2|||
48773984|NCT00259857|157016723|FG000|24 Months Treatment|Lost to Follow-up|0|||
48773985|NCT00259857|157016724|FG001|24 Months Treatment|Lost to Follow-up|3|||
48773986|NCT03837899|157016725|FG000|Overall Study|Death|6|||
48773987|NCT03837899|157016726|FG001|Overall Study|Death|8|||
48773988|NCT03837899|157016727|FG002|Overall Study|Death|3|||
48773989|NCT03837899|157016728|FG003|Overall Study|Death|7|||
48773990|NCT03837899|157016729|FG004|Overall Study|Death|8|||
48773991|NCT03837899|157016730|FG005|Overall Study|Death|7|||
48773992|NCT03837899|157016725|FG000|Overall Study|Moved to post-trial access program|0|||
48773993|NCT03837899|157016726|FG001|Overall Study|Moved to post-trial access program|1|||
48773994|NCT03837899|157016727|FG002|Overall Study|Moved to post-trial access program|0|||
48773995|NCT03837899|157016728|FG003|Overall Study|Moved to post-trial access program|0|||
48773996|NCT03837899|157016729|FG004|Overall Study|Moved to post-trial access program|0|||
48773997|NCT03837899|157016730|FG005|Overall Study|Moved to post-trial access program|0|||
48773998|NCT03837899|157016725|FG000|Overall Study|Other|0|||
48773999|NCT03837899|157016726|FG001|Overall Study|Other|0|||
48774000|NCT03837899|157016727|FG002|Overall Study|Other|0|||
48774001|NCT03837899|157016728|FG003|Overall Study|Other|0|||
48774002|NCT03837899|157016729|FG004|Overall Study|Other|0|||
48774003|NCT03837899|157016730|FG005|Overall Study|Other|2|||
48774004|NCT03837899|157016725|FG000|Overall Study|Lost to Follow-up|0|||
48774005|NCT03837899|157016726|FG001|Overall Study|Lost to Follow-up|1|||
48774006|NCT03837899|157016727|FG002|Overall Study|Lost to Follow-up|0|||
48774007|NCT03837899|157016728|FG003|Overall Study|Lost to Follow-up|0|||
48774008|NCT03837899|157016729|FG004|Overall Study|Lost to Follow-up|0|||
48774009|NCT03837899|157016730|FG005|Overall Study|Lost to Follow-up|0|||
48774010|NCT03837899|157016725|FG000|Overall Study|Withdrawal by Subject|0|||
48774011|NCT03837899|157016726|FG001|Overall Study|Withdrawal by Subject|0|||
48774012|NCT03837899|157016727|FG002|Overall Study|Withdrawal by Subject|0|||
48774013|NCT03837899|157016728|FG003|Overall Study|Withdrawal by Subject|1|||
48774014|NCT03837899|157016729|FG004|Overall Study|Withdrawal by Subject|0|||
48774015|NCT03837899|157016730|FG005|Overall Study|Withdrawal by Subject|0|||
48774016|NCT03837899|157016725|FG000|Overall Study|Study specific discontinuation criteria|0|||
48774017|NCT03837899|157016726|FG001|Overall Study|Study specific discontinuation criteria|1|||
48774018|NCT03837899|157016727|FG002|Overall Study|Study specific discontinuation criteria|0|||
48774019|NCT03837899|157016728|FG003|Overall Study|Study specific discontinuation criteria|0|||
48774020|NCT03837899|157016729|FG004|Overall Study|Study specific discontinuation criteria|3|||
48774021|NCT03837899|157016730|FG005|Overall Study|Study specific discontinuation criteria|1|||
48774022|NCT00393939|157016731|FG000|Overall Study|Protocol Violation|1|||
48774023|NCT00393939|157016732|FG001|Overall Study|Protocol Violation|1|||
48774024|NCT00393939|157016731|FG000|Overall Study|Lost to Follow-up|2|||
48774025|NCT00393939|157016732|FG001|Overall Study|Lost to Follow-up|4|||
48774026|NCT00393939|157016731|FG000|Overall Study|Death|10|||
48774027|NCT00393939|157016732|FG001|Overall Study|Death|4|||
48774028|NCT00393939|157016731|FG000|Overall Study|Sponsor|5|||
48774029|NCT00393939|157016732|FG001|Overall Study|Sponsor|13|||
48774030|NCT00393939|157016731|FG000|Overall Study|Objective progression or relapse|239|||
48774031|NCT00393939|157016732|FG001|Overall Study|Objective progression or relapse|223|||
48774032|NCT00393939|157016731|FG000|Overall Study|Withdrawal by Subject|2|||
48774033|NCT00393939|157016732|FG001|Overall Study|Withdrawal by Subject|7|||
48774034|NCT00393939|157016731|FG000|Overall Study|Other|37|||
48774035|NCT00393939|157016732|FG001|Overall Study|Other|45|||
48774036|NCT00637195|157016733|FG000|Overall Study|Lost to Follow-up|1|||
48774037|NCT00637195|157016734|FG001|Overall Study|Lost to Follow-up|0|||
48774038|NCT00637195|157016733|FG000|Overall Study|Other|2|||
48774039|NCT00637195|157016734|FG001|Overall Study|Other|0|||
48774040|NCT00637195|157016733|FG000|Overall Study|Withdrawal by Subject|0|||
48774041|NCT00637195|157016734|FG001|Overall Study|Withdrawal by Subject|1|||
48774042|NCT04542070|157016737|FG000|Maintenance Period (Day 1 - Month 12)|Adverse Event|10|||
48774043|NCT04542070|157016738|FG001|Maintenance Period (Day 1 - Month 12)|Adverse Event|3|||
48774044|NCT04542070|157016739|FG002|Maintenance Period (Day 1 - Month 12)|Adverse Event|1|||
48774045|NCT04542070|157016740|FG003|Maintenance Period (Day 1 - Month 12)|Adverse Event|0|||
49027472|NCT00984126|157939140|FG002|Overall Study|Withdrawal criteria|3|||
48774046|NCT04542070|157016737|FG000|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|1|||
48774047|NCT04542070|157016738|FG001|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|2|||
48774048|NCT04542070|157016739|FG002|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
48774049|NCT04542070|157016740|FG003|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
48774050|NCT04542070|157016737|FG000|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|3|||
48774051|NCT04542070|157016738|FG001|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|4|||
48774052|NCT04542070|157016739|FG002|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|2|||
48774053|NCT04542070|157016740|FG003|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|0|||
48774054|NCT04542070|157016737|FG000|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
48774055|NCT04542070|157016738|FG001|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
48774056|NCT04542070|157016739|FG002|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
48774057|NCT04542070|157016740|FG003|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
48774058|NCT04542070|157016737|FG000|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|5|||
48774059|NCT04542070|157016738|FG001|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|8|||
48774060|NCT04542070|157016739|FG002|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|9|||
48774061|NCT04542070|157016740|FG003|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|0|||
48774062|NCT04542070|157016737|FG000|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|2|||
48774063|NCT04542070|157016738|FG001|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|6|||
48774064|NCT04542070|157016739|FG002|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|1|||
48774065|NCT04542070|157016740|FG003|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|0|||
48774066|NCT04542070|157016737|FG000|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
48774067|NCT04542070|157016738|FG001|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
49027473|NCT00984126|157939141|FG003|Overall Study|Withdrawal criteria|9|||
49027474|NCT02373098|157939142|FG000|Overall Study|Lost to Follow-up|1|||
49027475|NCT02373098|157939143|FG001|Overall Study|Lost to Follow-up|0|||
48774068|NCT04542070|157016739|FG002|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
48774069|NCT04542070|157016740|FG003|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
48774070|NCT04542070|157016737|FG000|Maintenance + Extension Period|Adverse Event|10|||
48774071|NCT04542070|157016738|FG001|Maintenance + Extension Period|Adverse Event|2|||
48774072|NCT04542070|157016739|FG002|Maintenance + Extension Period|Adverse Event|0|||
48774073|NCT04542070|157016740|FG003|Maintenance + Extension Period|Adverse Event|0|||
48774074|NCT04542070|157016737|FG000|Maintenance + Extension Period|Lack of Efficacy|2|||
48774075|NCT04542070|157016738|FG001|Maintenance + Extension Period|Lack of Efficacy|2|||
48774076|NCT04542070|157016739|FG002|Maintenance + Extension Period|Lack of Efficacy|0|||
48774077|NCT04542070|157016740|FG003|Maintenance + Extension Period|Lack of Efficacy|0|||
48774078|NCT04542070|157016737|FG000|Maintenance + Extension Period|Lost to Follow-up|3|||
48774079|NCT04542070|157016738|FG001|Maintenance + Extension Period|Lost to Follow-up|4|||
48774080|NCT04542070|157016739|FG002|Maintenance + Extension Period|Lost to Follow-up|0|||
48774081|NCT04542070|157016740|FG003|Maintenance + Extension Period|Lost to Follow-up|0|||
48774082|NCT04542070|157016737|FG000|Maintenance + Extension Period|Physician Decision|1|||
48774083|NCT04542070|157016738|FG001|Maintenance + Extension Period|Physician Decision|1|||
48774084|NCT04542070|157016739|FG002|Maintenance + Extension Period|Physician Decision|0|||
48774085|NCT04542070|157016740|FG003|Maintenance + Extension Period|Physician Decision|0|||
48774086|NCT04542070|157016737|FG000|Maintenance + Extension Period|Protocol Violation|2|||
48774087|NCT04542070|157016738|FG001|Maintenance + Extension Period|Protocol Violation|5|||
48774088|NCT04542070|157016739|FG002|Maintenance + Extension Period|Protocol Violation|0|||
48774089|NCT04542070|157016740|FG003|Maintenance + Extension Period|Protocol Violation|0|||
48774090|NCT04542070|157016737|FG000|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
48774091|NCT04542070|157016738|FG001|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
48774092|NCT04542070|157016739|FG002|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
48774093|NCT04542070|157016740|FG003|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
48774094|NCT04542070|157016737|FG000|Maintenance + Extension Period|Withdrawal by Subject|4|||
48774095|NCT04542070|157016738|FG001|Maintenance + Extension Period|Withdrawal by Subject|12|||
48774096|NCT04542070|157016739|FG002|Maintenance + Extension Period|Withdrawal by Subject|0|||
48774097|NCT04542070|157016740|FG003|Maintenance + Extension Period|Withdrawal by Subject|0|||
48774098|NCT04542070|157016737|FG000|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
48774099|NCT04542070|157016738|FG001|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
48774100|NCT04542070|157016739|FG002|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
48774101|NCT04542070|157016740|FG003|Extension Period (Month 13 - Month 27)|Adverse Event|4|||
49027476|NCT02373098|157939142|FG000|Overall Study|Protocol Violation|3|||
49027477|NCT02373098|157939143|FG001|Overall Study|Protocol Violation|0|||
49027478|NCT02373098|157939142|FG000|Overall Study|Withdrawal by Subject|5|||
49027479|NCT02373098|157939143|FG001|Overall Study|Withdrawal by Subject|0|||
49027480|NCT02373098|157939142|FG000|Overall Study|Adverse Event|3|||
49027481|NCT02373098|157939143|FG001|Overall Study|Adverse Event|0|||
49027482|NCT02008565|157939147|FG000|Overall Study|Protocol Violation|1|||
49027483|NCT02008565|157939148|FG001|Overall Study|Protocol Violation|1|||
49027484|NCT02008565|157939149|FG002|Overall Study|Protocol Violation|2|||
49027485|NCT02008565|157939150|FG003|Overall Study|Protocol Violation|0|||
48774102|NCT04542070|157016737|FG000|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
49027486|NCT00318461|157939151|FG000|Double-Blind, 6 Months|Adverse Event|11|||
49027487|NCT00318461|157939152|FG001|Double-Blind, 6 Months|Adverse Event|23|||
49027488|NCT00318461|157939153|FG002|Double-Blind, 6 Months|Adverse Event|29|||
49027489|NCT00318461|157939154|FG003|Double-Blind, 6 Months|Adverse Event|2|||
48774103|NCT04542070|157016738|FG001|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
48774104|NCT04542070|157016739|FG002|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
48774105|NCT04542070|157016740|FG003|Extension Period (Month 13 - Month 27)|Lack of Efficacy|1|||
48774106|NCT04542070|157016737|FG000|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
48774107|NCT04542070|157016738|FG001|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
48774108|NCT04542070|157016739|FG002|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
48774109|NCT04542070|157016740|FG003|Extension Period (Month 13 - Month 27)|Lost to Follow-up|1|||
48774110|NCT04542070|157016737|FG000|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
48774111|NCT04542070|157016738|FG001|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
48774112|NCT04542070|157016739|FG002|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
48774113|NCT04542070|157016740|FG003|Extension Period (Month 13 - Month 27)|Physician Decision|2|||
49027490|NCT00318461|157939155|FG004|Double-Blind, 6 Months|Adverse Event|8|||
49027491|NCT00318461|157939151|FG000|Double-Blind, 6 Months|Lack of Efficacy|19|||
49027492|NCT00318461|157939152|FG001|Double-Blind, 6 Months|Lack of Efficacy|8|||
49027493|NCT00318461|157939153|FG002|Double-Blind, 6 Months|Lack of Efficacy|13|||
49027494|NCT00318461|157939154|FG003|Double-Blind, 6 Months|Lack of Efficacy|29|||
49027495|NCT00318461|157939155|FG004|Double-Blind, 6 Months|Lack of Efficacy|9|||
48774114|NCT04542070|157016737|FG000|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
48774115|NCT04542070|157016738|FG001|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
48774116|NCT04542070|157016739|FG002|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
48774117|NCT04542070|157016740|FG003|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|5|||
48774118|NCT00550836|157016743|FG000|Overall Study|Withdrawal by Subject|3|||
48774119|NCT00550836|157016744|FG001|Overall Study|Withdrawal by Subject|9|||
48774120|NCT04085523|157016745|FG000|Open-Label Period (Weeks 52 to 156)|Study Ongoing|0|||
48774121|NCT04085523|157016746|FG001|Open-Label Period (Weeks 52 to 156)|Study Ongoing|0|||
48774122|NCT04085523|157016747|FG002|Open-Label Period (Weeks 52 to 156)|Study Ongoing|0|||
48774123|NCT04085523|157016748|FG003|Open-Label Period (Weeks 52 to 156)|Study Ongoing|0|||
48774124|NCT04085523|157016749|FG004|Open-Label Period (Weeks 52 to 156)|Study Ongoing|0|||
48774125|NCT04085523|157016750|FG005|Open-Label Period (Weeks 52 to 156)|Study Ongoing|57|||
48774126|NCT00715793|157016751|FG000|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1|||
48774127|NCT00715793|157016752|FG001|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0|||
48774128|NCT00715793|157016751|FG000|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0|||
48774129|NCT00715793|157016752|FG001|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2|||
48774130|NCT03194646|157016755|FG000|Overall Study|Adverse Event|24|||
48774131|NCT03194646|157016756|FG001|Overall Study|Adverse Event|25|||
48774132|NCT03194646|157016757|FG002|Overall Study|Adverse Event|14|||
48774133|NCT03194646|157016758|FG003|Overall Study|Adverse Event|17|||
48774134|NCT03194646|157016755|FG000|Overall Study|Lack of Efficacy|4|||
48774135|NCT03194646|157016756|FG001|Overall Study|Lack of Efficacy|2|||
48774136|NCT03194646|157016757|FG002|Overall Study|Lack of Efficacy|2|||
48774137|NCT03194646|157016758|FG003|Overall Study|Lack of Efficacy|12|||
48774138|NCT03194646|157016755|FG000|Overall Study|Lost to Follow-up|30|||
48774139|NCT03194646|157016756|FG001|Overall Study|Lost to Follow-up|22|||
48774140|NCT03194646|157016757|FG002|Overall Study|Lost to Follow-up|12|||
48774141|NCT03194646|157016758|FG003|Overall Study|Lost to Follow-up|35|||
48774142|NCT03194646|157016755|FG000|Overall Study|Non-compliance with study drug|4|||
48774143|NCT03194646|157016756|FG001|Overall Study|Non-compliance with study drug|0|||
48774144|NCT03194646|157016757|FG002|Overall Study|Non-compliance with study drug|1|||
48774145|NCT03194646|157016758|FG003|Overall Study|Non-compliance with study drug|1|||
48774146|NCT03194646|157016755|FG000|Overall Study|Other|89|||
48774147|NCT03194646|157016756|FG001|Overall Study|Other|68|||
48774148|NCT03194646|157016757|FG002|Overall Study|Other|34|||
48774149|NCT03194646|157016758|FG003|Overall Study|Other|31|||
48774150|NCT03194646|157016755|FG000|Overall Study|Physician Decision|7|||
48774151|NCT03194646|157016756|FG001|Overall Study|Physician Decision|9|||
48774152|NCT03194646|157016757|FG002|Overall Study|Physician Decision|5|||
48774153|NCT03194646|157016758|FG003|Overall Study|Physician Decision|4|||
49027496|NCT00318461|157939151|FG000|Double-Blind, 6 Months|Protocol Violation|2|||
49027497|NCT00318461|157939152|FG001|Double-Blind, 6 Months|Protocol Violation|4|||
49027498|NCT00318461|157939153|FG002|Double-Blind, 6 Months|Protocol Violation|4|||
49027499|NCT00318461|157939154|FG003|Double-Blind, 6 Months|Protocol Violation|4|||
49027500|NCT00318461|157939155|FG004|Double-Blind, 6 Months|Protocol Violation|5|||
49027501|NCT00318461|157939151|FG000|Double-Blind, 6 Months|Lost to follow up|0|||
49027502|NCT00318461|157939152|FG001|Double-Blind, 6 Months|Lost to follow up|1|||
49027503|NCT00318461|157939153|FG002|Double-Blind, 6 Months|Lost to follow up|0|||
49027504|NCT00318461|157939154|FG003|Double-Blind, 6 Months|Lost to follow up|0|||
49027505|NCT00318461|157939155|FG004|Double-Blind, 6 Months|Lost to follow up|0|||
48774154|NCT03194646|157016755|FG000|Overall Study|Pregnancy|4|||
49027506|NCT00318461|157939151|FG000|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
49027507|NCT00318461|157939152|FG001|Double-Blind, 6 Months|Poor compliance/Non-compliance|1|||
49027508|NCT00318461|157939153|FG002|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
49027509|NCT00318461|157939154|FG003|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
49098994|NCT01744184|158197014|FG001|Overall Study|Adverse Event|0|||
48774155|NCT03194646|157016756|FG001|Overall Study|Pregnancy|5|||
48774156|NCT03194646|157016757|FG002|Overall Study|Pregnancy|1|||
48774157|NCT03194646|157016758|FG003|Overall Study|Pregnancy|2|||
48774158|NCT03194646|157016755|FG000|Overall Study|Protocol Violation|4|||
48774159|NCT03194646|157016756|FG001|Overall Study|Protocol Violation|2|||
48774160|NCT03194646|157016757|FG002|Overall Study|Protocol Violation|1|||
48774161|NCT03194646|157016758|FG003|Overall Study|Protocol Violation|1|||
48774162|NCT03194646|157016755|FG000|Overall Study|Site terminated by sponsor|0|||
48774163|NCT03194646|157016756|FG001|Overall Study|Site terminated by sponsor|0|||
48774164|NCT03194646|157016757|FG002|Overall Study|Site terminated by sponsor|2|||
48774165|NCT03194646|157016758|FG003|Overall Study|Site terminated by sponsor|0|||
48774166|NCT03194646|157016755|FG000|Overall Study|Study terminated by sponsor|62|||
48774167|NCT03194646|157016756|FG001|Overall Study|Study terminated by sponsor|61|||
48774168|NCT03194646|157016757|FG002|Overall Study|Study terminated by sponsor|30|||
48774169|NCT03194646|157016758|FG003|Overall Study|Study terminated by sponsor|34|||
48774170|NCT03194646|157016755|FG000|Overall Study|Withdrawal by Subject|75|||
48774171|NCT03194646|157016756|FG001|Overall Study|Withdrawal by Subject|74|||
48774172|NCT03194646|157016757|FG002|Overall Study|Withdrawal by Subject|36|||
48774173|NCT03194646|157016758|FG003|Overall Study|Withdrawal by Subject|131|||
48774174|NCT03194646|157016755|FG000|Overall Study|Missing|1|||
48774175|NCT03194646|157016756|FG001|Overall Study|Missing|0|||
48774176|NCT03194646|157016757|FG002|Overall Study|Missing|1|||
48774177|NCT03194646|157016758|FG003|Overall Study|Missing|12|||
48774178|NCT03417141|157016761|FG000|Overall Study|Withdrawal by Subject|1|||
48774179|NCT03417141|157016761|FG000|Overall Study|Protocol Violation|3|||
48774180|NCT01712984|157016769|FG000|Overall Study|Adverse Event|0|||
48774181|NCT01712984|157016770|FG001|Overall Study|Adverse Event|0|||
48774182|NCT01712984|157016771|FG002|Overall Study|Adverse Event|1|||
48774183|NCT01712984|157016769|FG000|Overall Study|Protocol Violation|2|||
48774184|NCT01712984|157016770|FG001|Overall Study|Protocol Violation|0|||
48774185|NCT01712984|157016771|FG002|Overall Study|Protocol Violation|1|||
48774186|NCT01712984|157016769|FG000|Overall Study|Lost to Follow-up|8|||
48774187|NCT01712984|157016770|FG001|Overall Study|Lost to Follow-up|10|||
48774188|NCT01712984|157016771|FG002|Overall Study|Lost to Follow-up|1|||
48774189|NCT01712984|157016769|FG000|Overall Study|Withdrawal by Subject|6|||
48774190|NCT01712984|157016770|FG001|Overall Study|Withdrawal by Subject|6|||
48774191|NCT01712984|157016771|FG002|Overall Study|Withdrawal by Subject|7|||
48774192|NCT01800903|157016772|FG000|Second Test Period|unable to catheterise|1|||
48774193|NCT01800903|157016773|FG001|Second Test Period|unable to catheterise|0|||
48774194|NCT01800903|157016774|FG002|Second Test Period|unable to catheterise|0|||
49027510|NCT00318461|157939155|FG004|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
49027511|NCT00318461|157939151|FG000|Double-Blind, 6 Months|Consent withdrawn|0|||
48774195|NCT01800903|157016775|FG003|Second Test Period|unable to catheterise|0|||
48774196|NCT01800903|157016776|FG004|Second Test Period|unable to catheterise|0|||
48774197|NCT01800903|157016777|FG005|Second Test Period|unable to catheterise|0|||
48774198|NCT01328002|157016781|FG000|Open-Label Period|Inclusion/exclusion criteria not met|66|||
48774199|NCT01328002|157016782|FG001|Open-Label Period|Inclusion/exclusion criteria not met|0|||
48774200|NCT01328002|157016781|FG000|Open-Label Period|Adverse Event|8|||
48774201|NCT01328002|157016782|FG001|Open-Label Period|Adverse Event|0|||
48774202|NCT01328002|157016781|FG000|Open-Label Period|Lack of Efficacy|3|||
48774203|NCT01328002|157016782|FG001|Open-Label Period|Lack of Efficacy|0|||
48774204|NCT01328002|157016781|FG000|Open-Label Period|Protocol Violation|2|||
48774205|NCT01328002|157016782|FG001|Open-Label Period|Protocol Violation|0|||
48774206|NCT01328002|157016781|FG000|Open-Label Period|Withdrawal by Subject|9|||
48774207|NCT01328002|157016782|FG001|Open-Label Period|Withdrawal by Subject|0|||
48774208|NCT01328002|157016781|FG000|Open-Label Period|Lost to Follow-up|6|||
48774209|NCT01328002|157016782|FG001|Open-Label Period|Lost to Follow-up|0|||
48774210|NCT01328002|157016781|FG000|Open-Label Period|Other Reason|2|||
48774211|NCT01328002|157016782|FG001|Open-Label Period|Other Reason|0|||
48774212|NCT01328002|157016781|FG000|Double-Blind Period|Adverse Event|1|||
48774213|NCT01328002|157016782|FG001|Double-Blind Period|Adverse Event|0|||
48774214|NCT01328002|157016781|FG000|Double-Blind Period|Lack of Efficacy|1|||
48774215|NCT01328002|157016782|FG001|Double-Blind Period|Lack of Efficacy|0|||
48774216|NCT01208233|157016786|FG000|Overall Study|Adverse Event|0|||
48774217|NCT01208233|157016787|FG001|Overall Study|Adverse Event|1|||
48774218|NCT01208233|157016788|FG002|Overall Study|Adverse Event|2|||
48774219|NCT01208233|157016789|FG003|Overall Study|Adverse Event|0|||
48774220|NCT01208233|157016790|FG004|Overall Study|Adverse Event|3|||
48774221|NCT01208233|157016791|FG005|Overall Study|Adverse Event|5|||
48774222|NCT01208233|157016786|FG000|Overall Study|Death|0|||
48774223|NCT01208233|157016787|FG001|Overall Study|Death|0|||
48774224|NCT01208233|157016788|FG002|Overall Study|Death|0|||
48774225|NCT01208233|157016789|FG003|Overall Study|Death|0|||
48774226|NCT01208233|157016790|FG004|Overall Study|Death|3|||
48774227|NCT01208233|157016791|FG005|Overall Study|Death|5|||
48774228|NCT01208233|157016786|FG000|Overall Study|Did not meet entrance criteria|2|||
49027512|NCT00318461|157939152|FG001|Double-Blind, 6 Months|Consent withdrawn|3|||
48774229|NCT01208233|157016787|FG001|Overall Study|Did not meet entrance criteria|1|||
49027513|NCT00318461|157939153|FG002|Double-Blind, 6 Months|Consent withdrawn|4|||
49027514|NCT00318461|157939154|FG003|Double-Blind, 6 Months|Consent withdrawn|10|||
49027515|NCT00318461|157939155|FG004|Double-Blind, 6 Months|Consent withdrawn|4|||
49027516|NCT00318461|157939151|FG000|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
49027517|NCT00318461|157939152|FG001|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
49027518|NCT00318461|157939153|FG002|Double-Blind, 6 Months|Subject decision/No wish to continue|1|||
49027519|NCT00318461|157939154|FG003|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
49027520|NCT00318461|157939155|FG004|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
49027521|NCT00318461|157939151|FG000|Double-Blind, 6 Months|Move|0|||
49027522|NCT00318461|157939152|FG001|Double-Blind, 6 Months|Move|1|||
49027523|NCT00318461|157939153|FG002|Double-Blind, 6 Months|Move|0|||
49027524|NCT00318461|157939154|FG003|Double-Blind, 6 Months|Move|0|||
49027525|NCT00318461|157939155|FG004|Double-Blind, 6 Months|Move|0|||
49027526|NCT00318461|157939151|FG000|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
49027527|NCT00318461|157939152|FG001|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
49027528|NCT00318461|157939153|FG002|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
49027529|NCT00318461|157939154|FG003|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
49027530|NCT00318461|157939155|FG004|Double-Blind, 6 Months|Tendency to low blood glucose levels|1|||
49027531|NCT00318461|157939151|FG000|Double-Blind, 6 Months|FPG exceeds limits/too high|1|||
49027532|NCT00318461|157939152|FG001|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
49027533|NCT00318461|157939153|FG002|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
49027534|NCT00318461|157939154|FG003|Double-Blind, 6 Months|FPG exceeds limits/too high|2|||
49027535|NCT00318461|157939155|FG004|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
48774230|NCT01208233|157016788|FG002|Overall Study|Did not meet entrance criteria|1|||
48774231|NCT01208233|157016789|FG003|Overall Study|Did not meet entrance criteria|0|||
48774232|NCT01208233|157016790|FG004|Overall Study|Did not meet entrance criteria|1|||
48774233|NCT01208233|157016791|FG005|Overall Study|Did not meet entrance criteria|0|||
48774234|NCT01208233|157016786|FG000|Overall Study|Medication error without adverse event|0|||
48774235|NCT01208233|157016787|FG001|Overall Study|Medication error without adverse event|0|||
48774236|NCT01208233|157016788|FG002|Overall Study|Medication error without adverse event|0|||
48774237|NCT01208233|157016789|FG003|Overall Study|Medication error without adverse event|0|||
48774238|NCT01208233|157016790|FG004|Overall Study|Medication error without adverse event|0|||
48774239|NCT01208233|157016791|FG005|Overall Study|Medication error without adverse event|1|||
48774240|NCT01208233|157016786|FG000|Overall Study|Study terminated by sponsor|0|||
48774241|NCT01208233|157016787|FG001|Overall Study|Study terminated by sponsor|0|||
48774242|NCT01208233|157016788|FG002|Overall Study|Study terminated by sponsor|0|||
48774243|NCT01208233|157016789|FG003|Overall Study|Study terminated by sponsor|0|||
48774244|NCT01208233|157016790|FG004|Overall Study|Study terminated by sponsor|10|||
48774245|NCT01208233|157016791|FG005|Overall Study|Study terminated by sponsor|7|||
48774246|NCT01208233|157016786|FG000|Overall Study|Protocol Violation|0|||
48774247|NCT01208233|157016787|FG001|Overall Study|Protocol Violation|0|||
48774248|NCT01208233|157016788|FG002|Overall Study|Protocol Violation|0|||
48774249|NCT01208233|157016789|FG003|Overall Study|Protocol Violation|0|||
48774250|NCT01208233|157016790|FG004|Overall Study|Protocol Violation|3|||
48774251|NCT01208233|157016791|FG005|Overall Study|Protocol Violation|0|||
48774252|NCT01208233|157016786|FG000|Overall Study|Other|2|||
48774253|NCT01208233|157016787|FG001|Overall Study|Other|1|||
48774254|NCT01208233|157016788|FG002|Overall Study|Other|0|||
48774255|NCT01208233|157016789|FG003|Overall Study|Other|0|||
48774256|NCT01208233|157016790|FG004|Overall Study|Other|0|||
48774257|NCT01208233|157016791|FG005|Overall Study|Other|1|||
48774258|NCT01208233|157016786|FG000|Overall Study|Withdrawal by Subject|1|||
48774259|NCT01208233|157016787|FG001|Overall Study|Withdrawal by Subject|0|||
48774260|NCT01208233|157016788|FG002|Overall Study|Withdrawal by Subject|1|||
48774261|NCT01208233|157016789|FG003|Overall Study|Withdrawal by Subject|1|||
48774262|NCT01208233|157016790|FG004|Overall Study|Withdrawal by Subject|4|||
48774263|NCT01208233|157016791|FG005|Overall Study|Withdrawal by Subject|2|||
48774264|NCT01110239|157016794|FG000|Sham Preconditioning|Withdrawal by Subject|0|||
48774265|NCT01110239|157016795|FG001|Sham Preconditioning|Withdrawal by Subject|0|||
48774266|NCT01110239|157016796|FG002|Sham Preconditioning|Withdrawal by Subject|1|||
49027536|NCT00318461|157939151|FG000|Double-Blind, 6 Months|Work commitment|0|||
49027537|NCT00318461|157939152|FG001|Double-Blind, 6 Months|Work commitment|0|||
48774267|NCT01110239|157016797|FG003|Sham Preconditioning|Withdrawal by Subject|0|||
48774268|NCT01110239|157016794|FG000|7.5 Min Ischemia|Withdrawal by Subject|0|||
48774269|NCT01110239|157016795|FG001|7.5 Min Ischemia|Withdrawal by Subject|0|||
48774270|NCT01110239|157016796|FG002|7.5 Min Ischemia|Withdrawal by Subject|1|||
48774271|NCT01110239|157016797|FG003|7.5 Min Ischemia|Withdrawal by Subject|0|||
48774272|NCT03135522|157016798|FG000|Overall Study|Adverse Event|1|||
48774273|NCT03135522|157016799|FG001|Overall Study|Adverse Event|0|||
49027538|NCT00318461|157939153|FG002|Double-Blind, 6 Months|Work commitment|0|||
49027539|NCT00318461|157939154|FG003|Double-Blind, 6 Months|Work commitment|0|||
49027540|NCT00318461|157939155|FG004|Double-Blind, 6 Months|Work commitment|1|||
48774274|NCT00459134|157016801|FG000|Overall Study|Physician Decision|1|||
48774275|NCT00459134|157016802|FG001|Overall Study|Physician Decision|1|||
48774276|NCT00459134|157016801|FG000|Overall Study|Withdrawal by Subject|8|||
48774277|NCT00459134|157016802|FG001|Overall Study|Withdrawal by Subject|7|||
48774278|NCT00459134|157016801|FG000|Overall Study|Lost to Follow-up|6|||
48774279|NCT00459134|157016802|FG001|Overall Study|Lost to Follow-up|7|||
48774280|NCT00459134|157016801|FG000|Overall Study|Surgery|1|||
48774281|NCT00459134|157016802|FG001|Overall Study|Surgery|2|||
48774282|NCT00459134|157016801|FG000|Overall Study|Toxicity|4|||
48774283|NCT00459134|157016802|FG001|Overall Study|Toxicity|5|||
48774284|NCT00459134|157016801|FG000|Overall Study|Progression|1|||
48774285|NCT00459134|157016802|FG001|Overall Study|Progression|0|||
48774286|NCT00459134|157016801|FG000|Overall Study|Multiple Reasons|2|||
48774287|NCT00459134|157016802|FG001|Overall Study|Multiple Reasons|3|||
48774288|NCT01332149|157018705|FG000|Overall Study|Adverse Event|11|||
48774289|NCT01332149|157018706|FG001|Overall Study|Adverse Event|9|||
48774290|NCT01332149|157018705|FG000|Overall Study|Other unspecified|5|||
48774291|NCT01332149|157018706|FG001|Overall Study|Other unspecified|7|||
48774292|NCT01332149|157018705|FG000|Overall Study|Protocol Violation|1|||
48774293|NCT01332149|157018706|FG001|Overall Study|Protocol Violation|3|||
48774294|NCT01332149|157018705|FG000|Overall Study|Withdrawal by Subject|4|||
48774295|NCT01332149|157018706|FG001|Overall Study|Withdrawal by Subject|5|||
48774296|NCT01332149|157018705|FG000|Overall Study|Lost to Follow-up|1|||
48774297|NCT01332149|157018706|FG001|Overall Study|Lost to Follow-up|1|||
48774298|NCT01332149|157018705|FG000|Overall Study|Insufficient clinical response|4|||
48774299|NCT01332149|157018706|FG001|Overall Study|Insufficient clinical response|7|||
48774300|NCT01332149|157018705|FG000|Overall Study|Did not meet entrance criteria|3|||
48774301|NCT01332149|157018706|FG001|Overall Study|Did not meet entrance criteria|4|||
48774302|NCT01332149|157018705|FG000|Overall Study|Randomized but not treated|1|||
48774303|NCT01332149|157018706|FG001|Overall Study|Randomized but not treated|2|||
48774304|NCT00192075|157018711|FG000|Overall Study|Disease Progression|23|||
48774305|NCT00192075|157018712|FG001|Overall Study|Disease Progression|6|||
48774306|NCT00192075|157018711|FG000|Overall Study|Adverse Event|1|||
48774307|NCT00192075|157018712|FG001|Overall Study|Adverse Event|3|||
48774308|NCT00192075|157018711|FG000|Overall Study|Death|0|||
48774309|NCT00192075|157018712|FG001|Overall Study|Death|1|||
48774310|NCT00192075|157018711|FG000|Overall Study|Lack of Efficacy|0|||
48774311|NCT00192075|157018712|FG001|Overall Study|Lack of Efficacy|0|||
48774312|NCT00192075|157018711|FG000|Overall Study|Physician Decision|3|||
48774313|NCT00192075|157018712|FG001|Overall Study|Physician Decision|0|||
48774314|NCT00192075|157018711|FG000|Overall Study|Withdrawal by Subject|5|||
48774315|NCT00192075|157018712|FG001|Overall Study|Withdrawal by Subject|5|||
48774316|NCT00192075|157018711|FG000|Overall Study|Patient Non-Compliance|0|||
48774317|NCT00192075|157018712|FG001|Overall Study|Patient Non-Compliance|1|||
48774318|NCT00192075|157018711|FG000|Overall Study|Unacceptable Toxicity Exhibited by Drug|2|||
48774319|NCT00192075|157018712|FG001|Overall Study|Unacceptable Toxicity Exhibited by Drug|1|||
48774320|NCT00192075|157018711|FG000|Overall Study|Other|5|||
48774321|NCT00192075|157018712|FG001|Overall Study|Other|2|||
48774322|NCT02331446|157018715|FG000|Overall Study|Lost to Follow-up|2|||
48774323|NCT02331446|157018716|FG001|Overall Study|Lost to Follow-up|1|||
48774324|NCT02331446|157018717|FG002|Overall Study|Lost to Follow-up|0|||
48774325|NCT02331446|157018718|FG003|Overall Study|Lost to Follow-up|1|||
48774326|NCT02331446|157018715|FG000|Overall Study|Personal Problem|2|||
48774327|NCT02331446|157018716|FG001|Overall Study|Personal Problem|0|||
48774328|NCT02331446|157018717|FG002|Overall Study|Personal Problem|0|||
48774329|NCT02331446|157018718|FG003|Overall Study|Personal Problem|0|||
48774330|NCT02331446|157018715|FG000|Overall Study|Disease|0|||
48774331|NCT02331446|157018716|FG001|Overall Study|Disease|2|||
48774332|NCT02331446|157018717|FG002|Overall Study|Disease|2|||
48774333|NCT02331446|157018718|FG003|Overall Study|Disease|1|||
48774334|NCT02331446|157018715|FG000|Overall Study|Physician Decision|0|||
48774335|NCT02331446|157018716|FG001|Overall Study|Physician Decision|1|||
48774336|NCT02331446|157018717|FG002|Overall Study|Physician Decision|0|||
48774337|NCT02331446|157018718|FG003|Overall Study|Physician Decision|1|||
48774338|NCT02331446|157018715|FG000|Overall Study|Lost before baseline analysis|0|||
48774339|NCT02331446|157018716|FG001|Overall Study|Lost before baseline analysis|1|||
48774340|NCT02331446|157018717|FG002|Overall Study|Lost before baseline analysis|1|||
48774341|NCT02331446|157018718|FG003|Overall Study|Lost before baseline analysis|0|||
48774342|NCT01863446|157018722|FG000|Overall Study|Withdrawal by Subject|1|||
48774343|NCT01863446|157018723|FG001|Overall Study|Withdrawal by Subject|0|||
48774344|NCT01863446|157018724|FG002|Overall Study|Withdrawal by Subject|1|||
48774345|NCT01863446|157018725|FG003|Overall Study|Withdrawal by Subject|2|||
48774346|NCT01863446|157018722|FG000|Overall Study|Physician Decision|0|||
48774347|NCT01863446|157018723|FG001|Overall Study|Physician Decision|0|||
48774348|NCT01863446|157018724|FG002|Overall Study|Physician Decision|1|||
48774349|NCT01863446|157018725|FG003|Overall Study|Physician Decision|0|||
48774350|NCT00529386|157018728|FG000|Overall Study|Lost to Follow-up|1|||
48774351|NCT03592641|157018729|FG000|Overall Study|Withdrawal by Subject|1|||
48774352|NCT04086472|157018730|FG000|Overall Study|Lost to Follow-up|1|||
48774353|NCT04086472|157018731|FG001|Overall Study|Lost to Follow-up|0|||
48774354|NCT04086472|157018732|FG002|Overall Study|Lost to Follow-up|0|||
48774355|NCT04086472|157018733|FG003|Overall Study|Lost to Follow-up|0|||
48774356|NCT04086472|157018734|FG004|Overall Study|Lost to Follow-up|1|||
48774357|NCT04086472|157018730|FG000|Overall Study|Physician Decision|0|||
48774358|NCT04086472|157018731|FG001|Overall Study|Physician Decision|1|||
48774359|NCT04086472|157018732|FG002|Overall Study|Physician Decision|1|||
48774360|NCT04086472|157018733|FG003|Overall Study|Physician Decision|0|||
48774361|NCT04086472|157018734|FG004|Overall Study|Physician Decision|0|||
48774362|NCT04086472|157018730|FG000|Overall Study|Withdrawal by Subject|1|||
48774363|NCT04086472|157018731|FG001|Overall Study|Withdrawal by Subject|1|||
48774364|NCT04086472|157018732|FG002|Overall Study|Withdrawal by Subject|1|||
48774365|NCT04086472|157018733|FG003|Overall Study|Withdrawal by Subject|0|||
48774366|NCT04086472|157018734|FG004|Overall Study|Withdrawal by Subject|0|||
48774367|NCT04086472|157018730|FG000|Overall Study|Various reasons|2|||
48774368|NCT04086472|157018731|FG001|Overall Study|Various reasons|0|||
49027541|NCT00318461|157939151|FG000|Double-Blind, 6 Months|Investigator decision|0|||
49027542|NCT00318461|157939152|FG001|Double-Blind, 6 Months|Investigator decision|0|||
49027543|NCT00318461|157939153|FG002|Double-Blind, 6 Months|Investigator decision|0|||
49027544|NCT00318461|157939154|FG003|Double-Blind, 6 Months|Investigator decision|0|||
49027545|NCT00318461|157939155|FG004|Double-Blind, 6 Months|Investigator decision|1|||
49027546|NCT00318461|157939151|FG000|Double-Blind, 6 Months|Lack of time|1|||
49027547|NCT00318461|157939152|FG001|Double-Blind, 6 Months|Lack of time|0|||
49027548|NCT00318461|157939153|FG002|Double-Blind, 6 Months|Lack of time|0|||
49027549|NCT00318461|157939154|FG003|Double-Blind, 6 Months|Lack of time|0|||
49027550|NCT00318461|157939155|FG004|Double-Blind, 6 Months|Lack of time|0|||
49027551|NCT00318461|157939151|FG000|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
49027552|NCT00318461|157939152|FG001|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
49027553|NCT00318461|157939153|FG002|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
49027554|NCT00318461|157939154|FG003|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
49027555|NCT00318461|157939155|FG004|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2|||
49027556|NCT00318461|157939151|FG000|Double-Blind, 6 Months|Hyperglicaemia|0|||
49027557|NCT00318461|157939152|FG001|Double-Blind, 6 Months|Hyperglicaemia|0|||
49027558|NCT00318461|157939153|FG002|Double-Blind, 6 Months|Hyperglicaemia|0|||
49027559|NCT00318461|157939154|FG003|Double-Blind, 6 Months|Hyperglicaemia|1|||
49027560|NCT00318461|157939155|FG004|Double-Blind, 6 Months|Hyperglicaemia|0|||
49027561|NCT00318461|157939151|FG000|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
49027562|NCT00318461|157939152|FG001|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
49027563|NCT00318461|157939153|FG002|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
49027564|NCT00318461|157939154|FG003|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
49027565|NCT00318461|157939155|FG004|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1|||
49027566|NCT00318461|157939151|FG000|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
48774369|NCT04086472|157018732|FG002|Overall Study|Various reasons|0|||
48774370|NCT04086472|157018733|FG003|Overall Study|Various reasons|3|||
48774371|NCT04086472|157018734|FG004|Overall Study|Various reasons|1|||
48774372|NCT03100825|157018735|FG000|Overall Study|Participant/Guardian Decision|7|||
48774373|NCT03100825|157018735|FG000|Overall Study|Physician Decision|1|||
48774374|NCT00436280|157018736|FG000|Period 1: Induction|Adverse Event|8|||
48774375|NCT00436280|157018736|FG000|Period 1: Induction|Progressive Disease|12|||
48774376|NCT00436280|157018736|FG000|Period 1: Induction|Stable Disease|6|||
48774377|NCT00436280|157018736|FG000|Period 1: Induction|Withdrawal by Subject|1|||
48774378|NCT00436280|157018736|FG000|Period 1: Induction|Death|1|||
48774379|NCT00436280|157018736|FG000|Period 2: Consolidation|Adverse Event|1|||
48774380|NCT00436280|157018736|FG000|Period 2: Consolidation|Progressive Disease|10|||
48774381|NCT00436280|157018736|FG000|Period 2: Consolidation|Stable Disease|1|||
48774382|NCT00436280|157018736|FG000|Period 2: Consolidation|Physician Decision|2|||
48774383|NCT00436280|157018736|FG000|Period 2: Consolidation|Withdrawal by Subject|2|||
48774384|NCT00436280|157018736|FG000|Period 2: Consolidation|Death|1|||
48774385|NCT00436280|157018736|FG000|Period 3: Maintenance|Adverse Event|6|||
48774386|NCT00436280|157018736|FG000|Period 3: Maintenance|Progressive Disease|12|||
48774387|NCT02103478|157018739|FG000|Overall Study|Adverse Event|0|||
48774388|NCT02103478|157018740|FG001|Overall Study|Adverse Event|0|||
48774389|NCT02103478|157018741|FG002|Overall Study|Adverse Event|1|||
48774390|NCT02103478|157018742|FG003|Overall Study|Adverse Event|1|||
49027567|NCT00318461|157939152|FG001|Double-Blind, 6 Months|Fear of experiencing AE again|1|||
49027568|NCT00318461|157939153|FG002|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
48774391|NCT02103478|157018743|FG004|Overall Study|Adverse Event|2|||
48774392|NCT02103478|157018744|FG005|Overall Study|Adverse Event|1|||
48774393|NCT02103478|157018745|FG006|Overall Study|Adverse Event|0|||
48774394|NCT02103478|157018746|FG007|Overall Study|Adverse Event|0|||
48774395|NCT02103478|157018747|FG008|Overall Study|Adverse Event|0|||
48774396|NCT02103478|157018739|FG000|Overall Study|Death|2|||
48774397|NCT02103478|157018740|FG001|Overall Study|Death|2|||
48774398|NCT02103478|157018741|FG002|Overall Study|Death|1|||
48774399|NCT02103478|157018742|FG003|Overall Study|Death|1|||
48774400|NCT02103478|157018743|FG004|Overall Study|Death|5|||
48774401|NCT02103478|157018744|FG005|Overall Study|Death|15|||
48774402|NCT02103478|157018745|FG006|Overall Study|Death|14|||
48774403|NCT02103478|157018746|FG007|Overall Study|Death|10|||
48774404|NCT02103478|157018747|FG008|Overall Study|Death|11|||
48774405|NCT02103478|157018739|FG000|Overall Study|Progressive Disease|2|||
48774406|NCT02103478|157018740|FG001|Overall Study|Progressive Disease|1|||
48774407|NCT02103478|157018741|FG002|Overall Study|Progressive Disease|2|||
48774408|NCT02103478|157018742|FG003|Overall Study|Progressive Disease|0|||
48774409|NCT02103478|157018743|FG004|Overall Study|Progressive Disease|9|||
48774410|NCT02103478|157018744|FG005|Overall Study|Progressive Disease|1|||
48774411|NCT02103478|157018745|FG006|Overall Study|Progressive Disease|2|||
48774412|NCT02103478|157018746|FG007|Overall Study|Progressive Disease|0|||
48774413|NCT02103478|157018747|FG008|Overall Study|Progressive Disease|1|||
48774414|NCT02103478|157018739|FG000|Overall Study|Withdrawal by Subject|2|||
48774415|NCT02103478|157018740|FG001|Overall Study|Withdrawal by Subject|0|||
48774416|NCT02103478|157018741|FG002|Overall Study|Withdrawal by Subject|0|||
48774417|NCT02103478|157018742|FG003|Overall Study|Withdrawal by Subject|4|||
49027569|NCT00318461|157939154|FG003|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
48774418|NCT02103478|157018743|FG004|Overall Study|Withdrawal by Subject|0|||
48774419|NCT02103478|157018744|FG005|Overall Study|Withdrawal by Subject|0|||
48774420|NCT02103478|157018745|FG006|Overall Study|Withdrawal by Subject|1|||
48774421|NCT02103478|157018746|FG007|Overall Study|Withdrawal by Subject|1|||
48774422|NCT02103478|157018747|FG008|Overall Study|Withdrawal by Subject|0|||
48774423|NCT02103478|157018739|FG000|Overall Study|Lost to Follow-up|0|||
48774424|NCT02103478|157018740|FG001|Overall Study|Lost to Follow-up|0|||
48774425|NCT02103478|157018741|FG002|Overall Study|Lost to Follow-up|0|||
48774426|NCT02103478|157018742|FG003|Overall Study|Lost to Follow-up|0|||
48774427|NCT02103478|157018743|FG004|Overall Study|Lost to Follow-up|0|||
48774428|NCT02103478|157018744|FG005|Overall Study|Lost to Follow-up|0|||
48774429|NCT02103478|157018745|FG006|Overall Study|Lost to Follow-up|0|||
48774430|NCT02103478|157018746|FG007|Overall Study|Lost to Follow-up|1|||
48774431|NCT02103478|157018747|FG008|Overall Study|Lost to Follow-up|0|||
48774432|NCT02103478|157018739|FG000|Overall Study|Other|1|||
48774433|NCT02103478|157018740|FG001|Overall Study|Other|3|||
48774434|NCT02103478|157018741|FG002|Overall Study|Other|2|||
48774435|NCT02103478|157018742|FG003|Overall Study|Other|0|||
48774436|NCT02103478|157018743|FG004|Overall Study|Other|3|||
48774437|NCT02103478|157018744|FG005|Overall Study|Other|8|||
48774438|NCT02103478|157018745|FG006|Overall Study|Other|8|||
48774439|NCT02103478|157018746|FG007|Overall Study|Other|4|||
48774440|NCT02103478|157018747|FG008|Overall Study|Other|2|||
48774441|NCT02566759|157018749|FG000|All Parts|Withdrawal by Subject|0|||
48774442|NCT02566759|157018750|FG001|All Parts|Withdrawal by Subject|1|||
48774443|NCT02566759|157018751|FG002|All Parts|Withdrawal by Subject|0|||
48774444|NCT02566759|157018752|FG003|All Parts|Withdrawal by Subject|0|||
48774445|NCT02566759|157018753|FG004|All Parts|Withdrawal by Subject|0|||
48774446|NCT02566759|157018754|FG005|All Parts|Withdrawal by Subject|0|||
48774447|NCT02566759|157018755|FG006|All Parts|Withdrawal by Subject|0|||
48774448|NCT02566759|157018756|FG007|All Parts|Withdrawal by Subject|0|||
48774449|NCT02566759|157018757|FG008|All Parts|Withdrawal by Subject|0|||
48876907|NCT00362375|157388459|FG001|Overall Study|Lost to Follow-up|35|||
48876908|NCT02840474|157388461|FG000|Overall Study|Lost to Follow-up|1|||
48774450|NCT02566759|157018758|FG009|All Parts|Withdrawal by Subject|0|||
48774451|NCT02566759|157018759|FG010|All Parts|Withdrawal by Subject|0|||
48774452|NCT02566759|157018760|FG011|All Parts|Withdrawal by Subject|0|||
48774453|NCT02566759|157018761|FG012|All Parts|Withdrawal by Subject|0|||
48774454|NCT02566759|157018762|FG013|All Parts|Withdrawal by Subject|0|||
48774455|NCT02566759|157018763|FG014|All Parts|Withdrawal by Subject|0|||
48774456|NCT02566759|157018764|FG015|All Parts|Withdrawal by Subject|0|||
48774457|NCT02566759|157018765|FG016|All Parts|Withdrawal by Subject|0|||
48774458|NCT02566759|157018749|FG000|All Parts|Adverse Event|0|||
48876909|NCT02840474|157388462|FG001|Overall Study|Lost to Follow-up|0|||
49027570|NCT00318461|157939155|FG004|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
48774459|NCT02566759|157018750|FG001|All Parts|Adverse Event|0|||
48774460|NCT02566759|157018751|FG002|All Parts|Adverse Event|0|||
48774461|NCT02566759|157018752|FG003|All Parts|Adverse Event|0|||
48774462|NCT02566759|157018753|FG004|All Parts|Adverse Event|0|||
48774463|NCT02566759|157018754|FG005|All Parts|Adverse Event|0|||
48774464|NCT02566759|157018755|FG006|All Parts|Adverse Event|0|||
48774465|NCT02566759|157018756|FG007|All Parts|Adverse Event|0|||
48774466|NCT02566759|157018757|FG008|All Parts|Adverse Event|0|||
48774467|NCT02566759|157018758|FG009|All Parts|Adverse Event|0|||
48774468|NCT02566759|157018759|FG010|All Parts|Adverse Event|0|||
48774469|NCT02566759|157018760|FG011|All Parts|Adverse Event|0|||
48774470|NCT02566759|157018761|FG012|All Parts|Adverse Event|1|||
48774471|NCT02566759|157018762|FG013|All Parts|Adverse Event|3|||
48774472|NCT02566759|157018763|FG014|All Parts|Adverse Event|0|||
48774473|NCT02566759|157018764|FG015|All Parts|Adverse Event|0|||
48774474|NCT02566759|157018765|FG016|All Parts|Adverse Event|0|||
48774475|NCT02566759|157018749|FG000|All Parts|Other|0|||
48876910|NCT00944229|157388463|FG000|Overall Study|Withdrawal by Subject|11|||
48774476|NCT02566759|157018750|FG001|All Parts|Other|0|||
48774477|NCT02566759|157018751|FG002|All Parts|Other|0|||
48774478|NCT02566759|157018752|FG003|All Parts|Other|0|||
48774479|NCT02566759|157018753|FG004|All Parts|Other|0|||
48774480|NCT02566759|157018754|FG005|All Parts|Other|0|||
48774481|NCT02566759|157018755|FG006|All Parts|Other|0|||
48774482|NCT02566759|157018756|FG007|All Parts|Other|0|||
48774483|NCT02566759|157018757|FG008|All Parts|Other|0|||
48774484|NCT02566759|157018758|FG009|All Parts|Other|0|||
48774485|NCT02566759|157018759|FG010|All Parts|Other|0|||
48774486|NCT02566759|157018760|FG011|All Parts|Other|0|||
48774487|NCT02566759|157018761|FG012|All Parts|Other|0|||
48774488|NCT02566759|157018762|FG013|All Parts|Other|2|||
48774489|NCT02566759|157018763|FG014|All Parts|Other|0|||
48774490|NCT02566759|157018764|FG015|All Parts|Other|0|||
48774491|NCT02566759|157018765|FG016|All Parts|Other|0|||
48774492|NCT02566759|157018749|FG000|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
48774493|NCT02566759|157018750|FG001|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
48774494|NCT02566759|157018751|FG002|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
48774495|NCT02566759|157018752|FG003|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
48774496|NCT02566759|157018753|FG004|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
48774497|NCT02566759|157018754|FG005|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
48774498|NCT02566759|157018755|FG006|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
48774499|NCT02566759|157018756|FG007|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
48774500|NCT02566759|157018757|FG008|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
48774501|NCT02566759|157018758|FG009|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
48774502|NCT02566759|157018759|FG010|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
48774503|NCT02566759|157018760|FG011|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
48774504|NCT02566759|157018761|FG012|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
48774505|NCT02566759|157018762|FG013|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
48774506|NCT02566759|157018763|FG014|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
48774507|NCT02566759|157018764|FG015|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
48774508|NCT02566759|157018765|FG016|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1|||
48774509|NCT00087568|157018766|FG000|Overall Study|Adverse Event|4|||
48774510|NCT00087568|157018767|FG001|Overall Study|Adverse Event|0|||
48774511|NCT00087568|157018766|FG000|Overall Study|Withdrawal by Subject|1|||
48774512|NCT00087568|157018767|FG001|Overall Study|Withdrawal by Subject|1|||
48774513|NCT00087568|157018766|FG000|Overall Study|Lost to Follow-up|1|||
48774514|NCT00087568|157018767|FG001|Overall Study|Lost to Follow-up|0|||
48774515|NCT00087568|157018766|FG000|Overall Study|Lack of Efficacy|24|||
48774516|NCT00087568|157018767|FG001|Overall Study|Lack of Efficacy|1|||
48774517|NCT00441337|157018768|FG000|Overall Study|Disease Progression|6|||
48774518|NCT00441337|157018769|FG001|Overall Study|Disease Progression|6|||
48774519|NCT00441337|157018770|FG002|Overall Study|Disease Progression|4|||
48774520|NCT00441337|157018771|FG003|Overall Study|Disease Progression|18|||
48774521|NCT00441337|157018768|FG000|Overall Study|Lost to Follow-up|0|||
48774522|NCT00441337|157018769|FG001|Overall Study|Lost to Follow-up|0|||
48774523|NCT00441337|157018770|FG002|Overall Study|Lost to Follow-up|0|||
48774524|NCT00441337|157018771|FG003|Overall Study|Lost to Follow-up|1|||
48774525|NCT00441337|157018768|FG000|Overall Study|Sponsor Decision|0|||
48774526|NCT00441337|157018769|FG001|Overall Study|Sponsor Decision|0|||
48774527|NCT00441337|157018770|FG002|Overall Study|Sponsor Decision|1|||
48774528|NCT00441337|157018771|FG003|Overall Study|Sponsor Decision|2|||
48774529|NCT00441337|157018768|FG000|Overall Study|Did not meet inclusion criteria|0|||
48774530|NCT00441337|157018769|FG001|Overall Study|Did not meet inclusion criteria|0|||
48774531|NCT00441337|157018770|FG002|Overall Study|Did not meet inclusion criteria|1|||
48774532|NCT00441337|157018771|FG003|Overall Study|Did not meet inclusion criteria|0|||
48774533|NCT03064126|157018774|FG000|Overall Study|Death|40|||
48774534|NCT03064126|157018775|FG001|Overall Study|Death|16|||
48774535|NCT03064126|157018776|FG002|Overall Study|Death|4|||
48876911|NCT00944229|157388463|FG000|Overall Study|Physician Decision|14|||
49027571|NCT00318461|157939151|FG000|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19|||
49027572|NCT00318461|157939152|FG001|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14|||
49027573|NCT00318461|157939153|FG002|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27|||
48774536|NCT03064126|157018777|FG003|Overall Study|Death|2|||
48774537|NCT03064126|157018774|FG000|Overall Study|Withdrawal by Subject|17|||
48774538|NCT03064126|157018775|FG001|Overall Study|Withdrawal by Subject|9|||
48774539|NCT03064126|157018776|FG002|Overall Study|Withdrawal by Subject|0|||
48774540|NCT03064126|157018777|FG003|Overall Study|Withdrawal by Subject|2|||
48774541|NCT03064126|157018774|FG000|Overall Study|Lost to Follow-up|7|||
48774542|NCT03064126|157018775|FG001|Overall Study|Lost to Follow-up|3|||
48774543|NCT03064126|157018776|FG002|Overall Study|Lost to Follow-up|0|||
48774544|NCT03064126|157018777|FG003|Overall Study|Lost to Follow-up|0|||
48774545|NCT03064126|157018774|FG000|Overall Study|Adverse Event|2|||
48774546|NCT03064126|157018775|FG001|Overall Study|Adverse Event|0|||
48774547|NCT03064126|157018776|FG002|Overall Study|Adverse Event|0|||
48774548|NCT03064126|157018777|FG003|Overall Study|Adverse Event|0|||
48876912|NCT01270828|157388464|FG000|Pregabalin CR SB|Reason Unspecified|0|||
48774549|NCT03064126|157018774|FG000|Overall Study|Physician Decision|3|||
48774550|NCT03064126|157018775|FG001|Overall Study|Physician Decision|0|||
48774551|NCT03064126|157018776|FG002|Overall Study|Physician Decision|0|||
48774552|NCT03064126|157018777|FG003|Overall Study|Physician Decision|0|||
48774553|NCT03064126|157018774|FG000|Overall Study|Other reason for early termination|3|||
48774554|NCT03064126|157018775|FG001|Overall Study|Other reason for early termination|2|||
48774555|NCT03064126|157018776|FG002|Overall Study|Other reason for early termination|0|||
48774556|NCT03064126|157018777|FG003|Overall Study|Other reason for early termination|0|||
48774557|NCT03064126|157018774|FG000|Overall Study|Missed Visit|3|||
48774558|NCT03064126|157018775|FG001|Overall Study|Missed Visit|1|||
48774559|NCT03064126|157018776|FG002|Overall Study|Missed Visit|0|||
48774560|NCT03064126|157018777|FG003|Overall Study|Missed Visit|0|||
48774561|NCT05074433|157018781|FG000|Overall Study|Adverse Event|0|||
48774562|NCT05074433|157018782|FG001|Overall Study|Adverse Event|2|||
48774563|NCT05074433|157018783|FG002|Overall Study|Adverse Event|0|||
48774564|NCT05074433|157018784|FG003|Overall Study|Adverse Event|1|||
48774565|NCT05074433|157018781|FG000|Overall Study|Sponsor Request|0|||
48774566|NCT05074433|157018782|FG001|Overall Study|Sponsor Request|1|||
48774567|NCT05074433|157018783|FG002|Overall Study|Sponsor Request|1|||
48774568|NCT05074433|157018784|FG003|Overall Study|Sponsor Request|0|||
48774569|NCT05074433|157018781|FG000|Overall Study|Death|1|||
48774570|NCT05074433|157018782|FG001|Overall Study|Death|0|||
48774571|NCT05074433|157018783|FG002|Overall Study|Death|0|||
48774572|NCT05074433|157018784|FG003|Overall Study|Death|0|||
48774573|NCT05074433|157018781|FG000|Overall Study|Lost to Follow-up|0|||
48774574|NCT05074433|157018782|FG001|Overall Study|Lost to Follow-up|0|||
48774575|NCT05074433|157018783|FG002|Overall Study|Lost to Follow-up|2|||
48774576|NCT05074433|157018784|FG003|Overall Study|Lost to Follow-up|0|||
48774577|NCT05074433|157018781|FG000|Overall Study|Subject Decision|8|||
48774578|NCT05074433|157018782|FG001|Overall Study|Subject Decision|6|||
48774579|NCT05074433|157018783|FG002|Overall Study|Subject Decision|4|||
48774580|NCT05074433|157018784|FG003|Overall Study|Subject Decision|5|||
48774581|NCT01859715|157018785|FG000|Overall Study|No 2nd VAS|16|||
48774582|NCT01859715|157018786|FG001|Overall Study|No 2nd VAS|8|||
48774583|NCT01859715|157018787|FG002|Overall Study|No 2nd VAS|23|||
48774584|NCT00833924|157018788|FG000|Overall Study|Death|21|||
48774585|NCT00833924|157018788|FG000|Overall Study|Conversion|2|||
48774586|NCT00833924|157018788|FG000|Overall Study|Lost to Follow-up|2|||
48774587|NCT00833924|157018788|FG000|Overall Study|Withdrawal by Subject|13|||
48774588|NCT00833924|157018788|FG000|Overall Study|In study follow-up|71|||
48774589|NCT01485861|157018791|FG000|Phase Ib|Death|1|||
48774590|NCT01485861|157018792|FG001|Phase Ib|Death|0|||
48774591|NCT01485861|157018793|FG002|Phase Ib|Death|0|||
48774592|NCT01485861|157018794|FG003|Phase Ib|Death|0|||
48774593|NCT01485861|157018795|FG004|Phase Ib|Death|0|||
48774594|NCT01485861|157018796|FG005|Phase Ib|Death|0|||
48774595|NCT01485861|157018791|FG000|Phase Ib|Physician Decision|1|||
48774596|NCT01485861|157018792|FG001|Phase Ib|Physician Decision|1|||
48774597|NCT01485861|157018793|FG002|Phase Ib|Physician Decision|0|||
48774598|NCT01485861|157018794|FG003|Phase Ib|Physician Decision|0|||
48774599|NCT01485861|157018795|FG004|Phase Ib|Physician Decision|0|||
48774600|NCT01485861|157018796|FG005|Phase Ib|Physician Decision|0|||
48774601|NCT01485861|157018791|FG000|Phase Ib|Adverse Event|0|||
48774602|NCT01485861|157018792|FG001|Phase Ib|Adverse Event|4|||
48774603|NCT01485861|157018793|FG002|Phase Ib|Adverse Event|0|||
48774604|NCT01485861|157018794|FG003|Phase Ib|Adverse Event|0|||
48774605|NCT01485861|157018795|FG004|Phase Ib|Adverse Event|0|||
48774606|NCT01485861|157018796|FG005|Phase Ib|Adverse Event|0|||
48774607|NCT01485861|157018791|FG000|Phase Ib|Progression of disease|5|||
48774608|NCT01485861|157018792|FG001|Phase Ib|Progression of disease|0|||
48774609|NCT01485861|157018793|FG002|Phase Ib|Progression of disease|0|||
48774610|NCT01485861|157018794|FG003|Phase Ib|Progression of disease|0|||
48774611|NCT01485861|157018795|FG004|Phase Ib|Progression of disease|0|||
48774612|NCT01485861|157018796|FG005|Phase Ib|Progression of disease|0|||
48774613|NCT01485861|157018791|FG000|Phase Ib|Other|3|||
48774614|NCT01485861|157018792|FG001|Phase Ib|Other|0|||
48774615|NCT01485861|157018793|FG002|Phase Ib|Other|0|||
48774616|NCT01485861|157018794|FG003|Phase Ib|Other|0|||
48774617|NCT01485861|157018795|FG004|Phase Ib|Other|0|||
48774618|NCT01485861|157018796|FG005|Phase Ib|Other|0|||
48774619|NCT01485861|157018791|FG000|Phase Ib|Withdrawal by Subject|4|||
48774620|NCT01485861|157018792|FG001|Phase Ib|Withdrawal by Subject|1|||
48774621|NCT01485861|157018793|FG002|Phase Ib|Withdrawal by Subject|0|||
48774622|NCT01485861|157018794|FG003|Phase Ib|Withdrawal by Subject|0|||
48774623|NCT01485861|157018795|FG004|Phase Ib|Withdrawal by Subject|0|||
48774624|NCT01485861|157018796|FG005|Phase Ib|Withdrawal by Subject|0|||
48774625|NCT01485861|157018791|FG000|Phase II|Death|0|||
48774626|NCT01485861|157018792|FG001|Phase II|Death|0|||
48774627|NCT01485861|157018793|FG002|Phase II|Death|67|||
48774628|NCT01485861|157018794|FG003|Phase II|Death|71|||
48774629|NCT01485861|157018795|FG004|Phase II|Death|68|||
48774630|NCT01485861|157018796|FG005|Phase II|Death|0|||
48774631|NCT01485861|157018791|FG000|Phase II|Progression of Disease|0|||
48774632|NCT01485861|157018792|FG001|Phase II|Progression of Disease|0|||
48774633|NCT01485861|157018793|FG002|Phase II|Progression of Disease|1|||
48774634|NCT01485861|157018794|FG003|Phase II|Progression of Disease|0|||
48774635|NCT01485861|157018795|FG004|Phase II|Progression of Disease|0|||
48774636|NCT01485861|157018796|FG005|Phase II|Progression of Disease|0|||
48774637|NCT01485861|157018791|FG000|Phase II|Other|0|||
48774638|NCT01485861|157018792|FG001|Phase II|Other|0|||
48774639|NCT01485861|157018793|FG002|Phase II|Other|0|||
48774640|NCT01485861|157018794|FG003|Phase II|Other|1|||
48774641|NCT01485861|157018795|FG004|Phase II|Other|0|||
48774642|NCT01485861|157018796|FG005|Phase II|Other|0|||
48774643|NCT01485861|157018791|FG000|Phase II|Withdrawal by Subject|0|||
48774644|NCT01485861|157018792|FG001|Phase II|Withdrawal by Subject|0|||
48774645|NCT01485861|157018793|FG002|Phase II|Withdrawal by Subject|6|||
48774646|NCT01485861|157018794|FG003|Phase II|Withdrawal by Subject|3|||
48774647|NCT01485861|157018795|FG004|Phase II|Withdrawal by Subject|4|||
48774648|NCT01485861|157018796|FG005|Phase II|Withdrawal by Subject|0|||
48774649|NCT01485861|157018791|FG000|Phase II|Lost to Follow-up|0|||
48774650|NCT01485861|157018792|FG001|Phase II|Lost to Follow-up|0|||
48774651|NCT01485861|157018793|FG002|Phase II|Lost to Follow-up|2|||
48774652|NCT01485861|157018794|FG003|Phase II|Lost to Follow-up|3|||
48774653|NCT01485861|157018795|FG004|Phase II|Lost to Follow-up|5|||
48774654|NCT01485861|157018796|FG005|Phase II|Lost to Follow-up|0|||
48774655|NCT01485861|157018791|FG000|Phase II|Study Ended|0|||
48774656|NCT01485861|157018792|FG001|Phase II|Study Ended|0|||
48774657|NCT01485861|157018793|FG002|Phase II|Study Ended|7|||
48774658|NCT01485861|157018794|FG003|Phase II|Study Ended|8|||
48774659|NCT01485861|157018795|FG004|Phase II|Study Ended|6|||
48774660|NCT01485861|157018796|FG005|Phase II|Study Ended|0|||
48774661|NCT01485861|157018791|FG000|Safety Phase|Death|0|||
48774662|NCT01485861|157018792|FG001|Safety Phase|Death|0|||
48774663|NCT01485861|157018793|FG002|Safety Phase|Death|0|||
48774664|NCT01485861|157018794|FG003|Safety Phase|Death|0|||
48774665|NCT01485861|157018795|FG004|Safety Phase|Death|0|||
48774666|NCT01485861|157018796|FG005|Safety Phase|Death|2|||
48774667|NCT01485861|157018791|FG000|Safety Phase|Adverse Event|0|||
48774668|NCT01485861|157018792|FG001|Safety Phase|Adverse Event|0|||
48774669|NCT01485861|157018793|FG002|Safety Phase|Adverse Event|0|||
48774670|NCT01485861|157018794|FG003|Safety Phase|Adverse Event|0|||
48774671|NCT01485861|157018795|FG004|Safety Phase|Adverse Event|0|||
48774672|NCT01485861|157018796|FG005|Safety Phase|Adverse Event|1|||
48774673|NCT01485861|157018791|FG000|Safety Phase|Other|0|||
48774674|NCT01485861|157018792|FG001|Safety Phase|Other|0|||
48774675|NCT01485861|157018793|FG002|Safety Phase|Other|0|||
48774676|NCT01485861|157018794|FG003|Safety Phase|Other|0|||
48774677|NCT01485861|157018795|FG004|Safety Phase|Other|0|||
48774678|NCT01485861|157018796|FG005|Safety Phase|Other|5|||
48774679|NCT01485861|157018791|FG000|Safety Phase|Progression of Disease|0|||
48774680|NCT01485861|157018792|FG001|Safety Phase|Progression of Disease|0|||
48774681|NCT01485861|157018793|FG002|Safety Phase|Progression of Disease|0|||
48774682|NCT01485861|157018794|FG003|Safety Phase|Progression of Disease|0|||
48774683|NCT01485861|157018795|FG004|Safety Phase|Progression of Disease|0|||
48774684|NCT01485861|157018796|FG005|Safety Phase|Progression of Disease|9|||
48774685|NCT01485861|157018791|FG000|Safety Phase|Withdrawal by Subject|0|||
48774686|NCT01485861|157018792|FG001|Safety Phase|Withdrawal by Subject|0|||
48774687|NCT01485861|157018793|FG002|Safety Phase|Withdrawal by Subject|0|||
48774688|NCT01485861|157018794|FG003|Safety Phase|Withdrawal by Subject|0|||
48774689|NCT01485861|157018795|FG004|Safety Phase|Withdrawal by Subject|0|||
48774690|NCT01485861|157018796|FG005|Safety Phase|Withdrawal by Subject|6|||
48774691|NCT01485861|157018791|FG000|Safety Phase|Discontinuation of Survival Follow-up|0|||
48774692|NCT01485861|157018792|FG001|Safety Phase|Discontinuation of Survival Follow-up|0|||
48774693|NCT01485861|157018793|FG002|Safety Phase|Discontinuation of Survival Follow-up|0|||
48774694|NCT01485861|157018794|FG003|Safety Phase|Discontinuation of Survival Follow-up|0|||
48774695|NCT01485861|157018795|FG004|Safety Phase|Discontinuation of Survival Follow-up|0|||
48774696|NCT01485861|157018796|FG005|Safety Phase|Discontinuation of Survival Follow-up|2|||
48774697|NCT01158924|157018799|FG000|Overall Study|Withdrawal by Subject|1|||
48774698|NCT01158924|157018800|FG001|Overall Study|Withdrawal by Subject|2|||
48774699|NCT01158924|157018799|FG000|Overall Study|Lost to Follow-up|0|||
48774700|NCT01158924|157018800|FG001|Overall Study|Lost to Follow-up|1|||
48774701|NCT03795922|157018801|FG000|Overall Study|Adverse Event|2|||
48774702|NCT03795922|157018802|FG001|Overall Study|Adverse Event|1|||
48774703|NCT03795922|157018801|FG000|Overall Study|Withdrawal by Subject|5|||
48774704|NCT03795922|157018802|FG001|Overall Study|Withdrawal by Subject|13|||
48774705|NCT03795922|157018801|FG000|Overall Study|Lost to Follow-up|2|||
48774706|NCT03795922|157018802|FG001|Overall Study|Lost to Follow-up|3|||
48774707|NCT03795922|157018801|FG000|Overall Study|Pregnancy|0|||
48774708|NCT03795922|157018802|FG001|Overall Study|Pregnancy|1|||
48774709|NCT03795922|157018801|FG000|Overall Study|Physician Decision|1|||
48774710|NCT03795922|157018802|FG001|Overall Study|Physician Decision|2|||
48774711|NCT03795922|157018801|FG000|Overall Study|Protocol Violation|0|||
48774712|NCT03795922|157018802|FG001|Overall Study|Protocol Violation|1|||
48774713|NCT03795922|157018801|FG000|Overall Study|Other (Early termination, COVID, Family issue)|3|||
48774714|NCT03795922|157018802|FG001|Overall Study|Other (Early termination, COVID, Family issue)|4|||
48774715|NCT01632800|157018806|FG000|Overall Study|Subject did not fit in apparatus|1|||
48774716|NCT01000051|157018808|FG000|Overall Study|Withdrawal by Subject|1|||
48774717|NCT01000051|157018809|FG001|Overall Study|Withdrawal by Subject|1|||
48774718|NCT01000051|157018808|FG000|Overall Study|Disease Progression|1|||
48774719|NCT01000051|157018809|FG001|Overall Study|Disease Progression|0|||
48774720|NCT01000051|157018808|FG000|Overall Study|Serious noncompliance|1|||
48774721|NCT01000051|157018809|FG001|Overall Study|Serious noncompliance|0|||
48774722|NCT04439240|157018810|FG000|Overall Study|Ineligible|2|||
48774723|NCT04439240|157018810|FG000|Overall Study|Never started treatment|2|||
48774724|NCT04439240|157018810|FG000|Overall Study|Adverse Event|12|||
48774725|NCT04439240|157018810|FG000|Overall Study|Death|2|||
48774726|NCT04439240|157018810|FG000|Overall Study|Disease progression|25|||
48774727|NCT04439240|157018810|FG000|Overall Study|Other diseases|2|||
48774728|NCT04439240|157018810|FG000|Overall Study|Withdrawal by Subject|3|||
48774729|NCT04439240|157018810|FG000|Overall Study|Clinical concerns for progression and increasing tumor marker|1|||
48774730|NCT04439240|157018810|FG000|Overall Study|Symptomatic decline|1|||
48774731|NCT04439240|157018810|FG000|Overall Study|Pogression of the lymphadenopathy|1|||
48774732|NCT04439240|157018810|FG000|Overall Study|Clinical progression|1|||
48774733|NCT00673452|157018811|FG000|Acute Double-Blind Phase|Adverse Event|41|||
48774734|NCT00673452|157018812|FG001|Acute Double-Blind Phase|Adverse Event|24|||
48774735|NCT00673452|157018811|FG000|Acute Double-Blind Phase|Lack of Efficacy|9|||
48774736|NCT00673452|157018812|FG001|Acute Double-Blind Phase|Lack of Efficacy|14|||
48774737|NCT00673452|157018811|FG000|Acute Double-Blind Phase|Lost to Follow-up|16|||
48774738|NCT00673452|157018812|FG001|Acute Double-Blind Phase|Lost to Follow-up|19|||
48774739|NCT00673452|157018811|FG000|Acute Double-Blind Phase|Physician Decision|0|||
48774740|NCT00673452|157018812|FG001|Acute Double-Blind Phase|Physician Decision|6|||
48774741|NCT00673452|157018811|FG000|Acute Double-Blind Phase|Protocol Violation|5|||
48774742|NCT00673452|157018812|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
48774743|NCT00673452|157018811|FG000|Acute Double-Blind Phase|Sponsor Decision|0|||
48774744|NCT00673452|157018812|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
48774745|NCT00673452|157018811|FG000|Acute Double-Blind Phase|Withdrawal by Subject|16|||
48774746|NCT00673452|157018812|FG001|Acute Double-Blind Phase|Withdrawal by Subject|13|||
48774747|NCT00673452|157018811|FG000|Continuation Double-Blind Phase|Adverse Event|5|||
48774748|NCT00673452|157018812|FG001|Continuation Double-Blind Phase|Adverse Event|13|||
48774749|NCT00673452|157018811|FG000|Continuation Double-Blind Phase|Withdrawal by Subject|9|||
48774750|NCT00673452|157018812|FG001|Continuation Double-Blind Phase|Withdrawal by Subject|5|||
48774751|NCT00673452|157018811|FG000|Continuation Double-Blind Phase|Lost to Follow-up|4|||
48774752|NCT00673452|157018812|FG001|Continuation Double-Blind Phase|Lost to Follow-up|5|||
48774753|NCT00673452|157018811|FG000|Continuation Double-Blind Phase|Lack of Efficacy|2|||
48774754|NCT00673452|157018812|FG001|Continuation Double-Blind Phase|Lack of Efficacy|5|||
48774755|NCT00673452|157018811|FG000|Continuation Double-Blind Phase|Protocol Violation|2|||
48774756|NCT00673452|157018812|FG001|Continuation Double-Blind Phase|Protocol Violation|3|||
48774757|NCT00673452|157018811|FG000|Continuation Double-Blind Phase|Sponsor Decision|0|||
48774758|NCT00673452|157018812|FG001|Continuation Double-Blind Phase|Sponsor Decision|3|||
48774759|NCT00673452|157018811|FG000|Continuation Double-Blind Phase|Physician Decision|2|||
48774760|NCT00673452|157018812|FG001|Continuation Double-Blind Phase|Physician Decision|0|||
48774761|NCT00673452|157018811|FG000|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1|||
48774762|NCT00673452|157018812|FG001|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0|||
48774763|NCT00813124|157018813|FG000|Overall Study|Death|2|||
48774764|NCT00813124|157018813|FG000|Overall Study|Ineligible - Participants did not received Azacytidine|9|||
48774765|NCT00813124|157018813|FG000|Overall Study|Withdrawal by Subject|1|||
48774766|NCT00733824|157018814|FG000|Phase I|Withdrawal by Subject|1|||
48774767|NCT00733824|157018815|FG001|Phase I|Withdrawal by Subject|0|||
48774768|NCT00733824|157018816|FG002|Phase I|Withdrawal by Subject|0|||
48774769|NCT00733824|157018817|FG003|Phase I|Withdrawal by Subject|0|||
48876913|NCT01270828|157388465|FG001|Pregabalin CR SB|Reason Unspecified|0|||
49027574|NCT00318461|157939154|FG003|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11|||
49027575|NCT00318461|157939155|FG004|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22|||
48774770|NCT00733824|157018818|FG004|Phase I|Withdrawal by Subject|0|||
48774771|NCT03773757|157018822|FG000|Overall Study|Withdrawal by Subject|2|||
48774772|NCT03773757|157018823|FG001|Overall Study|Withdrawal by Subject|4|||
48774773|NCT03056690|157018824|FG000|Overall Study|Adverse Event|3|||
48774774|NCT03056690|157018825|FG001|Overall Study|Adverse Event|2|||
49027576|NCT00318461|157939151|FG000|Open-Label Extension, 18 Months|Adverse Event|11|||
48774775|NCT03056690|157018824|FG000|Overall Study|Lack of Efficacy|1|||
48774776|NCT03056690|157018825|FG001|Overall Study|Lack of Efficacy|2|||
48774777|NCT03056690|157018824|FG000|Overall Study|Lost to Follow-up|3|||
48774778|NCT03056690|157018825|FG001|Overall Study|Lost to Follow-up|2|||
48774779|NCT03056690|157018824|FG000|Overall Study|Protocol Violation|2|||
48774780|NCT03056690|157018825|FG001|Overall Study|Protocol Violation|2|||
48774781|NCT03056690|157018824|FG000|Overall Study|Withdrawal by Subject|3|||
48774782|NCT03056690|157018825|FG001|Overall Study|Withdrawal by Subject|6|||
48774783|NCT03056690|157018824|FG000|Overall Study|Non-compliance with Study Drug|1|||
48774784|NCT03056690|157018825|FG001|Overall Study|Non-compliance with Study Drug|0|||
48774785|NCT03056690|157018824|FG000|Overall Study|Miscellaneous|1|||
48774786|NCT03056690|157018825|FG001|Overall Study|Miscellaneous|2|||
48774787|NCT01585766|157018826|FG000|Overall Study|Withdrawal by Subject|0|||
48774788|NCT01585766|157018827|FG001|Overall Study|Withdrawal by Subject|1|||
48774789|NCT01585766|157018828|FG002|Overall Study|Withdrawal by Subject|1|||
48774790|NCT01585766|157018829|FG003|Overall Study|Withdrawal by Subject|0|||
48774791|NCT01585766|157018830|FG004|Overall Study|Withdrawal by Subject|0|||
48774792|NCT01585766|157018831|FG005|Overall Study|Withdrawal by Subject|0|||
48774793|NCT01585766|157018826|FG000|Overall Study|Death|0|||
48774794|NCT01585766|157018827|FG001|Overall Study|Death|1|||
48774795|NCT01585766|157018828|FG002|Overall Study|Death|0|||
48774796|NCT01585766|157018829|FG003|Overall Study|Death|0|||
48774797|NCT01585766|157018830|FG004|Overall Study|Death|0|||
48774798|NCT01585766|157018831|FG005|Overall Study|Death|0|||
48774799|NCT01585766|157018826|FG000|Overall Study|Physician Decision|0|||
48774800|NCT01585766|157018827|FG001|Overall Study|Physician Decision|0|||
48774801|NCT01585766|157018828|FG002|Overall Study|Physician Decision|1|||
48774802|NCT01585766|157018829|FG003|Overall Study|Physician Decision|0|||
48774803|NCT01585766|157018830|FG004|Overall Study|Physician Decision|0|||
48774804|NCT01585766|157018831|FG005|Overall Study|Physician Decision|0|||
48774805|NCT01701258|157018832|FG000|Assessment and Scheduling|Found to be Ineligible|57|||
48774806|NCT01701258|157018833|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
48774807|NCT01701258|157018834|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
48774808|NCT01701258|157018835|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
48774809|NCT01701258|157018836|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
48774810|NCT01701258|157018837|FG005|Assessment and Scheduling|Found to be Ineligible|0|||
48774811|NCT01701258|157018838|FG006|Assessment and Scheduling|Found to be Ineligible|0|||
48774812|NCT01701258|157018839|FG007|Assessment and Scheduling|Found to be Ineligible|0|||
48774813|NCT01701258|157018840|FG008|Assessment and Scheduling|Found to be Ineligible|0|||
48774814|NCT01701258|157018841|FG009|Assessment and Scheduling|Found to be Ineligible|0|||
48774815|NCT01701258|157018842|FG010|Assessment and Scheduling|Found to be Ineligible|0|||
48774816|NCT01701258|157018843|FG011|Assessment and Scheduling|Found to be Ineligible|0|||
48774817|NCT01701258|157018844|FG012|Assessment and Scheduling|Found to be Ineligible|0|||
48774818|NCT01701258|157018832|FG000|Assessment and Scheduling|Lost to Follow-up|10|||
48774819|NCT01701258|157018833|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
48774820|NCT01701258|157018834|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
48774821|NCT01701258|157018835|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
48774822|NCT01701258|157018836|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
48774823|NCT01701258|157018837|FG005|Assessment and Scheduling|Lost to Follow-up|0|||
48774824|NCT01701258|157018838|FG006|Assessment and Scheduling|Lost to Follow-up|0|||
48774825|NCT01701258|157018839|FG007|Assessment and Scheduling|Lost to Follow-up|0|||
48774826|NCT01701258|157018840|FG008|Assessment and Scheduling|Lost to Follow-up|0|||
48774827|NCT01701258|157018841|FG009|Assessment and Scheduling|Lost to Follow-up|0|||
48774828|NCT01701258|157018842|FG010|Assessment and Scheduling|Lost to Follow-up|0|||
48774829|NCT01701258|157018843|FG011|Assessment and Scheduling|Lost to Follow-up|0|||
48774830|NCT01701258|157018844|FG012|Assessment and Scheduling|Lost to Follow-up|0|||
48774831|NCT01701258|157018832|FG000|Assessment and Scheduling|Withdrawal by Subject|14|||
48774832|NCT01701258|157018833|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
48774833|NCT01701258|157018834|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
48774834|NCT01701258|157018835|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
48774835|NCT01701258|157018836|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
48774836|NCT01701258|157018837|FG005|Assessment and Scheduling|Withdrawal by Subject|0|||
48774837|NCT01701258|157018838|FG006|Assessment and Scheduling|Withdrawal by Subject|0|||
48774838|NCT01701258|157018839|FG007|Assessment and Scheduling|Withdrawal by Subject|0|||
48774839|NCT01701258|157018840|FG008|Assessment and Scheduling|Withdrawal by Subject|0|||
48774840|NCT01701258|157018841|FG009|Assessment and Scheduling|Withdrawal by Subject|0|||
48774841|NCT01701258|157018842|FG010|Assessment and Scheduling|Withdrawal by Subject|0|||
48774842|NCT01701258|157018843|FG011|Assessment and Scheduling|Withdrawal by Subject|0|||
48774843|NCT01701258|157018844|FG012|Assessment and Scheduling|Withdrawal by Subject|0|||
48774844|NCT01701258|157018832|FG000|Assessment and Scheduling|Investigator Terminated|2|||
48774845|NCT01701258|157018833|FG001|Assessment and Scheduling|Investigator Terminated|0|||
48774846|NCT01701258|157018834|FG002|Assessment and Scheduling|Investigator Terminated|0|||
48774847|NCT01701258|157018835|FG003|Assessment and Scheduling|Investigator Terminated|0|||
48774848|NCT01701258|157018836|FG004|Assessment and Scheduling|Investigator Terminated|0|||
48774849|NCT01701258|157018837|FG005|Assessment and Scheduling|Investigator Terminated|0|||
48774850|NCT01701258|157018838|FG006|Assessment and Scheduling|Investigator Terminated|0|||
48774851|NCT01701258|157018839|FG007|Assessment and Scheduling|Investigator Terminated|0|||
48774852|NCT01701258|157018840|FG008|Assessment and Scheduling|Investigator Terminated|0|||
48774853|NCT01701258|157018841|FG009|Assessment and Scheduling|Investigator Terminated|0|||
48774854|NCT01701258|157018842|FG010|Assessment and Scheduling|Investigator Terminated|0|||
48774855|NCT01701258|157018843|FG011|Assessment and Scheduling|Investigator Terminated|0|||
48774856|NCT01701258|157018844|FG012|Assessment and Scheduling|Investigator Terminated|0|||
48774857|NCT02052739|157018845|FG000|Overall Study|Withdrew due to Adverse Event|3|||
48774858|NCT02052739|157018846|FG001|Overall Study|Withdrew due to Adverse Event|0|||
48774859|NCT02052739|157018845|FG000|Overall Study|Participant Died|2|||
48774860|NCT02052739|157018846|FG001|Overall Study|Participant Died|1|||
48774861|NCT01785602|157018847|FG000|Overall Study|Withdrawal by Subject|2|||
48774862|NCT01785602|157018848|FG001|Overall Study|Withdrawal by Subject|0|||
48774863|NCT01785602|157018847|FG000|Overall Study|Lost to Follow-up|1|||
48774864|NCT01785602|157018848|FG001|Overall Study|Lost to Follow-up|1|||
48774865|NCT01785602|157018847|FG000|Overall Study|Adverse Event|3|||
48774866|NCT01785602|157018848|FG001|Overall Study|Adverse Event|5|||
48774867|NCT01785602|157018847|FG000|Overall Study|Administrative problems|7|||
48774868|NCT01785602|157018848|FG001|Overall Study|Administrative problems|3|||
48774869|NCT04251533|157018849|FG000|Overall Study|Progressive disease|33|||
48774870|NCT04251533|157018850|FG001|Overall Study|Progressive disease|29|||
48774871|NCT04251533|157018851|FG002|Overall Study|Progressive disease|22|||
48774872|NCT04251533|157018849|FG000|Overall Study|Death|5|||
48774873|NCT04251533|157018850|FG001|Overall Study|Death|1|||
48774874|NCT04251533|157018851|FG002|Overall Study|Death|3|||
48774875|NCT04251533|157018849|FG000|Overall Study|Physician Decision|3|||
48774876|NCT04251533|157018850|FG001|Overall Study|Physician Decision|2|||
48774877|NCT04251533|157018851|FG002|Overall Study|Physician Decision|4|||
48774878|NCT04251533|157018849|FG000|Overall Study|Participant decision|1|||
48774879|NCT04251533|157018850|FG001|Overall Study|Participant decision|3|||
48774880|NCT04251533|157018851|FG002|Overall Study|Participant decision|1|||
48774881|NCT04251533|157018849|FG000|Overall Study|Adverse Event|2|||
48774882|NCT04251533|157018850|FG001|Overall Study|Adverse Event|1|||
48774883|NCT04251533|157018851|FG002|Overall Study|Adverse Event|1|||
48774884|NCT00595582|157018861|FG000|Overall Study|Pilot study that PI terminated|2|||
48774885|NCT00595582|157018861|FG000|Overall Study|Lost to Follow-up|1|||
48774886|NCT00595582|157018861|FG000|Overall Study|Adverse Event|2|||
48774887|NCT00595582|157018861|FG000|Overall Study|Physician Decision|5|||
48774888|NCT00983814|157018864|FG000|Open-Label (6 Weeks)|Adverse Event|3|||
48774889|NCT00983814|157018865|FG001|Open-Label (6 Weeks)|Adverse Event|0|||
48774890|NCT00983814|157018866|FG002|Open-Label (6 Weeks)|Adverse Event|0|||
48774891|NCT00983814|157018864|FG000|Open-Label (6 Weeks)|Withdrawal by Subject|2|||
48774892|NCT00983814|157018865|FG001|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
48774893|NCT00983814|157018866|FG002|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
48774894|NCT00983814|157018864|FG000|Open-Label (6 Weeks)|Physician Decision|1|||
48774895|NCT00983814|157018865|FG001|Open-Label (6 Weeks)|Physician Decision|0|||
48774896|NCT00983814|157018866|FG002|Open-Label (6 Weeks)|Physician Decision|0|||
48774897|NCT00983814|157018864|FG000|Open-Label (6 Weeks)|Lost to Follow-up|1|||
48774898|NCT00983814|157018865|FG001|Open-Label (6 Weeks)|Lost to Follow-up|0|||
48774899|NCT00983814|157018866|FG002|Open-Label (6 Weeks)|Lost to Follow-up|0|||
48774900|NCT00983814|157018864|FG000|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
48774901|NCT00983814|157018865|FG001|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
48774902|NCT00983814|157018866|FG002|Double-Blind (2 Weeks)|Withdrawal by Subject|1|||
48774903|NCT03779841|157018875|FG000|Randomized Population|Did Not Receive Treatment|3|||
48774904|NCT03779841|157018876|FG001|Randomized Population|Did Not Receive Treatment|1|||
48774905|NCT03779841|157018877|FG002|Randomized Population|Did Not Receive Treatment|0|||
48774906|NCT03779841|157018875|FG000|Treated (Safety) Population|Adverse Event|1|||
48774907|NCT03779841|157018876|FG001|Treated (Safety) Population|Adverse Event|1|||
48774908|NCT03779841|157018877|FG002|Treated (Safety) Population|Adverse Event|0|||
49027577|NCT00318461|157939152|FG001|Open-Label Extension, 18 Months|Adverse Event|8|||
49027578|NCT00318461|157939153|FG002|Open-Label Extension, 18 Months|Adverse Event|6|||
48774909|NCT03779841|157018875|FG000|Treated (Safety) Population|Withdrawal by Subject|4|||
48774910|NCT03779841|157018876|FG001|Treated (Safety) Population|Withdrawal by Subject|8|||
48774911|NCT03779841|157018877|FG002|Treated (Safety) Population|Withdrawal by Subject|6|||
48774912|NCT03779841|157018875|FG000|Treated (Safety) Population|Lost to Follow-up|5|||
48774913|NCT03779841|157018876|FG001|Treated (Safety) Population|Lost to Follow-up|9|||
48774914|NCT03779841|157018877|FG002|Treated (Safety) Population|Lost to Follow-up|8|||
48774915|NCT03779841|157018875|FG000|Treated (Safety) Population|Death|1|||
48774916|NCT03779841|157018876|FG001|Treated (Safety) Population|Death|0|||
48774917|NCT03779841|157018877|FG002|Treated (Safety) Population|Death|2|||
48774918|NCT02447991|157018878|FG000|Overall Study|Withdrawn by subject - no data|0|||
48774919|NCT02447991|157018879|FG001|Overall Study|Withdrawn by subject - no data|2|||
48774920|NCT02447991|157018878|FG000|Overall Study|Withdrawn by Subject - with data|4|||
48774921|NCT02447991|157018879|FG001|Overall Study|Withdrawn by Subject - with data|4|||
48774922|NCT02447991|157018878|FG000|Overall Study|Lost to Follow-up - no data|3|||
48774923|NCT02447991|157018879|FG001|Overall Study|Lost to Follow-up - no data|6|||
48774924|NCT02447991|157018878|FG000|Overall Study|Lost to follow-up - with data|0|||
48774925|NCT02447991|157018879|FG001|Overall Study|Lost to follow-up - with data|3|||
48774926|NCT02447991|157018878|FG000|Overall Study|End of study - no treatment results|3|||
48774927|NCT02447991|157018879|FG001|Overall Study|End of study - no treatment results|6|||
48774928|NCT02447991|157018878|FG000|Overall Study|End of study - partial treatment results|0|||
48774929|NCT02447991|157018879|FG001|Overall Study|End of study - partial treatment results|9|||
48774930|NCT01581593|157019894|FG000|Overall Study|Withdrawal by Subject|1|||
48774931|NCT00779675|157019897|FG000|Treatment Period|Adverse Event|87|||
48774932|NCT00779675|157019897|FG000|Treatment Period|Treatment Failure|80|||
48774933|NCT00779675|157019897|FG000|Treatment Period|Transferred to Another Study|38|||
48774934|NCT00779675|157019897|FG000|Treatment Period|Lost to Follow-up|23|||
48774935|NCT00779675|157019897|FG000|Treatment Period|Withdrawal by Subject|46|||
48774936|NCT00779675|157019897|FG000|Treatment Period|Protocol Violation|54|||
48774937|NCT00779675|157019897|FG000|Treatment Period|Did Not Meet Protocol Eligibility|1|||
48774938|NCT00779675|157019897|FG000|Treatment Period|Administrative|3|||
48774939|NCT00779675|157019897|FG000|Extended Treatment Period|Reasons unrelated to study treatment|9|||
48774940|NCT00779675|157019897|FG000|Extended Treatment Period|Protocol Violation|13|||
48774941|NCT00779675|157019897|FG000|Extended Treatment Period|Adverse Event|6|||
48774942|NCT00779675|157019897|FG000|Extended Treatment Period|Treatment Failure|11|||
48774943|NCT00779675|157019897|FG000|Extended Treatment Period|Protocol defined clinical event|1|||
48774944|NCT00779675|157019897|FG000|Extended Treatment Period|Lost to Follow-up|6|||
48774945|NCT01400841|157019901|FG000|Initial Study Phase (6 Months)|Death|1|||
48774946|NCT01400841|157019901|FG000|Extended Study Phase (2 Years)|Adverse Event|2|||
48774947|NCT04537806|157019904|FG000|Overall Study|Randomized but not treated|1|||
48774948|NCT04537806|157019905|FG001|Overall Study|Randomized but not treated|0|||
49027579|NCT00318461|157939154|FG003|Open-Label Extension, 18 Months|Adverse Event|1|||
48774949|NCT04537806|157019904|FG000|Overall Study|Adverse Event|1|||
48774950|NCT04537806|157019905|FG001|Overall Study|Adverse Event|1|||
48774951|NCT04304001|157019914|FG000|Overall Study|Lost to Follow-up|13|||
48774952|NCT04304001|157019915|FG001|Overall Study|Lost to Follow-up|9|||
48774953|NCT00705575|157019919|FG000|Overall Study|Abnormal laboratory value(s)|0|||
48774954|NCT00705575|157019920|FG001|Overall Study|Abnormal laboratory value(s)|3|||
48774955|NCT00705575|157019919|FG000|Overall Study|Abnormal test procedure result(s)|2|||
48774956|NCT00705575|157019920|FG001|Overall Study|Abnormal test procedure result(s)|12|||
48774957|NCT00705575|157019919|FG000|Overall Study|Adverse Event|11|||
48774958|NCT00705575|157019920|FG001|Overall Study|Adverse Event|15|||
48774959|NCT00705575|157019919|FG000|Overall Study|Lost to Follow-up|3|||
48774960|NCT00705575|157019920|FG001|Overall Study|Lost to Follow-up|4|||
48774961|NCT00705575|157019919|FG000|Overall Study|Protocol Violation|2|||
48774962|NCT00705575|157019920|FG001|Overall Study|Protocol Violation|2|||
48774963|NCT00705575|157019919|FG000|Overall Study|Withdrawal by Subject|5|||
48774964|NCT00705575|157019920|FG001|Overall Study|Withdrawal by Subject|10|||
48774965|NCT00724451|157019923|FG000|Overall Study|Excluded - Prior Use of Peginterferon|7|||
48774966|NCT00724451|157019923|FG000|Overall Study|Excluded - Hepatitis C Virus Negative|3|||
48774967|NCT00724451|157019923|FG000|Overall Study|Not Eligible for Treatment|431|||
48774968|NCT00724451|157019923|FG000|Overall Study|Participant Refused Treatment|89|||
48774969|NCT00724451|157019923|FG000|Overall Study|Never Started Treatment|89|||
48774970|NCT00724451|157019923|FG000|Overall Study|Unknown; No Data Sources Available|9|||
48774971|NCT00724451|157019923|FG000|Overall Study|Physician Decision|116|||
48774972|NCT00724451|157019923|FG000|Overall Study|Withdrawal by Subject|45|||
48774973|NCT00724451|157019923|FG000|Overall Study|Investigator + Participant Decision|13|||
48774974|NCT01110915|157019930|FG000|Overall Study|Death|2|||
48774975|NCT01110915|157019931|FG001|Overall Study|Death|1|||
48774976|NCT01110915|157019930|FG000|Overall Study|Lost to Follow-up|1|||
48774977|NCT01110915|157019931|FG001|Overall Study|Lost to Follow-up|0|||
48774978|NCT01110915|157019930|FG000|Overall Study|Withdrawal by Subject|7|||
48774979|NCT01110915|157019931|FG001|Overall Study|Withdrawal by Subject|1|||
48774980|NCT02948842|157019933|FG000|Overall Study|Withdrawal by Subject|4|||
48774981|NCT00578565|157019934|FG000|Overall Study|Adverse Event|3|||
48774982|NCT01649856|157019935|FG000|Overall Study|Withdrawal by Subject|14|||
48774983|NCT01649856|157019936|FG001|Overall Study|Withdrawal by Subject|14|||
48774984|NCT01649856|157019935|FG000|Overall Study|Protocol Violation|4|||
48774985|NCT01649856|157019936|FG001|Overall Study|Protocol Violation|4|||
48774986|NCT01649856|157019935|FG000|Overall Study|Treatment Failure|1|||
48774987|NCT01649856|157019936|FG001|Overall Study|Treatment Failure|1|||
49027580|NCT00318461|157939155|FG004|Open-Label Extension, 18 Months|Adverse Event|6|||
48774988|NCT01649856|157019935|FG000|Overall Study|Death|69|||
48774989|NCT01649856|157019936|FG001|Overall Study|Death|34|||
48774990|NCT01649856|157019935|FG000|Overall Study|Stable or Progressed Disease|5|||
48774991|NCT01649856|157019936|FG001|Overall Study|Stable or Progressed Disease|3|||
48774992|NCT01649856|157019935|FG000|Overall Study|Lost to Follow-up|20|||
48774993|NCT01649856|157019936|FG001|Overall Study|Lost to Follow-up|16|||
48774994|NCT01649856|157019935|FG000|Overall Study|Lack of Compliance|6|||
48774995|NCT01649856|157019936|FG001|Overall Study|Lack of Compliance|1|||
48774996|NCT01649856|157019935|FG000|Overall Study|Other|20|||
48774997|NCT01649856|157019936|FG001|Overall Study|Other|5|||
48774998|NCT00179647|157019937|FG000|Overall Study|Adverse Event|294|||
48774999|NCT00179647|157019937|FG000|Overall Study|Lack of Efficacy|478|||
48775000|NCT00179647|157019937|FG000|Overall Study|Withdrawal by Subject|83|||
48775001|NCT00179647|157019937|FG000|Overall Study|Lost to Follow-up|4|||
48775002|NCT00179647|157019937|FG000|Overall Study|Death|94|||
48775003|NCT00179647|157019937|FG000|Overall Study|Other|960|||
48775004|NCT02550652|157019938|FG000|Overall Study|Death|1|||
48775005|NCT02550652|157019939|FG001|Overall Study|Death|4|||
49027581|NCT00318461|157939151|FG000|Open-Label Extension, 18 Months|Lack of Efficacy|41|||
49027582|NCT00318461|157939152|FG001|Open-Label Extension, 18 Months|Lack of Efficacy|33|||
49027583|NCT00318461|157939153|FG002|Open-Label Extension, 18 Months|Lack of Efficacy|37|||
49027584|NCT00318461|157939154|FG003|Open-Label Extension, 18 Months|Lack of Efficacy|27|||
49027585|NCT00318461|157939155|FG004|Open-Label Extension, 18 Months|Lack of Efficacy|63|||
49027586|NCT00318461|157939151|FG000|Open-Label Extension, 18 Months|Protocol Violation|7|||
49027587|NCT00318461|157939152|FG001|Open-Label Extension, 18 Months|Protocol Violation|5|||
49027588|NCT00318461|157939153|FG002|Open-Label Extension, 18 Months|Protocol Violation|3|||
49027589|NCT00318461|157939154|FG003|Open-Label Extension, 18 Months|Protocol Violation|4|||
49027590|NCT00318461|157939155|FG004|Open-Label Extension, 18 Months|Protocol Violation|6|||
49027591|NCT01864174|157939156|FG000|Double Blind Treatment - All Treated|Removed due to site non-compliance|15|||
49027592|NCT01864174|157939157|FG001|Double Blind Treatment - All Treated|Removed due to site non-compliance|14|||
49027593|NCT01864174|157939156|FG000|Double Blind - Compliant Randomized|Adverse Event|6|||
49027594|NCT01864174|157939157|FG001|Double Blind - Compliant Randomized|Adverse Event|1|||
49027595|NCT01864174|157939156|FG000|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2|||
49027596|NCT01864174|157939157|FG001|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0|||
49027597|NCT01864174|157939156|FG000|Double Blind - Compliant Randomized|Subject Withdrew Consent|4|||
49027598|NCT01864174|157939157|FG001|Double Blind - Compliant Randomized|Subject Withdrew Consent|5|||
49027599|NCT01864174|157939156|FG000|Double Blind - Compliant Randomized|Death|1|||
49027600|NCT01864174|157939157|FG001|Double Blind - Compliant Randomized|Death|0|||
49027601|NCT01864174|157939156|FG000|Double Blind - Compliant Randomized|Lost to Follow-up|3|||
49027602|NCT01864174|157939157|FG001|Double Blind - Compliant Randomized|Lost to Follow-up|10|||
49027603|NCT01864174|157939156|FG000|Double Blind - Compliant Randomized|Poor/Non-compliance|1|||
48775006|NCT02550652|157019938|FG000|Overall Study|Lack of Efficacy|1|||
48775007|NCT02550652|157019939|FG001|Overall Study|Lack of Efficacy|0|||
48775008|NCT02550652|157019938|FG000|Overall Study|Withdrawal by Subject|4|||
49027604|NCT01864174|157939157|FG001|Double Blind - Compliant Randomized|Poor/Non-compliance|0|||
49027605|NCT01864174|157939156|FG000|Double Blind - Compliant Randomized|Other|6|||
49027606|NCT01864174|157939157|FG001|Double Blind - Compliant Randomized|Other|10|||
49027607|NCT01864174|157939156|FG000|Off Treatment Follow-Up|Other|2|||
49027608|NCT01864174|157939157|FG001|Off Treatment Follow-Up|Other|0|||
49027609|NCT01864174|157939156|FG000|Off Treatment Follow-Up|Subject Withdrew Consent|1|||
49027610|NCT01864174|157939157|FG001|Off Treatment Follow-Up|Subject Withdrew Consent|0|||
48775009|NCT02550652|157019939|FG001|Overall Study|Withdrawal by Subject|7|||
48775010|NCT02550652|157019938|FG000|Overall Study|Post Trial Access|1|||
49027611|NCT02327130|157939158|FG000|Overall Study|Discharged in less than 5 days|5|||
49027612|NCT02327130|157939158|FG000|Overall Study|Physician Decision|2|||
49027613|NCT02327130|157939158|FG000|Overall Study|Unable to provide breath sample|1|||
49027614|NCT02327130|157939158|FG000|Overall Study|Incorrectly place ventilator adaptor|1|||
49027615|NCT02327130|157939158|FG000|Overall Study|Met exclusion criteria|3|||
49027616|NCT00420238|157939162|FG000|12 Week Double-Blind Treatment Period 1|Adverse Event|1|||
49027617|NCT00420238|157939163|FG001|12 Week Double-Blind Treatment Period 1|Adverse Event|0|||
49027618|NCT00420238|157939162|FG000|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0|||
49027619|NCT00420238|157939163|FG001|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2|||
49027620|NCT00420238|157939162|FG000|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0|||
49027621|NCT00420238|157939163|FG001|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1|||
49027622|NCT00420238|157939162|FG000|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0|||
49027623|NCT00420238|157939163|FG001|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1|||
49027624|NCT00420238|157939162|FG000|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1|||
49027625|NCT00420238|157939163|FG001|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0|||
49027626|NCT00420238|157939162|FG000|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
49027627|NCT00420238|157939163|FG001|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
49027628|NCT05214560|157939164|FG000|Overall Study|Screening Failure|1|||
49027629|NCT05214560|157939164|FG000|Overall Study|Physician Decision|4|||
49027630|NCT05214560|157939164|FG000|Overall Study|Withdrawal by Subject|1|||
48775011|NCT02550652|157019939|FG001|Overall Study|Post Trial Access|0|||
48775012|NCT02550652|157019938|FG000|Overall Study|Lost to Follow-up|1|||
48775013|NCT02550652|157019939|FG001|Overall Study|Lost to Follow-up|3|||
48775014|NCT02550652|157019938|FG000|Overall Study|Physician Decision|0|||
48775015|NCT02550652|157019939|FG001|Overall Study|Physician Decision|2|||
49027631|NCT05214560|157939164|FG000|Overall Study|Lost to Follow-up|2|||
48775016|NCT02550652|157019938|FG000|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|0|||
48775017|NCT02550652|157019939|FG001|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|2|||
48775018|NCT02127307|157019940|FG000|Overall Study|Protocol Violation|36|||
48775019|NCT02127307|157019940|FG000|Overall Study|Lost to Follow-up|2|||
48775020|NCT02127307|157019940|FG000|Overall Study|Death|101|||
48775021|NCT02127307|157019940|FG000|Overall Study|Other than specified above|169|||
48775022|NCT00958880|157019943|FG000|Overall Study|Lost to Follow-up|2|||
48775023|NCT00958880|157019944|FG001|Overall Study|Lost to Follow-up|2|||
48775024|NCT02442830|157019946|FG000|Overall Study|Technical Failure|0|||
48775025|NCT02442830|157019947|FG001|Overall Study|Technical Failure|1|||
48775026|NCT03191903|157019951|FG000|Overall Study|Withdrawal by Subject|6|||
48775027|NCT03191903|157019952|FG001|Overall Study|Withdrawal by Subject|5|||
48775028|NCT03191903|157019953|FG002|Overall Study|Withdrawal by Subject|4|||
48775029|NCT03191903|157019951|FG000|Overall Study|Adverse Event|1|||
48775030|NCT03191903|157019952|FG001|Overall Study|Adverse Event|0|||
48775031|NCT03191903|157019953|FG002|Overall Study|Adverse Event|0|||
48775032|NCT00813761|157019954|FG000|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2|||
48775033|NCT00813761|157019955|FG001|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
48775034|NCT00813761|157019956|FG002|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
48775035|NCT00813761|157019957|FG003|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
48775036|NCT00813761|157019954|FG000|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
48775037|NCT00813761|157019955|FG001|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
48775038|NCT00813761|157019956|FG002|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3|||
48775039|NCT00813761|157019957|FG003|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1|||
48775040|NCT00813761|157019954|FG000|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
48775041|NCT00813761|157019955|FG001|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
48775042|NCT00813761|157019956|FG002|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
48775043|NCT00813761|157019957|FG003|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0|||
48775044|NCT00813761|157019954|FG000|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
48775045|NCT00813761|157019955|FG001|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
48775046|NCT00813761|157019956|FG002|Phase 1 (Baseline to 4 Weeks)|poor vision|3|||
48775047|NCT00813761|157019957|FG003|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
48775048|NCT00813761|157019954|FG000|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
48775049|NCT00813761|157019955|FG001|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
48775050|NCT00813761|157019956|FG002|Phase 1 (Baseline to 4 Weeks)|poor comfort|5|||
48775051|NCT00813761|157019957|FG003|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
48775052|NCT00813761|157019954|FG000|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
48775053|NCT00813761|157019955|FG001|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1|||
48775054|NCT00813761|157019956|FG002|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
48775055|NCT00813761|157019957|FG003|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
48775056|NCT00813761|157019954|FG000|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2|||
48775057|NCT00813761|157019955|FG001|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3|||
48775058|NCT00813761|157019956|FG002|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
48775059|NCT00813761|157019957|FG003|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
48775060|NCT00813761|157019954|FG000|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3|||
48775061|NCT00813761|157019955|FG001|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0|||
48775062|NCT00813761|157019956|FG002|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2|||
48775063|NCT00813761|157019957|FG003|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1|||
48775064|NCT00813761|157019954|FG000|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
48775065|NCT00813761|157019955|FG001|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
48775066|NCT00813761|157019956|FG002|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
48775067|NCT00813761|157019957|FG003|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
48775068|NCT00813761|157019954|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
48775069|NCT00813761|157019955|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
48775070|NCT00813761|157019956|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
48775071|NCT00813761|157019957|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0|||
48775072|NCT00813761|157019954|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1|||
48775073|NCT00813761|157019955|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4|||
48775074|NCT00813761|157019956|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0|||
48775075|NCT00813761|157019957|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3|||
48775076|NCT00813761|157019954|FG000|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9|||
48775077|NCT00813761|157019955|FG001|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
48775078|NCT00813761|157019956|FG002|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6|||
48775079|NCT00813761|157019957|FG003|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
48775080|NCT00691210|157019958|FG000|Overall Study|Progression of Disease|0|||
48775081|NCT00691210|157019959|FG001|Overall Study|Progression of Disease|0|||
48775082|NCT00691210|157019960|FG002|Overall Study|Progression of Disease|0|||
48775083|NCT00691210|157019961|FG003|Overall Study|Progression of Disease|2|||
48775084|NCT00691210|157019962|FG004|Overall Study|Progression of Disease|0|||
48775085|NCT00691210|157019963|FG005|Overall Study|Progression of Disease|0|||
48775086|NCT00691210|157019964|FG006|Overall Study|Progression of Disease|0|||
48775087|NCT00691210|157019965|FG007|Overall Study|Progression of Disease|0|||
48775088|NCT00691210|157019958|FG000|Overall Study|Lack of Efficacy|0|||
48775089|NCT00691210|157019959|FG001|Overall Study|Lack of Efficacy|0|||
48775090|NCT00691210|157019960|FG002|Overall Study|Lack of Efficacy|0|||
48775091|NCT00691210|157019961|FG003|Overall Study|Lack of Efficacy|1|||
48775092|NCT00691210|157019962|FG004|Overall Study|Lack of Efficacy|0|||
48775093|NCT00691210|157019963|FG005|Overall Study|Lack of Efficacy|1|||
48775094|NCT00691210|157019964|FG006|Overall Study|Lack of Efficacy|0|||
49027632|NCT05214560|157939164|FG000|Overall Study|General anesthesia at the request of the surgeon|2|||
49027633|NCT05214560|157939164|FG000|Overall Study|Study physician not available for the anesthesia|3|||
49027634|NCT05214560|157939164|FG000|Overall Study|Anesthesia rejected by the patient on the day of surgery|1|||
49027635|NCT05214560|157939164|FG000|Overall Study|Device not listed in the study was used for the procedure|1|||
49027636|NCT05214560|157939164|FG000|Overall Study|Surgery not performed|3|||
49027637|NCT02296684|157939165|FG000|Overall Study|Withdrawal by Subject|0|||
49027638|NCT02296684|157939166|FG001|Overall Study|Withdrawal by Subject|1|||
49027639|NCT02296684|157939167|FG002|Overall Study|Withdrawal by Subject|1|||
49027640|NCT02296684|157939165|FG000|Overall Study|Death|2|||
49027641|NCT02296684|157939166|FG001|Overall Study|Death|0|||
49027642|NCT02296684|157939167|FG002|Overall Study|Death|0|||
49027643|NCT01474551|157939168|FG000|Overall Study|Death|1|||
49027644|NCT02392000|157939175|FG000|Overall Study|Greater than mild sleep apnea exclusion|18|||
49027645|NCT02392000|157939175|FG000|Overall Study|Withdrawal by Subject|1|||
49027646|NCT02392000|157939175|FG000|Overall Study|Lost to Follow-up|8|||
49027647|NCT04384978|157939177|FG000|Overall Study|Withdrawal by Subject|4|||
49027648|NCT04384978|157939178|FG001|Overall Study|Withdrawal by Subject|0|||
49027649|NCT00385593|157939180|FG000|Overall Study|Adverse Event|3|||
49027650|NCT00385593|157939181|FG001|Overall Study|Adverse Event|2|||
49027651|NCT00385593|157939180|FG000|Overall Study|Withdrawal by Subject|17|||
49027652|NCT00385593|157939181|FG001|Overall Study|Withdrawal by Subject|7|||
49027653|NCT00385593|157939180|FG000|Overall Study|Lost to Follow-up|12|||
49027654|NCT00385593|157939181|FG001|Overall Study|Lost to Follow-up|8|||
49027655|NCT00385593|157939180|FG000|Overall Study|Protocol Violation|7|||
48775095|NCT00691210|157019965|FG007|Overall Study|Lack of Efficacy|0|||
48775096|NCT01306617|157019969|FG000|Overall Study|Adverse Event|1|||
48775097|NCT01306617|157019970|FG001|Overall Study|Adverse Event|0|||
48775098|NCT01306617|157019971|FG002|Overall Study|Adverse Event|0|||
48775099|NCT01306617|157019969|FG000|Overall Study|Virologic Failure|0|||
48775100|NCT01306617|157019970|FG001|Overall Study|Virologic Failure|0|||
48775101|NCT01306617|157019971|FG002|Overall Study|Virologic Failure|5|||
48775102|NCT01306617|157019969|FG000|Overall Study|Non-compliance|0|||
48775103|NCT01306617|157019970|FG001|Overall Study|Non-compliance|1|||
48775104|NCT01306617|157019971|FG002|Overall Study|Non-compliance|0|||
48775105|NCT01850004|157019979|FG000|Overall Study|Poor/Non-compliance|1|||
48775106|NCT01850004|157019979|FG000|Overall Study|Participant Withdrew Consent|9|||
48775107|NCT01850004|157019979|FG000|Overall Study|Participant Request to Discontinue Treatment|2|||
48775108|NCT01850004|157019979|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
48775109|NCT01850004|157019979|FG000|Overall Study|Adverse Event Related to Study Drug|4|||
48775110|NCT01850004|157019979|FG000|Overall Study|Other Reasons|2|||
48775111|NCT01850004|157019979|FG000|Overall Study|Participant No Longer Meets Study Criteria|1|||
48775112|NCT01850004|157019979|FG000|Overall Study|Maximum Clinical Benefit|4|||
48775113|NCT00428610|157019980|FG000|Overall Study|Death Due to Adverse Event|3|||
48775114|NCT00428610|157019981|FG001|Overall Study|Death Due to Adverse Event|0|||
48775115|NCT00428610|157019982|FG002|Overall Study|Death Due to Adverse Event|5|||
48775116|NCT00428610|157019980|FG000|Overall Study|Death Due to Progressive Disease|0|||
48775117|NCT00428610|157019981|FG001|Overall Study|Death Due to Progressive Disease|0|||
48775118|NCT00428610|157019982|FG002|Overall Study|Death Due to Progressive Disease|2|||
48775119|NCT00428610|157019980|FG000|Overall Study|Adverse Event|2|||
48775120|NCT00428610|157019981|FG001|Overall Study|Adverse Event|3|||
48775121|NCT00428610|157019982|FG002|Overall Study|Adverse Event|2|||
48775122|NCT00428610|157019980|FG000|Overall Study|Investigator Decision|2|||
48876914|NCT01270828|157388466|FG002|Pregabalin CR SB|Reason Unspecified|8|||
49027656|NCT00385593|157939181|FG001|Overall Study|Protocol Violation|4|||
49027657|NCT00385593|157939180|FG000|Overall Study|Several reasons|17|||
49027658|NCT00385593|157939181|FG001|Overall Study|Several reasons|15|||
49027659|NCT00385593|157939180|FG000|Overall Study|Incorrect inclusion|2|||
48775123|NCT00428610|157019981|FG001|Overall Study|Investigator Decision|1|||
48775124|NCT00428610|157019982|FG002|Overall Study|Investigator Decision|1|||
48775125|NCT00428610|157019980|FG000|Overall Study|Progressive Disease|42|||
48775126|NCT00428610|157019981|FG001|Overall Study|Progressive Disease|14|||
48775127|NCT00428610|157019982|FG002|Overall Study|Progressive Disease|22|||
48775128|NCT00428610|157019980|FG000|Overall Study|Withdrawal by Subject|4|||
48775129|NCT00428610|157019981|FG001|Overall Study|Withdrawal by Subject|0|||
48775130|NCT00428610|157019982|FG002|Overall Study|Withdrawal by Subject|0|||
48775131|NCT04369469|157019985|FG000|Overall Study|Lost to Follow-up|2|||
48775132|NCT04369469|157019986|FG001|Overall Study|Lost to Follow-up|4|||
48775133|NCT04369469|157019985|FG000|Overall Study|Physician Decision|2|||
48775134|NCT04369469|157019986|FG001|Overall Study|Physician Decision|1|||
48775135|NCT04369469|157019985|FG000|Overall Study|Withdrawal by Subject|2|||
48775136|NCT04369469|157019986|FG001|Overall Study|Withdrawal by Subject|3|||
48775137|NCT04369469|157019985|FG000|Overall Study|Adverse Event|1|||
48775138|NCT04369469|157019986|FG001|Overall Study|Adverse Event|0|||
48775139|NCT04369469|157019985|FG000|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|2|||
49027660|NCT00385593|157939181|FG001|Overall Study|Incorrect inclusion|0|||
48775140|NCT04369469|157019986|FG001|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|0|||
48775141|NCT04369469|157019985|FG000|Overall Study|Not Qualified due to History of Anaphylaxis|1|||
48775142|NCT04369469|157019986|FG001|Overall Study|Not Qualified due to History of Anaphylaxis|0|||
48775143|NCT04369469|157019985|FG000|Overall Study|Unable to Provide Consent|0|||
48775144|NCT04369469|157019986|FG001|Overall Study|Unable to Provide Consent|1|||
48775145|NCT02707640|157019994|FG000|Overall Study|Adverse Event|4|||
48775146|NCT02707640|157019995|FG001|Overall Study|Adverse Event|2|||
49027661|NCT00385593|157939180|FG000|Overall Study|Incorrect randomization|0|||
49027662|NCT00385593|157939181|FG001|Overall Study|Incorrect randomization|1|||
49027663|NCT04419311|157939182|FG000|Overall Study|Lost to Follow-up|1|||
49027664|NCT04419311|157939183|FG001|Overall Study|Lost to Follow-up|0|||
49027665|NCT00304083|157939184|FG000|Overall Study|Withdrawal by Subject|4|||
49027666|NCT00304083|157939185|FG001|Overall Study|Withdrawal by Subject|2|||
49027667|NCT00304083|157939184|FG000|Overall Study|Physician Decision|8|||
49027668|NCT00304083|157939185|FG001|Overall Study|Physician Decision|3|||
49027669|NCT00304083|157939184|FG000|Overall Study|Disease Progression|5|||
49027670|NCT00304083|157939185|FG001|Overall Study|Disease Progression|1|||
48775147|NCT02707640|157019994|FG000|Overall Study|Death|1|||
48775148|NCT02707640|157019995|FG001|Overall Study|Death|2|||
48775149|NCT02707640|157019994|FG000|Overall Study|Physician Decision|2|||
48775150|NCT02707640|157019995|FG001|Overall Study|Physician Decision|0|||
48775151|NCT02707640|157019994|FG000|Overall Study|Withdrawal by Subject|0|||
48775152|NCT02707640|157019995|FG001|Overall Study|Withdrawal by Subject|1|||
48775153|NCT02707640|157019994|FG000|Overall Study|Participant's Personal Decision|1|||
48775154|NCT02707640|157019995|FG001|Overall Study|Participant's Personal Decision|2|||
48775155|NCT02707640|157019994|FG000|Overall Study|Sponsor Discretion|1|||
48775156|NCT02707640|157019995|FG001|Overall Study|Sponsor Discretion|0|||
48775157|NCT00555438|157019996|FG000|10 Days Post-operative|Death|4|||
48775158|NCT00555438|157019996|FG000|Between 10 Days and 30 Days Postoperativ|Death|5|||
48775159|NCT01312467|157020000|FG000|Overall Study|Adverse Event|4|||
48775160|NCT01312467|157020000|FG000|Overall Study|Lost to Follow-up|1|||
48775161|NCT01312467|157020000|FG000|Overall Study|Withdrawal by Subject|2|||
48775162|NCT01312467|157020000|FG000|Overall Study|Deported to country of origin|1|||
48775163|NCT01312467|157020000|FG000|Overall Study|Another medical condition|1|||
48775164|NCT01312467|157020000|FG000|Overall Study|Ineligible|4|||
48775165|NCT02199691|157020001|FG000|Overall Study|Protocol Violation|3|||
48775166|NCT02199691|157020002|FG001|Overall Study|Protocol Violation|3|||
48775167|NCT02199691|157020003|FG002|Overall Study|Protocol Violation|6|||
48775168|NCT02199691|157020004|FG003|Overall Study|Protocol Violation|7|||
48775169|NCT02199691|157020001|FG000|Overall Study|Withdrawal by Subject|5|||
48775170|NCT02199691|157020002|FG001|Overall Study|Withdrawal by Subject|3|||
48775171|NCT02199691|157020003|FG002|Overall Study|Withdrawal by Subject|12|||
48775172|NCT02199691|157020004|FG003|Overall Study|Withdrawal by Subject|13|||
48775173|NCT02199691|157020001|FG000|Overall Study|Lost to Follow-up|2|||
48775174|NCT02199691|157020002|FG001|Overall Study|Lost to Follow-up|1|||
48775175|NCT02199691|157020003|FG002|Overall Study|Lost to Follow-up|9|||
48775176|NCT02199691|157020004|FG003|Overall Study|Lost to Follow-up|10|||
48775177|NCT01976845|157020007|FG000|Overall Study|Physician Decision|8|||
48775178|NCT01976845|157020008|FG001|Overall Study|Physician Decision|8|||
48775179|NCT01976845|157020009|FG002|Overall Study|Physician Decision|3|||
48775180|NCT01336738|157021798|FG000|Overall Study|Adverse Event|0|||
49027671|NCT00304083|157939184|FG000|Overall Study|Other|5|||
49027672|NCT00304083|157939185|FG001|Overall Study|Other|2|||
49027673|NCT03725605|157939186|FG000|Overall Study|Unsuccessful TIL expansion|2|||
49027674|NCT03555305|157939187|FG000|Period 1|Physician Decision|0|||
49027675|NCT03555305|157939188|FG001|Period 1|Physician Decision|1|||
49027676|NCT03555305|157939187|FG000|Period 1|Adverse Event|0|||
49027677|NCT03555305|157939188|FG001|Period 1|Adverse Event|1|||
49027678|NCT03325985|157939189|FG000|Overall Study|Lost to Follow-up|122|||
49027679|NCT03325985|157939190|FG001|Overall Study|Lost to Follow-up|26|||
49027680|NCT03325985|157939191|FG002|Overall Study|Lost to Follow-up|141|||
49027681|NCT03325985|157939192|FG003|Overall Study|Lost to Follow-up|28|||
49027682|NCT03325985|157939189|FG000|Overall Study|Death|99|||
49027683|NCT03325985|157939190|FG001|Overall Study|Death|36|||
49027684|NCT03325985|157939191|FG002|Overall Study|Death|94|||
49027685|NCT03325985|157939192|FG003|Overall Study|Death|32|||
49027686|NCT02100228|157939195|FG000|Overall Study|Other|19|||
48775181|NCT01336738|157021799|FG001|Overall Study|Adverse Event|3|||
48775182|NCT01336738|157021800|FG002|Overall Study|Adverse Event|2|||
48775183|NCT01336738|157021801|FG003|Overall Study|Adverse Event|1|||
48775184|NCT01336738|157021802|FG004|Overall Study|Adverse Event|3|||
48775185|NCT01336738|157021798|FG000|Overall Study|Lost to Follow-up|2|||
48775186|NCT01336738|157021799|FG001|Overall Study|Lost to Follow-up|1|||
48775187|NCT01336738|157021800|FG002|Overall Study|Lost to Follow-up|2|||
48775188|NCT01336738|157021801|FG003|Overall Study|Lost to Follow-up|2|||
48775189|NCT01336738|157021802|FG004|Overall Study|Lost to Follow-up|2|||
49027687|NCT02100228|157939196|FG001|Overall Study|Other|19|||
49027688|NCT02100228|157939195|FG000|Overall Study|Administrative reason|0|||
49027689|NCT02100228|157939196|FG001|Overall Study|Administrative reason|1|||
49027690|NCT02100228|157939195|FG000|Overall Study|Inclusion/Exclusion criteria not met|12|||
49027691|NCT02100228|157939196|FG001|Overall Study|Inclusion/Exclusion criteria not met|16|||
49027692|NCT02100228|157939195|FG000|Overall Study|Non-compliance|0|||
49027693|NCT02100228|157939196|FG001|Overall Study|Non-compliance|3|||
49027694|NCT02100228|157939195|FG000|Overall Study|Lost to Follow-up|0|||
49027695|NCT02100228|157939196|FG001|Overall Study|Lost to Follow-up|1|||
49027696|NCT02100228|157939195|FG000|Overall Study|Withdrawal by Subject|27|||
49027697|NCT02100228|157939196|FG001|Overall Study|Withdrawal by Subject|37|||
48876915|NCT01270828|157388464|FG000|Pregabalin CR SB|Enrolled but not treated|0|||
48876916|NCT01270828|157388465|FG001|Pregabalin CR SB|Enrolled but not treated|0|||
48876917|NCT01270828|157388466|FG002|Pregabalin CR SB|Enrolled but not treated|5|||
48876918|NCT01270828|157388464|FG000|Pregabalin CR SB|Related adverse event|0|||
48876919|NCT01270828|157388465|FG001|Pregabalin CR SB|Related adverse event|0|||
48876920|NCT01270828|157388466|FG002|Pregabalin CR SB|Related adverse event|46|||
48876921|NCT01270828|157388464|FG000|Pregabalin CR SB|Lack of Efficacy|0|||
48876922|NCT01270828|157388465|FG001|Pregabalin CR SB|Lack of Efficacy|0|||
48876923|NCT01270828|157388466|FG002|Pregabalin CR SB|Lack of Efficacy|32|||
48876924|NCT01270828|157388464|FG000|Pregabalin CR SB|Withdrawal by Subject|0|||
48876925|NCT01270828|157388465|FG001|Pregabalin CR SB|Withdrawal by Subject|0|||
48876926|NCT01270828|157388466|FG002|Pregabalin CR SB|Withdrawal by Subject|29|||
49027698|NCT02100228|157939195|FG000|Overall Study|Adverse Event|16|||
49027699|NCT02100228|157939196|FG001|Overall Study|Adverse Event|12|||
49027700|NCT02100228|157939195|FG000|Overall Study|Death|1|||
49027701|NCT02100228|157939196|FG001|Overall Study|Death|1|||
49027702|NCT02605928|157939199|FG000|Overall Study|Model tuning phase|28|||
49027703|NCT02605928|157939199|FG000|Overall Study|Lack of Efficacy|5|||
49027704|NCT02374853|157939202|FG000|Overall Study|Surgery Cancelled|5|||
49027705|NCT02374853|157939203|FG001|Overall Study|Surgery Cancelled|11|||
49027706|NCT03243630|157939204|FG000|Overall Study|Protocol Violation|1|||
49027707|NCT03243630|157939204|FG000|Overall Study|Physician Decision|1|||
49027708|NCT04611789|157939205|FG000|Overall Study|Lost to Follow-up|1|||
49027709|NCT04611789|157939206|FG001|Overall Study|Lost to Follow-up|0|||
49027710|NCT04611789|157939207|FG002|Overall Study|Lost to Follow-up|0|||
49027711|NCT03707912|157939208|FG000|Overall Study|Violation of inclusion criteria|1|||
49027712|NCT03707912|157939209|FG001|Overall Study|Violation of inclusion criteria|0|||
49027713|NCT01027143|157941074|FG000|Overall Study|Lost to Follow-up|9|||
49027714|NCT01027143|157941075|FG001|Overall Study|Lost to Follow-up|4|||
49027715|NCT00416520|157941077|FG000|Open-label Period|Adverse Event|28|||
49027716|NCT00416520|157941078|FG001|Open-label Period|Adverse Event|10|||
49027717|NCT00416520|157941079|FG002|Open-label Period|Adverse Event|0|||
48775190|NCT01336738|157021798|FG000|Overall Study|Did not meet entrance criteria|0|||
48775191|NCT01336738|157021799|FG001|Overall Study|Did not meet entrance criteria|1|||
48775192|NCT01336738|157021800|FG002|Overall Study|Did not meet entrance criteria|0|||
48775193|NCT01336738|157021801|FG003|Overall Study|Did not meet entrance criteria|0|||
48775194|NCT01336738|157021802|FG004|Overall Study|Did not meet entrance criteria|0|||
48775195|NCT01336738|157021798|FG000|Overall Study|Protocol Violation|0|||
48775196|NCT01336738|157021799|FG001|Overall Study|Protocol Violation|1|||
48775197|NCT01336738|157021800|FG002|Overall Study|Protocol Violation|0|||
48775198|NCT01336738|157021801|FG003|Overall Study|Protocol Violation|0|||
48775199|NCT01336738|157021802|FG004|Overall Study|Protocol Violation|0|||
48775200|NCT01336738|157021798|FG000|Overall Study|Withdrawal by Subject|2|||
48775201|NCT01336738|157021799|FG001|Overall Study|Withdrawal by Subject|0|||
48775202|NCT01336738|157021800|FG002|Overall Study|Withdrawal by Subject|2|||
48775203|NCT01336738|157021801|FG003|Overall Study|Withdrawal by Subject|1|||
48775204|NCT01336738|157021802|FG004|Overall Study|Withdrawal by Subject|1|||
48775205|NCT01336738|157021798|FG000|Overall Study|Other|3|||
48775206|NCT01336738|157021799|FG001|Overall Study|Other|3|||
48775207|NCT01336738|157021800|FG002|Overall Study|Other|2|||
48775208|NCT01336738|157021801|FG003|Overall Study|Other|3|||
48775209|NCT01336738|157021802|FG004|Overall Study|Other|4|||
48775210|NCT03042312|157021803|FG000|Overall Study|Administrative Reason|1|||
48775211|NCT03042312|157021804|FG001|Overall Study|Administrative Reason|1|||
48775212|NCT03042312|157021803|FG000|Overall Study|Adverse Event|0|||
48775213|NCT03042312|157021804|FG001|Overall Study|Adverse Event|1|||
48775214|NCT03042312|157021803|FG000|Overall Study|Lost to Follow-up|1|||
48775215|NCT03042312|157021804|FG001|Overall Study|Lost to Follow-up|3|||
48775216|NCT03042312|157021803|FG000|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4|||
48775217|NCT03042312|157021804|FG001|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2|||
49027718|NCT00416520|157941080|FG003|Open-label Period|Adverse Event|0|||
49027719|NCT00416520|157941077|FG000|Open-label Period|Death|2|||
49027720|NCT00416520|157941078|FG001|Open-label Period|Death|1|||
48775218|NCT03042312|157021803|FG000|Overall Study|Withdrawal by Subject|4|||
48775219|NCT03042312|157021804|FG001|Overall Study|Withdrawal by Subject|5|||
48876927|NCT01270828|157388464|FG000|Pregabalin CR SB|Lost to Follow-up|0|||
48876928|NCT01270828|157388465|FG001|Pregabalin CR SB|Lost to Follow-up|0|||
48876929|NCT01270828|157388466|FG002|Pregabalin CR SB|Lost to Follow-up|10|||
49027721|NCT00416520|157941079|FG002|Open-label Period|Death|0|||
49027722|NCT00416520|157941080|FG003|Open-label Period|Death|0|||
49027723|NCT00416520|157941077|FG000|Open-label Period|Lack of Efficacy|8|||
49027724|NCT00416520|157941078|FG001|Open-label Period|Lack of Efficacy|1|||
49027725|NCT00416520|157941079|FG002|Open-label Period|Lack of Efficacy|0|||
48775220|NCT03003520|157021813|FG000|Overall Study|Adverse Event|9|||
48775221|NCT03003520|157021814|FG001|Overall Study|Adverse Event|0|||
48775222|NCT03003520|157021813|FG000|Overall Study|Death|1|||
48775223|NCT03003520|157021814|FG001|Overall Study|Death|0|||
48775224|NCT03003520|157021813|FG000|Overall Study|Other reasons|4|||
48775225|NCT03003520|157021814|FG001|Overall Study|Other reasons|0|||
48775226|NCT03003520|157021813|FG000|Overall Study|Withdrawal by Subject|6|||
48775227|NCT03003520|157021814|FG001|Overall Study|Withdrawal by Subject|0|||
48775228|NCT03003520|157021813|FG000|Overall Study|Progressive disease|9|||
49027726|NCT00416520|157941080|FG003|Open-label Period|Lack of Efficacy|0|||
49027727|NCT00416520|157941077|FG000|Open-label Period|Protocol Violation|3|||
49027728|NCT00416520|157941078|FG001|Open-label Period|Protocol Violation|3|||
49027729|NCT00416520|157941079|FG002|Open-label Period|Protocol Violation|0|||
49027730|NCT00416520|157941080|FG003|Open-label Period|Protocol Violation|0|||
49027731|NCT00416520|157941077|FG000|Open-label Period|Withdrawal by Subject|16|||
49027732|NCT00416520|157941078|FG001|Open-label Period|Withdrawal by Subject|5|||
49027733|NCT00416520|157941079|FG002|Open-label Period|Withdrawal by Subject|0|||
49027734|NCT00416520|157941080|FG003|Open-label Period|Withdrawal by Subject|0|||
49027735|NCT00416520|157941077|FG000|Open-label Period|Other Reasons|3|||
49027736|NCT00416520|157941078|FG001|Open-label Period|Other Reasons|12|||
49027737|NCT00416520|157941079|FG002|Open-label Period|Other Reasons|0|||
49027738|NCT00416520|157941080|FG003|Open-label Period|Other Reasons|0|||
49027739|NCT00416520|157941077|FG000|Placebo-controlled Withdrawal Period|Adverse Event|0|||
49027740|NCT00416520|157941078|FG001|Placebo-controlled Withdrawal Period|Adverse Event|0|||
49027741|NCT00416520|157941079|FG002|Placebo-controlled Withdrawal Period|Adverse Event|0|||
49027742|NCT00416520|157941080|FG003|Placebo-controlled Withdrawal Period|Adverse Event|1|||
49027743|NCT00416520|157941077|FG000|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
49027744|NCT00416520|157941078|FG001|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
49027745|NCT00416520|157941079|FG002|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
49027746|NCT00416520|157941080|FG003|Placebo-controlled Withdrawal Period|Lack of Efficacy|3|||
49027747|NCT00416520|157941077|FG000|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
49027748|NCT00416520|157941078|FG001|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
49027749|NCT00416520|157941079|FG002|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
49027750|NCT00416520|157941080|FG003|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
49027751|NCT03292653|157941081|FG000|Overall Study|Adverse Event|0|||
49027752|NCT03292653|157941082|FG001|Overall Study|Adverse Event|0|||
49027753|NCT03292653|157941083|FG002|Overall Study|Adverse Event|1|||
49027754|NCT03292653|157941081|FG000|Overall Study|Did not Receive Treatment|1|||
49027755|NCT03292653|157941082|FG001|Overall Study|Did not Receive Treatment|0|||
49027756|NCT03292653|157941083|FG002|Overall Study|Did not Receive Treatment|0|||
49027757|NCT04178733|157941084|FG000|Overall Study|Investigator Decision|0|||
49027758|NCT04178733|157941085|FG001|Overall Study|Investigator Decision|0|||
48775229|NCT03003520|157021814|FG001|Overall Study|Progressive disease|1|||
48775230|NCT00827372|157021815|FG000|Overall Study|Adverse Event|5|||
48775231|NCT00827372|157021815|FG000|Overall Study|Lack of Efficacy|3|||
48775232|NCT03085927|157021816|FG000|Overall Study|Withdrawal by Subject|1|||
48775233|NCT03085927|157021817|FG001|Overall Study|Withdrawal by Subject|4|||
48775234|NCT03085927|157021816|FG000|Overall Study|Lost to Follow-up|3|||
48775235|NCT03085927|157021817|FG001|Overall Study|Lost to Follow-up|1|||
48775236|NCT03085927|157021816|FG000|Overall Study|Death|1|||
48775237|NCT03085927|157021817|FG001|Overall Study|Death|0|||
48775238|NCT03085927|157021816|FG000|Overall Study|Child Toxicity/Side Effects of Treatment|1|||
48775239|NCT03085927|157021817|FG001|Overall Study|Child Toxicity/Side Effects of Treatment|0|||
48775240|NCT03085927|157021816|FG000|Overall Study|Dyad Became Ineligible|0|||
48775241|NCT03085927|157021817|FG001|Overall Study|Dyad Became Ineligible|1|||
48775242|NCT02565381|157021821|FG000|Overall Study|Lost to Follow-up|1|||
48775243|NCT02565381|157021822|FG001|Overall Study|Lost to Follow-up|0|||
48775244|NCT02565381|157021823|FG002|Overall Study|Lost to Follow-up|1|||
48775245|NCT03036566|157021830|FG000|Overall Study|Lost to Follow-up|3|||
48775246|NCT00672477|157021831|FG000|Overall Study|Adverse Event|10|||
48775247|NCT00672477|157021832|FG001|Overall Study|Adverse Event|7|||
48775248|NCT00672477|157021831|FG000|Overall Study|Death|7|||
48775249|NCT00672477|157021832|FG001|Overall Study|Death|11|||
48775250|NCT00672477|157021831|FG000|Overall Study|Physician Decision|2|||
48775251|NCT00672477|157021832|FG001|Overall Study|Physician Decision|0|||
48775252|NCT00672477|157021831|FG000|Overall Study|Protocol Violation|1|||
48775253|NCT00672477|157021832|FG001|Overall Study|Protocol Violation|1|||
49027759|NCT04178733|157941086|FG002|Overall Study|Investigator Decision|0|||
48775254|NCT00672477|157021831|FG000|Overall Study|Withdrawal by Subject|5|||
48775255|NCT00672477|157021832|FG001|Overall Study|Withdrawal by Subject|3|||
48775256|NCT00672477|157021831|FG000|Overall Study|Lack of Efficacy|1|||
48775257|NCT00672477|157021832|FG001|Overall Study|Lack of Efficacy|1|||
48775258|NCT00672477|157021831|FG000|Overall Study|no study drug for low GFR, health cond.|1|||
48775259|NCT00672477|157021832|FG001|Overall Study|no study drug for low GFR, health cond.|3|||
48775260|NCT03986944|157021833|FG000|Overall Study|Adverse Event|1|||
48775261|NCT03986944|157021834|FG001|Overall Study|Adverse Event|2|||
48775262|NCT03986944|157021835|FG002|Overall Study|Adverse Event|3|||
48775263|NCT03986944|157021833|FG000|Overall Study|Protocol Violation|0|||
48775264|NCT03986944|157021834|FG001|Overall Study|Protocol Violation|1|||
48775265|NCT03986944|157021835|FG002|Overall Study|Protocol Violation|1|||
48775266|NCT03986944|157021833|FG000|Overall Study|Withdrawal by Subject|3|||
48775267|NCT03986944|157021834|FG001|Overall Study|Withdrawal by Subject|5|||
48775268|NCT03986944|157021835|FG002|Overall Study|Withdrawal by Subject|5|||
48775269|NCT03986944|157021833|FG000|Overall Study|Study termination|10|||
48775270|NCT03986944|157021834|FG001|Overall Study|Study termination|10|||
48775271|NCT03986944|157021835|FG002|Overall Study|Study termination|10|||
48775272|NCT03986944|157021833|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|1|||
48775273|NCT03986944|157021834|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
48775274|NCT03986944|157021835|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
48775275|NCT03986944|157021833|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
48775276|NCT03986944|157021834|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|1|||
48775277|NCT03986944|157021835|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
48775278|NCT00634647|157021839|FG000|Overall Study|death on study|3|||
48775279|NCT00634647|157021839|FG000|Overall Study|refused further treatment|3|||
48775280|NCT00634647|157021839|FG000|Overall Study|declined to participate before treatment|1|||
48775281|NCT02984020|157021840|FG000|Overall Study|Experienced off-label use against Xeljanz local product document|21|||
48775282|NCT02984020|157021840|FG000|Overall Study|Not met the inclusion/exclusion criterion|9|||
48775283|NCT02984020|157021840|FG000|Overall Study|Other significant protocol violation|2|||
48775284|NCT01529645|157021841|FG000|Overall Study|Lost to Follow-up|0|||
48775285|NCT01529645|157021842|FG001|Overall Study|Lost to Follow-up|1|||
48775286|NCT01529645|157021843|FG002|Overall Study|Lost to Follow-up|1|||
48775287|NCT01529645|157021844|FG003|Overall Study|Lost to Follow-up|1|||
48775288|NCT01529645|157021845|FG004|Overall Study|Lost to Follow-up|1|||
48775289|NCT01529645|157021846|FG005|Overall Study|Lost to Follow-up|0|||
48775290|NCT01529645|157021847|FG006|Overall Study|Lost to Follow-up|2|||
48775291|NCT01529645|157021848|FG007|Overall Study|Lost to Follow-up|0|||
48775292|NCT01529645|157021849|FG008|Overall Study|Lost to Follow-up|1|||
48775293|NCT01529645|157021850|FG009|Overall Study|Lost to Follow-up|0|||
48775294|NCT01529645|157021841|FG000|Overall Study|SAE - Premature contractions|0|||
48775295|NCT01529645|157021842|FG001|Overall Study|SAE - Premature contractions|0|||
48775296|NCT01529645|157021843|FG002|Overall Study|SAE - Premature contractions|1|||
48775297|NCT01529645|157021844|FG003|Overall Study|SAE - Premature contractions|0|||
48775298|NCT01529645|157021845|FG004|Overall Study|SAE - Premature contractions|0|||
48775299|NCT01529645|157021846|FG005|Overall Study|SAE - Premature contractions|0|||
48775300|NCT01529645|157021847|FG006|Overall Study|SAE - Premature contractions|0|||
48775301|NCT01529645|157021848|FG007|Overall Study|SAE - Premature contractions|0|||
48775302|NCT01529645|157021849|FG008|Overall Study|SAE - Premature contractions|0|||
48775303|NCT01529645|157021850|FG009|Overall Study|SAE - Premature contractions|0|||
48775304|NCT01529645|157021841|FG000|Overall Study|Withdrawal by Subject|2|||
48775305|NCT01529645|157021842|FG001|Overall Study|Withdrawal by Subject|0|||
48775306|NCT01529645|157021843|FG002|Overall Study|Withdrawal by Subject|0|||
48775307|NCT01529645|157021844|FG003|Overall Study|Withdrawal by Subject|1|||
48775308|NCT01529645|157021845|FG004|Overall Study|Withdrawal by Subject|1|||
48775309|NCT01529645|157021846|FG005|Overall Study|Withdrawal by Subject|1|||
48775310|NCT01529645|157021847|FG006|Overall Study|Withdrawal by Subject|0|||
48775311|NCT01529645|157021848|FG007|Overall Study|Withdrawal by Subject|0|||
48775312|NCT01529645|157021849|FG008|Overall Study|Withdrawal by Subject|0|||
48775313|NCT01529645|157021850|FG009|Overall Study|Withdrawal by Subject|0|||
48775314|NCT02880371|157021854|FG000|Phase 1b|Lost to Follow-up|1|||
48775315|NCT02880371|157021855|FG001|Phase 1b|Lost to Follow-up|0|||
48775316|NCT02880371|157021856|FG002|Phase 1b|Lost to Follow-up|0|||
48775317|NCT02880371|157021857|FG003|Phase 1b|Lost to Follow-up|0|||
48775318|NCT02880371|157021858|FG004|Phase 1b|Lost to Follow-up|0|||
48775319|NCT02880371|157021859|FG005|Phase 1b|Lost to Follow-up|0|||
48775320|NCT02880371|157021860|FG006|Phase 1b|Lost to Follow-up|0|||
48775321|NCT02880371|157021861|FG007|Phase 1b|Lost to Follow-up|0|||
48775322|NCT02880371|157021854|FG000|Phase 1b|Participants terminated by Sponsor|1|||
48775323|NCT02880371|157021855|FG001|Phase 1b|Participants terminated by Sponsor|0|||
48775324|NCT02880371|157021856|FG002|Phase 1b|Participants terminated by Sponsor|0|||
48775325|NCT02880371|157021857|FG003|Phase 1b|Participants terminated by Sponsor|0|||
48775326|NCT02880371|157021858|FG004|Phase 1b|Participants terminated by Sponsor|0|||
48775327|NCT02880371|157021859|FG005|Phase 1b|Participants terminated by Sponsor|0|||
48775328|NCT02880371|157021860|FG006|Phase 1b|Participants terminated by Sponsor|0|||
48775329|NCT02880371|157021861|FG007|Phase 1b|Participants terminated by Sponsor|0|||
48982474|NCT03345849|157767603|FG003|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|1|||
48775330|NCT02880371|157021854|FG000|Phase 1b|Withdrawal by Subject|0|||
48775331|NCT02880371|157021855|FG001|Phase 1b|Withdrawal by Subject|0|||
48775332|NCT02880371|157021856|FG002|Phase 1b|Withdrawal by Subject|1|||
48775333|NCT02880371|157021857|FG003|Phase 1b|Withdrawal by Subject|0|||
48775334|NCT02880371|157021858|FG004|Phase 1b|Withdrawal by Subject|0|||
48775335|NCT02880371|157021859|FG005|Phase 1b|Withdrawal by Subject|0|||
48775336|NCT02880371|157021860|FG006|Phase 1b|Withdrawal by Subject|0|||
48775337|NCT02880371|157021861|FG007|Phase 1b|Withdrawal by Subject|0|||
48775338|NCT02880371|157021854|FG000|Phase 1b|Death|4|||
48775339|NCT02880371|157021855|FG001|Phase 1b|Death|6|||
48775340|NCT02880371|157021856|FG002|Phase 1b|Death|5|||
48775341|NCT02880371|157021857|FG003|Phase 1b|Death|1|||
48775342|NCT02880371|157021858|FG004|Phase 1b|Death|0|||
48775343|NCT02880371|157021859|FG005|Phase 1b|Death|0|||
48775344|NCT02880371|157021860|FG006|Phase 1b|Death|0|||
48775345|NCT02880371|157021861|FG007|Phase 1b|Death|0|||
48775346|NCT02880371|157021854|FG000|Phase 1b|Enrolled but not Treated|0|||
48775347|NCT02880371|157021855|FG001|Phase 1b|Enrolled but not Treated|1|||
48775348|NCT02880371|157021856|FG002|Phase 1b|Enrolled but not Treated|0|||
48775349|NCT02880371|157021857|FG003|Phase 1b|Enrolled but not Treated|0|||
48775350|NCT02880371|157021858|FG004|Phase 1b|Enrolled but not Treated|0|||
48775351|NCT02880371|157021859|FG005|Phase 1b|Enrolled but not Treated|0|||
48775352|NCT02880371|157021860|FG006|Phase 1b|Enrolled but not Treated|0|||
48775353|NCT02880371|157021861|FG007|Phase 1b|Enrolled but not Treated|0|||
48775354|NCT02880371|157021854|FG000|Phase 2|Enrolled but not Treated|0|||
48775355|NCT02880371|157021855|FG001|Phase 2|Enrolled but not Treated|0|||
48775356|NCT02880371|157021856|FG002|Phase 2|Enrolled but not Treated|0|||
48775357|NCT02880371|157021857|FG003|Phase 2|Enrolled but not Treated|0|||
48775358|NCT02880371|157021858|FG004|Phase 2|Enrolled but not Treated|0|||
48775359|NCT02880371|157021859|FG005|Phase 2|Enrolled but not Treated|1|||
48775360|NCT02880371|157021860|FG006|Phase 2|Enrolled but not Treated|1|||
48775361|NCT02880371|157021861|FG007|Phase 2|Enrolled but not Treated|0|||
48775362|NCT02880371|157021854|FG000|Phase 2|Other|0|||
48775363|NCT02880371|157021855|FG001|Phase 2|Other|0|||
48775364|NCT02880371|157021856|FG002|Phase 2|Other|0|||
48775365|NCT02880371|157021857|FG003|Phase 2|Other|0|||
48775366|NCT02880371|157021858|FG004|Phase 2|Other|0|||
48775367|NCT02880371|157021859|FG005|Phase 2|Other|1|||
48775368|NCT02880371|157021860|FG006|Phase 2|Other|2|||
48775369|NCT02880371|157021861|FG007|Phase 2|Other|1|||
48775370|NCT02880371|157021854|FG000|Phase 2|Participants terminated by Sponsor|0|||
48775371|NCT02880371|157021855|FG001|Phase 2|Participants terminated by Sponsor|0|||
48775372|NCT02880371|157021856|FG002|Phase 2|Participants terminated by Sponsor|0|||
48775373|NCT02880371|157021857|FG003|Phase 2|Participants terminated by Sponsor|0|||
48775374|NCT02880371|157021858|FG004|Phase 2|Participants terminated by Sponsor|1|||
48775375|NCT02880371|157021859|FG005|Phase 2|Participants terminated by Sponsor|6|||
48775376|NCT02880371|157021860|FG006|Phase 2|Participants terminated by Sponsor|1|||
48775377|NCT02880371|157021861|FG007|Phase 2|Participants terminated by Sponsor|5|||
48775378|NCT02880371|157021854|FG000|Phase 2|Death|0|||
48775379|NCT02880371|157021855|FG001|Phase 2|Death|0|||
48775380|NCT02880371|157021856|FG002|Phase 2|Death|0|||
48775381|NCT02880371|157021857|FG003|Phase 2|Death|0|||
48775382|NCT02880371|157021858|FG004|Phase 2|Death|1|||
48775383|NCT02880371|157021859|FG005|Phase 2|Death|10|||
48775384|NCT02880371|157021860|FG006|Phase 2|Death|20|||
48775385|NCT02880371|157021861|FG007|Phase 2|Death|5|||
48775386|NCT02880371|157021854|FG000|Phase 2|Lost to Follow-up|0|||
48775387|NCT02880371|157021855|FG001|Phase 2|Lost to Follow-up|0|||
48775388|NCT02880371|157021856|FG002|Phase 2|Lost to Follow-up|0|||
48775389|NCT02880371|157021857|FG003|Phase 2|Lost to Follow-up|0|||
48775390|NCT02880371|157021858|FG004|Phase 2|Lost to Follow-up|0|||
48775391|NCT02880371|157021859|FG005|Phase 2|Lost to Follow-up|0|||
48775392|NCT02880371|157021860|FG006|Phase 2|Lost to Follow-up|3|||
48775393|NCT02880371|157021861|FG007|Phase 2|Lost to Follow-up|0|||
48775394|NCT02880371|157021854|FG000|Phase 2|Withdrawal by Subject|0|||
48775395|NCT02880371|157021855|FG001|Phase 2|Withdrawal by Subject|0|||
48775396|NCT02880371|157021856|FG002|Phase 2|Withdrawal by Subject|0|||
48775397|NCT02880371|157021857|FG003|Phase 2|Withdrawal by Subject|0|||
48775398|NCT02880371|157021858|FG004|Phase 2|Withdrawal by Subject|0|||
48775399|NCT02880371|157021859|FG005|Phase 2|Withdrawal by Subject|1|||
48775400|NCT02880371|157021860|FG006|Phase 2|Withdrawal by Subject|1|||
48775401|NCT02880371|157021861|FG007|Phase 2|Withdrawal by Subject|0|||
48775402|NCT02880371|157021854|FG000|Phase 2|End of Study page not completed by error|0|||
48775403|NCT02880371|157021855|FG001|Phase 2|End of Study page not completed by error|0|||
48775404|NCT02880371|157021856|FG002|Phase 2|End of Study page not completed by error|0|||
48775405|NCT02880371|157021857|FG003|Phase 2|End of Study page not completed by error|0|||
48775406|NCT02880371|157021858|FG004|Phase 2|End of Study page not completed by error|0|||
48982475|NCT03345849|157767600|FG000|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
48775407|NCT02880371|157021859|FG005|Phase 2|End of Study page not completed by error|1|||
48775408|NCT02880371|157021860|FG006|Phase 2|End of Study page not completed by error|0|||
48775409|NCT02880371|157021861|FG007|Phase 2|End of Study page not completed by error|0|||
48775410|NCT02649972|157021864|FG000|Overall Study|Not treated|1|||
49027760|NCT04178733|157941087|FG003|Overall Study|Investigator Decision|1|||
49027761|NCT04178733|157941088|FG004|Overall Study|Investigator Decision|2|||
49027762|NCT00864097|157941091|FG000|Overall Study|Death|0|||
48982476|NCT03345849|157767601|FG001|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
48982477|NCT03345849|157767602|FG002|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|1|||
48982478|NCT03345849|157767603|FG003|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|5|||
48982479|NCT03345849|157767600|FG000|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
48982480|NCT03345849|157767601|FG001|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
49027763|NCT00864097|157941092|FG001|Overall Study|Death|1|||
48775411|NCT01777997|157021868|FG000|12 Week lead-in of no ART|Severe debilitation|2|||
48775412|NCT01777997|157021868|FG000|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1|||
48775413|NCT01777997|157021868|FG000|Weeks 48 to 72/96 on ART|Death|1|||
48775414|NCT01777997|157021868|FG000|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1|||
48775415|NCT00306592|157021876|FG000|Overall Study|Adverse Event|8|||
48775416|NCT00306592|157021877|FG001|Overall Study|Adverse Event|15|||
48775417|NCT00306592|157021876|FG000|Overall Study|Lost to Follow-up|1|||
48775418|NCT00306592|157021877|FG001|Overall Study|Lost to Follow-up|0|||
48775419|NCT00306592|157021876|FG000|Overall Study|Noncompliance|0|||
48775420|NCT00306592|157021877|FG001|Overall Study|Noncompliance|2|||
48775421|NCT00306592|157021876|FG000|Overall Study|Persistent Antibodies|6|||
48775422|NCT00306592|157021877|FG001|Overall Study|Persistent Antibodies|3|||
48775423|NCT00306592|157021876|FG000|Overall Study|Voluntary|10|||
48775424|NCT00306592|157021877|FG001|Overall Study|Voluntary|6|||
48775425|NCT00306592|157021876|FG000|Overall Study|Other|5|||
48775426|NCT00306592|157021877|FG001|Overall Study|Other|10|||
48775427|NCT00306592|157021876|FG000|Overall Study|Other|1|||
48775428|NCT00306592|157021877|FG001|Overall Study|Other|2|||
48775429|NCT00306592|157021876|FG000|Overall Study|48-week Treatment Period Ongoing|0|||
48775430|NCT00306592|157021877|FG001|Overall Study|48-week Treatment Period Ongoing|20|||
48775431|NCT01302964|157021878|FG000|Overall Study|Adverse Event|1|||
48775432|NCT01302964|157021879|FG001|Overall Study|Adverse Event|0|||
48775433|NCT04640311|157021884|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
48775434|NCT04640311|157021885|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
48775435|NCT04640311|157021886|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
48775436|NCT04640311|157021887|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
48775437|NCT04640311|157021888|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
48775438|NCT04640311|157021889|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
48775439|NCT04640311|157021890|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
48775440|NCT04640311|157021891|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
48775441|NCT04640311|157021892|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
48775442|NCT04640311|157021893|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
48775443|NCT04640311|157021894|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
48775444|NCT04640311|157021895|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
48775445|NCT04640311|157021896|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
48775446|NCT04640311|157021884|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
48775447|NCT04640311|157021885|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|1|||
48775448|NCT04640311|157021886|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
48775449|NCT04640311|157021887|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
48775450|NCT04640311|157021888|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
48775451|NCT04640311|157021889|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
48775452|NCT04640311|157021890|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
48775453|NCT04640311|157021891|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
48775454|NCT04640311|157021892|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
48775455|NCT04640311|157021893|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
48775456|NCT04640311|157021894|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
48775457|NCT04640311|157021895|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
48775458|NCT04640311|157021896|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
48775459|NCT04640311|157021884|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
48775460|NCT04640311|157021885|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|1|||
48775461|NCT04640311|157021886|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
48775462|NCT04640311|157021887|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
48775463|NCT04640311|157021888|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
48775464|NCT04640311|157021889|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
48982481|NCT03345849|157767602|FG002|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
49027764|NCT00864097|157941093|FG002|Overall Study|Death|0|||
49027765|NCT00864097|157941094|FG003|Overall Study|Death|0|||
48775465|NCT04640311|157021890|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
48775466|NCT04640311|157021891|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
48775467|NCT04640311|157021892|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
48775468|NCT04640311|157021893|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
48775469|NCT04640311|157021894|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
48775470|NCT04640311|157021895|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
48775471|NCT04640311|157021896|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
48775472|NCT04640311|157021884|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|3|||
48775473|NCT04640311|157021885|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|5|||
48775474|NCT04640311|157021886|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|6|||
48775475|NCT04640311|157021887|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
48775476|NCT04640311|157021888|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
48775477|NCT04640311|157021889|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
48775478|NCT04640311|157021890|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
48775479|NCT04640311|157021891|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
48775480|NCT04640311|157021892|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
48775481|NCT04640311|157021893|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
48775482|NCT04640311|157021894|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
48775483|NCT04640311|157021895|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
48775484|NCT04640311|157021896|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
48775485|NCT04640311|157021884|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
48775486|NCT04640311|157021885|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
48775487|NCT04640311|157021886|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|2|||
48775488|NCT04640311|157021887|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
48775489|NCT04640311|157021888|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
48775490|NCT04640311|157021889|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
48775491|NCT04640311|157021890|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
48775492|NCT04640311|157021891|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
48775493|NCT04640311|157021892|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
48775494|NCT04640311|157021893|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
48775495|NCT04640311|157021894|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
48775496|NCT04640311|157021895|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
48775497|NCT04640311|157021896|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
48775498|NCT04640311|157021884|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
48775499|NCT04640311|157021885|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
48775500|NCT04640311|157021886|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
48876930|NCT01270828|157388464|FG000|Pregabalin CR SB|Unrelated AE|0|||
48982482|NCT03345849|157767603|FG003|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|1|||
48982483|NCT03345849|157767600|FG000|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
48982484|NCT03345849|157767601|FG001|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
48982485|NCT03345849|157767602|FG002|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|1|||
48982486|NCT03345849|157767603|FG003|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
48982487|NCT03345849|157767600|FG000|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
48982488|NCT03345849|157767601|FG001|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
49027766|NCT00864097|157941091|FG000|Overall Study|Adverse Event|6|||
49027767|NCT00864097|157941092|FG001|Overall Study|Adverse Event|8|||
49027768|NCT00864097|157941093|FG002|Overall Study|Adverse Event|11|||
49027769|NCT00864097|157941094|FG003|Overall Study|Adverse Event|9|||
49027770|NCT00864097|157941091|FG000|Overall Study|Lack of Efficacy|9|||
49027771|NCT00864097|157941092|FG001|Overall Study|Lack of Efficacy|3|||
49027772|NCT00864097|157941093|FG002|Overall Study|Lack of Efficacy|7|||
49027773|NCT00864097|157941094|FG003|Overall Study|Lack of Efficacy|2|||
49027774|NCT00864097|157941091|FG000|Overall Study|Lost to Follow-up|0|||
49027775|NCT00864097|157941092|FG001|Overall Study|Lost to Follow-up|1|||
49027776|NCT00864097|157941093|FG002|Overall Study|Lost to Follow-up|0|||
49027777|NCT00864097|157941094|FG003|Overall Study|Lost to Follow-up|1|||
49027778|NCT00864097|157941091|FG000|Overall Study|Withdrawal by Subject|15|||
49027779|NCT00864097|157941092|FG001|Overall Study|Withdrawal by Subject|11|||
49027780|NCT00864097|157941093|FG002|Overall Study|Withdrawal by Subject|11|||
49027781|NCT00864097|157941094|FG003|Overall Study|Withdrawal by Subject|12|||
49027782|NCT00864097|157941091|FG000|Overall Study|Protocol Violation|2|||
49027783|NCT00864097|157941092|FG001|Overall Study|Protocol Violation|1|||
49027784|NCT00864097|157941093|FG002|Overall Study|Protocol Violation|0|||
49027785|NCT00864097|157941094|FG003|Overall Study|Protocol Violation|1|||
49027786|NCT00864097|157941091|FG000|Overall Study|Terminated by sponsor|105|||
49027787|NCT00864097|157941092|FG001|Overall Study|Terminated by sponsor|112|||
49027788|NCT00864097|157941093|FG002|Overall Study|Terminated by sponsor|102|||
49027789|NCT00864097|157941094|FG003|Overall Study|Terminated by sponsor|99|||
49027790|NCT00864097|157941091|FG000|Overall Study|Randomized but not treated|2|||
49027791|NCT00864097|157941092|FG001|Overall Study|Randomized but not treated|0|||
49027792|NCT00864097|157941093|FG002|Overall Study|Randomized but not treated|1|||
49027793|NCT00864097|157941094|FG003|Overall Study|Randomized but not treated|0|||
49027794|NCT00864097|157941091|FG000|Overall Study|Other|0|||
49027795|NCT00864097|157941092|FG001|Overall Study|Other|0|||
48775501|NCT04640311|157021887|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
48775502|NCT04640311|157021888|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
48775503|NCT04640311|157021889|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
48775504|NCT04640311|157021890|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
48775505|NCT04640311|157021891|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
48775506|NCT04640311|157021892|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
48775507|NCT04640311|157021893|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
48775508|NCT04640311|157021894|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
48775509|NCT04640311|157021895|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
48775510|NCT04640311|157021896|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
48876931|NCT01270828|157388465|FG001|Pregabalin CR SB|Unrelated AE|0|||
48876932|NCT01270828|157388466|FG002|Pregabalin CR SB|Unrelated AE|8|||
48876933|NCT01270828|157388464|FG000|Pregabalin CR SB|Protocol Violation|0|||
48876934|NCT01270828|157388465|FG001|Pregabalin CR SB|Protocol Violation|0|||
49027796|NCT00864097|157941093|FG002|Overall Study|Other|0|||
49027797|NCT00864097|157941094|FG003|Overall Study|Other|1|||
49027798|NCT03785548|157941095|FG000|Overall Study|age > 80|1|||
49027799|NCT03785548|157941096|FG001|Overall Study|age > 80|0|||
49027800|NCT03785548|157941095|FG000|Overall Study|no Postop queries|1|||
49027801|NCT03785548|157941096|FG001|Overall Study|no Postop queries|0|||
48775511|NCT04640311|157021884|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
48775512|NCT04640311|157021885|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
48775513|NCT04640311|157021886|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
48775514|NCT04640311|157021887|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
48876935|NCT01270828|157388466|FG002|Pregabalin CR SB|Protocol Violation|8|||
48876936|NCT01270828|157388464|FG000|Double Blind Phase|Death|0|||
48876937|NCT01270828|157388465|FG001|Double Blind Phase|Death|1|||
48876938|NCT01270828|157388466|FG002|Double Blind Phase|Death|0|||
48876939|NCT01270828|157388464|FG000|Double Blind Phase|Protocol Violation|0|||
48876940|NCT01270828|157388465|FG001|Double Blind Phase|Protocol Violation|1|||
48876941|NCT01270828|157388466|FG002|Double Blind Phase|Protocol Violation|0|||
48876942|NCT01270828|157388464|FG000|Double Blind Phase|Protocol and GCP non-compliance|4|||
48876943|NCT01270828|157388465|FG001|Double Blind Phase|Protocol and GCP non-compliance|3|||
48876944|NCT01270828|157388466|FG002|Double Blind Phase|Protocol and GCP non-compliance|0|||
48876945|NCT01270828|157388464|FG000|Double Blind Phase|Reason Unspecified|7|||
48876946|NCT01270828|157388465|FG001|Double Blind Phase|Reason Unspecified|4|||
48876947|NCT01270828|157388466|FG002|Double Blind Phase|Reason Unspecified|0|||
48876948|NCT01270828|157388464|FG000|Double Blind Phase|Withdrawal by Subject|6|||
48876949|NCT01270828|157388465|FG001|Double Blind Phase|Withdrawal by Subject|15|||
49027802|NCT03033576|157941097|FG000|Overall Study|Ineligible|1|||
49027803|NCT03033576|157941098|FG001|Overall Study|Ineligible|1|||
49027804|NCT03033576|157941097|FG000|Overall Study|Adverse Event|4|||
49027805|NCT03033576|157941098|FG001|Overall Study|Adverse Event|20|||
49027806|NCT03033576|157941097|FG000|Overall Study|Progression/relapse|9|||
49027807|NCT03033576|157941098|FG001|Overall Study|Progression/relapse|36|||
49027808|NCT03033576|157941097|FG000|Overall Study|Death|1|||
49027809|NCT03033576|157941098|FG001|Overall Study|Death|1|||
49027810|NCT03033576|157941097|FG000|Overall Study|Patient refusal|1|||
49027811|NCT03033576|157941098|FG001|Overall Study|Patient refusal|6|||
49027812|NCT03033576|157941097|FG000|Overall Study|Other, unspecified reasons|0|||
49027813|NCT03033576|157941098|FG001|Overall Study|Other, unspecified reasons|4|||
49027814|NCT03033576|157941097|FG000|Overall Study|Currently on protocol therapy|0|||
49027815|NCT03033576|157941098|FG001|Overall Study|Currently on protocol therapy|2|||
49027816|NCT00849901|157941100|FG000|Acute Treatment Phase|Adverse Event|9|||
49027817|NCT00849901|157941101|FG001|Acute Treatment Phase|Adverse Event|1|||
48876950|NCT01270828|157388466|FG002|Double Blind Phase|Withdrawal by Subject|0|||
48876951|NCT01270828|157388464|FG000|Double Blind Phase|Lost to Follow-up|1|||
48876952|NCT01270828|157388465|FG001|Double Blind Phase|Lost to Follow-up|2|||
49027818|NCT00849901|157941102|FG002|Acute Treatment Phase|Adverse Event|3|||
49027819|NCT00849901|157941100|FG000|Acute Treatment Phase|Lost to Follow-up|2|||
48775515|NCT04640311|157021888|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
48775516|NCT04640311|157021889|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
48775517|NCT04640311|157021890|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
48775518|NCT04640311|157021891|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
48775519|NCT04640311|157021892|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|2|||
48775520|NCT04640311|157021893|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
48775521|NCT04640311|157021894|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
48775522|NCT04640311|157021895|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
48775523|NCT04640311|157021896|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
48775524|NCT04640311|157021884|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
48775525|NCT04640311|157021885|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
48775526|NCT04640311|157021886|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
48775527|NCT04640311|157021887|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
48775528|NCT04640311|157021888|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
48775529|NCT04640311|157021889|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
48775530|NCT04640311|157021890|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
48775531|NCT04640311|157021891|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
48775532|NCT04640311|157021892|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
48876953|NCT01270828|157388466|FG002|Double Blind Phase|Lost to Follow-up|0|||
48775533|NCT04640311|157021893|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
48775534|NCT04640311|157021894|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
48775535|NCT04640311|157021895|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
48775536|NCT04640311|157021896|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
48775537|NCT04640311|157021884|FG000|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
48775538|NCT04640311|157021885|FG001|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
48775539|NCT04640311|157021886|FG002|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
48775540|NCT04640311|157021887|FG003|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
48775541|NCT04640311|157021888|FG004|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
48775542|NCT04640311|157021889|FG005|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
48775543|NCT04640311|157021890|FG006|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
48775544|NCT04640311|157021891|FG007|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
48775545|NCT04640311|157021892|FG008|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
48775546|NCT04640311|157021893|FG009|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
48775547|NCT04640311|157021894|FG010|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
48775548|NCT04640311|157021895|FG011|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|1|||
48775549|NCT04640311|157021896|FG012|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
48775550|NCT04101526|157021899|FG000|Overall Study|Did not complete all sleep diary entries|0|||
48775551|NCT04101526|157021900|FG001|Overall Study|Did not complete all sleep diary entries|1|||
48775552|NCT02944578|157021901|FG000|Overall Study|Physician Decision|1|||
48775553|NCT02944578|157021902|FG001|Overall Study|Physician Decision|0|||
48775554|NCT01257204|157021903|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
48775555|NCT01257204|157021904|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
48775556|NCT01257204|157021905|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|3|||
48775557|NCT01257204|157021903|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
48775558|NCT01257204|157021904|FG001|Treatment Period (up to Week 24)|Adverse Event|1|||
48775559|NCT01257204|157021905|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
48775560|NCT01257204|157021903|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
48775561|NCT01257204|157021904|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|0|||
48775562|NCT01257204|157021905|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
48775563|NCT01257204|157021903|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
48775564|NCT01257204|157021904|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
48775565|NCT01257204|157021905|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
48775566|NCT01257204|157021903|FG000|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
48775567|NCT01257204|157021904|FG001|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
48775568|NCT01257204|157021905|FG002|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1|||
48876954|NCT01270828|157388464|FG000|Double Blind Phase|Lack of Efficacy|2|||
48876955|NCT01270828|157388465|FG001|Double Blind Phase|Lack of Efficacy|11|||
48876956|NCT01270828|157388466|FG002|Double Blind Phase|Lack of Efficacy|0|||
48982489|NCT03345849|157767602|FG002|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
48982490|NCT03345849|157767603|FG003|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
48982491|NCT03261037|157767604|FG000|Overall Study|Withdrawal by Subject|2|||
48982492|NCT03261037|157767605|FG001|Overall Study|Withdrawal by Subject|13|||
48982493|NCT03261037|157767606|FG002|Overall Study|Withdrawal by Subject|0|||
48982494|NCT03261037|157767607|FG003|Overall Study|Withdrawal by Subject|18|||
48982495|NCT03261037|157767604|FG000|Overall Study|Non-compliance with study procedures|0|||
48982496|NCT03261037|157767605|FG001|Overall Study|Non-compliance with study procedures|2|||
48775569|NCT01257204|157021903|FG000|Treatment Period (up to Week 24)|Participant's request to discontinue|1|||
48775570|NCT01257204|157021904|FG001|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
48775571|NCT01257204|157021905|FG002|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
48775572|NCT01257204|157021903|FG000|Follow-up Period (up to Week 48)|Withdrawal by Subject|0|||
48775573|NCT01257204|157021904|FG001|Follow-up Period (up to Week 48)|Withdrawal by Subject|2|||
48775574|NCT01257204|157021905|FG002|Follow-up Period (up to Week 48)|Withdrawal by Subject|1|||
48775575|NCT01257204|157021903|FG000|Follow-up Period (up to Week 48)|Lost to Follow-up|1|||
48775576|NCT01257204|157021904|FG001|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
48775577|NCT01257204|157021905|FG002|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
48775578|NCT01257204|157021903|FG000|Follow-up Period (up to Week 48)|Other|0|||
48775579|NCT01257204|157021904|FG001|Follow-up Period (up to Week 48)|Other|0|||
48775580|NCT01257204|157021905|FG002|Follow-up Period (up to Week 48)|Other|5|||
48775581|NCT00145509|157021906|FG000|Overall Study|Adverse Event|10|||
48775582|NCT00145509|157021907|FG001|Overall Study|Adverse Event|3|||
48775583|NCT00145509|157021906|FG000|Overall Study|Lack of Efficacy|3|||
48775584|NCT00145509|157021907|FG001|Overall Study|Lack of Efficacy|1|||
48775585|NCT00145509|157021906|FG000|Overall Study|Lost to Follow-up|5|||
48775586|NCT00145509|157021907|FG001|Overall Study|Lost to Follow-up|9|||
48775587|NCT00145509|157021906|FG000|Overall Study|Withdrew Consent|2|||
48775588|NCT00145509|157021907|FG001|Overall Study|Withdrew Consent|7|||
48775589|NCT00145509|157021906|FG000|Overall Study|Reason not provided|2|||
48775590|NCT00145509|157021907|FG001|Overall Study|Reason not provided|1|||
48775591|NCT01481116|157021909|FG000|Overall Study|Adverse Event|26|||
48775592|NCT01481116|157021910|FG001|Overall Study|Adverse Event|26|||
48775593|NCT01481116|157021911|FG002|Overall Study|Adverse Event|42|||
48775594|NCT01481116|157021909|FG000|Overall Study|Major Protocol Deviation|3|||
48775595|NCT01481116|157021910|FG001|Overall Study|Major Protocol Deviation|7|||
48775596|NCT01481116|157021911|FG002|Overall Study|Major Protocol Deviation|1|||
48775597|NCT01481116|157021909|FG000|Overall Study|Lost to Follow-up|8|||
48775598|NCT01481116|157021910|FG001|Overall Study|Lost to Follow-up|12|||
48775599|NCT01481116|157021911|FG002|Overall Study|Lost to Follow-up|11|||
48775600|NCT01481116|157021909|FG000|Overall Study|Withdrawal by Subject|37|||
48775601|NCT01481116|157021910|FG001|Overall Study|Withdrawal by Subject|33|||
48775602|NCT01481116|157021911|FG002|Overall Study|Withdrawal by Subject|37|||
48775603|NCT01481116|157021909|FG000|Overall Study|Study Termination|730|||
48775604|NCT01481116|157021910|FG001|Overall Study|Study Termination|729|||
48775605|NCT01481116|157021911|FG002|Overall Study|Study Termination|713|||
48775606|NCT01481116|157021909|FG000|Overall Study|Pregnancy|0|||
48775607|NCT01481116|157021910|FG001|Overall Study|Pregnancy|0|||
48775608|NCT01481116|157021911|FG002|Overall Study|Pregnancy|1|||
48775609|NCT01481116|157021909|FG000|Overall Study|Lack of Efficacy|3|||
48775610|NCT01481116|157021910|FG001|Overall Study|Lack of Efficacy|3|||
48775611|NCT01481116|157021911|FG002|Overall Study|Lack of Efficacy|1|||
48775612|NCT01481116|157021909|FG000|Overall Study|Contraindications|1|||
48775613|NCT01481116|157021910|FG001|Overall Study|Contraindications|1|||
48775614|NCT01481116|157021911|FG002|Overall Study|Contraindications|0|||
48775615|NCT01481116|157021909|FG000|Overall Study|Other|1|||
48775616|NCT01481116|157021910|FG001|Overall Study|Other|1|||
48775617|NCT01481116|157021911|FG002|Overall Study|Other|0|||
48775618|NCT01481116|157021909|FG000|Overall Study|Participant Started Taking Glipizide|1|||
48775619|NCT01481116|157021910|FG001|Overall Study|Participant Started Taking Glipizide|0|||
48775620|NCT01481116|157021911|FG002|Overall Study|Participant Started Taking Glipizide|0|||
48775621|NCT01481116|157021909|FG000|Overall Study|Participant Moved Out of Area|2|||
49027820|NCT00849901|157941101|FG001|Acute Treatment Phase|Lost to Follow-up|4|||
49027821|NCT00849901|157941102|FG002|Acute Treatment Phase|Lost to Follow-up|1|||
49027822|NCT00849901|157941100|FG000|Acute Treatment Phase|Protocol Violation|0|||
49027823|NCT00849901|157941101|FG001|Acute Treatment Phase|Protocol Violation|2|||
49027824|NCT00849901|157941102|FG002|Acute Treatment Phase|Protocol Violation|1|||
48775622|NCT01481116|157021910|FG001|Overall Study|Participant Moved Out of Area|0|||
48775623|NCT01481116|157021911|FG002|Overall Study|Participant Moved Out of Area|1|||
48775624|NCT01481116|157021909|FG000|Overall Study|Participant Moved Out of Country|1|||
48775625|NCT01481116|157021910|FG001|Overall Study|Participant Moved Out of Country|0|||
48775626|NCT01481116|157021911|FG002|Overall Study|Participant Moved Out of Country|1|||
48775627|NCT01481116|157021909|FG000|Overall Study|Investigator Decision|3|||
48775628|NCT01481116|157021910|FG001|Overall Study|Investigator Decision|2|||
48775629|NCT01481116|157021911|FG002|Overall Study|Investigator Decision|1|||
48775630|NCT01481116|157021909|FG000|Overall Study|Sponsor Decision|0|||
48775631|NCT01481116|157021910|FG001|Overall Study|Sponsor Decision|1|||
48775632|NCT01481116|157021911|FG002|Overall Study|Sponsor Decision|3|||
48775633|NCT01481116|157021909|FG000|Overall Study|Non-Compliant With Study Drug|0|||
48775634|NCT01481116|157021910|FG001|Overall Study|Non-Compliant With Study Drug|1|||
48775635|NCT01481116|157021911|FG002|Overall Study|Non-Compliant With Study Drug|1|||
48775636|NCT01481116|157021909|FG000|Overall Study|Investigator's Discretion|2|||
48775637|NCT01481116|157021910|FG001|Overall Study|Investigator's Discretion|0|||
49027825|NCT00849901|157941100|FG000|Acute Treatment Phase|Withdrawal by Subject|4|||
48775638|NCT01481116|157021911|FG002|Overall Study|Investigator's Discretion|0|||
48775639|NCT01481116|157021909|FG000|Overall Study|Death|2|||
48775640|NCT01481116|157021910|FG001|Overall Study|Death|1|||
48775641|NCT01481116|157021911|FG002|Overall Study|Death|0|||
48775642|NCT01481116|157021909|FG000|Overall Study|Hypoglycemic Event|4|||
48775643|NCT01481116|157021910|FG001|Overall Study|Hypoglycemic Event|0|||
48775644|NCT01481116|157021911|FG002|Overall Study|Hypoglycemic Event|0|||
48775645|NCT02433834|157021912|FG000|Overall Study|Protocol-specified criteria|7|||
48775646|NCT02433834|157021912|FG000|Overall Study|Protocol Violation|3|||
48775647|NCT02433834|157021912|FG000|Overall Study|Lost to Follow-up|6|||
48775648|NCT02433834|157021912|FG000|Overall Study|Withdrawal by Subject|14|||
48775649|NCT02433834|157021912|FG000|Overall Study|Adverse Event|6|||
48775650|NCT02433834|157021912|FG000|Overall Study|Physician Decision|1|||
48775651|NCT00333229|157021914|FG000|Overall Study|Lack of Efficacy|0|||
48775652|NCT00333229|157021915|FG001|Overall Study|Lack of Efficacy|1|||
48775653|NCT00548808|157021918|FG000|Overall Study|Lost to Follow-up|9|||
48775654|NCT00548808|157021919|FG001|Overall Study|Lost to Follow-up|3|||
48775655|NCT00548808|157021918|FG000|Overall Study|Protocol Violation|8|||
48775656|NCT00548808|157021919|FG001|Overall Study|Protocol Violation|8|||
48775657|NCT00548808|157021918|FG000|Overall Study|Withdrawal by Subject|8|||
48775658|NCT00548808|157021919|FG001|Overall Study|Withdrawal by Subject|4|||
48775659|NCT00548808|157021918|FG000|Overall Study|Physician Decision|6|||
48775660|NCT00548808|157021919|FG001|Overall Study|Physician Decision|3|||
48775661|NCT00548808|157021918|FG000|Overall Study|Adverse Event|4|||
48775662|NCT00548808|157021919|FG001|Overall Study|Adverse Event|5|||
48775663|NCT00548808|157021918|FG000|Overall Study|Death|2|||
48775664|NCT00548808|157021919|FG001|Overall Study|Death|0|||
48775665|NCT00548808|157021918|FG000|Overall Study|Entry Criteria Not Met|2|||
48775666|NCT00548808|157021919|FG001|Overall Study|Entry Criteria Not Met|2|||
48775667|NCT00548808|157021918|FG000|Overall Study|Lack of Efficacy|2|||
48775668|NCT00548808|157021919|FG001|Overall Study|Lack of Efficacy|0|||
48775669|NCT00548808|157021918|FG000|Overall Study|Sponsor Decision|1|||
48775670|NCT00548808|157021919|FG001|Overall Study|Sponsor Decision|1|||
48775671|NCT01375049|157021920|FG000|Overall Study|Adverse Event|2|||
48775672|NCT01375049|157021920|FG000|Overall Study|Lost to Follow-up|1|||
48775673|NCT01375049|157021920|FG000|Overall Study|Withdrawal by Subject|2|||
48775674|NCT01375049|157021920|FG000|Overall Study|Protocol-Specified Withdrawal Criteria|45|||
48775675|NCT03394391|157021921|FG000|Overall Study|Lost to Follow-up|1|||
48775676|NCT03394391|157021922|FG001|Overall Study|Lost to Follow-up|2|||
48775677|NCT00910715|157021923|FG000|Overall Study|Lost to Follow-up|22|||
48775678|NCT00910715|157021924|FG001|Overall Study|Lost to Follow-up|26|||
48775679|NCT00910715|157021925|FG002|Overall Study|Lost to Follow-up|0|||
48775680|NCT03354429|157021926|FG000|Overall Study|Withdrawal by Subject|8|||
48775681|NCT03354429|157021927|FG001|Overall Study|Withdrawal by Subject|7|||
48775682|NCT03354429|157021926|FG000|Overall Study|Lost to Follow-up|1|||
48775683|NCT03354429|157021927|FG001|Overall Study|Lost to Follow-up|0|||
48775684|NCT00912405|157021930|FG000|Overall Study|Lost to Follow-up|5|||
48775685|NCT01049919|157021943|FG000|Overall Study|Met study endpoint (major amputation, death)|36|||
48775686|NCT01049919|157021944|FG001|Overall Study|Met study endpoint (major amputation, death)|16|||
48775687|NCT01049919|157021943|FG000|Overall Study|Withdrawal by Subject|5|||
48775688|NCT01049919|157021944|FG001|Overall Study|Withdrawal by Subject|0|||
48775689|NCT01049919|157021943|FG000|Overall Study|Lost to Follow-up|6|||
48775690|NCT01049919|157021944|FG001|Overall Study|Lost to Follow-up|1|||
48775691|NCT01049919|157021943|FG000|Overall Study|Physician Decision|2|||
48775692|NCT01049919|157021944|FG001|Overall Study|Physician Decision|0|||
48775693|NCT01049919|157021943|FG000|Overall Study|Received 2nd treatment via compassionate use|1|||
48775694|NCT01049919|157021944|FG001|Overall Study|Received 2nd treatment via compassionate use|0|||
48775695|NCT01049919|157021943|FG000|Overall Study|Early study termination by sponsor.|2|||
48775696|NCT01049919|157021944|FG001|Overall Study|Early study termination by sponsor.|0|||
48775697|NCT00844545|157021945|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
48775698|NCT00844545|157021945|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
48775699|NCT00844545|157021945|FG000|Extension Treatment Period|Adverse Event|2|||
48775700|NCT00844545|157021945|FG000|Post Treatment Period|Withdrawal by Subject|1|||
48982497|NCT03261037|157767606|FG002|Overall Study|Non-compliance with study procedures|0|||
48775701|NCT01532687|157021949|FG000|Overall Study|Death|2|||
48775702|NCT01532687|157021950|FG001|Overall Study|Death|0|||
48775703|NCT01532687|157021949|FG000|Overall Study|Adverse Event|6|||
48775704|NCT01532687|157021950|FG001|Overall Study|Adverse Event|1|||
48775705|NCT01532687|157021949|FG000|Overall Study|Withdrawal by Subject|1|||
48982498|NCT03261037|157767607|FG003|Overall Study|Non-compliance with study procedures|6|||
48775706|NCT01532687|157021950|FG001|Overall Study|Withdrawal by Subject|0|||
48775707|NCT01532687|157021949|FG000|Overall Study|Physician Decision|2|||
48775708|NCT01532687|157021950|FG001|Overall Study|Physician Decision|1|||
48775709|NCT01532687|157021949|FG000|Overall Study|Protocol-defined delay > 3 weeks|3|||
48775710|NCT01532687|157021950|FG001|Overall Study|Protocol-defined delay > 3 weeks|0|||
48775711|NCT00807092|157021951|FG000|Overall Study|Adverse Event|0|||
48775712|NCT00807092|157021952|FG001|Overall Study|Adverse Event|1|||
48775713|NCT00807092|157021951|FG000|Overall Study|Protocol Violation|0|||
48775714|NCT00807092|157021952|FG001|Overall Study|Protocol Violation|2|||
48775715|NCT00807092|157021951|FG000|Overall Study|Withdrawal by Subject|1|||
48775716|NCT00807092|157021952|FG001|Overall Study|Withdrawal by Subject|0|||
48775717|NCT00807092|157021951|FG000|Overall Study|CGMS data collection failed|0|||
48775718|NCT00807092|157021952|FG001|Overall Study|CGMS data collection failed|1|||
48775719|NCT03160703|157021953|FG000|Overall Study|Withdrawal by Subject|0|||
48775720|NCT03160703|157021954|FG001|Overall Study|Withdrawal by Subject|0|||
48775721|NCT03160703|157021955|FG002|Overall Study|Withdrawal by Subject|0|||
48775722|NCT03160703|157021956|FG003|Overall Study|Withdrawal by Subject|1|||
48775723|NCT03728582|157021957|FG000|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|0|||
48775724|NCT03728582|157021958|FG001|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|1|||
48775725|NCT03728582|157021957|FG000|Washout (8 Weeks)|Withdrawal by Subject|1|||
48775726|NCT03728582|157021958|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
48775727|NCT02738775|157021959|FG000|Overall Study|Withdrawal by Subject|0|||
48775728|NCT02738775|157021960|FG001|Overall Study|Withdrawal by Subject|1|||
48775729|NCT02738775|157021961|FG002|Overall Study|Withdrawal by Subject|0|||
48775730|NCT02738775|157021962|FG003|Overall Study|Withdrawal by Subject|0|||
48775731|NCT02738775|157021963|FG004|Overall Study|Withdrawal by Subject|0|||
48775732|NCT02738775|157021964|FG005|Overall Study|Withdrawal by Subject|0|||
48775733|NCT02738775|157021959|FG000|Overall Study|Adverse Event|0|||
48775734|NCT02738775|157021960|FG001|Overall Study|Adverse Event|0|||
48775735|NCT02738775|157021961|FG002|Overall Study|Adverse Event|0|||
48775736|NCT02738775|157021962|FG003|Overall Study|Adverse Event|1|||
48775737|NCT02738775|157021963|FG004|Overall Study|Adverse Event|0|||
48775738|NCT02738775|157021964|FG005|Overall Study|Adverse Event|0|||
49027826|NCT00849901|157941101|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
48775739|NCT02738775|157021959|FG000|Overall Study|Pregnancy|0|||
48775740|NCT02738775|157021960|FG001|Overall Study|Pregnancy|1|||
48775741|NCT02738775|157021961|FG002|Overall Study|Pregnancy|0|||
48775742|NCT02738775|157021962|FG003|Overall Study|Pregnancy|0|||
48775743|NCT02738775|157021963|FG004|Overall Study|Pregnancy|0|||
48775744|NCT02738775|157021964|FG005|Overall Study|Pregnancy|0|||
49027827|NCT00849901|157941102|FG002|Acute Treatment Phase|Withdrawal by Subject|4|||
49027828|NCT00849901|157941100|FG000|Acute Treatment Phase|Parent or Caregiver Decision|11|||
49027829|NCT00849901|157941101|FG001|Acute Treatment Phase|Parent or Caregiver Decision|5|||
48775745|NCT02738775|157021959|FG000|Overall Study|Missing|0|||
48775746|NCT02738775|157021960|FG001|Overall Study|Missing|0|||
48775747|NCT02738775|157021961|FG002|Overall Study|Missing|0|||
48775748|NCT02738775|157021962|FG003|Overall Study|Missing|0|||
48775749|NCT02738775|157021963|FG004|Overall Study|Missing|0|||
48775750|NCT02738775|157021964|FG005|Overall Study|Missing|1|||
48775751|NCT04808609|157021967|FG000|Overall Study|Lost to Follow-up|0|||
48775752|NCT04808609|157021968|FG001|Overall Study|Lost to Follow-up|2|||
48775753|NCT04808609|157021967|FG000|Overall Study|Administrative Withdrawal|0|||
48775754|NCT04808609|157021968|FG001|Overall Study|Administrative Withdrawal|1|||
48775755|NCT01274637|157021969|FG000|Overall Study|Withdrawal by Subject|0|||
48775756|NCT01274637|157021970|FG001|Overall Study|Withdrawal by Subject|1|||
48775757|NCT01274637|157021969|FG000|Overall Study|Lost to Follow-up|0|||
48775758|NCT01274637|157021970|FG001|Overall Study|Lost to Follow-up|1|||
48775759|NCT04096560|157021971|FG000|Overall Study|Reason not Specified|1|||
48775760|NCT04096560|157021972|FG001|Overall Study|Reason not Specified|0|||
48775761|NCT04096560|157021973|FG002|Overall Study|Reason not Specified|0|||
48775762|NCT04096560|157021974|FG003|Overall Study|Reason not Specified|0|||
48775763|NCT04096560|157021975|FG004|Overall Study|Reason not Specified|1|||
48775764|NCT04096560|157021976|FG005|Overall Study|Reason not Specified|1|||
48775765|NCT04096560|157021977|FG006|Overall Study|Reason not Specified|1|||
48775766|NCT04096560|157021978|FG007|Overall Study|Reason not Specified|0|||
48775767|NCT04096560|157021971|FG000|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
48775768|NCT04096560|157021972|FG001|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
48775769|NCT04096560|157021973|FG002|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
48775770|NCT04096560|157021974|FG003|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
48775771|NCT04096560|157021975|FG004|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
48775772|NCT04096560|157021976|FG005|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
48775773|NCT04096560|157021977|FG006|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
48775774|NCT04096560|157021978|FG007|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
48775775|NCT04096560|157021971|FG000|Overall Study|Study Terminated by Sponsor|0|||
48775776|NCT04096560|157021972|FG001|Overall Study|Study Terminated by Sponsor|0|||
48775777|NCT04096560|157021973|FG002|Overall Study|Study Terminated by Sponsor|0|||
48775778|NCT04096560|157021974|FG003|Overall Study|Study Terminated by Sponsor|5|||
48775779|NCT04096560|157021975|FG004|Overall Study|Study Terminated by Sponsor|6|||
48775780|NCT04096560|157021976|FG005|Overall Study|Study Terminated by Sponsor|4|||
48775781|NCT04096560|157021977|FG006|Overall Study|Study Terminated by Sponsor|6|||
48775782|NCT04096560|157021978|FG007|Overall Study|Study Terminated by Sponsor|1|||
48775783|NCT04096560|157021971|FG000|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
48775784|NCT04096560|157021972|FG001|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
48775785|NCT04096560|157021973|FG002|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
48775786|NCT04096560|157021974|FG003|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
48775787|NCT04096560|157021975|FG004|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
48775788|NCT04096560|157021976|FG005|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
48775789|NCT04096560|157021977|FG006|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
48775790|NCT04096560|157021978|FG007|Overall Study|Met the Discontinuation Criteria of the Protocol|1|||
48775791|NCT02047604|157021981|FG000|Overall Study|Withdrawal by Subject|0|||
48775792|NCT02047604|157021982|FG001|Overall Study|Withdrawal by Subject|0|||
48775793|NCT02047604|157021983|FG002|Overall Study|Withdrawal by Subject|0|||
48775794|NCT02047604|157021984|FG003|Overall Study|Withdrawal by Subject|0|||
48775795|NCT02047604|157021985|FG004|Overall Study|Withdrawal by Subject|1|||
48775796|NCT02047604|157021986|FG005|Overall Study|Withdrawal by Subject|1|||
48775797|NCT01692197|157021994|FG000|Overall Study|Failed Screening|3|||
48775798|NCT02120924|157021995|FG000|Overall Study|Lack of Efficacy|1|||
48775799|NCT02120924|157021996|FG001|Overall Study|Lack of Efficacy|2|||
48775800|NCT02120924|157021997|FG002|Overall Study|Lack of Efficacy|3|||
48775801|NCT02120924|157021995|FG000|Overall Study|Adverse Event|0|||
48775802|NCT02120924|157021996|FG001|Overall Study|Adverse Event|1|||
48775803|NCT02120924|157021997|FG002|Overall Study|Adverse Event|3|||
48775804|NCT02120924|157021995|FG000|Overall Study|Withdrawal by Subject|16|||
48775805|NCT02120924|157021996|FG001|Overall Study|Withdrawal by Subject|20|||
48775806|NCT02120924|157021997|FG002|Overall Study|Withdrawal by Subject|8|||
48775807|NCT02120924|157021995|FG000|Overall Study|Lost to Follow-up|14|||
48775808|NCT02120924|157021996|FG001|Overall Study|Lost to Follow-up|14|||
48775809|NCT02120924|157021997|FG002|Overall Study|Lost to Follow-up|11|||
48775810|NCT02120924|157021995|FG000|Overall Study|Pregnancy|2|||
48775811|NCT02120924|157021996|FG001|Overall Study|Pregnancy|0|||
48775812|NCT02120924|157021997|FG002|Overall Study|Pregnancy|0|||
48775813|NCT02120924|157021995|FG000|Overall Study|Protocol Violation|3|||
48775814|NCT02120924|157021996|FG001|Overall Study|Protocol Violation|7|||
48775815|NCT02120924|157021997|FG002|Overall Study|Protocol Violation|2|||
48775816|NCT02120924|157021995|FG000|Overall Study|Physician Decision|0|||
48775817|NCT02120924|157021996|FG001|Overall Study|Physician Decision|1|||
48775818|NCT02120924|157021997|FG002|Overall Study|Physician Decision|1|||
48775819|NCT02120924|157021995|FG000|Overall Study|Death|1|||
48775820|NCT02120924|157021996|FG001|Overall Study|Death|0|||
48775821|NCT02120924|157021997|FG002|Overall Study|Death|0|||
48775822|NCT02120924|157021995|FG000|Overall Study|Compliance with IP|5|||
48775823|NCT02120924|157021996|FG001|Overall Study|Compliance with IP|1|||
48775824|NCT02120924|157021997|FG002|Overall Study|Compliance with IP|1|||
48775825|NCT02770391|157021998|FG000|Overall Study|Lost to Follow-up|2|||
48775826|NCT02770391|157021998|FG000|Overall Study|Withdrawal by Subject|1|||
48775827|NCT02770391|157021998|FG000|Overall Study|Surgery delayed unevaluable|2|||
48775828|NCT02770391|157021998|FG000|Overall Study|Treatment discontinued due to treatment inturruption|1|||
48775829|NCT00612313|157022001|FG000|Overall Study|Withdrawal by Subject|6|||
48775830|NCT00612313|157022002|FG001|Overall Study|Withdrawal by Subject|9|||
48775831|NCT00612313|157022001|FG000|Overall Study|Lost to Follow-up|11|||
48775832|NCT00612313|157022002|FG001|Overall Study|Lost to Follow-up|4|||
48775833|NCT03952039|157022003|FG000|Overall Study|Adverse Event|22|||
48775834|NCT03952039|157022004|FG001|Overall Study|Adverse Event|8|||
48775835|NCT03952039|157022003|FG000|Overall Study|Withdrawal by Participant|17|||
48775836|NCT03952039|157022004|FG001|Overall Study|Withdrawal by Participant|12|||
48775837|NCT03952039|157022003|FG000|Overall Study|Death|13|||
48775838|NCT03952039|157022004|FG001|Overall Study|Death|6|||
48775839|NCT03952039|157022003|FG000|Overall Study|Lack of Efficacy|12|||
48775840|NCT03952039|157022004|FG001|Overall Study|Lack of Efficacy|2|||
48876957|NCT01270828|157388464|FG000|Double Blind Phase|Adverse event not related to study drug|1|||
48876958|NCT01270828|157388465|FG001|Double Blind Phase|Adverse event not related to study drug|1|||
48876959|NCT01270828|157388466|FG002|Double Blind Phase|Adverse event not related to study drug|0|||
48775841|NCT03952039|157022003|FG000|Overall Study|Physician Decision|9|||
48775842|NCT03952039|157022004|FG001|Overall Study|Physician Decision|3|||
48775843|NCT03952039|157022003|FG000|Overall Study|Progressive Disease|6|||
48775844|NCT03952039|157022004|FG001|Overall Study|Progressive Disease|4|||
48775845|NCT03952039|157022003|FG000|Overall Study|Other Reasons|12|||
48775846|NCT03952039|157022004|FG001|Overall Study|Other Reasons|4|||
48775847|NCT03370341|157023608|FG000|Overall Study|Lost to Follow-up|0|||
48775848|NCT03370341|157023609|FG001|Overall Study|Lost to Follow-up|1|||
48775849|NCT00938431|157023613|FG000|Overall Study|Adverse Event|5|||
48775850|NCT00938431|157023614|FG001|Overall Study|Adverse Event|8|||
48775851|NCT00938431|157023615|FG002|Overall Study|Adverse Event|6|||
48775852|NCT00938431|157023613|FG000|Overall Study|Lack of Efficacy|0|||
48775853|NCT00938431|157023614|FG001|Overall Study|Lack of Efficacy|1|||
48775854|NCT00938431|157023615|FG002|Overall Study|Lack of Efficacy|0|||
48775855|NCT00938431|157023613|FG000|Overall Study|Did not up titrate to 12 mg kg/day|1|||
48775856|NCT00938431|157023614|FG001|Overall Study|Did not up titrate to 12 mg kg/day|0|||
48775857|NCT00938431|157023615|FG002|Overall Study|Did not up titrate to 12 mg kg/day|0|||
48775858|NCT00938431|157023613|FG000|Overall Study|Dosing compliance issue|0|||
48775859|NCT00938431|157023614|FG001|Overall Study|Dosing compliance issue|0|||
48775860|NCT00938431|157023615|FG002|Overall Study|Dosing compliance issue|1|||
48775861|NCT00938431|157023613|FG000|Overall Study|Reached maximum dose early|0|||
48775862|NCT00938431|157023614|FG001|Overall Study|Reached maximum dose early|0|||
48775863|NCT00938431|157023615|FG002|Overall Study|Reached maximum dose early|1|||
48775864|NCT01816139|157023620|FG000|Overall Study|Adverse Event|6|||
48775865|NCT01816139|157023621|FG001|Overall Study|Adverse Event|8|||
48775866|NCT01816139|157023620|FG000|Overall Study|Lack of Efficacy|1|||
48775867|NCT01816139|157023621|FG001|Overall Study|Lack of Efficacy|2|||
48876960|NCT01270828|157388464|FG000|Double Blind Phase|Adverse event related to study drug|5|||
49027830|NCT00849901|157941102|FG002|Acute Treatment Phase|Parent or Caregiver Decision|4|||
49027831|NCT00849901|157941100|FG000|Acute Treatment Phase|Physician Decision|1|||
48775868|NCT01816139|157023620|FG000|Overall Study|Lost to Follow-up|5|||
48775869|NCT01816139|157023621|FG001|Overall Study|Lost to Follow-up|3|||
48775870|NCT01816139|157023620|FG000|Overall Study|Withdrew Consent|6|||
48775871|NCT01816139|157023621|FG001|Overall Study|Withdrew Consent|4|||
48775872|NCT01816139|157023620|FG000|Overall Study|Protocol Violation|6|||
48775873|NCT01816139|157023621|FG001|Overall Study|Protocol Violation|3|||
48775874|NCT01816139|157023620|FG000|Overall Study|Reason not Specified|4|||
48775875|NCT01816139|157023621|FG001|Overall Study|Reason not Specified|2|||
48775876|NCT02212730|157023622|FG000|Overall Study|Tumor not of the required cell histology|1|||
48775877|NCT02212730|157023623|FG001|Overall Study|Tumor not of the required cell histology|0|||
48775878|NCT02212730|157023622|FG000|Overall Study|Withdrawal by Subject|1|||
48775879|NCT02212730|157023623|FG001|Overall Study|Withdrawal by Subject|0|||
48775880|NCT02212730|157023622|FG000|Overall Study|Disease progression prior to RCC surgery|0|||
48775881|NCT02212730|157023623|FG001|Overall Study|Disease progression prior to RCC surgery|1|||
48775882|NCT00298896|157023626|FG000|Overall Study|Death|3|||
48775883|NCT00298896|157023626|FG000|Overall Study|Physician Decision|2|||
48775884|NCT00298896|157023626|FG000|Overall Study|Intercurrent Illness|1|||
48775885|NCT00298896|157023626|FG000|Overall Study|Disease Progression|41|||
48775886|NCT00298896|157023626|FG000|Overall Study|Withdrawal by Subject|2|||
48775887|NCT00298896|157023626|FG000|Overall Study|Assigned to treatment in error|1|||
48775888|NCT04709237|157023627|FG000|Overall Study|Lost to Follow-up|1|||
48775889|NCT04709237|157023628|FG001|Overall Study|Lost to Follow-up|0|||
48775890|NCT04709237|157023629|FG002|Overall Study|Lost to Follow-up|0|||
48775891|NCT01344057|157023634|FG000|Overall Study|Premature Withdrawal|1|||
48775892|NCT00466193|157023635|FG000|Overall Study|Adverse Event|0|||
48775893|NCT00466193|157023636|FG001|Overall Study|Adverse Event|1|||
48775894|NCT00466193|157023635|FG000|Overall Study|Lost to Follow-up|2|||
48775895|NCT00466193|157023636|FG001|Overall Study|Lost to Follow-up|4|||
48775896|NCT00466193|157023635|FG000|Overall Study|Physician Decision|1|||
48775897|NCT00466193|157023636|FG001|Overall Study|Physician Decision|0|||
48775898|NCT00466193|157023635|FG000|Overall Study|Protocol Violation|1|||
48775899|NCT00466193|157023636|FG001|Overall Study|Protocol Violation|1|||
48775900|NCT00466193|157023635|FG000|Overall Study|Withdrawal by Subject|7|||
48775901|NCT00466193|157023636|FG001|Overall Study|Withdrawal by Subject|2|||
49027832|NCT00849901|157941101|FG001|Acute Treatment Phase|Physician Decision|1|||
49027833|NCT00849901|157941102|FG002|Acute Treatment Phase|Physician Decision|1|||
49027834|NCT00849901|157941100|FG000|Acute Treatment Phase|Sponsor Decision|1|||
49027835|NCT00849901|157941101|FG001|Acute Treatment Phase|Sponsor Decision|0|||
49027836|NCT00849901|157941102|FG002|Acute Treatment Phase|Sponsor Decision|0|||
49027837|NCT00849901|157941100|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
49027838|NCT00849901|157941101|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
49027839|NCT00849901|157941102|FG002|Acute Treatment Phase|Lack of Efficacy|2|||
49027840|NCT00849901|157941100|FG000|Extension Phase|Adverse Event|2|||
49027841|NCT00849901|157941101|FG001|Extension Phase|Adverse Event|8|||
49027842|NCT00849901|157941102|FG002|Extension Phase|Adverse Event|4|||
48775902|NCT00466193|157023635|FG000|Overall Study|Patient refused Visit 4 procedures|1|||
48775903|NCT00466193|157023636|FG001|Overall Study|Patient refused Visit 4 procedures|0|||
48775904|NCT05044234|157023637|FG000|Overall Study|Lost to Follow-up|2|||
48775905|NCT05044234|157023638|FG001|Overall Study|Lost to Follow-up|1|||
48775906|NCT05044234|157023639|FG002|Overall Study|Lost to Follow-up|1|||
48775907|NCT05044234|157023640|FG003|Overall Study|Lost to Follow-up|2|||
48775908|NCT05044234|157023637|FG000|Overall Study|Withdrawal by Subject|6|||
48775909|NCT05044234|157023638|FG001|Overall Study|Withdrawal by Subject|4|||
48775910|NCT05044234|157023639|FG002|Overall Study|Withdrawal by Subject|5|||
48876961|NCT01270828|157388465|FG001|Double Blind Phase|Adverse event related to study drug|7|||
49027843|NCT00849901|157941100|FG000|Extension Phase|Lost to Follow-up|3|||
49027844|NCT00849901|157941101|FG001|Extension Phase|Lost to Follow-up|0|||
48775911|NCT05044234|157023640|FG003|Overall Study|Withdrawal by Subject|8|||
48775912|NCT05044234|157023637|FG000|Overall Study|Study terminated by Sponsor|21|||
49027845|NCT00849901|157941102|FG002|Extension Phase|Lost to Follow-up|1|||
49027846|NCT00849901|157941100|FG000|Extension Phase|Protocol Violation|2|||
48775913|NCT05044234|157023638|FG001|Overall Study|Study terminated by Sponsor|21|||
49027847|NCT00849901|157941101|FG001|Extension Phase|Protocol Violation|2|||
49027848|NCT00849901|157941102|FG002|Extension Phase|Protocol Violation|4|||
49027849|NCT00849901|157941100|FG000|Extension Phase|Withdrawal by Subject|7|||
49027850|NCT00849901|157941101|FG001|Extension Phase|Withdrawal by Subject|6|||
49027851|NCT00849901|157941102|FG002|Extension Phase|Withdrawal by Subject|3|||
49027852|NCT00849901|157941100|FG000|Extension Phase|Parent or Caregiver Decision|10|||
49027853|NCT00849901|157941101|FG001|Extension Phase|Parent or Caregiver Decision|4|||
49027854|NCT00849901|157941102|FG002|Extension Phase|Parent or Caregiver Decision|4|||
49027855|NCT00849901|157941100|FG000|Extension Phase|Physician Decision|1|||
49027856|NCT00849901|157941101|FG001|Extension Phase|Physician Decision|2|||
49027857|NCT00849901|157941102|FG002|Extension Phase|Physician Decision|0|||
48775914|NCT05044234|157023639|FG002|Overall Study|Study terminated by Sponsor|20|||
48775915|NCT05044234|157023640|FG003|Overall Study|Study terminated by Sponsor|14|||
48775916|NCT05044234|157023637|FG000|Overall Study|Other, not specified|0|||
48775917|NCT05044234|157023638|FG001|Overall Study|Other, not specified|0|||
48775918|NCT05044234|157023639|FG002|Overall Study|Other, not specified|1|||
48775919|NCT05044234|157023640|FG003|Overall Study|Other, not specified|2|||
48775920|NCT05044234|157023637|FG000|Overall Study|Delayed data entry|0|||
48775921|NCT05044234|157023638|FG001|Overall Study|Delayed data entry|0|||
48775922|NCT05044234|157023639|FG002|Overall Study|Delayed data entry|0|||
48775923|NCT05044234|157023640|FG003|Overall Study|Delayed data entry|1|||
48775924|NCT02896127|157023641|FG000|COMPLETED WEEK 52|Adverse Event|9|||
48775925|NCT02896127|157023642|FG001|COMPLETED WEEK 52|Adverse Event|2|||
48775926|NCT02896127|157023641|FG000|COMPLETED WEEK 52|Lack of Efficacy|2|||
48775927|NCT02896127|157023642|FG001|COMPLETED WEEK 52|Lack of Efficacy|3|||
48775928|NCT02896127|157023641|FG000|COMPLETED WEEK 52|Lost to Follow-up|0|||
48775929|NCT02896127|157023642|FG001|COMPLETED WEEK 52|Lost to Follow-up|1|||
48775930|NCT02896127|157023641|FG000|COMPLETED WEEK 52|Physician Decision|1|||
48775931|NCT02896127|157023642|FG001|COMPLETED WEEK 52|Physician Decision|1|||
48775932|NCT02896127|157023641|FG000|COMPLETED WEEK 52|Pregnancy|2|||
48775933|NCT02896127|157023642|FG001|COMPLETED WEEK 52|Pregnancy|0|||
48775934|NCT02896127|157023641|FG000|COMPLETED WEEK 52|Withdrawal by Subject|12|||
48775935|NCT02896127|157023642|FG001|COMPLETED WEEK 52|Withdrawal by Subject|4|||
48775936|NCT02896127|157023641|FG000|COMPLETED WEEK 52|Technical problems|1|||
48775937|NCT02896127|157023642|FG001|COMPLETED WEEK 52|Technical problems|0|||
48775938|NCT02896127|157023641|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2|||
48775939|NCT02896127|157023642|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3|||
48775940|NCT02896127|157023641|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0|||
48775941|NCT02896127|157023642|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1|||
48775942|NCT02896127|157023641|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1|||
48775943|NCT02896127|157023642|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0|||
48775944|NCT02896127|157023641|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1|||
48775945|NCT02896127|157023642|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0|||
48775946|NCT02896127|157023641|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0|||
48775947|NCT02896127|157023642|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1|||
48775948|NCT01023659|157023643|FG000|Overall Study|Lost to Follow-up|73|||
48775949|NCT01023659|157023644|FG001|Overall Study|Lost to Follow-up|228|||
48775950|NCT01023659|157023645|FG002|Overall Study|Lost to Follow-up|99|||
48775951|NCT02477020|157023647|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
48775952|NCT02477020|157023648|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
48775953|NCT02477020|157023647|FG000|Overall Study|Voluntary Withdrawal|7|||
48775954|NCT02477020|157023648|FG001|Overall Study|Voluntary Withdrawal|16|||
48775955|NCT02477020|157023647|FG000|Overall Study|Reason not Specified|3|||
48775956|NCT02477020|157023648|FG001|Overall Study|Reason not Specified|1|||
48775957|NCT02477020|157023647|FG000|Overall Study|Lack of Efficacy|14|||
48775958|NCT02477020|157023648|FG001|Overall Study|Lack of Efficacy|5|||
48775959|NCT00451282|157023649|FG000|Overall Study|Lost to Follow-up|6|||
48775960|NCT00451282|157023650|FG001|Overall Study|Lost to Follow-up|5|||
48775961|NCT00563797|157023652|FG000|Overall Study|Lost to Follow-up|7|||
48775962|NCT00563797|157023653|FG001|Overall Study|Lost to Follow-up|2|||
48775963|NCT01276327|157023654|FG000|Overall Study|Adverse Event|1|||
48775964|NCT01276327|157023655|FG001|Overall Study|Adverse Event|3|||
48775965|NCT01276327|157023654|FG000|Overall Study|Withdrawal by Subject|1|||
48775966|NCT01276327|157023655|FG001|Overall Study|Withdrawal by Subject|0|||
48775967|NCT02809976|157023656|FG000|Overall Study|Lost to Follow-up|1|||
48775968|NCT02809976|157023656|FG000|Overall Study|Withdrawal by Subject|1|||
48775969|NCT01513291|157023657|FG000|Treatment Period|Adverse Event|8|||
48775970|NCT01513291|157023658|FG001|Treatment Period|Adverse Event|4|||
48775971|NCT01513291|157023659|FG002|Treatment Period|Adverse Event|0|||
48775972|NCT01513291|157023660|FG003|Treatment Period|Adverse Event|0|||
48775973|NCT01513291|157023661|FG004|Treatment Period|Adverse Event|0|||
49027858|NCT00849901|157941100|FG000|Extension Phase|Lack of Efficacy|2|||
49027859|NCT00849901|157941101|FG001|Extension Phase|Lack of Efficacy|4|||
48775974|NCT01513291|157023657|FG000|Treatment Period|Lack of Efficacy|3|||
49027860|NCT00849901|157941102|FG002|Extension Phase|Lack of Efficacy|1|||
48775975|NCT01513291|157023658|FG001|Treatment Period|Lack of Efficacy|0|||
48982499|NCT03261037|157767604|FG000|Overall Study|Participant moving away and can no longer be in study|0|||
48982500|NCT03261037|157767605|FG001|Overall Study|Participant moving away and can no longer be in study|1|||
48982501|NCT03261037|157767606|FG002|Overall Study|Participant moving away and can no longer be in study|0|||
48982502|NCT03261037|157767607|FG003|Overall Study|Participant moving away and can no longer be in study|0|||
48982503|NCT03261037|157767604|FG000|Overall Study|Participant came out of study due to investigator discretion|0|||
48982504|NCT03261037|157767605|FG001|Overall Study|Participant came out of study due to investigator discretion|2|||
48982505|NCT03261037|157767606|FG002|Overall Study|Participant came out of study due to investigator discretion|0|||
48982506|NCT03261037|157767607|FG003|Overall Study|Participant came out of study due to investigator discretion|0|||
48982507|NCT03261037|157767604|FG000|Overall Study|Diagnosed but protocol deviation|1|||
48982508|NCT03261037|157767605|FG001|Overall Study|Diagnosed but protocol deviation|0|||
48982509|NCT03261037|157767606|FG002|Overall Study|Diagnosed but protocol deviation|0|||
48982510|NCT03261037|157767607|FG003|Overall Study|Diagnosed but protocol deviation|0|||
48982511|NCT03261037|157767604|FG000|Overall Study|Participant did not want to continue the study|0|||
48982512|NCT03261037|157767605|FG001|Overall Study|Participant did not want to continue the study|1|||
48982513|NCT03261037|157767606|FG002|Overall Study|Participant did not want to continue the study|0|||
48982514|NCT03261037|157767607|FG003|Overall Study|Participant did not want to continue the study|0|||
48982515|NCT03261037|157767604|FG000|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
48982516|NCT03261037|157767605|FG001|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
48982517|NCT03261037|157767606|FG002|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
48982518|NCT03261037|157767607|FG003|Overall Study|Participant did not want to continue the diagnostic procedures|1|||
48982519|NCT03261037|157767604|FG000|Overall Study|Participant presented clinical improvement|0|||
48982520|NCT03261037|157767605|FG001|Overall Study|Participant presented clinical improvement|2|||
48982521|NCT03261037|157767606|FG002|Overall Study|Participant presented clinical improvement|0|||
48982522|NCT03261037|157767607|FG003|Overall Study|Participant presented clinical improvement|0|||
48982523|NCT03261037|157767604|FG000|Overall Study|Technical difficulties|0|||
48982524|NCT03261037|157767605|FG001|Overall Study|Technical difficulties|0|||
48982525|NCT03261037|157767606|FG002|Overall Study|Technical difficulties|0|||
48982526|NCT03261037|157767607|FG003|Overall Study|Technical difficulties|1|||
48982527|NCT03261037|157767604|FG000|Overall Study|Equipment failed to work|0|||
48982528|NCT03261037|157767605|FG001|Overall Study|Equipment failed to work|0|||
48982529|NCT03261037|157767606|FG002|Overall Study|Equipment failed to work|0|||
48982530|NCT03261037|157767607|FG003|Overall Study|Equipment failed to work|1|||
48982531|NCT03261037|157767604|FG000|Overall Study|End of study for participant and no follow up|0|||
48982532|NCT03261037|157767605|FG001|Overall Study|End of study for participant and no follow up|0|||
48982533|NCT03261037|157767606|FG002|Overall Study|End of study for participant and no follow up|0|||
48982534|NCT03261037|157767607|FG003|Overall Study|End of study for participant and no follow up|1|||
48982535|NCT03261037|157767604|FG000|Overall Study|Participant was too weak to continue in study|1|||
48982536|NCT03261037|157767605|FG001|Overall Study|Participant was too weak to continue in study|0|||
48982537|NCT03261037|157767606|FG002|Overall Study|Participant was too weak to continue in study|0|||
48982538|NCT03261037|157767607|FG003|Overall Study|Participant was too weak to continue in study|0|||
48982539|NCT02943577|157767608|FG000|Overall Study|Protocol Violation|0|||
48982540|NCT02943577|157767609|FG001|Overall Study|Protocol Violation|1|||
48982541|NCT02943577|157767608|FG000|Overall Study|Adverse Event|3|||
48982542|NCT02943577|157767609|FG001|Overall Study|Adverse Event|2|||
48982543|NCT02943577|157767608|FG000|Overall Study|Lost to Follow-up|0|||
48982544|NCT02943577|157767609|FG001|Overall Study|Lost to Follow-up|1|||
48982545|NCT02943577|157767608|FG000|Overall Study|Withdrawal by Subject|1|||
48982546|NCT02943577|157767609|FG001|Overall Study|Withdrawal by Subject|1|||
48982547|NCT02943577|157767608|FG000|Overall Study|Pregnancy|1|||
48982548|NCT02943577|157767609|FG001|Overall Study|Pregnancy|0|||
48982549|NCT00170846|157767619|FG000|Overall Study|Subject withdrew Informed Consent|5|||
48982550|NCT00170846|157767620|FG001|Overall Study|Subject withdrew Informed Consent|12|||
48775976|NCT01513291|157023659|FG002|Treatment Period|Lack of Efficacy|0|||
48775977|NCT01513291|157023660|FG003|Treatment Period|Lack of Efficacy|0|||
48775978|NCT01513291|157023661|FG004|Treatment Period|Lack of Efficacy|0|||
48775979|NCT01513291|157023657|FG000|Treatment Period|Lost to Follow-up|2|||
48775980|NCT01513291|157023658|FG001|Treatment Period|Lost to Follow-up|3|||
48775981|NCT01513291|157023659|FG002|Treatment Period|Lost to Follow-up|0|||
48775982|NCT01513291|157023660|FG003|Treatment Period|Lost to Follow-up|0|||
48775983|NCT01513291|157023661|FG004|Treatment Period|Lost to Follow-up|0|||
48775984|NCT01513291|157023657|FG000|Treatment Period|Physician Decision|1|||
48775985|NCT01513291|157023658|FG001|Treatment Period|Physician Decision|0|||
48982551|NCT00170846|157767621|FG002|Overall Study|Subject withdrew Informed Consent|8|||
48982552|NCT00170846|157767619|FG000|Overall Study|Lost to Follow-up|6|||
48982553|NCT00170846|157767620|FG001|Overall Study|Lost to Follow-up|3|||
48982554|NCT00170846|157767621|FG002|Overall Study|Lost to Follow-up|2|||
48982555|NCT00170846|157767619|FG000|Overall Study|Death|0|||
48982556|NCT00170846|157767620|FG001|Overall Study|Death|3|||
48982557|NCT00170846|157767621|FG002|Overall Study|Death|3|||
48982558|NCT00170846|157767619|FG000|Overall Study|Reason Missing|0|||
48982559|NCT00170846|157767620|FG001|Overall Study|Reason Missing|1|||
48982560|NCT00170846|157767621|FG002|Overall Study|Reason Missing|0|||
48982561|NCT01657253|157767626|FG000|Overall Study|Lost to Follow-up|6|||
48982562|NCT01657253|157767627|FG001|Overall Study|Lost to Follow-up|5|||
48775986|NCT01513291|157023659|FG002|Treatment Period|Physician Decision|0|||
48775987|NCT01513291|157023660|FG003|Treatment Period|Physician Decision|0|||
48775988|NCT01513291|157023661|FG004|Treatment Period|Physician Decision|0|||
48775989|NCT01513291|157023657|FG000|Treatment Period|Protocol Violation|1|||
48775990|NCT01513291|157023658|FG001|Treatment Period|Protocol Violation|2|||
48775991|NCT01513291|157023659|FG002|Treatment Period|Protocol Violation|0|||
48775992|NCT01513291|157023660|FG003|Treatment Period|Protocol Violation|0|||
48775993|NCT01513291|157023661|FG004|Treatment Period|Protocol Violation|0|||
48775994|NCT01513291|157023657|FG000|Treatment Period|Withdrawal by Subject|8|||
48775995|NCT01513291|157023658|FG001|Treatment Period|Withdrawal by Subject|5|||
48775996|NCT01513291|157023659|FG002|Treatment Period|Withdrawal by Subject|0|||
48775997|NCT01513291|157023660|FG003|Treatment Period|Withdrawal by Subject|0|||
48775998|NCT01513291|157023661|FG004|Treatment Period|Withdrawal by Subject|0|||
48775999|NCT01513291|157023657|FG000|Treatment Period|Randomized not treated|0|||
48776000|NCT01513291|157023658|FG001|Treatment Period|Randomized not treated|2|||
48776001|NCT01513291|157023659|FG002|Treatment Period|Randomized not treated|0|||
48776002|NCT01513291|157023660|FG003|Treatment Period|Randomized not treated|0|||
48776003|NCT01513291|157023661|FG004|Treatment Period|Randomized not treated|0|||
48776004|NCT01513291|157023657|FG000|Run-out Period|Lost to Follow-up|0|||
48776005|NCT01513291|157023658|FG001|Run-out Period|Lost to Follow-up|0|||
48776006|NCT01513291|157023659|FG002|Run-out Period|Lost to Follow-up|0|||
48776007|NCT01513291|157023660|FG003|Run-out Period|Lost to Follow-up|1|||
48776008|NCT01513291|157023661|FG004|Run-out Period|Lost to Follow-up|0|||
48776009|NCT01513291|157023657|FG000|Run-out Period|Withdrawal by Subject|0|||
48776010|NCT01513291|157023658|FG001|Run-out Period|Withdrawal by Subject|0|||
48776011|NCT01513291|157023659|FG002|Run-out Period|Withdrawal by Subject|0|||
48776012|NCT01513291|157023660|FG003|Run-out Period|Withdrawal by Subject|1|||
48776013|NCT01513291|157023661|FG004|Run-out Period|Withdrawal by Subject|0|||
48776014|NCT02984995|157023665|FG000|Overall Study|Required stem cell transplant|13|||
48776015|NCT02984995|157023666|FG001|Overall Study|Required stem cell transplant|2|||
48776016|NCT02984995|157023665|FG000|Overall Study|Progressive disease|11|||
48776017|NCT02984995|157023666|FG001|Overall Study|Progressive disease|1|||
48776018|NCT02984995|157023665|FG000|Overall Study|Adverse Event|1|||
48776019|NCT02984995|157023666|FG001|Overall Study|Adverse Event|0|||
48776020|NCT04354831|157023667|FG000|Overall Study|No blood type specific convalescent plasma was available|0|||
48776021|NCT04354831|157023668|FG001|Overall Study|No blood type specific convalescent plasma was available|1|||
48776022|NCT02992899|157023669|FG000|Overall Study|Withdrawal by Subject|1|||
48776023|NCT02992899|157023670|FG001|Overall Study|Withdrawal by Subject|0|||
48776024|NCT02992899|157023669|FG000|Overall Study|Lost to Follow-up|1|||
48776025|NCT02992899|157023670|FG001|Overall Study|Lost to Follow-up|3|||
48776026|NCT01034397|157023671|FG000|Overall Study|Lack of compliance|0|||
48776027|NCT01034397|157023672|FG001|Overall Study|Lack of compliance|1|||
48776028|NCT01034397|157023671|FG000|Overall Study|Lack of Efficacy|3|||
48776029|NCT01034397|157023672|FG001|Overall Study|Lack of Efficacy|0|||
48776030|NCT01034397|157023671|FG000|Overall Study|Adverse Event|4|||
48776031|NCT01034397|157023672|FG001|Overall Study|Adverse Event|0|||
48776032|NCT01034397|157023671|FG000|Overall Study|Other|0|||
48776033|NCT01034397|157023672|FG001|Overall Study|Other|1|||
48776034|NCT04027686|157023673|FG000|Overall Study|Lost to Follow-up|2|||
48776035|NCT04027686|157023674|FG001|Overall Study|Lost to Follow-up|0|||
48776036|NCT04027686|157023673|FG000|Overall Study|Withdrawal by Subject|0|||
48776037|NCT04027686|157023674|FG001|Overall Study|Withdrawal by Subject|1|||
48776038|NCT04713748|157023675|FG000|Overall Study|Not enough kits allocated|35|||
48776039|NCT00096941|157023676|FG000|Overall Study|disease progression|3|||
48776040|NCT01611259|157023677|FG000|Overall Study|Physician Decision|1|||
48776041|NCT01611259|157023677|FG000|Overall Study|Lack of Efficacy|2|||
48776042|NCT01611259|157023677|FG000|Overall Study|Adverse Event|4|||
48776043|NCT01611259|157023677|FG000|Overall Study|Withdrawal by Subject|7|||
48776044|NCT00439140|157023681|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
48776045|NCT00439140|157023682|FG001|Treatment Cycle 1|Lost to Follow-up|1|||
48776046|NCT00439140|157023683|FG002|Treatment Cycle 1|Lost to Follow-up|1|||
48776047|NCT00439140|157023681|FG000|Treatment Cycle 1|Personal reasons|0|||
48776048|NCT00439140|157023682|FG001|Treatment Cycle 1|Personal reasons|2|||
48776049|NCT00439140|157023683|FG002|Treatment Cycle 1|Personal reasons|0|||
48776050|NCT00439140|157023681|FG000|Treatment Cycle 1|Withdrawal by Subject|0|||
48776051|NCT00439140|157023682|FG001|Treatment Cycle 1|Withdrawal by Subject|1|||
48776052|NCT00439140|157023683|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
48776053|NCT00439140|157023681|FG000|Treatment Cycle 2|Withdrawal by Subject|1|||
48776054|NCT00439140|157023682|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
48982563|NCT01657253|157767626|FG000|Overall Study|Withdrawal by Subject|11|||
48982564|NCT01657253|157767627|FG001|Overall Study|Withdrawal by Subject|12|||
48776055|NCT00439140|157023683|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
48776056|NCT00439140|157023681|FG000|Treatment Cycle 2|Lost to Follow-up|1|||
48776057|NCT00439140|157023682|FG001|Treatment Cycle 2|Lost to Follow-up|1|||
48776058|NCT00439140|157023683|FG002|Treatment Cycle 2|Lost to Follow-up|0|||
48776059|NCT02203591|157023686|FG000|Overall Study|Did not meet treatment day baseline|147|||
48776060|NCT02203591|157023687|FG001|Overall Study|Did not meet treatment day baseline|141|||
48776061|NCT02203591|157023688|FG002|Overall Study|Did not meet treatment day baseline|150|||
48776062|NCT02203591|157023689|FG003|Overall Study|Did not meet treatment day baseline|45|||
48776063|NCT02203591|157023690|FG004|Overall Study|Did not meet treatment day baseline|33|||
48776064|NCT02203591|157023691|FG005|Overall Study|Did not meet treatment day baseline|35|||
48776065|NCT02203591|157023692|FG006|Overall Study|Did not meet treatment day baseline|29|||
48776066|NCT02203591|157023693|FG007|Overall Study|Did not meet treatment day baseline|12|||
48776067|NCT02203591|157023686|FG000|Overall Study|Discontinued early due to compromised test sites|0|||
48776068|NCT02203591|157023687|FG001|Overall Study|Discontinued early due to compromised test sites|1|||
48776069|NCT02203591|157023688|FG002|Overall Study|Discontinued early due to compromised test sites|1|||
48776070|NCT02203591|157023689|FG003|Overall Study|Discontinued early due to compromised test sites|0|||
48776071|NCT02203591|157023690|FG004|Overall Study|Discontinued early due to compromised test sites|1|||
48776072|NCT02203591|157023691|FG005|Overall Study|Discontinued early due to compromised test sites|0|||
48776073|NCT02203591|157023692|FG006|Overall Study|Discontinued early due to compromised test sites|0|||
48776074|NCT02203591|157023693|FG007|Overall Study|Discontinued early due to compromised test sites|1|||
48776075|NCT00281840|157023694|FG000|Overall Study|Adverse Event|12|||
48776076|NCT00281840|157023694|FG000|Overall Study|Physician Decision|6|||
48776077|NCT00281840|157023694|FG000|Overall Study|Withdrawal by Subject|3|||
48776078|NCT00281840|157023694|FG000|Overall Study|Disease Progression|2|||
48776079|NCT00281840|157023694|FG000|Overall Study|exceed maximum delay in treatment|1|||
48776080|NCT00281840|157023694|FG000|Overall Study|Complicating Disease|1|||
48776081|NCT03921411|157023704|FG000|Overall Study|Withdrawal by Subject|1|||
48776082|NCT03921411|157023704|FG000|Overall Study|Protocol Deviation|2|||
48776083|NCT03921411|157023704|FG000|Overall Study|Enrolled, but never treated|2|||
48776084|NCT01578551|157023712|FG000|Overall Study|Adverse Event|1|||
48776085|NCT01578551|157023713|FG001|Overall Study|Adverse Event|0|||
48776086|NCT00061048|157023714|FG000|Overall Study|Adverse Event|2|||
48776087|NCT00061048|157023714|FG000|Overall Study|disease progression|20|||
48776088|NCT01632579|157023715|FG000|Washout Period|Adverse Event|1|||
48776089|NCT01632579|157023716|FG001|Washout Period|Adverse Event|0|||
48776090|NCT01632579|157023717|FG002|Washout Period|Adverse Event|0|||
48776091|NCT01632579|157023718|FG003|Washout Period|Adverse Event|0|||
48776092|NCT01632579|157023719|FG004|Washout Period|Adverse Event|0|||
48776093|NCT01632579|157023720|FG005|Washout Period|Adverse Event|0|||
48776094|NCT01632579|157023721|FG006|Washout Period|Adverse Event|0|||
48776095|NCT01632579|157023722|FG007|Washout Period|Adverse Event|0|||
48776096|NCT01632579|157023723|FG008|Washout Period|Adverse Event|0|||
48776097|NCT01632579|157023715|FG000|Period 2 (Second Intervention)|Adverse Event|1|||
48776098|NCT01632579|157023716|FG001|Period 2 (Second Intervention)|Adverse Event|0|||
48776099|NCT01632579|157023717|FG002|Period 2 (Second Intervention)|Adverse Event|0|||
48776100|NCT01632579|157023718|FG003|Period 2 (Second Intervention)|Adverse Event|0|||
48776101|NCT01632579|157023719|FG004|Period 2 (Second Intervention)|Adverse Event|0|||
48776102|NCT01632579|157023720|FG005|Period 2 (Second Intervention)|Adverse Event|0|||
48776103|NCT01632579|157023721|FG006|Period 2 (Second Intervention)|Adverse Event|0|||
48776104|NCT01632579|157023722|FG007|Period 2 (Second Intervention)|Adverse Event|0|||
48776105|NCT01632579|157023723|FG008|Period 2 (Second Intervention)|Adverse Event|0|||
48776106|NCT00162136|157023724|FG000|Overall Study|Adverse Event|1|||
48776107|NCT00162136|157023724|FG000|Overall Study|Death|1|||
48776108|NCT00162136|157023724|FG000|Overall Study|Disease Progression/Relapse|23|||
48776109|NCT00162136|157023724|FG000|Overall Study|Investigator Request|5|||
48776110|NCT00162136|157023724|FG000|Overall Study|Study Drug Toxicity|4|||
48776111|NCT00162136|157023724|FG000|Overall Study|Withdrawal by Subject|1|||
48776112|NCT02788175|157023725|FG000|Overall Study|Protocol Violation|3|||
48776113|NCT02788175|157023725|FG000|Overall Study|Withdrawal by Subject|4|||
48776114|NCT02788175|157023725|FG000|Overall Study|Ineligible prior to study agent|6|||
48776115|NCT03930745|157023726|FG000|Overall Study|Lost to Follow-up|10|||
48776116|NCT03930745|157023727|FG001|Overall Study|Lost to Follow-up|5|||
48776117|NCT03930745|157023726|FG000|Overall Study|Withdrawal by Subject|1|||
48776118|NCT03930745|157023727|FG001|Overall Study|Withdrawal by Subject|2|||
48776119|NCT03930745|157023726|FG000|Overall Study|Protocol Violation|2|||
48776120|NCT03930745|157023727|FG001|Overall Study|Protocol Violation|2|||
48776121|NCT03930745|157023726|FG000|Overall Study|COVID-19 Shelter in Place Order|3|||
48776122|NCT03930745|157023727|FG001|Overall Study|COVID-19 Shelter in Place Order|5|||
48776123|NCT03930745|157023726|FG000|Overall Study|Adverse Event|0|||
48776124|NCT03930745|157023727|FG001|Overall Study|Adverse Event|1|||
48776125|NCT03930745|157023726|FG000|Overall Study|Pregnancy|0|||
48776126|NCT03930745|157023727|FG001|Overall Study|Pregnancy|1|||
48776127|NCT00818441|157023732|FG000|Overall Study|Death|69|||
48776128|NCT00818441|157023733|FG001|Overall Study|Death|26|||
48776129|NCT00818441|157023732|FG000|Overall Study|Other|5|||
48776130|NCT00818441|157023733|FG001|Overall Study|Other|0|||
48776131|NCT00818441|157023732|FG000|Overall Study|Lost to Follow-up|2|||
48776132|NCT00818441|157023733|FG001|Overall Study|Lost to Follow-up|1|||
48776133|NCT00818441|157023732|FG000|Overall Study|Withdrawal by Subject|2|||
48776134|NCT00818441|157023733|FG001|Overall Study|Withdrawal by Subject|0|||
48776135|NCT00818441|157023732|FG000|Overall Study|Adverse Event|0|||
48776136|NCT00818441|157023733|FG001|Overall Study|Adverse Event|1|||
48776137|NCT00818441|157023732|FG000|Overall Study|Study terminated by sponsor|11|||
48776138|NCT00818441|157023733|FG001|Overall Study|Study terminated by sponsor|2|||
48776139|NCT00829621|157023746|FG000|Overall Study|Death|1|||
48776140|NCT00829621|157023747|FG001|Overall Study|Death|0|||
48776141|NCT00829621|157023746|FG000|Overall Study|Lost to Follow-up|3|||
48776142|NCT00829621|157023747|FG001|Overall Study|Lost to Follow-up|4|||
48776143|NCT01438541|157023751|FG000|Overall Study|Physician Decision|1|||
48776144|NCT01438541|157023751|FG000|Overall Study|Withdrawal by Subject|1|||
48776145|NCT01438541|157023751|FG000|Overall Study|discharge from the hospital|5|||
48776146|NCT02091167|157023753|FG000|Overall Study|Lost to Follow-up|0|||
48776147|NCT02091167|157023754|FG001|Overall Study|Lost to Follow-up|2|||
48776148|NCT03096782|157023757|FG000|Overall Study|Death|1|||
48776149|NCT03096782|157023757|FG000|Overall Study|Participant Relapsed|1|||
48776150|NCT03662750|157023758|FG000|Overall Study|Withdrawal by Subject|1|||
48776151|NCT03823651|157023765|FG000|Overall Study|Death|5|||
48776152|NCT03823651|157023766|FG001|Overall Study|Death|0|||
48776153|NCT03823651|157023765|FG000|Overall Study|Physician Decision|1|||
48776154|NCT03823651|157023766|FG001|Overall Study|Physician Decision|0|||
48776155|NCT03823651|157023765|FG000|Overall Study|Caregiver to patient who died|0|||
48776156|NCT03823651|157023766|FG001|Overall Study|Caregiver to patient who died|5|||
48776157|NCT03823651|157023765|FG000|Overall Study|Caregiver to patient who was withdrawn due to physician decision|0|||
48776158|NCT03823651|157023766|FG001|Overall Study|Caregiver to patient who was withdrawn due to physician decision|1|||
48776159|NCT04346615|157025914|FG000|Overall Study|Lost to Follow-up|0|||
48776160|NCT04346615|157025915|FG001|Overall Study|Lost to Follow-up|2|||
48776161|NCT04346615|157025914|FG000|Overall Study|Withdrawal by Subject|1|||
48776162|NCT04346615|157025915|FG001|Overall Study|Withdrawal by Subject|0|||
48776163|NCT04346615|157025914|FG000|Overall Study|Death|5|||
48776164|NCT04346615|157025915|FG001|Overall Study|Death|1|||
48776165|NCT04346615|157025914|FG000|Overall Study|Other|0|||
48776166|NCT04346615|157025915|FG001|Overall Study|Other|2|||
48776167|NCT04346615|157025914|FG000|Overall Study|Randomized not treated|1|||
49027861|NCT03952143|157941104|FG000|Lead-In Period|Adverse Event|2|||
49027862|NCT03952143|157941105|FG001|Lead-In Period|Adverse Event|0|||
49027863|NCT03952143|157941106|FG002|Lead-In Period|Adverse Event|0|||
49027864|NCT03952143|157941104|FG000|Lead-In Period|Lack of Efficacy|2|||
49027865|NCT03952143|157941105|FG001|Lead-In Period|Lack of Efficacy|0|||
49027866|NCT03952143|157941106|FG002|Lead-In Period|Lack of Efficacy|0|||
49027867|NCT03952143|157941104|FG000|Lead-In Period|Physician Decision|5|||
49027868|NCT03952143|157941105|FG001|Lead-In Period|Physician Decision|0|||
49027869|NCT03952143|157941106|FG002|Lead-In Period|Physician Decision|0|||
49027870|NCT03952143|157941104|FG000|Lead-In Period|Protocol Violation|5|||
49027871|NCT03952143|157941105|FG001|Lead-In Period|Protocol Violation|0|||
49027872|NCT03952143|157941106|FG002|Lead-In Period|Protocol Violation|0|||
49027873|NCT03952143|157941104|FG000|Lead-In Period|Withdrawal by Subject|19|||
49027874|NCT03952143|157941105|FG001|Lead-In Period|Withdrawal by Subject|0|||
49027875|NCT03952143|157941106|FG002|Lead-In Period|Withdrawal by Subject|0|||
49027876|NCT03952143|157941104|FG000|Treatment Period|Adverse Event|0|||
49027877|NCT03952143|157941105|FG001|Treatment Period|Adverse Event|0|||
49027878|NCT03952143|157941106|FG002|Treatment Period|Adverse Event|1|||
49027879|NCT03952143|157941104|FG000|Treatment Period|Lost to Follow-up|0|||
48776168|NCT04346615|157025915|FG001|Overall Study|Randomized not treated|0|||
48776169|NCT00941733|157025916|FG000|Overall Study|Death|24|||
48776170|NCT00941733|157025917|FG001|Overall Study|Death|10|||
48776171|NCT00941733|157025916|FG000|Overall Study|Withdrawal by Subject|14|||
48776172|NCT00941733|157025917|FG001|Overall Study|Withdrawal by Subject|6|||
48776173|NCT00941733|157025916|FG000|Overall Study|Adverse Event|20|||
48776174|NCT00941733|157025917|FG001|Overall Study|Adverse Event|4|||
49027880|NCT03952143|157941105|FG001|Treatment Period|Lost to Follow-up|2|||
49027881|NCT03952143|157941106|FG002|Treatment Period|Lost to Follow-up|0|||
49027882|NCT03952143|157941104|FG000|Treatment Period|Physician Decision|0|||
49027883|NCT03952143|157941105|FG001|Treatment Period|Physician Decision|0|||
48776175|NCT00941733|157025916|FG000|Overall Study|Lost to Follow-up|1|||
48776176|NCT00941733|157025917|FG001|Overall Study|Lost to Follow-up|2|||
48776177|NCT00941733|157025916|FG000|Overall Study|Protocol Violation|15|||
48776178|NCT00941733|157025917|FG001|Overall Study|Protocol Violation|6|||
48776179|NCT00773175|157025927|FG000|Overall Study|Adverse Event|2|||
48776180|NCT00773175|157025928|FG001|Overall Study|Adverse Event|0|||
48776181|NCT00773175|157025927|FG000|Overall Study|Consent Withdrawn|0|||
48776182|NCT00773175|157025928|FG001|Overall Study|Consent Withdrawn|2|||
49027884|NCT03952143|157941106|FG002|Treatment Period|Physician Decision|2|||
49027885|NCT03952143|157941104|FG000|Treatment Period|Protocol Violation|0|||
49027886|NCT03952143|157941105|FG001|Treatment Period|Protocol Violation|0|||
48776183|NCT03285646|157025929|FG000|Overall Study|Adverse Event|1|||
48776184|NCT03285646|157025930|FG001|Overall Study|Adverse Event|0|||
48776185|NCT03285646|157025929|FG000|Overall Study|Withdrawal by Subject|10|||
48776186|NCT03285646|157025930|FG001|Overall Study|Withdrawal by Subject|2|||
48776187|NCT03285646|157025929|FG000|Overall Study|Lost to Follow-up|2|||
48776188|NCT03285646|157025930|FG001|Overall Study|Lost to Follow-up|1|||
48776189|NCT03285646|157025929|FG000|Overall Study|Investigator/Sponsor Decision|0|||
48776190|NCT03285646|157025930|FG001|Overall Study|Investigator/Sponsor Decision|1|||
48776191|NCT01465802|157025932|FG000|Overall Study|Study terminated by sponsor|1|||
48776192|NCT01465802|157025933|FG001|Overall Study|Study terminated by sponsor|0|||
48776193|NCT01465802|157025934|FG002|Overall Study|Study terminated by sponsor|0|||
48776194|NCT01465802|157025935|FG003|Overall Study|Study terminated by sponsor|1|||
48776195|NCT01465802|157025936|FG004|Overall Study|Study terminated by sponsor|7|||
48776196|NCT01465802|157025932|FG000|Overall Study|Withdrawal by Subject|7|||
48776197|NCT01465802|157025933|FG001|Overall Study|Withdrawal by Subject|7|||
48776198|NCT01465802|157025934|FG002|Overall Study|Withdrawal by Subject|0|||
48776199|NCT01465802|157025935|FG003|Overall Study|Withdrawal by Subject|8|||
48776200|NCT01465802|157025936|FG004|Overall Study|Withdrawal by Subject|1|||
48776201|NCT01465802|157025932|FG000|Overall Study|Lost to Follow-up|1|||
48776202|NCT01465802|157025933|FG001|Overall Study|Lost to Follow-up|1|||
48776203|NCT01465802|157025934|FG002|Overall Study|Lost to Follow-up|0|||
48776204|NCT01465802|157025935|FG003|Overall Study|Lost to Follow-up|0|||
48776205|NCT01465802|157025936|FG004|Overall Study|Lost to Follow-up|0|||
48776206|NCT01465802|157025932|FG000|Overall Study|Reason not specified|9|||
48776207|NCT01465802|157025933|FG001|Overall Study|Reason not specified|4|||
48776208|NCT01465802|157025934|FG002|Overall Study|Reason not specified|0|||
48776209|NCT01465802|157025935|FG003|Overall Study|Reason not specified|10|||
48776210|NCT01465802|157025936|FG004|Overall Study|Reason not specified|2|||
48776211|NCT01465802|157025932|FG000|Overall Study|Death|15|||
48776212|NCT01465802|157025933|FG001|Overall Study|Death|12|||
48776213|NCT01465802|157025934|FG002|Overall Study|Death|0|||
48776214|NCT01465802|157025935|FG003|Overall Study|Death|10|||
48776215|NCT01465802|157025936|FG004|Overall Study|Death|2|||
48776216|NCT00456092|157025938|FG000|Extension Phase|Grade 2 or Greater AE|2|||
48776217|NCT00456092|157025939|FG001|Extension Phase|Grade 2 or Greater AE|2|||
48776218|NCT00456092|157025940|FG002|Extension Phase|Grade 2 or Greater AE|0|||
48776219|NCT00456092|157025941|FG003|Extension Phase|Grade 2 or Greater AE|0|||
48776220|NCT00456092|157025942|FG004|Extension Phase|Grade 2 or Greater AE|2|||
48776221|NCT00456092|157025938|FG000|Extension Phase|Flare of Psoriatic Arthritis|1|||
48776222|NCT00456092|157025939|FG001|Extension Phase|Flare of Psoriatic Arthritis|0|||
48776223|NCT00456092|157025940|FG002|Extension Phase|Flare of Psoriatic Arthritis|0|||
48776224|NCT00456092|157025941|FG003|Extension Phase|Flare of Psoriatic Arthritis|0|||
48776225|NCT00456092|157025942|FG004|Extension Phase|Flare of Psoriatic Arthritis|1|||
48776226|NCT00456092|157025938|FG000|Extension Phase|Worsening / Not Responding to Study Drug|3|||
48776227|NCT00456092|157025939|FG001|Extension Phase|Worsening / Not Responding to Study Drug|1|||
48776228|NCT00456092|157025940|FG002|Extension Phase|Worsening / Not Responding to Study Drug|0|||
48776229|NCT00456092|157025941|FG003|Extension Phase|Worsening / Not Responding to Study Drug|0|||
48776230|NCT00456092|157025942|FG004|Extension Phase|Worsening / Not Responding to Study Drug|2|||
48776231|NCT00456092|157025938|FG000|Extension Phase|Withdrew Consent|2|||
48776232|NCT00456092|157025939|FG001|Extension Phase|Withdrew Consent|0|||
48776233|NCT00456092|157025940|FG002|Extension Phase|Withdrew Consent|0|||
48776234|NCT00456092|157025941|FG003|Extension Phase|Withdrew Consent|0|||
48776235|NCT00456092|157025942|FG004|Extension Phase|Withdrew Consent|0|||
48776236|NCT00456092|157025938|FG000|Extension Phase|Lost to Follow-up|1|||
48776237|NCT00456092|157025939|FG001|Extension Phase|Lost to Follow-up|1|||
48776238|NCT00456092|157025940|FG002|Extension Phase|Lost to Follow-up|0|||
48776239|NCT00456092|157025941|FG003|Extension Phase|Lost to Follow-up|0|||
48776240|NCT00456092|157025942|FG004|Extension Phase|Lost to Follow-up|1|||
48776241|NCT00456092|157025938|FG000|Extension Phase|Other|2|||
48776242|NCT00456092|157025939|FG001|Extension Phase|Other|0|||
48776243|NCT00456092|157025940|FG002|Extension Phase|Other|0|||
48776244|NCT00456092|157025941|FG003|Extension Phase|Other|1|||
48776245|NCT00456092|157025942|FG004|Extension Phase|Other|1|||
48876962|NCT01270828|157388466|FG002|Double Blind Phase|Adverse event related to study drug|0|||
48876963|NCT02994784|157388467|FG000|6 Months Follow-up|Lost to Follow-up|3|||
48876964|NCT01165177|157388481|FG000|Overall Study|Serious Adverse Event|227|||
48982565|NCT01657253|157767626|FG000|Overall Study|Adverse Event|0|||
48982566|NCT01657253|157767627|FG001|Overall Study|Adverse Event|1|||
48982567|NCT01970540|157767635|FG000|Overall Study|Non-treatment-related AE|0|||
48982568|NCT01970540|157767636|FG001|Overall Study|Non-treatment-related AE|0|||
48982569|NCT01970540|157767637|FG002|Overall Study|Non-treatment-related AE|1|||
48982570|NCT01970540|157767635|FG000|Overall Study|Progressive disease|55|||
48776246|NCT00456092|157025938|FG000|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3|||
48776247|NCT00456092|157025939|FG001|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4|||
48982571|NCT01970540|157767636|FG001|Overall Study|Progressive disease|23|||
48776248|NCT00456092|157025940|FG002|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2|||
48776249|NCT00456092|157025941|FG003|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
48776250|NCT00456092|157025942|FG004|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
48776251|NCT00456092|157025938|FG000|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1|||
48776252|NCT00456092|157025939|FG001|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2|||
49027887|NCT03952143|157941106|FG002|Treatment Period|Protocol Violation|1|||
49027888|NCT03952143|157941104|FG000|Treatment Period|Withdrawal by Subject|0|||
49027889|NCT03952143|157941105|FG001|Treatment Period|Withdrawal by Subject|5|||
49027890|NCT03952143|157941106|FG002|Treatment Period|Withdrawal by Subject|26|||
49027891|NCT03952143|157941104|FG000|Treatment Period|Due to COVID 19 restrictions|0|||
49027892|NCT03952143|157941105|FG001|Treatment Period|Due to COVID 19 restrictions|2|||
49027893|NCT03952143|157941106|FG002|Treatment Period|Due to COVID 19 restrictions|5|||
49027894|NCT03952143|157941104|FG000|Treatment Period|Participant had taken prohibited concomitant medication|0|||
49027895|NCT03952143|157941105|FG001|Treatment Period|Participant had taken prohibited concomitant medication|0|||
49027896|NCT03952143|157941106|FG002|Treatment Period|Participant had taken prohibited concomitant medication|1|||
49027897|NCT01367457|157941107|FG000|Overall Study|Death|2|||
49027898|NCT01367457|157941108|FG001|Overall Study|Death|0|||
49027899|NCT01367457|157941109|FG002|Overall Study|Death|0|||
49027900|NCT01367457|157941107|FG000|Overall Study|Investigator's decision|2|||
49027901|NCT01367457|157941108|FG001|Overall Study|Investigator's decision|0|||
49027902|NCT01367457|157941109|FG002|Overall Study|Investigator's decision|0|||
49027903|NCT01367457|157941107|FG000|Overall Study|Clinical decline (CD)|2|||
49027904|NCT01367457|157941108|FG001|Overall Study|Clinical decline (CD)|0|||
49027905|NCT01367457|157941109|FG002|Overall Study|Clinical decline (CD)|0|||
49027906|NCT01367457|157941107|FG000|Overall Study|Progression and death|8|||
49027907|NCT01367457|157941108|FG001|Overall Study|Progression and death|0|||
49027908|NCT01367457|157941109|FG002|Overall Study|Progression and death|0|||
49027909|NCT01367457|157941107|FG000|Overall Study|Toxicity|16|||
49027910|NCT01367457|157941108|FG001|Overall Study|Toxicity|0|||
49027911|NCT01367457|157941109|FG002|Overall Study|Toxicity|0|||
49027912|NCT01367457|157941107|FG000|Overall Study|Progression|137|||
49027913|NCT01367457|157941108|FG001|Overall Study|Progression|0|||
49027914|NCT01367457|157941109|FG002|Overall Study|Progression|0|||
49027915|NCT01367457|157941107|FG000|Overall Study|Patient asks for rest + slow progression|1|||
49027916|NCT01367457|157941108|FG001|Overall Study|Patient asks for rest + slow progression|0|||
49027917|NCT01367457|157941109|FG002|Overall Study|Patient asks for rest + slow progression|0|||
49027918|NCT01367457|157941107|FG000|Overall Study|Investigator's opinion, stable disease|1|||
49027919|NCT01367457|157941108|FG001|Overall Study|Investigator's opinion, stable disease|0|||
49027920|NCT01367457|157941109|FG002|Overall Study|Investigator's opinion, stable disease|0|||
49027921|NCT01367457|157941107|FG000|Overall Study|Bleeding from cavernous haemangioma|1|||
49027922|NCT01367457|157941108|FG001|Overall Study|Bleeding from cavernous haemangioma|0|||
49027923|NCT01367457|157941109|FG002|Overall Study|Bleeding from cavernous haemangioma|0|||
49027924|NCT01367457|157941107|FG000|Overall Study|3 yr Temsirolimus treatment (no disease)|1|||
49027925|NCT01367457|157941108|FG001|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
49027926|NCT01367457|157941109|FG002|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
49027927|NCT01367457|157941107|FG000|Overall Study|low grade toxicities + stable disease|1|||
49027928|NCT01367457|157941108|FG001|Overall Study|low grade toxicities + stable disease|0|||
49027929|NCT01367457|157941109|FG002|Overall Study|low grade toxicities + stable disease|0|||
49027930|NCT01367457|157941107|FG000|Overall Study|Choledocolithiasis and pancreatitis|1|||
49027931|NCT01367457|157941108|FG001|Overall Study|Choledocolithiasis and pancreatitis|0|||
49027932|NCT01367457|157941109|FG002|Overall Study|Choledocolithiasis and pancreatitis|0|||
49027933|NCT01367457|157941107|FG000|Overall Study|Withdrawal by Subject|1|||
49027934|NCT01367457|157941108|FG001|Overall Study|Withdrawal by Subject|0|||
49027935|NCT01367457|157941109|FG002|Overall Study|Withdrawal by Subject|0|||
49027936|NCT01367457|157941107|FG000|Overall Study|CD, associated leukaemia|1|||
49027937|NCT01367457|157941108|FG001|Overall Study|CD, associated leukaemia|0|||
48776253|NCT00456092|157025940|FG002|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
48776254|NCT00456092|157025941|FG003|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
48776255|NCT00456092|157025942|FG004|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
48776256|NCT00456092|157025938|FG000|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2|||
48776257|NCT00456092|157025939|FG001|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
48776258|NCT00456092|157025940|FG002|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
48776259|NCT00456092|157025941|FG003|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
48776260|NCT00456092|157025942|FG004|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
48776261|NCT00456092|157025938|FG000|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
48776262|NCT00456092|157025939|FG001|Treatment Phase (12 Weeks)|Flare of Psoriasis|1|||
49027938|NCT01367457|157941109|FG002|Overall Study|CD, associated leukaemia|0|||
49027939|NCT01367457|157941107|FG000|Overall Study|Uncontrolled pain|1|||
49027940|NCT01367457|157941108|FG001|Overall Study|Uncontrolled pain|0|||
49027941|NCT01367457|157941109|FG002|Overall Study|Uncontrolled pain|0|||
49027942|NCT01367457|157941107|FG000|Overall Study|Overall status worsens to grade 4|1|||
48776263|NCT00456092|157025940|FG002|Treatment Phase (12 Weeks)|Flare of Psoriasis|2|||
48776264|NCT00456092|157025941|FG003|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
48776265|NCT00456092|157025942|FG004|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
48776266|NCT00456092|157025938|FG000|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
48776267|NCT00456092|157025939|FG001|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
48776268|NCT00456092|157025940|FG002|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
48776269|NCT00456092|157025941|FG003|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
48776270|NCT00456092|157025942|FG004|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
48776271|NCT00456092|157025938|FG000|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
48776272|NCT00456092|157025939|FG001|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2|||
48776273|NCT00456092|157025940|FG002|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7|||
48776274|NCT00456092|157025941|FG003|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
48776275|NCT00456092|157025942|FG004|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
48776276|NCT00456092|157025938|FG000|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
48776277|NCT00456092|157025939|FG001|Treatment Phase (12 Weeks)|Withdrew Consent|1|||
48776278|NCT00456092|157025940|FG002|Treatment Phase (12 Weeks)|Withdrew Consent|2|||
48776279|NCT00456092|157025941|FG003|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
48776280|NCT00456092|157025942|FG004|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
48776281|NCT00456092|157025938|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
48776282|NCT00456092|157025939|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
48776283|NCT00456092|157025940|FG002|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
48776284|NCT00456092|157025941|FG003|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
48776285|NCT00456092|157025942|FG004|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
48776286|NCT00456092|157025938|FG000|Treatment Phase (12 Weeks)|Other|1|||
48776287|NCT00456092|157025939|FG001|Treatment Phase (12 Weeks)|Other|0|||
48776288|NCT00456092|157025940|FG002|Treatment Phase (12 Weeks)|Other|1|||
48776289|NCT00456092|157025941|FG003|Treatment Phase (12 Weeks)|Other|0|||
48776290|NCT00456092|157025942|FG004|Treatment Phase (12 Weeks)|Other|0|||
48776291|NCT01565993|157025945|FG000|Overall Study|Physician Decision|0|||
48776292|NCT01565993|157025946|FG001|Overall Study|Physician Decision|3|||
48776293|NCT01824303|157025947|FG000|Randomized Study|Withdrawal by Subject|1|||
48776294|NCT01824303|157025948|FG001|Randomized Study|Withdrawal by Subject|1|||
48776295|NCT01824303|157025947|FG000|Randomized Study|Other Miscellaneous Reasons|1|||
48776296|NCT01824303|157025948|FG001|Randomized Study|Other Miscellaneous Reasons|0|||
48776297|NCT03219333|157025949|FG000|Overall Study|Withdrawal by Subject|9|||
48776298|NCT03219333|157025950|FG001|Overall Study|Withdrawal by Subject|4|||
48776299|NCT03219333|157025949|FG000|Overall Study|Lost to Follow-up|1|||
48776300|NCT03219333|157025950|FG001|Overall Study|Lost to Follow-up|1|||
49027943|NCT01367457|157941108|FG001|Overall Study|Overall status worsens to grade 4|0|||
49027944|NCT01367457|157941109|FG002|Overall Study|Overall status worsens to grade 4|0|||
49027945|NCT01367457|157941107|FG000|Overall Study|Stabilisation + frequent infections|1|||
49027946|NCT01367457|157941108|FG001|Overall Study|Stabilisation + frequent infections|0|||
49027947|NCT01367457|157941109|FG002|Overall Study|Stabilisation + frequent infections|0|||
49027948|NCT01367457|157941107|FG000|Overall Study|No clinical benefit|1|||
49027949|NCT01367457|157941108|FG001|Overall Study|No clinical benefit|0|||
48776301|NCT03219333|157025949|FG000|Overall Study|Death|104|||
48776302|NCT03219333|157025950|FG001|Overall Study|Death|72|||
48776303|NCT03219333|157025949|FG000|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
48776304|NCT03219333|157025950|FG001|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
48776305|NCT03219333|157025949|FG000|Overall Study|Other|2|||
48776306|NCT03219333|157025950|FG001|Overall Study|Other|2|||
48776307|NCT01126541|157025953|FG000|Overall Study|Adverse Event|0|||
48776308|NCT01126541|157025954|FG001|Overall Study|Adverse Event|2|||
48776309|NCT01126541|157025955|FG002|Overall Study|Adverse Event|4|||
48776310|NCT01126541|157025953|FG000|Overall Study|Death|0|||
48776311|NCT01126541|157025954|FG001|Overall Study|Death|1|||
48776312|NCT01126541|157025955|FG002|Overall Study|Death|0|||
48776313|NCT01126541|157025953|FG000|Overall Study|Lack of Efficacy|6|||
48776314|NCT01126541|157025954|FG001|Overall Study|Lack of Efficacy|1|||
48776315|NCT01126541|157025955|FG002|Overall Study|Lack of Efficacy|11|||
48776316|NCT01126541|157025953|FG000|Overall Study|Lost to Follow-up|1|||
48776317|NCT01126541|157025954|FG001|Overall Study|Lost to Follow-up|2|||
48776318|NCT01126541|157025955|FG002|Overall Study|Lost to Follow-up|2|||
48776319|NCT01126541|157025953|FG000|Overall Study|Withdrawal by Subject|2|||
48776320|NCT01126541|157025954|FG001|Overall Study|Withdrawal by Subject|5|||
48776321|NCT01126541|157025955|FG002|Overall Study|Withdrawal by Subject|6|||
48776322|NCT01126541|157025953|FG000|Overall Study|Protocol Violation|0|||
48776323|NCT01126541|157025954|FG001|Overall Study|Protocol Violation|0|||
48776324|NCT01126541|157025955|FG002|Overall Study|Protocol Violation|1|||
48776325|NCT01126541|157025953|FG000|Overall Study|Administrative reason or other|1|||
48776326|NCT01126541|157025954|FG001|Overall Study|Administrative reason or other|1|||
48776327|NCT01126541|157025955|FG002|Overall Study|Administrative reason or other|2|||
49027950|NCT01367457|157941109|FG002|Overall Study|No clinical benefit|0|||
48776328|NCT02732847|157025956|FG000|Overall Study|some filled early|42|||
48776329|NCT02732847|157025957|FG001|Overall Study|some filled early|42|||
48776330|NCT02956629|157025958|FG000|Overall Study|Adverse Event|0|||
48776331|NCT02956629|157025959|FG001|Overall Study|Adverse Event|0|||
49027951|NCT01367457|157941107|FG000|Overall Study|Intestinal obstruction with necrosis|1|||
49027952|NCT01367457|157941108|FG001|Overall Study|Intestinal obstruction with necrosis|0|||
49027953|NCT01367457|157941109|FG002|Overall Study|Intestinal obstruction with necrosis|0|||
49027954|NCT01367457|157941107|FG000|Overall Study|Overall decline|1|||
49027955|NCT01367457|157941108|FG001|Overall Study|Overall decline|0|||
49027956|NCT01367457|157941109|FG002|Overall Study|Overall decline|0|||
49027957|NCT01367457|157941107|FG000|Overall Study|Rejection of treatment|1|||
49027958|NCT01367457|157941108|FG001|Overall Study|Rejection of treatment|0|||
49027959|NCT01367457|157941109|FG002|Overall Study|Rejection of treatment|0|||
49027960|NCT01367457|157941107|FG000|Overall Study|Lost to Follow-up|1|||
49027961|NCT01367457|157941108|FG001|Overall Study|Lost to Follow-up|0|||
49027962|NCT01367457|157941109|FG002|Overall Study|Lost to Follow-up|0|||
49027963|NCT01367457|157941107|FG000|Overall Study|Death from septic shock|1|||
49027964|NCT01367457|157941108|FG001|Overall Study|Death from septic shock|0|||
48776332|NCT02956629|157025960|FG002|Overall Study|Adverse Event|1|||
48776333|NCT02956629|157025961|FG003|Overall Study|Adverse Event|0|||
49027965|NCT01367457|157941109|FG002|Overall Study|Death from septic shock|0|||
49027966|NCT01367457|157941107|FG000|Overall Study|CD, Suspected disease progression (DP)|1|||
49027967|NCT01367457|157941108|FG001|Overall Study|CD, Suspected disease progression (DP)|0|||
49027968|NCT01367457|157941109|FG002|Overall Study|CD, Suspected disease progression (DP)|0|||
49027969|NCT01367457|157941107|FG000|Overall Study|Patient's Wish|1|||
49027970|NCT01367457|157941108|FG001|Overall Study|Patient's Wish|0|||
49027971|NCT01367457|157941109|FG002|Overall Study|Patient's Wish|0|||
49027972|NCT01367457|157941107|FG000|Overall Study|Palliative. Overall decline|1|||
49027973|NCT01367457|157941108|FG001|Overall Study|Palliative. Overall decline|0|||
49027974|NCT01367457|157941109|FG002|Overall Study|Palliative. Overall decline|0|||
49027975|NCT01367457|157941107|FG000|Overall Study|Suspected DP/suspected active infection|1|||
49027976|NCT01367457|157941108|FG001|Overall Study|Suspected DP/suspected active infection|0|||
49027977|NCT01367457|157941109|FG002|Overall Study|Suspected DP/suspected active infection|0|||
49027978|NCT00533273|157941115|FG000|Double-blind|Withdrew consent|0|||
49027979|NCT00533273|157941116|FG001|Double-blind|Withdrew consent|2|||
49027980|NCT00533273|157941115|FG000|Open-label|Withdrawal by Subject|6|||
49027981|NCT00533273|157941116|FG001|Open-label|Withdrawal by Subject|0|||
49027982|NCT02794974|157941119|FG000|Overall Study|Physician Decision|0|||
49027983|NCT02794974|157941120|FG001|Overall Study|Physician Decision|1|||
49027984|NCT02438722|157941121|FG000|Overall Study|Adverse Event|12|||
49027985|NCT02438722|157941122|FG001|Overall Study|Adverse Event|9|||
49027986|NCT02438722|157941121|FG000|Overall Study|Refusal unrelated to AE|2|||
49027987|NCT02438722|157941122|FG001|Overall Study|Refusal unrelated to AE|5|||
49027988|NCT02438722|157941121|FG000|Overall Study|Disease progression/relapse|46|||
49027989|NCT02438722|157941122|FG001|Overall Study|Disease progression/relapse|51|||
49027990|NCT02438722|157941121|FG000|Overall Study|Death|0|||
49027991|NCT02438722|157941122|FG001|Overall Study|Death|3|||
49027992|NCT02438722|157941121|FG000|Overall Study|Physician Decision|2|||
49027993|NCT02438722|157941122|FG001|Overall Study|Physician Decision|2|||
49027994|NCT02438722|157941121|FG000|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1|||
49027995|NCT02438722|157941122|FG001|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0|||
49027996|NCT02438722|157941121|FG000|Overall Study|Withdrawal by Subject|0|||
49027997|NCT02438722|157941122|FG001|Overall Study|Withdrawal by Subject|1|||
48776334|NCT02956629|157025962|FG004|Overall Study|Adverse Event|0|||
48776335|NCT02956629|157025963|FG005|Overall Study|Adverse Event|0|||
48776336|NCT02956629|157025958|FG000|Overall Study|Lost to Follow-up|2|||
48776337|NCT02956629|157025959|FG001|Overall Study|Lost to Follow-up|5|||
48776338|NCT02956629|157025960|FG002|Overall Study|Lost to Follow-up|3|||
48776339|NCT02956629|157025961|FG003|Overall Study|Lost to Follow-up|1|||
48776340|NCT02956629|157025962|FG004|Overall Study|Lost to Follow-up|0|||
48776341|NCT02956629|157025963|FG005|Overall Study|Lost to Follow-up|1|||
48776342|NCT02956629|157025958|FG000|Overall Study|Withdrawal by Subject|3|||
48776343|NCT02956629|157025959|FG001|Overall Study|Withdrawal by Subject|1|||
48776344|NCT02956629|157025960|FG002|Overall Study|Withdrawal by Subject|0|||
48776345|NCT02956629|157025961|FG003|Overall Study|Withdrawal by Subject|0|||
48776346|NCT02956629|157025962|FG004|Overall Study|Withdrawal by Subject|0|||
48776347|NCT02956629|157025963|FG005|Overall Study|Withdrawal by Subject|0|||
48776348|NCT00812929|157025964|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
48776349|NCT00812929|157025965|FG001|Washout Period 1 (7 Days)|Physician Decision|0|||
49027998|NCT02438722|157941121|FG000|Overall Study|On protocol treatment|15|||
49027999|NCT02438722|157941122|FG001|Overall Study|On protocol treatment|14|||
49028000|NCT02438722|157941121|FG000|Overall Study|Did not receive protocol treatment|5|||
48776350|NCT00812929|157025966|FG002|Washout Period 1 (7 Days)|Physician Decision|1|||
48776351|NCT00812929|157025967|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
48776352|NCT00812929|157025968|FG004|Washout Period 1 (7 Days)|Physician Decision|0|||
48776353|NCT00812929|157025969|FG005|Washout Period 1 (7 Days)|Physician Decision|0|||
48776354|NCT00812929|157025970|FG006|Washout Period 1 (7 Days)|Physician Decision|0|||
48776355|NCT00812929|157025971|FG007|Washout Period 1 (7 Days)|Physician Decision|0|||
48776356|NCT00812929|157025972|FG008|Washout Period 1 (7 Days)|Physician Decision|0|||
48776357|NCT00812929|157025973|FG009|Washout Period 1 (7 Days)|Physician Decision|0|||
48776358|NCT00812929|157025964|FG000|Washout Period 2 (7 Days)|Physician Decision|0|||
48776359|NCT00812929|157025965|FG001|Washout Period 2 (7 Days)|Physician Decision|0|||
48776360|NCT00812929|157025966|FG002|Washout Period 2 (7 Days)|Physician Decision|0|||
48776361|NCT00812929|157025967|FG003|Washout Period 2 (7 Days)|Physician Decision|0|||
48776362|NCT00812929|157025968|FG004|Washout Period 2 (7 Days)|Physician Decision|0|||
48776363|NCT00812929|157025969|FG005|Washout Period 2 (7 Days)|Physician Decision|0|||
48776364|NCT00812929|157025970|FG006|Washout Period 2 (7 Days)|Physician Decision|0|||
48776365|NCT00812929|157025971|FG007|Washout Period 2 (7 Days)|Physician Decision|0|||
48776366|NCT00812929|157025972|FG008|Washout Period 2 (7 Days)|Physician Decision|0|||
48776367|NCT00812929|157025973|FG009|Washout Period 2 (7 Days)|Physician Decision|1|||
48776368|NCT00812929|157025964|FG000|Washout Period 3 (7 Days)|Adverse Event|0|||
48776369|NCT00812929|157025965|FG001|Washout Period 3 (7 Days)|Adverse Event|0|||
48776370|NCT00812929|157025966|FG002|Washout Period 3 (7 Days)|Adverse Event|0|||
48776371|NCT00812929|157025967|FG003|Washout Period 3 (7 Days)|Adverse Event|0|||
48776372|NCT00812929|157025968|FG004|Washout Period 3 (7 Days)|Adverse Event|0|||
48776373|NCT00812929|157025969|FG005|Washout Period 3 (7 Days)|Adverse Event|1|||
48776374|NCT00812929|157025970|FG006|Washout Period 3 (7 Days)|Adverse Event|0|||
48776375|NCT00812929|157025971|FG007|Washout Period 3 (7 Days)|Adverse Event|0|||
48776376|NCT00812929|157025972|FG008|Washout Period 3 (7 Days)|Adverse Event|0|||
48776377|NCT00812929|157025973|FG009|Washout Period 3 (7 Days)|Adverse Event|0|||
48776378|NCT01600040|157025974|FG000|Overall Study|Withdrawal by Subject|1|||
48776379|NCT00047463|157025976|FG000|Overall Study|Withdrawal by Subject|0|||
48776380|NCT00047463|157025977|FG001|Overall Study|Withdrawal by Subject|3|||
48776381|NCT00113516|157025978|FG000|Part 1|Adverse Event|6|||
48776382|NCT00113516|157025979|FG001|Part 1|Adverse Event|0|||
48776383|NCT00113516|157025978|FG000|Part 1|Death|3|||
48776384|NCT00113516|157025979|FG001|Part 1|Death|0|||
48776385|NCT00113516|157025978|FG000|Part 1|Other|3|||
48776386|NCT00113516|157025979|FG001|Part 1|Other|0|||
48776387|NCT00113516|157025978|FG000|Part 1|Withdrawal by Subject|2|||
48776388|NCT00113516|157025979|FG001|Part 1|Withdrawal by Subject|0|||
48776389|NCT00113516|157025978|FG000|Part 1|Lack of Efficacy|2|||
48776390|NCT00113516|157025979|FG001|Part 1|Lack of Efficacy|0|||
48776391|NCT00113516|157025978|FG000|Part 1|Did Not Meet Entrance Criteria|1|||
48776392|NCT00113516|157025979|FG001|Part 1|Did Not Meet Entrance Criteria|0|||
48776393|NCT00113516|157025978|FG000|Part 1|Laboratory Abnormality|1|||
48776394|NCT00113516|157025979|FG001|Part 1|Laboratory Abnormality|0|||
48776395|NCT00113516|157025978|FG000|Part 1|Ongoing|1|||
48776396|NCT00113516|157025979|FG001|Part 1|Ongoing|0|||
48776397|NCT00113516|157025978|FG000|Part 1|Missing|65|||
48776398|NCT00113516|157025979|FG001|Part 1|Missing|0|||
48776399|NCT00113516|157025978|FG000|Part 2|Adverse Event|0|||
48776400|NCT00113516|157025979|FG001|Part 2|Adverse Event|16|||
48776401|NCT00113516|157025978|FG000|Part 2|Death|0|||
48776402|NCT00113516|157025979|FG001|Part 2|Death|5|||
48776403|NCT00113516|157025978|FG000|Part 2|Lack of Efficacy|0|||
48776404|NCT00113516|157025979|FG001|Part 2|Lack of Efficacy|37|||
48776405|NCT00113516|157025978|FG000|Part 2|Withdrawal by Subject|0|||
48776406|NCT00113516|157025979|FG001|Part 2|Withdrawal by Subject|3|||
48776407|NCT00113516|157025978|FG000|Part 2|Other|0|||
48776408|NCT00113516|157025979|FG001|Part 2|Other|3|||
48776409|NCT00113516|157025978|FG000|Part 2|Laboratory Abnormality|0|||
48776410|NCT00113516|157025979|FG001|Part 2|Laboratory Abnormality|1|||
48776411|NCT00113516|157025978|FG000|Part 2|Ongoing|0|||
48776412|NCT00113516|157025979|FG001|Part 2|Ongoing|1|||
48776413|NCT02443298|157025980|FG000|Overall Study|Adverse Event|3|||
48776414|NCT02443298|157025981|FG001|Overall Study|Adverse Event|3|||
48776415|NCT02443298|157025980|FG000|Overall Study|Withdrawal by Subject|1|||
48776416|NCT02443298|157025981|FG001|Overall Study|Withdrawal by Subject|2|||
48776417|NCT00797667|157025984|FG000|Overall Study|Lack of Efficacy|0|||
48776418|NCT00797667|157025985|FG001|Overall Study|Lack of Efficacy|1|||
48876965|NCT01165177|157388482|FG001|Overall Study|Serious Adverse Event|235|||
48776419|NCT00797667|157025986|FG002|Overall Study|Lack of Efficacy|0|||
48776420|NCT00797667|157025984|FG000|Overall Study|Lost to Follow-up|8|||
48776421|NCT00797667|157025985|FG001|Overall Study|Lost to Follow-up|12|||
48776422|NCT00797667|157025986|FG002|Overall Study|Lost to Follow-up|2|||
48776423|NCT00797667|157025984|FG000|Overall Study|Physician Decision|3|||
48776424|NCT00797667|157025985|FG001|Overall Study|Physician Decision|1|||
48776425|NCT00797667|157025986|FG002|Overall Study|Physician Decision|0|||
48776426|NCT00797667|157025984|FG000|Overall Study|Pregnancy|2|||
48776427|NCT00797667|157025985|FG001|Overall Study|Pregnancy|0|||
48776428|NCT00797667|157025986|FG002|Overall Study|Pregnancy|0|||
48776429|NCT00797667|157025984|FG000|Overall Study|Protocol Violation|2|||
48776430|NCT00797667|157025985|FG001|Overall Study|Protocol Violation|7|||
48776431|NCT00797667|157025986|FG002|Overall Study|Protocol Violation|0|||
49028001|NCT02438722|157941122|FG001|Overall Study|Did not receive protocol treatment|0|||
49028002|NCT02202850|157941127|FG000|Overall Study|Other|2|||
49028003|NCT02202850|157941128|FG001|Overall Study|Other|2|||
49028004|NCT02202850|157941127|FG000|Overall Study|Enbrel treatment discontinued|15|||
49028005|NCT02202850|157941128|FG001|Overall Study|Enbrel treatment discontinued|3|||
49028006|NCT02202850|157941127|FG000|Overall Study|Lost to Follow-up|7|||
49028007|NCT02202850|157941128|FG001|Overall Study|Lost to Follow-up|1|||
49028008|NCT02761057|157941129|FG000|Overall Study|Ineligible - No Measurable Disease|1|||
49028009|NCT02761057|157941130|FG001|Overall Study|Ineligible - No Measurable Disease|1|||
49028010|NCT02761057|157941131|FG002|Overall Study|Ineligible - No Measurable Disease|0|||
49028011|NCT02761057|157941132|FG003|Overall Study|Ineligible - No Measurable Disease|1|||
49028012|NCT02761057|157941129|FG000|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
49028013|NCT02761057|157941130|FG001|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
49028014|NCT02761057|157941131|FG002|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
49028015|NCT02761057|157941132|FG003|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
49028016|NCT02761057|157941129|FG000|Overall Study|Currently On Study Treatment|0|||
49028017|NCT02761057|157941130|FG001|Overall Study|Currently On Study Treatment|3|||
49028018|NCT02761057|157941131|FG002|Overall Study|Currently On Study Treatment|0|||
49028019|NCT02761057|157941132|FG003|Overall Study|Currently On Study Treatment|0|||
49028020|NCT02761057|157941129|FG000|Overall Study|Adverse Event|11|||
49028021|NCT02761057|157941130|FG001|Overall Study|Adverse Event|9|||
49028022|NCT02761057|157941131|FG002|Overall Study|Adverse Event|5|||
49028023|NCT02761057|157941132|FG003|Overall Study|Adverse Event|3|||
49028024|NCT02761057|157941129|FG000|Overall Study|Refusal Unrelated to Adverse Event|2|||
49028025|NCT02761057|157941130|FG001|Overall Study|Refusal Unrelated to Adverse Event|2|||
49028026|NCT02761057|157941131|FG002|Overall Study|Refusal Unrelated to Adverse Event|0|||
49028027|NCT02761057|157941132|FG003|Overall Study|Refusal Unrelated to Adverse Event|2|||
49028028|NCT02761057|157941129|FG000|Overall Study|Progression/Relapse|29|||
49028029|NCT02761057|157941130|FG001|Overall Study|Progression/Relapse|27|||
49028030|NCT02761057|157941131|FG002|Overall Study|Progression/Relapse|20|||
49028031|NCT02761057|157941132|FG003|Overall Study|Progression/Relapse|23|||
49028032|NCT02761057|157941129|FG000|Overall Study|Death|2|||
49028033|NCT02761057|157941130|FG001|Overall Study|Death|2|||
49028034|NCT02761057|157941131|FG002|Overall Study|Death|1|||
49028035|NCT02761057|157941132|FG003|Overall Study|Death|1|||
49028036|NCT02761057|157941129|FG000|Overall Study|Other - Not Protocol Specified|2|||
49028037|NCT02761057|157941130|FG001|Overall Study|Other - Not Protocol Specified|1|||
49028038|NCT02761057|157941131|FG002|Overall Study|Other - Not Protocol Specified|2|||
49028039|NCT02761057|157941132|FG003|Overall Study|Other - Not Protocol Specified|0|||
49028040|NCT03854227|157941133|FG000|Overall Study|Adverse Event|0|||
49028041|NCT03854227|157941134|FG001|Overall Study|Adverse Event|0|||
49028042|NCT03854227|157941135|FG002|Overall Study|Adverse Event|0|||
49028043|NCT03854227|157941136|FG003|Overall Study|Adverse Event|1|||
49028044|NCT03854227|157941137|FG004|Overall Study|Adverse Event|0|||
49028045|NCT03854227|157941138|FG005|Overall Study|Adverse Event|0|||
49028046|NCT03854227|157941139|FG006|Overall Study|Adverse Event|1|||
49028047|NCT03854227|157941140|FG007|Overall Study|Adverse Event|0|||
49028048|NCT03854227|157941141|FG008|Overall Study|Adverse Event|0|||
49028049|NCT03854227|157941142|FG009|Overall Study|Adverse Event|3|||
49028050|NCT03854227|157941143|FG010|Overall Study|Adverse Event|0|||
49028051|NCT03854227|157941144|FG011|Overall Study|Adverse Event|1|||
49028052|NCT03854227|157941133|FG000|Overall Study|Death|0|||
49028053|NCT03854227|157941134|FG001|Overall Study|Death|0|||
49028054|NCT03854227|157941135|FG002|Overall Study|Death|0|||
49028055|NCT03854227|157941136|FG003|Overall Study|Death|0|||
49028056|NCT03854227|157941137|FG004|Overall Study|Death|0|||
49028057|NCT03854227|157941138|FG005|Overall Study|Death|1|||
49028058|NCT03854227|157941139|FG006|Overall Study|Death|0|||
49028059|NCT03854227|157941140|FG007|Overall Study|Death|0|||
49028060|NCT03854227|157941141|FG008|Overall Study|Death|0|||
49028061|NCT03854227|157941142|FG009|Overall Study|Death|1|||
49028062|NCT03854227|157941143|FG010|Overall Study|Death|0|||
49028063|NCT03854227|157941144|FG011|Overall Study|Death|1|||
49028064|NCT03854227|157941133|FG000|Overall Study|Physician Decision|0|||
49028065|NCT03854227|157941134|FG001|Overall Study|Physician Decision|0|||
49028066|NCT03854227|157941135|FG002|Overall Study|Physician Decision|0|||
49028067|NCT03854227|157941136|FG003|Overall Study|Physician Decision|0|||
49028068|NCT03854227|157941137|FG004|Overall Study|Physician Decision|0|||
49028069|NCT03854227|157941138|FG005|Overall Study|Physician Decision|1|||
49028070|NCT03854227|157941139|FG006|Overall Study|Physician Decision|0|||
49028071|NCT03854227|157941140|FG007|Overall Study|Physician Decision|0|||
49028072|NCT03854227|157941141|FG008|Overall Study|Physician Decision|1|||
49028073|NCT03854227|157941142|FG009|Overall Study|Physician Decision|1|||
49028074|NCT03854227|157941143|FG010|Overall Study|Physician Decision|0|||
49028075|NCT03854227|157941144|FG011|Overall Study|Physician Decision|1|||
49028076|NCT03854227|157941133|FG000|Overall Study|Progressive disease|1|||
49028077|NCT03854227|157941134|FG001|Overall Study|Progressive disease|1|||
49028078|NCT03854227|157941135|FG002|Overall Study|Progressive disease|1|||
48776432|NCT00797667|157025984|FG000|Overall Study|Study Terminated by Sponsor|217|||
48776433|NCT00797667|157025985|FG001|Overall Study|Study Terminated by Sponsor|216|||
48776434|NCT00797667|157025986|FG002|Overall Study|Study Terminated by Sponsor|115|||
48776435|NCT00797667|157025984|FG000|Overall Study|Withdrawal by Subject|9|||
48776436|NCT00797667|157025985|FG001|Overall Study|Withdrawal by Subject|14|||
48776437|NCT00797667|157025986|FG002|Overall Study|Withdrawal by Subject|2|||
48776438|NCT00797667|157025984|FG000|Overall Study|Adverse Event|19|||
48776439|NCT00797667|157025985|FG001|Overall Study|Adverse Event|8|||
48776440|NCT00797667|157025986|FG002|Overall Study|Adverse Event|8|||
48776441|NCT03732248|157025991|FG000|Overall Study|Withdrawal by Subject|1|||
48776442|NCT03732248|157025992|FG001|Overall Study|Withdrawal by Subject|0|||
48776443|NCT04796610|157025993|FG000|Overall Study|Withdrawal by Subject|1|||
48776444|NCT04796610|157025994|FG001|Overall Study|Withdrawal by Subject|0|||
48776445|NCT04796610|157025995|FG002|Overall Study|Withdrawal by Subject|0|||
48776446|NCT04796610|157025996|FG003|Overall Study|Withdrawal by Subject|0|||
48776447|NCT04796610|157025993|FG000|Overall Study|Lost to Follow-up|2|||
48776448|NCT04796610|157025994|FG001|Overall Study|Lost to Follow-up|0|||
48776449|NCT04796610|157025995|FG002|Overall Study|Lost to Follow-up|1|||
48776450|NCT04796610|157025996|FG003|Overall Study|Lost to Follow-up|1|||
48776451|NCT01599650|157025997|FG000|Overall Study|Administrative issue|1|||
48776452|NCT01599650|157025998|FG001|Overall Study|Administrative issue|0|||
48776453|NCT01599650|157025999|FG002|Overall Study|Administrative issue|1|||
48776454|NCT01599650|157025997|FG000|Overall Study|Physician Decision|2|||
48776455|NCT01599650|157025998|FG001|Overall Study|Physician Decision|0|||
48776456|NCT01599650|157025999|FG002|Overall Study|Physician Decision|7|||
48776457|NCT01599650|157025997|FG000|Overall Study|Protocol Violation|0|||
48776458|NCT01599650|157025998|FG001|Overall Study|Protocol Violation|3|||
48776459|NCT01599650|157025999|FG002|Overall Study|Protocol Violation|0|||
48776460|NCT01599650|157025997|FG000|Overall Study|Death|2|||
48776461|NCT01599650|157025998|FG001|Overall Study|Death|1|||
48776462|NCT01599650|157025999|FG002|Overall Study|Death|2|||
48776463|NCT01599650|157025997|FG000|Overall Study|Lost to Follow-up|3|||
48776464|NCT01599650|157025998|FG001|Overall Study|Lost to Follow-up|3|||
48776465|NCT01599650|157025999|FG002|Overall Study|Lost to Follow-up|3|||
48776466|NCT01599650|157025997|FG000|Overall Study|Withdrawal by Subject|11|||
48776467|NCT01599650|157025998|FG001|Overall Study|Withdrawal by Subject|11|||
48776468|NCT01599650|157025999|FG002|Overall Study|Withdrawal by Subject|10|||
48776469|NCT01599650|157025997|FG000|Overall Study|Adverse Event|3|||
48776470|NCT01599650|157025998|FG001|Overall Study|Adverse Event|8|||
48776471|NCT01599650|157025999|FG002|Overall Study|Adverse Event|4|||
48776472|NCT01243944|157026000|FG000|Overall Study|Adverse Event|15|||
48776473|NCT01243944|157026001|FG001|Overall Study|Adverse Event|13|||
48776474|NCT01243944|157026000|FG000|Overall Study|Lost to Follow-up|2|||
48776475|NCT01243944|157026001|FG001|Overall Study|Lost to Follow-up|1|||
48776476|NCT01243944|157026000|FG000|Overall Study|Physician Decision|2|||
48776477|NCT01243944|157026001|FG001|Overall Study|Physician Decision|7|||
48776478|NCT01243944|157026000|FG000|Overall Study|Disease progression|12|||
48776479|NCT01243944|157026001|FG001|Overall Study|Disease progression|11|||
48776480|NCT01243944|157026000|FG000|Overall Study|Protocol deviation|1|||
48776481|NCT01243944|157026001|FG001|Overall Study|Protocol deviation|1|||
48776482|NCT01243944|157026000|FG000|Overall Study|Participant decision|10|||
48776483|NCT01243944|157026001|FG001|Overall Study|Participant decision|15|||
48776484|NCT01243944|157026000|FG000|Overall Study|Death|2|||
48776485|NCT01243944|157026001|FG001|Overall Study|Death|3|||
48776486|NCT01243944|157026000|FG000|Overall Study|Non-compliance with study treatment|1|||
48776487|NCT01243944|157026001|FG001|Overall Study|Non-compliance with study treatment|0|||
48776488|NCT03323099|157026007|FG000|Overall Study|Withdrawal by Subject|6|||
48776489|NCT03323099|157026008|FG001|Overall Study|Withdrawal by Subject|12|||
48776490|NCT03323099|157026007|FG000|Overall Study|Did not complete AFEQT, or failed to start the study period|109|||
48776491|NCT03323099|157026008|FG001|Overall Study|Did not complete AFEQT, or failed to start the study period|52|||
48776492|NCT03495908|157026013|FG000|Overall Study|Withdrawal by Subject|3|||
48776493|NCT03495908|157026014|FG001|Overall Study|Withdrawal by Subject|1|||
48776494|NCT03495908|157026013|FG000|Overall Study|Lost to Follow-up|1|||
49028079|NCT03854227|157941136|FG003|Overall Study|Progressive disease|2|||
48776495|NCT03495908|157026014|FG001|Overall Study|Lost to Follow-up|4|||
48776496|NCT03495908|157026013|FG000|Overall Study|Adverse Event|0|||
48776497|NCT03495908|157026014|FG001|Overall Study|Adverse Event|2|||
48776498|NCT03495908|157026013|FG000|Overall Study|Death|1|||
48776499|NCT03495908|157026014|FG001|Overall Study|Death|0|||
48776500|NCT03495908|157026013|FG000|Overall Study|Physician Decision|5|||
48776501|NCT03495908|157026014|FG001|Overall Study|Physician Decision|4|||
48776502|NCT03495908|157026013|FG000|Overall Study|No documented reason|0|||
48776503|NCT03495908|157026014|FG001|Overall Study|No documented reason|2|||
48776504|NCT00413413|157026015|FG000|Single-Blind|Adverse Event|0|||
48776505|NCT00413413|157026016|FG001|Single-Blind|Adverse Event|9|||
48776506|NCT00413413|157026017|FG002|Single-Blind|Adverse Event|0|||
48776507|NCT00413413|157026015|FG000|Single-Blind|Lack of Efficacy|0|||
48776508|NCT00413413|157026016|FG001|Single-Blind|Lack of Efficacy|5|||
48776509|NCT00413413|157026017|FG002|Single-Blind|Lack of Efficacy|0|||
49028080|NCT03854227|157941137|FG004|Overall Study|Progressive disease|3|||
49028081|NCT03854227|157941138|FG005|Overall Study|Progressive disease|1|||
49028082|NCT03854227|157941139|FG006|Overall Study|Progressive disease|2|||
49028083|NCT03854227|157941140|FG007|Overall Study|Progressive disease|5|||
49028084|NCT03854227|157941141|FG008|Overall Study|Progressive disease|2|||
49028085|NCT03854227|157941142|FG009|Overall Study|Progressive disease|5|||
49028086|NCT03854227|157941143|FG010|Overall Study|Progressive disease|1|||
49028087|NCT03854227|157941144|FG011|Overall Study|Progressive disease|6|||
49028088|NCT03854227|157941133|FG000|Overall Study|Study terminated by sponsor|0|||
49028089|NCT03854227|157941134|FG001|Overall Study|Study terminated by sponsor|0|||
49028090|NCT03854227|157941135|FG002|Overall Study|Study terminated by sponsor|0|||
49028091|NCT03854227|157941136|FG003|Overall Study|Study terminated by sponsor|0|||
49028092|NCT03854227|157941137|FG004|Overall Study|Study terminated by sponsor|0|||
49028093|NCT03854227|157941138|FG005|Overall Study|Study terminated by sponsor|0|||
49028094|NCT03854227|157941139|FG006|Overall Study|Study terminated by sponsor|0|||
49028095|NCT03854227|157941140|FG007|Overall Study|Study terminated by sponsor|0|||
49028096|NCT03854227|157941141|FG008|Overall Study|Study terminated by sponsor|0|||
49028097|NCT03854227|157941142|FG009|Overall Study|Study terminated by sponsor|1|||
48776510|NCT00413413|157026015|FG000|Single-Blind|Subject no longer requires study drug|0|||
48776511|NCT00413413|157026016|FG001|Single-Blind|Subject no longer requires study drug|151|||
48776512|NCT00413413|157026017|FG002|Single-Blind|Subject no longer requires study drug|0|||
48776513|NCT00413413|157026015|FG000|Single-Blind|Protocol Violation|0|||
48776514|NCT00413413|157026016|FG001|Single-Blind|Protocol Violation|16|||
49028098|NCT03854227|157941143|FG010|Overall Study|Study terminated by sponsor|0|||
49028099|NCT03854227|157941144|FG011|Overall Study|Study terminated by sponsor|0|||
49028100|NCT03854227|157941133|FG000|Overall Study|Withdrawal by Subject|0|||
49028101|NCT03854227|157941134|FG001|Overall Study|Withdrawal by Subject|0|||
49028102|NCT03854227|157941135|FG002|Overall Study|Withdrawal by Subject|1|||
49028103|NCT03854227|157941136|FG003|Overall Study|Withdrawal by Subject|0|||
49028104|NCT03854227|157941137|FG004|Overall Study|Withdrawal by Subject|0|||
49028105|NCT03854227|157941138|FG005|Overall Study|Withdrawal by Subject|0|||
49028106|NCT03854227|157941139|FG006|Overall Study|Withdrawal by Subject|0|||
49028107|NCT03854227|157941140|FG007|Overall Study|Withdrawal by Subject|0|||
49028108|NCT03854227|157941141|FG008|Overall Study|Withdrawal by Subject|0|||
49028109|NCT03854227|157941142|FG009|Overall Study|Withdrawal by Subject|1|||
49028110|NCT03854227|157941143|FG010|Overall Study|Withdrawal by Subject|1|||
48776515|NCT00413413|157026017|FG002|Single-Blind|Protocol Violation|0|||
48776516|NCT00413413|157026015|FG000|Single-Blind|Withdrawal by Subject|0|||
48776517|NCT00413413|157026016|FG001|Single-Blind|Withdrawal by Subject|27|||
48776518|NCT00413413|157026017|FG002|Single-Blind|Withdrawal by Subject|0|||
48776519|NCT00413413|157026015|FG000|Single-Blind|Lost to Follow-up|0|||
48776520|NCT00413413|157026016|FG001|Single-Blind|Lost to Follow-up|8|||
48776521|NCT00413413|157026017|FG002|Single-Blind|Lost to Follow-up|0|||
48776522|NCT00413413|157026015|FG000|Double-Blind|Adverse Event|6|||
48776523|NCT00413413|157026016|FG001|Double-Blind|Adverse Event|0|||
48776524|NCT00413413|157026017|FG002|Double-Blind|Adverse Event|5|||
48776525|NCT00413413|157026015|FG000|Double-Blind|Unsatisfactory therapeutic effect|1|||
48776526|NCT00413413|157026016|FG001|Double-Blind|Unsatisfactory therapeutic effect|2|||
48776527|NCT00413413|157026017|FG002|Double-Blind|Unsatisfactory therapeutic effect|1|||
48776528|NCT00413413|157026015|FG000|Double-Blind|Protocol deviation|1|||
48776529|NCT00413413|157026016|FG001|Double-Blind|Protocol deviation|2|||
48776530|NCT00413413|157026017|FG002|Double-Blind|Protocol deviation|1|||
48776531|NCT00413413|157026015|FG000|Double-Blind|Subject withdrew consent|4|||
48776532|NCT00413413|157026016|FG001|Double-Blind|Subject withdrew consent|6|||
48776533|NCT00413413|157026017|FG002|Double-Blind|Subject withdrew consent|9|||
48776534|NCT00413413|157026015|FG000|Double-Blind|Lost to Follow-up|3|||
48776535|NCT00413413|157026016|FG001|Double-Blind|Lost to Follow-up|4|||
48776536|NCT00413413|157026017|FG002|Double-Blind|Lost to Follow-up|2|||
48776537|NCT01410110|157026018|FG000|Overall Study|Withdrawal by Subject|4|||
48776538|NCT01410110|157026019|FG001|Overall Study|Withdrawal by Subject|2|||
48776539|NCT01416805|157026022|FG000|Overall Study|Lost to Follow-up|4|||
48776540|NCT01416805|157026023|FG001|Overall Study|Lost to Follow-up|4|||
48776541|NCT01732835|157026031|FG000|6-month Primary Endpoint|Did not receive device|19|||
48776542|NCT01732835|157026031|FG000|6-month Primary Endpoint|Withdrawal by Subject|2|||
48776543|NCT01732835|157026031|FG000|6-month Primary Endpoint|Adverse Event|3|||
48776544|NCT01732835|157026031|FG000|2-year Extended Follow-up|Withdrawal by Subject|1|||
48776545|NCT01732835|157026031|FG000|2-year Extended Follow-up|Adverse Event|3|||
48776546|NCT01732835|157026031|FG000|2-year Extended Follow-up|Death|1|||
48776547|NCT02334748|157026032|FG000|Overall Study|Adverse Event|1|||
48776548|NCT02334748|157026032|FG000|Overall Study|Inclusion in the CACZ8852306 study|1|||
48776549|NCT02334748|157026032|FG000|Overall Study|Patient no longer required study drug|2|||
49028111|NCT03854227|157941144|FG011|Overall Study|Withdrawal by Subject|0|||
49028112|NCT03854227|157941133|FG000|Overall Study|Disease relapse|0|||
48776550|NCT02334748|157026032|FG000|Overall Study|Lack of Efficacy|4|||
49028113|NCT03854227|157941134|FG001|Overall Study|Disease relapse|0|||
49028114|NCT03854227|157941135|FG002|Overall Study|Disease relapse|0|||
48776551|NCT02604589|157026035|FG000|Overall Study|catheter dislodgement|0|||
48776552|NCT02604589|157026036|FG001|Overall Study|catheter dislodgement|0|||
48776553|NCT02604589|157026037|FG002|Overall Study|catheter dislodgement|1|||
48776554|NCT05061446|157026042|FG000|Overall Study|Adverse Event|2|||
48776555|NCT05061446|157026043|FG001|Overall Study|Adverse Event|0|||
48776556|NCT05061446|157026044|FG002|Overall Study|Adverse Event|0|||
48776557|NCT05061446|157026042|FG000|Overall Study|Participant no longer available due to personal reason|0|||
48776558|NCT05061446|157026043|FG001|Overall Study|Participant no longer available due to personal reason|1|||
48776559|NCT05061446|157026044|FG002|Overall Study|Participant no longer available due to personal reason|0|||
48776560|NCT04111497|157026045|FG000|Overall Study|relapse of primary disease|1|||
48776561|NCT04111497|157026045|FG000|Overall Study|toxicity and/or lack of efficacy|13|||
48776562|NCT01767116|157026056|FG000|Overall Study|Lost to Follow-up|2|||
48776563|NCT01767116|157026057|FG001|Overall Study|Lost to Follow-up|2|||
48776564|NCT02209324|157026062|FG000|Overall Study|Adverse Event|2|||
48776565|NCT02209324|157026062|FG000|Overall Study|Lack of Efficacy|1|||
48776566|NCT02209324|157026062|FG000|Overall Study|Lost to Follow-up|1|||
48776567|NCT02209324|157026062|FG000|Overall Study|Physician Decision|3|||
48776568|NCT02209324|157026062|FG000|Overall Study|Protocol Violation|14|||
48776569|NCT02209324|157026062|FG000|Overall Study|Withdrawal by Subject|8|||
48776570|NCT02209324|157026062|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|4|||
48776571|NCT02209324|157026062|FG000|Overall Study|Platelet count < LLN in Laboratory test|7|||
48776572|NCT02209324|157026062|FG000|Overall Study|QT interval >-450 ms on measurement of an ECG|5|||
48776573|NCT03511560|157026064|FG000|Overall Study|Death|0|||
48776574|NCT03511560|157026065|FG001|Overall Study|Death|1|||
48776575|NCT03511560|157026064|FG000|Overall Study|Adverse Event|0|||
48776576|NCT03511560|157026065|FG001|Overall Study|Adverse Event|2|||
48776577|NCT03511560|157026064|FG000|Overall Study|Transplant cancelled|0|||
48776578|NCT03511560|157026065|FG001|Overall Study|Transplant cancelled|1|||
48776579|NCT03511560|157026064|FG000|Overall Study|Patient switched to another drug|1|||
48776580|NCT03511560|157026065|FG001|Overall Study|Patient switched to another drug|0|||
48776581|NCT04496258|157026070|FG000|Overall Study|Withdrawal by Subject|2|||
48776582|NCT04496258|157026071|FG001|Overall Study|Withdrawal by Subject|1|||
48776583|NCT02985736|157026072|FG000|Overall Study|Lost to Follow-up|3|||
48776584|NCT03049813|157026073|FG000|Randomized Control Trial Phase|Participant placed in nursing home|0|||
48776585|NCT03049813|157026074|FG001|Randomized Control Trial Phase|Participant placed in nursing home|1|||
48776586|NCT03049813|157026075|FG002|Randomized Control Trial Phase|Participant placed in nursing home|0|||
48776587|NCT03049813|157026076|FG003|Randomized Control Trial Phase|Participant placed in nursing home|0|||
48776588|NCT03049813|157026073|FG000|Randomized Control Trial Phase|COVID Quarantine|2|||
48776589|NCT03049813|157026074|FG001|Randomized Control Trial Phase|COVID Quarantine|3|||
48776590|NCT03049813|157026075|FG002|Randomized Control Trial Phase|COVID Quarantine|0|||
48776591|NCT03049813|157026076|FG003|Randomized Control Trial Phase|COVID Quarantine|0|||
48776592|NCT03049813|157026073|FG000|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
48776593|NCT03049813|157026074|FG001|Randomized Control Trial Phase|Participant was in another concurrent study|1|||
48776594|NCT03049813|157026075|FG002|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
48776595|NCT03049813|157026076|FG003|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
48776596|NCT03049813|157026073|FG000|Randomized Control Trial Phase|Lost to Follow-up|0|||
48776597|NCT03049813|157026074|FG001|Randomized Control Trial Phase|Lost to Follow-up|2|||
48776598|NCT03049813|157026075|FG002|Randomized Control Trial Phase|Lost to Follow-up|3|||
48776599|NCT03049813|157026076|FG003|Randomized Control Trial Phase|Lost to Follow-up|0|||
48776600|NCT01813019|157026077|FG000|Overall Study|Adverse Event|0|||
48776601|NCT01813019|157026078|FG001|Overall Study|Adverse Event|3|||
48776602|NCT01813019|157026077|FG000|Overall Study|Withdrawal by Subject|3|||
48776603|NCT01813019|157026078|FG001|Overall Study|Withdrawal by Subject|2|||
48776604|NCT01813019|157026077|FG000|Overall Study|administrative problems|2|||
48776605|NCT01813019|157026078|FG001|Overall Study|administrative problems|0|||
48776606|NCT01813019|157026077|FG000|Overall Study|Protocol Deviation|2|||
48776607|NCT01813019|157026078|FG001|Overall Study|Protocol Deviation|1|||
48776608|NCT03169153|157026081|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
48776609|NCT03169153|157026082|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
48776610|NCT03169153|157026081|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|2|||
48776611|NCT03169153|157026082|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|3|||
48776612|NCT03169153|157026081|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
48776613|NCT03169153|157026082|FG001|Period 2, Second 30 Days of Wear|Adverse Event|2|||
48776614|NCT03169153|157026081|FG000|Period 2, Second 30 Days of Wear|Could not attend visit|1|||
48982572|NCT01970540|157767637|FG002|Overall Study|Progressive disease|10|||
48982573|NCT01970540|157767635|FG000|Overall Study|Treatment delay over protocol|0|||
48982574|NCT01970540|157767636|FG001|Overall Study|Treatment delay over protocol|0|||
48982575|NCT01970540|157767637|FG002|Overall Study|Treatment delay over protocol|1|||
48982576|NCT01970540|157767635|FG000|Overall Study|Physician Decision|7|||
48982577|NCT01970540|157767636|FG001|Overall Study|Physician Decision|2|||
48982578|NCT01970540|157767637|FG002|Overall Study|Physician Decision|0|||
48776615|NCT03169153|157026082|FG001|Period 2, Second 30 Days of Wear|Could not attend visit|0|||
48776616|NCT00622635|157026083|FG000|Treatment Period 1|Adverse Event|0|||
48776617|NCT00622635|157026084|FG001|Treatment Period 1|Adverse Event|0|||
48776618|NCT00622635|157026085|FG002|Treatment Period 1|Adverse Event|1|||
48776619|NCT00622635|157026086|FG003|Treatment Period 1|Adverse Event|0|||
48776620|NCT00622635|157026087|FG004|Treatment Period 1|Adverse Event|0|||
48776621|NCT00622635|157026088|FG005|Treatment Period 1|Adverse Event|0|||
48776622|NCT00622635|157026083|FG000|Treatment Period 1|Withdrawal by Subject|0|||
48776623|NCT00622635|157026084|FG001|Treatment Period 1|Withdrawal by Subject|1|||
48776624|NCT00622635|157026085|FG002|Treatment Period 1|Withdrawal by Subject|0|||
48776625|NCT00622635|157026086|FG003|Treatment Period 1|Withdrawal by Subject|0|||
48776626|NCT00622635|157026087|FG004|Treatment Period 1|Withdrawal by Subject|0|||
48776627|NCT00622635|157026088|FG005|Treatment Period 1|Withdrawal by Subject|0|||
48776628|NCT00622635|157026083|FG000|Treatment Period 1|Abnormal test procedure result(s)|0|||
48776629|NCT00622635|157026084|FG001|Treatment Period 1|Abnormal test procedure result(s)|0|||
48776630|NCT00622635|157026085|FG002|Treatment Period 1|Abnormal test procedure result(s)|0|||
48776631|NCT00622635|157026086|FG003|Treatment Period 1|Abnormal test procedure result(s)|0|||
48776632|NCT00622635|157026087|FG004|Treatment Period 1|Abnormal test procedure result(s)|1|||
48776633|NCT00622635|157026088|FG005|Treatment Period 1|Abnormal test procedure result(s)|0|||
48776634|NCT00622635|157026083|FG000|Treatment Period 2|Adverse Event|1|||
48776635|NCT00622635|157026084|FG001|Treatment Period 2|Adverse Event|0|||
48776636|NCT00622635|157026085|FG002|Treatment Period 2|Adverse Event|0|||
48776637|NCT00622635|157026086|FG003|Treatment Period 2|Adverse Event|0|||
48776638|NCT00622635|157026087|FG004|Treatment Period 2|Adverse Event|0|||
48776639|NCT00622635|157026088|FG005|Treatment Period 2|Adverse Event|0|||
48776640|NCT00622635|157026083|FG000|Treatment Period 3|Adverse Event|0|||
48776641|NCT00622635|157026084|FG001|Treatment Period 3|Adverse Event|0|||
48776642|NCT00622635|157026085|FG002|Treatment Period 3|Adverse Event|0|||
48776643|NCT00622635|157026086|FG003|Treatment Period 3|Adverse Event|2|||
48776644|NCT00622635|157026087|FG004|Treatment Period 3|Adverse Event|0|||
48776645|NCT00622635|157026088|FG005|Treatment Period 3|Adverse Event|0|||
48776646|NCT00622635|157026083|FG000|Treatment Period 3|Withdrawal by Subject|0|||
48776647|NCT00622635|157026084|FG001|Treatment Period 3|Withdrawal by Subject|0|||
48776648|NCT00622635|157026085|FG002|Treatment Period 3|Withdrawal by Subject|0|||
48776649|NCT00622635|157026086|FG003|Treatment Period 3|Withdrawal by Subject|1|||
48776650|NCT00622635|157026087|FG004|Treatment Period 3|Withdrawal by Subject|0|||
48776651|NCT00622635|157026088|FG005|Treatment Period 3|Withdrawal by Subject|0|||
48776652|NCT03120013|157026089|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
48776653|NCT03120013|157026090|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
48776654|NCT03286140|157026091|FG000|Overall Study|Withdrawal by Subject|10|||
48776655|NCT03286140|157026092|FG001|Overall Study|Withdrawal by Subject|5|||
48776656|NCT03286140|157026091|FG000|Overall Study|Lost to Follow-up|5|||
48776657|NCT03286140|157026092|FG001|Overall Study|Lost to Follow-up|10|||
48776658|NCT03286140|157026091|FG000|Overall Study|Failure to comply|0|||
48776659|NCT03286140|157026092|FG001|Overall Study|Failure to comply|1|||
48776660|NCT04382612|157026102|FG000|Overall Study|Screen failure - no attempt to use the device|1|||
48776661|NCT00718718|157026103|FG000|Prior to Week 12|Adverse Event|0|||
48776662|NCT00718718|157026104|FG001|Prior to Week 12|Adverse Event|0|||
48776663|NCT00718718|157026105|FG002|Prior to Week 12|Adverse Event|0|||
48776664|NCT00718718|157026106|FG003|Prior to Week 12|Adverse Event|0|||
48776665|NCT00718718|157026107|FG004|Prior to Week 12|Adverse Event|0|||
48776666|NCT00718718|157026108|FG005|Prior to Week 12|Adverse Event|0|||
48776667|NCT00718718|157026109|FG006|Prior to Week 12|Adverse Event|0|||
48776668|NCT00718718|157026110|FG007|Prior to Week 12|Adverse Event|1|||
48776669|NCT00718718|157026111|FG008|Prior to Week 12|Adverse Event|1|||
48776670|NCT00718718|157026112|FG009|Prior to Week 12|Adverse Event|0|||
48776671|NCT00718718|157026103|FG000|Prior to Week 12|Withdrawal by Subject|0|||
48776672|NCT00718718|157026104|FG001|Prior to Week 12|Withdrawal by Subject|0|||
48776673|NCT00718718|157026105|FG002|Prior to Week 12|Withdrawal by Subject|0|||
48776674|NCT00718718|157026106|FG003|Prior to Week 12|Withdrawal by Subject|0|||
48776675|NCT00718718|157026107|FG004|Prior to Week 12|Withdrawal by Subject|3|||
48776676|NCT00718718|157026108|FG005|Prior to Week 12|Withdrawal by Subject|0|||
48776677|NCT00718718|157026109|FG006|Prior to Week 12|Withdrawal by Subject|1|||
48776678|NCT00718718|157026110|FG007|Prior to Week 12|Withdrawal by Subject|1|||
48776679|NCT00718718|157026111|FG008|Prior to Week 12|Withdrawal by Subject|1|||
48776680|NCT00718718|157026112|FG009|Prior to Week 12|Withdrawal by Subject|0|||
48776681|NCT00718718|157026103|FG000|Prior to Week 12|Other|1|||
48776682|NCT00718718|157026104|FG001|Prior to Week 12|Other|0|||
48776683|NCT00718718|157026105|FG002|Prior to Week 12|Other|1|||
48776684|NCT00718718|157026106|FG003|Prior to Week 12|Other|0|||
48776685|NCT00718718|157026107|FG004|Prior to Week 12|Other|0|||
48776686|NCT00718718|157026108|FG005|Prior to Week 12|Other|0|||
48776687|NCT00718718|157026109|FG006|Prior to Week 12|Other|0|||
48776688|NCT00718718|157026110|FG007|Prior to Week 12|Other|0|||
48776689|NCT00718718|157026111|FG008|Prior to Week 12|Other|0|||
48776690|NCT00718718|157026112|FG009|Prior to Week 12|Other|0|||
48776691|NCT00718718|157026103|FG000|Week 12 to End of Study|Adverse Event|0|||
49028115|NCT03854227|157941136|FG003|Overall Study|Disease relapse|0|||
48776692|NCT00718718|157026104|FG001|Week 12 to End of Study|Adverse Event|0|||
48776693|NCT00718718|157026105|FG002|Week 12 to End of Study|Adverse Event|0|||
48776694|NCT00718718|157026106|FG003|Week 12 to End of Study|Adverse Event|0|||
48776695|NCT00718718|157026107|FG004|Week 12 to End of Study|Adverse Event|0|||
48776696|NCT00718718|157026108|FG005|Week 12 to End of Study|Adverse Event|0|||
48776697|NCT00718718|157026109|FG006|Week 12 to End of Study|Adverse Event|0|||
48776698|NCT00718718|157026110|FG007|Week 12 to End of Study|Adverse Event|1|||
48776699|NCT00718718|157026111|FG008|Week 12 to End of Study|Adverse Event|0|||
48776700|NCT00718718|157026112|FG009|Week 12 to End of Study|Adverse Event|0|||
48776701|NCT00718718|157026103|FG000|Week 12 to End of Study|Death|0|||
48776702|NCT00718718|157026104|FG001|Week 12 to End of Study|Death|0|||
48776703|NCT00718718|157026105|FG002|Week 12 to End of Study|Death|0|||
48776704|NCT00718718|157026106|FG003|Week 12 to End of Study|Death|0|||
48776705|NCT00718718|157026107|FG004|Week 12 to End of Study|Death|0|||
48776706|NCT00718718|157026108|FG005|Week 12 to End of Study|Death|1|||
48776707|NCT00718718|157026109|FG006|Week 12 to End of Study|Death|0|||
48776708|NCT00718718|157026110|FG007|Week 12 to End of Study|Death|0|||
48776709|NCT00718718|157026111|FG008|Week 12 to End of Study|Death|0|||
48776710|NCT00718718|157026112|FG009|Week 12 to End of Study|Death|0|||
48776711|NCT00718718|157026103|FG000|Week 12 to End of Study|Withdrawal by Subject|0|||
48776712|NCT00718718|157026104|FG001|Week 12 to End of Study|Withdrawal by Subject|0|||
48776713|NCT00718718|157026105|FG002|Week 12 to End of Study|Withdrawal by Subject|0|||
48776714|NCT00718718|157026106|FG003|Week 12 to End of Study|Withdrawal by Subject|0|||
48776715|NCT00718718|157026107|FG004|Week 12 to End of Study|Withdrawal by Subject|0|||
48776716|NCT00718718|157026108|FG005|Week 12 to End of Study|Withdrawal by Subject|2|||
48776717|NCT00718718|157026109|FG006|Week 12 to End of Study|Withdrawal by Subject|1|||
48776718|NCT00718718|157026110|FG007|Week 12 to End of Study|Withdrawal by Subject|0|||
48776719|NCT00718718|157026111|FG008|Week 12 to End of Study|Withdrawal by Subject|0|||
48776720|NCT00718718|157026112|FG009|Week 12 to End of Study|Withdrawal by Subject|0|||
48776721|NCT00718718|157026103|FG000|Week 12 to End of Study|Lost to Follow-up|0|||
48776722|NCT00718718|157026104|FG001|Week 12 to End of Study|Lost to Follow-up|0|||
48776723|NCT00718718|157026105|FG002|Week 12 to End of Study|Lost to Follow-up|0|||
48776724|NCT00718718|157026106|FG003|Week 12 to End of Study|Lost to Follow-up|0|||
48776725|NCT00718718|157026107|FG004|Week 12 to End of Study|Lost to Follow-up|0|||
48776726|NCT00718718|157026108|FG005|Week 12 to End of Study|Lost to Follow-up|0|||
48776727|NCT00718718|157026109|FG006|Week 12 to End of Study|Lost to Follow-up|0|||
48776728|NCT00718718|157026110|FG007|Week 12 to End of Study|Lost to Follow-up|0|||
48776729|NCT00718718|157026111|FG008|Week 12 to End of Study|Lost to Follow-up|1|||
48776730|NCT00718718|157026112|FG009|Week 12 to End of Study|Lost to Follow-up|0|||
48776731|NCT00718718|157026103|FG000|Week 12 to End of Study|Other|0|||
48776732|NCT00718718|157026104|FG001|Week 12 to End of Study|Other|1|||
48776733|NCT00718718|157026105|FG002|Week 12 to End of Study|Other|0|||
48776734|NCT00718718|157026106|FG003|Week 12 to End of Study|Other|1|||
48776735|NCT00718718|157026107|FG004|Week 12 to End of Study|Other|0|||
49028116|NCT03854227|157941137|FG004|Overall Study|Disease relapse|0|||
49028117|NCT03854227|157941138|FG005|Overall Study|Disease relapse|0|||
48776736|NCT00718718|157026108|FG005|Week 12 to End of Study|Other|0|||
48776737|NCT00718718|157026109|FG006|Week 12 to End of Study|Other|1|||
48776738|NCT00718718|157026110|FG007|Week 12 to End of Study|Other|0|||
48776739|NCT00718718|157026111|FG008|Week 12 to End of Study|Other|0|||
48776740|NCT00718718|157026112|FG009|Week 12 to End of Study|Other|0|||
48776741|NCT03285477|157026115|FG000|Treatment and Response Assessment Period|Death|1|||
48776742|NCT03285477|157026116|FG001|Treatment and Response Assessment Period|Death|0|||
48776743|NCT03285477|157026115|FG000|Treatment and Response Assessment Period|Withdrawn of Consent|1|||
48776744|NCT03285477|157026116|FG001|Treatment and Response Assessment Period|Withdrawn of Consent|0|||
48776745|NCT03285477|157026115|FG000|Recurrence Follow-up Period|Lost to Follow-up|0|||
48776746|NCT03285477|157026116|FG001|Recurrence Follow-up Period|Lost to Follow-up|1|||
48776747|NCT03285477|157026115|FG000|Recurrence Follow-up Period|Withdrawal of consent|1|||
48776748|NCT03285477|157026116|FG001|Recurrence Follow-up Period|Withdrawal of consent|3|||
48776749|NCT03285477|157026115|FG000|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5|||
48776750|NCT03285477|157026116|FG001|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51|||
48776751|NCT00852397|157026117|FG000|Overall Study|Adverse Event|4|||
48776752|NCT00852397|157026118|FG001|Overall Study|Adverse Event|6|||
48776753|NCT00852397|157026119|FG002|Overall Study|Adverse Event|4|||
48776754|NCT00852397|157026117|FG000|Overall Study|Death|0|||
48776755|NCT00852397|157026118|FG001|Overall Study|Death|0|||
48776756|NCT00852397|157026119|FG002|Overall Study|Death|1|||
48776757|NCT00852397|157026117|FG000|Overall Study|Withdrawal by Subject|4|||
48776758|NCT00852397|157026118|FG001|Overall Study|Withdrawal by Subject|1|||
48776759|NCT00852397|157026119|FG002|Overall Study|Withdrawal by Subject|2|||
48776760|NCT00852397|157026117|FG000|Overall Study|Study terminated by sponsor|2|||
48776761|NCT00852397|157026118|FG001|Overall Study|Study terminated by sponsor|1|||
48776762|NCT00852397|157026119|FG002|Overall Study|Study terminated by sponsor|6|||
49028118|NCT03854227|157941139|FG006|Overall Study|Disease relapse|0|||
48776763|NCT00852397|157026117|FG000|Overall Study|Difficulty in study site visit|1|||
48776764|NCT00852397|157026118|FG001|Overall Study|Difficulty in study site visit|0|||
48776765|NCT00852397|157026119|FG002|Overall Study|Difficulty in study site visit|0|||
48776766|NCT00852397|157026117|FG000|Overall Study|Protocol Violation|0|||
48776767|NCT00852397|157026118|FG001|Overall Study|Protocol Violation|0|||
48776768|NCT00852397|157026119|FG002|Overall Study|Protocol Violation|1|||
48776769|NCT02556710|157028423|FG000|Overall Study|Surgical treatment|3|||
48776770|NCT02556710|157028424|FG001|Overall Study|Surgical treatment|0|||
48776771|NCT02556710|157028423|FG000|Overall Study|Required proscribed pain medication|2|||
48776772|NCT02556710|157028424|FG001|Overall Study|Required proscribed pain medication|1|||
48776773|NCT02556710|157028423|FG000|Overall Study|Lack of Efficacy|1|||
48776774|NCT02556710|157028424|FG001|Overall Study|Lack of Efficacy|0|||
48876966|NCT01165177|157388481|FG000|Overall Study|Withdrawal by Subject|368|||
48876967|NCT01165177|157388482|FG001|Overall Study|Withdrawal by Subject|354|||
48876968|NCT01165177|157388481|FG000|Overall Study|Protocol Violation|19|||
48876969|NCT01165177|157388482|FG001|Overall Study|Protocol Violation|21|||
48876970|NCT01165177|157388481|FG000|Overall Study|Non-serious adverse event|30|||
48876971|NCT01165177|157388482|FG001|Overall Study|Non-serious adverse event|18|||
48876972|NCT01165177|157388481|FG000|Overall Study|Other unspecified reasons|47|||
48876973|NCT01165177|157388482|FG001|Overall Study|Other unspecified reasons|35|||
48876974|NCT01165177|157388481|FG000|Overall Study|Suspected HZ episode|0|||
48876975|NCT01165177|157388482|FG001|Overall Study|Suspected HZ episode|2|||
48876976|NCT01165177|157388481|FG000|Overall Study|Lost to Follow-up|183|||
48876977|NCT01165177|157388482|FG001|Overall Study|Lost to Follow-up|194|||
48876978|NCT01165177|157388481|FG000|Overall Study|Migrated/ moved from study area|48|||
48876979|NCT01165177|157388482|FG001|Overall Study|Migrated/ moved from study area|43|||
48876980|NCT00013611|157388483|FG000|Overall Study|Lost to Follow-up|91|||
48876981|NCT00013611|157388484|FG001|Overall Study|Lost to Follow-up|100|||
48876982|NCT03194867|157388485|FG000|Overall Study|Incorrect completion of end of study form|0|||
48876983|NCT03194867|157388486|FG001|Overall Study|Incorrect completion of end of study form|0|||
48876984|NCT03194867|157388487|FG002|Overall Study|Incorrect completion of end of study form|1|||
48876985|NCT03194867|157388488|FG003|Overall Study|Incorrect completion of end of study form|0|||
48876986|NCT00884650|157388489|FG000|Overall Study|Did not return complete pain diaries|7|||
49028119|NCT03854227|157941140|FG007|Overall Study|Disease relapse|0|||
49028120|NCT03854227|157941141|FG008|Overall Study|Disease relapse|1|||
49028121|NCT03854227|157941142|FG009|Overall Study|Disease relapse|0|||
48776775|NCT02556710|157028423|FG000|Overall Study|Worsening osteoarthritis|1|||
48776776|NCT02556710|157028424|FG001|Overall Study|Worsening osteoarthritis|0|||
48776777|NCT02556710|157028423|FG000|Overall Study|Moved out of state|1|||
48776778|NCT02556710|157028424|FG001|Overall Study|Moved out of state|0|||
48776779|NCT02556710|157028423|FG000|Overall Study|Missing reason|3|||
48776780|NCT02556710|157028424|FG001|Overall Study|Missing reason|1|||
49028122|NCT03854227|157941143|FG010|Overall Study|Disease relapse|0|||
49028123|NCT03854227|157941144|FG011|Overall Study|Disease relapse|0|||
48776781|NCT02556710|157028423|FG000|Overall Study|Pain as lack of efficacy|0|||
48776782|NCT02556710|157028424|FG001|Overall Study|Pain as lack of efficacy|4|||
48776783|NCT00991302|157028425|FG000|Overall Study|Death|0|||
48776784|NCT00991302|157028426|FG001|Overall Study|Death|1|||
48776785|NCT00991302|157028425|FG000|Overall Study|Lost to Follow-up|14|||
48776786|NCT00991302|157028426|FG001|Overall Study|Lost to Follow-up|12|||
48776787|NCT02383758|157028427|FG000|Overall Study|Withdrawal by Subject|0|||
48776788|NCT02383758|157028428|FG001|Overall Study|Withdrawal by Subject|2|||
48776789|NCT04258839|157028431|FG000|Overall Study|Adverse Event|2|||
48776790|NCT04258839|157028432|FG001|Overall Study|Adverse Event|4|||
48776791|NCT04258839|157028431|FG000|Overall Study|Lack of Efficacy|0|||
48776792|NCT04258839|157028432|FG001|Overall Study|Lack of Efficacy|2|||
48776793|NCT04258839|157028431|FG000|Overall Study|Lost to Follow-up|2|||
48776794|NCT04258839|157028432|FG001|Overall Study|Lost to Follow-up|0|||
48776795|NCT04258839|157028431|FG000|Overall Study|Withdrawal by Subject|1|||
48776796|NCT04258839|157028432|FG001|Overall Study|Withdrawal by Subject|2|||
48776797|NCT04258839|157028431|FG000|Overall Study|Withdrawal by Caregiver|5|||
48776798|NCT04258839|157028432|FG001|Overall Study|Withdrawal by Caregiver|6|||
48776799|NCT04258839|157028431|FG000|Overall Study|Reason not Specified|0|||
48876987|NCT00884650|157388490|FG001|Overall Study|Did not return complete pain diaries|7|||
48876988|NCT00884650|157388489|FG000|Overall Study|Admitted Post-Op|1|||
48876989|NCT00884650|157388490|FG001|Overall Study|Admitted Post-Op|0|||
48876990|NCT00884650|157388489|FG000|Overall Study|Femoral Stress Fracture|1|||
48876991|NCT00884650|157388490|FG001|Overall Study|Femoral Stress Fracture|0|||
48876992|NCT00884650|157388489|FG000|Overall Study|Pain Pump Complication|0|||
48776800|NCT04258839|157028432|FG001|Overall Study|Reason not Specified|1|||
48776801|NCT02970968|157028433|FG000|Overall Study|Withdrawal by Subject|3|||
48776802|NCT02970968|157028434|FG001|Overall Study|Withdrawal by Subject|3|||
48776803|NCT02970968|157028433|FG000|Overall Study|Adverse Event|1|||
48776804|NCT02970968|157028434|FG001|Overall Study|Adverse Event|2|||
48776805|NCT02970968|157028433|FG000|Overall Study|Lost to Follow-up|1|||
48776806|NCT02970968|157028434|FG001|Overall Study|Lost to Follow-up|1|||
48776807|NCT02970968|157028433|FG000|Overall Study|Non-Compliance|0|||
48776808|NCT02970968|157028434|FG001|Overall Study|Non-Compliance|1|||
48776809|NCT00653224|157028435|FG000|Overall Study|Adverse Event|2|||
48776810|NCT00653224|157028436|FG001|Overall Study|Adverse Event|1|||
48776811|NCT00653224|157028435|FG000|Overall Study|Lack of Efficacy|1|||
48776812|NCT00653224|157028436|FG001|Overall Study|Lack of Efficacy|2|||
48776813|NCT00653224|157028435|FG000|Overall Study|Loss of efficacy|1|||
48776814|NCT00653224|157028436|FG001|Overall Study|Loss of efficacy|0|||
48776815|NCT00653224|157028435|FG000|Overall Study|Lost to Follow-up|1|||
49028124|NCT03854227|157941133|FG000|Overall Study|Global deterioration of health status|0|||
49028125|NCT03854227|157941134|FG001|Overall Study|Global deterioration of health status|0|||
48776816|NCT00653224|157028436|FG001|Overall Study|Lost to Follow-up|0|||
48776817|NCT00653224|157028435|FG000|Overall Study|Other|2|||
48776818|NCT00653224|157028436|FG001|Overall Study|Other|4|||
48776819|NCT00646958|157028437|FG000|Overall Study|Lack of Efficacy|1|||
48776820|NCT00646958|157028438|FG001|Overall Study|Lack of Efficacy|0|||
49028126|NCT03854227|157941135|FG002|Overall Study|Global deterioration of health status|0|||
49028127|NCT03854227|157941136|FG003|Overall Study|Global deterioration of health status|0|||
49028128|NCT03854227|157941137|FG004|Overall Study|Global deterioration of health status|0|||
49028129|NCT03854227|157941138|FG005|Overall Study|Global deterioration of health status|1|||
49028130|NCT03854227|157941139|FG006|Overall Study|Global deterioration of health status|0|||
49028131|NCT03854227|157941140|FG007|Overall Study|Global deterioration of health status|1|||
49028132|NCT03854227|157941141|FG008|Overall Study|Global deterioration of health status|0|||
49028133|NCT03854227|157941142|FG009|Overall Study|Global deterioration of health status|0|||
49028134|NCT03854227|157941143|FG010|Overall Study|Global deterioration of health status|0|||
48776821|NCT00646958|157028439|FG002|Overall Study|Lack of Efficacy|0|||
48776822|NCT00646958|157028437|FG000|Overall Study|Adverse Event|4|||
48776823|NCT00646958|157028438|FG001|Overall Study|Adverse Event|0|||
48776824|NCT00646958|157028439|FG002|Overall Study|Adverse Event|0|||
48776825|NCT00646958|157028437|FG000|Overall Study|Lost to Follow-up|1|||
48776826|NCT00646958|157028438|FG001|Overall Study|Lost to Follow-up|5|||
48776827|NCT00646958|157028439|FG002|Overall Study|Lost to Follow-up|7|||
48776828|NCT00646958|157028437|FG000|Overall Study|Protocol Violation|1|||
48776829|NCT00646958|157028438|FG001|Overall Study|Protocol Violation|1|||
48776830|NCT00646958|157028439|FG002|Overall Study|Protocol Violation|0|||
48776831|NCT00646958|157028437|FG000|Overall Study|Abnormal screening lab tests|1|||
48776832|NCT00646958|157028438|FG001|Overall Study|Abnormal screening lab tests|1|||
48776833|NCT00646958|157028439|FG002|Overall Study|Abnormal screening lab tests|0|||
48776834|NCT00646958|157028437|FG000|Overall Study|Withdrawal by Subject|1|||
48776835|NCT00646958|157028438|FG001|Overall Study|Withdrawal by Subject|2|||
48776836|NCT00646958|157028439|FG002|Overall Study|Withdrawal by Subject|0|||
48776837|NCT00646958|157028437|FG000|Overall Study|Did not receive study drug|2|||
48776838|NCT00646958|157028438|FG001|Overall Study|Did not receive study drug|0|||
48776839|NCT00646958|157028439|FG002|Overall Study|Did not receive study drug|2|||
48776840|NCT02293005|157028441|FG000|Overall Study|Adverse Event|2|||
48776841|NCT02293005|157028441|FG000|Overall Study|Death|4|||
48776842|NCT02293005|157028441|FG000|Overall Study|Lost to Follow-up|1|||
48776843|NCT02293005|157028441|FG000|Overall Study|Withdrawal by Subject|2|||
48776844|NCT02293005|157028441|FG000|Overall Study|Progression|17|||
48776845|NCT04982029|157028442|FG000|Overall Study|Lost to Follow-up|2|||
48776846|NCT04982029|157028443|FG001|Overall Study|Lost to Follow-up|3|||
48776847|NCT00600821|157028445|FG000|Overall Study|Death|45|||
48776848|NCT00600821|157028446|FG001|Overall Study|Death|46|||
48776849|NCT00600821|157028445|FG000|Overall Study|Lost to Follow-up|2|||
49028135|NCT03854227|157941144|FG011|Overall Study|Global deterioration of health status|0|||
49028136|NCT03854227|157941133|FG000|Overall Study|Refused further treatment|0|||
48776850|NCT00600821|157028446|FG001|Overall Study|Lost to Follow-up|2|||
48776851|NCT00600821|157028445|FG000|Overall Study|Withdrawal by Subject|1|||
48776852|NCT00600821|157028446|FG001|Overall Study|Withdrawal by Subject|1|||
48776853|NCT00600821|157028445|FG000|Overall Study|Terminated by sponsor|8|||
48776854|NCT00600821|157028446|FG001|Overall Study|Terminated by sponsor|6|||
48776855|NCT00600821|157028445|FG000|Overall Study|Objective progression or relapse|0|||
48776856|NCT00600821|157028446|FG001|Overall Study|Objective progression or relapse|1|||
48776857|NCT00600821|157028445|FG000|Overall Study|Randomized but not treated|0|||
48776858|NCT00600821|157028446|FG001|Overall Study|Randomized but not treated|1|||
48776859|NCT00600821|157028445|FG000|Overall Study|Other|2|||
48776860|NCT00600821|157028446|FG001|Overall Study|Other|3|||
48776861|NCT01310413|157028448|FG000|Day 0 to Day 385|Withdrawal by Subject|5|||
48776862|NCT01310413|157028449|FG001|Day 0 to Day 385|Withdrawal by Subject|2|||
48776863|NCT01310413|157028450|FG002|Day 0 to Day 385|Withdrawal by Subject|0|||
48776864|NCT01310413|157028451|FG003|Day 0 to Day 385|Withdrawal by Subject|2|||
48776865|NCT01310413|157028452|FG004|Day 0 to Day 385|Withdrawal by Subject|1|||
48776866|NCT01310413|157028453|FG005|Day 0 to Day 385|Withdrawal by Subject|1|||
49028137|NCT03854227|157941134|FG001|Overall Study|Refused further treatment|0|||
49028138|NCT03854227|157941135|FG002|Overall Study|Refused further treatment|0|||
48776867|NCT01310413|157028454|FG006|Day 0 to Day 385|Withdrawal by Subject|0|||
48776868|NCT01310413|157028448|FG000|Day 0 to Day 385|Lost to Follow-up|18|||
48776869|NCT01310413|157028449|FG001|Day 0 to Day 385|Lost to Follow-up|3|||
48776870|NCT01310413|157028450|FG002|Day 0 to Day 385|Lost to Follow-up|3|||
48876993|NCT00884650|157388490|FG001|Overall Study|Pain Pump Complication|1|||
48876994|NCT04334278|157388491|FG000|Overall Study|Lost to Follow-up|0|||
48876995|NCT04334278|157388492|FG001|Overall Study|Lost to Follow-up|3|||
48876996|NCT04334278|157388491|FG000|Overall Study|Withdrawal by Subject|4|||
48876997|NCT04334278|157388492|FG001|Overall Study|Withdrawal by Subject|2|||
48776871|NCT01310413|157028451|FG003|Day 0 to Day 385|Lost to Follow-up|5|||
48776872|NCT01310413|157028452|FG004|Day 0 to Day 385|Lost to Follow-up|1|||
48776873|NCT01310413|157028453|FG005|Day 0 to Day 385|Lost to Follow-up|2|||
48776874|NCT01310413|157028454|FG006|Day 0 to Day 385|Lost to Follow-up|0|||
48776875|NCT01310413|157028448|FG000|Day 0 to Day 385|Migrated/moved from study area|3|||
48776876|NCT01310413|157028449|FG001|Day 0 to Day 385|Migrated/moved from study area|3|||
48776877|NCT01310413|157028450|FG002|Day 0 to Day 385|Migrated/moved from study area|1|||
48776878|NCT01310413|157028451|FG003|Day 0 to Day 385|Migrated/moved from study area|1|||
48776879|NCT01310413|157028452|FG004|Day 0 to Day 385|Migrated/moved from study area|1|||
48776880|NCT01310413|157028453|FG005|Day 0 to Day 385|Migrated/moved from study area|0|||
48776881|NCT01310413|157028454|FG006|Day 0 to Day 385|Migrated/moved from study area|0|||
48776882|NCT01310413|157028448|FG000|Day 0 to Day 385|Other|1|||
48776883|NCT01310413|157028449|FG001|Day 0 to Day 385|Other|0|||
48776884|NCT01310413|157028450|FG002|Day 0 to Day 385|Other|3|||
48776885|NCT01310413|157028451|FG003|Day 0 to Day 385|Other|0|||
48776886|NCT01310413|157028452|FG004|Day 0 to Day 385|Other|0|||
48776887|NCT01310413|157028453|FG005|Day 0 to Day 385|Other|0|||
48776888|NCT01310413|157028454|FG006|Day 0 to Day 385|Other|0|||
48776889|NCT01310413|157028448|FG000|From Day U0 to Day U385|Withdrawal by Subject|0|||
48776890|NCT01310413|157028449|FG001|From Day U0 to Day U385|Withdrawal by Subject|0|||
48776891|NCT01310413|157028450|FG002|From Day U0 to Day U385|Withdrawal by Subject|0|||
48776892|NCT01310413|157028451|FG003|From Day U0 to Day U385|Withdrawal by Subject|0|||
48776893|NCT01310413|157028452|FG004|From Day U0 to Day U385|Withdrawal by Subject|0|||
48776894|NCT01310413|157028453|FG005|From Day U0 to Day U385|Withdrawal by Subject|0|||
48776895|NCT01310413|157028454|FG006|From Day U0 to Day U385|Withdrawal by Subject|1|||
48776896|NCT01310413|157028448|FG000|From Day U0 to Day U385|Lost to Follow-up|0|||
48776897|NCT01310413|157028449|FG001|From Day U0 to Day U385|Lost to Follow-up|0|||
48776898|NCT01310413|157028450|FG002|From Day U0 to Day U385|Lost to Follow-up|0|||
48776899|NCT01310413|157028451|FG003|From Day U0 to Day U385|Lost to Follow-up|0|||
48776900|NCT01310413|157028452|FG004|From Day U0 to Day U385|Lost to Follow-up|0|||
48776901|NCT01310413|157028453|FG005|From Day U0 to Day U385|Lost to Follow-up|0|||
48776902|NCT01310413|157028454|FG006|From Day U0 to Day U385|Lost to Follow-up|2|||
48776903|NCT02564471|157028455|FG000|Overall Study|Adverse Event|1|||
48776904|NCT02564471|157028456|FG001|Overall Study|Adverse Event|0|||
48776905|NCT02564471|157028457|FG002|Overall Study|Adverse Event|0|||
48776906|NCT02564471|157028458|FG003|Overall Study|Adverse Event|0|||
48776907|NCT02564471|157028455|FG000|Overall Study|Withdrawal by Subject|2|||
48776908|NCT02564471|157028456|FG001|Overall Study|Withdrawal by Subject|1|||
48776909|NCT02564471|157028457|FG002|Overall Study|Withdrawal by Subject|3|||
48776910|NCT02564471|157028458|FG003|Overall Study|Withdrawal by Subject|0|||
48776911|NCT02564471|157028455|FG000|Overall Study|Lost to Follow-up|0|||
48776912|NCT02564471|157028456|FG001|Overall Study|Lost to Follow-up|2|||
48776913|NCT02564471|157028457|FG002|Overall Study|Lost to Follow-up|0|||
48776914|NCT02564471|157028458|FG003|Overall Study|Lost to Follow-up|0|||
48776915|NCT00194012|157028459|FG000|Randomized Phase|Lack of Efficacy|8|||
48776916|NCT00194012|157028460|FG001|Randomized Phase|Lack of Efficacy|18|||
48776917|NCT00194012|157028459|FG000|Randomized Phase|Study nonadherence|2|||
48776918|NCT00194012|157028460|FG001|Randomized Phase|Study nonadherence|1|||
48776919|NCT00194012|157028459|FG000|Randomized Phase|Withdrawal by Subject|3|||
48776920|NCT00194012|157028460|FG001|Randomized Phase|Withdrawal by Subject|3|||
48776921|NCT00194012|157028459|FG000|Randomized Phase|Adverse Event|2|||
48776922|NCT00194012|157028460|FG001|Randomized Phase|Adverse Event|1|||
48776923|NCT00194012|157028459|FG000|Randomized Phase|Participant reported having a rash|1|||
48776924|NCT00194012|157028460|FG001|Randomized Phase|Participant reported having a rash|0|||
48776925|NCT00194012|157028459|FG000|Randomized Phase|Emesis and enuresis|0|||
48776926|NCT00194012|157028460|FG001|Randomized Phase|Emesis and enuresis|1|||
48776927|NCT00194012|157028459|FG000|Randomized Phase|Oral/nasal twitching|0|||
48876998|NCT03065933|157388493|FG000|Overall Study|study terminated|5|||
48876999|NCT04351269|157388494|FG000|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|70|||
48877000|NCT04351269|157388495|FG001|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|32|||
48776928|NCT00194012|157028460|FG001|Randomized Phase|Oral/nasal twitching|1|||
48776929|NCT00194012|157028459|FG000|Open Label Extension (OLE)|Weight Gain|1|||
48776930|NCT00194012|157028460|FG001|Open Label Extension (OLE)|Weight Gain|0|||
48776931|NCT00194012|157028459|FG000|Open Label Extension (OLE)|Drowsiness; Jittery|0|||
48776932|NCT00194012|157028460|FG001|Open Label Extension (OLE)|Drowsiness; Jittery|1|||
48776933|NCT00194012|157028459|FG000|Open Label Extension (OLE)|Lost to Follow-up|3|||
48776934|NCT00194012|157028460|FG001|Open Label Extension (OLE)|Lost to Follow-up|5|||
48776935|NCT00194012|157028459|FG000|Open Label Extension (OLE)|Lack of Efficacy|1|||
48982579|NCT01970540|157767635|FG000|Overall Study|Clinical progression|0|||
48776936|NCT00194012|157028460|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
48776937|NCT01643473|157028461|FG000|Overall Study|Lost to Follow-up|1|||
48776938|NCT01643473|157028462|FG001|Overall Study|Lost to Follow-up|0|||
48776939|NCT00659646|157028463|FG000|Overall Study|Protocol Violation|12|||
48776940|NCT00659646|157028464|FG001|Overall Study|Protocol Violation|8|||
48776941|NCT00659646|157028463|FG000|Overall Study|Adverse Event|1|||
48776942|NCT00659646|157028464|FG001|Overall Study|Adverse Event|0|||
48776943|NCT00659646|157028463|FG000|Overall Study|Lost to Follow-up|1|||
48776944|NCT00659646|157028464|FG001|Overall Study|Lost to Follow-up|0|||
48776945|NCT00659646|157028463|FG000|Overall Study|protocol noncompliance after randomized|1|||
48776946|NCT00659646|157028464|FG001|Overall Study|protocol noncompliance after randomized|0|||
48776947|NCT02453594|157028466|FG000|Overall Study|Protocol Violation|0|||
48776948|NCT02453594|157028467|FG001|Overall Study|Protocol Violation|0|||
48776949|NCT02453594|157028468|FG002|Overall Study|Protocol Violation|1|||
48776950|NCT02453594|157028466|FG000|Overall Study|Cohort Was Closed|17|||
49028139|NCT03854227|157941136|FG003|Overall Study|Refused further treatment|0|||
49028140|NCT03854227|157941137|FG004|Overall Study|Refused further treatment|0|||
49028141|NCT03854227|157941138|FG005|Overall Study|Refused further treatment|0|||
49028142|NCT03854227|157941139|FG006|Overall Study|Refused further treatment|0|||
49028143|NCT03854227|157941140|FG007|Overall Study|Refused further treatment|0|||
49028144|NCT03854227|157941141|FG008|Overall Study|Refused further treatment|0|||
49028145|NCT03854227|157941142|FG009|Overall Study|Refused further treatment|1|||
49028146|NCT03854227|157941143|FG010|Overall Study|Refused further treatment|0|||
49028147|NCT03854227|157941144|FG011|Overall Study|Refused further treatment|1|||
49028148|NCT03854227|157941133|FG000|Overall Study|Other|0|||
49028149|NCT03854227|157941134|FG001|Overall Study|Other|0|||
49028150|NCT03854227|157941135|FG002|Overall Study|Other|0|||
49028151|NCT03854227|157941136|FG003|Overall Study|Other|0|||
49028152|NCT03854227|157941137|FG004|Overall Study|Other|0|||
49028153|NCT03854227|157941138|FG005|Overall Study|Other|0|||
49028154|NCT03854227|157941139|FG006|Overall Study|Other|0|||
49028155|NCT03854227|157941140|FG007|Overall Study|Other|0|||
49028156|NCT03854227|157941141|FG008|Overall Study|Other|1|||
49028157|NCT03854227|157941142|FG009|Overall Study|Other|1|||
49028158|NCT03854227|157941143|FG010|Overall Study|Other|0|||
49028159|NCT03854227|157941144|FG011|Overall Study|Other|0|||
49028160|NCT02457520|157941145|FG000|Active Treatment Phase|Adverse Event|10|||
49028161|NCT02457520|157941145|FG000|Active Treatment Phase|Lost to Follow-up|8|||
49028162|NCT02457520|157941145|FG000|Active Treatment Phase|Non-compliance with Study Treatment|3|||
49028163|NCT02457520|157941145|FG000|Active Treatment Phase|other|4|||
49028164|NCT02457520|157941145|FG000|Active Treatment Phase|Physician Decision|1|||
49028165|NCT02457520|157941145|FG000|Active Treatment Phase|Protocol Violation|1|||
49028166|NCT02457520|157941145|FG000|Active Treatment Phase|Withdrawal by Subject|7|||
49028167|NCT02457520|157941145|FG000|Post-treatment Period|Other: Retreatment Required|7|||
49028168|NCT02457520|157941145|FG000|Post-treatment Period|Lost to Follow-up|23|||
49028169|NCT02457520|157941145|FG000|Post-treatment Period|Other|3|||
49028170|NCT02457520|157941145|FG000|Post-treatment Period|Physician Decision|1|||
48776951|NCT02453594|157028467|FG001|Overall Study|Cohort Was Closed|21|||
48776952|NCT02453594|157028468|FG002|Overall Study|Cohort Was Closed|14|||
48776953|NCT02453594|157028466|FG000|Overall Study|Death|20|||
48776954|NCT02453594|157028467|FG001|Overall Study|Death|24|||
48776955|NCT02453594|157028468|FG002|Overall Study|Death|16|||
48776956|NCT02453594|157028466|FG000|Overall Study|Lost to Follow-up|6|||
48776957|NCT02453594|157028467|FG001|Overall Study|Lost to Follow-up|14|||
48776958|NCT02453594|157028468|FG002|Overall Study|Lost to Follow-up|2|||
48776959|NCT02453594|157028466|FG000|Overall Study|Physician Decision|2|||
48776960|NCT02453594|157028467|FG001|Overall Study|Physician Decision|4|||
48776961|NCT02453594|157028468|FG002|Overall Study|Physician Decision|0|||
48776962|NCT02453594|157028466|FG000|Overall Study|Site Terminated by Sponsor|1|||
48776963|NCT02453594|157028467|FG001|Overall Study|Site Terminated by Sponsor|0|||
48776964|NCT02453594|157028468|FG002|Overall Study|Site Terminated by Sponsor|1|||
48776965|NCT02453594|157028466|FG000|Overall Study|Transitioned to Extension Study|16|||
48776966|NCT02453594|157028467|FG001|Overall Study|Transitioned to Extension Study|9|||
48776967|NCT02453594|157028468|FG002|Overall Study|Transitioned to Extension Study|16|||
49028171|NCT02457520|157941145|FG000|Post-treatment Period|Withdrawal by Subject|14|||
48776968|NCT02453594|157028466|FG000|Overall Study|Withdrawal by Subject|7|||
48776969|NCT02453594|157028467|FG001|Overall Study|Withdrawal by Subject|9|||
48776970|NCT02453594|157028468|FG002|Overall Study|Withdrawal by Subject|11|||
48776971|NCT00587587|157028471|FG000|Overall Study|Lost to Follow-up|6|||
48776972|NCT00587587|157028472|FG001|Overall Study|Lost to Follow-up|1|||
48776973|NCT04622254|157028475|FG000|Main Period (Up to 22 Weeks)|Adverse Event|0|||
49028172|NCT02587962|157941146|FG000|Overall Study|Adverse Event|0|||
49028173|NCT02587962|157941147|FG001|Overall Study|Adverse Event|0|||
49028174|NCT02587962|157941148|FG002|Overall Study|Adverse Event|1|||
49028175|NCT02587962|157941149|FG003|Overall Study|Adverse Event|0|||
48776974|NCT04622254|157028476|FG001|Main Period (Up to 22 Weeks)|Adverse Event|1|||
48776975|NCT04622254|157028477|FG002|Main Period (Up to 22 Weeks)|Adverse Event|0|||
49028176|NCT02587962|157941150|FG004|Overall Study|Adverse Event|0|||
48776976|NCT04622254|157028478|FG003|Main Period (Up to 22 Weeks)|Adverse Event|0|||
48776977|NCT04622254|157028479|FG004|Main Period (Up to 22 Weeks)|Adverse Event|0|||
48776978|NCT04622254|157028480|FG005|Main Period (Up to 22 Weeks)|Adverse Event|0|||
48776979|NCT04622254|157028475|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
48776980|NCT04622254|157028476|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
48776981|NCT04622254|157028477|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
48776982|NCT04622254|157028478|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
48776983|NCT04622254|157028479|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
48776984|NCT04622254|157028480|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
48776985|NCT04622254|157028475|FG000|Main Period (Up to 22 Weeks)|Protocol Violation|1|||
48776986|NCT04622254|157028476|FG001|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
48776987|NCT04622254|157028477|FG002|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
48776988|NCT04622254|157028478|FG003|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
48776989|NCT04622254|157028479|FG004|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
48776990|NCT04622254|157028480|FG005|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
48776991|NCT04622254|157028475|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
48776992|NCT04622254|157028476|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|2|||
48776993|NCT04622254|157028477|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
48776994|NCT04622254|157028478|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
48776995|NCT04622254|157028479|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
48776996|NCT04622254|157028480|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
48776997|NCT04622254|157028475|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
48776998|NCT04622254|157028476|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
48776999|NCT04622254|157028477|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
48777000|NCT04622254|157028478|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|1|||
48777001|NCT04622254|157028479|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
48777002|NCT04622254|157028480|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
48777003|NCT04622254|157028475|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
48777004|NCT04622254|157028476|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
48777005|NCT04622254|157028477|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
48777006|NCT04622254|157028478|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|3|||
48777007|NCT04622254|157028479|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
48777008|NCT04622254|157028480|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
48777009|NCT04622254|157028475|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
48777010|NCT04622254|157028476|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
48777011|NCT04622254|157028477|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
48777012|NCT04622254|157028478|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
48777013|NCT04622254|157028479|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
48777014|NCT04622254|157028480|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
48777015|NCT04622254|157028475|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
48777016|NCT04622254|157028476|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
48777017|NCT04622254|157028477|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
48777018|NCT04622254|157028478|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
48777019|NCT04622254|157028479|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
48777020|NCT04622254|157028480|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
48777021|NCT04622254|157028475|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
48777022|NCT04622254|157028476|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
48777023|NCT04622254|157028477|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
48777024|NCT04622254|157028478|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|1|||
48777025|NCT04622254|157028479|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|9|||
48777026|NCT04622254|157028480|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|3|||
48777027|NCT04622254|157028475|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
48777028|NCT04622254|157028476|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
48777029|NCT04622254|157028477|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
48777030|NCT04622254|157028478|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|1|||
48777031|NCT04622254|157028479|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|5|||
48777032|NCT04622254|157028480|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
48777033|NCT04622254|157028475|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
48777034|NCT04622254|157028476|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
48777035|NCT04622254|157028477|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
48777036|NCT04622254|157028478|FG003|OLEX Period (Up to 39 Weeks)|Other|0|||
48777037|NCT04622254|157028479|FG004|OLEX Period (Up to 39 Weeks)|Other|0|||
48777038|NCT04622254|157028480|FG005|OLEX Period (Up to 39 Weeks)|Other|2|||
48777039|NCT02057757|157028481|FG000|Overall Study|Withdrawal by Subject|3|||
48777040|NCT02057757|157028482|FG001|Overall Study|Withdrawal by Subject|5|||
48777041|NCT02057757|157028481|FG000|Overall Study|Death|2|||
48777042|NCT02057757|157028482|FG001|Overall Study|Death|0|||
48777043|NCT02057757|157028481|FG000|Overall Study|Lost to Follow-up|8|||
48777044|NCT02057757|157028482|FG001|Overall Study|Lost to Follow-up|3|||
48777045|NCT02057757|157028481|FG000|Overall Study|Non-compliance|1|||
48777046|NCT02057757|157028482|FG001|Overall Study|Non-compliance|0|||
48777047|NCT03614793|157028483|FG000|Overall Study|Lost to Follow-up|1|||
48777048|NCT03614793|157028484|FG001|Overall Study|Lost to Follow-up|2|||
48777049|NCT03614793|157028483|FG000|Overall Study|Lack of Efficacy|0|||
48777050|NCT03614793|157028484|FG001|Overall Study|Lack of Efficacy|5|||
48777051|NCT03614793|157028483|FG000|Overall Study|Withdrawal by Subject|0|||
48777052|NCT03614793|157028484|FG001|Overall Study|Withdrawal by Subject|1|||
48777053|NCT03614793|157028483|FG000|Overall Study|Insurance denied coverage of the procedure|0|||
48777054|NCT03614793|157028484|FG001|Overall Study|Insurance denied coverage of the procedure|5|||
48777055|NCT01168999|157028485|FG000|Overall Study|Lost to Follow-up|2|||
48777056|NCT01168999|157028486|FG001|Overall Study|Lost to Follow-up|1|||
48777057|NCT01168999|157028487|FG002|Overall Study|Lost to Follow-up|0|||
48777058|NCT01168999|157028488|FG003|Overall Study|Lost to Follow-up|0|||
48777059|NCT03586869|157028489|FG000|Overall Study|Progressive Disease|3|||
48777060|NCT04116229|157028490|FG000|Overall Study|Met exclusion criteria during screeneing on day of study visit.|2|||
48777061|NCT04116229|157028491|FG001|Overall Study|Met exclusion criteria during screeneing on day of study visit.|3|||
48777062|NCT04116229|157028490|FG000|Overall Study|Scheduling not possible.|0|||
48777063|NCT04116229|157028491|FG001|Overall Study|Scheduling not possible.|1|||
48777064|NCT04394351|157028492|FG000|Part A (16 Weeks)|Adverse Event|1|||
48777065|NCT04394351|157028493|FG001|Part A (16 Weeks)|Adverse Event|0|||
48777066|NCT04394351|157028494|FG002|Part A (16 Weeks)|Adverse Event|0|||
48777067|NCT04394351|157028495|FG003|Part A (16 Weeks)|Adverse Event|0|||
48777068|NCT04394351|157028496|FG004|Part A (16 Weeks)|Adverse Event|0|||
48777069|NCT04394351|157028497|FG005|Part A (16 Weeks)|Adverse Event|0|||
48777070|NCT04394351|157028498|FG006|Part A (16 Weeks)|Adverse Event|0|||
48777071|NCT04394351|157028499|FG007|Part A (16 Weeks)|Adverse Event|0|||
48777072|NCT04394351|157028492|FG000|Part A (16 Weeks)|Physician Decision|0|||
48777073|NCT04394351|157028493|FG001|Part A (16 Weeks)|Physician Decision|1|||
48777074|NCT04394351|157028494|FG002|Part A (16 Weeks)|Physician Decision|0|||
48777075|NCT04394351|157028495|FG003|Part A (16 Weeks)|Physician Decision|0|||
48777076|NCT04394351|157028496|FG004|Part A (16 Weeks)|Physician Decision|0|||
48777077|NCT04394351|157028497|FG005|Part A (16 Weeks)|Physician Decision|0|||
48777078|NCT04394351|157028498|FG006|Part A (16 Weeks)|Physician Decision|0|||
48777079|NCT04394351|157028499|FG007|Part A (16 Weeks)|Physician Decision|0|||
48777080|NCT04394351|157028492|FG000|Part A (16 Weeks)|Withdrawal by Subject|0|||
48777081|NCT04394351|157028493|FG001|Part A (16 Weeks)|Withdrawal by Subject|1|||
48777082|NCT04394351|157028494|FG002|Part A (16 Weeks)|Withdrawal by Subject|0|||
48777083|NCT04394351|157028495|FG003|Part A (16 Weeks)|Withdrawal by Subject|0|||
48777084|NCT04394351|157028496|FG004|Part A (16 Weeks)|Withdrawal by Subject|0|||
48777085|NCT04394351|157028497|FG005|Part A (16 Weeks)|Withdrawal by Subject|0|||
48777086|NCT04394351|157028498|FG006|Part A (16 Weeks)|Withdrawal by Subject|0|||
48777087|NCT04394351|157028499|FG007|Part A (16 Weeks)|Withdrawal by Subject|0|||
48777088|NCT04394351|157028492|FG000|Part B (36 Weeks)|Adverse Event|0|||
48777089|NCT04394351|157028493|FG001|Part B (36 Weeks)|Adverse Event|0|||
48777090|NCT04394351|157028494|FG002|Part B (36 Weeks)|Adverse Event|0|||
48777091|NCT04394351|157028495|FG003|Part B (36 Weeks)|Adverse Event|0|||
48777092|NCT04394351|157028496|FG004|Part B (36 Weeks)|Adverse Event|0|||
48777093|NCT04394351|157028497|FG005|Part B (36 Weeks)|Adverse Event|0|||
48777094|NCT04394351|157028498|FG006|Part B (36 Weeks)|Adverse Event|1|||
48777095|NCT04394351|157028499|FG007|Part B (36 Weeks)|Adverse Event|0|||
48777096|NCT02461589|157028503|FG000|Overall Study|Withdrawal by Subject|5|||
48777097|NCT02461589|157028504|FG001|Overall Study|Withdrawal by Subject|1|||
48777098|NCT02461589|157028505|FG002|Overall Study|Withdrawal by Subject|3|||
48777099|NCT02461589|157028506|FG003|Overall Study|Withdrawal by Subject|2|||
48777100|NCT02461589|157028507|FG004|Overall Study|Withdrawal by Subject|1|||
48777101|NCT02461589|157028508|FG005|Overall Study|Withdrawal by Subject|2|||
48777102|NCT02461589|157028509|FG006|Overall Study|Withdrawal by Subject|1|||
48777103|NCT02461589|157028510|FG007|Overall Study|Withdrawal by Subject|3|||
48777104|NCT02461589|157028511|FG008|Overall Study|Withdrawal by Subject|3|||
48777105|NCT02461589|157028512|FG009|Overall Study|Withdrawal by Subject|1|||
48777106|NCT02461589|157028503|FG000|Overall Study|Lost to Follow-up|0|||
48777107|NCT02461589|157028504|FG001|Overall Study|Lost to Follow-up|0|||
48777108|NCT02461589|157028505|FG002|Overall Study|Lost to Follow-up|2|||
48777109|NCT02461589|157028506|FG003|Overall Study|Lost to Follow-up|3|||
48777110|NCT02461589|157028507|FG004|Overall Study|Lost to Follow-up|1|||
48777111|NCT02461589|157028508|FG005|Overall Study|Lost to Follow-up|1|||
48777112|NCT02461589|157028509|FG006|Overall Study|Lost to Follow-up|3|||
48777113|NCT02461589|157028510|FG007|Overall Study|Lost to Follow-up|1|||
48777114|NCT02461589|157028511|FG008|Overall Study|Lost to Follow-up|3|||
48777115|NCT02461589|157028512|FG009|Overall Study|Lost to Follow-up|1|||
48777116|NCT02461589|157028503|FG000|Overall Study|Death|0|||
48777117|NCT02461589|157028504|FG001|Overall Study|Death|0|||
48777118|NCT02461589|157028505|FG002|Overall Study|Death|0|||
48777119|NCT02461589|157028506|FG003|Overall Study|Death|0|||
48777120|NCT02461589|157028507|FG004|Overall Study|Death|0|||
48777121|NCT02461589|157028508|FG005|Overall Study|Death|0|||
48777122|NCT02461589|157028509|FG006|Overall Study|Death|0|||
48777123|NCT02461589|157028510|FG007|Overall Study|Death|1|||
48777124|NCT02461589|157028511|FG008|Overall Study|Death|0|||
48777125|NCT02461589|157028512|FG009|Overall Study|Death|0|||
48777126|NCT02461589|157028503|FG000|Overall Study|Unclassified|0|||
48777127|NCT02461589|157028504|FG001|Overall Study|Unclassified|0|||
48777128|NCT02461589|157028505|FG002|Overall Study|Unclassified|0|||
48777129|NCT02461589|157028506|FG003|Overall Study|Unclassified|0|||
48777130|NCT02461589|157028507|FG004|Overall Study|Unclassified|0|||
48777131|NCT02461589|157028508|FG005|Overall Study|Unclassified|0|||
48777132|NCT02461589|157028509|FG006|Overall Study|Unclassified|1|||
48777133|NCT02461589|157028510|FG007|Overall Study|Unclassified|0|||
48777134|NCT02461589|157028511|FG008|Overall Study|Unclassified|0|||
48777135|NCT02461589|157028512|FG009|Overall Study|Unclassified|2|||
48777136|NCT02461589|157028503|FG000|Overall Study|Missing follow-up information|1|||
48777137|NCT02461589|157028504|FG001|Overall Study|Missing follow-up information|1|||
48777138|NCT02461589|157028505|FG002|Overall Study|Missing follow-up information|0|||
48777139|NCT02461589|157028506|FG003|Overall Study|Missing follow-up information|0|||
48777140|NCT02461589|157028507|FG004|Overall Study|Missing follow-up information|0|||
48777141|NCT02461589|157028508|FG005|Overall Study|Missing follow-up information|0|||
48777142|NCT02461589|157028509|FG006|Overall Study|Missing follow-up information|1|||
48777143|NCT02461589|157028510|FG007|Overall Study|Missing follow-up information|0|||
48777144|NCT02461589|157028511|FG008|Overall Study|Missing follow-up information|0|||
48777145|NCT02461589|157028512|FG009|Overall Study|Missing follow-up information|0|||
48777146|NCT02461589|157028503|FG000|Overall Study|Withdrawal from trial before exposure|0|||
48777147|NCT02461589|157028504|FG001|Overall Study|Withdrawal from trial before exposure|0|||
48777148|NCT02461589|157028505|FG002|Overall Study|Withdrawal from trial before exposure|0|||
48777149|NCT02461589|157028506|FG003|Overall Study|Withdrawal from trial before exposure|0|||
48777150|NCT02461589|157028507|FG004|Overall Study|Withdrawal from trial before exposure|0|||
48777151|NCT02461589|157028508|FG005|Overall Study|Withdrawal from trial before exposure|0|||
48777152|NCT02461589|157028509|FG006|Overall Study|Withdrawal from trial before exposure|0|||
48777153|NCT02461589|157028510|FG007|Overall Study|Withdrawal from trial before exposure|0|||
48777154|NCT02461589|157028511|FG008|Overall Study|Withdrawal from trial before exposure|0|||
48777155|NCT02461589|157028512|FG009|Overall Study|Withdrawal from trial before exposure|1|||
48777156|NCT03669081|157028526|FG000|Overall Study|Data could not be validated|1|||
48777157|NCT03669081|157028527|FG001|Overall Study|Data could not be validated|1|||
48777158|NCT03217136|157028529|FG000|Overall Study|Lost to Follow-up|2|||
48777159|NCT03217136|157028530|FG001|Overall Study|Lost to Follow-up|1|||
48777160|NCT03217136|157028529|FG000|Overall Study|Site Randomized Participant in Error|0|||
48777161|NCT03217136|157028530|FG001|Overall Study|Site Randomized Participant in Error|1|||
48777162|NCT03217136|157028529|FG000|Overall Study|Did Not Meet Criteria after Randomization|0|||
48777163|NCT03217136|157028530|FG001|Overall Study|Did Not Meet Criteria after Randomization|1|||
48777164|NCT03217136|157028529|FG000|Overall Study|Dispensing Error|1|||
48777165|NCT03217136|157028530|FG001|Overall Study|Dispensing Error|0|||
48777166|NCT03217136|157028529|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
48777167|NCT03217136|157028530|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
48777168|NCT00812812|157028531|FG000|Overall Study|Adverse Event|2|||
48777169|NCT00812812|157028532|FG001|Overall Study|Adverse Event|1|||
48777170|NCT00812812|157028531|FG000|Overall Study|Lack of Efficacy|1|||
48777171|NCT00812812|157028532|FG001|Overall Study|Lack of Efficacy|0|||
48777172|NCT00812812|157028531|FG000|Overall Study|Lost to Follow-up|0|||
48777173|NCT00812812|157028532|FG001|Overall Study|Lost to Follow-up|1|||
48777174|NCT00812812|157028531|FG000|Overall Study|Withdrawal by Subject|0|||
48777175|NCT00812812|157028532|FG001|Overall Study|Withdrawal by Subject|2|||
48777176|NCT01401530|157028533|FG000|Overall Study|Disease Progression|1|||
48777177|NCT01401530|157028534|FG001|Overall Study|Disease Progression|2|||
48777178|NCT01401530|157028535|FG002|Overall Study|Disease Progression|1|||
48777179|NCT01401530|157028533|FG000|Overall Study|Adverse Event|1|||
48777180|NCT01401530|157028534|FG001|Overall Study|Adverse Event|1|||
48777181|NCT01401530|157028535|FG002|Overall Study|Adverse Event|1|||
48777182|NCT01401530|157028533|FG000|Overall Study|Participant Choice|1|||
48777183|NCT01401530|157028534|FG001|Overall Study|Participant Choice|2|||
48777184|NCT01401530|157028535|FG002|Overall Study|Participant Choice|1|||
48777185|NCT01401530|157028533|FG000|Overall Study|Physician Decision|0|||
48777186|NCT01401530|157028534|FG001|Overall Study|Physician Decision|1|||
48777187|NCT01401530|157028535|FG002|Overall Study|Physician Decision|0|||
48877001|NCT04351269|157388496|FG002|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|29|||
48777188|NCT03755765|157028536|FG000|Overall Study|Withdrawal by Subject|2|||
48777189|NCT03755765|157028537|FG001|Overall Study|Withdrawal by Subject|4|||
48777190|NCT03755765|157028538|FG002|Overall Study|Withdrawal by Subject|4|||
48777191|NCT02104557|157028539|FG000|Overall Study|Adverse Event|24|||
48777192|NCT02104557|157028539|FG000|Overall Study|Lost to Follow-up|34|||
48777193|NCT02104557|157028539|FG000|Overall Study|Violated the usage and dosage|14|||
48777194|NCT02104557|157028539|FG000|Overall Study|No longer met inclusion/exclusion criteria|1|||
48777195|NCT02104557|157028539|FG000|Overall Study|Administered Sayana prior to the contract|1|||
48777196|NCT02104557|157028539|FG000|Overall Study|Other|17|||
49028177|NCT02587962|157941146|FG000|Overall Study|Withdrawal by Subject|0|||
49028178|NCT02587962|157941147|FG001|Overall Study|Withdrawal by Subject|0|||
49028179|NCT02587962|157941148|FG002|Overall Study|Withdrawal by Subject|1|||
49028180|NCT02587962|157941149|FG003|Overall Study|Withdrawal by Subject|1|||
49028181|NCT02587962|157941150|FG004|Overall Study|Withdrawal by Subject|4|||
48777197|NCT02104557|157028539|FG000|Overall Study|Change to other contraception methods|5|||
48777198|NCT02104557|157028539|FG000|Overall Study|Discontinuation due to no pain|1|||
48777199|NCT02104557|157028539|FG000|Overall Study|Withdrawal consent|2|||
48777200|NCT02104557|157028539|FG000|Overall Study|Refusal of administration due to unknown reasons|69|||
48777201|NCT02104557|157028539|FG000|Overall Study|Discontinuation of contraception|9|||
48777202|NCT01046110|157028542|FG000|Overall Study|Adverse Event|9|||
48777203|NCT01046110|157028543|FG001|Overall Study|Adverse Event|2|||
48777204|NCT01046110|157028542|FG000|Overall Study|Lack of Efficacy|0|||
48777205|NCT01046110|157028543|FG001|Overall Study|Lack of Efficacy|1|||
48777206|NCT01046110|157028542|FG000|Overall Study|Protocol Violation|7|||
48777207|NCT01046110|157028543|FG001|Overall Study|Protocol Violation|12|||
48777208|NCT01046110|157028542|FG000|Overall Study|Withdrawal Criteria|3|||
48777209|NCT01046110|157028543|FG001|Overall Study|Withdrawal Criteria|5|||
48777210|NCT01046110|157028542|FG000|Overall Study|Unclassified|36|||
48777211|NCT01046110|157028543|FG001|Overall Study|Unclassified|35|||
48777212|NCT04360824|157028550|FG000|Overall Study|Withdrawal by Subject|2|||
48777213|NCT04360824|157028551|FG001|Overall Study|Withdrawal by Subject|1|||
48777214|NCT04360824|157028550|FG000|Overall Study|Did not receive assigned treatment|1|||
48777215|NCT04360824|157028551|FG001|Overall Study|Did not receive assigned treatment|3|||
48777216|NCT00718042|157028552|FG000|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
48777217|NCT00718042|157028553|FG001|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
48777218|NCT00718042|157028554|FG002|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
48777219|NCT00718042|157028555|FG003|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
48777220|NCT00718042|157028556|FG004|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2|||
48777221|NCT00718042|157028557|FG005|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
48777222|NCT00718042|157028552|FG000|ABBOTT PRISM Chagas Testing|Protocol Violation|64|||
48777223|NCT00718042|157028553|FG001|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
48777224|NCT00718042|157028554|FG002|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
48777225|NCT00718042|157028555|FG003|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
48777226|NCT00718042|157028556|FG004|ABBOTT PRISM Chagas Testing|Protocol Violation|36|||
48777227|NCT00718042|157028557|FG005|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
48777228|NCT00718042|157028552|FG000|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
48777229|NCT00718042|157028553|FG001|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
48777230|NCT00718042|157028554|FG002|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
48777231|NCT00718042|157028555|FG003|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
48777232|NCT00718042|157028556|FG004|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
48777233|NCT00718042|157028557|FG005|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
48777234|NCT00718042|157028552|FG000|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
48777235|NCT00718042|157028553|FG001|ABBOTT PRISM Chagas Testing|No result on comparator assay|1|||
48777236|NCT00718042|157028554|FG002|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
48777237|NCT00718042|157028555|FG003|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
48777238|NCT00718042|157028556|FG004|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
48777239|NCT00718042|157028557|FG005|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
48777240|NCT00718042|157028552|FG000|Donor Follow-up|Lost to Follow-up|13|||
48777241|NCT00718042|157028553|FG001|Donor Follow-up|Lost to Follow-up|0|||
48777242|NCT00718042|157028554|FG002|Donor Follow-up|Lost to Follow-up|0|||
48777243|NCT00718042|157028555|FG003|Donor Follow-up|Lost to Follow-up|0|||
48777244|NCT00718042|157028556|FG004|Donor Follow-up|Lost to Follow-up|19|||
48777245|NCT00718042|157028557|FG005|Donor Follow-up|Lost to Follow-up|0|||
48777246|NCT00304070|157028558|FG000|Overall Study|Death|0|||
48777247|NCT00304070|157028559|FG001|Overall Study|Death|0|||
48777248|NCT00304070|157028560|FG002|Overall Study|Death|3|||
48777249|NCT00304070|157028558|FG000|Overall Study|Lost to Follow-up|0|||
48777250|NCT00304070|157028559|FG001|Overall Study|Lost to Follow-up|0|||
49028182|NCT02587962|157941146|FG000|Overall Study|Radiological progression|2|||
49028183|NCT02587962|157941147|FG001|Overall Study|Radiological progression|2|||
49028184|NCT02587962|157941148|FG002|Overall Study|Radiological progression|2|||
49028185|NCT02587962|157941149|FG003|Overall Study|Radiological progression|5|||
48777251|NCT00304070|157028560|FG002|Overall Study|Lost to Follow-up|1|||
48777252|NCT00304070|157028558|FG000|Overall Study|Physician Decision|0|||
48777253|NCT00304070|157028559|FG001|Overall Study|Physician Decision|0|||
48777254|NCT00304070|157028560|FG002|Overall Study|Physician Decision|3|||
48777255|NCT00304070|157028558|FG000|Overall Study|Withdrawal by Subject|0|||
48777256|NCT00304070|157028559|FG001|Overall Study|Withdrawal by Subject|0|||
49028186|NCT02587962|157941150|FG004|Overall Study|Radiological progression|10|||
48777257|NCT00304070|157028560|FG002|Overall Study|Withdrawal by Subject|1|||
48777258|NCT00304070|157028558|FG000|Overall Study|Progressive Disease|3|||
48777259|NCT00304070|157028559|FG001|Overall Study|Progressive Disease|7|||
49028187|NCT02587962|157941146|FG000|Overall Study|Clinical progression|0|||
49028188|NCT02587962|157941147|FG001|Overall Study|Clinical progression|1|||
49028189|NCT02587962|157941148|FG002|Overall Study|Clinical progression|2|||
49028190|NCT02587962|157941149|FG003|Overall Study|Clinical progression|0|||
49028191|NCT02587962|157941150|FG004|Overall Study|Clinical progression|1|||
49028192|NCT01981720|157941151|FG000|Overall Study|Adverse Event|1|||
49028193|NCT01981720|157941151|FG000|Overall Study|Withdrawal by Subject|3|||
49028194|NCT01981720|157941151|FG000|Overall Study|Pregnancy|1|||
49028195|NCT02458469|157941152|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
49028196|NCT02458469|157941153|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
49028197|NCT02458469|157941154|FG002|First Intervention (2 Weeks)|Lost to Follow-up|1|||
49028198|NCT02458469|157941155|FG003|First Intervention (2 Weeks)|Lost to Follow-up|0|||
49028199|NCT02458469|157941156|FG004|First Intervention (2 Weeks)|Lost to Follow-up|0|||
49028200|NCT02458469|157941157|FG005|First Intervention (2 Weeks)|Lost to Follow-up|0|||
49028201|NCT02458469|157941152|FG000|First Intervention (2 Weeks)|Physician Decision|1|||
49028202|NCT02458469|157941153|FG001|First Intervention (2 Weeks)|Physician Decision|0|||
49028203|NCT02458469|157941154|FG002|First Intervention (2 Weeks)|Physician Decision|0|||
49028204|NCT02458469|157941155|FG003|First Intervention (2 Weeks)|Physician Decision|0|||
48777260|NCT00304070|157028560|FG002|Overall Study|Progressive Disease|4|||
48777261|NCT00575588|157028561|FG000|Overall Study|Adverse Event|11|||
48777262|NCT00575588|157028562|FG001|Overall Study|Adverse Event|13|||
48777263|NCT00575588|157028561|FG000|Overall Study|Withdrawal by Subject|27|||
48777264|NCT00575588|157028562|FG001|Overall Study|Withdrawal by Subject|31|||
48777265|NCT00575588|157028561|FG000|Overall Study|Lost to Follow-up|1|||
49028205|NCT02458469|157941156|FG004|First Intervention (2 Weeks)|Physician Decision|0|||
49028206|NCT02458469|157941157|FG005|First Intervention (2 Weeks)|Physician Decision|0|||
49028207|NCT02458469|157941152|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
49028208|NCT02458469|157941153|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
49028209|NCT02458469|157941154|FG002|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
49028210|NCT02458469|157941155|FG003|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
48777266|NCT00575588|157028562|FG001|Overall Study|Lost to Follow-up|3|||
48777267|NCT00575588|157028561|FG000|Overall Study|Death|4|||
48777268|NCT00575588|157028562|FG001|Overall Study|Death|2|||
48777269|NCT00575588|157028561|FG000|Overall Study|Incorrect enrollment|8|||
48777270|NCT00575588|157028562|FG001|Overall Study|Incorrect enrollment|4|||
48777271|NCT00575588|157028561|FG000|Overall Study|Study specific discontinuation criteria|203|||
48777272|NCT00575588|157028562|FG001|Overall Study|Study specific discontinuation criteria|218|||
48777273|NCT00575588|157028561|FG000|Overall Study|Severe non-compliance to protocol|5|||
48777274|NCT00575588|157028562|FG001|Overall Study|Severe non-compliance to protocol|7|||
48777275|NCT00575588|157028561|FG000|Overall Study|Safety reasons|2|||
48777276|NCT00575588|157028562|FG001|Overall Study|Safety reasons|1|||
48777277|NCT00575588|157028561|FG000|Overall Study|Elevated triglyceride|1|||
48777278|NCT00575588|157028562|FG001|Overall Study|Elevated triglyceride|0|||
48777279|NCT00575588|157028561|FG000|Overall Study|Patient moved|1|||
48777280|NCT00575588|157028562|FG001|Overall Study|Patient moved|3|||
48777281|NCT00575588|157028561|FG000|Overall Study|Impossible to determine HbA1c|0|||
48777282|NCT00575588|157028562|FG001|Overall Study|Impossible to determine HbA1c|1|||
48777283|NCT00377676|157028563|FG000|Overall Study|Adverse Event|498|||
48777284|NCT00377676|157028564|FG001|Overall Study|Adverse Event|107|||
48777285|NCT00377676|157028563|FG000|Overall Study|Protocol Violation|33|||
48777286|NCT00377676|157028564|FG001|Overall Study|Protocol Violation|27|||
48777287|NCT00377676|157028563|FG000|Overall Study|Death|5|||
48777288|NCT00377676|157028564|FG001|Overall Study|Death|2|||
48777289|NCT00377676|157028563|FG000|Overall Study|Withdrawal by Subject|187|||
48777290|NCT00377676|157028564|FG001|Overall Study|Withdrawal by Subject|72|||
48777291|NCT00377676|157028563|FG000|Overall Study|Lost to Follow-up|120|||
48777292|NCT00377676|157028564|FG001|Overall Study|Lost to Follow-up|56|||
48777293|NCT00377676|157028563|FG000|Overall Study|Other|118|||
48777294|NCT00377676|157028564|FG001|Overall Study|Other|58|||
48777295|NCT01412424|157028566|FG000|Core Treatment Period|Treatment Failure|24|||
48777296|NCT01412424|157028566|FG000|Core Treatment Period|Adverse Event|21|||
48777297|NCT01412424|157028566|FG000|Core Treatment Period|Patient Request|5|||
48777298|NCT01412424|157028566|FG000|Core Treatment Period|Lost to Follow-up|2|||
48777299|NCT01412424|157028566|FG000|Core Treatment Period|Sponsor Request|1|||
48777300|NCT01412424|157028566|FG000|Extension Treatment Period|Adverse Event|2|||
49028211|NCT02458469|157941156|FG004|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
48777301|NCT01412424|157028566|FG000|Extension Treatment Period|Treatment Failure|2|||
48777302|NCT01412424|157028566|FG000|Extension Treatment Period|Patient Request|2|||
49028212|NCT02458469|157941157|FG005|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
49028213|NCT01422538|157941158|FG000|Overall Study|Lost to Follow-up|0|||
49028214|NCT01422538|157941159|FG001|Overall Study|Lost to Follow-up|1|||
49028215|NCT01422538|157941160|FG002|Overall Study|Lost to Follow-up|1|||
49028216|NCT01422538|157941158|FG000|Overall Study|Missed visit|0|||
48777303|NCT03586999|157028577|FG000|Overall Study|Lack of Efficacy|2|||
48777304|NCT02664038|157028581|FG000|13 Week|Lost to Follow-up|7|||
48777305|NCT02664038|157028582|FG001|13 Week|Lost to Follow-up|14|||
48777306|NCT02664038|157028581|FG000|13 Week|Withdrawal by Subject|1|||
48777307|NCT02664038|157028582|FG001|13 Week|Withdrawal by Subject|0|||
48777308|NCT02664038|157028581|FG000|26 Week|Lost to Follow-up|5|||
48777309|NCT02664038|157028582|FG001|26 Week|Lost to Follow-up|4|||
48777310|NCT03296696|157028598|FG000|Overall Study|Started Other Antitumor Therapy|1|||
48777311|NCT03296696|157028599|FG001|Overall Study|Started Other Antitumor Therapy|2|||
48777312|NCT03296696|157028600|FG002|Overall Study|Started Other Antitumor Therapy|1|||
48777313|NCT03296696|157028601|FG003|Overall Study|Started Other Antitumor Therapy|2|||
48777314|NCT03296696|157028602|FG004|Overall Study|Started Other Antitumor Therapy|1|||
48777315|NCT03296696|157028603|FG005|Overall Study|Started Other Antitumor Therapy|1|||
48777316|NCT03296696|157028604|FG006|Overall Study|Started Other Antitumor Therapy|2|||
48777317|NCT03296696|157028605|FG007|Overall Study|Started Other Antitumor Therapy|3|||
48777318|NCT03296696|157028606|FG008|Overall Study|Started Other Antitumor Therapy|1|||
48777319|NCT03296696|157028607|FG009|Overall Study|Started Other Antitumor Therapy|0|||
48777320|NCT03296696|157028598|FG000|Overall Study|Death|0|||
48777321|NCT03296696|157028599|FG001|Overall Study|Death|1|||
48777322|NCT03296696|157028600|FG002|Overall Study|Death|1|||
48777323|NCT03296696|157028601|FG003|Overall Study|Death|2|||
48777324|NCT03296696|157028602|FG004|Overall Study|Death|2|||
48777325|NCT03296696|157028603|FG005|Overall Study|Death|3|||
48777326|NCT03296696|157028604|FG006|Overall Study|Death|1|||
48777327|NCT03296696|157028605|FG007|Overall Study|Death|2|||
48777328|NCT03296696|157028606|FG008|Overall Study|Death|0|||
48777329|NCT03296696|157028607|FG009|Overall Study|Death|0|||
48777330|NCT03296696|157028598|FG000|Overall Study|Withdrawal by Subject|0|||
48777331|NCT03296696|157028599|FG001|Overall Study|Withdrawal by Subject|0|||
48777332|NCT03296696|157028600|FG002|Overall Study|Withdrawal by Subject|1|||
48777333|NCT03296696|157028601|FG003|Overall Study|Withdrawal by Subject|0|||
48777334|NCT03296696|157028602|FG004|Overall Study|Withdrawal by Subject|1|||
48777335|NCT03296696|157028603|FG005|Overall Study|Withdrawal by Subject|0|||
48777336|NCT03296696|157028604|FG006|Overall Study|Withdrawal by Subject|0|||
48777337|NCT03296696|157028605|FG007|Overall Study|Withdrawal by Subject|0|||
48777338|NCT03296696|157028606|FG008|Overall Study|Withdrawal by Subject|0|||
48777339|NCT03296696|157028607|FG009|Overall Study|Withdrawal by Subject|1|||
48777340|NCT00699699|157028608|FG000|Overall Study|Adverse Event|36|||
48777341|NCT00699699|157028608|FG000|Overall Study|Individual different reasons|21|||
48777342|NCT01752933|157028609|FG000|Treatment|Disease Progression|3|||
48777343|NCT01752933|157028610|FG001|Treatment|Disease Progression|29|||
48777344|NCT01752933|157028609|FG000|Treatment|Withdrawal by Subject|0|||
48777345|NCT01752933|157028610|FG001|Treatment|Withdrawal by Subject|5|||
48777346|NCT01752933|157028609|FG000|Treatment|Adverse Event|1|||
48777347|NCT01752933|157028610|FG001|Treatment|Adverse Event|4|||
48777348|NCT01752933|157028609|FG000|Treatment|Physician Decision|0|||
48777349|NCT01752933|157028610|FG001|Treatment|Physician Decision|3|||
48777350|NCT01752933|157028609|FG000|Treatment|Death|0|||
48777351|NCT01752933|157028610|FG001|Treatment|Death|2|||
48777352|NCT01752933|157028609|FG000|Treatment|Hepatocellular carcinoma not confirmed|0|||
48777353|NCT01752933|157028610|FG001|Treatment|Hepatocellular carcinoma not confirmed|1|||
48777354|NCT01752933|157028609|FG000|Treatment|Patient noncompliant|0|||
48777355|NCT01752933|157028610|FG001|Treatment|Patient noncompliant|1|||
48777356|NCT01752933|157028609|FG000|Treatment|Patient unable to travel to appointments|0|||
48777357|NCT01752933|157028610|FG001|Treatment|Patient unable to travel to appointments|1|||
48777358|NCT01752933|157028609|FG000|Overall Study and Follow-up|Death|4|||
48777359|NCT01752933|157028610|FG001|Overall Study and Follow-up|Death|34|||
48777360|NCT01752933|157028609|FG000|Overall Study and Follow-up|Sponsor terminated study/Database lock|0|||
48777361|NCT01752933|157028610|FG001|Overall Study and Follow-up|Sponsor terminated study/Database lock|7|||
48777362|NCT01752933|157028609|FG000|Overall Study and Follow-up|Withdrawal by Subject|0|||
48777363|NCT01752933|157028610|FG001|Overall Study and Follow-up|Withdrawal by Subject|3|||
48777364|NCT01752933|157028609|FG000|Overall Study and Follow-up|Lost to Follow-up|0|||
48777365|NCT01752933|157028610|FG001|Overall Study and Follow-up|Lost to Follow-up|2|||
48777366|NCT01866709|157028616|FG000|Overall Study|Adverse Event|1|||
48777367|NCT01866709|157028617|FG001|Overall Study|Adverse Event|0|||
48777368|NCT01858194|157028618|FG000|Overall Study|Total Artificial Heart Implant|0|||
48777369|NCT01858194|157028619|FG001|Overall Study|Total Artificial Heart Implant|1|||
48777370|NCT01858194|157028618|FG000|Overall Study|Lost to Follow-up|0|||
48777371|NCT01858194|157028619|FG001|Overall Study|Lost to Follow-up|1|||
48777372|NCT01079234|157028626|FG000|Main: Week 0 to 26|Adverse Event|5|||
48777373|NCT01079234|157028627|FG001|Main: Week 0 to 26|Adverse Event|4|||
48777374|NCT01079234|157028628|FG002|Main: Week 0 to 26|Adverse Event|1|||
48777375|NCT01079234|157028629|FG003|Main: Week 0 to 26|Adverse Event|0|||
48777376|NCT01079234|157028626|FG000|Main: Week 0 to 26|Lack of Efficacy|2|||
48777377|NCT01079234|157028627|FG001|Main: Week 0 to 26|Lack of Efficacy|1|||
48777378|NCT01079234|157028628|FG002|Main: Week 0 to 26|Lack of Efficacy|1|||
48777379|NCT01079234|157028629|FG003|Main: Week 0 to 26|Lack of Efficacy|0|||
48777380|NCT01079234|157028626|FG000|Main: Week 0 to 26|Protocol Violation|6|||
48777381|NCT01079234|157028627|FG001|Main: Week 0 to 26|Protocol Violation|2|||
48777382|NCT01079234|157028628|FG002|Main: Week 0 to 26|Protocol Violation|4|||
48777383|NCT01079234|157028629|FG003|Main: Week 0 to 26|Protocol Violation|0|||
48777384|NCT01079234|157028626|FG000|Main: Week 0 to 26|Withdrawal criteria|6|||
48777385|NCT01079234|157028627|FG001|Main: Week 0 to 26|Withdrawal criteria|6|||
48777386|NCT01079234|157028628|FG002|Main: Week 0 to 26|Withdrawal criteria|2|||
48777387|NCT01079234|157028629|FG003|Main: Week 0 to 26|Withdrawal criteria|0|||
48777388|NCT01079234|157028626|FG000|Main: Week 0 to 26|Unclassified|7|||
48777389|NCT01079234|157028627|FG001|Main: Week 0 to 26|Unclassified|13|||
48777390|NCT01079234|157028628|FG002|Main: Week 0 to 26|Unclassified|4|||
48777391|NCT01079234|157028629|FG003|Main: Week 0 to 26|Unclassified|0|||
48777392|NCT01079234|157028626|FG000|Extension: Week 27 to 52|Adverse Event|0|||
48777393|NCT01079234|157028627|FG001|Extension: Week 27 to 52|Adverse Event|0|||
48777394|NCT01079234|157028628|FG002|Extension: Week 27 to 52|Adverse Event|1|||
48777395|NCT01079234|157028629|FG003|Extension: Week 27 to 52|Adverse Event|0|||
48777396|NCT01079234|157028626|FG000|Extension: Week 27 to 52|Lack of Efficacy|0|||
48777397|NCT01079234|157028627|FG001|Extension: Week 27 to 52|Lack of Efficacy|0|||
48777398|NCT01079234|157028628|FG002|Extension: Week 27 to 52|Lack of Efficacy|0|||
48777399|NCT01079234|157028629|FG003|Extension: Week 27 to 52|Lack of Efficacy|2|||
48777400|NCT01079234|157028626|FG000|Extension: Week 27 to 52|Protocol Violation|0|||
48777401|NCT01079234|157028627|FG001|Extension: Week 27 to 52|Protocol Violation|0|||
48777402|NCT01079234|157028628|FG002|Extension: Week 27 to 52|Protocol Violation|2|||
48777403|NCT01079234|157028629|FG003|Extension: Week 27 to 52|Protocol Violation|5|||
48777404|NCT01079234|157028626|FG000|Extension: Week 27 to 52|Withdrawal criteria|0|||
48777405|NCT01079234|157028627|FG001|Extension: Week 27 to 52|Withdrawal criteria|0|||
48777406|NCT01079234|157028628|FG002|Extension: Week 27 to 52|Withdrawal criteria|4|||
48777407|NCT01079234|157028629|FG003|Extension: Week 27 to 52|Withdrawal criteria|2|||
48777408|NCT01079234|157028626|FG000|Extension: Week 27 to 52|Unclassified|0|||
48777409|NCT01079234|157028627|FG001|Extension: Week 27 to 52|Unclassified|0|||
48777410|NCT01079234|157028628|FG002|Extension: Week 27 to 52|Unclassified|4|||
48777411|NCT01079234|157028629|FG003|Extension: Week 27 to 52|Unclassified|7|||
48777412|NCT00132769|157028630|FG000|Overall Study|Withdrawal by Subject|1|||
48777413|NCT00132769|157028631|FG001|Overall Study|Withdrawal by Subject|3|||
48777414|NCT00132769|157028630|FG000|Overall Study|Lack of Efficacy|7|||
48777415|NCT00132769|157028631|FG001|Overall Study|Lack of Efficacy|6|||
48777416|NCT00132769|157028630|FG000|Overall Study|Adverse Event|2|||
48777417|NCT00132769|157028631|FG001|Overall Study|Adverse Event|1|||
48777418|NCT00132769|157028630|FG000|Overall Study|Protocol Violation|1|||
48777419|NCT00132769|157028631|FG001|Overall Study|Protocol Violation|1|||
48777420|NCT03832192|157028632|FG000|Overall Study|Participants are disenrolled upon hospital discharge.|152|||
48777421|NCT03832192|157028633|FG001|Overall Study|Participants are disenrolled upon hospital discharge.|149|||
48777422|NCT03099382|157028634|FG000|Overall Study|Protocol Violation|2|||
48777423|NCT03099382|157028635|FG001|Overall Study|Protocol Violation|3|||
48777424|NCT00499369|157028636|FG000|Overall Study|Adverse Event|2|||
48777425|NCT00499369|157028637|FG001|Overall Study|Adverse Event|2|||
48777426|NCT00499369|157028638|FG002|Overall Study|Adverse Event|3|||
48777427|NCT00499369|157028639|FG003|Overall Study|Adverse Event|1|||
48777428|NCT00499369|157028640|FG004|Overall Study|Adverse Event|2|||
48777429|NCT00499369|157028636|FG000|Overall Study|Withdrawal by Subject|0|||
48777430|NCT00499369|157028637|FG001|Overall Study|Withdrawal by Subject|1|||
48777431|NCT00499369|157028638|FG002|Overall Study|Withdrawal by Subject|1|||
48777432|NCT00499369|157028639|FG003|Overall Study|Withdrawal by Subject|0|||
48777433|NCT00499369|157028640|FG004|Overall Study|Withdrawal by Subject|0|||
48777434|NCT00499369|157028636|FG000|Overall Study|Progression|10|||
48777435|NCT00499369|157028637|FG001|Overall Study|Progression|12|||
48777436|NCT00499369|157028638|FG002|Overall Study|Progression|9|||
48777437|NCT00499369|157028639|FG003|Overall Study|Progression|6|||
48777438|NCT00499369|157028640|FG004|Overall Study|Progression|10|||
48777439|NCT00499369|157028636|FG000|Overall Study|Death|0|||
48777440|NCT00499369|157028637|FG001|Overall Study|Death|1|||
48777441|NCT00499369|157028638|FG002|Overall Study|Death|0|||
48777442|NCT00499369|157028639|FG003|Overall Study|Death|0|||
48777443|NCT00499369|157028640|FG004|Overall Study|Death|0|||
48777444|NCT00499369|157028636|FG000|Overall Study|Not protocol specified|2|||
48777445|NCT00499369|157028637|FG001|Overall Study|Not protocol specified|0|||
48777446|NCT00499369|157028638|FG002|Overall Study|Not protocol specified|3|||
48777447|NCT00499369|157028639|FG003|Overall Study|Not protocol specified|1|||
48777448|NCT00499369|157028640|FG004|Overall Study|Not protocol specified|0|||
48777449|NCT00499369|157028636|FG000|Overall Study|Ineligible|2|||
48777450|NCT00499369|157028637|FG001|Overall Study|Ineligible|2|||
48777451|NCT00499369|157028638|FG002|Overall Study|Ineligible|1|||
48777452|NCT00499369|157028639|FG003|Overall Study|Ineligible|1|||
48777453|NCT00499369|157028640|FG004|Overall Study|Ineligible|0|||
48777454|NCT02096835|157030603|FG000|Overall Study|Withdrawal by Subject|1|||
48777455|NCT02096835|157030604|FG001|Overall Study|Withdrawal by Subject|0|||
48777456|NCT02096835|157030605|FG002|Overall Study|Withdrawal by Subject|0|||
48777457|NCT02096835|157030603|FG000|Overall Study|converted to open procedures|1|||
48777458|NCT02096835|157030604|FG001|Overall Study|converted to open procedures|0|||
48777459|NCT02096835|157030605|FG002|Overall Study|converted to open procedures|0|||
48777460|NCT02096835|157030603|FG000|Overall Study|Lost to Follow-up|1|||
48777461|NCT02096835|157030604|FG001|Overall Study|Lost to Follow-up|0|||
48777462|NCT02096835|157030605|FG002|Overall Study|Lost to Follow-up|1|||
48777463|NCT02033889|157030606|FG000|Overall Study|Adverse Event|3|||
48777464|NCT02033889|157030607|FG001|Overall Study|Adverse Event|1|||
48877002|NCT04351269|157388494|FG000|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
48877003|NCT04351269|157388495|FG001|Overall Study|CanGaroo Envelope used during a previous procedure|1|||
48877004|NCT04351269|157388496|FG002|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
48877005|NCT04351269|157388494|FG000|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
48877006|NCT04351269|157388495|FG001|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
48877007|NCT04351269|157388496|FG002|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|0|||
48877008|NCT04351269|157388494|FG000|Overall Study|Subjects followed long-term at different health care system|0|||
48877009|NCT04351269|157388495|FG001|Overall Study|Subjects followed long-term at different health care system|4|||
48877010|NCT04351269|157388496|FG002|Overall Study|Subjects followed long-term at different health care system|0|||
48877011|NCT04351269|157388494|FG000|Overall Study|Lost to Follow-up|1|||
48877012|NCT04351269|157388495|FG001|Overall Study|Lost to Follow-up|3|||
48877013|NCT04351269|157388496|FG002|Overall Study|Lost to Follow-up|0|||
48877014|NCT02367352|157388497|FG000|Overall Study|Progressive disease|7|||
48877015|NCT02367352|157388498|FG001|Overall Study|Progressive disease|0|||
48877016|NCT02367352|157388499|FG002|Overall Study|Progressive disease|0|||
48877017|NCT02367352|157388497|FG000|Overall Study|Participant Received Alternative Therapy|1|||
48877018|NCT02367352|157388498|FG001|Overall Study|Participant Received Alternative Therapy|0|||
48877019|NCT02367352|157388499|FG002|Overall Study|Participant Received Alternative Therapy|0|||
48877020|NCT02367352|157388497|FG000|Overall Study|Adverse Event|1|||
48777465|NCT02033889|157030608|FG002|Overall Study|Adverse Event|3|||
48777466|NCT02033889|157030606|FG000|Overall Study|Death|3|||
48777467|NCT02033889|157030607|FG001|Overall Study|Death|1|||
48777468|NCT02033889|157030608|FG002|Overall Study|Death|2|||
48777469|NCT02033889|157030606|FG000|Overall Study|Excluded Medication|1|||
48777470|NCT02033889|157030607|FG001|Overall Study|Excluded Medication|1|||
48777471|NCT02033889|157030608|FG002|Overall Study|Excluded Medication|0|||
48777472|NCT02033889|157030606|FG000|Overall Study|Lost to Follow-up|8|||
48777473|NCT02033889|157030607|FG001|Overall Study|Lost to Follow-up|5|||
48777474|NCT02033889|157030608|FG002|Overall Study|Lost to Follow-up|6|||
48777475|NCT02033889|157030606|FG000|Overall Study|Non-Compliance With Study Drug|1|||
48777476|NCT02033889|157030607|FG001|Overall Study|Non-Compliance With Study Drug|0|||
48777477|NCT02033889|157030608|FG002|Overall Study|Non-Compliance With Study Drug|0|||
48777478|NCT02033889|157030606|FG000|Overall Study|Physician Decision|0|||
48777479|NCT02033889|157030607|FG001|Overall Study|Physician Decision|1|||
48777480|NCT02033889|157030608|FG002|Overall Study|Physician Decision|1|||
48777481|NCT02033889|157030606|FG000|Overall Study|Participant moved|0|||
48777482|NCT02033889|157030607|FG001|Overall Study|Participant moved|1|||
48777483|NCT02033889|157030608|FG002|Overall Study|Participant moved|0|||
48777484|NCT02033889|157030606|FG000|Overall Study|Withdrawal by Subject|18|||
48777485|NCT02033889|157030607|FG001|Overall Study|Withdrawal by Subject|10|||
48777486|NCT02033889|157030608|FG002|Overall Study|Withdrawal by Subject|13|||
48777487|NCT01312909|157030610|FG000|Overall Study|Randomized but not treated|1|||
48777488|NCT01312909|157030611|FG001|Overall Study|Randomized but not treated|3|||
48777489|NCT01312909|157030612|FG002|Overall Study|Randomized but not treated|1|||
48777490|NCT01312909|157030610|FG000|Overall Study|Adverse Event|1|||
48777491|NCT01312909|157030611|FG001|Overall Study|Adverse Event|0|||
48777492|NCT01312909|157030612|FG002|Overall Study|Adverse Event|3|||
48777493|NCT01312909|157030610|FG000|Overall Study|Protocol Violation|2|||
48777494|NCT01312909|157030611|FG001|Overall Study|Protocol Violation|0|||
48777495|NCT01312909|157030612|FG002|Overall Study|Protocol Violation|2|||
48777496|NCT01312909|157030610|FG000|Overall Study|Other|9|||
48777497|NCT01312909|157030611|FG001|Overall Study|Other|6|||
48777498|NCT01312909|157030612|FG002|Overall Study|Other|11|||
48777499|NCT01312909|157030610|FG000|Overall Study|Withdrawal by Subject|8|||
48777500|NCT01312909|157030611|FG001|Overall Study|Withdrawal by Subject|10|||
48777501|NCT01312909|157030612|FG002|Overall Study|Withdrawal by Subject|7|||
48777502|NCT01312909|157030610|FG000|Overall Study|Lost to Follow-up|21|||
48777503|NCT01312909|157030611|FG001|Overall Study|Lost to Follow-up|17|||
48777504|NCT01312909|157030612|FG002|Overall Study|Lost to Follow-up|20|||
48777505|NCT01312909|157030610|FG000|Overall Study|Insufficient clinical response|0|||
48777506|NCT01312909|157030611|FG001|Overall Study|Insufficient clinical response|0|||
48777507|NCT01312909|157030612|FG002|Overall Study|Insufficient clinical response|1|||
48877021|NCT02367352|157388498|FG001|Overall Study|Adverse Event|0|||
49028217|NCT01422538|157941159|FG001|Overall Study|Missed visit|1|||
48777508|NCT01312909|157030610|FG000|Overall Study|Entrance criteria not met|0|||
48777509|NCT01312909|157030611|FG001|Overall Study|Entrance criteria not met|0|||
48777510|NCT01312909|157030612|FG002|Overall Study|Entrance criteria not met|2|||
48777511|NCT03143829|157030615|FG000|Overall Study|Withdrawal by Subject|2|||
48777512|NCT03143829|157030616|FG001|Overall Study|Withdrawal by Subject|5|||
48777513|NCT03143829|157030615|FG000|Overall Study|Lost to Follow-up|0|||
48777514|NCT03143829|157030616|FG001|Overall Study|Lost to Follow-up|2|||
48877022|NCT02367352|157388499|FG002|Overall Study|Adverse Event|0|||
48877023|NCT00174447|157388500|FG000|Overall Study|Adverse Event|19|||
48877024|NCT00174447|157388500|FG000|Overall Study|Withdrawal by Subject|15|||
48877025|NCT00174447|157388500|FG000|Overall Study|Protocol Violation|1|||
48877026|NCT00174447|157388500|FG000|Overall Study|Lack of Efficacy|1|||
48877027|NCT00174447|157388500|FG000|Overall Study|Administrative reason/Other|2|||
48877028|NCT02153905|157388501|FG000|Overall Study|Death|1|||
48777515|NCT03143829|157030615|FG000|Overall Study|Death|1|||
48777516|NCT03143829|157030616|FG001|Overall Study|Death|1|||
48777517|NCT03143829|157030615|FG000|Overall Study|changed treatment, no longer eligible|2|||
48777518|NCT03143829|157030616|FG001|Overall Study|changed treatment, no longer eligible|2|||
48777519|NCT02391948|157030617|FG000|6-month Assessment|Death|0|||
48777520|NCT02391948|157030618|FG001|6-month Assessment|Death|0|||
48777521|NCT02391948|157030619|FG002|6-month Assessment|Death|0|||
48777522|NCT02391948|157030620|FG003|6-month Assessment|Death|0|||
48777523|NCT02391948|157030621|FG004|6-month Assessment|Death|1|||
48777524|NCT02391948|157030617|FG000|6-month Assessment|Withdrawal by Subject|0|||
48777525|NCT02391948|157030618|FG001|6-month Assessment|Withdrawal by Subject|0|||
48777526|NCT02391948|157030619|FG002|6-month Assessment|Withdrawal by Subject|1|||
48777527|NCT02391948|157030620|FG003|6-month Assessment|Withdrawal by Subject|2|||
48777528|NCT02391948|157030621|FG004|6-month Assessment|Withdrawal by Subject|0|||
48777529|NCT02391948|157030617|FG000|6-month Assessment|Lost to Follow-up|4|||
48777530|NCT02391948|157030618|FG001|6-month Assessment|Lost to Follow-up|5|||
48777531|NCT02391948|157030619|FG002|6-month Assessment|Lost to Follow-up|2|||
48777532|NCT02391948|157030620|FG003|6-month Assessment|Lost to Follow-up|3|||
48777533|NCT02391948|157030621|FG004|6-month Assessment|Lost to Follow-up|1|||
48777534|NCT02391948|157030617|FG000|6-month Assessment|Medical issue/illness|1|||
48777535|NCT02391948|157030618|FG001|6-month Assessment|Medical issue/illness|1|||
48777536|NCT02391948|157030619|FG002|6-month Assessment|Medical issue/illness|0|||
48777537|NCT02391948|157030620|FG003|6-month Assessment|Medical issue/illness|0|||
48777538|NCT02391948|157030621|FG004|6-month Assessment|Medical issue/illness|0|||
48777539|NCT02391948|157030617|FG000|6-month Assessment|Not able to schedule visit in timeframe|6|||
48777540|NCT02391948|157030618|FG001|6-month Assessment|Not able to schedule visit in timeframe|8|||
48777541|NCT02391948|157030619|FG002|6-month Assessment|Not able to schedule visit in timeframe|4|||
48777542|NCT02391948|157030620|FG003|6-month Assessment|Not able to schedule visit in timeframe|5|||
48777543|NCT02391948|157030621|FG004|6-month Assessment|Not able to schedule visit in timeframe|0|||
48777544|NCT02391948|157030617|FG000|6-month Assessment|In 2-visit study (6-month N/A)|68|||
48777545|NCT02391948|157030618|FG001|6-month Assessment|In 2-visit study (6-month N/A)|42|||
48777546|NCT02391948|157030619|FG002|6-month Assessment|In 2-visit study (6-month N/A)|24|||
48777547|NCT02391948|157030620|FG003|6-month Assessment|In 2-visit study (6-month N/A)|35|||
48777548|NCT02391948|157030621|FG004|6-month Assessment|In 2-visit study (6-month N/A)|24|||
48777549|NCT02391948|157030617|FG000|12-month Assessment|Death|0|||
48777550|NCT02391948|157030618|FG001|12-month Assessment|Death|0|||
48777551|NCT02391948|157030619|FG002|12-month Assessment|Death|0|||
48777552|NCT02391948|157030620|FG003|12-month Assessment|Death|1|||
48777553|NCT02391948|157030621|FG004|12-month Assessment|Death|0|||
48777554|NCT02391948|157030617|FG000|12-month Assessment|Withdrawal by Subject|1|||
48777555|NCT02391948|157030618|FG001|12-month Assessment|Withdrawal by Subject|0|||
48777556|NCT02391948|157030619|FG002|12-month Assessment|Withdrawal by Subject|0|||
48777557|NCT02391948|157030620|FG003|12-month Assessment|Withdrawal by Subject|1|||
48777558|NCT02391948|157030621|FG004|12-month Assessment|Withdrawal by Subject|0|||
48777559|NCT02391948|157030617|FG000|12-month Assessment|Lost to Follow-up|5|||
48777560|NCT02391948|157030618|FG001|12-month Assessment|Lost to Follow-up|4|||
48777561|NCT02391948|157030619|FG002|12-month Assessment|Lost to Follow-up|4|||
48777562|NCT02391948|157030620|FG003|12-month Assessment|Lost to Follow-up|4|||
48777563|NCT02391948|157030621|FG004|12-month Assessment|Lost to Follow-up|5|||
48777564|NCT02391948|157030617|FG000|12-month Assessment|Medical issue/illness|0|||
48777565|NCT02391948|157030618|FG001|12-month Assessment|Medical issue/illness|1|||
48777566|NCT02391948|157030619|FG002|12-month Assessment|Medical issue/illness|0|||
48777567|NCT02391948|157030620|FG003|12-month Assessment|Medical issue/illness|1|||
48777568|NCT02391948|157030621|FG004|12-month Assessment|Medical issue/illness|0|||
48777569|NCT02391948|157030617|FG000|12-month Assessment|Not able to schedule visit in timeframe|2|||
48777570|NCT02391948|157030618|FG001|12-month Assessment|Not able to schedule visit in timeframe|4|||
48777571|NCT02391948|157030619|FG002|12-month Assessment|Not able to schedule visit in timeframe|0|||
48777572|NCT02391948|157030620|FG003|12-month Assessment|Not able to schedule visit in timeframe|2|||
48877029|NCT02153905|157388502|FG001|Overall Study|Death|0|||
48982580|NCT01970540|157767636|FG001|Overall Study|Clinical progression|1|||
48777573|NCT02391948|157030621|FG004|12-month Assessment|Not able to schedule visit in timeframe|1|||
48777574|NCT02391948|157030617|FG000|18-month Assessment|Death|0|||
48777575|NCT02391948|157030618|FG001|18-month Assessment|Death|0|||
48777576|NCT02391948|157030619|FG002|18-month Assessment|Death|0|||
48777577|NCT02391948|157030620|FG003|18-month Assessment|Death|1|||
48877030|NCT01547598|157388513|FG000|Overall Study|Withdrew consent|1|||
48877031|NCT01547598|157388514|FG001|Overall Study|Withdrew consent|1|||
48877032|NCT01547598|157388513|FG000|Overall Study|Lost to Follow-up|1|||
48777578|NCT02391948|157030621|FG004|18-month Assessment|Death|1|||
48777579|NCT02391948|157030617|FG000|18-month Assessment|Withdrawal by Subject|1|||
48777580|NCT02391948|157030618|FG001|18-month Assessment|Withdrawal by Subject|0|||
48777581|NCT02391948|157030619|FG002|18-month Assessment|Withdrawal by Subject|0|||
48777582|NCT02391948|157030620|FG003|18-month Assessment|Withdrawal by Subject|1|||
48777583|NCT02391948|157030621|FG004|18-month Assessment|Withdrawal by Subject|0|||
48777584|NCT02391948|157030617|FG000|18-month Assessment|Lost to Follow-up|2|||
48777585|NCT02391948|157030618|FG001|18-month Assessment|Lost to Follow-up|6|||
48777586|NCT02391948|157030619|FG002|18-month Assessment|Lost to Follow-up|2|||
48777587|NCT02391948|157030620|FG003|18-month Assessment|Lost to Follow-up|2|||
48777588|NCT02391948|157030621|FG004|18-month Assessment|Lost to Follow-up|3|||
48777589|NCT02391948|157030617|FG000|18-month Assessment|Not able to schedule visit in timeframe|3|||
48777590|NCT02391948|157030618|FG001|18-month Assessment|Not able to schedule visit in timeframe|3|||
48777591|NCT02391948|157030619|FG002|18-month Assessment|Not able to schedule visit in timeframe|2|||
48777592|NCT02391948|157030620|FG003|18-month Assessment|Not able to schedule visit in timeframe|1|||
48777593|NCT02391948|157030621|FG004|18-month Assessment|Not able to schedule visit in timeframe|4|||
48777594|NCT02391948|157030617|FG000|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66|||
48777595|NCT02391948|157030618|FG001|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41|||
48777596|NCT02391948|157030619|FG002|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
48777597|NCT02391948|157030620|FG003|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31|||
48777598|NCT02391948|157030621|FG004|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
48777599|NCT02391948|157030617|FG000|24-month Assessment|Death|0|||
48777600|NCT02391948|157030618|FG001|24-month Assessment|Death|0|||
48777601|NCT02391948|157030619|FG002|24-month Assessment|Death|0|||
48777602|NCT02391948|157030620|FG003|24-month Assessment|Death|0|||
48777603|NCT02391948|157030621|FG004|24-month Assessment|Death|1|||
48777604|NCT02391948|157030617|FG000|24-month Assessment|Withdrawal by Subject|1|||
48777605|NCT02391948|157030618|FG001|24-month Assessment|Withdrawal by Subject|1|||
48777606|NCT02391948|157030619|FG002|24-month Assessment|Withdrawal by Subject|0|||
48777607|NCT02391948|157030620|FG003|24-month Assessment|Withdrawal by Subject|0|||
48777608|NCT02391948|157030621|FG004|24-month Assessment|Withdrawal by Subject|1|||
48777609|NCT02391948|157030617|FG000|24-month Assessment|Lost to Follow-up|5|||
48777610|NCT02391948|157030618|FG001|24-month Assessment|Lost to Follow-up|4|||
48777611|NCT02391948|157030619|FG002|24-month Assessment|Lost to Follow-up|0|||
48777612|NCT02391948|157030620|FG003|24-month Assessment|Lost to Follow-up|0|||
48777613|NCT02391948|157030621|FG004|24-month Assessment|Lost to Follow-up|0|||
48777614|NCT02391948|157030617|FG000|24-month Assessment|Medical issue/illness|0|||
48777615|NCT02391948|157030618|FG001|24-month Assessment|Medical issue/illness|0|||
48777616|NCT02391948|157030619|FG002|24-month Assessment|Medical issue/illness|1|||
48777617|NCT02391948|157030620|FG003|24-month Assessment|Medical issue/illness|0|||
48777618|NCT02391948|157030621|FG004|24-month Assessment|Medical issue/illness|0|||
48777619|NCT02391948|157030617|FG000|24-month Assessment|Not able to schedule visit in timeframe|8|||
48777620|NCT02391948|157030618|FG001|24-month Assessment|Not able to schedule visit in timeframe|5|||
48777621|NCT02391948|157030619|FG002|24-month Assessment|Not able to schedule visit in timeframe|2|||
48777622|NCT02391948|157030620|FG003|24-month Assessment|Not able to schedule visit in timeframe|9|||
48777623|NCT02391948|157030621|FG004|24-month Assessment|Not able to schedule visit in timeframe|8|||
48777624|NCT00023673|157030622|FG000|Overall Study|Ineligible / no protocol treatment|0|||
48777625|NCT00023673|157030623|FG001|Overall Study|Ineligible / no protocol treatment|0|||
48777626|NCT00023673|157030624|FG002|Overall Study|Ineligible / no protocol treatment|0|||
48877033|NCT01547598|157388514|FG001|Overall Study|Lost to Follow-up|1|||
49028218|NCT01422538|157941160|FG002|Overall Study|Missed visit|1|||
49028219|NCT00004562|157941161|FG000|Overall Study|Lost to Follow-up|102|||
49028220|NCT00004562|157941162|FG001|Overall Study|Lost to Follow-up|91|||
49028221|NCT02076022|157941164|FG000|Overall Study|Withdrawal by Subject|2|||
49028222|NCT02076022|157941165|FG001|Overall Study|Withdrawal by Subject|0|||
49028223|NCT04274686|157941166|FG000|Overall Study|Physician Decision|1|||
49028224|NCT04274686|157941167|FG001|Overall Study|Physician Decision|0|||
49028225|NCT00312663|157941168|FG000|Immunization Phase|Adverse Event|0|||
49028226|NCT00312663|157941169|FG001|Immunization Phase|Adverse Event|1|||
49028227|NCT00312663|157941170|FG002|Immunization Phase|Adverse Event|0|||
48777627|NCT00023673|157030625|FG003|Overall Study|Ineligible / no protocol treatment|1|||
48777628|NCT00023673|157030622|FG000|Overall Study|Patient withdrew consent|0|||
48777629|NCT00023673|157030623|FG001|Overall Study|Patient withdrew consent|0|||
48777630|NCT00023673|157030624|FG002|Overall Study|Patient withdrew consent|0|||
48777631|NCT00023673|157030625|FG003|Overall Study|Patient withdrew consent|1|||
48777632|NCT01040871|157030631|FG000|Overall Study|Adverse Event|6|||
48777633|NCT01040871|157030632|FG001|Overall Study|Adverse Event|2|||
48777634|NCT01040871|157030631|FG000|Overall Study|Withdrawal by Subject|2|||
48777635|NCT01040871|157030632|FG001|Overall Study|Withdrawal by Subject|0|||
48777636|NCT01040871|157030631|FG000|Overall Study|Death|1|||
48777637|NCT01040871|157030632|FG001|Overall Study|Death|3|||
48777638|NCT01040871|157030631|FG000|Overall Study|Lack of Efficacy|1|||
49028228|NCT00819741|157941172|FG000|Overall Study|Adverse Event|5|||
49028229|NCT00819741|157941173|FG001|Overall Study|Adverse Event|2|||
48777639|NCT01040871|157030632|FG001|Overall Study|Lack of Efficacy|1|||
48777640|NCT01040871|157030631|FG000|Overall Study|drug supply issue|1|||
48777641|NCT01040871|157030632|FG001|Overall Study|drug supply issue|0|||
48777642|NCT01040871|157030631|FG000|Overall Study|Randomized and Not Treated|2|||
48777643|NCT01040871|157030632|FG001|Overall Study|Randomized and Not Treated|1|||
48777644|NCT01175824|157030633|FG000|Overall Study|Adverse Event|2|||
48777645|NCT01175824|157030634|FG001|Overall Study|Adverse Event|1|||
48777646|NCT01175824|157030633|FG000|Overall Study|Lack of Efficacy|2|||
48777647|NCT01175824|157030634|FG001|Overall Study|Lack of Efficacy|0|||
48777648|NCT01175824|157030633|FG000|Overall Study|Lost to Follow-up|0|||
48777649|NCT01175824|157030634|FG001|Overall Study|Lost to Follow-up|1|||
48777650|NCT01175824|157030633|FG000|Overall Study|Physician Decision|0|||
48777651|NCT01175824|157030634|FG001|Overall Study|Physician Decision|4|||
48777652|NCT01175824|157030633|FG000|Overall Study|Protocol Violation|2|||
48777653|NCT01175824|157030634|FG001|Overall Study|Protocol Violation|5|||
48982581|NCT01970540|157767637|FG002|Overall Study|Clinical progression|1|||
48777654|NCT01175824|157030633|FG000|Overall Study|Withdrawal by Subject|3|||
48777655|NCT01175824|157030634|FG001|Overall Study|Withdrawal by Subject|7|||
48777656|NCT01175824|157030633|FG000|Overall Study|Sponsor Decision|1|||
48777657|NCT01175824|157030634|FG001|Overall Study|Sponsor Decision|0|||
48777658|NCT01175824|157030633|FG000|Overall Study|Entry Criteria Not Met|6|||
48777659|NCT01175824|157030634|FG001|Overall Study|Entry Criteria Not Met|4|||
48777660|NCT00274716|157030635|FG000|Phase A|Other non-reported reason|4|||
48777661|NCT00274716|157030636|FG001|Phase A|Other non-reported reason|2|||
48777662|NCT00274716|157030637|FG002|Phase A|Other non-reported reason|1|||
48777663|NCT00274716|157030638|FG003|Phase A|Other non-reported reason|2|||
48777664|NCT00274716|157030639|FG004|Phase A|Other non-reported reason|0|||
48777665|NCT00274716|157030640|FG005|Phase A|Other non-reported reason|1|||
48777666|NCT00274716|157030635|FG000|Phase A|Participant moved|0|||
48777667|NCT00274716|157030636|FG001|Phase A|Participant moved|0|||
48777668|NCT00274716|157030637|FG002|Phase A|Participant moved|1|||
48777669|NCT00274716|157030638|FG003|Phase A|Participant moved|0|||
48777670|NCT00274716|157030639|FG004|Phase A|Participant moved|0|||
48777671|NCT00274716|157030640|FG005|Phase A|Participant moved|1|||
48777672|NCT00274716|157030635|FG000|Phase A|Site Terminated|0|||
48777673|NCT00274716|157030636|FG001|Phase A|Site Terminated|0|||
48777674|NCT00274716|157030637|FG002|Phase A|Site Terminated|0|||
48777675|NCT00274716|157030638|FG003|Phase A|Site Terminated|1|||
48777676|NCT00274716|157030639|FG004|Phase A|Site Terminated|0|||
48777677|NCT00274716|157030640|FG005|Phase A|Site Terminated|0|||
48777678|NCT00274716|157030635|FG000|Phase A|Protocol Violation|1|||
48777679|NCT00274716|157030636|FG001|Phase A|Protocol Violation|0|||
48777680|NCT00274716|157030637|FG002|Phase A|Protocol Violation|0|||
48777681|NCT00274716|157030638|FG003|Phase A|Protocol Violation|1|||
48777682|NCT00274716|157030639|FG004|Phase A|Protocol Violation|0|||
48777683|NCT00274716|157030640|FG005|Phase A|Protocol Violation|0|||
48777684|NCT00274716|157030635|FG000|Phase A|Met criteria for discontinuation|1|||
48777685|NCT00274716|157030636|FG001|Phase A|Met criteria for discontinuation|1|||
48777686|NCT00274716|157030637|FG002|Phase A|Met criteria for discontinuation|0|||
48777687|NCT00274716|157030638|FG003|Phase A|Met criteria for discontinuation|0|||
48777688|NCT00274716|157030639|FG004|Phase A|Met criteria for discontinuation|0|||
48777689|NCT00274716|157030640|FG005|Phase A|Met criteria for discontinuation|0|||
48777690|NCT00274716|157030635|FG000|Phase A|Withdrawal by Subject|2|||
48777691|NCT00274716|157030636|FG001|Phase A|Withdrawal by Subject|2|||
48777692|NCT00274716|157030637|FG002|Phase A|Withdrawal by Subject|1|||
48777693|NCT00274716|157030638|FG003|Phase A|Withdrawal by Subject|3|||
48777694|NCT00274716|157030639|FG004|Phase A|Withdrawal by Subject|0|||
48777695|NCT00274716|157030640|FG005|Phase A|Withdrawal by Subject|1|||
48777696|NCT00274716|157030635|FG000|Phase A|Adverse Event|2|||
48777697|NCT00274716|157030636|FG001|Phase A|Adverse Event|3|||
48777698|NCT00274716|157030637|FG002|Phase A|Adverse Event|3|||
48777699|NCT00274716|157030638|FG003|Phase A|Adverse Event|0|||
48777700|NCT00274716|157030639|FG004|Phase A|Adverse Event|2|||
48777701|NCT00274716|157030640|FG005|Phase A|Adverse Event|0|||
48777702|NCT00274716|157030635|FG000|Phase A|Completed but did not enter Phase B|1|||
48777703|NCT00274716|157030636|FG001|Phase A|Completed but did not enter Phase B|2|||
48777704|NCT00274716|157030637|FG002|Phase A|Completed but did not enter Phase B|2|||
48777705|NCT00274716|157030638|FG003|Phase A|Completed but did not enter Phase B|2|||
48777706|NCT00274716|157030639|FG004|Phase A|Completed but did not enter Phase B|1|||
48777707|NCT00274716|157030640|FG005|Phase A|Completed but did not enter Phase B|1|||
48982582|NCT01970540|157767635|FG000|Overall Study|End of study|2|||
48982583|NCT01970540|157767636|FG001|Overall Study|End of study|0|||
48982584|NCT01970540|157767637|FG002|Overall Study|End of study|2|||
48982585|NCT01970540|157767635|FG000|Overall Study|Adverse Event|0|||
48982586|NCT01970540|157767636|FG001|Overall Study|Adverse Event|2|||
48982587|NCT01970540|157767637|FG002|Overall Study|Adverse Event|1|||
48777708|NCT00274716|157030635|FG000|Phase B|Adverse Event|0|||
48777709|NCT00274716|157030636|FG001|Phase B|Adverse Event|0|||
48982588|NCT01970540|157767635|FG000|Overall Study|Treatment-related AE|4|||
48777710|NCT00274716|157030637|FG002|Phase B|Adverse Event|2|||
48777711|NCT00274716|157030638|FG003|Phase B|Adverse Event|0|||
48777712|NCT00274716|157030639|FG004|Phase B|Adverse Event|0|||
48777713|NCT00274716|157030640|FG005|Phase B|Adverse Event|1|||
48777714|NCT00274716|157030635|FG000|Phase B|Protocol Violation|0|||
48777715|NCT00274716|157030636|FG001|Phase B|Protocol Violation|2|||
48777716|NCT00274716|157030637|FG002|Phase B|Protocol Violation|0|||
48777717|NCT00274716|157030638|FG003|Phase B|Protocol Violation|0|||
48777718|NCT00274716|157030639|FG004|Phase B|Protocol Violation|0|||
49028230|NCT00819741|157941172|FG000|Overall Study|Lack of Efficacy|0|||
49028231|NCT00819741|157941173|FG001|Overall Study|Lack of Efficacy|2|||
49028232|NCT00819741|157941172|FG000|Overall Study|Lost to Follow-up|3|||
49028233|NCT00819741|157941173|FG001|Overall Study|Lost to Follow-up|1|||
49028234|NCT00819741|157941172|FG000|Overall Study|Protocol Violation|3|||
49028235|NCT00819741|157941173|FG001|Overall Study|Protocol Violation|4|||
49028236|NCT00819741|157941172|FG000|Overall Study|Withdrawal by Subject|2|||
49028237|NCT00819741|157941173|FG001|Overall Study|Withdrawal by Subject|2|||
49028238|NCT00819741|157941172|FG000|Overall Study|Unclassified|6|||
49028239|NCT00819741|157941173|FG001|Overall Study|Unclassified|0|||
49028240|NCT00819741|157941172|FG000|Overall Study|Reasons unknown|3|||
49028241|NCT00819741|157941173|FG001|Overall Study|Reasons unknown|3|||
49028242|NCT00376623|157941174|FG000|Overall Study|Progressive disease|35|||
49028243|NCT00376623|157941175|FG001|Overall Study|Progressive disease|22|||
49028244|NCT00376623|157941176|FG002|Overall Study|Progressive disease|17|||
49028245|NCT00376623|157941174|FG000|Overall Study|Lost to Follow-up|0|||
49028246|NCT00376623|157941175|FG001|Overall Study|Lost to Follow-up|1|||
49028247|NCT00376623|157941176|FG002|Overall Study|Lost to Follow-up|0|||
49028248|NCT00376623|157941174|FG000|Overall Study|Adverse Event other than Dose Limiting Toxicity|6|||
49028249|NCT00376623|157941175|FG001|Overall Study|Adverse Event other than Dose Limiting Toxicity|1|||
49028250|NCT00376623|157941176|FG002|Overall Study|Adverse Event other than Dose Limiting Toxicity|2|||
49028251|NCT00376623|157941174|FG000|Overall Study|Not treated with BI 2536|1|||
49028252|NCT00376623|157941175|FG001|Overall Study|Not treated with BI 2536|0|||
49028253|NCT00376623|157941176|FG002|Overall Study|Not treated with BI 2536|0|||
49028254|NCT00376623|157941174|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
49028255|NCT00376623|157941175|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
49028256|NCT00376623|157941176|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
49028257|NCT00376623|157941174|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|1|||
49028258|NCT00376623|157941175|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
49028259|NCT00376623|157941176|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
49028260|NCT00376623|157941174|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|2|||
49028261|NCT00376623|157941175|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
49028262|NCT00376623|157941176|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
49028263|NCT00376623|157941174|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
49028264|NCT00376623|157941175|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536|1|||
49028265|NCT00376623|157941176|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
49028266|NCT00376623|157941174|FG000|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
49028267|NCT00376623|157941175|FG001|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
49028268|NCT00376623|157941176|FG002|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
49028269|NCT00376623|157941174|FG000|Overall Study|Participant's decision to stop treatment with BI 2536|2|||
49028270|NCT00376623|157941175|FG001|Overall Study|Participant's decision to stop treatment with BI 2536|0|||
49028271|NCT00376623|157941176|FG002|Overall Study|Participant's decision to stop treatment with BI 2536|1|||
49028272|NCT00376623|157941174|FG000|Overall Study|Increase of tumour markers|0|||
48777719|NCT00274716|157030640|FG005|Phase B|Protocol Violation|0|||
48777720|NCT00274716|157030635|FG000|Phase B|Withdrawal by Subject|0|||
48777721|NCT00274716|157030636|FG001|Phase B|Withdrawal by Subject|1|||
48777722|NCT00274716|157030637|FG002|Phase B|Withdrawal by Subject|0|||
48777723|NCT00274716|157030638|FG003|Phase B|Withdrawal by Subject|0|||
48777724|NCT00274716|157030639|FG004|Phase B|Withdrawal by Subject|0|||
48777725|NCT00274716|157030640|FG005|Phase B|Withdrawal by Subject|0|||
48777726|NCT00274716|157030635|FG000|Phase B|Participant moved|1|||
48777727|NCT00274716|157030636|FG001|Phase B|Participant moved|0|||
48777728|NCT00274716|157030637|FG002|Phase B|Participant moved|0|||
48777729|NCT00274716|157030638|FG003|Phase B|Participant moved|0|||
48777730|NCT00274716|157030639|FG004|Phase B|Participant moved|0|||
48777731|NCT00274716|157030640|FG005|Phase B|Participant moved|0|||
48777732|NCT00274716|157030635|FG000|Phase B|Other non-reported reason|0|||
48777733|NCT00274716|157030636|FG001|Phase B|Other non-reported reason|0|||
48777734|NCT00274716|157030637|FG002|Phase B|Other non-reported reason|1|||
48777735|NCT00274716|157030638|FG003|Phase B|Other non-reported reason|1|||
48777736|NCT00274716|157030639|FG004|Phase B|Other non-reported reason|0|||
48777737|NCT00274716|157030640|FG005|Phase B|Other non-reported reason|0|||
48777738|NCT00274716|157030635|FG000|Phase B|Lost to Follow-up|0|||
48777739|NCT00274716|157030636|FG001|Phase B|Lost to Follow-up|1|||
49028273|NCT00376623|157941175|FG001|Overall Study|Increase of tumour markers|1|||
49028274|NCT00376623|157941176|FG002|Overall Study|Increase of tumour markers|0|||
49028275|NCT00376623|157941174|FG000|Overall Study|Bone metastasis|1|||
49028276|NCT00376623|157941175|FG001|Overall Study|Bone metastasis|0|||
49028277|NCT00376623|157941176|FG002|Overall Study|Bone metastasis|0|||
49028278|NCT04652700|157941181|FG000|Part 1: Blinded Study Medication|Adverse Event|1|||
49028279|NCT04652700|157941182|FG001|Part 1: Blinded Study Medication|Adverse Event|0|||
49028280|NCT04652700|157941181|FG000|Part 1: Blinded Study Medication|Lost to Follow-up|7|||
49028281|NCT04652700|157941182|FG001|Part 1: Blinded Study Medication|Lost to Follow-up|2|||
49028282|NCT04652700|157941181|FG000|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|308|||
49028283|NCT04652700|157941182|FG001|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|160|||
49028284|NCT04652700|157941181|FG000|Part 1: Blinded Study Medication|Withdrawal by Subject|12|||
49028285|NCT04652700|157941182|FG001|Part 1: Blinded Study Medication|Withdrawal by Subject|4|||
49028286|NCT04652700|157941181|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|34|||
49028287|NCT04652700|157941182|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|9|||
49028288|NCT04652700|157941181|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|6|||
49028289|NCT04652700|157941182|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|1|||
49028290|NCT04652700|157941181|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|0|||
49028291|NCT04652700|157941182|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|2|||
49028292|NCT04652700|157941181|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|227|||
49028293|NCT04652700|157941182|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|119|||
49028294|NCT04652700|157941181|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|39|||
49028295|NCT04652700|157941182|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|23|||
49028296|NCT00286754|157941184|FG000|Overall Study|Adverse Event|2|||
49028297|NCT00286754|157941185|FG001|Overall Study|Adverse Event|2|||
49028298|NCT00286754|157941186|FG002|Overall Study|Adverse Event|3|||
49028299|NCT00286754|157941184|FG000|Overall Study|Withdrawal by Subject|6|||
49028300|NCT00286754|157941185|FG001|Overall Study|Withdrawal by Subject|2|||
49028301|NCT00286754|157941186|FG002|Overall Study|Withdrawal by Subject|0|||
49028302|NCT00286754|157941184|FG000|Overall Study|Lost to Follow-up|12|||
49028303|NCT00286754|157941185|FG001|Overall Study|Lost to Follow-up|14|||
49028304|NCT00286754|157941186|FG002|Overall Study|Lost to Follow-up|6|||
49028305|NCT00286754|157941184|FG000|Overall Study|Moved out of state|0|||
49028306|NCT00286754|157941185|FG001|Overall Study|Moved out of state|0|||
49028307|NCT00286754|157941186|FG002|Overall Study|Moved out of state|1|||
49028308|NCT01536405|157941187|FG000|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8|||
49028309|NCT01536405|157941188|FG001|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4|||
49028310|NCT01536405|157941187|FG000|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12|||
49028311|NCT01536405|157941188|FG001|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18|||
49028312|NCT01536405|157941187|FG000|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20|||
49028313|NCT01536405|157941188|FG001|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22|||
49028314|NCT01536405|157941187|FG000|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17|||
49028315|NCT01536405|157941188|FG001|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13|||
49028316|NCT01536405|157941187|FG000|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
49028317|NCT01536405|157941188|FG001|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
49028318|NCT01536405|157941187|FG000|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9|||
49028319|NCT01536405|157941188|FG001|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10|||
49028320|NCT01536405|157941187|FG000|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
49028321|NCT01536405|157941188|FG001|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
49028322|NCT01536405|157941187|FG000|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3|||
49028323|NCT01536405|157941188|FG001|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2|||
49028324|NCT01536405|157941187|FG000|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1|||
49028325|NCT01536405|157941188|FG001|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0|||
49028326|NCT01536405|157941187|FG000|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16|||
49028327|NCT01536405|157941188|FG001|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14|||
49028328|NCT01536405|157941187|FG000|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0|||
49028329|NCT01536405|157941188|FG001|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2|||
49028330|NCT01536405|157941187|FG000|Visit 4 to Extended Study Follow-up|Adverse Event|0|||
49028331|NCT01536405|157941188|FG001|Visit 4 to Extended Study Follow-up|Adverse Event|1|||
48777740|NCT00274716|157030637|FG002|Phase B|Lost to Follow-up|0|||
48777741|NCT00274716|157030638|FG003|Phase B|Lost to Follow-up|0|||
48777742|NCT00274716|157030639|FG004|Phase B|Lost to Follow-up|0|||
48777743|NCT00274716|157030640|FG005|Phase B|Lost to Follow-up|0|||
48777744|NCT02489981|157030642|FG000|Overall Study|Adverse Event|21|||
48777745|NCT02489981|157030642|FG000|Overall Study|Insufficient effectiveness|16|||
48777746|NCT02489981|157030642|FG000|Overall Study|Improved|31|||
49028332|NCT01536405|157941187|FG000|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
49028333|NCT01536405|157941188|FG001|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
48777747|NCT02489981|157030642|FG000|Overall Study|Lost to Follow-up|31|||
49028334|NCT02661295|157941189|FG000|Overall Study|Death|1|||
49028335|NCT02661295|157941189|FG000|Overall Study|Transferred Out|1|||
49028336|NCT02661295|157941189|FG000|Overall Study|Kidney Transplant|1|||
49028337|NCT02661295|157941189|FG000|Overall Study|Withdrawn due to side effects|8|||
49028338|NCT02661295|157941189|FG000|Overall Study|Withdrawn due to access type|1|||
49028339|NCT02661295|157941189|FG000|Overall Study|Withdrawn due to allergies|1|||
49028340|NCT02661295|157941189|FG000|Overall Study|Withdrawn due to non-compliance|1|||
49028341|NCT02661295|157941189|FG000|Overall Study|Withdrawal by Subject|3|||
49028342|NCT02661295|157941189|FG000|Overall Study|Failed screening|2|||
49028343|NCT00301366|157941190|FG000|Overall Study|Adverse Event|1|||
49028344|NCT04213326|157941191|FG000|Overall Study|Consent withdrawn|51|||
49028345|NCT04213326|157941192|FG001|Overall Study|Consent withdrawn|241|||
49028346|NCT04213326|157941191|FG000|Overall Study|Lost to Follow-up|50|||
49028347|NCT04213326|157941192|FG001|Overall Study|Lost to Follow-up|902|||
49028348|NCT04213326|157941191|FG000|Overall Study|Protocol Violation|3|||
49028349|NCT04213326|157941192|FG001|Overall Study|Protocol Violation|25|||
49028350|NCT04213326|157941191|FG000|Overall Study|Participant eligibility changed|106|||
49028351|NCT04213326|157941192|FG001|Overall Study|Participant eligibility changed|19|||
49028352|NCT04213326|157941191|FG000|Overall Study|SCRI confirmed to be withdrawal|0|||
49028353|NCT04213326|157941192|FG001|Overall Study|SCRI confirmed to be withdrawal|16|||
49028354|NCT04213326|157941191|FG000|Overall Study|Incomplete study visit|0|||
49028355|NCT04213326|157941192|FG001|Overall Study|Incomplete study visit|367|||
49028356|NCT01313273|157941197|FG000|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1|||
49028357|NCT01313273|157941198|FG001|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0|||
49028358|NCT01313273|157941197|FG000|Overall Study|Withdrawal by Subject|1|||
49028359|NCT01313273|157941198|FG001|Overall Study|Withdrawal by Subject|0|||
48777748|NCT02489981|157030642|FG000|Overall Study|Other than listed|28|||
48777749|NCT00796861|157030643|FG000|Overall Study|Withdrawal by Subject|2|||
48777750|NCT00796861|157030643|FG000|Overall Study|Death|2|||
48777751|NCT01358981|157030646|FG000|Period 1|Withdrawal by Subject|0|||
48777752|NCT01358981|157030647|FG001|Period 1|Withdrawal by Subject|0|||
48777753|NCT01358981|157030648|FG002|Period 1|Withdrawal by Subject|0|||
48777754|NCT01358981|157030649|FG003|Period 1|Withdrawal by Subject|1|||
48777755|NCT01358981|157030650|FG004|Period 1|Withdrawal by Subject|0|||
49028360|NCT01313273|157941197|FG000|Overall Study|Screening Chromogranin A-in normal range|0|||
49028361|NCT01313273|157941198|FG001|Overall Study|Screening Chromogranin A-in normal range|1|||
49028362|NCT02549092|157941199|FG000|Treatment Period|Adverse Event|2|||
49028363|NCT02549092|157941200|FG001|Treatment Period|Adverse Event|2|||
49028364|NCT02549092|157941199|FG000|Treatment Period|Withdrawal by Subject|1|||
49028365|NCT02549092|157941200|FG001|Treatment Period|Withdrawal by Subject|3|||
49028366|NCT02549092|157941199|FG000|Treatment Period|Lack of Efficacy|0|||
49028367|NCT02549092|157941200|FG001|Treatment Period|Lack of Efficacy|2|||
49028368|NCT02549092|157941199|FG000|Extension/Transition Period|Adverse Event|1|||
49028369|NCT02549092|157941200|FG001|Extension/Transition Period|Adverse Event|1|||
49028370|NCT02549092|157941199|FG000|Extension/Transition Period|Withdrawal by Subject|0|||
49028371|NCT02549092|157941200|FG001|Extension/Transition Period|Withdrawal by Subject|1|||
49028372|NCT02549092|157941199|FG000|Extension/Transition Period|Other, Not Specified|4|||
49028373|NCT02549092|157941200|FG001|Extension/Transition Period|Other, Not Specified|2|||
49028374|NCT03687736|157941205|FG000|Overall Study|Lost to Follow-up|7|||
49028375|NCT03687736|157941205|FG000|Overall Study|Withdrawal by Subject|3|||
49028376|NCT01496183|157941210|FG000|Overall Study|Physician Decision|3|||
49028377|NCT01496183|157941211|FG001|Overall Study|Physician Decision|1|||
49028378|NCT01496183|157941210|FG000|Overall Study|Withdrawal by Subject|0|||
49028379|NCT01496183|157941211|FG001|Overall Study|Withdrawal by Subject|1|||
49028380|NCT01546545|157941213|FG000|Overall Study|Withdrawal by Subject|1|||
49028381|NCT05093205|157941214|FG000|Part A Period 2 - Treatment|Physician Decision|0|||
49028382|NCT05093205|157941215|FG001|Part A Period 2 - Treatment|Physician Decision|1|||
49028383|NCT05093205|157941216|FG002|Part A Period 2 - Treatment|Physician Decision|0|||
49028384|NCT05093205|157941217|FG003|Part A Period 2 - Treatment|Physician Decision|0|||
49028385|NCT05093205|157941218|FG004|Part A Period 2 - Treatment|Physician Decision|0|||
49028386|NCT05093205|157941219|FG005|Part A Period 2 - Treatment|Physician Decision|0|||
49028387|NCT05093205|157941220|FG006|Part A Period 2 - Treatment|Physician Decision|0|||
48777756|NCT01358981|157030651|FG005|Period 1|Withdrawal by Subject|0|||
48777757|NCT01358981|157030652|FG006|Period 1|Withdrawal by Subject|0|||
49028388|NCT05093205|157941221|FG007|Part A Period 2 - Treatment|Physician Decision|0|||
49028389|NCT05093205|157941222|FG008|Part A Period 2 - Treatment|Physician Decision|0|||
49028390|NCT05093205|157941223|FG009|Part A Period 2 - Treatment|Physician Decision|0|||
49028391|NCT05093205|157941224|FG010|Part A Period 2 - Treatment|Physician Decision|0|||
49028392|NCT05093205|157941225|FG011|Part A Period 2 - Treatment|Physician Decision|0|||
49028393|NCT05093205|157941226|FG012|Part A Period 2 - Treatment|Physician Decision|0|||
49028394|NCT05093205|157941214|FG000|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
49028395|NCT05093205|157941215|FG001|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
49028396|NCT05093205|157941216|FG002|Part A Period 3 - Treatment|Withdrawal by Subject|1|||
48777758|NCT02370888|157030653|FG000|Overall Study|disease progression|2|||
48777759|NCT02370888|157030653|FG000|Overall Study|did not meet chimerism criteria|6|||
49028397|NCT05093205|157941217|FG003|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
49028398|NCT05093205|157941218|FG004|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
49028399|NCT05093205|157941219|FG005|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
49028400|NCT05093205|157941220|FG006|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
49028401|NCT05093205|157941221|FG007|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
49028402|NCT05093205|157941222|FG008|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
49028403|NCT05093205|157941223|FG009|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
49028404|NCT05093205|157941224|FG010|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
49028405|NCT05093205|157941225|FG011|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
49028406|NCT05093205|157941226|FG012|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
49028407|NCT05093205|157941214|FG000|Part A Period 3 - Treatment|Physician Decision|0|||
49028408|NCT05093205|157941215|FG001|Part A Period 3 - Treatment|Physician Decision|0|||
49028409|NCT05093205|157941216|FG002|Part A Period 3 - Treatment|Physician Decision|1|||
49028410|NCT05093205|157941217|FG003|Part A Period 3 - Treatment|Physician Decision|0|||
49028411|NCT05093205|157941218|FG004|Part A Period 3 - Treatment|Physician Decision|0|||
49028412|NCT05093205|157941219|FG005|Part A Period 3 - Treatment|Physician Decision|0|||
49028413|NCT05093205|157941220|FG006|Part A Period 3 - Treatment|Physician Decision|0|||
49028414|NCT05093205|157941221|FG007|Part A Period 3 - Treatment|Physician Decision|0|||
49028415|NCT05093205|157941222|FG008|Part A Period 3 - Treatment|Physician Decision|0|||
49028416|NCT05093205|157941223|FG009|Part A Period 3 - Treatment|Physician Decision|0|||
49028417|NCT05093205|157941224|FG010|Part A Period 3 - Treatment|Physician Decision|0|||
49028418|NCT05093205|157941225|FG011|Part A Period 3 - Treatment|Physician Decision|0|||
49028419|NCT05093205|157941226|FG012|Part A Period 3 - Treatment|Physician Decision|0|||
49028420|NCT05093205|157941214|FG000|Part A Period 3 - Treatment|Adverse Event|0|||
49028421|NCT05093205|157941215|FG001|Part A Period 3 - Treatment|Adverse Event|0|||
49028422|NCT05093205|157941216|FG002|Part A Period 3 - Treatment|Adverse Event|2|||
49028423|NCT05093205|157941217|FG003|Part A Period 3 - Treatment|Adverse Event|0|||
49028424|NCT05093205|157941218|FG004|Part A Period 3 - Treatment|Adverse Event|0|||
49028425|NCT05093205|157941219|FG005|Part A Period 3 - Treatment|Adverse Event|0|||
49028426|NCT05093205|157941220|FG006|Part A Period 3 - Treatment|Adverse Event|0|||
49028427|NCT05093205|157941221|FG007|Part A Period 3 - Treatment|Adverse Event|0|||
49028428|NCT05093205|157941222|FG008|Part A Period 3 - Treatment|Adverse Event|0|||
49028429|NCT05093205|157941223|FG009|Part A Period 3 - Treatment|Adverse Event|0|||
49028430|NCT05093205|157941224|FG010|Part A Period 3 - Treatment|Adverse Event|0|||
49028431|NCT05093205|157941225|FG011|Part A Period 3 - Treatment|Adverse Event|0|||
49028432|NCT05093205|157941226|FG012|Part A Period 3 - Treatment|Adverse Event|0|||
49028433|NCT05093205|157941214|FG000|Part A Period 6 - Treatment|Adverse Event|0|||
49028434|NCT05093205|157941215|FG001|Part A Period 6 - Treatment|Adverse Event|0|||
49028435|NCT05093205|157941216|FG002|Part A Period 6 - Treatment|Adverse Event|0|||
49028436|NCT05093205|157941217|FG003|Part A Period 6 - Treatment|Adverse Event|0|||
49028437|NCT05093205|157941218|FG004|Part A Period 6 - Treatment|Adverse Event|0|||
49028438|NCT05093205|157941219|FG005|Part A Period 6 - Treatment|Adverse Event|7|||
49028439|NCT05093205|157941220|FG006|Part A Period 6 - Treatment|Adverse Event|0|||
49028440|NCT05093205|157941221|FG007|Part A Period 6 - Treatment|Adverse Event|0|||
49028441|NCT05093205|157941222|FG008|Part A Period 6 - Treatment|Adverse Event|0|||
49028442|NCT05093205|157941223|FG009|Part A Period 6 - Treatment|Adverse Event|0|||
49028443|NCT05093205|157941224|FG010|Part A Period 6 - Treatment|Adverse Event|0|||
49028444|NCT05093205|157941225|FG011|Part A Period 6 - Treatment|Adverse Event|0|||
49028445|NCT05093205|157941226|FG012|Part A Period 6 - Treatment|Adverse Event|0|||
49028446|NCT05093205|157941214|FG000|Part A Period 8 - Treatment|Adverse Event|0|||
49028447|NCT05093205|157941215|FG001|Part A Period 8 - Treatment|Adverse Event|0|||
49028448|NCT05093205|157941216|FG002|Part A Period 8 - Treatment|Adverse Event|0|||
49028449|NCT05093205|157941217|FG003|Part A Period 8 - Treatment|Adverse Event|0|||
49028450|NCT05093205|157941218|FG004|Part A Period 8 - Treatment|Adverse Event|0|||
48777760|NCT01785524|157030654|FG000|Overall Study|Withdrawal by Subject|2|||
48777761|NCT01785524|157030655|FG001|Overall Study|Withdrawal by Subject|2|||
48777762|NCT01060384|157030656|FG000|Overall Study|Withdrawal by Subject|0|||
48777763|NCT01060384|157030657|FG001|Overall Study|Withdrawal by Subject|1|||
48777764|NCT01060384|157030658|FG002|Overall Study|Withdrawal by Subject|0|||
48777765|NCT01060384|157030659|FG003|Overall Study|Withdrawal by Subject|0|||
48877034|NCT01547598|157388513|FG000|Overall Study|Adverse Event|1|||
48877035|NCT01547598|157388514|FG001|Overall Study|Adverse Event|1|||
48877036|NCT01547598|157388513|FG000|Overall Study|Protocol Violation|1|||
49028451|NCT05093205|157941219|FG005|Part A Period 8 - Treatment|Adverse Event|0|||
49028452|NCT05093205|157941220|FG006|Part A Period 8 - Treatment|Adverse Event|0|||
49028453|NCT05093205|157941221|FG007|Part A Period 8 - Treatment|Adverse Event|1|||
49028454|NCT05093205|157941222|FG008|Part A Period 8 - Treatment|Adverse Event|0|||
49028455|NCT05093205|157941223|FG009|Part A Period 8 - Treatment|Adverse Event|0|||
49028456|NCT05093205|157941224|FG010|Part A Period 8 - Treatment|Adverse Event|0|||
49028457|NCT05093205|157941225|FG011|Part A Period 8 - Treatment|Adverse Event|0|||
49028458|NCT05093205|157941226|FG012|Part A Period 8 - Treatment|Adverse Event|0|||
48777766|NCT01060384|157030660|FG004|Overall Study|Withdrawal by Subject|0|||
48777767|NCT01060384|157030656|FG000|Overall Study|Death|0|||
48877037|NCT01547598|157388514|FG001|Overall Study|Protocol Violation|1|||
49028459|NCT05093205|157941214|FG000|Part B Period 1 - Treatment|Protocol Violation|0|||
49028460|NCT05093205|157941215|FG001|Part B Period 1 - Treatment|Protocol Violation|0|||
49028461|NCT05093205|157941216|FG002|Part B Period 1 - Treatment|Protocol Violation|0|||
49028462|NCT05093205|157941217|FG003|Part B Period 1 - Treatment|Protocol Violation|0|||
48777768|NCT01060384|157030657|FG001|Overall Study|Death|0|||
48777769|NCT01060384|157030658|FG002|Overall Study|Death|0|||
48777770|NCT01060384|157030659|FG003|Overall Study|Death|0|||
48777771|NCT01060384|157030660|FG004|Overall Study|Death|1|||
48777772|NCT01060384|157030656|FG000|Overall Study|Intercurrent illness|0|||
48777773|NCT01060384|157030657|FG001|Overall Study|Intercurrent illness|0|||
48777774|NCT01060384|157030658|FG002|Overall Study|Intercurrent illness|0|||
48777775|NCT01060384|157030659|FG003|Overall Study|Intercurrent illness|0|||
48777776|NCT01060384|157030660|FG004|Overall Study|Intercurrent illness|1|||
48777777|NCT02863354|157030664|FG000|Year 1|Lost to Follow-up|1|||
48777778|NCT02863354|157030665|FG001|Year 1|Lost to Follow-up|1|||
48777779|NCT02863354|157030664|FG000|Year 1|Withdrawal by Subject|3|||
48777780|NCT02863354|157030665|FG001|Year 1|Withdrawal by Subject|0|||
48777781|NCT02863354|157030664|FG000|Year 1|Death|0|||
48777782|NCT02863354|157030665|FG001|Year 1|Death|1|||
48777783|NCT02863354|157030664|FG000|Year 2|Lost to Follow-up|2|||
48777784|NCT02863354|157030665|FG001|Year 2|Lost to Follow-up|2|||
48777785|NCT02822794|157030666|FG000|Overall Study|Withdrew Consent|1|||
48777786|NCT02822794|157030667|FG001|Overall Study|Withdrew Consent|0|||
48777787|NCT02266381|157030668|FG000|Overall Study|Physician Decision|3|||
48777788|NCT02266381|157030669|FG001|Overall Study|Physician Decision|5|||
48777789|NCT02266381|157030670|FG002|Overall Study|Physician Decision|4|||
49028463|NCT05093205|157941218|FG004|Part B Period 1 - Treatment|Protocol Violation|0|||
49028464|NCT05093205|157941219|FG005|Part B Period 1 - Treatment|Protocol Violation|0|||
49028465|NCT05093205|157941220|FG006|Part B Period 1 - Treatment|Protocol Violation|0|||
49028466|NCT05093205|157941221|FG007|Part B Period 1 - Treatment|Protocol Violation|0|||
49028467|NCT05093205|157941222|FG008|Part B Period 1 - Treatment|Protocol Violation|1|||
49028468|NCT05093205|157941223|FG009|Part B Period 1 - Treatment|Protocol Violation|0|||
49028469|NCT05093205|157941224|FG010|Part B Period 1 - Treatment|Protocol Violation|0|||
49028470|NCT05093205|157941225|FG011|Part B Period 1 - Treatment|Protocol Violation|0|||
49028471|NCT05093205|157941226|FG012|Part B Period 1 - Treatment|Protocol Violation|0|||
49028472|NCT05093205|157941214|FG000|Part B Period 2 - Treatment|Adverse Event|0|||
49028473|NCT05093205|157941215|FG001|Part B Period 2 - Treatment|Adverse Event|0|||
49028474|NCT05093205|157941216|FG002|Part B Period 2 - Treatment|Adverse Event|0|||
49028475|NCT05093205|157941217|FG003|Part B Period 2 - Treatment|Adverse Event|0|||
49028476|NCT05093205|157941218|FG004|Part B Period 2 - Treatment|Adverse Event|0|||
49028477|NCT05093205|157941219|FG005|Part B Period 2 - Treatment|Adverse Event|0|||
49028478|NCT05093205|157941220|FG006|Part B Period 2 - Treatment|Adverse Event|0|||
49028479|NCT05093205|157941221|FG007|Part B Period 2 - Treatment|Adverse Event|0|||
49028480|NCT05093205|157941222|FG008|Part B Period 2 - Treatment|Adverse Event|0|||
49028481|NCT05093205|157941223|FG009|Part B Period 2 - Treatment|Adverse Event|2|||
49028482|NCT05093205|157941224|FG010|Part B Period 2 - Treatment|Adverse Event|0|||
49028483|NCT05093205|157941225|FG011|Part B Period 2 - Treatment|Adverse Event|0|||
49028484|NCT05093205|157941226|FG012|Part B Period 2 - Treatment|Adverse Event|0|||
49028485|NCT05093205|157941214|FG000|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
49028486|NCT05093205|157941215|FG001|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
49028487|NCT05093205|157941216|FG002|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
49028488|NCT05093205|157941217|FG003|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
49028489|NCT05093205|157941218|FG004|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
49028490|NCT05093205|157941219|FG005|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
49028491|NCT05093205|157941220|FG006|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
49028492|NCT05093205|157941221|FG007|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
49028493|NCT05093205|157941222|FG008|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
49028494|NCT05093205|157941223|FG009|Part B Period 2 - Follow-Up|Withdrawal by Subject|1|||
49028495|NCT05093205|157941224|FG010|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
49028496|NCT05093205|157941225|FG011|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
49028497|NCT05093205|157941226|FG012|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
49028498|NCT05093205|157941214|FG000|Part B Period 3 - Treatment|Adverse Event|0|||
49028499|NCT05093205|157941215|FG001|Part B Period 3 - Treatment|Adverse Event|0|||
49028500|NCT05093205|157941216|FG002|Part B Period 3 - Treatment|Adverse Event|0|||
49028501|NCT05093205|157941217|FG003|Part B Period 3 - Treatment|Adverse Event|0|||
49028502|NCT05093205|157941218|FG004|Part B Period 3 - Treatment|Adverse Event|0|||
49028503|NCT05093205|157941219|FG005|Part B Period 3 - Treatment|Adverse Event|0|||
49028504|NCT05093205|157941220|FG006|Part B Period 3 - Treatment|Adverse Event|0|||
49028505|NCT05093205|157941221|FG007|Part B Period 3 - Treatment|Adverse Event|0|||
48777790|NCT03433456|157030675|FG000|Overall Study|Death|1|||
48777791|NCT03433456|157030676|FG001|Overall Study|Death|1|||
48777792|NCT03433456|157030675|FG000|Overall Study|Lost to Follow-up|14|||
48777793|NCT03433456|157030676|FG001|Overall Study|Lost to Follow-up|11|||
48777794|NCT03433456|157030675|FG000|Overall Study|Pt in ICU and unable to complete follow-up visit|1|||
48777795|NCT03433456|157030676|FG001|Overall Study|Pt in ICU and unable to complete follow-up visit|0|||
49028506|NCT05093205|157941222|FG008|Part B Period 3 - Treatment|Adverse Event|0|||
49028507|NCT05093205|157941223|FG009|Part B Period 3 - Treatment|Adverse Event|0|||
48777796|NCT03251924|157030682|FG000|Overall Study|Disease Progression|6|||
48777797|NCT03251924|157030683|FG001|Overall Study|Disease Progression|6|||
48777798|NCT03251924|157030684|FG002|Overall Study|Disease Progression|7|||
48777799|NCT03251924|157030685|FG003|Overall Study|Disease Progression|8|||
48777800|NCT03251924|157030686|FG004|Overall Study|Disease Progression|8|||
48777801|NCT03251924|157030687|FG005|Overall Study|Disease Progression|7|||
48777802|NCT03251924|157030688|FG006|Overall Study|Disease Progression|6|||
48777803|NCT03251924|157030689|FG007|Overall Study|Disease Progression|10|||
48877038|NCT01547598|157388513|FG000|Overall Study|Other Miscellaneous Reasons|2|||
49028508|NCT05093205|157941224|FG010|Part B Period 3 - Treatment|Adverse Event|2|||
49028509|NCT05093205|157941225|FG011|Part B Period 3 - Treatment|Adverse Event|0|||
48777804|NCT03251924|157030690|FG008|Overall Study|Disease Progression|6|||
48777805|NCT03251924|157030682|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
48777806|NCT03251924|157030683|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
49028510|NCT05093205|157941226|FG012|Part B Period 3 - Treatment|Adverse Event|0|||
48777807|NCT03251924|157030684|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
48777808|NCT03251924|157030685|FG003|Overall Study|Adverse Event unrelated to study drug|1|||
48777809|NCT03251924|157030686|FG004|Overall Study|Adverse Event unrelated to study drug|0|||
48777810|NCT03251924|157030687|FG005|Overall Study|Adverse Event unrelated to study drug|1|||
48777811|NCT03251924|157030688|FG006|Overall Study|Adverse Event unrelated to study drug|1|||
48777812|NCT03251924|157030689|FG007|Overall Study|Adverse Event unrelated to study drug|0|||
48777813|NCT03251924|157030690|FG008|Overall Study|Adverse Event unrelated to study drug|0|||
48777814|NCT03251924|157030682|FG000|Overall Study|Death|0|||
48777815|NCT03251924|157030683|FG001|Overall Study|Death|1|||
48777816|NCT03251924|157030684|FG002|Overall Study|Death|0|||
48777817|NCT03251924|157030685|FG003|Overall Study|Death|1|||
48777818|NCT03251924|157030686|FG004|Overall Study|Death|1|||
48777819|NCT03251924|157030687|FG005|Overall Study|Death|1|||
48777820|NCT03251924|157030688|FG006|Overall Study|Death|0|||
48777821|NCT03251924|157030689|FG007|Overall Study|Death|0|||
48777822|NCT03251924|157030690|FG008|Overall Study|Death|0|||
48777823|NCT03251924|157030682|FG000|Overall Study|Study Drug Toxicity|0|||
48777824|NCT03251924|157030683|FG001|Overall Study|Study Drug Toxicity|0|||
48777825|NCT03251924|157030684|FG002|Overall Study|Study Drug Toxicity|0|||
48777826|NCT03251924|157030685|FG003|Overall Study|Study Drug Toxicity|1|||
48777827|NCT03251924|157030686|FG004|Overall Study|Study Drug Toxicity|0|||
48777828|NCT03251924|157030687|FG005|Overall Study|Study Drug Toxicity|0|||
48777829|NCT03251924|157030688|FG006|Overall Study|Study Drug Toxicity|0|||
48777830|NCT03251924|157030689|FG007|Overall Study|Study Drug Toxicity|0|||
48777831|NCT03251924|157030690|FG008|Overall Study|Study Drug Toxicity|1|||
48777832|NCT03251924|157030682|FG000|Overall Study|Other Reasons|0|||
48777833|NCT03251924|157030683|FG001|Overall Study|Other Reasons|0|||
48777834|NCT03251924|157030684|FG002|Overall Study|Other Reasons|0|||
48777835|NCT03251924|157030685|FG003|Overall Study|Other Reasons|0|||
48777836|NCT03251924|157030686|FG004|Overall Study|Other Reasons|0|||
48777837|NCT03251924|157030687|FG005|Overall Study|Other Reasons|0|||
48777838|NCT03251924|157030688|FG006|Overall Study|Other Reasons|0|||
48777839|NCT03251924|157030689|FG007|Overall Study|Other Reasons|0|||
48777840|NCT03251924|157030690|FG008|Overall Study|Other Reasons|1|||
49028511|NCT05093205|157941214|FG000|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
49028512|NCT05093205|157941215|FG001|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
49028513|NCT05093205|157941216|FG002|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
49028514|NCT05093205|157941217|FG003|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
49028515|NCT05093205|157941218|FG004|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
49028516|NCT05093205|157941219|FG005|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
49028517|NCT05093205|157941220|FG006|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
48777841|NCT03251924|157030682|FG000|Overall Study|Participant request to discontinue study treatment|0|||
48777842|NCT03251924|157030683|FG001|Overall Study|Participant request to discontinue study treatment|0|||
48777843|NCT03251924|157030684|FG002|Overall Study|Participant request to discontinue study treatment|0|||
48777844|NCT03251924|157030685|FG003|Overall Study|Participant request to discontinue study treatment|0|||
48777845|NCT03251924|157030686|FG004|Overall Study|Participant request to discontinue study treatment|0|||
48877039|NCT01547598|157388514|FG001|Overall Study|Other Miscellaneous Reasons|1|||
48877040|NCT00447590|157388519|FG000|Overall Study|Withdrawal by Subject|26|||
48777846|NCT03251924|157030687|FG005|Overall Study|Participant request to discontinue study treatment|0|||
48777847|NCT03251924|157030688|FG006|Overall Study|Participant request to discontinue study treatment|0|||
48777848|NCT03251924|157030689|FG007|Overall Study|Participant request to discontinue study treatment|1|||
48777849|NCT03251924|157030690|FG008|Overall Study|Participant request to discontinue study treatment|0|||
48777850|NCT01193556|157030691|FG000|Overall Study|Study termination|26|||
48877041|NCT00447590|157388519|FG000|Overall Study|Lost to Follow-up|24|||
48777851|NCT01193556|157030692|FG001|Overall Study|Study termination|25|||
48777852|NCT00887341|157030693|FG000|Overall Study|Refused treatment|1|||
48777853|NCT00887341|157030694|FG001|Overall Study|Refused treatment|0|||
49028518|NCT05093205|157941221|FG007|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
48777854|NCT00887341|157030693|FG000|Overall Study|Withdrawal by Subject|1|||
48777855|NCT00887341|157030694|FG001|Overall Study|Withdrawal by Subject|1|||
48777856|NCT00887341|157030693|FG000|Overall Study|Adverse Event|0|||
48777857|NCT00887341|157030694|FG001|Overall Study|Adverse Event|1|||
48777858|NCT00887341|157030693|FG000|Overall Study|Lost to Follow-up|0|||
48777859|NCT00887341|157030694|FG001|Overall Study|Lost to Follow-up|1|||
48777860|NCT02617589|157030695|FG000|Randomization|Request to Discontinue Study Treatment|1|||
48777861|NCT02617589|157030696|FG001|Randomization|Request to Discontinue Study Treatment|3|||
48777862|NCT02617589|157030695|FG000|Randomization|Participant Withdrew Consent|1|||
48777863|NCT02617589|157030696|FG001|Randomization|Participant Withdrew Consent|2|||
48777864|NCT02617589|157030695|FG000|Treatment|Other Reasons|3|||
48777865|NCT02617589|157030696|FG001|Treatment|Other Reasons|3|||
48777866|NCT02617589|157030695|FG000|Treatment|Poor/Non Compliance|1|||
48777867|NCT02617589|157030696|FG001|Treatment|Poor/Non Compliance|1|||
48777868|NCT02617589|157030695|FG000|Treatment|Maximum Clinical Benefit|0|||
48777869|NCT02617589|157030696|FG001|Treatment|Maximum Clinical Benefit|2|||
48777870|NCT02617589|157030695|FG000|Treatment|Participant Withdrew Consent|2|||
48777871|NCT02617589|157030696|FG001|Treatment|Participant Withdrew Consent|6|||
48777872|NCT02617589|157030695|FG000|Treatment|Participant Request to Discontinue|12|||
48777873|NCT02617589|157030696|FG001|Treatment|Participant Request to Discontinue|21|||
48777874|NCT02617589|157030695|FG000|Treatment|Adverse Event Unrelated to Study Drug|16|||
48777875|NCT02617589|157030696|FG001|Treatment|Adverse Event Unrelated to Study Drug|9|||
48777876|NCT02617589|157030695|FG000|Treatment|Death|1|||
48777877|NCT02617589|157030696|FG001|Treatment|Death|1|||
48777878|NCT02617589|157030695|FG000|Treatment|Study Drug Toxicity|27|||
48777879|NCT02617589|157030696|FG001|Treatment|Study Drug Toxicity|20|||
48777880|NCT02617589|157030695|FG000|Treatment|Disease Progression|216|||
48777881|NCT02617589|157030696|FG001|Treatment|Disease Progression|136|||
48777882|NCT02161718|157030697|FG000|Open-Label ALKS 3831 Period|Protocol Violation|2|||
48777883|NCT02161718|157030698|FG001|Open-Label ALKS 3831 Period|Protocol Violation|0|||
48777884|NCT02161718|157030699|FG002|Open-Label ALKS 3831 Period|Protocol Violation|0|||
48777885|NCT02161718|157030697|FG000|Open-Label ALKS 3831 Period|Physician Decision|1|||
48777886|NCT02161718|157030698|FG001|Open-Label ALKS 3831 Period|Physician Decision|0|||
48777887|NCT02161718|157030699|FG002|Open-Label ALKS 3831 Period|Physician Decision|0|||
48777888|NCT02161718|157030697|FG000|Open-Label ALKS 3831 Period|Non-compliance with study drug|1|||
48777889|NCT02161718|157030698|FG001|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
48777890|NCT02161718|157030699|FG002|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
48777891|NCT02161718|157030697|FG000|Open-Label ALKS 3831 Period|Lack of Efficacy|1|||
48777892|NCT02161718|157030698|FG001|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
48777893|NCT02161718|157030699|FG002|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
48777894|NCT02161718|157030697|FG000|Open-Label ALKS 3831 Period|Adverse Event|3|||
48777895|NCT02161718|157030698|FG001|Open-Label ALKS 3831 Period|Adverse Event|0|||
49028519|NCT05093205|157941222|FG008|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
49028520|NCT05093205|157941223|FG009|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
48777896|NCT02161718|157030699|FG002|Open-Label ALKS 3831 Period|Adverse Event|0|||
48777897|NCT02161718|157030697|FG000|Open-Label ALKS 3831 Period|Withdrawal by Subject|4|||
48777898|NCT02161718|157030698|FG001|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
48777899|NCT02161718|157030699|FG002|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
48777900|NCT02161718|157030697|FG000|Open-Label ALKS 3831 Period|Lost to Follow-up|3|||
48777901|NCT02161718|157030698|FG001|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
48777902|NCT02161718|157030699|FG002|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
48777903|NCT02161718|157030697|FG000|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6|||
48777904|NCT02161718|157030698|FG001|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
48777905|NCT02161718|157030699|FG002|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
48777906|NCT02161718|157030697|FG000|Post- Randomization Period|Withdrawal by Subject|0|||
48777907|NCT02161718|157030698|FG001|Post- Randomization Period|Withdrawal by Subject|23|||
48777908|NCT02161718|157030699|FG002|Post- Randomization Period|Withdrawal by Subject|18|||
48777909|NCT02161718|157030697|FG000|Post- Randomization Period|Lost to Follow-up|0|||
48777910|NCT02161718|157030698|FG001|Post- Randomization Period|Lost to Follow-up|9|||
48777911|NCT02161718|157030699|FG002|Post- Randomization Period|Lost to Follow-up|15|||
48877042|NCT00447590|157388519|FG000|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10|||
49028521|NCT05093205|157941224|FG010|Part B Period 3 - Follow-Up|Withdrawal by Subject|2|||
48777912|NCT02161718|157030697|FG000|Post- Randomization Period|Adverse Event|0|||
48777913|NCT02161718|157030698|FG001|Post- Randomization Period|Adverse Event|9|||
48777914|NCT02161718|157030699|FG002|Post- Randomization Period|Adverse Event|10|||
48777915|NCT02161718|157030697|FG000|Post- Randomization Period|Non- compliance with study drug|0|||
48777916|NCT02161718|157030698|FG001|Post- Randomization Period|Non- compliance with study drug|8|||
48777917|NCT02161718|157030699|FG002|Post- Randomization Period|Non- compliance with study drug|2|||
48777918|NCT02161718|157030697|FG000|Post- Randomization Period|Physician Decision|0|||
48777919|NCT02161718|157030698|FG001|Post- Randomization Period|Physician Decision|2|||
48777920|NCT02161718|157030699|FG002|Post- Randomization Period|Physician Decision|4|||
48777921|NCT02161718|157030697|FG000|Post- Randomization Period|Protocol Violation|0|||
48777922|NCT02161718|157030698|FG001|Post- Randomization Period|Protocol Violation|2|||
48777923|NCT02161718|157030699|FG002|Post- Randomization Period|Protocol Violation|3|||
48777924|NCT02161718|157030697|FG000|Post- Randomization Period|Lack of Efficacy|0|||
48777925|NCT02161718|157030698|FG001|Post- Randomization Period|Lack of Efficacy|0|||
48777926|NCT02161718|157030699|FG002|Post- Randomization Period|Lack of Efficacy|1|||
48777927|NCT02161718|157030697|FG000|Post- Randomization Period|Non-compliance with study procedures|0|||
48777928|NCT02161718|157030698|FG001|Post- Randomization Period|Non-compliance with study procedures|2|||
48777929|NCT02161718|157030699|FG002|Post- Randomization Period|Non-compliance with study procedures|4|||
48777930|NCT02161718|157030697|FG000|Post- Randomization Period|Received prohibitive treatment|0|||
48777931|NCT02161718|157030698|FG001|Post- Randomization Period|Received prohibitive treatment|1|||
48777932|NCT02161718|157030699|FG002|Post- Randomization Period|Received prohibitive treatment|2|||
48777933|NCT02161718|157030697|FG000|Post- Randomization Period|Relocation|0|||
48777934|NCT02161718|157030698|FG001|Post- Randomization Period|Relocation|3|||
48777935|NCT02161718|157030699|FG002|Post- Randomization Period|Relocation|0|||
48777936|NCT02138214|157030700|FG000|Overall Study|Withdrawal by Subject|0|||
48777937|NCT02138214|157030701|FG001|Overall Study|Withdrawal by Subject|1|||
48777938|NCT02138214|157030702|FG002|Overall Study|Withdrawal by Subject|0|||
48777939|NCT02138214|157030700|FG000|Overall Study|Lost to Follow-up|0|||
48777940|NCT02138214|157030701|FG001|Overall Study|Lost to Follow-up|2|||
48777941|NCT02138214|157030702|FG002|Overall Study|Lost to Follow-up|4|||
48777942|NCT02138214|157030700|FG000|Overall Study|Screen Failure|0|||
48777943|NCT02138214|157030701|FG001|Overall Study|Screen Failure|1|||
48777944|NCT02138214|157030702|FG002|Overall Study|Screen Failure|0|||
48777945|NCT01975389|157030703|FG000|Overall Study|Adverse Event|10|||
48777946|NCT01975389|157030704|FG001|Overall Study|Adverse Event|6|||
48777947|NCT01975389|157030703|FG000|Overall Study|Death|61|||
48777948|NCT01975389|157030704|FG001|Overall Study|Death|54|||
48777949|NCT01975389|157030703|FG000|Overall Study|Lost to Follow-up|81|||
48777950|NCT01975389|157030704|FG001|Overall Study|Lost to Follow-up|86|||
48777951|NCT01975389|157030703|FG000|Overall Study|Withdrawal by Subject|90|||
48777952|NCT01975389|157030704|FG001|Overall Study|Withdrawal by Subject|76|||
48777953|NCT01975389|157030703|FG000|Overall Study|Other|6|||
48777954|NCT01975389|157030704|FG001|Overall Study|Other|9|||
48777955|NCT01975389|157030703|FG000|Overall Study|Randomized, not treated|4|||
48777956|NCT01975389|157030704|FG001|Overall Study|Randomized, not treated|5|||
48777957|NCT01312961|157030705|FG000|Overall Study|Adverse Event|3|||
48777958|NCT01312961|157030706|FG001|Overall Study|Adverse Event|3|||
48777959|NCT01312961|157030705|FG000|Overall Study|Lack of Efficacy|11|||
48777960|NCT01312961|157030706|FG001|Overall Study|Lack of Efficacy|1|||
48777961|NCT01312961|157030705|FG000|Overall Study|Poor compliance to protocol|1|||
48777962|NCT01312961|157030706|FG001|Overall Study|Poor compliance to protocol|0|||
48777963|NCT01312961|157030705|FG000|Overall Study|Other than specified above|2|||
48777964|NCT01312961|157030706|FG001|Overall Study|Other than specified above|3|||
48777965|NCT03509948|157030707|FG000|Overall Study|Protocol Violation|0|||
48777966|NCT03509948|157030708|FG001|Overall Study|Protocol Violation|1|||
48777967|NCT04208412|157030709|FG000|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|8|||
48777968|NCT04208412|157030710|FG001|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|5|||
48777969|NCT04208412|157030709|FG000|Overall Study|Withdrawal by Subject|1|||
48777970|NCT04208412|157030710|FG001|Overall Study|Withdrawal by Subject|0|||
48777971|NCT04208412|157030709|FG000|Overall Study|Lost to Follow-up|0|||
48777972|NCT04208412|157030710|FG001|Overall Study|Lost to Follow-up|1|||
48777973|NCT02778204|157030711|FG000|Overall Study|Adverse Event|1|||
48777974|NCT02778204|157030712|FG001|Overall Study|Adverse Event|0|||
48777975|NCT02778204|157030713|FG002|Overall Study|Adverse Event|0|||
48877043|NCT02337829|157388521|FG000|Overall Study|Death|0|||
48877044|NCT02337829|157388522|FG001|Overall Study|Death|1|||
48777976|NCT02778204|157030714|FG003|Overall Study|Adverse Event|0|||
48777977|NCT02778204|157030711|FG000|Overall Study|Withdrawal by Subject|0|||
48777978|NCT02778204|157030712|FG001|Overall Study|Withdrawal by Subject|0|||
48777979|NCT02778204|157030713|FG002|Overall Study|Withdrawal by Subject|1|||
48777980|NCT02778204|157030714|FG003|Overall Study|Withdrawal by Subject|2|||
48777981|NCT02778204|157030711|FG000|Overall Study|Lost to Follow-up|1|||
48777982|NCT02778204|157030712|FG001|Overall Study|Lost to Follow-up|0|||
48777983|NCT02778204|157030713|FG002|Overall Study|Lost to Follow-up|2|||
48777984|NCT02778204|157030714|FG003|Overall Study|Lost to Follow-up|1|||
48777985|NCT02778204|157030711|FG000|Overall Study|Protocol Violation|0|||
48777986|NCT02778204|157030712|FG001|Overall Study|Protocol Violation|0|||
48777987|NCT02778204|157030713|FG002|Overall Study|Protocol Violation|1|||
48777988|NCT02778204|157030714|FG003|Overall Study|Protocol Violation|0|||
48777989|NCT02778204|157030711|FG000|Overall Study|Eligibility Violation|0|||
48777990|NCT02778204|157030712|FG001|Overall Study|Eligibility Violation|0|||
48877045|NCT02337829|157388523|FG002|Overall Study|Death|0|||
48777991|NCT02778204|157030713|FG002|Overall Study|Eligibility Violation|0|||
48877046|NCT02337829|157388524|FG003|Overall Study|Death|0|||
48877047|NCT02337829|157388521|FG000|Overall Study|Study terminated by sponsor|12|||
48877048|NCT02337829|157388522|FG001|Overall Study|Study terminated by sponsor|10|||
48877049|NCT02337829|157388523|FG002|Overall Study|Study terminated by sponsor|5|||
48877050|NCT02337829|157388524|FG003|Overall Study|Study terminated by sponsor|6|||
48877051|NCT02337829|157388521|FG000|Overall Study|discontinued for other reasons|6|||
48877052|NCT02337829|157388522|FG001|Overall Study|discontinued for other reasons|3|||
48877053|NCT02337829|157388523|FG002|Overall Study|discontinued for other reasons|1|||
48877054|NCT02337829|157388524|FG003|Overall Study|discontinued for other reasons|4|||
48877055|NCT00719043|157388540|FG000|Overall Study|Adverse Event|5|||
48877056|NCT00719043|157388541|FG001|Overall Study|Adverse Event|1|||
48877057|NCT00719043|157388542|FG002|Overall Study|Adverse Event|2|||
48877058|NCT00719043|157388543|FG003|Overall Study|Adverse Event|2|||
49028522|NCT05093205|157941225|FG011|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
49028523|NCT05093205|157941226|FG012|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
49028524|NCT05093205|157941214|FG000|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
49028525|NCT05093205|157941215|FG001|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
49028526|NCT05093205|157941216|FG002|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
49028527|NCT05093205|157941217|FG003|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
49028528|NCT05093205|157941218|FG004|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
49028529|NCT05093205|157941219|FG005|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
49028530|NCT05093205|157941220|FG006|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
49028531|NCT05093205|157941221|FG007|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
49028532|NCT05093205|157941222|FG008|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
49028533|NCT05093205|157941223|FG009|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
49028534|NCT05093205|157941224|FG010|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
49028535|NCT05093205|157941225|FG011|Part B Period 4 - Treatment|Withdrawal by Subject|1|||
49028536|NCT05093205|157941226|FG012|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
49028537|NCT05093205|157941214|FG000|Part B Period 4 - Treatment|Adverse Event|0|||
49028538|NCT05093205|157941215|FG001|Part B Period 4 - Treatment|Adverse Event|0|||
49028539|NCT05093205|157941216|FG002|Part B Period 4 - Treatment|Adverse Event|0|||
49028540|NCT05093205|157941217|FG003|Part B Period 4 - Treatment|Adverse Event|0|||
49028541|NCT05093205|157941218|FG004|Part B Period 4 - Treatment|Adverse Event|0|||
49028542|NCT05093205|157941219|FG005|Part B Period 4 - Treatment|Adverse Event|0|||
49028543|NCT05093205|157941220|FG006|Part B Period 4 - Treatment|Adverse Event|0|||
49028544|NCT05093205|157941221|FG007|Part B Period 4 - Treatment|Adverse Event|0|||
49028545|NCT05093205|157941222|FG008|Part B Period 4 - Treatment|Adverse Event|0|||
49028546|NCT05093205|157941223|FG009|Part B Period 4 - Treatment|Adverse Event|0|||
49028547|NCT05093205|157941224|FG010|Part B Period 4 - Treatment|Adverse Event|0|||
49028548|NCT05093205|157941225|FG011|Part B Period 4 - Treatment|Adverse Event|2|||
49028549|NCT05093205|157941226|FG012|Part B Period 4 - Treatment|Adverse Event|0|||
49028550|NCT05093205|157941214|FG000|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
49028551|NCT05093205|157941215|FG001|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
49028552|NCT05093205|157941216|FG002|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
49028553|NCT05093205|157941217|FG003|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
49028554|NCT05093205|157941218|FG004|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
49028555|NCT05093205|157941219|FG005|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
49028556|NCT05093205|157941220|FG006|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
49028557|NCT05093205|157941221|FG007|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
49028558|NCT05093205|157941222|FG008|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
49028559|NCT05093205|157941223|FG009|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
48777992|NCT02778204|157030714|FG003|Overall Study|Eligibility Violation|1|||
48777993|NCT01978184|157030715|FG000|Overall Study|Progressive disease|5|||
48777994|NCT01978184|157030716|FG001|Overall Study|Progressive disease|5|||
48777995|NCT01978184|157030715|FG000|Overall Study|Other than PDA|2|||
48777996|NCT01978184|157030716|FG001|Overall Study|Other than PDA|2|||
48777997|NCT01978184|157030715|FG000|Overall Study|Physician Decision|0|||
48777998|NCT01978184|157030716|FG001|Overall Study|Physician Decision|3|||
48777999|NCT01978184|157030715|FG000|Overall Study|Noncompliance|1|||
48778000|NCT01978184|157030716|FG001|Overall Study|Noncompliance|2|||
48778001|NCT01978184|157030715|FG000|Overall Study|Death|1|||
48778002|NCT01978184|157030716|FG001|Overall Study|Death|0|||
48778003|NCT01978184|157030715|FG000|Overall Study|Withdrew- toxicities or physical decline|4|||
48778004|NCT01978184|157030716|FG001|Overall Study|Withdrew- toxicities or physical decline|8|||
48778005|NCT02460198|157030717|FG000|Overall Study|Adverse Event|1|||
48778006|NCT02460198|157030718|FG001|Overall Study|Adverse Event|3|||
48778007|NCT02460198|157030717|FG000|Overall Study|Death|36|||
48778008|NCT02460198|157030718|FG001|Overall Study|Death|28|||
48778009|NCT02460198|157030717|FG000|Overall Study|Lost to Follow-up|1|||
48778010|NCT02460198|157030718|FG001|Overall Study|Lost to Follow-up|1|||
48778011|NCT02460198|157030717|FG000|Overall Study|Transferred to Extension Study|15|||
48877059|NCT00719043|157388544|FG004|Overall Study|Adverse Event|1|||
48877060|NCT00719043|157388545|FG005|Overall Study|Adverse Event|4|||
49028560|NCT05093205|157941224|FG010|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
49028561|NCT05093205|157941225|FG011|Part B Period 4 - Follow-Up|Withdrawal by Subject|1|||
49028562|NCT05093205|157941226|FG012|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
48778012|NCT02460198|157030718|FG001|Overall Study|Transferred to Extension Study|15|||
48778013|NCT02460198|157030717|FG000|Overall Study|Withdrawal by Subject|2|||
48778014|NCT02460198|157030718|FG001|Overall Study|Withdrawal by Subject|4|||
48778015|NCT02460198|157030717|FG000|Overall Study|Site Terminated By Sponsor|0|||
48778016|NCT02460198|157030718|FG001|Overall Study|Site Terminated By Sponsor|1|||
48778017|NCT02460198|157030717|FG000|Overall Study|Did Not Continue on Extension Study|6|||
48778018|NCT02460198|157030718|FG001|Overall Study|Did Not Continue on Extension Study|11|||
48778019|NCT03351049|157030719|FG000|Overall Study|Withdrawal|26|||
48778020|NCT03351049|157030720|FG001|Overall Study|Withdrawal|22|||
48778021|NCT00298038|157030723|FG000|Overall Study|Lost to Follow-up|0|||
48778022|NCT00298038|157030724|FG001|Overall Study|Lost to Follow-up|1|||
48778023|NCT00298038|157030723|FG000|Overall Study|Liver Transplant|0|||
48778024|NCT00298038|157030724|FG001|Overall Study|Liver Transplant|1|||
48778025|NCT00298038|157030723|FG000|Overall Study|Protocol Violation|1|||
48778026|NCT00298038|157030724|FG001|Overall Study|Protocol Violation|3|||
48778027|NCT00298038|157030723|FG000|Overall Study|Death|6|||
48778028|NCT00298038|157030724|FG001|Overall Study|Death|3|||
48778029|NCT00298038|157030723|FG000|Overall Study|Withdrawal by Subject|6|||
48778030|NCT00298038|157030724|FG001|Overall Study|Withdrawal by Subject|9|||
48778031|NCT00298038|157030723|FG000|Overall Study|Adverse Event|8|||
48778032|NCT00298038|157030724|FG001|Overall Study|Adverse Event|7|||
48778033|NCT00298038|157030723|FG000|Overall Study|Breakthrough overt HE episode|28|||
48778034|NCT00298038|157030724|FG001|Overall Study|Breakthrough overt HE episode|69|||
48778035|NCT00298038|157030723|FG000|Overall Study|Noncompliance|1|||
48778036|NCT00298038|157030724|FG001|Overall Study|Noncompliance|0|||
48778037|NCT00298038|157030723|FG000|Overall Study|Cocaine Abuse|1|||
48778038|NCT00298038|157030724|FG001|Overall Study|Cocaine Abuse|0|||
48778039|NCT00298038|157030723|FG000|Overall Study|Severe Gastrointestinal Bleed|1|||
48778040|NCT00298038|157030724|FG001|Overall Study|Severe Gastrointestinal Bleed|0|||
48778041|NCT00503685|157030725|FG000|Overall Study|Adverse Event|0|||
48778042|NCT00503685|157030726|FG001|Overall Study|Adverse Event|0|||
48778043|NCT00503685|157030727|FG002|Overall Study|Adverse Event|2|||
48778044|NCT00503685|157030725|FG000|Overall Study|Withdrawal by Subject|0|||
48778045|NCT00503685|157030726|FG001|Overall Study|Withdrawal by Subject|1|||
48778046|NCT00503685|157030727|FG002|Overall Study|Withdrawal by Subject|0|||
48778047|NCT00503685|157030725|FG000|Overall Study|Protocol Violation|0|||
48778048|NCT00503685|157030726|FG001|Overall Study|Protocol Violation|1|||
48778049|NCT00503685|157030727|FG002|Overall Study|Protocol Violation|0|||
48778050|NCT00503685|157030725|FG000|Overall Study|Eligibility Criteria Not Met|0|||
48982589|NCT01970540|157767636|FG001|Overall Study|Treatment-related AE|0|||
48982590|NCT01970540|157767637|FG002|Overall Study|Treatment-related AE|2|||
48982591|NCT01970540|157767635|FG000|Overall Study|Withdrawal by Subject|4|||
48982592|NCT01970540|157767636|FG001|Overall Study|Withdrawal by Subject|0|||
48982593|NCT01970540|157767637|FG002|Overall Study|Withdrawal by Subject|1|||
48982594|NCT01970540|157767635|FG000|Overall Study|Clinical deterioration|1|||
48982595|NCT01970540|157767636|FG001|Overall Study|Clinical deterioration|0|||
48982596|NCT01970540|157767637|FG002|Overall Study|Clinical deterioration|0|||
48982597|NCT02382276|157767649|FG000|Overall Study|Withdrawal by Subject|4|||
48982598|NCT02382276|157767650|FG001|Overall Study|Withdrawal by Subject|8|||
48982599|NCT02382276|157767651|FG002|Overall Study|Withdrawal by Subject|5|||
48982600|NCT02382276|157767649|FG000|Overall Study|Adverse Event|7|||
48982601|NCT02382276|157767650|FG001|Overall Study|Adverse Event|2|||
48982602|NCT02382276|157767651|FG002|Overall Study|Adverse Event|32|||
48982603|NCT02382276|157767649|FG000|Overall Study|Physician Decision|0|||
48982604|NCT02382276|157767650|FG001|Overall Study|Physician Decision|0|||
48982605|NCT02382276|157767651|FG002|Overall Study|Physician Decision|2|||
48982606|NCT01142791|157767652|FG000|Overall Study|Alternative Treatment|1|||
48982607|NCT01142791|157767653|FG001|Overall Study|Alternative Treatment|0|||
48982608|NCT01142791|157767652|FG000|Overall Study|Lost to Follow-up|1|||
48982609|NCT01142791|157767653|FG001|Overall Study|Lost to Follow-up|0|||
48982610|NCT01142791|157767652|FG000|Overall Study|Withdrawal by Subject|5|||
48982611|NCT01142791|157767653|FG001|Overall Study|Withdrawal by Subject|0|||
48982612|NCT01142791|157767652|FG000|Overall Study|Received only 1 sonication|0|||
48982613|NCT01142791|157767653|FG001|Overall Study|Received only 1 sonication|6|||
48982614|NCT02608892|157767658|FG000|Overall Study|Lost to Follow-up|1|||
48982615|NCT02608892|157767659|FG001|Overall Study|Lost to Follow-up|0|||
48982616|NCT02590406|157767660|FG000|Overall Study|Adverse Event|1|||
48982617|NCT02590406|157767661|FG001|Overall Study|Adverse Event|0|||
48982618|NCT02590406|157767660|FG000|Overall Study|Saturometer malfunction|0|||
48982619|NCT02590406|157767661|FG001|Overall Study|Saturometer malfunction|1|||
48982620|NCT01646255|157767664|FG000|Overall Study|Adverse Event|7|||
48982621|NCT01646255|157767665|FG001|Overall Study|Adverse Event|8|||
48982622|NCT01646255|157767664|FG000|Overall Study|Lack of Efficacy|2|||
48982623|NCT01646255|157767665|FG001|Overall Study|Lack of Efficacy|0|||
48982624|NCT01646255|157767664|FG000|Overall Study|Withdrawal by Subject|10|||
48982625|NCT01646255|157767665|FG001|Overall Study|Withdrawal by Subject|6|||
48982626|NCT01646255|157767664|FG000|Overall Study|Compliance is not well|1|||
48982627|NCT01646255|157767665|FG001|Overall Study|Compliance is not well|0|||
49028563|NCT00846495|157941230|FG000|Overall Study|Lost to Follow-up|1|||
49028564|NCT00846495|157941231|FG001|Overall Study|Lost to Follow-up|0|||
49028565|NCT00846495|157941230|FG000|Overall Study|Adverse Event|5|||
48778051|NCT00503685|157030726|FG001|Overall Study|Eligibility Criteria Not Met|1|||
48778052|NCT00503685|157030727|FG002|Overall Study|Eligibility Criteria Not Met|0|||
48778053|NCT01181895|157030728|FG000|Overall Study|Adverse Event|3|||
48778054|NCT01181895|157030729|FG001|Overall Study|Adverse Event|1|||
48778055|NCT01181895|157030730|FG002|Overall Study|Adverse Event|1|||
48778056|NCT01181895|157030728|FG000|Overall Study|Lack of Efficacy|8|||
48778057|NCT01181895|157030729|FG001|Overall Study|Lack of Efficacy|9|||
48778058|NCT01181895|157030730|FG002|Overall Study|Lack of Efficacy|9|||
48778059|NCT01181895|157030728|FG000|Overall Study|Protocol Violation|2|||
48778060|NCT01181895|157030729|FG001|Overall Study|Protocol Violation|1|||
48778061|NCT01181895|157030730|FG002|Overall Study|Protocol Violation|0|||
48778062|NCT01181895|157030728|FG000|Overall Study|Lost to Follow-up|0|||
49028566|NCT00846495|157941231|FG001|Overall Study|Adverse Event|1|||
49028567|NCT00846495|157941230|FG000|Overall Study|Lack of Efficacy|1|||
48778063|NCT01181895|157030729|FG001|Overall Study|Lost to Follow-up|1|||
48778064|NCT01181895|157030730|FG002|Overall Study|Lost to Follow-up|2|||
48778065|NCT01181895|157030728|FG000|Overall Study|Investigator Discretion|1|||
48778066|NCT01181895|157030729|FG001|Overall Study|Investigator Discretion|2|||
48778067|NCT01181895|157030730|FG002|Overall Study|Investigator Discretion|1|||
48778068|NCT01181895|157030728|FG000|Overall Study|Withdrawal by Subject|3|||
48778069|NCT01181895|157030729|FG001|Overall Study|Withdrawal by Subject|0|||
48778070|NCT01181895|157030730|FG002|Overall Study|Withdrawal by Subject|5|||
48778071|NCT04028388|157030734|FG000|Overall Study|Evaluations missing|3|||
48778072|NCT04028388|157030735|FG001|Overall Study|Evaluations missing|6|||
48778073|NCT04028388|157030734|FG000|Overall Study|Not started|2|||
48778074|NCT04028388|157030735|FG001|Overall Study|Not started|0|||
48778075|NCT05204134|157030736|FG000|Overall Study|Withdrawal by Subject|3|||
48778076|NCT05204134|157030736|FG000|Overall Study|Physician Decision|1|||
48778077|NCT02752048|157030739|FG000|Overall Study|Withdrawal by Subject|0|||
48778078|NCT02752048|157030740|FG001|Overall Study|Withdrawal by Subject|0|||
48778079|NCT02752048|157030741|FG002|Overall Study|Withdrawal by Subject|3|||
48778080|NCT02758236|157030749|FG000|Overall Study|Investigator discretion|43|||
48778081|NCT05789875|157030750|FG000|Overall Study|Lost to Follow-up|6|||
48778082|NCT01994395|157030751|FG000|Overall Study|Withdrawal by Subject|1|||
48778083|NCT01994395|157030752|FG001|Overall Study|Withdrawal by Subject|2|||
48778084|NCT01940705|157030757|FG000|Overall Study|Lost to Follow-up|1|||
48778085|NCT01940705|157030758|FG001|Overall Study|Lost to Follow-up|3|||
48778086|NCT01940705|157030759|FG002|Overall Study|Lost to Follow-up|2|||
48778087|NCT01940705|157030760|FG003|Overall Study|Lost to Follow-up|2|||
48778088|NCT01940705|157030757|FG000|Overall Study|Withdrawal by Subject|2|||
48778089|NCT01940705|157030758|FG001|Overall Study|Withdrawal by Subject|2|||
48778090|NCT01940705|157030759|FG002|Overall Study|Withdrawal by Subject|3|||
48778091|NCT01940705|157030760|FG003|Overall Study|Withdrawal by Subject|2|||
48778092|NCT01940705|157030757|FG000|Overall Study|Intervention not given|0|||
48778093|NCT01940705|157030758|FG001|Overall Study|Intervention not given|3|||
48778094|NCT01940705|157030759|FG002|Overall Study|Intervention not given|3|||
48778095|NCT01940705|157030760|FG003|Overall Study|Intervention not given|0|||
48778096|NCT01940705|157030757|FG000|Overall Study|Withdrawal by team - hearing aid change|1|||
48778097|NCT01940705|157030758|FG001|Overall Study|Withdrawal by team - hearing aid change|0|||
48778098|NCT01940705|157030759|FG002|Overall Study|Withdrawal by team - hearing aid change|0|||
48778099|NCT01940705|157030760|FG003|Overall Study|Withdrawal by team - hearing aid change|0|||
48778100|NCT01802411|157030763|FG000|Overall Study|Death|2|||
48778101|NCT01802411|157030764|FG001|Overall Study|Death|1|||
48778102|NCT01802411|157030763|FG000|Overall Study|Adverse Event|2|||
48778103|NCT01802411|157030764|FG001|Overall Study|Adverse Event|7|||
48778104|NCT01802411|157030763|FG000|Overall Study|Lack of Efficacy|8|||
48778105|NCT01802411|157030764|FG001|Overall Study|Lack of Efficacy|10|||
48778106|NCT01802411|157030763|FG000|Overall Study|Withdrawal by Subject|0|||
48778107|NCT01802411|157030764|FG001|Overall Study|Withdrawal by Subject|2|||
48778108|NCT01802411|157030763|FG000|Overall Study|Planned pleurodesis as part of the proc|1|||
48778109|NCT01802411|157030764|FG001|Overall Study|Planned pleurodesis as part of the proc|0|||
48778110|NCT01802411|157030763|FG000|Overall Study|Surgery aborted after bronchoscopy|1|||
48877061|NCT00719043|157388546|FG006|Overall Study|Adverse Event|4|||
48877062|NCT00719043|157388540|FG000|Overall Study|Lost to Follow-up|14|||
48778111|NCT01802411|157030764|FG001|Overall Study|Surgery aborted after bronchoscopy|0|||
48778112|NCT01802411|157030763|FG000|Overall Study|Proc changed to video-asst thorascopic|0|||
48778113|NCT01802411|157030764|FG001|Overall Study|Proc changed to video-asst thorascopic|1|||
48778114|NCT02663128|157030765|FG000|Period 2|Physician Decision|0|||
48778115|NCT02663128|157030766|FG001|Period 2|Physician Decision|0|||
48778116|NCT02663128|157030767|FG002|Period 2|Physician Decision|0|||
48778117|NCT02663128|157030768|FG003|Period 2|Physician Decision|0|||
48778118|NCT02663128|157030769|FG004|Period 2|Physician Decision|1|||
49028568|NCT00846495|157941231|FG001|Overall Study|Lack of Efficacy|2|||
49028569|NCT00846495|157941230|FG000|Overall Study|Physician Decision|1|||
48778119|NCT02663128|157030770|FG005|Period 2|Physician Decision|0|||
48778120|NCT01663636|157030771|FG000|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25|||
48778121|NCT01663636|157030772|FG001|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31|||
48778122|NCT00660010|157030775|FG000|Overall Study|Withdrawal by Subject|2|||
48778123|NCT00660010|157030775|FG000|Overall Study|Lost to Follow-up|3|||
48778124|NCT00660010|157030775|FG000|Overall Study|Adverse Event|1|||
48778125|NCT00660010|157030775|FG000|Overall Study|Noncompliance with visit schedule|3|||
48778126|NCT03864614|157030776|FG000|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|116|||
48778127|NCT03864614|157030777|FG001|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|173|||
48778128|NCT03864614|157030778|FG002|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
48778129|NCT03864614|157030779|FG003|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
48778130|NCT03864614|157030776|FG000|Overall Study|Withdrawal by Subject|72|||
48778131|NCT03864614|157030777|FG001|Overall Study|Withdrawal by Subject|100|||
48778132|NCT03864614|157030778|FG002|Overall Study|Withdrawal by Subject|1|||
48778133|NCT03864614|157030779|FG003|Overall Study|Withdrawal by Subject|21|||
48778134|NCT03864614|157030776|FG000|Overall Study|Lost to Follow-up|45|||
48778135|NCT03864614|157030777|FG001|Overall Study|Lost to Follow-up|54|||
48778136|NCT03864614|157030778|FG002|Overall Study|Lost to Follow-up|0|||
48778137|NCT03864614|157030779|FG003|Overall Study|Lost to Follow-up|9|||
48778138|NCT03864614|157030776|FG000|Overall Study|Adverse Event|42|||
48778139|NCT03864614|157030777|FG001|Overall Study|Adverse Event|30|||
48778140|NCT03864614|157030778|FG002|Overall Study|Adverse Event|1|||
48778141|NCT03864614|157030779|FG003|Overall Study|Adverse Event|9|||
48778142|NCT03864614|157030776|FG000|Overall Study|Protocol Deviation|6|||
48778143|NCT03864614|157030777|FG001|Overall Study|Protocol Deviation|26|||
48778144|NCT03864614|157030778|FG002|Overall Study|Protocol Deviation|0|||
48778145|NCT03864614|157030779|FG003|Overall Study|Protocol Deviation|1|||
48778146|NCT03864614|157030776|FG000|Overall Study|Physician Decision|7|||
48778147|NCT03864614|157030777|FG001|Overall Study|Physician Decision|10|||
48778148|NCT03864614|157030778|FG002|Overall Study|Physician Decision|1|||
48778149|NCT03864614|157030779|FG003|Overall Study|Physician Decision|5|||
48778150|NCT03864614|157030776|FG000|Overall Study|Non-compliance With Investigational Drug|4|||
48778151|NCT03864614|157030777|FG001|Overall Study|Non-compliance With Investigational Drug|4|||
48778152|NCT03864614|157030778|FG002|Overall Study|Non-compliance With Investigational Drug|0|||
48778153|NCT03864614|157030779|FG003|Overall Study|Non-compliance With Investigational Drug|0|||
48778154|NCT03864614|157030776|FG000|Overall Study|Sponsor Decision|1|||
48778155|NCT03864614|157030777|FG001|Overall Study|Sponsor Decision|2|||
48778156|NCT03864614|157030778|FG002|Overall Study|Sponsor Decision|0|||
49028570|NCT00846495|157941231|FG001|Overall Study|Physician Decision|0|||
49028571|NCT00550537|157941235|FG000|Overall Study|Death|18|||
49028572|NCT00550537|157941235|FG000|Overall Study|Adverse Event|20|||
49028573|NCT00550537|157941235|FG000|Overall Study|Disease progression before|46|||
49028574|NCT00550537|157941235|FG000|Overall Study|Withdrawal by Subject|7|||
49028575|NCT00550537|157941235|FG000|Overall Study|Change in treatment plan|4|||
49028576|NCT00550537|157941235|FG000|Overall Study|Other complicating ilness|3|||
49028577|NCT00550537|157941235|FG000|Overall Study|Declining performance status|2|||
49028578|NCT00550537|157941235|FG000|Overall Study|Treated closer to home|4|||
49028579|NCT01029340|157941236|FG000|Part B Treatment Period|Withdrawal by Subject|0|||
49028580|NCT01029340|157941237|FG001|Part B Treatment Period|Withdrawal by Subject|0|||
49028581|NCT01029340|157941238|FG002|Part B Treatment Period|Withdrawal by Subject|1|||
49028582|NCT01029340|157941239|FG003|Part B Treatment Period|Withdrawal by Subject|0|||
49028583|NCT01029340|157941240|FG004|Part B Treatment Period|Withdrawal by Subject|0|||
49028584|NCT01029340|157941241|FG005|Part B Treatment Period|Withdrawal by Subject|0|||
49028585|NCT01029340|157941236|FG000|Part B Treatment Period|Protocol Violation|0|||
49028586|NCT01029340|157941237|FG001|Part B Treatment Period|Protocol Violation|0|||
49028587|NCT01029340|157941238|FG002|Part B Treatment Period|Protocol Violation|1|||
49028588|NCT01029340|157941239|FG003|Part B Treatment Period|Protocol Violation|0|||
49028589|NCT01029340|157941240|FG004|Part B Treatment Period|Protocol Violation|0|||
49028590|NCT01029340|157941241|FG005|Part B Treatment Period|Protocol Violation|0|||
49028591|NCT01029340|157941236|FG000|Extension Period|Adverse Event|0|||
49028592|NCT01029340|157941237|FG001|Extension Period|Adverse Event|0|||
49028593|NCT01029340|157941238|FG002|Extension Period|Adverse Event|0|||
49028594|NCT01029340|157941239|FG003|Extension Period|Adverse Event|0|||
48778157|NCT03864614|157030779|FG003|Overall Study|Sponsor Decision|0|||
48778158|NCT03864614|157030776|FG000|Overall Study|Pregnancy|0|||
48778159|NCT03864614|157030777|FG001|Overall Study|Pregnancy|1|||
48778160|NCT03864614|157030778|FG002|Overall Study|Pregnancy|0|||
48778161|NCT03864614|157030779|FG003|Overall Study|Pregnancy|0|||
48778162|NCT03864614|157030776|FG000|Overall Study|Other|7|||
48778163|NCT03864614|157030777|FG001|Overall Study|Other|9|||
48778164|NCT03864614|157030778|FG002|Overall Study|Other|1|||
48778165|NCT03864614|157030779|FG003|Overall Study|Other|4|||
48778166|NCT03864614|157030776|FG000|Overall Study|Enrolled but did not receive SAGE-217|0|||
48778167|NCT03864614|157030777|FG001|Overall Study|Enrolled but did not receive SAGE-217|0|||
48778168|NCT03864614|157030778|FG002|Overall Study|Enrolled but did not receive SAGE-217|0|||
48778169|NCT03864614|157030779|FG003|Overall Study|Enrolled but did not receive SAGE-217|159|||
48778170|NCT00533949|157032563|FG000|Overall Study|Protocol Violation|12|||
48778171|NCT00533949|157032564|FG001|Overall Study|Protocol Violation|12|||
48778172|NCT00533949|157032565|FG002|Overall Study|Protocol Violation|9|||
48778173|NCT00533949|157032566|FG003|Overall Study|Protocol Violation|9|||
48778174|NCT00533949|157032563|FG000|Overall Study|Withdrawal by Subject|3|||
48778175|NCT00533949|157032564|FG001|Overall Study|Withdrawal by Subject|2|||
48778176|NCT00533949|157032565|FG002|Overall Study|Withdrawal by Subject|1|||
48778177|NCT00533949|157032566|FG003|Overall Study|Withdrawal by Subject|1|||
48778178|NCT02573324|157032567|FG000|Overall Study|Withdrawal by Subject|26|||
48778179|NCT02573324|157032568|FG001|Overall Study|Withdrawal by Subject|23|||
48778180|NCT02573324|157032569|FG002|Overall Study|Withdrawal by Subject|3|||
48778181|NCT02573324|157032567|FG000|Overall Study|Lost to Follow-up|4|||
48778182|NCT02573324|157032568|FG001|Overall Study|Lost to Follow-up|5|||
48778183|NCT02573324|157032569|FG002|Overall Study|Lost to Follow-up|0|||
48778184|NCT02573324|157032567|FG000|Overall Study|Study Terminated by Sponsor|107|||
48778185|NCT02573324|157032568|FG001|Overall Study|Study Terminated by Sponsor|89|||
48778186|NCT02573324|157032569|FG002|Overall Study|Study Terminated by Sponsor|2|||
48778187|NCT02573324|157032567|FG000|Overall Study|Death|182|||
48778188|NCT02573324|157032568|FG001|Overall Study|Death|200|||
48778189|NCT02573324|157032569|FG002|Overall Study|Death|1|||
48778190|NCT02573324|157032567|FG000|Overall Study|Other, Not Specified|20|||
48778191|NCT02573324|157032568|FG001|Overall Study|Other, Not Specified|27|||
48778192|NCT02573324|157032569|FG002|Overall Study|Other, Not Specified|0|||
48778193|NCT02573324|157032567|FG000|Overall Study|Unknown Reason|2|||
48778194|NCT02573324|157032568|FG001|Overall Study|Unknown Reason|0|||
48778195|NCT02573324|157032569|FG002|Overall Study|Unknown Reason|0|||
48778196|NCT00612066|157032570|FG000|Overall Study|Adverse Event|1|||
48778197|NCT01677195|157032571|FG000|Overall Study|Lost to Follow-up|14|||
48778198|NCT01677195|157032572|FG001|Overall Study|Lost to Follow-up|22|||
48778199|NCT01677195|157032573|FG002|Overall Study|Lost to Follow-up|22|||
48778200|NCT01677195|157032571|FG000|Overall Study|Withdrawal by Subject|1|||
48778201|NCT01677195|157032572|FG001|Overall Study|Withdrawal by Subject|0|||
48778202|NCT01677195|157032573|FG002|Overall Study|Withdrawal by Subject|1|||
48778203|NCT01677195|157032571|FG000|Overall Study|Adverse Event|6|||
48778204|NCT01677195|157032572|FG001|Overall Study|Adverse Event|4|||
48778205|NCT01677195|157032573|FG002|Overall Study|Adverse Event|1|||
48778206|NCT01677195|157032571|FG000|Overall Study|Physician Decision|1|||
48778207|NCT01677195|157032572|FG001|Overall Study|Physician Decision|2|||
48778208|NCT01677195|157032573|FG002|Overall Study|Physician Decision|2|||
48778209|NCT01677195|157032571|FG000|Overall Study|Pregnancy|0|||
48778210|NCT01677195|157032572|FG001|Overall Study|Pregnancy|1|||
48778211|NCT01677195|157032573|FG002|Overall Study|Pregnancy|0|||
48778212|NCT01677195|157032571|FG000|Overall Study|Protocol Violation|7|||
48778213|NCT01677195|157032572|FG001|Overall Study|Protocol Violation|3|||
48778214|NCT01677195|157032573|FG002|Overall Study|Protocol Violation|4|||
48778215|NCT01519518|157032575|FG000|Overall Study|Consent not available|7|||
48778216|NCT01519518|157032576|FG001|Overall Study|Consent not available|10|||
48778217|NCT01513317|157032577|FG000|Overall Study|Withdrawal by Subject|15|||
48778218|NCT01513317|157032578|FG001|Overall Study|Withdrawal by Subject|4|||
48778219|NCT01513317|157032577|FG000|Overall Study|Death|1|||
48778220|NCT01513317|157032578|FG001|Overall Study|Death|1|||
48778221|NCT01513317|157032577|FG000|Overall Study|Study terminated by sponsor|18|||
48778222|NCT01513317|157032578|FG001|Overall Study|Study terminated by sponsor|18|||
48778223|NCT01513317|157032577|FG000|Overall Study|Other|0|||
48778224|NCT01513317|157032578|FG001|Overall Study|Other|1|||
48778225|NCT02200042|157032585|FG000|Overall Study|Withdrawal by Subject|0|||
48778226|NCT02200042|157032586|FG001|Overall Study|Withdrawal by Subject|1|||
48778227|NCT01969838|157032587|FG000|Double-blind Phase|Adverse Event|10|||
48778228|NCT01969838|157032588|FG001|Double-blind Phase|Adverse Event|4|||
48778229|NCT01969838|157032589|FG002|Double-blind Phase|Adverse Event|0|||
48778230|NCT01969838|157032590|FG003|Double-blind Phase|Adverse Event|0|||
48778231|NCT01969838|157032587|FG000|Double-blind Phase|Death|5|||
48778232|NCT01969838|157032588|FG001|Double-blind Phase|Death|2|||
48778233|NCT01969838|157032589|FG002|Double-blind Phase|Death|0|||
48778234|NCT01969838|157032590|FG003|Double-blind Phase|Death|0|||
48778235|NCT01969838|157032587|FG000|Double-blind Phase|Physician Decision|5|||
48778236|NCT01969838|157032588|FG001|Double-blind Phase|Physician Decision|1|||
48778237|NCT01969838|157032589|FG002|Double-blind Phase|Physician Decision|0|||
48778238|NCT01969838|157032590|FG003|Double-blind Phase|Physician Decision|0|||
48778239|NCT01969838|157032587|FG000|Double-blind Phase|Subject Decision|4|||
48778240|NCT01969838|157032588|FG001|Double-blind Phase|Subject Decision|2|||
48778241|NCT01969838|157032589|FG002|Double-blind Phase|Subject Decision|0|||
48778242|NCT01969838|157032590|FG003|Double-blind Phase|Subject Decision|0|||
48778243|NCT01969838|157032587|FG000|Double-blind Phase|Disease Progression|2|||
48778244|NCT01969838|157032588|FG001|Double-blind Phase|Disease Progression|0|||
48778245|NCT01969838|157032589|FG002|Double-blind Phase|Disease Progression|0|||
48778246|NCT01969838|157032590|FG003|Double-blind Phase|Disease Progression|0|||
48778247|NCT01969838|157032587|FG000|Double-blind Phase|Symptomatic Spleen Growth|1|||
48778248|NCT01969838|157032588|FG001|Double-blind Phase|Symptomatic Spleen Growth|0|||
48778249|NCT01969838|157032589|FG002|Double-blind Phase|Symptomatic Spleen Growth|0|||
48778250|NCT01969838|157032590|FG003|Double-blind Phase|Symptomatic Spleen Growth|0|||
48778251|NCT01969838|157032587|FG000|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
48778252|NCT01969838|157032588|FG001|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
48778253|NCT01969838|157032589|FG002|Open-label Phase|Transferred to study SRA-MMB-4365|52|||
48778254|NCT01969838|157032590|FG003|Open-label Phase|Transferred to study SRA-MMB-4365|62|||
48778255|NCT01969838|157032587|FG000|Open-label Phase|Adverse Event|0|||
48778256|NCT01969838|157032588|FG001|Open-label Phase|Adverse Event|0|||
48778257|NCT01969838|157032589|FG002|Open-label Phase|Adverse Event|37|||
48778258|NCT01969838|157032590|FG003|Open-label Phase|Adverse Event|49|||
48778259|NCT01969838|157032587|FG000|Open-label Phase|Disease Progression|0|||
48778260|NCT01969838|157032588|FG001|Open-label Phase|Disease Progression|0|||
48778261|NCT01969838|157032589|FG002|Open-label Phase|Disease Progression|26|||
48778262|NCT01969838|157032590|FG003|Open-label Phase|Disease Progression|27|||
48778263|NCT01969838|157032587|FG000|Open-label Phase|Lack of Efficacy|0|||
48778264|NCT01969838|157032588|FG001|Open-label Phase|Lack of Efficacy|0|||
48778265|NCT01969838|157032589|FG002|Open-label Phase|Lack of Efficacy|17|||
48778266|NCT01969838|157032590|FG003|Open-label Phase|Lack of Efficacy|19|||
48778267|NCT01969838|157032587|FG000|Open-label Phase|Subject Decision|0|||
48778268|NCT01969838|157032588|FG001|Open-label Phase|Subject Decision|0|||
48778269|NCT01969838|157032589|FG002|Open-label Phase|Subject Decision|14|||
48778270|NCT01969838|157032590|FG003|Open-label Phase|Subject Decision|15|||
48778271|NCT01969838|157032587|FG000|Open-label Phase|Death|0|||
48778272|NCT01969838|157032588|FG001|Open-label Phase|Death|0|||
48778273|NCT01969838|157032589|FG002|Open-label Phase|Death|13|||
48778274|NCT01969838|157032590|FG003|Open-label Phase|Death|11|||
48778275|NCT01969838|157032587|FG000|Open-label Phase|Physician Decision|0|||
48778276|NCT01969838|157032588|FG001|Open-label Phase|Physician Decision|0|||
48778277|NCT01969838|157032589|FG002|Open-label Phase|Physician Decision|9|||
48778278|NCT01969838|157032590|FG003|Open-label Phase|Physician Decision|14|||
48778279|NCT01969838|157032587|FG000|Open-label Phase|Non-compliance with Study Drug|0|||
48778280|NCT01969838|157032588|FG001|Open-label Phase|Non-compliance with Study Drug|0|||
48778281|NCT01969838|157032589|FG002|Open-label Phase|Non-compliance with Study Drug|2|||
48778282|NCT01969838|157032590|FG003|Open-label Phase|Non-compliance with Study Drug|0|||
48778283|NCT02086591|157032593|FG000|Overall Study|Adverse Event|1|||
48778284|NCT02086591|157032593|FG000|Overall Study|Withdrawal by Subject|1|||
48778285|NCT02086591|157032593|FG000|Overall Study|protocol terminated|3|||
48778286|NCT03455855|157032594|FG000|Overall Study|Lost to Follow-up|4|||
48778287|NCT03455855|157032595|FG001|Overall Study|Lost to Follow-up|2|||
48778288|NCT01774903|157032596|FG000|Overall Study|Adverse Event|7|||
48778289|NCT01774903|157032596|FG000|Overall Study|Withdrawal by Subject|2|||
48778290|NCT01774903|157032596|FG000|Overall Study|Lack of Efficacy|1|||
48778291|NCT01774903|157032596|FG000|Overall Study|Ineligible to continue the trial|1|||
48778292|NCT00961259|157032603|FG000|Washout Period of 7 Days|due to concomitant medication used|0|||
48778293|NCT00961259|157032604|FG001|Washout Period of 7 Days|due to concomitant medication used|1|||
48778294|NCT00961259|157032605|FG002|Washout Period of 7 Days|due to concomitant medication used|0|||
48778295|NCT02167035|157032608|FG000|Overall Study|Adverse Event|2|||
48778296|NCT02167035|157032609|FG001|Overall Study|Adverse Event|2|||
48778297|NCT02167035|157032608|FG000|Overall Study|Lost to Follow-up|3|||
48778298|NCT02167035|157032609|FG001|Overall Study|Lost to Follow-up|3|||
48778299|NCT02167035|157032608|FG000|Overall Study|Randomized to incorrect Study Medication|0|||
48778300|NCT02167035|157032609|FG001|Overall Study|Randomized to incorrect Study Medication|1|||
48877063|NCT00719043|157388541|FG001|Overall Study|Lost to Follow-up|10|||
48877064|NCT00719043|157388542|FG002|Overall Study|Lost to Follow-up|8|||
48778301|NCT02252081|157032610|FG000|Overall Study|Withdrawal by Subject|2|||
48778302|NCT02252081|157032611|FG001|Overall Study|Withdrawal by Subject|1|||
48778303|NCT02252081|157032610|FG000|Overall Study|Adverse Event|4|||
48778304|NCT02252081|157032611|FG001|Overall Study|Adverse Event|1|||
48778305|NCT02252081|157032610|FG000|Overall Study|non compliance & others|0|||
48778306|NCT02252081|157032611|FG001|Overall Study|non compliance & others|2|||
48778307|NCT00048724|157032617|FG000|Overall Study|Adverse Event|53|||
48778308|NCT00048724|157032618|FG001|Overall Study|Adverse Event|12|||
48778309|NCT00048724|157032617|FG000|Overall Study|Withdrawal by Subject|34|||
48778310|NCT00048724|157032618|FG001|Overall Study|Withdrawal by Subject|54|||
48778311|NCT00048724|157032617|FG000|Overall Study|Lost to Follow-up|5|||
48778312|NCT00048724|157032618|FG001|Overall Study|Lost to Follow-up|5|||
48778313|NCT00048724|157032617|FG000|Overall Study|Protocol-defined Clinical Event|17|||
48778314|NCT00048724|157032618|FG001|Overall Study|Protocol-defined Clinical Event|32|||
48778315|NCT00048724|157032617|FG000|Overall Study|Noncompliance With Protocol|4|||
48778316|NCT00048724|157032618|FG001|Overall Study|Noncompliance With Protocol|12|||
48778317|NCT00048724|157032617|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
48778318|NCT00048724|157032618|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
48778319|NCT00048724|157032617|FG000|Overall Study|Administrative|1|||
48778320|NCT00048724|157032618|FG001|Overall Study|Administrative|1|||
48778321|NCT02039427|157032619|FG000|Overall Study|Duration of surgery > 3h|1|||
48778322|NCT02039427|157032620|FG001|Overall Study|Duration of surgery > 3h|1|||
48778323|NCT02039427|157032621|FG002|Overall Study|Duration of surgery > 3h|0|||
48778324|NCT02039427|157032622|FG003|Overall Study|Duration of surgery > 3h|0|||
48778325|NCT02039427|157032619|FG000|Overall Study|Withdrawal on concent|0|||
48778326|NCT02039427|157032620|FG001|Overall Study|Withdrawal on concent|0|||
48778327|NCT02039427|157032621|FG002|Overall Study|Withdrawal on concent|0|||
48778328|NCT02039427|157032622|FG003|Overall Study|Withdrawal on concent|1|||
48778329|NCT02039427|157032619|FG000|Overall Study|Cancellation of surgery|0|||
48778330|NCT02039427|157032620|FG001|Overall Study|Cancellation of surgery|0|||
48778331|NCT02039427|157032621|FG002|Overall Study|Cancellation of surgery|1|||
48778332|NCT02039427|157032622|FG003|Overall Study|Cancellation of surgery|0|||
48778333|NCT02039427|157032619|FG000|Overall Study|Loss of follow - up|1|||
48778334|NCT02039427|157032620|FG001|Overall Study|Loss of follow - up|0|||
48778335|NCT02039427|157032621|FG002|Overall Study|Loss of follow - up|2|||
48778336|NCT02039427|157032622|FG003|Overall Study|Loss of follow - up|4|||
48778337|NCT02039427|157032619|FG000|Overall Study|Steroid Use|1|||
48778338|NCT02039427|157032620|FG001|Overall Study|Steroid Use|0|||
48778339|NCT02039427|157032621|FG002|Overall Study|Steroid Use|0|||
48778340|NCT02039427|157032622|FG003|Overall Study|Steroid Use|0|||
48778341|NCT03603964|157032623|FG000|Overall Study|Death|9|||
48778342|NCT03603964|157032623|FG000|Overall Study|Withdrawal by participant|7|||
48778343|NCT03603964|157032623|FG000|Overall Study|Study terminated by Sponsor|19|||
48778344|NCT04317586|157032624|FG000|Overall Study|Participants/Hips Implanted Censored from Analysis|2|||
48778345|NCT04317586|157032624|FG000|Overall Study|Participants Terminated Early (*15 Hips Implanted)|14|||
48778346|NCT01148810|157032625|FG000|Overall Study|Adverse Event|0|||
48778347|NCT01148810|157032626|FG001|Overall Study|Adverse Event|2|||
48778348|NCT01148810|157032625|FG000|Overall Study|Lack of Efficacy|0|||
48778349|NCT01148810|157032626|FG001|Overall Study|Lack of Efficacy|1|||
48778350|NCT01148810|157032625|FG000|Overall Study|Withdrawal by Subject|0|||
48778351|NCT01148810|157032626|FG001|Overall Study|Withdrawal by Subject|2|||
48778352|NCT01148810|157032625|FG000|Overall Study|Protocol Violation|1|||
48778353|NCT01148810|157032626|FG001|Overall Study|Protocol Violation|0|||
48778354|NCT00403455|157032628|FG000|Overall Study|Withdrawal by Subject|1|||
48778355|NCT03003676|157032631|FG000|Overall Study|Lack of Efficacy|5|||
48778356|NCT03003676|157032632|FG001|Overall Study|Lack of Efficacy|7|||
48778357|NCT03003676|157032631|FG000|Overall Study|Withdrawal by Subject|0|||
48778358|NCT03003676|157032632|FG001|Overall Study|Withdrawal by Subject|1|||
48778359|NCT03003676|157032631|FG000|Overall Study|Hepatitis B infection|1|||
48778360|NCT03003676|157032632|FG001|Overall Study|Hepatitis B infection|0|||
48778361|NCT03732638|157032633|FG000|DBT Phase (Weeks 1 to 12)|Adverse Event|5|||
48778362|NCT03732638|157032634|FG001|DBT Phase (Weeks 1 to 12)|Adverse Event|2|||
48778363|NCT03732638|157032633|FG000|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|8|||
48778364|NCT03732638|157032634|FG001|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|13|||
48778365|NCT03732638|157032633|FG000|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
48778366|NCT03732638|157032634|FG001|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
48778367|NCT03732638|157032633|FG000|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|19|||
48778368|NCT03732638|157032634|FG001|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|12|||
48778369|NCT03732638|157032633|FG000|DBT Phase (Weeks 1 to 12)|Non-compliance|6|||
48778370|NCT03732638|157032634|FG001|DBT Phase (Weeks 1 to 12)|Non-compliance|5|||
48877065|NCT00719043|157388543|FG003|Overall Study|Lost to Follow-up|9|||
48877066|NCT00719043|157388544|FG004|Overall Study|Lost to Follow-up|10|||
48877067|NCT00719043|157388545|FG005|Overall Study|Lost to Follow-up|9|||
48778371|NCT03732638|157032633|FG000|DBT Phase (Weeks 1 to 12)|Physician Decision|0|||
48778372|NCT03732638|157032634|FG001|DBT Phase (Weeks 1 to 12)|Physician Decision|1|||
48877068|NCT00719043|157388546|FG006|Overall Study|Lost to Follow-up|9|||
48877069|NCT00719043|157388540|FG000|Overall Study|Protocol Violation|0|||
48877070|NCT00719043|157388541|FG001|Overall Study|Protocol Violation|0|||
48877071|NCT00719043|157388542|FG002|Overall Study|Protocol Violation|0|||
48877072|NCT00719043|157388543|FG003|Overall Study|Protocol Violation|0|||
48877073|NCT00719043|157388544|FG004|Overall Study|Protocol Violation|0|||
48778373|NCT03732638|157032633|FG000|DBT Phase (Weeks 1 to 12)|Protocol deviation|4|||
48778374|NCT03732638|157032634|FG001|DBT Phase (Weeks 1 to 12)|Protocol deviation|5|||
48982628|NCT01646255|157767664|FG000|Overall Study|Inclusion Criteria Deviation|1|||
48778375|NCT03732638|157032633|FG000|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|11|||
48778376|NCT03732638|157032634|FG001|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|22|||
48778377|NCT03732638|157032633|FG000|OLE Phase (Weeks 13 to 64)|Adverse Event|10|||
48778378|NCT03732638|157032634|FG001|OLE Phase (Weeks 13 to 64)|Adverse Event|9|||
48778379|NCT03732638|157032633|FG000|OLE Phase (Weeks 13 to 64)|Death|1|||
48778380|NCT03732638|157032634|FG001|OLE Phase (Weeks 13 to 64)|Death|1|||
48778381|NCT03732638|157032633|FG000|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|2|||
48778382|NCT03732638|157032634|FG001|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|0|||
48877074|NCT00719043|157388545|FG005|Overall Study|Protocol Violation|1|||
48877075|NCT00719043|157388546|FG006|Overall Study|Protocol Violation|0|||
48877076|NCT00719043|157388540|FG000|Overall Study|Other|1|||
48982629|NCT01646255|157767665|FG001|Overall Study|Inclusion Criteria Deviation|0|||
48877077|NCT00719043|157388541|FG001|Overall Study|Other|0|||
49028595|NCT01029340|157941240|FG004|Extension Period|Adverse Event|0|||
49028596|NCT01029340|157941241|FG005|Extension Period|Adverse Event|1|||
48778383|NCT03732638|157032633|FG000|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
48778384|NCT03732638|157032634|FG001|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
48778385|NCT03732638|157032633|FG000|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|19|||
48778386|NCT03732638|157032634|FG001|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|13|||
48778387|NCT03732638|157032633|FG000|OLE Phase (Weeks 13 to 64)|Non-compliance|15|||
48778388|NCT03732638|157032634|FG001|OLE Phase (Weeks 13 to 64)|Non-compliance|14|||
48778389|NCT03732638|157032633|FG000|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
48778390|NCT03732638|157032634|FG001|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
48778391|NCT03732638|157032633|FG000|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
48778392|NCT03732638|157032634|FG001|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
48778393|NCT03732638|157032633|FG000|OLE Phase (Weeks 13 to 64)|Protocol deviation|2|||
48778394|NCT03732638|157032634|FG001|OLE Phase (Weeks 13 to 64)|Protocol deviation|3|||
48778395|NCT03732638|157032633|FG000|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|1|||
48778396|NCT03732638|157032634|FG001|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|0|||
48778397|NCT03732638|157032633|FG000|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|29|||
48778398|NCT03732638|157032634|FG001|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|28|||
48778399|NCT03732638|157032633|FG000|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
48778400|NCT03732638|157032634|FG001|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
48778401|NCT03732638|157032633|FG000|Follow-up Phase (up to 72 Weeks)|Not reported|49|||
48778402|NCT03732638|157032634|FG001|Follow-up Phase (up to 72 Weeks)|Not reported|48|||
48778403|NCT03732638|157032633|FG000|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|10|||
48778404|NCT03732638|157032634|FG001|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|6|||
48778405|NCT03732638|157032633|FG000|Follow-up Phase (up to 72 Weeks)|Non-compliance|2|||
48778406|NCT03732638|157032634|FG001|Follow-up Phase (up to 72 Weeks)|Non-compliance|1|||
48778407|NCT03732638|157032633|FG000|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|4|||
48778408|NCT03732638|157032634|FG001|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|7|||
48778409|NCT03766646|157032635|FG000|Overall Study|Withdrawal by Subject|1|||
48778410|NCT03766646|157032636|FG001|Overall Study|Withdrawal by Subject|0|||
48778411|NCT03766646|157032635|FG000|Overall Study|Protocol Violation|0|||
48778412|NCT03766646|157032636|FG001|Overall Study|Protocol Violation|3|||
48778413|NCT01163682|157032640|FG000|Overall Study|Lost to Follow-up|6|||
48778414|NCT01163682|157032641|FG001|Overall Study|Lost to Follow-up|9|||
48778415|NCT00359762|157032643|FG000|Period II|Adverse Event|17|||
48778416|NCT00359762|157032644|FG001|Period II|Adverse Event|0|||
48778417|NCT00359762|157032645|FG002|Period II|Adverse Event|0|||
48778418|NCT00359762|157032646|FG003|Period II|Adverse Event|0|||
48778419|NCT00359762|157032647|FG004|Period II|Adverse Event|49|||
48778420|NCT00359762|157032643|FG000|Period II|Protocol Violation|18|||
48778421|NCT00359762|157032644|FG001|Period II|Protocol Violation|0|||
48778422|NCT00359762|157032645|FG002|Period II|Protocol Violation|0|||
48778423|NCT00359762|157032646|FG003|Period II|Protocol Violation|0|||
48778424|NCT00359762|157032647|FG004|Period II|Protocol Violation|11|||
48778425|NCT00359762|157032643|FG000|Period II|Physician Decision|17|||
48778426|NCT00359762|157032644|FG001|Period II|Physician Decision|0|||
48778427|NCT00359762|157032645|FG002|Period II|Physician Decision|0|||
48778428|NCT00359762|157032646|FG003|Period II|Physician Decision|0|||
48778429|NCT00359762|157032647|FG004|Period II|Physician Decision|23|||
48778430|NCT00359762|157032643|FG000|Period II|Death|2|||
48778431|NCT00359762|157032644|FG001|Period II|Death|0|||
48778432|NCT00359762|157032645|FG002|Period II|Death|0|||
48778433|NCT00359762|157032646|FG003|Period II|Death|0|||
48778434|NCT00359762|157032647|FG004|Period II|Death|4|||
48778435|NCT00359762|157032643|FG000|Period II|Lack of Efficacy|11|||
48778436|NCT00359762|157032644|FG001|Period II|Lack of Efficacy|0|||
48778437|NCT00359762|157032645|FG002|Period II|Lack of Efficacy|0|||
48778438|NCT00359762|157032646|FG003|Period II|Lack of Efficacy|0|||
48778439|NCT00359762|157032647|FG004|Period II|Lack of Efficacy|8|||
48778440|NCT00359762|157032643|FG000|Period II|Lost to follow up|5|||
49028597|NCT01029340|157941236|FG000|Extension Period|starting another study|0|||
49028598|NCT01029340|157941237|FG001|Extension Period|starting another study|0|||
49028599|NCT01029340|157941238|FG002|Extension Period|starting another study|0|||
48778441|NCT00359762|157032644|FG001|Period II|Lost to follow up|0|||
49028600|NCT01029340|157941239|FG003|Extension Period|starting another study|0|||
48778442|NCT00359762|157032645|FG002|Period II|Lost to follow up|0|||
48778443|NCT00359762|157032646|FG003|Period II|Lost to follow up|0|||
48778444|NCT00359762|157032647|FG004|Period II|Lost to follow up|5|||
48778445|NCT00359762|157032643|FG000|Period II|Entry Criteria Not Met|8|||
48778446|NCT00359762|157032644|FG001|Period II|Entry Criteria Not Met|0|||
48778447|NCT00359762|157032645|FG002|Period II|Entry Criteria Not Met|0|||
48778448|NCT00359762|157032646|FG003|Period II|Entry Criteria Not Met|0|||
48778449|NCT00359762|157032647|FG004|Period II|Entry Criteria Not Met|4|||
48778450|NCT00359762|157032643|FG000|Period II|Subject Decision|50|||
48778451|NCT00359762|157032644|FG001|Period II|Subject Decision|0|||
49028601|NCT01029340|157941240|FG004|Extension Period|starting another study|0|||
48778452|NCT00359762|157032645|FG002|Period II|Subject Decision|0|||
48778453|NCT00359762|157032646|FG003|Period II|Subject Decision|0|||
48778454|NCT00359762|157032647|FG004|Period II|Subject Decision|70|||
48778455|NCT00359762|157032643|FG000|Period III|Protocol Violation|0|||
48778456|NCT00359762|157032644|FG001|Period III|Protocol Violation|5|||
48778457|NCT00359762|157032645|FG002|Period III|Protocol Violation|3|||
48778458|NCT00359762|157032646|FG003|Period III|Protocol Violation|8|||
48778459|NCT00359762|157032647|FG004|Period III|Protocol Violation|0|||
48778460|NCT00359762|157032643|FG000|Period III|Adverse Event|0|||
48778461|NCT00359762|157032644|FG001|Period III|Adverse Event|3|||
48778462|NCT00359762|157032645|FG002|Period III|Adverse Event|4|||
48778463|NCT00359762|157032646|FG003|Period III|Adverse Event|10|||
48778464|NCT00359762|157032647|FG004|Period III|Adverse Event|0|||
48778465|NCT00359762|157032643|FG000|Period III|Physician Decision|0|||
48778466|NCT00359762|157032644|FG001|Period III|Physician Decision|5|||
48778467|NCT00359762|157032645|FG002|Period III|Physician Decision|9|||
48778468|NCT00359762|157032646|FG003|Period III|Physician Decision|15|||
48778469|NCT00359762|157032647|FG004|Period III|Physician Decision|0|||
48778470|NCT00359762|157032643|FG000|Period III|Lack of Efficacy|0|||
48778471|NCT00359762|157032644|FG001|Period III|Lack of Efficacy|7|||
48778472|NCT00359762|157032645|FG002|Period III|Lack of Efficacy|5|||
48778473|NCT00359762|157032646|FG003|Period III|Lack of Efficacy|9|||
48778474|NCT00359762|157032647|FG004|Period III|Lack of Efficacy|0|||
48778475|NCT00359762|157032643|FG000|Period III|Lost to follow up|0|||
49028602|NCT01029340|157941241|FG005|Extension Period|starting another study|8|||
49028603|NCT01029340|157941236|FG000|Extension Period|non-compliance|0|||
49028604|NCT01029340|157941237|FG001|Extension Period|non-compliance|0|||
49028605|NCT01029340|157941238|FG002|Extension Period|non-compliance|0|||
49028606|NCT01029340|157941239|FG003|Extension Period|non-compliance|0|||
49028607|NCT01029340|157941240|FG004|Extension Period|non-compliance|0|||
49028608|NCT01029340|157941241|FG005|Extension Period|non-compliance|1|||
49028609|NCT01029340|157941236|FG000|Extension Period|Withdrawal by Subject|0|||
49028610|NCT01029340|157941237|FG001|Extension Period|Withdrawal by Subject|0|||
49028611|NCT01029340|157941238|FG002|Extension Period|Withdrawal by Subject|0|||
49028612|NCT01029340|157941239|FG003|Extension Period|Withdrawal by Subject|0|||
48778476|NCT00359762|157032644|FG001|Period III|Lost to follow up|1|||
48778477|NCT00359762|157032645|FG002|Period III|Lost to follow up|1|||
48778478|NCT00359762|157032646|FG003|Period III|Lost to follow up|2|||
48778479|NCT00359762|157032647|FG004|Period III|Lost to follow up|0|||
48778480|NCT00359762|157032643|FG000|Period III|Entry Criteria Not Met|0|||
48778481|NCT00359762|157032644|FG001|Period III|Entry Criteria Not Met|1|||
48778482|NCT00359762|157032645|FG002|Period III|Entry Criteria Not Met|0|||
48778483|NCT00359762|157032646|FG003|Period III|Entry Criteria Not Met|1|||
49028613|NCT01029340|157941240|FG004|Extension Period|Withdrawal by Subject|0|||
49028614|NCT01029340|157941241|FG005|Extension Period|Withdrawal by Subject|1|||
49028615|NCT01029340|157941236|FG000|Extension Period|Physician Decision|0|||
49028616|NCT01029340|157941237|FG001|Extension Period|Physician Decision|0|||
49028617|NCT01029340|157941238|FG002|Extension Period|Physician Decision|0|||
49028618|NCT01029340|157941239|FG003|Extension Period|Physician Decision|0|||
49028619|NCT01029340|157941240|FG004|Extension Period|Physician Decision|0|||
49028620|NCT01029340|157941241|FG005|Extension Period|Physician Decision|1|||
49028621|NCT00268905|157941242|FG000|Overall Study|Adverse Event|3|||
49028622|NCT00268905|157941243|FG001|Overall Study|Adverse Event|0|||
49028623|NCT00268905|157941244|FG002|Overall Study|Adverse Event|4|||
49028624|NCT00268905|157941242|FG000|Overall Study|Lost to Follow-up|0|||
49028625|NCT00268905|157941243|FG001|Overall Study|Lost to Follow-up|1|||
49028626|NCT00268905|157941244|FG002|Overall Study|Lost to Follow-up|0|||
49028627|NCT00268905|157941242|FG000|Overall Study|Withdrawal by Subject|0|||
49028628|NCT00268905|157941243|FG001|Overall Study|Withdrawal by Subject|0|||
49028629|NCT00268905|157941244|FG002|Overall Study|Withdrawal by Subject|3|||
49028630|NCT00268905|157941242|FG000|Overall Study|Progressive Disease|28|||
49028631|NCT00268905|157941243|FG001|Overall Study|Progressive Disease|4|||
48778484|NCT00359762|157032647|FG004|Period III|Entry Criteria Not Met|0|||
48778485|NCT00359762|157032643|FG000|Period III|Subject Decision|0|||
48778486|NCT00359762|157032644|FG001|Period III|Subject Decision|7|||
48778487|NCT00359762|157032645|FG002|Period III|Subject Decision|8|||
48778488|NCT00359762|157032646|FG003|Period III|Subject Decision|20|||
48778489|NCT00359762|157032647|FG004|Period III|Subject Decision|0|||
48778490|NCT00530023|157032648|FG000|Overall Study|Withdrawal by Subject|0|||
48778491|NCT00530023|157032649|FG001|Overall Study|Withdrawal by Subject|1|||
48778492|NCT04574362|157032650|FG000|Overall Study|Other|0|||
48778493|NCT04574362|157032651|FG001|Overall Study|Other|5|||
48778494|NCT04574362|157032650|FG000|Overall Study|COVID-19|0|||
48778495|NCT04574362|157032651|FG001|Overall Study|COVID-19|1|||
49028632|NCT00268905|157941244|FG002|Overall Study|Progressive Disease|3|||
49028633|NCT00268905|157941242|FG000|Overall Study|Physician Decision|3|||
48778496|NCT04574362|157032650|FG000|Overall Study|Adverse Event|1|||
48778497|NCT04574362|157032651|FG001|Overall Study|Adverse Event|1|||
48778498|NCT04574362|157032650|FG000|Overall Study|Withdrawal by Subject|2|||
48778499|NCT04574362|157032651|FG001|Overall Study|Withdrawal by Subject|4|||
49028634|NCT00268905|157941243|FG001|Overall Study|Physician Decision|0|||
48778500|NCT04574362|157032650|FG000|Overall Study|Participant anxious to go to their hometown and withdrew from study|1|||
48778501|NCT04574362|157032651|FG001|Overall Study|Participant anxious to go to their hometown and withdrew from study|0|||
48778502|NCT04574362|157032650|FG000|Overall Study|Participant refused to come to the hospital|1|||
48778503|NCT04574362|157032651|FG001|Overall Study|Participant refused to come to the hospital|0|||
48778504|NCT04574362|157032650|FG000|Overall Study|Participant refused the visit|1|||
48778505|NCT04574362|157032651|FG001|Overall Study|Participant refused the visit|0|||
48778506|NCT04574362|157032650|FG000|Overall Study|Participant quit early because of business trip|1|||
48778507|NCT04574362|157032651|FG001|Overall Study|Participant quit early because of business trip|0|||
48877078|NCT00719043|157388542|FG002|Overall Study|Other|1|||
48778508|NCT00765245|157032653|FG000|Overall Study|disease progression|3|||
48778509|NCT00765245|157032654|FG001|Overall Study|disease progression|2|||
48778510|NCT00765245|157032653|FG000|Overall Study|Withdrawal by Subject|3|||
48778511|NCT00765245|157032654|FG001|Overall Study|Withdrawal by Subject|0|||
48778512|NCT00765245|157032653|FG000|Overall Study|Adverse Event|5|||
48778513|NCT00765245|157032654|FG001|Overall Study|Adverse Event|0|||
48778514|NCT00765245|157032653|FG000|Overall Study|Physician Decision|1|||
48778515|NCT00765245|157032654|FG001|Overall Study|Physician Decision|0|||
48877079|NCT00719043|157388543|FG003|Overall Study|Other|2|||
48877080|NCT00719043|157388544|FG004|Overall Study|Other|0|||
48877081|NCT00719043|157388545|FG005|Overall Study|Other|2|||
48877082|NCT00719043|157388546|FG006|Overall Study|Other|1|||
48877083|NCT00719043|157388540|FG000|Overall Study|Withdrawal by Subject|12|||
48877084|NCT00719043|157388541|FG001|Overall Study|Withdrawal by Subject|14|||
48877085|NCT00719043|157388542|FG002|Overall Study|Withdrawal by Subject|9|||
48877086|NCT00719043|157388543|FG003|Overall Study|Withdrawal by Subject|10|||
48877087|NCT00719043|157388544|FG004|Overall Study|Withdrawal by Subject|16|||
48877088|NCT00719043|157388545|FG005|Overall Study|Withdrawal by Subject|18|||
48877089|NCT00719043|157388546|FG006|Overall Study|Withdrawal by Subject|14|||
48877090|NCT01777490|157388550|FG000|Overall Study|Dyad withdrew with data use prohibition|0|||
48877091|NCT01777490|157388551|FG001|Overall Study|Dyad withdrew with data use prohibition|0|||
48877092|NCT01777490|157388552|FG002|Overall Study|Dyad withdrew with data use prohibition|1|||
48877093|NCT01777490|157388553|FG003|Overall Study|Dyad withdrew with data use prohibition|1|||
48877094|NCT02312206|157388554|FG000|Overall Study|Adverse Event|3|||
48877095|NCT02312206|157388555|FG001|Overall Study|Adverse Event|6|||
48877096|NCT02312206|157388554|FG000|Overall Study|Withdrawal by Subject|6|||
48877097|NCT02312206|157388555|FG001|Overall Study|Withdrawal by Subject|6|||
48877098|NCT02312206|157388554|FG000|Overall Study|Physician Decision|7|||
48877099|NCT02312206|157388555|FG001|Overall Study|Physician Decision|6|||
48877100|NCT02312206|157388554|FG000|Overall Study|Death|31|||
48877101|NCT02312206|157388555|FG001|Overall Study|Death|36|||
48877102|NCT02312206|157388554|FG000|Overall Study|Study Terminated by Sponsor|81|||
48877103|NCT02312206|157388555|FG001|Overall Study|Study Terminated by Sponsor|74|||
48877104|NCT02312206|157388554|FG000|Overall Study|Patient transferred to hospice|0|||
48877105|NCT02312206|157388555|FG001|Overall Study|Patient transferred to hospice|1|||
48877106|NCT02312206|157388554|FG000|Overall Study|Subject missed three consecutive treatment visits|0|||
48877107|NCT02312206|157388555|FG001|Overall Study|Subject missed three consecutive treatment visits|1|||
48877108|NCT02312206|157388554|FG000|Overall Study|Patient progression and institution of a new therapy|1|||
48877109|NCT02312206|157388555|FG001|Overall Study|Patient progression and institution of a new therapy|0|||
48877110|NCT02312206|157388554|FG000|Overall Study|Disease Progression|1|||
48877111|NCT02312206|157388555|FG001|Overall Study|Disease Progression|0|||
48877112|NCT06516705|157388558|FG000|T1( Before Hypoglycemia Education)|Withdrawal by Subject|1|||
48877113|NCT06516705|157388559|FG001|T1( Before Hypoglycemia Education)|Withdrawal by Subject|0|||
48877114|NCT06516705|157388558|FG000|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
48877115|NCT06516705|157388559|FG001|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
48877116|NCT06516705|157388558|FG000|T3 ( 3 Month After Education)|covid-19|1|||
48877117|NCT06516705|157388559|FG001|T3 ( 3 Month After Education)|covid-19|2|||
48877118|NCT06516705|157388558|FG000|T3 ( 3 Month After Education)|Refused to respond|0|||
49028635|NCT00268905|157941244|FG002|Overall Study|Physician Decision|1|||
49028636|NCT00268905|157941242|FG000|Overall Study|Clinical Progression|9|||
48778516|NCT00765245|157032653|FG000|Overall Study|Death|1|||
48877119|NCT06516705|157388559|FG001|T3 ( 3 Month After Education)|Refused to respond|1|||
48877120|NCT06516705|157388558|FG000|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
48877121|NCT06516705|157388559|FG001|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
48877122|NCT06516705|157388558|FG000|T4 ( 6 Month After Education)|covid-19|3|||
48877123|NCT06516705|157388559|FG001|T4 ( 6 Month After Education)|covid-19|2|||
48877124|NCT06516705|157388558|FG000|T4 ( 6 Month After Education)|Refused to respond|0|||
48778517|NCT00765245|157032654|FG001|Overall Study|Death|0|||
48778518|NCT04382326|157032655|FG000|Overall Study|Adverse Event, not serious|1|||
48877125|NCT06516705|157388559|FG001|T4 ( 6 Month After Education)|Refused to respond|1|||
48877126|NCT01336205|157388560|FG000|Overall Study|Other|22|||
48877127|NCT01336205|157388561|FG001|Overall Study|Other|9|||
49028637|NCT00268905|157941243|FG001|Overall Study|Clinical Progression|4|||
48778519|NCT04382326|157032656|FG001|Overall Study|Adverse Event, not serious|2|||
48877128|NCT01336205|157388560|FG000|Overall Study|Lost to Follow-up|40|||
48877129|NCT01336205|157388561|FG001|Overall Study|Lost to Follow-up|20|||
48877130|NCT01336205|157388560|FG000|Overall Study|Study-Specific Withdrawal Criteria|16|||
48877131|NCT01336205|157388561|FG001|Overall Study|Study-Specific Withdrawal Criteria|7|||
48877132|NCT01336205|157388560|FG000|Overall Study|Lack of Efficacy|4|||
48877133|NCT01336205|157388561|FG001|Overall Study|Lack of Efficacy|0|||
48877134|NCT01336205|157388560|FG000|Overall Study|Severe noncompliance with protocol|9|||
48877135|NCT01336205|157388561|FG001|Overall Study|Severe noncompliance with protocol|2|||
48877136|NCT01336205|157388560|FG000|Overall Study|Adverse Event|56|||
48877137|NCT01336205|157388561|FG001|Overall Study|Adverse Event|6|||
48877138|NCT01336205|157388560|FG000|Overall Study|Death|1|||
48877139|NCT01336205|157388561|FG001|Overall Study|Death|1|||
48877140|NCT01336205|157388560|FG000|Overall Study|Eligibility Criteria Not Fulfilled|9|||
48877141|NCT01336205|157388561|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
48877142|NCT01336205|157388560|FG000|Overall Study|Withdrawal by Subject|72|||
48877143|NCT01336205|157388561|FG001|Overall Study|Withdrawal by Subject|38|||
48877144|NCT01336205|157388560|FG000|Overall Study|Did not receive treatment|4|||
48877145|NCT01336205|157388561|FG001|Overall Study|Did not receive treatment|0|||
48877146|NCT01772563|157388562|FG000|Cycle 1|Dose limiting toxicity|2|||
48877147|NCT01772563|157388562|FG000|Cycle 1|Progressive disease|2|||
48877148|NCT01772563|157388562|FG000|Cycle 2 and Beyond|Progressive disease|17|||
48877149|NCT01772563|157388562|FG000|Cycle 2 and Beyond|Refused continuing medication|4|||
48877150|NCT01772563|157388562|FG000|Cycle 2 and Beyond|Withdrawal by Subject|2|||
48877151|NCT00905034|157388565|FG000|Overall Study|Withdrawal by Subject|1|||
48877152|NCT02561247|157388566|FG000|Overall Study|Protocol Violation|1|||
48877153|NCT02561247|157388566|FG000|Overall Study|Withdrawal by Subject|1|||
48877154|NCT02561247|157388566|FG000|Overall Study|Two filter changes required within the first 24 hours.|4|||
48877155|NCT00443209|157388567|FG000|Months 1 to 12 Treatment Period|Adverse Event|22|||
48877156|NCT00443209|157388568|FG001|Months 1 to 12 Treatment Period|Adverse Event|11|||
48877157|NCT00443209|157388567|FG000|Months 1 to 12 Treatment Period|Protocol Violation|14|||
48877158|NCT00443209|157388568|FG001|Months 1 to 12 Treatment Period|Protocol Violation|7|||
48877159|NCT00443209|157388567|FG000|Months 1 to 12 Treatment Period|Lack of Efficacy|50|||
48877160|NCT00443209|157388568|FG001|Months 1 to 12 Treatment Period|Lack of Efficacy|11|||
48877161|NCT00443209|157388567|FG000|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
48877162|NCT00443209|157388568|FG001|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
48877163|NCT00443209|157388567|FG000|Months 1 to 12 Treatment Period|Lost to Follow-up|36|||
48877164|NCT00443209|157388568|FG001|Months 1 to 12 Treatment Period|Lost to Follow-up|15|||
48877165|NCT00443209|157388567|FG000|Months 1 to 12 Treatment Period|Physician Decision|8|||
49028638|NCT00268905|157941244|FG002|Overall Study|Clinical Progression|1|||
49028639|NCT02648347|157941245|FG000|Overall Study|Death|174|||
49028640|NCT02648347|157941246|FG001|Overall Study|Death|167|||
49028641|NCT02648347|157941245|FG000|Overall Study|Withdrawal by Subject|16|||
48778520|NCT04382326|157032655|FG000|Overall Study|Other|1|||
48778521|NCT04382326|157032656|FG001|Overall Study|Other|0|||
48778522|NCT04382326|157032655|FG000|Overall Study|Withdrawal By Parent/Guardian|50|||
48778523|NCT04382326|157032656|FG001|Overall Study|Withdrawal By Parent/Guardian|54|||
48778524|NCT04382326|157032655|FG000|Overall Study|No Longer Meets Eligibility Criteria|50|||
48778525|NCT04382326|157032656|FG001|Overall Study|No Longer Meets Eligibility Criteria|44|||
48778526|NCT04382326|157032655|FG000|Overall Study|Protocol Violation|29|||
48778527|NCT04382326|157032656|FG001|Overall Study|Protocol Violation|23|||
48778528|NCT04382326|157032655|FG000|Overall Study|Physician Decision|0|||
48778529|NCT04382326|157032656|FG001|Overall Study|Physician Decision|1|||
48778530|NCT04382326|157032655|FG000|Overall Study|Lost to Follow-up|48|||
48778531|NCT04382326|157032656|FG001|Overall Study|Lost to Follow-up|63|||
48778532|NCT04382326|157032655|FG000|Overall Study|Adverse Event, non-fatal|1|||
48778533|NCT04382326|157032656|FG001|Overall Study|Adverse Event, non-fatal|1|||
48778534|NCT01263873|157032657|FG000|Overall Study|One provider unable to complete numbers|1|||
48778535|NCT01263873|157032658|FG001|Overall Study|One provider unable to complete numbers|1|||
48778536|NCT04067141|157032663|FG000|First Intervention|Withdrawal by Subject|0|||
48778537|NCT04067141|157032664|FG001|First Intervention|Withdrawal by Subject|1|||
48778538|NCT04067141|157032663|FG000|Second Intervention|Adverse Event|0|||
48778539|NCT04067141|157032664|FG001|Second Intervention|Adverse Event|2|||
48778540|NCT03525834|157032665|FG000|Overall Study|Progressive disease|1|||
48778541|NCT00614939|157032668|FG000|Overall Study|Withdrawal by Subject|10|||
48778542|NCT00614939|157032669|FG001|Overall Study|Withdrawal by Subject|17|||
48778543|NCT00614939|157032668|FG000|Overall Study|Study specific discontinuation criteris|13|||
48778544|NCT00614939|157032669|FG001|Overall Study|Study specific discontinuation criteris|16|||
48877166|NCT00443209|157388568|FG001|Months 1 to 12 Treatment Period|Physician Decision|4|||
48877167|NCT00443209|157388567|FG000|Months 1 to 12 Treatment Period|Pregnancy|3|||
48877168|NCT00443209|157388568|FG001|Months 1 to 12 Treatment Period|Pregnancy|4|||
48877169|NCT00443209|157388567|FG000|Months 1 to 12 Treatment Period|Trial Terminated|43|||
48877170|NCT00443209|157388568|FG001|Months 1 to 12 Treatment Period|Trial Terminated|23|||
48877171|NCT00443209|157388567|FG000|Months 1 to 12 Treatment Period|Withdrawal by Subject|95|||
49028642|NCT02648347|157941246|FG001|Overall Study|Withdrawal by Subject|9|||
48778545|NCT00614939|157032668|FG000|Overall Study|Adverse Event|2|||
48778546|NCT00614939|157032669|FG001|Overall Study|Adverse Event|5|||
48778547|NCT00614939|157032668|FG000|Overall Study|Incorrect enrollment|1|||
48778548|NCT00614939|157032669|FG001|Overall Study|Incorrect enrollment|2|||
48778549|NCT00614939|157032668|FG000|Overall Study|Death|4|||
48778550|NCT00614939|157032669|FG001|Overall Study|Death|3|||
48778551|NCT00614939|157032668|FG000|Overall Study|Poor/non-compliance|4|||
48778552|NCT00614939|157032669|FG001|Overall Study|Poor/non-compliance|0|||
48778553|NCT00614939|157032668|FG000|Overall Study|Hospitalized due to kidney transplant|1|||
48778554|NCT00614939|157032669|FG001|Overall Study|Hospitalized due to kidney transplant|0|||
48778555|NCT02667912|157032670|FG000|Overall Study|Death|3|||
48778556|NCT02667912|157032671|FG001|Overall Study|Death|1|||
48778557|NCT02667912|157032670|FG000|Overall Study|Withdrawal by Subject|1|||
48778558|NCT02667912|157032671|FG001|Overall Study|Withdrawal by Subject|2|||
48778559|NCT02667912|157032670|FG000|Overall Study|Withdrawal by Subject|1|||
48778560|NCT02667912|157032671|FG001|Overall Study|Withdrawal by Subject|0|||
48778561|NCT00534352|157032672|FG000|Treatment A: TMC125 + TDF/FTC|Physician Decision|1|||
48778562|NCT00534352|157032672|FG000|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1|||
48778563|NCT00534352|157032672|FG000|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1|||
48778564|NCT00534352|157032672|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1|||
48778565|NCT00534352|157032672|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2|||
48778566|NCT00534352|157032672|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1|||
48778567|NCT01986829|157032675|FG000|Overall Study|Death|1|||
48778568|NCT02504866|157032676|FG000|6-Month Follow up (CON Group Only)|Adverse Event|1|||
48778569|NCT02504866|157032677|FG001|6-Month Follow up (CON Group Only)|Adverse Event|0|||
48778570|NCT02504866|157032678|FG002|6-Month Follow up (CON Group Only)|Adverse Event|0|||
48778571|NCT01260922|157032679|FG000|First Intervention|Withdrawal by Subject|0|||
48778572|NCT01260922|157032680|FG001|First Intervention|Withdrawal by Subject|1|||
48778573|NCT01260922|157032679|FG000|Washout of 28 Days|Withdrawal by Subject|4|||
48778574|NCT01260922|157032680|FG001|Washout of 28 Days|Withdrawal by Subject|2|||
48778575|NCT01260922|157032679|FG000|Second Intervention|Emesis|0|||
48778576|NCT01260922|157032680|FG001|Second Intervention|Emesis|2|||
48778577|NCT01229436|157032685|FG000|Overall Study|Withdrawal by Subject|2|||
48778578|NCT01229436|157032685|FG000|Overall Study|Lost to Follow-up|3|||
48778579|NCT01459796|157032688|FG000|Overall Study|Non compliance with protocol|2|||
48778580|NCT01459796|157032689|FG001|Overall Study|Non compliance with protocol|4|||
48778581|NCT01459796|157032688|FG000|Overall Study|Adverse Event|5|||
48778582|NCT01459796|157032689|FG001|Overall Study|Adverse Event|5|||
48778583|NCT01459796|157032688|FG000|Overall Study|Withdrawal by Subject|6|||
48778584|NCT01459796|157032689|FG001|Overall Study|Withdrawal by Subject|3|||
48778585|NCT01459796|157032688|FG000|Overall Study|Lost to Follow-up|5|||
48778586|NCT01459796|157032689|FG001|Overall Study|Lost to Follow-up|4|||
48778587|NCT01459796|157032688|FG000|Overall Study|Reason unspecified|1|||
48778588|NCT01459796|157032689|FG001|Overall Study|Reason unspecified|2|||
48778589|NCT01459796|157032688|FG000|Overall Study|Decision by the sponsor|75|||
48778590|NCT01459796|157032689|FG001|Overall Study|Decision by the sponsor|108|||
48778591|NCT02170727|157032690|FG000|Overall Study|Lost to Follow-up|1|||
48778592|NCT02170727|157032691|FG001|Overall Study|Lost to Follow-up|0|||
48778593|NCT02170727|157032690|FG000|Overall Study|Withdrawal by Subject|2|||
48778594|NCT02170727|157032691|FG001|Overall Study|Withdrawal by Subject|0|||
48778595|NCT03231371|157032694|FG000|Overall Study|Withdrawal by Subject|1|||
48778596|NCT03231371|157032694|FG000|Overall Study|chose or were ineligible to have MRI|12|||
48778597|NCT01959581|157032695|FG000|Overall Study|Lost to Follow-up|5|||
48778598|NCT03246958|157032696|FG000|Overall Study|Withdrawal by Subject|0|||
48778599|NCT03246958|157032697|FG001|Overall Study|Withdrawal by Subject|1|||
48778600|NCT03246958|157032698|FG002|Overall Study|Withdrawal by Subject|0|||
48778601|NCT03246958|157032699|FG003|Overall Study|Withdrawal by Subject|0|||
48778602|NCT03246958|157032700|FG004|Overall Study|Withdrawal by Subject|0|||
48778603|NCT03246958|157032701|FG005|Overall Study|Withdrawal by Subject|1|||
48778604|NCT03246958|157032702|FG006|Overall Study|Withdrawal by Subject|0|||
48778605|NCT03246958|157032696|FG000|Overall Study|Progression|13|||
48877172|NCT00443209|157388568|FG001|Months 1 to 12 Treatment Period|Withdrawal by Subject|34|||
48877173|NCT00443209|157388567|FG000|Months 1 to 12 Treatment Period|Missing|2|||
48778606|NCT03246958|157032697|FG001|Overall Study|Progression|9|||
48778607|NCT03246958|157032698|FG002|Overall Study|Progression|3|||
48877174|NCT00443209|157388568|FG001|Months 1 to 12 Treatment Period|Missing|1|||
48778608|NCT03246958|157032699|FG003|Overall Study|Progression|2|||
48778609|NCT03246958|157032700|FG004|Overall Study|Progression|1|||
48778610|NCT03246958|157032701|FG005|Overall Study|Progression|2|||
48778611|NCT03246958|157032702|FG006|Overall Study|Progression|1|||
48982630|NCT05375838|157767671|FG000|Overall Study|Other|0|||
48982631|NCT05375838|157767672|FG001|Overall Study|Other|0|||
48778612|NCT03246958|157032696|FG000|Overall Study|Adverse Event|2|||
48778613|NCT03246958|157032697|FG001|Overall Study|Adverse Event|2|||
48778614|NCT03246958|157032698|FG002|Overall Study|Adverse Event|0|||
48778615|NCT03246958|157032699|FG003|Overall Study|Adverse Event|1|||
48778616|NCT03246958|157032700|FG004|Overall Study|Adverse Event|1|||
48778617|NCT03246958|157032701|FG005|Overall Study|Adverse Event|0|||
48778618|NCT03246958|157032702|FG006|Overall Study|Adverse Event|2|||
48778619|NCT03246958|157032696|FG000|Overall Study|Death|0|||
48778620|NCT03246958|157032697|FG001|Overall Study|Death|1|||
48778621|NCT03246958|157032698|FG002|Overall Study|Death|0|||
48778622|NCT03246958|157032699|FG003|Overall Study|Death|0|||
48778623|NCT03246958|157032700|FG004|Overall Study|Death|0|||
48778624|NCT03246958|157032701|FG005|Overall Study|Death|0|||
48778625|NCT03246958|157032702|FG006|Overall Study|Death|0|||
48778626|NCT03246958|157032696|FG000|Overall Study|Physician Decision|0|||
48778627|NCT03246958|157032697|FG001|Overall Study|Physician Decision|0|||
48778628|NCT03246958|157032698|FG002|Overall Study|Physician Decision|0|||
48778629|NCT03246958|157032699|FG003|Overall Study|Physician Decision|1|||
48778630|NCT03246958|157032700|FG004|Overall Study|Physician Decision|0|||
48778631|NCT03246958|157032701|FG005|Overall Study|Physician Decision|0|||
48778632|NCT03246958|157032702|FG006|Overall Study|Physician Decision|0|||
48778633|NCT03246958|157032696|FG000|Overall Study|Never start treatment|1|||
48778634|NCT03246958|157032697|FG001|Overall Study|Never start treatment|0|||
48778635|NCT03246958|157032698|FG002|Overall Study|Never start treatment|0|||
48778636|NCT03246958|157032699|FG003|Overall Study|Never start treatment|0|||
48778637|NCT03246958|157032700|FG004|Overall Study|Never start treatment|0|||
48778638|NCT03246958|157032701|FG005|Overall Study|Never start treatment|0|||
48778639|NCT03246958|157032702|FG006|Overall Study|Never start treatment|0|||
48778640|NCT03246958|157032696|FG000|Overall Study|Over enrollment|0|||
48778641|NCT03246958|157032697|FG001|Overall Study|Over enrollment|2|||
48778642|NCT03246958|157032698|FG002|Overall Study|Over enrollment|0|||
48778643|NCT03246958|157032699|FG003|Overall Study|Over enrollment|0|||
48778644|NCT03246958|157032700|FG004|Overall Study|Over enrollment|0|||
48778645|NCT03246958|157032701|FG005|Overall Study|Over enrollment|0|||
48778646|NCT03246958|157032702|FG006|Overall Study|Over enrollment|0|||
48778647|NCT03880578|157032705|FG000|Overall Study|Withdrawal by Subject|0|||
48778648|NCT03880578|157032706|FG001|Overall Study|Withdrawal by Subject|3|||
48778649|NCT03880578|157032707|FG002|Overall Study|Withdrawal by Subject|1|||
48778650|NCT03880578|157032705|FG000|Overall Study|Death|0|||
48778651|NCT03880578|157032706|FG001|Overall Study|Death|1|||
48778652|NCT03880578|157032707|FG002|Overall Study|Death|0|||
48778653|NCT04632940|157032708|FG000|DB Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
48778654|NCT04632940|157032709|FG001|DB Period (52 Weeks)|Participant/Legal Guardian Decision|0|||
48778655|NCT04632940|157032708|FG000|OLE Period (52 Weeks)|Adverse Event|1|||
48778656|NCT04632940|157032709|FG001|OLE Period (52 Weeks)|Adverse Event|0|||
48778657|NCT04632940|157032708|FG000|OLE Period (52 Weeks)|Lost to Follow-up|0|||
48778658|NCT04632940|157032709|FG001|OLE Period (52 Weeks)|Lost to Follow-up|1|||
48778659|NCT04632940|157032708|FG000|OLE Period (52 Weeks)|Physician Decision|1|||
48778660|NCT04632940|157032709|FG001|OLE Period (52 Weeks)|Physician Decision|0|||
48778661|NCT04632940|157032708|FG000|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|11|||
48778662|NCT04632940|157032709|FG001|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|13|||
48778663|NCT04632940|157032708|FG000|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|21|||
48778664|NCT04632940|157032709|FG001|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|19|||
48778665|NCT04632940|157032708|FG000|OLE Period (52 Weeks)|Other than specified|0|||
48778666|NCT04632940|157032709|FG001|OLE Period (52 Weeks)|Other than specified|1|||
48778667|NCT04632940|157032708|FG000|OLE Period (52 Weeks)|Entered into OLE but not treated|0|||
48778668|NCT04632940|157032709|FG001|OLE Period (52 Weeks)|Entered into OLE but not treated|1|||
48778669|NCT02610140|157032710|FG000|Randomization and Treatment Period|Radiological progression|23|||
48778670|NCT02610140|157032711|FG001|Randomization and Treatment Period|Radiological progression|15|||
48778671|NCT02610140|157032710|FG000|Randomization and Treatment Period|Progressive disease - radiological|54|||
48778672|NCT02610140|157032711|FG001|Randomization and Treatment Period|Progressive disease - radiological|23|||
48778673|NCT02610140|157032710|FG000|Randomization and Treatment Period|Protocol Violation|1|||
48778674|NCT02610140|157032711|FG001|Randomization and Treatment Period|Protocol Violation|0|||
48778675|NCT02610140|157032710|FG000|Randomization and Treatment Period|Physician Decision|0|||
48778676|NCT02610140|157032711|FG001|Randomization and Treatment Period|Physician Decision|1|||
48982632|NCT05375838|157767673|FG002|Overall Study|Other|0|||
48982633|NCT05375838|157767674|FG003|Overall Study|Other|1|||
48982634|NCT05375838|157767675|FG004|Overall Study|Other|1|||
48982635|NCT05375838|157767676|FG005|Overall Study|Other|0|||
48982636|NCT05375838|157767671|FG000|Overall Study|Withdrawal by Subject|2|||
48982637|NCT05375838|157767672|FG001|Overall Study|Withdrawal by Subject|1|||
48982638|NCT05375838|157767673|FG002|Overall Study|Withdrawal by Subject|3|||
48982639|NCT05375838|157767674|FG003|Overall Study|Withdrawal by Subject|2|||
48982640|NCT05375838|157767675|FG004|Overall Study|Withdrawal by Subject|2|||
48982641|NCT05375838|157767676|FG005|Overall Study|Withdrawal by Subject|0|||
48982642|NCT05375838|157767671|FG000|Overall Study|Protocol Violation|0|||
48982643|NCT05375838|157767672|FG001|Overall Study|Protocol Violation|0|||
48982644|NCT05375838|157767673|FG002|Overall Study|Protocol Violation|0|||
48982645|NCT05375838|157767674|FG003|Overall Study|Protocol Violation|0|||
48982646|NCT05375838|157767675|FG004|Overall Study|Protocol Violation|1|||
48778677|NCT02610140|157032710|FG000|Randomization and Treatment Period|Lack of Efficacy|1|||
48778678|NCT02610140|157032711|FG001|Randomization and Treatment Period|Lack of Efficacy|0|||
48778679|NCT02610140|157032710|FG000|Randomization and Treatment Period|Death|7|||
48778680|NCT02610140|157032711|FG001|Randomization and Treatment Period|Death|1|||
48778681|NCT02610140|157032710|FG000|Randomization and Treatment Period|Withdrawal by Subject|12|||
48778682|NCT02610140|157032711|FG001|Randomization and Treatment Period|Withdrawal by Subject|12|||
48778683|NCT02610140|157032710|FG000|Randomization and Treatment Period|Adverse Event|44|||
48778684|NCT02610140|157032711|FG001|Randomization and Treatment Period|Adverse Event|13|||
48778685|NCT02610140|157032710|FG000|Randomization and Treatment Period|Progressive disease - clinical|12|||
48778686|NCT02610140|157032711|FG001|Randomization and Treatment Period|Progressive disease - clinical|5|||
48778687|NCT02610140|157032710|FG000|Randomization and Treatment Period|Ongoing but not completed|9|||
48778688|NCT02610140|157032711|FG001|Randomization and Treatment Period|Ongoing but not completed|2|||
49028643|NCT02648347|157941245|FG000|Overall Study|Lost to Follow-up|18|||
49028644|NCT02648347|157941246|FG001|Overall Study|Lost to Follow-up|21|||
49028645|NCT02648347|157941245|FG000|Overall Study|Missing|1|||
49028646|NCT02648347|157941246|FG001|Overall Study|Missing|0|||
49028647|NCT03546842|157941251|FG000|Overall Study|Protocol Violation|1|||
49028648|NCT03546842|157941251|FG000|Overall Study|Withdrawal by Subject|2|||
49028649|NCT02739997|157941254|FG000|Overall Study|Death|1|||
48778689|NCT02610140|157032710|FG000|Randomization and Treatment Period|Not treated|3|||
48778690|NCT02610140|157032711|FG001|Randomization and Treatment Period|Not treated|10|||
48778691|NCT02610140|157032710|FG000|Safety Follow-up|Other|0|||
48778692|NCT02610140|157032711|FG001|Safety Follow-up|Other|2|||
49028650|NCT02739997|157941254|FG000|Overall Study|Withdrawal by Subject|1|||
49028651|NCT00468286|157941255|FG000|Overall Study|Adverse Event|1|||
49028652|NCT00468286|157941256|FG001|Overall Study|Adverse Event|6|||
49028653|NCT00468286|157941255|FG000|Overall Study|Protocol Violation|2|||
49028654|NCT00468286|157941256|FG001|Overall Study|Protocol Violation|2|||
49028655|NCT00468286|157941255|FG000|Overall Study|Withdrawal by Subject|4|||
49028656|NCT00468286|157941256|FG001|Overall Study|Withdrawal by Subject|3|||
49028657|NCT00468286|157941255|FG000|Overall Study|Physician Decision|0|||
49028658|NCT00468286|157941256|FG001|Overall Study|Physician Decision|1|||
49028659|NCT00617305|157941257|FG000|Overall Study|Adverse Event|4|||
49028660|NCT00617305|157941258|FG001|Overall Study|Adverse Event|0|||
49028661|NCT00617305|157941259|FG002|Overall Study|Adverse Event|0|||
49028662|NCT00617305|157941257|FG000|Overall Study|Death|1|||
49028663|NCT00617305|157941258|FG001|Overall Study|Death|0|||
49028664|NCT00617305|157941259|FG002|Overall Study|Death|0|||
49028665|NCT00617305|157941257|FG000|Overall Study|Physician Decision|1|||
49028666|NCT00617305|157941258|FG001|Overall Study|Physician Decision|0|||
49028667|NCT00617305|157941259|FG002|Overall Study|Physician Decision|0|||
49028668|NCT00617305|157941257|FG000|Overall Study|Protocol Violation|1|||
49028669|NCT00617305|157941258|FG001|Overall Study|Protocol Violation|0|||
49028670|NCT00617305|157941259|FG002|Overall Study|Protocol Violation|1|||
49028671|NCT00617305|157941257|FG000|Overall Study|Withdrawal by Subject|1|||
49028672|NCT00617305|157941258|FG001|Overall Study|Withdrawal by Subject|0|||
49028673|NCT00617305|157941259|FG002|Overall Study|Withdrawal by Subject|0|||
49028674|NCT02751528|157941270|FG000|Overall Study|Withdrawal by Subject|1|||
49028675|NCT02751528|157941270|FG000|Overall Study|Adverse Event|1|||
49028676|NCT02817841|157942391|FG000|Overall Study|Lost to Follow-up|287|||
48778693|NCT02610140|157032710|FG000|Safety Follow-up|Lost to Follow-up|1|||
48778694|NCT02610140|157032711|FG001|Safety Follow-up|Lost to Follow-up|0|||
48778695|NCT02610140|157032710|FG000|Safety Follow-up|No follow-up|5|||
48778696|NCT02610140|157032711|FG001|Safety Follow-up|No follow-up|3|||
48778697|NCT02610140|157032710|FG000|Safety Follow-up|Death|12|||
48778698|NCT02610140|157032711|FG001|Safety Follow-up|Death|2|||
48982647|NCT05375838|157767676|FG005|Overall Study|Protocol Violation|0|||
48982648|NCT05375838|157767671|FG000|Overall Study|Physician Decision|0|||
48982649|NCT05375838|157767672|FG001|Overall Study|Physician Decision|1|||
48982650|NCT05375838|157767673|FG002|Overall Study|Physician Decision|0|||
48982651|NCT05375838|157767674|FG003|Overall Study|Physician Decision|0|||
48982652|NCT05375838|157767675|FG004|Overall Study|Physician Decision|0|||
48982653|NCT05375838|157767676|FG005|Overall Study|Physician Decision|1|||
48982654|NCT05375838|157767671|FG000|Overall Study|Lost to Follow-up|2|||
48982655|NCT05375838|157767672|FG001|Overall Study|Lost to Follow-up|7|||
48982656|NCT05375838|157767673|FG002|Overall Study|Lost to Follow-up|0|||
48982657|NCT05375838|157767674|FG003|Overall Study|Lost to Follow-up|4|||
48982658|NCT05375838|157767675|FG004|Overall Study|Lost to Follow-up|2|||
48982659|NCT05375838|157767676|FG005|Overall Study|Lost to Follow-up|3|||
48982660|NCT00286156|157767679|FG000|Overall Study|Missed 12 month visit|0|||
48982661|NCT00286156|157767680|FG001|Overall Study|Missed 12 month visit|0|||
48982662|NCT00286156|157767681|FG002|Overall Study|Missed 12 month visit|1|||
48982663|NCT00286156|157767679|FG000|Overall Study|AE: pulmonary embolus|0|||
48982664|NCT00286156|157767680|FG001|Overall Study|AE: pulmonary embolus|1|||
48982665|NCT00286156|157767681|FG002|Overall Study|AE: pulmonary embolus|0|||
48982666|NCT00286156|157767679|FG000|Overall Study|AE: nephrotic-range proteinuruia|1|||
48982667|NCT00286156|157767680|FG001|Overall Study|AE: nephrotic-range proteinuruia|0|||
49028677|NCT02817841|157942391|FG000|Overall Study|Withdrawal by Subject|183|||
49028678|NCT02817841|157942391|FG000|Overall Study|Adverse event not related to bleeding|131|||
49028679|NCT02817841|157942391|FG000|Overall Study|Adverse event related to bleeding|51|||
49028680|NCT02817841|157942391|FG000|Overall Study|Pregnancy|32|||
49028681|NCT02817841|157942391|FG000|Overall Study|Pregnancy wish|17|||
49028682|NCT02817841|157942391|FG000|Overall Study|Other reasons|53|||
49028683|NCT02817841|157942391|FG000|Overall Study|Protocol Violation|94|||
49028684|NCT04657770|157942398|FG000|Overall Study|Withdrawal by Subject|3|||
49028685|NCT04657770|157942398|FG000|Overall Study|Completed training but withdrew before follow-up testing due to change in medical status|1|||
49028686|NCT00485472|157942399|FG000|Overall Study|Adverse Event|8|||
49028687|NCT00485472|157942400|FG001|Overall Study|Adverse Event|5|||
49028688|NCT00485472|157942399|FG000|Overall Study|Lack of Efficacy|5|||
49028689|NCT00485472|157942400|FG001|Overall Study|Lack of Efficacy|4|||
49028690|NCT00485472|157942399|FG000|Overall Study|Withdrawal by Subject|1|||
49028691|NCT00485472|157942400|FG001|Overall Study|Withdrawal by Subject|0|||
49028692|NCT00485472|157942399|FG000|Overall Study|Protocol Violation|0|||
49028693|NCT00485472|157942400|FG001|Overall Study|Protocol Violation|1|||
49028694|NCT00485472|157942399|FG000|Overall Study|Other|2|||
49028695|NCT00485472|157942400|FG001|Overall Study|Other|1|||
49028696|NCT00485472|157942399|FG000|Overall Study|Lost to Follow-up|0|||
49028697|NCT00485472|157942400|FG001|Overall Study|Lost to Follow-up|1|||
49028698|NCT00746798|157942401|FG000|Overall Study|Protocol Violation|0|||
49028699|NCT00746798|157942402|FG001|Overall Study|Protocol Violation|1|||
49028700|NCT00746798|157942403|FG002|Overall Study|Protocol Violation|0|||
49028701|NCT00746798|157942404|FG003|Overall Study|Protocol Violation|0|||
49028702|NCT00746798|157942401|FG000|Overall Study|Withdrawal by Subject|0|||
49028703|NCT00746798|157942402|FG001|Overall Study|Withdrawal by Subject|1|||
49028704|NCT00746798|157942403|FG002|Overall Study|Withdrawal by Subject|1|||
48778699|NCT02610140|157032710|FG000|Safety Follow-up|Deterioration of general conditions|15|||
48778700|NCT02610140|157032711|FG001|Safety Follow-up|Deterioration of general conditions|5|||
48778701|NCT02610140|157032710|FG000|Safety Follow-up|Withdrawal by Subject|12|||
48778702|NCT02610140|157032711|FG001|Safety Follow-up|Withdrawal by Subject|12|||
48778703|NCT02610140|157032710|FG000|Active Follow-up|Progressive disease - radiological|30|||
48778704|NCT02610140|157032711|FG001|Active Follow-up|Progressive disease - radiological|22|||
48778705|NCT02610140|157032710|FG000|Active Follow-up|Death|8|||
48778706|NCT02610140|157032711|FG001|Active Follow-up|Death|1|||
48778707|NCT02610140|157032710|FG000|Active Follow-up|Withdrawal by Subject|4|||
48778708|NCT02610140|157032711|FG001|Active Follow-up|Withdrawal by Subject|0|||
48778709|NCT02610140|157032710|FG000|Active Follow-up|Progressive disease - clinical|1|||
48778710|NCT02610140|157032711|FG001|Active Follow-up|Progressive disease - clinical|2|||
48778711|NCT02610140|157032710|FG000|Active Follow-up|Deterioration of general conditions|1|||
48778712|NCT02610140|157032711|FG001|Active Follow-up|Deterioration of general conditions|0|||
48778713|NCT02610140|157032710|FG000|Active Follow-up|Ongoing but not completed|4|||
48778714|NCT02610140|157032711|FG001|Active Follow-up|Ongoing but not completed|1|||
48778715|NCT02610140|157032710|FG000|Long-term Follow-up|Death|86|||
48778716|NCT02610140|157032711|FG001|Long-term Follow-up|Death|44|||
48778717|NCT02610140|157032710|FG000|Long-term Follow-up|Withdrawal by Subject|6|||
48778718|NCT02610140|157032711|FG001|Long-term Follow-up|Withdrawal by Subject|3|||
48778719|NCT02610140|157032710|FG000|Long-term Follow-up|Lost to Follow-up|1|||
48778720|NCT02610140|157032711|FG001|Long-term Follow-up|Lost to Follow-up|2|||
48778721|NCT02610140|157032710|FG000|Long-term Follow-up|Ongoing but not completed|30|||
48778722|NCT02610140|157032711|FG001|Long-term Follow-up|Ongoing but not completed|17|||
48778723|NCT01827904|157032712|FG000|Main Study|Withdrawal by Subject|1|||
48778724|NCT01827904|157032713|FG001|Main Study|Withdrawal by Subject|0|||
48778725|NCT01827904|157032714|FG002|Main Study|Withdrawal by Subject|0|||
48778726|NCT01827904|157032712|FG000|Main Study|Adverse Event|1|||
48778727|NCT01827904|157032713|FG001|Main Study|Adverse Event|0|||
48778728|NCT01827904|157032714|FG002|Main Study|Adverse Event|0|||
48778729|NCT01827904|157032712|FG000|Main Continuation / Crossover Phase|Alternative treatment|1|||
48778730|NCT01827904|157032713|FG001|Main Continuation / Crossover Phase|Alternative treatment|0|||
48778731|NCT01827904|157032714|FG002|Main Continuation / Crossover Phase|Alternative treatment|0|||
48778732|NCT01827904|157032712|FG000|Main Continuation / Crossover Phase|Withdrawal by Subject|1|||
48778733|NCT01827904|157032713|FG001|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
48778734|NCT01827904|157032714|FG002|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
48778735|NCT01827904|157032712|FG000|Main Continuation / Crossover Phase|Health reasons unrelated to study|1|||
49028705|NCT00746798|157942404|FG003|Overall Study|Withdrawal by Subject|0|||
49028706|NCT00746798|157942401|FG000|Overall Study|Death|0|||
49028707|NCT00746798|157942402|FG001|Overall Study|Death|0|||
49028708|NCT00746798|157942403|FG002|Overall Study|Death|2|||
49028709|NCT00746798|157942404|FG003|Overall Study|Death|0|||
48778736|NCT01827904|157032713|FG001|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
48778737|NCT01827904|157032714|FG002|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
48778738|NCT01827904|157032712|FG000|Long-term Annual Follow-up|Withdrawal by Subject|11|||
49028710|NCT00746798|157942401|FG000|Overall Study|Participant unable to return for visit|1|||
49028711|NCT00746798|157942402|FG001|Overall Study|Participant unable to return for visit|0|||
49028712|NCT00746798|157942403|FG002|Overall Study|Participant unable to return for visit|0|||
49028713|NCT00746798|157942404|FG003|Overall Study|Participant unable to return for visit|0|||
49028714|NCT01918397|157942405|FG000|Overall Study|Never started treatment|2|||
49028715|NCT01918397|157942406|FG001|Overall Study|Never started treatment|1|||
49028716|NCT01918397|157942407|FG002|Overall Study|Never started treatment|0|||
49028717|NCT01918397|157942408|FG003|Overall Study|Never started treatment|0|||
49028718|NCT01918397|157942405|FG000|Overall Study|Adverse Event|1|||
49028719|NCT01918397|157942406|FG001|Overall Study|Adverse Event|1|||
49028720|NCT01918397|157942407|FG002|Overall Study|Adverse Event|1|||
49028721|NCT01918397|157942408|FG003|Overall Study|Adverse Event|0|||
49028722|NCT01918397|157942405|FG000|Overall Study|Lack of compliance|2|||
48877175|NCT00443209|157388567|FG000|Months 1 to 12 Treatment Period|Not Treated|71|||
49028723|NCT01918397|157942406|FG001|Overall Study|Lack of compliance|2|||
49028724|NCT01918397|157942407|FG002|Overall Study|Lack of compliance|3|||
49028725|NCT01918397|157942408|FG003|Overall Study|Lack of compliance|0|||
49028726|NCT01918397|157942405|FG000|Overall Study|Pregnancy|0|||
49028727|NCT01918397|157942406|FG001|Overall Study|Pregnancy|1|||
49028728|NCT01918397|157942407|FG002|Overall Study|Pregnancy|0|||
49028729|NCT01918397|157942408|FG003|Overall Study|Pregnancy|0|||
49028730|NCT01918397|157942405|FG000|Overall Study|Rifampin susceptible|0|||
49028731|NCT01918397|157942406|FG001|Overall Study|Rifampin susceptible|0|||
49028732|NCT01918397|157942407|FG002|Overall Study|Rifampin susceptible|0|||
49028733|NCT01918397|157942408|FG003|Overall Study|Rifampin susceptible|2|||
49028734|NCT01918397|157942405|FG000|Overall Study|Treatment failure|0|||
49028735|NCT01918397|157942406|FG001|Overall Study|Treatment failure|0|||
49028736|NCT01918397|157942407|FG002|Overall Study|Treatment failure|0|||
49028737|NCT01918397|157942408|FG003|Overall Study|Treatment failure|1|||
49028738|NCT01918397|157942405|FG000|Overall Study|Withdrawal by Subject|3|||
49028739|NCT01918397|157942406|FG001|Overall Study|Withdrawal by Subject|2|||
49028740|NCT01918397|157942407|FG002|Overall Study|Withdrawal by Subject|1|||
49028741|NCT01918397|157942408|FG003|Overall Study|Withdrawal by Subject|1|||
49028742|NCT01918397|157942405|FG000|Overall Study|XDR at baseline|0|||
49028743|NCT01918397|157942406|FG001|Overall Study|XDR at baseline|0|||
49028744|NCT01918397|157942407|FG002|Overall Study|XDR at baseline|1|||
49028745|NCT01918397|157942408|FG003|Overall Study|XDR at baseline|0|||
49028746|NCT01918397|157942405|FG000|Overall Study|Lost to Follow-up|2|||
49028747|NCT01918397|157942406|FG001|Overall Study|Lost to Follow-up|1|||
49028748|NCT01918397|157942407|FG002|Overall Study|Lost to Follow-up|1|||
49028749|NCT01918397|157942408|FG003|Overall Study|Lost to Follow-up|1|||
49028750|NCT01918397|157942405|FG000|Overall Study|Increased QTc|1|||
49028751|NCT01918397|157942406|FG001|Overall Study|Increased QTc|0|||
49028752|NCT01918397|157942407|FG002|Overall Study|Increased QTc|0|||
49028753|NCT01918397|157942408|FG003|Overall Study|Increased QTc|1|||
49028754|NCT01918397|157942405|FG000|Overall Study|Death|0|||
49028755|NCT01918397|157942406|FG001|Overall Study|Death|0|||
49028756|NCT01918397|157942407|FG002|Overall Study|Death|1|||
49028757|NCT01918397|157942408|FG003|Overall Study|Death|0|||
49028758|NCT01918397|157942405|FG000|Overall Study|Involved in another investigative trial|0|||
49028759|NCT01918397|157942406|FG001|Overall Study|Involved in another investigative trial|0|||
49028760|NCT01918397|157942407|FG002|Overall Study|Involved in another investigative trial|0|||
49028761|NCT01918397|157942408|FG003|Overall Study|Involved in another investigative trial|1|||
49028762|NCT01591785|157942416|FG000|Overall Study|worsening condition|1|||
49028763|NCT01591785|157942417|FG001|Overall Study|worsening condition|2|||
49028764|NCT01591785|157942416|FG000|Overall Study|Protocol Violation|2|||
49028765|NCT01591785|157942417|FG001|Overall Study|Protocol Violation|0|||
49028766|NCT01591785|157942416|FG000|Overall Study|Lost to Follow-up|1|||
49028767|NCT01591785|157942417|FG001|Overall Study|Lost to Follow-up|0|||
49028768|NCT00667862|157942418|FG000|Overall Study|Adverse Event|9|||
49028769|NCT00667862|157942418|FG000|Overall Study|Death|1|||
49028770|NCT00667862|157942418|FG000|Overall Study|Disease Progression|22|||
48877176|NCT00443209|157388568|FG001|Months 1 to 12 Treatment Period|Not Treated|43|||
48877177|NCT00443209|157388567|FG000|Months 13 to 18 Treatment Period|Adverse Event|1|||
49028771|NCT00667862|157942418|FG000|Overall Study|Withdrawal by Subject|3|||
49028772|NCT00262223|157942421|FG000|Treatment Phase|Withdrawal by Subject|3|||
49028773|NCT00262223|157942422|FG001|Treatment Phase|Withdrawal by Subject|6|||
49028774|NCT00262223|157942421|FG000|Treatment Phase|Adverse Event|1|||
49028775|NCT00262223|157942422|FG001|Treatment Phase|Adverse Event|2|||
49028776|NCT00262223|157942421|FG000|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
49028777|NCT00262223|157942422|FG001|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
48877178|NCT00443209|157388568|FG001|Months 13 to 18 Treatment Period|Adverse Event|0|||
49028778|NCT00262223|157942421|FG000|6-month Post-treatment Follow-up|Lost to Follow-up|6|||
49028779|NCT00262223|157942422|FG001|6-month Post-treatment Follow-up|Lost to Follow-up|1|||
49028780|NCT00262223|157942421|FG000|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
49028781|NCT00262223|157942422|FG001|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
49028782|NCT00358449|157942423|FG000|Overall Study|Adverse Event|1|||
48877179|NCT00443209|157388567|FG000|Months 13 to 18 Treatment Period|Protocol Violation|1|||
49028783|NCT00358449|157942424|FG001|Overall Study|Adverse Event|0|||
49028784|NCT00358449|157942425|FG002|Overall Study|Adverse Event|1|||
49028785|NCT00358449|157942423|FG000|Overall Study|Lost to Follow-up|1|||
49028786|NCT00358449|157942424|FG001|Overall Study|Lost to Follow-up|0|||
48778739|NCT01827904|157032713|FG001|Long-term Annual Follow-up|Withdrawal by Subject|0|||
48778740|NCT01827904|157032714|FG002|Long-term Annual Follow-up|Withdrawal by Subject|5|||
48778741|NCT01827904|157032712|FG000|Long-term Annual Follow-up|Alternative Treatment|4|||
48778742|NCT01827904|157032713|FG001|Long-term Annual Follow-up|Alternative Treatment|0|||
48778743|NCT01827904|157032714|FG002|Long-term Annual Follow-up|Alternative Treatment|1|||
48778744|NCT01827904|157032712|FG000|Long-term Annual Follow-up|Unrelated Health Reason|2|||
48778745|NCT01827904|157032713|FG001|Long-term Annual Follow-up|Unrelated Health Reason|0|||
48778746|NCT01827904|157032714|FG002|Long-term Annual Follow-up|Unrelated Health Reason|1|||
48778747|NCT01827904|157032712|FG000|Long-term Annual Follow-up|Lost to Follow-up|2|||
48778748|NCT01827904|157032713|FG001|Long-term Annual Follow-up|Lost to Follow-up|0|||
48778749|NCT01827904|157032714|FG002|Long-term Annual Follow-up|Lost to Follow-up|0|||
48778750|NCT01827904|157032712|FG000|Long-term Annual Follow-up|Physician Decision|1|||
48778751|NCT01827904|157032713|FG001|Long-term Annual Follow-up|Physician Decision|0|||
48778752|NCT01827904|157032714|FG002|Long-term Annual Follow-up|Physician Decision|0|||
48778753|NCT01827904|157032712|FG000|Long-term Annual Follow-up|Lack of Efficacy|1|||
48778754|NCT01827904|157032713|FG001|Long-term Annual Follow-up|Lack of Efficacy|0|||
48778755|NCT01827904|157032714|FG002|Long-term Annual Follow-up|Lack of Efficacy|0|||
48778756|NCT01827904|157032712|FG000|Long-term Annual Follow-up|Suboptimal Treatment|1|||
48778757|NCT01827904|157032713|FG001|Long-term Annual Follow-up|Suboptimal Treatment|0|||
48778758|NCT01827904|157032714|FG002|Long-term Annual Follow-up|Suboptimal Treatment|0|||
49028787|NCT00358449|157942425|FG002|Overall Study|Lost to Follow-up|0|||
49028788|NCT00358449|157942423|FG000|Overall Study|Withdrawal by Subject|2|||
49028789|NCT00358449|157942424|FG001|Overall Study|Withdrawal by Subject|0|||
48778759|NCT03221257|157032718|FG000|Overall Study|Lost to Follow-up|0|||
48778760|NCT03221257|157032719|FG001|Overall Study|Lost to Follow-up|1|||
48778761|NCT03221257|157032718|FG000|Overall Study|Withdrawal by Subject|1|||
48778762|NCT03221257|157032719|FG001|Overall Study|Withdrawal by Subject|1|||
48778763|NCT02207829|157032720|FG000|Overall Study|Adverse Event|10|||
49028790|NCT00358449|157942425|FG002|Overall Study|Withdrawal by Subject|0|||
49028791|NCT00358449|157942423|FG000|Overall Study|Lack of Efficacy|0|||
49028792|NCT00358449|157942424|FG001|Overall Study|Lack of Efficacy|1|||
49028793|NCT00358449|157942425|FG002|Overall Study|Lack of Efficacy|0|||
49028794|NCT00358449|157942423|FG000|Overall Study|Steriod Inhaler was Increased|0|||
49028795|NCT00358449|157942424|FG001|Overall Study|Steriod Inhaler was Increased|0|||
49028796|NCT00358449|157942425|FG002|Overall Study|Steriod Inhaler was Increased|1|||
49028797|NCT01804270|157942426|FG000|Overall Study|Withdrawal by Subject|1|||
49028798|NCT01804270|157942427|FG001|Overall Study|Withdrawal by Subject|1|||
49028799|NCT01049334|157942429|FG000|Overall Study|Withdrawal by Subject|5|||
49028800|NCT01049334|157942430|FG001|Overall Study|Withdrawal by Subject|3|||
49028801|NCT01049334|157942429|FG000|Overall Study|Adverse Event|2|||
49028802|NCT01049334|157942430|FG001|Overall Study|Adverse Event|3|||
49028803|NCT01049334|157942429|FG000|Overall Study|Physician Decision|2|||
49028804|NCT01049334|157942430|FG001|Overall Study|Physician Decision|0|||
49028805|NCT01049334|157942429|FG000|Overall Study|Protocol Violation|0|||
49028806|NCT01049334|157942430|FG001|Overall Study|Protocol Violation|1|||
49028807|NCT00396279|157942433|FG000|Overall Study|Ongoing in study|26|||
49028808|NCT00396279|157942433|FG000|Overall Study|Disease progression|2|||
49028809|NCT00396279|157942433|FG000|Overall Study|Withdrawal by Subject|1|||
49028810|NCT00396279|157942433|FG000|Overall Study|Physician Decision|1|||
49028811|NCT02883452|157942434|FG000|Overall Study|Withdrawal by Subject|1|||
49028812|NCT02883452|157942435|FG001|Overall Study|Withdrawal by Subject|1|||
49028813|NCT02883452|157942436|FG002|Overall Study|Withdrawal by Subject|3|||
49028814|NCT02883452|157942437|FG003|Overall Study|Withdrawal by Subject|0|||
49028815|NCT02883452|157942438|FG004|Overall Study|Withdrawal by Subject|2|||
48778764|NCT02207829|157032721|FG001|Overall Study|Adverse Event|9|||
49028816|NCT02883452|157942439|FG005|Overall Study|Withdrawal by Subject|5|||
48778765|NCT02207829|157032720|FG000|Overall Study|Lack of Efficacy|7|||
48778766|NCT02207829|157032721|FG001|Overall Study|Lack of Efficacy|5|||
48778767|NCT02207829|157032720|FG000|Overall Study|Lost to Follow-up|2|||
48778768|NCT02207829|157032721|FG001|Overall Study|Lost to Follow-up|2|||
49028817|NCT02883452|157942434|FG000|Overall Study|Disease progression|1|||
49028818|NCT02883452|157942435|FG001|Overall Study|Disease progression|0|||
49028819|NCT02883452|157942436|FG002|Overall Study|Disease progression|0|||
49028820|NCT02883452|157942437|FG003|Overall Study|Disease progression|1|||
48778769|NCT02207829|157032720|FG000|Overall Study|Protocol deviation|5|||
49028821|NCT02883452|157942438|FG004|Overall Study|Disease progression|4|||
49028822|NCT02883452|157942439|FG005|Overall Study|Disease progression|5|||
49028823|NCT02883452|157942434|FG000|Overall Study|Adverse Event|2|||
49028824|NCT02883452|157942435|FG001|Overall Study|Adverse Event|1|||
49028825|NCT02883452|157942436|FG002|Overall Study|Adverse Event|1|||
49028826|NCT02883452|157942437|FG003|Overall Study|Adverse Event|1|||
49028827|NCT02883452|157942438|FG004|Overall Study|Adverse Event|1|||
49028828|NCT02883452|157942439|FG005|Overall Study|Adverse Event|3|||
49028829|NCT02883452|157942434|FG000|Overall Study|Physician Decision|0|||
49028830|NCT02883452|157942435|FG001|Overall Study|Physician Decision|0|||
49028831|NCT02883452|157942436|FG002|Overall Study|Physician Decision|0|||
49028832|NCT02883452|157942437|FG003|Overall Study|Physician Decision|0|||
49028833|NCT02883452|157942438|FG004|Overall Study|Physician Decision|4|||
49028834|NCT02883452|157942439|FG005|Overall Study|Physician Decision|1|||
49028835|NCT02883452|157942434|FG000|Overall Study|Death|1|||
49028836|NCT02883452|157942435|FG001|Overall Study|Death|0|||
49028837|NCT02883452|157942436|FG002|Overall Study|Death|1|||
49028838|NCT02883452|157942437|FG003|Overall Study|Death|0|||
49028839|NCT02883452|157942438|FG004|Overall Study|Death|0|||
49028840|NCT02883452|157942439|FG005|Overall Study|Death|0|||
49028841|NCT02883452|157942434|FG000|Overall Study|Other|0|||
49028842|NCT02883452|157942435|FG001|Overall Study|Other|0|||
49028843|NCT02883452|157942436|FG002|Overall Study|Other|0|||
49028844|NCT02883452|157942437|FG003|Overall Study|Other|0|||
49028845|NCT02883452|157942438|FG004|Overall Study|Other|0|||
48778770|NCT02207829|157032721|FG001|Overall Study|Protocol deviation|4|||
48778771|NCT02207829|157032720|FG000|Overall Study|Withdrew consent|18|||
48778772|NCT02207829|157032721|FG001|Overall Study|Withdrew consent|14|||
48778773|NCT00129259|157032722|FG000|Overall Study|Lost to Follow-up|1|||
48778774|NCT00129259|157032723|FG001|Overall Study|Lost to Follow-up|1|||
48778775|NCT00129259|157032722|FG000|Overall Study|Withdrawal by Subject|2|||
48778776|NCT00129259|157032723|FG001|Overall Study|Withdrawal by Subject|1|||
48778777|NCT00129259|157032722|FG000|Overall Study|Only available minimal phone assessments|0|||
48778778|NCT00129259|157032723|FG001|Overall Study|Only available minimal phone assessments|1|||
48778779|NCT01609556|157032724|FG000|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
48778780|NCT01609556|157032725|FG001|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
48778781|NCT01609556|157032726|FG002|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
48778782|NCT01609556|157032727|FG003|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
48778783|NCT01609556|157032728|FG004|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
48778784|NCT01609556|157032729|FG005|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
48778785|NCT01609556|157032730|FG006|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
48778786|NCT01609556|157032731|FG007|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
48778787|NCT01609556|157032732|FG008|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
48778788|NCT01609556|157032733|FG009|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
48778789|NCT01609556|157032734|FG010|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
48778790|NCT01609556|157032735|FG011|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
48778791|NCT01609556|157032736|FG012|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
48778792|NCT01609556|157032737|FG013|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
48778793|NCT01609556|157032738|FG014|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
48778794|NCT01609556|157032739|FG015|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
48778795|NCT01609556|157032724|FG000|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
48778796|NCT01609556|157032725|FG001|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
48778797|NCT01609556|157032726|FG002|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
48778798|NCT01609556|157032727|FG003|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
48778799|NCT01609556|157032728|FG004|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8|||
48778800|NCT01609556|157032729|FG005|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13|||
48778801|NCT01609556|157032730|FG006|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5|||
48778802|NCT01609556|157032731|FG007|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4|||
48778803|NCT01609556|157032732|FG008|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
49028846|NCT02883452|157942439|FG005|Overall Study|Other|1|||
49028847|NCT00553280|157942443|FG000|Overall Study|Adverse Event|19|||
49028848|NCT00553280|157942443|FG000|Overall Study|Lack of Efficacy|3|||
49028849|NCT00553280|157942443|FG000|Overall Study|Withdrawal by Subject|3|||
49028850|NCT00553280|157942443|FG000|Overall Study|Physician Decision|1|||
49028851|NCT02770820|157942448|FG000|Overall Study|Death|1|||
48778804|NCT01609556|157032733|FG009|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
48778805|NCT01609556|157032734|FG010|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6|||
48778806|NCT01609556|157032735|FG011|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
48778807|NCT01609556|157032736|FG012|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
48778808|NCT01609556|157032737|FG013|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
48778809|NCT01609556|157032738|FG014|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
48778810|NCT01609556|157032739|FG015|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
49028852|NCT02770820|157942448|FG000|Overall Study|Physician Decision|2|||
49028853|NCT00696020|157942449|FG000|Overall Study|Adverse Event|3|||
49028854|NCT00696020|157942450|FG001|Overall Study|Adverse Event|1|||
49028855|NCT00696020|157942451|FG002|Overall Study|Adverse Event|2|||
49028856|NCT00696020|157942452|FG003|Overall Study|Adverse Event|1|||
49028857|NCT00696020|157942449|FG000|Overall Study|Lack of Efficacy|1|||
49028858|NCT00696020|157942450|FG001|Overall Study|Lack of Efficacy|0|||
49028859|NCT00696020|157942451|FG002|Overall Study|Lack of Efficacy|0|||
49028860|NCT00696020|157942452|FG003|Overall Study|Lack of Efficacy|0|||
48778811|NCT01609556|157032724|FG000|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
48778812|NCT01609556|157032725|FG001|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
48778813|NCT01609556|157032726|FG002|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
48778814|NCT01609556|157032727|FG003|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
48778815|NCT01609556|157032728|FG004|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
48778816|NCT01609556|157032729|FG005|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
48778817|NCT01609556|157032730|FG006|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
48778818|NCT01609556|157032731|FG007|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
48778819|NCT01609556|157032732|FG008|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
48778820|NCT01609556|157032733|FG009|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
48778821|NCT01609556|157032734|FG010|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
48778822|NCT01609556|157032735|FG011|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
48778823|NCT01609556|157032736|FG012|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
48778824|NCT01609556|157032737|FG013|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
48778825|NCT01609556|157032738|FG014|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
48778826|NCT01609556|157032739|FG015|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
48778827|NCT01609556|157032724|FG000|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
48778828|NCT01609556|157032725|FG001|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
48778829|NCT01609556|157032726|FG002|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
48778830|NCT01609556|157032727|FG003|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
48778831|NCT01609556|157032728|FG004|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
48778832|NCT01609556|157032729|FG005|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
48778833|NCT01609556|157032730|FG006|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
48778834|NCT01609556|157032731|FG007|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
48778835|NCT01609556|157032732|FG008|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
48778836|NCT01609556|157032733|FG009|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
48778837|NCT01609556|157032734|FG010|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
48778838|NCT01609556|157032735|FG011|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
48778839|NCT01609556|157032736|FG012|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
48778840|NCT01609556|157032737|FG013|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
48778841|NCT01609556|157032738|FG014|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
48778842|NCT01609556|157032739|FG015|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
48778843|NCT01609556|157032724|FG000|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
48778844|NCT01609556|157032725|FG001|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
48778845|NCT01609556|157032726|FG002|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
48778846|NCT01609556|157032727|FG003|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
48778847|NCT01609556|157032728|FG004|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
48778848|NCT01609556|157032729|FG005|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1|||
48778849|NCT01609556|157032730|FG006|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
48778850|NCT01609556|157032731|FG007|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
48778851|NCT01609556|157032732|FG008|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
48778852|NCT01609556|157032733|FG009|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
48778853|NCT01609556|157032734|FG010|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
48778854|NCT01609556|157032735|FG011|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
48778855|NCT01609556|157032736|FG012|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
48778856|NCT01609556|157032737|FG013|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
48778857|NCT01609556|157032738|FG014|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
48778858|NCT01609556|157032739|FG015|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
48778859|NCT01609556|157032724|FG000|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
48778860|NCT01609556|157032725|FG001|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
48778861|NCT01609556|157032726|FG002|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
48778862|NCT01609556|157032727|FG003|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
48778863|NCT01609556|157032728|FG004|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
48778864|NCT01609556|157032729|FG005|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
49028861|NCT00696020|157942449|FG000|Overall Study|Protocol Violation|0|||
49028862|NCT00696020|157942450|FG001|Overall Study|Protocol Violation|0|||
49028863|NCT00696020|157942451|FG002|Overall Study|Protocol Violation|0|||
48778865|NCT01609556|157032730|FG006|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
48778866|NCT01609556|157032731|FG007|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
48778867|NCT01609556|157032732|FG008|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1|||
48778868|NCT01609556|157032733|FG009|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
49028864|NCT00696020|157942452|FG003|Overall Study|Protocol Violation|1|||
49028865|NCT00696020|157942449|FG000|Overall Study|Withdrawal by Subject|0|||
49028866|NCT00696020|157942450|FG001|Overall Study|Withdrawal by Subject|1|||
49028867|NCT00696020|157942451|FG002|Overall Study|Withdrawal by Subject|0|||
49028868|NCT00696020|157942452|FG003|Overall Study|Withdrawal by Subject|1|||
49028869|NCT00696020|157942449|FG000|Overall Study|Other not stated above|0|||
49028870|NCT00696020|157942450|FG001|Overall Study|Other not stated above|0|||
49028871|NCT00696020|157942451|FG002|Overall Study|Other not stated above|1|||
49028872|NCT00696020|157942452|FG003|Overall Study|Other not stated above|1|||
49028873|NCT00624065|157942453|FG000|Overall Study|Adverse Event|5|||
49028874|NCT00624065|157942454|FG001|Overall Study|Adverse Event|6|||
49028875|NCT00624065|157942453|FG000|Overall Study|Lost to Follow-up|4|||
49028876|NCT00624065|157942454|FG001|Overall Study|Lost to Follow-up|1|||
49028877|NCT00624065|157942453|FG000|Overall Study|Consent withdrawn|6|||
49028878|NCT00624065|157942454|FG001|Overall Study|Consent withdrawn|5|||
48778869|NCT01609556|157032734|FG010|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
48778870|NCT01609556|157032735|FG011|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
48778871|NCT01609556|157032736|FG012|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
48778872|NCT01609556|157032737|FG013|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
48778873|NCT01609556|157032738|FG014|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
48778874|NCT01609556|157032739|FG015|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
48778875|NCT01609556|157032724|FG000|Dose Escalation: Maximum 101.3 Weeks|Death|2|||
48778876|NCT01609556|157032725|FG001|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
48778877|NCT01609556|157032726|FG002|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
48778878|NCT01609556|157032727|FG003|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
48778879|NCT01609556|157032728|FG004|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
48778880|NCT01609556|157032729|FG005|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
48778881|NCT01609556|157032730|FG006|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
48778882|NCT01609556|157032731|FG007|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
48778883|NCT01609556|157032732|FG008|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
48778884|NCT01609556|157032733|FG009|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
48778885|NCT01609556|157032734|FG010|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
48778886|NCT01609556|157032735|FG011|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
48778887|NCT01609556|157032736|FG012|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
48778888|NCT01609556|157032737|FG013|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
48778889|NCT01609556|157032738|FG014|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
48778890|NCT01609556|157032739|FG015|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
48778891|NCT01609556|157032724|FG000|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
48778892|NCT01609556|157032725|FG001|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
48778893|NCT01609556|157032726|FG002|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
48778894|NCT01609556|157032727|FG003|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
48778895|NCT01609556|157032728|FG004|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
48778896|NCT01609556|157032729|FG005|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
48778897|NCT01609556|157032730|FG006|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
48778898|NCT01609556|157032731|FG007|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
48778899|NCT01609556|157032732|FG008|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
48778900|NCT01609556|157032733|FG009|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
48778901|NCT01609556|157032734|FG010|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
48778902|NCT01609556|157032735|FG011|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
48778903|NCT01609556|157032736|FG012|Dose Expansion: Maximum 124 Weeks|Adverse Event|4|||
48778904|NCT01609556|157032737|FG013|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
48778905|NCT01609556|157032738|FG014|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
49028879|NCT00624065|157942453|FG000|Overall Study|Lack of Efficacy|0|||
49028880|NCT00624065|157942454|FG001|Overall Study|Lack of Efficacy|3|||
49028881|NCT00624065|157942453|FG000|Overall Study|Met protocol-defined stopping criteria|4|||
49028882|NCT00624065|157942454|FG001|Overall Study|Met protocol-defined stopping criteria|9|||
49028883|NCT01387022|157942455|FG000|Overall Study|Death|1|||
49028884|NCT01387022|157942456|FG001|Overall Study|Death|1|||
49028885|NCT01387022|157942455|FG000|Overall Study|Lost to Follow-up|0|||
49028886|NCT01387022|157942456|FG001|Overall Study|Lost to Follow-up|3|||
49028887|NCT02331394|157942461|FG000|Overall Study|Disease progression|1|||
49028888|NCT02336165|157942462|FG000|Overall Study|Death|3|||
49028889|NCT02336165|157942463|FG001|Overall Study|Death|0|||
49028890|NCT02336165|157942464|FG002|Overall Study|Death|0|||
49028891|NCT02336165|157942465|FG003|Overall Study|Death|0|||
49028892|NCT02336165|157942466|FG004|Overall Study|Death|1|||
49028893|NCT02336165|157942462|FG000|Overall Study|Physician Decision|2|||
48778906|NCT01609556|157032739|FG015|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
48778907|NCT01609556|157032724|FG000|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
49028894|NCT02336165|157942463|FG001|Overall Study|Physician Decision|2|||
49028895|NCT02336165|157942464|FG002|Overall Study|Physician Decision|1|||
49028896|NCT02336165|157942465|FG003|Overall Study|Physician Decision|1|||
48778908|NCT01609556|157032725|FG001|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
49028897|NCT02336165|157942466|FG004|Overall Study|Physician Decision|0|||
49028898|NCT02336165|157942462|FG000|Overall Study|Withdrawal by Subject|0|||
49028899|NCT02336165|157942463|FG001|Overall Study|Withdrawal by Subject|0|||
49028900|NCT02336165|157942464|FG002|Overall Study|Withdrawal by Subject|1|||
49028901|NCT02336165|157942465|FG003|Overall Study|Withdrawal by Subject|0|||
49028902|NCT02336165|157942466|FG004|Overall Study|Withdrawal by Subject|1|||
49028903|NCT02336165|157942462|FG000|Overall Study|Adverse Event|4|||
49028904|NCT02336165|157942463|FG001|Overall Study|Adverse Event|1|||
48778909|NCT01609556|157032726|FG002|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
48778910|NCT01609556|157032727|FG003|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
48778911|NCT01609556|157032728|FG004|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
48778912|NCT01609556|157032729|FG005|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
48778913|NCT01609556|157032730|FG006|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
48778914|NCT01609556|157032731|FG007|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
48778915|NCT01609556|157032732|FG008|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
48778916|NCT01609556|157032733|FG009|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
48778917|NCT01609556|157032734|FG010|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
48778918|NCT01609556|157032735|FG011|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
49028905|NCT02336165|157942464|FG002|Overall Study|Adverse Event|2|||
48778919|NCT01609556|157032736|FG012|Dose Expansion: Maximum 124 Weeks|Disease Progression|32|||
48778920|NCT01609556|157032737|FG013|Dose Expansion: Maximum 124 Weeks|Disease Progression|13|||
48778921|NCT01609556|157032738|FG014|Dose Expansion: Maximum 124 Weeks|Disease Progression|20|||
48778922|NCT01609556|157032739|FG015|Dose Expansion: Maximum 124 Weeks|Disease Progression|27|||
48778923|NCT01609556|157032724|FG000|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
48778924|NCT01609556|157032725|FG001|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
48778925|NCT01609556|157032726|FG002|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
48778926|NCT01609556|157032727|FG003|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
48778927|NCT01609556|157032728|FG004|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
48778928|NCT01609556|157032729|FG005|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
48778929|NCT01609556|157032730|FG006|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
48778930|NCT01609556|157032731|FG007|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
48778931|NCT01609556|157032732|FG008|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
48778932|NCT01609556|157032733|FG009|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
48778933|NCT01609556|157032734|FG010|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
48778934|NCT01609556|157032735|FG011|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
48778935|NCT01609556|157032736|FG012|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
49028906|NCT02336165|157942465|FG003|Overall Study|Adverse Event|4|||
49028907|NCT02336165|157942466|FG004|Overall Study|Adverse Event|1|||
49028908|NCT02336165|157942462|FG000|Overall Study|Progressive disease|23|||
49028909|NCT02336165|157942463|FG001|Overall Study|Progressive disease|22|||
49028910|NCT02336165|157942464|FG002|Overall Study|Progressive disease|27|||
49028911|NCT02336165|157942465|FG003|Overall Study|Progressive disease|24|||
49028912|NCT02336165|157942466|FG004|Overall Study|Progressive disease|19|||
49028913|NCT02336165|157942462|FG000|Overall Study|Non-compliance|1|||
49028914|NCT02336165|157942463|FG001|Overall Study|Non-compliance|0|||
49028915|NCT02336165|157942464|FG002|Overall Study|Non-compliance|0|||
49028916|NCT02336165|157942465|FG003|Overall Study|Non-compliance|1|||
49028917|NCT02336165|157942466|FG004|Overall Study|Non-compliance|0|||
49028918|NCT02336165|157942462|FG000|Overall Study|Other|1|||
49028919|NCT02336165|157942463|FG001|Overall Study|Other|0|||
49028920|NCT02336165|157942464|FG002|Overall Study|Other|0|||
49028921|NCT02336165|157942465|FG003|Overall Study|Other|1|||
49028922|NCT02336165|157942466|FG004|Overall Study|Other|0|||
49028923|NCT00910663|157942467|FG000|Period 1|Withdrawal by Subject|0|||
49028924|NCT00910663|157942468|FG001|Period 1|Withdrawal by Subject|1|||
49028925|NCT02865850|157942469|FG000|Overall Study|Death|15|||
49028926|NCT02865850|157942470|FG001|Overall Study|Death|19|||
49028927|NCT02865850|157942469|FG000|Overall Study|Withdrawal by Subject|3|||
49028928|NCT02865850|157942470|FG001|Overall Study|Withdrawal by Subject|2|||
49028929|NCT02865850|157942469|FG000|Overall Study|Lost to Follow-up|3|||
49028930|NCT02865850|157942470|FG001|Overall Study|Lost to Follow-up|2|||
49028931|NCT02726581|157942471|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
49028932|NCT02726581|157942472|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
48778936|NCT01609556|157032737|FG013|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
48778937|NCT01609556|157032738|FG014|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
48778938|NCT01609556|157032739|FG015|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2|||
48778939|NCT01609556|157032724|FG000|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
48778940|NCT01609556|157032725|FG001|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
48778941|NCT01609556|157032726|FG002|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
48877180|NCT00443209|157388568|FG001|Months 13 to 18 Treatment Period|Protocol Violation|0|||
48877181|NCT00443209|157388567|FG000|Months 13 to 18 Treatment Period|Lack of Efficacy|1|||
48877182|NCT00443209|157388568|FG001|Months 13 to 18 Treatment Period|Lack of Efficacy|0|||
49028933|NCT02726581|157942473|FG002|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
49028934|NCT02726581|157942471|FG000|Pre-Treatment Period|Administrative reason by sponsor|2|||
48778942|NCT01609556|157032727|FG003|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
48778943|NCT01609556|157032728|FG004|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
48778944|NCT01609556|157032729|FG005|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
48778945|NCT01609556|157032730|FG006|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
48778946|NCT01609556|157032731|FG007|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
48778947|NCT01609556|157032732|FG008|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
48778948|NCT01609556|157032733|FG009|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
48778949|NCT01609556|157032734|FG010|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
48778950|NCT01609556|157032735|FG011|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
48778951|NCT01609556|157032736|FG012|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1|||
48778952|NCT01609556|157032737|FG013|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
48778953|NCT01609556|157032738|FG014|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
48778954|NCT01609556|157032739|FG015|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
48778955|NCT01609556|157032724|FG000|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
48778956|NCT01609556|157032725|FG001|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
48778957|NCT01609556|157032726|FG002|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
48778958|NCT01609556|157032727|FG003|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
48778959|NCT01609556|157032728|FG004|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
48778960|NCT01609556|157032729|FG005|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
48778961|NCT01609556|157032730|FG006|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
48778962|NCT01609556|157032731|FG007|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
48778963|NCT01609556|157032732|FG008|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
48778964|NCT01609556|157032733|FG009|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
48778965|NCT01609556|157032734|FG010|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
48778966|NCT01609556|157032735|FG011|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
48778967|NCT01609556|157032736|FG012|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1|||
48778968|NCT01609556|157032737|FG013|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4|||
48778969|NCT01609556|157032738|FG014|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2|||
48778970|NCT01609556|157032739|FG015|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5|||
48778971|NCT01609556|157032724|FG000|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
48778972|NCT01609556|157032725|FG001|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
48778973|NCT01609556|157032726|FG002|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
48778974|NCT01609556|157032727|FG003|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
48778975|NCT01609556|157032728|FG004|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
48778976|NCT01609556|157032729|FG005|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
48778977|NCT01609556|157032730|FG006|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
48778978|NCT01609556|157032731|FG007|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
48877183|NCT00443209|157388567|FG000|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
48877184|NCT00443209|157388568|FG001|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
48877185|NCT00443209|157388567|FG000|Months 13 to 18 Treatment Period|Trial Terminated|87|||
48877186|NCT00443209|157388568|FG001|Months 13 to 18 Treatment Period|Trial Terminated|43|||
48877187|NCT00443209|157388567|FG000|Months 13 to 18 Treatment Period|Withdrawal by Subject|7|||
49028935|NCT02726581|157942472|FG001|Pre-Treatment Period|Administrative reason by sponsor|0|||
49028936|NCT02726581|157942473|FG002|Pre-Treatment Period|Administrative reason by sponsor|0|||
49028937|NCT02726581|157942471|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
49028938|NCT02726581|157942472|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
49028939|NCT02726581|157942473|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
49028940|NCT02726581|157942471|FG000|Treatment Period|Disease progression|47|||
49028941|NCT02726581|157942472|FG001|Treatment Period|Disease progression|50|||
49028942|NCT02726581|157942473|FG002|Treatment Period|Disease progression|16|||
49028943|NCT02726581|157942471|FG000|Treatment Period|Other reasons|9|||
49028944|NCT02726581|157942472|FG001|Treatment Period|Other reasons|8|||
49028945|NCT02726581|157942473|FG002|Treatment Period|Other reasons|2|||
49028946|NCT02726581|157942471|FG000|Treatment Period|Study drug toxicity|6|||
49028947|NCT02726581|157942472|FG001|Treatment Period|Study drug toxicity|3|||
49028948|NCT02726581|157942473|FG002|Treatment Period|Study drug toxicity|2|||
49028949|NCT02726581|157942471|FG000|Treatment Period|Adverse event unrelated to study drug|4|||
49028950|NCT02726581|157942472|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
49028951|NCT02726581|157942473|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
49028952|NCT02726581|157942471|FG000|Treatment Period|Participant withdrew consent|3|||
48778979|NCT01609556|157032732|FG008|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
48778980|NCT01609556|157032733|FG009|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
48877188|NCT00443209|157388568|FG001|Months 13 to 18 Treatment Period|Withdrawal by Subject|2|||
48877189|NCT04295798|157388569|FG000|Overall Study|Lost to Follow-up|1|||
49028953|NCT02726581|157942472|FG001|Treatment Period|Participant withdrew consent|1|||
49028954|NCT02726581|157942473|FG002|Treatment Period|Participant withdrew consent|1|||
48778981|NCT01609556|157032734|FG010|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
48778982|NCT01609556|157032735|FG011|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
48778983|NCT01609556|157032736|FG012|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
48778984|NCT01609556|157032737|FG013|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
48778985|NCT01609556|157032738|FG014|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
48778986|NCT01609556|157032739|FG015|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1|||
48778987|NCT01609556|157032724|FG000|Dose Expansion: Maximum 124 Weeks|Death|0|||
48778988|NCT01609556|157032725|FG001|Dose Expansion: Maximum 124 Weeks|Death|0|||
48778989|NCT01609556|157032726|FG002|Dose Expansion: Maximum 124 Weeks|Death|0|||
48778990|NCT01609556|157032727|FG003|Dose Expansion: Maximum 124 Weeks|Death|0|||
48778991|NCT01609556|157032728|FG004|Dose Expansion: Maximum 124 Weeks|Death|0|||
48778992|NCT01609556|157032729|FG005|Dose Expansion: Maximum 124 Weeks|Death|0|||
48778993|NCT01609556|157032730|FG006|Dose Expansion: Maximum 124 Weeks|Death|0|||
48778994|NCT01609556|157032731|FG007|Dose Expansion: Maximum 124 Weeks|Death|0|||
48778995|NCT01609556|157032732|FG008|Dose Expansion: Maximum 124 Weeks|Death|0|||
48778996|NCT01609556|157032733|FG009|Dose Expansion: Maximum 124 Weeks|Death|0|||
48778997|NCT01609556|157032734|FG010|Dose Expansion: Maximum 124 Weeks|Death|0|||
48778998|NCT01609556|157032735|FG011|Dose Expansion: Maximum 124 Weeks|Death|0|||
48778999|NCT01609556|157032736|FG012|Dose Expansion: Maximum 124 Weeks|Death|4|||
48779000|NCT01609556|157032737|FG013|Dose Expansion: Maximum 124 Weeks|Death|2|||
48779001|NCT01609556|157032738|FG014|Dose Expansion: Maximum 124 Weeks|Death|0|||
48779002|NCT01609556|157032739|FG015|Dose Expansion: Maximum 124 Weeks|Death|3|||
48779003|NCT01609556|157032724|FG000|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
48779004|NCT01609556|157032725|FG001|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
48779005|NCT01609556|157032726|FG002|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
48779006|NCT01609556|157032727|FG003|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
48779007|NCT01609556|157032728|FG004|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
48779008|NCT01609556|157032729|FG005|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
48779009|NCT01609556|157032730|FG006|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
48779010|NCT01609556|157032731|FG007|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
48877190|NCT04245345|157388570|FG000|Overall Study|Death|1|||
49028955|NCT02726581|157942471|FG000|Treatment Period|Participant request to discontinue study treatment|1|||
49028956|NCT02726581|157942472|FG001|Treatment Period|Participant request to discontinue study treatment|1|||
49028957|NCT02726581|157942473|FG002|Treatment Period|Participant request to discontinue study treatment|1|||
49028958|NCT02726581|157942471|FG000|Treatment Period|Maximum clinical benefit|0|||
49028959|NCT02726581|157942472|FG001|Treatment Period|Maximum clinical benefit|2|||
48779011|NCT01609556|157032732|FG008|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
48779012|NCT01609556|157032733|FG009|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
48779013|NCT01609556|157032734|FG010|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
48779014|NCT01609556|157032735|FG011|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
48779015|NCT01609556|157032736|FG012|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1|||
48779016|NCT01609556|157032737|FG013|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
48779017|NCT01609556|157032738|FG014|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
48779018|NCT01609556|157032739|FG015|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
48779019|NCT02720484|157032743|FG000|Treatment on Study|Adverse Event|1|||
48779020|NCT02720484|157032743|FG000|Treatment on Study|Withdrawal by Subject|1|||
48779021|NCT02720484|157032743|FG000|Treatment on Study|Progressive Disease|4|||
48779022|NCT02720484|157032743|FG000|Follow Up for 2 Years|Withdrawal by Subject|1|||
48779023|NCT02720484|157032743|FG000|Follow Up for 2 Years|Death|3|||
48779024|NCT02720484|157032743|FG000|Follow Up for 2 Years|Lost to Follow-up|2|||
48779025|NCT05070897|157032744|FG000|Overall Study|Protocol Violation|123|||
48779026|NCT05070897|157032745|FG001|Overall Study|Protocol Violation|68|||
48779027|NCT01968434|157032749|FG000|Overall Study|Lost to Follow-up|3|||
48779028|NCT01968434|157032750|FG001|Overall Study|Lost to Follow-up|6|||
48779029|NCT01218646|157032751|FG000|Overall Study|Adverse Event|0|||
48779030|NCT01218646|157032752|FG001|Overall Study|Adverse Event|0|||
49028960|NCT02726581|157942473|FG002|Treatment Period|Maximum clinical benefit|0|||
49028961|NCT02726581|157942471|FG000|Treatment Period|Death|1|||
49028962|NCT02726581|157942472|FG001|Treatment Period|Death|0|||
48779031|NCT01218646|157032753|FG002|Overall Study|Adverse Event|1|||
48779032|NCT01218646|157032754|FG003|Overall Study|Adverse Event|0|||
48779033|NCT01218646|157032751|FG000|Overall Study|Lost to Follow-up|1|||
48779034|NCT01218646|157032752|FG001|Overall Study|Lost to Follow-up|0|||
48779035|NCT01218646|157032753|FG002|Overall Study|Lost to Follow-up|0|||
48779036|NCT01218646|157032754|FG003|Overall Study|Lost to Follow-up|0|||
48779037|NCT01218646|157032751|FG000|Overall Study|Protocol Violation|0|||
48779038|NCT01218646|157032752|FG001|Overall Study|Protocol Violation|0|||
48779039|NCT01218646|157032753|FG002|Overall Study|Protocol Violation|1|||
48779040|NCT01218646|157032754|FG003|Overall Study|Protocol Violation|1|||
48779041|NCT03246529|157032758|FG000|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
48779042|NCT03246529|157032759|FG001|Core Study (Until 100 d Post-transplant)|Adverse Event|2|||
48779043|NCT03246529|157032760|FG002|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
48779044|NCT03246529|157032758|FG000|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|0|||
48779045|NCT03246529|157032759|FG001|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
48779046|NCT03246529|157032760|FG002|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
48779047|NCT03246529|157032758|FG000|Core Study (Until 100 d Post-transplant)|Other Reasons|0|||
48779048|NCT03246529|157032759|FG001|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
48779049|NCT03246529|157032760|FG002|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
48779050|NCT03246529|157032758|FG000|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
48779051|NCT03246529|157032759|FG001|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
48779052|NCT03246529|157032760|FG002|Core Study (Until 100 d Post-transplant)|Physician Decision|1|||
48779053|NCT03246529|157032758|FG000|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|0|||
48779054|NCT03246529|157032759|FG001|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|1|||
48779055|NCT03246529|157032760|FG002|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|4|||
48779056|NCT03246529|157032758|FG000|Follow-up Period at 1 Year FU Completion|Disease progression|2|||
48779057|NCT03246529|157032759|FG001|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
48779058|NCT03246529|157032760|FG002|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
48779059|NCT03246529|157032758|FG000|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|1|||
48779060|NCT03246529|157032759|FG001|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|3|||
48779061|NCT03246529|157032760|FG002|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|0|||
48779062|NCT03246529|157032758|FG000|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
48779063|NCT03246529|157032759|FG001|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|3|||
48779064|NCT03246529|157032760|FG002|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
48779065|NCT03246529|157032758|FG000|Follow-up Period at 1 Year FU Completion|Death|0|||
48779066|NCT03246529|157032759|FG001|Follow-up Period at 1 Year FU Completion|Death|0|||
48779067|NCT03246529|157032760|FG002|Follow-up Period at 1 Year FU Completion|Death|1|||
48779068|NCT02742103|157034461|FG000|Overall Study|Protocol Violation|1|||
48779069|NCT02742103|157034462|FG001|Overall Study|Protocol Violation|0|||
48779070|NCT02742103|157034461|FG000|Overall Study|Death|2|||
48779071|NCT02742103|157034462|FG001|Overall Study|Death|2|||
48779072|NCT02742103|157034461|FG000|Overall Study|Adverse Event|1|||
48779073|NCT02742103|157034462|FG001|Overall Study|Adverse Event|0|||
48779074|NCT02742103|157034461|FG000|Overall Study|Moved to another town|0|||
48779075|NCT02742103|157034462|FG001|Overall Study|Moved to another town|1|||
48779076|NCT02742103|157034461|FG000|Overall Study|Withdrawal by Subject|5|||
48779077|NCT02742103|157034462|FG001|Overall Study|Withdrawal by Subject|2|||
48779078|NCT01818336|157034463|FG000|Overall Study|Declined retest visit|0|||
48779079|NCT01818336|157034464|FG001|Overall Study|Declined retest visit|11|||
48779080|NCT01818336|157034463|FG000|Overall Study|Lost to Follow-up|0|||
48779081|NCT01818336|157034464|FG001|Overall Study|Lost to Follow-up|1|||
48779082|NCT01709318|157034465|FG000|Overall Study|Adverse Event|3|||
48779083|NCT01709318|157034466|FG001|Overall Study|Adverse Event|4|||
48779084|NCT01709318|157034467|FG002|Overall Study|Adverse Event|2|||
48779085|NCT01709318|157034468|FG003|Overall Study|Adverse Event|2|||
48779086|NCT01709318|157034469|FG004|Overall Study|Adverse Event|0|||
48779087|NCT01709318|157034470|FG005|Overall Study|Adverse Event|1|||
48779088|NCT01709318|157034471|FG006|Overall Study|Adverse Event|2|||
48779089|NCT01709318|157034465|FG000|Overall Study|Lost to Follow-up|2|||
48779090|NCT01709318|157034466|FG001|Overall Study|Lost to Follow-up|0|||
48779091|NCT01709318|157034467|FG002|Overall Study|Lost to Follow-up|0|||
48779092|NCT01709318|157034468|FG003|Overall Study|Lost to Follow-up|0|||
48779093|NCT01709318|157034469|FG004|Overall Study|Lost to Follow-up|1|||
48779094|NCT01709318|157034470|FG005|Overall Study|Lost to Follow-up|1|||
48779095|NCT01709318|157034471|FG006|Overall Study|Lost to Follow-up|1|||
48779096|NCT01709318|157034465|FG000|Overall Study|Non-compliance with Study Drug|0|||
48779097|NCT01709318|157034466|FG001|Overall Study|Non-compliance with Study Drug|2|||
49028963|NCT02726581|157942473|FG002|Treatment Period|Death|0|||
49028964|NCT02726581|157942471|FG000|Treatment Period|Poor/non-compliance|1|||
49028965|NCT02726581|157942472|FG001|Treatment Period|Poor/non-compliance|0|||
49028966|NCT02726581|157942473|FG002|Treatment Period|Poor/non-compliance|0|||
49028967|NCT02726581|157942471|FG000|Treatment Period|Participant no longer meets study criteria|0|||
49028968|NCT02726581|157942472|FG001|Treatment Period|Participant no longer meets study criteria|1|||
49028969|NCT02726581|157942473|FG002|Treatment Period|Participant no longer meets study criteria|0|||
49028970|NCT00552669|157942477|FG000|Overall Study|Death|3|||
49028971|NCT00552669|157942478|FG001|Overall Study|Death|7|||
49028972|NCT01844375|157942479|FG000|Overall Study|Protocol Violation|1|||
48779098|NCT01709318|157034467|FG002|Overall Study|Non-compliance with Study Drug|1|||
49028973|NCT01844375|157942480|FG001|Overall Study|Protocol Violation|1|||
49028974|NCT01313780|157942481|FG000|Overall Study|Lack of Efficacy|4|||
48779099|NCT01709318|157034468|FG003|Overall Study|Non-compliance with Study Drug|1|||
48779100|NCT01709318|157034469|FG004|Overall Study|Non-compliance with Study Drug|0|||
49028975|NCT01313780|157942482|FG001|Overall Study|Lack of Efficacy|2|||
49028976|NCT01313780|157942481|FG000|Overall Study|Adverse Event|6|||
49028977|NCT01313780|157942482|FG001|Overall Study|Adverse Event|11|||
49028978|NCT01313780|157942481|FG000|Overall Study|Withdrawal by Subject|2|||
49028979|NCT01313780|157942482|FG001|Overall Study|Withdrawal by Subject|8|||
49028980|NCT01313780|157942481|FG000|Overall Study|Protocol Violation|10|||
48779101|NCT01709318|157034470|FG005|Overall Study|Non-compliance with Study Drug|0|||
48779102|NCT01709318|157034471|FG006|Overall Study|Non-compliance with Study Drug|2|||
48779103|NCT01709318|157034465|FG000|Overall Study|Physician Decision|0|||
48779104|NCT01709318|157034466|FG001|Overall Study|Physician Decision|0|||
48779105|NCT01709318|157034467|FG002|Overall Study|Physician Decision|0|||
48779106|NCT01709318|157034468|FG003|Overall Study|Physician Decision|0|||
48779107|NCT01709318|157034469|FG004|Overall Study|Physician Decision|0|||
48779108|NCT01709318|157034470|FG005|Overall Study|Physician Decision|0|||
48779109|NCT01709318|157034471|FG006|Overall Study|Physician Decision|1|||
48779110|NCT01709318|157034465|FG000|Overall Study|Pregnancy|0|||
48779111|NCT01709318|157034466|FG001|Overall Study|Pregnancy|0|||
48779112|NCT01709318|157034467|FG002|Overall Study|Pregnancy|0|||
48779113|NCT01709318|157034468|FG003|Overall Study|Pregnancy|0|||
48779114|NCT01709318|157034469|FG004|Overall Study|Pregnancy|1|||
48779115|NCT01709318|157034470|FG005|Overall Study|Pregnancy|0|||
48779116|NCT01709318|157034471|FG006|Overall Study|Pregnancy|0|||
48779117|NCT01709318|157034465|FG000|Overall Study|Protocol Violation|0|||
48779118|NCT01709318|157034466|FG001|Overall Study|Protocol Violation|0|||
48779119|NCT01709318|157034467|FG002|Overall Study|Protocol Violation|0|||
48779120|NCT01709318|157034468|FG003|Overall Study|Protocol Violation|0|||
48779121|NCT01709318|157034469|FG004|Overall Study|Protocol Violation|2|||
48779122|NCT01709318|157034470|FG005|Overall Study|Protocol Violation|0|||
48779123|NCT01709318|157034471|FG006|Overall Study|Protocol Violation|1|||
48779124|NCT01709318|157034465|FG000|Overall Study|Technical Problems|1|||
48779125|NCT01709318|157034466|FG001|Overall Study|Technical Problems|0|||
48779126|NCT01709318|157034467|FG002|Overall Study|Technical Problems|0|||
49028981|NCT01313780|157942482|FG001|Overall Study|Protocol Violation|4|||
49028982|NCT01313780|157942481|FG000|Overall Study|missing data|3|||
49028983|NCT01313780|157942482|FG001|Overall Study|missing data|3|||
49028984|NCT02158663|157942485|FG000|Overall Study|Withdrawal by Subject|5|||
49028985|NCT02158663|157942486|FG001|Overall Study|Withdrawal by Subject|4|||
49028986|NCT01265056|157942487|FG000|Initial Study Period|Withdrawal by Subject|1|||
49028987|NCT01265056|157942488|FG001|Initial Study Period|Withdrawal by Subject|1|||
49028988|NCT01265056|157942487|FG000|Initial Study Period|Withdrawal by Subject|1|||
49028989|NCT01265056|157942488|FG001|Initial Study Period|Withdrawal by Subject|1|||
49028990|NCT01265056|157942487|FG000|Follow up|Lost to Follow-up|7|||
49028991|NCT01265056|157942488|FG001|Follow up|Lost to Follow-up|3|||
49028992|NCT00465270|157942496|FG000|Overall Study|Death|7|||
49028993|NCT00465270|157942497|FG001|Overall Study|Death|11|||
49028994|NCT00465270|157942496|FG000|Overall Study|Withdrawal by Subject|34|||
49028995|NCT00465270|157942497|FG001|Overall Study|Withdrawal by Subject|78|||
49028996|NCT00465270|157942496|FG000|Overall Study|Lost to Follow-up|60|||
49028997|NCT00465270|157942497|FG001|Overall Study|Lost to Follow-up|67|||
49028998|NCT00465270|157942496|FG000|Overall Study|Investigator request|3|||
49028999|NCT00465270|157942497|FG001|Overall Study|Investigator request|4|||
49029000|NCT00424047|157942498|FG000|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18|||
49029001|NCT00424047|157942499|FG001|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12|||
49029002|NCT00424047|157942498|FG000|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67|||
49029003|NCT00424047|157942499|FG001|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122|||
49029004|NCT00424047|157942498|FG000|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1|||
49029005|NCT00424047|157942499|FG001|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3|||
49029006|NCT00424047|157942498|FG000|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23|||
49029007|NCT00424047|157942499|FG001|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8|||
49029008|NCT00424047|157942498|FG000|Blinded Treatment (Up to 03 Aug 2005)|Death|11|||
49029009|NCT00424047|157942499|FG001|Blinded Treatment (Up to 03 Aug 2005)|Death|10|||
49029010|NCT00424047|157942498|FG000|Blinded Treatment (Up to 03 Aug 2005)|Other|2|||
49029011|NCT00424047|157942499|FG001|Blinded Treatment (Up to 03 Aug 2005)|Other|1|||
48779127|NCT01709318|157034468|FG003|Overall Study|Technical Problems|0|||
48779128|NCT01709318|157034469|FG004|Overall Study|Technical Problems|0|||
48779129|NCT01709318|157034470|FG005|Overall Study|Technical Problems|0|||
48779130|NCT01709318|157034471|FG006|Overall Study|Technical Problems|0|||
48779131|NCT01709318|157034465|FG000|Overall Study|Withdrawal by Subject|3|||
48779132|NCT01709318|157034466|FG001|Overall Study|Withdrawal by Subject|0|||
48779133|NCT01709318|157034467|FG002|Overall Study|Withdrawal by Subject|3|||
48779134|NCT01709318|157034468|FG003|Overall Study|Withdrawal by Subject|3|||
48779135|NCT01709318|157034469|FG004|Overall Study|Withdrawal by Subject|0|||
48779136|NCT01709318|157034470|FG005|Overall Study|Withdrawal by Subject|2|||
48779137|NCT01709318|157034471|FG006|Overall Study|Withdrawal by Subject|4|||
48779138|NCT01709318|157034465|FG000|Overall Study|Other Protocol Specified Criteria|0|||
48779139|NCT01709318|157034466|FG001|Overall Study|Other Protocol Specified Criteria|1|||
48779140|NCT01709318|157034467|FG002|Overall Study|Other Protocol Specified Criteria|0|||
48779141|NCT01709318|157034468|FG003|Overall Study|Other Protocol Specified Criteria|0|||
48779142|NCT01709318|157034469|FG004|Overall Study|Other Protocol Specified Criteria|0|||
48779143|NCT01709318|157034470|FG005|Overall Study|Other Protocol Specified Criteria|0|||
48779144|NCT01709318|157034471|FG006|Overall Study|Other Protocol Specified Criteria|0|||
49029012|NCT00424047|157942498|FG000|On Study at Time of Unblinding|Adverse Event|22|||
49029013|NCT00424047|157942499|FG001|On Study at Time of Unblinding|Adverse Event|12|||
49029014|NCT00424047|157942498|FG000|On Study at Time of Unblinding|Progression of disease|92|||
49029015|NCT00424047|157942499|FG001|On Study at Time of Unblinding|Progression of disease|128|||
49029016|NCT00424047|157942498|FG000|On Study at Time of Unblinding|Lack of Efficacy|1|||
49029017|NCT00424047|157942499|FG001|On Study at Time of Unblinding|Lack of Efficacy|3|||
49029018|NCT00424047|157942498|FG000|On Study at Time of Unblinding|Withdrawal by Subject|24|||
49029019|NCT00424047|157942499|FG001|On Study at Time of Unblinding|Withdrawal by Subject|9|||
49029020|NCT00424047|157942498|FG000|On Study at Time of Unblinding|Death|11|||
49029021|NCT00424047|157942499|FG001|On Study at Time of Unblinding|Death|11|||
49029022|NCT00424047|157942498|FG000|On Study at Time of Unblinding|Other|5|||
49029023|NCT00424047|157942499|FG001|On Study at Time of Unblinding|Other|4|||
49029024|NCT00424047|157942498|FG000|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1|||
49029025|NCT00424047|157942499|FG001|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0|||
49029026|NCT00424047|157942498|FG000|Long Term Extension (Up to 25 Jun 2013)|Death|0|||
49029027|NCT00424047|157942499|FG001|Long Term Extension (Up to 25 Jun 2013)|Death|1|||
49029028|NCT00424047|157942498|FG000|Long Term Extension (Up to 25 Jun 2013)|Other|12|||
49029029|NCT00424047|157942499|FG001|Long Term Extension (Up to 25 Jun 2013)|Other|4|||
49029030|NCT00424047|157942498|FG000|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7|||
49029031|NCT00424047|157942499|FG001|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3|||
49029032|NCT00424047|157942498|FG000|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1|||
49029033|NCT00424047|157942499|FG001|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0|||
48779145|NCT01083433|157034474|FG000|Overall Study|Lost to Follow-up|2|||
48779146|NCT01083433|157034475|FG001|Overall Study|Lost to Follow-up|1|||
48779147|NCT01083433|157034476|FG002|Overall Study|Lost to Follow-up|1|||
48779148|NCT01083433|157034474|FG000|Overall Study|Withdrawal by Subject|0|||
48779149|NCT01083433|157034475|FG001|Overall Study|Withdrawal by Subject|5|||
48779150|NCT01083433|157034476|FG002|Overall Study|Withdrawal by Subject|3|||
48779151|NCT01083433|157034474|FG000|Overall Study|Pregnancy|0|||
48779152|NCT01083433|157034475|FG001|Overall Study|Pregnancy|0|||
48779153|NCT01083433|157034476|FG002|Overall Study|Pregnancy|1|||
48779154|NCT00982319|157034479|FG000|Overall Study|Surgery date change|1|||
48779155|NCT00982319|157034480|FG001|Overall Study|Surgery date change|0|||
48779156|NCT00982319|157034479|FG000|Overall Study|Preop values out of acceptable range|1|||
48779157|NCT00982319|157034480|FG001|Overall Study|Preop values out of acceptable range|1|||
48779158|NCT00982319|157034479|FG000|Overall Study|Pregnancy|0|||
48779159|NCT00982319|157034480|FG001|Overall Study|Pregnancy|1|||
48779160|NCT02610192|157034481|FG000|Overall Study|Received other treatment|8|||
48779161|NCT02610192|157034481|FG000|Overall Study|Physician Decision|1|||
48779162|NCT01694706|157034482|FG000|Overall Study|Adverse Event|0|||
48779163|NCT01694706|157034483|FG001|Overall Study|Adverse Event|1|||
48779164|NCT01694706|157034484|FG002|Overall Study|Adverse Event|0|||
48779165|NCT01694706|157034482|FG000|Overall Study|other reason not defined above|1|||
48779166|NCT01694706|157034483|FG001|Overall Study|other reason not defined above|0|||
48779167|NCT01694706|157034484|FG002|Overall Study|other reason not defined above|0|||
48779168|NCT01324024|157034485|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
48779169|NCT01324024|157034486|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
48779170|NCT00642304|157034501|FG000|Overall Study|Adverse Event|1|||
48779171|NCT00642304|157034501|FG000|Overall Study|Death|1|||
48779172|NCT00642304|157034501|FG000|Overall Study|Blood transfusion|2|||
48779173|NCT00642304|157034501|FG000|Overall Study|Erythropoiesis Stimulating Agent Use.|1|||
48779174|NCT00642304|157034501|FG000|Overall Study|Transplantation|1|||
48779175|NCT00889421|157034503|FG000|Overall Study|Lack of Efficacy|3|||
48779176|NCT04327934|157034506|FG000|Overall Study|Did not qualify|7|||
49029034|NCT00095212|157942500|FG000|Overall Study|Withdrawal by Subject|1|||
48779177|NCT04327934|157034507|FG001|Overall Study|Did not qualify|4|||
48779178|NCT04327934|157034506|FG000|Overall Study|Physician Decision|0|||
48779179|NCT04327934|157034507|FG001|Overall Study|Physician Decision|1|||
49029035|NCT00095212|157942501|FG001|Overall Study|Withdrawal by Subject|3|||
49029036|NCT02335658|157942503|FG000|Overall Study|Adverse Event|18|||
48779180|NCT01430130|157034508|FG000|Overall Study|Lost to Follow-up|1|||
48779181|NCT01430130|157034508|FG000|Overall Study|Infection on Control Side of Incision|1|||
48779182|NCT02265705|157034509|FG000|Treatment Period Week 0-24|Adverse Event|3|||
48779183|NCT02265705|157034510|FG001|Treatment Period Week 0-24|Adverse Event|2|||
49029037|NCT02335658|157942504|FG001|Overall Study|Adverse Event|12|||
48779184|NCT02265705|157034511|FG002|Treatment Period Week 0-24|Adverse Event|0|||
48779185|NCT02265705|157034512|FG003|Treatment Period Week 0-24|Adverse Event|0|||
48779186|NCT02265705|157034513|FG004|Treatment Period Week 0-24|Adverse Event|0|||
48779187|NCT02265705|157034514|FG005|Treatment Period Week 0-24|Adverse Event|0|||
48779188|NCT02265705|157034515|FG006|Treatment Period Week 0-24|Adverse Event|0|||
48779189|NCT02265705|157034509|FG000|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
48779190|NCT02265705|157034510|FG001|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
48779191|NCT02265705|157034511|FG002|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
48779192|NCT02265705|157034512|FG003|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
48779193|NCT02265705|157034513|FG004|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
48779194|NCT02265705|157034514|FG005|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
48779195|NCT02265705|157034515|FG006|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
48779196|NCT02265705|157034509|FG000|Treatment Period Week 0-24|Physician Decision|1|||
48779197|NCT02265705|157034510|FG001|Treatment Period Week 0-24|Physician Decision|0|||
48779198|NCT02265705|157034511|FG002|Treatment Period Week 0-24|Physician Decision|0|||
48779199|NCT02265705|157034512|FG003|Treatment Period Week 0-24|Physician Decision|0|||
48779200|NCT02265705|157034513|FG004|Treatment Period Week 0-24|Physician Decision|0|||
48779201|NCT02265705|157034514|FG005|Treatment Period Week 0-24|Physician Decision|0|||
48779202|NCT02265705|157034515|FG006|Treatment Period Week 0-24|Physician Decision|0|||
48779203|NCT02265705|157034509|FG000|Treatment Period Week 0-24|Withdrawal by Subject|7|||
48779204|NCT02265705|157034510|FG001|Treatment Period Week 0-24|Withdrawal by Subject|5|||
48779205|NCT02265705|157034511|FG002|Treatment Period Week 0-24|Withdrawal by Subject|0|||
48779206|NCT02265705|157034512|FG003|Treatment Period Week 0-24|Withdrawal by Subject|0|||
48779207|NCT02265705|157034513|FG004|Treatment Period Week 0-24|Withdrawal by Subject|0|||
48779208|NCT02265705|157034514|FG005|Treatment Period Week 0-24|Withdrawal by Subject|0|||
48779209|NCT02265705|157034515|FG006|Treatment Period Week 0-24|Withdrawal by Subject|0|||
48779210|NCT02265705|157034509|FG000|Treatment Period Week 0-24|Lack of Efficacy|0|||
48779211|NCT02265705|157034510|FG001|Treatment Period Week 0-24|Lack of Efficacy|1|||
48779212|NCT02265705|157034511|FG002|Treatment Period Week 0-24|Lack of Efficacy|0|||
48779213|NCT02265705|157034512|FG003|Treatment Period Week 0-24|Lack of Efficacy|0|||
48779214|NCT02265705|157034513|FG004|Treatment Period Week 0-24|Lack of Efficacy|0|||
48779215|NCT02265705|157034514|FG005|Treatment Period Week 0-24|Lack of Efficacy|0|||
48779216|NCT02265705|157034515|FG006|Treatment Period Week 0-24|Lack of Efficacy|0|||
48779217|NCT02265705|157034509|FG000|Rescue Period|Withdrawal by Subject|0|||
48877191|NCT04245345|157388570|FG000|Overall Study|Exited prior to implant|5|||
48877192|NCT04245345|157388570|FG000|Overall Study|Exited prior to 1-month|9|||
48877193|NCT04245345|157388570|FG000|Overall Study|Missed 1-month visit|3|||
48877194|NCT04245345|157388570|FG000|Overall Study|Predominant rhythm exclusion at 1-month|83|||
48877195|NCT04245345|157388570|FG000|Overall Study|Fewer than 500 evaluable beats|2|||
48877196|NCT00224029|157388571|FG000|Overall Study|Lost to Follow-up|1|||
48982668|NCT00286156|157767681|FG002|Overall Study|AE: nephrotic-range proteinuruia|0|||
48982669|NCT00286156|157767679|FG000|Overall Study|AE: pneumonia|1|||
48982670|NCT00286156|157767680|FG001|Overall Study|AE: pneumonia|0|||
48779218|NCT02265705|157034510|FG001|Rescue Period|Withdrawal by Subject|0|||
48779219|NCT02265705|157034511|FG002|Rescue Period|Withdrawal by Subject|1|||
48779220|NCT02265705|157034512|FG003|Rescue Period|Withdrawal by Subject|0|||
48779221|NCT02265705|157034513|FG004|Rescue Period|Withdrawal by Subject|0|||
48779222|NCT02265705|157034514|FG005|Rescue Period|Withdrawal by Subject|0|||
48779223|NCT02265705|157034515|FG006|Rescue Period|Withdrawal by Subject|0|||
48779224|NCT02265705|157034509|FG000|Rescue Period|Death|0|||
48779225|NCT02265705|157034510|FG001|Rescue Period|Death|0|||
48779226|NCT02265705|157034511|FG002|Rescue Period|Death|1|||
48779227|NCT02265705|157034512|FG003|Rescue Period|Death|0|||
48779228|NCT02265705|157034513|FG004|Rescue Period|Death|0|||
48779229|NCT02265705|157034514|FG005|Rescue Period|Death|0|||
48779230|NCT02265705|157034515|FG006|Rescue Period|Death|0|||
48779231|NCT02265705|157034509|FG000|Rescue Period|Lack of Efficacy|0|||
48779232|NCT02265705|157034510|FG001|Rescue Period|Lack of Efficacy|0|||
48779233|NCT02265705|157034511|FG002|Rescue Period|Lack of Efficacy|1|||
48779234|NCT02265705|157034512|FG003|Rescue Period|Lack of Efficacy|0|||
48779235|NCT02265705|157034513|FG004|Rescue Period|Lack of Efficacy|0|||
48779236|NCT02265705|157034514|FG005|Rescue Period|Lack of Efficacy|0|||
48779237|NCT02265705|157034515|FG006|Rescue Period|Lack of Efficacy|0|||
48877197|NCT00224029|157388571|FG000|Overall Study|Withdrawal by Subject|4|||
48877198|NCT00224029|157388571|FG000|Overall Study|Other|1|||
48877199|NCT03635086|157388572|FG000|Overall Study|Withdrawal of consent|0|||
48982671|NCT00286156|157767681|FG002|Overall Study|AE: pneumonia|0|||
48982672|NCT01685060|157769858|FG000|Overall Study|Rollover patients|16|||
48982673|NCT01685060|157769858|FG000|Overall Study|Adverse Event|12|||
48982674|NCT01685060|157769858|FG000|Overall Study|Progressive disease|69|||
48982675|NCT01685060|157769858|FG000|Overall Study|Physician Decision|14|||
48982676|NCT01685060|157769858|FG000|Overall Study|Subject/guardian decision|20|||
48982677|NCT01685060|157769858|FG000|Overall Study|Lost to Follow-up|1|||
48982678|NCT01685060|157769858|FG000|Overall Study|Death|8|||
48982679|NCT02531633|157769861|FG000|Part A (52 Weeks)|Sponsor request|24|||
48982680|NCT02531633|157769862|FG001|Part A (52 Weeks)|Sponsor request|24|||
48982681|NCT02531633|157769863|FG002|Part A (52 Weeks)|Sponsor request|18|||
48982682|NCT02531633|157769864|FG003|Part A (52 Weeks)|Sponsor request|18|||
48982683|NCT02531633|157769865|FG004|Part A (52 Weeks)|Sponsor request|19|||
48982684|NCT02531633|157769866|FG005|Part A (52 Weeks)|Sponsor request|0|||
48982685|NCT02531633|157769867|FG006|Part A (52 Weeks)|Sponsor request|0|||
48982686|NCT02531633|157769868|FG007|Part A (52 Weeks)|Sponsor request|0|||
48982687|NCT02531633|157769869|FG008|Part A (52 Weeks)|Sponsor request|0|||
49029038|NCT02335658|157942503|FG000|Overall Study|Lack of Efficacy|4|||
49029039|NCT02335658|157942504|FG001|Overall Study|Lack of Efficacy|5|||
49029040|NCT02335658|157942503|FG000|Overall Study|Pregnancy|1|||
49029041|NCT02335658|157942504|FG001|Overall Study|Pregnancy|0|||
49029042|NCT02335658|157942503|FG000|Overall Study|Withdrawal by Subject|13|||
49029043|NCT02335658|157942504|FG001|Overall Study|Withdrawal by Subject|21|||
48779238|NCT02265705|157034509|FG000|Open Label Period|Adverse Event|0|||
48779239|NCT02265705|157034510|FG001|Open Label Period|Adverse Event|0|||
48779240|NCT02265705|157034511|FG002|Open Label Period|Adverse Event|0|||
48779241|NCT02265705|157034512|FG003|Open Label Period|Adverse Event|2|||
48779242|NCT02265705|157034513|FG004|Open Label Period|Adverse Event|2|||
48779243|NCT02265705|157034514|FG005|Open Label Period|Adverse Event|0|||
48779244|NCT02265705|157034515|FG006|Open Label Period|Adverse Event|0|||
48779245|NCT02265705|157034509|FG000|Open Label Period|Physician Decision|0|||
48779246|NCT02265705|157034510|FG001|Open Label Period|Physician Decision|0|||
48779247|NCT02265705|157034511|FG002|Open Label Period|Physician Decision|0|||
48779248|NCT02265705|157034512|FG003|Open Label Period|Physician Decision|0|||
48779249|NCT02265705|157034513|FG004|Open Label Period|Physician Decision|1|||
48779250|NCT02265705|157034514|FG005|Open Label Period|Physician Decision|0|||
48779251|NCT02265705|157034515|FG006|Open Label Period|Physician Decision|0|||
48779252|NCT02265705|157034509|FG000|Open Label Period|Withdrawal by Subject|0|||
48779253|NCT02265705|157034510|FG001|Open Label Period|Withdrawal by Subject|0|||
48779254|NCT02265705|157034511|FG002|Open Label Period|Withdrawal by Subject|0|||
48779255|NCT02265705|157034512|FG003|Open Label Period|Withdrawal by Subject|0|||
48779256|NCT02265705|157034513|FG004|Open Label Period|Withdrawal by Subject|2|||
48779257|NCT02265705|157034514|FG005|Open Label Period|Withdrawal by Subject|0|||
48779258|NCT02265705|157034515|FG006|Open Label Period|Withdrawal by Subject|0|||
48779259|NCT02265705|157034509|FG000|Follow-up Period|Sponsor Decision|0|||
48779260|NCT02265705|157034510|FG001|Follow-up Period|Sponsor Decision|0|||
48779261|NCT02265705|157034511|FG002|Follow-up Period|Sponsor Decision|0|||
48779262|NCT02265705|157034512|FG003|Follow-up Period|Sponsor Decision|0|||
48779263|NCT02265705|157034513|FG004|Follow-up Period|Sponsor Decision|0|||
48779264|NCT02265705|157034514|FG005|Follow-up Period|Sponsor Decision|1|||
48779265|NCT02265705|157034515|FG006|Follow-up Period|Sponsor Decision|6|||
48779266|NCT02265705|157034509|FG000|Follow-up Period|Adverse Event|0|||
48779267|NCT02265705|157034510|FG001|Follow-up Period|Adverse Event|0|||
48779268|NCT02265705|157034511|FG002|Follow-up Period|Adverse Event|0|||
48779269|NCT02265705|157034512|FG003|Follow-up Period|Adverse Event|0|||
48779270|NCT02265705|157034513|FG004|Follow-up Period|Adverse Event|0|||
48779271|NCT02265705|157034514|FG005|Follow-up Period|Adverse Event|0|||
48779272|NCT02265705|157034515|FG006|Follow-up Period|Adverse Event|3|||
48779273|NCT02265705|157034509|FG000|Follow-up Period|Physician Decision|0|||
48779274|NCT02265705|157034510|FG001|Follow-up Period|Physician Decision|0|||
48779275|NCT02265705|157034511|FG002|Follow-up Period|Physician Decision|0|||
48779276|NCT02265705|157034512|FG003|Follow-up Period|Physician Decision|0|||
48779277|NCT02265705|157034513|FG004|Follow-up Period|Physician Decision|0|||
48779278|NCT02265705|157034514|FG005|Follow-up Period|Physician Decision|0|||
48779279|NCT02265705|157034515|FG006|Follow-up Period|Physician Decision|1|||
48779280|NCT02265705|157034509|FG000|Follow-up Period|Withdrawal by Subject|0|||
48779281|NCT02265705|157034510|FG001|Follow-up Period|Withdrawal by Subject|0|||
48779282|NCT02265705|157034511|FG002|Follow-up Period|Withdrawal by Subject|0|||
48779283|NCT02265705|157034512|FG003|Follow-up Period|Withdrawal by Subject|0|||
48779284|NCT02265705|157034513|FG004|Follow-up Period|Withdrawal by Subject|0|||
48779285|NCT02265705|157034514|FG005|Follow-up Period|Withdrawal by Subject|0|||
48779286|NCT02265705|157034515|FG006|Follow-up Period|Withdrawal by Subject|1|||
48779287|NCT03029208|157034523|FG000|Overall Study|Withdrawal by Subject|2|||
48779288|NCT03029208|157034524|FG001|Overall Study|Withdrawal by Subject|3|||
48779289|NCT03029208|157034523|FG000|Overall Study|Lost to Follow-up|0|||
48779290|NCT03029208|157034524|FG001|Overall Study|Lost to Follow-up|1|||
48779291|NCT01700946|157034525|FG000|Overall Study|Lost to Follow-up|1|||
48779292|NCT01700946|157034526|FG001|Overall Study|Lost to Follow-up|0|||
48779293|NCT01700946|157034525|FG000|Overall Study|Physician Decision|7|||
48779294|NCT01700946|157034526|FG001|Overall Study|Physician Decision|12|||
48779295|NCT01700946|157034525|FG000|Overall Study|Withdrawal by Subject|0|||
48779296|NCT01700946|157034526|FG001|Overall Study|Withdrawal by Subject|2|||
48779297|NCT01700946|157034525|FG000|Overall Study|Failed to achieve Complete Remission after Induction Block III|0|||
48779298|NCT01700946|157034526|FG001|Overall Study|Failed to achieve Complete Remission after Induction Block III|2|||
48779299|NCT01700946|157034525|FG000|Overall Study|Relapse|2|||
48779300|NCT01700946|157034526|FG001|Overall Study|Relapse|1|||
49029044|NCT02335658|157942503|FG000|Overall Study|non-compliance|2|||
48779301|NCT01700946|157034525|FG000|Overall Study|Unacceptable toxicity|1|||
49029045|NCT02335658|157942504|FG001|Overall Study|non-compliance|3|||
48779302|NCT01700946|157034526|FG001|Overall Study|Unacceptable toxicity|0|||
48779303|NCT04177108|157034527|FG000|Overall Study|Withdrawal by Subject|4|||
48779304|NCT04177108|157034528|FG001|Overall Study|Withdrawal by Subject|8|||
48779305|NCT04177108|157034529|FG002|Overall Study|Withdrawal by Subject|9|||
48779306|NCT04177108|157034530|FG003|Overall Study|Withdrawal by Subject|11|||
48779307|NCT04177108|157034531|FG004|Overall Study|Withdrawal by Subject|13|||
48779308|NCT04177108|157034527|FG000|Overall Study|Physician Decision|23|||
48779309|NCT04177108|157034528|FG001|Overall Study|Physician Decision|15|||
48779310|NCT04177108|157034529|FG002|Overall Study|Physician Decision|18|||
48779311|NCT04177108|157034530|FG003|Overall Study|Physician Decision|29|||
48779312|NCT04177108|157034531|FG004|Overall Study|Physician Decision|23|||
48779313|NCT04177108|157034527|FG000|Overall Study|Reason Not Specified|0|||
48779314|NCT04177108|157034528|FG001|Overall Study|Reason Not Specified|1|||
48779315|NCT04177108|157034529|FG002|Overall Study|Reason Not Specified|0|||
48779316|NCT04177108|157034530|FG003|Overall Study|Reason Not Specified|0|||
48779317|NCT04177108|157034531|FG004|Overall Study|Reason Not Specified|2|||
48779318|NCT04177108|157034527|FG000|Overall Study|Lost to Follow-up|0|||
48779319|NCT04177108|157034528|FG001|Overall Study|Lost to Follow-up|0|||
48779320|NCT04177108|157034529|FG002|Overall Study|Lost to Follow-up|1|||
48779321|NCT04177108|157034530|FG003|Overall Study|Lost to Follow-up|1|||
48779322|NCT04177108|157034531|FG004|Overall Study|Lost to Follow-up|1|||
48779323|NCT04177108|157034527|FG000|Overall Study|Death|16|||
48779324|NCT04177108|157034528|FG001|Overall Study|Death|19|||
48779325|NCT04177108|157034529|FG002|Overall Study|Death|13|||
48779326|NCT04177108|157034530|FG003|Overall Study|Death|17|||
48779327|NCT04177108|157034531|FG004|Overall Study|Death|18|||
48779328|NCT00382733|157034534|FG000|Overall Study|Withdrawal by Subject|0|||
48779329|NCT00382733|157034535|FG001|Overall Study|Withdrawal by Subject|1|||
48779330|NCT00382733|157034536|FG002|Overall Study|Withdrawal by Subject|0|||
48779331|NCT00382733|157034537|FG003|Overall Study|Withdrawal by Subject|0|||
48779332|NCT00382733|157034538|FG004|Overall Study|Withdrawal by Subject|0|||
48779333|NCT01458171|157034541|FG000|Overall Study|Adverse Event|1|||
48779334|NCT00153101|157034545|FG000|Overall Study|Lost to Follow-up|14|||
48779335|NCT00153101|157034546|FG001|Overall Study|Lost to Follow-up|14|||
48779336|NCT00153101|157034547|FG002|Overall Study|Lost to Follow-up|12|||
48779337|NCT00153101|157034548|FG003|Overall Study|Lost to Follow-up|5|||
48779338|NCT00153101|157034549|FG004|Overall Study|Lost to Follow-up|5|||
48779339|NCT00153101|157034545|FG000|Overall Study|Withdrawal by Subject|3|||
48779340|NCT00153101|157034546|FG001|Overall Study|Withdrawal by Subject|4|||
48779341|NCT00153101|157034547|FG002|Overall Study|Withdrawal by Subject|3|||
48779342|NCT00153101|157034548|FG003|Overall Study|Withdrawal by Subject|3|||
48779343|NCT00153101|157034549|FG004|Overall Study|Withdrawal by Subject|5|||
48779344|NCT04798586|157034552|FG000|Overall Study|Death|2|||
48779345|NCT01696032|157034558|FG000|Overall Study|Withdrawal by Subject|0|||
48779346|NCT01696032|157034559|FG001|Overall Study|Withdrawal by Subject|0|||
48779347|NCT01696032|157034560|FG002|Overall Study|Withdrawal by Subject|1|||
48982688|NCT02531633|157769870|FG009|Part A (52 Weeks)|Sponsor request|0|||
48982689|NCT02531633|157769861|FG000|Part A (52 Weeks)|Protocol Violation|1|||
48982690|NCT02531633|157769862|FG001|Part A (52 Weeks)|Protocol Violation|0|||
48982691|NCT02531633|157769863|FG002|Part A (52 Weeks)|Protocol Violation|0|||
48982692|NCT02531633|157769864|FG003|Part A (52 Weeks)|Protocol Violation|0|||
48982693|NCT02531633|157769865|FG004|Part A (52 Weeks)|Protocol Violation|0|||
48982694|NCT02531633|157769866|FG005|Part A (52 Weeks)|Protocol Violation|0|||
48982695|NCT02531633|157769867|FG006|Part A (52 Weeks)|Protocol Violation|0|||
48982696|NCT02531633|157769868|FG007|Part A (52 Weeks)|Protocol Violation|0|||
48982697|NCT02531633|157769869|FG008|Part A (52 Weeks)|Protocol Violation|0|||
48982698|NCT02531633|157769870|FG009|Part A (52 Weeks)|Protocol Violation|0|||
48982699|NCT02531633|157769861|FG000|Part A (52 Weeks)|Lost to Follow-up|0|||
48982700|NCT02531633|157769862|FG001|Part A (52 Weeks)|Lost to Follow-up|0|||
48982701|NCT02531633|157769863|FG002|Part A (52 Weeks)|Lost to Follow-up|0|||
48982702|NCT02531633|157769864|FG003|Part A (52 Weeks)|Lost to Follow-up|0|||
48982703|NCT02531633|157769865|FG004|Part A (52 Weeks)|Lost to Follow-up|1|||
48982704|NCT02531633|157769866|FG005|Part A (52 Weeks)|Lost to Follow-up|0|||
48982705|NCT02531633|157769867|FG006|Part A (52 Weeks)|Lost to Follow-up|0|||
48982706|NCT02531633|157769868|FG007|Part A (52 Weeks)|Lost to Follow-up|0|||
48982707|NCT02531633|157769869|FG008|Part A (52 Weeks)|Lost to Follow-up|0|||
48982708|NCT02531633|157769870|FG009|Part A (52 Weeks)|Lost to Follow-up|0|||
48982709|NCT02531633|157769861|FG000|Part A (52 Weeks)|Physician Decision|1|||
48982710|NCT02531633|157769862|FG001|Part A (52 Weeks)|Physician Decision|4|||
48982711|NCT02531633|157769863|FG002|Part A (52 Weeks)|Physician Decision|3|||
48982712|NCT02531633|157769864|FG003|Part A (52 Weeks)|Physician Decision|1|||
48982713|NCT02531633|157769865|FG004|Part A (52 Weeks)|Physician Decision|0|||
48982714|NCT02531633|157769866|FG005|Part A (52 Weeks)|Physician Decision|0|||
48982715|NCT02531633|157769867|FG006|Part A (52 Weeks)|Physician Decision|0|||
48982716|NCT02531633|157769868|FG007|Part A (52 Weeks)|Physician Decision|0|||
48982717|NCT02531633|157769869|FG008|Part A (52 Weeks)|Physician Decision|0|||
48982718|NCT02531633|157769870|FG009|Part A (52 Weeks)|Physician Decision|0|||
48982719|NCT02531633|157769861|FG000|Part A (52 Weeks)|Withdrawal by Subject|6|||
48982720|NCT02531633|157769862|FG001|Part A (52 Weeks)|Withdrawal by Subject|6|||
48982721|NCT02531633|157769863|FG002|Part A (52 Weeks)|Withdrawal by Subject|1|||
48982722|NCT02531633|157769864|FG003|Part A (52 Weeks)|Withdrawal by Subject|3|||
49029046|NCT02335658|157942503|FG000|Overall Study|other reason|2|||
49029047|NCT02335658|157942504|FG001|Overall Study|other reason|3|||
49029048|NCT02140060|157942506|FG000|Overall Study|Adverse Event|0|||
49029049|NCT02140060|157942507|FG001|Overall Study|Adverse Event|0|||
49029050|NCT02140060|157942508|FG002|Overall Study|Adverse Event|0|||
49029051|NCT02140060|157942509|FG003|Overall Study|Adverse Event|1|||
49029052|NCT02140060|157942510|FG004|Overall Study|Adverse Event|1|||
49029053|NCT02140060|157942511|FG005|Overall Study|Adverse Event|1|||
49029054|NCT02140060|157942506|FG000|Overall Study|Lack of Efficacy|0|||
49029055|NCT02140060|157942507|FG001|Overall Study|Lack of Efficacy|0|||
49029056|NCT02140060|157942508|FG002|Overall Study|Lack of Efficacy|0|||
49029057|NCT02140060|157942509|FG003|Overall Study|Lack of Efficacy|1|||
49029058|NCT02140060|157942510|FG004|Overall Study|Lack of Efficacy|0|||
49029059|NCT02140060|157942511|FG005|Overall Study|Lack of Efficacy|0|||
49029060|NCT02039908|157942512|FG000|Phase 1-Summer|Withdrawal by Subject|7|||
49029061|NCT02039908|157942513|FG001|Phase 1-Summer|Withdrawal by Subject|6|||
49029062|NCT02039908|157942514|FG002|Phase 1-Summer|Withdrawal by Subject|0|||
49029063|NCT02039908|157942515|FG003|Phase 1-Summer|Withdrawal by Subject|0|||
49029064|NCT02039908|157942512|FG000|Phase 1-Summer|Protocol Violation|6|||
49029065|NCT02039908|157942513|FG001|Phase 1-Summer|Protocol Violation|0|||
49029066|NCT02039908|157942514|FG002|Phase 1-Summer|Protocol Violation|0|||
49029067|NCT02039908|157942515|FG003|Phase 1-Summer|Protocol Violation|0|||
49029068|NCT02039908|157942512|FG000|Phase 2-School Year|Lost to Follow-up|0|||
49029069|NCT02039908|157942513|FG001|Phase 2-School Year|Lost to Follow-up|0|||
49029070|NCT02039908|157942514|FG002|Phase 2-School Year|Lost to Follow-up|1|||
49029071|NCT02039908|157942515|FG003|Phase 2-School Year|Lost to Follow-up|3|||
49029072|NCT02039908|157942512|FG000|Phase 2-School Year|Protocol Violation|0|||
49029073|NCT02039908|157942513|FG001|Phase 2-School Year|Protocol Violation|0|||
49029074|NCT02039908|157942514|FG002|Phase 2-School Year|Protocol Violation|3|||
49029075|NCT02039908|157942515|FG003|Phase 2-School Year|Protocol Violation|0|||
49029076|NCT02039908|157942512|FG000|Phase 2-School Year|Withdrawal by Subject|0|||
49029077|NCT02039908|157942513|FG001|Phase 2-School Year|Withdrawal by Subject|0|||
49029078|NCT02039908|157942514|FG002|Phase 2-School Year|Withdrawal by Subject|8|||
49029079|NCT02039908|157942515|FG003|Phase 2-School Year|Withdrawal by Subject|5|||
49029080|NCT04720664|157943656|FG000|Overall Study|Adverse Event|2|||
49029081|NCT04720664|157943656|FG000|Overall Study|Lack of Efficacy|9|||
49029082|NCT01108094|157943658|FG000|Overall Study|Adverse Event|2|||
49029083|NCT01108094|157943659|FG001|Overall Study|Adverse Event|0|||
49029084|NCT01108094|157943660|FG002|Overall Study|Adverse Event|0|||
49029085|NCT01108094|157943661|FG003|Overall Study|Adverse Event|0|||
49029086|NCT01108094|157943658|FG000|Overall Study|Withdrawal by Subject|1|||
49029087|NCT01108094|157943659|FG001|Overall Study|Withdrawal by Subject|0|||
49029088|NCT01108094|157943660|FG002|Overall Study|Withdrawal by Subject|0|||
49029089|NCT01108094|157943661|FG003|Overall Study|Withdrawal by Subject|0|||
49029090|NCT04349917|157943668|FG000|First Intervention (2-4 Hours)|Withdrawal by Subject|0|||
49029091|NCT04349917|157943669|FG001|First Intervention (2-4 Hours)|Withdrawal by Subject|1|||
49029092|NCT04349917|157943668|FG000|First Intervention (2-4 Hours)|Unable to Swallow Pill|0|||
49029093|NCT04349917|157943669|FG001|First Intervention (2-4 Hours)|Unable to Swallow Pill|1|||
49029094|NCT04188106|157943672|FG000|Overall Study|Lost to Follow-up|5|||
49029095|NCT04188106|157943672|FG000|Overall Study|Non-Compliance|1|||
49029096|NCT00441467|157943676|FG000|Overall Study|Adverse Event|6|||
49029097|NCT00441467|157943676|FG000|Overall Study|Withdrawal by Subject|3|||
49029098|NCT00441467|157943676|FG000|Overall Study|Progressive disease|9|||
49029099|NCT02262377|157943677|FG000|Overall Study|Lost to Follow-up|5|||
49029100|NCT02262377|157943678|FG001|Overall Study|Lost to Follow-up|6|||
49029101|NCT02262377|157943677|FG000|Overall Study|Found ineligible after enrollment|3|||
49029102|NCT02262377|157943678|FG001|Overall Study|Found ineligible after enrollment|0|||
49029103|NCT02262377|157943677|FG000|Overall Study|Withdrawal by Subject|4|||
49029104|NCT02262377|157943678|FG001|Overall Study|Withdrawal by Subject|0|||
49029105|NCT00437658|157943682|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
49029106|NCT00437658|157943683|FG001|Treatment Period (24 Weeks)|Adverse Event|7|||
49029107|NCT00437658|157943684|FG002|Treatment Period (24 Weeks)|Adverse Event|14|||
49029108|NCT00437658|157943682|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
49029109|NCT00437658|157943683|FG001|Treatment Period (24 Weeks)|Non-compliance|1|||
48779348|NCT01696032|157034561|FG003|Overall Study|Withdrawal by Subject|2|||
48779349|NCT01696032|157034558|FG000|Overall Study|Death|14|||
48779350|NCT01696032|157034559|FG001|Overall Study|Death|4|||
48779351|NCT01696032|157034560|FG002|Overall Study|Death|43|||
48779352|NCT01696032|157034561|FG003|Overall Study|Death|18|||
49029110|NCT00437658|157943684|FG002|Treatment Period (24 Weeks)|Non-compliance|4|||
48779353|NCT01696032|157034558|FG000|Overall Study|Lost to Follow-up|0|||
49029111|NCT00437658|157943682|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|9|||
49029112|NCT00437658|157943683|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
49029113|NCT00437658|157943684|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
49029114|NCT00437658|157943682|FG000|Treatment Period (24 Weeks)|Lack of Efficacy|4|||
49029115|NCT00437658|157943683|FG001|Treatment Period (24 Weeks)|Lack of Efficacy|2|||
49029116|NCT00437658|157943684|FG002|Treatment Period (24 Weeks)|Lack of Efficacy|3|||
48779354|NCT01696032|157034559|FG001|Overall Study|Lost to Follow-up|1|||
48779355|NCT01696032|157034560|FG002|Overall Study|Lost to Follow-up|0|||
48779356|NCT01696032|157034561|FG003|Overall Study|Lost to Follow-up|0|||
48779357|NCT01696032|157034558|FG000|Overall Study|Database lock|0|||
48779358|NCT01696032|157034559|FG001|Overall Study|Database lock|1|||
48779359|NCT01696032|157034560|FG002|Overall Study|Database lock|7|||
48779360|NCT01696032|157034561|FG003|Overall Study|Database lock|2|||
48779361|NCT02486406|157034562|FG000|Overall Study|Withdrew consent|1|||
48779362|NCT02486406|157034563|FG001|Overall Study|Withdrew consent|0|||
48779363|NCT02486406|157034564|FG002|Overall Study|Withdrew consent|0|||
48779364|NCT02486406|157034565|FG003|Overall Study|Withdrew consent|1|||
48779365|NCT02486406|157034562|FG000|Overall Study|Lost to Follow-up|1|||
48779366|NCT02486406|157034563|FG001|Overall Study|Lost to Follow-up|3|||
48779367|NCT02486406|157034564|FG002|Overall Study|Lost to Follow-up|1|||
48779368|NCT02486406|157034565|FG003|Overall Study|Lost to Follow-up|3|||
48779369|NCT02486406|157034562|FG000|Overall Study|Other, not specified|0|||
48779370|NCT02486406|157034563|FG001|Overall Study|Other, not specified|0|||
48779371|NCT02486406|157034564|FG002|Overall Study|Other, not specified|1|||
48779372|NCT02486406|157034565|FG003|Overall Study|Other, not specified|0|||
48779373|NCT01826825|157034566|FG000|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0|||
48779374|NCT01826825|157034567|FG001|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2|||
48779375|NCT00142909|157034568|FG000|Randomization|Various Reasons|7|||
48779376|NCT00142909|157034569|FG001|Randomization|Various Reasons|10|||
48779377|NCT00142909|157034568|FG000|Medications Begin|Protocol Violation|2|||
48779378|NCT00142909|157034569|FG001|Medications Begin|Protocol Violation|0|||
48779379|NCT00142909|157034568|FG000|Medications Begin|Withdrawal by Subject|5|||
48779380|NCT00142909|157034569|FG001|Medications Begin|Withdrawal by Subject|3|||
48779381|NCT00142909|157034568|FG000|Medications Begin|Withdrawal by Subject|2|||
48779382|NCT00142909|157034569|FG001|Medications Begin|Withdrawal by Subject|0|||
48779383|NCT02158039|157034570|FG000|Overall Study|Withdrawal by Subject|1|||
48779384|NCT02158039|157034570|FG000|Overall Study|Screen Failure|9|||
48779385|NCT03062891|157034579|FG000|Overall Study|Withdrawal by Subject|2|||
48779386|NCT03062891|157034580|FG001|Overall Study|Withdrawal by Subject|0|||
48779387|NCT03062891|157034579|FG000|Overall Study|Lost to Follow-up|50|||
48779388|NCT03062891|157034580|FG001|Overall Study|Lost to Follow-up|38|||
48779389|NCT02052466|157034584|FG000|Overall Study|Withdrawal by Subject|1|||
48779390|NCT02052466|157034584|FG000|Overall Study|Acromial fracture|1|||
48779391|NCT04666441|157034585|FG000|Overall Study|Lost to Follow-up|1|||
48779392|NCT04666441|157034586|FG001|Overall Study|Lost to Follow-up|4|||
48779393|NCT04666441|157034587|FG002|Overall Study|Lost to Follow-up|1|||
48779394|NCT04666441|157034588|FG003|Overall Study|Lost to Follow-up|3|||
48779395|NCT04666441|157034589|FG004|Overall Study|Lost to Follow-up|0|||
48779396|NCT04666441|157034590|FG005|Overall Study|Lost to Follow-up|2|||
48779397|NCT04666441|157034591|FG006|Overall Study|Lost to Follow-up|2|||
48779398|NCT04666441|157034592|FG007|Overall Study|Lost to Follow-up|2|||
48779399|NCT04666441|157034585|FG000|Overall Study|Subject Decision|1|||
48779400|NCT04666441|157034586|FG001|Overall Study|Subject Decision|1|||
48779401|NCT04666441|157034587|FG002|Overall Study|Subject Decision|3|||
48779402|NCT04666441|157034588|FG003|Overall Study|Subject Decision|1|||
48779403|NCT04666441|157034589|FG004|Overall Study|Subject Decision|0|||
48779404|NCT04666441|157034590|FG005|Overall Study|Subject Decision|1|||
48779405|NCT04666441|157034591|FG006|Overall Study|Subject Decision|3|||
48779406|NCT04666441|157034592|FG007|Overall Study|Subject Decision|2|||
48779407|NCT00965848|157034593|FG000|Overall Study|Protocol Violation|3|||
48779408|NCT00965848|157034594|FG001|Overall Study|Protocol Violation|0|||
48779409|NCT00965848|157034595|FG002|Overall Study|Protocol Violation|1|||
48779410|NCT00965848|157034593|FG000|Overall Study|Death|11|||
48779411|NCT00965848|157034594|FG001|Overall Study|Death|1|||
48779412|NCT00965848|157034595|FG002|Overall Study|Death|5|||
48779413|NCT00965848|157034593|FG000|Overall Study|Lost to Follow-up|0|||
48779414|NCT00965848|157034594|FG001|Overall Study|Lost to Follow-up|0|||
48779415|NCT00965848|157034595|FG002|Overall Study|Lost to Follow-up|1|||
48779416|NCT00965848|157034593|FG000|Overall Study|Withdrawal by Subject|1|||
48779417|NCT00965848|157034594|FG001|Overall Study|Withdrawal by Subject|0|||
48779418|NCT00965848|157034595|FG002|Overall Study|Withdrawal by Subject|0|||
48779419|NCT00965848|157034593|FG000|Overall Study|Indeterminate Clinical Outcome|2|||
48779420|NCT00965848|157034594|FG001|Overall Study|Indeterminate Clinical Outcome|0|||
48779421|NCT00965848|157034595|FG002|Overall Study|Indeterminate Clinical Outcome|1|||
48779422|NCT00965848|157034593|FG000|Overall Study|Not Clinically Evaluable|7|||
48779423|NCT00965848|157034594|FG001|Overall Study|Not Clinically Evaluable|1|||
48779424|NCT00965848|157034595|FG002|Overall Study|Not Clinically Evaluable|1|||
48779425|NCT00965848|157034593|FG000|Overall Study|Other|5|||
48779426|NCT00965848|157034594|FG001|Overall Study|Other|0|||
48779427|NCT00965848|157034595|FG002|Overall Study|Other|1|||
48779428|NCT03149328|157034596|FG000|Overall Study|Withdrawal by Subject|30|||
48779429|NCT03149328|157034597|FG001|Overall Study|Withdrawal by Subject|26|||
48779430|NCT03149328|157034596|FG000|Overall Study|Changed Dialysis Modality|18|||
48779431|NCT03149328|157034597|FG001|Overall Study|Changed Dialysis Modality|1|||
48779432|NCT03149328|157034596|FG000|Overall Study|Transplant|9|||
48779433|NCT03149328|157034597|FG001|Overall Study|Transplant|1|||
48779434|NCT03149328|157034596|FG000|Overall Study|Lost to Follow-up|25|||
48779435|NCT03149328|157034597|FG001|Overall Study|Lost to Follow-up|16|||
48779436|NCT03149328|157034596|FG000|Overall Study|Left Study Site|1|||
48779437|NCT03149328|157034597|FG001|Overall Study|Left Study Site|2|||
48779438|NCT03149328|157034596|FG000|Overall Study|Language Barrier|1|||
48779439|NCT03149328|157034597|FG001|Overall Study|Language Barrier|0|||
48779440|NCT00927927|157034598|FG000|Overall Study|Withdrawal by Subject|0|||
48779441|NCT00927927|157034599|FG001|Overall Study|Withdrawal by Subject|0|||
48779442|NCT00927927|157034600|FG002|Overall Study|Withdrawal by Subject|0|||
48779443|NCT00927927|157034601|FG003|Overall Study|Withdrawal by Subject|0|||
48779444|NCT00927927|157034602|FG004|Overall Study|Withdrawal by Subject|0|||
48779445|NCT00927927|157034603|FG005|Overall Study|Withdrawal by Subject|0|||
48779446|NCT00927927|157034604|FG006|Overall Study|Withdrawal by Subject|0|||
48779447|NCT00927927|157034605|FG007|Overall Study|Withdrawal by Subject|2|||
48779448|NCT00927927|157034606|FG008|Overall Study|Withdrawal by Subject|0|||
48779449|NCT00927927|157034607|FG009|Overall Study|Withdrawal by Subject|0|||
48779450|NCT00927927|157034608|FG010|Overall Study|Withdrawal by Subject|0|||
48779451|NCT00927927|157034609|FG011|Overall Study|Withdrawal by Subject|2|||
48779452|NCT00927927|157034610|FG012|Overall Study|Withdrawal by Subject|0|||
48779453|NCT00927927|157034611|FG013|Overall Study|Withdrawal by Subject|0|||
48779454|NCT00927927|157034612|FG014|Overall Study|Withdrawal by Subject|0|||
48779455|NCT03403634|157034613|FG000|Overall Study|Disease progression|3|||
48779456|NCT03403634|157034613|FG000|Overall Study|Did not meet eligibility criteria|4|||
48779457|NCT01431508|157034615|FG000|Overall Study|Lack of Efficacy|1|||
48779458|NCT01431508|157034615|FG000|Overall Study|Unable to Follow Protocol Procedures|1|||
48779459|NCT01337245|157034621|FG000|Overall Study|Lost to Follow-up|1|||
48779460|NCT01884350|157034622|FG000|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17|||
48779461|NCT01884350|157034623|FG001|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20|||
48779462|NCT01884350|157034624|FG002|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0|||
48779463|NCT01884350|157034622|FG000|Primary Efficacy Analysis Set (24 Weeks)|Death|6|||
48779464|NCT01884350|157034623|FG001|Primary Efficacy Analysis Set (24 Weeks)|Death|4|||
48779465|NCT01884350|157034624|FG002|Primary Efficacy Analysis Set (24 Weeks)|Death|0|||
48779466|NCT01884350|157034622|FG000|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
48779467|NCT01884350|157034623|FG001|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1|||
48779468|NCT01884350|157034624|FG002|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
48779469|NCT01884350|157034622|FG000|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7|||
48779470|NCT01884350|157034623|FG001|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6|||
48779471|NCT01884350|157034624|FG002|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0|||
48779472|NCT01884350|157034622|FG000|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15|||
48779473|NCT01884350|157034623|FG001|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11|||
48779474|NCT01884350|157034624|FG002|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0|||
48779475|NCT01884350|157034622|FG000|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
48779476|NCT01884350|157034623|FG001|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2|||
48779477|NCT01884350|157034624|FG002|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
48779478|NCT01884350|157034622|FG000|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2|||
48779479|NCT01884350|157034623|FG001|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5|||
48779480|NCT01884350|157034624|FG002|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0|||
48779481|NCT01884350|157034622|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2|||
48779482|NCT01884350|157034623|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
48779483|NCT01884350|157034624|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
48779484|NCT01884350|157034622|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
48779485|NCT01884350|157034623|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
48779486|NCT01884350|157034624|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0|||
48779487|NCT01884350|157034622|FG000|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
48779488|NCT01884350|157034623|FG001|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
48779489|NCT01884350|157034624|FG002|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0|||
48779490|NCT01884350|157034622|FG000|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
48779491|NCT01884350|157034623|FG001|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
48779492|NCT01884350|157034624|FG002|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0|||
48779493|NCT01884350|157034622|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21|||
48779494|NCT01884350|157034623|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0|||
48779495|NCT01884350|157034624|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2|||
48779496|NCT01884350|157034622|FG000|Primary Efficacy Analysis Set (48 Weeks)|Death|7|||
48779497|NCT01884350|157034623|FG001|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
48779498|NCT01884350|157034624|FG002|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
48779499|NCT01884350|157034622|FG000|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
48779500|NCT01884350|157034623|FG001|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0|||
48779501|NCT01884350|157034624|FG002|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
48779502|NCT01884350|157034622|FG000|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17|||
48779503|NCT01884350|157034623|FG001|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6|||
48779504|NCT01884350|157034624|FG002|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3|||
48779505|NCT01884350|157034622|FG000|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17|||
48779506|NCT01884350|157034623|FG001|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3|||
48779507|NCT01884350|157034624|FG002|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0|||
48779508|NCT01884350|157034622|FG000|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3|||
48779509|NCT01884350|157034623|FG001|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0|||
48779510|NCT01884350|157034624|FG002|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2|||
48779511|NCT01884350|157034622|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4|||
48779512|NCT01884350|157034623|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
48779513|NCT01884350|157034624|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
48779514|NCT01884350|157034622|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3|||
48779515|NCT01884350|157034623|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
48779516|NCT01884350|157034624|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
48779517|NCT01884350|157034622|FG000|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4|||
48779518|NCT01884350|157034623|FG001|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1|||
48779519|NCT01884350|157034624|FG002|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0|||
48779520|NCT01884350|157034622|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1|||
48779521|NCT01884350|157034623|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
48779522|NCT01884350|157034624|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
48779523|NCT01884350|157034622|FG000|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2|||
48779524|NCT01884350|157034623|FG001|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
48779525|NCT01884350|157034624|FG002|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
48779526|NCT00363766|157034629|FG000|Overall Study|Progressive Disease|15|||
48779527|NCT00363766|157034630|FG001|Overall Study|Progressive Disease|9|||
48779528|NCT00363766|157034629|FG000|Overall Study|Adverse Event|10|||
48779529|NCT00363766|157034630|FG001|Overall Study|Adverse Event|2|||
48779530|NCT00363766|157034629|FG000|Overall Study|Disease Related Death|1|||
48779531|NCT00363766|157034630|FG001|Overall Study|Disease Related Death|3|||
48779532|NCT00363766|157034629|FG000|Overall Study|Not Disease Related Death|3|||
48779533|NCT00363766|157034630|FG001|Overall Study|Not Disease Related Death|4|||
48779534|NCT00363766|157034629|FG000|Overall Study|Withdrawal by Subject|2|||
48779535|NCT00363766|157034630|FG001|Overall Study|Withdrawal by Subject|0|||
48779536|NCT00363766|157034629|FG000|Overall Study|Physician Decision|1|||
48779537|NCT00363766|157034630|FG001|Overall Study|Physician Decision|2|||
48779538|NCT03120624|157034631|FG000|Overall Study|Withdrawal by Subject|0|||
48779539|NCT03120624|157034632|FG001|Overall Study|Withdrawal by Subject|1|||
48779540|NCT03120624|157034633|FG002|Overall Study|Withdrawal by Subject|0|||
48779541|NCT03120624|157034634|FG003|Overall Study|Withdrawal by Subject|0|||
48779542|NCT03120624|157034635|FG004|Overall Study|Withdrawal by Subject|0|||
48779543|NCT03120624|157034636|FG005|Overall Study|Withdrawal by Subject|0|||
48779544|NCT03120624|157034637|FG006|Overall Study|Withdrawal by Subject|0|||
48779545|NCT03120624|157034638|FG007|Overall Study|Withdrawal by Subject|0|||
48779546|NCT00608829|157036374|FG000|Overall Study|Death|6|||
48779547|NCT00608829|157036374|FG000|Overall Study|Withdrawal by Subject|4|||
48779548|NCT00608829|157036374|FG000|Overall Study|Subject refuses to follow up or return.|5|||
48982723|NCT02531633|157769865|FG004|Part A (52 Weeks)|Withdrawal by Subject|3|||
48982724|NCT02531633|157769866|FG005|Part A (52 Weeks)|Withdrawal by Subject|0|||
48982725|NCT02531633|157769867|FG006|Part A (52 Weeks)|Withdrawal by Subject|0|||
48982726|NCT02531633|157769868|FG007|Part A (52 Weeks)|Withdrawal by Subject|0|||
48982727|NCT02531633|157769869|FG008|Part A (52 Weeks)|Withdrawal by Subject|0|||
48982728|NCT02531633|157769870|FG009|Part A (52 Weeks)|Withdrawal by Subject|0|||
48982729|NCT02531633|157769861|FG000|Part A (52 Weeks)|Other|2|||
48982730|NCT02531633|157769862|FG001|Part A (52 Weeks)|Other|0|||
48982731|NCT02531633|157769863|FG002|Part A (52 Weeks)|Other|0|||
48982732|NCT02531633|157769864|FG003|Part A (52 Weeks)|Other|0|||
48982733|NCT02531633|157769865|FG004|Part A (52 Weeks)|Other|0|||
48982734|NCT02531633|157769866|FG005|Part A (52 Weeks)|Other|0|||
48982735|NCT02531633|157769867|FG006|Part A (52 Weeks)|Other|0|||
48982736|NCT02531633|157769868|FG007|Part A (52 Weeks)|Other|0|||
48982737|NCT02531633|157769869|FG008|Part A (52 Weeks)|Other|0|||
48982738|NCT02531633|157769870|FG009|Part A (52 Weeks)|Other|0|||
48982739|NCT02531633|157769861|FG000|Part B (104 Weeks)|Sponsor request|0|||
48982740|NCT02531633|157769862|FG001|Part B (104 Weeks)|Sponsor request|0|||
48982741|NCT02531633|157769863|FG002|Part B (104 Weeks)|Sponsor request|0|||
48982742|NCT02531633|157769864|FG003|Part B (104 Weeks)|Sponsor request|0|||
48982743|NCT02531633|157769865|FG004|Part B (104 Weeks)|Sponsor request|0|||
48779549|NCT01607905|157036377|FG000|Overall Study|Withdrawal by participant|7|||
48779550|NCT01607905|157036378|FG001|Overall Study|Withdrawal by participant|2|||
48779551|NCT01607905|157036379|FG002|Overall Study|Withdrawal by participant|4|||
48779552|NCT01607905|157036380|FG003|Overall Study|Withdrawal by participant|6|||
48779553|NCT01607905|157036381|FG004|Overall Study|Withdrawal by participant|0|||
49029117|NCT00437658|157943682|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
49029118|NCT00437658|157943683|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|4|||
49029119|NCT00437658|157943684|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
49029120|NCT00437658|157943682|FG000|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5|||
49029121|NCT00437658|157943683|FG001|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
49029122|NCT00437658|157943684|FG002|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
49029123|NCT00437658|157943682|FG000|Post-treatment Period (24 Weeks)|Adverse Event|1|||
49029124|NCT00437658|157943683|FG001|Post-treatment Period (24 Weeks)|Adverse Event|0|||
49029125|NCT00437658|157943684|FG002|Post-treatment Period (24 Weeks)|Adverse Event|1|||
49029126|NCT00437658|157943682|FG000|Post-treatment Period (24 Weeks)|Non-compliance|3|||
49029127|NCT00437658|157943683|FG001|Post-treatment Period (24 Weeks)|Non-compliance|0|||
49029128|NCT00437658|157943684|FG002|Post-treatment Period (24 Weeks)|Non-compliance|1|||
49029129|NCT00437658|157943682|FG000|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12|||
49029130|NCT00437658|157943683|FG001|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6|||
49029131|NCT00437658|157943684|FG002|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8|||
49029132|NCT00437658|157943682|FG000|Post-treatment Period (24 Weeks)|Lack of Efficacy|0|||
49029133|NCT00437658|157943683|FG001|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
49029134|NCT00437658|157943684|FG002|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
49029135|NCT00437658|157943682|FG000|Post-treatment Period (24 Weeks)|Lost to Follow-up|5|||
49029136|NCT00437658|157943683|FG001|Post-treatment Period (24 Weeks)|Lost to Follow-up|0|||
49029137|NCT00437658|157943684|FG002|Post-treatment Period (24 Weeks)|Lost to Follow-up|1|||
49029138|NCT00437658|157943682|FG000|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3|||
49029139|NCT00437658|157943683|FG001|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
48779554|NCT01607905|157036382|FG005|Overall Study|Withdrawal by participant|4|||
48779555|NCT01607905|157036383|FG006|Overall Study|Withdrawal by participant|12|||
48779556|NCT01607905|157036377|FG000|Overall Study|Incidence or severity of AEs|5|||
48779557|NCT01607905|157036378|FG001|Overall Study|Incidence or severity of AEs|1|||
48779558|NCT01607905|157036379|FG002|Overall Study|Incidence or severity of AEs|1|||
48779559|NCT01607905|157036380|FG003|Overall Study|Incidence or severity of AEs|3|||
48779560|NCT01607905|157036381|FG004|Overall Study|Incidence or severity of AEs|0|||
48779561|NCT01607905|157036382|FG005|Overall Study|Incidence or severity of AEs|2|||
48779562|NCT01607905|157036383|FG006|Overall Study|Incidence or severity of AEs|8|||
48779563|NCT01607905|157036377|FG000|Overall Study|Disease progression|44|||
48779564|NCT01607905|157036378|FG001|Overall Study|Disease progression|16|||
48779565|NCT01607905|157036379|FG002|Overall Study|Disease progression|15|||
48779566|NCT01607905|157036380|FG003|Overall Study|Disease progression|11|||
48779567|NCT01607905|157036381|FG004|Overall Study|Disease progression|6|||
48779568|NCT01607905|157036382|FG005|Overall Study|Disease progression|7|||
48779569|NCT01607905|157036383|FG006|Overall Study|Disease progression|21|||
48779570|NCT01607905|157036377|FG000|Overall Study|Non-compliance with study procedures|0|||
48779571|NCT01607905|157036378|FG001|Overall Study|Non-compliance with study procedures|0|||
48779572|NCT01607905|157036379|FG002|Overall Study|Non-compliance with study procedures|0|||
48779573|NCT01607905|157036380|FG003|Overall Study|Non-compliance with study procedures|0|||
48779574|NCT01607905|157036381|FG004|Overall Study|Non-compliance with study procedures|0|||
48779575|NCT01607905|157036382|FG005|Overall Study|Non-compliance with study procedures|0|||
48779576|NCT01607905|157036383|FG006|Overall Study|Non-compliance with study procedures|1|||
48779577|NCT01607905|157036377|FG000|Overall Study|Death|1|||
48779578|NCT01607905|157036378|FG001|Overall Study|Death|1|||
48779579|NCT01607905|157036379|FG002|Overall Study|Death|1|||
48779580|NCT01607905|157036380|FG003|Overall Study|Death|1|||
48779581|NCT01607905|157036381|FG004|Overall Study|Death|0|||
48779582|NCT01607905|157036382|FG005|Overall Study|Death|0|||
48779583|NCT01607905|157036383|FG006|Overall Study|Death|3|||
48779584|NCT01607905|157036377|FG000|Overall Study|Other treatments become available|1|||
49029140|NCT00437658|157943684|FG002|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
49029141|NCT02152566|157943692|FG000|Overall Study|Lost to Follow-up|1|||
49029142|NCT02152566|157943692|FG000|Overall Study|Withdrawal by Subject|2|||
49029143|NCT02495857|157943696|FG000|Overall Study|Adverse Event|5|||
48779585|NCT01607905|157036378|FG001|Overall Study|Other treatments become available|0|||
48779586|NCT01607905|157036379|FG002|Overall Study|Other treatments become available|0|||
48779587|NCT01607905|157036380|FG003|Overall Study|Other treatments become available|0|||
48779588|NCT01607905|157036381|FG004|Overall Study|Other treatments become available|0|||
48779589|NCT01607905|157036382|FG005|Overall Study|Other treatments become available|0|||
48779590|NCT01607905|157036383|FG006|Overall Study|Other treatments become available|1|||
48779591|NCT01607905|157036377|FG000|Overall Study|Investigator discretion|0|||
48779592|NCT01607905|157036378|FG001|Overall Study|Investigator discretion|0|||
48779593|NCT01607905|157036379|FG002|Overall Study|Investigator discretion|0|||
48779594|NCT01607905|157036380|FG003|Overall Study|Investigator discretion|0|||
48779595|NCT01607905|157036381|FG004|Overall Study|Investigator discretion|0|||
48779596|NCT01607905|157036382|FG005|Overall Study|Investigator discretion|1|||
48779597|NCT01607905|157036383|FG006|Overall Study|Investigator discretion|0|||
48779598|NCT01607905|157036377|FG000|Overall Study|Other|1|||
48779599|NCT01607905|157036378|FG001|Overall Study|Other|0|||
48779600|NCT01607905|157036379|FG002|Overall Study|Other|0|||
48779601|NCT01607905|157036380|FG003|Overall Study|Other|0|||
48779602|NCT01607905|157036381|FG004|Overall Study|Other|0|||
48779603|NCT01607905|157036382|FG005|Overall Study|Other|0|||
48779604|NCT01607905|157036383|FG006|Overall Study|Other|1|||
48779605|NCT01607905|157036377|FG000|Overall Study|Randomized but not treated|1|||
48779606|NCT01607905|157036378|FG001|Overall Study|Randomized but not treated|0|||
48779607|NCT01607905|157036379|FG002|Overall Study|Randomized but not treated|0|||
48779608|NCT01607905|157036380|FG003|Overall Study|Randomized but not treated|0|||
48779609|NCT01607905|157036381|FG004|Overall Study|Randomized but not treated|1|||
48779610|NCT01607905|157036382|FG005|Overall Study|Randomized but not treated|1|||
48877200|NCT03635086|157388573|FG001|Overall Study|Withdrawal of consent|0|||
48877201|NCT03635086|157388574|FG002|Overall Study|Withdrawal of consent|1|||
48877202|NCT03635086|157388575|FG003|Overall Study|Withdrawal of consent|0|||
48877203|NCT03635086|157388576|FG004|Overall Study|Withdrawal of consent|0|||
48877204|NCT03635086|157388572|FG000|Overall Study|Adverse Event|0|||
48877205|NCT03635086|157388573|FG001|Overall Study|Adverse Event|1|||
48877206|NCT03635086|157388574|FG002|Overall Study|Adverse Event|0|||
49029144|NCT02495857|157943697|FG001|Overall Study|Adverse Event|0|||
49029145|NCT02495857|157943698|FG002|Overall Study|Adverse Event|1|||
48877207|NCT03635086|157388575|FG003|Overall Study|Adverse Event|0|||
48877208|NCT03635086|157388576|FG004|Overall Study|Adverse Event|0|||
48877209|NCT03635086|157388572|FG000|Overall Study|Lost to Follow-up|1|||
48877210|NCT03635086|157388573|FG001|Overall Study|Lost to Follow-up|0|||
48877211|NCT03635086|157388574|FG002|Overall Study|Lost to Follow-up|0|||
48877212|NCT03635086|157388575|FG003|Overall Study|Lost to Follow-up|0|||
48877213|NCT03635086|157388576|FG004|Overall Study|Lost to Follow-up|0|||
48877214|NCT02872012|157388577|FG000|Overall Study|Withdrawal by Subject|1|||
48877215|NCT02872012|157388578|FG001|Overall Study|Withdrawal by Subject|0|||
48877216|NCT02872012|157388579|FG002|Overall Study|Withdrawal by Subject|0|||
48877217|NCT02872012|157388580|FG003|Overall Study|Withdrawal by Subject|0|||
48877218|NCT02872012|157388581|FG004|Overall Study|Withdrawal by Subject|0|||
48877219|NCT03443414|157388582|FG000|Overall Study|Adverse Event|6|||
48877220|NCT03443414|157388583|FG001|Overall Study|Adverse Event|0|||
48877221|NCT03443414|157388584|FG002|Overall Study|Adverse Event|4|||
48877222|NCT03443414|157388585|FG003|Overall Study|Adverse Event|2|||
48877223|NCT03443414|157388586|FG004|Overall Study|Adverse Event|3|||
49029146|NCT02495857|157943696|FG000|Overall Study|Withdrawal by Subject|9|||
49029147|NCT02495857|157943697|FG001|Overall Study|Withdrawal by Subject|6|||
49029148|NCT02495857|157943698|FG002|Overall Study|Withdrawal by Subject|10|||
49029149|NCT02495857|157943696|FG000|Overall Study|Physician Decision|0|||
49029150|NCT02495857|157943697|FG001|Overall Study|Physician Decision|1|||
49029151|NCT02495857|157943698|FG002|Overall Study|Physician Decision|0|||
49029152|NCT02495857|157943696|FG000|Overall Study|Protocol Violation|1|||
49029153|NCT02495857|157943697|FG001|Overall Study|Protocol Violation|1|||
49029154|NCT02495857|157943698|FG002|Overall Study|Protocol Violation|2|||
49029155|NCT02495857|157943696|FG000|Overall Study|Lost to Follow-up|4|||
49029156|NCT02495857|157943697|FG001|Overall Study|Lost to Follow-up|5|||
49029157|NCT02495857|157943698|FG002|Overall Study|Lost to Follow-up|3|||
49029158|NCT02495857|157943696|FG000|Overall Study|Other|3|||
49029159|NCT02495857|157943697|FG001|Overall Study|Other|3|||
49029160|NCT02495857|157943698|FG002|Overall Study|Other|2|||
49029161|NCT00667095|157943701|FG000|Overall Study|Withdrawal by Subject|0|||
49029162|NCT00667095|157943702|FG001|Overall Study|Withdrawal by Subject|1|||
49029163|NCT04407806|157943703|FG000|Overall Study|Withdrawal by Subject|1|||
49029164|NCT04407806|157943704|FG001|Overall Study|Withdrawal by Subject|2|||
48779611|NCT01607905|157036383|FG006|Overall Study|Randomized but not treated|0|||
49029165|NCT01520909|157943705|FG000|Part 1 (Randomized Period)|Adverse Event|1|||
49029166|NCT01520909|157943706|FG001|Part 1 (Randomized Period)|Adverse Event|2|||
49029167|NCT01520909|157943707|FG002|Part 1 (Randomized Period)|Adverse Event|0|||
49029168|NCT01520909|157943705|FG000|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
48779612|NCT02602288|157036384|FG000|End of Treatment/3 Month Follow-up|Lost to Follow-up|14|||
48779613|NCT02602288|157036385|FG001|End of Treatment/3 Month Follow-up|Lost to Follow-up|10|||
48779614|NCT02602288|157036384|FG000|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
48877224|NCT03443414|157388582|FG000|Overall Study|Withdrawal by Subject|3|||
48877225|NCT03443414|157388583|FG001|Overall Study|Withdrawal by Subject|2|||
48877226|NCT03443414|157388584|FG002|Overall Study|Withdrawal by Subject|2|||
48877227|NCT03443414|157388585|FG003|Overall Study|Withdrawal by Subject|2|||
48877228|NCT03443414|157388586|FG004|Overall Study|Withdrawal by Subject|1|||
48877229|NCT03443414|157388582|FG000|Overall Study|Death|0|||
48877230|NCT03443414|157388583|FG001|Overall Study|Death|1|||
48877231|NCT03443414|157388584|FG002|Overall Study|Death|0|||
49029169|NCT01520909|157943706|FG001|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
49029170|NCT01520909|157943707|FG002|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4|||
49029171|NCT01520909|157943705|FG000|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
49029172|NCT01520909|157943706|FG001|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
48779615|NCT02602288|157036385|FG001|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
48779616|NCT02602288|157036384|FG000|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|9|||
48779617|NCT02602288|157036385|FG001|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|6|||
48779618|NCT02602288|157036384|FG000|12 Month Follow-up|Lost to Follow-up|0|||
48779619|NCT02602288|157036385|FG001|12 Month Follow-up|Lost to Follow-up|4|||
48779620|NCT02602288|157036384|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
48779621|NCT02602288|157036385|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
48779622|NCT00352534|157036390|FG000|Initial Staging|Ineligible|8|||
48779623|NCT00352534|157036391|FG001|Initial Staging|Ineligible|9|||
48779624|NCT00352534|157036392|FG002|Initial Staging|Ineligible|0|||
48779625|NCT00352534|157036393|FG003|Initial Staging|Ineligible|0|||
48779626|NCT00352534|157036394|FG004|Initial Staging|Ineligible|0|||
48779627|NCT00352534|157036395|FG005|Initial Staging|Ineligible|0|||
48779628|NCT00352534|157036396|FG006|Initial Staging|Ineligible|0|||
48779629|NCT00352534|157036390|FG000|Final Risk Group Assignment|Lack of Efficacy|0|||
48779630|NCT00352534|157036391|FG001|Final Risk Group Assignment|Lack of Efficacy|0|||
48779631|NCT00352534|157036392|FG002|Final Risk Group Assignment|Lack of Efficacy|0|||
48779632|NCT00352534|157036393|FG003|Final Risk Group Assignment|Lack of Efficacy|2|||
48779633|NCT00352534|157036394|FG004|Final Risk Group Assignment|Lack of Efficacy|1|||
48779634|NCT00352534|157036395|FG005|Final Risk Group Assignment|Lack of Efficacy|19|||
48779635|NCT00352534|157036396|FG006|Final Risk Group Assignment|Lack of Efficacy|0|||
48779636|NCT00352534|157036390|FG000|Final Risk Group Assignment|Physician Decision|0|||
48779637|NCT00352534|157036391|FG001|Final Risk Group Assignment|Physician Decision|0|||
48779638|NCT00352534|157036392|FG002|Final Risk Group Assignment|Physician Decision|0|||
48779639|NCT00352534|157036393|FG003|Final Risk Group Assignment|Physician Decision|0|||
48779640|NCT00352534|157036394|FG004|Final Risk Group Assignment|Physician Decision|0|||
48779641|NCT00352534|157036395|FG005|Final Risk Group Assignment|Physician Decision|8|||
48779642|NCT00352534|157036396|FG006|Final Risk Group Assignment|Physician Decision|0|||
48779643|NCT00352534|157036390|FG000|Final Risk Group Assignment|Withdrawal by Subject|0|||
48779644|NCT00352534|157036391|FG001|Final Risk Group Assignment|Withdrawal by Subject|0|||
48779645|NCT00352534|157036392|FG002|Final Risk Group Assignment|Withdrawal by Subject|0|||
48779646|NCT00352534|157036393|FG003|Final Risk Group Assignment|Withdrawal by Subject|0|||
48779647|NCT00352534|157036394|FG004|Final Risk Group Assignment|Withdrawal by Subject|0|||
48779648|NCT00352534|157036395|FG005|Final Risk Group Assignment|Withdrawal by Subject|3|||
48779649|NCT00352534|157036396|FG006|Final Risk Group Assignment|Withdrawal by Subject|0|||
48779650|NCT00352534|157036390|FG000|Final Risk Group Assignment|Ineligible|0|||
48779651|NCT00352534|157036391|FG001|Final Risk Group Assignment|Ineligible|0|||
48779652|NCT00352534|157036392|FG002|Final Risk Group Assignment|Ineligible|3|||
48779653|NCT00352534|157036393|FG003|Final Risk Group Assignment|Ineligible|1|||
48779654|NCT00352534|157036394|FG004|Final Risk Group Assignment|Ineligible|0|||
48779655|NCT00352534|157036395|FG005|Final Risk Group Assignment|Ineligible|13|||
48779656|NCT00352534|157036396|FG006|Final Risk Group Assignment|Ineligible|0|||
48779657|NCT00352534|157036390|FG000|Final Risk Group Assignment|Enrollment onto another COG study|0|||
48779658|NCT00352534|157036391|FG001|Final Risk Group Assignment|Enrollment onto another COG study|0|||
48779659|NCT00352534|157036392|FG002|Final Risk Group Assignment|Enrollment onto another COG study|0|||
48779660|NCT00352534|157036393|FG003|Final Risk Group Assignment|Enrollment onto another COG study|0|||
48779661|NCT00352534|157036394|FG004|Final Risk Group Assignment|Enrollment onto another COG study|0|||
48779662|NCT00352534|157036395|FG005|Final Risk Group Assignment|Enrollment onto another COG study|0|||
48779663|NCT00352534|157036396|FG006|Final Risk Group Assignment|Enrollment onto another COG study|28|||
48779664|NCT00352534|157036390|FG000|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
48779665|NCT00352534|157036391|FG001|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
48779666|NCT00352534|157036392|FG002|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
48779667|NCT00352534|157036393|FG003|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
48779668|NCT00352534|157036394|FG004|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
48877232|NCT03443414|157388585|FG003|Overall Study|Death|1|||
48877233|NCT03443414|157388586|FG004|Overall Study|Death|0|||
48877234|NCT03443414|157388582|FG000|Overall Study|Reason not specified|2|||
48779669|NCT00352534|157036395|FG005|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
48877235|NCT03443414|157388583|FG001|Overall Study|Reason not specified|0|||
48877236|NCT03443414|157388584|FG002|Overall Study|Reason not specified|0|||
49029173|NCT01520909|157943707|FG002|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2|||
48779670|NCT00352534|157036396|FG006|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11|||
48779671|NCT00352534|157036390|FG000|Final Risk Group Assignment|Death|0|||
48779672|NCT00352534|157036391|FG001|Final Risk Group Assignment|Death|0|||
48779673|NCT00352534|157036392|FG002|Final Risk Group Assignment|Death|0|||
48877237|NCT03443414|157388585|FG003|Overall Study|Reason not specified|0|||
49029174|NCT01520909|157943705|FG000|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
49029175|NCT01520909|157943706|FG001|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
49029176|NCT01520909|157943707|FG002|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1|||
49029177|NCT03447262|157943708|FG000|Overall Study|Adverse Event|7|||
49029178|NCT03447262|157943708|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
49029179|NCT03447262|157943708|FG000|Overall Study|Commercial Drug is Available for Participant|9|||
49029180|NCT03447262|157943708|FG000|Overall Study|Death|2|||
49029181|NCT03447262|157943708|FG000|Overall Study|Study Termination by Sponsor|455|||
49029182|NCT03447262|157943708|FG000|Overall Study|Other|4|||
49029183|NCT01882257|157943710|FG000|Study Origination to Beginning Therapy|Withdrawal by Subject|0|||
49029184|NCT01882257|157943711|FG001|Study Origination to Beginning Therapy|Withdrawal by Subject|2|||
49029185|NCT01882257|157943712|FG002|Study Origination to Beginning Therapy|Withdrawal by Subject|1|||
49029186|NCT01882257|157943710|FG000|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0|||
49029187|NCT01882257|157943711|FG001|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11|||
48779674|NCT00352534|157036393|FG003|Final Risk Group Assignment|Death|0|||
48779675|NCT00352534|157036394|FG004|Final Risk Group Assignment|Death|0|||
48779676|NCT00352534|157036395|FG005|Final Risk Group Assignment|Death|2|||
48779677|NCT00352534|157036396|FG006|Final Risk Group Assignment|Death|0|||
48779678|NCT00924950|157036397|FG000|Overall Study|Lost to Follow-up|2|||
48779679|NCT01075321|157036398|FG000|Overall Study|Withdrawal by Subject|0|||
48779680|NCT01075321|157036399|FG001|Overall Study|Withdrawal by Subject|0|||
48779681|NCT01075321|157036400|FG002|Overall Study|Withdrawal by Subject|1|||
48779682|NCT01075321|157036401|FG003|Overall Study|Withdrawal by Subject|1|||
48779683|NCT01075321|157036398|FG000|Overall Study|Protocol Violation|0|||
48779684|NCT01075321|157036399|FG001|Overall Study|Protocol Violation|0|||
48779685|NCT01075321|157036400|FG002|Overall Study|Protocol Violation|1|||
48779686|NCT01075321|157036401|FG003|Overall Study|Protocol Violation|0|||
48779687|NCT01075321|157036398|FG000|Overall Study|Treatment Incomplete due to progression|1|||
48779688|NCT01075321|157036399|FG001|Overall Study|Treatment Incomplete due to progression|0|||
48779689|NCT01075321|157036400|FG002|Overall Study|Treatment Incomplete due to progression|0|||
48779690|NCT01075321|157036401|FG003|Overall Study|Treatment Incomplete due to progression|0|||
48779691|NCT01075321|157036398|FG000|Overall Study|Ineligible (miscalculated lab value)|0|||
48779692|NCT01075321|157036399|FG001|Overall Study|Ineligible (miscalculated lab value)|0|||
48779693|NCT01075321|157036400|FG002|Overall Study|Ineligible (miscalculated lab value)|0|||
48779694|NCT01075321|157036401|FG003|Overall Study|Ineligible (miscalculated lab value)|1|||
48779695|NCT00503841|157036402|FG000|Overall Study|All screen failures|44|||
48779696|NCT02082522|157036403|FG000|Overall Study|Sponsor termination|5|||
48779697|NCT02082522|157036404|FG001|Overall Study|Sponsor termination|3|||
48779698|NCT02082522|157036403|FG000|Overall Study|Withdrawal by Subject|2|||
48779699|NCT02082522|157036404|FG001|Overall Study|Withdrawal by Subject|4|||
48779700|NCT02082522|157036403|FG000|Overall Study|Death|1|||
48779701|NCT02082522|157036404|FG001|Overall Study|Death|0|||
48779702|NCT02082522|157036403|FG000|Overall Study|Lost to Follow-up|1|||
48779703|NCT02082522|157036404|FG001|Overall Study|Lost to Follow-up|0|||
48779704|NCT02082522|157036403|FG000|Overall Study|Physician Decision|3|||
48779705|NCT02082522|157036404|FG001|Overall Study|Physician Decision|1|||
48779706|NCT02082522|157036403|FG000|Overall Study|Disease progression|2|||
48779707|NCT02082522|157036404|FG001|Overall Study|Disease progression|2|||
48779708|NCT02082522|157036403|FG000|Overall Study|Chemotherapy change|1|||
48779709|NCT02082522|157036404|FG001|Overall Study|Chemotherapy change|3|||
48779710|NCT01575561|157036407|FG000|Overall Study|Adverse Event|9|||
48779711|NCT01575561|157036407|FG000|Overall Study|Lack of Efficacy|8|||
48779712|NCT01575561|157036407|FG000|Overall Study|Lost to Follow-up|6|||
48779713|NCT01575561|157036407|FG000|Overall Study|Protocol Violation|4|||
48779714|NCT01575561|157036407|FG000|Overall Study|Withdrawal by Subject|11|||
48779715|NCT01575561|157036407|FG000|Overall Study|administration|1|||
48779716|NCT01175382|157036408|FG000|Overall Study|Lost to Follow-up|4|||
49029188|NCT01882257|157943712|FG002|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4|||
49029189|NCT00830206|157943714|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
49029190|NCT00830206|157943715|FG001|Washout: 21 Days|Withdrawal by Subject|1|||
49029191|NCT01866319|157943718|FG000|Overall Study|Adverse Event|12|||
49029192|NCT01866319|157943719|FG001|Overall Study|Adverse Event|5|||
49029193|NCT01866319|157943720|FG002|Overall Study|Adverse Event|9|||
49029194|NCT01866319|157943718|FG000|Overall Study|Clinical progression|3|||
49029195|NCT01866319|157943719|FG001|Overall Study|Clinical progression|2|||
48779717|NCT01175382|157036409|FG001|Overall Study|Lost to Follow-up|3|||
48779718|NCT01175382|157036410|FG002|Overall Study|Lost to Follow-up|1|||
48779719|NCT01175382|157036408|FG000|Overall Study|Physician Decision|0|||
48779720|NCT01175382|157036409|FG001|Overall Study|Physician Decision|1|||
48779721|NCT01175382|157036410|FG002|Overall Study|Physician Decision|0|||
48779722|NCT01175382|157036408|FG000|Overall Study|Withdrawal by Subject|0|||
48779723|NCT01175382|157036409|FG001|Overall Study|Withdrawal by Subject|0|||
48779724|NCT01175382|157036410|FG002|Overall Study|Withdrawal by Subject|1|||
48779725|NCT01175382|157036408|FG000|Overall Study|No longer having problem|1|||
48779726|NCT01175382|157036409|FG001|Overall Study|No longer having problem|0|||
48779727|NCT01175382|157036410|FG002|Overall Study|No longer having problem|1|||
48779728|NCT01175382|157036408|FG000|Overall Study|Unable/unwilling to attend visits|3|||
48779729|NCT01175382|157036409|FG001|Overall Study|Unable/unwilling to attend visits|1|||
48779730|NCT01175382|157036410|FG002|Overall Study|Unable/unwilling to attend visits|2|||
48779731|NCT01175382|157036408|FG000|Overall Study|Unwilling to follow protocol|0|||
48779732|NCT01175382|157036409|FG001|Overall Study|Unwilling to follow protocol|1|||
48779733|NCT01175382|157036410|FG002|Overall Study|Unwilling to follow protocol|0|||
48779734|NCT01175382|157036408|FG000|Overall Study|Unable to tolerate study meds|0|||
48779735|NCT01175382|157036409|FG001|Overall Study|Unable to tolerate study meds|1|||
48779736|NCT01175382|157036410|FG002|Overall Study|Unable to tolerate study meds|1|||
48779737|NCT00440271|157036411|FG000|Overall Study|Protocol Violation|1|||
48779738|NCT00440271|157036412|FG001|Overall Study|Protocol Violation|1|||
48779739|NCT00440271|157036411|FG000|Overall Study|Adverse Event|0|||
48779740|NCT00440271|157036412|FG001|Overall Study|Adverse Event|1|||
48779741|NCT00440271|157036411|FG000|Overall Study|Lost to Follow-up|1|||
48779742|NCT00440271|157036412|FG001|Overall Study|Lost to Follow-up|0|||
48779743|NCT00440271|157036411|FG000|Overall Study|Withdrawal by Subject|0|||
48779744|NCT00440271|157036412|FG001|Overall Study|Withdrawal by Subject|2|||
48779745|NCT00440271|157036411|FG000|Overall Study|Lack of Efficacy|0|||
48779746|NCT00440271|157036412|FG001|Overall Study|Lack of Efficacy|1|||
48779747|NCT00440271|157036411|FG000|Overall Study|Due to closure of trial|8|||
48779748|NCT00440271|157036412|FG001|Overall Study|Due to closure of trial|10|||
48779749|NCT00440271|157036411|FG000|Overall Study|Other|2|||
48779750|NCT00440271|157036412|FG001|Overall Study|Other|0|||
48779751|NCT00723801|157036413|FG000|Overall Study|Lost to Follow-up|1|||
48779752|NCT00723801|157036414|FG001|Overall Study|Lost to Follow-up|2|||
48779753|NCT00723801|157036413|FG000|Overall Study|Protocol Violation|2|||
48779754|NCT00723801|157036414|FG001|Overall Study|Protocol Violation|1|||
48779755|NCT00120042|157036415|FG000|Overall Study|all completed protocl|0|||
48779756|NCT00120042|157036416|FG001|Overall Study|all completed protocl|0|||
48779757|NCT00120042|157036417|FG002|Overall Study|all completed protocl|0|||
48779758|NCT00774787|157036418|FG000|Overall Study|Lost to Follow-up|1|||
48779759|NCT02554773|157036419|FG000|Original Dose Regimen (SAS 1)|Physician Decision|1|||
48779760|NCT02554773|157036420|FG001|Original Dose Regimen (SAS 1)|Physician Decision|0|||
48779761|NCT02554773|157036419|FG000|Original Dose Regimen (SAS 1)|Withdrawal by Subject|7|||
48779762|NCT02554773|157036420|FG001|Original Dose Regimen (SAS 1)|Withdrawal by Subject|0|||
48779763|NCT02554773|157036419|FG000|Original Dose Regimen (SAS 1)|Adverse Event|3|||
48779764|NCT02554773|157036420|FG001|Original Dose Regimen (SAS 1)|Adverse Event|0|||
48779765|NCT02554773|157036419|FG000|Original Dose Regimen (SAS 1)|Death|1|||
48779766|NCT02554773|157036420|FG001|Original Dose Regimen (SAS 1)|Death|0|||
48779767|NCT02554773|157036419|FG000|Original Dose Regimen (SAS 1)|Other|4|||
48779768|NCT02554773|157036420|FG001|Original Dose Regimen (SAS 1)|Other|0|||
48779769|NCT02554773|157036419|FG000|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|0|||
48779770|NCT02554773|157036420|FG001|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|1|||
48779771|NCT02554773|157036419|FG000|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|0|||
48779772|NCT02554773|157036420|FG001|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|1|||
48779773|NCT02554773|157036419|FG000|AT-Based Dose Regimen (SAS 2)|Adverse Event|0|||
48779774|NCT02554773|157036420|FG001|AT-Based Dose Regimen (SAS 2)|Adverse Event|1|||
48779775|NCT02554773|157036419|FG000|AT-Based Dose Regimen (SAS 2)|Other|0|||
48779776|NCT02554773|157036420|FG001|AT-Based Dose Regimen (SAS 2)|Other|3|||
48779777|NCT02496884|157036421|FG000|Overall Study|Counted twice as enrolled|2|||
48779778|NCT02496884|157036422|FG001|Overall Study|Counted twice as enrolled|0|||
48779779|NCT02496884|157036423|FG002|Overall Study|Counted twice as enrolled|0|||
48779780|NCT02496884|157036424|FG003|Overall Study|Counted twice as enrolled|0|||
48779781|NCT02496884|157036421|FG000|Overall Study|Withdrawal by Subject|0|||
48779782|NCT02496884|157036422|FG001|Overall Study|Withdrawal by Subject|3|||
48779783|NCT02496884|157036423|FG002|Overall Study|Withdrawal by Subject|0|||
48779784|NCT02496884|157036424|FG003|Overall Study|Withdrawal by Subject|0|||
48779785|NCT03348904|157036425|FG000|Overall Study|Administrative reason by the sponsor|0|||
48779786|NCT03348904|157036426|FG001|Overall Study|Administrative reason by the sponsor|1|||
48779787|NCT03348904|157036427|FG002|Overall Study|Administrative reason by the sponsor|0|||
48779788|NCT00097591|157036428|FG000|Overall Study|Withdrawal of consent|342|||
48779789|NCT00097591|157036429|FG001|Overall Study|Withdrawal of consent|323|||
49029196|NCT01866319|157943720|FG002|Overall Study|Clinical progression|2|||
48779790|NCT00097591|157036428|FG000|Overall Study|Less than 6 months on study drug|9|||
48779791|NCT00097591|157036429|FG001|Overall Study|Less than 6 months on study drug|7|||
48779792|NCT00097591|157036428|FG000|Overall Study|Unable to attend termination visit|53|||
48779793|NCT00097591|157036429|FG001|Overall Study|Unable to attend termination visit|51|||
48779794|NCT00097591|157036428|FG000|Overall Study|Lost to follow up|6|||
49029197|NCT01866319|157943718|FG000|Overall Study|Death|153|||
48779795|NCT00097591|157036429|FG001|Overall Study|Lost to follow up|10|||
48779796|NCT00097591|157036428|FG000|Overall Study|Other|0|||
49029198|NCT01866319|157943719|FG001|Overall Study|Death|154|||
48779797|NCT00097591|157036429|FG001|Overall Study|Other|3|||
48779798|NCT01978119|157036440|FG000|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1|||
48779799|NCT01978119|157036441|FG001|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0|||
48779800|NCT01978119|157036440|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
48779801|NCT01978119|157036441|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
48779802|NCT01978119|157036440|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
48779803|NCT01978119|157036441|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
48779804|NCT02352493|157036442|FG000|Overall Study|Pregnancy|0|||
48779805|NCT02352493|157036443|FG001|Overall Study|Pregnancy|0|||
48779806|NCT02352493|157036444|FG002|Overall Study|Pregnancy|0|||
48779807|NCT02352493|157036445|FG003|Overall Study|Pregnancy|0|||
48779808|NCT02352493|157036446|FG004|Overall Study|Pregnancy|0|||
48779809|NCT02352493|157036447|FG005|Overall Study|Pregnancy|0|||
48779810|NCT02352493|157036448|FG006|Overall Study|Pregnancy|1|||
48779811|NCT02352493|157036449|FG007|Overall Study|Pregnancy|0|||
48779812|NCT02352493|157036450|FG008|Overall Study|Pregnancy|1|||
48779813|NCT02352493|157036451|FG009|Overall Study|Pregnancy|0|||
48779814|NCT02352493|157036452|FG010|Overall Study|Pregnancy|0|||
48779815|NCT02352493|157036453|FG011|Overall Study|Pregnancy|0|||
48779816|NCT02352493|157036454|FG012|Overall Study|Pregnancy|0|||
48779817|NCT02352493|157036455|FG013|Overall Study|Pregnancy|0|||
48779818|NCT02352493|157036456|FG014|Overall Study|Pregnancy|0|||
48779819|NCT02352493|157036457|FG015|Overall Study|Pregnancy|0|||
48779820|NCT02352493|157036458|FG016|Overall Study|Pregnancy|0|||
48779821|NCT02352493|157036459|FG017|Overall Study|Pregnancy|0|||
48779822|NCT02352493|157036442|FG000|Overall Study|Withdrawal by Subject|0|||
48779823|NCT02352493|157036443|FG001|Overall Study|Withdrawal by Subject|0|||
48779824|NCT02352493|157036444|FG002|Overall Study|Withdrawal by Subject|0|||
48779825|NCT02352493|157036445|FG003|Overall Study|Withdrawal by Subject|0|||
48779826|NCT02352493|157036446|FG004|Overall Study|Withdrawal by Subject|0|||
48779827|NCT02352493|157036447|FG005|Overall Study|Withdrawal by Subject|0|||
48779828|NCT02352493|157036448|FG006|Overall Study|Withdrawal by Subject|0|||
48779829|NCT02352493|157036449|FG007|Overall Study|Withdrawal by Subject|0|||
48779830|NCT02352493|157036450|FG008|Overall Study|Withdrawal by Subject|1|||
48779831|NCT02352493|157036451|FG009|Overall Study|Withdrawal by Subject|0|||
48779832|NCT02352493|157036452|FG010|Overall Study|Withdrawal by Subject|0|||
48779833|NCT02352493|157036453|FG011|Overall Study|Withdrawal by Subject|0|||
48779834|NCT02352493|157036454|FG012|Overall Study|Withdrawal by Subject|0|||
48779835|NCT02352493|157036455|FG013|Overall Study|Withdrawal by Subject|0|||
48779836|NCT02352493|157036456|FG014|Overall Study|Withdrawal by Subject|1|||
48779837|NCT02352493|157036457|FG015|Overall Study|Withdrawal by Subject|0|||
48779838|NCT02352493|157036458|FG016|Overall Study|Withdrawal by Subject|0|||
48779839|NCT02352493|157036459|FG017|Overall Study|Withdrawal by Subject|0|||
48779840|NCT02352493|157036442|FG000|Overall Study|Lost to Follow-up|0|||
48779841|NCT02352493|157036443|FG001|Overall Study|Lost to Follow-up|0|||
48779842|NCT02352493|157036444|FG002|Overall Study|Lost to Follow-up|0|||
48779843|NCT02352493|157036445|FG003|Overall Study|Lost to Follow-up|0|||
48779844|NCT02352493|157036446|FG004|Overall Study|Lost to Follow-up|0|||
48779845|NCT02352493|157036447|FG005|Overall Study|Lost to Follow-up|0|||
48779846|NCT02352493|157036448|FG006|Overall Study|Lost to Follow-up|0|||
48779847|NCT02352493|157036449|FG007|Overall Study|Lost to Follow-up|0|||
48779848|NCT02352493|157036450|FG008|Overall Study|Lost to Follow-up|0|||
48779849|NCT02352493|157036451|FG009|Overall Study|Lost to Follow-up|1|||
48779850|NCT02352493|157036452|FG010|Overall Study|Lost to Follow-up|0|||
48779851|NCT02352493|157036453|FG011|Overall Study|Lost to Follow-up|0|||
48779852|NCT02352493|157036454|FG012|Overall Study|Lost to Follow-up|1|||
48779853|NCT02352493|157036455|FG013|Overall Study|Lost to Follow-up|2|||
48779854|NCT02352493|157036456|FG014|Overall Study|Lost to Follow-up|0|||
48779855|NCT02352493|157036457|FG015|Overall Study|Lost to Follow-up|0|||
48779856|NCT02352493|157036458|FG016|Overall Study|Lost to Follow-up|0|||
48779857|NCT02352493|157036459|FG017|Overall Study|Lost to Follow-up|0|||
49029199|NCT01866319|157943720|FG002|Overall Study|Death|147|||
49029200|NCT01866319|157943718|FG000|Overall Study|Lost to Follow-up|6|||
49029201|NCT01866319|157943719|FG001|Overall Study|Lost to Follow-up|3|||
49029202|NCT01866319|157943720|FG002|Overall Study|Lost to Follow-up|8|||
49029203|NCT01866319|157943718|FG000|Overall Study|Physician Decision|1|||
49029204|NCT01866319|157943719|FG001|Overall Study|Physician Decision|0|||
49029205|NCT01866319|157943720|FG002|Overall Study|Physician Decision|1|||
49029206|NCT01866319|157943718|FG000|Overall Study|Protocol Violation|0|||
48779858|NCT02317575|157036460|FG000|Period 1|Difficulty with venous cannulation|0|||
48779859|NCT02317575|157036461|FG001|Period 1|Difficulty with venous cannulation|1|||
48779860|NCT02317575|157036462|FG002|Period 1|Difficulty with venous cannulation|0|||
48779861|NCT02317575|157036463|FG003|Period 1|Difficulty with venous cannulation|0|||
48779862|NCT02317575|157036464|FG004|Period 1|Difficulty with venous cannulation|0|||
48779863|NCT02317575|157036460|FG000|Period 1|Withdrawal by Subject|1|||
48779864|NCT02317575|157036461|FG001|Period 1|Withdrawal by Subject|0|||
48779865|NCT02317575|157036462|FG002|Period 1|Withdrawal by Subject|0|||
48779866|NCT02317575|157036463|FG003|Period 1|Withdrawal by Subject|0|||
49029207|NCT01866319|157943719|FG001|Overall Study|Protocol Violation|0|||
48779867|NCT02317575|157036464|FG004|Period 1|Withdrawal by Subject|0|||
48779868|NCT02223390|157036465|FG000|Overall Study|Lost to Follow-up|9|||
48779869|NCT02223390|157036466|FG001|Overall Study|Lost to Follow-up|4|||
48779870|NCT01831089|157036467|FG000|Cohort I: Dose Level 1|Progressive disease|3|||
48779871|NCT01831089|157036468|FG001|Cohort I: Dose Level 1|Progressive disease|0|||
48779872|NCT01831089|157036469|FG002|Cohort I: Dose Level 1|Progressive disease|0|||
48779873|NCT01831089|157036470|FG003|Cohort I: Dose Level 1|Progressive disease|0|||
48779874|NCT01831089|157036471|FG004|Cohort I: Dose Level 1|Progressive disease|0|||
48779875|NCT01831089|157036472|FG005|Cohort I: Dose Level 1|Progressive disease|0|||
48779876|NCT01831089|157036467|FG000|Cohort II: Dose Level 2|Progressive disease|0|||
48779877|NCT01831089|157036468|FG001|Cohort II: Dose Level 2|Progressive disease|2|||
48779878|NCT01831089|157036469|FG002|Cohort II: Dose Level 2|Progressive disease|0|||
48779879|NCT01831089|157036470|FG003|Cohort II: Dose Level 2|Progressive disease|0|||
48779880|NCT01831089|157036471|FG004|Cohort II: Dose Level 2|Progressive disease|0|||
48779881|NCT01831089|157036472|FG005|Cohort II: Dose Level 2|Progressive disease|0|||
48779882|NCT01831089|157036467|FG000|Cohort II: Dose Level 2|Clinical progressive disease|0|||
48779883|NCT01831089|157036468|FG001|Cohort II: Dose Level 2|Clinical progressive disease|1|||
48779884|NCT01831089|157036469|FG002|Cohort II: Dose Level 2|Clinical progressive disease|0|||
48779885|NCT01831089|157036470|FG003|Cohort II: Dose Level 2|Clinical progressive disease|0|||
48779886|NCT01831089|157036471|FG004|Cohort II: Dose Level 2|Clinical progressive disease|0|||
48779887|NCT01831089|157036472|FG005|Cohort II: Dose Level 2|Clinical progressive disease|0|||
48779888|NCT01831089|157036467|FG000|Cohort III: Dose Level 3|Progressive disease|0|||
48779889|NCT01831089|157036468|FG001|Cohort III: Dose Level 3|Progressive disease|0|||
48779890|NCT01831089|157036469|FG002|Cohort III: Dose Level 3|Progressive disease|3|||
48779891|NCT01831089|157036470|FG003|Cohort III: Dose Level 3|Progressive disease|0|||
48779892|NCT01831089|157036471|FG004|Cohort III: Dose Level 3|Progressive disease|0|||
48779893|NCT01831089|157036472|FG005|Cohort III: Dose Level 3|Progressive disease|0|||
48779894|NCT01831089|157036467|FG000|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
48779895|NCT01831089|157036468|FG001|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
48779896|NCT01831089|157036469|FG002|Cohort III: Dose Level 3|Withdrawal by Subject|1|||
48779897|NCT01831089|157036470|FG003|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
48779898|NCT01831089|157036471|FG004|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
48779899|NCT01831089|157036472|FG005|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
48779900|NCT01831089|157036467|FG000|Cohort III: Dose Level 3|Adverse Event|0|||
48779901|NCT01831089|157036468|FG001|Cohort III: Dose Level 3|Adverse Event|0|||
48779902|NCT01831089|157036469|FG002|Cohort III: Dose Level 3|Adverse Event|1|||
48779903|NCT01831089|157036470|FG003|Cohort III: Dose Level 3|Adverse Event|0|||
48779904|NCT01831089|157036471|FG004|Cohort III: Dose Level 3|Adverse Event|0|||
48779905|NCT01831089|157036472|FG005|Cohort III: Dose Level 3|Adverse Event|0|||
48779906|NCT01831089|157036467|FG000|Cohort III: Dose Level 3|Global end of study|0|||
48779907|NCT01831089|157036468|FG001|Cohort III: Dose Level 3|Global end of study|0|||
48779908|NCT01831089|157036469|FG002|Cohort III: Dose Level 3|Global end of study|1|||
48779909|NCT01831089|157036470|FG003|Cohort III: Dose Level 3|Global end of study|0|||
48779910|NCT01831089|157036471|FG004|Cohort III: Dose Level 3|Global end of study|0|||
48779911|NCT01831089|157036472|FG005|Cohort III: Dose Level 3|Global end of study|0|||
48779912|NCT01831089|157036467|FG000|Cohort IV: Dose Level 4|Progressive disease|0|||
48779913|NCT01831089|157036468|FG001|Cohort IV: Dose Level 4|Progressive disease|0|||
48779914|NCT01831089|157036469|FG002|Cohort IV: Dose Level 4|Progressive disease|0|||
48779915|NCT01831089|157036470|FG003|Cohort IV: Dose Level 4|Progressive disease|6|||
48779916|NCT01831089|157036471|FG004|Cohort IV: Dose Level 4|Progressive disease|0|||
48779917|NCT01831089|157036472|FG005|Cohort IV: Dose Level 4|Progressive disease|0|||
48779918|NCT01831089|157036467|FG000|Cohort V: Dose Level 5|Progressive disease|0|||
48779919|NCT01831089|157036468|FG001|Cohort V: Dose Level 5|Progressive disease|0|||
48779920|NCT01831089|157036469|FG002|Cohort V: Dose Level 5|Progressive disease|0|||
48779921|NCT01831089|157036470|FG003|Cohort V: Dose Level 5|Progressive disease|0|||
49029208|NCT01866319|157943720|FG002|Overall Study|Protocol Violation|1|||
49029209|NCT01866319|157943718|FG000|Overall Study|Withdrawal by Subject|32|||
49029210|NCT01866319|157943719|FG001|Overall Study|Withdrawal by Subject|14|||
49029211|NCT01866319|157943720|FG002|Overall Study|Withdrawal by Subject|12|||
49029212|NCT04187833|157943722|FG000|Overall Study|Withdrawal by Subject|1|||
49029213|NCT01772537|157943724|FG000|Overall Study|unsuccessful lumbar drain placement|1|||
49029214|NCT01772537|157943725|FG001|Overall Study|unsuccessful lumbar drain placement|0|||
49029215|NCT01772537|157943726|FG002|Overall Study|unsuccessful lumbar drain placement|0|||
49029216|NCT02098876|157943728|FG000|Overall Study|Withdrawal by Subject|5|||
49029217|NCT02098876|157943729|FG001|Overall Study|Withdrawal by Subject|5|||
48779922|NCT01831089|157036471|FG004|Cohort V: Dose Level 5|Progressive disease|30|||
48779923|NCT01831089|157036472|FG005|Cohort V: Dose Level 5|Progressive disease|0|||
48779924|NCT01831089|157036467|FG000|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
48779925|NCT01831089|157036468|FG001|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
48779926|NCT01831089|157036469|FG002|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
48877238|NCT03443414|157388586|FG004|Overall Study|Reason not specified|1|||
48779927|NCT01831089|157036470|FG003|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
48779928|NCT01831089|157036471|FG004|Cohort V: Dose Level 5|Withdrawal by Subject|3|||
48779929|NCT01831089|157036472|FG005|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
49029218|NCT02511782|157943730|FG000|Overall Study|Withdrawal by Subject|1|||
49029219|NCT02511782|157943731|FG001|Overall Study|Withdrawal by Subject|0|||
49029220|NCT02511782|157943732|FG002|Overall Study|Withdrawal by Subject|0|||
48779930|NCT01831089|157036467|FG000|Cohort V: Dose Level 5|Death|0|||
48779931|NCT01831089|157036468|FG001|Cohort V: Dose Level 5|Death|0|||
48779932|NCT01831089|157036469|FG002|Cohort V: Dose Level 5|Death|0|||
48779933|NCT01831089|157036470|FG003|Cohort V: Dose Level 5|Death|0|||
48779934|NCT01831089|157036471|FG004|Cohort V: Dose Level 5|Death|1|||
48779935|NCT01831089|157036472|FG005|Cohort V: Dose Level 5|Death|0|||
48779936|NCT01831089|157036467|FG000|Cohort V: Dose Level 5|Global end of study|0|||
48779937|NCT01831089|157036468|FG001|Cohort V: Dose Level 5|Global end of study|0|||
48779938|NCT01831089|157036469|FG002|Cohort V: Dose Level 5|Global end of study|0|||
48779939|NCT01831089|157036470|FG003|Cohort V: Dose Level 5|Global end of study|0|||
48779940|NCT01831089|157036471|FG004|Cohort V: Dose Level 5|Global end of study|2|||
48779941|NCT01831089|157036472|FG005|Cohort V: Dose Level 5|Global end of study|0|||
48779942|NCT01831089|157036467|FG000|Cohort V: Dose Level 5|Lost to Follow-up|0|||
48779943|NCT01831089|157036468|FG001|Cohort V: Dose Level 5|Lost to Follow-up|0|||
48779944|NCT01831089|157036469|FG002|Cohort V: Dose Level 5|Lost to Follow-up|0|||
48779945|NCT01831089|157036470|FG003|Cohort V: Dose Level 5|Lost to Follow-up|0|||
48779946|NCT01831089|157036471|FG004|Cohort V: Dose Level 5|Lost to Follow-up|1|||
48779947|NCT01831089|157036472|FG005|Cohort V: Dose Level 5|Lost to Follow-up|0|||
48779948|NCT01831089|157036467|FG000|Cohort B: Arm B|Progressive disease|0|||
48779949|NCT01831089|157036468|FG001|Cohort B: Arm B|Progressive disease|0|||
48779950|NCT01831089|157036469|FG002|Cohort B: Arm B|Progressive disease|0|||
48779951|NCT01831089|157036470|FG003|Cohort B: Arm B|Progressive disease|0|||
48779952|NCT01831089|157036471|FG004|Cohort B: Arm B|Progressive disease|0|||
48779953|NCT01831089|157036472|FG005|Cohort B: Arm B|Progressive disease|8|||
48779954|NCT01831089|157036467|FG000|Cohort B: Arm B|Physician Decision|0|||
48779955|NCT01831089|157036468|FG001|Cohort B: Arm B|Physician Decision|0|||
48779956|NCT01831089|157036469|FG002|Cohort B: Arm B|Physician Decision|0|||
48779957|NCT01831089|157036470|FG003|Cohort B: Arm B|Physician Decision|0|||
48779958|NCT01831089|157036471|FG004|Cohort B: Arm B|Physician Decision|0|||
48779959|NCT01831089|157036472|FG005|Cohort B: Arm B|Physician Decision|2|||
48779960|NCT01831089|157036467|FG000|Cohort B: Arm B|Never treated|0|||
48779961|NCT01831089|157036468|FG001|Cohort B: Arm B|Never treated|0|||
48779962|NCT01831089|157036469|FG002|Cohort B: Arm B|Never treated|0|||
48779963|NCT01831089|157036470|FG003|Cohort B: Arm B|Never treated|0|||
48779964|NCT01831089|157036471|FG004|Cohort B: Arm B|Never treated|0|||
48779965|NCT01831089|157036472|FG005|Cohort B: Arm B|Never treated|2|||
48779966|NCT01831089|157036467|FG000|Cohort B: Arm B|Adverse Event|0|||
48779967|NCT01831089|157036468|FG001|Cohort B: Arm B|Adverse Event|0|||
48779968|NCT01831089|157036469|FG002|Cohort B: Arm B|Adverse Event|0|||
48779969|NCT01831089|157036470|FG003|Cohort B: Arm B|Adverse Event|0|||
48779970|NCT01831089|157036471|FG004|Cohort B: Arm B|Adverse Event|0|||
48779971|NCT01831089|157036472|FG005|Cohort B: Arm B|Adverse Event|1|||
48779972|NCT01831089|157036467|FG000|Cohort B: Arm B|Global end of study|0|||
48779973|NCT01831089|157036468|FG001|Cohort B: Arm B|Global end of study|0|||
48779974|NCT01831089|157036469|FG002|Cohort B: Arm B|Global end of study|0|||
48779975|NCT01831089|157036470|FG003|Cohort B: Arm B|Global end of study|0|||
48779976|NCT01831089|157036471|FG004|Cohort B: Arm B|Global end of study|0|||
48779977|NCT01831089|157036472|FG005|Cohort B: Arm B|Global end of study|1|||
48779978|NCT02480621|157036485|FG000|Randomization|Withdrawal by Subject|1|||
48779979|NCT02480621|157036486|FG001|Randomization|Withdrawal by Subject|0|||
48779980|NCT02480621|157036485|FG000|Randomization|Surgeon did not give intervention|0|||
48779981|NCT02480621|157036486|FG001|Randomization|Surgeon did not give intervention|1|||
48779982|NCT02480621|157036485|FG000|Follow Up|Lost to Follow-up|4|||
48779983|NCT02480621|157036486|FG001|Follow Up|Lost to Follow-up|2|||
48779984|NCT02799082|157036488|FG000|Overall Study|Refused second PDT or withdraw consent|4|||
48779985|NCT02799082|157036489|FG001|Overall Study|Refused second PDT or withdraw consent|3|||
48779986|NCT02799082|157036488|FG000|Overall Study|Protocol Violation|0|||
48779987|NCT02799082|157036489|FG001|Overall Study|Protocol Violation|1|||
48779988|NCT02520531|157036493|FG000|Overall Study|Revision of study device components|2|||
48877239|NCT00823836|157388587|FG000|NV and PR/XR Switching Phases|Adverse Event|22|||
48877240|NCT00823836|157388588|FG001|NV and PR/XR Switching Phases|Adverse Event|21|||
49029221|NCT01263704|157943733|FG000|Overall Study|Progressive disease|18|||
48779989|NCT02520531|157036494|FG001|Overall Study|Revision of study device components|2|||
48779990|NCT02520531|157036493|FG000|Overall Study|Death|1|||
48779991|NCT02520531|157036494|FG001|Overall Study|Death|2|||
48779992|NCT02520531|157036493|FG000|Overall Study|Lost to Follow-up|1|||
48779993|NCT02520531|157036494|FG001|Overall Study|Lost to Follow-up|1|||
48779994|NCT02520531|157036493|FG000|Overall Study|Meet exclusion criterion|0|||
48779995|NCT02520531|157036494|FG001|Overall Study|Meet exclusion criterion|1|||
48877241|NCT00823836|157388587|FG000|NV and PR/XR Switching Phases|Protocol Violation|1|||
49029222|NCT01263704|157943733|FG000|Overall Study|Adverse Event|3|||
49029223|NCT01263704|157943733|FG000|Overall Study|Death|2|||
49029224|NCT01263704|157943733|FG000|Overall Study|Patient withdrew consent|2|||
49029225|NCT01263704|157943733|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
49029226|NCT01263704|157943733|FG000|Overall Study|Lost to Follow-up|1|||
49029227|NCT01263704|157943733|FG000|Overall Study|Colon metastases|1|||
49029228|NCT01263704|157943733|FG000|Overall Study|Principal Investigator (PI) decision|1|||
49029229|NCT00905840|157943734|FG000|Overall Study|Lost to Follow-up|11|||
49029230|NCT00905840|157943734|FG000|Overall Study|Death|3|||
49029231|NCT00905840|157943734|FG000|Overall Study|Withdrawal by Subject|1|||
49029232|NCT00905840|157943734|FG000|Overall Study|Adverse Event|1|||
49029233|NCT00448019|157943735|FG000|Overall Study|Withdrawal by Subject|3|||
49029234|NCT00448019|157943735|FG000|Overall Study|Disease progression|1|||
49029235|NCT00448019|157943735|FG000|Overall Study|Death|2|||
49029236|NCT00448019|157943735|FG000|Overall Study|Insurance Issues|1|||
49029237|NCT03496623|157943736|FG000|Run-In Period (2 Weeks)|Death|1|||
49029238|NCT03496623|157943737|FG001|Run-In Period (2 Weeks)|Death|0|||
49029239|NCT03496623|157943738|FG002|Run-In Period (2 Weeks)|Death|0|||
49029240|NCT03496623|157943739|FG003|Run-In Period (2 Weeks)|Death|0|||
49029241|NCT03496623|157943740|FG004|Run-In Period (2 Weeks)|Death|0|||
49029242|NCT03496623|157943736|FG000|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|31|||
49029243|NCT03496623|157943737|FG001|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
49029244|NCT03496623|157943738|FG002|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
49029245|NCT03496623|157943739|FG003|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
49029246|NCT03496623|157943740|FG004|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
48779996|NCT02520531|157036493|FG000|Overall Study|Withdrawal by Subject|1|||
48779997|NCT02520531|157036494|FG001|Overall Study|Withdrawal by Subject|0|||
48779998|NCT02520531|157036493|FG000|Overall Study|Not study device|1|||
49029247|NCT03496623|157943736|FG000|Period 1 (12 Weeks)|Death|0|||
48779999|NCT02520531|157036494|FG001|Overall Study|Not study device|0|||
49029248|NCT03496623|157943737|FG001|Period 1 (12 Weeks)|Death|3|||
48780000|NCT03965052|157036495|FG000|Overall Study|Protocol Violation|1|||
48780001|NCT03965052|157036496|FG001|Overall Study|Protocol Violation|0|||
48780002|NCT01962974|157036502|FG000|Overall Study|Study termination|7|||
48780003|NCT02838017|157036503|FG000|Overall Study|Lost to Follow-up|14|||
48780004|NCT02838017|157036504|FG001|Overall Study|Lost to Follow-up|11|||
48780005|NCT01059617|157036509|FG000|Overall Study|Other|7|||
48780006|NCT01059617|157036510|FG001|Overall Study|Other|1|||
48780007|NCT01059617|157036511|FG002|Overall Study|Other|8|||
48780008|NCT01059617|157036512|FG003|Overall Study|Other|6|||
48780009|NCT01307501|157036513|FG000|Overall Study|Treatment Failure|1|||
48780010|NCT01307501|157036513|FG000|Overall Study|Death|20|||
48780011|NCT01307501|157036513|FG000|Overall Study|Lost to Follow-up|1|||
49029249|NCT03496623|157943738|FG002|Period 1 (12 Weeks)|Death|0|||
49029250|NCT03496623|157943739|FG003|Period 1 (12 Weeks)|Death|0|||
49029251|NCT03496623|157943740|FG004|Period 1 (12 Weeks)|Death|0|||
49029252|NCT03496623|157943736|FG000|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
49029253|NCT03496623|157943737|FG001|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
49029254|NCT03496623|157943738|FG002|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
49029255|NCT03496623|157943739|FG003|Period 1 (12 Weeks)|Study Terminated by Sponsor|1|||
49029256|NCT03496623|157943740|FG004|Period 1 (12 Weeks)|Study Terminated by Sponsor|2|||
49029257|NCT03496623|157943736|FG000|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
49029258|NCT03496623|157943737|FG001|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
49029259|NCT03496623|157943738|FG002|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
49029260|NCT03496623|157943739|FG003|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
49029261|NCT03496623|157943740|FG004|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
49029262|NCT03496623|157943736|FG000|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
49029263|NCT03496623|157943737|FG001|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|4|||
49029264|NCT03496623|157943738|FG002|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|5|||
49029265|NCT03496623|157943739|FG003|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
49029266|NCT03496623|157943740|FG004|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
49029267|NCT03496623|157943736|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
49029268|NCT03496623|157943737|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
48780012|NCT01307501|157036513|FG000|Overall Study|Starting Hospice|1|||
48780013|NCT00809757|157036514|FG000|Overall Study|Adverse Event|2|||
49029269|NCT03496623|157943738|FG002|Period 2 (12 Weeks)|Lost to Follow-up|1|||
49029270|NCT03496623|157943739|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
48780014|NCT00809757|157036515|FG001|Overall Study|Adverse Event|3|||
48780015|NCT00809757|157036516|FG002|Overall Study|Adverse Event|3|||
48780016|NCT00809757|157036514|FG000|Overall Study|Lost to Follow-up|0|||
49029271|NCT03496623|157943740|FG004|Period 2 (12 Weeks)|Lost to Follow-up|0|||
48780017|NCT00809757|157036515|FG001|Overall Study|Lost to Follow-up|0|||
48780018|NCT00809757|157036516|FG002|Overall Study|Lost to Follow-up|1|||
48780019|NCT00809757|157036514|FG000|Overall Study|Protocol Violation|1|||
49029272|NCT03496623|157943736|FG000|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
49029273|NCT03496623|157943737|FG001|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
48780020|NCT00809757|157036515|FG001|Overall Study|Protocol Violation|1|||
48877242|NCT00823836|157388588|FG001|NV and PR/XR Switching Phases|Protocol Violation|1|||
48877243|NCT00823836|157388587|FG000|NV and PR/XR Switching Phases|Physician Decision|5|||
48877244|NCT00823836|157388588|FG001|NV and PR/XR Switching Phases|Physician Decision|2|||
48780021|NCT00809757|157036516|FG002|Overall Study|Protocol Violation|1|||
48780022|NCT00809757|157036514|FG000|Overall Study|Withdrawal by Subject|2|||
48877245|NCT00823836|157388587|FG000|NV and PR/XR Switching Phases|Withdrawal by Subject|4|||
48877246|NCT00823836|157388588|FG001|NV and PR/XR Switching Phases|Withdrawal by Subject|5|||
48877247|NCT00823836|157388587|FG000|Long-term Phase|Adverse Event|3|||
48877248|NCT00823836|157388588|FG001|Long-term Phase|Adverse Event|2|||
48877249|NCT00823836|157388587|FG000|Long-term Phase|Physician Decision|1|||
48877250|NCT00823836|157388588|FG001|Long-term Phase|Physician Decision|2|||
48877251|NCT00823836|157388587|FG000|Long-term Phase|Withdrawal by Subject|1|||
48877252|NCT00823836|157388588|FG001|Long-term Phase|Withdrawal by Subject|1|||
48877253|NCT01791413|157388589|FG000|Overall Study|Lost to Follow-up|5|||
48877254|NCT01791413|157388590|FG001|Overall Study|Lost to Follow-up|1|||
48877255|NCT01602510|157388594|FG000|Open Label Phase|Adverse Event|46|||
48877256|NCT01602510|157388595|FG001|Open Label Phase|Adverse Event|0|||
48780023|NCT00809757|157036515|FG001|Overall Study|Withdrawal by Subject|1|||
48877257|NCT01602510|157388596|FG002|Open Label Phase|Adverse Event|0|||
48877258|NCT01602510|157388594|FG000|Open Label Phase|Lack of Efficacy|22|||
48877259|NCT01602510|157388595|FG001|Open Label Phase|Lack of Efficacy|0|||
48877260|NCT01602510|157388596|FG002|Open Label Phase|Lack of Efficacy|0|||
48877261|NCT01602510|157388594|FG000|Open Label Phase|Protocol Violation|15|||
48877262|NCT01602510|157388595|FG001|Open Label Phase|Protocol Violation|0|||
48877263|NCT01602510|157388596|FG002|Open Label Phase|Protocol Violation|0|||
48780024|NCT00809757|157036516|FG002|Overall Study|Withdrawal by Subject|3|||
48780025|NCT00809757|157036514|FG000|Overall Study|Subject Uncooperative|1|||
48780026|NCT00809757|157036515|FG001|Overall Study|Subject Uncooperative|0|||
48780027|NCT00809757|157036516|FG002|Overall Study|Subject Uncooperative|2|||
48780028|NCT00809757|157036514|FG000|Overall Study|Noncompliance with Medication|0|||
48780029|NCT00809757|157036515|FG001|Overall Study|Noncompliance with Medication|0|||
48780030|NCT00809757|157036516|FG002|Overall Study|Noncompliance with Medication|1|||
48780031|NCT05819749|157036517|FG000|Overall Study|Lost to Follow-up|1|||
48780032|NCT02139644|157038445|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|70|||
48780033|NCT02139644|157038446|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
48780034|NCT02139644|157038447|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
48780035|NCT02139644|157038448|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
48780036|NCT02139644|157038449|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
48780037|NCT02139644|157038450|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
48780038|NCT02139644|157038445|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|30|||
48780039|NCT02139644|157038446|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
48780040|NCT02139644|157038447|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
48780041|NCT02139644|157038448|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
48780042|NCT02139644|157038449|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
48780043|NCT02139644|157038450|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
48780044|NCT02139644|157038445|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|12|||
48780045|NCT02139644|157038446|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
48780046|NCT02139644|157038447|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
48780047|NCT02139644|157038448|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
48780048|NCT02139644|157038449|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
48780049|NCT02139644|157038450|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
48780050|NCT02139644|157038445|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|11|||
48780051|NCT02139644|157038446|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
48780052|NCT02139644|157038447|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
48780053|NCT02139644|157038448|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
48877264|NCT01602510|157388594|FG000|Open Label Phase|Met protocol-defined stopping criteria|122|||
48877265|NCT01602510|157388595|FG001|Open Label Phase|Met protocol-defined stopping criteria|0|||
48877266|NCT01602510|157388596|FG002|Open Label Phase|Met protocol-defined stopping criteria|0|||
48877267|NCT01602510|157388594|FG000|Open Label Phase|Lost to Follow-up|22|||
48877268|NCT01602510|157388595|FG001|Open Label Phase|Lost to Follow-up|0|||
48877269|NCT01602510|157388596|FG002|Open Label Phase|Lost to Follow-up|0|||
48877270|NCT01602510|157388594|FG000|Open Label Phase|Physician Decision|19|||
48780054|NCT02139644|157038449|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
48780055|NCT02139644|157038450|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
48877271|NCT01602510|157388595|FG001|Open Label Phase|Physician Decision|0|||
48877272|NCT01602510|157388596|FG002|Open Label Phase|Physician Decision|0|||
48877273|NCT01602510|157388594|FG000|Open Label Phase|Withdrawal by Subject|57|||
48877274|NCT01602510|157388595|FG001|Open Label Phase|Withdrawal by Subject|0|||
48877275|NCT01602510|157388596|FG002|Open Label Phase|Withdrawal by Subject|0|||
48877276|NCT01602510|157388594|FG000|Randomized Phase|Adverse Event|0|||
48877277|NCT01602510|157388595|FG001|Randomized Phase|Adverse Event|2|||
48780056|NCT02139644|157038445|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|8|||
48780057|NCT02139644|157038446|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
48780058|NCT02139644|157038447|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
48780059|NCT02139644|157038448|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
48780060|NCT02139644|157038449|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
48780061|NCT02139644|157038450|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
48780062|NCT02139644|157038445|FG000|Run-In Period (Pre-assignment)|Adverse Event|3|||
48780063|NCT02139644|157038446|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
48780064|NCT02139644|157038447|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
48780065|NCT02139644|157038448|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
48780066|NCT02139644|157038449|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
48780067|NCT02139644|157038450|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
48780068|NCT02139644|157038445|FG000|Run-In Period (Pre-assignment)|Other|6|||
48780069|NCT02139644|157038446|FG001|Run-In Period (Pre-assignment)|Other|0|||
48780070|NCT02139644|157038447|FG002|Run-In Period (Pre-assignment)|Other|0|||
48780071|NCT02139644|157038448|FG003|Run-In Period (Pre-assignment)|Other|0|||
48780072|NCT02139644|157038449|FG004|Run-In Period (Pre-assignment)|Other|0|||
48780073|NCT02139644|157038450|FG005|Run-In Period (Pre-assignment)|Other|0|||
48780074|NCT02139644|157038445|FG000|Treatment Period|Adverse Event|0|||
48780075|NCT02139644|157038446|FG001|Treatment Period|Adverse Event|0|||
48780076|NCT02139644|157038447|FG002|Treatment Period|Adverse Event|3|||
48780077|NCT02139644|157038448|FG003|Treatment Period|Adverse Event|2|||
48780078|NCT02139644|157038449|FG004|Treatment Period|Adverse Event|1|||
48780079|NCT02139644|157038450|FG005|Treatment Period|Adverse Event|6|||
48780080|NCT02139644|157038445|FG000|Treatment Period|Withdrawal by Subject|0|||
48780081|NCT02139644|157038446|FG001|Treatment Period|Withdrawal by Subject|0|||
48780082|NCT02139644|157038447|FG002|Treatment Period|Withdrawal by Subject|2|||
48780083|NCT02139644|157038448|FG003|Treatment Period|Withdrawal by Subject|2|||
48780084|NCT02139644|157038449|FG004|Treatment Period|Withdrawal by Subject|3|||
48780085|NCT02139644|157038450|FG005|Treatment Period|Withdrawal by Subject|2|||
48780086|NCT02139644|157038445|FG000|Treatment Period|Non-compliance|0|||
48780087|NCT02139644|157038446|FG001|Treatment Period|Non-compliance|0|||
48780088|NCT02139644|157038447|FG002|Treatment Period|Non-compliance|0|||
48780089|NCT02139644|157038448|FG003|Treatment Period|Non-compliance|1|||
48780090|NCT02139644|157038449|FG004|Treatment Period|Non-compliance|0|||
48780091|NCT02139644|157038450|FG005|Treatment Period|Non-compliance|0|||
48780092|NCT02139644|157038445|FG000|Treatment Period|Protocol Violation|0|||
48780093|NCT02139644|157038446|FG001|Treatment Period|Protocol Violation|0|||
48780094|NCT02139644|157038447|FG002|Treatment Period|Protocol Violation|0|||
48780095|NCT02139644|157038448|FG003|Treatment Period|Protocol Violation|1|||
48780096|NCT02139644|157038449|FG004|Treatment Period|Protocol Violation|1|||
48780097|NCT02139644|157038450|FG005|Treatment Period|Protocol Violation|1|||
48780098|NCT02139644|157038445|FG000|Treatment Period|Disease progression|0|||
48780099|NCT02139644|157038446|FG001|Treatment Period|Disease progression|0|||
48780100|NCT02139644|157038447|FG002|Treatment Period|Disease progression|0|||
48780101|NCT02139644|157038448|FG003|Treatment Period|Disease progression|1|||
48780102|NCT02139644|157038449|FG004|Treatment Period|Disease progression|1|||
48780103|NCT02139644|157038450|FG005|Treatment Period|Disease progression|2|||
48780104|NCT02139644|157038445|FG000|Treatment Period|Lost to Follow-up|0|||
48780105|NCT02139644|157038446|FG001|Treatment Period|Lost to Follow-up|0|||
48780106|NCT02139644|157038447|FG002|Treatment Period|Lost to Follow-up|1|||
48780107|NCT02139644|157038448|FG003|Treatment Period|Lost to Follow-up|1|||
48780108|NCT02139644|157038449|FG004|Treatment Period|Lost to Follow-up|1|||
48780109|NCT02139644|157038450|FG005|Treatment Period|Lost to Follow-up|1|||
48780110|NCT02139644|157038445|FG000|Treatment Period|Lack of Efficacy|0|||
48780111|NCT02139644|157038446|FG001|Treatment Period|Lack of Efficacy|0|||
48780112|NCT02139644|157038447|FG002|Treatment Period|Lack of Efficacy|1|||
48780113|NCT02139644|157038448|FG003|Treatment Period|Lack of Efficacy|0|||
48780114|NCT02139644|157038449|FG004|Treatment Period|Lack of Efficacy|1|||
48780115|NCT02139644|157038450|FG005|Treatment Period|Lack of Efficacy|4|||
48780116|NCT02139644|157038445|FG000|Treatment Period|Other|0|||
48780117|NCT02139644|157038446|FG001|Treatment Period|Other|3|||
48780118|NCT02139644|157038447|FG002|Treatment Period|Other|1|||
48780119|NCT02139644|157038448|FG003|Treatment Period|Other|1|||
48780120|NCT02139644|157038449|FG004|Treatment Period|Other|0|||
48780121|NCT02139644|157038450|FG005|Treatment Period|Other|1|||
48780122|NCT02066298|157038451|FG000|Overall Study|Lost to Follow-up|3|||
48780123|NCT02066298|157038452|FG001|Overall Study|Lost to Follow-up|2|||
48780124|NCT02066298|157038453|FG002|Overall Study|Lost to Follow-up|3|||
48780125|NCT02066298|157038454|FG003|Overall Study|Lost to Follow-up|2|||
48780126|NCT02066298|157038455|FG004|Overall Study|Lost to Follow-up|3|||
48780127|NCT02066298|157038456|FG005|Overall Study|Lost to Follow-up|4|||
48780128|NCT02066298|157038451|FG000|Overall Study|Withdrawal by Subject|6|||
48780129|NCT02066298|157038452|FG001|Overall Study|Withdrawal by Subject|6|||
48780130|NCT02066298|157038453|FG002|Overall Study|Withdrawal by Subject|6|||
48780131|NCT02066298|157038454|FG003|Overall Study|Withdrawal by Subject|4|||
48780132|NCT02066298|157038455|FG004|Overall Study|Withdrawal by Subject|5|||
48780133|NCT02066298|157038456|FG005|Overall Study|Withdrawal by Subject|8|||
48780134|NCT02066298|157038451|FG000|Overall Study|Physician Decision|0|||
48780135|NCT02066298|157038452|FG001|Overall Study|Physician Decision|0|||
48780136|NCT02066298|157038453|FG002|Overall Study|Physician Decision|1|||
48780137|NCT02066298|157038454|FG003|Overall Study|Physician Decision|0|||
48780138|NCT02066298|157038455|FG004|Overall Study|Physician Decision|1|||
48780139|NCT02066298|157038456|FG005|Overall Study|Physician Decision|0|||
48780140|NCT04260191|157038457|FG000|Overall Study|Decision by Sponsor|0|||
48780141|NCT04260191|157038458|FG001|Overall Study|Decision by Sponsor|1|||
48780142|NCT04260191|157038459|FG002|Overall Study|Decision by Sponsor|0|||
48780143|NCT04260191|157038457|FG000|Overall Study|Withdrawal by Subject|1|||
48780144|NCT04260191|157038458|FG001|Overall Study|Withdrawal by Subject|0|||
48780145|NCT04260191|157038459|FG002|Overall Study|Withdrawal by Subject|3|||
48780146|NCT04260191|157038457|FG000|Overall Study|Death|4|||
48780147|NCT04260191|157038458|FG001|Overall Study|Death|3|||
48780148|NCT04260191|157038459|FG002|Overall Study|Death|2|||
48780149|NCT00630877|157038462|FG000|Overall Study|Adverse Event|11|||
48780150|NCT00630877|157038463|FG001|Overall Study|Adverse Event|8|||
48780151|NCT00630877|157038464|FG002|Overall Study|Adverse Event|7|||
48780152|NCT00630877|157038462|FG000|Overall Study|Withdrawal by Subject|3|||
48780153|NCT00630877|157038463|FG001|Overall Study|Withdrawal by Subject|4|||
48780154|NCT00630877|157038464|FG002|Overall Study|Withdrawal by Subject|0|||
48780155|NCT00630877|157038462|FG000|Overall Study|Lost to Follow-up|2|||
48780156|NCT00630877|157038463|FG001|Overall Study|Lost to Follow-up|0|||
48780157|NCT00630877|157038464|FG002|Overall Study|Lost to Follow-up|0|||
48780158|NCT00630877|157038462|FG000|Overall Study|Noncompliance|2|||
48780159|NCT00630877|157038463|FG001|Overall Study|Noncompliance|3|||
48780160|NCT00630877|157038464|FG002|Overall Study|Noncompliance|1|||
48780161|NCT00630877|157038462|FG000|Overall Study|Protocol violation|1|||
48780162|NCT00630877|157038463|FG001|Overall Study|Protocol violation|0|||
48780163|NCT00630877|157038464|FG002|Overall Study|Protocol violation|1|||
48780164|NCT00630877|157038462|FG000|Overall Study|Personal reasons|0|||
48780165|NCT00630877|157038463|FG001|Overall Study|Personal reasons|0|||
48780166|NCT00630877|157038464|FG002|Overall Study|Personal reasons|1|||
48780167|NCT01913041|157038469|FG000|Overall Study|Protocol Violation|35|||
48780168|NCT01913041|157038469|FG000|Overall Study|Withdrawal by Subject|3|||
48780169|NCT01913041|157038469|FG000|Overall Study|Physician Decision|1|||
48780170|NCT01794949|157038472|FG000|Overall Study|Lost to Follow-up|1|||
48780171|NCT01794949|157038473|FG001|Overall Study|Lost to Follow-up|0|||
49029274|NCT03496623|157943738|FG002|Period 2 (12 Weeks)|Study Terminated by Sponsor|1|||
49029275|NCT03496623|157943739|FG003|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
49029276|NCT03496623|157943740|FG004|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
49029277|NCT03496623|157943736|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
49029278|NCT03496623|157943737|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|3|||
49029279|NCT03496623|157943738|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
49029280|NCT03496623|157943739|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
49029281|NCT03496623|157943740|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
49029282|NCT01518972|157943741|FG000|Overall Study|Lost to Follow-up|2|||
49029283|NCT01518972|157943742|FG001|Overall Study|Lost to Follow-up|1|||
49029284|NCT01518972|157943741|FG000|Overall Study|Withdrawal by Subject|1|||
49029285|NCT01518972|157943742|FG001|Overall Study|Withdrawal by Subject|0|||
49029286|NCT01518972|157943741|FG000|Overall Study|Moved from area|1|||
49029287|NCT01518972|157943742|FG001|Overall Study|Moved from area|0|||
49029288|NCT01518972|157943741|FG000|Overall Study|Transportation problems|1|||
49029289|NCT01518972|157943742|FG001|Overall Study|Transportation problems|0|||
49029290|NCT01518972|157943741|FG000|Overall Study|Exclusionary medical condition|1|||
49029291|NCT01518972|157943742|FG001|Overall Study|Exclusionary medical condition|0|||
49029292|NCT01518972|157943741|FG000|Overall Study|Missed safety visits|0|||
49029293|NCT01518972|157943742|FG001|Overall Study|Missed safety visits|1|||
49029294|NCT01518972|157943741|FG000|Overall Study|Exclusionary medication|0|||
49029295|NCT01518972|157943742|FG001|Overall Study|Exclusionary medication|1|||
49029296|NCT01518972|157943741|FG000|Overall Study|Declined medication starting on day 12|0|||
49029297|NCT01518972|157943742|FG001|Overall Study|Declined medication starting on day 12|1|||
49029298|NCT03459807|157943749|FG000|Overall Study|Withdrawal due to transplant|0|||
48780172|NCT00226941|157038474|FG000|Overall Study|Withdrawal by subject - toxicity|0|||
48780173|NCT00226941|157038475|FG001|Overall Study|Withdrawal by subject - toxicity|0|||
48780174|NCT00226941|157038476|FG002|Overall Study|Withdrawal by subject - toxicity|0|||
48780175|NCT00226941|157038477|FG003|Overall Study|Withdrawal by subject - toxicity|1|||
49029299|NCT03459807|157943750|FG001|Overall Study|Withdrawal due to transplant|1|||
49029300|NCT02414152|157943751|FG000|Overall Study|Withdrawal by Subject|1|||
49029301|NCT02414152|157943751|FG000|Overall Study|Lack of Efficacy|1|||
49029302|NCT01576042|157943757|FG000|Overall Study|Physician Decision|2|||
48780176|NCT00226941|157038474|FG000|Overall Study|Withdrawn by investigator - unrelated AE|0|||
48780177|NCT00226941|157038475|FG001|Overall Study|Withdrawn by investigator - unrelated AE|0|||
48780178|NCT00226941|157038476|FG002|Overall Study|Withdrawn by investigator - unrelated AE|0|||
48780179|NCT00226941|157038477|FG003|Overall Study|Withdrawn by investigator - unrelated AE|1|||
48780180|NCT00844194|157038482|FG000|Overall Study|Adverse Event|17|||
48780181|NCT00844194|157038483|FG001|Overall Study|Adverse Event|5|||
48780182|NCT00844194|157038482|FG000|Overall Study|Protocol Violation|1|||
48780183|NCT00844194|157038483|FG001|Overall Study|Protocol Violation|1|||
48780184|NCT00844194|157038482|FG000|Overall Study|Lost to Follow-up|1|||
48780185|NCT00844194|157038483|FG001|Overall Study|Lost to Follow-up|1|||
48780186|NCT00844194|157038482|FG000|Overall Study|Withdrawal by Subject|2|||
48780187|NCT00844194|157038483|FG001|Overall Study|Withdrawal by Subject|1|||
48780188|NCT00844194|157038482|FG000|Overall Study|Lack of Efficacy|3|||
48780189|NCT00844194|157038483|FG001|Overall Study|Lack of Efficacy|0|||
48780190|NCT00844194|157038482|FG000|Overall Study|Other reason (not specified)|1|||
48780191|NCT00844194|157038483|FG001|Overall Study|Other reason (not specified)|0|||
48780192|NCT01542528|157038484|FG000|Overall Study|Lost to Follow-up|2|||
48780193|NCT01542528|157038485|FG001|Overall Study|Lost to Follow-up|1|||
48780194|NCT01542528|157038484|FG000|Overall Study|Physician Decision|1|||
48780195|NCT01542528|157038485|FG001|Overall Study|Physician Decision|0|||
48780196|NCT01542528|157038484|FG000|Overall Study|Withdrawal by Subject|9|||
48780197|NCT01542528|157038485|FG001|Overall Study|Withdrawal by Subject|6|||
48780198|NCT05282004|157038486|FG000|Overall Study|Adverse Event|2|||
48780199|NCT01332305|157038487|FG000|Overall Study|Adverse Event|1|||
48780200|NCT01332305|157038488|FG001|Overall Study|Adverse Event|4|||
48780201|NCT01332305|157038489|FG002|Overall Study|Adverse Event|6|||
48780202|NCT01332305|157038490|FG003|Overall Study|Adverse Event|3|||
48780203|NCT01332305|157038491|FG004|Overall Study|Adverse Event|5|||
48780204|NCT01332305|157038487|FG000|Overall Study|Withdrawal by Subject|6|||
48780205|NCT01332305|157038488|FG001|Overall Study|Withdrawal by Subject|5|||
48780206|NCT01332305|157038489|FG002|Overall Study|Withdrawal by Subject|4|||
48780207|NCT01332305|157038490|FG003|Overall Study|Withdrawal by Subject|1|||
48780208|NCT01332305|157038491|FG004|Overall Study|Withdrawal by Subject|0|||
48780209|NCT01332305|157038487|FG000|Overall Study|Lost to Follow-up|0|||
48780210|NCT01332305|157038488|FG001|Overall Study|Lost to Follow-up|2|||
48780211|NCT01332305|157038489|FG002|Overall Study|Lost to Follow-up|3|||
48780212|NCT01332305|157038490|FG003|Overall Study|Lost to Follow-up|2|||
48780213|NCT01332305|157038491|FG004|Overall Study|Lost to Follow-up|3|||
48780214|NCT01332305|157038487|FG000|Overall Study|Protocol Violation|1|||
48780215|NCT01332305|157038488|FG001|Overall Study|Protocol Violation|2|||
48780216|NCT01332305|157038489|FG002|Overall Study|Protocol Violation|1|||
48780217|NCT01332305|157038490|FG003|Overall Study|Protocol Violation|0|||
48780218|NCT01332305|157038491|FG004|Overall Study|Protocol Violation|3|||
48780219|NCT01332305|157038487|FG000|Overall Study|Withdrawal by Sponsor|1|||
48780220|NCT01332305|157038488|FG001|Overall Study|Withdrawal by Sponsor|0|||
48780221|NCT01332305|157038489|FG002|Overall Study|Withdrawal by Sponsor|0|||
48780222|NCT01332305|157038490|FG003|Overall Study|Withdrawal by Sponsor|1|||
48780223|NCT01332305|157038491|FG004|Overall Study|Withdrawal by Sponsor|1|||
48780224|NCT01332305|157038487|FG000|Overall Study|Treatment Failure|1|||
48780225|NCT01332305|157038488|FG001|Overall Study|Treatment Failure|1|||
48780226|NCT01332305|157038489|FG002|Overall Study|Treatment Failure|0|||
48780227|NCT01332305|157038490|FG003|Overall Study|Treatment Failure|0|||
48780228|NCT01332305|157038491|FG004|Overall Study|Treatment Failure|0|||
48780229|NCT01332305|157038487|FG000|Overall Study|Physician Decision|0|||
48780230|NCT01332305|157038488|FG001|Overall Study|Physician Decision|0|||
48780231|NCT01332305|157038489|FG002|Overall Study|Physician Decision|0|||
48780232|NCT01332305|157038490|FG003|Overall Study|Physician Decision|1|||
48780233|NCT01332305|157038491|FG004|Overall Study|Physician Decision|0|||
49029303|NCT01576042|157943758|FG001|Overall Study|Physician Decision|0|||
49029304|NCT00214422|157943768|FG000|Overall Study|Physician Decision|2|||
49029305|NCT00214422|157943769|FG001|Overall Study|Physician Decision|0|||
49029306|NCT00214422|157943770|FG002|Overall Study|Physician Decision|0|||
49029307|NCT00214422|157943768|FG000|Overall Study|Developed esophageal ca|1|||
49029308|NCT00214422|157943769|FG001|Overall Study|Developed esophageal ca|0|||
49029309|NCT00214422|157943770|FG002|Overall Study|Developed esophageal ca|0|||
49029310|NCT00214422|157943768|FG000|Overall Study|Pt taken off study|1|||
49029311|NCT00214422|157943769|FG001|Overall Study|Pt taken off study|1|||
48780234|NCT01931839|157038492|FG000|Overall Study|Death|0|||
48780235|NCT01931839|157038493|FG001|Overall Study|Death|1|||
48780236|NCT01931839|157038494|FG002|Overall Study|Death|2|||
48780237|NCT01931839|157038495|FG003|Overall Study|Death|0|||
48780238|NCT01931839|157038496|FG004|Overall Study|Death|0|||
48780239|NCT01931839|157038497|FG005|Overall Study|Death|0|||
48780240|NCT01931839|157038498|FG006|Overall Study|Death|0|||
48780241|NCT01931839|157038492|FG000|Overall Study|Physician Decision|1|||
48780242|NCT01931839|157038493|FG001|Overall Study|Physician Decision|0|||
48780243|NCT01931839|157038494|FG002|Overall Study|Physician Decision|1|||
48780244|NCT01931839|157038495|FG003|Overall Study|Physician Decision|0|||
48780245|NCT01931839|157038496|FG004|Overall Study|Physician Decision|0|||
48780246|NCT01931839|157038497|FG005|Overall Study|Physician Decision|0|||
48780247|NCT01931839|157038498|FG006|Overall Study|Physician Decision|1|||
48780248|NCT01931839|157038492|FG000|Overall Study|Withdrawal of consent|0|||
49029312|NCT00214422|157943770|FG002|Overall Study|Pt taken off study|0|||
49029313|NCT00214422|157943768|FG000|Overall Study|Disease progression on study|1|||
48780249|NCT01931839|157038493|FG001|Overall Study|Withdrawal of consent|0|||
48780250|NCT01931839|157038494|FG002|Overall Study|Withdrawal of consent|0|||
48780251|NCT01931839|157038495|FG003|Overall Study|Withdrawal of consent|0|||
48780252|NCT01931839|157038496|FG004|Overall Study|Withdrawal of consent|1|||
48780253|NCT01931839|157038497|FG005|Overall Study|Withdrawal of consent|0|||
48780254|NCT01931839|157038498|FG006|Overall Study|Withdrawal of consent|0|||
48780255|NCT01931839|157038492|FG000|Overall Study|Adverse Event|9|||
48780256|NCT01931839|157038493|FG001|Overall Study|Adverse Event|4|||
48780257|NCT01931839|157038494|FG002|Overall Study|Adverse Event|1|||
48780258|NCT01931839|157038495|FG003|Overall Study|Adverse Event|3|||
48780259|NCT01931839|157038496|FG004|Overall Study|Adverse Event|0|||
48780260|NCT01931839|157038497|FG005|Overall Study|Adverse Event|0|||
48780261|NCT01931839|157038498|FG006|Overall Study|Adverse Event|1|||
48780262|NCT01931839|157038492|FG000|Overall Study|Withdrawal of consent (not due to AE)|11|||
48780263|NCT01931839|157038493|FG001|Overall Study|Withdrawal of consent (not due to AE)|8|||
48780264|NCT01931839|157038494|FG002|Overall Study|Withdrawal of consent (not due to AE)|13|||
48780265|NCT01931839|157038495|FG003|Overall Study|Withdrawal of consent (not due to AE)|3|||
48780266|NCT01931839|157038496|FG004|Overall Study|Withdrawal of consent (not due to AE)|0|||
48780267|NCT01931839|157038497|FG005|Overall Study|Withdrawal of consent (not due to AE)|2|||
48780268|NCT01931839|157038498|FG006|Overall Study|Withdrawal of consent (not due to AE)|2|||
48780269|NCT01931839|157038492|FG000|Overall Study|Other non-compliance|15|||
48877278|NCT01602510|157388596|FG002|Randomized Phase|Adverse Event|6|||
48877279|NCT01602510|157388594|FG000|Randomized Phase|Lack of Efficacy|0|||
48877280|NCT01602510|157388595|FG001|Randomized Phase|Lack of Efficacy|4|||
48877281|NCT01602510|157388596|FG002|Randomized Phase|Lack of Efficacy|4|||
48877282|NCT01602510|157388594|FG000|Randomized Phase|Protocol Violation|0|||
48877283|NCT01602510|157388595|FG001|Randomized Phase|Protocol Violation|3|||
48877284|NCT01602510|157388596|FG002|Randomized Phase|Protocol Violation|3|||
48877285|NCT01602510|157388594|FG000|Randomized Phase|Met protocol-defined stopping criteria|0|||
48877286|NCT01602510|157388595|FG001|Randomized Phase|Met protocol-defined stopping criteria|58|||
48877287|NCT01602510|157388596|FG002|Randomized Phase|Met protocol-defined stopping criteria|48|||
48877288|NCT01602510|157388594|FG000|Randomized Phase|Lost to Follow-up|0|||
48877289|NCT01602510|157388595|FG001|Randomized Phase|Lost to Follow-up|1|||
48877290|NCT01602510|157388596|FG002|Randomized Phase|Lost to Follow-up|3|||
48877291|NCT01602510|157388594|FG000|Randomized Phase|Physician Decision|0|||
48877292|NCT01602510|157388595|FG001|Randomized Phase|Physician Decision|0|||
48877293|NCT01602510|157388596|FG002|Randomized Phase|Physician Decision|2|||
48877294|NCT01602510|157388594|FG000|Randomized Phase|Withdrawal by Subject|0|||
48877295|NCT01602510|157388595|FG001|Randomized Phase|Withdrawal by Subject|6|||
48877296|NCT01602510|157388596|FG002|Randomized Phase|Withdrawal by Subject|7|||
48877297|NCT00547534|157388599|FG000|Overall Study|Adverse Event|7|||
48877298|NCT00547534|157388599|FG000|Overall Study|Disease Progression|4|||
48877299|NCT01151215|157388600|FG000|Overall Study|Worsening of condition under study|1|||
48877300|NCT01151215|157388601|FG001|Overall Study|Worsening of condition under study|1|||
48877301|NCT01151215|157388602|FG002|Overall Study|Worsening of condition under study|1|||
48877302|NCT01151215|157388600|FG000|Overall Study|Death|16|||
48877303|NCT01151215|157388601|FG001|Overall Study|Death|20|||
48877304|NCT01151215|157388602|FG002|Overall Study|Death|11|||
48780270|NCT01931839|157038493|FG001|Overall Study|Other non-compliance|9|||
48780271|NCT01931839|157038494|FG002|Overall Study|Other non-compliance|12|||
48780272|NCT01931839|157038495|FG003|Overall Study|Other non-compliance|3|||
48780273|NCT01931839|157038496|FG004|Overall Study|Other non-compliance|0|||
48780274|NCT01931839|157038497|FG005|Overall Study|Other non-compliance|3|||
48780275|NCT01931839|157038498|FG006|Overall Study|Other non-compliance|0|||
48780276|NCT01931839|157038492|FG000|Overall Study|Lost to Follow-up|1|||
48780277|NCT01931839|157038493|FG001|Overall Study|Lost to Follow-up|2|||
48780278|NCT01931839|157038494|FG002|Overall Study|Lost to Follow-up|4|||
48780279|NCT01931839|157038495|FG003|Overall Study|Lost to Follow-up|5|||
48780280|NCT01931839|157038496|FG004|Overall Study|Lost to Follow-up|0|||
48780281|NCT01931839|157038497|FG005|Overall Study|Lost to Follow-up|0|||
48780282|NCT01931839|157038498|FG006|Overall Study|Lost to Follow-up|0|||
48780283|NCT01931839|157038492|FG000|Overall Study|Other|4|||
48780284|NCT01931839|157038493|FG001|Overall Study|Other|2|||
48877305|NCT01151215|157388600|FG000|Overall Study|Lost to Follow-up|0|||
48877306|NCT01151215|157388601|FG001|Overall Study|Lost to Follow-up|0|||
48877307|NCT01151215|157388602|FG002|Overall Study|Lost to Follow-up|3|||
48877308|NCT01151215|157388600|FG000|Overall Study|Withdrawal by Subject|3|||
48877309|NCT01151215|157388601|FG001|Overall Study|Withdrawal by Subject|1|||
48877310|NCT01151215|157388602|FG002|Overall Study|Withdrawal by Subject|2|||
48877311|NCT01151215|157388600|FG000|Overall Study|Disease progression|0|||
48877312|NCT01151215|157388601|FG001|Overall Study|Disease progression|1|||
48877313|NCT01151215|157388602|FG002|Overall Study|Disease progression|1|||
48877314|NCT01151215|157388600|FG000|Overall Study|Safety as judged by the investigator|0|||
48877315|NCT01151215|157388601|FG001|Overall Study|Safety as judged by the investigator|0|||
48877316|NCT01151215|157388602|FG002|Overall Study|Safety as judged by the investigator|1|||
48877317|NCT01574274|157388609|FG000|Overall Study|Ineligible|0|||
48780285|NCT01931839|157038494|FG002|Overall Study|Other|6|||
48780286|NCT01931839|157038495|FG003|Overall Study|Other|0|||
48780287|NCT01931839|157038496|FG004|Overall Study|Other|0|||
48780288|NCT01931839|157038497|FG005|Overall Study|Other|0|||
48780289|NCT01931839|157038498|FG006|Overall Study|Other|0|||
48780290|NCT03224468|157038499|FG000|Overall Study|Did not obtain MM card|53|||
48780291|NCT03224468|157038500|FG001|Overall Study|Did not obtain MM card|0|||
48780292|NCT03224468|157038499|FG000|Overall Study|Lost to Follow-up|4|||
48780293|NCT03224468|157038500|FG001|Overall Study|Lost to Follow-up|11|||
48780294|NCT03224468|157038499|FG000|Overall Study|Cannabis Use Disorder at Baseline|11|||
48780295|NCT03224468|157038500|FG001|Overall Study|Cannabis Use Disorder at Baseline|4|||
48780296|NCT01557946|157038501|FG000|Overall Study|Adverse Event|3|||
48780297|NCT01557946|157038502|FG001|Overall Study|Adverse Event|0|||
48780298|NCT04321460|157038503|FG000|Overall Study|Participants who had no defecation or no data about it|1|||
48780299|NCT04321460|157038504|FG001|Overall Study|Participants who had no defecation or no data about it|1|||
48780300|NCT01038921|157038505|FG000|Overall Study|Withdrawal by Subject|1|||
48780301|NCT01038921|157038506|FG001|Overall Study|Withdrawal by Subject|0|||
48780302|NCT01038921|157038505|FG000|Overall Study|Physician Decision|1|||
48780303|NCT01038921|157038506|FG001|Overall Study|Physician Decision|0|||
48780304|NCT01709227|157038507|FG000|Overall Study|Physician Decision|1|||
48780305|NCT01709227|157038508|FG001|Overall Study|Physician Decision|0|||
48780306|NCT01709227|157038507|FG000|Overall Study|Pleural Peritoneal communication|0|||
48780307|NCT01709227|157038508|FG001|Overall Study|Pleural Peritoneal communication|9|||
48780308|NCT00572572|157038510|FG000|Overall Study|Withdrawal by Subject|3|||
48780309|NCT00572572|157038511|FG001|Overall Study|Withdrawal by Subject|6|||
48780310|NCT01958918|157038516|FG000|Overall Study|Death|1|||
48780311|NCT01958918|157038517|FG001|Overall Study|Death|3|||
48780312|NCT01958918|157038516|FG000|Overall Study|Lost to Follow-up|4|||
48780313|NCT01958918|157038517|FG001|Overall Study|Lost to Follow-up|7|||
48780314|NCT01958918|157038516|FG000|Overall Study|Withdrawal by Subject|13|||
48780315|NCT01958918|157038517|FG001|Overall Study|Withdrawal by Subject|8|||
48780316|NCT01958918|157038516|FG000|Overall Study|Lack of Efficacy|13|||
48780317|NCT01958918|157038517|FG001|Overall Study|Lack of Efficacy|10|||
48780318|NCT01958918|157038516|FG000|Overall Study|Adverse Event|12|||
48780319|NCT01958918|157038517|FG001|Overall Study|Adverse Event|12|||
48780320|NCT01958918|157038516|FG000|Overall Study|administrative problems|0|||
48780321|NCT01958918|157038517|FG001|Overall Study|administrative problems|2|||
48780322|NCT00659269|157038518|FG000|Overall Study|Physician Decision|1|||
48780323|NCT00659269|157038519|FG001|Overall Study|Physician Decision|1|||
48780324|NCT04258020|157038520|FG000|Overall Study|Withdrawal by Subject|1|||
48780325|NCT04258020|157038521|FG001|Overall Study|Withdrawal by Subject|0|||
48780326|NCT01047683|157038522|FG000|Overall Study|Adverse Event|3|||
48780327|NCT01047683|157038523|FG001|Overall Study|Adverse Event|1|||
48780328|NCT01047683|157038524|FG002|Overall Study|Adverse Event|0|||
48780329|NCT01047683|157038522|FG000|Overall Study|Withdrew Consent|1|||
48780330|NCT01047683|157038523|FG001|Overall Study|Withdrew Consent|4|||
48780331|NCT01047683|157038524|FG002|Overall Study|Withdrew Consent|2|||
48780332|NCT01047683|157038522|FG000|Overall Study|Lost to Follow-up|0|||
48780333|NCT01047683|157038523|FG001|Overall Study|Lost to Follow-up|1|||
48780334|NCT01047683|157038524|FG002|Overall Study|Lost to Follow-up|0|||
48780335|NCT01047683|157038522|FG000|Overall Study|Triglycerides >2000 mg/dL|1|||
48780336|NCT01047683|157038523|FG001|Overall Study|Triglycerides >2000 mg/dL|0|||
48780337|NCT01047683|157038524|FG002|Overall Study|Triglycerides >2000 mg/dL|1|||
48780338|NCT03095417|157038525|FG000|Overall Study|missed|1|||
48780339|NCT03095417|157038526|FG001|Overall Study|missed|2|||
48780340|NCT03095417|157038527|FG002|Overall Study|missed|0|||
48780341|NCT03095417|157038528|FG003|Overall Study|missed|1|||
48780342|NCT03095417|157038525|FG000|Overall Study|Lost to Follow-up|2|||
48780343|NCT03095417|157038526|FG001|Overall Study|Lost to Follow-up|2|||
48780344|NCT03095417|157038527|FG002|Overall Study|Lost to Follow-up|1|||
48780345|NCT03095417|157038528|FG003|Overall Study|Lost to Follow-up|0|||
48780346|NCT03095417|157038525|FG000|Overall Study|refusal|0|||
48780347|NCT03095417|157038526|FG001|Overall Study|refusal|1|||
48780348|NCT03095417|157038527|FG002|Overall Study|refusal|0|||
48780349|NCT03095417|157038528|FG003|Overall Study|refusal|1|||
48780350|NCT03095417|157038525|FG000|Overall Study|Withdrawal by Subject|8|||
48780351|NCT03095417|157038526|FG001|Overall Study|Withdrawal by Subject|2|||
48780352|NCT03095417|157038527|FG002|Overall Study|Withdrawal by Subject|5|||
48780353|NCT03095417|157038528|FG003|Overall Study|Withdrawal by Subject|4|||
48780354|NCT03095417|157038525|FG000|Overall Study|Physician Decision|1|||
48780355|NCT03095417|157038526|FG001|Overall Study|Physician Decision|2|||
48780356|NCT03095417|157038527|FG002|Overall Study|Physician Decision|2|||
48780357|NCT03095417|157038528|FG003|Overall Study|Physician Decision|2|||
48780358|NCT03095417|157038525|FG000|Overall Study|Death|1|||
48780359|NCT03095417|157038526|FG001|Overall Study|Death|2|||
48780360|NCT03095417|157038527|FG002|Overall Study|Death|1|||
48780361|NCT03095417|157038528|FG003|Overall Study|Death|3|||
48780362|NCT02806986|157038529|FG000|Treatment Stage 1|Adverse Event|1|||
48780363|NCT02806986|157038529|FG000|Treatment Stage 2|Adverse Event|3|||
48780364|NCT02806986|157038529|FG000|Treatment Stage 2|Withdrawal by Subject|2|||
48780365|NCT00346034|157038530|FG000|Overall Study|Adverse Event|34|||
48780366|NCT00346034|157038530|FG000|Overall Study|Lack of Efficacy|8|||
48780367|NCT00346034|157038530|FG000|Overall Study|Withdrawal by Subject|13|||
48780368|NCT00346034|157038530|FG000|Overall Study|Patient Stopped Taking Study Drug|1|||
48780369|NCT00346034|157038530|FG000|Overall Study|Not Willing to Follow Dosing Regimen|1|||
48780370|NCT01877421|157038531|FG000|Phase 2|Lost to Follow-up|0|||
48780371|NCT01877421|157038532|FG001|Phase 2|Lost to Follow-up|0|||
48780372|NCT01877421|157038533|FG002|Phase 2|Lost to Follow-up|0|||
48780373|NCT01877421|157038534|FG003|Phase 2|Lost to Follow-up|0|||
48780374|NCT01877421|157038535|FG004|Phase 2|Lost to Follow-up|0|||
48780375|NCT01877421|157038536|FG005|Phase 2|Lost to Follow-up|0|||
48780376|NCT01877421|157038537|FG006|Phase 2|Lost to Follow-up|1|||
48780377|NCT01877421|157038538|FG007|Phase 2|Lost to Follow-up|0|||
48780378|NCT01877421|157038539|FG008|Phase 2|Lost to Follow-up|0|||
48780379|NCT01877421|157038540|FG009|Phase 2|Lost to Follow-up|0|||
48780380|NCT01877421|157038541|FG010|Phase 2|Lost to Follow-up|0|||
48780381|NCT01877421|157038542|FG011|Phase 2|Lost to Follow-up|0|||
48780382|NCT01877421|157038543|FG012|Phase 2|Lost to Follow-up|0|||
48780383|NCT01877421|157038544|FG013|Phase 2|Lost to Follow-up|0|||
48780384|NCT01877421|157038545|FG014|Phase 2|Lost to Follow-up|0|||
48780385|NCT01877421|157038546|FG015|Phase 2|Lost to Follow-up|0|||
48780386|NCT01877421|157038547|FG016|Phase 2|Lost to Follow-up|0|||
48877318|NCT01574274|157388610|FG001|Overall Study|Ineligible|1|||
48877319|NCT01574274|157388609|FG000|Overall Study|Withdrawal of Consent During Induction|1|||
48877320|NCT01574274|157388610|FG001|Overall Study|Withdrawal of Consent During Induction|1|||
49029314|NCT00214422|157943769|FG001|Overall Study|Disease progression on study|0|||
49029315|NCT00214422|157943770|FG002|Overall Study|Disease progression on study|0|||
49029316|NCT00214422|157943768|FG000|Overall Study|Unable to make a radiation treatment|0|||
49029317|NCT00214422|157943769|FG001|Overall Study|Unable to make a radiation treatment|0|||
49029318|NCT00214422|157943770|FG002|Overall Study|Unable to make a radiation treatment|1|||
49029319|NCT03134222|157943771|FG000|Treatment Period (Up to Week 12)|Adverse Event|4|||
49029320|NCT03134222|157943772|FG001|Treatment Period (Up to Week 12)|Adverse Event|1|||
49029321|NCT03134222|157943773|FG002|Treatment Period (Up to Week 12)|Adverse Event|0|||
49029322|NCT03134222|157943774|FG003|Treatment Period (Up to Week 12)|Adverse Event|0|||
49029323|NCT03134222|157943775|FG004|Treatment Period (Up to Week 12)|Adverse Event|0|||
49029324|NCT03134222|157943771|FG000|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
49029325|NCT03134222|157943772|FG001|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
49029326|NCT03134222|157943773|FG002|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
49029327|NCT03134222|157943774|FG003|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
49029328|NCT03134222|157943775|FG004|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
49029329|NCT03134222|157943771|FG000|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
49029330|NCT03134222|157943772|FG001|Treatment Period (Up to Week 12)|Withdrew Consent|1|||
49029331|NCT03134222|157943773|FG002|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
49029332|NCT03134222|157943774|FG003|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
49029333|NCT03134222|157943775|FG004|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
49029334|NCT03134222|157943771|FG000|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
49029335|NCT03134222|157943772|FG001|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
49029336|NCT03134222|157943773|FG002|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
49029337|NCT03134222|157943774|FG003|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
49029338|NCT03134222|157943775|FG004|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
49029339|NCT03134222|157943771|FG000|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
49029340|NCT03134222|157943772|FG001|Treatment Period (Week 12 to 48)|Withdrew Consent|2|||
49029341|NCT03134222|157943773|FG002|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
49029342|NCT03134222|157943774|FG003|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
49029343|NCT03134222|157943775|FG004|Treatment Period (Week 12 to 48)|Withdrew Consent|1|||
49029344|NCT03134222|157943771|FG000|Treatment Period (Week 12 to 48)|Lack of Efficacy|2|||
49029345|NCT03134222|157943772|FG001|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
49029346|NCT03134222|157943773|FG002|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
49029347|NCT03134222|157943774|FG003|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
49029348|NCT03134222|157943775|FG004|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
49029349|NCT03134222|157943771|FG000|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
49029350|NCT03134222|157943772|FG001|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
49029351|NCT03134222|157943773|FG002|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
49029352|NCT03134222|157943774|FG003|Treatment Period (Week 12 to 48)|Investigator's Discretion|1|||
48780387|NCT01877421|157038548|FG017|Phase 2|Lost to Follow-up|0|||
48780388|NCT01877421|157038531|FG000|Phase 2|Withdrawal by Subject|0|||
49029353|NCT03134222|157943775|FG004|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
49029354|NCT03134222|157943771|FG000|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
49029355|NCT03134222|157943772|FG001|Treatment Period (Week 12 to 48)|Lost to Follow-up|1|||
48780389|NCT01877421|157038532|FG001|Phase 2|Withdrawal by Subject|0|||
48780390|NCT01877421|157038533|FG002|Phase 2|Withdrawal by Subject|0|||
48780391|NCT01877421|157038534|FG003|Phase 2|Withdrawal by Subject|0|||
48780392|NCT01877421|157038535|FG004|Phase 2|Withdrawal by Subject|0|||
48780393|NCT01877421|157038536|FG005|Phase 2|Withdrawal by Subject|0|||
48780394|NCT01877421|157038537|FG006|Phase 2|Withdrawal by Subject|0|||
48780395|NCT01877421|157038538|FG007|Phase 2|Withdrawal by Subject|0|||
48780396|NCT01877421|157038539|FG008|Phase 2|Withdrawal by Subject|1|||
48780397|NCT01877421|157038540|FG009|Phase 2|Withdrawal by Subject|0|||
48780398|NCT01877421|157038541|FG010|Phase 2|Withdrawal by Subject|1|||
48780399|NCT01877421|157038542|FG011|Phase 2|Withdrawal by Subject|0|||
49029356|NCT03134222|157943773|FG002|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
49029357|NCT03134222|157943774|FG003|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
49029358|NCT03134222|157943775|FG004|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
49029359|NCT02089997|157943776|FG000|Overall Study|Case report forms uncollected|99|||
49029360|NCT02089997|157943776|FG000|Overall Study|Protocol Violation|147|||
49029361|NCT03600376|157943777|FG000|Overall Study|Adverse Event|1|||
49029362|NCT03600376|157943778|FG001|Overall Study|Adverse Event|1|||
49029363|NCT03600376|157943777|FG000|Overall Study|Transferred to other facility|1|||
48780400|NCT01877421|157038543|FG012|Phase 2|Withdrawal by Subject|1|||
48780401|NCT01877421|157038544|FG013|Phase 2|Withdrawal by Subject|0|||
48780402|NCT01877421|157038545|FG014|Phase 2|Withdrawal by Subject|0|||
48780403|NCT01877421|157038546|FG015|Phase 2|Withdrawal by Subject|1|||
48780404|NCT01877421|157038547|FG016|Phase 2|Withdrawal by Subject|0|||
48780405|NCT01877421|157038548|FG017|Phase 2|Withdrawal by Subject|0|||
48780406|NCT01877421|157038531|FG000|Phase 2|Protocol Violation|0|||
48780407|NCT01877421|157038532|FG001|Phase 2|Protocol Violation|0|||
48780408|NCT01877421|157038533|FG002|Phase 2|Protocol Violation|0|||
48780409|NCT01877421|157038534|FG003|Phase 2|Protocol Violation|0|||
48780410|NCT01877421|157038535|FG004|Phase 2|Protocol Violation|0|||
48780411|NCT01877421|157038536|FG005|Phase 2|Protocol Violation|0|||
48780412|NCT01877421|157038537|FG006|Phase 2|Protocol Violation|0|||
48780413|NCT01877421|157038538|FG007|Phase 2|Protocol Violation|0|||
48780414|NCT01877421|157038539|FG008|Phase 2|Protocol Violation|0|||
48780415|NCT01877421|157038540|FG009|Phase 2|Protocol Violation|0|||
48780416|NCT01877421|157038541|FG010|Phase 2|Protocol Violation|1|||
48780417|NCT01877421|157038542|FG011|Phase 2|Protocol Violation|0|||
48780418|NCT01877421|157038543|FG012|Phase 2|Protocol Violation|0|||
48780419|NCT01877421|157038544|FG013|Phase 2|Protocol Violation|0|||
48780420|NCT01877421|157038545|FG014|Phase 2|Protocol Violation|0|||
48780421|NCT01877421|157038546|FG015|Phase 2|Protocol Violation|0|||
48780422|NCT01877421|157038547|FG016|Phase 2|Protocol Violation|0|||
48780423|NCT01877421|157038548|FG017|Phase 2|Protocol Violation|0|||
48780424|NCT00383435|157038549|FG000|26-Week Double-Blind Treatment Period|Adverse Event|10|||
48780425|NCT00383435|157038550|FG001|26-Week Double-Blind Treatment Period|Adverse Event|2|||
48780426|NCT00383435|157038551|FG002|26-Week Double-Blind Treatment Period|Adverse Event|8|||
48780427|NCT00383435|157038552|FG003|26-Week Double-Blind Treatment Period|Adverse Event|6|||
48780428|NCT00383435|157038553|FG004|26-Week Double-Blind Treatment Period|Adverse Event|8|||
48780429|NCT00383435|157038549|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
48780430|NCT00383435|157038550|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|2|||
48780431|NCT00383435|157038551|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
48780432|NCT00383435|157038552|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|5|||
48780433|NCT00383435|157038553|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
48780434|NCT00383435|157038549|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
48780435|NCT00383435|157038550|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
48780436|NCT00383435|157038551|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
48780437|NCT00383435|157038552|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
48780438|NCT00383435|157038553|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
48780439|NCT00383435|157038549|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7|||
49029364|NCT03600376|157943778|FG001|Overall Study|Transferred to other facility|0|||
49029365|NCT03600376|157943777|FG000|Overall Study|Investigator Decision|0|||
49029366|NCT03600376|157943778|FG001|Overall Study|Investigator Decision|4|||
49029367|NCT03600376|157943777|FG000|Overall Study|Determined to be ineligible for study|0|||
48780440|NCT00383435|157038550|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
48780441|NCT00383435|157038551|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14|||
48780442|NCT00383435|157038552|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
49029368|NCT03600376|157943778|FG001|Overall Study|Determined to be ineligible for study|1|||
48780443|NCT00383435|157038553|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17|||
48780444|NCT00383435|157038549|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|2|||
48780445|NCT00383435|157038550|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
48780446|NCT00383435|157038551|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
49029369|NCT00415363|157943779|FG000|Overall Study|Withdrawal by Subject|4|||
49029370|NCT00415363|157943780|FG001|Overall Study|Withdrawal by Subject|4|||
49029371|NCT00415363|157943779|FG000|Overall Study|Adverse Event|4|||
48780447|NCT00383435|157038552|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
48877321|NCT01574274|157388609|FG000|Overall Study|Ph+ B-ALL|3|||
48780448|NCT00383435|157038553|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
48780449|NCT00383435|157038549|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1|||
48780450|NCT00383435|157038550|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
48780451|NCT00383435|157038551|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3|||
48780452|NCT00383435|157038552|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
48780453|NCT00383435|157038553|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
48780454|NCT00383435|157038549|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10|||
48780455|NCT00383435|157038550|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8|||
48780456|NCT00383435|157038551|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9|||
48780457|NCT00383435|157038552|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
48780458|NCT00383435|157038553|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
48780459|NCT00383435|157038549|FG000|26-Week Double-Blind Treatment Period|Administrative|5|||
48780460|NCT00383435|157038550|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
48780461|NCT00383435|157038551|FG002|26-Week Double-Blind Treatment Period|Administrative|1|||
48780462|NCT00383435|157038552|FG003|26-Week Double-Blind Treatment Period|Administrative|1|||
48780463|NCT00383435|157038553|FG004|26-Week Double-Blind Treatment Period|Administrative|1|||
48780464|NCT00383435|157038549|FG000|26-Week Treatment Safety Extension|Adverse Event|4|||
48780465|NCT00383435|157038550|FG001|26-Week Treatment Safety Extension|Adverse Event|2|||
48780466|NCT00383435|157038551|FG002|26-Week Treatment Safety Extension|Adverse Event|5|||
48780467|NCT00383435|157038552|FG003|26-Week Treatment Safety Extension|Adverse Event|5|||
48780468|NCT00383435|157038553|FG004|26-Week Treatment Safety Extension|Adverse Event|1|||
48780469|NCT00383435|157038549|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
48780470|NCT00383435|157038550|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
48780471|NCT00383435|157038551|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
48780472|NCT00383435|157038552|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
48780473|NCT00383435|157038553|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
48780474|NCT00383435|157038549|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
48780475|NCT00383435|157038550|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
48780476|NCT00383435|157038551|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
48780477|NCT00383435|157038552|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
48780478|NCT00383435|157038553|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
48877322|NCT01574274|157388610|FG001|Overall Study|Ph+ B-ALL|4|||
48982744|NCT02531633|157769866|FG005|Part B (104 Weeks)|Sponsor request|8|||
48982745|NCT02531633|157769867|FG006|Part B (104 Weeks)|Sponsor request|5|||
48982746|NCT02531633|157769868|FG007|Part B (104 Weeks)|Sponsor request|3|||
48982747|NCT02531633|157769869|FG008|Part B (104 Weeks)|Sponsor request|5|||
48982748|NCT02531633|157769870|FG009|Part B (104 Weeks)|Sponsor request|4|||
48982749|NCT02531633|157769861|FG000|Part B (104 Weeks)|Lost to Follow-up|0|||
48982750|NCT02531633|157769862|FG001|Part B (104 Weeks)|Lost to Follow-up|0|||
48982751|NCT02531633|157769863|FG002|Part B (104 Weeks)|Lost to Follow-up|0|||
48982752|NCT02531633|157769864|FG003|Part B (104 Weeks)|Lost to Follow-up|0|||
48982753|NCT02531633|157769865|FG004|Part B (104 Weeks)|Lost to Follow-up|0|||
48982754|NCT02531633|157769866|FG005|Part B (104 Weeks)|Lost to Follow-up|0|||
48982755|NCT02531633|157769867|FG006|Part B (104 Weeks)|Lost to Follow-up|0|||
48982756|NCT02531633|157769868|FG007|Part B (104 Weeks)|Lost to Follow-up|1|||
48982757|NCT02531633|157769869|FG008|Part B (104 Weeks)|Lost to Follow-up|0|||
48982758|NCT02531633|157769870|FG009|Part B (104 Weeks)|Lost to Follow-up|0|||
48982759|NCT00364611|157769871|FG000|Overall Study|Did not receive study medication|0|||
48982760|NCT00364611|157769872|FG001|Overall Study|Did not receive study medication|1|||
48982761|NCT00364611|157769871|FG000|Overall Study|Adverse Event|7|||
48982762|NCT00364611|157769872|FG001|Overall Study|Adverse Event|4|||
48982763|NCT00364611|157769871|FG000|Overall Study|Participant's Request|3|||
48982764|NCT00364611|157769872|FG001|Overall Study|Participant's Request|4|||
48982765|NCT00364611|157769871|FG000|Overall Study|Disease Progression|38|||
48982766|NCT00364611|157769872|FG001|Overall Study|Disease Progression|8|||
48982767|NCT00364611|157769871|FG000|Overall Study|Investigator decision|2|||
48982768|NCT00364611|157769872|FG001|Overall Study|Investigator decision|2|||
48982769|NCT00364611|157769871|FG000|Overall Study|Found Ineligible|1|||
48982770|NCT00364611|157769872|FG001|Overall Study|Found Ineligible|0|||
48982771|NCT00364611|157769871|FG000|Overall Study|Presumed CR on Study|0|||
48982772|NCT00364611|157769872|FG001|Overall Study|Presumed CR on Study|1|||
48982773|NCT00364611|157769871|FG000|Overall Study|Receiving Liver Ablation|0|||
48982774|NCT00364611|157769872|FG001|Overall Study|Receiving Liver Ablation|1|||
48982775|NCT03661983|157769873|FG000|Open Label Stabilization Phase|Adverse Event|5|||
48982776|NCT03661983|157769874|FG001|Open Label Stabilization Phase|Adverse Event|0|||
48982777|NCT03661983|157769875|FG002|Open Label Stabilization Phase|Adverse Event|0|||
48982778|NCT03661983|157769876|FG003|Open Label Stabilization Phase|Adverse Event|0|||
48982779|NCT03661983|157769873|FG000|Open Label Stabilization Phase|Lack of Efficacy|1|||
48982780|NCT03661983|157769874|FG001|Open Label Stabilization Phase|Lack of Efficacy|0|||
48982781|NCT03661983|157769875|FG002|Open Label Stabilization Phase|Lack of Efficacy|0|||
48780479|NCT00383435|157038549|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
48780480|NCT00383435|157038550|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
48780481|NCT00383435|157038551|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
48780482|NCT00383435|157038552|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
48780483|NCT00383435|157038553|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
48780484|NCT00383435|157038549|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
48780485|NCT00383435|157038550|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
48780486|NCT00383435|157038551|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|2|||
48780487|NCT00383435|157038552|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
48780488|NCT00383435|157038553|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
48780489|NCT00383435|157038549|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
48780490|NCT00383435|157038550|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
48780491|NCT00383435|157038551|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
48780492|NCT00383435|157038552|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
48780493|NCT00383435|157038553|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
48780494|NCT00383435|157038549|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
48780495|NCT00383435|157038550|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
48780496|NCT00383435|157038551|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
48780497|NCT00383435|157038552|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
48780498|NCT00383435|157038553|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
48780499|NCT00383435|157038549|FG000|26-Week Treatment Safety Extension|Administrative|1|||
48780500|NCT00383435|157038550|FG001|26-Week Treatment Safety Extension|Administrative|1|||
48780501|NCT00383435|157038551|FG002|26-Week Treatment Safety Extension|Administrative|0|||
48780502|NCT00383435|157038552|FG003|26-Week Treatment Safety Extension|Administrative|1|||
48780503|NCT00383435|157038553|FG004|26-Week Treatment Safety Extension|Administrative|0|||
48780504|NCT01751568|157038554|FG000|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1|||
48780505|NCT01751568|157038555|FG001|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
48780506|NCT01751568|157038556|FG002|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
48780507|NCT04776148|157038557|FG000|Overall Study|Death|172|||
48780508|NCT04776148|157038558|FG001|Overall Study|Death|188|||
48780509|NCT04776148|157038557|FG000|Overall Study|Lost to Follow-up|0|||
48780510|NCT04776148|157038558|FG001|Overall Study|Lost to Follow-up|1|||
48780511|NCT04776148|157038557|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
48780512|NCT04776148|157038558|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
48780513|NCT04776148|157038557|FG000|Overall Study|Withdrawal by Subject|2|||
48780514|NCT04776148|157038558|FG001|Overall Study|Withdrawal by Subject|4|||
48780515|NCT04776148|157038557|FG000|Overall Study|Ongoing in Study|67|||
48780516|NCT04776148|157038558|FG001|Overall Study|Ongoing in Study|45|||
48780517|NCT02464969|157038561|FG000|Main Phase (Day 1 to Day 84)|Adverse Event|7|||
48780518|NCT02464969|157038562|FG001|Main Phase (Day 1 to Day 84)|Adverse Event|0|||
48780519|NCT02464969|157038561|FG000|Main Phase (Day 1 to Day 84)|Death|1|||
48780520|NCT02464969|157038562|FG001|Main Phase (Day 1 to Day 84)|Death|1|||
48780521|NCT02464969|157038561|FG000|Main Phase (Day 1 to Day 84)|Lost to Follow-up|3|||
48780522|NCT02464969|157038562|FG001|Main Phase (Day 1 to Day 84)|Lost to Follow-up|0|||
48780523|NCT02464969|157038561|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|0|||
48780524|NCT02464969|157038562|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|4|||
48780525|NCT02464969|157038561|FG000|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|0|||
48780526|NCT02464969|157038562|FG001|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|1|||
48780527|NCT02464969|157038561|FG000|Main Phase (Day 1 to Day 84)|Other Reasons|4|||
48780528|NCT02464969|157038562|FG001|Main Phase (Day 1 to Day 84)|Other Reasons|2|||
48780529|NCT02464969|157038561|FG000|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
48780530|NCT02464969|157038562|FG001|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
48780531|NCT02464969|157038561|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|1|||
48780532|NCT02464969|157038562|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|0|||
48780533|NCT02464969|157038561|FG000|Extension Phase (Day 85 to Day 168)|Adverse Event|1|||
48780534|NCT02464969|157038562|FG001|Extension Phase (Day 85 to Day 168)|Adverse Event|0|||
48780535|NCT02464969|157038561|FG000|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|1|||
48780536|NCT02464969|157038562|FG001|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|0|||
48780537|NCT02464969|157038561|FG000|Extension Phase (Day 85 to Day 168)|Other Reasons|1|||
48780538|NCT02464969|157038562|FG001|Extension Phase (Day 85 to Day 168)|Other Reasons|0|||
48780539|NCT04572633|157038563|FG000|Overall Study|Participant in active follow-up at 30 days|47|||
48780540|NCT02606136|157038566|FG000|Main Study (104 Weeks)|Participant/Legal Guardian Decision|5|||
48982782|NCT03661983|157769876|FG003|Open Label Stabilization Phase|Lack of Efficacy|0|||
48982783|NCT03661983|157769873|FG000|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2|||
49029372|NCT00415363|157943780|FG001|Overall Study|Adverse Event|4|||
48780541|NCT02606136|157038566|FG000|Main Study (104 Weeks)|Withdrawal by Subject|1|||
48780542|NCT02606136|157038566|FG000|OLE (Up to 208 Weeks)|Participant/Legal Guardian Decision|1|||
48780543|NCT02606136|157038566|FG000|OLE (Up to 208 Weeks)|Sponsor Decision to Terminate Study|14|||
48780544|NCT04456699|157038567|FG000|Overall Study|Death|48|||
48780545|NCT04456699|157038568|FG001|Overall Study|Death|50|||
48780546|NCT04456699|157038569|FG002|Overall Study|Death|52|||
48780547|NCT04456699|157038567|FG000|Overall Study|Physician Decision|0|||
48780548|NCT04456699|157038568|FG001|Overall Study|Physician Decision|0|||
48780549|NCT04456699|157038569|FG002|Overall Study|Physician Decision|2|||
48780550|NCT04456699|157038567|FG000|Overall Study|Sponsor Decision|55|||
48780551|NCT04456699|157038568|FG001|Overall Study|Sponsor Decision|61|||
48780552|NCT04456699|157038569|FG002|Overall Study|Sponsor Decision|50|||
48780553|NCT04456699|157038567|FG000|Overall Study|Withdrawal by Subject|8|||
48780554|NCT04456699|157038568|FG001|Overall Study|Withdrawal by Subject|4|||
49029373|NCT00415363|157943779|FG000|Overall Study|Lost to Follow-up|2|||
49029374|NCT00415363|157943780|FG001|Overall Study|Lost to Follow-up|1|||
49029375|NCT00415363|157943779|FG000|Overall Study|Physician Decision|3|||
48780555|NCT04456699|157038569|FG002|Overall Study|Withdrawal by Subject|5|||
48780556|NCT04079933|157038570|FG000|Overall Study|Withdrawal by Subject|3|||
48780557|NCT04079933|157038571|FG001|Overall Study|Withdrawal by Subject|4|||
48780558|NCT04079933|157038570|FG000|Overall Study|Lost to Follow-up|0|||
48780559|NCT04079933|157038571|FG001|Overall Study|Lost to Follow-up|1|||
48780560|NCT04788147|157038572|FG000|Overall Study|Screen Failure|3|||
48780561|NCT04788147|157038573|FG001|Overall Study|Screen Failure|10|||
48780562|NCT04788147|157038572|FG000|Overall Study|Incomplete RMRS image session|2|||
48780563|NCT04788147|157038573|FG001|Overall Study|Incomplete RMRS image session|0|||
48780564|NCT00781326|157038576|FG000|Phase I|Adverse Event|1|||
48780565|NCT00781326|157038576|FG000|Phase I|Withdrawal by Subject|1|||
48780566|NCT00781326|157038576|FG000|Phase I|Physician Decision|2|||
48780567|NCT05101252|157038577|FG000|Overall Study|Unsatisfactory Test Article|1|||
48780568|NCT05101252|157038578|FG001|Overall Study|Unsatisfactory Test Article|0|||
48780569|NCT05101252|157038577|FG000|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
48780570|NCT05101252|157038578|FG001|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
48780571|NCT05101252|157038577|FG000|Overall Study|Withdrew Consent during study|0|||
48780572|NCT05101252|157038578|FG001|Overall Study|Withdrew Consent during study|1|||
48780573|NCT05101252|157038577|FG000|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
48780574|NCT05101252|157038578|FG001|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
48780575|NCT01775137|157038579|FG000|Overall Study|Death|1|||
48780576|NCT01775137|157038579|FG000|Overall Study|Protocol deviation|2|||
48780577|NCT01775137|157038579|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
48780578|NCT01775137|157038579|FG000|Overall Study|Adverse Event|1|||
48780579|NCT01775137|157038579|FG000|Overall Study|Withdrawal by participants|5|||
48780580|NCT00701051|157038580|FG000|Screening|Failed Screening|40|||
48780581|NCT00701051|157038581|FG001|Screening|Failed Screening|0|||
48780582|NCT00701051|157038582|FG002|Screening|Failed Screening|0|||
48780583|NCT00701051|157038580|FG000|Screening|Time conflicts|19|||
48780584|NCT00701051|157038581|FG001|Screening|Time conflicts|0|||
48780585|NCT00701051|157038582|FG002|Screening|Time conflicts|0|||
48780586|NCT00701051|157038580|FG000|Exercise Intervention|time conflict; non-study related illness|0|||
48780587|NCT00701051|157038581|FG001|Exercise Intervention|time conflict; non-study related illness|5|||
48780588|NCT00701051|157038582|FG002|Exercise Intervention|time conflict; non-study related illness|3|||
48780589|NCT00345579|157038587|FG000|Overall Study|Adverse Event|9|||
48780590|NCT00345579|157038588|FG001|Overall Study|Adverse Event|6|||
48780591|NCT00345579|157038587|FG000|Overall Study|Protocol Violation|14|||
48780592|NCT00345579|157038588|FG001|Overall Study|Protocol Violation|5|||
48780593|NCT00345579|157038587|FG000|Overall Study|Withdrawal by Subject|50|||
48780594|NCT00345579|157038588|FG001|Overall Study|Withdrawal by Subject|17|||
48780595|NCT00345579|157038587|FG000|Overall Study|Lost to Follow-up|82|||
48780596|NCT00345579|157038588|FG001|Overall Study|Lost to Follow-up|36|||
48780597|NCT00345579|157038587|FG000|Overall Study|Other|9|||
48780598|NCT00345579|157038588|FG001|Overall Study|Other|1|||
48780599|NCT01731171|157038589|FG000|Overall Study|Withdrawal by Subject|4|||
49029376|NCT00415363|157943780|FG001|Overall Study|Physician Decision|1|||
48780600|NCT01731171|157038590|FG001|Overall Study|Withdrawal by Subject|1|||
48877323|NCT01574274|157388609|FG000|Overall Study|Induction Death|2|||
49029377|NCT00415363|157943779|FG000|Overall Study|Death|16|||
48780601|NCT01731171|157038589|FG000|Overall Study|Lost to Follow-up|3|||
48780602|NCT01731171|157038590|FG001|Overall Study|Lost to Follow-up|2|||
48780603|NCT01731171|157038589|FG000|Overall Study|Moved out of Area|0|||
48780604|NCT01731171|157038590|FG001|Overall Study|Moved out of Area|2|||
48780605|NCT01731171|157038589|FG000|Overall Study|Terminated for Lack of Adherence|0|||
48780606|NCT01731171|157038590|FG001|Overall Study|Terminated for Lack of Adherence|1|||
48780607|NCT01731171|157038589|FG000|Overall Study|Terminated for Safety Reasons|0|||
48780608|NCT01731171|157038590|FG001|Overall Study|Terminated for Safety Reasons|1|||
48780609|NCT03653429|157038594|FG000|Overall Study|Physician Decision|4|||
48780610|NCT03653429|157038595|FG001|Overall Study|Physician Decision|10|||
48780611|NCT01040130|157038596|FG000|Overall Study|Adverse Event|1|||
48780612|NCT01040130|157038597|FG001|Overall Study|Adverse Event|1|||
48780613|NCT01040130|157038598|FG002|Overall Study|Adverse Event|0|||
48780614|NCT01040130|157038599|FG003|Overall Study|Adverse Event|5|||
48780615|NCT01040130|157038600|FG004|Overall Study|Adverse Event|0|||
48780616|NCT01040130|157038601|FG005|Overall Study|Adverse Event|3|||
48780617|NCT01040130|157038596|FG000|Overall Study|Protocol Violation|0|||
48780618|NCT01040130|157038597|FG001|Overall Study|Protocol Violation|0|||
48780619|NCT01040130|157038598|FG002|Overall Study|Protocol Violation|2|||
48780620|NCT01040130|157038599|FG003|Overall Study|Protocol Violation|0|||
48780621|NCT01040130|157038600|FG004|Overall Study|Protocol Violation|0|||
48780622|NCT01040130|157038601|FG005|Overall Study|Protocol Violation|0|||
48780623|NCT01040130|157038596|FG000|Overall Study|Withdrawal by Subject|0|||
48780624|NCT01040130|157038597|FG001|Overall Study|Withdrawal by Subject|2|||
48780625|NCT01040130|157038598|FG002|Overall Study|Withdrawal by Subject|0|||
48780626|NCT01040130|157038599|FG003|Overall Study|Withdrawal by Subject|0|||
48780627|NCT01040130|157038600|FG004|Overall Study|Withdrawal by Subject|0|||
48780628|NCT01040130|157038601|FG005|Overall Study|Withdrawal by Subject|1|||
48780629|NCT01040130|157038596|FG000|Overall Study|Other reasons not listed above|2|||
48780630|NCT01040130|157038597|FG001|Overall Study|Other reasons not listed above|0|||
48780631|NCT01040130|157038598|FG002|Overall Study|Other reasons not listed above|0|||
48780632|NCT01040130|157038599|FG003|Overall Study|Other reasons not listed above|0|||
48780633|NCT01040130|157038600|FG004|Overall Study|Other reasons not listed above|0|||
48780634|NCT01040130|157038601|FG005|Overall Study|Other reasons not listed above|0|||
48780635|NCT02673697|157038602|FG000|Overall Study|Adverse Event|2|||
48780636|NCT02673697|157038603|FG001|Overall Study|Adverse Event|0|||
48780637|NCT02673697|157038602|FG000|Overall Study|Death|32|||
48780638|NCT02673697|157038603|FG001|Overall Study|Death|24|||
48780639|NCT02673697|157038602|FG000|Overall Study|Lost to Follow-up|5|||
48780640|NCT02673697|157038603|FG001|Overall Study|Lost to Follow-up|2|||
48780641|NCT02673697|157038602|FG000|Overall Study|Physician Decision|2|||
48780642|NCT02673697|157038603|FG001|Overall Study|Physician Decision|1|||
48780643|NCT02673697|157038602|FG000|Overall Study|Withdrawal by Subject|10|||
48780644|NCT02673697|157038603|FG001|Overall Study|Withdrawal by Subject|7|||
48780645|NCT02673697|157038602|FG000|Overall Study|Change subj medical status|1|||
48780646|NCT02673697|157038603|FG001|Overall Study|Change subj medical status|2|||
48780647|NCT02673697|157038602|FG000|Overall Study|Explant|10|||
48780648|NCT02673697|157038603|FG001|Overall Study|Explant|5|||
48780649|NCT02673697|157038602|FG000|Overall Study|Sponsor Decision to stop follow up|391|||
48780650|NCT02673697|157038603|FG001|Overall Study|Sponsor Decision to stop follow up|416|||
48780651|NCT01591681|157038606|FG000|Overall Study|Didn't meet min hypoglycemia requirement|3|||
48780652|NCT01591681|157038606|FG000|Overall Study|Failed to use system during run-in|1|||
48780653|NCT01723904|157038607|FG000|Overall Study|Noncompliant|3|||
48780654|NCT01723904|157038607|FG000|Overall Study|Adverse Event|5|||
48780655|NCT01723904|157038607|FG000|Overall Study|Unable to follow protocol/ judged by inv|3|||
48780656|NCT00690755|157038618|FG000|Overall Study|Physician Decision|2|||
48780657|NCT00690755|157038619|FG001|Overall Study|Physician Decision|0|||
48780658|NCT00690755|157038620|FG002|Overall Study|Physician Decision|46|||
48780659|NCT00690755|157038621|FG003|Overall Study|Physician Decision|5|||
48780660|NCT00690755|157038622|FG004|Overall Study|Physician Decision|0|||
49029378|NCT00415363|157943780|FG001|Overall Study|Death|12|||
49029379|NCT00415363|157943779|FG000|Overall Study|Progressive disease|26|||
49029380|NCT00415363|157943780|FG001|Overall Study|Progressive disease|32|||
49029381|NCT03123471|157943783|FG000|Placebo-controlled Phase|Adverse Event|3|||
49029382|NCT03123471|157943784|FG001|Placebo-controlled Phase|Adverse Event|8|||
49029383|NCT03123471|157943783|FG000|Placebo-controlled Phase|Lack of Efficacy|3|||
49029384|NCT03123471|157943784|FG001|Placebo-controlled Phase|Lack of Efficacy|4|||
49029385|NCT03123471|157943783|FG000|Placebo-controlled Phase|Withdrawal by Subject|6|||
49029386|NCT03123471|157943784|FG001|Placebo-controlled Phase|Withdrawal by Subject|16|||
49029387|NCT03123471|157943783|FG000|Placebo-controlled Phase|Non-compliance with Study Drug|3|||
49029388|NCT03123471|157943784|FG001|Placebo-controlled Phase|Non-compliance with Study Drug|0|||
49029389|NCT03123471|157943783|FG000|Placebo-controlled Phase|Lost to Follow-up|1|||
49029390|NCT03123471|157943784|FG001|Placebo-controlled Phase|Lost to Follow-up|3|||
48780661|NCT00690755|157038623|FG005|Overall Study|Physician Decision|4|||
48780662|NCT00690755|157038624|FG006|Overall Study|Physician Decision|0|||
48780663|NCT03855189|157038625|FG000|Overall Study|Adverse Event|5|||
49029391|NCT03123471|157943783|FG000|Placebo-controlled Phase|Protocol Deviation|2|||
48780664|NCT03855189|157038626|FG001|Overall Study|Adverse Event|2|||
48780665|NCT03855189|157038627|FG002|Overall Study|Adverse Event|4|||
48780666|NCT03855189|157038625|FG000|Overall Study|Treatment Failure|1|||
48780667|NCT03855189|157038626|FG001|Overall Study|Treatment Failure|1|||
48780668|NCT03855189|157038627|FG002|Overall Study|Treatment Failure|2|||
48780669|NCT03855189|157038625|FG000|Overall Study|Noncompliance with Protocol|0|||
48780670|NCT03855189|157038626|FG001|Overall Study|Noncompliance with Protocol|1|||
48780671|NCT03855189|157038627|FG002|Overall Study|Noncompliance with Protocol|0|||
48780672|NCT03855189|157038625|FG000|Overall Study|Did Not Return|4|||
48780673|NCT03855189|157038626|FG001|Overall Study|Did Not Return|3|||
48780674|NCT03855189|157038627|FG002|Overall Study|Did Not Return|0|||
48780675|NCT00861341|157038628|FG000|Overall Study|Withdrawal by Subject|2|||
48780676|NCT01870843|157038629|FG000|Overall Study|Adverse Event|10|||
48780677|NCT01870843|157038629|FG000|Overall Study|Lost to Follow-up|24|||
48780678|NCT01870843|157038629|FG000|Overall Study|Death|1|||
48780679|NCT01870843|157038629|FG000|Overall Study|Withdrawal by Subject|18|||
48780680|NCT04095858|157038630|FG000|Overall Study|Death|1|||
48780681|NCT04095858|157038631|FG001|Overall Study|Death|0|||
48780682|NCT04095858|157038630|FG000|Overall Study|Study terminated by Sponsor|2|||
48780683|NCT04095858|157038631|FG001|Overall Study|Study terminated by Sponsor|4|||
48780684|NCT03156023|157038632|FG000|Overall Study|Withdrawal by Subject|1|||
48780685|NCT03156023|157038633|FG001|Overall Study|Withdrawal by Subject|0|||
48780686|NCT03156023|157038634|FG002|Overall Study|Withdrawal by Subject|2|||
48780687|NCT03156023|157038635|FG003|Overall Study|Withdrawal by Subject|1|||
48780688|NCT03156023|157038636|FG004|Overall Study|Withdrawal by Subject|1|||
48780689|NCT03156023|157038632|FG000|Overall Study|Lost to Follow-up|0|||
48780690|NCT03156023|157038633|FG001|Overall Study|Lost to Follow-up|0|||
48780691|NCT03156023|157038634|FG002|Overall Study|Lost to Follow-up|0|||
48780692|NCT03156023|157038635|FG003|Overall Study|Lost to Follow-up|0|||
48780693|NCT03156023|157038636|FG004|Overall Study|Lost to Follow-up|1|||
48780694|NCT01105533|157040074|FG000|Overall Study|Death|0|||
48780695|NCT01105533|157040075|FG001|Overall Study|Death|0|||
48780696|NCT01105533|157040076|FG002|Overall Study|Death|0|||
48780697|NCT01105533|157040077|FG003|Overall Study|Death|0|||
48780698|NCT01105533|157040078|FG004|Overall Study|Death|1|||
48780699|NCT01105533|157040079|FG005|Overall Study|Death|0|||
48780700|NCT01105533|157040080|FG006|Overall Study|Death|0|||
48780701|NCT01105533|157040081|FG007|Overall Study|Death|0|||
48780702|NCT01105533|157040082|FG008|Overall Study|Death|0|||
48780703|NCT01105533|157040074|FG000|Overall Study|Lack of Efficacy|1|||
48780704|NCT01105533|157040075|FG001|Overall Study|Lack of Efficacy|1|||
48780705|NCT01105533|157040076|FG002|Overall Study|Lack of Efficacy|3|||
48780706|NCT01105533|157040077|FG003|Overall Study|Lack of Efficacy|3|||
48780707|NCT01105533|157040078|FG004|Overall Study|Lack of Efficacy|4|||
48780708|NCT01105533|157040079|FG005|Overall Study|Lack of Efficacy|5|||
48780709|NCT01105533|157040080|FG006|Overall Study|Lack of Efficacy|3|||
48780710|NCT01105533|157040081|FG007|Overall Study|Lack of Efficacy|2|||
48780711|NCT01105533|157040082|FG008|Overall Study|Lack of Efficacy|9|||
48780712|NCT01105533|157040074|FG000|Overall Study|Adverse Event|0|||
48780713|NCT01105533|157040075|FG001|Overall Study|Adverse Event|0|||
48780714|NCT01105533|157040076|FG002|Overall Study|Adverse Event|0|||
48780715|NCT01105533|157040077|FG003|Overall Study|Adverse Event|0|||
48780716|NCT01105533|157040078|FG004|Overall Study|Adverse Event|1|||
48780717|NCT01105533|157040079|FG005|Overall Study|Adverse Event|2|||
48780718|NCT01105533|157040080|FG006|Overall Study|Adverse Event|2|||
48780719|NCT01105533|157040081|FG007|Overall Study|Adverse Event|0|||
48780720|NCT01105533|157040082|FG008|Overall Study|Adverse Event|1|||
48780721|NCT01105533|157040074|FG000|Overall Study|Other|0|||
48780722|NCT01105533|157040075|FG001|Overall Study|Other|0|||
48780723|NCT01105533|157040076|FG002|Overall Study|Other|0|||
48780724|NCT01105533|157040077|FG003|Overall Study|Other|0|||
48780725|NCT01105533|157040078|FG004|Overall Study|Other|1|||
48780726|NCT01105533|157040079|FG005|Overall Study|Other|0|||
48780727|NCT01105533|157040080|FG006|Overall Study|Other|3|||
48780728|NCT01105533|157040081|FG007|Overall Study|Other|1|||
48877324|NCT01574274|157388610|FG001|Overall Study|Induction Death|0|||
48877325|NCT01574274|157388609|FG000|Overall Study|Induction Failure|4|||
48877326|NCT01574274|157388610|FG001|Overall Study|Induction Failure|1|||
48877327|NCT01574274|157388609|FG000|Overall Study|Adverse Event|16|||
48877328|NCT01574274|157388610|FG001|Overall Study|Adverse Event|13|||
48877329|NCT01574274|157388609|FG000|Overall Study|Remission Death|1|||
48877330|NCT01574274|157388610|FG001|Overall Study|Remission Death|0|||
49029392|NCT03123471|157943784|FG001|Placebo-controlled Phase|Protocol Deviation|1|||
48780729|NCT01105533|157040082|FG008|Overall Study|Other|2|||
48780730|NCT01105533|157040074|FG000|Overall Study|Physician Decision|0|||
48780731|NCT01105533|157040075|FG001|Overall Study|Physician Decision|0|||
48780732|NCT01105533|157040076|FG002|Overall Study|Physician Decision|0|||
48780733|NCT01105533|157040077|FG003|Overall Study|Physician Decision|0|||
48780734|NCT01105533|157040078|FG004|Overall Study|Physician Decision|0|||
48780735|NCT01105533|157040079|FG005|Overall Study|Physician Decision|0|||
48780736|NCT01105533|157040080|FG006|Overall Study|Physician Decision|0|||
48780737|NCT01105533|157040081|FG007|Overall Study|Physician Decision|1|||
48780738|NCT01105533|157040082|FG008|Overall Study|Physician Decision|0|||
48780739|NCT03892889|157040083|FG000|Overall Study|Adverse Event|17|||
48780740|NCT03892889|157040083|FG000|Overall Study|Lack of Efficacy|1|||
48780741|NCT03892889|157040083|FG000|Overall Study|Lost to Follow-up|46|||
48877331|NCT01574274|157388609|FG000|Overall Study|Withdrawal from Treatment but Agrees to be Followed|2|||
48780742|NCT03892889|157040083|FG000|Overall Study|Non-compliance with study drug|22|||
48780743|NCT03892889|157040083|FG000|Overall Study|Pregnancy|1|||
48780744|NCT03892889|157040083|FG000|Overall Study|Protocol Deviation|3|||
48780745|NCT03892889|157040083|FG000|Overall Study|Withdrawal by Subject|50|||
48780746|NCT03892889|157040083|FG000|Overall Study|Withdrawal by Caregiver|1|||
48780747|NCT03892889|157040083|FG000|Overall Study|Study Terminated by Sponsor|50|||
48780748|NCT03892889|157040083|FG000|Overall Study|Physician Decision|8|||
48780749|NCT03892889|157040083|FG000|Overall Study|Reason not Specified|5|||
48780750|NCT02348489|157040088|FG000|Overall Study|Death|336|||
48780751|NCT02348489|157040089|FG001|Overall Study|Death|335|||
48780752|NCT02348489|157040088|FG000|Overall Study|Withdrawal by Subject|14|||
48780753|NCT02348489|157040089|FG001|Overall Study|Withdrawal by Subject|27|||
48780754|NCT02348489|157040088|FG000|Overall Study|Lost to Follow-up|3|||
48780755|NCT02348489|157040089|FG001|Overall Study|Lost to Follow-up|5|||
48780756|NCT01933334|157040094|FG000|Overall Study|Adverse Event|5|||
48780757|NCT01933334|157040095|FG001|Overall Study|Adverse Event|1|||
48780758|NCT01933334|157040094|FG000|Overall Study|Withdrawal by Subject|0|||
48780759|NCT01933334|157040095|FG001|Overall Study|Withdrawal by Subject|1|||
48780760|NCT01923181|157040098|FG000|Overall Study|Protocol Violation|2|||
48780761|NCT01923181|157040099|FG001|Overall Study|Protocol Violation|2|||
48780762|NCT01923181|157040100|FG002|Overall Study|Protocol Violation|0|||
48780763|NCT01923181|157040101|FG003|Overall Study|Protocol Violation|2|||
48780764|NCT01923181|157040102|FG004|Overall Study|Protocol Violation|2|||
48780765|NCT01923181|157040103|FG005|Overall Study|Protocol Violation|1|||
48780766|NCT01923181|157040104|FG006|Overall Study|Protocol Violation|1|||
48780767|NCT01923181|157040105|FG007|Overall Study|Protocol Violation|2|||
48780768|NCT01923181|157040106|FG008|Overall Study|Protocol Violation|1|||
48780769|NCT01923181|157040098|FG000|Overall Study|Withdrawal by Subject|0|||
48780770|NCT01923181|157040099|FG001|Overall Study|Withdrawal by Subject|1|||
48780771|NCT01923181|157040100|FG002|Overall Study|Withdrawal by Subject|0|||
48780772|NCT01923181|157040101|FG003|Overall Study|Withdrawal by Subject|1|||
48780773|NCT01923181|157040102|FG004|Overall Study|Withdrawal by Subject|4|||
48780774|NCT01923181|157040103|FG005|Overall Study|Withdrawal by Subject|2|||
48780775|NCT01923181|157040104|FG006|Overall Study|Withdrawal by Subject|4|||
48780776|NCT01923181|157040105|FG007|Overall Study|Withdrawal by Subject|3|||
48982784|NCT03661983|157769874|FG001|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
48780777|NCT01923181|157040106|FG008|Overall Study|Withdrawal by Subject|1|||
48780778|NCT01923181|157040098|FG000|Overall Study|Other|1|||
48780779|NCT01923181|157040099|FG001|Overall Study|Other|0|||
48780780|NCT01923181|157040100|FG002|Overall Study|Other|0|||
48780781|NCT01923181|157040101|FG003|Overall Study|Other|1|||
48780782|NCT01923181|157040102|FG004|Overall Study|Other|0|||
48780783|NCT01923181|157040103|FG005|Overall Study|Other|0|||
48780784|NCT01923181|157040104|FG006|Overall Study|Other|0|||
48780785|NCT01923181|157040105|FG007|Overall Study|Other|0|||
48780786|NCT01923181|157040106|FG008|Overall Study|Other|0|||
48780787|NCT01923181|157040098|FG000|Overall Study|Lost to Follow-up|0|||
48780788|NCT01923181|157040099|FG001|Overall Study|Lost to Follow-up|3|||
48780789|NCT01923181|157040100|FG002|Overall Study|Lost to Follow-up|2|||
48780790|NCT01923181|157040101|FG003|Overall Study|Lost to Follow-up|1|||
48780791|NCT01923181|157040102|FG004|Overall Study|Lost to Follow-up|2|||
48982785|NCT03661983|157769875|FG002|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
48982786|NCT03661983|157769876|FG003|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
48982787|NCT03661983|157769873|FG000|Open Label Stabilization Phase|Study Terminated by Sponsor|3|||
48982788|NCT03661983|157769874|FG001|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
48982789|NCT03661983|157769875|FG002|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
48982790|NCT03661983|157769876|FG003|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
48982791|NCT03661983|157769873|FG000|Double-blind Randomized Phase|Adverse Event|0|||
48982792|NCT03661983|157769874|FG001|Double-blind Randomized Phase|Adverse Event|1|||
48982793|NCT03661983|157769875|FG002|Double-blind Randomized Phase|Adverse Event|0|||
48982794|NCT03661983|157769876|FG003|Double-blind Randomized Phase|Adverse Event|0|||
48982795|NCT03661983|157769873|FG000|Double-blind Randomized Phase|Disease Relapse|0|||
48982796|NCT03661983|157769874|FG001|Double-blind Randomized Phase|Disease Relapse|0|||
48982797|NCT03661983|157769875|FG002|Double-blind Randomized Phase|Disease Relapse|0|||
48982798|NCT03661983|157769876|FG003|Double-blind Randomized Phase|Disease Relapse|6|||
48982799|NCT03661983|157769873|FG000|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
48982800|NCT03661983|157769874|FG001|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
48982801|NCT03661983|157769875|FG002|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
48982802|NCT03661983|157769876|FG003|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1|||
48780792|NCT01923181|157040103|FG005|Overall Study|Lost to Follow-up|1|||
48780793|NCT01923181|157040104|FG006|Overall Study|Lost to Follow-up|3|||
48780794|NCT01923181|157040105|FG007|Overall Study|Lost to Follow-up|3|||
48780795|NCT01923181|157040106|FG008|Overall Study|Lost to Follow-up|1|||
48780796|NCT01172938|157040107|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|11|||
48780797|NCT01172938|157040108|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|8|||
48780798|NCT01172938|157040109|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|10|||
48780799|NCT01172938|157040110|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
48780800|NCT01172938|157040111|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
48780801|NCT01172938|157040112|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
49029393|NCT03123471|157943783|FG000|Placebo-controlled Phase|Miscellaneous|0|||
49029394|NCT03123471|157943784|FG001|Placebo-controlled Phase|Miscellaneous|1|||
49029395|NCT03123471|157943783|FG000|Apremilast Extension Phase|Lost to Follow-up|2|||
48780802|NCT01172938|157040113|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
48780803|NCT01172938|157040114|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
48780804|NCT01172938|157040115|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
48780805|NCT01172938|157040107|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
48780806|NCT01172938|157040108|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
48780807|NCT01172938|157040109|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
48780808|NCT01172938|157040110|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
48780809|NCT01172938|157040111|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
48780810|NCT01172938|157040112|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
48780811|NCT01172938|157040113|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
48780812|NCT01172938|157040114|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
48780813|NCT01172938|157040115|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
48780814|NCT01172938|157040107|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
48780815|NCT01172938|157040108|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
48780816|NCT01172938|157040109|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2|||
48780817|NCT01172938|157040110|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
48780818|NCT01172938|157040111|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
48780819|NCT01172938|157040112|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
48780820|NCT01172938|157040113|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
48780821|NCT01172938|157040114|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
48780822|NCT01172938|157040115|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
48780823|NCT01172938|157040107|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2|||
48780824|NCT01172938|157040108|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
48780825|NCT01172938|157040109|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
48780826|NCT01172938|157040110|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
48780827|NCT01172938|157040111|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
48780828|NCT01172938|157040112|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
48780829|NCT01172938|157040113|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
48780830|NCT01172938|157040114|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
48780831|NCT01172938|157040115|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
48780832|NCT01172938|157040107|FG000|Placebo-controlled Phase (Week 0-24)|Death|0|||
48780833|NCT01172938|157040108|FG001|Placebo-controlled Phase (Week 0-24)|Death|1|||
48780834|NCT01172938|157040109|FG002|Placebo-controlled Phase (Week 0-24)|Death|0|||
49029396|NCT03123471|157943784|FG001|Apremilast Extension Phase|Lost to Follow-up|5|||
49029397|NCT03123471|157943783|FG000|Apremilast Extension Phase|Adverse Event|1|||
48780835|NCT01172938|157040110|FG003|Placebo-controlled Phase (Week 0-24)|Death|0|||
48780836|NCT01172938|157040111|FG004|Placebo-controlled Phase (Week 0-24)|Death|0|||
48780837|NCT01172938|157040112|FG005|Placebo-controlled Phase (Week 0-24)|Death|0|||
48780838|NCT01172938|157040113|FG006|Placebo-controlled Phase (Week 0-24)|Death|0|||
48780839|NCT01172938|157040114|FG007|Placebo-controlled Phase (Week 0-24)|Death|0|||
48780840|NCT01172938|157040115|FG008|Placebo-controlled Phase (Week 0-24)|Death|0|||
48780841|NCT01172938|157040107|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1|||
48780842|NCT01172938|157040108|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
48780843|NCT01172938|157040109|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
48780844|NCT01172938|157040110|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
48780845|NCT01172938|157040111|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
48780846|NCT01172938|157040112|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
48780847|NCT01172938|157040113|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
48780848|NCT01172938|157040114|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
48780849|NCT01172938|157040115|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
48780850|NCT01172938|157040107|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
48780851|NCT01172938|157040108|FG001|Placebo-controlled Phase (Week 0-24)|Other|2|||
48780852|NCT01172938|157040109|FG002|Placebo-controlled Phase (Week 0-24)|Other|1|||
48780853|NCT01172938|157040110|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
48780854|NCT01172938|157040111|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
48780855|NCT01172938|157040112|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
48780856|NCT01172938|157040113|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
48780857|NCT01172938|157040114|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
49029398|NCT03123471|157943784|FG001|Apremilast Extension Phase|Adverse Event|5|||
48780858|NCT01172938|157040115|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
48877332|NCT01574274|157388610|FG001|Overall Study|Withdrawal from Treatment but Agrees to be Followed|0|||
49029399|NCT03123471|157943783|FG000|Apremilast Extension Phase|Lack of Efficacy|2|||
49029400|NCT03123471|157943784|FG001|Apremilast Extension Phase|Lack of Efficacy|8|||
48780859|NCT01172938|157040107|FG000|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
48780860|NCT01172938|157040108|FG001|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
48780861|NCT01172938|157040109|FG002|Active Treatment Phase (Weeks 25-52)|Adverse Event|5|||
48877333|NCT01574274|157388609|FG000|Overall Study|Other, unknown|3|||
48877334|NCT01574274|157388610|FG001|Overall Study|Other, unknown|2|||
48877335|NCT02498236|157388611|FG000|Overall Study|Did not show for testing|1|||
48877336|NCT02498236|157388612|FG001|Overall Study|Did not show for testing|0|||
48877337|NCT02498236|157388613|FG002|Overall Study|Did not show for testing|0|||
48877338|NCT02498236|157388614|FG003|Overall Study|Did not show for testing|0|||
48877339|NCT02498236|157388615|FG004|Overall Study|Did not show for testing|0|||
48877340|NCT02498236|157388616|FG005|Overall Study|Did not show for testing|0|||
48877341|NCT02498236|157388617|FG006|Overall Study|Did not show for testing|0|||
48877342|NCT02498236|157388618|FG007|Overall Study|Did not show for testing|1|||
48877343|NCT02498236|157388611|FG000|Overall Study|Equipment failure|0|||
48877344|NCT02498236|157388612|FG001|Overall Study|Equipment failure|0|||
48877345|NCT02498236|157388613|FG002|Overall Study|Equipment failure|0|||
48877346|NCT02498236|157388614|FG003|Overall Study|Equipment failure|0|||
48877347|NCT02498236|157388615|FG004|Overall Study|Equipment failure|0|||
48877348|NCT02498236|157388616|FG005|Overall Study|Equipment failure|0|||
48877349|NCT02498236|157388617|FG006|Overall Study|Equipment failure|1|||
48982803|NCT03661983|157769873|FG000|Double-blind Randomized Phase|Study Terminated by Sponsor|0|||
48982804|NCT03661983|157769874|FG001|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
48780862|NCT01172938|157040110|FG003|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
48780863|NCT01172938|157040111|FG004|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
48780864|NCT01172938|157040112|FG005|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
48780865|NCT01172938|157040113|FG006|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
48780866|NCT01172938|157040114|FG007|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
48780867|NCT01172938|157040115|FG008|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
48780868|NCT01172938|157040107|FG000|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
48780869|NCT01172938|157040108|FG001|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4|||
48780870|NCT01172938|157040109|FG002|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7|||
48780871|NCT01172938|157040110|FG003|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
48780872|NCT01172938|157040111|FG004|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1|||
48780873|NCT01172938|157040112|FG005|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
48780874|NCT01172938|157040113|FG006|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
48780875|NCT01172938|157040114|FG007|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
48780876|NCT01172938|157040115|FG008|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
48780877|NCT01172938|157040107|FG000|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
48780878|NCT01172938|157040108|FG001|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
48780879|NCT01172938|157040109|FG002|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1|||
48780880|NCT01172938|157040110|FG003|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
48780881|NCT01172938|157040111|FG004|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
48780882|NCT01172938|157040112|FG005|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
48780883|NCT01172938|157040113|FG006|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
48780884|NCT01172938|157040114|FG007|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
48780885|NCT01172938|157040115|FG008|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
48780886|NCT01172938|157040107|FG000|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
48780887|NCT01172938|157040108|FG001|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5|||
48780888|NCT01172938|157040109|FG002|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
48780889|NCT01172938|157040110|FG003|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
48780890|NCT01172938|157040111|FG004|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
48780891|NCT01172938|157040112|FG005|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9|||
48780892|NCT01172938|157040113|FG006|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
48780893|NCT01172938|157040114|FG007|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
48780894|NCT01172938|157040115|FG008|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
48780895|NCT01172938|157040107|FG000|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
48780896|NCT01172938|157040108|FG001|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
48877350|NCT02498236|157388618|FG007|Overall Study|Equipment failure|0|||
48877351|NCT02498236|157388611|FG000|Overall Study|Withdrawal by Subject|0|||
48877352|NCT02498236|157388612|FG001|Overall Study|Withdrawal by Subject|0|||
48877353|NCT02498236|157388613|FG002|Overall Study|Withdrawal by Subject|0|||
48877354|NCT02498236|157388614|FG003|Overall Study|Withdrawal by Subject|0|||
48877355|NCT02498236|157388615|FG004|Overall Study|Withdrawal by Subject|1|||
48877356|NCT02498236|157388616|FG005|Overall Study|Withdrawal by Subject|0|||
48877357|NCT02498236|157388617|FG006|Overall Study|Withdrawal by Subject|0|||
48877358|NCT02498236|157388618|FG007|Overall Study|Withdrawal by Subject|0|||
48877359|NCT01191008|157388624|FG000|Overall Study|Protocol Violation|7|||
48877360|NCT01191008|157388624|FG000|Overall Study|Lost to Follow-up|8|||
48780897|NCT01172938|157040109|FG002|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
48780898|NCT01172938|157040110|FG003|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
48780899|NCT01172938|157040111|FG004|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
48780900|NCT01172938|157040112|FG005|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
48780901|NCT01172938|157040113|FG006|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
48780902|NCT01172938|157040114|FG007|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
48780903|NCT01172938|157040115|FG008|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
48780904|NCT01172938|157040107|FG000|Active Treatment Phase (Weeks 25-52)|Other|0|||
48780905|NCT01172938|157040108|FG001|Active Treatment Phase (Weeks 25-52)|Other|0|||
48780906|NCT01172938|157040109|FG002|Active Treatment Phase (Weeks 25-52)|Other|0|||
48780907|NCT01172938|157040110|FG003|Active Treatment Phase (Weeks 25-52)|Other|0|||
48780908|NCT01172938|157040111|FG004|Active Treatment Phase (Weeks 25-52)|Other|0|||
48780909|NCT01172938|157040112|FG005|Active Treatment Phase (Weeks 25-52)|Other|1|||
48780910|NCT01172938|157040113|FG006|Active Treatment Phase (Weeks 25-52)|Other|1|||
48780911|NCT01172938|157040114|FG007|Active Treatment Phase (Weeks 25-52)|Other|0|||
48780912|NCT01172938|157040115|FG008|Active Treatment Phase (Weeks 25-52)|Other|0|||
48780913|NCT01172938|157040107|FG000|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
48780914|NCT01172938|157040108|FG001|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2|||
48780915|NCT01172938|157040109|FG002|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
48780916|NCT01172938|157040110|FG003|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
48780917|NCT01172938|157040111|FG004|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
48780918|NCT01172938|157040112|FG005|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
48780919|NCT01172938|157040113|FG006|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
48780920|NCT01172938|157040114|FG007|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3|||
48780921|NCT01172938|157040115|FG008|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
48780922|NCT01172938|157040107|FG000|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
48780923|NCT01172938|157040108|FG001|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7|||
48780924|NCT01172938|157040109|FG002|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8|||
48780925|NCT01172938|157040110|FG003|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
48780926|NCT01172938|157040111|FG004|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
48780927|NCT01172938|157040112|FG005|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
48780928|NCT01172938|157040113|FG006|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
48780929|NCT01172938|157040114|FG007|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4|||
48780930|NCT01172938|157040115|FG008|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
48780931|NCT01172938|157040107|FG000|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
48780932|NCT01172938|157040108|FG001|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
48780933|NCT01172938|157040109|FG002|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2|||
48780934|NCT01172938|157040110|FG003|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
48780935|NCT01172938|157040111|FG004|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
48780936|NCT01172938|157040112|FG005|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
48780937|NCT01172938|157040113|FG006|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
48780938|NCT01172938|157040114|FG007|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
48780939|NCT01172938|157040115|FG008|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
48780940|NCT01172938|157040107|FG000|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
48780941|NCT01172938|157040108|FG001|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10|||
48780942|NCT01172938|157040109|FG002|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8|||
48780943|NCT01172938|157040110|FG003|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
48780944|NCT01172938|157040111|FG004|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
48780945|NCT01172938|157040112|FG005|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
48780946|NCT01172938|157040113|FG006|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
48780947|NCT01172938|157040114|FG007|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5|||
48780948|NCT01172938|157040115|FG008|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2|||
48780949|NCT01172938|157040107|FG000|Active-Treatment Phase (Weeks 52-104)|Death|0|||
48780950|NCT01172938|157040108|FG001|Active-Treatment Phase (Weeks 52-104)|Death|0|||
48780951|NCT01172938|157040109|FG002|Active-Treatment Phase (Weeks 52-104)|Death|1|||
48780952|NCT01172938|157040110|FG003|Active-Treatment Phase (Weeks 52-104)|Death|0|||
48780953|NCT01172938|157040111|FG004|Active-Treatment Phase (Weeks 52-104)|Death|0|||
48780954|NCT01172938|157040112|FG005|Active-Treatment Phase (Weeks 52-104)|Death|0|||
48780955|NCT01172938|157040113|FG006|Active-Treatment Phase (Weeks 52-104)|Death|0|||
48780956|NCT01172938|157040114|FG007|Active-Treatment Phase (Weeks 52-104)|Death|0|||
48780957|NCT01172938|157040115|FG008|Active-Treatment Phase (Weeks 52-104)|Death|0|||
48780958|NCT01172938|157040107|FG000|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
48780959|NCT01172938|157040108|FG001|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
48780960|NCT01172938|157040109|FG002|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
48982805|NCT03661983|157769875|FG002|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
48780961|NCT01172938|157040110|FG003|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
48780962|NCT01172938|157040111|FG004|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
48780963|NCT01172938|157040112|FG005|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
48780964|NCT01172938|157040113|FG006|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
48780965|NCT01172938|157040114|FG007|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3|||
48780966|NCT01172938|157040115|FG008|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
48780967|NCT01172938|157040107|FG000|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
48780968|NCT01172938|157040108|FG001|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2|||
48780969|NCT01172938|157040109|FG002|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
48780970|NCT01172938|157040110|FG003|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
48780971|NCT01172938|157040111|FG004|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
48780972|NCT01172938|157040112|FG005|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
48780973|NCT01172938|157040113|FG006|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
48780974|NCT01172938|157040114|FG007|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
48780975|NCT01172938|157040115|FG008|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1|||
48780976|NCT01172938|157040107|FG000|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
48780977|NCT01172938|157040108|FG001|Active-Treatment Phase (Weeks 52-104)|Missing|1|||
48780978|NCT01172938|157040109|FG002|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
48780979|NCT01172938|157040110|FG003|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
48780980|NCT01172938|157040111|FG004|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
48780981|NCT01172938|157040112|FG005|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
48780982|NCT01172938|157040113|FG006|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
48780983|NCT01172938|157040114|FG007|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
48780984|NCT01172938|157040115|FG008|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
48780985|NCT01172938|157040107|FG000|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
48780986|NCT01172938|157040108|FG001|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
48780987|NCT01172938|157040109|FG002|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
48780988|NCT01172938|157040110|FG003|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
48780989|NCT01172938|157040111|FG004|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
48780990|NCT01172938|157040112|FG005|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
48780991|NCT01172938|157040113|FG006|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
48780992|NCT01172938|157040114|FG007|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
48780993|NCT01172938|157040115|FG008|Active-Treatment Phase Weeks (104-156)|Adverse Event|1|||
48780994|NCT01172938|157040107|FG000|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
48780995|NCT01172938|157040108|FG001|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4|||
48780996|NCT01172938|157040109|FG002|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
48780997|NCT01172938|157040110|FG003|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
48780998|NCT01172938|157040111|FG004|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
48780999|NCT01172938|157040112|FG005|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
48781000|NCT01172938|157040113|FG006|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
48781001|NCT01172938|157040114|FG007|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
48781002|NCT01172938|157040115|FG008|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
48781003|NCT01172938|157040107|FG000|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
48781004|NCT01172938|157040108|FG001|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6|||
48781005|NCT01172938|157040109|FG002|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3|||
48781006|NCT01172938|157040110|FG003|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
48781007|NCT01172938|157040111|FG004|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
48982806|NCT03661983|157769876|FG003|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
48982807|NCT00290355|157769881|FG000|Overall Study|Serious adverse event|7|||
48982808|NCT00290355|157769882|FG001|Overall Study|Serious adverse event|4|||
48982809|NCT00290355|157769881|FG000|Overall Study|Study product reactogenicity|1|||
48982810|NCT00290355|157769882|FG001|Overall Study|Study product reactogenicity|0|||
48982811|NCT00290355|157769881|FG000|Overall Study|Protocol Violation|1|||
48982812|NCT00290355|157769882|FG001|Overall Study|Protocol Violation|0|||
48982813|NCT00290355|157769881|FG000|Overall Study|Withdrawal by Subject|2|||
48982814|NCT00290355|157769882|FG001|Overall Study|Withdrawal by Subject|0|||
48982815|NCT00290355|157769881|FG000|Overall Study|Migrated / moved from the study area|1|||
48982816|NCT00290355|157769882|FG001|Overall Study|Migrated / moved from the study area|0|||
48982817|NCT00290355|157769881|FG000|Overall Study|Lost to Follow-up|3|||
48982818|NCT00290355|157769882|FG001|Overall Study|Lost to Follow-up|1|||
48982819|NCT00290355|157769881|FG000|Overall Study|Other|2|||
48982820|NCT00290355|157769882|FG001|Overall Study|Other|0|||
48982821|NCT00846027|157769883|FG000|Overall Study|Death|3|||
48982822|NCT00846027|157769883|FG000|Overall Study|Disease Progression|30|||
48982823|NCT00846027|157769883|FG000|Overall Study|Toxicity|12|||
48982824|NCT00846027|157769883|FG000|Overall Study|Patient Decision|7|||
48982825|NCT00846027|157769883|FG000|Overall Study|Investigator Discretion|29|||
48982826|NCT00846027|157769883|FG000|Overall Study|Protocol Violation|2|||
48982827|NCT00846027|157769883|FG000|Overall Study|Subject Not Treated|7|||
48781008|NCT01172938|157040112|FG005|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
48781009|NCT01172938|157040113|FG006|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
48781010|NCT01172938|157040114|FG007|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2|||
48781011|NCT01172938|157040115|FG008|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1|||
48781012|NCT01172938|157040107|FG000|Active-Treatment Phase Weeks (104-156)|Death|0|||
48781013|NCT01172938|157040108|FG001|Active-Treatment Phase Weeks (104-156)|Death|0|||
48781014|NCT01172938|157040109|FG002|Active-Treatment Phase Weeks (104-156)|Death|0|||
48781015|NCT01172938|157040110|FG003|Active-Treatment Phase Weeks (104-156)|Death|0|||
48781016|NCT01172938|157040111|FG004|Active-Treatment Phase Weeks (104-156)|Death|0|||
48781017|NCT01172938|157040112|FG005|Active-Treatment Phase Weeks (104-156)|Death|0|||
48781018|NCT01172938|157040113|FG006|Active-Treatment Phase Weeks (104-156)|Death|0|||
48781019|NCT01172938|157040114|FG007|Active-Treatment Phase Weeks (104-156)|Death|1|||
48781020|NCT01172938|157040115|FG008|Active-Treatment Phase Weeks (104-156)|Death|0|||
48781021|NCT01172938|157040107|FG000|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
48781022|NCT01172938|157040108|FG001|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1|||
48781023|NCT01172938|157040109|FG002|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
48781024|NCT01172938|157040110|FG003|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
48781025|NCT01172938|157040111|FG004|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
48781026|NCT01172938|157040112|FG005|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
48781027|NCT01172938|157040113|FG006|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
48781028|NCT01172938|157040114|FG007|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
48781029|NCT01172938|157040115|FG008|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
48781030|NCT01172938|157040107|FG000|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
48781031|NCT01172938|157040108|FG001|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
48781032|NCT01172938|157040109|FG002|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2|||
48781033|NCT01172938|157040110|FG003|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
48781034|NCT01172938|157040111|FG004|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
48781035|NCT01172938|157040112|FG005|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
48781036|NCT01172938|157040113|FG006|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
48781037|NCT01172938|157040114|FG007|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
48781038|NCT01172938|157040115|FG008|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
48781039|NCT01172938|157040107|FG000|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
48781040|NCT01172938|157040108|FG001|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4|||
48781041|NCT01172938|157040109|FG002|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1|||
48781042|NCT01172938|157040110|FG003|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
48781043|NCT01172938|157040111|FG004|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
48781044|NCT01172938|157040112|FG005|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
48781045|NCT01172938|157040113|FG006|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
48781046|NCT01172938|157040114|FG007|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3|||
48781047|NCT01172938|157040115|FG008|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
48781048|NCT01172938|157040107|FG000|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
48781049|NCT01172938|157040108|FG001|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
48781050|NCT01172938|157040109|FG002|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
48781051|NCT01172938|157040110|FG003|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
48781052|NCT01172938|157040111|FG004|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
48781053|NCT01172938|157040112|FG005|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
48781054|NCT01172938|157040113|FG006|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
48781055|NCT01172938|157040114|FG007|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3|||
48781056|NCT01172938|157040115|FG008|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2|||
48781057|NCT01172938|157040107|FG000|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
48781058|NCT01172938|157040108|FG001|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
48781059|NCT01172938|157040109|FG002|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
48781060|NCT01172938|157040110|FG003|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
48781061|NCT01172938|157040111|FG004|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
48781062|NCT01172938|157040112|FG005|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
48781063|NCT01172938|157040113|FG006|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
48781064|NCT01172938|157040114|FG007|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
48781065|NCT01172938|157040115|FG008|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
48781066|NCT01172938|157040107|FG000|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
48781067|NCT01172938|157040108|FG001|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
48781068|NCT01172938|157040109|FG002|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
48781069|NCT01172938|157040110|FG003|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
48781070|NCT01172938|157040111|FG004|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
48781071|NCT01172938|157040112|FG005|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
49029401|NCT03123471|157943783|FG000|Apremilast Extension Phase|Withdrawal by Subject|3|||
48781072|NCT01172938|157040113|FG006|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
48781073|NCT01172938|157040114|FG007|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
48781074|NCT01172938|157040115|FG008|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
48781075|NCT01172938|157040107|FG000|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
48781076|NCT01172938|157040108|FG001|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
48781077|NCT01172938|157040109|FG002|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
48781078|NCT01172938|157040110|FG003|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
48781079|NCT01172938|157040111|FG004|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
48781080|NCT01172938|157040112|FG005|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
48781081|NCT01172938|157040113|FG006|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
48781082|NCT01172938|157040114|FG007|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1|||
48781083|NCT01172938|157040115|FG008|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
48781084|NCT01172938|157040107|FG000|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
48781085|NCT01172938|157040108|FG001|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
48781086|NCT01172938|157040109|FG002|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
48781087|NCT01172938|157040110|FG003|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
48781088|NCT01172938|157040111|FG004|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
48781089|NCT01172938|157040112|FG005|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
48781090|NCT01172938|157040113|FG006|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
48781091|NCT01172938|157040114|FG007|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
48781092|NCT01172938|157040115|FG008|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
48781093|NCT01172938|157040107|FG000|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
48781094|NCT01172938|157040108|FG001|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
48781095|NCT01172938|157040109|FG002|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2|||
48781096|NCT01172938|157040110|FG003|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
48781097|NCT01172938|157040111|FG004|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
48781098|NCT01172938|157040112|FG005|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
48781099|NCT01172938|157040113|FG006|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
48781100|NCT01172938|157040114|FG007|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
48781101|NCT01172938|157040115|FG008|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
48781102|NCT01172938|157040107|FG000|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
48781103|NCT01172938|157040108|FG001|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
48781104|NCT01172938|157040109|FG002|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
48781105|NCT01172938|157040110|FG003|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
48781106|NCT01172938|157040111|FG004|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
48781107|NCT01172938|157040112|FG005|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
48781108|NCT01172938|157040113|FG006|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
48781109|NCT01172938|157040114|FG007|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
48781110|NCT01172938|157040115|FG008|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
48781111|NCT01172938|157040107|FG000|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
48781112|NCT01172938|157040108|FG001|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2|||
48781113|NCT01172938|157040109|FG002|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3|||
48781114|NCT01172938|157040110|FG003|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
48781115|NCT01172938|157040111|FG004|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
48781116|NCT01172938|157040112|FG005|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
48781117|NCT01172938|157040113|FG006|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
48781118|NCT01172938|157040114|FG007|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1|||
48781119|NCT01172938|157040115|FG008|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
48781120|NCT01172938|157040107|FG000|Active-Treatment Phase (Weeks 208-260)|Death|0|||
48781121|NCT01172938|157040108|FG001|Active-Treatment Phase (Weeks 208-260)|Death|0|||
48781122|NCT01172938|157040109|FG002|Active-Treatment Phase (Weeks 208-260)|Death|1|||
48781123|NCT01172938|157040110|FG003|Active-Treatment Phase (Weeks 208-260)|Death|0|||
48781124|NCT01172938|157040111|FG004|Active-Treatment Phase (Weeks 208-260)|Death|0|||
48781125|NCT01172938|157040112|FG005|Active-Treatment Phase (Weeks 208-260)|Death|0|||
48781126|NCT01172938|157040113|FG006|Active-Treatment Phase (Weeks 208-260)|Death|0|||
48781127|NCT01172938|157040114|FG007|Active-Treatment Phase (Weeks 208-260)|Death|0|||
48781128|NCT01172938|157040115|FG008|Active-Treatment Phase (Weeks 208-260)|Death|0|||
48781129|NCT01172938|157040107|FG000|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
48781130|NCT01172938|157040108|FG001|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
48781131|NCT01172938|157040109|FG002|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1|||
48781132|NCT01172938|157040110|FG003|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
48781133|NCT01172938|157040111|FG004|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
48781134|NCT01172938|157040112|FG005|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
48781135|NCT01172938|157040113|FG006|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
48781136|NCT01172938|157040114|FG007|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
48781137|NCT01172938|157040115|FG008|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
48781138|NCT01172938|157040107|FG000|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
48781139|NCT01172938|157040108|FG001|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
48781140|NCT01172938|157040109|FG002|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
48781141|NCT01172938|157040110|FG003|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
48781142|NCT01172938|157040111|FG004|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
48781143|NCT01172938|157040112|FG005|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
48781144|NCT01172938|157040113|FG006|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
48781145|NCT01172938|157040114|FG007|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
48781146|NCT01172938|157040115|FG008|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1|||
48781147|NCT01033747|157040116|FG000|Overall Study|Adverse Event|9|||
48781148|NCT01033747|157040117|FG001|Overall Study|Adverse Event|4|||
48781149|NCT01033747|157040116|FG000|Overall Study|Abnormal Laboratory Value|1|||
48781150|NCT01033747|157040117|FG001|Overall Study|Abnormal Laboratory Value|0|||
48781151|NCT01033747|157040116|FG000|Overall Study|Abnormal test procedure|0|||
48781152|NCT01033747|157040117|FG001|Overall Study|Abnormal test procedure|1|||
48781153|NCT01033747|157040116|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
48781154|NCT01033747|157040117|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
48781155|NCT01033747|157040116|FG000|Overall Study|Protocol Violation|1|||
48781156|NCT01033747|157040117|FG001|Overall Study|Protocol Violation|0|||
48781157|NCT01033747|157040116|FG000|Overall Study|Withdrawal by Subject|9|||
48781158|NCT01033747|157040117|FG001|Overall Study|Withdrawal by Subject|6|||
48781159|NCT01033747|157040116|FG000|Overall Study|Stopped at end of prolongation visit 1|1|||
48781160|NCT01033747|157040117|FG001|Overall Study|Stopped at end of prolongation visit 1|0|||
48781161|NCT01033747|157040116|FG000|Overall Study|Stopped at end of Extension 1|2|||
48781162|NCT01033747|157040117|FG001|Overall Study|Stopped at end of Extension 1|0|||
48781163|NCT00840970|157040122|FG000|Overall Study|Adverse Event|0|||
48781164|NCT00840970|157040123|FG001|Overall Study|Adverse Event|0|||
48781165|NCT00840970|157040124|FG002|Overall Study|Adverse Event|1|||
48781166|NCT00504829|157040125|FG000|Overall Study|Protocol Violation|6|||
48781167|NCT00504829|157040126|FG001|Overall Study|Protocol Violation|4|||
48781168|NCT00504829|157040127|FG002|Overall Study|Protocol Violation|10|||
48781169|NCT01490060|157040128|FG000|Cycle 1|Change of Treatment|0|||
48781170|NCT01490060|157040129|FG001|Cycle 1|Change of Treatment|1|||
48781171|NCT01490060|157040130|FG002|Cycle 1|Change of Treatment|1|||
48781172|NCT01490060|157040131|FG003|Cycle 1|Change of Treatment|1|||
48781173|NCT01490060|157040128|FG000|Cycle 1|Insurance Denied|0|||
48781174|NCT01490060|157040129|FG001|Cycle 1|Insurance Denied|0|||
48781175|NCT01490060|157040130|FG002|Cycle 1|Insurance Denied|2|||
48781176|NCT01490060|157040131|FG003|Cycle 1|Insurance Denied|0|||
48781177|NCT01490060|157040128|FG000|Cycle 1|Withdrawal by Subject|0|||
48781178|NCT01490060|157040129|FG001|Cycle 1|Withdrawal by Subject|0|||
48781179|NCT01490060|157040130|FG002|Cycle 1|Withdrawal by Subject|0|||
48781180|NCT01490060|157040131|FG003|Cycle 1|Withdrawal by Subject|1|||
48781181|NCT01490060|157040128|FG000|Cycle 1|Treatment at Another Facility|0|||
48781182|NCT01490060|157040129|FG001|Cycle 1|Treatment at Another Facility|0|||
48781183|NCT01490060|157040130|FG002|Cycle 1|Treatment at Another Facility|0|||
48781184|NCT01490060|157040131|FG003|Cycle 1|Treatment at Another Facility|1|||
48781185|NCT01490060|157040128|FG000|Cycle 2|Change of Treatment|1|||
48781186|NCT01490060|157040129|FG001|Cycle 2|Change of Treatment|1|||
48781187|NCT01490060|157040130|FG002|Cycle 2|Change of Treatment|0|||
48781188|NCT01490060|157040131|FG003|Cycle 2|Change of Treatment|0|||
48781189|NCT01490060|157040128|FG000|Cycle 2|Non-Compliance|0|||
48781190|NCT01490060|157040129|FG001|Cycle 2|Non-Compliance|0|||
48781191|NCT01490060|157040130|FG002|Cycle 2|Non-Compliance|1|||
49029402|NCT03123471|157943784|FG001|Apremilast Extension Phase|Withdrawal by Subject|7|||
49029403|NCT01880593|157943800|FG000|Overall Study|Adverse Event|1|||
49029404|NCT01880593|157943801|FG001|Overall Study|Adverse Event|0|||
49029405|NCT01880593|157943800|FG000|Overall Study|Lack of Efficacy|1|||
49029406|NCT01880593|157943801|FG001|Overall Study|Lack of Efficacy|5|||
48781192|NCT01490060|157040131|FG003|Cycle 2|Non-Compliance|0|||
48781193|NCT01490060|157040128|FG000|Cycle 2|Adverse Event Related to Chemotherapy|1|||
48781194|NCT01490060|157040129|FG001|Cycle 2|Adverse Event Related to Chemotherapy|0|||
48781195|NCT01490060|157040130|FG002|Cycle 2|Adverse Event Related to Chemotherapy|0|||
49029407|NCT01880593|157943800|FG000|Overall Study|Withdrawal by Subject|6|||
48781196|NCT01490060|157040131|FG003|Cycle 2|Adverse Event Related to Chemotherapy|0|||
48781197|NCT04443218|157040132|FG000|Overall Study|Exited study for other reasons|9|||
48781198|NCT04443218|157040132|FG000|Overall Study|Withdrawal by Subject|1|||
48781199|NCT04443218|157040132|FG000|Overall Study|Lost to Follow-up|4|||
48781200|NCT04443218|157040132|FG000|Overall Study|Death|19|||
48781201|NCT00403546|157040138|FG000|Signed Informed Consent/Open-Label|Withdrew Consent|6|||
48781202|NCT00403546|157040139|FG001|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
48781203|NCT00403546|157040140|FG002|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
48781204|NCT00403546|157040138|FG000|Signed Informed Consent/Open-Label|Early Termination|8|||
48781205|NCT00403546|157040139|FG001|Signed Informed Consent/Open-Label|Early Termination|0|||
48781206|NCT00403546|157040140|FG002|Signed Informed Consent/Open-Label|Early Termination|0|||
48781207|NCT00403546|157040138|FG000|Signed Informed Consent/Open-Label|Terminated by Investigator|9|||
48781208|NCT00403546|157040139|FG001|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
48781209|NCT00403546|157040140|FG002|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
48781210|NCT00403546|157040138|FG000|Signed Informed Consent/Open-Label|Adverse Event|5|||
48781211|NCT00403546|157040139|FG001|Signed Informed Consent/Open-Label|Adverse Event|0|||
48781212|NCT00403546|157040140|FG002|Signed Informed Consent/Open-Label|Adverse Event|0|||
48781213|NCT00403546|157040138|FG000|Screening Phase|Screening Failure|22|||
48781214|NCT00403546|157040139|FG001|Screening Phase|Screening Failure|0|||
48781215|NCT00403546|157040140|FG002|Screening Phase|Screening Failure|0|||
48781216|NCT00403546|157040138|FG000|Screening Phase|Adverse Event|1|||
48781217|NCT00403546|157040139|FG001|Screening Phase|Adverse Event|0|||
48781218|NCT00403546|157040140|FG002|Screening Phase|Adverse Event|0|||
48781219|NCT00403546|157040138|FG000|Screening Phase|Terminated Prior to Randomization|5|||
48781220|NCT00403546|157040139|FG001|Screening Phase|Terminated Prior to Randomization|0|||
48781221|NCT00403546|157040140|FG002|Screening Phase|Terminated Prior to Randomization|0|||
48781222|NCT00403546|157040138|FG000|Randomized Trial|Early Terminations|0|||
48781223|NCT00403546|157040139|FG001|Randomized Trial|Early Terminations|17|||
48781224|NCT00403546|157040140|FG002|Randomized Trial|Early Terminations|16|||
48781225|NCT03207750|157040143|FG000|Overall Study|Adverse Event|3|||
48781226|NCT03207750|157040144|FG001|Overall Study|Adverse Event|2|||
48781227|NCT03207750|157040143|FG000|Overall Study|Lost to Follow-up|21|||
48781228|NCT03207750|157040144|FG001|Overall Study|Lost to Follow-up|29|||
48781229|NCT03207750|157040143|FG000|Overall Study|Protocol Violation|0|||
48781230|NCT03207750|157040144|FG001|Overall Study|Protocol Violation|1|||
48781231|NCT03207750|157040143|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11|||
48781232|NCT03207750|157040144|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13|||
48781233|NCT03207750|157040143|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
48781234|NCT03207750|157040144|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10|||
48781235|NCT03207750|157040143|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10|||
48781236|NCT03207750|157040144|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5|||
48781237|NCT03207750|157040143|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1|||
48781238|NCT03207750|157040144|FG001|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2|||
48781239|NCT03207750|157040143|FG000|Overall Study|OTHER, NOT SPECIFIED|5|||
48781240|NCT03207750|157040144|FG001|Overall Study|OTHER, NOT SPECIFIED|4|||
48781241|NCT03893448|157040155|FG000|Overall Study|Withdrawal by Parent/Guardian|59|||
48781242|NCT03893448|157040156|FG001|Overall Study|Withdrawal by Parent/Guardian|85|||
48781243|NCT03893448|157040155|FG000|Overall Study|Physician Decision|8|||
48781244|NCT03893448|157040156|FG001|Overall Study|Physician Decision|14|||
48781245|NCT03893448|157040155|FG000|Overall Study|Lost to Follow-up|34|||
48781246|NCT03893448|157040156|FG001|Overall Study|Lost to Follow-up|27|||
48781247|NCT03893448|157040155|FG000|Overall Study|Death|1|||
48781248|NCT03893448|157040156|FG001|Overall Study|Death|0|||
48781249|NCT00793910|157040157|FG000|Overall Study|discarded study pills|0|||
48781250|NCT00793910|157040158|FG001|Overall Study|discarded study pills|1|||
48781251|NCT00793910|157040157|FG000|Overall Study|did not pick up medications|1|||
48781252|NCT00793910|157040158|FG001|Overall Study|did not pick up medications|1|||
48781253|NCT00793910|157040157|FG000|Overall Study|ineligible based on entry criteria|2|||
48781254|NCT00793910|157040158|FG001|Overall Study|ineligible based on entry criteria|3|||
48781255|NCT00793910|157040157|FG000|Overall Study|decided to undergo LASIK instead of PRK|2|||
48781256|NCT00793910|157040158|FG001|Overall Study|decided to undergo LASIK instead of PRK|1|||
48781257|NCT00793910|157040157|FG000|Overall Study|Withdrawal by Subject|0|||
48781258|NCT00793910|157040158|FG001|Overall Study|Withdrawal by Subject|1|||
48781259|NCT01525082|157040162|FG000|Overall Study|Death|1|||
48781260|NCT02056301|157040164|FG000|Overall Study|Protocol Violation|1|||
48781261|NCT02056301|157040165|FG001|Overall Study|Protocol Violation|2|||
48781262|NCT02056301|157040164|FG000|Overall Study|Surgical complications req. 2nd surgery|1|||
48781263|NCT02056301|157040165|FG001|Overall Study|Surgical complications req. 2nd surgery|0|||
48781264|NCT02056301|157040164|FG000|Overall Study|Withdrawal by Subject|0|||
48781265|NCT02056301|157040165|FG001|Overall Study|Withdrawal by Subject|1|||
48781266|NCT02056301|157040164|FG000|Overall Study|Issues with epidural|0|||
48781267|NCT02056301|157040165|FG001|Overall Study|Issues with epidural|3|||
48781268|NCT01748994|157040166|FG000|Overall Study|Lost to Follow-up|8|||
48781269|NCT01748994|157040167|FG001|Overall Study|Lost to Follow-up|6|||
48781270|NCT02041429|157040171|FG000|Overall Study|Progressive Disease|2|||
48781271|NCT02041429|157040172|FG001|Overall Study|Progressive Disease|2|||
48781272|NCT02041429|157040173|FG002|Overall Study|Progressive Disease|3|||
48781273|NCT02041429|157040174|FG003|Overall Study|Progressive Disease|2|||
48781274|NCT02041429|157040171|FG000|Overall Study|Toxicity|0|||
48781275|NCT02041429|157040172|FG001|Overall Study|Toxicity|1|||
48781276|NCT02041429|157040173|FG002|Overall Study|Toxicity|4|||
48781277|NCT02041429|157040174|FG003|Overall Study|Toxicity|2|||
48781278|NCT02041429|157040171|FG000|Overall Study|Withdrawal by Subject|0|||
48781279|NCT02041429|157040172|FG001|Overall Study|Withdrawal by Subject|1|||
48781280|NCT02041429|157040173|FG002|Overall Study|Withdrawal by Subject|0|||
48781281|NCT02041429|157040174|FG003|Overall Study|Withdrawal by Subject|0|||
48781282|NCT02041429|157040171|FG000|Overall Study|On Maintenance Therapy|1|||
48781283|NCT02041429|157040172|FG001|Overall Study|On Maintenance Therapy|0|||
48781284|NCT02041429|157040173|FG002|Overall Study|On Maintenance Therapy|0|||
48781285|NCT02041429|157040174|FG003|Overall Study|On Maintenance Therapy|2|||
48781286|NCT01427712|157040175|FG000|Overall Study|Transfer to a different hospital|2|||
48781287|NCT01427712|157040175|FG000|Overall Study|Lost to Follow-up|1|||
48781288|NCT01427712|157040175|FG000|Overall Study|Aggravation of cystic fibrosis|3|||
48781289|NCT01427712|157040175|FG000|Overall Study|Failure to visit|1|||
48781290|NCT02338362|157040176|FG000|Overall Study|Withdrawal by Subject|1|||
48781291|NCT02338362|157040177|FG001|Overall Study|Withdrawal by Subject|1|||
48781292|NCT01669343|157040179|FG000|Part A: All Patients|Withdrawal by Subject|7|||
48781293|NCT01669343|157040179|FG000|Part A: All Patients|Ineligibility discovered after enrollment|2|||
48781294|NCT01669343|157040179|FG000|Part B: Patients With BMI>=25|Withdrawal by Subject|13|||
48781295|NCT01669343|157040179|FG000|Part B: Patients With BMI>=25|Recruited during interim analysis|3|||
48781296|NCT01669343|157040179|FG000|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1|||
48781297|NCT00439777|157040180|FG000|Treatment Period|Death|29|||
48781298|NCT00439777|157040181|FG001|Treatment Period|Death|21|||
48781299|NCT00439777|157040180|FG000|Treatment Period|Study terminated by sponsor|125|||
48781300|NCT00439777|157040181|FG001|Treatment Period|Study terminated by sponsor|132|||
48781301|NCT00439777|157040180|FG000|Treatment Period|Site closed by investigator|0|||
48781302|NCT00439777|157040181|FG001|Treatment Period|Site closed by investigator|1|||
48781303|NCT00439777|157040180|FG000|Treatment Period|Did not take study treatment|7|||
48781304|NCT00439777|157040181|FG001|Treatment Period|Did not take study treatment|8|||
48781305|NCT00439777|157040180|FG000|Treatment Period|Adverse Event|111|||
48781306|NCT00439777|157040181|FG001|Treatment Period|Adverse Event|92|||
48781307|NCT00439777|157040180|FG000|Treatment Period|Protocol Violation|23|||
48781308|NCT00439777|157040181|FG001|Treatment Period|Protocol Violation|30|||
48781309|NCT00439777|157040180|FG000|Treatment Period|Withdrawal by Subject|66|||
48781310|NCT00439777|157040181|FG001|Treatment Period|Withdrawal by Subject|118|||
48781311|NCT00439777|157040180|FG000|Treatment Period|Lack of Efficacy|1|||
48781312|NCT00439777|157040181|FG001|Treatment Period|Lack of Efficacy|4|||
48781313|NCT00439777|157040180|FG000|Treatment Period|Lost to Follow-up|8|||
48781314|NCT00439777|157040181|FG001|Treatment Period|Lost to Follow-up|10|||
48781315|NCT00439777|157040180|FG000|Treatment Period|Protocol driven decision point|1|||
49029408|NCT01880593|157943801|FG001|Overall Study|Withdrawal by Subject|1|||
49029409|NCT03206177|157943802|FG000|Overall Study|Withdrawal by Subject|1|||
49029410|NCT00705536|157945084|FG000|Start Period 1|Withdrawal by Subject|0|||
48781316|NCT00439777|157040181|FG001|Treatment Period|Protocol driven decision point|3|||
48781317|NCT00439777|157040180|FG000|Treatment Period|Physician Decision|7|||
48781318|NCT00439777|157040181|FG001|Treatment Period|Physician Decision|18|||
48781319|NCT00439777|157040180|FG000|Treatment Period|Clinical endpoint reached|26|||
48781320|NCT00439777|157040181|FG001|Treatment Period|Clinical endpoint reached|13|||
48781321|NCT00439777|157040180|FG000|Treatment Period|Technical problems|3|||
48781322|NCT00439777|157040181|FG001|Treatment Period|Technical problems|1|||
48781323|NCT00439777|157040180|FG000|Treatment Period|Participant convenience|12|||
48781324|NCT00439777|157040181|FG001|Treatment Period|Participant convenience|8|||
48781325|NCT00439777|157040180|FG000|Observational Period|Protocol Violation|0|||
48781326|NCT00439777|157040181|FG001|Observational Period|Protocol Violation|2|||
48781327|NCT00439777|157040180|FG000|Observational Period|Withdrawal by Subject|9|||
48781328|NCT00439777|157040181|FG001|Observational Period|Withdrawal by Subject|5|||
48781329|NCT00439777|157040180|FG000|Observational Period|Lost to Follow-up|1|||
48781330|NCT00439777|157040181|FG001|Observational Period|Lost to Follow-up|11|||
48781331|NCT00439777|157040180|FG000|Observational Period|Death|27|||
48781332|NCT00439777|157040181|FG001|Observational Period|Death|20|||
48781333|NCT00439777|157040180|FG000|Observational Period|Study terminated by sponsor|3|||
48781334|NCT00439777|157040181|FG001|Observational Period|Study terminated by sponsor|1|||
48781335|NCT00439777|157040180|FG000|Observational Period|Protocol driven decision point|0|||
48781336|NCT00439777|157040181|FG001|Observational Period|Protocol driven decision point|1|||
48781337|NCT00439777|157040180|FG000|Observational Period|Lack of Efficacy|1|||
48781338|NCT00439777|157040181|FG001|Observational Period|Lack of Efficacy|0|||
48781339|NCT00439777|157040180|FG000|Observational Period|Technical problems|0|||
48781340|NCT00439777|157040181|FG001|Observational Period|Technical problems|1|||
49029411|NCT00705536|157945085|FG001|Start Period 1|Withdrawal by Subject|0|||
48781341|NCT00661492|157040182|FG000|Overall Study|Adverse Event|16|||
48781342|NCT00661492|157040183|FG001|Overall Study|Adverse Event|13|||
48781343|NCT00661492|157040182|FG000|Overall Study|Disease Progression|44|||
48781344|NCT00661492|157040183|FG001|Overall Study|Disease Progression|14|||
48781345|NCT00661492|157040182|FG000|Overall Study|Patient Request|6|||
48781346|NCT00661492|157040183|FG001|Overall Study|Patient Request|1|||
48781347|NCT00661492|157040182|FG000|Overall Study|Investigator Request|1|||
48781348|NCT00661492|157040183|FG001|Overall Study|Investigator Request|0|||
48781349|NCT00661492|157040182|FG000|Overall Study|Lost to Follow-up|0|||
48781350|NCT00661492|157040183|FG001|Overall Study|Lost to Follow-up|1|||
48781351|NCT00661492|157040182|FG000|Overall Study|Other|1|||
48781352|NCT00661492|157040183|FG001|Overall Study|Other|0|||
48781353|NCT01272934|157040184|FG000|Overall Study|Adverse Event|0|||
48781354|NCT01272934|157040185|FG001|Overall Study|Adverse Event|1|||
48781355|NCT01272934|157040184|FG000|Overall Study|Abnormal Laboratory Value|0|||
48781356|NCT01272934|157040185|FG001|Overall Study|Abnormal Laboratory Value|1|||
48781357|NCT01143259|157040188|FG000|Overall Study|Withdrawal by Subject|3|||
48781358|NCT01143259|157040189|FG001|Overall Study|Withdrawal by Subject|2|||
48781359|NCT01143259|157040188|FG000|Overall Study|Protocol Violation|13|||
48781360|NCT01143259|157040189|FG001|Overall Study|Protocol Violation|9|||
48781361|NCT01143259|157040188|FG000|Overall Study|Screen Failure|7|||
48781362|NCT01143259|157040189|FG001|Overall Study|Screen Failure|9|||
48781363|NCT00835406|157040192|FG000|Period: First Intervention|Adverse Event|0|||
48781364|NCT00835406|157040193|FG001|Period: First Intervention|Adverse Event|1|||
48781365|NCT00835406|157040192|FG000|Period: First Intervention|Withdrawal by Subject|2|||
48781366|NCT00835406|157040193|FG001|Period: First Intervention|Withdrawal by Subject|0|||
48781367|NCT00835406|157040192|FG000|Period: Washout of 7 Days|Withdrawal by Subject|0|||
49029412|NCT00705536|157945086|FG002|Start Period 1|Withdrawal by Subject|0|||
48781368|NCT00835406|157040193|FG001|Period: Washout of 7 Days|Withdrawal by Subject|2|||
48781369|NCT03864900|157040194|FG000|Overall Study|Withdrawal by Subject|1|||
48781370|NCT03864900|157040195|FG001|Overall Study|Withdrawal by Subject|1|||
48781371|NCT03864900|157040194|FG000|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2|||
48781372|NCT03864900|157040195|FG001|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5|||
48781373|NCT00499889|157040197|FG000|Overall Study|Infection prior to treatment|1|||
48781374|NCT01358526|157040201|FG000|Open-label Titration Period|Adverse Event|95|||
48781375|NCT01358526|157040202|FG001|Open-label Titration Period|Adverse Event|0|||
48781376|NCT01358526|157040203|FG002|Open-label Titration Period|Adverse Event|0|||
48781377|NCT01358526|157040201|FG000|Open-label Titration Period|Withdrawal by Subject|65|||
48781378|NCT01358526|157040202|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
48781379|NCT01358526|157040203|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
48781380|NCT01358526|157040201|FG000|Open-label Titration Period|Lost to Follow-up|25|||
48781381|NCT01358526|157040202|FG001|Open-label Titration Period|Lost to Follow-up|0|||
48781382|NCT01358526|157040203|FG002|Open-label Titration Period|Lost to Follow-up|0|||
48781383|NCT01358526|157040201|FG000|Open-label Titration Period|Lack of Efficacy|107|||
48781384|NCT01358526|157040202|FG001|Open-label Titration Period|Lack of Efficacy|0|||
48781385|NCT01358526|157040203|FG002|Open-label Titration Period|Lack of Efficacy|0|||
48781386|NCT01358526|157040201|FG000|Open-label Titration Period|Confirmed or suspected diversion|16|||
48781387|NCT01358526|157040202|FG001|Open-label Titration Period|Confirmed or suspected diversion|0|||
48781388|NCT01358526|157040203|FG002|Open-label Titration Period|Confirmed or suspected diversion|0|||
48781389|NCT01358526|157040201|FG000|Open-label Titration Period|Administrative|8|||
48781390|NCT01358526|157040202|FG001|Open-label Titration Period|Administrative|0|||
48781391|NCT01358526|157040203|FG002|Open-label Titration Period|Administrative|0|||
49029413|NCT00705536|157945087|FG003|Start Period 1|Withdrawal by Subject|1|||
48781392|NCT01358526|157040201|FG000|Open-label Titration Period|Did not qualify|178|||
49029414|NCT02918877|157945088|FG000|Overall Study|Withdrawal by Subject|2|||
49029415|NCT02918877|157945089|FG001|Overall Study|Withdrawal by Subject|2|||
49029416|NCT02918877|157945088|FG000|Overall Study|Surgery cancelled|1|||
49029417|NCT02918877|157945089|FG001|Overall Study|Surgery cancelled|0|||
49029418|NCT02918877|157945088|FG000|Overall Study|Physician Decision|1|||
49029419|NCT02918877|157945089|FG001|Overall Study|Physician Decision|0|||
49029420|NCT02918877|157945088|FG000|Overall Study|Received intraoperative steroids|1|||
49029421|NCT02918877|157945089|FG001|Overall Study|Received intraoperative steroids|0|||
49029422|NCT02918877|157945088|FG000|Overall Study|Unable to obtain lab samples|1|||
49029423|NCT02918877|157945089|FG001|Overall Study|Unable to obtain lab samples|0|||
48781393|NCT01358526|157040202|FG001|Open-label Titration Period|Did not qualify|0|||
48781394|NCT01358526|157040203|FG002|Open-label Titration Period|Did not qualify|0|||
49029424|NCT02918877|157945088|FG000|Overall Study|Unsafe to perform BAL|0|||
49029425|NCT02918877|157945089|FG001|Overall Study|Unsafe to perform BAL|1|||
48781395|NCT01358526|157040201|FG000|Double-blind Phase|Adverse Event|0|||
48781396|NCT01358526|157040202|FG001|Double-blind Phase|Adverse Event|24|||
49029426|NCT01328093|157945102|FG000|Double-Blind Phase|Adverse Event|78|||
49029427|NCT01328093|157945103|FG001|Double-Blind Phase|Adverse Event|15|||
49029428|NCT01328093|157945102|FG000|Double-Blind Phase|Withdrawal by Subject|42|||
49029429|NCT01328093|157945103|FG001|Double-Blind Phase|Withdrawal by Subject|14|||
48781397|NCT01358526|157040203|FG002|Double-blind Phase|Adverse Event|23|||
48781398|NCT01358526|157040201|FG000|Double-blind Phase|Withdrawal by Subject|0|||
48781399|NCT01358526|157040202|FG001|Double-blind Phase|Withdrawal by Subject|10|||
48781400|NCT01358526|157040203|FG002|Double-blind Phase|Withdrawal by Subject|8|||
48781401|NCT01358526|157040201|FG000|Double-blind Phase|Lost to Follow-up|0|||
48781402|NCT01358526|157040202|FG001|Double-blind Phase|Lost to Follow-up|4|||
48781403|NCT01358526|157040203|FG002|Double-blind Phase|Lost to Follow-up|1|||
49029430|NCT01328093|157945102|FG000|Double-Blind Phase|Lost to Follow-up|39|||
49029431|NCT01328093|157945103|FG001|Double-Blind Phase|Lost to Follow-up|14|||
48781404|NCT01358526|157040201|FG000|Double-blind Phase|Lack of Efficacy|0|||
48781405|NCT01358526|157040202|FG001|Double-blind Phase|Lack of Efficacy|31|||
48781406|NCT01358526|157040203|FG002|Double-blind Phase|Lack of Efficacy|73|||
48781407|NCT01358526|157040201|FG000|Double-blind Phase|Confirmed or suspected diversion|0|||
48781408|NCT01358526|157040202|FG001|Double-blind Phase|Confirmed or suspected diversion|5|||
48781409|NCT01358526|157040203|FG002|Double-blind Phase|Confirmed or suspected diversion|6|||
48781410|NCT01358526|157040201|FG000|Double-blind Phase|Administrative|0|||
48781411|NCT01358526|157040202|FG001|Double-blind Phase|Administrative|6|||
48781412|NCT01358526|157040203|FG002|Double-blind Phase|Administrative|10|||
48781413|NCT03394924|157040207|FG000|Overall Study|Adverse Event|0|||
48781414|NCT03394924|157040208|FG001|Overall Study|Adverse Event|5|||
48781415|NCT03394924|157040209|FG002|Overall Study|Adverse Event|0|||
48781416|NCT03394924|157040207|FG000|Overall Study|Withdrawal by Subject|2|||
48781417|NCT03394924|157040208|FG001|Overall Study|Withdrawal by Subject|0|||
48781418|NCT03394924|157040209|FG002|Overall Study|Withdrawal by Subject|0|||
48781419|NCT03394924|157040207|FG000|Overall Study|Lost to Follow-up|0|||
48781420|NCT03394924|157040208|FG001|Overall Study|Lost to Follow-up|1|||
48781421|NCT03394924|157040209|FG002|Overall Study|Lost to Follow-up|0|||
48781422|NCT03394924|157040207|FG000|Overall Study|Did not meet all inclusion criteria|1|||
48781423|NCT03394924|157040208|FG001|Overall Study|Did not meet all inclusion criteria|0|||
48781424|NCT03394924|157040209|FG002|Overall Study|Did not meet all inclusion criteria|0|||
48781425|NCT04223856|157040210|FG000|Overall Study|Progressive disease|153|||
48781426|NCT04223856|157040211|FG001|Overall Study|Progressive disease|73|||
48781427|NCT04223856|157040210|FG000|Overall Study|Adverse Event|97|||
48781428|NCT04223856|157040211|FG001|Overall Study|Adverse Event|62|||
48781429|NCT04223856|157040210|FG000|Overall Study|Physician Decision|9|||
48781430|NCT04223856|157040211|FG001|Overall Study|Physician Decision|28|||
48781431|NCT04223856|157040210|FG000|Overall Study|Withdrawal by Subject|22|||
48781432|NCT04223856|157040211|FG001|Overall Study|Withdrawal by Subject|24|||
48781433|NCT04223856|157040210|FG000|Overall Study|Other|7|||
48781434|NCT04223856|157040211|FG001|Overall Study|Other|2|||
48781435|NCT04223856|157040210|FG000|Overall Study|Randomized but not treated|2|||
48781436|NCT04223856|157040211|FG001|Overall Study|Randomized but not treated|11|||
48781437|NCT04223856|157040210|FG000|Overall Study|On-treatment|144|||
48781438|NCT04223856|157040211|FG001|Overall Study|On-treatment|0|||
48781439|NCT02349711|157042401|FG000|Overall Study|Withdrawal by Subject|2|||
48781440|NCT02349711|157042402|FG001|Overall Study|Withdrawal by Subject|1|||
48781441|NCT02349711|157042401|FG000|Overall Study|Lost to Follow-up|1|||
48781442|NCT02349711|157042402|FG001|Overall Study|Lost to Follow-up|1|||
48781443|NCT02343458|157042410|FG000|Overall Study|Adverse Event|15|||
48781444|NCT02343458|157042411|FG001|Overall Study|Adverse Event|14|||
49029432|NCT01328093|157945102|FG000|Double-Blind Phase|Protocol Violation|30|||
49029433|NCT01328093|157945103|FG001|Double-Blind Phase|Protocol Violation|10|||
49029434|NCT01328093|157945102|FG000|Double-Blind Phase|Lack of Efficacy|55|||
49029435|NCT01328093|157945103|FG001|Double-Blind Phase|Lack of Efficacy|13|||
49029436|NCT01328093|157945102|FG000|Double-Blind Phase|Sponsor Decision|17|||
49029437|NCT01328093|157945103|FG001|Double-Blind Phase|Sponsor Decision|3|||
49029438|NCT01328093|157945102|FG000|Double-Blind Phase|Entry Criteria Not Met|7|||
49029439|NCT01328093|157945103|FG001|Double-Blind Phase|Entry Criteria Not Met|5|||
49029440|NCT01328093|157945102|FG000|Double-Blind Phase|Scheduling conflict|8|||
49029441|NCT01328093|157945103|FG001|Double-Blind Phase|Scheduling conflict|3|||
49029442|NCT01328093|157945102|FG000|Double-Blind Phase|Subject is moving or has moved|8|||
49029443|NCT01328093|157945103|FG001|Double-Blind Phase|Subject is moving or has moved|1|||
49029444|NCT01328093|157945102|FG000|Double-Blind Phase|Death|1|||
49029445|NCT01328093|157945103|FG001|Double-Blind Phase|Death|0|||
49029446|NCT01328093|157945102|FG000|Open-Label Phase|Sponsor Decision|98|||
49029447|NCT01328093|157945103|FG001|Open-Label Phase|Sponsor Decision|34|||
49029448|NCT01328093|157945102|FG000|Open-Label Phase|Protocol Violation|8|||
49029449|NCT01328093|157945103|FG001|Open-Label Phase|Protocol Violation|3|||
49029450|NCT01328093|157945102|FG000|Open-Label Phase|Lost to Follow-up|10|||
49029451|NCT01328093|157945103|FG001|Open-Label Phase|Lost to Follow-up|1|||
49029452|NCT01328093|157945102|FG000|Open-Label Phase|Adverse Event|10|||
49029453|NCT01328093|157945103|FG001|Open-Label Phase|Adverse Event|4|||
48781445|NCT02343458|157042412|FG002|Overall Study|Adverse Event|15|||
48781446|NCT02343458|157042413|FG003|Overall Study|Adverse Event|3|||
48781447|NCT02343458|157042410|FG000|Overall Study|Lack of Efficacy|3|||
48781448|NCT02343458|157042411|FG001|Overall Study|Lack of Efficacy|8|||
48781449|NCT02343458|157042412|FG002|Overall Study|Lack of Efficacy|4|||
48781450|NCT02343458|157042413|FG003|Overall Study|Lack of Efficacy|8|||
48781451|NCT02343458|157042410|FG000|Overall Study|Withdrawal by Subject|18|||
49029454|NCT01328093|157945102|FG000|Open-Label Phase|Lack of Efficacy|5|||
49029455|NCT01328093|157945103|FG001|Open-Label Phase|Lack of Efficacy|6|||
49029456|NCT01328093|157945102|FG000|Open-Label Phase|Withdrawal by Subject|4|||
49029457|NCT01328093|157945103|FG001|Open-Label Phase|Withdrawal by Subject|1|||
48781452|NCT02343458|157042411|FG001|Overall Study|Withdrawal by Subject|17|||
48781453|NCT02343458|157042412|FG002|Overall Study|Withdrawal by Subject|23|||
48781454|NCT02343458|157042413|FG003|Overall Study|Withdrawal by Subject|14|||
48781455|NCT02343458|157042410|FG000|Overall Study|Physician Decision|1|||
48781456|NCT02343458|157042411|FG001|Overall Study|Physician Decision|4|||
48781457|NCT02343458|157042412|FG002|Overall Study|Physician Decision|2|||
48781458|NCT02343458|157042413|FG003|Overall Study|Physician Decision|2|||
48781459|NCT02343458|157042410|FG000|Overall Study|Lost to Follow-up|5|||
48781460|NCT02343458|157042411|FG001|Overall Study|Lost to Follow-up|5|||
48781461|NCT02343458|157042412|FG002|Overall Study|Lost to Follow-up|3|||
48781462|NCT02343458|157042413|FG003|Overall Study|Lost to Follow-up|1|||
48781463|NCT02343458|157042410|FG000|Overall Study|Protocol Violation|2|||
48781464|NCT02343458|157042411|FG001|Overall Study|Protocol Violation|5|||
48781465|NCT02343458|157042412|FG002|Overall Study|Protocol Violation|2|||
48781466|NCT02343458|157042413|FG003|Overall Study|Protocol Violation|2|||
48781467|NCT02343458|157042410|FG000|Overall Study|Protocol Specified Criteria|17|||
48781468|NCT02343458|157042411|FG001|Overall Study|Protocol Specified Criteria|13|||
48781469|NCT02343458|157042412|FG002|Overall Study|Protocol Specified Criteria|14|||
48781470|NCT02343458|157042413|FG003|Overall Study|Protocol Specified Criteria|8|||
48781471|NCT01043874|157042414|FG000|Overall Study|Adverse Event|3|||
48781472|NCT01043874|157042414|FG000|Overall Study|Withdrawal by Subject|1|||
48781473|NCT01043874|157042414|FG000|Overall Study|Lack of Efficacy|1|||
48781474|NCT01043874|157042414|FG000|Overall Study|Administrative Problems|1|||
48781475|NCT01265953|157042416|FG000|Overall Study|Non compliance|5|||
48781476|NCT01265953|157042417|FG001|Overall Study|Non compliance|3|||
48781477|NCT02564198|157042418|FG000|Overall Study|Withdrawal by Subject|2|||
48781478|NCT02564198|157042419|FG001|Overall Study|Withdrawal by Subject|4|||
48781479|NCT02564198|157042420|FG002|Overall Study|Withdrawal by Subject|0|||
48781480|NCT02564198|157042418|FG000|Overall Study|Adverse Event|0|||
48781481|NCT02564198|157042419|FG001|Overall Study|Adverse Event|1|||
48781482|NCT02564198|157042420|FG002|Overall Study|Adverse Event|0|||
48781483|NCT01640301|157042423|FG000|Overall Study|Death|0|||
48781484|NCT01640301|157042424|FG001|Overall Study|Death|8|||
48781485|NCT02055352|157042425|FG000|Overall Study|Adverse Event|0|||
48781486|NCT02055352|157042426|FG001|Overall Study|Adverse Event|1|||
48781487|NCT02055352|157042425|FG000|Overall Study|Non-eligible|0|||
48781488|NCT02055352|157042426|FG001|Overall Study|Non-eligible|1|||
48781489|NCT02055352|157042425|FG000|Overall Study|Poor compliance|1|||
48781490|NCT02055352|157042426|FG001|Overall Study|Poor compliance|1|||
48781491|NCT02055352|157042425|FG000|Overall Study|Death|1|||
48781492|NCT02055352|157042426|FG001|Overall Study|Death|2|||
48781493|NCT02055352|157042425|FG000|Overall Study|Patient decision|1|||
48781494|NCT02055352|157042426|FG001|Overall Study|Patient decision|1|||
48781495|NCT02055352|157042425|FG000|Overall Study|Use of prohibited treatment|0|||
48781496|NCT02055352|157042426|FG001|Overall Study|Use of prohibited treatment|3|||
48781497|NCT02055352|157042425|FG000|Overall Study|AE, study drug would be detrimental|1|||
48781498|NCT02055352|157042426|FG001|Overall Study|AE, study drug would be detrimental|3|||
48781499|NCT02055352|157042425|FG000|Overall Study|Withdrawal of informed consent|1|||
48781500|NCT02055352|157042426|FG001|Overall Study|Withdrawal of informed consent|0|||
48781501|NCT02055352|157042425|FG000|Overall Study|Reason unknown|1|||
48781502|NCT02055352|157042426|FG001|Overall Study|Reason unknown|5|||
48781503|NCT00127608|157042427|FG000|Overall Study|VZV DNA negative|1|||
48781504|NCT00408993|157042428|FG000|Overall Study|Adverse Event|15|||
48781505|NCT00408993|157042429|FG001|Overall Study|Adverse Event|4|||
48781506|NCT00408993|157042428|FG000|Overall Study|Protocol Violation|1|||
48781507|NCT00408993|157042429|FG001|Overall Study|Protocol Violation|6|||
48781508|NCT00408993|157042428|FG000|Overall Study|Lack of Efficacy|1|||
48781509|NCT00408993|157042429|FG001|Overall Study|Lack of Efficacy|4|||
48781510|NCT00408993|157042428|FG000|Overall Study|Withdrawal by Subject|2|||
48781511|NCT00408993|157042429|FG001|Overall Study|Withdrawal by Subject|3|||
48781512|NCT02473614|157042434|FG000|First Intervention (3 Weeks)|Job duties/lack of transportation|1|||
48781513|NCT02473614|157042435|FG001|First Intervention (3 Weeks)|Job duties/lack of transportation|0|||
48781514|NCT00633984|157042436|FG000|Overall Study|Lost to Follow-up|0|||
48781515|NCT00633984|157042437|FG001|Overall Study|Lost to Follow-up|6|||
48781516|NCT00633984|157042436|FG000|Overall Study|Withdrawal by Subject|8|||
48781517|NCT00633984|157042437|FG001|Overall Study|Withdrawal by Subject|7|||
48781518|NCT00633984|157042436|FG000|Overall Study|Hospitalized|1|||
48781519|NCT00633984|157042437|FG001|Overall Study|Hospitalized|0|||
48781520|NCT04532112|157042438|FG000|Overall Study|Adverse Event|3|||
48781521|NCT04532112|157042439|FG001|Overall Study|Adverse Event|0|||
48781522|NCT02019719|157042440|FG000|Overall Study|Adverse Event|1|||
48781523|NCT02019719|157042441|FG001|Overall Study|Adverse Event|0|||
48781524|NCT02019719|157042442|FG002|Overall Study|Adverse Event|0|||
48781525|NCT02019719|157042443|FG003|Overall Study|Adverse Event|1|||
48781526|NCT02019719|157042444|FG004|Overall Study|Adverse Event|1|||
48781527|NCT02019719|157042440|FG000|Overall Study|Protocol Violation|1|||
48781528|NCT02019719|157042441|FG001|Overall Study|Protocol Violation|1|||
48781529|NCT02019719|157042442|FG002|Overall Study|Protocol Violation|0|||
48781530|NCT02019719|157042443|FG003|Overall Study|Protocol Violation|0|||
48781531|NCT02019719|157042444|FG004|Overall Study|Protocol Violation|0|||
48781532|NCT02019719|157042440|FG000|Overall Study|Protocol defined stopping criteria|2|||
48781533|NCT02019719|157042441|FG001|Overall Study|Protocol defined stopping criteria|0|||
48781534|NCT02019719|157042442|FG002|Overall Study|Protocol defined stopping criteria|0|||
48781535|NCT02019719|157042443|FG003|Overall Study|Protocol defined stopping criteria|1|||
48781536|NCT02019719|157042444|FG004|Overall Study|Protocol defined stopping criteria|1|||
48781537|NCT02019719|157042440|FG000|Overall Study|Physician Decision|2|||
48781538|NCT02019719|157042441|FG001|Overall Study|Physician Decision|0|||
48781539|NCT02019719|157042442|FG002|Overall Study|Physician Decision|0|||
48781540|NCT02019719|157042443|FG003|Overall Study|Physician Decision|0|||
48781541|NCT02019719|157042444|FG004|Overall Study|Physician Decision|0|||
48781542|NCT02031276|157042445|FG000|Period 1 Double-blind IV|Adverse Event|6|||
48781543|NCT02031276|157042446|FG001|Period 1 Double-blind IV|Adverse Event|5|||
48781544|NCT02031276|157042447|FG002|Period 1 Double-blind IV|Adverse Event|1|||
48781545|NCT02031276|157042445|FG000|Period 1 Double-blind IV|Other|0|||
48781546|NCT02031276|157042446|FG001|Period 1 Double-blind IV|Other|1|||
48781547|NCT02031276|157042447|FG002|Period 1 Double-blind IV|Other|0|||
48781548|NCT02031276|157042445|FG000|Period 2 Open-label Risankizumab IV|Adverse Event|1|||
48781549|NCT02031276|157042446|FG001|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
48781550|NCT02031276|157042447|FG002|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
48781551|NCT02031276|157042445|FG000|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3|||
48781552|NCT02031276|157042446|FG001|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
48781553|NCT02031276|157042447|FG002|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
48781554|NCT02031276|157042445|FG000|Period 2 Open-label Risankizumab IV|Other|0|||
48781555|NCT02031276|157042446|FG001|Period 2 Open-label Risankizumab IV|Other|2|||
48781556|NCT02031276|157042447|FG002|Period 2 Open-label Risankizumab IV|Other|1|||
48781557|NCT02031276|157042445|FG000|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
48781558|NCT02031276|157042446|FG001|Period 3 Open-label Risankizumab SC|Adverse Event|2|||
48781559|NCT02031276|157042447|FG002|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
48781560|NCT02031276|157042445|FG000|Period 3 Open-label Risankizumab SC|Protocol Violation|2|||
48781561|NCT02031276|157042446|FG001|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
48781562|NCT02031276|157042447|FG002|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
48781563|NCT02031276|157042445|FG000|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
49029458|NCT01328093|157945102|FG000|Open-Label Phase|Scheduling conflict|2|||
48781564|NCT02031276|157042446|FG001|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
48877361|NCT04508309|157388628|FG000|Overall Study|Death|0|||
48877362|NCT04508309|157388629|FG001|Overall Study|Death|0|||
48877363|NCT04508309|157388630|FG002|Overall Study|Death|0|||
48877364|NCT04508309|157388631|FG003|Overall Study|Death|0|||
48877365|NCT04508309|157388632|FG004|Overall Study|Death|1|||
48877366|NCT04508309|157388628|FG000|Overall Study|Lost to Follow-up|0|||
48877367|NCT04508309|157388629|FG001|Overall Study|Lost to Follow-up|0|||
48877368|NCT04508309|157388630|FG002|Overall Study|Lost to Follow-up|1|||
48877369|NCT04508309|157388631|FG003|Overall Study|Lost to Follow-up|1|||
48877370|NCT04508309|157388632|FG004|Overall Study|Lost to Follow-up|0|||
48877371|NCT04508309|157388628|FG000|Overall Study|Withdrawal by Subject|0|||
48877372|NCT04508309|157388629|FG001|Overall Study|Withdrawal by Subject|0|||
48877373|NCT04508309|157388630|FG002|Overall Study|Withdrawal by Subject|0|||
48781565|NCT02031276|157042447|FG002|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
48781566|NCT02031276|157042445|FG000|Period 3 Open-label Risankizumab SC|Other|0|||
48781567|NCT02031276|157042446|FG001|Period 3 Open-label Risankizumab SC|Other|0|||
48781568|NCT02031276|157042447|FG002|Period 3 Open-label Risankizumab SC|Other|1|||
48781569|NCT02530619|157042462|FG000|Registered for Study|Withdrawal by Subject|2|||
48781570|NCT02530619|157042462|FG000|Continued Treatment Cycles 2 Through 6|Adverse Event|2|||
48781571|NCT02530619|157042462|FG000|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2|||
48781572|NCT02530619|157042462|FG000|Continued Treatment Cycles 2 Through 6|Progressive Disease|4|||
48781573|NCT02530619|157042462|FG000|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2|||
48781574|NCT02530619|157042462|FG000|Follow-up Period (6 Months)|Death|4|||
48781575|NCT02530619|157042462|FG000|Follow-up Period (6 Months)|Lost to Follow-up|2|||
48781576|NCT02530619|157042462|FG000|Follow-up Period (6 Months)|Withdrawal by Subject|5|||
48781577|NCT01993719|157042467|FG000|First Drug Administration|Not treated|1|||
48781578|NCT01993719|157042468|FG001|First Drug Administration|Not treated|0|||
48877374|NCT04508309|157388631|FG003|Overall Study|Withdrawal by Subject|0|||
48781579|NCT01993719|157042469|FG002|First Drug Administration|Not treated|0|||
48877375|NCT04508309|157388632|FG004|Overall Study|Withdrawal by Subject|1|||
49029459|NCT01328093|157945103|FG001|Open-Label Phase|Scheduling conflict|1|||
48877376|NCT02446236|157388638|FG000|Overall Study|Screen Failure|1|||
48877377|NCT02446236|157388639|FG001|Overall Study|Screen Failure|0|||
48877378|NCT02446236|157388640|FG002|Overall Study|Screen Failure|1|||
48877379|NCT02446236|157388638|FG000|Overall Study|Actively Receiving Therapy|0|||
48877380|NCT02446236|157388639|FG001|Overall Study|Actively Receiving Therapy|0|||
48781580|NCT01993719|157042470|FG003|First Drug Administration|Not treated|0|||
48781581|NCT01993719|157042471|FG004|First Drug Administration|Not treated|0|||
48781582|NCT01992536|157042472|FG000|Overall Study|Administrative Reason|0|||
48781583|NCT01992536|157042473|FG001|Overall Study|Administrative Reason|0|||
48877381|NCT02446236|157388640|FG002|Overall Study|Actively Receiving Therapy|1|||
48877382|NCT04147195|157388641|FG000|Overall Study|Adverse Event|0|||
48877383|NCT04147195|157388642|FG001|Overall Study|Adverse Event|3|||
48877384|NCT04147195|157388641|FG000|Overall Study|Study Terminated by Sponsor|4|||
48877385|NCT04147195|157388642|FG001|Overall Study|Study Terminated by Sponsor|2|||
48877386|NCT04147195|157388641|FG000|Overall Study|Withdrawal by Subject|0|||
48877387|NCT04147195|157388642|FG001|Overall Study|Withdrawal by Subject|1|||
48877388|NCT01190644|157390043|FG000|Overall Study|Death|2|||
48877389|NCT01190644|157390043|FG000|Overall Study|Disease progression|1|||
48877390|NCT00475644|157390044|FG000|Overall Study|Protocol Violation|13|||
48877391|NCT03113383|157390045|FG000|Overall Study|Death|4|||
48877392|NCT03113383|157390046|FG001|Overall Study|Death|0|||
48982828|NCT01944462|157769888|FG000|PPPP Educational Program|Lost to Follow-up|60|||
48982829|NCT04249076|157769889|FG000|Overall Study|Adverse Event|1|||
48781584|NCT01992536|157042474|FG002|Overall Study|Administrative Reason|0|||
48781585|NCT01992536|157042475|FG003|Overall Study|Administrative Reason|0|||
48781586|NCT01992536|157042476|FG004|Overall Study|Administrative Reason|0|||
48781587|NCT01992536|157042477|FG005|Overall Study|Administrative Reason|0|||
48781588|NCT01992536|157042478|FG006|Overall Study|Administrative Reason|7|||
48781589|NCT01992536|157042479|FG007|Overall Study|Administrative Reason|0|||
48781590|NCT01992536|157042480|FG008|Overall Study|Administrative Reason|0|||
48781591|NCT01992536|157042481|FG009|Overall Study|Administrative Reason|0|||
48781592|NCT01992536|157042472|FG000|Overall Study|Lost to Follow-up|4|||
48781593|NCT01992536|157042473|FG001|Overall Study|Lost to Follow-up|2|||
48781594|NCT01992536|157042474|FG002|Overall Study|Lost to Follow-up|1|||
48781595|NCT01992536|157042475|FG003|Overall Study|Lost to Follow-up|0|||
48781596|NCT01992536|157042476|FG004|Overall Study|Lost to Follow-up|0|||
48781597|NCT01992536|157042477|FG005|Overall Study|Lost to Follow-up|1|||
48781598|NCT01992536|157042478|FG006|Overall Study|Lost to Follow-up|0|||
48781599|NCT01992536|157042479|FG007|Overall Study|Lost to Follow-up|0|||
48781600|NCT01992536|157042480|FG008|Overall Study|Lost to Follow-up|1|||
48781601|NCT01992536|157042481|FG009|Overall Study|Lost to Follow-up|1|||
48781602|NCT01992536|157042472|FG000|Overall Study|Withdrawal by Subject|0|||
48781603|NCT01992536|157042473|FG001|Overall Study|Withdrawal by Subject|1|||
48781604|NCT01992536|157042474|FG002|Overall Study|Withdrawal by Subject|0|||
48781605|NCT01992536|157042475|FG003|Overall Study|Withdrawal by Subject|2|||
48781606|NCT01992536|157042476|FG004|Overall Study|Withdrawal by Subject|0|||
48781607|NCT01992536|157042477|FG005|Overall Study|Withdrawal by Subject|0|||
48781608|NCT01992536|157042478|FG006|Overall Study|Withdrawal by Subject|0|||
48781609|NCT01992536|157042479|FG007|Overall Study|Withdrawal by Subject|0|||
48781610|NCT01992536|157042480|FG008|Overall Study|Withdrawal by Subject|0|||
48781611|NCT01992536|157042481|FG009|Overall Study|Withdrawal by Subject|0|||
48781612|NCT01762761|157042482|FG000|Overall Study|Adverse Event|15|||
48781613|NCT01762761|157042483|FG001|Overall Study|Adverse Event|17|||
48781614|NCT01762761|157042482|FG000|Overall Study|Lack of Efficacy|9|||
48781615|NCT01762761|157042483|FG001|Overall Study|Lack of Efficacy|25|||
48781616|NCT01762761|157042482|FG000|Overall Study|Protocol Violation|1|||
48781617|NCT01762761|157042483|FG001|Overall Study|Protocol Violation|1|||
48781618|NCT01762761|157042482|FG000|Overall Study|Study closed/terminated|0|||
48781619|NCT01762761|157042483|FG001|Overall Study|Study closed/terminated|2|||
48781620|NCT01762761|157042482|FG000|Overall Study|Lost to Follow-up|3|||
48781621|NCT01762761|157042483|FG001|Overall Study|Lost to Follow-up|6|||
48781622|NCT01762761|157042482|FG000|Overall Study|Physician Decision|4|||
48781623|NCT01762761|157042483|FG001|Overall Study|Physician Decision|6|||
48781624|NCT01762761|157042482|FG000|Overall Study|Withdrawal by Subject|7|||
48781625|NCT01762761|157042483|FG001|Overall Study|Withdrawal by Subject|8|||
48781626|NCT02162810|157042485|FG000|Overall Study|Protocol Violation|1|||
48781627|NCT02162810|157042486|FG001|Overall Study|Protocol Violation|0|||
48781628|NCT02162810|157042485|FG000|Overall Study|patients did not report compliance|4|||
48781629|NCT02162810|157042486|FG001|Overall Study|patients did not report compliance|1|||
48781630|NCT03295201|157042487|FG000|Overall Study|Lost to Follow-up|1|||
48781631|NCT03295201|157042488|FG001|Overall Study|Lost to Follow-up|1|||
48781632|NCT03295201|157042487|FG000|Overall Study|Hospital admission|0|||
48781633|NCT03295201|157042488|FG001|Overall Study|Hospital admission|1|||
48781634|NCT00389324|157042489|FG000|Run-In Phase|Adverse Event|1|||
48781635|NCT00389324|157042489|FG000|Run-In Phase|Lost to Follow-up|1|||
48781636|NCT00389324|157042489|FG000|Run-In Phase|Withdrawal by Subject|1|||
48781637|NCT00389324|157042489|FG000|Subcutaneous Phase|Adverse Event|2|||
48781638|NCT00389324|157042489|FG000|Subcutaneous Phase|Non-compliance with study medication|2|||
48781639|NCT00389324|157042489|FG000|Subcutaneous Phase|Withdrawal by Subject|2|||
48781640|NCT00389324|157042489|FG000|Subcutaneous Phase|Lost to Follow-up|1|||
48877393|NCT02312960|157390049|FG000|Overall Study|Death|24|||
48877394|NCT02312960|157390050|FG001|Overall Study|Death|32|||
48982830|NCT04249076|157769890|FG001|Overall Study|Adverse Event|1|||
48982831|NCT04249076|157769889|FG000|Overall Study|Protocol Violation|1|||
48781641|NCT04726709|157042490|FG000|Overall Study|Withdrawal by Subject|2|||
48877395|NCT02312960|157390051|FG002|Overall Study|Death|25|||
48877396|NCT02312960|157390052|FG003|Overall Study|Death|11|||
48982832|NCT04249076|157769890|FG001|Overall Study|Protocol Violation|2|||
49029460|NCT01328093|157945102|FG000|Open-Label Phase|Subject is moving or has moved|2|||
49029461|NCT01328093|157945103|FG001|Open-Label Phase|Subject is moving or has moved|0|||
49029462|NCT01328093|157945102|FG000|Open-Label Phase|Entry Criteria Not Met|1|||
49029463|NCT01328093|157945103|FG001|Open-Label Phase|Entry Criteria Not Met|0|||
49029464|NCT03195491|157945104|FG000|Overall Study|Study drug toxicity|25|||
49029465|NCT03195491|157945105|FG001|Overall Study|Study drug toxicity|3|||
49029466|NCT03195491|157945104|FG000|Overall Study|Maximum clinical benefit|5|||
49029467|NCT03195491|157945105|FG001|Overall Study|Maximum clinical benefit|0|||
49029468|NCT03195491|157945104|FG000|Overall Study|Lost to Follow-up|1|||
49029469|NCT03195491|157945105|FG001|Overall Study|Lost to Follow-up|0|||
49029470|NCT03195491|157945104|FG000|Overall Study|Death|3|||
49029471|NCT03195491|157945105|FG001|Overall Study|Death|0|||
49029472|NCT03195491|157945104|FG000|Overall Study|Adverse event unrelated to study drug|19|||
49029473|NCT03195491|157945105|FG001|Overall Study|Adverse event unrelated to study drug|2|||
49029474|NCT03195491|157945104|FG000|Overall Study|Disease progression|266|||
49029475|NCT03195491|157945105|FG001|Overall Study|Disease progression|8|||
49029476|NCT03195491|157945104|FG000|Overall Study|Other reasons|10|||
49029477|NCT03195491|157945105|FG001|Overall Study|Other reasons|0|||
49029478|NCT03195491|157945104|FG000|Overall Study|Participant withdrew consent|8|||
49029479|NCT03195491|157945105|FG001|Overall Study|Participant withdrew consent|1|||
49029480|NCT03195491|157945104|FG000|Overall Study|Participant no longer meets study criteria|0|||
49029481|NCT03195491|157945105|FG001|Overall Study|Participant no longer meets study criteria|1|||
49029482|NCT03195491|157945104|FG000|Overall Study|Participant request to discontinue study treatment|10|||
49029483|NCT03195491|157945105|FG001|Overall Study|Participant request to discontinue study treatment|0|||
49029484|NCT01061866|157945108|FG000|Overall Study|Adverse Event|2|||
49029485|NCT00450190|157945109|FG000|Overall Study|Withdrawal by Subject|2|||
49029486|NCT01270503|157945110|FG000|Overall Study|Lost to Follow-up|1|||
49029487|NCT02543203|157945111|FG000|Overall Study|Unpalatable Fragrance|2|||
49029488|NCT02543203|157945112|FG001|Overall Study|Unpalatable Fragrance|2|||
49029489|NCT02543203|157945111|FG000|Overall Study|Lost to Follow-up|1|||
49029490|NCT02543203|157945112|FG001|Overall Study|Lost to Follow-up|0|||
49029491|NCT02543203|157945111|FG000|Overall Study|Increased Irritability|1|||
49029492|NCT02543203|157945112|FG001|Overall Study|Increased Irritability|0|||
49029493|NCT02543203|157945111|FG000|Overall Study|Family|1|||
49029494|NCT02543203|157945112|FG001|Overall Study|Family|2|||
49029495|NCT02543203|157945111|FG000|Overall Study|Negative Behavior|1|||
49029496|NCT02543203|157945112|FG001|Overall Study|Negative Behavior|0|||
49029497|NCT02543203|157945111|FG000|Overall Study|Withdrawal by Subject|0|||
49029498|NCT02543203|157945112|FG001|Overall Study|Withdrawal by Subject|1|||
49029499|NCT03020615|157945113|FG000|Overall Study|Physician Decision|3|||
49029500|NCT03020615|157945114|FG001|Overall Study|Physician Decision|1|||
49029501|NCT03020615|157945115|FG002|Overall Study|Physician Decision|2|||
49029502|NCT03020615|157945113|FG000|Overall Study|Parent/guardian/patient choice|3|||
49029503|NCT03020615|157945114|FG001|Overall Study|Parent/guardian/patient choice|0|||
49029504|NCT03020615|157945115|FG002|Overall Study|Parent/guardian/patient choice|4|||
49029505|NCT03020615|157945113|FG000|Overall Study|Screen failure|0|||
49029506|NCT03020615|157945114|FG001|Overall Study|Screen failure|0|||
49029507|NCT03020615|157945115|FG002|Overall Study|Screen failure|1|||
49029508|NCT03020615|157945113|FG000|Overall Study|Death|1|||
49029509|NCT03020615|157945114|FG001|Overall Study|Death|0|||
49029510|NCT03020615|157945115|FG002|Overall Study|Death|0|||
49029511|NCT03020615|157945113|FG000|Overall Study|Lost to Follow-up|0|||
49029512|NCT03020615|157945114|FG001|Overall Study|Lost to Follow-up|1|||
49029513|NCT03020615|157945115|FG002|Overall Study|Lost to Follow-up|0|||
49029514|NCT03002077|157945116|FG000|Overall Study|Non-compliance with Study Drug|4|||
49029515|NCT03002077|157945116|FG000|Overall Study|Non-compliance w/Background ADT|1|||
49029516|NCT03002077|157945116|FG000|Overall Study|Study Terminated by Sponsor|257|||
49029517|NCT03002077|157945116|FG000|Overall Study|Site Terminated by Sponsor|5|||
48781642|NCT04726709|157042491|FG001|Overall Study|Withdrawal by Subject|2|||
49029518|NCT03002077|157945116|FG000|Overall Study|Miscellaneous Reasons|10|||
49029519|NCT03002077|157945116|FG000|Overall Study|Adverse Event|23|||
49029520|NCT03002077|157945116|FG000|Overall Study|Lack of Efficacy|20|||
48781643|NCT01465334|157042492|FG000|Overall Study|Disease Progression|1|||
48781644|NCT01465334|157042493|FG001|Overall Study|Disease Progression|0|||
48781645|NCT01465334|157042492|FG000|Overall Study|Adverse Event|1|||
48781646|NCT01465334|157042493|FG001|Overall Study|Adverse Event|0|||
48781647|NCT01465334|157042492|FG000|Overall Study|Richter's transformation|0|||
49029521|NCT03002077|157945116|FG000|Overall Study|Withdrawal by Subject|72|||
49029522|NCT03002077|157945116|FG000|Overall Study|Lost to Follow-up|21|||
49029523|NCT03002077|157945116|FG000|Overall Study|Pregnancy|4|||
49029524|NCT03002077|157945116|FG000|Overall Study|Protocol Violation|21|||
49029525|NCT02459951|157945117|FG000|Overall Study|Unable to meet holding requirement|1|||
49029526|NCT02077465|157945124|FG000|Overall Study|Withdrew Consent|0|||
49029527|NCT02077465|157945125|FG001|Overall Study|Withdrew Consent|1|||
49029528|NCT02077465|157945124|FG000|Overall Study|Lost to Follow-up|1|||
49029529|NCT02077465|157945125|FG001|Overall Study|Lost to Follow-up|0|||
49029530|NCT00102440|157945126|FG000|Overall Study|Lost to Follow-up|25|||
49029531|NCT00102440|157945127|FG001|Overall Study|Lost to Follow-up|18|||
49029532|NCT00102440|157945128|FG002|Overall Study|Lost to Follow-up|21|||
49029533|NCT00102440|157945126|FG000|Overall Study|Adverse Event|16|||
49029534|NCT00102440|157945127|FG001|Overall Study|Adverse Event|23|||
49029535|NCT00102440|157945128|FG002|Overall Study|Adverse Event|8|||
49029536|NCT00102440|157945126|FG000|Overall Study|Gout Flare|10|||
49029537|NCT00102440|157945127|FG001|Overall Study|Gout Flare|28|||
49029538|NCT00102440|157945128|FG002|Overall Study|Gout Flare|9|||
49029539|NCT00102440|157945126|FG000|Overall Study|Personal Reason(s)|19|||
49029540|NCT00102440|157945127|FG001|Overall Study|Personal Reason(s)|13|||
49029541|NCT00102440|157945128|FG002|Overall Study|Personal Reason(s)|13|||
49029542|NCT00102440|157945126|FG000|Overall Study|Other|11|||
49029543|NCT00102440|157945127|FG001|Overall Study|Other|14|||
48781648|NCT01465334|157042493|FG001|Overall Study|Richter's transformation|3|||
48781649|NCT01465334|157042492|FG000|Overall Study|Refractory Disease|0|||
48781650|NCT01465334|157042493|FG001|Overall Study|Refractory Disease|3|||
48781651|NCT02117570|157042497|FG000|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0|||
48781652|NCT02117570|157042498|FG001|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2|||
48781653|NCT02117570|157042499|FG002|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1|||
48781654|NCT02117570|157042497|FG000|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
49029544|NCT00102440|157945128|FG002|Overall Study|Other|14|||
49029545|NCT00102440|157945126|FG000|Overall Study|Protocol Violation|7|||
49029546|NCT00102440|157945127|FG001|Overall Study|Protocol Violation|2|||
49029547|NCT00102440|157945128|FG002|Overall Study|Protocol Violation|1|||
49029548|NCT01376167|157945129|FG000|Overall Study|Lost to Follow-up|2|||
49029549|NCT01376167|157945130|FG001|Overall Study|Lost to Follow-up|4|||
49029550|NCT01376167|157945131|FG002|Overall Study|Lost to Follow-up|2|||
49029551|NCT01376167|157945129|FG000|Overall Study|Physician Decision|1|||
49029552|NCT01376167|157945130|FG001|Overall Study|Physician Decision|1|||
49029553|NCT01376167|157945131|FG002|Overall Study|Physician Decision|0|||
49029554|NCT01376167|157945129|FG000|Overall Study|Withdrawal by Subject|1|||
49029555|NCT01376167|157945130|FG001|Overall Study|Withdrawal by Subject|5|||
49029556|NCT01376167|157945131|FG002|Overall Study|Withdrawal by Subject|4|||
49029557|NCT00834756|157945132|FG000|First Intervention|Adverse Event|1|||
49029558|NCT00834756|157945133|FG001|First Intervention|Adverse Event|0|||
49029559|NCT00834756|157945132|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
49029560|NCT00834756|157945133|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
49029561|NCT01037114|157945136|FG000|Year 20|Others|1|||
49029562|NCT01602419|157945137|FG000|Overall Study|Not treated with Wilate|9|||
49029563|NCT01602419|157945137|FG000|Overall Study|Adverse Drug Reaction|4|||
49029564|NCT01602419|157945137|FG000|Overall Study|Insurance issues|3|||
49029565|NCT01602419|157945137|FG000|Overall Study|Changed treatment centre|1|||
49029566|NCT01602419|157945137|FG000|Overall Study|Treatment centre closed|1|||
49029567|NCT01602419|157945137|FG000|Overall Study|Withdrawal by Subject|5|||
49029568|NCT01602419|157945137|FG000|Overall Study|Lost to Follow-up|6|||
49029569|NCT03620747|157945138|FG000|Overall Study|Participant decision|7|||
49029570|NCT03620747|157945138|FG000|Overall Study|Adverse Event|6|||
49029571|NCT03620747|157945138|FG000|Overall Study|Lack of Efficacy|1|||
49029572|NCT03620747|157945138|FG000|Overall Study|Poor compliance to protocol|2|||
49029573|NCT03620747|157945138|FG000|Overall Study|Other-unspecified|3|||
49029574|NCT00296647|157945146|FG000|Overall Study|Death|4|||
49029575|NCT00296647|157945147|FG001|Overall Study|Death|1|||
49029576|NCT00296647|157945148|FG002|Overall Study|Death|2|||
49029577|NCT00296647|157945149|FG003|Overall Study|Death|1|||
49029578|NCT00296647|157945150|FG004|Overall Study|Death|1|||
49029579|NCT00296647|157945146|FG000|Overall Study|Withdrawal by Subject|28|||
49029580|NCT00296647|157945147|FG001|Overall Study|Withdrawal by Subject|27|||
49029581|NCT00296647|157945148|FG002|Overall Study|Withdrawal by Subject|32|||
48781655|NCT02117570|157042498|FG001|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
48781656|NCT02117570|157042499|FG002|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0|||
48781657|NCT02117570|157042497|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
48781658|NCT02117570|157042498|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
48781659|NCT02117570|157042499|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2|||
49029582|NCT00296647|157945149|FG003|Overall Study|Withdrawal by Subject|16|||
49029583|NCT00296647|157945150|FG004|Overall Study|Withdrawal by Subject|19|||
49029584|NCT04060147|157945151|FG000|Overall Study|Withdrew consent|1|||
49029585|NCT02196675|157945154|FG000|Overall Study|Withdrawal by Subject|1|||
49029586|NCT02196675|157945155|FG001|Overall Study|Withdrawal by Subject|0|||
49029587|NCT02196675|157945156|FG002|Overall Study|Withdrawal by Subject|0|||
49029588|NCT02196675|157945154|FG000|Overall Study|Intra-operative surgical exclusion|1|||
49029589|NCT02196675|157945155|FG001|Overall Study|Intra-operative surgical exclusion|1|||
49029590|NCT02196675|157945156|FG002|Overall Study|Intra-operative surgical exclusion|0|||
49029591|NCT02196675|157945154|FG000|Overall Study|Protocol Violation|0|||
49029592|NCT02196675|157945155|FG001|Overall Study|Protocol Violation|1|||
49029593|NCT02196675|157945156|FG002|Overall Study|Protocol Violation|0|||
49029594|NCT02196675|157945154|FG000|Overall Study|Death|0|||
49029595|NCT02196675|157945155|FG001|Overall Study|Death|0|||
49029596|NCT02196675|157945156|FG002|Overall Study|Death|1|||
49029597|NCT02711852|157945161|FG000|Overall Study|Death|5|||
49029598|NCT02711852|157945161|FG000|Overall Study|Lost to Follow-up|1|||
49029599|NCT02711852|157945161|FG000|Overall Study|Completed follow-up|3|||
49029600|NCT02711852|157945161|FG000|Overall Study|Withdrawal by Subject|1|||
49029601|NCT00537979|157945162|FG000|Overall Study|Adverse Event|2|||
49029602|NCT00537979|157945163|FG001|Overall Study|Adverse Event|2|||
49029603|NCT00537979|157945162|FG000|Overall Study|Withdrawal by Subject|1|||
49029604|NCT00537979|157945163|FG001|Overall Study|Withdrawal by Subject|4|||
49029605|NCT00537979|157945162|FG000|Overall Study|Lost to Follow-up|1|||
49029606|NCT00537979|157945163|FG001|Overall Study|Lost to Follow-up|4|||
49029607|NCT00537979|157945162|FG000|Overall Study|Lack of Efficacy|0|||
49029608|NCT00537979|157945163|FG001|Overall Study|Lack of Efficacy|1|||
49029609|NCT00537979|157945162|FG000|Overall Study|Non-compliance with treatment/procedure|2|||
49029610|NCT00537979|157945163|FG001|Overall Study|Non-compliance with treatment/procedure|2|||
49029611|NCT00537979|157945162|FG000|Overall Study|Death|0|||
49029612|NCT00537979|157945163|FG001|Overall Study|Death|3|||
49029613|NCT00537979|157945162|FG000|Overall Study|Kidney transplant|0|||
49029614|NCT00537979|157945163|FG001|Overall Study|Kidney transplant|3|||
49029615|NCT00537979|157945162|FG000|Overall Study|Heart failure|0|||
49029616|NCT00537979|157945163|FG001|Overall Study|Heart failure|1|||
49029617|NCT02412852|157945164|FG000|Overall Study|Withdrawal by Subject|0|||
49029618|NCT02412852|157945165|FG001|Overall Study|Withdrawal by Subject|1|||
49029619|NCT02412852|157945166|FG002|Overall Study|Withdrawal by Subject|0|||
49029620|NCT02412852|157945167|FG003|Overall Study|Withdrawal by Subject|0|||
49029621|NCT02412852|157945164|FG000|Overall Study|Physician Decision|0|||
49029622|NCT02412852|157945165|FG001|Overall Study|Physician Decision|0|||
49029623|NCT02412852|157945166|FG002|Overall Study|Physician Decision|0|||
49029624|NCT02412852|157945167|FG003|Overall Study|Physician Decision|1|||
49029625|NCT03552393|157945168|FG000|Core Period|Kidney Transplant|1|||
49029626|NCT03552393|157945168|FG000|Core Period|Prohibited Medication|1|||
49029627|NCT03552393|157945168|FG000|Safety Extension Period|Kidney Transplant|4|||
49029628|NCT02009163|157945169|FG000|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48|||
48781660|NCT02117570|157042497|FG000|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
49029629|NCT02009163|157945170|FG001|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
49029630|NCT02009163|157945171|FG002|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
49029631|NCT02009163|157945169|FG000|Open-label Period (Non-randomized)|Withdrawal by Subject|29|||
49029632|NCT02009163|157945170|FG001|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
49029633|NCT02009163|157945171|FG002|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
49029634|NCT02009163|157945169|FG000|Open-label Period (Non-randomized)|Adverse Event|22|||
49029635|NCT02009163|157945170|FG001|Open-label Period (Non-randomized)|Adverse Event|0|||
49029636|NCT02009163|157945171|FG002|Open-label Period (Non-randomized)|Adverse Event|0|||
49029637|NCT02009163|157945169|FG000|Open-label Period (Non-randomized)|Lost to Follow-up|20|||
49029638|NCT02009163|157945170|FG001|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
49029639|NCT02009163|157945171|FG002|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
49029640|NCT02009163|157945169|FG000|Open-label Period (Non-randomized)|Protocol Violation|10|||
49029641|NCT02009163|157945170|FG001|Open-label Period (Non-randomized)|Protocol Violation|0|||
49029642|NCT02009163|157945171|FG002|Open-label Period (Non-randomized)|Protocol Violation|0|||
49029643|NCT02009163|157945169|FG000|Open-label Period (Non-randomized)|Pregnancy|1|||
49029644|NCT02009163|157945170|FG001|Open-label Period (Non-randomized)|Pregnancy|0|||
48781661|NCT02117570|157042498|FG001|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
48781662|NCT02117570|157042499|FG002|Stage 2 Participants Aged 65 to 85 Years|Death|1|||
48781663|NCT02117570|157042497|FG000|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
48781664|NCT02117570|157042498|FG001|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
48781665|NCT02117570|157042499|FG002|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1|||
48781666|NCT02117570|157042497|FG000|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1|||
48781667|NCT02117570|157042498|FG001|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
48781668|NCT02117570|157042499|FG002|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
48781669|NCT02117570|157042497|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
48781670|NCT02117570|157042498|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1|||
48781671|NCT02117570|157042499|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
48781672|NCT00922428|157042500|FG000|Overall Study|retrospective/extremely implausible data|2|||
48781673|NCT00922428|157042500|FG000|Overall Study|no medication use or questionable use|13|||
48781674|NCT02114892|157042501|FG000|Overall Study|Lost to Follow-up|1|||
48781675|NCT02114892|157042502|FG001|Overall Study|Lost to Follow-up|2|||
49029645|NCT02009163|157945171|FG002|Open-label Period (Non-randomized)|Pregnancy|0|||
49029646|NCT02009163|157945169|FG000|Open-label Period (Non-randomized)|Other|13|||
49029647|NCT02009163|157945170|FG001|Open-label Period (Non-randomized)|Other|0|||
49029648|NCT02009163|157945171|FG002|Open-label Period (Non-randomized)|Other|0|||
49029649|NCT02009163|157945169|FG000|Randomized-withdrawal Period|Withdrawal by Subject|0|||
49029650|NCT02009163|157945170|FG001|Randomized-withdrawal Period|Withdrawal by Subject|25|||
48781676|NCT00680407|157042503|FG000|Overall Study|Lost to Follow-up|3|||
48781677|NCT00680407|157042504|FG001|Overall Study|Lost to Follow-up|3|||
48781678|NCT00680407|157042505|FG002|Overall Study|Lost to Follow-up|1|||
48781679|NCT00680407|157042503|FG000|Overall Study|Withdrawal by Subject|5|||
48781680|NCT00680407|157042504|FG001|Overall Study|Withdrawal by Subject|2|||
48781681|NCT00680407|157042505|FG002|Overall Study|Withdrawal by Subject|2|||
48781682|NCT00320216|157042506|FG000|Overall Study|Adverse Event|0|||
48781683|NCT00320216|157042507|FG001|Overall Study|Adverse Event|6|||
48781684|NCT00320216|157042508|FG002|Overall Study|Adverse Event|0|||
48781685|NCT00320216|157042509|FG003|Overall Study|Adverse Event|2|||
48781686|NCT00320216|157042510|FG004|Overall Study|Adverse Event|2|||
48781687|NCT00320216|157042506|FG000|Overall Study|Lack of Efficacy|6|||
48781688|NCT00320216|157042507|FG001|Overall Study|Lack of Efficacy|2|||
48781689|NCT00320216|157042508|FG002|Overall Study|Lack of Efficacy|1|||
48781690|NCT00320216|157042509|FG003|Overall Study|Lack of Efficacy|0|||
48781691|NCT00320216|157042510|FG004|Overall Study|Lack of Efficacy|1|||
48781692|NCT00320216|157042506|FG000|Overall Study|Lost to Follow-up|3|||
48781693|NCT00320216|157042507|FG001|Overall Study|Lost to Follow-up|0|||
48781694|NCT00320216|157042508|FG002|Overall Study|Lost to Follow-up|0|||
48781695|NCT00320216|157042509|FG003|Overall Study|Lost to Follow-up|0|||
48781696|NCT00320216|157042510|FG004|Overall Study|Lost to Follow-up|0|||
48781697|NCT00320216|157042506|FG000|Overall Study|Other|7|||
48781698|NCT00320216|157042507|FG001|Overall Study|Other|2|||
48781699|NCT00320216|157042508|FG002|Overall Study|Other|5|||
48781700|NCT00320216|157042509|FG003|Overall Study|Other|1|||
48781701|NCT00320216|157042510|FG004|Overall Study|Other|3|||
48781702|NCT00779246|157042511|FG000|Overall Study|Missing sufficient data for analysis|33|||
48781703|NCT00779246|157042512|FG001|Overall Study|Missing sufficient data for analysis|53|||
48781704|NCT00093145|157042513|FG000|Overall Study|Unacceptable Toxicity Only|2|||
48781705|NCT00093145|157042513|FG000|Overall Study|Physician Decision|5|||
48781706|NCT00093145|157042513|FG000|Overall Study|Withdrawal by Subject|9|||
48781707|NCT00093145|157042513|FG000|Overall Study|Other|1|||
48781708|NCT02371369|157042516|FG000|Part 1|Physician Decision|0|||
48781709|NCT02371369|157042517|FG001|Part 1|Physician Decision|3|||
48781710|NCT02371369|157042516|FG000|Part 1|Adverse Event|8|||
48781711|NCT02371369|157042517|FG001|Part 1|Adverse Event|0|||
48781712|NCT02371369|157042516|FG000|Part 1|Withdrawal by Subject|1|||
48781713|NCT02371369|157042517|FG001|Part 1|Withdrawal by Subject|6|||
48781714|NCT02371369|157042516|FG000|Part 1|Disease progression|0|||
48781715|NCT02371369|157042517|FG001|Part 1|Disease progression|1|||
48781716|NCT02371369|157042516|FG000|Part 1|Protocol Violation|0|||
48781717|NCT02371369|157042517|FG001|Part 1|Protocol Violation|1|||
48781718|NCT02371369|157042516|FG000|Part 2|Adverse Event|6|||
48781719|NCT02371369|157042517|FG001|Part 2|Adverse Event|5|||
48781720|NCT02371369|157042516|FG000|Part 2|Withdrawal by Subject|16|||
48781721|NCT02371369|157042517|FG001|Part 2|Withdrawal by Subject|6|||
48781722|NCT02371369|157042516|FG000|Part 2|Investigator decision|1|||
48781723|NCT02371369|157042517|FG001|Part 2|Investigator decision|2|||
48781724|NCT02371369|157042516|FG000|Part 2|Death|0|||
48781725|NCT02371369|157042517|FG001|Part 2|Death|1|||
48781726|NCT02371369|157042516|FG000|Part 2|Disease progression|1|||
48781727|NCT02371369|157042517|FG001|Part 2|Disease progression|0|||
48781728|NCT02371369|157042516|FG000|Part 2|Subject Noncompliance|1|||
48781729|NCT02371369|157042517|FG001|Part 2|Subject Noncompliance|0|||
48781730|NCT02371369|157042516|FG000|Part 2|Lost to Follow-up|1|||
48781731|NCT02371369|157042517|FG001|Part 2|Lost to Follow-up|1|||
48781732|NCT02371369|157042516|FG000|Part 2|Subject transitioned to commercial supply|6|||
48781733|NCT02371369|157042517|FG001|Part 2|Subject transitioned to commercial supply|4|||
48781734|NCT02371369|157042516|FG000|Part 2|Subject transitioned to another DS pexidartinib protocol|15|||
48781735|NCT02371369|157042517|FG001|Part 2|Subject transitioned to another DS pexidartinib protocol|9|||
48781736|NCT02371369|157042516|FG000|Part 2|Surgical resection of tumor|1|||
48781737|NCT02371369|157042517|FG001|Part 2|Surgical resection of tumor|1|||
48781738|NCT02371369|157042516|FG000|Part 2|Other|0|||
48781739|NCT02371369|157042517|FG001|Part 2|Other|1|||
48781740|NCT00803634|157042518|FG000|Overall Study|Withdrew Consent|1|||
48781741|NCT00803634|157042519|FG001|Overall Study|Withdrew Consent|0|||
48781742|NCT00803634|157042518|FG000|Overall Study|Lost to Follow-up|2|||
48781743|NCT00803634|157042519|FG001|Overall Study|Lost to Follow-up|3|||
48781744|NCT00803634|157042518|FG000|Overall Study|Death|3|||
48781745|NCT00803634|157042519|FG001|Overall Study|Death|2|||
48781746|NCT05077267|157042520|FG000|Treatment Period|Lost to Follow-up|0|||
48781747|NCT05077267|157042521|FG001|Treatment Period|Lost to Follow-up|1|||
48781748|NCT05077267|157042522|FG002|Treatment Period|Lost to Follow-up|0|||
48781749|NCT05077267|157042520|FG000|Treatment Period|Withdrawal by Subject|0|||
48781750|NCT05077267|157042521|FG001|Treatment Period|Withdrawal by Subject|1|||
48781751|NCT05077267|157042522|FG002|Treatment Period|Withdrawal by Subject|0|||
48781752|NCT05077267|157042520|FG000|Follow-up Period|Lost to Follow-up|0|||
48781753|NCT05077267|157042521|FG001|Follow-up Period|Lost to Follow-up|5|||
48781754|NCT05077267|157042522|FG002|Follow-up Period|Lost to Follow-up|7|||
48781755|NCT05077267|157042520|FG000|Follow-up Period|Withdrawal by Subject|0|||
48877397|NCT02312960|157390053|FG004|Overall Study|Death|5|||
48877398|NCT02312960|157390054|FG005|Overall Study|Death|5|||
48877399|NCT02312960|157390055|FG006|Overall Study|Death|8|||
48877400|NCT02312960|157390056|FG007|Overall Study|Death|5|||
48877401|NCT02312960|157390057|FG008|Overall Study|Death|7|||
48877402|NCT02312960|157390058|FG009|Overall Study|Death|3|||
48877403|NCT02312960|157390059|FG010|Overall Study|Death|3|||
48877404|NCT02312960|157390060|FG011|Overall Study|Death|1|||
48877405|NCT02312960|157390061|FG012|Overall Study|Death|25|||
48877406|NCT02312960|157390062|FG013|Overall Study|Death|19|||
48877407|NCT02312960|157390049|FG000|Overall Study|Missing|0|||
48877408|NCT02312960|157390050|FG001|Overall Study|Missing|0|||
48877409|NCT02312960|157390051|FG002|Overall Study|Missing|2|||
48877410|NCT02312960|157390052|FG003|Overall Study|Missing|0|||
48877411|NCT02312960|157390053|FG004|Overall Study|Missing|0|||
48877412|NCT02312960|157390054|FG005|Overall Study|Missing|0|||
48877413|NCT02312960|157390055|FG006|Overall Study|Missing|0|||
48877414|NCT02312960|157390056|FG007|Overall Study|Missing|0|||
48877415|NCT02312960|157390057|FG008|Overall Study|Missing|0|||
48877416|NCT02312960|157390058|FG009|Overall Study|Missing|0|||
48877417|NCT02312960|157390059|FG010|Overall Study|Missing|0|||
48877418|NCT02312960|157390060|FG011|Overall Study|Missing|0|||
48877419|NCT02312960|157390061|FG012|Overall Study|Missing|0|||
48877420|NCT02312960|157390062|FG013|Overall Study|Missing|0|||
48781756|NCT05077267|157042521|FG001|Follow-up Period|Withdrawal by Subject|2|||
48781757|NCT05077267|157042522|FG002|Follow-up Period|Withdrawal by Subject|5|||
48781758|NCT05077267|157042520|FG000|Follow-up Period|Study terminated by sponsor|0|||
48781759|NCT05077267|157042521|FG001|Follow-up Period|Study terminated by sponsor|27|||
48781760|NCT05077267|157042522|FG002|Follow-up Period|Study terminated by sponsor|23|||
48781761|NCT05077267|157042520|FG000|Follow-up Period|Received COVID-19 booster outside of trial|0|||
48781762|NCT05077267|157042521|FG001|Follow-up Period|Received COVID-19 booster outside of trial|66|||
48781763|NCT05077267|157042522|FG002|Follow-up Period|Received COVID-19 booster outside of trial|30|||
48781764|NCT05077267|157042520|FG000|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
48781765|NCT05077267|157042521|FG001|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
48781766|NCT05077267|157042522|FG002|Follow-up Period|Patient is busy at work and withdraws the IC|1|||
48781767|NCT03238001|157042531|FG000|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2|||
48781768|NCT03238001|157042531|FG000|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2|||
48781769|NCT03238001|157042531|FG000|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16|||
48781770|NCT03238001|157042531|FG000|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2|||
48781771|NCT03238001|157042531|FG000|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3|||
48781772|NCT03238001|157042531|FG000|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3|||
48781773|NCT03238001|157042531|FG000|Visit 2 (Secondary Endpoint Cohort)|Study completion|1|||
48781774|NCT03238001|157042531|FG000|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4|||
48781775|NCT01313559|157042532|FG000|Overall Study|Withdrawal by Subject|1|||
48781776|NCT01313559|157042533|FG001|Overall Study|Withdrawal by Subject|2|||
48781777|NCT01313559|157042532|FG000|Overall Study|Disease progression|1|||
48781778|NCT01313559|157042533|FG001|Overall Study|Disease progression|0|||
48781779|NCT01313559|157042532|FG000|Overall Study|Rising PSA|2|||
48781780|NCT01313559|157042533|FG001|Overall Study|Rising PSA|0|||
48781781|NCT01910519|157042537|FG000|Overall Study|Withdrawal by Subject|2|||
48781782|NCT01910519|157042538|FG001|Overall Study|Withdrawal by Subject|0|||
48781783|NCT01910519|157042537|FG000|Overall Study|Adverse Event|2|||
48781784|NCT01910519|157042538|FG001|Overall Study|Adverse Event|0|||
48877421|NCT02312960|157390049|FG000|Overall Study|Lost to Follow-up|0|||
48877422|NCT02312960|157390050|FG001|Overall Study|Lost to Follow-up|0|||
48877423|NCT02312960|157390051|FG002|Overall Study|Lost to Follow-up|1|||
48877424|NCT02312960|157390052|FG003|Overall Study|Lost to Follow-up|0|||
48982833|NCT04249076|157769889|FG000|Overall Study|Lack of Efficacy|0|||
48781785|NCT04964089|157042539|FG000|Overall Study|Adverse Event|8|||
48781786|NCT04964089|157042540|FG001|Overall Study|Adverse Event|6|||
48781787|NCT04964089|157042539|FG000|Overall Study|Non-compliance with study schedule|1|||
48781788|NCT04964089|157042540|FG001|Overall Study|Non-compliance with study schedule|0|||
48781789|NCT04964089|157042539|FG000|Overall Study|Withdrawal by Subject|6|||
48781790|NCT04964089|157042540|FG001|Overall Study|Withdrawal by Subject|5|||
48781791|NCT04964089|157042539|FG000|Overall Study|Lost to Follow-up|1|||
48781792|NCT04964089|157042540|FG001|Overall Study|Lost to Follow-up|1|||
48877425|NCT02312960|157390053|FG004|Overall Study|Lost to Follow-up|0|||
48877426|NCT02312960|157390054|FG005|Overall Study|Lost to Follow-up|0|||
48877427|NCT02312960|157390055|FG006|Overall Study|Lost to Follow-up|1|||
48877428|NCT02312960|157390056|FG007|Overall Study|Lost to Follow-up|1|||
48877429|NCT02312960|157390057|FG008|Overall Study|Lost to Follow-up|0|||
48877430|NCT02312960|157390058|FG009|Overall Study|Lost to Follow-up|1|||
48877431|NCT02312960|157390059|FG010|Overall Study|Lost to Follow-up|0|||
48877432|NCT02312960|157390060|FG011|Overall Study|Lost to Follow-up|0|||
48877433|NCT02312960|157390061|FG012|Overall Study|Lost to Follow-up|1|||
48877434|NCT02312960|157390062|FG013|Overall Study|Lost to Follow-up|0|||
48877435|NCT02312960|157390049|FG000|Overall Study|Withdrawal by Subject|1|||
48982834|NCT04249076|157769890|FG001|Overall Study|Lack of Efficacy|1|||
48781793|NCT04964089|157042539|FG000|Overall Study|Progressive disease|4|||
48781794|NCT04964089|157042540|FG001|Overall Study|Progressive disease|0|||
48781795|NCT04964089|157042539|FG000|Overall Study|Physician Decision|1|||
48781796|NCT04964089|157042540|FG001|Overall Study|Physician Decision|0|||
48781797|NCT04964089|157042539|FG000|Overall Study|Participant did not want to continue study treatment|1|||
48781798|NCT04964089|157042540|FG001|Overall Study|Participant did not want to continue study treatment|0|||
48781799|NCT04964089|157042539|FG000|Overall Study|Participant moved to different state|1|||
48781800|NCT04964089|157042540|FG001|Overall Study|Participant moved to different state|0|||
48781801|NCT04964089|157042539|FG000|Overall Study|Participant decided to discontinue|0|||
48781802|NCT04964089|157042540|FG001|Overall Study|Participant decided to discontinue|1|||
48781803|NCT04452344|157042541|FG000|Overall Study|Withdrawal by Subject|3|||
48781804|NCT04452344|157042542|FG001|Overall Study|Withdrawal by Subject|6|||
48781805|NCT04452344|157042541|FG000|Overall Study|Adverse Event|1|||
48781806|NCT04452344|157042542|FG001|Overall Study|Adverse Event|2|||
48781807|NCT04452344|157042541|FG000|Overall Study|Lost to Follow-up|2|||
48781808|NCT04452344|157042542|FG001|Overall Study|Lost to Follow-up|2|||
48781809|NCT04452344|157042541|FG000|Overall Study|No Post-Op Visit|6|||
48781810|NCT04452344|157042542|FG001|Overall Study|No Post-Op Visit|7|||
48781811|NCT00023452|157042543|FG000|Overall Study|Ineligible for Study|163|||
48781812|NCT00023452|157042544|FG001|Overall Study|Ineligible for Study|159|||
48781813|NCT00023452|157042543|FG000|Overall Study|Out of Window|129|||
48781814|NCT00023452|157042544|FG001|Overall Study|Out of Window|69|||
48781815|NCT00023452|157042543|FG000|Overall Study|Death|2|||
48781816|NCT00023452|157042544|FG001|Overall Study|Death|0|||
48781817|NCT00023452|157042543|FG000|Overall Study|Withdrawal by Subject|66|||
48781818|NCT00023452|157042544|FG001|Overall Study|Withdrawal by Subject|54|||
48781819|NCT00023452|157042543|FG000|Overall Study|Adverse Event|139|||
48781820|NCT00023452|157042544|FG001|Overall Study|Adverse Event|196|||
48781821|NCT00023452|157042543|FG000|Overall Study|Lost to Follow-up|293|||
48781822|NCT00023452|157042544|FG001|Overall Study|Lost to Follow-up|60|||
48781823|NCT00023452|157042543|FG000|Overall Study|Physician Decision|49|||
48781824|NCT00023452|157042544|FG001|Overall Study|Physician Decision|21|||
48781825|NCT00023452|157042543|FG000|Overall Study|Refused Treatment (continued follow-up)|225|||
48781826|NCT00023452|157042544|FG001|Overall Study|Refused Treatment (continued follow-up)|224|||
48781827|NCT00023452|157042543|FG000|Overall Study|Pregnant|53|||
48781828|NCT00023452|157042544|FG001|Overall Study|Pregnant|20|||
48781829|NCT00023452|157042543|FG000|Overall Study|Other|204|||
48781830|NCT00023452|157042544|FG001|Overall Study|Other|69|||
48781831|NCT01898195|157042545|FG000|Smoking Abstinence|Did not have good measurements|35|||
48781832|NCT01898195|157042546|FG001|Smoking Abstinence|Did not have good measurements|38|||
48781833|NCT01898195|157042547|FG002|Smoking Abstinence|Did not have good measurements|36|||
48781834|NCT01954017|157042550|FG000|Overall Study|Adverse Event|0|||
48781835|NCT01954017|157042551|FG001|Overall Study|Adverse Event|0|||
48781836|NCT01954017|157042552|FG002|Overall Study|Adverse Event|1|||
48781837|NCT01954017|157042550|FG000|Overall Study|Death|2|||
48781838|NCT01954017|157042551|FG001|Overall Study|Death|1|||
48781839|NCT01954017|157042552|FG002|Overall Study|Death|1|||
48781840|NCT01954017|157042550|FG000|Overall Study|Withdrawal by Subject|0|||
48781841|NCT01954017|157042551|FG001|Overall Study|Withdrawal by Subject|1|||
48781842|NCT01954017|157042552|FG002|Overall Study|Withdrawal by Subject|0|||
48781843|NCT01954017|157042550|FG000|Overall Study|Protocol Violation|0|||
48781844|NCT01954017|157042551|FG001|Overall Study|Protocol Violation|3|||
48781845|NCT01954017|157042552|FG002|Overall Study|Protocol Violation|2|||
48781846|NCT01954017|157042550|FG000|Overall Study|Necrotizing enterocolitis|1|||
48781847|NCT01954017|157042551|FG001|Overall Study|Necrotizing enterocolitis|0|||
48781848|NCT01954017|157042552|FG002|Overall Study|Necrotizing enterocolitis|1|||
48781849|NCT01954017|157042550|FG000|Overall Study|Enteral intake stopped >7 days|0|||
48781850|NCT01954017|157042551|FG001|Overall Study|Enteral intake stopped >7 days|1|||
48781851|NCT01954017|157042552|FG002|Overall Study|Enteral intake stopped >7 days|1|||
48781852|NCT01954017|157042550|FG000|Overall Study|All other reasons|2|||
48781853|NCT01954017|157042551|FG001|Overall Study|All other reasons|2|||
48781854|NCT01954017|157042552|FG002|Overall Study|All other reasons|7|||
48781855|NCT04598152|157042553|FG000|Overall Study|Lost to Follow-up|0|||
48781856|NCT04598152|157042554|FG001|Overall Study|Lost to Follow-up|1|||
48781857|NCT00932893|157042555|FG000|Overall Study|Death|115|||
48781858|NCT00932893|157042556|FG001|Overall Study|Death|24|||
48781859|NCT00932893|157042555|FG000|Overall Study|Lost to Follow-up|8|||
48781860|NCT00932893|157042556|FG001|Overall Study|Lost to Follow-up|0|||
48781861|NCT00932893|157042555|FG000|Overall Study|Withdrawal by Subject|5|||
48781862|NCT00932893|157042556|FG001|Overall Study|Withdrawal by Subject|2|||
48781863|NCT00932893|157042555|FG000|Overall Study|Other|5|||
48781864|NCT00932893|157042556|FG001|Overall Study|Other|144|||
48781865|NCT03891524|157042557|FG000|Overall Study|Death|0|||
48781866|NCT03891524|157042558|FG001|Overall Study|Death|0|||
48781867|NCT03891524|157042559|FG002|Overall Study|Death|0|||
48781868|NCT03891524|157042560|FG003|Overall Study|Death|0|||
48781869|NCT03891524|157042561|FG004|Overall Study|Death|0|||
48781870|NCT03891524|157042562|FG005|Overall Study|Death|0|||
48781871|NCT03891524|157042563|FG006|Overall Study|Death|0|||
49029651|NCT02009163|157945171|FG002|Randomized-withdrawal Period|Withdrawal by Subject|9|||
49029652|NCT02009163|157945169|FG000|Randomized-withdrawal Period|Lost to Follow-up|0|||
49029653|NCT02009163|157945170|FG001|Randomized-withdrawal Period|Lost to Follow-up|13|||
49029654|NCT02009163|157945171|FG002|Randomized-withdrawal Period|Lost to Follow-up|6|||
48781872|NCT03891524|157042564|FG007|Overall Study|Death|1|||
49029655|NCT02009163|157945169|FG000|Randomized-withdrawal Period|Adverse Event|0|||
49029656|NCT02009163|157945170|FG001|Randomized-withdrawal Period|Adverse Event|0|||
49029657|NCT02009163|157945171|FG002|Randomized-withdrawal Period|Adverse Event|6|||
49029658|NCT02009163|157945169|FG000|Randomized-withdrawal Period|Relapse Criteria Met|0|||
49029659|NCT02009163|157945170|FG001|Randomized-withdrawal Period|Relapse Criteria Met|40|||
49029660|NCT02009163|157945171|FG002|Randomized-withdrawal Period|Relapse Criteria Met|5|||
49029661|NCT02009163|157945169|FG000|Randomized-withdrawal Period|Protocol Violation|0|||
48781873|NCT03891524|157042557|FG000|Overall Study|Withdrawal by Subject|0|||
48781874|NCT03891524|157042558|FG001|Overall Study|Withdrawal by Subject|1|||
48781875|NCT03891524|157042559|FG002|Overall Study|Withdrawal by Subject|2|||
48781876|NCT03891524|157042560|FG003|Overall Study|Withdrawal by Subject|1|||
48781877|NCT03891524|157042561|FG004|Overall Study|Withdrawal by Subject|2|||
48781878|NCT03891524|157042562|FG005|Overall Study|Withdrawal by Subject|2|||
48781879|NCT03891524|157042563|FG006|Overall Study|Withdrawal by Subject|2|||
48781880|NCT03891524|157042564|FG007|Overall Study|Withdrawal by Subject|1|||
48781881|NCT03283670|157042567|FG000|Placebo Gas|Withdrawal by Subject|2|||
48781882|NCT03283670|157042567|FG000|25% Nitrous Oxide|Withdrawal by Subject|4|||
48781883|NCT03283670|157042567|FG000|50% Nitrous Oxide|Withdrawal by Subject|1|||
48781884|NCT02823145|157042568|FG000|Enrollment|Other|1|||
48781885|NCT02823145|157042569|FG001|Enrollment|Other|0|||
48781886|NCT02823145|157042568|FG000|Treatment|Adverse Event|0|||
48781887|NCT02823145|157042569|FG001|Treatment|Adverse Event|11|||
48781888|NCT02823145|157042568|FG000|Treatment|Death|0|||
48781889|NCT02823145|157042569|FG001|Treatment|Death|3|||
48781890|NCT02823145|157042568|FG000|Treatment|Family Decision|0|||
48781891|NCT02823145|157042569|FG001|Treatment|Family Decision|1|||
48781892|NCT02823145|157042568|FG000|Treatment|IP approved and subject moved to commercial drug|0|||
48781893|NCT02823145|157042569|FG001|Treatment|IP approved and subject moved to commercial drug|1|||
48781894|NCT02823145|157042568|FG000|Treatment|Lack of Efficacy|0|||
48781895|NCT02823145|157042569|FG001|Treatment|Lack of Efficacy|48|||
48781896|NCT02823145|157042568|FG000|Treatment|Non-Compliance With E-Diary|0|||
48781897|NCT02823145|157042569|FG001|Treatment|Non-Compliance With E-Diary|1|||
48781898|NCT02823145|157042568|FG000|Treatment|Physician Decision|0|||
48781899|NCT02823145|157042569|FG001|Treatment|Physician Decision|2|||
48781900|NCT02823145|157042568|FG000|Treatment|Subject has transitioned to study 1900 OLE study|0|||
48781901|NCT02823145|157042569|FG001|Treatment|Subject has transitioned to study 1900 OLE study|225|||
48781902|NCT02823145|157042568|FG000|Treatment|Subject needed to take prohibited medication|0|||
48781903|NCT02823145|157042569|FG001|Treatment|Subject needed to take prohibited medication|1|||
48781904|NCT02823145|157042568|FG000|Treatment|Subject transferred to direct access programme|0|||
48781905|NCT02823145|157042569|FG001|Treatment|Subject transferred to direct access programme|1|||
48781906|NCT02823145|157042568|FG000|Treatment|Switching to commercially available drug|0|||
48781907|NCT02823145|157042569|FG001|Treatment|Switching to commercially available drug|11|||
48781908|NCT02823145|157042568|FG000|Treatment|Transitioned to commercial supply of medication|0|||
48781909|NCT02823145|157042569|FG001|Treatment|Transitioned to commercial supply of medication|1|||
48781910|NCT02823145|157042568|FG000|Treatment|Withdrawal By Caregiver|0|||
48781911|NCT02823145|157042569|FG001|Treatment|Withdrawal By Caregiver|1|||
48781912|NCT02823145|157042568|FG000|Treatment|Withdrawal by sponsor due to lack of compliance|0|||
48781913|NCT02823145|157042569|FG001|Treatment|Withdrawal by sponsor due to lack of compliance|1|||
48781914|NCT02823145|157042568|FG000|Treatment|Withdrawal by Subject|0|||
48781915|NCT02823145|157042569|FG001|Treatment|Withdrawal by Subject|16|||
48781916|NCT02823145|157042568|FG000|Treatment|Reason unknown|0|||
48781917|NCT02823145|157042569|FG001|Treatment|Reason unknown|1|||
48781918|NCT03136068|157044484|FG000|Overall Study|Lost to Follow-up|1|||
48781919|NCT03136068|157044485|FG001|Overall Study|Lost to Follow-up|1|||
48781920|NCT03136068|157044484|FG000|Overall Study|Protocol Violation|1|||
48781921|NCT03136068|157044485|FG001|Overall Study|Protocol Violation|0|||
48781922|NCT00432380|157044488|FG000|Overall Study|Migrated/moved from study area|3|||
48781923|NCT00432380|157044489|FG001|Overall Study|Migrated/moved from study area|4|||
48781924|NCT00432380|157044490|FG002|Overall Study|Migrated/moved from study area|1|||
48781925|NCT00432380|157044488|FG000|Overall Study|Adverse Event|1|||
48781926|NCT00432380|157044489|FG001|Overall Study|Adverse Event|0|||
48781927|NCT00432380|157044490|FG002|Overall Study|Adverse Event|0|||
48781928|NCT01071395|157044491|FG000|Overall Study|Withdrawal by Subject|2|||
48781929|NCT01071395|157044492|FG001|Overall Study|Withdrawal by Subject|1|||
48781930|NCT01071395|157044491|FG000|Overall Study|Adverse Event|3|||
48781931|NCT01071395|157044492|FG001|Overall Study|Adverse Event|1|||
48781932|NCT02805257|157044493|FG000|Overall Study|Lost to Follow-up|7|||
48781933|NCT02805257|157044494|FG001|Overall Study|Lost to Follow-up|6|||
48781934|NCT02805257|157044493|FG000|Overall Study|Death|0|||
48781935|NCT02805257|157044494|FG001|Overall Study|Death|1|||
48877436|NCT02312960|157390050|FG001|Overall Study|Withdrawal by Subject|2|||
48877437|NCT02312960|157390051|FG002|Overall Study|Withdrawal by Subject|0|||
48877438|NCT02312960|157390052|FG003|Overall Study|Withdrawal by Subject|0|||
48877439|NCT02312960|157390053|FG004|Overall Study|Withdrawal by Subject|1|||
48877440|NCT02312960|157390054|FG005|Overall Study|Withdrawal by Subject|0|||
48877441|NCT02312960|157390055|FG006|Overall Study|Withdrawal by Subject|1|||
48877442|NCT02312960|157390056|FG007|Overall Study|Withdrawal by Subject|2|||
48877443|NCT02312960|157390057|FG008|Overall Study|Withdrawal by Subject|2|||
48877444|NCT02312960|157390058|FG009|Overall Study|Withdrawal by Subject|3|||
48781936|NCT01539291|157044495|FG000|Study GS-US-312-0116|Adverse Event|9|||
48781937|NCT01539291|157044496|FG001|Study GS-US-312-0116|Adverse Event|0|||
48781938|NCT01539291|157044497|FG002|Study GS-US-312-0116|Adverse Event|0|||
48781939|NCT01539291|157044498|FG003|Study GS-US-312-0116|Adverse Event|0|||
48781940|NCT01539291|157044495|FG000|Study GS-US-312-0116|Physician Decision|1|||
48781941|NCT01539291|157044496|FG001|Study GS-US-312-0116|Physician Decision|0|||
48781942|NCT01539291|157044497|FG002|Study GS-US-312-0116|Physician Decision|0|||
48781943|NCT01539291|157044498|FG003|Study GS-US-312-0116|Physician Decision|0|||
48781944|NCT01539291|157044495|FG000|Study GS-US-312-0116|Withdrawal by Subject|12|||
48781945|NCT01539291|157044496|FG001|Study GS-US-312-0116|Withdrawal by Subject|0|||
48781946|NCT01539291|157044497|FG002|Study GS-US-312-0116|Withdrawal by Subject|0|||
48781947|NCT01539291|157044498|FG003|Study GS-US-312-0116|Withdrawal by Subject|0|||
48781948|NCT01539291|157044495|FG000|Study GS-US-312-0116|Study Terminated by Sponsor|2|||
48781949|NCT01539291|157044496|FG001|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
48781950|NCT01539291|157044497|FG002|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
48781951|NCT01539291|157044498|FG003|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
48781952|NCT01539291|157044495|FG000|Study GS-US-312-0116|Other|1|||
48781953|NCT01539291|157044496|FG001|Study GS-US-312-0116|Other|0|||
48781954|NCT01539291|157044497|FG002|Study GS-US-312-0116|Other|0|||
48781955|NCT01539291|157044498|FG003|Study GS-US-312-0116|Other|0|||
48781956|NCT01539291|157044495|FG000|Study GS-US-312-0117|Adverse Event|22|||
48781957|NCT01539291|157044496|FG001|Study GS-US-312-0117|Adverse Event|1|||
48781958|NCT01539291|157044497|FG002|Study GS-US-312-0117|Adverse Event|9|||
48781959|NCT01539291|157044498|FG003|Study GS-US-312-0117|Adverse Event|12|||
48781960|NCT01539291|157044495|FG000|Study GS-US-312-0117|Physician Decision|9|||
48781961|NCT01539291|157044496|FG001|Study GS-US-312-0117|Physician Decision|0|||
48781962|NCT01539291|157044497|FG002|Study GS-US-312-0117|Physician Decision|6|||
48781963|NCT01539291|157044498|FG003|Study GS-US-312-0117|Physician Decision|4|||
48781964|NCT01539291|157044495|FG000|Study GS-US-312-0117|Withdrawal by Subject|5|||
48781965|NCT01539291|157044496|FG001|Study GS-US-312-0117|Withdrawal by Subject|0|||
48781966|NCT01539291|157044497|FG002|Study GS-US-312-0117|Withdrawal by Subject|6|||
48877445|NCT02312960|157390059|FG010|Overall Study|Withdrawal by Subject|0|||
49029662|NCT02009163|157945170|FG001|Randomized-withdrawal Period|Protocol Violation|1|||
49029663|NCT02009163|157945171|FG002|Randomized-withdrawal Period|Protocol Violation|2|||
49029664|NCT02009163|157945169|FG000|Randomized-withdrawal Period|Pregnancy|0|||
49029665|NCT02009163|157945170|FG001|Randomized-withdrawal Period|Pregnancy|0|||
49029666|NCT02009163|157945171|FG002|Randomized-withdrawal Period|Pregnancy|2|||
49029667|NCT02009163|157945169|FG000|Randomized-withdrawal Period|Other|0|||
49029668|NCT02009163|157945170|FG001|Randomized-withdrawal Period|Other|9|||
49029669|NCT02009163|157945171|FG002|Randomized-withdrawal Period|Other|5|||
48781967|NCT01539291|157044498|FG003|Study GS-US-312-0117|Withdrawal by Subject|4|||
48877446|NCT02312960|157390060|FG011|Overall Study|Withdrawal by Subject|0|||
48877447|NCT02312960|157390061|FG012|Overall Study|Withdrawal by Subject|2|||
48982835|NCT04249076|157769889|FG000|Overall Study|Withdrawal by Subject|0|||
48982836|NCT04249076|157769890|FG001|Overall Study|Withdrawal by Subject|1|||
48982837|NCT04785144|157769891|FG000|Overall Study|Withdrawal by Subject|4|||
48982838|NCT04785144|157769892|FG001|Overall Study|Withdrawal by Subject|1|||
48982839|NCT04785144|157769893|FG002|Overall Study|Withdrawal by Subject|0|||
48982840|NCT04785144|157769894|FG003|Overall Study|Withdrawal by Subject|0|||
48982841|NCT04785144|157769895|FG004|Overall Study|Withdrawal by Subject|0|||
48982842|NCT04785144|157769896|FG005|Overall Study|Withdrawal by Subject|2|||
48982843|NCT04785144|157769897|FG006|Overall Study|Withdrawal by Subject|2|||
48982844|NCT04785144|157769898|FG007|Overall Study|Withdrawal by Subject|0|||
48982845|NCT04785144|157769899|FG008|Overall Study|Withdrawal by Subject|1|||
48982846|NCT04785144|157769900|FG009|Overall Study|Withdrawal by Subject|0|||
48982847|NCT04785144|157769891|FG000|Overall Study|Lost to Follow-up|1|||
49029670|NCT00359281|157945172|FG000|Overall Study|Adverse Event|1|||
48781968|NCT01539291|157044495|FG000|Study GS-US-312-0117|Study Terminated by Sponsor|3|||
48781969|NCT01539291|157044496|FG001|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
48781970|NCT01539291|157044497|FG002|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
48781971|NCT01539291|157044498|FG003|Study GS-US-312-0117|Study Terminated by Sponsor|5|||
48781972|NCT01539291|157044495|FG000|Study GS-US-312-0117|Other|2|||
48781973|NCT01539291|157044496|FG001|Study GS-US-312-0117|Other|1|||
48877448|NCT02312960|157390062|FG013|Overall Study|Withdrawal by Subject|0|||
48982848|NCT04785144|157769892|FG001|Overall Study|Lost to Follow-up|0|||
48982849|NCT04785144|157769893|FG002|Overall Study|Lost to Follow-up|0|||
48781974|NCT01539291|157044497|FG002|Study GS-US-312-0117|Other|1|||
48781975|NCT01539291|157044498|FG003|Study GS-US-312-0117|Other|1|||
48781976|NCT01076400|157044499|FG000|Overall Study|Adverse Event|2|||
48781977|NCT01076400|157044500|FG001|Overall Study|Adverse Event|0|||
48781978|NCT01076400|157044501|FG002|Overall Study|Adverse Event|0|||
48781979|NCT01076400|157044499|FG000|Overall Study|Progressive Disease|5|||
48781980|NCT01076400|157044500|FG001|Overall Study|Progressive Disease|0|||
48781981|NCT01076400|157044501|FG002|Overall Study|Progressive Disease|0|||
48781982|NCT02766608|157044504|FG000|Overall Study|Adverse Event|27|||
48781983|NCT02766608|157044505|FG001|Overall Study|Adverse Event|22|||
48781984|NCT02766608|157044506|FG002|Overall Study|Adverse Event|17|||
48781985|NCT02766608|157044507|FG003|Overall Study|Adverse Event|13|||
48781986|NCT02766608|157044508|FG004|Overall Study|Adverse Event|12|||
48781987|NCT02766608|157044504|FG000|Overall Study|Withdrawal by Subject|21|||
48781988|NCT02766608|157044505|FG001|Overall Study|Withdrawal by Subject|20|||
48781989|NCT02766608|157044506|FG002|Overall Study|Withdrawal by Subject|24|||
48781990|NCT02766608|157044507|FG003|Overall Study|Withdrawal by Subject|13|||
48781991|NCT02766608|157044508|FG004|Overall Study|Withdrawal by Subject|10|||
48781992|NCT02766608|157044504|FG000|Overall Study|Lack of Efficacy|16|||
48781993|NCT02766608|157044505|FG001|Overall Study|Lack of Efficacy|15|||
48781994|NCT02766608|157044506|FG002|Overall Study|Lack of Efficacy|32|||
48781995|NCT02766608|157044507|FG003|Overall Study|Lack of Efficacy|8|||
48781996|NCT02766608|157044508|FG004|Overall Study|Lack of Efficacy|2|||
48781997|NCT02766608|157044504|FG000|Overall Study|Lost to Follow-up|6|||
48781998|NCT02766608|157044505|FG001|Overall Study|Lost to Follow-up|3|||
48781999|NCT02766608|157044506|FG002|Overall Study|Lost to Follow-up|5|||
48782000|NCT02766608|157044507|FG003|Overall Study|Lost to Follow-up|2|||
48782001|NCT02766608|157044508|FG004|Overall Study|Lost to Follow-up|2|||
48782002|NCT02766608|157044504|FG000|Overall Study|Physician Decision|3|||
48782003|NCT02766608|157044505|FG001|Overall Study|Physician Decision|2|||
48782004|NCT02766608|157044506|FG002|Overall Study|Physician Decision|3|||
48782005|NCT02766608|157044507|FG003|Overall Study|Physician Decision|1|||
48782006|NCT02766608|157044508|FG004|Overall Study|Physician Decision|2|||
48782007|NCT02766608|157044504|FG000|Overall Study|Protocol disc criteria|3|||
48782008|NCT02766608|157044505|FG001|Overall Study|Protocol disc criteria|3|||
48782009|NCT02766608|157044506|FG002|Overall Study|Protocol disc criteria|4|||
48782010|NCT02766608|157044507|FG003|Overall Study|Protocol disc criteria|0|||
48782011|NCT02766608|157044508|FG004|Overall Study|Protocol disc criteria|0|||
48782012|NCT02766608|157044504|FG000|Overall Study|Protocol Violation|0|||
48782013|NCT02766608|157044505|FG001|Overall Study|Protocol Violation|4|||
48782014|NCT02766608|157044506|FG002|Overall Study|Protocol Violation|4|||
48782015|NCT02766608|157044507|FG003|Overall Study|Protocol Violation|0|||
48782016|NCT02766608|157044508|FG004|Overall Study|Protocol Violation|1|||
49029671|NCT00359281|157945173|FG001|Overall Study|Adverse Event|0|||
49029672|NCT00359281|157945174|FG002|Overall Study|Adverse Event|0|||
49029673|NCT00359281|157945175|FG003|Overall Study|Adverse Event|0|||
49029674|NCT00359281|157945176|FG004|Overall Study|Adverse Event|0|||
49029675|NCT00359281|157945177|FG005|Overall Study|Adverse Event|0|||
49029676|NCT00359281|157945178|FG006|Overall Study|Adverse Event|1|||
49029677|NCT00359281|157945179|FG007|Overall Study|Adverse Event|0|||
49029678|NCT00359281|157945180|FG008|Overall Study|Adverse Event|0|||
49029679|NCT00359281|157945172|FG000|Overall Study|Withdrawal by Subject|0|||
49029680|NCT00359281|157945173|FG001|Overall Study|Withdrawal by Subject|0|||
49029681|NCT00359281|157945174|FG002|Overall Study|Withdrawal by Subject|0|||
49029682|NCT00359281|157945175|FG003|Overall Study|Withdrawal by Subject|0|||
49029683|NCT00359281|157945176|FG004|Overall Study|Withdrawal by Subject|0|||
49029684|NCT00359281|157945177|FG005|Overall Study|Withdrawal by Subject|0|||
49029685|NCT00359281|157945178|FG006|Overall Study|Withdrawal by Subject|1|||
49029686|NCT00359281|157945179|FG007|Overall Study|Withdrawal by Subject|0|||
49029687|NCT00359281|157945180|FG008|Overall Study|Withdrawal by Subject|0|||
48782017|NCT02766608|157044504|FG000|Overall Study|Administrative Reasons|3|||
48782018|NCT02766608|157044505|FG001|Overall Study|Administrative Reasons|1|||
48782019|NCT02766608|157044506|FG002|Overall Study|Administrative Reasons|1|||
48782020|NCT02766608|157044507|FG003|Overall Study|Administrative Reasons|0|||
48782021|NCT02766608|157044508|FG004|Overall Study|Administrative Reasons|0|||
48782022|NCT02239510|157044509|FG000|Overall Study|Lost to Follow-up|2|||
48782023|NCT02239510|157044510|FG001|Overall Study|Lost to Follow-up|1|||
48782024|NCT00182689|157044511|FG000|Overall Study|Adverse Event|8|||
48782025|NCT00182689|157044512|FG001|Overall Study|Adverse Event|11|||
48782026|NCT00182689|157044511|FG000|Overall Study|Withdrawal by Subject|2|||
48782027|NCT00182689|157044512|FG001|Overall Study|Withdrawal by Subject|2|||
48782028|NCT00182689|157044511|FG000|Overall Study|Progression|27|||
48782029|NCT00182689|157044512|FG001|Overall Study|Progression|29|||
48782030|NCT00182689|157044511|FG000|Overall Study|Death|1|||
48782031|NCT00182689|157044512|FG001|Overall Study|Death|0|||
49029688|NCT01289262|157945183|FG000|Overall Study|Lost to Follow-up|29|||
49029689|NCT01289262|157945184|FG001|Overall Study|Lost to Follow-up|16|||
48782032|NCT00182689|157044511|FG000|Overall Study|not protocol specified|0|||
49029690|NCT01289262|157945183|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
49029691|NCT01289262|157945184|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
49029692|NCT03586726|157945188|FG000|Overall Study|Withdrawal by Subject|1|||
48782033|NCT00182689|157044512|FG001|Overall Study|not protocol specified|3|||
48782034|NCT00182689|157044511|FG000|Overall Study|Ineligible|1|||
49029693|NCT03233724|157945189|FG000|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
49029694|NCT03233724|157945190|FG001|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
49029695|NCT03233724|157945191|FG002|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
49029696|NCT03233724|157945192|FG003|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
49029697|NCT03233724|157945193|FG004|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|1|||
48782035|NCT00182689|157044512|FG001|Overall Study|Ineligible|4|||
48782036|NCT00182689|157044511|FG000|Overall Study|Never received treatment|1|||
48782037|NCT00182689|157044512|FG001|Overall Study|Never received treatment|0|||
49029698|NCT03233724|157945189|FG000|Phase I Dose Escalation|Best interest of participant|1|||
48782038|NCT02866682|157044513|FG000|Overall Study|Death|0|||
48782039|NCT02866682|157044514|FG001|Overall Study|Death|1|||
48782040|NCT02866682|157044513|FG000|Overall Study|Lost to Follow-up|0|||
48782041|NCT02866682|157044514|FG001|Overall Study|Lost to Follow-up|4|||
48782042|NCT02866682|157044513|FG000|Overall Study|Tacrolimus Discontinued During Study|0|||
48782043|NCT02866682|157044514|FG001|Overall Study|Tacrolimus Discontinued During Study|6|||
48782044|NCT02866682|157044513|FG000|Overall Study|Other|0|||
48782045|NCT02866682|157044514|FG001|Overall Study|Other|1|||
48782046|NCT03738865|157044515|FG000|Overall Study|Withdrawal by Subject|3|||
48782047|NCT03738865|157044516|FG001|Overall Study|Withdrawal by Subject|3|||
48782048|NCT03738865|157044515|FG000|Overall Study|Adverse Event|2|||
48782049|NCT03738865|157044516|FG001|Overall Study|Adverse Event|0|||
48782050|NCT03738865|157044515|FG000|Overall Study|Physician Decision|0|||
48782051|NCT03738865|157044516|FG001|Overall Study|Physician Decision|1|||
48782052|NCT04193202|157044517|FG000|Overall Study|Adverse Event|2|||
48782053|NCT04193202|157044518|FG001|Overall Study|Adverse Event|1|||
48782054|NCT04193202|157044517|FG000|Overall Study|Death|0|||
48782055|NCT04193202|157044518|FG001|Overall Study|Death|1|||
48782056|NCT04193202|157044517|FG000|Overall Study|Physician Decision|1|||
48782057|NCT04193202|157044518|FG001|Overall Study|Physician Decision|1|||
48782058|NCT04193202|157044517|FG000|Overall Study|Protocol Violation|2|||
48782059|NCT04193202|157044518|FG001|Overall Study|Protocol Violation|2|||
48782060|NCT04193202|157044517|FG000|Overall Study|Withdrawal by Subject|11|||
48782061|NCT04193202|157044518|FG001|Overall Study|Withdrawal by Subject|5|||
48782062|NCT01602315|157044519|FG000|Overall Study|Protocol Violation|0|||
48782063|NCT01602315|157044520|FG001|Overall Study|Protocol Violation|0|||
48782064|NCT01602315|157044521|FG002|Overall Study|Protocol Violation|0|||
48782065|NCT01602315|157044522|FG003|Overall Study|Protocol Violation|0|||
48782066|NCT01602315|157044523|FG004|Overall Study|Protocol Violation|0|||
48782067|NCT01602315|157044524|FG005|Overall Study|Protocol Violation|1|||
48782068|NCT01602315|157044525|FG006|Overall Study|Protocol Violation|0|||
48782069|NCT01602315|157044519|FG000|Overall Study|Physician Decision|2|||
48782070|NCT01602315|157044520|FG001|Overall Study|Physician Decision|0|||
48782071|NCT01602315|157044521|FG002|Overall Study|Physician Decision|0|||
48782072|NCT01602315|157044522|FG003|Overall Study|Physician Decision|0|||
48782073|NCT01602315|157044523|FG004|Overall Study|Physician Decision|2|||
48782074|NCT01602315|157044524|FG005|Overall Study|Physician Decision|1|||
48782075|NCT01602315|157044525|FG006|Overall Study|Physician Decision|1|||
48782076|NCT01602315|157044519|FG000|Overall Study|Disease progression|6|||
48782077|NCT01602315|157044520|FG001|Overall Study|Disease progression|3|||
48782078|NCT01602315|157044521|FG002|Overall Study|Disease progression|10|||
48782079|NCT01602315|157044522|FG003|Overall Study|Disease progression|1|||
48782080|NCT01602315|157044523|FG004|Overall Study|Disease progression|41|||
48782081|NCT01602315|157044524|FG005|Overall Study|Disease progression|12|||
48782082|NCT01602315|157044525|FG006|Overall Study|Disease progression|15|||
48782083|NCT01602315|157044519|FG000|Overall Study|Death|1|||
48782084|NCT01602315|157044520|FG001|Overall Study|Death|1|||
48782085|NCT01602315|157044521|FG002|Overall Study|Death|1|||
48782086|NCT01602315|157044522|FG003|Overall Study|Death|1|||
48782087|NCT01602315|157044523|FG004|Overall Study|Death|7|||
48782088|NCT01602315|157044524|FG005|Overall Study|Death|2|||
48782089|NCT01602315|157044525|FG006|Overall Study|Death|2|||
48782090|NCT01602315|157044519|FG000|Overall Study|Withdrawal by Subject|2|||
48782091|NCT01602315|157044520|FG001|Overall Study|Withdrawal by Subject|0|||
48782092|NCT01602315|157044521|FG002|Overall Study|Withdrawal by Subject|2|||
48782093|NCT01602315|157044522|FG003|Overall Study|Withdrawal by Subject|0|||
48782094|NCT01602315|157044523|FG004|Overall Study|Withdrawal by Subject|6|||
48782095|NCT01602315|157044524|FG005|Overall Study|Withdrawal by Subject|0|||
48782096|NCT01602315|157044525|FG006|Overall Study|Withdrawal by Subject|1|||
48782097|NCT01602315|157044519|FG000|Overall Study|Adverse Event|5|||
48782098|NCT01602315|157044520|FG001|Overall Study|Adverse Event|1|||
48782099|NCT01602315|157044521|FG002|Overall Study|Adverse Event|5|||
49029699|NCT03233724|157945190|FG001|Phase I Dose Escalation|Best interest of participant|1|||
49029700|NCT03233724|157945191|FG002|Phase I Dose Escalation|Best interest of participant|1|||
49029701|NCT03233724|157945192|FG003|Phase I Dose Escalation|Best interest of participant|0|||
49029702|NCT03233724|157945193|FG004|Phase I Dose Escalation|Best interest of participant|0|||
49029703|NCT03233724|157945189|FG000|Phase I Dose Escalation|Physician Decision|0|||
49029704|NCT03233724|157945190|FG001|Phase I Dose Escalation|Physician Decision|0|||
49029705|NCT03233724|157945191|FG002|Phase I Dose Escalation|Physician Decision|1|||
49029706|NCT03233724|157945192|FG003|Phase I Dose Escalation|Physician Decision|0|||
49029707|NCT03233724|157945193|FG004|Phase I Dose Escalation|Physician Decision|0|||
49029708|NCT03233724|157945189|FG000|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
49029709|NCT03233724|157945190|FG001|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
49029710|NCT03233724|157945191|FG002|Phase I Dose Escalation|Delay >3 weeks on treatment|1|||
49029711|NCT03233724|157945192|FG003|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
49029712|NCT03233724|157945193|FG004|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
49029713|NCT03122457|157945194|FG000|Overall Study|Withdrawal by Subject|6|||
49029714|NCT00651820|157945200|FG000|Overall Study|Lost to Follow-up|2|||
49029715|NCT01110005|157945209|FG000|Overall Study|ineligible|1|||
49029716|NCT01110005|157945210|FG001|Overall Study|ineligible|2|||
49029717|NCT01110005|157945209|FG000|Overall Study|missing consent|3|||
49029718|NCT01110005|157945210|FG001|Overall Study|missing consent|2|||
49029719|NCT01110005|157945209|FG000|Overall Study|Withdrawal by Subject|0|||
49029720|NCT01110005|157945210|FG001|Overall Study|Withdrawal by Subject|1|||
49029721|NCT04646213|157945211|FG000|Overall Study|Physician Decision|3|||
49029722|NCT04646213|157945211|FG000|Overall Study|Withdrawal by Subject|2|||
49029723|NCT00950989|157945212|FG000|Overall Study|Death|0|||
48782100|NCT01602315|157044522|FG003|Overall Study|Adverse Event|4|||
48782101|NCT01602315|157044523|FG004|Overall Study|Adverse Event|15|||
48782102|NCT01602315|157044524|FG005|Overall Study|Adverse Event|3|||
48782103|NCT01602315|157044525|FG006|Overall Study|Adverse Event|9|||
48782104|NCT01602315|157044519|FG000|Overall Study|Subject/guardian decision|0|||
48782105|NCT01602315|157044520|FG001|Overall Study|Subject/guardian decision|0|||
48782106|NCT01602315|157044521|FG002|Overall Study|Subject/guardian decision|0|||
48782107|NCT01602315|157044522|FG003|Overall Study|Subject/guardian decision|0|||
48782108|NCT01602315|157044523|FG004|Overall Study|Subject/guardian decision|0|||
48782109|NCT01602315|157044524|FG005|Overall Study|Subject/guardian decision|0|||
48782110|NCT01602315|157044525|FG006|Overall Study|Subject/guardian decision|1|||
48782111|NCT01602315|157044519|FG000|Overall Study|Cross-over patients to combo treatment|0|||
48782112|NCT01602315|157044520|FG001|Overall Study|Cross-over patients to combo treatment|0|||
48782113|NCT01602315|157044521|FG002|Overall Study|Cross-over patients to combo treatment|0|||
48782114|NCT01602315|157044522|FG003|Overall Study|Cross-over patients to combo treatment|0|||
48782115|NCT01602315|157044523|FG004|Overall Study|Cross-over patients to combo treatment|0|||
48782116|NCT01602315|157044524|FG005|Overall Study|Cross-over patients to combo treatment|16|||
48782117|NCT01602315|157044525|FG006|Overall Study|Cross-over patients to combo treatment|0|||
48782118|NCT02660359|157044526|FG000|Overall Study|Protocol Deviation|0|||
48782119|NCT02660359|157044527|FG001|Overall Study|Protocol Deviation|0|||
48782120|NCT02660359|157044528|FG002|Overall Study|Protocol Deviation|1|||
48782121|NCT02660359|157044526|FG000|Overall Study|Sponsor Decision to Terminate Study|73|||
48782122|NCT02660359|157044527|FG001|Overall Study|Sponsor Decision to Terminate Study|75|||
48782123|NCT02660359|157044528|FG002|Overall Study|Sponsor Decision to Terminate Study|71|||
48782124|NCT02660359|157044526|FG000|Overall Study|Lack of Efficacy|1|||
48782125|NCT02660359|157044527|FG001|Overall Study|Lack of Efficacy|1|||
48782126|NCT02660359|157044528|FG002|Overall Study|Lack of Efficacy|1|||
48782127|NCT02660359|157044526|FG000|Overall Study|Adverse Event|0|||
48782128|NCT02660359|157044527|FG001|Overall Study|Adverse Event|1|||
48782129|NCT02660359|157044528|FG002|Overall Study|Adverse Event|0|||
48782130|NCT02660359|157044526|FG000|Overall Study|Other|2|||
48782131|NCT02660359|157044527|FG001|Overall Study|Other|1|||
48782132|NCT02660359|157044528|FG002|Overall Study|Other|3|||
48782133|NCT02660359|157044526|FG000|Overall Study|Withdrawal by Subject|7|||
48782134|NCT02660359|157044527|FG001|Overall Study|Withdrawal by Subject|5|||
48782135|NCT02660359|157044528|FG002|Overall Study|Withdrawal by Subject|8|||
49029724|NCT00950989|157945213|FG001|Overall Study|Death|0|||
49029725|NCT00950989|157945214|FG002|Overall Study|Death|1|||
48782136|NCT02660359|157044526|FG000|Overall Study|Lost to Follow-up|3|||
48782137|NCT02660359|157044527|FG001|Overall Study|Lost to Follow-up|3|||
48782138|NCT02660359|157044528|FG002|Overall Study|Lost to Follow-up|0|||
48782139|NCT00982020|157044530|FG000|Overall Study|Adverse Event|19|||
48782140|NCT00982020|157044531|FG001|Overall Study|Adverse Event|15|||
49029726|NCT00950989|157945215|FG003|Overall Study|Death|0|||
48782141|NCT00982020|157044530|FG000|Overall Study|Withdrawal by Subject|11|||
49029727|NCT00950989|157945212|FG000|Overall Study|Administrative Decision|0|||
49029728|NCT00950989|157945213|FG001|Overall Study|Administrative Decision|1|||
48782142|NCT00982020|157044531|FG001|Overall Study|Withdrawal by Subject|14|||
48782143|NCT00982020|157044530|FG000|Overall Study|Lost to Follow-up|5|||
48782144|NCT00982020|157044531|FG001|Overall Study|Lost to Follow-up|11|||
48782145|NCT00982020|157044530|FG000|Overall Study|Lack of Efficacy|10|||
48782146|NCT00982020|157044531|FG001|Overall Study|Lack of Efficacy|4|||
48782147|NCT00982020|157044530|FG000|Overall Study|Parent/Caregiver Decision|5|||
48782148|NCT00982020|157044531|FG001|Overall Study|Parent/Caregiver Decision|5|||
48782149|NCT00982020|157044530|FG000|Overall Study|Treatment Non-compliance|3|||
48782150|NCT00982020|157044531|FG001|Overall Study|Treatment Non-compliance|6|||
48782151|NCT00982020|157044530|FG000|Overall Study|Physician Decision|2|||
48782152|NCT00982020|157044531|FG001|Overall Study|Physician Decision|5|||
48782153|NCT00982020|157044530|FG000|Overall Study|Entry Criteria Not Met|2|||
48782154|NCT00982020|157044531|FG001|Overall Study|Entry Criteria Not Met|1|||
48782155|NCT00982020|157044530|FG000|Overall Study|Protocol Violation|0|||
48782156|NCT00982020|157044531|FG001|Overall Study|Protocol Violation|2|||
48782157|NCT00982020|157044530|FG000|Overall Study|Clinical Relapse|0|||
48782158|NCT00982020|157044531|FG001|Overall Study|Clinical Relapse|1|||
48782159|NCT00975975|157044532|FG000|Overall Study|Death|6|||
48782160|NCT01252251|157044533|FG000|Overall Study|Withdrawal by Subject|1|||
48782161|NCT02039505|157044534|FG000|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2|||
48782162|NCT02039505|157044535|FG001|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8|||
49029729|NCT00950989|157945214|FG002|Overall Study|Administrative Decision|0|||
49029730|NCT00950989|157945215|FG003|Overall Study|Administrative Decision|0|||
49029731|NCT00950989|157945212|FG000|Overall Study|Disease Progression|0|||
49029732|NCT00950989|157945213|FG001|Overall Study|Disease Progression|0|||
49029733|NCT00950989|157945214|FG002|Overall Study|Disease Progression|1|||
49029734|NCT00950989|157945215|FG003|Overall Study|Disease Progression|0|||
49029735|NCT00950989|157945212|FG000|Overall Study|Withdrawal by Subject|2|||
49029736|NCT00950989|157945213|FG001|Overall Study|Withdrawal by Subject|1|||
49029737|NCT00950989|157945214|FG002|Overall Study|Withdrawal by Subject|0|||
48782163|NCT02039505|157044536|FG002|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7|||
48782164|NCT02039505|157044537|FG003|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
48782165|NCT02039505|157044538|FG004|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
49029738|NCT00950989|157945215|FG003|Overall Study|Withdrawal by Subject|0|||
49029739|NCT00950989|157945212|FG000|Overall Study|Adverse Event|2|||
49029740|NCT00950989|157945213|FG001|Overall Study|Adverse Event|1|||
49029741|NCT00950989|157945214|FG002|Overall Study|Adverse Event|1|||
49029742|NCT00950989|157945215|FG003|Overall Study|Adverse Event|0|||
49029743|NCT02445339|157945216|FG000|Overall Study|Physician Decision|1|||
49029744|NCT02445339|157945217|FG001|Overall Study|Physician Decision|0|||
49029745|NCT02445339|157945216|FG000|Overall Study|Lost to Follow-up|11|||
48782166|NCT02039505|157044539|FG005|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
48782167|NCT02039505|157044540|FG006|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
49029746|NCT02445339|157945217|FG001|Overall Study|Lost to Follow-up|15|||
49029747|NCT02289963|157946841|FG000|Overall Study|Adverse Event|1|||
49029748|NCT02289963|157946842|FG001|Overall Study|Adverse Event|2|||
49029749|NCT02289963|157946841|FG000|Overall Study|Poor compliance to protocol|1|||
49029750|NCT02289963|157946842|FG001|Overall Study|Poor compliance to protocol|0|||
49029751|NCT02289963|157946841|FG000|Overall Study|Withdrawal by Subject|1|||
49029752|NCT02289963|157946842|FG001|Overall Study|Withdrawal by Subject|0|||
49029753|NCT02289963|157946841|FG000|Overall Study|Last injection missed|2|||
49029754|NCT02289963|157946842|FG001|Overall Study|Last injection missed|2|||
49029755|NCT02289963|157946841|FG000|Overall Study|End treatment visit outside visit window|0|||
49029756|NCT02289963|157946842|FG001|Overall Study|End treatment visit outside visit window|4|||
49029757|NCT02289963|157946841|FG000|Overall Study|Other than specified above|0|||
49029758|NCT02289963|157946842|FG001|Overall Study|Other than specified above|2|||
49029759|NCT00496964|157946851|FG000|Overall Study|Withdrawal by Subject|0|||
48782168|NCT02039505|157044534|FG000|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
48782169|NCT02039505|157044535|FG001|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
48782170|NCT02039505|157044536|FG002|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3|||
48782171|NCT02039505|157044537|FG003|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
48782172|NCT02039505|157044538|FG004|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
49029760|NCT00496964|157946852|FG001|Overall Study|Withdrawal by Subject|1|||
49029761|NCT02058498|157946853|FG000|Overall Study|Withdrawal by Subject|4|||
48782173|NCT02039505|157044539|FG005|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
48782174|NCT02039505|157044540|FG006|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
49029762|NCT03478397|157946854|FG000|Overall Study|Refused to participate|31|||
49029763|NCT03478397|157946855|FG001|Overall Study|Refused to participate|7|||
49029764|NCT01149473|157946856|FG000|First Intervention|Adverse Event|1|||
49029765|NCT01149473|157946857|FG001|First Intervention|Adverse Event|1|||
49029766|NCT01149473|157946856|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
49029767|NCT01149473|157946857|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
49029768|NCT01954394|157946860|FG000|Overall Study|Enrolled but not treated|1|||
49029769|NCT01954394|157946861|FG001|Overall Study|Enrolled but not treated|0|||
49029770|NCT01954394|157946860|FG000|Overall Study|Adverse Event|10|||
49029771|NCT01954394|157946861|FG001|Overall Study|Adverse Event|23|||
49029772|NCT01954394|157946860|FG000|Overall Study|Poor compliance to protocol|7|||
49029773|NCT01954394|157946861|FG001|Overall Study|Poor compliance to protocol|7|||
49029774|NCT01954394|157946860|FG000|Overall Study|Participant Moved|0|||
49029775|NCT01954394|157946861|FG001|Overall Study|Participant Moved|4|||
49029776|NCT01954394|157946860|FG000|Overall Study|Related to Study Drug administration|2|||
49029777|NCT01954394|157946861|FG001|Overall Study|Related to Study Drug administration|2|||
49029778|NCT01954394|157946860|FG000|Overall Study|Other than specified above|10|||
49029779|NCT01954394|157946861|FG001|Overall Study|Other than specified above|21|||
49029780|NCT00909610|157946862|FG000|Period: First Intervention|Adverse Event|0|||
49029781|NCT00909610|157946863|FG001|Period: First Intervention|Adverse Event|1|||
49029782|NCT00909610|157946862|FG000|Period: Washout of 28 Days|Withdrawal by Subject|3|||
49029783|NCT00909610|157946863|FG001|Period: Washout of 28 Days|Withdrawal by Subject|6|||
49029784|NCT00909610|157946862|FG000|Period: Second Intervention|Adverse Event|1|||
49029785|NCT00909610|157946863|FG001|Period: Second Intervention|Adverse Event|0|||
49029786|NCT05327491|157946874|FG000|Periods 1 & 2|Miscellaneous|0|||
49029787|NCT05327491|157946875|FG001|Periods 1 & 2|Miscellaneous|1|||
49029788|NCT05327491|157946876|FG002|Periods 1 & 2|Miscellaneous|0|||
49029789|NCT05327491|157946877|FG003|Periods 1 & 2|Miscellaneous|0|||
49029790|NCT05327491|157946874|FG000|Periods 1 & 2|Withdrawal by Subject|1|||
49029791|NCT05327491|157946875|FG001|Periods 1 & 2|Withdrawal by Subject|0|||
49029792|NCT05327491|157946876|FG002|Periods 1 & 2|Withdrawal by Subject|0|||
49029793|NCT05327491|157946877|FG003|Periods 1 & 2|Withdrawal by Subject|0|||
49029794|NCT02188303|157946878|FG000|Overall Study|Adverse Event|0|||
49029795|NCT02188303|157946879|FG001|Overall Study|Adverse Event|0|||
49029796|NCT02188303|157946880|FG002|Overall Study|Adverse Event|0|||
49029797|NCT02188303|157946881|FG003|Overall Study|Adverse Event|0|||
49029798|NCT02188303|157946882|FG004|Overall Study|Adverse Event|0|||
49029799|NCT02188303|157946883|FG005|Overall Study|Adverse Event|2|||
49029800|NCT02188303|157946884|FG006|Overall Study|Adverse Event|0|||
49029801|NCT02188303|157946885|FG007|Overall Study|Adverse Event|2|||
49029802|NCT02188303|157946878|FG000|Overall Study|Dose Termination Criteria Met|0|||
49029803|NCT02188303|157946879|FG001|Overall Study|Dose Termination Criteria Met|0|||
49029804|NCT02188303|157946880|FG002|Overall Study|Dose Termination Criteria Met|0|||
49029805|NCT02188303|157946881|FG003|Overall Study|Dose Termination Criteria Met|0|||
49029806|NCT02188303|157946882|FG004|Overall Study|Dose Termination Criteria Met|0|||
49029807|NCT02188303|157946883|FG005|Overall Study|Dose Termination Criteria Met|0|||
49029808|NCT02188303|157946884|FG006|Overall Study|Dose Termination Criteria Met|2|||
49029809|NCT02188303|157946885|FG007|Overall Study|Dose Termination Criteria Met|4|||
49029810|NCT04206332|157946886|FG000|Part A|Lost to Follow-up|0|||
48782175|NCT02039505|157044534|FG000|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1|||
49029811|NCT04206332|157946887|FG001|Part A|Lost to Follow-up|1|||
49029812|NCT04206332|157946888|FG002|Part A|Lost to Follow-up|0|||
49029813|NCT04206332|157946889|FG003|Part A|Lost to Follow-up|0|||
49029814|NCT04206332|157946890|FG004|Part A|Lost to Follow-up|0|||
49029815|NCT04206332|157946891|FG005|Part A|Lost to Follow-up|0|||
49029816|NCT04206332|157946892|FG006|Part A|Lost to Follow-up|0|||
49029817|NCT04206332|157946893|FG007|Part A|Lost to Follow-up|0|||
49029818|NCT04206332|157946894|FG008|Part A|Lost to Follow-up|0|||
49029819|NCT04206332|157946895|FG009|Part A|Lost to Follow-up|0|||
49029820|NCT04206332|157946896|FG010|Part A|Lost to Follow-up|0|||
49029821|NCT04206332|157946897|FG011|Part A|Lost to Follow-up|0|||
49029822|NCT04206332|157946898|FG012|Part A|Lost to Follow-up|0|||
49029823|NCT04206332|157946899|FG013|Part A|Lost to Follow-up|0|||
49029824|NCT04206332|157946900|FG014|Part A|Lost to Follow-up|0|||
49029825|NCT04206332|157946901|FG015|Part A|Lost to Follow-up|0|||
49029826|NCT04206332|157946902|FG016|Part A|Lost to Follow-up|0|||
49029827|NCT04206332|157946886|FG000|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
48782176|NCT02039505|157044535|FG001|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
48782177|NCT02039505|157044536|FG002|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
48782178|NCT02039505|157044537|FG003|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
48782179|NCT02039505|157044538|FG004|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
48782180|NCT02039505|157044539|FG005|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
48782181|NCT02039505|157044540|FG006|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
48782182|NCT02039505|157044534|FG000|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
49029828|NCT04206332|157946887|FG001|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
49029829|NCT04206332|157946888|FG002|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
49029830|NCT04206332|157946889|FG003|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
48782183|NCT02039505|157044535|FG001|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
48782184|NCT02039505|157044536|FG002|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
49029831|NCT04206332|157946890|FG004|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
49029832|NCT04206332|157946891|FG005|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|8|||
49029833|NCT04206332|157946892|FG006|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
49029834|NCT04206332|157946893|FG007|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
49029835|NCT04206332|157946894|FG008|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
49029836|NCT04206332|157946895|FG009|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
49029837|NCT04206332|157946896|FG010|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
49029838|NCT04206332|157946897|FG011|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
49029839|NCT04206332|157946898|FG012|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
49029840|NCT04206332|157946899|FG013|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
49029841|NCT04206332|157946900|FG014|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
49029842|NCT04206332|157946901|FG015|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
49029843|NCT04206332|157946902|FG016|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
49029844|NCT04206332|157946886|FG000|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
49029845|NCT04206332|157946887|FG001|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
49029846|NCT04206332|157946888|FG002|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
49029847|NCT04206332|157946889|FG003|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
49029848|NCT04206332|157946890|FG004|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
49029849|NCT04206332|157946891|FG005|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
49029850|NCT04206332|157946892|FG006|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
49029851|NCT04206332|157946893|FG007|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|3|||
49029852|NCT04206332|157946894|FG008|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
49029853|NCT04206332|157946895|FG009|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
49029854|NCT04206332|157946896|FG010|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
48782185|NCT02039505|157044537|FG003|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13|||
48782186|NCT02039505|157044538|FG004|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8|||
48782187|NCT02039505|157044539|FG005|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12|||
48782188|NCT02039505|157044540|FG006|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
48782189|NCT02039505|157044534|FG000|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
48782190|NCT02039505|157044535|FG001|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
49029855|NCT04206332|157946897|FG011|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
49029856|NCT04206332|157946898|FG012|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
49029857|NCT04206332|157946899|FG013|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
49029858|NCT04206332|157946900|FG014|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
49029859|NCT04206332|157946901|FG015|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
49029860|NCT04206332|157946902|FG016|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
49029861|NCT04206332|157946886|FG000|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
49029862|NCT04206332|157946887|FG001|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
49029863|NCT04206332|157946888|FG002|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
49029864|NCT04206332|157946889|FG003|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
49029865|NCT04206332|157946890|FG004|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
49029866|NCT04206332|157946891|FG005|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
49029867|NCT04206332|157946892|FG006|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
49029868|NCT04206332|157946893|FG007|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
49029869|NCT04206332|157946894|FG008|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
49029870|NCT04206332|157946895|FG009|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
49029871|NCT04206332|157946896|FG010|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
49029872|NCT04206332|157946897|FG011|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
49029873|NCT04206332|157946898|FG012|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
49029874|NCT04206332|157946899|FG013|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
49029875|NCT04206332|157946900|FG014|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
49029876|NCT04206332|157946901|FG015|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
49029877|NCT04206332|157946902|FG016|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
49029878|NCT04206332|157946886|FG000|Part C|Withdrawal by Subject|0|||
48797712|NCT00293267|157097060|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
48782191|NCT02039505|157044536|FG002|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
48782192|NCT02039505|157044537|FG003|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6|||
48782193|NCT02039505|157044538|FG004|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
48782194|NCT02039505|157044539|FG005|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
48782195|NCT02039505|157044540|FG006|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
48782196|NCT02039505|157044534|FG000|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
48782197|NCT02039505|157044535|FG001|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
48782198|NCT02039505|157044536|FG002|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
48782199|NCT02039505|157044537|FG003|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3|||
48782200|NCT02039505|157044538|FG004|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2|||
48782201|NCT02039505|157044539|FG005|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1|||
48782202|NCT02039505|157044540|FG006|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
48782203|NCT02039505|157044534|FG000|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
48782204|NCT02039505|157044535|FG001|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
48782205|NCT02039505|157044536|FG002|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
48782206|NCT02039505|157044537|FG003|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2|||
48782207|NCT02039505|157044538|FG004|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
48782208|NCT02039505|157044539|FG005|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
48782209|NCT02039505|157044540|FG006|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
48782210|NCT02039505|157044534|FG000|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
48782211|NCT02039505|157044535|FG001|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
48782212|NCT02039505|157044536|FG002|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
48782213|NCT02039505|157044537|FG003|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
48782214|NCT02039505|157044538|FG004|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
48782215|NCT02039505|157044539|FG005|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
48782216|NCT02039505|157044540|FG006|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44|||
48782217|NCT02039505|157044534|FG000|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
48782218|NCT02039505|157044535|FG001|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
48782219|NCT02039505|157044536|FG002|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
48782220|NCT02039505|157044537|FG003|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
48782221|NCT02039505|157044538|FG004|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
48782222|NCT02039505|157044539|FG005|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
49029879|NCT04206332|157946887|FG001|Part C|Withdrawal by Subject|0|||
49029880|NCT04206332|157946888|FG002|Part C|Withdrawal by Subject|0|||
49029881|NCT04206332|157946889|FG003|Part C|Withdrawal by Subject|0|||
49029882|NCT04206332|157946890|FG004|Part C|Withdrawal by Subject|0|||
49029883|NCT04206332|157946891|FG005|Part C|Withdrawal by Subject|0|||
49029884|NCT04206332|157946892|FG006|Part C|Withdrawal by Subject|0|||
49029885|NCT04206332|157946893|FG007|Part C|Withdrawal by Subject|0|||
49029886|NCT04206332|157946894|FG008|Part C|Withdrawal by Subject|0|||
49029887|NCT04206332|157946895|FG009|Part C|Withdrawal by Subject|0|||
49029888|NCT04206332|157946896|FG010|Part C|Withdrawal by Subject|0|||
49029889|NCT04206332|157946897|FG011|Part C|Withdrawal by Subject|0|||
49029890|NCT04206332|157946898|FG012|Part C|Withdrawal by Subject|0|||
49029891|NCT04206332|157946899|FG013|Part C|Withdrawal by Subject|0|||
49029892|NCT04206332|157946900|FG014|Part C|Withdrawal by Subject|2|||
49029893|NCT04206332|157946901|FG015|Part C|Withdrawal by Subject|0|||
49029894|NCT04206332|157946902|FG016|Part C|Withdrawal by Subject|0|||
49029895|NCT03627091|157946903|FG000|Overall Study|Adverse Event|0|||
49029896|NCT03627091|157946904|FG001|Overall Study|Adverse Event|0|||
49029897|NCT03627091|157946905|FG002|Overall Study|Adverse Event|2|||
49029898|NCT03627091|157946903|FG000|Overall Study|Withdrawal by Subject|2|||
49029899|NCT03627091|157946904|FG001|Overall Study|Withdrawal by Subject|0|||
49029900|NCT03627091|157946905|FG002|Overall Study|Withdrawal by Subject|2|||
49029901|NCT03627091|157946903|FG000|Overall Study|Physician Decision|2|||
49029902|NCT03627091|157946904|FG001|Overall Study|Physician Decision|0|||
49029903|NCT03627091|157946905|FG002|Overall Study|Physician Decision|0|||
49029904|NCT03627091|157946903|FG000|Overall Study|Site terminated by sponsor|0|||
49029905|NCT03627091|157946904|FG001|Overall Study|Site terminated by sponsor|1|||
49029906|NCT03627091|157946905|FG002|Overall Study|Site terminated by sponsor|0|||
49029907|NCT03627091|157946903|FG000|Overall Study|Disease relapse|7|||
49029908|NCT03627091|157946904|FG001|Overall Study|Disease relapse|5|||
48782223|NCT02039505|157044540|FG006|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19|||
48782224|NCT02039505|157044534|FG000|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
48877449|NCT02641587|157390063|FG000|Confinement Period|Adverse Event|1|||
49029909|NCT03627091|157946905|FG002|Overall Study|Disease relapse|1|||
49029910|NCT03627091|157946903|FG000|Overall Study|Other|1|||
49029911|NCT03627091|157946904|FG001|Overall Study|Other|0|||
49029912|NCT03627091|157946905|FG002|Overall Study|Other|0|||
49029913|NCT00089661|157946908|FG000|Overall Study|Adverse Event|0|||
49029914|NCT00089661|157946909|FG001|Overall Study|Adverse Event|2|||
49029915|NCT00089661|157946908|FG000|Overall Study|Death|1|||
49029916|NCT00089661|157946909|FG001|Overall Study|Death|0|||
49029917|NCT00089661|157946908|FG000|Overall Study|Lost to Follow-up|0|||
48782225|NCT02039505|157044535|FG001|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
48782226|NCT02039505|157044536|FG002|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
48782227|NCT02039505|157044537|FG003|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
48782228|NCT02039505|157044538|FG004|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
48782229|NCT02039505|157044539|FG005|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
48782230|NCT02039505|157044540|FG006|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7|||
48782231|NCT02039505|157044534|FG000|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
48782232|NCT02039505|157044535|FG001|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
48782233|NCT02039505|157044536|FG002|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
48782234|NCT02039505|157044537|FG003|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
48782235|NCT02039505|157044538|FG004|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
48782236|NCT02039505|157044539|FG005|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
48782237|NCT02039505|157044540|FG006|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1|||
48782238|NCT02525133|157044550|FG000|Overall Study|Adverse Event|0|||
48782239|NCT02525133|157044551|FG001|Overall Study|Adverse Event|1|||
48782240|NCT02525133|157044550|FG000|Overall Study|Death|0|||
48782241|NCT02525133|157044551|FG001|Overall Study|Death|1|||
48782242|NCT02525133|157044550|FG000|Overall Study|did not meet randomization criteria|1|||
48782243|NCT02525133|157044551|FG001|Overall Study|did not meet randomization criteria|0|||
48782244|NCT02525133|157044550|FG000|Overall Study|Lost to Follow-up|5|||
48782245|NCT02525133|157044551|FG001|Overall Study|Lost to Follow-up|1|||
48782246|NCT02525133|157044550|FG000|Overall Study|randomized not enrolled|3|||
48782247|NCT02525133|157044551|FG001|Overall Study|randomized not enrolled|0|||
48782248|NCT02525133|157044550|FG000|Overall Study|Withdrawal by Subject|1|||
48782249|NCT02525133|157044551|FG001|Overall Study|Withdrawal by Subject|0|||
48782250|NCT01075074|157044552|FG000|Overall Study|Surgeon changed to open incisional case|1|||
48782251|NCT01075074|157044553|FG001|Overall Study|Surgeon changed to open incisional case|2|||
48782252|NCT01075074|157044554|FG002|Overall Study|Surgeon changed to open incisional case|2|||
48782253|NCT02691455|157044556|FG000|Overall Study|Withdrawal by Subject|1|||
48782254|NCT02691455|157044557|FG001|Overall Study|Withdrawal by Subject|2|||
48782255|NCT02691455|157044556|FG000|Overall Study|Lost to Follow-up|15|||
48782256|NCT02691455|157044557|FG001|Overall Study|Lost to Follow-up|15|||
48782257|NCT00009737|157044558|FG000|Overall Study|Adverse Event|112|||
48782258|NCT00009737|157044559|FG001|Overall Study|Adverse Event|75|||
48782259|NCT00009737|157044558|FG000|Overall Study|Death|4|||
48782260|NCT00009737|157044559|FG001|Overall Study|Death|6|||
48782261|NCT00009737|157044558|FG000|Overall Study|Lack of Efficacy|17|||
48782262|NCT00009737|157044559|FG001|Overall Study|Lack of Efficacy|15|||
48782263|NCT00009737|157044558|FG000|Overall Study|Violation of Selection Criteria at Entry|13|||
48782264|NCT00009737|157044559|FG001|Overall Study|Violation of Selection Criteria at Entry|9|||
48782265|NCT00009737|157044558|FG000|Overall Study|Other Protocol Violation|1|||
48782266|NCT00009737|157044559|FG001|Overall Study|Other Protocol Violation|0|||
48782267|NCT00009737|157044558|FG000|Overall Study|Refused Treatment|15|||
48782268|NCT00009737|157044559|FG001|Overall Study|Refused Treatment|16|||
48782269|NCT00009737|157044558|FG000|Overall Study|Lost to Follow-up|1|||
48782270|NCT00009737|157044559|FG001|Overall Study|Lost to Follow-up|1|||
48782271|NCT00009737|157044558|FG000|Overall Study|Administrative/Other Reasons|7|||
48782272|NCT00009737|157044559|FG001|Overall Study|Administrative/Other Reasons|1|||
48782273|NCT00803023|157044562|FG000|Overall Study|Adverse Event|5|||
48782274|NCT00803023|157044563|FG001|Overall Study|Adverse Event|4|||
48782275|NCT00803023|157044564|FG002|Overall Study|Adverse Event|8|||
48782276|NCT00803023|157044565|FG003|Overall Study|Adverse Event|6|||
48782277|NCT00803023|157044562|FG000|Overall Study|Withdrawal by Subject|0|||
48782278|NCT00803023|157044563|FG001|Overall Study|Withdrawal by Subject|2|||
48782279|NCT00803023|157044564|FG002|Overall Study|Withdrawal by Subject|0|||
49029918|NCT00089661|157946909|FG001|Overall Study|Lost to Follow-up|3|||
49029919|NCT00089661|157946908|FG000|Overall Study|Withdrawal by Subject|11|||
48782280|NCT00803023|157044565|FG003|Overall Study|Withdrawal by Subject|0|||
48782281|NCT00803023|157044562|FG000|Overall Study|Lost to Follow-up|0|||
48782282|NCT00803023|157044563|FG001|Overall Study|Lost to Follow-up|1|||
48782283|NCT00803023|157044564|FG002|Overall Study|Lost to Follow-up|2|||
48782284|NCT00803023|157044565|FG003|Overall Study|Lost to Follow-up|1|||
49029920|NCT00089661|157946909|FG001|Overall Study|Withdrawal by Subject|9|||
48782285|NCT00803023|157044562|FG000|Overall Study|Lack of Efficacy|0|||
48782286|NCT00803023|157044563|FG001|Overall Study|Lack of Efficacy|1|||
48782287|NCT00803023|157044564|FG002|Overall Study|Lack of Efficacy|1|||
48782288|NCT00803023|157044565|FG003|Overall Study|Lack of Efficacy|1|||
48782289|NCT03465540|157044568|FG000|Overall Study|Withdrawal by Subject|0|||
48782290|NCT03465540|157044569|FG001|Overall Study|Withdrawal by Subject|0|||
48782291|NCT03465540|157044570|FG002|Overall Study|Withdrawal by Subject|1|||
48782292|NCT03465540|157044571|FG003|Overall Study|Withdrawal by Subject|1|||
49029921|NCT00089661|157946908|FG000|Overall Study|Disease progression|1|||
49029922|NCT00089661|157946909|FG001|Overall Study|Disease progression|3|||
49029923|NCT00089661|157946908|FG000|Overall Study|Ineligibility determined|4|||
49029924|NCT00089661|157946909|FG001|Overall Study|Ineligibility determined|4|||
49029925|NCT00089661|157946908|FG000|Overall Study|Noncompliance|2|||
49029926|NCT00089661|157946909|FG001|Overall Study|Noncompliance|4|||
49029927|NCT00089661|157946908|FG000|Overall Study|Other|2|||
48782293|NCT03465540|157044572|FG004|Overall Study|Withdrawal by Subject|1|||
48782294|NCT03465540|157044573|FG005|Overall Study|Withdrawal by Subject|0|||
48782295|NCT03465540|157044568|FG000|Overall Study|Lost to Follow-up|0|||
48782296|NCT03465540|157044569|FG001|Overall Study|Lost to Follow-up|1|||
49029928|NCT00089661|157946909|FG001|Overall Study|Other|1|||
48782297|NCT03465540|157044570|FG002|Overall Study|Lost to Follow-up|0|||
48782298|NCT03465540|157044571|FG003|Overall Study|Lost to Follow-up|0|||
48782299|NCT03465540|157044572|FG004|Overall Study|Lost to Follow-up|1|||
48782300|NCT03465540|157044573|FG005|Overall Study|Lost to Follow-up|0|||
48782301|NCT03465540|157044568|FG000|Overall Study|Death|1|||
48782302|NCT03465540|157044569|FG001|Overall Study|Death|1|||
48782303|NCT03465540|157044570|FG002|Overall Study|Death|0|||
48782304|NCT03465540|157044571|FG003|Overall Study|Death|2|||
48782305|NCT03465540|157044572|FG004|Overall Study|Death|0|||
48782306|NCT03465540|157044573|FG005|Overall Study|Death|2|||
48782307|NCT03465540|157044568|FG000|Overall Study|Protocol specified criteria|0|||
48782308|NCT03465540|157044569|FG001|Overall Study|Protocol specified criteria|2|||
48782309|NCT03465540|157044570|FG002|Overall Study|Protocol specified criteria|2|||
48782310|NCT03465540|157044571|FG003|Overall Study|Protocol specified criteria|0|||
48782311|NCT03465540|157044572|FG004|Overall Study|Protocol specified criteria|2|||
48782312|NCT03465540|157044573|FG005|Overall Study|Protocol specified criteria|0|||
48782313|NCT01519206|157044578|FG000|Overall Study|Lost to Follow-up|3|||
48782314|NCT01519206|157044578|FG000|Overall Study|Missed Visit|2|||
48782315|NCT02660944|157044580|FG000|Overall Study|Adverse Event|3|||
48782316|NCT02660944|157044581|FG001|Overall Study|Adverse Event|4|||
48782317|NCT02660944|157044580|FG000|Overall Study|Physician Decision|3|||
48782318|NCT02660944|157044581|FG001|Overall Study|Physician Decision|1|||
48782319|NCT02660944|157044580|FG000|Overall Study|Withdrawal by Subject|5|||
48782320|NCT02660944|157044581|FG001|Overall Study|Withdrawal by Subject|3|||
48782321|NCT02660944|157044580|FG000|Overall Study|Lost to Follow-up|4|||
49029929|NCT01273805|157946914|FG000|Overall Study|Radiologic PD or Symptom Deterioration|10|||
49029930|NCT01273805|157946915|FG001|Overall Study|Radiologic PD or Symptom Deterioration|10|||
48782322|NCT02660944|157044581|FG001|Overall Study|Lost to Follow-up|1|||
48782323|NCT02660944|157044580|FG000|Overall Study|Subject schedule|0|||
48782324|NCT02660944|157044581|FG001|Overall Study|Subject schedule|1|||
48782325|NCT02660944|157044580|FG000|Overall Study|Exclusion criteria met|2|||
48782326|NCT02660944|157044581|FG001|Overall Study|Exclusion criteria met|0|||
48782327|NCT01343056|157044584|FG000|Overall Study|Lost to Follow-up|7|||
48782328|NCT01343056|157044585|FG001|Overall Study|Lost to Follow-up|5|||
48782329|NCT01343056|157044586|FG002|Overall Study|Lost to Follow-up|3|||
48782330|NCT01343056|157044587|FG003|Overall Study|Lost to Follow-up|9|||
48782331|NCT02647359|157044593|FG000|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|0|||
48782332|NCT02647359|157044594|FG001|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|1|||
48782333|NCT02647359|157044593|FG000|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|4|||
48782334|NCT02647359|157044594|FG001|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|0|||
48782335|NCT02647359|157044593|FG000|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|2|||
48782336|NCT02647359|157044594|FG001|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|1|||
48782337|NCT02647359|157044593|FG000|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|8|||
48782338|NCT02647359|157044594|FG001|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|3|||
48782339|NCT02647359|157044593|FG000|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|1|||
48782340|NCT02647359|157044594|FG001|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|0|||
48782341|NCT02647359|157044593|FG000|Open-Label Sub-Study (96 Weeks)|Other than specified|7|||
48782342|NCT02647359|157044594|FG001|Open-Label Sub-Study (96 Weeks)|Other than specified|4|||
48782343|NCT03646513|157044595|FG000|Overall Study|Premature study termination|4|||
48782344|NCT03634579|157044598|FG000|Overall Study|study termination|9|||
48782345|NCT03067441|157044601|FG000|Overall Study|Withdrawal by Subject|16|||
48782346|NCT03067441|157044602|FG001|Overall Study|Withdrawal by Subject|34|||
48782347|NCT03067441|157044601|FG000|Overall Study|Lost to Follow-up|7|||
48782348|NCT03067441|157044602|FG001|Overall Study|Lost to Follow-up|5|||
48782349|NCT03067441|157044601|FG000|Overall Study|Adverse Event|7|||
48782350|NCT03067441|157044602|FG001|Overall Study|Adverse Event|14|||
48782351|NCT03067441|157044601|FG000|Overall Study|Study Terminated by Sponsor or Investigator|1|||
48782352|NCT03067441|157044602|FG001|Overall Study|Study Terminated by Sponsor or Investigator|0|||
48782353|NCT03067441|157044601|FG000|Overall Study|Physician Decision|1|||
48782354|NCT03067441|157044602|FG001|Overall Study|Physician Decision|3|||
48877450|NCT02641587|157390064|FG001|Confinement Period|Adverse Event|0|||
48877451|NCT02641587|157390063|FG000|Confinement Period|Withdrawal by Subject|2|||
49029931|NCT01190930|157946916|FG000|Induction|Adverse Event|17|||
49029932|NCT01190930|157946917|FG001|Induction|Adverse Event|0|||
49029933|NCT01190930|157946918|FG002|Induction|Adverse Event|0|||
48782355|NCT03067441|157044601|FG000|Overall Study|Other|1|||
48782356|NCT03067441|157044602|FG001|Overall Study|Other|1|||
48782357|NCT02543346|157044603|FG000|Second Priming Visit|Withdrawal by Subject|0|||
48782358|NCT02543346|157044604|FG001|Second Priming Visit|Withdrawal by Subject|2|||
48782359|NCT02543346|157044605|FG002|Second Priming Visit|Withdrawal by Subject|2|||
48782360|NCT02543346|157044606|FG003|Second Priming Visit|Withdrawal by Subject|2|||
48782361|NCT02543346|157044603|FG000|Second Priming Visit|Adverse Event|1|||
48782362|NCT02543346|157044604|FG001|Second Priming Visit|Adverse Event|0|||
48782363|NCT02543346|157044605|FG002|Second Priming Visit|Adverse Event|0|||
48782364|NCT02543346|157044606|FG003|Second Priming Visit|Adverse Event|0|||
48782365|NCT01198600|157044614|FG000|Phase 1: Period One, 30 Days of Wear|Inconvenience|1|||
49029934|NCT01190930|157946919|FG003|Induction|Adverse Event|0|||
49029935|NCT01190930|157946920|FG004|Induction|Adverse Event|0|||
49029936|NCT01190930|157946921|FG005|Induction|Adverse Event|0|||
49029937|NCT01190930|157946922|FG006|Induction|Adverse Event|0|||
49029938|NCT01190930|157946923|FG007|Induction|Adverse Event|0|||
49029939|NCT01190930|157946924|FG008|Induction|Adverse Event|0|||
49029940|NCT01190930|157946925|FG009|Induction|Adverse Event|0|||
49029941|NCT01190930|157946916|FG000|Induction|Death|34|||
49029942|NCT01190930|157946917|FG001|Induction|Death|0|||
49029943|NCT01190930|157946918|FG002|Induction|Death|0|||
49029944|NCT01190930|157946919|FG003|Induction|Death|0|||
49029945|NCT01190930|157946920|FG004|Induction|Death|0|||
49029946|NCT01190930|157946921|FG005|Induction|Death|0|||
49029947|NCT01190930|157946922|FG006|Induction|Death|0|||
49029948|NCT01190930|157946923|FG007|Induction|Death|0|||
49029949|NCT01190930|157946924|FG008|Induction|Death|0|||
49029950|NCT01190930|157946925|FG009|Induction|Death|0|||
49029951|NCT01190930|157946916|FG000|Induction|Lost to Follow-up|1|||
49029952|NCT01190930|157946917|FG001|Induction|Lost to Follow-up|0|||
49029953|NCT01190930|157946918|FG002|Induction|Lost to Follow-up|0|||
49029954|NCT01190930|157946919|FG003|Induction|Lost to Follow-up|0|||
49029955|NCT01190930|157946920|FG004|Induction|Lost to Follow-up|0|||
49029956|NCT01190930|157946921|FG005|Induction|Lost to Follow-up|0|||
49029957|NCT01190930|157946922|FG006|Induction|Lost to Follow-up|0|||
49029958|NCT01190930|157946923|FG007|Induction|Lost to Follow-up|0|||
49029959|NCT01190930|157946924|FG008|Induction|Lost to Follow-up|0|||
49029960|NCT01190930|157946925|FG009|Induction|Lost to Follow-up|0|||
49029961|NCT01190930|157946916|FG000|Induction|Physician Decision|125|||
49029962|NCT01190930|157946917|FG001|Induction|Physician Decision|3|||
49029963|NCT01190930|157946918|FG002|Induction|Physician Decision|0|||
49029964|NCT01190930|157946919|FG003|Induction|Physician Decision|0|||
49029965|NCT01190930|157946920|FG004|Induction|Physician Decision|0|||
49029966|NCT01190930|157946921|FG005|Induction|Physician Decision|0|||
49029967|NCT01190930|157946922|FG006|Induction|Physician Decision|0|||
49029968|NCT01190930|157946923|FG007|Induction|Physician Decision|0|||
49029969|NCT01190930|157946924|FG008|Induction|Physician Decision|0|||
49029970|NCT01190930|157946925|FG009|Induction|Physician Decision|0|||
49029971|NCT01190930|157946916|FG000|Induction|Withdrawal by Subject|9|||
49029972|NCT01190930|157946917|FG001|Induction|Withdrawal by Subject|0|||
49029973|NCT01190930|157946918|FG002|Induction|Withdrawal by Subject|0|||
49029974|NCT01190930|157946919|FG003|Induction|Withdrawal by Subject|0|||
49029975|NCT01190930|157946920|FG004|Induction|Withdrawal by Subject|0|||
49029976|NCT01190930|157946921|FG005|Induction|Withdrawal by Subject|0|||
49029977|NCT01190930|157946922|FG006|Induction|Withdrawal by Subject|0|||
49029978|NCT01190930|157946923|FG007|Induction|Withdrawal by Subject|0|||
49029979|NCT01190930|157946924|FG008|Induction|Withdrawal by Subject|0|||
49029980|NCT01190930|157946925|FG009|Induction|Withdrawal by Subject|0|||
49029981|NCT01190930|157946916|FG000|Induction|Refusal|235|||
49029982|NCT01190930|157946917|FG001|Induction|Refusal|0|||
49029983|NCT01190930|157946918|FG002|Induction|Refusal|0|||
49029984|NCT01190930|157946919|FG003|Induction|Refusal|0|||
49029985|NCT01190930|157946920|FG004|Induction|Refusal|0|||
49029986|NCT01190930|157946921|FG005|Induction|Refusal|0|||
49029987|NCT01190930|157946922|FG006|Induction|Refusal|0|||
48782366|NCT01198600|157044615|FG001|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
48877452|NCT02641587|157390064|FG001|Confinement Period|Withdrawal by Subject|1|||
49029988|NCT01190930|157946923|FG007|Induction|Refusal|0|||
49029989|NCT01190930|157946924|FG008|Induction|Refusal|0|||
49029990|NCT01190930|157946925|FG009|Induction|Refusal|0|||
48877453|NCT02641587|157390063|FG000|Ambulatory Period|Withdrawal by Subject|1|||
49029991|NCT01190930|157946916|FG000|Induction|Inevaluable|23|||
49029992|NCT01190930|157946917|FG001|Induction|Inevaluable|1|||
49029993|NCT01190930|157946918|FG002|Induction|Inevaluable|0|||
49029994|NCT01190930|157946919|FG003|Induction|Inevaluable|0|||
49029995|NCT01190930|157946920|FG004|Induction|Inevaluable|0|||
49029996|NCT01190930|157946921|FG005|Induction|Inevaluable|0|||
49029997|NCT01190930|157946922|FG006|Induction|Inevaluable|0|||
49029998|NCT01190930|157946923|FG007|Induction|Inevaluable|0|||
49029999|NCT01190930|157946924|FG008|Induction|Inevaluable|0|||
49030000|NCT01190930|157946925|FG009|Induction|Inevaluable|0|||
49030001|NCT01190930|157946916|FG000|Induction|BM MRD >= 0.01% on Day 29 of Induction|61|||
49030002|NCT01190930|157946917|FG001|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
49030003|NCT01190930|157946918|FG002|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
49030004|NCT01190930|157946919|FG003|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
49030005|NCT01190930|157946920|FG004|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
49030006|NCT01190930|157946921|FG005|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
49030007|NCT01190930|157946922|FG006|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
49030008|NCT01190930|157946923|FG007|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
49030009|NCT01190930|157946924|FG008|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
49030010|NCT01190930|157946925|FG009|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
49030011|NCT01190930|157946916|FG000|Induction|High Risk Downs|80|||
49030012|NCT01190930|157946917|FG001|Induction|High Risk Downs|0|||
49030013|NCT01190930|157946918|FG002|Induction|High Risk Downs|0|||
49030014|NCT01190930|157946919|FG003|Induction|High Risk Downs|0|||
49030015|NCT01190930|157946920|FG004|Induction|High Risk Downs|0|||
49030016|NCT01190930|157946921|FG005|Induction|High Risk Downs|0|||
49030017|NCT01190930|157946922|FG006|Induction|High Risk Downs|0|||
49030018|NCT01190930|157946923|FG007|Induction|High Risk Downs|0|||
49030019|NCT01190930|157946924|FG008|Induction|High Risk Downs|0|||
49030020|NCT01190930|157946925|FG009|Induction|High Risk Downs|0|||
49030021|NCT01190930|157946916|FG000|Induction|Enrollment onto another COG Protocol|1|||
49030022|NCT01190930|157946917|FG001|Induction|Enrollment onto another COG Protocol|0|||
49030023|NCT01190930|157946918|FG002|Induction|Enrollment onto another COG Protocol|0|||
49030024|NCT01190930|157946919|FG003|Induction|Enrollment onto another COG Protocol|0|||
49030025|NCT01190930|157946920|FG004|Induction|Enrollment onto another COG Protocol|0|||
49030026|NCT01190930|157946921|FG005|Induction|Enrollment onto another COG Protocol|0|||
49030027|NCT01190930|157946922|FG006|Induction|Enrollment onto another COG Protocol|0|||
49030028|NCT01190930|157946923|FG007|Induction|Enrollment onto another COG Protocol|0|||
49030029|NCT01190930|157946924|FG008|Induction|Enrollment onto another COG Protocol|0|||
49030030|NCT01190930|157946925|FG009|Induction|Enrollment onto another COG Protocol|0|||
49030031|NCT01190930|157946916|FG000|Induction|Average Risk|1847|||
49030032|NCT01190930|157946917|FG001|Induction|Average Risk|0|||
49030033|NCT01190930|157946918|FG002|Induction|Average Risk|0|||
49030034|NCT01190930|157946919|FG003|Induction|Average Risk|0|||
49030035|NCT01190930|157946920|FG004|Induction|Average Risk|0|||
49030036|NCT01190930|157946921|FG005|Induction|Average Risk|0|||
49030037|NCT01190930|157946922|FG006|Induction|Average Risk|0|||
49030038|NCT01190930|157946923|FG007|Induction|Average Risk|0|||
49030039|NCT01190930|157946924|FG008|Induction|Average Risk|0|||
49030040|NCT01190930|157946925|FG009|Induction|Average Risk|0|||
49030041|NCT01190930|157946916|FG000|Induction|High Risk|1227|||
49030042|NCT01190930|157946917|FG001|Induction|High Risk|0|||
49030043|NCT01190930|157946918|FG002|Induction|High Risk|0|||
49030044|NCT01190930|157946919|FG003|Induction|High Risk|0|||
49030045|NCT01190930|157946920|FG004|Induction|High Risk|0|||
49030046|NCT01190930|157946921|FG005|Induction|High Risk|0|||
49030047|NCT01190930|157946922|FG006|Induction|High Risk|0|||
49030048|NCT01190930|157946923|FG007|Induction|High Risk|0|||
49030049|NCT01190930|157946924|FG008|Induction|High Risk|0|||
49030050|NCT01190930|157946925|FG009|Induction|High Risk|0|||
49030051|NCT01190930|157946916|FG000|Induction|Low Risk|443|||
49030052|NCT01190930|157946917|FG001|Induction|Low Risk|0|||
49030053|NCT01190930|157946918|FG002|Induction|Low Risk|0|||
49030054|NCT01190930|157946919|FG003|Induction|Low Risk|0|||
49030055|NCT01190930|157946920|FG004|Induction|Low Risk|0|||
49030056|NCT01190930|157946921|FG005|Induction|Low Risk|0|||
49030057|NCT01190930|157946922|FG006|Induction|Low Risk|0|||
49030058|NCT01190930|157946923|FG007|Induction|Low Risk|0|||
49030059|NCT01190930|157946924|FG008|Induction|Low Risk|0|||
49030060|NCT01190930|157946925|FG009|Induction|Low Risk|0|||
49030061|NCT01190930|157946916|FG000|Induction|Very High Risk|1012|||
49030062|NCT01190930|157946917|FG001|Induction|Very High Risk|0|||
49030063|NCT01190930|157946918|FG002|Induction|Very High Risk|0|||
49030064|NCT01190930|157946919|FG003|Induction|Very High Risk|0|||
49030065|NCT01190930|157946920|FG004|Induction|Very High Risk|0|||
49030066|NCT01190930|157946921|FG005|Induction|Very High Risk|0|||
49030067|NCT01190930|157946922|FG006|Induction|Very High Risk|0|||
49030068|NCT01190930|157946923|FG007|Induction|Very High Risk|0|||
49030069|NCT01190930|157946924|FG008|Induction|Very High Risk|0|||
49030070|NCT01190930|157946925|FG009|Induction|Very High Risk|0|||
49030071|NCT01190930|157946916|FG000|Induction|Philadelphia chromosome-positive|99|||
49030072|NCT01190930|157946917|FG001|Induction|Philadelphia chromosome-positive|0|||
49030073|NCT01190930|157946918|FG002|Induction|Philadelphia chromosome-positive|0|||
49030074|NCT01190930|157946919|FG003|Induction|Philadelphia chromosome-positive|0|||
49030075|NCT01190930|157946920|FG004|Induction|Philadelphia chromosome-positive|0|||
49030076|NCT01190930|157946921|FG005|Induction|Philadelphia chromosome-positive|0|||
49030077|NCT01190930|157946922|FG006|Induction|Philadelphia chromosome-positive|0|||
49030078|NCT01190930|157946923|FG007|Induction|Philadelphia chromosome-positive|0|||
49030079|NCT01190930|157946924|FG008|Induction|Philadelphia chromosome-positive|0|||
49030080|NCT01190930|157946925|FG009|Induction|Philadelphia chromosome-positive|0|||
49030081|NCT01190930|157946916|FG000|Induction|Incomplete Induction data|63|||
49030082|NCT01190930|157946917|FG001|Induction|Incomplete Induction data|0|||
49030083|NCT01190930|157946918|FG002|Induction|Incomplete Induction data|0|||
49030084|NCT01190930|157946919|FG003|Induction|Incomplete Induction data|0|||
49030085|NCT01190930|157946920|FG004|Induction|Incomplete Induction data|0|||
49030086|NCT01190930|157946921|FG005|Induction|Incomplete Induction data|0|||
49030087|NCT01190930|157946922|FG006|Induction|Incomplete Induction data|0|||
49030088|NCT01190930|157946923|FG007|Induction|Incomplete Induction data|0|||
49030089|NCT01190930|157946924|FG008|Induction|Incomplete Induction data|0|||
49030090|NCT01190930|157946925|FG009|Induction|Incomplete Induction data|0|||
49030091|NCT01190930|157946916|FG000|Induction|Progressive disease|0|||
49030092|NCT01190930|157946917|FG001|Induction|Progressive disease|1|||
49030093|NCT01190930|157946918|FG002|Induction|Progressive disease|0|||
49030094|NCT01190930|157946919|FG003|Induction|Progressive disease|0|||
49030095|NCT01190930|157946920|FG004|Induction|Progressive disease|0|||
49030096|NCT01190930|157946921|FG005|Induction|Progressive disease|0|||
49030097|NCT01190930|157946922|FG006|Induction|Progressive disease|0|||
49030098|NCT01190930|157946923|FG007|Induction|Progressive disease|0|||
49030099|NCT01190930|157946924|FG008|Induction|Progressive disease|0|||
49030100|NCT01190930|157946925|FG009|Induction|Progressive disease|0|||
49030101|NCT01190930|157946916|FG000|Induction|No treatment|3|||
49030102|NCT01190930|157946917|FG001|Induction|No treatment|0|||
49030103|NCT01190930|157946918|FG002|Induction|No treatment|0|||
49030104|NCT01190930|157946919|FG003|Induction|No treatment|0|||
49030105|NCT01190930|157946920|FG004|Induction|No treatment|0|||
49030106|NCT01190930|157946921|FG005|Induction|No treatment|0|||
49030107|NCT01190930|157946922|FG006|Induction|No treatment|0|||
49030108|NCT01190930|157946923|FG007|Induction|No treatment|0|||
49030109|NCT01190930|157946924|FG008|Induction|No treatment|0|||
49030110|NCT01190930|157946925|FG009|Induction|No treatment|0|||
49030111|NCT01190930|157946916|FG000|Induction|Ineligible|69|||
49030112|NCT01190930|157946917|FG001|Induction|Ineligible|4|||
49030113|NCT01190930|157946918|FG002|Induction|Ineligible|0|||
49030114|NCT01190930|157946919|FG003|Induction|Ineligible|0|||
49030115|NCT01190930|157946920|FG004|Induction|Ineligible|0|||
49030116|NCT01190930|157946921|FG005|Induction|Ineligible|0|||
49030117|NCT01190930|157946922|FG006|Induction|Ineligible|0|||
49030118|NCT01190930|157946923|FG007|Induction|Ineligible|0|||
49030119|NCT01190930|157946924|FG008|Induction|Ineligible|0|||
49030120|NCT01190930|157946925|FG009|Induction|Ineligible|0|||
49030121|NCT01190930|157946916|FG000|Post Induction Pre-Maintenance|Adverse Event|0|||
49030122|NCT01190930|157946917|FG001|Post Induction Pre-Maintenance|Adverse Event|0|||
48782367|NCT01198600|157044616|FG002|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
48782368|NCT01198600|157044617|FG003|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
48782369|NCT01198600|157044614|FG000|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1|||
48782370|NCT01198600|157044615|FG001|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
48782371|NCT01198600|157044616|FG002|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
48782372|NCT01198600|157044617|FG003|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
48782373|NCT01198600|157044614|FG000|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
48782374|NCT01198600|157044615|FG001|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1|||
48782375|NCT01198600|157044616|FG002|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
48782376|NCT01198600|157044617|FG003|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
48782377|NCT01198600|157044614|FG000|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
48782378|NCT01198600|157044615|FG001|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1|||
48782379|NCT01198600|157044616|FG002|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
48782380|NCT01198600|157044617|FG003|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
48782381|NCT01198600|157044614|FG000|Phase 2: 56 Days of Wear|Inconvenience|0|||
48782382|NCT01198600|157044615|FG001|Phase 2: 56 Days of Wear|Inconvenience|0|||
48782383|NCT01198600|157044616|FG002|Phase 2: 56 Days of Wear|Inconvenience|2|||
48782384|NCT01198600|157044617|FG003|Phase 2: 56 Days of Wear|Inconvenience|0|||
48782385|NCT01198600|157044614|FG000|Phase 2: 56 Days of Wear|Relocation|0|||
48782386|NCT01198600|157044615|FG001|Phase 2: 56 Days of Wear|Relocation|0|||
48782387|NCT01198600|157044616|FG002|Phase 2: 56 Days of Wear|Relocation|2|||
48782388|NCT01198600|157044617|FG003|Phase 2: 56 Days of Wear|Relocation|0|||
48782389|NCT01198600|157044614|FG000|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
48782390|NCT01198600|157044615|FG001|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
49030123|NCT01190930|157946918|FG002|Post Induction Pre-Maintenance|Adverse Event|8|||
49030124|NCT01190930|157946919|FG003|Post Induction Pre-Maintenance|Adverse Event|0|||
49030125|NCT01190930|157946920|FG004|Post Induction Pre-Maintenance|Adverse Event|0|||
49030126|NCT01190930|157946921|FG005|Post Induction Pre-Maintenance|Adverse Event|0|||
49030127|NCT01190930|157946922|FG006|Post Induction Pre-Maintenance|Adverse Event|0|||
49030128|NCT01190930|157946923|FG007|Post Induction Pre-Maintenance|Adverse Event|0|||
49030129|NCT01190930|157946924|FG008|Post Induction Pre-Maintenance|Adverse Event|0|||
49030130|NCT01190930|157946925|FG009|Post Induction Pre-Maintenance|Adverse Event|0|||
49030131|NCT01190930|157946916|FG000|Post Induction Pre-Maintenance|Death|0|||
49030132|NCT01190930|157946917|FG001|Post Induction Pre-Maintenance|Death|0|||
49030133|NCT01190930|157946918|FG002|Post Induction Pre-Maintenance|Death|8|||
49030134|NCT01190930|157946919|FG003|Post Induction Pre-Maintenance|Death|4|||
49030135|NCT01190930|157946920|FG004|Post Induction Pre-Maintenance|Death|0|||
49030136|NCT01190930|157946921|FG005|Post Induction Pre-Maintenance|Death|0|||
49030137|NCT01190930|157946922|FG006|Post Induction Pre-Maintenance|Death|0|||
49030138|NCT01190930|157946923|FG007|Post Induction Pre-Maintenance|Death|0|||
49030139|NCT01190930|157946924|FG008|Post Induction Pre-Maintenance|Death|0|||
49030140|NCT01190930|157946925|FG009|Post Induction Pre-Maintenance|Death|0|||
49030141|NCT01190930|157946916|FG000|Post Induction Pre-Maintenance|Physician Decision|0|||
49030142|NCT01190930|157946917|FG001|Post Induction Pre-Maintenance|Physician Decision|2|||
49030143|NCT01190930|157946918|FG002|Post Induction Pre-Maintenance|Physician Decision|35|||
49030144|NCT01190930|157946919|FG003|Post Induction Pre-Maintenance|Physician Decision|7|||
49030145|NCT01190930|157946920|FG004|Post Induction Pre-Maintenance|Physician Decision|5|||
49030146|NCT01190930|157946921|FG005|Post Induction Pre-Maintenance|Physician Decision|3|||
49030147|NCT01190930|157946922|FG006|Post Induction Pre-Maintenance|Physician Decision|0|||
49030148|NCT01190930|157946923|FG007|Post Induction Pre-Maintenance|Physician Decision|0|||
49030149|NCT01190930|157946924|FG008|Post Induction Pre-Maintenance|Physician Decision|0|||
49030150|NCT01190930|157946925|FG009|Post Induction Pre-Maintenance|Physician Decision|0|||
49030151|NCT01190930|157946916|FG000|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
49030152|NCT01190930|157946917|FG001|Post Induction Pre-Maintenance|Withdrawal by Subject|1|||
49030153|NCT01190930|157946918|FG002|Post Induction Pre-Maintenance|Withdrawal by Subject|5|||
49030154|NCT01190930|157946919|FG003|Post Induction Pre-Maintenance|Withdrawal by Subject|2|||
49030155|NCT01190930|157946920|FG004|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
49030156|NCT01190930|157946921|FG005|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
49030157|NCT01190930|157946922|FG006|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
49030158|NCT01190930|157946923|FG007|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
49030159|NCT01190930|157946924|FG008|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
49030160|NCT01190930|157946925|FG009|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
49030161|NCT01190930|157946916|FG000|Post Induction Pre-Maintenance|Refusal|0|||
48877454|NCT02641587|157390064|FG001|Ambulatory Period|Withdrawal by Subject|0|||
48877455|NCT05082909|157390065|FG000|Overall Study|Protocol Violation|0|||
49030162|NCT01190930|157946917|FG001|Post Induction Pre-Maintenance|Refusal|2|||
49030163|NCT01190930|157946918|FG002|Post Induction Pre-Maintenance|Refusal|694|||
49030164|NCT01190930|157946919|FG003|Post Induction Pre-Maintenance|Refusal|4|||
49030165|NCT01190930|157946920|FG004|Post Induction Pre-Maintenance|Refusal|0|||
49030166|NCT01190930|157946921|FG005|Post Induction Pre-Maintenance|Refusal|3|||
49030167|NCT01190930|157946922|FG006|Post Induction Pre-Maintenance|Refusal|0|||
49030168|NCT01190930|157946923|FG007|Post Induction Pre-Maintenance|Refusal|0|||
48782391|NCT01198600|157044616|FG002|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1|||
48782392|NCT01198600|157044617|FG003|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
48782393|NCT00968617|157044620|FG000|Overall Study|Study terminated by sponsor|6|||
48782394|NCT02308033|157044628|FG000|Overall Study|Normal Gram stain at Baseline|13|||
48782395|NCT02308033|157044629|FG001|Overall Study|Normal Gram stain at Baseline|10|||
48782396|NCT02308033|157044628|FG000|Overall Study|Positive for STD at Baseline|7|||
48782397|NCT02308033|157044629|FG001|Overall Study|Positive for STD at Baseline|4|||
48782398|NCT02308033|157044628|FG000|Overall Study|Lost to Follow-up|6|||
48782399|NCT02308033|157044629|FG001|Overall Study|Lost to Follow-up|5|||
48782400|NCT03791398|157044630|FG000|Overall Study|Progression of Disease Under Study|2|||
48782401|NCT03791398|157044631|FG001|Overall Study|Progression of Disease Under Study|0|||
48782402|NCT03791398|157044632|FG002|Overall Study|Progression of Disease Under Study|0|||
48782403|NCT00766376|157044633|FG000|Overall Study|Withdrawal by Subject|27|||
48782404|NCT03021187|157044634|FG000|Overall Study|Death|0|||
48782405|NCT03021187|157044635|FG001|Overall Study|Death|0|||
48782406|NCT03021187|157044636|FG002|Overall Study|Death|3|||
48782407|NCT03021187|157044637|FG003|Overall Study|Death|0|||
48782408|NCT03021187|157044634|FG000|Overall Study|Withdrawal by Subject|0|||
48782409|NCT03021187|157044635|FG001|Overall Study|Withdrawal by Subject|6|||
48782410|NCT03021187|157044636|FG002|Overall Study|Withdrawal by Subject|2|||
48782411|NCT03021187|157044637|FG003|Overall Study|Withdrawal by Subject|5|||
48782412|NCT03021187|157044634|FG000|Overall Study|Lost to Follow-up|10|||
48782413|NCT03021187|157044635|FG001|Overall Study|Lost to Follow-up|3|||
48782414|NCT03021187|157044636|FG002|Overall Study|Lost to Follow-up|1|||
48877456|NCT05082909|157390066|FG001|Overall Study|Protocol Violation|0|||
48877457|NCT05082909|157390067|FG002|Overall Study|Protocol Violation|1|||
48877458|NCT05082909|157390068|FG003|Overall Study|Protocol Violation|0|||
49030169|NCT01190930|157946924|FG008|Post Induction Pre-Maintenance|Refusal|0|||
49030170|NCT01190930|157946925|FG009|Post Induction Pre-Maintenance|Refusal|0|||
49030171|NCT01190930|157946916|FG000|Post Induction Pre-Maintenance|Inevaluable|0|||
49030172|NCT01190930|157946917|FG001|Post Induction Pre-Maintenance|Inevaluable|0|||
49030173|NCT01190930|157946918|FG002|Post Induction Pre-Maintenance|Inevaluable|6|||
49030174|NCT01190930|157946919|FG003|Post Induction Pre-Maintenance|Inevaluable|0|||
49030175|NCT01190930|157946920|FG004|Post Induction Pre-Maintenance|Inevaluable|0|||
48782415|NCT03021187|157044637|FG003|Overall Study|Lost to Follow-up|4|||
48782416|NCT00766415|157044640|FG000|Overall Study|Withdrawal by Subject|0|||
48782417|NCT00766415|157044641|FG001|Overall Study|Withdrawal by Subject|1|||
48782418|NCT03738150|157044643|FG000|Base Study|Withdrawal by Subject|1|||
48782419|NCT03738150|157044643|FG000|Extension Study|Withdrawal by Subject|1|||
48782420|NCT03832946|157044644|FG000|Overall Study|Adverse Event|3|||
48782421|NCT03832946|157044645|FG001|Overall Study|Adverse Event|1|||
48782422|NCT03832946|157044644|FG000|Overall Study|Lost to Follow-up|1|||
48782423|NCT03832946|157044645|FG001|Overall Study|Lost to Follow-up|0|||
48782424|NCT03832946|157044644|FG000|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|30|||
48782425|NCT03832946|157044645|FG001|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|22|||
48782426|NCT03832946|157044644|FG000|Overall Study|Lack of Efficacy|1|||
48782427|NCT03832946|157044645|FG001|Overall Study|Lack of Efficacy|0|||
48782428|NCT03832946|157044644|FG000|Overall Study|Withdrawal by Subject|12|||
48782429|NCT03832946|157044645|FG001|Overall Study|Withdrawal by Subject|9|||
48782430|NCT01462344|157044646|FG000|Overall Study|Withdrawal by Subject|245|||
48782431|NCT01462344|157044647|FG001|Overall Study|Withdrawal by Subject|226|||
48782432|NCT01462344|157044646|FG000|Overall Study|Adverse Event|24|||
48782433|NCT01462344|157044647|FG001|Overall Study|Adverse Event|23|||
48877459|NCT05082909|157390069|FG004|Overall Study|Protocol Violation|0|||
48782434|NCT01462344|157044646|FG000|Overall Study|Asthma Exacerbation|34|||
48782435|NCT01462344|157044647|FG001|Overall Study|Asthma Exacerbation|35|||
48782436|NCT01462344|157044646|FG000|Overall Study|Lack of Efficacy|5|||
48782437|NCT01462344|157044647|FG001|Overall Study|Lack of Efficacy|6|||
48782438|NCT01462344|157044646|FG000|Overall Study|Protocol Violation|68|||
48782439|NCT01462344|157044647|FG001|Overall Study|Protocol Violation|53|||
48782440|NCT01462344|157044646|FG000|Overall Study|Lost to Follow-up|7|||
48782441|NCT01462344|157044647|FG001|Overall Study|Lost to Follow-up|7|||
48782442|NCT01003249|157044648|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
48782443|NCT01003249|157044649|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
48782444|NCT01003249|157044648|FG000|First Intervention (4 Weeks)|Non-Serious Event|1|||
48782445|NCT01003249|157044649|FG001|First Intervention (4 Weeks)|Non-Serious Event|1|||
48782446|NCT01003249|157044648|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
48782447|NCT01003249|157044649|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
48782448|NCT01003249|157044648|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
48782449|NCT01003249|157044649|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
48782450|NCT03483623|157044650|FG000|Overall Study|43 complete sets achieved|1|||
48782451|NCT00560833|157044651|FG000|Overall Study|Adverse Event|16|||
48782452|NCT00560833|157044652|FG001|Overall Study|Adverse Event|10|||
48782453|NCT00560833|157044653|FG002|Overall Study|Adverse Event|25|||
48782454|NCT00560833|157044654|FG003|Overall Study|Adverse Event|23|||
48782455|NCT00560833|157044655|FG004|Overall Study|Adverse Event|35|||
48782456|NCT00560833|157044651|FG000|Overall Study|Lost to Follow-up|0|||
48782457|NCT00560833|157044652|FG001|Overall Study|Lost to Follow-up|0|||
48782458|NCT00560833|157044653|FG002|Overall Study|Lost to Follow-up|1|||
48782459|NCT00560833|157044654|FG003|Overall Study|Lost to Follow-up|0|||
48782460|NCT00560833|157044655|FG004|Overall Study|Lost to Follow-up|0|||
48782461|NCT00560833|157044651|FG000|Overall Study|Lack of Efficacy|22|||
48782462|NCT00560833|157044652|FG001|Overall Study|Lack of Efficacy|9|||
48782463|NCT00560833|157044653|FG002|Overall Study|Lack of Efficacy|6|||
48782464|NCT00560833|157044654|FG003|Overall Study|Lack of Efficacy|4|||
48782465|NCT00560833|157044655|FG004|Overall Study|Lack of Efficacy|4|||
48782466|NCT00560833|157044651|FG000|Overall Study|Participant uncooperative|5|||
48782467|NCT00560833|157044652|FG001|Overall Study|Participant uncooperative|5|||
48782468|NCT00560833|157044653|FG002|Overall Study|Participant uncooperative|4|||
48782469|NCT00560833|157044654|FG003|Overall Study|Participant uncooperative|4|||
48782470|NCT00560833|157044655|FG004|Overall Study|Participant uncooperative|2|||
48782471|NCT00560833|157044651|FG000|Overall Study|Other|1|||
48782472|NCT00560833|157044652|FG001|Overall Study|Other|1|||
48782473|NCT00560833|157044653|FG002|Overall Study|Other|3|||
48782474|NCT00560833|157044654|FG003|Overall Study|Other|0|||
48782475|NCT00560833|157044655|FG004|Overall Study|Other|0|||
48782476|NCT00560833|157044651|FG000|Overall Study|Never received drug|0|||
48782477|NCT00560833|157044652|FG001|Overall Study|Never received drug|1|||
48782478|NCT00560833|157044653|FG002|Overall Study|Never received drug|0|||
48877460|NCT05082909|157390070|FG005|Overall Study|Protocol Violation|0|||
48877461|NCT00781937|157390071|FG000|Main Trial Period Through Week 56|Adverse Event|18|||
48782479|NCT00560833|157044654|FG003|Overall Study|Never received drug|0|||
48782480|NCT00560833|157044655|FG004|Overall Study|Never received drug|1|||
48782481|NCT02663817|157044667|FG000|Overall Study|Screen failure|2|||
48782482|NCT02899728|157044668|FG000|Overall Study|Withdrawal by Subject|1|||
48782483|NCT02899728|157044669|FG001|Overall Study|Withdrawal by Subject|1|||
48782484|NCT03328897|157046417|FG000|Randomized-treatment Epoch|Adverse Event|4|||
48782485|NCT03328897|157046418|FG001|Randomized-treatment Epoch|Adverse Event|1|||
48877462|NCT00781937|157390072|FG001|Main Trial Period Through Week 56|Adverse Event|18|||
49030176|NCT01190930|157946921|FG005|Post Induction Pre-Maintenance|Inevaluable|0|||
48782486|NCT03328897|157046419|FG002|Randomized-treatment Epoch|Adverse Event|1|||
48782487|NCT03328897|157046417|FG000|Randomized-treatment Epoch|Lost to Follow-up|0|||
48782488|NCT03328897|157046418|FG001|Randomized-treatment Epoch|Lost to Follow-up|1|||
48782489|NCT03328897|157046419|FG002|Randomized-treatment Epoch|Lost to Follow-up|0|||
48782490|NCT03328897|157046417|FG000|Randomized-treatment Epoch|Pregnancy|3|||
49030177|NCT01190930|157946922|FG006|Post Induction Pre-Maintenance|Inevaluable|0|||
48782491|NCT03328897|157046418|FG001|Randomized-treatment Epoch|Pregnancy|0|||
48782492|NCT03328897|157046419|FG002|Randomized-treatment Epoch|Pregnancy|0|||
48782493|NCT03328897|157046417|FG000|Randomized-treatment Epoch|Patient/guardian decision|8|||
48782494|NCT03328897|157046418|FG001|Randomized-treatment Epoch|Patient/guardian decision|3|||
48782495|NCT03328897|157046419|FG002|Randomized-treatment Epoch|Patient/guardian decision|1|||
48782496|NCT03328897|157046417|FG000|Randomized-treatment Epoch|Lack of Efficacy|1|||
48782497|NCT03328897|157046418|FG001|Randomized-treatment Epoch|Lack of Efficacy|0|||
48782498|NCT03328897|157046419|FG002|Randomized-treatment Epoch|Lack of Efficacy|0|||
48782499|NCT03328897|157046417|FG000|Follow-up Epoch|Adverse Event|4|||
48782500|NCT03328897|157046418|FG001|Follow-up Epoch|Adverse Event|0|||
48782501|NCT03328897|157046419|FG002|Follow-up Epoch|Adverse Event|1|||
48782502|NCT03328897|157046417|FG000|Follow-up Epoch|Lack of Efficacy|1|||
48782503|NCT03328897|157046418|FG001|Follow-up Epoch|Lack of Efficacy|1|||
48782504|NCT03328897|157046419|FG002|Follow-up Epoch|Lack of Efficacy|1|||
48782505|NCT03328897|157046417|FG000|Follow-up Epoch|Lost to Follow-up|0|||
48782506|NCT03328897|157046418|FG001|Follow-up Epoch|Lost to Follow-up|1|||
48782507|NCT03328897|157046419|FG002|Follow-up Epoch|Lost to Follow-up|0|||
48782508|NCT03328897|157046417|FG000|Follow-up Epoch|Pregnancy|1|||
48782509|NCT03328897|157046418|FG001|Follow-up Epoch|Pregnancy|0|||
48782510|NCT03328897|157046419|FG002|Follow-up Epoch|Pregnancy|0|||
48782511|NCT03328897|157046417|FG000|Follow-up Epoch|Patient/guardian decision|2|||
48782512|NCT03328897|157046418|FG001|Follow-up Epoch|Patient/guardian decision|1|||
48782513|NCT03328897|157046419|FG002|Follow-up Epoch|Patient/guardian decision|0|||
48782514|NCT02080091|157046420|FG000|Overall Study|Study Terminated|22|||
48782515|NCT02080091|157046420|FG000|Overall Study|Death|1|||
48782516|NCT02080091|157046420|FG000|Overall Study|Withdrawal by Subject|1|||
48782517|NCT02080091|157046420|FG000|Overall Study|Other|1|||
48782518|NCT03422003|157046421|FG000|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|7|||
48782519|NCT03422003|157046422|FG001|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|2|||
48782520|NCT03422003|157046421|FG000|6-month Follow-up|Withdrawal by subject, loss to follow-up|26|||
48782521|NCT03422003|157046422|FG001|6-month Follow-up|Withdrawal by subject, loss to follow-up|33|||
48782522|NCT03794089|157046425|FG000|Overall Study|Lost to Follow-up|4|||
48782523|NCT03794089|157046426|FG001|Overall Study|Lost to Follow-up|1|||
48782524|NCT03794089|157046425|FG000|Overall Study|Withdrawal by Subject|2|||
48782525|NCT03794089|157046426|FG001|Overall Study|Withdrawal by Subject|0|||
48782526|NCT01639001|157046427|FG000|Overall Study|Refused further follow-up|9|||
48782527|NCT01639001|157046428|FG001|Overall Study|Refused further follow-up|12|||
48782528|NCT01639001|157046427|FG000|Overall Study|Lost to Follow-up|3|||
49030178|NCT01190930|157946923|FG007|Post Induction Pre-Maintenance|Inevaluable|0|||
49030179|NCT01190930|157946924|FG008|Post Induction Pre-Maintenance|Inevaluable|0|||
49030180|NCT01190930|157946925|FG009|Post Induction Pre-Maintenance|Inevaluable|0|||
49030181|NCT01190930|157946916|FG000|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
49030182|NCT01190930|157946917|FG001|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1|||
49030183|NCT01190930|157946918|FG002|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
49030184|NCT01190930|157946919|FG003|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
49030185|NCT01190930|157946920|FG004|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
49030186|NCT01190930|157946921|FG005|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
49030187|NCT01190930|157946922|FG006|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
49030188|NCT01190930|157946923|FG007|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
49030189|NCT01190930|157946924|FG008|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
49030190|NCT01190930|157946925|FG009|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
49030191|NCT01190930|157946916|FG000|Post Induction Pre-Maintenance|Progressive disease|0|||
49030192|NCT01190930|157946917|FG001|Post Induction Pre-Maintenance|Progressive disease|0|||
49030193|NCT01190930|157946918|FG002|Post Induction Pre-Maintenance|Progressive disease|1|||
49030194|NCT01190930|157946919|FG003|Post Induction Pre-Maintenance|Progressive disease|0|||
49030195|NCT01190930|157946920|FG004|Post Induction Pre-Maintenance|Progressive disease|0|||
49030196|NCT01190930|157946921|FG005|Post Induction Pre-Maintenance|Progressive disease|0|||
49030197|NCT01190930|157946922|FG006|Post Induction Pre-Maintenance|Progressive disease|0|||
49030198|NCT01190930|157946923|FG007|Post Induction Pre-Maintenance|Progressive disease|0|||
49030199|NCT01190930|157946924|FG008|Post Induction Pre-Maintenance|Progressive disease|0|||
49030200|NCT01190930|157946925|FG009|Post Induction Pre-Maintenance|Progressive disease|0|||
48782529|NCT01639001|157046428|FG001|Overall Study|Lost to Follow-up|0|||
48782530|NCT01639001|157046427|FG000|Overall Study|Death|62|||
48782531|NCT01639001|157046428|FG001|Overall Study|Death|61|||
48782532|NCT01639001|157046427|FG000|Overall Study|Randomized but not treated|0|||
48782533|NCT01639001|157046428|FG001|Overall Study|Randomized but not treated|2|||
48782534|NCT01639001|157046427|FG000|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1|||
48797713|NCT00293267|157097059|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
48782535|NCT01639001|157046428|FG001|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2|||
48782536|NCT03811912|157046429|FG000|Overall Study|Withdrew Consent|4|||
48782537|NCT03811912|157046430|FG001|Overall Study|Withdrew Consent|2|||
48782538|NCT01438411|157046431|FG000|Overall Study|Adverse Event|8|||
48782539|NCT01438411|157046431|FG000|Overall Study|Lost to Follow-up|1|||
48782540|NCT01438411|157046431|FG000|Overall Study|Lack of Efficacy|1|||
48782541|NCT01438411|157046431|FG000|Overall Study|Withdrawal by Subject|3|||
48782542|NCT01782131|157046432|FG000|Overall Study|Death|93|||
48782543|NCT01782131|157046433|FG001|Overall Study|Death|96|||
48782544|NCT01782131|157046432|FG000|Overall Study|Lost to Follow-up|1|||
48782545|NCT01782131|157046433|FG001|Overall Study|Lost to Follow-up|3|||
48782546|NCT01782131|157046432|FG000|Overall Study|Withdrawal by Subject|10|||
48782547|NCT01782131|157046433|FG001|Overall Study|Withdrawal by Subject|10|||
48782548|NCT01782131|157046432|FG000|Overall Study|Randomized but not treated|5|||
48782549|NCT01782131|157046433|FG001|Overall Study|Randomized but not treated|5|||
48782550|NCT01782131|157046432|FG000|Overall Study|Reason not provided|0|||
48782551|NCT01782131|157046433|FG001|Overall Study|Reason not provided|1|||
48877463|NCT00781937|157390071|FG000|Main Trial Period Through Week 56|Lack of Efficacy|0|||
48877464|NCT00781937|157390072|FG001|Main Trial Period Through Week 56|Lack of Efficacy|2|||
48877465|NCT00781937|157390071|FG000|Main Trial Period Through Week 56|Protocol Violation|8|||
48877466|NCT00781937|157390072|FG001|Main Trial Period Through Week 56|Protocol Violation|5|||
49030201|NCT01190930|157946916|FG000|Post Induction Pre-Maintenance|Relapse|0|||
49030202|NCT01190930|157946917|FG001|Post Induction Pre-Maintenance|Relapse|0|||
48782552|NCT00796718|157046434|FG000|Overall Study|Adverse Event|2|||
48782553|NCT00796718|157046434|FG000|Overall Study|Exclusion Criteria|1|||
49030203|NCT01190930|157946918|FG002|Post Induction Pre-Maintenance|Relapse|1|||
49030204|NCT01190930|157946919|FG003|Post Induction Pre-Maintenance|Relapse|0|||
49030205|NCT01190930|157946920|FG004|Post Induction Pre-Maintenance|Relapse|0|||
49030206|NCT01190930|157946921|FG005|Post Induction Pre-Maintenance|Relapse|0|||
48782554|NCT00796718|157046434|FG000|Overall Study|Lost to Follow-up|5|||
48782555|NCT00796718|157046434|FG000|Overall Study|Withdrawal by Informed Consent|1|||
48782556|NCT02627677|157046435|FG000|Overall Study|Adverse event (not progressive disease)|1|||
48782557|NCT02627677|157046436|FG001|Overall Study|Adverse event (not progressive disease)|4|||
48782558|NCT02627677|157046437|FG002|Overall Study|Adverse event (not progressive disease)|1|||
48782559|NCT02627677|157046435|FG000|Overall Study|Progressive disease|1|||
48782560|NCT02627677|157046436|FG001|Overall Study|Progressive disease|3|||
48782561|NCT02627677|157046437|FG002|Overall Study|Progressive disease|0|||
48782562|NCT02627677|157046435|FG000|Overall Study|Lack of Efficacy|1|||
48782563|NCT02627677|157046436|FG001|Overall Study|Lack of Efficacy|2|||
48782564|NCT02627677|157046437|FG002|Overall Study|Lack of Efficacy|0|||
48782565|NCT02627677|157046435|FG000|Overall Study|Lost to Follow-up|0|||
48782566|NCT02627677|157046436|FG001|Overall Study|Lost to Follow-up|0|||
48782567|NCT02627677|157046437|FG002|Overall Study|Lost to Follow-up|1|||
48782568|NCT02627677|157046435|FG000|Overall Study|Pregnancy|0|||
48782569|NCT02627677|157046436|FG001|Overall Study|Pregnancy|1|||
48782570|NCT02627677|157046437|FG002|Overall Study|Pregnancy|0|||
48782571|NCT02627677|157046435|FG000|Overall Study|Study Terminated by Sponsor|5|||
48782572|NCT02627677|157046436|FG001|Overall Study|Study Terminated by Sponsor|10|||
48782573|NCT02627677|157046437|FG002|Overall Study|Study Terminated by Sponsor|6|||
48782574|NCT02627677|157046435|FG000|Overall Study|Physician Decision|0|||
48782575|NCT02627677|157046436|FG001|Overall Study|Physician Decision|0|||
48782576|NCT02627677|157046437|FG002|Overall Study|Physician Decision|2|||
48782577|NCT02627677|157046435|FG000|Overall Study|Withdrawal by Subject|2|||
48782578|NCT02627677|157046436|FG001|Overall Study|Withdrawal by Subject|1|||
48782579|NCT02627677|157046437|FG002|Overall Study|Withdrawal by Subject|1|||
48782580|NCT02627677|157046435|FG000|Overall Study|Reason not Specified|0|||
48782581|NCT02627677|157046436|FG001|Overall Study|Reason not Specified|0|||
48782582|NCT02627677|157046437|FG002|Overall Study|Reason not Specified|1|||
48782583|NCT02627677|157046435|FG000|Overall Study|Randomized but not Treated|1|||
48782584|NCT02627677|157046436|FG001|Overall Study|Randomized but not Treated|0|||
48782585|NCT02627677|157046437|FG002|Overall Study|Randomized but not Treated|0|||
48782586|NCT04329104|157046438|FG000|Efficacy Study|Withdrawal by Subject|0|||
48782587|NCT04329104|157046439|FG001|Efficacy Study|Withdrawal by Subject|0|||
48782588|NCT04329104|157046440|FG002|Efficacy Study|Withdrawal by Subject|0|||
48782589|NCT04329104|157046441|FG003|Efficacy Study|Withdrawal by Subject|5|||
48782590|NCT04329104|157046442|FG004|Efficacy Study|Withdrawal by Subject|6|||
48782591|NCT04329104|157046443|FG005|Efficacy Study|Withdrawal by Subject|8|||
48782592|NCT02886572|157046444|FG000|Overall Study|Death|8|||
48782593|NCT01153633|157046445|FG000|Overall Study|Protocol Violation|1|||
48782594|NCT01153633|157046446|FG001|Overall Study|Protocol Violation|1|||
48782595|NCT01153633|157046445|FG000|Overall Study|Therapeutic failure|3|||
48782596|NCT01153633|157046446|FG001|Overall Study|Therapeutic failure|3|||
48877467|NCT00781937|157390071|FG000|Main Trial Period Through Week 56|Withdrawal by Subject|17|||
48782597|NCT00384085|157046447|FG000|Overall Study|Adverse Event|5|||
48782598|NCT00384085|157046448|FG001|Overall Study|Adverse Event|5|||
48782599|NCT00384085|157046449|FG002|Overall Study|Adverse Event|4|||
48782600|NCT00384085|157046447|FG000|Overall Study|Lack of Efficacy|0|||
48782601|NCT00384085|157046448|FG001|Overall Study|Lack of Efficacy|3|||
48782602|NCT00384085|157046449|FG002|Overall Study|Lack of Efficacy|2|||
48782603|NCT00384085|157046447|FG000|Overall Study|No longer Requires Study Treatment|1|||
48782604|NCT00384085|157046448|FG001|Overall Study|No longer Requires Study Treatment|0|||
48782605|NCT00384085|157046449|FG002|Overall Study|No longer Requires Study Treatment|1|||
48782606|NCT00384085|157046447|FG000|Overall Study|Protocol Violation|2|||
48782607|NCT00384085|157046448|FG001|Overall Study|Protocol Violation|2|||
48782608|NCT00384085|157046449|FG002|Overall Study|Protocol Violation|2|||
48782609|NCT00384085|157046447|FG000|Overall Study|Lost to Follow-up|9|||
48782610|NCT00384085|157046448|FG001|Overall Study|Lost to Follow-up|9|||
48782611|NCT00384085|157046449|FG002|Overall Study|Lost to Follow-up|10|||
48782612|NCT00384085|157046447|FG000|Overall Study|Progressive Disease|0|||
48782613|NCT00384085|157046448|FG001|Overall Study|Progressive Disease|1|||
48877468|NCT00781937|157390072|FG001|Main Trial Period Through Week 56|Withdrawal by Subject|24|||
48877469|NCT00781937|157390071|FG000|Main Trial Period Through Week 56|Unclassified|10|||
49030207|NCT01190930|157946922|FG006|Post Induction Pre-Maintenance|Relapse|0|||
48877470|NCT00781937|157390072|FG001|Main Trial Period Through Week 56|Unclassified|15|||
48877471|NCT00781937|157390071|FG000|Follow up Period (Week 56-68)|Protocol Violation|1|||
48877472|NCT00781937|157390072|FG001|Follow up Period (Week 56-68)|Protocol Violation|1|||
48877473|NCT00781937|157390071|FG000|Follow up Period (Week 56-68)|Unclassified|5|||
48877474|NCT00781937|157390072|FG001|Follow up Period (Week 56-68)|Unclassified|4|||
49030208|NCT01190930|157946923|FG007|Post Induction Pre-Maintenance|Relapse|0|||
49030209|NCT01190930|157946924|FG008|Post Induction Pre-Maintenance|Relapse|0|||
49030210|NCT01190930|157946925|FG009|Post Induction Pre-Maintenance|Relapse|0|||
49030211|NCT01190930|157946916|FG000|Maintenance|Adverse Event|0|||
49030212|NCT01190930|157946917|FG001|Maintenance|Adverse Event|0|||
49030213|NCT01190930|157946918|FG002|Maintenance|Adverse Event|0|||
49030214|NCT01190930|157946919|FG003|Maintenance|Adverse Event|0|||
49030215|NCT01190930|157946920|FG004|Maintenance|Adverse Event|0|||
49030216|NCT01190930|157946921|FG005|Maintenance|Adverse Event|1|||
49030217|NCT01190930|157946922|FG006|Maintenance|Adverse Event|1|||
49030218|NCT01190930|157946923|FG007|Maintenance|Adverse Event|3|||
49030219|NCT01190930|157946924|FG008|Maintenance|Adverse Event|3|||
49030220|NCT01190930|157946925|FG009|Maintenance|Adverse Event|0|||
49030221|NCT01190930|157946916|FG000|Maintenance|Death|0|||
49030222|NCT01190930|157946917|FG001|Maintenance|Death|0|||
49030223|NCT01190930|157946918|FG002|Maintenance|Death|0|||
49030224|NCT01190930|157946919|FG003|Maintenance|Death|1|||
49030225|NCT01190930|157946920|FG004|Maintenance|Death|0|||
49030226|NCT01190930|157946921|FG005|Maintenance|Death|0|||
49030227|NCT01190930|157946922|FG006|Maintenance|Death|2|||
49030228|NCT01190930|157946923|FG007|Maintenance|Death|2|||
49030229|NCT01190930|157946924|FG008|Maintenance|Death|2|||
49030230|NCT01190930|157946925|FG009|Maintenance|Death|2|||
49030231|NCT01190930|157946916|FG000|Maintenance|Lost to Follow-up|0|||
49030232|NCT01190930|157946917|FG001|Maintenance|Lost to Follow-up|0|||
49030233|NCT01190930|157946918|FG002|Maintenance|Lost to Follow-up|0|||
49030234|NCT01190930|157946919|FG003|Maintenance|Lost to Follow-up|0|||
49030235|NCT01190930|157946920|FG004|Maintenance|Lost to Follow-up|0|||
49030236|NCT01190930|157946921|FG005|Maintenance|Lost to Follow-up|0|||
49030237|NCT01190930|157946922|FG006|Maintenance|Lost to Follow-up|1|||
49030238|NCT01190930|157946923|FG007|Maintenance|Lost to Follow-up|1|||
49030239|NCT01190930|157946924|FG008|Maintenance|Lost to Follow-up|1|||
49030240|NCT01190930|157946925|FG009|Maintenance|Lost to Follow-up|0|||
49030241|NCT01190930|157946916|FG000|Maintenance|Physician Decision|0|||
49030242|NCT01190930|157946917|FG001|Maintenance|Physician Decision|1|||
49030243|NCT01190930|157946918|FG002|Maintenance|Physician Decision|0|||
49030244|NCT01190930|157946919|FG003|Maintenance|Physician Decision|5|||
48782614|NCT00384085|157046449|FG002|Overall Study|Progressive Disease|0|||
48782615|NCT00384085|157046447|FG000|Overall Study|Withdrawal by Subject|14|||
48782616|NCT00384085|157046448|FG001|Overall Study|Withdrawal by Subject|19|||
48877475|NCT00634842|157390073|FG000|Overall Study|Adverse Event|2|||
48877476|NCT00634842|157390074|FG001|Overall Study|Adverse Event|3|||
49030245|NCT01190930|157946920|FG004|Maintenance|Physician Decision|9|||
49030246|NCT01190930|157946921|FG005|Maintenance|Physician Decision|4|||
49030247|NCT01190930|157946922|FG006|Maintenance|Physician Decision|8|||
49030248|NCT01190930|157946923|FG007|Maintenance|Physician Decision|8|||
49030249|NCT01190930|157946924|FG008|Maintenance|Physician Decision|10|||
49030250|NCT01190930|157946925|FG009|Maintenance|Physician Decision|17|||
49030251|NCT01190930|157946916|FG000|Maintenance|Withdrawal by Subject|0|||
48782617|NCT00384085|157046449|FG002|Overall Study|Withdrawal by Subject|29|||
48782618|NCT00384085|157046447|FG000|Overall Study|Patient non-compliant|4|||
48782619|NCT00384085|157046448|FG001|Overall Study|Patient non-compliant|4|||
49030252|NCT01190930|157946917|FG001|Maintenance|Withdrawal by Subject|0|||
49030253|NCT01190930|157946918|FG002|Maintenance|Withdrawal by Subject|0|||
49030254|NCT01190930|157946919|FG003|Maintenance|Withdrawal by Subject|0|||
49030255|NCT01190930|157946920|FG004|Maintenance|Withdrawal by Subject|0|||
49030256|NCT01190930|157946921|FG005|Maintenance|Withdrawal by Subject|0|||
49030257|NCT01190930|157946922|FG006|Maintenance|Withdrawal by Subject|2|||
49030258|NCT01190930|157946923|FG007|Maintenance|Withdrawal by Subject|1|||
48782620|NCT00384085|157046449|FG002|Overall Study|Patient non-compliant|5|||
49030259|NCT01190930|157946924|FG008|Maintenance|Withdrawal by Subject|4|||
49030260|NCT01190930|157946925|FG009|Maintenance|Withdrawal by Subject|1|||
49030261|NCT01190930|157946916|FG000|Maintenance|Refusal|0|||
49030262|NCT01190930|157946917|FG001|Maintenance|Refusal|1|||
49030263|NCT01190930|157946918|FG002|Maintenance|Refusal|0|||
49030264|NCT01190930|157946919|FG003|Maintenance|Refusal|2|||
49030265|NCT01190930|157946920|FG004|Maintenance|Refusal|0|||
49030266|NCT01190930|157946921|FG005|Maintenance|Refusal|4|||
49030267|NCT01190930|157946922|FG006|Maintenance|Refusal|5|||
49030268|NCT01190930|157946923|FG007|Maintenance|Refusal|17|||
49030269|NCT01190930|157946924|FG008|Maintenance|Refusal|13|||
48782621|NCT00384085|157046447|FG000|Overall Study|Physician Decision|1|||
48782622|NCT00384085|157046448|FG001|Overall Study|Physician Decision|0|||
48782623|NCT00384085|157046449|FG002|Overall Study|Physician Decision|0|||
48782624|NCT00384085|157046447|FG000|Overall Study|Loss of site personnel|1|||
48782625|NCT00384085|157046448|FG001|Overall Study|Loss of site personnel|0|||
48782626|NCT00384085|157046449|FG002|Overall Study|Loss of site personnel|1|||
48782627|NCT00384085|157046447|FG000|Overall Study|Sponsor decision|1|||
48782628|NCT00384085|157046448|FG001|Overall Study|Sponsor decision|2|||
48782629|NCT00384085|157046449|FG002|Overall Study|Sponsor decision|1|||
48782630|NCT00384085|157046447|FG000|Overall Study|Patient moved|1|||
48782631|NCT00384085|157046448|FG001|Overall Study|Patient moved|0|||
48782632|NCT00384085|157046449|FG002|Overall Study|Patient moved|1|||
48782633|NCT00384085|157046447|FG000|Overall Study|Patient required surgery|0|||
48782634|NCT00384085|157046448|FG001|Overall Study|Patient required surgery|1|||
48782635|NCT00384085|157046449|FG002|Overall Study|Patient required surgery|0|||
48782636|NCT02318329|157046454|FG000|Overall Study|Progressive Disease|2|||
48782637|NCT02318329|157046455|FG001|Overall Study|Progressive Disease|3|||
48782638|NCT02318329|157046456|FG002|Overall Study|Progressive Disease|2|||
48782639|NCT02318329|157046457|FG003|Overall Study|Progressive Disease|3|||
48782640|NCT02318329|157046458|FG004|Overall Study|Progressive Disease|3|||
48782641|NCT02318329|157046459|FG005|Overall Study|Progressive Disease|3|||
48782642|NCT02318329|157046460|FG006|Overall Study|Progressive Disease|1|||
48782643|NCT02318329|157046461|FG007|Overall Study|Progressive Disease|1|||
48782644|NCT02318329|157046462|FG008|Overall Study|Progressive Disease|5|||
48782645|NCT02318329|157046463|FG009|Overall Study|Progressive Disease|39|||
48782646|NCT02318329|157046454|FG000|Overall Study|Death|0|||
48782647|NCT02318329|157046455|FG001|Overall Study|Death|0|||
48782648|NCT02318329|157046456|FG002|Overall Study|Death|0|||
48782649|NCT02318329|157046457|FG003|Overall Study|Death|0|||
48782650|NCT02318329|157046458|FG004|Overall Study|Death|0|||
48782651|NCT02318329|157046459|FG005|Overall Study|Death|0|||
48782652|NCT02318329|157046460|FG006|Overall Study|Death|0|||
48782653|NCT02318329|157046461|FG007|Overall Study|Death|0|||
48782654|NCT02318329|157046462|FG008|Overall Study|Death|0|||
48782655|NCT02318329|157046463|FG009|Overall Study|Death|5|||
48782656|NCT02318329|157046454|FG000|Overall Study|Lost to Follow-up|0|||
48782657|NCT02318329|157046455|FG001|Overall Study|Lost to Follow-up|0|||
48782658|NCT02318329|157046456|FG002|Overall Study|Lost to Follow-up|0|||
48782659|NCT02318329|157046457|FG003|Overall Study|Lost to Follow-up|0|||
48782660|NCT02318329|157046458|FG004|Overall Study|Lost to Follow-up|0|||
48782661|NCT02318329|157046459|FG005|Overall Study|Lost to Follow-up|0|||
48782662|NCT02318329|157046460|FG006|Overall Study|Lost to Follow-up|0|||
48782663|NCT02318329|157046461|FG007|Overall Study|Lost to Follow-up|0|||
48782664|NCT02318329|157046462|FG008|Overall Study|Lost to Follow-up|0|||
48782665|NCT02318329|157046463|FG009|Overall Study|Lost to Follow-up|1|||
48782666|NCT02318329|157046454|FG000|Overall Study|Withdrawal by Subject|0|||
48782667|NCT02318329|157046455|FG001|Overall Study|Withdrawal by Subject|0|||
48782668|NCT02318329|157046456|FG002|Overall Study|Withdrawal by Subject|0|||
48782669|NCT02318329|157046457|FG003|Overall Study|Withdrawal by Subject|0|||
48782670|NCT02318329|157046458|FG004|Overall Study|Withdrawal by Subject|0|||
48782671|NCT02318329|157046459|FG005|Overall Study|Withdrawal by Subject|0|||
48782672|NCT02318329|157046460|FG006|Overall Study|Withdrawal by Subject|0|||
48782673|NCT02318329|157046461|FG007|Overall Study|Withdrawal by Subject|0|||
48782674|NCT02318329|157046462|FG008|Overall Study|Withdrawal by Subject|0|||
48782675|NCT02318329|157046463|FG009|Overall Study|Withdrawal by Subject|6|||
49030270|NCT01190930|157946925|FG009|Maintenance|Refusal|6|||
48782676|NCT02318329|157046454|FG000|Overall Study|Other|1|||
48782677|NCT02318329|157046455|FG001|Overall Study|Other|1|||
49030271|NCT01190930|157946916|FG000|Maintenance|second malignant neoplasm|0|||
49030272|NCT01190930|157946917|FG001|Maintenance|second malignant neoplasm|0|||
48782678|NCT02318329|157046456|FG002|Overall Study|Other|1|||
48782679|NCT02318329|157046457|FG003|Overall Study|Other|0|||
48782680|NCT02318329|157046458|FG004|Overall Study|Other|0|||
48782681|NCT02318329|157046459|FG005|Overall Study|Other|0|||
48782682|NCT02318329|157046460|FG006|Overall Study|Other|0|||
48782683|NCT02318329|157046461|FG007|Overall Study|Other|0|||
48782684|NCT02318329|157046462|FG008|Overall Study|Other|1|||
49030273|NCT01190930|157946918|FG002|Maintenance|second malignant neoplasm|0|||
49030274|NCT01190930|157946919|FG003|Maintenance|second malignant neoplasm|1|||
49030275|NCT01190930|157946920|FG004|Maintenance|second malignant neoplasm|0|||
48782685|NCT02318329|157046463|FG009|Overall Study|Other|1|||
48782686|NCT00581945|157046468|FG000|Overall Study|Adverse Event|4|||
48782687|NCT00581945|157046469|FG001|Overall Study|Adverse Event|4|||
48782688|NCT00581945|157046468|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
48782689|NCT00581945|157046469|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
48782690|NCT00581945|157046468|FG000|Overall Study|Withdrawal by Subject|2|||
48782691|NCT00581945|157046469|FG001|Overall Study|Withdrawal by Subject|6|||
48782692|NCT00581945|157046468|FG000|Overall Study|Death|1|||
48782693|NCT00581945|157046469|FG001|Overall Study|Death|0|||
48782694|NCT00767000|157046474|FG000|54-week Study|Adverse Event|4|||
48782695|NCT00767000|157046475|FG001|54-week Study|Adverse Event|6|||
48782696|NCT00767000|157046476|FG002|54-week Study|Adverse Event|6|||
48782697|NCT00767000|157046477|FG003|54-week Study|Adverse Event|8|||
48982850|NCT04785144|157769894|FG003|Overall Study|Lost to Follow-up|0|||
48982851|NCT04785144|157769895|FG004|Overall Study|Lost to Follow-up|1|||
48982852|NCT04785144|157769896|FG005|Overall Study|Lost to Follow-up|2|||
48982853|NCT04785144|157769897|FG006|Overall Study|Lost to Follow-up|1|||
48982854|NCT04785144|157769898|FG007|Overall Study|Lost to Follow-up|2|||
48982855|NCT04785144|157769899|FG008|Overall Study|Lost to Follow-up|4|||
48982856|NCT04785144|157769900|FG009|Overall Study|Lost to Follow-up|1|||
48982857|NCT04785144|157769891|FG000|Overall Study|Protocol Violation|0|||
48982858|NCT04785144|157769892|FG001|Overall Study|Protocol Violation|0|||
48982859|NCT04785144|157769893|FG002|Overall Study|Protocol Violation|0|||
48982860|NCT04785144|157769894|FG003|Overall Study|Protocol Violation|0|||
48982861|NCT04785144|157769895|FG004|Overall Study|Protocol Violation|0|||
48982862|NCT04785144|157769896|FG005|Overall Study|Protocol Violation|0|||
48982863|NCT04785144|157769897|FG006|Overall Study|Protocol Violation|1|||
48982864|NCT04785144|157769898|FG007|Overall Study|Protocol Violation|0|||
48982865|NCT04785144|157769899|FG008|Overall Study|Protocol Violation|0|||
48982866|NCT04785144|157769900|FG009|Overall Study|Protocol Violation|0|||
48982867|NCT04785144|157769891|FG000|Overall Study|Physician Decision|0|||
48982868|NCT04785144|157769892|FG001|Overall Study|Physician Decision|0|||
48982869|NCT04785144|157769893|FG002|Overall Study|Physician Decision|0|||
48982870|NCT04785144|157769894|FG003|Overall Study|Physician Decision|0|||
48982871|NCT04785144|157769895|FG004|Overall Study|Physician Decision|0|||
48982872|NCT04785144|157769896|FG005|Overall Study|Physician Decision|0|||
48982873|NCT04785144|157769897|FG006|Overall Study|Physician Decision|0|||
48982874|NCT04785144|157769898|FG007|Overall Study|Physician Decision|0|||
48982875|NCT04785144|157769899|FG008|Overall Study|Physician Decision|0|||
48982876|NCT04785144|157769900|FG009|Overall Study|Physician Decision|1|||
48982877|NCT04785144|157769891|FG000|Overall Study|Unable to continue due to work schedule|0|||
48982878|NCT04785144|157769892|FG001|Overall Study|Unable to continue due to work schedule|0|||
48982879|NCT04785144|157769893|FG002|Overall Study|Unable to continue due to work schedule|0|||
48982880|NCT04785144|157769894|FG003|Overall Study|Unable to continue due to work schedule|0|||
48982881|NCT04785144|157769895|FG004|Overall Study|Unable to continue due to work schedule|0|||
48982882|NCT04785144|157769896|FG005|Overall Study|Unable to continue due to work schedule|0|||
48982883|NCT04785144|157769897|FG006|Overall Study|Unable to continue due to work schedule|0|||
48982884|NCT04785144|157769898|FG007|Overall Study|Unable to continue due to work schedule|0|||
48982885|NCT04785144|157769899|FG008|Overall Study|Unable to continue due to work schedule|0|||
48982886|NCT04785144|157769900|FG009|Overall Study|Unable to continue due to work schedule|1|||
48982887|NCT01108263|157769901|FG000|Overall Study|Adverse Event|0|||
48982888|NCT01108263|157769902|FG001|Overall Study|Adverse Event|1|||
48982889|NCT02870348|157769903|FG000|Overall Study|Participants were discontinued and assessed for entry into post-marketing study (GTI1401-EXP)|4|||
48982890|NCT03233308|157769904|FG000|Overall Study|Adverse Event|1|||
48982891|NCT03233308|157769904|FG000|Overall Study|Protocol Violation|1|||
48982892|NCT03287830|157769912|FG000|Overall Study|Withdrawal by Subject|1|||
48982893|NCT03287830|157769913|FG001|Overall Study|Withdrawal by Subject|1|||
48982894|NCT03287830|157769912|FG000|Overall Study|not meeting inclusion criteria|5|||
48982895|NCT03287830|157769913|FG001|Overall Study|not meeting inclusion criteria|12|||
48982896|NCT02060903|157769914|FG000|Overall Study|Lost to Follow-up|4|||
48982897|NCT02060903|157769915|FG001|Overall Study|Lost to Follow-up|0|||
48982898|NCT02060903|157769914|FG000|Overall Study|Withdrawal by Subject|0|||
48982899|NCT02060903|157769915|FG001|Overall Study|Withdrawal by Subject|7|||
48982900|NCT00474539|157769916|FG000|Infant Series|Withdrawal by Subject|3|||
48982901|NCT00474539|157769917|FG001|Infant Series|Withdrawal by Subject|4|||
48982902|NCT00474539|157769916|FG000|Infant Series|Randomization error|5|||
48982903|NCT00474539|157769917|FG001|Infant Series|Randomization error|0|||
48982904|NCT00474539|157769916|FG000|Infant Series|Lost to Follow-up|2|||
48982905|NCT00474539|157769917|FG001|Infant Series|Lost to Follow-up|1|||
48982906|NCT00474539|157769916|FG000|Infant Series|Protocol Violation|0|||
48982907|NCT00474539|157769917|FG001|Infant Series|Protocol Violation|1|||
48982908|NCT00474539|157769916|FG000|After Infant Series|Lost to Follow-up|3|||
48982909|NCT00474539|157769917|FG001|After Infant Series|Lost to Follow-up|0|||
48782698|NCT00767000|157046478|FG004|54-week Study|Adverse Event|4|||
48982910|NCT00474539|157769916|FG000|After Infant Series|Withdrawal by Subject|1|||
48982911|NCT00474539|157769917|FG001|After Infant Series|Withdrawal by Subject|0|||
48982912|NCT00474539|157769916|FG000|Toddler Dose|Protocol Violation|1|||
49030276|NCT01190930|157946921|FG005|Maintenance|second malignant neoplasm|1|||
49030277|NCT01190930|157946922|FG006|Maintenance|second malignant neoplasm|0|||
49030278|NCT01190930|157946923|FG007|Maintenance|second malignant neoplasm|0|||
49030279|NCT01190930|157946924|FG008|Maintenance|second malignant neoplasm|1|||
49030280|NCT01190930|157946925|FG009|Maintenance|second malignant neoplasm|0|||
49030281|NCT01190930|157946916|FG000|Maintenance|Inevaluable|0|||
49030282|NCT01190930|157946917|FG001|Maintenance|Inevaluable|0|||
49030283|NCT01190930|157946918|FG002|Maintenance|Inevaluable|0|||
49030284|NCT01190930|157946919|FG003|Maintenance|Inevaluable|0|||
49030285|NCT01190930|157946920|FG004|Maintenance|Inevaluable|0|||
49030286|NCT01190930|157946921|FG005|Maintenance|Inevaluable|1|||
49030287|NCT01190930|157946922|FG006|Maintenance|Inevaluable|1|||
49030288|NCT01190930|157946923|FG007|Maintenance|Inevaluable|1|||
49030289|NCT01190930|157946924|FG008|Maintenance|Inevaluable|0|||
49030290|NCT01190930|157946925|FG009|Maintenance|Inevaluable|0|||
49030291|NCT01190930|157946916|FG000|Maintenance|Enrollment onto another COG Protocol|0|||
49030292|NCT01190930|157946917|FG001|Maintenance|Enrollment onto another COG Protocol|0|||
49030293|NCT01190930|157946918|FG002|Maintenance|Enrollment onto another COG Protocol|0|||
49030294|NCT01190930|157946919|FG003|Maintenance|Enrollment onto another COG Protocol|0|||
49030295|NCT01190930|157946920|FG004|Maintenance|Enrollment onto another COG Protocol|0|||
49030296|NCT01190930|157946921|FG005|Maintenance|Enrollment onto another COG Protocol|0|||
49030297|NCT01190930|157946922|FG006|Maintenance|Enrollment onto another COG Protocol|0|||
49030298|NCT01190930|157946923|FG007|Maintenance|Enrollment onto another COG Protocol|0|||
49030299|NCT01190930|157946924|FG008|Maintenance|Enrollment onto another COG Protocol|1|||
49030300|NCT01190930|157946925|FG009|Maintenance|Enrollment onto another COG Protocol|0|||
49030301|NCT01190930|157946916|FG000|Maintenance|Relapse|0|||
49030302|NCT01190930|157946917|FG001|Maintenance|Relapse|0|||
49030303|NCT01190930|157946918|FG002|Maintenance|Relapse|0|||
49030304|NCT01190930|157946919|FG003|Maintenance|Relapse|2|||
49030305|NCT01190930|157946920|FG004|Maintenance|Relapse|0|||
49030306|NCT01190930|157946921|FG005|Maintenance|Relapse|1|||
49030307|NCT01190930|157946922|FG006|Maintenance|Relapse|6|||
49030308|NCT01190930|157946923|FG007|Maintenance|Relapse|13|||
49030309|NCT01190930|157946924|FG008|Maintenance|Relapse|11|||
49030310|NCT01190930|157946925|FG009|Maintenance|Relapse|11|||
49030311|NCT01190930|157946916|FG000|Maintenance|Still on therapy|0|||
49030312|NCT01190930|157946917|FG001|Maintenance|Still on therapy|8|||
49030313|NCT01190930|157946918|FG002|Maintenance|Still on therapy|0|||
49030314|NCT01190930|157946919|FG003|Maintenance|Still on therapy|29|||
49030315|NCT01190930|157946920|FG004|Maintenance|Still on therapy|0|||
49030316|NCT01190930|157946921|FG005|Maintenance|Still on therapy|0|||
49030317|NCT01190930|157946922|FG006|Maintenance|Still on therapy|0|||
49030318|NCT01190930|157946923|FG007|Maintenance|Still on therapy|0|||
48782699|NCT00767000|157046474|FG000|54-week Study|Creaninine/creatinine clearance|2|||
48782700|NCT00767000|157046475|FG001|54-week Study|Creaninine/creatinine clearance|1|||
48782701|NCT00767000|157046476|FG002|54-week Study|Creaninine/creatinine clearance|2|||
48782702|NCT00767000|157046477|FG003|54-week Study|Creaninine/creatinine clearance|2|||
48782703|NCT00767000|157046478|FG004|54-week Study|Creaninine/creatinine clearance|4|||
48782704|NCT00767000|157046474|FG000|54-week Study|Hyperglycemia|0|||
48782705|NCT00767000|157046475|FG001|54-week Study|Hyperglycemia|0|||
48782706|NCT00767000|157046476|FG002|54-week Study|Hyperglycemia|1|||
48782707|NCT00767000|157046477|FG003|54-week Study|Hyperglycemia|0|||
48782708|NCT00767000|157046478|FG004|54-week Study|Hyperglycemia|1|||
48782709|NCT00767000|157046474|FG000|54-week Study|Hypoglycemia|0|||
48782710|NCT00767000|157046475|FG001|54-week Study|Hypoglycemia|1|||
48782711|NCT00767000|157046476|FG002|54-week Study|Hypoglycemia|0|||
48782712|NCT00767000|157046477|FG003|54-week Study|Hypoglycemia|0|||
48782713|NCT00767000|157046478|FG004|54-week Study|Hypoglycemia|0|||
48782714|NCT00767000|157046474|FG000|54-week Study|Interruption of study medication|0|||
48782715|NCT00767000|157046475|FG001|54-week Study|Interruption of study medication|0|||
48782716|NCT00767000|157046476|FG002|54-week Study|Interruption of study medication|1|||
48782717|NCT00767000|157046477|FG003|54-week Study|Interruption of study medication|0|||
48877477|NCT00634842|157390073|FG000|Overall Study|Protocol Violation|8|||
48877478|NCT00634842|157390074|FG001|Overall Study|Protocol Violation|4|||
48782718|NCT00767000|157046478|FG004|54-week Study|Interruption of study medication|0|||
48782719|NCT00767000|157046474|FG000|54-week Study|Lack of Efficacy|2|||
48782720|NCT00767000|157046475|FG001|54-week Study|Lack of Efficacy|0|||
48877479|NCT00634842|157390073|FG000|Overall Study|Move to another state|1|||
49030319|NCT01190930|157946924|FG008|Maintenance|Still on therapy|0|||
49030320|NCT01190930|157946925|FG009|Maintenance|Still on therapy|0|||
49030321|NCT02481830|157946926|FG000|Pre-treatment|Participant no longer meets Study Criteria|1|||
49030322|NCT02481830|157946927|FG001|Pre-treatment|Participant no longer meets Study Criteria|4|||
49030323|NCT02481830|157946926|FG000|Pre-treatment|Withdrawal by Subject|0|||
49030324|NCT02481830|157946927|FG001|Pre-treatment|Withdrawal by Subject|10|||
49030325|NCT02481830|157946926|FG000|Pre-treatment|Disease Progression|1|||
49030326|NCT02481830|157946927|FG001|Pre-treatment|Disease Progression|1|||
49030327|NCT02481830|157946926|FG000|Pre-treatment|Other reasons|0|||
49030328|NCT02481830|157946927|FG001|Pre-treatment|Other reasons|1|||
49030329|NCT02481830|157946926|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
49030330|NCT02481830|157946927|FG001|Pre-treatment|Participant request to discontinue study treatment|4|||
49030331|NCT02481830|157946926|FG000|Treatment|Disease Progression|233|||
48782721|NCT00767000|157046476|FG002|54-week Study|Lack of Efficacy|1|||
48782722|NCT00767000|157046477|FG003|54-week Study|Lack of Efficacy|0|||
48782723|NCT00767000|157046478|FG004|54-week Study|Lack of Efficacy|5|||
48782724|NCT00767000|157046474|FG000|54-week Study|Lost to Follow-up|4|||
48782725|NCT00767000|157046475|FG001|54-week Study|Lost to Follow-up|0|||
48782726|NCT00767000|157046476|FG002|54-week Study|Lost to Follow-up|1|||
48782727|NCT00767000|157046477|FG003|54-week Study|Lost to Follow-up|4|||
48782728|NCT00767000|157046478|FG004|54-week Study|Lost to Follow-up|2|||
48782729|NCT00767000|157046474|FG000|54-week Study|Physician Decision|4|||
48782730|NCT00767000|157046475|FG001|54-week Study|Physician Decision|0|||
48782731|NCT00767000|157046476|FG002|54-week Study|Physician Decision|1|||
48782732|NCT00767000|157046477|FG003|54-week Study|Physician Decision|1|||
48782733|NCT00767000|157046478|FG004|54-week Study|Physician Decision|1|||
48782734|NCT00767000|157046474|FG000|54-week Study|Progressive disease|0|||
48782735|NCT00767000|157046475|FG001|54-week Study|Progressive disease|0|||
48982913|NCT00474539|157769917|FG001|Toddler Dose|Protocol Violation|0|||
48982914|NCT02289833|157769922|FG000|Overall Study|Study discontinuation|0|||
48982915|NCT02289833|157769923|FG001|Overall Study|Study discontinuation|1|||
48982916|NCT02289833|157769922|FG000|Overall Study|Lost to Follow-up|4|||
48982917|NCT02289833|157769923|FG001|Overall Study|Lost to Follow-up|0|||
48982918|NCT02289833|157769922|FG000|Overall Study|Death|23|||
48982919|NCT02289833|157769923|FG001|Overall Study|Death|16|||
48982920|NCT00414973|157769928|FG000|Overall Study|Withdrawal by Subject|14|||
48982921|NCT00414973|157769929|FG001|Overall Study|Withdrawal by Subject|4|||
48982922|NCT00414973|157769930|FG002|Overall Study|Withdrawal by Subject|1|||
48982923|NCT00414973|157769931|FG003|Overall Study|Withdrawal by Subject|0|||
48982924|NCT00414973|157769928|FG000|Overall Study|Adverse Event|10|||
48982925|NCT00414973|157769929|FG001|Overall Study|Adverse Event|0|||
48982926|NCT00414973|157769930|FG002|Overall Study|Adverse Event|1|||
48982927|NCT00414973|157769931|FG003|Overall Study|Adverse Event|0|||
48982928|NCT00414973|157769928|FG000|Overall Study|Protocol Violation|3|||
48982929|NCT00414973|157769929|FG001|Overall Study|Protocol Violation|4|||
48982930|NCT00414973|157769930|FG002|Overall Study|Protocol Violation|0|||
48982931|NCT00414973|157769931|FG003|Overall Study|Protocol Violation|0|||
48982932|NCT00414973|157769928|FG000|Overall Study|Lost to Follow-up|0|||
48982933|NCT00414973|157769929|FG001|Overall Study|Lost to Follow-up|2|||
48982934|NCT00414973|157769930|FG002|Overall Study|Lost to Follow-up|0|||
48982935|NCT00414973|157769931|FG003|Overall Study|Lost to Follow-up|0|||
48982936|NCT00414973|157769928|FG000|Overall Study|Sponsor Decision|1|||
48982937|NCT00414973|157769929|FG001|Overall Study|Sponsor Decision|0|||
48982938|NCT00414973|157769930|FG002|Overall Study|Sponsor Decision|0|||
48982939|NCT00414973|157769931|FG003|Overall Study|Sponsor Decision|0|||
48982940|NCT00414973|157769928|FG000|Overall Study|Death|0|||
48982941|NCT00414973|157769929|FG001|Overall Study|Death|0|||
48982942|NCT00414973|157769930|FG002|Overall Study|Death|1|||
48982943|NCT00414973|157769931|FG003|Overall Study|Death|0|||
48982944|NCT03483012|157769932|FG000|Overall Study|Lack of Efficacy|6|||
48982945|NCT04652102|157769937|FG000|Overall Study|Adverse Event|14|||
48982946|NCT04652102|157769938|FG001|Overall Study|Adverse Event|13|||
48982947|NCT04652102|157769937|FG000|Overall Study|Subject Received Alternative Authorised Vaccine|1407|||
48982948|NCT04652102|157769938|FG001|Overall Study|Subject Received Alternative Authorised Vaccine|6552|||
48982949|NCT04652102|157769937|FG000|Overall Study|Physician Decision|78|||
48982950|NCT04652102|157769938|FG001|Overall Study|Physician Decision|40|||
48982951|NCT04652102|157769937|FG000|Overall Study|Study Ended by Sponsor|64|||
48982952|NCT04652102|157769938|FG001|Overall Study|Study Ended by Sponsor|17|||
48982953|NCT04652102|157769937|FG000|Overall Study|Withdrawal by Subject|4625|||
48982954|NCT04652102|157769938|FG001|Overall Study|Withdrawal by Subject|5594|||
48982955|NCT04652102|157769937|FG000|Overall Study|Lost to Follow-up|2019|||
48982956|NCT04652102|157769938|FG001|Overall Study|Lost to Follow-up|1082|||
48982957|NCT04652102|157769937|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|49|||
48982958|NCT04652102|157769938|FG001|Overall Study|Protocol Specified Withdrawal Criterion Met|2230|||
48982959|NCT04652102|157769937|FG000|Overall Study|Miscellaneous|80|||
48982960|NCT04652102|157769938|FG001|Overall Study|Miscellaneous|64|||
48982961|NCT02516306|157769939|FG000|Period 2: Day 8 - 91|Protocol Violation|1|||
48982962|NCT02516306|157769940|FG001|Period 2: Day 8 - 91|Protocol Violation|2|||
48982963|NCT02005211|157769943|FG000|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
48982964|NCT02005211|157769944|FG001|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
48982965|NCT02005211|157769945|FG002|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
48982966|NCT02005211|157769946|FG003|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
48982967|NCT02005211|157769947|FG004|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1|||
48982968|NCT02005211|157769948|FG005|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
48982969|NCT02005211|157769949|FG006|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
48982970|NCT02607865|157769950|FG000|Overall Study|Lost to Follow-up|9|||
48982971|NCT02607865|157769951|FG001|Overall Study|Lost to Follow-up|7|||
48782736|NCT00767000|157046476|FG002|54-week Study|Progressive disease|1|||
48782737|NCT00767000|157046477|FG003|54-week Study|Progressive disease|0|||
48782738|NCT00767000|157046478|FG004|54-week Study|Progressive disease|0|||
48782739|NCT00767000|157046474|FG000|54-week Study|Protocol Violation|0|||
48782740|NCT00767000|157046475|FG001|54-week Study|Protocol Violation|0|||
48782741|NCT00767000|157046476|FG002|54-week Study|Protocol Violation|1|||
48782742|NCT00767000|157046477|FG003|54-week Study|Protocol Violation|2|||
48782743|NCT00767000|157046478|FG004|54-week Study|Protocol Violation|0|||
48782744|NCT00767000|157046474|FG000|54-week Study|Withdrawal by Subject|2|||
48782745|NCT00767000|157046475|FG001|54-week Study|Withdrawal by Subject|3|||
48782746|NCT00767000|157046476|FG002|54-week Study|Withdrawal by Subject|5|||
48782747|NCT00767000|157046477|FG003|54-week Study|Withdrawal by Subject|11|||
48782748|NCT00767000|157046478|FG004|54-week Study|Withdrawal by Subject|13|||
48782749|NCT00767000|157046474|FG000|54-week Study|Study terminated by sponsor|90|||
48782750|NCT00767000|157046475|FG001|54-week Study|Study terminated by sponsor|102|||
48782751|NCT00767000|157046476|FG002|54-week Study|Study terminated by sponsor|89|||
48782752|NCT00767000|157046477|FG003|54-week Study|Study terminated by sponsor|196|||
48782753|NCT00767000|157046478|FG004|54-week Study|Study terminated by sponsor|194|||
48782754|NCT00767000|157046474|FG000|54-week Study|Reason not reported|0|||
48782755|NCT00767000|157046475|FG001|54-week Study|Reason not reported|0|||
48782756|NCT00767000|157046476|FG002|54-week Study|Reason not reported|0|||
48782757|NCT00767000|157046477|FG003|54-week Study|Reason not reported|1|||
48782758|NCT00767000|157046478|FG004|54-week Study|Reason not reported|0|||
48782759|NCT00767000|157046474|FG000|Optional 104-week Extension|Study terminated by sponsor|7|||
48782760|NCT00767000|157046475|FG001|Optional 104-week Extension|Study terminated by sponsor|3|||
48782761|NCT00767000|157046476|FG002|Optional 104-week Extension|Study terminated by sponsor|7|||
48782762|NCT00767000|157046477|FG003|Optional 104-week Extension|Study terminated by sponsor|2|||
48782763|NCT00767000|157046478|FG004|Optional 104-week Extension|Study terminated by sponsor|4|||
48782764|NCT02032901|157046479|FG000|Treatment Period (12 Weeks)|Pregnancy|1|||
48782765|NCT02032901|157046480|FG001|Treatment Period (12 Weeks)|Pregnancy|0|||
48782766|NCT02032901|157046479|FG000|Follow-Up Period (24 Weeks)|Lost to Follow-up|0|||
48782767|NCT02032901|157046480|FG001|Follow-Up Period (24 Weeks)|Lost to Follow-up|1|||
48782768|NCT01259713|157046481|FG000|Overall Study|Adverse Event|54|||
48782769|NCT01259713|157046482|FG001|Overall Study|Adverse Event|23|||
48782770|NCT01259713|157046481|FG000|Overall Study|Death Not Related to IFI|8|||
48782771|NCT01259713|157046482|FG001|Overall Study|Death Not Related to IFI|1|||
48782772|NCT01259713|157046481|FG000|Overall Study|Investigators Discretion|14|||
48782773|NCT01259713|157046482|FG001|Overall Study|Investigators Discretion|6|||
48782774|NCT01259713|157046481|FG000|Overall Study|Lack of Efficacy|2|||
48782775|NCT01259713|157046482|FG001|Overall Study|Lack of Efficacy|0|||
48782776|NCT01259713|157046481|FG000|Overall Study|Protocol Violation|5|||
48782777|NCT01259713|157046482|FG001|Overall Study|Protocol Violation|4|||
48782778|NCT01259713|157046481|FG000|Overall Study|Subject Withdrew Consent|12|||
48782779|NCT01259713|157046482|FG001|Overall Study|Subject Withdrew Consent|7|||
48782780|NCT01722331|157046483|FG000|Part 1|Adverse Event|5|||
48782781|NCT01722331|157046484|FG001|Part 1|Adverse Event|0|||
48782782|NCT01722331|157046485|FG002|Part 1|Adverse Event|0|||
48782783|NCT01722331|157046486|FG003|Part 1|Adverse Event|0|||
48982972|NCT02607865|157769952|FG002|Overall Study|Lost to Follow-up|7|||
48982973|NCT02607865|157769953|FG003|Overall Study|Lost to Follow-up|5|||
48982974|NCT02607865|157769950|FG000|Overall Study|Withdrawal by Subject|18|||
48982975|NCT02607865|157769951|FG001|Overall Study|Withdrawal by Subject|18|||
48982976|NCT02607865|157769952|FG002|Overall Study|Withdrawal by Subject|17|||
48982977|NCT02607865|157769953|FG003|Overall Study|Withdrawal by Subject|8|||
48982978|NCT02607865|157769950|FG000|Overall Study|Death|5|||
48982979|NCT02607865|157769951|FG001|Overall Study|Death|4|||
48982980|NCT02607865|157769952|FG002|Overall Study|Death|1|||
48982981|NCT02607865|157769953|FG003|Overall Study|Death|3|||
48982982|NCT02607865|157769950|FG000|Overall Study|Unclassified|1|||
48982983|NCT02607865|157769951|FG001|Overall Study|Unclassified|1|||
48982984|NCT02607865|157769952|FG002|Overall Study|Unclassified|2|||
48982985|NCT02607865|157769953|FG003|Overall Study|Unclassified|0|||
48982986|NCT03227692|157769954|FG000|Overall Study|Protocol Violation|1|||
48982987|NCT03227692|157769955|FG001|Overall Study|Protocol Violation|1|||
48982988|NCT03227692|157769954|FG000|Overall Study|Lost to Follow-up|4|||
48982989|NCT03227692|157769955|FG001|Overall Study|Lost to Follow-up|2|||
48982990|NCT03227692|157769954|FG000|Overall Study|Adverse Event|0|||
48982991|NCT03227692|157769955|FG001|Overall Study|Adverse Event|2|||
48982992|NCT00528840|157769956|FG000|Overall Study|Lost to Follow-up|10|||
48982993|NCT00528840|157769956|FG000|Overall Study|Adverse Event|1|||
48982994|NCT00528840|157769956|FG000|Overall Study|Withdrawal by Subject|17|||
48982995|NCT00528840|157769956|FG000|Overall Study|Death|2|||
48982996|NCT00528840|157769956|FG000|Overall Study|Administrative Reasons|1|||
48982997|NCT00528840|157769956|FG000|Overall Study|Other|2|||
49030332|NCT02481830|157946927|FG001|Treatment|Disease Progression|171|||
48782784|NCT01722331|157046487|FG004|Part 1|Adverse Event|0|||
48782785|NCT01722331|157046488|FG005|Part 1|Adverse Event|0|||
48782786|NCT01722331|157046489|FG006|Part 1|Adverse Event|0|||
49030333|NCT02481830|157946926|FG000|Treatment|Study drug toxicity|18|||
49030334|NCT02481830|157946927|FG001|Treatment|Study drug toxicity|38|||
49030335|NCT02481830|157946926|FG000|Treatment|Death|1|||
49030336|NCT02481830|157946927|FG001|Treatment|Death|1|||
49030337|NCT02481830|157946926|FG000|Treatment|Adverse Event unrelated to Study drug|14|||
49030338|NCT02481830|157946927|FG001|Treatment|Adverse Event unrelated to Study drug|11|||
49030339|NCT02481830|157946926|FG000|Treatment|Participants request to discontinue Study treatment|6|||
49030340|NCT02481830|157946927|FG001|Treatment|Participants request to discontinue Study treatment|34|||
49030341|NCT02481830|157946926|FG000|Treatment|Withdrawal by Subject|2|||
49030342|NCT02481830|157946927|FG001|Treatment|Withdrawal by Subject|3|||
49030343|NCT02481830|157946926|FG000|Treatment|Lost to Follow-up|1|||
49030344|NCT02481830|157946927|FG001|Treatment|Lost to Follow-up|0|||
48782787|NCT01722331|157046483|FG000|Part 1|Lack of Efficacy|0|||
48782788|NCT01722331|157046484|FG001|Part 1|Lack of Efficacy|0|||
48782789|NCT01722331|157046485|FG002|Part 1|Lack of Efficacy|1|||
48782790|NCT01722331|157046486|FG003|Part 1|Lack of Efficacy|0|||
48782791|NCT01722331|157046487|FG004|Part 1|Lack of Efficacy|2|||
48782792|NCT01722331|157046488|FG005|Part 1|Lack of Efficacy|0|||
48782793|NCT01722331|157046489|FG006|Part 1|Lack of Efficacy|0|||
48782794|NCT01722331|157046483|FG000|Part 1|Lost to Follow-up|1|||
48782795|NCT01722331|157046484|FG001|Part 1|Lost to Follow-up|0|||
48782796|NCT01722331|157046485|FG002|Part 1|Lost to Follow-up|2|||
49030345|NCT02481830|157946926|FG000|Treatment|Maximum Clinical Benefit|0|||
49030346|NCT02481830|157946927|FG001|Treatment|Maximum Clinical Benefit|5|||
49030347|NCT02481830|157946926|FG000|Treatment|Administrative reason by sponsor|1|||
49030348|NCT02481830|157946927|FG001|Treatment|Administrative reason by sponsor|1|||
49030349|NCT02481830|157946926|FG000|Treatment|Other reasons|6|||
49030350|NCT02481830|157946927|FG001|Treatment|Other reasons|1|||
48782797|NCT01722331|157046486|FG003|Part 1|Lost to Follow-up|0|||
48782798|NCT01722331|157046487|FG004|Part 1|Lost to Follow-up|1|||
48782799|NCT01722331|157046488|FG005|Part 1|Lost to Follow-up|0|||
48782800|NCT01722331|157046489|FG006|Part 1|Lost to Follow-up|0|||
48782801|NCT01722331|157046483|FG000|Part 1|Physician Decision|0|||
48782802|NCT01722331|157046484|FG001|Part 1|Physician Decision|0|||
48782803|NCT01722331|157046485|FG002|Part 1|Physician Decision|3|||
48782804|NCT01722331|157046486|FG003|Part 1|Physician Decision|0|||
48782805|NCT01722331|157046487|FG004|Part 1|Physician Decision|1|||
48782806|NCT01722331|157046488|FG005|Part 1|Physician Decision|0|||
48782807|NCT01722331|157046489|FG006|Part 1|Physician Decision|0|||
48782808|NCT01722331|157046483|FG000|Part 1|Pregnancy|1|||
48782809|NCT01722331|157046484|FG001|Part 1|Pregnancy|0|||
48782810|NCT01722331|157046485|FG002|Part 1|Pregnancy|0|||
48782811|NCT01722331|157046486|FG003|Part 1|Pregnancy|0|||
48782812|NCT01722331|157046487|FG004|Part 1|Pregnancy|0|||
48782813|NCT01722331|157046488|FG005|Part 1|Pregnancy|0|||
48782814|NCT01722331|157046489|FG006|Part 1|Pregnancy|0|||
48782815|NCT01722331|157046483|FG000|Part 1|Progressive Disease|0|||
48782816|NCT01722331|157046484|FG001|Part 1|Progressive Disease|0|||
48782817|NCT01722331|157046485|FG002|Part 1|Progressive Disease|0|||
48782818|NCT01722331|157046486|FG003|Part 1|Progressive Disease|0|||
48782819|NCT01722331|157046487|FG004|Part 1|Progressive Disease|1|||
48782820|NCT01722331|157046488|FG005|Part 1|Progressive Disease|0|||
48782821|NCT01722331|157046489|FG006|Part 1|Progressive Disease|0|||
48782822|NCT01722331|157046483|FG000|Part 1|Protocol Violation|1|||
48782823|NCT01722331|157046484|FG001|Part 1|Protocol Violation|0|||
48782824|NCT01722331|157046485|FG002|Part 1|Protocol Violation|0|||
48782825|NCT01722331|157046486|FG003|Part 1|Protocol Violation|0|||
48782826|NCT01722331|157046487|FG004|Part 1|Protocol Violation|1|||
48782827|NCT01722331|157046488|FG005|Part 1|Protocol Violation|0|||
48782828|NCT01722331|157046489|FG006|Part 1|Protocol Violation|0|||
48782829|NCT01722331|157046483|FG000|Part 1|Withdrawal by Subject|2|||
48782830|NCT01722331|157046484|FG001|Part 1|Withdrawal by Subject|0|||
49030351|NCT00772941|157946928|FG000|Overall Study|CRFs not available|195|||
49030352|NCT00772941|157946928|FG000|Overall Study|Study not completed|16|||
49030353|NCT00772941|157946928|FG000|Overall Study|Missed Visits|374|||
49030354|NCT00772941|157946928|FG000|Overall Study|Poor Compliance|7|||
49030355|NCT00772941|157946928|FG000|Overall Study|GPSP Violation|90|||
48782831|NCT01722331|157046485|FG002|Part 1|Withdrawal by Subject|3|||
48782832|NCT01722331|157046486|FG003|Part 1|Withdrawal by Subject|0|||
48782833|NCT01722331|157046487|FG004|Part 1|Withdrawal by Subject|3|||
48782834|NCT01722331|157046488|FG005|Part 1|Withdrawal by Subject|0|||
48782835|NCT01722331|157046489|FG006|Part 1|Withdrawal by Subject|0|||
49030356|NCT04627038|157946930|FG000|Overall Study|Adverse Event|36|||
49030357|NCT04627038|157946931|FG001|Overall Study|Adverse Event|8|||
49030358|NCT04627038|157946930|FG000|Overall Study|Lost to Follow-up|1|||
48782836|NCT01722331|157046483|FG000|Part 2|Adverse Event|3|||
48782837|NCT01722331|157046484|FG001|Part 2|Adverse Event|0|||
48782838|NCT01722331|157046485|FG002|Part 2|Adverse Event|0|||
48782839|NCT01722331|157046486|FG003|Part 2|Adverse Event|0|||
48782840|NCT01722331|157046487|FG004|Part 2|Adverse Event|0|||
48782841|NCT01722331|157046488|FG005|Part 2|Adverse Event|1|||
48782842|NCT01722331|157046489|FG006|Part 2|Adverse Event|0|||
48782843|NCT01722331|157046483|FG000|Part 2|Lack of Efficacy|3|||
48782844|NCT01722331|157046484|FG001|Part 2|Lack of Efficacy|0|||
48782845|NCT01722331|157046485|FG002|Part 2|Lack of Efficacy|11|||
49030359|NCT04627038|157946931|FG001|Overall Study|Lost to Follow-up|0|||
49030360|NCT04627038|157946930|FG000|Overall Study|Physician Decision|0|||
49030361|NCT04627038|157946931|FG001|Overall Study|Physician Decision|1|||
49030362|NCT04627038|157946930|FG000|Overall Study|Protocol Violation|3|||
49030363|NCT04627038|157946931|FG001|Overall Study|Protocol Violation|1|||
49030364|NCT04627038|157946930|FG000|Overall Study|Withdrawal by Subject|13|||
49030365|NCT04627038|157946931|FG001|Overall Study|Withdrawal by Subject|3|||
49030366|NCT04627038|157946930|FG000|Overall Study|Non-compliance with study drug|0|||
49030367|NCT04627038|157946931|FG001|Overall Study|Non-compliance with study drug|1|||
49030368|NCT04627038|157946930|FG000|Overall Study|Prohibited Concomitant Medication|1|||
49030369|NCT04627038|157946931|FG001|Overall Study|Prohibited Concomitant Medication|0|||
49030370|NCT04786184|157946932|FG000|Overall Study|Adverse Event|4|||
49030371|NCT04786184|157946933|FG001|Overall Study|Adverse Event|0|||
49030372|NCT04786184|157946932|FG000|Overall Study|Withdrawal by Subject|3|||
48782846|NCT01722331|157046486|FG003|Part 2|Lack of Efficacy|0|||
48782847|NCT01722331|157046487|FG004|Part 2|Lack of Efficacy|0|||
48782848|NCT01722331|157046488|FG005|Part 2|Lack of Efficacy|3|||
48782849|NCT01722331|157046489|FG006|Part 2|Lack of Efficacy|3|||
48782850|NCT01722331|157046483|FG000|Part 2|Lost to Follow-up|0|||
48782851|NCT01722331|157046484|FG001|Part 2|Lost to Follow-up|0|||
48782852|NCT01722331|157046485|FG002|Part 2|Lost to Follow-up|3|||
48782853|NCT01722331|157046486|FG003|Part 2|Lost to Follow-up|0|||
48782854|NCT01722331|157046487|FG004|Part 2|Lost to Follow-up|0|||
48782855|NCT01722331|157046488|FG005|Part 2|Lost to Follow-up|1|||
48782856|NCT01722331|157046489|FG006|Part 2|Lost to Follow-up|1|||
48782857|NCT01722331|157046483|FG000|Part 2|Non-Compliance with Study Drug|1|||
48782858|NCT01722331|157046484|FG001|Part 2|Non-Compliance with Study Drug|0|||
48782859|NCT01722331|157046485|FG002|Part 2|Non-Compliance with Study Drug|1|||
48782860|NCT01722331|157046486|FG003|Part 2|Non-Compliance with Study Drug|0|||
48782861|NCT01722331|157046487|FG004|Part 2|Non-Compliance with Study Drug|0|||
49030373|NCT04786184|157946933|FG001|Overall Study|Withdrawal by Subject|1|||
49030374|NCT04786184|157946932|FG000|Overall Study|Lost to Follow-up|4|||
48782862|NCT01722331|157046488|FG005|Part 2|Non-Compliance with Study Drug|0|||
49030375|NCT04786184|157946933|FG001|Overall Study|Lost to Follow-up|2|||
49030376|NCT02255097|157946934|FG000|Overall Study|Death|151|||
49030377|NCT02255097|157946934|FG000|Overall Study|Lost to Follow-up|5|||
49030378|NCT02255097|157946934|FG000|Overall Study|Participation in Study Discontinued by Sponsor|8|||
49030379|NCT02255097|157946934|FG000|Overall Study|Withdrawal by Subject|7|||
49030380|NCT02255097|157946934|FG000|Overall Study|Allocated but not treated|1|||
49030381|NCT00488774|157946935|FG000|Overall Study|Withdrawal of consent|2|||
49030382|NCT00488774|157946936|FG001|Overall Study|Withdrawal of consent|2|||
48782863|NCT01722331|157046489|FG006|Part 2|Non-Compliance with Study Drug|0|||
48782864|NCT01722331|157046483|FG000|Part 2|Physician Decision|0|||
48877480|NCT00634842|157390074|FG001|Overall Study|Move to another state|0|||
49030383|NCT00488774|157946937|FG002|Overall Study|Withdrawal of consent|2|||
49030384|NCT00488774|157946938|FG003|Overall Study|Withdrawal of consent|0|||
49030385|NCT00488774|157946935|FG000|Overall Study|Other|6|||
49030386|NCT00488774|157946936|FG001|Overall Study|Other|3|||
49030387|NCT00488774|157946937|FG002|Overall Study|Other|2|||
49030388|NCT00488774|157946938|FG003|Overall Study|Other|2|||
49030389|NCT00488774|157946935|FG000|Overall Study|Lost to Follow-up|0|||
48782865|NCT01722331|157046484|FG001|Part 2|Physician Decision|0|||
48782866|NCT01722331|157046485|FG002|Part 2|Physician Decision|2|||
48782867|NCT01722331|157046486|FG003|Part 2|Physician Decision|0|||
48782868|NCT01722331|157046487|FG004|Part 2|Physician Decision|0|||
48782869|NCT01722331|157046488|FG005|Part 2|Physician Decision|0|||
48782870|NCT01722331|157046489|FG006|Part 2|Physician Decision|0|||
48782871|NCT01722331|157046483|FG000|Part 2|Pregnancy|0|||
48782872|NCT01722331|157046484|FG001|Part 2|Pregnancy|0|||
48782873|NCT01722331|157046485|FG002|Part 2|Pregnancy|0|||
48782874|NCT01722331|157046486|FG003|Part 2|Pregnancy|0|||
48782875|NCT01722331|157046487|FG004|Part 2|Pregnancy|0|||
48782876|NCT01722331|157046488|FG005|Part 2|Pregnancy|1|||
48782877|NCT01722331|157046489|FG006|Part 2|Pregnancy|0|||
48782878|NCT01722331|157046483|FG000|Part 2|Progressive Disease|0|||
48782879|NCT01722331|157046484|FG001|Part 2|Progressive Disease|0|||
48877481|NCT00634842|157390073|FG000|Overall Study|Inclusion criteria were not met|1|||
49030390|NCT00488774|157946936|FG001|Overall Study|Lost to Follow-up|0|||
49030391|NCT00488774|157946937|FG002|Overall Study|Lost to Follow-up|1|||
49030392|NCT00488774|157946938|FG003|Overall Study|Lost to Follow-up|1|||
48782880|NCT01722331|157046485|FG002|Part 2|Progressive Disease|1|||
49030393|NCT01204294|157946939|FG000|Overall Study|Adverse Event|2|||
48782881|NCT01722331|157046486|FG003|Part 2|Progressive Disease|0|||
48782882|NCT01722331|157046487|FG004|Part 2|Progressive Disease|0|||
49030394|NCT01204294|157946940|FG001|Overall Study|Adverse Event|6|||
49030395|NCT01204294|157946941|FG002|Overall Study|Adverse Event|0|||
48782883|NCT01722331|157046488|FG005|Part 2|Progressive Disease|0|||
48782884|NCT01722331|157046489|FG006|Part 2|Progressive Disease|0|||
48782885|NCT01722331|157046483|FG000|Part 2|Protocol Violation|1|||
48782886|NCT01722331|157046484|FG001|Part 2|Protocol Violation|0|||
48782887|NCT01722331|157046485|FG002|Part 2|Protocol Violation|0|||
48782888|NCT01722331|157046486|FG003|Part 2|Protocol Violation|0|||
48782889|NCT01722331|157046487|FG004|Part 2|Protocol Violation|0|||
48782890|NCT01722331|157046488|FG005|Part 2|Protocol Violation|0|||
48782891|NCT01722331|157046489|FG006|Part 2|Protocol Violation|0|||
48782892|NCT01722331|157046483|FG000|Part 2|Withdrawal by Subject|5|||
48782893|NCT01722331|157046484|FG001|Part 2|Withdrawal by Subject|0|||
48782894|NCT01722331|157046485|FG002|Part 2|Withdrawal by Subject|3|||
48782895|NCT01722331|157046486|FG003|Part 2|Withdrawal by Subject|0|||
48782896|NCT01722331|157046487|FG004|Part 2|Withdrawal by Subject|0|||
48782897|NCT01722331|157046488|FG005|Part 2|Withdrawal by Subject|2|||
48782898|NCT01722331|157046489|FG006|Part 2|Withdrawal by Subject|2|||
48782899|NCT01722331|157046483|FG000|Part 2|Other Protocol Specified Criteria|6|||
48782900|NCT01722331|157046484|FG001|Part 2|Other Protocol Specified Criteria|0|||
48782901|NCT01722331|157046485|FG002|Part 2|Other Protocol Specified Criteria|10|||
48782902|NCT01722331|157046486|FG003|Part 2|Other Protocol Specified Criteria|0|||
48782903|NCT01722331|157046487|FG004|Part 2|Other Protocol Specified Criteria|0|||
48782904|NCT01722331|157046488|FG005|Part 2|Other Protocol Specified Criteria|2|||
48782905|NCT01722331|157046489|FG006|Part 2|Other Protocol Specified Criteria|1|||
48782906|NCT01722331|157046483|FG000|Part 3|Adverse Event|2|||
48782907|NCT01722331|157046484|FG001|Part 3|Adverse Event|2|||
48782908|NCT01722331|157046485|FG002|Part 3|Adverse Event|0|||
48782909|NCT01722331|157046486|FG003|Part 3|Adverse Event|1|||
48782910|NCT01722331|157046487|FG004|Part 3|Adverse Event|0|||
48782911|NCT01722331|157046488|FG005|Part 3|Adverse Event|0|||
48782912|NCT01722331|157046489|FG006|Part 3|Adverse Event|0|||
48782913|NCT01722331|157046483|FG000|Part 3|Death|1|||
48782914|NCT01722331|157046484|FG001|Part 3|Death|0|||
48782915|NCT01722331|157046485|FG002|Part 3|Death|0|||
48782916|NCT01722331|157046486|FG003|Part 3|Death|0|||
48782917|NCT01722331|157046487|FG004|Part 3|Death|0|||
48782918|NCT01722331|157046488|FG005|Part 3|Death|0|||
49030396|NCT01204294|157946942|FG003|Overall Study|Adverse Event|7|||
48782919|NCT01722331|157046489|FG006|Part 3|Death|0|||
48782920|NCT01722331|157046483|FG000|Part 3|Lack of Efficacy|1|||
48782921|NCT01722331|157046484|FG001|Part 3|Lack of Efficacy|0|||
48782922|NCT01722331|157046485|FG002|Part 3|Lack of Efficacy|0|||
48782923|NCT01722331|157046486|FG003|Part 3|Lack of Efficacy|0|||
48782924|NCT01722331|157046487|FG004|Part 3|Lack of Efficacy|0|||
48782925|NCT01722331|157046488|FG005|Part 3|Lack of Efficacy|0|||
48782926|NCT01722331|157046489|FG006|Part 3|Lack of Efficacy|0|||
48782927|NCT01722331|157046483|FG000|Part 3|Lost to Follow-up|3|||
48782928|NCT01722331|157046484|FG001|Part 3|Lost to Follow-up|4|||
48782929|NCT01722331|157046485|FG002|Part 3|Lost to Follow-up|0|||
48782930|NCT01722331|157046486|FG003|Part 3|Lost to Follow-up|0|||
48782931|NCT01722331|157046487|FG004|Part 3|Lost to Follow-up|0|||
48877482|NCT00634842|157390074|FG001|Overall Study|Inclusion criteria were not met|0|||
49030397|NCT01204294|157946943|FG004|Overall Study|Adverse Event|1|||
48782932|NCT01722331|157046488|FG005|Part 3|Lost to Follow-up|1|||
48782933|NCT01722331|157046489|FG006|Part 3|Lost to Follow-up|0|||
48782934|NCT01722331|157046483|FG000|Part 3|Non-Compliance with Study Drug|0|||
48782935|NCT01722331|157046484|FG001|Part 3|Non-Compliance with Study Drug|1|||
48782936|NCT01722331|157046485|FG002|Part 3|Non-Compliance with Study Drug|0|||
48782937|NCT01722331|157046486|FG003|Part 3|Non-Compliance with Study Drug|0|||
48782938|NCT01722331|157046487|FG004|Part 3|Non-Compliance with Study Drug|0|||
48782939|NCT01722331|157046488|FG005|Part 3|Non-Compliance with Study Drug|0|||
49030398|NCT01204294|157946944|FG005|Overall Study|Adverse Event|4|||
49030399|NCT01204294|157946945|FG006|Overall Study|Adverse Event|0|||
49030400|NCT01204294|157946939|FG000|Overall Study|Protocol Violation|1|||
49030401|NCT01204294|157946940|FG001|Overall Study|Protocol Violation|0|||
49030402|NCT01204294|157946941|FG002|Overall Study|Protocol Violation|2|||
49030403|NCT01204294|157946942|FG003|Overall Study|Protocol Violation|1|||
48782940|NCT01722331|157046489|FG006|Part 3|Non-Compliance with Study Drug|0|||
49030404|NCT01204294|157946943|FG004|Overall Study|Protocol Violation|0|||
49030405|NCT01204294|157946944|FG005|Overall Study|Protocol Violation|0|||
48782941|NCT01722331|157046483|FG000|Part 3|Physician Decision|1|||
48782942|NCT01722331|157046484|FG001|Part 3|Physician Decision|1|||
48782943|NCT01722331|157046485|FG002|Part 3|Physician Decision|0|||
48782944|NCT01722331|157046486|FG003|Part 3|Physician Decision|0|||
48782945|NCT01722331|157046487|FG004|Part 3|Physician Decision|0|||
48782946|NCT01722331|157046488|FG005|Part 3|Physician Decision|0|||
48782947|NCT01722331|157046489|FG006|Part 3|Physician Decision|1|||
48877483|NCT00634842|157390073|FG000|Overall Study|Lost to Follow-up|1|||
48782948|NCT01722331|157046483|FG000|Part 3|Protocol Violation|2|||
48782949|NCT01722331|157046484|FG001|Part 3|Protocol Violation|1|||
48782950|NCT01722331|157046485|FG002|Part 3|Protocol Violation|0|||
48782951|NCT01722331|157046486|FG003|Part 3|Protocol Violation|0|||
48782952|NCT01722331|157046487|FG004|Part 3|Protocol Violation|0|||
48782953|NCT01722331|157046488|FG005|Part 3|Protocol Violation|0|||
48782954|NCT01722331|157046489|FG006|Part 3|Protocol Violation|0|||
48782955|NCT01722331|157046483|FG000|Part 3|Withdrawal by Subject|4|||
48782956|NCT01722331|157046484|FG001|Part 3|Withdrawal by Subject|7|||
48782957|NCT01722331|157046485|FG002|Part 3|Withdrawal by Subject|0|||
48782958|NCT01722331|157046486|FG003|Part 3|Withdrawal by Subject|0|||
48782959|NCT01722331|157046487|FG004|Part 3|Withdrawal by Subject|0|||
48877484|NCT00634842|157390074|FG001|Overall Study|Lost to Follow-up|2|||
48782960|NCT01722331|157046488|FG005|Part 3|Withdrawal by Subject|2|||
48782961|NCT01722331|157046489|FG006|Part 3|Withdrawal by Subject|1|||
48782962|NCT01722331|157046483|FG000|Part 3|Other Protocol Specified Criteria|1|||
48782963|NCT01722331|157046484|FG001|Part 3|Other Protocol Specified Criteria|1|||
48782964|NCT01722331|157046485|FG002|Part 3|Other Protocol Specified Criteria|0|||
48782965|NCT01722331|157046486|FG003|Part 3|Other Protocol Specified Criteria|0|||
48782966|NCT01722331|157046487|FG004|Part 3|Other Protocol Specified Criteria|0|||
48782967|NCT01722331|157046488|FG005|Part 3|Other Protocol Specified Criteria|0|||
48782968|NCT01722331|157046489|FG006|Part 3|Other Protocol Specified Criteria|0|||
48782969|NCT02246998|157046490|FG000|Overall Study|Adverse Event|0|||
48782970|NCT02246998|157046491|FG001|Overall Study|Adverse Event|1|||
48782971|NCT02246998|157046492|FG002|Overall Study|Adverse Event|1|||
48782972|NCT02246998|157046493|FG003|Overall Study|Adverse Event|0|||
48782973|NCT02246998|157046490|FG000|Overall Study|Lost to Follow-up|1|||
48782974|NCT02246998|157046491|FG001|Overall Study|Lost to Follow-up|0|||
48782975|NCT02246998|157046492|FG002|Overall Study|Lost to Follow-up|0|||
48782976|NCT02246998|157046493|FG003|Overall Study|Lost to Follow-up|1|||
48782977|NCT02246998|157046490|FG000|Overall Study|Randomized but Never Dosed|1|||
48782978|NCT02246998|157046491|FG001|Overall Study|Randomized but Never Dosed|2|||
48782979|NCT02246998|157046492|FG002|Overall Study|Randomized but Never Dosed|2|||
48782980|NCT02246998|157046493|FG003|Overall Study|Randomized but Never Dosed|1|||
48782981|NCT01154166|157046495|FG000|Overall Study|Adverse Event|14|||
48782982|NCT01154166|157046496|FG001|Overall Study|Adverse Event|9|||
48782983|NCT01154166|157046495|FG000|Overall Study|Lost to Follow-up|1|||
48782984|NCT01154166|157046496|FG001|Overall Study|Lost to Follow-up|1|||
48782985|NCT01154166|157046495|FG000|Overall Study|Protocol Violation|4|||
48782986|NCT01154166|157046496|FG001|Overall Study|Protocol Violation|1|||
48782987|NCT01154166|157046495|FG000|Overall Study|Withdrawal by Subject|10|||
48782988|NCT01154166|157046496|FG001|Overall Study|Withdrawal by Subject|1|||
48782989|NCT01154166|157046495|FG000|Overall Study|Lack of Efficacy|3|||
48782990|NCT01154166|157046496|FG001|Overall Study|Lack of Efficacy|0|||
48782991|NCT01154166|157046495|FG000|Overall Study|Disease Progression|1|||
48782992|NCT01154166|157046496|FG001|Overall Study|Disease Progression|0|||
48782993|NCT01154166|157046495|FG000|Overall Study|Poor Compliance|1|||
48782994|NCT01154166|157046496|FG001|Overall Study|Poor Compliance|0|||
48782995|NCT04121962|157046497|FG000|Overall Study|Lost to Follow-up|42|||
48782996|NCT04121962|157046498|FG001|Overall Study|Lost to Follow-up|39|||
48982998|NCT03323086|157769957|FG000|Overall Study|Lost to Follow-up|3|||
48982999|NCT03323086|157769958|FG001|Overall Study|Lost to Follow-up|2|||
48983000|NCT03685643|157769959|FG000|Overall Study|Lost to Follow-up|14|||
48783000|NCT03701555|157046504|FG000|Part 2 (Day 1)|Lost to Follow-up|0|||
48783001|NCT03701555|157046505|FG001|Part 2 (Day 1)|Lost to Follow-up|0|||
48783002|NCT03701555|157046506|FG002|Part 2 (Day 1)|Lost to Follow-up|0|||
48783003|NCT03701555|157046507|FG003|Part 2 (Day 1)|Lost to Follow-up|0|||
48783004|NCT03701555|157046508|FG004|Part 2 (Day 1)|Lost to Follow-up|0|||
48783005|NCT03701555|157046509|FG005|Part 2 (Day 1)|Lost to Follow-up|0|||
48783006|NCT03701555|157046510|FG006|Part 2 (Day 1)|Lost to Follow-up|0|||
48783007|NCT03701555|157046511|FG007|Part 2 (Day 1)|Lost to Follow-up|0|||
48783008|NCT03701555|157046512|FG008|Part 2 (Day 1)|Lost to Follow-up|0|||
48783009|NCT03701555|157046513|FG009|Part 2 (Day 1)|Lost to Follow-up|0|||
48877485|NCT00634842|157390073|FG000|Overall Study|Physician Decision|1|||
48877486|NCT00634842|157390074|FG001|Overall Study|Physician Decision|0|||
48877487|NCT00634842|157390073|FG000|Overall Study|Withdrawal by Subject|1|||
48877488|NCT00634842|157390074|FG001|Overall Study|Withdrawal by Subject|3|||
48877489|NCT00634842|157390073|FG000|Overall Study|Lack of time and intolerance to drug|0|||
48877490|NCT00634842|157390074|FG001|Overall Study|Lack of time and intolerance to drug|1|||
48877491|NCT00634842|157390073|FG000|Overall Study|Discontinued due to injection|0|||
48877492|NCT00634842|157390074|FG001|Overall Study|Discontinued due to injection|2|||
48877493|NCT00634842|157390073|FG000|Overall Study|No need of study drug to treat diabetes|0|||
48877494|NCT00634842|157390074|FG001|Overall Study|No need of study drug to treat diabetes|1|||
48877495|NCT00634842|157390073|FG000|Overall Study|No wish to keep taking Avandia|0|||
48877496|NCT00634842|157390074|FG001|Overall Study|No wish to keep taking Avandia|1|||
48983001|NCT03685643|157769960|FG001|Overall Study|Lost to Follow-up|22|||
48783010|NCT03701555|157046514|FG010|Part 2 (Day 1)|Lost to Follow-up|0|||
48783011|NCT03701555|157046515|FG011|Part 2 (Day 1)|Lost to Follow-up|0|||
48983002|NCT01057394|157769961|FG000|Overall Study|Not eligible|0|||
48783012|NCT03701555|157046516|FG012|Part 2 (Day 1)|Lost to Follow-up|0|||
48783013|NCT03701555|157046517|FG013|Part 2 (Day 1)|Lost to Follow-up|0|||
48983003|NCT01057394|157769962|FG001|Overall Study|Not eligible|2|||
48983004|NCT01566981|157769965|FG000|Overall Study|Lost to Follow-up|5|||
48983005|NCT01566981|157769966|FG001|Overall Study|Lost to Follow-up|8|||
48983006|NCT00886587|157769967|FG000|Overall Study|Adverse Event|2|||
48983007|NCT00886587|157769968|FG001|Overall Study|Adverse Event|1|||
48983008|NCT00886587|157769967|FG000|Overall Study|Protocol Violation|2|||
48983009|NCT00886587|157769968|FG001|Overall Study|Protocol Violation|0|||
48983010|NCT00886587|157769967|FG000|Overall Study|Withdrawal by Subject|0|||
48983011|NCT00886587|157769968|FG001|Overall Study|Withdrawal by Subject|1|||
48983012|NCT01108068|157769969|FG000|Overall Study|5 not started, 1 stop due to side effect|6|||
49030406|NCT01204294|157946945|FG006|Overall Study|Protocol Violation|0|||
49030407|NCT01204294|157946939|FG000|Overall Study|Withdrawal by Subject|0|||
49030408|NCT01204294|157946940|FG001|Overall Study|Withdrawal by Subject|2|||
49030409|NCT01204294|157946941|FG002|Overall Study|Withdrawal by Subject|2|||
49030410|NCT01204294|157946942|FG003|Overall Study|Withdrawal by Subject|1|||
49030411|NCT01204294|157946943|FG004|Overall Study|Withdrawal by Subject|1|||
49030412|NCT01204294|157946944|FG005|Overall Study|Withdrawal by Subject|1|||
49030413|NCT01204294|157946945|FG006|Overall Study|Withdrawal by Subject|2|||
48783014|NCT03701555|157046518|FG014|Part 2 (Day 1)|Lost to Follow-up|0|||
48783015|NCT03701555|157046519|FG015|Part 2 (Day 1)|Lost to Follow-up|0|||
48783016|NCT03701555|157046520|FG016|Part 2 (Day 1)|Lost to Follow-up|0|||
49030414|NCT01204294|157946939|FG000|Overall Study|Lack of Efficacy|0|||
49030415|NCT01204294|157946940|FG001|Overall Study|Lack of Efficacy|0|||
48783017|NCT03701555|157046521|FG017|Part 2 (Day 1)|Lost to Follow-up|0|||
48783018|NCT03701555|157046522|FG018|Part 2 (Day 1)|Lost to Follow-up|0|||
48783019|NCT03701555|157046523|FG019|Part 2 (Day 1)|Lost to Follow-up|0|||
48783020|NCT03701555|157046524|FG020|Part 2 (Day 1)|Lost to Follow-up|0|||
48783021|NCT03701555|157046525|FG021|Part 2 (Day 1)|Lost to Follow-up|1|||
48783022|NCT03701555|157046526|FG022|Part 2 (Day 1)|Lost to Follow-up|0|||
48783023|NCT03701555|157046527|FG023|Part 2 (Day 1)|Lost to Follow-up|0|||
48783024|NCT03701555|157046528|FG024|Part 2 (Day 1)|Lost to Follow-up|0|||
49030416|NCT01204294|157946941|FG002|Overall Study|Lack of Efficacy|0|||
49030417|NCT01204294|157946942|FG003|Overall Study|Lack of Efficacy|2|||
49030418|NCT01204294|157946943|FG004|Overall Study|Lack of Efficacy|0|||
48783025|NCT03701555|157046529|FG025|Part 2 (Day 1)|Lost to Follow-up|0|||
48783026|NCT03701555|157046530|FG026|Part 2 (Day 1)|Lost to Follow-up|0|||
48783027|NCT03701555|157046531|FG027|Part 2 (Day 1)|Lost to Follow-up|0|||
48783028|NCT03701555|157046532|FG028|Part 2 (Day 1)|Lost to Follow-up|0|||
48783029|NCT03701555|157046533|FG029|Part 2 (Day 1)|Lost to Follow-up|0|||
48783030|NCT03701555|157046534|FG030|Part 2 (Day 1)|Lost to Follow-up|0|||
48783031|NCT03701555|157046535|FG031|Part 2 (Day 1)|Lost to Follow-up|0|||
48783032|NCT03701555|157046536|FG032|Part 2 (Day 1)|Lost to Follow-up|0|||
48783033|NCT03701555|157046537|FG033|Part 2 (Day 1)|Lost to Follow-up|0|||
48783034|NCT03701555|157046538|FG034|Part 2 (Day 1)|Lost to Follow-up|0|||
48783035|NCT03701555|157046539|FG035|Part 2 (Day 1)|Lost to Follow-up|0|||
48783036|NCT03701555|157046504|FG000|Part 2 (Day 1)|Subject Non-compliance|0|||
48783037|NCT03701555|157046505|FG001|Part 2 (Day 1)|Subject Non-compliance|0|||
48783038|NCT03701555|157046506|FG002|Part 2 (Day 1)|Subject Non-compliance|0|||
48783039|NCT03701555|157046507|FG003|Part 2 (Day 1)|Subject Non-compliance|0|||
48783040|NCT03701555|157046508|FG004|Part 2 (Day 1)|Subject Non-compliance|0|||
48783041|NCT03701555|157046509|FG005|Part 2 (Day 1)|Subject Non-compliance|0|||
48783042|NCT03701555|157046510|FG006|Part 2 (Day 1)|Subject Non-compliance|0|||
48783043|NCT03701555|157046511|FG007|Part 2 (Day 1)|Subject Non-compliance|0|||
48783044|NCT03701555|157046512|FG008|Part 2 (Day 1)|Subject Non-compliance|0|||
48783045|NCT03701555|157046513|FG009|Part 2 (Day 1)|Subject Non-compliance|0|||
48783046|NCT03701555|157046514|FG010|Part 2 (Day 1)|Subject Non-compliance|0|||
48783047|NCT03701555|157046515|FG011|Part 2 (Day 1)|Subject Non-compliance|0|||
48783048|NCT03701555|157046516|FG012|Part 2 (Day 1)|Subject Non-compliance|0|||
48877497|NCT00634842|157390073|FG000|Overall Study|Subject off study drug for too long|0|||
49030419|NCT01204294|157946944|FG005|Overall Study|Lack of Efficacy|0|||
49030420|NCT01204294|157946945|FG006|Overall Study|Lack of Efficacy|0|||
49030421|NCT01204294|157946939|FG000|Overall Study|Other (house moving)|0|||
49030422|NCT01204294|157946940|FG001|Overall Study|Other (house moving)|0|||
49030423|NCT01204294|157946941|FG002|Overall Study|Other (house moving)|1|||
48783049|NCT03701555|157046517|FG013|Part 2 (Day 1)|Subject Non-compliance|1|||
48783050|NCT03701555|157046518|FG014|Part 2 (Day 1)|Subject Non-compliance|0|||
48783051|NCT03701555|157046519|FG015|Part 2 (Day 1)|Subject Non-compliance|0|||
48783052|NCT03701555|157046520|FG016|Part 2 (Day 1)|Subject Non-compliance|1|||
48783053|NCT03701555|157046521|FG017|Part 2 (Day 1)|Subject Non-compliance|2|||
48783054|NCT03701555|157046522|FG018|Part 2 (Day 1)|Subject Non-compliance|0|||
48783055|NCT03701555|157046523|FG019|Part 2 (Day 1)|Subject Non-compliance|0|||
48783056|NCT03701555|157046524|FG020|Part 2 (Day 1)|Subject Non-compliance|0|||
48877498|NCT00634842|157390074|FG001|Overall Study|Subject off study drug for too long|1|||
48877499|NCT00543062|157390075|FG000|Overall Study|Withdrawal by Subject|1|||
48877500|NCT00543062|157390076|FG001|Overall Study|Withdrawal by Subject|0|||
48877501|NCT00543062|157390077|FG002|Overall Study|Withdrawal by Subject|2|||
48877502|NCT00543062|157390078|FG003|Overall Study|Withdrawal by Subject|0|||
48877503|NCT00543062|157390075|FG000|Overall Study|Adverse Event|0|||
48877504|NCT00543062|157390076|FG001|Overall Study|Adverse Event|1|||
49030424|NCT01204294|157946942|FG003|Overall Study|Other (house moving)|0|||
49030425|NCT01204294|157946943|FG004|Overall Study|Other (house moving)|0|||
48783057|NCT03701555|157046525|FG021|Part 2 (Day 1)|Subject Non-compliance|0|||
48783058|NCT03701555|157046526|FG022|Part 2 (Day 1)|Subject Non-compliance|0|||
48783059|NCT03701555|157046527|FG023|Part 2 (Day 1)|Subject Non-compliance|1|||
48783060|NCT03701555|157046528|FG024|Part 2 (Day 1)|Subject Non-compliance|0|||
48783061|NCT03701555|157046529|FG025|Part 2 (Day 1)|Subject Non-compliance|0|||
48783062|NCT03701555|157046530|FG026|Part 2 (Day 1)|Subject Non-compliance|0|||
48783063|NCT03701555|157046531|FG027|Part 2 (Day 1)|Subject Non-compliance|0|||
48783064|NCT03701555|157046532|FG028|Part 2 (Day 1)|Subject Non-compliance|0|||
48783065|NCT03701555|157046533|FG029|Part 2 (Day 1)|Subject Non-compliance|0|||
48783066|NCT03701555|157046534|FG030|Part 2 (Day 1)|Subject Non-compliance|0|||
48783067|NCT03701555|157046535|FG031|Part 2 (Day 1)|Subject Non-compliance|0|||
48783068|NCT03701555|157046536|FG032|Part 2 (Day 1)|Subject Non-compliance|0|||
48783069|NCT03701555|157046537|FG033|Part 2 (Day 1)|Subject Non-compliance|0|||
48783070|NCT03701555|157046538|FG034|Part 2 (Day 1)|Subject Non-compliance|0|||
48783071|NCT03701555|157046539|FG035|Part 2 (Day 1)|Subject Non-compliance|0|||
48783072|NCT03701555|157046504|FG000|Part 2 (Day 1)|Other|0|||
48783073|NCT03701555|157046505|FG001|Part 2 (Day 1)|Other|0|||
48783074|NCT03701555|157046506|FG002|Part 2 (Day 1)|Other|0|||
48783075|NCT03701555|157046507|FG003|Part 2 (Day 1)|Other|0|||
48783076|NCT03701555|157046508|FG004|Part 2 (Day 1)|Other|0|||
48783077|NCT03701555|157046509|FG005|Part 2 (Day 1)|Other|0|||
48783078|NCT03701555|157046510|FG006|Part 2 (Day 1)|Other|0|||
48783079|NCT03701555|157046511|FG007|Part 2 (Day 1)|Other|0|||
48783080|NCT03701555|157046512|FG008|Part 2 (Day 1)|Other|0|||
48783081|NCT03701555|157046513|FG009|Part 2 (Day 1)|Other|0|||
48783082|NCT03701555|157046514|FG010|Part 2 (Day 1)|Other|3|||
48783083|NCT03701555|157046515|FG011|Part 2 (Day 1)|Other|1|||
48783084|NCT03701555|157046516|FG012|Part 2 (Day 1)|Other|0|||
48783085|NCT03701555|157046517|FG013|Part 2 (Day 1)|Other|1|||
48783086|NCT03701555|157046518|FG014|Part 2 (Day 1)|Other|0|||
48783087|NCT03701555|157046519|FG015|Part 2 (Day 1)|Other|2|||
48783088|NCT03701555|157046520|FG016|Part 2 (Day 1)|Other|2|||
48783089|NCT03701555|157046521|FG017|Part 2 (Day 1)|Other|0|||
48783090|NCT03701555|157046522|FG018|Part 2 (Day 1)|Other|0|||
48783091|NCT03701555|157046523|FG019|Part 2 (Day 1)|Other|0|||
48783092|NCT03701555|157046524|FG020|Part 2 (Day 1)|Other|0|||
48783093|NCT03701555|157046525|FG021|Part 2 (Day 1)|Other|0|||
48783094|NCT03701555|157046526|FG022|Part 2 (Day 1)|Other|0|||
48783095|NCT03701555|157046527|FG023|Part 2 (Day 1)|Other|0|||
48783096|NCT03701555|157046528|FG024|Part 2 (Day 1)|Other|0|||
48783097|NCT03701555|157046529|FG025|Part 2 (Day 1)|Other|0|||
48783098|NCT03701555|157046530|FG026|Part 2 (Day 1)|Other|0|||
48783099|NCT03701555|157046531|FG027|Part 2 (Day 1)|Other|0|||
48783100|NCT03701555|157046532|FG028|Part 2 (Day 1)|Other|0|||
48783101|NCT03701555|157046533|FG029|Part 2 (Day 1)|Other|0|||
48783102|NCT03701555|157046534|FG030|Part 2 (Day 1)|Other|0|||
48783103|NCT03701555|157046535|FG031|Part 2 (Day 1)|Other|0|||
48783104|NCT03701555|157046536|FG032|Part 2 (Day 1)|Other|0|||
48783105|NCT03701555|157046537|FG033|Part 2 (Day 1)|Other|0|||
48783106|NCT03701555|157046538|FG034|Part 2 (Day 1)|Other|0|||
48783107|NCT03701555|157046539|FG035|Part 2 (Day 1)|Other|0|||
48783108|NCT03701555|157046504|FG000|Part 3 (Day 1)|Subject Non-compliance|0|||
48783109|NCT03701555|157046505|FG001|Part 3 (Day 1)|Subject Non-compliance|0|||
48783110|NCT03701555|157046506|FG002|Part 3 (Day 1)|Subject Non-compliance|0|||
48783111|NCT03701555|157046507|FG003|Part 3 (Day 1)|Subject Non-compliance|0|||
49030426|NCT01204294|157946944|FG005|Overall Study|Other (house moving)|0|||
49030427|NCT01204294|157946945|FG006|Overall Study|Other (house moving)|0|||
49030428|NCT01792635|157946954|FG000|Part B|Adverse Event|0|||
49030429|NCT01792635|157946955|FG001|Part B|Adverse Event|0|||
49030430|NCT01792635|157946956|FG002|Part B|Adverse Event|1|||
49030431|NCT01792635|157946954|FG000|Part B|Study terminated|0|||
49030432|NCT01792635|157946955|FG001|Part B|Study terminated|4|||
49030433|NCT01792635|157946956|FG002|Part B|Study terminated|3|||
49030434|NCT01667679|157946961|FG000|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2|||
49030435|NCT01667679|157946962|FG001|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6|||
49030436|NCT01667679|157946961|FG000|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2|||
49030437|NCT01667679|157946962|FG001|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0|||
49030438|NCT01667679|157946961|FG000|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2|||
49030439|NCT01667679|157946962|FG001|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0|||
48783112|NCT03701555|157046508|FG004|Part 3 (Day 1)|Subject Non-compliance|0|||
48783113|NCT03701555|157046509|FG005|Part 3 (Day 1)|Subject Non-compliance|0|||
48783114|NCT03701555|157046510|FG006|Part 3 (Day 1)|Subject Non-compliance|0|||
48783115|NCT03701555|157046511|FG007|Part 3 (Day 1)|Subject Non-compliance|0|||
48783116|NCT03701555|157046512|FG008|Part 3 (Day 1)|Subject Non-compliance|0|||
48783117|NCT03701555|157046513|FG009|Part 3 (Day 1)|Subject Non-compliance|0|||
48783118|NCT03701555|157046514|FG010|Part 3 (Day 1)|Subject Non-compliance|0|||
48783119|NCT03701555|157046515|FG011|Part 3 (Day 1)|Subject Non-compliance|0|||
48783120|NCT03701555|157046516|FG012|Part 3 (Day 1)|Subject Non-compliance|0|||
48783121|NCT03701555|157046517|FG013|Part 3 (Day 1)|Subject Non-compliance|0|||
48783122|NCT03701555|157046518|FG014|Part 3 (Day 1)|Subject Non-compliance|0|||
48783123|NCT03701555|157046519|FG015|Part 3 (Day 1)|Subject Non-compliance|0|||
48783124|NCT03701555|157046520|FG016|Part 3 (Day 1)|Subject Non-compliance|0|||
48783125|NCT03701555|157046521|FG017|Part 3 (Day 1)|Subject Non-compliance|0|||
48783126|NCT03701555|157046522|FG018|Part 3 (Day 1)|Subject Non-compliance|0|||
48783127|NCT03701555|157046523|FG019|Part 3 (Day 1)|Subject Non-compliance|0|||
48877505|NCT00543062|157390077|FG002|Overall Study|Adverse Event|1|||
48783128|NCT03701555|157046524|FG020|Part 3 (Day 1)|Subject Non-compliance|0|||
48783129|NCT03701555|157046525|FG021|Part 3 (Day 1)|Subject Non-compliance|0|||
48783130|NCT03701555|157046526|FG022|Part 3 (Day 1)|Subject Non-compliance|0|||
48783131|NCT03701555|157046527|FG023|Part 3 (Day 1)|Subject Non-compliance|0|||
48783132|NCT03701555|157046528|FG024|Part 3 (Day 1)|Subject Non-compliance|0|||
48783133|NCT03701555|157046529|FG025|Part 3 (Day 1)|Subject Non-compliance|0|||
48783134|NCT03701555|157046530|FG026|Part 3 (Day 1)|Subject Non-compliance|0|||
48783135|NCT03701555|157046531|FG027|Part 3 (Day 1)|Subject Non-compliance|0|||
48783136|NCT03701555|157046532|FG028|Part 3 (Day 1)|Subject Non-compliance|0|||
48783137|NCT03701555|157046533|FG029|Part 3 (Day 1)|Subject Non-compliance|1|||
48783138|NCT03701555|157046534|FG030|Part 3 (Day 1)|Subject Non-compliance|0|||
48783139|NCT03701555|157046535|FG031|Part 3 (Day 1)|Subject Non-compliance|1|||
48783140|NCT03701555|157046536|FG032|Part 3 (Day 1)|Subject Non-compliance|0|||
48783141|NCT03701555|157046537|FG033|Part 3 (Day 1)|Subject Non-compliance|0|||
48783142|NCT03701555|157046538|FG034|Part 3 (Day 1)|Subject Non-compliance|0|||
48783143|NCT03701555|157046539|FG035|Part 3 (Day 1)|Subject Non-compliance|0|||
48783144|NCT03701555|157046504|FG000|Part 3 (Day 1)|Subject Decision|0|||
48783145|NCT03701555|157046505|FG001|Part 3 (Day 1)|Subject Decision|0|||
48783146|NCT03701555|157046506|FG002|Part 3 (Day 1)|Subject Decision|0|||
48783147|NCT03701555|157046507|FG003|Part 3 (Day 1)|Subject Decision|0|||
48783148|NCT03701555|157046508|FG004|Part 3 (Day 1)|Subject Decision|0|||
48783149|NCT03701555|157046509|FG005|Part 3 (Day 1)|Subject Decision|0|||
48783150|NCT03701555|157046510|FG006|Part 3 (Day 1)|Subject Decision|0|||
48783151|NCT03701555|157046511|FG007|Part 3 (Day 1)|Subject Decision|0|||
48783152|NCT03701555|157046512|FG008|Part 3 (Day 1)|Subject Decision|0|||
48783153|NCT03701555|157046513|FG009|Part 3 (Day 1)|Subject Decision|0|||
48783154|NCT03701555|157046514|FG010|Part 3 (Day 1)|Subject Decision|0|||
48783155|NCT03701555|157046515|FG011|Part 3 (Day 1)|Subject Decision|0|||
48783156|NCT03701555|157046516|FG012|Part 3 (Day 1)|Subject Decision|0|||
48783157|NCT03701555|157046517|FG013|Part 3 (Day 1)|Subject Decision|0|||
48783158|NCT03701555|157046518|FG014|Part 3 (Day 1)|Subject Decision|0|||
48783159|NCT03701555|157046519|FG015|Part 3 (Day 1)|Subject Decision|0|||
49030440|NCT01667679|157946961|FG000|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1|||
48783160|NCT03701555|157046520|FG016|Part 3 (Day 1)|Subject Decision|0|||
48783161|NCT03701555|157046521|FG017|Part 3 (Day 1)|Subject Decision|0|||
49030441|NCT01667679|157946962|FG001|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0|||
48783162|NCT03701555|157046522|FG018|Part 3 (Day 1)|Subject Decision|0|||
48783163|NCT03701555|157046523|FG019|Part 3 (Day 1)|Subject Decision|0|||
48783164|NCT03701555|157046524|FG020|Part 3 (Day 1)|Subject Decision|0|||
48783165|NCT03701555|157046525|FG021|Part 3 (Day 1)|Subject Decision|0|||
48783166|NCT03701555|157046526|FG022|Part 3 (Day 1)|Subject Decision|0|||
48783167|NCT03701555|157046527|FG023|Part 3 (Day 1)|Subject Decision|0|||
48783168|NCT03701555|157046528|FG024|Part 3 (Day 1)|Subject Decision|0|||
48783169|NCT03701555|157046529|FG025|Part 3 (Day 1)|Subject Decision|0|||
48783170|NCT03701555|157046530|FG026|Part 3 (Day 1)|Subject Decision|1|||
48783171|NCT03701555|157046531|FG027|Part 3 (Day 1)|Subject Decision|0|||
48783172|NCT03701555|157046532|FG028|Part 3 (Day 1)|Subject Decision|0|||
48783173|NCT03701555|157046533|FG029|Part 3 (Day 1)|Subject Decision|0|||
48783174|NCT03701555|157046534|FG030|Part 3 (Day 1)|Subject Decision|0|||
48783175|NCT03701555|157046535|FG031|Part 3 (Day 1)|Subject Decision|2|||
48783176|NCT03701555|157046536|FG032|Part 3 (Day 1)|Subject Decision|1|||
48783177|NCT03701555|157046537|FG033|Part 3 (Day 1)|Subject Decision|1|||
48783178|NCT03701555|157046538|FG034|Part 3 (Day 1)|Subject Decision|0|||
48783179|NCT03701555|157046539|FG035|Part 3 (Day 1)|Subject Decision|0|||
48783180|NCT03701555|157046504|FG000|Part 3 (Day 1)|Other|0|||
48783181|NCT03701555|157046505|FG001|Part 3 (Day 1)|Other|0|||
48783182|NCT03701555|157046506|FG002|Part 3 (Day 1)|Other|0|||
48783183|NCT03701555|157046507|FG003|Part 3 (Day 1)|Other|0|||
48783184|NCT03701555|157046508|FG004|Part 3 (Day 1)|Other|0|||
48783185|NCT03701555|157046509|FG005|Part 3 (Day 1)|Other|0|||
48783186|NCT03701555|157046510|FG006|Part 3 (Day 1)|Other|0|||
48783187|NCT03701555|157046511|FG007|Part 3 (Day 1)|Other|0|||
48783188|NCT03701555|157046512|FG008|Part 3 (Day 1)|Other|0|||
48783189|NCT03701555|157046513|FG009|Part 3 (Day 1)|Other|0|||
48783190|NCT03701555|157046514|FG010|Part 3 (Day 1)|Other|0|||
49030442|NCT01667679|157946961|FG000|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6|||
48783191|NCT03701555|157046515|FG011|Part 3 (Day 1)|Other|0|||
48783192|NCT03701555|157046516|FG012|Part 3 (Day 1)|Other|0|||
48783193|NCT03701555|157046517|FG013|Part 3 (Day 1)|Other|0|||
48783194|NCT03701555|157046518|FG014|Part 3 (Day 1)|Other|0|||
48783195|NCT03701555|157046519|FG015|Part 3 (Day 1)|Other|0|||
48783196|NCT03701555|157046520|FG016|Part 3 (Day 1)|Other|0|||
48783197|NCT03701555|157046521|FG017|Part 3 (Day 1)|Other|0|||
48783198|NCT03701555|157046522|FG018|Part 3 (Day 1)|Other|0|||
48783199|NCT03701555|157046523|FG019|Part 3 (Day 1)|Other|0|||
48783200|NCT03701555|157046524|FG020|Part 3 (Day 1)|Other|0|||
48783201|NCT03701555|157046525|FG021|Part 3 (Day 1)|Other|0|||
48783202|NCT03701555|157046526|FG022|Part 3 (Day 1)|Other|0|||
48783203|NCT03701555|157046527|FG023|Part 3 (Day 1)|Other|0|||
48783204|NCT03701555|157046528|FG024|Part 3 (Day 1)|Other|1|||
48783205|NCT03701555|157046529|FG025|Part 3 (Day 1)|Other|1|||
48783206|NCT03701555|157046530|FG026|Part 3 (Day 1)|Other|0|||
48783207|NCT03701555|157046531|FG027|Part 3 (Day 1)|Other|0|||
48783208|NCT03701555|157046532|FG028|Part 3 (Day 1)|Other|0|||
48783209|NCT03701555|157046533|FG029|Part 3 (Day 1)|Other|1|||
48783210|NCT03701555|157046534|FG030|Part 3 (Day 1)|Other|1|||
48783211|NCT03701555|157046535|FG031|Part 3 (Day 1)|Other|0|||
48783212|NCT03701555|157046536|FG032|Part 3 (Day 1)|Other|1|||
48783213|NCT03701555|157046537|FG033|Part 3 (Day 1)|Other|1|||
48783214|NCT03701555|157046538|FG034|Part 3 (Day 1)|Other|0|||
48783215|NCT03701555|157046539|FG035|Part 3 (Day 1)|Other|0|||
48783216|NCT04757649|157046540|FG000|Overall Study|Withdrawal by Subject|1|||
48783217|NCT04757649|157046540|FG000|Overall Study|Adverse Event|1|||
48783218|NCT00795600|157046541|FG000|Overall Study|Adverse Event|1|||
48783219|NCT00795600|157046542|FG001|Overall Study|Adverse Event|1|||
48783220|NCT00795600|157046541|FG000|Overall Study|Protocol Violation|1|||
48783221|NCT00795600|157046542|FG001|Overall Study|Protocol Violation|2|||
48783222|NCT00795600|157046541|FG000|Overall Study|Withdrawal by Subject|1|||
48783223|NCT00795600|157046542|FG001|Overall Study|Withdrawal by Subject|0|||
48783224|NCT00795600|157046541|FG000|Overall Study|Unclassified|1|||
48783225|NCT00795600|157046542|FG001|Overall Study|Unclassified|1|||
48783226|NCT01286779|157046543|FG000|Overall Study|Withdrawal by Subject|9|||
48783227|NCT01286779|157046543|FG000|Overall Study|Protocol Violation|5|||
48783228|NCT01286779|157046543|FG000|Overall Study|Physician Decision|2|||
48783229|NCT01286779|157046543|FG000|Overall Study|Participant had scheduled surgery|1|||
48783230|NCT01286779|157046543|FG000|Overall Study|Participant moved to another country|1|||
48783231|NCT01286779|157046543|FG000|Overall Study|Discontinued by sponsor|1|||
48783232|NCT01255358|157046549|FG000|Overall Study|Adverse Event|2|||
48783233|NCT01255358|157046549|FG000|Overall Study|Protocol Violation|2|||
48783234|NCT04798781|157046550|FG000|Overall Study|Withdrawal by Subject|1|||
48783235|NCT01046643|157046551|FG000|First Period Treatment or Placebo|Withdrawal by Subject|0|||
48783236|NCT01046643|157046552|FG001|First Period Treatment or Placebo|Withdrawal by Subject|1|||
48783237|NCT01046643|157046553|FG002|First Period Treatment or Placebo|Withdrawal by Subject|0|||
48783238|NCT01046643|157046554|FG003|First Period Treatment or Placebo|Withdrawal by Subject|0|||
48783239|NCT02802345|157046555|FG000|Overall Study|Not Treated|0|||
48783240|NCT02802345|157046556|FG001|Overall Study|Not Treated|1|||
48783241|NCT02802345|157046555|FG000|Overall Study|Adverse Event|28|||
48783242|NCT02802345|157046556|FG001|Overall Study|Adverse Event|20|||
48783243|NCT02802345|157046555|FG000|Overall Study|Withdrawal by Subject|3|||
48783244|NCT02802345|157046556|FG001|Overall Study|Withdrawal by Subject|3|||
48783245|NCT02802345|157046555|FG000|Overall Study|Protocol Violation|0|||
48783246|NCT02802345|157046556|FG001|Overall Study|Protocol Violation|1|||
48783247|NCT02802345|157046555|FG000|Overall Study|Other than listed|1|||
48783248|NCT02802345|157046556|FG001|Overall Study|Other than listed|5|||
49030443|NCT01667679|157946962|FG001|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13|||
49030444|NCT01667679|157946961|FG000|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
49030445|NCT01667679|157946962|FG001|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
49030446|NCT01667679|157946961|FG000|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0|||
49030447|NCT01667679|157946962|FG001|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2|||
49030448|NCT01667679|157946961|FG000|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0|||
48783249|NCT00022516|157046557|FG000|Overall Study|Adverse Event|0|||
48783250|NCT00022516|157046558|FG001|Overall Study|Adverse Event|59|||
49030449|NCT01667679|157946962|FG001|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2|||
49030450|NCT01667679|157946961|FG000|Treatment Period 1 (<=12 Weeks)|Non-compliance|0|||
49030451|NCT01667679|157946962|FG001|Treatment Period 1 (<=12 Weeks)|Non-compliance|3|||
49030452|NCT01667679|157946961|FG000|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0|||
49030453|NCT01667679|157946962|FG001|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1|||
49030454|NCT01667679|157946961|FG000|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6|||
49030455|NCT01667679|157946962|FG001|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4|||
49030456|NCT01667679|157946961|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2|||
49030457|NCT01667679|157946962|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0|||
49030458|NCT01667679|157946961|FG000|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8|||
49030459|NCT01667679|157946962|FG001|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10|||
49030460|NCT01667679|157946961|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance|3|||
49030461|NCT01667679|157946962|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance|4|||
48783251|NCT00022516|157046557|FG000|Overall Study|Lack of Efficacy|0|||
49030462|NCT01667679|157946961|FG000|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1|||
48783252|NCT00022516|157046558|FG001|Overall Study|Lack of Efficacy|27|||
48783253|NCT00022516|157046557|FG000|Overall Study|Physician Decision|0|||
48783254|NCT00022516|157046558|FG001|Overall Study|Physician Decision|1|||
48783255|NCT00022516|157046557|FG000|Overall Study|Protocol Violation|1|||
48877506|NCT00543062|157390078|FG003|Overall Study|Adverse Event|1|||
48783256|NCT00022516|157046558|FG001|Overall Study|Protocol Violation|3|||
48783257|NCT00022516|157046557|FG000|Overall Study|Withdrawal by Subject|2|||
48783258|NCT00022516|157046558|FG001|Overall Study|Withdrawal by Subject|113|||
48783259|NCT00022516|157046557|FG000|Overall Study|Incomplete documentation|0|||
48783260|NCT00022516|157046558|FG001|Overall Study|Incomplete documentation|27|||
48783261|NCT03783923|157046564|FG000|Placebo-Controlled Period (26 Weeks)|Study Terminated|3|||
48783262|NCT03783923|157046565|FG001|Placebo-Controlled Period (26 Weeks)|Study Terminated|2|||
48783263|NCT03783923|157046564|FG000|Placebo-Controlled Period (26 Weeks)|Adverse Event|1|||
48783264|NCT03783923|157046565|FG001|Placebo-Controlled Period (26 Weeks)|Adverse Event|0|||
48783265|NCT03783923|157046564|FG000|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
48783266|NCT03783923|157046565|FG001|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
48783267|NCT03783923|157046564|FG000|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
48783268|NCT03783923|157046565|FG001|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
48783269|NCT03783923|157046564|FG000|Open-Label Extension (26 Weeks)|Study Terminated|0|||
48783270|NCT03783923|157046565|FG001|Open-Label Extension (26 Weeks)|Study Terminated|1|||
48783271|NCT01592708|157046568|FG000|Overall Study|Protocol Violation|3|||
48783272|NCT01592708|157046569|FG001|Overall Study|Protocol Violation|0|||
48783273|NCT00856583|157046570|FG000|Overall Study|Lack of Efficacy|389|||
48783274|NCT00856583|157046571|FG001|Overall Study|Lack of Efficacy|377|||
48783275|NCT00856583|157046570|FG000|Overall Study|Serious Adverse Event (SAE)|99|||
48783276|NCT00856583|157046571|FG001|Overall Study|Serious Adverse Event (SAE)|65|||
48783277|NCT00856583|157046570|FG000|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393|||
48783278|NCT00856583|157046571|FG001|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179|||
48783279|NCT00856583|157046570|FG000|Overall Study|Non-compliance|305|||
48783280|NCT00856583|157046571|FG001|Overall Study|Non-compliance|262|||
48783281|NCT00856583|157046570|FG000|Overall Study|Withdrawal by Subject|1092|||
48783282|NCT00856583|157046571|FG001|Overall Study|Withdrawal by Subject|919|||
48783283|NCT00856583|157046570|FG000|Overall Study|Physician Decision|59|||
48783284|NCT00856583|157046571|FG001|Overall Study|Physician Decision|82|||
48783285|NCT00856583|157046570|FG000|Overall Study|Pregnancy|14|||
48783286|NCT00856583|157046571|FG001|Overall Study|Pregnancy|5|||
48783287|NCT00856583|157046570|FG000|Overall Study|Other|92|||
48783288|NCT00856583|157046571|FG001|Overall Study|Other|104|||
48783289|NCT00856583|157046570|FG000|Overall Study|Non-evaluable: Patient on Polytherapy|694|||
48783290|NCT00856583|157046571|FG001|Overall Study|Non-evaluable: Patient on Polytherapy|604|||
49030463|NCT01667679|157946962|FG001|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0|||
49030464|NCT01667679|157946961|FG000|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1|||
49030465|NCT01667679|157946962|FG001|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0|||
49030466|NCT01667679|157946961|FG000|Treatment Period 2 (<=12 Weeks)|Adverse Event|1|||
49030467|NCT01667679|157946962|FG001|Treatment Period 2 (<=12 Weeks)|Adverse Event|0|||
49030468|NCT01667679|157946961|FG000|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0|||
49030469|NCT01667679|157946962|FG001|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1|||
49030470|NCT01667679|157946961|FG000|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0|||
49030471|NCT01667679|157946962|FG001|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1|||
49030472|NCT01667679|157946961|FG000|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0|||
49030473|NCT01667679|157946962|FG001|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1|||
49030474|NCT01667679|157946961|FG000|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0|||
49030475|NCT01667679|157946962|FG001|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1|||
49030476|NCT02159183|157946966|FG000|Analysis After the 36 Months Follow-up|Protocol Violation|2|||
49030477|NCT02159183|157946967|FG001|Analysis After the 36 Months Follow-up|Protocol Violation|1|||
49030478|NCT02159183|157946966|FG000|Analysis After the 36 Months Follow-up|Adverse Event|1|||
49030479|NCT02159183|157946967|FG001|Analysis After the 36 Months Follow-up|Adverse Event|0|||
49030480|NCT02159183|157946966|FG000|Analysis After the 36 Months Follow-up|Death|0|||
49030481|NCT02159183|157946967|FG001|Analysis After the 36 Months Follow-up|Death|1|||
49030482|NCT02159183|157946966|FG000|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1|||
49030483|NCT02159183|157946967|FG001|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0|||
49030484|NCT02159183|157946966|FG000|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2|||
49030485|NCT02159183|157946967|FG001|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1|||
49030486|NCT00986245|157946968|FG000|First Intervention|Poor compliance|8|||
49030487|NCT00986245|157946969|FG001|First Intervention|Poor compliance|4|||
49030488|NCT00986245|157946968|FG000|First Intervention|Lack of Efficacy|1|||
49030489|NCT00986245|157946969|FG001|First Intervention|Lack of Efficacy|2|||
49030490|NCT00986245|157946968|FG000|First Intervention|Withdrawal by Subject|0|||
49030491|NCT00986245|157946969|FG001|First Intervention|Withdrawal by Subject|1|||
49030492|NCT00986245|157946968|FG000|First Intervention|Protocol Violation|0|||
48783291|NCT03694548|157046579|FG000|Part A Survey|Protocol Violation|3|||
48783292|NCT03694548|157046580|FG001|Part A Survey|Protocol Violation|3|||
48783293|NCT03694548|157046581|FG002|Part A Survey|Protocol Violation|0|||
48783294|NCT03694548|157046579|FG000|Part B Yoga Program|Protocol Violation|0|||
48783295|NCT03694548|157046580|FG001|Part B Yoga Program|Protocol Violation|0|||
49030493|NCT00986245|157946969|FG001|First Intervention|Protocol Violation|1|||
49030494|NCT00986245|157946968|FG000|First Intervention|Out of indication|1|||
48783296|NCT03694548|157046581|FG002|Part B Yoga Program|Protocol Violation|3|||
48783297|NCT03694548|157046579|FG000|Part B Yoga Program|Did not attend intervention|0|||
49030495|NCT00986245|157946969|FG001|First Intervention|Out of indication|0|||
49030496|NCT00986245|157946968|FG000|Second Intervention|Poor compliance|1|||
48783298|NCT03694548|157046580|FG001|Part B Yoga Program|Did not attend intervention|0|||
48783299|NCT03694548|157046581|FG002|Part B Yoga Program|Did not attend intervention|8|||
48783300|NCT04102501|157046582|FG000|Overall Study|Withdrawal by Subject|7|||
48783301|NCT04102501|157046583|FG001|Overall Study|Withdrawal by Subject|9|||
48783302|NCT04102501|157046582|FG000|Overall Study|Adverse Event|1|||
48783303|NCT04102501|157046583|FG001|Overall Study|Adverse Event|3|||
48783304|NCT04433767|157046586|FG000|Overall Study|Adverse Event|1|||
48783305|NCT00759109|157046587|FG000|Overall Study|Adverse Event|17|||
49030497|NCT00986245|157946969|FG001|Second Intervention|Poor compliance|0|||
48783306|NCT00759109|157046588|FG001|Overall Study|Adverse Event|12|||
48783307|NCT00759109|157046587|FG000|Overall Study|Inability to comply|1|||
48783308|NCT00759109|157046588|FG001|Overall Study|Inability to comply|1|||
48783309|NCT00759109|157046587|FG000|Overall Study|Withdrawal by Subject|9|||
48783310|NCT00759109|157046588|FG001|Overall Study|Withdrawal by Subject|5|||
48783311|NCT00759109|157046587|FG000|Overall Study|Death|4|||
48783312|NCT00759109|157046588|FG001|Overall Study|Death|3|||
48783313|NCT00759109|157046587|FG000|Overall Study|Lost to Follow-up|4|||
48783314|NCT00759109|157046588|FG001|Overall Study|Lost to Follow-up|6|||
48783315|NCT00759109|157046587|FG000|Overall Study|Started new therapy|2|||
48783316|NCT00759109|157046588|FG001|Overall Study|Started new therapy|6|||
48783317|NCT00759109|157046587|FG000|Overall Study|HCV RNA negative|1|||
48783318|NCT00759109|157046588|FG001|Overall Study|HCV RNA negative|0|||
48783319|NCT00759109|157046587|FG000|Overall Study|Participant moved to a different city|0|||
48783320|NCT00759109|157046588|FG001|Overall Study|Participant moved to a different city|1|||
48783321|NCT00759109|157046587|FG000|Overall Study|Participant had a liver transplant|0|||
48783322|NCT00759109|157046588|FG001|Overall Study|Participant had a liver transplant|1|||
48783323|NCT00759109|157046587|FG000|Overall Study|Lost during study|1|||
48783324|NCT00759109|157046588|FG001|Overall Study|Lost during study|0|||
48783325|NCT03165045|157046589|FG000|Visit 1|No registration after visit 1|9|||
48783326|NCT03165045|157046589|FG000|Visit 1|No treatment documented|10|||
48783327|NCT03165045|157046589|FG000|Visit 1|No visit 1|10|||
48783328|NCT03165045|157046589|FG000|Visit 2|Available CCQ score at visit 1 only|109|||
48783329|NCT03165045|157046589|FG000|Visit 2|No available total CCQ score at all|29|||
48783330|NCT03165045|157046589|FG000|Visit 2|Available total CCQ score at vist 2 only|44|||
48783331|NCT03588572|157046590|FG000|Visitation 1|Lack of Efficacy|1|||
48783332|NCT03588572|157046591|FG001|Visitation 1|Lack of Efficacy|1|||
48783333|NCT03588572|157046590|FG000|Visitation 2|Lost to Follow-up|1|||
48783334|NCT03588572|157046591|FG001|Visitation 2|Lost to Follow-up|1|||
48783335|NCT03588572|157046590|FG000|Visitation 2|Lack of Efficacy|0|||
48783336|NCT03588572|157046591|FG001|Visitation 2|Lack of Efficacy|1|||
48783337|NCT03588572|157046590|FG000|Visitation 2|Withdrawal by Subject|1|||
48783338|NCT03588572|157046591|FG001|Visitation 2|Withdrawal by Subject|0|||
48783339|NCT03588572|157046590|FG000|Visitation 3|Lost to Follow-up|1|||
48783340|NCT03588572|157046591|FG001|Visitation 3|Lost to Follow-up|1|||
48783341|NCT03588572|157046590|FG000|Visitation 3|Physician Decision|1|||
49030498|NCT00986245|157946968|FG000|Second Intervention|Lost to Follow-up|1|||
49030499|NCT00986245|157946969|FG001|Second Intervention|Lost to Follow-up|0|||
49030500|NCT00986245|157946968|FG000|Second Intervention|Protocol Violation|0|||
49030501|NCT00986245|157946969|FG001|Second Intervention|Protocol Violation|1|||
49030502|NCT02453386|157946973|FG000|Overall Study|Adverse Event|22|||
49030503|NCT02453386|157946974|FG001|Overall Study|Adverse Event|30|||
49030504|NCT02453386|157946975|FG002|Overall Study|Adverse Event|15|||
49030505|NCT02453386|157946973|FG000|Overall Study|Protocol Violation|1|||
49030506|NCT02453386|157946974|FG001|Overall Study|Protocol Violation|0|||
49030507|NCT02453386|157946975|FG002|Overall Study|Protocol Violation|1|||
49030508|NCT02453386|157946973|FG000|Overall Study|Withdrawal by Subject|10|||
49030509|NCT02453386|157946974|FG001|Overall Study|Withdrawal by Subject|9|||
48783342|NCT03588572|157046591|FG001|Visitation 3|Physician Decision|1|||
48783343|NCT03588572|157046590|FG000|Visitation 3|Withdrawal by Subject|1|||
48783344|NCT03588572|157046591|FG001|Visitation 3|Withdrawal by Subject|0|||
48783345|NCT04602624|157046594|FG000|Overall Study|Protocol Deviation|1|||
48783346|NCT04602624|157046594|FG000|Overall Study|Withdrawal by Participant|1|||
48783347|NCT00464542|157048156|FG000|Pre-treatment|Withdrawal by Subject|2|||
48783348|NCT01610700|157048157|FG000|Overall Study|Adverse Event|3|||
49030510|NCT02453386|157946975|FG002|Overall Study|Withdrawal by Subject|9|||
49030511|NCT02453386|157946973|FG000|Overall Study|Sponsor Terminated Study|14|||
49030512|NCT02453386|157946974|FG001|Overall Study|Sponsor Terminated Study|8|||
48783349|NCT01610700|157048158|FG001|Overall Study|Adverse Event|1|||
48783350|NCT01610700|157048157|FG000|Overall Study|Withdrawal by Subject|0|||
48783351|NCT01610700|157048158|FG001|Overall Study|Withdrawal by Subject|1|||
48783352|NCT01610700|157048157|FG000|Overall Study|subject took one dose of street cannabis|0|||
48783353|NCT01610700|157048158|FG001|Overall Study|subject took one dose of street cannabis|1|||
48783354|NCT01045447|157048161|FG000|Overall Study|Adverse Event|0|||
48783355|NCT01045447|157048162|FG001|Overall Study|Adverse Event|1|||
48783356|NCT01045447|157048161|FG000|Overall Study|Lack of Efficacy|3|||
48783357|NCT01045447|157048162|FG001|Overall Study|Lack of Efficacy|1|||
48783358|NCT01045447|157048161|FG000|Overall Study|Protocol Violation|6|||
48783359|NCT01045447|157048162|FG001|Overall Study|Protocol Violation|3|||
48783360|NCT01045447|157048161|FG000|Overall Study|Withdrawal Criteria|10|||
48783361|NCT01045447|157048162|FG001|Overall Study|Withdrawal Criteria|10|||
48783362|NCT01045447|157048161|FG000|Overall Study|Unclassified|17|||
48783363|NCT01045447|157048162|FG001|Overall Study|Unclassified|13|||
48783364|NCT00262834|157048165|FG000|Overall Study|Surgery delayed/tissue not collected|1|||
48783365|NCT00262834|157048166|FG001|Overall Study|Surgery delayed/tissue not collected|4|||
48783366|NCT00003457|157048167|FG000|Overall Study|Not evaluable|9|||
48783367|NCT01054729|157048168|FG000|Overall Study|Randomized but Not Treated|0|||
48783368|NCT01054729|157048169|FG001|Overall Study|Randomized but Not Treated|1|||
48783369|NCT01054729|157048170|FG002|Overall Study|Randomized but Not Treated|0|||
48783370|NCT01054729|157048171|FG003|Overall Study|Randomized but Not Treated|0|||
48783371|NCT01054729|157048168|FG000|Overall Study|Adverse Event|1|||
48783372|NCT01054729|157048169|FG001|Overall Study|Adverse Event|1|||
48783373|NCT01054729|157048170|FG002|Overall Study|Adverse Event|2|||
48783374|NCT01054729|157048171|FG003|Overall Study|Adverse Event|1|||
48783375|NCT01054729|157048168|FG000|Overall Study|Withdrawal by Subject|1|||
48783376|NCT01054729|157048169|FG001|Overall Study|Withdrawal by Subject|0|||
48783377|NCT01054729|157048170|FG002|Overall Study|Withdrawal by Subject|1|||
48783378|NCT01054729|157048171|FG003|Overall Study|Withdrawal by Subject|0|||
48783379|NCT01054729|157048168|FG000|Overall Study|Lost to Follow-up|0|||
48783380|NCT01054729|157048169|FG001|Overall Study|Lost to Follow-up|1|||
48783381|NCT01054729|157048170|FG002|Overall Study|Lost to Follow-up|0|||
48783382|NCT01054729|157048171|FG003|Overall Study|Lost to Follow-up|0|||
48783383|NCT01054729|157048168|FG000|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
48783384|NCT01054729|157048169|FG001|Overall Study|Lost to Follow-up, Later Contacted Site|1|||
48783385|NCT01054729|157048170|FG002|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
48783386|NCT01054729|157048171|FG003|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
48783387|NCT01054729|157048168|FG000|Overall Study|Non-responder|1|||
48783388|NCT01054729|157048169|FG001|Overall Study|Non-responder|0|||
48783389|NCT01054729|157048170|FG002|Overall Study|Non-responder|1|||
48783390|NCT01054729|157048171|FG003|Overall Study|Non-responder|1|||
48783391|NCT01054729|157048168|FG000|Overall Study|PEG/RBV Non-responder|1|||
48783392|NCT01054729|157048169|FG001|Overall Study|PEG/RBV Non-responder|0|||
48783393|NCT01054729|157048170|FG002|Overall Study|PEG/RBV Non-responder|1|||
48783394|NCT01054729|157048171|FG003|Overall Study|PEG/RBV Non-responder|0|||
48783395|NCT01054729|157048168|FG000|Overall Study|Personal/Obligations|0|||
48783396|NCT01054729|157048169|FG001|Overall Study|Personal/Obligations|1|||
48783397|NCT01054729|157048170|FG002|Overall Study|Personal/Obligations|0|||
48783398|NCT01054729|157048171|FG003|Overall Study|Personal/Obligations|0|||
48783399|NCT01054729|157048168|FG000|Overall Study|Subject moved|0|||
48783400|NCT01054729|157048169|FG001|Overall Study|Subject moved|0|||
48783401|NCT01054729|157048170|FG002|Overall Study|Subject moved|1|||
48783402|NCT01054729|157048171|FG003|Overall Study|Subject moved|0|||
48783403|NCT01054729|157048168|FG000|Overall Study|Lack of Efficacy|0|||
48783404|NCT01054729|157048169|FG001|Overall Study|Lack of Efficacy|0|||
48783405|NCT01054729|157048170|FG002|Overall Study|Lack of Efficacy|0|||
48783406|NCT01054729|157048171|FG003|Overall Study|Lack of Efficacy|1|||
48783407|NCT04265755|157048175|FG000|Overall Study|Withdrawal by Subject|39|||
48783408|NCT04265755|157048175|FG000|Overall Study|Decision by sponsor|2|||
48783409|NCT04265755|157048175|FG000|Overall Study|Lost to Follow-up|11|||
48783410|NCT04265755|157048175|FG000|Overall Study|Death|1|||
48783411|NCT04535037|157048176|FG000|Overall Study|Protocol Violation|1|||
49030513|NCT02453386|157946975|FG002|Overall Study|Sponsor Terminated Study|11|||
49030514|NCT02453386|157946973|FG000|Overall Study|Subject Terminated by Sponsor|1|||
49030515|NCT02453386|157946974|FG001|Overall Study|Subject Terminated by Sponsor|1|||
49030516|NCT02453386|157946975|FG002|Overall Study|Subject Terminated by Sponsor|1|||
49030517|NCT02453386|157946973|FG000|Overall Study|Sponsor Terminated by Investigator|0|||
49030518|NCT02453386|157946974|FG001|Overall Study|Sponsor Terminated by Investigator|1|||
49030519|NCT02453386|157946975|FG002|Overall Study|Sponsor Terminated by Investigator|2|||
49030520|NCT02453386|157946973|FG000|Overall Study|Lost to Follow-up|0|||
48783412|NCT04535037|157048177|FG001|Overall Study|Protocol Violation|0|||
48783413|NCT04535037|157048176|FG000|Overall Study|Withdrawal by Subject|8|||
48783414|NCT04535037|157048177|FG001|Overall Study|Withdrawal by Subject|9|||
48783415|NCT04535037|157048176|FG000|Overall Study|Migrated / moved from the study area|1|||
48783416|NCT04535037|157048177|FG001|Overall Study|Migrated / moved from the study area|4|||
49030521|NCT02453386|157946974|FG001|Overall Study|Lost to Follow-up|0|||
48783417|NCT04535037|157048176|FG000|Overall Study|Other|2|||
48783418|NCT04535037|157048177|FG001|Overall Study|Other|5|||
48783419|NCT01854554|157048183|FG000|Overall Study|Denial of Insurance Coverage|12|||
48783420|NCT01854554|157048184|FG001|Overall Study|Denial of Insurance Coverage|0|||
48783421|NCT01854554|157048183|FG000|Overall Study|Decided to get treatment locally|1|||
48783422|NCT01854554|157048184|FG001|Overall Study|Decided to get treatment locally|5|||
48783423|NCT01854554|157048183|FG000|Overall Study|Received IMR only due to insurance analysis|1|||
48783424|NCT01854554|157048184|FG001|Overall Study|Received IMR only due to insurance analysis|0|||
48783425|NCT01854554|157048183|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
48783426|NCT01854554|157048184|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
48783427|NCT01854554|157048183|FG000|Overall Study|Progression|0|||
48783428|NCT01854554|157048184|FG001|Overall Study|Progression|1|||
48783429|NCT01854554|157048183|FG000|Overall Study|Lost to Follow-up|0|||
48783430|NCT01854554|157048184|FG001|Overall Study|Lost to Follow-up|1|||
48783431|NCT02731131|157048185|FG000|Overall Study|Psychiatric Disorder|0|||
48783432|NCT02731131|157048186|FG001|Overall Study|Psychiatric Disorder|1|||
48783433|NCT02731131|157048185|FG000|Overall Study|Refused Therapy|0|||
48783434|NCT02731131|157048186|FG001|Overall Study|Refused Therapy|1|||
48783435|NCT02819726|157048191|FG000|Part A (All Participants)|Lost to Follow-up|0|||
48783436|NCT02819726|157048192|FG001|Part A (All Participants)|Lost to Follow-up|1|||
48783437|NCT02819726|157048193|FG002|Part A (All Participants)|Lost to Follow-up|0|||
48783438|NCT02819726|157048194|FG003|Part A (All Participants)|Lost to Follow-up|0|||
48783439|NCT02819726|157048191|FG000|Part A (All Participants)|Withdrawal by Subject|3|||
48783440|NCT02819726|157048192|FG001|Part A (All Participants)|Withdrawal by Subject|5|||
48783441|NCT02819726|157048193|FG002|Part A (All Participants)|Withdrawal by Subject|6|||
48783442|NCT02819726|157048194|FG003|Part A (All Participants)|Withdrawal by Subject|0|||
48783443|NCT02819726|157048191|FG000|Part A (All Participants)|Protocol non-compliance|3|||
48783444|NCT02819726|157048192|FG001|Part A (All Participants)|Protocol non-compliance|4|||
48783445|NCT02819726|157048193|FG002|Part A (All Participants)|Protocol non-compliance|5|||
48783446|NCT02819726|157048194|FG003|Part A (All Participants)|Protocol non-compliance|0|||
48783447|NCT02819726|157048191|FG000|Part B (All Participants)|Lost to Follow-up|1|||
48783448|NCT02819726|157048192|FG001|Part B (All Participants)|Lost to Follow-up|1|||
48783449|NCT02819726|157048193|FG002|Part B (All Participants)|Lost to Follow-up|2|||
48783450|NCT02819726|157048194|FG003|Part B (All Participants)|Lost to Follow-up|2|||
48783451|NCT02819726|157048191|FG000|Part B (All Participants)|Withdrawal by Subject|2|||
48783452|NCT02819726|157048192|FG001|Part B (All Participants)|Withdrawal by Subject|1|||
48783453|NCT02819726|157048193|FG002|Part B (All Participants)|Withdrawal by Subject|1|||
48783454|NCT02819726|157048194|FG003|Part B (All Participants)|Withdrawal by Subject|0|||
48783455|NCT02819726|157048191|FG000|Part B (All Participants)|Protocol non-compliance|0|||
48783456|NCT02819726|157048192|FG001|Part B (All Participants)|Protocol non-compliance|0|||
48783457|NCT02819726|157048193|FG002|Part B (All Participants)|Protocol non-compliance|1|||
48783458|NCT02819726|157048194|FG003|Part B (All Participants)|Protocol non-compliance|0|||
48783459|NCT02536508|157048195|FG000|Overall Study|Withdrawal by Subject|18|||
48783460|NCT02536508|157048196|FG001|Overall Study|Withdrawal by Subject|13|||
48783461|NCT02536508|157048197|FG002|Overall Study|Withdrawal by Subject|7|||
48783462|NCT02536508|157048195|FG000|Overall Study|Adverse Event|14|||
48783463|NCT02536508|157048196|FG001|Overall Study|Adverse Event|13|||
49030522|NCT02453386|157946975|FG002|Overall Study|Lost to Follow-up|1|||
49030523|NCT02453386|157946973|FG000|Overall Study|Other|1|||
49030524|NCT02453386|157946974|FG001|Overall Study|Other|0|||
49030525|NCT02453386|157946975|FG002|Overall Study|Other|1|||
49030526|NCT02530905|157946977|FG000|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
49030527|NCT02530905|157946978|FG001|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
49030528|NCT02530905|157946979|FG002|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1|||
49030529|NCT00965185|157946982|FG000|Overall Study|Lost to Follow-up|2|||
49030530|NCT00965185|157946983|FG001|Overall Study|Lost to Follow-up|0|||
49030531|NCT00965185|157946982|FG000|Overall Study|Withdrawal by Subject|0|||
49030532|NCT00965185|157946983|FG001|Overall Study|Withdrawal by Subject|1|||
49030533|NCT03041025|157946987|FG000|Overall Study|Adverse Event|0|||
49030534|NCT03041025|157946988|FG001|Overall Study|Adverse Event|0|||
49030535|NCT03041025|157946989|FG002|Overall Study|Adverse Event|1|||
49030536|NCT03041025|157946987|FG000|Overall Study|Lost to Follow-up|1|||
49030537|NCT03041025|157946988|FG001|Overall Study|Lost to Follow-up|0|||
49030538|NCT03041025|157946989|FG002|Overall Study|Lost to Follow-up|0|||
49030539|NCT03041025|157946987|FG000|Overall Study|Withdrawal by Subject|0|||
49030540|NCT03041025|157946988|FG001|Overall Study|Withdrawal by Subject|0|||
49030541|NCT03041025|157946989|FG002|Overall Study|Withdrawal by Subject|1|||
49030542|NCT00837486|157946993|FG000|Blinded-treatment Phase|Physician Decision|1|||
48783464|NCT02536508|157048197|FG002|Overall Study|Adverse Event|6|||
49030543|NCT00837486|157946994|FG001|Blinded-treatment Phase|Physician Decision|0|||
49030544|NCT00837486|157946993|FG000|Long-term Follow-up Phase - Open Label|Physician Decision|2|||
48783465|NCT02536508|157048195|FG000|Overall Study|Lost to Follow-up|12|||
48783466|NCT02536508|157048196|FG001|Overall Study|Lost to Follow-up|4|||
48783467|NCT02536508|157048197|FG002|Overall Study|Lost to Follow-up|0|||
48783468|NCT02536508|157048195|FG000|Overall Study|Lack of Efficacy|3|||
48783469|NCT02536508|157048196|FG001|Overall Study|Lack of Efficacy|5|||
48783470|NCT02536508|157048197|FG002|Overall Study|Lack of Efficacy|4|||
48783471|NCT02536508|157048195|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
49030545|NCT00837486|157946994|FG001|Long-term Follow-up Phase - Open Label|Physician Decision|0|||
49030546|NCT00837486|157946993|FG000|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2|||
49030547|NCT00837486|157946994|FG001|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0|||
48783472|NCT02536508|157048196|FG001|Overall Study|Protocol Discontinuation Criteria|2|||
48783473|NCT02536508|157048197|FG002|Overall Study|Protocol Discontinuation Criteria|2|||
48783474|NCT02536508|157048195|FG000|Overall Study|Physician Decision|0|||
48783475|NCT02536508|157048196|FG001|Overall Study|Physician Decision|4|||
48783476|NCT02536508|157048197|FG002|Overall Study|Physician Decision|2|||
48783477|NCT02536508|157048195|FG000|Overall Study|Major Protocol Deviation|2|||
48783478|NCT02536508|157048196|FG001|Overall Study|Major Protocol Deviation|2|||
48783479|NCT02536508|157048197|FG002|Overall Study|Major Protocol Deviation|2|||
48783480|NCT02536508|157048195|FG000|Overall Study|Administrative Reasons|0|||
48783481|NCT02536508|157048196|FG001|Overall Study|Administrative Reasons|1|||
48783482|NCT02536508|157048197|FG002|Overall Study|Administrative Reasons|0|||
48783483|NCT00003498|157048198|FG000|Overall Study|Not evaluable.|4|||
48783484|NCT01055639|157048203|FG000|Overall Study|Adverse Event|0|||
48783485|NCT01055639|157048204|FG001|Overall Study|Adverse Event|1|||
48783486|NCT01055639|157048203|FG000|Overall Study|Lack of Efficacy|0|||
48783487|NCT01055639|157048204|FG001|Overall Study|Lack of Efficacy|1|||
48783488|NCT01055639|157048203|FG000|Overall Study|Lost to Follow-up|8|||
48783489|NCT01055639|157048204|FG001|Overall Study|Lost to Follow-up|11|||
48783490|NCT01055639|157048203|FG000|Overall Study|Protocol Violation|5|||
48783491|NCT01055639|157048204|FG001|Overall Study|Protocol Violation|5|||
48783492|NCT01055639|157048203|FG000|Overall Study|Withdrawal by Subject|8|||
48783493|NCT01055639|157048204|FG001|Overall Study|Withdrawal by Subject|11|||
48783494|NCT02417246|157048205|FG000|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
48783495|NCT02417246|157048206|FG001|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
48783496|NCT02417246|157048205|FG000|Phase 1 Brand Name Metoprolol ER|Physician Decision|1|||
48783497|NCT02417246|157048206|FG001|Phase 1 Brand Name Metoprolol ER|Physician Decision|0|||
48783498|NCT02417246|157048205|FG000|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2|||
48783499|NCT02417246|157048206|FG001|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3|||
48783500|NCT02417246|157048205|FG000|Phase 2 1st Generic Administered|Physician Decision|1|||
48783501|NCT02417246|157048206|FG001|Phase 2 1st Generic Administered|Physician Decision|0|||
48783502|NCT01181921|157048210|FG000|Overall Study|Lost to Follow-up|1|||
48783503|NCT04408469|157048215|FG000|Overall Study|Lost to Follow-up|6|||
48783504|NCT04408469|157048216|FG001|Overall Study|Lost to Follow-up|9|||
48783505|NCT04408469|157048215|FG000|Overall Study|Withdrawal by Subject|6|||
48783506|NCT04408469|157048216|FG001|Overall Study|Withdrawal by Subject|1|||
48783507|NCT04408469|157048215|FG000|Overall Study|Dismissal due to ineligibility|0|||
48783508|NCT04408469|157048216|FG001|Overall Study|Dismissal due to ineligibility|1|||
48783509|NCT02460991|157048222|FG000|Overall Study|Withdrawal by Subject|0|||
48783510|NCT02460991|157048223|FG001|Overall Study|Withdrawal by Subject|2|||
48783511|NCT02546544|157048224|FG000|Overall Study|Disease Progression|14|||
48783512|NCT02546544|157048224|FG000|Overall Study|Adverse Event|1|||
48783513|NCT02546544|157048224|FG000|Overall Study|Withdrawal by Subject|1|||
48783514|NCT01921348|157048225|FG000|Overall Study|Withdrawal by Subject|1|||
48783515|NCT01921348|157048226|FG001|Overall Study|Withdrawal by Subject|0|||
48783516|NCT01921348|157048225|FG000|Overall Study|Lost to Follow-up|0|||
48783517|NCT01921348|157048226|FG001|Overall Study|Lost to Follow-up|2|||
48783518|NCT03073603|157048227|FG000|Overall Study|Noncompliance|3|||
48783519|NCT03073603|157048228|FG001|Overall Study|Noncompliance|1|||
48783520|NCT03073603|157048227|FG000|Overall Study|Adverse Event|5|||
48783521|NCT03073603|157048228|FG001|Overall Study|Adverse Event|3|||
48783522|NCT03073603|157048227|FG000|Overall Study|Physician Decision|1|||
48783523|NCT03073603|157048228|FG001|Overall Study|Physician Decision|2|||
48783524|NCT03073603|157048227|FG000|Overall Study|Required treatment not allowed by protocol|1|||
48783525|NCT03073603|157048228|FG001|Overall Study|Required treatment not allowed by protocol|0|||
48783526|NCT03073603|157048227|FG000|Overall Study|Financial or insurance-related|8|||
49030548|NCT00837486|157946993|FG000|Long-term Follow-up Phase - Open Label|Death|1|||
49030549|NCT00837486|157946994|FG001|Long-term Follow-up Phase - Open Label|Death|0|||
49030550|NCT00813592|157946995|FG000|Overall Study|Disease assessment was not completed per|2|||
48783527|NCT03073603|157048228|FG001|Overall Study|Financial or insurance-related|0|||
48783528|NCT03073603|157048227|FG000|Overall Study|Withdrawal by Subject|0|||
48783529|NCT03073603|157048228|FG001|Overall Study|Withdrawal by Subject|1|||
48783530|NCT03073603|157048227|FG000|Overall Study|Discontinued DMT|4|||
48783531|NCT03073603|157048228|FG001|Overall Study|Discontinued DMT|0|||
48783532|NCT03073603|157048227|FG000|Overall Study|Restarted DMT|0|||
48783533|NCT03073603|157048228|FG001|Overall Study|Restarted DMT|1|||
48783534|NCT00455195|157048229|FG000|Double-blind Study AGLU02704|Adverse Event|2|||
48783535|NCT00455195|157048230|FG001|Double-blind Study AGLU02704|Adverse Event|1|||
48783536|NCT00455195|157048229|FG000|Double-blind Study AGLU02704|Death|1|||
48783537|NCT00455195|157048230|FG001|Double-blind Study AGLU02704|Death|0|||
48783538|NCT00455195|157048229|FG000|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
48783539|NCT00455195|157048230|FG001|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
48783540|NCT00455195|157048229|FG000|Double-blind Study AGLU02704|Unable to commit time to study|0|||
48783541|NCT00455195|157048230|FG001|Double-blind Study AGLU02704|Unable to commit time to study|1|||
48783542|NCT03936244|157048233|FG000|Overall Study|Lost to Follow-up|5|||
49030551|NCT02820350|157946996|FG000|Overall Study|Withdrawal by Subject|3|||
49030552|NCT02820350|157946996|FG000|Overall Study|Death|4|||
49030553|NCT04118894|157946997|FG000|Overall Study|Lost to Follow-up|21|||
49030554|NCT04118894|157946997|FG000|Overall Study|Withdrawal by Subject|10|||
49030555|NCT04118894|157946997|FG000|Overall Study|Adverse Event|4|||
49030556|NCT01042522|157949016|FG000|Overall Study|Adverse Event|1|||
48783543|NCT03936244|157048234|FG001|Overall Study|Lost to Follow-up|1|||
48783544|NCT03936244|157048233|FG000|Overall Study|Physician Decision|7|||
48783545|NCT03936244|157048234|FG001|Overall Study|Physician Decision|3|||
48783546|NCT01925183|157048235|FG000|Overall Study|Adverse Event|1|||
48783547|NCT01925183|157048236|FG001|Overall Study|Adverse Event|0|||
48783548|NCT01114646|157048237|FG000|Overall Study|Withdrawal by Subject|3|||
48783549|NCT01114646|157048238|FG001|Overall Study|Withdrawal by Subject|2|||
48783550|NCT01296568|157048242|FG000|Continued Access Phase|Lost to Follow-up|1|||
48783551|NCT01296568|157048242|FG000|Continued Access Phase|Withdrawal by Subject|1|||
48783552|NCT01296568|157048242|FG000|Continued Access Phase|Disease Progression|1|||
48783553|NCT02013765|157048243|FG000|Overall Study|Trial was terminated by sponsor|1|||
48783554|NCT00462384|157048244|FG000|Overall Study|Adverse Event|2|||
48783555|NCT00462384|157048244|FG000|Overall Study|Death|2|||
48783556|NCT00462384|157048244|FG000|Overall Study|Withdrawal by Subject|1|||
48783557|NCT00462384|157048244|FG000|Overall Study|Other|4|||
48783558|NCT02571452|157048246|FG000|Overall Study Treatment|Protocol Violation|0|||
48783559|NCT02571452|157048247|FG001|Overall Study Treatment|Protocol Violation|1|||
48783560|NCT02571452|157048246|FG000|Overall Study 6-Month Follow-up|Lost to Follow-up|4|||
48783561|NCT02571452|157048247|FG001|Overall Study 6-Month Follow-up|Lost to Follow-up|0|||
48783562|NCT02571452|157048246|FG000|Overall Study 6-Month Follow-up|Protocol Violation|1|||
48783563|NCT02571452|157048247|FG001|Overall Study 6-Month Follow-up|Protocol Violation|0|||
48783564|NCT04000165|157048248|FG000|Overall Study|Physician Decision|1|||
48783565|NCT04000165|157048248|FG000|Overall Study|Withdrawal by Subject|1|||
48783566|NCT02014116|157048250|FG000|Overall Study|Progressive Disease|3|||
48783567|NCT02014116|157048251|FG001|Overall Study|Progressive Disease|4|||
48783568|NCT02014116|157048252|FG002|Overall Study|Progressive Disease|2|||
48783569|NCT02014116|157048253|FG003|Overall Study|Progressive Disease|6|||
48783570|NCT02014116|157048254|FG004|Overall Study|Progressive Disease|1|||
48783571|NCT02014116|157048255|FG005|Overall Study|Progressive Disease|13|||
48783572|NCT02014116|157048256|FG006|Overall Study|Progressive Disease|1|||
48783573|NCT02014116|157048257|FG007|Overall Study|Progressive Disease|3|||
49030557|NCT01042522|157949017|FG001|Overall Study|Adverse Event|2|||
49030558|NCT01042522|157949016|FG000|Overall Study|Disease Progression|5|||
49030559|NCT01042522|157949017|FG001|Overall Study|Disease Progression|0|||
49030560|NCT01042522|157949016|FG000|Overall Study|Death|1|||
49030561|NCT01042522|157949017|FG001|Overall Study|Death|0|||
49030562|NCT01042522|157949016|FG000|Overall Study|Patient Refused|0|||
49030563|NCT01042522|157949017|FG001|Overall Study|Patient Refused|3|||
49030564|NCT01042522|157949016|FG000|Overall Study|Withdrawal by Subject|1|||
49030565|NCT01042522|157949017|FG001|Overall Study|Withdrawal by Subject|1|||
49030566|NCT01746017|157949018|FG000|Period 1|Withdrawal by Subject|0|||
49030567|NCT01746017|157949019|FG001|Period 1|Withdrawal by Subject|0|||
49030568|NCT01746017|157949020|FG002|Period 1|Withdrawal by Subject|0|||
49030569|NCT01746017|157949021|FG003|Period 1|Withdrawal by Subject|0|||
49030570|NCT01746017|157949022|FG004|Period 1|Withdrawal by Subject|0|||
49030571|NCT01746017|157949023|FG005|Period 1|Withdrawal by Subject|0|||
49030572|NCT01746017|157949024|FG006|Period 1|Withdrawal by Subject|1|||
49030573|NCT01746017|157949025|FG007|Period 1|Withdrawal by Subject|0|||
49030574|NCT01746017|157949026|FG008|Period 1|Withdrawal by Subject|0|||
49030575|NCT01746017|157949027|FG009|Period 1|Withdrawal by Subject|0|||
49030576|NCT01746017|157949028|FG010|Period 1|Withdrawal by Subject|0|||
49030577|NCT01746017|157949018|FG000|Period 3|Withdrawal by Subject|0|||
49030578|NCT01746017|157949019|FG001|Period 3|Withdrawal by Subject|0|||
49030579|NCT01746017|157949020|FG002|Period 3|Withdrawal by Subject|0|||
49030580|NCT01746017|157949021|FG003|Period 3|Withdrawal by Subject|0|||
49030581|NCT01746017|157949022|FG004|Period 3|Withdrawal by Subject|0|||
49030582|NCT01746017|157949023|FG005|Period 3|Withdrawal by Subject|1|||
48783574|NCT02014116|157048258|FG008|Overall Study|Progressive Disease|7|||
48783575|NCT02014116|157048250|FG000|Overall Study|Adverse Event|0|||
48783576|NCT02014116|157048251|FG001|Overall Study|Adverse Event|0|||
48783577|NCT02014116|157048252|FG002|Overall Study|Adverse Event|0|||
48783578|NCT02014116|157048253|FG003|Overall Study|Adverse Event|0|||
49030583|NCT01746017|157949024|FG006|Period 3|Withdrawal by Subject|0|||
49030584|NCT01746017|157949025|FG007|Period 3|Withdrawal by Subject|0|||
49030585|NCT01746017|157949026|FG008|Period 3|Withdrawal by Subject|0|||
48783579|NCT02014116|157048254|FG004|Overall Study|Adverse Event|1|||
48783580|NCT02014116|157048255|FG005|Overall Study|Adverse Event|0|||
48783581|NCT02014116|157048256|FG006|Overall Study|Adverse Event|0|||
48783582|NCT02014116|157048257|FG007|Overall Study|Adverse Event|1|||
49030586|NCT01746017|157949027|FG009|Period 3|Withdrawal by Subject|0|||
48783583|NCT02014116|157048258|FG008|Overall Study|Adverse Event|0|||
49030587|NCT01746017|157949028|FG010|Period 3|Withdrawal by Subject|0|||
49030588|NCT00549718|157949029|FG000|Overall Study|Insufficient clinical response|20|||
48783584|NCT02014116|157048250|FG000|Overall Study|Lost to Follow-up|0|||
48783585|NCT02014116|157048251|FG001|Overall Study|Lost to Follow-up|0|||
48783586|NCT02014116|157048252|FG002|Overall Study|Lost to Follow-up|0|||
48783587|NCT02014116|157048253|FG003|Overall Study|Lost to Follow-up|0|||
48783588|NCT02014116|157048254|FG004|Overall Study|Lost to Follow-up|0|||
48783589|NCT02014116|157048255|FG005|Overall Study|Lost to Follow-up|1|||
48783590|NCT02014116|157048256|FG006|Overall Study|Lost to Follow-up|0|||
48783591|NCT02014116|157048257|FG007|Overall Study|Lost to Follow-up|0|||
48783592|NCT02014116|157048258|FG008|Overall Study|Lost to Follow-up|1|||
48783593|NCT02014116|157048250|FG000|Overall Study|Death|0|||
48783594|NCT02014116|157048251|FG001|Overall Study|Death|0|||
48783595|NCT02014116|157048252|FG002|Overall Study|Death|0|||
48783596|NCT02014116|157048253|FG003|Overall Study|Death|0|||
48783597|NCT02014116|157048254|FG004|Overall Study|Death|0|||
48783598|NCT02014116|157048255|FG005|Overall Study|Death|0|||
48783599|NCT02014116|157048256|FG006|Overall Study|Death|0|||
48783600|NCT02014116|157048257|FG007|Overall Study|Death|1|||
48783601|NCT02014116|157048258|FG008|Overall Study|Death|1|||
48783602|NCT02014116|157048250|FG000|Overall Study|Withdrawal by Subject|0|||
48783603|NCT02014116|157048251|FG001|Overall Study|Withdrawal by Subject|0|||
48783604|NCT02014116|157048252|FG002|Overall Study|Withdrawal by Subject|1|||
48783605|NCT02014116|157048253|FG003|Overall Study|Withdrawal by Subject|1|||
48783606|NCT02014116|157048254|FG004|Overall Study|Withdrawal by Subject|0|||
48783607|NCT02014116|157048255|FG005|Overall Study|Withdrawal by Subject|1|||
48783608|NCT02014116|157048256|FG006|Overall Study|Withdrawal by Subject|0|||
48783609|NCT02014116|157048257|FG007|Overall Study|Withdrawal by Subject|0|||
48783610|NCT02014116|157048258|FG008|Overall Study|Withdrawal by Subject|0|||
48783611|NCT02014116|157048250|FG000|Overall Study|Withdrawal Caregiver Decision|0|||
48783612|NCT02014116|157048251|FG001|Overall Study|Withdrawal Caregiver Decision|0|||
49030589|NCT00549718|157949030|FG001|Overall Study|Insufficient clinical response|7|||
49030590|NCT00549718|157949031|FG002|Overall Study|Insufficient clinical response|18|||
49030591|NCT00549718|157949032|FG003|Overall Study|Insufficient clinical response|32|||
49030592|NCT00549718|157949029|FG000|Overall Study|Adverse Event|6|||
49030593|NCT00549718|157949030|FG001|Overall Study|Adverse Event|8|||
49030594|NCT00549718|157949031|FG002|Overall Study|Adverse Event|7|||
49030595|NCT00549718|157949032|FG003|Overall Study|Adverse Event|3|||
49030596|NCT00549718|157949029|FG000|Overall Study|Lost to Follow-up|4|||
49030597|NCT00549718|157949030|FG001|Overall Study|Lost to Follow-up|2|||
49030598|NCT00549718|157949031|FG002|Overall Study|Lost to Follow-up|0|||
49030599|NCT00549718|157949032|FG003|Overall Study|Lost to Follow-up|6|||
49030600|NCT00549718|157949029|FG000|Overall Study|Withdrawal by Subject|9|||
49030601|NCT00549718|157949030|FG001|Overall Study|Withdrawal by Subject|18|||
49030602|NCT00549718|157949031|FG002|Overall Study|Withdrawal by Subject|12|||
49030603|NCT00549718|157949032|FG003|Overall Study|Withdrawal by Subject|13|||
49030604|NCT00549718|157949029|FG000|Overall Study|Administrative|2|||
49030605|NCT00549718|157949030|FG001|Overall Study|Administrative|2|||
49030606|NCT00549718|157949031|FG002|Overall Study|Administrative|2|||
49030607|NCT00549718|157949032|FG003|Overall Study|Administrative|1|||
49030608|NCT02424097|157949035|FG000|Overall Study|Lost to Follow-up|1|||
49030609|NCT02424097|157949036|FG001|Overall Study|Lost to Follow-up|2|||
49030610|NCT01507051|157949042|FG000|Overall Study|Withdrawal by Subject|1|||
49030611|NCT01507051|157949043|FG001|Overall Study|Withdrawal by Subject|3|||
49030612|NCT01507051|157949044|FG002|Overall Study|Withdrawal by Subject|1|||
49030613|NCT01507051|157949045|FG003|Overall Study|Withdrawal by Subject|6|||
49030614|NCT01507051|157949042|FG000|Overall Study|Physician Decision|0|||
49030615|NCT01507051|157949043|FG001|Overall Study|Physician Decision|0|||
49030616|NCT01507051|157949044|FG002|Overall Study|Physician Decision|0|||
49030617|NCT01507051|157949045|FG003|Overall Study|Physician Decision|1|||
49030618|NCT01507051|157949042|FG000|Overall Study|Adverse Event|1|||
49030619|NCT01507051|157949043|FG001|Overall Study|Adverse Event|0|||
49030620|NCT01507051|157949044|FG002|Overall Study|Adverse Event|0|||
48783613|NCT02014116|157048252|FG002|Overall Study|Withdrawal Caregiver Decision|0|||
48783614|NCT02014116|157048253|FG003|Overall Study|Withdrawal Caregiver Decision|0|||
48783615|NCT02014116|157048254|FG004|Overall Study|Withdrawal Caregiver Decision|0|||
48783616|NCT02014116|157048255|FG005|Overall Study|Withdrawal Caregiver Decision|1|||
48783617|NCT02014116|157048256|FG006|Overall Study|Withdrawal Caregiver Decision|0|||
48783618|NCT02014116|157048257|FG007|Overall Study|Withdrawal Caregiver Decision|0|||
48783619|NCT02014116|157048258|FG008|Overall Study|Withdrawal Caregiver Decision|0|||
48783620|NCT02014116|157048250|FG000|Overall Study|Physician Decision|0|||
48783621|NCT02014116|157048251|FG001|Overall Study|Physician Decision|0|||
48783622|NCT02014116|157048252|FG002|Overall Study|Physician Decision|0|||
49030621|NCT01507051|157949045|FG003|Overall Study|Adverse Event|0|||
48783623|NCT02014116|157048253|FG003|Overall Study|Physician Decision|0|||
48783624|NCT02014116|157048254|FG004|Overall Study|Physician Decision|0|||
49030622|NCT01675622|157949046|FG000|Overall Study|Withdrawal by Subject|2|||
48783625|NCT02014116|157048255|FG005|Overall Study|Physician Decision|0|||
48783626|NCT02014116|157048256|FG006|Overall Study|Physician Decision|0|||
48783627|NCT02014116|157048257|FG007|Overall Study|Physician Decision|0|||
49030623|NCT01675622|157949047|FG001|Overall Study|Withdrawal by Subject|2|||
49030624|NCT01675622|157949046|FG000|Overall Study|Adverse Event|12|||
49030625|NCT01675622|157949047|FG001|Overall Study|Adverse Event|10|||
49030626|NCT01675622|157949046|FG000|Overall Study|Protocol Violation|4|||
49030627|NCT01675622|157949047|FG001|Overall Study|Protocol Violation|1|||
49030628|NCT01675622|157949046|FG000|Overall Study|Lack of Efficacy|2|||
49030629|NCT01675622|157949047|FG001|Overall Study|Lack of Efficacy|4|||
49030630|NCT01675622|157949046|FG000|Overall Study|Lost to Follow-up|1|||
49030631|NCT01675622|157949047|FG001|Overall Study|Lost to Follow-up|3|||
49030632|NCT01675622|157949046|FG000|Overall Study|Other|5|||
49030633|NCT01675622|157949047|FG001|Overall Study|Other|4|||
49030634|NCT01101022|157949049|FG000|Overall Study|Adverse Event|6|||
49030635|NCT01101022|157949050|FG001|Overall Study|Adverse Event|2|||
49030636|NCT01101022|157949049|FG000|Overall Study|Protocol Violation|4|||
49030637|NCT01101022|157949050|FG001|Overall Study|Protocol Violation|3|||
49030638|NCT01101022|157949049|FG000|Overall Study|Withdrawal by Subject|3|||
49030639|NCT01101022|157949050|FG001|Overall Study|Withdrawal by Subject|8|||
49030640|NCT01101022|157949049|FG000|Overall Study|Lost to Follow-up|1|||
49030641|NCT01101022|157949050|FG001|Overall Study|Lost to Follow-up|4|||
49030642|NCT01101022|157949049|FG000|Overall Study|Lack of Efficacy|0|||
49030643|NCT01101022|157949050|FG001|Overall Study|Lack of Efficacy|7|||
49030644|NCT01101022|157949049|FG000|Overall Study|Sponsor decision|1|||
49030645|NCT01101022|157949050|FG001|Overall Study|Sponsor decision|1|||
49030646|NCT01101022|157949049|FG000|Overall Study|Non-compliance|1|||
49030647|NCT01101022|157949050|FG001|Overall Study|Non-compliance|0|||
49030648|NCT01101022|157949049|FG000|Overall Study|Work schedule|1|||
49030649|NCT01101022|157949050|FG001|Overall Study|Work schedule|1|||
49030650|NCT01101022|157949049|FG000|Overall Study|Vacation|0|||
49030651|NCT01101022|157949050|FG001|Overall Study|Vacation|1|||
49030652|NCT01435265|157949053|FG000|Overall Study|Lost to Follow-up|0|||
49030653|NCT01435265|157949054|FG001|Overall Study|Lost to Follow-up|1|||
49030654|NCT03351335|157949055|FG000|Overall Study|Failure to maintain inclusion/exclusion|0|||
49030655|NCT03351335|157949056|FG001|Overall Study|Failure to maintain inclusion/exclusion|0|||
49030656|NCT03351335|157949057|FG002|Overall Study|Failure to maintain inclusion/exclusion|4|||
49030657|NCT04605094|157949058|FG000|Overall Study|Adverse Event|2|||
49030658|NCT04605094|157949059|FG001|Overall Study|Adverse Event|2|||
49030659|NCT04605094|157949058|FG000|Overall Study|Lost to Follow-up|1|||
49030660|NCT04605094|157949059|FG001|Overall Study|Lost to Follow-up|4|||
49030661|NCT04605094|157949058|FG000|Overall Study|Physician Decision|2|||
49030662|NCT04605094|157949059|FG001|Overall Study|Physician Decision|2|||
49030663|NCT04605094|157949058|FG000|Overall Study|Study terminated by Sponsor|31|||
49030664|NCT04605094|157949059|FG001|Overall Study|Study terminated by Sponsor|33|||
49030665|NCT04605094|157949058|FG000|Overall Study|Withdrawal by Subject|22|||
49030666|NCT04605094|157949059|FG001|Overall Study|Withdrawal by Subject|19|||
49030667|NCT04605094|157949058|FG000|Overall Study|Other|1|||
49030668|NCT04605094|157949059|FG001|Overall Study|Other|1|||
49030669|NCT02724462|157949060|FG000|3 Month Follow-up Survey|Lost to Follow-up|171|||
48783628|NCT02014116|157048258|FG008|Overall Study|Physician Decision|1|||
48783629|NCT00437489|157048269|FG000|Overall Study|Study terminated by sponsor|23|||
48783630|NCT00437489|157048270|FG001|Overall Study|Study terminated by sponsor|21|||
48783631|NCT00437489|157048269|FG000|Overall Study|Lost to Follow-up|0|||
48783632|NCT00437489|157048270|FG001|Overall Study|Lost to Follow-up|1|||
48783633|NCT04934670|157048271|FG000|Overall Study|Death|4|||
48783634|NCT04934670|157048272|FG001|Overall Study|Death|0|||
48783635|NCT04934670|157048271|FG000|Overall Study|Lost to Follow-up|1|||
49030670|NCT02724462|157949061|FG001|3 Month Follow-up Survey|Lost to Follow-up|151|||
49030671|NCT02724462|157949060|FG000|3 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
49030672|NCT02724462|157949061|FG001|3 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
49030673|NCT02724462|157949060|FG000|6 Month Follow-up Survey|Lost to Follow-up|156|||
49030674|NCT02724462|157949061|FG001|6 Month Follow-up Survey|Lost to Follow-up|123|||
49030675|NCT02724462|157949060|FG000|6 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
49030676|NCT02724462|157949061|FG001|6 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
49030677|NCT02724462|157949060|FG000|12 Month Follow-up Survey|Lost to Follow-up|174|||
49030678|NCT02724462|157949061|FG001|12 Month Follow-up Survey|Lost to Follow-up|134|||
49030679|NCT02724462|157949060|FG000|12 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
49030680|NCT02724462|157949061|FG001|12 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
49030681|NCT01900691|157949062|FG000|Overall Study|Death|7|||
49030682|NCT01900691|157949062|FG000|Overall Study|Lost to Follow-up|4|||
49030683|NCT01900691|157949062|FG000|Overall Study|Study Device Not Placed|3|||
48783636|NCT04934670|157048272|FG001|Overall Study|Lost to Follow-up|4|||
49030684|NCT01900691|157949062|FG000|Overall Study|Non study stent placed|2|||
49030685|NCT01900691|157949062|FG000|Overall Study|Six month Follow up completed, stent not removed|2|||
49030686|NCT01900691|157949062|FG000|Overall Study|Complete stent migration through digestive tract|1|||
49030687|NCT00469417|157949063|FG000|Overall Study|Treatment failure all lesions|18|||
49030688|NCT00469417|157949064|FG001|Overall Study|Treatment failure all lesions|11|||
48783637|NCT00099983|157048281|FG000|Overall Study|Lost to Follow-up|2|||
49030689|NCT00469417|157949063|FG000|Overall Study|Consent withdrawn|1|||
49030690|NCT00469417|157949064|FG001|Overall Study|Consent withdrawn|1|||
49030691|NCT00469417|157949063|FG000|Overall Study|Adverse Event|8|||
49030692|NCT00469417|157949064|FG001|Overall Study|Adverse Event|2|||
49030693|NCT00469417|157949063|FG000|Overall Study|Lost to Follow-up|1|||
49030694|NCT00469417|157949064|FG001|Overall Study|Lost to Follow-up|2|||
49030695|NCT00469417|157949063|FG000|Overall Study|Intercurrent disease|0|||
49030696|NCT00469417|157949064|FG001|Overall Study|Intercurrent disease|1|||
49030697|NCT00469417|157949063|FG000|Overall Study|Randomized but not treated|2|||
49030698|NCT00469417|157949064|FG001|Overall Study|Randomized but not treated|0|||
49030699|NCT02942264|157949065|FG000|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
49030700|NCT02942264|157949066|FG001|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
49030701|NCT02942264|157949067|FG002|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
49030702|NCT02942264|157949068|FG003|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
49030703|NCT02942264|157949069|FG004|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
49030704|NCT02942264|157949070|FG005|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
49030705|NCT02942264|157949071|FG006|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
49030706|NCT02942264|157949072|FG007|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
49030707|NCT02942264|157949073|FG008|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
49030708|NCT02942264|157949065|FG000|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
49030709|NCT02942264|157949066|FG001|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
49030710|NCT02942264|157949067|FG002|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
49030711|NCT02942264|157949068|FG003|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
49030712|NCT02942264|157949069|FG004|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
49030713|NCT02942264|157949070|FG005|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
49030714|NCT02942264|157949071|FG006|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
49030715|NCT02942264|157949072|FG007|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
49030716|NCT02942264|157949073|FG008|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1|||
49030717|NCT02647944|157949076|FG000|Overall Study|Withdrawal by Subject|0|||
49030718|NCT02647944|157949077|FG001|Overall Study|Withdrawal by Subject|3|||
49030719|NCT02647944|157949076|FG000|Overall Study|Adverse Event|2|||
49030720|NCT02647944|157949077|FG001|Overall Study|Adverse Event|0|||
49030721|NCT02514122|157949078|FG000|Overall Study|Withdrawal by Subject|2|||
49030722|NCT02514122|157949079|FG001|Overall Study|Withdrawal by Subject|0|||
49030723|NCT00794963|157949082|FG000|Overall Study|Withdrawal by Subject|1|||
49030724|NCT00794963|157949083|FG001|Overall Study|Withdrawal by Subject|4|||
49030725|NCT01827163|157949084|FG000|Overall Study|Hypersensitivity reaction to Paclitaxel|2|||
49030726|NCT01827163|157949084|FG000|Overall Study|Adverse Event|9|||
49030727|NCT03375463|157949085|FG000|Period 1|Lost to Follow-up|0|||
49030728|NCT03375463|157949086|FG001|Period 1|Lost to Follow-up|0|||
49030729|NCT03375463|157949087|FG002|Period 1|Lost to Follow-up|1|||
49030730|NCT03375463|157949088|FG003|Period 1|Lost to Follow-up|0|||
49030731|NCT03375463|157949089|FG004|Period 1|Lost to Follow-up|0|||
49030732|NCT03375463|157949090|FG005|Period 1|Lost to Follow-up|0|||
49030733|NCT03375463|157949085|FG000|Period 1|Adverse Event|0|||
49030734|NCT03375463|157949086|FG001|Period 1|Adverse Event|0|||
48783638|NCT00099983|157048282|FG001|Overall Study|Lost to Follow-up|3|||
48783639|NCT00099983|157048281|FG000|Overall Study|Missing Source Documents|14|||
48783640|NCT00099983|157048282|FG001|Overall Study|Missing Source Documents|15|||
48783641|NCT00099983|157048281|FG000|Overall Study|Withdrawal by Subject|3|||
48783642|NCT00099983|157048282|FG001|Overall Study|Withdrawal by Subject|2|||
48783643|NCT00099983|157048281|FG000|Overall Study|Adverse Event|1|||
48783644|NCT00099983|157048282|FG001|Overall Study|Adverse Event|1|||
48783645|NCT00099983|157048281|FG000|Overall Study|Lack of Efficacy|0|||
48783646|NCT00099983|157048282|FG001|Overall Study|Lack of Efficacy|1|||
48783647|NCT00099983|157048281|FG000|Overall Study|Unable to return for appointments|1|||
48783648|NCT00099983|157048282|FG001|Overall Study|Unable to return for appointments|1|||
48783649|NCT00099983|157048281|FG000|Overall Study|Moved|1|||
48783650|NCT00099983|157048282|FG001|Overall Study|Moved|0|||
48783651|NCT00099983|157048281|FG000|Overall Study|Other psychiatric problem|1|||
48783652|NCT00099983|157048282|FG001|Overall Study|Other psychiatric problem|0|||
48783653|NCT00099983|157048281|FG000|Overall Study|Incarcerated|0|||
48783654|NCT00099983|157048282|FG001|Overall Study|Incarcerated|1|||
48783655|NCT00099983|157048281|FG000|Overall Study|Intolerant of burden of visits|0|||
48783656|NCT00099983|157048282|FG001|Overall Study|Intolerant of burden of visits|1|||
48783657|NCT00099983|157048281|FG000|Overall Study|Other issue|1|||
48783658|NCT00099983|157048282|FG001|Overall Study|Other issue|0|||
49030735|NCT03375463|157949087|FG002|Period 1|Adverse Event|0|||
48783659|NCT02641080|157048283|FG000|Overall Study|Physician Decision|2|||
48783660|NCT02641080|157048284|FG001|Overall Study|Physician Decision|0|||
48783661|NCT02641080|157048283|FG000|Overall Study|Withdrawal by Subject|0|||
48783662|NCT02641080|157048284|FG001|Overall Study|Withdrawal by Subject|1|||
48783663|NCT02641080|157048283|FG000|Overall Study|Rehab Center denied use of pumps|0|||
49030736|NCT03375463|157949088|FG003|Period 1|Adverse Event|0|||
48783664|NCT02641080|157048284|FG001|Overall Study|Rehab Center denied use of pumps|3|||
49030737|NCT03375463|157949089|FG004|Period 1|Adverse Event|1|||
49030738|NCT03375463|157949090|FG005|Period 1|Adverse Event|0|||
49030739|NCT03375463|157949085|FG000|Period 2|Lost to Follow-up|1|||
49030740|NCT03375463|157949086|FG001|Period 2|Lost to Follow-up|1|||
49030741|NCT03375463|157949087|FG002|Period 2|Lost to Follow-up|0|||
49030742|NCT03375463|157949088|FG003|Period 2|Lost to Follow-up|0|||
49030743|NCT03375463|157949089|FG004|Period 2|Lost to Follow-up|0|||
49030744|NCT03375463|157949090|FG005|Period 2|Lost to Follow-up|0|||
49030745|NCT01010542|157949104|FG000|Overall Study|Adverse Event|0|||
49030746|NCT01010542|157949105|FG001|Overall Study|Adverse Event|1|||
48783665|NCT02641080|157048283|FG000|Overall Study|Lost to Follow-up|0|||
48783666|NCT02641080|157048284|FG001|Overall Study|Lost to Follow-up|3|||
49030747|NCT01010542|157949106|FG002|Overall Study|Adverse Event|0|||
49030748|NCT01010542|157949104|FG000|Overall Study|Lost to Follow-up|0|||
49030749|NCT01010542|157949105|FG001|Overall Study|Lost to Follow-up|1|||
49030750|NCT01010542|157949106|FG002|Overall Study|Lost to Follow-up|0|||
49030751|NCT01010542|157949104|FG000|Overall Study|Withdrawal by Subject|0|||
49030752|NCT01010542|157949105|FG001|Overall Study|Withdrawal by Subject|3|||
49030753|NCT01010542|157949106|FG002|Overall Study|Withdrawal by Subject|2|||
49030754|NCT01745120|157949107|FG000|Overall Study|Investigator decision|1|||
49030755|NCT01745120|157949108|FG001|Overall Study|Investigator decision|0|||
49030756|NCT02714062|157949111|FG000|Overall Study|Adverse Event|0|||
49030757|NCT02714062|157949112|FG001|Overall Study|Adverse Event|0|||
49030758|NCT02714062|157949113|FG002|Overall Study|Adverse Event|2|||
49030759|NCT02714062|157949111|FG000|Overall Study|Withdrawal by Subject|1|||
49030760|NCT02714062|157949112|FG001|Overall Study|Withdrawal by Subject|0|||
49030761|NCT02714062|157949113|FG002|Overall Study|Withdrawal by Subject|1|||
49030762|NCT02714062|157949111|FG000|Overall Study|Protocol Violation|0|||
49030763|NCT02714062|157949112|FG001|Overall Study|Protocol Violation|1|||
49030764|NCT02714062|157949113|FG002|Overall Study|Protocol Violation|0|||
48783667|NCT00965523|157048285|FG000|Study 221|Progressive Disease|4|||
48783668|NCT00965523|157048285|FG000|Study 221|Physician Decision|3|||
48783669|NCT00965523|157048285|FG000|Study 224|Progressive Disease|5|||
48783670|NCT00965523|157048285|FG000|Study 224|Physician Decision|1|||
48783671|NCT01136291|157048289|FG000|Overall Study|Lost to Follow-up|1|||
48783672|NCT01136291|157048290|FG001|Overall Study|Lost to Follow-up|1|||
48783673|NCT04773587|157048291|FG000|Overall Study|Lost to Follow-up|11|||
48783674|NCT04773587|157048292|FG001|Overall Study|Lost to Follow-up|3|||
48783675|NCT04773587|157048291|FG000|Overall Study|Adverse Event|6|||
48783676|NCT04773587|157048292|FG001|Overall Study|Adverse Event|3|||
48783677|NCT04773587|157048291|FG000|Overall Study|Lack of Efficacy|5|||
48783678|NCT04773587|157048292|FG001|Overall Study|Lack of Efficacy|2|||
48783679|NCT04773587|157048291|FG000|Overall Study|Withdrawal by Subject|4|||
48783680|NCT04773587|157048292|FG001|Overall Study|Withdrawal by Subject|5|||
48783681|NCT04773587|157048291|FG000|Overall Study|Noncompliance|1|||
48783682|NCT04773587|157048292|FG001|Overall Study|Noncompliance|0|||
48783683|NCT04773587|157048291|FG000|Overall Study|Protocol Violation|1|||
48783684|NCT04773587|157048292|FG001|Overall Study|Protocol Violation|0|||
48783685|NCT04773587|157048291|FG000|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|1|||
48783686|NCT04773587|157048292|FG001|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|0|||
48783687|NCT00724971|157048293|FG000|Overall Study|Adverse Event|5|||
48783688|NCT00724971|157048293|FG000|Overall Study|Withdrawal by Subject|1|||
48783689|NCT02194621|157048294|FG000|Overall Study|6 withdrew prior to randomization|2|||
48783690|NCT02194621|157048295|FG001|Overall Study|6 withdrew prior to randomization|2|||
48783691|NCT02194621|157048296|FG002|Overall Study|6 withdrew prior to randomization|2|||
48783692|NCT02194621|157048294|FG000|Overall Study|Withdrawal by Subject|4|||
48783693|NCT02194621|157048295|FG001|Overall Study|Withdrawal by Subject|4|||
48783694|NCT02194621|157048296|FG002|Overall Study|Withdrawal by Subject|7|||
48783695|NCT02345512|157048304|FG000|Overall Study|Adverse Event|1|||
48783696|NCT02345512|157048304|FG000|Overall Study|Withdrawal by Subject|1|||
48783697|NCT00253864|157048305|FG000|Overall Study|Lost to Follow-up|5|||
48783698|NCT00253864|157048306|FG001|Overall Study|Lost to Follow-up|8|||
48783699|NCT00659334|157048307|FG000|Overall Study|Screen Failure|8|||
48783700|NCT00659334|157048308|FG001|Overall Study|Screen Failure|5|||
48783701|NCT00659334|157048309|FG002|Overall Study|Screen Failure|0|||
48783702|NCT00659334|157048310|FG003|Overall Study|Screen Failure|0|||
48783703|NCT00659334|157048311|FG004|Overall Study|Screen Failure|0|||
48783704|NCT00659334|157048312|FG005|Overall Study|Screen Failure|0|||
48783705|NCT00659334|157048313|FG006|Overall Study|Screen Failure|1|||
48783706|NCT01410448|157048314|FG000|Overall Study|No conversion to everolimus|0|||
48783707|NCT01410448|157048315|FG001|Overall Study|No conversion to everolimus|24|||
48783708|NCT01410448|157048314|FG000|Overall Study|Graft loss|4|||
48783709|NCT01410448|157048315|FG001|Overall Study|Graft loss|1|||
49030765|NCT03956862|157949114|FG000|Overall Study|Lost to Follow-up|1|||
49030766|NCT03956862|157949115|FG001|Overall Study|Lost to Follow-up|1|||
49030767|NCT03956862|157949114|FG000|Overall Study|Withdrawal by Subject|1|||
49030768|NCT03956862|157949115|FG001|Overall Study|Withdrawal by Subject|1|||
49030769|NCT01498120|157949116|FG000|Overall Study|Lost to Follow-up|1|||
49030770|NCT01498120|157949116|FG000|Overall Study|Withdrawal by Subject|5|||
49030771|NCT01498120|157949116|FG000|Overall Study|AE, non-serious non-fatal|3|||
49030772|NCT01498120|157949116|FG000|Overall Study|Other|4|||
49030773|NCT02682238|157949119|FG000|Overall Study|Lost to Follow-up|0|||
49030774|NCT02682238|157949120|FG001|Overall Study|Lost to Follow-up|2|||
49030775|NCT02682238|157949119|FG000|Overall Study|Withdrawal by Subject|1|||
49030776|NCT02682238|157949120|FG001|Overall Study|Withdrawal by Subject|0|||
49030777|NCT02682238|157949119|FG000|Overall Study|Adverse Event|1|||
49030778|NCT02682238|157949120|FG001|Overall Study|Adverse Event|0|||
49030779|NCT02682238|157949119|FG000|Overall Study|Non-compliance with Study Drug|1|||
49030780|NCT02682238|157949120|FG001|Overall Study|Non-compliance with Study Drug|0|||
49030781|NCT02682238|157949119|FG000|Overall Study|Non-compliance with Protocol|0|||
49030782|NCT02682238|157949120|FG001|Overall Study|Non-compliance with Protocol|2|||
49030783|NCT01370317|157949123|FG000|Overall Study|Participant withdrew consent|1|||
48983013|NCT01108068|157769970|FG001|Overall Study|5 not started, 1 stop due to side effect|0|||
49030784|NCT01370317|157949124|FG001|Overall Study|Participant withdrew consent|0|||
49030785|NCT01370317|157949123|FG000|Overall Study|Protocol deviation|0|||
48783710|NCT01410448|157048314|FG000|Overall Study|Administrative issues|2|||
48783711|NCT01410448|157048315|FG001|Overall Study|Administrative issues|1|||
48983014|NCT04107935|157769971|FG000|Overall Study|Death|1|||
48983015|NCT04107935|157769972|FG001|Overall Study|Death|0|||
48983016|NCT01376908|157769974|FG000|Overall Study|Protocol Violation|1|||
48983017|NCT01376908|157769975|FG001|Overall Study|Protocol Violation|1|||
48983018|NCT01376908|157769974|FG000|Overall Study|Withdrawal by Subject|1|||
48983019|NCT01376908|157769975|FG001|Overall Study|Withdrawal by Subject|2|||
48983020|NCT00957723|157769978|FG000|Overall Study|Death|3|||
48983021|NCT00957723|157769978|FG000|Overall Study|Revision/ Removal of Study Implant|3|||
48983022|NCT00957723|157769978|FG000|Overall Study|Lost to Follow-up|8|||
48983023|NCT00957723|157769978|FG000|Overall Study|Withdrawal by Subject|24|||
48983024|NCT00957723|157769978|FG000|Overall Study|Investigative Site Terminated|61|||
48783712|NCT01410448|157048314|FG000|Overall Study|Lost to Follow-up|1|||
48783713|NCT01410448|157048315|FG001|Overall Study|Lost to Follow-up|0|||
48783714|NCT01410448|157048314|FG000|Overall Study|Withdrawal by Subject|3|||
48783715|NCT01410448|157048315|FG001|Overall Study|Withdrawal by Subject|2|||
48783716|NCT01410448|157048314|FG000|Overall Study|Protocol Violation|0|||
48783717|NCT01410448|157048315|FG001|Overall Study|Protocol Violation|4|||
48783718|NCT01410448|157048314|FG000|Overall Study|Death|2|||
48783719|NCT01410448|157048315|FG001|Overall Study|Death|3|||
48783720|NCT01308580|157048316|FG000|Overall Study|Lost to Follow-up|12|||
48783721|NCT01308580|157048317|FG001|Overall Study|Lost to Follow-up|7|||
48783722|NCT03712917|157048323|FG000|Overall Study|Pregnancy|0|||
48783723|NCT03712917|157048324|FG001|Overall Study|Pregnancy|0|||
48783724|NCT03712917|157048325|FG002|Overall Study|Pregnancy|1|||
48783725|NCT03712917|157048323|FG000|Overall Study|Adverse Event|0|||
48783726|NCT03712917|157048324|FG001|Overall Study|Adverse Event|4|||
48783727|NCT03712917|157048325|FG002|Overall Study|Adverse Event|3|||
48783728|NCT03712917|157048323|FG000|Overall Study|Lost to Follow-up|9|||
48783729|NCT03712917|157048324|FG001|Overall Study|Lost to Follow-up|4|||
48783730|NCT03712917|157048325|FG002|Overall Study|Lost to Follow-up|5|||
48783731|NCT00110617|157048326|FG000|Overall Study|Adverse Event|2|||
48783732|NCT00110617|157048327|FG001|Overall Study|Adverse Event|4|||
48783733|NCT00110617|157048326|FG000|Overall Study|Abnormal Laboratory Value|4|||
48783734|NCT00110617|157048327|FG001|Overall Study|Abnormal Laboratory Value|2|||
48783735|NCT00110617|157048326|FG000|Overall Study|Lack of Efficacy|1|||
48783736|NCT00110617|157048327|FG001|Overall Study|Lack of Efficacy|0|||
48783737|NCT00110617|157048326|FG000|Overall Study|Patient no longer requires study drug|1|||
48983025|NCT00957723|157769978|FG000|Overall Study|Intercurrent Illness|2|||
48983026|NCT00957723|157769978|FG000|Overall Study|2yr ROM Data Not Evaluable|12|||
48983027|NCT00877890|157769979|FG000|Overall Study|Adverse Event|6|||
49030786|NCT01370317|157949124|FG001|Overall Study|Protocol deviation|1|||
49030787|NCT03128723|157949126|FG000|Overall Study|Withdrawal by Subject|2|||
49030788|NCT00579670|157949129|FG000|Overall Study|Death|1|||
48783738|NCT00110617|157048327|FG001|Overall Study|Patient no longer requires study drug|0|||
48783739|NCT00110617|157048326|FG000|Overall Study|Protocol Violation|5|||
48783740|NCT00110617|157048327|FG001|Overall Study|Protocol Violation|0|||
48783741|NCT00110617|157048326|FG000|Overall Study|Withdrawal by Subject|10|||
48783742|NCT00110617|157048327|FG001|Overall Study|Withdrawal by Subject|4|||
48983028|NCT00877890|157769980|FG001|Overall Study|Adverse Event|6|||
49030789|NCT00579670|157949130|FG001|Overall Study|Death|0|||
49030790|NCT00579670|157949131|FG002|Overall Study|Death|0|||
48783743|NCT00110617|157048326|FG000|Overall Study|Lost to Follow-up|9|||
48783744|NCT00110617|157048327|FG001|Overall Study|Lost to Follow-up|1|||
48783745|NCT00110617|157048326|FG000|Overall Study|Administrative problems|6|||
48783746|NCT00110617|157048327|FG001|Overall Study|Administrative problems|5|||
48783747|NCT00110617|157048326|FG000|Overall Study|Death|1|||
48783748|NCT00110617|157048327|FG001|Overall Study|Death|1|||
48783749|NCT00110617|157048326|FG000|Overall Study|Did not receive study drug|0|||
48783750|NCT00110617|157048327|FG001|Overall Study|Did not receive study drug|12|||
48783751|NCT00618514|157049990|FG000|Overall Study|Lost to Follow-up|11|||
48783752|NCT00618514|157049991|FG001|Overall Study|Lost to Follow-up|12|||
49030791|NCT00579670|157949132|FG003|Overall Study|Death|0|||
49030792|NCT00579670|157949133|FG004|Overall Study|Death|0|||
49030793|NCT00579670|157949129|FG000|Overall Study|Adverse Event|1|||
49030794|NCT00579670|157949130|FG001|Overall Study|Adverse Event|0|||
49030795|NCT00579670|157949131|FG002|Overall Study|Adverse Event|1|||
49030796|NCT00579670|157949132|FG003|Overall Study|Adverse Event|2|||
49030797|NCT00579670|157949133|FG004|Overall Study|Adverse Event|0|||
49030798|NCT00579670|157949129|FG000|Overall Study|Lack of Efficacy|0|||
49030799|NCT00579670|157949130|FG001|Overall Study|Lack of Efficacy|0|||
49030800|NCT00579670|157949131|FG002|Overall Study|Lack of Efficacy|1|||
49030801|NCT00579670|157949132|FG003|Overall Study|Lack of Efficacy|14|||
49030802|NCT00579670|157949133|FG004|Overall Study|Lack of Efficacy|0|||
49030803|NCT00579670|157949129|FG000|Overall Study|Lost to Follow-up|0|||
49030804|NCT00579670|157949130|FG001|Overall Study|Lost to Follow-up|1|||
49030805|NCT00579670|157949131|FG002|Overall Study|Lost to Follow-up|0|||
49030806|NCT00579670|157949132|FG003|Overall Study|Lost to Follow-up|4|||
49030807|NCT00579670|157949133|FG004|Overall Study|Lost to Follow-up|0|||
49030808|NCT00579670|157949129|FG000|Overall Study|Other|0|||
49030809|NCT00579670|157949130|FG001|Overall Study|Other|0|||
49030810|NCT00579670|157949131|FG002|Overall Study|Other|1|||
49030811|NCT00579670|157949132|FG003|Overall Study|Other|2|||
49030812|NCT00579670|157949133|FG004|Overall Study|Other|0|||
49030813|NCT00579670|157949129|FG000|Overall Study|Withdrawal by Subject|0|||
49030814|NCT00579670|157949130|FG001|Overall Study|Withdrawal by Subject|0|||
49030815|NCT00579670|157949131|FG002|Overall Study|Withdrawal by Subject|1|||
49030816|NCT00579670|157949132|FG003|Overall Study|Withdrawal by Subject|0|||
49030817|NCT00579670|157949133|FG004|Overall Study|Withdrawal by Subject|0|||
49030818|NCT02909907|157949136|FG000|Overall Study|Withdrawal by Subject|0|||
49030819|NCT02909907|157949137|FG001|Overall Study|Withdrawal by Subject|1|||
49030820|NCT02902211|157949138|FG000|First Three Months|Withdrawal by Subject|7|||
49030821|NCT02902211|157949139|FG001|First Three Months|Withdrawal by Subject|3|||
49030822|NCT00075478|157949143|FG000|Overall Study|not eligible|1|||
49030823|NCT00075478|157949144|FG001|Overall Study|not eligible|0|||
49030824|NCT00075478|157949143|FG000|Overall Study|Physician Decision|0|||
49030825|NCT00075478|157949144|FG001|Overall Study|Physician Decision|1|||
49030826|NCT01513174|157949150|FG000|Overall Study|Inclusion Error|1|||
49030827|NCT01513174|157949151|FG001|Overall Study|Inclusion Error|7|||
49030828|NCT01513174|157949150|FG000|Overall Study|Not receive study treatment|3|||
49030829|NCT01513174|157949151|FG001|Overall Study|Not receive study treatment|1|||
49030830|NCT00850174|157949152|FG000|Washout: One Week|Withdrawal by Subject|0|||
49030831|NCT00850174|157949153|FG001|Washout: One Week|Withdrawal by Subject|2|||
49030832|NCT00850174|157949152|FG000|Second Intervention|Withdrawal by Subject|1|||
49030833|NCT00850174|157949153|FG001|Second Intervention|Withdrawal by Subject|0|||
49030834|NCT01900626|157949154|FG000|Overall Study|study was closed due to low enrollment|1|||
49030835|NCT01900626|157949155|FG001|Overall Study|study was closed due to low enrollment|1|||
49030836|NCT02057458|157949165|FG000|Met Inclusion Criteria|Prior history of migraine headaches|0|||
49030837|NCT02057458|157949166|FG001|Met Inclusion Criteria|Prior history of migraine headaches|1|||
49030838|NCT02057458|157949167|FG002|Met Inclusion Criteria|Prior history of migraine headaches|0|||
49030839|NCT02057458|157949165|FG000|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2|||
49030840|NCT02057458|157949166|FG001|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
49030841|NCT02057458|157949167|FG002|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
49030842|NCT02057458|157949165|FG000|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1|||
49030843|NCT02057458|157949166|FG001|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
49030844|NCT02057458|157949167|FG002|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
49030845|NCT04263649|157949168|FG000|Overall Study|Adverse Event|53|||
49030846|NCT04263649|157949168|FG000|Overall Study|Lost to Follow-up|3|||
49030847|NCT04263649|157949168|FG000|Overall Study|Death|29|||
49030848|NCT04263649|157949168|FG000|Overall Study|Device deficiency|19|||
49030849|NCT04263649|157949168|FG000|Overall Study|other reasons|11|||
48783753|NCT00618514|157049992|FG002|Overall Study|Lost to Follow-up|4|||
49030850|NCT01171963|157949169|FG000|Overall Study|Adverse Event|10|||
49030851|NCT01171963|157949170|FG001|Overall Study|Adverse Event|15|||
48783754|NCT01760954|157049993|FG000|Treatment Period (6 Months)|Withdrawal by Subject|8|||
48783755|NCT01760954|157049994|FG001|Treatment Period (6 Months)|Withdrawal by Subject|8|||
49030852|NCT01171963|157949169|FG000|Overall Study|Lost to Follow-up|23|||
49030853|NCT01171963|157949170|FG001|Overall Study|Lost to Follow-up|24|||
49030854|NCT01171963|157949169|FG000|Overall Study|Other - diarrhoea|1|||
49030855|NCT01171963|157949170|FG001|Overall Study|Other - diarrhoea|0|||
49030856|NCT01171963|157949169|FG000|Overall Study|Withdrawal by Subject|114|||
49030857|NCT01171963|157949170|FG001|Overall Study|Withdrawal by Subject|129|||
49030858|NCT01615198|157949174|FG000|Overall Study|Withdrawal by Subject|5|||
49030859|NCT01615198|157949175|FG001|Overall Study|Withdrawal by Subject|5|||
49030860|NCT01615198|157949174|FG000|Overall Study|Protocol deviation|1|||
49030861|NCT01615198|157949175|FG001|Overall Study|Protocol deviation|1|||
49030862|NCT01615198|157949174|FG000|Overall Study|Physician Decision|5|||
49030863|NCT01615198|157949175|FG001|Overall Study|Physician Decision|1|||
49030864|NCT01615198|157949174|FG000|Overall Study|Lost to Follow-up|1|||
49030865|NCT01615198|157949175|FG001|Overall Study|Lost to Follow-up|1|||
49030866|NCT01615198|157949174|FG000|Overall Study|Lack of Efficacy|1|||
49030867|NCT01615198|157949175|FG001|Overall Study|Lack of Efficacy|6|||
49030868|NCT01615198|157949174|FG000|Overall Study|Adverse Event|11|||
49030869|NCT01615198|157949175|FG001|Overall Study|Adverse Event|5|||
49030870|NCT03236311|157949176|FG000|Overall Study|Study terminated by sponsor|0|||
49030871|NCT03236311|157949177|FG001|Overall Study|Study terminated by sponsor|2|||
49030872|NCT03236311|157949176|FG000|Overall Study|Adverse Event|0|||
48783756|NCT01760954|157049995|FG002|Treatment Period (6 Months)|Withdrawal by Subject|4|||
48783757|NCT01760954|157049996|FG003|Treatment Period (6 Months)|Withdrawal by Subject|5|||
48783758|NCT01760954|157049993|FG000|Treatment Period (6 Months)|Adverse Event|5|||
48783759|NCT01760954|157049994|FG001|Treatment Period (6 Months)|Adverse Event|3|||
48783760|NCT01760954|157049995|FG002|Treatment Period (6 Months)|Adverse Event|4|||
48783761|NCT01760954|157049996|FG003|Treatment Period (6 Months)|Adverse Event|10|||
48783762|NCT01760954|157049993|FG000|Treatment Period (6 Months)|Lost to Follow-up|9|||
48783763|NCT01760954|157049994|FG001|Treatment Period (6 Months)|Lost to Follow-up|1|||
48783764|NCT01760954|157049995|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
48783765|NCT01760954|157049996|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
48783766|NCT01760954|157049993|FG000|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
48783767|NCT01760954|157049994|FG001|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
48783768|NCT01760954|157049995|FG002|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
48783769|NCT01760954|157049996|FG003|Treatment Period (6 Months)|Surgery or invasive intervention for end|2|||
48783770|NCT01760954|157049993|FG000|Treatment Period (6 Months)|Pregnancy|5|||
48783771|NCT01760954|157049994|FG001|Treatment Period (6 Months)|Pregnancy|0|||
48783772|NCT01760954|157049995|FG002|Treatment Period (6 Months)|Pregnancy|3|||
48783773|NCT01760954|157049996|FG003|Treatment Period (6 Months)|Pregnancy|2|||
48783774|NCT01760954|157049993|FG000|Treatment Period (6 Months)|Non-compliance|1|||
48783775|NCT01760954|157049994|FG001|Treatment Period (6 Months)|Non-compliance|4|||
49030873|NCT03236311|157949177|FG001|Overall Study|Adverse Event|1|||
49030874|NCT01757392|157949178|FG000|Overall Study|Withdrawal by Subject|1|||
49030875|NCT01757392|157949178|FG000|Overall Study|Screen Fail|3|||
49030876|NCT02388191|157949185|FG000|Overall Study|Patient did not receive IUD|1|||
49030877|NCT02388191|157949186|FG001|Overall Study|Patient did not receive IUD|0|||
48783776|NCT01760954|157049995|FG002|Treatment Period (6 Months)|Non-compliance|0|||
48783777|NCT01760954|157049996|FG003|Treatment Period (6 Months)|Non-compliance|3|||
48783778|NCT01760954|157049993|FG000|Treatment Period (6 Months)|Other|0|||
48783779|NCT01760954|157049994|FG001|Treatment Period (6 Months)|Other|3|||
48783780|NCT01760954|157049995|FG002|Treatment Period (6 Months)|Other|3|||
48783781|NCT01760954|157049996|FG003|Treatment Period (6 Months)|Other|1|||
48783782|NCT01760954|157049993|FG000|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1|||
48783783|NCT01760954|157049994|FG001|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6|||
48783784|NCT01760954|157049995|FG002|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
48783785|NCT01760954|157049996|FG003|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
48783786|NCT01760954|157049993|FG000|Treatment Period (6 Months)|Exclusionary Medication|1|||
48783787|NCT01760954|157049994|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
48783788|NCT01760954|157049995|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
48783789|NCT01760954|157049996|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
48783790|NCT01760954|157049993|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
48783791|NCT01760954|157049994|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
48783792|NCT01760954|157049995|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
48783793|NCT01760954|157049996|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9|||
48783794|NCT01760954|157049993|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4|||
48783795|NCT01760954|157049994|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7|||
48783796|NCT01760954|157049995|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2|||
48783797|NCT01760954|157049996|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0|||
48783798|NCT01760954|157049993|FG000|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6|||
48783799|NCT01760954|157049994|FG001|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10|||
49030878|NCT03135834|157949187|FG000|Stage 1|Adverse Event|1|||
49030879|NCT03135834|157949188|FG001|Stage 1|Adverse Event|2|||
49030880|NCT03135834|157949189|FG002|Stage 1|Adverse Event|2|||
49030881|NCT03135834|157949190|FG003|Stage 1|Adverse Event|1|||
49030882|NCT03135834|157949187|FG000|Stage 1|Death|1|||
49030883|NCT03135834|157949188|FG001|Stage 1|Death|0|||
49030884|NCT03135834|157949189|FG002|Stage 1|Death|0|||
49030885|NCT03135834|157949190|FG003|Stage 1|Death|0|||
49030886|NCT03135834|157949187|FG000|Stage 1|Lost to Follow-up|17|||
49030887|NCT03135834|157949188|FG001|Stage 1|Lost to Follow-up|24|||
49030888|NCT03135834|157949189|FG002|Stage 1|Lost to Follow-up|21|||
49030889|NCT03135834|157949190|FG003|Stage 1|Lost to Follow-up|38|||
49030890|NCT03135834|157949187|FG000|Stage 1|No longer met eligibility criteria|1|||
49030891|NCT03135834|157949188|FG001|Stage 1|No longer met eligibility criteria|6|||
49030892|NCT03135834|157949189|FG002|Stage 1|No longer met eligibility criteria|2|||
49030893|NCT03135834|157949190|FG003|Stage 1|No longer met eligibility criteria|5|||
49030894|NCT03135834|157949187|FG000|Stage 1|Other|0|||
49030895|NCT03135834|157949188|FG001|Stage 1|Other|2|||
49030896|NCT03135834|157949189|FG002|Stage 1|Other|1|||
49030897|NCT03135834|157949190|FG003|Stage 1|Other|0|||
49030898|NCT03135834|157949187|FG000|Stage 1|Physician Decision|0|||
49030899|NCT03135834|157949188|FG001|Stage 1|Physician Decision|1|||
49030900|NCT03135834|157949189|FG002|Stage 1|Physician Decision|0|||
49030901|NCT03135834|157949190|FG003|Stage 1|Physician Decision|0|||
49030902|NCT03135834|157949187|FG000|Stage 1|Pregnancy|0|||
49030903|NCT03135834|157949188|FG001|Stage 1|Pregnancy|4|||
49030904|NCT03135834|157949189|FG002|Stage 1|Pregnancy|2|||
49030905|NCT03135834|157949190|FG003|Stage 1|Pregnancy|4|||
49030906|NCT03135834|157949187|FG000|Stage 1|Protocol Violation|1|||
49030907|NCT03135834|157949188|FG001|Stage 1|Protocol Violation|1|||
49030908|NCT03135834|157949189|FG002|Stage 1|Protocol Violation|2|||
49030909|NCT03135834|157949190|FG003|Stage 1|Protocol Violation|1|||
49030910|NCT03135834|157949187|FG000|Stage 1|Withdrawal by parent/guardian|2|||
49030911|NCT03135834|157949188|FG001|Stage 1|Withdrawal by parent/guardian|10|||
49030912|NCT03135834|157949189|FG002|Stage 1|Withdrawal by parent/guardian|2|||
49030913|NCT03135834|157949190|FG003|Stage 1|Withdrawal by parent/guardian|1|||
49030914|NCT03135834|157949187|FG000|Stage 1|Withdrawal by Subject|16|||
49030915|NCT03135834|157949188|FG001|Stage 1|Withdrawal by Subject|22|||
49030916|NCT03135834|157949189|FG002|Stage 1|Withdrawal by Subject|7|||
49030917|NCT03135834|157949190|FG003|Stage 1|Withdrawal by Subject|10|||
49030918|NCT03135834|157949187|FG000|Stage 1|Randomized but not Vaccinated|0|||
49030919|NCT03135834|157949188|FG001|Stage 1|Randomized but not Vaccinated|3|||
49030920|NCT03135834|157949189|FG002|Stage 1|Randomized but not Vaccinated|1|||
49030921|NCT03135834|157949190|FG003|Stage 1|Randomized but not Vaccinated|6|||
49030922|NCT03135834|157949187|FG000|Stage 2|Lost to Follow-up|0|||
49030923|NCT03135834|157949188|FG001|Stage 2|Lost to Follow-up|1|||
49030924|NCT03135834|157949189|FG002|Stage 2|Lost to Follow-up|0|||
49030925|NCT03135834|157949190|FG003|Stage 2|Lost to Follow-up|0|||
49030926|NCT03135834|157949187|FG000|Stage 2|Withdrawal by Subject|0|||
49030927|NCT03135834|157949188|FG001|Stage 2|Withdrawal by Subject|1|||
49030928|NCT03135834|157949189|FG002|Stage 2|Withdrawal by Subject|0|||
49030929|NCT03135834|157949190|FG003|Stage 2|Withdrawal by Subject|0|||
49030930|NCT03135834|157949187|FG000|Stage 2|Withdrawn Before Booster Vaccination|46|||
49030931|NCT03135834|157949188|FG001|Stage 2|Withdrawn Before Booster Vaccination|24|||
49030932|NCT03135834|157949189|FG002|Stage 2|Withdrawn Before Booster Vaccination|24|||
49030933|NCT03135834|157949190|FG003|Stage 2|Withdrawn Before Booster Vaccination|15|||
49030934|NCT03135834|157949187|FG000|Stage 2|Did not receive Booster Vaccination|1|||
48783800|NCT01760954|157049995|FG002|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
48783801|NCT01760954|157049996|FG003|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
48783802|NCT01760954|157049993|FG000|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1|||
48783803|NCT01760954|157049994|FG001|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4|||
48783804|NCT01760954|157049995|FG002|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
48783805|NCT01760954|157049996|FG003|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
48783806|NCT01760954|157049993|FG000|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
48783807|NCT01760954|157049994|FG001|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
48783808|NCT01760954|157049995|FG002|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1|||
48783809|NCT01760954|157049996|FG003|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
48783810|NCT01760954|157049993|FG000|Post-treatment Follow-up (12 Months)|Other|13|||
48783811|NCT01760954|157049994|FG001|Post-treatment Follow-up (12 Months)|Other|8|||
49030935|NCT03135834|157949188|FG001|Stage 2|Did not receive Booster Vaccination|1|||
49030936|NCT03135834|157949189|FG002|Stage 2|Did not receive Booster Vaccination|0|||
49030937|NCT03135834|157949190|FG003|Stage 2|Did not receive Booster Vaccination|0|||
48783812|NCT01760954|157049995|FG002|Post-treatment Follow-up (12 Months)|Other|9|||
48783813|NCT01760954|157049996|FG003|Post-treatment Follow-up (12 Months)|Other|6|||
48783814|NCT03564496|157049997|FG000|Overall Study|Withdrawal by Subject|1|||
48783815|NCT03564496|157049998|FG001|Overall Study|Withdrawal by Subject|1|||
48783816|NCT03564496|157049999|FG002|Overall Study|Withdrawal by Subject|0|||
48783817|NCT03564496|157049997|FG000|Overall Study|Screen failure|0|||
48783818|NCT03564496|157049998|FG001|Overall Study|Screen failure|3|||
48783819|NCT03564496|157049999|FG002|Overall Study|Screen failure|0|||
48783820|NCT02696850|157050001|FG000|Overall Study|Withdrawal by Subject|3|||
49030938|NCT00576056|157949193|FG000|Overall Study|Adverse Event|1|||
49030939|NCT00576056|157949193|FG000|Overall Study|Death|1|||
49030940|NCT00576056|157949193|FG000|Overall Study|Lack of Efficacy|1|||
49030941|NCT00576056|157949193|FG000|Overall Study|Withdrawal by Subject|2|||
49030942|NCT00576056|157949193|FG000|Overall Study|did not meet eligibility criteria|8|||
49030943|NCT00576056|157949193|FG000|Overall Study|Physician Decision|1|||
49030944|NCT03197883|157949194|FG000|Overall Study|Adverse Event|1|||
49030945|NCT03197883|157949195|FG001|Overall Study|Adverse Event|1|||
49030946|NCT03197883|157949194|FG000|Overall Study|Lost to Follow-up|1|||
49030947|NCT03197883|157949195|FG001|Overall Study|Lost to Follow-up|0|||
49030948|NCT03197883|157949194|FG000|Overall Study|Protocol Violation|1|||
49030949|NCT03197883|157949195|FG001|Overall Study|Protocol Violation|0|||
49030950|NCT03197883|157949194|FG000|Overall Study|Other (Not Specified)|0|||
49030951|NCT03197883|157949195|FG001|Overall Study|Other (Not Specified)|5|||
49030952|NCT01854047|157949196|FG000|Overall Study|Lack of Efficacy|1|||
49030953|NCT01854047|157949197|FG001|Overall Study|Lack of Efficacy|0|||
49030954|NCT01854047|157949198|FG002|Overall Study|Lack of Efficacy|0|||
49030955|NCT01854047|157949199|FG003|Overall Study|Lack of Efficacy|0|||
49030956|NCT01854047|157949200|FG004|Overall Study|Lack of Efficacy|0|||
49030957|NCT01854047|157949196|FG000|Overall Study|Poor compliance to protocol|3|||
49030958|NCT01854047|157949197|FG001|Overall Study|Poor compliance to protocol|0|||
49030959|NCT01854047|157949198|FG002|Overall Study|Poor compliance to protocol|2|||
49030960|NCT01854047|157949199|FG003|Overall Study|Poor compliance to protocol|0|||
49030961|NCT01854047|157949200|FG004|Overall Study|Poor compliance to protocol|0|||
48783821|NCT02696850|157050002|FG001|Overall Study|Withdrawal by Subject|3|||
48783822|NCT02696850|157050001|FG000|Overall Study|Lost to Follow-up|8|||
48783823|NCT02696850|157050002|FG001|Overall Study|Lost to Follow-up|5|||
48783824|NCT02621606|157050005|FG000|Overall Study|Withdrawal by Subject|0|||
48783825|NCT02621606|157050006|FG001|Overall Study|Withdrawal by Subject|1|||
48783826|NCT02621606|157050007|FG002|Overall Study|Withdrawal by Subject|0|||
48783827|NCT04820673|157050009|FG000|Overall Study|Adverse Event|6|||
48783828|NCT04820673|157050009|FG000|Overall Study|Due to Lack of Effectiveness|1|||
48783829|NCT04820673|157050009|FG000|Overall Study|Pregnancy|1|||
48783830|NCT04820673|157050009|FG000|Overall Study|Voluntary Withdrawal|20|||
48783831|NCT04820673|157050009|FG000|Overall Study|Lost to Follow-up|10|||
48783832|NCT04001829|157050010|FG000|Overall Study|Never start protocol therapy|5|||
48783833|NCT04001829|157050011|FG001|Overall Study|Never start protocol therapy|5|||
48783834|NCT04001829|157050010|FG000|Overall Study|Adverse Event|11|||
48783835|NCT04001829|157050011|FG001|Overall Study|Adverse Event|7|||
48783836|NCT04001829|157050010|FG000|Overall Study|Alternative therapy|1|||
48783837|NCT04001829|157050011|FG001|Overall Study|Alternative therapy|2|||
48783838|NCT04001829|157050010|FG000|Overall Study|Disease progression/relapse|2|||
48783839|NCT04001829|157050011|FG001|Overall Study|Disease progression/relapse|1|||
48783840|NCT04001829|157050010|FG000|Overall Study|Other complicating disease|1|||
48783841|NCT04001829|157050011|FG001|Overall Study|Other complicating disease|0|||
48783842|NCT04001829|157050010|FG000|Overall Study|Withdrawal by Subject|1|||
48783843|NCT04001829|157050011|FG001|Overall Study|Withdrawal by Subject|4|||
48783844|NCT04001829|157050010|FG000|Overall Study|Ineligible|2|||
48783845|NCT04001829|157050011|FG001|Overall Study|Ineligible|2|||
48783846|NCT04001829|157050010|FG000|Overall Study|Reason missing due to delinquent data|1|||
48783847|NCT04001829|157050011|FG001|Overall Study|Reason missing due to delinquent data|0|||
48783848|NCT00086346|157050012|FG000|Randomization|Did not receive test article|4|||
48783849|NCT00086346|157050013|FG001|Randomization|Did not receive test article|4|||
48783850|NCT00086346|157050012|FG000|Patients Dosed With Test Article|Adverse Event|94|||
48783851|NCT00086346|157050013|FG001|Patients Dosed With Test Article|Adverse Event|11|||
48783852|NCT00086346|157050012|FG000|Patients Dosed With Test Article|Lost to Follow-up|1|||
48783853|NCT00086346|157050013|FG001|Patients Dosed With Test Article|Lost to Follow-up|3|||
48783854|NCT00086346|157050012|FG000|Patients Dosed With Test Article|Nonmedical event|7|||
48783855|NCT00086346|157050013|FG001|Patients Dosed With Test Article|Nonmedical event|3|||
48783856|NCT00086346|157050012|FG000|Patients Dosed With Test Article|Withdrawal by Subject|16|||
48783857|NCT00086346|157050013|FG001|Patients Dosed With Test Article|Withdrawal by Subject|3|||
49030962|NCT01854047|157949196|FG000|Overall Study|Adverse Event|5|||
49030963|NCT01854047|157949197|FG001|Overall Study|Adverse Event|4|||
49030964|NCT01854047|157949198|FG002|Overall Study|Adverse Event|6|||
49030965|NCT01854047|157949199|FG003|Overall Study|Adverse Event|10|||
49030966|NCT01854047|157949200|FG004|Overall Study|Adverse Event|7|||
49030967|NCT01854047|157949196|FG000|Overall Study|Randomized but not treated|0|||
49030968|NCT01854047|157949197|FG001|Overall Study|Randomized but not treated|1|||
49030969|NCT01854047|157949198|FG002|Overall Study|Randomized but not treated|2|||
49030970|NCT01854047|157949199|FG003|Overall Study|Randomized but not treated|0|||
48783858|NCT00086346|157050012|FG000|Patients Dosed With Test Article|Protocol Violation|11|||
48783859|NCT00086346|157050013|FG001|Patients Dosed With Test Article|Protocol Violation|3|||
48783860|NCT00086346|157050012|FG000|Patients Dosed With Test Article|Lack of Efficacy|11|||
48783861|NCT00086346|157050013|FG001|Patients Dosed With Test Article|Lack of Efficacy|0|||
48877507|NCT00543062|157390075|FG000|Overall Study|Protocol Violation|1|||
48877508|NCT00543062|157390076|FG001|Overall Study|Protocol Violation|0|||
48783862|NCT04495374|157050014|FG000|Overall Study|Protocol Violation|2|||
48783863|NCT04495374|157050015|FG001|Overall Study|Protocol Violation|1|||
48783864|NCT00353704|157050016|FG000|Overall Study|Protocol Violation|3|||
48783865|NCT00353704|157050017|FG001|Overall Study|Protocol Violation|1|||
48783866|NCT02807948|157050018|FG000|Overall Study|Physician Decision|1|||
49030971|NCT01854047|157949200|FG004|Overall Study|Randomized but not treated|4|||
49030972|NCT01854047|157949196|FG000|Overall Study|Other than specified above|3|||
49030973|NCT01854047|157949197|FG001|Overall Study|Other than specified above|3|||
49030974|NCT01854047|157949198|FG002|Overall Study|Other than specified above|3|||
49030975|NCT01854047|157949199|FG003|Overall Study|Other than specified above|5|||
48783867|NCT02807948|157050019|FG001|Overall Study|Physician Decision|0|||
48783868|NCT01303627|157050021|FG000|Overall Study|the failure while performing URS|0|||
48783869|NCT01303627|157050022|FG001|Overall Study|the failure while performing URS|1|||
48783870|NCT02416791|157050023|FG000|6 Months|Lost to Follow-up|0|||
48783871|NCT02416791|157050024|FG001|6 Months|Lost to Follow-up|0|||
48783872|NCT02416791|157050025|FG002|6 Months|Lost to Follow-up|1|||
48783873|NCT00406029|157050034|FG000|Overall Study|Adverse Event|12|||
48783874|NCT00406029|157050035|FG001|Overall Study|Adverse Event|2|||
48783875|NCT00406029|157050036|FG002|Overall Study|Adverse Event|5|||
48783876|NCT00406029|157050037|FG003|Overall Study|Adverse Event|10|||
48783877|NCT00406029|157050038|FG004|Overall Study|Adverse Event|7|||
48783878|NCT00406029|157050034|FG000|Overall Study|Withdrawal by Subject|3|||
48783879|NCT00406029|157050035|FG001|Overall Study|Withdrawal by Subject|4|||
49030976|NCT01854047|157949200|FG004|Overall Study|Other than specified above|8|||
49030977|NCT03966365|157949201|FG000|Overall Study|Protocol Violation|1|||
49030978|NCT03966365|157949202|FG001|Overall Study|Protocol Violation|0|||
49030979|NCT01841554|157949207|FG000|Overall Study|Death|7|||
49030980|NCT01841554|157949207|FG000|Overall Study|No Implantation|1|||
49030981|NCT01841554|157949207|FG000|Overall Study|Discontinued Follow Up|5|||
49030982|NCT01841554|157949207|FG000|Overall Study|Study exit due to secondary intervention|6|||
49030983|NCT00312897|157949208|FG000|Overall Study|Adverse Event|1|||
49030984|NCT00312897|157949209|FG001|Overall Study|Adverse Event|0|||
49030985|NCT00312897|157949208|FG000|Overall Study|Lost to Follow-up|2|||
49030986|NCT00312897|157949209|FG001|Overall Study|Lost to Follow-up|0|||
49030987|NCT00312897|157949208|FG000|Overall Study|Physician Decision|1|||
48783880|NCT00406029|157050036|FG002|Overall Study|Withdrawal by Subject|2|||
49030988|NCT00312897|157949209|FG001|Overall Study|Physician Decision|0|||
49030989|NCT00312897|157949208|FG000|Overall Study|Withdrawal by Subject|1|||
49030990|NCT00312897|157949209|FG001|Overall Study|Withdrawal by Subject|3|||
49030991|NCT00312897|157949208|FG000|Overall Study|Pregnancy|1|||
49030992|NCT00312897|157949209|FG001|Overall Study|Pregnancy|0|||
49030993|NCT00312897|157949208|FG000|Overall Study|discontinued prior to getting treatment|0|||
49030994|NCT00312897|157949209|FG001|Overall Study|discontinued prior to getting treatment|3|||
49030995|NCT01473953|157949210|FG000|Overall Study|Other|1|||
48783881|NCT00406029|157050037|FG003|Overall Study|Withdrawal by Subject|2|||
49030996|NCT01473953|157949211|FG001|Overall Study|Other|0|||
49030997|NCT01473953|157949212|FG002|Overall Study|Other|0|||
49030998|NCT01473953|157949213|FG003|Overall Study|Other|0|||
49030999|NCT01473953|157949214|FG004|Overall Study|Other|0|||
49031000|NCT00397488|157950755|FG000|Overall Study|Withdrawal by Subject|3|||
49031001|NCT00397488|157950755|FG000|Overall Study|Adverse Event|3|||
49031002|NCT00397488|157950755|FG000|Overall Study|Death|1|||
48783882|NCT00406029|157050038|FG004|Overall Study|Withdrawal by Subject|0|||
48783883|NCT00406029|157050034|FG000|Overall Study|Protocol Violation|1|||
48783884|NCT00406029|157050035|FG001|Overall Study|Protocol Violation|2|||
48783885|NCT00406029|157050036|FG002|Overall Study|Protocol Violation|0|||
48783886|NCT00406029|157050037|FG003|Overall Study|Protocol Violation|2|||
48783887|NCT00406029|157050038|FG004|Overall Study|Protocol Violation|0|||
48783888|NCT00406029|157050034|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
48783889|NCT00406029|157050035|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
48783890|NCT00406029|157050036|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
48783891|NCT00406029|157050037|FG003|Overall Study|Did Not Meet Eligibility Criteria|0|||
48783892|NCT00406029|157050038|FG004|Overall Study|Did Not Meet Eligibility Criteria|0|||
48783893|NCT00406029|157050034|FG000|Overall Study|Randomized in Error|0|||
48783894|NCT00406029|157050035|FG001|Overall Study|Randomized in Error|0|||
48783895|NCT00406029|157050036|FG002|Overall Study|Randomized in Error|2|||
48783896|NCT00406029|157050037|FG003|Overall Study|Randomized in Error|3|||
48783897|NCT00406029|157050038|FG004|Overall Study|Randomized in Error|1|||
48783898|NCT02519504|157050042|FG000|Overall Study|Protocol Violation|6|||
48783899|NCT02519504|157050043|FG001|Overall Study|Protocol Violation|5|||
48783900|NCT02519504|157050042|FG000|Overall Study|Ineligible for direct testing|12|||
48783901|NCT02519504|157050043|FG001|Overall Study|Ineligible for direct testing|12|||
48783902|NCT02519504|157050042|FG000|Overall Study|Did not participate in direct testing|95|||
48783903|NCT02519504|157050043|FG001|Overall Study|Did not participate in direct testing|86|||
49031003|NCT01215981|157950756|FG000|Overall Study|Physician Decision|0|||
49031004|NCT01215981|157950757|FG001|Overall Study|Physician Decision|1|||
49031005|NCT01215981|157950756|FG000|Overall Study|Protocol Violation|1|||
49031006|NCT01215981|157950757|FG001|Overall Study|Protocol Violation|0|||
48783904|NCT00856856|157050044|FG000|2-year Clinical Follow-up|Lost to Follow-up|1|||
49031007|NCT01215981|157950756|FG000|Overall Study|Withdrawal by Subject|1|||
49031008|NCT01215981|157950757|FG001|Overall Study|Withdrawal by Subject|0|||
49031009|NCT04032977|157950758|FG000|Overall Study|Withdrawal by Subject|6|||
49031010|NCT04032977|157950759|FG001|Overall Study|Withdrawal by Subject|1|||
48783905|NCT00856856|157050044|FG000|4-year Clinical Follow-up|Missed visit|1|||
48783906|NCT02473952|157050049|FG000|Overall Study|Adverse Event|2|||
48783907|NCT02473952|157050050|FG001|Overall Study|Adverse Event|2|||
48783908|NCT02473952|157050049|FG000|Overall Study|Withdrawal by Subject|0|||
48783909|NCT02473952|157050050|FG001|Overall Study|Withdrawal by Subject|6|||
48783910|NCT01205685|157050051|FG000|Overall Study|Disease Progression|10|||
48783911|NCT01205685|157050051|FG000|Overall Study|Withdrawal by Subject|1|||
48783912|NCT03349710|157050052|FG000|Treatment Period|Death|0|||
48783913|NCT03349710|157050053|FG001|Treatment Period|Death|0|||
48783914|NCT03349710|157050054|FG002|Treatment Period|Death|1|||
48783915|NCT03349710|157050055|FG003|Treatment Period|Death|0|||
48783916|NCT03349710|157050052|FG000|Treatment Period|Disease Progression|0|||
48783917|NCT03349710|157050053|FG001|Treatment Period|Disease Progression|2|||
48783918|NCT03349710|157050054|FG002|Treatment Period|Disease Progression|0|||
48783919|NCT03349710|157050055|FG003|Treatment Period|Disease Progression|1|||
48783920|NCT03349710|157050052|FG000|Treatment Period|Study Drug Toxicity|1|||
48783921|NCT03349710|157050053|FG001|Treatment Period|Study Drug Toxicity|0|||
48783922|NCT03349710|157050054|FG002|Treatment Period|Study Drug Toxicity|1|||
48783923|NCT03349710|157050055|FG003|Treatment Period|Study Drug Toxicity|1|||
48783924|NCT03349710|157050052|FG000|Treatment Period|Adverse event unrelated to Study Drug|2|||
48783925|NCT03349710|157050053|FG001|Treatment Period|Adverse event unrelated to Study Drug|1|||
48783926|NCT03349710|157050054|FG002|Treatment Period|Adverse event unrelated to Study Drug|1|||
48783927|NCT03349710|157050055|FG003|Treatment Period|Adverse event unrelated to Study Drug|1|||
48783928|NCT03349710|157050052|FG000|Treatment Period|admin reason by sponsor|0|||
48783929|NCT03349710|157050053|FG001|Treatment Period|admin reason by sponsor|7|||
48783930|NCT03349710|157050054|FG002|Treatment Period|admin reason by sponsor|0|||
48783931|NCT03349710|157050055|FG003|Treatment Period|admin reason by sponsor|19|||
48783932|NCT03349710|157050052|FG000|Treatment Period|Other Reason|2|||
48783933|NCT03349710|157050053|FG001|Treatment Period|Other Reason|0|||
48783934|NCT03349710|157050054|FG002|Treatment Period|Other Reason|2|||
48783935|NCT03349710|157050055|FG003|Treatment Period|Other Reason|1|||
48783936|NCT03349710|157050052|FG000|Treatment Period|completed|6|||
48783937|NCT03349710|157050053|FG001|Treatment Period|completed|0|||
48783938|NCT03349710|157050054|FG002|Treatment Period|completed|18|||
48783939|NCT03349710|157050055|FG003|Treatment Period|completed|1|||
48783940|NCT03349710|157050052|FG000|Treatment Period|participant request to discontinue|0|||
49031011|NCT04032977|157950758|FG000|Overall Study|Lost to Follow-up|2|||
49031012|NCT04032977|157950759|FG001|Overall Study|Lost to Follow-up|7|||
49031013|NCT04032977|157950758|FG000|Overall Study|Pregnancy|1|||
49031014|NCT04032977|157950759|FG001|Overall Study|Pregnancy|0|||
48783941|NCT03349710|157050053|FG001|Treatment Period|participant request to discontinue|0|||
48783942|NCT03349710|157050054|FG002|Treatment Period|participant request to discontinue|4|||
48783943|NCT03349710|157050055|FG003|Treatment Period|participant request to discontinue|0|||
48783944|NCT03349710|157050052|FG000|Treatment Period|participant withdrew consent|1|||
48783945|NCT03349710|157050053|FG001|Treatment Period|participant withdrew consent|0|||
48783946|NCT03349710|157050054|FG002|Treatment Period|participant withdrew consent|0|||
48783947|NCT03349710|157050055|FG003|Treatment Period|participant withdrew consent|0|||
48783948|NCT02159482|157050056|FG000|Overall Study|Withdrawal by Subject|2|||
48783949|NCT02159482|157050056|FG000|Overall Study|Physician Decision|3|||
48783950|NCT01202773|157050059|FG000|Overall Study|Adverse Event|4|||
48783951|NCT01202773|157050060|FG001|Overall Study|Adverse Event|5|||
48783952|NCT01202773|157050061|FG002|Overall Study|Adverse Event|5|||
48783953|NCT01202773|157050059|FG000|Overall Study|Lack of Efficacy|5|||
48783954|NCT01202773|157050060|FG001|Overall Study|Lack of Efficacy|4|||
48783955|NCT01202773|157050061|FG002|Overall Study|Lack of Efficacy|9|||
48783956|NCT01202773|157050059|FG000|Overall Study|Entry Criteria Not Met|2|||
48783957|NCT01202773|157050060|FG001|Overall Study|Entry Criteria Not Met|0|||
48783958|NCT01202773|157050061|FG002|Overall Study|Entry Criteria Not Met|1|||
48783959|NCT01202773|157050059|FG000|Overall Study|Lost to Follow-up|1|||
48783960|NCT01202773|157050060|FG001|Overall Study|Lost to Follow-up|2|||
48783961|NCT01202773|157050061|FG002|Overall Study|Lost to Follow-up|2|||
48783962|NCT01202773|157050059|FG000|Overall Study|Withdrawal by Subject|13|||
48783963|NCT01202773|157050060|FG001|Overall Study|Withdrawal by Subject|6|||
49031015|NCT02880761|157950760|FG000|Overall Study|Death|6|||
49031016|NCT02880761|157950761|FG001|Overall Study|Death|8|||
49031017|NCT02880761|157950760|FG000|Overall Study|Withdrawal by Subject|3|||
48783964|NCT01202773|157050061|FG002|Overall Study|Withdrawal by Subject|5|||
48783965|NCT01202773|157050059|FG000|Overall Study|Physician Decision|2|||
48783966|NCT01202773|157050060|FG001|Overall Study|Physician Decision|0|||
49031018|NCT02880761|157950761|FG001|Overall Study|Withdrawal by Subject|6|||
48783967|NCT01202773|157050061|FG002|Overall Study|Physician Decision|0|||
48783968|NCT01202773|157050059|FG000|Overall Study|Protocol Violation|11|||
48783969|NCT01202773|157050060|FG001|Overall Study|Protocol Violation|6|||
48783970|NCT01202773|157050061|FG002|Overall Study|Protocol Violation|10|||
48877509|NCT00543062|157390077|FG002|Overall Study|Protocol Violation|0|||
49031019|NCT02880761|157950760|FG000|Overall Study|Protocol Violation|4|||
48783971|NCT01202773|157050059|FG000|Overall Study|Sponsor Decision|19|||
48783972|NCT01202773|157050060|FG001|Overall Study|Sponsor Decision|20|||
48783973|NCT01202773|157050061|FG002|Overall Study|Sponsor Decision|23|||
48783974|NCT03434119|157050068|FG000|Overall Study|Randomized but not treated|1|||
48783975|NCT03434119|157050069|FG001|Overall Study|Randomized but not treated|0|||
48783976|NCT03434119|157050068|FG000|Overall Study|Adverse Event|1|||
49031020|NCT02880761|157950761|FG001|Overall Study|Protocol Violation|3|||
49031021|NCT02880761|157950760|FG000|Overall Study|Lost to Follow-up|3|||
49031022|NCT02880761|157950761|FG001|Overall Study|Lost to Follow-up|4|||
49031023|NCT03075761|157950762|FG000|Overall Study|Lost to Follow-up|1|||
49031024|NCT03075761|157950763|FG001|Overall Study|Lost to Follow-up|6|||
49031025|NCT01519661|157950764|FG000|Overall Study|Protocol deviation|6|||
49031026|NCT01519661|157950764|FG000|Overall Study|Lost to Follow-up|3|||
49031027|NCT01519661|157950764|FG000|Overall Study|Withdrawal by Subject|17|||
49031028|NCT01519661|157950764|FG000|Overall Study|Lack of Efficacy|6|||
49031029|NCT01519661|157950764|FG000|Overall Study|Adverse Event|29|||
49031030|NCT01139047|157950765|FG000|Overall Study|Withdrawal by Subject|1|||
49031031|NCT03597256|157950766|FG000|Overall Study|Lost to Follow-up|3|||
49031032|NCT03597256|157950767|FG001|Overall Study|Lost to Follow-up|1|||
49031033|NCT03597256|157950766|FG000|Overall Study|Withdrawal by Subject|0|||
49031034|NCT03597256|157950767|FG001|Overall Study|Withdrawal by Subject|1|||
49031035|NCT03597256|157950766|FG000|Overall Study|Could not return for treatment|0|||
49031036|NCT03597256|157950767|FG001|Overall Study|Could not return for treatment|1|||
49031037|NCT03597256|157950766|FG000|Overall Study|Moved from location|0|||
49031038|NCT03597256|157950767|FG001|Overall Study|Moved from location|1|||
48783977|NCT03434119|157050069|FG001|Overall Study|Adverse Event|0|||
48783978|NCT03434119|157050068|FG000|Overall Study|Poor Compliance to Protocol|0|||
48783979|NCT03434119|157050069|FG001|Overall Study|Poor Compliance to Protocol|1|||
48783980|NCT03434119|157050068|FG000|Overall Study|Study Terminated by Sponsor|91|||
48783981|NCT03434119|157050069|FG001|Overall Study|Study Terminated by Sponsor|102|||
48783982|NCT03434119|157050068|FG000|Overall Study|Withdrawal by Subject|7|||
48783983|NCT03434119|157050069|FG001|Overall Study|Withdrawal by Subject|5|||
48783984|NCT03434119|157050068|FG000|Overall Study|Other than specified|7|||
48783985|NCT03434119|157050069|FG001|Overall Study|Other than specified|5|||
48783986|NCT00148343|157050077|FG000|Overall Study|Withdrawal by Subject|12|||
48783987|NCT00148343|157050078|FG001|Overall Study|Withdrawal by Subject|7|||
48783988|NCT00148343|157050077|FG000|Overall Study|Physician Decision|3|||
48783989|NCT00148343|157050078|FG001|Overall Study|Physician Decision|4|||
48783990|NCT00736996|157050082|FG000|Overall Study|Lost to Follow-up|1|||
48783991|NCT00736996|157050083|FG001|Overall Study|Lost to Follow-up|9|||
48783992|NCT00736996|157050084|FG002|Overall Study|Lost to Follow-up|2|||
48783993|NCT00941603|157050085|FG000|Overall Study|Adverse Event|10|||
48783994|NCT00941603|157050086|FG001|Overall Study|Adverse Event|15|||
48783995|NCT00941603|157050087|FG002|Overall Study|Adverse Event|5|||
48783996|NCT00941603|157050088|FG003|Overall Study|Adverse Event|1|||
48783997|NCT00941603|157050089|FG004|Overall Study|Adverse Event|4|||
48783998|NCT00941603|157050090|FG005|Overall Study|Adverse Event|0|||
48783999|NCT00941603|157050085|FG000|Overall Study|Lost to Follow-up|0|||
48784000|NCT00941603|157050086|FG001|Overall Study|Lost to Follow-up|0|||
48784001|NCT00941603|157050087|FG002|Overall Study|Lost to Follow-up|0|||
48784002|NCT00941603|157050088|FG003|Overall Study|Lost to Follow-up|1|||
48784003|NCT00941603|157050089|FG004|Overall Study|Lost to Follow-up|0|||
48784004|NCT00941603|157050090|FG005|Overall Study|Lost to Follow-up|2|||
48784005|NCT00941603|157050085|FG000|Overall Study|Withdrawal by Subject|0|||
48784006|NCT00941603|157050086|FG001|Overall Study|Withdrawal by Subject|0|||
48784007|NCT00941603|157050087|FG002|Overall Study|Withdrawal by Subject|0|||
48784008|NCT00941603|157050088|FG003|Overall Study|Withdrawal by Subject|2|||
48784009|NCT00941603|157050089|FG004|Overall Study|Withdrawal by Subject|0|||
48784010|NCT00941603|157050090|FG005|Overall Study|Withdrawal by Subject|1|||
48784011|NCT00941603|157050085|FG000|Overall Study|Protocol Violation|0|||
48784012|NCT00941603|157050086|FG001|Overall Study|Protocol Violation|1|||
48784013|NCT00941603|157050087|FG002|Overall Study|Protocol Violation|0|||
48784014|NCT00941603|157050088|FG003|Overall Study|Protocol Violation|0|||
48784015|NCT00941603|157050089|FG004|Overall Study|Protocol Violation|0|||
48784016|NCT00941603|157050090|FG005|Overall Study|Protocol Violation|0|||
48784017|NCT00941603|157050085|FG000|Overall Study|Did not meet protocol eligibility|1|||
48784018|NCT00941603|157050086|FG001|Overall Study|Did not meet protocol eligibility|0|||
48784019|NCT00941603|157050087|FG002|Overall Study|Did not meet protocol eligibility|0|||
48877510|NCT00543062|157390078|FG003|Overall Study|Protocol Violation|0|||
48877511|NCT00464945|157390079|FG000|Infant Series|Withdrawal by parent/guardian request|2|||
49031039|NCT03597256|157950766|FG000|Overall Study|Not accepted the treatment|0|||
49031040|NCT03597256|157950767|FG001|Overall Study|Not accepted the treatment|1|||
49031041|NCT02106156|157950768|FG000|Overall Study|Patient Died|19|||
49031042|NCT02106156|157950769|FG001|Overall Study|Patient Died|0|||
49031043|NCT02106156|157950770|FG002|Overall Study|Patient Died|0|||
48784020|NCT00941603|157050088|FG003|Overall Study|Did not meet protocol eligibility|0|||
48784021|NCT00941603|157050089|FG004|Overall Study|Did not meet protocol eligibility|0|||
48784022|NCT00941603|157050090|FG005|Overall Study|Did not meet protocol eligibility|0|||
48784023|NCT00583557|157050091|FG000|Overall Study|Withdrawal by Subject|18|||
48784024|NCT00583557|157050091|FG000|Overall Study|Adverse Event|9|||
48784025|NCT00583557|157050091|FG000|Overall Study|Lack of Efficacy|31|||
48784026|NCT00583557|157050091|FG000|Overall Study|Lack of Compliance|5|||
48784027|NCT00583557|157050091|FG000|Overall Study|Other|5|||
48784028|NCT00583557|157050091|FG000|Overall Study|Did not receive belimumab in LBRA99|2|||
49031044|NCT02106156|157950768|FG000|Overall Study|Lack of Tolerability|305|||
49031045|NCT02106156|157950769|FG001|Overall Study|Lack of Tolerability|3|||
49031046|NCT02106156|157950770|FG002|Overall Study|Lack of Tolerability|0|||
49031047|NCT02106156|157950768|FG000|Overall Study|Lack of Virological Response|1044|||
49031048|NCT02106156|157950769|FG001|Overall Study|Lack of Virological Response|8|||
49031049|NCT02106156|157950770|FG002|Overall Study|Lack of Virological Response|0|||
49031050|NCT02106156|157950768|FG000|Overall Study|Concomitant Disease|74|||
49031051|NCT02106156|157950769|FG001|Overall Study|Concomitant Disease|2|||
49031052|NCT02106156|157950770|FG002|Overall Study|Concomitant Disease|0|||
49031053|NCT02106156|157950768|FG000|Overall Study|Lack of Compliance|211|||
49031054|NCT02106156|157950769|FG001|Overall Study|Lack of Compliance|7|||
49031055|NCT02106156|157950770|FG002|Overall Study|Lack of Compliance|0|||
49031056|NCT02106156|157950768|FG000|Overall Study|Patients Request|307|||
49031057|NCT02106156|157950769|FG001|Overall Study|Patients Request|9|||
49031058|NCT02106156|157950770|FG002|Overall Study|Patients Request|0|||
49031059|NCT02106156|157950768|FG000|Overall Study|Lost to Follow-up|451|||
49031060|NCT02106156|157950769|FG001|Overall Study|Lost to Follow-up|8|||
49031061|NCT02106156|157950770|FG002|Overall Study|Lost to Follow-up|0|||
49031062|NCT02106156|157950768|FG000|Overall Study|Unplanned Event|82|||
49031063|NCT02106156|157950769|FG001|Overall Study|Unplanned Event|2|||
49031064|NCT02106156|157950770|FG002|Overall Study|Unplanned Event|0|||
49031065|NCT02106156|157950768|FG000|Overall Study|Change of Laboratory Parameter|10|||
49031066|NCT02106156|157950769|FG001|Overall Study|Change of Laboratory Parameter|0|||
49031067|NCT02106156|157950770|FG002|Overall Study|Change of Laboratory Parameter|0|||
49031068|NCT02106156|157950768|FG000|Overall Study|Hospitalization/Surgical Intervention|6|||
49031069|NCT02106156|157950769|FG001|Overall Study|Hospitalization/Surgical Intervention|0|||
49031070|NCT02106156|157950770|FG002|Overall Study|Hospitalization/Surgical Intervention|0|||
49031071|NCT02106156|157950768|FG000|Overall Study|Relocation/Change of Physician|40|||
49031072|NCT02106156|157950769|FG001|Overall Study|Relocation/Change of Physician|1|||
49031073|NCT02106156|157950770|FG002|Overall Study|Relocation/Change of Physician|0|||
49031074|NCT02943447|157950771|FG000|Blinded Study Phase|Withdrew Consent|1|||
49031075|NCT02943447|157950772|FG001|Blinded Study Phase|Withdrew Consent|2|||
49031076|NCT02943447|157950773|FG002|Blinded Study Phase|Withdrew Consent|1|||
49031077|NCT02943447|157950771|FG000|Blinded Study Phase|Adverse Event|3|||
49031078|NCT02943447|157950772|FG001|Blinded Study Phase|Adverse Event|0|||
49031079|NCT02943447|157950773|FG002|Blinded Study Phase|Adverse Event|0|||
49031080|NCT02943447|157950771|FG000|Blinded Study Phase|Investigator's discretion|1|||
49031081|NCT02943447|157950772|FG001|Blinded Study Phase|Investigator's discretion|0|||
49031082|NCT02943447|157950773|FG002|Blinded Study Phase|Investigator's discretion|0|||
49031083|NCT02943447|157950771|FG000|Open-Label Extension Phase|Study terminated by sponsor|10|||
49031084|NCT02943447|157950772|FG001|Open-Label Extension Phase|Study terminated by sponsor|12|||
49031085|NCT02943447|157950773|FG002|Open-Label Extension Phase|Study terminated by sponsor|6|||
49031086|NCT02943447|157950771|FG000|Open-Label Extension Phase|Adverse Event|4|||
49031087|NCT02943447|157950772|FG001|Open-Label Extension Phase|Adverse Event|7|||
49031088|NCT02943447|157950773|FG002|Open-Label Extension Phase|Adverse Event|3|||
49031089|NCT02943447|157950771|FG000|Open-Label Extension Phase|Lack of Efficacy|3|||
49031090|NCT02943447|157950772|FG001|Open-Label Extension Phase|Lack of Efficacy|4|||
49031091|NCT02943447|157950773|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
49031092|NCT02943447|157950771|FG000|Open-Label Extension Phase|Withdrew consent|1|||
49031093|NCT02943447|157950772|FG001|Open-Label Extension Phase|Withdrew consent|1|||
49031094|NCT02943447|157950773|FG002|Open-Label Extension Phase|Withdrew consent|1|||
49031095|NCT02943447|157950771|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
49031096|NCT02943447|157950772|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
49031097|NCT02943447|157950773|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
49031098|NCT00834522|157950775|FG000|Washout|Adverse Event|1|||
49031099|NCT00834522|157950776|FG001|Washout|Adverse Event|0|||
49031100|NCT00834522|157950775|FG000|Washout|Withdrawal by Subject|2|||
49031101|NCT00834522|157950776|FG001|Washout|Withdrawal by Subject|1|||
49031102|NCT00905346|157950777|FG000|Period 1|Withdrawal by Subject|1|||
49031103|NCT00905346|157950778|FG001|Period 1|Withdrawal by Subject|0|||
49031104|NCT04089735|157950779|FG000|Overall Study|Adverse Event|1|||
49031105|NCT04089735|157950780|FG001|Overall Study|Adverse Event|0|||
49031106|NCT04089735|157950781|FG002|Overall Study|Adverse Event|1|||
49031107|NCT04089735|157950782|FG003|Overall Study|Adverse Event|1|||
49031108|NCT04089735|157950783|FG004|Overall Study|Adverse Event|0|||
49031109|NCT04089735|157950784|FG005|Overall Study|Adverse Event|0|||
49031110|NCT04089735|157950779|FG000|Overall Study|Physician Decision|0|||
49031111|NCT04089735|157950780|FG001|Overall Study|Physician Decision|3|||
49031112|NCT04089735|157950781|FG002|Overall Study|Physician Decision|0|||
49031113|NCT04089735|157950782|FG003|Overall Study|Physician Decision|0|||
49031114|NCT04089735|157950783|FG004|Overall Study|Physician Decision|0|||
49031115|NCT04089735|157950784|FG005|Overall Study|Physician Decision|0|||
49031116|NCT04089735|157950779|FG000|Overall Study|Withdrawal by Subject|0|||
49031117|NCT04089735|157950780|FG001|Overall Study|Withdrawal by Subject|0|||
49031118|NCT04089735|157950781|FG002|Overall Study|Withdrawal by Subject|1|||
49031119|NCT04089735|157950782|FG003|Overall Study|Withdrawal by Subject|0|||
49031120|NCT04089735|157950783|FG004|Overall Study|Withdrawal by Subject|0|||
49031121|NCT04089735|157950784|FG005|Overall Study|Withdrawal by Subject|0|||
49031122|NCT04089735|157950779|FG000|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
49031123|NCT04089735|157950780|FG001|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|3|||
49031124|NCT04089735|157950781|FG002|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
49031125|NCT04089735|157950782|FG003|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|5|||
49031126|NCT04089735|157950783|FG004|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|1|||
49031127|NCT04089735|157950784|FG005|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|6|||
49031128|NCT02334722|157950788|FG000|Overall Study|Lost to Follow-up|4|||
49031129|NCT02334722|157950789|FG001|Overall Study|Lost to Follow-up|0|||
49031130|NCT02334722|157950788|FG000|Overall Study|6 week questionnaire not completed|2|||
49031131|NCT02334722|157950789|FG001|Overall Study|6 week questionnaire not completed|0|||
49031132|NCT02334722|157950788|FG000|Overall Study|Unable to obtain medication|1|||
49031133|NCT02334722|157950789|FG001|Overall Study|Unable to obtain medication|1|||
48784029|NCT01131312|157050092|FG000|Overall Study|Lost to Follow-up|425|||
48784030|NCT01131312|157050093|FG001|Overall Study|Lost to Follow-up|229|||
48784031|NCT01131312|157050094|FG002|Overall Study|Lost to Follow-up|351|||
48784032|NCT02401672|157050097|FG000|Overall Study|Withdrawal by Subject|1|||
48784033|NCT02401672|157050098|FG001|Overall Study|Withdrawal by Subject|3|||
48784034|NCT04389840|157050101|FG000|Overall Study|Adverse Event|0|||
48784035|NCT04389840|157050102|FG001|Overall Study|Adverse Event|0|||
48784036|NCT04389840|157050103|FG002|Overall Study|Adverse Event|0|||
48784037|NCT04389840|157050104|FG003|Overall Study|Adverse Event|1|||
48784038|NCT04389840|157050105|FG004|Overall Study|Adverse Event|0|||
48784039|NCT04389840|157050106|FG005|Overall Study|Adverse Event|0|||
48784040|NCT04389840|157050101|FG000|Overall Study|Subject request and prohibited concomitant medication|2|||
49031134|NCT02334722|157950788|FG000|Overall Study|Withdrawal by Subject|0|||
49031135|NCT02334722|157950789|FG001|Overall Study|Withdrawal by Subject|3|||
49031136|NCT02334722|157950788|FG000|Overall Study|Adverse Event|0|||
49031137|NCT02334722|157950789|FG001|Overall Study|Adverse Event|2|||
49031138|NCT02334722|157950788|FG000|Overall Study|Physician Decision|0|||
49031139|NCT02334722|157950789|FG001|Overall Study|Physician Decision|1|||
49031140|NCT02128997|157950791|FG000|Overall Study|Lost to Follow-up|6|||
49031141|NCT02128997|157950792|FG001|Overall Study|Lost to Follow-up|11|||
49031142|NCT04000815|157950799|FG000|Overall Study|Lost to Follow-up|9|||
49031143|NCT04000815|157950800|FG001|Overall Study|Lost to Follow-up|2|||
49031144|NCT04000815|157950801|FG002|Overall Study|Lost to Follow-up|3|||
49031145|NCT04000815|157950799|FG000|Overall Study|Withdrawal by Subject|4|||
49031146|NCT04000815|157950800|FG001|Overall Study|Withdrawal by Subject|3|||
49031147|NCT04000815|157950801|FG002|Overall Study|Withdrawal by Subject|2|||
49031148|NCT04000815|157950799|FG000|Overall Study|Right ovarian cyst occured|1|||
49031149|NCT04000815|157950800|FG001|Overall Study|Right ovarian cyst occured|0|||
49031150|NCT04000815|157950801|FG002|Overall Study|Right ovarian cyst occured|0|||
49031151|NCT04000815|157950799|FG000|Overall Study|Hypertension occured on follow up|0|||
48784041|NCT04389840|157050102|FG001|Overall Study|Subject request and prohibited concomitant medication|0|||
48784042|NCT04389840|157050103|FG002|Overall Study|Subject request and prohibited concomitant medication|0|||
48784043|NCT04389840|157050104|FG003|Overall Study|Subject request and prohibited concomitant medication|0|||
48784044|NCT04389840|157050105|FG004|Overall Study|Subject request and prohibited concomitant medication|1|||
48784045|NCT04389840|157050106|FG005|Overall Study|Subject request and prohibited concomitant medication|0|||
48784046|NCT04389840|157050101|FG000|Overall Study|Death|0|||
48784047|NCT04389840|157050102|FG001|Overall Study|Death|1|||
48784048|NCT04389840|157050103|FG002|Overall Study|Death|0|||
48784049|NCT04389840|157050104|FG003|Overall Study|Death|0|||
48784050|NCT04389840|157050105|FG004|Overall Study|Death|0|||
48784051|NCT04389840|157050106|FG005|Overall Study|Death|0|||
48784052|NCT03321019|157050107|FG000|Overall Study|Withdrawal by Subject|0|||
48784053|NCT03321019|157050108|FG001|Overall Study|Withdrawal by Subject|6|||
48784054|NCT03321019|157050107|FG000|Overall Study|Lost to Follow-up|0|||
48784055|NCT03321019|157050108|FG001|Overall Study|Lost to Follow-up|22|||
48784056|NCT00709722|157050110|FG000|Overall Study|Adverse Event|1|||
48784057|NCT03359096|157050111|FG000|HGNS Washout (1 Week)|Withdrawal by Subject|0|||
48784058|NCT03359096|157050112|FG001|HGNS Washout (1 Week)|Withdrawal by Subject|1|||
48784059|NCT03359096|157050111|FG000|First Intervention (4 Weeks)|Death|1|||
48784060|NCT03359096|157050112|FG001|First Intervention (4 Weeks)|Death|0|||
48784061|NCT03359096|157050111|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
49031152|NCT04000815|157950800|FG001|Overall Study|Hypertension occured on follow up|0|||
49031153|NCT04000815|157950801|FG002|Overall Study|Hypertension occured on follow up|2|||
48784062|NCT03359096|157050112|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
48784063|NCT02007577|157050114|FG000|Overall Study|Adverse Event|1|||
48784064|NCT02007577|157050115|FG001|Overall Study|Adverse Event|0|||
48784065|NCT02007577|157050114|FG000|Overall Study|Withdrawal by Subject|0|||
49031154|NCT00519194|157950804|FG000|Overall Study|Withdrawal by Subject|9|||
49031155|NCT00519194|157950804|FG000|Overall Study|Death|9|||
49031156|NCT00519194|157950804|FG000|Overall Study|Lost to Follow-up|3|||
49031157|NCT00252720|157950813|FG000|Overall Study|Withdrawal by Subject|95|||
49031158|NCT00252720|157950814|FG001|Overall Study|Withdrawal by Subject|97|||
49031159|NCT00252720|157950813|FG000|Overall Study|Death|7|||
49031160|NCT00252720|157950814|FG001|Overall Study|Death|8|||
49031161|NCT00252720|157950813|FG000|Overall Study|Moving|23|||
49031162|NCT00252720|157950814|FG001|Overall Study|Moving|42|||
49031163|NCT00252720|157950813|FG000|Overall Study|Mainly patients lost to follow-up|7|||
49031164|NCT00252720|157950814|FG001|Overall Study|Mainly patients lost to follow-up|18|||
48784066|NCT02007577|157050115|FG001|Overall Study|Withdrawal by Subject|1|||
49031165|NCT01536574|157950816|FG000|Overall Study|Adverse Event|4|||
49031166|NCT01536574|157950817|FG001|Overall Study|Adverse Event|5|||
49031167|NCT01536574|157950816|FG000|Overall Study|Withdrawal by Subject|1|||
49031168|NCT01536574|157950817|FG001|Overall Study|Withdrawal by Subject|2|||
49031169|NCT01536574|157950816|FG000|Overall Study|Lack of Efficacy|1|||
49031170|NCT01536574|157950817|FG001|Overall Study|Lack of Efficacy|0|||
48784067|NCT05799495|157050119|FG000|Treatment (Up to 5 Days)|Adverse Event|0|||
48784068|NCT05799495|157050120|FG001|Treatment (Up to 5 Days)|Adverse Event|1|||
48784069|NCT05799495|157050121|FG002|Treatment (Up to 5 Days)|Adverse Event|1|||
48784070|NCT05799495|157050122|FG003|Treatment (Up to 5 Days)|Adverse Event|0|||
48784071|NCT05799495|157050119|FG000|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
48784072|NCT05799495|157050120|FG001|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
48784073|NCT05799495|157050121|FG002|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
48784074|NCT05799495|157050122|FG003|Treatment (Up to 5 Days)|Non-compliance with study drug|1|||
48784075|NCT05799495|157050119|FG000|Treatment (Up to 5 Days)|Other|0|||
48784076|NCT05799495|157050120|FG001|Treatment (Up to 5 Days)|Other|1|||
48784077|NCT05799495|157050121|FG002|Treatment (Up to 5 Days)|Other|0|||
48784078|NCT05799495|157050122|FG003|Treatment (Up to 5 Days)|Other|0|||
48784079|NCT05799495|157050119|FG000|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
48784080|NCT05799495|157050120|FG001|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
48784081|NCT05799495|157050121|FG002|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
48784082|NCT05799495|157050122|FG003|Treatment (Up to 5 Days)|Withdrawal by Subject|3|||
48784083|NCT05799495|157050119|FG000|Treatment (Up to 5 Days)|Randomized not treated|0|||
49031171|NCT02193165|157950818|FG000|4 Week Product Use|Lost to Follow-up|1|||
49031172|NCT02193165|157950819|FG001|4 Week Product Use|Lost to Follow-up|1|||
49031173|NCT02193165|157950820|FG002|4 Week Product Use|Lost to Follow-up|1|||
49031174|NCT02193165|157950818|FG000|6 Week Product Use|Lost to Follow-up|0|||
49031175|NCT02193165|157950819|FG001|6 Week Product Use|Lost to Follow-up|1|||
49031176|NCT02193165|157950820|FG002|6 Week Product Use|Lost to Follow-up|0|||
49031177|NCT02760368|157950821|FG000|Overall Study|Withdrawal by Subject|8|||
49031178|NCT02760368|157950822|FG001|Overall Study|Withdrawal by Subject|12|||
49031179|NCT02760368|157950823|FG002|Overall Study|Withdrawal by Subject|9|||
49031180|NCT02760368|157950821|FG000|Overall Study|Screen Failure|0|||
49031181|NCT02760368|157950822|FG001|Overall Study|Screen Failure|0|||
49031182|NCT02760368|157950823|FG002|Overall Study|Screen Failure|1|||
49031183|NCT02760368|157950821|FG000|Overall Study|Death|0|||
49031184|NCT02760368|157950822|FG001|Overall Study|Death|1|||
49031185|NCT02760368|157950823|FG002|Overall Study|Death|0|||
49031186|NCT02760368|157950821|FG000|Overall Study|Withdrawal by Sponsor|0|||
49031187|NCT02760368|157950822|FG001|Overall Study|Withdrawal by Sponsor|0|||
49031188|NCT02760368|157950823|FG002|Overall Study|Withdrawal by Sponsor|1|||
49031189|NCT04239872|157950824|FG000|Overall Study|Lost to Follow-up|0|||
49031190|NCT04239872|157950825|FG001|Overall Study|Lost to Follow-up|1|||
49031191|NCT01173692|157950831|FG000|Overall Study|Adverse Event|1|||
49031192|NCT01173692|157950832|FG001|Overall Study|Adverse Event|2|||
49031193|NCT01173692|157950831|FG000|Overall Study|Withdrawal by Subject|1|||
49031194|NCT01173692|157950832|FG001|Overall Study|Withdrawal by Subject|3|||
49031195|NCT02294604|157950833|FG000|Overall Study|Did not provide samples for culture|0|||
49031196|NCT02294604|157950834|FG001|Overall Study|Did not provide samples for culture|1|||
48784084|NCT05799495|157050120|FG001|Treatment (Up to 5 Days)|Randomized not treated|1|||
48784085|NCT05799495|157050121|FG002|Treatment (Up to 5 Days)|Randomized not treated|1|||
48784086|NCT05799495|157050122|FG003|Treatment (Up to 5 Days)|Randomized not treated|1|||
48784087|NCT05799495|157050119|FG000|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
48784088|NCT05799495|157050120|FG001|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
48784089|NCT05799495|157050121|FG002|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|1|||
48784090|NCT05799495|157050122|FG003|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
48784091|NCT00214136|157050123|FG000|Overall Study|Death|5|||
48784092|NCT01024387|157050124|FG000|Overall Study|Radiographic Progression|29|||
48784093|NCT01024387|157050124|FG000|Overall Study|Symptomatic Progression|10|||
48784094|NCT01024387|157050124|FG000|Overall Study|Physician Decision|5|||
48784095|NCT01024387|157050124|FG000|Overall Study|Withdrawal by Subject|5|||
48784096|NCT01024387|157050124|FG000|Overall Study|Death|2|||
49031197|NCT02294604|157950835|FG002|Overall Study|Did not provide samples for culture|0|||
49031198|NCT02294604|157950833|FG000|Overall Study|Culture contamination|1|||
49031199|NCT02294604|157950834|FG001|Overall Study|Culture contamination|2|||
49031200|NCT02294604|157950835|FG002|Overall Study|Culture contamination|0|||
49031201|NCT01472341|157950836|FG000|Overall Study|Started insulin therapy|55|||
49031202|NCT01472341|157950836|FG000|Overall Study|Started therapy with a DPP-IV/GLP-1|92|||
49031203|NCT01472341|157950836|FG000|Overall Study|Withdrawal by Subject|39|||
49031204|NCT01472341|157950836|FG000|Overall Study|Lost to Follow-up|52|||
49031205|NCT01472341|157950836|FG000|Overall Study|Laboratory parameters unavailable|25|||
49031206|NCT01472341|157950836|FG000|Overall Study|Death|9|||
49031207|NCT01363765|157950840|FG000|Overall Study|non-diagnostic|2621|||
49031208|NCT01363765|157950841|FG001|Overall Study|non-diagnostic|1124|||
48784097|NCT01024387|157050124|FG000|Overall Study|Prolonged Treatment Delay|1|||
48784098|NCT01024387|157050124|FG000|Overall Study|Adverse Event|3|||
48784099|NCT01024387|157050124|FG000|Overall Study|Other|5|||
48784100|NCT04287920|157050125|FG000|Overall Study|Lost to Follow-up|1|||
48784101|NCT04287920|157050126|FG001|Overall Study|Lost to Follow-up|1|||
48784102|NCT04287920|157050125|FG000|Overall Study|Withdrawal by Subject|0|||
48784103|NCT04287920|157050126|FG001|Overall Study|Withdrawal by Subject|3|||
48784104|NCT01226745|157050127|FG000|Overall Study|Did not complete schedule of assessments|8|||
48784105|NCT01226745|157050128|FG001|Overall Study|Did not complete schedule of assessments|3|||
48784106|NCT01226745|157050129|FG002|Overall Study|Did not complete schedule of assessments|6|||
48784107|NCT01226745|157050130|FG003|Overall Study|Did not complete schedule of assessments|0|||
48784108|NCT01226745|157050131|FG004|Overall Study|Did not complete schedule of assessments|0|||
48784109|NCT01226745|157050132|FG005|Overall Study|Did not complete schedule of assessments|1|||
48784110|NCT01226745|157050127|FG000|Overall Study|Lost to Follow-up|2|||
48784111|NCT01226745|157050128|FG001|Overall Study|Lost to Follow-up|6|||
49031209|NCT01363765|157950840|FG000|Overall Study|duplicate records|736|||
49031210|NCT01363765|157950841|FG001|Overall Study|duplicate records|3177|||
49031211|NCT01363765|157950840|FG000|Overall Study|non-resident|156|||
49031212|NCT01363765|157950841|FG001|Overall Study|non-resident|76|||
49031213|NCT01363765|157950840|FG000|Overall Study|age not recorded (used for cross-linkage|117|||
49031214|NCT01363765|157950841|FG001|Overall Study|age not recorded (used for cross-linkage|354|||
49031215|NCT01363765|157950840|FG000|Overall Study|smear during intervention|2170|||
49031216|NCT01363765|157950841|FG001|Overall Study|smear during intervention|0|||
49031217|NCT00635492|157950842|FG000|Overall Study|Death|12|||
49031218|NCT00635492|157950843|FG001|Overall Study|Death|40|||
49031219|NCT00635492|157950842|FG000|Overall Study|Lost to Follow-up|151|||
49031220|NCT00635492|157950843|FG001|Overall Study|Lost to Follow-up|172|||
49031221|NCT00635492|157950842|FG000|Overall Study|Physician Decision|32|||
49031222|NCT00635492|157950843|FG001|Overall Study|Physician Decision|22|||
49031223|NCT00635492|157950842|FG000|Overall Study|Sponsor decision|2|||
49031224|NCT00635492|157950843|FG001|Overall Study|Sponsor decision|3|||
49031225|NCT00635492|157950842|FG000|Overall Study|Withdrawal by Subject|82|||
49031226|NCT00635492|157950843|FG001|Overall Study|Withdrawal by Subject|45|||
49031227|NCT02075463|157950845|FG000|Overall Study|Adverse Event|3|||
49031228|NCT02075463|157950845|FG000|Overall Study|Par. reached stopping criteria|4|||
49031229|NCT02075463|157950845|FG000|Overall Study|Withdrawal by Subject|1|||
49031230|NCT01702987|157950849|FG000|Overall Study|Withdrawal by Subject|1|||
49031231|NCT01702987|157950850|FG001|Overall Study|Withdrawal by Subject|0|||
49031232|NCT04405570|157950851|FG000|Overall Study|Adverse Event|0|||
49031233|NCT04405570|157950852|FG001|Overall Study|Adverse Event|1|||
49031234|NCT04405570|157950853|FG002|Overall Study|Adverse Event|1|||
49031235|NCT04405570|157950854|FG003|Overall Study|Adverse Event|1|||
49031236|NCT04405570|157950851|FG000|Overall Study|Lost to Follow-up|0|||
49031237|NCT04405570|157950852|FG001|Overall Study|Lost to Follow-up|1|||
49031238|NCT04405570|157950853|FG002|Overall Study|Lost to Follow-up|0|||
49031239|NCT04405570|157950854|FG003|Overall Study|Lost to Follow-up|0|||
49031240|NCT04405570|157950851|FG000|Overall Study|Physician Decision|0|||
49031241|NCT04405570|157950852|FG001|Overall Study|Physician Decision|0|||
49031242|NCT04405570|157950853|FG002|Overall Study|Physician Decision|1|||
49031243|NCT04405570|157950854|FG003|Overall Study|Physician Decision|0|||
49031244|NCT04405570|157950851|FG000|Overall Study|Withdrawal by Subject|0|||
49031245|NCT04405570|157950852|FG001|Overall Study|Withdrawal by Subject|1|||
48784112|NCT01226745|157050129|FG002|Overall Study|Lost to Follow-up|6|||
48784113|NCT01226745|157050130|FG003|Overall Study|Lost to Follow-up|1|||
48784114|NCT01226745|157050131|FG004|Overall Study|Lost to Follow-up|1|||
49031246|NCT04405570|157950853|FG002|Overall Study|Withdrawal by Subject|1|||
49031247|NCT04405570|157950854|FG003|Overall Study|Withdrawal by Subject|0|||
49031248|NCT04405570|157950851|FG000|Overall Study|Randomized not dosed|0|||
49031249|NCT04405570|157950852|FG001|Overall Study|Randomized not dosed|2|||
49031250|NCT04405570|157950853|FG002|Overall Study|Randomized not dosed|0|||
49031251|NCT04405570|157950854|FG003|Overall Study|Randomized not dosed|0|||
49031252|NCT00467363|157950857|FG000|Overall Study|Lost to Follow-up|80|||
49031253|NCT00467363|157950858|FG001|Overall Study|Lost to Follow-up|70|||
49031254|NCT00112463|157950859|FG000|Overall Study|Physician Decision|1|||
48784115|NCT01226745|157050132|FG005|Overall Study|Lost to Follow-up|2|||
49031255|NCT00112463|157950859|FG000|Overall Study|Progression|30|||
49031256|NCT00112463|157950859|FG000|Overall Study|Second Primary|1|||
49031257|NCT00112463|157950859|FG000|Overall Study|Toxicity|3|||
49031258|NCT00112463|157950859|FG000|Overall Study|Withdrawal by Subject|2|||
49031259|NCT00112463|157950859|FG000|Overall Study|Never started treatment|2|||
49031260|NCT01118312|157950866|FG000|Overall Study|Lost to Follow-up|33|||
49031261|NCT01118312|157950867|FG001|Overall Study|Lost to Follow-up|32|||
49031262|NCT01118312|157950866|FG000|Overall Study|Withdrawal by Subject|1|||
49031263|NCT01118312|157950867|FG001|Overall Study|Withdrawal by Subject|3|||
49031264|NCT02017223|157950868|FG000|Overall Study|Algorithm problems|2|||
49031265|NCT01534520|157950869|FG000|Overall Study|Adverse Event|0|||
49031266|NCT01534520|157950870|FG001|Overall Study|Adverse Event|1|||
48784116|NCT01226745|157050127|FG000|Overall Study|Death|1|||
48784117|NCT01226745|157050128|FG001|Overall Study|Death|0|||
48784118|NCT01226745|157050129|FG002|Overall Study|Death|0|||
48784119|NCT01226745|157050130|FG003|Overall Study|Death|0|||
48784120|NCT01226745|157050131|FG004|Overall Study|Death|0|||
48784121|NCT01226745|157050132|FG005|Overall Study|Death|1|||
48784122|NCT01226745|157050127|FG000|Overall Study|Other|6|||
48784123|NCT01226745|157050128|FG001|Overall Study|Other|7|||
48784124|NCT01226745|157050129|FG002|Overall Study|Other|8|||
48784125|NCT01226745|157050130|FG003|Overall Study|Other|4|||
48784126|NCT01226745|157050131|FG004|Overall Study|Other|3|||
48784127|NCT01226745|157050132|FG005|Overall Study|Other|1|||
48784128|NCT04307186|157050133|FG000|Period 1 - Gadobutrol|Withdrawal by Subject|1|||
48784129|NCT04307186|157050133|FG000|Washout 3-14 Days|Withdrawal by Subject|1|||
48784130|NCT04307186|157050133|FG000|Washout 3-14 Days|Progressive disease|1|||
49031267|NCT01214850|157950875|FG000|Overall Study|Withdrawal by Subject|38|||
49031268|NCT01214850|157950876|FG001|Overall Study|Withdrawal by Subject|31|||
49031269|NCT01214850|157950877|FG002|Overall Study|Withdrawal by Subject|28|||
49031270|NCT01214850|157950875|FG000|Overall Study|Lost to Follow-up|124|||
49031271|NCT01214850|157950876|FG001|Overall Study|Lost to Follow-up|98|||
49031272|NCT01214850|157950877|FG002|Overall Study|Lost to Follow-up|123|||
49031273|NCT01214850|157950875|FG000|Overall Study|Protocol Violation|5|||
49031274|NCT01214850|157950876|FG001|Overall Study|Protocol Violation|5|||
49031275|NCT01214850|157950877|FG002|Overall Study|Protocol Violation|6|||
49031276|NCT01214850|157950875|FG000|Overall Study|Adverse event or death|11|||
49031277|NCT01214850|157950876|FG001|Overall Study|Adverse event or death|8|||
49031278|NCT01214850|157950877|FG002|Overall Study|Adverse event or death|3|||
49031279|NCT01214850|157950875|FG000|Overall Study|Inappropriate enrollment|2|||
49031280|NCT01214850|157950876|FG001|Overall Study|Inappropriate enrollment|1|||
49031281|NCT01214850|157950877|FG002|Overall Study|Inappropriate enrollment|0|||
49031282|NCT01214850|157950875|FG000|Overall Study|Administrative reason|1|||
49031283|NCT01214850|157950876|FG001|Overall Study|Administrative reason|0|||
49031284|NCT01214850|157950877|FG002|Overall Study|Administrative reason|0|||
49031285|NCT01214850|157950875|FG000|Overall Study|Unable to classify|2|||
49031286|NCT01214850|157950876|FG001|Overall Study|Unable to classify|1|||
49031287|NCT01214850|157950877|FG002|Overall Study|Unable to classify|1|||
49031288|NCT01294917|157950878|FG000|Overall Study|Relocation|5|||
49031289|NCT01294917|157950878|FG000|Overall Study|Inconvenience|1|||
49031290|NCT03290781|157950879|FG000|Overall Study|Adverse Event|5|||
49031291|NCT03290781|157950880|FG001|Overall Study|Adverse Event|7|||
49031292|NCT03290781|157950881|FG002|Overall Study|Adverse Event|4|||
49031293|NCT03290781|157950882|FG003|Overall Study|Adverse Event|1|||
49031294|NCT03290781|157950883|FG004|Overall Study|Adverse Event|0|||
49031295|NCT03290781|157950884|FG005|Overall Study|Adverse Event|0|||
49031296|NCT03290781|157950885|FG006|Overall Study|Adverse Event|0|||
49031297|NCT03290781|157950879|FG000|Overall Study|Death|0|||
49031298|NCT03290781|157950880|FG001|Overall Study|Death|0|||
49031299|NCT03290781|157950881|FG002|Overall Study|Death|1|||
49031300|NCT03290781|157950882|FG003|Overall Study|Death|0|||
49031301|NCT03290781|157950883|FG004|Overall Study|Death|1|||
49031302|NCT03290781|157950884|FG005|Overall Study|Death|0|||
49031303|NCT03290781|157950885|FG006|Overall Study|Death|0|||
48784131|NCT04307186|157050133|FG000|Washout 3-14 Days|Pre-specified withdrawal criterion met|1|||
48784132|NCT04307186|157050133|FG000|Period 2 - Gadoquatrane|Protocol Violation|1|||
48784133|NCT00355082|157050134|FG000|Double-Blind (DB) Treatment Phase|Adverse Event|4|||
48784134|NCT00355082|157050135|FG001|Double-Blind (DB) Treatment Phase|Adverse Event|10|||
49031304|NCT03290781|157950879|FG000|Overall Study|Withdrawal by Subject|6|||
49031305|NCT03290781|157950880|FG001|Overall Study|Withdrawal by Subject|5|||
49031306|NCT03290781|157950881|FG002|Overall Study|Withdrawal by Subject|9|||
49031307|NCT03290781|157950882|FG003|Overall Study|Withdrawal by Subject|10|||
49031308|NCT03290781|157950883|FG004|Overall Study|Withdrawal by Subject|1|||
49031309|NCT03290781|157950884|FG005|Overall Study|Withdrawal by Subject|2|||
49031310|NCT03290781|157950885|FG006|Overall Study|Withdrawal by Subject|0|||
49031311|NCT03290781|157950879|FG000|Overall Study|Physician Decision|0|||
49031312|NCT03290781|157950880|FG001|Overall Study|Physician Decision|1|||
49031313|NCT03290781|157950881|FG002|Overall Study|Physician Decision|0|||
48784135|NCT00355082|157050136|FG002|Double-Blind (DB) Treatment Phase|Adverse Event|0|||
48784136|NCT00355082|157050134|FG000|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9|||
49031314|NCT03290781|157950882|FG003|Overall Study|Physician Decision|0|||
49031315|NCT03290781|157950883|FG004|Overall Study|Physician Decision|0|||
49031316|NCT03290781|157950884|FG005|Overall Study|Physician Decision|0|||
48784137|NCT00355082|157050135|FG001|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8|||
48784138|NCT00355082|157050136|FG002|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0|||
48784139|NCT00355082|157050134|FG000|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6|||
48784140|NCT00355082|157050135|FG001|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7|||
48784141|NCT00355082|157050136|FG002|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0|||
48784142|NCT00355082|157050134|FG000|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
48784143|NCT00355082|157050135|FG001|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4|||
48784144|NCT00355082|157050136|FG002|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
48784145|NCT00355082|157050134|FG000|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
48784146|NCT00355082|157050135|FG001|Double-Blind (DB) Treatment Phase|Protocol Violation|4|||
48784147|NCT00355082|157050136|FG002|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
48784148|NCT00355082|157050134|FG000|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
48784149|NCT00355082|157050135|FG001|Double-Blind (DB) Treatment Phase|Pregnancy|1|||
48784150|NCT00355082|157050136|FG002|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
48784151|NCT00355082|157050134|FG000|Continuation Phase|Adverse Event|2|||
48784152|NCT00355082|157050135|FG001|Continuation Phase|Adverse Event|0|||
48784153|NCT00355082|157050136|FG002|Continuation Phase|Adverse Event|1|||
48784154|NCT00355082|157050134|FG000|Continuation Phase|Lost to Follow-up|2|||
48784155|NCT00355082|157050135|FG001|Continuation Phase|Lost to Follow-up|0|||
48784156|NCT00355082|157050136|FG002|Continuation Phase|Lost to Follow-up|1|||
48784157|NCT00355082|157050134|FG000|Continuation Phase|Protocol Violation|1|||
48784158|NCT00355082|157050135|FG001|Continuation Phase|Protocol Violation|0|||
48784159|NCT00355082|157050136|FG002|Continuation Phase|Protocol Violation|1|||
48784160|NCT00355082|157050134|FG000|Continuation Phase|Withdrawal by Subject|4|||
48784161|NCT00355082|157050135|FG001|Continuation Phase|Withdrawal by Subject|0|||
48784162|NCT00355082|157050136|FG002|Continuation Phase|Withdrawal by Subject|0|||
48784163|NCT00355082|157050134|FG000|Continuation Phase|Lack of Efficacy|5|||
48784164|NCT00355082|157050135|FG001|Continuation Phase|Lack of Efficacy|0|||
48784165|NCT00355082|157050136|FG002|Continuation Phase|Lack of Efficacy|0|||
48784166|NCT00355082|157050134|FG000|Continuation Phase|Site Closed by Sponsor|8|||
48784167|NCT00355082|157050135|FG001|Continuation Phase|Site Closed by Sponsor|0|||
48784168|NCT00355082|157050136|FG002|Continuation Phase|Site Closed by Sponsor|0|||
48784169|NCT00355082|157050134|FG000|Continuation Phase|Scheduling Error|1|||
49031317|NCT03290781|157950885|FG006|Overall Study|Physician Decision|0|||
48784170|NCT00355082|157050135|FG001|Continuation Phase|Scheduling Error|0|||
48784171|NCT00355082|157050136|FG002|Continuation Phase|Scheduling Error|0|||
48784172|NCT00355082|157050134|FG000|Continuation Phase|Ran Out of Drug Due to Travel|1|||
48784173|NCT00355082|157050135|FG001|Continuation Phase|Ran Out of Drug Due to Travel|0|||
48784174|NCT00355082|157050136|FG002|Continuation Phase|Ran Out of Drug Due to Travel|0|||
48784175|NCT01808313|157050137|FG000|Overall Study|Adverse Event|5|||
48784176|NCT01808313|157050137|FG000|Overall Study|Protocol Violation|2|||
48784177|NCT01808313|157050137|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
48784178|NCT01808313|157050137|FG000|Overall Study|Lost to Follow-up|1|||
48784179|NCT01808313|157050137|FG000|Overall Study|Physician Decision|1|||
48784180|NCT00710424|157050150|FG000|Overall Study|Adverse Event|30|||
48784181|NCT00710424|157050151|FG001|Overall Study|Adverse Event|12|||
48784182|NCT00710424|157050150|FG000|Overall Study|Lack of Efficacy|4|||
48784183|NCT00710424|157050151|FG001|Overall Study|Lack of Efficacy|5|||
48784184|NCT00710424|157050150|FG000|Overall Study|Withdrawal by Subject|5|||
48784185|NCT00710424|157050151|FG001|Overall Study|Withdrawal by Subject|3|||
48784186|NCT00710424|157050150|FG000|Overall Study|Lost to Follow-up|0|||
48784187|NCT00710424|157050151|FG001|Overall Study|Lost to Follow-up|1|||
48784188|NCT00710424|157050150|FG000|Overall Study|Refused medication, no side effects|1|||
48784189|NCT00710424|157050151|FG001|Overall Study|Refused medication, no side effects|0|||
48784190|NCT00710424|157050150|FG000|Overall Study|Non-compliance with stable analgesia|1|||
48784191|NCT00710424|157050151|FG001|Overall Study|Non-compliance with stable analgesia|0|||
48784192|NCT00710424|157050150|FG000|Overall Study|Did not meet entry criteria at visit 1|1|||
48784193|NCT00710424|157050151|FG001|Overall Study|Did not meet entry criteria at visit 1|0|||
48784194|NCT00710424|157050150|FG000|Overall Study|Subject thought medication changed|1|||
48784195|NCT00710424|157050151|FG001|Overall Study|Subject thought medication changed|0|||
48784196|NCT00710424|157050150|FG000|Overall Study|Ceased treatment due to travel|1|||
48784197|NCT00710424|157050151|FG001|Overall Study|Ceased treatment due to travel|0|||
48784198|NCT00710424|157050150|FG000|Overall Study|Subject preferred paracetamol|0|||
48784199|NCT00710424|157050151|FG001|Overall Study|Subject preferred paracetamol|1|||
48784200|NCT00710424|157050150|FG000|Overall Study|Felt good so stopped treatment|0|||
48784201|NCT00710424|157050151|FG001|Overall Study|Felt good so stopped treatment|1|||
48784202|NCT03859323|157051639|FG000|Overall Study|Lost to Follow-up|0|||
48784203|NCT03859323|157051640|FG001|Overall Study|Lost to Follow-up|0|||
48784204|NCT03859323|157051641|FG002|Overall Study|Lost to Follow-up|0|||
48784205|NCT03859323|157051642|FG003|Overall Study|Lost to Follow-up|0|||
48784206|NCT03859323|157051643|FG004|Overall Study|Lost to Follow-up|0|||
48784207|NCT03859323|157051644|FG005|Overall Study|Lost to Follow-up|0|||
48784208|NCT03859323|157051645|FG006|Overall Study|Lost to Follow-up|1|||
49031318|NCT03290781|157950879|FG000|Overall Study|Site Terminated by Sponsor|1|||
49031319|NCT03290781|157950880|FG001|Overall Study|Site Terminated by Sponsor|0|||
49031320|NCT03290781|157950881|FG002|Overall Study|Site Terminated by Sponsor|2|||
48784209|NCT03859323|157051646|FG007|Overall Study|Lost to Follow-up|0|||
48784210|NCT03859323|157051647|FG008|Overall Study|Lost to Follow-up|0|||
48784211|NCT03859323|157051648|FG009|Overall Study|Lost to Follow-up|0|||
48784212|NCT03859323|157051649|FG010|Overall Study|Lost to Follow-up|0|||
48784213|NCT03859323|157051650|FG011|Overall Study|Lost to Follow-up|0|||
48784214|NCT03859323|157051651|FG012|Overall Study|Lost to Follow-up|0|||
48784215|NCT03859323|157051639|FG000|Overall Study|Withdrawal by Subject|0|||
48784216|NCT03859323|157051640|FG001|Overall Study|Withdrawal by Subject|0|||
48784217|NCT03859323|157051641|FG002|Overall Study|Withdrawal by Subject|1|||
48784218|NCT03859323|157051642|FG003|Overall Study|Withdrawal by Subject|0|||
48784219|NCT03859323|157051643|FG004|Overall Study|Withdrawal by Subject|0|||
48784220|NCT03859323|157051644|FG005|Overall Study|Withdrawal by Subject|1|||
48784221|NCT03859323|157051645|FG006|Overall Study|Withdrawal by Subject|0|||
48784222|NCT03859323|157051646|FG007|Overall Study|Withdrawal by Subject|0|||
48784223|NCT03859323|157051647|FG008|Overall Study|Withdrawal by Subject|0|||
48784224|NCT03859323|157051648|FG009|Overall Study|Withdrawal by Subject|1|||
48784225|NCT03859323|157051649|FG010|Overall Study|Withdrawal by Subject|1|||
48784226|NCT03859323|157051650|FG011|Overall Study|Withdrawal by Subject|2|||
48784227|NCT03859323|157051651|FG012|Overall Study|Withdrawal by Subject|1|||
48784228|NCT03859323|157051639|FG000|Overall Study|Pregnancy|0|||
48784229|NCT03859323|157051640|FG001|Overall Study|Pregnancy|0|||
48784230|NCT03859323|157051641|FG002|Overall Study|Pregnancy|0|||
48784231|NCT03859323|157051642|FG003|Overall Study|Pregnancy|0|||
48784232|NCT03859323|157051643|FG004|Overall Study|Pregnancy|0|||
48784233|NCT03859323|157051644|FG005|Overall Study|Pregnancy|0|||
48784234|NCT03859323|157051645|FG006|Overall Study|Pregnancy|0|||
48784235|NCT03859323|157051646|FG007|Overall Study|Pregnancy|0|||
48784236|NCT03859323|157051647|FG008|Overall Study|Pregnancy|0|||
48784237|NCT03859323|157051648|FG009|Overall Study|Pregnancy|1|||
48784238|NCT03859323|157051649|FG010|Overall Study|Pregnancy|0|||
48784239|NCT03859323|157051650|FG011|Overall Study|Pregnancy|0|||
48784240|NCT03859323|157051651|FG012|Overall Study|Pregnancy|0|||
48784241|NCT01432366|157051655|FG000|Overall Study|Non-Responder|7|||
48784242|NCT01432366|157051655|FG000|Overall Study|Adverse Event|8|||
48784243|NCT01432366|157051655|FG000|Overall Study|Withdrawal Due to Non-Compliance|3|||
48784244|NCT01432366|157051655|FG000|Overall Study|Pregnancy|1|||
48784245|NCT01432366|157051655|FG000|Overall Study|Lost to Follow-up|13|||
48784246|NCT01432366|157051655|FG000|Overall Study|Lack of Efficacy|1|||
48784247|NCT01432366|157051655|FG000|Overall Study|Site Closed|20|||
48784248|NCT01432366|157051655|FG000|Overall Study|Investigator Forget to Complete Visits|1|||
48784249|NCT01432366|157051655|FG000|Overall Study|Other|14|||
48784250|NCT01917526|157051659|FG000|Overall Study|Protocol Violation|1|||
48784251|NCT01917526|157051660|FG001|Overall Study|Protocol Violation|1|||
48784252|NCT03131648|157051664|FG000|Initial Treatment Period|Not dosed|2|||
48784253|NCT03131648|157051665|FG001|Initial Treatment Period|Not dosed|2|||
48784254|NCT03131648|157051666|FG002|Initial Treatment Period|Not dosed|0|||
48784255|NCT03131648|157051667|FG003|Initial Treatment Period|Not dosed|0|||
48784256|NCT03131648|157051668|FG004|Initial Treatment Period|Not dosed|0|||
48784257|NCT03131648|157051669|FG005|Initial Treatment Period|Not dosed|0|||
48784258|NCT03131648|157051670|FG006|Initial Treatment Period|Not dosed|0|||
48784259|NCT03131648|157051671|FG007|Initial Treatment Period|Not dosed|0|||
48784260|NCT03131648|157051664|FG000|Initial Treatment Period|Discontinued IMP before Week 16|51|||
48784261|NCT03131648|157051665|FG001|Initial Treatment Period|Discontinued IMP before Week 16|18|||
48784262|NCT03131648|157051666|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
48784263|NCT03131648|157051667|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
48784264|NCT03131648|157051668|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
48784265|NCT03131648|157051669|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
48784266|NCT03131648|157051670|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
48877512|NCT00464945|157390080|FG001|Infant Series|Withdrawal by parent/guardian request|1|||
48784267|NCT03131648|157051671|FG007|Initial Treatment Period|Discontinued IMP before Week 16|0|||
48784268|NCT03131648|157051664|FG000|Open-label Treatment|Discontinued IMP|0|||
48784269|NCT03131648|157051665|FG001|Open-label Treatment|Discontinued IMP|0|||
48784270|NCT03131648|157051666|FG002|Open-label Treatment|Discontinued IMP|0|||
48784271|NCT03131648|157051667|FG003|Open-label Treatment|Discontinued IMP|0|||
48784272|NCT03131648|157051668|FG004|Open-label Treatment|Discontinued IMP|0|||
48784273|NCT03131648|157051669|FG005|Open-label Treatment|Discontinued IMP|0|||
48784274|NCT03131648|157051670|FG006|Open-label Treatment|Discontinued IMP|112|||
48784275|NCT03131648|157051671|FG007|Open-label Treatment|Discontinued IMP|0|||
48784276|NCT03131648|157051664|FG000|Open-label Treatment|Completed Week 50|0|||
48784277|NCT03131648|157051665|FG001|Open-label Treatment|Completed Week 50|0|||
48784278|NCT03131648|157051666|FG002|Open-label Treatment|Completed Week 50|0|||
48784279|NCT03131648|157051667|FG003|Open-label Treatment|Completed Week 50|0|||
48784280|NCT03131648|157051668|FG004|Open-label Treatment|Completed Week 50|0|||
48784281|NCT03131648|157051669|FG005|Open-label Treatment|Completed Week 50|0|||
49031321|NCT03290781|157950882|FG003|Overall Study|Site Terminated by Sponsor|1|||
49031322|NCT03290781|157950883|FG004|Overall Study|Site Terminated by Sponsor|0|||
49031323|NCT03290781|157950884|FG005|Overall Study|Site Terminated by Sponsor|0|||
49031324|NCT03290781|157950885|FG006|Overall Study|Site Terminated by Sponsor|0|||
49031325|NCT03290781|157950879|FG000|Overall Study|Lost to Follow-up|0|||
49031326|NCT03290781|157950880|FG001|Overall Study|Lost to Follow-up|0|||
49031327|NCT03290781|157950881|FG002|Overall Study|Lost to Follow-up|0|||
49031328|NCT03290781|157950882|FG003|Overall Study|Lost to Follow-up|1|||
49031329|NCT03290781|157950883|FG004|Overall Study|Lost to Follow-up|0|||
49031330|NCT03290781|157950884|FG005|Overall Study|Lost to Follow-up|0|||
49031331|NCT03290781|157950885|FG006|Overall Study|Lost to Follow-up|0|||
49031332|NCT03290781|157950879|FG000|Overall Study|Protocol Deviation|2|||
49031333|NCT03290781|157950880|FG001|Overall Study|Protocol Deviation|0|||
49031334|NCT03290781|157950881|FG002|Overall Study|Protocol Deviation|0|||
49031335|NCT03290781|157950882|FG003|Overall Study|Protocol Deviation|1|||
49031336|NCT03290781|157950883|FG004|Overall Study|Protocol Deviation|0|||
49031337|NCT03290781|157950884|FG005|Overall Study|Protocol Deviation|0|||
49031338|NCT03290781|157950885|FG006|Overall Study|Protocol Deviation|0|||
49031339|NCT03290781|157950879|FG000|Overall Study|Disease Relapse|32|||
49031340|NCT03290781|157950880|FG001|Overall Study|Disease Relapse|5|||
49031341|NCT03290781|157950881|FG002|Overall Study|Disease Relapse|38|||
49031342|NCT03290781|157950882|FG003|Overall Study|Disease Relapse|7|||
49031343|NCT03290781|157950883|FG004|Overall Study|Disease Relapse|3|||
49031344|NCT03290781|157950884|FG005|Overall Study|Disease Relapse|1|||
49031345|NCT03290781|157950885|FG006|Overall Study|Disease Relapse|4|||
49031346|NCT03290781|157950879|FG000|Overall Study|Other|3|||
49031347|NCT03290781|157950880|FG001|Overall Study|Other|0|||
49031348|NCT03290781|157950881|FG002|Overall Study|Other|2|||
49031349|NCT03290781|157950882|FG003|Overall Study|Other|2|||
49031350|NCT03290781|157950883|FG004|Overall Study|Other|0|||
49031351|NCT03290781|157950884|FG005|Overall Study|Other|0|||
49031352|NCT03290781|157950885|FG006|Overall Study|Other|0|||
49031353|NCT02159950|157950886|FG000|Overall Study|Adverse Event|0|||
49031354|NCT02159950|157950887|FG001|Overall Study|Adverse Event|1|||
49031355|NCT02159950|157950886|FG000|Overall Study|Progression|0|||
49031356|NCT02159950|157950887|FG001|Overall Study|Progression|1|||
48784282|NCT03131648|157051670|FG006|Open-label Treatment|Completed Week 50|6|||
48784283|NCT03131648|157051671|FG007|Open-label Treatment|Completed Week 50|0|||
48784284|NCT03131648|157051664|FG000|Maintenance Treatment Period|Not dosed|0|||
48784285|NCT03131648|157051665|FG001|Maintenance Treatment Period|Not dosed|0|||
48784286|NCT03131648|157051666|FG002|Maintenance Treatment Period|Not dosed|3|||
48784287|NCT03131648|157051667|FG003|Maintenance Treatment Period|Not dosed|2|||
48784288|NCT03131648|157051668|FG004|Maintenance Treatment Period|Not dosed|1|||
48784289|NCT03131648|157051669|FG005|Maintenance Treatment Period|Not dosed|0|||
48784290|NCT03131648|157051670|FG006|Maintenance Treatment Period|Not dosed|0|||
48784291|NCT03131648|157051671|FG007|Maintenance Treatment Period|Not dosed|0|||
48784292|NCT03131648|157051664|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
48784293|NCT03131648|157051665|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
48784294|NCT03131648|157051666|FG002|Maintenance Treatment Period|Discontinued IMP|3|||
48784295|NCT03131648|157051667|FG003|Maintenance Treatment Period|Discontinued IMP|5|||
48784296|NCT03131648|157051668|FG004|Maintenance Treatment Period|Discontinued IMP|4|||
48784297|NCT03131648|157051669|FG005|Maintenance Treatment Period|Discontinued IMP|4|||
48784298|NCT03131648|157051670|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
48784299|NCT03131648|157051671|FG007|Maintenance Treatment Period|Discontinued IMP|0|||
48784300|NCT03131648|157051664|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
48784301|NCT03131648|157051665|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
48784302|NCT03131648|157051666|FG002|Maintenance Treatment Period|Transfer to open-label treatment|21|||
48784303|NCT03131648|157051667|FG003|Maintenance Treatment Period|Transfer to open-label treatment|18|||
48784304|NCT03131648|157051668|FG004|Maintenance Treatment Period|Transfer to open-label treatment|9|||
48784305|NCT03131648|157051669|FG005|Maintenance Treatment Period|Transfer to open-label treatment|10|||
48784306|NCT03131648|157051670|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
48784307|NCT03131648|157051671|FG007|Maintenance Treatment Period|Transfer to open-label treatment|0|||
48784308|NCT03131648|157051664|FG000|Maintenance Treatment Period|Completed Week 50|0|||
49031357|NCT01629381|157950888|FG000|Overall Study|Withdrawal by Subject|2|||
49031358|NCT01629381|157950889|FG001|Overall Study|Withdrawal by Subject|5|||
49031359|NCT01097577|157950893|FG000|Overall Study|Adverse Event|0|||
48784309|NCT03131648|157051665|FG001|Maintenance Treatment Period|Completed Week 50|0|||
48784310|NCT03131648|157051666|FG002|Maintenance Treatment Period|Completed Week 50|0|||
48784311|NCT03131648|157051667|FG003|Maintenance Treatment Period|Completed Week 50|0|||
49031360|NCT01097577|157950894|FG001|Overall Study|Adverse Event|1|||
49031361|NCT01249651|157950896|FG000|Overall Study|Withdrawal by Subject|4|||
49031362|NCT01249651|157950896|FG000|Overall Study|Adverse Event|1|||
49031363|NCT01249651|157950896|FG000|Overall Study|Protocol Violation|1|||
49031364|NCT01249651|157950896|FG000|Overall Study|Sponsor Decision|1|||
49031365|NCT01421277|157950897|FG000|Overall Study|Lack of qualifying event|0|||
49031366|NCT01421277|157950898|FG001|Overall Study|Lack of qualifying event|61|||
49031367|NCT01421277|157950897|FG000|Overall Study|Incomplete baseline data|0|||
49031368|NCT01421277|157950898|FG001|Overall Study|Incomplete baseline data|31|||
49031369|NCT03235739|157953318|FG000|Overall Study|Withdrawal by Subject|2|||
49031370|NCT03235739|157953319|FG001|Overall Study|Withdrawal by Subject|2|||
49031371|NCT03235739|157953318|FG000|Overall Study|Physician Decision|0|||
49031372|NCT03235739|157953319|FG001|Overall Study|Physician Decision|1|||
49031373|NCT00840632|157953324|FG000|First Intervention|Withdrawal by Subject|0|||
48784312|NCT03131648|157051668|FG004|Maintenance Treatment Period|Completed Week 50|1|||
48784313|NCT03131648|157051669|FG005|Maintenance Treatment Period|Completed Week 50|0|||
48784314|NCT03131648|157051670|FG006|Maintenance Treatment Period|Completed Week 50|0|||
48784315|NCT03131648|157051671|FG007|Maintenance Treatment Period|Completed Week 50|0|||
48784316|NCT03131648|157051664|FG000|Open-label (Short Term Extension)|Discontinued IMP|0|||
48784317|NCT03131648|157051665|FG001|Open-label (Short Term Extension)|Discontinued IMP|0|||
48784318|NCT03131648|157051666|FG002|Open-label (Short Term Extension)|Discontinued IMP|0|||
48784319|NCT03131648|157051667|FG003|Open-label (Short Term Extension)|Discontinued IMP|0|||
48784320|NCT03131648|157051668|FG004|Open-label (Short Term Extension)|Discontinued IMP|0|||
48784321|NCT03131648|157051669|FG005|Open-label (Short Term Extension)|Discontinued IMP|0|||
48784322|NCT03131648|157051670|FG006|Open-label (Short Term Extension)|Discontinued IMP|0|||
48784323|NCT03131648|157051671|FG007|Open-label (Short Term Extension)|Discontinued IMP|3|||
48784324|NCT01753193|157051676|FG000|Overall Study|Withdrawal by Subject|23|||
48784325|NCT01753193|157051676|FG000|Overall Study|Lost to Follow-up|6|||
48784326|NCT01753193|157051676|FG000|Overall Study|Death|1|||
48784327|NCT01753193|157051676|FG000|Overall Study|Other|16|||
48784328|NCT02682264|157051677|FG000|Overall Study|Withdrawal by Subject|56|||
48784329|NCT02682264|157051678|FG001|Overall Study|Withdrawal by Subject|45|||
48784330|NCT02682264|157051677|FG000|Overall Study|Lost to Follow-up|49|||
48784331|NCT02682264|157051678|FG001|Overall Study|Lost to Follow-up|41|||
48784332|NCT02682264|157051677|FG000|Overall Study|Lack of Efficacy|14|||
48784333|NCT02682264|157051678|FG001|Overall Study|Lack of Efficacy|16|||
48784334|NCT02682264|157051677|FG000|Overall Study|Withdrawal by Parent|6|||
48784335|NCT02682264|157051678|FG001|Overall Study|Withdrawal by Parent|7|||
48784336|NCT02682264|157051677|FG000|Overall Study|Adverse Event|9|||
48784337|NCT02682264|157051678|FG001|Overall Study|Adverse Event|0|||
48784338|NCT02682264|157051677|FG000|Overall Study|Noncompliance with study drug|1|||
48784339|NCT02682264|157051678|FG001|Overall Study|Noncompliance with study drug|4|||
48784340|NCT02682264|157051677|FG000|Overall Study|Pregnancy|1|||
48784341|NCT02682264|157051678|FG001|Overall Study|Pregnancy|2|||
48784342|NCT02682264|157051677|FG000|Overall Study|Recovery|1|||
48784343|NCT02682264|157051678|FG001|Overall Study|Recovery|2|||
48784344|NCT02682264|157051677|FG000|Overall Study|Progressive Disease|1|||
48784345|NCT02682264|157051678|FG001|Overall Study|Progressive Disease|0|||
48784346|NCT02682264|157051677|FG000|Overall Study|Technical Problems|0|||
48784347|NCT02682264|157051678|FG001|Overall Study|Technical Problems|1|||
48784348|NCT02682264|157051677|FG000|Overall Study|Moved abroad and unable to continue|0|||
48784349|NCT02682264|157051678|FG001|Overall Study|Moved abroad and unable to continue|3|||
48784350|NCT02682264|157051677|FG000|Overall Study|Stopped test article application|0|||
48784351|NCT02682264|157051678|FG001|Overall Study|Stopped test article application|1|||
48784352|NCT00971048|157051679|FG000|Overall Study|Protocol Violation|1|||
48784353|NCT00971048|157051680|FG001|Overall Study|Protocol Violation|2|||
48784354|NCT00971048|157051681|FG002|Overall Study|Protocol Violation|0|||
48784355|NCT00971048|157051682|FG003|Overall Study|Protocol Violation|1|||
48784356|NCT00971048|157051679|FG000|Overall Study|Adverse Event|0|||
48784357|NCT00971048|157051680|FG001|Overall Study|Adverse Event|0|||
48784358|NCT00971048|157051681|FG002|Overall Study|Adverse Event|1|||
48784359|NCT00971048|157051682|FG003|Overall Study|Adverse Event|0|||
48784360|NCT00971048|157051679|FG000|Overall Study|Physician Decision|0|||
48784361|NCT00971048|157051680|FG001|Overall Study|Physician Decision|0|||
48784362|NCT00971048|157051681|FG002|Overall Study|Physician Decision|0|||
48784363|NCT00971048|157051682|FG003|Overall Study|Physician Decision|1|||
48784364|NCT02843568|157051683|FG000|Overall Study|Excluded from Primary Population due to change in treatment|4|||
48784365|NCT02843568|157051684|FG001|Overall Study|Excluded from Primary Population due to change in treatment|2|||
49031374|NCT00840632|157953325|FG001|First Intervention|Withdrawal by Subject|1|||
49031375|NCT00840632|157953324|FG000|Washout|Withdrawal by Subject|1|||
49031376|NCT00840632|157953325|FG001|Washout|Withdrawal by Subject|1|||
49031377|NCT01370733|157953326|FG000|Overall Study|Withdrawal by Subject|8|||
48784366|NCT02843568|157051683|FG000|Overall Study|Death|3|||
48784367|NCT02843568|157051684|FG001|Overall Study|Death|3|||
48784368|NCT02843568|157051683|FG000|Overall Study|Withdrawal by Subject|1|||
48784369|NCT02843568|157051684|FG001|Overall Study|Withdrawal by Subject|1|||
48784370|NCT02843568|157051683|FG000|Overall Study|Lost to Follow-up|2|||
48784371|NCT02843568|157051684|FG001|Overall Study|Lost to Follow-up|0|||
48784372|NCT03879798|157051685|FG000|Overall Study|Adverse Event|0|||
48784373|NCT03879798|157051686|FG001|Overall Study|Adverse Event|0|||
48784374|NCT03879798|157051687|FG002|Overall Study|Adverse Event|0|||
48784375|NCT03879798|157051688|FG003|Overall Study|Adverse Event|0|||
49031378|NCT01370733|157953327|FG001|Overall Study|Withdrawal by Subject|8|||
48877513|NCT00464945|157390079|FG000|Infant Series|Protocol Violation|1|||
48877514|NCT00464945|157390080|FG001|Infant Series|Protocol Violation|0|||
49031379|NCT01370733|157953326|FG000|Overall Study|Lost to Follow-up|3|||
49031380|NCT01370733|157953327|FG001|Overall Study|Lost to Follow-up|0|||
49031381|NCT01370733|157953326|FG000|Overall Study|Adverse Event|2|||
49031382|NCT01370733|157953327|FG001|Overall Study|Adverse Event|4|||
49031383|NCT01370733|157953326|FG000|Overall Study|Lack of Efficacy|3|||
49031384|NCT01370733|157953327|FG001|Overall Study|Lack of Efficacy|5|||
49031385|NCT01370733|157953326|FG000|Overall Study|Physician Decision|0|||
49031386|NCT01370733|157953327|FG001|Overall Study|Physician Decision|2|||
49031387|NCT01370733|157953326|FG000|Overall Study|Protocol Violation|1|||
48784376|NCT03879798|157051689|FG004|Overall Study|Adverse Event|0|||
48784377|NCT03879798|157051690|FG005|Overall Study|Adverse Event|1|||
48784378|NCT03879798|157051685|FG000|Overall Study|Lack of Efficacy|0|||
48784379|NCT03879798|157051686|FG001|Overall Study|Lack of Efficacy|0|||
48784380|NCT03879798|157051687|FG002|Overall Study|Lack of Efficacy|0|||
48784381|NCT03879798|157051688|FG003|Overall Study|Lack of Efficacy|0|||
48784382|NCT03879798|157051689|FG004|Overall Study|Lack of Efficacy|0|||
48784383|NCT03879798|157051690|FG005|Overall Study|Lack of Efficacy|1|||
48784384|NCT03879798|157051685|FG000|Overall Study|Withdrawal by Subject|0|||
48784385|NCT03879798|157051686|FG001|Overall Study|Withdrawal by Subject|0|||
48784386|NCT03879798|157051687|FG002|Overall Study|Withdrawal by Subject|0|||
48784387|NCT03879798|157051688|FG003|Overall Study|Withdrawal by Subject|0|||
48784388|NCT03879798|157051689|FG004|Overall Study|Withdrawal by Subject|0|||
48784389|NCT03879798|157051690|FG005|Overall Study|Withdrawal by Subject|1|||
48784390|NCT05348681|157051692|FG000|Overall Study|Study terminated by Sponsor|8|||
48784391|NCT05348681|157051693|FG001|Overall Study|Study terminated by Sponsor|3|||
48784392|NCT05348681|157051692|FG000|Overall Study|Withdrawal by Subject|1|||
48784393|NCT05348681|157051693|FG001|Overall Study|Withdrawal by Subject|1|||
48784394|NCT05348681|157051692|FG000|Overall Study|Lost to Follow-up|1|||
48784395|NCT05348681|157051693|FG001|Overall Study|Lost to Follow-up|1|||
48784396|NCT05348681|157051692|FG000|Overall Study|Adverse Event|1|||
48784397|NCT05348681|157051693|FG001|Overall Study|Adverse Event|0|||
48784398|NCT05348681|157051692|FG000|Overall Study|Other|2|||
48784399|NCT05348681|157051693|FG001|Overall Study|Other|1|||
48784400|NCT02493361|157051694|FG000|Overall Study|Withdrawal by Subject|3|||
48784401|NCT02219932|157051696|FG000|Overall Study|Other|5|||
48784402|NCT02219932|157051697|FG001|Overall Study|Other|11|||
48784403|NCT02219932|157051696|FG000|Overall Study|Death|1|||
48784404|NCT02219932|157051697|FG001|Overall Study|Death|1|||
48784405|NCT02219932|157051696|FG000|Overall Study|Investigator Decision|0|||
48784406|NCT02219932|157051697|FG001|Overall Study|Investigator Decision|1|||
48784407|NCT02219932|157051696|FG000|Overall Study|Consent Withdrawn|11|||
48784408|NCT02219932|157051697|FG001|Overall Study|Consent Withdrawn|7|||
48784409|NCT02219932|157051696|FG000|Overall Study|Lack of Efficacy (Subject Perception)|10|||
48784410|NCT02219932|157051697|FG001|Overall Study|Lack of Efficacy (Subject Perception)|2|||
48784411|NCT02219932|157051696|FG000|Overall Study|Protocol Violation|10|||
48784412|NCT02219932|157051697|FG001|Overall Study|Protocol Violation|6|||
48784413|NCT02219932|157051696|FG000|Overall Study|Pregnancy|1|||
48784414|NCT02219932|157051697|FG001|Overall Study|Pregnancy|0|||
48784415|NCT02219932|157051696|FG000|Overall Study|Lost to Follow-up|4|||
49031388|NCT01370733|157953327|FG001|Overall Study|Protocol Violation|3|||
49031389|NCT00239577|157953329|FG000|Primary Phase|Adverse Event|0|||
49031390|NCT00239577|157953330|FG001|Primary Phase|Adverse Event|0|||
49031391|NCT00239577|157953331|FG002|Primary Phase|Adverse Event|1|||
49031392|NCT00239577|157953332|FG003|Primary Phase|Adverse Event|0|||
49031393|NCT00239577|157953329|FG000|Primary Phase|Other|5|||
49031394|NCT00239577|157953330|FG001|Primary Phase|Other|3|||
49031395|NCT00239577|157953331|FG002|Primary Phase|Other|2|||
48784416|NCT02219932|157051697|FG001|Overall Study|Lost to Follow-up|2|||
48784417|NCT02219932|157051696|FG000|Overall Study|Adverse Event|23|||
48784418|NCT02219932|157051697|FG001|Overall Study|Adverse Event|21|||
48784419|NCT03321981|157051700|FG000|Overall Study|Progressive Disease (PD)|15|||
49031396|NCT00239577|157953332|FG003|Primary Phase|Other|0|||
49031397|NCT03988803|157953335|FG000|Period 2|Prematurely discontinued from medication|2|||
48784420|NCT03321981|157051701|FG001|Overall Study|Progressive Disease (PD)|30|||
48784421|NCT03321981|157051702|FG002|Overall Study|Progressive Disease (PD)|47|||
48784422|NCT03321981|157051700|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
48784423|NCT03321981|157051701|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|2|||
48784424|NCT03321981|157051702|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
48784425|NCT03321981|157051700|FG000|Overall Study|Adverse Event|0|||
48784426|NCT03321981|157051701|FG001|Overall Study|Adverse Event|0|||
48784427|NCT03321981|157051702|FG002|Overall Study|Adverse Event|2|||
48784428|NCT03321981|157051700|FG000|Overall Study|symptomatic deterioration|0|||
48784429|NCT03321981|157051701|FG001|Overall Study|symptomatic deterioration|1|||
49031398|NCT03988803|157953335|FG000|Period 2|Adverse Event|1|||
49031399|NCT02422264|157953336|FG000|Overall Study|Serious Adverse Event|1|||
49031400|NCT02422264|157953337|FG001|Overall Study|Serious Adverse Event|0|||
49031401|NCT02422264|157953336|FG000|Overall Study|Withdrawal by Subject|1|||
49031402|NCT02422264|157953337|FG001|Overall Study|Withdrawal by Subject|2|||
49031403|NCT02422264|157953336|FG000|Overall Study|Migrated/moved from study area|3|||
48784430|NCT03321981|157051702|FG002|Overall Study|symptomatic deterioration|1|||
48784431|NCT03321981|157051700|FG000|Overall Study|Lack of compliance|0|||
48784432|NCT03321981|157051701|FG001|Overall Study|Lack of compliance|1|||
48784433|NCT03321981|157051702|FG002|Overall Study|Lack of compliance|0|||
48784434|NCT03321981|157051700|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
48784435|NCT03321981|157051701|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|1|||
48784436|NCT03321981|157051702|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
48784437|NCT03321981|157051700|FG000|Overall Study|Death|0|||
48784438|NCT03321981|157051701|FG001|Overall Study|Death|1|||
48784439|NCT03321981|157051702|FG002|Overall Study|Death|0|||
48784440|NCT03321981|157051700|FG000|Overall Study|Subject withdrawal of investigational product|0|||
48784441|NCT03321981|157051701|FG001|Overall Study|Subject withdrawal of investigational product|1|||
48784442|NCT03321981|157051702|FG002|Overall Study|Subject withdrawal of investigational product|0|||
48784443|NCT03321981|157051700|FG000|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
48784444|NCT03321981|157051701|FG001|Overall Study|Treating physician decision due to lack of clinical benefit for patient|1|||
48784445|NCT03321981|157051702|FG002|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
48784446|NCT03321981|157051700|FG000|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
48784447|NCT03321981|157051701|FG001|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|1|||
48784448|NCT03321981|157051702|FG002|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
48784449|NCT00096135|157051710|FG000|Overall Study|Physician Decision|20|||
48784450|NCT00096135|157051711|FG001|Overall Study|Physician Decision|4|||
48784451|NCT00096135|157051710|FG000|Overall Study|Refusal of further protocol therapy|4|||
48784452|NCT00096135|157051711|FG001|Overall Study|Refusal of further protocol therapy|1|||
48784453|NCT00096135|157051710|FG000|Overall Study|Progressive disease, Marrow,CNS, Relapse|22|||
48784454|NCT00096135|157051711|FG001|Overall Study|Progressive disease, Marrow,CNS, Relapse|7|||
48784455|NCT00096135|157051710|FG000|Overall Study|Other, specify|15|||
48784456|NCT00096135|157051711|FG001|Overall Study|Other, specify|3|||
48784457|NCT00096135|157051710|FG000|Overall Study|Ineligible|2|||
48784458|NCT00096135|157051711|FG001|Overall Study|Ineligible|0|||
48784459|NCT00968669|157051714|FG000|Overall Study|Lost to Follow-up|5|||
48784460|NCT00968669|157051715|FG001|Overall Study|Lost to Follow-up|2|||
48784461|NCT00968669|157051716|FG002|Overall Study|Lost to Follow-up|1|||
48784462|NCT00968669|157051717|FG003|Overall Study|Lost to Follow-up|4|||
48784463|NCT00968669|157051714|FG000|Overall Study|Withdrawal by Subject|9|||
48784464|NCT00968669|157051715|FG001|Overall Study|Withdrawal by Subject|7|||
48784465|NCT00968669|157051716|FG002|Overall Study|Withdrawal by Subject|5|||
48784466|NCT00968669|157051717|FG003|Overall Study|Withdrawal by Subject|3|||
48784467|NCT00968669|157051714|FG000|Overall Study|Pregnancy|0|||
48784468|NCT00968669|157051715|FG001|Overall Study|Pregnancy|0|||
48784469|NCT00968669|157051716|FG002|Overall Study|Pregnancy|2|||
48784470|NCT00968669|157051717|FG003|Overall Study|Pregnancy|0|||
48784471|NCT00968669|157051714|FG000|Overall Study|AE|1|||
48784472|NCT00968669|157051715|FG001|Overall Study|AE|0|||
48784473|NCT00968669|157051716|FG002|Overall Study|AE|0|||
48784474|NCT00968669|157051717|FG003|Overall Study|AE|0|||
48784475|NCT00968669|157051714|FG000|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
48784476|NCT00968669|157051715|FG001|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
48784477|NCT00968669|157051716|FG002|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
48784478|NCT00968669|157051717|FG003|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1|||
48784479|NCT00968669|157051714|FG000|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1|||
48784480|NCT00968669|157051715|FG001|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
48784481|NCT00968669|157051716|FG002|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
48784482|NCT00968669|157051717|FG003|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
48784483|NCT00968669|157051714|FG000|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1|||
48784484|NCT00968669|157051715|FG001|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
48784485|NCT00968669|157051716|FG002|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
48784486|NCT00968669|157051717|FG003|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
48784487|NCT00968669|157051714|FG000|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
48784488|NCT00968669|157051715|FG001|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
48784489|NCT00968669|157051716|FG002|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1|||
48784490|NCT00968669|157051717|FG003|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
48784491|NCT00968669|157051714|FG000|Overall Study|EARLY WITHDRAWAL|0|||
48784492|NCT00968669|157051715|FG001|Overall Study|EARLY WITHDRAWAL|1|||
49031404|NCT02422264|157953337|FG001|Overall Study|Migrated/moved from study area|1|||
49031405|NCT02422264|157953336|FG000|Overall Study|Subject vaccinated outside of the study|0|||
49031406|NCT02422264|157953337|FG001|Overall Study|Subject vaccinated outside of the study|1|||
48784493|NCT00968669|157051716|FG002|Overall Study|EARLY WITHDRAWAL|0|||
48784494|NCT00968669|157051717|FG003|Overall Study|EARLY WITHDRAWAL|0|||
48784495|NCT00968669|157051714|FG000|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
48784496|NCT00968669|157051715|FG001|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
48784497|NCT00968669|157051716|FG002|Overall Study|ERROR IN HADS ADMINISTRATION|1|||
48784498|NCT00968669|157051717|FG003|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
48784499|NCT00968669|157051714|FG000|Overall Study|INEGIBILITY TO PERFORM VISIT|1|||
48784500|NCT00968669|157051715|FG001|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
48784501|NCT00968669|157051716|FG002|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
48784502|NCT00968669|157051717|FG003|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
48784503|NCT00968669|157051714|FG000|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
48784504|NCT00968669|157051715|FG001|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1|||
48784505|NCT00968669|157051716|FG002|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
48784506|NCT00968669|157051717|FG003|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
48784507|NCT00968669|157051714|FG000|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
48784508|NCT00968669|157051715|FG001|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1|||
48784509|NCT00968669|157051716|FG002|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
48784510|NCT00968669|157051717|FG003|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
48784511|NCT00968669|157051714|FG000|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
48784512|NCT00968669|157051715|FG001|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1|||
48784513|NCT00968669|157051716|FG002|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
48784514|NCT00968669|157051717|FG003|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
48784515|NCT00968669|157051714|FG000|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
48784516|NCT00968669|157051715|FG001|Overall Study|PATIENT WILL BE WORKING ABROAD|1|||
48784517|NCT00968669|157051716|FG002|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
48784518|NCT00968669|157051717|FG003|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
48784519|NCT00968669|157051714|FG000|Overall Study|SPONSOR DECISION|0|||
48784520|NCT00968669|157051715|FG001|Overall Study|SPONSOR DECISION|1|||
48784521|NCT00968669|157051716|FG002|Overall Study|SPONSOR DECISION|0|||
48784522|NCT00968669|157051717|FG003|Overall Study|SPONSOR DECISION|0|||
48784523|NCT00968669|157051714|FG000|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
48784524|NCT00968669|157051715|FG001|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
48784525|NCT00968669|157051716|FG002|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1|||
48784526|NCT00968669|157051717|FG003|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
48784527|NCT00968669|157051714|FG000|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
48784528|NCT00968669|157051715|FG001|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1|||
48784529|NCT00968669|157051716|FG002|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
48784530|NCT00968669|157051717|FG003|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
48784531|NCT00968669|157051714|FG000|Overall Study|SUBJECT INCARCERATED|0|||
48784532|NCT00968669|157051715|FG001|Overall Study|SUBJECT INCARCERATED|1|||
48784533|NCT00968669|157051716|FG002|Overall Study|SUBJECT INCARCERATED|0|||
48784534|NCT00968669|157051717|FG003|Overall Study|SUBJECT INCARCERATED|0|||
48784535|NCT00968669|157051714|FG000|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
48784536|NCT00968669|157051715|FG001|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1|||
48784537|NCT00968669|157051716|FG002|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
48784538|NCT00968669|157051717|FG003|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
48784539|NCT00968669|157051714|FG000|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
48784540|NCT00968669|157051715|FG001|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
48784541|NCT00968669|157051716|FG002|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
48784542|NCT00968669|157051717|FG003|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1|||
48784543|NCT01109992|157051723|FG000|Overall Study|Withdrawal by Subject|0|||
48784544|NCT01109992|157051724|FG001|Overall Study|Withdrawal by Subject|1|||
48784545|NCT01109992|157051723|FG000|Overall Study|Movement during rest scan.|0|||
48784546|NCT01109992|157051724|FG001|Overall Study|Movement during rest scan.|1|||
48784547|NCT03538626|157051730|FG000|Overall Study|Withdrawal by Subject|0|||
48784548|NCT03538626|157051731|FG001|Overall Study|Withdrawal by Subject|1|||
48784549|NCT03538626|157051732|FG002|Overall Study|Withdrawal by Subject|0|||
48784550|NCT03538626|157051733|FG003|Overall Study|Withdrawal by Subject|0|||
48784551|NCT03538626|157051734|FG004|Overall Study|Withdrawal by Subject|0|||
48784552|NCT03538626|157051735|FG005|Overall Study|Withdrawal by Subject|0|||
48784553|NCT03538626|157051736|FG006|Overall Study|Withdrawal by Subject|0|||
48784554|NCT03538626|157051737|FG007|Overall Study|Withdrawal by Subject|0|||
48784555|NCT03538626|157051730|FG000|Overall Study|Lost to Follow-up|0|||
48784556|NCT03538626|157051731|FG001|Overall Study|Lost to Follow-up|0|||
48784557|NCT03538626|157051732|FG002|Overall Study|Lost to Follow-up|0|||
48784558|NCT03538626|157051733|FG003|Overall Study|Lost to Follow-up|0|||
48784559|NCT03538626|157051734|FG004|Overall Study|Lost to Follow-up|0|||
48784560|NCT03538626|157051735|FG005|Overall Study|Lost to Follow-up|0|||
48784561|NCT03538626|157051736|FG006|Overall Study|Lost to Follow-up|1|||
48784562|NCT03538626|157051737|FG007|Overall Study|Lost to Follow-up|0|||
48784563|NCT00345397|157051750|FG000|Overall Study|Death|1|||
48784564|NCT04266028|157051753|FG000|Overall Study|Adverse Event|0|||
48784565|NCT04266028|157051754|FG001|Overall Study|Adverse Event|0|||
48784566|NCT04266028|157051755|FG002|Overall Study|Adverse Event|1|||
48784567|NCT04266028|157051756|FG003|Overall Study|Adverse Event|0|||
48784568|NCT04266028|157051757|FG004|Overall Study|Adverse Event|1|||
48784569|NCT04266028|157051758|FG005|Overall Study|Adverse Event|0|||
48784570|NCT04266028|157051759|FG006|Overall Study|Adverse Event|2|||
48784571|NCT04266028|157051760|FG007|Overall Study|Adverse Event|0|||
48784572|NCT04266028|157051753|FG000|Overall Study|temporary halt of the study|0|||
48784573|NCT04266028|157051754|FG001|Overall Study|temporary halt of the study|0|||
48784574|NCT04266028|157051755|FG002|Overall Study|temporary halt of the study|0|||
48784575|NCT04266028|157051756|FG003|Overall Study|temporary halt of the study|0|||
48784576|NCT04266028|157051757|FG004|Overall Study|temporary halt of the study|0|||
48784577|NCT04266028|157051758|FG005|Overall Study|temporary halt of the study|0|||
48784578|NCT04266028|157051759|FG006|Overall Study|temporary halt of the study|2|||
48784579|NCT04266028|157051760|FG007|Overall Study|temporary halt of the study|1|||
48784580|NCT04266028|157051753|FG000|Overall Study|Onset of birch pollen season|0|||
48784581|NCT04266028|157051754|FG001|Overall Study|Onset of birch pollen season|0|||
48784582|NCT04266028|157051755|FG002|Overall Study|Onset of birch pollen season|0|||
48784583|NCT04266028|157051756|FG003|Overall Study|Onset of birch pollen season|0|||
48784584|NCT04266028|157051757|FG004|Overall Study|Onset of birch pollen season|1|||
48784585|NCT04266028|157051758|FG005|Overall Study|Onset of birch pollen season|0|||
48784586|NCT04266028|157051759|FG006|Overall Study|Onset of birch pollen season|0|||
48784587|NCT04266028|157051760|FG007|Overall Study|Onset of birch pollen season|0|||
48784588|NCT01178853|157051762|FG000|Period 1 (Warfarin Titration)|INR Out of Range|1|||
48784589|NCT01178853|157051763|FG001|Period 1 (Warfarin Titration)|INR Out of Range|2|||
48784590|NCT01178853|157051762|FG000|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
48784591|NCT01178853|157051763|FG001|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
48784592|NCT01178853|157051762|FG000|Period 3 (Warfarin Titration)|Adverse Event|1|||
49031407|NCT03021018|157953339|FG000|Overall Study|Adverse Event|1|||
48784593|NCT01178853|157051763|FG001|Period 3 (Warfarin Titration)|Adverse Event|0|||
48784594|NCT01178853|157051762|FG000|Period 4 (Warfarin + Study Drug)|Adverse Event|0|||
48784595|NCT01178853|157051763|FG001|Period 4 (Warfarin + Study Drug)|Adverse Event|2|||
48784596|NCT01178853|157051762|FG000|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
48784597|NCT01178853|157051763|FG001|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
48784598|NCT01682837|157051764|FG000|Baseline|Withdrawal by Subject|5|||
48784599|NCT04558346|157051775|FG000|Overall Study|Withdrawal by Subject|2|||
48784600|NCT04558346|157051776|FG001|Overall Study|Withdrawal by Subject|0|||
49031408|NCT03021018|157953340|FG001|Overall Study|Adverse Event|0|||
49031409|NCT03021018|157953341|FG002|Overall Study|Adverse Event|0|||
49031410|NCT03021018|157953339|FG000|Overall Study|Fall with subsequent nasal fracture|1|||
49031411|NCT03021018|157953340|FG001|Overall Study|Fall with subsequent nasal fracture|0|||
49031412|NCT03021018|157953341|FG002|Overall Study|Fall with subsequent nasal fracture|0|||
48784601|NCT04558346|157051775|FG000|Overall Study|Lost to Follow-up|0|||
48784602|NCT04558346|157051776|FG001|Overall Study|Lost to Follow-up|1|||
48784603|NCT04558346|157051775|FG000|Overall Study|Adverse Event|0|||
48784604|NCT04558346|157051776|FG001|Overall Study|Adverse Event|1|||
48784605|NCT02715765|157051777|FG000|Overall Study|Study Termination|3|||
48784606|NCT02715765|157051778|FG001|Overall Study|Study Termination|0|||
48784607|NCT02715765|157051779|FG002|Overall Study|Study Termination|0|||
48784608|NCT02331134|157051780|FG000|Overall Study|Withdrawal by Subject|1|||
48784609|NCT03086447|157051783|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
48784610|NCT03086447|157051784|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
48784611|NCT03086447|157051783|FG000|Overall Study|Lost Lens|2|||
48784612|NCT03086447|157051784|FG001|Overall Study|Lost Lens|5|||
48784613|NCT03086447|157051783|FG000|Overall Study|Product quality complaint|0|||
48784614|NCT03086447|157051784|FG001|Overall Study|Product quality complaint|1|||
48784615|NCT03086447|157051783|FG000|Overall Study|Lens Damage|1|||
48784616|NCT03086447|157051784|FG001|Overall Study|Lens Damage|6|||
48784617|NCT03086447|157051783|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
48784618|NCT03086447|157051784|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
48784619|NCT03086447|157051783|FG000|Overall Study|Test Article No Longer Available|1|||
48784620|NCT03086447|157051784|FG001|Overall Study|Test Article No Longer Available|0|||
48784621|NCT03086447|157051783|FG000|Overall Study|Protocol Violation|2|||
48784622|NCT03086447|157051784|FG001|Overall Study|Protocol Violation|4|||
48784623|NCT03086447|157051783|FG000|Overall Study|Lost to Follow-up|0|||
48784624|NCT03086447|157051784|FG001|Overall Study|Lost to Follow-up|1|||
48784625|NCT03086447|157051783|FG000|Overall Study|Adverse Event|3|||
48784626|NCT03086447|157051784|FG001|Overall Study|Adverse Event|0|||
48784627|NCT03086447|157051783|FG000|Overall Study|Lens Discomfort|2|||
48784628|NCT03086447|157051784|FG001|Overall Study|Lens Discomfort|1|||
48784629|NCT03346759|157051787|FG000|Enrollment to Baseline Data Collected|Lost to Follow-up|2|||
48784630|NCT03346759|157051788|FG001|Enrollment to Baseline Data Collected|Lost to Follow-up|3|||
48784631|NCT03346759|157051787|FG000|First Menstrual Cycle|Withdrawal by Subject|1|||
48784632|NCT03346759|157051788|FG001|First Menstrual Cycle|Withdrawal by Subject|0|||
49031413|NCT03925532|157953342|FG000|Overall Study|Lost to Follow-up|1|||
49031414|NCT01404988|157953343|FG000|Overall Study|Death|2|||
48784633|NCT03346759|157051787|FG000|Second Menstrual Cycle|Lost to Follow-up|1|||
48784634|NCT03346759|157051788|FG001|Second Menstrual Cycle|Lost to Follow-up|0|||
48784635|NCT02863991|157051789|FG000|Overall Study|Death|0|||
48784636|NCT02863991|157051790|FG001|Overall Study|Death|3|||
48784637|NCT02863991|157051789|FG000|Overall Study|Lack of Efficacy|0|||
48784638|NCT02863991|157051790|FG001|Overall Study|Lack of Efficacy|1|||
48784639|NCT02863991|157051789|FG000|Overall Study|Study Terminated|2|||
48784640|NCT02863991|157051790|FG001|Overall Study|Study Terminated|8|||
48784641|NCT00364858|157051792|FG000|Overall Study|Adverse Event|1|||
48784642|NCT00364858|157051793|FG001|Overall Study|Adverse Event|5|||
48784643|NCT00364858|157051792|FG000|Overall Study|Withdrawal by Subject|1|||
48784644|NCT00364858|157051793|FG001|Overall Study|Withdrawal by Subject|1|||
48784645|NCT00364858|157051792|FG000|Overall Study|Pregnancy|1|||
48784646|NCT00364858|157051793|FG001|Overall Study|Pregnancy|1|||
48784647|NCT00364858|157051792|FG000|Overall Study|Clinical failure|2|||
48784648|NCT00364858|157051793|FG001|Overall Study|Clinical failure|13|||
48784649|NCT00364858|157051792|FG000|Overall Study|Discontinuation at baseline|1|||
48784650|NCT00364858|157051793|FG001|Overall Study|Discontinuation at baseline|0|||
48784651|NCT00364858|157051792|FG000|Overall Study|Non-compliant|1|||
48784652|NCT00364858|157051793|FG001|Overall Study|Non-compliant|0|||
48784653|NCT00364858|157051792|FG000|Overall Study|Return to Q2 regimen|0|||
48784654|NCT00364858|157051793|FG001|Overall Study|Return to Q2 regimen|1|||
48784655|NCT00364858|157051792|FG000|Overall Study|Clinical baseline issue|0|||
48784656|NCT00364858|157051793|FG001|Overall Study|Clinical baseline issue|1|||
48784657|NCT02132611|157051794|FG000|Overall Study|Death|2|||
48784658|NCT02005471|157051796|FG000|Main Study|Adverse Event|0|||
48784659|NCT02005471|157051797|FG001|Main Study|Adverse Event|1|||
48784660|NCT02005471|157051798|FG002|Main Study|Adverse Event|0|||
48784661|NCT02005471|157051799|FG003|Main Study|Adverse Event|0|||
48784662|NCT02005471|157051796|FG000|Main Study|Death|83|||
48784663|NCT02005471|157051797|FG001|Main Study|Death|52|||
48784664|NCT02005471|157051798|FG002|Main Study|Death|0|||
48784665|NCT02005471|157051799|FG003|Main Study|Death|0|||
48784666|NCT02005471|157051796|FG000|Main Study|Lost to Follow-up|4|||
49031415|NCT01404988|157953344|FG001|Overall Study|Death|0|||
49031416|NCT01404988|157953345|FG002|Overall Study|Death|2|||
49031417|NCT01404988|157953343|FG000|Overall Study|Adverse Event|1|||
49031418|NCT01404988|157953344|FG001|Overall Study|Adverse Event|0|||
49031419|NCT01404988|157953345|FG002|Overall Study|Adverse Event|0|||
49031420|NCT01404988|157953343|FG000|Overall Study|Withdrawal by Subject|2|||
49031421|NCT01404988|157953344|FG001|Overall Study|Withdrawal by Subject|2|||
49031422|NCT01404988|157953345|FG002|Overall Study|Withdrawal by Subject|0|||
49031423|NCT01404988|157953343|FG000|Overall Study|Lost to Follow-up|1|||
49031424|NCT01404988|157953344|FG001|Overall Study|Lost to Follow-up|2|||
49031425|NCT01404988|157953345|FG002|Overall Study|Lost to Follow-up|1|||
49031426|NCT03194217|157953346|FG000|Overall Study|Adverse Event|0|||
49031427|NCT03194217|157953347|FG001|Overall Study|Adverse Event|2|||
49031428|NCT03194217|157953348|FG002|Overall Study|Adverse Event|3|||
49031429|NCT03194217|157953349|FG003|Overall Study|Adverse Event|3|||
49031430|NCT03194217|157953346|FG000|Overall Study|Failure to meet randomisation criteria|0|||
49031431|NCT03194217|157953347|FG001|Overall Study|Failure to meet randomisation criteria|0|||
49031432|NCT03194217|157953348|FG002|Overall Study|Failure to meet randomisation criteria|0|||
49031433|NCT03194217|157953349|FG003|Overall Study|Failure to meet randomisation criteria|1|||
49031434|NCT03194217|157953346|FG000|Overall Study|Other|0|||
49031435|NCT03194217|157953347|FG001|Overall Study|Other|1|||
49031436|NCT03194217|157953348|FG002|Overall Study|Other|1|||
49031437|NCT03194217|157953349|FG003|Overall Study|Other|0|||
49031438|NCT03874715|157953350|FG000|Overall Study|Adverse Event|2|||
49031439|NCT03874715|157953351|FG001|Overall Study|Adverse Event|0|||
49031440|NCT03874715|157953350|FG000|Overall Study|Poor compliance to protocol|5|||
48877515|NCT00464945|157390079|FG000|Infant Series|Lost to Follow-up|1|||
49031441|NCT03874715|157953351|FG001|Overall Study|Poor compliance to protocol|1|||
49031442|NCT03874715|157953350|FG000|Overall Study|Withdrawal by Subject|1|||
49031443|NCT03874715|157953351|FG001|Overall Study|Withdrawal by Subject|0|||
49031444|NCT03874715|157953350|FG000|Overall Study|Other-unspecified|1|||
48877516|NCT00464945|157390080|FG001|Infant Series|Lost to Follow-up|0|||
48877517|NCT00464945|157390079|FG000|After Infant Series|Withdrawal by Subject|0|||
49031445|NCT03874715|157953351|FG001|Overall Study|Other-unspecified|0|||
49031446|NCT00934050|157953352|FG000|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
49031447|NCT00934050|157953353|FG001|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
49031448|NCT00934050|157953354|FG002|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
49031449|NCT00934050|157953355|FG003|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
49031450|NCT00934050|157953356|FG004|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
48877518|NCT00464945|157390080|FG001|After Infant Series|Withdrawal by Subject|2|||
48877519|NCT00464945|157390079|FG000|Toddler Dose|Lost to Follow-up|0|||
48784667|NCT02005471|157051797|FG001|Main Study|Lost to Follow-up|5|||
48784668|NCT02005471|157051798|FG002|Main Study|Lost to Follow-up|0|||
48784669|NCT02005471|157051799|FG003|Main Study|Lost to Follow-up|0|||
48784670|NCT02005471|157051796|FG000|Main Study|Physician Decision|3|||
49031451|NCT00934050|157953357|FG005|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
49031452|NCT00934050|157953352|FG000|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
49031453|NCT00934050|157953353|FG001|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12|||
49031454|NCT00934050|157953354|FG002|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
49031455|NCT00934050|157953355|FG003|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13|||
49031456|NCT00934050|157953356|FG004|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
49031457|NCT00934050|157953357|FG005|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
49031458|NCT00934050|157953352|FG000|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
49031459|NCT00934050|157953353|FG001|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
48784671|NCT02005471|157051797|FG001|Main Study|Physician Decision|1|||
48784672|NCT02005471|157051798|FG002|Main Study|Physician Decision|0|||
48784673|NCT02005471|157051799|FG003|Main Study|Physician Decision|0|||
48784674|NCT02005471|157051796|FG000|Main Study|Withdrawal by Subject|26|||
48784675|NCT02005471|157051797|FG001|Main Study|Withdrawal by Subject|11|||
48784676|NCT02005471|157051798|FG002|Main Study|Withdrawal by Subject|0|||
48784677|NCT02005471|157051799|FG003|Main Study|Withdrawal by Subject|0|||
48784678|NCT02005471|157051796|FG000|Main Study|Reason not Specified|0|||
48784679|NCT02005471|157051797|FG001|Main Study|Reason not Specified|6|||
48784680|NCT02005471|157051798|FG002|Main Study|Reason not Specified|0|||
48784681|NCT02005471|157051799|FG003|Main Study|Reason not Specified|0|||
48784682|NCT02005471|157051796|FG000|Main Study|Randomized but not Dosed|8|||
48784683|NCT02005471|157051797|FG001|Main Study|Randomized but not Dosed|0|||
48784684|NCT02005471|157051798|FG002|Main Study|Randomized but not Dosed|0|||
48784685|NCT02005471|157051799|FG003|Main Study|Randomized but not Dosed|0|||
48784686|NCT02005471|157051796|FG000|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
48784687|NCT02005471|157051797|FG001|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
48784688|NCT02005471|157051798|FG002|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
48784689|NCT02005471|157051799|FG003|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|1|||
48784690|NCT02005471|157051796|FG000|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
48784691|NCT02005471|157051797|FG001|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
48784692|NCT02005471|157051798|FG002|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
48784693|NCT02005471|157051799|FG003|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
48784694|NCT02005471|157051796|FG000|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
48784695|NCT02005471|157051797|FG001|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
48784696|NCT02005471|157051798|FG002|Re-Treatment/Crossover (R/C) Substudy|Death|1|||
48784697|NCT02005471|157051799|FG003|Re-Treatment/Crossover (R/C) Substudy|Death|8|||
48784698|NCT00898677|157051800|FG000|Overall Study|Adverse Event|0|||
48784699|NCT00898677|157051801|FG001|Overall Study|Adverse Event|0|||
48784700|NCT00898677|157051802|FG002|Overall Study|Adverse Event|1|||
48784701|NCT00898677|157051803|FG003|Overall Study|Adverse Event|0|||
48784702|NCT00898677|157051800|FG000|Overall Study|Lost to Follow-up|0|||
48784703|NCT00898677|157051801|FG001|Overall Study|Lost to Follow-up|0|||
48784704|NCT00898677|157051802|FG002|Overall Study|Lost to Follow-up|2|||
48784705|NCT00898677|157051803|FG003|Overall Study|Lost to Follow-up|0|||
48784706|NCT00898677|157051800|FG000|Overall Study|Protocol Violation|1|||
48784707|NCT00898677|157051801|FG001|Overall Study|Protocol Violation|1|||
49031460|NCT00934050|157953354|FG002|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1|||
49031461|NCT00934050|157953355|FG003|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
49031462|NCT00934050|157953356|FG004|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
49031463|NCT00934050|157953357|FG005|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
49031464|NCT00934050|157953352|FG000|Enrolled After 15 Dec 2009|Adverse Event|0|||
49031465|NCT00934050|157953353|FG001|Enrolled After 15 Dec 2009|Adverse Event|0|||
49031466|NCT00934050|157953354|FG002|Enrolled After 15 Dec 2009|Adverse Event|0|||
49031467|NCT00934050|157953355|FG003|Enrolled After 15 Dec 2009|Adverse Event|0|||
49031468|NCT00934050|157953356|FG004|Enrolled After 15 Dec 2009|Adverse Event|3|||
49031469|NCT00934050|157953357|FG005|Enrolled After 15 Dec 2009|Adverse Event|0|||
49031470|NCT00934050|157953352|FG000|Enrolled After 15 Dec 2009|Death|0|||
49031471|NCT00934050|157953353|FG001|Enrolled After 15 Dec 2009|Death|0|||
49031472|NCT00934050|157953354|FG002|Enrolled After 15 Dec 2009|Death|0|||
49031473|NCT00934050|157953355|FG003|Enrolled After 15 Dec 2009|Death|0|||
49031474|NCT00934050|157953356|FG004|Enrolled After 15 Dec 2009|Death|0|||
49031475|NCT00934050|157953357|FG005|Enrolled After 15 Dec 2009|Death|1|||
49031476|NCT00934050|157953352|FG000|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
49031477|NCT00934050|157953353|FG001|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
49031478|NCT00934050|157953354|FG002|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
49031479|NCT00934050|157953355|FG003|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
49031480|NCT00934050|157953356|FG004|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
48784708|NCT00898677|157051802|FG002|Overall Study|Protocol Violation|2|||
48784709|NCT00898677|157051803|FG003|Overall Study|Protocol Violation|0|||
48784710|NCT00898677|157051800|FG000|Overall Study|Withdrawal by Subject|0|||
48784711|NCT00898677|157051801|FG001|Overall Study|Withdrawal by Subject|0|||
48784712|NCT00898677|157051802|FG002|Overall Study|Withdrawal by Subject|0|||
48784713|NCT00898677|157051803|FG003|Overall Study|Withdrawal by Subject|1|||
49031481|NCT00934050|157953357|FG005|Enrolled After 15 Dec 2009|Lost to Follow-up|1|||
48784714|NCT00898677|157051800|FG000|Overall Study|Not Treated: Adverse Event|0|||
48877520|NCT00464945|157390080|FG001|Toddler Dose|Lost to Follow-up|1|||
48784715|NCT00898677|157051801|FG001|Overall Study|Not Treated: Adverse Event|2|||
48784716|NCT00898677|157051802|FG002|Overall Study|Not Treated: Adverse Event|1|||
48784717|NCT00898677|157051803|FG003|Overall Study|Not Treated: Adverse Event|0|||
48784718|NCT00898677|157051800|FG000|Overall Study|Not Treated: Lost to Follow-Up|0|||
48784719|NCT00898677|157051801|FG001|Overall Study|Not Treated: Lost to Follow-Up|5|||
48784720|NCT00898677|157051802|FG002|Overall Study|Not Treated: Lost to Follow-Up|5|||
48784721|NCT00898677|157051803|FG003|Overall Study|Not Treated: Lost to Follow-Up|2|||
48784722|NCT00898677|157051800|FG000|Overall Study|Not Treated: Pregnancy|0|||
48784723|NCT00898677|157051801|FG001|Overall Study|Not Treated: Pregnancy|0|||
48784724|NCT00898677|157051802|FG002|Overall Study|Not Treated: Pregnancy|1|||
48784725|NCT00898677|157051803|FG003|Overall Study|Not Treated: Pregnancy|0|||
48784726|NCT00898677|157051800|FG000|Overall Study|Not Treated: Protocol Violation|2|||
48784727|NCT00898677|157051801|FG001|Overall Study|Not Treated: Protocol Violation|0|||
48784728|NCT00898677|157051802|FG002|Overall Study|Not Treated: Protocol Violation|2|||
48784729|NCT00898677|157051803|FG003|Overall Study|Not Treated: Protocol Violation|0|||
48784730|NCT00898677|157051800|FG000|Overall Study|Not Treated: Withdraw by Subject|2|||
48784731|NCT00898677|157051801|FG001|Overall Study|Not Treated: Withdraw by Subject|16|||
48784732|NCT00898677|157051802|FG002|Overall Study|Not Treated: Withdraw by Subject|11|||
48784733|NCT00898677|157051803|FG003|Overall Study|Not Treated: Withdraw by Subject|3|||
48784734|NCT00898677|157051800|FG000|Overall Study|Not Treated: Patient uncooperative|2|||
48784735|NCT00898677|157051801|FG001|Overall Study|Not Treated: Patient uncooperative|3|||
48784736|NCT00898677|157051802|FG002|Overall Study|Not Treated: Patient uncooperative|1|||
48784737|NCT00898677|157051803|FG003|Overall Study|Not Treated: Patient uncooperative|0|||
48784738|NCT00898677|157051800|FG000|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
48784739|NCT00898677|157051801|FG001|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
48784740|NCT00898677|157051802|FG002|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
48784741|NCT00898677|157051803|FG003|Overall Study|Not Treated: Abnormal Prestudy Labs|1|||
48784742|NCT00898677|157051800|FG000|Overall Study|Not Treated: Abnormal Baseline ECG|1|||
48784743|NCT00898677|157051801|FG001|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
48784744|NCT00898677|157051802|FG002|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
49031482|NCT00934050|157953352|FG000|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
49031483|NCT00934050|157953353|FG001|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
49031484|NCT00934050|157953354|FG002|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
49031485|NCT00934050|157953355|FG003|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
49031486|NCT00934050|157953356|FG004|Enrolled After 15 Dec 2009|Withdrawal by Subject|4|||
49031487|NCT00934050|157953357|FG005|Enrolled After 15 Dec 2009|Withdrawal by Subject|2|||
48784745|NCT00898677|157051803|FG003|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
48784746|NCT00898677|157051800|FG000|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
48784747|NCT00898677|157051801|FG001|Overall Study|Not Treated: No Longer Met Inc Criteria|3|||
48784748|NCT00898677|157051802|FG002|Overall Study|Not Treated: No Longer Met Inc Criteria|1|||
48784749|NCT00898677|157051803|FG003|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
48784750|NCT00898677|157051800|FG000|Overall Study|Not Treated: Lack of Migraine Attack|9|||
48784751|NCT00898677|157051801|FG001|Overall Study|Not Treated: Lack of Migraine Attack|39|||
49031488|NCT00723710|157953364|FG000|Overall Study|Disease progression|48|||
49031489|NCT00723710|157953364|FG000|Overall Study|Adverse Event|88|||
48784752|NCT00898677|157051802|FG002|Overall Study|Not Treated: Lack of Migraine Attack|43|||
48784753|NCT00898677|157051803|FG003|Overall Study|Not Treated: Lack of Migraine Attack|12|||
48784754|NCT00898677|157051800|FG000|Overall Study|Not Treated: Other (Not Specified)|0|||
48784755|NCT00898677|157051801|FG001|Overall Study|Not Treated: Other (Not Specified)|0|||
48784756|NCT00898677|157051802|FG002|Overall Study|Not Treated: Other (Not Specified)|2|||
48784757|NCT00898677|157051803|FG003|Overall Study|Not Treated: Other (Not Specified)|0|||
48784758|NCT03387852|157051804|FG000|Overall Study|Adverse event (AE)|3|||
48784759|NCT03387852|157051805|FG001|Overall Study|Adverse event (AE)|0|||
48784760|NCT03387852|157051806|FG002|Overall Study|Adverse event (AE)|2|||
48784761|NCT03387852|157051807|FG003|Overall Study|Adverse event (AE)|0|||
48784762|NCT03387852|157051804|FG000|Overall Study|Loss of asthma control (LOAC)|28|||
48784763|NCT03387852|157051805|FG001|Overall Study|Loss of asthma control (LOAC)|16|||
48784764|NCT03387852|157051806|FG002|Overall Study|Loss of asthma control (LOAC)|20|||
48784765|NCT03387852|157051807|FG003|Overall Study|Loss of asthma control (LOAC)|14|||
48784766|NCT03387852|157051804|FG000|Overall Study|Withdrawal by participant|1|||
48784767|NCT03387852|157051805|FG001|Overall Study|Withdrawal by participant|1|||
48784768|NCT03387852|157051806|FG002|Overall Study|Withdrawal by participant|3|||
48784769|NCT03387852|157051807|FG003|Overall Study|Withdrawal by participant|2|||
48784770|NCT03387852|157051804|FG000|Overall Study|Other- Unspecified|1|||
48784771|NCT03387852|157051805|FG001|Overall Study|Other- Unspecified|1|||
48784772|NCT03387852|157051806|FG002|Overall Study|Other- Unspecified|2|||
48784773|NCT03387852|157051807|FG003|Overall Study|Other- Unspecified|1|||
48784774|NCT03387852|157051804|FG000|Overall Study|Poor compliance to protocol|0|||
48784775|NCT03387852|157051805|FG001|Overall Study|Poor compliance to protocol|0|||
48784776|NCT03387852|157051806|FG002|Overall Study|Poor compliance to protocol|0|||
48784777|NCT03387852|157051807|FG003|Overall Study|Poor compliance to protocol|1|||
48784778|NCT03387852|157051804|FG000|Overall Study|Randomized and not treated|0|||
48784779|NCT03387852|157051805|FG001|Overall Study|Randomized and not treated|0|||
48784780|NCT03387852|157051806|FG002|Overall Study|Randomized and not treated|0|||
48784781|NCT03387852|157051807|FG003|Overall Study|Randomized and not treated|1|||
48784782|NCT02730819|157051811|FG000|Overall Study|Lost to Follow-up|9|||
48784783|NCT02763384|157051812|FG000|Overall Study|Physician Decision|1|||
48784784|NCT02763384|157051812|FG000|Overall Study|Rapid decline - went on hospice|1|||
48784785|NCT02121847|157051813|FG000|Overall Study|Administrative Reasons|1|||
48784786|NCT02121847|157051813|FG000|Overall Study|Adverse Event|2|||
48784787|NCT02535065|157051814|FG000|Overall Study|Death|13|||
48784788|NCT02535065|157051814|FG000|Overall Study|Lost to Follow-up|1|||
48784789|NCT02535065|157051814|FG000|Overall Study|Withdrawal by Subject|6|||
48784790|NCT01329029|157051815|FG000|Overall Study|Withdrawal by Subject|117|||
48784791|NCT01329029|157051816|FG001|Overall Study|Withdrawal by Subject|87|||
48784792|NCT01329029|157051815|FG000|Overall Study|Adverse Event|82|||
48784793|NCT01329029|157051816|FG001|Overall Study|Adverse Event|29|||
48784794|NCT01329029|157051815|FG000|Overall Study|Death|16|||
48784795|NCT01329029|157051816|FG001|Overall Study|Death|19|||
48784796|NCT01329029|157051815|FG000|Overall Study|Other|14|||
48784797|NCT01329029|157051816|FG001|Overall Study|Other|20|||
48784798|NCT01329029|157051815|FG000|Overall Study|COPD Exacerbation|11|||
48784799|NCT01329029|157051816|FG001|Overall Study|COPD Exacerbation|18|||
48784800|NCT01329029|157051815|FG000|Overall Study|Physician Decision|16|||
48784801|NCT01329029|157051816|FG001|Overall Study|Physician Decision|13|||
48784802|NCT01329029|157051815|FG000|Overall Study|Lost to Follow-up|8|||
48784803|NCT01329029|157051816|FG001|Overall Study|Lost to Follow-up|5|||
48784804|NCT01329029|157051815|FG000|Overall Study|Met Pre-defined Discontinuation Criteria|5|||
48784805|NCT01329029|157051816|FG001|Overall Study|Met Pre-defined Discontinuation Criteria|1|||
48784806|NCT02352948|157051817|FG000|Overall Study|Death|47|||
48784807|NCT02352948|157051818|FG001|Overall Study|Death|48|||
48784808|NCT02352948|157051819|FG002|Overall Study|Death|114|||
48784809|NCT02352948|157051820|FG003|Overall Study|Death|74|||
48784810|NCT02352948|157051821|FG004|Overall Study|Death|77|||
48784811|NCT02352948|157051822|FG005|Overall Study|Death|44|||
48784812|NCT02352948|157051817|FG000|Overall Study|Lost to Follow-up|1|||
48784813|NCT02352948|157051818|FG001|Overall Study|Lost to Follow-up|0|||
48784814|NCT02352948|157051819|FG002|Overall Study|Lost to Follow-up|2|||
48784815|NCT02352948|157051820|FG003|Overall Study|Lost to Follow-up|1|||
48784816|NCT02352948|157051821|FG004|Overall Study|Lost to Follow-up|2|||
48784817|NCT02352948|157051822|FG005|Overall Study|Lost to Follow-up|1|||
48784818|NCT02352948|157051817|FG000|Overall Study|Withdrawal by Subject|1|||
48784819|NCT02352948|157051818|FG001|Overall Study|Withdrawal by Subject|10|||
48784820|NCT02352948|157051819|FG002|Overall Study|Withdrawal by Subject|11|||
48784821|NCT02352948|157051820|FG003|Overall Study|Withdrawal by Subject|23|||
48784822|NCT02352948|157051821|FG004|Overall Study|Withdrawal by Subject|9|||
48784823|NCT02352948|157051822|FG005|Overall Study|Withdrawal by Subject|4|||
48784824|NCT02352948|157051817|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
48784825|NCT02352948|157051818|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
48784826|NCT02352948|157051819|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
48784827|NCT02352948|157051820|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
48784828|NCT02352948|157051821|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
48784829|NCT02352948|157051822|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
48784830|NCT02352948|157051817|FG000|Overall Study|Other|0|||
48784831|NCT02352948|157051818|FG001|Overall Study|Other|0|||
48784832|NCT02352948|157051819|FG002|Overall Study|Other|2|||
48784833|NCT02352948|157051820|FG003|Overall Study|Other|0|||
48784834|NCT02352948|157051821|FG004|Overall Study|Other|0|||
48784835|NCT02352948|157051822|FG005|Overall Study|Other|0|||
48784836|NCT01337089|157053332|FG000|Overall Study|Adverse Event|237|||
48784837|NCT01337089|157053332|FG000|Overall Study|Withdrawal by Subject|129|||
48784838|NCT01337089|157053332|FG000|Overall Study|Withdrawal by Investigator|33|||
48784839|NCT01337089|157053332|FG000|Overall Study|Met Withdrawal Criteria|3|||
48784840|NCT01337089|157053332|FG000|Overall Study|Lost to Follow-up|2|||
48784841|NCT03778294|157053333|FG000|Overall Study|Death|1|||
48784842|NCT03778294|157053333|FG000|Overall Study|Issues with insurance|1|||
48784843|NCT03778294|157053333|FG000|Overall Study|disease progression before treatment|2|||
48983029|NCT00877890|157769979|FG000|Overall Study|Lost to Follow-up|5|||
48784844|NCT04419493|157053335|FG000|Wash-out After Period 1|Adverse Event|1|||
48784845|NCT04419493|157053336|FG001|Wash-out After Period 1|Adverse Event|2|||
48784846|NCT04419493|157053337|FG002|Wash-out After Period 1|Adverse Event|1|||
48784847|NCT04419493|157053338|FG003|Wash-out After Period 1|Adverse Event|0|||
48784848|NCT00524134|157053339|FG000|Overall Study|Withdrawal by Subject|1|||
48784849|NCT00524134|157053339|FG000|Overall Study|Physician Decision|1|||
48784850|NCT00970502|157053340|FG000|Overall Study|Withdrawal by Subject|1|||
48784851|NCT01627249|157053341|FG000|Overall Study|Death|3|||
48784852|NCT01627249|157053342|FG001|Overall Study|Death|5|||
48784853|NCT01627249|157053343|FG002|Overall Study|Death|3|||
48784854|NCT01627249|157053341|FG000|Overall Study|Withdrawal by Subject|12|||
48784855|NCT01627249|157053342|FG001|Overall Study|Withdrawal by Subject|6|||
48784856|NCT01627249|157053343|FG002|Overall Study|Withdrawal by Subject|9|||
48784857|NCT01627249|157053341|FG000|Overall Study|Missed Visit|1|||
48784858|NCT01627249|157053342|FG001|Overall Study|Missed Visit|1|||
48784859|NCT01627249|157053343|FG002|Overall Study|Missed Visit|0|||
48784860|NCT00201006|157053344|FG000|Overall Study|Withdrawal by Subject|7|||
48784861|NCT00201006|157053345|FG001|Overall Study|Withdrawal by Subject|2|||
48784862|NCT00201006|157053346|FG002|Overall Study|Withdrawal by Subject|3|||
48784863|NCT00201006|157053344|FG000|Overall Study|Adverse Event|1|||
48784864|NCT00201006|157053345|FG001|Overall Study|Adverse Event|0|||
48784865|NCT00201006|157053346|FG002|Overall Study|Adverse Event|1|||
48784866|NCT02707055|157053347|FG000|Phase 1|Withdrawal by Subject|1|||
48784867|NCT02707055|157053348|FG001|Phase 1|Withdrawal by Subject|2|||
48784868|NCT02707055|157053347|FG000|Phase 1|Physician Decision|0|||
48784869|NCT02707055|157053348|FG001|Phase 1|Physician Decision|1|||
48784870|NCT02707055|157053347|FG000|Phase 2|Adverse Event|1|||
48784871|NCT02707055|157053348|FG001|Phase 2|Adverse Event|2|||
48784872|NCT03266588|157053349|FG000|Observational Period|Screen Failure: Eligibility Criteria|439|||
48784873|NCT03266588|157053350|FG001|Observational Period|Screen Failure: Eligibility Criteria|228|||
48784874|NCT03266588|157053351|FG002|Observational Period|Screen Failure: Eligibility Criteria|140|||
48784875|NCT03266588|157053349|FG000|Observational Period|Withdrawal by Subject|44|||
48784876|NCT03266588|157053350|FG001|Observational Period|Withdrawal by Subject|22|||
48784877|NCT03266588|157053351|FG002|Observational Period|Withdrawal by Subject|13|||
48784878|NCT03266588|157053349|FG000|Observational Period|Non-compliance|18|||
48784879|NCT03266588|157053350|FG001|Observational Period|Non-compliance|12|||
48784880|NCT03266588|157053351|FG002|Observational Period|Non-compliance|10|||
48784881|NCT03266588|157053349|FG000|Observational Period|Lost to Follow-up|8|||
48784882|NCT03266588|157053350|FG001|Observational Period|Lost to Follow-up|12|||
48784883|NCT03266588|157053351|FG002|Observational Period|Lost to Follow-up|4|||
48784884|NCT03266588|157053349|FG000|Observational Period|Eligibility Failure- Baseline Lab Values|3|||
48784885|NCT03266588|157053350|FG001|Observational Period|Eligibility Failure- Baseline Lab Values|1|||
48784886|NCT03266588|157053351|FG002|Observational Period|Eligibility Failure- Baseline Lab Values|0|||
48784887|NCT03266588|157053349|FG000|Observational Period|Protocol Deviation|1|||
48784888|NCT03266588|157053350|FG001|Observational Period|Protocol Deviation|0|||
48784889|NCT03266588|157053351|FG002|Observational Period|Protocol Deviation|0|||
48784890|NCT03266588|157053349|FG000|Observational Period|Other Reasons|3|||
48784891|NCT03266588|157053350|FG001|Observational Period|Other Reasons|0|||
48784892|NCT03266588|157053351|FG002|Observational Period|Other Reasons|1|||
48784893|NCT03266588|157053349|FG000|Long-term Treatment Period|Adverse Event|33|||
48784894|NCT03266588|157053350|FG001|Long-term Treatment Period|Adverse Event|17|||
48784895|NCT03266588|157053351|FG002|Long-term Treatment Period|Adverse Event|8|||
48784896|NCT03266588|157053349|FG000|Long-term Treatment Period|Lack of Efficacy|41|||
48784897|NCT03266588|157053350|FG001|Long-term Treatment Period|Lack of Efficacy|31|||
48784898|NCT03266588|157053351|FG002|Long-term Treatment Period|Lack of Efficacy|5|||
48784899|NCT03266588|157053349|FG000|Long-term Treatment Period|Lost to Follow-up|39|||
48784900|NCT03266588|157053350|FG001|Long-term Treatment Period|Lost to Follow-up|37|||
48784901|NCT03266588|157053351|FG002|Long-term Treatment Period|Lost to Follow-up|8|||
48784902|NCT03266588|157053349|FG000|Long-term Treatment Period|Non-Compliance|126|||
48784903|NCT03266588|157053350|FG001|Long-term Treatment Period|Non-Compliance|57|||
48784904|NCT03266588|157053351|FG002|Long-term Treatment Period|Non-Compliance|7|||
48784905|NCT03266588|157053349|FG000|Long-term Treatment Period|Pregnancy|11|||
48784906|NCT03266588|157053350|FG001|Long-term Treatment Period|Pregnancy|5|||
48784907|NCT03266588|157053351|FG002|Long-term Treatment Period|Pregnancy|0|||
49031490|NCT00723710|157953364|FG000|Overall Study|Withdrawal by Subject|36|||
48784908|NCT03266588|157053349|FG000|Long-term Treatment Period|Protocol Deviation|17|||
48784909|NCT03266588|157053350|FG001|Long-term Treatment Period|Protocol Deviation|10|||
48784910|NCT03266588|157053351|FG002|Long-term Treatment Period|Protocol Deviation|4|||
48784911|NCT03266588|157053349|FG000|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33|||
48784912|NCT03266588|157053350|FG001|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
48784913|NCT03266588|157053351|FG002|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
48784914|NCT03266588|157053349|FG000|Long-term Treatment Period|Withdrawal by Subject|100|||
48784915|NCT03266588|157053350|FG001|Long-term Treatment Period|Withdrawal by Subject|63|||
48784916|NCT03266588|157053351|FG002|Long-term Treatment Period|Withdrawal by Subject|16|||
49031491|NCT00723710|157953364|FG000|Overall Study|Physician Decision|2|||
49031492|NCT02682784|157953365|FG000|Overall Study|Withdrawal by Subject|0|||
48784917|NCT03266588|157053349|FG000|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1|||
48784918|NCT03266588|157053350|FG001|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2|||
48784919|NCT03266588|157053351|FG002|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0|||
48784920|NCT03266588|157053349|FG000|Long-term Treatment Period|Other Reasons|5|||
48784921|NCT03266588|157053350|FG001|Long-term Treatment Period|Other Reasons|0|||
48784922|NCT03266588|157053351|FG002|Long-term Treatment Period|Other Reasons|0|||
48784923|NCT03266588|157053349|FG000|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
48784924|NCT03266588|157053350|FG001|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1|||
48784925|NCT03266588|157053351|FG002|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
48784926|NCT02244944|157053353|FG000|Overall Study|Withdrawal by Subject|1|||
48784927|NCT02244944|157053353|FG000|Overall Study|Study Terminated|1|||
48784928|NCT01750268|157053354|FG000|Overall Study|Lost to Follow-up|0|||
48784929|NCT01750268|157053355|FG001|Overall Study|Lost to Follow-up|2|||
49031493|NCT02682784|157953366|FG001|Overall Study|Withdrawal by Subject|2|||
49031494|NCT02682784|157953367|FG002|Overall Study|Withdrawal by Subject|1|||
49031495|NCT02682784|157953368|FG003|Overall Study|Withdrawal by Subject|2|||
49031496|NCT02682784|157953365|FG000|Overall Study|Physician Decision|1|||
49031497|NCT02682784|157953366|FG001|Overall Study|Physician Decision|0|||
49031498|NCT02682784|157953367|FG002|Overall Study|Physician Decision|1|||
49031499|NCT02682784|157953368|FG003|Overall Study|Physician Decision|1|||
49031500|NCT00731783|157953369|FG000|One Month Follow-Up Visit|Lost to Follow-up|14|||
49031501|NCT00731783|157953370|FG001|One Month Follow-Up Visit|Lost to Follow-up|22|||
49031502|NCT00731783|157953369|FG000|Three Month Follow-Up Visit|Lost to Follow-up|7|||
49031503|NCT00731783|157953370|FG001|Three Month Follow-Up Visit|Lost to Follow-up|16|||
49031504|NCT00731783|157953369|FG000|Six Month Follow-Up Visit|Lost to Follow-up|6|||
49031505|NCT00731783|157953370|FG001|Six Month Follow-Up Visit|Lost to Follow-up|3|||
49031506|NCT00731783|157953369|FG000|12 Month Follow-Up Visit|Lost to Follow-up|6|||
49031507|NCT00731783|157953370|FG001|12 Month Follow-Up Visit|Lost to Follow-up|7|||
49031508|NCT01401647|157953372|FG000|Overall Study|Withdrawal by Subject|1|||
49031509|NCT01401647|157953373|FG001|Overall Study|Withdrawal by Subject|5|||
49031510|NCT01401647|157953374|FG002|Overall Study|Withdrawal by Subject|2|||
49031511|NCT01401647|157953372|FG000|Overall Study|Lost to Follow-up|3|||
49031512|NCT01401647|157953373|FG001|Overall Study|Lost to Follow-up|3|||
49031513|NCT01401647|157953374|FG002|Overall Study|Lost to Follow-up|1|||
49031514|NCT00904215|157953377|FG000|Overall Study|Adverse Event|25|||
49031515|NCT00904215|157953377|FG000|Overall Study|Protocol Violation|10|||
49031516|NCT00904215|157953377|FG000|Overall Study|Lost to Follow-up|63|||
49031517|NCT00904215|157953377|FG000|Overall Study|Withdrawal by Subject|9|||
49031518|NCT00904215|157953377|FG000|Overall Study|Other|28|||
49031519|NCT01175018|157953384|FG000|Overall Study|Adverse Event|3|||
49031520|NCT01175018|157953385|FG001|Overall Study|Adverse Event|1|||
49031521|NCT02089685|157953388|FG000|Overall Study|Adverse Event|1|||
49031522|NCT02089685|157953389|FG001|Overall Study|Adverse Event|0|||
49031523|NCT02089685|157953390|FG002|Overall Study|Adverse Event|0|||
49031524|NCT02089685|157953391|FG003|Overall Study|Adverse Event|0|||
49031525|NCT02089685|157953392|FG004|Overall Study|Adverse Event|1|||
49031526|NCT02089685|157953393|FG005|Overall Study|Adverse Event|0|||
49031527|NCT02089685|157953388|FG000|Overall Study|Clinical Progression|4|||
49031528|NCT02089685|157953389|FG001|Overall Study|Clinical Progression|0|||
49031529|NCT02089685|157953390|FG002|Overall Study|Clinical Progression|0|||
49031530|NCT02089685|157953391|FG003|Overall Study|Clinical Progression|5|||
49031531|NCT02089685|157953392|FG004|Overall Study|Clinical Progression|1|||
49031532|NCT02089685|157953393|FG005|Overall Study|Clinical Progression|2|||
49031533|NCT02089685|157953388|FG000|Overall Study|Excluded Medication|1|||
49031534|NCT02089685|157953389|FG001|Overall Study|Excluded Medication|0|||
48784930|NCT01750268|157053354|FG000|Overall Study|Physician Decision|0|||
48784931|NCT01750268|157053355|FG001|Overall Study|Physician Decision|3|||
48784932|NCT01750268|157053354|FG000|Overall Study|Withdrawal by Subject|2|||
48784933|NCT01750268|157053355|FG001|Overall Study|Withdrawal by Subject|0|||
48784934|NCT00966940|157053359|FG000|Period 1, First 6 Weeks|Withdrawal by Subject|2|||
48784935|NCT00966940|157053360|FG001|Period 1, First 6 Weeks|Withdrawal by Subject|0|||
48784936|NCT00966940|157053359|FG000|Period 1, First 6 Weeks|Protocol Violation|1|||
48784937|NCT00966940|157053360|FG001|Period 1, First 6 Weeks|Protocol Violation|0|||
48784938|NCT03087591|157053364|FG000|Overall Study|Disease progression before starting treatment, removed from study|1|||
48784939|NCT03087591|157053364|FG000|Overall Study|Withdrawal by Subject|1|||
48784940|NCT01073618|157053365|FG000|Overall Study|Death|208|||
48784941|NCT01073618|157053365|FG000|Overall Study|Adverse Event|19|||
48784942|NCT01073618|157053365|FG000|Overall Study|Other|80|||
48784943|NCT03725982|157053366|FG000|First Intervention|Withdrawal by Subject|0|||
48784944|NCT03725982|157053367|FG001|First Intervention|Withdrawal by Subject|1|||
49031535|NCT02089685|157953390|FG002|Overall Study|Excluded Medication|0|||
49031536|NCT02089685|157953391|FG003|Overall Study|Excluded Medication|11|||
49031537|NCT02089685|157953392|FG004|Overall Study|Excluded Medication|2|||
49031538|NCT02089685|157953393|FG005|Overall Study|Excluded Medication|1|||
49031539|NCT02089685|157953388|FG000|Overall Study|Progressive disease|13|||
49031540|NCT02089685|157953389|FG001|Overall Study|Progressive disease|10|||
48784945|NCT03725982|157053366|FG000|First Intervention|Physician Decision|1|||
48784946|NCT03725982|157053367|FG001|First Intervention|Physician Decision|1|||
48784947|NCT04743908|157053368|FG000|Overall Study|Death|1|||
48784948|NCT04743908|157053369|FG001|Overall Study|Death|0|||
49031541|NCT02089685|157953390|FG002|Overall Study|Progressive disease|3|||
49031542|NCT02089685|157953391|FG003|Overall Study|Progressive disease|51|||
49031543|NCT02089685|157953392|FG004|Overall Study|Progressive disease|17|||
49031544|NCT02089685|157953393|FG005|Overall Study|Progressive disease|12|||
48784949|NCT04743908|157053368|FG000|Overall Study|Lost to Follow-up|181|||
49031545|NCT02089685|157953388|FG000|Overall Study|Follow up ended by sponsor|2|||
48784950|NCT04743908|157053369|FG001|Overall Study|Lost to Follow-up|180|||
48784951|NCT04743908|157053368|FG000|Overall Study|Withdrawal by Subject|1|||
48784952|NCT04743908|157053369|FG001|Overall Study|Withdrawal by Subject|2|||
48784953|NCT02044510|157053370|FG000|Overall Study|Adverse Event|1|||
48784954|NCT02044510|157053371|FG001|Overall Study|Adverse Event|2|||
48784955|NCT02979535|157053372|FG000|Overall Study|Non compliance with the protocol|78|||
48784956|NCT02979535|157053373|FG001|Overall Study|Non compliance with the protocol|82|||
48784957|NCT02979535|157053372|FG000|Overall Study|Consent withdrawn by participant|11|||
48784958|NCT02979535|157053373|FG001|Overall Study|Consent withdrawn by participant|18|||
48784959|NCT02979535|157053372|FG000|Overall Study|Lost to Follow-up|6|||
48784960|NCT02979535|157053373|FG001|Overall Study|Lost to Follow-up|1|||
48784961|NCT00512135|157053374|FG000|Overall Study|Not Treated|5|||
48784962|NCT00512135|157053374|FG000|Overall Study|Lack of Efficacy|2|||
48784963|NCT00512135|157053374|FG000|Overall Study|Adverse Event|6|||
48877521|NCT05382039|157390083|FG000|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|5|||
48784964|NCT00512135|157053374|FG000|Overall Study|Withdrawal by Subject|22|||
48784965|NCT00512135|157053374|FG000|Overall Study|Lost to Follow-up|27|||
48784966|NCT00512135|157053374|FG000|Overall Study|Other|22|||
48784967|NCT01343082|157053375|FG000|The run-in Period|Not meeting criteria|3|||
48784968|NCT01343082|157053376|FG001|The run-in Period|Not meeting criteria|4|||
48784969|NCT01343082|157053377|FG002|The run-in Period|Not meeting criteria|5|||
48784970|NCT01343082|157053375|FG000|Treatment Period , Switched to DE-111|Adverse Event|1|||
48784971|NCT01343082|157053376|FG001|Treatment Period , Switched to DE-111|Adverse Event|4|||
48784972|NCT01343082|157053377|FG002|Treatment Period , Switched to DE-111|Adverse Event|3|||
48784973|NCT01343082|157053375|FG000|Treatment Period , Switched to DE-111|Lack of Efficacy|0|||
48784974|NCT01343082|157053376|FG001|Treatment Period , Switched to DE-111|Lack of Efficacy|1|||
48784975|NCT01343082|157053377|FG002|Treatment Period , Switched to DE-111|Lack of Efficacy|2|||
48784976|NCT01343082|157053375|FG000|Treatment Period , Switched to DE-111|Physician Decision|0|||
48784977|NCT01343082|157053376|FG001|Treatment Period , Switched to DE-111|Physician Decision|2|||
48784978|NCT01343082|157053377|FG002|Treatment Period , Switched to DE-111|Physician Decision|2|||
48784979|NCT01343082|157053375|FG000|Treatment Period , Switched to DE-111|Withdrawal by Subject|4|||
48784980|NCT01343082|157053376|FG001|Treatment Period , Switched to DE-111|Withdrawal by Subject|2|||
48784981|NCT01343082|157053377|FG002|Treatment Period , Switched to DE-111|Withdrawal by Subject|5|||
48784982|NCT00467870|157053378|FG000|Overall Study|Adverse Event|13|||
48784983|NCT00467870|157053379|FG001|Overall Study|Adverse Event|9|||
48784984|NCT00467870|157053380|FG002|Overall Study|Adverse Event|1|||
48784985|NCT00467870|157053381|FG003|Overall Study|Adverse Event|15|||
48784986|NCT00467870|157053382|FG004|Overall Study|Adverse Event|15|||
48784987|NCT00467870|157053383|FG005|Overall Study|Adverse Event|1|||
48784988|NCT00467870|157053378|FG000|Overall Study|Protocol Violation|2|||
48784989|NCT00467870|157053379|FG001|Overall Study|Protocol Violation|1|||
48784990|NCT00467870|157053380|FG002|Overall Study|Protocol Violation|1|||
48784991|NCT00467870|157053381|FG003|Overall Study|Protocol Violation|2|||
48784992|NCT00467870|157053382|FG004|Overall Study|Protocol Violation|0|||
48784993|NCT00467870|157053383|FG005|Overall Study|Protocol Violation|0|||
48784994|NCT00467870|157053378|FG000|Overall Study|Withdrawal by Subject|14|||
48784995|NCT00467870|157053379|FG001|Overall Study|Withdrawal by Subject|21|||
48784996|NCT00467870|157053380|FG002|Overall Study|Withdrawal by Subject|0|||
48784997|NCT00467870|157053381|FG003|Overall Study|Withdrawal by Subject|9|||
48784998|NCT00467870|157053382|FG004|Overall Study|Withdrawal by Subject|10|||
48784999|NCT00467870|157053383|FG005|Overall Study|Withdrawal by Subject|1|||
48785000|NCT00467870|157053378|FG000|Overall Study|Lost to Follow-up|5|||
48785001|NCT00467870|157053379|FG001|Overall Study|Lost to Follow-up|3|||
48785002|NCT00467870|157053380|FG002|Overall Study|Lost to Follow-up|1|||
48785003|NCT00467870|157053381|FG003|Overall Study|Lost to Follow-up|1|||
48785004|NCT00467870|157053382|FG004|Overall Study|Lost to Follow-up|3|||
48785005|NCT00467870|157053383|FG005|Overall Study|Lost to Follow-up|0|||
48785006|NCT00467870|157053378|FG000|Overall Study|Subject Non-compliance|3|||
48785007|NCT00467870|157053379|FG001|Overall Study|Subject Non-compliance|4|||
48785008|NCT00467870|157053380|FG002|Overall Study|Subject Non-compliance|0|||
48785009|NCT00467870|157053381|FG003|Overall Study|Subject Non-compliance|1|||
48785010|NCT00467870|157053382|FG004|Overall Study|Subject Non-compliance|5|||
48785011|NCT00467870|157053383|FG005|Overall Study|Subject Non-compliance|0|||
48785012|NCT00467870|157053378|FG000|Overall Study|Other/Unknown|8|||
48785013|NCT00467870|157053379|FG001|Overall Study|Other/Unknown|5|||
48877522|NCT05382039|157390084|FG001|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
48877523|NCT05382039|157390085|FG002|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
48983030|NCT00877890|157769980|FG001|Overall Study|Lost to Follow-up|5|||
48785014|NCT00467870|157053380|FG002|Overall Study|Other/Unknown|1|||
48785015|NCT00467870|157053381|FG003|Overall Study|Other/Unknown|5|||
48785016|NCT00467870|157053382|FG004|Overall Study|Other/Unknown|4|||
48785017|NCT00467870|157053383|FG005|Overall Study|Other/Unknown|0|||
48785018|NCT02624804|157053384|FG000|Overall Study|Screen Failure|5|||
48785019|NCT02613481|157053385|FG000|Overall Study|Lost to Follow-up|7|||
48785020|NCT02613481|157053385|FG000|Overall Study|Withdrawal by Subject|2|||
48785021|NCT02348216|157053386|FG000|Overall Study|Death|5|||
48785022|NCT02348216|157053387|FG001|Overall Study|Death|53|||
48785023|NCT02348216|157053388|FG002|Overall Study|Death|11|||
48785024|NCT02348216|157053389|FG003|Overall Study|Death|20|||
48785025|NCT02348216|157053390|FG004|Overall Study|Death|16|||
48785026|NCT02348216|157053391|FG005|Overall Study|Death|32|||
48785027|NCT02348216|157053392|FG006|Overall Study|Death|17|||
48785028|NCT02348216|157053386|FG000|Overall Study|Full consent withdrawal|0|||
48785029|NCT02348216|157053387|FG001|Overall Study|Full consent withdrawal|0|||
48785030|NCT02348216|157053388|FG002|Overall Study|Full consent withdrawal|0|||
48785031|NCT02348216|157053389|FG003|Overall Study|Full consent withdrawal|1|||
48785032|NCT02348216|157053390|FG004|Overall Study|Full consent withdrawal|3|||
48785033|NCT02348216|157053391|FG005|Overall Study|Full consent withdrawal|0|||
48785034|NCT02348216|157053392|FG006|Overall Study|Full consent withdrawal|3|||
48785035|NCT02348216|157053386|FG000|Overall Study|Lost to Follow-up|0|||
48785036|NCT02348216|157053387|FG001|Overall Study|Lost to Follow-up|5|||
48785037|NCT02348216|157053388|FG002|Overall Study|Lost to Follow-up|2|||
48785038|NCT02348216|157053389|FG003|Overall Study|Lost to Follow-up|0|||
48785039|NCT02348216|157053390|FG004|Overall Study|Lost to Follow-up|1|||
48785040|NCT02348216|157053391|FG005|Overall Study|Lost to Follow-up|1|||
48785041|NCT02348216|157053392|FG006|Overall Study|Lost to Follow-up|1|||
48785042|NCT02348216|157053386|FG000|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|1|||
48785043|NCT02348216|157053387|FG001|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
48785044|NCT02348216|157053388|FG002|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|6|||
48785045|NCT02348216|157053389|FG003|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
48785046|NCT02348216|157053390|FG004|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|5|||
48785047|NCT02348216|157053391|FG005|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|8|||
48785048|NCT02348216|157053392|FG006|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|2|||
48785049|NCT02348216|157053386|FG000|Overall Study|Reason not specified|2|||
48785050|NCT02348216|157053387|FG001|Overall Study|Reason not specified|19|||
48785051|NCT02348216|157053388|FG002|Overall Study|Reason not specified|11|||
48785052|NCT02348216|157053389|FG003|Overall Study|Reason not specified|17|||
48785053|NCT02348216|157053390|FG004|Overall Study|Reason not specified|21|||
48785054|NCT02348216|157053391|FG005|Overall Study|Reason not specified|17|||
48785055|NCT02348216|157053392|FG006|Overall Study|Reason not specified|19|||
48785056|NCT00562159|157053393|FG000|Overall Study|Adverse Event|11|||
48785057|NCT00562159|157053394|FG001|Overall Study|Adverse Event|8|||
48785058|NCT00562159|157053393|FG000|Overall Study|Lost to Follow-up|5|||
48785059|NCT00562159|157053394|FG001|Overall Study|Lost to Follow-up|4|||
48785060|NCT00562159|157053393|FG000|Overall Study|Withdrawal by Subject|9|||
48785061|NCT00562159|157053394|FG001|Overall Study|Withdrawal by Subject|8|||
48785062|NCT00562159|157053393|FG000|Overall Study|Protocol Violation|12|||
48785063|NCT00562159|157053394|FG001|Overall Study|Protocol Violation|12|||
48983031|NCT00877890|157769979|FG000|Overall Study|Protocol Violation|0|||
48785064|NCT00562159|157053393|FG000|Overall Study|Did not meet protocol eligibility|1|||
48785065|NCT00562159|157053394|FG001|Overall Study|Did not meet protocol eligibility|1|||
48785066|NCT00434057|157053397|FG000|Overall Study|Withdrawal by Subject|1|||
48785067|NCT01233817|157053406|FG000|Overall Study|Lost to Follow-up|1|||
48785068|NCT01233817|157053406|FG000|Overall Study|Withdrawal by Subject|2|||
48785069|NCT00599326|157053408|FG000|Overall Study|Lost to Follow-up|1|||
48785070|NCT00599326|157053408|FG000|Overall Study|Noncompliant|1|||
48983032|NCT00877890|157769980|FG001|Overall Study|Protocol Violation|1|||
48983033|NCT00877890|157769979|FG000|Overall Study|Withdrawal of Consent|6|||
48983034|NCT00877890|157769980|FG001|Overall Study|Withdrawal of Consent|12|||
48983035|NCT00877890|157769979|FG000|Overall Study|Investigator Decision|0|||
48983036|NCT00877890|157769980|FG001|Overall Study|Investigator Decision|2|||
48983037|NCT00877890|157769979|FG000|Overall Study|Loss of Glucose Control|3|||
48983038|NCT00877890|157769980|FG001|Overall Study|Loss of Glucose Control|4|||
48983039|NCT00656799|157769981|FG000|Overall Study|Death|2|||
48983040|NCT00742391|157769984|FG000|Overall Study|Adverse Event|2|||
48983041|NCT00742391|157769985|FG001|Overall Study|Adverse Event|1|||
48983042|NCT00742391|157769984|FG000|Overall Study|Lost to Follow-up|1|||
48983043|NCT00742391|157769985|FG001|Overall Study|Lost to Follow-up|0|||
48983044|NCT00742391|157769984|FG000|Overall Study|Protocol Violation|1|||
48983045|NCT00742391|157769985|FG001|Overall Study|Protocol Violation|0|||
48983046|NCT02394028|157769986|FG000|Induction Phase|Adverse Event|2|||
48983047|NCT02394028|157769987|FG001|Induction Phase|Adverse Event|4|||
48983048|NCT02394028|157769988|FG002|Induction Phase|Adverse Event|1|||
48983049|NCT02394028|157769989|FG003|Induction Phase|Adverse Event|2|||
48983050|NCT02394028|157769990|FG004|Induction Phase|Adverse Event|5|||
48983051|NCT02394028|157769991|FG005|Induction Phase|Adverse Event|2|||
48983052|NCT02394028|157769992|FG006|Induction Phase|Adverse Event|0|||
48983053|NCT02394028|157769993|FG007|Induction Phase|Adverse Event|0|||
48983054|NCT02394028|157769994|FG008|Induction Phase|Adverse Event|0|||
48983055|NCT02394028|157769995|FG009|Induction Phase|Adverse Event|0|||
48785071|NCT03105362|157053415|FG000|Overall Study|Withdrawal by Subject|1|||
48785072|NCT03105362|157053415|FG000|Overall Study|Lost to Follow-up|1|||
48785073|NCT00144339|157053416|FG000|Overall Study|Adverse Event|746|||
48785074|NCT00144339|157053417|FG001|Overall Study|Adverse Event|627|||
48785075|NCT00144339|157053416|FG000|Overall Study|Protocol Violation|75|||
48785076|NCT00144339|157053417|FG001|Overall Study|Protocol Violation|48|||
48785077|NCT00144339|157053416|FG000|Overall Study|Withdrawal by Subject|403|||
48785078|NCT00144339|157053417|FG001|Overall Study|Withdrawal by Subject|300|||
48785079|NCT00144339|157053416|FG000|Overall Study|Lost to Follow-up|76|||
48785080|NCT00144339|157053417|FG001|Overall Study|Lost to Follow-up|64|||
48785081|NCT00144339|157053416|FG000|Overall Study|Other|58|||
48785082|NCT00144339|157053417|FG001|Overall Study|Other|60|||
48785083|NCT00305058|157053418|FG000|Overall Study|Participant too young|1|||
48785084|NCT00305058|157053419|FG001|Overall Study|Participant too young|0|||
48785085|NCT00305058|157053418|FG000|Overall Study|Missing data collection instrument|3|||
48785086|NCT00305058|157053419|FG001|Overall Study|Missing data collection instrument|2|||
48785087|NCT00305058|157053418|FG000|Overall Study|Missing outcome data|3|||
48785088|NCT00305058|157053419|FG001|Overall Study|Missing outcome data|2|||
48785089|NCT00586105|157053424|FG000|Overall Study|Adverse Event|4|||
48785090|NCT00586105|157053424|FG000|Overall Study|Death|2|||
48785091|NCT00586105|157053424|FG000|Overall Study|Protocol Violation|1|||
48785092|NCT00586105|157053424|FG000|Overall Study|Withdrawal by Subject|3|||
48785093|NCT00586105|157053424|FG000|Overall Study|Disease progression|19|||
48785094|NCT00586105|157053424|FG000|Overall Study|Switched to commercial drug|9|||
48785095|NCT00586105|157053424|FG000|Overall Study|Reason not reported|1|||
48785096|NCT01435577|157053425|FG000|Overall Study|Adverse Event|10|||
48785097|NCT01435577|157053426|FG001|Overall Study|Adverse Event|0|||
48785098|NCT01435577|157053425|FG000|Overall Study|Lack of Efficacy|7|||
48785099|NCT01435577|157053426|FG001|Overall Study|Lack of Efficacy|51|||
48785100|NCT01435577|157053425|FG000|Overall Study|Alternative treatment started|0|||
48785101|NCT01435577|157053426|FG001|Overall Study|Alternative treatment started|1|||
48785102|NCT01220557|157053431|FG000|Overall Study|Lost to Follow-up|5|||
48785103|NCT01220557|157053432|FG001|Overall Study|Lost to Follow-up|3|||
48785104|NCT01220557|157053431|FG000|Overall Study|attended less than 6 lessons|1|||
48785105|NCT01220557|157053432|FG001|Overall Study|attended less than 6 lessons|2|||
48785106|NCT02911948|157053434|FG000|Overall Study|Protocol Violation|0|||
48785107|NCT02911948|157053435|FG001|Overall Study|Protocol Violation|1|||
49031546|NCT02089685|157953389|FG001|Overall Study|Follow up ended by sponsor|2|||
49031547|NCT02089685|157953390|FG002|Overall Study|Follow up ended by sponsor|0|||
49031548|NCT02089685|157953391|FG003|Overall Study|Follow up ended by sponsor|70|||
49031549|NCT02089685|157953392|FG004|Overall Study|Follow up ended by sponsor|26|||
49031550|NCT02089685|157953393|FG005|Overall Study|Follow up ended by sponsor|26|||
49031551|NCT02089685|157953388|FG000|Overall Study|Withdrawal by Subject|0|||
49031552|NCT02089685|157953389|FG001|Overall Study|Withdrawal by Subject|2|||
49031553|NCT02089685|157953390|FG002|Overall Study|Withdrawal by Subject|0|||
49031554|NCT02089685|157953391|FG003|Overall Study|Withdrawal by Subject|8|||
49031555|NCT02089685|157953392|FG004|Overall Study|Withdrawal by Subject|1|||
49031556|NCT02089685|157953393|FG005|Overall Study|Withdrawal by Subject|1|||
49031557|NCT02089685|157953388|FG000|Overall Study|Status not recorded|1|||
49031558|NCT02089685|157953389|FG001|Overall Study|Status not recorded|0|||
49031559|NCT02089685|157953390|FG002|Overall Study|Status not recorded|0|||
49031560|NCT02089685|157953391|FG003|Overall Study|Status not recorded|0|||
49031561|NCT02089685|157953392|FG004|Overall Study|Status not recorded|1|||
49031562|NCT02089685|157953393|FG005|Overall Study|Status not recorded|0|||
49031563|NCT02089685|157953388|FG000|Overall Study|Death|0|||
49031564|NCT02089685|157953389|FG001|Overall Study|Death|0|||
49031565|NCT02089685|157953390|FG002|Overall Study|Death|0|||
49031566|NCT02089685|157953391|FG003|Overall Study|Death|7|||
48785108|NCT02911948|157053434|FG000|Overall Study|Withdrawal by Subject|0|||
48785109|NCT02911948|157053435|FG001|Overall Study|Withdrawal by Subject|2|||
48785110|NCT02911948|157053434|FG000|Overall Study|Lack of Efficacy|0|||
48785111|NCT02911948|157053435|FG001|Overall Study|Lack of Efficacy|1|||
48785112|NCT02911948|157053434|FG000|Overall Study|Unclassified|0|||
48785113|NCT02911948|157053435|FG001|Overall Study|Unclassified|3|||
48785114|NCT03867734|157053436|FG000|Overall Study|Lost to Follow-up|2|||
48785115|NCT02265237|157053437|FG000|As Treated (Overall Study)|Adverse Event|1|||
49031567|NCT02089685|157953392|FG004|Overall Study|Death|2|||
48785116|NCT02265237|157053438|FG001|As Treated (Overall Study)|Adverse Event|1|||
48785117|NCT02265237|157053439|FG002|As Treated (Overall Study)|Adverse Event|0|||
48785118|NCT02265237|157053440|FG003|As Treated (Overall Study)|Adverse Event|0|||
48785119|NCT02265237|157053437|FG000|As Treated (Overall Study)|Withdrawal by Subject|1|||
48785120|NCT02265237|157053438|FG001|As Treated (Overall Study)|Withdrawal by Subject|0|||
48785121|NCT02265237|157053439|FG002|As Treated (Overall Study)|Withdrawal by Subject|1|||
49031568|NCT02089685|157953393|FG005|Overall Study|Death|5|||
49031569|NCT02089685|157953388|FG000|Overall Study|Lost to Follow-up|0|||
49031570|NCT02089685|157953389|FG001|Overall Study|Lost to Follow-up|0|||
49031571|NCT02089685|157953390|FG002|Overall Study|Lost to Follow-up|0|||
49031572|NCT02089685|157953391|FG003|Overall Study|Lost to Follow-up|1|||
49031573|NCT02089685|157953392|FG004|Overall Study|Lost to Follow-up|0|||
49031574|NCT02089685|157953393|FG005|Overall Study|Lost to Follow-up|0|||
49031575|NCT02089685|157953388|FG000|Overall Study|Physician Decision|0|||
49031576|NCT02089685|157953389|FG001|Overall Study|Physician Decision|0|||
49031577|NCT02089685|157953390|FG002|Overall Study|Physician Decision|0|||
49031578|NCT02089685|157953391|FG003|Overall Study|Physician Decision|0|||
49031579|NCT02089685|157953392|FG004|Overall Study|Physician Decision|0|||
49031580|NCT02089685|157953393|FG005|Overall Study|Physician Decision|4|||
49031581|NCT02089685|157953388|FG000|Overall Study|Screen failure|1|||
49031582|NCT02089685|157953389|FG001|Overall Study|Screen failure|0|||
49031583|NCT02089685|157953390|FG002|Overall Study|Screen failure|0|||
49031584|NCT02089685|157953391|FG003|Overall Study|Screen failure|0|||
49031585|NCT02089685|157953392|FG004|Overall Study|Screen failure|0|||
49031586|NCT02089685|157953393|FG005|Overall Study|Screen failure|0|||
49031587|NCT00796653|157953395|FG000|Overall Study|Adverse Event|19|||
49031588|NCT00796653|157953396|FG001|Overall Study|Adverse Event|16|||
49031589|NCT00796653|157953397|FG002|Overall Study|Adverse Event|16|||
48785122|NCT02265237|157053440|FG003|As Treated (Overall Study)|Withdrawal by Subject|0|||
48785123|NCT02265237|157053437|FG000|As Treated (Overall Study)|Lost to Follow-up|1|||
48785124|NCT02265237|157053438|FG001|As Treated (Overall Study)|Lost to Follow-up|2|||
48785125|NCT02265237|157053439|FG002|As Treated (Overall Study)|Lost to Follow-up|6|||
48785126|NCT02265237|157053440|FG003|As Treated (Overall Study)|Lost to Follow-up|0|||
48785127|NCT02265237|157053437|FG000|As Treated (Overall Study)|Other|2|||
48785128|NCT02265237|157053438|FG001|As Treated (Overall Study)|Other|0|||
48785129|NCT02265237|157053439|FG002|As Treated (Overall Study)|Other|3|||
48785130|NCT02265237|157053440|FG003|As Treated (Overall Study)|Other|1|||
48785131|NCT01458574|157053442|FG000|Overall Study|Adverse Event|5|||
48785132|NCT01458574|157053443|FG001|Overall Study|Adverse Event|9|||
48785133|NCT01458574|157053444|FG002|Overall Study|Adverse Event|7|||
48785134|NCT01458574|157053442|FG000|Overall Study|Lack of Efficacy|70|||
48785135|NCT01458574|157053443|FG001|Overall Study|Lack of Efficacy|53|||
48785136|NCT01458574|157053444|FG002|Overall Study|Lack of Efficacy|132|||
48785137|NCT01458574|157053442|FG000|Overall Study|Lost to Follow-up|3|||
48785138|NCT01458574|157053443|FG001|Overall Study|Lost to Follow-up|2|||
48785139|NCT01458574|157053444|FG002|Overall Study|Lost to Follow-up|1|||
48785140|NCT01458574|157053442|FG000|Overall Study|Pregnancy|1|||
48785141|NCT01458574|157053443|FG001|Overall Study|Pregnancy|1|||
48785142|NCT01458574|157053444|FG002|Overall Study|Pregnancy|0|||
48785143|NCT01458574|157053442|FG000|Overall Study|Protocol Violation|0|||
48785144|NCT01458574|157053443|FG001|Overall Study|Protocol Violation|1|||
48785145|NCT01458574|157053444|FG002|Overall Study|Protocol Violation|0|||
48785146|NCT01458574|157053442|FG000|Overall Study|Withdrawal by Subject|6|||
48785147|NCT01458574|157053443|FG001|Overall Study|Withdrawal by Subject|3|||
48785148|NCT01458574|157053444|FG002|Overall Study|Withdrawal by Subject|5|||
48785149|NCT01458574|157053442|FG000|Overall Study|Other|2|||
48785150|NCT01458574|157053443|FG001|Overall Study|Other|1|||
48785151|NCT01458574|157053444|FG002|Overall Study|Other|0|||
48785152|NCT01458574|157053442|FG000|Overall Study|Randomized but not treated|0|||
48785153|NCT01458574|157053443|FG001|Overall Study|Randomized but not treated|1|||
48785154|NCT01458574|157053444|FG002|Overall Study|Randomized but not treated|0|||
48785155|NCT04782323|157053445|FG000|Overall Study|Death|1|||
48785156|NCT04782323|157053446|FG001|Overall Study|Death|0|||
48785157|NCT04782323|157053447|FG002|Overall Study|Death|0|||
48785158|NCT04782323|157053448|FG003|Overall Study|Death|0|||
48785159|NCT04782323|157053449|FG004|Overall Study|Death|1|||
48785160|NCT04782323|157053450|FG005|Overall Study|Death|1|||
48785161|NCT04782323|157053451|FG006|Overall Study|Death|1|||
48785162|NCT04782323|157053452|FG007|Overall Study|Death|0|||
48785163|NCT04782323|157053445|FG000|Overall Study|Withdrawal by Subject|0|||
48785164|NCT04782323|157053446|FG001|Overall Study|Withdrawal by Subject|0|||
48785165|NCT04782323|157053447|FG002|Overall Study|Withdrawal by Subject|1|||
48785166|NCT04782323|157053448|FG003|Overall Study|Withdrawal by Subject|0|||
48785167|NCT04782323|157053449|FG004|Overall Study|Withdrawal by Subject|0|||
48785168|NCT04782323|157053450|FG005|Overall Study|Withdrawal by Subject|1|||
48785169|NCT04782323|157053451|FG006|Overall Study|Withdrawal by Subject|0|||
48785170|NCT04782323|157053452|FG007|Overall Study|Withdrawal by Subject|1|||
48785171|NCT04782323|157053445|FG000|Overall Study|Lost to Follow-up|0|||
48785172|NCT04782323|157053446|FG001|Overall Study|Lost to Follow-up|1|||
48785173|NCT04782323|157053447|FG002|Overall Study|Lost to Follow-up|1|||
48785174|NCT04782323|157053448|FG003|Overall Study|Lost to Follow-up|0|||
48785175|NCT04782323|157053449|FG004|Overall Study|Lost to Follow-up|0|||
48785176|NCT04782323|157053450|FG005|Overall Study|Lost to Follow-up|1|||
48785177|NCT04782323|157053451|FG006|Overall Study|Lost to Follow-up|1|||
48785178|NCT04782323|157053452|FG007|Overall Study|Lost to Follow-up|2|||
49031590|NCT00796653|157953398|FG003|Overall Study|Adverse Event|16|||
49031591|NCT00796653|157953395|FG000|Overall Study|Lost to Follow-up|2|||
49031592|NCT00796653|157953396|FG001|Overall Study|Lost to Follow-up|1|||
49031593|NCT00796653|157953397|FG002|Overall Study|Lost to Follow-up|2|||
49031594|NCT00796653|157953398|FG003|Overall Study|Lost to Follow-up|3|||
49031595|NCT00796653|157953395|FG000|Overall Study|Withdrawal by Subject|16|||
48785179|NCT04782323|157053445|FG000|Overall Study|randomization in error|1|||
48785180|NCT04782323|157053446|FG001|Overall Study|randomization in error|0|||
48785181|NCT04782323|157053447|FG002|Overall Study|randomization in error|0|||
48785182|NCT04782323|157053448|FG003|Overall Study|randomization in error|0|||
48785183|NCT04782323|157053449|FG004|Overall Study|randomization in error|0|||
48785184|NCT04782323|157053450|FG005|Overall Study|randomization in error|0|||
48785185|NCT04782323|157053451|FG006|Overall Study|randomization in error|0|||
48785186|NCT04782323|157053452|FG007|Overall Study|randomization in error|0|||
48785187|NCT01617629|157053455|FG000|Overall Study|Death|2|||
48785188|NCT01617629|157053455|FG000|Overall Study|Investigator's Clinical Judgement|1|||
48785189|NCT01617629|157053455|FG000|Overall Study|Reason Not Specified|1|||
48785190|NCT01617629|157053455|FG000|Overall Study|Participant Withdrew Consent|2|||
48785191|NCT00558285|157053456|FG000|Overall Study|Adverse Event|1|||
48785192|NCT00558285|157053457|FG001|Overall Study|Adverse Event|1|||
48785193|NCT00558285|157053458|FG002|Overall Study|Adverse Event|4|||
48785194|NCT00558285|157053459|FG003|Overall Study|Adverse Event|1|||
48785195|NCT00558285|157053460|FG004|Overall Study|Adverse Event|2|||
48785196|NCT00558285|157053456|FG000|Overall Study|Abnormal test procedure result(s)|1|||
48785197|NCT00558285|157053457|FG001|Overall Study|Abnormal test procedure result(s)|0|||
48785198|NCT00558285|157053458|FG002|Overall Study|Abnormal test procedure result(s)|0|||
48785199|NCT00558285|157053459|FG003|Overall Study|Abnormal test procedure result(s)|0|||
48785200|NCT00558285|157053460|FG004|Overall Study|Abnormal test procedure result(s)|0|||
48785201|NCT00558285|157053456|FG000|Overall Study|Subject withdrew consent|2|||
48785202|NCT00558285|157053457|FG001|Overall Study|Subject withdrew consent|0|||
49031596|NCT00796653|157953396|FG001|Overall Study|Withdrawal by Subject|8|||
49031597|NCT00796653|157953397|FG002|Overall Study|Withdrawal by Subject|8|||
49031598|NCT00796653|157953398|FG003|Overall Study|Withdrawal by Subject|13|||
49031599|NCT00796653|157953395|FG000|Overall Study|Lack of Efficacy|8|||
49031600|NCT00796653|157953396|FG001|Overall Study|Lack of Efficacy|1|||
49031601|NCT00796653|157953397|FG002|Overall Study|Lack of Efficacy|3|||
49031602|NCT00796653|157953398|FG003|Overall Study|Lack of Efficacy|2|||
49031603|NCT00796653|157953395|FG000|Overall Study|Non compliance with protocol|2|||
49031604|NCT00796653|157953396|FG001|Overall Study|Non compliance with protocol|2|||
49031605|NCT00796653|157953397|FG002|Overall Study|Non compliance with protocol|0|||
49031606|NCT00796653|157953398|FG003|Overall Study|Non compliance with protocol|2|||
48785203|NCT00558285|157053458|FG002|Overall Study|Subject withdrew consent|1|||
48785204|NCT00558285|157053459|FG003|Overall Study|Subject withdrew consent|1|||
48785205|NCT00558285|157053460|FG004|Overall Study|Subject withdrew consent|1|||
48785206|NCT00558285|157053456|FG000|Overall Study|Lost to Follow-up|1|||
48785207|NCT00558285|157053457|FG001|Overall Study|Lost to Follow-up|1|||
48785208|NCT00558285|157053458|FG002|Overall Study|Lost to Follow-up|0|||
48785209|NCT00558285|157053459|FG003|Overall Study|Lost to Follow-up|0|||
48785210|NCT00558285|157053460|FG004|Overall Study|Lost to Follow-up|0|||
48785211|NCT00558285|157053456|FG000|Overall Study|Administrative problems|0|||
48785212|NCT00558285|157053457|FG001|Overall Study|Administrative problems|0|||
48785213|NCT00558285|157053458|FG002|Overall Study|Administrative problems|0|||
48785214|NCT00558285|157053459|FG003|Overall Study|Administrative problems|1|||
48785215|NCT00558285|157053460|FG004|Overall Study|Administrative problems|1|||
48785216|NCT00558285|157053456|FG000|Overall Study|Protocol deviation|1|||
48785217|NCT00558285|157053457|FG001|Overall Study|Protocol deviation|1|||
48785218|NCT00558285|157053458|FG002|Overall Study|Protocol deviation|0|||
48785219|NCT00558285|157053459|FG003|Overall Study|Protocol deviation|1|||
48785220|NCT00558285|157053460|FG004|Overall Study|Protocol deviation|0|||
48785221|NCT03478891|157053461|FG000|Overall Study|Enrolled, but product never administered|0|||
48785222|NCT03478891|157053462|FG001|Overall Study|Enrolled, but product never administered|0|||
48785223|NCT03478891|157053463|FG002|Overall Study|Enrolled, but product never administered|1|||
48785224|NCT03478891|157053461|FG000|Overall Study|Moved from area|0|||
48785225|NCT03478891|157053462|FG001|Overall Study|Moved from area|0|||
48785226|NCT03478891|157053463|FG002|Overall Study|Moved from area|1|||
48785227|NCT03478891|157053461|FG000|Overall Study|Lost to Follow-up|1|||
48785228|NCT03478891|157053462|FG001|Overall Study|Lost to Follow-up|0|||
48785229|NCT03478891|157053463|FG002|Overall Study|Lost to Follow-up|1|||
48785230|NCT01174342|157053464|FG000|Overall Study|Conversion to cesarean section|4|||
48785231|NCT01773226|157055611|FG000|Overall Study|Withdrawal by Subject|1|||
48785232|NCT03985423|157055617|FG000|Overall Study|Adverse Event|1|||
49031607|NCT00796653|157953395|FG000|Overall Study|Other reason not described above|4|||
48785233|NCT03985423|157055617|FG000|Overall Study|Death|2|||
48785234|NCT03985423|157055617|FG000|Overall Study|Physician Decision|1|||
48785235|NCT03985423|157055617|FG000|Overall Study|Withdrawal by Subject|2|||
48785236|NCT03985423|157055617|FG000|Overall Study|Lack of insurance and citizenship|1|||
48785237|NCT00724282|157055618|FG000|Overall Study|Withdrawal by Subject|3|||
48785238|NCT00724282|157055618|FG000|Overall Study|Physician Decision|1|||
48785239|NCT00993447|157055619|FG000|Overall Study|Withdrawal by Subject|23|||
49031608|NCT00796653|157953396|FG001|Overall Study|Other reason not described above|9|||
49031609|NCT00796653|157953397|FG002|Overall Study|Other reason not described above|7|||
49031610|NCT00796653|157953398|FG003|Overall Study|Other reason not described above|4|||
48785240|NCT00993447|157055620|FG001|Overall Study|Withdrawal by Subject|8|||
48785241|NCT00993447|157055619|FG000|Overall Study|Protocol Violation|12|||
48785242|NCT00993447|157055620|FG001|Overall Study|Protocol Violation|8|||
48785243|NCT00993447|157055619|FG000|Overall Study|Lost to Follow-up|1|||
48785244|NCT00993447|157055620|FG001|Overall Study|Lost to Follow-up|3|||
48785245|NCT00993447|157055619|FG000|Overall Study|Adverse Event|1|||
48785246|NCT00993447|157055620|FG001|Overall Study|Adverse Event|0|||
48785247|NCT00129987|157055623|FG000|1st Educational Session|Withdrawal by Subject|141|||
48785248|NCT00129987|157055624|FG001|1st Educational Session|Withdrawal by Subject|109|||
48785249|NCT00129987|157055623|FG000|1 Year|Withdrawal by Subject|32|||
48785250|NCT00129987|157055624|FG001|1 Year|Withdrawal by Subject|21|||
48785251|NCT04401579|157055625|FG000|Overall Study|Death|23|||
48785252|NCT04401579|157055626|FG001|Overall Study|Death|36|||
48785253|NCT04401579|157055625|FG000|Overall Study|Lost to Follow-up|40|||
48785254|NCT04401579|157055626|FG001|Overall Study|Lost to Follow-up|41|||
48785255|NCT04401579|157055625|FG000|Overall Study|Withdrawal by Subject|8|||
48785256|NCT04401579|157055626|FG001|Overall Study|Withdrawal by Subject|16|||
48785257|NCT04401579|157055625|FG000|Overall Study|Physician Decision|1|||
48785258|NCT04401579|157055626|FG001|Overall Study|Physician Decision|2|||
48785259|NCT04401579|157055625|FG000|Overall Study|Became ineligible after enrollment|1|||
48785260|NCT04401579|157055626|FG001|Overall Study|Became ineligible after enrollment|1|||
48785261|NCT04401579|157055625|FG000|Overall Study|Enrolled but treatment not administered|7|||
48785262|NCT04401579|157055626|FG001|Overall Study|Enrolled but treatment not administered|9|||
48785263|NCT04401579|157055625|FG000|Overall Study|Adverse Event|2|||
48785264|NCT04401579|157055626|FG001|Overall Study|Adverse Event|1|||
48785265|NCT04401579|157055625|FG000|Overall Study|Scheduling error|1|||
48785266|NCT04401579|157055626|FG001|Overall Study|Scheduling error|2|||
48785267|NCT04401579|157055625|FG000|Overall Study|Transferred to another hospital|1|||
48785268|NCT04401579|157055626|FG001|Overall Study|Transferred to another hospital|2|||
48785269|NCT03836053|157055627|FG000|Overall Study|Protocol-specified criteria|0|||
48785270|NCT03836053|157055628|FG001|Overall Study|Protocol-specified criteria|2|||
48785271|NCT03836053|157055629|FG002|Overall Study|Protocol-specified criteria|1|||
48785272|NCT03836053|157055627|FG000|Overall Study|Death|1|||
48785273|NCT03836053|157055628|FG001|Overall Study|Death|6|||
48785274|NCT03836053|157055629|FG002|Overall Study|Death|4|||
48785275|NCT03836053|157055627|FG000|Overall Study|Withdrawal of consent from study|0|||
48785276|NCT03836053|157055628|FG001|Overall Study|Withdrawal of consent from study|0|||
48785277|NCT03836053|157055629|FG002|Overall Study|Withdrawal of consent from study|1|||
48785278|NCT03836053|157055627|FG000|Overall Study|Decision by sponsor|0|||
48785279|NCT03836053|157055628|FG001|Overall Study|Decision by sponsor|2|||
48785280|NCT03836053|157055629|FG002|Overall Study|Decision by sponsor|4|||
48785281|NCT01863680|157055633|FG000|Overall Study|Adverse Event|17|||
48785282|NCT01863680|157055633|FG000|Overall Study|Risk of OHSS|17|||
48785283|NCT01863680|157055633|FG000|Overall Study|Spontaneous pregnancy|2|||
48785284|NCT01863680|157055633|FG000|Overall Study|Withdrawal by Subject|1|||
48785285|NCT01863680|157055633|FG000|Overall Study|Did not undergo IVF/ET|14|||
48785286|NCT01863680|157055633|FG000|Overall Study|Other|6|||
48785287|NCT00566228|157055638|FG000|Overall Study|Withdrawal by Subject|1|||
48785288|NCT00566228|157055639|FG001|Overall Study|Withdrawal by Subject|0|||
48785289|NCT00566228|157055638|FG000|Overall Study|Attempt to mobilize stem cells failed|2|||
48785290|NCT00566228|157055639|FG001|Overall Study|Attempt to mobilize stem cells failed|2|||
48785291|NCT00566228|157055638|FG000|Overall Study|Unable to collect sufficient CD34 cells|3|||
48785292|NCT00566228|157055639|FG001|Overall Study|Unable to collect sufficient CD34 cells|2|||
48785293|NCT00566228|157055638|FG000|Overall Study|progressed before infusion could occur|0|||
48785294|NCT00566228|157055639|FG001|Overall Study|progressed before infusion could occur|1|||
48785295|NCT01159938|157055640|FG000|First Study Period|Protocol Violation (Microalbuminuria)|0|||
48785296|NCT01159938|157055641|FG001|First Study Period|Protocol Violation (Microalbuminuria)|0|||
48785297|NCT01159938|157055642|FG002|First Study Period|Protocol Violation (Microalbuminuria)|1|||
48785298|NCT01159938|157055643|FG003|First Study Period|Protocol Violation (Microalbuminuria)|0|||
48785299|NCT01159938|157055644|FG004|First Study Period|Protocol Violation (Microalbuminuria)|0|||
48785300|NCT02646423|157055647|FG000|Overall Study|Adverse Event|5|||
48785301|NCT02646423|157055648|FG001|Overall Study|Adverse Event|7|||
48785302|NCT02646423|157055647|FG000|Overall Study|Ineligible|2|||
48785303|NCT02646423|157055648|FG001|Overall Study|Ineligible|1|||
48785304|NCT02548962|157055654|FG000|Overall Study|Withdrawal by Subject|1|||
48785305|NCT02548962|157055655|FG001|Overall Study|Withdrawal by Subject|0|||
48785306|NCT00823719|157055656|FG000|Overall Study|Adverse Event|1|||
48785307|NCT00823719|157055657|FG001|Overall Study|Adverse Event|2|||
48785308|NCT00823719|157055656|FG000|Overall Study|Physician Decision|1|||
48785309|NCT00823719|157055657|FG001|Overall Study|Physician Decision|4|||
48785310|NCT00823719|157055656|FG000|Overall Study|Withdrawal by Subject|0|||
48785311|NCT00823719|157055657|FG001|Overall Study|Withdrawal by Subject|1|||
48785312|NCT00823719|157055656|FG000|Overall Study|Disease Progression|4|||
48877524|NCT05382039|157390083|FG000|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
48785313|NCT00823719|157055657|FG001|Overall Study|Disease Progression|4|||
48785314|NCT02696317|157055658|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|2|||
48785315|NCT02696317|157055659|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|4|||
48785316|NCT02696317|157055658|FG000|Period 2, 10 Days of Wear|Withdrawal by Subject|1|||
48785317|NCT02696317|157055659|FG001|Period 2, 10 Days of Wear|Withdrawal by Subject|0|||
48785318|NCT00237744|157055660|FG000|Overall Study|Withdrawal by Subject|3|||
48785319|NCT00237744|157055661|FG001|Overall Study|Withdrawal by Subject|1|||
48785320|NCT00237744|157055662|FG002|Overall Study|Withdrawal by Subject|0|||
48785321|NCT00563784|157055665|FG000|Overall Study|Withdrawal by Subject|2|||
48785322|NCT00563784|157055665|FG000|Overall Study|Screen Failures|20|||
48785323|NCT02828111|157055666|FG000|Overall Study|Withdrawal by Subject|0|||
48785324|NCT02828111|157055667|FG001|Overall Study|Withdrawal by Subject|0|||
48785325|NCT02828111|157055668|FG002|Overall Study|Withdrawal by Subject|2|||
48785326|NCT02828111|157055669|FG003|Overall Study|Withdrawal by Subject|0|||
48785327|NCT02828111|157055670|FG004|Overall Study|Withdrawal by Subject|0|||
48785328|NCT02828111|157055666|FG000|Overall Study|Lost to Follow-up|0|||
48785329|NCT02828111|157055667|FG001|Overall Study|Lost to Follow-up|0|||
48785330|NCT02828111|157055668|FG002|Overall Study|Lost to Follow-up|0|||
48877525|NCT05382039|157390084|FG001|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
48785331|NCT02828111|157055669|FG003|Overall Study|Lost to Follow-up|1|||
48785332|NCT02828111|157055670|FG004|Overall Study|Lost to Follow-up|1|||
48785333|NCT02528214|157055671|FG000|Overall Study|Protocol Violation|0|||
48785334|NCT02528214|157055672|FG001|Overall Study|Protocol Violation|1|||
48785335|NCT02528214|157055671|FG000|Overall Study|Adverse Event|0|||
48785336|NCT02528214|157055672|FG001|Overall Study|Adverse Event|1|||
48785337|NCT02528214|157055671|FG000|Overall Study|Other than specified above|0|||
48785338|NCT02528214|157055672|FG001|Overall Study|Other than specified above|1|||
48785339|NCT00407537|157055673|FG000|Overall Study|Death|5|||
48785340|NCT00407537|157055674|FG001|Overall Study|Death|2|||
48785341|NCT00407537|157055673|FG000|Overall Study|Adverse Event|36|||
48785342|NCT00407537|157055674|FG001|Overall Study|Adverse Event|0|||
48785343|NCT00407537|157055673|FG000|Overall Study|Lost to Follow-up|12|||
48785344|NCT00407537|157055674|FG001|Overall Study|Lost to Follow-up|19|||
48785345|NCT00407537|157055673|FG000|Overall Study|Other|6|||
48785346|NCT00407537|157055674|FG001|Overall Study|Other|7|||
48785347|NCT00407537|157055673|FG000|Overall Study|Withdrawal by Subject|34|||
48785348|NCT00407537|157055674|FG001|Overall Study|Withdrawal by Subject|16|||
48785349|NCT01026974|157055676|FG000|Overall Study|Withdrawal by Subject|0|||
48785350|NCT01026974|157055677|FG001|Overall Study|Withdrawal by Subject|1|||
48785351|NCT01026974|157055678|FG002|Overall Study|Withdrawal by Subject|7|||
48785352|NCT01026974|157055679|FG003|Overall Study|Withdrawal by Subject|2|||
48785353|NCT01026974|157055676|FG000|Overall Study|Lost to Follow-up|1|||
48785354|NCT01026974|157055677|FG001|Overall Study|Lost to Follow-up|1|||
48785355|NCT01026974|157055678|FG002|Overall Study|Lost to Follow-up|4|||
48785356|NCT01026974|157055679|FG003|Overall Study|Lost to Follow-up|0|||
48785357|NCT01026974|157055676|FG000|Overall Study|Adverse Event|0|||
48785358|NCT01026974|157055677|FG001|Overall Study|Adverse Event|0|||
48785359|NCT01026974|157055678|FG002|Overall Study|Adverse Event|0|||
48785360|NCT01026974|157055679|FG003|Overall Study|Adverse Event|1|||
48785361|NCT01026974|157055676|FG000|Overall Study|Inappropriate enrollment|0|||
48785362|NCT01026974|157055677|FG001|Overall Study|Inappropriate enrollment|0|||
48785363|NCT01026974|157055678|FG002|Overall Study|Inappropriate enrollment|1|||
48785364|NCT01026974|157055679|FG003|Overall Study|Inappropriate enrollment|0|||
48785365|NCT02864082|157055680|FG000|Overall Study|Adverse Event|1|||
48785366|NCT02864082|157055681|FG001|Overall Study|Adverse Event|1|||
48785367|NCT02864082|157055680|FG000|Overall Study|Lost to Follow-up|0|||
48785368|NCT02864082|157055681|FG001|Overall Study|Lost to Follow-up|1|||
48785369|NCT02864082|157055680|FG000|Overall Study|Withdrawal by Subject|2|||
48785370|NCT02864082|157055681|FG001|Overall Study|Withdrawal by Subject|2|||
48785371|NCT04179032|157055682|FG000|Part B (Up to Week 52)|Adverse Event|1|||
48785372|NCT04179032|157055682|FG000|Part B (Up to Week 52)|INVESTIGATOR DISCRETION|1|||
48785373|NCT04179032|157055682|FG000|Access Extension Phase|Ongoing|11|||
48785374|NCT00817089|157055683|FG000|First Alcohol Challenge|Lost to Follow-up|0|||
48785375|NCT00817089|157055684|FG001|First Alcohol Challenge|Lost to Follow-up|0|||
48785376|NCT00817089|157055685|FG002|First Alcohol Challenge|Lost to Follow-up|0|||
48785377|NCT00817089|157055686|FG003|First Alcohol Challenge|Lost to Follow-up|1|||
48785378|NCT00817089|157055683|FG000|Second Alcohol Challenge|Lost to Follow-up|0|||
48785379|NCT00817089|157055684|FG001|Second Alcohol Challenge|Lost to Follow-up|1|||
48785380|NCT00817089|157055685|FG002|Second Alcohol Challenge|Lost to Follow-up|0|||
48785381|NCT00817089|157055686|FG003|Second Alcohol Challenge|Lost to Follow-up|0|||
48785382|NCT04667117|157055687|FG000|Investigational Period|Lost to Follow-up|0|||
48785383|NCT04667117|157055688|FG001|Investigational Period|Lost to Follow-up|0|||
48983056|NCT02394028|157769996|FG010|Induction Phase|Adverse Event|0|||
48785384|NCT04667117|157055689|FG002|Investigational Period|Lost to Follow-up|1|||
48785385|NCT04667117|157055687|FG000|Investigational Period|Protocol Deviation|0|||
48785386|NCT04667117|157055688|FG001|Investigational Period|Protocol Deviation|1|||
48785387|NCT04667117|157055689|FG002|Investigational Period|Protocol Deviation|0|||
48785388|NCT04667117|157055687|FG000|Extension Period|Lost to Follow-up|1|||
48877526|NCT05382039|157390085|FG002|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|1|||
49031611|NCT02601560|157953401|FG000|Overall Study|Other|0|||
48785389|NCT04667117|157055688|FG001|Extension Period|Lost to Follow-up|0|||
48785390|NCT04667117|157055689|FG002|Extension Period|Lost to Follow-up|0|||
48785391|NCT00874029|157055690|FG000|Overall Study|Withdrawal by Subject|10|||
48785392|NCT00874029|157055690|FG000|Overall Study|Pregnancy|4|||
48785393|NCT00874029|157055690|FG000|Overall Study|Physician Decision|1|||
48785394|NCT00874029|157055690|FG000|Overall Study|Adverse Event|1|||
48785395|NCT00874029|157055690|FG000|Overall Study|Lost to Follow-up|5|||
48785396|NCT02328326|157055694|FG000|Overall Study|Withdrawal by Subject|10|||
48785397|NCT02328326|157055695|FG001|Overall Study|Withdrawal by Subject|3|||
48785398|NCT02328326|157055694|FG000|Overall Study|Death|2|||
48785399|NCT02328326|157055695|FG001|Overall Study|Death|1|||
48785400|NCT02328326|157055694|FG000|Overall Study|Lost to Follow-up|10|||
48785401|NCT02328326|157055695|FG001|Overall Study|Lost to Follow-up|4|||
48785402|NCT02252211|157055696|FG000|Overall Study|Adverse Event|0|||
48785403|NCT02252211|157055697|FG001|Overall Study|Adverse Event|1|||
48785404|NCT02252211|157055698|FG002|Overall Study|Adverse Event|0|||
48785405|NCT02252211|157055696|FG000|Overall Study|Progressive disease|3|||
48785406|NCT02252211|157055697|FG001|Overall Study|Progressive disease|2|||
48785407|NCT02252211|157055698|FG002|Overall Study|Progressive disease|0|||
48785408|NCT02252211|157055696|FG000|Overall Study|Withdrawal by Subject|1|||
48785409|NCT02252211|157055697|FG001|Overall Study|Withdrawal by Subject|0|||
48785410|NCT02252211|157055698|FG002|Overall Study|Withdrawal by Subject|0|||
48785411|NCT02252211|157055696|FG000|Overall Study|Serious Adverse Event During Screening|1|||
48785412|NCT02252211|157055697|FG001|Overall Study|Serious Adverse Event During Screening|0|||
48785413|NCT02252211|157055698|FG002|Overall Study|Serious Adverse Event During Screening|1|||
48785414|NCT01953926|157055699|FG000|Overall Study|Withdrawal by Subject|23|||
48785415|NCT01953926|157055700|FG001|Overall Study|Withdrawal by Subject|3|||
48785416|NCT01953926|157055701|FG002|Overall Study|Withdrawal by Subject|3|||
48785417|NCT01953926|157055702|FG003|Overall Study|Withdrawal by Subject|5|||
48785418|NCT01953926|157055703|FG004|Overall Study|Withdrawal by Subject|6|||
48785419|NCT01953926|157055704|FG005|Overall Study|Withdrawal by Subject|0|||
48785420|NCT01953926|157055705|FG006|Overall Study|Withdrawal by Subject|1|||
48785421|NCT01953926|157055699|FG000|Overall Study|Physician Decision|1|||
48785422|NCT01953926|157055700|FG001|Overall Study|Physician Decision|0|||
48785423|NCT01953926|157055701|FG002|Overall Study|Physician Decision|0|||
48785424|NCT01953926|157055702|FG003|Overall Study|Physician Decision|0|||
48785425|NCT01953926|157055703|FG004|Overall Study|Physician Decision|2|||
48785426|NCT01953926|157055704|FG005|Overall Study|Physician Decision|0|||
48785427|NCT01953926|157055705|FG006|Overall Study|Physician Decision|0|||
48785428|NCT01953926|157055699|FG000|Overall Study|Lost to Follow-up|18|||
48785429|NCT01953926|157055700|FG001|Overall Study|Lost to Follow-up|3|||
48785430|NCT01953926|157055701|FG002|Overall Study|Lost to Follow-up|0|||
48785431|NCT01953926|157055702|FG003|Overall Study|Lost to Follow-up|5|||
48785432|NCT01953926|157055703|FG004|Overall Study|Lost to Follow-up|3|||
49031612|NCT02601560|157953402|FG001|Overall Study|Other|0|||
49031613|NCT02601560|157953403|FG002|Overall Study|Other|0|||
49031614|NCT02601560|157953404|FG003|Overall Study|Other|0|||
49031615|NCT02601560|157953405|FG004|Overall Study|Other|0|||
49031616|NCT02601560|157953406|FG005|Overall Study|Other|0|||
49031617|NCT02601560|157953407|FG006|Overall Study|Other|1|||
49031618|NCT02601560|157953408|FG007|Overall Study|Other|0|||
49031619|NCT01940341|157953409|FG000|Period 1: Double-blind Phase|Withdrew Consent|7|||
49031620|NCT01940341|157953410|FG001|Period 1: Double-blind Phase|Withdrew Consent|4|||
49031621|NCT01940341|157953411|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
49031622|NCT01940341|157953412|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
49031623|NCT01940341|157953409|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
49031624|NCT01940341|157953410|FG001|Period 1: Double-blind Phase|Lost to Follow-up|1|||
49031625|NCT01940341|157953411|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
49031626|NCT01940341|157953412|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
49031627|NCT01940341|157953409|FG000|Period 1: Double-blind Phase|Adverse Event|4|||
49031628|NCT01940341|157953410|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
49031629|NCT01940341|157953411|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
48785433|NCT01953926|157055704|FG005|Overall Study|Lost to Follow-up|0|||
48785434|NCT01953926|157055705|FG006|Overall Study|Lost to Follow-up|0|||
48785435|NCT01953926|157055699|FG000|Overall Study|Protocol Violation|1|||
48785436|NCT01953926|157055700|FG001|Overall Study|Protocol Violation|0|||
48785437|NCT01953926|157055701|FG002|Overall Study|Protocol Violation|0|||
48785438|NCT01953926|157055702|FG003|Overall Study|Protocol Violation|0|||
48785439|NCT01953926|157055703|FG004|Overall Study|Protocol Violation|0|||
48785440|NCT01953926|157055704|FG005|Overall Study|Protocol Violation|0|||
48785441|NCT01953926|157055705|FG006|Overall Study|Protocol Violation|0|||
48877527|NCT05382039|157390083|FG000|Overall Study|waiting for confirmation|0|||
48785442|NCT01953926|157055699|FG000|Overall Study|Other, Disease progression|2|||
48785443|NCT01953926|157055700|FG001|Overall Study|Other, Disease progression|1|||
48785444|NCT01953926|157055701|FG002|Overall Study|Other, Disease progression|0|||
48785445|NCT01953926|157055702|FG003|Overall Study|Other, Disease progression|0|||
48785446|NCT01953926|157055703|FG004|Overall Study|Other, Disease progression|1|||
48785447|NCT01953926|157055704|FG005|Overall Study|Other, Disease progression|0|||
48785448|NCT01953926|157055705|FG006|Overall Study|Other, Disease progression|0|||
48785449|NCT01953926|157055699|FG000|Overall Study|Discontinuation of study by sponsor|41|||
48785450|NCT01953926|157055700|FG001|Overall Study|Discontinuation of study by sponsor|7|||
48785451|NCT01953926|157055701|FG002|Overall Study|Discontinuation of study by sponsor|5|||
48785452|NCT01953926|157055702|FG003|Overall Study|Discontinuation of study by sponsor|12|||
48785453|NCT01953926|157055703|FG004|Overall Study|Discontinuation of study by sponsor|46|||
48785454|NCT01953926|157055704|FG005|Overall Study|Discontinuation of study by sponsor|5|||
48785455|NCT01953926|157055705|FG006|Overall Study|Discontinuation of study by sponsor|6|||
48785456|NCT01953926|157055699|FG000|Overall Study|Not Treated|1|||
48785457|NCT01953926|157055700|FG001|Overall Study|Not Treated|0|||
48785458|NCT01953926|157055701|FG002|Overall Study|Not Treated|1|||
48785459|NCT01953926|157055702|FG003|Overall Study|Not Treated|0|||
48785460|NCT01953926|157055703|FG004|Overall Study|Not Treated|0|||
48785461|NCT01953926|157055704|FG005|Overall Study|Not Treated|0|||
48785462|NCT01953926|157055705|FG006|Overall Study|Not Treated|0|||
48785463|NCT02310750|157055709|FG000|HP Period 1|Lost to Follow-up|0|||
48785464|NCT02310750|157055710|FG001|HP Period 1|Lost to Follow-up|0|||
48785465|NCT02310750|157055711|FG002|HP Period 1|Lost to Follow-up|0|||
48785466|NCT02310750|157055712|FG003|HP Period 1|Lost to Follow-up|0|||
48785467|NCT02310750|157055713|FG004|HP Period 1|Lost to Follow-up|0|||
48785468|NCT02310750|157055714|FG005|HP Period 1|Lost to Follow-up|0|||
48785469|NCT02310750|157055715|FG006|HP Period 1|Lost to Follow-up|1|||
48785470|NCT02310750|157055716|FG007|HP Period 1|Lost to Follow-up|0|||
48785471|NCT02310750|157055717|FG008|HP Period 1|Lost to Follow-up|0|||
48785472|NCT02310750|157055718|FG009|HP Period 1|Lost to Follow-up|0|||
48785473|NCT02310750|157055719|FG010|HP Period 1|Lost to Follow-up|0|||
48785474|NCT02310750|157055720|FG011|HP Period 1|Lost to Follow-up|0|||
48785475|NCT02310750|157055721|FG012|HP Period 1|Lost to Follow-up|0|||
48785476|NCT02310750|157055722|FG013|HP Period 1|Lost to Follow-up|0|||
48785477|NCT02310750|157055723|FG014|HP Period 1|Lost to Follow-up|0|||
48785478|NCT02310750|157055724|FG015|HP Period 1|Lost to Follow-up|0|||
48785479|NCT02310750|157055709|FG000|HP Period 1|Withdrawal by Subject|1|||
48785480|NCT02310750|157055710|FG001|HP Period 1|Withdrawal by Subject|0|||
48785481|NCT02310750|157055711|FG002|HP Period 1|Withdrawal by Subject|0|||
48785482|NCT02310750|157055712|FG003|HP Period 1|Withdrawal by Subject|1|||
48785483|NCT02310750|157055713|FG004|HP Period 1|Withdrawal by Subject|0|||
48785484|NCT02310750|157055714|FG005|HP Period 1|Withdrawal by Subject|0|||
48785485|NCT02310750|157055715|FG006|HP Period 1|Withdrawal by Subject|0|||
48785486|NCT02310750|157055716|FG007|HP Period 1|Withdrawal by Subject|0|||
48785487|NCT02310750|157055717|FG008|HP Period 1|Withdrawal by Subject|0|||
48785488|NCT02310750|157055718|FG009|HP Period 1|Withdrawal by Subject|0|||
48785489|NCT02310750|157055719|FG010|HP Period 1|Withdrawal by Subject|0|||
48785490|NCT02310750|157055720|FG011|HP Period 1|Withdrawal by Subject|0|||
48785491|NCT02310750|157055721|FG012|HP Period 1|Withdrawal by Subject|0|||
48785492|NCT02310750|157055722|FG013|HP Period 1|Withdrawal by Subject|0|||
48785493|NCT02310750|157055723|FG014|HP Period 1|Withdrawal by Subject|0|||
48785494|NCT02310750|157055724|FG015|HP Period 1|Withdrawal by Subject|0|||
48785495|NCT02310750|157055709|FG000|HP Washout 1|Lost to Follow-up|0|||
48785496|NCT02310750|157055710|FG001|HP Washout 1|Lost to Follow-up|0|||
48785497|NCT02310750|157055711|FG002|HP Washout 1|Lost to Follow-up|1|||
48785498|NCT02310750|157055712|FG003|HP Washout 1|Lost to Follow-up|1|||
48785499|NCT02310750|157055713|FG004|HP Washout 1|Lost to Follow-up|2|||
48785500|NCT02310750|157055714|FG005|HP Washout 1|Lost to Follow-up|2|||
48785501|NCT02310750|157055715|FG006|HP Washout 1|Lost to Follow-up|3|||
48785502|NCT02310750|157055716|FG007|HP Washout 1|Lost to Follow-up|0|||
48785503|NCT02310750|157055717|FG008|HP Washout 1|Lost to Follow-up|0|||
48785504|NCT02310750|157055718|FG009|HP Washout 1|Lost to Follow-up|0|||
48785505|NCT02310750|157055719|FG010|HP Washout 1|Lost to Follow-up|0|||
48785506|NCT02310750|157055720|FG011|HP Washout 1|Lost to Follow-up|0|||
48785507|NCT02310750|157055721|FG012|HP Washout 1|Lost to Follow-up|0|||
48785508|NCT02310750|157055722|FG013|HP Washout 1|Lost to Follow-up|0|||
48785509|NCT02310750|157055723|FG014|HP Washout 1|Lost to Follow-up|0|||
48785510|NCT02310750|157055724|FG015|HP Washout 1|Lost to Follow-up|0|||
48785511|NCT02310750|157055709|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
48785512|NCT02310750|157055710|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
48785513|NCT02310750|157055711|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
48785514|NCT02310750|157055712|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
48785515|NCT02310750|157055713|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
48785516|NCT02310750|157055714|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2|||
48785517|NCT02310750|157055715|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
48785518|NCT02310750|157055716|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
48785519|NCT02310750|157055717|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6|||
48785520|NCT02310750|157055718|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
48785521|NCT02310750|157055719|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
48785522|NCT02310750|157055720|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
48785523|NCT02310750|157055721|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
48785524|NCT02310750|157055722|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
48785525|NCT02310750|157055723|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
48785526|NCT02310750|157055724|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
48785527|NCT02310750|157055709|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
48785528|NCT02310750|157055710|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
48785529|NCT02310750|157055711|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
48877528|NCT05382039|157390084|FG001|Overall Study|waiting for confirmation|0|||
49031630|NCT01940341|157953412|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
49031631|NCT01940341|157953409|FG000|Period 1: Double-blind Phase|Investigator's Discretion|3|||
49031632|NCT01940341|157953410|FG001|Period 1: Double-blind Phase|Investigator's Discretion|1|||
49031633|NCT01940341|157953411|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
49031634|NCT01940341|157953412|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
49031635|NCT01940341|157953409|FG000|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
49031636|NCT01940341|157953410|FG001|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
49031637|NCT01940341|157953411|FG002|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
49031638|NCT01940341|157953412|FG003|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
49031639|NCT01940341|157953409|FG000|Period 1: Double-blind Phase|Death|0|||
49031640|NCT01940341|157953410|FG001|Period 1: Double-blind Phase|Death|1|||
49031641|NCT01940341|157953411|FG002|Period 1: Double-blind Phase|Death|0|||
49031642|NCT01940341|157953412|FG003|Period 1: Double-blind Phase|Death|0|||
48785530|NCT02310750|157055712|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
48785531|NCT02310750|157055713|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
48785532|NCT02310750|157055714|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
48785533|NCT02310750|157055715|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
48785534|NCT02310750|157055716|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
48785535|NCT02310750|157055717|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
48785536|NCT02310750|157055718|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1|||
48785537|NCT02310750|157055719|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
48785538|NCT02310750|157055720|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
48785539|NCT02310750|157055721|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
48785540|NCT02310750|157055722|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
48785541|NCT02310750|157055723|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
48785542|NCT02310750|157055724|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
48785543|NCT02310750|157055709|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
48785544|NCT02310750|157055710|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
48785545|NCT02310750|157055711|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
48785546|NCT02310750|157055712|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
48785547|NCT02310750|157055713|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
48785548|NCT02310750|157055714|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
48785549|NCT02310750|157055715|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
48785550|NCT02310750|157055716|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
48785551|NCT02310750|157055717|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
48785552|NCT02310750|157055718|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
48785553|NCT02310750|157055719|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
48785554|NCT02310750|157055720|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
48785555|NCT02310750|157055721|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
48785556|NCT02310750|157055722|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
48785557|NCT02310750|157055723|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
48785558|NCT02310750|157055724|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
48785559|NCT02310750|157055709|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
48785560|NCT02310750|157055710|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
48785561|NCT02310750|157055711|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
48785562|NCT02310750|157055712|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
48785563|NCT02310750|157055713|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
48785564|NCT02310750|157055714|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
48785565|NCT02310750|157055715|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
48785566|NCT02310750|157055716|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
48785567|NCT02310750|157055717|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
48785568|NCT02310750|157055718|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
48785569|NCT02310750|157055719|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
48785570|NCT02310750|157055720|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
48785571|NCT02310750|157055721|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
48785572|NCT02310750|157055722|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
48785573|NCT02310750|157055723|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
49031643|NCT01940341|157953409|FG000|Period 1: Double-blind Phase|Pregnancy|0|||
48785574|NCT02310750|157055724|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
48785575|NCT02310750|157055709|FG000|HP Washout 2|Lost to Follow-up|0|||
48785576|NCT02310750|157055710|FG001|HP Washout 2|Lost to Follow-up|0|||
48785577|NCT02310750|157055711|FG002|HP Washout 2|Lost to Follow-up|0|||
48785578|NCT02310750|157055712|FG003|HP Washout 2|Lost to Follow-up|0|||
48785579|NCT02310750|157055713|FG004|HP Washout 2|Lost to Follow-up|1|||
48785580|NCT02310750|157055714|FG005|HP Washout 2|Lost to Follow-up|0|||
48785581|NCT02310750|157055715|FG006|HP Washout 2|Lost to Follow-up|7|||
48785582|NCT02310750|157055716|FG007|HP Washout 2|Lost to Follow-up|0|||
48785583|NCT02310750|157055717|FG008|HP Washout 2|Lost to Follow-up|0|||
48785584|NCT02310750|157055718|FG009|HP Washout 2|Lost to Follow-up|0|||
48785585|NCT02310750|157055719|FG010|HP Washout 2|Lost to Follow-up|0|||
48785586|NCT02310750|157055720|FG011|HP Washout 2|Lost to Follow-up|0|||
48785587|NCT02310750|157055721|FG012|HP Washout 2|Lost to Follow-up|0|||
48785588|NCT02310750|157055722|FG013|HP Washout 2|Lost to Follow-up|0|||
48785589|NCT02310750|157055723|FG014|HP Washout 2|Lost to Follow-up|0|||
48785590|NCT02310750|157055724|FG015|HP Washout 2|Lost to Follow-up|0|||
48785591|NCT00288587|157055729|FG000|Overall Study|Death|4|||
48785592|NCT00288587|157055730|FG001|Overall Study|Death|4|||
48785593|NCT00288587|157055729|FG000|Overall Study|Transplant|0|||
48785594|NCT00288587|157055730|FG001|Overall Study|Transplant|3|||
48785595|NCT00288587|157055729|FG000|Overall Study|Adverse Event|0|||
48785596|NCT00288587|157055730|FG001|Overall Study|Adverse Event|1|||
48785597|NCT00288587|157055729|FG000|Overall Study|Physician Decision|0|||
48785598|NCT00288587|157055730|FG001|Overall Study|Physician Decision|2|||
48785599|NCT00288587|157055729|FG000|Overall Study|Severe Aortic Stenosis|1|||
48785600|NCT00288587|157055730|FG001|Overall Study|Severe Aortic Stenosis|0|||
48785601|NCT04323436|157055733|FG000|Overall Study|Adverse Event|7|||
48785602|NCT04323436|157055734|FG001|Overall Study|Adverse Event|0|||
48785603|NCT04323436|157055735|FG002|Overall Study|Adverse Event|0|||
48785604|NCT04323436|157055733|FG000|Overall Study|Transfer to another clinical study or to other alternative treatment option|8|||
48785605|NCT04323436|157055734|FG001|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
48785606|NCT04323436|157055735|FG002|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
48785607|NCT04323436|157055733|FG000|Overall Study|Death|1|||
48785608|NCT04323436|157055734|FG001|Overall Study|Death|0|||
48785609|NCT04323436|157055735|FG002|Overall Study|Death|0|||
48785610|NCT04323436|157055733|FG000|Overall Study|Physician Decision|2|||
48785611|NCT04323436|157055734|FG001|Overall Study|Physician Decision|0|||
48785612|NCT04323436|157055735|FG002|Overall Study|Physician Decision|0|||
48785613|NCT04323436|157055733|FG000|Overall Study|Progressive disease|10|||
49031644|NCT01940341|157953410|FG001|Period 1: Double-blind Phase|Pregnancy|1|||
49031645|NCT01940341|157953411|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
48785614|NCT04323436|157055734|FG001|Overall Study|Progressive disease|0|||
48785615|NCT04323436|157055735|FG002|Overall Study|Progressive disease|0|||
48785616|NCT04323436|157055733|FG000|Overall Study|Subject decision|3|||
48785617|NCT04323436|157055734|FG001|Overall Study|Subject decision|0|||
48785618|NCT04323436|157055735|FG002|Overall Study|Subject decision|0|||
48785619|NCT01344460|157055736|FG000|Overall Study|Withdrawal by Subject|1|||
48785620|NCT01344460|157055736|FG000|Overall Study|Lost to Follow-up|2|||
48785621|NCT02276482|157055737|FG000|Overall Study|Adverse Event|1|||
48785622|NCT02276482|157055738|FG001|Overall Study|Adverse Event|0|||
48785623|NCT02276482|157055737|FG000|Overall Study|Withdrawal by Subject|1|||
48785624|NCT02276482|157055738|FG001|Overall Study|Withdrawal by Subject|0|||
48785625|NCT02276482|157055737|FG000|Overall Study|Gram-negative infection|1|||
48785626|NCT02276482|157055738|FG001|Overall Study|Gram-negative infection|0|||
48785627|NCT02276482|157055737|FG000|Overall Study|Reason not specified|0|||
48785628|NCT02276482|157055738|FG001|Overall Study|Reason not specified|1|||
48785629|NCT00506493|157055739|FG000|Overall Study|Death|6|||
49031646|NCT01940341|157953412|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
48785630|NCT00506493|157055739|FG000|Overall Study|Withdrawal by Subject|5|||
48785631|NCT02653482|157055743|FG000|Overall Study|Death|1|||
48785632|NCT02653482|157055744|FG001|Overall Study|Death|1|||
48785633|NCT03230916|157055745|FG000|Overall Study|Withdrawal by Subject|0|||
49031647|NCT01940341|157953409|FG000|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|1|||
48785634|NCT03230916|157055746|FG001|Overall Study|Withdrawal by Subject|0|||
48785635|NCT03230916|157055747|FG002|Overall Study|Withdrawal by Subject|0|||
48785636|NCT03230916|157055748|FG003|Overall Study|Withdrawal by Subject|0|||
49031648|NCT01940341|157953410|FG001|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
48785637|NCT03230916|157055749|FG004|Overall Study|Withdrawal by Subject|0|||
48785638|NCT03230916|157055750|FG005|Overall Study|Withdrawal by Subject|1|||
48785639|NCT03230916|157055751|FG006|Overall Study|Withdrawal by Subject|0|||
48785640|NCT03230916|157055752|FG007|Overall Study|Withdrawal by Subject|0|||
48785641|NCT03230916|157055753|FG008|Overall Study|Withdrawal by Subject|0|||
48785642|NCT03230916|157055754|FG009|Overall Study|Withdrawal by Subject|0|||
48785643|NCT03230916|157055755|FG010|Overall Study|Withdrawal by Subject|0|||
48785644|NCT05132699|157055756|FG000|Overall Study|Withdrawal by Subject|3|||
48785645|NCT05132699|157055757|FG001|Overall Study|Withdrawal by Subject|0|||
48785646|NCT01404312|157057453|FG000|Overall Study|Death|21|||
48785647|NCT01404312|157057454|FG001|Overall Study|Death|27|||
48785648|NCT01404312|157057453|FG000|Overall Study|Withdrawal by Subject|15|||
48785649|NCT01404312|157057454|FG001|Overall Study|Withdrawal by Subject|18|||
48785650|NCT01404312|157057453|FG000|Overall Study|Participant Unable to get to clinic|93|||
48785651|NCT01404312|157057454|FG001|Overall Study|Participant Unable to get to clinic|103|||
48785652|NCT01404312|157057453|FG000|Overall Study|Lost to Follow-up|115|||
48785653|NCT01404312|157057454|FG001|Overall Study|Lost to Follow-up|111|||
48785654|NCT01404312|157057453|FG000|Overall Study|Site closed|22|||
48785655|NCT01404312|157057454|FG001|Overall Study|Site closed|21|||
48785656|NCT01404312|157057453|FG000|Overall Study|Participant not willing to adhere to req|31|||
48785657|NCT01404312|157057454|FG001|Overall Study|Participant not willing to adhere to req|29|||
48785658|NCT01404312|157057453|FG000|Overall Study|Severe debilitation, unable to continue|1|||
48785659|NCT01404312|157057454|FG001|Overall Study|Severe debilitation, unable to continue|2|||
48785660|NCT01490632|157057456|FG000|Part A: Initial Treatment Period|Adverse Event|0|||
48785661|NCT01490632|157057457|FG001|Part A: Initial Treatment Period|Adverse Event|0|||
48785662|NCT01490632|157057458|FG002|Part A: Initial Treatment Period|Adverse Event|2|||
48785663|NCT01490632|157057459|FG003|Part A: Initial Treatment Period|Adverse Event|4|||
48785664|NCT01490632|157057460|FG004|Part A: Initial Treatment Period|Adverse Event|4|||
48785665|NCT01490632|157057461|FG005|Part A: Initial Treatment Period|Adverse Event|0|||
48785666|NCT01490632|157057462|FG006|Part A: Initial Treatment Period|Adverse Event|0|||
48785667|NCT01490632|157057463|FG007|Part A: Initial Treatment Period|Adverse Event|0|||
48785668|NCT01490632|157057464|FG008|Part A: Initial Treatment Period|Adverse Event|0|||
48785669|NCT01490632|157057465|FG009|Part A: Initial Treatment Period|Adverse Event|0|||
48785670|NCT01490632|157057466|FG010|Part A: Initial Treatment Period|Adverse Event|0|||
48785671|NCT01490632|157057467|FG011|Part A: Initial Treatment Period|Adverse Event|0|||
48785672|NCT01490632|157057468|FG012|Part A: Initial Treatment Period|Adverse Event|0|||
48785673|NCT01490632|157057469|FG013|Part A: Initial Treatment Period|Adverse Event|0|||
48785674|NCT01490632|157057470|FG014|Part A: Initial Treatment Period|Adverse Event|0|||
48785675|NCT01490632|157057471|FG015|Part A: Initial Treatment Period|Adverse Event|0|||
48785676|NCT01490632|157057472|FG016|Part A: Initial Treatment Period|Adverse Event|0|||
48785677|NCT01490632|157057473|FG017|Part A: Initial Treatment Period|Adverse Event|0|||
48785678|NCT01490632|157057474|FG018|Part A: Initial Treatment Period|Adverse Event|0|||
48785679|NCT01490632|157057475|FG019|Part A: Initial Treatment Period|Adverse Event|0|||
48785680|NCT01490632|157057456|FG000|Part A: Initial Treatment Period|Lack of Efficacy|3|||
48785681|NCT01490632|157057457|FG001|Part A: Initial Treatment Period|Lack of Efficacy|1|||
48785682|NCT01490632|157057458|FG002|Part A: Initial Treatment Period|Lack of Efficacy|2|||
48785683|NCT01490632|157057459|FG003|Part A: Initial Treatment Period|Lack of Efficacy|2|||
48785684|NCT01490632|157057460|FG004|Part A: Initial Treatment Period|Lack of Efficacy|0|||
48785685|NCT01490632|157057461|FG005|Part A: Initial Treatment Period|Lack of Efficacy|0|||
48785686|NCT01490632|157057462|FG006|Part A: Initial Treatment Period|Lack of Efficacy|0|||
48785687|NCT01490632|157057463|FG007|Part A: Initial Treatment Period|Lack of Efficacy|0|||
48785688|NCT01490632|157057464|FG008|Part A: Initial Treatment Period|Lack of Efficacy|0|||
48785689|NCT01490632|157057465|FG009|Part A: Initial Treatment Period|Lack of Efficacy|0|||
48877529|NCT05382039|157390085|FG002|Overall Study|waiting for confirmation|1|||
48877530|NCT02577003|157390091|FG000|Overall Study|Adverse Event|2|||
48877531|NCT02577003|157390092|FG001|Overall Study|Adverse Event|4|||
49031649|NCT01940341|157953411|FG002|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
49031650|NCT01940341|157953412|FG003|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
49031651|NCT01940341|157953409|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
49031652|NCT01940341|157953410|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
49031653|NCT01940341|157953411|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
49031654|NCT01940341|157953412|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
49031655|NCT01940341|157953409|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
49031656|NCT01940341|157953410|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
49031657|NCT01940341|157953411|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|17|||
49031658|NCT01940341|157953412|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|4|||
49031659|NCT01940341|157953409|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
49031660|NCT01940341|157953410|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
49031661|NCT01940341|157953411|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|3|||
49031662|NCT01940341|157953412|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
49031663|NCT01940341|157953409|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
49031664|NCT01940341|157953410|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
49031665|NCT01940341|157953411|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|6|||
48785690|NCT01490632|157057466|FG010|Part A: Initial Treatment Period|Lack of Efficacy|0|||
48785691|NCT01490632|157057467|FG011|Part A: Initial Treatment Period|Lack of Efficacy|0|||
48785692|NCT01490632|157057468|FG012|Part A: Initial Treatment Period|Lack of Efficacy|0|||
48785693|NCT01490632|157057469|FG013|Part A: Initial Treatment Period|Lack of Efficacy|0|||
48785694|NCT01490632|157057470|FG014|Part A: Initial Treatment Period|Lack of Efficacy|0|||
48785695|NCT01490632|157057471|FG015|Part A: Initial Treatment Period|Lack of Efficacy|0|||
48785696|NCT01490632|157057472|FG016|Part A: Initial Treatment Period|Lack of Efficacy|0|||
48785697|NCT01490632|157057473|FG017|Part A: Initial Treatment Period|Lack of Efficacy|0|||
48785698|NCT01490632|157057474|FG018|Part A: Initial Treatment Period|Lack of Efficacy|0|||
48785699|NCT01490632|157057475|FG019|Part A: Initial Treatment Period|Lack of Efficacy|0|||
48785700|NCT01490632|157057456|FG000|Part A: Initial Treatment Period|Lost to Follow-up|0|||
48785701|NCT01490632|157057457|FG001|Part A: Initial Treatment Period|Lost to Follow-up|0|||
48785702|NCT01490632|157057458|FG002|Part A: Initial Treatment Period|Lost to Follow-up|1|||
48785703|NCT01490632|157057459|FG003|Part A: Initial Treatment Period|Lost to Follow-up|1|||
48785704|NCT01490632|157057460|FG004|Part A: Initial Treatment Period|Lost to Follow-up|2|||
48785705|NCT01490632|157057461|FG005|Part A: Initial Treatment Period|Lost to Follow-up|0|||
48785706|NCT01490632|157057462|FG006|Part A: Initial Treatment Period|Lost to Follow-up|0|||
49031666|NCT01940341|157953412|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
49031667|NCT01940341|157953409|FG000|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
48785707|NCT01490632|157057463|FG007|Part A: Initial Treatment Period|Lost to Follow-up|0|||
48785708|NCT01490632|157057464|FG008|Part A: Initial Treatment Period|Lost to Follow-up|0|||
48785709|NCT01490632|157057465|FG009|Part A: Initial Treatment Period|Lost to Follow-up|0|||
48785710|NCT01490632|157057466|FG010|Part A: Initial Treatment Period|Lost to Follow-up|0|||
48785711|NCT01490632|157057467|FG011|Part A: Initial Treatment Period|Lost to Follow-up|0|||
48785712|NCT01490632|157057468|FG012|Part A: Initial Treatment Period|Lost to Follow-up|0|||
49031668|NCT01940341|157953410|FG001|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
49031669|NCT01940341|157953411|FG002|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|3|||
49031670|NCT01940341|157953412|FG003|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|1|||
49031671|NCT01940341|157953409|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
49031672|NCT01940341|157953410|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
49031673|NCT01940341|157953411|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|2|||
49031674|NCT01940341|157953412|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
49031675|NCT01940341|157953409|FG000|Period 2: Open-Label TAF Extension Phase|Death|0|||
49031676|NCT01940341|157953410|FG001|Period 2: Open-Label TAF Extension Phase|Death|0|||
49031677|NCT01940341|157953411|FG002|Period 2: Open-Label TAF Extension Phase|Death|1|||
49031678|NCT01940341|157953412|FG003|Period 2: Open-Label TAF Extension Phase|Death|0|||
49031679|NCT01940341|157953409|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
49031680|NCT01940341|157953410|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
49031681|NCT01940341|157953411|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
49031682|NCT01940341|157953412|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
49031683|NCT01940341|157953409|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
49031684|NCT01940341|157953410|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
49031685|NCT01940341|157953411|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
49031686|NCT01940341|157953412|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
49031687|NCT01940341|157953409|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
49031688|NCT01940341|157953410|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
49031689|NCT01940341|157953411|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
49031690|NCT01940341|157953412|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|1|||
49031691|NCT01940341|157953409|FG000|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
49031692|NCT01940341|157953410|FG001|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
48785713|NCT01490632|157057469|FG013|Part A: Initial Treatment Period|Lost to Follow-up|0|||
48785714|NCT01490632|157057470|FG014|Part A: Initial Treatment Period|Lost to Follow-up|0|||
48785715|NCT01490632|157057471|FG015|Part A: Initial Treatment Period|Lost to Follow-up|0|||
48785716|NCT01490632|157057472|FG016|Part A: Initial Treatment Period|Lost to Follow-up|0|||
48785717|NCT01490632|157057473|FG017|Part A: Initial Treatment Period|Lost to Follow-up|0|||
48785718|NCT01490632|157057474|FG018|Part A: Initial Treatment Period|Lost to Follow-up|0|||
48785719|NCT01490632|157057475|FG019|Part A: Initial Treatment Period|Lost to Follow-up|0|||
48785720|NCT01490632|157057456|FG000|Part A: Initial Treatment Period|Physician Decision|0|||
48785721|NCT01490632|157057457|FG001|Part A: Initial Treatment Period|Physician Decision|1|||
48785722|NCT01490632|157057458|FG002|Part A: Initial Treatment Period|Physician Decision|0|||
48785723|NCT01490632|157057459|FG003|Part A: Initial Treatment Period|Physician Decision|1|||
48785724|NCT01490632|157057460|FG004|Part A: Initial Treatment Period|Physician Decision|0|||
48785725|NCT01490632|157057461|FG005|Part A: Initial Treatment Period|Physician Decision|0|||
48785726|NCT01490632|157057462|FG006|Part A: Initial Treatment Period|Physician Decision|0|||
48785727|NCT01490632|157057463|FG007|Part A: Initial Treatment Period|Physician Decision|0|||
48785728|NCT01490632|157057464|FG008|Part A: Initial Treatment Period|Physician Decision|0|||
48785729|NCT01490632|157057465|FG009|Part A: Initial Treatment Period|Physician Decision|0|||
48785730|NCT01490632|157057466|FG010|Part A: Initial Treatment Period|Physician Decision|0|||
48785731|NCT01490632|157057467|FG011|Part A: Initial Treatment Period|Physician Decision|0|||
48785732|NCT01490632|157057468|FG012|Part A: Initial Treatment Period|Physician Decision|0|||
48785733|NCT01490632|157057469|FG013|Part A: Initial Treatment Period|Physician Decision|0|||
48785734|NCT01490632|157057470|FG014|Part A: Initial Treatment Period|Physician Decision|0|||
48785735|NCT01490632|157057471|FG015|Part A: Initial Treatment Period|Physician Decision|0|||
48785736|NCT01490632|157057472|FG016|Part A: Initial Treatment Period|Physician Decision|0|||
48785737|NCT01490632|157057473|FG017|Part A: Initial Treatment Period|Physician Decision|0|||
48785738|NCT01490632|157057474|FG018|Part A: Initial Treatment Period|Physician Decision|0|||
48785739|NCT01490632|157057475|FG019|Part A: Initial Treatment Period|Physician Decision|0|||
48785740|NCT01490632|157057456|FG000|Part A: Initial Treatment Period|Sponsor Decision|2|||
48785741|NCT01490632|157057457|FG001|Part A: Initial Treatment Period|Sponsor Decision|0|||
48785742|NCT01490632|157057458|FG002|Part A: Initial Treatment Period|Sponsor Decision|0|||
48785743|NCT01490632|157057459|FG003|Part A: Initial Treatment Period|Sponsor Decision|0|||
48785744|NCT01490632|157057460|FG004|Part A: Initial Treatment Period|Sponsor Decision|0|||
48785745|NCT01490632|157057461|FG005|Part A: Initial Treatment Period|Sponsor Decision|0|||
48785746|NCT01490632|157057462|FG006|Part A: Initial Treatment Period|Sponsor Decision|0|||
48785747|NCT01490632|157057463|FG007|Part A: Initial Treatment Period|Sponsor Decision|0|||
48785748|NCT01490632|157057464|FG008|Part A: Initial Treatment Period|Sponsor Decision|0|||
48785749|NCT01490632|157057465|FG009|Part A: Initial Treatment Period|Sponsor Decision|0|||
48785750|NCT01490632|157057466|FG010|Part A: Initial Treatment Period|Sponsor Decision|0|||
48785751|NCT01490632|157057467|FG011|Part A: Initial Treatment Period|Sponsor Decision|0|||
48785752|NCT01490632|157057468|FG012|Part A: Initial Treatment Period|Sponsor Decision|0|||
48785753|NCT01490632|157057469|FG013|Part A: Initial Treatment Period|Sponsor Decision|0|||
48785754|NCT01490632|157057470|FG014|Part A: Initial Treatment Period|Sponsor Decision|0|||
48785755|NCT01490632|157057471|FG015|Part A: Initial Treatment Period|Sponsor Decision|0|||
48785756|NCT01490632|157057472|FG016|Part A: Initial Treatment Period|Sponsor Decision|0|||
48785757|NCT01490632|157057473|FG017|Part A: Initial Treatment Period|Sponsor Decision|0|||
48785758|NCT01490632|157057474|FG018|Part A: Initial Treatment Period|Sponsor Decision|0|||
48785759|NCT01490632|157057475|FG019|Part A: Initial Treatment Period|Sponsor Decision|0|||
48785760|NCT01490632|157057456|FG000|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
48785761|NCT01490632|157057457|FG001|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
48785762|NCT01490632|157057458|FG002|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
48785763|NCT01490632|157057459|FG003|Part A: Initial Treatment Period|Withdrawal by Subject|1|||
48785764|NCT01490632|157057460|FG004|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
48785765|NCT01490632|157057461|FG005|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
48785766|NCT01490632|157057462|FG006|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
48785767|NCT01490632|157057463|FG007|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
48785768|NCT01490632|157057464|FG008|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
48785769|NCT01490632|157057465|FG009|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
48785770|NCT01490632|157057466|FG010|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
48785771|NCT01490632|157057467|FG011|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
48785772|NCT01490632|157057468|FG012|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
48785773|NCT01490632|157057469|FG013|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
48785774|NCT01490632|157057470|FG014|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
48785775|NCT01490632|157057471|FG015|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
48785776|NCT01490632|157057472|FG016|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
48785777|NCT01490632|157057473|FG017|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
48785778|NCT01490632|157057474|FG018|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
48785779|NCT01490632|157057475|FG019|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
48785780|NCT01490632|157057456|FG000|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
48785781|NCT01490632|157057457|FG001|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
48785782|NCT01490632|157057458|FG002|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
48785783|NCT01490632|157057459|FG003|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
48785784|NCT01490632|157057460|FG004|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9|||
48785785|NCT01490632|157057461|FG005|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
48785786|NCT01490632|157057462|FG006|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
48785787|NCT01490632|157057463|FG007|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
48785788|NCT01490632|157057464|FG008|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
48785789|NCT01490632|157057465|FG009|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
48785790|NCT01490632|157057466|FG010|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
48785791|NCT01490632|157057467|FG011|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
48785792|NCT01490632|157057468|FG012|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
48785793|NCT01490632|157057469|FG013|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
48785794|NCT01490632|157057470|FG014|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
48785795|NCT01490632|157057471|FG015|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
48797714|NCT00293267|157097060|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
48785796|NCT01490632|157057472|FG016|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
48785797|NCT01490632|157057473|FG017|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
48785798|NCT01490632|157057474|FG018|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
48785799|NCT01490632|157057475|FG019|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
48785800|NCT01490632|157057456|FG000|Part B: Extension or Step-Up Period|Adverse Event|0|||
48785801|NCT01490632|157057457|FG001|Part B: Extension or Step-Up Period|Adverse Event|0|||
48785802|NCT01490632|157057458|FG002|Part B: Extension or Step-Up Period|Adverse Event|0|||
48785803|NCT01490632|157057459|FG003|Part B: Extension or Step-Up Period|Adverse Event|0|||
48785804|NCT01490632|157057460|FG004|Part B: Extension or Step-Up Period|Adverse Event|0|||
48785805|NCT01490632|157057461|FG005|Part B: Extension or Step-Up Period|Adverse Event|2|||
48785806|NCT01490632|157057462|FG006|Part B: Extension or Step-Up Period|Adverse Event|2|||
48785807|NCT01490632|157057463|FG007|Part B: Extension or Step-Up Period|Adverse Event|0|||
48785808|NCT01490632|157057464|FG008|Part B: Extension or Step-Up Period|Adverse Event|0|||
48785809|NCT01490632|157057465|FG009|Part B: Extension or Step-Up Period|Adverse Event|2|||
48785810|NCT01490632|157057466|FG010|Part B: Extension or Step-Up Period|Adverse Event|3|||
48785811|NCT01490632|157057467|FG011|Part B: Extension or Step-Up Period|Adverse Event|1|||
48785812|NCT01490632|157057468|FG012|Part B: Extension or Step-Up Period|Adverse Event|0|||
48785813|NCT01490632|157057469|FG013|Part B: Extension or Step-Up Period|Adverse Event|0|||
48785814|NCT01490632|157057470|FG014|Part B: Extension or Step-Up Period|Adverse Event|0|||
48785815|NCT01490632|157057471|FG015|Part B: Extension or Step-Up Period|Adverse Event|0|||
48785816|NCT01490632|157057472|FG016|Part B: Extension or Step-Up Period|Adverse Event|0|||
48785817|NCT01490632|157057473|FG017|Part B: Extension or Step-Up Period|Adverse Event|0|||
48785818|NCT01490632|157057474|FG018|Part B: Extension or Step-Up Period|Adverse Event|0|||
48785819|NCT01490632|157057475|FG019|Part B: Extension or Step-Up Period|Adverse Event|0|||
48785820|NCT01490632|157057456|FG000|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
48785821|NCT01490632|157057457|FG001|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
48785822|NCT01490632|157057458|FG002|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
48785823|NCT01490632|157057459|FG003|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
48785824|NCT01490632|157057460|FG004|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
48785825|NCT01490632|157057461|FG005|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
48785826|NCT01490632|157057462|FG006|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
48785827|NCT01490632|157057463|FG007|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
48785828|NCT01490632|157057464|FG008|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
48785829|NCT01490632|157057465|FG009|Part B: Extension or Step-Up Period|Lack of Efficacy|3|||
48785830|NCT01490632|157057466|FG010|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
48785831|NCT01490632|157057467|FG011|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
48785832|NCT01490632|157057468|FG012|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
48785833|NCT01490632|157057469|FG013|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
48785834|NCT01490632|157057470|FG014|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
48785835|NCT01490632|157057471|FG015|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
48785836|NCT01490632|157057472|FG016|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
48785837|NCT01490632|157057473|FG017|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
48785838|NCT01490632|157057474|FG018|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
48785839|NCT01490632|157057475|FG019|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
48785840|NCT01490632|157057456|FG000|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
48785841|NCT01490632|157057457|FG001|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
48785842|NCT01490632|157057458|FG002|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
48785843|NCT01490632|157057459|FG003|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
48785844|NCT01490632|157057460|FG004|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
48785845|NCT01490632|157057461|FG005|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
48785846|NCT01490632|157057462|FG006|Part B: Extension or Step-Up Period|Lost to Follow-up|2|||
48785847|NCT01490632|157057463|FG007|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
48785848|NCT01490632|157057464|FG008|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
49031693|NCT01940341|157953411|FG002|Period 2: Open-Label TAF Extension Phase|Progressive Disease|1|||
49031694|NCT01940341|157953412|FG003|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
49031695|NCT04078022|157953418|FG000|Vaccination Phase|Withdrawal prior to challenge|2|||
49031696|NCT04078022|157953419|FG001|Vaccination Phase|Withdrawal prior to challenge|3|||
49031697|NCT00251979|157953422|FG000|Overall Study|Protocol Violation|3|||
49031698|NCT00251979|157953423|FG001|Overall Study|Protocol Violation|5|||
49031699|NCT00251979|157953422|FG000|Overall Study|Adverse Event|11|||
48785849|NCT01490632|157057465|FG009|Part B: Extension or Step-Up Period|Lost to Follow-up|1|||
48785850|NCT01490632|157057466|FG010|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
48785851|NCT01490632|157057467|FG011|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
48785852|NCT01490632|157057468|FG012|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
49031700|NCT00251979|157953423|FG001|Overall Study|Adverse Event|17|||
49031701|NCT00251979|157953422|FG000|Overall Study|Withdrawal by Subject|13|||
49031702|NCT00251979|157953423|FG001|Overall Study|Withdrawal by Subject|7|||
48785853|NCT01490632|157057469|FG013|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
48785854|NCT01490632|157057470|FG014|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
48785855|NCT01490632|157057471|FG015|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
48785856|NCT01490632|157057472|FG016|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
48785857|NCT01490632|157057473|FG017|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
48785858|NCT01490632|157057474|FG018|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
48785859|NCT01490632|157057475|FG019|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
48785860|NCT01490632|157057456|FG000|Part B: Extension or Step-Up Period|Physician Decision|0|||
48785861|NCT01490632|157057457|FG001|Part B: Extension or Step-Up Period|Physician Decision|0|||
48785862|NCT01490632|157057458|FG002|Part B: Extension or Step-Up Period|Physician Decision|0|||
48785863|NCT01490632|157057459|FG003|Part B: Extension or Step-Up Period|Physician Decision|0|||
48785864|NCT01490632|157057460|FG004|Part B: Extension or Step-Up Period|Physician Decision|0|||
48785865|NCT01490632|157057461|FG005|Part B: Extension or Step-Up Period|Physician Decision|0|||
48785866|NCT01490632|157057462|FG006|Part B: Extension or Step-Up Period|Physician Decision|1|||
48785867|NCT01490632|157057463|FG007|Part B: Extension or Step-Up Period|Physician Decision|0|||
48785868|NCT01490632|157057464|FG008|Part B: Extension or Step-Up Period|Physician Decision|0|||
48785869|NCT01490632|157057465|FG009|Part B: Extension or Step-Up Period|Physician Decision|0|||
48785870|NCT01490632|157057466|FG010|Part B: Extension or Step-Up Period|Physician Decision|0|||
48785871|NCT01490632|157057467|FG011|Part B: Extension or Step-Up Period|Physician Decision|0|||
48785872|NCT01490632|157057468|FG012|Part B: Extension or Step-Up Period|Physician Decision|0|||
48785873|NCT01490632|157057469|FG013|Part B: Extension or Step-Up Period|Physician Decision|0|||
48785874|NCT01490632|157057470|FG014|Part B: Extension or Step-Up Period|Physician Decision|0|||
48785875|NCT01490632|157057471|FG015|Part B: Extension or Step-Up Period|Physician Decision|0|||
48785876|NCT01490632|157057472|FG016|Part B: Extension or Step-Up Period|Physician Decision|0|||
48785877|NCT01490632|157057473|FG017|Part B: Extension or Step-Up Period|Physician Decision|0|||
48785878|NCT01490632|157057474|FG018|Part B: Extension or Step-Up Period|Physician Decision|0|||
48785879|NCT01490632|157057475|FG019|Part B: Extension or Step-Up Period|Physician Decision|0|||
48785880|NCT01490632|157057456|FG000|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
48785881|NCT01490632|157057457|FG001|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
48785882|NCT01490632|157057458|FG002|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
48785883|NCT01490632|157057459|FG003|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
48785884|NCT01490632|157057460|FG004|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
48785885|NCT01490632|157057461|FG005|Part B: Extension or Step-Up Period|Sponsor Decision|1|||
48785886|NCT01490632|157057462|FG006|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
48785887|NCT01490632|157057463|FG007|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
48785888|NCT01490632|157057464|FG008|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
48785889|NCT01490632|157057465|FG009|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
48785890|NCT01490632|157057466|FG010|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
48785891|NCT01490632|157057467|FG011|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
48785892|NCT01490632|157057468|FG012|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
48785893|NCT01490632|157057469|FG013|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
48785894|NCT01490632|157057470|FG014|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
48785895|NCT01490632|157057471|FG015|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
48785896|NCT01490632|157057472|FG016|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
48785897|NCT01490632|157057473|FG017|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
48785898|NCT01490632|157057474|FG018|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
48785899|NCT01490632|157057475|FG019|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
48785900|NCT01490632|157057456|FG000|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
48785901|NCT01490632|157057457|FG001|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
48785902|NCT01490632|157057458|FG002|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
48785903|NCT01490632|157057459|FG003|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
49031703|NCT00251979|157953422|FG000|Overall Study|Lost to Follow-up|8|||
49031704|NCT00251979|157953423|FG001|Overall Study|Lost to Follow-up|6|||
49031705|NCT00251979|157953422|FG000|Overall Study|Death|3|||
49031706|NCT00251979|157953423|FG001|Overall Study|Death|5|||
49031707|NCT00840411|157953426|FG000|First Intervention|Adverse Event|1|||
48785904|NCT01490632|157057460|FG004|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
48785905|NCT01490632|157057461|FG005|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
48785906|NCT01490632|157057462|FG006|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
48785907|NCT01490632|157057463|FG007|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
48785908|NCT01490632|157057464|FG008|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
48785909|NCT01490632|157057465|FG009|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
48785910|NCT01490632|157057466|FG010|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
48785911|NCT01490632|157057467|FG011|Part B: Extension or Step-Up Period|Withdrawal by Subject|2|||
48785912|NCT01490632|157057468|FG012|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
49031708|NCT00840411|157953427|FG001|First Intervention|Adverse Event|0|||
49031709|NCT00840411|157953426|FG000|Washout|Withdrawal by Subject|1|||
48785913|NCT01490632|157057469|FG013|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
48785914|NCT01490632|157057470|FG014|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
48785915|NCT01490632|157057471|FG015|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
48785916|NCT01490632|157057472|FG016|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
48785917|NCT01490632|157057473|FG017|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
48785918|NCT01490632|157057474|FG018|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
48785919|NCT01490632|157057475|FG019|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
48785920|NCT01490632|157057456|FG000|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
48785921|NCT01490632|157057457|FG001|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
48785922|NCT01490632|157057458|FG002|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
48785923|NCT01490632|157057459|FG003|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
48785924|NCT01490632|157057460|FG004|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
48785925|NCT01490632|157057461|FG005|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1|||
48785926|NCT01490632|157057462|FG006|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
48785927|NCT01490632|157057463|FG007|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
48785928|NCT01490632|157057464|FG008|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8|||
48785929|NCT01490632|157057465|FG009|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19|||
48785930|NCT01490632|157057466|FG010|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16|||
48785931|NCT01490632|157057467|FG011|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5|||
48785932|NCT01490632|157057468|FG012|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
48785933|NCT01490632|157057469|FG013|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
48877532|NCT02577003|157390091|FG000|Overall Study|Withdrawal by Subject|0|||
48785934|NCT01490632|157057470|FG014|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
48785935|NCT01490632|157057471|FG015|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
48785936|NCT01490632|157057472|FG016|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
48785937|NCT01490632|157057473|FG017|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
48785938|NCT01490632|157057474|FG018|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
48785939|NCT01490632|157057475|FG019|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
48785940|NCT01490632|157057456|FG000|Part C: Washout or Step-Down Period|Adverse Event|0|||
48785941|NCT01490632|157057457|FG001|Part C: Washout or Step-Down Period|Adverse Event|0|||
48785942|NCT01490632|157057458|FG002|Part C: Washout or Step-Down Period|Adverse Event|0|||
48785943|NCT01490632|157057459|FG003|Part C: Washout or Step-Down Period|Adverse Event|0|||
48785944|NCT01490632|157057460|FG004|Part C: Washout or Step-Down Period|Adverse Event|0|||
48785945|NCT01490632|157057461|FG005|Part C: Washout or Step-Down Period|Adverse Event|0|||
48785946|NCT01490632|157057462|FG006|Part C: Washout or Step-Down Period|Adverse Event|0|||
48785947|NCT01490632|157057463|FG007|Part C: Washout or Step-Down Period|Adverse Event|0|||
48785948|NCT01490632|157057464|FG008|Part C: Washout or Step-Down Period|Adverse Event|0|||
48785949|NCT01490632|157057465|FG009|Part C: Washout or Step-Down Period|Adverse Event|0|||
48785950|NCT01490632|157057466|FG010|Part C: Washout or Step-Down Period|Adverse Event|0|||
48785951|NCT01490632|157057467|FG011|Part C: Washout or Step-Down Period|Adverse Event|0|||
48785952|NCT01490632|157057468|FG012|Part C: Washout or Step-Down Period|Adverse Event|0|||
48785953|NCT01490632|157057469|FG013|Part C: Washout or Step-Down Period|Adverse Event|0|||
48785954|NCT01490632|157057470|FG014|Part C: Washout or Step-Down Period|Adverse Event|2|||
48785955|NCT01490632|157057471|FG015|Part C: Washout or Step-Down Period|Adverse Event|2|||
48785956|NCT01490632|157057472|FG016|Part C: Washout or Step-Down Period|Adverse Event|0|||
48785957|NCT01490632|157057473|FG017|Part C: Washout or Step-Down Period|Adverse Event|0|||
48785958|NCT01490632|157057474|FG018|Part C: Washout or Step-Down Period|Adverse Event|0|||
48785959|NCT01490632|157057475|FG019|Part C: Washout or Step-Down Period|Adverse Event|0|||
48785960|NCT01490632|157057456|FG000|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
48785961|NCT01490632|157057457|FG001|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
48785962|NCT01490632|157057458|FG002|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
48785963|NCT01490632|157057459|FG003|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
48785964|NCT01490632|157057460|FG004|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
48785965|NCT01490632|157057461|FG005|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
48785966|NCT01490632|157057462|FG006|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
48785967|NCT01490632|157057463|FG007|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
48785968|NCT01490632|157057464|FG008|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
48785969|NCT01490632|157057465|FG009|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
48785970|NCT01490632|157057466|FG010|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
48785971|NCT01490632|157057467|FG011|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
48785972|NCT01490632|157057468|FG012|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
48785973|NCT01490632|157057469|FG013|Part C: Washout or Step-Down Period|Lost to Follow-up|1|||
48785974|NCT01490632|157057470|FG014|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
48785975|NCT01490632|157057471|FG015|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
48785976|NCT01490632|157057472|FG016|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
48785977|NCT01490632|157057473|FG017|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
48785978|NCT01490632|157057474|FG018|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
48785979|NCT01490632|157057475|FG019|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
48785980|NCT01490632|157057456|FG000|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
48785981|NCT01490632|157057457|FG001|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
48785982|NCT01490632|157057458|FG002|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
48785983|NCT01490632|157057459|FG003|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
48785984|NCT01490632|157057460|FG004|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
48785985|NCT01490632|157057461|FG005|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
48785986|NCT01490632|157057462|FG006|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
48785987|NCT01490632|157057463|FG007|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
48785988|NCT01490632|157057464|FG008|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
48785989|NCT01490632|157057465|FG009|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
48785990|NCT01490632|157057466|FG010|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
48785991|NCT01490632|157057467|FG011|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
48785992|NCT01490632|157057468|FG012|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
48785993|NCT01490632|157057469|FG013|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
48785994|NCT01490632|157057470|FG014|Part C: Washout or Step-Down Period|Withdrawal by Subject|2|||
48785995|NCT01490632|157057471|FG015|Part C: Washout or Step-Down Period|Withdrawal by Subject|1|||
48785996|NCT01490632|157057472|FG016|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
48785997|NCT01490632|157057473|FG017|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
48785998|NCT01490632|157057474|FG018|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
48785999|NCT01490632|157057475|FG019|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
48786000|NCT01490632|157057456|FG000|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
48786001|NCT01490632|157057457|FG001|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
48786002|NCT01490632|157057458|FG002|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
48786003|NCT01490632|157057459|FG003|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
48786004|NCT01490632|157057460|FG004|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
48786005|NCT01490632|157057461|FG005|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
48786006|NCT01490632|157057462|FG006|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
48786007|NCT01490632|157057463|FG007|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
48786008|NCT01490632|157057464|FG008|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
48983057|NCT02394028|157769986|FG000|Induction Phase|Lack of Efficacy|3|||
48983058|NCT02394028|157769987|FG001|Induction Phase|Lack of Efficacy|6|||
48983059|NCT02394028|157769988|FG002|Induction Phase|Lack of Efficacy|2|||
48983060|NCT02394028|157769989|FG003|Induction Phase|Lack of Efficacy|17|||
48983061|NCT02394028|157769990|FG004|Induction Phase|Lack of Efficacy|14|||
48983062|NCT02394028|157769991|FG005|Induction Phase|Lack of Efficacy|8|||
48983063|NCT02394028|157769992|FG006|Induction Phase|Lack of Efficacy|17|||
48983064|NCT02394028|157769993|FG007|Induction Phase|Lack of Efficacy|23|||
48983065|NCT02394028|157769994|FG008|Induction Phase|Lack of Efficacy|0|||
48983066|NCT02394028|157769995|FG009|Induction Phase|Lack of Efficacy|0|||
48983067|NCT02394028|157769996|FG010|Induction Phase|Lack of Efficacy|0|||
48983068|NCT02394028|157769986|FG000|Induction Phase|Lost to Follow-up|1|||
48983069|NCT02394028|157769987|FG001|Induction Phase|Lost to Follow-up|0|||
48983070|NCT02394028|157769988|FG002|Induction Phase|Lost to Follow-up|0|||
48983071|NCT02394028|157769989|FG003|Induction Phase|Lost to Follow-up|1|||
48983072|NCT02394028|157769990|FG004|Induction Phase|Lost to Follow-up|0|||
48983073|NCT02394028|157769991|FG005|Induction Phase|Lost to Follow-up|0|||
48983074|NCT02394028|157769992|FG006|Induction Phase|Lost to Follow-up|1|||
48983075|NCT02394028|157769993|FG007|Induction Phase|Lost to Follow-up|0|||
48983076|NCT02394028|157769994|FG008|Induction Phase|Lost to Follow-up|0|||
48983077|NCT02394028|157769995|FG009|Induction Phase|Lost to Follow-up|0|||
48983078|NCT02394028|157769996|FG010|Induction Phase|Lost to Follow-up|0|||
48983079|NCT02394028|157769986|FG000|Induction Phase|Non-compliance|0|||
48983080|NCT02394028|157769987|FG001|Induction Phase|Non-compliance|1|||
48983081|NCT02394028|157769988|FG002|Induction Phase|Non-compliance|3|||
48983082|NCT02394028|157769989|FG003|Induction Phase|Non-compliance|1|||
48983083|NCT02394028|157769990|FG004|Induction Phase|Non-compliance|3|||
48983084|NCT02394028|157769991|FG005|Induction Phase|Non-compliance|0|||
48983085|NCT02394028|157769992|FG006|Induction Phase|Non-compliance|1|||
48983086|NCT02394028|157769993|FG007|Induction Phase|Non-compliance|1|||
48983087|NCT02394028|157769994|FG008|Induction Phase|Non-compliance|0|||
48983088|NCT02394028|157769995|FG009|Induction Phase|Non-compliance|0|||
48983089|NCT02394028|157769996|FG010|Induction Phase|Non-compliance|0|||
48983090|NCT02394028|157769986|FG000|Induction Phase|Physician Decision|0|||
48983091|NCT02394028|157769987|FG001|Induction Phase|Physician Decision|0|||
48786009|NCT01490632|157057465|FG009|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
48786010|NCT01490632|157057466|FG010|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
48786011|NCT01490632|157057467|FG011|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
48786012|NCT01490632|157057468|FG012|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5|||
48786013|NCT01490632|157057469|FG013|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9|||
48786014|NCT01490632|157057470|FG014|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14|||
48786015|NCT01490632|157057471|FG015|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34|||
48786016|NCT01490632|157057472|FG016|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
48786017|NCT01490632|157057473|FG017|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
48786018|NCT01490632|157057474|FG018|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
48786019|NCT01490632|157057475|FG019|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
48786020|NCT01490632|157057456|FG000|Part D: Re-Treatment Period|Adverse Event|0|||
48786021|NCT01490632|157057457|FG001|Part D: Re-Treatment Period|Adverse Event|0|||
48786022|NCT01490632|157057458|FG002|Part D: Re-Treatment Period|Adverse Event|0|||
48786023|NCT01490632|157057459|FG003|Part D: Re-Treatment Period|Adverse Event|0|||
48786024|NCT01490632|157057460|FG004|Part D: Re-Treatment Period|Adverse Event|0|||
48786025|NCT01490632|157057461|FG005|Part D: Re-Treatment Period|Adverse Event|0|||
48786026|NCT01490632|157057462|FG006|Part D: Re-Treatment Period|Adverse Event|0|||
48786027|NCT01490632|157057463|FG007|Part D: Re-Treatment Period|Adverse Event|0|||
48786028|NCT01490632|157057464|FG008|Part D: Re-Treatment Period|Adverse Event|0|||
48786029|NCT01490632|157057465|FG009|Part D: Re-Treatment Period|Adverse Event|0|||
48786030|NCT01490632|157057466|FG010|Part D: Re-Treatment Period|Adverse Event|0|||
48786031|NCT01490632|157057467|FG011|Part D: Re-Treatment Period|Adverse Event|0|||
48786032|NCT01490632|157057468|FG012|Part D: Re-Treatment Period|Adverse Event|0|||
48786033|NCT01490632|157057469|FG013|Part D: Re-Treatment Period|Adverse Event|0|||
48786034|NCT01490632|157057470|FG014|Part D: Re-Treatment Period|Adverse Event|0|||
48786035|NCT01490632|157057471|FG015|Part D: Re-Treatment Period|Adverse Event|0|||
48786036|NCT01490632|157057472|FG016|Part D: Re-Treatment Period|Adverse Event|0|||
48786037|NCT01490632|157057473|FG017|Part D: Re-Treatment Period|Adverse Event|1|||
48786038|NCT01490632|157057474|FG018|Part D: Re-Treatment Period|Adverse Event|1|||
48786039|NCT01490632|157057475|FG019|Part D: Re-Treatment Period|Adverse Event|3|||
48786040|NCT01490632|157057456|FG000|Part D: Re-Treatment Period|Death|0|||
48786041|NCT01490632|157057457|FG001|Part D: Re-Treatment Period|Death|0|||
48786042|NCT01490632|157057458|FG002|Part D: Re-Treatment Period|Death|0|||
48786043|NCT01490632|157057459|FG003|Part D: Re-Treatment Period|Death|0|||
48786044|NCT01490632|157057460|FG004|Part D: Re-Treatment Period|Death|0|||
48786045|NCT01490632|157057461|FG005|Part D: Re-Treatment Period|Death|0|||
48786046|NCT01490632|157057462|FG006|Part D: Re-Treatment Period|Death|0|||
48786047|NCT01490632|157057463|FG007|Part D: Re-Treatment Period|Death|0|||
48786048|NCT01490632|157057464|FG008|Part D: Re-Treatment Period|Death|0|||
48786049|NCT01490632|157057465|FG009|Part D: Re-Treatment Period|Death|0|||
48786050|NCT01490632|157057466|FG010|Part D: Re-Treatment Period|Death|0|||
48786051|NCT01490632|157057467|FG011|Part D: Re-Treatment Period|Death|0|||
48786052|NCT01490632|157057468|FG012|Part D: Re-Treatment Period|Death|0|||
48786053|NCT01490632|157057469|FG013|Part D: Re-Treatment Period|Death|0|||
49031710|NCT00840411|157953427|FG001|Washout|Withdrawal by Subject|0|||
49031711|NCT01921062|157953428|FG000|Overall Study|Withdrawal by Subject|0|||
49031712|NCT01921062|157953429|FG001|Overall Study|Withdrawal by Subject|7|||
48786054|NCT01490632|157057470|FG014|Part D: Re-Treatment Period|Death|0|||
49031713|NCT01921062|157953428|FG000|Overall Study|Adverse Event|5|||
48786055|NCT01490632|157057471|FG015|Part D: Re-Treatment Period|Death|0|||
48786056|NCT01490632|157057472|FG016|Part D: Re-Treatment Period|Death|0|||
48786057|NCT01490632|157057473|FG017|Part D: Re-Treatment Period|Death|0|||
48786058|NCT01490632|157057474|FG018|Part D: Re-Treatment Period|Death|1|||
48786059|NCT01490632|157057475|FG019|Part D: Re-Treatment Period|Death|0|||
48786060|NCT01490632|157057456|FG000|Part D: Re-Treatment Period|Lack of Efficacy|0|||
48786061|NCT01490632|157057457|FG001|Part D: Re-Treatment Period|Lack of Efficacy|0|||
48786062|NCT01490632|157057458|FG002|Part D: Re-Treatment Period|Lack of Efficacy|0|||
48786063|NCT01490632|157057459|FG003|Part D: Re-Treatment Period|Lack of Efficacy|0|||
48786064|NCT01490632|157057460|FG004|Part D: Re-Treatment Period|Lack of Efficacy|0|||
48786065|NCT01490632|157057461|FG005|Part D: Re-Treatment Period|Lack of Efficacy|0|||
48786066|NCT01490632|157057462|FG006|Part D: Re-Treatment Period|Lack of Efficacy|0|||
48786067|NCT01490632|157057463|FG007|Part D: Re-Treatment Period|Lack of Efficacy|0|||
48786068|NCT01490632|157057464|FG008|Part D: Re-Treatment Period|Lack of Efficacy|0|||
48786069|NCT01490632|157057465|FG009|Part D: Re-Treatment Period|Lack of Efficacy|0|||
48786070|NCT01490632|157057466|FG010|Part D: Re-Treatment Period|Lack of Efficacy|0|||
48786071|NCT01490632|157057467|FG011|Part D: Re-Treatment Period|Lack of Efficacy|0|||
48786072|NCT01490632|157057468|FG012|Part D: Re-Treatment Period|Lack of Efficacy|0|||
48786073|NCT01490632|157057469|FG013|Part D: Re-Treatment Period|Lack of Efficacy|0|||
48786074|NCT01490632|157057470|FG014|Part D: Re-Treatment Period|Lack of Efficacy|0|||
48786075|NCT01490632|157057471|FG015|Part D: Re-Treatment Period|Lack of Efficacy|0|||
49031714|NCT01921062|157953429|FG001|Overall Study|Adverse Event|6|||
48786076|NCT01490632|157057472|FG016|Part D: Re-Treatment Period|Lack of Efficacy|0|||
48786077|NCT01490632|157057473|FG017|Part D: Re-Treatment Period|Lack of Efficacy|3|||
48786078|NCT01490632|157057474|FG018|Part D: Re-Treatment Period|Lack of Efficacy|1|||
48786079|NCT01490632|157057475|FG019|Part D: Re-Treatment Period|Lack of Efficacy|2|||
48786080|NCT01490632|157057456|FG000|Part D: Re-Treatment Period|Lost to Follow-up|0|||
48786081|NCT01490632|157057457|FG001|Part D: Re-Treatment Period|Lost to Follow-up|0|||
48786082|NCT01490632|157057458|FG002|Part D: Re-Treatment Period|Lost to Follow-up|0|||
48786083|NCT01490632|157057459|FG003|Part D: Re-Treatment Period|Lost to Follow-up|0|||
48786084|NCT01490632|157057460|FG004|Part D: Re-Treatment Period|Lost to Follow-up|0|||
48786085|NCT01490632|157057461|FG005|Part D: Re-Treatment Period|Lost to Follow-up|0|||
48786086|NCT01490632|157057462|FG006|Part D: Re-Treatment Period|Lost to Follow-up|0|||
48786087|NCT01490632|157057463|FG007|Part D: Re-Treatment Period|Lost to Follow-up|0|||
48786088|NCT01490632|157057464|FG008|Part D: Re-Treatment Period|Lost to Follow-up|0|||
48786089|NCT01490632|157057465|FG009|Part D: Re-Treatment Period|Lost to Follow-up|0|||
48786090|NCT01490632|157057466|FG010|Part D: Re-Treatment Period|Lost to Follow-up|0|||
48786091|NCT01490632|157057467|FG011|Part D: Re-Treatment Period|Lost to Follow-up|0|||
48786092|NCT01490632|157057468|FG012|Part D: Re-Treatment Period|Lost to Follow-up|0|||
48786093|NCT01490632|157057469|FG013|Part D: Re-Treatment Period|Lost to Follow-up|0|||
48786094|NCT01490632|157057470|FG014|Part D: Re-Treatment Period|Lost to Follow-up|0|||
48786095|NCT01490632|157057471|FG015|Part D: Re-Treatment Period|Lost to Follow-up|0|||
48786096|NCT01490632|157057472|FG016|Part D: Re-Treatment Period|Lost to Follow-up|0|||
48786097|NCT01490632|157057473|FG017|Part D: Re-Treatment Period|Lost to Follow-up|0|||
48786098|NCT01490632|157057474|FG018|Part D: Re-Treatment Period|Lost to Follow-up|1|||
48786099|NCT01490632|157057475|FG019|Part D: Re-Treatment Period|Lost to Follow-up|0|||
48786100|NCT01490632|157057456|FG000|Part D: Re-Treatment Period|Physician Decision|0|||
48786101|NCT01490632|157057457|FG001|Part D: Re-Treatment Period|Physician Decision|0|||
48786102|NCT01490632|157057458|FG002|Part D: Re-Treatment Period|Physician Decision|0|||
48786103|NCT01490632|157057459|FG003|Part D: Re-Treatment Period|Physician Decision|0|||
48786104|NCT01490632|157057460|FG004|Part D: Re-Treatment Period|Physician Decision|0|||
48786105|NCT01490632|157057461|FG005|Part D: Re-Treatment Period|Physician Decision|0|||
48786106|NCT01490632|157057462|FG006|Part D: Re-Treatment Period|Physician Decision|0|||
48786107|NCT01490632|157057463|FG007|Part D: Re-Treatment Period|Physician Decision|0|||
48786108|NCT01490632|157057464|FG008|Part D: Re-Treatment Period|Physician Decision|0|||
48786109|NCT01490632|157057465|FG009|Part D: Re-Treatment Period|Physician Decision|0|||
48786110|NCT01490632|157057466|FG010|Part D: Re-Treatment Period|Physician Decision|0|||
48786111|NCT01490632|157057467|FG011|Part D: Re-Treatment Period|Physician Decision|0|||
48786112|NCT01490632|157057468|FG012|Part D: Re-Treatment Period|Physician Decision|0|||
48786113|NCT01490632|157057469|FG013|Part D: Re-Treatment Period|Physician Decision|0|||
48786114|NCT01490632|157057470|FG014|Part D: Re-Treatment Period|Physician Decision|0|||
48786115|NCT01490632|157057471|FG015|Part D: Re-Treatment Period|Physician Decision|0|||
48786116|NCT01490632|157057472|FG016|Part D: Re-Treatment Period|Physician Decision|0|||
48786117|NCT01490632|157057473|FG017|Part D: Re-Treatment Period|Physician Decision|0|||
48786118|NCT01490632|157057474|FG018|Part D: Re-Treatment Period|Physician Decision|1|||
48786119|NCT01490632|157057475|FG019|Part D: Re-Treatment Period|Physician Decision|1|||
48786120|NCT01490632|157057456|FG000|Part D: Re-Treatment Period|Protocol Violation|0|||
48786121|NCT01490632|157057457|FG001|Part D: Re-Treatment Period|Protocol Violation|0|||
48786122|NCT01490632|157057458|FG002|Part D: Re-Treatment Period|Protocol Violation|0|||
48786123|NCT01490632|157057459|FG003|Part D: Re-Treatment Period|Protocol Violation|0|||
48786124|NCT01490632|157057460|FG004|Part D: Re-Treatment Period|Protocol Violation|0|||
48786125|NCT01490632|157057461|FG005|Part D: Re-Treatment Period|Protocol Violation|0|||
48786126|NCT01490632|157057462|FG006|Part D: Re-Treatment Period|Protocol Violation|0|||
48786127|NCT01490632|157057463|FG007|Part D: Re-Treatment Period|Protocol Violation|0|||
48786128|NCT01490632|157057464|FG008|Part D: Re-Treatment Period|Protocol Violation|0|||
48786129|NCT01490632|157057465|FG009|Part D: Re-Treatment Period|Protocol Violation|0|||
48786130|NCT01490632|157057466|FG010|Part D: Re-Treatment Period|Protocol Violation|0|||
48786131|NCT01490632|157057467|FG011|Part D: Re-Treatment Period|Protocol Violation|0|||
48786132|NCT01490632|157057468|FG012|Part D: Re-Treatment Period|Protocol Violation|0|||
48786133|NCT01490632|157057469|FG013|Part D: Re-Treatment Period|Protocol Violation|0|||
48786134|NCT01490632|157057470|FG014|Part D: Re-Treatment Period|Protocol Violation|0|||
48786135|NCT01490632|157057471|FG015|Part D: Re-Treatment Period|Protocol Violation|0|||
48786136|NCT01490632|157057472|FG016|Part D: Re-Treatment Period|Protocol Violation|0|||
48786137|NCT01490632|157057473|FG017|Part D: Re-Treatment Period|Protocol Violation|0|||
48786138|NCT01490632|157057474|FG018|Part D: Re-Treatment Period|Protocol Violation|1|||
48786139|NCT01490632|157057475|FG019|Part D: Re-Treatment Period|Protocol Violation|0|||
48786140|NCT01490632|157057456|FG000|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
48786141|NCT01490632|157057457|FG001|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
48786142|NCT01490632|157057458|FG002|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
48786143|NCT01490632|157057459|FG003|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
48786144|NCT01490632|157057460|FG004|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
48786145|NCT01490632|157057461|FG005|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
48786146|NCT01490632|157057462|FG006|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
48786147|NCT01490632|157057463|FG007|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
48786148|NCT01490632|157057464|FG008|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
48786149|NCT01490632|157057465|FG009|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
48786150|NCT01490632|157057466|FG010|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
48786151|NCT01490632|157057467|FG011|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
48786152|NCT01490632|157057468|FG012|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
48786153|NCT01490632|157057469|FG013|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
48786154|NCT01490632|157057470|FG014|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
49031715|NCT01921062|157953428|FG000|Overall Study|Protocol Violation|0|||
49031716|NCT01921062|157953429|FG001|Overall Study|Protocol Violation|1|||
49031717|NCT01921062|157953428|FG000|Overall Study|VMIQ score > 72|4|||
48786155|NCT01490632|157057471|FG015|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
48786156|NCT01490632|157057472|FG016|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
48786157|NCT01490632|157057473|FG017|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
48786158|NCT01490632|157057474|FG018|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
48786159|NCT01490632|157057475|FG019|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
48786160|NCT00673049|157057476|FG000|Before Progression on Erlotinib|Randomized but not treated|3|||
48786161|NCT00673049|157057477|FG001|Before Progression on Erlotinib|Randomized but not treated|1|||
48786162|NCT00673049|157057478|FG002|Before Progression on Erlotinib|Randomized but not treated|0|||
48786163|NCT00673049|157057479|FG003|Before Progression on Erlotinib|Randomized but not treated|0|||
48786164|NCT00673049|157057476|FG000|Before Progression on Erlotinib|Death|235|||
48786165|NCT00673049|157057477|FG001|Before Progression on Erlotinib|Death|167|||
48786166|NCT00673049|157057478|FG002|Before Progression on Erlotinib|Death|1|||
48786167|NCT00673049|157057479|FG003|Before Progression on Erlotinib|Death|0|||
48786168|NCT00673049|157057476|FG000|Before Progression on Erlotinib|Lost to Follow-up|9|||
48786169|NCT00673049|157057477|FG001|Before Progression on Erlotinib|Lost to Follow-up|5|||
48786170|NCT00673049|157057478|FG002|Before Progression on Erlotinib|Lost to Follow-up|0|||
48786171|NCT00673049|157057479|FG003|Before Progression on Erlotinib|Lost to Follow-up|0|||
48786172|NCT00673049|157057476|FG000|Before Progression on Erlotinib|Withdrawal by Subject|26|||
48786173|NCT00673049|157057477|FG001|Before Progression on Erlotinib|Withdrawal by Subject|18|||
48786174|NCT00673049|157057478|FG002|Before Progression on Erlotinib|Withdrawal by Subject|0|||
48786175|NCT00673049|157057479|FG003|Before Progression on Erlotinib|Withdrawal by Subject|0|||
48786176|NCT00673049|157057476|FG000|Before Progression on Erlotinib|Other|1|||
48786177|NCT00673049|157057477|FG001|Before Progression on Erlotinib|Other|2|||
48786178|NCT00673049|157057478|FG002|Before Progression on Erlotinib|Other|0|||
48786179|NCT00673049|157057479|FG003|Before Progression on Erlotinib|Other|0|||
48786180|NCT00673049|157057476|FG000|Before Progression on Erlotinib|study terminated by sponsor|18|||
48786181|NCT00673049|157057477|FG001|Before Progression on Erlotinib|study terminated by sponsor|14|||
48786182|NCT00673049|157057478|FG002|Before Progression on Erlotinib|study terminated by sponsor|0|||
48786183|NCT00673049|157057479|FG003|Before Progression on Erlotinib|study terminated by sponsor|0|||
48786184|NCT00673049|157057476|FG000|Before Progression on Erlotinib|Switched to figitumumab|0|||
49031718|NCT01921062|157953429|FG001|Overall Study|VMIQ score > 72|1|||
49031719|NCT01921062|157953428|FG000|Overall Study|Logistic error|0|||
48786185|NCT00673049|157057477|FG001|Before Progression on Erlotinib|Switched to figitumumab|83|||
48786186|NCT00673049|157057478|FG002|Before Progression on Erlotinib|Switched to figitumumab|0|||
48786187|NCT00673049|157057479|FG003|Before Progression on Erlotinib|Switched to figitumumab|0|||
48786188|NCT00673049|157057476|FG000|After Progression on Erlotinib|Death|0|||
48786189|NCT00673049|157057477|FG001|After Progression on Erlotinib|Death|0|||
48786190|NCT00673049|157057478|FG002|After Progression on Erlotinib|Death|0|||
48786191|NCT00673049|157057479|FG003|After Progression on Erlotinib|Death|71|||
48786192|NCT00673049|157057476|FG000|After Progression on Erlotinib|Lost to Follow-up|0|||
48786193|NCT00673049|157057477|FG001|After Progression on Erlotinib|Lost to Follow-up|0|||
48786194|NCT00673049|157057478|FG002|After Progression on Erlotinib|Lost to Follow-up|0|||
48786195|NCT00673049|157057479|FG003|After Progression on Erlotinib|Lost to Follow-up|3|||
48786196|NCT00673049|157057476|FG000|After Progression on Erlotinib|Withdrawal by Subject|0|||
48786197|NCT00673049|157057477|FG001|After Progression on Erlotinib|Withdrawal by Subject|0|||
48786198|NCT00673049|157057478|FG002|After Progression on Erlotinib|Withdrawal by Subject|0|||
48786199|NCT00673049|157057479|FG003|After Progression on Erlotinib|Withdrawal by Subject|5|||
48786200|NCT00673049|157057476|FG000|After Progression on Erlotinib|study terminated by sponsor|0|||
48786201|NCT00673049|157057477|FG001|After Progression on Erlotinib|study terminated by sponsor|0|||
48786202|NCT00673049|157057478|FG002|After Progression on Erlotinib|study terminated by sponsor|0|||
48786203|NCT00673049|157057479|FG003|After Progression on Erlotinib|study terminated by sponsor|4|||
48786204|NCT04837482|157057480|FG000|Period 2|Withdrawal by Subject|0|||
48786205|NCT04837482|157057481|FG001|Period 2|Withdrawal by Subject|1|||
48786206|NCT01197950|157057490|FG000|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
48786207|NCT01197950|157057491|FG001|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
48797715|NCT00293267|157097059|FG000|Primary Study - Double-Blind Week 0-48|Death|3|||
48786208|NCT01197950|157057492|FG002|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|18|||
48786209|NCT01793792|157057503|FG000|Overall Study|Death|5|||
48786210|NCT01793792|157057503|FG000|Overall Study|Lost to Follow-up|5|||
48786211|NCT01793792|157057503|FG000|Overall Study|Withdrawal by Subject|1|||
48786212|NCT01793792|157057503|FG000|Overall Study|Device Not Implanted|1|||
48786213|NCT01248884|157057504|FG000|Overall Study|Withdrawal by Subject|1|||
49031720|NCT01921062|157953429|FG001|Overall Study|Logistic error|1|||
49031721|NCT03686033|157953434|FG000|Treatment Period 2 (1 Day)|Adverse Event|0|||
49031722|NCT03686033|157953435|FG001|Treatment Period 2 (1 Day)|Adverse Event|0|||
49031723|NCT03686033|157953436|FG002|Treatment Period 2 (1 Day)|Adverse Event|0|||
49031724|NCT03686033|157953437|FG003|Treatment Period 2 (1 Day)|Adverse Event|0|||
49031725|NCT03686033|157953438|FG004|Treatment Period 2 (1 Day)|Adverse Event|1|||
49031726|NCT03686033|157953439|FG005|Treatment Period 2 (1 Day)|Adverse Event|0|||
49031727|NCT01045161|157953440|FG000|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8|||
48786214|NCT01248884|157057505|FG001|Overall Study|Withdrawal by Subject|3|||
48786215|NCT01248884|157057506|FG002|Overall Study|Withdrawal by Subject|1|||
48786216|NCT01248884|157057504|FG000|Overall Study|Adverse Event|1|||
48786217|NCT01248884|157057505|FG001|Overall Study|Adverse Event|0|||
48786218|NCT01248884|157057506|FG002|Overall Study|Adverse Event|0|||
48786219|NCT04479618|157057507|FG000|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
48786220|NCT04479618|157057508|FG001|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|0|||
48786221|NCT04479618|157057509|FG002|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
48786222|NCT04479618|157057507|FG000|Overall Study|Lack of Efficacy|1|||
48786223|NCT04479618|157057508|FG001|Overall Study|Lack of Efficacy|0|||
48786224|NCT04479618|157057509|FG002|Overall Study|Lack of Efficacy|0|||
48786225|NCT04479618|157057507|FG000|Overall Study|No reliable phone and unable to come in weekly|0|||
48786226|NCT04479618|157057508|FG001|Overall Study|No reliable phone and unable to come in weekly|1|||
48786227|NCT04479618|157057509|FG002|Overall Study|No reliable phone and unable to come in weekly|1|||
48786228|NCT04479618|157057507|FG000|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
48786229|NCT04479618|157057508|FG001|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
48786230|NCT04479618|157057509|FG002|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|1|||
48786231|NCT04479618|157057507|FG000|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
48786232|NCT04479618|157057508|FG001|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
48786233|NCT04479618|157057509|FG002|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|1|||
48786234|NCT04479618|157057507|FG000|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
48786235|NCT04479618|157057508|FG001|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
48786236|NCT04479618|157057509|FG002|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|1|||
48786237|NCT04969250|157057515|FG000|Overall Study|Protocol Violation|0|||
48786238|NCT04969250|157057516|FG001|Overall Study|Protocol Violation|2|||
48786239|NCT04969250|157057517|FG002|Overall Study|Protocol Violation|3|||
48786240|NCT04969250|157057518|FG003|Overall Study|Protocol Violation|8|||
48786241|NCT04969250|157057515|FG000|Overall Study|Withdrawal by Subject|0|||
48786242|NCT04969250|157057516|FG001|Overall Study|Withdrawal by Subject|1|||
49031728|NCT01045161|157953441|FG001|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12|||
49031729|NCT01045161|157953442|FG002|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6|||
49031730|NCT01045161|157953440|FG000|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4|||
49031731|NCT01045161|157953441|FG001|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3|||
49031732|NCT01045161|157953442|FG002|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8|||
48786243|NCT04969250|157057517|FG002|Overall Study|Withdrawal by Subject|0|||
49031733|NCT01045161|157953440|FG000|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6|||
49031734|NCT01045161|157953441|FG001|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3|||
49031735|NCT01045161|157953442|FG002|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2|||
49031736|NCT01045161|157953440|FG000|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4|||
49031737|NCT01045161|157953441|FG001|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1|||
49031738|NCT01045161|157953442|FG002|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6|||
49031739|NCT01045161|157953440|FG000|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
49031740|NCT01045161|157953441|FG001|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
49031741|NCT01045161|157953442|FG002|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
49031742|NCT01045161|157953440|FG000|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
49031743|NCT01045161|157953441|FG001|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4|||
49031744|NCT01045161|157953442|FG002|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
49031745|NCT01045161|157953440|FG000|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
49031746|NCT01045161|157953441|FG001|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
49031747|NCT01045161|157953442|FG002|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2|||
48786244|NCT04969250|157057518|FG003|Overall Study|Withdrawal by Subject|0|||
48786245|NCT03647501|157057519|FG000|Overall Study|Lost to Follow-up|1|||
48786246|NCT03647501|157057520|FG001|Overall Study|Lost to Follow-up|1|||
48786247|NCT03647501|157057519|FG000|Overall Study|Withdrawal by Subject|0|||
48786248|NCT03647501|157057520|FG001|Overall Study|Withdrawal by Subject|1|||
48786249|NCT02079805|157057521|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
48786250|NCT02079805|157057522|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
48786251|NCT02079805|157057521|FG000|Overall Study|Voluntary Withdrawal|0|||
48786252|NCT02079805|157057522|FG001|Overall Study|Voluntary Withdrawal|1|||
48786253|NCT03447769|157057523|FG000|Overall Study|Progressive disease|138|||
48786254|NCT03447769|157057524|FG001|Overall Study|Progressive disease|148|||
48786255|NCT03447769|157057523|FG000|Overall Study|Study terminated by Sponsor|60|||
48786256|NCT03447769|157057524|FG001|Overall Study|Study terminated by Sponsor|44|||
48786257|NCT03447769|157057523|FG000|Overall Study|Adverse Event|34|||
48786258|NCT03447769|157057524|FG001|Overall Study|Adverse Event|31|||
48786259|NCT03447769|157057523|FG000|Overall Study|Patient decision|27|||
48786260|NCT03447769|157057524|FG001|Overall Study|Patient decision|27|||
48786261|NCT03447769|157057523|FG000|Overall Study|Protocol deviation|4|||
48786262|NCT03447769|157057524|FG001|Overall Study|Protocol deviation|6|||
48786263|NCT03447769|157057523|FG000|Overall Study|Death|2|||
48786264|NCT03447769|157057524|FG001|Overall Study|Death|7|||
48786265|NCT03447769|157057523|FG000|Overall Study|Technical problems|1|||
48786266|NCT03447769|157057524|FG001|Overall Study|Technical problems|0|||
48786267|NCT03447769|157057523|FG000|Overall Study|Lost to Follow-up|0|||
48786268|NCT03447769|157057524|FG001|Overall Study|Lost to Follow-up|1|||
48786269|NCT03447769|157057523|FG000|Overall Study|Physician Decision|13|||
48786270|NCT03447769|157057524|FG001|Overall Study|Physician Decision|5|||
48786271|NCT03759873|157057526|FG000|Overall Study|Not appropriate for cardiac rehab|4|||
48786272|NCT03759873|157057527|FG001|Overall Study|Not appropriate for cardiac rehab|4|||
48786273|NCT03759873|157057528|FG002|Overall Study|Not appropriate for cardiac rehab|4|||
48786274|NCT03759873|157057529|FG003|Overall Study|Not appropriate for cardiac rehab|2|||
48786275|NCT03759873|157057526|FG000|Overall Study|Moved outside eligible area|0|||
49031748|NCT01045161|157953440|FG000|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10|||
49031749|NCT01045161|157953441|FG001|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7|||
49031750|NCT01045161|157953442|FG002|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9|||
49031751|NCT01045161|157953440|FG000|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
49031752|NCT01045161|157953441|FG001|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
49031753|NCT01045161|157953442|FG002|Part B - 40 Additional Weeks Open Label|Adverse Event|7|||
49031754|NCT01045161|157953440|FG000|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3|||
49031755|NCT01045161|157953441|FG001|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
49031756|NCT01045161|157953442|FG002|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
49031757|NCT01045161|157953440|FG000|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
49031758|NCT01045161|157953441|FG001|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5|||
49031759|NCT01045161|157953442|FG002|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
49031760|NCT01045161|157953440|FG000|Part B - 40 Additional Weeks Open Label|Other Reason|4|||
49031761|NCT01045161|157953441|FG001|Part B - 40 Additional Weeks Open Label|Other Reason|2|||
49031762|NCT01045161|157953442|FG002|Part B - 40 Additional Weeks Open Label|Other Reason|1|||
49031763|NCT01045161|157953440|FG000|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
49031764|NCT01045161|157953441|FG001|Part B - 40 Additional Weeks Open Label|Protocol Violation|6|||
49031765|NCT01045161|157953442|FG002|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
49031766|NCT01045161|157953440|FG000|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5|||
49031767|NCT01045161|157953441|FG001|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1|||
49031768|NCT01045161|157953442|FG002|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6|||
49031769|NCT01911676|157953445|FG000|Period 1 of Study|Withdrawal by Subject|4|||
49031770|NCT01911676|157953446|FG001|Period 1 of Study|Withdrawal by Subject|2|||
49031771|NCT01911676|157953447|FG002|Period 1 of Study|Withdrawal by Subject|1|||
48786276|NCT03759873|157057527|FG001|Overall Study|Moved outside eligible area|2|||
48786277|NCT03759873|157057528|FG002|Overall Study|Moved outside eligible area|0|||
48786278|NCT03759873|157057529|FG003|Overall Study|Moved outside eligible area|0|||
48786279|NCT03759873|157057526|FG000|Overall Study|Withdrawal by Subject|0|||
49031772|NCT01911676|157953448|FG003|Period 1 of Study|Withdrawal by Subject|2|||
49031773|NCT01911676|157953445|FG000|Period 1 of Study|Physician Decision|2|||
49031774|NCT01911676|157953446|FG001|Period 1 of Study|Physician Decision|0|||
49031775|NCT01911676|157953447|FG002|Period 1 of Study|Physician Decision|0|||
48786280|NCT03759873|157057527|FG001|Overall Study|Withdrawal by Subject|0|||
48786281|NCT03759873|157057528|FG002|Overall Study|Withdrawal by Subject|1|||
48786282|NCT03759873|157057529|FG003|Overall Study|Withdrawal by Subject|0|||
48786283|NCT03579563|157057530|FG000|Overall Study|Lost to Follow-up|0|||
48786284|NCT03579563|157057531|FG001|Overall Study|Lost to Follow-up|0|||
48786285|NCT03579563|157057532|FG002|Overall Study|Lost to Follow-up|0|||
48786286|NCT03579563|157057533|FG003|Overall Study|Lost to Follow-up|0|||
48786287|NCT03579563|157057534|FG004|Overall Study|Lost to Follow-up|1|||
48786288|NCT03579563|157057535|FG005|Overall Study|Lost to Follow-up|0|||
48786289|NCT03579563|157057530|FG000|Overall Study|Lack of Efficacy|1|||
48786290|NCT03579563|157057531|FG001|Overall Study|Lack of Efficacy|1|||
48786291|NCT03579563|157057532|FG002|Overall Study|Lack of Efficacy|4|||
48786292|NCT03579563|157057533|FG003|Overall Study|Lack of Efficacy|1|||
48786293|NCT03579563|157057534|FG004|Overall Study|Lack of Efficacy|2|||
48786294|NCT03579563|157057535|FG005|Overall Study|Lack of Efficacy|3|||
48786295|NCT03579563|157057530|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
48786296|NCT03579563|157057531|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
48786297|NCT03579563|157057532|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
48786298|NCT03579563|157057533|FG003|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
48786299|NCT03579563|157057534|FG004|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
48786300|NCT03579563|157057535|FG005|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
48786301|NCT03579563|157057530|FG000|Overall Study|Time/distance concern|0|||
48786302|NCT03579563|157057531|FG001|Overall Study|Time/distance concern|0|||
48786303|NCT03579563|157057532|FG002|Overall Study|Time/distance concern|1|||
48786304|NCT03579563|157057533|FG003|Overall Study|Time/distance concern|0|||
48786305|NCT03579563|157057534|FG004|Overall Study|Time/distance concern|0|||
48786306|NCT03579563|157057535|FG005|Overall Study|Time/distance concern|1|||
48786307|NCT03579563|157057530|FG000|Overall Study|COVID shutdown|2|||
48786308|NCT03579563|157057531|FG001|Overall Study|COVID shutdown|3|||
48786309|NCT03579563|157057532|FG002|Overall Study|COVID shutdown|4|||
48786310|NCT03579563|157057533|FG003|Overall Study|COVID shutdown|3|||
48786311|NCT03579563|157057534|FG004|Overall Study|COVID shutdown|1|||
48786312|NCT03579563|157057535|FG005|Overall Study|COVID shutdown|2|||
48786313|NCT03579563|157057530|FG000|Overall Study|Protocol administration error|1|||
48786314|NCT03579563|157057531|FG001|Overall Study|Protocol administration error|0|||
48786315|NCT03579563|157057532|FG002|Overall Study|Protocol administration error|1|||
48786316|NCT03579563|157057533|FG003|Overall Study|Protocol administration error|0|||
48786317|NCT03579563|157057534|FG004|Overall Study|Protocol administration error|1|||
48786318|NCT03579563|157057535|FG005|Overall Study|Protocol administration error|5|||
48786319|NCT04139317|157057536|FG000|Overall Study|Adverse Event|10|||
48786320|NCT04139317|157057537|FG001|Overall Study|Adverse Event|2|||
48786321|NCT04139317|157057536|FG000|Overall Study|Death|6|||
48786322|NCT04139317|157057537|FG001|Overall Study|Death|4|||
48786323|NCT04139317|157057536|FG000|Overall Study|Lost to Follow-up|1|||
48786324|NCT04139317|157057537|FG001|Overall Study|Lost to Follow-up|0|||
48786325|NCT04139317|157057536|FG000|Overall Study|Physician Decision|3|||
48786326|NCT04139317|157057537|FG001|Overall Study|Physician Decision|1|||
48786327|NCT04139317|157057536|FG000|Overall Study|Progressive Disease|19|||
48786328|NCT04139317|157057537|FG001|Overall Study|Progressive Disease|9|||
48786329|NCT04139317|157057536|FG000|Overall Study|Subject Decision|2|||
48786330|NCT04139317|157057537|FG001|Overall Study|Subject Decision|2|||
48786331|NCT00511004|157057538|FG000|Overall Study|Lost to Follow-up|0|||
48786332|NCT00511004|157057539|FG001|Overall Study|Lost to Follow-up|0|||
48786333|NCT00511004|157057540|FG002|Overall Study|Lost to Follow-up|4|||
48786334|NCT01568047|157057541|FG000|Overall Study|Ineligibility|1|||
48786335|NCT01568047|157057542|FG001|Overall Study|Ineligibility|0|||
48786336|NCT01568047|157057543|FG002|Overall Study|Ineligibility|0|||
48786337|NCT01568047|157057544|FG003|Overall Study|Ineligibility|0|||
48786338|NCT01568047|157057541|FG000|Overall Study|Withdrawal by Subject|0|||
48786339|NCT01568047|157057542|FG001|Overall Study|Withdrawal by Subject|1|||
48786340|NCT01568047|157057543|FG002|Overall Study|Withdrawal by Subject|0|||
48786341|NCT01568047|157057544|FG003|Overall Study|Withdrawal by Subject|0|||
48786342|NCT01568047|157057541|FG000|Overall Study|Adverse Event|0|||
48786343|NCT01568047|157057542|FG001|Overall Study|Adverse Event|0|||
48786344|NCT01568047|157057543|FG002|Overall Study|Adverse Event|1|||
48786345|NCT01568047|157057544|FG003|Overall Study|Adverse Event|1|||
48786346|NCT02043782|157057545|FG000|Period 1|Adverse Event|0|||
48786347|NCT02043782|157057546|FG001|Period 1|Adverse Event|0|||
48786348|NCT02043782|157057547|FG002|Period 1|Adverse Event|1|||
48786349|NCT02043782|157057548|FG003|Period 1|Adverse Event|0|||
48786350|NCT02043782|157057549|FG004|Period 1|Adverse Event|0|||
48786351|NCT02043782|157057550|FG005|Period 1|Adverse Event|0|||
48786352|NCT04818346|157057551|FG000|24-Week Placebo-controlled Period|Adverse Event|1|||
48786353|NCT04818346|157057552|FG001|24-Week Placebo-controlled Period|Adverse Event|2|||
48786354|NCT04818346|157057553|FG002|24-Week Placebo-controlled Period|Adverse Event|0|||
48786355|NCT04818346|157057554|FG003|24-Week Placebo-controlled Period|Adverse Event|3|||
48786356|NCT04818346|157057551|FG000|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
48786357|NCT04818346|157057552|FG001|24-Week Placebo-controlled Period|Lost to Follow-up|2|||
48786358|NCT04818346|157057553|FG002|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
48786359|NCT04818346|157057554|FG003|24-Week Placebo-controlled Period|Lost to Follow-up|1|||
48786360|NCT04818346|157057551|FG000|24-Week Placebo-controlled Period|Physician Decision|1|||
48786361|NCT04818346|157057552|FG001|24-Week Placebo-controlled Period|Physician Decision|0|||
48786362|NCT04818346|157057553|FG002|24-Week Placebo-controlled Period|Physician Decision|0|||
48786363|NCT04818346|157057554|FG003|24-Week Placebo-controlled Period|Physician Decision|0|||
48786364|NCT04818346|157057551|FG000|24-Week Placebo-controlled Period|Protocol Violation|0|||
48786365|NCT04818346|157057552|FG001|24-Week Placebo-controlled Period|Protocol Violation|0|||
48786366|NCT04818346|157057553|FG002|24-Week Placebo-controlled Period|Protocol Violation|1|||
48786367|NCT04818346|157057554|FG003|24-Week Placebo-controlled Period|Protocol Violation|1|||
48786368|NCT04818346|157057551|FG000|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
48786369|NCT04818346|157057552|FG001|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
48786370|NCT04818346|157057553|FG002|24-Week Placebo-controlled Period|Withdrawal by Subject|6|||
48786371|NCT04818346|157057554|FG003|24-Week Placebo-controlled Period|Withdrawal by Subject|2|||
48786372|NCT04818346|157057551|FG000|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|1|||
48786373|NCT04818346|157057552|FG001|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
48786374|NCT04818346|157057553|FG002|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
48786375|NCT04818346|157057554|FG003|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
48786376|NCT04818346|157057551|FG000|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|1|||
48786377|NCT04818346|157057552|FG001|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
48786378|NCT04818346|157057553|FG002|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
48786379|NCT04818346|157057554|FG003|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
48786380|NCT04818346|157057551|FG000|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
48786381|NCT04818346|157057552|FG001|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
48786382|NCT04818346|157057553|FG002|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|1|||
48786383|NCT04818346|157057554|FG003|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
48786384|NCT04818346|157057551|FG000|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
48786385|NCT04818346|157057552|FG001|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
48786386|NCT04818346|157057553|FG002|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
48786387|NCT04818346|157057554|FG003|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|1|||
48786388|NCT04818346|157057551|FG000|28-Week Double-blind Extension Period|Adverse Event|1|||
48786389|NCT04818346|157057552|FG001|28-Week Double-blind Extension Period|Adverse Event|0|||
48786390|NCT04818346|157057553|FG002|28-Week Double-blind Extension Period|Adverse Event|1|||
48786391|NCT04818346|157057554|FG003|28-Week Double-blind Extension Period|Adverse Event|1|||
48786392|NCT04818346|157057551|FG000|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
48786393|NCT04818346|157057552|FG001|28-Week Double-blind Extension Period|Lost to Follow-up|2|||
48786394|NCT04818346|157057553|FG002|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
48786395|NCT04818346|157057554|FG003|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
48786396|NCT04818346|157057551|FG000|28-Week Double-blind Extension Period|Withdrawal by Subject|0|||
48786397|NCT04818346|157057552|FG001|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
48786398|NCT04818346|157057553|FG002|28-Week Double-blind Extension Period|Withdrawal by Subject|4|||
48786399|NCT04818346|157057554|FG003|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
48786400|NCT04818346|157057551|FG000|28-Week Double-blind Extension Period|Non-compliance|0|||
48786401|NCT04818346|157057552|FG001|28-Week Double-blind Extension Period|Non-compliance|1|||
48786402|NCT04818346|157057553|FG002|28-Week Double-blind Extension Period|Non-compliance|0|||
48786403|NCT04818346|157057554|FG003|28-Week Double-blind Extension Period|Non-compliance|0|||
48786404|NCT04818346|157057551|FG000|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
48786405|NCT04818346|157057552|FG001|28-Week Double-blind Extension Period|Non-compliance with Study Drug|1|||
48786406|NCT04818346|157057553|FG002|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
48786407|NCT04818346|157057554|FG003|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
48786408|NCT04818346|157057551|FG000|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
48786409|NCT04818346|157057552|FG001|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
48786410|NCT04818346|157057553|FG002|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
48786411|NCT04818346|157057554|FG003|28-Week Double-blind Extension Period|Scheduling Conflicts|1|||
48786412|NCT01985126|157057559|FG000|Overall Study|Death|15|||
48786413|NCT01985126|157057560|FG001|Overall Study|Death|69|||
48786414|NCT01985126|157057559|FG000|Overall Study|Lost to Follow-up|0|||
48786415|NCT01985126|157057560|FG001|Overall Study|Lost to Follow-up|8|||
48786416|NCT01985126|157057559|FG000|Overall Study|Study Terminated By Sponsor|1|||
48786417|NCT01985126|157057560|FG001|Overall Study|Study Terminated By Sponsor|22|||
48786418|NCT01985126|157057559|FG000|Overall Study|Withdrawal by Subject|2|||
48786419|NCT01985126|157057560|FG001|Overall Study|Withdrawal by Subject|7|||
48786420|NCT01434602|157057561|FG000|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
48786421|NCT01434602|157057562|FG001|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|1|||
48786422|NCT01434602|157057563|FG002|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
48786423|NCT01434602|157057564|FG003|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
48786424|NCT01434602|157057565|FG004|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
48786425|NCT01434602|157057561|FG000|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
48786426|NCT01434602|157057562|FG001|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
48786427|NCT01434602|157057563|FG002|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
48786428|NCT01434602|157057564|FG003|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|1|||
48786429|NCT01434602|157057565|FG004|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
48786430|NCT01434602|157057561|FG000|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
48786431|NCT01434602|157057562|FG001|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
48786432|NCT01434602|157057563|FG002|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
48786433|NCT01434602|157057564|FG003|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|1|||
48786434|NCT01434602|157057565|FG004|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
48786435|NCT01434602|157057561|FG000|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
48786436|NCT01434602|157057562|FG001|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
48786437|NCT01434602|157057563|FG002|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
48786438|NCT01434602|157057564|FG003|Phase II Recommended Phase 2 Dose|Started new therapy|1|||
48786439|NCT01434602|157057565|FG004|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
48786440|NCT01434602|157057561|FG000|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
48786441|NCT01434602|157057562|FG001|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
48786442|NCT01434602|157057563|FG002|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
48786443|NCT01434602|157057564|FG003|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|1|||
48786444|NCT01434602|157057565|FG004|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
48786445|NCT01434602|157057561|FG000|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
48786446|NCT01434602|157057562|FG001|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
48786447|NCT01434602|157057563|FG002|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
48786448|NCT01434602|157057564|FG003|Phase II Recommended Phase 2 Dose|Transfer of care|1|||
48786449|NCT01434602|157057565|FG004|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
48786450|NCT01434602|157057561|FG000|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
48786451|NCT01434602|157057562|FG001|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
48786452|NCT01434602|157057563|FG002|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
48786453|NCT01434602|157057564|FG003|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
48786454|NCT01434602|157057565|FG004|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|1|||
48786455|NCT01434602|157057561|FG000|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
48786456|NCT01434602|157057562|FG001|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
48786457|NCT01434602|157057563|FG002|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
48786458|NCT01434602|157057564|FG003|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
48786459|NCT01434602|157057565|FG004|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
48786460|NCT01434602|157057561|FG000|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
48786461|NCT01434602|157057562|FG001|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
48786462|NCT01434602|157057563|FG002|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
48786463|NCT01434602|157057564|FG003|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|1|||
48786464|NCT01434602|157057565|FG004|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
48786465|NCT01434602|157057561|FG000|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
48786466|NCT01434602|157057562|FG001|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
48786467|NCT01434602|157057563|FG002|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
48786468|NCT01434602|157057564|FG003|Phase II Recommended Phase 2 Dose|Refused further treatment|2|||
48786469|NCT01434602|157057565|FG004|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
48786470|NCT00380068|157057568|FG000|Overall Study|Adverse Event|40|||
48786471|NCT00380068|157057568|FG000|Overall Study|Withdrawal by Subject|10|||
48786472|NCT00380068|157057568|FG000|Overall Study|Not compliant|6|||
48786473|NCT00380068|157057568|FG000|Overall Study|Lost to Follow-up|1|||
48786474|NCT00380068|157057568|FG000|Overall Study|Addition of other PAH therapeutic agent|1|||
48786475|NCT00380068|157057568|FG000|Overall Study|Lung transplant|3|||
48786476|NCT00380068|157057568|FG000|Overall Study|Physician Decision|2|||
48786477|NCT00380068|157057568|FG000|Overall Study|Partipant moved away|1|||
48786478|NCT00380068|157057568|FG000|Overall Study|Lack of Efficacy|5|||
48786479|NCT03301051|157057569|FG000|Overall Study|Adverse Event|0|||
48786480|NCT03301051|157057570|FG001|Overall Study|Adverse Event|4|||
48786481|NCT03301051|157057569|FG000|Overall Study|Withdrawal by Subject|59|||
49031776|NCT01911676|157953448|FG003|Period 1 of Study|Physician Decision|1|||
49031777|NCT01911676|157953445|FG000|Period 2 of Study|Physician Decision|2|||
49031778|NCT01911676|157953446|FG001|Period 2 of Study|Physician Decision|0|||
49031779|NCT01911676|157953447|FG002|Period 2 of Study|Physician Decision|0|||
48786482|NCT03301051|157057570|FG001|Overall Study|Withdrawal by Subject|65|||
48786483|NCT03301051|157057569|FG000|Overall Study|Lost to Follow-up|263|||
48786484|NCT03301051|157057570|FG001|Overall Study|Lost to Follow-up|282|||
48786485|NCT03301051|157057569|FG000|Overall Study|Protocol Violation|1|||
48786486|NCT03301051|157057570|FG001|Overall Study|Protocol Violation|3|||
48786487|NCT03301051|157057569|FG000|Overall Study|Physician Decision|1|||
48786488|NCT03301051|157057570|FG001|Overall Study|Physician Decision|3|||
48786489|NCT03301051|157057569|FG000|Overall Study|Death|1|||
48786490|NCT03301051|157057570|FG001|Overall Study|Death|1|||
48786491|NCT03301051|157057569|FG000|Overall Study|Miscellaneous|8|||
48786492|NCT03301051|157057570|FG001|Overall Study|Miscellaneous|4|||
48786493|NCT03301051|157057569|FG000|Overall Study|Randomized, not vaccinated|13|||
48786494|NCT03301051|157057570|FG001|Overall Study|Randomized, not vaccinated|10|||
48786495|NCT01165281|157057582|FG000|Overall Study|Adverse Event|12|||
48786496|NCT01165281|157057583|FG001|Overall Study|Adverse Event|14|||
48786497|NCT01165281|157057582|FG000|Overall Study|Death|3|||
48786498|NCT01165281|157057583|FG001|Overall Study|Death|4|||
48786499|NCT01165281|157057582|FG000|Overall Study|Lack of Efficacy|4|||
48786500|NCT01165281|157057583|FG001|Overall Study|Lack of Efficacy|1|||
48786501|NCT01165281|157057582|FG000|Overall Study|Lost to Follow-up|0|||
48786502|NCT01165281|157057583|FG001|Overall Study|Lost to Follow-up|1|||
48786503|NCT01165281|157057582|FG000|Overall Study|Physician Decision|8|||
48786504|NCT01165281|157057583|FG001|Overall Study|Physician Decision|1|||
48786505|NCT01165281|157057582|FG000|Overall Study|Protocol Violation|6|||
48786506|NCT01165281|157057583|FG001|Overall Study|Protocol Violation|5|||
48786507|NCT01165281|157057582|FG000|Overall Study|Withdrawal by Subject|8|||
48786508|NCT01165281|157057583|FG001|Overall Study|Withdrawal by Subject|7|||
48786509|NCT01165281|157057582|FG000|Overall Study|Noncompliance with Study Drug|1|||
48786510|NCT01165281|157057583|FG001|Overall Study|Noncompliance with Study Drug|4|||
48786511|NCT01165281|157057582|FG000|Overall Study|Progressive Disease|10|||
48786512|NCT01165281|157057583|FG001|Overall Study|Progressive Disease|14|||
48786513|NCT01165281|157057582|FG000|Overall Study|Other|6|||
48786514|NCT01165281|157057583|FG001|Overall Study|Other|0|||
48786515|NCT00714168|157057584|FG000|Overall Study|Pregnancy|5|||
48786516|NCT00714168|157057585|FG001|Overall Study|Pregnancy|4|||
48786517|NCT00714168|157057584|FG000|Overall Study|Lost to Follow-up|32|||
48786518|NCT00714168|157057585|FG001|Overall Study|Lost to Follow-up|50|||
48786519|NCT00714168|157057584|FG000|Overall Study|Relocation|4|||
48786520|NCT00714168|157057585|FG001|Overall Study|Relocation|3|||
48786521|NCT00714168|157057584|FG000|Overall Study|Non-study medical condition|3|||
48786522|NCT00714168|157057585|FG001|Overall Study|Non-study medical condition|2|||
48786523|NCT04764396|157057591|FG000|Overall Study|Physician Decision|1|||
48786524|NCT04764396|157057592|FG001|Overall Study|Physician Decision|0|||
48786525|NCT01669122|157057594|FG000|Period I|Lost to Follow-up|1|||
48786526|NCT01669122|157057594|FG000|Washout Period II|Protocol Violation|2|||
48786527|NCT02075593|157057596|FG000|Overall Study|Withdrawal by Subject|1|||
48786528|NCT01389973|157057597|FG000|Overall Study|Lost to Follow-up|1|||
48786529|NCT01389973|157057597|FG000|Overall Study|Trial Stopped by Sponsor|9|||
48786530|NCT01389973|157057597|FG000|Overall Study|Other|10|||
48786531|NCT01962493|157057598|FG000|Overall Study|Adverse Event|1|||
48786532|NCT01962493|157057599|FG001|Overall Study|Adverse Event|2|||
48786533|NCT01962493|157057598|FG000|Overall Study|Protocol Violation|0|||
48786534|NCT01962493|157057599|FG001|Overall Study|Protocol Violation|1|||
48786535|NCT01962493|157057598|FG000|Overall Study|Withdrawal by Subject|4|||
48786536|NCT01962493|157057599|FG001|Overall Study|Withdrawal by Subject|2|||
48786537|NCT03776136|157057600|FG000|Overall Study|Death|85|||
48786538|NCT03776136|157057600|FG000|Overall Study|Withdrawal by Subject|3|||
48786539|NCT03776136|157057600|FG000|Overall Study|Sponsor Decision|15|||
48786540|NCT00613951|157057601|FG000|Overall Study|Adverse Event|1|||
48786541|NCT00613951|157057602|FG001|Overall Study|Adverse Event|0|||
48786542|NCT00613951|157057603|FG002|Overall Study|Adverse Event|1|||
48786543|NCT00613951|157057601|FG000|Overall Study|Lack of Efficacy|0|||
48786544|NCT00613951|157057602|FG001|Overall Study|Lack of Efficacy|1|||
48786545|NCT00613951|157057603|FG002|Overall Study|Lack of Efficacy|1|||
48786546|NCT00613951|157057601|FG000|Overall Study|Protocol Violation|1|||
48786547|NCT00613951|157057602|FG001|Overall Study|Protocol Violation|1|||
48786548|NCT00613951|157057603|FG002|Overall Study|Protocol Violation|1|||
48786549|NCT00613951|157057601|FG000|Overall Study|Unclassified|5|||
48786550|NCT00613951|157057602|FG001|Overall Study|Unclassified|3|||
48786551|NCT00613951|157057603|FG002|Overall Study|Unclassified|2|||
48786552|NCT00655980|157057606|FG000|Overall Study|surgery canceled; or subject or anesthes|26|||
48786553|NCT00655980|157057607|FG001|Overall Study|surgery canceled; or subject or anesthes|31|||
48786554|NCT00655980|157057608|FG002|Overall Study|surgery canceled; or subject or anesthes|5|||
48786555|NCT00936390|157057611|FG000|Overall Study|Protocol Violation|21|||
48786556|NCT00936390|157057612|FG001|Overall Study|Protocol Violation|25|||
48786557|NCT04348604|157057613|FG000|Week 8|Withdrawal by Subject|1|||
48786558|NCT04348604|157057614|FG001|Week 8|Withdrawal by Subject|1|||
48786559|NCT04348604|157057613|FG000|Week 8|Lost to Follow-up|1|||
48786560|NCT04348604|157057614|FG001|Week 8|Lost to Follow-up|2|||
48786561|NCT04348604|157057613|FG000|Week 8|Suspended|0|||
48786562|NCT04348604|157057614|FG001|Week 8|Suspended|1|||
48786563|NCT04348604|157057613|FG000|Week 12|Lost to Follow-up|1|||
48786564|NCT04348604|157057614|FG001|Week 12|Lost to Follow-up|2|||
48786565|NCT04348604|157057613|FG000|Week 12|Withdrawal by Subject|1|||
48786566|NCT04348604|157057614|FG001|Week 12|Withdrawal by Subject|0|||
48786567|NCT04348604|157057613|FG000|Week 24|Lost to Follow-up|2|||
48786568|NCT04348604|157057614|FG001|Week 24|Lost to Follow-up|1|||
48786569|NCT02459574|157057615|FG000|Overall Study|Withdrawal by Subject|6|||
48786570|NCT02459574|157057616|FG001|Overall Study|Withdrawal by Subject|6|||
48786571|NCT02459574|157057617|FG002|Overall Study|Withdrawal by Subject|2|||
48786572|NCT02459574|157057615|FG000|Overall Study|Lost to Follow-up|1|||
48786573|NCT02459574|157057616|FG001|Overall Study|Lost to Follow-up|1|||
48786574|NCT02459574|157057617|FG002|Overall Study|Lost to Follow-up|0|||
48786575|NCT02459574|157057615|FG000|Overall Study|Death|0|||
48786576|NCT02459574|157057616|FG001|Overall Study|Death|1|||
48786577|NCT02459574|157057617|FG002|Overall Study|Death|0|||
48786578|NCT05245864|157057618|FG000|Overall Study|Withdrawal by Subject|1|||
48786579|NCT05245864|157057619|FG001|Overall Study|Withdrawal by Subject|1|||
48786580|NCT03690869|157057622|FG000|Overall Study|Adverse Event|0|||
48786581|NCT03690869|157057623|FG001|Overall Study|Adverse Event|0|||
48786582|NCT03690869|157057624|FG002|Overall Study|Adverse Event|0|||
48786583|NCT03690869|157057625|FG003|Overall Study|Adverse Event|1|||
48786584|NCT03690869|157057626|FG004|Overall Study|Adverse Event|0|||
48786585|NCT03690869|157057627|FG005|Overall Study|Adverse Event|0|||
48786586|NCT03690869|157057628|FG006|Overall Study|Adverse Event|0|||
48786587|NCT03690869|157057629|FG007|Overall Study|Adverse Event|1|||
48786588|NCT03690869|157057630|FG008|Overall Study|Adverse Event|0|||
48786589|NCT03690869|157057631|FG009|Overall Study|Adverse Event|1|||
48786590|NCT03690869|157057622|FG000|Overall Study|Death|1|||
48786591|NCT03690869|157057623|FG001|Overall Study|Death|1|||
48786592|NCT03690869|157057624|FG002|Overall Study|Death|1|||
48786593|NCT03690869|157057625|FG003|Overall Study|Death|4|||
48786594|NCT03690869|157057626|FG004|Overall Study|Death|2|||
48786595|NCT03690869|157057627|FG005|Overall Study|Death|5|||
48786596|NCT03690869|157057628|FG006|Overall Study|Death|3|||
48786597|NCT03690869|157057629|FG007|Overall Study|Death|2|||
48786598|NCT03690869|157057630|FG008|Overall Study|Death|0|||
48786599|NCT03690869|157057631|FG009|Overall Study|Death|3|||
48786600|NCT03690869|157057622|FG000|Overall Study|Lost to Follow-up|0|||
48786601|NCT03690869|157057623|FG001|Overall Study|Lost to Follow-up|0|||
48877533|NCT02577003|157390092|FG001|Overall Study|Withdrawal by Subject|1|||
48877534|NCT03210519|157390093|FG000|Overall Study|Adverse Event|2|||
48877535|NCT03210519|157390094|FG001|Overall Study|Adverse Event|0|||
48877536|NCT01657799|157390099|FG000|Overall Study|Adverse Event Related to progression|6|||
48877537|NCT01657799|157390100|FG001|Overall Study|Adverse Event Related to progression|8|||
48877538|NCT01657799|157390101|FG002|Overall Study|Adverse Event Related to progression|12|||
48877539|NCT01657799|157390099|FG000|Overall Study|Adverse Event Not Related to Progression|5|||
48877540|NCT01657799|157390100|FG001|Overall Study|Adverse Event Not Related to Progression|4|||
48877541|NCT01657799|157390101|FG002|Overall Study|Adverse Event Not Related to Progression|4|||
48877542|NCT01657799|157390099|FG000|Overall Study|Withdrawal by Subject|13|||
48877543|NCT01657799|157390100|FG001|Overall Study|Withdrawal by Subject|10|||
48877544|NCT01657799|157390101|FG002|Overall Study|Withdrawal by Subject|10|||
48877545|NCT01657799|157390099|FG000|Overall Study|Lost to Follow-up|1|||
48877546|NCT01657799|157390100|FG001|Overall Study|Lost to Follow-up|0|||
48877547|NCT01657799|157390101|FG002|Overall Study|Lost to Follow-up|1|||
48877548|NCT01657799|157390099|FG000|Overall Study|Disease Progression|2|||
48877549|NCT01657799|157390100|FG001|Overall Study|Disease Progression|4|||
48877550|NCT01657799|157390101|FG002|Overall Study|Disease Progression|4|||
48877551|NCT01657799|157390099|FG000|Overall Study|Progressive Disease Clinical|7|||
48877552|NCT01657799|157390100|FG001|Overall Study|Progressive Disease Clinical|4|||
48877553|NCT01657799|157390101|FG002|Overall Study|Progressive Disease Clinical|7|||
48786602|NCT03690869|157057624|FG002|Overall Study|Lost to Follow-up|1|||
48786603|NCT03690869|157057625|FG003|Overall Study|Lost to Follow-up|0|||
48786604|NCT03690869|157057626|FG004|Overall Study|Lost to Follow-up|0|||
48786605|NCT03690869|157057627|FG005|Overall Study|Lost to Follow-up|0|||
48877554|NCT01657799|157390099|FG000|Overall Study|Radiographic & Clinical Progression|16|||
48877555|NCT01657799|157390100|FG001|Overall Study|Radiographic & Clinical Progression|11|||
48786606|NCT03690869|157057628|FG006|Overall Study|Lost to Follow-up|0|||
48786607|NCT03690869|157057629|FG007|Overall Study|Lost to Follow-up|0|||
48786608|NCT03690869|157057630|FG008|Overall Study|Lost to Follow-up|0|||
48786609|NCT03690869|157057631|FG009|Overall Study|Lost to Follow-up|0|||
48786610|NCT03690869|157057622|FG000|Overall Study|Other Treatment|1|||
48786611|NCT03690869|157057623|FG001|Overall Study|Other Treatment|1|||
48786612|NCT03690869|157057624|FG002|Overall Study|Other Treatment|1|||
48786613|NCT03690869|157057625|FG003|Overall Study|Other Treatment|2|||
48786614|NCT03690869|157057626|FG004|Overall Study|Other Treatment|3|||
48786615|NCT03690869|157057627|FG005|Overall Study|Other Treatment|1|||
48786616|NCT03690869|157057628|FG006|Overall Study|Other Treatment|2|||
48786617|NCT03690869|157057629|FG007|Overall Study|Other Treatment|7|||
48786618|NCT03690869|157057630|FG008|Overall Study|Other Treatment|0|||
48786619|NCT03690869|157057631|FG009|Overall Study|Other Treatment|3|||
48786620|NCT03690869|157057622|FG000|Overall Study|Physician Decision|0|||
48786621|NCT03690869|157057623|FG001|Overall Study|Physician Decision|1|||
48786622|NCT03690869|157057624|FG002|Overall Study|Physician Decision|0|||
48786623|NCT03690869|157057625|FG003|Overall Study|Physician Decision|0|||
48786624|NCT03690869|157057626|FG004|Overall Study|Physician Decision|0|||
48786625|NCT03690869|157057627|FG005|Overall Study|Physician Decision|0|||
48786626|NCT03690869|157057628|FG006|Overall Study|Physician Decision|0|||
48786627|NCT03690869|157057629|FG007|Overall Study|Physician Decision|0|||
48786628|NCT03690869|157057630|FG008|Overall Study|Physician Decision|0|||
48786629|NCT03690869|157057631|FG009|Overall Study|Physician Decision|0|||
48786630|NCT03690869|157057622|FG000|Overall Study|Progressive Disease|1|||
48786631|NCT03690869|157057623|FG001|Overall Study|Progressive Disease|2|||
48786632|NCT03690869|157057624|FG002|Overall Study|Progressive Disease|0|||
48786633|NCT03690869|157057625|FG003|Overall Study|Progressive Disease|1|||
48786634|NCT03690869|157057626|FG004|Overall Study|Progressive Disease|0|||
48786635|NCT03690869|157057627|FG005|Overall Study|Progressive Disease|0|||
48786636|NCT03690869|157057628|FG006|Overall Study|Progressive Disease|0|||
48786637|NCT03690869|157057629|FG007|Overall Study|Progressive Disease|0|||
48786638|NCT03690869|157057630|FG008|Overall Study|Progressive Disease|1|||
48786639|NCT03690869|157057631|FG009|Overall Study|Progressive Disease|1|||
48786640|NCT03690869|157057622|FG000|Overall Study|Subject Decision|0|||
48786641|NCT03690869|157057623|FG001|Overall Study|Subject Decision|0|||
48786642|NCT03690869|157057624|FG002|Overall Study|Subject Decision|0|||
48786643|NCT03690869|157057625|FG003|Overall Study|Subject Decision|1|||
48786644|NCT03690869|157057626|FG004|Overall Study|Subject Decision|0|||
48786645|NCT03690869|157057627|FG005|Overall Study|Subject Decision|0|||
48786646|NCT03690869|157057628|FG006|Overall Study|Subject Decision|0|||
48786647|NCT03690869|157057629|FG007|Overall Study|Subject Decision|1|||
48786648|NCT03690869|157057630|FG008|Overall Study|Subject Decision|0|||
48786649|NCT03690869|157057631|FG009|Overall Study|Subject Decision|0|||
48786650|NCT03870763|157059012|FG000|Overall Study|Study terminated by sponsor|0|||
48786651|NCT03870763|157059013|FG001|Overall Study|Study terminated by sponsor|2|||
48786652|NCT03870763|157059014|FG002|Overall Study|Study terminated by sponsor|0|||
48786653|NCT03870763|157059012|FG000|Overall Study|Withdrawal by Subject|0|||
48786654|NCT03870763|157059013|FG001|Overall Study|Withdrawal by Subject|1|||
48786655|NCT03870763|157059014|FG002|Overall Study|Withdrawal by Subject|0|||
48786656|NCT03870763|157059012|FG000|Overall Study|Worsening of multiple sclerosis attack|0|||
48786657|NCT03870763|157059013|FG001|Overall Study|Worsening of multiple sclerosis attack|0|||
48786658|NCT03870763|157059014|FG002|Overall Study|Worsening of multiple sclerosis attack|1|||
48786659|NCT03521635|157059017|FG000|Overall Study|Adverse Event|1|||
48786660|NCT03521635|157059018|FG001|Overall Study|Adverse Event|1|||
48786661|NCT03521635|157059017|FG000|Overall Study|Refused to complete study visit|1|||
48786662|NCT03521635|157059018|FG001|Overall Study|Refused to complete study visit|0|||
48786663|NCT03521635|157059017|FG000|Overall Study|Refused to continue trial medication|2|||
48786664|NCT03521635|157059018|FG001|Overall Study|Refused to continue trial medication|2|||
48786665|NCT03521635|157059017|FG000|Overall Study|Lost to Follow-up|0|||
48786666|NCT03521635|157059018|FG001|Overall Study|Lost to Follow-up|1|||
48786667|NCT03521635|157059017|FG000|Overall Study|Meet exclusion criteria|0|||
48786668|NCT03521635|157059018|FG001|Overall Study|Meet exclusion criteria|1|||
48786669|NCT03521635|157059017|FG000|Overall Study|Patient not taken study medicine|0|||
48786670|NCT03521635|157059018|FG001|Overall Study|Patient not taken study medicine|1|||
48786671|NCT03727750|157059021|FG000|Overall Study|Death|45|||
48786672|NCT03727750|157059021|FG000|Overall Study|Withdrawal by Subject|2|||
48786673|NCT03727750|157059021|FG000|Overall Study|Lost to Follow-up|1|||
48786674|NCT03727750|157059021|FG000|Overall Study|Other|1|||
48786675|NCT02099838|157059022|FG000|Overall Study|Death|1|||
48786676|NCT02099838|157059023|FG001|Overall Study|Death|0|||
48786677|NCT02099838|157059022|FG000|Overall Study|Lost to Follow-up|3|||
48786678|NCT02099838|157059023|FG001|Overall Study|Lost to Follow-up|1|||
48786679|NCT02099838|157059022|FG000|Overall Study|Withdrawal by Subject|0|||
48786680|NCT02099838|157059023|FG001|Overall Study|Withdrawal by Subject|1|||
48786681|NCT01227889|157059024|FG000|Randomized Phase (RP)|Adverse Event|13|||
48786682|NCT01227889|157059025|FG001|Randomized Phase (RP)|Adverse Event|0|||
48786683|NCT01227889|157059024|FG000|Randomized Phase (RP)|Physician Decision|13|||
48786684|NCT01227889|157059025|FG001|Randomized Phase (RP)|Physician Decision|5|||
48786685|NCT01227889|157059024|FG000|Randomized Phase (RP)|Progressive Disease|135|||
48786686|NCT01227889|157059025|FG001|Randomized Phase (RP)|Progressive Disease|52|||
48786687|NCT01227889|157059024|FG000|Randomized Phase (RP)|Study terminated by sponsor|10|||
48786688|NCT01227889|157059025|FG001|Randomized Phase (RP)|Study terminated by sponsor|0|||
48786689|NCT01227889|157059024|FG000|Randomized Phase (RP)|Missing|1|||
48786690|NCT01227889|157059025|FG001|Randomized Phase (RP)|Missing|3|||
48786691|NCT01227889|157059024|FG000|Randomized Phase (RP)|Withdrawal by Subject|15|||
48786692|NCT01227889|157059025|FG001|Randomized Phase (RP)|Withdrawal by Subject|3|||
48786693|NCT01227889|157059024|FG000|Crossover Phase|Adverse Event|0|||
48786694|NCT01227889|157059025|FG001|Crossover Phase|Adverse Event|1|||
48786695|NCT01227889|157059024|FG000|Crossover Phase|Physician Decision|0|||
48786696|NCT01227889|157059025|FG001|Crossover Phase|Physician Decision|3|||
48786697|NCT01227889|157059024|FG000|Crossover Phase|Progressive Disease|0|||
48786698|NCT01227889|157059025|FG001|Crossover Phase|Progressive Disease|31|||
48786699|NCT01227889|157059024|FG000|Crossover Phase|Study Terminated By Sponsor|0|||
48786700|NCT01227889|157059025|FG001|Crossover Phase|Study Terminated By Sponsor|1|||
48786701|NCT01227889|157059024|FG000|Crossover Phase|Withdrawal by Subject|0|||
48786702|NCT01227889|157059025|FG001|Crossover Phase|Withdrawal by Subject|1|||
48786703|NCT03268811|157059026|FG000|Overall Study|Adverse Event|0|||
48786704|NCT03268811|157059027|FG001|Overall Study|Adverse Event|1|||
48786705|NCT00254982|157059028|FG000|Overall Study|Other|2|||
48786706|NCT00254982|157059029|FG001|Overall Study|Other|1|||
48786707|NCT00254982|157059028|FG000|Overall Study|Lack of Efficacy|5|||
48786708|NCT00254982|157059029|FG001|Overall Study|Lack of Efficacy|3|||
48786709|NCT00254982|157059028|FG000|Overall Study|Lost to Follow-up|5|||
48786710|NCT00254982|157059029|FG001|Overall Study|Lost to Follow-up|3|||
48786711|NCT00254982|157059028|FG000|Overall Study|Adverse Event|18|||
48786712|NCT00254982|157059029|FG001|Overall Study|Adverse Event|16|||
48786713|NCT00254982|157059028|FG000|Overall Study|Withdrawal by Subject|1|||
48786714|NCT00254982|157059029|FG001|Overall Study|Withdrawal by Subject|1|||
48786715|NCT00254982|157059028|FG000|Overall Study|Inclusion/exclusion criteria violation|0|||
48786716|NCT00254982|157059029|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
48786717|NCT00254982|157059028|FG000|Overall Study|Protocol deviation|1|||
48786718|NCT00254982|157059029|FG001|Overall Study|Protocol deviation|1|||
48786719|NCT00254982|157059028|FG000|Overall Study|Diagnosis of Tuberculosis|1|||
48786720|NCT00254982|157059029|FG001|Overall Study|Diagnosis of Tuberculosis|1|||
48786721|NCT00254982|157059028|FG000|Overall Study|Malignancy|0|||
48786722|NCT00254982|157059029|FG001|Overall Study|Malignancy|2|||
48786723|NCT00254982|157059028|FG000|Overall Study|Opportunistic infection|1|||
48786724|NCT00254982|157059029|FG001|Overall Study|Opportunistic infection|0|||
48786725|NCT00254982|157059028|FG000|Overall Study|Abnormal liver function tests|2|||
48786726|NCT00254982|157059029|FG001|Overall Study|Abnormal liver function tests|1|||
48786727|NCT01308749|157059035|FG000|Period 1: Double Blind Treatment|Adverse Event|1|||
48786728|NCT01308749|157059036|FG001|Period 1: Double Blind Treatment|Adverse Event|0|||
48786729|NCT01308749|157059035|FG000|Period 2: Open Label Treatment|Adverse Event|0|||
48786730|NCT01308749|157059036|FG001|Period 2: Open Label Treatment|Adverse Event|1|||
48786731|NCT01308749|157059035|FG000|Period 2: Open Label Treatment|Lost to Follow-up|0|||
48786732|NCT01308749|157059036|FG001|Period 2: Open Label Treatment|Lost to Follow-up|1|||
48786733|NCT02553330|157059037|FG000|Overall Study|Study Terminated by Sponsor|2|||
48786734|NCT02553330|157059038|FG001|Overall Study|Study Terminated by Sponsor|13|||
48786735|NCT02553330|157059039|FG002|Overall Study|Study Terminated by Sponsor|12|||
48786736|NCT02553330|157059037|FG000|Overall Study|Withdrawal by Subject|3|||
48786737|NCT02553330|157059038|FG001|Overall Study|Withdrawal by Subject|19|||
48786738|NCT02553330|157059039|FG002|Overall Study|Withdrawal by Subject|21|||
48786739|NCT02553330|157059037|FG000|Overall Study|Other|0|||
48786740|NCT02553330|157059038|FG001|Overall Study|Other|1|||
48786741|NCT02553330|157059039|FG002|Overall Study|Other|0|||
48786742|NCT02553330|157059037|FG000|Overall Study|Non compliance to study treatment|0|||
48786743|NCT02553330|157059038|FG001|Overall Study|Non compliance to study treatment|1|||
48786744|NCT02553330|157059039|FG002|Overall Study|Non compliance to study treatment|0|||
48786745|NCT02553330|157059037|FG000|Overall Study|Adverse Event|0|||
48786746|NCT02553330|157059038|FG001|Overall Study|Adverse Event|1|||
48786747|NCT02553330|157059039|FG002|Overall Study|Adverse Event|0|||
48786748|NCT02553330|157059037|FG000|Overall Study|Lost to Follow-up|0|||
48786749|NCT02553330|157059038|FG001|Overall Study|Lost to Follow-up|4|||
48786750|NCT02553330|157059039|FG002|Overall Study|Lost to Follow-up|4|||
48786751|NCT02896855|157059043|FG000|Overall Study|Death|50|||
48786752|NCT02896855|157059044|FG001|Overall Study|Death|40|||
48786753|NCT02896855|157059043|FG000|Overall Study|Lost to Follow-up|15|||
48786754|NCT02896855|157059044|FG001|Overall Study|Lost to Follow-up|9|||
48786755|NCT02896855|157059043|FG000|Overall Study|Withdrawal by Subject|7|||
48786756|NCT02896855|157059044|FG001|Overall Study|Withdrawal by Subject|4|||
48786757|NCT00448539|157059045|FG000|Overall Study|Medication non-compliance|4|||
48786758|NCT00448539|157059046|FG001|Overall Study|Medication non-compliance|1|||
48786759|NCT00448539|157059045|FG000|Overall Study|Protocol Violation|1|||
48786760|NCT00448539|157059046|FG001|Overall Study|Protocol Violation|0|||
48786761|NCT00448539|157059045|FG000|Overall Study|Request of the investigator or sponsor|67|||
48786762|NCT00448539|157059046|FG001|Overall Study|Request of the investigator or sponsor|54|||
48786763|NCT00448539|157059045|FG000|Overall Study|Withdrawal by Subject|20|||
48786764|NCT00448539|157059046|FG001|Overall Study|Withdrawal by Subject|24|||
48786765|NCT00448539|157059045|FG000|Overall Study|Diary non-compliance|1|||
48786766|NCT00448539|157059046|FG001|Overall Study|Diary non-compliance|0|||
48786767|NCT00448539|157059045|FG000|Overall Study|Adverse Event|9|||
48786768|NCT00448539|157059046|FG001|Overall Study|Adverse Event|26|||
48786769|NCT00448539|157059045|FG000|Overall Study|Lack of Efficacy|27|||
48786770|NCT00448539|157059046|FG001|Overall Study|Lack of Efficacy|40|||
48786771|NCT00448539|157059045|FG000|Overall Study|Miscellaneous|2|||
48786772|NCT00448539|157059046|FG001|Overall Study|Miscellaneous|1|||
48786773|NCT00448539|157059045|FG000|Overall Study|Change of meds|2|||
48786774|NCT00448539|157059046|FG001|Overall Study|Change of meds|3|||
48786775|NCT00448539|157059045|FG000|Overall Study|Lost to Follow-up|1|||
48786776|NCT00448539|157059046|FG001|Overall Study|Lost to Follow-up|3|||
48786777|NCT04862143|157059047|FG000|Overall Study|Adverse Event|1|||
48786778|NCT04862143|157059047|FG000|Overall Study|Study terminated by sponsor|1|||
48786779|NCT01666002|157059051|FG000|Overall Study|Lost to Follow-up|5|||
48786780|NCT01666002|157059052|FG001|Overall Study|Lost to Follow-up|0|||
48786781|NCT04955639|157059053|FG000|Overall Study|Withdrawal by Subject|2|||
48786782|NCT04955639|157059054|FG001|Overall Study|Withdrawal by Subject|2|||
48786783|NCT04955639|157059053|FG000|Overall Study|Week 26 survey not completed|2|||
48786784|NCT04955639|157059054|FG001|Overall Study|Week 26 survey not completed|2|||
48786785|NCT02479412|157059057|FG000|Overall Study|Adverse Event|0|||
48786786|NCT02479412|157059058|FG001|Overall Study|Adverse Event|0|||
48786787|NCT02479412|157059059|FG002|Overall Study|Adverse Event|1|||
48786788|NCT02479412|157059060|FG003|Overall Study|Adverse Event|0|||
48786789|NCT02479412|157059061|FG004|Overall Study|Adverse Event|0|||
48786790|NCT02479412|157059062|FG005|Overall Study|Adverse Event|0|||
48786791|NCT02479412|157059063|FG006|Overall Study|Adverse Event|0|||
48786792|NCT02479412|157059064|FG007|Overall Study|Adverse Event|0|||
48786793|NCT02479412|157059065|FG008|Overall Study|Adverse Event|0|||
48786794|NCT02479412|157059057|FG000|Overall Study|Study-specific withdrawal criteria|0|||
48786795|NCT02479412|157059058|FG001|Overall Study|Study-specific withdrawal criteria|0|||
48786796|NCT02479412|157059059|FG002|Overall Study|Study-specific withdrawal criteria|1|||
48786797|NCT02479412|157059060|FG003|Overall Study|Study-specific withdrawal criteria|1|||
48786798|NCT02479412|157059061|FG004|Overall Study|Study-specific withdrawal criteria|0|||
48786799|NCT02479412|157059062|FG005|Overall Study|Study-specific withdrawal criteria|0|||
48786800|NCT02479412|157059063|FG006|Overall Study|Study-specific withdrawal criteria|0|||
48786801|NCT02479412|157059064|FG007|Overall Study|Study-specific withdrawal criteria|1|||
48786802|NCT02479412|157059065|FG008|Overall Study|Study-specific withdrawal criteria|1|||
48786803|NCT02479412|157059057|FG000|Overall Study|Randomization to wrong PK sampling group|0|||
48786804|NCT02479412|157059058|FG001|Overall Study|Randomization to wrong PK sampling group|0|||
48786805|NCT02479412|157059059|FG002|Overall Study|Randomization to wrong PK sampling group|0|||
48786806|NCT02479412|157059060|FG003|Overall Study|Randomization to wrong PK sampling group|0|||
48786807|NCT02479412|157059061|FG004|Overall Study|Randomization to wrong PK sampling group|1|||
48786808|NCT02479412|157059062|FG005|Overall Study|Randomization to wrong PK sampling group|0|||
48786809|NCT02479412|157059063|FG006|Overall Study|Randomization to wrong PK sampling group|0|||
48786810|NCT02479412|157059064|FG007|Overall Study|Randomization to wrong PK sampling group|0|||
48786811|NCT02479412|157059065|FG008|Overall Study|Randomization to wrong PK sampling group|0|||
48786812|NCT03305016|157059068|FG000|Overall Study|Withdrawal by Subject|2|||
48786813|NCT03579459|157059071|FG000|Overall Study|Adverse Event|7|||
48786814|NCT03579459|157059072|FG001|Overall Study|Adverse Event|6|||
48786815|NCT03579459|157059073|FG002|Overall Study|Adverse Event|2|||
48786816|NCT03579459|157059074|FG003|Overall Study|Adverse Event|6|||
48786817|NCT03579459|157059071|FG000|Overall Study|Death|1|||
48786818|NCT03579459|157059072|FG001|Overall Study|Death|0|||
48786819|NCT03579459|157059073|FG002|Overall Study|Death|1|||
48786820|NCT03579459|157059074|FG003|Overall Study|Death|2|||
48786821|NCT03579459|157059071|FG000|Overall Study|Lost to Follow-up|6|||
48786822|NCT03579459|157059072|FG001|Overall Study|Lost to Follow-up|2|||
48786823|NCT03579459|157059073|FG002|Overall Study|Lost to Follow-up|4|||
48786824|NCT03579459|157059074|FG003|Overall Study|Lost to Follow-up|1|||
48786825|NCT03579459|157059071|FG000|Overall Study|Physician Decision|0|||
48786826|NCT03579459|157059072|FG001|Overall Study|Physician Decision|1|||
48786827|NCT03579459|157059073|FG002|Overall Study|Physician Decision|0|||
48786828|NCT03579459|157059074|FG003|Overall Study|Physician Decision|1|||
48786829|NCT03579459|157059071|FG000|Overall Study|Protocol Violation|1|||
48786830|NCT03579459|157059072|FG001|Overall Study|Protocol Violation|2|||
48786831|NCT03579459|157059073|FG002|Overall Study|Protocol Violation|3|||
48786832|NCT03579459|157059074|FG003|Overall Study|Protocol Violation|5|||
48786833|NCT03579459|157059071|FG000|Overall Study|Withdrawal by Subject|12|||
48786834|NCT03579459|157059072|FG001|Overall Study|Withdrawal by Subject|8|||
48786835|NCT03579459|157059073|FG002|Overall Study|Withdrawal by Subject|11|||
48786836|NCT03579459|157059074|FG003|Overall Study|Withdrawal by Subject|8|||
48786837|NCT03579459|157059071|FG000|Overall Study|Medication error without associated adverse event|2|||
48786838|NCT03579459|157059072|FG001|Overall Study|Medication error without associated adverse event|1|||
48786839|NCT03579459|157059073|FG002|Overall Study|Medication error without associated adverse event|1|||
48786840|NCT03579459|157059074|FG003|Overall Study|Medication error without associated adverse event|0|||
48786841|NCT03579459|157059071|FG000|Overall Study|Other|0|||
48786842|NCT03579459|157059072|FG001|Overall Study|Other|1|||
48786843|NCT03579459|157059073|FG002|Overall Study|Other|1|||
48786844|NCT03579459|157059074|FG003|Overall Study|Other|0|||
48786845|NCT03579459|157059071|FG000|Overall Study|Randomized not vaccinated|0|||
48786846|NCT03579459|157059072|FG001|Overall Study|Randomized not vaccinated|2|||
48786847|NCT03579459|157059073|FG002|Overall Study|Randomized not vaccinated|0|||
48786848|NCT03579459|157059074|FG003|Overall Study|Randomized not vaccinated|1|||
48786849|NCT03043664|157059075|FG000|Overall Study|Lost to Follow-up|1|||
48877556|NCT01657799|157390101|FG002|Overall Study|Radiographic & Clinical Progression|15|||
48877557|NCT01657799|157390099|FG000|Overall Study|Other|52|||
48877558|NCT01657799|157390100|FG001|Overall Study|Other|62|||
48877559|NCT01657799|157390101|FG002|Overall Study|Other|49|||
48877560|NCT03445533|157390103|FG000|Overall Study|Progressive Disease|48|||
48877561|NCT03445533|157390104|FG001|Overall Study|Progressive Disease|81|||
48877562|NCT03445533|157390103|FG000|Overall Study|Adverse Event|60|||
48877563|NCT03445533|157390104|FG001|Overall Study|Adverse Event|64|||
48877564|NCT03445533|157390103|FG000|Overall Study|Death|9|||
48877565|NCT03445533|157390104|FG001|Overall Study|Death|19|||
48877566|NCT03445533|157390103|FG000|Overall Study|Miscellaneous|0|||
48877567|NCT03445533|157390104|FG001|Overall Study|Miscellaneous|16|||
48877568|NCT03445533|157390103|FG000|Overall Study|Withdrawal by Subject|3|||
48877569|NCT03445533|157390104|FG001|Overall Study|Withdrawal by Subject|4|||
48877570|NCT03445533|157390103|FG000|Overall Study|Physician Decision|1|||
48877571|NCT03445533|157390104|FG001|Overall Study|Physician Decision|3|||
48877572|NCT03445533|157390103|FG000|Overall Study|Sponsor Decision|0|||
48877573|NCT03445533|157390104|FG001|Overall Study|Sponsor Decision|1|||
49031780|NCT01911676|157953448|FG003|Period 2 of Study|Physician Decision|1|||
48786850|NCT03713593|157059077|FG000|Overall Study|Participants Ongoing|140|||
48786851|NCT03713593|157059078|FG001|Overall Study|Participants Ongoing|114|||
49031781|NCT01911676|157953445|FG000|Period 2 of Study|Lost to Follow-up|0|||
49031782|NCT01911676|157953446|FG001|Period 2 of Study|Lost to Follow-up|0|||
48786852|NCT03713593|157059077|FG000|Overall Study|Withdrawal by Subject|3|||
48786853|NCT03713593|157059078|FG001|Overall Study|Withdrawal by Subject|6|||
48786854|NCT03713593|157059077|FG000|Overall Study|Death|252|||
48786855|NCT03713593|157059078|FG001|Overall Study|Death|279|||
48786856|NCT02975882|157059079|FG000|Overall Study|Adverse Event|1|||
48786857|NCT02975882|157059080|FG001|Overall Study|Adverse Event|2|||
48786858|NCT02975882|157059081|FG002|Overall Study|Adverse Event|1|||
48786859|NCT02975882|157059082|FG003|Overall Study|Adverse Event|1|||
48786860|NCT02975882|157059079|FG000|Overall Study|Death|0|||
48786861|NCT02975882|157059080|FG001|Overall Study|Death|1|||
48786862|NCT02975882|157059081|FG002|Overall Study|Death|0|||
48786863|NCT02975882|157059082|FG003|Overall Study|Death|0|||
48786864|NCT02975882|157059079|FG000|Overall Study|Lack of Efficacy|3|||
48786865|NCT02975882|157059080|FG001|Overall Study|Lack of Efficacy|7|||
48786866|NCT02975882|157059081|FG002|Overall Study|Lack of Efficacy|4|||
48786867|NCT02975882|157059082|FG003|Overall Study|Lack of Efficacy|3|||
48786868|NCT02975882|157059079|FG000|Overall Study|Physician Decision|0|||
48786869|NCT02975882|157059080|FG001|Overall Study|Physician Decision|2|||
48786870|NCT02975882|157059081|FG002|Overall Study|Physician Decision|4|||
48786871|NCT02975882|157059082|FG003|Overall Study|Physician Decision|2|||
48786872|NCT02975882|157059079|FG000|Overall Study|Ineligible|0|||
48786873|NCT02975882|157059080|FG001|Overall Study|Ineligible|1|||
48786874|NCT02975882|157059081|FG002|Overall Study|Ineligible|0|||
48786875|NCT02975882|157059082|FG003|Overall Study|Ineligible|0|||
48786876|NCT02515773|157059083|FG000|Overall Study|Withdrawal by Subject|12|||
48786877|NCT02515773|157059084|FG001|Overall Study|Withdrawal by Subject|2|||
48786878|NCT02515773|157059083|FG000|Overall Study|Lost to Follow-up|119|||
48786879|NCT02515773|157059084|FG001|Overall Study|Lost to Follow-up|126|||
48786880|NCT02515773|157059083|FG000|Overall Study|Discharged from Clinic Services|53|||
48786881|NCT02515773|157059084|FG001|Overall Study|Discharged from Clinic Services|84|||
48786882|NCT02515773|157059083|FG000|Overall Study|Censored (study ended before participant could complete)|18|||
48786883|NCT02515773|157059084|FG001|Overall Study|Censored (study ended before participant could complete)|24|||
48786884|NCT02515773|157059083|FG000|Overall Study|Follow-up at non-study site|8|||
48786885|NCT02515773|157059084|FG001|Overall Study|Follow-up at non-study site|16|||
48786886|NCT02515773|157059083|FG000|Overall Study|Moved from area|9|||
48786887|NCT02515773|157059084|FG001|Overall Study|Moved from area|14|||
48786888|NCT04642638|157059090|FG000|Overall Study|Withdrawal by Subject|23|||
48786889|NCT04642638|157059091|FG001|Overall Study|Withdrawal by Subject|29|||
48786890|NCT04642638|157059092|FG002|Overall Study|Withdrawal by Subject|9|||
48786891|NCT04642638|157059093|FG003|Overall Study|Withdrawal by Subject|7|||
48786892|NCT04642638|157059094|FG004|Overall Study|Withdrawal by Subject|61|||
48877574|NCT03445533|157390103|FG000|Overall Study|Lost to Follow-up|0|||
49031783|NCT01911676|157953447|FG002|Period 2 of Study|Lost to Follow-up|0|||
49031784|NCT01911676|157953448|FG003|Period 2 of Study|Lost to Follow-up|1|||
48786893|NCT04642638|157059095|FG005|Overall Study|Withdrawal by Subject|27|||
48786894|NCT04642638|157059090|FG000|Overall Study|Lost to Follow-up|17|||
48786895|NCT04642638|157059091|FG001|Overall Study|Lost to Follow-up|18|||
48786896|NCT04642638|157059092|FG002|Overall Study|Lost to Follow-up|5|||
48877575|NCT03445533|157390104|FG001|Overall Study|Lost to Follow-up|1|||
48877576|NCT03445533|157390103|FG000|Overall Study|Never Received any Study Treatment|7|||
48877577|NCT03445533|157390104|FG001|Overall Study|Never Received any Study Treatment|4|||
48786897|NCT04642638|157059093|FG003|Overall Study|Lost to Follow-up|5|||
48786898|NCT04642638|157059094|FG004|Overall Study|Lost to Follow-up|6|||
48786899|NCT04642638|157059095|FG005|Overall Study|Lost to Follow-up|3|||
48786900|NCT04642638|157059090|FG000|Overall Study|Adverse Event|0|||
48786901|NCT04642638|157059091|FG001|Overall Study|Adverse Event|0|||
49031785|NCT00773253|157953450|FG000|First Intervention (Week 0-24)|Frontalis Test Negative|0|||
49031786|NCT00773253|157953451|FG001|First Intervention (Week 0-24)|Frontalis Test Negative|1|||
49031787|NCT01878292|157953458|FG000|Randomized|Protocol Violation|1|||
49031788|NCT01878292|157953459|FG001|Randomized|Protocol Violation|0|||
49031789|NCT01878292|157953460|FG002|Randomized|Protocol Violation|0|||
49031790|NCT01878292|157953458|FG000|Randomized|Lost to Follow-up|1|||
49031791|NCT01878292|157953459|FG001|Randomized|Lost to Follow-up|0|||
49031792|NCT01878292|157953460|FG002|Randomized|Lost to Follow-up|0|||
49031793|NCT01878292|157953458|FG000|Randomized|Adverse Event|1|||
49031794|NCT01878292|157953459|FG001|Randomized|Adverse Event|0|||
49031795|NCT01878292|157953460|FG002|Randomized|Adverse Event|0|||
49031796|NCT01878292|157953458|FG000|Double-blind Treatment Period|Other Reasons|2|||
49031797|NCT01878292|157953459|FG001|Double-blind Treatment Period|Other Reasons|0|||
49031798|NCT01878292|157953460|FG002|Double-blind Treatment Period|Other Reasons|0|||
49031799|NCT01878292|157953458|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
49031800|NCT01878292|157953459|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
49031801|NCT01878292|157953460|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
49031802|NCT01878292|157953458|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
49031803|NCT01878292|157953459|FG001|Double-blind Treatment Period|Withdrawal by Subject|7|||
49031804|NCT01878292|157953460|FG002|Double-blind Treatment Period|Withdrawal by Subject|8|||
49031805|NCT01878292|157953458|FG000|Double-blind Treatment Period|Protocol Violation|3|||
49031806|NCT01878292|157953459|FG001|Double-blind Treatment Period|Protocol Violation|4|||
49031807|NCT01878292|157953460|FG002|Double-blind Treatment Period|Protocol Violation|2|||
49031808|NCT01878292|157953458|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
49031809|NCT01878292|157953459|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
49031810|NCT01878292|157953460|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
49031811|NCT01878292|157953458|FG000|Double-blind Treatment Period|Adverse Event|4|||
49031812|NCT01878292|157953459|FG001|Double-blind Treatment Period|Adverse Event|9|||
49031813|NCT01878292|157953460|FG002|Double-blind Treatment Period|Adverse Event|8|||
49031814|NCT01878292|157953458|FG000|Double-blind Down-Taper Period|Withdrawal by Subject|5|||
49031815|NCT01878292|157953459|FG001|Double-blind Down-Taper Period|Withdrawal by Subject|8|||
49031816|NCT01878292|157953460|FG002|Double-blind Down-Taper Period|Withdrawal by Subject|4|||
49031817|NCT01348789|157953461|FG000|Overall Study|Protocol Violation|2|||
49031818|NCT01348789|157953461|FG000|Overall Study|Withdrawal by Subject|2|||
49031819|NCT03606408|157953463|FG000|Overall Study|Adverse Event|13|||
49031820|NCT03606408|157953463|FG000|Overall Study|Withdrawal by Subject|7|||
49031821|NCT03606408|157953463|FG000|Overall Study|Physician Decision|4|||
49031822|NCT03606408|157953463|FG000|Overall Study|Lack of Efficacy|2|||
49031823|NCT03606408|157953463|FG000|Overall Study|Death|1|||
49031824|NCT03606408|157953463|FG000|Overall Study|new therapy for study indication|1|||
49031825|NCT01494532|157953464|FG000|Overall Study|Adverse Event|4|||
49031826|NCT01494532|157953465|FG001|Overall Study|Adverse Event|1|||
49031827|NCT01494532|157953466|FG002|Overall Study|Adverse Event|8|||
49031828|NCT01494532|157953467|FG003|Overall Study|Adverse Event|6|||
48786902|NCT04642638|157059092|FG002|Overall Study|Adverse Event|1|||
48786903|NCT04642638|157059093|FG003|Overall Study|Adverse Event|0|||
48786904|NCT04642638|157059094|FG004|Overall Study|Adverse Event|10|||
49031829|NCT01494532|157953468|FG004|Overall Study|Adverse Event|5|||
49031830|NCT01494532|157953469|FG005|Overall Study|Adverse Event|0|||
49031831|NCT01494532|157953464|FG000|Overall Study|Lack of Efficacy|0|||
49031832|NCT01494532|157953465|FG001|Overall Study|Lack of Efficacy|0|||
48786905|NCT04642638|157059095|FG005|Overall Study|Adverse Event|3|||
48786906|NCT04642638|157059090|FG000|Overall Study|Reason Not Specified|1|||
48786907|NCT04642638|157059091|FG001|Overall Study|Reason Not Specified|4|||
49031833|NCT01494532|157953466|FG002|Overall Study|Lack of Efficacy|0|||
49031834|NCT01494532|157953467|FG003|Overall Study|Lack of Efficacy|0|||
49031835|NCT01494532|157953468|FG004|Overall Study|Lack of Efficacy|2|||
49031836|NCT01494532|157953469|FG005|Overall Study|Lack of Efficacy|0|||
49031837|NCT01494532|157953464|FG000|Overall Study|Protocol deviation|2|||
49031838|NCT01494532|157953465|FG001|Overall Study|Protocol deviation|1|||
49031839|NCT01494532|157953466|FG002|Overall Study|Protocol deviation|3|||
49031840|NCT01494532|157953467|FG003|Overall Study|Protocol deviation|2|||
49031841|NCT01494532|157953468|FG004|Overall Study|Protocol deviation|3|||
49031842|NCT01494532|157953469|FG005|Overall Study|Protocol deviation|0|||
49031843|NCT01494532|157953464|FG000|Overall Study|Protocol-defined stopping criteria|0|||
49031844|NCT01494532|157953465|FG001|Overall Study|Protocol-defined stopping criteria|0|||
49031845|NCT01494532|157953466|FG002|Overall Study|Protocol-defined stopping criteria|1|||
49031846|NCT01494532|157953467|FG003|Overall Study|Protocol-defined stopping criteria|0|||
49031847|NCT01494532|157953468|FG004|Overall Study|Protocol-defined stopping criteria|0|||
49031848|NCT01494532|157953469|FG005|Overall Study|Protocol-defined stopping criteria|0|||
48786908|NCT04642638|157059092|FG002|Overall Study|Reason Not Specified|0|||
48786909|NCT04642638|157059093|FG003|Overall Study|Reason Not Specified|0|||
48786910|NCT04642638|157059094|FG004|Overall Study|Reason Not Specified|38|||
48877578|NCT01077128|157390105|FG000|Overall Study|Adverse Event|8|||
48877579|NCT01077128|157390105|FG000|Overall Study|Lack of Efficacy|1|||
48877580|NCT01077128|157390105|FG000|Overall Study|Disease exacerbation|1|||
48877581|NCT01077128|157390105|FG000|Overall Study|Adverse event and consent withdrawal|1|||
48877582|NCT01077128|157390105|FG000|Overall Study|Adverse event and disease exacerbation|1|||
48877583|NCT01077128|157390105|FG000|Overall Study|Lack of efficacy/disease exacerbation|1|||
48877584|NCT01077128|157390105|FG000|Overall Study|Other|54|||
48877585|NCT00943787|157390106|FG000|Overall Study|Physician Decision|4|||
48877586|NCT00943787|157390106|FG000|Overall Study|Withdrawal by Subject|3|||
48877587|NCT00520845|157390107|FG000|Overall Study|Death|3|||
48877588|NCT00520845|157390107|FG000|Overall Study|Adverse Event|4|||
48877589|NCT00520845|157390107|FG000|Overall Study|Disease Progression, relapse|13|||
48786911|NCT04642638|157059095|FG005|Overall Study|Reason Not Specified|16|||
48786912|NCT04642638|157059090|FG000|Overall Study|Physician Decision|0|||
48786913|NCT04642638|157059091|FG001|Overall Study|Physician Decision|0|||
48786914|NCT04642638|157059092|FG002|Overall Study|Physician Decision|0|||
48786915|NCT04642638|157059093|FG003|Overall Study|Physician Decision|0|||
48786916|NCT04642638|157059094|FG004|Overall Study|Physician Decision|2|||
48786917|NCT04642638|157059095|FG005|Overall Study|Physician Decision|1|||
48786918|NCT04642638|157059090|FG000|Overall Study|Protocol Deviation|0|||
48786919|NCT04642638|157059091|FG001|Overall Study|Protocol Deviation|0|||
48877590|NCT00520845|157390107|FG000|Overall Study|Withdrawal by Subject|1|||
48877591|NCT00520845|157390107|FG000|Overall Study|Alternative Therapy|1|||
48877592|NCT01015677|157390108|FG000|Overall Study|Adverse Event|0|||
48877593|NCT01015677|157390109|FG001|Overall Study|Adverse Event|1|||
49031849|NCT01494532|157953464|FG000|Overall Study|Lost to Follow-up|1|||
49031850|NCT01494532|157953465|FG001|Overall Study|Lost to Follow-up|0|||
49031851|NCT01494532|157953466|FG002|Overall Study|Lost to Follow-up|0|||
49031852|NCT01494532|157953467|FG003|Overall Study|Lost to Follow-up|2|||
49031853|NCT01494532|157953468|FG004|Overall Study|Lost to Follow-up|0|||
48786920|NCT04642638|157059092|FG002|Overall Study|Protocol Deviation|0|||
48786921|NCT04642638|157059093|FG003|Overall Study|Protocol Deviation|0|||
48786922|NCT04642638|157059094|FG004|Overall Study|Protocol Deviation|1|||
48786923|NCT04642638|157059095|FG005|Overall Study|Protocol Deviation|3|||
48786924|NCT04642638|157059090|FG000|Overall Study|Study Terminated|0|||
48786925|NCT04642638|157059091|FG001|Overall Study|Study Terminated|0|||
48786926|NCT04642638|157059092|FG002|Overall Study|Study Terminated|0|||
48786927|NCT04642638|157059093|FG003|Overall Study|Study Terminated|0|||
48786928|NCT04642638|157059094|FG004|Overall Study|Study Terminated|484|||
48786929|NCT04642638|157059095|FG005|Overall Study|Study Terminated|250|||
49031854|NCT01494532|157953469|FG005|Overall Study|Lost to Follow-up|0|||
48786930|NCT04642638|157059090|FG000|Overall Study|Pregnancy|0|||
48786931|NCT04642638|157059091|FG001|Overall Study|Pregnancy|0|||
48786932|NCT04642638|157059092|FG002|Overall Study|Pregnancy|0|||
48786933|NCT04642638|157059093|FG003|Overall Study|Pregnancy|0|||
48786934|NCT04642638|157059094|FG004|Overall Study|Pregnancy|1|||
48786935|NCT04642638|157059095|FG005|Overall Study|Pregnancy|0|||
48786936|NCT00990652|157059096|FG000|Pre-surgical Bortezomib|Adverse Event|1|||
48786937|NCT00990652|157059096|FG000|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1|||
48786938|NCT00553267|157059097|FG000|Overall Study|Adverse Event|8|||
48786939|NCT00553267|157059098|FG001|Overall Study|Adverse Event|10|||
48786940|NCT00553267|157059099|FG002|Overall Study|Adverse Event|5|||
48786941|NCT00553267|157059097|FG000|Overall Study|Non compliant with protocol|3|||
48786942|NCT00553267|157059098|FG001|Overall Study|Non compliant with protocol|3|||
48786943|NCT00553267|157059099|FG002|Overall Study|Non compliant with protocol|2|||
49031855|NCT01494532|157953464|FG000|Overall Study|Physician Decision|0|||
48786944|NCT00553267|157059097|FG000|Overall Study|Lost to Follow-up|0|||
48786945|NCT00553267|157059098|FG001|Overall Study|Lost to Follow-up|0|||
48786946|NCT00553267|157059099|FG002|Overall Study|Lost to Follow-up|1|||
48786947|NCT00553267|157059097|FG000|Overall Study|Consent withdrawn|2|||
48786948|NCT00553267|157059098|FG001|Overall Study|Consent withdrawn|3|||
48786949|NCT00553267|157059099|FG002|Overall Study|Consent withdrawn|1|||
48786950|NCT00553267|157059097|FG000|Overall Study|Specified category|1|||
48786951|NCT00553267|157059098|FG001|Overall Study|Specified category|2|||
48786952|NCT00553267|157059099|FG002|Overall Study|Specified category|1|||
49031856|NCT01494532|157953465|FG001|Overall Study|Physician Decision|1|||
49031857|NCT01494532|157953466|FG002|Overall Study|Physician Decision|1|||
48786953|NCT01944046|157059105|FG000|Randomized to DB|Adverse Event|5|||
48786954|NCT01944046|157059106|FG001|Randomized to DB|Adverse Event|2|||
48786955|NCT01944046|157059105|FG000|Randomized to DB|Clinical Worsening|3|||
48786956|NCT01944046|157059106|FG001|Randomized to DB|Clinical Worsening|2|||
48786957|NCT01944046|157059105|FG000|Randomized to DB|Lost to Follow-up|3|||
48877594|NCT01015677|157390110|FG002|Overall Study|Adverse Event|0|||
48877595|NCT01015677|157390108|FG000|Overall Study|Lack of Efficacy|0|||
48786958|NCT01944046|157059106|FG001|Randomized to DB|Lost to Follow-up|3|||
48786959|NCT01944046|157059105|FG000|Randomized to DB|Withdrawal by Subject|2|||
48786960|NCT01944046|157059106|FG001|Randomized to DB|Withdrawal by Subject|4|||
48786961|NCT01944046|157059105|FG000|Randomized to DB|Physician Decision|1|||
49031858|NCT01494532|157953467|FG003|Overall Study|Physician Decision|2|||
48786962|NCT01944046|157059106|FG001|Randomized to DB|Physician Decision|2|||
48786963|NCT01944046|157059105|FG000|Randomized to DB|Did not have baseline ABC-SW|2|||
48786964|NCT01944046|157059106|FG001|Randomized to DB|Did not have baseline ABC-SW|0|||
48786965|NCT01944046|157059105|FG000|Randomized to DB|Did not have a postbaseline ABC SW|5|||
48786966|NCT01944046|157059106|FG001|Randomized to DB|Did not have a postbaseline ABC SW|6|||
48786967|NCT01944046|157059105|FG000|Open Label Eligible and Consented|Lost to Follow-up|3|||
48786968|NCT01944046|157059106|FG001|Open Label Eligible and Consented|Lost to Follow-up|5|||
48786969|NCT01944046|157059105|FG000|Open Label Eligible and Consented|Adverse Event|6|||
48786970|NCT01944046|157059106|FG001|Open Label Eligible and Consented|Adverse Event|1|||
48786971|NCT01944046|157059105|FG000|Open Label Eligible and Consented|Clinical Worsening|4|||
48786972|NCT01944046|157059106|FG001|Open Label Eligible and Consented|Clinical Worsening|2|||
48786973|NCT01944046|157059105|FG000|Open Label Eligible and Consented|Withdrawal by Subject|1|||
48786974|NCT01944046|157059106|FG001|Open Label Eligible and Consented|Withdrawal by Subject|0|||
48786975|NCT02937545|157059108|FG000|Overall Study|Withdrawal by Subject|1|||
48786976|NCT02937545|157059109|FG001|Overall Study|Withdrawal by Subject|2|||
48786977|NCT02937545|157059110|FG002|Overall Study|Withdrawal by Subject|6|||
48786978|NCT02937545|157059111|FG003|Overall Study|Withdrawal by Subject|7|||
48786979|NCT02937545|157059108|FG000|Overall Study|Lost to Follow-up|1|||
48786980|NCT02937545|157059109|FG001|Overall Study|Lost to Follow-up|0|||
48786981|NCT02937545|157059110|FG002|Overall Study|Lost to Follow-up|0|||
48786982|NCT02937545|157059111|FG003|Overall Study|Lost to Follow-up|0|||
48786983|NCT02504294|157059112|FG000|Overall Study|Adverse Event|15|||
48786984|NCT02504294|157059113|FG001|Overall Study|Adverse Event|12|||
48786985|NCT02504294|157059112|FG000|Overall Study|Withdrawal by Subject|7|||
48786986|NCT02504294|157059113|FG001|Overall Study|Withdrawal by Subject|1|||
48786987|NCT02504294|157059112|FG000|Overall Study|Protocol Violation|27|||
48786988|NCT02504294|157059113|FG001|Overall Study|Protocol Violation|26|||
48786989|NCT02504294|157059112|FG000|Overall Study|Physician Decision|1|||
48786990|NCT02504294|157059113|FG001|Overall Study|Physician Decision|2|||
48786991|NCT02504294|157059112|FG000|Overall Study|Lost to Follow-up|6|||
48786992|NCT02504294|157059113|FG001|Overall Study|Lost to Follow-up|7|||
48786993|NCT01934218|157059123|FG000|Double-blind Phase|Adverse Event|8|||
48786994|NCT01934218|157059124|FG001|Double-blind Phase|Adverse Event|8|||
48786995|NCT01934218|157059123|FG000|Double-blind Phase|Lack of Efficacy|6|||
48786996|NCT01934218|157059124|FG001|Double-blind Phase|Lack of Efficacy|7|||
48786997|NCT01934218|157059123|FG000|Double-blind Phase|Lost to Follow-up|7|||
48786998|NCT01934218|157059124|FG001|Double-blind Phase|Lost to Follow-up|14|||
48786999|NCT01934218|157059123|FG000|Double-blind Phase|Physician Decision|1|||
48787000|NCT01934218|157059124|FG001|Double-blind Phase|Physician Decision|2|||
48787001|NCT01934218|157059123|FG000|Double-blind Phase|Protocol Violation|4|||
48787002|NCT01934218|157059124|FG001|Double-blind Phase|Protocol Violation|0|||
48787003|NCT01934218|157059123|FG000|Double-blind Phase|Withdrawal by Subject|16|||
48787004|NCT01934218|157059124|FG001|Double-blind Phase|Withdrawal by Subject|13|||
48787005|NCT01934218|157059123|FG000|Double-blind Phase|Noncompliance with Study Protocol|5|||
48787006|NCT01934218|157059124|FG001|Double-blind Phase|Noncompliance with Study Protocol|8|||
48787007|NCT01934218|157059123|FG000|Double-blind Phase|Protocol Violation of Study Eligibility|1|||
48787008|NCT01934218|157059124|FG001|Double-blind Phase|Protocol Violation of Study Eligibility|2|||
48787009|NCT01934218|157059123|FG000|Open-Label Phase|Adverse Event|2|||
48787010|NCT01934218|157059124|FG001|Open-Label Phase|Adverse Event|4|||
48787011|NCT01934218|157059123|FG000|Open-Label Phase|Lack of Efficacy|1|||
48787012|NCT01934218|157059124|FG001|Open-Label Phase|Lack of Efficacy|4|||
48787013|NCT01934218|157059123|FG000|Open-Label Phase|Lost to Follow-up|4|||
48787014|NCT01934218|157059124|FG001|Open-Label Phase|Lost to Follow-up|2|||
48787015|NCT01934218|157059123|FG000|Open-Label Phase|Physician Decision|1|||
48787016|NCT01934218|157059124|FG001|Open-Label Phase|Physician Decision|0|||
48787017|NCT01934218|157059123|FG000|Open-Label Phase|Protocol Violation|1|||
48787018|NCT01934218|157059124|FG001|Open-Label Phase|Protocol Violation|0|||
48787019|NCT01934218|157059123|FG000|Open-Label Phase|Withdrawal by Subject|13|||
48787020|NCT01934218|157059124|FG001|Open-Label Phase|Withdrawal by Subject|11|||
48787021|NCT01934218|157059123|FG000|Open-Label Phase|Noncompliance with Study Protocol|4|||
48787022|NCT01934218|157059124|FG001|Open-Label Phase|Noncompliance with Study Protocol|2|||
48787023|NCT01934218|157059123|FG000|Open-Label Phase|Failure to Exam Primary Evaluation|0|||
48787024|NCT01934218|157059124|FG001|Open-Label Phase|Failure to Exam Primary Evaluation|1|||
48787025|NCT01365494|157059128|FG000|Overall Study|Adverse Event|1|||
48787026|NCT01365494|157059129|FG001|Overall Study|Adverse Event|0|||
48787027|NCT01365494|157059128|FG000|Overall Study|Withdrawal by Subject|0|||
48787028|NCT01365494|157059129|FG001|Overall Study|Withdrawal by Subject|1|||
48787029|NCT01365494|157059128|FG000|Overall Study|Lost to Follow-up|1|||
48787030|NCT01365494|157059129|FG001|Overall Study|Lost to Follow-up|2|||
48787031|NCT02648698|157061018|FG000|Overall Study|Protocol Violation|1|||
48787032|NCT02648698|157061019|FG001|Overall Study|Protocol Violation|5|||
48787033|NCT00116805|157061020|FG000|Double-blind Period Through Week 48|Lost to Follow-up|6|||
48787034|NCT00116805|157061021|FG001|Double-blind Period Through Week 48|Lost to Follow-up|2|||
48787035|NCT00116805|157061020|FG000|Double-blind Period Through Week 48|Protocol Violation|1|||
48787036|NCT00116805|157061021|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
48877596|NCT01015677|157390109|FG001|Overall Study|Lack of Efficacy|1|||
48787037|NCT00116805|157061020|FG000|Double-blind Period Through Week 48|Withdrew Consent|4|||
49031859|NCT01494532|157953468|FG004|Overall Study|Physician Decision|0|||
49031860|NCT01494532|157953469|FG005|Overall Study|Physician Decision|0|||
49031861|NCT01494532|157953464|FG000|Overall Study|Withdrawal by Subject|3|||
49031862|NCT01494532|157953465|FG001|Overall Study|Withdrawal by Subject|1|||
49031863|NCT01494532|157953466|FG002|Overall Study|Withdrawal by Subject|4|||
49031864|NCT01494532|157953467|FG003|Overall Study|Withdrawal by Subject|3|||
48787038|NCT00116805|157061021|FG001|Double-blind Period Through Week 48|Withdrew Consent|2|||
48787039|NCT00116805|157061020|FG000|Open-label Period Weeks 49 - 96|Investigator's Discretion|1|||
48787040|NCT00116805|157061021|FG001|Open-label Period Weeks 49 - 96|Investigator's Discretion|0|||
48787041|NCT00116805|157061020|FG000|Open-label Period Weeks 49 - 96|Lost to Follow-up|2|||
48787042|NCT00116805|157061021|FG001|Open-label Period Weeks 49 - 96|Lost to Follow-up|0|||
48787043|NCT00116805|157061020|FG000|Open-label Period Weeks 49 - 96|Protocol Violation|2|||
48787044|NCT00116805|157061021|FG001|Open-label Period Weeks 49 - 96|Protocol Violation|0|||
48787045|NCT00116805|157061020|FG000|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
48787046|NCT00116805|157061021|FG001|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0|||
48787047|NCT00116805|157061020|FG000|Open-label Period Weeks 49 - 96|Seroconversion|2|||
48787048|NCT00116805|157061021|FG001|Open-label Period Weeks 49 - 96|Seroconversion|0|||
48877597|NCT01015677|157390110|FG002|Overall Study|Lack of Efficacy|0|||
48877598|NCT01015677|157390108|FG000|Overall Study|Protocol Violation|0|||
48877599|NCT01015677|157390109|FG001|Overall Study|Protocol Violation|1|||
48877600|NCT01015677|157390110|FG002|Overall Study|Protocol Violation|0|||
48877601|NCT01015677|157390108|FG000|Overall Study|Withdrawal by Subject|1|||
48877602|NCT01015677|157390109|FG001|Overall Study|Withdrawal by Subject|1|||
48877603|NCT01015677|157390110|FG002|Overall Study|Withdrawal by Subject|0|||
48877604|NCT02229227|157390111|FG000|Overall Study|Adverse Event|14|||
48877605|NCT02229227|157390112|FG001|Overall Study|Adverse Event|9|||
48877606|NCT02229227|157390111|FG000|Overall Study|Lack of Efficacy|3|||
48877607|NCT02229227|157390112|FG001|Overall Study|Lack of Efficacy|3|||
48877608|NCT02229227|157390111|FG000|Overall Study|Protocol Violation|6|||
48877609|NCT02229227|157390112|FG001|Overall Study|Protocol Violation|8|||
48877610|NCT02229227|157390111|FG000|Overall Study|Protocol defined stopping criteria|1|||
48877611|NCT02229227|157390112|FG001|Overall Study|Protocol defined stopping criteria|3|||
48877612|NCT02229227|157390111|FG000|Overall Study|Lost to Follow-up|3|||
48877613|NCT02229227|157390112|FG001|Overall Study|Lost to Follow-up|3|||
48877614|NCT02229227|157390111|FG000|Overall Study|Study terminated by sponsor|11|||
48877615|NCT02229227|157390112|FG001|Overall Study|Study terminated by sponsor|11|||
48877616|NCT02229227|157390111|FG000|Overall Study|Withdrawal by Subject|8|||
48877617|NCT02229227|157390112|FG001|Overall Study|Withdrawal by Subject|12|||
48877618|NCT02229227|157390111|FG000|Overall Study|Other|0|||
48877619|NCT02229227|157390112|FG001|Overall Study|Other|1|||
48877620|NCT02229227|157390111|FG000|Overall Study|Physician Decision|5|||
48877621|NCT02229227|157390112|FG001|Overall Study|Physician Decision|12|||
48877622|NCT00872001|157390115|FG000|Overall Study|Adverse Event|34|||
48877623|NCT00872001|157390116|FG001|Overall Study|Adverse Event|23|||
48877624|NCT00872001|157390115|FG000|Overall Study|Protocol Defined Clinical Event|5|||
48877625|NCT00872001|157390116|FG001|Overall Study|Protocol Defined Clinical Event|7|||
48877626|NCT00872001|157390115|FG000|Overall Study|Lost to Follow-up|13|||
48877627|NCT00872001|157390116|FG001|Overall Study|Lost to Follow-up|12|||
48877628|NCT00872001|157390115|FG000|Overall Study|Withdrawal by Subject|18|||
48877629|NCT00872001|157390116|FG001|Overall Study|Withdrawal by Subject|30|||
48877630|NCT00872001|157390115|FG000|Overall Study|Protocol Violation|5|||
48877631|NCT00872001|157390116|FG001|Overall Study|Protocol Violation|8|||
48877632|NCT00872001|157390115|FG000|Overall Study|Did Not Meet Protocol Eligibility|38|||
48877633|NCT00872001|157390116|FG001|Overall Study|Did Not Meet Protocol Eligibility|36|||
48877634|NCT00872001|157390115|FG000|Overall Study|Administrative|23|||
48877635|NCT00872001|157390116|FG001|Overall Study|Administrative|15|||
48877636|NCT01453023|157390117|FG000|Treatment Period (TP) 1|Protocol Violation|1|||
48877637|NCT01453023|157390118|FG001|Treatment Period (TP) 1|Protocol Violation|0|||
48877638|NCT01453023|157390117|FG000|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0|||
48877639|NCT01453023|157390118|FG001|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1|||
48877640|NCT01453023|157390117|FG000|Treatment Period 2|Protocol Violation|0|||
48877641|NCT01453023|157390118|FG001|Treatment Period 2|Protocol Violation|1|||
48877642|NCT02232399|157390119|FG000|Overall Study|Adverse Event|1|||
48877643|NCT02232399|157390120|FG001|Overall Study|Adverse Event|0|||
49031865|NCT01494532|157953468|FG004|Overall Study|Withdrawal by Subject|2|||
48877644|NCT02232399|157390119|FG000|Overall Study|Withdrawal by Subject|0|||
48877645|NCT02232399|157390120|FG001|Overall Study|Withdrawal by Subject|1|||
48877646|NCT01660256|157390121|FG000|Overall Study|Adverse Event|4|||
48877647|NCT01660256|157390122|FG001|Overall Study|Adverse Event|0|||
48877648|NCT01660256|157390123|FG002|Overall Study|Adverse Event|2|||
48877649|NCT01660256|157390121|FG000|Overall Study|Withdrawal by Subject|1|||
48877650|NCT01660256|157390122|FG001|Overall Study|Withdrawal by Subject|0|||
48877651|NCT01660256|157390123|FG002|Overall Study|Withdrawal by Subject|2|||
49031866|NCT01494532|157953469|FG005|Overall Study|Withdrawal by Subject|0|||
48877652|NCT04468230|157390126|FG000|Overall Study|Adverse Event|2|||
48877653|NCT05177848|157390127|FG000|Overall Study|Lost to Follow-up|1|||
48877654|NCT05177848|157390128|FG001|Overall Study|Lost to Follow-up|4|||
48877655|NCT05177848|157390127|FG000|Overall Study|Discontinued|2|||
48877656|NCT05177848|157390128|FG001|Overall Study|Discontinued|1|||
48877657|NCT00794924|157390134|FG000|Overall Study|Lost to Follow-up|6|||
48877658|NCT00794924|157390135|FG001|Overall Study|Lost to Follow-up|8|||
48877659|NCT00794924|157390134|FG000|Overall Study|Withdrawal by Subject|48|||
48877660|NCT00794924|157390135|FG001|Overall Study|Withdrawal by Subject|60|||
48983092|NCT02394028|157769988|FG002|Induction Phase|Physician Decision|1|||
48983093|NCT02394028|157769989|FG003|Induction Phase|Physician Decision|4|||
48983094|NCT02394028|157769990|FG004|Induction Phase|Physician Decision|0|||
48983095|NCT02394028|157769991|FG005|Induction Phase|Physician Decision|2|||
48983096|NCT02394028|157769992|FG006|Induction Phase|Physician Decision|1|||
48983097|NCT02394028|157769993|FG007|Induction Phase|Physician Decision|0|||
48983098|NCT02394028|157769994|FG008|Induction Phase|Physician Decision|0|||
48983099|NCT02394028|157769995|FG009|Induction Phase|Physician Decision|0|||
48983100|NCT02394028|157769996|FG010|Induction Phase|Physician Decision|0|||
48983101|NCT02394028|157769986|FG000|Induction Phase|Protocol Violation|0|||
48983102|NCT02394028|157769987|FG001|Induction Phase|Protocol Violation|2|||
48983103|NCT02394028|157769988|FG002|Induction Phase|Protocol Violation|0|||
48983104|NCT02394028|157769989|FG003|Induction Phase|Protocol Violation|3|||
48983105|NCT02394028|157769990|FG004|Induction Phase|Protocol Violation|0|||
48983106|NCT02394028|157769991|FG005|Induction Phase|Protocol Violation|1|||
48983107|NCT02394028|157769992|FG006|Induction Phase|Protocol Violation|1|||
48983108|NCT02394028|157769993|FG007|Induction Phase|Protocol Violation|0|||
48983109|NCT02394028|157769994|FG008|Induction Phase|Protocol Violation|0|||
48983110|NCT02394028|157769995|FG009|Induction Phase|Protocol Violation|0|||
48983111|NCT02394028|157769996|FG010|Induction Phase|Protocol Violation|0|||
48983112|NCT02394028|157769986|FG000|Induction Phase|Withdrawal by Subject|1|||
48983113|NCT02394028|157769987|FG001|Induction Phase|Withdrawal by Subject|2|||
48983114|NCT02394028|157769988|FG002|Induction Phase|Withdrawal by Subject|4|||
48983115|NCT02394028|157769989|FG003|Induction Phase|Withdrawal by Subject|6|||
48983116|NCT02394028|157769990|FG004|Induction Phase|Withdrawal by Subject|7|||
48983117|NCT02394028|157769991|FG005|Induction Phase|Withdrawal by Subject|4|||
48983118|NCT02394028|157769992|FG006|Induction Phase|Withdrawal by Subject|3|||
48983119|NCT02394028|157769993|FG007|Induction Phase|Withdrawal by Subject|6|||
48983120|NCT02394028|157769994|FG008|Induction Phase|Withdrawal by Subject|0|||
48983121|NCT02394028|157769995|FG009|Induction Phase|Withdrawal by Subject|0|||
48983122|NCT02394028|157769996|FG010|Induction Phase|Withdrawal by Subject|0|||
48983123|NCT02394028|157769986|FG000|Induction Phase|Early withdrawal and roll over to a different study|0|||
48983124|NCT02394028|157769987|FG001|Induction Phase|Early withdrawal and roll over to a different study|0|||
48983125|NCT02394028|157769988|FG002|Induction Phase|Early withdrawal and roll over to a different study|0|||
48983126|NCT02394028|157769989|FG003|Induction Phase|Early withdrawal and roll over to a different study|0|||
48983127|NCT02394028|157769990|FG004|Induction Phase|Early withdrawal and roll over to a different study|0|||
48983128|NCT02394028|157769991|FG005|Induction Phase|Early withdrawal and roll over to a different study|0|||
48983129|NCT02394028|157769992|FG006|Induction Phase|Early withdrawal and roll over to a different study|1|||
48983130|NCT02394028|157769993|FG007|Induction Phase|Early withdrawal and roll over to a different study|0|||
48983131|NCT02394028|157769994|FG008|Induction Phase|Early withdrawal and roll over to a different study|0|||
48983132|NCT02394028|157769995|FG009|Induction Phase|Early withdrawal and roll over to a different study|0|||
48983133|NCT02394028|157769996|FG010|Induction Phase|Early withdrawal and roll over to a different study|0|||
48983134|NCT02394028|157769986|FG000|Induction Phase|Sponsor decision|0|||
48983135|NCT02394028|157769987|FG001|Induction Phase|Sponsor decision|1|||
48983136|NCT02394028|157769988|FG002|Induction Phase|Sponsor decision|2|||
48983137|NCT02394028|157769989|FG003|Induction Phase|Sponsor decision|0|||
48983138|NCT02394028|157769990|FG004|Induction Phase|Sponsor decision|0|||
48983139|NCT02394028|157769991|FG005|Induction Phase|Sponsor decision|0|||
48983140|NCT02394028|157769992|FG006|Induction Phase|Sponsor decision|0|||
48787049|NCT00116805|157061020|FG000|Open-label Period Weeks 49 - 96|Withdrew Consent|2|||
48787050|NCT00116805|157061021|FG001|Open-label Period Weeks 49 - 96|Withdrew Consent|1|||
48787051|NCT00116805|157061020|FG000|Open-label Period Weeks 97 - 144|Completed Study|1|||
48787052|NCT00116805|157061021|FG001|Open-label Period Weeks 97 - 144|Completed Study|0|||
48787053|NCT00116805|157061020|FG000|Open-label Period Weeks 97 - 144|Investigator's Discretion|2|||
48787054|NCT00116805|157061021|FG001|Open-label Period Weeks 97 - 144|Investigator's Discretion|0|||
48787055|NCT00116805|157061020|FG000|Open-label Period Weeks 97 - 144|Lost to Follow-up|5|||
48787056|NCT00116805|157061021|FG001|Open-label Period Weeks 97 - 144|Lost to Follow-up|2|||
48983141|NCT02394028|157769993|FG007|Induction Phase|Sponsor decision|0|||
48983142|NCT02394028|157769994|FG008|Induction Phase|Sponsor decision|0|||
48983143|NCT02394028|157769995|FG009|Induction Phase|Sponsor decision|0|||
48983144|NCT02394028|157769996|FG010|Induction Phase|Sponsor decision|0|||
48983145|NCT02394028|157769986|FG000|Induction Phase|Technical reason|0|||
48983146|NCT02394028|157769987|FG001|Induction Phase|Technical reason|0|||
48787057|NCT00116805|157061020|FG000|Open-label Period Weeks 97 - 144|Protocol Violation|0|||
48787058|NCT00116805|157061021|FG001|Open-label Period Weeks 97 - 144|Protocol Violation|1|||
48787059|NCT00116805|157061020|FG000|Open-label Period Weeks 97 - 144|Seroconversion|2|||
48787060|NCT00116805|157061021|FG001|Open-label Period Weeks 97 - 144|Seroconversion|3|||
48787061|NCT00116805|157061020|FG000|Open-label Period Weeks 97 - 144|Withdrew Consent|1|||
48787062|NCT00116805|157061021|FG001|Open-label Period Weeks 97 - 144|Withdrew Consent|3|||
48787063|NCT00116805|157061020|FG000|Open-label Period Weeks 145 - 192|Completed Study|1|||
48787064|NCT00116805|157061021|FG001|Open-label Period Weeks 145 - 192|Completed Study|1|||
48787065|NCT00116805|157061020|FG000|Open-label Period Weeks 145 - 192|Investigator's Discretion|2|||
48787066|NCT00116805|157061021|FG001|Open-label Period Weeks 145 - 192|Investigator's Discretion|0|||
48787067|NCT00116805|157061020|FG000|Open-label Period Weeks 145 - 192|Lost to Follow-up|3|||
48787068|NCT00116805|157061021|FG001|Open-label Period Weeks 145 - 192|Lost to Follow-up|1|||
48787069|NCT00116805|157061020|FG000|Open-label Period Weeks 145 - 192|Protocol Violation|1|||
48787070|NCT00116805|157061021|FG001|Open-label Period Weeks 145 - 192|Protocol Violation|0|||
48787071|NCT00116805|157061020|FG000|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0|||
48787072|NCT00116805|157061021|FG001|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1|||
48787073|NCT00116805|157061020|FG000|Open-label Period Weeks 145 - 192|Seroconversion|0|||
48787074|NCT00116805|157061021|FG001|Open-label Period Weeks 145 - 192|Seroconversion|1|||
48787075|NCT00116805|157061020|FG000|Open-label Period Weeks 145 - 192|Withdrew Consent|3|||
48787076|NCT00116805|157061021|FG001|Open-label Period Weeks 145 - 192|Withdrew Consent|2|||
48787077|NCT00116805|157061020|FG000|Open-label Period Weeks 193 - 240|Completed Study|0|||
48787078|NCT00116805|157061021|FG001|Open-label Period Weeks 193 - 240|Completed Study|1|||
48787079|NCT00116805|157061020|FG000|Open-label Period Weeks 193 - 240|Investigator's Discretion|1|||
48787080|NCT00116805|157061021|FG001|Open-label Period Weeks 193 - 240|Investigator's Discretion|0|||
48787081|NCT00116805|157061020|FG000|Open-label Period Weeks 193 - 240|Lost to Follow-up|3|||
48787082|NCT00116805|157061021|FG001|Open-label Period Weeks 193 - 240|Lost to Follow-up|0|||
48787083|NCT00116805|157061020|FG000|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
48787084|NCT00116805|157061021|FG001|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
48787085|NCT00116805|157061020|FG000|Open-label Period Weeks 193 - 240|Withdrew Consent|7|||
48787086|NCT00116805|157061021|FG001|Open-label Period Weeks 193 - 240|Withdrew Consent|1|||
48787087|NCT00116805|157061020|FG000|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2|||
48787088|NCT00116805|157061021|FG001|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
48787089|NCT00116805|157061020|FG000|Open-label Period Weeks 241 - 288|Withdrew Consent|4|||
48787090|NCT00116805|157061021|FG001|Open-label Period Weeks 241 - 288|Withdrew Consent|0|||
48787091|NCT00116805|157061020|FG000|Open-label Period Weeks 289 - 336|Completed Study|0|||
48787092|NCT00116805|157061021|FG001|Open-label Period Weeks 289 - 336|Completed Study|1|||
48787093|NCT00116805|157061020|FG000|Open-label Period Weeks 289 - 336|Investigator's Discretion|3|||
48787094|NCT00116805|157061021|FG001|Open-label Period Weeks 289 - 336|Investigator's Discretion|2|||
48787095|NCT00116805|157061020|FG000|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
48787096|NCT00116805|157061021|FG001|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
48787097|NCT00116805|157061020|FG000|Open-label Period Weeks 289 - 336|Protocol Violation|0|||
48787098|NCT00116805|157061021|FG001|Open-label Period Weeks 289 - 336|Protocol Violation|1|||
48787099|NCT00116805|157061020|FG000|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0|||
48787100|NCT00116805|157061021|FG001|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1|||
48787101|NCT00116805|157061020|FG000|Open-label Period Weeks 289 - 336|Study Site Discontinued|0|||
48787102|NCT00116805|157061021|FG001|Open-label Period Weeks 289 - 336|Study Site Discontinued|1|||
48787103|NCT00116805|157061020|FG000|Open-label Period Weeks 289 - 336|Withdrew Consent|2|||
48787104|NCT00116805|157061021|FG001|Open-label Period Weeks 289 - 336|Withdrew Consent|0|||
48787105|NCT00116805|157061020|FG000|Open-label Period Weeks 337 - 384|Completed Study|1|||
48787106|NCT00116805|157061021|FG001|Open-label Period Weeks 337 - 384|Completed Study|0|||
48787107|NCT00116805|157061020|FG000|Open-label Period Weeks 337 - 384|Investigator's Discretion|1|||
48787108|NCT00116805|157061021|FG001|Open-label Period Weeks 337 - 384|Investigator's Discretion|0|||
48787109|NCT00116805|157061020|FG000|Open-label Period Weeks 337 - 384|Lost to Follow-up|2|||
48787110|NCT00116805|157061021|FG001|Open-label Period Weeks 337 - 384|Lost to Follow-up|0|||
48787111|NCT00116805|157061020|FG000|Open-label Period Weeks 337 - 384|Protocol Violation|1|||
48787112|NCT00116805|157061021|FG001|Open-label Period Weeks 337 - 384|Protocol Violation|0|||
48787113|NCT00116805|157061020|FG000|Open-label Period Weeks 337 - 384|Withdrew Consent|3|||
48787114|NCT00116805|157061021|FG001|Open-label Period Weeks 337 - 384|Withdrew Consent|1|||
48787115|NCT00116805|157061020|FG000|Open-label Period Weeks 385 - 432|Investigator's Discretion|1|||
48787116|NCT00116805|157061021|FG001|Open-label Period Weeks 385 - 432|Investigator's Discretion|0|||
48787117|NCT00116805|157061020|FG000|Open-label Period Weeks 385 - 432|Withdrew Consent|1|||
48787118|NCT00116805|157061021|FG001|Open-label Period Weeks 385 - 432|Withdrew Consent|0|||
48787119|NCT00116805|157061020|FG000|Open-label Period Weeks 433 - 480|Investigator's Discretion|1|||
48787120|NCT00116805|157061021|FG001|Open-label Period Weeks 433 - 480|Investigator's Discretion|0|||
48787121|NCT00116805|157061020|FG000|Open-label Period Weeks 433 - 480|Withdrew Consent|3|||
48787122|NCT00116805|157061021|FG001|Open-label Period Weeks 433 - 480|Withdrew Consent|0|||
48787123|NCT02053350|157061022|FG000|Overall Study|Withdrawal by Subject|1|||
48787124|NCT02053350|157061022|FG000|Overall Study|Adverse Event|4|||
48787125|NCT00317772|157061023|FG000|Overall Study|Adverse Event|0|||
48787126|NCT00317772|157061024|FG001|Overall Study|Adverse Event|0|||
48787127|NCT00317772|157061025|FG002|Overall Study|Adverse Event|0|||
48787128|NCT00317772|157061026|FG003|Overall Study|Adverse Event|2|||
48787129|NCT00317772|157061023|FG000|Overall Study|Disease Progression|2|||
48787130|NCT00317772|157061024|FG001|Overall Study|Disease Progression|2|||
48787131|NCT00317772|157061025|FG002|Overall Study|Disease Progression|1|||
48787132|NCT00317772|157061026|FG003|Overall Study|Disease Progression|7|||
48787133|NCT01159691|157061027|FG000|Overall Study|Lost to Follow-up|2|||
48787134|NCT01159691|157061027|FG000|Overall Study|Unknown reasons|1|||
48787135|NCT01159691|157061027|FG000|Overall Study|Discontinued Neupro due to Adverse Event|6|||
48787136|NCT01159691|157061027|FG000|Overall Study|Discontinued Neupro due to other reasons|1|||
48787137|NCT01159691|157061027|FG000|Overall Study|Disc. Neupro other & lost to follow-up|2|||
48787138|NCT01159691|157061027|FG000|Overall Study|Disc. Neupro other & unknown reasons|7|||
48787139|NCT01159691|157061027|FG000|Overall Study|Disc. Neupro due to AE & unknown reasons|2|||
48787140|NCT01159691|157061027|FG000|Overall Study|Disc. Neupro lack of efficacy & unknown|1|||
48787141|NCT03019536|157061031|FG000|Overall Study|Withdrawal by Subject|1|||
48787142|NCT03019536|157061032|FG001|Overall Study|Withdrawal by Subject|1|||
48787143|NCT03019536|157061033|FG002|Overall Study|Withdrawal by Subject|0|||
48787144|NCT03019536|157061031|FG000|Overall Study|Adverse Event|0|||
48787145|NCT03019536|157061032|FG001|Overall Study|Adverse Event|0|||
48787146|NCT03019536|157061033|FG002|Overall Study|Adverse Event|2|||
48787147|NCT00071487|157061038|FG000|52-Week Double-Blind Period|Adverse Event|5|||
48787148|NCT00071487|157061039|FG001|52-Week Double-Blind Period|Adverse Event|8|||
48787149|NCT00071487|157061040|FG002|52-Week Double-Blind Period|Adverse Event|4|||
48787150|NCT00071487|157061041|FG003|52-Week Double-Blind Period|Adverse Event|8|||
48787151|NCT00071487|157061038|FG000|52-Week Double-Blind Period|Lack of Efficacy|1|||
48787152|NCT00071487|157061039|FG001|52-Week Double-Blind Period|Lack of Efficacy|2|||
48787153|NCT00071487|157061040|FG002|52-Week Double-Blind Period|Lack of Efficacy|0|||
48787154|NCT00071487|157061041|FG003|52-Week Double-Blind Period|Lack of Efficacy|1|||
48787155|NCT00071487|157061038|FG000|52-Week Double-Blind Period|Withdrawal by Subject|7|||
48787156|NCT00071487|157061039|FG001|52-Week Double-Blind Period|Withdrawal by Subject|11|||
48787157|NCT00071487|157061040|FG002|52-Week Double-Blind Period|Withdrawal by Subject|7|||
48787158|NCT00071487|157061041|FG003|52-Week Double-Blind Period|Withdrawal by Subject|7|||
48787159|NCT00071487|157061038|FG000|52-Week Double-Blind Period|Physician Decision|1|||
48787160|NCT00071487|157061039|FG001|52-Week Double-Blind Period|Physician Decision|0|||
48787161|NCT00071487|157061040|FG002|52-Week Double-Blind Period|Physician Decision|0|||
48787162|NCT00071487|157061041|FG003|52-Week Double-Blind Period|Physician Decision|0|||
48787163|NCT00071487|157061038|FG000|52-Week Double-Blind Period|Lost to Follow-up|0|||
48787164|NCT00071487|157061039|FG001|52-Week Double-Blind Period|Lost to Follow-up|0|||
48787165|NCT00071487|157061040|FG002|52-Week Double-Blind Period|Lost to Follow-up|2|||
48787166|NCT00071487|157061041|FG003|52-Week Double-Blind Period|Lost to Follow-up|2|||
48787167|NCT00071487|157061038|FG000|52-Week Double-Blind Period|Pregnancy|0|||
48787168|NCT00071487|157061039|FG001|52-Week Double-Blind Period|Pregnancy|1|||
48787169|NCT00071487|157061040|FG002|52-Week Double-Blind Period|Pregnancy|0|||
48787170|NCT00071487|157061041|FG003|52-Week Double-Blind Period|Pregnancy|0|||
49031867|NCT01597245|157953470|FG000|Induction Period (Week 0 - Week 12)|Adverse Event|1|||
49031868|NCT01597245|157953471|FG001|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
49031869|NCT01597245|157953472|FG002|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
49031870|NCT01597245|157953473|FG003|Induction Period (Week 0 - Week 12)|Adverse Event|4|||
49031871|NCT01597245|157953474|FG004|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
48787171|NCT00071487|157061038|FG000|52-Week Double-Blind Period|Protocol Violation|0|||
48787172|NCT00071487|157061039|FG001|52-Week Double-Blind Period|Protocol Violation|1|||
48787173|NCT00071487|157061040|FG002|52-Week Double-Blind Period|Protocol Violation|1|||
48787174|NCT00071487|157061041|FG003|52-Week Double-Blind Period|Protocol Violation|0|||
48787175|NCT00071487|157061038|FG000|52-Week Double-Blind Period|Death|0|||
48787176|NCT00071487|157061039|FG001|52-Week Double-Blind Period|Death|1|||
48787177|NCT00071487|157061040|FG002|52-Week Double-Blind Period|Death|0|||
48787178|NCT00071487|157061041|FG003|52-Week Double-Blind Period|Death|0|||
48787179|NCT00071487|157061038|FG000|52-Week Double-Blind Period|Lack of Compliance|6|||
48787180|NCT00071487|157061039|FG001|52-Week Double-Blind Period|Lack of Compliance|3|||
48787181|NCT00071487|157061040|FG002|52-Week Double-Blind Period|Lack of Compliance|3|||
49031872|NCT01597245|157953475|FG005|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
49031873|NCT01597245|157953476|FG006|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
48787182|NCT00071487|157061041|FG003|52-Week Double-Blind Period|Lack of Compliance|3|||
48787183|NCT00071487|157061038|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
48787184|NCT00071487|157061039|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
48787185|NCT00071487|157061040|FG002|24-Week Open-Label Extension Period|Adverse Event|1|||
48787186|NCT00071487|157061041|FG003|24-Week Open-Label Extension Period|Adverse Event|6|||
48787187|NCT00071487|157061038|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
48787188|NCT00071487|157061039|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
48787189|NCT00071487|157061040|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
48787190|NCT00071487|157061041|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|3|||
48787191|NCT00071487|157061038|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
48787192|NCT00071487|157061039|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
48787193|NCT00071487|157061040|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
48787194|NCT00071487|157061041|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|9|||
48787195|NCT00071487|157061038|FG000|24-Week Open-Label Extension Period|Pregnancy|0|||
48787196|NCT00071487|157061039|FG001|24-Week Open-Label Extension Period|Pregnancy|0|||
48787197|NCT00071487|157061040|FG002|24-Week Open-Label Extension Period|Pregnancy|0|||
48787198|NCT00071487|157061041|FG003|24-Week Open-Label Extension Period|Pregnancy|1|||
48787199|NCT00071487|157061038|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
48787200|NCT00071487|157061039|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
48787201|NCT00071487|157061040|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
48787202|NCT00071487|157061041|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
48787203|NCT00071487|157061038|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
48787204|NCT00071487|157061039|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
48787205|NCT00071487|157061040|FG002|24-Week Open-Label Extension Period|Lack of Compliance|0|||
48787206|NCT00071487|157061041|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
48787207|NCT00352365|157061042|FG000|Induction Therapy|Adverse Event|7|||
48787208|NCT00352365|157061042|FG000|Induction Therapy|Progression/Relapse|8|||
48787209|NCT00352365|157061042|FG000|Induction Therapy|Death|7|||
48787210|NCT00352365|157061042|FG000|Induction Therapy|Not protocol specified|1|||
48787211|NCT00352365|157061042|FG000|Induction Therapy|Not eligible|3|||
48787212|NCT00352365|157061042|FG000|Induction Therapy|Death before starting protocol therapy|1|||
48787213|NCT00352365|157061042|FG000|Maintenance Therapy|Progression/Relapse|3|||
48787214|NCT00352365|157061042|FG000|Maintenance Therapy|Death|2|||
48787215|NCT00352365|157061042|FG000|Maintenance Therapy|Not protocol specified|3|||
48787216|NCT00352365|157061042|FG000|Maintenance Therapy|Not eligible|4|||
48787217|NCT00987467|157061043|FG000|Overall Study|Lost to Follow-up|2|||
48787218|NCT01517802|157061049|FG000|Overall Study|Death|1|||
48787219|NCT02590354|157061050|FG000|Phase 1|Active hepatitis B or C infection|1|||
48787220|NCT02590354|157061050|FG000|Phase 1|Confirmed neutrophil count <1200/µl|1|||
48787221|NCT02590354|157061050|FG000|Phase 1|Detectable level of HIV DNA or caRNA|75|||
48787222|NCT02590354|157061050|FG000|Phase 1|Subject does not want to participate|20|||
48787223|NCT02590354|157061050|FG000|Phase 1|Lost to Follow-up|1|||
48787224|NCT02590354|157061050|FG000|Phase 2 - Treatment Interruption|Lost to Follow-up|2|||
48787225|NCT00996996|157061051|FG000|Overall Study|Progressive Disease|10|||
48787226|NCT00996996|157061051|FG000|Overall Study|Non-compliance|8|||
48787227|NCT00996996|157061051|FG000|Overall Study|Lost to Follow-up|9|||
48787228|NCT00996996|157061051|FG000|Overall Study|Death|5|||
48787229|NCT00996996|157061051|FG000|Overall Study|Did Not Receive Study Medications|1|||
48787230|NCT04831736|157061054|FG000|Overall Study|Withdrawal by Subject|0|||
48787231|NCT04831736|157061055|FG001|Overall Study|Withdrawal by Subject|1|||
48787232|NCT01659021|157061069|FG000|Main Study|Adverse Event|2|||
48787233|NCT01659021|157061070|FG001|Main Study|Adverse Event|3|||
48787234|NCT01659021|157061069|FG000|Main Study|Lost to Follow-up|1|||
48787235|NCT01659021|157061070|FG001|Main Study|Lost to Follow-up|0|||
48787236|NCT01659021|157061069|FG000|Main Study|Unknown Reasons|2|||
48787237|NCT01659021|157061070|FG001|Main Study|Unknown Reasons|1|||
48787238|NCT01659021|157061069|FG000|Main Study|Physician Decision|34|||
48787239|NCT01659021|157061070|FG001|Main Study|Physician Decision|16|||
48787240|NCT01659021|157061069|FG000|Main Study|Withdrawal by Subject|19|||
48787241|NCT01659021|157061070|FG001|Main Study|Withdrawal by Subject|16|||
48787242|NCT01659021|157061069|FG000|Main Study|Study Terminated by Sponsor|16|||
48787243|NCT01659021|157061070|FG001|Main Study|Study Terminated by Sponsor|1|||
48787244|NCT01659021|157061069|FG000|Long-Term Follow Up|Lost to Follow-up|3|||
48787245|NCT01659021|157061070|FG001|Long-Term Follow Up|Lost to Follow-up|3|||
48787246|NCT01659021|157061069|FG000|Long-Term Follow Up|Withdrawal by Subject|2|||
48787247|NCT01659021|157061070|FG001|Long-Term Follow Up|Withdrawal by Subject|1|||
48787248|NCT03551938|157061071|FG000|3-Month Follow Up|Lost to Follow-up|39|||
48787249|NCT03551938|157061072|FG001|3-Month Follow Up|Lost to Follow-up|38|||
48787250|NCT03551938|157061071|FG000|6-Month Follow Up|Lost to Follow-up|46|||
48787251|NCT03551938|157061072|FG001|6-Month Follow Up|Lost to Follow-up|42|||
48787252|NCT03551938|157061071|FG000|9-Month Follow Up|Lost to Follow-up|44|||
48787253|NCT03551938|157061072|FG001|9-Month Follow Up|Lost to Follow-up|43|||
48787254|NCT02103439|157061073|FG000|Overall Study|Adverse Event|0|||
48787255|NCT02103439|157061074|FG001|Overall Study|Adverse Event|2|||
48787256|NCT02103439|157061073|FG000|Overall Study|Withdrawal by Subject|3|||
48787257|NCT02103439|157061074|FG001|Overall Study|Withdrawal by Subject|1|||
48787258|NCT01343368|157061075|FG000|Overall Study|Death|1|||
48787259|NCT01343368|157061076|FG001|Overall Study|Death|0|||
48787260|NCT01343368|157061075|FG000|Overall Study|Lost to Follow-up|1|||
48787261|NCT01343368|157061076|FG001|Overall Study|Lost to Follow-up|0|||
48787262|NCT02511431|157061077|FG000|Treatment|Lost to Follow-up|0|||
48787263|NCT02511431|157061078|FG001|Treatment|Lost to Follow-up|0|||
48787264|NCT02511431|157061079|FG002|Treatment|Lost to Follow-up|1|||
49031874|NCT01597245|157953477|FG007|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
49031875|NCT01597245|157953478|FG008|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
49031876|NCT01597245|157953479|FG009|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
49031877|NCT01597245|157953480|FG010|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
49031878|NCT01597245|157953481|FG011|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
49031879|NCT01597245|157953482|FG012|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
49031880|NCT01597245|157953483|FG013|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
49031881|NCT01597245|157953484|FG014|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
49031882|NCT01597245|157953485|FG015|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
49031883|NCT01597245|157953486|FG016|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
49031884|NCT01597245|157953487|FG017|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
49031885|NCT01597245|157953488|FG018|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
49031886|NCT01597245|157953489|FG019|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
49031887|NCT01597245|157953490|FG020|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
49031888|NCT01597245|157953470|FG000|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
49031889|NCT01597245|157953471|FG001|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8|||
49031890|NCT01597245|157953472|FG002|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6|||
49031891|NCT01597245|157953473|FG003|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
49031892|NCT01597245|157953474|FG004|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
49031893|NCT01597245|157953475|FG005|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
49031894|NCT01597245|157953476|FG006|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
49031895|NCT01597245|157953477|FG007|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
49031896|NCT01597245|157953478|FG008|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
49031897|NCT01597245|157953479|FG009|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
49031898|NCT01597245|157953480|FG010|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
49031899|NCT01597245|157953481|FG011|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
49031900|NCT01597245|157953482|FG012|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
49031901|NCT01597245|157953483|FG013|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
49031902|NCT01597245|157953484|FG014|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
49031903|NCT01597245|157953485|FG015|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
49031904|NCT01597245|157953486|FG016|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
49031905|NCT01597245|157953487|FG017|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
49031906|NCT01597245|157953488|FG018|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
49031907|NCT01597245|157953489|FG019|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
49031908|NCT01597245|157953490|FG020|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
49031909|NCT01597245|157953470|FG000|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
49031910|NCT01597245|157953471|FG001|Induction Period (Week 0 - Week 12)|Protocol Violation|4|||
49031911|NCT01597245|157953472|FG002|Induction Period (Week 0 - Week 12)|Protocol Violation|5|||
49031912|NCT01597245|157953473|FG003|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
49031913|NCT01597245|157953474|FG004|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
49031914|NCT01597245|157953475|FG005|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
49031915|NCT01597245|157953476|FG006|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
49031916|NCT01597245|157953477|FG007|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
48787265|NCT02511431|157061080|FG003|Treatment|Lost to Follow-up|0|||
48787266|NCT02511431|157061081|FG004|Treatment|Lost to Follow-up|0|||
48787267|NCT02511431|157061082|FG005|Treatment|Lost to Follow-up|1|||
48787268|NCT01369342|157061083|FG000|Overall Study|Withdrawal by Subject|7|||
48787269|NCT01369342|157061084|FG001|Overall Study|Withdrawal by Subject|7|||
48787270|NCT01369342|157061085|FG002|Overall Study|Withdrawal by Subject|2|||
48787271|NCT01369342|157061083|FG000|Overall Study|Lost to Follow-up|5|||
48787272|NCT01369342|157061084|FG001|Overall Study|Lost to Follow-up|2|||
48787273|NCT01369342|157061085|FG002|Overall Study|Lost to Follow-up|1|||
48787274|NCT01369342|157061083|FG000|Overall Study|Not Treated|1|||
48787275|NCT01369342|157061084|FG001|Overall Study|Not Treated|0|||
49031917|NCT01597245|157953478|FG008|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
49031918|NCT01597245|157953479|FG009|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
49031919|NCT01597245|157953480|FG010|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
49031920|NCT01597245|157953481|FG011|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
49031921|NCT01597245|157953482|FG012|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
49031922|NCT01597245|157953483|FG013|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
49031923|NCT01597245|157953484|FG014|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
48787276|NCT01369342|157061085|FG002|Overall Study|Not Treated|0|||
48787277|NCT00321854|157061086|FG000|Overall Study|Adverse Event|41|||
48787278|NCT00321854|157061087|FG001|Overall Study|Adverse Event|43|||
48787279|NCT00321854|157061086|FG000|Overall Study|Lack of Efficacy|9|||
48787280|NCT00321854|157061087|FG001|Overall Study|Lack of Efficacy|14|||
48787281|NCT00321854|157061086|FG000|Overall Study|Protocol Violation|6|||
48787282|NCT00321854|157061087|FG001|Overall Study|Protocol Violation|5|||
48787283|NCT00321854|157061086|FG000|Overall Study|Lost to Follow-up|0|||
48787284|NCT00321854|157061087|FG001|Overall Study|Lost to Follow-up|2|||
48787285|NCT00321854|157061086|FG000|Overall Study|Withdrawal by Subject|6|||
48787286|NCT00321854|157061087|FG001|Overall Study|Withdrawal by Subject|17|||
48787287|NCT00321854|157061086|FG000|Overall Study|Other|1|||
48787288|NCT00321854|157061087|FG001|Overall Study|Other|1|||
48877661|NCT00794924|157390134|FG000|Overall Study|Adverse Event|6|||
48877662|NCT00794924|157390135|FG001|Overall Study|Adverse Event|2|||
48877663|NCT00727506|157390136|FG000|Overall Study|Adverse Event|0|||
48877664|NCT00727506|157390137|FG001|Overall Study|Adverse Event|0|||
48877665|NCT00727506|157390138|FG002|Overall Study|Adverse Event|4|||
48877666|NCT00727506|157390139|FG003|Overall Study|Adverse Event|4|||
48877667|NCT00727506|157390140|FG004|Overall Study|Adverse Event|1|||
48877668|NCT00727506|157390141|FG005|Overall Study|Adverse Event|8|||
48877669|NCT00727506|157390136|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
48877670|NCT00727506|157390137|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
48877671|NCT00727506|157390138|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
48877672|NCT00727506|157390139|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
48787289|NCT00413153|157061090|FG000|Overall Study|Withdrawal by Subject|1|||
48787290|NCT00413153|157061091|FG001|Overall Study|Withdrawal by Subject|1|||
48787291|NCT00413153|157061090|FG000|Overall Study|Adverse Event|1|||
48787292|NCT00413153|157061091|FG001|Overall Study|Adverse Event|0|||
48787293|NCT01571362|157061092|FG000|Open-Label Conversion + Titration Period|Withdrawal by Subject|11|||
48787294|NCT01571362|157061093|FG001|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
48787295|NCT01571362|157061094|FG002|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
48787296|NCT01571362|157061092|FG000|Open-Label Conversion + Titration Period|Protocol Violation|7|||
48787297|NCT01571362|157061093|FG001|Open-Label Conversion + Titration Period|Protocol Violation|0|||
48787298|NCT01571362|157061094|FG002|Open-Label Conversion + Titration Period|Protocol Violation|0|||
48787299|NCT01571362|157061092|FG000|Open-Label Conversion + Titration Period|Adverse Event|57|||
48787300|NCT01571362|157061093|FG001|Open-Label Conversion + Titration Period|Adverse Event|0|||
48787301|NCT01571362|157061094|FG002|Open-Label Conversion + Titration Period|Adverse Event|0|||
48787302|NCT01571362|157061092|FG000|Open-Label Conversion + Titration Period|Lost to Follow-up|10|||
48787303|NCT01571362|157061093|FG001|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
48787304|NCT01571362|157061094|FG002|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
48787305|NCT01571362|157061092|FG000|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41|||
48787306|NCT01571362|157061093|FG001|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
48787307|NCT01571362|157061094|FG002|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
48787308|NCT01571362|157061092|FG000|Open-Label Conversion + Titration Period|Other - unspecified|3|||
48787309|NCT01571362|157061093|FG001|Open-Label Conversion + Titration Period|Other - unspecified|0|||
48787310|NCT01571362|157061094|FG002|Open-Label Conversion + Titration Period|Other - unspecified|0|||
48787311|NCT01571362|157061092|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
48787312|NCT01571362|157061093|FG001|Double-Blind Treatment Period|Withdrawal by Subject|11|||
48787313|NCT01571362|157061094|FG002|Double-Blind Treatment Period|Withdrawal by Subject|5|||
48787314|NCT01571362|157061092|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
48787315|NCT01571362|157061093|FG001|Double-Blind Treatment Period|Protocol Violation|8|||
48787316|NCT01571362|157061094|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
48787317|NCT01571362|157061092|FG000|Double-Blind Treatment Period|Adverse Event|0|||
48787318|NCT01571362|157061093|FG001|Double-Blind Treatment Period|Adverse Event|9|||
48787319|NCT01571362|157061094|FG002|Double-Blind Treatment Period|Adverse Event|14|||
48787320|NCT01571362|157061092|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
48787321|NCT01571362|157061093|FG001|Double-Blind Treatment Period|Lost to Follow-up|3|||
48787322|NCT01571362|157061094|FG002|Double-Blind Treatment Period|Lost to Follow-up|6|||
48787323|NCT01571362|157061092|FG000|Double-Blind Treatment Period|Insufficient clinical response|0|||
48787324|NCT01571362|157061093|FG001|Double-Blind Treatment Period|Insufficient clinical response|16|||
48787325|NCT01571362|157061094|FG002|Double-Blind Treatment Period|Insufficient clinical response|4|||
48787326|NCT01571362|157061092|FG000|Double-Blind Treatment Period|Other - unspecified|0|||
48787327|NCT01571362|157061093|FG001|Double-Blind Treatment Period|Other - unspecified|6|||
48787328|NCT01571362|157061094|FG002|Double-Blind Treatment Period|Other - unspecified|1|||
48787329|NCT03667053|157061098|FG000|Overall Study|Withdrawal by Subject|1|||
48787330|NCT03667053|157061099|FG001|Overall Study|Withdrawal by Subject|0|||
48787331|NCT03667053|157061100|FG002|Overall Study|Withdrawal by Subject|0|||
48787332|NCT01127178|157061102|FG000|Dose Escalation: Treatment Phase|Adverse Event|1|||
48787333|NCT01127178|157061103|FG001|Dose Escalation: Treatment Phase|Adverse Event|0|||
48787334|NCT01127178|157061102|FG000|Dose Escalation: Treatment Phase|Withdrawal by Subject|1|||
48877673|NCT00727506|157390140|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
48877674|NCT00727506|157390141|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
48787335|NCT01127178|157061103|FG001|Dose Escalation: Treatment Phase|Withdrawal by Subject|0|||
48877675|NCT00727506|157390136|FG000|Overall Study|Progressive disease|4|||
48877676|NCT00727506|157390137|FG001|Overall Study|Progressive disease|7|||
48787336|NCT01127178|157061102|FG000|Dose Escalation: Treatment Phase|Other|2|||
48787337|NCT01127178|157061103|FG001|Dose Escalation: Treatment Phase|Other|0|||
48787338|NCT01127178|157061102|FG000|Dose Escalation: Extension Phase|Adverse Event|0|||
48787339|NCT01127178|157061103|FG001|Dose Escalation: Extension Phase|Adverse Event|1|||
48787340|NCT01127178|157061102|FG000|Dose Escalation: Extension Phase|Withdrawal by Subject|1|||
48787341|NCT01127178|157061103|FG001|Dose Escalation: Extension Phase|Withdrawal by Subject|0|||
48787342|NCT01127178|157061102|FG000|Dose Escalation: Extension Phase|Other|1|||
48787343|NCT01127178|157061103|FG001|Dose Escalation: Extension Phase|Other|0|||
48787344|NCT04971395|157061106|FG000|Overall Study|Withdrawal by Subject|0|||
48787345|NCT04971395|157061107|FG001|Overall Study|Withdrawal by Subject|1|||
48787346|NCT04971395|157061108|FG002|Overall Study|Withdrawal by Subject|0|||
48787347|NCT03264989|157061109|FG000|Overall Study|Lost to Follow-up|1|||
48787348|NCT03264989|157061110|FG001|Overall Study|Lost to Follow-up|0|||
48787349|NCT03264989|157061109|FG000|Overall Study|New Therapy for study Indication|1|||
48787350|NCT03264989|157061110|FG001|Overall Study|New Therapy for study Indication|0|||
48787351|NCT03264989|157061109|FG000|Overall Study|Protocol Violation|0|||
48787352|NCT03264989|157061110|FG001|Overall Study|Protocol Violation|1|||
48787353|NCT03264989|157061109|FG000|Overall Study|Patient decision|13|||
48787354|NCT03264989|157061110|FG001|Overall Study|Patient decision|0|||
48787355|NCT03264989|157061109|FG000|Overall Study|Physician Decision|6|||
48787356|NCT03264989|157061110|FG001|Overall Study|Physician Decision|4|||
48787357|NCT03264989|157061109|FG000|Overall Study|Adverse Event|2|||
48787358|NCT03264989|157061110|FG001|Overall Study|Adverse Event|1|||
48787359|NCT03264989|157061109|FG000|Overall Study|Death|1|||
48787360|NCT03264989|157061110|FG001|Overall Study|Death|1|||
48787361|NCT03264989|157061109|FG000|Overall Study|Pregnancy|2|||
48787362|NCT03264989|157061110|FG001|Overall Study|Pregnancy|0|||
48787363|NCT03264989|157061109|FG000|Overall Study|End of Study|19|||
48787364|NCT03264989|157061110|FG001|Overall Study|End of Study|5|||
48787365|NCT04185298|157061111|FG000|Overall Study|Lost to Follow-up|1|||
48787366|NCT04185298|157061112|FG001|Overall Study|Lost to Follow-up|3|||
48787367|NCT04185298|157061111|FG000|Overall Study|Withdrawal by Subject|0|||
48787368|NCT04185298|157061112|FG001|Overall Study|Withdrawal by Subject|3|||
48787369|NCT01310036|157061121|FG000|Overall Study|Administrative/other|10|||
48787370|NCT01310036|157061121|FG000|Overall Study|Withdrew Consent|11|||
48787371|NCT01310036|157061121|FG000|Overall Study|Refused Treatment/Did not Cooperate|4|||
48787372|NCT01310036|157061121|FG000|Overall Study|Progression of Disease|164|||
48787373|NCT01310036|157061121|FG000|Overall Study|Death|1|||
48787374|NCT01310036|157061121|FG000|Overall Study|Adverse event or intercurrent illness|12|||
48787375|NCT01175668|157061122|FG000|Overall Study|Withdrawal by Subject|2|||
48787376|NCT01175668|157061123|FG001|Overall Study|Withdrawal by Subject|0|||
48787377|NCT04575467|157061126|FG000|Overall Study|Adverse Event|0|||
48787378|NCT04575467|157061127|FG001|Overall Study|Adverse Event|1|||
48787379|NCT04575467|157061128|FG002|Overall Study|Adverse Event|0|||
48787380|NCT04575467|157061129|FG003|Overall Study|Adverse Event|0|||
48787381|NCT03085810|157061130|FG000|Main Study|Withdrawal by Subject|77|||
48787382|NCT03085810|157061131|FG001|Main Study|Withdrawal by Subject|0|||
48787383|NCT03085810|157061132|FG002|Main Study|Withdrawal by Subject|0|||
48787384|NCT03085810|157061130|FG000|Main Study|Terminated By Sponsor|14|||
48787385|NCT03085810|157061131|FG001|Main Study|Terminated By Sponsor|0|||
48787386|NCT03085810|157061132|FG002|Main Study|Terminated By Sponsor|0|||
48787387|NCT03085810|157061130|FG000|Main Study|Protocol Violation|15|||
48787388|NCT03085810|157061131|FG001|Main Study|Protocol Violation|0|||
48787389|NCT03085810|157061132|FG002|Main Study|Protocol Violation|0|||
48787390|NCT03085810|157061130|FG000|Main Study|Physician Decision|13|||
48787391|NCT03085810|157061131|FG001|Main Study|Physician Decision|0|||
48787392|NCT03085810|157061132|FG002|Main Study|Physician Decision|0|||
48787393|NCT03085810|157061130|FG000|Main Study|Lost to Follow-up|17|||
48787394|NCT03085810|157061131|FG001|Main Study|Lost to Follow-up|0|||
48787395|NCT03085810|157061132|FG002|Main Study|Lost to Follow-up|0|||
48787396|NCT03085810|157061130|FG000|Main Study|Adverse Event|25|||
48787397|NCT03085810|157061131|FG001|Main Study|Adverse Event|0|||
48787398|NCT03085810|157061132|FG002|Main Study|Adverse Event|0|||
49031924|NCT01597245|157953485|FG015|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
49031925|NCT01597245|157953486|FG016|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
49031926|NCT01597245|157953487|FG017|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
48787399|NCT03085810|157061130|FG000|Main Study|Pregnancy|7|||
48787400|NCT03085810|157061131|FG001|Main Study|Pregnancy|0|||
48787401|NCT03085810|157061132|FG002|Main Study|Pregnancy|0|||
48787402|NCT03085810|157061130|FG000|Main Study|Changed to Commercial Ocrelizumab|4|||
48787403|NCT03085810|157061131|FG001|Main Study|Changed to Commercial Ocrelizumab|0|||
48787404|NCT03085810|157061132|FG002|Main Study|Changed to Commercial Ocrelizumab|0|||
48787405|NCT03085810|157061130|FG000|Main Study|Lack of Efficacy|10|||
48787406|NCT03085810|157061131|FG001|Main Study|Lack of Efficacy|0|||
48787407|NCT03085810|157061132|FG002|Main Study|Lack of Efficacy|0|||
48787408|NCT03085810|157061130|FG000|Main Study|Death|12|||
48787409|NCT03085810|157061131|FG001|Main Study|Death|0|||
48787410|NCT03085810|157061132|FG002|Main Study|Death|0|||
48787411|NCT03085810|157061130|FG000|Main Study|Disease progression|1|||
48787412|NCT03085810|157061131|FG001|Main Study|Disease progression|0|||
49031927|NCT01597245|157953488|FG018|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
49031928|NCT01597245|157953489|FG019|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
48787413|NCT03085810|157061132|FG002|Main Study|Disease progression|0|||
48787414|NCT03085810|157061130|FG000|Main Study|Site Closure|3|||
48787415|NCT03085810|157061131|FG001|Main Study|Site Closure|0|||
48787416|NCT03085810|157061132|FG002|Main Study|Site Closure|0|||
48787417|NCT03085810|157061130|FG000|Main Study|Planned pregnancy|17|||
48787418|NCT03085810|157061131|FG001|Main Study|Planned pregnancy|0|||
48787419|NCT03085810|157061132|FG002|Main Study|Planned pregnancy|0|||
48787420|NCT03085810|157061130|FG000|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
48787421|NCT03085810|157061131|FG001|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
48787422|NCT03085810|157061132|FG002|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|3|||
48787423|NCT03085810|157061130|FG000|Substudy (Week 24 to Week 144)|Withdrawal by Subject|0|||
48787424|NCT03085810|157061131|FG001|Substudy (Week 24 to Week 144)|Withdrawal by Subject|5|||
48787425|NCT03085810|157061132|FG002|Substudy (Week 24 to Week 144)|Withdrawal by Subject|7|||
48787426|NCT03085810|157061130|FG000|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|0|||
48787427|NCT03085810|157061131|FG001|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|355|||
48787428|NCT03085810|157061132|FG002|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|352|||
48787429|NCT03085810|157061130|FG000|Substudy (Week 24 to Week 144)|Reason Not Specified|0|||
48787430|NCT03085810|157061131|FG001|Substudy (Week 24 to Week 144)|Reason Not Specified|13|||
48787431|NCT03085810|157061132|FG002|Substudy (Week 24 to Week 144)|Reason Not Specified|8|||
48787432|NCT00784043|157061135|FG000|Overall Study|Withdrawal by Subject|8|||
48787433|NCT00784043|157061136|FG001|Overall Study|Withdrawal by Subject|5|||
48787434|NCT00784043|157061135|FG000|Overall Study|Protocol Terminated|23|||
48787435|NCT00784043|157061136|FG001|Overall Study|Protocol Terminated|1|||
48787436|NCT02415400|157061137|FG000|Overall Study|Adverse Event|0|||
48787437|NCT02415400|157061138|FG001|Overall Study|Adverse Event|1|||
48787438|NCT02415400|157061139|FG002|Overall Study|Adverse Event|1|||
48787439|NCT02415400|157061140|FG003|Overall Study|Adverse Event|2|||
48787440|NCT02415400|157061137|FG000|Overall Study|Participant request to stop therapy|4|||
48787441|NCT02415400|157061138|FG001|Overall Study|Participant request to stop therapy|3|||
48787442|NCT02415400|157061139|FG002|Overall Study|Participant request to stop therapy|8|||
48787443|NCT02415400|157061140|FG003|Overall Study|Participant request to stop therapy|6|||
48787444|NCT02415400|157061137|FG000|Overall Study|Participant withdrew consent|14|||
48787445|NCT02415400|157061138|FG001|Overall Study|Participant withdrew consent|12|||
48787446|NCT02415400|157061139|FG002|Overall Study|Participant withdrew consent|30|||
48787447|NCT02415400|157061140|FG003|Overall Study|Participant withdrew consent|21|||
48787448|NCT02415400|157061137|FG000|Overall Study|Death|39|||
48787449|NCT02415400|157061138|FG001|Overall Study|Death|41|||
48787450|NCT02415400|157061139|FG002|Overall Study|Death|35|||
48787451|NCT02415400|157061140|FG003|Overall Study|Death|42|||
48787452|NCT02415400|157061137|FG000|Overall Study|Lost to Follow-up|3|||
48787453|NCT02415400|157061138|FG001|Overall Study|Lost to Follow-up|3|||
48787454|NCT02415400|157061139|FG002|Overall Study|Lost to Follow-up|2|||
48787455|NCT02415400|157061140|FG003|Overall Study|Lost to Follow-up|5|||
48787456|NCT02415400|157061137|FG000|Overall Study|Poor/Non-Compliance|0|||
48787457|NCT02415400|157061138|FG001|Overall Study|Poor/Non-Compliance|1|||
48787458|NCT02415400|157061139|FG002|Overall Study|Poor/Non-Compliance|3|||
48787459|NCT02415400|157061140|FG003|Overall Study|Poor/Non-Compliance|4|||
48787460|NCT02415400|157061137|FG000|Overall Study|Participant no longer meets criteria|2|||
48787461|NCT02415400|157061138|FG001|Overall Study|Participant no longer meets criteria|0|||
48787462|NCT02415400|157061139|FG002|Overall Study|Participant no longer meets criteria|0|||
48787463|NCT02415400|157061140|FG003|Overall Study|Participant no longer meets criteria|1|||
48787464|NCT02415400|157061137|FG000|Overall Study|Participant doesn't answer phone|1|||
48787465|NCT02415400|157061138|FG001|Overall Study|Participant doesn't answer phone|0|||
48787466|NCT02415400|157061139|FG002|Overall Study|Participant doesn't answer phone|0|||
48787467|NCT02415400|157061140|FG003|Overall Study|Participant doesn't answer phone|0|||
48787468|NCT02415400|157061137|FG000|Overall Study|Participant wanted home visits|1|||
48787469|NCT02415400|157061138|FG001|Overall Study|Participant wanted home visits|0|||
48787470|NCT02415400|157061139|FG002|Overall Study|Participant wanted home visits|0|||
48787471|NCT02415400|157061140|FG003|Overall Study|Participant wanted home visits|0|||
48787472|NCT02415400|157061137|FG000|Overall Study|Randomized in error|2|||
48787473|NCT02415400|157061138|FG001|Overall Study|Randomized in error|0|||
48787474|NCT02415400|157061139|FG002|Overall Study|Randomized in error|0|||
48787475|NCT02415400|157061140|FG003|Overall Study|Randomized in error|0|||
48787476|NCT02415400|157061137|FG000|Overall Study|No study drug on site|0|||
48787477|NCT02415400|157061138|FG001|Overall Study|No study drug on site|1|||
48787478|NCT02415400|157061139|FG002|Overall Study|No study drug on site|0|||
48787479|NCT02415400|157061140|FG003|Overall Study|No study drug on site|0|||
48787480|NCT02415400|157061137|FG000|Overall Study|Stroke and stroke rehabilitation|0|||
48787481|NCT02415400|157061138|FG001|Overall Study|Stroke and stroke rehabilitation|0|||
48787482|NCT02415400|157061139|FG002|Overall Study|Stroke and stroke rehabilitation|1|||
48787483|NCT02415400|157061140|FG003|Overall Study|Stroke and stroke rehabilitation|0|||
48787484|NCT02415400|157061137|FG000|Overall Study|Coagulation values cannot be set|0|||
48787485|NCT02415400|157061138|FG001|Overall Study|Coagulation values cannot be set|0|||
48787486|NCT02415400|157061139|FG002|Overall Study|Coagulation values cannot be set|1|||
48787487|NCT02415400|157061140|FG003|Overall Study|Coagulation values cannot be set|0|||
48787488|NCT02415400|157061137|FG000|Overall Study|State regulations prevent participation|0|||
48787489|NCT02415400|157061138|FG001|Overall Study|State regulations prevent participation|0|||
48787490|NCT02415400|157061139|FG002|Overall Study|State regulations prevent participation|1|||
48787491|NCT02415400|157061140|FG003|Overall Study|State regulations prevent participation|0|||
48787492|NCT02415400|157061137|FG000|Overall Study|Poor treatment monitoring|0|||
48787493|NCT02415400|157061138|FG001|Overall Study|Poor treatment monitoring|0|||
48787494|NCT02415400|157061139|FG002|Overall Study|Poor treatment monitoring|1|||
48787495|NCT02415400|157061140|FG003|Overall Study|Poor treatment monitoring|0|||
48787496|NCT02415400|157061137|FG000|Overall Study|Participant in jail|0|||
48787497|NCT02415400|157061138|FG001|Overall Study|Participant in jail|0|||
48787498|NCT02415400|157061139|FG002|Overall Study|Participant in jail|1|||
48787499|NCT02415400|157061140|FG003|Overall Study|Participant in jail|0|||
48787500|NCT02415400|157061137|FG000|Overall Study|Investigator decision|0|||
48787501|NCT02415400|157061138|FG001|Overall Study|Investigator decision|0|||
48787502|NCT02415400|157061139|FG002|Overall Study|Investigator decision|1|||
48787503|NCT02415400|157061140|FG003|Overall Study|Investigator decision|1|||
48787504|NCT02415400|157061137|FG000|Overall Study|Site closure; participant won't transfer|0|||
48787505|NCT02415400|157061138|FG001|Overall Study|Site closure; participant won't transfer|0|||
48787506|NCT02415400|157061139|FG002|Overall Study|Site closure; participant won't transfer|0|||
48787507|NCT02415400|157061140|FG003|Overall Study|Site closure; participant won't transfer|1|||
48787508|NCT02105948|157061144|FG000|Overall Study|Adverse Event|10|||
48787509|NCT02105948|157061145|FG001|Overall Study|Adverse Event|7|||
48787510|NCT02105948|157061146|FG002|Overall Study|Adverse Event|11|||
48877677|NCT00727506|157390138|FG002|Overall Study|Progressive disease|9|||
49031929|NCT01597245|157953490|FG020|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
49031930|NCT01597245|157953470|FG000|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1|||
49031931|NCT01597245|157953471|FG001|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5|||
48787511|NCT02105948|157061147|FG003|Overall Study|Adverse Event|11|||
48787512|NCT02105948|157061144|FG000|Overall Study|Lack of Efficacy|0|||
48787513|NCT02105948|157061145|FG001|Overall Study|Lack of Efficacy|1|||
48787514|NCT02105948|157061146|FG002|Overall Study|Lack of Efficacy|3|||
48787515|NCT02105948|157061147|FG003|Overall Study|Lack of Efficacy|2|||
48787516|NCT02105948|157061144|FG000|Overall Study|Lost to Follow-up|0|||
48787517|NCT02105948|157061145|FG001|Overall Study|Lost to Follow-up|0|||
48787518|NCT02105948|157061146|FG002|Overall Study|Lost to Follow-up|2|||
48787519|NCT02105948|157061147|FG003|Overall Study|Lost to Follow-up|1|||
48787520|NCT02105948|157061144|FG000|Overall Study|Physician Decision|2|||
48787521|NCT02105948|157061145|FG001|Overall Study|Physician Decision|2|||
48787522|NCT02105948|157061146|FG002|Overall Study|Physician Decision|2|||
48787523|NCT02105948|157061147|FG003|Overall Study|Physician Decision|2|||
48787524|NCT02105948|157061144|FG000|Overall Study|Withdrawal by Subject|15|||
48787525|NCT02105948|157061145|FG001|Overall Study|Withdrawal by Subject|10|||
48787526|NCT02105948|157061146|FG002|Overall Study|Withdrawal by Subject|10|||
48787527|NCT02105948|157061147|FG003|Overall Study|Withdrawal by Subject|11|||
48787528|NCT01650259|157061152|FG000|Overall Study|Improvement|105|||
48787529|NCT01650259|157061153|FG001|Overall Study|Improvement|0|||
48787530|NCT01650259|157061152|FG000|Overall Study|Adverse Event|127|||
48787531|NCT01650259|157061153|FG001|Overall Study|Adverse Event|0|||
48787532|NCT01650259|157061152|FG000|Overall Study|Lack of Efficacy|143|||
48787533|NCT01650259|157061153|FG001|Overall Study|Lack of Efficacy|0|||
48787534|NCT01650259|157061152|FG000|Overall Study|Lost to Follow-up|435|||
48787535|NCT01650259|157061153|FG001|Overall Study|Lost to Follow-up|0|||
48787536|NCT01650259|157061152|FG000|Overall Study|Patients had no visit after entry|70|||
48787537|NCT01650259|157061153|FG001|Overall Study|Patients had no visit after entry|0|||
48787538|NCT01650259|157061152|FG000|Overall Study|CRF not collected|98|||
48787539|NCT01650259|157061153|FG001|Overall Study|CRF not collected|82|||
48787540|NCT01650259|157061152|FG000|Overall Study|Not treated|1|||
48787541|NCT01650259|157061153|FG001|Overall Study|Not treated|7|||
48787542|NCT01650259|157061152|FG000|Overall Study|Other than listed|64|||
48787543|NCT01650259|157061153|FG001|Overall Study|Other than listed|146|||
48787544|NCT00936858|157061154|FG000|Overall Study|Death|3|||
48787545|NCT00936858|157061154|FG000|Overall Study|Progression|29|||
48787546|NCT00936858|157061154|FG000|Overall Study|Withdrawal by Subject|5|||
48787547|NCT00936858|157061154|FG000|Overall Study|Adverse Event|1|||
48787548|NCT00936858|157061154|FG000|Overall Study|Physician Decision|7|||
48787549|NCT00936858|157061154|FG000|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4|||
48787550|NCT00936858|157061154|FG000|Overall Study|Lost to Follow-up|1|||
48787551|NCT04615273|157061157|FG000|Overall Study|Withdrawal by Subject|3|||
48787552|NCT04615273|157061158|FG001|Overall Study|Withdrawal by Subject|1|||
48787553|NCT04615273|157061159|FG002|Overall Study|Withdrawal by Subject|2|||
48787554|NCT04615273|157061157|FG000|Overall Study|Adverse Event|1|||
48787555|NCT04615273|157061158|FG001|Overall Study|Adverse Event|0|||
48787556|NCT04615273|157061159|FG002|Overall Study|Adverse Event|1|||
48787557|NCT04615273|157061157|FG000|Overall Study|Lost to Follow-up|0|||
48787558|NCT04615273|157061158|FG001|Overall Study|Lost to Follow-up|1|||
48787559|NCT04615273|157061159|FG002|Overall Study|Lost to Follow-up|0|||
48787560|NCT04615273|157061157|FG000|Overall Study|Physician Decision|0|||
48787561|NCT04615273|157061158|FG001|Overall Study|Physician Decision|0|||
48787562|NCT04615273|157061159|FG002|Overall Study|Physician Decision|1|||
48787563|NCT04615273|157061157|FG000|Overall Study|Other|0|||
48787564|NCT04615273|157061158|FG001|Overall Study|Other|1|||
49031932|NCT01597245|157953472|FG002|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2|||
49031933|NCT01597245|157953473|FG003|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
49031934|NCT01597245|157953474|FG004|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
49031935|NCT01597245|157953475|FG005|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
49031936|NCT01597245|157953476|FG006|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
49031937|NCT01597245|157953477|FG007|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
49031938|NCT01597245|157953478|FG008|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
49031939|NCT01597245|157953479|FG009|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
49031940|NCT01597245|157953480|FG010|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
49031941|NCT01597245|157953481|FG011|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
49031942|NCT01597245|157953482|FG012|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
49031943|NCT01597245|157953483|FG013|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
49031944|NCT01597245|157953484|FG014|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
49031945|NCT01597245|157953485|FG015|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
49031946|NCT01597245|157953486|FG016|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
48787565|NCT04615273|157061159|FG002|Overall Study|Other|0|||
48787566|NCT04615273|157061157|FG000|Overall Study|Randomized but not treated|1|||
48787567|NCT04615273|157061158|FG001|Overall Study|Randomized but not treated|3|||
48787568|NCT04615273|157061159|FG002|Overall Study|Randomized but not treated|1|||
48787569|NCT00435370|157061165|FG000|Overall Study|Adverse Event|8|||
48787570|NCT00435370|157061166|FG001|Overall Study|Adverse Event|8|||
48787571|NCT00435370|157061165|FG000|Overall Study|Withdrawal by Subject|10|||
48787572|NCT00435370|157061166|FG001|Overall Study|Withdrawal by Subject|10|||
48787573|NCT00435370|157061165|FG000|Overall Study|Antipsychotic medication changed|4|||
48787574|NCT00435370|157061166|FG001|Overall Study|Antipsychotic medication changed|2|||
48787575|NCT03277313|157061169|FG000|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|1|||
48787576|NCT03277313|157061170|FG001|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|0|||
48787577|NCT03277313|157061169|FG000|Epoch 2 (36 Months After Epoch 1)|Adverse Event|0|||
48787578|NCT03277313|157061170|FG001|Epoch 2 (36 Months After Epoch 1)|Adverse Event|1|||
48787579|NCT03277313|157061169|FG000|Epoch 2 (36 Months After Epoch 1)|Physician Decision|0|||
48787580|NCT03277313|157061170|FG001|Epoch 2 (36 Months After Epoch 1)|Physician Decision|1|||
48787581|NCT03277313|157061169|FG000|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|0|||
48787582|NCT03277313|157061170|FG001|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|6|||
48787583|NCT03277313|157061169|FG000|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|0|||
48787584|NCT03277313|157061170|FG001|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|1|||
48787585|NCT01965834|157061171|FG000|Overall Study|Lack of Efficacy|4|||
48787586|NCT03943095|157061174|FG000|Overall Study|Incorrectly dispensed wrong box kit|0|||
48787587|NCT03943095|157061175|FG001|Overall Study|Incorrectly dispensed wrong box kit|1|||
48787588|NCT03943095|157061174|FG000|Overall Study|Withdrawal by Subject|1|||
48787589|NCT03943095|157061175|FG001|Overall Study|Withdrawal by Subject|0|||
48787590|NCT04571619|157061176|FG000|Phase 1|Death|22|||
48787591|NCT04571619|157061177|FG001|Phase 1|Death|18|||
48787592|NCT04571619|157061176|FG000|Phase 1|Withdrawal by Subject|7|||
48787593|NCT04571619|157061177|FG001|Phase 1|Withdrawal by Subject|2|||
48787594|NCT04571619|157061176|FG000|Phase 2|Death|13|||
48787595|NCT04571619|157061177|FG001|Phase 2|Death|16|||
48787596|NCT04571619|157061176|FG000|Phase 2|Withdrawal by Subject|6|||
48787597|NCT04571619|157061177|FG001|Phase 2|Withdrawal by Subject|4|||
49031947|NCT01597245|157953487|FG017|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
49031948|NCT01597245|157953488|FG018|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
48787598|NCT02493127|157061179|FG000|Overall Study|Lost to Follow-up|1|||
48787599|NCT02493127|157061180|FG001|Overall Study|Lost to Follow-up|1|||
48787600|NCT01660906|157061181|FG000|Overall Study|Discontinued due to study drug toxicity|3|||
48787601|NCT02096900|157061187|FG000|Overall Study|Did not receive medication|3|||
48787602|NCT02096900|157061188|FG001|Overall Study|Did not receive medication|1|||
48787603|NCT02096900|157061187|FG000|Overall Study|Surgery cancelled- medication received|1|||
48787604|NCT02096900|157061188|FG001|Overall Study|Surgery cancelled- medication received|1|||
48787605|NCT03896516|157063449|FG000|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|1|||
48787606|NCT03896516|157063450|FG001|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|0|||
48787607|NCT03896516|157063449|FG000|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
48787608|NCT03896516|157063450|FG001|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
48787609|NCT03896516|157063449|FG000|Washout Period|Physician Decision|3|||
48787610|NCT03896516|157063450|FG001|Washout Period|Physician Decision|1|||
48787611|NCT03896516|157063449|FG000|Stage II (GLWL-01 or Placebo)|Physician Decision|0|||
48787612|NCT03896516|157063450|FG001|Stage II (GLWL-01 or Placebo)|Physician Decision|1|||
48787613|NCT02605954|157063451|FG000|Overall Study|Adverse Event|5|||
48787614|NCT02605954|157063452|FG001|Overall Study|Adverse Event|1|||
48787615|NCT02605954|157063451|FG000|Overall Study|Investigator's Discretion|1|||
48787616|NCT02605954|157063452|FG001|Overall Study|Investigator's Discretion|0|||
48787617|NCT02605954|157063451|FG000|Overall Study|Non-Compliance with Study Drug|1|||
48787618|NCT02605954|157063452|FG001|Overall Study|Non-Compliance with Study Drug|0|||
48787619|NCT02605954|157063451|FG000|Overall Study|Withdrew Consent|2|||
48787620|NCT02605954|157063452|FG001|Overall Study|Withdrew Consent|2|||
48787621|NCT02605954|157063451|FG000|Overall Study|Lost to Follow-up|3|||
48787622|NCT02605954|157063452|FG001|Overall Study|Lost to Follow-up|0|||
48787623|NCT02605954|157063451|FG000|Overall Study|Randomized but not treated|0|||
48787624|NCT02605954|157063452|FG001|Overall Study|Randomized but not treated|1|||
48787625|NCT04739956|157063480|FG000|Overall Study|Withdrawal by Subject|1|||
48787626|NCT04739956|157063481|FG001|Overall Study|Withdrawal by Subject|1|||
48787627|NCT05794243|157063482|FG000|Overall Study|Withdrawal by Subject|1|||
48787628|NCT05794243|157063483|FG001|Overall Study|Withdrawal by Subject|0|||
48787629|NCT05794243|157063484|FG002|Overall Study|Withdrawal by Subject|1|||
48787630|NCT05794243|157063482|FG000|Overall Study|Physician Decision|0|||
48787631|NCT05794243|157063483|FG001|Overall Study|Physician Decision|3|||
48787632|NCT05794243|157063484|FG002|Overall Study|Physician Decision|1|||
48787633|NCT03150173|157063485|FG000|Overall Study|Lost to Follow-up|13|||
48787634|NCT03150173|157063486|FG001|Overall Study|Lost to Follow-up|5|||
48787635|NCT03133546|157063487|FG000|Overall Study|Death|46|||
48787636|NCT03133546|157063488|FG001|Overall Study|Death|43|||
48787637|NCT03133546|157063487|FG000|Overall Study|Withdrawal/Lost to follow-up|5|||
48787638|NCT03133546|157063488|FG001|Overall Study|Withdrawal/Lost to follow-up|7|||
48787639|NCT04979442|157063489|FG000|Overall Study|Death|43|||
48787640|NCT04979442|157063490|FG001|Overall Study|Death|30|||
48787641|NCT04979442|157063489|FG000|Overall Study|Withdrawal by Subject|8|||
48787642|NCT04979442|157063490|FG001|Overall Study|Withdrawal by Subject|13|||
48787643|NCT04979442|157063489|FG000|Overall Study|Physician Decision|1|||
48787644|NCT04979442|157063490|FG001|Overall Study|Physician Decision|1|||
48787645|NCT04979442|157063489|FG000|Overall Study|Lost to Follow-up|0|||
48787646|NCT04979442|157063490|FG001|Overall Study|Lost to Follow-up|2|||
48787647|NCT04979442|157063489|FG000|Overall Study|do not want to continue|0|||
48787648|NCT04979442|157063490|FG001|Overall Study|do not want to continue|1|||
48787649|NCT00833989|157063494|FG000|Overall Study|Physician Decision|0|||
48787650|NCT00833989|157063495|FG001|Overall Study|Physician Decision|0|||
48787651|NCT00833989|157063496|FG002|Overall Study|Physician Decision|0|||
48787652|NCT00833989|157063497|FG003|Overall Study|Physician Decision|1|||
48787653|NCT00833989|157063494|FG000|Overall Study|Withdrawal by Subject|3|||
48787654|NCT00833989|157063495|FG001|Overall Study|Withdrawal by Subject|0|||
48787655|NCT00833989|157063496|FG002|Overall Study|Withdrawal by Subject|1|||
48787656|NCT00833989|157063497|FG003|Overall Study|Withdrawal by Subject|1|||
48787657|NCT01949480|157063498|FG000|Overall Study|Physician Decision|5|||
48787658|NCT01949480|157063499|FG001|Overall Study|Physician Decision|8|||
48787659|NCT04053764|157063500|FG000|Overall Study|Withdrawal by Subject|6|||
48787660|NCT04053764|157063501|FG001|Overall Study|Withdrawal by Subject|2|||
48787661|NCT04053764|157063500|FG000|Overall Study|Physician Decision|2|||
48787662|NCT04053764|157063501|FG001|Overall Study|Physician Decision|1|||
48787663|NCT04053764|157063500|FG000|Overall Study|Adverse Event|1|||
48787664|NCT04053764|157063501|FG001|Overall Study|Adverse Event|0|||
48787665|NCT04053764|157063500|FG000|Overall Study|Pregnancy|1|||
48787666|NCT04053764|157063501|FG001|Overall Study|Pregnancy|0|||
48787667|NCT03998618|157063502|FG000|Overall Study|Death|7|||
48787668|NCT03998618|157063503|FG001|Overall Study|Death|11|||
48787669|NCT03998618|157063502|FG000|Overall Study|hospice enrollment|3|||
48787670|NCT03998618|157063503|FG001|Overall Study|hospice enrollment|3|||
48787671|NCT03998618|157063502|FG000|Overall Study|Not feeling well/health problems|3|||
48787672|NCT03998618|157063503|FG001|Overall Study|Not feeling well/health problems|5|||
48787673|NCT03998618|157063502|FG000|Overall Study|Lost to Follow-up|6|||
48877678|NCT00727506|157390139|FG003|Overall Study|Progressive disease|28|||
48877679|NCT00727506|157390140|FG004|Overall Study|Progressive disease|38|||
48787674|NCT03998618|157063503|FG001|Overall Study|Lost to Follow-up|6|||
48787675|NCT03998618|157063502|FG000|Overall Study|Withdrawal by Subject|0|||
48787676|NCT03998618|157063503|FG001|Overall Study|Withdrawal by Subject|4|||
48787677|NCT01910129|157063508|FG000|Randomized Phase 2|Withdrawal by Subject|2|||
48787678|NCT01910129|157063509|FG001|Randomized Phase 2|Withdrawal by Subject|1|||
48787679|NCT01910129|157063510|FG002|Randomized Phase 2|Withdrawal by Subject|0|||
48787680|NCT01910129|157063508|FG000|Randomized Phase 3|Withdrawal by Subject|0|||
48787681|NCT01910129|157063509|FG001|Randomized Phase 3|Withdrawal by Subject|1|||
48787682|NCT01910129|157063510|FG002|Randomized Phase 3|Withdrawal by Subject|0|||
48787683|NCT04313634|157063511|FG000|Overall Study|Adverse Event|2|||
48787684|NCT04313634|157063512|FG001|Overall Study|Adverse Event|2|||
48787685|NCT04313634|157063513|FG002|Overall Study|Adverse Event|0|||
49031949|NCT01597245|157953489|FG019|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
48787686|NCT04313634|157063511|FG000|Overall Study|Withdrawal by Subject|1|||
48787687|NCT04313634|157063512|FG001|Overall Study|Withdrawal by Subject|0|||
48787688|NCT04313634|157063513|FG002|Overall Study|Withdrawal by Subject|1|||
48787689|NCT04313634|157063511|FG000|Overall Study|Protocol Violation|0|||
48787690|NCT04313634|157063512|FG001|Overall Study|Protocol Violation|0|||
48787691|NCT04313634|157063513|FG002|Overall Study|Protocol Violation|1|||
48787692|NCT00319098|157063514|FG000|Overall Study|Serious adverse event|3|||
48787693|NCT00319098|157063515|FG001|Overall Study|Serious adverse event|0|||
48787694|NCT00319098|157063514|FG000|Overall Study|Adverse Event|20|||
48787695|NCT00319098|157063515|FG001|Overall Study|Adverse Event|1|||
48787696|NCT00319098|157063514|FG000|Overall Study|Withdrawal by Subject|37|||
48787697|NCT00319098|157063515|FG001|Overall Study|Withdrawal by Subject|8|||
48787698|NCT00319098|157063514|FG000|Overall Study|Migrated/moved from study area|2|||
48787699|NCT00319098|157063515|FG001|Overall Study|Migrated/moved from study area|1|||
48787700|NCT00319098|157063514|FG000|Overall Study|Lost to Follow-up|37|||
48787701|NCT00319098|157063515|FG001|Overall Study|Lost to Follow-up|13|||
48787702|NCT00319098|157063514|FG000|Overall Study|Others|33|||
48787703|NCT00319098|157063515|FG001|Overall Study|Others|8|||
48787704|NCT00319098|157063514|FG000|Overall Study|Protocol Violation|3|||
48787705|NCT00319098|157063515|FG001|Overall Study|Protocol Violation|1|||
48787706|NCT03585244|157063518|FG000|Overall Study|Withdrawal by Subject|15|||
48787707|NCT06281548|157063519|FG000|Overall Study|Lost to Follow-up|3|||
48787708|NCT01618838|157063520|FG000|Overall Study|slow accrual, trial closed prematurely.|4|||
48787709|NCT00700401|157063525|FG000|Overall Study|Detectable HCV RNA after Week 4|82|||
48787710|NCT00700401|157063525|FG000|Overall Study|Adverse Event|5|||
48787711|NCT00700401|157063525|FG000|Overall Study|Refused Treatment|2|||
48787712|NCT00700401|157063525|FG000|Overall Study|Lost to Follow-up|1|||
48787713|NCT00700401|157063525|FG000|Overall Study|Treatment never started|1|||
48787714|NCT00700401|157063525|FG000|Overall Study|HCV RNA not detected at baseline and SAE|1|||
48787715|NCT00700401|157063525|FG000|Overall Study|Withdrawal by Subject|2|||
48787716|NCT02717507|157063526|FG000|Overall Study|Lost to Follow-up|5|||
48787717|NCT02717507|157063527|FG001|Overall Study|Lost to Follow-up|8|||
48787718|NCT02717507|157063526|FG000|Overall Study|Pregnancy|1|||
48787719|NCT02717507|157063527|FG001|Overall Study|Pregnancy|1|||
48787720|NCT02717507|157063526|FG000|Overall Study|Protocol Violation|2|||
48787721|NCT02717507|157063527|FG001|Overall Study|Protocol Violation|2|||
48787722|NCT02717507|157063526|FG000|Overall Study|Withdrawal by Subject|20|||
48787723|NCT02717507|157063527|FG001|Overall Study|Withdrawal by Subject|20|||
48787724|NCT02717507|157063526|FG000|Overall Study|Relapse|1|||
48787725|NCT02717507|157063527|FG001|Overall Study|Relapse|1|||
48787726|NCT02717507|157063526|FG000|Overall Study|Cardiac Event|2|||
48787727|NCT02717507|157063527|FG001|Overall Study|Cardiac Event|6|||
48787728|NCT00295750|157063528|FG000|Overall Study|Adverse Event|19|||
48787729|NCT00295750|157063529|FG001|Overall Study|Adverse Event|15|||
48787730|NCT00295750|157063530|FG002|Overall Study|Adverse Event|12|||
48787731|NCT00295750|157063528|FG000|Overall Study|Lack of Efficacy|1|||
48787732|NCT00295750|157063529|FG001|Overall Study|Lack of Efficacy|1|||
48787733|NCT00295750|157063530|FG002|Overall Study|Lack of Efficacy|0|||
48787734|NCT00295750|157063528|FG000|Overall Study|Lost to Follow-up|1|||
48787735|NCT00295750|157063529|FG001|Overall Study|Lost to Follow-up|4|||
48787736|NCT00295750|157063530|FG002|Overall Study|Lost to Follow-up|1|||
48787737|NCT00295750|157063528|FG000|Overall Study|Taking prohibited therapy|2|||
48787738|NCT00295750|157063529|FG001|Overall Study|Taking prohibited therapy|3|||
48787739|NCT00295750|157063530|FG002|Overall Study|Taking prohibited therapy|2|||
48787740|NCT00295750|157063528|FG000|Overall Study|Administrative errors|2|||
48787741|NCT00295750|157063529|FG001|Overall Study|Administrative errors|4|||
48787742|NCT00295750|157063530|FG002|Overall Study|Administrative errors|5|||
48787743|NCT00295750|157063528|FG000|Overall Study|Trial drug errors|1|||
48787744|NCT00295750|157063529|FG001|Overall Study|Trial drug errors|1|||
48787745|NCT00295750|157063530|FG002|Overall Study|Trial drug errors|0|||
48787746|NCT00295750|157063528|FG000|Overall Study|Disease progression|2|||
48787747|NCT00295750|157063529|FG001|Overall Study|Disease progression|1|||
48787748|NCT00295750|157063530|FG002|Overall Study|Disease progression|0|||
48787749|NCT00295750|157063528|FG000|Overall Study|Personal reasons|0|||
48787750|NCT00295750|157063529|FG001|Overall Study|Personal reasons|1|||
48787751|NCT00295750|157063530|FG002|Overall Study|Personal reasons|0|||
48787752|NCT00295750|157063528|FG000|Overall Study|Randomized but never received trial drug|4|||
48787753|NCT00295750|157063529|FG001|Overall Study|Randomized but never received trial drug|3|||
48787754|NCT00295750|157063530|FG002|Overall Study|Randomized but never received trial drug|3|||
48787755|NCT00295750|157063528|FG000|Overall Study|Withdrawal by Subject|9|||
48787756|NCT00295750|157063529|FG001|Overall Study|Withdrawal by Subject|4|||
48787757|NCT00295750|157063530|FG002|Overall Study|Withdrawal by Subject|7|||
48787758|NCT00295750|157063528|FG000|Overall Study|Protocol Violation|2|||
48787759|NCT00295750|157063529|FG001|Overall Study|Protocol Violation|4|||
48787760|NCT00295750|157063530|FG002|Overall Study|Protocol Violation|2|||
48787761|NCT03835533|157063541|FG000|Overall Study|Death|5|||
48787762|NCT03835533|157063542|FG001|Overall Study|Death|10|||
48787763|NCT03835533|157063543|FG002|Overall Study|Death|9|||
48787764|NCT03835533|157063541|FG000|Overall Study|Withdrawal by Subject|2|||
48787765|NCT03835533|157063542|FG001|Overall Study|Withdrawal by Subject|2|||
48787766|NCT03835533|157063543|FG002|Overall Study|Withdrawal by Subject|2|||
48787767|NCT03835533|157063541|FG000|Overall Study|Lost to Follow-up|1|||
48787768|NCT03835533|157063542|FG001|Overall Study|Lost to Follow-up|0|||
48787769|NCT03835533|157063543|FG002|Overall Study|Lost to Follow-up|0|||
48787770|NCT03152552|157063544|FG000|Treatment Period 1 (12 Weeks)|Death|0|||
48787771|NCT03152552|157063545|FG001|Treatment Period 1 (12 Weeks)|Death|1|||
48787772|NCT03152552|157063546|FG002|Treatment Period 1 (12 Weeks)|Death|0|||
48787773|NCT03152552|157063547|FG003|Treatment Period 1 (12 Weeks)|Death|0|||
48787774|NCT03152552|157063548|FG004|Treatment Period 1 (12 Weeks)|Death|1|||
48787775|NCT03152552|157063544|FG000|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
48787776|NCT03152552|157063545|FG001|Treatment Period 1 (12 Weeks)|Protocol deviation|1|||
48787777|NCT03152552|157063546|FG002|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
48787778|NCT03152552|157063547|FG003|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
48787779|NCT03152552|157063548|FG004|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
48787780|NCT03152552|157063544|FG000|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8|||
48787781|NCT03152552|157063545|FG001|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9|||
48787782|NCT03152552|157063546|FG002|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
48787783|NCT03152552|157063547|FG003|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
48787784|NCT03152552|157063548|FG004|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20|||
48787785|NCT03152552|157063544|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
48787786|NCT03152552|157063545|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
48787787|NCT03152552|157063546|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
48787788|NCT03152552|157063547|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
48787789|NCT03152552|157063548|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
48787790|NCT03152552|157063544|FG000|Treatment Period 1 (12 Weeks)|Technical problems|0|||
48787791|NCT03152552|157063545|FG001|Treatment Period 1 (12 Weeks)|Technical problems|0|||
48787792|NCT03152552|157063546|FG002|Treatment Period 1 (12 Weeks)|Technical problems|1|||
48787793|NCT03152552|157063547|FG003|Treatment Period 1 (12 Weeks)|Technical problems|0|||
48787794|NCT03152552|157063548|FG004|Treatment Period 1 (12 Weeks)|Technical problems|0|||
48787795|NCT03152552|157063544|FG000|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
48787796|NCT03152552|157063545|FG001|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
48787797|NCT03152552|157063546|FG002|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
48787798|NCT03152552|157063547|FG003|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1|||
48787799|NCT03152552|157063548|FG004|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
48787800|NCT03152552|157063544|FG000|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6|||
48787801|NCT03152552|157063545|FG001|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5|||
48787802|NCT03152552|157063546|FG002|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
48787803|NCT03152552|157063547|FG003|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
48787804|NCT03152552|157063548|FG004|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11|||
48787805|NCT04757753|157063552|FG000|Overall Study|Lost to Follow-up|7|||
48787806|NCT04757753|157063553|FG001|Overall Study|Lost to Follow-up|7|||
48787807|NCT04757753|157063552|FG000|Overall Study|Withdrawal by Subject|0|||
48787808|NCT04757753|157063553|FG001|Overall Study|Withdrawal by Subject|3|||
48787809|NCT04757753|157063552|FG000|Overall Study|Endodontic treatment failure|1|||
48787810|NCT04757753|157063553|FG001|Overall Study|Endodontic treatment failure|2|||
48787811|NCT04757753|157063552|FG000|Overall Study|Tooth fracture/extraction|3|||
48787812|NCT04757753|157063553|FG001|Overall Study|Tooth fracture/extraction|0|||
48787813|NCT03249090|157063554|FG000|Enrollment|Excluded after randomization for ineligibility|4|||
48787814|NCT03249090|157063555|FG001|Enrollment|Excluded after randomization for ineligibility|2|||
48787815|NCT03249090|157063554|FG000|3 Month Time Point|Death, hospice, discontinued therapy|41|||
48787816|NCT03249090|157063555|FG001|3 Month Time Point|Death, hospice, discontinued therapy|37|||
48787817|NCT03249090|157063554|FG000|3 Month Time Point|Voluntary withdrawal|6|||
48787818|NCT03249090|157063555|FG001|3 Month Time Point|Voluntary withdrawal|3|||
48787819|NCT03249090|157063554|FG000|3 Month Time Point|Changed oncology practice|4|||
48787820|NCT03249090|157063555|FG001|3 Month Time Point|Changed oncology practice|2|||
48787821|NCT03249090|157063554|FG000|12 Month Time Point|Death, hospice, discontinued therapy|172|||
48787822|NCT03249090|157063555|FG001|12 Month Time Point|Death, hospice, discontinued therapy|175|||
48787823|NCT03249090|157063554|FG000|12 Month Time Point|Voluntary withdrawal|35|||
48787824|NCT03249090|157063555|FG001|12 Month Time Point|Voluntary withdrawal|4|||
48787825|NCT03249090|157063554|FG000|12 Month Time Point|Changed oncology practice|20|||
48787826|NCT03249090|157063555|FG001|12 Month Time Point|Changed oncology practice|9|||
48787827|NCT02717611|157063556|FG000|Overall Study|Death|13|||
48787828|NCT02717611|157063556|FG000|Overall Study|Withdrawal by Subject|6|||
48787829|NCT02717611|157063556|FG000|Overall Study|Active, not recruiting|40|||
49031950|NCT01597245|157953490|FG020|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
48787830|NCT02717611|157063556|FG000|Overall Study|Complicating disease|1|||
48787831|NCT02372409|157063557|FG000|Overall Study|Lost to Follow-up|1|||
48787832|NCT02372409|157063558|FG001|Overall Study|Lost to Follow-up|0|||
48787833|NCT02372409|157063557|FG000|Overall Study|Disease progression|1|||
48787834|NCT02372409|157063558|FG001|Overall Study|Disease progression|1|||
48787835|NCT04157348|157063559|FG000|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
48787836|NCT04157348|157063560|FG001|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
48787837|NCT04157348|157063559|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
48787838|NCT04157348|157063560|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
48787839|NCT04157348|157063559|FG000|Double-blind Treatment Period|Adverse Event|0|||
48787840|NCT04157348|157063560|FG001|Double-blind Treatment Period|Adverse Event|1|||
48787841|NCT04157348|157063559|FG000|Open-label Extension Period|Adverse Event|1|||
48787842|NCT04157348|157063560|FG001|Open-label Extension Period|Adverse Event|1|||
48787843|NCT04157348|157063559|FG000|Open-label Extension Period|Death|0|||
48787844|NCT04157348|157063560|FG001|Open-label Extension Period|Death|1|||
48787845|NCT04157348|157063559|FG000|Open-label Extension Period|Lack of Efficacy|2|||
48787846|NCT04157348|157063560|FG001|Open-label Extension Period|Lack of Efficacy|2|||
48787847|NCT04157348|157063559|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
48787848|NCT04157348|157063560|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
48787849|NCT04157348|157063559|FG000|Open-label Extension Period|Ongoing|60|||
48787850|NCT04157348|157063560|FG001|Open-label Extension Period|Ongoing|57|||
48787851|NCT04157348|157063559|FG000|Open-label Extension Period|other reasons|1|||
48787852|NCT04157348|157063560|FG001|Open-label Extension Period|other reasons|1|||
48787853|NCT03325712|157063565|FG000|Overall Study|Protocol Violation|0|||
48787854|NCT03325712|157063566|FG001|Overall Study|Protocol Violation|0|||
48787855|NCT03325712|157063567|FG002|Overall Study|Protocol Violation|0|||
49031951|NCT01597245|157953470|FG000|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
49031952|NCT01597245|157953471|FG001|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
49031953|NCT01597245|157953472|FG002|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
49031954|NCT01597245|157953473|FG003|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
49031955|NCT01597245|157953474|FG004|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
49031956|NCT01597245|157953475|FG005|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
49031957|NCT01597245|157953476|FG006|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
49031958|NCT01597245|157953477|FG007|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
49031959|NCT01597245|157953478|FG008|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
49031960|NCT01597245|157953479|FG009|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
49031961|NCT01597245|157953480|FG010|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
49031962|NCT01597245|157953481|FG011|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
49031963|NCT01597245|157953482|FG012|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
49031964|NCT01597245|157953483|FG013|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
49031965|NCT01597245|157953484|FG014|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
49031966|NCT01597245|157953485|FG015|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
49031967|NCT01597245|157953486|FG016|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
49031968|NCT01597245|157953487|FG017|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
49031969|NCT01597245|157953488|FG018|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
49031970|NCT01597245|157953489|FG019|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
49031971|NCT01597245|157953490|FG020|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
49031972|NCT01597245|157953470|FG000|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
48787856|NCT03325712|157063568|FG003|Overall Study|Protocol Violation|0|||
48787857|NCT03325712|157063569|FG004|Overall Study|Protocol Violation|1|||
48787858|NCT03325712|157063570|FG005|Overall Study|Protocol Violation|0|||
48787859|NCT03325712|157063571|FG006|Overall Study|Protocol Violation|0|||
48787860|NCT03325712|157063572|FG007|Overall Study|Protocol Violation|0|||
48787861|NCT03325712|157063565|FG000|Overall Study|Adverse Event|0|||
48787862|NCT03325712|157063566|FG001|Overall Study|Adverse Event|0|||
48787863|NCT03325712|157063567|FG002|Overall Study|Adverse Event|0|||
48787864|NCT03325712|157063568|FG003|Overall Study|Adverse Event|0|||
48787865|NCT03325712|157063569|FG004|Overall Study|Adverse Event|1|||
48787866|NCT03325712|157063570|FG005|Overall Study|Adverse Event|0|||
48787867|NCT03325712|157063571|FG006|Overall Study|Adverse Event|0|||
48787868|NCT03325712|157063572|FG007|Overall Study|Adverse Event|0|||
48787869|NCT03550313|157063573|FG000|Overall Study|Adverse Event|0|||
48787870|NCT03550313|157063574|FG001|Overall Study|Adverse Event|1|||
48787871|NCT03550313|157063575|FG002|Overall Study|Adverse Event|0|||
48787872|NCT03550313|157063573|FG000|Overall Study|Lost to Follow-up|5|||
48787873|NCT03550313|157063574|FG001|Overall Study|Lost to Follow-up|7|||
48787874|NCT03550313|157063575|FG002|Overall Study|Lost to Follow-up|12|||
48787875|NCT03550313|157063573|FG000|Overall Study|Study terminated by sponsor|44|||
49031973|NCT01597245|157953471|FG001|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
49031974|NCT01597245|157953472|FG002|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1|||
49031975|NCT01597245|157953473|FG003|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
49031976|NCT01597245|157953474|FG004|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
49031977|NCT01597245|157953475|FG005|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
48787876|NCT03550313|157063574|FG001|Overall Study|Study terminated by sponsor|37|||
48787877|NCT03550313|157063575|FG002|Overall Study|Study terminated by sponsor|48|||
48787878|NCT03550313|157063573|FG000|Overall Study|No longer met eligibility criteria|3|||
48877680|NCT00727506|157390141|FG005|Overall Study|Progressive disease|28|||
48877681|NCT00727506|157390136|FG000|Overall Study|Refused to continue medication|0|||
48877682|NCT00727506|157390137|FG001|Overall Study|Refused to continue medication|1|||
48877683|NCT00727506|157390138|FG002|Overall Study|Refused to continue medication|2|||
48877684|NCT00727506|157390139|FG003|Overall Study|Refused to continue medication|3|||
48877685|NCT00727506|157390140|FG004|Overall Study|Refused to continue medication|1|||
48877686|NCT00727506|157390141|FG005|Overall Study|Refused to continue medication|2|||
48877687|NCT00727506|157390136|FG000|Overall Study|Other reason not described above|0|||
49031978|NCT01597245|157953476|FG006|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
49031979|NCT01597245|157953477|FG007|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
49031980|NCT01597245|157953478|FG008|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
49031981|NCT01597245|157953479|FG009|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
49031982|NCT01597245|157953480|FG010|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
49031983|NCT01597245|157953481|FG011|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
49031984|NCT01597245|157953482|FG012|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
49031985|NCT01597245|157953483|FG013|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
49031986|NCT01597245|157953484|FG014|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
49031987|NCT01597245|157953485|FG015|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
49031988|NCT01597245|157953486|FG016|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
49031989|NCT01597245|157953487|FG017|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
49031990|NCT01597245|157953488|FG018|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
49031991|NCT01597245|157953489|FG019|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
49031992|NCT01597245|157953490|FG020|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
49031993|NCT01597245|157953470|FG000|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
49031994|NCT01597245|157953471|FG001|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
49031995|NCT01597245|157953472|FG002|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
49031996|NCT01597245|157953473|FG003|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
49031997|NCT01597245|157953474|FG004|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
49031998|NCT01597245|157953475|FG005|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
49031999|NCT01597245|157953476|FG006|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
49032000|NCT01597245|157953477|FG007|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
49032001|NCT01597245|157953478|FG008|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
49032002|NCT01597245|157953479|FG009|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
49032003|NCT01597245|157953480|FG010|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
49032004|NCT01597245|157953481|FG011|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
49032005|NCT01597245|157953482|FG012|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
49032006|NCT01597245|157953483|FG013|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
49032007|NCT01597245|157953484|FG014|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
49032008|NCT01597245|157953485|FG015|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
48787879|NCT03550313|157063574|FG001|Overall Study|No longer met eligibility criteria|5|||
48787880|NCT03550313|157063575|FG002|Overall Study|No longer met eligibility criteria|6|||
48787881|NCT03550313|157063573|FG000|Overall Study|Withdrawal by parent/guardian|20|||
48787882|NCT03550313|157063574|FG001|Overall Study|Withdrawal by parent/guardian|18|||
48787883|NCT03550313|157063575|FG002|Overall Study|Withdrawal by parent/guardian|26|||
48787884|NCT03550313|157063573|FG000|Overall Study|Other|4|||
48787885|NCT03550313|157063574|FG001|Overall Study|Other|2|||
48787886|NCT03550313|157063575|FG002|Overall Study|Other|2|||
48787887|NCT03550313|157063573|FG000|Overall Study|Randomized but not vaccinated|3|||
48787888|NCT03550313|157063574|FG001|Overall Study|Randomized but not vaccinated|23|||
48787889|NCT03550313|157063575|FG002|Overall Study|Randomized but not vaccinated|2|||
48787890|NCT03550313|157063573|FG000|Overall Study|Sites terminated due to quality issues|18|||
48787891|NCT03550313|157063574|FG001|Overall Study|Sites terminated due to quality issues|17|||
48787892|NCT03550313|157063575|FG002|Overall Study|Sites terminated due to quality issues|18|||
48787893|NCT04656847|157063576|FG000|3 Month After Inclusion|lack of data on myocardial infarction and/or data by visits|23|||
48787894|NCT00839072|157063577|FG000|First Intervention Period|Withdrawal by Subject|1|||
48787895|NCT00839072|157063578|FG001|First Intervention Period|Withdrawal by Subject|0|||
48787896|NCT00839072|157063577|FG000|First Intervention Period|Adverse Event|1|||
48787897|NCT00839072|157063578|FG001|First Intervention Period|Adverse Event|1|||
48787898|NCT00839072|157063577|FG000|Second Intervention Period|Withdrawal by Subject|1|||
48787899|NCT00839072|157063578|FG001|Second Intervention Period|Withdrawal by Subject|0|||
48787900|NCT01297062|157063580|FG000|Overall Study|Adverse Event|2|||
48787901|NCT01297062|157063581|FG001|Overall Study|Adverse Event|0|||
48787902|NCT01297062|157063582|FG002|Overall Study|Adverse Event|1|||
48787903|NCT01297062|157063583|FG003|Overall Study|Adverse Event|0|||
48787904|NCT01297062|157063584|FG004|Overall Study|Adverse Event|0|||
48787905|NCT01297062|157063585|FG005|Overall Study|Adverse Event|0|||
48787906|NCT01297062|157063586|FG006|Overall Study|Adverse Event|0|||
48787907|NCT01297062|157063580|FG000|Overall Study|Physician Decision|1|||
48787908|NCT01297062|157063581|FG001|Overall Study|Physician Decision|0|||
48787909|NCT01297062|157063582|FG002|Overall Study|Physician Decision|1|||
48787910|NCT01297062|157063583|FG003|Overall Study|Physician Decision|0|||
48787911|NCT01297062|157063584|FG004|Overall Study|Physician Decision|0|||
48787912|NCT01297062|157063585|FG005|Overall Study|Physician Decision|0|||
48787913|NCT01297062|157063586|FG006|Overall Study|Physician Decision|6|||
48787914|NCT01297062|157063580|FG000|Overall Study|Protocol Violation|0|||
48787915|NCT01297062|157063581|FG001|Overall Study|Protocol Violation|0|||
48787916|NCT01297062|157063582|FG002|Overall Study|Protocol Violation|0|||
48787917|NCT01297062|157063583|FG003|Overall Study|Protocol Violation|0|||
48787918|NCT01297062|157063584|FG004|Overall Study|Protocol Violation|1|||
48787919|NCT01297062|157063585|FG005|Overall Study|Protocol Violation|0|||
48787920|NCT01297062|157063586|FG006|Overall Study|Protocol Violation|0|||
48787921|NCT01297062|157063580|FG000|Overall Study|Subject Decision|1|||
48787922|NCT01297062|157063581|FG001|Overall Study|Subject Decision|1|||
48787923|NCT01297062|157063582|FG002|Overall Study|Subject Decision|0|||
48787924|NCT01297062|157063583|FG003|Overall Study|Subject Decision|1|||
48787925|NCT01297062|157063584|FG004|Overall Study|Subject Decision|1|||
48787926|NCT01297062|157063585|FG005|Overall Study|Subject Decision|1|||
48787927|NCT01297062|157063586|FG006|Overall Study|Subject Decision|2|||
48787928|NCT01196975|157063587|FG000|Overall Study|Adverse Event|2|||
48787929|NCT01196975|157063588|FG001|Overall Study|Adverse Event|2|||
48787930|NCT01196975|157063589|FG002|Overall Study|Adverse Event|0|||
48787931|NCT01196975|157063590|FG003|Overall Study|Adverse Event|0|||
48787932|NCT01196975|157063591|FG004|Overall Study|Adverse Event|2|||
48787933|NCT01196975|157063587|FG000|Overall Study|Withdrawal by Subject|2|||
48787934|NCT01196975|157063588|FG001|Overall Study|Withdrawal by Subject|1|||
48787935|NCT01196975|157063589|FG002|Overall Study|Withdrawal by Subject|0|||
48787936|NCT01196975|157063590|FG003|Overall Study|Withdrawal by Subject|1|||
48787937|NCT01196975|157063591|FG004|Overall Study|Withdrawal by Subject|0|||
48787938|NCT01196975|157063587|FG000|Overall Study|Lost to Follow-up|11|||
48787939|NCT01196975|157063588|FG001|Overall Study|Lost to Follow-up|6|||
48787940|NCT01196975|157063589|FG002|Overall Study|Lost to Follow-up|5|||
48787941|NCT01196975|157063590|FG003|Overall Study|Lost to Follow-up|5|||
48787942|NCT01196975|157063591|FG004|Overall Study|Lost to Follow-up|11|||
48787943|NCT01664078|157063594|FG000|Overall Study|Death|9|||
48787944|NCT01664078|157063594|FG000|Overall Study|Withdrawal by Subject|4|||
48787945|NCT01664078|157063594|FG000|Overall Study|Lost to Follow-up|2|||
48787946|NCT01664078|157063594|FG000|Overall Study|missed 5 year visit|1|||
48787947|NCT01664078|157063594|FG000|Overall Study|Other|53|||
48787948|NCT03743038|157063595|FG000|Overall Study|Physician Decision|1|||
48787949|NCT03674177|157063596|FG000|Overall Study|Lost to Follow-up|2|||
48787950|NCT03674177|157063597|FG001|Overall Study|Lost to Follow-up|1|||
48787951|NCT03674177|157063598|FG002|Overall Study|Lost to Follow-up|0|||
48787952|NCT03674177|157063599|FG003|Overall Study|Lost to Follow-up|2|||
48787953|NCT00360529|157063603|FG000|Overall Study|Adverse Event|10|||
48787954|NCT00360529|157063604|FG001|Overall Study|Adverse Event|23|||
48787955|NCT00360529|157063605|FG002|Overall Study|Adverse Event|33|||
48787956|NCT00360529|157063603|FG000|Overall Study|Protocol Violation|3|||
48787957|NCT00360529|157063604|FG001|Overall Study|Protocol Violation|3|||
48787958|NCT00360529|157063605|FG002|Overall Study|Protocol Violation|11|||
48787959|NCT00360529|157063603|FG000|Overall Study|Lost to Follow-up|14|||
48787960|NCT00360529|157063604|FG001|Overall Study|Lost to Follow-up|10|||
48787961|NCT00360529|157063605|FG002|Overall Study|Lost to Follow-up|13|||
48787962|NCT00360529|157063603|FG000|Overall Study|Withdrawal by Subject|22|||
48787963|NCT00360529|157063604|FG001|Overall Study|Withdrawal by Subject|14|||
48787964|NCT00360529|157063605|FG002|Overall Study|Withdrawal by Subject|18|||
48787965|NCT00360529|157063603|FG000|Overall Study|Lack of Efficacy|8|||
48787966|NCT00360529|157063604|FG001|Overall Study|Lack of Efficacy|6|||
48787967|NCT00360529|157063605|FG002|Overall Study|Lack of Efficacy|5|||
48787968|NCT00360529|157063603|FG000|Overall Study|Reason discontinued not explained above|4|||
48877688|NCT00727506|157390137|FG001|Overall Study|Other reason not described above|0|||
48877689|NCT00727506|157390138|FG002|Overall Study|Other reason not described above|1|||
48787969|NCT00360529|157063604|FG001|Overall Study|Reason discontinued not explained above|9|||
48787970|NCT00360529|157063605|FG002|Overall Study|Reason discontinued not explained above|11|||
48787971|NCT00744653|157063606|FG000|Overall Study|antineoplastic treatment|11|||
48787972|NCT00744653|157063606|FG000|Overall Study|Death|1|||
48787973|NCT00744653|157063606|FG000|Overall Study|Lost to Follow-up|1|||
48787974|NCT00744653|157063606|FG000|Overall Study|Physician Decision|3|||
48787975|NCT03826667|157063607|FG000|Overall Study|Protocol deviation|21|||
48787976|NCT00808808|157063609|FG000|Overall Study|Vaccinated; survey not completed|131|||
48787977|NCT00808808|157063610|FG001|Overall Study|Vaccinated; survey not completed|169|||
48787978|NCT00808808|157063611|FG002|Overall Study|Vaccinated; survey not completed|302|||
48787979|NCT00808808|157063609|FG000|Overall Study|Employee was not vaccinated.|2686|||
48787980|NCT00808808|157063610|FG001|Overall Study|Employee was not vaccinated.|2268|||
48787981|NCT00808808|157063611|FG002|Overall Study|Employee was not vaccinated.|2255|||
48787982|NCT02012491|157063613|FG000|Overall Study|Lost to Follow-up|1|||
48787983|NCT02012491|157063614|FG001|Overall Study|Lost to Follow-up|0|||
48787984|NCT02012491|157063613|FG000|Overall Study|Protocol Violation|0|||
48877690|NCT00727506|157390139|FG003|Overall Study|Other reason not described above|4|||
48877691|NCT00727506|157390140|FG004|Overall Study|Other reason not described above|1|||
48877692|NCT00727506|157390141|FG005|Overall Study|Other reason not described above|1|||
48877693|NCT03229486|157390142|FG000|Overall Study|Protocol Violation|0|||
48877694|NCT03229486|157390143|FG001|Overall Study|Protocol Violation|1|||
48877695|NCT00383123|157390147|FG000|Overall Study|Adverse Event|1|||
48877696|NCT00383123|157390148|FG001|Overall Study|Adverse Event|0|||
48877697|NCT00383123|157390147|FG000|Overall Study|Lost to Follow-up|68|||
48877698|NCT00383123|157390148|FG001|Overall Study|Lost to Follow-up|61|||
48877699|NCT00383123|157390147|FG000|Overall Study|Protocol Violation|5|||
48877700|NCT00383123|157390148|FG001|Overall Study|Protocol Violation|1|||
48877701|NCT00383123|157390147|FG000|Overall Study|Withdrawal by Subject|27|||
48877702|NCT00383123|157390148|FG001|Overall Study|Withdrawal by Subject|18|||
48877703|NCT00383123|157390147|FG000|Overall Study|Other reason|10|||
48877704|NCT00383123|157390148|FG001|Overall Study|Other reason|6|||
48877705|NCT00455741|157390149|FG000|Overall Study|Physician Decision|0|||
48877706|NCT00455741|157390150|FG001|Overall Study|Physician Decision|1|||
48877707|NCT00245960|157390151|FG000|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|6|||
48877708|NCT00245960|157390152|FG001|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|7|||
48877709|NCT00245960|157390151|FG000|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|0|||
48877710|NCT00245960|157390152|FG001|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|1|||
48877711|NCT00245960|157390151|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|2|||
48877712|NCT00245960|157390152|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|0|||
48877713|NCT00245960|157390151|FG000|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|2|||
48877714|NCT00245960|157390152|FG001|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|1|||
48877715|NCT00245960|157390151|FG000|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|3|||
48787985|NCT02012491|157063614|FG001|Overall Study|Protocol Violation|1|||
48787986|NCT02012491|157063613|FG000|Overall Study|Withdrawal by Subject|1|||
48787987|NCT02012491|157063614|FG001|Overall Study|Withdrawal by Subject|0|||
48787988|NCT01781572|157063617|FG000|MEK162 45mg BID+LEE011 200mg|Adverse Event|7|||
48787989|NCT01781572|157063618|FG001|MEK162 45mg BID+LEE011 200mg|Adverse Event|0|||
48787990|NCT01781572|157063619|FG002|MEK162 45mg BID+LEE011 200mg|Adverse Event|11|||
48787991|NCT01781572|157063617|FG000|MEK162 45mg BID+LEE011 200mg|Progressive disease|8|||
48787992|NCT01781572|157063618|FG001|MEK162 45mg BID+LEE011 200mg|Progressive disease|6|||
48787993|NCT01781572|157063619|FG002|MEK162 45mg BID+LEE011 200mg|Progressive disease|23|||
48787994|NCT01781572|157063617|FG000|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1|||
48787995|NCT01781572|157063618|FG001|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0|||
48787996|NCT01781572|157063619|FG002|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2|||
48787997|NCT01781572|157063617|FG000|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
48787998|NCT01781572|157063618|FG001|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
48787999|NCT01781572|157063619|FG002|MEK162 45mg BID+LEE011 200mg|Physician Decision|4|||
48788000|NCT01781572|157063617|FG000|MEK162 45mg BID+LEE011 200mg|Death|0|||
48788001|NCT01781572|157063618|FG001|MEK162 45mg BID+LEE011 200mg|Death|0|||
48788002|NCT01781572|157063619|FG002|MEK162 45mg BID+LEE011 200mg|Death|1|||
48788003|NCT01781572|157063617|FG000|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2|||
48788004|NCT01781572|157063618|FG001|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
48788005|NCT01781572|157063619|FG002|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
48788006|NCT01781572|157063617|FG000|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1|||
48788007|NCT01781572|157063618|FG001|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
48788008|NCT01781572|157063619|FG002|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
48788009|NCT01781572|157063617|FG000|MEK162 30mg BID+LEE011 300mg|Adverse Event|1|||
48788010|NCT01781572|157063618|FG001|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
48788011|NCT01781572|157063619|FG002|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
48788012|NCT01781572|157063617|FG000|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3|||
48788013|NCT01781572|157063618|FG001|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2|||
48788014|NCT01781572|157063619|FG002|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0|||
48788015|NCT01781572|157063617|FG000|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
48788016|NCT01781572|157063618|FG001|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
48788017|NCT01781572|157063619|FG002|MEK162 45mg BID+LEE011 300mg|Adverse Event|0|||
48788018|NCT01781572|157063617|FG000|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4|||
48788019|NCT01781572|157063618|FG001|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3|||
48877716|NCT00245960|157390152|FG001|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|0|||
48877717|NCT00245960|157390151|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
48788020|NCT01781572|157063619|FG002|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0|||
48788021|NCT01781572|157063617|FG000|MEK162 45mg BID+LEE011 300mg|Death|1|||
48877718|NCT00245960|157390152|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
48877719|NCT00245960|157390151|FG000|Period 2 (Open Label): 13-24 Weeks|Adverse Event|8|||
48983147|NCT02394028|157769988|FG002|Induction Phase|Technical reason|0|||
48983148|NCT02394028|157769989|FG003|Induction Phase|Technical reason|1|||
48983149|NCT02394028|157769990|FG004|Induction Phase|Technical reason|0|||
48983150|NCT02394028|157769991|FG005|Induction Phase|Technical reason|0|||
48983151|NCT02394028|157769992|FG006|Induction Phase|Technical reason|0|||
48788022|NCT01781572|157063618|FG001|MEK162 45mg BID+LEE011 300mg|Death|0|||
48788023|NCT01781572|157063619|FG002|MEK162 45mg BID+LEE011 300mg|Death|0|||
48788024|NCT01781572|157063617|FG000|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
48788025|NCT01781572|157063618|FG001|MEK162 30mg LEE011 200mg|Progressive Disease|5|||
48788026|NCT01781572|157063619|FG002|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
48788027|NCT01781572|157063617|FG000|MEK162 45mg LEE011 450mg|Adverse Event|0|||
48788028|NCT01781572|157063618|FG001|MEK162 45mg LEE011 450mg|Adverse Event|1|||
48788029|NCT01781572|157063619|FG002|MEK162 45mg LEE011 450mg|Adverse Event|0|||
48788030|NCT01781572|157063617|FG000|MEK162 45mg LEE011 450mg|Physician Decision|0|||
48788031|NCT01781572|157063618|FG001|MEK162 45mg LEE011 450mg|Physician Decision|2|||
48788032|NCT01781572|157063619|FG002|MEK162 45mg LEE011 450mg|Physician Decision|0|||
48788033|NCT01781572|157063617|FG000|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
48788034|NCT01781572|157063618|FG001|MEK162 45mg LEE011 450mg|Progressive Disease|6|||
49032009|NCT01597245|157953486|FG016|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
49032010|NCT01597245|157953487|FG017|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
49032011|NCT01597245|157953488|FG018|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
49032012|NCT01597245|157953489|FG019|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
49032013|NCT01597245|157953490|FG020|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
49032014|NCT01597245|157953470|FG000|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
49032015|NCT01597245|157953471|FG001|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
49032016|NCT01597245|157953472|FG002|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
49032017|NCT01597245|157953473|FG003|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
48788035|NCT01781572|157063619|FG002|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
48788036|NCT01781572|157063617|FG000|MEK162 45mg LEE011 600mg|Adverse Event|0|||
48788037|NCT01781572|157063618|FG001|MEK162 45mg LEE011 600mg|Adverse Event|1|||
48788038|NCT01781572|157063619|FG002|MEK162 45mg LEE011 600mg|Adverse Event|0|||
48788039|NCT01781572|157063617|FG000|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
48788040|NCT01781572|157063618|FG001|MEK162 45mg LEE011 600mg|Progressive Disease|5|||
48788041|NCT01781572|157063619|FG002|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
48788042|NCT05557942|157063623|FG000|Overall Study|Death|0|||
48788043|NCT05557942|157063624|FG001|Overall Study|Death|0|||
48877720|NCT00245960|157390152|FG001|Period 2 (Open Label): 13-24 Weeks|Adverse Event|4|||
48877721|NCT00245960|157390151|FG000|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
48877722|NCT00245960|157390152|FG001|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
48877723|NCT00245960|157390151|FG000|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|2|||
48877724|NCT00245960|157390152|FG001|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|5|||
48877725|NCT00245960|157390151|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|1|||
48877726|NCT00245960|157390152|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|3|||
48877727|NCT00245960|157390151|FG000|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|1|||
48877728|NCT00245960|157390152|FG001|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|3|||
48877729|NCT00245960|157390151|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|0|||
48877730|NCT00245960|157390152|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|1|||
48877731|NCT00978562|157390158|FG000|Overall Study|Withdrawal by participant before receiving study drug/imaging|2|||
48877732|NCT00570908|157390159|FG000|Overall Study|Adverse Event|5|||
48877733|NCT00570908|157390159|FG000|Overall Study|Withdrawal by Subject|2|||
48877734|NCT00632502|157390160|FG000|Overall Study|Adverse Event|0|||
48877735|NCT00632502|157390161|FG001|Overall Study|Adverse Event|1|||
48877736|NCT00632502|157390160|FG000|Overall Study|Randomized not treated|3|||
48877737|NCT00632502|157390161|FG001|Overall Study|Randomized not treated|0|||
48877738|NCT04097028|157390164|FG000|Overall Study|Disease Progression Prior to completion of Chemoradiation|2|||
48877739|NCT04097028|157390164|FG000|Overall Study|Adverse Event prior to Completion of Chemoradiation|2|||
48877740|NCT04097028|157390164|FG000|Overall Study|Disease Progression prior to Surgery|2|||
48877741|NCT04097028|157390164|FG000|Overall Study|Adverse Event prior to Surgery|1|||
48877742|NCT05452460|157390167|FG000|Overall Study|Lost to Follow-up|3|||
48877743|NCT05452460|157390168|FG001|Overall Study|Lost to Follow-up|3|||
48877744|NCT05452460|157390167|FG000|Overall Study|Did not receive intervention|1|||
48877745|NCT05452460|157390168|FG001|Overall Study|Did not receive intervention|0|||
48877746|NCT05906784|157390169|FG000|Overall Study|Lost to Follow-up|2|||
49032018|NCT01597245|157953474|FG004|Maintenance Period (Week 12 to Week 60)|Relapsed|150|||
49032019|NCT01597245|157953475|FG005|Maintenance Period (Week 12 to Week 60)|Relapsed|22|||
48788044|NCT05557942|157063625|FG002|Overall Study|Death|0|||
48788045|NCT05557942|157063626|FG003|Overall Study|Death|2|||
48788046|NCT05557942|157063627|FG004|Overall Study|Death|1|||
48788047|NCT05557942|157063628|FG005|Overall Study|Death|1|||
48788048|NCT05557942|157063623|FG000|Overall Study|Physician Decision|1|||
48788049|NCT05557942|157063624|FG001|Overall Study|Physician Decision|1|||
48788050|NCT05557942|157063625|FG002|Overall Study|Physician Decision|2|||
48788051|NCT05557942|157063626|FG003|Overall Study|Physician Decision|3|||
48877747|NCT05906784|157390170|FG001|Overall Study|Lost to Follow-up|1|||
48877748|NCT05906784|157390171|FG002|Overall Study|Lost to Follow-up|1|||
48877749|NCT05906784|157390172|FG003|Overall Study|Lost to Follow-up|1|||
48877750|NCT00356811|157390174|FG000|Overall Study|Death|35|||
48877751|NCT00356811|157390174|FG000|Overall Study|Lost to Follow-up|2|||
48877752|NCT00356811|157390174|FG000|Overall Study|Withdrawal by Subject|6|||
48877753|NCT00356811|157390174|FG000|Overall Study|Participant Could Not Make a Checkup|1|||
48877754|NCT00356811|157390174|FG000|Overall Study|Study Is Terminating|3|||
48877755|NCT00356811|157390174|FG000|Overall Study|Site Closed during Follow-up|2|||
48983152|NCT02394028|157769993|FG007|Induction Phase|Technical reason|0|||
48983153|NCT02394028|157769994|FG008|Induction Phase|Technical reason|0|||
48983154|NCT02394028|157769995|FG009|Induction Phase|Technical reason|0|||
48983155|NCT02394028|157769996|FG010|Induction Phase|Technical reason|0|||
48983156|NCT02394028|157769986|FG000|Induction Phase|:ack of calculation|0|||
48983157|NCT02394028|157769987|FG001|Induction Phase|:ack of calculation|0|||
48983158|NCT02394028|157769988|FG002|Induction Phase|:ack of calculation|0|||
48983159|NCT02394028|157769989|FG003|Induction Phase|:ack of calculation|0|||
48983160|NCT02394028|157769990|FG004|Induction Phase|:ack of calculation|0|||
48983161|NCT02394028|157769991|FG005|Induction Phase|:ack of calculation|0|||
48983162|NCT02394028|157769992|FG006|Induction Phase|:ack of calculation|0|||
48983163|NCT02394028|157769993|FG007|Induction Phase|:ack of calculation|1|||
48983164|NCT02394028|157769994|FG008|Induction Phase|:ack of calculation|0|||
48983165|NCT02394028|157769995|FG009|Induction Phase|:ack of calculation|0|||
48983166|NCT02394028|157769996|FG010|Induction Phase|:ack of calculation|0|||
48983167|NCT02394028|157769986|FG000|Maintenance Phase|Protocol Violation|0|||
48983168|NCT02394028|157769987|FG001|Maintenance Phase|Protocol Violation|0|||
48983169|NCT02394028|157769988|FG002|Maintenance Phase|Protocol Violation|0|||
48983170|NCT02394028|157769989|FG003|Maintenance Phase|Protocol Violation|0|||
48983171|NCT02394028|157769990|FG004|Maintenance Phase|Protocol Violation|0|||
48983172|NCT02394028|157769991|FG005|Maintenance Phase|Protocol Violation|0|||
48983173|NCT02394028|157769992|FG006|Maintenance Phase|Protocol Violation|0|||
48983174|NCT02394028|157769993|FG007|Maintenance Phase|Protocol Violation|0|||
48983175|NCT02394028|157769994|FG008|Maintenance Phase|Protocol Violation|0|||
48983176|NCT02394028|157769995|FG009|Maintenance Phase|Protocol Violation|0|||
48983177|NCT02394028|157769996|FG010|Maintenance Phase|Protocol Violation|1|||
48983178|NCT02394028|157769986|FG000|Maintenance Phase|Physician Decision|0|||
48983179|NCT02394028|157769987|FG001|Maintenance Phase|Physician Decision|0|||
48983180|NCT02394028|157769988|FG002|Maintenance Phase|Physician Decision|0|||
48983181|NCT02394028|157769989|FG003|Maintenance Phase|Physician Decision|0|||
48983182|NCT02394028|157769990|FG004|Maintenance Phase|Physician Decision|0|||
48983183|NCT02394028|157769991|FG005|Maintenance Phase|Physician Decision|0|||
48983184|NCT02394028|157769992|FG006|Maintenance Phase|Physician Decision|0|||
48788052|NCT05557942|157063627|FG004|Overall Study|Physician Decision|0|||
48788053|NCT05557942|157063628|FG005|Overall Study|Physician Decision|2|||
48788054|NCT05557942|157063623|FG000|Overall Study|Study terminated by sponsor|17|||
48788055|NCT05557942|157063624|FG001|Overall Study|Study terminated by sponsor|17|||
48788056|NCT05557942|157063625|FG002|Overall Study|Study terminated by sponsor|14|||
48788057|NCT05557942|157063626|FG003|Overall Study|Study terminated by sponsor|40|||
48788058|NCT05557942|157063627|FG004|Overall Study|Study terminated by sponsor|45|||
48788059|NCT05557942|157063628|FG005|Overall Study|Study terminated by sponsor|37|||
48788060|NCT05557942|157063623|FG000|Overall Study|Protocol Violation|0|||
48788061|NCT05557942|157063624|FG001|Overall Study|Protocol Violation|0|||
48788062|NCT05557942|157063625|FG002|Overall Study|Protocol Violation|0|||
48983185|NCT02394028|157769993|FG007|Maintenance Phase|Physician Decision|0|||
48983186|NCT02394028|157769994|FG008|Maintenance Phase|Physician Decision|1|||
48983187|NCT02394028|157769995|FG009|Maintenance Phase|Physician Decision|3|||
48983188|NCT02394028|157769996|FG010|Maintenance Phase|Physician Decision|2|||
48983189|NCT02394028|157769986|FG000|Maintenance Phase|Lack of Efficacy|0|||
48983190|NCT02394028|157769987|FG001|Maintenance Phase|Lack of Efficacy|0|||
48983191|NCT02394028|157769988|FG002|Maintenance Phase|Lack of Efficacy|0|||
48983192|NCT02394028|157769989|FG003|Maintenance Phase|Lack of Efficacy|0|||
48983193|NCT02394028|157769990|FG004|Maintenance Phase|Lack of Efficacy|0|||
49032020|NCT01597245|157953476|FG006|Maintenance Period (Week 12 to Week 60)|Relapsed|80|||
49032021|NCT01597245|157953477|FG007|Maintenance Period (Week 12 to Week 60)|Relapsed|2|||
49032022|NCT01597245|157953478|FG008|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
48788063|NCT05557942|157063626|FG003|Overall Study|Protocol Violation|0|||
48788064|NCT05557942|157063627|FG004|Overall Study|Protocol Violation|0|||
48788065|NCT05557942|157063628|FG005|Overall Study|Protocol Violation|1|||
48788066|NCT05557942|157063623|FG000|Overall Study|Withdrawal by Subject|0|||
48788067|NCT05557942|157063624|FG001|Overall Study|Withdrawal by Subject|0|||
48788068|NCT05557942|157063625|FG002|Overall Study|Withdrawal by Subject|0|||
48788069|NCT05557942|157063626|FG003|Overall Study|Withdrawal by Subject|0|||
48788070|NCT05557942|157063627|FG004|Overall Study|Withdrawal by Subject|2|||
48788071|NCT05557942|157063628|FG005|Overall Study|Withdrawal by Subject|0|||
48983194|NCT02394028|157769991|FG005|Maintenance Phase|Lack of Efficacy|0|||
48983195|NCT02394028|157769992|FG006|Maintenance Phase|Lack of Efficacy|0|||
48983196|NCT02394028|157769993|FG007|Maintenance Phase|Lack of Efficacy|0|||
48983197|NCT02394028|157769994|FG008|Maintenance Phase|Lack of Efficacy|7|||
48983198|NCT02394028|157769995|FG009|Maintenance Phase|Lack of Efficacy|25|||
48983199|NCT02394028|157769996|FG010|Maintenance Phase|Lack of Efficacy|33|||
48788072|NCT02693665|157063629|FG000|Overall Study|Death|3|||
48788073|NCT02693665|157063630|FG001|Overall Study|Death|2|||
48788074|NCT02693665|157063629|FG000|Overall Study|Lost to Follow-up|7|||
48788075|NCT02693665|157063630|FG001|Overall Study|Lost to Follow-up|3|||
48788076|NCT02693665|157063629|FG000|Overall Study|Protocol Violation|1|||
48788077|NCT02693665|157063630|FG001|Overall Study|Protocol Violation|0|||
48788078|NCT02693665|157063629|FG000|Overall Study|Withdrawal by Subject|2|||
48788079|NCT02693665|157063630|FG001|Overall Study|Withdrawal by Subject|0|||
48788080|NCT02693665|157063629|FG000|Overall Study|patient wanted to leave it behind|1|||
48788081|NCT02693665|157063630|FG001|Overall Study|patient wanted to leave it behind|0|||
48788082|NCT02693665|157063629|FG000|Overall Study|anxiety|1|||
48788083|NCT02693665|157063630|FG001|Overall Study|anxiety|0|||
48788084|NCT02693665|157063629|FG000|Overall Study|family issues|1|||
48788085|NCT02693665|157063630|FG001|Overall Study|family issues|0|||
48788086|NCT02693665|157063629|FG000|Overall Study|no reason given|1|||
48788087|NCT02693665|157063630|FG001|Overall Study|no reason given|0|||
48788088|NCT04304833|157063631|FG000|Overall Study|Due to the pandemic in person visits were not allowed|4|||
48788089|NCT04304833|157063632|FG001|Overall Study|Due to the pandemic in person visits were not allowed|2|||
48788090|NCT03972488|157063634|FG000|Overall Study|Progressive disease|42|||
48788091|NCT03972488|157063635|FG001|Overall Study|Progressive disease|44|||
48788092|NCT03972488|157063634|FG000|Overall Study|Physician Decision|13|||
48788093|NCT03972488|157063635|FG001|Overall Study|Physician Decision|7|||
48788094|NCT03972488|157063634|FG000|Overall Study|Adverse Event|8|||
48788095|NCT03972488|157063635|FG001|Overall Study|Adverse Event|1|||
48788096|NCT03972488|157063634|FG000|Overall Study|Death|4|||
48788097|NCT03972488|157063635|FG001|Overall Study|Death|4|||
48788098|NCT03972488|157063634|FG000|Overall Study|Withdrawal by Subject|3|||
48788099|NCT03972488|157063635|FG001|Overall Study|Withdrawal by Subject|4|||
48788100|NCT03972488|157063634|FG000|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|3|||
48788101|NCT03972488|157063635|FG001|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|0|||
48788102|NCT00626522|157065901|FG000|Overall Study|Protocol Violation|0|||
48788103|NCT00626522|157065902|FG001|Overall Study|Protocol Violation|0|||
48788104|NCT00626522|157065903|FG002|Overall Study|Protocol Violation|0|||
48788105|NCT00626522|157065904|FG003|Overall Study|Protocol Violation|0|||
48788106|NCT00626522|157065905|FG004|Overall Study|Protocol Violation|1|||
48788107|NCT00626522|157065906|FG005|Overall Study|Protocol Violation|0|||
48788108|NCT00626522|157065901|FG000|Overall Study|Adverse Event|2|||
48788109|NCT00626522|157065902|FG001|Overall Study|Adverse Event|1|||
48788110|NCT00626522|157065903|FG002|Overall Study|Adverse Event|2|||
48788111|NCT00626522|157065904|FG003|Overall Study|Adverse Event|0|||
48788112|NCT00626522|157065905|FG004|Overall Study|Adverse Event|1|||
48788113|NCT00626522|157065906|FG005|Overall Study|Adverse Event|1|||
48788114|NCT00626522|157065901|FG000|Overall Study|Withdrawal by Subject|2|||
48788115|NCT00626522|157065902|FG001|Overall Study|Withdrawal by Subject|5|||
48983200|NCT02394028|157769986|FG000|Maintenance Phase|Death|0|||
48983201|NCT02394028|157769987|FG001|Maintenance Phase|Death|0|||
48788116|NCT00626522|157065903|FG002|Overall Study|Withdrawal by Subject|5|||
48788117|NCT00626522|157065904|FG003|Overall Study|Withdrawal by Subject|0|||
48788118|NCT00626522|157065905|FG004|Overall Study|Withdrawal by Subject|4|||
48788119|NCT00626522|157065906|FG005|Overall Study|Withdrawal by Subject|1|||
48788120|NCT00626522|157065901|FG000|Overall Study|COPD exacerbation|0|||
48788121|NCT00626522|157065902|FG001|Overall Study|COPD exacerbation|0|||
48788122|NCT00626522|157065903|FG002|Overall Study|COPD exacerbation|0|||
48788123|NCT00626522|157065904|FG003|Overall Study|COPD exacerbation|1|||
48788124|NCT00626522|157065905|FG004|Overall Study|COPD exacerbation|1|||
48788125|NCT00626522|157065906|FG005|Overall Study|COPD exacerbation|0|||
48788126|NCT00626522|157065901|FG000|Overall Study|Lost to Follow-up|0|||
48788127|NCT00626522|157065902|FG001|Overall Study|Lost to Follow-up|1|||
48788128|NCT00626522|157065903|FG002|Overall Study|Lost to Follow-up|0|||
48788129|NCT00626522|157065904|FG003|Overall Study|Lost to Follow-up|0|||
48788130|NCT00626522|157065905|FG004|Overall Study|Lost to Follow-up|0|||
48788131|NCT00626522|157065906|FG005|Overall Study|Lost to Follow-up|0|||
48788132|NCT00626522|157065901|FG000|Overall Study|Inconsistent reason reported|1|||
48788133|NCT00626522|157065902|FG001|Overall Study|Inconsistent reason reported|0|||
48788134|NCT00626522|157065903|FG002|Overall Study|Inconsistent reason reported|0|||
48788135|NCT00626522|157065904|FG003|Overall Study|Inconsistent reason reported|0|||
48788136|NCT00626522|157065905|FG004|Overall Study|Inconsistent reason reported|0|||
48788137|NCT00626522|157065906|FG005|Overall Study|Inconsistent reason reported|0|||
48788138|NCT00626522|157065901|FG000|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
48788139|NCT00626522|157065902|FG001|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
48788140|NCT00626522|157065903|FG002|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
48788141|NCT00626522|157065904|FG003|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
48983202|NCT02394028|157769988|FG002|Maintenance Phase|Death|0|||
48788142|NCT00626522|157065905|FG004|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
48788143|NCT00626522|157065906|FG005|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
48877756|NCT01867047|157392049|FG000|Overall Study|Lost to Follow-up|3|||
48788144|NCT01412944|157065907|FG000|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
48788145|NCT01412944|157065908|FG001|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
48788146|NCT01412944|157065909|FG002|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1|||
48788147|NCT01412944|157065910|FG003|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
48788148|NCT01412944|157065911|FG004|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
48788149|NCT01412944|157065912|FG005|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
48788150|NCT01412944|157065907|FG000|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
48788151|NCT01412944|157065908|FG001|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
48788152|NCT01412944|157065909|FG002|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
48788153|NCT01412944|157065910|FG003|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
48788154|NCT01412944|157065911|FG004|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
48788155|NCT01412944|157065912|FG005|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1|||
48788156|NCT01412944|157065907|FG000|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
48788157|NCT01412944|157065908|FG001|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
48788158|NCT01412944|157065909|FG002|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
48788159|NCT01412944|157065910|FG003|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
48788160|NCT01412944|157065911|FG004|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
48788161|NCT01412944|157065912|FG005|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1|||
48788162|NCT01412944|157065907|FG000|IV: Per CAIN457A2307|Withdrawal by Subject|1|||
48788163|NCT01412944|157065908|FG001|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
48788164|NCT01412944|157065909|FG002|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
48788165|NCT01412944|157065910|FG003|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
48788166|NCT01412944|157065911|FG004|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
48788167|NCT01412944|157065912|FG005|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
48788168|NCT01412944|157065907|FG000|IV: Per CAIN457A2307|Protocol deviation|0|||
48788169|NCT01412944|157065908|FG001|IV: Per CAIN457A2307|Protocol deviation|1|||
48788170|NCT01412944|157065909|FG002|IV: Per CAIN457A2307|Protocol deviation|0|||
48788171|NCT01412944|157065910|FG003|IV: Per CAIN457A2307|Protocol deviation|0|||
48788172|NCT01412944|157065911|FG004|IV: Per CAIN457A2307|Protocol deviation|0|||
48788173|NCT01412944|157065912|FG005|IV: Per CAIN457A2307|Protocol deviation|0|||
48788174|NCT01412944|157065907|FG000|IV: Per CAIN457A2307|Lost to Follow-up|0|||
48788175|NCT01412944|157065908|FG001|IV: Per CAIN457A2307|Lost to Follow-up|1|||
48788176|NCT01412944|157065909|FG002|IV: Per CAIN457A2307|Lost to Follow-up|0|||
48788177|NCT01412944|157065910|FG003|IV: Per CAIN457A2307|Lost to Follow-up|0|||
48788178|NCT01412944|157065911|FG004|IV: Per CAIN457A2307|Lost to Follow-up|0|||
48788179|NCT01412944|157065912|FG005|IV: Per CAIN457A2307|Lost to Follow-up|0|||
48788180|NCT01412944|157065907|FG000|Entire: IV + Maintenance|Withdrawal by Subject|0|||
48788181|NCT01412944|157065908|FG001|Entire: IV + Maintenance|Withdrawal by Subject|0|||
48788182|NCT01412944|157065909|FG002|Entire: IV + Maintenance|Withdrawal by Subject|1|||
48788183|NCT01412944|157065910|FG003|Entire: IV + Maintenance|Withdrawal by Subject|1|||
48788184|NCT01412944|157065911|FG004|Entire: IV + Maintenance|Withdrawal by Subject|1|||
48788185|NCT01412944|157065912|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
48788186|NCT01412944|157065907|FG000|Entire: IV + Maintenance|Adverse Event|0|||
48788187|NCT01412944|157065908|FG001|Entire: IV + Maintenance|Adverse Event|0|||
48788188|NCT01412944|157065909|FG002|Entire: IV + Maintenance|Adverse Event|0|||
48788189|NCT01412944|157065910|FG003|Entire: IV + Maintenance|Adverse Event|0|||
48788190|NCT01412944|157065911|FG004|Entire: IV + Maintenance|Adverse Event|1|||
48788191|NCT01412944|157065912|FG005|Entire: IV + Maintenance|Adverse Event|0|||
48788192|NCT01412944|157065907|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
48788193|NCT01412944|157065908|FG001|Entire: IV + Maintenance|Protocol deviation|0|||
48788194|NCT01412944|157065909|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
48788195|NCT01412944|157065910|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
48788196|NCT01412944|157065911|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
48788197|NCT01412944|157065912|FG005|Entire: IV + Maintenance|Protocol deviation|1|||
48788198|NCT01412944|157065907|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
48788199|NCT01412944|157065908|FG001|Entire: IV + Maintenance|Lost to Follow-up|0|||
48788200|NCT01412944|157065909|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
48788201|NCT01412944|157065910|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
48788202|NCT01412944|157065911|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
48788203|NCT01412944|157065912|FG005|Entire: IV + Maintenance|Lost to Follow-up|1|||
48877757|NCT01867047|157392050|FG001|Overall Study|Lost to Follow-up|3|||
48877758|NCT01867047|157392049|FG000|Overall Study|Withdrawal by Subject|2|||
49032023|NCT01597245|157953479|FG009|Maintenance Period (Week 12 to Week 60)|Relapsed|114|||
48788204|NCT01412944|157065907|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
48788205|NCT01412944|157065908|FG001|Entire: IV + Maintenance|Lack of Efficacy|0|||
48788206|NCT01412944|157065909|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
48788207|NCT01412944|157065910|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
48788208|NCT01412944|157065911|FG004|Entire: IV + Maintenance|Lack of Efficacy|1|||
48788209|NCT01412944|157065912|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
48877759|NCT01867047|157392050|FG001|Overall Study|Withdrawal by Subject|0|||
48788210|NCT01412944|157065907|FG000|Entire: IV + Maintenance|Withdrawal by Subject|2|||
48788211|NCT01412944|157065908|FG001|Entire: IV + Maintenance|Withdrawal by Subject|1|||
48788212|NCT01412944|157065909|FG002|Entire: IV + Maintenance|Withdrawal by Subject|0|||
48788213|NCT01412944|157065910|FG003|Entire: IV + Maintenance|Withdrawal by Subject|0|||
48788214|NCT01412944|157065911|FG004|Entire: IV + Maintenance|Withdrawal by Subject|0|||
48788215|NCT01412944|157065912|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
48788216|NCT01412944|157065907|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
48788217|NCT01412944|157065908|FG001|Entire: IV + Maintenance|Protocol deviation|1|||
48788218|NCT01412944|157065909|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
48788219|NCT01412944|157065910|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
48788220|NCT01412944|157065911|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
48788221|NCT01412944|157065912|FG005|Entire: IV + Maintenance|Protocol deviation|0|||
48788222|NCT01412944|157065907|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
48788223|NCT01412944|157065908|FG001|Entire: IV + Maintenance|Lost to Follow-up|1|||
48788224|NCT01412944|157065909|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
48788225|NCT01412944|157065910|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
48788226|NCT01412944|157065911|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
48788227|NCT01412944|157065912|FG005|Entire: IV + Maintenance|Lost to Follow-up|0|||
48788228|NCT01412944|157065907|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
48788229|NCT01412944|157065908|FG001|Entire: IV + Maintenance|Lack of Efficacy|1|||
48788230|NCT01412944|157065909|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
48788231|NCT01412944|157065910|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
48788232|NCT01412944|157065911|FG004|Entire: IV + Maintenance|Lack of Efficacy|0|||
48788233|NCT01412944|157065912|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
48788234|NCT01412944|157065907|FG000|Entire: IV + Maintenance|Adverse Event|0|||
48788235|NCT01412944|157065908|FG001|Entire: IV + Maintenance|Adverse Event|1|||
48788236|NCT01412944|157065909|FG002|Entire: IV + Maintenance|Adverse Event|0|||
48788237|NCT01412944|157065910|FG003|Entire: IV + Maintenance|Adverse Event|0|||
48788238|NCT01412944|157065911|FG004|Entire: IV + Maintenance|Adverse Event|0|||
48788239|NCT01412944|157065912|FG005|Entire: IV + Maintenance|Adverse Event|0|||
48788240|NCT00360308|157065913|FG000|Overall Study|Adverse Event|15|||
48788241|NCT00360308|157065914|FG001|Overall Study|Adverse Event|14|||
48788242|NCT00360308|157065915|FG002|Overall Study|Adverse Event|25|||
48788243|NCT00360308|157065913|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
48788244|NCT00360308|157065914|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
48788245|NCT00360308|157065915|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
48788246|NCT00360308|157065913|FG000|Overall Study|Protocol Violation|2|||
48788247|NCT00360308|157065914|FG001|Overall Study|Protocol Violation|1|||
48788248|NCT00360308|157065915|FG002|Overall Study|Protocol Violation|2|||
48788249|NCT00360308|157065913|FG000|Overall Study|Withdrawal by Subject|11|||
48788250|NCT00360308|157065914|FG001|Overall Study|Withdrawal by Subject|7|||
48788251|NCT00360308|157065915|FG002|Overall Study|Withdrawal by Subject|14|||
48788252|NCT00360308|157065913|FG000|Overall Study|Lack of Efficacy|3|||
48788253|NCT00360308|157065914|FG001|Overall Study|Lack of Efficacy|0|||
48788254|NCT00360308|157065915|FG002|Overall Study|Lack of Efficacy|2|||
48788255|NCT00360308|157065913|FG000|Overall Study|Other|2|||
48788256|NCT00360308|157065914|FG001|Overall Study|Other|1|||
48788257|NCT00360308|157065915|FG002|Overall Study|Other|1|||
48788258|NCT00360308|157065913|FG000|Overall Study|Study termination by sponsor|43|||
48788259|NCT00360308|157065914|FG001|Overall Study|Study termination by sponsor|55|||
48788260|NCT00360308|157065915|FG002|Overall Study|Study termination by sponsor|44|||
48788261|NCT00377819|157065919|FG000|Overall Study|Adverse Event|2|||
48788262|NCT00377819|157065920|FG001|Overall Study|Adverse Event|3|||
48788263|NCT00377819|157065919|FG000|Overall Study|Withdrawal by Subject|10|||
48788264|NCT00377819|157065920|FG001|Overall Study|Withdrawal by Subject|4|||
48788265|NCT00377819|157065919|FG000|Overall Study|Death|0|||
48788266|NCT00377819|157065920|FG001|Overall Study|Death|1|||
48788267|NCT00377819|157065919|FG000|Overall Study|Lost to Follow-up|0|||
48788268|NCT00377819|157065920|FG001|Overall Study|Lost to Follow-up|1|||
48788269|NCT00377819|157065919|FG000|Overall Study|Protocol Violation|1|||
48788270|NCT00377819|157065920|FG001|Overall Study|Protocol Violation|1|||
48788271|NCT01914926|157065921|FG000|Overall Study|Adverse Event|1|||
48788272|NCT01914926|157065922|FG001|Overall Study|Adverse Event|0|||
48788273|NCT01914926|157065921|FG000|Overall Study|uncooperative, agitated and removed|0|||
48788274|NCT01914926|157065922|FG001|Overall Study|uncooperative, agitated and removed|1|||
48788275|NCT00321919|157065923|FG000|Overall Study|Adverse Event|17|||
48788276|NCT00321919|157065924|FG001|Overall Study|Adverse Event|10|||
48788277|NCT00321919|157065923|FG000|Overall Study|Death|21|||
48788278|NCT00321919|157065924|FG001|Overall Study|Death|17|||
48788279|NCT00321919|157065923|FG000|Overall Study|Insufficient Therapeutic Response|1|||
48788280|NCT00321919|157065924|FG001|Overall Study|Insufficient Therapeutic Response|0|||
48788281|NCT00321919|157065923|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
48788282|NCT00321919|157065924|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
48788283|NCT00321919|157065923|FG000|Overall Study|Refused Treatment|23|||
48788284|NCT00321919|157065924|FG001|Overall Study|Refused Treatment|14|||
48788285|NCT00321919|157065923|FG000|Overall Study|Other Protocol Violation|2|||
48788286|NCT00321919|157065924|FG001|Overall Study|Other Protocol Violation|3|||
48788287|NCT00321919|157065923|FG000|Overall Study|Failure to Return|3|||
48788288|NCT00321919|157065924|FG001|Overall Study|Failure to Return|1|||
48788289|NCT00321919|157065923|FG000|Overall Study|Other withdrawal reason|7|||
48788290|NCT00321919|157065924|FG001|Overall Study|Other withdrawal reason|6|||
48788291|NCT02148250|157065927|FG000|Screening|Withdrawal by Subject|5|||
48788292|NCT02148250|157065928|FG001|Screening|Withdrawal by Subject|0|||
48788293|NCT02508311|157065931|FG000|Overall Study|Withdrawal by Subject|1|||
48788294|NCT02508311|157065932|FG001|Overall Study|Withdrawal by Subject|0|||
48788295|NCT02169674|157065933|FG000|Overall Study|Withdrawal by Subject|2|||
48788296|NCT02169674|157065934|FG001|Overall Study|Withdrawal by Subject|1|||
48788297|NCT02169674|157065933|FG000|Overall Study|Seroprotected|30|||
48788298|NCT02169674|157065934|FG001|Overall Study|Seroprotected|76|||
48788299|NCT02169674|157065933|FG000|Overall Study|Lost to Follow-up|0|||
48788300|NCT02169674|157065934|FG001|Overall Study|Lost to Follow-up|1|||
48788301|NCT02370602|157065935|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
48788302|NCT02370602|157065936|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
48788303|NCT02370602|157065937|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
48788304|NCT02370602|157065938|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
48788305|NCT02370602|157065939|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
48788306|NCT02370602|157065940|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
48788307|NCT00695903|157065941|FG000|Had End of Therapy (EOT) Assessment|Randomized not treated|0|||
48788308|NCT00695903|157065942|FG001|Had End of Therapy (EOT) Assessment|Randomized not treated|2|||
48788309|NCT00695903|157065941|FG000|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
48788310|NCT00695903|157065942|FG001|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
48788311|NCT00695903|157065941|FG000|Had End of Therapy (EOT) Assessment|Adverse Event|1|||
48788312|NCT00695903|157065942|FG001|Had End of Therapy (EOT) Assessment|Adverse Event|0|||
48788313|NCT00695903|157065941|FG000|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
48788314|NCT00695903|157065942|FG001|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
48788315|NCT00695903|157065941|FG000|Had End of Therapy (EOT) Assessment|Physician Decision|0|||
48788316|NCT00695903|157065942|FG001|Had End of Therapy (EOT) Assessment|Physician Decision|1|||
48788317|NCT00695903|157065941|FG000|Had End of Therapy (EOT) Assessment|Protocol Violation|1|||
48788318|NCT00695903|157065942|FG001|Had End of Therapy (EOT) Assessment|Protocol Violation|2|||
48788319|NCT00695903|157065941|FG000|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1|||
48788320|NCT00695903|157065942|FG001|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0|||
48788321|NCT00695903|157065941|FG000|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1|||
48788322|NCT00695903|157065942|FG001|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0|||
48788323|NCT00695903|157065941|FG000|Had Test of Cure (TOC) Assessment|Adverse Event|0|||
48788324|NCT00695903|157065942|FG001|Had Test of Cure (TOC) Assessment|Adverse Event|1|||
48788325|NCT04137380|157065950|FG000|Overall Study|Physician Decision|0|||
48788326|NCT04137380|157065951|FG001|Overall Study|Physician Decision|0|||
48788327|NCT04137380|157065952|FG002|Overall Study|Physician Decision|0|||
48788328|NCT04137380|157065953|FG003|Overall Study|Physician Decision|1|||
48788329|NCT04137380|157065954|FG004|Overall Study|Physician Decision|0|||
48788330|NCT04137380|157065955|FG005|Overall Study|Physician Decision|0|||
48788331|NCT04137380|157065956|FG006|Overall Study|Physician Decision|0|||
48788332|NCT01613248|157065957|FG000|Overall Study|Adverse Event|0|||
48788333|NCT01613248|157065958|FG001|Overall Study|Adverse Event|0|||
48788334|NCT01613248|157065959|FG002|Overall Study|Adverse Event|0|||
48788335|NCT01613248|157065960|FG003|Overall Study|Adverse Event|1|||
48788336|NCT01613248|157065961|FG004|Overall Study|Adverse Event|0|||
48788337|NCT01613248|157065962|FG005|Overall Study|Adverse Event|0|||
48788338|NCT01613248|157065957|FG000|Overall Study|Withdrawal by Subject|3|||
48788339|NCT01613248|157065958|FG001|Overall Study|Withdrawal by Subject|2|||
48788340|NCT01613248|157065959|FG002|Overall Study|Withdrawal by Subject|2|||
48788341|NCT01613248|157065960|FG003|Overall Study|Withdrawal by Subject|5|||
48788342|NCT01613248|157065961|FG004|Overall Study|Withdrawal by Subject|0|||
48788343|NCT01613248|157065962|FG005|Overall Study|Withdrawal by Subject|1|||
48788344|NCT01613248|157065957|FG000|Overall Study|Lost to Follow-up|5|||
48788345|NCT01613248|157065958|FG001|Overall Study|Lost to Follow-up|7|||
48788346|NCT01613248|157065959|FG002|Overall Study|Lost to Follow-up|4|||
48788347|NCT01613248|157065960|FG003|Overall Study|Lost to Follow-up|8|||
48788348|NCT01613248|157065961|FG004|Overall Study|Lost to Follow-up|4|||
48788349|NCT01613248|157065962|FG005|Overall Study|Lost to Follow-up|2|||
48788350|NCT01613248|157065957|FG000|Overall Study|Study Terminated by Sponsor|4|||
48788351|NCT01613248|157065958|FG001|Overall Study|Study Terminated by Sponsor|6|||
48788352|NCT01613248|157065959|FG002|Overall Study|Study Terminated by Sponsor|8|||
48788353|NCT01613248|157065960|FG003|Overall Study|Study Terminated by Sponsor|8|||
48877760|NCT01867047|157392049|FG000|Overall Study|Physician Decision|2|||
48788354|NCT01613248|157065961|FG004|Overall Study|Study Terminated by Sponsor|9|||
48788355|NCT01613248|157065962|FG005|Overall Study|Study Terminated by Sponsor|11|||
48788356|NCT01613248|157065957|FG000|Overall Study|Physician Decision|8|||
48788357|NCT01613248|157065958|FG001|Overall Study|Physician Decision|8|||
48788358|NCT01613248|157065959|FG002|Overall Study|Physician Decision|9|||
48788359|NCT01613248|157065960|FG003|Overall Study|Physician Decision|4|||
48788360|NCT01613248|157065961|FG004|Overall Study|Physician Decision|7|||
48788361|NCT01613248|157065962|FG005|Overall Study|Physician Decision|6|||
48788362|NCT01613248|157065957|FG000|Overall Study|Lack of Qualifying Event|9|||
48788363|NCT01613248|157065958|FG001|Overall Study|Lack of Qualifying Event|11|||
48788364|NCT01613248|157065959|FG002|Overall Study|Lack of Qualifying Event|10|||
48788365|NCT01613248|157065960|FG003|Overall Study|Lack of Qualifying Event|11|||
48788366|NCT01613248|157065961|FG004|Overall Study|Lack of Qualifying Event|15|||
48788367|NCT01613248|157065962|FG005|Overall Study|Lack of Qualifying Event|18|||
48788368|NCT01613248|157065957|FG000|Overall Study|Pregnancy|0|||
48788369|NCT01613248|157065958|FG001|Overall Study|Pregnancy|0|||
48788370|NCT01613248|157065959|FG002|Overall Study|Pregnancy|0|||
48788371|NCT01613248|157065960|FG003|Overall Study|Pregnancy|1|||
48788372|NCT01613248|157065961|FG004|Overall Study|Pregnancy|0|||
48788373|NCT01613248|157065962|FG005|Overall Study|Pregnancy|0|||
48788374|NCT00121238|157065963|FG000|Overall Study|disease progression before intervention|1|||
48788375|NCT00121238|157065963|FG000|Overall Study|Protocol Violation|2|||
48788376|NCT03056755|157065964|FG000|Treatment- Core Phase|Progressive disease|89|||
48788377|NCT03056755|157065965|FG001|Treatment- Core Phase|Progressive disease|88|||
48788378|NCT03056755|157065966|FG002|Treatment- Core Phase|Progressive disease|90|||
48788379|NCT03056755|157065964|FG000|Treatment- Core Phase|Adverse Event|20|||
48788380|NCT03056755|157065965|FG001|Treatment- Core Phase|Adverse Event|14|||
48788381|NCT03056755|157065966|FG002|Treatment- Core Phase|Adverse Event|13|||
48788382|NCT03056755|157065964|FG000|Treatment- Core Phase|Physician Decision|7|||
48788383|NCT03056755|157065965|FG001|Treatment- Core Phase|Physician Decision|13|||
48788384|NCT03056755|157065966|FG002|Treatment- Core Phase|Physician Decision|5|||
48788385|NCT03056755|157065964|FG000|Treatment- Core Phase|Subject/guardian decision|5|||
48788386|NCT03056755|157065965|FG001|Treatment- Core Phase|Subject/guardian decision|8|||
48788387|NCT03056755|157065966|FG002|Treatment- Core Phase|Subject/guardian decision|4|||
48788388|NCT03056755|157065964|FG000|Treatment- Core Phase|Death|3|||
48788389|NCT03056755|157065965|FG001|Treatment- Core Phase|Death|2|||
48788390|NCT03056755|157065966|FG002|Treatment- Core Phase|Death|4|||
48788391|NCT03056755|157065964|FG000|Treatment- Core Phase|Protocol deviation|1|||
48788392|NCT03056755|157065965|FG001|Treatment- Core Phase|Protocol deviation|1|||
48788393|NCT03056755|157065966|FG002|Treatment- Core Phase|Protocol deviation|0|||
49032024|NCT01597245|157953480|FG010|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
49032025|NCT01597245|157953481|FG011|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
49032026|NCT01597245|157953482|FG012|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
49032027|NCT01597245|157953483|FG013|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
49032028|NCT01597245|157953484|FG014|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
49032029|NCT01597245|157953485|FG015|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
49032030|NCT01597245|157953486|FG016|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
49032031|NCT01597245|157953487|FG017|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
49032032|NCT01597245|157953488|FG018|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
49032033|NCT01597245|157953489|FG019|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
49032034|NCT01597245|157953490|FG020|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
49032035|NCT01597245|157953470|FG000|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
49032036|NCT01597245|157953471|FG001|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
49032037|NCT01597245|157953472|FG002|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
49032038|NCT01597245|157953473|FG003|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
49032039|NCT01597245|157953474|FG004|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
49032040|NCT01597245|157953475|FG005|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1|||
48788394|NCT03056755|157065964|FG000|Treatment- Core Phase|Technical problems|1|||
48788395|NCT03056755|157065965|FG001|Treatment- Core Phase|Technical problems|0|||
48788396|NCT03056755|157065966|FG002|Treatment- Core Phase|Technical problems|0|||
48788397|NCT03056755|157065964|FG000|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
48788398|NCT03056755|157065965|FG001|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
48788399|NCT03056755|157065966|FG002|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|2|||
48788400|NCT03056755|157065964|FG000|Post-treatment Efficacy - Core Phase|Progressive disease|11|||
48788401|NCT03056755|157065965|FG001|Post-treatment Efficacy - Core Phase|Progressive disease|9|||
48788402|NCT03056755|157065966|FG002|Post-treatment Efficacy - Core Phase|Progressive disease|5|||
48788403|NCT03056755|157065964|FG000|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
48788404|NCT03056755|157065965|FG001|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
48788405|NCT03056755|157065966|FG002|Post-treatment Efficacy - Core Phase|Adverse Event|0|||
49032041|NCT01597245|157953476|FG006|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
48788406|NCT03056755|157065964|FG000|Post-treatment Efficacy - Core Phase|Death|1|||
48788407|NCT03056755|157065965|FG001|Post-treatment Efficacy - Core Phase|Death|3|||
48788408|NCT03056755|157065966|FG002|Post-treatment Efficacy - Core Phase|Death|0|||
48788409|NCT05554237|157065969|FG000|Part 2 (7 Days)|Adverse Event|0|||
49032042|NCT01597245|157953477|FG007|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
49032043|NCT01597245|157953478|FG008|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3|||
48788410|NCT05554237|157065970|FG001|Part 2 (7 Days)|Adverse Event|0|||
48788411|NCT05554237|157065971|FG002|Part 2 (7 Days)|Adverse Event|0|||
48788412|NCT05554237|157065972|FG003|Part 2 (7 Days)|Adverse Event|0|||
48788413|NCT05554237|157065973|FG004|Part 2 (7 Days)|Adverse Event|2|||
48788414|NCT05554237|157065974|FG005|Part 2 (7 Days)|Adverse Event|0|||
48788415|NCT05554237|157065975|FG006|Part 2 (7 Days)|Adverse Event|0|||
48788416|NCT05554237|157065976|FG007|Part 2 (7 Days)|Adverse Event|0|||
48788417|NCT05554237|157065977|FG008|Part 2 (7 Days)|Adverse Event|0|||
48788418|NCT05554237|157065978|FG009|Part 2 (7 Days)|Adverse Event|1|||
48788419|NCT05554237|157065979|FG010|Part 2 (7 Days)|Adverse Event|0|||
48788420|NCT05554237|157065980|FG011|Part 2 (7 Days)|Adverse Event|0|||
48788421|NCT05554237|157065981|FG012|Part 2 (7 Days)|Adverse Event|1|||
48788422|NCT05554237|157065982|FG013|Part 2 (7 Days)|Adverse Event|0|||
48788423|NCT03720795|157065986|FG000|Phase 1|Lost to Follow-up|4|||
48788424|NCT03720795|157065986|FG000|Phase 1|Withdrawal by Subject|6|||
48788425|NCT03720795|157065986|FG000|Phase 1|Protocol Violation|1|||
48788426|NCT03720795|157065986|FG000|Phase 1|Other|1|||
48788427|NCT03720795|157065986|FG000|Phase 2|Lost to Follow-up|5|||
48788428|NCT03720795|157065986|FG000|Phase 2|Withdrawal by Subject|10|||
48788429|NCT03720795|157065986|FG000|Phase 2|Protocol Violation|2|||
48788430|NCT03720795|157065986|FG000|3 Month Follow Up|Lost to Follow-up|2|||
48788431|NCT01306162|157065991|FG000|Period 1|Adverse Event|0|||
48788432|NCT01306162|157065992|FG001|Period 1|Adverse Event|0|||
48788433|NCT01306162|157065993|FG002|Period 1|Adverse Event|0|||
48788434|NCT01306162|157065994|FG003|Period 1|Adverse Event|1|||
48788435|NCT01306162|157065991|FG000|Washout 1|Non-compliance to protocol|0|||
48788436|NCT01306162|157065992|FG001|Washout 1|Non-compliance to protocol|1|||
48788437|NCT01306162|157065993|FG002|Washout 1|Non-compliance to protocol|0|||
48788438|NCT01306162|157065994|FG003|Washout 1|Non-compliance to protocol|0|||
48788439|NCT01556438|157065995|FG000|Overall Study|Adverse Event|4|||
48788440|NCT01556438|157065996|FG001|Overall Study|Adverse Event|2|||
48788441|NCT01556438|157065995|FG000|Overall Study|Sponsor Decision|0|||
48788442|NCT01556438|157065996|FG001|Overall Study|Sponsor Decision|2|||
48788443|NCT01556438|157065995|FG000|Overall Study|Progressive Disease|0|||
48788444|NCT01556438|157065996|FG001|Overall Study|Progressive Disease|6|||
48788445|NCT01556438|157065995|FG000|Overall Study|Death|0|||
48788446|NCT01556438|157065996|FG001|Overall Study|Death|1|||
48788447|NCT00092131|157065997|FG000|Treatment Period I|Adverse Event|1|||
48788448|NCT00092131|157065998|FG001|Treatment Period I|Adverse Event|0|||
48788449|NCT00092131|157065997|FG000|Treatment Period II|Adverse Event|0|||
48788450|NCT00092131|157065998|FG001|Treatment Period II|Adverse Event|1|||
48788451|NCT01660763|157065999|FG000|Overall Study|Lack of Efficacy|45|||
48788452|NCT01660763|157066000|FG001|Overall Study|Lack of Efficacy|50|||
48788453|NCT01660763|157065999|FG000|Overall Study|Adverse Event|22|||
48788454|NCT01660763|157066000|FG001|Overall Study|Adverse Event|7|||
48788455|NCT01660763|157065999|FG000|Overall Study|Protocol Violation|1|||
48788456|NCT01660763|157066000|FG001|Overall Study|Protocol Violation|0|||
48788457|NCT01660763|157065999|FG000|Overall Study|Withdrawal by Subject|4|||
48788458|NCT01660763|157066000|FG001|Overall Study|Withdrawal by Subject|0|||
48788459|NCT01660763|157065999|FG000|Overall Study|Patient ready for early discharge|28|||
48788460|NCT01660763|157066000|FG001|Overall Study|Patient ready for early discharge|4|||
48788461|NCT04709419|157066003|FG000|Overall Study|Physician Decision|1|||
48788462|NCT04709419|157066004|FG001|Overall Study|Physician Decision|0|||
48788463|NCT03034577|157066005|FG000|Overall Study|Withdrawal by Subject|6|||
48788464|NCT03034577|157066006|FG001|Overall Study|Withdrawal by Subject|9|||
48788465|NCT03034577|157066005|FG000|Overall Study|Lost to Follow-up|25|||
48788466|NCT03034577|157066006|FG001|Overall Study|Lost to Follow-up|26|||
48788467|NCT03358472|157066007|FG000|Overall Study|Death|6|||
48788468|NCT03358472|157066008|FG001|Overall Study|Death|3|||
48788469|NCT03358472|157066009|FG002|Overall Study|Death|10|||
48788470|NCT03358472|157066007|FG000|Overall Study|Physician Decision|0|||
48788471|NCT03358472|157066008|FG001|Overall Study|Physician Decision|1|||
48983203|NCT02394028|157769989|FG003|Maintenance Phase|Death|0|||
48983204|NCT02394028|157769990|FG004|Maintenance Phase|Death|0|||
48983205|NCT02394028|157769991|FG005|Maintenance Phase|Death|0|||
48983206|NCT02394028|157769992|FG006|Maintenance Phase|Death|0|||
48788472|NCT03358472|157066009|FG002|Overall Study|Physician Decision|0|||
48788473|NCT03358472|157066007|FG000|Overall Study|Withdrawal by Subject|0|||
48788474|NCT03358472|157066008|FG001|Overall Study|Withdrawal by Subject|0|||
48788475|NCT03358472|157066009|FG002|Overall Study|Withdrawal by Subject|1|||
48788476|NCT03358472|157066007|FG000|Overall Study|On-going at clinical cut off date|9|||
48788477|NCT03358472|157066008|FG001|Overall Study|On-going at clinical cut off date|6|||
48788478|NCT03358472|157066009|FG002|Overall Study|On-going at clinical cut off date|5|||
48788479|NCT00490646|157066010|FG000|Overall Study|Still on trastuzumab monotherapy|1|||
48788480|NCT00490646|157066011|FG001|Overall Study|Still on trastuzumab monotherapy|1|||
48788481|NCT00490646|157066010|FG000|Overall Study|Never Treated (had an adverse event)|1|||
48788482|NCT00490646|157066011|FG001|Overall Study|Never Treated (had an adverse event)|0|||
48788483|NCT00490646|157066010|FG000|Overall Study|Never Treated (withdrew consent)|0|||
48983207|NCT02394028|157769993|FG007|Maintenance Phase|Death|0|||
48877761|NCT01867047|157392050|FG001|Overall Study|Physician Decision|0|||
48788484|NCT00490646|157066011|FG001|Overall Study|Never Treated (withdrew consent)|1|||
48788485|NCT01453595|157066015|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
48788486|NCT01453595|157066016|FG001|Overall Study|Dose Limiting Toxicity (DLT)|1|||
48788487|NCT01453595|157066017|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
48788488|NCT02130193|157066018|FG000|Part B: 52-week Double-blind Period|Adverse Event|0|||
48788489|NCT02130193|157066019|FG001|Part B: 52-week Double-blind Period|Adverse Event|5|||
48788490|NCT02130193|157066020|FG002|Part B: 52-week Double-blind Period|Adverse Event|3|||
48788491|NCT02130193|157066018|FG000|Part B: 52-week Double-blind Period|Protocol Violation|0|||
48788492|NCT02130193|157066019|FG001|Part B: 52-week Double-blind Period|Protocol Violation|2|||
48788493|NCT02130193|157066020|FG002|Part B: 52-week Double-blind Period|Protocol Violation|1|||
48788494|NCT02130193|157066018|FG000|Part B: 52-week Double-blind Period|Physician Decision|0|||
48788495|NCT02130193|157066019|FG001|Part B: 52-week Double-blind Period|Physician Decision|0|||
48788496|NCT02130193|157066020|FG002|Part B: 52-week Double-blind Period|Physician Decision|1|||
48788497|NCT02130193|157066018|FG000|Part B: 52-week Double-blind Period|Withdrawal by Subject|0|||
48788498|NCT02130193|157066019|FG001|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
48788499|NCT02130193|157066020|FG002|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
48788500|NCT01218438|157066021|FG000|Epoch 1|Physician Decision|2|||
48788501|NCT01218438|157066021|FG000|Epoch 1|Adverse Event|1|||
48788502|NCT01218438|157066021|FG000|Epoch 3|Withdrawal by Subject|3|||
48788503|NCT01218438|157066021|FG000|Epoch 3|Adverse Event|1|||
48788504|NCT01218438|157066021|FG000|Epoch 4|Physician Decision|1|||
48788505|NCT01218438|157066021|FG000|Epoch 4|Withdrawal by Subject|2|||
48788506|NCT01212770|157066024|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
48788507|NCT01212770|157066025|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
48788508|NCT01212770|157066026|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8|||
48788509|NCT01212770|157066027|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
48788510|NCT01212770|157066028|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
48788511|NCT01212770|157066029|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
48788512|NCT01212770|157066030|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
48788513|NCT01212770|157066031|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
48788514|NCT01212770|157066032|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
48788515|NCT01212770|157066024|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
48788516|NCT01212770|157066025|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5|||
48788517|NCT01212770|157066026|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7|||
48788518|NCT01212770|157066027|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
48788519|NCT01212770|157066028|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
48788520|NCT01212770|157066029|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
48788521|NCT01212770|157066030|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
48788522|NCT01212770|157066031|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
48788523|NCT01212770|157066032|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
48788524|NCT01212770|157066024|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
48788525|NCT01212770|157066025|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
48788526|NCT01212770|157066026|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
48788527|NCT01212770|157066027|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
48788528|NCT01212770|157066028|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
48788529|NCT01212770|157066029|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
48788530|NCT01212770|157066030|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
48788531|NCT01212770|157066031|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
48788532|NCT01212770|157066032|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
48788533|NCT01212770|157066024|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
48788534|NCT01212770|157066025|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
48788535|NCT01212770|157066026|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3|||
48788536|NCT01212770|157066027|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
48788537|NCT01212770|157066028|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
48788538|NCT01212770|157066029|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
48788539|NCT01212770|157066030|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
48788540|NCT01212770|157066031|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
48788541|NCT01212770|157066032|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
48788542|NCT01212770|157066024|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
48788543|NCT01212770|157066025|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
48788544|NCT01212770|157066026|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
49032044|NCT01597245|157953479|FG009|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
48788545|NCT01212770|157066027|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
48788546|NCT01212770|157066028|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
49032045|NCT01597245|157953480|FG010|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2|||
49032046|NCT01597245|157953481|FG011|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10|||
48788547|NCT01212770|157066029|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
48788548|NCT01212770|157066030|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
48788549|NCT01212770|157066031|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
48788550|NCT01212770|157066032|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
48788551|NCT01212770|157066024|FG000|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3|||
48788552|NCT01212770|157066025|FG001|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1|||
48788553|NCT01212770|157066026|FG002|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2|||
48788554|NCT01212770|157066027|FG003|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
48788555|NCT01212770|157066028|FG004|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
48788556|NCT01212770|157066029|FG005|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
48788557|NCT01212770|157066030|FG006|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
48788558|NCT01212770|157066031|FG007|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
48788559|NCT01212770|157066032|FG008|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
48788560|NCT01212770|157066024|FG000|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
48788561|NCT01212770|157066025|FG001|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6|||
48788562|NCT01212770|157066026|FG002|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
48788563|NCT01212770|157066027|FG003|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
48788564|NCT01212770|157066028|FG004|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
48788565|NCT01212770|157066029|FG005|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
48788566|NCT01212770|157066030|FG006|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1|||
48788567|NCT01212770|157066031|FG007|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
48788568|NCT01212770|157066032|FG008|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
48788569|NCT01212770|157066024|FG000|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
48788570|NCT01212770|157066025|FG001|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7|||
48788571|NCT01212770|157066026|FG002|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5|||
48788572|NCT01212770|157066027|FG003|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4|||
48788573|NCT01212770|157066028|FG004|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1|||
48788574|NCT01212770|157066029|FG005|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2|||
48788575|NCT01212770|157066030|FG006|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
48788576|NCT01212770|157066031|FG007|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
48788577|NCT01212770|157066032|FG008|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
48788578|NCT01212770|157066024|FG000|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
48788579|NCT01212770|157066025|FG001|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6|||
48788580|NCT01212770|157066026|FG002|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
48788581|NCT01212770|157066027|FG003|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
48788582|NCT01212770|157066028|FG004|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
48788583|NCT01212770|157066029|FG005|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
48788584|NCT01212770|157066030|FG006|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
48788585|NCT01212770|157066031|FG007|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
48788586|NCT01212770|157066032|FG008|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
48788587|NCT01212770|157066024|FG000|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
48788588|NCT01212770|157066025|FG001|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
48788589|NCT01212770|157066026|FG002|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1|||
48788590|NCT01212770|157066027|FG003|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
48788591|NCT01212770|157066028|FG004|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
48788592|NCT01212770|157066029|FG005|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
48788593|NCT01212770|157066030|FG006|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
48788594|NCT01212770|157066031|FG007|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
48788595|NCT01212770|157066032|FG008|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
48788596|NCT01212770|157066024|FG000|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
48788597|NCT01212770|157066025|FG001|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
48788598|NCT01212770|157066026|FG002|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
48788599|NCT01212770|157066027|FG003|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1|||
48788600|NCT01212770|157066028|FG004|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
48788601|NCT01212770|157066029|FG005|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
48788602|NCT01212770|157066030|FG006|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
48983208|NCT02394028|157769994|FG008|Maintenance Phase|Death|0|||
48983209|NCT02394028|157769995|FG009|Maintenance Phase|Death|0|||
48983210|NCT02394028|157769996|FG010|Maintenance Phase|Death|1|||
48983211|NCT02394028|157769986|FG000|Maintenance Phase|Adverse Event|0|||
48983212|NCT02394028|157769987|FG001|Maintenance Phase|Adverse Event|0|||
48983213|NCT02394028|157769988|FG002|Maintenance Phase|Adverse Event|0|||
48983214|NCT02394028|157769989|FG003|Maintenance Phase|Adverse Event|0|||
48983215|NCT02394028|157769990|FG004|Maintenance Phase|Adverse Event|0|||
48983216|NCT02394028|157769991|FG005|Maintenance Phase|Adverse Event|0|||
48983217|NCT02394028|157769992|FG006|Maintenance Phase|Adverse Event|0|||
48983218|NCT02394028|157769993|FG007|Maintenance Phase|Adverse Event|0|||
48983219|NCT02394028|157769994|FG008|Maintenance Phase|Adverse Event|1|||
48788603|NCT01212770|157066031|FG007|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
48788604|NCT01212770|157066032|FG008|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
48788605|NCT01212770|157066024|FG000|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
48788606|NCT01212770|157066025|FG001|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
48788607|NCT01212770|157066026|FG002|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
48788608|NCT01212770|157066027|FG003|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
48788609|NCT01212770|157066028|FG004|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
48788610|NCT01212770|157066029|FG005|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
49032047|NCT01597245|157953482|FG012|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4|||
49032048|NCT01597245|157953483|FG013|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
49032049|NCT01597245|157953484|FG014|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
49032050|NCT01597245|157953485|FG015|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
49032051|NCT01597245|157953486|FG016|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
49032052|NCT01597245|157953487|FG017|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
49032053|NCT01597245|157953488|FG018|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
49032054|NCT01597245|157953489|FG019|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
49032055|NCT01597245|157953490|FG020|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
49032056|NCT01597245|157953470|FG000|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
49032057|NCT01597245|157953471|FG001|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
49032058|NCT01597245|157953472|FG002|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
49032059|NCT01597245|157953473|FG003|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
49032060|NCT01597245|157953474|FG004|Maintenance Period (Week 12 to Week 60)|Adverse Event|4|||
49032061|NCT01597245|157953475|FG005|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
48788611|NCT01212770|157066030|FG006|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
48788612|NCT01212770|157066031|FG007|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
48788613|NCT01212770|157066032|FG008|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
48788614|NCT01212770|157066024|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
48788615|NCT01212770|157066025|FG001|Long-term Safety Phase (Year 2)|Adverse Event|3|||
48788616|NCT01212770|157066026|FG002|Long-term Safety Phase (Year 2)|Adverse Event|3|||
48788617|NCT01212770|157066027|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
48788618|NCT01212770|157066028|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
48788619|NCT01212770|157066029|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
48788620|NCT01212770|157066030|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
48788621|NCT01212770|157066031|FG007|Long-term Safety Phase (Year 2)|Adverse Event|0|||
48788622|NCT01212770|157066032|FG008|Long-term Safety Phase (Year 2)|Adverse Event|2|||
48788623|NCT01212770|157066024|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
48788624|NCT01212770|157066025|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
48788625|NCT01212770|157066026|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
48788626|NCT01212770|157066027|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
48788627|NCT01212770|157066028|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
48788628|NCT01212770|157066029|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
48788629|NCT01212770|157066030|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
48788630|NCT01212770|157066031|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
48788631|NCT01212770|157066032|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
48788632|NCT01212770|157066024|FG000|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
48788633|NCT01212770|157066025|FG001|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1|||
48788634|NCT01212770|157066026|FG002|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
48788635|NCT01212770|157066027|FG003|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
48788636|NCT01212770|157066028|FG004|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
48788637|NCT01212770|157066029|FG005|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
48788638|NCT01212770|157066030|FG006|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
48788639|NCT01212770|157066031|FG007|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
48788640|NCT01212770|157066032|FG008|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
48788641|NCT01212770|157066024|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
48788642|NCT01212770|157066025|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9|||
48788643|NCT01212770|157066026|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
48788644|NCT01212770|157066027|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
48788645|NCT01212770|157066028|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
48788646|NCT01212770|157066029|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
48788647|NCT01212770|157066030|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
48788648|NCT01212770|157066031|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
48788649|NCT01212770|157066032|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
49032062|NCT01597245|157953476|FG006|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
49032063|NCT01597245|157953477|FG007|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
48788650|NCT01212770|157066024|FG000|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
48788651|NCT01212770|157066025|FG001|Long-term Safety Phase (Year 2)|Lost to Follow-up|2|||
48788652|NCT01212770|157066026|FG002|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
48788653|NCT01212770|157066027|FG003|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
48788654|NCT01212770|157066028|FG004|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
48788655|NCT01212770|157066029|FG005|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
48788656|NCT01212770|157066030|FG006|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
48788657|NCT01212770|157066031|FG007|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
48788658|NCT01212770|157066032|FG008|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
48788659|NCT01212770|157066024|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
48788660|NCT01212770|157066025|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|2|||
48788661|NCT01212770|157066026|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
48788662|NCT01212770|157066027|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
48788663|NCT01212770|157066028|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
48788664|NCT01212770|157066029|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
48788665|NCT01212770|157066030|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
48788666|NCT01212770|157066031|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
48788667|NCT01212770|157066032|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
48788668|NCT01212770|157066024|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
48788669|NCT01212770|157066025|FG001|Long-term Safety Phase (Year 3)|Adverse Event|2|||
48788670|NCT01212770|157066026|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
48788671|NCT01212770|157066027|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
48788672|NCT01212770|157066028|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
48788673|NCT01212770|157066029|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
48788674|NCT01212770|157066030|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
48788675|NCT01212770|157066031|FG007|Long-term Safety Phase (Year 3)|Adverse Event|2|||
48788676|NCT01212770|157066032|FG008|Long-term Safety Phase (Year 3)|Adverse Event|1|||
48788677|NCT01212770|157066024|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
48788678|NCT01212770|157066025|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|3|||
48788679|NCT01212770|157066026|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
48788680|NCT01212770|157066027|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
48788681|NCT01212770|157066028|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
48788682|NCT01212770|157066029|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
48788683|NCT01212770|157066030|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
48788684|NCT01212770|157066031|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
48788685|NCT01212770|157066032|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
48788686|NCT01212770|157066024|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
49032064|NCT01597245|157953478|FG008|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
49032065|NCT01597245|157953479|FG009|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
49032066|NCT01597245|157953480|FG010|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
49032067|NCT01597245|157953481|FG011|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
48788687|NCT01212770|157066025|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3|||
48788688|NCT01212770|157066026|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
48788689|NCT01212770|157066027|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
48788690|NCT01212770|157066028|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
48788691|NCT01212770|157066029|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
48788692|NCT01212770|157066030|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
48788693|NCT01212770|157066031|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
48788694|NCT01212770|157066032|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
48788695|NCT01212770|157066024|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
48788696|NCT01212770|157066025|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
48788697|NCT01212770|157066026|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
48788698|NCT01212770|157066027|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
48788699|NCT01212770|157066028|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
48788700|NCT01212770|157066029|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
48788701|NCT01212770|157066030|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
48788702|NCT01212770|157066031|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
48788703|NCT01212770|157066032|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
48788704|NCT01212770|157066024|FG000|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
48788705|NCT01212770|157066025|FG001|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
48788706|NCT01212770|157066026|FG002|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
48788707|NCT01212770|157066027|FG003|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
48788708|NCT01212770|157066028|FG004|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
48788709|NCT01212770|157066029|FG005|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
48788710|NCT01212770|157066030|FG006|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
48788711|NCT01212770|157066031|FG007|Long-term Safety Phase (Year 3)|Protocol Violation|1|||
48788712|NCT01212770|157066032|FG008|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
48788713|NCT01212770|157066024|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
48788714|NCT01212770|157066025|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|2|||
48877762|NCT01867047|157392049|FG000|Overall Study|surgery not indicated in protocol|1|||
48788715|NCT01212770|157066026|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
48788716|NCT01212770|157066027|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
48788717|NCT01212770|157066028|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
48788718|NCT01212770|157066029|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
48788719|NCT01212770|157066030|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
48788720|NCT01212770|157066031|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
48788721|NCT01212770|157066032|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
48788722|NCT01212770|157066024|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
48788723|NCT01212770|157066025|FG001|Long-term Safety Phase (Year 4)|Adverse Event|1|||
48788724|NCT01212770|157066026|FG002|Long-term Safety Phase (Year 4)|Adverse Event|1|||
48788725|NCT01212770|157066027|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
48788726|NCT01212770|157066028|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
48788727|NCT01212770|157066029|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
48788728|NCT01212770|157066030|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
48788729|NCT01212770|157066031|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
48788730|NCT01212770|157066032|FG008|Long-term Safety Phase (Year 4)|Adverse Event|1|||
48788731|NCT01212770|157066024|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
48788732|NCT01212770|157066025|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
48788733|NCT01212770|157066026|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|5|||
48788734|NCT01212770|157066027|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
48788735|NCT01212770|157066028|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
48788736|NCT01212770|157066029|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
48788737|NCT01212770|157066030|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
48788738|NCT01212770|157066031|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|2|||
48788739|NCT01212770|157066032|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
48788740|NCT01212770|157066024|FG000|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
48788741|NCT01212770|157066025|FG001|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
48788742|NCT01212770|157066026|FG002|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
48788743|NCT01212770|157066027|FG003|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
48788744|NCT01212770|157066028|FG004|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
48788745|NCT01212770|157066029|FG005|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
48788746|NCT01212770|157066030|FG006|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
48788747|NCT01212770|157066031|FG007|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
48788748|NCT01212770|157066032|FG008|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
48788749|NCT01212770|157066024|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
48788750|NCT01212770|157066025|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2|||
48788751|NCT01212770|157066026|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3|||
48788752|NCT01212770|157066027|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
48788753|NCT01212770|157066028|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
48788754|NCT01212770|157066029|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
48788755|NCT01212770|157066030|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
48788756|NCT01212770|157066031|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
48788757|NCT01212770|157066032|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
48788758|NCT01212770|157066024|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
48788759|NCT01212770|157066025|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
48788760|NCT01212770|157066026|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
48788761|NCT01212770|157066027|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
48788762|NCT01212770|157066028|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
48788763|NCT01212770|157066029|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
48788764|NCT01212770|157066030|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
48788765|NCT01212770|157066031|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
48788766|NCT01212770|157066032|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
48788767|NCT01212770|157066024|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
48788768|NCT01212770|157066025|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
48788769|NCT01212770|157066026|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
48788770|NCT01212770|157066027|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
48788771|NCT01212770|157066028|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
48788772|NCT01212770|157066029|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
48788773|NCT01212770|157066030|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
48788774|NCT01212770|157066031|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
48788775|NCT01212770|157066032|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
48788776|NCT01212770|157066024|FG000|Long-term Safety Phase (Year 5)|Missing|0|||
48788777|NCT01212770|157066025|FG001|Long-term Safety Phase (Year 5)|Missing|0|||
48788778|NCT01212770|157066026|FG002|Long-term Safety Phase (Year 5)|Missing|1|||
48788779|NCT01212770|157066027|FG003|Long-term Safety Phase (Year 5)|Missing|0|||
48788780|NCT01212770|157066028|FG004|Long-term Safety Phase (Year 5)|Missing|0|||
48788781|NCT01212770|157066029|FG005|Long-term Safety Phase (Year 5)|Missing|0|||
48788782|NCT01212770|157066030|FG006|Long-term Safety Phase (Year 5)|Missing|0|||
48788783|NCT01212770|157066031|FG007|Long-term Safety Phase (Year 5)|Missing|0|||
48788784|NCT01212770|157066032|FG008|Long-term Safety Phase (Year 5)|Missing|0|||
48788785|NCT01212770|157066024|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
48788786|NCT01212770|157066025|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
48788787|NCT01212770|157066026|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|3|||
48788788|NCT01212770|157066027|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
48788789|NCT01212770|157066028|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
48788790|NCT01212770|157066029|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
48788791|NCT01212770|157066030|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
48788792|NCT01212770|157066031|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
48788793|NCT01212770|157066032|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
48788794|NCT01212770|157066024|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
48788795|NCT01212770|157066025|FG001|Long-term Safety Phase (Year 5)|Adverse Event|0|||
48788796|NCT01212770|157066026|FG002|Long-term Safety Phase (Year 5)|Adverse Event|2|||
48788797|NCT01212770|157066027|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
48877763|NCT01867047|157392050|FG001|Overall Study|surgery not indicated in protocol|2|||
48877764|NCT01090011|157392051|FG000|Overall Study|Progressive disease|128|||
48877765|NCT01090011|157392051|FG000|Overall Study|Adverse Event|32|||
48877766|NCT01090011|157392051|FG000|Overall Study|Protocol Violation|1|||
48877767|NCT01090011|157392051|FG000|Overall Study|Refusal to start/continue medication|5|||
48877768|NCT01090011|157392051|FG000|Overall Study|Other reason not defined above|5|||
48877769|NCT02825251|157392052|FG000|Overall Study|Adverse Event|0|||
48877770|NCT02825251|157392053|FG001|Overall Study|Adverse Event|1|||
48877771|NCT02825251|157392052|FG000|Overall Study|Lost to Follow-up|0|||
48877772|NCT02825251|157392053|FG001|Overall Study|Lost to Follow-up|1|||
48877773|NCT02825251|157392052|FG000|Overall Study|Withdrawal by Subject|1|||
48877774|NCT02825251|157392053|FG001|Overall Study|Withdrawal by Subject|4|||
48877775|NCT02825251|157392052|FG000|Overall Study|Unclassified|2|||
48877776|NCT02825251|157392053|FG001|Overall Study|Unclassified|0|||
48877777|NCT00612352|157392056|FG000|Overall Study|Adverse Event|1|||
48877778|NCT00612352|157392057|FG001|Overall Study|Adverse Event|0|||
48877779|NCT00612352|157392056|FG000|Overall Study|Withdrawal by Subject|3|||
48877780|NCT00612352|157392057|FG001|Overall Study|Withdrawal by Subject|5|||
48877781|NCT00612352|157392056|FG000|Overall Study|moved out of state|1|||
48877782|NCT00612352|157392057|FG001|Overall Study|moved out of state|0|||
48877783|NCT00612352|157392056|FG000|Overall Study|didn't return calls/show up on test date|4|||
48877784|NCT00612352|157392057|FG001|Overall Study|didn't return calls/show up on test date|1|||
48877785|NCT00575042|157392061|FG000|Overall Study|Adverse Event|2|||
48877786|NCT00575042|157392061|FG000|Overall Study|Lost to Follow-up|1|||
48877787|NCT00701909|157392065|FG000|Overall Study|Withdrawal by Subject|0|||
48877788|NCT00701909|157392066|FG001|Overall Study|Withdrawal by Subject|1|||
48877789|NCT03023722|157392067|FG000|Overall Study|No follow-up assessment|4|||
48877790|NCT01377389|157392070|FG000|Overall Study|Withdrawal by Subject|1|||
48877791|NCT01377389|157392070|FG000|Overall Study|Screen failure|2|||
48877792|NCT03024996|157392074|FG000|Overall Study|Death|57|||
48877793|NCT03024996|157392075|FG001|Overall Study|Death|55|||
48788798|NCT01212770|157066028|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
48788799|NCT01212770|157066029|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
48788800|NCT01212770|157066030|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
48788801|NCT01212770|157066031|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
48788802|NCT01212770|157066032|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
48788803|NCT01212770|157066024|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
48788804|NCT01212770|157066025|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
48788805|NCT01212770|157066026|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|4|||
48788806|NCT01212770|157066027|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
48788807|NCT01212770|157066028|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
48788808|NCT01212770|157066029|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
48788809|NCT01212770|157066030|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
48788810|NCT01212770|157066031|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
48788811|NCT01212770|157066032|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
48788812|NCT01212770|157066024|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
48788813|NCT01212770|157066025|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
48788814|NCT01212770|157066026|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
48788815|NCT01212770|157066027|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
48877794|NCT03024996|157392074|FG000|Overall Study|Disease relapse|1|||
48877795|NCT03024996|157392075|FG001|Overall Study|Disease relapse|0|||
48877796|NCT03024996|157392074|FG000|Overall Study|Lost to Follow-up|5|||
48788816|NCT01212770|157066028|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
48877797|NCT03024996|157392075|FG001|Overall Study|Lost to Follow-up|10|||
48877798|NCT03024996|157392074|FG000|Overall Study|Other|3|||
48877799|NCT03024996|157392075|FG001|Overall Study|Other|3|||
48877800|NCT03024996|157392074|FG000|Overall Study|Physician Decision|0|||
48877801|NCT03024996|157392075|FG001|Overall Study|Physician Decision|1|||
48877802|NCT03024996|157392074|FG000|Overall Study|Study terminated by sponsor|303|||
48877803|NCT03024996|157392075|FG001|Overall Study|Study terminated by sponsor|283|||
49032068|NCT01597245|157953482|FG012|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
49032069|NCT01597245|157953483|FG013|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
49032070|NCT01597245|157953484|FG014|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
48788817|NCT01212770|157066029|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
48788818|NCT01212770|157066030|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
48788819|NCT01212770|157066031|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
48788820|NCT01212770|157066032|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
48788821|NCT01212770|157066024|FG000|Long-term Safety Phase (Year 5)|Death|0|||
48788822|NCT01212770|157066025|FG001|Long-term Safety Phase (Year 5)|Death|0|||
48788823|NCT01212770|157066026|FG002|Long-term Safety Phase (Year 5)|Death|0|||
48788824|NCT01212770|157066027|FG003|Long-term Safety Phase (Year 5)|Death|0|||
48788825|NCT01212770|157066028|FG004|Long-term Safety Phase (Year 5)|Death|0|||
48788826|NCT01212770|157066029|FG005|Long-term Safety Phase (Year 5)|Death|0|||
48788827|NCT01212770|157066030|FG006|Long-term Safety Phase (Year 5)|Death|0|||
48788828|NCT01212770|157066031|FG007|Long-term Safety Phase (Year 5)|Death|1|||
48788829|NCT01212770|157066032|FG008|Long-term Safety Phase (Year 5)|Death|0|||
48788830|NCT00722761|157066036|FG000|Overall Study|Lost to Follow-up|1|||
48788831|NCT00722761|157066037|FG001|Overall Study|Lost to Follow-up|4|||
48788832|NCT00722761|157066036|FG000|Overall Study|Withdrawal by Subject|5|||
48788833|NCT00722761|157066037|FG001|Overall Study|Withdrawal by Subject|2|||
48788834|NCT03276676|157066038|FG000|Overall Study|Withdrawal by Subject|2|||
48788835|NCT03276676|157066039|FG001|Overall Study|Withdrawal by Subject|1|||
48788836|NCT01128413|157066040|FG000|Overall Study|Withdrawal by Subject|1|||
48788837|NCT01128413|157066041|FG001|Overall Study|Withdrawal by Subject|0|||
48788838|NCT01128413|157066040|FG000|Overall Study|NICOM Monitor Problems|2|||
48788839|NCT01128413|157066041|FG001|Overall Study|NICOM Monitor Problems|1|||
48788840|NCT01128413|157066040|FG000|Overall Study|Pt made DNR|1|||
48788841|NCT01128413|157066041|FG001|Overall Study|Pt made DNR|0|||
48788842|NCT00045110|157066042|FG000|100mg Phase 1 Dose Escalalation|did not initiate treatment|0|||
48788843|NCT00045110|157066043|FG001|100mg Phase 1 Dose Escalalation|did not initiate treatment|2|||
48788844|NCT00045110|157066044|FG002|100mg Phase 1 Dose Escalalation|did not initiate treatment|1|||
48788845|NCT00045110|157066042|FG000|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
48788846|NCT00045110|157066043|FG001|100mg Phase 1 Dose Escalalation|prior treatment history|4|||
48788847|NCT00045110|157066044|FG002|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
48788848|NCT00045110|157066042|FG000|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
48788849|NCT00045110|157066043|FG001|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
48788850|NCT00045110|157066044|FG002|100mg Phase 1 Dose Escalalation|ineligible histology|1|||
48788851|NCT01864564|157066045|FG000|Overall Study|Lost to Follow-up|17|||
48788852|NCT01864564|157066046|FG001|Overall Study|Lost to Follow-up|23|||
48788853|NCT01864564|157066045|FG000|Overall Study|Withdrawal by Subject|20|||
48788854|NCT01864564|157066046|FG001|Overall Study|Withdrawal by Subject|11|||
48788855|NCT01864564|157066045|FG000|Overall Study|Protocol Violation|0|||
48788856|NCT01864564|157066046|FG001|Overall Study|Protocol Violation|27|||
48788857|NCT01864564|157066045|FG000|Overall Study|not reported|0|||
48788858|NCT01864564|157066046|FG001|Overall Study|not reported|34|||
48788859|NCT04154787|157066047|FG000|Overall Study|Adverse Event|0|||
48788860|NCT04154787|157066048|FG001|Overall Study|Adverse Event|1|||
48788861|NCT04154787|157066049|FG002|Overall Study|Adverse Event|0|||
48788862|NCT04154787|157066047|FG000|Overall Study|Patient Requires Other Treatment|0|||
48788863|NCT04154787|157066048|FG001|Overall Study|Patient Requires Other Treatment|1|||
48788864|NCT04154787|157066049|FG002|Overall Study|Patient Requires Other Treatment|0|||
48788865|NCT04154787|157066047|FG000|Overall Study|Study Terminated By Sponsor|0|||
48788866|NCT04154787|157066048|FG001|Overall Study|Study Terminated By Sponsor|6|||
48788867|NCT04154787|157066049|FG002|Overall Study|Study Terminated By Sponsor|1|||
48788868|NCT04154787|157066047|FG000|Overall Study|Subject Decision|0|||
48788869|NCT04154787|157066048|FG001|Overall Study|Subject Decision|1|||
48788870|NCT04154787|157066049|FG002|Overall Study|Subject Decision|0|||
48788871|NCT04154787|157066047|FG000|Overall Study|Suspected Lack Of Efficacy|0|||
48788872|NCT04154787|157066048|FG001|Overall Study|Suspected Lack Of Efficacy|1|||
48788873|NCT04154787|157066049|FG002|Overall Study|Suspected Lack Of Efficacy|0|||
48788874|NCT02010060|157066050|FG000|Overall Study|Lost to Follow-up|1|||
48788875|NCT02010060|157066051|FG001|Overall Study|Lost to Follow-up|2|||
48788876|NCT02010060|157066052|FG002|Overall Study|Lost to Follow-up|2|||
48788877|NCT02010060|157066050|FG000|Overall Study|Injury|0|||
48788878|NCT02010060|157066051|FG001|Overall Study|Injury|1|||
48788879|NCT02010060|157066052|FG002|Overall Study|Injury|0|||
48788880|NCT02097108|157066065|FG000|Overall Study|Adverse Event|1|||
48788881|NCT02097108|157066065|FG000|Overall Study|patient was abroad for 6 months|1|||
48788882|NCT02412137|157066068|FG000|Overall Study|Withdrawal by Subject|2|||
48788883|NCT02412137|157066069|FG001|Overall Study|Withdrawal by Subject|0|||
48788884|NCT02412137|157066068|FG000|Overall Study|Lost to Follow-up|21|||
48788885|NCT02412137|157066069|FG001|Overall Study|Lost to Follow-up|14|||
48788886|NCT02412137|157066068|FG000|Overall Study|Physician Decision|28|||
48788887|NCT02412137|157066069|FG001|Overall Study|Physician Decision|9|||
48788888|NCT01170026|157067721|FG000|Overall Study|Lost to Follow-up|4|||
48788889|NCT01170026|157067722|FG001|Overall Study|Lost to Follow-up|2|||
48788890|NCT03598790|157067723|FG000|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
48788891|NCT03598790|157067724|FG001|Treatment Period (TP): Wk0-Wk144|Adverse Event|33|||
48788892|NCT03598790|157067725|FG002|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
48788893|NCT03598790|157067726|FG003|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
48788894|NCT03598790|157067727|FG004|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
48788895|NCT03598790|157067728|FG005|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
48788896|NCT03598790|157067729|FG006|Treatment Period (TP): Wk0-Wk144|Adverse Event|3|||
48788897|NCT03598790|157067730|FG007|Treatment Period (TP): Wk0-Wk144|Adverse Event|1|||
48788898|NCT03598790|157067731|FG008|Treatment Period (TP): Wk0-Wk144|Adverse Event|2|||
48788899|NCT03598790|157067723|FG000|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|4|||
48788900|NCT03598790|157067724|FG001|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|7|||
48788901|NCT03598790|157067725|FG002|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|5|||
48788902|NCT03598790|157067726|FG003|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
48788903|NCT03598790|157067727|FG004|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
48788904|NCT03598790|157067728|FG005|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
48788905|NCT03598790|157067729|FG006|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|2|||
48788906|NCT03598790|157067730|FG007|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
48788907|NCT03598790|157067731|FG008|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
48788908|NCT03598790|157067723|FG000|Treatment Period (TP): Wk0-Wk144|Protocol Violation|1|||
48788909|NCT03598790|157067724|FG001|Treatment Period (TP): Wk0-Wk144|Protocol Violation|2|||
48788910|NCT03598790|157067725|FG002|Treatment Period (TP): Wk0-Wk144|Protocol Violation|4|||
48788911|NCT03598790|157067726|FG003|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
48788912|NCT03598790|157067727|FG004|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
48788913|NCT03598790|157067728|FG005|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
48788914|NCT03598790|157067729|FG006|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
48788915|NCT03598790|157067730|FG007|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
48788916|NCT03598790|157067731|FG008|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
48788917|NCT03598790|157067723|FG000|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|7|||
48788918|NCT03598790|157067724|FG001|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|11|||
48788919|NCT03598790|157067725|FG002|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|14|||
48788920|NCT03598790|157067726|FG003|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
48788921|NCT03598790|157067727|FG004|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
48788922|NCT03598790|157067728|FG005|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
48788923|NCT03598790|157067729|FG006|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
48788924|NCT03598790|157067730|FG007|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
48788925|NCT03598790|157067731|FG008|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
48788926|NCT03598790|157067723|FG000|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|14|||
48788927|NCT03598790|157067724|FG001|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|26|||
48788928|NCT03598790|157067725|FG002|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|17|||
48788929|NCT03598790|157067726|FG003|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
48788930|NCT03598790|157067727|FG004|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
48788931|NCT03598790|157067728|FG005|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
48788932|NCT03598790|157067729|FG006|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|1|||
48788933|NCT03598790|157067730|FG007|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
48788934|NCT03598790|157067731|FG008|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
48788935|NCT03598790|157067723|FG000|Treatment Period (TP): Wk0-Wk144|Pregnancy|1|||
48788936|NCT03598790|157067724|FG001|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
48788937|NCT03598790|157067725|FG002|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
48788938|NCT03598790|157067726|FG003|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
48788939|NCT03598790|157067727|FG004|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
48788940|NCT03598790|157067728|FG005|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
48788941|NCT03598790|157067729|FG006|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
48788942|NCT03598790|157067730|FG007|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
48788943|NCT03598790|157067731|FG008|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
48788944|NCT03598790|157067723|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
48788945|NCT03598790|157067724|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
48788946|NCT03598790|157067725|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
48788947|NCT03598790|157067726|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
48788948|NCT03598790|157067727|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
48788949|NCT03598790|157067728|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
48788950|NCT03598790|157067729|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
48788951|NCT03598790|157067730|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
48788952|NCT03598790|157067731|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
48788953|NCT03598790|157067723|FG000|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
48788954|NCT03598790|157067724|FG001|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
48788955|NCT03598790|157067725|FG002|Treatment Period (TP): Wk0-Wk144|Physician Decision|1|||
48788956|NCT03598790|157067726|FG003|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
48788957|NCT03598790|157067727|FG004|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
48788958|NCT03598790|157067728|FG005|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
48788959|NCT03598790|157067729|FG006|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
48788960|NCT03598790|157067730|FG007|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
48788961|NCT03598790|157067731|FG008|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
48788962|NCT03598790|157067723|FG000|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|1|||
48788963|NCT03598790|157067724|FG001|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
48788964|NCT03598790|157067725|FG002|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
48788965|NCT03598790|157067726|FG003|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
48788966|NCT03598790|157067727|FG004|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
48788967|NCT03598790|157067728|FG005|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
48788968|NCT03598790|157067729|FG006|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
48788969|NCT03598790|157067730|FG007|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
48788970|NCT03598790|157067731|FG008|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
48788971|NCT03598790|157067723|FG000|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|1|||
48788972|NCT03598790|157067724|FG001|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
48788973|NCT03598790|157067725|FG002|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
48788974|NCT03598790|157067726|FG003|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
48788975|NCT03598790|157067727|FG004|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
48788976|NCT03598790|157067728|FG005|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
48788977|NCT03598790|157067729|FG006|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
48788978|NCT03598790|157067730|FG007|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
48788979|NCT03598790|157067731|FG008|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
48788980|NCT03598790|157067723|FG000|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|1|||
48788981|NCT03598790|157067724|FG001|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
48788982|NCT03598790|157067725|FG002|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
48788983|NCT03598790|157067726|FG003|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
48788984|NCT03598790|157067727|FG004|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
48788985|NCT03598790|157067728|FG005|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
48788986|NCT03598790|157067729|FG006|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
48788987|NCT03598790|157067730|FG007|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
48788988|NCT03598790|157067731|FG008|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
48788989|NCT03598790|157067723|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
48788990|NCT03598790|157067724|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|2|||
48788991|NCT03598790|157067725|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
48788992|NCT03598790|157067726|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
48788993|NCT03598790|157067727|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
48788994|NCT03598790|157067728|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
48788995|NCT03598790|157067729|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
48788996|NCT03598790|157067730|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
48788997|NCT03598790|157067731|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
48788998|NCT03598790|157067723|FG000|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|1|||
48788999|NCT03598790|157067724|FG001|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|2|||
48789000|NCT03598790|157067725|FG002|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
48789001|NCT03598790|157067726|FG003|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
48789002|NCT03598790|157067727|FG004|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
48789003|NCT03598790|157067728|FG005|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
48789004|NCT03598790|157067729|FG006|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
48789005|NCT03598790|157067730|FG007|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
48789006|NCT03598790|157067731|FG008|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
48789007|NCT03598790|157067723|FG000|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
48983220|NCT02394028|157769995|FG009|Maintenance Phase|Adverse Event|1|||
48983221|NCT02394028|157769996|FG010|Maintenance Phase|Adverse Event|3|||
48983222|NCT02394028|157769986|FG000|Maintenance Phase|Site closure|0|||
48983223|NCT02394028|157769987|FG001|Maintenance Phase|Site closure|0|||
48983224|NCT02394028|157769988|FG002|Maintenance Phase|Site closure|0|||
48983225|NCT02394028|157769989|FG003|Maintenance Phase|Site closure|0|||
48983226|NCT02394028|157769990|FG004|Maintenance Phase|Site closure|0|||
48983227|NCT02394028|157769991|FG005|Maintenance Phase|Site closure|0|||
48983228|NCT02394028|157769992|FG006|Maintenance Phase|Site closure|0|||
48983229|NCT02394028|157769993|FG007|Maintenance Phase|Site closure|0|||
48789008|NCT03598790|157067724|FG001|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|1|||
48789009|NCT03598790|157067725|FG002|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
48789010|NCT03598790|157067726|FG003|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
48789011|NCT03598790|157067727|FG004|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
48789012|NCT03598790|157067728|FG005|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
48789013|NCT03598790|157067729|FG006|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
48789014|NCT03598790|157067730|FG007|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
48789015|NCT03598790|157067731|FG008|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
48789016|NCT03598790|157067723|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
48789017|NCT03598790|157067724|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance|1|||
49032071|NCT01597245|157953485|FG015|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
48789018|NCT03598790|157067725|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
48789019|NCT03598790|157067726|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
48789020|NCT03598790|157067727|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
48789021|NCT03598790|157067728|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
48789022|NCT03598790|157067729|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
48789023|NCT03598790|157067730|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
48789024|NCT03598790|157067731|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
48789025|NCT03598790|157067723|FG000|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
48789026|NCT03598790|157067724|FG001|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
48789027|NCT03598790|157067725|FG002|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|1|||
48789028|NCT03598790|157067726|FG003|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
48789029|NCT03598790|157067727|FG004|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
48789030|NCT03598790|157067728|FG005|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
48789031|NCT03598790|157067729|FG006|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
48789032|NCT03598790|157067730|FG007|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
48789033|NCT03598790|157067731|FG008|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
48789034|NCT03598790|157067723|FG000|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
48789035|NCT03598790|157067724|FG001|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
48789036|NCT03598790|157067725|FG002|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|1|||
48789037|NCT03598790|157067726|FG003|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
48789038|NCT03598790|157067727|FG004|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
48789039|NCT03598790|157067728|FG005|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
48789040|NCT03598790|157067729|FG006|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
48789041|NCT03598790|157067730|FG007|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
48789042|NCT03598790|157067731|FG008|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
48789043|NCT03598790|157067723|FG000|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
48789044|NCT03598790|157067724|FG001|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
48789045|NCT03598790|157067725|FG002|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|1|||
48789046|NCT03598790|157067726|FG003|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
48789047|NCT03598790|157067727|FG004|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
48789048|NCT03598790|157067728|FG005|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
48789049|NCT03598790|157067729|FG006|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
48789050|NCT03598790|157067730|FG007|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
48789051|NCT03598790|157067731|FG008|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
48789052|NCT03598790|157067723|FG000|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
48789053|NCT03598790|157067724|FG001|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
48789054|NCT03598790|157067725|FG002|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
48789055|NCT03598790|157067726|FG003|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
48789056|NCT03598790|157067727|FG004|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
48789057|NCT03598790|157067728|FG005|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
48877804|NCT03024996|157392074|FG000|Overall Study|Withdrawal by Subject|21|||
48877805|NCT03024996|157392075|FG001|Overall Study|Withdrawal by Subject|36|||
48877806|NCT01667926|157392078|FG000|Overall Study|Withdrawal by Subject|1|||
49032072|NCT01597245|157953486|FG016|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
49032073|NCT01597245|157953487|FG017|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
49032074|NCT01597245|157953488|FG018|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
49032075|NCT01597245|157953489|FG019|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
49032076|NCT01597245|157953490|FG020|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
49032077|NCT01597245|157953470|FG000|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
49032078|NCT01597245|157953471|FG001|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
49032079|NCT01597245|157953472|FG002|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
49032080|NCT01597245|157953473|FG003|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
49032081|NCT01597245|157953474|FG004|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
49032082|NCT01597245|157953475|FG005|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
49032083|NCT01597245|157953476|FG006|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
49032084|NCT01597245|157953477|FG007|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
49032085|NCT01597245|157953478|FG008|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
49032086|NCT01597245|157953479|FG009|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
49032087|NCT01597245|157953480|FG010|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6|||
49032088|NCT01597245|157953481|FG011|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5|||
49032089|NCT01597245|157953482|FG012|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
49032090|NCT01597245|157953483|FG013|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
49032091|NCT01597245|157953484|FG014|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
49032092|NCT01597245|157953485|FG015|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
49032093|NCT01597245|157953486|FG016|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
49032094|NCT01597245|157953487|FG017|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
49032095|NCT01597245|157953488|FG018|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
49032096|NCT01597245|157953489|FG019|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
49032097|NCT01597245|157953490|FG020|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
48789058|NCT03598790|157067729|FG006|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|1|||
48789059|NCT03598790|157067730|FG007|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
48789060|NCT03598790|157067731|FG008|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
48789061|NCT03598790|157067723|FG000|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|3|||
48789062|NCT03598790|157067724|FG001|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|1|||
48789063|NCT03598790|157067725|FG002|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
48789064|NCT03598790|157067726|FG003|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
48789065|NCT03598790|157067727|FG004|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
48789066|NCT03598790|157067728|FG005|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
48789067|NCT03598790|157067729|FG006|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
48789068|NCT03598790|157067730|FG007|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
48789069|NCT03598790|157067731|FG008|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
48789070|NCT03598790|157067723|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
48789071|NCT03598790|157067724|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
48789072|NCT03598790|157067725|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|1|||
48789073|NCT03598790|157067726|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
48789074|NCT03598790|157067727|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
48789075|NCT03598790|157067728|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
48789076|NCT03598790|157067729|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
48789077|NCT03598790|157067730|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
48789078|NCT03598790|157067731|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
48789079|NCT03598790|157067723|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
48789080|NCT03598790|157067724|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
48789081|NCT03598790|157067725|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
48789082|NCT03598790|157067726|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
48789083|NCT03598790|157067727|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
48789084|NCT03598790|157067728|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
48789085|NCT03598790|157067729|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
48789086|NCT03598790|157067730|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
48789087|NCT03598790|157067731|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
48789088|NCT03598790|157067723|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
48789089|NCT03598790|157067724|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
48789090|NCT03598790|157067725|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
48789091|NCT03598790|157067726|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|2|||
48789092|NCT03598790|157067727|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
48789093|NCT03598790|157067728|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
48877807|NCT01667926|157392079|FG001|Overall Study|Withdrawal by Subject|2|||
48877808|NCT01667926|157392080|FG002|Overall Study|Withdrawal by Subject|2|||
48877809|NCT01667926|157392078|FG000|Overall Study|Physician Decision|0|||
48789094|NCT03598790|157067729|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
48789095|NCT03598790|157067730|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
48789096|NCT03598790|157067731|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
48789097|NCT03598790|157067723|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
48789098|NCT03598790|157067724|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
48789099|NCT03598790|157067725|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
48789100|NCT03598790|157067726|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|4|||
48789101|NCT03598790|157067727|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
48789102|NCT03598790|157067728|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
48789103|NCT03598790|157067729|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
48789104|NCT03598790|157067730|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
48789105|NCT03598790|157067731|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
48789106|NCT03598790|157067723|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
48789107|NCT03598790|157067724|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
48789108|NCT03598790|157067725|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
48789109|NCT03598790|157067726|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
48789110|NCT03598790|157067727|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
48789111|NCT03598790|157067728|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
48789112|NCT03598790|157067729|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
48789113|NCT03598790|157067730|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
48789114|NCT03598790|157067731|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
48789115|NCT03598790|157067723|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
48789116|NCT03598790|157067724|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
48789117|NCT03598790|157067725|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
48789118|NCT03598790|157067726|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|1|||
48789119|NCT03598790|157067727|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
48789120|NCT03598790|157067728|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
48789121|NCT03598790|157067729|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
48789122|NCT03598790|157067730|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
48789123|NCT03598790|157067731|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
48789124|NCT00377234|157067740|FG000|Overall Study|Adverse Event|14|||
48789125|NCT00377234|157067741|FG001|Overall Study|Adverse Event|17|||
48789126|NCT00377234|157067740|FG000|Overall Study|Withdrawal by Subject|11|||
48789127|NCT00377234|157067741|FG001|Overall Study|Withdrawal by Subject|9|||
48789128|NCT00377234|157067740|FG000|Overall Study|Lost to Follow-up|4|||
48789129|NCT00377234|157067741|FG001|Overall Study|Lost to Follow-up|2|||
48789130|NCT00377234|157067740|FG000|Overall Study|Administrative|2|||
49032098|NCT01597245|157953470|FG000|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
49032099|NCT01597245|157953471|FG001|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
49032100|NCT01597245|157953472|FG002|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
49032101|NCT01597245|157953473|FG003|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
48789131|NCT00377234|157067741|FG001|Overall Study|Administrative|1|||
48789132|NCT00377234|157067740|FG000|Overall Study|Not assigned|3|||
48789133|NCT00377234|157067741|FG001|Overall Study|Not assigned|2|||
48789134|NCT01585103|157067742|FG000|Overall Study|Unable to swallow Cytosponge|6|||
48789135|NCT02564523|157067743|FG000|Overall Study|Withdrawal by Subject|3|||
48789136|NCT02564523|157067744|FG001|Overall Study|Withdrawal by Subject|0|||
48789137|NCT02564523|157067745|FG002|Overall Study|Withdrawal by Subject|1|||
48789138|NCT02564523|157067746|FG003|Overall Study|Withdrawal by Subject|0|||
48789139|NCT02564523|157067747|FG004|Overall Study|Withdrawal by Subject|1|||
48789140|NCT02564523|157067748|FG005|Overall Study|Withdrawal by Subject|0|||
48789141|NCT02564523|157067749|FG006|Overall Study|Withdrawal by Subject|1|||
48789142|NCT02564523|157067750|FG007|Overall Study|Withdrawal by Subject|0|||
48877810|NCT01667926|157392079|FG001|Overall Study|Physician Decision|0|||
48877811|NCT01667926|157392080|FG002|Overall Study|Physician Decision|1|||
48789143|NCT02564523|157067751|FG008|Overall Study|Withdrawal by Subject|0|||
48789144|NCT02564523|157067752|FG009|Overall Study|Withdrawal by Subject|0|||
48789145|NCT02564523|157067753|FG010|Overall Study|Withdrawal by Subject|1|||
48789146|NCT02564523|157067754|FG011|Overall Study|Withdrawal by Subject|0|||
48789147|NCT02564523|157067755|FG012|Overall Study|Withdrawal by Subject|1|||
48789148|NCT02564523|157067756|FG013|Overall Study|Withdrawal by Subject|0|||
49032102|NCT01597245|157953474|FG004|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
49032103|NCT01597245|157953475|FG005|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
49032104|NCT01597245|157953476|FG006|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
48789149|NCT02564523|157067757|FG014|Overall Study|Withdrawal by Subject|0|||
48789150|NCT02564523|157067758|FG015|Overall Study|Withdrawal by Subject|0|||
48789151|NCT02564523|157067759|FG016|Overall Study|Withdrawal by Subject|0|||
49032105|NCT01597245|157953477|FG007|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
48789152|NCT02564523|157067760|FG017|Overall Study|Withdrawal by Subject|0|||
48789153|NCT02564523|157067743|FG000|Overall Study|Adverse Event|0|||
48789154|NCT02564523|157067744|FG001|Overall Study|Adverse Event|0|||
48789155|NCT02564523|157067745|FG002|Overall Study|Adverse Event|0|||
48789156|NCT02564523|157067746|FG003|Overall Study|Adverse Event|0|||
48789157|NCT02564523|157067747|FG004|Overall Study|Adverse Event|0|||
48789158|NCT02564523|157067748|FG005|Overall Study|Adverse Event|0|||
48789159|NCT02564523|157067749|FG006|Overall Study|Adverse Event|0|||
48789160|NCT02564523|157067750|FG007|Overall Study|Adverse Event|0|||
48789161|NCT02564523|157067751|FG008|Overall Study|Adverse Event|0|||
48789162|NCT02564523|157067752|FG009|Overall Study|Adverse Event|0|||
48789163|NCT02564523|157067753|FG010|Overall Study|Adverse Event|0|||
48789164|NCT02564523|157067754|FG011|Overall Study|Adverse Event|0|||
48789165|NCT02564523|157067755|FG012|Overall Study|Adverse Event|0|||
48789166|NCT02564523|157067756|FG013|Overall Study|Adverse Event|0|||
48789167|NCT02564523|157067757|FG014|Overall Study|Adverse Event|0|||
48789168|NCT02564523|157067758|FG015|Overall Study|Adverse Event|0|||
48789169|NCT02564523|157067759|FG016|Overall Study|Adverse Event|0|||
48789170|NCT02564523|157067760|FG017|Overall Study|Adverse Event|1|||
48789171|NCT02564523|157067743|FG000|Overall Study|Death|0|||
48789172|NCT02564523|157067744|FG001|Overall Study|Death|0|||
48789173|NCT02564523|157067745|FG002|Overall Study|Death|0|||
48789174|NCT02564523|157067746|FG003|Overall Study|Death|0|||
48789175|NCT02564523|157067747|FG004|Overall Study|Death|0|||
48789176|NCT02564523|157067748|FG005|Overall Study|Death|0|||
48789177|NCT02564523|157067749|FG006|Overall Study|Death|1|||
48789178|NCT02564523|157067750|FG007|Overall Study|Death|0|||
48789179|NCT02564523|157067751|FG008|Overall Study|Death|0|||
48789180|NCT02564523|157067752|FG009|Overall Study|Death|0|||
48789181|NCT02564523|157067753|FG010|Overall Study|Death|1|||
48789182|NCT02564523|157067754|FG011|Overall Study|Death|0|||
48789183|NCT02564523|157067755|FG012|Overall Study|Death|0|||
48789184|NCT02564523|157067756|FG013|Overall Study|Death|0|||
48789185|NCT02564523|157067757|FG014|Overall Study|Death|0|||
48789186|NCT02564523|157067758|FG015|Overall Study|Death|0|||
48789187|NCT02564523|157067759|FG016|Overall Study|Death|0|||
48789188|NCT02564523|157067760|FG017|Overall Study|Death|0|||
48789189|NCT02564523|157067743|FG000|Overall Study|Lost to Follow-up|2|||
48789190|NCT02564523|157067744|FG001|Overall Study|Lost to Follow-up|1|||
48789191|NCT02564523|157067745|FG002|Overall Study|Lost to Follow-up|4|||
48789192|NCT02564523|157067746|FG003|Overall Study|Lost to Follow-up|0|||
48789193|NCT02564523|157067747|FG004|Overall Study|Lost to Follow-up|1|||
48789194|NCT02564523|157067748|FG005|Overall Study|Lost to Follow-up|0|||
48789195|NCT02564523|157067749|FG006|Overall Study|Lost to Follow-up|1|||
48789196|NCT02564523|157067750|FG007|Overall Study|Lost to Follow-up|0|||
48789197|NCT02564523|157067751|FG008|Overall Study|Lost to Follow-up|0|||
48789198|NCT02564523|157067752|FG009|Overall Study|Lost to Follow-up|0|||
48789199|NCT02564523|157067753|FG010|Overall Study|Lost to Follow-up|0|||
48789200|NCT02564523|157067754|FG011|Overall Study|Lost to Follow-up|1|||
48789201|NCT02564523|157067755|FG012|Overall Study|Lost to Follow-up|1|||
48789202|NCT02564523|157067756|FG013|Overall Study|Lost to Follow-up|0|||
48789203|NCT02564523|157067757|FG014|Overall Study|Lost to Follow-up|0|||
48789204|NCT02564523|157067758|FG015|Overall Study|Lost to Follow-up|0|||
48789205|NCT02564523|157067759|FG016|Overall Study|Lost to Follow-up|0|||
48789206|NCT02564523|157067760|FG017|Overall Study|Lost to Follow-up|0|||
48789207|NCT02564523|157067743|FG000|Overall Study|Physician Decision|0|||
48789208|NCT02564523|157067744|FG001|Overall Study|Physician Decision|0|||
48789209|NCT02564523|157067745|FG002|Overall Study|Physician Decision|0|||
48789210|NCT02564523|157067746|FG003|Overall Study|Physician Decision|0|||
48789211|NCT02564523|157067747|FG004|Overall Study|Physician Decision|1|||
48789212|NCT02564523|157067748|FG005|Overall Study|Physician Decision|0|||
48789213|NCT02564523|157067749|FG006|Overall Study|Physician Decision|0|||
48789214|NCT02564523|157067750|FG007|Overall Study|Physician Decision|0|||
48789215|NCT02564523|157067751|FG008|Overall Study|Physician Decision|0|||
48789216|NCT02564523|157067752|FG009|Overall Study|Physician Decision|0|||
48789217|NCT02564523|157067753|FG010|Overall Study|Physician Decision|1|||
48789218|NCT02564523|157067754|FG011|Overall Study|Physician Decision|0|||
48789219|NCT02564523|157067755|FG012|Overall Study|Physician Decision|0|||
48983230|NCT02394028|157769994|FG008|Maintenance Phase|Site closure|0|||
48983231|NCT02394028|157769995|FG009|Maintenance Phase|Site closure|1|||
48983232|NCT02394028|157769996|FG010|Maintenance Phase|Site closure|0|||
48983233|NCT02394028|157769986|FG000|Maintenance Phase|Withdrawal by Subject|0|||
48983234|NCT02394028|157769987|FG001|Maintenance Phase|Withdrawal by Subject|0|||
48983235|NCT02394028|157769988|FG002|Maintenance Phase|Withdrawal by Subject|0|||
48983236|NCT02394028|157769989|FG003|Maintenance Phase|Withdrawal by Subject|0|||
48983237|NCT02394028|157769990|FG004|Maintenance Phase|Withdrawal by Subject|0|||
48983238|NCT02394028|157769991|FG005|Maintenance Phase|Withdrawal by Subject|0|||
48983239|NCT02394028|157769992|FG006|Maintenance Phase|Withdrawal by Subject|0|||
48789220|NCT02564523|157067756|FG013|Overall Study|Physician Decision|0|||
48789221|NCT02564523|157067757|FG014|Overall Study|Physician Decision|0|||
48789222|NCT02564523|157067758|FG015|Overall Study|Physician Decision|0|||
48789223|NCT02564523|157067759|FG016|Overall Study|Physician Decision|0|||
48789224|NCT02564523|157067760|FG017|Overall Study|Physician Decision|0|||
48789225|NCT02564523|157067743|FG000|Overall Study|Protocol Violation|2|||
48789226|NCT02564523|157067744|FG001|Overall Study|Protocol Violation|2|||
48789227|NCT02564523|157067745|FG002|Overall Study|Protocol Violation|5|||
48789228|NCT02564523|157067746|FG003|Overall Study|Protocol Violation|0|||
48789229|NCT02564523|157067747|FG004|Overall Study|Protocol Violation|1|||
48789230|NCT02564523|157067748|FG005|Overall Study|Protocol Violation|0|||
48789231|NCT02564523|157067749|FG006|Overall Study|Protocol Violation|0|||
48789232|NCT02564523|157067750|FG007|Overall Study|Protocol Violation|0|||
48789233|NCT02564523|157067751|FG008|Overall Study|Protocol Violation|0|||
48789234|NCT02564523|157067752|FG009|Overall Study|Protocol Violation|0|||
48789235|NCT02564523|157067753|FG010|Overall Study|Protocol Violation|0|||
48789236|NCT02564523|157067754|FG011|Overall Study|Protocol Violation|0|||
48789237|NCT02564523|157067755|FG012|Overall Study|Protocol Violation|0|||
48789238|NCT02564523|157067756|FG013|Overall Study|Protocol Violation|0|||
48789239|NCT02564523|157067757|FG014|Overall Study|Protocol Violation|0|||
48789240|NCT02564523|157067758|FG015|Overall Study|Protocol Violation|0|||
48789241|NCT02564523|157067759|FG016|Overall Study|Protocol Violation|0|||
48789242|NCT02564523|157067760|FG017|Overall Study|Protocol Violation|0|||
48789243|NCT02564523|157067743|FG000|Overall Study|Other|3|||
48789244|NCT02564523|157067744|FG001|Overall Study|Other|0|||
48789245|NCT02564523|157067745|FG002|Overall Study|Other|0|||
48789246|NCT02564523|157067746|FG003|Overall Study|Other|1|||
48789247|NCT02564523|157067747|FG004|Overall Study|Other|0|||
48789248|NCT02564523|157067748|FG005|Overall Study|Other|0|||
48789249|NCT02564523|157067749|FG006|Overall Study|Other|0|||
48789250|NCT02564523|157067750|FG007|Overall Study|Other|0|||
48789251|NCT02564523|157067751|FG008|Overall Study|Other|0|||
48789252|NCT02564523|157067752|FG009|Overall Study|Other|0|||
48789253|NCT02564523|157067753|FG010|Overall Study|Other|0|||
48789254|NCT02564523|157067754|FG011|Overall Study|Other|0|||
48789255|NCT02564523|157067755|FG012|Overall Study|Other|0|||
48789256|NCT02564523|157067756|FG013|Overall Study|Other|0|||
48789257|NCT02564523|157067757|FG014|Overall Study|Other|0|||
48789258|NCT02564523|157067758|FG015|Overall Study|Other|0|||
48789259|NCT02564523|157067759|FG016|Overall Study|Other|0|||
48789260|NCT02564523|157067760|FG017|Overall Study|Other|0|||
48789261|NCT02097472|157067764|FG000|Received Vaccination 2|Adverse Event|0|||
48789262|NCT02097472|157067765|FG001|Received Vaccination 2|Adverse Event|0|||
48789263|NCT02097472|157067766|FG002|Received Vaccination 2|Adverse Event|0|||
48789264|NCT02097472|157067767|FG003|Received Vaccination 2|Adverse Event|0|||
48789265|NCT02097472|157067768|FG004|Received Vaccination 2|Adverse Event|0|||
48789266|NCT02097472|157067769|FG005|Received Vaccination 2|Adverse Event|0|||
48789267|NCT02097472|157067770|FG006|Received Vaccination 2|Adverse Event|1|||
48789268|NCT02097472|157067771|FG007|Received Vaccination 2|Adverse Event|0|||
48789269|NCT01221597|157067772|FG000|Overall Study|Adverse Event|4|||
48789270|NCT01221597|157067773|FG001|Overall Study|Adverse Event|1|||
48789271|NCT01221597|157067772|FG000|Overall Study|Withdrawal by Subject|20|||
48789272|NCT01221597|157067773|FG001|Overall Study|Withdrawal by Subject|6|||
48789273|NCT01221597|157067772|FG000|Overall Study|Lost to Follow-up|6|||
48789274|NCT01221597|157067773|FG001|Overall Study|Lost to Follow-up|5|||
48789275|NCT01221597|157067772|FG000|Overall Study|Protocol Violation|1|||
48789276|NCT01221597|157067773|FG001|Overall Study|Protocol Violation|0|||
48789277|NCT01221597|157067772|FG000|Overall Study|Other|3|||
48789278|NCT01221597|157067773|FG001|Overall Study|Other|4|||
48789279|NCT01221597|157067772|FG000|Overall Study|Death|2|||
48789280|NCT01221597|157067773|FG001|Overall Study|Death|0|||
48789281|NCT03643952|157067774|FG000|Overall Study|Lack of Efficacy|1|||
48789282|NCT02592330|157067778|FG000|Overall Study|Withdrawal by Subject|1|||
48789283|NCT02592330|157067779|FG001|Overall Study|Withdrawal by Subject|0|||
48789284|NCT02592330|157067778|FG000|Overall Study|Failed Biopsy|1|||
48789285|NCT02592330|157067779|FG001|Overall Study|Failed Biopsy|0|||
48789286|NCT01854827|157067780|FG000|Overall Study|Death|1|||
48789287|NCT01491854|157067781|FG000|Overall Study|mainly due to premature termination|93|||
48789288|NCT01491854|157067781|FG000|Overall Study|Death|1|||
48789289|NCT01491854|157067781|FG000|Overall Study|Withdrawal by Subject|3|||
48789290|NCT01491854|157067781|FG000|Overall Study|Lost to Follow-up|33|||
48789291|NCT02347761|157067784|FG000|All Collected|Death|1|||
48789292|NCT02347761|157067785|FG001|All Collected|Death|0|||
48789293|NCT02347761|157067786|FG002|All Collected|Death|0|||
48789294|NCT02347761|157067784|FG000|All Collected|Lost to Follow-up|3|||
48789295|NCT02347761|157067785|FG001|All Collected|Lost to Follow-up|2|||
48789296|NCT02347761|157067786|FG002|All Collected|Lost to Follow-up|3|||
48789297|NCT02347761|157067784|FG000|All Collected|Withdrawal by Subject|11|||
48789298|NCT02347761|157067785|FG001|All Collected|Withdrawal by Subject|11|||
48789299|NCT02347761|157067786|FG002|All Collected|Withdrawal by Subject|22|||
48789300|NCT02347761|157067784|FG000|All Collected|invetigator disretion|2|||
48789301|NCT02347761|157067785|FG001|All Collected|invetigator disretion|0|||
48789302|NCT02347761|157067786|FG002|All Collected|invetigator disretion|0|||
48789303|NCT02347761|157067784|FG000|All Collected|instillation site pain|0|||
48789304|NCT02347761|157067785|FG001|All Collected|instillation site pain|0|||
48877812|NCT01667926|157392078|FG000|Overall Study|Time committment|0|||
48789305|NCT02347761|157067786|FG002|All Collected|instillation site pain|1|||
48789306|NCT02347761|157067784|FG000|All Collected|exacerbation of COPD|0|||
48789307|NCT02347761|157067785|FG001|All Collected|exacerbation of COPD|0|||
48789308|NCT02347761|157067786|FG002|All Collected|exacerbation of COPD|1|||
48789309|NCT02347761|157067784|FG000|All Collected|moved/travel|0|||
48789310|NCT02347761|157067785|FG001|All Collected|moved/travel|1|||
48789311|NCT02347761|157067786|FG002|All Collected|moved/travel|0|||
48789312|NCT02347761|157067784|FG000|On Study Treatment|Lack of Efficacy|2|||
48789313|NCT02347761|157067785|FG001|On Study Treatment|Lack of Efficacy|3|||
48789314|NCT02347761|157067786|FG002|On Study Treatment|Lack of Efficacy|4|||
48789315|NCT02347761|157067784|FG000|On Study Treatment|non-compliance with study medication|0|||
48789316|NCT02347761|157067785|FG001|On Study Treatment|non-compliance with study medication|0|||
48789317|NCT02347761|157067786|FG002|On Study Treatment|non-compliance with study medication|2|||
48789318|NCT02347761|157067784|FG000|On Study Treatment|Withdrawal by Subject|7|||
48789319|NCT02347761|157067785|FG001|On Study Treatment|Withdrawal by Subject|3|||
48789320|NCT02347761|157067786|FG002|On Study Treatment|Withdrawal by Subject|5|||
48789321|NCT02347761|157067784|FG000|On Study Treatment|move/travel|2|||
48789322|NCT02347761|157067785|FG001|On Study Treatment|move/travel|6|||
48789323|NCT02347761|157067786|FG002|On Study Treatment|move/travel|5|||
48789324|NCT02347761|157067784|FG000|On Study Treatment|dissastisfaction with device|2|||
48789325|NCT02347761|157067785|FG001|On Study Treatment|dissastisfaction with device|1|||
48789326|NCT02347761|157067786|FG002|On Study Treatment|dissastisfaction with device|4|||
48789327|NCT02347761|157067784|FG000|On Study Treatment|Lost to Follow-up|2|||
48789328|NCT02347761|157067785|FG001|On Study Treatment|Lost to Follow-up|1|||
48789329|NCT02347761|157067786|FG002|On Study Treatment|Lost to Follow-up|1|||
48789330|NCT02347761|157067784|FG000|On Study Treatment|investigator discretion|2|||
48789331|NCT02347761|157067785|FG001|On Study Treatment|investigator discretion|0|||
48789332|NCT02347761|157067786|FG002|On Study Treatment|investigator discretion|0|||
48789333|NCT02347761|157067784|FG000|On Study Treatment|durg not working|0|||
48789334|NCT02347761|157067785|FG001|On Study Treatment|durg not working|1|||
48789335|NCT02347761|157067786|FG002|On Study Treatment|durg not working|1|||
48789336|NCT02347761|157067784|FG000|On Study Treatment|Adverse Event|10|||
48789337|NCT02347761|157067785|FG001|On Study Treatment|Adverse Event|8|||
48789338|NCT02347761|157067786|FG002|On Study Treatment|Adverse Event|20|||
48789339|NCT01380327|157067787|FG000|Overall Study|Lost to Follow-up|0|||
48789340|NCT01380327|157067788|FG001|Overall Study|Lost to Follow-up|1|||
48789341|NCT01380327|157067789|FG002|Overall Study|Lost to Follow-up|1|||
48789342|NCT01380327|157067787|FG000|Overall Study|Protocol Violation|3|||
48789343|NCT01380327|157067788|FG001|Overall Study|Protocol Violation|2|||
48983240|NCT02394028|157769993|FG007|Maintenance Phase|Withdrawal by Subject|0|||
48983241|NCT02394028|157769994|FG008|Maintenance Phase|Withdrawal by Subject|3|||
48983242|NCT02394028|157769995|FG009|Maintenance Phase|Withdrawal by Subject|12|||
48983243|NCT02394028|157769996|FG010|Maintenance Phase|Withdrawal by Subject|12|||
48983244|NCT00281528|157769997|FG000|Overall Study|Progressive Disease|28|||
48983245|NCT00281528|157769998|FG001|Overall Study|Progressive Disease|18|||
48789344|NCT01380327|157067789|FG002|Overall Study|Protocol Violation|3|||
48789345|NCT01380327|157067787|FG000|Overall Study|Withdrawal by Subject|0|||
48789346|NCT01380327|157067788|FG001|Overall Study|Withdrawal by Subject|0|||
48789347|NCT01380327|157067789|FG002|Overall Study|Withdrawal by Subject|1|||
48789348|NCT01380327|157067787|FG000|Overall Study|Housing situation precluded ability to k|0|||
48789349|NCT01380327|157067788|FG001|Overall Study|Housing situation precluded ability to k|0|||
48789350|NCT01380327|157067789|FG002|Overall Study|Housing situation precluded ability to k|1|||
48789351|NCT01380327|157067787|FG000|Overall Study|Questionable onset of epilepsy|0|||
48789352|NCT01380327|157067788|FG001|Overall Study|Questionable onset of epilepsy|0|||
48789353|NCT01380327|157067789|FG002|Overall Study|Questionable onset of epilepsy|1|||
48789354|NCT00476476|157067790|FG000|Overall Study|Adverse Event|2|||
48789355|NCT00476476|157067791|FG001|Overall Study|Adverse Event|7|||
48983246|NCT00281528|157769999|FG002|Overall Study|Progressive Disease|27|||
48983247|NCT00281528|157769997|FG000|Overall Study|Unacceptable Toxicity-related to trt|21|||
48983248|NCT00281528|157769998|FG001|Overall Study|Unacceptable Toxicity-related to trt|24|||
48983249|NCT00281528|157769999|FG002|Overall Study|Unacceptable Toxicity-related to trt|32|||
48983250|NCT00281528|157769997|FG000|Overall Study|Adverse Event-unrelated to treatment|3|||
48983251|NCT00281528|157769998|FG001|Overall Study|Adverse Event-unrelated to treatment|0|||
48983252|NCT00281528|157769999|FG002|Overall Study|Adverse Event-unrelated to treatment|2|||
48983253|NCT00281528|157769997|FG000|Overall Study|Physician Decision|11|||
48983254|NCT00281528|157769998|FG001|Overall Study|Physician Decision|4|||
48983255|NCT00281528|157769999|FG002|Overall Study|Physician Decision|5|||
48983256|NCT00281528|157769997|FG000|Overall Study|Protocol Violation|1|||
48983257|NCT00281528|157769998|FG001|Overall Study|Protocol Violation|0|||
48983258|NCT00281528|157769999|FG002|Overall Study|Protocol Violation|1|||
48983259|NCT00281528|157769997|FG000|Overall Study|Withdrawal by Subject|5|||
48983260|NCT00281528|157769998|FG001|Overall Study|Withdrawal by Subject|5|||
48789356|NCT00476476|157067790|FG000|Overall Study|Progressive Disease|0|||
48789357|NCT00476476|157067791|FG001|Overall Study|Progressive Disease|17|||
48789358|NCT01540851|157067792|FG000|Overall Study|Lost to Follow-up|14|||
49032106|NCT01597245|157953478|FG008|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3|||
49032107|NCT01597245|157953479|FG009|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
49032108|NCT01597245|157953480|FG010|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2|||
48789359|NCT01540851|157067793|FG001|Overall Study|Lost to Follow-up|15|||
48789360|NCT01540851|157067792|FG000|Overall Study|Withdrawal by Subject|7|||
48789361|NCT01540851|157067793|FG001|Overall Study|Withdrawal by Subject|3|||
48789362|NCT00937924|157067796|FG000|Overall Study|Lost to Follow-up|44|||
48789363|NCT00937924|157067797|FG001|Overall Study|Lost to Follow-up|44|||
48789364|NCT00937924|157067798|FG002|Overall Study|Lost to Follow-up|41|||
48789365|NCT04515576|157067801|FG000|Overall Study|Withdrawal by Subject|0|||
48789366|NCT04515576|157067802|FG001|Overall Study|Withdrawal by Subject|0|||
48789367|NCT04515576|157067803|FG002|Overall Study|Withdrawal by Subject|0|||
48789368|NCT04515576|157067804|FG003|Overall Study|Withdrawal by Subject|0|||
48789369|NCT04515576|157067805|FG004|Overall Study|Withdrawal by Subject|0|||
48789370|NCT04515576|157067806|FG005|Overall Study|Withdrawal by Subject|1|||
48789371|NCT03850678|157067807|FG000|Overall Study|Withdrawal by Subject|3|||
48789372|NCT03850678|157067808|FG001|Overall Study|Withdrawal by Subject|0|||
48789373|NCT03850678|157067807|FG000|Overall Study|Experimenter Error|1|||
48789374|NCT03850678|157067808|FG001|Overall Study|Experimenter Error|1|||
48789375|NCT03850678|157067807|FG000|Overall Study|Did Not Condition To Experiment|7|||
48789376|NCT03850678|157067808|FG001|Overall Study|Did Not Condition To Experiment|2|||
48789377|NCT00099437|157067814|FG000|Overall Study|Lost to Follow-up|30|||
48789378|NCT00099437|157067815|FG001|Overall Study|Lost to Follow-up|33|||
48789379|NCT00099437|157067814|FG000|Overall Study|Death|293|||
48789380|NCT00099437|157067815|FG001|Overall Study|Death|261|||
48789381|NCT00099437|157067814|FG000|Overall Study|Withdrawal by Subject|6|||
48789382|NCT00099437|157067815|FG001|Overall Study|Withdrawal by Subject|10|||
48789383|NCT00099437|157067814|FG000|Overall Study|Ongoing in FU but not on treatment|37|||
48789384|NCT00099437|157067815|FG001|Overall Study|Ongoing in FU but not on treatment|45|||
48789385|NCT04973254|157067816|FG000|Overall Study|Not adherent|0|||
48789386|NCT04973254|157067817|FG001|Overall Study|Not adherent|1|||
48789387|NCT04973254|157067818|FG002|Overall Study|Not adherent|0|||
48789388|NCT02288247|157067819|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|52|||
48789389|NCT02288247|157067820|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|0|||
48789390|NCT02288247|157067819|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Death|35|||
48789391|NCT02288247|157067820|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Death|0|||
48789392|NCT02288247|157067819|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|1|||
48789393|NCT02288247|157067820|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|0|||
48789394|NCT02288247|157067819|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|393|||
48789395|NCT02288247|157067820|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|0|||
48789396|NCT02288247|157067819|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|9|||
48789397|NCT02288247|157067820|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|0|||
48789398|NCT02288247|157067819|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|54|||
48789399|NCT02288247|157067820|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|0|||
48789400|NCT02288247|157067819|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Other|142|||
48789401|NCT02288247|157067820|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Other|0|||
48789402|NCT02288247|157067819|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|2|||
48789403|NCT02288247|157067820|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|0|||
48789404|NCT02288247|157067819|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|10|||
48789405|NCT02288247|157067820|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|8|||
48789406|NCT02288247|157067819|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Death|8|||
48789407|NCT02288247|157067820|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Death|4|||
48789408|NCT02288247|157067819|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|1|||
48789409|NCT02288247|157067820|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|0|||
48789410|NCT02288247|157067819|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|87|||
48789411|NCT02288247|157067820|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|94|||
48789412|NCT02288247|157067819|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|2|||
48789413|NCT02288247|157067820|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|1|||
48789414|NCT02288247|157067819|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
48789415|NCT02288247|157067820|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
48789416|NCT02288247|157067819|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
48789417|NCT02288247|157067820|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
48789418|NCT02288247|157067819|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|1|||
48789419|NCT02288247|157067820|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|0|||
48789420|NCT01672801|157067823|FG000|Overall Study|Screen Failure|0|||
48789421|NCT01672801|157067824|FG001|Overall Study|Screen Failure|1|||
48789422|NCT01362140|157067825|FG000|Overall Study|Noncompliance|1|||
48789423|NCT01362140|157067826|FG001|Overall Study|Noncompliance|0|||
48789424|NCT01362140|157067825|FG000|Overall Study|Adverse Event|2|||
48877813|NCT01667926|157392079|FG001|Overall Study|Time committment|0|||
48877814|NCT01667926|157392080|FG002|Overall Study|Time committment|2|||
48877815|NCT01667926|157392078|FG000|Overall Study|Inclusion/Exclusion Criteria|0|||
48877816|NCT01667926|157392079|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
48877817|NCT01667926|157392080|FG002|Overall Study|Inclusion/Exclusion Criteria|5|||
48877818|NCT01667926|157392078|FG000|Overall Study|Lost to Follow-up|1|||
48877819|NCT01667926|157392079|FG001|Overall Study|Lost to Follow-up|2|||
48877820|NCT01667926|157392080|FG002|Overall Study|Lost to Follow-up|1|||
48789425|NCT01362140|157067826|FG001|Overall Study|Adverse Event|2|||
48789426|NCT01362140|157067825|FG000|Overall Study|Withdrawal by Subject|3|||
48789427|NCT01362140|157067826|FG001|Overall Study|Withdrawal by Subject|3|||
48789428|NCT01362140|157067825|FG000|Overall Study|Administrative Decision|0|||
48789429|NCT01362140|157067826|FG001|Overall Study|Administrative Decision|1|||
48877821|NCT01667926|157392078|FG000|Overall Study|Side effects|3|||
48877822|NCT01667926|157392079|FG001|Overall Study|Side effects|0|||
48877823|NCT01667926|157392080|FG002|Overall Study|Side effects|0|||
48877824|NCT03897686|157392081|FG000|Overall Study|Protocol Violation|1|||
48877825|NCT03897686|157392082|FG001|Overall Study|Protocol Violation|1|||
48877826|NCT03897686|157392081|FG000|Overall Study|Withdrawal by Subject|1|||
48877827|NCT03897686|157392082|FG001|Overall Study|Withdrawal by Subject|1|||
48877828|NCT00730015|157392083|FG000|Overall Study|Adverse Event|11|||
48877829|NCT00730015|157392084|FG001|Overall Study|Adverse Event|10|||
48877830|NCT00730015|157392085|FG002|Overall Study|Adverse Event|8|||
48877831|NCT00730015|157392083|FG000|Overall Study|Protocol Violation|2|||
48877832|NCT00730015|157392084|FG001|Overall Study|Protocol Violation|6|||
48877833|NCT00730015|157392085|FG002|Overall Study|Protocol Violation|4|||
48877834|NCT00730015|157392083|FG000|Overall Study|Withdrawal by Subject|12|||
48877835|NCT00730015|157392084|FG001|Overall Study|Withdrawal by Subject|12|||
48877836|NCT00730015|157392085|FG002|Overall Study|Withdrawal by Subject|8|||
48877837|NCT00730015|157392083|FG000|Overall Study|Lost to Follow-up|4|||
48877838|NCT00730015|157392084|FG001|Overall Study|Lost to Follow-up|10|||
49032109|NCT01597245|157953481|FG011|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
48789430|NCT01362140|157067825|FG000|Overall Study|Death|2|||
48789431|NCT01362140|157067826|FG001|Overall Study|Death|1|||
48789432|NCT01362140|157067825|FG000|Overall Study|Other|1|||
48789433|NCT01362140|157067826|FG001|Overall Study|Other|1|||
48789434|NCT01362140|157067825|FG000|Overall Study|Protocol-specified Criteria|1|||
48789435|NCT01362140|157067826|FG001|Overall Study|Protocol-specified Criteria|2|||
48789436|NCT01362140|157067825|FG000|Overall Study|Discontinued Without Receiving Treatment|0|||
48789437|NCT01362140|157067826|FG001|Overall Study|Discontinued Without Receiving Treatment|1|||
48789438|NCT05553808|157067827|FG000|Overall Study|Death|25|||
48789439|NCT05553808|157067828|FG001|Overall Study|Death|62|||
48789440|NCT05553808|157067827|FG000|Overall Study|Site Closed|6|||
48789441|NCT05553808|157067828|FG001|Overall Study|Site Closed|6|||
48789442|NCT05553808|157067827|FG000|Overall Study|Lost to Follow-up|1|||
48789443|NCT05553808|157067828|FG001|Overall Study|Lost to Follow-up|0|||
48789444|NCT05553808|157067827|FG000|Overall Study|Withdrawal by Subject|3|||
48789445|NCT05553808|157067828|FG001|Overall Study|Withdrawal by Subject|2|||
48789446|NCT02734212|157067830|FG000|Overall Study|Lost to Follow-up|5|||
48789447|NCT02734212|157067831|FG001|Overall Study|Lost to Follow-up|10|||
48789448|NCT01764945|157067837|FG000|Overall Study|Adverse Event|0|||
48789449|NCT01764945|157067838|FG001|Overall Study|Adverse Event|1|||
48789450|NCT01764945|157067839|FG002|Overall Study|Adverse Event|0|||
48789451|NCT01764945|157067840|FG003|Overall Study|Adverse Event|0|||
48789452|NCT01764945|157067841|FG004|Overall Study|Adverse Event|0|||
48789453|NCT01764945|157067842|FG005|Overall Study|Adverse Event|0|||
48789454|NCT01764945|157067843|FG006|Overall Study|Adverse Event|1|||
48789455|NCT01764945|157067844|FG007|Overall Study|Adverse Event|0|||
48789456|NCT02576067|157067856|FG000|Overall Study|Death|0|||
48789457|NCT02576067|157067857|FG001|Overall Study|Death|1|||
48789458|NCT02576067|157067856|FG000|Overall Study|Lack of Efficacy|1|||
48877839|NCT00730015|157392085|FG002|Overall Study|Lost to Follow-up|3|||
48877840|NCT00730015|157392083|FG000|Overall Study|Lack of Efficacy|1|||
48877841|NCT00730015|157392084|FG001|Overall Study|Lack of Efficacy|2|||
48877842|NCT00730015|157392085|FG002|Overall Study|Lack of Efficacy|8|||
48789459|NCT02576067|157067857|FG001|Overall Study|Lack of Efficacy|0|||
48789460|NCT02576067|157067856|FG000|Overall Study|Lost to Follow-up|11|||
48789461|NCT02576067|157067857|FG001|Overall Study|Lost to Follow-up|0|||
48877843|NCT00730015|157392083|FG000|Overall Study|Other Reason|1|||
48877844|NCT00730015|157392084|FG001|Overall Study|Other Reason|0|||
48877845|NCT00730015|157392085|FG002|Overall Study|Other Reason|1|||
48877846|NCT02906020|157392090|FG000|Part 1: Dose Escalation Period|Adverse Event|0|||
48789462|NCT02576067|157067856|FG000|Overall Study|Withdrawal by Subject|11|||
48789463|NCT02576067|157067857|FG001|Overall Study|Withdrawal by Subject|2|||
48789464|NCT02576067|157067856|FG000|Overall Study|study closure of main CIRT trial)|0|||
48789465|NCT02576067|157067857|FG001|Overall Study|study closure of main CIRT trial)|8|||
48877847|NCT02906020|157392091|FG001|Part 1: Dose Escalation Period|Adverse Event|1|||
48877848|NCT02906020|157392092|FG002|Part 1: Dose Escalation Period|Adverse Event|0|||
48877849|NCT02906020|157392093|FG003|Part 1: Dose Escalation Period|Adverse Event|1|||
48789466|NCT02576067|157067856|FG000|Overall Study|not randomized, failed run-in|7|||
48789467|NCT02576067|157067857|FG001|Overall Study|not randomized, failed run-in|0|||
48789468|NCT02576067|157067856|FG000|Overall Study|screen failure/ re-enrolled|0|||
48789469|NCT02576067|157067857|FG001|Overall Study|screen failure/ re-enrolled|25|||
48789470|NCT02576067|157067856|FG000|Overall Study|Physician Decision|4|||
48789471|NCT02576067|157067857|FG001|Overall Study|Physician Decision|0|||
48789472|NCT00622167|157067858|FG000|Overall Study|Did not meet angiographic criteria|20|||
48789473|NCT03336619|157067859|FG000|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|192|||
48789474|NCT03336619|157067860|FG001|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|204|||
48789475|NCT03336619|157067859|FG000|Overall Study|Withdrawal by Subject|17|||
48789476|NCT03336619|157067860|FG001|Overall Study|Withdrawal by Subject|16|||
48789477|NCT03336619|157067859|FG000|Overall Study|Adverse Event|2|||
48789478|NCT03336619|157067860|FG001|Overall Study|Adverse Event|5|||
48789479|NCT03336619|157067859|FG000|Overall Study|Physician Decision|3|||
48789480|NCT03336619|157067860|FG001|Overall Study|Physician Decision|0|||
48789481|NCT00627705|157067863|FG000|Overall Study|Unwilling to take the compound (taste)|1|||
48789482|NCT00627705|157067864|FG001|Overall Study|Unwilling to take the compound (taste)|3|||
48789483|NCT00627705|157067863|FG000|Overall Study|Adverse Event|1|||
48789484|NCT00627705|157067864|FG001|Overall Study|Adverse Event|0|||
48789485|NCT00627705|157067863|FG000|Overall Study|Withdrawal by Subject|0|||
48789486|NCT00627705|157067864|FG001|Overall Study|Withdrawal by Subject|2|||
48789487|NCT00627705|157067863|FG000|Overall Study|Lost to Follow-up|0|||
48789488|NCT00627705|157067864|FG001|Overall Study|Lost to Follow-up|1|||
48789489|NCT02625623|157067866|FG000|Overall Study|Participants randomized but not treated|9|||
48789490|NCT02625623|157067867|FG001|Overall Study|Participants randomized but not treated|1|||
48789491|NCT01371851|157067868|FG000|Overall Study|Lost to Follow-up|5|||
48789492|NCT01371851|157067869|FG001|Overall Study|Lost to Follow-up|8|||
48789493|NCT01371851|157067868|FG000|Overall Study|was arrested and put in jail|0|||
48789494|NCT01371851|157067869|FG001|Overall Study|was arrested and put in jail|1|||
48789495|NCT01371851|157067868|FG000|Overall Study|non study related adverse event|1|||
48789496|NCT01371851|157067869|FG001|Overall Study|non study related adverse event|0|||
48789497|NCT01371851|157067868|FG000|Overall Study|Blood Pressure outside study parameters|2|||
48789498|NCT01371851|157067869|FG001|Overall Study|Blood Pressure outside study parameters|0|||
48789499|NCT02137369|157067871|FG000|Overall Study|Withdrawal by Subject|3|||
48789500|NCT02137369|157067872|FG001|Overall Study|Withdrawal by Subject|2|||
48789501|NCT02137369|157067871|FG000|Overall Study|Adverse Event|2|||
48789502|NCT02137369|157067872|FG001|Overall Study|Adverse Event|0|||
48789503|NCT02137369|157067871|FG000|Overall Study|Lost to Follow-up|1|||
48789504|NCT02137369|157067872|FG001|Overall Study|Lost to Follow-up|0|||
48789505|NCT02137369|157067871|FG000|Overall Study|Moved away|2|||
48789506|NCT02137369|157067872|FG001|Overall Study|Moved away|0|||
48789507|NCT05608629|157067874|FG000|Overall Study|Lost to Follow-up|2|||
48789508|NCT01667432|157067877|FG000|Overall Study|Premature Study Termination|26|||
48789509|NCT01667432|157067877|FG000|Overall Study|Failure to Return|10|||
48789510|NCT01667432|157067877|FG000|Overall Study|Moved to Another Center|3|||
48983261|NCT00281528|157769999|FG002|Overall Study|Withdrawal by Subject|7|||
48983262|NCT00281528|157769997|FG000|Overall Study|Other|6|||
48983263|NCT00281528|157769998|FG001|Overall Study|Other|3|||
48983264|NCT00281528|157769999|FG002|Overall Study|Other|5|||
48983265|NCT02543801|157770000|FG000|Overall Study|Protocol Violation|1|||
48983266|NCT02543801|157770001|FG001|Overall Study|Protocol Violation|2|||
48983267|NCT02543801|157770002|FG002|Overall Study|Protocol Violation|0|||
48983268|NCT02543801|157770003|FG003|Overall Study|Protocol Violation|0|||
48983269|NCT02967562|157770004|FG000|Overall Study|Consent not obtained|1|||
48983270|NCT02967562|157770005|FG001|Overall Study|Consent not obtained|0|||
48983271|NCT02967562|157770004|FG000|Overall Study|High leak precluding analysis|1|||
48983272|NCT02967562|157770005|FG001|Overall Study|High leak precluding analysis|1|||
48983273|NCT03595176|157770006|FG000|Overall Study|Death|0|||
48983274|NCT03595176|157770007|FG001|Overall Study|Death|2|||
48983275|NCT03595176|157770006|FG000|Overall Study|Lost to Follow-up|0|||
48983276|NCT03595176|157770007|FG001|Overall Study|Lost to Follow-up|1|||
48983277|NCT02520141|157770019|FG000|Overall Study|Rapid decline clinically and thus unable to enroll|1|||
48983278|NCT00443534|157772237|FG000|Overall Study|Lack of Efficacy|67|||
48983279|NCT00443534|157772237|FG000|Overall Study|Adverse Event|16|||
48983280|NCT00443534|157772237|FG000|Overall Study|Death|9|||
48983281|NCT00443534|157772237|FG000|Overall Study|Withdrawal by Subject|8|||
48983282|NCT00443534|157772237|FG000|Overall Study|Study Terminated by Sponsor|12|||
48983283|NCT00443534|157772237|FG000|Overall Study|Other|10|||
48983284|NCT00443534|157772237|FG000|Overall Study|Enrolled, Not Treated|1|||
48983285|NCT02710422|157772240|FG000|Overall Study|Termination of study|9|||
48789511|NCT01667432|157067877|FG000|Overall Study|Lost to Follow-up|3|||
48789512|NCT01667432|157067877|FG000|Overall Study|Refused Treatment/Withdrew Consent|1|||
48983286|NCT02710422|157772241|FG001|Overall Study|Termination of study|9|||
48983287|NCT01081951|157772246|FG000|Overall Study|Death|54|||
48983288|NCT01081951|157772247|FG001|Overall Study|Death|47|||
48983289|NCT01081951|157772246|FG000|Overall Study|Withdrawal by Subject|2|||
48789513|NCT01667432|157067877|FG000|Overall Study|Insufficient Therapeutic Response|4|||
48789514|NCT01667432|157067877|FG000|Overall Study|Adverse Event|1|||
48789515|NCT01667432|157067877|FG000|Overall Study|Protocol Deviation|2|||
48789516|NCT01667432|157067877|FG000|Overall Study|Principal Investigator Decision|1|||
48789517|NCT01667432|157067877|FG000|Overall Study|Reason Not Specified|2|||
48789518|NCT01667432|157067877|FG000|Overall Study|Missing Information|4|||
48789519|NCT03077724|157067878|FG000|Overall Study|Lost to Follow-up|5|||
48789520|NCT03077724|157067879|FG001|Overall Study|Lost to Follow-up|1|||
48789521|NCT03077724|157067878|FG000|Overall Study|Withdrawal by Subject|3|||
48789522|NCT03077724|157067879|FG001|Overall Study|Withdrawal by Subject|1|||
48789523|NCT02269670|157067880|FG000|Overall Study|All subjects have not completed all research related interventions|3|||
48789524|NCT04707768|157067887|FG000|Overall Study|Adverse Event|9|||
48789525|NCT04707768|157067888|FG001|Overall Study|Adverse Event|18|||
48789526|NCT04707768|157067889|FG002|Overall Study|Adverse Event|3|||
48789527|NCT04707768|157067887|FG000|Overall Study|Investigator's Discretion|8|||
48789528|NCT04707768|157067888|FG001|Overall Study|Investigator's Discretion|4|||
48789529|NCT04707768|157067889|FG002|Overall Study|Investigator's Discretion|3|||
48789530|NCT04707768|157067887|FG000|Overall Study|Withdrawal by Subject|6|||
48789531|NCT04707768|157067888|FG001|Overall Study|Withdrawal by Subject|8|||
48789532|NCT04707768|157067889|FG002|Overall Study|Withdrawal by Subject|2|||
48789533|NCT04707768|157067887|FG000|Overall Study|Lack of Efficacy|1|||
48789534|NCT04707768|157067888|FG001|Overall Study|Lack of Efficacy|3|||
48789535|NCT04707768|157067889|FG002|Overall Study|Lack of Efficacy|0|||
48789536|NCT04707768|157067887|FG000|Overall Study|Lost to Follow-up|0|||
48789537|NCT04707768|157067888|FG001|Overall Study|Lost to Follow-up|0|||
48789538|NCT04707768|157067889|FG002|Overall Study|Lost to Follow-up|3|||
48789539|NCT04707768|157067887|FG000|Overall Study|Death|13|||
48789540|NCT04707768|157067888|FG001|Overall Study|Death|11|||
48789541|NCT04707768|157067889|FG002|Overall Study|Death|13|||
48789542|NCT04707768|157067887|FG000|Overall Study|Protocol Violation|2|||
48789543|NCT04707768|157067888|FG001|Overall Study|Protocol Violation|1|||
48789544|NCT04707768|157067889|FG002|Overall Study|Protocol Violation|0|||
48789545|NCT04707768|157067887|FG000|Overall Study|Non Compliance with Study Drug|1|||
48789546|NCT04707768|157067888|FG001|Overall Study|Non Compliance with Study Drug|0|||
48789547|NCT04707768|157067889|FG002|Overall Study|Non Compliance with Study Drug|0|||
48789548|NCT04707768|157067887|FG000|Overall Study|Transplant|4|||
48789549|NCT04707768|157067888|FG001|Overall Study|Transplant|4|||
48789550|NCT04707768|157067889|FG002|Overall Study|Transplant|8|||
48789551|NCT04707768|157067887|FG000|Overall Study|Other|9|||
48789552|NCT04707768|157067888|FG001|Overall Study|Other|5|||
48789553|NCT04707768|157067889|FG002|Overall Study|Other|2|||
48789554|NCT02489500|157069728|FG000|Overall Study|Death|1|||
48789555|NCT02489500|157069729|FG001|Overall Study|Death|1|||
48789556|NCT03912259|157069732|FG000|Overall Study|Adverse Event (AE)|2|||
48789557|NCT03912259|157069733|FG001|Overall Study|Adverse Event (AE)|4|||
48789558|NCT03912259|157069732|FG000|Overall Study|Lack of Efficacy|4|||
48789559|NCT03912259|157069733|FG001|Overall Study|Lack of Efficacy|1|||
48789560|NCT03912259|157069732|FG000|Overall Study|Withdrawal by Subject|11|||
48789561|NCT03912259|157069733|FG001|Overall Study|Withdrawal by Subject|1|||
48789562|NCT02091726|157069734|FG000|Overall Study|Lost to Follow-up|6|||
48789563|NCT04786444|157069735|FG000|Overall Study|Withdrawal by Subject|4|||
48789564|NCT04786444|157069736|FG001|Overall Study|Withdrawal by Subject|7|||
48789565|NCT04786444|157069737|FG002|Overall Study|Withdrawal by Subject|2|||
48789566|NCT04786444|157069735|FG000|Overall Study|Lost to Follow-up|11|||
48789567|NCT04786444|157069736|FG001|Overall Study|Lost to Follow-up|9|||
48789568|NCT04786444|157069737|FG002|Overall Study|Lost to Follow-up|10|||
48789569|NCT04786444|157069735|FG000|Overall Study|Subject would like to become pregnant|0|||
48789570|NCT04786444|157069736|FG001|Overall Study|Subject would like to become pregnant|1|||
48789571|NCT04786444|157069737|FG002|Overall Study|Subject would like to become pregnant|0|||
48789572|NCT01054820|157069738|FG000|Overall Study|Withdrawal by Subject|2|||
48789573|NCT02462876|157069739|FG000|Overall Study|Death|3|||
48789574|NCT02462876|157069739|FG000|Overall Study|Lost to Follow-up|7|||
49032110|NCT01597245|157953482|FG012|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
49032111|NCT01597245|157953483|FG013|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
49032112|NCT01597245|157953484|FG014|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
49032113|NCT01597245|157953485|FG015|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
48789575|NCT02462876|157069739|FG000|Overall Study|Surgical Bypass|9|||
48789576|NCT02462876|157069739|FG000|Overall Study|Amputation Above the Metatarsals|1|||
48789577|NCT02462876|157069739|FG000|Overall Study|36 months follow-up visit missed|1|||
48789578|NCT02462876|157069739|FG000|Overall Study|Patient did not come back since 4 months follow-up|1|||
49032114|NCT01597245|157953486|FG016|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
48789579|NCT02462876|157069739|FG000|Overall Study|Patient did not come back to the vascular department|1|||
48789580|NCT02462876|157069739|FG000|Overall Study|Patient contacted by phone but never came back for his follow-up visits|1|||
48789581|NCT02462876|157069739|FG000|Overall Study|Patient refused to come back|1|||
48789582|NCT02462876|157069739|FG000|Overall Study|Patient was contacted on Sep 2020. He is fine but refused to come back for his 36 months|1|||
48789583|NCT02462876|157069739|FG000|Overall Study|Patient cancelled the follow-up visit twice time|1|||
48789584|NCT01217073|157069740|FG000|Base Period|Adverse Event|1|||
48789585|NCT01217073|157069741|FG001|Base Period|Adverse Event|0|||
48789586|NCT01217073|157069742|FG002|Base Period|Adverse Event|1|||
48789587|NCT01217073|157069743|FG003|Base Period|Adverse Event|0|||
48789588|NCT01217073|157069744|FG004|Base Period|Adverse Event|4|||
48789589|NCT01217073|157069745|FG005|Base Period|Adverse Event|1|||
48789590|NCT01217073|157069746|FG006|Base Period|Adverse Event|0|||
48789591|NCT01217073|157069747|FG007|Base Period|Adverse Event|0|||
48789592|NCT01217073|157069740|FG000|Base Period|Alanine aminotransferase (ALT)/AST|1|||
48789593|NCT01217073|157069741|FG001|Base Period|Alanine aminotransferase (ALT)/AST|0|||
48789594|NCT01217073|157069742|FG002|Base Period|Alanine aminotransferase (ALT)/AST|0|||
48789595|NCT01217073|157069743|FG003|Base Period|Alanine aminotransferase (ALT)/AST|0|||
48789596|NCT01217073|157069744|FG004|Base Period|Alanine aminotransferase (ALT)/AST|0|||
48789597|NCT01217073|157069745|FG005|Base Period|Alanine aminotransferase (ALT)/AST|0|||
48789598|NCT01217073|157069746|FG006|Base Period|Alanine aminotransferase (ALT)/AST|0|||
48789599|NCT01217073|157069747|FG007|Base Period|Alanine aminotransferase (ALT)/AST|0|||
48789600|NCT01217073|157069740|FG000|Base Period|Excluded medication|0|||
48789601|NCT01217073|157069741|FG001|Base Period|Excluded medication|0|||
48789602|NCT01217073|157069742|FG002|Base Period|Excluded medication|0|||
48789603|NCT01217073|157069743|FG003|Base Period|Excluded medication|0|||
48789604|NCT01217073|157069744|FG004|Base Period|Excluded medication|1|||
48789605|NCT01217073|157069745|FG005|Base Period|Excluded medication|0|||
48789606|NCT01217073|157069746|FG006|Base Period|Excluded medication|0|||
49032115|NCT01597245|157953487|FG017|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
49032116|NCT01597245|157953488|FG018|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
49032117|NCT01597245|157953489|FG019|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
49032118|NCT01597245|157953490|FG020|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
49032119|NCT01597245|157953470|FG000|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
49032120|NCT01597245|157953471|FG001|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
48789607|NCT01217073|157069747|FG007|Base Period|Excluded medication|0|||
48789608|NCT01217073|157069740|FG000|Base Period|Lack of Efficacy|0|||
49032121|NCT01597245|157953472|FG002|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
49032122|NCT01597245|157953473|FG003|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
49032123|NCT01597245|157953474|FG004|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3|||
49032124|NCT01597245|157953475|FG005|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4|||
49032125|NCT01597245|157953476|FG006|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
49032126|NCT01597245|157953477|FG007|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
49032127|NCT01597245|157953478|FG008|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
49032128|NCT01597245|157953479|FG009|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
49032129|NCT01597245|157953480|FG010|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
49032130|NCT01597245|157953481|FG011|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
49032131|NCT01597245|157953482|FG012|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
49032132|NCT01597245|157953483|FG013|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
49032133|NCT01597245|157953484|FG014|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
48789609|NCT01217073|157069741|FG001|Base Period|Lack of Efficacy|0|||
48789610|NCT01217073|157069742|FG002|Base Period|Lack of Efficacy|0|||
48789611|NCT01217073|157069743|FG003|Base Period|Lack of Efficacy|0|||
48789612|NCT01217073|157069744|FG004|Base Period|Lack of Efficacy|0|||
48789613|NCT01217073|157069745|FG005|Base Period|Lack of Efficacy|1|||
48789614|NCT01217073|157069746|FG006|Base Period|Lack of Efficacy|0|||
48789615|NCT01217073|157069747|FG007|Base Period|Lack of Efficacy|0|||
48789616|NCT01217073|157069740|FG000|Base Period|Lost to Follow-up|0|||
48789617|NCT01217073|157069741|FG001|Base Period|Lost to Follow-up|0|||
48789618|NCT01217073|157069742|FG002|Base Period|Lost to Follow-up|1|||
48789619|NCT01217073|157069743|FG003|Base Period|Lost to Follow-up|1|||
48789620|NCT01217073|157069744|FG004|Base Period|Lost to Follow-up|3|||
48789621|NCT01217073|157069745|FG005|Base Period|Lost to Follow-up|0|||
48789622|NCT01217073|157069746|FG006|Base Period|Lost to Follow-up|0|||
48789623|NCT01217073|157069747|FG007|Base Period|Lost to Follow-up|0|||
48789624|NCT01217073|157069740|FG000|Base Period|Physician Decision|0|||
49032134|NCT01597245|157953485|FG015|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
48789625|NCT01217073|157069741|FG001|Base Period|Physician Decision|0|||
48789626|NCT01217073|157069742|FG002|Base Period|Physician Decision|0|||
48789627|NCT01217073|157069743|FG003|Base Period|Physician Decision|0|||
48789628|NCT01217073|157069744|FG004|Base Period|Physician Decision|1|||
48789629|NCT01217073|157069745|FG005|Base Period|Physician Decision|0|||
48789630|NCT01217073|157069746|FG006|Base Period|Physician Decision|0|||
48789631|NCT01217073|157069747|FG007|Base Period|Physician Decision|0|||
48789632|NCT01217073|157069740|FG000|Base Period|Protocol Violation|1|||
48789633|NCT01217073|157069741|FG001|Base Period|Protocol Violation|0|||
48789634|NCT01217073|157069742|FG002|Base Period|Protocol Violation|0|||
48789635|NCT01217073|157069743|FG003|Base Period|Protocol Violation|0|||
48789636|NCT01217073|157069744|FG004|Base Period|Protocol Violation|1|||
48789637|NCT01217073|157069745|FG005|Base Period|Protocol Violation|2|||
48789638|NCT01217073|157069746|FG006|Base Period|Protocol Violation|0|||
48789639|NCT01217073|157069747|FG007|Base Period|Protocol Violation|0|||
48789640|NCT01217073|157069740|FG000|Base Period|Withdrawal by Subject|4|||
48789641|NCT01217073|157069741|FG001|Base Period|Withdrawal by Subject|5|||
48789642|NCT01217073|157069742|FG002|Base Period|Withdrawal by Subject|5|||
48789643|NCT01217073|157069743|FG003|Base Period|Withdrawal by Subject|1|||
48789644|NCT01217073|157069744|FG004|Base Period|Withdrawal by Subject|5|||
48789645|NCT01217073|157069745|FG005|Base Period|Withdrawal by Subject|5|||
48789646|NCT01217073|157069746|FG006|Base Period|Withdrawal by Subject|0|||
48789647|NCT01217073|157069747|FG007|Base Period|Withdrawal by Subject|0|||
48789648|NCT01217073|157069740|FG000|Extension Period|Adverse Event|0|||
48789649|NCT01217073|157069741|FG001|Extension Period|Adverse Event|0|||
48789650|NCT01217073|157069742|FG002|Extension Period|Adverse Event|0|||
48789651|NCT01217073|157069743|FG003|Extension Period|Adverse Event|0|||
48789652|NCT01217073|157069744|FG004|Extension Period|Adverse Event|0|||
48789653|NCT01217073|157069745|FG005|Extension Period|Adverse Event|0|||
49032135|NCT01597245|157953486|FG016|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
49032136|NCT01597245|157953487|FG017|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
49032137|NCT01597245|157953488|FG018|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
49032138|NCT01597245|157953489|FG019|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
49032139|NCT01597245|157953490|FG020|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
49032140|NCT01597245|157953470|FG000|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
49032141|NCT01597245|157953471|FG001|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
49032142|NCT01597245|157953472|FG002|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
49032143|NCT01597245|157953473|FG003|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
49032144|NCT01597245|157953474|FG004|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
49032145|NCT01597245|157953475|FG005|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
49032146|NCT01597245|157953476|FG006|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
49032147|NCT01597245|157953477|FG007|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
49032148|NCT01597245|157953478|FG008|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
49032149|NCT01597245|157953479|FG009|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
49032150|NCT01597245|157953480|FG010|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
49032151|NCT01597245|157953481|FG011|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
49032152|NCT01597245|157953482|FG012|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
49032153|NCT01597245|157953483|FG013|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
48789654|NCT01217073|157069746|FG006|Extension Period|Adverse Event|19|||
48789655|NCT01217073|157069747|FG007|Extension Period|Adverse Event|5|||
48789656|NCT01217073|157069740|FG000|Extension Period|ALT/AST|0|||
48789657|NCT01217073|157069741|FG001|Extension Period|ALT/AST|0|||
48789658|NCT01217073|157069742|FG002|Extension Period|ALT/AST|0|||
48789659|NCT01217073|157069743|FG003|Extension Period|ALT/AST|0|||
48789660|NCT01217073|157069744|FG004|Extension Period|ALT/AST|0|||
48789661|NCT01217073|157069745|FG005|Extension Period|ALT/AST|0|||
48789662|NCT01217073|157069746|FG006|Extension Period|ALT/AST|2|||
48789663|NCT01217073|157069747|FG007|Extension Period|ALT/AST|0|||
48789664|NCT01217073|157069740|FG000|Extension Period|Contraindication to study medication|0|||
48789665|NCT01217073|157069741|FG001|Extension Period|Contraindication to study medication|0|||
48789666|NCT01217073|157069742|FG002|Extension Period|Contraindication to study medication|0|||
48789667|NCT01217073|157069743|FG003|Extension Period|Contraindication to study medication|0|||
48789668|NCT01217073|157069744|FG004|Extension Period|Contraindication to study medication|0|||
48789669|NCT01217073|157069745|FG005|Extension Period|Contraindication to study medication|0|||
48789670|NCT01217073|157069746|FG006|Extension Period|Contraindication to study medication|1|||
48877850|NCT02906020|157392094|FG004|Part 1: Dose Escalation Period|Adverse Event|0|||
48877851|NCT02906020|157392095|FG005|Part 1: Dose Escalation Period|Adverse Event|0|||
48877852|NCT02906020|157392096|FG006|Part 1: Dose Escalation Period|Adverse Event|0|||
48877853|NCT02906020|157392097|FG007|Part 1: Dose Escalation Period|Adverse Event|0|||
49032154|NCT01597245|157953484|FG014|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
48789671|NCT01217073|157069747|FG007|Extension Period|Contraindication to study medication|0|||
48789672|NCT01217073|157069740|FG000|Extension Period|Creatinine/eGFR|0|||
48789673|NCT01217073|157069741|FG001|Extension Period|Creatinine/eGFR|0|||
48789674|NCT01217073|157069742|FG002|Extension Period|Creatinine/eGFR|0|||
48789675|NCT01217073|157069743|FG003|Extension Period|Creatinine/eGFR|0|||
48789676|NCT01217073|157069744|FG004|Extension Period|Creatinine/eGFR|0|||
48789677|NCT01217073|157069745|FG005|Extension Period|Creatinine/eGFR|0|||
48789678|NCT01217073|157069746|FG006|Extension Period|Creatinine/eGFR|11|||
48789679|NCT01217073|157069747|FG007|Extension Period|Creatinine/eGFR|1|||
48789680|NCT01217073|157069740|FG000|Extension Period|Death|0|||
48789681|NCT01217073|157069741|FG001|Extension Period|Death|0|||
48789682|NCT01217073|157069742|FG002|Extension Period|Death|0|||
48789683|NCT01217073|157069743|FG003|Extension Period|Death|0|||
48877854|NCT02906020|157392098|FG008|Part 1: Dose Escalation Period|Adverse Event|0|||
48877855|NCT02906020|157392099|FG009|Part 1: Dose Escalation Period|Adverse Event|0|||
49032155|NCT01597245|157953485|FG015|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
49032156|NCT01597245|157953486|FG016|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
48789684|NCT01217073|157069744|FG004|Extension Period|Death|0|||
48789685|NCT01217073|157069745|FG005|Extension Period|Death|0|||
48789686|NCT01217073|157069746|FG006|Extension Period|Death|1|||
48789687|NCT01217073|157069747|FG007|Extension Period|Death|0|||
48789688|NCT01217073|157069740|FG000|Extension Period|Excluded medication|0|||
48789689|NCT01217073|157069741|FG001|Extension Period|Excluded medication|0|||
48789690|NCT01217073|157069742|FG002|Extension Period|Excluded medication|0|||
48789691|NCT01217073|157069743|FG003|Extension Period|Excluded medication|0|||
48789692|NCT01217073|157069744|FG004|Extension Period|Excluded medication|0|||
48789693|NCT01217073|157069745|FG005|Extension Period|Excluded medication|0|||
48789694|NCT01217073|157069746|FG006|Extension Period|Excluded medication|2|||
48789695|NCT01217073|157069747|FG007|Extension Period|Excluded medication|0|||
48789696|NCT01217073|157069740|FG000|Extension Period|Lack of Efficacy|0|||
48789697|NCT01217073|157069741|FG001|Extension Period|Lack of Efficacy|0|||
48789698|NCT01217073|157069742|FG002|Extension Period|Lack of Efficacy|0|||
48789699|NCT01217073|157069743|FG003|Extension Period|Lack of Efficacy|0|||
48789700|NCT01217073|157069744|FG004|Extension Period|Lack of Efficacy|0|||
48789701|NCT01217073|157069745|FG005|Extension Period|Lack of Efficacy|0|||
48789702|NCT01217073|157069746|FG006|Extension Period|Lack of Efficacy|3|||
48789703|NCT01217073|157069747|FG007|Extension Period|Lack of Efficacy|0|||
48789704|NCT01217073|157069740|FG000|Extension Period|Lost to Follow-up|0|||
48789705|NCT01217073|157069741|FG001|Extension Period|Lost to Follow-up|0|||
48789706|NCT01217073|157069742|FG002|Extension Period|Lost to Follow-up|0|||
48789707|NCT01217073|157069743|FG003|Extension Period|Lost to Follow-up|0|||
48789708|NCT01217073|157069744|FG004|Extension Period|Lost to Follow-up|0|||
48789709|NCT01217073|157069745|FG005|Extension Period|Lost to Follow-up|0|||
48789710|NCT01217073|157069746|FG006|Extension Period|Lost to Follow-up|9|||
48789711|NCT01217073|157069747|FG007|Extension Period|Lost to Follow-up|1|||
48789712|NCT01217073|157069740|FG000|Extension Period|Non-compliance with study drug|0|||
48789713|NCT01217073|157069741|FG001|Extension Period|Non-compliance with study drug|0|||
48789714|NCT01217073|157069742|FG002|Extension Period|Non-compliance with study drug|0|||
48789715|NCT01217073|157069743|FG003|Extension Period|Non-compliance with study drug|0|||
48789716|NCT01217073|157069744|FG004|Extension Period|Non-compliance with study drug|0|||
48789717|NCT01217073|157069745|FG005|Extension Period|Non-compliance with study drug|0|||
48789718|NCT01217073|157069746|FG006|Extension Period|Non-compliance with study drug|0|||
48789719|NCT01217073|157069747|FG007|Extension Period|Non-compliance with study drug|1|||
48789720|NCT01217073|157069740|FG000|Extension Period|Physician Decision|0|||
48789721|NCT01217073|157069741|FG001|Extension Period|Physician Decision|0|||
48789722|NCT01217073|157069742|FG002|Extension Period|Physician Decision|0|||
48789723|NCT01217073|157069743|FG003|Extension Period|Physician Decision|0|||
48789724|NCT01217073|157069744|FG004|Extension Period|Physician Decision|0|||
48789725|NCT01217073|157069745|FG005|Extension Period|Physician Decision|0|||
48789726|NCT01217073|157069746|FG006|Extension Period|Physician Decision|4|||
48789727|NCT01217073|157069747|FG007|Extension Period|Physician Decision|1|||
48789728|NCT01217073|157069740|FG000|Extension Period|Protocol Violation|0|||
48789729|NCT01217073|157069741|FG001|Extension Period|Protocol Violation|0|||
48789730|NCT01217073|157069742|FG002|Extension Period|Protocol Violation|0|||
48789731|NCT01217073|157069743|FG003|Extension Period|Protocol Violation|0|||
48789732|NCT01217073|157069744|FG004|Extension Period|Protocol Violation|0|||
48789733|NCT01217073|157069745|FG005|Extension Period|Protocol Violation|0|||
48789734|NCT01217073|157069746|FG006|Extension Period|Protocol Violation|2|||
48789735|NCT01217073|157069747|FG007|Extension Period|Protocol Violation|1|||
48789736|NCT01217073|157069740|FG000|Extension Period|Site discontinued study participation|0|||
48789737|NCT01217073|157069741|FG001|Extension Period|Site discontinued study participation|0|||
48789738|NCT01217073|157069742|FG002|Extension Period|Site discontinued study participation|0|||
48789739|NCT01217073|157069743|FG003|Extension Period|Site discontinued study participation|0|||
48789740|NCT01217073|157069744|FG004|Extension Period|Site discontinued study participation|0|||
48789741|NCT01217073|157069745|FG005|Extension Period|Site discontinued study participation|0|||
48789742|NCT01217073|157069746|FG006|Extension Period|Site discontinued study participation|7|||
48789743|NCT01217073|157069747|FG007|Extension Period|Site discontinued study participation|2|||
48789744|NCT01217073|157069740|FG000|Extension Period|Withdrawal by Subject|0|||
48789745|NCT01217073|157069741|FG001|Extension Period|Withdrawal by Subject|0|||
48789746|NCT01217073|157069742|FG002|Extension Period|Withdrawal by Subject|0|||
48789747|NCT01217073|157069743|FG003|Extension Period|Withdrawal by Subject|0|||
48789748|NCT01217073|157069744|FG004|Extension Period|Withdrawal by Subject|0|||
48789749|NCT01217073|157069745|FG005|Extension Period|Withdrawal by Subject|0|||
48789750|NCT01217073|157069746|FG006|Extension Period|Withdrawal by Subject|30|||
48789751|NCT01217073|157069747|FG007|Extension Period|Withdrawal by Subject|8|||
48789752|NCT02301143|157069748|FG000|Induction Period|Enrolled But Not Treated|1|||
48789753|NCT02301143|157069749|FG001|Induction Period|Enrolled But Not Treated|0|||
48789754|NCT02301143|157069748|FG000|Induction Period|Death|1|||
48789755|NCT02301143|157069749|FG001|Induction Period|Death|0|||
48789756|NCT02301143|157069748|FG000|Induction Period|Adverse Event|22|||
48789757|NCT02301143|157069749|FG001|Induction Period|Adverse Event|0|||
48789758|NCT02301143|157069748|FG000|Induction Period|Progressive Disease|8|||
48789759|NCT02301143|157069749|FG001|Induction Period|Progressive Disease|0|||
48789760|NCT02301143|157069748|FG000|Induction Period|Withdrawal by Subject|3|||
48789761|NCT02301143|157069749|FG001|Induction Period|Withdrawal by Subject|0|||
48789762|NCT02301143|157069748|FG000|Induction Period|Noncompliance with Study Drug|1|||
48789763|NCT02301143|157069749|FG001|Induction Period|Noncompliance with Study Drug|0|||
48789764|NCT02301143|157069748|FG000|Induction Period|Physician Decision|4|||
48789765|NCT02301143|157069749|FG001|Induction Period|Physician Decision|0|||
48789766|NCT02301143|157069748|FG000|Induction Period|Symptomatic Deterioration|2|||
48789767|NCT02301143|157069749|FG001|Induction Period|Symptomatic Deterioration|0|||
48789768|NCT02301143|157069748|FG000|Induction Period|Protocol Violation|2|||
48789769|NCT02301143|157069749|FG001|Induction Period|Protocol Violation|0|||
48789770|NCT02301143|157069748|FG000|Induction Period|Other|1|||
48789771|NCT02301143|157069749|FG001|Induction Period|Other|0|||
48789772|NCT02301143|157069748|FG000|Investigator's Choice|Adverse Event|0|||
48789773|NCT02301143|157069749|FG001|Investigator's Choice|Adverse Event|3|||
48789774|NCT02301143|157069748|FG000|Investigator's Choice|Progressive Disease|0|||
48789775|NCT02301143|157069749|FG001|Investigator's Choice|Progressive Disease|3|||
48789776|NCT02301143|157069748|FG000|Investigator's Choice|Noncompliance With Study Drug|0|||
48789777|NCT02301143|157069749|FG001|Investigator's Choice|Noncompliance With Study Drug|1|||
48789778|NCT02301143|157069748|FG000|Investigator's Choice|Symptomatic Deterioration|0|||
48789779|NCT02301143|157069749|FG001|Investigator's Choice|Symptomatic Deterioration|1|||
48789780|NCT02301143|157069748|FG000|Investigator's Choice|Other|0|||
48789781|NCT02301143|157069749|FG001|Investigator's Choice|Other|1|||
48789782|NCT02301143|157069748|FG000|Investigator's Choice|Unresectable Surgery|0|||
48789783|NCT02301143|157069749|FG001|Investigator's Choice|Unresectable Surgery|1|||
48789784|NCT04066114|157069752|FG000|Overall Study|Adverse Event|1|||
48789785|NCT04066114|157069753|FG001|Overall Study|Adverse Event|0|||
48789786|NCT04066114|157069754|FG002|Overall Study|Adverse Event|0|||
48789787|NCT04066114|157069752|FG000|Overall Study|Withdrawal by Subject|1|||
48789788|NCT04066114|157069753|FG001|Overall Study|Withdrawal by Subject|0|||
48789789|NCT04066114|157069754|FG002|Overall Study|Withdrawal by Subject|0|||
48789790|NCT04066114|157069752|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
48789791|NCT04066114|157069753|FG001|Overall Study|Did Not Meet Eligibility Criteria|7|||
48789792|NCT04066114|157069754|FG002|Overall Study|Did Not Meet Eligibility Criteria|0|||
48789793|NCT00726752|157069757|FG000|Overall Study|Lack of Efficacy|6|||
48789794|NCT04447404|157069758|FG000|Overall Study|Death|2|||
49032157|NCT01597245|157953487|FG017|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
49032158|NCT01597245|157953488|FG018|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
48789795|NCT04447404|157069759|FG001|Overall Study|Death|0|||
48789796|NCT01816594|157069762|FG000|Overall Study|Local Progress|0|||
48789797|NCT01816594|157069763|FG001|Overall Study|Local Progress|2|||
48789798|NCT01816594|157069762|FG000|Overall Study|Adverse Event|9|||
48789799|NCT01816594|157069763|FG001|Overall Study|Adverse Event|0|||
48789800|NCT01816594|157069762|FG000|Overall Study|Withdrawal by Subject|1|||
48789801|NCT01816594|157069763|FG001|Overall Study|Withdrawal by Subject|0|||
48789802|NCT01816594|157069762|FG000|Overall Study|Physician Decision|1|||
48789803|NCT01816594|157069763|FG001|Overall Study|Physician Decision|0|||
48789804|NCT02862106|157069768|FG000|Overall Study|Adverse Event|4|||
48789805|NCT02862106|157069769|FG001|Overall Study|Adverse Event|0|||
49032159|NCT01597245|157953489|FG019|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
48789806|NCT02862106|157069768|FG000|Overall Study|Protocol Violation|16|||
48789807|NCT02862106|157069769|FG001|Overall Study|Protocol Violation|1|||
48789808|NCT02862106|157069768|FG000|Overall Study|Lost to Follow-up|15|||
48789809|NCT02862106|157069769|FG001|Overall Study|Lost to Follow-up|5|||
48789810|NCT02862106|157069768|FG000|Overall Study|Withdrawal by Subject|2|||
48789811|NCT02862106|157069769|FG001|Overall Study|Withdrawal by Subject|0|||
48789812|NCT02862106|157069768|FG000|Overall Study|Subjects moved to other city|1|||
48789813|NCT02862106|157069769|FG001|Overall Study|Subjects moved to other city|0|||
48789814|NCT00487162|157069770|FG000|Overall Study|Adverse Event|0|||
48789815|NCT00487162|157069771|FG001|Overall Study|Adverse Event|1|||
48789816|NCT00487162|157069770|FG000|Overall Study|Physician Decision|0|||
48789817|NCT00487162|157069771|FG001|Overall Study|Physician Decision|1|||
48789818|NCT00487162|157069770|FG000|Overall Study|Withdrawal by Subject|2|||
48789819|NCT00487162|157069771|FG001|Overall Study|Withdrawal by Subject|3|||
48789820|NCT01814371|157069772|FG000|Overall Study|Lost to Follow-up|30|||
48789821|NCT01814371|157069773|FG001|Overall Study|Lost to Follow-up|27|||
48789822|NCT03593655|157069776|FG000|First Product Use Period|Withdrawal by Subject|1|||
48789823|NCT03593655|157069777|FG001|First Product Use Period|Withdrawal by Subject|1|||
48789824|NCT03593655|157069776|FG000|First Product Use Period|Lost to Follow-up|1|||
48789825|NCT03593655|157069777|FG001|First Product Use Period|Lost to Follow-up|3|||
48789826|NCT03593655|157069776|FG000|Second Product Use Period|Withdrawal by Subject|1|||
48789827|NCT03593655|157069777|FG001|Second Product Use Period|Withdrawal by Subject|1|||
48789828|NCT03593655|157069776|FG000|Second Product Use Period|Lost to Follow-up|1|||
48789829|NCT03593655|157069777|FG001|Second Product Use Period|Lost to Follow-up|0|||
48789830|NCT03593655|157069776|FG000|Third Product Use Period|Lost to Follow-up|1|||
48789831|NCT03593655|157069777|FG001|Third Product Use Period|Lost to Follow-up|2|||
48789832|NCT03593655|157069776|FG000|Third Product Use Period|Physician Decision|0|||
48789833|NCT03593655|157069777|FG001|Third Product Use Period|Physician Decision|1|||
48789834|NCT03593655|157069776|FG000|Third Product Use Period|Withdrawal by Subject|0|||
48789835|NCT03593655|157069777|FG001|Third Product Use Period|Withdrawal by Subject|1|||
48789836|NCT05046795|157069778|FG000|Overall Study|Adverse Event|13|||
48789837|NCT05046795|157069779|FG001|Overall Study|Adverse Event|15|||
48983290|NCT01081951|157772247|FG001|Overall Study|Withdrawal by Subject|6|||
48789838|NCT05046795|157069778|FG000|Overall Study|Withdrawal by Subject|4|||
48789839|NCT05046795|157069779|FG001|Overall Study|Withdrawal by Subject|7|||
48789840|NCT05046795|157069778|FG000|Overall Study|Physician Decision|1|||
48789841|NCT05046795|157069779|FG001|Overall Study|Physician Decision|2|||
48789842|NCT05046795|157069778|FG000|Overall Study|Protocol Violation|1|||
48789843|NCT05046795|157069779|FG001|Overall Study|Protocol Violation|2|||
48789844|NCT05046795|157069778|FG000|Overall Study|Death|1|||
48789845|NCT05046795|157069779|FG001|Overall Study|Death|0|||
48789846|NCT05046795|157069778|FG000|Overall Study|Public health emergency (COVID-19) restrictions|2|||
48789847|NCT05046795|157069779|FG001|Overall Study|Public health emergency (COVID-19) restrictions|3|||
48789848|NCT03923959|157069780|FG000|Overall Study|Death|16|||
48789849|NCT03923959|157069781|FG001|Overall Study|Death|12|||
48789850|NCT03923959|157069780|FG000|Overall Study|Lost to Follow-up|56|||
48789851|NCT03923959|157069781|FG001|Overall Study|Lost to Follow-up|56|||
48789852|NCT03923959|157069780|FG000|Overall Study|Withdrawal by Subject|1|||
48789853|NCT03923959|157069781|FG001|Overall Study|Withdrawal by Subject|1|||
48789854|NCT03923959|157069780|FG000|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|0|||
48789855|NCT03923959|157069781|FG001|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|1|||
48789856|NCT03526250|157069787|FG000|Overall Study|Adverse Event|4|||
48789857|NCT03526250|157069787|FG000|Overall Study|Progressive Disease|16|||
48789858|NCT03526250|157069787|FG000|Overall Study|No Treatment|3|||
48789859|NCT00782340|157069788|FG000|Open Label Titration|Adverse Event|12|||
48789860|NCT00782340|157069789|FG001|Open Label Titration|Adverse Event|0|||
48789861|NCT00782340|157069790|FG002|Open Label Titration|Adverse Event|0|||
48789862|NCT00782340|157069788|FG000|Open Label Titration|Treatment failure|50|||
48789863|NCT00782340|157069789|FG001|Open Label Titration|Treatment failure|0|||
48789864|NCT00782340|157069790|FG002|Open Label Titration|Treatment failure|0|||
48789865|NCT00782340|157069788|FG000|Open Label Titration|Protocol Violation|5|||
48789866|NCT00782340|157069789|FG001|Open Label Titration|Protocol Violation|0|||
48789867|NCT00782340|157069790|FG002|Open Label Titration|Protocol Violation|0|||
48789868|NCT00782340|157069788|FG000|Open Label Titration|Withdrawal by Subject|5|||
48789869|NCT00782340|157069789|FG001|Open Label Titration|Withdrawal by Subject|0|||
48789870|NCT00782340|157069790|FG002|Open Label Titration|Withdrawal by Subject|0|||
48789871|NCT00782340|157069788|FG000|Open Label Titration|Enrollment capped|16|||
48789872|NCT00782340|157069789|FG001|Open Label Titration|Enrollment capped|0|||
48789873|NCT00782340|157069790|FG002|Open Label Titration|Enrollment capped|0|||
48789874|NCT00782340|157069788|FG000|Open Label Titration|Did not meet responder criteria|2|||
48789875|NCT00782340|157069789|FG001|Open Label Titration|Did not meet responder criteria|0|||
48789876|NCT00782340|157069790|FG002|Open Label Titration|Did not meet responder criteria|0|||
48789877|NCT00782340|157069788|FG000|Open Label Titration|Lost to Follow-up|5|||
48789878|NCT00782340|157069789|FG001|Open Label Titration|Lost to Follow-up|0|||
48789879|NCT00782340|157069790|FG002|Open Label Titration|Lost to Follow-up|0|||
48789880|NCT00782340|157069788|FG000|Open Label Titration|Randomized in error|6|||
48789881|NCT00782340|157069789|FG001|Open Label Titration|Randomized in error|0|||
48789882|NCT00782340|157069790|FG002|Open Label Titration|Randomized in error|0|||
48789883|NCT04171999|157069791|FG000|Overall Study|deemed ineligible after randomization|2|||
48789884|NCT04171999|157069792|FG001|Overall Study|deemed ineligible after randomization|1|||
48789885|NCT02959437|157069795|FG000|Overall Study|Death|33|||
48789886|NCT02959437|157069796|FG001|Overall Study|Death|3|||
48789887|NCT02959437|157069797|FG002|Overall Study|Death|0|||
48789888|NCT02959437|157069798|FG003|Overall Study|Death|0|||
48789889|NCT02959437|157069795|FG000|Overall Study|Lost to Follow-up|3|||
48789890|NCT02959437|157069796|FG001|Overall Study|Lost to Follow-up|1|||
48789891|NCT02959437|157069797|FG002|Overall Study|Lost to Follow-up|0|||
48789892|NCT02959437|157069798|FG003|Overall Study|Lost to Follow-up|0|||
48983291|NCT01081951|157772246|FG000|Overall Study|Allocated treatment but did not take it|0|||
48983292|NCT01081951|157772247|FG001|Overall Study|Allocated treatment but did not take it|1|||
48983293|NCT01081951|157772246|FG000|Overall Study|Lost to Follow-up|0|||
48789893|NCT02959437|157069795|FG000|Overall Study|Withdrawal by Subject|11|||
48789894|NCT02959437|157069796|FG001|Overall Study|Withdrawal by Subject|3|||
48983294|NCT01081951|157772247|FG001|Overall Study|Lost to Follow-up|1|||
48789895|NCT02959437|157069797|FG002|Overall Study|Withdrawal by Subject|0|||
48789896|NCT02959437|157069798|FG003|Overall Study|Withdrawal by Subject|0|||
48789897|NCT02959437|157069795|FG000|Overall Study|Progressive Disease|9|||
48789898|NCT02959437|157069796|FG001|Overall Study|Progressive Disease|1|||
48789899|NCT02959437|157069797|FG002|Overall Study|Progressive Disease|0|||
48789900|NCT02959437|157069798|FG003|Overall Study|Progressive Disease|0|||
49032160|NCT01597245|157953490|FG020|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
49032161|NCT01597245|157953470|FG000|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
49032162|NCT01597245|157953471|FG001|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
49032163|NCT01597245|157953472|FG002|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
49032164|NCT01597245|157953473|FG003|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
49032165|NCT01597245|157953474|FG004|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
49032166|NCT01597245|157953475|FG005|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
49032167|NCT01597245|157953476|FG006|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
49032168|NCT01597245|157953477|FG007|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
49032169|NCT01597245|157953478|FG008|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
49032170|NCT01597245|157953479|FG009|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
48789901|NCT02959437|157069795|FG000|Overall Study|Study Terminated by Sponsor|4|||
48789902|NCT02959437|157069796|FG001|Overall Study|Study Terminated by Sponsor|0|||
48789903|NCT02959437|157069797|FG002|Overall Study|Study Terminated by Sponsor|0|||
48789904|NCT02959437|157069798|FG003|Overall Study|Study Terminated by Sponsor|0|||
48789905|NCT02959437|157069795|FG000|Overall Study|Other Unspecified|2|||
48789906|NCT02959437|157069796|FG001|Overall Study|Other Unspecified|0|||
48789907|NCT02959437|157069797|FG002|Overall Study|Other Unspecified|0|||
48789908|NCT02959437|157069798|FG003|Overall Study|Other Unspecified|0|||
48789909|NCT05671653|157069804|FG000|Cohort 1 Period 6 - Treatment|Other|0|||
48789910|NCT05671653|157069805|FG001|Cohort 1 Period 6 - Treatment|Other|0|||
48789911|NCT05671653|157069806|FG002|Cohort 1 Period 6 - Treatment|Other|0|||
48789912|NCT05671653|157069807|FG003|Cohort 1 Period 6 - Treatment|Other|0|||
48789913|NCT05671653|157069808|FG004|Cohort 1 Period 6 - Treatment|Other|0|||
48789914|NCT05671653|157069809|FG005|Cohort 1 Period 6 - Treatment|Other|1|||
48789915|NCT05671653|157069810|FG006|Cohort 1 Period 6 - Treatment|Other|0|||
48789916|NCT05671653|157069811|FG007|Cohort 1 Period 6 - Treatment|Other|0|||
48789917|NCT05671653|157069812|FG008|Cohort 1 Period 6 - Treatment|Other|0|||
48789918|NCT05671653|157069813|FG009|Cohort 1 Period 6 - Treatment|Other|0|||
48789919|NCT05671653|157069814|FG010|Cohort 1 Period 6 - Treatment|Other|0|||
48789920|NCT05671653|157069815|FG011|Cohort 1 Period 6 - Treatment|Other|0|||
48789921|NCT05671653|157069816|FG012|Cohort 1 Period 6 - Treatment|Other|0|||
48789922|NCT05671653|157069804|FG000|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
48789923|NCT05671653|157069805|FG001|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
48789924|NCT05671653|157069806|FG002|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
48789925|NCT05671653|157069807|FG003|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
48789926|NCT05671653|157069808|FG004|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
48983295|NCT01599585|157772248|FG000|Overall Study|Withdrawal by Subject|16|||
48983296|NCT01599585|157772249|FG001|Overall Study|Withdrawal by Subject|9|||
48983297|NCT01599585|157772248|FG000|Overall Study|Lost to Follow-up|3|||
48983298|NCT01599585|157772249|FG001|Overall Study|Lost to Follow-up|5|||
48983299|NCT01599585|157772248|FG000|Overall Study|randomized did not start treatment|3|||
48983300|NCT01599585|157772249|FG001|Overall Study|randomized did not start treatment|3|||
48983301|NCT05049122|157772250|FG000|Overall Study|Adverse event not related to Coronavirus Diesease-2019|1|||
48983302|NCT05049122|157772250|FG000|Overall Study|Participant moved|1|||
48983303|NCT05049122|157772250|FG000|Overall Study|At the direction of the doctor|1|||
48983304|NCT00137267|157772253|FG000|Overall Study|Lost to Follow-up|15|||
48983305|NCT00137267|157772254|FG001|Overall Study|Lost to Follow-up|21|||
48983306|NCT00853112|157772255|FG000|Overall Study|Randomized but not treated|0|||
48983307|NCT00853112|157772256|FG001|Overall Study|Randomized but not treated|1|||
48983308|NCT00853112|157772257|FG002|Overall Study|Randomized but not treated|0|||
48983309|NCT00853112|157772258|FG003|Overall Study|Randomized but not treated|2|||
48983310|NCT00853112|157772259|FG004|Overall Study|Randomized but not treated|0|||
48983311|NCT00853112|157772260|FG005|Overall Study|Randomized but not treated|0|||
48983312|NCT00853112|157772261|FG006|Overall Study|Randomized but not treated|1|||
48983313|NCT02477800|157772262|FG000|Placebo-Controlled Period|Adverse Event|16|||
48983314|NCT02477800|157772263|FG001|Placebo-Controlled Period|Adverse Event|25|||
48983315|NCT02477800|157772264|FG002|Placebo-Controlled Period|Adverse Event|28|||
48983316|NCT02477800|157772265|FG003|Placebo-Controlled Period|Adverse Event|0|||
48789927|NCT05671653|157069809|FG005|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|5|||
48789928|NCT05671653|157069810|FG006|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
48983317|NCT02477800|157772266|FG004|Placebo-Controlled Period|Adverse Event|0|||
48983318|NCT02477800|157772267|FG005|Placebo-Controlled Period|Adverse Event|0|||
48983319|NCT02477800|157772268|FG006|Placebo-Controlled Period|Adverse Event|0|||
48983320|NCT02477800|157772262|FG000|Placebo-Controlled Period|Change of Treatment|1|||
48983321|NCT02477800|157772263|FG001|Placebo-Controlled Period|Change of Treatment|2|||
48789929|NCT05671653|157069811|FG007|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
48789930|NCT05671653|157069812|FG008|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
48789931|NCT05671653|157069813|FG009|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
48789932|NCT05671653|157069814|FG010|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
48789933|NCT05671653|157069815|FG011|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
48789934|NCT05671653|157069816|FG012|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
48789935|NCT05671653|157069804|FG000|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
48789936|NCT05671653|157069805|FG001|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
48789937|NCT05671653|157069806|FG002|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
48789938|NCT05671653|157069807|FG003|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
48789939|NCT05671653|157069808|FG004|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
48789940|NCT05671653|157069809|FG005|Cohort 1 Period 6 - Treatment|Adverse Event|2|||
48789941|NCT05671653|157069810|FG006|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
48789942|NCT05671653|157069811|FG007|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
48789943|NCT05671653|157069812|FG008|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
48789944|NCT05671653|157069813|FG009|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
48789945|NCT05671653|157069814|FG010|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
48789946|NCT05671653|157069815|FG011|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
48789947|NCT05671653|157069816|FG012|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
48789948|NCT05671653|157069804|FG000|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
48789949|NCT05671653|157069805|FG001|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
48789950|NCT05671653|157069806|FG002|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
48789951|NCT05671653|157069807|FG003|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
48789952|NCT05671653|157069808|FG004|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
48789953|NCT05671653|157069809|FG005|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
48789954|NCT05671653|157069810|FG006|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
48789955|NCT05671653|157069811|FG007|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
48789956|NCT05671653|157069812|FG008|Cohort 1 Period 9 - Treatment|Adverse Event|1|||
48789957|NCT05671653|157069813|FG009|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
48789958|NCT05671653|157069814|FG010|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
48877856|NCT02906020|157392100|FG010|Part 1: Dose Escalation Period|Adverse Event|0|||
48877857|NCT02906020|157392101|FG011|Part 1: Dose Escalation Period|Adverse Event|0|||
48877858|NCT02906020|157392102|FG012|Part 1: Dose Escalation Period|Adverse Event|0|||
48877859|NCT02906020|157392103|FG013|Part 1: Dose Escalation Period|Adverse Event|0|||
48877860|NCT02906020|157392104|FG014|Part 1: Dose Escalation Period|Adverse Event|0|||
48877861|NCT02906020|157392105|FG015|Part 1: Dose Escalation Period|Adverse Event|0|||
48877862|NCT02906020|157392090|FG000|Part 2: Double-blind Treatment Period|Adverse Event|0|||
48877863|NCT02906020|157392091|FG001|Part 2: Double-blind Treatment Period|Adverse Event|0|||
48877864|NCT02906020|157392092|FG002|Part 2: Double-blind Treatment Period|Adverse Event|0|||
48877865|NCT02906020|157392093|FG003|Part 2: Double-blind Treatment Period|Adverse Event|0|||
48877866|NCT02906020|157392094|FG004|Part 2: Double-blind Treatment Period|Adverse Event|0|||
48877867|NCT02906020|157392095|FG005|Part 2: Double-blind Treatment Period|Adverse Event|0|||
48877868|NCT02906020|157392096|FG006|Part 2: Double-blind Treatment Period|Adverse Event|0|||
48877869|NCT02906020|157392097|FG007|Part 2: Double-blind Treatment Period|Adverse Event|0|||
48877870|NCT02906020|157392098|FG008|Part 2: Double-blind Treatment Period|Adverse Event|6|||
48877871|NCT02906020|157392099|FG009|Part 2: Double-blind Treatment Period|Adverse Event|15|||
48877872|NCT02906020|157392100|FG010|Part 2: Double-blind Treatment Period|Adverse Event|0|||
48877873|NCT02906020|157392101|FG011|Part 2: Double-blind Treatment Period|Adverse Event|0|||
48877874|NCT02906020|157392102|FG012|Part 2: Double-blind Treatment Period|Adverse Event|0|||
49032171|NCT01597245|157953480|FG010|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1|||
49032172|NCT01597245|157953481|FG011|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
49032173|NCT01597245|157953482|FG012|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
49032174|NCT01597245|157953483|FG013|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
49032175|NCT01597245|157953484|FG014|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
49032176|NCT01597245|157953485|FG015|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
49032177|NCT01597245|157953486|FG016|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
49032178|NCT01597245|157953487|FG017|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
49032179|NCT01597245|157953488|FG018|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
49032180|NCT01597245|157953489|FG019|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
48789959|NCT05671653|157069815|FG011|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
48789960|NCT05671653|157069816|FG012|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
48789961|NCT05671653|157069804|FG000|Cohort 2 Period 2|Adverse Event|0|||
48789962|NCT05671653|157069805|FG001|Cohort 2 Period 2|Adverse Event|0|||
48789963|NCT05671653|157069806|FG002|Cohort 2 Period 2|Adverse Event|0|||
48789964|NCT05671653|157069807|FG003|Cohort 2 Period 2|Adverse Event|0|||
48789965|NCT05671653|157069808|FG004|Cohort 2 Period 2|Adverse Event|0|||
48789966|NCT05671653|157069809|FG005|Cohort 2 Period 2|Adverse Event|0|||
48877875|NCT02906020|157392103|FG013|Part 2: Double-blind Treatment Period|Adverse Event|0|||
48877876|NCT02906020|157392104|FG014|Part 2: Double-blind Treatment Period|Adverse Event|0|||
48789967|NCT05671653|157069810|FG006|Cohort 2 Period 2|Adverse Event|0|||
48789968|NCT05671653|157069811|FG007|Cohort 2 Period 2|Adverse Event|0|||
48789969|NCT05671653|157069812|FG008|Cohort 2 Period 2|Adverse Event|0|||
48789970|NCT05671653|157069813|FG009|Cohort 2 Period 2|Adverse Event|0|||
48789971|NCT05671653|157069814|FG010|Cohort 2 Period 2|Adverse Event|1|||
48789972|NCT05671653|157069815|FG011|Cohort 2 Period 2|Adverse Event|0|||
48789973|NCT05671653|157069816|FG012|Cohort 2 Period 2|Adverse Event|0|||
48789974|NCT05671653|157069804|FG000|Cohort 2 Period 2|Lost to Follow-up|0|||
48877877|NCT02906020|157392105|FG015|Part 2: Double-blind Treatment Period|Adverse Event|0|||
48877878|NCT02906020|157392090|FG000|Part 2: Double-blind Treatment Period|Other|0|||
48789975|NCT05671653|157069805|FG001|Cohort 2 Period 2|Lost to Follow-up|0|||
48789976|NCT05671653|157069806|FG002|Cohort 2 Period 2|Lost to Follow-up|0|||
48789977|NCT05671653|157069807|FG003|Cohort 2 Period 2|Lost to Follow-up|0|||
48789978|NCT05671653|157069808|FG004|Cohort 2 Period 2|Lost to Follow-up|0|||
48789979|NCT05671653|157069809|FG005|Cohort 2 Period 2|Lost to Follow-up|0|||
48789980|NCT05671653|157069810|FG006|Cohort 2 Period 2|Lost to Follow-up|0|||
48789981|NCT05671653|157069811|FG007|Cohort 2 Period 2|Lost to Follow-up|0|||
48789982|NCT05671653|157069812|FG008|Cohort 2 Period 2|Lost to Follow-up|0|||
48877879|NCT02906020|157392091|FG001|Part 2: Double-blind Treatment Period|Other|0|||
48877880|NCT02906020|157392092|FG002|Part 2: Double-blind Treatment Period|Other|0|||
48877881|NCT02906020|157392093|FG003|Part 2: Double-blind Treatment Period|Other|0|||
48877882|NCT02906020|157392094|FG004|Part 2: Double-blind Treatment Period|Other|0|||
48877883|NCT02906020|157392095|FG005|Part 2: Double-blind Treatment Period|Other|0|||
48877884|NCT02906020|157392096|FG006|Part 2: Double-blind Treatment Period|Other|0|||
48789983|NCT05671653|157069813|FG009|Cohort 2 Period 2|Lost to Follow-up|0|||
48789984|NCT05671653|157069814|FG010|Cohort 2 Period 2|Lost to Follow-up|1|||
48789985|NCT05671653|157069815|FG011|Cohort 2 Period 2|Lost to Follow-up|0|||
48789986|NCT05671653|157069816|FG012|Cohort 2 Period 2|Lost to Follow-up|0|||
48789987|NCT05671653|157069804|FG000|Cohort 2 Period 2|Pregnancy|0|||
48789988|NCT05671653|157069805|FG001|Cohort 2 Period 2|Pregnancy|0|||
48789989|NCT05671653|157069806|FG002|Cohort 2 Period 2|Pregnancy|0|||
48789990|NCT05671653|157069807|FG003|Cohort 2 Period 2|Pregnancy|0|||
48789991|NCT05671653|157069808|FG004|Cohort 2 Period 2|Pregnancy|0|||
48789992|NCT05671653|157069809|FG005|Cohort 2 Period 2|Pregnancy|0|||
48789993|NCT05671653|157069810|FG006|Cohort 2 Period 2|Pregnancy|0|||
48789994|NCT05671653|157069811|FG007|Cohort 2 Period 2|Pregnancy|0|||
48789995|NCT05671653|157069812|FG008|Cohort 2 Period 2|Pregnancy|0|||
48789996|NCT05671653|157069813|FG009|Cohort 2 Period 2|Pregnancy|0|||
48789997|NCT05671653|157069814|FG010|Cohort 2 Period 2|Pregnancy|1|||
48789998|NCT05671653|157069815|FG011|Cohort 2 Period 2|Pregnancy|0|||
48789999|NCT05671653|157069816|FG012|Cohort 2 Period 2|Pregnancy|0|||
48790000|NCT05671653|157069804|FG000|Cohort 2 Period 2|Withdrawal by Subject|0|||
48790001|NCT05671653|157069805|FG001|Cohort 2 Period 2|Withdrawal by Subject|0|||
48790002|NCT05671653|157069806|FG002|Cohort 2 Period 2|Withdrawal by Subject|0|||
48790003|NCT05671653|157069807|FG003|Cohort 2 Period 2|Withdrawal by Subject|0|||
48790004|NCT05671653|157069808|FG004|Cohort 2 Period 2|Withdrawal by Subject|0|||
48790005|NCT05671653|157069809|FG005|Cohort 2 Period 2|Withdrawal by Subject|0|||
48790006|NCT05671653|157069810|FG006|Cohort 2 Period 2|Withdrawal by Subject|0|||
48790007|NCT05671653|157069811|FG007|Cohort 2 Period 2|Withdrawal by Subject|0|||
48790008|NCT05671653|157069812|FG008|Cohort 2 Period 2|Withdrawal by Subject|0|||
48790009|NCT05671653|157069813|FG009|Cohort 2 Period 2|Withdrawal by Subject|0|||
48790010|NCT05671653|157069814|FG010|Cohort 2 Period 2|Withdrawal by Subject|1|||
48790011|NCT05671653|157069815|FG011|Cohort 2 Period 2|Withdrawal by Subject|0|||
48790012|NCT05671653|157069816|FG012|Cohort 2 Period 2|Withdrawal by Subject|0|||
48790013|NCT05671653|157069804|FG000|Cohort 2 Period 2|Other|0|||
48790014|NCT05671653|157069805|FG001|Cohort 2 Period 2|Other|0|||
48790015|NCT05671653|157069806|FG002|Cohort 2 Period 2|Other|0|||
48790016|NCT05671653|157069807|FG003|Cohort 2 Period 2|Other|0|||
48790017|NCT05671653|157069808|FG004|Cohort 2 Period 2|Other|0|||
48790018|NCT05671653|157069809|FG005|Cohort 2 Period 2|Other|0|||
48790019|NCT05671653|157069810|FG006|Cohort 2 Period 2|Other|0|||
48877885|NCT02906020|157392097|FG007|Part 2: Double-blind Treatment Period|Other|0|||
48983322|NCT02477800|157772264|FG002|Placebo-Controlled Period|Change of Treatment|1|||
48790020|NCT05671653|157069811|FG007|Cohort 2 Period 2|Other|0|||
48790021|NCT05671653|157069812|FG008|Cohort 2 Period 2|Other|0|||
48983323|NCT02477800|157772265|FG003|Placebo-Controlled Period|Change of Treatment|0|||
48983324|NCT02477800|157772266|FG004|Placebo-Controlled Period|Change of Treatment|0|||
48790022|NCT05671653|157069813|FG009|Cohort 2 Period 2|Other|0|||
48790023|NCT05671653|157069814|FG010|Cohort 2 Period 2|Other|1|||
48790024|NCT05671653|157069815|FG011|Cohort 2 Period 2|Other|0|||
48790025|NCT05671653|157069816|FG012|Cohort 2 Period 2|Other|0|||
48983325|NCT02477800|157772267|FG005|Placebo-Controlled Period|Change of Treatment|0|||
48790026|NCT05671653|157069804|FG000|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
48790027|NCT05671653|157069805|FG001|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
48790028|NCT05671653|157069806|FG002|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
48790029|NCT05671653|157069807|FG003|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
48790030|NCT05671653|157069808|FG004|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
48790031|NCT05671653|157069809|FG005|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
48790032|NCT05671653|157069810|FG006|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
48790033|NCT05671653|157069811|FG007|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
48790034|NCT05671653|157069812|FG008|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
48790035|NCT05671653|157069813|FG009|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
48790036|NCT05671653|157069814|FG010|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
48790037|NCT05671653|157069815|FG011|Cohort 2 Period 3 - Treatment|Adverse Event|1|||
48790038|NCT05671653|157069816|FG012|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
48790039|NCT00688636|157069817|FG000|Overall Study|Adverse Event|2|||
48790040|NCT00688636|157069818|FG001|Overall Study|Adverse Event|1|||
48790041|NCT01572727|157069819|FG000|Overall Study|Adverse Event|43|||
48790042|NCT01572727|157069820|FG001|Overall Study|Adverse Event|15|||
48790043|NCT01572727|157069819|FG000|Overall Study|Lost to Follow-up|1|||
48790044|NCT01572727|157069820|FG001|Overall Study|Lost to Follow-up|1|||
48790045|NCT01572727|157069819|FG000|Overall Study|Physician Decision|23|||
48790046|NCT01572727|157069820|FG001|Overall Study|Physician Decision|9|||
48790047|NCT01572727|157069819|FG000|Overall Study|Progressive disease|59|||
48790048|NCT01572727|157069820|FG001|Overall Study|Progressive disease|82|||
48790049|NCT01572727|157069819|FG000|Overall Study|Protocol Violation|0|||
48790050|NCT01572727|157069820|FG001|Overall Study|Protocol Violation|1|||
48790051|NCT01572727|157069819|FG000|Overall Study|Study terminated by sponsor|61|||
48790052|NCT01572727|157069820|FG001|Overall Study|Study terminated by sponsor|83|||
48790053|NCT01572727|157069819|FG000|Overall Study|Parent/guardian decision|14|||
48790054|NCT01572727|157069820|FG001|Overall Study|Parent/guardian decision|9|||
48790055|NCT01572727|157069819|FG000|Overall Study|Death|2|||
48790056|NCT01572727|157069820|FG001|Overall Study|Death|2|||
48790057|NCT01572727|157069819|FG000|Overall Study|Untreated|4|||
49032181|NCT01597245|157953490|FG020|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
49032182|NCT01597245|157953470|FG000|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
49032183|NCT01597245|157953471|FG001|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
49032184|NCT01597245|157953472|FG002|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
49032185|NCT01597245|157953473|FG003|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
49032186|NCT01597245|157953474|FG004|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
49032187|NCT01597245|157953475|FG005|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
49032188|NCT01597245|157953476|FG006|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
49032189|NCT01597245|157953477|FG007|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
49032190|NCT01597245|157953478|FG008|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
49032191|NCT01597245|157953479|FG009|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
49032192|NCT01597245|157953480|FG010|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
49032193|NCT01597245|157953481|FG011|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
49032194|NCT01597245|157953482|FG012|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
49032195|NCT01597245|157953483|FG013|Long Term Extension (Week 60 - Week 264)|Adverse Event|1|||
49032196|NCT01597245|157953484|FG014|Long Term Extension (Week 60 - Week 264)|Adverse Event|69|||
49032197|NCT01597245|157953485|FG015|Long Term Extension (Week 60 - Week 264)|Adverse Event|70|||
49032198|NCT01597245|157953486|FG016|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
49032199|NCT01597245|157953487|FG017|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
49032200|NCT01597245|157953488|FG018|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
49032201|NCT01597245|157953489|FG019|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
49032202|NCT01597245|157953490|FG020|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
49032203|NCT01597245|157953470|FG000|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
49032204|NCT01597245|157953471|FG001|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
49032205|NCT01597245|157953472|FG002|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
49032206|NCT01597245|157953473|FG003|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
49032207|NCT01597245|157953474|FG004|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
49032208|NCT01597245|157953475|FG005|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
49032209|NCT01597245|157953476|FG006|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
49032210|NCT01597245|157953477|FG007|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
49032211|NCT01597245|157953478|FG008|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
49032212|NCT01597245|157953479|FG009|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
48790058|NCT01572727|157069820|FG001|Overall Study|Untreated|7|||
48790059|NCT02384954|157069823|FG000|Phase 1|Progressive Disease|2|||
48790060|NCT02384954|157069824|FG001|Phase 1|Progressive Disease|0|||
49032213|NCT01597245|157953480|FG010|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
48877886|NCT02906020|157392098|FG008|Part 2: Double-blind Treatment Period|Other|6|||
48790061|NCT02384954|157069825|FG002|Phase 1|Progressive Disease|1|||
48790062|NCT02384954|157069826|FG003|Phase 1|Progressive Disease|1|||
48877887|NCT02906020|157392099|FG009|Part 2: Double-blind Treatment Period|Other|10|||
48790063|NCT02384954|157069827|FG004|Phase 1|Progressive Disease|0|||
48790064|NCT02384954|157069828|FG005|Phase 1|Progressive Disease|0|||
48877888|NCT02906020|157392100|FG010|Part 2: Double-blind Treatment Period|Other|0|||
48790065|NCT02384954|157069829|FG006|Phase 1|Progressive Disease|0|||
48790066|NCT02384954|157069830|FG007|Phase 1|Progressive Disease|0|||
48790067|NCT02384954|157069831|FG008|Phase 1|Progressive Disease|0|||
48790068|NCT02384954|157069823|FG000|Phase 1|Adverse Event|0|||
48790069|NCT02384954|157069824|FG001|Phase 1|Adverse Event|0|||
48790070|NCT02384954|157069825|FG002|Phase 1|Adverse Event|1|||
48790071|NCT02384954|157069826|FG003|Phase 1|Adverse Event|0|||
48790072|NCT02384954|157069827|FG004|Phase 1|Adverse Event|0|||
48790073|NCT02384954|157069828|FG005|Phase 1|Adverse Event|0|||
48790074|NCT02384954|157069829|FG006|Phase 1|Adverse Event|0|||
48790075|NCT02384954|157069830|FG007|Phase 1|Adverse Event|0|||
48790076|NCT02384954|157069831|FG008|Phase 1|Adverse Event|0|||
48790077|NCT02384954|157069823|FG000|Phase 2|Progressive Disease|0|||
48790078|NCT02384954|157069824|FG001|Phase 2|Progressive Disease|0|||
48790079|NCT02384954|157069825|FG002|Phase 2|Progressive Disease|0|||
48790080|NCT02384954|157069826|FG003|Phase 2|Progressive Disease|0|||
48790081|NCT02384954|157069827|FG004|Phase 2|Progressive Disease|0|||
48790082|NCT02384954|157069828|FG005|Phase 2|Progressive Disease|0|||
48790083|NCT02384954|157069829|FG006|Phase 2|Progressive Disease|0|||
48790084|NCT02384954|157069830|FG007|Phase 2|Progressive Disease|1|||
48790085|NCT02384954|157069831|FG008|Phase 2|Progressive Disease|2|||
48790086|NCT02384954|157069823|FG000|Phase 2|Adverse Event|0|||
48983326|NCT02477800|157772268|FG006|Placebo-Controlled Period|Change of Treatment|0|||
48790087|NCT02384954|157069824|FG001|Phase 2|Adverse Event|0|||
48790088|NCT02384954|157069825|FG002|Phase 2|Adverse Event|0|||
48790089|NCT02384954|157069826|FG003|Phase 2|Adverse Event|0|||
48790090|NCT02384954|157069827|FG004|Phase 2|Adverse Event|0|||
48790091|NCT02384954|157069828|FG005|Phase 2|Adverse Event|0|||
48790092|NCT02384954|157069829|FG006|Phase 2|Adverse Event|0|||
48790093|NCT02384954|157069830|FG007|Phase 2|Adverse Event|1|||
48790094|NCT02384954|157069831|FG008|Phase 2|Adverse Event|1|||
48790095|NCT02384954|157069823|FG000|Phase 2|Failure to meet continuation criteria|0|||
48790096|NCT02384954|157069824|FG001|Phase 2|Failure to meet continuation criteria|0|||
48790097|NCT02384954|157069825|FG002|Phase 2|Failure to meet continuation criteria|0|||
48790098|NCT02384954|157069826|FG003|Phase 2|Failure to meet continuation criteria|0|||
48790099|NCT02384954|157069827|FG004|Phase 2|Failure to meet continuation criteria|0|||
48790100|NCT02384954|157069828|FG005|Phase 2|Failure to meet continuation criteria|0|||
48790101|NCT02384954|157069829|FG006|Phase 2|Failure to meet continuation criteria|0|||
48790102|NCT02384954|157069830|FG007|Phase 2|Failure to meet continuation criteria|1|||
48790103|NCT02384954|157069831|FG008|Phase 2|Failure to meet continuation criteria|0|||
48790104|NCT01474681|157069832|FG000|Overall Study|Death|0|||
48790105|NCT01474681|157069833|FG001|Overall Study|Death|3|||
48790106|NCT01474681|157069834|FG002|Overall Study|Death|2|||
48790107|NCT01474681|157069835|FG003|Overall Study|Death|6|||
48790108|NCT01328574|157069836|FG000|Overall Study|Refused further treatment|1|||
48790109|NCT05073458|157069838|FG000|24-week Double-blind Period|Adverse Event|1|||
48790110|NCT05073458|157069839|FG001|24-week Double-blind Period|Adverse Event|0|||
48790111|NCT05073458|157069838|FG000|24-week Double-blind Period|Physician Decision|1|||
48790112|NCT05073458|157069839|FG001|24-week Double-blind Period|Physician Decision|0|||
48790113|NCT05073458|157069838|FG000|24-week Double-blind Period|Study Terminated by Sponsor|1|||
48790114|NCT05073458|157069839|FG001|24-week Double-blind Period|Study Terminated by Sponsor|1|||
48790115|NCT05073458|157069838|FG000|24-week Double-blind Period|Withdrawal by Subject|0|||
48790116|NCT05073458|157069839|FG001|24-week Double-blind Period|Withdrawal by Subject|1|||
48790117|NCT05073458|157069838|FG000|24-week Open-label Period|Withdrawal by Subject|1|||
48790118|NCT05073458|157069839|FG001|24-week Open-label Period|Withdrawal by Subject|0|||
48790119|NCT05073458|157069838|FG000|24-week Open-label Period|Adverse Event|1|||
48790120|NCT05073458|157069839|FG001|24-week Open-label Period|Adverse Event|2|||
48790121|NCT03150056|157069840|FG000|Overall Study|Withdrawal by Subject|0|||
48790122|NCT03150056|157069841|FG001|Overall Study|Withdrawal by Subject|0|||
48790123|NCT03150056|157069842|FG002|Overall Study|Withdrawal by Subject|0|||
48790124|NCT03150056|157069843|FG003|Overall Study|Withdrawal by Subject|0|||
48790125|NCT03150056|157069844|FG004|Overall Study|Withdrawal by Subject|0|||
48790126|NCT03150056|157069845|FG005|Overall Study|Withdrawal by Subject|2|||
48790127|NCT03150056|157069840|FG000|Overall Study|Study terminated by Sponsor|1|||
48790128|NCT03150056|157069841|FG001|Overall Study|Study terminated by Sponsor|3|||
48790129|NCT03150056|157069842|FG002|Overall Study|Study terminated by Sponsor|1|||
48790130|NCT03150056|157069843|FG003|Overall Study|Study terminated by Sponsor|1|||
48790131|NCT03150056|157069844|FG004|Overall Study|Study terminated by Sponsor|5|||
48790132|NCT03150056|157069845|FG005|Overall Study|Study terminated by Sponsor|6|||
48790133|NCT03150056|157069840|FG000|Overall Study|Death|9|||
48790134|NCT03150056|157069841|FG001|Overall Study|Death|2|||
48790135|NCT03150056|157069842|FG002|Overall Study|Death|2|||
48877889|NCT02906020|157392101|FG011|Part 2: Double-blind Treatment Period|Other|0|||
48983327|NCT02477800|157772262|FG000|Placebo-Controlled Period|Consent Withdrawn|26|||
48790136|NCT03150056|157069843|FG003|Overall Study|Death|7|||
48790137|NCT03150056|157069844|FG004|Overall Study|Death|8|||
48790138|NCT03150056|157069845|FG005|Overall Study|Death|10|||
48790139|NCT02952924|157069848|FG000|Overall Study|Protocol Violation|0|||
48790140|NCT02952924|157069849|FG001|Overall Study|Protocol Violation|0|||
49032214|NCT01597245|157953481|FG011|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
49032215|NCT01597245|157953482|FG012|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
49032216|NCT01597245|157953483|FG013|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1|||
49032217|NCT01597245|157953484|FG014|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62|||
49032218|NCT01597245|157953485|FG015|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63|||
49032219|NCT01597245|157953486|FG016|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
49032220|NCT01597245|157953487|FG017|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
49032221|NCT01597245|157953488|FG018|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
49032222|NCT01597245|157953489|FG019|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
49032223|NCT01597245|157953490|FG020|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
49032224|NCT01597245|157953470|FG000|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
49032225|NCT01597245|157953471|FG001|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
49032226|NCT01597245|157953472|FG002|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
49032227|NCT01597245|157953473|FG003|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
49032228|NCT01597245|157953474|FG004|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
49032229|NCT01597245|157953475|FG005|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
49032230|NCT01597245|157953476|FG006|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
49032231|NCT01597245|157953477|FG007|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
48790141|NCT02952924|157069850|FG002|Overall Study|Protocol Violation|0|||
48790142|NCT02952924|157069851|FG003|Overall Study|Protocol Violation|0|||
49032232|NCT01597245|157953478|FG008|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
48790143|NCT02952924|157069852|FG004|Overall Study|Protocol Violation|0|||
48790144|NCT02952924|157069853|FG005|Overall Study|Protocol Violation|0|||
48790145|NCT02952924|157069854|FG006|Overall Study|Protocol Violation|0|||
48790146|NCT02952924|157069855|FG007|Overall Study|Protocol Violation|0|||
49032233|NCT01597245|157953479|FG009|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
48790147|NCT02952924|157069856|FG008|Overall Study|Protocol Violation|0|||
48790148|NCT02952924|157069857|FG009|Overall Study|Protocol Violation|0|||
48790149|NCT02952924|157069858|FG010|Overall Study|Protocol Violation|0|||
48790150|NCT02952924|157069859|FG011|Overall Study|Protocol Violation|0|||
48790151|NCT02952924|157069860|FG012|Overall Study|Protocol Violation|0|||
48790152|NCT02952924|157069861|FG013|Overall Study|Protocol Violation|0|||
48790153|NCT02952924|157069862|FG014|Overall Study|Protocol Violation|0|||
48790154|NCT02952924|157069863|FG015|Overall Study|Protocol Violation|0|||
48790155|NCT02952924|157069864|FG016|Overall Study|Protocol Violation|0|||
48790156|NCT02952924|157069865|FG017|Overall Study|Protocol Violation|0|||
48790157|NCT02952924|157069866|FG018|Overall Study|Protocol Violation|0|||
48790158|NCT02952924|157069867|FG019|Overall Study|Protocol Violation|1|||
48790159|NCT02952924|157069868|FG020|Overall Study|Protocol Violation|0|||
48790160|NCT02952924|157069869|FG021|Overall Study|Protocol Violation|0|||
48790161|NCT02952924|157069848|FG000|Overall Study|Participant refused to adhere to study protocol|0|||
48790162|NCT02952924|157069849|FG001|Overall Study|Participant refused to adhere to study protocol|0|||
48790163|NCT02952924|157069850|FG002|Overall Study|Participant refused to adhere to study protocol|0|||
48790164|NCT02952924|157069851|FG003|Overall Study|Participant refused to adhere to study protocol|0|||
48790165|NCT02952924|157069852|FG004|Overall Study|Participant refused to adhere to study protocol|0|||
48790166|NCT02952924|157069853|FG005|Overall Study|Participant refused to adhere to study protocol|0|||
48790167|NCT02952924|157069854|FG006|Overall Study|Participant refused to adhere to study protocol|0|||
48790168|NCT02952924|157069855|FG007|Overall Study|Participant refused to adhere to study protocol|0|||
48790169|NCT02952924|157069856|FG008|Overall Study|Participant refused to adhere to study protocol|0|||
48790170|NCT02952924|157069857|FG009|Overall Study|Participant refused to adhere to study protocol|0|||
48790171|NCT02952924|157069858|FG010|Overall Study|Participant refused to adhere to study protocol|0|||
48790172|NCT02952924|157069859|FG011|Overall Study|Participant refused to adhere to study protocol|0|||
48790173|NCT02952924|157069860|FG012|Overall Study|Participant refused to adhere to study protocol|0|||
48790174|NCT02952924|157069861|FG013|Overall Study|Participant refused to adhere to study protocol|0|||
48790175|NCT02952924|157069862|FG014|Overall Study|Participant refused to adhere to study protocol|0|||
48790176|NCT02952924|157069863|FG015|Overall Study|Participant refused to adhere to study protocol|0|||
48790177|NCT02952924|157069864|FG016|Overall Study|Participant refused to adhere to study protocol|0|||
48790178|NCT02952924|157069865|FG017|Overall Study|Participant refused to adhere to study protocol|1|||
48983328|NCT02477800|157772263|FG001|Placebo-Controlled Period|Consent Withdrawn|16|||
48983329|NCT02477800|157772264|FG002|Placebo-Controlled Period|Consent Withdrawn|27|||
48983330|NCT02477800|157772265|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
48983331|NCT02477800|157772266|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
48983332|NCT02477800|157772267|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
48983333|NCT02477800|157772268|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
48983334|NCT02477800|157772262|FG000|Placebo-Controlled Period|Death|0|||
48983335|NCT02477800|157772263|FG001|Placebo-Controlled Period|Death|3|||
48983336|NCT02477800|157772264|FG002|Placebo-Controlled Period|Death|2|||
48983337|NCT02477800|157772265|FG003|Placebo-Controlled Period|Death|0|||
48877890|NCT02906020|157392102|FG012|Part 2: Double-blind Treatment Period|Other|0|||
48790179|NCT02952924|157069866|FG018|Overall Study|Participant refused to adhere to study protocol|0|||
48790180|NCT02952924|157069867|FG019|Overall Study|Participant refused to adhere to study protocol|0|||
48790181|NCT02952924|157069868|FG020|Overall Study|Participant refused to adhere to study protocol|0|||
48790182|NCT02952924|157069869|FG021|Overall Study|Participant refused to adhere to study protocol|0|||
48790183|NCT02952924|157069848|FG000|Overall Study|Participant unable to adhere to study visit schedule|0|||
48790184|NCT02952924|157069849|FG001|Overall Study|Participant unable to adhere to study visit schedule|0|||
48790185|NCT02952924|157069850|FG002|Overall Study|Participant unable to adhere to study visit schedule|0|||
48790186|NCT02952924|157069851|FG003|Overall Study|Participant unable to adhere to study visit schedule|0|||
48790187|NCT02952924|157069852|FG004|Overall Study|Participant unable to adhere to study visit schedule|0|||
48790188|NCT02952924|157069853|FG005|Overall Study|Participant unable to adhere to study visit schedule|0|||
48790189|NCT02952924|157069854|FG006|Overall Study|Participant unable to adhere to study visit schedule|0|||
48790190|NCT02952924|157069855|FG007|Overall Study|Participant unable to adhere to study visit schedule|0|||
48790191|NCT02952924|157069856|FG008|Overall Study|Participant unable to adhere to study visit schedule|0|||
48790192|NCT02952924|157069857|FG009|Overall Study|Participant unable to adhere to study visit schedule|0|||
48877891|NCT02906020|157392103|FG013|Part 2: Double-blind Treatment Period|Other|0|||
48877892|NCT02906020|157392104|FG014|Part 2: Double-blind Treatment Period|Other|0|||
48877893|NCT02906020|157392105|FG015|Part 2: Double-blind Treatment Period|Other|0|||
48877894|NCT02906020|157392090|FG000|Part 2: Long-term Follow-up Period|Adverse Event|0|||
48877895|NCT02906020|157392091|FG001|Part 2: Long-term Follow-up Period|Adverse Event|0|||
48877896|NCT02906020|157392092|FG002|Part 2: Long-term Follow-up Period|Adverse Event|0|||
48877897|NCT02906020|157392093|FG003|Part 2: Long-term Follow-up Period|Adverse Event|0|||
48877898|NCT02906020|157392094|FG004|Part 2: Long-term Follow-up Period|Adverse Event|0|||
48877899|NCT02906020|157392095|FG005|Part 2: Long-term Follow-up Period|Adverse Event|0|||
48877900|NCT02906020|157392096|FG006|Part 2: Long-term Follow-up Period|Adverse Event|0|||
48877901|NCT02906020|157392097|FG007|Part 2: Long-term Follow-up Period|Adverse Event|0|||
48877902|NCT02906020|157392098|FG008|Part 2: Long-term Follow-up Period|Adverse Event|0|||
48877903|NCT02906020|157392099|FG009|Part 2: Long-term Follow-up Period|Adverse Event|0|||
48877904|NCT02906020|157392100|FG010|Part 2: Long-term Follow-up Period|Adverse Event|0|||
48877905|NCT02906020|157392101|FG011|Part 2: Long-term Follow-up Period|Adverse Event|0|||
48877906|NCT02906020|157392102|FG012|Part 2: Long-term Follow-up Period|Adverse Event|10|||
48877907|NCT02906020|157392103|FG013|Part 2: Long-term Follow-up Period|Adverse Event|4|||
48877908|NCT02906020|157392104|FG014|Part 2: Long-term Follow-up Period|Adverse Event|0|||
48877909|NCT02906020|157392105|FG015|Part 2: Long-term Follow-up Period|Adverse Event|0|||
48877910|NCT02906020|157392090|FG000|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
48877911|NCT02906020|157392091|FG001|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
48877912|NCT02906020|157392092|FG002|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
48877913|NCT02906020|157392093|FG003|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
48877914|NCT02906020|157392094|FG004|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
48877915|NCT02906020|157392095|FG005|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
48877916|NCT02906020|157392096|FG006|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
48877917|NCT02906020|157392097|FG007|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
48877918|NCT02906020|157392098|FG008|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
48877919|NCT02906020|157392099|FG009|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
48877920|NCT02906020|157392100|FG010|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
48877921|NCT02906020|157392101|FG011|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
48877922|NCT02906020|157392102|FG012|Part 2: Long-term Follow-up Period|Progressive Disease|7|||
48877923|NCT02906020|157392103|FG013|Part 2: Long-term Follow-up Period|Progressive Disease|4|||
48877924|NCT02906020|157392104|FG014|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
48877925|NCT02906020|157392105|FG015|Part 2: Long-term Follow-up Period|Progressive Disease|1|||
48877926|NCT02906020|157392090|FG000|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
48877927|NCT02906020|157392091|FG001|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
49032234|NCT01597245|157953480|FG010|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
48790193|NCT02952924|157069858|FG010|Overall Study|Participant unable to adhere to study visit schedule|0|||
48790194|NCT02952924|157069859|FG011|Overall Study|Participant unable to adhere to study visit schedule|0|||
48877928|NCT02906020|157392092|FG002|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
48877929|NCT02906020|157392093|FG003|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
48877930|NCT02906020|157392094|FG004|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
48877931|NCT02906020|157392095|FG005|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
48877932|NCT02906020|157392096|FG006|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
48877933|NCT02906020|157392097|FG007|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
48877934|NCT02906020|157392098|FG008|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
48877935|NCT02906020|157392099|FG009|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
49032235|NCT01597245|157953481|FG011|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
49032236|NCT01597245|157953482|FG012|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
48877936|NCT02906020|157392100|FG010|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
48877937|NCT02906020|157392101|FG011|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
48877938|NCT02906020|157392102|FG012|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
48877939|NCT02906020|157392103|FG013|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
48877940|NCT02906020|157392104|FG014|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
48877941|NCT02906020|157392105|FG015|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
48877942|NCT02906020|157392090|FG000|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
48877943|NCT02906020|157392091|FG001|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
48877944|NCT02906020|157392092|FG002|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
48877945|NCT02906020|157392093|FG003|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
48877946|NCT02906020|157392094|FG004|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
48877947|NCT02906020|157392095|FG005|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
48877948|NCT02906020|157392096|FG006|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
48877949|NCT02906020|157392097|FG007|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
48877950|NCT02906020|157392098|FG008|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
48877951|NCT02906020|157392099|FG009|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
48877952|NCT02906020|157392100|FG010|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
49032237|NCT01597245|157953483|FG013|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
49032238|NCT01597245|157953484|FG014|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
49032239|NCT01597245|157953485|FG015|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
49032240|NCT01597245|157953486|FG016|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
49032241|NCT01597245|157953487|FG017|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
49032242|NCT01597245|157953488|FG018|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
49032243|NCT01597245|157953489|FG019|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
49032244|NCT01597245|157953490|FG020|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
49032245|NCT01597245|157953470|FG000|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
49032246|NCT01597245|157953471|FG001|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
49032247|NCT01597245|157953472|FG002|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
49032248|NCT01597245|157953473|FG003|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
49032249|NCT01597245|157953474|FG004|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
49032250|NCT01597245|157953475|FG005|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
48790195|NCT02952924|157069860|FG012|Overall Study|Participant unable to adhere to study visit schedule|0|||
48790196|NCT02952924|157069861|FG013|Overall Study|Participant unable to adhere to study visit schedule|0|||
48790197|NCT02952924|157069862|FG014|Overall Study|Participant unable to adhere to study visit schedule|0|||
48790198|NCT02952924|157069863|FG015|Overall Study|Participant unable to adhere to study visit schedule|0|||
48790199|NCT02952924|157069864|FG016|Overall Study|Participant unable to adhere to study visit schedule|0|||
48790200|NCT02952924|157069865|FG017|Overall Study|Participant unable to adhere to study visit schedule|0|||
48790201|NCT02952924|157069866|FG018|Overall Study|Participant unable to adhere to study visit schedule|0|||
48790202|NCT02952924|157069867|FG019|Overall Study|Participant unable to adhere to study visit schedule|0|||
48790203|NCT02952924|157069868|FG020|Overall Study|Participant unable to adhere to study visit schedule|0|||
48790204|NCT02952924|157069869|FG021|Overall Study|Participant unable to adhere to study visit schedule|1|||
48790205|NCT02952924|157069848|FG000|Overall Study|Noncompliance with study drug|0|||
48790206|NCT02952924|157069849|FG001|Overall Study|Noncompliance with study drug|0|||
48790207|NCT02952924|157069850|FG002|Overall Study|Noncompliance with study drug|0|||
48790208|NCT02952924|157069851|FG003|Overall Study|Noncompliance with study drug|0|||
48790209|NCT02952924|157069852|FG004|Overall Study|Noncompliance with study drug|0|||
48790210|NCT02952924|157069853|FG005|Overall Study|Noncompliance with study drug|0|||
48790211|NCT02952924|157069854|FG006|Overall Study|Noncompliance with study drug|0|||
48790212|NCT02952924|157069855|FG007|Overall Study|Noncompliance with study drug|0|||
48790213|NCT02952924|157069856|FG008|Overall Study|Noncompliance with study drug|0|||
48790214|NCT02952924|157069857|FG009|Overall Study|Noncompliance with study drug|0|||
48790215|NCT02952924|157069858|FG010|Overall Study|Noncompliance with study drug|0|||
48790216|NCT02952924|157069859|FG011|Overall Study|Noncompliance with study drug|0|||
48790217|NCT02952924|157069860|FG012|Overall Study|Noncompliance with study drug|0|||
48790218|NCT02952924|157069861|FG013|Overall Study|Noncompliance with study drug|0|||
48790219|NCT02952924|157069862|FG014|Overall Study|Noncompliance with study drug|0|||
48790220|NCT02952924|157069863|FG015|Overall Study|Noncompliance with study drug|0|||
48790221|NCT02952924|157069864|FG016|Overall Study|Noncompliance with study drug|0|||
48790222|NCT02952924|157069865|FG017|Overall Study|Noncompliance with study drug|0|||
48790223|NCT02952924|157069866|FG018|Overall Study|Noncompliance with study drug|0|||
48877953|NCT02906020|157392101|FG011|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
48790224|NCT02952924|157069867|FG019|Overall Study|Noncompliance with study drug|0|||
48790225|NCT02952924|157069868|FG020|Overall Study|Noncompliance with study drug|0|||
48790226|NCT02952924|157069869|FG021|Overall Study|Noncompliance with study drug|1|||
48790227|NCT01581281|157069871|FG000|Overall Study|Early Study Closure|15|||
48790228|NCT01581281|157069872|FG001|Overall Study|Early Study Closure|6|||
48790229|NCT01581281|157069873|FG002|Overall Study|Early Study Closure|12|||
48790230|NCT02081846|157069875|FG000|Overall Study|Withdrawal by Subject|1|||
48790231|NCT02081846|157069876|FG001|Overall Study|Withdrawal by Subject|0|||
48790232|NCT02081846|157069875|FG000|Overall Study|invalid consent|1|||
48790233|NCT02081846|157069876|FG001|Overall Study|invalid consent|0|||
48790234|NCT01939028|157069877|FG000|Overall Study|Withdrawal by Subject|5|||
48790235|NCT01939028|157069877|FG000|Overall Study|Physician Decision|7|||
48790236|NCT03282227|157069878|FG000|Overall Study|Exposure Goals Achieved|60|||
48790237|NCT03282227|157069878|FG000|Overall Study|Non-compliance w/ protocol requirements|79|||
48790238|NCT03282227|157069878|FG000|Overall Study|Adverse Event|15|||
48790239|NCT03282227|157069878|FG000|Overall Study|Lost to Follow-up|21|||
48790240|NCT03282227|157069878|FG000|Overall Study|Withdrawal by Subject|20|||
48790241|NCT03282227|157069878|FG000|Overall Study|Lack of Efficacy|12|||
48790242|NCT03282227|157069878|FG000|Overall Study|Sponsor decision|3|||
48790243|NCT03282227|157069878|FG000|Overall Study|Physician Decision|2|||
48790244|NCT03282227|157069878|FG000|Overall Study|Pregnancy|2|||
48790245|NCT03282227|157069878|FG000|Overall Study|Other|1|||
48790246|NCT02232893|157069879|FG000|Overall Study|Withdrawal by Subject|4|||
48790247|NCT02232893|157069880|FG001|Overall Study|Withdrawal by Subject|1|||
48790248|NCT02232893|157069879|FG000|Overall Study|Adverse Event|0|||
48790249|NCT02232893|157069880|FG001|Overall Study|Adverse Event|1|||
48790250|NCT02232893|157069879|FG000|Overall Study|Sponsor request early termination|0|||
48790251|NCT02232893|157069880|FG001|Overall Study|Sponsor request early termination|1|||
48790252|NCT02232893|157069879|FG000|Overall Study|Developed exclusion criteria|0|||
48790253|NCT02232893|157069880|FG001|Overall Study|Developed exclusion criteria|1|||
48790254|NCT02232893|157069879|FG000|Overall Study|Other|0|||
48790255|NCT02232893|157069880|FG001|Overall Study|Other|3|||
48790256|NCT03273946|157069881|FG000|Overall Study|Withdrawal by Subject|5|||
48790257|NCT03273946|157069881|FG000|Overall Study|Unwillingness of the guardian|1|||
48790258|NCT03273946|157069881|FG000|Overall Study|Participant refused to use the drug|2|||
48790259|NCT03273946|157069881|FG000|Overall Study|Participant relative refused to use drug|1|||
48790260|NCT02293538|157069883|FG000|Overall Study|Adverse Event|0|||
48790261|NCT02293538|157069884|FG001|Overall Study|Adverse Event|1|||
48790262|NCT02293538|157069883|FG000|Overall Study|Lost to Follow-up|1|||
48790263|NCT02293538|157069884|FG001|Overall Study|Lost to Follow-up|0|||
48790264|NCT02293538|157069883|FG000|Overall Study|Withdrawal by Subject|0|||
48790265|NCT02293538|157069884|FG001|Overall Study|Withdrawal by Subject|1|||
48790266|NCT03342638|157069885|FG000|Overall Study|Withdrawal by Subject|1|||
48790267|NCT03342638|157069886|FG001|Overall Study|Withdrawal by Subject|0|||
48790268|NCT03342638|157069885|FG000|Overall Study|Physician Decision|0|||
48790269|NCT03342638|157069886|FG001|Overall Study|Physician Decision|1|||
48790270|NCT04498390|157069889|FG000|Overall Study|Adverse Event|0|||
48790271|NCT04498390|157069890|FG001|Overall Study|Adverse Event|0|||
48790272|NCT04498390|157069891|FG002|Overall Study|Adverse Event|1|||
48790273|NCT04498390|157069892|FG003|Overall Study|Adverse Event|0|||
48790274|NCT04498390|157069893|FG004|Overall Study|Adverse Event|0|||
48790275|NCT04498390|157069889|FG000|Overall Study|Withdrawal by Subject|0|||
48790276|NCT04498390|157069890|FG001|Overall Study|Withdrawal by Subject|0|||
48790277|NCT04498390|157069891|FG002|Overall Study|Withdrawal by Subject|0|||
48790278|NCT04498390|157069892|FG003|Overall Study|Withdrawal by Subject|1|||
48790279|NCT04498390|157069893|FG004|Overall Study|Withdrawal by Subject|0|||
48790280|NCT04177758|157069899|FG000|Overall Study|Lost to Follow-up|19|||
48790281|NCT04177758|157069900|FG001|Overall Study|Lost to Follow-up|11|||
48790282|NCT01475136|157069904|FG000|Overall Study|Sponsor Decision|0|||
48790283|NCT01475136|157069905|FG001|Overall Study|Sponsor Decision|1|||
48790284|NCT01475136|157069906|FG002|Overall Study|Sponsor Decision|0|||
48790285|NCT01475136|157069907|FG003|Overall Study|Sponsor Decision|0|||
48790286|NCT01475136|157069904|FG000|Overall Study|Entry Criteria Not Met|0|||
48790287|NCT01475136|157069905|FG001|Overall Study|Entry Criteria Not Met|2|||
48790288|NCT01475136|157069906|FG002|Overall Study|Entry Criteria Not Met|3|||
48790289|NCT01475136|157069907|FG003|Overall Study|Entry Criteria Not Met|1|||
48790290|NCT01475136|157069904|FG000|Overall Study|Withdrawal by Subject|0|||
48790291|NCT01475136|157069905|FG001|Overall Study|Withdrawal by Subject|0|||
48790292|NCT01475136|157069906|FG002|Overall Study|Withdrawal by Subject|0|||
48790293|NCT01475136|157069907|FG003|Overall Study|Withdrawal by Subject|2|||
48790294|NCT01475136|157069904|FG000|Overall Study|Adverse Event|1|||
48790295|NCT01475136|157069905|FG001|Overall Study|Adverse Event|0|||
48790296|NCT01475136|157069906|FG002|Overall Study|Adverse Event|0|||
48790297|NCT01475136|157069907|FG003|Overall Study|Adverse Event|1|||
48790298|NCT01475136|157069904|FG000|Overall Study|Death|0|||
48790299|NCT01475136|157069905|FG001|Overall Study|Death|0|||
48790300|NCT01475136|157069906|FG002|Overall Study|Death|0|||
48790301|NCT01475136|157069907|FG003|Overall Study|Death|1|||
48790302|NCT00791765|157071371|FG000|Weeks 1 to 12|Adverse Event|0|||
48790303|NCT00791765|157071372|FG001|Weeks 1 to 12|Adverse Event|1|||
48790304|NCT00791765|157071371|FG000|Weeks 1 to 12|Lost to Follow-up|1|||
48790305|NCT00791765|157071372|FG001|Weeks 1 to 12|Lost to Follow-up|0|||
48790306|NCT00791765|157071371|FG000|Weeks 1 to 12|Withdrawal by Subject|3|||
48790307|NCT00791765|157071372|FG001|Weeks 1 to 12|Withdrawal by Subject|0|||
48790308|NCT00791765|157071371|FG000|Weeks 1 to 12|Physician Decision|1|||
48790309|NCT00791765|157071372|FG001|Weeks 1 to 12|Physician Decision|0|||
48790310|NCT00791765|157071371|FG000|Weeks 1 to 12|Disease progression|3|||
48790311|NCT00791765|157071372|FG001|Weeks 1 to 12|Disease progression|0|||
48790312|NCT00791765|157071371|FG000|Weeks 1 to 12|Ineligibility determined|0|||
48790313|NCT00791765|157071372|FG001|Weeks 1 to 12|Ineligibility determined|3|||
48790314|NCT00791765|157071371|FG000|Weeks 13 to 24|Protocol deviation|2|||
48790315|NCT00791765|157071372|FG001|Weeks 13 to 24|Protocol deviation|0|||
48790316|NCT00791765|157071371|FG000|Weeks 13 to 24|Adverse Event|0|||
48790317|NCT00791765|157071372|FG001|Weeks 13 to 24|Adverse Event|3|||
48790318|NCT00791765|157071371|FG000|Weeks 13 to 24|Withdrawal by Subject|2|||
48790319|NCT00791765|157071372|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
48790320|NCT00791765|157071371|FG000|Weeks 13 to 24|Disease progression|0|||
48983338|NCT02477800|157772266|FG004|Placebo-Controlled Period|Death|0|||
48983339|NCT02477800|157772267|FG005|Placebo-Controlled Period|Death|0|||
48983340|NCT02477800|157772268|FG006|Placebo-Controlled Period|Death|0|||
48983341|NCT02477800|157772262|FG000|Placebo-Controlled Period|Disease Progression|1|||
48983342|NCT02477800|157772263|FG001|Placebo-Controlled Period|Disease Progression|0|||
48983343|NCT02477800|157772264|FG002|Placebo-Controlled Period|Disease Progression|1|||
48983344|NCT02477800|157772265|FG003|Placebo-Controlled Period|Disease Progression|0|||
48983345|NCT02477800|157772266|FG004|Placebo-Controlled Period|Disease Progression|0|||
48983346|NCT02477800|157772267|FG005|Placebo-Controlled Period|Disease Progression|0|||
48983347|NCT02477800|157772268|FG006|Placebo-Controlled Period|Disease Progression|0|||
48983348|NCT02477800|157772262|FG000|Placebo-Controlled Period|Investigator Decision|3|||
48983349|NCT02477800|157772263|FG001|Placebo-Controlled Period|Investigator Decision|2|||
48983350|NCT02477800|157772264|FG002|Placebo-Controlled Period|Investigator Decision|1|||
48983351|NCT02477800|157772265|FG003|Placebo-Controlled Period|Investigator Decision|0|||
48983352|NCT02477800|157772266|FG004|Placebo-Controlled Period|Investigator Decision|0|||
48983353|NCT02477800|157772267|FG005|Placebo-Controlled Period|Investigator Decision|0|||
48983354|NCT02477800|157772268|FG006|Placebo-Controlled Period|Investigator Decision|0|||
48983355|NCT02477800|157772262|FG000|Placebo-Controlled Period|Lost to Follow-up|1|||
48983356|NCT02477800|157772263|FG001|Placebo-Controlled Period|Lost to Follow-up|3|||
48983357|NCT02477800|157772264|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
48983358|NCT02477800|157772265|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
48983359|NCT02477800|157772266|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
48983360|NCT02477800|157772267|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
48983361|NCT02477800|157772268|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
48983362|NCT02477800|157772262|FG000|Placebo-Controlled Period|Relocation|2|||
48983363|NCT02477800|157772263|FG001|Placebo-Controlled Period|Relocation|0|||
48983364|NCT02477800|157772264|FG002|Placebo-Controlled Period|Relocation|0|||
48983365|NCT02477800|157772265|FG003|Placebo-Controlled Period|Relocation|0|||
48983366|NCT02477800|157772266|FG004|Placebo-Controlled Period|Relocation|0|||
48983367|NCT02477800|157772267|FG005|Placebo-Controlled Period|Relocation|0|||
48983368|NCT02477800|157772268|FG006|Placebo-Controlled Period|Relocation|0|||
48983369|NCT02477800|157772262|FG000|Placebo-Controlled Period|Site Terminated by Investigator|1|||
48983370|NCT02477800|157772263|FG001|Placebo-Controlled Period|Site Terminated by Investigator|1|||
48983371|NCT02477800|157772264|FG002|Placebo-Controlled Period|Site Terminated by Investigator|1|||
48983372|NCT02477800|157772265|FG003|Placebo-Controlled Period|Site Terminated by Investigator|0|||
48983373|NCT02477800|157772266|FG004|Placebo-Controlled Period|Site Terminated by Investigator|0|||
48983374|NCT02477800|157772267|FG005|Placebo-Controlled Period|Site Terminated by Investigator|0|||
48983375|NCT02477800|157772268|FG006|Placebo-Controlled Period|Site Terminated by Investigator|0|||
48983376|NCT02477800|157772262|FG000|Placebo-Controlled Period|Site Terminated by Sponsor|2|||
48983377|NCT02477800|157772263|FG001|Placebo-Controlled Period|Site Terminated by Sponsor|1|||
48983378|NCT02477800|157772264|FG002|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
48983379|NCT02477800|157772265|FG003|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
48983380|NCT02477800|157772266|FG004|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
48983381|NCT02477800|157772267|FG005|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
48983382|NCT02477800|157772268|FG006|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
48983383|NCT02477800|157772262|FG000|Placebo-Controlled Period|Study Visit Burden|5|||
48983384|NCT02477800|157772263|FG001|Placebo-Controlled Period|Study Visit Burden|3|||
48790321|NCT00791765|157071372|FG001|Weeks 13 to 24|Disease progression|1|||
48790322|NCT00791765|157071371|FG000|Weeks 13 to 24|Lost to Follow-up|1|||
48790323|NCT00791765|157071372|FG001|Weeks 13 to 24|Lost to Follow-up|2|||
48790324|NCT00791765|157071371|FG000|Weeks 13 to 24|Other|0|||
48790325|NCT00791765|157071372|FG001|Weeks 13 to 24|Other|1|||
48983385|NCT02477800|157772264|FG002|Placebo-Controlled Period|Study Visit Burden|11|||
48983386|NCT02477800|157772265|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
48983387|NCT02477800|157772266|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
48983388|NCT02477800|157772267|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
48790326|NCT01682460|157071373|FG000|Overall Study|Withdrawal by Subject|2|||
48790327|NCT01682460|157071373|FG000|Overall Study|Did not meet inclusion criteria|2|||
48790328|NCT00920426|157071374|FG000|ITZ111451|Adverse Event|1|||
48790329|NCT00920426|157071375|FG001|ITZ111451|Adverse Event|0|||
48790330|NCT00920426|157071376|FG002|ITZ111451|Adverse Event|0|||
48790331|NCT00920426|157071377|FG003|ITZ111451|Adverse Event|0|||
48790332|NCT01292603|157071378|FG000|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
48790333|NCT01292603|157071379|FG001|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
48790334|NCT01292603|157071380|FG002|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
48790335|NCT01292603|157071381|FG003|Part 1: Pilot Dose Selection Period|Adverse Event|4|||
48790336|NCT01292603|157071382|FG004|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
48790337|NCT01292603|157071383|FG005|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
48790338|NCT01292603|157071378|FG000|Part 1: Pilot Dose Selection Period|Death|0|||
48790339|NCT01292603|157071379|FG001|Part 1: Pilot Dose Selection Period|Death|0|||
48790340|NCT01292603|157071380|FG002|Part 1: Pilot Dose Selection Period|Death|0|||
48790341|NCT01292603|157071381|FG003|Part 1: Pilot Dose Selection Period|Death|1|||
48790342|NCT01292603|157071382|FG004|Part 1: Pilot Dose Selection Period|Death|0|||
48790343|NCT01292603|157071383|FG005|Part 1: Pilot Dose Selection Period|Death|0|||
48790344|NCT01292603|157071378|FG000|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
48790345|NCT01292603|157071379|FG001|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
48790346|NCT01292603|157071380|FG002|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
48790347|NCT01292603|157071381|FG003|Part 1: Pilot Dose Selection Period|Protocol Violation|2|||
48790348|NCT01292603|157071382|FG004|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
48790349|NCT01292603|157071383|FG005|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
48790350|NCT01292603|157071378|FG000|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
48790351|NCT01292603|157071379|FG001|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
48790352|NCT01292603|157071380|FG002|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
48790353|NCT01292603|157071381|FG003|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1|||
48790354|NCT01292603|157071382|FG004|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
48790355|NCT01292603|157071383|FG005|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
48790356|NCT01292603|157071378|FG000|Part 1: Regular Follow-Up Period|Death|3|||
48790357|NCT01292603|157071379|FG001|Part 1: Regular Follow-Up Period|Death|1|||
48790358|NCT01292603|157071380|FG002|Part 1: Regular Follow-Up Period|Death|3|||
48790359|NCT01292603|157071381|FG003|Part 1: Regular Follow-Up Period|Death|1|||
48790360|NCT01292603|157071382|FG004|Part 1: Regular Follow-Up Period|Death|0|||
48790361|NCT01292603|157071383|FG005|Part 1: Regular Follow-Up Period|Death|0|||
48790362|NCT01292603|157071378|FG000|Part 1: Regular Follow-Up Period|Disease Progression|3|||
48790363|NCT01292603|157071379|FG001|Part 1: Regular Follow-Up Period|Disease Progression|6|||
48790364|NCT01292603|157071380|FG002|Part 1: Regular Follow-Up Period|Disease Progression|3|||
48790365|NCT01292603|157071381|FG003|Part 1: Regular Follow-Up Period|Disease Progression|0|||
48790366|NCT01292603|157071382|FG004|Part 1: Regular Follow-Up Period|Disease Progression|0|||
48790367|NCT01292603|157071383|FG005|Part 1: Regular Follow-Up Period|Disease Progression|0|||
48790368|NCT01292603|157071378|FG000|Part 2: Dose Confirmation Period|Death|0|||
48790369|NCT01292603|157071379|FG001|Part 2: Dose Confirmation Period|Death|0|||
48790370|NCT01292603|157071380|FG002|Part 2: Dose Confirmation Period|Death|0|||
48790371|NCT01292603|157071381|FG003|Part 2: Dose Confirmation Period|Death|0|||
48790372|NCT01292603|157071382|FG004|Part 2: Dose Confirmation Period|Death|1|||
48790373|NCT01292603|157071383|FG005|Part 2: Dose Confirmation Period|Death|0|||
48790374|NCT01292603|157071378|FG000|Part 2: Dose Confirmation Period|Physician Decision|0|||
48790375|NCT01292603|157071379|FG001|Part 2: Dose Confirmation Period|Physician Decision|0|||
48790376|NCT01292603|157071380|FG002|Part 2: Dose Confirmation Period|Physician Decision|0|||
48790377|NCT01292603|157071381|FG003|Part 2: Dose Confirmation Period|Physician Decision|0|||
48790378|NCT01292603|157071382|FG004|Part 2: Dose Confirmation Period|Physician Decision|2|||
48790379|NCT01292603|157071383|FG005|Part 2: Dose Confirmation Period|Physician Decision|0|||
48790380|NCT01292603|157071378|FG000|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
48790381|NCT01292603|157071379|FG001|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
48790382|NCT01292603|157071380|FG002|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
48790383|NCT01292603|157071381|FG003|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
48790384|NCT01292603|157071382|FG004|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
48983389|NCT02477800|157772268|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
48983390|NCT02477800|157772262|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
48983391|NCT02477800|157772263|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5|||
48983392|NCT02477800|157772264|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3|||
48983393|NCT02477800|157772265|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
48790385|NCT01292603|157071383|FG005|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
48790386|NCT01292603|157071378|FG000|Part 2: Dose Confirmation Period|Adverse Event|0|||
48790387|NCT01292603|157071379|FG001|Part 2: Dose Confirmation Period|Adverse Event|0|||
48790388|NCT01292603|157071380|FG002|Part 2: Dose Confirmation Period|Adverse Event|0|||
48983394|NCT02477800|157772266|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
48790389|NCT01292603|157071381|FG003|Part 2: Dose Confirmation Period|Adverse Event|0|||
48790390|NCT01292603|157071382|FG004|Part 2: Dose Confirmation Period|Adverse Event|7|||
48790391|NCT01292603|157071383|FG005|Part 2: Dose Confirmation Period|Adverse Event|9|||
48790392|NCT01292603|157071378|FG000|Part 2: Dose Confirmation Period|Protocol Violation|0|||
48877954|NCT02906020|157392102|FG012|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|1|||
48877955|NCT02906020|157392103|FG013|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|4|||
48877956|NCT02906020|157392104|FG014|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
48790393|NCT01292603|157071379|FG001|Part 2: Dose Confirmation Period|Protocol Violation|0|||
48790394|NCT01292603|157071380|FG002|Part 2: Dose Confirmation Period|Protocol Violation|0|||
48790395|NCT01292603|157071381|FG003|Part 2: Dose Confirmation Period|Protocol Violation|0|||
48790396|NCT01292603|157071382|FG004|Part 2: Dose Confirmation Period|Protocol Violation|5|||
48790397|NCT01292603|157071383|FG005|Part 2: Dose Confirmation Period|Protocol Violation|3|||
48790398|NCT01292603|157071378|FG000|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
48790399|NCT01292603|157071379|FG001|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
48790400|NCT01292603|157071380|FG002|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
48790401|NCT01292603|157071381|FG003|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
48790402|NCT01292603|157071382|FG004|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
48790403|NCT01292603|157071383|FG005|Part 2: Dose Confirmation Period|Withdrawal by Subject|2|||
48790404|NCT01292603|157071378|FG000|Part 2: Regular Follow-Up|Death|0|||
48790405|NCT01292603|157071379|FG001|Part 2: Regular Follow-Up|Death|0|||
48790406|NCT01292603|157071380|FG002|Part 2: Regular Follow-Up|Death|0|||
48790407|NCT01292603|157071381|FG003|Part 2: Regular Follow-Up|Death|0|||
48790408|NCT01292603|157071382|FG004|Part 2: Regular Follow-Up|Death|6|||
48790409|NCT01292603|157071383|FG005|Part 2: Regular Follow-Up|Death|3|||
48877957|NCT02906020|157392105|FG015|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
48790410|NCT01292603|157071378|FG000|Part 2: Regular Follow-Up|Disease Progression|0|||
48790411|NCT01292603|157071379|FG001|Part 2: Regular Follow-Up|Disease Progression|0|||
48790412|NCT01292603|157071380|FG002|Part 2: Regular Follow-Up|Disease Progression|0|||
48790413|NCT01292603|157071381|FG003|Part 2: Regular Follow-Up|Disease Progression|0|||
48790414|NCT01292603|157071382|FG004|Part 2: Regular Follow-Up|Disease Progression|5|||
48790415|NCT01292603|157071383|FG005|Part 2: Regular Follow-Up|Disease Progression|5|||
48790416|NCT01292603|157071378|FG000|Part 2: Regular Follow-Up|Noncompliance|0|||
48790417|NCT01292603|157071379|FG001|Part 2: Regular Follow-Up|Noncompliance|0|||
48790418|NCT01292603|157071380|FG002|Part 2: Regular Follow-Up|Noncompliance|0|||
48790419|NCT01292603|157071381|FG003|Part 2: Regular Follow-Up|Noncompliance|0|||
48790420|NCT01292603|157071382|FG004|Part 2: Regular Follow-Up|Noncompliance|1|||
48790421|NCT01292603|157071383|FG005|Part 2: Regular Follow-Up|Noncompliance|0|||
48790422|NCT01292603|157071378|FG000|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
48790423|NCT01292603|157071379|FG001|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
48790424|NCT01292603|157071380|FG002|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
48790425|NCT01292603|157071381|FG003|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
48790426|NCT01292603|157071382|FG004|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
48790427|NCT01292603|157071383|FG005|Part 2: Regular Follow-Up|Withdrawal by Subject|1|||
48790428|NCT01292603|157071378|FG000|Part 2: Regular Follow-Up|Protocol Violation|0|||
48877958|NCT02906020|157392090|FG000|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
48983395|NCT02477800|157772267|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
48983396|NCT02477800|157772268|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
48983397|NCT02477800|157772262|FG000|Placebo-Controlled Period|Reason not Specified|161|||
48983398|NCT02477800|157772263|FG001|Placebo-Controlled Period|Reason not Specified|161|||
48983399|NCT02477800|157772264|FG002|Placebo-Controlled Period|Reason not Specified|189|||
48983400|NCT02477800|157772265|FG003|Placebo-Controlled Period|Reason not Specified|0|||
48983401|NCT02477800|157772266|FG004|Placebo-Controlled Period|Reason not Specified|0|||
48983402|NCT02477800|157772267|FG005|Placebo-Controlled Period|Reason not Specified|0|||
48983403|NCT02477800|157772268|FG006|Placebo-Controlled Period|Reason not Specified|0|||
48983404|NCT02477800|157772262|FG000|Long Term Extension Period|Adverse Event|0|||
48983405|NCT02477800|157772263|FG001|Long Term Extension Period|Adverse Event|0|||
48983406|NCT02477800|157772264|FG002|Long Term Extension Period|Adverse Event|0|||
48983407|NCT02477800|157772265|FG003|Long Term Extension Period|Adverse Event|6|||
48983408|NCT02477800|157772266|FG004|Long Term Extension Period|Adverse Event|2|||
48983409|NCT02477800|157772267|FG005|Long Term Extension Period|Adverse Event|4|||
48983410|NCT02477800|157772268|FG006|Long Term Extension Period|Adverse Event|3|||
48983411|NCT02477800|157772262|FG000|Long Term Extension Period|Death|0|||
48983412|NCT02477800|157772263|FG001|Long Term Extension Period|Death|0|||
48983413|NCT02477800|157772264|FG002|Long Term Extension Period|Death|0|||
48983414|NCT02477800|157772265|FG003|Long Term Extension Period|Death|1|||
48983415|NCT02477800|157772266|FG004|Long Term Extension Period|Death|1|||
48983416|NCT02477800|157772267|FG005|Long Term Extension Period|Death|1|||
48983417|NCT02477800|157772268|FG006|Long Term Extension Period|Death|2|||
48983418|NCT02477800|157772262|FG000|Long Term Extension Period|Consent Withdrawn|0|||
48983419|NCT02477800|157772263|FG001|Long Term Extension Period|Consent Withdrawn|0|||
48983420|NCT02477800|157772264|FG002|Long Term Extension Period|Consent Withdrawn|0|||
48790429|NCT01292603|157071379|FG001|Part 2: Regular Follow-Up|Protocol Violation|0|||
48790430|NCT01292603|157071380|FG002|Part 2: Regular Follow-Up|Protocol Violation|0|||
48790431|NCT01292603|157071381|FG003|Part 2: Regular Follow-Up|Protocol Violation|0|||
48983421|NCT02477800|157772265|FG003|Long Term Extension Period|Consent Withdrawn|10|||
48983422|NCT02477800|157772266|FG004|Long Term Extension Period|Consent Withdrawn|4|||
48983423|NCT02477800|157772267|FG005|Long Term Extension Period|Consent Withdrawn|13|||
48983424|NCT02477800|157772268|FG006|Long Term Extension Period|Consent Withdrawn|16|||
48983425|NCT02477800|157772262|FG000|Long Term Extension Period|Disease Progression|0|||
48983426|NCT02477800|157772263|FG001|Long Term Extension Period|Disease Progression|0|||
48983427|NCT02477800|157772264|FG002|Long Term Extension Period|Disease Progression|0|||
48983428|NCT02477800|157772265|FG003|Long Term Extension Period|Disease Progression|3|||
48983429|NCT02477800|157772266|FG004|Long Term Extension Period|Disease Progression|1|||
48983430|NCT02477800|157772267|FG005|Long Term Extension Period|Disease Progression|1|||
48983431|NCT02477800|157772268|FG006|Long Term Extension Period|Disease Progression|0|||
48983432|NCT02477800|157772262|FG000|Long Term Extension Period|Investigator Decision|0|||
48983433|NCT02477800|157772263|FG001|Long Term Extension Period|Investigator Decision|0|||
48983434|NCT02477800|157772264|FG002|Long Term Extension Period|Investigator Decision|0|||
48983435|NCT02477800|157772265|FG003|Long Term Extension Period|Investigator Decision|0|||
48983436|NCT02477800|157772266|FG004|Long Term Extension Period|Investigator Decision|0|||
48983437|NCT02477800|157772267|FG005|Long Term Extension Period|Investigator Decision|0|||
48983438|NCT02477800|157772268|FG006|Long Term Extension Period|Investigator Decision|2|||
48983439|NCT02477800|157772262|FG000|Long Term Extension Period|Lost to Follow-up|0|||
48983440|NCT02477800|157772263|FG001|Long Term Extension Period|Lost to Follow-up|0|||
48983441|NCT02477800|157772264|FG002|Long Term Extension Period|Lost to Follow-up|0|||
48983442|NCT02477800|157772265|FG003|Long Term Extension Period|Lost to Follow-up|0|||
48983443|NCT02477800|157772266|FG004|Long Term Extension Period|Lost to Follow-up|1|||
48983444|NCT02477800|157772267|FG005|Long Term Extension Period|Lost to Follow-up|3|||
48983445|NCT02477800|157772268|FG006|Long Term Extension Period|Lost to Follow-up|0|||
48983446|NCT02477800|157772262|FG000|Long Term Extension Period|Site Terminated By Sponsor|0|||
48983447|NCT02477800|157772263|FG001|Long Term Extension Period|Site Terminated By Sponsor|0|||
48983448|NCT02477800|157772264|FG002|Long Term Extension Period|Site Terminated By Sponsor|0|||
48983449|NCT02477800|157772265|FG003|Long Term Extension Period|Site Terminated By Sponsor|0|||
49032251|NCT01597245|157953476|FG006|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
49032252|NCT01597245|157953477|FG007|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
49032253|NCT01597245|157953478|FG008|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
49032254|NCT01597245|157953479|FG009|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
49032255|NCT01597245|157953480|FG010|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
49032256|NCT01597245|157953481|FG011|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
49032257|NCT01597245|157953482|FG012|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
49032258|NCT01597245|157953483|FG013|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
49032259|NCT01597245|157953484|FG014|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
49032260|NCT01597245|157953485|FG015|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
49032261|NCT01597245|157953486|FG016|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
49032262|NCT01597245|157953487|FG017|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
49032263|NCT01597245|157953488|FG018|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
49032264|NCT01597245|157953489|FG019|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
49032265|NCT01597245|157953490|FG020|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
49032266|NCT01597245|157953470|FG000|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
49032267|NCT01597245|157953471|FG001|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
49032268|NCT01597245|157953472|FG002|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
49032269|NCT01597245|157953473|FG003|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
49032270|NCT01597245|157953474|FG004|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
49032271|NCT01597245|157953475|FG005|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
49032272|NCT01597245|157953476|FG006|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
49032273|NCT01597245|157953477|FG007|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
48790432|NCT01292603|157071382|FG004|Part 2: Regular Follow-Up|Protocol Violation|2|||
48790433|NCT01292603|157071383|FG005|Part 2: Regular Follow-Up|Protocol Violation|0|||
48790434|NCT01292603|157071378|FG000|Part 2: Regular Follow-Up|Physician Decision|0|||
48790435|NCT01292603|157071379|FG001|Part 2: Regular Follow-Up|Physician Decision|0|||
48790436|NCT01292603|157071380|FG002|Part 2: Regular Follow-Up|Physician Decision|0|||
48790437|NCT01292603|157071381|FG003|Part 2: Regular Follow-Up|Physician Decision|0|||
48790438|NCT01292603|157071382|FG004|Part 2: Regular Follow-Up|Physician Decision|2|||
48790439|NCT01292603|157071383|FG005|Part 2: Regular Follow-Up|Physician Decision|0|||
48790440|NCT01292603|157071378|FG000|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
48790441|NCT01292603|157071379|FG001|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
48790442|NCT01292603|157071380|FG002|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
48790443|NCT01292603|157071381|FG003|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
48790444|NCT01292603|157071382|FG004|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
48790445|NCT01292603|157071383|FG005|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
48790446|NCT01292603|157071378|FG000|Part 2: Regular Follow-Up|Adverse Event|0|||
48790447|NCT01292603|157071379|FG001|Part 2: Regular Follow-Up|Adverse Event|0|||
48790448|NCT01292603|157071380|FG002|Part 2: Regular Follow-Up|Adverse Event|0|||
48790449|NCT01292603|157071381|FG003|Part 2: Regular Follow-Up|Adverse Event|0|||
48790450|NCT01292603|157071382|FG004|Part 2: Regular Follow-Up|Adverse Event|2|||
48790451|NCT01292603|157071383|FG005|Part 2: Regular Follow-Up|Adverse Event|2|||
48790452|NCT01292603|157071378|FG000|Overall Survival Status|Death|3|||
48790453|NCT01292603|157071379|FG001|Overall Survival Status|Death|1|||
48790454|NCT01292603|157071380|FG002|Overall Survival Status|Death|3|||
48790455|NCT01292603|157071381|FG003|Overall Survival Status|Death|1|||
48790456|NCT01292603|157071382|FG004|Overall Survival Status|Death|16|||
48790457|NCT01292603|157071383|FG005|Overall Survival Status|Death|10|||
48790458|NCT01808690|157071384|FG000|Overall Study|Withdrawal by Subject|1|||
48790459|NCT01808690|157071385|FG001|Overall Study|Withdrawal by Subject|2|||
48790460|NCT03586648|157071390|FG000|Period 1|Withdrawal by Subject|0|||
48790461|NCT03586648|157071391|FG001|Period 1|Withdrawal by Subject|1|||
48790462|NCT03586648|157071390|FG000|Period 1|Lost to Follow-up|1|||
48790463|NCT03586648|157071391|FG001|Period 1|Lost to Follow-up|1|||
48790464|NCT03586648|157071390|FG000|Period 1|Adverse Event|1|||
48790465|NCT03586648|157071391|FG001|Period 1|Adverse Event|0|||
48790466|NCT03586648|157071390|FG000|Period 1|Study related symptoms or complaints|2|||
48790467|NCT03586648|157071391|FG001|Period 1|Study related symptoms or complaints|1|||
48790468|NCT03586648|157071390|FG000|Period 1|Physician Decision|0|||
48790469|NCT03586648|157071391|FG001|Period 1|Physician Decision|1|||
48790470|NCT03586648|157071390|FG000|Period 2|Adverse Event|1|||
48790471|NCT03586648|157071391|FG001|Period 2|Adverse Event|0|||
48790472|NCT02041195|157071392|FG000|Overall Study|Adverse Event|1|||
48790473|NCT02041195|157071393|FG001|Overall Study|Adverse Event|2|||
48790474|NCT02041195|157071394|FG002|Overall Study|Adverse Event|0|||
48790475|NCT02041195|157071395|FG003|Overall Study|Adverse Event|0|||
48790476|NCT02041195|157071396|FG004|Overall Study|Adverse Event|0|||
48790477|NCT02041195|157071397|FG005|Overall Study|Adverse Event|0|||
49032274|NCT01597245|157953478|FG008|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
48790478|NCT02041195|157071398|FG006|Overall Study|Adverse Event|3|||
48790479|NCT02041195|157071399|FG007|Overall Study|Adverse Event|0|||
48790480|NCT02041195|157071392|FG000|Overall Study|Withdrawal by Subject|1|||
48790481|NCT02041195|157071393|FG001|Overall Study|Withdrawal by Subject|0|||
48790482|NCT02041195|157071394|FG002|Overall Study|Withdrawal by Subject|0|||
48790483|NCT02041195|157071395|FG003|Overall Study|Withdrawal by Subject|0|||
48790484|NCT02041195|157071396|FG004|Overall Study|Withdrawal by Subject|0|||
48790485|NCT02041195|157071397|FG005|Overall Study|Withdrawal by Subject|0|||
48790486|NCT02041195|157071398|FG006|Overall Study|Withdrawal by Subject|4|||
48790487|NCT02041195|157071399|FG007|Overall Study|Withdrawal by Subject|3|||
48790488|NCT02041195|157071392|FG000|Overall Study|Unable to comply with study visits|0|||
48790489|NCT02041195|157071393|FG001|Overall Study|Unable to comply with study visits|1|||
48790490|NCT02041195|157071394|FG002|Overall Study|Unable to comply with study visits|0|||
48790491|NCT02041195|157071395|FG003|Overall Study|Unable to comply with study visits|0|||
48790492|NCT02041195|157071396|FG004|Overall Study|Unable to comply with study visits|1|||
48790493|NCT02041195|157071397|FG005|Overall Study|Unable to comply with study visits|0|||
48790494|NCT02041195|157071398|FG006|Overall Study|Unable to comply with study visits|0|||
48790495|NCT02041195|157071399|FG007|Overall Study|Unable to comply with study visits|0|||
48790496|NCT02395120|157071400|FG000|Overall Study|Missed follow-up dental exam|57|||
48790497|NCT02395120|157071401|FG001|Overall Study|Missed follow-up dental exam|62|||
48790498|NCT02395120|157071402|FG002|Overall Study|Missed follow-up dental exam|6|||
48790499|NCT02395120|157071403|FG003|Overall Study|Missed follow-up dental exam|6|||
48790500|NCT02395120|157071404|FG004|Overall Study|Missed follow-up dental exam|51|||
48790501|NCT00907153|157071411|FG000|Overall Study|Lost to Follow-up|1|||
48790502|NCT00907153|157071412|FG001|Overall Study|Lost to Follow-up|1|||
48790503|NCT00907153|157071411|FG000|Overall Study|Withdrawal by Subject|1|||
48790504|NCT00907153|157071412|FG001|Overall Study|Withdrawal by Subject|3|||
48790505|NCT01780298|157071413|FG000|Overall Study|Physician Decision|1|||
48790506|NCT01780298|157071414|FG001|Overall Study|Physician Decision|5|||
48790507|NCT01780298|157071415|FG002|Overall Study|Physician Decision|1|||
48790508|NCT01780298|157071416|FG003|Overall Study|Physician Decision|1|||
48790509|NCT01780298|157071413|FG000|Overall Study|Subject not matched|1|||
48790510|NCT01780298|157071414|FG001|Overall Study|Subject not matched|0|||
48790511|NCT01780298|157071415|FG002|Overall Study|Subject not matched|1|||
48790512|NCT01780298|157071416|FG003|Overall Study|Subject not matched|0|||
48790513|NCT01780298|157071413|FG000|Overall Study|Adverse Event|0|||
48790514|NCT01780298|157071414|FG001|Overall Study|Adverse Event|0|||
48790515|NCT01780298|157071415|FG002|Overall Study|Adverse Event|2|||
48790516|NCT01780298|157071416|FG003|Overall Study|Adverse Event|0|||
48790517|NCT01983293|157071417|FG000|Overall Study|Withdrawal by Subject|29|||
48790518|NCT01983293|157071418|FG001|Overall Study|Withdrawal by Subject|15|||
48790519|NCT01983293|157071417|FG000|Overall Study|Missing 12-month visit|3|||
48790520|NCT01983293|157071418|FG001|Overall Study|Missing 12-month visit|3|||
48790521|NCT01983293|157071417|FG000|Overall Study|Missing NYHA/Patient Global Assessment|1|||
48790522|NCT01983293|157071418|FG001|Overall Study|Missing NYHA/Patient Global Assessment|1|||
48790523|NCT01349569|157071419|FG000|Overall Study|Lack of Efficacy|4|||
48790524|NCT03581305|157071420|FG000|Dopaminergic Study|Withdrawal by Subject|1|||
48790525|NCT03581305|157071421|FG001|Dopaminergic Study|Withdrawal by Subject|1|||
48790526|NCT03581305|157071420|FG000|Dopaminergic Study|could not finish FDOPA scan|2|||
48790527|NCT03581305|157071421|FG001|Dopaminergic Study|could not finish FDOPA scan|0|||
48790528|NCT03581305|157071420|FG000|Serotonergic Study|Withdrawal by Subject|5|||
48790529|NCT03581305|157071421|FG001|Serotonergic Study|Withdrawal by Subject|1|||
48877959|NCT02906020|157392091|FG001|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
48877960|NCT02906020|157392092|FG002|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
48877961|NCT02906020|157392093|FG003|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
48790530|NCT01747772|157071422|FG000|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9|||
48790531|NCT03147248|157071423|FG000|Overall Study|Adverse Event|0|||
48790532|NCT03147248|157071424|FG001|Overall Study|Adverse Event|2|||
48790533|NCT03147248|157071425|FG002|Overall Study|Adverse Event|2|||
48790534|NCT03147248|157071426|FG003|Overall Study|Adverse Event|2|||
48790535|NCT03147248|157071427|FG004|Overall Study|Adverse Event|6|||
48790536|NCT03147248|157071428|FG005|Overall Study|Adverse Event|11|||
48790537|NCT03147248|157071423|FG000|Overall Study|Disease progression|1|||
48790538|NCT03147248|157071424|FG001|Overall Study|Disease progression|0|||
48790539|NCT03147248|157071425|FG002|Overall Study|Disease progression|0|||
48790540|NCT03147248|157071426|FG003|Overall Study|Disease progression|0|||
48790541|NCT03147248|157071427|FG004|Overall Study|Disease progression|0|||
48790542|NCT03147248|157071428|FG005|Overall Study|Disease progression|2|||
48790543|NCT03147248|157071423|FG000|Overall Study|Withdrawal by Subject|0|||
48790544|NCT03147248|157071424|FG001|Overall Study|Withdrawal by Subject|0|||
48790545|NCT03147248|157071425|FG002|Overall Study|Withdrawal by Subject|0|||
48790546|NCT03147248|157071426|FG003|Overall Study|Withdrawal by Subject|0|||
48790547|NCT03147248|157071427|FG004|Overall Study|Withdrawal by Subject|12|||
48790548|NCT03147248|157071428|FG005|Overall Study|Withdrawal by Subject|9|||
48790549|NCT03147248|157071423|FG000|Overall Study|Protocol Violation|0|||
48790550|NCT03147248|157071424|FG001|Overall Study|Protocol Violation|0|||
48790551|NCT03147248|157071425|FG002|Overall Study|Protocol Violation|0|||
48790552|NCT03147248|157071426|FG003|Overall Study|Protocol Violation|0|||
48790553|NCT03147248|157071427|FG004|Overall Study|Protocol Violation|2|||
48877962|NCT02906020|157392094|FG004|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
48983450|NCT02477800|157772266|FG004|Long Term Extension Period|Site Terminated By Sponsor|0|||
48790554|NCT03147248|157071428|FG005|Overall Study|Protocol Violation|0|||
48790555|NCT03147248|157071423|FG000|Overall Study|Lost to Follow-up|0|||
48790556|NCT03147248|157071424|FG001|Overall Study|Lost to Follow-up|0|||
48790557|NCT03147248|157071425|FG002|Overall Study|Lost to Follow-up|0|||
48790558|NCT03147248|157071426|FG003|Overall Study|Lost to Follow-up|0|||
48790559|NCT03147248|157071427|FG004|Overall Study|Lost to Follow-up|2|||
48790560|NCT03147248|157071428|FG005|Overall Study|Lost to Follow-up|0|||
48790561|NCT03147248|157071423|FG000|Overall Study|Pregnancy|0|||
48790562|NCT03147248|157071424|FG001|Overall Study|Pregnancy|0|||
48790563|NCT03147248|157071425|FG002|Overall Study|Pregnancy|0|||
48790564|NCT03147248|157071426|FG003|Overall Study|Pregnancy|0|||
48790565|NCT03147248|157071427|FG004|Overall Study|Pregnancy|1|||
48790566|NCT03147248|157071428|FG005|Overall Study|Pregnancy|0|||
48790567|NCT03147248|157071423|FG000|Overall Study|Death|0|||
48790568|NCT03147248|157071424|FG001|Overall Study|Death|0|||
48790569|NCT03147248|157071425|FG002|Overall Study|Death|0|||
48790570|NCT03147248|157071426|FG003|Overall Study|Death|0|||
48790571|NCT03147248|157071427|FG004|Overall Study|Death|0|||
48790572|NCT03147248|157071428|FG005|Overall Study|Death|4|||
48790573|NCT03147248|157071423|FG000|Overall Study|Physician Decision|0|||
48790574|NCT03147248|157071424|FG001|Overall Study|Physician Decision|0|||
48790575|NCT03147248|157071425|FG002|Overall Study|Physician Decision|0|||
48790576|NCT03147248|157071426|FG003|Overall Study|Physician Decision|0|||
48790577|NCT03147248|157071427|FG004|Overall Study|Physician Decision|2|||
48790578|NCT03147248|157071428|FG005|Overall Study|Physician Decision|4|||
48790579|NCT03147248|157071423|FG000|Overall Study|Prolonged Dosing Interval|0|||
48790580|NCT03147248|157071424|FG001|Overall Study|Prolonged Dosing Interval|0|||
48790581|NCT03147248|157071425|FG002|Overall Study|Prolonged Dosing Interval|0|||
48790582|NCT03147248|157071426|FG003|Overall Study|Prolonged Dosing Interval|0|||
48790583|NCT03147248|157071427|FG004|Overall Study|Prolonged Dosing Interval|1|||
48790584|NCT03147248|157071428|FG005|Overall Study|Prolonged Dosing Interval|1|||
48790585|NCT02780388|157071437|FG000|Overall Study|Lost to Follow-up|0|||
48790586|NCT02780388|157071438|FG001|Overall Study|Lost to Follow-up|1|||
48790587|NCT02780388|157071439|FG002|Overall Study|Lost to Follow-up|0|||
48790588|NCT02780388|157071440|FG003|Overall Study|Lost to Follow-up|0|||
48790589|NCT02780388|157071441|FG004|Overall Study|Lost to Follow-up|0|||
48790590|NCT02780388|157071437|FG000|Overall Study|Withdrawal by Subject|1|||
48790591|NCT02780388|157071438|FG001|Overall Study|Withdrawal by Subject|1|||
48790592|NCT02780388|157071439|FG002|Overall Study|Withdrawal by Subject|0|||
48790593|NCT02780388|157071440|FG003|Overall Study|Withdrawal by Subject|0|||
48790594|NCT02780388|157071441|FG004|Overall Study|Withdrawal by Subject|0|||
48790595|NCT03832010|157071446|FG000|Overall Study|Withdrawal by Subject|2|||
48790596|NCT03832010|157071447|FG001|Overall Study|Withdrawal by Subject|1|||
48790597|NCT03832010|157071448|FG002|Overall Study|Withdrawal by Subject|0|||
48790598|NCT03832010|157071446|FG000|Overall Study|Lost to Follow-up|2|||
48790599|NCT03832010|157071447|FG001|Overall Study|Lost to Follow-up|1|||
48790600|NCT03832010|157071448|FG002|Overall Study|Lost to Follow-up|1|||
48790601|NCT00838110|157071449|FG000|Overall Study|Death|0|||
48790602|NCT00838110|157071450|FG001|Overall Study|Death|0|||
48790603|NCT00838110|157071451|FG002|Overall Study|Death|1|||
48790604|NCT00838110|157071452|FG003|Overall Study|Death|2|||
48790605|NCT00838110|157071449|FG000|Overall Study|Adverse Event|11|||
48790606|NCT00838110|157071450|FG001|Overall Study|Adverse Event|10|||
48790607|NCT00838110|157071451|FG002|Overall Study|Adverse Event|8|||
48790608|NCT00838110|157071452|FG003|Overall Study|Adverse Event|7|||
48790609|NCT00838110|157071449|FG000|Overall Study|Withdrawal by Subject|5|||
48790610|NCT00838110|157071450|FG001|Overall Study|Withdrawal by Subject|6|||
48983451|NCT02477800|157772267|FG005|Long Term Extension Period|Site Terminated By Sponsor|2|||
48983452|NCT02477800|157772268|FG006|Long Term Extension Period|Site Terminated By Sponsor|1|||
48790611|NCT00838110|157071451|FG002|Overall Study|Withdrawal by Subject|3|||
48790612|NCT00838110|157071452|FG003|Overall Study|Withdrawal by Subject|4|||
48790613|NCT00838110|157071449|FG000|Overall Study|Other|3|||
48790614|NCT00838110|157071450|FG001|Overall Study|Other|3|||
48790615|NCT00838110|157071451|FG002|Overall Study|Other|3|||
48790616|NCT00838110|157071452|FG003|Overall Study|Other|2|||
48790617|NCT00838110|157071449|FG000|Overall Study|Protocol Violation|0|||
49032275|NCT01597245|157953479|FG009|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
49032276|NCT01597245|157953480|FG010|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
48790618|NCT00838110|157071450|FG001|Overall Study|Protocol Violation|2|||
48790619|NCT00838110|157071451|FG002|Overall Study|Protocol Violation|1|||
48790620|NCT00838110|157071452|FG003|Overall Study|Protocol Violation|1|||
48790621|NCT00838110|157071449|FG000|Overall Study|Lost to Follow-up|3|||
48790622|NCT00838110|157071450|FG001|Overall Study|Lost to Follow-up|0|||
48790623|NCT00838110|157071451|FG002|Overall Study|Lost to Follow-up|0|||
48790624|NCT00838110|157071452|FG003|Overall Study|Lost to Follow-up|0|||
48790625|NCT00838110|157071449|FG000|Overall Study|Did not meet eligibility criteria|0|||
48790626|NCT00838110|157071450|FG001|Overall Study|Did not meet eligibility criteria|0|||
48790627|NCT00838110|157071451|FG002|Overall Study|Did not meet eligibility criteria|1|||
48790628|NCT00838110|157071452|FG003|Overall Study|Did not meet eligibility criteria|2|||
48790629|NCT00838110|157071449|FG000|Overall Study|Randomized but not treated|0|||
48790630|NCT00838110|157071450|FG001|Overall Study|Randomized but not treated|1|||
48790631|NCT00838110|157071451|FG002|Overall Study|Randomized but not treated|0|||
48790632|NCT00838110|157071452|FG003|Overall Study|Randomized but not treated|0|||
48790633|NCT02388724|157071463|FG000|Overall Study|Reason not Specified|0|||
48790634|NCT02388724|157071464|FG001|Overall Study|Reason not Specified|1|||
48790635|NCT02388724|157071463|FG000|Overall Study|Major Protocol Deviation|3|||
48790636|NCT02388724|157071464|FG001|Overall Study|Major Protocol Deviation|3|||
48790637|NCT02388724|157071463|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
48790638|NCT02388724|157071464|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
48790639|NCT02388724|157071463|FG000|Overall Study|Voluntary Withdrawal|6|||
48790640|NCT02388724|157071464|FG001|Overall Study|Voluntary Withdrawal|5|||
48790641|NCT02388724|157071463|FG000|Overall Study|Randomized but not Treated|0|||
48790642|NCT02388724|157071464|FG001|Overall Study|Randomized but not Treated|2|||
48790643|NCT01549613|157071471|FG000|Overall Study|Lost to Follow-up|11|||
48790644|NCT01549613|157071472|FG001|Overall Study|Lost to Follow-up|11|||
48790645|NCT03166618|157071476|FG000|Overall Study|Study was Terminated|0|||
48790646|NCT03166618|157071477|FG001|Overall Study|Study was Terminated|1|||
48790647|NCT04717596|157071478|FG000|Overall Study|Withdrawal by Subject|4|||
48790648|NCT03555396|157071479|FG000|Overall Study|Death|3|||
48790649|NCT03555396|157071480|FG001|Overall Study|Death|1|||
48790650|NCT03555396|157071479|FG000|Overall Study|Lost to Follow-up|0|||
48790651|NCT03555396|157071480|FG001|Overall Study|Lost to Follow-up|2|||
48790652|NCT02647658|157071481|FG000|Overall Study|Consent refusal|15|||
48790653|NCT02647658|157071482|FG001|Overall Study|Consent refusal|24|||
48790654|NCT00784810|157071485|FG000|Overall Study|Adverse Event|32|||
48790655|NCT00784810|157071486|FG001|Overall Study|Adverse Event|20|||
48790656|NCT00784810|157071485|FG000|Overall Study|Lack of Efficacy|14|||
48790657|NCT00784810|157071486|FG001|Overall Study|Lack of Efficacy|11|||
48790658|NCT00784810|157071485|FG000|Overall Study|Withdrawal by Subject|11|||
48790659|NCT00784810|157071486|FG001|Overall Study|Withdrawal by Subject|9|||
48790660|NCT00784810|157071485|FG000|Overall Study|Administrative|5|||
48790661|NCT00784810|157071486|FG001|Overall Study|Administrative|8|||
48790662|NCT00784810|157071485|FG000|Overall Study|Lost to Follow-up|1|||
48790663|NCT00784810|157071486|FG001|Overall Study|Lost to Follow-up|1|||
48790664|NCT03568318|157071488|FG000|Overall Study|Adverse Event|3|||
48790665|NCT03568318|157071489|FG001|Overall Study|Adverse Event|1|||
48790666|NCT03568318|157071490|FG002|Overall Study|Adverse Event|1|||
48790667|NCT03568318|157071491|FG003|Overall Study|Adverse Event|0|||
48790668|NCT03568318|157071492|FG004|Overall Study|Adverse Event|1|||
48790669|NCT03568318|157071493|FG005|Overall Study|Adverse Event|0|||
48790670|NCT03568318|157071488|FG000|Overall Study|Withdrawal by Subject|6|||
48790671|NCT03568318|157071489|FG001|Overall Study|Withdrawal by Subject|5|||
48790672|NCT03568318|157071490|FG002|Overall Study|Withdrawal by Subject|2|||
48790673|NCT03568318|157071491|FG003|Overall Study|Withdrawal by Subject|1|||
49032277|NCT01597245|157953481|FG011|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
48877963|NCT02906020|157392095|FG005|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
48877964|NCT02906020|157392096|FG006|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
48877965|NCT02906020|157392097|FG007|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
48877966|NCT02906020|157392098|FG008|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
48877967|NCT02906020|157392099|FG009|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
48877968|NCT02906020|157392100|FG010|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
48877969|NCT02906020|157392101|FG011|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
48877970|NCT02906020|157392102|FG012|Part 2: Long-term Follow-up Period|Study terminated by sponsor|67|||
48877971|NCT02906020|157392103|FG013|Part 2: Long-term Follow-up Period|Study terminated by sponsor|64|||
48877972|NCT02906020|157392104|FG014|Part 2: Long-term Follow-up Period|Study terminated by sponsor|7|||
48877973|NCT02906020|157392105|FG015|Part 2: Long-term Follow-up Period|Study terminated by sponsor|8|||
48877974|NCT02906020|157392090|FG000|Part 2: Long-term Follow-up Period|Other|0|||
48877975|NCT02906020|157392091|FG001|Part 2: Long-term Follow-up Period|Other|0|||
48877976|NCT02906020|157392092|FG002|Part 2: Long-term Follow-up Period|Other|0|||
48877977|NCT02906020|157392093|FG003|Part 2: Long-term Follow-up Period|Other|0|||
48877978|NCT02906020|157392094|FG004|Part 2: Long-term Follow-up Period|Other|0|||
48877979|NCT02906020|157392095|FG005|Part 2: Long-term Follow-up Period|Other|0|||
48877980|NCT02906020|157392096|FG006|Part 2: Long-term Follow-up Period|Other|0|||
48877981|NCT02906020|157392097|FG007|Part 2: Long-term Follow-up Period|Other|0|||
48877982|NCT02906020|157392098|FG008|Part 2: Long-term Follow-up Period|Other|0|||
48877983|NCT02906020|157392099|FG009|Part 2: Long-term Follow-up Period|Other|0|||
48877984|NCT02906020|157392100|FG010|Part 2: Long-term Follow-up Period|Other|0|||
48877985|NCT02906020|157392101|FG011|Part 2: Long-term Follow-up Period|Other|0|||
48877986|NCT02906020|157392102|FG012|Part 2: Long-term Follow-up Period|Other|13|||
48877987|NCT02906020|157392103|FG013|Part 2: Long-term Follow-up Period|Other|8|||
48877988|NCT02906020|157392104|FG014|Part 2: Long-term Follow-up Period|Other|3|||
48877989|NCT02906020|157392105|FG015|Part 2: Long-term Follow-up Period|Other|2|||
48877990|NCT04075292|157392108|FG000|Overall Study|Withdrawal by Subject|1|||
48877991|NCT04075292|157392109|FG001|Overall Study|Withdrawal by Subject|9|||
48877992|NCT04075292|157392108|FG000|Overall Study|Death|2|||
48877993|NCT04075292|157392109|FG001|Overall Study|Death|5|||
48877994|NCT04075292|157392108|FG000|Overall Study|Remained on study at time of DCO|74|||
48877995|NCT04075292|157392109|FG001|Overall Study|Remained on study at time of DCO|64|||
48877996|NCT01150045|157392110|FG000|Overall Study|Protocol Violation|0|||
48877997|NCT01150045|157392111|FG001|Overall Study|Protocol Violation|1|||
48877998|NCT01150045|157392112|FG002|Overall Study|Protocol Violation|0|||
48877999|NCT01150045|157392113|FG003|Overall Study|Protocol Violation|1|||
48878000|NCT01821937|157392114|FG000|Overall Study|Adverse Event|0|||
48878001|NCT01821937|157392115|FG001|Overall Study|Adverse Event|3|||
48878002|NCT01732549|157392116|FG000|Overall Study|Adverse Event|13|||
48878003|NCT01732549|157392117|FG001|Overall Study|Adverse Event|3|||
48878004|NCT01732549|157392116|FG000|Overall Study|Consent withdrawn|13|||
48878005|NCT01732549|157392117|FG001|Overall Study|Consent withdrawn|6|||
48878006|NCT01732549|157392116|FG000|Overall Study|Disease progression|37|||
48878007|NCT01732549|157392117|FG001|Overall Study|Disease progression|50|||
48878008|NCT01732549|157392116|FG000|Overall Study|Other|8|||
48878009|NCT01732549|157392117|FG001|Overall Study|Other|14|||
48878010|NCT05186311|157392118|FG000|Part A: Serum|Withdrawal by Subject|1|||
48878011|NCT03721705|157392119|FG000|Overall Study|Adverse Event|2|||
48878012|NCT03721705|157392120|FG001|Overall Study|Adverse Event|0|||
48878013|NCT03721705|157392119|FG000|Overall Study|Withdrawal by Subject|4|||
48878014|NCT03721705|157392120|FG001|Overall Study|Withdrawal by Subject|10|||
48790674|NCT03568318|157071492|FG004|Overall Study|Withdrawal by Subject|0|||
48790675|NCT03568318|157071493|FG005|Overall Study|Withdrawal by Subject|0|||
48790676|NCT03568318|157071488|FG000|Overall Study|Lost to Follow-up|3|||
48790677|NCT03568318|157071489|FG001|Overall Study|Lost to Follow-up|2|||
48790678|NCT03568318|157071490|FG002|Overall Study|Lost to Follow-up|2|||
48790679|NCT03568318|157071491|FG003|Overall Study|Lost to Follow-up|2|||
48790680|NCT03568318|157071492|FG004|Overall Study|Lost to Follow-up|1|||
48790681|NCT03568318|157071493|FG005|Overall Study|Lost to Follow-up|0|||
48790682|NCT03568318|157071488|FG000|Overall Study|Other|3|||
48878015|NCT03721705|157392119|FG000|Overall Study|No Suitable Study Partner|1|||
48878016|NCT03721705|157392120|FG001|Overall Study|No Suitable Study Partner|0|||
48983453|NCT02477800|157772262|FG000|Long Term Extension Period|Study Visit Burden|0|||
48790683|NCT03568318|157071489|FG001|Overall Study|Other|1|||
48790684|NCT03568318|157071490|FG002|Overall Study|Other|3|||
48878017|NCT03721705|157392119|FG000|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|3|||
48878018|NCT03721705|157392120|FG001|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|7|||
48878019|NCT03721705|157392119|FG000|Overall Study|Death|0|||
48878020|NCT03721705|157392120|FG001|Overall Study|Death|1|||
48878021|NCT01646385|157392121|FG000|Overall Study|Death|202|||
48878022|NCT01646385|157392122|FG001|Overall Study|Death|222|||
48790685|NCT03568318|157071491|FG003|Overall Study|Other|0|||
49032278|NCT01597245|157953482|FG012|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
49032279|NCT01597245|157953483|FG013|Long Term Extension (Week 60 - Week 264)|Physician Decision|1|||
49032280|NCT01597245|157953484|FG014|Long Term Extension (Week 60 - Week 264)|Physician Decision|11|||
49032281|NCT01597245|157953485|FG015|Long Term Extension (Week 60 - Week 264)|Physician Decision|12|||
49032282|NCT01597245|157953486|FG016|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
49032283|NCT01597245|157953487|FG017|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
49032284|NCT01597245|157953488|FG018|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
49032285|NCT01597245|157953489|FG019|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
49032286|NCT01597245|157953490|FG020|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
49032287|NCT01597245|157953470|FG000|Long Term Extension (Week 60 - Week 264)|Death|0|||
49032288|NCT01597245|157953471|FG001|Long Term Extension (Week 60 - Week 264)|Death|0|||
49032289|NCT01597245|157953472|FG002|Long Term Extension (Week 60 - Week 264)|Death|0|||
49032290|NCT01597245|157953473|FG003|Long Term Extension (Week 60 - Week 264)|Death|0|||
49032291|NCT01597245|157953474|FG004|Long Term Extension (Week 60 - Week 264)|Death|0|||
49032292|NCT01597245|157953475|FG005|Long Term Extension (Week 60 - Week 264)|Death|0|||
49032293|NCT01597245|157953476|FG006|Long Term Extension (Week 60 - Week 264)|Death|0|||
49032294|NCT01597245|157953477|FG007|Long Term Extension (Week 60 - Week 264)|Death|0|||
49032295|NCT01597245|157953478|FG008|Long Term Extension (Week 60 - Week 264)|Death|0|||
49032296|NCT01597245|157953479|FG009|Long Term Extension (Week 60 - Week 264)|Death|0|||
49032297|NCT01597245|157953480|FG010|Long Term Extension (Week 60 - Week 264)|Death|0|||
49032298|NCT01597245|157953481|FG011|Long Term Extension (Week 60 - Week 264)|Death|0|||
49032299|NCT01597245|157953482|FG012|Long Term Extension (Week 60 - Week 264)|Death|0|||
49032300|NCT01597245|157953483|FG013|Long Term Extension (Week 60 - Week 264)|Death|0|||
49032301|NCT01597245|157953484|FG014|Long Term Extension (Week 60 - Week 264)|Death|8|||
49032302|NCT01597245|157953485|FG015|Long Term Extension (Week 60 - Week 264)|Death|8|||
49032303|NCT01597245|157953486|FG016|Long Term Extension (Week 60 - Week 264)|Death|0|||
49032304|NCT01597245|157953487|FG017|Long Term Extension (Week 60 - Week 264)|Death|0|||
49032305|NCT01597245|157953488|FG018|Long Term Extension (Week 60 - Week 264)|Death|0|||
49032306|NCT01597245|157953489|FG019|Long Term Extension (Week 60 - Week 264)|Death|0|||
49032307|NCT01597245|157953490|FG020|Long Term Extension (Week 60 - Week 264)|Death|0|||
49032308|NCT01597245|157953470|FG000|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
49032309|NCT01597245|157953471|FG001|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
49032310|NCT01597245|157953472|FG002|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
49032311|NCT01597245|157953473|FG003|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
49032312|NCT01597245|157953474|FG004|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
49032313|NCT01597245|157953475|FG005|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
49032314|NCT01597245|157953476|FG006|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
49032315|NCT01597245|157953477|FG007|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
49032316|NCT01597245|157953478|FG008|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
48790686|NCT03568318|157071492|FG004|Overall Study|Other|0|||
48790687|NCT03568318|157071493|FG005|Overall Study|Other|0|||
48790688|NCT03568318|157071488|FG000|Overall Study|Ongoing at Time of Analysis|5|||
48790689|NCT03568318|157071489|FG001|Overall Study|Ongoing at Time of Analysis|3|||
48790690|NCT03568318|157071490|FG002|Overall Study|Ongoing at Time of Analysis|2|||
48790691|NCT03568318|157071491|FG003|Overall Study|Ongoing at Time of Analysis|1|||
48790692|NCT03568318|157071492|FG004|Overall Study|Ongoing at Time of Analysis|0|||
48790693|NCT03568318|157071493|FG005|Overall Study|Ongoing at Time of Analysis|0|||
48790694|NCT01358968|157071495|FG000|Period 2|Adverse Event|0|||
48790695|NCT01358968|157071496|FG001|Period 2|Adverse Event|1|||
48790696|NCT01358968|157071497|FG002|Period 2|Adverse Event|0|||
48790697|NCT01358968|157071498|FG003|Period 2|Adverse Event|0|||
48790698|NCT01358968|157071495|FG000|Continued Access Phase|Progression of Disease|0|||
48790699|NCT01358968|157071496|FG001|Continued Access Phase|Progression of Disease|0|||
48790700|NCT01358968|157071497|FG002|Continued Access Phase|Progression of Disease|8|||
48790701|NCT01358968|157071498|FG003|Continued Access Phase|Progression of Disease|4|||
48790702|NCT01358968|157071495|FG000|Continued Access Phase|Protocol Violation|0|||
48790703|NCT01358968|157071496|FG001|Continued Access Phase|Protocol Violation|0|||
48790704|NCT01358968|157071497|FG002|Continued Access Phase|Protocol Violation|0|||
48790705|NCT01358968|157071498|FG003|Continued Access Phase|Protocol Violation|2|||
48790706|NCT01358968|157071495|FG000|Continued Access Phase|Withdrawal by Subject|0|||
48790707|NCT01358968|157071496|FG001|Continued Access Phase|Withdrawal by Subject|0|||
48790708|NCT01358968|157071497|FG002|Continued Access Phase|Withdrawal by Subject|3|||
48790709|NCT01358968|157071498|FG003|Continued Access Phase|Withdrawal by Subject|0|||
48790710|NCT01358968|157071495|FG000|Continued Access Phase|Death|0|||
48790711|NCT01358968|157071496|FG001|Continued Access Phase|Death|0|||
48790712|NCT01358968|157071497|FG002|Continued Access Phase|Death|1|||
48790713|NCT01358968|157071498|FG003|Continued Access Phase|Death|1|||
48790714|NCT05224050|157071502|FG000|Overall Study|Withdrawal by Subject|9|||
48790715|NCT05224050|157071502|FG000|Overall Study|Lost to Follow-up|3|||
48790716|NCT01640808|157071503|FG000|Overall Study|Unable to continue dynamic CT|14|||
49032317|NCT01597245|157953479|FG009|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
48790717|NCT01640808|157071504|FG001|Overall Study|Unable to continue dynamic CT|4|||
48790718|NCT01640808|157071503|FG000|Overall Study|Withdrawal by Subject|12|||
48790719|NCT01640808|157071504|FG001|Overall Study|Withdrawal by Subject|4|||
48790720|NCT01640808|157071503|FG000|Overall Study|Lost to Follow-up|4|||
48790721|NCT01640808|157071504|FG001|Overall Study|Lost to Follow-up|0|||
48790722|NCT01640808|157071503|FG000|Overall Study|Start an antiviral therapy using IFN|3|||
48790723|NCT01640808|157071504|FG001|Overall Study|Start an antiviral therapy using IFN|0|||
48790724|NCT01640808|157071503|FG000|Overall Study|Administration of anticancer drugs|2|||
48790725|NCT01640808|157071504|FG001|Overall Study|Administration of anticancer drugs|1|||
48790726|NCT01640808|157071503|FG000|Overall Study|Physician Decision|19|||
48790727|NCT01640808|157071504|FG001|Overall Study|Physician Decision|5|||
48790728|NCT01640808|157071503|FG000|Overall Study|Randomized but not treated|4|||
48790729|NCT01640808|157071504|FG001|Overall Study|Randomized but not treated|2|||
48790730|NCT02273141|157071510|FG000|Overall Study|Adverse Event|0|||
48790731|NCT02273141|157071511|FG001|Overall Study|Adverse Event|1|||
48790732|NCT02273141|157071510|FG000|Overall Study|Lost to Follow-up|1|||
48790733|NCT02273141|157071511|FG001|Overall Study|Lost to Follow-up|3|||
48790734|NCT02273141|157071510|FG000|Overall Study|Withdrawal by Subject|10|||
48790735|NCT02273141|157071511|FG001|Overall Study|Withdrawal by Subject|15|||
48790736|NCT02273141|157071510|FG000|Overall Study|Various|6|||
48790737|NCT02273141|157071511|FG001|Overall Study|Various|6|||
48983454|NCT02477800|157772263|FG001|Long Term Extension Period|Study Visit Burden|0|||
48983455|NCT02477800|157772264|FG002|Long Term Extension Period|Study Visit Burden|0|||
48983456|NCT02477800|157772265|FG003|Long Term Extension Period|Study Visit Burden|3|||
48983457|NCT02477800|157772266|FG004|Long Term Extension Period|Study Visit Burden|0|||
48983458|NCT02477800|157772267|FG005|Long Term Extension Period|Study Visit Burden|2|||
48983459|NCT02477800|157772268|FG006|Long Term Extension Period|Study Visit Burden|2|||
48790744|NCT02372396|157071517|FG000|Overall Study|Lost to Follow-up|7|||
48790745|NCT02372396|157071518|FG001|Overall Study|Lost to Follow-up|9|||
48790746|NCT00522275|157071523|FG000|Overall Study|Adverse Event|35|||
48790747|NCT00522275|157071523|FG000|Overall Study|Lack of Efficacy|80|||
48790748|NCT00522275|157071523|FG000|Overall Study|Subject withdrew consent|16|||
48790749|NCT00522275|157071523|FG000|Overall Study|Protocol deviation|1|||
48790750|NCT00522275|157071523|FG000|Overall Study|Unsatisfactory compliance|11|||
48790751|NCT00522275|157071523|FG000|Overall Study|Lost to Follow-up|8|||
48790752|NCT00522275|157071523|FG000|Overall Study|Other: Subject wants to become pregnant|2|||
48790753|NCT00522275|157071523|FG000|Overall Study|Other: Subject is pregnant|2|||
48790754|NCT00522275|157071523|FG000|Overall Study|Other: Subject relocated|2|||
48790755|NCT00522275|157071523|FG000|Overall Study|Other: Subject arrested|1|||
48790756|NCT00522275|157071523|FG000|Overall Study|Other: Site / clinic closed|4|||
48790757|NCT00522275|157071523|FG000|Overall Study|Other: Travel to / from site difficulty|3|||
48790758|NCT00522275|157071523|FG000|Overall Study|Other: Sponsor request|2|||
48790759|NCT00522275|157071523|FG000|Overall Study|Other: Subject ran out of medication|1|||
48790760|NCT00522275|157071523|FG000|Overall Study|Other: Subject had surgery for epilepsy|2|||
48790761|NCT02341417|157071524|FG000|Overall Study|Withdrawal by Subject|0|||
48790762|NCT02341417|157071525|FG001|Overall Study|Withdrawal by Subject|2|||
48790763|NCT02341417|157071526|FG002|Overall Study|Withdrawal by Subject|0|||
48790764|NCT02341417|157071524|FG000|Overall Study|Decision by sponsor|2|||
48790765|NCT02341417|157071525|FG001|Overall Study|Decision by sponsor|0|||
48790766|NCT02341417|157071526|FG002|Overall Study|Decision by sponsor|0|||
48790767|NCT02341417|157071524|FG000|Overall Study|Death|0|||
48790768|NCT02341417|157071525|FG001|Overall Study|Death|0|||
48790769|NCT02341417|157071526|FG002|Overall Study|Death|1|||
48790770|NCT04403698|157071527|FG000|Overall Study|Adverse Event|1|||
48790771|NCT04403698|157071528|FG001|Overall Study|Adverse Event|1|||
48790772|NCT04403698|157071527|FG000|Overall Study|Lost to Follow-up|1|||
48790773|NCT04403698|157071528|FG001|Overall Study|Lost to Follow-up|0|||
48790774|NCT04403698|157071527|FG000|Overall Study|Protocol Violation|0|||
48790775|NCT04403698|157071528|FG001|Overall Study|Protocol Violation|1|||
48790776|NCT04899349|157071534|FG000|Overall Study|Study terminated by Sponsor|2|||
48790777|NCT04899349|157071535|FG001|Overall Study|Study terminated by Sponsor|0|||
48790778|NCT02300220|157071536|FG000|Overall Study|Lost to Follow-up|1|||
48790779|NCT02300220|157071537|FG001|Overall Study|Lost to Follow-up|2|||
48790780|NCT02300220|157071536|FG000|Overall Study|Death|1|||
48790781|NCT02300220|157071537|FG001|Overall Study|Death|1|||
48790782|NCT02300220|157071536|FG000|Overall Study|Adverse Event|1|||
48790783|NCT02300220|157071537|FG001|Overall Study|Adverse Event|1|||
48790784|NCT02300220|157071536|FG000|Overall Study|Protocol Violation|1|||
48790785|NCT02300220|157071537|FG001|Overall Study|Protocol Violation|0|||
48790786|NCT02300220|157071536|FG000|Overall Study|Withdrawal by Subject|0|||
48790787|NCT02300220|157071537|FG001|Overall Study|Withdrawal by Subject|2|||
48790788|NCT02300220|157071536|FG000|Overall Study|Did not tolerate IMP|0|||
48790789|NCT02300220|157071537|FG001|Overall Study|Did not tolerate IMP|1|||
48983460|NCT02477800|157772262|FG000|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
48983461|NCT02477800|157772263|FG001|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
49032318|NCT01597245|157953480|FG010|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
49032319|NCT01597245|157953481|FG011|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
49032320|NCT01597245|157953482|FG012|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
49032321|NCT01597245|157953483|FG013|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
49032322|NCT01597245|157953484|FG014|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
49032323|NCT01597245|157953485|FG015|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
49032324|NCT01597245|157953486|FG016|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
49032325|NCT01597245|157953487|FG017|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
49032326|NCT01597245|157953488|FG018|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
49032327|NCT01597245|157953489|FG019|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
48790790|NCT03069482|157074061|FG000|Overall Study|Lost to Follow-up|0|||
48790791|NCT03069482|157074062|FG001|Overall Study|Lost to Follow-up|1|||
48790792|NCT03069482|157074061|FG000|Overall Study|Physician Decision|1|||
48790793|NCT03069482|157074062|FG001|Overall Study|Physician Decision|0|||
48790794|NCT00251745|157074063|FG000|Overall Study|Adverse Event|7|||
48790795|NCT00251745|157074064|FG001|Overall Study|Adverse Event|9|||
48790796|NCT00251745|157074065|FG002|Overall Study|Adverse Event|11|||
48790797|NCT00251745|157074063|FG000|Overall Study|Lost to Follow-up|4|||
48790798|NCT00251745|157074064|FG001|Overall Study|Lost to Follow-up|2|||
48790799|NCT00251745|157074065|FG002|Overall Study|Lost to Follow-up|5|||
48790800|NCT00251745|157074063|FG000|Overall Study|Withdrawal by Subject|13|||
48790801|NCT00251745|157074064|FG001|Overall Study|Withdrawal by Subject|7|||
48790802|NCT00251745|157074065|FG002|Overall Study|Withdrawal by Subject|3|||
48790803|NCT00251745|157074063|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
48790804|NCT00251745|157074064|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
48790805|NCT00251745|157074065|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
48790806|NCT00251745|157074063|FG000|Overall Study|Lack of Efficacy|3|||
48790807|NCT00251745|157074064|FG001|Overall Study|Lack of Efficacy|0|||
48790808|NCT00251745|157074065|FG002|Overall Study|Lack of Efficacy|0|||
48790809|NCT00251745|157074063|FG000|Overall Study|Noncompliant|0|||
48790810|NCT00251745|157074064|FG001|Overall Study|Noncompliant|2|||
48790811|NCT00251745|157074065|FG002|Overall Study|Noncompliant|2|||
48790812|NCT00251745|157074063|FG000|Overall Study|Pregnancy|0|||
48790813|NCT00251745|157074064|FG001|Overall Study|Pregnancy|1|||
48790814|NCT00251745|157074065|FG002|Overall Study|Pregnancy|0|||
48790815|NCT00251745|157074063|FG000|Overall Study|Per Subject Request|0|||
48790816|NCT00251745|157074064|FG001|Overall Study|Per Subject Request|0|||
48790817|NCT00251745|157074065|FG002|Overall Study|Per Subject Request|1|||
48790818|NCT00251745|157074063|FG000|Overall Study|Per Investigator Request|1|||
48790819|NCT00251745|157074064|FG001|Overall Study|Per Investigator Request|0|||
48790820|NCT00251745|157074065|FG002|Overall Study|Per Investigator Request|0|||
48790821|NCT00489970|157074066|FG000|Persistence Year 9|Lost to Follow-up|2|||
48790822|NCT00489970|157074067|FG001|Persistence Year 9|Lost to Follow-up|2|||
48790823|NCT00489970|157074068|FG002|Persistence Year 9|Lost to Follow-up|3|||
48790824|NCT00489970|157074066|FG000|Persistence Year 9|Other|1|||
48790825|NCT00489970|157074067|FG001|Persistence Year 9|Other|0|||
48790826|NCT00489970|157074068|FG002|Persistence Year 9|Other|2|||
48790827|NCT02891187|157074069|FG000|Overall Study|Lost to Follow-up|1|||
48790828|NCT02891187|157074070|FG001|Overall Study|Lost to Follow-up|2|||
48790829|NCT03320070|157074073|FG000|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
48790830|NCT03320070|157074074|FG001|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
48790831|NCT03320070|157074073|FG000|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
48790832|NCT03320070|157074074|FG001|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
48790833|NCT03320070|157074073|FG000|OLE Phase (Week 25 to Week 48)|Adverse Event|3|||
48790834|NCT03320070|157074074|FG001|OLE Phase (Week 25 to Week 48)|Adverse Event|0|||
48790835|NCT03320070|157074073|FG000|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|0|||
48790836|NCT03320070|157074074|FG001|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|1|||
48790837|NCT03320070|157074073|FG000|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|1|||
48790838|NCT03320070|157074074|FG001|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|0|||
48790839|NCT03320070|157074073|FG000|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
48790840|NCT03320070|157074074|FG001|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
48790841|NCT01880424|157074078|FG000|Overall Study|Adverse Event|7|||
48790842|NCT01880424|157074079|FG001|Overall Study|Adverse Event|6|||
48790843|NCT01880424|157074078|FG000|Overall Study|Lack of Efficacy|1|||
48790844|NCT01880424|157074079|FG001|Overall Study|Lack of Efficacy|4|||
48790845|NCT01880424|157074078|FG000|Overall Study|Lost to Follow-up|3|||
48790846|NCT01880424|157074079|FG001|Overall Study|Lost to Follow-up|2|||
48790847|NCT01880424|157074078|FG000|Overall Study|Protocol Violation|11|||
48790848|NCT01880424|157074079|FG001|Overall Study|Protocol Violation|13|||
48790849|NCT01880424|157074078|FG000|Overall Study|Withdrawal by Subject|10|||
48790850|NCT01880424|157074079|FG001|Overall Study|Withdrawal by Subject|30|||
48790851|NCT01880424|157074078|FG000|Overall Study|Other|1|||
48790852|NCT01880424|157074079|FG001|Overall Study|Other|0|||
48790853|NCT01275625|157074080|FG000|Overall Study|Death|1|||
48790854|NCT01275625|157074080|FG000|Overall Study|Lack of Efficacy|2|||
48790855|NCT01275625|157074080|FG000|Overall Study|Lost to Follow-up|1|||
48790856|NCT01275625|157074080|FG000|Overall Study|Withdrawal by Subject|3|||
48790857|NCT01275625|157074080|FG000|Overall Study|Protocol Violation|1|||
48790858|NCT01275625|157074080|FG000|Overall Study|Adverse Event|4|||
48790859|NCT01275625|157074080|FG000|Overall Study|Other|1|||
48790860|NCT02062632|157074083|FG000|Overall Study|No treatment data|1|||
48790861|NCT05403801|157074084|FG000|Overall Study|Withdrawal by Subject|2|||
48983462|NCT02477800|157772264|FG002|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
48983463|NCT02477800|157772265|FG003|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
48983464|NCT02477800|157772266|FG004|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
48983465|NCT02477800|157772267|FG005|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
48790866|NCT02105116|157074087|FG000|Overall Study|not eligible for step 2 of trial|5|||
48790867|NCT02105116|157074087|FG000|Overall Study|Death|1|||
48790868|NCT00263666|157074088|FG000|Overall Study|Adverse Event|6|||
48790869|NCT00263666|157074089|FG001|Overall Study|Adverse Event|8|||
48790870|NCT00263666|157074088|FG000|Overall Study|Lost to Follow-up|1|||
48790871|NCT00263666|157074089|FG001|Overall Study|Lost to Follow-up|2|||
48790872|NCT00263666|157074088|FG000|Overall Study|Withdrawal by Subject|0|||
48790873|NCT00263666|157074089|FG001|Overall Study|Withdrawal by Subject|1|||
48790874|NCT00896168|157074090|FG000|Overall Study|Adverse Event|4|||
48790875|NCT00896168|157074091|FG001|Overall Study|Adverse Event|7|||
48790876|NCT00896168|157074090|FG000|Overall Study|Treatment failure|8|||
48790877|NCT00896168|157074091|FG001|Overall Study|Treatment failure|10|||
48790878|NCT00896168|157074090|FG000|Overall Study|Lost to Follow-up|1|||
48790879|NCT00896168|157074091|FG001|Overall Study|Lost to Follow-up|1|||
48790880|NCT00896168|157074090|FG000|Overall Study|Other|1|||
48790881|NCT00896168|157074091|FG001|Overall Study|Other|1|||
48790882|NCT00902304|157074092|FG000|Overall Study|Adverse Event|4|||
48790883|NCT00902304|157074093|FG001|Overall Study|Adverse Event|10|||
48790884|NCT00902304|157074094|FG002|Overall Study|Adverse Event|25|||
48790885|NCT00902304|157074092|FG000|Overall Study|Investigator discretion|3|||
48790886|NCT00902304|157074093|FG001|Overall Study|Investigator discretion|5|||
48790887|NCT00902304|157074094|FG002|Overall Study|Investigator discretion|13|||
48790888|NCT00902304|157074092|FG000|Overall Study|Lost to Follow-up|7|||
48790889|NCT00902304|157074093|FG001|Overall Study|Lost to Follow-up|7|||
48790890|NCT00902304|157074094|FG002|Overall Study|Lost to Follow-up|7|||
48790891|NCT00902304|157074092|FG000|Overall Study|Protocol Violation|9|||
48790892|NCT00902304|157074093|FG001|Overall Study|Protocol Violation|18|||
48790893|NCT00902304|157074094|FG002|Overall Study|Protocol Violation|20|||
48790894|NCT00902304|157074092|FG000|Overall Study|Withdrawal by Subject|32|||
48790895|NCT00902304|157074093|FG001|Overall Study|Withdrawal by Subject|22|||
48790896|NCT00902304|157074094|FG002|Overall Study|Withdrawal by Subject|43|||
48790897|NCT00902304|157074092|FG000|Overall Study|includes pregnancy|3|||
48790898|NCT00902304|157074093|FG001|Overall Study|includes pregnancy|9|||
48790899|NCT00902304|157074094|FG002|Overall Study|includes pregnancy|2|||
48790900|NCT01262651|157074099|FG000|Overall Study|Adverse Event|40|||
48790901|NCT01262651|157074100|FG001|Overall Study|Adverse Event|35|||
48790902|NCT01262651|157074099|FG000|Overall Study|Withdrawal by Subject|15|||
48790903|NCT01262651|157074100|FG001|Overall Study|Withdrawal by Subject|11|||
48790904|NCT01262651|157074099|FG000|Overall Study|Withdrawal by Investigator|2|||
48790905|NCT01262651|157074100|FG001|Overall Study|Withdrawal by Investigator|2|||
48790906|NCT01262651|157074099|FG000|Overall Study|Met Withdrawal Criteria|1|||
48790907|NCT01262651|157074100|FG001|Overall Study|Met Withdrawal Criteria|0|||
48790908|NCT03162224|157074104|FG000|Overall Study|Death|4|||
48790909|NCT03162224|157074105|FG001|Overall Study|Death|5|||
48790910|NCT03162224|157074106|FG002|Overall Study|Death|8|||
48790911|NCT03162224|157074104|FG000|Overall Study|Withdrawal by Subject|1|||
48790912|NCT03162224|157074105|FG001|Overall Study|Withdrawal by Subject|0|||
48790913|NCT03162224|157074106|FG002|Overall Study|Withdrawal by Subject|1|||
48790914|NCT03162224|157074104|FG000|Overall Study|Lost to Follow-up|0|||
48790915|NCT03162224|157074105|FG001|Overall Study|Lost to Follow-up|1|||
48790916|NCT03162224|157074106|FG002|Overall Study|Lost to Follow-up|0|||
48790917|NCT03162224|157074104|FG000|Overall Study|Other|6|||
48790918|NCT03162224|157074105|FG001|Overall Study|Other|2|||
48790919|NCT03162224|157074106|FG002|Overall Study|Other|1|||
48790920|NCT05021640|157074107|FG000|Overall Study|Lost to Follow-up|0|||
48790921|NCT05021640|157074108|FG001|Overall Study|Lost to Follow-up|0|||
48790922|NCT05021640|157074109|FG002|Overall Study|Lost to Follow-up|0|||
48790923|NCT05021640|157074110|FG003|Overall Study|Lost to Follow-up|0|||
48790924|NCT05021640|157074111|FG004|Overall Study|Lost to Follow-up|1|||
48790925|NCT02566031|157074112|FG000|Overall Study|Patient/guardian decision|14|||
48790926|NCT02566031|157074113|FG001|Overall Study|Patient/guardian decision|7|||
48790927|NCT02566031|157074112|FG000|Overall Study|Protocol deviation|2|||
48790928|NCT02566031|157074113|FG001|Overall Study|Protocol deviation|3|||
48790929|NCT02566031|157074112|FG000|Overall Study|Adverse Event|3|||
48790930|NCT02566031|157074113|FG001|Overall Study|Adverse Event|1|||
48790931|NCT02566031|157074112|FG000|Overall Study|Lost to Follow-up|1|||
48790932|NCT02566031|157074113|FG001|Overall Study|Lost to Follow-up|1|||
48983466|NCT02477800|157772268|FG006|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
48790933|NCT03204279|157074114|FG000|Overall Study|Withdrawal by Subject|0|||
48790934|NCT03204279|157074115|FG001|Overall Study|Withdrawal by Subject|1|||
48790935|NCT02277106|157074116|FG000|Stage 2|Adverse Event|0|||
48790936|NCT02277106|157074117|FG001|Stage 2|Adverse Event|0|||
48790937|NCT02277106|157074118|FG002|Stage 2|Adverse Event|1|||
48790938|NCT01064739|157074119|FG000|Fixed Sodium Diet + Fava Beans|Adverse Event|1|||
48790939|NCT04827212|157074122|FG000|Baseline to 16 Weeks|Lost to Follow-up|2|||
48790940|NCT04827212|157074123|FG001|Baseline to 16 Weeks|Lost to Follow-up|2|||
48790941|NCT04827212|157074122|FG000|16 to 24 Weeks|Lost to Follow-up|3|||
48790942|NCT04827212|157074123|FG001|16 to 24 Weeks|Lost to Follow-up|4|||
48790943|NCT03058679|157074126|FG000|Baseline to Week 6|Lost to Follow-up|3|||
48790944|NCT03058679|157074127|FG001|Baseline to Week 6|Lost to Follow-up|2|||
48790945|NCT03058679|157074126|FG000|Baseline to Week 6|Change in Crohn's disease medication|4|||
48790946|NCT03058679|157074127|FG001|Baseline to Week 6|Change in Crohn's disease medication|2|||
48790947|NCT03058679|157074126|FG000|Baseline to Week 6|Adverse Event|6|||
48790948|NCT03058679|157074127|FG001|Baseline to Week 6|Adverse Event|6|||
48790949|NCT03058679|157074126|FG000|Baseline to Week 6|Withdrawal by Subject|4|||
48790950|NCT03058679|157074127|FG001|Baseline to Week 6|Withdrawal by Subject|3|||
48790951|NCT03058679|157074126|FG000|Baseline to Week 6|Difficulty following the diet|0|||
48790952|NCT03058679|157074127|FG001|Baseline to Week 6|Difficulty following the diet|2|||
48790953|NCT03058679|157074126|FG000|Baseline to Week 6|Physician Decision|1|||
48790954|NCT03058679|157074127|FG001|Baseline to Week 6|Physician Decision|0|||
48790955|NCT03058679|157074126|FG000|Week 6 to Week 12|Change in medication|5|||
48790956|NCT03058679|157074127|FG001|Week 6 to Week 12|Change in medication|7|||
48790957|NCT03058679|157074126|FG000|Week 6 to Week 12|Adverse Event|4|||
48790958|NCT03058679|157074127|FG001|Week 6 to Week 12|Adverse Event|3|||
48790959|NCT03058679|157074126|FG000|Week 6 to Week 12|Withdrawal by Subject|9|||
48790960|NCT03058679|157074127|FG001|Week 6 to Week 12|Withdrawal by Subject|4|||
48790961|NCT03058679|157074126|FG000|Week 6 to Week 12|Difficulty following the assigned diet|2|||
48790962|NCT03058679|157074127|FG001|Week 6 to Week 12|Difficulty following the assigned diet|3|||
48790963|NCT01260350|157074130|FG000|Overall Study|Lack of Efficacy|0|||
48790964|NCT01260350|157074131|FG001|Overall Study|Lack of Efficacy|0|||
48790965|NCT01260350|157074132|FG002|Overall Study|Lack of Efficacy|0|||
48790966|NCT01260350|157074133|FG003|Overall Study|Lack of Efficacy|0|||
48790967|NCT01260350|157074134|FG004|Overall Study|Lack of Efficacy|0|||
48790968|NCT01260350|157074135|FG005|Overall Study|Lack of Efficacy|0|||
48790969|NCT01260350|157074136|FG006|Overall Study|Lack of Efficacy|0|||
48790970|NCT01260350|157074137|FG007|Overall Study|Lack of Efficacy|0|||
48790971|NCT01260350|157074138|FG008|Overall Study|Lack of Efficacy|0|||
48790972|NCT01260350|157074139|FG009|Overall Study|Lack of Efficacy|0|||
48790973|NCT01260350|157074140|FG010|Overall Study|Lack of Efficacy|0|||
48790974|NCT01260350|157074141|FG011|Overall Study|Lack of Efficacy|0|||
48790975|NCT01260350|157074142|FG012|Overall Study|Lack of Efficacy|0|||
48790976|NCT01260350|157074143|FG013|Overall Study|Lack of Efficacy|0|||
48790977|NCT01260350|157074144|FG014|Overall Study|Lack of Efficacy|0|||
48790978|NCT01260350|157074145|FG015|Overall Study|Lack of Efficacy|0|||
48790979|NCT01260350|157074146|FG016|Overall Study|Lack of Efficacy|0|||
48790980|NCT01260350|157074147|FG017|Overall Study|Lack of Efficacy|1|||
48790981|NCT01260350|157074148|FG018|Overall Study|Lack of Efficacy|0|||
48790982|NCT01260350|157074149|FG019|Overall Study|Lack of Efficacy|0|||
48790983|NCT01260350|157074150|FG020|Overall Study|Lack of Efficacy|3|||
48790984|NCT01260350|157074151|FG021|Overall Study|Lack of Efficacy|0|||
48790985|NCT01260350|157074130|FG000|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
48790986|NCT01260350|157074131|FG001|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
48790987|NCT01260350|157074132|FG002|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
48790988|NCT01260350|157074133|FG003|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
48790989|NCT01260350|157074134|FG004|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
48790990|NCT01260350|157074135|FG005|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
48790991|NCT01260350|157074136|FG006|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
48790992|NCT01260350|157074137|FG007|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
48790993|NCT01260350|157074138|FG008|Overall Study|Did Not Complete Follow-up 12 Visit|1|||
48790994|NCT01260350|157074139|FG009|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
48790995|NCT01260350|157074140|FG010|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
48790996|NCT01260350|157074141|FG011|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
48790997|NCT01260350|157074142|FG012|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
48790998|NCT01260350|157074143|FG013|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
48790999|NCT01260350|157074144|FG014|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
48791000|NCT01260350|157074145|FG015|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
48791001|NCT01260350|157074146|FG016|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
48791002|NCT01260350|157074147|FG017|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
48791003|NCT01260350|157074148|FG018|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
49032328|NCT01597245|157953490|FG020|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
48791004|NCT01260350|157074149|FG019|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
48791005|NCT01260350|157074150|FG020|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
48791006|NCT01260350|157074151|FG021|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
48791007|NCT03834779|157074154|FG000|Overall Study|Death|1|||
48878023|NCT01646385|157392121|FG000|Overall Study|Switched to alternate biologic|636|||
48878024|NCT01646385|157392122|FG001|Overall Study|Switched to alternate biologic|649|||
48878025|NCT03721172|157392123|FG000|Placebo-controlled Phase|Adverse Event|7|||
48878026|NCT03721172|157392124|FG001|Placebo-controlled Phase|Adverse Event|7|||
48878027|NCT03721172|157392125|FG002|Placebo-controlled Phase|Adverse Event|0|||
48878028|NCT03721172|157392123|FG000|Placebo-controlled Phase|Lack of Efficacy|4|||
48878029|NCT03721172|157392124|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
48878030|NCT03721172|157392125|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
48878031|NCT03721172|157392123|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
48878032|NCT03721172|157392124|FG001|Placebo-controlled Phase|Non-compliance with study drug|1|||
48878033|NCT03721172|157392125|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
48878034|NCT03721172|157392123|FG000|Placebo-controlled Phase|Lost to Follow-up|15|||
48878035|NCT03721172|157392124|FG001|Placebo-controlled Phase|Lost to Follow-up|13|||
48878036|NCT03721172|157392125|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
48878037|NCT03721172|157392123|FG000|Placebo-controlled Phase|Withdrawal by Subject|23|||
48878038|NCT03721172|157392124|FG001|Placebo-controlled Phase|Withdrawal by Subject|18|||
48878039|NCT03721172|157392125|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
49032329|NCT01597245|157953470|FG000|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
49032330|NCT01597245|157953471|FG001|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
49032331|NCT01597245|157953472|FG002|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
49032332|NCT01597245|157953473|FG003|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
49032333|NCT01597245|157953474|FG004|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
49032334|NCT01597245|157953475|FG005|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
49032335|NCT01597245|157953476|FG006|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
49032336|NCT01597245|157953477|FG007|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
49032337|NCT01597245|157953478|FG008|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
49032338|NCT01597245|157953479|FG009|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
49032339|NCT01597245|157953480|FG010|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
48791008|NCT03834779|157074155|FG001|Overall Study|Death|2|||
48878040|NCT03721172|157392123|FG000|Placebo-controlled Phase|Other|3|||
48878041|NCT03721172|157392124|FG001|Placebo-controlled Phase|Other|0|||
48878042|NCT03721172|157392125|FG002|Placebo-controlled Phase|Other|0|||
48791009|NCT03834779|157074154|FG000|Overall Study|Lost to Follow-up|6|||
48791010|NCT03834779|157074155|FG001|Overall Study|Lost to Follow-up|4|||
48791011|NCT02530671|157074156|FG000|Overall Study|Lost to Follow-up|2|||
48791012|NCT02530671|157074157|FG001|Overall Study|Lost to Follow-up|0|||
48791013|NCT02530671|157074156|FG000|Overall Study|Withdrawal by Subject|1|||
48791014|NCT02530671|157074157|FG001|Overall Study|Withdrawal by Subject|0|||
48791015|NCT05178316|157074158|FG000|Overall Study|Adverse Event|5|||
48878043|NCT03721172|157392123|FG000|Apremilast Extension Phase|Adverse Event|0|||
48878044|NCT03721172|157392124|FG001|Apremilast Extension Phase|Adverse Event|0|||
48878045|NCT03721172|157392125|FG002|Apremilast Extension Phase|Adverse Event|10|||
48878046|NCT03721172|157392123|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
48878047|NCT03721172|157392124|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
48878048|NCT03721172|157392125|FG002|Apremilast Extension Phase|Lack of Efficacy|2|||
48878049|NCT03721172|157392123|FG000|Apremilast Extension Phase|Non-compliance with study drug|0|||
48878050|NCT03721172|157392124|FG001|Apremilast Extension Phase|Non-compliance with study drug|0|||
49032340|NCT01597245|157953481|FG011|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
49032341|NCT01597245|157953482|FG012|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
49032342|NCT01597245|157953483|FG013|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
49032343|NCT01597245|157953484|FG014|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
48791016|NCT05178316|157074159|FG001|Overall Study|Adverse Event|4|||
48791017|NCT05178316|157074160|FG002|Overall Study|Adverse Event|9|||
48791018|NCT05178316|157074158|FG000|Overall Study|Enrolled in Error|1|||
48791019|NCT05178316|157074159|FG001|Overall Study|Enrolled in Error|2|||
48791020|NCT05178316|157074160|FG002|Overall Study|Enrolled in Error|1|||
48791021|NCT05178316|157074158|FG000|Overall Study|Lost to Follow-up|3|||
48791022|NCT05178316|157074159|FG001|Overall Study|Lost to Follow-up|15|||
48791023|NCT05178316|157074160|FG002|Overall Study|Lost to Follow-up|11|||
48791024|NCT05178316|157074158|FG000|Overall Study|Noncompliance|1|||
48791025|NCT05178316|157074159|FG001|Overall Study|Noncompliance|3|||
48878051|NCT03721172|157392125|FG002|Apremilast Extension Phase|Non-compliance with study drug|1|||
49032344|NCT01597245|157953485|FG015|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
49032345|NCT01597245|157953486|FG016|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
48878052|NCT03721172|157392123|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
48878053|NCT03721172|157392124|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
48791026|NCT05178316|157074160|FG002|Overall Study|Noncompliance|1|||
48878054|NCT03721172|157392125|FG002|Apremilast Extension Phase|Lost to Follow-up|20|||
48878055|NCT03721172|157392123|FG000|Apremilast Extension Phase|Protocol Violation|0|||
48878056|NCT03721172|157392124|FG001|Apremilast Extension Phase|Protocol Violation|0|||
48878057|NCT03721172|157392125|FG002|Apremilast Extension Phase|Protocol Violation|1|||
48878058|NCT03721172|157392123|FG000|Apremilast Extension Phase|Physician Decision|0|||
48878059|NCT03721172|157392124|FG001|Apremilast Extension Phase|Physician Decision|0|||
48878060|NCT03721172|157392125|FG002|Apremilast Extension Phase|Physician Decision|1|||
48878061|NCT03721172|157392123|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
48878062|NCT03721172|157392124|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
48878063|NCT03721172|157392125|FG002|Apremilast Extension Phase|Withdrawal by Subject|21|||
48878064|NCT03721172|157392123|FG000|Apremilast Extension Phase|Other|0|||
48791027|NCT05178316|157074158|FG000|Overall Study|Other|0|||
48791028|NCT05178316|157074159|FG001|Overall Study|Other|1|||
48791029|NCT05178316|157074160|FG002|Overall Study|Other|0|||
48791030|NCT05178316|157074158|FG000|Overall Study|Physician Decision|0|||
48791031|NCT05178316|157074159|FG001|Overall Study|Physician Decision|3|||
48791032|NCT05178316|157074160|FG002|Overall Study|Physician Decision|2|||
48791033|NCT05178316|157074158|FG000|Overall Study|Protocol deviation|1|||
48791034|NCT05178316|157074159|FG001|Overall Study|Protocol deviation|0|||
48791035|NCT05178316|157074160|FG002|Overall Study|Protocol deviation|1|||
48791036|NCT05178316|157074158|FG000|Overall Study|Sponsor decision|1|||
48791037|NCT05178316|157074159|FG001|Overall Study|Sponsor decision|0|||
48791038|NCT05178316|157074160|FG002|Overall Study|Sponsor decision|1|||
48791039|NCT05178316|157074158|FG000|Overall Study|Withdrawal by Subject|5|||
48791040|NCT05178316|157074159|FG001|Overall Study|Withdrawal by Subject|11|||
48791041|NCT05178316|157074160|FG002|Overall Study|Withdrawal by Subject|5|||
48791042|NCT00418886|157074161|FG000|Randomized Period|discontinue treatment survival follow-up|90|||
48791043|NCT00418886|157074162|FG001|Randomized Period|discontinue treatment survival follow-up|91|||
48791044|NCT00418886|157074161|FG000|Randomized Period|Death|122|||
48791045|NCT00418886|157074162|FG001|Randomized Period|Death|147|||
48791046|NCT00418886|157074161|FG000|Randomized Period|Withdrawal by Subject|9|||
48791047|NCT00418886|157074162|FG001|Randomized Period|Withdrawal by Subject|10|||
48791048|NCT00418886|157074161|FG000|Randomized Period|Lost to Follow-up|4|||
48791049|NCT00418886|157074162|FG001|Randomized Period|Lost to Follow-up|6|||
48791050|NCT00418886|157074161|FG000|Randomized Period|withdrawn due to other reason|1|||
48791051|NCT00418886|157074162|FG001|Randomized Period|withdrawn due to other reason|0|||
48791052|NCT00418886|157074161|FG000|Randomized Period|randomised but no treatment received|0|||
48791053|NCT00418886|157074162|FG001|Randomized Period|randomised but no treatment received|1|||
48791054|NCT01343407|157074163|FG000|Second Treatment Period (Part 2)|Adverse Event|0|||
48791055|NCT01343407|157074164|FG001|Second Treatment Period (Part 2)|Adverse Event|0|||
48791056|NCT01343407|157074165|FG002|Second Treatment Period (Part 2)|Adverse Event|1|||
48791057|NCT01343407|157074166|FG003|Second Treatment Period (Part 2)|Adverse Event|0|||
48791058|NCT01343407|157074167|FG004|Second Treatment Period (Part 2)|Adverse Event|0|||
48791059|NCT01343407|157074168|FG005|Second Treatment Period (Part 2)|Adverse Event|0|||
48878065|NCT03721172|157392124|FG001|Apremilast Extension Phase|Other|0|||
48878066|NCT03721172|157392125|FG002|Apremilast Extension Phase|Other|3|||
48878067|NCT03721172|157392123|FG000|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
48878068|NCT03721172|157392124|FG001|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
48878069|NCT03721172|157392125|FG002|Apremilast Extension Phase|Other (Related to COVID-19)|7|||
48878070|NCT01216072|157392129|FG000|Open-Label Core Period ( 6 Months)|Adverse Event|40|||
48878071|NCT01216072|157392130|FG001|Open-Label Core Period ( 6 Months)|Adverse Event|4|||
48791060|NCT01343407|157074163|FG000|Second Washout (Part 2)|Withdrawal by Subject|0|||
48791061|NCT01343407|157074164|FG001|Second Washout (Part 2)|Withdrawal by Subject|0|||
48791062|NCT01343407|157074165|FG002|Second Washout (Part 2)|Withdrawal by Subject|1|||
48791063|NCT01343407|157074166|FG003|Second Washout (Part 2)|Withdrawal by Subject|0|||
48791064|NCT01343407|157074167|FG004|Second Washout (Part 2)|Withdrawal by Subject|0|||
48791065|NCT01343407|157074168|FG005|Second Washout (Part 2)|Withdrawal by Subject|0|||
48791066|NCT03950739|157074169|FG000|Treatment Phase|Adverse Event|2|||
48791067|NCT03950739|157074169|FG000|Optional Extension Phase|Death|1|||
48791068|NCT03950739|157074169|FG000|Optional Extension Phase|Progressive Disease|5|||
48791069|NCT03950739|157074169|FG000|Optional Extension Phase|Adverse Event|7|||
48791070|NCT03950739|157074169|FG000|Optional Extension Phase|Lost to Follow-up|2|||
48791071|NCT03950739|157074169|FG000|Optional Extension Phase|Site Closure|2|||
48791072|NCT03950739|157074169|FG000|Optional Extension Phase|Pregnancy|1|||
48791073|NCT01972841|157074170|FG000|Overall Study|Randomized but Never Received Treatment|2|||
48791074|NCT01972841|157074171|FG001|Overall Study|Randomized but Never Received Treatment|5|||
48791075|NCT01972841|157074172|FG002|Overall Study|Randomized but Never Received Treatment|4|||
48791076|NCT01972841|157074173|FG003|Overall Study|Randomized but Never Received Treatment|2|||
48791077|NCT01972841|157074174|FG004|Overall Study|Randomized but Never Received Treatment|6|||
48791078|NCT01972841|157074175|FG005|Overall Study|Randomized but Never Received Treatment|13|||
48791079|NCT01972841|157074170|FG000|Overall Study|Adverse Event|13|||
48791080|NCT01972841|157074171|FG001|Overall Study|Adverse Event|8|||
48791081|NCT01972841|157074172|FG002|Overall Study|Adverse Event|12|||
48791082|NCT01972841|157074173|FG003|Overall Study|Adverse Event|9|||
48791083|NCT01972841|157074174|FG004|Overall Study|Adverse Event|21|||
48791084|NCT01972841|157074175|FG005|Overall Study|Adverse Event|26|||
48791085|NCT01972841|157074170|FG000|Overall Study|Lack of Efficacy|1|||
48791086|NCT01972841|157074171|FG001|Overall Study|Lack of Efficacy|0|||
48791087|NCT01972841|157074172|FG002|Overall Study|Lack of Efficacy|0|||
48791088|NCT01972841|157074173|FG003|Overall Study|Lack of Efficacy|2|||
48791089|NCT01972841|157074174|FG004|Overall Study|Lack of Efficacy|4|||
48791090|NCT01972841|157074175|FG005|Overall Study|Lack of Efficacy|1|||
48791091|NCT01972841|157074170|FG000|Overall Study|Lost to Follow-up|4|||
48791092|NCT01972841|157074171|FG001|Overall Study|Lost to Follow-up|2|||
48791093|NCT01972841|157074172|FG002|Overall Study|Lost to Follow-up|4|||
48791094|NCT01972841|157074173|FG003|Overall Study|Lost to Follow-up|2|||
48791095|NCT01972841|157074174|FG004|Overall Study|Lost to Follow-up|9|||
48791096|NCT01972841|157074175|FG005|Overall Study|Lost to Follow-up|3|||
48791097|NCT01972841|157074170|FG000|Overall Study|Protocol Violation|2|||
48791098|NCT01972841|157074171|FG001|Overall Study|Protocol Violation|2|||
48791099|NCT01972841|157074172|FG002|Overall Study|Protocol Violation|3|||
48791100|NCT01972841|157074173|FG003|Overall Study|Protocol Violation|5|||
48791101|NCT01972841|157074174|FG004|Overall Study|Protocol Violation|9|||
48791102|NCT01972841|157074175|FG005|Overall Study|Protocol Violation|4|||
48791103|NCT01972841|157074170|FG000|Overall Study|Withdrawal by participants|21|||
48791104|NCT01972841|157074171|FG001|Overall Study|Withdrawal by participants|27|||
48791105|NCT01972841|157074172|FG002|Overall Study|Withdrawal by participants|23|||
48791106|NCT01972841|157074173|FG003|Overall Study|Withdrawal by participants|16|||
48791107|NCT01972841|157074174|FG004|Overall Study|Withdrawal by participants|33|||
48791108|NCT01972841|157074175|FG005|Overall Study|Withdrawal by participants|34|||
48791109|NCT01972841|157074170|FG000|Overall Study|Miscellaneous|0|||
48791110|NCT01972841|157074171|FG001|Overall Study|Miscellaneous|0|||
48791111|NCT01972841|157074172|FG002|Overall Study|Miscellaneous|4|||
48791112|NCT01972841|157074173|FG003|Overall Study|Miscellaneous|1|||
48791113|NCT01972841|157074174|FG004|Overall Study|Miscellaneous|0|||
48791114|NCT01972841|157074175|FG005|Overall Study|Miscellaneous|4|||
48791115|NCT01972841|157074170|FG000|Overall Study|Did not have end of treatment page|0|||
48791116|NCT01972841|157074171|FG001|Overall Study|Did not have end of treatment page|0|||
48791117|NCT01972841|157074172|FG002|Overall Study|Did not have end of treatment page|0|||
48791118|NCT01972841|157074173|FG003|Overall Study|Did not have end of treatment page|0|||
48791119|NCT01972841|157074174|FG004|Overall Study|Did not have end of treatment page|1|||
48791120|NCT01972841|157074175|FG005|Overall Study|Did not have end of treatment page|0|||
48791121|NCT04526704|157074177|FG000|Overall Study|Adverse Event|1|||
48791122|NCT04526704|157074178|FG001|Overall Study|Adverse Event|0|||
48791123|NCT04526704|157074177|FG000|Overall Study|Physician Decision|1|||
48791124|NCT04526704|157074178|FG001|Overall Study|Physician Decision|0|||
48791125|NCT04526704|157074177|FG000|Overall Study|Withdrawal by Subject|2|||
48791126|NCT04526704|157074178|FG001|Overall Study|Withdrawal by Subject|0|||
48791127|NCT05453773|157074179|FG000|Overall Study|Withdrawal by Subject|3|||
48791128|NCT05453773|157074179|FG000|Overall Study|Lost to Follow-up|3|||
48791129|NCT05453773|157074179|FG000|Overall Study|Difficult Blood Draw|3|||
48791130|NCT01715805|157074181|FG000|Placebo + ADT Lead-in Period|Adverse Event|41|||
48791131|NCT01715805|157074182|FG001|Placebo + ADT Lead-in Period|Adverse Event|0|||
48791132|NCT01715805|157074183|FG002|Placebo + ADT Lead-in Period|Adverse Event|0|||
48791133|NCT01715805|157074184|FG003|Placebo + ADT Lead-in Period|Adverse Event|0|||
48791134|NCT01715805|157074181|FG000|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6|||
48791135|NCT01715805|157074182|FG001|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
48791136|NCT01715805|157074183|FG002|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
48791137|NCT01715805|157074184|FG003|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
48791138|NCT01715805|157074181|FG000|Placebo + ADT Lead-in Period|Protocol Violation|74|||
48791139|NCT01715805|157074182|FG001|Placebo + ADT Lead-in Period|Protocol Violation|0|||
48791140|NCT01715805|157074183|FG002|Placebo + ADT Lead-in Period|Protocol Violation|0|||
48791141|NCT01715805|157074184|FG003|Placebo + ADT Lead-in Period|Protocol Violation|0|||
48791142|NCT01715805|157074181|FG000|Placebo + ADT Lead-in Period|Withdrawal of Consent|49|||
48791143|NCT01715805|157074182|FG001|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
48791144|NCT01715805|157074183|FG002|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
48791145|NCT01715805|157074184|FG003|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
48791146|NCT01715805|157074181|FG000|Placebo + ADT Lead-in Period|Lost to Follow-up|34|||
48791147|NCT01715805|157074182|FG001|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
48791148|NCT01715805|157074183|FG002|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
48791149|NCT01715805|157074184|FG003|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
48791150|NCT01715805|157074181|FG000|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1|||
48791151|NCT01715805|157074182|FG001|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
49032346|NCT01597245|157953487|FG017|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
49032347|NCT01597245|157953488|FG018|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
49032348|NCT01597245|157953489|FG019|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
49032349|NCT01597245|157953490|FG020|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
48791152|NCT01715805|157074183|FG002|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
48791153|NCT01715805|157074184|FG003|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
48791154|NCT01715805|157074181|FG000|Placebo + ADT Lead-in Period|Other Reason Not Specified|10|||
48791155|NCT01715805|157074182|FG001|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
48791156|NCT01715805|157074183|FG002|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
48791157|NCT01715805|157074184|FG003|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
48791158|NCT01715805|157074181|FG000|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
48791159|NCT01715805|157074182|FG001|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
48791160|NCT01715805|157074183|FG002|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
48791161|NCT01715805|157074184|FG003|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1|||
48791162|NCT01715805|157074181|FG000|Double-Blind or Continued Treatment|Adverse Event|0|||
48791163|NCT01715805|157074182|FG001|Double-Blind or Continued Treatment|Adverse Event|3|||
48791164|NCT01715805|157074183|FG002|Double-Blind or Continued Treatment|Adverse Event|23|||
48791165|NCT01715805|157074184|FG003|Double-Blind or Continued Treatment|Adverse Event|2|||
48791166|NCT01715805|157074181|FG000|Double-Blind or Continued Treatment|Protocol Violation|0|||
48791167|NCT01715805|157074182|FG001|Double-Blind or Continued Treatment|Protocol Violation|14|||
48791168|NCT01715805|157074183|FG002|Double-Blind or Continued Treatment|Protocol Violation|12|||
48791169|NCT01715805|157074184|FG003|Double-Blind or Continued Treatment|Protocol Violation|19|||
48791170|NCT01715805|157074181|FG000|Double-Blind or Continued Treatment|Withdrawal of consent|0|||
48791171|NCT01715805|157074182|FG001|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
48791172|NCT01715805|157074183|FG002|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
48791173|NCT01715805|157074184|FG003|Double-Blind or Continued Treatment|Withdrawal of consent|13|||
48791174|NCT01715805|157074181|FG000|Double-Blind or Continued Treatment|Lost to Follow-up|0|||
48791175|NCT01715805|157074182|FG001|Double-Blind or Continued Treatment|Lost to Follow-up|7|||
48791176|NCT01715805|157074183|FG002|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
48791177|NCT01715805|157074184|FG003|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
48791178|NCT01715805|157074181|FG000|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
48791179|NCT01715805|157074182|FG001|Double-Blind or Continued Treatment|Other Reason Not Specified|1|||
48791180|NCT01715805|157074183|FG002|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
48791181|NCT01715805|157074184|FG003|Double-Blind or Continued Treatment|Other Reason Not Specified|3|||
48791182|NCT01715805|157074181|FG000|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
48791183|NCT01715805|157074182|FG001|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3|||
48791184|NCT01715805|157074183|FG002|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
48791185|NCT01715805|157074184|FG003|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
48791186|NCT04313881|157074185|FG000|Overall Study|Death|138|||
48791187|NCT04313881|157074186|FG001|Overall Study|Death|126|||
48791188|NCT04313881|157074185|FG000|Overall Study|Study terminated by sponsor|108|||
48791189|NCT04313881|157074186|FG001|Overall Study|Study terminated by sponsor|129|||
48791190|NCT04313881|157074185|FG000|Overall Study|Consent withdrawn|19|||
48791191|NCT04313881|157074186|FG001|Overall Study|Consent withdrawn|15|||
48791192|NCT04313881|157074185|FG000|Overall Study|Reason not Specified|3|||
48791193|NCT04313881|157074186|FG001|Overall Study|Reason not Specified|1|||
48791194|NCT02534909|157074191|FG000|Treatment Period 1 to 3 (up to Week 312)|Withdrawal by Subject|1|||
48791195|NCT01454583|157074193|FG000|1st Year|Lost to Follow-up|1057|||
48791196|NCT01454583|157074194|FG001|1st Year|Lost to Follow-up|318|||
48791197|NCT01454583|157074195|FG002|1st Year|Lost to Follow-up|180|||
48791198|NCT01454583|157074193|FG000|2nd Year|Lost to Follow-up|3965|||
48791199|NCT01454583|157074194|FG001|2nd Year|Lost to Follow-up|1049|||
48791200|NCT01454583|157074195|FG002|2nd Year|Lost to Follow-up|737|||
48791201|NCT01454583|157074193|FG000|3rd Year|Lost to Follow-up|1959|||
48791202|NCT01454583|157074194|FG001|3rd Year|Lost to Follow-up|512|||
48791203|NCT01454583|157074195|FG002|3rd Year|Lost to Follow-up|297|||
48791204|NCT02491671|157074196|FG000|Overall Study|Adverse Event|6|||
48791205|NCT02491671|157074197|FG001|Overall Study|Adverse Event|8|||
48791206|NCT02491671|157074196|FG000|Overall Study|Death|0|||
48791207|NCT02491671|157074197|FG001|Overall Study|Death|2|||
48791208|NCT02491671|157074196|FG000|Overall Study|Use of sealants other than Hemopatch|5|||
48791209|NCT02491671|157074197|FG001|Overall Study|Use of sealants other than Hemopatch|3|||
48791210|NCT01090453|157074198|FG000|Overall Study|Withdrawal by Subject|1|||
48791211|NCT01090453|157074199|FG001|Overall Study|Withdrawal by Subject|2|||
48791212|NCT01090453|157074198|FG000|Overall Study|Lost to Follow-up|7|||
48791213|NCT01090453|157074199|FG001|Overall Study|Lost to Follow-up|7|||
48791214|NCT01090453|157074198|FG000|Overall Study|Non serious AEs|1|||
48791215|NCT01090453|157074199|FG001|Overall Study|Non serious AEs|0|||
48791216|NCT01090453|157074198|FG000|Overall Study|Protocol Violation|2|||
48791217|NCT01090453|157074199|FG001|Overall Study|Protocol Violation|0|||
48791218|NCT01090453|157074198|FG000|Overall Study|Other|2|||
48791219|NCT01090453|157074199|FG001|Overall Study|Other|4|||
48791220|NCT01090453|157074198|FG000|Overall Study|Eligibility Criteria|0|||
48791221|NCT01090453|157074199|FG001|Overall Study|Eligibility Criteria|1|||
48791222|NCT03964454|157074202|FG000|Overall Study|Lost to Follow-up|13|||
48791223|NCT03964454|157074203|FG001|Overall Study|Lost to Follow-up|7|||
48791224|NCT03964454|157074202|FG000|Overall Study|Withdrawal by Subject|4|||
48791225|NCT03964454|157074203|FG001|Overall Study|Withdrawal by Subject|11|||
48791226|NCT01302119|157074204|FG000|Overall Study|Withdrawal by Subject|30|||
48791227|NCT01302119|157074205|FG001|Overall Study|Withdrawal by Subject|20|||
48791228|NCT01302119|157074204|FG000|Overall Study|Lost to Follow-up|10|||
48791229|NCT01302119|157074205|FG001|Overall Study|Lost to Follow-up|4|||
48791230|NCT01302119|157074204|FG000|Overall Study|Adverse Event|2|||
48791231|NCT01302119|157074205|FG001|Overall Study|Adverse Event|1|||
48791232|NCT01302119|157074204|FG000|Overall Study|Non-compliance|4|||
48791233|NCT01302119|157074205|FG001|Overall Study|Non-compliance|2|||
48791234|NCT01302119|157074204|FG000|Overall Study|Non-specific|4|||
48791235|NCT01302119|157074205|FG001|Overall Study|Non-specific|1|||
48791236|NCT01300546|157074212|FG000|Overall Study|Withdrawal by Subject|1|||
48791237|NCT01300546|157074213|FG001|Overall Study|Withdrawal by Subject|0|||
48791238|NCT01300546|157074212|FG000|Overall Study|Lost to Follow-up|0|||
48791239|NCT01300546|157074213|FG001|Overall Study|Lost to Follow-up|2|||
48791240|NCT01300546|157074212|FG000|Overall Study|Lack of Efficacy|0|||
48791241|NCT01300546|157074213|FG001|Overall Study|Lack of Efficacy|3|||
48791242|NCT01300546|157074212|FG000|Overall Study|Adverse Event|0|||
48791243|NCT01300546|157074213|FG001|Overall Study|Adverse Event|1|||
48791244|NCT01909934|157074217|FG000|Overall Study|Ongoing|23|||
48791245|NCT01909934|157074217|FG000|Overall Study|Withdrawal by Subject|3|||
48791246|NCT01909934|157074217|FG000|Overall Study|Lost to Follow-up|1|||
48791247|NCT01909934|157074217|FG000|Overall Study|Withdrawal of Informed Consent|1|||
48791248|NCT01909934|157074217|FG000|Overall Study|Death|22|||
48791249|NCT04988308|157074218|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|2|||
48791250|NCT04988308|157074219|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
48791251|NCT04988308|157074220|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
48791252|NCT04988308|157074221|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
48791253|NCT04988308|157074222|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
48791254|NCT04988308|157074223|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
48791255|NCT04988308|157074218|FG000|Placebo Controlled Period (Weeks 0-16)|Death|0|||
48791256|NCT04988308|157074219|FG001|Placebo Controlled Period (Weeks 0-16)|Death|0|||
48791257|NCT04988308|157074220|FG002|Placebo Controlled Period (Weeks 0-16)|Death|1|||
48791258|NCT04988308|157074221|FG003|Placebo Controlled Period (Weeks 0-16)|Death|0|||
48791259|NCT04988308|157074222|FG004|Placebo Controlled Period (Weeks 0-16)|Death|0|||
48791260|NCT04988308|157074223|FG005|Placebo Controlled Period (Weeks 0-16)|Death|0|||
48791261|NCT04988308|157074218|FG000|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
48791262|NCT04988308|157074219|FG001|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
48791263|NCT04988308|157074220|FG002|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
48791264|NCT04988308|157074221|FG003|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
48791265|NCT04988308|157074222|FG004|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
48791266|NCT04988308|157074223|FG005|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
48791267|NCT04988308|157074218|FG000|Placebo Controlled Period (Weeks 0-16)|Other|10|||
48791268|NCT04988308|157074219|FG001|Placebo Controlled Period (Weeks 0-16)|Other|9|||
48791269|NCT04988308|157074220|FG002|Placebo Controlled Period (Weeks 0-16)|Other|14|||
48791270|NCT04988308|157074221|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
48791271|NCT04988308|157074222|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
48791272|NCT04988308|157074223|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
48791273|NCT04988308|157074218|FG000|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|6|||
48791274|NCT04988308|157074219|FG001|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|4|||
48791275|NCT04988308|157074220|FG002|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|3|||
48791276|NCT04988308|157074221|FG003|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
48791277|NCT04988308|157074222|FG004|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
48791278|NCT04988308|157074223|FG005|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
48791279|NCT04988308|157074218|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
48791280|NCT04988308|157074219|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
48791281|NCT04988308|157074220|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
48791282|NCT04988308|157074221|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|3|||
48791283|NCT04988308|157074222|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
48791284|NCT04988308|157074223|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
48791285|NCT04988308|157074218|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
48791286|NCT04988308|157074219|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
48791287|NCT04988308|157074220|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
48878072|NCT01216072|157392129|FG000|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2|||
48878073|NCT01216072|157392130|FG001|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0|||
48878074|NCT01216072|157392129|FG000|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3|||
48878075|NCT01216072|157392130|FG001|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0|||
49032350|NCT01597245|157953470|FG000|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
49032351|NCT01597245|157953471|FG001|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
49032352|NCT01597245|157953472|FG002|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
49032353|NCT01597245|157953473|FG003|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
49032354|NCT01597245|157953474|FG004|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
49032355|NCT01597245|157953475|FG005|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
48791288|NCT04988308|157074221|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
48791289|NCT04988308|157074222|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
48791290|NCT04988308|157074223|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
48791291|NCT04988308|157074218|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
48791292|NCT04988308|157074219|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
48791293|NCT04988308|157074220|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
48791294|NCT04988308|157074221|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
48791295|NCT04988308|157074222|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
48791296|NCT04988308|157074223|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|14|||
48791297|NCT04988308|157074218|FG000|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
48791298|NCT04988308|157074219|FG001|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
48791299|NCT04988308|157074220|FG002|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
48791300|NCT04988308|157074221|FG003|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|5|||
48791301|NCT04988308|157074222|FG004|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|6|||
48791302|NCT04988308|157074223|FG005|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|2|||
48791303|NCT04302350|157074225|FG000|Overall Study|Physician Decision|1|||
48791304|NCT04302350|157074226|FG001|Overall Study|Physician Decision|1|||
48791305|NCT04302350|157074227|FG002|Overall Study|Physician Decision|2|||
48791306|NCT04302350|157074225|FG000|Overall Study|Lack of Efficacy|1|||
48791307|NCT04302350|157074226|FG001|Overall Study|Lack of Efficacy|1|||
48791308|NCT04302350|157074227|FG002|Overall Study|Lack of Efficacy|4|||
48791309|NCT04302350|157074225|FG000|Overall Study|Adverse Event|0|||
48791310|NCT04302350|157074226|FG001|Overall Study|Adverse Event|1|||
48791311|NCT04302350|157074227|FG002|Overall Study|Adverse Event|2|||
48791312|NCT02313428|157074228|FG000|Overall Study|Lost to Follow-up|1|||
48791313|NCT02313428|157074229|FG001|Overall Study|Lost to Follow-up|1|||
48791314|NCT04482647|157074230|FG000|Overall Study|Time constraints|2|||
48791315|NCT04482647|157074230|FG000|Overall Study|Health issues|1|||
48791316|NCT04482647|157074230|FG000|Overall Study|Death in the family|1|||
48791317|NCT04482647|157074230|FG000|Overall Study|Disliked the intervention|1|||
48791318|NCT04482647|157074230|FG000|Overall Study|No reasons specified|7|||
48791319|NCT04537923|157076982|FG000|Overall Study|Adverse Event|2|||
48791320|NCT04537923|157076983|FG001|Overall Study|Adverse Event|1|||
48791321|NCT04537923|157076984|FG002|Overall Study|Adverse Event|2|||
48791322|NCT04537923|157076985|FG003|Overall Study|Adverse Event|4|||
48791323|NCT04537923|157076982|FG000|Overall Study|Death|3|||
48791324|NCT04537923|157076983|FG001|Overall Study|Death|3|||
48791325|NCT04537923|157076984|FG002|Overall Study|Death|1|||
48791326|NCT04537923|157076985|FG003|Overall Study|Death|11|||
48791327|NCT04537923|157076982|FG000|Overall Study|Lost to Follow-up|1|||
48791328|NCT04537923|157076983|FG001|Overall Study|Lost to Follow-up|2|||
48791329|NCT04537923|157076984|FG002|Overall Study|Lost to Follow-up|1|||
48791330|NCT04537923|157076985|FG003|Overall Study|Lost to Follow-up|6|||
48791331|NCT04537923|157076982|FG000|Overall Study|Physician Decision|1|||
48791332|NCT04537923|157076983|FG001|Overall Study|Physician Decision|0|||
48791333|NCT04537923|157076984|FG002|Overall Study|Physician Decision|2|||
48791334|NCT04537923|157076985|FG003|Overall Study|Physician Decision|5|||
48791335|NCT04537923|157076982|FG000|Overall Study|Pregnancy|1|||
48791336|NCT04537923|157076983|FG001|Overall Study|Pregnancy|0|||
48791337|NCT04537923|157076984|FG002|Overall Study|Pregnancy|0|||
48791338|NCT04537923|157076985|FG003|Overall Study|Pregnancy|0|||
48791339|NCT04537923|157076982|FG000|Overall Study|Withdrawal by Subject|4|||
48791340|NCT04537923|157076983|FG001|Overall Study|Withdrawal by Subject|4|||
48791341|NCT04537923|157076984|FG002|Overall Study|Withdrawal by Subject|4|||
48791342|NCT04537923|157076985|FG003|Overall Study|Withdrawal by Subject|58|||
48791343|NCT04537923|157076982|FG000|Overall Study|Missed study visits|2|||
48791344|NCT04537923|157076983|FG001|Overall Study|Missed study visits|0|||
48791345|NCT04537923|157076984|FG002|Overall Study|Missed study visits|0|||
48791346|NCT04537923|157076985|FG003|Overall Study|Missed study visits|3|||
48791347|NCT04537923|157076982|FG000|Overall Study|Sponsor's decision|0|||
48791348|NCT04537923|157076983|FG001|Overall Study|Sponsor's decision|0|||
48791349|NCT04537923|157076984|FG002|Overall Study|Sponsor's decision|1|||
48791350|NCT04537923|157076985|FG003|Overall Study|Sponsor's decision|1|||
48791351|NCT04537923|157076982|FG000|Overall Study|Safety reasons|1|||
48791352|NCT04537923|157076983|FG001|Overall Study|Safety reasons|0|||
48791353|NCT04537923|157076984|FG002|Overall Study|Safety reasons|0|||
48791354|NCT04537923|157076985|FG003|Overall Study|Safety reasons|0|||
48791355|NCT05349617|157076990|FG000|Overall Study|Death|1|||
48791356|NCT05349617|157076991|FG001|Overall Study|Death|1|||
48791357|NCT05349617|157076990|FG000|Overall Study|Lost to Follow-up|3|||
48791358|NCT05349617|157076991|FG001|Overall Study|Lost to Follow-up|8|||
48791359|NCT05349617|157076990|FG000|Overall Study|Withdrawal by Subject|2|||
48791360|NCT05349617|157076991|FG001|Overall Study|Withdrawal by Subject|10|||
48791361|NCT00674986|157076992|FG000|Overall Study|Adverse Event|2|||
48791362|NCT00674986|157076993|FG001|Overall Study|Adverse Event|1|||
48791363|NCT00674986|157076992|FG000|Overall Study|Subject withdrew consent|12|||
48791364|NCT00674986|157076993|FG001|Overall Study|Subject withdrew consent|19|||
48791365|NCT00674986|157076992|FG000|Overall Study|Lost to Follow-up|25|||
48791366|NCT00674986|157076993|FG001|Overall Study|Lost to Follow-up|53|||
48791367|NCT00674986|157076992|FG000|Overall Study|Other reasons|4|||
48791368|NCT00674986|157076993|FG001|Overall Study|Other reasons|8|||
48791369|NCT01912612|157076996|FG000|Overall Study|Adverse Event|4|||
48791370|NCT01912612|157076997|FG001|Overall Study|Adverse Event|0|||
48791371|NCT01912612|157076998|FG002|Overall Study|Adverse Event|0|||
48791372|NCT01912612|157076996|FG000|Overall Study|Withdrew consent|1|||
48791373|NCT01912612|157076997|FG001|Overall Study|Withdrew consent|0|||
48791374|NCT01912612|157076998|FG002|Overall Study|Withdrew consent|0|||
48791375|NCT01912612|157076996|FG000|Overall Study|Study design change|0|||
48791376|NCT01912612|157076997|FG001|Overall Study|Study design change|0|||
48791377|NCT01912612|157076998|FG002|Overall Study|Study design change|3|||
48791378|NCT01588184|157076999|FG000|Overall Study|Death|1|||
48791379|NCT01588184|157077000|FG001|Overall Study|Death|0|||
48791380|NCT01588184|157077001|FG002|Overall Study|Death|0|||
48791381|NCT01588184|157077002|FG003|Overall Study|Death|1|||
48791382|NCT01588184|157077003|FG004|Overall Study|Death|1|||
48791383|NCT01588184|157077004|FG005|Overall Study|Death|1|||
48791384|NCT01588184|157076999|FG000|Overall Study|Withdrawal by Subject|2|||
48791385|NCT01588184|157077000|FG001|Overall Study|Withdrawal by Subject|4|||
48791386|NCT01588184|157077001|FG002|Overall Study|Withdrawal by Subject|0|||
48791387|NCT01588184|157077002|FG003|Overall Study|Withdrawal by Subject|1|||
48791388|NCT01588184|157077003|FG004|Overall Study|Withdrawal by Subject|0|||
48791389|NCT01588184|157077004|FG005|Overall Study|Withdrawal by Subject|0|||
48791390|NCT01588184|157076999|FG000|Overall Study|Bevacizumab treatment provision changed|0|||
48791391|NCT01588184|157077000|FG001|Overall Study|Bevacizumab treatment provision changed|6|||
48791392|NCT01588184|157077001|FG002|Overall Study|Bevacizumab treatment provision changed|2|||
48791393|NCT01588184|157077002|FG003|Overall Study|Bevacizumab treatment provision changed|0|||
48791394|NCT01588184|157077003|FG004|Overall Study|Bevacizumab treatment provision changed|1|||
48791395|NCT01588184|157077004|FG005|Overall Study|Bevacizumab treatment provision changed|3|||
48791396|NCT01588184|157076999|FG000|Overall Study|multiple reasons|0|||
48791397|NCT01588184|157077000|FG001|Overall Study|multiple reasons|3|||
48791398|NCT01588184|157077001|FG002|Overall Study|multiple reasons|0|||
48791399|NCT01588184|157077002|FG003|Overall Study|multiple reasons|1|||
48791400|NCT01588184|157077003|FG004|Overall Study|multiple reasons|0|||
48791401|NCT01588184|157077004|FG005|Overall Study|multiple reasons|0|||
48791402|NCT01140880|157077005|FG000|Overall Study|Death|0|||
48791403|NCT01140880|157077006|FG001|Overall Study|Death|1|||
48791404|NCT01140880|157077005|FG000|Overall Study|Withdrawal by Subject|6|||
48791405|NCT01140880|157077006|FG001|Overall Study|Withdrawal by Subject|3|||
48791406|NCT01140880|157077005|FG000|Overall Study|Lost to Follow-up|8|||
48791407|NCT01140880|157077006|FG001|Overall Study|Lost to Follow-up|10|||
48791408|NCT01140880|157077005|FG000|Overall Study|Protocol Violation|0|||
48791409|NCT01140880|157077006|FG001|Overall Study|Protocol Violation|30|||
48791410|NCT02844946|157077013|FG000|Overall Study|Lost to Follow-up|7|||
48791411|NCT02844946|157077014|FG001|Overall Study|Lost to Follow-up|0|||
48791412|NCT01605617|157077015|FG000|First Intervention|Adverse Event|0|||
48791413|NCT01605617|157077016|FG001|First Intervention|Adverse Event|1|||
48791414|NCT01605617|157077015|FG000|Washout Period of 4 Weeks|Study Terminated|2|||
48791415|NCT01605617|157077016|FG001|Washout Period of 4 Weeks|Study Terminated|1|||
48791416|NCT00868439|157077017|FG000|Overall Study|Adverse Event|4|||
48791417|NCT00868439|157077018|FG001|Overall Study|Adverse Event|3|||
48791418|NCT00868439|157077017|FG000|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2|||
48791419|NCT00868439|157077018|FG001|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3|||
48791420|NCT00868439|157077017|FG000|Overall Study|Death|0|||
48791421|NCT00868439|157077018|FG001|Overall Study|Death|1|||
48791422|NCT00868439|157077017|FG000|Overall Study|Protocol Violation|1|||
48791423|NCT00868439|157077018|FG001|Overall Study|Protocol Violation|1|||
48791424|NCT00868439|157077017|FG000|Overall Study|Physician Decision|1|||
48791425|NCT00868439|157077018|FG001|Overall Study|Physician Decision|0|||
48791426|NCT00868439|157077017|FG000|Overall Study|Withdrawal by Subject|0|||
48791427|NCT00868439|157077018|FG001|Overall Study|Withdrawal by Subject|1|||
48791428|NCT04903288|157077019|FG000|Extension Phase (48 Weeks)|Withdrawal by Subject|1|||
48791429|NCT04903288|157077019|FG000|Extension Phase (48 Weeks)|Ongoing in the Study|3|||
48791430|NCT04903288|157077019|FG000|Long-Term Extension Phase (60 Months)|Withdrawal by Subject|1|||
48791431|NCT04903288|157077019|FG000|Long-Term Extension Phase (60 Months)|Ongoing in the Study|6|||
48791432|NCT03241745|157077023|FG000|Overall Study|Adverse Event|7|||
48791433|NCT03241745|157077023|FG000|Overall Study|Death|1|||
48791434|NCT03241745|157077023|FG000|Overall Study|Withdrawal by Subject|5|||
48791435|NCT03241745|157077023|FG000|Overall Study|Treatment delay >28 days|2|||
48791436|NCT03241745|157077023|FG000|Overall Study|Lack of Efficacy|14|||
48791437|NCT04391023|157077033|FG000|Overall Study|Withdrawal by Subject|2|||
48791438|NCT04391023|157077034|FG001|Overall Study|Withdrawal by Subject|2|||
48791439|NCT02085408|157077039|FG000|Step 1: Induction|Disease Progression|19|||
48791440|NCT02085408|157077040|FG001|Step 1: Induction|Disease Progression|19|||
48791441|NCT02085408|157077039|FG000|Step 1: Induction|Adverse Event|18|||
48791442|NCT02085408|157077040|FG001|Step 1: Induction|Adverse Event|17|||
48791443|NCT02085408|157077039|FG000|Step 1: Induction|Death|33|||
48791444|NCT02085408|157077040|FG001|Step 1: Induction|Death|30|||
48791445|NCT02085408|157077039|FG000|Step 1: Induction|Withdrawal by Subject|16|||
48791446|NCT02085408|157077040|FG001|Step 1: Induction|Withdrawal by Subject|8|||
48791447|NCT02085408|157077039|FG000|Step 1: Induction|Alternative Therapy|15|||
48791448|NCT02085408|157077040|FG001|Step 1: Induction|Alternative Therapy|19|||
48791449|NCT02085408|157077039|FG000|Step 1: Induction|Complicating Disease|2|||
48791450|NCT02085408|157077040|FG001|Step 1: Induction|Complicating Disease|3|||
48791451|NCT02085408|157077039|FG000|Step 1: Induction|Other|27|||
48791452|NCT02085408|157077040|FG001|Step 1: Induction|Other|39|||
48791453|NCT02085408|157077039|FG000|Step 1: Induction|Never started treatment|6|||
48791454|NCT02085408|157077040|FG001|Step 1: Induction|Never started treatment|4|||
48791455|NCT02085408|157077039|FG000|Step 2: Consolidation|Disease Progression|5|||
48791456|NCT02085408|157077040|FG001|Step 2: Consolidation|Disease Progression|20|||
48791457|NCT02085408|157077039|FG000|Step 2: Consolidation|Adverse Event|9|||
48791458|NCT02085408|157077040|FG001|Step 2: Consolidation|Adverse Event|8|||
48791459|NCT02085408|157077039|FG000|Step 2: Consolidation|Death|4|||
48791460|NCT02085408|157077040|FG001|Step 2: Consolidation|Death|3|||
48791461|NCT02085408|157077039|FG000|Step 2: Consolidation|Withdrawal by Subject|8|||
48791462|NCT02085408|157077040|FG001|Step 2: Consolidation|Withdrawal by Subject|5|||
48791463|NCT02085408|157077039|FG000|Step 2: Consolidation|Alternative Therapy|9|||
48791464|NCT02085408|157077040|FG001|Step 2: Consolidation|Alternative Therapy|3|||
48791465|NCT02085408|157077039|FG000|Step 2: Consolidation|Complicating Disease|0|||
48791466|NCT02085408|157077040|FG001|Step 2: Consolidation|Complicating Disease|2|||
48791467|NCT02085408|157077039|FG000|Step 2: Consolidation|Other|6|||
48791468|NCT02085408|157077040|FG001|Step 2: Consolidation|Other|6|||
48791469|NCT02085408|157077039|FG000|Step 2: Consolidation|Never started treatment|4|||
48791470|NCT02085408|157077040|FG001|Step 2: Consolidation|Never started treatment|3|||
48791471|NCT02085408|157077039|FG000|Step 3: Maintenance|Disease Progression|13|||
48791472|NCT02085408|157077040|FG001|Step 3: Maintenance|Disease Progression|11|||
48791473|NCT02085408|157077039|FG000|Step 3: Maintenance|Adverse Event|2|||
48791474|NCT02085408|157077040|FG001|Step 3: Maintenance|Adverse Event|4|||
48791475|NCT02085408|157077039|FG000|Step 3: Maintenance|Death|1|||
48791476|NCT02085408|157077040|FG001|Step 3: Maintenance|Death|2|||
48791477|NCT02085408|157077039|FG000|Step 3: Maintenance|Alternative Therapy|1|||
48791478|NCT02085408|157077040|FG001|Step 3: Maintenance|Alternative Therapy|1|||
48791479|NCT02085408|157077039|FG000|Step 3: Maintenance|Complicating Disease|0|||
48791480|NCT02085408|157077040|FG001|Step 3: Maintenance|Complicating Disease|1|||
48791481|NCT02085408|157077039|FG000|Step 3: Maintenance|Other|3|||
48791482|NCT02085408|157077040|FG001|Step 3: Maintenance|Other|2|||
48791483|NCT02085408|157077039|FG000|Step 3: Maintenance|Never started treatment|5|||
48791484|NCT02085408|157077040|FG001|Step 3: Maintenance|Never started treatment|1|||
48791485|NCT04233216|157077041|FG000|Overall Study|Lost to Follow-up|1|||
48791486|NCT04233216|157077042|FG001|Overall Study|Lost to Follow-up|0|||
48791487|NCT04233216|157077043|FG002|Overall Study|Lost to Follow-up|2|||
48791488|NCT04233216|157077044|FG003|Overall Study|Lost to Follow-up|0|||
48791489|NCT04233216|157077041|FG000|Overall Study|Physician Decision|0|||
48791490|NCT04233216|157077042|FG001|Overall Study|Physician Decision|3|||
48791491|NCT04233216|157077043|FG002|Overall Study|Physician Decision|0|||
48791492|NCT04233216|157077044|FG003|Overall Study|Physician Decision|2|||
48791493|NCT04233216|157077041|FG000|Overall Study|Withdrawal by Subject|0|||
48791494|NCT04233216|157077042|FG001|Overall Study|Withdrawal by Subject|2|||
48791495|NCT04233216|157077043|FG002|Overall Study|Withdrawal by Subject|1|||
48791496|NCT04233216|157077044|FG003|Overall Study|Withdrawal by Subject|0|||
48791497|NCT00715429|157077046|FG000|Overall Study|Did not complete the study diary|0|||
48791498|NCT00715429|157077047|FG001|Overall Study|Did not complete the study diary|1|||
48791499|NCT00492284|157077048|FG000|Overall Study|Adverse Event|0|||
48791500|NCT00492284|157077049|FG001|Overall Study|Adverse Event|1|||
48791501|NCT00492284|157077050|FG002|Overall Study|Adverse Event|1|||
48791502|NCT00492284|157077051|FG003|Overall Study|Adverse Event|2|||
48791503|NCT00492284|157077048|FG000|Overall Study|Lost to Follow-up|0|||
48791504|NCT00492284|157077049|FG001|Overall Study|Lost to Follow-up|0|||
48791505|NCT00492284|157077050|FG002|Overall Study|Lost to Follow-up|3|||
48791506|NCT00492284|157077051|FG003|Overall Study|Lost to Follow-up|1|||
48791507|NCT00492284|157077048|FG000|Overall Study|Death|0|||
48791508|NCT00492284|157077049|FG001|Overall Study|Death|3|||
48791509|NCT00492284|157077050|FG002|Overall Study|Death|2|||
48791510|NCT00492284|157077051|FG003|Overall Study|Death|5|||
48791511|NCT00492284|157077048|FG000|Overall Study|Withdrawal by Subject|1|||
48791512|NCT00492284|157077049|FG001|Overall Study|Withdrawal by Subject|0|||
48791513|NCT00492284|157077050|FG002|Overall Study|Withdrawal by Subject|0|||
49032356|NCT01597245|157953476|FG006|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
49032357|NCT01597245|157953477|FG007|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
49032358|NCT01597245|157953478|FG008|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
49032359|NCT01597245|157953479|FG009|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
49032360|NCT01597245|157953480|FG010|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
49032361|NCT01597245|157953481|FG011|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
49032362|NCT01597245|157953482|FG012|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
49032363|NCT01597245|157953483|FG013|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
49032364|NCT01597245|157953484|FG014|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
49032365|NCT01597245|157953485|FG015|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
49032366|NCT01597245|157953486|FG016|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
49032367|NCT01597245|157953487|FG017|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
49032368|NCT01597245|157953488|FG018|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
49032369|NCT01597245|157953489|FG019|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
49032370|NCT01597245|157953490|FG020|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
49032371|NCT01597245|157953470|FG000|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
49032372|NCT01597245|157953471|FG001|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
49032373|NCT01597245|157953472|FG002|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
49032374|NCT01597245|157953473|FG003|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
49032375|NCT01597245|157953474|FG004|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
49032376|NCT01597245|157953475|FG005|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
49032377|NCT01597245|157953476|FG006|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
49032378|NCT01597245|157953477|FG007|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
49032379|NCT01597245|157953478|FG008|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
49032380|NCT01597245|157953479|FG009|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
49032381|NCT01597245|157953480|FG010|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
49032382|NCT01597245|157953481|FG011|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
49032383|NCT01597245|157953482|FG012|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
49032384|NCT01597245|157953483|FG013|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23|||
49032385|NCT01597245|157953484|FG014|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
49032386|NCT01597245|157953485|FG015|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
49032387|NCT01597245|157953486|FG016|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
48791514|NCT00492284|157077051|FG003|Overall Study|Withdrawal by Subject|2|||
48791515|NCT03695172|157077054|FG000|Overall Study|Withdrawal by Subject|1|||
48791516|NCT03695172|157077055|FG001|Overall Study|Withdrawal by Subject|1|||
48791517|NCT03695172|157077056|FG002|Overall Study|Withdrawal by Subject|0|||
48791518|NCT03624504|157077057|FG000|Overall Study|Unsuccessful Implant|1|||
48791519|NCT00727272|157077058|FG000|Washout Period A|Adverse Event|0|||
48791520|NCT00727272|157077059|FG001|Washout Period A|Adverse Event|0|||
48791521|NCT00727272|157077060|FG002|Washout Period A|Adverse Event|1|||
48791522|NCT00727272|157077058|FG000|Washout Period B|Withdrawal by Subject|0|||
48791523|NCT00727272|157077059|FG001|Washout Period B|Withdrawal by Subject|0|||
48791524|NCT00727272|157077060|FG002|Washout Period B|Withdrawal by Subject|1|||
48791525|NCT02834780|157077061|FG000|Overall Study|Disease Progression -Radiologically Confirmed|1|||
48791526|NCT02834780|157077062|FG001|Overall Study|Disease Progression -Radiologically Confirmed|3|||
48791527|NCT02834780|157077063|FG002|Overall Study|Disease Progression -Radiologically Confirmed|2|||
48791528|NCT02834780|157077064|FG003|Overall Study|Disease Progression -Radiologically Confirmed|7|||
48791529|NCT02834780|157077065|FG004|Overall Study|Disease Progression -Radiologically Confirmed|1|||
48791530|NCT02834780|157077066|FG005|Overall Study|Disease Progression -Radiologically Confirmed|6|||
48791531|NCT02834780|157077067|FG006|Overall Study|Disease Progression -Radiologically Confirmed|2|||
48791532|NCT02834780|157077068|FG007|Overall Study|Disease Progression -Radiologically Confirmed|4|||
48791533|NCT02834780|157077069|FG008|Overall Study|Disease Progression -Radiologically Confirmed|3|||
48791534|NCT02834780|157077070|FG009|Overall Study|Disease Progression -Radiologically Confirmed|6|||
48791535|NCT02834780|157077071|FG010|Overall Study|Disease Progression -Radiologically Confirmed|3|||
48791536|NCT02834780|157077072|FG011|Overall Study|Disease Progression -Radiologically Confirmed|24|||
48791537|NCT02834780|157077073|FG012|Overall Study|Disease Progression -Radiologically Confirmed|32|||
48791538|NCT02834780|157077061|FG000|Overall Study|Withdrawal by Subject|0|||
48791539|NCT02834780|157077062|FG001|Overall Study|Withdrawal by Subject|0|||
48791540|NCT02834780|157077063|FG002|Overall Study|Withdrawal by Subject|1|||
48791541|NCT02834780|157077064|FG003|Overall Study|Withdrawal by Subject|0|||
48791542|NCT02834780|157077065|FG004|Overall Study|Withdrawal by Subject|0|||
48791543|NCT02834780|157077066|FG005|Overall Study|Withdrawal by Subject|0|||
48791544|NCT02834780|157077067|FG006|Overall Study|Withdrawal by Subject|0|||
48791545|NCT02834780|157077068|FG007|Overall Study|Withdrawal by Subject|0|||
48791546|NCT02834780|157077069|FG008|Overall Study|Withdrawal by Subject|0|||
48791547|NCT02834780|157077070|FG009|Overall Study|Withdrawal by Subject|0|||
48791548|NCT02834780|157077071|FG010|Overall Study|Withdrawal by Subject|1|||
48791549|NCT02834780|157077072|FG011|Overall Study|Withdrawal by Subject|0|||
48791550|NCT02834780|157077073|FG012|Overall Study|Withdrawal by Subject|0|||
48791551|NCT02834780|157077061|FG000|Overall Study|Adverse Event|0|||
48791552|NCT02834780|157077062|FG001|Overall Study|Adverse Event|0|||
48791553|NCT02834780|157077063|FG002|Overall Study|Adverse Event|0|||
48791554|NCT02834780|157077064|FG003|Overall Study|Adverse Event|0|||
48791555|NCT02834780|157077065|FG004|Overall Study|Adverse Event|1|||
48791556|NCT02834780|157077066|FG005|Overall Study|Adverse Event|0|||
48791557|NCT02834780|157077067|FG006|Overall Study|Adverse Event|1|||
48791558|NCT02834780|157077068|FG007|Overall Study|Adverse Event|1|||
48791559|NCT02834780|157077069|FG008|Overall Study|Adverse Event|0|||
48791560|NCT02834780|157077070|FG009|Overall Study|Adverse Event|2|||
48791561|NCT02834780|157077071|FG010|Overall Study|Adverse Event|0|||
48791562|NCT02834780|157077072|FG011|Overall Study|Adverse Event|3|||
48791563|NCT02834780|157077073|FG012|Overall Study|Adverse Event|2|||
48791564|NCT02834780|157077061|FG000|Overall Study|Disease Progression - Clinically Confirmed|1|||
48791565|NCT02834780|157077062|FG001|Overall Study|Disease Progression - Clinically Confirmed|0|||
48791566|NCT02834780|157077063|FG002|Overall Study|Disease Progression - Clinically Confirmed|0|||
48791567|NCT02834780|157077064|FG003|Overall Study|Disease Progression - Clinically Confirmed|1|||
48791568|NCT02834780|157077065|FG004|Overall Study|Disease Progression - Clinically Confirmed|1|||
48791569|NCT02834780|157077066|FG005|Overall Study|Disease Progression - Clinically Confirmed|1|||
48791570|NCT02834780|157077067|FG006|Overall Study|Disease Progression - Clinically Confirmed|1|||
48791571|NCT02834780|157077068|FG007|Overall Study|Disease Progression - Clinically Confirmed|2|||
48791572|NCT02834780|157077069|FG008|Overall Study|Disease Progression - Clinically Confirmed|0|||
48791573|NCT02834780|157077070|FG009|Overall Study|Disease Progression - Clinically Confirmed|2|||
48791574|NCT02834780|157077071|FG010|Overall Study|Disease Progression - Clinically Confirmed|1|||
48791575|NCT02834780|157077072|FG011|Overall Study|Disease Progression - Clinically Confirmed|2|||
48791576|NCT02834780|157077073|FG012|Overall Study|Disease Progression - Clinically Confirmed|5|||
48791577|NCT02834780|157077061|FG000|Overall Study|Other|1|||
48791578|NCT02834780|157077062|FG001|Overall Study|Other|0|||
48791579|NCT02834780|157077063|FG002|Overall Study|Other|1|||
48791580|NCT02834780|157077064|FG003|Overall Study|Other|2|||
48791581|NCT02834780|157077065|FG004|Overall Study|Other|0|||
48791582|NCT02834780|157077066|FG005|Overall Study|Other|0|||
48791583|NCT02834780|157077067|FG006|Overall Study|Other|0|||
48791584|NCT02834780|157077068|FG007|Overall Study|Other|0|||
48791585|NCT02834780|157077069|FG008|Overall Study|Other|0|||
48791586|NCT02834780|157077070|FG009|Overall Study|Other|0|||
48791587|NCT02834780|157077071|FG010|Overall Study|Other|0|||
48791588|NCT02834780|157077072|FG011|Overall Study|Other|0|||
48791589|NCT02834780|157077073|FG012|Overall Study|Other|1|||
48791590|NCT03449030|157077074|FG000|Overall Study|Withdrawal by Subject|0|||
48791591|NCT03449030|157077075|FG001|Overall Study|Withdrawal by Subject|0|||
48791592|NCT03449030|157077076|FG002|Overall Study|Withdrawal by Subject|0|||
48791593|NCT03449030|157077077|FG003|Overall Study|Withdrawal by Subject|1|||
48791594|NCT03449030|157077078|FG004|Overall Study|Withdrawal by Subject|1|||
48791595|NCT03449030|157077079|FG005|Overall Study|Withdrawal by Subject|1|||
48791596|NCT03449030|157077080|FG006|Overall Study|Withdrawal by Subject|1|||
48791597|NCT03449030|157077081|FG007|Overall Study|Withdrawal by Subject|2|||
48791598|NCT03449030|157077082|FG008|Overall Study|Withdrawal by Subject|0|||
48791599|NCT03449030|157077083|FG009|Overall Study|Withdrawal by Subject|0|||
48791600|NCT03449030|157077074|FG000|Overall Study|Symptomatic Deterioration|0|||
48791601|NCT03449030|157077075|FG001|Overall Study|Symptomatic Deterioration|1|||
48791602|NCT03449030|157077076|FG002|Overall Study|Symptomatic Deterioration|0|||
48791603|NCT03449030|157077077|FG003|Overall Study|Symptomatic Deterioration|0|||
48791604|NCT03449030|157077078|FG004|Overall Study|Symptomatic Deterioration|0|||
48791605|NCT03449030|157077079|FG005|Overall Study|Symptomatic Deterioration|1|||
48791606|NCT03449030|157077080|FG006|Overall Study|Symptomatic Deterioration|1|||
48791607|NCT03449030|157077081|FG007|Overall Study|Symptomatic Deterioration|0|||
48791608|NCT03449030|157077082|FG008|Overall Study|Symptomatic Deterioration|2|||
48791609|NCT03449030|157077083|FG009|Overall Study|Symptomatic Deterioration|0|||
48791610|NCT03449030|157077074|FG000|Overall Study|Progressive Disease|1|||
48791611|NCT03449030|157077075|FG001|Overall Study|Progressive Disease|0|||
48791612|NCT03449030|157077076|FG002|Overall Study|Progressive Disease|1|||
49032388|NCT01597245|157953487|FG017|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
49032389|NCT01597245|157953488|FG018|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
48791613|NCT03449030|157077077|FG003|Overall Study|Progressive Disease|4|||
48791614|NCT03449030|157077078|FG004|Overall Study|Progressive Disease|5|||
48791615|NCT03449030|157077079|FG005|Overall Study|Progressive Disease|3|||
48791616|NCT03449030|157077080|FG006|Overall Study|Progressive Disease|0|||
48791617|NCT03449030|157077081|FG007|Overall Study|Progressive Disease|1|||
48791618|NCT03449030|157077082|FG008|Overall Study|Progressive Disease|1|||
48878076|NCT01216072|157392129|FG000|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3|||
48791619|NCT03449030|157077083|FG009|Overall Study|Progressive Disease|1|||
48791620|NCT03449030|157077074|FG000|Overall Study|Adverse Event|0|||
48791621|NCT03449030|157077075|FG001|Overall Study|Adverse Event|0|||
48791622|NCT03449030|157077076|FG002|Overall Study|Adverse Event|0|||
48791623|NCT03449030|157077077|FG003|Overall Study|Adverse Event|0|||
48791624|NCT03449030|157077078|FG004|Overall Study|Adverse Event|0|||
48791625|NCT03449030|157077079|FG005|Overall Study|Adverse Event|2|||
48791626|NCT03449030|157077080|FG006|Overall Study|Adverse Event|0|||
48791627|NCT03449030|157077081|FG007|Overall Study|Adverse Event|0|||
48791628|NCT03449030|157077082|FG008|Overall Study|Adverse Event|0|||
48791629|NCT03449030|157077083|FG009|Overall Study|Adverse Event|0|||
48791630|NCT03449030|157077074|FG000|Overall Study|Death|0|||
48791631|NCT03449030|157077075|FG001|Overall Study|Death|0|||
48791632|NCT03449030|157077076|FG002|Overall Study|Death|0|||
48791633|NCT03449030|157077077|FG003|Overall Study|Death|0|||
48791634|NCT03449030|157077078|FG004|Overall Study|Death|1|||
48791635|NCT03449030|157077079|FG005|Overall Study|Death|0|||
48791636|NCT03449030|157077080|FG006|Overall Study|Death|0|||
48791637|NCT03449030|157077081|FG007|Overall Study|Death|0|||
48791638|NCT03449030|157077082|FG008|Overall Study|Death|0|||
48791639|NCT03449030|157077083|FG009|Overall Study|Death|0|||
48791640|NCT02270450|157077084|FG000|Overall Study|Refusal unrelated to adverse event|3|||
48791641|NCT02270450|157077085|FG001|Overall Study|Refusal unrelated to adverse event|1|||
48791642|NCT02270450|157077086|FG002|Overall Study|Refusal unrelated to adverse event|5|||
48791643|NCT02270450|157077087|FG003|Overall Study|Refusal unrelated to adverse event|14|||
48791644|NCT02270450|157077084|FG000|Overall Study|Progression/relapse|1|||
48791645|NCT02270450|157077085|FG001|Overall Study|Progression/relapse|2|||
48791646|NCT02270450|157077086|FG002|Overall Study|Progression/relapse|4|||
48791647|NCT02270450|157077087|FG003|Overall Study|Progression/relapse|9|||
48791648|NCT02270450|157077084|FG000|Overall Study|Death|19|||
48791649|NCT02270450|157077085|FG001|Overall Study|Death|19|||
48791650|NCT02270450|157077086|FG002|Overall Study|Death|31|||
48791651|NCT02270450|157077087|FG003|Overall Study|Death|59|||
48791652|NCT03595904|157077092|FG000|Overall Study|Protocol Violation|3|||
48791653|NCT03595904|157077093|FG001|Overall Study|Protocol Violation|1|||
48791654|NCT03595904|157077092|FG000|Overall Study|Deemed medically ineligible for direct access colonoscopy|4|||
48791655|NCT03595904|157077093|FG001|Overall Study|Deemed medically ineligible for direct access colonoscopy|3|||
48791656|NCT03595904|157077092|FG000|Overall Study|Insurance complications|1|||
48791657|NCT03595904|157077093|FG001|Overall Study|Insurance complications|0|||
48791658|NCT03595904|157077092|FG000|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2|||
48791659|NCT03595904|157077093|FG001|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1|||
48791660|NCT03182868|157077096|FG000|Overall Study|Protocol Violation|3|||
48791661|NCT03182868|157077097|FG001|Overall Study|Protocol Violation|0|||
48791662|NCT03182868|157077098|FG002|Overall Study|Protocol Violation|4|||
48791663|NCT03182868|157077099|FG003|Overall Study|Protocol Violation|1|||
48791664|NCT03182868|157077100|FG004|Overall Study|Protocol Violation|8|||
48791665|NCT01587651|157077104|FG000|Overall Study|Adverse Event|0|||
48791666|NCT01587651|157077105|FG001|Overall Study|Adverse Event|1|||
48791667|NCT01587651|157077106|FG002|Overall Study|Adverse Event|0|||
48791668|NCT01587651|157077104|FG000|Overall Study|Protocol Violation|0|||
48791669|NCT01587651|157077105|FG001|Overall Study|Protocol Violation|1|||
48791670|NCT01587651|157077106|FG002|Overall Study|Protocol Violation|1|||
48791671|NCT01587651|157077104|FG000|Overall Study|Withdrawal by Subject|0|||
48791672|NCT01587651|157077105|FG001|Overall Study|Withdrawal by Subject|1|||
48791673|NCT01587651|157077106|FG002|Overall Study|Withdrawal by Subject|0|||
48791674|NCT00518115|157077113|FG000|Overall Study|Adverse Event|6|||
48791675|NCT00518115|157077114|FG001|Overall Study|Adverse Event|1|||
48791676|NCT00518115|157077115|FG002|Overall Study|Adverse Event|5|||
48791677|NCT00518115|157077116|FG003|Overall Study|Adverse Event|6|||
48791678|NCT00518115|157077117|FG004|Overall Study|Adverse Event|5|||
48791679|NCT00518115|157077118|FG005|Overall Study|Adverse Event|5|||
48791680|NCT00518115|157077119|FG006|Overall Study|Adverse Event|5|||
48791681|NCT00518115|157077120|FG007|Overall Study|Adverse Event|10|||
48791682|NCT00518115|157077121|FG008|Overall Study|Adverse Event|2|||
48791683|NCT00518115|157077122|FG009|Overall Study|Adverse Event|9|||
48791684|NCT00518115|157077113|FG000|Overall Study|Lost to Follow-up|0|||
48791685|NCT00518115|157077114|FG001|Overall Study|Lost to Follow-up|0|||
48791686|NCT00518115|157077115|FG002|Overall Study|Lost to Follow-up|2|||
49032390|NCT01597245|157953489|FG019|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
49032391|NCT01597245|157953490|FG020|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
49032392|NCT01597245|157953470|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
48791687|NCT00518115|157077116|FG003|Overall Study|Lost to Follow-up|3|||
48791688|NCT00518115|157077117|FG004|Overall Study|Lost to Follow-up|1|||
48791689|NCT00518115|157077118|FG005|Overall Study|Lost to Follow-up|3|||
48791690|NCT00518115|157077119|FG006|Overall Study|Lost to Follow-up|0|||
48791691|NCT00518115|157077120|FG007|Overall Study|Lost to Follow-up|1|||
48791692|NCT00518115|157077121|FG008|Overall Study|Lost to Follow-up|1|||
48791693|NCT00518115|157077122|FG009|Overall Study|Lost to Follow-up|1|||
48791694|NCT00518115|157077113|FG000|Overall Study|Protocol Violation|1|||
48791695|NCT00518115|157077114|FG001|Overall Study|Protocol Violation|3|||
48791696|NCT00518115|157077115|FG002|Overall Study|Protocol Violation|1|||
48791697|NCT00518115|157077116|FG003|Overall Study|Protocol Violation|0|||
48791698|NCT00518115|157077117|FG004|Overall Study|Protocol Violation|0|||
48791699|NCT00518115|157077118|FG005|Overall Study|Protocol Violation|0|||
48791700|NCT00518115|157077119|FG006|Overall Study|Protocol Violation|0|||
48791701|NCT00518115|157077120|FG007|Overall Study|Protocol Violation|0|||
48791702|NCT00518115|157077121|FG008|Overall Study|Protocol Violation|0|||
48791703|NCT00518115|157077122|FG009|Overall Study|Protocol Violation|0|||
48791704|NCT00518115|157077113|FG000|Overall Study|Withdrawal by Subject|1|||
48791705|NCT00518115|157077114|FG001|Overall Study|Withdrawal by Subject|1|||
48791706|NCT00518115|157077115|FG002|Overall Study|Withdrawal by Subject|5|||
48791707|NCT00518115|157077116|FG003|Overall Study|Withdrawal by Subject|0|||
48791708|NCT00518115|157077117|FG004|Overall Study|Withdrawal by Subject|2|||
48791709|NCT00518115|157077118|FG005|Overall Study|Withdrawal by Subject|1|||
48791710|NCT00518115|157077119|FG006|Overall Study|Withdrawal by Subject|0|||
48791711|NCT00518115|157077120|FG007|Overall Study|Withdrawal by Subject|2|||
48791712|NCT00518115|157077121|FG008|Overall Study|Withdrawal by Subject|1|||
48791713|NCT00518115|157077122|FG009|Overall Study|Withdrawal by Subject|3|||
48791714|NCT00518115|157077113|FG000|Overall Study|Lack of Efficacy|1|||
48791715|NCT00518115|157077114|FG001|Overall Study|Lack of Efficacy|0|||
48791716|NCT00518115|157077115|FG002|Overall Study|Lack of Efficacy|1|||
48791717|NCT00518115|157077116|FG003|Overall Study|Lack of Efficacy|1|||
48791718|NCT00518115|157077117|FG004|Overall Study|Lack of Efficacy|0|||
48791719|NCT00518115|157077118|FG005|Overall Study|Lack of Efficacy|0|||
48983467|NCT02477800|157772262|FG000|Long Term Extension Period|Reason not Specified|0|||
48791720|NCT00518115|157077119|FG006|Overall Study|Lack of Efficacy|0|||
48791721|NCT00518115|157077120|FG007|Overall Study|Lack of Efficacy|1|||
48791722|NCT00518115|157077121|FG008|Overall Study|Lack of Efficacy|0|||
48791723|NCT00518115|157077122|FG009|Overall Study|Lack of Efficacy|0|||
48791724|NCT00518115|157077113|FG000|Overall Study|Non-Compliance|1|||
48791725|NCT00518115|157077114|FG001|Overall Study|Non-Compliance|0|||
48791726|NCT00518115|157077115|FG002|Overall Study|Non-Compliance|1|||
48791727|NCT00518115|157077116|FG003|Overall Study|Non-Compliance|0|||
48791728|NCT00518115|157077117|FG004|Overall Study|Non-Compliance|1|||
48791729|NCT00518115|157077118|FG005|Overall Study|Non-Compliance|1|||
48791730|NCT00518115|157077119|FG006|Overall Study|Non-Compliance|1|||
48791731|NCT00518115|157077120|FG007|Overall Study|Non-Compliance|1|||
48791732|NCT00518115|157077121|FG008|Overall Study|Non-Compliance|0|||
48791733|NCT00518115|157077122|FG009|Overall Study|Non-Compliance|1|||
48791734|NCT00518115|157077113|FG000|Overall Study|Treatment Eligibility Criteria Not Met|1|||
48791735|NCT00518115|157077114|FG001|Overall Study|Treatment Eligibility Criteria Not Met|1|||
48791736|NCT00518115|157077115|FG002|Overall Study|Treatment Eligibility Criteria Not Met|0|||
48791737|NCT00518115|157077116|FG003|Overall Study|Treatment Eligibility Criteria Not Met|0|||
48791738|NCT00518115|157077117|FG004|Overall Study|Treatment Eligibility Criteria Not Met|0|||
48791739|NCT00518115|157077118|FG005|Overall Study|Treatment Eligibility Criteria Not Met|4|||
48791740|NCT00518115|157077119|FG006|Overall Study|Treatment Eligibility Criteria Not Met|0|||
48791741|NCT00518115|157077120|FG007|Overall Study|Treatment Eligibility Criteria Not Met|0|||
48791742|NCT00518115|157077121|FG008|Overall Study|Treatment Eligibility Criteria Not Met|0|||
48791743|NCT00518115|157077122|FG009|Overall Study|Treatment Eligibility Criteria Not Met|0|||
48791744|NCT00518115|157077113|FG000|Overall Study|Physician Prescribed Antidiabetic Drug|1|||
48791745|NCT00518115|157077114|FG001|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
48791746|NCT00518115|157077115|FG002|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
48791747|NCT00518115|157077116|FG003|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
48791748|NCT00518115|157077117|FG004|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
48791749|NCT00518115|157077118|FG005|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
48791750|NCT00518115|157077119|FG006|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
48791751|NCT00518115|157077120|FG007|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
48791752|NCT00518115|157077121|FG008|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
48791753|NCT00518115|157077122|FG009|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
48791754|NCT00518115|157077113|FG000|Overall Study|Different Monotherapy Diabetic Drug|0|||
48791755|NCT00518115|157077114|FG001|Overall Study|Different Monotherapy Diabetic Drug|0|||
48791756|NCT00518115|157077115|FG002|Overall Study|Different Monotherapy Diabetic Drug|1|||
48791757|NCT00518115|157077116|FG003|Overall Study|Different Monotherapy Diabetic Drug|0|||
48791758|NCT00518115|157077117|FG004|Overall Study|Different Monotherapy Diabetic Drug|0|||
48791759|NCT00518115|157077118|FG005|Overall Study|Different Monotherapy Diabetic Drug|0|||
48791760|NCT00518115|157077119|FG006|Overall Study|Different Monotherapy Diabetic Drug|0|||
48791761|NCT00518115|157077120|FG007|Overall Study|Different Monotherapy Diabetic Drug|0|||
48791762|NCT00518115|157077121|FG008|Overall Study|Different Monotherapy Diabetic Drug|1|||
48791763|NCT00518115|157077122|FG009|Overall Study|Different Monotherapy Diabetic Drug|0|||
48791764|NCT00518115|157077113|FG000|Overall Study|Wrong Monotherapy Administered|0|||
48791765|NCT00518115|157077114|FG001|Overall Study|Wrong Monotherapy Administered|0|||
48791766|NCT00518115|157077115|FG002|Overall Study|Wrong Monotherapy Administered|1|||
48791767|NCT00518115|157077116|FG003|Overall Study|Wrong Monotherapy Administered|0|||
48791768|NCT00518115|157077117|FG004|Overall Study|Wrong Monotherapy Administered|0|||
48791769|NCT00518115|157077118|FG005|Overall Study|Wrong Monotherapy Administered|0|||
48791770|NCT00518115|157077119|FG006|Overall Study|Wrong Monotherapy Administered|1|||
48791771|NCT00518115|157077120|FG007|Overall Study|Wrong Monotherapy Administered|0|||
48791772|NCT00518115|157077121|FG008|Overall Study|Wrong Monotherapy Administered|0|||
48791773|NCT00518115|157077122|FG009|Overall Study|Wrong Monotherapy Administered|0|||
48791774|NCT00518115|157077113|FG000|Overall Study|Violation of Exclusion Criteria|0|||
48791775|NCT00518115|157077114|FG001|Overall Study|Violation of Exclusion Criteria|0|||
48791776|NCT00518115|157077115|FG002|Overall Study|Violation of Exclusion Criteria|0|||
48791777|NCT00518115|157077116|FG003|Overall Study|Violation of Exclusion Criteria|1|||
48791778|NCT00518115|157077117|FG004|Overall Study|Violation of Exclusion Criteria|0|||
48791779|NCT00518115|157077118|FG005|Overall Study|Violation of Exclusion Criteria|0|||
48791780|NCT00518115|157077119|FG006|Overall Study|Violation of Exclusion Criteria|1|||
48791781|NCT00518115|157077120|FG007|Overall Study|Violation of Exclusion Criteria|0|||
48791782|NCT00518115|157077121|FG008|Overall Study|Violation of Exclusion Criteria|0|||
48791783|NCT00518115|157077122|FG009|Overall Study|Violation of Exclusion Criteria|0|||
48791784|NCT00518115|157077113|FG000|Overall Study|Family Emergency; Had to Go to England|0|||
48791785|NCT00518115|157077114|FG001|Overall Study|Family Emergency; Had to Go to England|0|||
48791786|NCT00518115|157077115|FG002|Overall Study|Family Emergency; Had to Go to England|0|||
48791787|NCT00518115|157077116|FG003|Overall Study|Family Emergency; Had to Go to England|0|||
48791788|NCT00518115|157077117|FG004|Overall Study|Family Emergency; Had to Go to England|1|||
48791789|NCT00518115|157077118|FG005|Overall Study|Family Emergency; Had to Go to England|0|||
48791790|NCT00518115|157077119|FG006|Overall Study|Family Emergency; Had to Go to England|0|||
48791791|NCT00518115|157077120|FG007|Overall Study|Family Emergency; Had to Go to England|0|||
48791792|NCT00518115|157077121|FG008|Overall Study|Family Emergency; Had to Go to England|0|||
48791793|NCT00518115|157077122|FG009|Overall Study|Family Emergency; Had to Go to England|0|||
48791794|NCT00518115|157077113|FG000|Overall Study|Withdrew Consent|0|||
48791795|NCT00518115|157077114|FG001|Overall Study|Withdrew Consent|0|||
48791796|NCT00518115|157077115|FG002|Overall Study|Withdrew Consent|0|||
48791797|NCT00518115|157077116|FG003|Overall Study|Withdrew Consent|0|||
48791798|NCT00518115|157077117|FG004|Overall Study|Withdrew Consent|0|||
48791799|NCT00518115|157077118|FG005|Overall Study|Withdrew Consent|1|||
48791800|NCT00518115|157077119|FG006|Overall Study|Withdrew Consent|0|||
48791801|NCT00518115|157077120|FG007|Overall Study|Withdrew Consent|0|||
48791802|NCT00518115|157077121|FG008|Overall Study|Withdrew Consent|0|||
48791803|NCT00518115|157077122|FG009|Overall Study|Withdrew Consent|0|||
48791804|NCT00518115|157077113|FG000|Overall Study|Moved Out of State|0|||
48791805|NCT00518115|157077114|FG001|Overall Study|Moved Out of State|0|||
48791806|NCT00518115|157077115|FG002|Overall Study|Moved Out of State|0|||
48791807|NCT00518115|157077116|FG003|Overall Study|Moved Out of State|0|||
48791808|NCT00518115|157077117|FG004|Overall Study|Moved Out of State|0|||
48791809|NCT00518115|157077118|FG005|Overall Study|Moved Out of State|0|||
48791810|NCT00518115|157077119|FG006|Overall Study|Moved Out of State|0|||
48791811|NCT00518115|157077120|FG007|Overall Study|Moved Out of State|0|||
48791812|NCT00518115|157077121|FG008|Overall Study|Moved Out of State|0|||
48791813|NCT00518115|157077122|FG009|Overall Study|Moved Out of State|1|||
48791814|NCT00047879|157077123|FG000|Overall Study|Progressive disease|4|||
48791815|NCT00047879|157077124|FG001|Overall Study|Progressive disease|3|||
48791816|NCT02291614|157077125|FG000|Overall Study|Lost to Follow-up|0|||
48791817|NCT02291614|157077126|FG001|Overall Study|Lost to Follow-up|0|||
48791818|NCT02291614|157077127|FG002|Overall Study|Lost to Follow-up|0|||
48791819|NCT02291614|157077128|FG003|Overall Study|Lost to Follow-up|0|||
48791820|NCT02291614|157077129|FG004|Overall Study|Lost to Follow-up|0|||
48791821|NCT02291614|157077130|FG005|Overall Study|Lost to Follow-up|0|||
48791822|NCT02291614|157077131|FG006|Overall Study|Lost to Follow-up|0|||
48791823|NCT02291614|157077132|FG007|Overall Study|Lost to Follow-up|1|||
48791824|NCT02291614|157077133|FG008|Overall Study|Lost to Follow-up|0|||
48791825|NCT02291614|157077134|FG009|Overall Study|Lost to Follow-up|0|||
48791826|NCT02291614|157077135|FG010|Overall Study|Lost to Follow-up|0|||
48791827|NCT02291614|157077125|FG000|Overall Study|Withdrawal by Subject|0|||
48791828|NCT02291614|157077126|FG001|Overall Study|Withdrawal by Subject|1|||
48791829|NCT02291614|157077127|FG002|Overall Study|Withdrawal by Subject|0|||
48791830|NCT02291614|157077128|FG003|Overall Study|Withdrawal by Subject|0|||
48692358|NCT03982199|156722581|FG013|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
48692359|NCT00057863|156722582|FG000|Overall Study|Death|1|||
48692360|NCT00057863|156722582|FG000|Overall Study|Withdrawal by Subject|2|||
48692361|NCT02090426|156722583|FG000|Overall Study|Lost to Follow-up|12|||
48692362|NCT02090426|156722584|FG001|Overall Study|Lost to Follow-up|6|||
48692363|NCT00953667|156722589|FG000|Overall Study|Lost to Follow-up|11|||
48692364|NCT00953667|156722589|FG000|Overall Study|Physician Decision|35|||
48692365|NCT00953667|156722589|FG000|Overall Study|Withdrawal by Subject|63|||
48692366|NCT00953667|156722589|FG000|Overall Study|Adverse Event|10|||
48692367|NCT00953667|156722589|FG000|Overall Study|poor venous access,unable to draw blood|4|||
48692368|NCT00703014|156722590|FG000|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33|||
48692369|NCT00703014|156722591|FG001|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32|||
48692370|NCT00703014|156722592|FG002|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
48692371|NCT00703014|156722593|FG003|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
48692372|NCT00703014|156722590|FG000|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
48692373|NCT00703014|156722591|FG001|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
48692374|NCT00703014|156722592|FG002|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47|||
48692375|NCT00703014|156722593|FG003|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42|||
48692376|NCT04999839|156722594|FG000|Overall Study|Adverse Event|1|||
48692377|NCT04999839|156722595|FG001|Overall Study|Adverse Event|1|||
48692378|NCT04999839|156722596|FG002|Overall Study|Adverse Event|1|||
48692379|NCT04999839|156722597|FG003|Overall Study|Adverse Event|1|||
48692380|NCT04999839|156722598|FG004|Overall Study|Adverse Event|1|||
48692381|NCT04999839|156722594|FG000|Overall Study|Lost to Follow-up|2|||
48692382|NCT04999839|156722595|FG001|Overall Study|Lost to Follow-up|0|||
48692383|NCT04999839|156722596|FG002|Overall Study|Lost to Follow-up|2|||
48692384|NCT04999839|156722597|FG003|Overall Study|Lost to Follow-up|4|||
48692385|NCT04999839|156722598|FG004|Overall Study|Lost to Follow-up|1|||
48692386|NCT04999839|156722594|FG000|Overall Study|Withdrawal by Subject|6|||
48692387|NCT04999839|156722595|FG001|Overall Study|Withdrawal by Subject|5|||
48692388|NCT04999839|156722596|FG002|Overall Study|Withdrawal by Subject|3|||
48692389|NCT04999839|156722597|FG003|Overall Study|Withdrawal by Subject|2|||
48692390|NCT04999839|156722598|FG004|Overall Study|Withdrawal by Subject|2|||
48692391|NCT04999839|156722594|FG000|Overall Study|Lack of Efficacy|0|||
48692392|NCT04999839|156722595|FG001|Overall Study|Lack of Efficacy|1|||
48692393|NCT04999839|156722596|FG002|Overall Study|Lack of Efficacy|0|||
48692394|NCT04999839|156722597|FG003|Overall Study|Lack of Efficacy|0|||
48692395|NCT04999839|156722598|FG004|Overall Study|Lack of Efficacy|0|||
48692396|NCT04999839|156722594|FG000|Overall Study|Physician Decision|0|||
48692397|NCT04999839|156722595|FG001|Overall Study|Physician Decision|0|||
48692398|NCT04999839|156722596|FG002|Overall Study|Physician Decision|0|||
48692399|NCT04999839|156722597|FG003|Overall Study|Physician Decision|0|||
48692400|NCT04999839|156722598|FG004|Overall Study|Physician Decision|1|||
48692401|NCT04999839|156722594|FG000|Overall Study|Sponsor request|0|||
48692402|NCT04999839|156722595|FG001|Overall Study|Sponsor request|1|||
48692403|NCT04999839|156722596|FG002|Overall Study|Sponsor request|0|||
48692404|NCT04999839|156722597|FG003|Overall Study|Sponsor request|0|||
48692405|NCT04999839|156722598|FG004|Overall Study|Sponsor request|0|||
48692406|NCT04999839|156722594|FG000|Overall Study|Other|0|||
48692407|NCT04999839|156722595|FG001|Overall Study|Other|0|||
48692408|NCT04999839|156722596|FG002|Overall Study|Other|1|||
48791831|NCT02291614|157077129|FG004|Overall Study|Withdrawal by Subject|0|||
48878077|NCT01216072|157392130|FG001|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4|||
48878078|NCT01216072|157392129|FG000|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12|||
48878079|NCT01216072|157392130|FG001|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22|||
48878080|NCT01216072|157392129|FG000|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5|||
48878081|NCT01216072|157392130|FG001|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0|||
48878082|NCT01216072|157392129|FG000|Open-Label Core Period ( 6 Months)|Protocol Deviation|11|||
48878083|NCT01216072|157392130|FG001|Open-Label Core Period ( 6 Months)|Protocol Deviation|4|||
48878084|NCT01216072|157392129|FG000|Open-Label Extension Period (3 Months)|Adverse Event|0|||
48878085|NCT01216072|157392130|FG001|Open-Label Extension Period (3 Months)|Adverse Event|10|||
48983468|NCT02477800|157772263|FG001|Long Term Extension Period|Reason not Specified|0|||
48983469|NCT02477800|157772264|FG002|Long Term Extension Period|Reason not Specified|0|||
48983470|NCT02477800|157772265|FG003|Long Term Extension Period|Reason not Specified|126|||
48791832|NCT02291614|157077130|FG005|Overall Study|Withdrawal by Subject|0|||
48791833|NCT02291614|157077131|FG006|Overall Study|Withdrawal by Subject|0|||
48791834|NCT02291614|157077132|FG007|Overall Study|Withdrawal by Subject|0|||
48791835|NCT02291614|157077133|FG008|Overall Study|Withdrawal by Subject|0|||
48791836|NCT02291614|157077134|FG009|Overall Study|Withdrawal by Subject|2|||
48791837|NCT02291614|157077135|FG010|Overall Study|Withdrawal by Subject|2|||
48791838|NCT02291614|157077125|FG000|Overall Study|Decision by sponsor|0|||
48791839|NCT02291614|157077126|FG001|Overall Study|Decision by sponsor|0|||
48791840|NCT02291614|157077127|FG002|Overall Study|Decision by sponsor|0|||
48791841|NCT02291614|157077128|FG003|Overall Study|Decision by sponsor|1|||
48791842|NCT02291614|157077129|FG004|Overall Study|Decision by sponsor|0|||
48791843|NCT02291614|157077130|FG005|Overall Study|Decision by sponsor|0|||
48791844|NCT02291614|157077131|FG006|Overall Study|Decision by sponsor|0|||
48791845|NCT02291614|157077132|FG007|Overall Study|Decision by sponsor|0|||
48791846|NCT02291614|157077133|FG008|Overall Study|Decision by sponsor|0|||
48791847|NCT02291614|157077134|FG009|Overall Study|Decision by sponsor|0|||
48791848|NCT02291614|157077135|FG010|Overall Study|Decision by sponsor|0|||
48791849|NCT02291614|157077125|FG000|Overall Study|Death|0|||
48791850|NCT02291614|157077126|FG001|Overall Study|Death|0|||
48791851|NCT02291614|157077127|FG002|Overall Study|Death|1|||
48791852|NCT02291614|157077128|FG003|Overall Study|Death|0|||
48791853|NCT02291614|157077129|FG004|Overall Study|Death|1|||
48791854|NCT02291614|157077130|FG005|Overall Study|Death|1|||
48791855|NCT02291614|157077131|FG006|Overall Study|Death|1|||
48692409|NCT04999839|156722597|FG003|Overall Study|Other|0|||
48983471|NCT02477800|157772266|FG004|Long Term Extension Period|Reason not Specified|140|||
48692410|NCT04999839|156722598|FG004|Overall Study|Other|0|||
48692411|NCT00982735|156722601|FG000|Overall Study|Lost to Follow-up|6|||
48692412|NCT00982735|156722601|FG000|Overall Study|Patient ineligible for trial|224|||
48692413|NCT00292942|156722603|FG000|Overall Study|Withdrawal by Subject|0|||
48692414|NCT00292942|156722604|FG001|Overall Study|Withdrawal by Subject|0|||
48692415|NCT00292942|156722605|FG002|Overall Study|Withdrawal by Subject|1|||
48692416|NCT00292942|156722606|FG003|Overall Study|Withdrawal by Subject|0|||
48692417|NCT00292942|156722603|FG000|Overall Study|Adverse Event|0|||
48692418|NCT00292942|156722604|FG001|Overall Study|Adverse Event|0|||
48692419|NCT00292942|156722605|FG002|Overall Study|Adverse Event|0|||
48692420|NCT00292942|156722606|FG003|Overall Study|Adverse Event|1|||
48692421|NCT00112736|156722612|FG000|Overall Study|1 pt never had had RX due rapid decline|1|||
48692422|NCT00112736|156722613|FG001|Overall Study|1 pt never had had RX due rapid decline|0|||
48692423|NCT02021565|156722614|FG000|Baseline Through Intervention|Death|0|||
48692424|NCT02021565|156722615|FG001|Baseline Through Intervention|Death|1|||
48692425|NCT02021565|156722614|FG000|Baseline Through Intervention|Withdrawal by Subject|8|||
48692426|NCT02021565|156722615|FG001|Baseline Through Intervention|Withdrawal by Subject|8|||
48692427|NCT02021565|156722614|FG000|Baseline Through Intervention|Protocol Violation|0|||
48692428|NCT02021565|156722615|FG001|Baseline Through Intervention|Protocol Violation|7|||
48692429|NCT02021565|156722614|FG000|Baseline Through Intervention|Lost to Follow-up|4|||
48692430|NCT02021565|156722615|FG001|Baseline Through Intervention|Lost to Follow-up|2|||
48692431|NCT02021565|156722614|FG000|3-month Follow-up|Death|3|||
48692432|NCT02021565|156722615|FG001|3-month Follow-up|Death|0|||
48692433|NCT02021565|156722614|FG000|3-month Follow-up|Withdrawal by Subject|4|||
48692434|NCT02021565|156722615|FG001|3-month Follow-up|Withdrawal by Subject|0|||
48692435|NCT02021565|156722614|FG000|3-month Follow-up|Protocol Violation|3|||
48692436|NCT02021565|156722615|FG001|3-month Follow-up|Protocol Violation|2|||
48692437|NCT02735239|156724492|FG000|Overall Study|Adverse Event|0|||
48692438|NCT02735239|156724493|FG001|Overall Study|Adverse Event|0|||
48692439|NCT02735239|156724494|FG002|Overall Study|Adverse Event|4|||
48692440|NCT02735239|156724495|FG003|Overall Study|Adverse Event|0|||
48692441|NCT02735239|156724496|FG004|Overall Study|Adverse Event|0|||
48692442|NCT02735239|156724497|FG005|Overall Study|Adverse Event|0|||
48692443|NCT02735239|156724492|FG000|Overall Study|Death|1|||
48692444|NCT02735239|156724493|FG001|Overall Study|Death|1|||
48692445|NCT02735239|156724494|FG002|Overall Study|Death|0|||
48692446|NCT02735239|156724495|FG003|Overall Study|Death|0|||
48692447|NCT02735239|156724496|FG004|Overall Study|Death|0|||
48692448|NCT02735239|156724497|FG005|Overall Study|Death|0|||
48692449|NCT02735239|156724492|FG000|Overall Study|Physician Decision|0|||
48692450|NCT02735239|156724493|FG001|Overall Study|Physician Decision|0|||
48692451|NCT02735239|156724494|FG002|Overall Study|Physician Decision|1|||
48692452|NCT02735239|156724495|FG003|Overall Study|Physician Decision|0|||
48692453|NCT02735239|156724496|FG004|Overall Study|Physician Decision|0|||
48692454|NCT02735239|156724497|FG005|Overall Study|Physician Decision|0|||
48692455|NCT02735239|156724492|FG000|Overall Study|Progressive disease|3|||
48692456|NCT02735239|156724493|FG001|Overall Study|Progressive disease|1|||
48692457|NCT02735239|156724494|FG002|Overall Study|Progressive disease|3|||
48692458|NCT02735239|156724495|FG003|Overall Study|Progressive disease|0|||
48692459|NCT02735239|156724496|FG004|Overall Study|Progressive disease|0|||
48692460|NCT02735239|156724497|FG005|Overall Study|Progressive disease|2|||
48692461|NCT02735239|156724492|FG000|Overall Study|Withdrawal by Subject|0|||
48692462|NCT02735239|156724493|FG001|Overall Study|Withdrawal by Subject|1|||
48692463|NCT02735239|156724494|FG002|Overall Study|Withdrawal by Subject|0|||
48692464|NCT02735239|156724495|FG003|Overall Study|Withdrawal by Subject|0|||
48692465|NCT02735239|156724496|FG004|Overall Study|Withdrawal by Subject|0|||
48692466|NCT02735239|156724497|FG005|Overall Study|Withdrawal by Subject|0|||
48692467|NCT03287791|156724500|FG000|Overall Study|Insufficient Therapeutic Response|0|||
48692468|NCT03287791|156724501|FG001|Overall Study|Insufficient Therapeutic Response|0|||
48692469|NCT03287791|156724502|FG002|Overall Study|Insufficient Therapeutic Response|1|||
48692470|NCT03287791|156724500|FG000|Overall Study|Adverse Event|0|||
48692471|NCT03287791|156724501|FG001|Overall Study|Adverse Event|4|||
48692472|NCT03287791|156724502|FG002|Overall Study|Adverse Event|3|||
48692473|NCT03287791|156724500|FG000|Overall Study|Withdrawal by Subject|12|||
48692474|NCT03287791|156724501|FG001|Overall Study|Withdrawal by Subject|12|||
48692475|NCT03287791|156724502|FG002|Overall Study|Withdrawal by Subject|17|||
48692476|NCT03287791|156724500|FG000|Overall Study|Missed more than 6 consecutive doses|3|||
48692477|NCT03287791|156724501|FG001|Overall Study|Missed more than 6 consecutive doses|2|||
48692478|NCT03287791|156724502|FG002|Overall Study|Missed more than 6 consecutive doses|2|||
48692479|NCT03287791|156724500|FG000|Overall Study|Lost to Follow-up|8|||
48692480|NCT03287791|156724501|FG001|Overall Study|Lost to Follow-up|14|||
48692481|NCT03287791|156724502|FG002|Overall Study|Lost to Follow-up|11|||
48791856|NCT02291614|157077132|FG007|Overall Study|Death|0|||
48791857|NCT02291614|157077133|FG008|Overall Study|Death|0|||
48791858|NCT02291614|157077134|FG009|Overall Study|Death|0|||
48791859|NCT02291614|157077135|FG010|Overall Study|Death|0|||
48791860|NCT03298451|157077137|FG000|Overall Study|Death|275|||
48791861|NCT03298451|157077138|FG001|Overall Study|Death|260|||
48791862|NCT03298451|157077139|FG002|Overall Study|Death|122|||
48791863|NCT03298451|157077140|FG003|Overall Study|Death|280|||
48791864|NCT03298451|157077137|FG000|Overall Study|Lost to Follow-up|1|||
48791865|NCT03298451|157077138|FG001|Overall Study|Lost to Follow-up|1|||
48791866|NCT03298451|157077139|FG002|Overall Study|Lost to Follow-up|0|||
48791867|NCT03298451|157077140|FG003|Overall Study|Lost to Follow-up|7|||
48791868|NCT03298451|157077137|FG000|Overall Study|Withdrawal by Subject|9|||
48791869|NCT03298451|157077138|FG001|Overall Study|Withdrawal by Subject|7|||
48791870|NCT03298451|157077139|FG002|Overall Study|Withdrawal by Subject|1|||
48791871|NCT03298451|157077140|FG003|Overall Study|Withdrawal by Subject|20|||
48791872|NCT01565707|157077141|FG000|Overall Study|Adverse Event|1|||
48791873|NCT01565707|157077142|FG001|Overall Study|Adverse Event|6|||
48791874|NCT01565707|157077143|FG002|Overall Study|Adverse Event|2|||
48983472|NCT02477800|157772267|FG005|Long Term Extension Period|Reason not Specified|270|||
48983473|NCT02477800|157772268|FG006|Long Term Extension Period|Reason not Specified|224|||
48791875|NCT01565707|157077144|FG003|Overall Study|Adverse Event|1|||
48791876|NCT01565707|157077141|FG000|Overall Study|Lost to Follow-up|1|||
48791877|NCT01565707|157077142|FG001|Overall Study|Lost to Follow-up|0|||
48791878|NCT01565707|157077143|FG002|Overall Study|Lost to Follow-up|0|||
48791879|NCT01565707|157077144|FG003|Overall Study|Lost to Follow-up|0|||
48791880|NCT01565707|157077141|FG000|Overall Study|Protocol Violation|1|||
48791881|NCT01565707|157077142|FG001|Overall Study|Protocol Violation|0|||
48791882|NCT01565707|157077143|FG002|Overall Study|Protocol Violation|0|||
48791883|NCT01565707|157077144|FG003|Overall Study|Protocol Violation|1|||
48791884|NCT01565707|157077141|FG000|Overall Study|Withdrawal by Subject|3|||
48791885|NCT01565707|157077142|FG001|Overall Study|Withdrawal by Subject|1|||
48791886|NCT01565707|157077143|FG002|Overall Study|Withdrawal by Subject|1|||
48791887|NCT01565707|157077144|FG003|Overall Study|Withdrawal by Subject|1|||
48791888|NCT01565707|157077141|FG000|Overall Study|Randomized but not evaluable|2|||
48791889|NCT01565707|157077142|FG001|Overall Study|Randomized but not evaluable|0|||
48791890|NCT01565707|157077143|FG002|Overall Study|Randomized but not evaluable|0|||
48791891|NCT01565707|157077144|FG003|Overall Study|Randomized but not evaluable|0|||
48791892|NCT01565707|157077141|FG000|Overall Study|Miscellaneous|1|||
48791893|NCT01565707|157077142|FG001|Overall Study|Miscellaneous|1|||
48791894|NCT01565707|157077143|FG002|Overall Study|Miscellaneous|0|||
48791895|NCT01565707|157077144|FG003|Overall Study|Miscellaneous|2|||
48791896|NCT02298192|157077154|FG000|Overall Study|Unclassified|3|||
48791897|NCT02298192|157077155|FG001|Overall Study|Unclassified|2|||
48791898|NCT02298192|157077154|FG000|Overall Study|Withdrawal criteria|2|||
48791899|NCT02298192|157077155|FG001|Overall Study|Withdrawal criteria|0|||
48791900|NCT02298192|157077154|FG000|Overall Study|Withdrawal by Subject|6|||
48791901|NCT02298192|157077155|FG001|Overall Study|Withdrawal by Subject|1|||
48791902|NCT02298192|157077154|FG000|Overall Study|Lost to Follow-up|2|||
48791903|NCT02298192|157077155|FG001|Overall Study|Lost to Follow-up|1|||
48791904|NCT02298192|157077154|FG000|Overall Study|Adverse Event|6|||
48791905|NCT02298192|157077155|FG001|Overall Study|Adverse Event|2|||
48791906|NCT00374322|157077156|FG000|Overall Study|Lost to Follow-up|92|||
48791907|NCT00374322|157077157|FG001|Overall Study|Lost to Follow-up|90|||
48791908|NCT00374322|157077156|FG000|Overall Study|Protocol Violation|8|||
48791909|NCT00374322|157077157|FG001|Overall Study|Protocol Violation|3|||
48791910|NCT00374322|157077156|FG000|Overall Study|Withdrawal by Subject|235|||
48791911|NCT00374322|157077157|FG001|Overall Study|Withdrawal by Subject|167|||
48791912|NCT00374322|157077156|FG000|Overall Study|Sponsor Terminated Study|866|||
48791913|NCT00374322|157077157|FG001|Overall Study|Sponsor Terminated Study|990|||
48791914|NCT00374322|157077156|FG000|Overall Study|Physician Decision|36|||
48791915|NCT00374322|157077157|FG001|Overall Study|Physician Decision|32|||
48791916|NCT00374322|157077156|FG000|Overall Study|Par. Consented to Survival FU Only|3|||
48791917|NCT00374322|157077157|FG001|Overall Study|Par. Consented to Survival FU Only|1|||
48791918|NCT00374322|157077156|FG000|Overall Study|Sponsor Decision|2|||
48791919|NCT00374322|157077157|FG001|Overall Study|Sponsor Decision|3|||
48791920|NCT00374322|157077156|FG000|Overall Study|FU by a Non-Principal Investigator (PI)|2|||
48791921|NCT00374322|157077157|FG001|Overall Study|FU by a Non-Principal Investigator (PI)|3|||
48791922|NCT00374322|157077156|FG000|Overall Study|Seen in FU by a Non-Primary Investigator|1|||
48791923|NCT00374322|157077157|FG001|Overall Study|Seen in FU by a Non-Primary Investigator|0|||
48791924|NCT00374322|157077156|FG000|Overall Study|Severe Toxicity|1|||
48791925|NCT00374322|157077157|FG001|Overall Study|Severe Toxicity|0|||
48791926|NCT00374322|157077156|FG000|Overall Study|Site Closed|2|||
48791927|NCT00374322|157077157|FG001|Overall Study|Site Closed|2|||
48791928|NCT00374322|157077156|FG000|Overall Study|Participant Changed Physician|1|||
48791929|NCT00374322|157077157|FG001|Overall Study|Participant Changed Physician|0|||
48791930|NCT00374322|157077156|FG000|Overall Study|Started Another Chemotherapy Regimen|0|||
48983474|NCT00129376|157772269|FG000|Overall Study|Adverse Event|1|||
48791931|NCT00374322|157077157|FG001|Overall Study|Started Another Chemotherapy Regimen|1|||
48791932|NCT00374322|157077156|FG000|Overall Study|Noncompliance with Study Requirements|0|||
48791933|NCT00374322|157077157|FG001|Overall Study|Noncompliance with Study Requirements|1|||
48791934|NCT00374322|157077156|FG000|Overall Study|Withdrew Consent During Follow-up|0|||
48791935|NCT00374322|157077157|FG001|Overall Study|Withdrew Consent During Follow-up|5|||
48791936|NCT00374322|157077156|FG000|Overall Study|Did Not Receive Study Medication|8|||
48791937|NCT00374322|157077157|FG001|Overall Study|Did Not Receive Study Medication|6|||
48791938|NCT01178086|157077158|FG000|Overall Study|Participant refusal|7|||
48791939|NCT01178086|157077158|FG000|Overall Study|Physician Decision|44|||
48791940|NCT01178086|157077158|FG000|Overall Study|Switch to other CLL therapy|113|||
48791941|NCT01178086|157077158|FG000|Overall Study|Death|59|||
48791942|NCT01178086|157077158|FG000|Overall Study|Other unspecified|89|||
48791943|NCT01178086|157077158|FG000|Overall Study|Excluded from EAS|20|||
48791944|NCT00058123|157077161|FG000|Overall Study|Wrong histology|9|||
48791945|NCT00058123|157077161|FG000|Overall Study|Received >3 prior treatments|1|||
48791946|NCT00234065|157077169|FG000|Overall Study|Adverse Event|268|||
48791947|NCT00234065|157077170|FG001|Overall Study|Adverse Event|166|||
48791948|NCT00234065|157077169|FG000|Overall Study|Withdrawal by Subject|73|||
48791949|NCT00234065|157077170|FG001|Overall Study|Withdrawal by Subject|56|||
48791950|NCT00234065|157077169|FG000|Overall Study|Physician Decision|23|||
48791951|NCT00234065|157077170|FG001|Overall Study|Physician Decision|22|||
48791952|NCT00234065|157077169|FG000|Overall Study|Not Classified|111|||
48791953|NCT00234065|157077170|FG001|Overall Study|Not Classified|112|||
48791954|NCT00126438|157077171|FG000|Overall Study|Withdrawal due to adverse event|1|||
48791955|NCT00126438|157077172|FG001|Overall Study|Withdrawal due to adverse event|0|||
48791956|NCT00126438|157077171|FG000|Overall Study|Lost to Follow-up|22|||
48791957|NCT00126438|157077172|FG001|Overall Study|Lost to Follow-up|0|||
48791958|NCT00126438|157077171|FG000|Overall Study|Protocol Violation|8|||
48791959|NCT00126438|157077172|FG001|Overall Study|Protocol Violation|8|||
48791960|NCT00126438|157077171|FG000|Overall Study|Withdrawal by Subject|3|||
48791961|NCT00126438|157077172|FG001|Overall Study|Withdrawal by Subject|2|||
48791962|NCT05374421|157077173|FG000|Overall Study|Withdrawal by Subject|3|||
48791963|NCT05374421|157077174|FG001|Overall Study|Withdrawal by Subject|4|||
48791964|NCT02477618|157077185|FG000|Overall Study|Completed Visits but Discontinued Drug|2|||
48791965|NCT02477618|157077186|FG001|Overall Study|Completed Visits but Discontinued Drug|1|||
48791966|NCT02477618|157077185|FG000|Overall Study|Died in Double-Blind Treatment Period|11|||
48791967|NCT02477618|157077186|FG001|Overall Study|Died in Double-Blind Treatment Period|11|||
48791968|NCT02477618|157077185|FG000|Overall Study|Adverse Event|1|||
48791969|NCT02477618|157077186|FG001|Overall Study|Adverse Event|1|||
48791970|NCT02477618|157077185|FG000|Overall Study|Transferred Away from Study Site|1|||
48791971|NCT02477618|157077186|FG001|Overall Study|Transferred Away from Study Site|0|||
48791972|NCT02477618|157077185|FG000|Overall Study|Left Study Site for Rehabilitation|0|||
48791973|NCT02477618|157077186|FG001|Overall Study|Left Study Site for Rehabilitation|1|||
48791974|NCT03053050|157077189|FG000|Randomized Phase|Study Terminated by Sponsor|259|||
48791975|NCT03053050|157077190|FG001|Randomized Phase|Study Terminated by Sponsor|260|||
48791976|NCT03053050|157077191|FG002|Randomized Phase|Study Terminated by Sponsor|128|||
48791977|NCT03053050|157077192|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
48791978|NCT03053050|157077189|FG000|Randomized Phase|Withdrew Consent|16|||
48791979|NCT03053050|157077190|FG001|Randomized Phase|Withdrew Consent|8|||
48791980|NCT03053050|157077191|FG002|Randomized Phase|Withdrew Consent|9|||
48791981|NCT03053050|157077192|FG003|Randomized Phase|Withdrew Consent|0|||
48791982|NCT03053050|157077189|FG000|Randomized Phase|Investigator's Discretion|6|||
48791983|NCT03053050|157077190|FG001|Randomized Phase|Investigator's Discretion|6|||
48791984|NCT03053050|157077191|FG002|Randomized Phase|Investigator's Discretion|3|||
48791985|NCT03053050|157077192|FG003|Randomized Phase|Investigator's Discretion|0|||
48791986|NCT03053050|157077189|FG000|Randomized Phase|Lost to Follow-up|5|||
48791987|NCT03053050|157077190|FG001|Randomized Phase|Lost to Follow-up|1|||
48791988|NCT03053050|157077191|FG002|Randomized Phase|Lost to Follow-up|1|||
48791989|NCT03053050|157077192|FG003|Randomized Phase|Lost to Follow-up|0|||
48791990|NCT03053050|157077189|FG000|Randomized Phase|Adverse Event|0|||
48791991|NCT03053050|157077190|FG001|Randomized Phase|Adverse Event|1|||
48791992|NCT03053050|157077191|FG002|Randomized Phase|Adverse Event|0|||
48791993|NCT03053050|157077192|FG003|Randomized Phase|Adverse Event|0|||
48791994|NCT03053050|157077189|FG000|Randomized Phase|Randomized but Never Treated|2|||
48791995|NCT03053050|157077190|FG001|Randomized Phase|Randomized but Never Treated|2|||
48791996|NCT03053050|157077191|FG002|Randomized Phase|Randomized but Never Treated|2|||
48983475|NCT00129376|157772269|FG000|Overall Study|Lack of Efficacy|1|||
48983476|NCT02061540|157772276|FG000|Overall Study|Adverse Event|2|||
48983477|NCT02061540|157772276|FG000|Overall Study|Withdrawal by Subject|2|||
48983478|NCT01227252|157772278|FG000|Overall Study|Sponsor Decision|0|||
48983479|NCT01227252|157772279|FG001|Overall Study|Sponsor Decision|1|||
48983480|NCT01227252|157772280|FG002|Overall Study|Sponsor Decision|0|||
48983481|NCT01227252|157772281|FG003|Overall Study|Sponsor Decision|0|||
48983482|NCT01227252|157772278|FG000|Overall Study|Lost to Follow-up|0|||
48983483|NCT01227252|157772279|FG001|Overall Study|Lost to Follow-up|1|||
49032393|NCT01597245|157953471|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
49032394|NCT01597245|157953472|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
48791997|NCT03053050|157077192|FG003|Randomized Phase|Randomized but Never Treated|0|||
48791998|NCT03053050|157077189|FG000|Randomized Phase|Entered the Open-Label Phase|36|||
48791999|NCT03053050|157077190|FG001|Randomized Phase|Entered the Open-Label Phase|45|||
48792000|NCT03053050|157077191|FG002|Randomized Phase|Entered the Open-Label Phase|18|||
48792001|NCT03053050|157077192|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
48792002|NCT03053050|157077189|FG000|Open-label Phase|Study Terminated by Sponsor|0|||
48792003|NCT03053050|157077190|FG001|Open-label Phase|Study Terminated by Sponsor|0|||
48792004|NCT03053050|157077191|FG002|Open-label Phase|Study Terminated by Sponsor|0|||
48792005|NCT03053050|157077192|FG003|Open-label Phase|Study Terminated by Sponsor|89|||
48792006|NCT03053050|157077189|FG000|Open-label Phase|Withdrew Consent|0|||
48792007|NCT03053050|157077190|FG001|Open-label Phase|Withdrew Consent|0|||
48792008|NCT03053050|157077191|FG002|Open-label Phase|Withdrew Consent|0|||
48792009|NCT03053050|157077192|FG003|Open-label Phase|Withdrew Consent|6|||
48792010|NCT03053050|157077189|FG000|Open-label Phase|Investigator's Discretion|0|||
48792011|NCT03053050|157077190|FG001|Open-label Phase|Investigator's Discretion|0|||
48792012|NCT03053050|157077191|FG002|Open-label Phase|Investigator's Discretion|0|||
48792013|NCT03053050|157077192|FG003|Open-label Phase|Investigator's Discretion|4|||
48792014|NCT05239039|157077193|FG000|Overall Study|Withdrawal by Subject|0|||
48792015|NCT05239039|157077194|FG001|Overall Study|Withdrawal by Subject|1|||
48792016|NCT02492100|157079178|FG000|Overall Study|Death|1|||
48792017|NCT05706506|157079179|FG000|Overall Study|Adverse Event|1|||
48792018|NCT05706506|157079179|FG000|Overall Study|Withdrawal by Subject|4|||
48792019|NCT05706506|157079179|FG000|Overall Study|Lost to Follow-up|2|||
48792020|NCT05706506|157079179|FG000|Overall Study|Inadvertent Enrolment|12|||
48792021|NCT05706506|157079179|FG000|Overall Study|Early Discontinuation Due to Hyperglycemia|1|||
48792022|NCT05706506|157079179|FG000|Overall Study|Participant Moved Out of State|1|||
48792023|NCT03656562|157079180|FG000|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|19|||
48792024|NCT03656562|157079181|FG001|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|13|||
48792025|NCT03656562|157079182|FG002|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|5|||
48792026|NCT03656562|157079183|FG003|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|4|||
48792027|NCT03656562|157079180|FG000|Overall Study|Physician Decision|1|||
48792028|NCT03656562|157079181|FG001|Overall Study|Physician Decision|2|||
48792029|NCT03656562|157079182|FG002|Overall Study|Physician Decision|0|||
48792030|NCT03656562|157079183|FG003|Overall Study|Physician Decision|0|||
48792031|NCT03656562|157079180|FG000|Overall Study|Subject Decision|3|||
48792032|NCT03656562|157079181|FG001|Overall Study|Subject Decision|5|||
48792033|NCT03656562|157079182|FG002|Overall Study|Subject Decision|0|||
48792034|NCT03656562|157079183|FG003|Overall Study|Subject Decision|2|||
48792035|NCT02473250|157079184|FG000|Overall Study|Lost to Follow-up|10|||
48792036|NCT02473250|157079184|FG000|Overall Study|Physician Decision|5|||
48792037|NCT02473250|157079184|FG000|Overall Study|Did not tolerate medication washout|3|||
48792038|NCT02473250|157079184|FG000|Overall Study|Antidepressant effect of divalproex|2|||
48792039|NCT03575052|157079185|FG000|Overall Study|Adverse Event|6|||
48792040|NCT03575052|157079186|FG001|Overall Study|Adverse Event|10|||
48792041|NCT03575052|157079185|FG000|Overall Study|Not further specified|5|||
48792042|NCT03575052|157079186|FG001|Overall Study|Not further specified|7|||
48792043|NCT03575052|157079185|FG000|Overall Study|Withdrawal by Subject|5|||
48792044|NCT03575052|157079186|FG001|Overall Study|Withdrawal by Subject|6|||
48792045|NCT03575052|157079185|FG000|Overall Study|Lost to Follow-up|3|||
48792046|NCT03575052|157079186|FG001|Overall Study|Lost to Follow-up|0|||
48792047|NCT03575052|157079185|FG000|Overall Study|Death|2|||
48792048|NCT03575052|157079186|FG001|Overall Study|Death|1|||
48792049|NCT03575052|157079185|FG000|Overall Study|Lack of Efficacy|2|||
48792050|NCT03575052|157079186|FG001|Overall Study|Lack of Efficacy|1|||
48792051|NCT03575052|157079185|FG000|Overall Study|Study drug noncompliance|1|||
48792052|NCT03575052|157079186|FG001|Overall Study|Study drug noncompliance|2|||
48792053|NCT03575052|157079185|FG000|Overall Study|Protocol Violation|0|||
48792054|NCT03575052|157079186|FG001|Overall Study|Protocol Violation|2|||
48792055|NCT03575052|157079185|FG000|Overall Study|Physician Decision|1|||
48792056|NCT03575052|157079186|FG001|Overall Study|Physician Decision|0|||
48792057|NCT03822533|157079188|FG000|3 Month Follow-up|Withdrawal by Subject|3|||
48792058|NCT03822533|157079189|FG001|3 Month Follow-up|Withdrawal by Subject|4|||
48792059|NCT03822533|157079188|FG000|3 Month Follow-up|Lost to Follow-up|2|||
48792060|NCT03822533|157079189|FG001|3 Month Follow-up|Lost to Follow-up|2|||
48792061|NCT03822533|157079188|FG000|6 Month Follow-up|Lost to Follow-up|3|||
48792062|NCT03822533|157079189|FG001|6 Month Follow-up|Lost to Follow-up|0|||
48792063|NCT03822533|157079188|FG000|12 Month Follow-up|Lost to Follow-up|2|||
48792064|NCT03822533|157079189|FG001|12 Month Follow-up|Lost to Follow-up|3|||
48792065|NCT03822533|157079188|FG000|12 Month Follow-up|Pregnancy|0|||
48792066|NCT03822533|157079189|FG001|12 Month Follow-up|Pregnancy|1|||
48792067|NCT03822533|157079188|FG000|12 Month Follow-up|Surgery|2|||
48792068|NCT03822533|157079189|FG001|12 Month Follow-up|Surgery|0|||
48792069|NCT03822533|157079188|FG000|12 Month Follow-up|Wrong address|1|||
49032395|NCT01597245|157953473|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
49032396|NCT01597245|157953474|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
49032397|NCT01597245|157953475|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
49032398|NCT01597245|157953476|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
49032399|NCT01597245|157953477|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
49032400|NCT01597245|157953478|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
49032401|NCT01597245|157953479|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
49032402|NCT01597245|157953480|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
49032403|NCT01597245|157953481|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
48792070|NCT03822533|157079189|FG001|12 Month Follow-up|Wrong address|0|||
48792071|NCT03822533|157079188|FG000|12 Month Follow-up|No symptoms|1|||
48792072|NCT03822533|157079189|FG001|12 Month Follow-up|No symptoms|0|||
48792073|NCT03822533|157079188|FG000|12 Month Follow-up|Changed primary care center|0|||
48792074|NCT03822533|157079189|FG001|12 Month Follow-up|Changed primary care center|1|||
48792075|NCT01990950|157079192|FG000|Overall Study|Death|3|||
48792076|NCT01990950|157079192|FG000|Overall Study|Lost to Follow-up|2|||
48792077|NCT01990950|157079192|FG000|Overall Study|Withdrawal by Subject|6|||
48792078|NCT03484702|157079193|FG000|Treatment Period|Death|3|||
48792079|NCT03484702|157079194|FG001|Treatment Period|Death|1|||
48792080|NCT03484702|157079195|FG002|Treatment Period|Death|0|||
48792081|NCT03484702|157079196|FG003|Treatment Period|Death|0|||
48792082|NCT03484702|157079197|FG004|Treatment Period|Death|0|||
48792083|NCT03484702|157079198|FG005|Treatment Period|Death|0|||
48792084|NCT03484702|157079193|FG000|Treatment Period|Adverse Event|1|||
48792085|NCT03484702|157079194|FG001|Treatment Period|Adverse Event|0|||
48792086|NCT03484702|157079195|FG002|Treatment Period|Adverse Event|0|||
48792087|NCT03484702|157079196|FG003|Treatment Period|Adverse Event|0|||
48792088|NCT03484702|157079197|FG004|Treatment Period|Adverse Event|0|||
48792089|NCT03484702|157079198|FG005|Treatment Period|Adverse Event|0|||
48792090|NCT03484702|157079193|FG000|Treatment Period|Participant Withdrew from Study|0|||
48792091|NCT03484702|157079194|FG001|Treatment Period|Participant Withdrew from Study|1|||
48792092|NCT03484702|157079195|FG002|Treatment Period|Participant Withdrew from Study|0|||
48792093|NCT03484702|157079196|FG003|Treatment Period|Participant Withdrew from Study|0|||
48792094|NCT03484702|157079197|FG004|Treatment Period|Participant Withdrew from Study|0|||
48792095|NCT03484702|157079198|FG005|Treatment Period|Participant Withdrew from Study|0|||
48792096|NCT03484702|157079193|FG000|Treatment Period|Physician Decision|0|||
48792097|NCT03484702|157079194|FG001|Treatment Period|Physician Decision|1|||
48792098|NCT03484702|157079195|FG002|Treatment Period|Physician Decision|0|||
48792099|NCT03484702|157079196|FG003|Treatment Period|Physician Decision|0|||
48792100|NCT03484702|157079197|FG004|Treatment Period|Physician Decision|0|||
48792101|NCT03484702|157079198|FG005|Treatment Period|Physician Decision|1|||
48792102|NCT01830595|157079201|FG000|First Period|Withdrawal by Subject|1|||
48792103|NCT01830595|157079202|FG001|First Period|Withdrawal by Subject|3|||
48792104|NCT01830595|157079201|FG000|Washout|Withdrawal by Subject|2|||
48792105|NCT01830595|157079202|FG001|Washout|Withdrawal by Subject|2|||
48792106|NCT04154956|157079205|FG000|Overall Study|Death|109|||
48792107|NCT04154956|157079206|FG001|Overall Study|Death|110|||
48792108|NCT04154956|157079205|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
48792109|NCT04154956|157079206|FG001|Overall Study|Not related to Coronavirus disease 2019|1|||
48792110|NCT04154956|157079205|FG000|Overall Study|Withdrawal by Subject|1|||
48792111|NCT04154956|157079206|FG001|Overall Study|Withdrawal by Subject|7|||
48792112|NCT04154956|157079205|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|36|||
48792113|NCT04154956|157079206|FG001|Overall Study|Ongoing study treatment at the time of primary analysis|25|||
48792114|NCT05374837|157079207|FG000|Overall Study|Lost to Follow-up|17|||
48792115|NCT05374837|157079208|FG001|Overall Study|Lost to Follow-up|18|||
48792116|NCT00676715|157079209|FG000|Treatment Period (TP)|Adverse Event|0|||
48792117|NCT00676715|157079210|FG001|Treatment Period (TP)|Adverse Event|3|||
48792118|NCT00676715|157079211|FG002|Treatment Period (TP)|Adverse Event|2|||
48792119|NCT00676715|157079212|FG003|Treatment Period (TP)|Adverse Event|2|||
48792120|NCT00676715|157079209|FG000|Treatment Period (TP)|Death|0|||
48792121|NCT00676715|157079210|FG001|Treatment Period (TP)|Death|0|||
48792122|NCT00676715|157079211|FG002|Treatment Period (TP)|Death|1|||
48792123|NCT00676715|157079212|FG003|Treatment Period (TP)|Death|0|||
48792124|NCT00676715|157079209|FG000|Treatment Period (TP)|Failure to return|1|||
48792125|NCT00676715|157079210|FG001|Treatment Period (TP)|Failure to return|0|||
48792126|NCT00676715|157079211|FG002|Treatment Period (TP)|Failure to return|0|||
48792127|NCT00676715|157079212|FG003|Treatment Period (TP)|Failure to return|0|||
48792128|NCT00676715|157079209|FG000|Treatment Period (TP)|Violation of selection criteria at entry|0|||
49032404|NCT01597245|157953482|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
48792129|NCT00676715|157079210|FG001|Treatment Period (TP)|Violation of selection criteria at entry|0|||
48792130|NCT00676715|157079211|FG002|Treatment Period (TP)|Violation of selection criteria at entry|1|||
48792131|NCT00676715|157079212|FG003|Treatment Period (TP)|Violation of selection criteria at entry|0|||
48792132|NCT00676715|157079209|FG000|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
48792133|NCT00676715|157079210|FG001|Treatment Period (TP)|Refused treatment/did not cooperate|2|||
48792134|NCT00676715|157079211|FG002|Treatment Period (TP)|Refused treatment/did not cooperate|3|||
48792135|NCT00676715|157079212|FG003|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
48792136|NCT00676715|157079209|FG000|Treatment Period (TP)|Withdrew consent|3|||
48792137|NCT00676715|157079210|FG001|Treatment Period (TP)|Withdrew consent|3|||
48792138|NCT00676715|157079211|FG002|Treatment Period (TP)|Withdrew consent|3|||
48792139|NCT00676715|157079212|FG003|Treatment Period (TP)|Withdrew consent|3|||
48792140|NCT00676715|157079209|FG000|Treatment Period (TP)|Insufficient therapeutic response|1|||
48792141|NCT00676715|157079210|FG001|Treatment Period (TP)|Insufficient therapeutic response|1|||
48792142|NCT00676715|157079211|FG002|Treatment Period (TP)|Insufficient therapeutic response|2|||
48792143|NCT00676715|157079212|FG003|Treatment Period (TP)|Insufficient therapeutic response|1|||
48792144|NCT00676715|157079209|FG000|Treatment Period (TP)|Administrative|0|||
48792145|NCT00676715|157079210|FG001|Treatment Period (TP)|Administrative|0|||
48792146|NCT00676715|157079211|FG002|Treatment Period (TP)|Administrative|0|||
48792147|NCT00676715|157079212|FG003|Treatment Period (TP)|Administrative|1|||
48792148|NCT00676715|157079209|FG000|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
48792149|NCT00676715|157079210|FG001|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
48792150|NCT00676715|157079211|FG002|Treatment-free Period (TFP)|Withdrawal by Subject|4|||
48792151|NCT00676715|157079212|FG003|Treatment-free Period (TFP)|Withdrawal by Subject|5|||
48792152|NCT00676715|157079209|FG000|Treatment-free Period (TFP)|Reason not provided|8|||
48792153|NCT00676715|157079210|FG001|Treatment-free Period (TFP)|Reason not provided|10|||
48792154|NCT00676715|157079211|FG002|Treatment-free Period (TFP)|Reason not provided|8|||
48792155|NCT00676715|157079212|FG003|Treatment-free Period (TFP)|Reason not provided|7|||
48792156|NCT00676715|157079209|FG000|Treatment-free Period (TFP)|Lost to Follow-up|2|||
48792157|NCT00676715|157079210|FG001|Treatment-free Period (TFP)|Lost to Follow-up|2|||
48792158|NCT00676715|157079211|FG002|Treatment-free Period (TFP)|Lost to Follow-up|6|||
48792159|NCT00676715|157079212|FG003|Treatment-free Period (TFP)|Lost to Follow-up|2|||
48792160|NCT00676715|157079209|FG000|Treatment-free Period (TFP)|Adverse Event|0|||
48792161|NCT00676715|157079210|FG001|Treatment-free Period (TFP)|Adverse Event|0|||
48792162|NCT00676715|157079211|FG002|Treatment-free Period (TFP)|Adverse Event|1|||
48792163|NCT00676715|157079212|FG003|Treatment-free Period (TFP)|Adverse Event|0|||
48792164|NCT00676715|157079209|FG000|Treatment-free Period (TFP)|Death|1|||
48792165|NCT00676715|157079210|FG001|Treatment-free Period (TFP)|Death|1|||
48792166|NCT00676715|157079211|FG002|Treatment-free Period (TFP)|Death|1|||
48792167|NCT00676715|157079212|FG003|Treatment-free Period (TFP)|Death|0|||
48792168|NCT00676715|157079209|FG000|Open Label Extension (OLE)|Reason not provided|3|||
48792169|NCT00676715|157079210|FG001|Open Label Extension (OLE)|Reason not provided|4|||
48792170|NCT00676715|157079211|FG002|Open Label Extension (OLE)|Reason not provided|1|||
48792171|NCT00676715|157079212|FG003|Open Label Extension (OLE)|Reason not provided|4|||
48792172|NCT00676715|157079209|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
48792173|NCT00676715|157079210|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
48792174|NCT00676715|157079211|FG002|Open Label Extension (OLE)|Lost to Follow-up|1|||
48792175|NCT00676715|157079212|FG003|Open Label Extension (OLE)|Lost to Follow-up|1|||
48792176|NCT00676715|157079209|FG000|Open Label Extension (OLE)|Withdrawal by Subject|2|||
48792177|NCT00676715|157079210|FG001|Open Label Extension (OLE)|Withdrawal by Subject|4|||
48792178|NCT00676715|157079211|FG002|Open Label Extension (OLE)|Withdrawal by Subject|3|||
48792179|NCT00676715|157079212|FG003|Open Label Extension (OLE)|Withdrawal by Subject|3|||
48792180|NCT00676715|157079209|FG000|Open Label Extension (OLE)|Adverse Event|0|||
48792181|NCT00676715|157079210|FG001|Open Label Extension (OLE)|Adverse Event|3|||
48792182|NCT00676715|157079211|FG002|Open Label Extension (OLE)|Adverse Event|1|||
48792183|NCT00676715|157079212|FG003|Open Label Extension (OLE)|Adverse Event|0|||
48792184|NCT00676715|157079209|FG000|Open Label Extension (OLE)|Death|2|||
48792185|NCT00676715|157079210|FG001|Open Label Extension (OLE)|Death|0|||
48792186|NCT00676715|157079211|FG002|Open Label Extension (OLE)|Death|2|||
48792187|NCT00676715|157079212|FG003|Open Label Extension (OLE)|Death|2|||
48792188|NCT02506153|157079213|FG000|Overall Study|Adverse Event|359|||
48792189|NCT02506153|157079214|FG001|Overall Study|Adverse Event|114|||
48792190|NCT02506153|157079213|FG000|Overall Study|Refused unrelated to adverse event|127|||
48792191|NCT02506153|157079214|FG001|Overall Study|Refused unrelated to adverse event|18|||
48792192|NCT02506153|157079213|FG000|Overall Study|Progression/relapse|91|||
48792193|NCT02506153|157079214|FG001|Overall Study|Progression/relapse|136|||
48792194|NCT02506153|157079213|FG000|Overall Study|Death|2|||
48792195|NCT02506153|157079214|FG001|Overall Study|Death|1|||
48792196|NCT02506153|157079213|FG000|Overall Study|Other - not protocol specified|23|||
48792197|NCT02506153|157079214|FG001|Overall Study|Other - not protocol specified|12|||
48792198|NCT03905655|157079216|FG000|Overall Study|Adverse Event|1|||
48792199|NCT03905655|157079217|FG001|Overall Study|Adverse Event|0|||
48792200|NCT03905655|157079218|FG002|Overall Study|Adverse Event|1|||
48792201|NCT03905655|157079219|FG003|Overall Study|Adverse Event|1|||
48792202|NCT03117738|157079222|FG000|Overall Study|Withdrawal by Subject|3|||
48792203|NCT03117738|157079223|FG001|Overall Study|Withdrawal by Subject|1|||
48792204|NCT03117738|157079222|FG000|Overall Study|Lost to Follow-up|1|||
48878086|NCT01216072|157392129|FG000|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0|||
48878087|NCT01216072|157392130|FG001|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1|||
48878088|NCT01216072|157392129|FG000|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0|||
48878089|NCT01216072|157392130|FG001|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3|||
48878090|NCT00756457|157392131|FG000|Overall Study|Lost to Follow-up|1|||
48878091|NCT00756457|157392132|FG001|Overall Study|Lost to Follow-up|2|||
48878092|NCT02402322|157392134|FG000|Pretreatment|Withdrawal by Subject|3|||
48878093|NCT02402322|157392135|FG001|Pretreatment|Withdrawal by Subject|1|||
48878094|NCT02402322|157392136|FG002|Pretreatment|Withdrawal by Subject|1|||
48878095|NCT02402322|157392134|FG000|Follow-up|Withdrawal by Subject|6|||
48878096|NCT02402322|157392135|FG001|Follow-up|Withdrawal by Subject|3|||
48878097|NCT02402322|157392136|FG002|Follow-up|Withdrawal by Subject|24|||
48878098|NCT00952848|157392137|FG000|Overall Study|Withdrawal by Subject|4|||
48878099|NCT00755417|157392138|FG000|Overall Study|Adverse Event|28|||
48878100|NCT00755417|157392139|FG001|Overall Study|Adverse Event|20|||
48878101|NCT00755417|157392140|FG002|Overall Study|Adverse Event|7|||
48878102|NCT00755417|157392138|FG000|Overall Study|Lack of Efficacy|8|||
48878103|NCT00755417|157392139|FG001|Overall Study|Lack of Efficacy|4|||
48878104|NCT00755417|157392140|FG002|Overall Study|Lack of Efficacy|9|||
48878105|NCT00755417|157392138|FG000|Overall Study|Protocol Violation|2|||
48878106|NCT00755417|157392139|FG001|Overall Study|Protocol Violation|1|||
48878107|NCT00755417|157392140|FG002|Overall Study|Protocol Violation|1|||
48878108|NCT00755417|157392138|FG000|Overall Study|Lost to Follow-up|3|||
48878109|NCT00755417|157392139|FG001|Overall Study|Lost to Follow-up|0|||
48878110|NCT00755417|157392140|FG002|Overall Study|Lost to Follow-up|1|||
48878111|NCT00755417|157392138|FG000|Overall Study|Withdrawal by Subject|12|||
48878112|NCT00755417|157392139|FG001|Overall Study|Withdrawal by Subject|12|||
48878113|NCT00755417|157392140|FG002|Overall Study|Withdrawal by Subject|12|||
48878114|NCT00755417|157392138|FG000|Overall Study|Not specified or missing data|9|||
48878115|NCT00755417|157392139|FG001|Overall Study|Not specified or missing data|18|||
48878116|NCT00755417|157392140|FG002|Overall Study|Not specified or missing data|12|||
48878117|NCT02643628|157392142|FG000|Overall Study|Lost to Follow-up|1|||
48878118|NCT02643628|157392143|FG001|Overall Study|Lost to Follow-up|4|||
48878119|NCT02643628|157392142|FG000|Overall Study|Withdrawal by Subject|0|||
48878120|NCT02643628|157392143|FG001|Overall Study|Withdrawal by Subject|1|||
49032405|NCT01597245|157953483|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
48792205|NCT03117738|157079223|FG001|Overall Study|Lost to Follow-up|4|||
48792206|NCT01669629|157079224|FG000|Period 1|protocol deviation|1|||
48792207|NCT01669629|157079225|FG001|Period 1|protocol deviation|2|||
48792208|NCT01754467|157079226|FG000|Overall Study|Lost to Follow-up|1|||
48792209|NCT02794285|157079227|FG000|Overall Study|Adverse Event|11|||
48792210|NCT02794285|157079228|FG001|Overall Study|Adverse Event|4|||
48792211|NCT02794285|157079229|FG002|Overall Study|Adverse Event|5|||
48792212|NCT02794285|157079230|FG003|Overall Study|Adverse Event|8|||
48792213|NCT02794285|157079227|FG000|Overall Study|Condition Under Investigation Improved|1|||
48792214|NCT02794285|157079228|FG001|Overall Study|Condition Under Investigation Improved|0|||
49032406|NCT01597245|157953484|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
48792215|NCT02794285|157079229|FG002|Overall Study|Condition Under Investigation Improved|0|||
48792216|NCT02794285|157079230|FG003|Overall Study|Condition Under Investigation Improved|0|||
48792217|NCT02794285|157079227|FG000|Overall Study|Condition Under Investigation Worsened|0|||
48792218|NCT02794285|157079228|FG001|Overall Study|Condition Under Investigation Worsened|2|||
48792219|NCT02794285|157079229|FG002|Overall Study|Condition Under Investigation Worsened|1|||
49032407|NCT01597245|157953485|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
49032408|NCT01597245|157953486|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9|||
48792220|NCT02794285|157079230|FG003|Overall Study|Condition Under Investigation Worsened|0|||
48792221|NCT02794285|157079227|FG000|Overall Study|Death|2|||
48792222|NCT02794285|157079228|FG001|Overall Study|Death|1|||
48792223|NCT02794285|157079229|FG002|Overall Study|Death|2|||
48792224|NCT02794285|157079230|FG003|Overall Study|Death|0|||
48792225|NCT02794285|157079227|FG000|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
48792226|NCT02794285|157079228|FG001|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
48792227|NCT02794285|157079229|FG002|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
48792228|NCT02794285|157079230|FG003|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
48792229|NCT02794285|157079227|FG000|Overall Study|Failure to Meet Randomisation Criteria|0|||
48792230|NCT02794285|157079228|FG001|Overall Study|Failure to Meet Randomisation Criteria|0|||
48792231|NCT02794285|157079229|FG002|Overall Study|Failure to Meet Randomisation Criteria|1|||
48792232|NCT02794285|157079230|FG003|Overall Study|Failure to Meet Randomisation Criteria|0|||
48792233|NCT02794285|157079227|FG000|Overall Study|Lack of Efficacy|10|||
48792234|NCT02794285|157079228|FG001|Overall Study|Lack of Efficacy|6|||
48792235|NCT02794285|157079229|FG002|Overall Study|Lack of Efficacy|3|||
48792236|NCT02794285|157079230|FG003|Overall Study|Lack of Efficacy|3|||
48792237|NCT02794285|157079227|FG000|Overall Study|Lost to Follow-up|5|||
48792238|NCT02794285|157079228|FG001|Overall Study|Lost to Follow-up|6|||
48792239|NCT02794285|157079229|FG002|Overall Study|Lost to Follow-up|3|||
48792240|NCT02794285|157079230|FG003|Overall Study|Lost to Follow-up|1|||
48792241|NCT02794285|157079227|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
48792242|NCT02794285|157079228|FG001|Overall Study|Severe Non-compliance to Protocol|2|||
48792243|NCT02794285|157079229|FG002|Overall Study|Severe Non-compliance to Protocol|1|||
48792244|NCT02794285|157079230|FG003|Overall Study|Severe Non-compliance to Protocol|0|||
48792245|NCT02794285|157079227|FG000|Overall Study|Withdrawal by Subject|38|||
48792246|NCT02794285|157079228|FG001|Overall Study|Withdrawal by Subject|29|||
48792247|NCT02794285|157079229|FG002|Overall Study|Withdrawal by Subject|20|||
48792248|NCT02794285|157079230|FG003|Overall Study|Withdrawal by Subject|12|||
48792249|NCT02794285|157079227|FG000|Overall Study|Missing|1|||
48792250|NCT02794285|157079228|FG001|Overall Study|Missing|0|||
48792251|NCT02794285|157079229|FG002|Overall Study|Missing|0|||
48792252|NCT02794285|157079230|FG003|Overall Study|Missing|0|||
48792253|NCT02794285|157079227|FG000|Overall Study|Due to COVID-19 Pandemic|7|||
48792254|NCT02794285|157079228|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
48792255|NCT02794285|157079229|FG002|Overall Study|Due to COVID-19 Pandemic|4|||
48792256|NCT02794285|157079230|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
48792257|NCT02794285|157079227|FG000|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
48792258|NCT02794285|157079228|FG001|Overall Study|Other - Not Due to COVID-19 Pandemic|6|||
48792259|NCT02794285|157079229|FG002|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
48792260|NCT02794285|157079230|FG003|Overall Study|Other - Not Due to COVID-19 Pandemic|1|||
48792261|NCT03252587|157079231|FG000|Overall Study|Adverse Event|3|||
48792262|NCT03252587|157079232|FG001|Overall Study|Adverse Event|8|||
48792263|NCT03252587|157079233|FG002|Overall Study|Adverse Event|6|||
48792264|NCT03252587|157079234|FG003|Overall Study|Adverse Event|12|||
48792265|NCT03252587|157079231|FG000|Overall Study|Lack of Efficacy|7|||
48792266|NCT03252587|157079232|FG001|Overall Study|Lack of Efficacy|2|||
48792267|NCT03252587|157079233|FG002|Overall Study|Lack of Efficacy|2|||
48792268|NCT03252587|157079234|FG003|Overall Study|Lack of Efficacy|4|||
48792269|NCT03252587|157079231|FG000|Overall Study|Lost to Follow-up|2|||
48792270|NCT03252587|157079232|FG001|Overall Study|Lost to Follow-up|0|||
48792271|NCT03252587|157079233|FG002|Overall Study|Lost to Follow-up|0|||
48792272|NCT03252587|157079234|FG003|Overall Study|Lost to Follow-up|2|||
48792273|NCT03252587|157079231|FG000|Overall Study|Pregnancy|2|||
48983484|NCT01227252|157772280|FG002|Overall Study|Lost to Follow-up|0|||
48983485|NCT01227252|157772281|FG003|Overall Study|Lost to Follow-up|0|||
48983486|NCT01227252|157772278|FG000|Overall Study|Withdrawal by Subject|0|||
48983487|NCT01227252|157772279|FG001|Overall Study|Withdrawal by Subject|1|||
48983488|NCT01227252|157772280|FG002|Overall Study|Withdrawal by Subject|0|||
48983489|NCT01227252|157772281|FG003|Overall Study|Withdrawal by Subject|0|||
48983490|NCT02449915|157772283|FG000|Overall Study|Exclusion criteria - drug use|1|||
48983491|NCT02449915|157772284|FG001|Overall Study|Exclusion criteria - drug use|0|||
48983492|NCT02449915|157772283|FG000|Overall Study|Withdrawal by Subject|0|||
48983493|NCT02449915|157772284|FG001|Overall Study|Withdrawal by Subject|2|||
48983494|NCT02449915|157772283|FG000|Overall Study|Intraoperative surgical findings|1|||
48983495|NCT02449915|157772284|FG001|Overall Study|Intraoperative surgical findings|1|||
48983496|NCT02449915|157772283|FG000|Overall Study|Abnormal preop lab|0|||
48983497|NCT02449915|157772284|FG001|Overall Study|Abnormal preop lab|1|||
48983498|NCT00811395|157772287|FG000|Extension Treatment|Adverse Event|1|||
48983499|NCT00811395|157772288|FG001|Extension Treatment|Adverse Event|2|||
48983500|NCT00811395|157772289|FG002|Extension Treatment|Adverse Event|2|||
48983501|NCT00811395|157772290|FG003|Extension Treatment|Adverse Event|2|||
48983502|NCT00811395|157772291|FG004|Extension Treatment|Adverse Event|0|||
48983503|NCT00811395|157772292|FG005|Extension Treatment|Adverse Event|1|||
48983504|NCT00811395|157772287|FG000|Extension Treatment|Progressive disease|1|||
48983505|NCT00811395|157772288|FG001|Extension Treatment|Progressive disease|1|||
48983506|NCT00811395|157772289|FG002|Extension Treatment|Progressive disease|0|||
48983507|NCT00811395|157772290|FG003|Extension Treatment|Progressive disease|0|||
48983508|NCT00811395|157772291|FG004|Extension Treatment|Progressive disease|0|||
48983509|NCT00811395|157772292|FG005|Extension Treatment|Progressive disease|0|||
48983510|NCT00811395|157772287|FG000|Extension Treatment|Participant did not wish to continue|0|||
48983511|NCT00811395|157772288|FG001|Extension Treatment|Participant did not wish to continue|3|||
48983512|NCT00811395|157772289|FG002|Extension Treatment|Participant did not wish to continue|0|||
48983513|NCT00811395|157772290|FG003|Extension Treatment|Participant did not wish to continue|1|||
48792274|NCT03252587|157079232|FG001|Overall Study|Pregnancy|1|||
48792275|NCT03252587|157079233|FG002|Overall Study|Pregnancy|0|||
48792276|NCT03252587|157079234|FG003|Overall Study|Pregnancy|1|||
48792277|NCT03252587|157079231|FG000|Overall Study|Withdrawal by Subject|8|||
48792278|NCT03252587|157079232|FG001|Overall Study|Withdrawal by Subject|4|||
48792279|NCT03252587|157079233|FG002|Overall Study|Withdrawal by Subject|4|||
48792280|NCT03252587|157079234|FG003|Overall Study|Withdrawal by Subject|4|||
48792281|NCT03252587|157079231|FG000|Overall Study|Other Reasons|2|||
48983514|NCT00811395|157772291|FG004|Extension Treatment|Participant did not wish to continue|0|||
48983515|NCT00811395|157772292|FG005|Extension Treatment|Participant did not wish to continue|1|||
48983516|NCT00811395|157772287|FG000|Extension Treatment|Other than above|0|||
49032409|NCT01597245|157953487|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5|||
48792282|NCT03252587|157079232|FG001|Overall Study|Other Reasons|5|||
49032410|NCT01597245|157953488|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8|||
49032411|NCT01597245|157953489|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63|||
49032412|NCT01597245|157953490|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13|||
49032413|NCT01597245|157953470|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
49032414|NCT01597245|157953471|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
49032415|NCT01597245|157953472|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
49032416|NCT01597245|157953473|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
48792283|NCT03252587|157079233|FG002|Overall Study|Other Reasons|5|||
48792284|NCT03252587|157079234|FG003|Overall Study|Other Reasons|4|||
48792285|NCT00325468|157079246|FG000|Overall Study|Adverse Event|1|||
48792286|NCT00325468|157079247|FG001|Overall Study|Adverse Event|1|||
48792287|NCT00325468|157079248|FG002|Overall Study|Adverse Event|0|||
48792288|NCT00325468|157079249|FG003|Overall Study|Adverse Event|5|||
48792289|NCT00325468|157079250|FG004|Overall Study|Adverse Event|1|||
48792290|NCT00325468|157079246|FG000|Overall Study|Death|2|||
48792291|NCT00325468|157079247|FG001|Overall Study|Death|0|||
48792292|NCT00325468|157079248|FG002|Overall Study|Death|2|||
48792293|NCT00325468|157079249|FG003|Overall Study|Death|4|||
48792294|NCT00325468|157079250|FG004|Overall Study|Death|0|||
48792295|NCT00325468|157079246|FG000|Overall Study|Lost to Follow-up|0|||
48792296|NCT00325468|157079247|FG001|Overall Study|Lost to Follow-up|0|||
48792297|NCT00325468|157079248|FG002|Overall Study|Lost to Follow-up|1|||
48792298|NCT00325468|157079249|FG003|Overall Study|Lost to Follow-up|2|||
48792299|NCT00325468|157079250|FG004|Overall Study|Lost to Follow-up|2|||
48792300|NCT00325468|157079246|FG000|Overall Study|Physician Decision|1|||
48792301|NCT00325468|157079247|FG001|Overall Study|Physician Decision|1|||
48792302|NCT00325468|157079248|FG002|Overall Study|Physician Decision|0|||
48792303|NCT00325468|157079249|FG003|Overall Study|Physician Decision|1|||
48792304|NCT00325468|157079250|FG004|Overall Study|Physician Decision|0|||
48792305|NCT00325468|157079246|FG000|Overall Study|Withdrawal by Subject|3|||
48792306|NCT00325468|157079247|FG001|Overall Study|Withdrawal by Subject|1|||
48792307|NCT00325468|157079248|FG002|Overall Study|Withdrawal by Subject|0|||
48792308|NCT00325468|157079249|FG003|Overall Study|Withdrawal by Subject|14|||
48792309|NCT00325468|157079250|FG004|Overall Study|Withdrawal by Subject|4|||
48792310|NCT00325468|157079246|FG000|Overall Study|site closure etc|4|||
48792311|NCT00325468|157079247|FG001|Overall Study|site closure etc|2|||
48792312|NCT00325468|157079248|FG002|Overall Study|site closure etc|1|||
48792313|NCT00325468|157079249|FG003|Overall Study|site closure etc|8|||
48792314|NCT00325468|157079250|FG004|Overall Study|site closure etc|1|||
48792315|NCT01654549|157079251|FG000|Overall Study|H.pylori eradication not successful|0|||
48792316|NCT01654549|157079252|FG001|Overall Study|H.pylori eradication not successful|1|||
48792317|NCT03732209|157079253|FG000|Overall Study|Lost to Follow-up|4|||
48792318|NCT03732209|157079254|FG001|Overall Study|Lost to Follow-up|4|||
48792319|NCT03732209|157079253|FG000|Overall Study|Withdrawal by Subject|8|||
48792320|NCT03732209|157079254|FG001|Overall Study|Withdrawal by Subject|9|||
48792321|NCT00594854|157079267|FG000|Overall Study|Study terminated|7|||
48792322|NCT00594854|157079268|FG001|Overall Study|Study terminated|10|||
48792323|NCT04867369|157079269|FG000|Overall Study|Withdrawal by Subject|1|||
48792324|NCT04867369|157079270|FG001|Overall Study|Withdrawal by Subject|0|||
48792325|NCT04382404|157079271|FG000|Overall Study|Adverse Event|1|||
48792326|NCT04382404|157079271|FG000|Overall Study|Lost to Follow-up|2|||
48792327|NCT04936035|157079273|FG000|Overall Study|Adverse Event|0|||
48792328|NCT04936035|157079274|FG001|Overall Study|Adverse Event|1|||
48792329|NCT04936035|157079275|FG002|Overall Study|Adverse Event|0|||
48792330|NCT04936035|157079276|FG003|Overall Study|Adverse Event|0|||
48792331|NCT04936035|157079277|FG004|Overall Study|Adverse Event|0|||
48792332|NCT04936035|157079273|FG000|Overall Study|Death|0|||
48792333|NCT04936035|157079274|FG001|Overall Study|Death|0|||
48792334|NCT04936035|157079275|FG002|Overall Study|Death|0|||
48792335|NCT04936035|157079276|FG003|Overall Study|Death|1|||
48878121|NCT02643628|157392142|FG000|Overall Study|Relocated out of state|0|||
48878122|NCT02643628|157392143|FG001|Overall Study|Relocated out of state|1|||
48878123|NCT01628692|157392144|FG000|Overall Study|Lack of Efficacy|4|||
48878124|NCT01628692|157392145|FG001|Overall Study|Lack of Efficacy|4|||
48878125|NCT01628692|157392146|FG002|Overall Study|Lack of Efficacy|5|||
48878126|NCT01628692|157392147|FG003|Overall Study|Lack of Efficacy|1|||
48878127|NCT01628692|157392148|FG004|Overall Study|Lack of Efficacy|4|||
48792336|NCT04936035|157079277|FG004|Overall Study|Death|0|||
48792337|NCT04936035|157079273|FG000|Overall Study|Lost to Follow-up|0|||
48792338|NCT04936035|157079274|FG001|Overall Study|Lost to Follow-up|1|||
48792339|NCT04936035|157079275|FG002|Overall Study|Lost to Follow-up|1|||
48792340|NCT04936035|157079276|FG003|Overall Study|Lost to Follow-up|2|||
48792341|NCT04936035|157079277|FG004|Overall Study|Lost to Follow-up|1|||
48792342|NCT04936035|157079273|FG000|Overall Study|Physician Decision|0|||
48792343|NCT04936035|157079274|FG001|Overall Study|Physician Decision|1|||
48878128|NCT01628692|157392149|FG005|Overall Study|Lack of Efficacy|7|||
48792344|NCT04936035|157079275|FG002|Overall Study|Physician Decision|0|||
48792345|NCT04936035|157079276|FG003|Overall Study|Physician Decision|0|||
48792346|NCT04936035|157079277|FG004|Overall Study|Physician Decision|0|||
48792347|NCT04936035|157079273|FG000|Overall Study|Protocol Deviation|0|||
48792348|NCT04936035|157079274|FG001|Overall Study|Protocol Deviation|0|||
48792349|NCT04936035|157079275|FG002|Overall Study|Protocol Deviation|1|||
48792350|NCT04936035|157079276|FG003|Overall Study|Protocol Deviation|0|||
48792351|NCT04936035|157079277|FG004|Overall Study|Protocol Deviation|0|||
48792352|NCT04936035|157079273|FG000|Overall Study|Subject Stopped Participation in the Study|5|||
48792353|NCT04936035|157079274|FG001|Overall Study|Subject Stopped Participation in the Study|5|||
48792354|NCT04936035|157079275|FG002|Overall Study|Subject Stopped Participation in the Study|1|||
48792355|NCT04936035|157079276|FG003|Overall Study|Subject Stopped Participation in the Study|2|||
48792356|NCT04936035|157079277|FG004|Overall Study|Subject Stopped Participation in the Study|3|||
48792357|NCT04936035|157079273|FG000|Overall Study|Reason Unknown|0|||
48792358|NCT04936035|157079274|FG001|Overall Study|Reason Unknown|0|||
48792359|NCT04936035|157079275|FG002|Overall Study|Reason Unknown|0|||
48792360|NCT04936035|157079276|FG003|Overall Study|Reason Unknown|0|||
48792361|NCT04936035|157079277|FG004|Overall Study|Reason Unknown|1|||
48792362|NCT04936035|157079273|FG000|Overall Study|Withdrawal by Subject|1|||
48792363|NCT04936035|157079274|FG001|Overall Study|Withdrawal by Subject|0|||
48792364|NCT04936035|157079275|FG002|Overall Study|Withdrawal by Subject|0|||
48792365|NCT04936035|157079276|FG003|Overall Study|Withdrawal by Subject|0|||
48792366|NCT04936035|157079277|FG004|Overall Study|Withdrawal by Subject|0|||
48792367|NCT04936035|157079273|FG000|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
48792368|NCT04936035|157079274|FG001|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
48792369|NCT04936035|157079275|FG002|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
48792370|NCT04936035|157079276|FG003|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|2|||
48792371|NCT04936035|157079277|FG004|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
48792372|NCT04936035|157079273|FG000|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
48792373|NCT04936035|157079274|FG001|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
48792374|NCT04936035|157079275|FG002|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
48792375|NCT04936035|157079276|FG003|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
48792376|NCT04936035|157079277|FG004|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|1|||
48792377|NCT04936035|157079273|FG000|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
48792378|NCT04936035|157079274|FG001|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
48792379|NCT04936035|157079275|FG002|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
48792380|NCT04936035|157079276|FG003|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
48792381|NCT04936035|157079277|FG004|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|1|||
48792382|NCT03996473|157079278|FG000|Treatment Assignment|Withdrawal by Subject|1|||
48792383|NCT03996473|157079278|FG000|Treatment Assignment|Progressive disease|6|||
48792384|NCT03996473|157079278|FG000|Treatment Assignment|Study drug never administered|1|||
48792385|NCT03996473|157079278|FG000|Active Follow-up|Death|1|||
48792386|NCT03996473|157079278|FG000|Long-term Follow-up|Death|5|||
48792387|NCT00070499|157079279|FG000|Overall Study|Adverse Event|6|||
48792388|NCT00070499|157079280|FG001|Overall Study|Adverse Event|6|||
48792389|NCT00070499|157079281|FG002|Overall Study|Adverse Event|19|||
48792390|NCT00070499|157079282|FG003|Overall Study|Adverse Event|15|||
48792391|NCT00070499|157079279|FG000|Overall Study|Refusal unrelated to adverse effects|7|||
48792392|NCT00070499|157079280|FG001|Overall Study|Refusal unrelated to adverse effects|5|||
48792393|NCT00070499|157079281|FG002|Overall Study|Refusal unrelated to adverse effects|5|||
48792394|NCT00070499|157079282|FG003|Overall Study|Refusal unrelated to adverse effects|8|||
48792395|NCT00070499|157079279|FG000|Overall Study|Progression/relapse|4|||
48792396|NCT00070499|157079280|FG001|Overall Study|Progression/relapse|2|||
48792397|NCT00070499|157079281|FG002|Overall Study|Progression/relapse|1|||
48792398|NCT00070499|157079282|FG003|Overall Study|Progression/relapse|4|||
48792399|NCT00070499|157079279|FG000|Overall Study|Death|1|||
48792400|NCT00070499|157079280|FG001|Overall Study|Death|1|||
48792401|NCT00070499|157079281|FG002|Overall Study|Death|1|||
48792402|NCT00070499|157079282|FG003|Overall Study|Death|2|||
48792403|NCT00070499|157079279|FG000|Overall Study|Other - not protocol specified|7|||
48792404|NCT00070499|157079280|FG001|Overall Study|Other - not protocol specified|3|||
48792405|NCT00070499|157079281|FG002|Overall Study|Other - not protocol specified|12|||
48792406|NCT00070499|157079282|FG003|Overall Study|Other - not protocol specified|20|||
48792407|NCT00070499|157079279|FG000|Overall Study|Still on protocol treatment|10|||
48792408|NCT00070499|157079280|FG001|Overall Study|Still on protocol treatment|4|||
48792409|NCT00070499|157079281|FG002|Overall Study|Still on protocol treatment|79|||
48792410|NCT00070499|157079282|FG003|Overall Study|Still on protocol treatment|57|||
48878129|NCT01628692|157392144|FG000|Overall Study|Adverse Event|2|||
48878130|NCT01628692|157392145|FG001|Overall Study|Adverse Event|0|||
49032417|NCT01597245|157953474|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
49032418|NCT01597245|157953475|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
48792411|NCT00070499|157079279|FG000|Overall Study|Did not start treatment|1|||
48792412|NCT00070499|157079280|FG001|Overall Study|Did not start treatment|0|||
48792413|NCT00070499|157079281|FG002|Overall Study|Did not start treatment|0|||
48792414|NCT00070499|157079282|FG003|Overall Study|Did not start treatment|2|||
48792415|NCT00070499|157079279|FG000|Overall Study|Not eligible|2|||
48792416|NCT00070499|157079280|FG001|Overall Study|Not eligible|5|||
48792417|NCT00070499|157079281|FG002|Overall Study|Not eligible|3|||
48792418|NCT00070499|157079282|FG003|Overall Study|Not eligible|2|||
48792419|NCT05569252|157079283|FG000|Overall Study|Adverse event (central vision loss)|1|||
48792420|NCT05569252|157079284|FG001|Overall Study|Adverse event (central vision loss)|0|||
48792421|NCT05569252|157079285|FG002|Overall Study|Adverse event (central vision loss)|0|||
48792422|NCT05569252|157079286|FG003|Overall Study|Adverse event (central vision loss)|0|||
48792423|NCT02923180|157079293|FG000|Overall Study|Off Study Due to Detectable PSA|13|||
48792424|NCT02923180|157079293|FG000|Overall Study|Remaining in Long Term Follow Up for PSA|13|||
48792425|NCT04293055|157079294|FG000|Overall Study|Lost to Follow-up|1|||
48792426|NCT04293055|157079295|FG001|Overall Study|Lost to Follow-up|1|||
48792427|NCT04293055|157079294|FG000|Overall Study|Did not trigger randomization|6|||
48792428|NCT04293055|157079295|FG001|Overall Study|Did not trigger randomization|5|||
48792429|NCT05071053|157079296|FG000|Overall Study|Ongoing study treatment at the time of primary analysis completion|2|||
48792430|NCT05071053|157079296|FG000|Overall Study|Progressive disease|28|||
48792431|NCT05071053|157079296|FG000|Overall Study|Adverse Event|5|||
48792432|NCT06390839|157079297|FG000|Overall Study|Ineligible|2|||
48792433|NCT06390839|157079297|FG000|Overall Study|Never start protocol therapy|3|||
48792434|NCT06390839|157079297|FG000|Overall Study|Adverse Event|1|||
48792435|NCT06390839|157079297|FG000|Overall Study|Alternative therapy|2|||
48792436|NCT06390839|157079297|FG000|Overall Study|Death|3|||
48792437|NCT06390839|157079297|FG000|Overall Study|Disease progression|28|||
48792438|NCT06390839|157079297|FG000|Overall Study|Withdrawal by Subject|2|||
48792439|NCT06390839|157079297|FG000|Overall Study|Complicating disease|1|||
48792440|NCT06390839|157079297|FG000|Overall Study|Noncompliance|1|||
48792441|NCT01381692|157079298|FG000|Overall Study|Adverse Event|1|||
48792442|NCT01381692|157079299|FG001|Overall Study|Adverse Event|0|||
48792443|NCT01381692|157079300|FG002|Overall Study|Adverse Event|0|||
48792444|NCT01381692|157079301|FG003|Overall Study|Adverse Event|0|||
48792445|NCT01381692|157079302|FG004|Overall Study|Adverse Event|0|||
48792446|NCT01381692|157079303|FG005|Overall Study|Adverse Event|0|||
48792447|NCT03315455|157079304|FG000|Overall Study|Ongoing in the Study|13|||
48792448|NCT03315455|157079305|FG001|Overall Study|Ongoing in the Study|24|||
48792449|NCT03315455|157079306|FG002|Overall Study|Ongoing in the Study|17|||
48792450|NCT03315455|157079307|FG003|Overall Study|Ongoing in the Study|15|||
48792451|NCT03315455|157079304|FG000|Overall Study|Withdrawal by Subject|0|||
48792452|NCT03315455|157079305|FG001|Overall Study|Withdrawal by Subject|1|||
48792453|NCT03315455|157079306|FG002|Overall Study|Withdrawal by Subject|0|||
48792454|NCT03315455|157079307|FG003|Overall Study|Withdrawal by Subject|0|||
48792455|NCT04575051|157079310|FG000|Time Period 0|Discontinued due to death or moving to higher level of care|15|||
48792456|NCT04575051|157079311|FG001|Time Period 0|Discontinued due to death or moving to higher level of care|6|||
48792457|NCT04575051|157079312|FG002|Time Period 0|Discontinued due to death or moving to higher level of care|19|||
48792458|NCT04575051|157079313|FG003|Time Period 0|Discontinued due to death or moving to higher level of care|9|||
48792459|NCT04575051|157079314|FG004|Time Period 0|Discontinued due to death or moving to higher level of care|8|||
48792460|NCT04575051|157079310|FG000|Time Period 1|Missing follow up|1|||
48792461|NCT04575051|157079311|FG001|Time Period 1|Missing follow up|3|||
48792462|NCT04575051|157079312|FG002|Time Period 1|Missing follow up|1|||
48792463|NCT04575051|157079313|FG003|Time Period 1|Missing follow up|3|||
48792464|NCT04575051|157079314|FG004|Time Period 1|Missing follow up|2|||
48792465|NCT04575051|157079310|FG000|Time Period 1|Discontinued due to death or moving to higher level of care|13|||
48792466|NCT04575051|157079311|FG001|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
48792467|NCT04575051|157079312|FG002|Time Period 1|Discontinued due to death or moving to higher level of care|9|||
48792468|NCT04575051|157079313|FG003|Time Period 1|Discontinued due to death or moving to higher level of care|15|||
48792469|NCT04575051|157079314|FG004|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
48792470|NCT04575051|157079310|FG000|Time Period 2|Missing follow up|1|||
48792471|NCT04575051|157079311|FG001|Time Period 2|Missing follow up|8|||
48792472|NCT04575051|157079312|FG002|Time Period 2|Missing follow up|7|||
48792473|NCT04575051|157079313|FG003|Time Period 2|Missing follow up|0|||
48792474|NCT04575051|157079314|FG004|Time Period 2|Missing follow up|1|||
48792475|NCT04575051|157079310|FG000|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
48792476|NCT04575051|157079311|FG001|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
48792477|NCT04575051|157079312|FG002|Time Period 2|Discontinued due to death or moved to higher level of care|20|||
48792478|NCT04575051|157079313|FG003|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
48792479|NCT04575051|157079314|FG004|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
48792480|NCT04575051|157079310|FG000|Time Period 3|Missing follow up|8|||
48792481|NCT04575051|157079311|FG001|Time Period 3|Missing follow up|6|||
48792482|NCT04575051|157079312|FG002|Time Period 3|Missing follow up|4|||
48792483|NCT04575051|157079313|FG003|Time Period 3|Missing follow up|3|||
48792484|NCT04575051|157079314|FG004|Time Period 3|Missing follow up|0|||
48792485|NCT04575051|157079310|FG000|Time Period 3|Discontinued due to death or moved to higher level of care|5|||
48792486|NCT04575051|157079311|FG001|Time Period 3|Discontinued due to death or moved to higher level of care|4|||
48792487|NCT04575051|157079312|FG002|Time Period 3|Discontinued due to death or moved to higher level of care|11|||
48792488|NCT04575051|157079313|FG003|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
48792489|NCT04575051|157079314|FG004|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
48792490|NCT04575051|157079310|FG000|Time Period 4|Missing follow up|17|||
48792491|NCT04575051|157079311|FG001|Time Period 4|Missing follow up|3|||
48792492|NCT04575051|157079312|FG002|Time Period 4|Missing follow up|4|||
48792493|NCT04575051|157079313|FG003|Time Period 4|Missing follow up|2|||
48792494|NCT04575051|157079314|FG004|Time Period 4|Missing follow up|1|||
48792495|NCT04575051|157079310|FG000|Time Period 4|Discontinued due to death or moved to higher level of care|2|||
48792496|NCT04575051|157079311|FG001|Time Period 4|Discontinued due to death or moved to higher level of care|3|||
48792497|NCT04575051|157079312|FG002|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
48792498|NCT04575051|157079313|FG003|Time Period 4|Discontinued due to death or moved to higher level of care|1|||
48792499|NCT04575051|157079314|FG004|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
48792500|NCT04575051|157079310|FG000|Time Period 5|Missing follow up|11|||
48792501|NCT04575051|157079311|FG001|Time Period 5|Missing follow up|8|||
48792502|NCT04575051|157079312|FG002|Time Period 5|Missing follow up|12|||
48792503|NCT04575051|157079313|FG003|Time Period 5|Missing follow up|3|||
48792504|NCT04575051|157079314|FG004|Time Period 5|Missing follow up|11|||
48792505|NCT00529399|157079315|FG000|Overall Study|Lost to Follow-up|1|||
48792506|NCT00529399|157079316|FG001|Overall Study|Lost to Follow-up|0|||
48792507|NCT00529399|157079317|FG002|Overall Study|Lost to Follow-up|1|||
48792508|NCT00529399|157079315|FG000|Overall Study|Withdrawal by Subject|1|||
48792509|NCT00529399|157079316|FG001|Overall Study|Withdrawal by Subject|0|||
49032419|NCT01597245|157953476|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
49032420|NCT01597245|157953477|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
48792510|NCT00529399|157079317|FG002|Overall Study|Withdrawal by Subject|1|||
48792511|NCT00529399|157079315|FG000|Overall Study|Non-compliant|0|||
48792512|NCT00529399|157079316|FG001|Overall Study|Non-compliant|1|||
48792513|NCT00529399|157079317|FG002|Overall Study|Non-compliant|0|||
48792514|NCT04393441|157079329|FG000|Overall Study|Adverse Event|0|||
48792515|NCT04393441|157079330|FG001|Overall Study|Adverse Event|3|||
48792516|NCT04393441|157079329|FG000|Overall Study|Withdrawal by Subject|5|||
48792517|NCT04393441|157079330|FG001|Overall Study|Withdrawal by Subject|7|||
48792518|NCT04393441|157079329|FG000|Overall Study|Lost to Follow-up|0|||
48792519|NCT04393441|157079330|FG001|Overall Study|Lost to Follow-up|2|||
48792520|NCT04393441|157079329|FG000|Overall Study|Protocol Deviation|2|||
48878131|NCT01628692|157392146|FG002|Overall Study|Adverse Event|2|||
48792521|NCT04393441|157079330|FG001|Overall Study|Protocol Deviation|1|||
48792522|NCT04393441|157079329|FG000|Overall Study|Reason not Specified|1|||
48792523|NCT04393441|157079330|FG001|Overall Study|Reason not Specified|1|||
48878132|NCT01628692|157392147|FG003|Overall Study|Adverse Event|0|||
49032421|NCT01597245|157953478|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
49032422|NCT01597245|157953479|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
49032423|NCT01597245|157953480|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
49032424|NCT01597245|157953481|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
49032425|NCT01597245|157953482|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
49032426|NCT01597245|157953483|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
49032427|NCT01597245|157953484|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
49032428|NCT01597245|157953485|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
49032429|NCT01597245|157953486|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
49032430|NCT01597245|157953487|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
49032431|NCT01597245|157953488|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
49032432|NCT01597245|157953489|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41|||
48792524|NCT02363738|157079331|FG000|Overall Study|Adverse Event|5|||
48878133|NCT01628692|157392148|FG004|Overall Study|Adverse Event|0|||
48878134|NCT01628692|157392149|FG005|Overall Study|Adverse Event|0|||
49032433|NCT01597245|157953490|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13|||
49032434|NCT01597245|157953470|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
49032435|NCT01597245|157953471|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
48792525|NCT02363738|157079332|FG001|Overall Study|Adverse Event|2|||
48792526|NCT02363738|157079331|FG000|Overall Study|Lack of Efficacy|1|||
48792527|NCT02363738|157079332|FG001|Overall Study|Lack of Efficacy|2|||
48792528|NCT02363738|157079331|FG000|Overall Study|Lost to Follow-up|2|||
48792529|NCT02363738|157079332|FG001|Overall Study|Lost to Follow-up|1|||
48792530|NCT02187991|157079333|FG000|Overall Study|Adverse Event|13|||
48792531|NCT02187991|157079334|FG001|Overall Study|Adverse Event|14|||
48792532|NCT02187991|157079335|FG002|Overall Study|Adverse Event|3|||
48792533|NCT02187991|157079336|FG003|Overall Study|Adverse Event|2|||
48792534|NCT02187991|157079333|FG000|Overall Study|Withdrawal by Subject|9|||
48792535|NCT02187991|157079334|FG001|Overall Study|Withdrawal by Subject|6|||
48792536|NCT02187991|157079335|FG002|Overall Study|Withdrawal by Subject|3|||
48792537|NCT02187991|157079336|FG003|Overall Study|Withdrawal by Subject|2|||
48792538|NCT02187991|157079333|FG000|Overall Study|Physician Decision|4|||
48792539|NCT02187991|157079334|FG001|Overall Study|Physician Decision|4|||
48792540|NCT02187991|157079335|FG002|Overall Study|Physician Decision|0|||
48792541|NCT02187991|157079336|FG003|Overall Study|Physician Decision|2|||
48792542|NCT02187991|157079333|FG000|Overall Study|Other, unrelated complication|7|||
48792543|NCT02187991|157079334|FG001|Overall Study|Other, unrelated complication|1|||
48792544|NCT02187991|157079335|FG002|Overall Study|Other, unrelated complication|1|||
48792545|NCT02187991|157079336|FG003|Overall Study|Other, unrelated complication|2|||
48792546|NCT02187991|157079333|FG000|Overall Study|Death|1|||
48792547|NCT02187991|157079334|FG001|Overall Study|Death|3|||
48792548|NCT02187991|157079335|FG002|Overall Study|Death|0|||
48792549|NCT02187991|157079336|FG003|Overall Study|Death|0|||
48792550|NCT01392560|157079337|FG000|Overall Study|Adverse Event|2|||
48792551|NCT01392560|157079337|FG000|Overall Study|not entered|8|||
48792552|NCT01392560|157079337|FG000|Overall Study|discontinued during placebo run-in|2|||
48792553|NCT02576678|157079339|FG000|Overall Study|Adverse Event|0|||
48792554|NCT02576678|157079340|FG001|Overall Study|Adverse Event|0|||
48792555|NCT02576678|157079341|FG002|Overall Study|Adverse Event|2|||
48792556|NCT02576678|157079339|FG000|Overall Study|Withdrawal by Subject|3|||
48792557|NCT02576678|157079340|FG001|Overall Study|Withdrawal by Subject|1|||
48792558|NCT02576678|157079341|FG002|Overall Study|Withdrawal by Subject|2|||
48792559|NCT02576678|157079339|FG000|Overall Study|Lost to Follow-up|0|||
48792560|NCT02576678|157079340|FG001|Overall Study|Lost to Follow-up|0|||
48792561|NCT02576678|157079341|FG002|Overall Study|Lost to Follow-up|1|||
48792562|NCT02576678|157079339|FG000|Overall Study|Miscellaneous|2|||
48792563|NCT02576678|157079340|FG001|Overall Study|Miscellaneous|0|||
48792564|NCT02576678|157079341|FG002|Overall Study|Miscellaneous|0|||
48792565|NCT03687086|157079342|FG000|Overall Study|Withdrawal by Subject|3|||
48792566|NCT03687086|157079343|FG001|Overall Study|Withdrawal by Subject|4|||
48792567|NCT03687086|157079342|FG000|Overall Study|Lost to Follow-up|1|||
48792568|NCT03687086|157079343|FG001|Overall Study|Lost to Follow-up|1|||
48792569|NCT03687086|157079342|FG000|Overall Study|Death|1|||
48792570|NCT03687086|157079343|FG001|Overall Study|Death|0|||
48792571|NCT03687086|157079342|FG000|Overall Study|Incomplete assessment|0|||
48792572|NCT03687086|157079343|FG001|Overall Study|Incomplete assessment|2|||
48792573|NCT02363946|157079347|FG000|Overall Study|Lost to Follow-up|0|||
48792574|NCT02363946|157079348|FG001|Overall Study|Lost to Follow-up|0|||
48792575|NCT02363946|157079349|FG002|Overall Study|Lost to Follow-up|0|||
48792576|NCT02363946|157079350|FG003|Overall Study|Lost to Follow-up|0|||
48792577|NCT02363946|157079351|FG004|Overall Study|Lost to Follow-up|0|||
48792578|NCT02363946|157079352|FG005|Overall Study|Lost to Follow-up|0|||
48792579|NCT02363946|157079353|FG006|Overall Study|Lost to Follow-up|0|||
48792580|NCT02363946|157079354|FG007|Overall Study|Lost to Follow-up|1|||
48792581|NCT02363946|157079355|FG008|Overall Study|Lost to Follow-up|0|||
48792582|NCT02363946|157079356|FG009|Overall Study|Lost to Follow-up|0|||
48792583|NCT02363946|157079357|FG010|Overall Study|Lost to Follow-up|0|||
48792584|NCT02363946|157079358|FG011|Overall Study|Lost to Follow-up|0|||
48792585|NCT02363946|157079359|FG012|Overall Study|Lost to Follow-up|0|||
48792586|NCT00113568|157079360|FG000|Overall Study|Adverse Event|97|||
48792587|NCT00113568|157079360|FG000|Overall Study|Death|1|||
48792588|NCT00113568|157079360|FG000|Overall Study|Lack of Efficacy|30|||
48792589|NCT00113568|157079360|FG000|Overall Study|Lost to Follow-up|156|||
48792590|NCT00113568|157079360|FG000|Overall Study|Protocol Violation|32|||
48792591|NCT00113568|157079360|FG000|Overall Study|Withdrawal by Subject|117|||
48792592|NCT00113568|157079360|FG000|Overall Study|Other|112|||
48792593|NCT00989287|157079362|FG000|Overall Study|Adverse Event|1|||
48792594|NCT00989287|157079363|FG001|Overall Study|Adverse Event|0|||
48792595|NCT00989287|157079362|FG000|Overall Study|Lost to Follow-up|0|||
48792596|NCT00989287|157079363|FG001|Overall Study|Lost to Follow-up|1|||
48792597|NCT00729833|157079364|FG000|Overall Study|Death|5|||
48792598|NCT00729833|157079365|FG001|Overall Study|Death|1|||
48792599|NCT00729833|157079366|FG002|Overall Study|Death|3|||
48792600|NCT00729833|157079367|FG003|Overall Study|Death|5|||
48792601|NCT00729833|157079364|FG000|Overall Study|Study Terminated by Sponsor|0|||
48792602|NCT00729833|157079365|FG001|Overall Study|Study Terminated by Sponsor|0|||
48792603|NCT00729833|157079366|FG002|Overall Study|Study Terminated by Sponsor|1|||
48792604|NCT00729833|157079367|FG003|Overall Study|Study Terminated by Sponsor|0|||
48792605|NCT00729833|157079364|FG000|Overall Study|Lost to Follow-up|1|||
48792606|NCT00729833|157079365|FG001|Overall Study|Lost to Follow-up|0|||
48792607|NCT00729833|157079366|FG002|Overall Study|Lost to Follow-up|0|||
48792608|NCT00729833|157079367|FG003|Overall Study|Lost to Follow-up|0|||
48792609|NCT00729833|157079364|FG000|Overall Study|Withdrawal by Subject|3|||
49032436|NCT01597245|157953472|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
49032437|NCT01597245|157953473|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
49032438|NCT01597245|157953474|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
48792610|NCT00729833|157079365|FG001|Overall Study|Withdrawal by Subject|1|||
48792611|NCT00729833|157079366|FG002|Overall Study|Withdrawal by Subject|3|||
48792612|NCT00729833|157079367|FG003|Overall Study|Withdrawal by Subject|0|||
48792613|NCT00729833|157079364|FG000|Overall Study|Unspecified Reasons|11|||
48792614|NCT00729833|157079365|FG001|Overall Study|Unspecified Reasons|5|||
48792615|NCT00729833|157079366|FG002|Overall Study|Unspecified Reasons|5|||
48792616|NCT00729833|157079367|FG003|Overall Study|Unspecified Reasons|1|||
48792617|NCT00417079|157079368|FG000|Overall Study|Disease progression|267|||
48792618|NCT00417079|157079369|FG001|Overall Study|Disease progression|180|||
48792619|NCT00417079|157079368|FG000|Overall Study|Adverse Event|32|||
48792620|NCT00417079|157079369|FG001|Overall Study|Adverse Event|67|||
48792621|NCT00417079|157079368|FG000|Overall Study|Non-compliance to protocol|0|||
48792622|NCT00417079|157079369|FG001|Overall Study|Non-compliance to protocol|1|||
48792623|NCT00417079|157079368|FG000|Overall Study|Lost to Follow-up|2|||
48792624|NCT00417079|157079369|FG001|Overall Study|Lost to Follow-up|0|||
48792625|NCT00417079|157079368|FG000|Overall Study|Withdrawal by Subject|17|||
48792626|NCT00417079|157079369|FG001|Overall Study|Withdrawal by Subject|8|||
48792627|NCT00417079|157079368|FG000|Overall Study|Not treated|6|||
48792628|NCT00417079|157079369|FG001|Overall Study|Not treated|7|||
48792629|NCT00417079|157079368|FG000|Overall Study|Screened failure|2|||
48792630|NCT00417079|157079369|FG001|Overall Study|Screened failure|1|||
48792631|NCT00417079|157079368|FG000|Overall Study|Investigator's decision|1|||
48792632|NCT00417079|157079369|FG001|Overall Study|Investigator's decision|4|||
48792633|NCT00417079|157079368|FG000|Overall Study|Non-confirmed Disease progression|1|||
48792634|NCT00417079|157079369|FG001|Overall Study|Non-confirmed Disease progression|1|||
48792635|NCT00417079|157079368|FG000|Overall Study|Clinical deterioration|1|||
48792636|NCT00417079|157079369|FG001|Overall Study|Clinical deterioration|0|||
48792637|NCT00417079|157079368|FG000|Overall Study|Screening error|2|||
48792638|NCT00417079|157079369|FG001|Overall Study|Screening error|1|||
48792639|NCT00417079|157079368|FG000|Overall Study|Withdrawal by subject's family|0|||
48792640|NCT00417079|157079369|FG001|Overall Study|Withdrawal by subject's family|1|||
48792641|NCT00417079|157079368|FG000|Overall Study|Patient unable to come to the clinic|0|||
48792642|NCT00417079|157079369|FG001|Overall Study|Patient unable to come to the clinic|1|||
48792643|NCT00417079|157079368|FG000|Overall Study|abnormal liver function tests|0|||
48792644|NCT00417079|157079369|FG001|Overall Study|abnormal liver function tests|1|||
48792645|NCT00833638|157079374|FG000|Phase 2: Double-blind Treatment Phase|Adverse Event|1|||
48792646|NCT00833638|157079375|FG001|Phase 2: Double-blind Treatment Phase|Adverse Event|2|||
48792647|NCT00833638|157079376|FG002|Phase 2: Double-blind Treatment Phase|Adverse Event|0|||
48792648|NCT00833638|157079374|FG000|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3|||
48792649|NCT00833638|157079375|FG001|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2|||
48792650|NCT00833638|157079376|FG002|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1|||
48792651|NCT00833638|157079374|FG000|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
48792652|NCT00833638|157079375|FG001|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2|||
48792653|NCT00833638|157079376|FG002|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
48792654|NCT00833638|157079374|FG000|Phase 2: Double-blind Treatment Phase|Physician Decision|1|||
48792655|NCT00833638|157079375|FG001|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
48792656|NCT00833638|157079376|FG002|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
48792657|NCT00833638|157079374|FG000|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
48792658|NCT00833638|157079375|FG001|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
48792659|NCT00833638|157079376|FG002|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
48792660|NCT00833638|157079374|FG000|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
48792661|NCT00833638|157079375|FG001|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
48792662|NCT00833638|157079376|FG002|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2|||
48792663|NCT00833638|157079374|FG000|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
48792664|NCT00833638|157079375|FG001|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
48792665|NCT00833638|157079376|FG002|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2|||
48792666|NCT00833638|157079374|FG000|Phase 3: Open-label Extension Phase|Lost to Follow-up|1|||
48792667|NCT00833638|157079375|FG001|Phase 3: Open-label Extension Phase|Lost to Follow-up|2|||
48792668|NCT00833638|157079376|FG002|Phase 3: Open-label Extension Phase|Lost to Follow-up|0|||
48792669|NCT00833638|157079374|FG000|Phase 3: Open-label Extension Phase|Protocol Violation|0|||
48792670|NCT00833638|157079375|FG001|Phase 3: Open-label Extension Phase|Protocol Violation|1|||
48792671|NCT00833638|157079376|FG002|Phase 3: Open-label Extension Phase|Protocol Violation|2|||
48792672|NCT03969719|157079377|FG000|Overall Study|Other reasons not specified|1|||
48792673|NCT03969719|157079378|FG001|Overall Study|Other reasons not specified|1|||
48792674|NCT03969719|157079379|FG002|Overall Study|Other reasons not specified|3|||
48792675|NCT03969719|157079377|FG000|Overall Study|Withdrawal by Subject|2|||
48792676|NCT03969719|157079378|FG001|Overall Study|Withdrawal by Subject|3|||
48792677|NCT03969719|157079379|FG002|Overall Study|Withdrawal by Subject|2|||
49032439|NCT01597245|157953475|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
49032440|NCT01597245|157953476|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
49032441|NCT01597245|157953477|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
49032442|NCT01597245|157953478|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
49032443|NCT01597245|157953479|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
49032444|NCT01597245|157953480|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
49032445|NCT01597245|157953481|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
49032446|NCT01597245|157953482|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
49032447|NCT01597245|157953483|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
49032448|NCT01597245|157953484|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
49032449|NCT01597245|157953485|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
49032450|NCT01597245|157953486|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2|||
49032451|NCT01597245|157953487|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
49032452|NCT01597245|157953488|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
49032453|NCT01597245|157953489|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29|||
49032454|NCT01597245|157953490|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3|||
49032455|NCT01597245|157953470|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
49032456|NCT01597245|157953471|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
49032457|NCT01597245|157953472|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
49032458|NCT01597245|157953473|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
49032459|NCT01597245|157953474|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
48792678|NCT03969719|157079377|FG000|Overall Study|Protocol Violation|1|||
48792679|NCT03969719|157079378|FG001|Overall Study|Protocol Violation|2|||
48792680|NCT03969719|157079379|FG002|Overall Study|Protocol Violation|0|||
48792681|NCT03969719|157079377|FG000|Overall Study|Adverse Event|0|||
48792682|NCT03969719|157079378|FG001|Overall Study|Adverse Event|2|||
48792683|NCT03969719|157079379|FG002|Overall Study|Adverse Event|0|||
48792684|NCT03969719|157079377|FG000|Overall Study|Lost to Follow-up|0|||
48792685|NCT03969719|157079378|FG001|Overall Study|Lost to Follow-up|1|||
48792686|NCT03969719|157079379|FG002|Overall Study|Lost to Follow-up|0|||
48792687|NCT02527798|157080875|FG000|Overall Study|Physician Decision|1|||
48792688|NCT02527798|157080876|FG001|Overall Study|Physician Decision|0|||
48792689|NCT02527798|157080877|FG002|Overall Study|Physician Decision|1|||
48792690|NCT02527798|157080878|FG003|Overall Study|Physician Decision|1|||
48792691|NCT02527798|157080879|FG004|Overall Study|Physician Decision|0|||
48792692|NCT02527798|157080880|FG005|Overall Study|Physician Decision|0|||
48792693|NCT02527798|157080875|FG000|Overall Study|Death|0|||
48792694|NCT02527798|157080876|FG001|Overall Study|Death|0|||
49032460|NCT01597245|157953475|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
49032461|NCT01597245|157953476|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
49032462|NCT01597245|157953477|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
49032463|NCT01597245|157953478|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
49032464|NCT01597245|157953479|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
49032465|NCT01597245|157953480|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
49032466|NCT01597245|157953481|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
49032467|NCT01597245|157953482|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
49032468|NCT01597245|157953483|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
49032469|NCT01597245|157953484|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
48792695|NCT02527798|157080877|FG002|Overall Study|Death|1|||
48792696|NCT02527798|157080878|FG003|Overall Study|Death|0|||
48792697|NCT02527798|157080879|FG004|Overall Study|Death|0|||
48792698|NCT02527798|157080880|FG005|Overall Study|Death|0|||
48792699|NCT02527798|157080875|FG000|Overall Study|Withdrawal by Subject|0|||
48792700|NCT02527798|157080876|FG001|Overall Study|Withdrawal by Subject|1|||
48792701|NCT02527798|157080877|FG002|Overall Study|Withdrawal by Subject|2|||
48792702|NCT02527798|157080878|FG003|Overall Study|Withdrawal by Subject|0|||
48792703|NCT02527798|157080879|FG004|Overall Study|Withdrawal by Subject|0|||
48792704|NCT02527798|157080880|FG005|Overall Study|Withdrawal by Subject|0|||
48792705|NCT02527798|157080875|FG000|Overall Study|Reason undisclosed|1|||
48792706|NCT02527798|157080876|FG001|Overall Study|Reason undisclosed|0|||
48792707|NCT02527798|157080877|FG002|Overall Study|Reason undisclosed|1|||
48792708|NCT02527798|157080878|FG003|Overall Study|Reason undisclosed|0|||
48792709|NCT02527798|157080879|FG004|Overall Study|Reason undisclosed|0|||
48878135|NCT01628692|157392144|FG000|Overall Study|Withdrawal by Subject|0|||
49032470|NCT01597245|157953485|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
49032471|NCT01597245|157953486|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
48792710|NCT02527798|157080880|FG005|Overall Study|Reason undisclosed|0|||
48792711|NCT02527798|157080875|FG000|Overall Study|Did not receive intervention|1|||
48792712|NCT02527798|157080876|FG001|Overall Study|Did not receive intervention|1|||
48792713|NCT02527798|157080877|FG002|Overall Study|Did not receive intervention|0|||
48792714|NCT02527798|157080878|FG003|Overall Study|Did not receive intervention|0|||
49032472|NCT01597245|157953487|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
49032473|NCT01597245|157953488|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1|||
49032474|NCT01597245|157953489|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14|||
49032475|NCT01597245|157953490|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4|||
49032476|NCT01597245|157953470|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
49032477|NCT01597245|157953471|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
49032478|NCT01597245|157953472|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
49032479|NCT01597245|157953473|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
49032480|NCT01597245|157953474|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
49032481|NCT01597245|157953475|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
49032482|NCT01597245|157953476|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
49032483|NCT01597245|157953477|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
49032484|NCT01597245|157953478|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
49032485|NCT01597245|157953479|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
49032486|NCT01597245|157953480|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
48792715|NCT02527798|157080879|FG004|Overall Study|Did not receive intervention|0|||
48792716|NCT02527798|157080880|FG005|Overall Study|Did not receive intervention|0|||
48792717|NCT02526693|157080883|FG000|Overall Study|Physician Decision|3|||
48792718|NCT02526693|157080884|FG001|Overall Study|Physician Decision|1|||
48792719|NCT03750552|157080887|FG000|Overall Study|Adverse Event|5|||
48792720|NCT03750552|157080888|FG001|Overall Study|Adverse Event|1|||
48792721|NCT03750552|157080887|FG000|Overall Study|Withdrawal by Subject|1|||
48792722|NCT03750552|157080888|FG001|Overall Study|Withdrawal by Subject|1|||
48792723|NCT03750552|157080887|FG000|Overall Study|Other|2|||
48792724|NCT03750552|157080888|FG001|Overall Study|Other|0|||
48792725|NCT02367911|157080889|FG000|Overall Study|Withdrawal by Subject|3|||
48792726|NCT02367911|157080890|FG001|Overall Study|Withdrawal by Subject|2|||
48792727|NCT02367911|157080889|FG000|Overall Study|Lost to Follow-up|2|||
48792728|NCT02367911|157080890|FG001|Overall Study|Lost to Follow-up|2|||
48792729|NCT00773968|157080891|FG000|Overall Study|Adverse Event|2|||
48792730|NCT00773968|157080891|FG000|Overall Study|Death|1|||
48792731|NCT00773968|157080891|FG000|Overall Study|Failure to Return|2|||
48792732|NCT00773968|157080891|FG000|Overall Study|Lack of Efficacy|3|||
48792733|NCT00773968|157080891|FG000|Overall Study|Protocol Violation|1|||
48792734|NCT00773968|157080891|FG000|Overall Study|Withdrawal by Subject|11|||
48792735|NCT00773968|157080891|FG000|Overall Study|Screen Failure|17|||
48792736|NCT00773968|157080891|FG000|Overall Study|Other|8|||
48792737|NCT01003899|157080893|FG000|Overall Study|Other Adverse Event|8|||
48792738|NCT01003899|157080893|FG000|Overall Study|Not entered|4|||
48792739|NCT01003899|157080893|FG000|Overall Study|Not treated|1|||
48792740|NCT01003899|157080893|FG000|Overall Study|Progressive disease|34|||
48792741|NCT02522494|157080894|FG000|Overall Study|Lost to Follow-up|6|||
48792742|NCT02522494|157080895|FG001|Overall Study|Lost to Follow-up|2|||
48792743|NCT02522494|157080894|FG000|Overall Study|Withdrawal by Subject|1|||
48792744|NCT02522494|157080895|FG001|Overall Study|Withdrawal by Subject|0|||
48792745|NCT02522494|157080894|FG000|Overall Study|CVT visit cancelled or no-show for CVT visit|6|||
48792746|NCT02522494|157080895|FG001|Overall Study|CVT visit cancelled or no-show for CVT visit|2|||
48792747|NCT02522494|157080894|FG000|Overall Study|Participant did not watch the video|1|||
48792748|NCT02522494|157080895|FG001|Overall Study|Participant did not watch the video|0|||
48792749|NCT02522494|157080894|FG000|Overall Study|Death|0|||
48792750|NCT02522494|157080895|FG001|Overall Study|Death|1|||
48792751|NCT00328510|157080896|FG000|Overall Study|Gag disorder, could not use frame|4|||
48792752|NCT00328510|157080897|FG001|Overall Study|Gag disorder, could not use frame|0|||
48792753|NCT00328510|157080896|FG000|Overall Study|Dentition problems, could not use frame|1|||
48792754|NCT00328510|157080897|FG001|Overall Study|Dentition problems, could not use frame|0|||
48792755|NCT00328510|157080896|FG000|Overall Study|Withdrawal by Subject|4|||
48792756|NCT00328510|157080897|FG001|Overall Study|Withdrawal by Subject|2|||
48792757|NCT00328510|157080896|FG000|Overall Study|Severe kyphosis, could not use mask|0|||
48792758|NCT00328510|157080897|FG001|Overall Study|Severe kyphosis, could not use mask|1|||
48792759|NCT00328510|157080896|FG000|Overall Study|Treatment changed to a single fraction|1|||
48792760|NCT00328510|157080897|FG001|Overall Study|Treatment changed to a single fraction|1|||
48792761|NCT02349295|157080899|FG000|Double Blind Treatment (Week 0-24)|Adverse Event|7|||
48792762|NCT02349295|157080900|FG001|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
48792763|NCT02349295|157080901|FG002|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
48792764|NCT02349295|157080902|FG003|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
48792765|NCT02349295|157080903|FG004|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
48792766|NCT02349295|157080904|FG005|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
48792767|NCT02349295|157080905|FG006|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
48792768|NCT02349295|157080906|FG007|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
48792769|NCT02349295|157080907|FG008|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
48792770|NCT02349295|157080908|FG009|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
48792771|NCT02349295|157080909|FG010|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
48792772|NCT02349295|157080910|FG011|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
48792773|NCT02349295|157080911|FG012|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
48792774|NCT02349295|157080912|FG013|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
48792775|NCT02349295|157080899|FG000|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4|||
48792776|NCT02349295|157080900|FG001|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2|||
48792777|NCT02349295|157080901|FG002|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9|||
48792778|NCT02349295|157080902|FG003|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
48792779|NCT02349295|157080903|FG004|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
48792780|NCT02349295|157080904|FG005|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
48792781|NCT02349295|157080905|FG006|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
48792782|NCT02349295|157080906|FG007|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
48792783|NCT02349295|157080907|FG008|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
48792784|NCT02349295|157080908|FG009|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
48792785|NCT02349295|157080909|FG010|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
48792786|NCT02349295|157080910|FG011|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
48792787|NCT02349295|157080911|FG012|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
48792788|NCT02349295|157080912|FG013|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
48792789|NCT02349295|157080899|FG000|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
48792790|NCT02349295|157080900|FG001|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
48792791|NCT02349295|157080901|FG002|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7|||
48792792|NCT02349295|157080902|FG003|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
48792793|NCT02349295|157080903|FG004|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
48792794|NCT02349295|157080904|FG005|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
48792795|NCT02349295|157080905|FG006|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
48792796|NCT02349295|157080906|FG007|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
48792797|NCT02349295|157080907|FG008|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
48792798|NCT02349295|157080908|FG009|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
48792799|NCT02349295|157080909|FG010|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
48792800|NCT02349295|157080910|FG011|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
48792801|NCT02349295|157080911|FG012|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
48792802|NCT02349295|157080912|FG013|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
48792803|NCT02349295|157080899|FG000|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
48792804|NCT02349295|157080900|FG001|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
48792805|NCT02349295|157080901|FG002|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2|||
48792806|NCT02349295|157080902|FG003|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
48792807|NCT02349295|157080903|FG004|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
48792808|NCT02349295|157080904|FG005|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
48792809|NCT02349295|157080905|FG006|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
48792810|NCT02349295|157080906|FG007|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
48792811|NCT02349295|157080907|FG008|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
48792812|NCT02349295|157080908|FG009|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
48792813|NCT02349295|157080909|FG010|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
48792814|NCT02349295|157080910|FG011|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
48792815|NCT02349295|157080911|FG012|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
48792816|NCT02349295|157080912|FG013|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
48792817|NCT02349295|157080899|FG000|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
48792818|NCT02349295|157080900|FG001|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
48792819|NCT02349295|157080901|FG002|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
48792820|NCT02349295|157080902|FG003|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
48792821|NCT02349295|157080903|FG004|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
48792822|NCT02349295|157080904|FG005|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
48792823|NCT02349295|157080905|FG006|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
48792824|NCT02349295|157080906|FG007|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
48792825|NCT02349295|157080907|FG008|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
48792826|NCT02349295|157080908|FG009|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
48792827|NCT02349295|157080909|FG010|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
48792828|NCT02349295|157080910|FG011|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
48792829|NCT02349295|157080911|FG012|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
48878136|NCT01628692|157392145|FG001|Overall Study|Withdrawal by Subject|1|||
49032487|NCT01597245|157953481|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
49032488|NCT01597245|157953482|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
49032489|NCT01597245|157953483|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
49032490|NCT01597245|157953484|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
48878137|NCT01628692|157392146|FG002|Overall Study|Withdrawal by Subject|1|||
48792830|NCT02349295|157080912|FG013|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
48792831|NCT02349295|157080899|FG000|IR (Week 16-24)|Lack of Efficacy|0|||
48792832|NCT02349295|157080900|FG001|IR (Week 16-24)|Lack of Efficacy|0|||
48792833|NCT02349295|157080901|FG002|IR (Week 16-24)|Lack of Efficacy|0|||
48792834|NCT02349295|157080902|FG003|IR (Week 16-24)|Lack of Efficacy|1|||
48792835|NCT02349295|157080903|FG004|IR (Week 16-24)|Lack of Efficacy|0|||
48792836|NCT02349295|157080904|FG005|IR (Week 16-24)|Lack of Efficacy|0|||
48792837|NCT02349295|157080905|FG006|IR (Week 16-24)|Lack of Efficacy|0|||
48792838|NCT02349295|157080906|FG007|IR (Week 16-24)|Lack of Efficacy|0|||
48792839|NCT02349295|157080907|FG008|IR (Week 16-24)|Lack of Efficacy|0|||
48792840|NCT02349295|157080908|FG009|IR (Week 16-24)|Lack of Efficacy|0|||
48792841|NCT02349295|157080909|FG010|IR (Week 16-24)|Lack of Efficacy|0|||
48792842|NCT02349295|157080910|FG011|IR (Week 16-24)|Lack of Efficacy|0|||
48792843|NCT02349295|157080911|FG012|IR (Week 16-24)|Lack of Efficacy|0|||
48792844|NCT02349295|157080912|FG013|IR (Week 16-24)|Lack of Efficacy|0|||
48792845|NCT02349295|157080899|FG000|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
48792846|NCT02349295|157080900|FG001|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
48792847|NCT02349295|157080901|FG002|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
48792848|NCT02349295|157080902|FG003|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
48792849|NCT02349295|157080903|FG004|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
48792850|NCT02349295|157080904|FG005|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
48792851|NCT02349295|157080905|FG006|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
48792852|NCT02349295|157080906|FG007|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32|||
48792853|NCT02349295|157080907|FG008|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25|||
48792854|NCT02349295|157080908|FG009|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19|||
48792855|NCT02349295|157080909|FG010|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18|||
48792856|NCT02349295|157080910|FG011|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
48792857|NCT02349295|157080911|FG012|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
48792858|NCT02349295|157080912|FG013|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
48792859|NCT02349295|157080899|FG000|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
48792860|NCT02349295|157080900|FG001|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
48792861|NCT02349295|157080901|FG002|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
48792862|NCT02349295|157080902|FG003|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
48792863|NCT02349295|157080903|FG004|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
48792864|NCT02349295|157080904|FG005|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
48792865|NCT02349295|157080905|FG006|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
48792866|NCT02349295|157080906|FG007|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
48792867|NCT02349295|157080907|FG008|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
48792868|NCT02349295|157080908|FG009|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
48792869|NCT02349295|157080909|FG010|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
48792870|NCT02349295|157080910|FG011|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
48792871|NCT02349295|157080911|FG012|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
48792872|NCT02349295|157080912|FG013|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
48792873|NCT02349295|157080899|FG000|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
48792874|NCT02349295|157080900|FG001|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
48792875|NCT02349295|157080901|FG002|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
48792876|NCT02349295|157080902|FG003|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
48792877|NCT02349295|157080903|FG004|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
48792878|NCT02349295|157080904|FG005|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
48792879|NCT02349295|157080905|FG006|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
48792880|NCT02349295|157080906|FG007|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2|||
48792881|NCT02349295|157080907|FG008|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
48792882|NCT02349295|157080908|FG009|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3|||
48792883|NCT02349295|157080909|FG010|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
48792884|NCT02349295|157080910|FG011|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
48792885|NCT02349295|157080911|FG012|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
48792886|NCT02349295|157080912|FG013|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
48792887|NCT02349295|157080899|FG000|Long-Term Extension Period (Week 24-156)|Death|0|||
48792888|NCT02349295|157080900|FG001|Long-Term Extension Period (Week 24-156)|Death|0|||
48792889|NCT02349295|157080901|FG002|Long-Term Extension Period (Week 24-156)|Death|0|||
48792890|NCT02349295|157080902|FG003|Long-Term Extension Period (Week 24-156)|Death|0|||
48792891|NCT02349295|157080903|FG004|Long-Term Extension Period (Week 24-156)|Death|0|||
48792892|NCT02349295|157080904|FG005|Long-Term Extension Period (Week 24-156)|Death|0|||
48878138|NCT01628692|157392147|FG003|Overall Study|Withdrawal by Subject|0|||
49032491|NCT01597245|157953485|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
49032492|NCT01597245|157953486|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
49032493|NCT01597245|157953487|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
49032494|NCT01597245|157953488|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
48792893|NCT02349295|157080905|FG006|Long-Term Extension Period (Week 24-156)|Death|0|||
48792894|NCT02349295|157080906|FG007|Long-Term Extension Period (Week 24-156)|Death|1|||
48792895|NCT02349295|157080907|FG008|Long-Term Extension Period (Week 24-156)|Death|1|||
48792896|NCT02349295|157080908|FG009|Long-Term Extension Period (Week 24-156)|Death|1|||
48792897|NCT02349295|157080909|FG010|Long-Term Extension Period (Week 24-156)|Death|0|||
48792898|NCT02349295|157080910|FG011|Long-Term Extension Period (Week 24-156)|Death|0|||
48792899|NCT02349295|157080911|FG012|Long-Term Extension Period (Week 24-156)|Death|0|||
48792900|NCT02349295|157080912|FG013|Long-Term Extension Period (Week 24-156)|Death|0|||
48792901|NCT02349295|157080899|FG000|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
48792902|NCT02349295|157080900|FG001|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
48792903|NCT02349295|157080901|FG002|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
48792904|NCT02349295|157080902|FG003|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
48792905|NCT02349295|157080903|FG004|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
48792906|NCT02349295|157080904|FG005|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
48792907|NCT02349295|157080905|FG006|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
48792908|NCT02349295|157080906|FG007|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4|||
48792909|NCT02349295|157080907|FG008|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2|||
48792910|NCT02349295|157080908|FG009|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1|||
48792911|NCT02349295|157080909|FG010|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3|||
48792912|NCT02349295|157080910|FG011|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
48792913|NCT02349295|157080911|FG012|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
48792914|NCT02349295|157080912|FG013|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
48792915|NCT02349295|157080899|FG000|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
48792916|NCT02349295|157080900|FG001|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
48792917|NCT02349295|157080901|FG002|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
48792918|NCT02349295|157080902|FG003|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
48792919|NCT02349295|157080903|FG004|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
48792920|NCT02349295|157080904|FG005|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
48792921|NCT02349295|157080905|FG006|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
48792922|NCT02349295|157080906|FG007|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
48792923|NCT02349295|157080907|FG008|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
48792924|NCT02349295|157080908|FG009|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
48792925|NCT02349295|157080909|FG010|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
48792926|NCT02349295|157080910|FG011|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
48792927|NCT02349295|157080911|FG012|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
48792928|NCT02349295|157080912|FG013|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
48792929|NCT02349295|157080899|FG000|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
48792930|NCT02349295|157080900|FG001|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
48792931|NCT02349295|157080901|FG002|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
48792932|NCT02349295|157080902|FG003|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
48792933|NCT02349295|157080903|FG004|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
48792934|NCT02349295|157080904|FG005|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
48792935|NCT02349295|157080905|FG006|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
48792936|NCT02349295|157080906|FG007|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
48792937|NCT02349295|157080907|FG008|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
48792938|NCT02349295|157080908|FG009|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
48792939|NCT02349295|157080909|FG010|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
48792940|NCT02349295|157080910|FG011|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
48792941|NCT02349295|157080911|FG012|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
48792942|NCT02349295|157080912|FG013|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
48792943|NCT02349295|157080899|FG000|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
48792944|NCT02349295|157080900|FG001|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
48792945|NCT02349295|157080901|FG002|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
48792946|NCT02349295|157080902|FG003|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
48792947|NCT02349295|157080903|FG004|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
48792948|NCT02349295|157080904|FG005|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
48792949|NCT02349295|157080905|FG006|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
48792950|NCT02349295|157080906|FG007|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
48792951|NCT02349295|157080907|FG008|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
48792952|NCT02349295|157080908|FG009|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
49032495|NCT01597245|157953489|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9|||
49032496|NCT01597245|157953490|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
48792953|NCT02349295|157080909|FG010|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
48792954|NCT02349295|157080910|FG011|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
48792955|NCT02349295|157080911|FG012|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5|||
48792956|NCT02349295|157080912|FG013|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
48792957|NCT02349295|157080899|FG000|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
48792958|NCT02349295|157080900|FG001|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
48792959|NCT02349295|157080901|FG002|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
48792960|NCT02349295|157080902|FG003|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
48792961|NCT02349295|157080903|FG004|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
48792962|NCT02349295|157080904|FG005|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
48792963|NCT02349295|157080905|FG006|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
48792964|NCT02349295|157080906|FG007|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
48792965|NCT02349295|157080907|FG008|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
48792966|NCT02349295|157080908|FG009|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
49032497|NCT01597245|157953470|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
49032498|NCT01597245|157953471|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
49032499|NCT01597245|157953472|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
49032500|NCT01597245|157953473|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
49032501|NCT01597245|157953474|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
49032502|NCT01597245|157953475|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
49032503|NCT01597245|157953476|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
49032504|NCT01597245|157953477|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
49032505|NCT01597245|157953478|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
49032506|NCT01597245|157953479|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
49032507|NCT01597245|157953480|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
49032508|NCT01597245|157953481|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
49032509|NCT01597245|157953482|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
49032510|NCT01597245|157953483|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
49032511|NCT01597245|157953484|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
49032512|NCT01597245|157953485|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
49032513|NCT01597245|157953486|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1|||
49032514|NCT01597245|157953487|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
49032515|NCT01597245|157953488|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
49032516|NCT01597245|157953489|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6|||
49032517|NCT01597245|157953490|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2|||
49032518|NCT01597245|157953470|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
49032519|NCT01597245|157953471|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
49032520|NCT01597245|157953472|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
49032521|NCT01597245|157953473|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
49032522|NCT01597245|157953474|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
49032523|NCT01597245|157953475|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
49032524|NCT01597245|157953476|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
48792967|NCT02349295|157080909|FG010|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
48792968|NCT02349295|157080910|FG011|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1|||
48792969|NCT02349295|157080911|FG012|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2|||
48792970|NCT02349295|157080912|FG013|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
48792971|NCT02349295|157080899|FG000|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
48792972|NCT02349295|157080900|FG001|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
48792973|NCT02349295|157080901|FG002|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
48792974|NCT02349295|157080902|FG003|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
48792975|NCT02349295|157080903|FG004|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
48792976|NCT02349295|157080904|FG005|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
48792977|NCT02349295|157080905|FG006|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
48792978|NCT02349295|157080906|FG007|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
48792979|NCT02349295|157080907|FG008|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
48792980|NCT02349295|157080908|FG009|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
48792981|NCT02349295|157080909|FG010|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
48792982|NCT02349295|157080910|FG011|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
48792983|NCT02349295|157080911|FG012|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
48792984|NCT02349295|157080912|FG013|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
48792985|NCT02349295|157080899|FG000|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
48792986|NCT02349295|157080900|FG001|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
48792987|NCT02349295|157080901|FG002|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
48792988|NCT02349295|157080902|FG003|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
48792989|NCT02349295|157080903|FG004|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
48792990|NCT02349295|157080904|FG005|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
48792991|NCT02349295|157080905|FG006|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
49032525|NCT01597245|157953477|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
49032526|NCT01597245|157953478|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
48792992|NCT02349295|157080906|FG007|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
48792993|NCT02349295|157080907|FG008|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
48792994|NCT02349295|157080908|FG009|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
48792995|NCT02349295|157080909|FG010|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
48792996|NCT02349295|157080910|FG011|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2|||
48792997|NCT02349295|157080911|FG012|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
48792998|NCT02349295|157080912|FG013|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
48792999|NCT02349295|157080899|FG000|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
48793000|NCT02349295|157080900|FG001|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
48793001|NCT02349295|157080901|FG002|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
48793002|NCT02349295|157080902|FG003|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
48793003|NCT02349295|157080903|FG004|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
48793004|NCT02349295|157080904|FG005|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
48793005|NCT02349295|157080905|FG006|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
48793006|NCT02349295|157080906|FG007|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
48793007|NCT02349295|157080907|FG008|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
48793008|NCT02349295|157080908|FG009|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
48793009|NCT02349295|157080909|FG010|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
48878139|NCT01628692|157392148|FG004|Overall Study|Withdrawal by Subject|0|||
48878140|NCT01628692|157392149|FG005|Overall Study|Withdrawal by Subject|0|||
48878141|NCT01628692|157392144|FG000|Overall Study|Death|0|||
48878142|NCT01628692|157392145|FG001|Overall Study|Death|1|||
48878143|NCT01628692|157392146|FG002|Overall Study|Death|0|||
48878144|NCT01628692|157392147|FG003|Overall Study|Death|0|||
48878145|NCT01628692|157392148|FG004|Overall Study|Death|0|||
48878146|NCT01628692|157392149|FG005|Overall Study|Death|0|||
48878147|NCT01628692|157392144|FG000|Overall Study|Poor compliance/noncompliance|1|||
48878148|NCT01628692|157392145|FG001|Overall Study|Poor compliance/noncompliance|0|||
48878149|NCT01628692|157392146|FG002|Overall Study|Poor compliance/noncompliance|0|||
48878150|NCT01628692|157392147|FG003|Overall Study|Poor compliance/noncompliance|0|||
48878151|NCT01628692|157392148|FG004|Overall Study|Poor compliance/noncompliance|0|||
48878152|NCT01628692|157392149|FG005|Overall Study|Poor compliance/noncompliance|0|||
48878153|NCT01628692|157392144|FG000|Overall Study|Administrative reason by sponsor|0|||
48878154|NCT01628692|157392145|FG001|Overall Study|Administrative reason by sponsor|0|||
48878155|NCT01628692|157392146|FG002|Overall Study|Administrative reason by sponsor|0|||
48878156|NCT01628692|157392147|FG003|Overall Study|Administrative reason by sponsor|0|||
48878157|NCT01628692|157392148|FG004|Overall Study|Administrative reason by sponsor|0|||
48878158|NCT01628692|157392149|FG005|Overall Study|Administrative reason by sponsor|1|||
48878159|NCT01628692|157392144|FG000|Overall Study|Completed 12 Week only|0|||
48878160|NCT01628692|157392145|FG001|Overall Study|Completed 12 Week only|0|||
49032527|NCT01597245|157953479|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
49032528|NCT01597245|157953480|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
49032529|NCT01597245|157953481|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
49032530|NCT01597245|157953482|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
49032531|NCT01597245|157953483|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
49032532|NCT01597245|157953484|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
49032533|NCT01597245|157953485|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
48793010|NCT02349295|157080910|FG011|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4|||
48793011|NCT02349295|157080911|FG012|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
48793012|NCT02349295|157080912|FG013|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
48793013|NCT02863926|157080913|FG000|Overall Study|Physician Decision|1|||
48793014|NCT02863926|157080914|FG001|Overall Study|Physician Decision|0|||
48793015|NCT02863926|157080913|FG000|Overall Study|Lost to Follow-up|1|||
48793016|NCT02863926|157080914|FG001|Overall Study|Lost to Follow-up|1|||
48793017|NCT00739648|157080915|FG000|Overall Study|Adverse Event|3|||
48793018|NCT00739648|157080916|FG001|Overall Study|Adverse Event|15|||
48878161|NCT01628692|157392146|FG002|Overall Study|Completed 12 Week only|0|||
48878162|NCT01628692|157392147|FG003|Overall Study|Completed 12 Week only|0|||
48878163|NCT01628692|157392148|FG004|Overall Study|Completed 12 Week only|0|||
48878164|NCT01628692|157392149|FG005|Overall Study|Completed 12 Week only|1|||
48793019|NCT00739648|157080915|FG000|Overall Study|Withdrawal by Subject|13|||
48878165|NCT01390441|157392151|FG000|Treatment Period|Protocol Violation|0|||
48878166|NCT01390441|157392152|FG001|Treatment Period|Protocol Violation|1|||
48878167|NCT01390441|157392153|FG002|Treatment Period|Protocol Violation|0|||
48878168|NCT01390441|157392154|FG003|Treatment Period|Protocol Violation|0|||
48878169|NCT01390441|157392155|FG004|Treatment Period|Protocol Violation|0|||
48793020|NCT00739648|157080916|FG001|Overall Study|Withdrawal by Subject|25|||
48793021|NCT00739648|157080915|FG000|Overall Study|Lost to Follow-up|4|||
48793022|NCT00739648|157080916|FG001|Overall Study|Lost to Follow-up|7|||
48793023|NCT00739648|157080915|FG000|Overall Study|Death|2|||
48793024|NCT00739648|157080916|FG001|Overall Study|Death|0|||
48793025|NCT00739648|157080915|FG000|Overall Study|Do not know|4|||
48793026|NCT00739648|157080916|FG001|Overall Study|Do not know|6|||
48793027|NCT03422250|157080917|FG000|Intervention|Adverse Event|0|||
48793028|NCT03422250|157080918|FG001|Intervention|Adverse Event|1|||
48793029|NCT03422250|157080919|FG002|Intervention|Adverse Event|0|||
48793030|NCT03422250|157080920|FG003|Intervention|Adverse Event|1|||
48793031|NCT03422250|157080917|FG000|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1|||
48793032|NCT03422250|157080918|FG001|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
48793033|NCT03422250|157080919|FG002|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2|||
48793034|NCT03422250|157080920|FG003|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
48793035|NCT03422250|157080917|FG000|Follow-up|Withdrawal by Subject|0|||
48793036|NCT03422250|157080918|FG001|Follow-up|Withdrawal by Subject|0|||
48793037|NCT03422250|157080919|FG002|Follow-up|Withdrawal by Subject|0|||
48793038|NCT03422250|157080920|FG003|Follow-up|Withdrawal by Subject|1|||
48793039|NCT03422250|157080917|FG000|Follow-up|Adverse Event|0|||
48793040|NCT03422250|157080918|FG001|Follow-up|Adverse Event|0|||
48793041|NCT03422250|157080919|FG002|Follow-up|Adverse Event|0|||
48793042|NCT03422250|157080920|FG003|Follow-up|Adverse Event|1|||
48793043|NCT02216123|157080922|FG000|Overall Study|Lost to Follow-up|4|||
48793044|NCT02216123|157080923|FG001|Overall Study|Lost to Follow-up|2|||
48793045|NCT02216123|157080922|FG000|Overall Study|Withdrawal by Subject|2|||
48793046|NCT02216123|157080923|FG001|Overall Study|Withdrawal by Subject|0|||
48793047|NCT02239679|157080924|FG000|Overall Study|Lost to Follow-up|1|||
48793048|NCT02239679|157080925|FG001|Overall Study|Lost to Follow-up|0|||
48793049|NCT02239679|157080926|FG002|Overall Study|Lost to Follow-up|0|||
48793050|NCT02239679|157080924|FG000|Overall Study|Withdrawal by Subject|2|||
48793051|NCT02239679|157080925|FG001|Overall Study|Withdrawal by Subject|3|||
48793052|NCT02239679|157080926|FG002|Overall Study|Withdrawal by Subject|1|||
48793053|NCT01786512|157080928|FG000|Overall Study|Lost to Follow-up|0|||
48793054|NCT01786512|157080929|FG001|Overall Study|Lost to Follow-up|0|||
48793055|NCT01786512|157080930|FG002|Overall Study|Lost to Follow-up|0|||
48793056|NCT01786512|157080931|FG003|Overall Study|Lost to Follow-up|0|||
48793057|NCT01786512|157080932|FG004|Overall Study|Lost to Follow-up|0|||
48793058|NCT01786512|157080933|FG005|Overall Study|Lost to Follow-up|0|||
48793059|NCT01786512|157080934|FG006|Overall Study|Lost to Follow-up|0|||
48793060|NCT01786512|157080935|FG007|Overall Study|Lost to Follow-up|0|||
48793061|NCT01786512|157080936|FG008|Overall Study|Lost to Follow-up|0|||
48793062|NCT01786512|157080937|FG009|Overall Study|Lost to Follow-up|1|||
48793063|NCT01786512|157080938|FG010|Overall Study|Lost to Follow-up|0|||
48793064|NCT01786512|157080928|FG000|Overall Study|Decision by sponsor|0|||
48793065|NCT01786512|157080929|FG001|Overall Study|Decision by sponsor|0|||
48793066|NCT01786512|157080930|FG002|Overall Study|Decision by sponsor|0|||
48793067|NCT01786512|157080931|FG003|Overall Study|Decision by sponsor|0|||
48793068|NCT01786512|157080932|FG004|Overall Study|Decision by sponsor|0|||
48793069|NCT01786512|157080933|FG005|Overall Study|Decision by sponsor|0|||
48793070|NCT01786512|157080934|FG006|Overall Study|Decision by sponsor|0|||
48793071|NCT01786512|157080935|FG007|Overall Study|Decision by sponsor|0|||
48793072|NCT01786512|157080936|FG008|Overall Study|Decision by sponsor|0|||
48793073|NCT01786512|157080937|FG009|Overall Study|Decision by sponsor|0|||
48793074|NCT01786512|157080938|FG010|Overall Study|Decision by sponsor|2|||
48793075|NCT01786512|157080928|FG000|Overall Study|Withdrawal by Subject|0|||
48793076|NCT01786512|157080929|FG001|Overall Study|Withdrawal by Subject|1|||
48793077|NCT01786512|157080930|FG002|Overall Study|Withdrawal by Subject|0|||
48793078|NCT01786512|157080931|FG003|Overall Study|Withdrawal by Subject|0|||
48793079|NCT01786512|157080932|FG004|Overall Study|Withdrawal by Subject|0|||
48793080|NCT01786512|157080933|FG005|Overall Study|Withdrawal by Subject|0|||
48793081|NCT01786512|157080934|FG006|Overall Study|Withdrawal by Subject|1|||
48793082|NCT01786512|157080935|FG007|Overall Study|Withdrawal by Subject|0|||
48793083|NCT01786512|157080936|FG008|Overall Study|Withdrawal by Subject|0|||
48793084|NCT01786512|157080937|FG009|Overall Study|Withdrawal by Subject|3|||
48793085|NCT01786512|157080938|FG010|Overall Study|Withdrawal by Subject|7|||
48793086|NCT01786512|157080928|FG000|Overall Study|Death|0|||
48793087|NCT01786512|157080929|FG001|Overall Study|Death|0|||
48793088|NCT01786512|157080930|FG002|Overall Study|Death|0|||
48793089|NCT01786512|157080931|FG003|Overall Study|Death|0|||
48793090|NCT01786512|157080932|FG004|Overall Study|Death|0|||
48793091|NCT01786512|157080933|FG005|Overall Study|Death|0|||
48793092|NCT01786512|157080934|FG006|Overall Study|Death|0|||
48793093|NCT01786512|157080935|FG007|Overall Study|Death|0|||
48793094|NCT01786512|157080936|FG008|Overall Study|Death|4|||
48793095|NCT01786512|157080937|FG009|Overall Study|Death|1|||
48793096|NCT01786512|157080938|FG010|Overall Study|Death|3|||
48878170|NCT01390441|157392151|FG000|Treatment Period|Physician Decision|0|||
48793097|NCT03137303|157080939|FG000|T1: 3-month Follow-up|Withdrawal by Subject|1|||
48793098|NCT03137303|157080940|FG001|T1: 3-month Follow-up|Withdrawal by Subject|4|||
48793099|NCT03137303|157080939|FG000|T1: 3-month Follow-up|Lost to Follow-up|5|||
48793100|NCT03137303|157080940|FG001|T1: 3-month Follow-up|Lost to Follow-up|6|||
48793101|NCT03137303|157080939|FG000|T2: 6-month Follow-up|Lost to Follow-up|5|||
48793102|NCT03137303|157080940|FG001|T2: 6-month Follow-up|Lost to Follow-up|5|||
48793103|NCT03137303|157080939|FG000|T3: 9-month Follow-up|Death|1|||
48793104|NCT03137303|157080940|FG001|T3: 9-month Follow-up|Death|0|||
48793105|NCT03137303|157080939|FG000|T3: 9-month Follow-up|Lost to Follow-up|4|||
48793106|NCT03137303|157080940|FG001|T3: 9-month Follow-up|Lost to Follow-up|4|||
48793107|NCT03137303|157080939|FG000|T4: 12-month Follow-up|Withdrawal by Subject|0|||
48793108|NCT03137303|157080940|FG001|T4: 12-month Follow-up|Withdrawal by Subject|1|||
48793109|NCT03137303|157080939|FG000|T4: 12-month Follow-up|Lost to Follow-up|7|||
48793110|NCT03137303|157080940|FG001|T4: 12-month Follow-up|Lost to Follow-up|4|||
48793111|NCT00760929|157080941|FG000|Overall Study|Adverse Event|2|||
48793112|NCT00760929|157080942|FG001|Overall Study|Adverse Event|0|||
48793113|NCT00760929|157080943|FG002|Overall Study|Adverse Event|6|||
48793114|NCT00760929|157080944|FG003|Overall Study|Adverse Event|10|||
48793115|NCT00760929|157080941|FG000|Overall Study|Lack of Efficacy|0|||
48793116|NCT00760929|157080942|FG001|Overall Study|Lack of Efficacy|2|||
48793117|NCT00760929|157080943|FG002|Overall Study|Lack of Efficacy|1|||
48793118|NCT00760929|157080944|FG003|Overall Study|Lack of Efficacy|0|||
48793119|NCT00760929|157080941|FG000|Overall Study|Withdrawal by Subject|1|||
48793120|NCT00760929|157080942|FG001|Overall Study|Withdrawal by Subject|0|||
48793121|NCT00760929|157080943|FG002|Overall Study|Withdrawal by Subject|9|||
48793122|NCT00760929|157080944|FG003|Overall Study|Withdrawal by Subject|1|||
48793123|NCT00760929|157080941|FG000|Overall Study|Lost to Follow-up|0|||
48793124|NCT00760929|157080942|FG001|Overall Study|Lost to Follow-up|0|||
48793125|NCT00760929|157080943|FG002|Overall Study|Lost to Follow-up|1|||
48793126|NCT00760929|157080944|FG003|Overall Study|Lost to Follow-up|0|||
48793127|NCT00760929|157080941|FG000|Overall Study|Progression of Disease|21|||
48793128|NCT00760929|157080942|FG001|Overall Study|Progression of Disease|26|||
48793129|NCT00760929|157080943|FG002|Overall Study|Progression of Disease|38|||
48793130|NCT00760929|157080944|FG003|Overall Study|Progression of Disease|42|||
48793131|NCT00760929|157080941|FG000|Overall Study|Other|2|||
48793132|NCT00760929|157080942|FG001|Overall Study|Other|0|||
48793133|NCT00760929|157080943|FG002|Overall Study|Other|2|||
48793134|NCT00760929|157080944|FG003|Overall Study|Other|1|||
48793135|NCT00760929|157080941|FG000|Overall Study|Death|0|||
48793136|NCT00760929|157080942|FG001|Overall Study|Death|0|||
48793137|NCT00760929|157080943|FG002|Overall Study|Death|1|||
48793138|NCT00760929|157080944|FG003|Overall Study|Death|0|||
48793139|NCT00760929|157080941|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
48793140|NCT00760929|157080942|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
48793141|NCT00760929|157080943|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
48793142|NCT00760929|157080944|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
48793143|NCT04060355|157080946|FG000|Overall Study|Lost to Follow-up|41|||
48793144|NCT00574080|157080947|FG000|Overall Study|Death|10|||
48793145|NCT00574080|157080948|FG001|Overall Study|Death|10|||
48793146|NCT03966157|157080949|FG000|Overall Study|Physician Decision|1|||
48793147|NCT03966157|157080950|FG001|Overall Study|Physician Decision|0|||
48793148|NCT01597050|157080951|FG000|Overall Study|Withdrawal by Subject|1|||
48793149|NCT01597050|157080952|FG001|Overall Study|Withdrawal by Subject|0|||
48793150|NCT02065336|157080953|FG000|Extension Phase|Study Terminated by Sponsor|0|||
48793151|NCT02065336|157080954|FG001|Extension Phase|Study Terminated by Sponsor|0|||
48793152|NCT02065336|157080955|FG002|Extension Phase|Study Terminated by Sponsor|0|||
48793153|NCT02065336|157080956|FG003|Extension Phase|Study Terminated by Sponsor|0|||
48793154|NCT02065336|157080957|FG004|Extension Phase|Study Terminated by Sponsor|0|||
48793155|NCT02065336|157080958|FG005|Extension Phase|Study Terminated by Sponsor|0|||
48793156|NCT02065336|157080959|FG006|Extension Phase|Study Terminated by Sponsor|0|||
48793157|NCT02065336|157080960|FG007|Extension Phase|Study Terminated by Sponsor|0|||
48793158|NCT02065336|157080961|FG008|Extension Phase|Study Terminated by Sponsor|2|||
48793159|NCT02065336|157080962|FG009|Extension Phase|Study Terminated by Sponsor|8|||
48793160|NCT02278328|157080966|FG000|Neuropsych Screening|found ineligible on neuropsych|1|||
48793161|NCT02278328|157080967|FG001|Neuropsych Screening|found ineligible on neuropsych|0|||
48793162|NCT02278328|157080968|FG002|Neuropsych Screening|found ineligible on neuropsych|0|||
48793163|NCT02278328|157080966|FG000|Neuropsych Screening|Withdrawal by Subject|0|||
48793164|NCT02278328|157080967|FG001|Neuropsych Screening|Withdrawal by Subject|1|||
48793165|NCT02278328|157080968|FG002|Neuropsych Screening|Withdrawal by Subject|0|||
48793166|NCT02278328|157080966|FG000|Neuropsych Screening|incomplete consent|0|||
48793167|NCT02278328|157080967|FG001|Neuropsych Screening|incomplete consent|0|||
48793168|NCT02278328|157080968|FG002|Neuropsych Screening|incomplete consent|2|||
48793169|NCT04794803|157080970|FG000|Overall Study|Death|1|||
48793170|NCT04794803|157080971|FG001|Overall Study|Death|3|||
48793171|NCT04794803|157080970|FG000|Overall Study|Lost to Follow-up|2|||
48793172|NCT04794803|157080971|FG001|Overall Study|Lost to Follow-up|2|||
48793173|NCT04794803|157080970|FG000|Overall Study|Withdrawal by Subject|1|||
48793174|NCT04794803|157080971|FG001|Overall Study|Withdrawal by Subject|0|||
48793175|NCT04794803|157080970|FG000|Overall Study|Physician Decision|1|||
48793176|NCT04794803|157080971|FG001|Overall Study|Physician Decision|1|||
48793177|NCT04794803|157080970|FG000|Overall Study|Patient transferred to another centre for oxygen rehabilitation|4|||
48793178|NCT04794803|157080971|FG001|Overall Study|Patient transferred to another centre for oxygen rehabilitation|1|||
48793179|NCT04794803|157080970|FG000|Overall Study|Refused to continue the treatment|1|||
48793180|NCT04794803|157080971|FG001|Overall Study|Refused to continue the treatment|0|||
48793181|NCT04794803|157080970|FG000|Overall Study|Patient admitted to ICU|0|||
48793182|NCT04794803|157080971|FG001|Overall Study|Patient admitted to ICU|1|||
48793183|NCT01388816|157080972|FG000|Overall Study|Adverse Event|0|||
48793184|NCT01388816|157080973|FG001|Overall Study|Adverse Event|2|||
48793185|NCT01388816|157080974|FG002|Overall Study|Adverse Event|0|||
48793186|NCT01388816|157080975|FG003|Overall Study|Adverse Event|0|||
48793187|NCT01388816|157080972|FG000|Overall Study|Lost to Follow-up|0|||
48793188|NCT01388816|157080973|FG001|Overall Study|Lost to Follow-up|1|||
48793189|NCT01388816|157080974|FG002|Overall Study|Lost to Follow-up|0|||
48793190|NCT01388816|157080975|FG003|Overall Study|Lost to Follow-up|0|||
48793191|NCT01388816|157080972|FG000|Overall Study|Withdrawal by Subject|2|||
48793192|NCT01388816|157080973|FG001|Overall Study|Withdrawal by Subject|1|||
48793193|NCT01388816|157080974|FG002|Overall Study|Withdrawal by Subject|1|||
48793194|NCT01388816|157080975|FG003|Overall Study|Withdrawal by Subject|0|||
48793195|NCT01388816|157080972|FG000|Overall Study|Protocol Violation|0|||
48793196|NCT01388816|157080973|FG001|Overall Study|Protocol Violation|0|||
48793197|NCT01388816|157080974|FG002|Overall Study|Protocol Violation|2|||
48793198|NCT01388816|157080975|FG003|Overall Study|Protocol Violation|0|||
48793199|NCT01995461|157080978|FG000|Overall Study|Death|1|||
48793200|NCT01995461|157080978|FG000|Overall Study|Lost to Follow-up|2|||
48793201|NCT01995461|157080978|FG000|Overall Study|Withdrawal by Subject|2|||
48793202|NCT03240692|157080982|FG000|Overall Study|Physician Decision|1|||
48793203|NCT03240692|157080982|FG000|Overall Study|Withdrawal by Subject|1|||
48793204|NCT01857531|157080983|FG000|Overall Study|Withdrawal by Subject|4|||
48793205|NCT01775904|157080986|FG000|LY2886721 Capsule (Water, Fasting)|Adverse Event|1|||
48793206|NCT01775904|157080986|FG000|LY2886721 ODT (Water, Fasting)|Adverse Event|1|||
48793207|NCT02820623|157080987|FG000|Overall Study|Withdrawal by Subject|1|||
48793208|NCT02820623|157080988|FG001|Overall Study|Withdrawal by Subject|3|||
48793209|NCT02820623|157080989|FG002|Overall Study|Withdrawal by Subject|3|||
48793210|NCT02820623|157080987|FG000|Overall Study|Participation interrupted due to COVID-19|3|||
48793211|NCT02820623|157080988|FG001|Overall Study|Participation interrupted due to COVID-19|3|||
48793212|NCT02820623|157080989|FG002|Overall Study|Participation interrupted due to COVID-19|2|||
48793213|NCT02820623|157080987|FG000|Overall Study|Therapist unable to enroll clients|1|||
48793214|NCT02820623|157080988|FG001|Overall Study|Therapist unable to enroll clients|1|||
48793215|NCT02820623|157080989|FG002|Overall Study|Therapist unable to enroll clients|3|||
48793216|NCT02820623|157080987|FG000|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
48793217|NCT02820623|157080988|FG001|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
48793218|NCT02820623|157080989|FG002|Overall Study|Clients declined, piloting condition, or only telehealth|3|||
48793219|NCT00617344|157080990|FG000|Overall Study|Serious adverse event|1|||
48793220|NCT00617344|157080991|FG001|Overall Study|Serious adverse event|0|||
48793221|NCT00617344|157080992|FG002|Overall Study|Serious adverse event|0|||
48793222|NCT00617344|157080990|FG000|Overall Study|Other Adverse Event|1|||
48793223|NCT00617344|157080991|FG001|Overall Study|Other Adverse Event|1|||
48793224|NCT00617344|157080992|FG002|Overall Study|Other Adverse Event|0|||
48793225|NCT00617344|157080990|FG000|Overall Study|Protocol Violation|10|||
48793226|NCT00617344|157080991|FG001|Overall Study|Protocol Violation|8|||
48793227|NCT00617344|157080992|FG002|Overall Study|Protocol Violation|5|||
48793228|NCT00617344|157080990|FG000|Overall Study|Lost to Follow-up|5|||
48793229|NCT00617344|157080991|FG001|Overall Study|Lost to Follow-up|4|||
48793230|NCT00617344|157080992|FG002|Overall Study|Lost to Follow-up|1|||
48793231|NCT00617344|157080990|FG000|Overall Study|Withdrawal by Subject|8|||
48793232|NCT00617344|157080991|FG001|Overall Study|Withdrawal by Subject|9|||
48793233|NCT00617344|157080992|FG002|Overall Study|Withdrawal by Subject|2|||
48793234|NCT00983073|157080993|FG000|Titration and Optimal Dose Period|Adverse Event|19|||
48793235|NCT00983073|157080993|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|11|||
48793236|NCT00983073|157080993|FG000|Titration and Optimal Dose Period|Lack of Efficacy|5|||
48793237|NCT00983073|157080993|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
48793238|NCT00983073|157080993|FG000|Titration and Optimal Dose Period|Other reason|4|||
48793239|NCT00983073|157080993|FG000|Maintenance Period|Adverse Event|5|||
48793240|NCT00983073|157080993|FG000|Maintenance Period|Withdrawal by Subject|2|||
48793241|NCT00983073|157080993|FG000|Maintenance Period|Lack of Efficacy|2|||
48793242|NCT00983073|157080993|FG000|Maintenance Period|Other Reason|7|||
48793243|NCT00636610|157080998|FG000|Overall Study|Adverse Event|4|||
48793244|NCT00636610|157080999|FG001|Overall Study|Adverse Event|4|||
48793245|NCT00636610|157080998|FG000|Overall Study|Death|6|||
48793246|NCT00636610|157080999|FG001|Overall Study|Death|3|||
48878171|NCT01390441|157392152|FG001|Treatment Period|Physician Decision|0|||
48878172|NCT01390441|157392153|FG002|Treatment Period|Physician Decision|0|||
48878173|NCT01390441|157392154|FG003|Treatment Period|Physician Decision|1|||
48878174|NCT01390441|157392155|FG004|Treatment Period|Physician Decision|0|||
48878175|NCT01390441|157392151|FG000|Treatment Period|Lack of Efficacy|0|||
48878176|NCT01390441|157392152|FG001|Treatment Period|Lack of Efficacy|0|||
48878177|NCT01390441|157392153|FG002|Treatment Period|Lack of Efficacy|0|||
48878178|NCT01390441|157392154|FG003|Treatment Period|Lack of Efficacy|0|||
48878179|NCT01390441|157392155|FG004|Treatment Period|Lack of Efficacy|1|||
48878180|NCT01390441|157392151|FG000|Treatment Period|Unknown due to early stopping of study|0|||
48878181|NCT01390441|157392152|FG001|Treatment Period|Unknown due to early stopping of study|0|||
48878182|NCT01390441|157392153|FG002|Treatment Period|Unknown due to early stopping of study|8|||
48878183|NCT01390441|157392154|FG003|Treatment Period|Unknown due to early stopping of study|11|||
48878184|NCT01390441|157392155|FG004|Treatment Period|Unknown due to early stopping of study|7|||
48878185|NCT01390441|157392151|FG000|Treatment Period|Adverse Event|0|||
48878186|NCT01390441|157392152|FG001|Treatment Period|Adverse Event|0|||
48878187|NCT01390441|157392153|FG002|Treatment Period|Adverse Event|1|||
48878188|NCT01390441|157392154|FG003|Treatment Period|Adverse Event|1|||
48878189|NCT01390441|157392155|FG004|Treatment Period|Adverse Event|2|||
48878190|NCT01390441|157392151|FG000|Treatment Period|Withdrawal by Subject|0|||
48878191|NCT01390441|157392152|FG001|Treatment Period|Withdrawal by Subject|0|||
48878192|NCT01390441|157392153|FG002|Treatment Period|Withdrawal by Subject|1|||
48878193|NCT01390441|157392154|FG003|Treatment Period|Withdrawal by Subject|0|||
48878194|NCT01390441|157392155|FG004|Treatment Period|Withdrawal by Subject|1|||
48878195|NCT01390441|157392151|FG000|Treatment Period|Lost to Follow-up|1|||
48878196|NCT01390441|157392152|FG001|Treatment Period|Lost to Follow-up|0|||
48878197|NCT01390441|157392153|FG002|Treatment Period|Lost to Follow-up|0|||
48878198|NCT01390441|157392154|FG003|Treatment Period|Lost to Follow-up|0|||
48878199|NCT01390441|157392155|FG004|Treatment Period|Lost to Follow-up|0|||
48878200|NCT01390441|157392151|FG000|Extension Period|Protocol Violation|3|||
48878201|NCT01390441|157392152|FG001|Extension Period|Protocol Violation|1|||
48878202|NCT01390441|157392153|FG002|Extension Period|Protocol Violation|0|||
48878203|NCT01390441|157392154|FG003|Extension Period|Protocol Violation|1|||
48878204|NCT01390441|157392155|FG004|Extension Period|Protocol Violation|0|||
48878205|NCT01807182|157392163|FG000|Overall Study|Death|1|||
48878206|NCT01807182|157392163|FG000|Overall Study|New therapy|1|||
48878207|NCT01807182|157392163|FG000|Overall Study|Moved to hospice care|1|||
48878208|NCT01263509|157392166|FG000|Entered - Long-Term Extension Study|Adverse Event|5|||
48878209|NCT01263509|157392167|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
48878210|NCT01263509|157392168|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
48878211|NCT01263509|157392169|FG003|Entered - Long-Term Extension Study|Adverse Event|1|||
48878212|NCT01263509|157392166|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
48878213|NCT01263509|157392167|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
48878214|NCT01263509|157392168|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
48878215|NCT01263509|157392169|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
48878216|NCT01263509|157392166|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
48878217|NCT01263509|157392167|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
48878218|NCT01263509|157392168|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
48878219|NCT01263509|157392169|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
48878220|NCT01263509|157392166|FG000|Entered - Long-Term Extension Study|Participant Unavailability|1|||
48878221|NCT01263509|157392167|FG001|Entered - Long-Term Extension Study|Participant Unavailability|1|||
48878222|NCT01263509|157392168|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
48878223|NCT01263509|157392169|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
48793247|NCT00636610|157080998|FG000|Overall Study|Physician decision to withdraw patient|15|||
48793248|NCT00636610|157080999|FG001|Overall Study|Physician decision to withdraw patient|9|||
48793249|NCT00636610|157080998|FG000|Overall Study|Subject decision to withdraw|15|||
48793250|NCT00636610|157080999|FG001|Overall Study|Subject decision to withdraw|11|||
48793251|NCT00636610|157080998|FG000|Overall Study|Disease progression - radiographic|41|||
48793252|NCT00636610|157080999|FG001|Overall Study|Disease progression - radiographic|51|||
48793253|NCT00636610|157080998|FG000|Overall Study|Disease progression - clinical|8|||
48793254|NCT00636610|157080999|FG001|Overall Study|Disease progression - clinical|3|||
48793255|NCT00636610|157080998|FG000|Overall Study|Reason for discontinuation not available|3|||
48793256|NCT00636610|157080999|FG001|Overall Study|Reason for discontinuation not available|2|||
48793257|NCT03762473|157081000|FG000|Overall Study|Death|1|||
48793258|NCT03762473|157081001|FG001|Overall Study|Death|0|||
48793259|NCT00941330|157081004|FG000|Overall Study|Other|1|||
48793260|NCT00941330|157081005|FG001|Overall Study|Other|0|||
48793261|NCT00941330|157081004|FG000|Overall Study|Physician Decision|0|||
48793262|NCT00941330|157081005|FG001|Overall Study|Physician Decision|2|||
48793263|NCT00818753|157081006|FG000|Overall Study|Protocol Violation|1|||
48793264|NCT00818753|157081007|FG001|Overall Study|Protocol Violation|0|||
48793265|NCT00818753|157081008|FG002|Overall Study|Protocol Violation|0|||
48793266|NCT00818753|157081006|FG000|Overall Study|Other reason (not specified)|0|||
49032534|NCT01597245|157953486|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2|||
49032535|NCT01597245|157953487|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
48793267|NCT00818753|157081007|FG001|Overall Study|Other reason (not specified)|0|||
48793268|NCT00818753|157081008|FG002|Overall Study|Other reason (not specified)|1|||
48793269|NCT00818753|157081006|FG000|Overall Study|Randomised and not treated|2|||
48793270|NCT00818753|157081007|FG001|Overall Study|Randomised and not treated|0|||
48793271|NCT00818753|157081008|FG002|Overall Study|Randomised and not treated|0|||
48793272|NCT00725296|157081010|FG000|Overall Study|Adverse Event|11|||
48793273|NCT00725296|157081010|FG000|Overall Study|Lack of Efficacy|7|||
48793274|NCT00725296|157081010|FG000|Overall Study|Withdrawal by Subject|3|||
48793275|NCT00725296|157081010|FG000|Overall Study|Non-Compliance|2|||
48793276|NCT00725296|157081010|FG000|Overall Study|Lost to Follow-up|1|||
48793277|NCT00725296|157081010|FG000|Overall Study|Other|38|||
48793278|NCT00657618|157081013|FG000|Overall Study|Adverse Event|32|||
48793279|NCT00657618|157081013|FG000|Overall Study|Withdrawal by Subject|8|||
48793280|NCT00657618|157081013|FG000|Overall Study|negative for leishmaniasis|2|||
48793281|NCT00657618|157081013|FG000|Overall Study|didn't start due to schedule conflicts|1|||
48793282|NCT04980300|157081016|FG000|Baseline to 12 Weeks|Withdrawal by Subject|2|||
48793283|NCT04980300|157081017|FG001|Baseline to 12 Weeks|Withdrawal by Subject|1|||
48793284|NCT04980300|157081016|FG000|Baseline to 12 Weeks|Lost to Follow-up|4|||
48793285|NCT04980300|157081017|FG001|Baseline to 12 Weeks|Lost to Follow-up|0|||
48793286|NCT04980300|157081016|FG000|12 Weeks to 24 Weeks|Withdrawal by Subject|2|||
48793287|NCT04980300|157081017|FG001|12 Weeks to 24 Weeks|Withdrawal by Subject|1|||
48793288|NCT04980300|157081016|FG000|12 Weeks to 24 Weeks|Lost to Follow-up|2|||
48793289|NCT04980300|157081017|FG001|12 Weeks to 24 Weeks|Lost to Follow-up|4|||
48793290|NCT04940624|157081019|FG000|Overall Study|Adverse Event|4|||
48793291|NCT04940624|157081020|FG001|Overall Study|Adverse Event|11|||
48793292|NCT04940624|157081019|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
48793293|NCT04940624|157081020|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
48793294|NCT04940624|157081019|FG000|Overall Study|Physician Decision|1|||
48793295|NCT04940624|157081020|FG001|Overall Study|Physician Decision|0|||
48793296|NCT04940624|157081019|FG000|Overall Study|Lost to Follow-up|1|||
48793297|NCT04940624|157081020|FG001|Overall Study|Lost to Follow-up|0|||
48793298|NCT04940624|157081019|FG000|Overall Study|Reason Not Specified|1|||
48793299|NCT04940624|157081020|FG001|Overall Study|Reason Not Specified|0|||
48793300|NCT00423176|157082149|FG000|Overall Study|Adverse Event|4|||
48793301|NCT00423176|157082150|FG001|Overall Study|Adverse Event|6|||
48793302|NCT00423176|157082149|FG000|Overall Study|Treatment Failure|1|||
48793303|NCT00423176|157082150|FG001|Overall Study|Treatment Failure|6|||
48793304|NCT00423176|157082149|FG000|Overall Study|Lost to Follow-up|4|||
48793305|NCT00423176|157082150|FG001|Overall Study|Lost to Follow-up|7|||
48793306|NCT00423176|157082149|FG000|Overall Study|Withdrawal by Subject|4|||
48793307|NCT00423176|157082150|FG001|Overall Study|Withdrawal by Subject|3|||
48793308|NCT00423176|157082149|FG000|Overall Study|Protocol Violation|1|||
48793309|NCT00423176|157082150|FG001|Overall Study|Protocol Violation|3|||
48793310|NCT00423176|157082149|FG000|Overall Study|Did not meet protocol eligibility|2|||
48793311|NCT00423176|157082150|FG001|Overall Study|Did not meet protocol eligibility|4|||
48793312|NCT05072080|157082151|FG000|Overall Study|Death|0|||
48793313|NCT05072080|157082152|FG001|Overall Study|Death|0|||
48793314|NCT05072080|157082153|FG002|Overall Study|Death|1|||
48793315|NCT05072080|157082154|FG003|Overall Study|Death|0|||
48793316|NCT05072080|157082151|FG000|Overall Study|Lost to Follow-up|65|||
48793317|NCT05072080|157082152|FG001|Overall Study|Lost to Follow-up|70|||
48793318|NCT05072080|157082153|FG002|Overall Study|Lost to Follow-up|58|||
48793319|NCT05072080|157082154|FG003|Overall Study|Lost to Follow-up|23|||
48793320|NCT05072080|157082151|FG000|Overall Study|Physician Decision|2|||
48793321|NCT05072080|157082152|FG001|Overall Study|Physician Decision|1|||
48793322|NCT05072080|157082153|FG002|Overall Study|Physician Decision|1|||
48793323|NCT05072080|157082154|FG003|Overall Study|Physician Decision|0|||
48793324|NCT05072080|157082151|FG000|Overall Study|Withdrawal by Subject|45|||
48793325|NCT05072080|157082152|FG001|Overall Study|Withdrawal by Subject|30|||
48793326|NCT05072080|157082153|FG002|Overall Study|Withdrawal by Subject|27|||
48793327|NCT05072080|157082154|FG003|Overall Study|Withdrawal by Subject|7|||
48793328|NCT05072080|157082151|FG000|Overall Study|Sponsor Decision|0|||
48793329|NCT05072080|157082152|FG001|Overall Study|Sponsor Decision|1|||
48793330|NCT05072080|157082153|FG002|Overall Study|Sponsor Decision|0|||
48793331|NCT05072080|157082154|FG003|Overall Study|Sponsor Decision|0|||
49032536|NCT01597245|157953488|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
48793332|NCT05072080|157082151|FG000|Overall Study|Subject moved|1|||
48793333|NCT05072080|157082152|FG001|Overall Study|Subject moved|3|||
48793334|NCT05072080|157082153|FG002|Overall Study|Subject moved|5|||
49032537|NCT01597245|157953489|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3|||
48793335|NCT05072080|157082154|FG003|Overall Study|Subject moved|2|||
48793336|NCT05072080|157082151|FG000|Overall Study|Withdrawal by parent|0|||
48793337|NCT05072080|157082152|FG001|Overall Study|Withdrawal by parent|0|||
48793338|NCT05072080|157082153|FG002|Overall Study|Withdrawal by parent|1|||
48793339|NCT05072080|157082154|FG003|Overall Study|Withdrawal by parent|0|||
48878224|NCT01263509|157392166|FG000|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
48878225|NCT01263509|157392167|FG001|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
48878226|NCT01263509|157392168|FG002|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
48878227|NCT01263509|157392169|FG003|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1|||
48878228|NCT00478205|157392170|FG000|Overall Study|Adverse Event|182|||
48878229|NCT00478205|157392171|FG001|Overall Study|Adverse Event|39|||
48793340|NCT05072080|157082151|FG000|Overall Study|Subject was deployed|0|||
48793341|NCT05072080|157082152|FG001|Overall Study|Subject was deployed|1|||
48793342|NCT05072080|157082153|FG002|Overall Study|Subject was deployed|0|||
48793343|NCT05072080|157082154|FG003|Overall Study|Subject was deployed|0|||
48793344|NCT05072080|157082151|FG000|Overall Study|Subject left site without receiving dose|0|||
48793345|NCT05072080|157082152|FG001|Overall Study|Subject left site without receiving dose|1|||
48793346|NCT05072080|157082153|FG002|Overall Study|Subject left site without receiving dose|0|||
48793347|NCT05072080|157082154|FG003|Overall Study|Subject left site without receiving dose|0|||
48793348|NCT05072080|157082151|FG000|Overall Study|Subject incarcerated|0|||
48793349|NCT05072080|157082152|FG001|Overall Study|Subject incarcerated|1|||
48793350|NCT05072080|157082153|FG002|Overall Study|Subject incarcerated|0|||
48793351|NCT05072080|157082154|FG003|Overall Study|Subject incarcerated|1|||
48793352|NCT05072080|157082151|FG000|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|0|||
48793353|NCT05072080|157082152|FG001|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|2|||
48793354|NCT05072080|157082153|FG002|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
48793355|NCT05072080|157082154|FG003|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
48793356|NCT05072080|157082151|FG000|Overall Study|Subject missed last visit (Day 183)|3|||
48793357|NCT05072080|157082152|FG001|Overall Study|Subject missed last visit (Day 183)|1|||
48793358|NCT05072080|157082153|FG002|Overall Study|Subject missed last visit (Day 183)|1|||
48793359|NCT05072080|157082154|FG003|Overall Study|Subject missed last visit (Day 183)|0|||
48793360|NCT03763708|157082155|FG000|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|4|||
48793361|NCT03763708|157082156|FG001|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
48793362|NCT03763708|157082157|FG002|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
48793363|NCT03763708|157082158|FG003|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
48793364|NCT03763708|157082159|FG004|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
48793365|NCT03763708|157082160|FG005|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
48793366|NCT03763708|157082161|FG006|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
48793367|NCT03763708|157082162|FG007|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
48793368|NCT03763708|157082163|FG008|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
48793369|NCT03763708|157082155|FG000|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
48793370|NCT03763708|157082156|FG001|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
48793371|NCT03763708|157082157|FG002|Cohort 3: Cycling Evolve|Withdrawal by Subject|1|||
48793372|NCT03763708|157082158|FG003|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
48793373|NCT03763708|157082159|FG004|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
48793374|NCT03763708|157082160|FG005|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
48793375|NCT03763708|157082161|FG006|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
48793376|NCT03763708|157082162|FG007|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
48793377|NCT03763708|157082163|FG008|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
48793378|NCT03763708|157082155|FG000|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
48793379|NCT03763708|157082156|FG001|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
48793380|NCT03763708|157082157|FG002|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
48793381|NCT03763708|157082158|FG003|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|2|||
48793382|NCT03763708|157082159|FG004|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
48793383|NCT03763708|157082160|FG005|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
48793384|NCT03763708|157082161|FG006|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
48793385|NCT03763708|157082162|FG007|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
48793386|NCT03763708|157082163|FG008|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
48793387|NCT03763708|157082155|FG000|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
48793388|NCT03763708|157082156|FG001|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
48793389|NCT03763708|157082157|FG002|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
48793390|NCT03763708|157082158|FG003|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
48793391|NCT03763708|157082159|FG004|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|2|||
48878230|NCT00478205|157392170|FG000|Overall Study|Medication Non-compliance|9|||
48878231|NCT00478205|157392171|FG001|Overall Study|Medication Non-compliance|4|||
48878232|NCT00478205|157392170|FG000|Overall Study|Protocol Violation|15|||
48793392|NCT03763708|157082160|FG005|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
48793393|NCT03763708|157082161|FG006|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
48878233|NCT00478205|157392171|FG001|Overall Study|Protocol Violation|5|||
48878234|NCT00478205|157392170|FG000|Overall Study|Request of Investigator or Sponsor|4|||
48878235|NCT00478205|157392171|FG001|Overall Study|Request of Investigator or Sponsor|5|||
48878236|NCT00478205|157392170|FG000|Overall Study|Withdrawal by Subject|61|||
48878237|NCT00478205|157392171|FG001|Overall Study|Withdrawal by Subject|22|||
48793394|NCT03763708|157082162|FG007|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
48793395|NCT03763708|157082163|FG008|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
48793396|NCT03763708|157082155|FG000|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
48793397|NCT03763708|157082156|FG001|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
48793398|NCT03763708|157082157|FG002|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
48793399|NCT03763708|157082158|FG003|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
48793400|NCT03763708|157082159|FG004|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
48793401|NCT03763708|157082160|FG005|Cohort 6: DTM-LE SCS|Withdrawal by Subject|2|||
48793402|NCT03763708|157082161|FG006|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
48793403|NCT03763708|157082162|FG007|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
48793404|NCT03763708|157082163|FG008|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
48793405|NCT03763708|157082155|FG000|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
48793406|NCT03763708|157082156|FG001|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
48793407|NCT03763708|157082157|FG002|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
48793408|NCT03763708|157082158|FG003|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
48793409|NCT03763708|157082159|FG004|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
48793410|NCT03763708|157082160|FG005|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
48793411|NCT03763708|157082161|FG006|Cohort 7: Super Cycle|Withdrawal by Subject|9|||
48793412|NCT03763708|157082162|FG007|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
48793413|NCT03763708|157082163|FG008|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
48793414|NCT03763708|157082155|FG000|Cohort 7: Super Cycle|Adverse Event|0|||
48793415|NCT03763708|157082156|FG001|Cohort 7: Super Cycle|Adverse Event|0|||
48793416|NCT03763708|157082157|FG002|Cohort 7: Super Cycle|Adverse Event|0|||
48793417|NCT03763708|157082158|FG003|Cohort 7: Super Cycle|Adverse Event|0|||
48793418|NCT03763708|157082159|FG004|Cohort 7: Super Cycle|Adverse Event|0|||
48793419|NCT03763708|157082160|FG005|Cohort 7: Super Cycle|Adverse Event|0|||
48793420|NCT03763708|157082161|FG006|Cohort 7: Super Cycle|Adverse Event|1|||
48793421|NCT03763708|157082162|FG007|Cohort 7: Super Cycle|Adverse Event|0|||
48793422|NCT03763708|157082163|FG008|Cohort 7: Super Cycle|Adverse Event|0|||
48793423|NCT03763708|157082155|FG000|Cohort 7: Super Cycle|Screen Failure|0|||
48793424|NCT03763708|157082156|FG001|Cohort 7: Super Cycle|Screen Failure|0|||
48793425|NCT03763708|157082157|FG002|Cohort 7: Super Cycle|Screen Failure|0|||
48793426|NCT03763708|157082158|FG003|Cohort 7: Super Cycle|Screen Failure|0|||
48793427|NCT03763708|157082159|FG004|Cohort 7: Super Cycle|Screen Failure|0|||
48793428|NCT03763708|157082160|FG005|Cohort 7: Super Cycle|Screen Failure|0|||
48793429|NCT03763708|157082161|FG006|Cohort 7: Super Cycle|Screen Failure|1|||
48793430|NCT03763708|157082162|FG007|Cohort 7: Super Cycle|Screen Failure|0|||
48793431|NCT03763708|157082163|FG008|Cohort 7: Super Cycle|Screen Failure|0|||
48793432|NCT03763708|157082155|FG000|Cohort 9: DPN Flow|Screen Failure|0|||
48793433|NCT03763708|157082156|FG001|Cohort 9: DPN Flow|Screen Failure|0|||
49032538|NCT01597245|157953490|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
49032539|NCT01597245|157953470|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
49032540|NCT01597245|157953471|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
49032541|NCT01597245|157953472|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
49032542|NCT01597245|157953473|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
49032543|NCT01597245|157953474|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
49032544|NCT01597245|157953475|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
49032545|NCT01597245|157953476|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
49032546|NCT01597245|157953477|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
49032547|NCT01597245|157953478|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
48793434|NCT03763708|157082157|FG002|Cohort 9: DPN Flow|Screen Failure|0|||
48793435|NCT03763708|157082158|FG003|Cohort 9: DPN Flow|Screen Failure|0|||
48793436|NCT03763708|157082159|FG004|Cohort 9: DPN Flow|Screen Failure|0|||
48793437|NCT03763708|157082160|FG005|Cohort 9: DPN Flow|Screen Failure|0|||
48793438|NCT03763708|157082161|FG006|Cohort 9: DPN Flow|Screen Failure|0|||
48793439|NCT03763708|157082162|FG007|Cohort 9: DPN Flow|Screen Failure|0|||
48793440|NCT03763708|157082163|FG008|Cohort 9: DPN Flow|Screen Failure|1|||
48793441|NCT03768505|157082165|FG000|Overall Study|sponsor decision|76|||
48793442|NCT03768505|157082165|FG000|Overall Study|Death|35|||
48793443|NCT03768505|157082165|FG000|Overall Study|Other -Various|30|||
48793444|NCT03768505|157082165|FG000|Overall Study|Withdrawal by Subject|22|||
48793445|NCT03768505|157082165|FG000|Overall Study|Lost to Follow-up|6|||
48793446|NCT03896035|157082168|FG000|Overall Study|Lost to Follow-up|2|||
48793447|NCT03896035|157082169|FG001|Overall Study|Lost to Follow-up|6|||
48793448|NCT03896035|157082168|FG000|Overall Study|Withdrawal by Subject|0|||
48793449|NCT03896035|157082169|FG001|Overall Study|Withdrawal by Subject|1|||
49032548|NCT01597245|157953479|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
49032549|NCT01597245|157953480|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
48793450|NCT03896035|157082168|FG000|Overall Study|Health/family health issues during COVID|0|||
48793451|NCT03896035|157082169|FG001|Overall Study|Health/family health issues during COVID|4|||
48793452|NCT00827918|157082179|FG000|Overall Study|Adverse Event|4|||
48793453|NCT00827918|157082180|FG001|Overall Study|Adverse Event|0|||
48793454|NCT00827918|157082181|FG002|Overall Study|Adverse Event|0|||
49032550|NCT01597245|157953481|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
49032551|NCT01597245|157953482|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
49032552|NCT01597245|157953483|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
49032553|NCT01597245|157953484|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
49032554|NCT01597245|157953485|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
49032555|NCT01597245|157953486|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
49032556|NCT01597245|157953487|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
49032557|NCT01597245|157953488|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
49032558|NCT01597245|157953489|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
49032559|NCT01597245|157953490|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
49032560|NCT01597245|157953470|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
49032561|NCT01597245|157953471|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
49032562|NCT01597245|157953472|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
49032563|NCT01597245|157953473|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
49032564|NCT01597245|157953474|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
49032565|NCT01597245|157953475|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
49032566|NCT01597245|157953476|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
49032567|NCT01597245|157953477|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
49032568|NCT01597245|157953478|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
49032569|NCT01597245|157953479|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
49032570|NCT01597245|157953480|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
49032571|NCT01597245|157953481|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
49032572|NCT01597245|157953482|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
49032573|NCT01597245|157953483|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
49032574|NCT01597245|157953484|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
49032575|NCT01597245|157953485|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
49032576|NCT01597245|157953486|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
49032577|NCT01597245|157953487|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
48793455|NCT00827918|157082179|FG000|Overall Study|Lack of Efficacy|16|||
48793456|NCT00827918|157082180|FG001|Overall Study|Lack of Efficacy|4|||
48793457|NCT00827918|157082181|FG002|Overall Study|Lack of Efficacy|15|||
48793458|NCT00827918|157082179|FG000|Overall Study|Physician Decision|1|||
48793459|NCT00827918|157082180|FG001|Overall Study|Physician Decision|0|||
48793460|NCT00827918|157082181|FG002|Overall Study|Physician Decision|0|||
49032578|NCT01597245|157953488|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
48793461|NCT00827918|157082179|FG000|Overall Study|Pregnancy|0|||
48793462|NCT00827918|157082180|FG001|Overall Study|Pregnancy|1|||
48793463|NCT00827918|157082181|FG002|Overall Study|Pregnancy|0|||
48793464|NCT00827918|157082179|FG000|Overall Study|Progressive Disease|1|||
48793465|NCT00827918|157082180|FG001|Overall Study|Progressive Disease|1|||
48793466|NCT00827918|157082181|FG002|Overall Study|Progressive Disease|0|||
48793467|NCT00827918|157082179|FG000|Overall Study|Protocol Violation|0|||
48793468|NCT00827918|157082180|FG001|Overall Study|Protocol Violation|1|||
48793469|NCT00827918|157082181|FG002|Overall Study|Protocol Violation|0|||
48793470|NCT00827918|157082179|FG000|Overall Study|Withdrawal by Subject|6|||
48793471|NCT00827918|157082180|FG001|Overall Study|Withdrawal by Subject|2|||
48793472|NCT00827918|157082181|FG002|Overall Study|Withdrawal by Subject|6|||
48793473|NCT01302847|157082182|FG000|Overall Study|Death|0|||
48793474|NCT01302847|157082183|FG001|Overall Study|Death|1|||
48793475|NCT01302847|157082184|FG002|Overall Study|Death|0|||
48793476|NCT01302847|157082185|FG003|Overall Study|Death|0|||
48793477|NCT01302847|157082186|FG004|Overall Study|Death|0|||
48793478|NCT01302847|157082187|FG005|Overall Study|Death|1|||
48793479|NCT01302847|157082188|FG006|Overall Study|Death|1|||
48793480|NCT01302847|157082189|FG007|Overall Study|Death|0|||
48793481|NCT01302847|157082182|FG000|Overall Study|Pregnancy|2|||
48793482|NCT01302847|157082183|FG001|Overall Study|Pregnancy|0|||
48793483|NCT01302847|157082184|FG002|Overall Study|Pregnancy|0|||
48793484|NCT01302847|157082185|FG003|Overall Study|Pregnancy|0|||
48793485|NCT01302847|157082186|FG004|Overall Study|Pregnancy|0|||
48793486|NCT01302847|157082187|FG005|Overall Study|Pregnancy|0|||
48793487|NCT01302847|157082188|FG006|Overall Study|Pregnancy|0|||
48793488|NCT01302847|157082189|FG007|Overall Study|Pregnancy|0|||
48793489|NCT01302847|157082182|FG000|Overall Study|Virologic failure|0|||
48793490|NCT01302847|157082183|FG001|Overall Study|Virologic failure|2|||
48793491|NCT01302847|157082184|FG002|Overall Study|Virologic failure|0|||
48793492|NCT01302847|157082185|FG003|Overall Study|Virologic failure|2|||
48793493|NCT01302847|157082186|FG004|Overall Study|Virologic failure|1|||
48793494|NCT01302847|157082187|FG005|Overall Study|Virologic failure|3|||
48793495|NCT01302847|157082188|FG006|Overall Study|Virologic failure|1|||
48793496|NCT01302847|157082189|FG007|Overall Study|Virologic failure|2|||
48793497|NCT01302847|157082182|FG000|Overall Study|Severe debilitation, unable to continue|0|||
48793498|NCT01302847|157082183|FG001|Overall Study|Severe debilitation, unable to continue|0|||
48793499|NCT01302847|157082184|FG002|Overall Study|Severe debilitation, unable to continue|0|||
48793500|NCT01302847|157082185|FG003|Overall Study|Severe debilitation, unable to continue|0|||
48793501|NCT01302847|157082186|FG004|Overall Study|Severe debilitation, unable to continue|0|||
48793502|NCT01302847|157082187|FG005|Overall Study|Severe debilitation, unable to continue|1|||
48793503|NCT01302847|157082188|FG006|Overall Study|Severe debilitation, unable to continue|1|||
48793504|NCT01302847|157082189|FG007|Overall Study|Severe debilitation, unable to continue|0|||
48793505|NCT01302847|157082182|FG000|Overall Study|Not able to get to clinic|1|||
48793506|NCT01302847|157082183|FG001|Overall Study|Not able to get to clinic|1|||
48793507|NCT01302847|157082184|FG002|Overall Study|Not able to get to clinic|0|||
48793508|NCT01302847|157082185|FG003|Overall Study|Not able to get to clinic|0|||
48793509|NCT01302847|157082186|FG004|Overall Study|Not able to get to clinic|0|||
48793510|NCT01302847|157082187|FG005|Overall Study|Not able to get to clinic|0|||
48793511|NCT01302847|157082188|FG006|Overall Study|Not able to get to clinic|0|||
48793512|NCT01302847|157082189|FG007|Overall Study|Not able to get to clinic|0|||
48793513|NCT01302847|157082182|FG000|Overall Study|Site closing|2|||
48793514|NCT01302847|157082183|FG001|Overall Study|Site closing|2|||
48793515|NCT01302847|157082184|FG002|Overall Study|Site closing|0|||
48793516|NCT01302847|157082185|FG003|Overall Study|Site closing|0|||
48793517|NCT01302847|157082186|FG004|Overall Study|Site closing|0|||
48793518|NCT01302847|157082187|FG005|Overall Study|Site closing|0|||
48793519|NCT01302847|157082188|FG006|Overall Study|Site closing|0|||
48793520|NCT01302847|157082189|FG007|Overall Study|Site closing|0|||
48793521|NCT01302847|157082182|FG000|Overall Study|Withdrawal by Subject|1|||
48793522|NCT01302847|157082183|FG001|Overall Study|Withdrawal by Subject|0|||
48793523|NCT01302847|157082184|FG002|Overall Study|Withdrawal by Subject|0|||
48793524|NCT01302847|157082185|FG003|Overall Study|Withdrawal by Subject|0|||
48793525|NCT01302847|157082186|FG004|Overall Study|Withdrawal by Subject|1|||
48793526|NCT01302847|157082187|FG005|Overall Study|Withdrawal by Subject|0|||
48793527|NCT01302847|157082188|FG006|Overall Study|Withdrawal by Subject|0|||
48793528|NCT01302847|157082189|FG007|Overall Study|Withdrawal by Subject|1|||
48793529|NCT01302847|157082182|FG000|Overall Study|Not willing to adhere to requirements|5|||
48793530|NCT01302847|157082183|FG001|Overall Study|Not willing to adhere to requirements|0|||
48793531|NCT01302847|157082184|FG002|Overall Study|Not willing to adhere to requirements|1|||
48793532|NCT01302847|157082185|FG003|Overall Study|Not willing to adhere to requirements|0|||
48793533|NCT01302847|157082186|FG004|Overall Study|Not willing to adhere to requirements|0|||
48793534|NCT01302847|157082187|FG005|Overall Study|Not willing to adhere to requirements|0|||
48793535|NCT01302847|157082188|FG006|Overall Study|Not willing to adhere to requirements|0|||
48793536|NCT01302847|157082189|FG007|Overall Study|Not willing to adhere to requirements|2|||
48793537|NCT01302847|157082182|FG000|Overall Study|Site unable to contact participant|2|||
48793538|NCT01302847|157082183|FG001|Overall Study|Site unable to contact participant|1|||
48793539|NCT01302847|157082184|FG002|Overall Study|Site unable to contact participant|0|||
48793540|NCT01302847|157082185|FG003|Overall Study|Site unable to contact participant|0|||
48793541|NCT01302847|157082186|FG004|Overall Study|Site unable to contact participant|0|||
48793542|NCT01302847|157082187|FG005|Overall Study|Site unable to contact participant|0|||
48793543|NCT01302847|157082188|FG006|Overall Study|Site unable to contact participant|2|||
48793544|NCT01302847|157082189|FG007|Overall Study|Site unable to contact participant|0|||
48793545|NCT04871529|157082190|FG000|Overall Study|Withdrawal by Subject|0|||
49032579|NCT01597245|157953489|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1|||
49032580|NCT01597245|157953490|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
49032581|NCT00323882|157953493|FG000|Overall Study|Adverse Event|2|||
49032582|NCT00323882|157953494|FG001|Overall Study|Adverse Event|1|||
49032583|NCT00323882|157953495|FG002|Overall Study|Adverse Event|1|||
49032584|NCT00323882|157953496|FG003|Overall Study|Adverse Event|1|||
49032585|NCT00323882|157953497|FG004|Overall Study|Adverse Event|3|||
48793546|NCT04871529|157082191|FG001|Overall Study|Withdrawal by Subject|1|||
48793547|NCT04871529|157082190|FG000|Overall Study|Death|0|||
48793548|NCT04871529|157082191|FG001|Overall Study|Death|1|||
48793549|NCT04871529|157082190|FG000|Overall Study|Not protocol specified|0|||
48793550|NCT04871529|157082191|FG001|Overall Study|Not protocol specified|1|||
48793551|NCT00679939|157082196|FG000|52-Week Double-Blind (DB) Period|Withdrew Consent|17|||
48793552|NCT00679939|157082197|FG001|52-Week Double-Blind (DB) Period|Withdrew Consent|13|||
48793553|NCT00679939|157082196|FG000|52-Week Double-Blind (DB) Period|Adverse Event|14|||
48793554|NCT00679939|157082197|FG001|52-Week Double-Blind (DB) Period|Adverse Event|12|||
48793555|NCT00679939|157082196|FG000|52-Week Double-Blind (DB) Period|Investigator Discretion|5|||
48793556|NCT00679939|157082197|FG001|52-Week Double-Blind (DB) Period|Investigator Discretion|0|||
48793557|NCT00679939|157082196|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|1|||
48793558|NCT00679939|157082197|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
48793559|NCT00679939|157082196|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
48793560|NCT00679939|157082197|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|2|||
48793561|NCT00679939|157082196|FG000|24-Week Open-Label (OL) Period|Adverse Event|0|||
48793562|NCT00679939|157082197|FG001|24-Week Open-Label (OL) Period|Adverse Event|1|||
48793563|NCT00679939|157082196|FG000|24-Week Open-Label (OL) Period|Protocol Violation|1|||
49032586|NCT00323882|157953493|FG000|Overall Study|Disease Progression|6|||
49032587|NCT00323882|157953494|FG001|Overall Study|Disease Progression|4|||
49032588|NCT00323882|157953495|FG002|Overall Study|Disease Progression|10|||
48793564|NCT00679939|157082197|FG001|24-Week Open-Label (OL) Period|Protocol Violation|1|||
48793565|NCT00679939|157082196|FG000|24-Week Open-Label (OL) Period|Met Stopping Criteria|3|||
48793566|NCT00679939|157082197|FG001|24-Week Open-Label (OL) Period|Met Stopping Criteria|1|||
48793567|NCT00679939|157082196|FG000|24-Week Open-Label (OL) Period|Physician Decision|1|||
48793568|NCT00679939|157082197|FG001|24-Week Open-Label (OL) Period|Physician Decision|0|||
48793569|NCT00679939|157082196|FG000|24-Week Open-Label (OL) Period|Withdrawal by Subject|2|||
48793570|NCT00679939|157082197|FG001|24-Week Open-Label (OL) Period|Withdrawal by Subject|1|||
48793571|NCT02962908|157082198|FG000|Overall Study|Lost to Follow-up|0|||
48793572|NCT02962908|157082199|FG001|Overall Study|Lost to Follow-up|3|||
48793573|NCT02962908|157082200|FG002|Overall Study|Lost to Follow-up|0|||
48793574|NCT02962908|157082201|FG003|Overall Study|Lost to Follow-up|1|||
48793575|NCT02962908|157082198|FG000|Overall Study|Withdrawal by Subject|0|||
48793576|NCT02962908|157082199|FG001|Overall Study|Withdrawal by Subject|3|||
48793577|NCT02962908|157082200|FG002|Overall Study|Withdrawal by Subject|0|||
48793578|NCT02962908|157082201|FG003|Overall Study|Withdrawal by Subject|2|||
48793579|NCT02962908|157082198|FG000|Overall Study|Protocol Violation|0|||
48793580|NCT02962908|157082199|FG001|Overall Study|Protocol Violation|1|||
48793581|NCT02962908|157082200|FG002|Overall Study|Protocol Violation|0|||
48793582|NCT02962908|157082201|FG003|Overall Study|Protocol Violation|0|||
48793583|NCT02962908|157082198|FG000|Overall Study|Physician Decision|0|||
48793584|NCT02962908|157082199|FG001|Overall Study|Physician Decision|1|||
48793585|NCT02962908|157082200|FG002|Overall Study|Physician Decision|0|||
48793586|NCT02962908|157082201|FG003|Overall Study|Physician Decision|0|||
48793587|NCT03543254|157082202|FG000|Overall Study|Lost to Follow-up|1|||
48793588|NCT00707031|157082203|FG000|Overall Study|Adverse Event|45|||
48793589|NCT00707031|157082204|FG001|Overall Study|Adverse Event|45|||
48793590|NCT00707031|157082203|FG000|Overall Study|Lack of Efficacy|19|||
48793591|NCT00707031|157082204|FG001|Overall Study|Lack of Efficacy|6|||
48793592|NCT00707031|157082203|FG000|Overall Study|Lost to Follow-up|2|||
48793593|NCT00707031|157082204|FG001|Overall Study|Lost to Follow-up|1|||
48793594|NCT00707031|157082203|FG000|Overall Study|Protocol Violation|1|||
48793595|NCT00707031|157082204|FG001|Overall Study|Protocol Violation|0|||
48793596|NCT00707031|157082203|FG000|Overall Study|Withdrawal by Subject|7|||
48793597|NCT00707031|157082204|FG001|Overall Study|Withdrawal by Subject|8|||
48793598|NCT00707031|157082203|FG000|Overall Study|Poor Compliance to Protocol|7|||
48793599|NCT00707031|157082204|FG001|Overall Study|Poor Compliance to Protocol|13|||
48793600|NCT00707031|157082203|FG000|Overall Study|Familial or Personal Reasons|12|||
48793601|NCT00707031|157082204|FG001|Overall Study|Familial or Personal Reasons|15|||
48793602|NCT00707031|157082203|FG000|Overall Study|Serious Noncompliance|2|||
48793603|NCT00707031|157082204|FG001|Overall Study|Serious Noncompliance|3|||
48793604|NCT00707031|157082203|FG000|Overall Study|Sponsor Decision|9|||
48793605|NCT00707031|157082204|FG001|Overall Study|Sponsor Decision|8|||
48793606|NCT03221387|157082205|FG000|Overall Study|Lost to Follow-up|1|||
48793607|NCT03221387|157082205|FG000|Overall Study|Lung transplant|1|||
48793608|NCT02085252|157082206|FG000|Overall Study|Withdrawal of Consent|1|||
48793609|NCT02085252|157082207|FG001|Overall Study|Withdrawal of Consent|0|||
48793610|NCT02085252|157082206|FG000|Overall Study|Adverse Event|0|||
48793611|NCT02085252|157082207|FG001|Overall Study|Adverse Event|1|||
48878238|NCT00478205|157392170|FG000|Overall Study|Lack of Efficacy|1|||
48878239|NCT00478205|157392171|FG001|Overall Study|Lack of Efficacy|0|||
48878240|NCT00478205|157392170|FG000|Overall Study|Other|24|||
48878241|NCT00478205|157392171|FG001|Overall Study|Other|12|||
48878242|NCT02287233|157392172|FG000|Overall Study|Adverse Event Not Related to Progression|1|||
48878243|NCT02287233|157392173|FG001|Overall Study|Adverse Event Not Related to Progression|2|||
48878244|NCT02287233|157392174|FG002|Overall Study|Adverse Event Not Related to Progression|10|||
48878245|NCT02287233|157392172|FG000|Overall Study|Adverse Event Related to Progression|0|||
48878246|NCT02287233|157392173|FG001|Overall Study|Adverse Event Related to Progression|2|||
48878247|NCT02287233|157392174|FG002|Overall Study|Adverse Event Related to Progression|8|||
48878248|NCT02287233|157392172|FG000|Overall Study|Physician Decision|1|||
48878249|NCT02287233|157392173|FG001|Overall Study|Physician Decision|2|||
48878250|NCT02287233|157392174|FG002|Overall Study|Physician Decision|4|||
48793612|NCT02085252|157082206|FG000|Overall Study|Discontinuation Due to Patient Decision|0|||
48878251|NCT02287233|157392172|FG000|Overall Study|Progressive Disease with Death|0|||
48878252|NCT02287233|157392173|FG001|Overall Study|Progressive Disease with Death|0|||
48878253|NCT02287233|157392174|FG002|Overall Study|Progressive Disease with Death|10|||
48878254|NCT02287233|157392172|FG000|Overall Study|Progressive Disease Without Death|2|||
48878255|NCT02287233|157392173|FG001|Overall Study|Progressive Disease Without Death|3|||
48878256|NCT02287233|157392174|FG002|Overall Study|Progressive Disease Without Death|20|||
48878257|NCT02287233|157392172|FG000|Overall Study|Withdrawal by Subject|1|||
48878258|NCT02287233|157392173|FG001|Overall Study|Withdrawal by Subject|1|||
48878259|NCT02287233|157392174|FG002|Overall Study|Withdrawal by Subject|7|||
48878260|NCT02287233|157392172|FG000|Overall Study|Other|3|||
48878261|NCT02287233|157392173|FG001|Overall Study|Other|0|||
48878262|NCT02287233|157392174|FG002|Overall Study|Other|15|||
48878263|NCT02287233|157392172|FG000|Overall Study|Did Not Receive Treatment|0|||
48793613|NCT02085252|157082207|FG001|Overall Study|Discontinuation Due to Patient Decision|1|||
48793614|NCT02085252|157082206|FG000|Overall Study|Reason Not Specified|0|||
48793615|NCT02085252|157082207|FG001|Overall Study|Reason Not Specified|1|||
48793616|NCT02085252|157082206|FG000|Overall Study|Reason Unknown|0|||
48793617|NCT02085252|157082207|FG001|Overall Study|Reason Unknown|1|||
48793618|NCT04068831|157082208|FG000|Overall Study|Disease Progression|10|||
48793619|NCT04068831|157082209|FG001|Overall Study|Disease Progression|8|||
48793620|NCT00677365|157082212|FG000|Overall Study|Adverse Event|2|||
48793621|NCT00677365|157082213|FG001|Overall Study|Adverse Event|1|||
48793622|NCT00677365|157082214|FG002|Overall Study|Adverse Event|1|||
48793623|NCT00677365|157082215|FG003|Overall Study|Adverse Event|2|||
48793624|NCT00677365|157082212|FG000|Overall Study|Withdrawal by Subject|0|||
48793625|NCT00677365|157082213|FG001|Overall Study|Withdrawal by Subject|0|||
48793626|NCT00677365|157082214|FG002|Overall Study|Withdrawal by Subject|1|||
48793627|NCT00677365|157082215|FG003|Overall Study|Withdrawal by Subject|0|||
48793628|NCT00677365|157082212|FG000|Overall Study|Other reason|0|||
48793629|NCT00677365|157082213|FG001|Overall Study|Other reason|0|||
48793630|NCT00677365|157082214|FG002|Overall Study|Other reason|0|||
48793631|NCT00677365|157082215|FG003|Overall Study|Other reason|1|||
48793632|NCT02858895|157082218|FG000|Overall Study|Disease progression|31|||
48793633|NCT02858895|157082218|FG000|Overall Study|Death|2|||
48793634|NCT02858895|157082218|FG000|Overall Study|Adverse Event|1|||
48793635|NCT02858895|157082218|FG000|Overall Study|Withdrawal by Subject|3|||
48793636|NCT02858895|157082218|FG000|Overall Study|hospice,|1|||
48793637|NCT02858895|157082218|FG000|Overall Study|did not receive drug due to catheters misplaced|1|||
48793638|NCT05073133|157082225|FG000|Overall Study|Death|2|||
48793639|NCT04795245|157082230|FG000|Overall Study|Unkown reason|7|||
48793640|NCT04795245|157082230|FG000|Overall Study|Death|17|||
48793641|NCT04795245|157082230|FG000|Overall Study|Other than listed|19|||
48793642|NCT04795245|157082230|FG000|Overall Study|Adverse Event|143|||
48793643|NCT04795245|157082230|FG000|Overall Study|Progressive disease|512|||
48793644|NCT04795245|157082230|FG000|Overall Study|Unknown if patients were still on treatment at end of observation period|22|||
48793645|NCT04866017|157082231|FG000|Overall Study|Study Terminated by Sponsor|13|||
48793646|NCT04866017|157082232|FG001|Overall Study|Study Terminated by Sponsor|14|||
48793647|NCT04866017|157082233|FG002|Overall Study|Study Terminated by Sponsor|13|||
48793648|NCT04866017|157082231|FG000|Overall Study|Death|8|||
48793649|NCT04866017|157082232|FG001|Overall Study|Death|4|||
48793650|NCT04866017|157082233|FG002|Overall Study|Death|8|||
48793651|NCT04866017|157082231|FG000|Overall Study|Withdrawal by Subject|1|||
48793652|NCT04866017|157082232|FG001|Overall Study|Withdrawal by Subject|0|||
48793653|NCT04866017|157082233|FG002|Overall Study|Withdrawal by Subject|1|||
48793654|NCT04866017|157082231|FG000|Overall Study|Physician Decision|0|||
48793655|NCT04866017|157082232|FG001|Overall Study|Physician Decision|1|||
48793656|NCT04866017|157082233|FG002|Overall Study|Physician Decision|0|||
48793657|NCT04046549|157082234|FG000|Overall Study|Adverse Event|1|||
48793658|NCT04046549|157082234|FG000|Overall Study|Physician Decision|1|||
48793659|NCT04046549|157082234|FG000|Overall Study|Withdrawal by Subject|3|||
48793660|NCT04046549|157082234|FG000|Overall Study|Other, Not Specified|5|||
48793661|NCT03141359|157082235|FG000|Overall Study|Death|32|||
48793662|NCT03141359|157082235|FG000|Overall Study|Still On Study (in follow up)|29|||
48793663|NCT01261611|157083329|FG000|Treatment Cycle 1|Withdrawal by Subject|3|||
48793664|NCT01261611|157083330|FG001|Treatment Cycle 1|Withdrawal by Subject|2|||
48793665|NCT01261611|157083331|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
48793666|NCT01261611|157083329|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
48793667|NCT01261611|157083330|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
48793668|NCT01261611|157083331|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
48793669|NCT01261611|157083329|FG000|Treatment Cycle 1|Adverse Event|0|||
48793670|NCT01261611|157083330|FG001|Treatment Cycle 1|Adverse Event|1|||
48793671|NCT01261611|157083331|FG002|Treatment Cycle 1|Adverse Event|0|||
48793672|NCT01261611|157083329|FG000|Treatment Cycle 1|Protocol Violation|0|||
48793673|NCT01261611|157083330|FG001|Treatment Cycle 1|Protocol Violation|0|||
49032589|NCT00323882|157953496|FG003|Overall Study|Disease Progression|5|||
48793674|NCT01261611|157083331|FG002|Treatment Cycle 1|Protocol Violation|2|||
48793675|NCT01261611|157083329|FG000|Treatment Cycle 2|Completed study|4|||
48793676|NCT01261611|157083330|FG001|Treatment Cycle 2|Completed study|0|||
48793677|NCT01261611|157083331|FG002|Treatment Cycle 2|Completed study|0|||
48793678|NCT01261611|157083329|FG000|Treatment Cycle 2|Withdrawal by Subject|4|||
48793679|NCT01261611|157083330|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
48793680|NCT01261611|157083331|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
48793681|NCT01261611|157083329|FG000|Treatment Cycle 2|Adverse Event|1|||
48793682|NCT01261611|157083330|FG001|Treatment Cycle 2|Adverse Event|0|||
49032590|NCT00323882|157953497|FG004|Overall Study|Disease Progression|22|||
48793683|NCT01261611|157083331|FG002|Treatment Cycle 2|Adverse Event|0|||
48793684|NCT01261611|157083329|FG000|Treatment Cycle 2|Protocol Violation|2|||
48793685|NCT01261611|157083330|FG001|Treatment Cycle 2|Protocol Violation|0|||
48793686|NCT01261611|157083331|FG002|Treatment Cycle 2|Protocol Violation|0|||
49032591|NCT00323882|157953493|FG000|Overall Study|Death|0|||
49032592|NCT00323882|157953494|FG001|Overall Study|Death|1|||
48793687|NCT01261611|157083329|FG000|Treatment Cycle 2|Not otherwise specified|2|||
49032593|NCT00323882|157953495|FG002|Overall Study|Death|1|||
48793688|NCT01261611|157083330|FG001|Treatment Cycle 2|Not otherwise specified|0|||
48793689|NCT01261611|157083331|FG002|Treatment Cycle 2|Not otherwise specified|0|||
48793690|NCT01261611|157083329|FG000|Treatment Cycle 3|Completed study|24|||
48793691|NCT01261611|157083330|FG001|Treatment Cycle 3|Completed study|0|||
48793692|NCT01261611|157083331|FG002|Treatment Cycle 3|Completed study|0|||
48793693|NCT01261611|157083329|FG000|Treatment Cycle 3|Withdrawal by Subject|4|||
48793694|NCT01261611|157083330|FG001|Treatment Cycle 3|Withdrawal by Subject|0|||
48793695|NCT01261611|157083331|FG002|Treatment Cycle 3|Withdrawal by Subject|0|||
48793696|NCT01261611|157083329|FG000|Treatment Cycle 3|Adverse Event|1|||
48793697|NCT01261611|157083330|FG001|Treatment Cycle 3|Adverse Event|0|||
48793698|NCT01261611|157083331|FG002|Treatment Cycle 3|Adverse Event|0|||
48878264|NCT02287233|157392173|FG001|Overall Study|Did Not Receive Treatment|0|||
48878265|NCT02287233|157392174|FG002|Overall Study|Did Not Receive Treatment|2|||
48793699|NCT01261611|157083329|FG000|Treatment Cycle 3|Lost to Follow-up|1|||
48793700|NCT01261611|157083330|FG001|Treatment Cycle 3|Lost to Follow-up|0|||
48793701|NCT01261611|157083331|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
48793702|NCT01261611|157083329|FG000|Treatment Cycle 4|Completed study|87|||
48793703|NCT01261611|157083330|FG001|Treatment Cycle 4|Completed study|0|||
48793704|NCT01261611|157083331|FG002|Treatment Cycle 4|Completed study|0|||
48793705|NCT01261611|157083329|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
48793706|NCT01261611|157083330|FG001|Treatment Cycle 4|Withdrawal by Subject|0|||
48793707|NCT01261611|157083331|FG002|Treatment Cycle 4|Withdrawal by Subject|0|||
48793708|NCT01261611|157083329|FG000|Treatment Cycle 4|Adverse Event|1|||
48793709|NCT01261611|157083330|FG001|Treatment Cycle 4|Adverse Event|0|||
48793710|NCT01261611|157083331|FG002|Treatment Cycle 4|Adverse Event|0|||
48793711|NCT01261611|157083329|FG000|Treatment Cycle 4|Lost to Follow-up|2|||
48793712|NCT01261611|157083330|FG001|Treatment Cycle 4|Lost to Follow-up|0|||
48793713|NCT01261611|157083331|FG002|Treatment Cycle 4|Lost to Follow-up|0|||
48793714|NCT01261611|157083329|FG000|Treatment Cycle 4|Not otherwise specified|3|||
48793715|NCT01261611|157083330|FG001|Treatment Cycle 4|Not otherwise specified|0|||
48793716|NCT01261611|157083331|FG002|Treatment Cycle 4|Not otherwise specified|0|||
48793717|NCT01261611|157083329|FG000|Treatment Cycle 5|Withdrawal by Subject|1|||
48793718|NCT01261611|157083330|FG001|Treatment Cycle 5|Withdrawal by Subject|0|||
48793719|NCT01261611|157083331|FG002|Treatment Cycle 5|Withdrawal by Subject|0|||
48793720|NCT01261611|157083329|FG000|Treatment Cycle 5|Adverse Event|1|||
48793721|NCT01261611|157083330|FG001|Treatment Cycle 5|Adverse Event|0|||
48793722|NCT01261611|157083331|FG002|Treatment Cycle 5|Adverse Event|0|||
48793723|NCT01261611|157083329|FG000|Treatment Cycle 5|Lost to Follow-up|1|||
48793724|NCT01261611|157083330|FG001|Treatment Cycle 5|Lost to Follow-up|0|||
48793725|NCT01261611|157083331|FG002|Treatment Cycle 5|Lost to Follow-up|0|||
48793726|NCT02621931|157083335|FG000|Overall Study|Death|0|||
48793727|NCT02621931|157083336|FG001|Overall Study|Death|1|||
48793728|NCT02621931|157083337|FG002|Overall Study|Death|0|||
48793729|NCT02621931|157083335|FG000|Overall Study|Adverse Event|8|||
48793730|NCT02621931|157083336|FG001|Overall Study|Adverse Event|5|||
48793731|NCT02621931|157083337|FG002|Overall Study|Adverse Event|7|||
48793732|NCT02621931|157083335|FG000|Overall Study|Withdrawal by Subject|12|||
48793733|NCT02621931|157083336|FG001|Overall Study|Withdrawal by Subject|10|||
48793734|NCT02621931|157083337|FG002|Overall Study|Withdrawal by Subject|11|||
48793735|NCT02621931|157083335|FG000|Overall Study|Protocol Violation|2|||
48793736|NCT02621931|157083336|FG001|Overall Study|Protocol Violation|2|||
48793737|NCT02621931|157083337|FG002|Overall Study|Protocol Violation|2|||
48793738|NCT02621931|157083335|FG000|Overall Study|Pregnancy|2|||
48793739|NCT02621931|157083336|FG001|Overall Study|Pregnancy|0|||
48793740|NCT02621931|157083337|FG002|Overall Study|Pregnancy|0|||
48793741|NCT02621931|157083335|FG000|Overall Study|Noncompliance to study procedures|0|||
48793742|NCT02621931|157083336|FG001|Overall Study|Noncompliance to study procedures|1|||
48793743|NCT02621931|157083337|FG002|Overall Study|Noncompliance to study procedures|2|||
48793744|NCT02621931|157083335|FG000|Overall Study|Lost to Follow-up|8|||
48793745|NCT02621931|157083336|FG001|Overall Study|Lost to Follow-up|7|||
48793746|NCT02621931|157083337|FG002|Overall Study|Lost to Follow-up|10|||
48793747|NCT02621931|157083335|FG000|Overall Study|Lack of Efficacy|0|||
48793748|NCT02621931|157083336|FG001|Overall Study|Lack of Efficacy|0|||
48878266|NCT03178045|157392177|FG000|Overall Study|Withdrawal by Subject|5|||
48793749|NCT02621931|157083337|FG002|Overall Study|Lack of Efficacy|1|||
48793750|NCT02621931|157083335|FG000|Overall Study|Other|1|||
48793751|NCT02621931|157083336|FG001|Overall Study|Other|1|||
48793752|NCT02621931|157083337|FG002|Overall Study|Other|3|||
48793753|NCT00074282|157083338|FG000|Step 1|Adverse Event|32|||
48793754|NCT00074282|157083339|FG001|Step 1|Adverse Event|0|||
48793755|NCT00074282|157083340|FG002|Step 1|Adverse Event|0|||
48793756|NCT00074282|157083338|FG000|Step 1|Death|6|||
48793757|NCT00074282|157083339|FG001|Step 1|Death|0|||
48793758|NCT00074282|157083340|FG002|Step 1|Death|0|||
48793759|NCT00074282|157083338|FG000|Step 1|Withdrawal by Subject|7|||
48793760|NCT00074282|157083339|FG001|Step 1|Withdrawal by Subject|0|||
48793761|NCT00074282|157083340|FG002|Step 1|Withdrawal by Subject|0|||
48793762|NCT00074282|157083338|FG000|Step 1|Disease progression|2|||
48793763|NCT00074282|157083339|FG001|Step 1|Disease progression|0|||
48793764|NCT00074282|157083340|FG002|Step 1|Disease progression|0|||
49032594|NCT00323882|157953496|FG003|Overall Study|Death|0|||
49032595|NCT00323882|157953497|FG004|Overall Study|Death|5|||
49032596|NCT00323882|157953493|FG000|Overall Study|Lost to Follow-up|0|||
49032597|NCT00323882|157953494|FG001|Overall Study|Lost to Follow-up|0|||
49032598|NCT00323882|157953495|FG002|Overall Study|Lost to Follow-up|1|||
49032599|NCT00323882|157953496|FG003|Overall Study|Lost to Follow-up|0|||
49032600|NCT00323882|157953497|FG004|Overall Study|Lost to Follow-up|1|||
49032601|NCT00323882|157953493|FG000|Overall Study|Other|0|||
49032602|NCT00323882|157953494|FG001|Overall Study|Other|0|||
49032603|NCT00323882|157953495|FG002|Overall Study|Other|0|||
49032604|NCT00323882|157953496|FG003|Overall Study|Other|1|||
49032605|NCT00323882|157953497|FG004|Overall Study|Other|1|||
49032606|NCT03649477|157953498|FG000|Overall Study|Adverse Event|2|||
49032607|NCT03649477|157953499|FG001|Overall Study|Adverse Event|0|||
49032608|NCT03649477|157953500|FG002|Overall Study|Adverse Event|0|||
49032609|NCT01456221|157953501|FG000|Overall Study|Withdrawal by Subject|56|||
49032610|NCT01456221|157953502|FG001|Overall Study|Withdrawal by Subject|49|||
49032611|NCT01456221|157953501|FG000|Overall Study|Lost to Follow-up|1|||
49032612|NCT01456221|157953502|FG001|Overall Study|Lost to Follow-up|4|||
49032613|NCT01456221|157953501|FG000|Overall Study|Received medication|3|||
49032614|NCT01456221|157953502|FG001|Overall Study|Received medication|2|||
49032615|NCT01456221|157953501|FG000|Overall Study|Incomplete data|4|||
49032616|NCT01456221|157953502|FG001|Overall Study|Incomplete data|2|||
49032617|NCT02409355|157953503|FG000|Overall Study|Withdrawal by Subject|1|||
49032618|NCT02409355|157953504|FG001|Overall Study|Withdrawal by Subject|0|||
49032619|NCT02409355|157953503|FG000|Overall Study|Death|1|||
49032620|NCT02409355|157953504|FG001|Overall Study|Death|1|||
49032621|NCT02409355|157953503|FG000|Overall Study|Study terminated by Sponsor|2|||
49032622|NCT02409355|157953504|FG001|Overall Study|Study terminated by Sponsor|3|||
49032623|NCT03880266|157953507|FG000|Overall Study|Withdrawal by Subject|0|||
49032624|NCT03880266|157953508|FG001|Overall Study|Withdrawal by Subject|1|||
49032625|NCT03880266|157953509|FG002|Overall Study|Withdrawal by Subject|1|||
49032626|NCT03880266|157953510|FG003|Overall Study|Withdrawal by Subject|0|||
49032627|NCT03880266|157953511|FG004|Overall Study|Withdrawal by Subject|0|||
49032628|NCT03880266|157953512|FG005|Overall Study|Withdrawal by Subject|0|||
49032629|NCT03880266|157953513|FG006|Overall Study|Withdrawal by Subject|0|||
49032630|NCT03880266|157953514|FG007|Overall Study|Withdrawal by Subject|0|||
49032631|NCT01279486|157953515|FG000|Overall Study|Lost to Follow-up|1|||
49032632|NCT02178787|157953520|FG000|Overall Study|Lost to Follow-up|1|||
49032633|NCT02178787|157953521|FG001|Overall Study|Lost to Follow-up|0|||
49032634|NCT02178787|157953520|FG000|Overall Study|Withdrawal by Subject|0|||
49032635|NCT02178787|157953521|FG001|Overall Study|Withdrawal by Subject|2|||
49032636|NCT02178787|157953520|FG000|Overall Study|No TCD window|3|||
49032637|NCT02178787|157953521|FG001|Overall Study|No TCD window|7|||
49032638|NCT02178787|157953520|FG000|Overall Study|Physician Decision|1|||
49032639|NCT02178787|157953521|FG001|Overall Study|Physician Decision|0|||
49032640|NCT01577381|157953522|FG000|Overall Study|Discontinued|2|||
49032641|NCT01577381|157953523|FG001|Overall Study|Discontinued|1|||
49032642|NCT01577381|157953524|FG002|Overall Study|Discontinued|2|||
49032643|NCT01577381|157953525|FG003|Overall Study|Discontinued|2|||
49032644|NCT01577381|157953522|FG000|Overall Study|Ongoing at Date of Cut-Off|0|||
49032645|NCT01577381|157953523|FG001|Overall Study|Ongoing at Date of Cut-Off|2|||
49032646|NCT01577381|157953524|FG002|Overall Study|Ongoing at Date of Cut-Off|1|||
49032647|NCT01577381|157953525|FG003|Overall Study|Ongoing at Date of Cut-Off|0|||
49032648|NCT04175808|157955523|FG000|Part A|Miscellaneous|2|||
49032649|NCT04175808|157955524|FG001|Part A|Miscellaneous|0|||
49032650|NCT04175808|157955525|FG002|Part A|Miscellaneous|0|||
49032651|NCT04175808|157955526|FG003|Part A|Miscellaneous|0|||
49032652|NCT04175808|157955527|FG004|Part A|Miscellaneous|0|||
49032653|NCT04175808|157955528|FG005|Part A|Miscellaneous|0|||
49032654|NCT04175808|157955529|FG006|Part A|Miscellaneous|0|||
49032655|NCT01066143|157955530|FG000|Overall Study|ineligible for the study|8|||
49032656|NCT00420303|157955531|FG000|Overall Study|Serious Adverse Event|1|||
49032657|NCT00420303|157955532|FG001|Overall Study|Serious Adverse Event|0|||
49032658|NCT00420303|157955531|FG000|Overall Study|Lack of Efficacy|0|||
49032659|NCT00420303|157955532|FG001|Overall Study|Lack of Efficacy|3|||
49032660|NCT00420303|157955531|FG000|Overall Study|Physician Decision|0|||
49032661|NCT00420303|157955532|FG001|Overall Study|Physician Decision|1|||
49032662|NCT01294787|157955533|FG000|Period 1|Adverse Event|0|||
49032663|NCT01294787|157955534|FG001|Period 1|Adverse Event|0|||
49032664|NCT01294787|157955535|FG002|Period 1|Adverse Event|0|||
49032665|NCT01294787|157955536|FG003|Period 1|Adverse Event|0|||
49032666|NCT01294787|157955537|FG004|Period 1|Adverse Event|1|||
49032667|NCT01294787|157955538|FG005|Period 1|Adverse Event|0|||
49032668|NCT01294787|157955533|FG000|Period 1|Withdrawal by Subject|0|||
49032669|NCT01294787|157955534|FG001|Period 1|Withdrawal by Subject|0|||
49032670|NCT01294787|157955535|FG002|Period 1|Withdrawal by Subject|0|||
49032671|NCT01294787|157955536|FG003|Period 1|Withdrawal by Subject|1|||
49032672|NCT01294787|157955537|FG004|Period 1|Withdrawal by Subject|1|||
49032673|NCT01294787|157955538|FG005|Period 1|Withdrawal by Subject|1|||
49032674|NCT01294787|157955533|FG000|Period 1|Administrative problem|0|||
49032675|NCT01294787|157955534|FG001|Period 1|Administrative problem|0|||
49032676|NCT01294787|157955535|FG002|Period 1|Administrative problem|1|||
49032677|NCT01294787|157955536|FG003|Period 1|Administrative problem|0|||
49032678|NCT01294787|157955537|FG004|Period 1|Administrative problem|0|||
49032679|NCT01294787|157955538|FG005|Period 1|Administrative problem|1|||
49032680|NCT01294787|157955533|FG000|Period 2|Adverse Event|0|||
49032681|NCT01294787|157955534|FG001|Period 2|Adverse Event|3|||
49032682|NCT01294787|157955535|FG002|Period 2|Adverse Event|0|||
49032683|NCT01294787|157955536|FG003|Period 2|Adverse Event|1|||
49032684|NCT01294787|157955537|FG004|Period 2|Adverse Event|0|||
49032685|NCT01294787|157955538|FG005|Period 2|Adverse Event|0|||
49032686|NCT01294787|157955533|FG000|Period 2|No longer needs study drug|0|||
49032687|NCT01294787|157955534|FG001|Period 2|No longer needs study drug|0|||
49032688|NCT01294787|157955535|FG002|Period 2|No longer needs study drug|0|||
49032689|NCT01294787|157955536|FG003|Period 2|No longer needs study drug|1|||
49032690|NCT01294787|157955537|FG004|Period 2|No longer needs study drug|0|||
49032691|NCT01294787|157955538|FG005|Period 2|No longer needs study drug|0|||
49032692|NCT01294787|157955533|FG000|Period 3|Adverse Event|0|||
49032693|NCT01294787|157955534|FG001|Period 3|Adverse Event|0|||
49032694|NCT01294787|157955535|FG002|Period 3|Adverse Event|0|||
49032695|NCT01294787|157955536|FG003|Period 3|Adverse Event|0|||
49032696|NCT01294787|157955537|FG004|Period 3|Adverse Event|1|||
49032697|NCT01294787|157955538|FG005|Period 3|Adverse Event|0|||
48793765|NCT00074282|157083338|FG000|Step 1|Alternative therapy|2|||
48793766|NCT00074282|157083339|FG001|Step 1|Alternative therapy|0|||
48793767|NCT00074282|157083340|FG002|Step 1|Alternative therapy|0|||
48793768|NCT00074282|157083338|FG000|Step 1|Other complicating disease|2|||
48793769|NCT00074282|157083339|FG001|Step 1|Other complicating disease|0|||
48793770|NCT00074282|157083340|FG002|Step 1|Other complicating disease|0|||
48793771|NCT00074282|157083338|FG000|Step 1|Physician Decision|1|||
48793772|NCT00074282|157083339|FG001|Step 1|Physician Decision|0|||
49032698|NCT05017480|157955539|FG000|Stage 1 Study|Withdrawal by Subject|8|||
49032699|NCT05017480|157955540|FG001|Stage 1 Study|Withdrawal by Subject|6|||
49032700|NCT05017480|157955541|FG002|Stage 1 Study|Withdrawal by Subject|0|||
49032701|NCT05017480|157955542|FG003|Stage 1 Study|Withdrawal by Subject|0|||
49032702|NCT05017480|157955543|FG004|Stage 1 Study|Withdrawal by Subject|0|||
49032703|NCT05017480|157955539|FG000|Stage 1 Study|Adverse Event|1|||
49032704|NCT05017480|157955540|FG001|Stage 1 Study|Adverse Event|1|||
49032705|NCT05017480|157955541|FG002|Stage 1 Study|Adverse Event|0|||
48793773|NCT00074282|157083340|FG002|Step 1|Physician Decision|0|||
48793774|NCT00074282|157083338|FG000|Step 1|Ineligible|4|||
49032706|NCT05017480|157955542|FG003|Stage 1 Study|Adverse Event|0|||
49032707|NCT05017480|157955543|FG004|Stage 1 Study|Adverse Event|0|||
49032708|NCT05017480|157955539|FG000|Stage 1 Study|Poor Compliance|1|||
49032709|NCT05017480|157955540|FG001|Stage 1 Study|Poor Compliance|1|||
49032710|NCT05017480|157955541|FG002|Stage 1 Study|Poor Compliance|0|||
49032711|NCT05017480|157955542|FG003|Stage 1 Study|Poor Compliance|0|||
49032712|NCT05017480|157955543|FG004|Stage 1 Study|Poor Compliance|0|||
48793775|NCT00074282|157083339|FG001|Step 1|Ineligible|0|||
48793776|NCT00074282|157083340|FG002|Step 1|Ineligible|0|||
48793777|NCT00074282|157083338|FG000|Step 1|Never started treatment|2|||
48793778|NCT00074282|157083339|FG001|Step 1|Never started treatment|0|||
48793779|NCT00074282|157083340|FG002|Step 1|Never started treatment|0|||
48793780|NCT00074282|157083338|FG000|Step 2|Adverse Event|0|||
48793781|NCT00074282|157083339|FG001|Step 2|Adverse Event|2|||
48793782|NCT00074282|157083340|FG002|Step 2|Adverse Event|12|||
48793783|NCT00074282|157083338|FG000|Step 2|Disease progression|0|||
48793784|NCT00074282|157083339|FG001|Step 2|Disease progression|0|||
48793785|NCT00074282|157083340|FG002|Step 2|Disease progression|5|||
48793786|NCT00074282|157083338|FG000|Step 2|Death|0|||
48793787|NCT00074282|157083339|FG001|Step 2|Death|0|||
48793788|NCT00074282|157083340|FG002|Step 2|Death|3|||
48793789|NCT00074282|157083338|FG000|Step 2|Withdrawal by Subject|0|||
48793790|NCT00074282|157083339|FG001|Step 2|Withdrawal by Subject|0|||
48793791|NCT00074282|157083340|FG002|Step 2|Withdrawal by Subject|2|||
48793792|NCT00074282|157083338|FG000|Step 2|Physician Decision|0|||
49032713|NCT05017480|157955539|FG000|Stage 1 Study|Physician Decision|0|||
49032714|NCT05017480|157955540|FG001|Stage 1 Study|Physician Decision|1|||
49032715|NCT05017480|157955541|FG002|Stage 1 Study|Physician Decision|0|||
49032716|NCT05017480|157955542|FG003|Stage 1 Study|Physician Decision|0|||
49032717|NCT05017480|157955543|FG004|Stage 1 Study|Physician Decision|0|||
49032718|NCT05017480|157955539|FG000|Stage 2 Study|Withdrawal by Subject|0|||
49032719|NCT05017480|157955540|FG001|Stage 2 Study|Withdrawal by Subject|0|||
49032720|NCT05017480|157955541|FG002|Stage 2 Study|Withdrawal by Subject|6|||
49032721|NCT05017480|157955542|FG003|Stage 2 Study|Withdrawal by Subject|9|||
49032722|NCT05017480|157955543|FG004|Stage 2 Study|Withdrawal by Subject|11|||
49032723|NCT05017480|157955539|FG000|Stage 2 Study|Lost to Follow-up|0|||
48793793|NCT00074282|157083339|FG001|Step 2|Physician Decision|0|||
48793794|NCT00074282|157083340|FG002|Step 2|Physician Decision|1|||
48793795|NCT00074282|157083338|FG000|Step 2|Ineligible|0|||
48793796|NCT00074282|157083339|FG001|Step 2|Ineligible|0|||
48793797|NCT00074282|157083340|FG002|Step 2|Ineligible|1|||
49032724|NCT05017480|157955540|FG001|Stage 2 Study|Lost to Follow-up|0|||
49032725|NCT05017480|157955541|FG002|Stage 2 Study|Lost to Follow-up|0|||
49032726|NCT05017480|157955542|FG003|Stage 2 Study|Lost to Follow-up|2|||
49032727|NCT05017480|157955543|FG004|Stage 2 Study|Lost to Follow-up|1|||
49032728|NCT05017480|157955539|FG000|Stage 2 Study|Adverse Event|0|||
49032729|NCT05017480|157955540|FG001|Stage 2 Study|Adverse Event|0|||
49032730|NCT05017480|157955541|FG002|Stage 2 Study|Adverse Event|0|||
49032731|NCT05017480|157955542|FG003|Stage 2 Study|Adverse Event|1|||
49032732|NCT05017480|157955543|FG004|Stage 2 Study|Adverse Event|0|||
48793798|NCT02811861|157083345|FG000|Overall Study|Radiological Disease Progression|123|||
48793799|NCT02811861|157083346|FG001|Overall Study|Radiological Disease Progression|97|||
48793800|NCT02811861|157083347|FG002|Overall Study|Radiological Disease Progression|174|||
48793801|NCT02811861|157083345|FG000|Overall Study|Clinical Disease Progression|20|||
48793802|NCT02811861|157083346|FG001|Overall Study|Clinical Disease Progression|19|||
48793803|NCT02811861|157083347|FG002|Overall Study|Clinical Disease Progression|22|||
48793804|NCT02811861|157083345|FG000|Overall Study|Adverse Event|63|||
48793805|NCT02811861|157083346|FG001|Overall Study|Adverse Event|60|||
48793806|NCT02811861|157083347|FG002|Overall Study|Adverse Event|41|||
48793807|NCT02811861|157083345|FG000|Overall Study|Lost to Follow-up|0|||
48793808|NCT02811861|157083346|FG001|Overall Study|Lost to Follow-up|0|||
48793809|NCT02811861|157083347|FG002|Overall Study|Lost to Follow-up|1|||
48793810|NCT02811861|157083345|FG000|Overall Study|Subject Choice|29|||
48793811|NCT02811861|157083346|FG001|Overall Study|Subject Choice|17|||
48793812|NCT02811861|157083347|FG002|Overall Study|Subject Choice|23|||
48793813|NCT02811861|157083345|FG000|Overall Study|Withdrawal by Subject|4|||
48793814|NCT02811861|157083346|FG001|Overall Study|Withdrawal by Subject|4|||
48793815|NCT02811861|157083347|FG002|Overall Study|Withdrawal by Subject|9|||
48793816|NCT02811861|157083345|FG000|Overall Study|Other|4|||
48793817|NCT02811861|157083346|FG001|Overall Study|Other|13|||
48793818|NCT02811861|157083347|FG002|Overall Study|Other|3|||
48793819|NCT02811861|157083345|FG000|Overall Study|Treatment Ongoing at Cutoff Date|112|||
48793820|NCT02811861|157083346|FG001|Overall Study|Treatment Ongoing at Cutoff Date|142|||
48793821|NCT02811861|157083347|FG002|Overall Study|Treatment Ongoing at Cutoff Date|67|||
48793822|NCT02811861|157083345|FG000|Overall Study|Randomized but not treated|2|||
48793823|NCT02811861|157083346|FG001|Overall Study|Randomized but not treated|3|||
48793824|NCT02811861|157083347|FG002|Overall Study|Randomized but not treated|17|||
48793825|NCT02925455|157083348|FG000|Overall Study|Withdrawal by Subject|2|||
48793826|NCT02925455|157083349|FG001|Overall Study|Withdrawal by Subject|0|||
48793827|NCT03461003|157083358|FG000|Overall Study|Lost to Follow-up|2|||
48793828|NCT03461003|157083359|FG001|Overall Study|Lost to Follow-up|2|||
48793829|NCT03461003|157083358|FG000|Overall Study|Withdrawal by Subject|3|||
48793830|NCT03461003|157083359|FG001|Overall Study|Withdrawal by Subject|1|||
48793831|NCT00605293|157083360|FG000|Overall Study|Death|2|||
48793832|NCT00605293|157083361|FG001|Overall Study|Death|1|||
48793833|NCT00605293|157083360|FG000|Overall Study|Insufficient Therapeutic Response|2|||
48793834|NCT00605293|157083361|FG001|Overall Study|Insufficient Therapeutic Response|0|||
48793835|NCT00605293|157083360|FG000|Overall Study|Adverse Event|1|||
48793836|NCT00605293|157083361|FG001|Overall Study|Adverse Event|0|||
48793837|NCT00605293|157083360|FG000|Overall Study|Holidays Dialysis Out|1|||
48793838|NCT00605293|157083361|FG001|Overall Study|Holidays Dialysis Out|0|||
48793839|NCT00605293|157083360|FG000|Overall Study|Blood Transfusion|7|||
48793840|NCT00605293|157083361|FG001|Overall Study|Blood Transfusion|1|||
48793841|NCT00605293|157083360|FG000|Overall Study|Renal Transplantation|3|||
48793842|NCT00605293|157083361|FG001|Overall Study|Renal Transplantation|1|||
48793843|NCT00605293|157083360|FG000|Overall Study|Incorrect Epoetin Beta Administration|1|||
48793844|NCT00605293|157083361|FG001|Overall Study|Incorrect Epoetin Beta Administration|0|||
49032733|NCT05017480|157955539|FG000|Stage 2 Study|COVID-19|0|||
48793845|NCT00605293|157083360|FG000|Overall Study|Dialysis Out of Centre for 3 Months|0|||
48793846|NCT00605293|157083361|FG001|Overall Study|Dialysis Out of Centre for 3 Months|1|||
48793847|NCT00605293|157083360|FG000|Overall Study|Principal Investigator Decision|0|||
48793848|NCT00605293|157083361|FG001|Overall Study|Principal Investigator Decision|1|||
48793849|NCT02119416|157083362|FG000|Overall Study|Protocol Violation|1|||
48793850|NCT02119416|157083363|FG001|Overall Study|Protocol Violation|1|||
48793851|NCT02119416|157083364|FG002|Overall Study|Protocol Violation|1|||
48793852|NCT02119416|157083362|FG000|Overall Study|wrong pubertal stage|1|||
48793853|NCT02119416|157083363|FG001|Overall Study|wrong pubertal stage|0|||
48793854|NCT02119416|157083364|FG002|Overall Study|wrong pubertal stage|1|||
48793855|NCT01692782|157083365|FG000|Overall Study|Adverse Event|12|||
49032734|NCT05017480|157955540|FG001|Stage 2 Study|COVID-19|0|||
48793856|NCT01692782|157083366|FG001|Overall Study|Adverse Event|32|||
48793857|NCT01692782|157083367|FG002|Overall Study|Adverse Event|2|||
48793858|NCT01692782|157083365|FG000|Overall Study|Lack of Efficacy|1|||
49032735|NCT05017480|157955541|FG002|Stage 2 Study|COVID-19|0|||
49032736|NCT05017480|157955542|FG003|Stage 2 Study|COVID-19|1|||
49032737|NCT05017480|157955543|FG004|Stage 2 Study|COVID-19|0|||
48793859|NCT01692782|157083366|FG001|Overall Study|Lack of Efficacy|2|||
48793860|NCT01692782|157083367|FG002|Overall Study|Lack of Efficacy|0|||
48793861|NCT01692782|157083365|FG000|Overall Study|Lost to Follow-up|2|||
49032738|NCT05017480|157955539|FG000|Stage 2 Study|Pregnancy|0|||
48793862|NCT01692782|157083366|FG001|Overall Study|Lost to Follow-up|7|||
48793863|NCT01692782|157083367|FG002|Overall Study|Lost to Follow-up|1|||
48793864|NCT01692782|157083365|FG000|Overall Study|Pregnancy|1|||
48793865|NCT01692782|157083366|FG001|Overall Study|Pregnancy|0|||
48793866|NCT01692782|157083367|FG002|Overall Study|Pregnancy|0|||
48793867|NCT01692782|157083365|FG000|Overall Study|Protocol Violation|1|||
48878267|NCT03178045|157392178|FG001|Overall Study|Withdrawal by Subject|7|||
48878268|NCT03178045|157392177|FG000|Overall Study|Surgery Cancelled/Relocated|34|||
48878269|NCT03178045|157392178|FG001|Overall Study|Surgery Cancelled/Relocated|30|||
48878270|NCT03178045|157392177|FG000|Overall Study|Procedure Ineligible Post-Operatively/Pr|47|||
48878271|NCT03178045|157392178|FG001|Overall Study|Procedure Ineligible Post-Operatively/Pr|46|||
48878272|NCT02344342|157392182|FG000|Overall Study|Industry partner dropped out|11|||
48878273|NCT02344342|157392183|FG001|Overall Study|Industry partner dropped out|9|||
48878274|NCT02344342|157392184|FG002|Overall Study|Industry partner dropped out|14|||
48878275|NCT02344342|157392185|FG003|Overall Study|Industry partner dropped out|10|||
48878276|NCT00798304|157392187|FG000|Overall Study|Adverse Event|0|||
48878277|NCT00798304|157392188|FG001|Overall Study|Adverse Event|1|||
48878278|NCT00798304|157392189|FG002|Overall Study|Adverse Event|1|||
48878279|NCT00798304|157392187|FG000|Overall Study|Discontinuation by Sponsor|14|||
48878280|NCT00798304|157392188|FG001|Overall Study|Discontinuation by Sponsor|21|||
48878281|NCT00798304|157392189|FG002|Overall Study|Discontinuation by Sponsor|9|||
48878282|NCT00658606|157392190|FG000|Overall Study|Adverse Event|2|||
48878283|NCT00658606|157392191|FG001|Overall Study|Adverse Event|1|||
48878284|NCT00658606|157392190|FG000|Overall Study|Lack of Efficacy|6|||
48878285|NCT00658606|157392191|FG001|Overall Study|Lack of Efficacy|3|||
48878286|NCT00658606|157392190|FG000|Overall Study|Lost to Follow-up|1|||
48878287|NCT00658606|157392191|FG001|Overall Study|Lost to Follow-up|0|||
48878288|NCT00658606|157392190|FG000|Overall Study|Withdrawal by Subject|7|||
48878289|NCT00658606|157392191|FG001|Overall Study|Withdrawal by Subject|16|||
48878290|NCT00658606|157392190|FG000|Overall Study|Lack of Compliance|0|||
48878291|NCT00658606|157392191|FG001|Overall Study|Lack of Compliance|3|||
48878292|NCT00856245|157392197|FG000|Overall Study|Was not transplanted|5|||
48878293|NCT03448536|157392198|FG000|Overall Study|Protocol Violation|2|||
48878294|NCT03448536|157392199|FG001|Overall Study|Protocol Violation|0|||
48878295|NCT03448536|157392198|FG000|Overall Study|Pregnancy|1|||
48878296|NCT03448536|157392199|FG001|Overall Study|Pregnancy|0|||
48878297|NCT03448536|157392198|FG000|Overall Study|Withdrawal by Subject|1|||
48878298|NCT03448536|157392199|FG001|Overall Study|Withdrawal by Subject|2|||
48878299|NCT03448536|157392198|FG000|Overall Study|Lost to Follow-up|3|||
48878300|NCT03448536|157392199|FG001|Overall Study|Lost to Follow-up|2|||
48878301|NCT03448536|157392198|FG000|Overall Study|Inadequate pain reporter|1|||
48878302|NCT03448536|157392199|FG001|Overall Study|Inadequate pain reporter|0|||
48878303|NCT03448536|157392198|FG000|Overall Study|Other|3|||
48878304|NCT03448536|157392199|FG001|Overall Study|Other|0|||
48878305|NCT03448536|157392198|FG000|Overall Study|Physician Decision|1|||
48878306|NCT03448536|157392199|FG001|Overall Study|Physician Decision|0|||
48878307|NCT05144009|157392202|FG000|Overall Study|Lost to Follow-up|0|||
48878308|NCT05144009|157392203|FG001|Overall Study|Lost to Follow-up|1|||
48878309|NCT05144009|157392202|FG000|Overall Study|Study Termination by the Sponsor|11|||
48878310|NCT05144009|157392203|FG001|Overall Study|Study Termination by the Sponsor|11|||
48878311|NCT05144009|157392202|FG000|Overall Study|Disease Progression|1|||
48878312|NCT05144009|157392203|FG001|Overall Study|Disease Progression|0|||
48878313|NCT05144009|157392202|FG000|Overall Study|Participant Decision|0|||
48878314|NCT05144009|157392203|FG001|Overall Study|Participant Decision|2|||
49032739|NCT05017480|157955540|FG001|Stage 2 Study|Pregnancy|0|||
49032740|NCT05017480|157955541|FG002|Stage 2 Study|Pregnancy|0|||
48793868|NCT01692782|157083366|FG001|Overall Study|Protocol Violation|0|||
48793869|NCT01692782|157083367|FG002|Overall Study|Protocol Violation|2|||
48793870|NCT01692782|157083365|FG000|Overall Study|Non-complance with study drug|0|||
48793871|NCT01692782|157083366|FG001|Overall Study|Non-complance with study drug|4|||
48793872|NCT01692782|157083367|FG002|Overall Study|Non-complance with study drug|1|||
48793873|NCT01692782|157083365|FG000|Overall Study|Non-compliant with study visits|0|||
48878315|NCT05144009|157392202|FG000|Overall Study|Death|5|||
48878316|NCT05144009|157392203|FG001|Overall Study|Death|10|||
48878317|NCT01447576|157392204|FG000|Overall Study|Lost to Follow-up|52|||
48878318|NCT01447576|157392204|FG000|Overall Study|Adverse Event|127|||
48878319|NCT01447576|157392204|FG000|Overall Study|Participant met withdrawal criteria|40|||
48793874|NCT01692782|157083366|FG001|Overall Study|Non-compliant with study visits|0|||
48793875|NCT01692782|157083367|FG002|Overall Study|Non-compliant with study visits|1|||
48878320|NCT01447576|157392204|FG000|Overall Study|Withdrawal by Subject|100|||
48878321|NCT01447576|157392204|FG000|Overall Study|Protocol deviation|83|||
48878322|NCT01447576|157392204|FG000|Overall Study|Lack of Efficacy|68|||
48878323|NCT01447576|157392204|FG000|Overall Study|Physician Decision|6|||
48793876|NCT01692782|157083365|FG000|Overall Study|SAE not related to study drug|0|||
48793877|NCT01692782|157083366|FG001|Overall Study|SAE not related to study drug|1|||
48878324|NCT00486252|157392209|FG000|Overall Study|Adverse Event|7|||
48878325|NCT00486252|157392209|FG000|Overall Study|Lack of Efficacy|9|||
49032741|NCT05017480|157955542|FG003|Stage 2 Study|Pregnancy|0|||
48878326|NCT00486252|157392209|FG000|Overall Study|Lost to Follow-up|24|||
48878327|NCT00486252|157392209|FG000|Overall Study|Other|18|||
48878328|NCT04463680|157392210|FG000|Overall Study|Not eligible due to laboratory criteria|5|||
48878329|NCT04463680|157392210|FG000|Overall Study|Not eligible due to implant duration of use|1|||
48878330|NCT04463680|157392210|FG000|Overall Study|Withdrawal by Subject|3|||
48878331|NCT01999972|157394278|FG000|Dose Escalation Part|Participant refused further follow-up|1|||
48878332|NCT01999972|157394279|FG001|Dose Escalation Part|Participant refused further follow-up|0|||
48878333|NCT01999972|157394280|FG002|Dose Escalation Part|Participant refused further follow-up|1|||
48878334|NCT01999972|157394281|FG003|Dose Escalation Part|Participant refused further follow-up|1|||
48878335|NCT01999972|157394282|FG004|Dose Escalation Part|Participant refused further follow-up|0|||
48878336|NCT01999972|157394283|FG005|Dose Escalation Part|Participant refused further follow-up|0|||
48878337|NCT01999972|157394278|FG000|Dose Escalation Part|Death|0|||
48878338|NCT01999972|157394279|FG001|Dose Escalation Part|Death|1|||
48878339|NCT01999972|157394280|FG002|Dose Escalation Part|Death|0|||
48878340|NCT01999972|157394281|FG003|Dose Escalation Part|Death|0|||
48878341|NCT01999972|157394282|FG004|Dose Escalation Part|Death|0|||
48878342|NCT01999972|157394283|FG005|Dose Escalation Part|Death|0|||
48878343|NCT01999972|157394278|FG000|Dose Escalation Part|Enrolled but not treated|0|||
48878344|NCT01999972|157394279|FG001|Dose Escalation Part|Enrolled but not treated|0|||
48878345|NCT01999972|157394280|FG002|Dose Escalation Part|Enrolled but not treated|1|||
48878346|NCT01999972|157394281|FG003|Dose Escalation Part|Enrolled but not treated|1|||
48878347|NCT01999972|157394282|FG004|Dose Escalation Part|Enrolled but not treated|0|||
48878348|NCT01999972|157394283|FG005|Dose Escalation Part|Enrolled but not treated|0|||
48878349|NCT01999972|157394278|FG000|Dose Escalation Part|Disease progression|3|||
48878350|NCT01999972|157394279|FG001|Dose Escalation Part|Disease progression|2|||
48878351|NCT01999972|157394280|FG002|Dose Escalation Part|Disease progression|3|||
48878352|NCT01999972|157394281|FG003|Dose Escalation Part|Disease progression|6|||
48878353|NCT01999972|157394282|FG004|Dose Escalation Part|Disease progression|0|||
48878354|NCT01999972|157394283|FG005|Dose Escalation Part|Disease progression|0|||
48878355|NCT01999972|157394278|FG000|Dose Escalation Part|Adverse Event|0|||
48878356|NCT01999972|157394279|FG001|Dose Escalation Part|Adverse Event|0|||
48878357|NCT01999972|157394280|FG002|Dose Escalation Part|Adverse Event|0|||
48878358|NCT01999972|157394281|FG003|Dose Escalation Part|Adverse Event|2|||
48793878|NCT01692782|157083367|FG002|Overall Study|SAE not related to study drug|0|||
48793879|NCT01692782|157083365|FG000|Overall Study|Withdrawal by Subject|3|||
48793880|NCT01692782|157083366|FG001|Overall Study|Withdrawal by Subject|10|||
48793881|NCT01692782|157083367|FG002|Overall Study|Withdrawal by Subject|3|||
48793882|NCT03575325|157083368|FG000|Overall Study|Death|1|||
48793883|NCT02192502|157083369|FG000|Overall Study|Did not receive intervention due to euvolemia|4|||
48793884|NCT02192502|157083370|FG001|Overall Study|Did not receive intervention due to euvolemia|1|||
48793885|NCT02192502|157083369|FG000|Overall Study|did not receive intervention due to circulatory arrest|2|||
48793886|NCT02192502|157083370|FG001|Overall Study|did not receive intervention due to circulatory arrest|0|||
48793887|NCT02192502|157083369|FG000|Overall Study|did not receive intervention due to logistic reasons|1|||
48793888|NCT02192502|157083370|FG001|Overall Study|did not receive intervention due to logistic reasons|0|||
48793889|NCT00696111|157083374|FG000|Overall Study|Withdrawal by Subject|17|||
48793890|NCT04330638|157083375|FG000|Overall Study|Adverse Event|9|||
48793891|NCT04330638|157083376|FG001|Overall Study|Adverse Event|10|||
48793892|NCT04330638|157083377|FG002|Overall Study|Adverse Event|15|||
48793893|NCT04330638|157083378|FG003|Overall Study|Adverse Event|6|||
48793894|NCT04330638|157083379|FG004|Overall Study|Adverse Event|10|||
48793895|NCT04330638|157083380|FG005|Overall Study|Adverse Event|5|||
48793896|NCT04330638|157083375|FG000|Overall Study|Other|2|||
48793897|NCT04330638|157083376|FG001|Overall Study|Other|2|||
48793898|NCT04330638|157083377|FG002|Overall Study|Other|5|||
48793899|NCT04330638|157083378|FG003|Overall Study|Other|1|||
48793900|NCT04330638|157083379|FG004|Overall Study|Other|3|||
48793901|NCT04330638|157083380|FG005|Overall Study|Other|2|||
48793902|NCT04330638|157083375|FG000|Overall Study|Withdrawal by Subject|4|||
48793903|NCT04330638|157083376|FG001|Overall Study|Withdrawal by Subject|0|||
48793904|NCT04330638|157083377|FG002|Overall Study|Withdrawal by Subject|0|||
48793905|NCT04330638|157083378|FG003|Overall Study|Withdrawal by Subject|0|||
48793906|NCT04330638|157083379|FG004|Overall Study|Withdrawal by Subject|0|||
48793907|NCT04330638|157083380|FG005|Overall Study|Withdrawal by Subject|0|||
48793908|NCT04330638|157083375|FG000|Overall Study|Lost to Follow-up|3|||
48793909|NCT04330638|157083376|FG001|Overall Study|Lost to Follow-up|2|||
48793910|NCT04330638|157083377|FG002|Overall Study|Lost to Follow-up|3|||
48793911|NCT04330638|157083378|FG003|Overall Study|Lost to Follow-up|2|||
48878359|NCT01999972|157394282|FG004|Dose Escalation Part|Adverse Event|0|||
48878360|NCT01999972|157394283|FG005|Dose Escalation Part|Adverse Event|0|||
48878361|NCT01999972|157394278|FG000|Dose Escalation Part|Global deterioration of health status|1|||
48793912|NCT04330638|157083379|FG004|Overall Study|Lost to Follow-up|3|||
48793913|NCT04330638|157083380|FG005|Overall Study|Lost to Follow-up|0|||
48793914|NCT04435665|157083391|FG000|Overall Study|Lost to Follow-up|0|||
48793915|NCT04435665|157083392|FG001|Overall Study|Lost to Follow-up|0|||
48793916|NCT04435665|157083393|FG002|Overall Study|Lost to Follow-up|0|||
48878362|NCT01999972|157394279|FG001|Dose Escalation Part|Global deterioration of health status|0|||
48878363|NCT01999972|157394280|FG002|Dose Escalation Part|Global deterioration of health status|0|||
48878364|NCT01999972|157394281|FG003|Dose Escalation Part|Global deterioration of health status|1|||
48878365|NCT01999972|157394282|FG004|Dose Escalation Part|Global deterioration of health status|0|||
48878366|NCT01999972|157394283|FG005|Dose Escalation Part|Global deterioration of health status|0|||
48878367|NCT01999972|157394278|FG000|Dose Expansion Part|Death|0|||
48878368|NCT01999972|157394279|FG001|Dose Expansion Part|Death|0|||
48878369|NCT01999972|157394280|FG002|Dose Expansion Part|Death|0|||
48878370|NCT01999972|157394281|FG003|Dose Expansion Part|Death|0|||
48878371|NCT01999972|157394282|FG004|Dose Expansion Part|Death|2|||
48878372|NCT01999972|157394283|FG005|Dose Expansion Part|Death|1|||
48878373|NCT01999972|157394278|FG000|Dose Expansion Part|Disease progression|0|||
48878374|NCT01999972|157394279|FG001|Dose Expansion Part|Disease progression|0|||
48878375|NCT01999972|157394280|FG002|Dose Expansion Part|Disease progression|0|||
48878376|NCT01999972|157394281|FG003|Dose Expansion Part|Disease progression|0|||
48878377|NCT01999972|157394282|FG004|Dose Expansion Part|Disease progression|9|||
48878378|NCT01999972|157394283|FG005|Dose Expansion Part|Disease progression|3|||
48878379|NCT01999972|157394278|FG000|Dose Expansion Part|Sponsor decision|0|||
48878380|NCT01999972|157394279|FG001|Dose Expansion Part|Sponsor decision|0|||
48878381|NCT01999972|157394280|FG002|Dose Expansion Part|Sponsor decision|0|||
48878382|NCT01999972|157394281|FG003|Dose Expansion Part|Sponsor decision|0|||
48878383|NCT01999972|157394282|FG004|Dose Expansion Part|Sponsor decision|1|||
48878384|NCT01999972|157394283|FG005|Dose Expansion Part|Sponsor decision|0|||
48878385|NCT01999972|157394278|FG000|Dose Expansion Part|Adverse Event|0|||
48878386|NCT01999972|157394279|FG001|Dose Expansion Part|Adverse Event|0|||
48878387|NCT01999972|157394280|FG002|Dose Expansion Part|Adverse Event|0|||
48878388|NCT01999972|157394281|FG003|Dose Expansion Part|Adverse Event|0|||
48878389|NCT01999972|157394282|FG004|Dose Expansion Part|Adverse Event|4|||
48878390|NCT01999972|157394283|FG005|Dose Expansion Part|Adverse Event|2|||
48878391|NCT01999972|157394278|FG000|Dose Expansion Part|Participant's non-compliance|0|||
48878392|NCT01999972|157394279|FG001|Dose Expansion Part|Participant's non-compliance|0|||
48878393|NCT01999972|157394280|FG002|Dose Expansion Part|Participant's non-compliance|0|||
48878394|NCT01999972|157394281|FG003|Dose Expansion Part|Participant's non-compliance|0|||
48878395|NCT01999972|157394282|FG004|Dose Expansion Part|Participant's non-compliance|0|||
48878396|NCT01999972|157394283|FG005|Dose Expansion Part|Participant's non-compliance|1|||
48878397|NCT01999972|157394278|FG000|Dose Expansion Part|Participant refused further follow-up|0|||
48878398|NCT01999972|157394279|FG001|Dose Expansion Part|Participant refused further follow-up|0|||
48878399|NCT01999972|157394280|FG002|Dose Expansion Part|Participant refused further follow-up|0|||
48878400|NCT01999972|157394281|FG003|Dose Expansion Part|Participant refused further follow-up|0|||
48878401|NCT01999972|157394282|FG004|Dose Expansion Part|Participant refused further follow-up|4|||
49032742|NCT05017480|157955543|FG004|Stage 2 Study|Pregnancy|1|||
49032743|NCT02632344|157955544|FG000|Overall Study|Adverse Event|3|||
48878402|NCT01999972|157394283|FG005|Dose Expansion Part|Participant refused further follow-up|0|||
49032744|NCT02632344|157955544|FG000|Overall Study|Lack of Efficacy|3|||
49032745|NCT02632344|157955544|FG000|Overall Study|Withdrawal by Subject|2|||
49032746|NCT01136382|157955547|FG000|Overall Study|Other|8|||
49032747|NCT01136382|157955548|FG001|Overall Study|Other|3|||
49032748|NCT01136382|157955547|FG000|Overall Study|Study-Specific Withdrawal Criteria|48|||
48793917|NCT04435665|157083394|FG003|Overall Study|Lost to Follow-up|1|||
48793918|NCT00419263|157083398|FG000|Overall Study|Lost to Follow-up|2|||
48793919|NCT00419263|157083399|FG001|Overall Study|Lost to Follow-up|1|||
48793920|NCT00419263|157083400|FG002|Overall Study|Lost to Follow-up|1|||
48793921|NCT00419263|157083398|FG000|Overall Study|Randomized in Error, Not Treated|1|||
48793922|NCT00419263|157083399|FG001|Overall Study|Randomized in Error, Not Treated|1|||
48793923|NCT00419263|157083400|FG002|Overall Study|Randomized in Error, Not Treated|0|||
48793924|NCT00419263|157083398|FG000|Overall Study|Adverse Event|0|||
48793925|NCT00419263|157083399|FG001|Overall Study|Adverse Event|0|||
48793926|NCT00419263|157083400|FG002|Overall Study|Adverse Event|1|||
48793927|NCT00419263|157083398|FG000|Overall Study|Withdrawal by Subject|0|||
48793928|NCT00419263|157083399|FG001|Overall Study|Withdrawal by Subject|0|||
48793929|NCT00419263|157083400|FG002|Overall Study|Withdrawal by Subject|1|||
48793930|NCT05045625|157083401|FG000|Overall Study|Lost to Follow-up|3|||
48793931|NCT01041638|157083402|FG000|Overall Study|Adverse Event|4|||
48793932|NCT01041638|157083402|FG000|Overall Study|Death|1|||
48793933|NCT01041638|157083402|FG000|Overall Study|Lack of Efficacy|7|||
48878403|NCT01999972|157394278|FG000|Dose Expansion Part|Changed to standard of care|0|||
48878404|NCT01999972|157394279|FG001|Dose Expansion Part|Changed to standard of care|0|||
48878405|NCT01999972|157394280|FG002|Dose Expansion Part|Changed to standard of care|0|||
48878406|NCT01999972|157394281|FG003|Dose Expansion Part|Changed to standard of care|0|||
48878407|NCT01999972|157394282|FG004|Dose Expansion Part|Changed to standard of care|1|||
48878408|NCT01999972|157394283|FG005|Dose Expansion Part|Changed to standard of care|0|||
49032749|NCT01136382|157955548|FG001|Overall Study|Study-Specific Withdrawal Criteria|25|||
49032750|NCT01136382|157955547|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
49032751|NCT01136382|157955548|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
48793934|NCT01041638|157083402|FG000|Overall Study|Physician Decision|4|||
48793935|NCT01041638|157083402|FG000|Overall Study|Withdrawal by Subject|11|||
48793936|NCT01777854|157083405|FG000|Overall Study|Physician Decision|3|||
48793937|NCT01777854|157083406|FG001|Overall Study|Physician Decision|3|||
48793938|NCT03792126|157083407|FG000|Overall Study|Adverse Event|1|||
48793939|NCT03792126|157083408|FG001|Overall Study|Adverse Event|2|||
48793940|NCT03792126|157083407|FG000|Overall Study|Death|0|||
48793941|NCT03792126|157083408|FG001|Overall Study|Death|1|||
48793942|NCT03792126|157083407|FG000|Overall Study|Lost to Follow-up|1|||
48793943|NCT03792126|157083408|FG001|Overall Study|Lost to Follow-up|0|||
48793944|NCT03792126|157083407|FG000|Overall Study|Withdrawal by Subject|0|||
48793945|NCT03792126|157083408|FG001|Overall Study|Withdrawal by Subject|1|||
48793946|NCT03792126|157083407|FG000|Overall Study|COVID-19 Restrictions|1|||
48793947|NCT03792126|157083408|FG001|Overall Study|COVID-19 Restrictions|3|||
48793948|NCT03792126|157083407|FG000|Overall Study|Symptoms resolved|0|||
48793949|NCT03792126|157083408|FG001|Overall Study|Symptoms resolved|3|||
48793950|NCT04322682|157083413|FG000|Overall Study|Withdrawal by Subject|33|||
48793951|NCT04322682|157083414|FG001|Overall Study|Withdrawal by Subject|47|||
48793952|NCT04322682|157083413|FG000|Overall Study|Death|5|||
48793953|NCT04322682|157083414|FG001|Overall Study|Death|9|||
48793954|NCT04322682|157083413|FG000|Overall Study|Lost to Follow-up|4|||
48793955|NCT04322682|157083414|FG001|Overall Study|Lost to Follow-up|8|||
48793956|NCT04322682|157083413|FG000|Overall Study|Admitted to Hospital and Intubated|1|||
48793957|NCT04322682|157083414|FG001|Overall Study|Admitted to Hospital and Intubated|0|||
48793958|NCT02638948|157083415|FG000|Overall Study|Withdrawal by Subject|4|||
48793959|NCT02638948|157083416|FG001|Overall Study|Withdrawal by Subject|5|||
48793960|NCT02638948|157083417|FG002|Overall Study|Withdrawal by Subject|3|||
48793961|NCT02638948|157083418|FG003|Overall Study|Withdrawal by Subject|1|||
48793962|NCT02638948|157083415|FG000|Overall Study|Administrative Reason by Sponsor|0|||
48793963|NCT02638948|157083416|FG001|Overall Study|Administrative Reason by Sponsor|1|||
48793964|NCT02638948|157083417|FG002|Overall Study|Administrative Reason by Sponsor|0|||
48793965|NCT02638948|157083418|FG003|Overall Study|Administrative Reason by Sponsor|4|||
48793966|NCT02638948|157083415|FG000|Overall Study|Adverse Event|0|||
48793967|NCT02638948|157083416|FG001|Overall Study|Adverse Event|0|||
48793968|NCT02638948|157083417|FG002|Overall Study|Adverse Event|1|||
48793969|NCT02638948|157083418|FG003|Overall Study|Adverse Event|1|||
48793970|NCT02638948|157083415|FG000|Overall Study|Lack of Efficacy|1|||
48793971|NCT02638948|157083416|FG001|Overall Study|Lack of Efficacy|1|||
48793972|NCT02638948|157083417|FG002|Overall Study|Lack of Efficacy|0|||
48793973|NCT02638948|157083418|FG003|Overall Study|Lack of Efficacy|0|||
48793974|NCT02638948|157083415|FG000|Overall Study|Lost to Follow-up|0|||
48793975|NCT02638948|157083416|FG001|Overall Study|Lost to Follow-up|0|||
48793976|NCT02638948|157083417|FG002|Overall Study|Lost to Follow-up|1|||
48793977|NCT02638948|157083418|FG003|Overall Study|Lost to Follow-up|1|||
48793978|NCT02638948|157083415|FG000|Overall Study|Poor/Non-Compliance|0|||
48793979|NCT02638948|157083416|FG001|Overall Study|Poor/Non-Compliance|2|||
48793980|NCT02638948|157083417|FG002|Overall Study|Poor/Non-Compliance|1|||
48793981|NCT02638948|157083418|FG003|Overall Study|Poor/Non-Compliance|0|||
48793982|NCT02638948|157083415|FG000|Overall Study|Participant no longer met study criteria|0|||
48793983|NCT02638948|157083416|FG001|Overall Study|Participant no longer met study criteria|1|||
48793984|NCT02638948|157083417|FG002|Overall Study|Participant no longer met study criteria|0|||
48793985|NCT02638948|157083418|FG003|Overall Study|Participant no longer met study criteria|0|||
48793986|NCT02638948|157083415|FG000|Overall Study|Other than specified above|4|||
48793987|NCT02638948|157083416|FG001|Overall Study|Other than specified above|1|||
48793988|NCT02638948|157083417|FG002|Overall Study|Other than specified above|1|||
48793989|NCT02638948|157083418|FG003|Overall Study|Other than specified above|1|||
48793990|NCT03085485|157083420|FG000|Overall Study|Death|1|||
48793991|NCT03085485|157083421|FG001|Overall Study|Death|0|||
48793992|NCT03085485|157083420|FG000|Overall Study|Lost to Follow-up|1|||
48793993|NCT03085485|157083421|FG001|Overall Study|Lost to Follow-up|0|||
48793994|NCT01022762|157083422|FG000|Overall Study|Adverse Event|3|||
48793995|NCT01022762|157083423|FG001|Overall Study|Adverse Event|1|||
48793996|NCT01022762|157083422|FG000|Overall Study|Lack of Efficacy|0|||
48793997|NCT01022762|157083423|FG001|Overall Study|Lack of Efficacy|1|||
48793998|NCT01022762|157083422|FG000|Overall Study|Protocol Violation|7|||
48793999|NCT01022762|157083423|FG001|Overall Study|Protocol Violation|6|||
48794000|NCT01022762|157083422|FG000|Overall Study|Unclassified|12|||
48794001|NCT01022762|157083423|FG001|Overall Study|Unclassified|20|||
48794002|NCT00605280|157083424|FG000|Year 1|Protocol Violation|0|||
48794003|NCT00605280|157083425|FG001|Year 1|Protocol Violation|0|||
48794004|NCT00605280|157083426|FG002|Year 1|Protocol Violation|0|||
48794005|NCT00605280|157083427|FG003|Year 1|Protocol Violation|1|||
48794006|NCT00605280|157083424|FG000|Year 1|Adverse Event|3|||
48794007|NCT00605280|157083425|FG001|Year 1|Adverse Event|1|||
48794008|NCT00605280|157083426|FG002|Year 1|Adverse Event|1|||
48794009|NCT00605280|157083427|FG003|Year 1|Adverse Event|5|||
48794010|NCT00605280|157083424|FG000|Year 1|Physician Decision|7|||
48794011|NCT00605280|157083425|FG001|Year 1|Physician Decision|4|||
48794012|NCT00605280|157083426|FG002|Year 1|Physician Decision|0|||
48794013|NCT00605280|157083427|FG003|Year 1|Physician Decision|6|||
48794014|NCT00605280|157083424|FG000|Year 1|Withdrawal by Subject|2|||
48794015|NCT00605280|157083425|FG001|Year 1|Withdrawal by Subject|4|||
48794016|NCT00605280|157083426|FG002|Year 1|Withdrawal by Subject|0|||
48794017|NCT00605280|157083427|FG003|Year 1|Withdrawal by Subject|4|||
48794018|NCT00605280|157083424|FG000|Year 1|Other|2|||
48794019|NCT00605280|157083425|FG001|Year 1|Other|1|||
48794020|NCT00605280|157083426|FG002|Year 1|Other|0|||
48794021|NCT00605280|157083427|FG003|Year 1|Other|1|||
48794022|NCT00605280|157083424|FG000|Year 1|Lost to Follow-up or Patient non-comply|5|||
48794023|NCT00605280|157083425|FG001|Year 1|Lost to Follow-up or Patient non-comply|1|||
48794024|NCT00605280|157083426|FG002|Year 1|Lost to Follow-up or Patient non-comply|0|||
48794025|NCT00605280|157083427|FG003|Year 1|Lost to Follow-up or Patient non-comply|2|||
48794026|NCT00605280|157083424|FG000|Year 2|Adverse Event|4|||
48794027|NCT00605280|157083425|FG001|Year 2|Adverse Event|0|||
48794028|NCT00605280|157083426|FG002|Year 2|Adverse Event|2|||
48794029|NCT00605280|157083427|FG003|Year 2|Adverse Event|4|||
48794030|NCT00605280|157083424|FG000|Year 2|Physician Decision|11|||
48794031|NCT00605280|157083425|FG001|Year 2|Physician Decision|6|||
49032752|NCT01136382|157955547|FG000|Overall Study|Withdrawal by Subject|4|||
48794032|NCT00605280|157083426|FG002|Year 2|Physician Decision|4|||
48794033|NCT00605280|157083427|FG003|Year 2|Physician Decision|11|||
48794034|NCT00605280|157083424|FG000|Year 2|Withdrawal by Subject|4|||
48794035|NCT00605280|157083425|FG001|Year 2|Withdrawal by Subject|0|||
48794036|NCT00605280|157083426|FG002|Year 2|Withdrawal by Subject|0|||
48794037|NCT00605280|157083427|FG003|Year 2|Withdrawal by Subject|4|||
48794038|NCT00605280|157083424|FG000|Year 2|Other|1|||
48794039|NCT00605280|157083425|FG001|Year 2|Other|0|||
48794040|NCT00605280|157083426|FG002|Year 2|Other|0|||
48794041|NCT00605280|157083427|FG003|Year 2|Other|1|||
48794042|NCT00605280|157083424|FG000|Year 2|Lost to Follow-up or Patient non-comply|4|||
48794043|NCT00605280|157083425|FG001|Year 2|Lost to Follow-up or Patient non-comply|0|||
48794044|NCT00605280|157083426|FG002|Year 2|Lost to Follow-up or Patient non-comply|0|||
48794045|NCT00605280|157083427|FG003|Year 2|Lost to Follow-up or Patient non-comply|2|||
48794046|NCT00605280|157083424|FG000|Year 3 Extension|Adverse Event|2|||
48794047|NCT00605280|157083425|FG001|Year 3 Extension|Adverse Event|0|||
48794048|NCT00605280|157083426|FG002|Year 3 Extension|Adverse Event|0|||
48794049|NCT00605280|157083427|FG003|Year 3 Extension|Adverse Event|2|||
48794050|NCT00605280|157083424|FG000|Year 3 Extension|Physician Decision|0|||
48794051|NCT00605280|157083425|FG001|Year 3 Extension|Physician Decision|0|||
48794052|NCT00605280|157083426|FG002|Year 3 Extension|Physician Decision|0|||
48794053|NCT00605280|157083427|FG003|Year 3 Extension|Physician Decision|2|||
48794054|NCT00605280|157083424|FG000|Year 3 Extension|Withdrawal by Subject|2|||
48794055|NCT00605280|157083425|FG001|Year 3 Extension|Withdrawal by Subject|0|||
48794056|NCT00605280|157083426|FG002|Year 3 Extension|Withdrawal by Subject|0|||
48794057|NCT00605280|157083427|FG003|Year 3 Extension|Withdrawal by Subject|5|||
48794058|NCT00605280|157083424|FG000|Year 3 Extension|Other|2|||
48794059|NCT00605280|157083425|FG001|Year 3 Extension|Other|0|||
48794060|NCT00605280|157083426|FG002|Year 3 Extension|Other|0|||
48794061|NCT00605280|157083427|FG003|Year 3 Extension|Other|0|||
48794062|NCT00605280|157083424|FG000|Year 3 Extension|Lost to Follow-up or Patient non-comply|2|||
48794063|NCT00605280|157083425|FG001|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
48794064|NCT00605280|157083426|FG002|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
48794065|NCT00605280|157083427|FG003|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
48794066|NCT04891419|157083428|FG000|Overall Study|Withdrawal by Subject|4|||
48794067|NCT04891419|157083429|FG001|Overall Study|Withdrawal by Subject|0|||
48794068|NCT04891419|157083428|FG000|Overall Study|Lost to Follow-up|1|||
48794069|NCT04891419|157083429|FG001|Overall Study|Lost to Follow-up|3|||
48794070|NCT00802074|157083430|FG000|Overall Study|Adverse Event|1|||
48794071|NCT00802074|157083431|FG001|Overall Study|Adverse Event|1|||
48794072|NCT00802074|157083432|FG002|Overall Study|Adverse Event|1|||
48794073|NCT00802074|157083433|FG003|Overall Study|Adverse Event|0|||
49032753|NCT01136382|157955548|FG001|Overall Study|Withdrawal by Subject|1|||
49032754|NCT02847650|157955551|FG000|Overall Study|Adverse Event|2|||
49032755|NCT02847650|157955552|FG001|Overall Study|Adverse Event|4|||
49032756|NCT02847650|157955551|FG000|Overall Study|Lost to Follow-up|1|||
48794074|NCT00802074|157083434|FG004|Overall Study|Adverse Event|0|||
48878409|NCT01689363|157394284|FG000|Overall Study|Protocol Violation|0|||
49032757|NCT02847650|157955552|FG001|Overall Study|Lost to Follow-up|0|||
48794075|NCT00802074|157083435|FG005|Overall Study|Adverse Event|0|||
48794076|NCT00802074|157083430|FG000|Overall Study|Withdrawal by Subject|1|||
48794077|NCT00802074|157083431|FG001|Overall Study|Withdrawal by Subject|0|||
48794078|NCT00802074|157083432|FG002|Overall Study|Withdrawal by Subject|0|||
48794079|NCT00802074|157083433|FG003|Overall Study|Withdrawal by Subject|0|||
48794080|NCT00802074|157083434|FG004|Overall Study|Withdrawal by Subject|0|||
48794081|NCT00802074|157083435|FG005|Overall Study|Withdrawal by Subject|0|||
48794082|NCT00127101|157083436|FG000|Base Protocol|Adverse Event|0|||
48794083|NCT00127101|157083437|FG001|Base Protocol|Adverse Event|2|||
48794084|NCT00127101|157083438|FG002|Base Protocol|Adverse Event|1|||
48794085|NCT00127101|157083439|FG003|Base Protocol|Adverse Event|0|||
48794086|NCT00127101|157083440|FG004|Base Protocol|Adverse Event|0|||
48794087|NCT00127101|157083441|FG005|Base Protocol|Adverse Event|0|||
48794088|NCT00127101|157083436|FG000|Base Protocol|Lack of Efficacy|1|||
48794089|NCT00127101|157083437|FG001|Base Protocol|Lack of Efficacy|0|||
49032758|NCT02847650|157955551|FG000|Overall Study|Protocol Violation|0|||
49032759|NCT02847650|157955552|FG001|Overall Study|Protocol Violation|1|||
49032760|NCT02847650|157955551|FG000|Overall Study|Withdrawal by Subject|1|||
49032761|NCT02847650|157955552|FG001|Overall Study|Withdrawal by Subject|1|||
49032762|NCT00467896|157955553|FG000|Overall Study|Consent Withdrawal|18|||
49032763|NCT00467896|157955553|FG000|Overall Study|Adverse Event|7|||
49032764|NCT00467896|157955553|FG000|Overall Study|Serious Adverse Event|13|||
49032765|NCT00467896|157955553|FG000|Overall Study|Non-compliance|3|||
49032766|NCT00467896|157955553|FG000|Overall Study|Changed therapy|2|||
49032767|NCT00467896|157955553|FG000|Overall Study|Patient received transplant|2|||
49032768|NCT00467896|157955553|FG000|Overall Study|Patient had atrial septostomy|1|||
49032769|NCT00467896|157955553|FG000|Overall Study|Patient weaned off iloprost|1|||
49032770|NCT00467896|157955553|FG000|Overall Study|Mainly used Prodose not I-neb® device|1|||
49032771|NCT00467896|157955553|FG000|Overall Study|Started intravenous prostacyclin|1|||
49032772|NCT00467896|157955553|FG000|Overall Study|Started inhaled Remodulin|1|||
49032773|NCT00467896|157955553|FG000|Overall Study|Patient had no improvement|1|||
49032774|NCT00088829|157955557|FG000|Overall Study|PI left institution and study was close|22|||
49032775|NCT00633594|157955558|FG000|Overall Study|Adverse Event|0|||
49032776|NCT00633594|157955559|FG001|Overall Study|Adverse Event|4|||
49032777|NCT00633594|157955560|FG002|Overall Study|Adverse Event|7|||
49032778|NCT00633594|157955558|FG000|Overall Study|Death|0|||
49032779|NCT00633594|157955559|FG001|Overall Study|Death|1|||
49032780|NCT00633594|157955560|FG002|Overall Study|Death|2|||
49032781|NCT00633594|157955558|FG000|Overall Study|Disease Progression|0|||
49032782|NCT00633594|157955559|FG001|Overall Study|Disease Progression|0|||
49032783|NCT00633594|157955560|FG002|Overall Study|Disease Progression|1|||
49032784|NCT03165994|157955565|FG000|Overall Study|Confirmed Radiographic Disease Progression|4|||
49032785|NCT03165994|157955565|FG000|Overall Study|Death|2|||
49032786|NCT03165994|157955565|FG000|Overall Study|Non-Compliance With Study Treatment or Procedure Requirements|3|||
49032787|NCT03165994|157955565|FG000|Overall Study|Physician Decision, other than adverse event (AE)|9|||
48794090|NCT00127101|157083438|FG002|Base Protocol|Lack of Efficacy|0|||
48794091|NCT00127101|157083439|FG003|Base Protocol|Lack of Efficacy|0|||
48794092|NCT00127101|157083440|FG004|Base Protocol|Lack of Efficacy|2|||
48794093|NCT00127101|157083441|FG005|Base Protocol|Lack of Efficacy|0|||
48794094|NCT00127101|157083436|FG000|Base Protocol|Withdrawal by Subject|1|||
48794095|NCT00127101|157083437|FG001|Base Protocol|Withdrawal by Subject|2|||
48794096|NCT00127101|157083438|FG002|Base Protocol|Withdrawal by Subject|1|||
48794097|NCT00127101|157083439|FG003|Base Protocol|Withdrawal by Subject|0|||
48794098|NCT00127101|157083440|FG004|Base Protocol|Withdrawal by Subject|0|||
48794099|NCT00127101|157083441|FG005|Base Protocol|Withdrawal by Subject|1|||
48794100|NCT00127101|157083436|FG000|Continuation Phase|Adverse Event|0|||
48794101|NCT00127101|157083437|FG001|Continuation Phase|Adverse Event|0|||
48794102|NCT00127101|157083438|FG002|Continuation Phase|Adverse Event|0|||
48794103|NCT00127101|157083439|FG003|Continuation Phase|Adverse Event|0|||
48794104|NCT00127101|157083440|FG004|Continuation Phase|Adverse Event|1|||
48794105|NCT00127101|157083441|FG005|Continuation Phase|Adverse Event|1|||
48794106|NCT00127101|157083436|FG000|Continuation Phase|Lack of Efficacy|0|||
48794107|NCT00127101|157083437|FG001|Continuation Phase|Lack of Efficacy|0|||
48794108|NCT00127101|157083438|FG002|Continuation Phase|Lack of Efficacy|0|||
48794109|NCT00127101|157083439|FG003|Continuation Phase|Lack of Efficacy|0|||
48794110|NCT00127101|157083440|FG004|Continuation Phase|Lack of Efficacy|0|||
48794111|NCT00127101|157083441|FG005|Continuation Phase|Lack of Efficacy|1|||
48794112|NCT00127101|157083436|FG000|Continuation Phase|Withdrawal by Subject|0|||
48794113|NCT00127101|157083437|FG001|Continuation Phase|Withdrawal by Subject|0|||
49032788|NCT03165994|157955565|FG000|Overall Study|Participant or Legal Representative Withdraws Consent|1|||
49032789|NCT03165994|157955565|FG000|Overall Study|Miscellaneous|1|||
48794114|NCT00127101|157083438|FG002|Continuation Phase|Withdrawal by Subject|1|||
48794115|NCT00127101|157083439|FG003|Continuation Phase|Withdrawal by Subject|0|||
48794116|NCT00127101|157083440|FG004|Continuation Phase|Withdrawal by Subject|2|||
48794117|NCT00127101|157083441|FG005|Continuation Phase|Withdrawal by Subject|1|||
48794118|NCT00843167|157083442|FG000|Treatment Period|Adverse Event|1|||
48794119|NCT00843167|157083443|FG001|Treatment Period|Adverse Event|5|||
48794120|NCT00843167|157083442|FG000|Treatment Period|Withdrawal by Subject|2|||
48794121|NCT00843167|157083443|FG001|Treatment Period|Withdrawal by Subject|3|||
48794122|NCT01662310|157083444|FG000|Run-In or Stabilization Phase|Adverse Event|11|||
48794123|NCT01662310|157083445|FG001|Run-In or Stabilization Phase|Adverse Event|0|||
48794124|NCT01662310|157083446|FG002|Run-In or Stabilization Phase|Adverse Event|0|||
49032790|NCT02736721|157955566|FG000|Overall Study|Adverse Event|8|||
49032791|NCT02736721|157955566|FG000|Overall Study|Lost to Follow-up|3|||
49032792|NCT02736721|157955566|FG000|Overall Study|Other|5|||
49032793|NCT00473330|157955571|FG000|Core Study|Adverse Event|4|||
49032794|NCT00473330|157955572|FG001|Core Study|Adverse Event|4|||
49032795|NCT00473330|157955573|FG002|Core Study|Adverse Event|1|||
49032796|NCT00473330|157955571|FG000|Core Study|Death|6|||
49032797|NCT00473330|157955572|FG001|Core Study|Death|4|||
49032798|NCT00473330|157955573|FG002|Core Study|Death|4|||
49032799|NCT00473330|157955571|FG000|Core Study|Lost to Follow-up|5|||
49032800|NCT00473330|157955572|FG001|Core Study|Lost to Follow-up|5|||
49032801|NCT00473330|157955573|FG002|Core Study|Lost to Follow-up|10|||
49032802|NCT00473330|157955571|FG000|Core Study|Physician Decision|2|||
49032803|NCT00473330|157955572|FG001|Core Study|Physician Decision|1|||
49032804|NCT00473330|157955573|FG002|Core Study|Physician Decision|3|||
49032805|NCT00473330|157955571|FG000|Core Study|Subject Non-compliance|1|||
49032806|NCT00473330|157955572|FG001|Core Study|Subject Non-compliance|2|||
49032807|NCT00473330|157955573|FG002|Core Study|Subject Non-compliance|1|||
49032808|NCT00473330|157955571|FG000|Core Study|Subject Required Other Therapy|0|||
49032809|NCT00473330|157955572|FG001|Core Study|Subject Required Other Therapy|1|||
49032810|NCT00473330|157955573|FG002|Core Study|Subject Required Other Therapy|3|||
49032811|NCT00473330|157955571|FG000|Core Study|Subject's Decision|9|||
49032812|NCT00473330|157955572|FG001|Core Study|Subject's Decision|8|||
49032813|NCT00473330|157955573|FG002|Core Study|Subject's Decision|19|||
49032814|NCT00473330|157955571|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
49032815|NCT00473330|157955572|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
49032816|NCT00473330|157955573|FG002|Open-label Extension Through Month 48|Adverse Event|2|||
49032817|NCT00473330|157955571|FG000|Open-label Extension Through Month 48|Death|2|||
49032818|NCT00473330|157955572|FG001|Open-label Extension Through Month 48|Death|0|||
49032819|NCT00473330|157955573|FG002|Open-label Extension Through Month 48|Death|0|||
49032820|NCT00473330|157955571|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
49032821|NCT00473330|157955572|FG001|Open-label Extension Through Month 48|Lost to Follow-up|0|||
49032822|NCT00473330|157955573|FG002|Open-label Extension Through Month 48|Lost to Follow-up|2|||
49032823|NCT00473330|157955571|FG000|Open-label Extension Through Month 48|Physician's Decision|2|||
49032824|NCT00473330|157955572|FG001|Open-label Extension Through Month 48|Physician's Decision|1|||
49032825|NCT00473330|157955573|FG002|Open-label Extension Through Month 48|Physician's Decision|3|||
49032826|NCT00473330|157955571|FG000|Open-label Extension Through Month 48|Subject's Decision|1|||
49032827|NCT00473330|157955572|FG001|Open-label Extension Through Month 48|Subject's Decision|3|||
49032828|NCT00473330|157955573|FG002|Open-label Extension Through Month 48|Subject's Decision|3|||
49032829|NCT00473330|157955571|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18|||
49032830|NCT00473330|157955572|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15|||
49032831|NCT00473330|157955573|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16|||
49032832|NCT00473330|157955571|FG000|Open-label Extension Through Month 48|Subject Non-compliance|2|||
49032833|NCT00473330|157955572|FG001|Open-label Extension Through Month 48|Subject Non-compliance|1|||
49032834|NCT00473330|157955573|FG002|Open-label Extension Through Month 48|Subject Non-compliance|0|||
48794125|NCT01662310|157083447|FG003|Run-In or Stabilization Phase|Adverse Event|0|||
48794126|NCT01662310|157083448|FG004|Run-In or Stabilization Phase|Adverse Event|0|||
48794127|NCT01662310|157083444|FG000|Run-In or Stabilization Phase|Lack of Efficacy|9|||
48794128|NCT01662310|157083445|FG001|Run-In or Stabilization Phase|Lack of Efficacy|0|||
48794129|NCT01662310|157083446|FG002|Run-In or Stabilization Phase|Lack of Efficacy|0|||
49032835|NCT00473330|157955571|FG000|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
49032836|NCT00473330|157955572|FG001|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
49032837|NCT00473330|157955573|FG002|Open-label Extension Through Month 48|Subject Required Other Therapy|1|||
49032838|NCT00473330|157955571|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
49032839|NCT00473330|157955572|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
49032840|NCT00473330|157955573|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
49032841|NCT00473330|157955571|FG000|Open-label Extension Through Month 60|Death|2|||
49032842|NCT00473330|157955572|FG001|Open-label Extension Through Month 60|Death|2|||
49032843|NCT00473330|157955573|FG002|Open-label Extension Through Month 60|Death|1|||
48794130|NCT01662310|157083447|FG003|Run-In or Stabilization Phase|Lack of Efficacy|0|||
48794131|NCT01662310|157083448|FG004|Run-In or Stabilization Phase|Lack of Efficacy|0|||
48794132|NCT01662310|157083444|FG000|Run-In or Stabilization Phase|Lost to Follow-up|4|||
48794133|NCT01662310|157083445|FG001|Run-In or Stabilization Phase|Lost to Follow-up|0|||
48794134|NCT01662310|157083446|FG002|Run-In or Stabilization Phase|Lost to Follow-up|0|||
48794135|NCT01662310|157083447|FG003|Run-In or Stabilization Phase|Lost to Follow-up|0|||
48794136|NCT01662310|157083448|FG004|Run-In or Stabilization Phase|Lost to Follow-up|0|||
48794137|NCT01662310|157083444|FG000|Run-In or Stabilization Phase|Protocol Violation|15|||
48794138|NCT01662310|157083445|FG001|Run-In or Stabilization Phase|Protocol Violation|0|||
48794139|NCT01662310|157083446|FG002|Run-In or Stabilization Phase|Protocol Violation|0|||
48794140|NCT01662310|157083447|FG003|Run-In or Stabilization Phase|Protocol Violation|0|||
48794141|NCT01662310|157083448|FG004|Run-In or Stabilization Phase|Protocol Violation|0|||
49032844|NCT00473330|157955571|FG000|Open-label Extension Through Month 60|Lost to Follow-up|3|||
49032845|NCT00473330|157955572|FG001|Open-label Extension Through Month 60|Lost to Follow-up|0|||
49032846|NCT00473330|157955573|FG002|Open-label Extension Through Month 60|Lost to Follow-up|4|||
49032847|NCT00473330|157955571|FG000|Open-label Extension Through Month 60|Physician's Decision|2|||
49032848|NCT00473330|157955572|FG001|Open-label Extension Through Month 60|Physician's Decision|1|||
48878410|NCT01689363|157394285|FG001|Overall Study|Protocol Violation|1|||
48878411|NCT01689363|157394286|FG002|Overall Study|Protocol Violation|0|||
48878412|NCT01689363|157394287|FG003|Overall Study|Protocol Violation|0|||
48878413|NCT01689363|157394288|FG004|Overall Study|Protocol Violation|0|||
48878414|NCT01689363|157394289|FG005|Overall Study|Protocol Violation|0|||
48878415|NCT01689363|157394290|FG006|Overall Study|Protocol Violation|0|||
48878416|NCT01689363|157394291|FG007|Overall Study|Protocol Violation|0|||
48878417|NCT01639742|157394294|FG000|Overall Study|Study Ongoing|17|||
48878418|NCT01639742|157394294|FG000|Overall Study|Lost to Follow-up|1|||
48878419|NCT00321685|157394295|FG000|Overall Study|Adverse Event|18|||
48878420|NCT00321685|157394295|FG000|Overall Study|Death|2|||
48878421|NCT00321685|157394295|FG000|Overall Study|Withdrawal by Subject|8|||
48878422|NCT00321685|157394295|FG000|Overall Study|Alternative therapy|1|||
48878423|NCT00321685|157394295|FG000|Overall Study|Complicating disese|1|||
48878424|NCT00321685|157394295|FG000|Overall Study|Other|5|||
48878425|NCT00321685|157394295|FG000|Overall Study|Not start protocol therapy|2|||
48878426|NCT00321685|157394295|FG000|Overall Study|Ineligible|2|||
48878427|NCT00263211|157394296|FG000|Overall Study|Death|1|||
48878428|NCT00263211|157394297|FG001|Overall Study|Death|0|||
48878429|NCT00263211|157394296|FG000|Overall Study|Withdrawal by Subject|3|||
48878430|NCT00263211|157394297|FG001|Overall Study|Withdrawal by Subject|0|||
48878431|NCT00263211|157394296|FG000|Overall Study|Protocol Violation|1|||
48878432|NCT00263211|157394297|FG001|Overall Study|Protocol Violation|0|||
48878433|NCT00263211|157394296|FG000|Overall Study|Disease Progression|0|||
48878434|NCT00263211|157394297|FG001|Overall Study|Disease Progression|1|||
48878435|NCT02034162|157394298|FG000|Double-blind|Lost to Follow-up|3|||
48878436|NCT02034162|157394299|FG001|Double-blind|Lost to Follow-up|0|||
48878437|NCT02034162|157394300|FG002|Double-blind|Lost to Follow-up|0|||
48878438|NCT02034162|157394298|FG000|Double-blind|Physician Decision|1|||
48878439|NCT02034162|157394299|FG001|Double-blind|Physician Decision|0|||
48878440|NCT02034162|157394300|FG002|Double-blind|Physician Decision|0|||
48878441|NCT02034162|157394298|FG000|Double-blind|Protocol Violation|0|||
48878442|NCT02034162|157394299|FG001|Double-blind|Protocol Violation|1|||
48878443|NCT02034162|157394300|FG002|Double-blind|Protocol Violation|0|||
48878444|NCT02034162|157394298|FG000|Double-blind|Withdrawal by Subject|5|||
48878445|NCT02034162|157394299|FG001|Double-blind|Withdrawal by Subject|7|||
48878446|NCT02034162|157394300|FG002|Double-blind|Withdrawal by Subject|0|||
48878447|NCT00590564|157394304|FG000|Overall Study|Withdrawal by Subject|4|||
48878448|NCT00590564|157394304|FG000|Overall Study|Lost to Follow-up|6|||
48794142|NCT01662310|157083444|FG000|Run-In or Stabilization Phase|Withdrawal by Subject|25|||
48794143|NCT01662310|157083445|FG001|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
48794144|NCT01662310|157083446|FG002|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
48794145|NCT01662310|157083447|FG003|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
48794146|NCT01662310|157083448|FG004|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
48794147|NCT01662310|157083444|FG000|Run-In or Stabilization Phase|Other|1|||
48794148|NCT01662310|157083445|FG001|Run-In or Stabilization Phase|Other|0|||
48794149|NCT01662310|157083446|FG002|Run-In or Stabilization Phase|Other|0|||
48794150|NCT01662310|157083447|FG003|Run-In or Stabilization Phase|Other|0|||
48794151|NCT01662310|157083448|FG004|Run-In or Stabilization Phase|Other|0|||
48794152|NCT01662310|157083444|FG000|Double-Blind Phase|Adverse Event|0|||
48794153|NCT01662310|157083445|FG001|Double-Blind Phase|Adverse Event|0|||
48794154|NCT01662310|157083446|FG002|Double-Blind Phase|Adverse Event|1|||
48794155|NCT01662310|157083447|FG003|Double-Blind Phase|Adverse Event|0|||
48794156|NCT01662310|157083448|FG004|Double-Blind Phase|Adverse Event|0|||
48794157|NCT01662310|157083444|FG000|Double-Blind Phase|Lost to Follow-up|0|||
48794158|NCT01662310|157083445|FG001|Double-Blind Phase|Lost to Follow-up|3|||
48794159|NCT01662310|157083446|FG002|Double-Blind Phase|Lost to Follow-up|0|||
48794160|NCT01662310|157083447|FG003|Double-Blind Phase|Lost to Follow-up|0|||
48794161|NCT01662310|157083448|FG004|Double-Blind Phase|Lost to Follow-up|0|||
48794162|NCT01662310|157083444|FG000|Double-Blind Phase|Pregnancy|0|||
48794163|NCT01662310|157083445|FG001|Double-Blind Phase|Pregnancy|2|||
48794164|NCT01662310|157083446|FG002|Double-Blind Phase|Pregnancy|0|||
48794165|NCT01662310|157083447|FG003|Double-Blind Phase|Pregnancy|0|||
48794166|NCT01662310|157083448|FG004|Double-Blind Phase|Pregnancy|0|||
48794167|NCT01662310|157083444|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
48794168|NCT01662310|157083445|FG001|Double-Blind Phase|Withdrawal by Subject|9|||
48794169|NCT01662310|157083446|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
48794170|NCT01662310|157083447|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
48794171|NCT01662310|157083448|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
48794172|NCT01662310|157083444|FG000|Double-Blind Phase|Other|0|||
48794173|NCT01662310|157083445|FG001|Double-Blind Phase|Other|0|||
48878449|NCT00590564|157394304|FG000|Overall Study|Protocol Violation|1|||
48878450|NCT00590564|157394304|FG000|Overall Study|Patient Found to be Ineligible|1|||
48794174|NCT01662310|157083446|FG002|Double-Blind Phase|Other|1|||
48794175|NCT01662310|157083447|FG003|Double-Blind Phase|Other|0|||
48794176|NCT01662310|157083448|FG004|Double-Blind Phase|Other|0|||
48878451|NCT00590564|157394304|FG000|Overall Study|Patient Non-compliance|6|||
48878452|NCT00416598|157394305|FG000|Induction & Intensification|Adverse Event|38|||
48878453|NCT00416598|157394305|FG000|Induction & Intensification|Death|32|||
48794177|NCT01662310|157083444|FG000|Double-Blind Phase|Randomized but not treated|0|||
48794178|NCT01662310|157083445|FG001|Double-Blind Phase|Randomized but not treated|1|||
48794179|NCT01662310|157083446|FG002|Double-Blind Phase|Randomized but not treated|0|||
48794180|NCT01662310|157083447|FG003|Double-Blind Phase|Randomized but not treated|0|||
48794181|NCT01662310|157083448|FG004|Double-Blind Phase|Randomized but not treated|0|||
48794182|NCT01662310|157083444|FG000|Open-Label Extension Phase|Adverse Event|0|||
48794183|NCT01662310|157083445|FG001|Open-Label Extension Phase|Adverse Event|0|||
48794184|NCT01662310|157083446|FG002|Open-Label Extension Phase|Adverse Event|0|||
48794185|NCT01662310|157083447|FG003|Open-Label Extension Phase|Adverse Event|3|||
48794186|NCT01662310|157083448|FG004|Open-Label Extension Phase|Adverse Event|0|||
48794187|NCT01662310|157083444|FG000|Open-Label Extension Phase|Death|0|||
48794188|NCT01662310|157083445|FG001|Open-Label Extension Phase|Death|0|||
48794189|NCT01662310|157083446|FG002|Open-Label Extension Phase|Death|0|||
48794190|NCT01662310|157083447|FG003|Open-Label Extension Phase|Death|1|||
48794191|NCT01662310|157083448|FG004|Open-Label Extension Phase|Death|0|||
48794192|NCT01662310|157083444|FG000|Open-Label Extension Phase|Lack of Efficacy|0|||
48794193|NCT01662310|157083445|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
48794194|NCT01662310|157083446|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
48794195|NCT01662310|157083447|FG003|Open-Label Extension Phase|Lack of Efficacy|2|||
48794196|NCT01662310|157083448|FG004|Open-Label Extension Phase|Lack of Efficacy|2|||
48794197|NCT01662310|157083444|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
48794198|NCT01662310|157083445|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
48794199|NCT01662310|157083446|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
48794200|NCT01662310|157083447|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
48794201|NCT01662310|157083448|FG004|Open-Label Extension Phase|Lost to Follow-up|1|||
48794202|NCT01662310|157083444|FG000|Open-Label Extension Phase|Pregnancy|0|||
48794203|NCT01662310|157083445|FG001|Open-Label Extension Phase|Pregnancy|0|||
49032849|NCT00473330|157955573|FG002|Open-label Extension Through Month 60|Physician's Decision|3|||
49032850|NCT00473330|157955571|FG000|Open-label Extension Through Month 60|Subject's Decision|1|||
49032851|NCT00473330|157955572|FG001|Open-label Extension Through Month 60|Subject's Decision|3|||
49032852|NCT00473330|157955573|FG002|Open-label Extension Through Month 60|Subject's Decision|4|||
49032853|NCT00473330|157955571|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77|||
49032854|NCT00473330|157955572|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71|||
49032855|NCT00473330|157955573|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62|||
48794204|NCT01662310|157083446|FG002|Open-Label Extension Phase|Pregnancy|0|||
48794205|NCT01662310|157083447|FG003|Open-Label Extension Phase|Pregnancy|1|||
48794206|NCT01662310|157083448|FG004|Open-Label Extension Phase|Pregnancy|0|||
48794207|NCT01662310|157083444|FG000|Open-Label Extension Phase|Withdrawal by Subject|0|||
48794208|NCT01662310|157083445|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
48794209|NCT01662310|157083446|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
48794210|NCT01662310|157083447|FG003|Open-Label Extension Phase|Withdrawal by Subject|2|||
48794211|NCT01662310|157083448|FG004|Open-Label Extension Phase|Withdrawal by Subject|7|||
48794212|NCT05012163|157083451|FG000|Overall Study|Protocol Violation|0|||
48794213|NCT05012163|157083452|FG001|Overall Study|Protocol Violation|0|||
48794214|NCT05012163|157083453|FG002|Overall Study|Protocol Violation|1|||
48794215|NCT05012163|157083454|FG003|Overall Study|Protocol Violation|1|||
48794216|NCT03355326|157083457|FG000|Overall Study|Protocol Violation|3|||
48794217|NCT03355326|157083458|FG001|Overall Study|Protocol Violation|3|||
48794218|NCT03493542|157083460|FG000|Base Study|Withdrawal by Subject|0|||
48794219|NCT03493542|157083461|FG001|Base Study|Withdrawal by Subject|4|||
48794220|NCT03493542|157083462|FG002|Base Study|Withdrawal by Subject|0|||
48794221|NCT03493542|157083460|FG000|Extension Study|Consent withdrawal by parent/guardian|0|||
48794222|NCT03493542|157083461|FG001|Extension Study|Consent withdrawal by parent/guardian|0|||
48794223|NCT03493542|157083462|FG002|Extension Study|Consent withdrawal by parent/guardian|2|||
48794224|NCT03493542|157083460|FG000|Extension Study|Withdrawal by Subject|0|||
48794225|NCT03493542|157083461|FG001|Extension Study|Withdrawal by Subject|0|||
48794226|NCT03493542|157083462|FG002|Extension Study|Withdrawal by Subject|25|||
48794227|NCT04368429|157084965|FG000|Overall Study|Adverse Event|1|||
48794228|NCT04368429|157084966|FG001|Overall Study|Adverse Event|0|||
48794229|NCT00608582|157084967|FG000|Overall Study|Lost to Follow-up|2|||
48794230|NCT00608582|157084968|FG001|Overall Study|Lost to Follow-up|0|||
48794231|NCT00608582|157084967|FG000|Overall Study|No Best Response in Phase 1 located|1|||
48794232|NCT00608582|157084968|FG001|Overall Study|No Best Response in Phase 1 located|1|||
48794233|NCT00608582|157084967|FG000|Overall Study|Illicit Drug Use|1|||
48794234|NCT00608582|157084968|FG001|Overall Study|Illicit Drug Use|0|||
48794235|NCT00608582|157084967|FG000|Overall Study|Early stage Design Change|0|||
48794236|NCT00608582|157084968|FG001|Overall Study|Early stage Design Change|3|||
48794237|NCT00156065|157084970|FG000|Overall Study|Enrolled But Never Received Treatment|1|||
48794238|NCT00156065|157084971|FG001|Overall Study|Enrolled But Never Received Treatment|1|||
48794239|NCT00156065|157084972|FG002|Overall Study|Enrolled But Never Received Treatment|0|||
48794240|NCT00156065|157084970|FG000|Overall Study|Adverse Event|8|||
48794241|NCT00156065|157084971|FG001|Overall Study|Adverse Event|11|||
48794242|NCT00156065|157084972|FG002|Overall Study|Adverse Event|4|||
49032856|NCT00473330|157955571|FG000|Open-label Extension Through Month 60|Subject Non-compliance|2|||
49032857|NCT00473330|157955572|FG001|Open-label Extension Through Month 60|Subject Non-compliance|1|||
49032858|NCT00473330|157955573|FG002|Open-label Extension Through Month 60|Subject Non-compliance|0|||
49032859|NCT00473330|157955571|FG000|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
49032860|NCT00473330|157955572|FG001|Open-label Extension Through Month 60|Subject Required Other Therapy|0|||
49032861|NCT00473330|157955573|FG002|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
49032862|NCT01975948|157955574|FG000|Overall Study|Withdrawal by Subject|17|||
49032863|NCT01975948|157955575|FG001|Overall Study|Withdrawal by Subject|21|||
48794243|NCT00156065|157084970|FG000|Overall Study|Lack of Efficacy|2|||
48794244|NCT00156065|157084971|FG001|Overall Study|Lack of Efficacy|9|||
48794245|NCT00156065|157084972|FG002|Overall Study|Lack of Efficacy|3|||
48794246|NCT00156065|157084970|FG000|Overall Study|Withdrawal by Subject|13|||
48794247|NCT00156065|157084971|FG001|Overall Study|Withdrawal by Subject|26|||
48794248|NCT00156065|157084972|FG002|Overall Study|Withdrawal by Subject|16|||
48794249|NCT00156065|157084970|FG000|Overall Study|Lost to Follow-up|5|||
48794250|NCT00156065|157084971|FG001|Overall Study|Lost to Follow-up|7|||
48794251|NCT00156065|157084972|FG002|Overall Study|Lost to Follow-up|1|||
48794252|NCT00156065|157084970|FG000|Overall Study|Other|2|||
48794253|NCT00156065|157084971|FG001|Overall Study|Other|9|||
48794254|NCT00156065|157084972|FG002|Overall Study|Other|3|||
48794255|NCT04546581|157084975|FG000|Overall Study|Adverse Event|9|||
48794256|NCT04546581|157084976|FG001|Overall Study|Adverse Event|3|||
48794257|NCT04546581|157084975|FG000|Overall Study|Physician Decision|0|||
48794258|NCT04546581|157084976|FG001|Overall Study|Physician Decision|1|||
48794259|NCT04546581|157084975|FG000|Overall Study|Protocol Violation|1|||
48794260|NCT04546581|157084976|FG001|Overall Study|Protocol Violation|2|||
48794261|NCT04546581|157084975|FG000|Overall Study|Withdrawal by Subject|3|||
48794262|NCT04546581|157084976|FG001|Overall Study|Withdrawal by Subject|7|||
48794263|NCT01798927|157084977|FG000|Overall Study|Withdrawal by Subject|1|||
48794264|NCT01928719|157084978|FG000|Overall Study|Lost to Follow-up|26|||
48794265|NCT01928719|157084979|FG001|Overall Study|Lost to Follow-up|11|||
48794266|NCT01928719|157084978|FG000|Overall Study|Withdrawal by Subject|22|||
48794267|NCT01928719|157084979|FG001|Overall Study|Withdrawal by Subject|7|||
48794268|NCT01928719|157084978|FG000|Overall Study|Protocol Violation|3|||
48794269|NCT01928719|157084979|FG001|Overall Study|Protocol Violation|1|||
48794270|NCT01928719|157084978|FG000|Overall Study|Adverse Event|1|||
48794271|NCT01928719|157084979|FG001|Overall Study|Adverse Event|0|||
48794272|NCT02280044|157084980|FG000|Overall Study|Planned alternate|0|||
48794273|NCT02280044|157084981|FG001|Overall Study|Planned alternate|2|||
48794274|NCT02207816|157084987|FG000|Overall Study|Serious Adverse Event|0|||
48794275|NCT02207816|157084988|FG001|Overall Study|Serious Adverse Event|5|||
48794276|NCT02207816|157084989|FG002|Overall Study|Serious Adverse Event|2|||
48794277|NCT02207816|157084987|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
48794278|NCT02207816|157084988|FG001|Overall Study|Eligibility Criteria Not Fulfilled|1|||
48794279|NCT02207816|157084989|FG002|Overall Study|Eligibility Criteria Not Fulfilled|2|||
48794280|NCT02207816|157084987|FG000|Overall Study|Withdrawal by Subject|4|||
48794281|NCT02207816|157084988|FG001|Overall Study|Withdrawal by Subject|9|||
48794282|NCT02207816|157084989|FG002|Overall Study|Withdrawal by Subject|7|||
48794283|NCT02207816|157084987|FG000|Overall Study|Migrated/Moved From Study Area|41|||
48794284|NCT02207816|157084988|FG001|Overall Study|Migrated/Moved From Study Area|60|||
48794285|NCT02207816|157084989|FG002|Overall Study|Migrated/Moved From Study Area|51|||
48794286|NCT02207816|157084987|FG000|Overall Study|Lost to Follow-up|3|||
48794287|NCT02207816|157084988|FG001|Overall Study|Lost to Follow-up|9|||
48794288|NCT02207816|157084989|FG002|Overall Study|Lost to Follow-up|1|||
48794289|NCT02207816|157084987|FG000|Overall Study|Other|1|||
48794290|NCT02207816|157084988|FG001|Overall Study|Other|2|||
48794291|NCT02207816|157084989|FG002|Overall Study|Other|4|||
48794292|NCT04004611|157084992|FG000|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
48794293|NCT04004611|157084993|FG001|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
48794294|NCT04004611|157084994|FG002|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
48794295|NCT04004611|157084995|FG003|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
48794296|NCT04004611|157084996|FG004|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
48794297|NCT04004611|157084997|FG005|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
49032864|NCT01975948|157955576|FG002|Overall Study|Withdrawal by Subject|7|||
49032865|NCT01975948|157955577|FG003|Overall Study|Withdrawal by Subject|6|||
48794298|NCT04004611|157084998|FG006|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
48794299|NCT04004611|157084999|FG007|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
48794300|NCT04004611|157085000|FG008|OL Maintenance Period (Wk 12-52)|Adverse Event|1|||
48794301|NCT04004611|157084992|FG000|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
48794302|NCT04004611|157084993|FG001|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
48794303|NCT04004611|157084994|FG002|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
48794304|NCT04004611|157084995|FG003|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
48794305|NCT04004611|157084996|FG004|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
48794306|NCT04004611|157084997|FG005|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
48794307|NCT04004611|157084998|FG006|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
48794308|NCT04004611|157084999|FG007|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
48794309|NCT04004611|157085000|FG008|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|3|||
48794310|NCT04004611|157084992|FG000|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
48794311|NCT04004611|157084993|FG001|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
48794312|NCT04004611|157084994|FG002|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
48794313|NCT04004611|157084995|FG003|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
48794314|NCT04004611|157084996|FG004|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|1|||
48794315|NCT04004611|157084997|FG005|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
48794316|NCT04004611|157084998|FG006|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
48794317|NCT04004611|157084999|FG007|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
48794318|NCT04004611|157085000|FG008|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
48794319|NCT04004611|157084992|FG000|OL Induction and Maintenance Period|Adverse Event|0|||
48794320|NCT04004611|157084993|FG001|OL Induction and Maintenance Period|Adverse Event|0|||
48794321|NCT04004611|157084994|FG002|OL Induction and Maintenance Period|Adverse Event|1|||
49032866|NCT01675765|157955578|FG000|Overall Study|Progressive disease|4|||
48794322|NCT04004611|157084995|FG003|OL Induction and Maintenance Period|Adverse Event|0|||
48794323|NCT04004611|157084996|FG004|OL Induction and Maintenance Period|Adverse Event|0|||
48794324|NCT04004611|157084997|FG005|OL Induction and Maintenance Period|Adverse Event|0|||
48794325|NCT04004611|157084998|FG006|OL Induction and Maintenance Period|Adverse Event|0|||
48794326|NCT04004611|157084999|FG007|OL Induction and Maintenance Period|Adverse Event|0|||
48794327|NCT04004611|157085000|FG008|OL Induction and Maintenance Period|Adverse Event|0|||
48794328|NCT04004611|157084992|FG000|OL Induction and Maintenance Period|Lack of Efficacy|1|||
48794329|NCT04004611|157084993|FG001|OL Induction and Maintenance Period|Lack of Efficacy|0|||
48794330|NCT04004611|157084994|FG002|OL Induction and Maintenance Period|Lack of Efficacy|4|||
48794331|NCT04004611|157084995|FG003|OL Induction and Maintenance Period|Lack of Efficacy|0|||
48794332|NCT04004611|157084996|FG004|OL Induction and Maintenance Period|Lack of Efficacy|0|||
48794333|NCT04004611|157084997|FG005|OL Induction and Maintenance Period|Lack of Efficacy|0|||
48794334|NCT04004611|157084998|FG006|OL Induction and Maintenance Period|Lack of Efficacy|0|||
48794335|NCT04004611|157084999|FG007|OL Induction and Maintenance Period|Lack of Efficacy|0|||
48794336|NCT04004611|157085000|FG008|OL Induction and Maintenance Period|Lack of Efficacy|0|||
48794337|NCT04004611|157084992|FG000|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
48794338|NCT04004611|157084993|FG001|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|1|||
48794339|NCT04004611|157084994|FG002|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
48794340|NCT04004611|157084995|FG003|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
48794341|NCT04004611|157084996|FG004|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
48794342|NCT04004611|157084997|FG005|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
48794343|NCT04004611|157084998|FG006|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
48794344|NCT04004611|157084999|FG007|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
48794345|NCT04004611|157085000|FG008|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
48794346|NCT01292928|157085003|FG000|Overall Study|Death|8|||
48794347|NCT01292928|157085003|FG000|Overall Study|Withdrawal by Subject|8|||
48878454|NCT00416598|157394305|FG000|Induction & Intensification|Withdrawal by Subject|46|||
48878455|NCT00416598|157394305|FG000|Induction & Intensification|Alternative Treatment|135|||
48878456|NCT00416598|157394305|FG000|Induction & Intensification|Physician discretion/other medical issue|45|||
48878457|NCT00416598|157394305|FG000|Induction & Intensification|Relapse/progression|29|||
48878458|NCT00416598|157394305|FG000|Induction & Intensification|Failed induction|87|||
48878459|NCT00416598|157394305|FG000|Decitabine Maintenance|Adverse Event|5|||
48878460|NCT00416598|157394305|FG000|Decitabine Maintenance|Withdrawal by Subject|18|||
48878461|NCT00416598|157394305|FG000|Decitabine Maintenance|Progression/relapse|38|||
48878462|NCT00416598|157394305|FG000|Decitabine Maintenance|Alternative treatment|2|||
48878463|NCT00416598|157394305|FG000|Decitabine Maintenance|Physician discretion/other medical issue|9|||
49032867|NCT01675765|157955579|FG001|Overall Study|Progressive disease|4|||
49032868|NCT01675765|157955578|FG000|Overall Study|Adverse Event|1|||
49032869|NCT01675765|157955579|FG001|Overall Study|Adverse Event|2|||
49032870|NCT01675765|157955578|FG000|Overall Study|Withdrawal by Subject|2|||
49032871|NCT01675765|157955579|FG001|Overall Study|Withdrawal by Subject|0|||
49032872|NCT01675765|157955578|FG000|Overall Study|Death|1|||
49032873|NCT01675765|157955579|FG001|Overall Study|Death|0|||
49032874|NCT01675765|157955578|FG000|Overall Study|Clinical progression|3|||
49032875|NCT01675765|157955579|FG001|Overall Study|Clinical progression|2|||
49032876|NCT01200810|157955584|FG000|Overall Study|Physician Decision|1|||
48878464|NCT02053610|157394306|FG000|Overall Study|Adverse Event/Intercurrent Illness|25|||
48878465|NCT02053610|157394307|FG001|Overall Study|Adverse Event/Intercurrent Illness|43|||
49032877|NCT01200810|157955585|FG001|Overall Study|Physician Decision|0|||
49032878|NCT01200810|157955584|FG000|Overall Study|Withdrawal by Subject|1|||
49032879|NCT01200810|157955585|FG001|Overall Study|Withdrawal by Subject|2|||
49032880|NCT01200810|157955584|FG000|Overall Study|Sponsor stopped making study drug|3|||
49032881|NCT01200810|157955585|FG001|Overall Study|Sponsor stopped making study drug|3|||
48794348|NCT01292928|157085003|FG000|Overall Study|Lost to Follow-up|6|||
48794349|NCT01292928|157085003|FG000|Overall Study|Physician Decision|2|||
48794350|NCT04263311|157085004|FG000|Overall Study|Lost to Follow-up|1|||
48794351|NCT04263311|157085005|FG001|Overall Study|Lost to Follow-up|2|||
48794352|NCT04263311|157085006|FG002|Overall Study|Lost to Follow-up|0|||
48794353|NCT04263311|157085004|FG000|Overall Study|Health Issues|1|||
48794354|NCT04263311|157085005|FG001|Overall Study|Health Issues|0|||
48794355|NCT04263311|157085006|FG002|Overall Study|Health Issues|0|||
48794356|NCT04263311|157085004|FG000|Overall Study|Left the country|1|||
48794357|NCT04263311|157085005|FG001|Overall Study|Left the country|0|||
48794358|NCT04263311|157085006|FG002|Overall Study|Left the country|0|||
48794359|NCT04263311|157085004|FG000|Overall Study|Unable to maintain time commitment|1|||
48794360|NCT04263311|157085005|FG001|Overall Study|Unable to maintain time commitment|0|||
48794361|NCT04263311|157085006|FG002|Overall Study|Unable to maintain time commitment|0|||
48794362|NCT04263311|157085004|FG000|Overall Study|No longer interested|1|||
48794363|NCT04263311|157085005|FG001|Overall Study|No longer interested|0|||
48794364|NCT04263311|157085006|FG002|Overall Study|No longer interested|0|||
48794365|NCT04263311|157085004|FG000|Overall Study|Ineligible post consent|0|||
48794366|NCT04263311|157085005|FG001|Overall Study|Ineligible post consent|0|||
48794367|NCT04263311|157085006|FG002|Overall Study|Ineligible post consent|5|||
48794368|NCT01059565|157085007|FG000|24-Week Randomized Phase|Randomized but not treated|1|||
48794369|NCT01059565|157085008|FG001|24-Week Randomized Phase|Randomized but not treated|0|||
48794370|NCT01059565|157085007|FG000|24-Week Randomized Phase|Adverse Event|5|||
48794371|NCT01059565|157085008|FG001|24-Week Randomized Phase|Adverse Event|0|||
48794372|NCT01059565|157085007|FG000|24-Week Randomized Phase|Withdrawal by Subject|3|||
48794373|NCT01059565|157085008|FG001|24-Week Randomized Phase|Withdrawal by Subject|1|||
48794374|NCT01059565|157085007|FG000|24-Week Randomized Phase|Lost to Follow-up|0|||
48794375|NCT01059565|157085008|FG001|24-Week Randomized Phase|Lost to Follow-up|1|||
48794376|NCT01059565|157085007|FG000|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1|||
48794377|NCT01059565|157085008|FG001|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5|||
48794378|NCT01059565|157085007|FG000|24-Week Open-Label Phase|Adverse Event|2|||
48794379|NCT01059565|157085008|FG001|24-Week Open-Label Phase|Adverse Event|0|||
48794380|NCT01059565|157085007|FG000|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
48794381|NCT01059565|157085008|FG001|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
48794382|NCT01059565|157085007|FG000|24-Week Open-Label Phase|Withdrawal by Subject|1|||
48794383|NCT01059565|157085008|FG001|24-Week Open-Label Phase|Withdrawal by Subject|0|||
48794384|NCT01059565|157085007|FG000|24-Week Open-Label Phase|Subject noncompliance|1|||
48794385|NCT01059565|157085008|FG001|24-Week Open-Label Phase|Subject noncompliance|0|||
48794386|NCT01059565|157085007|FG000|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0|||
48794387|NCT01059565|157085008|FG001|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1|||
48794388|NCT01059565|157085007|FG000|24-Week Open-Label Phase|Pulmonologist/participant decision|0|||
48794389|NCT01059565|157085008|FG001|24-Week Open-Label Phase|Pulmonologist/participant decision|1|||
48794390|NCT03927950|157085014|FG000|Overall Study|Adverse Event|9|||
48794391|NCT03945188|157085017|FG000|Overall Study|Protocol Violation|1|||
48794392|NCT03945188|157085018|FG001|Overall Study|Protocol Violation|0|||
48794393|NCT03945188|157085017|FG000|Overall Study|Disease worsening|79|||
48794394|NCT03945188|157085018|FG001|Overall Study|Disease worsening|73|||
48794395|NCT03945188|157085017|FG000|Overall Study|Physician Decision|2|||
48794396|NCT03945188|157085018|FG001|Overall Study|Physician Decision|2|||
48794397|NCT03945188|157085017|FG000|Overall Study|Lack of Efficacy|7|||
48794398|NCT03945188|157085018|FG001|Overall Study|Lack of Efficacy|4|||
48794399|NCT03945188|157085017|FG000|Overall Study|Pregnancy|2|||
48794400|NCT03945188|157085018|FG001|Overall Study|Pregnancy|0|||
48794401|NCT03945188|157085017|FG000|Overall Study|Withdrawal by participant or parent/guardian|24|||
48794402|NCT03945188|157085018|FG001|Overall Study|Withdrawal by participant or parent/guardian|10|||
48794403|NCT03945188|157085017|FG000|Overall Study|Adverse Event|10|||
48794404|NCT03945188|157085018|FG001|Overall Study|Adverse Event|5|||
48794405|NCT03945188|157085017|FG000|Overall Study|Other|2|||
48794406|NCT03945188|157085018|FG001|Overall Study|Other|2|||
48794407|NCT03945188|157085017|FG000|Overall Study|Lost to Follow-up|1|||
48794408|NCT03945188|157085018|FG001|Overall Study|Lost to Follow-up|2|||
48794409|NCT02219048|157085019|FG000|Overall Study|Adverse Event|2|||
48794410|NCT02219048|157085020|FG001|Overall Study|Adverse Event|5|||
48794411|NCT02219048|157085019|FG000|Overall Study|No longer meets eligibility criteria|1|||
48794412|NCT02219048|157085020|FG001|Overall Study|No longer meets eligibility criteria|0|||
48794413|NCT02219048|157085019|FG000|Overall Study|Study terminated by sponsor|16|||
48794414|NCT02219048|157085020|FG001|Overall Study|Study terminated by sponsor|15|||
48794415|NCT02219048|157085019|FG000|Overall Study|Withdrawal by Subject|2|||
48983517|NCT00811395|157772288|FG001|Extension Treatment|Other than above|0|||
48983518|NCT00811395|157772289|FG002|Extension Treatment|Other than above|1|||
48983519|NCT00811395|157772290|FG003|Extension Treatment|Other than above|0|||
48983520|NCT00811395|157772291|FG004|Extension Treatment|Other than above|0|||
48983521|NCT00811395|157772292|FG005|Extension Treatment|Other than above|0|||
48983522|NCT01034709|157772295|FG000|Overall Study|Protocol Violation|9|||
48878466|NCT02053610|157394306|FG000|Overall Study|Withdrew Consent|2|||
48878467|NCT02053610|157394307|FG001|Overall Study|Withdrew Consent|9|||
48878468|NCT02053610|157394306|FG000|Overall Study|Death|5|||
49032882|NCT00365846|157955586|FG000|Overall Study|Lost to Follow-up|1|||
49032883|NCT02911792|157955589|FG000|Overall Study|Lost to Follow-up|3|||
49032884|NCT02911792|157955590|FG001|Overall Study|Lost to Follow-up|3|||
48794416|NCT02219048|157085020|FG001|Overall Study|Withdrawal by Subject|0|||
48794417|NCT02219048|157085019|FG000|Overall Study|Other|0|||
48794418|NCT02219048|157085020|FG001|Overall Study|Other|1|||
48794419|NCT02015676|157085021|FG000|Overall Study|Adverse Event|2|||
48794420|NCT02015676|157085022|FG001|Overall Study|Adverse Event|18|||
48794421|NCT02015676|157085023|FG002|Overall Study|Adverse Event|0|||
48794422|NCT02015676|157085021|FG000|Overall Study|Lack of Efficacy|2|||
48794423|NCT02015676|157085022|FG001|Overall Study|Lack of Efficacy|4|||
48794424|NCT02015676|157085023|FG002|Overall Study|Lack of Efficacy|0|||
48794425|NCT02015676|157085021|FG000|Overall Study|Protocol Violation|1|||
48794426|NCT02015676|157085022|FG001|Overall Study|Protocol Violation|0|||
48794427|NCT02015676|157085023|FG002|Overall Study|Protocol Violation|0|||
48794428|NCT02015676|157085021|FG000|Overall Study|Withdrawal by Subject|1|||
48794429|NCT02015676|157085022|FG001|Overall Study|Withdrawal by Subject|7|||
48794430|NCT02015676|157085023|FG002|Overall Study|Withdrawal by Subject|1|||
48794431|NCT02015676|157085021|FG000|Overall Study|Administrative reasons|0|||
48794432|NCT02015676|157085022|FG001|Overall Study|Administrative reasons|3|||
48794433|NCT02015676|157085023|FG002|Overall Study|Administrative reasons|1|||
48794434|NCT02015676|157085021|FG000|Overall Study|Death|0|||
48794435|NCT02015676|157085022|FG001|Overall Study|Death|1|||
48794436|NCT02015676|157085023|FG002|Overall Study|Death|0|||
48794437|NCT02015676|157085021|FG000|Overall Study|Disease progression|3|||
48794438|NCT02015676|157085022|FG001|Overall Study|Disease progression|1|||
48794439|NCT02015676|157085023|FG002|Overall Study|Disease progression|1|||
48794440|NCT00952367|157085024|FG000|Overall Study|Withdrawal by Subject|2|||
48794441|NCT00952367|157085024|FG000|Overall Study|Noncoordination|1|||
48794442|NCT00952367|157085024|FG000|Overall Study|Protocol Violation|3|||
48794443|NCT03625570|157085028|FG000|Primary Endpoint - Immediate Post|Withdrawal by Subject|2|||
48794444|NCT03625570|157085029|FG001|Primary Endpoint - Immediate Post|Withdrawal by Subject|1|||
48794445|NCT03625570|157085028|FG000|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|1|||
48794446|NCT03625570|157085029|FG001|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|0|||
48794447|NCT03625570|157085028|FG000|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|0|||
48794448|NCT03625570|157085029|FG001|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|1|||
48794449|NCT04728347|157085030|FG000|Overall Study|Sponsor decision|0|||
48794450|NCT04728347|157085031|FG001|Overall Study|Sponsor decision|0|||
48794451|NCT04728347|157085032|FG002|Overall Study|Sponsor decision|1|||
48794452|NCT04728347|157085033|FG003|Overall Study|Sponsor decision|0|||
48794453|NCT03644186|157085034|FG000|Overall Study|Withdrawal by Subject|1|||
48794454|NCT03644186|157085035|FG001|Overall Study|Withdrawal by Subject|1|||
48794455|NCT03853109|157085036|FG000|Overall Study|Withdrawal by Subject|0|||
48794456|NCT03853109|157085037|FG001|Overall Study|Withdrawal by Subject|0|||
48794457|NCT03853109|157085038|FG002|Overall Study|Withdrawal by Subject|1|||
48794458|NCT03853109|157085039|FG003|Overall Study|Withdrawal by Subject|2|||
48794459|NCT03853109|157085040|FG004|Overall Study|Withdrawal by Subject|1|||
48794460|NCT03853109|157085041|FG005|Overall Study|Withdrawal by Subject|4|||
48794461|NCT03853109|157085042|FG006|Overall Study|Withdrawal by Subject|5|||
48794462|NCT03853109|157085043|FG007|Overall Study|Withdrawal by Subject|3|||
48794463|NCT03853109|157085036|FG000|Overall Study|Decision by Sponsor|0|||
48794464|NCT03853109|157085037|FG001|Overall Study|Decision by Sponsor|0|||
48794465|NCT03853109|157085038|FG002|Overall Study|Decision by Sponsor|1|||
48794466|NCT03853109|157085039|FG003|Overall Study|Decision by Sponsor|0|||
48794467|NCT03853109|157085040|FG004|Overall Study|Decision by Sponsor|1|||
48794468|NCT03853109|157085041|FG005|Overall Study|Decision by Sponsor|1|||
48794469|NCT03853109|157085042|FG006|Overall Study|Decision by Sponsor|10|||
48794470|NCT03853109|157085043|FG007|Overall Study|Decision by Sponsor|2|||
48794471|NCT03853109|157085036|FG000|Overall Study|Lost to Follow-up|0|||
48794472|NCT03853109|157085037|FG001|Overall Study|Lost to Follow-up|0|||
48794473|NCT03853109|157085038|FG002|Overall Study|Lost to Follow-up|0|||
48794474|NCT03853109|157085039|FG003|Overall Study|Lost to Follow-up|0|||
48794475|NCT03853109|157085040|FG004|Overall Study|Lost to Follow-up|1|||
48794476|NCT03853109|157085041|FG005|Overall Study|Lost to Follow-up|3|||
48794477|NCT03853109|157085042|FG006|Overall Study|Lost to Follow-up|0|||
48794478|NCT03853109|157085043|FG007|Overall Study|Lost to Follow-up|0|||
48878469|NCT02053610|157394307|FG001|Overall Study|Death|5|||
48794479|NCT03853109|157085036|FG000|Overall Study|Death|2|||
48794480|NCT03853109|157085037|FG001|Overall Study|Death|5|||
48794481|NCT03853109|157085038|FG002|Overall Study|Death|8|||
48794482|NCT03853109|157085039|FG003|Overall Study|Death|10|||
48794483|NCT03853109|157085040|FG004|Overall Study|Death|3|||
48794484|NCT03853109|157085041|FG005|Overall Study|Death|20|||
48878470|NCT02053610|157394306|FG000|Overall Study|Administrative/Other|1|||
48878471|NCT02053610|157394307|FG001|Overall Study|Administrative/Other|1|||
49032885|NCT02911792|157955591|FG002|Overall Study|Lost to Follow-up|3|||
48794485|NCT03853109|157085042|FG006|Overall Study|Death|10|||
48794486|NCT03853109|157085043|FG007|Overall Study|Death|5|||
48794487|NCT00651664|157085050|FG000|Overall Study|Occurrence of Adverse Event(s)|0|||
48794488|NCT00651664|157085051|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
48794489|NCT00651664|157085052|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
48794490|NCT00651664|157085053|FG003|Overall Study|Occurrence of Adverse Event(s)|0|||
48794491|NCT00651664|157085054|FG004|Overall Study|Occurrence of Adverse Event(s)|0|||
48794492|NCT00651664|157085055|FG005|Overall Study|Occurrence of Adverse Event(s)|0|||
48794493|NCT00651664|157085056|FG006|Overall Study|Occurrence of Adverse Event(s)|1|||
48794494|NCT00651664|157085057|FG007|Overall Study|Occurrence of Adverse Event(s)|0|||
48794495|NCT00651664|157085058|FG008|Overall Study|Occurrence of Adverse Event(s)|1|||
48794496|NCT00651664|157085059|FG009|Overall Study|Occurrence of Adverse Event(s)|0|||
48794497|NCT00651664|157085050|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
48794498|NCT00651664|157085051|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
48794499|NCT00651664|157085052|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
48794500|NCT00651664|157085053|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
48794501|NCT00651664|157085054|FG004|Overall Study|Unsatisfactory Therapeutic Response|1|||
48794502|NCT00651664|157085055|FG005|Overall Study|Unsatisfactory Therapeutic Response|1|||
48794503|NCT00651664|157085056|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
48794504|NCT00651664|157085057|FG007|Overall Study|Unsatisfactory Therapeutic Response|1|||
48794505|NCT00651664|157085058|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
48794506|NCT00651664|157085059|FG009|Overall Study|Unsatisfactory Therapeutic Response|1|||
48794507|NCT00651664|157085050|FG000|Overall Study|Progressive Disease|3|||
48794508|NCT00651664|157085051|FG001|Overall Study|Progressive Disease|3|||
48794509|NCT00651664|157085052|FG002|Overall Study|Progressive Disease|3|||
48794510|NCT00651664|157085053|FG003|Overall Study|Progressive Disease|12|||
48794511|NCT00651664|157085054|FG004|Overall Study|Progressive Disease|4|||
48794512|NCT00651664|157085055|FG005|Overall Study|Progressive Disease|1|||
48794513|NCT00651664|157085056|FG006|Overall Study|Progressive Disease|3|||
48794514|NCT00651664|157085057|FG007|Overall Study|Progressive Disease|6|||
48794515|NCT00651664|157085058|FG008|Overall Study|Progressive Disease|5|||
48794516|NCT00651664|157085059|FG009|Overall Study|Progressive Disease|5|||
48794517|NCT00651664|157085050|FG000|Overall Study|Patient Declined Further Treatment|0|||
48794518|NCT00651664|157085051|FG001|Overall Study|Patient Declined Further Treatment|0|||
48794519|NCT00651664|157085052|FG002|Overall Study|Patient Declined Further Treatment|0|||
48794520|NCT00651664|157085053|FG003|Overall Study|Patient Declined Further Treatment|1|||
48794521|NCT00651664|157085054|FG004|Overall Study|Patient Declined Further Treatment|1|||
48794522|NCT00651664|157085055|FG005|Overall Study|Patient Declined Further Treatment|1|||
48794523|NCT00651664|157085056|FG006|Overall Study|Patient Declined Further Treatment|0|||
48794524|NCT00651664|157085057|FG007|Overall Study|Patient Declined Further Treatment|0|||
48794525|NCT00651664|157085058|FG008|Overall Study|Patient Declined Further Treatment|0|||
48794526|NCT00651664|157085059|FG009|Overall Study|Patient Declined Further Treatment|1|||
48794527|NCT00651664|157085050|FG000|Overall Study|Symptomatic Deterioration|0|||
48794528|NCT00651664|157085051|FG001|Overall Study|Symptomatic Deterioration|0|||
48794529|NCT00651664|157085052|FG002|Overall Study|Symptomatic Deterioration|0|||
48794530|NCT00651664|157085053|FG003|Overall Study|Symptomatic Deterioration|1|||
48794531|NCT00651664|157085054|FG004|Overall Study|Symptomatic Deterioration|0|||
48794532|NCT00651664|157085055|FG005|Overall Study|Symptomatic Deterioration|0|||
48794533|NCT00651664|157085056|FG006|Overall Study|Symptomatic Deterioration|1|||
48794534|NCT00651664|157085057|FG007|Overall Study|Symptomatic Deterioration|0|||
48794535|NCT00651664|157085058|FG008|Overall Study|Symptomatic Deterioration|1|||
48794536|NCT00651664|157085059|FG009|Overall Study|Symptomatic Deterioration|0|||
48794537|NCT00651664|157085050|FG000|Overall Study|Reason not Specified|0|||
48794538|NCT00651664|157085051|FG001|Overall Study|Reason not Specified|0|||
48794539|NCT00651664|157085052|FG002|Overall Study|Reason not Specified|0|||
48794540|NCT00651664|157085053|FG003|Overall Study|Reason not Specified|0|||
48794541|NCT00651664|157085054|FG004|Overall Study|Reason not Specified|0|||
48794542|NCT00651664|157085055|FG005|Overall Study|Reason not Specified|0|||
48794543|NCT00651664|157085056|FG006|Overall Study|Reason not Specified|1|||
48794544|NCT00651664|157085057|FG007|Overall Study|Reason not Specified|0|||
48794545|NCT00651664|157085058|FG008|Overall Study|Reason not Specified|0|||
48794546|NCT00651664|157085059|FG009|Overall Study|Reason not Specified|0|||
48794547|NCT02765412|157085060|FG000|Overall Study|Death|482|||
48794548|NCT02765412|157085061|FG001|Overall Study|Death|855|||
48794549|NCT03206203|157085062|FG000|Treatment|Death|38|||
48794550|NCT03206203|157085063|FG001|Treatment|Death|26|||
48794551|NCT03206203|157085064|FG002|Treatment|Death|0|||
48794552|NCT03206203|157085062|FG000|Treatment|Withdrawal by Subject|1|||
48794553|NCT03206203|157085063|FG001|Treatment|Withdrawal by Subject|0|||
48794554|NCT03206203|157085064|FG002|Treatment|Withdrawal by Subject|0|||
48794555|NCT03206203|157085062|FG000|Treatment|Lost to Follow-up|4|||
48794556|NCT03206203|157085063|FG001|Treatment|Lost to Follow-up|0|||
48794557|NCT03206203|157085064|FG002|Treatment|Lost to Follow-up|0|||
48794558|NCT03206203|157085062|FG000|Treatment|N/A in Follow-Up|8|||
48794559|NCT03206203|157085063|FG001|Treatment|N/A in Follow-Up|1|||
48794560|NCT03206203|157085064|FG002|Treatment|N/A in Follow-Up|0|||
48878472|NCT02053610|157394306|FG000|Overall Study|Disease Progression|2|||
48878473|NCT02053610|157394307|FG001|Overall Study|Disease Progression|3|||
48878474|NCT02053610|157394306|FG000|Overall Study|Refused treatment/Did not cooperate|1|||
48878475|NCT02053610|157394307|FG001|Overall Study|Refused treatment/Did not cooperate|3|||
48878476|NCT02053610|157394306|FG000|Overall Study|Did not Receive Treatment|4|||
48878477|NCT02053610|157394307|FG001|Overall Study|Did not Receive Treatment|2|||
48878478|NCT02053610|157394306|FG000|Overall Study|Insufficient Therapeutic Response|1|||
48878479|NCT02053610|157394307|FG001|Overall Study|Insufficient Therapeutic Response|1|||
48794561|NCT03206203|157085062|FG000|Treatment|Disease progression|0|||
48794562|NCT03206203|157085063|FG001|Treatment|Disease progression|1|||
48794563|NCT03206203|157085064|FG002|Treatment|Disease progression|0|||
48794564|NCT03206203|157085062|FG000|Treatment|Refused follow-up|0|||
48794565|NCT03206203|157085063|FG001|Treatment|Refused follow-up|1|||
48794566|NCT03206203|157085064|FG002|Treatment|Refused follow-up|0|||
48794567|NCT03206203|157085062|FG000|Treatment|Cross over to Arm 1|0|||
48794568|NCT03206203|157085063|FG001|Treatment|Cross over to Arm 1|19|||
48794569|NCT03206203|157085064|FG002|Treatment|Cross over to Arm 1|0|||
48794570|NCT03206203|157085062|FG000|Optional Cross-Over|Death|0|||
48794571|NCT03206203|157085063|FG001|Optional Cross-Over|Death|0|||
48794572|NCT03206203|157085064|FG002|Optional Cross-Over|Death|14|||
48794573|NCT03206203|157085062|FG000|Optional Cross-Over|Refused follow-up|0|||
48794574|NCT03206203|157085063|FG001|Optional Cross-Over|Refused follow-up|0|||
48794575|NCT03206203|157085064|FG002|Optional Cross-Over|Refused follow-up|2|||
48794576|NCT00951483|157085065|FG000|Overall Study|Physician Decision|4|||
48794577|NCT00951483|157085066|FG001|Overall Study|Physician Decision|0|||
48794578|NCT00951483|157085065|FG000|Overall Study|Withdrawal by Subject|15|||
48794579|NCT00951483|157085066|FG001|Overall Study|Withdrawal by Subject|0|||
48794580|NCT03565887|157085069|FG000|Overall Study|Adverse Event|1|||
48794581|NCT03565887|157085070|FG001|Overall Study|Adverse Event|0|||
48794582|NCT03565887|157085069|FG000|Overall Study|Withdrawal by Subject|0|||
48794583|NCT03565887|157085070|FG001|Overall Study|Withdrawal by Subject|2|||
48794584|NCT01152580|157085071|FG000|Overall Study|Withdrawal by Subject|0|||
48794585|NCT01152580|157085072|FG001|Overall Study|Withdrawal by Subject|1|||
48794586|NCT02677116|157085078|FG000|Overall Study|Adverse Event|0|||
48794587|NCT02677116|157085079|FG001|Overall Study|Adverse Event|1|||
48794588|NCT02677116|157085080|FG002|Overall Study|Adverse Event|0|||
48794589|NCT02677116|157085081|FG003|Overall Study|Adverse Event|0|||
48794590|NCT02677116|157085082|FG004|Overall Study|Adverse Event|0|||
48794591|NCT02677116|157085083|FG005|Overall Study|Adverse Event|1|||
48794592|NCT02677116|157085084|FG006|Overall Study|Adverse Event|1|||
48794593|NCT02677116|157085085|FG007|Overall Study|Adverse Event|0|||
48794594|NCT02677116|157085086|FG008|Overall Study|Adverse Event|0|||
48794595|NCT02677116|157085078|FG000|Overall Study|Physician Decision|0|||
48794596|NCT02677116|157085079|FG001|Overall Study|Physician Decision|2|||
48794597|NCT02677116|157085080|FG002|Overall Study|Physician Decision|3|||
48794598|NCT02677116|157085081|FG003|Overall Study|Physician Decision|2|||
48794599|NCT02677116|157085082|FG004|Overall Study|Physician Decision|1|||
48794600|NCT02677116|157085083|FG005|Overall Study|Physician Decision|3|||
48794601|NCT02677116|157085084|FG006|Overall Study|Physician Decision|1|||
48794602|NCT02677116|157085085|FG007|Overall Study|Physician Decision|1|||
48794603|NCT02677116|157085086|FG008|Overall Study|Physician Decision|2|||
48794604|NCT02677116|157085078|FG000|Overall Study|Withdrawal by parent or guardian|2|||
48794605|NCT02677116|157085079|FG001|Overall Study|Withdrawal by parent or guardian|1|||
48794606|NCT02677116|157085080|FG002|Overall Study|Withdrawal by parent or guardian|0|||
48794607|NCT02677116|157085081|FG003|Overall Study|Withdrawal by parent or guardian|1|||
48794608|NCT02677116|157085082|FG004|Overall Study|Withdrawal by parent or guardian|0|||
48878480|NCT02053610|157394306|FG000|Overall Study|Violation of Selection Criteria|1|||
48878481|NCT02053610|157394307|FG001|Overall Study|Violation of Selection Criteria|0|||
48878482|NCT01375673|157394308|FG000|Overall Study|Withdrawal by Subject|0|||
48878483|NCT01375673|157394309|FG001|Overall Study|Withdrawal by Subject|1|||
48878484|NCT02536742|157394310|FG000|Overall Study|Did not start protocol therapy|1|||
49032886|NCT02911792|157955592|FG003|Overall Study|Lost to Follow-up|3|||
49032887|NCT00927069|157955593|FG000|Week 0 to Week 12|Worsening of psoriasis|1|||
48794609|NCT02677116|157085083|FG005|Overall Study|Withdrawal by parent or guardian|0|||
48794610|NCT02677116|157085084|FG006|Overall Study|Withdrawal by parent or guardian|2|||
48794611|NCT02677116|157085085|FG007|Overall Study|Withdrawal by parent or guardian|1|||
48794612|NCT02677116|157085086|FG008|Overall Study|Withdrawal by parent or guardian|0|||
48794613|NCT02677116|157085078|FG000|Overall Study|Withdrawal by Subject|1|||
48878485|NCT02536742|157394310|FG000|Overall Study|Patient determined to have triple-negative breast cancer, thus not having the target disease|1|||
48794614|NCT02677116|157085079|FG001|Overall Study|Withdrawal by Subject|0|||
48794615|NCT02677116|157085080|FG002|Overall Study|Withdrawal by Subject|0|||
48794616|NCT02677116|157085081|FG003|Overall Study|Withdrawal by Subject|0|||
48794617|NCT02677116|157085082|FG004|Overall Study|Withdrawal by Subject|0|||
48878486|NCT02980523|157394311|FG000|Overall Study|Lost to Follow-up|1|||
48794618|NCT02677116|157085083|FG005|Overall Study|Withdrawal by Subject|0|||
48794619|NCT02677116|157085084|FG006|Overall Study|Withdrawal by Subject|0|||
49032888|NCT00927069|157955594|FG001|Week 0 to Week 12|Worsening of psoriasis|1|||
49032889|NCT00927069|157955595|FG002|Week 0 to Week 12|Worsening of psoriasis|0|||
49032890|NCT00927069|157955596|FG003|Week 0 to Week 12|Worsening of psoriasis|0|||
49032891|NCT00927069|157955593|FG000|Week 12 to Week 24|Lack of Efficacy|0|||
49032892|NCT00927069|157955594|FG001|Week 12 to Week 24|Lack of Efficacy|0|||
49032893|NCT00927069|157955595|FG002|Week 12 to Week 24|Lack of Efficacy|2|||
49032894|NCT00927069|157955596|FG003|Week 12 to Week 24|Lack of Efficacy|3|||
48794620|NCT02677116|157085085|FG007|Overall Study|Withdrawal by Subject|0|||
48794621|NCT02677116|157085086|FG008|Overall Study|Withdrawal by Subject|0|||
48794622|NCT02660827|157085087|FG000|From Study to End of Continued Access|Withdrawal by Subject|21|||
49032895|NCT00927069|157955593|FG000|Week 12 to Week 24|Lost to Follow-up|0|||
49032896|NCT00927069|157955594|FG001|Week 12 to Week 24|Lost to Follow-up|0|||
49032897|NCT00927069|157955595|FG002|Week 12 to Week 24|Lost to Follow-up|1|||
49032898|NCT00927069|157955596|FG003|Week 12 to Week 24|Lost to Follow-up|0|||
49032899|NCT00927069|157955593|FG000|Week 12 to Week 24|Withdrawal by Subject|1|||
49032900|NCT00927069|157955594|FG001|Week 12 to Week 24|Withdrawal by Subject|0|||
49032901|NCT00927069|157955595|FG002|Week 12 to Week 24|Withdrawal by Subject|0|||
49032902|NCT00927069|157955596|FG003|Week 12 to Week 24|Withdrawal by Subject|0|||
49032903|NCT00927069|157955593|FG000|Week 12 to Week 24|Had a vaccination, removed from study|1|||
49032904|NCT00927069|157955594|FG001|Week 12 to Week 24|Had a vaccination, removed from study|0|||
49032905|NCT00927069|157955595|FG002|Week 12 to Week 24|Had a vaccination, removed from study|0|||
49032906|NCT00927069|157955596|FG003|Week 12 to Week 24|Had a vaccination, removed from study|0|||
49032907|NCT03017885|157955597|FG000|Overall Study|Adverse Event|2|||
49032908|NCT03017885|157955598|FG001|Overall Study|Adverse Event|0|||
49032909|NCT03017885|157955599|FG002|Overall Study|Adverse Event|0|||
49032910|NCT03017885|157955600|FG003|Overall Study|Adverse Event|0|||
49032911|NCT03017885|157955601|FG004|Overall Study|Adverse Event|0|||
49032912|NCT03017885|157955602|FG005|Overall Study|Adverse Event|0|||
49032913|NCT03017885|157955597|FG000|Overall Study|Progression of disease|4|||
49032914|NCT03017885|157955598|FG001|Overall Study|Progression of disease|3|||
49032915|NCT03017885|157955599|FG002|Overall Study|Progression of disease|4|||
49032916|NCT03017885|157955600|FG003|Overall Study|Progression of disease|0|||
49032917|NCT03017885|157955601|FG004|Overall Study|Progression of disease|0|||
49032918|NCT03017885|157955602|FG005|Overall Study|Progression of disease|0|||
49032919|NCT03017885|157955597|FG000|Overall Study|Other than listed|1|||
49032920|NCT03017885|157955598|FG001|Overall Study|Other than listed|2|||
49032921|NCT03017885|157955599|FG002|Overall Study|Other than listed|1|||
49032922|NCT03017885|157955600|FG003|Overall Study|Other than listed|0|||
48794623|NCT02660827|157085087|FG000|From Study to End of Continued Access|Withdrawal by Sponsor|2|||
48794624|NCT02660827|157085087|FG000|From Study to End of Continued Access|Adverse Event|3|||
48794625|NCT02660827|157085087|FG000|From Study to End of Continued Access|didn't participate continued access period|5|||
48794626|NCT02660827|157085087|FG000|Period 1: Study Period|Withdrawal by Subject|1|||
48794627|NCT02660827|157085087|FG000|Period 2: Continued Access Period|Withdrawal by Subject|20|||
48794628|NCT02660827|157085087|FG000|Period 2: Continued Access Period|Withdrawal by Sponsor|2|||
48794629|NCT02660827|157085087|FG000|Period 2: Continued Access Period|Adverse Event|3|||
48794630|NCT03265600|157085088|FG000|Overall Study|Lost to Follow-up|17|||
48794631|NCT03265600|157085089|FG001|Overall Study|Lost to Follow-up|5|||
48794632|NCT03265600|157085088|FG000|Overall Study|Withdrawal by Subject|4|||
48794633|NCT03265600|157085089|FG001|Overall Study|Withdrawal by Subject|2|||
48794634|NCT03265600|157085088|FG000|Overall Study|Partially completed 8 wk or 24 wk survey|3|||
48794635|NCT03265600|157085089|FG001|Overall Study|Partially completed 8 wk or 24 wk survey|5|||
48794636|NCT00535730|157085090|FG000|Overall Study|Adverse Event|1|||
48794637|NCT00535730|157085091|FG001|Overall Study|Adverse Event|1|||
48794638|NCT00535730|157085090|FG000|Overall Study|Lost to Follow-up|0|||
48794639|NCT00535730|157085091|FG001|Overall Study|Lost to Follow-up|1|||
48794640|NCT00535730|157085090|FG000|Overall Study|Physician Decision|0|||
48794641|NCT00535730|157085091|FG001|Overall Study|Physician Decision|1|||
48794642|NCT00535730|157085090|FG000|Overall Study|Protocol Violation|1|||
48794643|NCT00535730|157085091|FG001|Overall Study|Protocol Violation|0|||
48794644|NCT00535730|157085090|FG000|Overall Study|Withdrawal by Subject|0|||
48794645|NCT00535730|157085091|FG001|Overall Study|Withdrawal by Subject|4|||
48794646|NCT00765388|157085098|FG000|Period 1|Lack of Efficacy|1|||
48794647|NCT00765388|157085099|FG001|Period 1|Lack of Efficacy|2|||
48794648|NCT00765388|157085098|FG000|Period 1|Lost to Follow-up|0|||
48794649|NCT00765388|157085099|FG001|Period 1|Lost to Follow-up|1|||
48794650|NCT00765388|157085098|FG000|Period 1|Herpes Zoster|0|||
48794651|NCT00765388|157085099|FG001|Period 1|Herpes Zoster|1|||
48794652|NCT00765388|157085098|FG000|Period 1|Hip operation|0|||
48794653|NCT00765388|157085099|FG001|Period 1|Hip operation|1|||
48794654|NCT01988779|157085100|FG000|Overall Study|Withdrawal by Subject|2|||
49032923|NCT03017885|157955601|FG004|Overall Study|Other than listed|0|||
49032924|NCT03017885|157955602|FG005|Overall Study|Other than listed|0|||
48794655|NCT01988779|157085101|FG001|Overall Study|Withdrawal by Subject|2|||
48794656|NCT01988779|157085100|FG000|Overall Study|Protocol Violation|1|||
48794657|NCT01988779|157085101|FG001|Overall Study|Protocol Violation|0|||
48794658|NCT04072159|157085102|FG000|Overall Study|Lost to Follow-up|6|||
48878487|NCT02980523|157394312|FG001|Overall Study|Lost to Follow-up|4|||
48878488|NCT02980523|157394313|FG002|Overall Study|Lost to Follow-up|1|||
48878489|NCT02980523|157394314|FG003|Overall Study|Lost to Follow-up|2|||
48878490|NCT02980523|157394315|FG004|Overall Study|Lost to Follow-up|1|||
48878491|NCT02980523|157394311|FG000|Overall Study|Excluded from analysis|1|||
48878492|NCT02980523|157394312|FG001|Overall Study|Excluded from analysis|3|||
48878493|NCT02980523|157394313|FG002|Overall Study|Excluded from analysis|1|||
48878494|NCT02980523|157394314|FG003|Overall Study|Excluded from analysis|1|||
48878495|NCT02980523|157394315|FG004|Overall Study|Excluded from analysis|1|||
48878496|NCT02980523|157394311|FG000|Overall Study|Lack of Efficacy|1|||
48878497|NCT02980523|157394312|FG001|Overall Study|Lack of Efficacy|4|||
48878498|NCT02980523|157394313|FG002|Overall Study|Lack of Efficacy|4|||
48878499|NCT02980523|157394314|FG003|Overall Study|Lack of Efficacy|5|||
48878500|NCT02980523|157394315|FG004|Overall Study|Lack of Efficacy|8|||
48878501|NCT02980523|157394311|FG000|Overall Study|Did not receive intervention|0|||
48878502|NCT02980523|157394312|FG001|Overall Study|Did not receive intervention|0|||
48878503|NCT02980523|157394313|FG002|Overall Study|Did not receive intervention|0|||
48878504|NCT02980523|157394314|FG003|Overall Study|Did not receive intervention|1|||
48878505|NCT02980523|157394315|FG004|Overall Study|Did not receive intervention|0|||
48878506|NCT00882115|157394316|FG000|Overall Study|Withdrawal by Subject|3|||
48878507|NCT00882115|157394316|FG000|Overall Study|did not respond to DEP challe|6|||
48878508|NCT03865953|157394317|FG000|First Intervention (4 Weeks)|Lost to Follow-up|2|||
48878509|NCT03865953|157394318|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
48878510|NCT03865953|157394317|FG000|First Intervention (4 Weeks)|Protocol Violation|0|||
48878511|NCT03865953|157394318|FG001|First Intervention (4 Weeks)|Protocol Violation|1|||
48878512|NCT03865953|157394317|FG000|Second Intervention (4 Weeks)|Lost to Follow-up|0|||
48878513|NCT03865953|157394318|FG001|Second Intervention (4 Weeks)|Lost to Follow-up|2|||
48878514|NCT04431726|157394332|FG000|Overall Study|Ongoing in the Study|55|||
48878515|NCT00632021|157394333|FG000|Overall Study|Withdrawal/death|4|||
48878516|NCT00632021|157394334|FG001|Overall Study|Withdrawal/death|7|||
48878517|NCT02803593|157394335|FG000|Overall Study|Lost to Follow-up|17|||
48878518|NCT02803593|157394336|FG001|Overall Study|Lost to Follow-up|35|||
48878519|NCT02601209|157394339|FG000|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
49032925|NCT03017885|157955597|FG000|Overall Study|Lost to Follow-up|2|||
49032926|NCT03017885|157955598|FG001|Overall Study|Lost to Follow-up|0|||
49032927|NCT03017885|157955599|FG002|Overall Study|Lost to Follow-up|3|||
49032928|NCT03017885|157955600|FG003|Overall Study|Lost to Follow-up|0|||
49032929|NCT03017885|157955601|FG004|Overall Study|Lost to Follow-up|0|||
49032930|NCT03017885|157955602|FG005|Overall Study|Lost to Follow-up|0|||
49032931|NCT03017885|157955597|FG000|Overall Study|Change to other anti-cancer therapy|0|||
49032932|NCT03017885|157955598|FG001|Overall Study|Change to other anti-cancer therapy|0|||
49032933|NCT03017885|157955599|FG002|Overall Study|Change to other anti-cancer therapy|1|||
49032934|NCT03017885|157955600|FG003|Overall Study|Change to other anti-cancer therapy|0|||
49032935|NCT03017885|157955601|FG004|Overall Study|Change to other anti-cancer therapy|0|||
49032936|NCT03017885|157955602|FG005|Overall Study|Change to other anti-cancer therapy|0|||
49032937|NCT03663179|157955605|FG000|Overall Study|Withdrawal by Subject|2|||
49032938|NCT03663179|157955606|FG001|Overall Study|Withdrawal by Subject|0|||
49032939|NCT03663179|157955605|FG000|Overall Study|Lost to Follow-up|1|||
49032940|NCT03663179|157955606|FG001|Overall Study|Lost to Follow-up|1|||
49032941|NCT03663179|157955605|FG000|Overall Study|Revealed exclusionary condition|1|||
49032942|NCT03663179|157955606|FG001|Overall Study|Revealed exclusionary condition|0|||
49032943|NCT02645409|157955607|FG000|Overall Study|Withdrawal by Subject|3|||
48794659|NCT04072159|157085103|FG001|Overall Study|Lost to Follow-up|6|||
48794660|NCT04072159|157085102|FG000|Overall Study|Withdrawal by Subject|2|||
48794661|NCT04072159|157085103|FG001|Overall Study|Withdrawal by Subject|0|||
48794662|NCT04450264|157086197|FG000|Overall Study|Incomplete survey|13|||
48794663|NCT04450264|157086198|FG001|Overall Study|Incomplete survey|19|||
48794664|NCT01738984|157086199|FG000|Overall Study|Pregnancy|4|||
48794665|NCT01738984|157086200|FG001|Overall Study|Pregnancy|0|||
48794666|NCT01738984|157086199|FG000|Overall Study|Withdrawal by Subject|1|||
48794667|NCT01738984|157086200|FG001|Overall Study|Withdrawal by Subject|0|||
48794668|NCT01738984|157086199|FG000|Overall Study|Lost to Follow-up|59|||
48794669|NCT01738984|157086200|FG001|Overall Study|Lost to Follow-up|39|||
48794670|NCT01625897|157086201|FG000|Overall Study|Adverse Event|27|||
48794671|NCT01625897|157086202|FG001|Overall Study|Adverse Event|10|||
48794672|NCT01625897|157086201|FG000|Overall Study|Physician Decision|0|||
48794673|NCT01625897|157086202|FG001|Overall Study|Physician Decision|1|||
48878520|NCT02601209|157394340|FG001|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
48878521|NCT02601209|157394341|FG002|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
48878522|NCT02601209|157394342|FG003|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
48878523|NCT02601209|157394343|FG004|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
49032944|NCT02645409|157955608|FG001|Overall Study|Withdrawal by Subject|0|||
49032945|NCT02645409|157955607|FG000|Overall Study|Physician Decision|1|||
48794674|NCT01625897|157086201|FG000|Overall Study|Withdrawal by Subject|25|||
48794675|NCT01625897|157086202|FG001|Overall Study|Withdrawal by Subject|3|||
48794676|NCT04050865|157086203|FG000|Overall Study|Adverse Event|1|||
48794677|NCT04050865|157086204|FG001|Overall Study|Adverse Event|0|||
48794678|NCT04050865|157086203|FG000|Overall Study|no insert|1|||
48794679|NCT04050865|157086204|FG001|Overall Study|no insert|0|||
48794680|NCT04050865|157086203|FG000|Overall Study|Only 1 insert|2|||
48794681|NCT04050865|157086204|FG001|Overall Study|Only 1 insert|3|||
48794682|NCT04050865|157086203|FG000|Overall Study|Physician Decision|0|||
48794683|NCT04050865|157086204|FG001|Overall Study|Physician Decision|1|||
48794684|NCT04050865|157086203|FG000|Overall Study|Withdrawal by Subject|0|||
48794685|NCT04050865|157086204|FG001|Overall Study|Withdrawal by Subject|1|||
48794686|NCT03597568|157086205|FG000|Overall Study|Withdrawal by Subject|1|||
48794687|NCT03597568|157086206|FG001|Overall Study|Withdrawal by Subject|1|||
48794688|NCT03597568|157086205|FG000|Overall Study|Unable to analyze vascular data|1|||
48794689|NCT03597568|157086206|FG001|Overall Study|Unable to analyze vascular data|1|||
48794690|NCT01471054|157086210|FG000|Overall Study|Study terminated prematurely|4|||
48794691|NCT01471054|157086211|FG001|Overall Study|Study terminated prematurely|0|||
48794692|NCT00686166|157086212|FG000|Overall Study|Adverse Event|7|||
48794693|NCT00686166|157086212|FG000|Overall Study|Withdrawal by Subject|1|||
48794694|NCT00686166|157086212|FG000|Overall Study|Progression/Relapse|1|||
48794695|NCT00686166|157086212|FG000|Overall Study|Death|1|||
48794696|NCT00686166|157086212|FG000|Overall Study|Not Protocol Specified|1|||
48794697|NCT00686166|157086212|FG000|Overall Study|Ineligible|5|||
48794698|NCT00686166|157086212|FG000|Overall Study|Did not begin protocol therapy|4|||
48794699|NCT03318523|157086213|FG000|PC Period: Up to Year 1|Adverse Event|1|||
48794700|NCT03318523|157086214|FG001|PC Period: Up to Year 1|Adverse Event|0|||
48794701|NCT03318523|157086215|FG002|PC Period: Up to Year 1|Adverse Event|2|||
48794702|NCT03318523|157086216|FG003|PC Period: Up to Year 1|Adverse Event|0|||
48794703|NCT03318523|157086217|FG004|PC Period: Up to Year 1|Adverse Event|0|||
48794704|NCT03318523|157086218|FG005|PC Period: Up to Year 1|Adverse Event|0|||
48794705|NCT03318523|157086219|FG006|PC Period: Up to Year 1|Adverse Event|0|||
48794706|NCT03318523|157086220|FG007|PC Period: Up to Year 1|Adverse Event|0|||
48794707|NCT03318523|157086221|FG008|PC Period: Up to Year 1|Adverse Event|0|||
48794708|NCT03318523|157086222|FG009|PC Period: Up to Year 1|Adverse Event|0|||
48794709|NCT03318523|157086213|FG000|PC Period: Up to Year 1|Consent Withdrawn|3|||
48794710|NCT03318523|157086214|FG001|PC Period: Up to Year 1|Consent Withdrawn|2|||
48794711|NCT03318523|157086215|FG002|PC Period: Up to Year 1|Consent Withdrawn|0|||
48794712|NCT03318523|157086216|FG003|PC Period: Up to Year 1|Consent Withdrawn|4|||
48794713|NCT03318523|157086217|FG004|PC Period: Up to Year 1|Consent Withdrawn|0|||
48794714|NCT03318523|157086218|FG005|PC Period: Up to Year 1|Consent Withdrawn|0|||
48794715|NCT03318523|157086219|FG006|PC Period: Up to Year 1|Consent Withdrawn|0|||
48794716|NCT03318523|157086220|FG007|PC Period: Up to Year 1|Consent Withdrawn|0|||
48794717|NCT03318523|157086221|FG008|PC Period: Up to Year 1|Consent Withdrawn|0|||
48794718|NCT03318523|157086222|FG009|PC Period: Up to Year 1|Consent Withdrawn|0|||
48794719|NCT03318523|157086213|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
48794720|NCT03318523|157086214|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
48794721|NCT03318523|157086215|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
48794722|NCT03318523|157086216|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
48794723|NCT03318523|157086217|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
48794724|NCT03318523|157086218|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
48794725|NCT03318523|157086219|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
48983523|NCT01034709|157772296|FG001|Overall Study|Protocol Violation|16|||
48983524|NCT01947127|157772297|FG000|Overall Study|Protocol Violation|18|||
48983525|NCT01947127|157772298|FG001|Overall Study|Protocol Violation|38|||
48983526|NCT01947127|157772297|FG000|Overall Study|Withdrawal by Subject|1|||
48983527|NCT01947127|157772298|FG001|Overall Study|Withdrawal by Subject|1|||
48983528|NCT01947127|157772297|FG000|Overall Study|Data loss|4|||
48983529|NCT01947127|157772298|FG001|Overall Study|Data loss|4|||
48983530|NCT01196091|157772299|FG000|Overall Study|Adverse Event|22|||
48983531|NCT01196091|157772300|FG001|Overall Study|Adverse Event|27|||
48983532|NCT01196091|157772301|FG002|Overall Study|Adverse Event|26|||
48983533|NCT01196091|157772299|FG000|Overall Study|Death|3|||
48983534|NCT01196091|157772300|FG001|Overall Study|Death|2|||
48983535|NCT01196091|157772301|FG002|Overall Study|Death|2|||
48983536|NCT01196091|157772299|FG000|Overall Study|Entry Criteria Not Met|11|||
48983537|NCT01196091|157772300|FG001|Overall Study|Entry Criteria Not Met|11|||
48983538|NCT01196091|157772301|FG002|Overall Study|Entry Criteria Not Met|10|||
48983539|NCT01196091|157772299|FG000|Overall Study|Lack of Efficacy|15|||
48983540|NCT01196091|157772300|FG001|Overall Study|Lack of Efficacy|12|||
48983541|NCT01196091|157772301|FG002|Overall Study|Lack of Efficacy|17|||
48983542|NCT01196091|157772299|FG000|Overall Study|Lost to Follow-up|5|||
48983543|NCT01196091|157772300|FG001|Overall Study|Lost to Follow-up|5|||
48983544|NCT01196091|157772301|FG002|Overall Study|Lost to Follow-up|6|||
48983545|NCT01196091|157772299|FG000|Overall Study|Parent/Caregiver Decision|0|||
48983546|NCT01196091|157772300|FG001|Overall Study|Parent/Caregiver Decision|0|||
48983547|NCT01196091|157772301|FG002|Overall Study|Parent/Caregiver Decision|1|||
48983548|NCT01196091|157772299|FG000|Overall Study|Withdrawal by Subject|16|||
48983549|NCT01196091|157772300|FG001|Overall Study|Withdrawal by Subject|19|||
48794726|NCT03318523|157086220|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
48794727|NCT03318523|157086221|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
48794728|NCT03318523|157086222|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|2|||
48794729|NCT03318523|157086213|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
48794730|NCT03318523|157086214|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
48794731|NCT03318523|157086215|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
49032946|NCT02645409|157955608|FG001|Overall Study|Physician Decision|0|||
49032947|NCT01723397|157955614|FG000|Study Period 1|Protocol Violation|0|||
49032948|NCT01723397|157955615|FG001|Study Period 1|Protocol Violation|1|||
49032949|NCT01723397|157955614|FG000|Study Period 2|Protocol Violation|0|||
49032950|NCT01723397|157955615|FG001|Study Period 2|Protocol Violation|1|||
49032951|NCT03084471|157955619|FG000|Overall Study|Development of study specific discontinuation criteria|2|||
49032952|NCT03084471|157955619|FG000|Overall Study|Condition under investigation worsened|84|||
49032953|NCT03084471|157955619|FG000|Overall Study|Lack of therapeutic response|2|||
49032954|NCT03084471|157955619|FG000|Overall Study|Protocol Violation|1|||
49032955|NCT03084471|157955619|FG000|Overall Study|Adverse Event|73|||
49032956|NCT03084471|157955619|FG000|Overall Study|Withdrawal by Subject|12|||
49032957|NCT03084471|157955619|FG000|Overall Study|Disease relapse|181|||
49032958|NCT03084471|157955619|FG000|Overall Study|Subjective disease progression|359|||
49032959|NCT03084471|157955619|FG000|Overall Study|Other (as recorded)|33|||
49032960|NCT03084471|157955619|FG000|Overall Study|Patients who were still on study treatment at Data Cutoff|120|||
49032961|NCT01848938|157955624|FG000|Overall Study|Lost to Follow-up|1|||
49032962|NCT01848938|157955625|FG001|Overall Study|Lost to Follow-up|1|||
49032963|NCT04608188|157955629|FG000|Overall Study|Withdrawal by Subject|4|||
49032964|NCT04608188|157955630|FG001|Overall Study|Withdrawal by Subject|8|||
49032965|NCT01250912|157955633|FG000|Overall Study|Lost to Follow-up|1|||
49032966|NCT01218867|157955636|FG000|Overall Study|Death during treatment|0|||
49032967|NCT01218867|157955637|FG001|Overall Study|Death during treatment|0|||
49032968|NCT01218867|157955638|FG002|Overall Study|Death during treatment|0|||
49032969|NCT01218867|157955639|FG003|Overall Study|Death during treatment|0|||
49032970|NCT01218867|157955640|FG004|Overall Study|Death during treatment|0|||
49032971|NCT01218867|157955641|FG005|Overall Study|Death during treatment|0|||
49032972|NCT01218867|157955642|FG006|Overall Study|Death during treatment|1|||
49032973|NCT01218867|157955643|FG007|Overall Study|Death during treatment|0|||
49032974|NCT01218867|157955644|FG008|Overall Study|Death during treatment|0|||
49032975|NCT01218867|157955645|FG009|Overall Study|Death during treatment|0|||
49032976|NCT01218867|157955646|FG010|Overall Study|Death during treatment|0|||
49032977|NCT03792477|157955648|FG000|Overall Study|Adverse Event|0|||
49032978|NCT03792477|157955649|FG001|Overall Study|Adverse Event|0|||
49032979|NCT03792477|157955650|FG002|Overall Study|Adverse Event|0|||
49032980|NCT03792477|157955651|FG003|Overall Study|Adverse Event|1|||
49032981|NCT03792477|157955652|FG004|Overall Study|Adverse Event|0|||
49032982|NCT03792477|157955648|FG000|Overall Study|Lost to Follow-up|0|||
48794732|NCT03318523|157086216|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
49032983|NCT03792477|157955649|FG001|Overall Study|Lost to Follow-up|0|||
48794733|NCT03318523|157086217|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
48794734|NCT03318523|157086218|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
48794735|NCT03318523|157086219|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
48794736|NCT03318523|157086220|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
48794737|NCT03318523|157086221|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|3|||
48794738|NCT03318523|157086222|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|2|||
48794739|NCT03318523|157086213|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
48794740|NCT03318523|157086214|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
48794741|NCT03318523|157086215|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
48794742|NCT03318523|157086216|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
49032984|NCT03792477|157955650|FG002|Overall Study|Lost to Follow-up|2|||
49032985|NCT03792477|157955651|FG003|Overall Study|Lost to Follow-up|0|||
49032986|NCT03792477|157955652|FG004|Overall Study|Lost to Follow-up|0|||
49032987|NCT03792477|157955648|FG000|Overall Study|Other|0|||
49032988|NCT03792477|157955649|FG001|Overall Study|Other|0|||
49032989|NCT03792477|157955650|FG002|Overall Study|Other|0|||
49032990|NCT03792477|157955651|FG003|Overall Study|Other|0|||
49032991|NCT03792477|157955652|FG004|Overall Study|Other|1|||
49032992|NCT00073307|157955653|FG000|Double-Blind (DB, as of ~31May2005)|Adverse Event|22|||
48794743|NCT03318523|157086217|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
49032993|NCT00073307|157955654|FG001|Double-Blind (DB, as of ~31May2005)|Adverse Event|17|||
49032994|NCT00073307|157955655|FG002|Double-Blind (DB, as of ~31May2005)|Adverse Event|0|||
49032995|NCT00073307|157955653|FG000|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1|||
49032996|NCT00073307|157955654|FG001|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6|||
49032997|NCT00073307|157955655|FG002|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0|||
49032998|NCT00073307|157955653|FG000|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6|||
49032999|NCT00073307|157955654|FG001|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11|||
48794744|NCT03318523|157086218|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|1|||
48794745|NCT03318523|157086219|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
48794746|NCT03318523|157086220|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
48794747|NCT03318523|157086221|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
48794748|NCT03318523|157086222|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
48794749|NCT03318523|157086213|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
48794750|NCT03318523|157086214|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
48794751|NCT03318523|157086215|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
48794752|NCT03318523|157086216|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
48794753|NCT03318523|157086217|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
48794754|NCT03318523|157086218|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
48794755|NCT03318523|157086219|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
48794756|NCT03318523|157086220|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
48794757|NCT03318523|157086221|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
48794758|NCT03318523|157086222|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|1|||
48794759|NCT03318523|157086213|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
48794760|NCT03318523|157086214|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
48794761|NCT03318523|157086215|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
48794762|NCT03318523|157086216|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
48794763|NCT03318523|157086217|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|17|||
48794764|NCT03318523|157086218|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|36|||
48794765|NCT03318523|157086219|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|39|||
48794766|NCT03318523|157086220|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|48|||
48794767|NCT03318523|157086221|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|94|||
48794768|NCT03318523|157086222|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|91|||
48794769|NCT03318523|157086213|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
48794770|NCT03318523|157086214|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
48794771|NCT03318523|157086215|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
48794772|NCT03318523|157086216|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
48794773|NCT03318523|157086217|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|1|||
48794774|NCT03318523|157086218|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
48794775|NCT03318523|157086219|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
48794776|NCT03318523|157086220|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|2|||
48794777|NCT03318523|157086221|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|3|||
48794778|NCT03318523|157086222|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
48794779|NCT03031938|157086223|FG000|Overall Study|Death|1|||
48794780|NCT03031938|157086224|FG001|Overall Study|Death|0|||
49033000|NCT00073307|157955655|FG002|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0|||
49033001|NCT00073307|157955653|FG000|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
48794781|NCT00454051|157086225|FG000|Overall Study|Adverse Event|1|||
48794782|NCT00454051|157086226|FG001|Overall Study|Adverse Event|2|||
48794783|NCT00454051|157086225|FG000|Overall Study|Withdrawal by Subject|1|||
48794784|NCT00454051|157086226|FG001|Overall Study|Withdrawal by Subject|0|||
48794785|NCT00454051|157086225|FG000|Overall Study|Protocol Violation|1|||
48794786|NCT00454051|157086226|FG001|Overall Study|Protocol Violation|1|||
48794787|NCT02261493|157086227|FG000|Overall Study|Noncompliance|0|||
48794788|NCT02261493|157086228|FG001|Overall Study|Noncompliance|0|||
48794789|NCT02261493|157086229|FG002|Overall Study|Noncompliance|2|||
48794790|NCT02261493|157086227|FG000|Overall Study|Physician Decision|0|||
48794791|NCT02261493|157086228|FG001|Overall Study|Physician Decision|1|||
48794792|NCT02261493|157086229|FG002|Overall Study|Physician Decision|0|||
48794793|NCT02261493|157086227|FG000|Overall Study|Undisclosed alcohol abuse|0|||
48794794|NCT02261493|157086228|FG001|Overall Study|Undisclosed alcohol abuse|1|||
48794795|NCT02261493|157086229|FG002|Overall Study|Undisclosed alcohol abuse|0|||
48794796|NCT02261493|157086227|FG000|Overall Study|Protocol Violation|1|||
48794797|NCT02261493|157086228|FG001|Overall Study|Protocol Violation|0|||
48794798|NCT02261493|157086229|FG002|Overall Study|Protocol Violation|0|||
49033002|NCT00073307|157955654|FG001|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
49033003|NCT00073307|157955655|FG002|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0|||
49033004|NCT00073307|157955653|FG000|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1|||
49033005|NCT00073307|157955654|FG001|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2|||
48794799|NCT02261493|157086227|FG000|Overall Study|Personal Reasons|14|||
48794800|NCT02261493|157086228|FG001|Overall Study|Personal Reasons|14|||
48794801|NCT02261493|157086229|FG002|Overall Study|Personal Reasons|16|||
48794802|NCT02261493|157086227|FG000|Overall Study|Lost to Follow-up|14|||
48878524|NCT02601209|157394344|FG005|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
49033006|NCT00073307|157955655|FG002|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0|||
49033007|NCT00073307|157955653|FG000|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1|||
49033008|NCT00073307|157955654|FG001|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
48794803|NCT02261493|157086228|FG001|Overall Study|Lost to Follow-up|27|||
48794804|NCT02261493|157086229|FG002|Overall Study|Lost to Follow-up|8|||
48794805|NCT02261493|157086227|FG000|Overall Study|Pregnancy|1|||
48794806|NCT02261493|157086228|FG001|Overall Study|Pregnancy|2|||
48794807|NCT02261493|157086229|FG002|Overall Study|Pregnancy|0|||
48794808|NCT02261493|157086227|FG000|Overall Study|Lack of Efficacy|0|||
48794809|NCT02261493|157086228|FG001|Overall Study|Lack of Efficacy|1|||
48794810|NCT02261493|157086229|FG002|Overall Study|Lack of Efficacy|0|||
48794811|NCT02261493|157086227|FG000|Overall Study|Adverse Event|0|||
48794812|NCT02261493|157086228|FG001|Overall Study|Adverse Event|1|||
48794813|NCT02261493|157086229|FG002|Overall Study|Adverse Event|0|||
48794814|NCT01984684|157086234|FG000|Overall Study|Lost to Follow-up|25|||
48794815|NCT01984684|157086235|FG001|Overall Study|Lost to Follow-up|24|||
48794816|NCT01984684|157086234|FG000|Overall Study|Adverse Event|8|||
48794817|NCT01984684|157086235|FG001|Overall Study|Adverse Event|12|||
48794818|NCT01984684|157086234|FG000|Overall Study|Withdrawal by Subject|9|||
48794819|NCT01984684|157086235|FG001|Overall Study|Withdrawal by Subject|9|||
48794820|NCT01984684|157086234|FG000|Overall Study|Lack of Efficacy|3|||
48794821|NCT01984684|157086235|FG001|Overall Study|Lack of Efficacy|6|||
48794822|NCT01984684|157086234|FG000|Overall Study|Physician Decision|4|||
48794823|NCT01984684|157086235|FG001|Overall Study|Physician Decision|2|||
48794824|NCT01984684|157086234|FG000|Overall Study|Protocol Violation|4|||
48794825|NCT01984684|157086235|FG001|Overall Study|Protocol Violation|2|||
48794826|NCT01984684|157086234|FG000|Overall Study|Death|0|||
48794827|NCT01984684|157086235|FG001|Overall Study|Death|1|||
48794828|NCT01984684|157086234|FG000|Overall Study|Noncompliance with study drug|2|||
49033009|NCT00073307|157955655|FG002|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
49033010|NCT00073307|157955653|FG000|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
49033011|NCT00073307|157955654|FG001|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1|||
49033012|NCT00073307|157955655|FG002|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
49033013|NCT00073307|157955653|FG000|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165|||
49033014|NCT00073307|157955654|FG001|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114|||
49033015|NCT00073307|157955655|FG002|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0|||
49033016|NCT00073307|157955653|FG000|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
49033017|NCT00073307|157955654|FG001|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1|||
49033018|NCT00073307|157955655|FG002|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
49033019|NCT00073307|157955653|FG000|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17|||
49033020|NCT00073307|157955654|FG001|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0|||
49033021|NCT00073307|157955655|FG002|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19|||
49033022|NCT00073307|157955653|FG000|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
49033023|NCT00073307|157955654|FG001|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0|||
49033024|NCT00073307|157955655|FG002|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
49033025|NCT00073307|157955653|FG000|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19|||
49033026|NCT00073307|157955654|FG001|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0|||
49033027|NCT00073307|157955655|FG002|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9|||
49033028|NCT00073307|157955653|FG000|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37|||
49033029|NCT00073307|157955654|FG001|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0|||
49033030|NCT00073307|157955655|FG002|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28|||
49033031|NCT00073307|157955653|FG000|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
49033032|NCT00073307|157955654|FG001|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0|||
48794829|NCT01984684|157086235|FG001|Overall Study|Noncompliance with study drug|1|||
48794830|NCT01984684|157086234|FG000|Overall Study|Subject incarcerated|1|||
48794831|NCT01984684|157086235|FG001|Overall Study|Subject incarcerated|0|||
48794832|NCT01984684|157086234|FG000|Overall Study|Study drug not available at site|1|||
48794833|NCT01984684|157086235|FG001|Overall Study|Study drug not available at site|1|||
48794834|NCT01984684|157086234|FG000|Overall Study|Subject had inadequate IV access|0|||
48794835|NCT01984684|157086235|FG001|Overall Study|Subject had inadequate IV access|1|||
48794836|NCT03152526|157086236|FG000|Overall Study|Withdrawal by Subject|0|||
48794837|NCT03152526|157086237|FG001|Overall Study|Withdrawal by Subject|1|||
48794838|NCT00512070|157086238|FG000|Phase I - Olanzapine Only|Lost to Follow-up|4|||
48794839|NCT00512070|157086239|FG001|Phase I - Olanzapine Only|Lost to Follow-up|0|||
48794840|NCT00512070|157086240|FG002|Phase I - Olanzapine Only|Lost to Follow-up|0|||
48794841|NCT00512070|157086238|FG000|Phase II - Randomization to Melatonin|Data unable to be collected|0|||
48794842|NCT00512070|157086239|FG001|Phase II - Randomization to Melatonin|Data unable to be collected|2|||
48794843|NCT00512070|157086240|FG002|Phase II - Randomization to Melatonin|Data unable to be collected|1|||
48794844|NCT04307004|157086241|FG000|Randomization 1|Withdrawal by Subject|25|||
48794845|NCT04307004|157086242|FG001|Randomization 1|Withdrawal by Subject|26|||
48794846|NCT04307004|157086243|FG002|Randomization 1|Withdrawal by Subject|0|||
48794847|NCT04307004|157086244|FG003|Randomization 1|Withdrawal by Subject|0|||
48794848|NCT04307004|157086241|FG000|Randomization 2|Withdrawal by Subject|0|||
48794849|NCT04307004|157086242|FG001|Randomization 2|Withdrawal by Subject|0|||
48794850|NCT04307004|157086243|FG002|Randomization 2|Withdrawal by Subject|28|||
48794851|NCT04307004|157086244|FG003|Randomization 2|Withdrawal by Subject|23|||
48794852|NCT04702568|157086256|FG000|Overall Study|Transitioned to the BCX9930-205 roll-over study|10|||
48794853|NCT04702568|157086257|FG001|Overall Study|Transitioned to the BCX9930-205 roll-over study|4|||
48794854|NCT04702568|157086256|FG000|Overall Study|Pregnancy|1|||
49033033|NCT00073307|157955655|FG002|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
49033034|NCT00073307|157955653|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
49033035|NCT00073307|157955654|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0|||
49033036|NCT00073307|157955655|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
48794855|NCT04702568|157086257|FG001|Overall Study|Pregnancy|0|||
48794856|NCT04702568|157086256|FG000|Overall Study|Bone marrow transplant|1|||
48794857|NCT04702568|157086257|FG001|Overall Study|Bone marrow transplant|0|||
48794858|NCT04702568|157086256|FG000|Overall Study|Withdrawn due to Investigator decision|0|||
48794859|NCT04702568|157086257|FG001|Overall Study|Withdrawn due to Investigator decision|1|||
48794860|NCT04702568|157086256|FG000|Overall Study|Withdrawal by Subject|0|||
48794861|NCT04702568|157086257|FG001|Overall Study|Withdrawal by Subject|2|||
48794862|NCT02395042|157086258|FG000|Treatment 1 Period|Adverse Event|1|||
48794863|NCT02395042|157086259|FG001|Treatment 1 Period|Adverse Event|3|||
48794864|NCT02395042|157086260|FG002|Treatment 1 Period|Adverse Event|1|||
48794865|NCT02395042|157086258|FG000|Treatment 1 Period|Lack of Efficacy|1|||
48794866|NCT02395042|157086259|FG001|Treatment 1 Period|Lack of Efficacy|1|||
48794867|NCT02395042|157086260|FG002|Treatment 1 Period|Lack of Efficacy|0|||
48794868|NCT02395042|157086258|FG000|Treatment 1 Period|Lost to Follow-up|1|||
48794869|NCT02395042|157086259|FG001|Treatment 1 Period|Lost to Follow-up|0|||
48794870|NCT02395042|157086260|FG002|Treatment 1 Period|Lost to Follow-up|0|||
48794871|NCT02395042|157086258|FG000|Treatment 1 Period|Other Miscellaneous Reasons|0|||
48794872|NCT02395042|157086259|FG001|Treatment 1 Period|Other Miscellaneous Reasons|2|||
48794873|NCT02395042|157086260|FG002|Treatment 1 Period|Other Miscellaneous Reasons|1|||
48794874|NCT02395042|157086258|FG000|Treatment 2 Period|Lack of Efficacy|1|||
48794875|NCT02395042|157086259|FG001|Treatment 2 Period|Lack of Efficacy|1|||
48794876|NCT02395042|157086260|FG002|Treatment 2 Period|Lack of Efficacy|0|||
48794877|NCT04485039|157086261|FG000|TPOXX Only|Adverse Event|2|||
48794878|NCT04485039|157086261|FG000|TPOXX Only|Physician Decision|1|||
48794879|NCT04485039|157086261|FG000|TPOXX With Sevelamer Carbonate|Adverse Event|1|||
48794880|NCT04485039|157086261|FG000|TPOXX With Sevelamer Carbonate|Withdrawal by Subject|1|||
48794881|NCT01483924|157086262|FG000|Overall Study|Withdrawal by Subject|2|||
48794882|NCT01483924|157086263|FG001|Overall Study|Withdrawal by Subject|0|||
48794883|NCT01483924|157086264|FG002|Overall Study|Withdrawal by Subject|0|||
48794884|NCT01483924|157086265|FG003|Overall Study|Withdrawal by Subject|1|||
48794885|NCT01483924|157086266|FG004|Overall Study|Withdrawal by Subject|1|||
48794886|NCT01483924|157086262|FG000|Overall Study|Adverse Event|0|||
48794887|NCT01483924|157086263|FG001|Overall Study|Adverse Event|0|||
48794888|NCT01483924|157086264|FG002|Overall Study|Adverse Event|1|||
48794889|NCT01483924|157086265|FG003|Overall Study|Adverse Event|1|||
48794890|NCT01483924|157086266|FG004|Overall Study|Adverse Event|0|||
48794891|NCT01483924|157086262|FG000|Overall Study|Non-compliance|0|||
48794892|NCT01483924|157086263|FG001|Overall Study|Non-compliance|0|||
48794893|NCT01483924|157086264|FG002|Overall Study|Non-compliance|0|||
48794894|NCT01483924|157086265|FG003|Overall Study|Non-compliance|1|||
48794895|NCT01483924|157086266|FG004|Overall Study|Non-compliance|1|||
48794896|NCT01483924|157086262|FG000|Overall Study|Sponsor concern over ECG result|0|||
48794897|NCT01483924|157086263|FG001|Overall Study|Sponsor concern over ECG result|0|||
48794898|NCT01483924|157086264|FG002|Overall Study|Sponsor concern over ECG result|0|||
48794899|NCT01483924|157086265|FG003|Overall Study|Sponsor concern over ECG result|1|||
48794900|NCT01483924|157086266|FG004|Overall Study|Sponsor concern over ECG result|0|||
48794901|NCT01596582|157086267|FG000|Overall Study|Deemed ineligible after study visit|3|||
48794902|NCT01596582|157086268|FG001|Overall Study|Deemed ineligible after study visit|6|||
48794903|NCT01596582|157086267|FG000|Overall Study|Missing all outcome data|1|||
48794904|NCT01596582|157086268|FG001|Overall Study|Missing all outcome data|1|||
48794905|NCT00695669|157086279|FG000|Overall Study|Adverse Event|0|||
48794906|NCT00695669|157086280|FG001|Overall Study|Adverse Event|0|||
48794907|NCT00695669|157086281|FG002|Overall Study|Adverse Event|2|||
48794908|NCT00695669|157086282|FG003|Overall Study|Adverse Event|0|||
48794909|NCT00695669|157086279|FG000|Overall Study|Lost to Follow-up|4|||
48794910|NCT00695669|157086280|FG001|Overall Study|Lost to Follow-up|4|||
48794911|NCT00695669|157086281|FG002|Overall Study|Lost to Follow-up|1|||
48794912|NCT00695669|157086282|FG003|Overall Study|Lost to Follow-up|4|||
48794913|NCT02191267|157086283|FG000|Overall Study|Withdrawal by Subject|1|||
48794914|NCT02191267|157086284|FG001|Overall Study|Withdrawal by Subject|0|||
48794915|NCT02191267|157086285|FG002|Overall Study|Withdrawal by Subject|0|||
48794916|NCT00528775|157086288|FG000|Overall Study|Other not specified|1|||
48794917|NCT01018394|157086289|FG000|Overall Study|Withdrawal by Subject|5|||
48794918|NCT01018394|157086290|FG001|Overall Study|Withdrawal by Subject|5|||
48794919|NCT01018394|157086289|FG000|Overall Study|Lost to Follow-up|4|||
48794920|NCT01018394|157086290|FG001|Overall Study|Lost to Follow-up|3|||
48794921|NCT05576155|157086291|FG000|Overall Study|Withdrawal by Subject|1|||
48794922|NCT05576155|157086292|FG001|Overall Study|Withdrawal by Subject|1|||
48794923|NCT04625725|157086295|FG000|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|1|||
48794924|NCT04625725|157086296|FG001|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
48794925|NCT04625725|157086297|FG002|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
48794926|NCT04625725|157086298|FG003|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
48794927|NCT04625725|157086299|FG004|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
48794928|NCT04625725|157086300|FG005|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
48794929|NCT04625725|157086295|FG000|Provent Main Study|Withdrawal by Subject|242|||
48794930|NCT04625725|157086296|FG001|Provent Main Study|Withdrawal by Subject|144|||
48794931|NCT04625725|157086297|FG002|Provent Main Study|Withdrawal by Subject|0|||
48794932|NCT04625725|157086298|FG003|Provent Main Study|Withdrawal by Subject|0|||
48794933|NCT04625725|157086299|FG004|Provent Main Study|Withdrawal by Subject|0|||
48878525|NCT02601209|157394345|FG006|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
48878526|NCT02601209|157394346|FG007|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
48878527|NCT02601209|157394347|FG008|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
48878528|NCT02601209|157394339|FG000|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
48878529|NCT02601209|157394340|FG001|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
48878530|NCT02601209|157394341|FG002|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
48878531|NCT02601209|157394342|FG003|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
48878532|NCT02601209|157394343|FG004|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
48878533|NCT02601209|157394344|FG005|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2|||
48878534|NCT02601209|157394345|FG006|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
48878535|NCT02601209|157394346|FG007|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
48794934|NCT04625725|157086300|FG005|Provent Main Study|Withdrawal by Subject|0|||
48794935|NCT04625725|157086295|FG000|Provent Main Study|Physician Decision|5|||
48794936|NCT04625725|157086296|FG001|Provent Main Study|Physician Decision|0|||
48794937|NCT04625725|157086297|FG002|Provent Main Study|Physician Decision|0|||
48794938|NCT04625725|157086298|FG003|Provent Main Study|Physician Decision|0|||
48794939|NCT04625725|157086299|FG004|Provent Main Study|Physician Decision|0|||
48794940|NCT04625725|157086300|FG005|Provent Main Study|Physician Decision|0|||
48794941|NCT04625725|157086295|FG000|Provent Main Study|Protocol Violation|1|||
48794942|NCT04625725|157086296|FG001|Provent Main Study|Protocol Violation|0|||
48794943|NCT04625725|157086297|FG002|Provent Main Study|Protocol Violation|0|||
48794944|NCT04625725|157086298|FG003|Provent Main Study|Protocol Violation|0|||
48794945|NCT04625725|157086299|FG004|Provent Main Study|Protocol Violation|0|||
48794946|NCT04625725|157086300|FG005|Provent Main Study|Protocol Violation|0|||
48794947|NCT04625725|157086295|FG000|Provent Main Study|Lost to Follow-up|357|||
48794948|NCT04625725|157086296|FG001|Provent Main Study|Lost to Follow-up|200|||
48794949|NCT04625725|157086297|FG002|Provent Main Study|Lost to Follow-up|0|||
48794950|NCT04625725|157086298|FG003|Provent Main Study|Lost to Follow-up|0|||
48794951|NCT04625725|157086299|FG004|Provent Main Study|Lost to Follow-up|0|||
48794952|NCT04625725|157086300|FG005|Provent Main Study|Lost to Follow-up|0|||
48794953|NCT04625725|157086295|FG000|Provent Main Study|Death|22|||
48794954|NCT04625725|157086296|FG001|Provent Main Study|Death|10|||
48794955|NCT04625725|157086297|FG002|Provent Main Study|Death|0|||
48794956|NCT04625725|157086298|FG003|Provent Main Study|Death|0|||
48794957|NCT04625725|157086299|FG004|Provent Main Study|Death|0|||
48794958|NCT04625725|157086300|FG005|Provent Main Study|Death|0|||
48794959|NCT04625725|157086295|FG000|Provent Main Study|Adverse Event|2|||
48794960|NCT04625725|157086296|FG001|Provent Main Study|Adverse Event|1|||
48794961|NCT04625725|157086297|FG002|Provent Main Study|Adverse Event|0|||
48794962|NCT04625725|157086298|FG003|Provent Main Study|Adverse Event|0|||
48794963|NCT04625725|157086299|FG004|Provent Main Study|Adverse Event|0|||
48794964|NCT04625725|157086300|FG005|Provent Main Study|Adverse Event|0|||
48794965|NCT04625725|157086295|FG000|Provent Main Study|Participants dosed in sub-study|310|||
48794966|NCT04625725|157086296|FG001|Provent Main Study|Participants dosed in sub-study|193|||
48794967|NCT04625725|157086297|FG002|Provent Main Study|Participants dosed in sub-study|0|||
48794968|NCT04625725|157086298|FG003|Provent Main Study|Participants dosed in sub-study|0|||
48794969|NCT04625725|157086299|FG004|Provent Main Study|Participants dosed in sub-study|0|||
48794970|NCT04625725|157086300|FG005|Provent Main Study|Participants dosed in sub-study|0|||
48794971|NCT04625725|157086295|FG000|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
48794972|NCT04625725|157086296|FG001|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
48794973|NCT04625725|157086297|FG002|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
48794974|NCT04625725|157086298|FG003|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
48794975|NCT04625725|157086299|FG004|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
48794976|NCT04625725|157086300|FG005|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
48794977|NCT04625725|157086295|FG000|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|14|||
48878536|NCT02601209|157394347|FG008|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
48878537|NCT00572533|157394350|FG000|Overall Study|Death|4|||
48878538|NCT00572533|157394351|FG001|Overall Study|Death|1|||
48878539|NCT00572533|157394350|FG000|Overall Study|Received Kidney Transplant|2|||
48878540|NCT00572533|157394351|FG001|Overall Study|Received Kidney Transplant|1|||
48878541|NCT00572533|157394350|FG000|Overall Study|Social Issues|1|||
48878542|NCT00572533|157394351|FG001|Overall Study|Social Issues|0|||
48878543|NCT00572533|157394350|FG000|Overall Study|Transfer out of Facility|0|||
48878544|NCT00572533|157394351|FG001|Overall Study|Transfer out of Facility|1|||
48878545|NCT00825305|157394353|FG000|Overall Study|Adverse Event|1|||
48878546|NCT00825305|157394354|FG001|Overall Study|Adverse Event|1|||
48878547|NCT00825305|157394353|FG000|Overall Study|Withdrawal by Subject|6|||
48878548|NCT00825305|157394354|FG001|Overall Study|Withdrawal by Subject|12|||
48878549|NCT00825305|157394353|FG000|Overall Study|Inappropriate inclusion|1|||
48878550|NCT00825305|157394354|FG001|Overall Study|Inappropriate inclusion|0|||
48878551|NCT00825305|157394353|FG000|Overall Study|Protocol Violation|9|||
48878552|NCT00825305|157394354|FG001|Overall Study|Protocol Violation|9|||
48878553|NCT00825305|157394353|FG000|Overall Study|Can not be classified|0|||
48878554|NCT00825305|157394354|FG001|Overall Study|Can not be classified|1|||
48878555|NCT01485120|157394355|FG000|Overall Study|Withdrawal by Subject|2|||
48878556|NCT00422734|157394356|FG000|Overall Study|Physician Decision|1|||
48878557|NCT00422734|157394357|FG001|Overall Study|Physician Decision|1|||
48878558|NCT00422734|157394356|FG000|Overall Study|Protocol Violation|1|||
48878559|NCT00422734|157394357|FG001|Overall Study|Protocol Violation|6|||
48878560|NCT00422734|157394356|FG000|Overall Study|Withdrawal by Subject|12|||
48878561|NCT00422734|157394357|FG001|Overall Study|Withdrawal by Subject|8|||
48878562|NCT00422734|157394356|FG000|Overall Study|Adverse Event|0|||
48878563|NCT00422734|157394357|FG001|Overall Study|Adverse Event|3|||
48878564|NCT00422734|157394356|FG000|Overall Study|Partner Decision|0|||
48878565|NCT00422734|157394357|FG001|Overall Study|Partner Decision|3|||
48878566|NCT00848484|157394358|FG000|First Intervention (Treatment Period 1)|Adverse Event|2|||
48878567|NCT00848484|157394359|FG001|First Intervention (Treatment Period 1)|Adverse Event|1|||
48878568|NCT00848484|157394358|FG000|First Intervention (Treatment Period 1)|Physician Decision|0|||
48878569|NCT00848484|157394359|FG001|First Intervention (Treatment Period 1)|Physician Decision|1|||
48878570|NCT00848484|157394358|FG000|First Intervention (Treatment Period 1)|Withdrawal by Subject|0|||
48878571|NCT00848484|157394359|FG001|First Intervention (Treatment Period 1)|Withdrawal by Subject|1|||
48878572|NCT00848484|157394358|FG000|Washout Period of Two Weeks|Withdrawal by Subject|0|||
48878573|NCT00848484|157394359|FG001|Washout Period of Two Weeks|Withdrawal by Subject|3|||
48878574|NCT00848484|157394358|FG000|Second Intervention (Treatment Period 2)|Lost to Follow-up|0|||
48878575|NCT00848484|157394359|FG001|Second Intervention (Treatment Period 2)|Lost to Follow-up|1|||
48878576|NCT00267098|157394364|FG000|Overall Study|Death|0|||
48878577|NCT00267098|157394365|FG001|Overall Study|Death|0|||
48878578|NCT00267098|157394366|FG002|Overall Study|Death|57|||
48878579|NCT00267098|157394367|FG003|Overall Study|Death|66|||
48878580|NCT00267098|157394368|FG004|Overall Study|Death|14|||
48878581|NCT00267098|157394369|FG005|Overall Study|Death|23|||
48878582|NCT00267098|157394370|FG006|Overall Study|Death|28|||
48878583|NCT00267098|157394371|FG007|Overall Study|Death|9|||
48878584|NCT00267098|157394364|FG000|Overall Study|Lost to Follow-up|0|||
48878585|NCT00267098|157394365|FG001|Overall Study|Lost to Follow-up|0|||
48878586|NCT00267098|157394366|FG002|Overall Study|Lost to Follow-up|6|||
48878587|NCT00267098|157394367|FG003|Overall Study|Lost to Follow-up|5|||
48878588|NCT00267098|157394368|FG004|Overall Study|Lost to Follow-up|2|||
48878589|NCT00267098|157394369|FG005|Overall Study|Lost to Follow-up|3|||
48878590|NCT00267098|157394370|FG006|Overall Study|Lost to Follow-up|1|||
48878591|NCT00267098|157394371|FG007|Overall Study|Lost to Follow-up|1|||
48878592|NCT00267098|157394364|FG000|Overall Study|Withdrawal by Subject|8|||
48878593|NCT00267098|157394365|FG001|Overall Study|Withdrawal by Subject|0|||
48878594|NCT00267098|157394366|FG002|Overall Study|Withdrawal by Subject|24|||
48878595|NCT00267098|157394367|FG003|Overall Study|Withdrawal by Subject|21|||
48878596|NCT00267098|157394368|FG004|Overall Study|Withdrawal by Subject|12|||
48878597|NCT00267098|157394369|FG005|Overall Study|Withdrawal by Subject|9|||
48878598|NCT00267098|157394370|FG006|Overall Study|Withdrawal by Subject|12|||
48878599|NCT00267098|157394371|FG007|Overall Study|Withdrawal by Subject|5|||
48878600|NCT00267098|157394364|FG000|Overall Study|Physician Decision|5|||
48878601|NCT00267098|157394365|FG001|Overall Study|Physician Decision|0|||
48878602|NCT00267098|157394366|FG002|Overall Study|Physician Decision|7|||
48878603|NCT00267098|157394367|FG003|Overall Study|Physician Decision|11|||
48878604|NCT00267098|157394368|FG004|Overall Study|Physician Decision|5|||
48878605|NCT00267098|157394369|FG005|Overall Study|Physician Decision|4|||
48878606|NCT00267098|157394370|FG006|Overall Study|Physician Decision|3|||
48878607|NCT00267098|157394371|FG007|Overall Study|Physician Decision|0|||
48878608|NCT00267098|157394364|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|96|||
48878609|NCT00267098|157394365|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
48878610|NCT00267098|157394366|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
48878611|NCT00267098|157394367|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
49033037|NCT00073307|157955653|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
49033038|NCT00073307|157955654|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
49033039|NCT00073307|157955655|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3|||
48794978|NCT04625725|157086296|FG001|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|2|||
48794979|NCT04625725|157086297|FG002|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
48794980|NCT04625725|157086298|FG003|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
48794981|NCT04625725|157086299|FG004|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
48794982|NCT04625725|157086300|FG005|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
48794983|NCT04625725|157086295|FG000|Provent Main Study|INCARCERATION|3|||
48794984|NCT04625725|157086296|FG001|Provent Main Study|INCARCERATION|0|||
48794985|NCT04625725|157086297|FG002|Provent Main Study|INCARCERATION|0|||
48794986|NCT04625725|157086298|FG003|Provent Main Study|INCARCERATION|0|||
48794987|NCT04625725|157086299|FG004|Provent Main Study|INCARCERATION|0|||
48794988|NCT04625725|157086300|FG005|Provent Main Study|INCARCERATION|0|||
48794989|NCT04625725|157086295|FG000|Provent Main Study|WITHDRAWAL OF CONSENT|3|||
48794990|NCT04625725|157086296|FG001|Provent Main Study|WITHDRAWAL OF CONSENT|2|||
48794991|NCT04625725|157086297|FG002|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
48794992|NCT04625725|157086298|FG003|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
48794993|NCT04625725|157086299|FG004|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
48794994|NCT04625725|157086300|FG005|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
48794995|NCT04625725|157086295|FG000|Provent Main Study|MOVED ABROAD / LOCATION|7|||
48794996|NCT04625725|157086296|FG001|Provent Main Study|MOVED ABROAD / LOCATION|2|||
48794997|NCT04625725|157086297|FG002|Provent Main Study|MOVED ABROAD / LOCATION|0|||
48794998|NCT04625725|157086298|FG003|Provent Main Study|MOVED ABROAD / LOCATION|0|||
48794999|NCT04625725|157086299|FG004|Provent Main Study|MOVED ABROAD / LOCATION|0|||
48795000|NCT04625725|157086300|FG005|Provent Main Study|MOVED ABROAD / LOCATION|0|||
48795001|NCT04625725|157086295|FG000|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
48795002|NCT04625725|157086296|FG001|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
48795003|NCT04625725|157086297|FG002|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
48795004|NCT04625725|157086298|FG003|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
48795005|NCT04625725|157086299|FG004|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
48795006|NCT04625725|157086300|FG005|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
48795007|NCT04625725|157086295|FG000|Provent Main Study|MISSING REASON|0|||
48795008|NCT04625725|157086296|FG001|Provent Main Study|MISSING REASON|1|||
48795009|NCT04625725|157086297|FG002|Provent Main Study|MISSING REASON|0|||
48795010|NCT04625725|157086298|FG003|Provent Main Study|MISSING REASON|0|||
48795011|NCT04625725|157086299|FG004|Provent Main Study|MISSING REASON|0|||
48795012|NCT04625725|157086300|FG005|Provent Main Study|MISSING REASON|0|||
48795013|NCT04625725|157086295|FG000|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
48795014|NCT04625725|157086296|FG001|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
48795015|NCT04625725|157086297|FG002|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
48795016|NCT04625725|157086298|FG003|Provent Sub Study|SUBJECT MOVED OUT OF AREA|1|||
48795017|NCT04625725|157086299|FG004|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
48795018|NCT04625725|157086300|FG005|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
48795019|NCT04625725|157086295|FG000|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
48795020|NCT04625725|157086296|FG001|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
48795021|NCT04625725|157086297|FG002|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|1|||
48795022|NCT04625725|157086298|FG003|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
48795023|NCT04625725|157086299|FG004|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
48795024|NCT04625725|157086300|FG005|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
48795025|NCT04625725|157086295|FG000|Provent Sub Study|Lost to Follow-up|0|||
48795026|NCT04625725|157086296|FG001|Provent Sub Study|Lost to Follow-up|0|||
48795027|NCT04625725|157086297|FG002|Provent Sub Study|Lost to Follow-up|20|||
48795028|NCT04625725|157086298|FG003|Provent Sub Study|Lost to Follow-up|10|||
48795029|NCT04625725|157086299|FG004|Provent Sub Study|Lost to Follow-up|6|||
48795030|NCT04625725|157086300|FG005|Provent Sub Study|Lost to Follow-up|4|||
48795031|NCT04625725|157086295|FG000|Provent Sub Study|Death|0|||
48795032|NCT04625725|157086296|FG001|Provent Sub Study|Death|0|||
48795033|NCT04625725|157086297|FG002|Provent Sub Study|Death|8|||
48795034|NCT04625725|157086298|FG003|Provent Sub Study|Death|5|||
48795035|NCT04625725|157086299|FG004|Provent Sub Study|Death|0|||
48795036|NCT04625725|157086300|FG005|Provent Sub Study|Death|1|||
48795037|NCT04625725|157086295|FG000|Provent Sub Study|Adverse Event|0|||
48795038|NCT04625725|157086296|FG001|Provent Sub Study|Adverse Event|0|||
48795039|NCT04625725|157086297|FG002|Provent Sub Study|Adverse Event|0|||
48795040|NCT04625725|157086298|FG003|Provent Sub Study|Adverse Event|0|||
48795041|NCT04625725|157086299|FG004|Provent Sub Study|Adverse Event|0|||
48795042|NCT04625725|157086300|FG005|Provent Sub Study|Adverse Event|1|||
48795043|NCT04625725|157086295|FG000|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
48795044|NCT04625725|157086296|FG001|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
49033040|NCT00073307|157955653|FG000|Open Label-Sorafenib Only [30Jun2008]|Missing|3|||
49033041|NCT00073307|157955654|FG001|Open Label-Sorafenib Only [30Jun2008]|Missing|0|||
49033042|NCT00073307|157955655|FG002|Open Label-Sorafenib Only [30Jun2008]|Missing|1|||
49033043|NCT00073307|157955653|FG000|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19|||
49033044|NCT00073307|157955654|FG001|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0|||
49033045|NCT00073307|157955655|FG002|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9|||
49033046|NCT00073307|157955653|FG000|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35|||
49033047|NCT00073307|157955654|FG001|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0|||
49033048|NCT00073307|157955655|FG002|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83|||
49033049|NCT03173547|157955662|FG000|Overall Study|Adverse Event|2|||
49033050|NCT03173547|157955663|FG001|Overall Study|Adverse Event|0|||
49033051|NCT03173547|157955662|FG000|Overall Study|Withdrawal by Subject|2|||
48795045|NCT04625725|157086297|FG002|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
48795046|NCT04625725|157086298|FG003|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
48795047|NCT04625725|157086299|FG004|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|1|||
48795048|NCT04625725|157086300|FG005|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
48795049|NCT04625725|157086295|FG000|Provent Sub Study|Withdrawal by Subject|0|||
48795050|NCT04625725|157086296|FG001|Provent Sub Study|Withdrawal by Subject|0|||
48795051|NCT04625725|157086297|FG002|Provent Sub Study|Withdrawal by Subject|11|||
48795052|NCT04625725|157086298|FG003|Provent Sub Study|Withdrawal by Subject|13|||
48795053|NCT04625725|157086299|FG004|Provent Sub Study|Withdrawal by Subject|5|||
48795054|NCT04625725|157086300|FG005|Provent Sub Study|Withdrawal by Subject|6|||
48795055|NCT04625725|157086295|FG000|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
48795056|NCT04625725|157086296|FG001|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
48795057|NCT04625725|157086297|FG002|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
48795058|NCT04625725|157086298|FG003|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
48795059|NCT04625725|157086299|FG004|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
48795060|NCT04625725|157086300|FG005|Provent Sub Study|NON COMPLIANCE BY SUBJECT|1|||
48795061|NCT01297959|157086302|FG000|Overall Study|Adverse Event|0|||
48795062|NCT01297959|157086303|FG001|Overall Study|Adverse Event|1|||
48795063|NCT01297959|157086302|FG000|Overall Study|Protocol Violation|2|||
48795064|NCT01297959|157086303|FG001|Overall Study|Protocol Violation|1|||
48795065|NCT01297959|157086302|FG000|Overall Study|Withdrawal by Subject|5|||
48795066|NCT01297959|157086303|FG001|Overall Study|Withdrawal by Subject|4|||
48795067|NCT01297959|157086302|FG000|Overall Study|Physician Decision|0|||
48795068|NCT01297959|157086303|FG001|Overall Study|Physician Decision|1|||
48795069|NCT01297959|157086302|FG000|Overall Study|Unrelated medical illness / complication|0|||
48795070|NCT01297959|157086303|FG001|Overall Study|Unrelated medical illness / complication|2|||
48795071|NCT01297959|157086302|FG000|Overall Study|Other|13|||
48795072|NCT01297959|157086303|FG001|Overall Study|Other|7|||
48795073|NCT00829387|157086304|FG000|Overall Study|Withdrawal by Subject|2|||
48795074|NCT00829387|157086305|FG001|Overall Study|Withdrawal by Subject|3|||
48795075|NCT00829387|157086304|FG000|Overall Study|Disqualified by PI|1|||
48795076|NCT00829387|157086305|FG001|Overall Study|Disqualified by PI|0|||
48795077|NCT03657277|157086312|FG000|Overall Study|Physician Decision|2|||
48795078|NCT03657277|157086312|FG000|Overall Study|Lost to Follow-up|1|||
48795079|NCT03657277|157086312|FG000|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8|||
48795080|NCT02626780|157086313|FG000|Overall Study|Withdrawal by Subject|3|||
48795081|NCT05318287|157086314|FG000|Overall Study|Lost to Follow-up|8|||
48795082|NCT05338333|157086315|FG000|Period 1, Approximately 30 Days|Adverse Event|1|||
48795083|NCT05338333|157086316|FG001|Period 1, Approximately 30 Days|Adverse Event|0|||
48795084|NCT05112900|157086317|FG000|Overall Study|Withdrawal by Subject|960|||
48795085|NCT05112900|157086318|FG001|Overall Study|Withdrawal by Subject|921|||
48795086|NCT05112900|157086319|FG002|Overall Study|Withdrawal by Subject|968|||
48795087|NCT04573881|157086320|FG000|Overall Study|Participant in active follow-up at 30 days|24|||
48795088|NCT01925950|157088198|FG000|Part 2|Withdrawal by Subject|1|||
48795089|NCT01925950|157088199|FG001|Part 2|Withdrawal by Subject|0|||
48795090|NCT00725452|157088203|FG000|Overall Study|Adverse Event|3|||
48795091|NCT00725452|157088203|FG000|Overall Study|Lack of Efficacy|2|||
48795092|NCT00725452|157088203|FG000|Overall Study|Reason not specified|1|||
48795093|NCT00725452|157088203|FG000|Overall Study|Physician Decision|1|||
48795094|NCT00725452|157088203|FG000|Overall Study|Withdrawal by Subject|3|||
48878612|NCT00267098|157394368|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
49033052|NCT03173547|157955663|FG001|Overall Study|Withdrawal by Subject|2|||
49033053|NCT00858845|157955664|FG000|Overall Study|Patient underwent heart transplant.|0|||
48795095|NCT00725452|157088203|FG000|Overall Study|Lost to Follow-up|1|||
48795096|NCT00713648|157088204|FG000|Overall Study|Adverse Event|1|||
48795097|NCT00713648|157088204|FG000|Overall Study|Unclassified|2|||
48795098|NCT00713648|157088204|FG000|Overall Study|According to Protocol|2|||
49033054|NCT00858845|157955665|FG001|Overall Study|Patient underwent heart transplant.|1|||
48795099|NCT00713648|157088204|FG000|Overall Study|Development of antibodies|3|||
48795100|NCT02633800|157088205|FG000|Overall Study|Death|3|||
48795101|NCT02633800|157088206|FG001|Overall Study|Death|3|||
48795102|NCT02633800|157088205|FG000|Overall Study|Reason not provided|1|||
48795103|NCT02633800|157088206|FG001|Overall Study|Reason not provided|0|||
48795104|NCT02633800|157088205|FG000|Overall Study|Radiologic(al) progression|23|||
48795105|NCT02633800|157088206|FG001|Overall Study|Radiologic(al) progression|23|||
48795106|NCT02633800|157088205|FG000|Overall Study|Clinical progression|3|||
48795107|NCT02633800|157088206|FG001|Overall Study|Clinical progression|6|||
48795108|NCT02633800|157088205|FG000|Overall Study|Study terminated by sponsor|6|||
48795109|NCT02633800|157088206|FG001|Overall Study|Study terminated by sponsor|5|||
48795110|NCT02633800|157088205|FG000|Overall Study|Adverse event, non-fatal|7|||
48795111|NCT02633800|157088206|FG001|Overall Study|Adverse event, non-fatal|2|||
48795112|NCT02633800|157088205|FG000|Overall Study|Withdrawal by Subject|0|||
48795113|NCT02633800|157088206|FG001|Overall Study|Withdrawal by Subject|3|||
48795114|NCT02633800|157088205|FG000|Overall Study|Patient Request|1|||
48795115|NCT02633800|157088206|FG001|Overall Study|Patient Request|1|||
48795116|NCT01615328|157088207|FG000|Overall Study|Lost to Follow-up|3|||
48795117|NCT01615328|157088208|FG001|Overall Study|Lost to Follow-up|5|||
48795118|NCT00746590|157088209|FG000|Overall Study|Death|1|||
48795119|NCT00464815|157088212|FG000|Overall Study|Withdrawal by Subject|6|||
48795120|NCT00464815|157088213|FG001|Overall Study|Withdrawal by Subject|3|||
48795121|NCT05054374|157088216|FG000|Overall Study|Withdrawal by Subject|1|||
48795122|NCT05054374|157088217|FG001|Overall Study|Withdrawal by Subject|0|||
48795123|NCT05054374|157088218|FG002|Overall Study|Withdrawal by Subject|0|||
48795124|NCT05054374|157088219|FG003|Overall Study|Withdrawal by Subject|0|||
48795125|NCT05054374|157088216|FG000|Overall Study|Progressive Disease|5|||
48795126|NCT05054374|157088217|FG001|Overall Study|Progressive Disease|0|||
48795127|NCT05054374|157088218|FG002|Overall Study|Progressive Disease|0|||
48795128|NCT05054374|157088219|FG003|Overall Study|Progressive Disease|0|||
48795129|NCT00558428|157088220|FG000|Overall Study|Adverse Event|6|||
48795130|NCT00558428|157088221|FG001|Overall Study|Adverse Event|22|||
48795131|NCT00558428|157088222|FG002|Overall Study|Adverse Event|3|||
48795132|NCT00558428|157088223|FG003|Overall Study|Adverse Event|4|||
48795133|NCT00558428|157088220|FG000|Overall Study|Lost to Follow-up|0|||
48795134|NCT00558428|157088221|FG001|Overall Study|Lost to Follow-up|1|||
48795135|NCT00558428|157088222|FG002|Overall Study|Lost to Follow-up|0|||
48795136|NCT00558428|157088223|FG003|Overall Study|Lost to Follow-up|0|||
48795137|NCT00558428|157088220|FG000|Overall Study|Lack of Efficacy|0|||
48795138|NCT00558428|157088221|FG001|Overall Study|Lack of Efficacy|0|||
48795139|NCT00558428|157088222|FG002|Overall Study|Lack of Efficacy|1|||
48795140|NCT00558428|157088223|FG003|Overall Study|Lack of Efficacy|2|||
48795141|NCT00558428|157088220|FG000|Overall Study|Non compliant with protocol|1|||
48795142|NCT00558428|157088221|FG001|Overall Study|Non compliant with protocol|0|||
48795143|NCT00558428|157088222|FG002|Overall Study|Non compliant with protocol|0|||
48795144|NCT00558428|157088223|FG003|Overall Study|Non compliant with protocol|3|||
48795145|NCT00558428|157088220|FG000|Overall Study|Consent withdrawn|2|||
48795146|NCT00558428|157088221|FG001|Overall Study|Consent withdrawn|1|||
48795147|NCT00558428|157088222|FG002|Overall Study|Consent withdrawn|0|||
48795148|NCT00558428|157088223|FG003|Overall Study|Consent withdrawn|1|||
48795149|NCT00558428|157088220|FG000|Overall Study|Other|3|||
48795150|NCT00558428|157088221|FG001|Overall Study|Other|0|||
48795151|NCT00558428|157088222|FG002|Overall Study|Other|0|||
48795152|NCT00558428|157088223|FG003|Overall Study|Other|1|||
48795153|NCT00530855|157088227|FG000|Overall Study|Lack of Efficacy|20|||
48795154|NCT00530855|157088227|FG000|Overall Study|Withdrawal by Subject|30|||
48795155|NCT00530855|157088227|FG000|Overall Study|Fatal Serious AE|3|||
48795156|NCT00530855|157088227|FG000|Overall Study|Non Fatal Serious AE|7|||
48795157|NCT00530855|157088227|FG000|Overall Study|Non Fatal Non Serious AE|12|||
48795158|NCT00530855|157088227|FG000|Overall Study|Protocol Violation|3|||
48795159|NCT00530855|157088227|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
48795160|NCT00530855|157088227|FG000|Overall Study|Lost to Follow-up|9|||
48795161|NCT00530855|157088227|FG000|Overall Study|Other reason for premature termination|17|||
48795162|NCT00626028|157088228|FG000|Overall Study|Adverse Event|1|||
48878613|NCT00267098|157394369|FG005|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
48795163|NCT00626028|157088229|FG001|Overall Study|Adverse Event|1|||
48795164|NCT00626028|157088228|FG000|Overall Study|Device Failure|0|||
48795165|NCT00626028|157088229|FG001|Overall Study|Device Failure|1|||
48795166|NCT00626028|157088228|FG000|Overall Study|Physician Decision|2|||
48795167|NCT00626028|157088229|FG001|Overall Study|Physician Decision|1|||
48878614|NCT00267098|157394370|FG006|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
48795168|NCT00626028|157088228|FG000|Overall Study|Inclusion/Exclusion Criteria|3|||
48795169|NCT00626028|157088229|FG001|Overall Study|Inclusion/Exclusion Criteria|6|||
48878615|NCT00267098|157394371|FG007|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
48795170|NCT00831779|157088236|FG000|Overall Study|Lost to Follow-up|1|||
48795171|NCT00831779|157088237|FG001|Overall Study|Lost to Follow-up|0|||
48795172|NCT00831779|157088236|FG000|Overall Study|No longer met criteria|0|||
48795173|NCT00831779|157088237|FG001|Overall Study|No longer met criteria|1|||
48795174|NCT00130533|157088242|FG000|Overall Study|Withdrawal by Subject|33|||
48795175|NCT00130533|157088243|FG001|Overall Study|Withdrawal by Subject|6|||
48795176|NCT00130533|157088242|FG000|Overall Study|Adverse Event|34|||
48795177|NCT00130533|157088243|FG001|Overall Study|Adverse Event|1|||
48795178|NCT00130533|157088242|FG000|Overall Study|Disease relapse|9|||
48795179|NCT00130533|157088243|FG001|Overall Study|Disease relapse|13|||
48795180|NCT00130533|157088242|FG000|Overall Study|Interruption of treatment > 3 weeks|11|||
48795181|NCT00130533|157088243|FG001|Overall Study|Interruption of treatment > 3 weeks|0|||
48795182|NCT00130533|157088242|FG000|Overall Study|Death|4|||
48795183|NCT00130533|157088243|FG001|Overall Study|Death|2|||
48795184|NCT00130533|157088242|FG000|Overall Study|Protocol Violation|5|||
48795185|NCT00130533|157088243|FG001|Overall Study|Protocol Violation|1|||
48795186|NCT00130533|157088242|FG000|Overall Study|Lost to Follow-up|1|||
48795187|NCT00130533|157088243|FG001|Overall Study|Lost to Follow-up|1|||
48795188|NCT00130533|157088242|FG000|Overall Study|Sponsor´s decision|2|||
48795189|NCT00130533|157088243|FG001|Overall Study|Sponsor´s decision|0|||
48795190|NCT00130533|157088242|FG000|Overall Study|Second Primary Malignancy|0|||
48795191|NCT00130533|157088243|FG001|Overall Study|Second Primary Malignancy|1|||
48795192|NCT00130533|157088242|FG000|Overall Study|Other|12|||
48795193|NCT00130533|157088243|FG001|Overall Study|Other|5|||
48795194|NCT00515502|157088246|FG000|Treatment Period 1|Adverse Event|0|||
48795195|NCT00515502|157088247|FG001|Treatment Period 1|Adverse Event|0|||
48795196|NCT00515502|157088248|FG002|Treatment Period 1|Adverse Event|0|||
48795197|NCT00515502|157088249|FG003|Treatment Period 1|Adverse Event|0|||
48795198|NCT00515502|157088250|FG004|Treatment Period 1|Adverse Event|0|||
48795199|NCT00515502|157088251|FG005|Treatment Period 1|Adverse Event|0|||
48795200|NCT00515502|157088252|FG006|Treatment Period 1|Adverse Event|1|||
48795201|NCT00515502|157088253|FG007|Treatment Period 1|Adverse Event|0|||
48795202|NCT00515502|157088254|FG008|Treatment Period 1|Adverse Event|1|||
48795203|NCT00515502|157088255|FG009|Treatment Period 1|Adverse Event|0|||
48795204|NCT00515502|157088256|FG010|Treatment Period 1|Adverse Event|0|||
48795205|NCT00515502|157088257|FG011|Treatment Period 1|Adverse Event|1|||
48795206|NCT00515502|157088246|FG000|Treatment Period 2|Adverse Event|0|||
49033055|NCT03031847|157955666|FG000|Overall Study|Death|1|||
49033056|NCT03031847|157955667|FG001|Overall Study|Death|1|||
49033057|NCT03031847|157955668|FG002|Overall Study|Death|2|||
49033058|NCT03031847|157955669|FG003|Overall Study|Death|3|||
49033059|NCT03031847|157955666|FG000|Overall Study|Lost to Follow-up|1|||
49033060|NCT03031847|157955667|FG001|Overall Study|Lost to Follow-up|1|||
49033061|NCT03031847|157955668|FG002|Overall Study|Lost to Follow-up|2|||
49033062|NCT03031847|157955669|FG003|Overall Study|Lost to Follow-up|3|||
49033063|NCT00657553|157955670|FG000|Overall Study|low accrual, no analysis run|5|||
49033064|NCT00657553|157955671|FG001|Overall Study|low accrual, no analysis run|5|||
49033065|NCT01237054|157955672|FG000|Overall Study|imaging 10C0096|1|||
49033066|NCT00436163|157955675|FG000|Overall Study|Lost to Follow-up|2|||
49033067|NCT00436163|157955675|FG000|Overall Study|Adverse Event|1|||
48795207|NCT00515502|157088247|FG001|Treatment Period 2|Adverse Event|1|||
48795208|NCT00515502|157088248|FG002|Treatment Period 2|Adverse Event|0|||
49033068|NCT00147498|157955678|FG000|Overall Study|Adverse Event|1|||
48795209|NCT00515502|157088249|FG003|Treatment Period 2|Adverse Event|0|||
48795210|NCT00515502|157088250|FG004|Treatment Period 2|Adverse Event|0|||
48795211|NCT00515502|157088251|FG005|Treatment Period 2|Adverse Event|0|||
48795212|NCT00515502|157088252|FG006|Treatment Period 2|Adverse Event|0|||
48795213|NCT00515502|157088253|FG007|Treatment Period 2|Adverse Event|0|||
48795214|NCT00515502|157088254|FG008|Treatment Period 2|Adverse Event|0|||
48795215|NCT00515502|157088255|FG009|Treatment Period 2|Adverse Event|0|||
48795216|NCT00515502|157088256|FG010|Treatment Period 2|Adverse Event|0|||
48795217|NCT00515502|157088257|FG011|Treatment Period 2|Adverse Event|0|||
48795218|NCT01059175|157088258|FG000|Overall Study|Death|17|||
48795219|NCT01059175|157088259|FG001|Overall Study|Death|17|||
48795220|NCT01059175|157088258|FG000|Overall Study|Adverse Event|4|||
48795221|NCT01059175|157088259|FG001|Overall Study|Adverse Event|2|||
48795222|NCT01059175|157088258|FG000|Overall Study|Lost to Follow-up|0|||
48795223|NCT01059175|157088259|FG001|Overall Study|Lost to Follow-up|1|||
48795224|NCT02525874|157088263|FG000|Overall Study|Other|1|||
48795225|NCT02525874|157088263|FG000|Overall Study|Investigator Decision|1|||
49033069|NCT00147498|157955679|FG001|Overall Study|Adverse Event|6|||
49033070|NCT00147498|157955680|FG002|Overall Study|Adverse Event|7|||
49033071|NCT00147498|157955681|FG003|Overall Study|Adverse Event|3|||
49033072|NCT00147498|157955678|FG000|Overall Study|Lack of Efficacy|1|||
49033073|NCT00147498|157955679|FG001|Overall Study|Lack of Efficacy|1|||
49033074|NCT00147498|157955680|FG002|Overall Study|Lack of Efficacy|1|||
49033075|NCT00147498|157955681|FG003|Overall Study|Lack of Efficacy|8|||
48795226|NCT02525874|157088263|FG000|Overall Study|Consent withdrawn|22|||
48795227|NCT02525874|157088263|FG000|Overall Study|Non-compliance with study drug|3|||
48795228|NCT02525874|157088263|FG000|Overall Study|Adverse Event|17|||
48795229|NCT02525874|157088263|FG000|Overall Study|Lost to Follow-up|7|||
48795230|NCT02525874|157088263|FG000|Overall Study|Disease progression, defined by protocol|2|||
48795231|NCT02525874|157088263|FG000|Overall Study|Disease relapse|4|||
48795232|NCT02525874|157088263|FG000|Overall Study|Alternative Treatment for MS|2|||
48795233|NCT02525874|157088263|FG000|Overall Study|New lesions in Brain|1|||
48795234|NCT03263429|157088268|FG000|Overall Study|Withdrawal by Subject|0|||
48795235|NCT03263429|157088269|FG001|Overall Study|Withdrawal by Subject|1|||
48795236|NCT03263429|157088270|FG002|Overall Study|Withdrawal by Subject|0|||
48795237|NCT03263429|157088268|FG000|Overall Study|Follow-Up Period Completed|0|||
48795238|NCT03263429|157088269|FG001|Overall Study|Follow-Up Period Completed|2|||
48795239|NCT03263429|157088270|FG002|Overall Study|Follow-Up Period Completed|0|||
48795240|NCT03263429|157088268|FG000|Overall Study|Death|3|||
48795241|NCT03263429|157088269|FG001|Overall Study|Death|5|||
48795242|NCT03263429|157088270|FG002|Overall Study|Death|16|||
48878616|NCT00267098|157394364|FG000|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
48878617|NCT00267098|157394365|FG001|Overall Study|Unsuccessful Implant Exit Per Protocol|51|||
48878618|NCT00267098|157394366|FG002|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
48878619|NCT00267098|157394367|FG003|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
48878620|NCT00267098|157394368|FG004|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
48878621|NCT00267098|157394369|FG005|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
48878622|NCT00267098|157394370|FG006|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
48878623|NCT00267098|157394371|FG007|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
48878624|NCT00267098|157394364|FG000|Overall Study|Site closure|0|||
48878625|NCT00267098|157394365|FG001|Overall Study|Site closure|0|||
48878626|NCT00267098|157394366|FG002|Overall Study|Site closure|0|||
48878627|NCT00267098|157394367|FG003|Overall Study|Site closure|1|||
48878628|NCT00267098|157394368|FG004|Overall Study|Site closure|0|||
48878629|NCT00267098|157394369|FG005|Overall Study|Site closure|1|||
48878630|NCT00267098|157394370|FG006|Overall Study|Site closure|1|||
48878631|NCT00267098|157394371|FG007|Overall Study|Site closure|0|||
48878632|NCT00267098|157394364|FG000|Overall Study|Explanted Medtronic device|0|||
48878633|NCT00267098|157394365|FG001|Overall Study|Explanted Medtronic device|0|||
48878634|NCT00267098|157394366|FG002|Overall Study|Explanted Medtronic device|0|||
48878635|NCT00267098|157394367|FG003|Overall Study|Explanted Medtronic device|1|||
49033076|NCT00147498|157955678|FG000|Overall Study|Laboratory abnormality|0|||
49033077|NCT00147498|157955679|FG001|Overall Study|Laboratory abnormality|0|||
49033078|NCT00147498|157955680|FG002|Overall Study|Laboratory abnormality|2|||
49033079|NCT00147498|157955681|FG003|Overall Study|Laboratory abnormality|0|||
49033080|NCT00147498|157955678|FG000|Overall Study|Participant defaulted|0|||
49033081|NCT00147498|157955679|FG001|Overall Study|Participant defaulted|1|||
49033082|NCT00147498|157955680|FG002|Overall Study|Participant defaulted|4|||
49033083|NCT00147498|157955681|FG003|Overall Study|Participant defaulted|3|||
49033084|NCT00147498|157955678|FG000|Overall Study|Other|1|||
49033085|NCT00147498|157955679|FG001|Overall Study|Other|1|||
49033086|NCT00147498|157955680|FG002|Overall Study|Other|3|||
49033087|NCT00147498|157955681|FG003|Overall Study|Other|3|||
49033088|NCT03804983|157955685|FG000|Overall Study|Adverse Event|0|||
49033089|NCT03804983|157955686|FG001|Overall Study|Adverse Event|1|||
49033090|NCT03804983|157955685|FG000|Overall Study|Family Obligation|1|||
49033091|NCT03804983|157955686|FG001|Overall Study|Family Obligation|0|||
48795243|NCT03263429|157088268|FG000|Overall Study|Participant unable to return|0|||
48795244|NCT03263429|157088269|FG001|Overall Study|Participant unable to return|0|||
48795245|NCT03263429|157088270|FG002|Overall Study|Participant unable to return|1|||
48795246|NCT03263429|157088268|FG000|Overall Study|Study Closed|0|||
48795247|NCT03263429|157088269|FG001|Overall Study|Study Closed|0|||
48795248|NCT03263429|157088270|FG002|Overall Study|Study Closed|1|||
48795249|NCT04530448|157088271|FG000|Overall Study|Physician Decision|3|||
48795250|NCT04530448|157088272|FG001|Overall Study|Physician Decision|0|||
48795251|NCT04838262|157088296|FG000|Overall Study|Withdrawal by Subject|9|||
48795252|NCT04838262|157088297|FG001|Overall Study|Withdrawal by Subject|4|||
48795253|NCT01618162|157088298|FG000|Overall Study|Protocol Violation|13|||
48795254|NCT01618162|157088299|FG001|Overall Study|Protocol Violation|10|||
48795255|NCT01618162|157088298|FG000|Overall Study|Adverse Event|9|||
48795256|NCT01618162|157088299|FG001|Overall Study|Adverse Event|2|||
48795257|NCT01618162|157088298|FG000|Overall Study|Withdrawal Criteria|2|||
48795258|NCT01618162|157088299|FG001|Overall Study|Withdrawal Criteria|10|||
48795259|NCT01618162|157088298|FG000|Overall Study|Unclassified|14|||
48795260|NCT01618162|157088299|FG001|Overall Study|Unclassified|13|||
48795261|NCT03321396|157088300|FG000|Overall Study|Physician Decision|1|||
48795262|NCT01970982|157088306|FG000|Overall Study|Withdrawal by Subject|0|||
49033092|NCT02152163|157955687|FG000|Overall Study|Physician Decision|12|||
49033093|NCT02152163|157955688|FG001|Overall Study|Physician Decision|13|||
48795263|NCT01970982|157088307|FG001|Overall Study|Withdrawal by Subject|0|||
48795264|NCT01970982|157088308|FG002|Overall Study|Withdrawal by Subject|2|||
48795265|NCT05130970|157088313|FG000|Overall Study|Adverse Event|1|||
48878636|NCT00267098|157394368|FG004|Overall Study|Explanted Medtronic device|0|||
48878637|NCT00267098|157394369|FG005|Overall Study|Explanted Medtronic device|0|||
48878638|NCT00267098|157394370|FG006|Overall Study|Explanted Medtronic device|0|||
49033094|NCT01963728|157955693|FG000|Overall Study|Study terminated early|0|||
49033095|NCT01963728|157955694|FG001|Overall Study|Study terminated early|1|||
49033096|NCT01686477|157955701|FG000|Feeding Intervention|Death|1|||
48795266|NCT05130970|157088314|FG001|Overall Study|Adverse Event|1|||
48795267|NCT05130970|157088313|FG000|Overall Study|Death|0|||
48795268|NCT05130970|157088314|FG001|Overall Study|Death|1|||
48795269|NCT05130970|157088313|FG000|Overall Study|Lost to Follow-up|0|||
48795270|NCT05130970|157088314|FG001|Overall Study|Lost to Follow-up|1|||
48795271|NCT05130970|157088313|FG000|Overall Study|Physician Decision|0|||
48795272|NCT05130970|157088314|FG001|Overall Study|Physician Decision|1|||
48795273|NCT05130970|157088313|FG000|Overall Study|Withdrawal by Subject|1|||
48795274|NCT05130970|157088314|FG001|Overall Study|Withdrawal by Subject|1|||
48795275|NCT02975934|157088317|FG000|Treatment Phase|Ongoing at data-analysis|33|||
48795276|NCT02975934|157088318|FG001|Treatment Phase|Ongoing at data-analysis|5|||
48795277|NCT02975934|157088317|FG000|Treatment Phase|Discontinued prior to study drug|0|||
48795278|NCT02975934|157088318|FG001|Treatment Phase|Discontinued prior to study drug|5|||
48795279|NCT02975934|157088317|FG000|Cross-Over Phase|Ongoing at data-analysis|0|||
48795280|NCT02975934|157088318|FG001|Cross-Over Phase|Ongoing at data-analysis|7|||
48795281|NCT04435366|157088319|FG000|Year 1 (12 Months)|Adverse Event|3|||
48795282|NCT04435366|157088320|FG001|Year 1 (12 Months)|Adverse Event|0|||
48795283|NCT04435366|157088321|FG002|Year 1 (12 Months)|Adverse Event|2|||
48795284|NCT04435366|157088319|FG000|Year 1 (12 Months)|Death|2|||
48795285|NCT04435366|157088320|FG001|Year 1 (12 Months)|Death|0|||
48795286|NCT04435366|157088321|FG002|Year 1 (12 Months)|Death|1|||
48795287|NCT04435366|157088319|FG000|Year 1 (12 Months)|Lost to Follow-up|2|||
48795288|NCT04435366|157088320|FG001|Year 1 (12 Months)|Lost to Follow-up|0|||
48795289|NCT04435366|157088321|FG002|Year 1 (12 Months)|Lost to Follow-up|1|||
48795290|NCT04435366|157088319|FG000|Year 1 (12 Months)|Withdrawal by Subject|17|||
48795291|NCT04435366|157088320|FG001|Year 1 (12 Months)|Withdrawal by Subject|0|||
48795292|NCT04435366|157088321|FG002|Year 1 (12 Months)|Withdrawal by Subject|13|||
48795293|NCT04435366|157088319|FG000|Year 1 (12 Months)|Patient non-compliance|1|||
48795294|NCT04435366|157088320|FG001|Year 1 (12 Months)|Patient non-compliance|0|||
48795295|NCT04435366|157088321|FG002|Year 1 (12 Months)|Patient non-compliance|0|||
48795296|NCT04435366|157088319|FG000|Year 1 (12 Months)|Not treated|0|||
48795297|NCT04435366|157088320|FG001|Year 1 (12 Months)|Not treated|0|||
48795298|NCT04435366|157088321|FG002|Year 1 (12 Months)|Not treated|1|||
48795299|NCT04435366|157088319|FG000|Year 2 (12 Months)|Death|1|||
48795300|NCT04435366|157088320|FG001|Year 2 (12 Months)|Death|4|||
48795301|NCT04435366|157088321|FG002|Year 2 (12 Months)|Death|6|||
48795302|NCT04435366|157088319|FG000|Year 2 (12 Months)|Lost to Follow-up|0|||
48795303|NCT04435366|157088320|FG001|Year 2 (12 Months)|Lost to Follow-up|2|||
48795304|NCT04435366|157088321|FG002|Year 2 (12 Months)|Lost to Follow-up|0|||
48795305|NCT04435366|157088319|FG000|Year 2 (12 Months)|Withdrawal by Subject|4|||
48795306|NCT04435366|157088320|FG001|Year 2 (12 Months)|Withdrawal by Subject|3|||
48795307|NCT04435366|157088321|FG002|Year 2 (12 Months)|Withdrawal by Subject|7|||
48795308|NCT04435366|157088319|FG000|Year 2 (12 Months)|Adverse Event|2|||
48795309|NCT04435366|157088320|FG001|Year 2 (12 Months)|Adverse Event|1|||
48795310|NCT04435366|157088321|FG002|Year 2 (12 Months)|Adverse Event|6|||
48795311|NCT04495179|157088322|FG000|Overall Study|Lost to Follow-up|0|||
48795312|NCT04495179|157088323|FG001|Overall Study|Lost to Follow-up|1|||
48795313|NCT04495179|157088322|FG000|Overall Study|Withdrawal by Subject|2|||
48795314|NCT04495179|157088323|FG001|Overall Study|Withdrawal by Subject|4|||
48795315|NCT04495179|157088322|FG000|Overall Study|Study terminated by sponsor|0|||
48795316|NCT04495179|157088323|FG001|Overall Study|Study terminated by sponsor|18|||
48795317|NCT04495179|157088322|FG000|Overall Study|Death|0|||
48795318|NCT04495179|157088323|FG001|Overall Study|Death|4|||
48795319|NCT04495179|157088322|FG000|Overall Study|Adverse Event|0|||
48795320|NCT04495179|157088323|FG001|Overall Study|Adverse Event|1|||
48795321|NCT03707977|157088326|FG000|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
48795322|NCT03707977|157088327|FG001|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
48795323|NCT03707977|157088328|FG002|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|3|||
48795324|NCT03707977|157088326|FG000|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
48795325|NCT03707977|157088327|FG001|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
48795326|NCT03707977|157088328|FG002|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|14|||
48795327|NCT02618967|157088329|FG000|Overall Study|Lost to Follow-up|0|||
48795328|NCT02618967|157088330|FG001|Overall Study|Lost to Follow-up|0|||
48795329|NCT02618967|157088331|FG002|Overall Study|Lost to Follow-up|1|||
48795330|NCT02618967|157088332|FG003|Overall Study|Lost to Follow-up|0|||
48795331|NCT02618967|157088333|FG004|Overall Study|Lost to Follow-up|2|||
48795332|NCT02618967|157088334|FG005|Overall Study|Lost to Follow-up|0|||
48795333|NCT02618967|157088335|FG006|Overall Study|Lost to Follow-up|0|||
48795334|NCT02618967|157088336|FG007|Overall Study|Lost to Follow-up|0|||
48795335|NCT02618967|157088329|FG000|Overall Study|Withdrawal by Subject|1|||
48795336|NCT02618967|157088330|FG001|Overall Study|Withdrawal by Subject|0|||
48795337|NCT02618967|157088331|FG002|Overall Study|Withdrawal by Subject|0|||
48795338|NCT02618967|157088332|FG003|Overall Study|Withdrawal by Subject|0|||
48795339|NCT02618967|157088333|FG004|Overall Study|Withdrawal by Subject|0|||
48795340|NCT02618967|157088334|FG005|Overall Study|Withdrawal by Subject|0|||
48795341|NCT02618967|157088335|FG006|Overall Study|Withdrawal by Subject|0|||
48795342|NCT02618967|157088336|FG007|Overall Study|Withdrawal by Subject|0|||
48795343|NCT02061202|157088338|FG000|Overall Study|Lost to Follow-up|1|||
48795344|NCT02061202|157088339|FG001|Overall Study|Lost to Follow-up|1|||
48795345|NCT04212091|157088340|FG000|Overall Study|Lost to Follow-up|0|||
48795346|NCT04212091|157088341|FG001|Overall Study|Lost to Follow-up|0|||
48795347|NCT04212091|157088342|FG002|Overall Study|Lost to Follow-up|0|||
48795348|NCT04212091|157088343|FG003|Overall Study|Lost to Follow-up|0|||
48795349|NCT04212091|157088344|FG004|Overall Study|Lost to Follow-up|1|||
48795350|NCT04212091|157088345|FG005|Overall Study|Lost to Follow-up|1|||
48795351|NCT04212091|157088340|FG000|Overall Study|Participant unable to adhere to visit|0|||
48795352|NCT04212091|157088341|FG001|Overall Study|Participant unable to adhere to visit|0|||
48795353|NCT04212091|157088342|FG002|Overall Study|Participant unable to adhere to visit|0|||
48795354|NCT04212091|157088343|FG003|Overall Study|Participant unable to adhere to visit|0|||
48795355|NCT04212091|157088344|FG004|Overall Study|Participant unable to adhere to visit|1|||
48795356|NCT04212091|157088345|FG005|Overall Study|Participant unable to adhere to visit|0|||
48795357|NCT03492281|157088348|FG000|Overall Study|Withdrawal by Subject|21|||
48795358|NCT03492281|157088349|FG001|Overall Study|Withdrawal by Subject|14|||
48795359|NCT03492281|157088350|FG002|Overall Study|Withdrawal by Subject|13|||
48795360|NCT03492281|157088348|FG000|Overall Study|Lost to Follow-up|14|||
48795361|NCT03492281|157088349|FG001|Overall Study|Lost to Follow-up|15|||
48795362|NCT03492281|157088350|FG002|Overall Study|Lost to Follow-up|10|||
48795363|NCT03492281|157088348|FG000|Overall Study|Adverse Event|6|||
48795364|NCT03492281|157088349|FG001|Overall Study|Adverse Event|8|||
48795365|NCT03492281|157088350|FG002|Overall Study|Adverse Event|13|||
48795366|NCT03492281|157088348|FG000|Overall Study|Lack of Efficacy|3|||
48795367|NCT03492281|157088349|FG001|Overall Study|Lack of Efficacy|0|||
48795368|NCT03492281|157088350|FG002|Overall Study|Lack of Efficacy|1|||
48795369|NCT03492281|157088348|FG000|Overall Study|Physician Decision|1|||
48795370|NCT03492281|157088349|FG001|Overall Study|Physician Decision|0|||
48795371|NCT03492281|157088350|FG002|Overall Study|Physician Decision|3|||
48795372|NCT03492281|157088348|FG000|Overall Study|Protocol Violation|0|||
48795373|NCT03492281|157088349|FG001|Overall Study|Protocol Violation|2|||
48795374|NCT03492281|157088350|FG002|Overall Study|Protocol Violation|1|||
48795375|NCT03492281|157088348|FG000|Overall Study|Withdrawn Due to Sponsor|1|||
48795376|NCT03492281|157088349|FG001|Overall Study|Withdrawn Due to Sponsor|0|||
48795377|NCT03492281|157088350|FG002|Overall Study|Withdrawn Due to Sponsor|1|||
48795378|NCT03492281|157088348|FG000|Overall Study|Death|0|||
48795379|NCT03492281|157088349|FG001|Overall Study|Death|0|||
48795380|NCT03492281|157088350|FG002|Overall Study|Death|1|||
48795381|NCT03492281|157088348|FG000|Overall Study|Captured as Other in Database|8|||
48795382|NCT03492281|157088349|FG001|Overall Study|Captured as Other in Database|6|||
48795383|NCT03492281|157088350|FG002|Overall Study|Captured as Other in Database|3|||
48795384|NCT01506193|157088351|FG000|Overall Study|Protocol Violation|1|||
48795385|NCT01506193|157088352|FG001|Overall Study|Protocol Violation|0|||
48795386|NCT01506193|157088353|FG002|Overall Study|Protocol Violation|1|||
48795387|NCT01506193|157088351|FG000|Overall Study|Migrated/moved from study area|0|||
48795388|NCT01506193|157088352|FG001|Overall Study|Migrated/moved from study area|0|||
48795389|NCT01506193|157088353|FG002|Overall Study|Migrated/moved from study area|1|||
48795390|NCT01506193|157088351|FG000|Overall Study|Adverse event, non-fatal|0|||
48795391|NCT01506193|157088352|FG001|Overall Study|Adverse event, non-fatal|0|||
48795392|NCT01506193|157088353|FG002|Overall Study|Adverse event, non-fatal|1|||
48795393|NCT01506193|157088351|FG000|Overall Study|Withdrawal by Subject|5|||
48795394|NCT01506193|157088352|FG001|Overall Study|Withdrawal by Subject|1|||
48795395|NCT01506193|157088353|FG002|Overall Study|Withdrawal by Subject|8|||
48795396|NCT01506193|157088351|FG000|Overall Study|Lost to Follow-up|8|||
48795397|NCT01506193|157088352|FG001|Overall Study|Lost to Follow-up|3|||
48795398|NCT01506193|157088353|FG002|Overall Study|Lost to Follow-up|3|||
48795399|NCT02199028|157088354|FG000|Week 1|Adverse Event|1|||
48795400|NCT02199028|157088355|FG001|Week 1|Adverse Event|0|||
48795401|NCT02199028|157088354|FG000|Week 3|Adverse Event|1|||
48795402|NCT02199028|157088355|FG001|Week 3|Adverse Event|0|||
48795403|NCT00862134|157088357|FG000|Overall Study|Death|1|||
48795404|NCT00862134|157088358|FG001|Overall Study|Death|0|||
48795405|NCT00862134|157088357|FG000|Overall Study|Physician Decision|0|||
48795406|NCT00862134|157088358|FG001|Overall Study|Physician Decision|1|||
48795407|NCT00862134|157088357|FG000|Overall Study|Withdrawal by Subject|1|||
48795408|NCT00862134|157088358|FG001|Overall Study|Withdrawal by Subject|2|||
48795409|NCT00862134|157088357|FG000|Overall Study|Sponsor terminated study|5|||
48795410|NCT00862134|157088358|FG001|Overall Study|Sponsor terminated study|7|||
48795411|NCT00862134|157088357|FG000|Overall Study|Adverse Event|2|||
48795412|NCT00862134|157088358|FG001|Overall Study|Adverse Event|2|||
48795413|NCT00862134|157088357|FG000|Overall Study|Withdrew prior to dosing|2|||
48795414|NCT00862134|157088358|FG001|Overall Study|Withdrew prior to dosing|0|||
48795415|NCT00765674|157088359|FG000|Overall Study|Adverse Event|7|||
48795416|NCT00765674|157088360|FG001|Overall Study|Adverse Event|2|||
48795417|NCT00765674|157088361|FG002|Overall Study|Adverse Event|8|||
48795418|NCT00765674|157088362|FG003|Overall Study|Adverse Event|11|||
48795419|NCT00765674|157088359|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
48795420|NCT00765674|157088360|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
48795421|NCT00765674|157088361|FG002|Overall Study|Abnormal Laboratory Value(s)|1|||
48795422|NCT00765674|157088362|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
48795423|NCT00765674|157088359|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
48795424|NCT00765674|157088360|FG001|Overall Study|Abnormal Test Procedure Result(s)|3|||
48795425|NCT00765674|157088361|FG002|Overall Study|Abnormal Test Procedure Result(s)|1|||
48795426|NCT00765674|157088362|FG003|Overall Study|Abnormal Test Procedure Result(s)|2|||
48795427|NCT00765674|157088359|FG000|Overall Study|Lack of Efficacy|2|||
48795428|NCT00765674|157088360|FG001|Overall Study|Lack of Efficacy|3|||
48795429|NCT00765674|157088361|FG002|Overall Study|Lack of Efficacy|1|||
48795430|NCT00765674|157088362|FG003|Overall Study|Lack of Efficacy|2|||
48795431|NCT00765674|157088359|FG000|Overall Study|Protocol Violation|2|||
48795432|NCT00765674|157088360|FG001|Overall Study|Protocol Violation|0|||
48795433|NCT00765674|157088361|FG002|Overall Study|Protocol Violation|1|||
48795434|NCT00765674|157088362|FG003|Overall Study|Protocol Violation|0|||
48795435|NCT00765674|157088359|FG000|Overall Study|Withdrawal by Subject|5|||
48795436|NCT00765674|157088360|FG001|Overall Study|Withdrawal by Subject|7|||
48795437|NCT00765674|157088361|FG002|Overall Study|Withdrawal by Subject|3|||
48795438|NCT00765674|157088362|FG003|Overall Study|Withdrawal by Subject|8|||
48795439|NCT00765674|157088359|FG000|Overall Study|Lost to Follow-up|4|||
48795440|NCT00765674|157088360|FG001|Overall Study|Lost to Follow-up|6|||
48795441|NCT00765674|157088361|FG002|Overall Study|Lost to Follow-up|2|||
48795442|NCT00765674|157088362|FG003|Overall Study|Lost to Follow-up|1|||
48795443|NCT00765674|157088359|FG000|Overall Study|Randomized in Error - No Study Drug|0|||
48795444|NCT00765674|157088360|FG001|Overall Study|Randomized in Error - No Study Drug|1|||
48795445|NCT00765674|157088361|FG002|Overall Study|Randomized in Error - No Study Drug|0|||
48795446|NCT00765674|157088362|FG003|Overall Study|Randomized in Error - No Study Drug|1|||
48795447|NCT03015402|157088363|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
48795448|NCT03015402|157088364|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|2|||
48795449|NCT03015402|157088363|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
48795450|NCT03015402|157088364|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
48795451|NCT03213158|157088365|FG000|Overall Study|Withdrawal by Subject|1|||
48795452|NCT03213158|157088365|FG000|Overall Study|Physician Decision|2|||
48795453|NCT00587964|157088366|FG000|Overall Study|Withdrawal by Subject|1|||
48795454|NCT00587964|157088366|FG000|Overall Study|Lost to Follow-up|1|||
48795455|NCT00587964|157088366|FG000|Overall Study|Patient found to be ineligible|1|||
48795456|NCT00587964|157088366|FG000|Overall Study|Patient did not receive intervention|5|||
48795457|NCT00587964|157088366|FG000|Overall Study|Progression of Disease|4|||
48795458|NCT03311373|157088370|FG000|Overall Study|Adverse Event|1|||
48795459|NCT03311373|157088370|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
48795460|NCT03311373|157088370|FG000|Overall Study|Lost to Follow-up|1|||
48795461|NCT03311373|157088370|FG000|Overall Study|Physician Decision|1|||
48795462|NCT03311373|157088370|FG000|Overall Study|Withdrawal by Subject|3|||
48795463|NCT01239030|157088371|FG000|Double Blind|Adverse Event|0|||
48795464|NCT01239030|157088372|FG001|Double Blind|Adverse Event|1|||
48795465|NCT01239030|157088373|FG002|Double Blind|Adverse Event|0|||
48795466|NCT01239030|157088374|FG003|Double Blind|Adverse Event|2|||
48795467|NCT01239030|157088375|FG004|Double Blind|Adverse Event|0|||
48795468|NCT01239030|157088371|FG000|Double Blind|Withdrawal by Subject|0|||
48795469|NCT01239030|157088372|FG001|Double Blind|Withdrawal by Subject|1|||
48795470|NCT01239030|157088373|FG002|Double Blind|Withdrawal by Subject|1|||
48795471|NCT01239030|157088374|FG003|Double Blind|Withdrawal by Subject|0|||
48795472|NCT01239030|157088375|FG004|Double Blind|Withdrawal by Subject|1|||
48795473|NCT01239030|157088371|FG000|Double Blind|Lost to Follow-up|1|||
48795474|NCT01239030|157088372|FG001|Double Blind|Lost to Follow-up|1|||
48795475|NCT01239030|157088373|FG002|Double Blind|Lost to Follow-up|0|||
48795476|NCT01239030|157088374|FG003|Double Blind|Lost to Follow-up|0|||
48795477|NCT01239030|157088375|FG004|Double Blind|Lost to Follow-up|0|||
48795478|NCT01239030|157088371|FG000|Double Blind|Physician Decision|0|||
48795479|NCT01239030|157088372|FG001|Double Blind|Physician Decision|1|||
48795480|NCT01239030|157088373|FG002|Double Blind|Physician Decision|0|||
48795481|NCT01239030|157088374|FG003|Double Blind|Physician Decision|0|||
48795482|NCT01239030|157088375|FG004|Double Blind|Physician Decision|0|||
48795483|NCT01239030|157088371|FG000|Dose Optimization (Open Label)|Adverse Event|2|||
48795484|NCT01239030|157088372|FG001|Dose Optimization (Open Label)|Adverse Event|0|||
48795485|NCT01239030|157088373|FG002|Dose Optimization (Open Label)|Adverse Event|2|||
48795486|NCT01239030|157088374|FG003|Dose Optimization (Open Label)|Adverse Event|0|||
48795487|NCT01239030|157088375|FG004|Dose Optimization (Open Label)|Adverse Event|5|||
48795488|NCT01239030|157088371|FG000|Dose Optimization (Open Label)|Withdrawal by Subject|4|||
48795489|NCT01239030|157088372|FG001|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
48795490|NCT01239030|157088373|FG002|Dose Optimization (Open Label)|Withdrawal by Subject|0|||
48795491|NCT01239030|157088374|FG003|Dose Optimization (Open Label)|Withdrawal by Subject|2|||
48795492|NCT01239030|157088375|FG004|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
48795493|NCT01239030|157088371|FG000|Dose Optimization (Open Label)|Lost to Follow-up|1|||
48795494|NCT01239030|157088372|FG001|Dose Optimization (Open Label)|Lost to Follow-up|1|||
48795495|NCT01239030|157088373|FG002|Dose Optimization (Open Label)|Lost to Follow-up|0|||
48795496|NCT01239030|157088374|FG003|Dose Optimization (Open Label)|Lost to Follow-up|0|||
48795497|NCT01239030|157088375|FG004|Dose Optimization (Open Label)|Lost to Follow-up|1|||
48795498|NCT01239030|157088371|FG000|Dose Optimization (Open Label)|Physician Decision|0|||
48795499|NCT01239030|157088372|FG001|Dose Optimization (Open Label)|Physician Decision|0|||
48795500|NCT01239030|157088373|FG002|Dose Optimization (Open Label)|Physician Decision|0|||
48795501|NCT01239030|157088374|FG003|Dose Optimization (Open Label)|Physician Decision|1|||
48795502|NCT01239030|157088375|FG004|Dose Optimization (Open Label)|Physician Decision|0|||
48795503|NCT02077166|157088376|FG000|Overall Study|Death|6|||
48795504|NCT02077166|157088377|FG001|Overall Study|Death|7|||
48795505|NCT02077166|157088378|FG002|Overall Study|Death|5|||
48795506|NCT02077166|157088379|FG003|Overall Study|Death|6|||
48795507|NCT02077166|157088380|FG004|Overall Study|Death|4|||
48795508|NCT02077166|157088381|FG005|Overall Study|Death|32|||
48795509|NCT02077166|157088382|FG006|Overall Study|Death|22|||
48795510|NCT02077166|157088376|FG000|Overall Study|Study Closure by Sponsor|3|||
48795511|NCT02077166|157088377|FG001|Overall Study|Study Closure by Sponsor|0|||
48795512|NCT02077166|157088378|FG002|Overall Study|Study Closure by Sponsor|2|||
48795513|NCT02077166|157088379|FG003|Overall Study|Study Closure by Sponsor|2|||
48795514|NCT02077166|157088380|FG004|Overall Study|Study Closure by Sponsor|2|||
48795515|NCT02077166|157088381|FG005|Overall Study|Study Closure by Sponsor|12|||
48795516|NCT02077166|157088382|FG006|Overall Study|Study Closure by Sponsor|4|||
48795517|NCT02077166|157088376|FG000|Overall Study|Lost to Follow-up|0|||
48795518|NCT02077166|157088377|FG001|Overall Study|Lost to Follow-up|0|||
48795519|NCT02077166|157088378|FG002|Overall Study|Lost to Follow-up|0|||
48795520|NCT02077166|157088379|FG003|Overall Study|Lost to Follow-up|0|||
48795521|NCT02077166|157088380|FG004|Overall Study|Lost to Follow-up|0|||
48795522|NCT02077166|157088381|FG005|Overall Study|Lost to Follow-up|1|||
48795523|NCT02077166|157088382|FG006|Overall Study|Lost to Follow-up|0|||
48795524|NCT02077166|157088376|FG000|Overall Study|Withdrawal by Subject|3|||
48795525|NCT02077166|157088377|FG001|Overall Study|Withdrawal by Subject|0|||
48795526|NCT02077166|157088378|FG002|Overall Study|Withdrawal by Subject|1|||
48795527|NCT02077166|157088379|FG003|Overall Study|Withdrawal by Subject|1|||
48795528|NCT02077166|157088380|FG004|Overall Study|Withdrawal by Subject|1|||
48795529|NCT02077166|157088381|FG005|Overall Study|Withdrawal by Subject|3|||
48795530|NCT02077166|157088382|FG006|Overall Study|Withdrawal by Subject|0|||
48795531|NCT02077166|157088376|FG000|Overall Study|Other, Not Specified|0|||
48795532|NCT02077166|157088377|FG001|Overall Study|Other, Not Specified|0|||
48795533|NCT02077166|157088378|FG002|Overall Study|Other, Not Specified|1|||
48795534|NCT02077166|157088379|FG003|Overall Study|Other, Not Specified|0|||
48795535|NCT02077166|157088380|FG004|Overall Study|Other, Not Specified|1|||
48795536|NCT02077166|157088381|FG005|Overall Study|Other, Not Specified|7|||
48795537|NCT02077166|157088382|FG006|Overall Study|Other, Not Specified|8|||
48795538|NCT03832595|157088383|FG000|Overall Study|Death|142|||
48795539|NCT03832595|157088384|FG001|Overall Study|Death|130|||
48795540|NCT03832595|157088383|FG000|Overall Study|Medical management without dialysis|37|||
48795541|NCT03832595|157088384|FG001|Overall Study|Medical management without dialysis|1|||
48795542|NCT01338025|157088385|FG000|Overall Study|Unexpected closure of study|10|||
48795543|NCT01338025|157088386|FG001|Overall Study|Unexpected closure of study|9|||
48795544|NCT01338025|157088385|FG000|Overall Study|Withdrawal by Subject|0|||
48795545|NCT01338025|157088386|FG001|Overall Study|Withdrawal by Subject|2|||
48795546|NCT01338025|157088385|FG000|Overall Study|Found ineligible after starting|1|||
48795547|NCT01338025|157088386|FG001|Overall Study|Found ineligible after starting|0|||
48795548|NCT04602728|157088389|FG000|Overall Study|Lost to Follow-up|4|||
48795549|NCT04602728|157088390|FG001|Overall Study|Lost to Follow-up|4|||
48795550|NCT04508699|157088393|FG000|Overall Study|Lack of Efficacy|2|||
48795551|NCT04508699|157088394|FG001|Overall Study|Lack of Efficacy|15|||
48795552|NCT04508699|157088393|FG000|Overall Study|Withdrawal by Subject|0|||
48795553|NCT04508699|157088394|FG001|Overall Study|Withdrawal by Subject|2|||
48795554|NCT00136955|157090027|FG000|Overall Study|Adverse Event|8|||
48795555|NCT00136955|157090027|FG000|Overall Study|Lost to Follow-up|1|||
48795556|NCT00136955|157090027|FG000|Overall Study|Withdrawal by Subject|2|||
48795557|NCT00136955|157090027|FG000|Overall Study|Incl. prog. disease, protocol violation|12|||
48795558|NCT00955357|157090032|FG000|Titration Phase|Adverse Event|9|||
48795559|NCT00955357|157090033|FG001|Titration Phase|Adverse Event|46|||
48795560|NCT00955357|157090032|FG000|Titration Phase|Lack of Efficacy|0|||
48795561|NCT00955357|157090033|FG001|Titration Phase|Lack of Efficacy|2|||
48795562|NCT00955357|157090032|FG000|Titration Phase|Protocol Violation|3|||
48795563|NCT00955357|157090033|FG001|Titration Phase|Protocol Violation|7|||
48795564|NCT00955357|157090032|FG000|Titration Phase|Lost to Follow-up|1|||
48795565|NCT00955357|157090033|FG001|Titration Phase|Lost to Follow-up|3|||
48795566|NCT00955357|157090032|FG000|Titration Phase|Withdrawal by Subject|3|||
48795567|NCT00955357|157090033|FG001|Titration Phase|Withdrawal by Subject|5|||
48795568|NCT00955357|157090032|FG000|Titration Phase|Prohibited Antiepileptic Drug change|0|||
48795569|NCT00955357|157090033|FG001|Titration Phase|Prohibited Antiepileptic Drug change|1|||
48795570|NCT00955357|157090032|FG000|Titration Phase|Study medication not tolerated|0|||
49033097|NCT01686477|157955702|FG001|Feeding Intervention|Death|0|||
48795571|NCT00955357|157090033|FG001|Titration Phase|Study medication not tolerated|1|||
48795572|NCT00955357|157090032|FG000|Titration Phase|Non compliance to study procedures|0|||
48795573|NCT00955357|157090033|FG001|Titration Phase|Non compliance to study procedures|1|||
48795574|NCT00955357|157090032|FG000|Maintenance Phase|Adverse Event|3|||
48795575|NCT00955357|157090033|FG001|Maintenance Phase|Adverse Event|23|||
48795576|NCT00955357|157090032|FG000|Maintenance Phase|Lack of Efficacy|0|||
48795577|NCT00955357|157090033|FG001|Maintenance Phase|Lack of Efficacy|4|||
48795578|NCT00955357|157090032|FG000|Maintenance Phase|Protocol Violation|2|||
48795579|NCT00955357|157090033|FG001|Maintenance Phase|Protocol Violation|6|||
48795580|NCT00955357|157090032|FG000|Maintenance Phase|Lost to Follow-up|2|||
48795581|NCT00955357|157090033|FG001|Maintenance Phase|Lost to Follow-up|7|||
48795582|NCT00955357|157090032|FG000|Maintenance Phase|Withdrawal by Subject|4|||
48795583|NCT00955357|157090033|FG001|Maintenance Phase|Withdrawal by Subject|4|||
48795584|NCT00955357|157090032|FG000|Maintenance Phase|Patient moving out of area|0|||
48795585|NCT00955357|157090033|FG001|Maintenance Phase|Patient moving out of area|1|||
48795586|NCT00955357|157090032|FG000|Maintenance Phase|Non compliance to study procedures|1|||
48795587|NCT00955357|157090033|FG001|Maintenance Phase|Non compliance to study procedures|0|||
48795588|NCT02985866|157090034|FG000|Overall Study|Poor CGM data|1|||
48795589|NCT02985866|157090035|FG001|Overall Study|Poor CGM data|1|||
48795590|NCT00447057|157090036|FG000|Overall Study|Adverse Event|4|||
48795591|NCT00447057|157090037|FG001|Overall Study|Adverse Event|10|||
48795592|NCT00447057|157090038|FG002|Overall Study|Adverse Event|0|||
48795593|NCT00447057|157090039|FG003|Overall Study|Adverse Event|3|||
48795594|NCT00447057|157090036|FG000|Overall Study|Death due to study disease|6|||
48795595|NCT00447057|157090037|FG001|Overall Study|Death due to study disease|4|||
48795596|NCT00447057|157090038|FG002|Overall Study|Death due to study disease|1|||
48795597|NCT00447057|157090039|FG003|Overall Study|Death due to study disease|1|||
48795598|NCT00447057|157090036|FG000|Overall Study|Lost to Follow-up|0|||
48795599|NCT00447057|157090037|FG001|Overall Study|Lost to Follow-up|1|||
48795600|NCT00447057|157090038|FG002|Overall Study|Lost to Follow-up|0|||
48795601|NCT00447057|157090039|FG003|Overall Study|Lost to Follow-up|0|||
48795602|NCT00447057|157090036|FG000|Overall Study|Entry criteria not met|1|||
48795603|NCT00447057|157090037|FG001|Overall Study|Entry criteria not met|1|||
48795604|NCT00447057|157090038|FG002|Overall Study|Entry criteria not met|0|||
48795605|NCT00447057|157090039|FG003|Overall Study|Entry criteria not met|0|||
48795606|NCT00447057|157090036|FG000|Overall Study|Protocol Violation|0|||
48795607|NCT00447057|157090037|FG001|Overall Study|Protocol Violation|1|||
48795608|NCT00447057|157090038|FG002|Overall Study|Protocol Violation|0|||
48795609|NCT00447057|157090039|FG003|Overall Study|Protocol Violation|0|||
48795610|NCT00447057|157090036|FG000|Overall Study|Withdrawal by Subject|4|||
48795611|NCT00447057|157090037|FG001|Overall Study|Withdrawal by Subject|5|||
48795612|NCT00447057|157090038|FG002|Overall Study|Withdrawal by Subject|1|||
48795613|NCT00447057|157090039|FG003|Overall Study|Withdrawal by Subject|1|||
48795614|NCT00447057|157090036|FG000|Overall Study|Physician Decision|9|||
48795615|NCT00447057|157090037|FG001|Overall Study|Physician Decision|6|||
48795616|NCT00447057|157090038|FG002|Overall Study|Physician Decision|3|||
48795617|NCT00447057|157090039|FG003|Overall Study|Physician Decision|1|||
48795618|NCT00447057|157090036|FG000|Overall Study|Sponsor decision|1|||
48795619|NCT00447057|157090037|FG001|Overall Study|Sponsor decision|1|||
48795620|NCT00447057|157090038|FG002|Overall Study|Sponsor decision|0|||
48795621|NCT00447057|157090039|FG003|Overall Study|Sponsor decision|0|||
48795622|NCT00447057|157090036|FG000|Overall Study|Progressive disease|58|||
48795623|NCT00447057|157090037|FG001|Overall Study|Progressive disease|43|||
48795624|NCT00447057|157090038|FG002|Overall Study|Progressive disease|13|||
48795625|NCT00447057|157090039|FG003|Overall Study|Progressive disease|18|||
48795626|NCT00447057|157090036|FG000|Overall Study|Death due to adverse event|0|||
48795627|NCT00447057|157090037|FG001|Overall Study|Death due to adverse event|0|||
49033098|NCT01686477|157955703|FG002|Feeding Intervention|Death|1|||
49033099|NCT01686477|157955701|FG000|Feeding Intervention|Withdrawal by Subject|0|||
49033100|NCT01686477|157955702|FG001|Feeding Intervention|Withdrawal by Subject|6|||
49033101|NCT01686477|157955703|FG002|Feeding Intervention|Withdrawal by Subject|0|||
49033102|NCT01686477|157955701|FG000|Feeding Intervention|Physician Decision|1|||
49033103|NCT01686477|157955702|FG001|Feeding Intervention|Physician Decision|2|||
49033104|NCT01686477|157955703|FG002|Feeding Intervention|Physician Decision|0|||
49033105|NCT01686477|157955701|FG000|Feeding Intervention|Met pre-defined safety threshold|1|||
48795628|NCT00447057|157090038|FG002|Overall Study|Death due to adverse event|1|||
48795629|NCT00447057|157090039|FG003|Overall Study|Death due to adverse event|2|||
48795630|NCT00447057|157090036|FG000|Overall Study|Death, study drug related|0|||
48795631|NCT00447057|157090037|FG001|Overall Study|Death, study drug related|1|||
48795632|NCT00447057|157090038|FG002|Overall Study|Death, study drug related|0|||
48795633|NCT00447057|157090039|FG003|Overall Study|Death, study drug related|0|||
48795634|NCT00160680|157090040|FG000|Overall Study|Adverse Event|0|||
48795635|NCT00160680|157090041|FG001|Overall Study|Adverse Event|1|||
48795636|NCT00160680|157090040|FG000|Overall Study|Lack of Efficacy|2|||
48795637|NCT00160680|157090041|FG001|Overall Study|Lack of Efficacy|1|||
48795638|NCT00160680|157090040|FG000|Overall Study|Lost to Follow-up|3|||
48795639|NCT00160680|157090041|FG001|Overall Study|Lost to Follow-up|2|||
48795640|NCT00160680|157090040|FG000|Overall Study|Withdrawal by Subject|4|||
48795641|NCT00160680|157090041|FG001|Overall Study|Withdrawal by Subject|9|||
48795642|NCT00951041|157090044|FG000|Overall Study|Withdrawal by Subject|1|||
48795643|NCT00951041|157090045|FG001|Overall Study|Withdrawal by Subject|1|||
48795644|NCT00951041|157090044|FG000|Overall Study|Lost to Follow-up|1|||
48795645|NCT00951041|157090045|FG001|Overall Study|Lost to Follow-up|0|||
48795646|NCT00951041|157090044|FG000|Overall Study|Other|3|||
48795647|NCT00951041|157090045|FG001|Overall Study|Other|0|||
48795648|NCT02131272|157090046|FG000|Overall Study|Withdrawal by parent|0|||
48795649|NCT02131272|157090047|FG001|Overall Study|Withdrawal by parent|1|||
48795650|NCT02131272|157090046|FG000|Overall Study|Withdrawal by Subject|0|||
48795651|NCT02131272|157090047|FG001|Overall Study|Withdrawal by Subject|1|||
48795652|NCT02131272|157090046|FG000|Overall Study|Withdrawal Criteria|1|||
48795653|NCT02131272|157090047|FG001|Overall Study|Withdrawal Criteria|0|||
48795654|NCT00381940|157090050|FG000|Overall Study|Lack of Efficacy|3|||
48795655|NCT00381940|157090050|FG000|Overall Study|Protocol Violation|1|||
48795656|NCT00381940|157090050|FG000|Overall Study|Ineligible|1|||
48795657|NCT04162769|157090051|FG000|Double-blind Treatment (12-Week)|Adverse Event|2|||
48795658|NCT04162769|157090052|FG001|Double-blind Treatment (12-Week)|Adverse Event|5|||
48795659|NCT04162769|157090053|FG002|Double-blind Treatment (12-Week)|Adverse Event|0|||
48795660|NCT04162769|157090054|FG003|Double-blind Treatment (12-Week)|Adverse Event|0|||
48795661|NCT04162769|157090051|FG000|Double-blind Treatment (12-Week)|Withdrawal by Subject|4|||
48795662|NCT04162769|157090052|FG001|Double-blind Treatment (12-Week)|Withdrawal by Subject|3|||
48795663|NCT04162769|157090053|FG002|Double-blind Treatment (12-Week)|Withdrawal by Subject|2|||
48795664|NCT04162769|157090054|FG003|Double-blind Treatment (12-Week)|Withdrawal by Subject|0|||
48795665|NCT04162769|157090051|FG000|Double-blind Treatment (12-Week)|Physician Decision|1|||
48795666|NCT04162769|157090052|FG001|Double-blind Treatment (12-Week)|Physician Decision|0|||
48795667|NCT04162769|157090053|FG002|Double-blind Treatment (12-Week)|Physician Decision|0|||
48795668|NCT04162769|157090054|FG003|Double-blind Treatment (12-Week)|Physician Decision|0|||
48795669|NCT04162769|157090051|FG000|Double-blind Treatment (12-Week)|Lost to Follow-up|5|||
48795670|NCT04162769|157090052|FG001|Double-blind Treatment (12-Week)|Lost to Follow-up|1|||
48795671|NCT04162769|157090053|FG002|Double-blind Treatment (12-Week)|Lost to Follow-up|6|||
48795672|NCT04162769|157090054|FG003|Double-blind Treatment (12-Week)|Lost to Follow-up|0|||
49033106|NCT01686477|157955702|FG001|Feeding Intervention|Met pre-defined safety threshold|0|||
48795673|NCT04162769|157090051|FG000|Double-blind Treatment (12-Week)|Protocol deviation|1|||
48795674|NCT04162769|157090052|FG001|Double-blind Treatment (12-Week)|Protocol deviation|1|||
48795675|NCT04162769|157090053|FG002|Double-blind Treatment (12-Week)|Protocol deviation|0|||
48795676|NCT04162769|157090054|FG003|Double-blind Treatment (12-Week)|Protocol deviation|0|||
48795677|NCT04162769|157090051|FG000|Double-blind Treatment (12-Week)|Other|0|||
48795678|NCT04162769|157090052|FG001|Double-blind Treatment (12-Week)|Other|1|||
48795679|NCT04162769|157090053|FG002|Double-blind Treatment (12-Week)|Other|1|||
48878639|NCT00267098|157394371|FG007|Overall Study|Explanted Medtronic device|0|||
48878640|NCT00267098|157394364|FG000|Overall Study|Non-Medtronic LV Lead Implanted|0|||
49033107|NCT01686477|157955703|FG002|Feeding Intervention|Met pre-defined safety threshold|1|||
49033108|NCT01686477|157955701|FG000|Feeding Intervention|Transfer to a non-participating hospital|0|||
49033109|NCT01686477|157955702|FG001|Feeding Intervention|Transfer to a non-participating hospital|1|||
49033110|NCT01686477|157955703|FG002|Feeding Intervention|Transfer to a non-participating hospital|1|||
49033111|NCT01686477|157955701|FG000|Primary Outcome Term Scan|Withdrawal by Subject|6|||
49033112|NCT01686477|157955702|FG001|Primary Outcome Term Scan|Withdrawal by Subject|5|||
49033113|NCT01686477|157955703|FG002|Primary Outcome Term Scan|Withdrawal by Subject|5|||
49033114|NCT01686477|157955701|FG000|Primary Outcome Term Scan|Lost to Follow-up|1|||
49033115|NCT01686477|157955702|FG001|Primary Outcome Term Scan|Lost to Follow-up|1|||
49033116|NCT01686477|157955703|FG002|Primary Outcome Term Scan|Lost to Follow-up|1|||
49033117|NCT01686477|157955701|FG000|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|2|||
49033118|NCT01686477|157955702|FG001|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
49033119|NCT01686477|157955703|FG002|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
49033120|NCT01686477|157955701|FG000|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|7|||
49033121|NCT01686477|157955702|FG001|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|12|||
49033122|NCT01686477|157955703|FG002|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|5|||
49033123|NCT01686477|157955701|FG000|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
49033124|NCT01686477|157955702|FG001|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|2|||
48795680|NCT04162769|157090054|FG003|Double-blind Treatment (12-Week)|Other|0|||
48795681|NCT04162769|157090051|FG000|OLE Period (52-Week)|Adverse Event|0|||
48795682|NCT04162769|157090052|FG001|OLE Period (52-Week)|Adverse Event|0|||
48795683|NCT04162769|157090053|FG002|OLE Period (52-Week)|Adverse Event|0|||
48795684|NCT04162769|157090054|FG003|OLE Period (52-Week)|Adverse Event|5|||
48795685|NCT04162769|157090051|FG000|OLE Period (52-Week)|Withdrawal by Subject|0|||
48878641|NCT00267098|157394365|FG001|Overall Study|Non-Medtronic LV Lead Implanted|0|||
48795686|NCT04162769|157090052|FG001|OLE Period (52-Week)|Withdrawal by Subject|0|||
48795687|NCT04162769|157090053|FG002|OLE Period (52-Week)|Withdrawal by Subject|0|||
49033125|NCT01686477|157955703|FG002|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
49033126|NCT02963259|157955704|FG000|Overall Study|IPG Replacement not Done with Abbott Device|2|||
48795688|NCT04162769|157090054|FG003|OLE Period (52-Week)|Withdrawal by Subject|10|||
48795689|NCT04162769|157090051|FG000|OLE Period (52-Week)|Physician Decision|0|||
48795690|NCT04162769|157090052|FG001|OLE Period (52-Week)|Physician Decision|0|||
48795691|NCT04162769|157090053|FG002|OLE Period (52-Week)|Physician Decision|0|||
48795692|NCT04162769|157090054|FG003|OLE Period (52-Week)|Physician Decision|1|||
49033127|NCT02963259|157955704|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
49033128|NCT02963259|157955704|FG000|Overall Study|Death|1|||
49033129|NCT02963259|157955704|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
49033130|NCT01136174|157955705|FG000|Overall Study|Adverse Event|0|||
49033131|NCT01136174|157955706|FG001|Overall Study|Adverse Event|0|||
49033132|NCT01136174|157955707|FG002|Overall Study|Adverse Event|0|||
49033133|NCT01136174|157955708|FG003|Overall Study|Adverse Event|4|||
49033134|NCT03161405|157955709|FG000|Second Intervention Period (6 Days)|Positive urine drug screen|1|||
49033135|NCT02655679|157955710|FG000|Overall Study|Adverse Event|0|||
49033136|NCT02655679|157955711|FG001|Overall Study|Adverse Event|1|||
49033137|NCT02655679|157955712|FG002|Overall Study|Adverse Event|0|||
49033138|NCT02655679|157955713|FG003|Overall Study|Adverse Event|0|||
49033139|NCT02655679|157955714|FG004|Overall Study|Adverse Event|0|||
49033140|NCT02655679|157955710|FG000|Overall Study|Withdrawal by Subject|1|||
49033141|NCT02655679|157955711|FG001|Overall Study|Withdrawal by Subject|1|||
49033142|NCT02655679|157955712|FG002|Overall Study|Withdrawal by Subject|0|||
48795693|NCT04162769|157090051|FG000|OLE Period (52-Week)|Lost to Follow-up|0|||
48795694|NCT04162769|157090052|FG001|OLE Period (52-Week)|Lost to Follow-up|0|||
48795695|NCT04162769|157090053|FG002|OLE Period (52-Week)|Lost to Follow-up|0|||
48795696|NCT04162769|157090054|FG003|OLE Period (52-Week)|Lost to Follow-up|9|||
48795697|NCT04162769|157090051|FG000|OLE Period (52-Week)|Protocol deviation|0|||
48795698|NCT04162769|157090052|FG001|OLE Period (52-Week)|Protocol deviation|0|||
48795699|NCT04162769|157090053|FG002|OLE Period (52-Week)|Protocol deviation|0|||
48795700|NCT04162769|157090054|FG003|OLE Period (52-Week)|Protocol deviation|2|||
48795701|NCT01688466|157090055|FG000|Overall Study|Withdrawal by Subject|2|||
48795702|NCT01688466|157090056|FG001|Overall Study|Withdrawal by Subject|1|||
48795703|NCT01688466|157090055|FG000|Overall Study|Death|0|||
48795704|NCT01688466|157090056|FG001|Overall Study|Death|1|||
48795705|NCT01688466|157090055|FG000|Overall Study|Adverse Event|0|||
48795706|NCT01688466|157090056|FG001|Overall Study|Adverse Event|4|||
48795707|NCT01688466|157090055|FG000|Overall Study|Not evaluable|0|||
48795708|NCT01688466|157090056|FG001|Overall Study|Not evaluable|1|||
48795709|NCT02732938|157090059|FG000|Overall Study|Death|0|||
48795710|NCT02732938|157090060|FG001|Overall Study|Death|11|||
48795711|NCT02732938|157090061|FG002|Overall Study|Death|0|||
48795712|NCT02732938|157090059|FG000|Overall Study|Randomized but did not receive treatment|0|||
48795713|NCT02732938|157090060|FG001|Overall Study|Randomized but did not receive treatment|1|||
48795714|NCT02732938|157090061|FG002|Overall Study|Randomized but did not receive treatment|0|||
48795715|NCT02732938|157090059|FG000|Overall Study|Refused further follow-up|1|||
48795716|NCT02732938|157090060|FG001|Overall Study|Refused further follow-up|0|||
48795717|NCT02732938|157090061|FG002|Overall Study|Refused further follow-up|0|||
48795718|NCT02732938|157090059|FG000|Overall Study|Study terminated by sponsor|3|||
48795719|NCT02732938|157090060|FG001|Overall Study|Study terminated by sponsor|6|||
48795720|NCT02732938|157090061|FG002|Overall Study|Study terminated by sponsor|0|||
48795721|NCT01040260|157090062|FG000|Overall Study|Withdrawal by Subject|12|||
48795722|NCT01040260|157090063|FG001|Overall Study|Withdrawal by Subject|6|||
48795723|NCT01040260|157090062|FG000|Overall Study|Lost to Follow-up|3|||
48795724|NCT01040260|157090063|FG001|Overall Study|Lost to Follow-up|5|||
48795725|NCT04124926|157090064|FG000|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|3|||
48795726|NCT04124926|157090065|FG001|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|7|||
48795727|NCT04124926|157090066|FG002|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
48795728|NCT04124926|157090067|FG003|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
48795729|NCT04124926|157090068|FG004|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
48795730|NCT04124926|157090064|FG000|Healing Phase|Protocol Violation|0|||
48795731|NCT04124926|157090065|FG001|Healing Phase|Protocol Violation|1|||
48795732|NCT04124926|157090066|FG002|Healing Phase|Protocol Violation|0|||
49033143|NCT02655679|157955713|FG003|Overall Study|Withdrawal by Subject|3|||
49033144|NCT02655679|157955714|FG004|Overall Study|Withdrawal by Subject|1|||
49033145|NCT02655679|157955710|FG000|Overall Study|Inability to Comply with the Protocol|1|||
48795733|NCT04124926|157090067|FG003|Healing Phase|Protocol Violation|0|||
48795734|NCT04124926|157090068|FG004|Healing Phase|Protocol Violation|0|||
48795735|NCT04124926|157090064|FG000|Healing Phase|Lost to Follow-up|5|||
48795736|NCT04124926|157090065|FG001|Healing Phase|Lost to Follow-up|4|||
48795737|NCT04124926|157090066|FG002|Healing Phase|Lost to Follow-up|0|||
48795738|NCT04124926|157090067|FG003|Healing Phase|Lost to Follow-up|0|||
48795739|NCT04124926|157090068|FG004|Healing Phase|Lost to Follow-up|0|||
48795740|NCT04124926|157090064|FG000|Healing Phase|Voluntary Withdrawal|10|||
48795741|NCT04124926|157090065|FG001|Healing Phase|Voluntary Withdrawal|7|||
48878642|NCT00267098|157394366|FG002|Overall Study|Non-Medtronic LV Lead Implanted|0|||
48878643|NCT00267098|157394367|FG003|Overall Study|Non-Medtronic LV Lead Implanted|0|||
48878644|NCT00267098|157394368|FG004|Overall Study|Non-Medtronic LV Lead Implanted|2|||
48878645|NCT00267098|157394369|FG005|Overall Study|Non-Medtronic LV Lead Implanted|0|||
48878646|NCT00267098|157394370|FG006|Overall Study|Non-Medtronic LV Lead Implanted|0|||
48878647|NCT00267098|157394371|FG007|Overall Study|Non-Medtronic LV Lead Implanted|0|||
48878648|NCT00267098|157394364|FG000|Overall Study|Subject listed for heart transplant|0|||
48878649|NCT00267098|157394365|FG001|Overall Study|Subject listed for heart transplant|0|||
48878650|NCT00267098|157394366|FG002|Overall Study|Subject listed for heart transplant|0|||
48878651|NCT00267098|157394367|FG003|Overall Study|Subject listed for heart transplant|0|||
48878652|NCT00267098|157394368|FG004|Overall Study|Subject listed for heart transplant|0|||
48878653|NCT00267098|157394369|FG005|Overall Study|Subject listed for heart transplant|0|||
48878654|NCT00267098|157394370|FG006|Overall Study|Subject listed for heart transplant|1|||
48878655|NCT00267098|157394371|FG007|Overall Study|Subject listed for heart transplant|0|||
48878656|NCT00267098|157394364|FG000|Overall Study|Sponsor withdrew subject|0|||
48878657|NCT00267098|157394365|FG001|Overall Study|Sponsor withdrew subject|0|||
48878658|NCT00267098|157394366|FG002|Overall Study|Sponsor withdrew subject|0|||
48878659|NCT00267098|157394367|FG003|Overall Study|Sponsor withdrew subject|1|||
48878660|NCT00267098|157394368|FG004|Overall Study|Sponsor withdrew subject|0|||
48878661|NCT00267098|157394369|FG005|Overall Study|Sponsor withdrew subject|0|||
48878662|NCT00267098|157394370|FG006|Overall Study|Sponsor withdrew subject|0|||
48878663|NCT00267098|157394371|FG007|Overall Study|Sponsor withdrew subject|0|||
48878664|NCT01721954|157394372|FG000|Overall Study|Death|58|||
48878665|NCT01721954|157394373|FG001|Overall Study|Death|64|||
48878666|NCT01721954|157394372|FG000|Overall Study|Withdrawal by Subject|8|||
48878667|NCT01721954|157394373|FG001|Overall Study|Withdrawal by Subject|4|||
48878668|NCT01721954|157394372|FG000|Overall Study|Adverse Event|2|||
48878669|NCT01721954|157394373|FG001|Overall Study|Adverse Event|0|||
48878670|NCT01721954|157394372|FG000|Overall Study|Lost to Follow-up|2|||
48878671|NCT01721954|157394373|FG001|Overall Study|Lost to Follow-up|1|||
48878672|NCT00965497|157394374|FG000|Overall Study|Physician Decision|1|||
48878673|NCT01825577|157394377|FG000|Overall Study|Physician Decision|2|||
48878674|NCT01825577|157394377|FG000|Overall Study|Withdrawal by Subject|1|||
48878675|NCT01825577|157394377|FG000|Overall Study|Withdrawn by family members|2|||
48878676|NCT01825577|157394377|FG000|Overall Study|Lack of Efficacy|3|||
48878677|NCT02838134|157394378|FG000|Overall Study|Lost to Follow-up|1|||
48878678|NCT02838134|157394379|FG001|Overall Study|Lost to Follow-up|2|||
48878679|NCT02838134|157394378|FG000|Overall Study|logistic problems|1|||
48878680|NCT02838134|157394379|FG001|Overall Study|logistic problems|1|||
48878681|NCT01299480|157394380|FG000|Overall Study|No longer willing to participate|19|||
48878682|NCT01299480|157394381|FG001|Overall Study|No longer willing to participate|17|||
48878683|NCT01299480|157394382|FG002|Overall Study|No longer willing to participate|14|||
48878684|NCT01299480|157394383|FG003|Overall Study|No longer willing to participate|13|||
48878685|NCT01299480|157394384|FG004|Overall Study|No longer willing to participate|10|||
49033146|NCT02655679|157955711|FG001|Overall Study|Inability to Comply with the Protocol|0|||
49033147|NCT02655679|157955712|FG002|Overall Study|Inability to Comply with the Protocol|0|||
49033148|NCT02655679|157955713|FG003|Overall Study|Inability to Comply with the Protocol|0|||
49033149|NCT02655679|157955714|FG004|Overall Study|Inability to Comply with the Protocol|0|||
49033150|NCT02655679|157955710|FG000|Overall Study|Lost to Follow-up|0|||
49033151|NCT02655679|157955711|FG001|Overall Study|Lost to Follow-up|1|||
49033152|NCT02655679|157955712|FG002|Overall Study|Lost to Follow-up|1|||
49033153|NCT02655679|157955713|FG003|Overall Study|Lost to Follow-up|1|||
49033154|NCT02655679|157955714|FG004|Overall Study|Lost to Follow-up|0|||
49033155|NCT02655679|157955710|FG000|Overall Study|Other Miscellaneous Reasons|1|||
49033156|NCT02655679|157955711|FG001|Overall Study|Other Miscellaneous Reasons|0|||
49033157|NCT02655679|157955712|FG002|Overall Study|Other Miscellaneous Reasons|0|||
49033158|NCT02655679|157955713|FG003|Overall Study|Other Miscellaneous Reasons|0|||
49033159|NCT02655679|157955714|FG004|Overall Study|Other Miscellaneous Reasons|0|||
49033160|NCT02554890|157955715|FG000|Double-blind|Adverse Event|45|||
48878686|NCT01299480|157394380|FG000|Overall Study|Protocol Violation|7|||
48878687|NCT01299480|157394381|FG001|Overall Study|Protocol Violation|5|||
48878688|NCT01299480|157394382|FG002|Overall Study|Protocol Violation|8|||
48878689|NCT01299480|157394383|FG003|Overall Study|Protocol Violation|1|||
48878690|NCT01299480|157394384|FG004|Overall Study|Protocol Violation|1|||
48878691|NCT01299480|157394380|FG000|Overall Study|Withdrawal by Subject|3|||
48878692|NCT01299480|157394381|FG001|Overall Study|Withdrawal by Subject|4|||
48878693|NCT01299480|157394382|FG002|Overall Study|Withdrawal by Subject|7|||
48878694|NCT01299480|157394383|FG003|Overall Study|Withdrawal by Subject|3|||
48878695|NCT01299480|157394384|FG004|Overall Study|Withdrawal by Subject|4|||
48878696|NCT01299480|157394380|FG000|Overall Study|Adverse Event|6|||
48878697|NCT01299480|157394381|FG001|Overall Study|Adverse Event|4|||
48878698|NCT01299480|157394382|FG002|Overall Study|Adverse Event|5|||
49033161|NCT02554890|157955716|FG001|Double-blind|Adverse Event|51|||
48878699|NCT01299480|157394383|FG003|Overall Study|Adverse Event|4|||
49033162|NCT02554890|157955715|FG000|Double-blind|Death|6|||
49033163|NCT02554890|157955716|FG001|Double-blind|Death|4|||
48795742|NCT04124926|157090066|FG002|Healing Phase|Voluntary Withdrawal|0|||
48795743|NCT04124926|157090067|FG003|Healing Phase|Voluntary Withdrawal|0|||
48795744|NCT04124926|157090068|FG004|Healing Phase|Voluntary Withdrawal|0|||
48795745|NCT04124926|157090064|FG000|Healing Phase|Withdrawal of Consent|5|||
48795746|NCT04124926|157090065|FG001|Healing Phase|Withdrawal of Consent|3|||
48795747|NCT04124926|157090066|FG002|Healing Phase|Withdrawal of Consent|0|||
48795748|NCT04124926|157090067|FG003|Healing Phase|Withdrawal of Consent|0|||
48795749|NCT04124926|157090068|FG004|Healing Phase|Withdrawal of Consent|0|||
48795750|NCT04124926|157090064|FG000|Healing Phase|Miscellaneous|8|||
48795751|NCT04124926|157090065|FG001|Healing Phase|Miscellaneous|7|||
48795752|NCT04124926|157090066|FG002|Healing Phase|Miscellaneous|0|||
48795753|NCT04124926|157090067|FG003|Healing Phase|Miscellaneous|0|||
48795754|NCT04124926|157090068|FG004|Healing Phase|Miscellaneous|0|||
48795755|NCT04124926|157090064|FG000|Healing Phase|Randomized but not Treated|0|||
48795756|NCT04124926|157090065|FG001|Healing Phase|Randomized but not Treated|3|||
48795757|NCT04124926|157090066|FG002|Healing Phase|Randomized but not Treated|0|||
48795758|NCT04124926|157090067|FG003|Healing Phase|Randomized but not Treated|0|||
48795759|NCT04124926|157090068|FG004|Healing Phase|Randomized but not Treated|0|||
48795760|NCT04124926|157090064|FG000|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
48795761|NCT04124926|157090065|FG001|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
48878700|NCT01299480|157394384|FG004|Overall Study|Adverse Event|0|||
48878701|NCT01299480|157394380|FG000|Overall Study|Withdrawal due to pregnancy|0|||
48878702|NCT01299480|157394381|FG001|Overall Study|Withdrawal due to pregnancy|1|||
48878703|NCT01299480|157394382|FG002|Overall Study|Withdrawal due to pregnancy|1|||
48878704|NCT01299480|157394383|FG003|Overall Study|Withdrawal due to pregnancy|0|||
48878705|NCT01299480|157394384|FG004|Overall Study|Withdrawal due to pregnancy|0|||
48878706|NCT01299480|157394380|FG000|Overall Study|Physician Decision|1|||
48795762|NCT04124926|157090066|FG002|Maintenance Phase|Pretreatment Event, AE, or SAE|3|||
48795763|NCT04124926|157090067|FG003|Maintenance Phase|Pretreatment Event, AE, or SAE|5|||
48795764|NCT04124926|157090068|FG004|Maintenance Phase|Pretreatment Event, AE, or SAE|4|||
48795765|NCT04124926|157090064|FG000|Maintenance Phase|Protocol Violation|0|||
48795766|NCT04124926|157090065|FG001|Maintenance Phase|Protocol Violation|0|||
48795767|NCT04124926|157090066|FG002|Maintenance Phase|Protocol Violation|3|||
48795768|NCT04124926|157090067|FG003|Maintenance Phase|Protocol Violation|0|||
48795769|NCT04124926|157090068|FG004|Maintenance Phase|Protocol Violation|0|||
48795770|NCT04124926|157090064|FG000|Maintenance Phase|Lost to Follow-up|0|||
48795771|NCT04124926|157090065|FG001|Maintenance Phase|Lost to Follow-up|0|||
48795772|NCT04124926|157090066|FG002|Maintenance Phase|Lost to Follow-up|7|||
48795773|NCT04124926|157090067|FG003|Maintenance Phase|Lost to Follow-up|8|||
48795774|NCT04124926|157090068|FG004|Maintenance Phase|Lost to Follow-up|9|||
48795775|NCT04124926|157090064|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
48795776|NCT04124926|157090065|FG001|Maintenance Phase|Voluntary Withdrawal|0|||
48795777|NCT04124926|157090066|FG002|Maintenance Phase|Voluntary Withdrawal|3|||
48795778|NCT04124926|157090067|FG003|Maintenance Phase|Voluntary Withdrawal|6|||
48795779|NCT04124926|157090068|FG004|Maintenance Phase|Voluntary Withdrawal|5|||
48795780|NCT04124926|157090064|FG000|Maintenance Phase|Pregnancy|0|||
48795781|NCT04124926|157090065|FG001|Maintenance Phase|Pregnancy|0|||
48795782|NCT04124926|157090066|FG002|Maintenance Phase|Pregnancy|0|||
48795783|NCT04124926|157090067|FG003|Maintenance Phase|Pregnancy|1|||
48795784|NCT04124926|157090068|FG004|Maintenance Phase|Pregnancy|0|||
48795785|NCT04124926|157090064|FG000|Maintenance Phase|Lack of Efficacy|0|||
48878707|NCT01299480|157394381|FG001|Overall Study|Physician Decision|1|||
48878708|NCT01299480|157394382|FG002|Overall Study|Physician Decision|0|||
48878709|NCT01299480|157394383|FG003|Overall Study|Physician Decision|2|||
48795786|NCT04124926|157090065|FG001|Maintenance Phase|Lack of Efficacy|0|||
48795787|NCT04124926|157090066|FG002|Maintenance Phase|Lack of Efficacy|0|||
48795788|NCT04124926|157090067|FG003|Maintenance Phase|Lack of Efficacy|0|||
48795789|NCT04124926|157090068|FG004|Maintenance Phase|Lack of Efficacy|1|||
48795790|NCT04124926|157090064|FG000|Maintenance Phase|Withdrawal of Consent|0|||
48795791|NCT04124926|157090065|FG001|Maintenance Phase|Withdrawal of Consent|0|||
48795792|NCT04124926|157090066|FG002|Maintenance Phase|Withdrawal of Consent|5|||
48878710|NCT01299480|157394384|FG004|Overall Study|Physician Decision|0|||
48878711|NCT01299480|157394380|FG000|Overall Study|Lost to Follow-up|3|||
48878712|NCT01299480|157394381|FG001|Overall Study|Lost to Follow-up|1|||
48878713|NCT01299480|157394382|FG002|Overall Study|Lost to Follow-up|2|||
48878714|NCT01299480|157394383|FG003|Overall Study|Lost to Follow-up|1|||
48878715|NCT01299480|157394384|FG004|Overall Study|Lost to Follow-up|2|||
48878716|NCT01299480|157394380|FG000|Overall Study|Other|3|||
48795793|NCT04124926|157090067|FG003|Maintenance Phase|Withdrawal of Consent|5|||
48795794|NCT04124926|157090068|FG004|Maintenance Phase|Withdrawal of Consent|5|||
48795795|NCT04124926|157090064|FG000|Maintenance Phase|Miscellaneous|0|||
48795796|NCT04124926|157090065|FG001|Maintenance Phase|Miscellaneous|0|||
48795797|NCT04124926|157090066|FG002|Maintenance Phase|Miscellaneous|1|||
48795798|NCT04124926|157090067|FG003|Maintenance Phase|Miscellaneous|2|||
48795799|NCT04124926|157090068|FG004|Maintenance Phase|Miscellaneous|4|||
48878717|NCT01299480|157394381|FG001|Overall Study|Other|2|||
48878718|NCT01299480|157394382|FG002|Overall Study|Other|3|||
49033164|NCT02554890|157955715|FG000|Double-blind|Protocol Violation|1|||
49033165|NCT02554890|157955716|FG001|Double-blind|Protocol Violation|1|||
49033166|NCT02554890|157955715|FG000|Double-blind|Physician Decision|4|||
49033167|NCT02554890|157955716|FG001|Double-blind|Physician Decision|3|||
49033168|NCT02554890|157955715|FG000|Double-blind|Subject/Guardian decision|21|||
49033169|NCT02554890|157955716|FG001|Double-blind|Subject/Guardian decision|16|||
49033170|NCT02554890|157955715|FG000|Double-blind|Lost to Follow-up|7|||
49033171|NCT02554890|157955716|FG001|Double-blind|Lost to Follow-up|5|||
49033172|NCT02554890|157955715|FG000|Double-blind|Technical problems|1|||
49033173|NCT02554890|157955716|FG001|Double-blind|Technical problems|0|||
49033174|NCT02554890|157955715|FG000|Double-blind|Withdrawal by Subject|5|||
49033175|NCT02554890|157955716|FG001|Double-blind|Withdrawal by Subject|6|||
48795800|NCT04124926|157090064|FG000|Maintenance Phase|Randomized but not Treated|0|||
48795801|NCT04124926|157090065|FG001|Maintenance Phase|Randomized but not Treated|0|||
48795802|NCT04124926|157090066|FG002|Maintenance Phase|Randomized but not Treated|2|||
48795803|NCT04124926|157090067|FG003|Maintenance Phase|Randomized but not Treated|2|||
48795804|NCT04124926|157090068|FG004|Maintenance Phase|Randomized but not Treated|0|||
48795805|NCT00338884|157090069|FG000|Overall Study|Objective Disease Progression or Relapse|44|||
48795806|NCT00338884|157090069|FG000|Overall Study|Adverse Event|14|||
48795807|NCT00338884|157090069|FG000|Overall Study|Death|8|||
48795808|NCT00338884|157090069|FG000|Overall Study|Other|4|||
48795809|NCT00338884|157090069|FG000|Overall Study|Global Deterioration of Health Status|3|||
48795810|NCT00338884|157090069|FG000|Overall Study|Withdrawal by Subject|3|||
48795811|NCT00338884|157090069|FG000|Overall Study|Lost to Follow-up|1|||
48795812|NCT00338884|157090069|FG000|Overall Study|Randomized But Did Not Receive Treatment|1|||
48795813|NCT04764448|157090071|FG000|Overall Study|Study terminated by sponsor|2|||
48795814|NCT04764448|157090072|FG001|Overall Study|Study terminated by sponsor|2|||
48795815|NCT04764448|157090073|FG002|Overall Study|Study terminated by sponsor|5|||
48795816|NCT04764448|157090071|FG000|Overall Study|Withdrawal by Subject|3|||
48795817|NCT04764448|157090072|FG001|Overall Study|Withdrawal by Subject|3|||
48878719|NCT01299480|157394383|FG003|Overall Study|Other|0|||
48878720|NCT01299480|157394384|FG004|Overall Study|Other|3|||
48878721|NCT01299480|157394380|FG000|Overall Study|Started, but not vaccinated|0|||
48878722|NCT01299480|157394381|FG001|Overall Study|Started, but not vaccinated|0|||
48878723|NCT01299480|157394382|FG002|Overall Study|Started, but not vaccinated|1|||
48878724|NCT01299480|157394383|FG003|Overall Study|Started, but not vaccinated|1|||
48878725|NCT01299480|157394384|FG004|Overall Study|Started, but not vaccinated|0|||
48878726|NCT04978090|157394387|FG000|Overall Study|unable to adequately fit device|2|||
48878727|NCT01077518|157394389|FG000|Treatment Phase - no Optional Ofa|Lost to Follow-up|8|||
48878728|NCT01077518|157394390|FG001|Treatment Phase - no Optional Ofa|Lost to Follow-up|4|||
48878729|NCT01077518|157394391|FG002|Treatment Phase - no Optional Ofa|Lost to Follow-up|0|||
48878730|NCT01077518|157394389|FG000|Treatment Phase - no Optional Ofa|Physician Decision|10|||
48878731|NCT01077518|157394390|FG001|Treatment Phase - no Optional Ofa|Physician Decision|11|||
48878732|NCT01077518|157394391|FG002|Treatment Phase - no Optional Ofa|Physician Decision|0|||
48878733|NCT01077518|157394389|FG000|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28|||
48878734|NCT01077518|157394390|FG001|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22|||
48878735|NCT01077518|157394391|FG002|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0|||
48878736|NCT01077518|157394389|FG000|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32|||
48878737|NCT01077518|157394390|FG001|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28|||
48878738|NCT01077518|157394391|FG002|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0|||
48878739|NCT01077518|157394389|FG000|Optional Ofa Phase|Physician Decision|0|||
48878740|NCT01077518|157394390|FG001|Optional Ofa Phase|Physician Decision|0|||
48878741|NCT01077518|157394391|FG002|Optional Ofa Phase|Physician Decision|1|||
48878742|NCT01077518|157394389|FG000|Optional Ofa Phase|Study Terminated by Sponsor|0|||
48878743|NCT01077518|157394390|FG001|Optional Ofa Phase|Study Terminated by Sponsor|0|||
48878744|NCT01077518|157394391|FG002|Optional Ofa Phase|Study Terminated by Sponsor|12|||
48795818|NCT04764448|157090073|FG002|Overall Study|Withdrawal by Subject|1|||
48795819|NCT05711641|157090074|FG000|Washout (2 Weeks)|Lost to Follow-up|2|||
48795820|NCT05711641|157090075|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
48795821|NCT05711641|157090074|FG000|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|1|||
48795822|NCT05711641|157090075|FG001|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|0|||
48795823|NCT02243605|157090077|FG000|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
48795824|NCT02243605|157090078|FG001|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
48795825|NCT02243605|157090077|FG000|Stage 1 - Interim Analysis Population|Adverse Event|1|||
48795826|NCT02243605|157090078|FG001|Stage 1 - Interim Analysis Population|Adverse Event|0|||
48795827|NCT02243605|157090077|FG000|Stage 2 - Final Analysis Population|Protocol Violation|5|||
48795828|NCT02243605|157090078|FG001|Stage 2 - Final Analysis Population|Protocol Violation|1|||
48878745|NCT01077518|157394389|FG000|Optional Ofa Phase|Withdrawal by Subject|0|||
48878746|NCT01077518|157394390|FG001|Optional Ofa Phase|Withdrawal by Subject|0|||
49033176|NCT02554890|157955715|FG000|Double-blind|Noncompliance with study treatment|6|||
49033177|NCT02554890|157955716|FG001|Double-blind|Noncompliance with study treatment|5|||
49033178|NCT02554890|157955715|FG000|Open-label|Adverse Event|0|||
48795829|NCT02243605|157090077|FG000|Stage 2 - Final Analysis Population|Adverse Event|1|||
48795830|NCT02243605|157090078|FG001|Stage 2 - Final Analysis Population|Adverse Event|1|||
48795831|NCT02243605|157090077|FG000|Stage 2 - Final Analysis Population|Progression|0|||
48795832|NCT02243605|157090078|FG001|Stage 2 - Final Analysis Population|Progression|1|||
48795833|NCT02477111|157090079|FG000|Overall Study|Death|28|||
48795834|NCT02477111|157090079|FG000|Overall Study|Withdrawal by Subject|19|||
48795835|NCT02477111|157090079|FG000|Overall Study|Lost to Follow-up|4|||
48795836|NCT01618864|157090082|FG000|Overall Study|Withdrawal by Subject|2|||
48795837|NCT01618864|157090082|FG000|Overall Study|Lost to Follow-up|2|||
48795838|NCT03178266|157090086|FG000|Overall Study|Death|0|||
48795839|NCT03178266|157090087|FG001|Overall Study|Death|1|||
48795840|NCT03178266|157090086|FG000|Overall Study|Disont. Early|0|||
48878747|NCT01077518|157394391|FG002|Optional Ofa Phase|Withdrawal by Subject|3|||
48795841|NCT03178266|157090087|FG001|Overall Study|Disont. Early|1|||
48795842|NCT03178266|157090086|FG000|Overall Study|Withdrawal by Subject|0|||
48795843|NCT03178266|157090087|FG001|Overall Study|Withdrawal by Subject|2|||
48795844|NCT01749982|157090090|FG000|Overall Study|Physician Decision|0|||
48795845|NCT01749982|157090091|FG001|Overall Study|Physician Decision|0|||
48795846|NCT01749982|157090092|FG002|Overall Study|Physician Decision|0|||
48795847|NCT01749982|157090093|FG003|Overall Study|Physician Decision|1|||
48795848|NCT01749982|157090090|FG000|Overall Study|Lost to Follow-up|0|||
48795849|NCT01749982|157090091|FG001|Overall Study|Lost to Follow-up|0|||
48795850|NCT01749982|157090092|FG002|Overall Study|Lost to Follow-up|0|||
48795851|NCT01749982|157090093|FG003|Overall Study|Lost to Follow-up|1|||
48795852|NCT01749982|157090090|FG000|Overall Study|Withdrawal by Subject|0|||
48795853|NCT01749982|157090091|FG001|Overall Study|Withdrawal by Subject|0|||
48795854|NCT01749982|157090092|FG002|Overall Study|Withdrawal by Subject|0|||
48795855|NCT01749982|157090093|FG003|Overall Study|Withdrawal by Subject|1|||
48795856|NCT00262821|157090095|FG000|Overall Study|Ineligible - wrong stage|0|||
48795857|NCT00262821|157090096|FG001|Overall Study|Ineligible - wrong stage|3|||
48795858|NCT00262821|157090095|FG000|Overall Study|Ineligible - wrong cell type|2|||
48795859|NCT00262821|157090096|FG001|Overall Study|Ineligible - wrong cell type|2|||
48795860|NCT00262821|157090095|FG000|Overall Study|Ineligible - wrong primary|0|||
48795861|NCT00262821|157090096|FG001|Overall Study|Ineligible - wrong primary|1|||
48878748|NCT05792085|157394393|FG000|Overall Study|Death|0|||
48878749|NCT05792085|157394394|FG001|Overall Study|Death|0|||
48878750|NCT05792085|157394395|FG002|Overall Study|Death|0|||
48878751|NCT05792085|157394396|FG003|Overall Study|Death|0|||
48878752|NCT05792085|157394397|FG004|Overall Study|Death|1|||
48878753|NCT03974178|157394398|FG000|Overall Study|Death|0|||
48878754|NCT03974178|157394399|FG001|Overall Study|Death|1|||
48878755|NCT03604692|157394400|FG000|Overall Study|Investigator's Decision|0|||
48878756|NCT03604692|157394401|FG001|Overall Study|Investigator's Decision|0|||
48878757|NCT03604692|157394402|FG002|Overall Study|Investigator's Decision|0|||
48878758|NCT03604692|157394403|FG003|Overall Study|Investigator's Decision|1|||
48878759|NCT03604692|157394404|FG004|Overall Study|Investigator's Decision|0|||
48878760|NCT03604692|157394405|FG005|Overall Study|Investigator's Decision|7|||
48878761|NCT03604692|157394400|FG000|Overall Study|Withdrawal by Subject|0|||
48878762|NCT03604692|157394401|FG001|Overall Study|Withdrawal by Subject|0|||
48878763|NCT03604692|157394402|FG002|Overall Study|Withdrawal by Subject|0|||
48878764|NCT03604692|157394403|FG003|Overall Study|Withdrawal by Subject|0|||
48878765|NCT03604692|157394404|FG004|Overall Study|Withdrawal by Subject|0|||
48878766|NCT03604692|157394405|FG005|Overall Study|Withdrawal by Subject|2|||
48878767|NCT03604692|157394400|FG000|Overall Study|Progressive Disease|1|||
48795862|NCT00262821|157090095|FG000|Overall Study|Ineligible - inadequate pathology|1|||
48795863|NCT00262821|157090096|FG001|Overall Study|Ineligible - inadequate pathology|3|||
48795864|NCT00262821|157090095|FG000|Overall Study|Ineligible - elevated creatinine|0|||
48878768|NCT03604692|157394401|FG001|Overall Study|Progressive Disease|0|||
48878769|NCT03604692|157394402|FG002|Overall Study|Progressive Disease|1|||
48878770|NCT03604692|157394403|FG003|Overall Study|Progressive Disease|0|||
48878771|NCT03604692|157394404|FG004|Overall Study|Progressive Disease|3|||
48878772|NCT03604692|157394405|FG005|Overall Study|Progressive Disease|4|||
48878773|NCT03604692|157394400|FG000|Overall Study|Difficulty Coming into Site.|0|||
48878774|NCT03604692|157394401|FG001|Overall Study|Difficulty Coming into Site.|0|||
48878775|NCT03604692|157394402|FG002|Overall Study|Difficulty Coming into Site.|0|||
48878776|NCT03604692|157394403|FG003|Overall Study|Difficulty Coming into Site.|0|||
48878777|NCT03604692|157394404|FG004|Overall Study|Difficulty Coming into Site.|0|||
48878778|NCT03604692|157394405|FG005|Overall Study|Difficulty Coming into Site.|1|||
48795865|NCT00262821|157090096|FG001|Overall Study|Ineligible - elevated creatinine|2|||
48795866|NCT00262821|157090095|FG000|Overall Study|Ineligible - required test not done|1|||
48795867|NCT00262821|157090096|FG001|Overall Study|Ineligible - required test not done|4|||
48878779|NCT03604692|157394400|FG000|Overall Study|Death|0|||
48878780|NCT03604692|157394401|FG001|Overall Study|Death|0|||
48795868|NCT00262821|157090095|FG000|Overall Study|Inevaluable - inadequate data|0|||
48878781|NCT03604692|157394402|FG002|Overall Study|Death|1|||
48878782|NCT03604692|157394403|FG003|Overall Study|Death|0|||
49033179|NCT02554890|157955716|FG001|Open-label|Adverse Event|30|||
49033180|NCT02554890|157955715|FG000|Open-label|Death|0|||
49033181|NCT02554890|157955716|FG001|Open-label|Death|1|||
49033182|NCT02554890|157955715|FG000|Open-label|Physician Decision|0|||
49033183|NCT02554890|157955716|FG001|Open-label|Physician Decision|1|||
49033184|NCT02554890|157955715|FG000|Open-label|Subject/Guardian decision|0|||
48795869|NCT00262821|157090096|FG001|Overall Study|Inevaluable - inadequate data|4|||
48795870|NCT01881126|157090097|FG000|Overall Study|Non-compliance|1|||
48795871|NCT01881126|157090098|FG001|Overall Study|Non-compliance|1|||
48795872|NCT01881126|157090097|FG000|Overall Study|Adverse Event|0|||
48795873|NCT01881126|157090098|FG001|Overall Study|Adverse Event|1|||
48795874|NCT04672941|157090099|FG000|Overall Study|Investigator decision|1|||
48795875|NCT04672941|157090099|FG000|Overall Study|Treatment with Spiolto® Respimat® discontinuation|2|||
48795876|NCT04672941|157090099|FG000|Overall Study|COVID-19 related but no adverse event|1|||
48795877|NCT04672941|157090099|FG000|Overall Study|Adverse Event|2|||
48795878|NCT04672941|157090099|FG000|Overall Study|Lost to Follow-up|2|||
48795879|NCT00584727|157090103|FG000|First Intervention|Discontinuation|0|||
49033185|NCT02554890|157955716|FG001|Open-label|Subject/Guardian decision|11|||
49033186|NCT02554890|157955715|FG000|Open-label|Lost to Follow-up|0|||
48795880|NCT00584727|157090104|FG001|First Intervention|Discontinuation|0|||
48795881|NCT00584727|157090105|FG002|First Intervention|Discontinuation|1|||
48795882|NCT00584727|157090106|FG003|First Intervention|Discontinuation|0|||
48795883|NCT00584727|157090107|FG004|First Intervention|Discontinuation|0|||
48795884|NCT00584727|157090108|FG005|First Intervention|Discontinuation|0|||
48795885|NCT00584727|157090103|FG000|Third Intervention|Protocol Violation|0|||
48795886|NCT00584727|157090104|FG001|Third Intervention|Protocol Violation|0|||
48795887|NCT00584727|157090105|FG002|Third Intervention|Protocol Violation|1|||
48795888|NCT00584727|157090106|FG003|Third Intervention|Protocol Violation|0|||
48795889|NCT00584727|157090107|FG004|Third Intervention|Protocol Violation|4|||
48795890|NCT00584727|157090108|FG005|Third Intervention|Protocol Violation|2|||
48795891|NCT01328080|157090109|FG000|Overall Study|Lost to Follow-up|5|||
48795892|NCT02657031|157090110|FG000|Overall Study|Adverse Event|1|||
48795893|NCT02657031|157090111|FG001|Overall Study|Adverse Event|2|||
48795894|NCT00313820|157090115|FG000|Assigned to Treatment|Other|1|||
48795895|NCT00313820|157090116|FG001|Assigned to Treatment|Other|0|||
48795896|NCT00313820|157090115|FG000|Pregabalin or Placebo Treatment Period|Adverse Event|9|||
48795897|NCT00313820|157090116|FG001|Pregabalin or Placebo Treatment Period|Adverse Event|4|||
48795898|NCT00313820|157090115|FG000|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0|||
48795899|NCT00313820|157090116|FG001|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1|||
48795900|NCT00313820|157090115|FG000|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0|||
48795901|NCT00313820|157090116|FG001|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7|||
48795902|NCT00313820|157090115|FG000|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6|||
48795903|NCT00313820|157090116|FG001|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4|||
48795904|NCT00313820|157090115|FG000|Pregabalin or Placebo Treatment Period|Other|2|||
48795905|NCT00313820|157090116|FG001|Pregabalin or Placebo Treatment Period|Other|3|||
48795906|NCT00265889|157090117|FG000|Overall Study|Physician Decision|1|||
48795907|NCT00265889|157090117|FG000|Overall Study|Protocol Violation|1|||
48795908|NCT00265889|157090117|FG000|Overall Study|Insurance denied the request|3|||
48795909|NCT03519854|157090121|FG000|Overall Study|Technical Error|0|||
48795910|NCT03519854|157090122|FG001|Overall Study|Technical Error|0|||
48795911|NCT03519854|157090123|FG002|Overall Study|Technical Error|1|||
48795912|NCT03519854|157090124|FG003|Overall Study|Technical Error|0|||
48795913|NCT03519854|157090125|FG004|Overall Study|Technical Error|0|||
48795914|NCT03519854|157090126|FG005|Overall Study|Technical Error|0|||
48795915|NCT03519854|157090127|FG006|Overall Study|Technical Error|0|||
48795916|NCT03519854|157090128|FG007|Overall Study|Technical Error|0|||
48795917|NCT03519854|157090129|FG008|Overall Study|Technical Error|0|||
48878783|NCT03604692|157394404|FG004|Overall Study|Death|0|||
48795918|NCT03519854|157090130|FG009|Overall Study|Technical Error|0|||
48795919|NCT03519854|157090131|FG010|Overall Study|Technical Error|0|||
48795920|NCT03519854|157090132|FG011|Overall Study|Technical Error|0|||
48795921|NCT03519854|157090133|FG012|Overall Study|Technical Error|0|||
48795922|NCT03519854|157090134|FG013|Overall Study|Technical Error|0|||
48795923|NCT03519854|157090135|FG014|Overall Study|Technical Error|0|||
48795924|NCT03519854|157090136|FG015|Overall Study|Technical Error|0|||
48795925|NCT03519854|157090137|FG016|Overall Study|Technical Error|0|||
48795926|NCT03519854|157090138|FG017|Overall Study|Technical Error|0|||
48795927|NCT00553696|157090141|FG000|Overall Study|Adverse Event|2|||
48795928|NCT00553696|157090142|FG001|Overall Study|Adverse Event|4|||
48878784|NCT03604692|157394405|FG005|Overall Study|Death|0|||
48878785|NCT03604692|157394400|FG000|Overall Study|Drug Intolerance|0|||
48795929|NCT00553696|157090143|FG002|Overall Study|Adverse Event|0|||
48795930|NCT00553696|157090144|FG003|Overall Study|Adverse Event|1|||
48795931|NCT00553696|157090141|FG000|Overall Study|Global deterioration of health status|0|||
49033187|NCT02554890|157955716|FG001|Open-label|Lost to Follow-up|7|||
49033188|NCT02554890|157955715|FG000|Open-label|Technical problems|0|||
48795932|NCT00553696|157090142|FG001|Overall Study|Global deterioration of health status|2|||
48878786|NCT03604692|157394401|FG001|Overall Study|Drug Intolerance|0|||
48878787|NCT03604692|157394402|FG002|Overall Study|Drug Intolerance|0|||
48878788|NCT03604692|157394403|FG003|Overall Study|Drug Intolerance|1|||
48878789|NCT03604692|157394404|FG004|Overall Study|Drug Intolerance|0|||
48878790|NCT03604692|157394405|FG005|Overall Study|Drug Intolerance|0|||
48878791|NCT03604692|157394400|FG000|Overall Study|Noncompliance with follow-up visit|0|||
48878792|NCT03604692|157394401|FG001|Overall Study|Noncompliance with follow-up visit|0|||
48878793|NCT03604692|157394402|FG002|Overall Study|Noncompliance with follow-up visit|0|||
48878794|NCT03604692|157394403|FG003|Overall Study|Noncompliance with follow-up visit|1|||
48878795|NCT03604692|157394404|FG004|Overall Study|Noncompliance with follow-up visit|0|||
48878796|NCT03604692|157394405|FG005|Overall Study|Noncompliance with follow-up visit|0|||
48878797|NCT03604692|157394400|FG000|Overall Study|Continuing Treatment/In Follow-Up|0|||
48878798|NCT03604692|157394401|FG001|Overall Study|Continuing Treatment/In Follow-Up|0|||
48878799|NCT03604692|157394402|FG002|Overall Study|Continuing Treatment/In Follow-Up|1|||
48878800|NCT03604692|157394403|FG003|Overall Study|Continuing Treatment/In Follow-Up|1|||
48878801|NCT03604692|157394404|FG004|Overall Study|Continuing Treatment/In Follow-Up|0|||
48878802|NCT03604692|157394405|FG005|Overall Study|Continuing Treatment/In Follow-Up|0|||
48878803|NCT03604692|157394400|FG000|Overall Study|Not Treated|0|||
48878804|NCT03604692|157394401|FG001|Overall Study|Not Treated|0|||
48878805|NCT03604692|157394402|FG002|Overall Study|Not Treated|0|||
48878806|NCT03604692|157394403|FG003|Overall Study|Not Treated|0|||
48878807|NCT03604692|157394404|FG004|Overall Study|Not Treated|1|||
48878808|NCT03604692|157394405|FG005|Overall Study|Not Treated|0|||
48878809|NCT01948076|157394406|FG000|Overall Study|Withdrawal by Subject|0|||
48878810|NCT01948076|157394407|FG001|Overall Study|Withdrawal by Subject|1|||
48878811|NCT02209181|157394420|FG000|Overall Study|Adverse Event|1|||
48878812|NCT02209181|157394421|FG001|Overall Study|Adverse Event|0|||
48878813|NCT02209181|157394422|FG002|Overall Study|Adverse Event|1|||
48878814|NCT02209181|157394423|FG003|Overall Study|Adverse Event|0|||
48878815|NCT02209181|157394420|FG000|Overall Study|Withdrawal by Subject|0|||
48878816|NCT02209181|157394421|FG001|Overall Study|Withdrawal by Subject|1|||
48878817|NCT02209181|157394422|FG002|Overall Study|Withdrawal by Subject|0|||
49033189|NCT02554890|157955716|FG001|Open-label|Technical problems|1|||
49033190|NCT02554890|157955715|FG000|Open-label|Withdrawal by Subject|0|||
49033191|NCT02554890|157955716|FG001|Open-label|Withdrawal by Subject|1|||
49033192|NCT02186821|157955721|FG000|Overall Study|Adverse Event|9|||
49033193|NCT02186821|157955721|FG000|Overall Study|Death|2|||
49033194|NCT02186821|157955721|FG000|Overall Study|Disease progression|32|||
49033195|NCT02186821|157955721|FG000|Overall Study|Protocol Violation|1|||
49033196|NCT02186821|157955721|FG000|Overall Study|Physician Decision|1|||
49033197|NCT02186821|157955721|FG000|Overall Study|Study terminated by sponsor|2|||
49033198|NCT00811655|157955722|FG000|Overall Study|Physician Decision|1|||
49033199|NCT04852978|157955727|FG000|Overall Study|Physician Decision|0|||
49033200|NCT04852978|157955728|FG001|Overall Study|Physician Decision|1|||
49033201|NCT04852978|157955729|FG002|Overall Study|Physician Decision|0|||
49033202|NCT04852978|157955730|FG003|Overall Study|Physician Decision|0|||
49033203|NCT04852978|157955731|FG004|Overall Study|Physician Decision|0|||
48795933|NCT00553696|157090143|FG002|Overall Study|Global deterioration of health status|0|||
49033204|NCT04852978|157955732|FG005|Overall Study|Physician Decision|0|||
49033205|NCT04852978|157955733|FG006|Overall Study|Physician Decision|0|||
49033206|NCT04852978|157955734|FG007|Overall Study|Physician Decision|2|||
49033207|NCT04852978|157955735|FG008|Overall Study|Physician Decision|0|||
49033208|NCT04852978|157955727|FG000|Overall Study|Sponsor request|0|||
49033209|NCT04852978|157955728|FG001|Overall Study|Sponsor request|0|||
49033210|NCT04852978|157955729|FG002|Overall Study|Sponsor request|1|||
49033211|NCT04852978|157955730|FG003|Overall Study|Sponsor request|0|||
49033212|NCT04852978|157955731|FG004|Overall Study|Sponsor request|0|||
48795934|NCT00553696|157090144|FG003|Overall Study|Global deterioration of health status|0|||
48795935|NCT00553696|157090141|FG000|Overall Study|Objective progression or relapse|2|||
48795936|NCT00553696|157090142|FG001|Overall Study|Objective progression or relapse|9|||
48795937|NCT00553696|157090143|FG002|Overall Study|Objective progression or relapse|6|||
48795938|NCT00553696|157090144|FG003|Overall Study|Objective progression or relapse|0|||
48795939|NCT00553696|157090141|FG000|Overall Study|Withdrawal by Subject|0|||
48795940|NCT00553696|157090142|FG001|Overall Study|Withdrawal by Subject|1|||
48795941|NCT00553696|157090143|FG002|Overall Study|Withdrawal by Subject|0|||
48795942|NCT00553696|157090144|FG003|Overall Study|Withdrawal by Subject|0|||
48795943|NCT02747238|157090145|FG000|Overall Study|Lack of Efficacy|0|||
48795944|NCT02747238|157090146|FG001|Overall Study|Lack of Efficacy|1|||
48795945|NCT02747238|157090145|FG000|Overall Study|Data lost|3|||
48795946|NCT02747238|157090146|FG001|Overall Study|Data lost|5|||
48795947|NCT00951275|157090150|FG000|Overall Study|Administrative Reason|1|||
49033213|NCT04852978|157955732|FG005|Overall Study|Sponsor request|0|||
48795948|NCT00951275|157090150|FG000|Overall Study|Adverse Event|7|||
48878818|NCT02209181|157394423|FG003|Overall Study|Withdrawal by Subject|0|||
48878819|NCT04427072|157394424|FG000|Randomized Treatment Phase|Progressive disease|9|||
48878820|NCT04427072|157394425|FG001|Randomized Treatment Phase|Progressive disease|4|||
48878821|NCT04427072|157394424|FG000|Randomized Treatment Phase|Adverse Event|3|||
49033214|NCT04852978|157955733|FG006|Overall Study|Sponsor request|0|||
49033215|NCT04852978|157955734|FG007|Overall Study|Sponsor request|0|||
48795949|NCT00951275|157090150|FG000|Overall Study|Withdrawal by Subject|4|||
48795950|NCT00951275|157090150|FG000|Overall Study|Protocol Violation|1|||
48795951|NCT01298999|157090151|FG000|Overall Study|Physician Decision|0|||
48795952|NCT01298999|157090152|FG001|Overall Study|Physician Decision|1|||
48795953|NCT01298999|157090151|FG000|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|3|||
48795954|NCT01298999|157090152|FG001|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|0|||
48795955|NCT00803452|157090153|FG000|Overall Study|Adverse Event|0|||
48795956|NCT00803452|157090154|FG001|Overall Study|Adverse Event|2|||
48795957|NCT00803452|157090153|FG000|Overall Study|Lost to Follow-up|0|||
48795958|NCT00803452|157090154|FG001|Overall Study|Lost to Follow-up|3|||
48795959|NCT02816138|157090155|FG000|Overall Study|Adverse Event|1|||
48795960|NCT02693743|157090156|FG000|Overall Study|Physician Decision|1|||
48795961|NCT02693743|157090157|FG001|Overall Study|Physician Decision|0|||
48795962|NCT04157517|157090158|FG000|Overall Study|Death|1|||
48795963|NCT04157517|157090159|FG001|Overall Study|Death|2|||
48795964|NCT04157517|157090160|FG002|Overall Study|Death|2|||
48795965|NCT04157517|157090161|FG003|Overall Study|Death|3|||
48795966|NCT04157517|157090162|FG004|Overall Study|Death|3|||
48795967|NCT04157517|157090163|FG005|Overall Study|Death|4|||
48795968|NCT04157517|157090164|FG006|Overall Study|Death|1|||
48795969|NCT04157517|157090165|FG007|Overall Study|Death|2|||
48795970|NCT04157517|157090166|FG008|Overall Study|Death|4|||
48795971|NCT04157517|157090167|FG009|Overall Study|Death|0|||
48795972|NCT04157517|157090158|FG000|Overall Study|Withdrawal by Subject|1|||
48795973|NCT04157517|157090159|FG001|Overall Study|Withdrawal by Subject|1|||
48795974|NCT04157517|157090160|FG002|Overall Study|Withdrawal by Subject|1|||
48795975|NCT04157517|157090161|FG003|Overall Study|Withdrawal by Subject|0|||
48795976|NCT04157517|157090162|FG004|Overall Study|Withdrawal by Subject|0|||
48795977|NCT04157517|157090163|FG005|Overall Study|Withdrawal by Subject|1|||
48795978|NCT04157517|157090164|FG006|Overall Study|Withdrawal by Subject|0|||
48795979|NCT04157517|157090165|FG007|Overall Study|Withdrawal by Subject|0|||
48795980|NCT04157517|157090166|FG008|Overall Study|Withdrawal by Subject|1|||
48795981|NCT04157517|157090167|FG009|Overall Study|Withdrawal by Subject|0|||
48795982|NCT04157517|157090158|FG000|Overall Study|Other|1|||
48795983|NCT04157517|157090159|FG001|Overall Study|Other|0|||
48795984|NCT04157517|157090160|FG002|Overall Study|Other|0|||
48795985|NCT04157517|157090161|FG003|Overall Study|Other|0|||
48795986|NCT04157517|157090162|FG004|Overall Study|Other|0|||
48795987|NCT04157517|157090163|FG005|Overall Study|Other|1|||
48795988|NCT04157517|157090164|FG006|Overall Study|Other|2|||
48795989|NCT04157517|157090165|FG007|Overall Study|Other|7|||
48795990|NCT04157517|157090166|FG008|Overall Study|Other|7|||
48795991|NCT04157517|157090167|FG009|Overall Study|Other|0|||
48795992|NCT00924287|157091413|FG000|Overall Study|Death|1|||
48795993|NCT02030015|157091417|FG000|Overall Study|Withdrawal by Subject|3|||
48795994|NCT02030015|157091417|FG000|Overall Study|Death|13|||
48795995|NCT01258608|157091418|FG000|Overall Study|Metastatic Hepatocellular Carcinoma|1|||
48795996|NCT01258608|157091419|FG001|Overall Study|Metastatic Hepatocellular Carcinoma|0|||
48795997|NCT01258608|157091418|FG000|Overall Study|Clinical progression|1|||
48795998|NCT01258608|157091419|FG001|Overall Study|Clinical progression|0|||
48795999|NCT01258608|157091418|FG000|Overall Study|Sponsor decision|0|||
48796000|NCT01258608|157091419|FG001|Overall Study|Sponsor decision|1|||
48796001|NCT01258608|157091418|FG000|Overall Study|Physician Decision|6|||
48796002|NCT01258608|157091419|FG001|Overall Study|Physician Decision|1|||
48796003|NCT01258608|157091418|FG000|Overall Study|Lost to Follow-up|0|||
48796004|NCT01258608|157091419|FG001|Overall Study|Lost to Follow-up|1|||
48796005|NCT01258608|157091418|FG000|Overall Study|Lack of compliance|1|||
48796006|NCT01258608|157091419|FG001|Overall Study|Lack of compliance|0|||
48796007|NCT01258608|157091418|FG000|Overall Study|Lack of Efficacy|0|||
48796008|NCT01258608|157091419|FG001|Overall Study|Lack of Efficacy|1|||
48796009|NCT01258608|157091418|FG000|Overall Study|Adverse Event|6|||
48796010|NCT01258608|157091419|FG001|Overall Study|Adverse Event|10|||
48796011|NCT01258608|157091418|FG000|Overall Study|Withdrawal by Subject|6|||
48796012|NCT01258608|157091419|FG001|Overall Study|Withdrawal by Subject|5|||
48796013|NCT01332227|157091420|FG000|Overall Study|Adverse Event|4|||
48796014|NCT01332227|157091421|FG001|Overall Study|Adverse Event|1|||
48796015|NCT01332227|157091420|FG000|Overall Study|Withdrawal by Subject|5|||
48796016|NCT01332227|157091421|FG001|Overall Study|Withdrawal by Subject|1|||
48796017|NCT01332227|157091420|FG000|Overall Study|Lost to Follow-up|2|||
48796018|NCT01332227|157091421|FG001|Overall Study|Lost to Follow-up|0|||
48796019|NCT01332227|157091420|FG000|Overall Study|Lack of Efficacy|3|||
48796020|NCT01332227|157091421|FG001|Overall Study|Lack of Efficacy|1|||
48796021|NCT01332227|157091420|FG000|Overall Study|Poor compliance/noncompliance|1|||
48796022|NCT01332227|157091421|FG001|Overall Study|Poor compliance/noncompliance|1|||
48796023|NCT01332227|157091420|FG000|Overall Study|Patient moved from area|1|||
48796024|NCT01332227|157091421|FG001|Overall Study|Patient moved from area|0|||
48796025|NCT01332227|157091420|FG000|Overall Study|Patient began prohibited medication|0|||
48796026|NCT01332227|157091421|FG001|Overall Study|Patient began prohibited medication|1|||
49033216|NCT04852978|157955735|FG008|Overall Study|Sponsor request|0|||
49033217|NCT04852978|157955727|FG000|Overall Study|Death|0|||
49033218|NCT04852978|157955728|FG001|Overall Study|Death|0|||
49033219|NCT04852978|157955729|FG002|Overall Study|Death|0|||
49033220|NCT04852978|157955730|FG003|Overall Study|Death|0|||
49033221|NCT04852978|157955731|FG004|Overall Study|Death|0|||
49033222|NCT04852978|157955732|FG005|Overall Study|Death|0|||
49033223|NCT04852978|157955733|FG006|Overall Study|Death|1|||
49033224|NCT04852978|157955734|FG007|Overall Study|Death|0|||
49033225|NCT04852978|157955735|FG008|Overall Study|Death|0|||
49033226|NCT04852978|157955727|FG000|Overall Study|Lost to Follow-up|3|||
49033227|NCT04852978|157955728|FG001|Overall Study|Lost to Follow-up|2|||
49033228|NCT04852978|157955729|FG002|Overall Study|Lost to Follow-up|2|||
49033229|NCT04852978|157955730|FG003|Overall Study|Lost to Follow-up|0|||
49033230|NCT04852978|157955731|FG004|Overall Study|Lost to Follow-up|2|||
49033231|NCT04852978|157955732|FG005|Overall Study|Lost to Follow-up|4|||
49033232|NCT04852978|157955733|FG006|Overall Study|Lost to Follow-up|1|||
49033233|NCT04852978|157955734|FG007|Overall Study|Lost to Follow-up|2|||
49033234|NCT04852978|157955735|FG008|Overall Study|Lost to Follow-up|2|||
49033235|NCT04852978|157955727|FG000|Overall Study|Withdrawal by Subject|4|||
49033236|NCT04852978|157955728|FG001|Overall Study|Withdrawal by Subject|2|||
49033237|NCT04852978|157955729|FG002|Overall Study|Withdrawal by Subject|2|||
49033238|NCT04852978|157955730|FG003|Overall Study|Withdrawal by Subject|1|||
49033239|NCT04852978|157955731|FG004|Overall Study|Withdrawal by Subject|5|||
49033240|NCT04852978|157955732|FG005|Overall Study|Withdrawal by Subject|3|||
48796027|NCT02943408|157091424|FG000|Overall Study|Lost to Follow-up|7|||
48796028|NCT02943408|157091425|FG001|Overall Study|Lost to Follow-up|1|||
48796029|NCT02943408|157091424|FG000|Overall Study|Withdrawal by Subject|0|||
48796030|NCT02943408|157091425|FG001|Overall Study|Withdrawal by Subject|1|||
48796031|NCT00886340|157091433|FG000|Overall Study|Withdrawal by Subject|0|||
48796032|NCT00886340|157091434|FG001|Overall Study|Withdrawal by Subject|7|||
48796033|NCT02338154|157091435|FG000|Overall Study|Death|46|||
49033241|NCT04852978|157955733|FG006|Overall Study|Withdrawal by Subject|2|||
49033242|NCT04852978|157955734|FG007|Overall Study|Withdrawal by Subject|2|||
49033243|NCT04852978|157955735|FG008|Overall Study|Withdrawal by Subject|1|||
49033244|NCT00859430|157955736|FG000|First Intervention|Withdrawal by Subject|0|||
49033245|NCT00859430|157955737|FG001|First Intervention|Withdrawal by Subject|1|||
49033246|NCT02311361|157956859|FG000|Overall Study|Did not receive treatment|0|||
49033247|NCT02311361|157956860|FG001|Overall Study|Did not receive treatment|1|||
49033248|NCT02311361|157956861|FG002|Overall Study|Did not receive treatment|0|||
49033249|NCT02311361|157956862|FG003|Overall Study|Did not receive treatment|1|||
49033250|NCT01725529|157956863|FG000|Overall Study|Adverse Event|1|||
49033251|NCT01725529|157956864|FG001|Overall Study|Adverse Event|0|||
49033252|NCT01725529|157956865|FG002|Overall Study|Adverse Event|0|||
49033253|NCT01725529|157956863|FG000|Overall Study|Lost to Follow-up|2|||
49033254|NCT01725529|157956864|FG001|Overall Study|Lost to Follow-up|1|||
49033255|NCT01725529|157956865|FG002|Overall Study|Lost to Follow-up|1|||
49033256|NCT01725529|157956863|FG000|Overall Study|Protocol Violation|0|||
49033257|NCT01725529|157956864|FG001|Overall Study|Protocol Violation|1|||
49033258|NCT01725529|157956865|FG002|Overall Study|Protocol Violation|1|||
49033259|NCT01725529|157956863|FG000|Overall Study|Withdrawal by Subject|12|||
49033260|NCT01725529|157956864|FG001|Overall Study|Withdrawal by Subject|14|||
49033261|NCT01725529|157956865|FG002|Overall Study|Withdrawal by Subject|8|||
49033262|NCT03772522|157956867|FG000|Pre-intervention|Withdrawal by Subject|3|||
49033263|NCT03772522|157956868|FG001|Pre-intervention|Withdrawal by Subject|4|||
49033264|NCT03772522|157956867|FG000|Intervention|Withdrawal by Subject|1|||
48796034|NCT02338154|157091435|FG000|Overall Study|Valve Implant Failure|17|||
48796035|NCT02338154|157091435|FG000|Overall Study|Valve Explant|11|||
48796036|NCT02338154|157091435|FG000|Overall Study|Withdrawal by Subject or by Investigator|10|||
48796037|NCT02338154|157091435|FG000|Overall Study|Lost to Follow-up|8|||
48796038|NCT02338154|157091435|FG000|Overall Study|Other Reason|3|||
48796039|NCT02338154|157091435|FG000|Overall Study|Patients Without Exit Form|47|||
48796040|NCT02338154|157091435|FG000|Overall Study|Missing Exit Reason on Exit Form|1|||
48796041|NCT02822222|157091436|FG000|Overall Study|Protocol requirement SBP<110 mmHg|1|||
48796042|NCT02822222|157091437|FG001|Overall Study|Protocol requirement SBP<110 mmHg|0|||
49033265|NCT03772522|157956868|FG001|Intervention|Withdrawal by Subject|0|||
49033266|NCT03772522|157956867|FG000|Post-intervention Follow-up|Lost to Follow-up|1|||
49033267|NCT03772522|157956868|FG001|Post-intervention Follow-up|Lost to Follow-up|0|||
49033268|NCT05376319|157956869|FG000|Overall Study|Funding termination|2|||
49033269|NCT05376319|157956870|FG001|Overall Study|Funding termination|4|||
49033270|NCT00001703|157956871|FG000|Overall Study|progressed disease|2|||
49033271|NCT00001703|157956871|FG000|Overall Study|No evidence of disease|1|||
48796043|NCT00440531|157091438|FG000|Overall Study|Adverse Event|1|||
49033272|NCT00001703|157956871|FG000|Overall Study|recurrent disease|2|||
49033273|NCT01124175|157956872|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
49033274|NCT01124175|157956873|FG001|Washout of 7 Days|Withdrawal by Subject|2|||
49033275|NCT05612724|157956879|FG000|Overall Study|Lost to Follow-up|4|||
48796044|NCT00440531|157091439|FG001|Overall Study|Adverse Event|0|||
48796045|NCT00440531|157091440|FG002|Overall Study|Adverse Event|2|||
48796046|NCT00440531|157091438|FG000|Overall Study|Withdrawal by Subject|2|||
48796047|NCT00440531|157091439|FG001|Overall Study|Withdrawal by Subject|0|||
48796048|NCT00440531|157091440|FG002|Overall Study|Withdrawal by Subject|0|||
48796049|NCT00440531|157091438|FG000|Overall Study|Protocol Violation|1|||
48796050|NCT00440531|157091439|FG001|Overall Study|Protocol Violation|2|||
48796051|NCT00440531|157091440|FG002|Overall Study|Protocol Violation|0|||
48796052|NCT00440531|157091438|FG000|Overall Study|Lost to Follow-up|4|||
48796053|NCT00440531|157091439|FG001|Overall Study|Lost to Follow-up|3|||
48796054|NCT00440531|157091440|FG002|Overall Study|Lost to Follow-up|5|||
48796055|NCT00440531|157091438|FG000|Overall Study|see pre-assignment details|2|||
48796056|NCT00440531|157091439|FG001|Overall Study|see pre-assignment details|0|||
48796057|NCT00440531|157091440|FG002|Overall Study|see pre-assignment details|0|||
48796058|NCT03561090|157091449|FG000|Overall Study|Adverse Event|11|||
48796059|NCT03561090|157091450|FG001|Overall Study|Adverse Event|7|||
48796060|NCT03561090|157091449|FG000|Overall Study|Non-Compliance With Study Drug|2|||
48796061|NCT03561090|157091450|FG001|Overall Study|Non-Compliance With Study Drug|0|||
48796062|NCT03561090|157091449|FG000|Overall Study|Protocol Violation|2|||
48796063|NCT03561090|157091450|FG001|Overall Study|Protocol Violation|2|||
48796064|NCT03561090|157091449|FG000|Overall Study|Withdrawal by Subject|7|||
48796065|NCT03561090|157091450|FG001|Overall Study|Withdrawal by Subject|7|||
48796066|NCT03561090|157091449|FG000|Overall Study|Lost to Follow-up|7|||
48796067|NCT03561090|157091450|FG001|Overall Study|Lost to Follow-up|2|||
49033276|NCT00316186|157956880|FG000|Overall Study|Adverse Event|6|||
49033277|NCT00316186|157956880|FG000|Overall Study|Disease Progression|4|||
49033278|NCT00316186|157956880|FG000|Overall Study|Lost to Follow-up|1|||
48796068|NCT03561090|157091449|FG000|Overall Study|Study Terminated by Sponsor|10|||
48796069|NCT03561090|157091450|FG001|Overall Study|Study Terminated by Sponsor|15|||
48796070|NCT03561090|157091449|FG000|Overall Study|Randomized by Mistake|1|||
48796071|NCT03561090|157091450|FG001|Overall Study|Randomized by Mistake|1|||
48796072|NCT03561090|157091449|FG000|Overall Study|Other Not Specified|0|||
48878822|NCT04427072|157394425|FG001|Randomized Treatment Phase|Adverse Event|1|||
49033279|NCT00316186|157956880|FG000|Overall Study|Other|1|||
49033280|NCT01439880|157956881|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|24|||
49033281|NCT01439880|157956882|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|38|||
49033282|NCT01439880|157956881|FG000|SOC-controlled Period (Year 1)|Death|2|||
49033283|NCT01439880|157956882|FG001|SOC-controlled Period (Year 1)|Death|1|||
49033284|NCT01439880|157956881|FG000|SOC-controlled Period (Year 1)|Sponsor Decision|0|||
49033285|NCT01439880|157956882|FG001|SOC-controlled Period (Year 1)|Sponsor Decision|1|||
49033286|NCT01439880|157956881|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|10|||
49033287|NCT01439880|157956882|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|5|||
49033288|NCT01439880|157956881|FG000|SOC-controlled Period (Year 1)|Other|8|||
49033289|NCT01439880|157956882|FG001|SOC-controlled Period (Year 1)|Other|13|||
49033290|NCT01439880|157956881|FG000|SOC-controlled Period (Year 1)|Reason Missing|0|||
49033291|NCT01439880|157956882|FG001|SOC-controlled Period (Year 1)|Reason Missing|2|||
48796073|NCT03561090|157091450|FG001|Overall Study|Other Not Specified|2|||
48796074|NCT01270347|157091457|FG000|Core Phase|Adverse Event|1|||
48796075|NCT01270347|157091458|FG001|Core Phase|Adverse Event|6|||
48796076|NCT01270347|157091457|FG000|Core Phase|Withdrawal by Subject|1|||
48796077|NCT01270347|157091458|FG001|Core Phase|Withdrawal by Subject|2|||
48796078|NCT01270347|157091457|FG000|Core Phase|Lost to Follow-up|0|||
48796079|NCT01270347|157091458|FG001|Core Phase|Lost to Follow-up|1|||
48796080|NCT01270347|157091457|FG000|Core Phase|Miscellaneous|8|||
48796081|NCT01270347|157091458|FG001|Core Phase|Miscellaneous|14|||
48796082|NCT01270347|157091457|FG000|Extension Phase|Adverse Event|1|||
48796083|NCT01270347|157091458|FG001|Extension Phase|Adverse Event|3|||
48796084|NCT01270347|157091457|FG000|Extension Phase|Withdrawal by Subject|3|||
48796085|NCT01270347|157091458|FG001|Extension Phase|Withdrawal by Subject|4|||
48796086|NCT01270347|157091457|FG000|Extension Phase|Miscellaneous|2|||
48796087|NCT01270347|157091458|FG001|Extension Phase|Miscellaneous|2|||
48796088|NCT02612311|157091459|FG000|Overall Study|Adverse Event|16|||
48796089|NCT02612311|157091460|FG001|Overall Study|Adverse Event|12|||
48796090|NCT02612311|157091461|FG002|Overall Study|Adverse Event|7|||
48796091|NCT02612311|157091462|FG003|Overall Study|Adverse Event|13|||
48796092|NCT02612311|157091459|FG000|Overall Study|Death|29|||
48796093|NCT02612311|157091460|FG001|Overall Study|Death|10|||
48878823|NCT04427072|157394424|FG000|Randomized Treatment Phase|Study terminated by sponsor|3|||
49033292|NCT01439880|157956881|FG000|All-IP Period (Years 2 to 5)|Lost to Follow-up|21|||
49033293|NCT01439880|157956882|FG001|All-IP Period (Years 2 to 5)|Lost to Follow-up|30|||
49033294|NCT01439880|157956881|FG000|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30|||
48796094|NCT02612311|157091461|FG002|Overall Study|Death|11|||
48796095|NCT02612311|157091462|FG003|Overall Study|Death|11|||
48796096|NCT02612311|157091459|FG000|Overall Study|Initiation of Non-protocol Intervention|5|||
48796097|NCT02612311|157091460|FG001|Overall Study|Initiation of Non-protocol Intervention|3|||
48796098|NCT02612311|157091461|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
48796099|NCT02612311|157091462|FG003|Overall Study|Initiation of Non-protocol Intervention|0|||
48796100|NCT02612311|157091459|FG000|Overall Study|Investigator's Decision|11|||
49033295|NCT01439880|157956882|FG001|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66|||
49033296|NCT01439880|157956881|FG000|All-IP Period (Years 2 to 5)|Death|3|||
49033297|NCT01439880|157956882|FG001|All-IP Period (Years 2 to 5)|Death|13|||
49033298|NCT01439880|157956881|FG000|All-IP Period (Years 2 to 5)|Sponsor Decision|1|||
49033299|NCT01439880|157956882|FG001|All-IP Period (Years 2 to 5)|Sponsor Decision|0|||
49033300|NCT01439880|157956881|FG000|All-IP Period (Years 2 to 5)|Other|14|||
49033301|NCT01439880|157956882|FG001|All-IP Period (Years 2 to 5)|Other|31|||
49033302|NCT01439880|157956881|FG000|All-IP Period (Years 2 to 5)|Reason Missing|1|||
49033303|NCT01439880|157956882|FG001|All-IP Period (Years 2 to 5)|Reason Missing|0|||
49033304|NCT00461786|157956888|FG000|Overall Study|Entry Criteria Not Met|2|||
49033305|NCT00461786|157956888|FG000|Overall Study|Inevaluable (Never Treated)|1|||
49033306|NCT02301975|157956889|FG000|Overall Study|Adverse Event|8|||
49033307|NCT02301975|157956890|FG001|Overall Study|Adverse Event|3|||
49033308|NCT02301975|157956891|FG002|Overall Study|Adverse Event|2|||
49033309|NCT02301975|157956889|FG000|Overall Study|Lack of Efficacy|1|||
49033310|NCT02301975|157956890|FG001|Overall Study|Lack of Efficacy|1|||
49033311|NCT02301975|157956891|FG002|Overall Study|Lack of Efficacy|1|||
49033312|NCT02301975|157956889|FG000|Overall Study|Protocol Violation|3|||
49033313|NCT02301975|157956890|FG001|Overall Study|Protocol Violation|5|||
49033314|NCT02301975|157956891|FG002|Overall Study|Protocol Violation|3|||
49033315|NCT02301975|157956889|FG000|Overall Study|Lost to Follow-up|0|||
49033316|NCT02301975|157956890|FG001|Overall Study|Lost to Follow-up|2|||
48796101|NCT02612311|157091460|FG001|Overall Study|Investigator's Decision|15|||
48796102|NCT02612311|157091461|FG002|Overall Study|Investigator's Decision|6|||
48796103|NCT02612311|157091462|FG003|Overall Study|Investigator's Decision|6|||
48796104|NCT02612311|157091459|FG000|Overall Study|Lack of Efficacy|0|||
48796105|NCT02612311|157091460|FG001|Overall Study|Lack of Efficacy|0|||
48796106|NCT02612311|157091461|FG002|Overall Study|Lack of Efficacy|1|||
48796107|NCT02612311|157091462|FG003|Overall Study|Lack of Efficacy|1|||
48796108|NCT02612311|157091459|FG000|Overall Study|Lost to Follow-up|2|||
48796109|NCT02612311|157091460|FG001|Overall Study|Lost to Follow-up|2|||
48796110|NCT02612311|157091461|FG002|Overall Study|Lost to Follow-up|1|||
48796111|NCT02612311|157091462|FG003|Overall Study|Lost to Follow-up|2|||
48796112|NCT02612311|157091459|FG000|Overall Study|Progressive Disease Confirmed by Central Radiology|75|||
48796113|NCT02612311|157091460|FG001|Overall Study|Progressive Disease Confirmed by Central Radiology|113|||
48796114|NCT02612311|157091461|FG002|Overall Study|Progressive Disease Confirmed by Central Radiology|38|||
48796115|NCT02612311|157091462|FG003|Overall Study|Progressive Disease Confirmed by Central Radiology|43|||
48796116|NCT02612311|157091459|FG000|Overall Study|Site Terminated by Sponsor|29|||
48796117|NCT02612311|157091460|FG001|Overall Study|Site Terminated by Sponsor|12|||
48796118|NCT02612311|157091461|FG002|Overall Study|Site Terminated by Sponsor|13|||
48796119|NCT02612311|157091462|FG003|Overall Study|Site Terminated by Sponsor|5|||
48796120|NCT02612311|157091459|FG000|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|29|||
48878824|NCT04427072|157394425|FG001|Randomized Treatment Phase|Study terminated by sponsor|0|||
49033317|NCT02301975|157956891|FG002|Overall Study|Lost to Follow-up|2|||
49033318|NCT02301975|157956889|FG000|Overall Study|Physician Decision|4|||
49033319|NCT02301975|157956890|FG001|Overall Study|Physician Decision|2|||
49033320|NCT02301975|157956891|FG002|Overall Study|Physician Decision|3|||
49033321|NCT02301975|157956889|FG000|Overall Study|Withdrawal by Subject|15|||
49033322|NCT02301975|157956890|FG001|Overall Study|Withdrawal by Subject|12|||
49033323|NCT02301975|157956891|FG002|Overall Study|Withdrawal by Subject|11|||
49033324|NCT01802320|157956892|FG000|Overall Study|Death|1|||
49033325|NCT01802320|157956892|FG000|Overall Study|Withdrawal by Subject|1|||
48796121|NCT02612311|157091460|FG001|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|24|||
48796122|NCT02612311|157091461|FG002|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|6|||
48796123|NCT02612311|157091462|FG003|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|5|||
48796124|NCT02612311|157091459|FG000|Overall Study|Reason Not Specified|3|||
48796125|NCT02612311|157091460|FG001|Overall Study|Reason Not Specified|7|||
48796126|NCT02612311|157091461|FG002|Overall Study|Reason Not Specified|4|||
48796127|NCT02612311|157091462|FG003|Overall Study|Reason Not Specified|5|||
48796128|NCT02612311|157091459|FG000|Overall Study|Unknown/Missing|10|||
48796129|NCT02612311|157091460|FG001|Overall Study|Unknown/Missing|13|||
48796130|NCT02612311|157091461|FG002|Overall Study|Unknown/Missing|4|||
48796131|NCT02612311|157091462|FG003|Overall Study|Unknown/Missing|0|||
48796132|NCT02612311|157091459|FG000|Overall Study|Non-Compliance with Study|1|||
48796133|NCT02612311|157091460|FG001|Overall Study|Non-Compliance with Study|0|||
48796134|NCT02612311|157091461|FG002|Overall Study|Non-Compliance with Study|0|||
48796135|NCT02612311|157091462|FG003|Overall Study|Non-Compliance with Study|0|||
48796136|NCT02862457|157091465|FG000|Overall Study|Death|1|||
48878825|NCT04427072|157394424|FG000|Randomized Treatment Phase|Death|0|||
49033326|NCT04123548|157956893|FG000|Overall Study|Withdrawal by Subject|1|||
49033327|NCT04123548|157956893|FG000|Overall Study|Lost to Follow-up|8|||
49033328|NCT04123548|157956893|FG000|Overall Study|Death|4|||
49033329|NCT04123548|157956893|FG000|Overall Study|Reason Not Specified|1|||
49033330|NCT00328926|157956894|FG000|Overall Study|Pregnancy|2|||
49033331|NCT00328926|157956895|FG001|Overall Study|Pregnancy|1|||
48796137|NCT02862457|157091466|FG001|Overall Study|Death|3|||
48796138|NCT02862457|157091467|FG002|Overall Study|Death|2|||
48796139|NCT02862457|157091468|FG003|Overall Study|Death|3|||
48796140|NCT02862457|157091469|FG004|Overall Study|Death|0|||
48796141|NCT02862457|157091470|FG005|Overall Study|Death|2|||
48796142|NCT02862457|157091471|FG006|Overall Study|Death|1|||
48796143|NCT02862457|157091465|FG000|Overall Study|Lost to Follow-up|1|||
48796144|NCT02862457|157091466|FG001|Overall Study|Lost to Follow-up|0|||
48796145|NCT02862457|157091467|FG002|Overall Study|Lost to Follow-up|0|||
48796146|NCT02862457|157091468|FG003|Overall Study|Lost to Follow-up|1|||
48796147|NCT02862457|157091469|FG004|Overall Study|Lost to Follow-up|0|||
48796148|NCT02862457|157091470|FG005|Overall Study|Lost to Follow-up|0|||
48796149|NCT02862457|157091471|FG006|Overall Study|Lost to Follow-up|0|||
48796150|NCT02862457|157091465|FG000|Overall Study|Withdrawal by Subject|0|||
48796151|NCT02862457|157091466|FG001|Overall Study|Withdrawal by Subject|0|||
48796152|NCT02862457|157091467|FG002|Overall Study|Withdrawal by Subject|1|||
48796153|NCT02862457|157091468|FG003|Overall Study|Withdrawal by Subject|0|||
48796154|NCT02862457|157091469|FG004|Overall Study|Withdrawal by Subject|0|||
48796155|NCT02862457|157091470|FG005|Overall Study|Withdrawal by Subject|1|||
48796156|NCT02862457|157091471|FG006|Overall Study|Withdrawal by Subject|0|||
48796157|NCT00743366|157091473|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
48796158|NCT00743366|157091474|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
48796159|NCT01799265|157091475|FG000|Overall Study|Lost to Follow-up|1|||
48796160|NCT01799265|157091476|FG001|Overall Study|Lost to Follow-up|0|||
48796161|NCT01799265|157091475|FG000|Overall Study|Protocol Violation|2|||
48878826|NCT04427072|157394425|FG001|Randomized Treatment Phase|Death|1|||
48878827|NCT04427072|157394424|FG000|Randomized Treatment Phase|Not treated (participant decision)|0|||
48878828|NCT04427072|157394425|FG001|Randomized Treatment Phase|Not treated (participant decision)|1|||
48878829|NCT04427072|157394424|FG000|Extension Treatment Phase|Progressive disease|0|||
48878830|NCT04427072|157394425|FG001|Extension Treatment Phase|Progressive disease|5|||
48878831|NCT02559310|157394426|FG000|Overall Study|Death|4|||
48878832|NCT02559310|157394427|FG001|Overall Study|Death|3|||
48878833|NCT02559310|157394426|FG000|Overall Study|Lost to Follow-up|5|||
48878834|NCT02559310|157394427|FG001|Overall Study|Lost to Follow-up|3|||
48878835|NCT02559310|157394426|FG000|Overall Study|Physician Decision|2|||
48878836|NCT02559310|157394427|FG001|Overall Study|Physician Decision|1|||
48878837|NCT02559310|157394426|FG000|Overall Study|Withdrawal by Subject|13|||
48878838|NCT02559310|157394427|FG001|Overall Study|Withdrawal by Subject|9|||
48878839|NCT02559310|157394426|FG000|Overall Study|Sponsor Decision|0|||
48878840|NCT02559310|157394427|FG001|Overall Study|Sponsor Decision|1|||
48878841|NCT02559310|157394426|FG000|Overall Study|Randomized but not treated|3|||
48878842|NCT02559310|157394427|FG001|Overall Study|Randomized but not treated|2|||
48878843|NCT02671435|157394431|FG000|Overall Study|Death|1|||
48878844|NCT02671435|157394432|FG001|Overall Study|Death|3|||
48878845|NCT02671435|157394433|FG002|Overall Study|Death|0|||
48878846|NCT02671435|157394434|FG003|Overall Study|Death|16|||
48878847|NCT02671435|157394435|FG004|Overall Study|Death|14|||
48878848|NCT02671435|157394436|FG005|Overall Study|Death|29|||
48878849|NCT02671435|157394437|FG006|Overall Study|Death|34|||
48878850|NCT02671435|157394438|FG007|Overall Study|Death|28|||
48878851|NCT02671435|157394439|FG008|Overall Study|Death|19|||
48878852|NCT02671435|157394440|FG009|Overall Study|Death|10|||
48878853|NCT02671435|157394441|FG010|Overall Study|Death|8|||
48878854|NCT02671435|157394442|FG011|Overall Study|Death|29|||
48878855|NCT02671435|157394443|FG012|Overall Study|Death|29|||
48878856|NCT02671435|157394444|FG013|Overall Study|Death|29|||
48878857|NCT02671435|157394445|FG014|Overall Study|Death|27|||
48878858|NCT02671435|157394431|FG000|Overall Study|Lost to Follow-up|0|||
48878859|NCT02671435|157394432|FG001|Overall Study|Lost to Follow-up|0|||
48878860|NCT02671435|157394433|FG002|Overall Study|Lost to Follow-up|1|||
48878861|NCT02671435|157394434|FG003|Overall Study|Lost to Follow-up|0|||
48878862|NCT02671435|157394435|FG004|Overall Study|Lost to Follow-up|1|||
48878863|NCT02671435|157394436|FG005|Overall Study|Lost to Follow-up|1|||
48878864|NCT02671435|157394437|FG006|Overall Study|Lost to Follow-up|2|||
48878865|NCT02671435|157394438|FG007|Overall Study|Lost to Follow-up|2|||
48878866|NCT02671435|157394439|FG008|Overall Study|Lost to Follow-up|0|||
48878867|NCT02671435|157394440|FG009|Overall Study|Lost to Follow-up|2|||
48878868|NCT02671435|157394441|FG010|Overall Study|Lost to Follow-up|0|||
48878869|NCT02671435|157394442|FG011|Overall Study|Lost to Follow-up|3|||
48878870|NCT02671435|157394443|FG012|Overall Study|Lost to Follow-up|3|||
48796162|NCT01799265|157091476|FG001|Overall Study|Protocol Violation|1|||
48796163|NCT01799265|157091475|FG000|Overall Study|inadequate sleep study|0|||
48878871|NCT02671435|157394444|FG013|Overall Study|Lost to Follow-up|2|||
48878872|NCT02671435|157394445|FG014|Overall Study|Lost to Follow-up|0|||
48878873|NCT02671435|157394431|FG000|Overall Study|Withdrawal by Subject|2|||
48878874|NCT02671435|157394432|FG001|Overall Study|Withdrawal by Subject|0|||
48878875|NCT02671435|157394433|FG002|Overall Study|Withdrawal by Subject|2|||
48878876|NCT02671435|157394434|FG003|Overall Study|Withdrawal by Subject|2|||
48878877|NCT02671435|157394435|FG004|Overall Study|Withdrawal by Subject|2|||
48878878|NCT02671435|157394436|FG005|Overall Study|Withdrawal by Subject|7|||
49033332|NCT00328926|157956896|FG002|Overall Study|Pregnancy|0|||
49033333|NCT00328926|157956894|FG000|Overall Study|Lost to Follow-up|0|||
49033334|NCT00328926|157956895|FG001|Overall Study|Lost to Follow-up|1|||
49033335|NCT00328926|157956896|FG002|Overall Study|Lost to Follow-up|0|||
49033336|NCT00328926|157956894|FG000|Overall Study|Death|0|||
49033337|NCT00328926|157956895|FG001|Overall Study|Death|0|||
49033338|NCT00328926|157956896|FG002|Overall Study|Death|1|||
49033339|NCT00328926|157956894|FG000|Overall Study|In vitro fertilization treatment|0|||
49033340|NCT00328926|157956895|FG001|Overall Study|In vitro fertilization treatment|0|||
49033341|NCT00328926|157956896|FG002|Overall Study|In vitro fertilization treatment|1|||
49033342|NCT00328926|157956894|FG000|Overall Study|Lack of ovarian response|0|||
49033343|NCT00328926|157956895|FG001|Overall Study|Lack of ovarian response|1|||
49033344|NCT00328926|157956896|FG002|Overall Study|Lack of ovarian response|0|||
49033345|NCT05038293|157956901|FG000|Overall Study|device was not operating properly for one subject.|1|||
49033346|NCT05038293|157956902|FG001|Overall Study|device was not operating properly for one subject.|0|||
49033347|NCT05038293|157956901|FG000|Overall Study|one subject was dropped due to a behavioral issue|1|||
48878879|NCT02671435|157394437|FG006|Overall Study|Withdrawal by Subject|2|||
48878880|NCT02671435|157394438|FG007|Overall Study|Withdrawal by Subject|7|||
48878881|NCT02671435|157394439|FG008|Overall Study|Withdrawal by Subject|1|||
48878882|NCT02671435|157394440|FG009|Overall Study|Withdrawal by Subject|1|||
48878883|NCT02671435|157394441|FG010|Overall Study|Withdrawal by Subject|2|||
48878884|NCT02671435|157394442|FG011|Overall Study|Withdrawal by Subject|4|||
48878885|NCT02671435|157394443|FG012|Overall Study|Withdrawal by Subject|4|||
48878886|NCT02671435|157394444|FG013|Overall Study|Withdrawal by Subject|4|||
48878887|NCT02671435|157394445|FG014|Overall Study|Withdrawal by Subject|2|||
48878888|NCT02671435|157394431|FG000|Overall Study|Un-specified|0|||
48878889|NCT02671435|157394432|FG001|Overall Study|Un-specified|0|||
48878890|NCT02671435|157394433|FG002|Overall Study|Un-specified|0|||
48878891|NCT02671435|157394434|FG003|Overall Study|Un-specified|0|||
48878892|NCT02671435|157394435|FG004|Overall Study|Un-specified|1|||
48878893|NCT02671435|157394436|FG005|Overall Study|Un-specified|3|||
48878894|NCT02671435|157394437|FG006|Overall Study|Un-specified|2|||
48878895|NCT02671435|157394438|FG007|Overall Study|Un-specified|3|||
48878896|NCT02671435|157394439|FG008|Overall Study|Un-specified|0|||
48878897|NCT02671435|157394440|FG009|Overall Study|Un-specified|5|||
48878898|NCT02671435|157394441|FG010|Overall Study|Un-specified|8|||
48878899|NCT02671435|157394442|FG011|Overall Study|Un-specified|4|||
48878900|NCT02671435|157394443|FG012|Overall Study|Un-specified|5|||
48878901|NCT02671435|157394444|FG013|Overall Study|Un-specified|9|||
48878902|NCT02671435|157394445|FG014|Overall Study|Un-specified|8|||
48878903|NCT03277352|157394450|FG000|Overall Study|Study Terminated By Sponsor|2|||
48878904|NCT03277352|157394450|FG000|Overall Study|Withdrawal by Subject|4|||
48878905|NCT03277352|157394450|FG000|Overall Study|Death|4|||
48878906|NCT02284009|157394451|FG000|Overall Study|Adverse Event|3|||
48878907|NCT02284009|157394452|FG001|Overall Study|Adverse Event|0|||
48878908|NCT02284009|157394451|FG000|Overall Study|Lost to Follow-up|1|||
48878909|NCT02284009|157394452|FG001|Overall Study|Lost to Follow-up|3|||
48878910|NCT02284009|157394451|FG000|Overall Study|Physician Decision|0|||
48878911|NCT02284009|157394452|FG001|Overall Study|Physician Decision|2|||
48878912|NCT02284009|157394451|FG000|Overall Study|Withdrawal by Subject|2|||
48878913|NCT02284009|157394452|FG001|Overall Study|Withdrawal by Subject|5|||
48878914|NCT02397447|157394453|FG000|Overall Study|Lost to Follow-up|2|||
48878915|NCT02397447|157394454|FG001|Overall Study|Lost to Follow-up|2|||
48878916|NCT03614676|157396074|FG000|Overall Study|Delivery before planned visit|2|||
48878917|NCT03614676|157396075|FG001|Overall Study|Delivery before planned visit|0|||
48878918|NCT03614676|157396074|FG000|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|34|||
48878919|NCT03614676|157396075|FG001|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|0|||
49033348|NCT05038293|157956902|FG001|Overall Study|one subject was dropped due to a behavioral issue|0|||
49033349|NCT00834249|157956907|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
49033350|NCT00834249|157956908|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
49033351|NCT00834249|157956907|FG000|Second Intervention|Adverse Event|1|||
49033352|NCT00834249|157956908|FG001|Second Intervention|Adverse Event|0|||
49033353|NCT02440711|157956910|FG000|Second Intervention|Lost to Follow-up|1|||
49033354|NCT02440711|157956911|FG001|Second Intervention|Lost to Follow-up|0|||
49033355|NCT01838941|157956912|FG000|Overall Study|Adverse Event|1|||
49033356|NCT01838941|157956912|FG000|Overall Study|Withdrawal by Subject|1|||
49033357|NCT04533594|157956913|FG000|Overall Study|Death|26|||
49033358|NCT03181594|157956914|FG000|Initial Study Protocol (12-month FU)|Lost to Follow-up|4|||
48878920|NCT03614676|157396074|FG000|Overall Study|Migrated / moved from the study area|30|||
48878921|NCT03614676|157396075|FG001|Overall Study|Migrated / moved from the study area|22|||
48878922|NCT03614676|157396074|FG000|Overall Study|Lost to Follow-up|17|||
48878923|NCT03614676|157396075|FG001|Overall Study|Lost to Follow-up|42|||
48878924|NCT03614676|157396074|FG000|Overall Study|Not willing/ not able to participate in this visit|17|||
48878925|NCT03614676|157396075|FG001|Overall Study|Not willing/ not able to participate in this visit|16|||
48878926|NCT03614676|157396074|FG000|Overall Study|Other|16|||
48878927|NCT03614676|157396075|FG001|Overall Study|Other|47|||
48878928|NCT03614676|157396074|FG000|Overall Study|Protocol Violation|0|||
48878929|NCT03614676|157396075|FG001|Overall Study|Protocol Violation|2|||
48796164|NCT01799265|157091476|FG001|Overall Study|inadequate sleep study|2|||
48796165|NCT00003298|157091477|FG000|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1|||
48796166|NCT00003298|157091477|FG000|Step 1 (Neoadjuvant Therapy)|Adverse Event|3|||
48796167|NCT00003298|157091477|FG000|Surgery|Unresectable at surgery|3|||
48796168|NCT00003298|157091477|FG000|Surgery|Progression before surgery|2|||
48796169|NCT00003298|157091477|FG000|Surgery|Unevaluable and off study|2|||
48796170|NCT00003298|157091477|FG000|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7|||
48796171|NCT00003298|157091477|FG000|Re-register to Step 2 After Surgery|Positive margins|5|||
48796172|NCT00003298|157091477|FG000|Re-register to Step 2 After Surgery|Other complications|2|||
48796173|NCT00003298|157091477|FG000|Re-register to Step 2 After Surgery|Reason unknown|1|||
48796174|NCT00003298|157091477|FG000|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3|||
48796175|NCT00003298|157091477|FG000|Step 2 (Adjuvant Therapy)|Ineligible|1|||
48796176|NCT00003298|157091477|FG000|Step 2 (Adjuvant Therapy)|Death|1|||
48796177|NCT00003298|157091477|FG000|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1|||
48796178|NCT00003298|157091477|FG000|Step 2 (Adjuvant Therapy)|Excessive complication|1|||
48796179|NCT00003298|157091477|FG000|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2|||
48796180|NCT00514735|157091478|FG000|Overall Study|Withdrawal by Subject|13|||
48796181|NCT00514735|157091479|FG001|Overall Study|Withdrawal by Subject|5|||
48796182|NCT00514735|157091478|FG000|Overall Study|Death|1|||
48796183|NCT00514735|157091479|FG001|Overall Study|Death|0|||
48796184|NCT00514735|157091478|FG000|Overall Study|Lost to Follow-up|0|||
48796185|NCT00514735|157091479|FG001|Overall Study|Lost to Follow-up|1|||
48796186|NCT00335322|157091480|FG000|Overall Study|Randomised but withdrew prior to ART sta|1|||
48796187|NCT00335322|157091481|FG001|Overall Study|Randomised but withdrew prior to ART sta|2|||
48796188|NCT00335322|157091482|FG002|Overall Study|Randomised but withdrew prior to ART sta|2|||
48796189|NCT02308748|157091485|FG000|Period 1|Withdrawal by Subject|0|||
48796190|NCT02308748|157091486|FG001|Period 1|Withdrawal by Subject|0|||
48796191|NCT02308748|157091487|FG002|Period 1|Withdrawal by Subject|1|||
48796192|NCT02308748|157091488|FG003|Period 1|Withdrawal by Subject|0|||
48796193|NCT02308748|157091489|FG004|Period 1|Withdrawal by Subject|0|||
48796194|NCT02308748|157091490|FG005|Period 1|Withdrawal by Subject|0|||
48796195|NCT02308748|157091491|FG006|Period 1|Withdrawal by Subject|0|||
48796196|NCT02308748|157091492|FG007|Period 1|Withdrawal by Subject|0|||
48796197|NCT02308748|157091493|FG008|Period 1|Withdrawal by Subject|0|||
48796198|NCT02308748|157091494|FG009|Period 1|Withdrawal by Subject|0|||
48796199|NCT02308748|157091485|FG000|Period 2|Adverse Event|0|||
48796200|NCT02308748|157091486|FG001|Period 2|Adverse Event|0|||
48796201|NCT02308748|157091487|FG002|Period 2|Adverse Event|0|||
48796202|NCT02308748|157091488|FG003|Period 2|Adverse Event|0|||
48796203|NCT02308748|157091489|FG004|Period 2|Adverse Event|0|||
48796204|NCT02308748|157091490|FG005|Period 2|Adverse Event|0|||
48796205|NCT02308748|157091491|FG006|Period 2|Adverse Event|0|||
48796206|NCT02308748|157091492|FG007|Period 2|Adverse Event|1|||
48796207|NCT02308748|157091493|FG008|Period 2|Adverse Event|0|||
48796208|NCT02308748|157091494|FG009|Period 2|Adverse Event|0|||
48796209|NCT02308748|157091485|FG000|Period 3|Protocol Violation|0|||
48796210|NCT02308748|157091486|FG001|Period 3|Protocol Violation|0|||
48796211|NCT02308748|157091487|FG002|Period 3|Protocol Violation|0|||
48796212|NCT02308748|157091488|FG003|Period 3|Protocol Violation|0|||
48796213|NCT02308748|157091489|FG004|Period 3|Protocol Violation|0|||
48796214|NCT02308748|157091490|FG005|Period 3|Protocol Violation|0|||
48796215|NCT02308748|157091491|FG006|Period 3|Protocol Violation|0|||
48796216|NCT02308748|157091492|FG007|Period 3|Protocol Violation|0|||
48796217|NCT02308748|157091493|FG008|Period 3|Protocol Violation|0|||
48796218|NCT02308748|157091494|FG009|Period 3|Protocol Violation|1|||
48796219|NCT02308748|157091485|FG000|Period 5|Adverse Event|1|||
48796220|NCT02308748|157091486|FG001|Period 5|Adverse Event|0|||
48796221|NCT02308748|157091487|FG002|Period 5|Adverse Event|0|||
48796222|NCT02308748|157091488|FG003|Period 5|Adverse Event|0|||
48796223|NCT02308748|157091489|FG004|Period 5|Adverse Event|0|||
48796224|NCT02308748|157091490|FG005|Period 5|Adverse Event|0|||
48796225|NCT02308748|157091491|FG006|Period 5|Adverse Event|0|||
48796226|NCT02308748|157091492|FG007|Period 5|Adverse Event|0|||
48796227|NCT02308748|157091493|FG008|Period 5|Adverse Event|1|||
48796228|NCT02308748|157091494|FG009|Period 5|Adverse Event|0|||
48796229|NCT03364751|157091495|FG000|Overall Study|Withdrawal by Subject|1|||
48796230|NCT03364751|157091496|FG001|Overall Study|Withdrawal by Subject|0|||
48796231|NCT03364751|157091497|FG002|Overall Study|Withdrawal by Subject|0|||
48796232|NCT03364751|157091498|FG003|Overall Study|Withdrawal by Subject|0|||
48796233|NCT03364751|157091495|FG000|Overall Study|Lost to Follow-up|0|||
48796234|NCT03364751|157091496|FG001|Overall Study|Lost to Follow-up|1|||
48796235|NCT03364751|157091497|FG002|Overall Study|Lost to Follow-up|0|||
48796236|NCT03364751|157091498|FG003|Overall Study|Lost to Follow-up|0|||
48796237|NCT02975973|157091499|FG000|Overall Study|Adverse Event|1|||
48796238|NCT02975973|157091500|FG001|Overall Study|Adverse Event|1|||
48878930|NCT03614676|157396074|FG000|Overall Study|Neonatal event of interest|0|||
48878931|NCT03614676|157396075|FG001|Overall Study|Neonatal event of interest|6|||
48878932|NCT03614676|157396074|FG000|Overall Study|Death in infant greater than 28 days old|0|||
48878933|NCT03614676|157396075|FG001|Overall Study|Death in infant greater than 28 days old|12|||
48878934|NCT03614676|157396074|FG000|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|0|||
48878935|NCT03614676|157396075|FG001|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|17|||
48878936|NCT01845805|157396079|FG000|Overall Study|Withdrawal by Subject|1|||
48878937|NCT01845805|157396080|FG001|Overall Study|Withdrawal by Subject|2|||
48878938|NCT01845805|157396079|FG000|Overall Study|Disease Progression|13|||
48878939|NCT01845805|157396080|FG001|Overall Study|Disease Progression|14|||
48878940|NCT01845805|157396079|FG000|Overall Study|Drug-related Toxicity|4|||
48878941|NCT01845805|157396080|FG001|Overall Study|Drug-related Toxicity|0|||
48878942|NCT02172911|157396081|FG000|Overall Study|Serious Adverse Event|0|||
48878943|NCT02172911|157396082|FG001|Overall Study|Serious Adverse Event|1|||
48878944|NCT02172911|157396081|FG000|Overall Study|Progression of Disease|0|||
48878945|NCT02172911|157396082|FG001|Overall Study|Progression of Disease|1|||
48878946|NCT02172911|157396081|FG000|Overall Study|Loss of insurance coverage|1|||
48878947|NCT02172911|157396082|FG001|Overall Study|Loss of insurance coverage|0|||
48878948|NCT01053247|157396085|FG000|Overall Study|Withdrawal by Subject|9|||
48878949|NCT01053247|157396086|FG001|Overall Study|Withdrawal by Subject|4|||
48878950|NCT01053247|157396087|FG002|Overall Study|Withdrawal by Subject|15|||
48878951|NCT01053247|157396085|FG000|Overall Study|Lack of Efficacy|1|||
48878952|NCT01053247|157396086|FG001|Overall Study|Lack of Efficacy|0|||
48878953|NCT01053247|157396087|FG002|Overall Study|Lack of Efficacy|1|||
48878954|NCT01053247|157396085|FG000|Overall Study|Protocol Violation|2|||
48878955|NCT01053247|157396086|FG001|Overall Study|Protocol Violation|1|||
48878956|NCT01053247|157396087|FG002|Overall Study|Protocol Violation|2|||
48878957|NCT01053247|157396085|FG000|Overall Study|Lost to Follow-up|8|||
48878958|NCT01053247|157396086|FG001|Overall Study|Lost to Follow-up|5|||
48878959|NCT01053247|157396087|FG002|Overall Study|Lost to Follow-up|7|||
48878960|NCT01053247|157396085|FG000|Overall Study|Adverse Event|0|||
48878961|NCT01053247|157396086|FG001|Overall Study|Adverse Event|9|||
48878962|NCT01053247|157396087|FG002|Overall Study|Adverse Event|3|||
48878963|NCT03167151|157396091|FG000|Overall Study|Withdrawal by Subject|1|||
48878964|NCT03167151|157396092|FG001|Overall Study|Withdrawal by Subject|0|||
48878965|NCT03167151|157396093|FG002|Overall Study|Withdrawal by Subject|0|||
48878966|NCT03167151|157396091|FG000|Overall Study|No evidence of tumour at surgery|0|||
48878967|NCT03167151|157396092|FG001|Overall Study|No evidence of tumour at surgery|1|||
48878968|NCT03167151|157396093|FG002|Overall Study|No evidence of tumour at surgery|1|||
48878969|NCT00953147|157396094|FG000|Overall Study|Adverse Event|8|||
48878970|NCT00953147|157396095|FG001|Overall Study|Adverse Event|16|||
48878971|NCT00953147|157396096|FG002|Overall Study|Adverse Event|6|||
48878972|NCT00953147|157396094|FG000|Overall Study|Protocol Violation|2|||
48878973|NCT00953147|157396095|FG001|Overall Study|Protocol Violation|8|||
48878974|NCT00953147|157396096|FG002|Overall Study|Protocol Violation|4|||
48878975|NCT00953147|157396094|FG000|Overall Study|Withdrawal by Subject|13|||
48878976|NCT00953147|157396095|FG001|Overall Study|Withdrawal by Subject|15|||
48878977|NCT00953147|157396096|FG002|Overall Study|Withdrawal by Subject|12|||
48878978|NCT00953147|157396094|FG000|Overall Study|Lost to Follow-up|8|||
48878979|NCT00953147|157396095|FG001|Overall Study|Lost to Follow-up|9|||
48878980|NCT00953147|157396096|FG002|Overall Study|Lost to Follow-up|4|||
48878981|NCT00953147|157396094|FG000|Overall Study|Physician Decision|2|||
48878982|NCT00953147|157396095|FG001|Overall Study|Physician Decision|7|||
48878983|NCT00953147|157396096|FG002|Overall Study|Physician Decision|3|||
48878984|NCT00953147|157396094|FG000|Overall Study|Other|4|||
48878985|NCT00953147|157396095|FG001|Overall Study|Other|11|||
48878986|NCT00953147|157396096|FG002|Overall Study|Other|13|||
48878987|NCT03602586|157396097|FG000|Overall Study|Withdrawal by Subject|3|||
48878988|NCT00516139|157396099|FG000|Overall Study|Adverse Event|27|||
48878989|NCT00516139|157396099|FG000|Overall Study|Lost to Follow-up|1|||
48878990|NCT00516139|157396099|FG000|Overall Study|Protocol Violation|1|||
48878991|NCT00516139|157396099|FG000|Overall Study|Withdrawal by Subject|8|||
48878992|NCT00516139|157396099|FG000|Overall Study|Lack of Efficacy|1|||
48878993|NCT00334542|157396101|FG000|Overall Study|Adverse Event|3|||
48878994|NCT00334542|157396101|FG000|Overall Study|Withdrawal by Subject|1|||
48878995|NCT00334542|157396101|FG000|Overall Study|New cancer diagnosis|1|||
48878996|NCT02370251|157396105|FG000|Overall Study|Received less than 8 days of Omegaven|7|||
48878997|NCT02370251|157396105|FG000|Overall Study|Death|4|||
48878998|NCT01952847|157396106|FG000|Overall Study|Ineligible|1|||
48878999|NCT01952847|157396107|FG001|Overall Study|Ineligible|0|||
48879000|NCT01952847|157396108|FG002|Overall Study|Ineligible|0|||
48879001|NCT01952847|157396109|FG003|Overall Study|Ineligible|0|||
48879002|NCT01952847|157396106|FG000|Overall Study|Lack of Insurance Coverage|0|||
48879003|NCT01952847|157396107|FG001|Overall Study|Lack of Insurance Coverage|1|||
48879004|NCT01952847|157396108|FG002|Overall Study|Lack of Insurance Coverage|0|||
48879005|NCT01952847|157396109|FG003|Overall Study|Lack of Insurance Coverage|0|||
48879006|NCT01952847|157396106|FG000|Overall Study|Withdrawal by Subject|1|||
48879007|NCT01952847|157396107|FG001|Overall Study|Withdrawal by Subject|1|||
48879008|NCT01952847|157396108|FG002|Overall Study|Withdrawal by Subject|0|||
48879009|NCT01952847|157396109|FG003|Overall Study|Withdrawal by Subject|1|||
48879010|NCT01784523|157396110|FG000|Overall Study|Study closed early|7|||
48879011|NCT01784523|157396111|FG001|Overall Study|Study closed early|4|||
48879012|NCT05144945|157396114|FG000|Overall Study|Withdrawal by Subject|1|||
48879013|NCT05144945|157396115|FG001|Overall Study|Withdrawal by Subject|0|||
48879014|NCT01432626|157396116|FG000|Overall Study|LV function recovered|2|||
48879015|NCT01432626|157396116|FG000|Overall Study|Withdrawal by Subject|2|||
48879016|NCT01432626|157396116|FG000|Overall Study|Only 1 image competed|2|||
48879017|NCT01432626|157396116|FG000|Overall Study|Imaging agent not available|1|||
48879018|NCT01124097|157396117|FG000|Overall Study|Withdrawal by Subject|4|||
48879019|NCT01124097|157396118|FG001|Overall Study|Withdrawal by Subject|3|||
48879020|NCT01124097|157396119|FG002|Overall Study|Withdrawal by Subject|2|||
48879021|NCT01124097|157396120|FG003|Overall Study|Withdrawal by Subject|3|||
48879022|NCT01124097|157396117|FG000|Overall Study|Lack of Efficacy|2|||
48879023|NCT01124097|157396118|FG001|Overall Study|Lack of Efficacy|3|||
48879024|NCT01124097|157396119|FG002|Overall Study|Lack of Efficacy|1|||
48879025|NCT01124097|157396120|FG003|Overall Study|Lack of Efficacy|3|||
48879026|NCT01124097|157396117|FG000|Overall Study|Adverse Event|24|||
48879027|NCT01124097|157396118|FG001|Overall Study|Adverse Event|15|||
48879028|NCT01124097|157396119|FG002|Overall Study|Adverse Event|15|||
48879029|NCT01124097|157396120|FG003|Overall Study|Adverse Event|7|||
48879030|NCT01124097|157396117|FG000|Overall Study|Protocol Violation|2|||
48879031|NCT01124097|157396118|FG001|Overall Study|Protocol Violation|0|||
48879032|NCT01124097|157396119|FG002|Overall Study|Protocol Violation|2|||
48879033|NCT01124097|157396120|FG003|Overall Study|Protocol Violation|1|||
48879034|NCT01124097|157396117|FG000|Overall Study|Physician Decision|2|||
48879035|NCT01124097|157396118|FG001|Overall Study|Physician Decision|1|||
48879036|NCT01124097|157396119|FG002|Overall Study|Physician Decision|0|||
48879037|NCT01124097|157396120|FG003|Overall Study|Physician Decision|0|||
48879038|NCT02960893|157396121|FG000|Randomization Phase (8-week)|Adverse Event|5|||
48879039|NCT02960893|157396122|FG001|Randomization Phase (8-week)|Adverse Event|0|||
48879040|NCT02960893|157396121|FG000|Randomization Phase (8-week)|Withdrawal by Subject|2|||
48879041|NCT02960893|157396122|FG001|Randomization Phase (8-week)|Withdrawal by Subject|1|||
48879042|NCT02960893|157396121|FG000|Randomization Phase (8-week)|Reason Not Specified|0|||
48879043|NCT02960893|157396122|FG001|Randomization Phase (8-week)|Reason Not Specified|1|||
48879044|NCT02960893|157396121|FG000|Extension Phase (48-week)|Adverse Event|2|||
48879045|NCT02960893|157396122|FG001|Extension Phase (48-week)|Adverse Event|3|||
48879046|NCT02960893|157396121|FG000|Extension Phase (48-week)|Withdrawal by Subject|8|||
48879047|NCT02960893|157396122|FG001|Extension Phase (48-week)|Withdrawal by Subject|8|||
48879048|NCT02960893|157396121|FG000|Extension Phase (48-week)|Other Reason|2|||
48879049|NCT02960893|157396122|FG001|Extension Phase (48-week)|Other Reason|1|||
48879050|NCT02960893|157396121|FG000|Extension Phase (48-week)|Lost to Follow-up|1|||
48879051|NCT02960893|157396122|FG001|Extension Phase (48-week)|Lost to Follow-up|1|||
48879052|NCT02960893|157396121|FG000|Extension Phase (48-week)|Sponsors Decision|1|||
48879053|NCT02960893|157396122|FG001|Extension Phase (48-week)|Sponsors Decision|0|||
48879054|NCT02786004|157396123|FG000|Overall Study|Withdrawal by Subject|0|||
48879055|NCT02786004|157396124|FG001|Overall Study|Withdrawal by Subject|1|||
48879056|NCT01677299|157396125|FG000|Overall Study|Adverse Event|0|||
48879057|NCT01677299|157396126|FG001|Overall Study|Adverse Event|2|||
48879058|NCT01677299|157396127|FG002|Overall Study|Adverse Event|1|||
48879059|NCT01677299|157396128|FG003|Overall Study|Adverse Event|0|||
48879060|NCT01677299|157396125|FG000|Overall Study|Withdrawal by Subject|0|||
48879061|NCT01677299|157396126|FG001|Overall Study|Withdrawal by Subject|1|||
48879062|NCT01677299|157396127|FG002|Overall Study|Withdrawal by Subject|0|||
48879063|NCT01677299|157396128|FG003|Overall Study|Withdrawal by Subject|1|||
48879064|NCT00126659|157396131|FG000|Overall Study|Adverse Event|0|||
48879065|NCT00126659|157396132|FG001|Overall Study|Adverse Event|0|||
48879066|NCT00126659|157396133|FG002|Overall Study|Adverse Event|2|||
48879067|NCT01437423|157396136|FG000|Overall Study|Lost to Follow-up|12|||
48879068|NCT01437423|157396136|FG000|Overall Study|Off label usage|3|||
48879069|NCT02552147|157396141|FG000|First Intervention (7 Days)|Protocol Violation|1|||
48879070|NCT02552147|157396142|FG001|First Intervention (7 Days)|Protocol Violation|0|||
48879071|NCT02552147|157396141|FG000|Second Intervention (7 Days)|Protocol Violation|2|||
48879072|NCT02552147|157396142|FG001|Second Intervention (7 Days)|Protocol Violation|0|||
48879073|NCT00425607|157396147|FG000|Overall Study|Death|1|||
48879074|NCT00425607|157396147|FG000|Overall Study|Withdrawal by Subject|1|||
48879075|NCT00079339|157396148|FG000|Overall Study|Adverse Event|1|||
48879076|NCT00079339|157396149|FG001|Overall Study|Adverse Event|7|||
48879077|NCT00079339|157396150|FG002|Overall Study|Adverse Event|2|||
48879078|NCT00079339|157396148|FG000|Overall Study|Death|1|||
48879079|NCT00079339|157396149|FG001|Overall Study|Death|0|||
48879080|NCT00079339|157396150|FG002|Overall Study|Death|0|||
48879081|NCT00079339|157396148|FG000|Overall Study|Non-compliance|0|||
48879082|NCT00079339|157396149|FG001|Overall Study|Non-compliance|0|||
48879083|NCT00079339|157396150|FG002|Overall Study|Non-compliance|1|||
48879084|NCT00079339|157396148|FG000|Overall Study|Withdrawal by Subject|0|||
48879085|NCT00079339|157396149|FG001|Overall Study|Withdrawal by Subject|4|||
48879086|NCT00079339|157396150|FG002|Overall Study|Withdrawal by Subject|1|||
48879087|NCT00079339|157396148|FG000|Overall Study|Disease progression|3|||
48879088|NCT00079339|157396149|FG001|Overall Study|Disease progression|28|||
48879089|NCT00079339|157396150|FG002|Overall Study|Disease progression|2|||
48879090|NCT02229578|157396151|FG000|Overall Study|Withdrawal by Subject|1|||
48879091|NCT02229578|157396152|FG001|Overall Study|Withdrawal by Subject|3|||
48879092|NCT02229578|157396151|FG000|Overall Study|Protocol Violation|2|||
48879093|NCT02229578|157396152|FG001|Overall Study|Protocol Violation|0|||
48879094|NCT00940875|157396154|FG000|Treatment Phase|Adverse Event|9|||
48879095|NCT00940875|157396155|FG001|Treatment Phase|Adverse Event|3|||
48879096|NCT00940875|157396154|FG000|Treatment Phase|Death|3|||
48879097|NCT00940875|157396155|FG001|Treatment Phase|Death|5|||
48879098|NCT00940875|157396154|FG000|Treatment Phase|Lack of Efficacy|1|||
48879099|NCT00940875|157396155|FG001|Treatment Phase|Lack of Efficacy|0|||
48879100|NCT00940875|157396154|FG000|Treatment Phase|Withdrawal by Subject|3|||
48879101|NCT00940875|157396155|FG001|Treatment Phase|Withdrawal by Subject|0|||
48879102|NCT00940875|157396154|FG000|Treatment Phase|Disease progression|9|||
48879103|NCT00940875|157396155|FG001|Treatment Phase|Disease progression|11|||
48879104|NCT00940875|157396154|FG000|Treatment Phase|Physician Decision|1|||
48879105|NCT00940875|157396155|FG001|Treatment Phase|Physician Decision|0|||
48879106|NCT00940875|157396154|FG000|Post-Study Treatment|Death|0|||
48879107|NCT00940875|157396155|FG001|Post-Study Treatment|Death|1|||
48879108|NCT00940875|157396154|FG000|Post-Study Treatment|Disease Progression|0|||
48879109|NCT00940875|157396155|FG001|Post-Study Treatment|Disease Progression|2|||
48879110|NCT01288209|157396159|FG000|Overall Study|Withdrawal by Subject|1|||
48879111|NCT01288209|157396160|FG001|Overall Study|Withdrawal by Subject|3|||
48879112|NCT01288209|157396159|FG000|Overall Study|Other|1|||
48879113|NCT01288209|157396160|FG001|Overall Study|Other|0|||
48879114|NCT03334253|157396162|FG000|Overall Study|Withdrawal by Subject|1|||
48879115|NCT03334253|157396163|FG001|Overall Study|Withdrawal by Subject|0|||
48879116|NCT03334253|157396162|FG000|Overall Study|Lost to Follow-up|4|||
48879117|NCT03334253|157396163|FG001|Overall Study|Lost to Follow-up|3|||
48879118|NCT03334253|157396162|FG000|Overall Study|Moved residence|2|||
48879119|NCT03334253|157396163|FG001|Overall Study|Moved residence|2|||
48879120|NCT01516749|157396165|FG000|Active Therapy|Lost to Follow-up|1|||
48879121|NCT01516749|157396165|FG000|Follow-up Off Therapy|Lost to Follow-up|1|||
48879122|NCT00351377|157396166|FG000|Overall Study|Adverse Event|5|||
48879123|NCT00351377|157396166|FG000|Overall Study|Death|1|||
48879124|NCT00351377|157396166|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
48879125|NCT00731133|157396167|FG000|Overall Study|Withdrawal by Subject|10|||
48879126|NCT03809039|157396168|FG000|Part 1|Withdrawal by Subject|1|||
48879127|NCT03809039|157396169|FG001|Part 1|Withdrawal by Subject|0|||
48879128|NCT03809039|157396170|FG002|Part 1|Withdrawal by Subject|0|||
48879129|NCT03809039|157396171|FG003|Part 1|Withdrawal by Subject|1|||
48879130|NCT03809039|157396172|FG004|Part 1|Withdrawal by Subject|0|||
48879131|NCT03809039|157396173|FG005|Part 1|Withdrawal by Subject|0|||
48879132|NCT03809039|157396174|FG006|Part 1|Withdrawal by Subject|0|||
48879133|NCT03809039|157396175|FG007|Part 1|Withdrawal by Subject|0|||
48879134|NCT03809039|157396176|FG008|Part 1|Withdrawal by Subject|0|||
48879135|NCT03809039|157396168|FG000|Part 3|Withdrawn by study termination|0|||
48879136|NCT03809039|157396169|FG001|Part 3|Withdrawn by study termination|0|||
48879137|NCT03809039|157396170|FG002|Part 3|Withdrawn by study termination|0|||
48879138|NCT03809039|157396171|FG003|Part 3|Withdrawn by study termination|0|||
48879139|NCT03809039|157396172|FG004|Part 3|Withdrawn by study termination|0|||
49033359|NCT03181594|157956914|FG000|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3|||
49033360|NCT03181594|157956914|FG000|Initial Study Protocol (12-month FU)|Physician Decision|1|||
49033361|NCT03181594|157956914|FG000|Initial Study Protocol (12-month FU)|Death|1|||
48879140|NCT03809039|157396173|FG005|Part 3|Withdrawn by study termination|0|||
48879141|NCT03809039|157396174|FG006|Part 3|Withdrawn by study termination|0|||
48879142|NCT03809039|157396175|FG007|Part 3|Withdrawn by study termination|2|||
48879143|NCT03809039|157396176|FG008|Part 3|Withdrawn by study termination|6|||
48879144|NCT01790295|157396177|FG000|Overall Study|Adverse Event|1|||
48879145|NCT01790295|157396177|FG000|Overall Study|Death|4|||
48879146|NCT01790295|157396177|FG000|Overall Study|Lack of Efficacy|2|||
48879147|NCT01790295|157396177|FG000|Overall Study|Study closure|4|||
49033362|NCT03181594|157956914|FG000|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3|||
48879148|NCT01327612|157396178|FG000|Overall Study|Withdrawal by Subject|0|||
48879149|NCT01327612|157396179|FG001|Overall Study|Withdrawal by Subject|0|||
48879150|NCT01327612|157396180|FG002|Overall Study|Withdrawal by Subject|0|||
48879151|NCT01327612|157396181|FG003|Overall Study|Withdrawal by Subject|0|||
48879152|NCT01327612|157396182|FG004|Overall Study|Withdrawal by Subject|0|||
48879153|NCT01327612|157396183|FG005|Overall Study|Withdrawal by Subject|1|||
48879154|NCT01327612|157396184|FG006|Overall Study|Withdrawal by Subject|0|||
48879155|NCT01327612|157396178|FG000|Overall Study|Disease Progression|1|||
48879156|NCT01327612|157396179|FG001|Overall Study|Disease Progression|1|||
48879157|NCT01327612|157396180|FG002|Overall Study|Disease Progression|1|||
49033363|NCT03181594|157956914|FG000|Long-term Extension (15-24 Month FU)|Death|2|||
48879158|NCT01327612|157396181|FG003|Overall Study|Disease Progression|0|||
48879159|NCT01327612|157396182|FG004|Overall Study|Disease Progression|1|||
48879160|NCT01327612|157396183|FG005|Overall Study|Disease Progression|2|||
48879161|NCT01327612|157396184|FG006|Overall Study|Disease Progression|2|||
48879162|NCT01327612|157396178|FG000|Overall Study|Administrative Decision|0|||
48879163|NCT01327612|157396179|FG001|Overall Study|Administrative Decision|0|||
48879164|NCT01327612|157396180|FG002|Overall Study|Administrative Decision|0|||
48879165|NCT01327612|157396181|FG003|Overall Study|Administrative Decision|1|||
48879166|NCT01327612|157396182|FG004|Overall Study|Administrative Decision|0|||
48879167|NCT01327612|157396183|FG005|Overall Study|Administrative Decision|0|||
48879168|NCT01327612|157396184|FG006|Overall Study|Administrative Decision|0|||
48879169|NCT01327612|157396178|FG000|Overall Study|Death|0|||
48879170|NCT01327612|157396179|FG001|Overall Study|Death|0|||
48879171|NCT01327612|157396180|FG002|Overall Study|Death|0|||
48879172|NCT01327612|157396181|FG003|Overall Study|Death|0|||
48879173|NCT01327612|157396182|FG004|Overall Study|Death|1|||
48879174|NCT01327612|157396183|FG005|Overall Study|Death|0|||
49033364|NCT00678639|157956924|FG000|Overall Study|Lost to Follow-up at 30 days|2|||
49033365|NCT00678639|157956925|FG001|Overall Study|Lost to Follow-up at 30 days|0|||
48796239|NCT02975973|157091501|FG002|Overall Study|Adverse Event|1|||
48796240|NCT02975973|157091502|FG003|Overall Study|Adverse Event|0|||
48796241|NCT00675766|157091507|FG000|Overall Study|Lost to Follow-up|6|||
48796242|NCT00675766|157091508|FG001|Overall Study|Lost to Follow-up|5|||
48796243|NCT00675766|157091509|FG002|Overall Study|Lost to Follow-up|21|||
48796244|NCT00675766|157091510|FG003|Overall Study|Lost to Follow-up|26|||
48796245|NCT02515279|157091511|FG000|Overall Study|Adverse Event|7|||
48796246|NCT02515279|157091511|FG000|Overall Study|Lack of Efficacy|31|||
48796247|NCT02515279|157091511|FG000|Overall Study|Lost to Follow-up|9|||
48796248|NCT02515279|157091511|FG000|Overall Study|Withdrawal by Subject|18|||
48796249|NCT02515279|157091511|FG000|Overall Study|End-of-treatment visit not attended|17|||
48796250|NCT02515279|157091511|FG000|Overall Study|Other|22|||
48796251|NCT03583554|157091512|FG000|Period 2|Did not receive treatment due to loss of contact|1|||
48796252|NCT03583554|157091513|FG001|Period 2|Did not receive treatment due to loss of contact|0|||
48796253|NCT03583554|157091514|FG002|Period 2|Did not receive treatment due to loss of contact|1|||
48796254|NCT01800968|157091516|FG000|Overall Study|Death|23|||
48796255|NCT01800968|157091517|FG001|Overall Study|Death|16|||
48796256|NCT01800968|157091516|FG000|Overall Study|Lost to Follow-up|5|||
48796257|NCT01800968|157091517|FG001|Overall Study|Lost to Follow-up|7|||
48796258|NCT01800968|157091516|FG000|Overall Study|Withdrawal by Subject|7|||
48796259|NCT01800968|157091517|FG001|Overall Study|Withdrawal by Subject|9|||
48796260|NCT01800968|157091516|FG000|Overall Study|Physician Decision|1|||
48796261|NCT01800968|157091517|FG001|Overall Study|Physician Decision|0|||
48796262|NCT02472964|157091518|FG000|Part 1 (up to Week 24)|Adverse Event|2|||
48796263|NCT02472964|157091519|FG001|Part 1 (up to Week 24)|Adverse Event|4|||
48796264|NCT02472964|157091518|FG000|Part 1 (up to Week 24)|disease progression|58|||
48796265|NCT02472964|157091519|FG001|Part 1 (up to Week 24)|disease progression|47|||
48796266|NCT02472964|157091518|FG000|Part 1 (up to Week 24)|Death|3|||
48796267|NCT02472964|157091519|FG001|Part 1 (up to Week 24)|Death|6|||
48796268|NCT02472964|157091518|FG000|Part 1 (up to Week 24)|Physician Decision|3|||
48796269|NCT02472964|157091519|FG001|Part 1 (up to Week 24)|Physician Decision|1|||
48796270|NCT02472964|157091518|FG000|Part 1 (up to Week 24)|Lost to Follow-up|0|||
48796271|NCT02472964|157091519|FG001|Part 1 (up to Week 24)|Lost to Follow-up|1|||
48796272|NCT02472964|157091518|FG000|Part 1 (up to Week 24)|Withdrawal by Subject|7|||
48796273|NCT02472964|157091519|FG001|Part 1 (up to Week 24)|Withdrawal by Subject|2|||
48796274|NCT02472964|157091518|FG000|Part 1 (up to Week 24)|Other|2|||
48796275|NCT02472964|157091519|FG001|Part 1 (up to Week 24)|Other|1|||
48796276|NCT02472964|157091518|FG000|Part 2 (Week 24-week 48)|Adverse Event|4|||
48796277|NCT02472964|157091519|FG001|Part 2 (Week 24-week 48)|Adverse Event|2|||
48796278|NCT02472964|157091518|FG000|Part 2 (Week 24-week 48)|Disease Progression|52|||
48796279|NCT02472964|157091519|FG001|Part 2 (Week 24-week 48)|Disease Progression|56|||
48796280|NCT02472964|157091518|FG000|Part 2 (Week 24-week 48)|Death|0|||
48796281|NCT02472964|157091519|FG001|Part 2 (Week 24-week 48)|Death|1|||
48796282|NCT02472964|157091518|FG000|Part 2 (Week 24-week 48)|Physician Decision|1|||
48796283|NCT02472964|157091519|FG001|Part 2 (Week 24-week 48)|Physician Decision|1|||
48796284|NCT02472964|157091518|FG000|Part 2 (Week 24-week 48)|Lost to Follow-up|2|||
48796285|NCT02472964|157091519|FG001|Part 2 (Week 24-week 48)|Lost to Follow-up|1|||
48796286|NCT02472964|157091518|FG000|Part 2 (Week 24-week 48)|Withdrawal by Subject|3|||
48796287|NCT02472964|157091519|FG001|Part 2 (Week 24-week 48)|Withdrawal by Subject|1|||
48796288|NCT02472964|157091518|FG000|Part 2 (Week 24-week 48)|Protocol Violation|3|||
48796289|NCT02472964|157091519|FG001|Part 2 (Week 24-week 48)|Protocol Violation|1|||
48796290|NCT00322348|157091530|FG000|Overall Study|Adverse Event|0|||
48796291|NCT00322348|157091531|FG001|Overall Study|Adverse Event|1|||
48796292|NCT00322348|157091530|FG000|Overall Study|Withdrawal by Subject|1|||
48796293|NCT00322348|157091531|FG001|Overall Study|Withdrawal by Subject|4|||
48796294|NCT00322348|157091530|FG000|Overall Study|Lost to Follow-up|1|||
48879175|NCT01327612|157396184|FG006|Overall Study|Death|0|||
48879176|NCT01843777|157396187|FG000|Overall Study|Withdrawal by Subject|1|||
48879177|NCT01843777|157396188|FG001|Overall Study|Withdrawal by Subject|0|||
48879178|NCT01199068|157396193|FG000|Overall Study|Unacceptable toxicity|0|||
48879179|NCT01199068|157396194|FG001|Overall Study|Unacceptable toxicity|0|||
48879180|NCT01199068|157396195|FG002|Overall Study|Unacceptable toxicity|2|||
48879181|NCT01199068|157396193|FG000|Overall Study|Progressive disease|3|||
48879182|NCT01199068|157396194|FG001|Overall Study|Progressive disease|3|||
48879183|NCT01199068|157396195|FG002|Overall Study|Progressive disease|6|||
48879184|NCT01199068|157396193|FG000|Overall Study|Withdrawal by Subject|0|||
48879185|NCT01199068|157396194|FG001|Overall Study|Withdrawal by Subject|0|||
48879186|NCT01199068|157396195|FG002|Overall Study|Withdrawal by Subject|1|||
48879187|NCT01967069|157396196|FG000|Overall Study|Adverse Event|2|||
48879188|NCT01967069|157396197|FG001|Overall Study|Adverse Event|2|||
48879189|NCT01967069|157396196|FG000|Overall Study|Lost to Follow-up|5|||
48879190|NCT01967069|157396197|FG001|Overall Study|Lost to Follow-up|2|||
48879191|NCT01967069|157396196|FG000|Overall Study|Withdrawal by Subject|1|||
48879192|NCT01967069|157396197|FG001|Overall Study|Withdrawal by Subject|3|||
48879193|NCT01967069|157396196|FG000|Overall Study|Lack of Efficacy|0|||
48879194|NCT01967069|157396197|FG001|Overall Study|Lack of Efficacy|1|||
48879195|NCT01475461|157396199|FG000|Run-in Period|Not meet eligibility criteria|16|||
48879196|NCT01475461|157396200|FG001|Run-in Period|Not meet eligibility criteria|0|||
48879197|NCT01475461|157396201|FG002|Run-in Period|Not meet eligibility criteria|0|||
48879198|NCT01475461|157396202|FG003|Run-in Period|Not meet eligibility criteria|0|||
48879199|NCT01475461|157396203|FG004|Run-in Period|Not meet eligibility criteria|0|||
48879200|NCT01475461|157396204|FG005|Run-in Period|Not meet eligibility criteria|0|||
48879201|NCT01475461|157396205|FG006|Run-in Period|Not meet eligibility criteria|0|||
48879202|NCT01475461|157396199|FG000|Run-in Period|Lost to Follow-up|7|||
48879203|NCT01475461|157396200|FG001|Run-in Period|Lost to Follow-up|0|||
48879204|NCT01475461|157396201|FG002|Run-in Period|Lost to Follow-up|0|||
48879205|NCT01475461|157396202|FG003|Run-in Period|Lost to Follow-up|0|||
48879206|NCT01475461|157396203|FG004|Run-in Period|Lost to Follow-up|0|||
48879207|NCT01475461|157396204|FG005|Run-in Period|Lost to Follow-up|0|||
48879208|NCT01475461|157396205|FG006|Run-in Period|Lost to Follow-up|0|||
48879209|NCT01475461|157396199|FG000|Run-in Period|Withdrawal by Subject|11|||
48879210|NCT01475461|157396200|FG001|Run-in Period|Withdrawal by Subject|0|||
48879211|NCT01475461|157396201|FG002|Run-in Period|Withdrawal by Subject|0|||
48879212|NCT01475461|157396202|FG003|Run-in Period|Withdrawal by Subject|0|||
48879213|NCT01475461|157396203|FG004|Run-in Period|Withdrawal by Subject|0|||
48879214|NCT01475461|157396204|FG005|Run-in Period|Withdrawal by Subject|0|||
48879215|NCT01475461|157396205|FG006|Run-in Period|Withdrawal by Subject|0|||
48879216|NCT01475461|157396199|FG000|Run-in Period|Other|3|||
48879217|NCT01475461|157396200|FG001|Run-in Period|Other|0|||
48879218|NCT01475461|157396201|FG002|Run-in Period|Other|0|||
48879219|NCT01475461|157396202|FG003|Run-in Period|Other|0|||
48879220|NCT01475461|157396203|FG004|Run-in Period|Other|0|||
48879221|NCT01475461|157396204|FG005|Run-in Period|Other|0|||
48879222|NCT01475461|157396205|FG006|Run-in Period|Other|0|||
48879223|NCT01475461|157396199|FG000|Run-in Period|Protocol Violation|4|||
48879224|NCT01475461|157396200|FG001|Run-in Period|Protocol Violation|0|||
48879225|NCT01475461|157396201|FG002|Run-in Period|Protocol Violation|0|||
48879226|NCT01475461|157396202|FG003|Run-in Period|Protocol Violation|0|||
48879227|NCT01475461|157396203|FG004|Run-in Period|Protocol Violation|0|||
48879228|NCT01475461|157396204|FG005|Run-in Period|Protocol Violation|0|||
48879229|NCT01475461|157396205|FG006|Run-in Period|Protocol Violation|0|||
48879230|NCT01475461|157396199|FG000|Treatment Period|Death|0|||
48879231|NCT01475461|157396200|FG001|Treatment Period|Death|0|||
48879232|NCT01475461|157396201|FG002|Treatment Period|Death|0|||
48879233|NCT01475461|157396202|FG003|Treatment Period|Death|1|||
48879234|NCT01475461|157396203|FG004|Treatment Period|Death|0|||
48879235|NCT01475461|157396204|FG005|Treatment Period|Death|0|||
48879236|NCT01475461|157396205|FG006|Treatment Period|Death|0|||
48879237|NCT01475461|157396199|FG000|Treatment Period|Lost to Follow-up|0|||
48879238|NCT01475461|157396200|FG001|Treatment Period|Lost to Follow-up|3|||
48879239|NCT01475461|157396201|FG002|Treatment Period|Lost to Follow-up|2|||
48879240|NCT01475461|157396202|FG003|Treatment Period|Lost to Follow-up|3|||
48879241|NCT01475461|157396203|FG004|Treatment Period|Lost to Follow-up|1|||
48879242|NCT01475461|157396204|FG005|Treatment Period|Lost to Follow-up|2|||
48879243|NCT01475461|157396205|FG006|Treatment Period|Lost to Follow-up|1|||
48879244|NCT01475461|157396199|FG000|Treatment Period|Withdrawal by Subject|0|||
48879245|NCT01475461|157396200|FG001|Treatment Period|Withdrawal by Subject|2|||
48879246|NCT01475461|157396201|FG002|Treatment Period|Withdrawal by Subject|2|||
48879247|NCT01475461|157396202|FG003|Treatment Period|Withdrawal by Subject|0|||
48879248|NCT01475461|157396203|FG004|Treatment Period|Withdrawal by Subject|2|||
48879249|NCT01475461|157396204|FG005|Treatment Period|Withdrawal by Subject|2|||
48879250|NCT01475461|157396205|FG006|Treatment Period|Withdrawal by Subject|0|||
48879251|NCT01475461|157396199|FG000|Treatment Period|Other|0|||
48879252|NCT01475461|157396200|FG001|Treatment Period|Other|1|||
48879253|NCT01475461|157396201|FG002|Treatment Period|Other|0|||
48879254|NCT01475461|157396202|FG003|Treatment Period|Other|0|||
48879255|NCT01475461|157396203|FG004|Treatment Period|Other|0|||
48879256|NCT01475461|157396204|FG005|Treatment Period|Other|0|||
48879257|NCT01475461|157396205|FG006|Treatment Period|Other|0|||
48879258|NCT01475461|157396199|FG000|Treatment Period|Protocol Violation|0|||
48879259|NCT01475461|157396200|FG001|Treatment Period|Protocol Violation|1|||
48879260|NCT01475461|157396201|FG002|Treatment Period|Protocol Violation|0|||
48879261|NCT01475461|157396202|FG003|Treatment Period|Protocol Violation|0|||
48879262|NCT01475461|157396203|FG004|Treatment Period|Protocol Violation|0|||
48879263|NCT01475461|157396204|FG005|Treatment Period|Protocol Violation|0|||
48879264|NCT01475461|157396205|FG006|Treatment Period|Protocol Violation|1|||
48879265|NCT01475461|157396199|FG000|Treatment Period|Lack of Efficacy|0|||
48879266|NCT01475461|157396200|FG001|Treatment Period|Lack of Efficacy|2|||
48879267|NCT01475461|157396201|FG002|Treatment Period|Lack of Efficacy|0|||
48879268|NCT01475461|157396202|FG003|Treatment Period|Lack of Efficacy|2|||
48879269|NCT01475461|157396203|FG004|Treatment Period|Lack of Efficacy|1|||
48879270|NCT01475461|157396204|FG005|Treatment Period|Lack of Efficacy|1|||
48879271|NCT01475461|157396205|FG006|Treatment Period|Lack of Efficacy|0|||
48879272|NCT01475461|157396199|FG000|Treatment Period|Medication Error|0|||
48879273|NCT01475461|157396200|FG001|Treatment Period|Medication Error|0|||
48879274|NCT01475461|157396201|FG002|Treatment Period|Medication Error|0|||
48879275|NCT01475461|157396202|FG003|Treatment Period|Medication Error|1|||
48879276|NCT01475461|157396203|FG004|Treatment Period|Medication Error|0|||
48879277|NCT01475461|157396204|FG005|Treatment Period|Medication Error|0|||
48879278|NCT01475461|157396205|FG006|Treatment Period|Medication Error|0|||
48879279|NCT01475461|157396199|FG000|Treatment Period|Adverse Event|0|||
48879280|NCT01475461|157396200|FG001|Treatment Period|Adverse Event|0|||
48879281|NCT01475461|157396201|FG002|Treatment Period|Adverse Event|0|||
48879282|NCT01475461|157396202|FG003|Treatment Period|Adverse Event|1|||
48879283|NCT01475461|157396203|FG004|Treatment Period|Adverse Event|0|||
48879284|NCT01475461|157396204|FG005|Treatment Period|Adverse Event|0|||
48879285|NCT01475461|157396205|FG006|Treatment Period|Adverse Event|0|||
48879286|NCT00420784|157396206|FG000|Overall Study|Adverse Event|11|||
48879287|NCT00420784|157396207|FG001|Overall Study|Adverse Event|29|||
48879288|NCT00420784|157396208|FG002|Overall Study|Adverse Event|10|||
48879289|NCT00420784|157396209|FG003|Overall Study|Adverse Event|5|||
48879290|NCT00420784|157396206|FG000|Overall Study|Withdrawal by Subject|0|||
48879291|NCT00420784|157396207|FG001|Overall Study|Withdrawal by Subject|1|||
48879292|NCT00420784|157396208|FG002|Overall Study|Withdrawal by Subject|0|||
48879293|NCT00420784|157396209|FG003|Overall Study|Withdrawal by Subject|0|||
48879294|NCT00420784|157396206|FG000|Overall Study|Lost to Follow-up|0|||
48879295|NCT00420784|157396207|FG001|Overall Study|Lost to Follow-up|0|||
48879296|NCT00420784|157396208|FG002|Overall Study|Lost to Follow-up|2|||
48879297|NCT00420784|157396209|FG003|Overall Study|Lost to Follow-up|1|||
48879298|NCT00420784|157396206|FG000|Overall Study|Virologic Stopping Rule|17|||
48879299|NCT00420784|157396207|FG001|Overall Study|Virologic Stopping Rule|26|||
48879300|NCT00420784|157396208|FG002|Overall Study|Virologic Stopping Rule|41|||
48879301|NCT00420784|157396209|FG003|Overall Study|Virologic Stopping Rule|67|||
48879302|NCT00420784|157396206|FG000|Overall Study|Other|1|||
48879303|NCT00420784|157396207|FG001|Overall Study|Other|2|||
48879304|NCT00420784|157396208|FG002|Overall Study|Other|0|||
48879305|NCT00420784|157396209|FG003|Overall Study|Other|5|||
48879306|NCT00992992|157396212|FG000|Overall Study|Lost to Follow-up|3|||
48879307|NCT00992992|157396212|FG000|Overall Study|Death|16|||
48879308|NCT00992992|157396212|FG000|Overall Study|GlaxoSmithKline Closed the Study|2|||
48879309|NCT00992992|157396212|FG000|Overall Study|Sponsor Closed the Study|4|||
48879310|NCT01304498|157396213|FG000|Overall Study|Adverse Event|1|||
48879311|NCT01304498|157396214|FG001|Overall Study|Adverse Event|1|||
48879312|NCT01304498|157396213|FG000|Overall Study|Withdrawal by Subject|2|||
48879313|NCT01304498|157396214|FG001|Overall Study|Withdrawal by Subject|3|||
48879314|NCT01304498|157396213|FG000|Overall Study|Protocol Violation|1|||
48879315|NCT01304498|157396214|FG001|Overall Study|Protocol Violation|0|||
48879316|NCT01304498|157396213|FG000|Overall Study|Lost to Follow-up|2|||
48879317|NCT01304498|157396214|FG001|Overall Study|Lost to Follow-up|1|||
48879318|NCT00839956|157396216|FG000|Overall Study|Adverse Event|2|||
48879319|NCT00839956|157396216|FG000|Overall Study|Lack of Efficacy|6|||
48879320|NCT00839956|157396216|FG000|Overall Study|Physician Decision|1|||
48879321|NCT00839956|157396216|FG000|Overall Study|Withdrawal by Subject|3|||
48879322|NCT00935532|157396217|FG000|Overall Study|Adverse Event|11|||
48879323|NCT00935532|157396218|FG001|Overall Study|Adverse Event|6|||
48879324|NCT00935532|157396217|FG000|Overall Study|Death|1|||
48879325|NCT00935532|157396218|FG001|Overall Study|Death|0|||
48879326|NCT00935532|157396217|FG000|Overall Study|Lost to Follow-up|1|||
48879327|NCT00935532|157396218|FG001|Overall Study|Lost to Follow-up|0|||
48879328|NCT00935532|157396217|FG000|Overall Study|Physician Decision|1|||
48879329|NCT00935532|157396218|FG001|Overall Study|Physician Decision|2|||
48879330|NCT00935532|157396217|FG000|Overall Study|Protocol Violation|2|||
48879331|NCT00935532|157396218|FG001|Overall Study|Protocol Violation|1|||
48879332|NCT00935532|157396217|FG000|Overall Study|Subject Decision|2|||
48879333|NCT00935532|157396218|FG001|Overall Study|Subject Decision|1|||
48879334|NCT00935532|157396217|FG000|Overall Study|Sponsor Decision|0|||
48879335|NCT00935532|157396218|FG001|Overall Study|Sponsor Decision|1|||
48879336|NCT00935532|157396217|FG000|Overall Study|Loss Glucose Control|4|||
48879337|NCT00935532|157396218|FG001|Overall Study|Loss Glucose Control|0|||
48879338|NCT00402051|157396219|FG000|Overall Study|Progressive Disease|13|||
48879339|NCT00402051|157396220|FG001|Overall Study|Progressive Disease|20|||
48879340|NCT00402051|157396219|FG000|Overall Study|Adverse Event|11|||
48879341|NCT00402051|157396220|FG001|Overall Study|Adverse Event|4|||
48879342|NCT00402051|157396219|FG000|Overall Study|Physician Decision|7|||
48879343|NCT00402051|157396220|FG001|Overall Study|Physician Decision|3|||
48879344|NCT00402051|157396219|FG000|Overall Study|Withdrawal by Subject|3|||
48879345|NCT00402051|157396220|FG001|Overall Study|Withdrawal by Subject|3|||
48879346|NCT00402051|157396219|FG000|Overall Study|Death - Related to Study Drug|1|||
48879347|NCT00402051|157396220|FG001|Overall Study|Death - Related to Study Drug|2|||
48879348|NCT00402051|157396219|FG000|Overall Study|Death Due to Study Disease|2|||
48879349|NCT00402051|157396220|FG001|Overall Study|Death Due to Study Disease|1|||
48879350|NCT00402051|157396219|FG000|Overall Study|Death Due to Adverse Event|0|||
48879351|NCT00402051|157396220|FG001|Overall Study|Death Due to Adverse Event|2|||
48879352|NCT00402051|157396219|FG000|Overall Study|Lost to Follow-up|1|||
48879353|NCT00402051|157396220|FG001|Overall Study|Lost to Follow-up|0|||
48879354|NCT04954326|157396227|FG000|Overall Study|Protocol Violation|0|||
48879355|NCT04954326|157396228|FG001|Overall Study|Protocol Violation|1|||
48879356|NCT04954326|157396227|FG000|Overall Study|Death|0|||
48879357|NCT04954326|157396228|FG001|Overall Study|Death|2|||
48879358|NCT04954326|157396227|FG000|Overall Study|Physician Decision|0|||
48879359|NCT04954326|157396228|FG001|Overall Study|Physician Decision|1|||
48879360|NCT00281320|157396229|FG000|Overall Study|Adverse Event|12|||
48879361|NCT00281320|157396230|FG001|Overall Study|Adverse Event|9|||
48879362|NCT00281320|157396229|FG000|Overall Study|Lack of Efficacy|4|||
48879363|NCT00281320|157396230|FG001|Overall Study|Lack of Efficacy|3|||
48879364|NCT00281320|157396229|FG000|Overall Study|Withdrawal by Subject|5|||
48879365|NCT00281320|157396230|FG001|Overall Study|Withdrawal by Subject|6|||
48879366|NCT00281320|157396229|FG000|Overall Study|Lost to Follow-up|1|||
48879367|NCT00281320|157396230|FG001|Overall Study|Lost to Follow-up|2|||
48879368|NCT00281320|157396229|FG000|Overall Study|Other|3|||
48879369|NCT00281320|157396230|FG001|Overall Study|Other|1|||
48879370|NCT00798434|157396231|FG000|Double-Blind|Adverse Event|22|||
48879371|NCT00798434|157396232|FG001|Double-Blind|Adverse Event|46|||
48879372|NCT00798434|157396231|FG000|Double-Blind|Death|0|||
48879373|NCT00798434|157396232|FG001|Double-Blind|Death|1|||
48879374|NCT00798434|157396231|FG000|Double-Blind|Lost to Follow-up|1|||
48879375|NCT00798434|157396232|FG001|Double-Blind|Lost to Follow-up|0|||
48879376|NCT00798434|157396231|FG000|Double-Blind|Lack of Efficacy|8|||
48879377|NCT00798434|157396232|FG001|Double-Blind|Lack of Efficacy|12|||
48879378|NCT00798434|157396231|FG000|Double-Blind|Withdrawal by Subject|17|||
48879379|NCT00798434|157396232|FG001|Double-Blind|Withdrawal by Subject|14|||
48879380|NCT00798434|157396231|FG000|Double-Blind|Protocol Violation|1|||
48879381|NCT00798434|157396232|FG001|Double-Blind|Protocol Violation|4|||
48879382|NCT00798434|157396231|FG000|Double-Blind|Did Not Meet Entrance Criteria|2|||
48879383|NCT00798434|157396232|FG001|Double-Blind|Did Not Meet Entrance Criteria|1|||
48879384|NCT00798434|157396231|FG000|Double-Blind|Other|1|||
48879385|NCT00798434|157396232|FG001|Double-Blind|Other|0|||
48879386|NCT00798434|157396231|FG000|Double-Blind|Not Treated|3|||
48879387|NCT00798434|157396232|FG001|Double-Blind|Not Treated|6|||
48879388|NCT00798434|157396231|FG000|Open-Label|Adverse Event|33|||
48879389|NCT00798434|157396232|FG001|Open-Label|Adverse Event|11|||
48879390|NCT00798434|157396231|FG000|Open-Label|Lack of Efficacy|5|||
48879391|NCT00798434|157396232|FG001|Open-Label|Lack of Efficacy|11|||
48879392|NCT00798434|157396231|FG000|Open-Label|Withdrawal by Subject|2|||
48879393|NCT00798434|157396232|FG001|Open-Label|Withdrawal by Subject|7|||
48879394|NCT00798434|157396231|FG000|Open-Label|Protocol Violation|1|||
48879395|NCT00798434|157396232|FG001|Open-Label|Protocol Violation|0|||
48879396|NCT00798434|157396231|FG000|Open-Label|Other|1|||
48879397|NCT00798434|157396232|FG001|Open-Label|Other|2|||
48879398|NCT00798434|157396231|FG000|Open-Label|Not Treated|0|||
48879399|NCT00798434|157396232|FG001|Open-Label|Not Treated|1|||
48879400|NCT06122194|157396235|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
48879401|NCT06122194|157396236|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
48879402|NCT06122194|157396237|FG002|Treatment Period 1 (3 Days)|Adverse Event|1|||
48879403|NCT06122194|157396238|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
48879404|NCT02035696|157398740|FG000|Overall Study|Lost to Follow-up|0|||
48879405|NCT02035696|157398741|FG001|Overall Study|Lost to Follow-up|3|||
48879406|NCT02035696|157398742|FG002|Overall Study|Lost to Follow-up|1|||
48879407|NCT02035696|157398743|FG003|Overall Study|Lost to Follow-up|2|||
48879408|NCT02035696|157398740|FG000|Overall Study|Withdrawal by Subject|3|||
48879409|NCT02035696|157398741|FG001|Overall Study|Withdrawal by Subject|0|||
48879410|NCT02035696|157398742|FG002|Overall Study|Withdrawal by Subject|2|||
48879411|NCT02035696|157398743|FG003|Overall Study|Withdrawal by Subject|1|||
48879412|NCT04650698|157398744|FG000|Overall Study|Protocol Violation|2|||
48879413|NCT04650698|157398745|FG001|Overall Study|Protocol Violation|1|||
48879414|NCT04650698|157398744|FG000|Overall Study|Withdrawal by Subject|0|||
48879415|NCT04650698|157398745|FG001|Overall Study|Withdrawal by Subject|1|||
48879416|NCT00307047|157398746|FG000|Overall Study|Lost to Follow-up|35|||
48879417|NCT00307047|157398747|FG001|Overall Study|Lost to Follow-up|24|||
48879418|NCT00307047|157398746|FG000|Overall Study|Withdrawal by Subject|6|||
48879419|NCT00307047|157398747|FG001|Overall Study|Withdrawal by Subject|6|||
48879420|NCT00307047|157398746|FG000|Overall Study|Physician Decision|1|||
48879421|NCT00307047|157398747|FG001|Overall Study|Physician Decision|2|||
48879422|NCT00307047|157398746|FG000|Overall Study|Lost to follow-up for other reasons|0|||
48983550|NCT01196091|157772301|FG002|Overall Study|Withdrawal by Subject|22|||
48983551|NCT01196091|157772299|FG000|Overall Study|Physician Decision|3|||
48983552|NCT01196091|157772300|FG001|Overall Study|Physician Decision|3|||
48983553|NCT01196091|157772301|FG002|Overall Study|Physician Decision|4|||
48983554|NCT01196091|157772299|FG000|Overall Study|Protocol Violation|1|||
48983555|NCT01196091|157772300|FG001|Overall Study|Protocol Violation|3|||
48983556|NCT01196091|157772301|FG002|Overall Study|Protocol Violation|3|||
48983557|NCT01196091|157772299|FG000|Overall Study|Sponsor Decision|6|||
48983558|NCT01196091|157772300|FG001|Overall Study|Sponsor Decision|5|||
48983559|NCT01196091|157772301|FG002|Overall Study|Sponsor Decision|4|||
48983560|NCT01196091|157772299|FG000|Overall Study|Excluded Site|5|||
48983561|NCT01196091|157772300|FG001|Overall Study|Excluded Site|11|||
48983562|NCT01196091|157772301|FG002|Overall Study|Excluded Site|8|||
48983563|NCT01196091|157772299|FG000|Overall Study|Randomized, No Study Drug Received|1|||
48983564|NCT01196091|157772300|FG001|Overall Study|Randomized, No Study Drug Received|0|||
48983565|NCT01196091|157772301|FG002|Overall Study|Randomized, No Study Drug Received|1|||
48983566|NCT03696576|157772302|FG000|Overall Study|Soreness of throat after therapy|1|||
48983567|NCT03696576|157772303|FG001|Overall Study|Soreness of throat after therapy|1|||
48983568|NCT03696576|157772302|FG000|Overall Study|Lost to Follow-up|2|||
48983569|NCT03696576|157772303|FG001|Overall Study|Lost to Follow-up|4|||
48983570|NCT00850135|157772304|FG000|Overall Study|Physician Decision|1|||
48983571|NCT02202161|157772307|FG000|Overall Study|Adverse Event|1|||
48983572|NCT02202161|157772308|FG001|Overall Study|Adverse Event|1|||
48983573|NCT02202161|157772309|FG002|Overall Study|Adverse Event|0|||
48983574|NCT02202161|157772310|FG003|Overall Study|Adverse Event|0|||
48983575|NCT02202161|157772311|FG004|Overall Study|Adverse Event|0|||
48983576|NCT02202161|157772312|FG005|Overall Study|Adverse Event|1|||
48983577|NCT02202161|157772313|FG006|Overall Study|Adverse Event|0|||
48983578|NCT02202161|157772314|FG007|Overall Study|Adverse Event|0|||
48983579|NCT02202161|157772307|FG000|Overall Study|Did not meet continuation criteria|0|||
48983580|NCT02202161|157772308|FG001|Overall Study|Did not meet continuation criteria|0|||
48983581|NCT02202161|157772309|FG002|Overall Study|Did not meet continuation criteria|0|||
48983582|NCT02202161|157772310|FG003|Overall Study|Did not meet continuation criteria|0|||
48983583|NCT02202161|157772311|FG004|Overall Study|Did not meet continuation criteria|0|||
48983584|NCT02202161|157772312|FG005|Overall Study|Did not meet continuation criteria|0|||
48983585|NCT02202161|157772313|FG006|Overall Study|Did not meet continuation criteria|0|||
48983586|NCT02202161|157772314|FG007|Overall Study|Did not meet continuation criteria|3|||
48983587|NCT02202161|157772307|FG000|Overall Study|Physician Decision|0|||
48983588|NCT02202161|157772308|FG001|Overall Study|Physician Decision|0|||
48983589|NCT02202161|157772309|FG002|Overall Study|Physician Decision|0|||
48983590|NCT02202161|157772310|FG003|Overall Study|Physician Decision|0|||
48983591|NCT02202161|157772311|FG004|Overall Study|Physician Decision|0|||
48983592|NCT02202161|157772312|FG005|Overall Study|Physician Decision|0|||
48983593|NCT02202161|157772313|FG006|Overall Study|Physician Decision|0|||
48983594|NCT02202161|157772314|FG007|Overall Study|Physician Decision|3|||
48983595|NCT02202161|157772307|FG000|Overall Study|Withdrawal by Subject|0|||
48983596|NCT02202161|157772308|FG001|Overall Study|Withdrawal by Subject|0|||
48983597|NCT02202161|157772309|FG002|Overall Study|Withdrawal by Subject|0|||
48983598|NCT02202161|157772310|FG003|Overall Study|Withdrawal by Subject|0|||
48983599|NCT02202161|157772311|FG004|Overall Study|Withdrawal by Subject|1|||
49033366|NCT01527006|157956926|FG000|Core Study|Adverse Event|0|||
49033367|NCT01527006|157956927|FG001|Core Study|Adverse Event|2|||
48983600|NCT02202161|157772312|FG005|Overall Study|Withdrawal by Subject|0|||
48983601|NCT02202161|157772313|FG006|Overall Study|Withdrawal by Subject|0|||
48983602|NCT02202161|157772314|FG007|Overall Study|Withdrawal by Subject|0|||
48983603|NCT00355615|157772315|FG000|Randomized Double Blind Period|Adverse Event|1|||
48983604|NCT00355615|157772316|FG001|Randomized Double Blind Period|Adverse Event|0|||
48983605|NCT00355615|157772317|FG002|Randomized Double Blind Period|Adverse Event|0|||
48983606|NCT00355615|157772318|FG003|Randomized Double Blind Period|Adverse Event|0|||
48983607|NCT00355615|157772319|FG004|Randomized Double Blind Period|Adverse Event|0|||
48983608|NCT00355615|157772315|FG000|Randomized Double Blind Period|Protocol Violation|0|||
48983609|NCT00355615|157772316|FG001|Randomized Double Blind Period|Protocol Violation|0|||
48983610|NCT00355615|157772317|FG002|Randomized Double Blind Period|Protocol Violation|1|||
48983611|NCT00355615|157772318|FG003|Randomized Double Blind Period|Protocol Violation|1|||
48983612|NCT00355615|157772319|FG004|Randomized Double Blind Period|Protocol Violation|0|||
48983613|NCT00355615|157772315|FG000|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
48983614|NCT00355615|157772316|FG001|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
48983615|NCT00355615|157772317|FG002|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
48983616|NCT00355615|157772318|FG003|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
48879423|NCT00307047|157398747|FG001|Overall Study|Lost to follow-up for other reasons|1|||
48879424|NCT00307047|157398746|FG000|Overall Study|All death, all MI, all Revascularization|27|||
48879425|NCT00307047|157398747|FG001|Overall Study|All death, all MI, all Revascularization|16|||
48879426|NCT00379769|157398748|FG000|Main Study|Death|57|||
48879427|NCT00379769|157398749|FG001|Main Study|Death|67|||
48879428|NCT00379769|157398750|FG002|Main Study|Death|54|||
48879429|NCT00379769|157398751|FG003|Main Study|Death|72|||
48879430|NCT00379769|157398752|FG004|Main Study|Death|0|||
49033368|NCT01527006|157956926|FG000|Core Study|Lost to Follow-up|0|||
49033369|NCT01527006|157956927|FG001|Core Study|Lost to Follow-up|1|||
49033370|NCT01527006|157956926|FG000|Core Study|Subject Choice|1|||
49033371|NCT01527006|157956927|FG001|Core Study|Subject Choice|0|||
49033372|NCT01527006|157956926|FG000|Core Study|Inadequate Therapeutic Effect|1|||
49033373|NCT01527006|157956927|FG001|Core Study|Inadequate Therapeutic Effect|0|||
49033374|NCT01527006|157956926|FG000|Core Study|Withdrawal by Subject|0|||
49033375|NCT01527006|157956927|FG001|Core Study|Withdrawal by Subject|1|||
49033376|NCT01527006|157956926|FG000|Core Study|Other|0|||
49033377|NCT01527006|157956927|FG001|Core Study|Other|2|||
49033378|NCT01527006|157956926|FG000|Extension Phase|Adverse Event|4|||
49033379|NCT01527006|157956927|FG001|Extension Phase|Adverse Event|2|||
49033380|NCT01527006|157956926|FG000|Extension Phase|Lost to Follow-up|0|||
49033381|NCT01527006|157956927|FG001|Extension Phase|Lost to Follow-up|1|||
49033382|NCT01527006|157956926|FG000|Extension Phase|Subject Choice|1|||
49033383|NCT01527006|157956927|FG001|Extension Phase|Subject Choice|1|||
49033384|NCT01527006|157956926|FG000|Extension Phase|Inadequate therapeutic effect|1|||
49033385|NCT01527006|157956927|FG001|Extension Phase|Inadequate therapeutic effect|1|||
49033386|NCT01527006|157956926|FG000|Extension Phase|Other|0|||
49033387|NCT01527006|157956927|FG001|Extension Phase|Other|3|||
49033388|NCT00960297|157956928|FG000|Overall Study|Physician Decision|1|||
49033389|NCT00960297|157956928|FG000|Overall Study|Venous port infection|1|||
49033390|NCT00960297|157956928|FG000|Overall Study|Disease progression|1|||
49033391|NCT00824291|157956929|FG000|Overall Study|Adverse Event|15|||
49033392|NCT00824291|157956930|FG001|Overall Study|Adverse Event|6|||
49033393|NCT00824291|157956929|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
49033394|NCT00824291|157956930|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
49033395|NCT00824291|157956929|FG000|Overall Study|Lost to Follow-up|11|||
49033396|NCT00824291|157956930|FG001|Overall Study|Lost to Follow-up|9|||
49033397|NCT00824291|157956929|FG000|Overall Study|Non-compliance|1|||
49033398|NCT00824291|157956930|FG001|Overall Study|Non-compliance|1|||
49033399|NCT00824291|157956929|FG000|Overall Study|Protocol Violation|4|||
49033400|NCT00824291|157956930|FG001|Overall Study|Protocol Violation|1|||
49033401|NCT00824291|157956929|FG000|Overall Study|Withdrawal by Subject|14|||
49033402|NCT00824291|157956930|FG001|Overall Study|Withdrawal by Subject|8|||
49033403|NCT00824291|157956929|FG000|Overall Study|Lack of Efficacy|7|||
49033404|NCT00824291|157956930|FG001|Overall Study|Lack of Efficacy|8|||
49033405|NCT00824291|157956929|FG000|Overall Study|Participant on prohibited medication|1|||
49033406|NCT00824291|157956930|FG001|Overall Study|Participant on prohibited medication|0|||
48879431|NCT00379769|157398753|FG005|Main Study|Death|0|||
48879432|NCT00379769|157398748|FG000|Main Study|Adverse Event|5|||
48879433|NCT00379769|157398749|FG001|Main Study|Adverse Event|8|||
48879434|NCT00379769|157398750|FG002|Main Study|Adverse Event|10|||
48879435|NCT00379769|157398751|FG003|Main Study|Adverse Event|11|||
48879436|NCT00379769|157398752|FG004|Main Study|Adverse Event|0|||
48879437|NCT00379769|157398753|FG005|Main Study|Adverse Event|0|||
48879438|NCT00379769|157398748|FG000|Main Study|Lost to Follow-up|29|||
48879439|NCT00379769|157398749|FG001|Main Study|Lost to Follow-up|29|||
48879440|NCT00379769|157398750|FG002|Main Study|Lost to Follow-up|25|||
48879441|NCT00379769|157398751|FG003|Main Study|Lost to Follow-up|26|||
48879442|NCT00379769|157398752|FG004|Main Study|Lost to Follow-up|0|||
48879443|NCT00379769|157398753|FG005|Main Study|Lost to Follow-up|0|||
48879444|NCT00379769|157398748|FG000|Main Study|Withdrawal by Subject|46|||
48879445|NCT00379769|157398749|FG001|Main Study|Withdrawal by Subject|56|||
49033407|NCT03965091|157956932|FG000|Overall Study|Adverse Event|0|||
49033408|NCT03965091|157956933|FG001|Overall Study|Adverse Event|2|||
48879446|NCT00379769|157398750|FG002|Main Study|Withdrawal by Subject|72|||
48879447|NCT00379769|157398751|FG003|Main Study|Withdrawal by Subject|70|||
48879448|NCT00379769|157398752|FG004|Main Study|Withdrawal by Subject|0|||
49033409|NCT03965091|157956934|FG002|Overall Study|Adverse Event|3|||
49033410|NCT03965091|157956932|FG000|Overall Study|Withdrawal by Subject|11|||
48879449|NCT00379769|157398753|FG005|Main Study|Withdrawal by Subject|0|||
49033411|NCT03965091|157956933|FG001|Overall Study|Withdrawal by Subject|3|||
49033412|NCT03965091|157956934|FG002|Overall Study|Withdrawal by Subject|5|||
49033413|NCT03965091|157956932|FG000|Overall Study|Non-compliance with study drug|0|||
49033414|NCT03965091|157956933|FG001|Overall Study|Non-compliance with study drug|0|||
49033415|NCT03965091|157956934|FG002|Overall Study|Non-compliance with study drug|1|||
49033416|NCT03965091|157956932|FG000|Overall Study|Lost to Follow-up|1|||
49033417|NCT03965091|157956933|FG001|Overall Study|Lost to Follow-up|1|||
48879450|NCT00379769|157398748|FG000|Main Study|Moved to survival status follow-up only|27|||
49033418|NCT03965091|157956934|FG002|Overall Study|Lost to Follow-up|1|||
49033419|NCT03965091|157956932|FG000|Overall Study|Lack of Efficacy|2|||
48879451|NCT00379769|157398749|FG001|Main Study|Moved to survival status follow-up only|25|||
48879452|NCT00379769|157398750|FG002|Main Study|Moved to survival status follow-up only|32|||
48879453|NCT00379769|157398751|FG003|Main Study|Moved to survival status follow-up only|36|||
48879454|NCT00379769|157398752|FG004|Main Study|Moved to survival status follow-up only|0|||
48879455|NCT00379769|157398753|FG005|Main Study|Moved to survival status follow-up only|0|||
48879456|NCT00379769|157398748|FG000|Main Study|Participant moved|3|||
48879457|NCT00379769|157398749|FG001|Main Study|Participant moved|2|||
48879458|NCT00379769|157398750|FG002|Main Study|Participant moved|3|||
48879459|NCT00379769|157398751|FG003|Main Study|Participant moved|3|||
48879460|NCT00379769|157398752|FG004|Main Study|Participant moved|0|||
48879461|NCT00379769|157398753|FG005|Main Study|Participant moved|0|||
48879462|NCT00379769|157398748|FG000|Main Study|Poor compliance|3|||
48879463|NCT00379769|157398749|FG001|Main Study|Poor compliance|2|||
48879464|NCT00379769|157398750|FG002|Main Study|Poor compliance|2|||
48879465|NCT00379769|157398751|FG003|Main Study|Poor compliance|1|||
48879466|NCT00379769|157398752|FG004|Main Study|Poor compliance|0|||
48879467|NCT00379769|157398753|FG005|Main Study|Poor compliance|0|||
48879468|NCT00379769|157398748|FG000|Main Study|Prohibited glucose lowering medication|0|||
48879469|NCT00379769|157398749|FG001|Main Study|Prohibited glucose lowering medication|3|||
48879470|NCT00379769|157398750|FG002|Main Study|Prohibited glucose lowering medication|0|||
48879471|NCT00379769|157398751|FG003|Main Study|Prohibited glucose lowering medication|1|||
48879472|NCT00379769|157398752|FG004|Main Study|Prohibited glucose lowering medication|0|||
48879473|NCT00379769|157398753|FG005|Main Study|Prohibited glucose lowering medication|0|||
48879474|NCT00379769|157398748|FG000|Main Study|Site closed|4|||
48879475|NCT00379769|157398749|FG001|Main Study|Site closed|4|||
48879476|NCT00379769|157398750|FG002|Main Study|Site closed|4|||
48879477|NCT00379769|157398751|FG003|Main Study|Site closed|8|||
48879478|NCT00379769|157398752|FG004|Main Study|Site closed|0|||
48879479|NCT00379769|157398753|FG005|Main Study|Site closed|0|||
48879480|NCT00379769|157398748|FG000|Main Study|Entry criteria violation|0|||
48879481|NCT00379769|157398749|FG001|Main Study|Entry criteria violation|0|||
48879482|NCT00379769|157398750|FG002|Main Study|Entry criteria violation|1|||
48879483|NCT00379769|157398751|FG003|Main Study|Entry criteria violation|1|||
48879484|NCT00379769|157398752|FG004|Main Study|Entry criteria violation|0|||
48879485|NCT00379769|157398753|FG005|Main Study|Entry criteria violation|0|||
48879486|NCT00379769|157398748|FG000|Main Study|Participant did not take study drug|0|||
48879487|NCT00379769|157398749|FG001|Main Study|Participant did not take study drug|0|||
48879488|NCT00379769|157398750|FG002|Main Study|Participant did not take study drug|1|||
48879489|NCT00379769|157398751|FG003|Main Study|Participant did not take study drug|0|||
48879490|NCT00379769|157398752|FG004|Main Study|Participant did not take study drug|0|||
48879491|NCT00379769|157398753|FG005|Main Study|Participant did not take study drug|0|||
48879492|NCT00379769|157398748|FG000|Main Study|Physician Decision|2|||
48879493|NCT00379769|157398749|FG001|Main Study|Physician Decision|2|||
48879494|NCT00379769|157398750|FG002|Main Study|Physician Decision|1|||
48879495|NCT00379769|157398751|FG003|Main Study|Physician Decision|1|||
48879496|NCT00379769|157398752|FG004|Main Study|Physician Decision|0|||
48879497|NCT00379769|157398753|FG005|Main Study|Physician Decision|0|||
48879498|NCT00379769|157398748|FG000|Main Study|Participant completed study at visit 27|1|||
48879499|NCT00379769|157398749|FG001|Main Study|Participant completed study at visit 27|0|||
48879500|NCT00379769|157398750|FG002|Main Study|Participant completed study at visit 27|0|||
48879501|NCT00379769|157398751|FG003|Main Study|Participant completed study at visit 27|0|||
48879502|NCT00379769|157398752|FG004|Main Study|Participant completed study at visit 27|0|||
48879503|NCT00379769|157398753|FG005|Main Study|Participant completed study at visit 27|0|||
48879504|NCT00379769|157398748|FG000|Main Study|Personal reasons|1|||
48879505|NCT00379769|157398749|FG001|Main Study|Personal reasons|0|||
48879506|NCT00379769|157398750|FG002|Main Study|Personal reasons|0|||
48879507|NCT00379769|157398751|FG003|Main Study|Personal reasons|0|||
48879508|NCT00379769|157398752|FG004|Main Study|Personal reasons|0|||
48879509|NCT00379769|157398753|FG005|Main Study|Personal reasons|0|||
48879510|NCT00379769|157398748|FG000|Main Study|Risk of heart failure|0|||
48879511|NCT00379769|157398749|FG001|Main Study|Risk of heart failure|1|||
48879512|NCT00379769|157398750|FG002|Main Study|Risk of heart failure|0|||
48879513|NCT00379769|157398751|FG003|Main Study|Risk of heart failure|0|||
48879514|NCT00379769|157398752|FG004|Main Study|Risk of heart failure|0|||
48879515|NCT00379769|157398753|FG005|Main Study|Risk of heart failure|0|||
48879516|NCT00379769|157398748|FG000|Main Study|Investigator refused to log temperature|0|||
48879517|NCT00379769|157398749|FG001|Main Study|Investigator refused to log temperature|0|||
48879518|NCT00379769|157398750|FG002|Main Study|Investigator refused to log temperature|1|||
48879519|NCT00379769|157398751|FG003|Main Study|Investigator refused to log temperature|0|||
48879520|NCT00379769|157398752|FG004|Main Study|Investigator refused to log temperature|0|||
48879521|NCT00379769|157398753|FG005|Main Study|Investigator refused to log temperature|0|||
48879522|NCT00379769|157398748|FG000|Main Study|Reason unspecified|0|||
48879523|NCT00379769|157398749|FG001|Main Study|Reason unspecified|0|||
48879524|NCT00379769|157398750|FG002|Main Study|Reason unspecified|1|||
48879525|NCT00379769|157398751|FG003|Main Study|Reason unspecified|0|||
48879526|NCT00379769|157398752|FG004|Main Study|Reason unspecified|0|||
48879527|NCT00379769|157398753|FG005|Main Study|Reason unspecified|0|||
48879528|NCT00379769|157398748|FG000|Observational Follow-up|Death|0|||
48879529|NCT00379769|157398749|FG001|Observational Follow-up|Death|0|||
48879530|NCT00379769|157398750|FG002|Observational Follow-up|Death|0|||
48879531|NCT00379769|157398751|FG003|Observational Follow-up|Death|0|||
48879532|NCT00379769|157398752|FG004|Observational Follow-up|Death|78|||
48879533|NCT00379769|157398753|FG005|Observational Follow-up|Death|70|||
48879534|NCT00379769|157398748|FG000|Observational Follow-up|Adverse Event|0|||
48879535|NCT00379769|157398749|FG001|Observational Follow-up|Adverse Event|0|||
48879536|NCT00379769|157398750|FG002|Observational Follow-up|Adverse Event|0|||
48879537|NCT00379769|157398751|FG003|Observational Follow-up|Adverse Event|0|||
48879538|NCT00379769|157398752|FG004|Observational Follow-up|Adverse Event|1|||
48879539|NCT00379769|157398753|FG005|Observational Follow-up|Adverse Event|0|||
48879540|NCT00379769|157398748|FG000|Observational Follow-up|Lost to Follow-up|0|||
48879541|NCT00379769|157398749|FG001|Observational Follow-up|Lost to Follow-up|0|||
48879542|NCT00379769|157398750|FG002|Observational Follow-up|Lost to Follow-up|0|||
48879543|NCT00379769|157398751|FG003|Observational Follow-up|Lost to Follow-up|0|||
48879544|NCT00379769|157398752|FG004|Observational Follow-up|Lost to Follow-up|25|||
48879545|NCT00379769|157398753|FG005|Observational Follow-up|Lost to Follow-up|27|||
48879546|NCT00379769|157398748|FG000|Observational Follow-up|Withdrawal by Subject|0|||
48879547|NCT00379769|157398749|FG001|Observational Follow-up|Withdrawal by Subject|0|||
48879548|NCT00379769|157398750|FG002|Observational Follow-up|Withdrawal by Subject|0|||
48879549|NCT00379769|157398751|FG003|Observational Follow-up|Withdrawal by Subject|0|||
48879550|NCT00379769|157398752|FG004|Observational Follow-up|Withdrawal by Subject|12|||
48879551|NCT00379769|157398753|FG005|Observational Follow-up|Withdrawal by Subject|12|||
48879552|NCT00379769|157398748|FG000|Observational Follow-up|Entered into Another Clinical Trial|0|||
48879553|NCT00379769|157398749|FG001|Observational Follow-up|Entered into Another Clinical Trial|0|||
48879554|NCT00379769|157398750|FG002|Observational Follow-up|Entered into Another Clinical Trial|0|||
48879555|NCT00379769|157398751|FG003|Observational Follow-up|Entered into Another Clinical Trial|0|||
48879556|NCT00379769|157398752|FG004|Observational Follow-up|Entered into Another Clinical Trial|18|||
48879557|NCT00379769|157398753|FG005|Observational Follow-up|Entered into Another Clinical Trial|22|||
48879558|NCT00379769|157398748|FG000|Observational Follow-up|Physician Decision|0|||
48879559|NCT00379769|157398749|FG001|Observational Follow-up|Physician Decision|0|||
48879560|NCT00379769|157398750|FG002|Observational Follow-up|Physician Decision|0|||
48879561|NCT00379769|157398751|FG003|Observational Follow-up|Physician Decision|0|||
48879562|NCT00379769|157398752|FG004|Observational Follow-up|Physician Decision|8|||
48879563|NCT00379769|157398753|FG005|Observational Follow-up|Physician Decision|8|||
48879564|NCT00379769|157398748|FG000|Observational Follow-up|Site Closed Early|0|||
48879565|NCT00379769|157398749|FG001|Observational Follow-up|Site Closed Early|0|||
48879566|NCT00379769|157398750|FG002|Observational Follow-up|Site Closed Early|0|||
48879567|NCT00379769|157398751|FG003|Observational Follow-up|Site Closed Early|0|||
48879568|NCT00379769|157398752|FG004|Observational Follow-up|Site Closed Early|6|||
48879569|NCT00379769|157398753|FG005|Observational Follow-up|Site Closed Early|7|||
48879570|NCT00379769|157398748|FG000|Observational Follow-up|Participant Moved|0|||
48879571|NCT00379769|157398749|FG001|Observational Follow-up|Participant Moved|0|||
48879572|NCT00379769|157398750|FG002|Observational Follow-up|Participant Moved|0|||
48879573|NCT00379769|157398751|FG003|Observational Follow-up|Participant Moved|0|||
48879574|NCT00379769|157398752|FG004|Observational Follow-up|Participant Moved|0|||
48879575|NCT00379769|157398753|FG005|Observational Follow-up|Participant Moved|1|||
48879576|NCT00379769|157398748|FG000|Observational Follow-up|Unknown; Reason Not Provided|0|||
48879577|NCT00379769|157398749|FG001|Observational Follow-up|Unknown; Reason Not Provided|0|||
48879578|NCT00379769|157398750|FG002|Observational Follow-up|Unknown; Reason Not Provided|0|||
48879579|NCT00379769|157398751|FG003|Observational Follow-up|Unknown; Reason Not Provided|0|||
48879580|NCT00379769|157398752|FG004|Observational Follow-up|Unknown; Reason Not Provided|1|||
48879581|NCT00379769|157398753|FG005|Observational Follow-up|Unknown; Reason Not Provided|1|||
48879582|NCT04949802|157398754|FG000|Overall Study|Lost to Follow-up|3|||
48879583|NCT01932762|157398755|FG000|Overall Study|Withdrawal by Subject|1|||
48879584|NCT01932762|157398756|FG001|Overall Study|Withdrawal by Subject|2|||
48879585|NCT01932762|157398757|FG002|Overall Study|Withdrawal by Subject|0|||
48879586|NCT01932762|157398758|FG003|Overall Study|Withdrawal by Subject|0|||
48879587|NCT01932762|157398755|FG000|Overall Study|Lost to Follow-up|4|||
48879588|NCT01932762|157398756|FG001|Overall Study|Lost to Follow-up|0|||
48879589|NCT01932762|157398757|FG002|Overall Study|Lost to Follow-up|0|||
48879590|NCT01932762|157398758|FG003|Overall Study|Lost to Follow-up|1|||
48879591|NCT01932762|157398755|FG000|Overall Study|Physician Decision|1|||
48879592|NCT01932762|157398756|FG001|Overall Study|Physician Decision|0|||
48879593|NCT01932762|157398757|FG002|Overall Study|Physician Decision|0|||
48879594|NCT01932762|157398758|FG003|Overall Study|Physician Decision|0|||
48879595|NCT00497874|157398759|FG000|Overall Study|Withdrawal by Subject|48|||
48983617|NCT00355615|157772319|FG004|40-week Rosuvastatin Open Label Period|Adverse Event|4|||
48983618|NCT00355615|157772315|FG000|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
48983619|NCT00355615|157772316|FG001|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
48879596|NCT00497874|157398760|FG001|Overall Study|Withdrawal by Subject|17|||
48879597|NCT00497874|157398759|FG000|Overall Study|Illness|8|||
48879598|NCT00497874|157398760|FG001|Overall Study|Illness|4|||
48879599|NCT00497874|157398759|FG000|Overall Study|Death|2|||
48879600|NCT00497874|157398760|FG001|Overall Study|Death|4|||
48879601|NCT00497874|157398759|FG000|Overall Study|Unable to contact|52|||
48879602|NCT00497874|157398760|FG001|Overall Study|Unable to contact|67|||
48879603|NCT00497874|157398759|FG000|Overall Study|Unable to schedule|37|||
48879604|NCT00497874|157398760|FG001|Overall Study|Unable to schedule|24|||
48879605|NCT01986114|157398765|FG000|Overall Study|Adverse Event|59|||
48879606|NCT01986114|157398765|FG000|Overall Study|Lack of Efficacy|23|||
48879607|NCT01986114|157398765|FG000|Overall Study|Withdrawal by Subject|58|||
48879608|NCT01986114|157398765|FG000|Overall Study|Noncompliance|3|||
48879609|NCT01986114|157398765|FG000|Overall Study|Protocol Violation|1|||
48879610|NCT01986114|157398765|FG000|Overall Study|Lost to Follow-up|5|||
48879611|NCT01986114|157398765|FG000|Overall Study|Other reason|7|||
48879612|NCT02366143|157398766|FG000|Overall Study|Death|307|||
48879613|NCT02366143|157398767|FG001|Overall Study|Death|278|||
48879614|NCT02366143|157398768|FG002|Overall Study|Death|280|||
48879615|NCT02366143|157398766|FG000|Overall Study|Lost to Follow-up|2|||
48879616|NCT02366143|157398767|FG001|Overall Study|Lost to Follow-up|4|||
48879617|NCT02366143|157398768|FG002|Overall Study|Lost to Follow-up|2|||
48879618|NCT02366143|157398766|FG000|Overall Study|Physician Decision|1|||
49033420|NCT03965091|157956933|FG001|Overall Study|Lack of Efficacy|0|||
48879619|NCT02366143|157398767|FG001|Overall Study|Physician Decision|2|||
48879620|NCT02366143|157398768|FG002|Overall Study|Physician Decision|1|||
48879621|NCT02366143|157398766|FG000|Overall Study|Protocol Violation|0|||
48879622|NCT02366143|157398767|FG001|Overall Study|Protocol Violation|0|||
48879623|NCT02366143|157398768|FG002|Overall Study|Protocol Violation|2|||
48879624|NCT02366143|157398766|FG000|Overall Study|Withdrawal by Subject|16|||
48879625|NCT02366143|157398767|FG001|Overall Study|Withdrawal by Subject|17|||
48879626|NCT02366143|157398768|FG002|Overall Study|Withdrawal by Subject|22|||
48879627|NCT02366143|157398766|FG000|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
48879628|NCT02366143|157398767|FG001|Overall Study|Sponsor request to withdraw/discontinue patient|6|||
48879629|NCT02366143|157398768|FG002|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
48879630|NCT02366143|157398766|FG000|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
48879631|NCT02366143|157398767|FG001|Overall Study|Increased Microscopic RBCS on Urinalysis|1|||
48879632|NCT02366143|157398768|FG002|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
48879633|NCT02366143|157398766|FG000|Overall Study|Randomization Error|1|||
48879634|NCT02366143|157398767|FG001|Overall Study|Randomization Error|0|||
48879635|NCT02366143|157398768|FG002|Overall Study|Randomization Error|0|||
48879636|NCT02366143|157398766|FG000|Overall Study|PI Move and Site Closure|1|||
48879637|NCT02366143|157398767|FG001|Overall Study|PI Move and Site Closure|0|||
48879638|NCT02366143|157398768|FG002|Overall Study|PI Move and Site Closure|1|||
48879639|NCT02366143|157398766|FG000|Overall Study|Study Terminated By Sponsor|0|||
48879640|NCT02366143|157398767|FG001|Overall Study|Study Terminated By Sponsor|0|||
48879641|NCT02366143|157398768|FG002|Overall Study|Study Terminated By Sponsor|2|||
48879642|NCT02366143|157398766|FG000|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70|||
48879643|NCT02366143|157398767|FG001|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57|||
48879644|NCT02366143|157398768|FG002|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52|||
48879645|NCT02366143|157398766|FG000|Overall Study|Patient moved to roll-over study|1|||
48879646|NCT02366143|157398767|FG001|Overall Study|Patient moved to roll-over study|19|||
48879647|NCT02366143|157398768|FG002|Overall Study|Patient moved to roll-over study|28|||
48879648|NCT02366143|157398766|FG000|Overall Study|Patient moved to commercial stock|0|||
48879649|NCT02366143|157398767|FG001|Overall Study|Patient moved to commercial stock|0|||
48879650|NCT02366143|157398768|FG002|Overall Study|Patient moved to commercial stock|1|||
48879651|NCT02366143|157398766|FG000|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
48879652|NCT02366143|157398767|FG001|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
48879653|NCT02366143|157398768|FG002|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1|||
48879654|NCT02366143|157398766|FG000|Overall Study|Patient rolling over to patient assistance program|0|||
48879655|NCT02366143|157398767|FG001|Overall Study|Patient rolling over to patient assistance program|0|||
48879656|NCT02366143|157398768|FG002|Overall Study|Patient rolling over to patient assistance program|1|||
48879657|NCT02366143|157398766|FG000|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
48879658|NCT02366143|157398767|FG001|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
48879659|NCT02366143|157398768|FG002|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1|||
48879660|NCT02366143|157398766|FG000|Overall Study|Requester's instructions|1|||
48879661|NCT02366143|157398767|FG001|Overall Study|Requester's instructions|1|||
48879662|NCT02366143|157398768|FG002|Overall Study|Requester's instructions|1|||
48879663|NCT02366143|157398766|FG000|Overall Study|Uneligible|0|||
48879664|NCT02366143|157398767|FG001|Overall Study|Uneligible|1|||
48879665|NCT02366143|157398768|FG002|Overall Study|Uneligible|0|||
48879666|NCT02366143|157398766|FG000|Overall Study|Post Trial Migration|0|||
48879667|NCT02366143|157398767|FG001|Overall Study|Post Trial Migration|1|||
48879668|NCT02366143|157398768|FG002|Overall Study|Post Trial Migration|0|||
48879669|NCT02366143|157398766|FG000|Overall Study|Patient moving onto PTAP commercial stock|0|||
48879670|NCT02366143|157398767|FG001|Overall Study|Patient moving onto PTAP commercial stock|1|||
48879671|NCT02366143|157398768|FG002|Overall Study|Patient moving onto PTAP commercial stock|0|||
48879672|NCT02366143|157398766|FG000|Overall Study|Patient switched to PTAP|0|||
48879673|NCT02366143|157398767|FG001|Overall Study|Patient switched to PTAP|1|||
48879674|NCT02366143|157398768|FG002|Overall Study|Patient switched to PTAP|0|||
48879675|NCT02366143|157398766|FG000|Overall Study|Patient moved to commercial atezolizumab use|0|||
48879676|NCT02366143|157398767|FG001|Overall Study|Patient moved to commercial atezolizumab use|11|||
48879677|NCT02366143|157398768|FG002|Overall Study|Patient moved to commercial atezolizumab use|7|||
48879678|NCT00127842|157398769|FG000|Overall Study|Adverse Event|15|||
48879679|NCT00127842|157398769|FG000|Overall Study|Withdrawal by Subject|3|||
48879680|NCT00127842|157398769|FG000|Overall Study|Lost to Follow-up|1|||
48879681|NCT00127842|157398769|FG000|Overall Study|Lack of Efficacy|12|||
48879682|NCT00127842|157398769|FG000|Overall Study|Noncompliance|2|||
48879683|NCT00127842|157398769|FG000|Overall Study|Protocol Violation|1|||
48879684|NCT00127842|157398769|FG000|Overall Study|Other|5|||
48879685|NCT03898700|157398770|FG000|Overall Study|Withdrawal by Subject|2|||
48879686|NCT01536587|157398771|FG000|Overall Study|Adverse Event|2|||
48879687|NCT01434680|157398772|FG000|Overall Study|Withdrawal by Subject|1|||
48879688|NCT01434680|157398773|FG001|Overall Study|Withdrawal by Subject|0|||
48879689|NCT01434680|157398774|FG002|Overall Study|Withdrawal by Subject|2|||
48879690|NCT01434680|157398775|FG003|Overall Study|Withdrawal by Subject|0|||
48879691|NCT01434680|157398772|FG000|Overall Study|Lost to Follow-up|1|||
48879692|NCT01434680|157398773|FG001|Overall Study|Lost to Follow-up|1|||
48879693|NCT01434680|157398774|FG002|Overall Study|Lost to Follow-up|0|||
48879694|NCT01434680|157398775|FG003|Overall Study|Lost to Follow-up|0|||
48879695|NCT01434680|157398772|FG000|Overall Study|Protocol Violation|1|||
48879696|NCT01434680|157398773|FG001|Overall Study|Protocol Violation|1|||
48879697|NCT01434680|157398774|FG002|Overall Study|Protocol Violation|0|||
48879698|NCT01434680|157398775|FG003|Overall Study|Protocol Violation|0|||
48879699|NCT01663506|157398776|FG000|Overall Study|Lack of Efficacy|3|||
48879700|NCT01663506|157398776|FG000|Overall Study|Consent Withdrawal by Subject|1|||
48879701|NCT01663506|157398776|FG000|Overall Study|Lost to Follow-up|1|||
48879702|NCT01663506|157398776|FG000|Overall Study|Adverse Event|1|||
48879703|NCT01663506|157398776|FG000|Overall Study|Switched to Subcutaneous Tocilizumab|2|||
48879704|NCT02094898|157398777|FG000|Overall Study|Clinical Worsening|2|||
48879705|NCT02094898|157398777|FG000|Overall Study|Adverse Event|2|||
48879706|NCT02094898|157398777|FG000|Overall Study|Lack of Efficacy|1|||
48879707|NCT01513330|157398778|FG000|SenSura Mio First,|Adverse Event|2|||
48879708|NCT01513330|157398779|FG001|SenSura Mio First,|Adverse Event|0|||
48879709|NCT01513330|157398778|FG000|SenSura Mio First,|Lack of Efficacy|0|||
48879710|NCT01513330|157398779|FG001|SenSura Mio First,|Lack of Efficacy|1|||
48879711|NCT01513330|157398778|FG000|SenSura Mio First,|Withdrawal by Subject|1|||
48879712|NCT01513330|157398779|FG001|SenSura Mio First,|Withdrawal by Subject|1|||
48879713|NCT01513330|157398778|FG000|SenSura Mio First,|Other|1|||
48879714|NCT01513330|157398779|FG001|SenSura Mio First,|Other|0|||
48879715|NCT01513330|157398778|FG000|Standard Care First,|Lack of Efficacy|2|||
48879716|NCT01513330|157398779|FG001|Standard Care First,|Lack of Efficacy|2|||
48879717|NCT01513330|157398778|FG000|Standard Care First,|Withdrawal by Subject|1|||
48879718|NCT01513330|157398779|FG001|Standard Care First,|Withdrawal by Subject|2|||
48879719|NCT01513330|157398778|FG000|Standard Care First,|Other|1|||
48879720|NCT01513330|157398779|FG001|Standard Care First,|Other|0|||
48879721|NCT01013961|157398781|FG000|Overall Study|Adverse Event|2|||
48879722|NCT01013961|157398782|FG001|Overall Study|Adverse Event|2|||
48879723|NCT01013961|157398781|FG000|Overall Study|Withdrawal by Subject|1|||
48879724|NCT01013961|157398782|FG001|Overall Study|Withdrawal by Subject|0|||
48879725|NCT01013961|157398781|FG000|Overall Study|Physician Decision|0|||
48879726|NCT01013961|157398782|FG001|Overall Study|Physician Decision|1|||
48879727|NCT00633945|157398783|FG000|Overall Study|Physician Decision|2|||
48879728|NCT02375347|157398784|FG000|Overall Study|Protocol Violation|1|||
48879729|NCT00121667|157398787|FG000|Short Term (ST) Period|Lack of Efficacy|25|||
49033421|NCT03965091|157956934|FG002|Overall Study|Lack of Efficacy|0|||
48879730|NCT00121667|157398788|FG001|Short Term (ST) Period|Lack of Efficacy|22|||
48879731|NCT00121667|157398789|FG002|Short Term (ST) Period|Lack of Efficacy|27|||
48879732|NCT00121667|157398790|FG003|Short Term (ST) Period|Lack of Efficacy|44|||
48879733|NCT00121667|157398787|FG000|Short Term (ST) Period|Subject Withdrew Consent|8|||
48879734|NCT00121667|157398788|FG001|Short Term (ST) Period|Subject Withdrew Consent|13|||
48879735|NCT00121667|157398789|FG002|Short Term (ST) Period|Subject Withdrew Consent|4|||
48879736|NCT00121667|157398790|FG003|Short Term (ST) Period|Subject Withdrew Consent|11|||
48879737|NCT00121667|157398787|FG000|Short Term (ST) Period|Adverse Event|5|||
48879738|NCT00121667|157398788|FG001|Short Term (ST) Period|Adverse Event|6|||
48879739|NCT00121667|157398789|FG002|Short Term (ST) Period|Adverse Event|5|||
48879740|NCT00121667|157398790|FG003|Short Term (ST) Period|Adverse Event|3|||
48879741|NCT00121667|157398787|FG000|Short Term (ST) Period|Lost to Follow-up|3|||
48879742|NCT00121667|157398788|FG001|Short Term (ST) Period|Lost to Follow-up|4|||
48879743|NCT00121667|157398789|FG002|Short Term (ST) Period|Lost to Follow-up|4|||
48879744|NCT00121667|157398790|FG003|Short Term (ST) Period|Lost to Follow-up|3|||
48879745|NCT00121667|157398787|FG000|Short Term (ST) Period|Poor / Non-compliance|0|||
48879746|NCT00121667|157398788|FG001|Short Term (ST) Period|Poor / Non-compliance|1|||
48879747|NCT00121667|157398789|FG002|Short Term (ST) Period|Poor / Non-compliance|1|||
48879748|NCT00121667|157398790|FG003|Short Term (ST) Period|Poor / Non-compliance|2|||
48879749|NCT00121667|157398787|FG000|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
48879750|NCT00121667|157398788|FG001|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
48879751|NCT00121667|157398789|FG002|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
48879752|NCT00121667|157398790|FG003|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
48879753|NCT00121667|157398787|FG000|Short Term (ST) Period|Other Reason|3|||
48879754|NCT00121667|157398788|FG001|Short Term (ST) Period|Other Reason|0|||
48879755|NCT00121667|157398789|FG002|Short Term (ST) Period|Other Reason|0|||
48879756|NCT00121667|157398790|FG003|Short Term (ST) Period|Other Reason|0|||
48879757|NCT00121667|157398787|FG000|Short Term (ST) Period|Death|0|||
48879758|NCT00121667|157398788|FG001|Short Term (ST) Period|Death|0|||
48879759|NCT00121667|157398789|FG002|Short Term (ST) Period|Death|0|||
48879760|NCT00121667|157398790|FG003|Short Term (ST) Period|Death|1|||
49033422|NCT03965091|157956932|FG000|Overall Study|Other than specified|9|||
49033423|NCT03965091|157956933|FG001|Overall Study|Other than specified|11|||
49033424|NCT03965091|157956934|FG002|Overall Study|Other than specified|8|||
49033425|NCT03351244|157956937|FG000|Overall Study|Adverse Event|7|||
49033426|NCT03351244|157956938|FG001|Overall Study|Adverse Event|11|||
49033427|NCT03351244|157956939|FG002|Overall Study|Adverse Event|12|||
48879761|NCT00121667|157398787|FG000|Short Term (ST) Period|Pregnancy|0|||
48879762|NCT00121667|157398788|FG001|Short Term (ST) Period|Pregnancy|0|||
48879763|NCT00121667|157398789|FG002|Short Term (ST) Period|Pregnancy|0|||
48879764|NCT00121667|157398790|FG003|Short Term (ST) Period|Pregnancy|1|||
48879765|NCT00121667|157398787|FG000|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54|||
48879766|NCT00121667|157398788|FG001|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51|||
48879767|NCT00121667|157398789|FG002|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42|||
48879768|NCT00121667|157398790|FG003|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65|||
48879769|NCT00121667|157398787|FG000|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38|||
48879770|NCT00121667|157398788|FG001|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34|||
48879771|NCT00121667|157398789|FG002|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26|||
48879772|NCT00121667|157398790|FG003|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30|||
48879773|NCT00121667|157398787|FG000|Short Term (ST) + Long Term (LT) Period|Adverse Event|12|||
48879774|NCT00121667|157398788|FG001|Short Term (ST) + Long Term (LT) Period|Adverse Event|18|||
48879775|NCT00121667|157398789|FG002|Short Term (ST) + Long Term (LT) Period|Adverse Event|13|||
48879776|NCT00121667|157398790|FG003|Short Term (ST) + Long Term (LT) Period|Adverse Event|10|||
48879777|NCT00121667|157398787|FG000|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
48879778|NCT00121667|157398788|FG001|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
48879779|NCT00121667|157398789|FG002|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13|||
48879780|NCT00121667|157398790|FG003|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16|||
48879781|NCT00121667|157398787|FG000|Short Term (ST) + Long Term (LT) Period|Other Reason|5|||
48879782|NCT00121667|157398788|FG001|Short Term (ST) + Long Term (LT) Period|Other Reason|7|||
48879783|NCT00121667|157398789|FG002|Short Term (ST) + Long Term (LT) Period|Other Reason|6|||
48879784|NCT00121667|157398790|FG003|Short Term (ST) + Long Term (LT) Period|Other Reason|3|||
48879785|NCT00121667|157398787|FG000|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3|||
48879786|NCT00121667|157398788|FG001|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6|||
49033428|NCT03351244|157956937|FG000|Overall Study|Investigator's decision|0|||
49033429|NCT03351244|157956938|FG001|Overall Study|Investigator's decision|0|||
49033430|NCT03351244|157956939|FG002|Overall Study|Investigator's decision|2|||
49033431|NCT03351244|157956937|FG000|Overall Study|System error|0|||
48879787|NCT00121667|157398789|FG002|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5|||
48879788|NCT00121667|157398790|FG003|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9|||
48879789|NCT00121667|157398787|FG000|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3|||
48879790|NCT00121667|157398788|FG001|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5|||
48879791|NCT00121667|157398789|FG002|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8|||
48879792|NCT00121667|157398790|FG003|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4|||
48879793|NCT00121667|157398787|FG000|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
49033432|NCT03351244|157956938|FG001|Overall Study|System error|0|||
48879794|NCT00121667|157398788|FG001|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
48879795|NCT00121667|157398789|FG002|Short Term (ST) + Long Term (LT) Period|Pregnancy|0|||
48879796|NCT00121667|157398790|FG003|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
49033433|NCT03351244|157956939|FG002|Overall Study|System error|2|||
49033434|NCT03351244|157956937|FG000|Overall Study|COVID-19 restrictions|3|||
48879797|NCT00121667|157398787|FG000|Short Term (ST) + Long Term (LT) Period|Death|1|||
48879798|NCT00121667|157398788|FG001|Short Term (ST) + Long Term (LT) Period|Death|0|||
48879799|NCT00121667|157398789|FG002|Short Term (ST) + Long Term (LT) Period|Death|0|||
48879800|NCT00121667|157398790|FG003|Short Term (ST) + Long Term (LT) Period|Death|2|||
48879801|NCT03510455|157398791|FG000|Overall Study|Physician Decision|1|||
48879802|NCT03054337|157398792|FG000|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
48879803|NCT03054337|157398793|FG001|Dose Adjustment and Maintenance Period|Investigator discretion|2|||
48879804|NCT03054337|157398794|FG002|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
48879805|NCT03054337|157398795|FG003|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
48879806|NCT03054337|157398796|FG004|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
48879807|NCT03054337|157398797|FG005|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
48879808|NCT00609947|157398802|FG000|Overall Study|Death|1|||
48879809|NCT03603639|157398803|FG000|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
48879810|NCT03603639|157398804|FG001|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
48879811|NCT03603639|157398805|FG002|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
48879812|NCT03603639|157398806|FG003|Washout Period (at Least 3 Weeks)|Adverse Event|1|||
48879813|NCT03603639|157398807|FG004|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
48879814|NCT03603639|157398808|FG005|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
48879815|NCT03603639|157398803|FG000|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
48879816|NCT03603639|157398804|FG001|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
48879817|NCT03603639|157398805|FG002|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
48879818|NCT03603639|157398806|FG003|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
48879819|NCT03603639|157398807|FG004|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
48879820|NCT03603639|157398808|FG005|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
48879821|NCT01318876|157398809|FG000|Day 8 Survey|email address invalid|96|||
48879822|NCT01318876|157398809|FG000|Day 8 Survey|survey not completed-don't know why|1724|||
48879823|NCT01318876|157398809|FG000|Day 29 Survey|survey not completed-don't know why|1825|||
48879824|NCT04042077|157398812|FG000|Overall Study|Adverse Event|0|||
48879825|NCT04042077|157398813|FG001|Overall Study|Adverse Event|1|||
48879826|NCT04042077|157398812|FG000|Overall Study|Death|2|||
48879827|NCT04042077|157398813|FG001|Overall Study|Death|1|||
48879828|NCT04042077|157398812|FG000|Overall Study|Physician Decision|2|||
48879829|NCT04042077|157398813|FG001|Overall Study|Physician Decision|0|||
48879830|NCT04042077|157398812|FG000|Overall Study|Withdrawal by Subject|3|||
48879831|NCT04042077|157398813|FG001|Overall Study|Withdrawal by Subject|2|||
48879832|NCT04042077|157398812|FG000|Overall Study|Lack of Efficacy|0|||
48879833|NCT04042077|157398813|FG001|Overall Study|Lack of Efficacy|1|||
48879834|NCT03325777|157398814|FG000|Overall Study|Lost to Follow-up|9|||
48879835|NCT03325777|157398815|FG001|Overall Study|Lost to Follow-up|12|||
48879836|NCT03004404|157398819|FG000|Period 2|Adverse Event|0|||
48879837|NCT03004404|157398820|FG001|Period 2|Adverse Event|0|||
48879838|NCT03004404|157398821|FG002|Period 2|Adverse Event|0|||
48879839|NCT03004404|157398822|FG003|Period 2|Adverse Event|0|||
48879840|NCT03004404|157398823|FG004|Period 2|Adverse Event|0|||
48879841|NCT03004404|157398824|FG005|Period 2|Adverse Event|0|||
48879842|NCT03004404|157398825|FG006|Period 2|Adverse Event|0|||
48879843|NCT03004404|157398826|FG007|Period 2|Adverse Event|0|||
48879844|NCT03004404|157398827|FG008|Period 2|Adverse Event|1|||
48879845|NCT03004404|157398828|FG009|Period 2|Adverse Event|0|||
48879846|NCT03004404|157398829|FG010|Period 2|Adverse Event|0|||
48879847|NCT03004404|157398830|FG011|Period 2|Adverse Event|0|||
48879848|NCT03004404|157398831|FG012|Period 2|Adverse Event|0|||
48879849|NCT03004404|157398832|FG013|Period 2|Adverse Event|0|||
48879850|NCT03004404|157398833|FG014|Period 2|Adverse Event|0|||
48879851|NCT03004404|157398834|FG015|Period 2|Adverse Event|1|||
48879852|NCT03482752|157398837|FG000|Overall Study|Withdrawal by Subject|2|||
48879853|NCT03482752|157398837|FG000|Overall Study|Lost to Follow-up|1|||
48879854|NCT03482752|157398837|FG000|Overall Study|1 participant died 24 days after last dose ie outside the definition of treatment-emergent|1|||
48879855|NCT01080300|157398839|FG000|Overall Study|Adverse Event|49|||
48879856|NCT01080300|157398840|FG001|Overall Study|Adverse Event|35|||
48879857|NCT01080300|157398839|FG000|Overall Study|Lack of Efficacy|12|||
48879858|NCT01080300|157398840|FG001|Overall Study|Lack of Efficacy|15|||
48879859|NCT01080300|157398839|FG000|Overall Study|Protocol Violation|7|||
48879860|NCT01080300|157398840|FG001|Overall Study|Protocol Violation|13|||
48879861|NCT01080300|157398839|FG000|Overall Study|Lost to Follow-up|10|||
48879862|NCT01080300|157398840|FG001|Overall Study|Lost to Follow-up|6|||
49033435|NCT03351244|157956938|FG001|Overall Study|COVID-19 restrictions|0|||
49033436|NCT03351244|157956939|FG002|Overall Study|COVID-19 restrictions|1|||
48879863|NCT01080300|157398839|FG000|Overall Study|Death|0|||
48879864|NCT01080300|157398840|FG001|Overall Study|Death|1|||
48879865|NCT01080300|157398839|FG000|Overall Study|Withdrawal by Subject|12|||
48879866|NCT01080300|157398840|FG001|Overall Study|Withdrawal by Subject|28|||
48879867|NCT01080300|157398839|FG000|Overall Study|Reasons not specified|4|||
48879868|NCT01080300|157398840|FG001|Overall Study|Reasons not specified|6|||
48879869|NCT01436305|157398841|FG000|Overall Study|Death|1|||
48879870|NCT01436305|157398842|FG001|Overall Study|Death|0|||
48879871|NCT01436305|157398843|FG002|Overall Study|Death|0|||
48879872|NCT01436305|157398841|FG000|Overall Study|Lost to Follow-up|0|||
48879873|NCT01436305|157398842|FG001|Overall Study|Lost to Follow-up|1|||
48879874|NCT01436305|157398843|FG002|Overall Study|Lost to Follow-up|0|||
48879875|NCT01436305|157398841|FG000|Overall Study|Withdrawal by Subject|1|||
48879876|NCT01436305|157398842|FG001|Overall Study|Withdrawal by Subject|3|||
48879877|NCT01436305|157398843|FG002|Overall Study|Withdrawal by Subject|0|||
49033437|NCT03351244|157956937|FG000|Overall Study|Non-compliance|2|||
49033438|NCT03351244|157956938|FG001|Overall Study|Non-compliance|5|||
48879878|NCT01012947|157398844|FG000|Overall Study|Lost to Follow-up|131|||
48879879|NCT01012947|157398845|FG001|Overall Study|Lost to Follow-up|135|||
48879880|NCT01012947|157398846|FG002|Overall Study|Lost to Follow-up|130|||
48879881|NCT01012947|157398847|FG003|Overall Study|Lost to Follow-up|118|||
48879882|NCT01012947|157398848|FG004|Overall Study|Lost to Follow-up|142|||
48879883|NCT02353468|157398851|FG000|Overall Study|Study terminated|3|||
49033439|NCT03351244|157956939|FG002|Overall Study|Non-compliance|0|||
49033440|NCT03351244|157956937|FG000|Overall Study|Withdrawal by Subject|11|||
49033441|NCT03351244|157956938|FG001|Overall Study|Withdrawal by Subject|16|||
49033442|NCT03351244|157956939|FG002|Overall Study|Withdrawal by Subject|13|||
49033443|NCT03351244|157956937|FG000|Overall Study|Lost to Follow-up|2|||
49033444|NCT03351244|157956938|FG001|Overall Study|Lost to Follow-up|6|||
48879884|NCT02493946|157398852|FG000|DB Period|Withdrawal by Subject|8|||
48879885|NCT02493946|157398853|FG001|DB Period|Withdrawal by Subject|5|||
48879886|NCT02493946|157398854|FG002|DB Period|Withdrawal by Subject|0|||
48879887|NCT02493946|157398852|FG000|Open Label Period|Withdrawal by Subject|0|||
48879888|NCT02493946|157398853|FG001|Open Label Period|Withdrawal by Subject|0|||
48879889|NCT02493946|157398854|FG002|Open Label Period|Withdrawal by Subject|74|||
48879890|NCT02493946|157398852|FG000|Open Label Period|Adverse Event|0|||
48879891|NCT02493946|157398853|FG001|Open Label Period|Adverse Event|0|||
48879892|NCT02493946|157398854|FG002|Open Label Period|Adverse Event|4|||
48879893|NCT02493946|157398852|FG000|Open Label Period|Lost to Follow-up|0|||
48879894|NCT02493946|157398853|FG001|Open Label Period|Lost to Follow-up|0|||
48879895|NCT02493946|157398854|FG002|Open Label Period|Lost to Follow-up|1|||
48879896|NCT02493946|157398852|FG000|Open Label Period|Investigator decision, non-compliance|0|||
48879897|NCT02493946|157398853|FG001|Open Label Period|Investigator decision, non-compliance|0|||
48879898|NCT02493946|157398854|FG002|Open Label Period|Investigator decision, non-compliance|2|||
48879899|NCT02493946|157398852|FG000|Open Label Period|Investigator decision, non-availability|0|||
48879900|NCT02493946|157398853|FG001|Open Label Period|Investigator decision, non-availability|0|||
48879901|NCT02493946|157398854|FG002|Open Label Period|Investigator decision, non-availability|1|||
48879902|NCT02493946|157398852|FG000|Open Label Period|Pregnancy|0|||
48879903|NCT02493946|157398853|FG001|Open Label Period|Pregnancy|0|||
48879904|NCT02493946|157398854|FG002|Open Label Period|Pregnancy|3|||
48879905|NCT02493946|157398852|FG000|Open Label Period|Site error|0|||
48879906|NCT02493946|157398853|FG001|Open Label Period|Site error|0|||
48879907|NCT02493946|157398854|FG002|Open Label Period|Site error|1|||
48879908|NCT00895895|157398858|FG000|Period 1|Adverse Event|7|||
48879909|NCT00895895|157398859|FG001|Period 1|Adverse Event|6|||
48879910|NCT00895895|157398860|FG002|Period 1|Adverse Event|4|||
48879911|NCT00895895|157398861|FG003|Period 1|Adverse Event|6|||
48879912|NCT00895895|157398862|FG004|Period 1|Adverse Event|7|||
48879913|NCT00895895|157398858|FG000|Period 1|Death|0|||
48879914|NCT00895895|157398859|FG001|Period 1|Death|0|||
48879915|NCT00895895|157398860|FG002|Period 1|Death|0|||
48879916|NCT00895895|157398861|FG003|Period 1|Death|0|||
48879917|NCT00895895|157398862|FG004|Period 1|Death|1|||
48879918|NCT00895895|157398858|FG000|Period 1|discontinued by sponsor|2|||
48879919|NCT00895895|157398859|FG001|Period 1|discontinued by sponsor|1|||
48879920|NCT00895895|157398860|FG002|Period 1|discontinued by sponsor|2|||
48879921|NCT00895895|157398861|FG003|Period 1|discontinued by sponsor|1|||
48879922|NCT00895895|157398862|FG004|Period 1|discontinued by sponsor|1|||
48879923|NCT00895895|157398858|FG000|Period 1|failed to return|0|||
48879924|NCT00895895|157398859|FG001|Period 1|failed to return|0|||
48879925|NCT00895895|157398860|FG002|Period 1|failed to return|1|||
48879926|NCT00895895|157398861|FG003|Period 1|failed to return|0|||
48879927|NCT00895895|157398862|FG004|Period 1|failed to return|1|||
48879928|NCT00895895|157398858|FG000|Period 1|investigator request|0|||
49033445|NCT03351244|157956939|FG002|Overall Study|Lost to Follow-up|4|||
48879929|NCT00895895|157398859|FG001|Period 1|investigator request|1|||
48879930|NCT00895895|157398860|FG002|Period 1|investigator request|0|||
48879931|NCT00895895|157398861|FG003|Period 1|investigator request|0|||
48879932|NCT00895895|157398862|FG004|Period 1|investigator request|0|||
48879933|NCT00895895|157398858|FG000|Period 1|Lost to Follow-up|2|||
48879934|NCT00895895|157398859|FG001|Period 1|Lost to Follow-up|1|||
48879935|NCT00895895|157398860|FG002|Period 1|Lost to Follow-up|3|||
48879936|NCT00895895|157398861|FG003|Period 1|Lost to Follow-up|2|||
48879937|NCT00895895|157398862|FG004|Period 1|Lost to Follow-up|3|||
49033446|NCT03351244|157956937|FG000|Overall Study|Protocol Violation|2|||
48879938|NCT00895895|157398858|FG000|Period 1|Other|1|||
48879939|NCT00895895|157398859|FG001|Period 1|Other|2|||
48879940|NCT00895895|157398860|FG002|Period 1|Other|1|||
48879941|NCT00895895|157398861|FG003|Period 1|Other|1|||
48879942|NCT00895895|157398862|FG004|Period 1|Other|1|||
48879943|NCT00895895|157398858|FG000|Period 1|Protocol Violation|0|||
48879944|NCT00895895|157398859|FG001|Period 1|Protocol Violation|1|||
48879945|NCT00895895|157398860|FG002|Period 1|Protocol Violation|0|||
48879946|NCT00895895|157398861|FG003|Period 1|Protocol Violation|0|||
48879947|NCT00895895|157398862|FG004|Period 1|Protocol Violation|0|||
48879948|NCT00895895|157398858|FG000|Period 1|Withdrawal by Subject|6|||
48879949|NCT00895895|157398859|FG001|Period 1|Withdrawal by Subject|6|||
48879950|NCT00895895|157398860|FG002|Period 1|Withdrawal by Subject|8|||
48879951|NCT00895895|157398861|FG003|Period 1|Withdrawal by Subject|2|||
48879952|NCT00895895|157398862|FG004|Period 1|Withdrawal by Subject|4|||
48879953|NCT00895895|157398858|FG000|Period 1|unsatisfactory response-efficacy|2|||
48879954|NCT00895895|157398859|FG001|Period 1|unsatisfactory response-efficacy|0|||
48879955|NCT00895895|157398860|FG002|Period 1|unsatisfactory response-efficacy|0|||
48879956|NCT00895895|157398861|FG003|Period 1|unsatisfactory response-efficacy|0|||
48879957|NCT00895895|157398862|FG004|Period 1|unsatisfactory response-efficacy|0|||
48879958|NCT00895895|157398858|FG000|Period 1|randomized and not treated|1|||
48879959|NCT00895895|157398859|FG001|Period 1|randomized and not treated|3|||
48879960|NCT00895895|157398860|FG002|Period 1|randomized and not treated|1|||
48879961|NCT00895895|157398861|FG003|Period 1|randomized and not treated|1|||
48879962|NCT00895895|157398862|FG004|Period 1|randomized and not treated|2|||
48879963|NCT00895895|157398858|FG000|After Period 1, Prior to Period 2|Adverse Event|0|||
48879964|NCT00895895|157398859|FG001|After Period 1, Prior to Period 2|Adverse Event|0|||
48879965|NCT00895895|157398860|FG002|After Period 1, Prior to Period 2|Adverse Event|1|||
48879966|NCT00895895|157398861|FG003|After Period 1, Prior to Period 2|Adverse Event|0|||
48879967|NCT00895895|157398862|FG004|After Period 1, Prior to Period 2|Adverse Event|0|||
49033447|NCT03351244|157956938|FG001|Overall Study|Protocol Violation|2|||
49033448|NCT03351244|157956939|FG002|Overall Study|Protocol Violation|0|||
48879968|NCT00895895|157398858|FG000|After Period 1, Prior to Period 2|Other|0|||
48879969|NCT00895895|157398859|FG001|After Period 1, Prior to Period 2|Other|0|||
48879970|NCT00895895|157398860|FG002|After Period 1, Prior to Period 2|Other|1|||
49033449|NCT03247972|157956940|FG000|High Dose Statin Run-In Period (8 Weeks)|Withdrawal by Subject|4|||
49033450|NCT03247972|157956940|FG000|High Dose Statins + Evolocumab (8 Weeks)|Withdrawal by Subject|2|||
49033451|NCT00968812|157956941|FG000|Overall Study|Adverse Event|30|||
49033452|NCT00968812|157956942|FG001|Overall Study|Adverse Event|46|||
49033453|NCT00968812|157956943|FG002|Overall Study|Adverse Event|33|||
49033454|NCT00968812|157956941|FG000|Overall Study|Death|2|||
49033455|NCT00968812|157956942|FG001|Overall Study|Death|2|||
49033456|NCT00968812|157956943|FG002|Overall Study|Death|1|||
49033457|NCT00968812|157956941|FG000|Overall Study|Lack of Efficacy|9|||
48879971|NCT00895895|157398861|FG003|After Period 1, Prior to Period 2|Other|0|||
48879972|NCT00895895|157398862|FG004|After Period 1, Prior to Period 2|Other|0|||
48879973|NCT00895895|157398858|FG000|After Period 1, Prior to Period 2|Protocol Violation|0|||
48879974|NCT00895895|157398859|FG001|After Period 1, Prior to Period 2|Protocol Violation|0|||
48879975|NCT00895895|157398860|FG002|After Period 1, Prior to Period 2|Protocol Violation|0|||
48879976|NCT00895895|157398861|FG003|After Period 1, Prior to Period 2|Protocol Violation|0|||
48879977|NCT00895895|157398862|FG004|After Period 1, Prior to Period 2|Protocol Violation|1|||
48879978|NCT00895895|157398858|FG000|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
48879979|NCT00895895|157398859|FG001|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
48879980|NCT00895895|157398860|FG002|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
48879981|NCT00895895|157398861|FG003|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
48879982|NCT00895895|157398862|FG004|After Period 1, Prior to Period 2|Withdrawal by Subject|1|||
48879983|NCT00895895|157398858|FG000|Period 2|Adverse Event|3|||
48879984|NCT00895895|157398859|FG001|Period 2|Adverse Event|3|||
48879985|NCT00895895|157398860|FG002|Period 2|Adverse Event|5|||
48879986|NCT00895895|157398861|FG003|Period 2|Adverse Event|2|||
48879987|NCT00895895|157398862|FG004|Period 2|Adverse Event|5|||
48879988|NCT00895895|157398858|FG000|Period 2|Death|0|||
48879989|NCT00895895|157398859|FG001|Period 2|Death|0|||
48879990|NCT00895895|157398860|FG002|Period 2|Death|1|||
48879991|NCT00895895|157398861|FG003|Period 2|Death|0|||
48879992|NCT00895895|157398862|FG004|Period 2|Death|0|||
48879993|NCT00895895|157398858|FG000|Period 2|discontinued by sponsor|44|||
49033458|NCT00968812|157956942|FG001|Overall Study|Lack of Efficacy|7|||
49033459|NCT00968812|157956943|FG002|Overall Study|Lack of Efficacy|16|||
48879994|NCT00895895|157398859|FG001|Period 2|discontinued by sponsor|44|||
48879995|NCT00895895|157398860|FG002|Period 2|discontinued by sponsor|38|||
48879996|NCT00895895|157398861|FG003|Period 2|discontinued by sponsor|46|||
48879997|NCT00895895|157398862|FG004|Period 2|discontinued by sponsor|37|||
48879998|NCT00895895|157398858|FG000|Period 2|failed to return|2|||
48879999|NCT00895895|157398859|FG001|Period 2|failed to return|0|||
48880000|NCT00895895|157398860|FG002|Period 2|failed to return|0|||
48880001|NCT00895895|157398861|FG003|Period 2|failed to return|0|||
48880002|NCT00895895|157398862|FG004|Period 2|failed to return|0|||
48880003|NCT00895895|157398858|FG000|Period 2|investigator request|2|||
48880004|NCT00895895|157398859|FG001|Period 2|investigator request|0|||
48880005|NCT00895895|157398860|FG002|Period 2|investigator request|0|||
48880006|NCT00895895|157398861|FG003|Period 2|investigator request|0|||
48880007|NCT00895895|157398862|FG004|Period 2|investigator request|0|||
48880008|NCT00895895|157398858|FG000|Period 2|Lost to Follow-up|1|||
48880009|NCT00895895|157398859|FG001|Period 2|Lost to Follow-up|2|||
48880010|NCT00895895|157398860|FG002|Period 2|Lost to Follow-up|1|||
48880011|NCT00895895|157398861|FG003|Period 2|Lost to Follow-up|1|||
48880012|NCT00895895|157398862|FG004|Period 2|Lost to Follow-up|0|||
48880013|NCT00895895|157398858|FG000|Period 2|Other|1|||
48880014|NCT00895895|157398859|FG001|Period 2|Other|1|||
48880015|NCT00895895|157398860|FG002|Period 2|Other|3|||
48880016|NCT00895895|157398861|FG003|Period 2|Other|1|||
48880017|NCT00895895|157398862|FG004|Period 2|Other|1|||
48880018|NCT00895895|157398858|FG000|Period 2|Protocol Violation|1|||
48880019|NCT00895895|157398859|FG001|Period 2|Protocol Violation|0|||
48880020|NCT00895895|157398860|FG002|Period 2|Protocol Violation|1|||
48880021|NCT00895895|157398861|FG003|Period 2|Protocol Violation|1|||
48880022|NCT00895895|157398862|FG004|Period 2|Protocol Violation|1|||
48880023|NCT00895895|157398858|FG000|Period 2|Withdrawal by Subject|0|||
48880024|NCT00895895|157398859|FG001|Period 2|Withdrawal by Subject|2|||
48880025|NCT00895895|157398860|FG002|Period 2|Withdrawal by Subject|0|||
48880026|NCT00895895|157398861|FG003|Period 2|Withdrawal by Subject|3|||
48880027|NCT00895895|157398862|FG004|Period 2|Withdrawal by Subject|5|||
48880028|NCT00895895|157398858|FG000|Period 2|unsatisfactory response-efficacy|2|||
48880029|NCT00895895|157398859|FG001|Period 2|unsatisfactory response-efficacy|1|||
48880030|NCT00895895|157398860|FG002|Period 2|unsatisfactory response-efficacy|0|||
48880031|NCT00895895|157398861|FG003|Period 2|unsatisfactory response-efficacy|0|||
48880032|NCT00895895|157398862|FG004|Period 2|unsatisfactory response-efficacy|0|||
48880033|NCT01289210|157398868|FG000|Overall Study|Adverse Event|1|||
48880034|NCT02595372|157398869|FG000|Overall Study|Adverse Event|6|||
48880035|NCT02595372|157398869|FG000|Overall Study|Physician Decision|2|||
48880036|NCT02595372|157398869|FG000|Overall Study|Disease Progression|1|||
48880037|NCT02688530|157398870|FG000|Overall Study|Withdrawal by Subject|0|||
48880038|NCT02688530|157398871|FG001|Overall Study|Withdrawal by Subject|1|||
48880039|NCT02688530|157398872|FG002|Overall Study|Withdrawal by Subject|0|||
48880040|NCT02688530|157398873|FG003|Overall Study|Withdrawal by Subject|0|||
48880041|NCT02688530|157398870|FG000|Overall Study|Lost to Follow-up|0|||
48880042|NCT02688530|157398871|FG001|Overall Study|Lost to Follow-up|0|||
48880043|NCT02688530|157398872|FG002|Overall Study|Lost to Follow-up|2|||
48880044|NCT02688530|157398873|FG003|Overall Study|Lost to Follow-up|0|||
48880045|NCT00763451|157398879|FG000|Overall Study|Adverse Event|4|||
48880046|NCT00763451|157398880|FG001|Overall Study|Adverse Event|6|||
49033460|NCT00968812|157956941|FG000|Overall Study|Lost to Follow-up|17|||
48880047|NCT00763451|157398881|FG002|Overall Study|Adverse Event|19|||
48880048|NCT00763451|157398882|FG003|Overall Study|Adverse Event|14|||
48880049|NCT00763451|157398879|FG000|Overall Study|Lack of Efficacy|1|||
48880050|NCT00763451|157398880|FG001|Overall Study|Lack of Efficacy|4|||
48880051|NCT00763451|157398881|FG002|Overall Study|Lack of Efficacy|3|||
48880052|NCT00763451|157398882|FG003|Overall Study|Lack of Efficacy|2|||
48880053|NCT00763451|157398879|FG000|Overall Study|Withdrawal by Subject|1|||
48880054|NCT00763451|157398880|FG001|Overall Study|Withdrawal by Subject|6|||
48880055|NCT00763451|157398881|FG002|Overall Study|Withdrawal by Subject|9|||
48880056|NCT00763451|157398882|FG003|Overall Study|Withdrawal by Subject|7|||
48880057|NCT00763451|157398879|FG000|Overall Study|Protocol Violation|0|||
48880058|NCT00763451|157398880|FG001|Overall Study|Protocol Violation|0|||
48880059|NCT00763451|157398881|FG002|Overall Study|Protocol Violation|1|||
48880060|NCT00763451|157398882|FG003|Overall Study|Protocol Violation|0|||
48880061|NCT00763451|157398879|FG000|Overall Study|Poor Compliance to Protocol|1|||
48880062|NCT00763451|157398880|FG001|Overall Study|Poor Compliance to Protocol|1|||
48880063|NCT00763451|157398881|FG002|Overall Study|Poor Compliance to Protocol|2|||
48880064|NCT00763451|157398882|FG003|Overall Study|Poor Compliance to Protocol|2|||
48880065|NCT00763451|157398879|FG000|Overall Study|Familial and Personal Reasons|5|||
48880066|NCT00763451|157398880|FG001|Overall Study|Familial and Personal Reasons|3|||
48880067|NCT00763451|157398881|FG002|Overall Study|Familial and Personal Reasons|5|||
48880068|NCT00763451|157398882|FG003|Overall Study|Familial and Personal Reasons|4|||
48880069|NCT00763451|157398879|FG000|Overall Study|Randomized but not Treated|1|||
49033461|NCT00968812|157956942|FG001|Overall Study|Lost to Follow-up|12|||
49033462|NCT00968812|157956943|FG002|Overall Study|Lost to Follow-up|11|||
48880070|NCT00763451|157398880|FG001|Overall Study|Randomized but not Treated|1|||
48880071|NCT00763451|157398881|FG002|Overall Study|Randomized but not Treated|0|||
48880072|NCT00763451|157398882|FG003|Overall Study|Randomized but not Treated|0|||
48880073|NCT00763451|157398879|FG000|Overall Study|Study Site Reason|0|||
48880074|NCT00763451|157398880|FG001|Overall Study|Study Site Reason|1|||
48880075|NCT00763451|157398881|FG002|Overall Study|Study Site Reason|1|||
48880076|NCT00763451|157398882|FG003|Overall Study|Study Site Reason|1|||
48880077|NCT03995316|157398885|FG000|Overall Study|Lost to Follow-up|10|||
48880078|NCT03995316|157398886|FG001|Overall Study|Lost to Follow-up|3|||
48880079|NCT01294436|157398887|FG000|Overall Study|Adverse Event|10|||
48880080|NCT01294436|157398888|FG001|Overall Study|Adverse Event|17|||
48880081|NCT01294436|157398887|FG000|Overall Study|Withdrawal by Subject|11|||
48880082|NCT01294436|157398888|FG001|Overall Study|Withdrawal by Subject|28|||
49033463|NCT00968812|157956941|FG000|Overall Study|Physician Decision|8|||
48880083|NCT01294436|157398887|FG000|Overall Study|subject no longer meets study criteria|5|||
48880084|NCT01294436|157398888|FG001|Overall Study|subject no longer meets study criteria|20|||
48880085|NCT01294436|157398887|FG000|Overall Study|poor/non-compliance|2|||
48880086|NCT01294436|157398888|FG001|Overall Study|poor/non-compliance|5|||
48880087|NCT02296892|157398889|FG000|Overall Study|Exclusion Criteria at Day of Procedure|7|||
48880088|NCT02296892|157398890|FG001|Overall Study|Exclusion Criteria at Day of Procedure|4|||
48880089|NCT02296892|157398891|FG002|Overall Study|Exclusion Criteria at Day of Procedure|4|||
48880090|NCT02296892|157398889|FG000|Overall Study|Lost to Follow-up|5|||
48880091|NCT02296892|157398890|FG001|Overall Study|Lost to Follow-up|0|||
48880092|NCT02296892|157398891|FG002|Overall Study|Lost to Follow-up|1|||
48880093|NCT01814072|157398894|FG000|Overall Study|Lost to Follow-up|2|||
48880094|NCT01814072|157398895|FG001|Overall Study|Lost to Follow-up|2|||
48880095|NCT01814072|157398896|FG002|Overall Study|Lost to Follow-up|2|||
48880096|NCT01814072|157398897|FG003|Overall Study|Lost to Follow-up|0|||
48880097|NCT01814072|157398898|FG004|Overall Study|Lost to Follow-up|2|||
48880098|NCT01814072|157398899|FG005|Overall Study|Lost to Follow-up|3|||
48880099|NCT01814072|157398900|FG006|Overall Study|Lost to Follow-up|3|||
48880100|NCT01814072|157398901|FG007|Overall Study|Lost to Follow-up|1|||
48880101|NCT01814072|157398902|FG008|Overall Study|Lost to Follow-up|2|||
48880102|NCT01814072|157398903|FG009|Overall Study|Lost to Follow-up|3|||
48880103|NCT01814072|157398904|FG010|Overall Study|Lost to Follow-up|1|||
48880104|NCT01814072|157398905|FG011|Overall Study|Lost to Follow-up|2|||
48880105|NCT01814072|157398906|FG012|Overall Study|Lost to Follow-up|2|||
48880106|NCT01814072|157398907|FG013|Overall Study|Lost to Follow-up|1|||
48880107|NCT01814072|157398908|FG014|Overall Study|Lost to Follow-up|2|||
48880108|NCT01814072|157398909|FG015|Overall Study|Lost to Follow-up|1|||
48880109|NCT01814072|157398910|FG016|Overall Study|Lost to Follow-up|3|||
48880110|NCT01814072|157398911|FG017|Overall Study|Lost to Follow-up|1|||
48880111|NCT01814072|157398912|FG018|Overall Study|Lost to Follow-up|3|||
48880112|NCT01814072|157398913|FG019|Overall Study|Lost to Follow-up|3|||
48880113|NCT01814072|157398914|FG020|Overall Study|Lost to Follow-up|2|||
48880114|NCT01814072|157398915|FG021|Overall Study|Lost to Follow-up|1|||
48880115|NCT01814072|157398916|FG022|Overall Study|Lost to Follow-up|3|||
48880116|NCT01814072|157398917|FG023|Overall Study|Lost to Follow-up|1|||
48880117|NCT01814072|157398918|FG024|Overall Study|Lost to Follow-up|4|||
48880118|NCT01814072|157398919|FG025|Overall Study|Lost to Follow-up|1|||
48880119|NCT01814072|157398920|FG026|Overall Study|Lost to Follow-up|1|||
48880120|NCT01814072|157398921|FG027|Overall Study|Lost to Follow-up|2|||
48880121|NCT01814072|157398922|FG028|Overall Study|Lost to Follow-up|3|||
48880122|NCT01814072|157398923|FG029|Overall Study|Lost to Follow-up|3|||
48880123|NCT01814072|157398924|FG030|Overall Study|Lost to Follow-up|2|||
48880124|NCT01814072|157398925|FG031|Overall Study|Lost to Follow-up|0|||
48880125|NCT01814072|157398894|FG000|Overall Study|Withdrawal by Subject|2|||
48880126|NCT01814072|157398895|FG001|Overall Study|Withdrawal by Subject|0|||
48880127|NCT01814072|157398896|FG002|Overall Study|Withdrawal by Subject|1|||
48880128|NCT01814072|157398897|FG003|Overall Study|Withdrawal by Subject|0|||
48880129|NCT01814072|157398898|FG004|Overall Study|Withdrawal by Subject|2|||
48880130|NCT01814072|157398899|FG005|Overall Study|Withdrawal by Subject|3|||
48880131|NCT01814072|157398900|FG006|Overall Study|Withdrawal by Subject|1|||
48880132|NCT01814072|157398901|FG007|Overall Study|Withdrawal by Subject|0|||
48880133|NCT01814072|157398902|FG008|Overall Study|Withdrawal by Subject|1|||
48880134|NCT01814072|157398903|FG009|Overall Study|Withdrawal by Subject|2|||
48880135|NCT01814072|157398904|FG010|Overall Study|Withdrawal by Subject|0|||
48880136|NCT01814072|157398905|FG011|Overall Study|Withdrawal by Subject|0|||
48880137|NCT01814072|157398906|FG012|Overall Study|Withdrawal by Subject|1|||
48880138|NCT01814072|157398907|FG013|Overall Study|Withdrawal by Subject|1|||
48880139|NCT01814072|157398908|FG014|Overall Study|Withdrawal by Subject|1|||
48880140|NCT01814072|157398909|FG015|Overall Study|Withdrawal by Subject|1|||
48880141|NCT01814072|157398910|FG016|Overall Study|Withdrawal by Subject|0|||
48880142|NCT01814072|157398911|FG017|Overall Study|Withdrawal by Subject|0|||
48880143|NCT01814072|157398912|FG018|Overall Study|Withdrawal by Subject|0|||
48880144|NCT01814072|157398913|FG019|Overall Study|Withdrawal by Subject|2|||
48880145|NCT01814072|157398914|FG020|Overall Study|Withdrawal by Subject|0|||
48880146|NCT01814072|157398915|FG021|Overall Study|Withdrawal by Subject|0|||
48880147|NCT01814072|157398916|FG022|Overall Study|Withdrawal by Subject|1|||
48880148|NCT01814072|157398917|FG023|Overall Study|Withdrawal by Subject|0|||
48880149|NCT01814072|157398918|FG024|Overall Study|Withdrawal by Subject|2|||
48880150|NCT01814072|157398919|FG025|Overall Study|Withdrawal by Subject|1|||
48880151|NCT01814072|157398920|FG026|Overall Study|Withdrawal by Subject|1|||
48880152|NCT01814072|157398921|FG027|Overall Study|Withdrawal by Subject|2|||
48880153|NCT01814072|157398922|FG028|Overall Study|Withdrawal by Subject|1|||
48880154|NCT01814072|157398923|FG029|Overall Study|Withdrawal by Subject|0|||
48880155|NCT01814072|157398924|FG030|Overall Study|Withdrawal by Subject|0|||
48880156|NCT01814072|157398925|FG031|Overall Study|Withdrawal by Subject|0|||
48880157|NCT00760747|157398926|FG000|Study Period II|Adverse Event|3|||
48880158|NCT00760747|157398927|FG001|Study Period II|Adverse Event|4|||
48880159|NCT00760747|157398926|FG000|Study Period II|Lack of Efficacy|0|||
49033464|NCT00968812|157956942|FG001|Overall Study|Physician Decision|5|||
49033465|NCT00968812|157956943|FG002|Overall Study|Physician Decision|9|||
49033466|NCT00968812|157956941|FG000|Overall Study|Protocol Violation|7|||
49033467|NCT00968812|157956942|FG001|Overall Study|Protocol Violation|4|||
49033468|NCT00968812|157956943|FG002|Overall Study|Protocol Violation|3|||
49033469|NCT00968812|157956941|FG000|Overall Study|Withdrawal by Subject|17|||
49033470|NCT00968812|157956942|FG001|Overall Study|Withdrawal by Subject|23|||
49033471|NCT00968812|157956943|FG002|Overall Study|Withdrawal by Subject|25|||
49033472|NCT00968812|157956941|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|9|||
49033473|NCT00968812|157956942|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|13|||
49033474|NCT00968812|157956943|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|7|||
49033475|NCT00968812|157956941|FG000|Overall Study|Noncompliance with study drug|4|||
49033476|NCT00968812|157956942|FG001|Overall Study|Noncompliance with study drug|1|||
49033477|NCT00968812|157956943|FG002|Overall Study|Noncompliance with study drug|6|||
49033478|NCT00968812|157956941|FG000|Overall Study|Unable to take rescue therapy|12|||
49033479|NCT00968812|157956942|FG001|Overall Study|Unable to take rescue therapy|12|||
49033480|NCT00968812|157956943|FG002|Overall Study|Unable to take rescue therapy|17|||
49033481|NCT00968812|157956941|FG000|Overall Study|Other|25|||
49033482|NCT00968812|157956942|FG001|Overall Study|Other|37|||
49033483|NCT00968812|157956943|FG002|Overall Study|Other|40|||
49033484|NCT02576938|157956946|FG000|Overall Study|Adverse Event|5|||
49033485|NCT02576938|157956947|FG001|Overall Study|Adverse Event|3|||
49033486|NCT02576938|157956948|FG002|Overall Study|Adverse Event|6|||
49033487|NCT02576938|157956946|FG000|Overall Study|Protocol Violation|1|||
49033488|NCT02576938|157956947|FG001|Overall Study|Protocol Violation|1|||
49033489|NCT02576938|157956948|FG002|Overall Study|Protocol Violation|1|||
49033490|NCT02576938|157956946|FG000|Overall Study|Withdrawal by Subject|3|||
49033491|NCT02576938|157956947|FG001|Overall Study|Withdrawal by Subject|2|||
49033492|NCT02576938|157956948|FG002|Overall Study|Withdrawal by Subject|4|||
49033493|NCT02576938|157956946|FG000|Overall Study|Lack of Efficacy|9|||
49033494|NCT02576938|157956947|FG001|Overall Study|Lack of Efficacy|4|||
49033495|NCT02576938|157956948|FG002|Overall Study|Lack of Efficacy|0|||
49033496|NCT02576938|157956946|FG000|Overall Study|Lost to Follow-up|2|||
49033497|NCT02576938|157956947|FG001|Overall Study|Lost to Follow-up|0|||
49033498|NCT02576938|157956948|FG002|Overall Study|Lost to Follow-up|1|||
49033499|NCT02576938|157956946|FG000|Overall Study|Physician Decision|0|||
49033500|NCT02576938|157956947|FG001|Overall Study|Physician Decision|1|||
49033501|NCT02576938|157956948|FG002|Overall Study|Physician Decision|0|||
49033502|NCT02576938|157956946|FG000|Overall Study|Met Exclusion Criteria|0|||
49033503|NCT02576938|157956947|FG001|Overall Study|Met Exclusion Criteria|1|||
49033504|NCT02576938|157956948|FG002|Overall Study|Met Exclusion Criteria|0|||
49033505|NCT01244620|157956952|FG000|Overall Study|Study terminated|4|||
49033506|NCT01244620|157956953|FG001|Overall Study|Study terminated|4|||
49033507|NCT01244620|157956954|FG002|Overall Study|Study terminated|4|||
49033508|NCT01244620|157956955|FG003|Overall Study|Study terminated|4|||
49033509|NCT03872128|157956961|FG000|Overall Study|Dropped out before treatment|1|||
49033510|NCT03872128|157956962|FG001|Overall Study|Dropped out before treatment|0|||
49033511|NCT03872128|157956963|FG002|Overall Study|Dropped out before treatment|4|||
49033512|NCT03872128|157956961|FG000|Overall Study|Lost to Follow-up|2|||
49033513|NCT03872128|157956962|FG001|Overall Study|Lost to Follow-up|5|||
49033514|NCT03872128|157956963|FG002|Overall Study|Lost to Follow-up|8|||
49033515|NCT02286739|157958570|FG000|Overall Study|Verasense type posterior stabilizing (PS)|37|||
49033516|NCT02286739|157958571|FG001|Overall Study|Verasense type posterior stabilizing (PS)|16|||
49033517|NCT02286739|157958570|FG000|Overall Study|No Verasense type documented|0|||
49033518|NCT02286739|157958571|FG001|Overall Study|No Verasense type documented|23|||
49033519|NCT02286739|157958570|FG000|Overall Study|Adverse Event|1|||
49033520|NCT02286739|157958571|FG001|Overall Study|Adverse Event|2|||
49033521|NCT02286739|157958570|FG000|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|86|||
49033522|NCT02286739|157958571|FG001|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|112|||
49033523|NCT00835991|157958582|FG000|First Intervention|Adverse Event|0|||
48880160|NCT00760747|157398927|FG001|Study Period II|Lack of Efficacy|6|||
48880161|NCT00760747|157398926|FG000|Study Period II|Parent/Caregiver Decision|3|||
48880162|NCT00760747|157398927|FG001|Study Period II|Parent/Caregiver Decision|0|||
48880163|NCT00760747|157398926|FG000|Study Period II|Protocol Violation|6|||
48880164|NCT00760747|157398927|FG001|Study Period II|Protocol Violation|3|||
48880165|NCT00760747|157398926|FG000|Study Period II|Withdrawal by Subject|1|||
48880166|NCT00760747|157398927|FG001|Study Period II|Withdrawal by Subject|0|||
49033524|NCT00835991|157958583|FG001|First Intervention|Adverse Event|1|||
49033525|NCT00835991|157958582|FG000|Washout|Protocol Violation|0|||
48880167|NCT00760747|157398926|FG000|Study Period II|No drug administered|0|||
48880168|NCT00760747|157398927|FG001|Study Period II|No drug administered|1|||
48880169|NCT00760747|157398926|FG000|Study Period III|Adverse Event|1|||
48880170|NCT00760747|157398927|FG001|Study Period III|Adverse Event|0|||
48880171|NCT00760747|157398926|FG000|Study Period III|Lack of Efficacy|1|||
48880172|NCT00760747|157398927|FG001|Study Period III|Lack of Efficacy|0|||
49033526|NCT00835991|157958583|FG001|Washout|Protocol Violation|2|||
49033527|NCT00835991|157958582|FG000|Washout|Withdrawal by Subject|3|||
49033528|NCT00835991|157958583|FG001|Washout|Withdrawal by Subject|1|||
49033529|NCT02149420|157958584|FG000|Core Study|Administrative problems|0|||
49033530|NCT02149420|157958585|FG001|Core Study|Administrative problems|1|||
49033531|NCT02149420|157958586|FG002|Core Study|Administrative problems|2|||
49033532|NCT02149420|157958584|FG000|Open Label VAY736 10 mg/kg Extension|Administrative problems|1|||
49033533|NCT02149420|157958585|FG001|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
49033534|NCT02149420|157958586|FG002|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
48880173|NCT00760747|157398926|FG000|Study Period III|Parent/Caregiver Decision|0|||
48880174|NCT00760747|157398927|FG001|Study Period III|Parent/Caregiver Decision|1|||
48880175|NCT00760747|157398926|FG000|Study Period III|Protocol Violation|1|||
48880176|NCT00760747|157398927|FG001|Study Period III|Protocol Violation|1|||
48880177|NCT00760747|157398926|FG000|Study Period III|Physician Decision|0|||
48880178|NCT00760747|157398927|FG001|Study Period III|Physician Decision|1|||
48880179|NCT03566979|157398928|FG000|Overall Study|Withdrawal by Subject|2|||
48880180|NCT03566979|157398929|FG001|Overall Study|Withdrawal by Subject|0|||
48880181|NCT03566979|157398930|FG002|Overall Study|Withdrawal by Subject|1|||
48880182|NCT03566979|157398931|FG003|Overall Study|Withdrawal by Subject|1|||
48880183|NCT03566979|157398928|FG000|Overall Study|Lost to Follow-up|2|||
48880184|NCT03566979|157398929|FG001|Overall Study|Lost to Follow-up|7|||
48880185|NCT03566979|157398930|FG002|Overall Study|Lost to Follow-up|9|||
48880186|NCT03566979|157398931|FG003|Overall Study|Lost to Follow-up|5|||
48880187|NCT03566979|157398928|FG000|Overall Study|Adverse Event|1|||
48880188|NCT03566979|157398929|FG001|Overall Study|Adverse Event|0|||
48880189|NCT03566979|157398930|FG002|Overall Study|Adverse Event|0|||
48880190|NCT03566979|157398931|FG003|Overall Study|Adverse Event|0|||
48880191|NCT04887506|157398934|FG000|Overall Study|Death|1|||
48880192|NCT04887506|157398935|FG001|Overall Study|Death|1|||
48880193|NCT04887506|157398934|FG000|Overall Study|Withdrawal by Subject|0|||
48880194|NCT04887506|157398935|FG001|Overall Study|Withdrawal by Subject|3|||
48880195|NCT04887506|157398934|FG000|Overall Study|Adverse Event|4|||
48880196|NCT04887506|157398935|FG001|Overall Study|Adverse Event|3|||
48880197|NCT04887506|157398934|FG000|Overall Study|Other - Not Reported|1|||
48880198|NCT04887506|157398935|FG001|Overall Study|Other - Not Reported|1|||
48880199|NCT04547023|157398936|FG000|Overall Study|Did Not Receive Intervention|3|||
48880200|NCT04547023|157398937|FG001|Overall Study|Did Not Receive Intervention|2|||
48880201|NCT04547023|157398936|FG000|Overall Study|Lost to Follow-up|1|||
48880202|NCT04547023|157398937|FG001|Overall Study|Lost to Follow-up|1|||
48880203|NCT02336451|157398940|FG000|Overall Study|Adverse Event|1|||
48880204|NCT02336451|157398941|FG001|Overall Study|Adverse Event|2|||
48880205|NCT02336451|157398942|FG002|Overall Study|Adverse Event|0|||
48880206|NCT02336451|157398943|FG003|Overall Study|Adverse Event|6|||
49033535|NCT02269657|157958587|FG000|Overall Study|Protocol Violation|3|||
49033536|NCT00856388|157958589|FG000|Overall Study|Other|1|||
49033537|NCT01111461|157958590|FG000|Overall Study|Adverse Event|32|||
49033538|NCT01111461|157958590|FG000|Overall Study|Participant choice|11|||
49033539|NCT01111461|157958590|FG000|Overall Study|Lost to Follow-up|1|||
49033540|NCT01111461|157958590|FG000|Overall Study|Withdrawal by Subject|1|||
49033541|NCT01111461|157958590|FG000|Overall Study|Other|6|||
49033542|NCT00851877|157958591|FG000|Phase I-1|Death|1|||
49033543|NCT00851877|157958592|FG001|Phase I-1|Death|0|||
49033544|NCT00851877|157958593|FG002|Phase I-1|Death|0|||
49033545|NCT00851877|157958591|FG000|Phase II|Withdrawal by Subject|0|||
49033546|NCT00851877|157958592|FG001|Phase II|Withdrawal by Subject|0|||
49033547|NCT00851877|157958593|FG002|Phase II|Withdrawal by Subject|3|||
49033548|NCT04278560|157958594|FG000|Overall Study|Adverse Event|1|||
49033549|NCT04278560|157958595|FG001|Overall Study|Adverse Event|2|||
49033550|NCT04278560|157958594|FG000|Overall Study|Withdrawal by Subject|0|||
49033551|NCT04278560|157958595|FG001|Overall Study|Withdrawal by Subject|1|||
49033552|NCT01247701|157958597|FG000|Overall Study|Death|2|||
49033553|NCT01247701|157958597|FG000|Overall Study|Relapsed|8|||
49033554|NCT00834067|157958598|FG000|Washout of 21 Days|Protocol Violation|0|||
48880207|NCT02336451|157398944|FG004|Overall Study|Adverse Event|4|||
48880208|NCT02336451|157398940|FG000|Overall Study|Death|6|||
48880209|NCT02336451|157398941|FG001|Overall Study|Death|2|||
48880210|NCT02336451|157398942|FG002|Overall Study|Death|3|||
48880211|NCT02336451|157398943|FG003|Overall Study|Death|6|||
48880212|NCT02336451|157398944|FG004|Overall Study|Death|6|||
48880213|NCT02336451|157398940|FG000|Overall Study|Physician Decision|9|||
49033555|NCT00834067|157958599|FG001|Washout of 21 Days|Protocol Violation|1|||
49033556|NCT00272779|157958601|FG000|Baseline Through Week 48|Adverse event before Week 48|10|||
49033557|NCT00272779|157958602|FG001|Baseline Through Week 48|Adverse event before Week 48|14|||
49033558|NCT00272779|157958601|FG000|Baseline Through Week 48|Death before Week 48|4|||
48880214|NCT02336451|157398941|FG001|Overall Study|Physician Decision|6|||
48880215|NCT02336451|157398942|FG002|Overall Study|Physician Decision|7|||
49033559|NCT00272779|157958602|FG001|Baseline Through Week 48|Death before Week 48|4|||
49033560|NCT00272779|157958601|FG000|Baseline Through Week 48|Lack of efficacy before Week 48|5|||
48880216|NCT02336451|157398943|FG003|Overall Study|Physician Decision|16|||
48880217|NCT02336451|157398944|FG004|Overall Study|Physician Decision|3|||
48880218|NCT02336451|157398940|FG000|Overall Study|Progressive disease|23|||
48880219|NCT02336451|157398941|FG001|Overall Study|Progressive disease|26|||
48880220|NCT02336451|157398942|FG002|Overall Study|Progressive disease|2|||
48880221|NCT02336451|157398943|FG003|Overall Study|Progressive disease|14|||
48880222|NCT02336451|157398944|FG004|Overall Study|Progressive disease|4|||
48880223|NCT02336451|157398940|FG000|Overall Study|Protocol Violation|1|||
48880224|NCT02336451|157398941|FG001|Overall Study|Protocol Violation|0|||
48880225|NCT02336451|157398942|FG002|Overall Study|Protocol Violation|0|||
48880226|NCT02336451|157398943|FG003|Overall Study|Protocol Violation|0|||
48880227|NCT02336451|157398944|FG004|Overall Study|Protocol Violation|0|||
48880228|NCT02336451|157398940|FG000|Overall Study|Patient/guardian decision|2|||
48880229|NCT02336451|157398941|FG001|Overall Study|Patient/guardian decision|4|||
48880230|NCT02336451|157398942|FG002|Overall Study|Patient/guardian decision|0|||
48880231|NCT02336451|157398943|FG003|Overall Study|Patient/guardian decision|2|||
48880232|NCT02336451|157398944|FG004|Overall Study|Patient/guardian decision|1|||
48880233|NCT03786471|157398945|FG000|Overall Study|Death|254|||
48880234|NCT03786471|157398946|FG001|Overall Study|Death|223|||
48880235|NCT03786471|157398947|FG002|Overall Study|Death|37|||
48880236|NCT03786471|157398945|FG000|Overall Study|Lost to Follow-up|63|||
48880237|NCT03786471|157398946|FG001|Overall Study|Lost to Follow-up|50|||
48880238|NCT03786471|157398947|FG002|Overall Study|Lost to Follow-up|15|||
48880239|NCT03786471|157398945|FG000|Overall Study|Withdrawal by Subject|99|||
49033561|NCT00272779|157958602|FG001|Baseline Through Week 48|Lack of efficacy before Week 48|8|||
49033562|NCT00272779|157958601|FG000|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
49033563|NCT00272779|157958602|FG001|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
49033564|NCT00272779|157958601|FG000|Baseline Through Week 48|Viral load rebound before Week 48|1|||
49033565|NCT00272779|157958602|FG001|Baseline Through Week 48|Viral load rebound before Week 48|0|||
49033566|NCT00272779|157958601|FG000|Baseline Through Week 48|Poor/non compliance before Week 48|6|||
49033567|NCT00272779|157958602|FG001|Baseline Through Week 48|Poor/non compliance before Week 48|9|||
49033568|NCT00272779|157958601|FG000|Baseline Through Week 48|Pregnancy before Week 48|2|||
48880240|NCT03786471|157398946|FG001|Overall Study|Withdrawal by Subject|81|||
48880241|NCT03786471|157398947|FG002|Overall Study|Withdrawal by Subject|11|||
48880242|NCT00760513|157400140|FG000|Overall Study|Withdrawal by Subject|5|||
48880243|NCT00760513|157400141|FG001|Overall Study|Withdrawal by Subject|7|||
48880244|NCT04596995|157400144|FG000|Overall Study|Lack of Efficacy|8|||
48880245|NCT04596995|157400144|FG000|Overall Study|Lost to Follow-up|3|||
48880246|NCT04596995|157400144|FG000|Overall Study|Withdrawal by Subject|12|||
48880247|NCT04596995|157400144|FG000|Overall Study|Sponsor decision|3|||
48880248|NCT04596995|157400144|FG000|Overall Study|Enrolled in managed access program|3|||
48880249|NCT01458522|157400146|FG000|Overall Study|Withdrawal by Subject|2|||
48880250|NCT01458522|157400147|FG001|Overall Study|Withdrawal by Subject|2|||
48880251|NCT01458522|157400146|FG000|Overall Study|Physician Decision|1|||
48880252|NCT01458522|157400147|FG001|Overall Study|Physician Decision|9|||
48880253|NCT02763215|157400156|FG000|Overall Study|Participants withdrew from study|3|||
48880254|NCT02763215|157400156|FG000|Overall Study|Missed visit|1|||
48880255|NCT02763215|157400156|FG000|Overall Study|Visit outside visit-window|1|||
48880256|NCT02763215|157400156|FG000|Overall Study|Death|1|||
48880257|NCT02763215|157400156|FG000|Overall Study|Lost to Follow-up|1|||
48880258|NCT00589303|157400157|FG000|Overall Study|Withdrawal by Subject|2|||
48880259|NCT00589303|157400158|FG001|Overall Study|Withdrawal by Subject|1|||
48880260|NCT01411241|157400159|FG000|Overall Study|Protocol Violation|0|||
48880261|NCT01411241|157400160|FG001|Overall Study|Protocol Violation|5|||
48880262|NCT01411241|157400159|FG000|Overall Study|Withdrawal by Subject|9|||
48880263|NCT01411241|157400160|FG001|Overall Study|Withdrawal by Subject|10|||
48880264|NCT01411241|157400159|FG000|Overall Study|Serious Adverse Event|0|||
48880265|NCT01411241|157400160|FG001|Overall Study|Serious Adverse Event|3|||
48880266|NCT01411241|157400159|FG000|Overall Study|Lost to Follow-up|2|||
48880267|NCT01411241|157400160|FG001|Overall Study|Lost to Follow-up|4|||
48880268|NCT01483144|157400161|FG000|Overall Study|Adverse Event|9|||
48880269|NCT01483144|157400162|FG001|Overall Study|Adverse Event|4|||
48880270|NCT01483144|157400163|FG002|Overall Study|Adverse Event|6|||
48880271|NCT01483144|157400161|FG000|Overall Study|Withdrawal by Subject|0|||
48880272|NCT01483144|157400162|FG001|Overall Study|Withdrawal by Subject|2|||
48880273|NCT01483144|157400163|FG002|Overall Study|Withdrawal by Subject|5|||
48880274|NCT01483144|157400161|FG000|Overall Study|Physician Decision|1|||
48880275|NCT01483144|157400162|FG001|Overall Study|Physician Decision|0|||
48880276|NCT01483144|157400163|FG002|Overall Study|Physician Decision|0|||
48880277|NCT01483144|157400161|FG000|Overall Study|Lost to Follow-up|2|||
48880278|NCT01483144|157400162|FG001|Overall Study|Lost to Follow-up|4|||
48880279|NCT01483144|157400163|FG002|Overall Study|Lost to Follow-up|1|||
48880280|NCT01483144|157400161|FG000|Overall Study|Protocol Violation|3|||
48880281|NCT01483144|157400162|FG001|Overall Study|Protocol Violation|3|||
48880282|NCT01483144|157400163|FG002|Overall Study|Protocol Violation|3|||
48880283|NCT00983749|157400164|FG000|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1|||
48880284|NCT00983749|157400165|FG001|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3|||
48880285|NCT04829747|157400174|FG000|Overall Study|Protocol Violation|1|||
48880286|NCT04593823|157400182|FG000|Overall Study|Withdrawal by Subject|1|||
48880287|NCT04593823|157400183|FG001|Overall Study|Withdrawal by Subject|1|||
48880288|NCT04593823|157400182|FG000|Overall Study|Lost to Follow-up|0|||
48880289|NCT04593823|157400183|FG001|Overall Study|Lost to Follow-up|1|||
48880290|NCT01296555|157400184|FG000|Overall Study|Adverse Event|0|||
48880291|NCT01296555|157400185|FG001|Overall Study|Adverse Event|0|||
48880292|NCT01296555|157400186|FG002|Overall Study|Adverse Event|1|||
48880293|NCT01296555|157400187|FG003|Overall Study|Adverse Event|1|||
48880294|NCT01296555|157400188|FG004|Overall Study|Adverse Event|2|||
48880295|NCT01296555|157400189|FG005|Overall Study|Adverse Event|4|||
48880296|NCT01296555|157400190|FG006|Overall Study|Adverse Event|1|||
48880297|NCT01296555|157400191|FG007|Overall Study|Adverse Event|4|||
48880298|NCT01296555|157400192|FG008|Overall Study|Adverse Event|3|||
48880299|NCT01296555|157400193|FG009|Overall Study|Adverse Event|1|||
48880300|NCT01296555|157400194|FG010|Overall Study|Adverse Event|0|||
48880301|NCT01296555|157400195|FG011|Overall Study|Adverse Event|4|||
48880302|NCT01296555|157400196|FG012|Overall Study|Adverse Event|1|||
48880303|NCT01296555|157400197|FG013|Overall Study|Adverse Event|4|||
48880304|NCT01296555|157400198|FG014|Overall Study|Adverse Event|0|||
48880305|NCT01296555|157400199|FG015|Overall Study|Adverse Event|0|||
48880306|NCT01296555|157400200|FG016|Overall Study|Adverse Event|0|||
48880307|NCT01296555|157400201|FG017|Overall Study|Adverse Event|0|||
48880308|NCT01296555|157400202|FG018|Overall Study|Adverse Event|0|||
48880309|NCT01296555|157400203|FG019|Overall Study|Adverse Event|1|||
48880310|NCT01296555|157400204|FG020|Overall Study|Adverse Event|0|||
48880311|NCT01296555|157400205|FG021|Overall Study|Adverse Event|0|||
48880312|NCT01296555|157400206|FG022|Overall Study|Adverse Event|0|||
48880313|NCT01296555|157400207|FG023|Overall Study|Adverse Event|0|||
48880314|NCT01296555|157400208|FG024|Overall Study|Adverse Event|0|||
48880315|NCT01296555|157400209|FG025|Overall Study|Adverse Event|0|||
48880316|NCT01296555|157400210|FG026|Overall Study|Adverse Event|0|||
48880317|NCT01296555|157400211|FG027|Overall Study|Adverse Event|0|||
48880318|NCT01296555|157400212|FG028|Overall Study|Adverse Event|0|||
48880319|NCT01296555|157400184|FG000|Overall Study|Reason Not Specified|0|||
48880320|NCT01296555|157400185|FG001|Overall Study|Reason Not Specified|0|||
48880321|NCT01296555|157400186|FG002|Overall Study|Reason Not Specified|0|||
48880322|NCT01296555|157400187|FG003|Overall Study|Reason Not Specified|0|||
48880323|NCT01296555|157400188|FG004|Overall Study|Reason Not Specified|0|||
48880324|NCT01296555|157400189|FG005|Overall Study|Reason Not Specified|0|||
48880325|NCT01296555|157400190|FG006|Overall Study|Reason Not Specified|0|||
48880326|NCT01296555|157400191|FG007|Overall Study|Reason Not Specified|0|||
48880327|NCT01296555|157400192|FG008|Overall Study|Reason Not Specified|0|||
48880328|NCT01296555|157400193|FG009|Overall Study|Reason Not Specified|0|||
48880329|NCT01296555|157400194|FG010|Overall Study|Reason Not Specified|0|||
48880330|NCT01296555|157400195|FG011|Overall Study|Reason Not Specified|0|||
48880331|NCT01296555|157400196|FG012|Overall Study|Reason Not Specified|0|||
48880332|NCT01296555|157400197|FG013|Overall Study|Reason Not Specified|1|||
48880333|NCT01296555|157400198|FG014|Overall Study|Reason Not Specified|2|||
48880334|NCT01296555|157400199|FG015|Overall Study|Reason Not Specified|3|||
48880335|NCT01296555|157400200|FG016|Overall Study|Reason Not Specified|7|||
48880336|NCT01296555|157400201|FG017|Overall Study|Reason Not Specified|4|||
48880337|NCT01296555|157400202|FG018|Overall Study|Reason Not Specified|3|||
48880338|NCT01296555|157400203|FG019|Overall Study|Reason Not Specified|7|||
48880339|NCT01296555|157400204|FG020|Overall Study|Reason Not Specified|11|||
48880340|NCT01296555|157400205|FG021|Overall Study|Reason Not Specified|5|||
48880341|NCT01296555|157400206|FG022|Overall Study|Reason Not Specified|5|||
49033569|NCT00272779|157958602|FG001|Baseline Through Week 48|Pregnancy before Week 48|2|||
49033570|NCT00272779|157958601|FG000|Baseline Through Week 48|No longer meets criteria before Week 48|1|||
48880342|NCT01296555|157400207|FG023|Overall Study|Reason Not Specified|7|||
48880343|NCT01296555|157400208|FG024|Overall Study|Reason Not Specified|2|||
48880344|NCT01296555|157400209|FG025|Overall Study|Reason Not Specified|2|||
48880345|NCT01296555|157400210|FG026|Overall Study|Reason Not Specified|19|||
48880346|NCT01296555|157400211|FG027|Overall Study|Reason Not Specified|11|||
48880347|NCT01296555|157400212|FG028|Overall Study|Reason Not Specified|9|||
48880348|NCT01296555|157400184|FG000|Overall Study|Physician Decision|0|||
48880349|NCT01296555|157400185|FG001|Overall Study|Physician Decision|0|||
48880350|NCT01296555|157400186|FG002|Overall Study|Physician Decision|0|||
49033571|NCT00272779|157958602|FG001|Baseline Through Week 48|No longer meets criteria before Week 48|0|||
48880351|NCT01296555|157400187|FG003|Overall Study|Physician Decision|0|||
48880352|NCT01296555|157400188|FG004|Overall Study|Physician Decision|1|||
48880353|NCT01296555|157400189|FG005|Overall Study|Physician Decision|0|||
48880354|NCT01296555|157400190|FG006|Overall Study|Physician Decision|0|||
48880355|NCT01296555|157400191|FG007|Overall Study|Physician Decision|0|||
48880356|NCT01296555|157400192|FG008|Overall Study|Physician Decision|0|||
48880357|NCT01296555|157400193|FG009|Overall Study|Physician Decision|0|||
48880358|NCT01296555|157400194|FG010|Overall Study|Physician Decision|0|||
48880359|NCT01296555|157400195|FG011|Overall Study|Physician Decision|0|||
48880360|NCT01296555|157400196|FG012|Overall Study|Physician Decision|0|||
48880361|NCT01296555|157400197|FG013|Overall Study|Physician Decision|1|||
48880362|NCT01296555|157400198|FG014|Overall Study|Physician Decision|0|||
48880363|NCT01296555|157400199|FG015|Overall Study|Physician Decision|0|||
48880364|NCT01296555|157400200|FG016|Overall Study|Physician Decision|0|||
48880365|NCT01296555|157400201|FG017|Overall Study|Physician Decision|0|||
48880366|NCT01296555|157400202|FG018|Overall Study|Physician Decision|0|||
48880367|NCT01296555|157400203|FG019|Overall Study|Physician Decision|1|||
48880368|NCT01296555|157400204|FG020|Overall Study|Physician Decision|0|||
48880369|NCT01296555|157400205|FG021|Overall Study|Physician Decision|0|||
48880370|NCT01296555|157400206|FG022|Overall Study|Physician Decision|0|||
48880371|NCT01296555|157400207|FG023|Overall Study|Physician Decision|0|||
48880372|NCT01296555|157400208|FG024|Overall Study|Physician Decision|0|||
48880373|NCT01296555|157400209|FG025|Overall Study|Physician Decision|0|||
49033572|NCT00272779|157958601|FG000|Baseline Through Week 48|Withdrew consent before Week 48|4|||
49033573|NCT00272779|157958602|FG001|Baseline Through Week 48|Withdrew consent before Week 48|13|||
49033574|NCT00272779|157958601|FG000|Baseline Through Week 48|Participant's decision before wk 48|0|||
49033575|NCT00272779|157958602|FG001|Baseline Through Week 48|Participant's decision before wk 48|1|||
48880374|NCT01296555|157400210|FG026|Overall Study|Physician Decision|0|||
48880375|NCT01296555|157400211|FG027|Overall Study|Physician Decision|0|||
48880376|NCT01296555|157400212|FG028|Overall Study|Physician Decision|0|||
48880377|NCT01296555|157400184|FG000|Overall Study|Progressive Disease|6|||
48880378|NCT01296555|157400185|FG001|Overall Study|Progressive Disease|3|||
48880379|NCT01296555|157400186|FG002|Overall Study|Progressive Disease|3|||
48880380|NCT01296555|157400187|FG003|Overall Study|Progressive Disease|7|||
48880381|NCT01296555|157400188|FG004|Overall Study|Progressive Disease|6|||
48880382|NCT01296555|157400189|FG005|Overall Study|Progressive Disease|16|||
48880383|NCT01296555|157400190|FG006|Overall Study|Progressive Disease|16|||
48880384|NCT01296555|157400191|FG007|Overall Study|Progressive Disease|8|||
48880385|NCT01296555|157400192|FG008|Overall Study|Progressive Disease|7|||
48880386|NCT01296555|157400193|FG009|Overall Study|Progressive Disease|18|||
48880387|NCT01296555|157400194|FG010|Overall Study|Progressive Disease|7|||
48880388|NCT01296555|157400195|FG011|Overall Study|Progressive Disease|14|||
48880389|NCT01296555|157400196|FG012|Overall Study|Progressive Disease|5|||
48880390|NCT01296555|157400197|FG013|Overall Study|Progressive Disease|12|||
48880391|NCT01296555|157400198|FG014|Overall Study|Progressive Disease|1|||
48880392|NCT01296555|157400199|FG015|Overall Study|Progressive Disease|1|||
48880393|NCT01296555|157400200|FG016|Overall Study|Progressive Disease|0|||
48880394|NCT01296555|157400201|FG017|Overall Study|Progressive Disease|0|||
48880395|NCT01296555|157400202|FG018|Overall Study|Progressive Disease|0|||
48880396|NCT01296555|157400203|FG019|Overall Study|Progressive Disease|1|||
48880397|NCT01296555|157400204|FG020|Overall Study|Progressive Disease|0|||
48880398|NCT01296555|157400205|FG021|Overall Study|Progressive Disease|0|||
48880399|NCT01296555|157400206|FG022|Overall Study|Progressive Disease|0|||
48880400|NCT01296555|157400207|FG023|Overall Study|Progressive Disease|0|||
48880401|NCT01296555|157400208|FG024|Overall Study|Progressive Disease|1|||
48880402|NCT01296555|157400209|FG025|Overall Study|Progressive Disease|0|||
48880403|NCT01296555|157400210|FG026|Overall Study|Progressive Disease|5|||
48880404|NCT01296555|157400211|FG027|Overall Study|Progressive Disease|1|||
48880405|NCT01296555|157400212|FG028|Overall Study|Progressive Disease|0|||
48880406|NCT01296555|157400184|FG000|Overall Study|Protocol Violation|0|||
48880407|NCT01296555|157400185|FG001|Overall Study|Protocol Violation|0|||
48880408|NCT01296555|157400186|FG002|Overall Study|Protocol Violation|0|||
48880409|NCT01296555|157400187|FG003|Overall Study|Protocol Violation|0|||
48880410|NCT01296555|157400188|FG004|Overall Study|Protocol Violation|0|||
48880411|NCT01296555|157400189|FG005|Overall Study|Protocol Violation|0|||
48880412|NCT01296555|157400190|FG006|Overall Study|Protocol Violation|0|||
48880413|NCT01296555|157400191|FG007|Overall Study|Protocol Violation|0|||
48880414|NCT01296555|157400192|FG008|Overall Study|Protocol Violation|0|||
48880415|NCT01296555|157400193|FG009|Overall Study|Protocol Violation|0|||
48880416|NCT01296555|157400194|FG010|Overall Study|Protocol Violation|0|||
48880417|NCT01296555|157400195|FG011|Overall Study|Protocol Violation|0|||
48880418|NCT01296555|157400196|FG012|Overall Study|Protocol Violation|0|||
48880419|NCT01296555|157400197|FG013|Overall Study|Protocol Violation|1|||
48880420|NCT01296555|157400198|FG014|Overall Study|Protocol Violation|0|||
49033576|NCT00272779|157958601|FG000|Baseline Through Week 48|Chose different site before wk 48|0|||
48880421|NCT01296555|157400199|FG015|Overall Study|Protocol Violation|0|||
48880422|NCT01296555|157400200|FG016|Overall Study|Protocol Violation|0|||
48880423|NCT01296555|157400201|FG017|Overall Study|Protocol Violation|0|||
48880424|NCT01296555|157400202|FG018|Overall Study|Protocol Violation|0|||
48880425|NCT01296555|157400203|FG019|Overall Study|Protocol Violation|0|||
48880426|NCT01296555|157400204|FG020|Overall Study|Protocol Violation|0|||
48880427|NCT01296555|157400205|FG021|Overall Study|Protocol Violation|0|||
48880428|NCT01296555|157400206|FG022|Overall Study|Protocol Violation|0|||
48880429|NCT01296555|157400207|FG023|Overall Study|Protocol Violation|0|||
48880430|NCT01296555|157400208|FG024|Overall Study|Protocol Violation|0|||
48880431|NCT01296555|157400209|FG025|Overall Study|Protocol Violation|0|||
48880432|NCT01296555|157400210|FG026|Overall Study|Protocol Violation|0|||
48880433|NCT01296555|157400211|FG027|Overall Study|Protocol Violation|0|||
48880434|NCT01296555|157400212|FG028|Overall Study|Protocol Violation|0|||
48880435|NCT01296555|157400184|FG000|Overall Study|Study Terminated By Sponsor|0|||
48880436|NCT01296555|157400185|FG001|Overall Study|Study Terminated By Sponsor|0|||
48880437|NCT01296555|157400186|FG002|Overall Study|Study Terminated By Sponsor|0|||
48880438|NCT01296555|157400187|FG003|Overall Study|Study Terminated By Sponsor|0|||
48880439|NCT01296555|157400188|FG004|Overall Study|Study Terminated By Sponsor|0|||
48880440|NCT01296555|157400189|FG005|Overall Study|Study Terminated By Sponsor|0|||
48880441|NCT01296555|157400190|FG006|Overall Study|Study Terminated By Sponsor|0|||
48880442|NCT01296555|157400191|FG007|Overall Study|Study Terminated By Sponsor|0|||
48880443|NCT01296555|157400192|FG008|Overall Study|Study Terminated By Sponsor|0|||
48880444|NCT01296555|157400193|FG009|Overall Study|Study Terminated By Sponsor|0|||
48880445|NCT01296555|157400194|FG010|Overall Study|Study Terminated By Sponsor|0|||
48880446|NCT01296555|157400195|FG011|Overall Study|Study Terminated By Sponsor|0|||
48880447|NCT01296555|157400196|FG012|Overall Study|Study Terminated By Sponsor|0|||
48880448|NCT01296555|157400197|FG013|Overall Study|Study Terminated By Sponsor|0|||
48880449|NCT01296555|157400198|FG014|Overall Study|Study Terminated By Sponsor|0|||
48880450|NCT01296555|157400199|FG015|Overall Study|Study Terminated By Sponsor|0|||
49033577|NCT00272779|157958602|FG001|Baseline Through Week 48|Chose different site before wk 48|1|||
49033578|NCT00272779|157958601|FG000|Baseline Through Week 48|Adverse event on/after Week 48|1|||
49033579|NCT00272779|157958602|FG001|Baseline Through Week 48|Adverse event on/after Week 48|1|||
49033580|NCT00272779|157958601|FG000|Baseline Through Week 48|Death on/after Week 48|1|||
49033581|NCT00272779|157958602|FG001|Baseline Through Week 48|Death on/after Week 48|1|||
49033582|NCT00272779|157958601|FG000|Baseline Through Week 48|Lack of efficacy on/after Week 48|7|||
49033583|NCT00272779|157958602|FG001|Baseline Through Week 48|Lack of efficacy on/after Week 48|1|||
49033584|NCT00272779|157958601|FG000|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
49033585|NCT00272779|157958602|FG001|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
49033586|NCT00272779|157958601|FG000|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
49033587|NCT00272779|157958602|FG001|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
49033588|NCT00272779|157958601|FG000|Baseline Through Week 48|Pregnancy on/after Week 48|1|||
49033589|NCT00272779|157958602|FG001|Baseline Through Week 48|Pregnancy on/after Week 48|2|||
49033590|NCT00272779|157958601|FG000|Baseline Through Week 48|Withdrew consent on/after Week 48|0|||
48880451|NCT01296555|157400200|FG016|Overall Study|Study Terminated By Sponsor|0|||
48880452|NCT01296555|157400201|FG017|Overall Study|Study Terminated By Sponsor|0|||
48880453|NCT01296555|157400202|FG018|Overall Study|Study Terminated By Sponsor|0|||
48880454|NCT01296555|157400203|FG019|Overall Study|Study Terminated By Sponsor|0|||
48880455|NCT01296555|157400204|FG020|Overall Study|Study Terminated By Sponsor|0|||
48880456|NCT01296555|157400205|FG021|Overall Study|Study Terminated By Sponsor|0|||
48880457|NCT01296555|157400206|FG022|Overall Study|Study Terminated By Sponsor|0|||
48880458|NCT01296555|157400207|FG023|Overall Study|Study Terminated By Sponsor|0|||
48880459|NCT01296555|157400208|FG024|Overall Study|Study Terminated By Sponsor|0|||
48880460|NCT01296555|157400209|FG025|Overall Study|Study Terminated By Sponsor|1|||
48880461|NCT01296555|157400210|FG026|Overall Study|Study Terminated By Sponsor|0|||
48880462|NCT01296555|157400211|FG027|Overall Study|Study Terminated By Sponsor|0|||
48880463|NCT01296555|157400212|FG028|Overall Study|Study Terminated By Sponsor|0|||
48880464|NCT01296555|157400184|FG000|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
48880465|NCT01296555|157400185|FG001|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
48880466|NCT01296555|157400186|FG002|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
48880467|NCT01296555|157400187|FG003|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
48880468|NCT01296555|157400188|FG004|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
48880469|NCT01296555|157400189|FG005|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
48880470|NCT01296555|157400190|FG006|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
48880471|NCT01296555|157400191|FG007|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
48880472|NCT01296555|157400192|FG008|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
48880473|NCT01296555|157400193|FG009|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
48880474|NCT01296555|157400194|FG010|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
48880475|NCT01296555|157400195|FG011|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
48880476|NCT01296555|157400196|FG012|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
48880477|NCT01296555|157400197|FG013|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
48880478|NCT01296555|157400198|FG014|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
48880479|NCT01296555|157400199|FG015|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
48880480|NCT01296555|157400200|FG016|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
48880481|NCT01296555|157400201|FG017|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
48880482|NCT01296555|157400202|FG018|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
48880483|NCT01296555|157400203|FG019|Overall Study|Use Of Another Anti-Cancer Therapy|2|||
48880484|NCT01296555|157400204|FG020|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
48880485|NCT01296555|157400205|FG021|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
48880486|NCT01296555|157400206|FG022|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
48880487|NCT01296555|157400207|FG023|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
48880488|NCT01296555|157400208|FG024|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
48880489|NCT01296555|157400209|FG025|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
48880490|NCT01296555|157400210|FG026|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
49033591|NCT00272779|157958602|FG001|Baseline Through Week 48|Withdrew consent on/after Week 48|2|||
49033592|NCT00272779|157958601|FG000|Baseline Through Week 48|Continuing treatment|385|||
49033593|NCT00272779|157958602|FG001|Baseline Through Week 48|Continuing treatment|368|||
49033594|NCT00272779|157958601|FG000|Baseline Through Week 48|Lost to follow-up on/after Week 48|0|||
49033595|NCT00272779|157958602|FG001|Baseline Through Week 48|Lost to follow-up on/after Week 48|3|||
49033596|NCT00272779|157958601|FG000|Baseline Through Week 48|Never treated|2|||
49033597|NCT00272779|157958602|FG001|Baseline Through Week 48|Never treated|3|||
49033598|NCT00272779|157958601|FG000|Baseline Through Week 96|Adverse event before Week 96|13|||
49033599|NCT00272779|157958602|FG001|Baseline Through Week 96|Adverse event before Week 96|22|||
49033600|NCT00272779|157958601|FG000|Baseline Through Week 96|Death before Week 96|6|||
49033601|NCT00272779|157958602|FG001|Baseline Through Week 96|Death before Week 96|5|||
49033602|NCT00272779|157958601|FG000|Baseline Through Week 96|Lack of efficacy before Week 96|16|||
49033603|NCT00272779|157958602|FG001|Baseline Through Week 96|Lack of efficacy before Week 96|10|||
49033604|NCT00272779|157958601|FG000|Baseline Through Week 96|Lost to follow up before Week 96|10|||
49033605|NCT00272779|157958602|FG001|Baseline Through Week 96|Lost to follow up before Week 96|13|||
49033606|NCT00272779|157958601|FG000|Baseline Through Week 96|Participant Imprisoned before Week 96|1|||
49033607|NCT00272779|157958602|FG001|Baseline Through Week 96|Participant Imprisoned before Week 96|0|||
49033608|NCT00272779|157958601|FG000|Baseline Through Week 96|Poor/non compliance before Week 96|12|||
49033609|NCT00272779|157958602|FG001|Baseline Through Week 96|Poor/non compliance before Week 96|16|||
49033610|NCT00272779|157958601|FG000|Baseline Through Week 96|Pregnancy before Week 96|5|||
49033611|NCT00272779|157958602|FG001|Baseline Through Week 96|Pregnancy before Week 96|7|||
48880491|NCT01296555|157400211|FG027|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
48880492|NCT01296555|157400212|FG028|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
48880493|NCT01296555|157400184|FG000|Overall Study|Death|0|||
48880494|NCT01296555|157400185|FG001|Overall Study|Death|0|||
48880495|NCT01296555|157400186|FG002|Overall Study|Death|0|||
48880496|NCT01296555|157400187|FG003|Overall Study|Death|2|||
48880497|NCT01296555|157400188|FG004|Overall Study|Death|1|||
48880498|NCT01296555|157400189|FG005|Overall Study|Death|0|||
48880499|NCT01296555|157400190|FG006|Overall Study|Death|2|||
48880500|NCT01296555|157400191|FG007|Overall Study|Death|0|||
48880501|NCT01296555|157400192|FG008|Overall Study|Death|0|||
48880502|NCT01296555|157400193|FG009|Overall Study|Death|1|||
48880503|NCT01296555|157400194|FG010|Overall Study|Death|0|||
48880504|NCT01296555|157400195|FG011|Overall Study|Death|1|||
48880505|NCT01296555|157400196|FG012|Overall Study|Death|0|||
48880506|NCT01296555|157400197|FG013|Overall Study|Death|2|||
49033612|NCT00272779|157958601|FG000|Baseline Through Week 96|No longer meets criteria before Week 96|4|||
49033613|NCT00272779|157958602|FG001|Baseline Through Week 96|No longer meets criteria before Week 96|3|||
49033614|NCT00272779|157958601|FG000|Baseline Through Week 96|Withdrew consent before Week 96|5|||
49033615|NCT00272779|157958602|FG001|Baseline Through Week 96|Withdrew consent before Week 96|18|||
49033616|NCT00272779|157958601|FG000|Baseline Through Week 96|Changed address before Week 96|0|||
49033617|NCT00272779|157958602|FG001|Baseline Through Week 96|Changed address before Week 96|1|||
48880507|NCT01296555|157400198|FG014|Overall Study|Death|27|||
48880508|NCT01296555|157400199|FG015|Overall Study|Death|15|||
48880509|NCT01296555|157400200|FG016|Overall Study|Death|11|||
48880510|NCT01296555|157400201|FG017|Overall Study|Death|11|||
48880511|NCT01296555|157400202|FG018|Overall Study|Death|17|||
48880512|NCT01296555|157400203|FG019|Overall Study|Death|12|||
48880513|NCT01296555|157400204|FG020|Overall Study|Death|13|||
48880514|NCT01296555|157400205|FG021|Overall Study|Death|12|||
48880515|NCT01296555|157400206|FG022|Overall Study|Death|12|||
48880516|NCT01296555|157400207|FG023|Overall Study|Death|13|||
48880517|NCT01296555|157400208|FG024|Overall Study|Death|7|||
48880518|NCT01296555|157400209|FG025|Overall Study|Death|7|||
48880519|NCT01296555|157400210|FG026|Overall Study|Death|35|||
48880520|NCT01296555|157400211|FG027|Overall Study|Death|92|||
48880521|NCT01296555|157400212|FG028|Overall Study|Death|44|||
48880522|NCT01296555|157400184|FG000|Overall Study|Lost to Follow-up|0|||
48880523|NCT01296555|157400185|FG001|Overall Study|Lost to Follow-up|0|||
48880524|NCT01296555|157400186|FG002|Overall Study|Lost to Follow-up|0|||
48880525|NCT01296555|157400187|FG003|Overall Study|Lost to Follow-up|0|||
48880526|NCT01296555|157400188|FG004|Overall Study|Lost to Follow-up|0|||
48880527|NCT01296555|157400189|FG005|Overall Study|Lost to Follow-up|0|||
48880528|NCT01296555|157400190|FG006|Overall Study|Lost to Follow-up|0|||
48880529|NCT01296555|157400191|FG007|Overall Study|Lost to Follow-up|0|||
48880530|NCT01296555|157400192|FG008|Overall Study|Lost to Follow-up|0|||
49033618|NCT00272779|157958601|FG000|Baseline Through Week 96|Lost to follow-up at Week 96|1|||
48880531|NCT01296555|157400193|FG009|Overall Study|Lost to Follow-up|0|||
48880532|NCT01296555|157400194|FG010|Overall Study|Lost to Follow-up|0|||
48880533|NCT01296555|157400195|FG011|Overall Study|Lost to Follow-up|0|||
48880534|NCT01296555|157400196|FG012|Overall Study|Lost to Follow-up|0|||
48880535|NCT01296555|157400197|FG013|Overall Study|Lost to Follow-up|0|||
48880536|NCT01296555|157400198|FG014|Overall Study|Lost to Follow-up|2|||
48880537|NCT01296555|157400199|FG015|Overall Study|Lost to Follow-up|1|||
48880538|NCT01296555|157400200|FG016|Overall Study|Lost to Follow-up|0|||
49033619|NCT00272779|157958602|FG001|Baseline Through Week 96|Lost to follow-up at Week 96|0|||
49033620|NCT00272779|157958601|FG000|Baseline Through Week 96|Poor/non compliance at Week 96]|2|||
49033621|NCT00272779|157958602|FG001|Baseline Through Week 96|Poor/non compliance at Week 96]|0|||
49033622|NCT00272779|157958601|FG000|Baseline Through Week 96|Pregnancy at Week 96|1|||
49033623|NCT00272779|157958602|FG001|Baseline Through Week 96|Pregnancy at Week 96|0|||
49033624|NCT00272779|157958601|FG000|Baseline Through Week 96|Never treated|2|||
49033625|NCT00272779|157958602|FG001|Baseline Through Week 96|Never treated|3|||
49033626|NCT00272779|157958601|FG000|Baseline Through Week 96|Continuing on treatment|61|||
49033627|NCT00272779|157958602|FG001|Baseline Through Week 96|Continuing on treatment|38|||
49033628|NCT00561015|157958603|FG000|Overall Study|Adverse Event|0|||
49033629|NCT00561015|157958604|FG001|Overall Study|Adverse Event|0|||
48880539|NCT01296555|157400201|FG017|Overall Study|Lost to Follow-up|2|||
48880540|NCT01296555|157400202|FG018|Overall Study|Lost to Follow-up|0|||
48880541|NCT01296555|157400203|FG019|Overall Study|Lost to Follow-up|2|||
48880542|NCT01296555|157400204|FG020|Overall Study|Lost to Follow-up|3|||
48880543|NCT01296555|157400205|FG021|Overall Study|Lost to Follow-up|2|||
48880544|NCT01296555|157400206|FG022|Overall Study|Lost to Follow-up|0|||
48880545|NCT01296555|157400207|FG023|Overall Study|Lost to Follow-up|0|||
48880546|NCT01296555|157400208|FG024|Overall Study|Lost to Follow-up|0|||
48880547|NCT01296555|157400209|FG025|Overall Study|Lost to Follow-up|0|||
48880548|NCT01296555|157400210|FG026|Overall Study|Lost to Follow-up|3|||
48880549|NCT01296555|157400211|FG027|Overall Study|Lost to Follow-up|13|||
48880550|NCT01296555|157400212|FG028|Overall Study|Lost to Follow-up|5|||
48880551|NCT01296555|157400184|FG000|Overall Study|Non-Compliance With Study Drug|0|||
48880552|NCT01296555|157400185|FG001|Overall Study|Non-Compliance With Study Drug|0|||
48880553|NCT01296555|157400186|FG002|Overall Study|Non-Compliance With Study Drug|0|||
48880554|NCT01296555|157400187|FG003|Overall Study|Non-Compliance With Study Drug|0|||
48880555|NCT01296555|157400188|FG004|Overall Study|Non-Compliance With Study Drug|0|||
48880556|NCT01296555|157400189|FG005|Overall Study|Non-Compliance With Study Drug|0|||
48880557|NCT01296555|157400190|FG006|Overall Study|Non-Compliance With Study Drug|0|||
48880558|NCT01296555|157400191|FG007|Overall Study|Non-Compliance With Study Drug|1|||
48880559|NCT01296555|157400192|FG008|Overall Study|Non-Compliance With Study Drug|0|||
48880560|NCT01296555|157400193|FG009|Overall Study|Non-Compliance With Study Drug|0|||
48880561|NCT01296555|157400194|FG010|Overall Study|Non-Compliance With Study Drug|0|||
48880562|NCT01296555|157400195|FG011|Overall Study|Non-Compliance With Study Drug|0|||
48880563|NCT01296555|157400196|FG012|Overall Study|Non-Compliance With Study Drug|0|||
48880564|NCT01296555|157400197|FG013|Overall Study|Non-Compliance With Study Drug|0|||
48880565|NCT01296555|157400198|FG014|Overall Study|Non-Compliance With Study Drug|0|||
48880566|NCT01296555|157400199|FG015|Overall Study|Non-Compliance With Study Drug|0|||
48880567|NCT01296555|157400200|FG016|Overall Study|Non-Compliance With Study Drug|0|||
48880568|NCT01296555|157400201|FG017|Overall Study|Non-Compliance With Study Drug|0|||
48880569|NCT01296555|157400202|FG018|Overall Study|Non-Compliance With Study Drug|0|||
48880570|NCT01296555|157400203|FG019|Overall Study|Non-Compliance With Study Drug|0|||
48880571|NCT01296555|157400204|FG020|Overall Study|Non-Compliance With Study Drug|0|||
48880572|NCT01296555|157400205|FG021|Overall Study|Non-Compliance With Study Drug|0|||
48880573|NCT01296555|157400206|FG022|Overall Study|Non-Compliance With Study Drug|0|||
48880574|NCT01296555|157400207|FG023|Overall Study|Non-Compliance With Study Drug|0|||
48880575|NCT01296555|157400208|FG024|Overall Study|Non-Compliance With Study Drug|0|||
48880576|NCT01296555|157400209|FG025|Overall Study|Non-Compliance With Study Drug|0|||
48880577|NCT01296555|157400210|FG026|Overall Study|Non-Compliance With Study Drug|0|||
48880578|NCT01296555|157400211|FG027|Overall Study|Non-Compliance With Study Drug|0|||
48880579|NCT01296555|157400212|FG028|Overall Study|Non-Compliance With Study Drug|0|||
48880580|NCT01296555|157400184|FG000|Overall Study|Withdrawal by Subject|0|||
48880581|NCT01296555|157400185|FG001|Overall Study|Withdrawal by Subject|0|||
48880582|NCT01296555|157400186|FG002|Overall Study|Withdrawal by Subject|0|||
48880583|NCT01296555|157400187|FG003|Overall Study|Withdrawal by Subject|0|||
48880584|NCT01296555|157400188|FG004|Overall Study|Withdrawal by Subject|1|||
48880585|NCT01296555|157400189|FG005|Overall Study|Withdrawal by Subject|0|||
48880586|NCT01296555|157400190|FG006|Overall Study|Withdrawal by Subject|1|||
48880587|NCT01296555|157400191|FG007|Overall Study|Withdrawal by Subject|0|||
48880588|NCT01296555|157400192|FG008|Overall Study|Withdrawal by Subject|0|||
48880589|NCT01296555|157400193|FG009|Overall Study|Withdrawal by Subject|0|||
48880590|NCT01296555|157400194|FG010|Overall Study|Withdrawal by Subject|1|||
48880591|NCT01296555|157400195|FG011|Overall Study|Withdrawal by Subject|1|||
48880592|NCT01296555|157400196|FG012|Overall Study|Withdrawal by Subject|0|||
48880593|NCT01296555|157400197|FG013|Overall Study|Withdrawal by Subject|0|||
48880594|NCT01296555|157400198|FG014|Overall Study|Withdrawal by Subject|3|||
49033630|NCT00561015|157958605|FG002|Overall Study|Adverse Event|0|||
49033631|NCT00561015|157958606|FG003|Overall Study|Adverse Event|0|||
49033632|NCT00561015|157958607|FG004|Overall Study|Adverse Event|1|||
49033633|NCT00561015|157958608|FG005|Overall Study|Adverse Event|0|||
48880595|NCT01296555|157400199|FG015|Overall Study|Withdrawal by Subject|0|||
48880596|NCT01296555|157400200|FG016|Overall Study|Withdrawal by Subject|2|||
49033634|NCT00561015|157958603|FG000|Overall Study|Lost to Follow-up|2|||
49033635|NCT00561015|157958604|FG001|Overall Study|Lost to Follow-up|0|||
49033636|NCT00561015|157958605|FG002|Overall Study|Lost to Follow-up|0|||
49033637|NCT00561015|157958606|FG003|Overall Study|Lost to Follow-up|1|||
49033638|NCT00561015|157958607|FG004|Overall Study|Lost to Follow-up|0|||
49033639|NCT00561015|157958608|FG005|Overall Study|Lost to Follow-up|3|||
49033640|NCT00561015|157958603|FG000|Overall Study|Participant non-compliance|2|||
49033641|NCT00561015|157958604|FG001|Overall Study|Participant non-compliance|0|||
49033642|NCT00561015|157958605|FG002|Overall Study|Participant non-compliance|0|||
49033643|NCT00561015|157958606|FG003|Overall Study|Participant non-compliance|0|||
49033644|NCT00561015|157958607|FG004|Overall Study|Participant non-compliance|0|||
49033645|NCT00561015|157958608|FG005|Overall Study|Participant non-compliance|0|||
49033646|NCT00096447|157958611|FG000|Overall Study|Never treated|1|||
49033647|NCT03733730|157958613|FG000|Overall Study|Lost to Follow-up|1|||
49033648|NCT03733730|157958614|FG001|Overall Study|Lost to Follow-up|32|||
49033649|NCT03733730|157958613|FG000|Overall Study|Other|1|||
49033650|NCT03733730|157958614|FG001|Overall Study|Other|0|||
49033651|NCT03733730|157958613|FG000|Overall Study|Adverse Event|0|||
49033652|NCT03733730|157958614|FG001|Overall Study|Adverse Event|4|||
49033653|NCT03733730|157958613|FG000|Overall Study|Death|0|||
49033654|NCT03733730|157958614|FG001|Overall Study|Death|5|||
49033655|NCT03733730|157958613|FG000|Overall Study|Withdrawal by Subject|0|||
49033656|NCT03733730|157958614|FG001|Overall Study|Withdrawal by Subject|8|||
49033657|NCT03450057|157958615|FG000|Overall Study|Death|17|||
49033658|NCT03450057|157958615|FG000|Overall Study|ICF withdrawal|4|||
49033659|NCT03450057|157958615|FG000|Overall Study|Lost to Follow-up|2|||
49033660|NCT02146105|157958616|FG000|Overall Study|Adverse Event|1|||
49033661|NCT02146105|157958616|FG000|Overall Study|Withdrawal by Subject|5|||
49033662|NCT00573066|157958617|FG000|Overall Study|Exclusion criteria|18|||
49033663|NCT00573066|157958617|FG000|Overall Study|IV malfunction|1|||
49033664|NCT00573066|157958617|FG000|Overall Study|Postoperative bleeding|1|||
49033665|NCT00933686|157958618|FG000|Overall Study|Protocol Violation|0|||
49033666|NCT00933686|157958619|FG001|Overall Study|Protocol Violation|1|||
48880597|NCT01296555|157400201|FG017|Overall Study|Withdrawal by Subject|1|||
48880598|NCT01296555|157400202|FG018|Overall Study|Withdrawal by Subject|0|||
48880599|NCT01296555|157400203|FG019|Overall Study|Withdrawal by Subject|1|||
48880600|NCT01296555|157400204|FG020|Overall Study|Withdrawal by Subject|1|||
48880601|NCT01296555|157400205|FG021|Overall Study|Withdrawal by Subject|1|||
48880602|NCT01296555|157400206|FG022|Overall Study|Withdrawal by Subject|3|||
48880603|NCT01296555|157400207|FG023|Overall Study|Withdrawal by Subject|0|||
48880604|NCT01296555|157400208|FG024|Overall Study|Withdrawal by Subject|0|||
48880605|NCT01296555|157400209|FG025|Overall Study|Withdrawal by Subject|0|||
48880606|NCT01296555|157400210|FG026|Overall Study|Withdrawal by Subject|8|||
48880607|NCT01296555|157400211|FG027|Overall Study|Withdrawal by Subject|4|||
48880608|NCT01296555|157400212|FG028|Overall Study|Withdrawal by Subject|2|||
48880609|NCT04210843|157400213|FG000|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|134|||
48880610|NCT04210843|157400214|FG001|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|322|||
48880611|NCT04210843|157400213|FG000|First Half Treatment Period (52 Weeks)|Subject decision|11|||
48880612|NCT04210843|157400214|FG001|First Half Treatment Period (52 Weeks)|Subject decision|28|||
48880613|NCT04210843|157400213|FG000|First Half Treatment Period (52 Weeks)|Lost to Follow-up|4|||
48880614|NCT04210843|157400214|FG001|First Half Treatment Period (52 Weeks)|Lost to Follow-up|2|||
48880615|NCT04210843|157400213|FG000|First Half Treatment Period (52 Weeks)|Adverse Event|1|||
48880616|NCT04210843|157400214|FG001|First Half Treatment Period (52 Weeks)|Adverse Event|11|||
48880617|NCT04210843|157400213|FG000|First Half Treatment Period (52 Weeks)|Physician Decision|0|||
48880618|NCT04210843|157400214|FG001|First Half Treatment Period (52 Weeks)|Physician Decision|3|||
48880619|NCT04210843|157400213|FG000|First Half Treatment Period (52 Weeks)|Protocol deviation|0|||
48880620|NCT04210843|157400214|FG001|First Half Treatment Period (52 Weeks)|Protocol deviation|3|||
49033667|NCT00933686|157958618|FG000|Overall Study|Lost to Follow-up|2|||
49033668|NCT00933686|157958619|FG001|Overall Study|Lost to Follow-up|2|||
49033669|NCT00933686|157958618|FG000|Overall Study|Withdrawal by Subject|6|||
49033670|NCT00933686|157958619|FG001|Overall Study|Withdrawal by Subject|5|||
49033671|NCT00933686|157958618|FG000|Overall Study|Adverse Event|1|||
49033672|NCT00933686|157958619|FG001|Overall Study|Adverse Event|1|||
49033673|NCT00933686|157958618|FG000|Overall Study|Physician Decision|1|||
49033674|NCT00933686|157958619|FG001|Overall Study|Physician Decision|0|||
49033675|NCT00933686|157958618|FG000|Overall Study|Failure to show up at endpoint visits|0|||
49033676|NCT00933686|157958619|FG001|Overall Study|Failure to show up at endpoint visits|2|||
49033677|NCT01383486|157958620|FG000|Overall Study|Lost to Follow-up|10|||
49033678|NCT01383486|157958620|FG000|Overall Study|Incomplete information for analysis|2|||
49033679|NCT01383486|157958620|FG000|Overall Study|Did not take any product|6|||
49033680|NCT00123734|157958628|FG000|Overall Study|Death|3|||
49033681|NCT00123734|157958628|FG000|Overall Study|Lost to Follow-up|3|||
49033682|NCT00123734|157958628|FG000|Overall Study|Dropout|1|||
49033683|NCT00123734|157958628|FG000|Overall Study|Withdrawal by Subject|1|||
49033684|NCT00113386|157958629|FG000|Overall Study|Withdrawal by Subject|1|||
49033685|NCT00113386|157958630|FG001|Overall Study|Withdrawal by Subject|0|||
49033686|NCT00113386|157958629|FG000|Overall Study|Physician Decision|0|||
49033687|NCT00113386|157958630|FG001|Overall Study|Physician Decision|1|||
49033688|NCT00113386|157958629|FG000|Overall Study|Toxicity|3|||
49033689|NCT00113386|157958630|FG001|Overall Study|Toxicity|0|||
49033690|NCT00113386|157958629|FG000|Overall Study|Ineligible|1|||
49033691|NCT00113386|157958630|FG001|Overall Study|Ineligible|2|||
49033692|NCT00113386|157958629|FG000|Overall Study|Unknown - Lost to Follow-Up|2|||
49033693|NCT00113386|157958630|FG001|Overall Study|Unknown - Lost to Follow-Up|1|||
49033694|NCT01839279|157958631|FG000|Overall Study|Adverse Event|4|||
49033695|NCT01839279|157958632|FG001|Overall Study|Adverse Event|1|||
49033696|NCT01839279|157958633|FG002|Overall Study|Adverse Event|1|||
49033697|NCT01839279|157958631|FG000|Overall Study|Withdrawal by Subject|4|||
49033698|NCT01839279|157958632|FG001|Overall Study|Withdrawal by Subject|1|||
49033699|NCT01839279|157958633|FG002|Overall Study|Withdrawal by Subject|1|||
49033700|NCT01839279|157958631|FG000|Overall Study|Classified as 'Other'|5|||
49033701|NCT01839279|157958632|FG001|Overall Study|Classified as 'Other'|0|||
49033702|NCT01839279|157958633|FG002|Overall Study|Classified as 'Other'|0|||
49033703|NCT00448591|157958638|FG000|Overall Study|Withdrawal by Subject|178|||
49033704|NCT00448591|157958638|FG000|Overall Study|Progressive Disease|1382|||
49033705|NCT00448591|157958638|FG000|Overall Study|Adverse Event|382|||
49033706|NCT00448591|157958638|FG000|Overall Study|Protocol Violation|41|||
49033707|NCT00448591|157958638|FG000|Overall Study|Lost to Follow-up|19|||
49033708|NCT00448591|157958638|FG000|Overall Study|Treatment Regimen Completed|70|||
49033709|NCT00448591|157958638|FG000|Overall Study|Other|154|||
49033710|NCT00448591|157958638|FG000|Overall Study|Termination of Study|70|||
49033711|NCT00640562|157958639|FG000|Overall Study|Adverse Event|8|||
49033712|NCT00640562|157958640|FG001|Overall Study|Adverse Event|5|||
49033713|NCT00640562|157958639|FG000|Overall Study|Lack of Efficacy|1|||
49033714|NCT00640562|157958640|FG001|Overall Study|Lack of Efficacy|4|||
49033715|NCT00640562|157958639|FG000|Overall Study|Protocol Violation|2|||
49033716|NCT00640562|157958640|FG001|Overall Study|Protocol Violation|4|||
49033717|NCT00640562|157958639|FG000|Overall Study|Withdrawal by Subject|6|||
49033718|NCT00640562|157958640|FG001|Overall Study|Withdrawal by Subject|10|||
49033719|NCT00640562|157958639|FG000|Overall Study|Known risperidone intolerance|0|||
49033720|NCT00640562|157958640|FG001|Overall Study|Known risperidone intolerance|1|||
49033721|NCT00640562|157958639|FG000|Overall Study|Past use of Seroquel -stopped due to AE|0|||
49033722|NCT00640562|157958640|FG001|Overall Study|Past use of Seroquel -stopped due to AE|1|||
49033723|NCT00640562|157958639|FG000|Overall Study|Low study drug dose|0|||
49033724|NCT00640562|157958640|FG001|Overall Study|Low study drug dose|1|||
49033725|NCT00640562|157958639|FG000|Overall Study|Glycosylated Hemoglobin >8|1|||
49033726|NCT00640562|157958640|FG001|Overall Study|Glycosylated Hemoglobin >8|0|||
49033727|NCT03276754|157958643|FG000|Overall Study|Withdrawal of informed consent|4|||
49033728|NCT03276754|157958643|FG000|Overall Study|Presence of any immunosuppressive condition|8|||
49033729|NCT03276754|157958643|FG000|Overall Study|Lost to Follow-up|27|||
49033730|NCT03276754|157958643|FG000|Overall Study|No data reported at Month 24|31|||
49033731|NCT03276754|157958643|FG000|Overall Study|Death|39|||
49033732|NCT03098394|157958644|FG000|Overall Study|Pregnancy|0|||
49033733|NCT03098394|157958645|FG001|Overall Study|Pregnancy|1|||
49033734|NCT00840073|157958646|FG000|Second Intervention|Missed 72 hour blood draw|1|||
49033735|NCT00840073|157958647|FG001|Second Intervention|Missed 72 hour blood draw|1|||
49033736|NCT02321098|157958649|FG000|12 Weeks Treament|Lost to Follow-up|1|||
49033737|NCT02321098|157958650|FG001|12 Weeks Treament|Lost to Follow-up|1|||
49033738|NCT02321098|157958651|FG002|12 Weeks Treament|Lost to Follow-up|0|||
49033739|NCT02321098|157958649|FG000|Additional 15 Months Treatment|Lack of Efficacy|0|||
49033740|NCT02321098|157958650|FG001|Additional 15 Months Treatment|Lack of Efficacy|0|||
49033741|NCT02321098|157958651|FG002|Additional 15 Months Treatment|Lack of Efficacy|6|||
49033742|NCT02321098|157958649|FG000|Additional 15 Months Treatment|Lost to Follow-up|0|||
49033743|NCT02321098|157958650|FG001|Additional 15 Months Treatment|Lost to Follow-up|0|||
49033744|NCT02321098|157958651|FG002|Additional 15 Months Treatment|Lost to Follow-up|1|||
49033745|NCT02321098|157958649|FG000|Additional 15 Months Treatment|Withdrawal by Subject|0|||
49033746|NCT02321098|157958650|FG001|Additional 15 Months Treatment|Withdrawal by Subject|0|||
49033747|NCT02321098|157958651|FG002|Additional 15 Months Treatment|Withdrawal by Subject|1|||
49033748|NCT01663233|157958652|FG000|Overall Study|Withdrawal by Subject|3|||
49033749|NCT01663233|157958653|FG001|Overall Study|Withdrawal by Subject|2|||
49033750|NCT01663233|157958652|FG000|Overall Study|Protocol Deviation|1|||
49033751|NCT01663233|157958653|FG001|Overall Study|Protocol Deviation|4|||
49033752|NCT01663233|157958652|FG000|Overall Study|Lost to Follow-up|0|||
49033753|NCT01663233|157958653|FG001|Overall Study|Lost to Follow-up|1|||
49033754|NCT00787254|157958654|FG000|Overall Study|Adverse Event|24|||
49033755|NCT00787254|157958655|FG001|Overall Study|Adverse Event|23|||
49033756|NCT00787254|157958654|FG000|Overall Study|Protocol Violation|26|||
49033757|NCT00787254|157958655|FG001|Overall Study|Protocol Violation|23|||
48880621|NCT04210843|157400213|FG000|First Half Treatment Period (52 Weeks)|Death|0|||
48880622|NCT04210843|157400214|FG001|First Half Treatment Period (52 Weeks)|Death|2|||
48880623|NCT04210843|157400213|FG000|First Half Treatment Period (52 Weeks)|Lack of Efficacy|0|||
48880624|NCT04210843|157400214|FG001|First Half Treatment Period (52 Weeks)|Lack of Efficacy|2|||
49033758|NCT00787254|157958654|FG000|Overall Study|Withdrawal by Subject|16|||
48880625|NCT04210843|157400213|FG000|First Half Treatment Period (52 Weeks)|Pregnancy|0|||
48880626|NCT04210843|157400214|FG001|First Half Treatment Period (52 Weeks)|Pregnancy|1|||
48880627|NCT04210843|157400213|FG000|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|71|||
49033759|NCT00787254|157958655|FG001|Overall Study|Withdrawal by Subject|11|||
48880628|NCT04210843|157400214|FG001|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|195|||
48880629|NCT04210843|157400213|FG000|Second Half Treatment Period (52 Weeks)|Subject decision|5|||
48880630|NCT04210843|157400214|FG001|Second Half Treatment Period (52 Weeks)|Subject decision|8|||
48880631|NCT04210843|157400213|FG000|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|0|||
48880632|NCT04210843|157400214|FG001|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|1|||
48880633|NCT04210843|157400213|FG000|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|45|||
48880634|NCT04210843|157400214|FG001|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|107|||
48880635|NCT04210843|157400213|FG000|Observation Period 2 (up to 52 Weeks)|Adverse Event|0|||
48880636|NCT04210843|157400214|FG001|Observation Period 2 (up to 52 Weeks)|Adverse Event|1|||
48880637|NCT04210843|157400213|FG000|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|0|||
48880638|NCT04210843|157400214|FG001|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|1|||
48880639|NCT04210843|157400213|FG000|Observation Period 2 (up to 52 Weeks)|Subject decision|0|||
48880640|NCT04210843|157400214|FG001|Observation Period 2 (up to 52 Weeks)|Subject decision|1|||
48880641|NCT04210843|157400213|FG000|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|16|||
48880642|NCT04210843|157400214|FG001|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|32|||
48880643|NCT04210843|157400213|FG000|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|4|||
48880644|NCT04210843|157400214|FG001|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|16|||
48880645|NCT04210843|157400213|FG000|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|1|||
48880646|NCT04210843|157400214|FG001|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|6|||
48880647|NCT04210843|157400213|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|0|||
48880648|NCT04210843|157400214|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|5|||
48880649|NCT04210843|157400213|FG000|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|2|||
48880650|NCT04210843|157400214|FG001|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|1|||
48880651|NCT04210843|157400213|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|0|||
48880652|NCT04210843|157400214|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|2|||
48880653|NCT04210843|157400213|FG000|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|0|||
48880654|NCT04210843|157400214|FG001|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|1|||
48880655|NCT04210843|157400213|FG000|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|0|||
48880656|NCT04210843|157400214|FG001|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|1|||
48880657|NCT00967005|157400221|FG000|Overall Study|Lost to Follow-up|7|||
48880658|NCT00967005|157400222|FG001|Overall Study|Lost to Follow-up|10|||
48880659|NCT02127125|157400223|FG000|Overall Study|Lost to Follow-up|0|||
48880660|NCT02127125|157400224|FG001|Overall Study|Lost to Follow-up|0|||
48880661|NCT02127125|157400225|FG002|Overall Study|Lost to Follow-up|0|||
48880662|NCT02127125|157400226|FG003|Overall Study|Lost to Follow-up|0|||
48880663|NCT02127125|157400227|FG004|Overall Study|Lost to Follow-up|2|||
48880664|NCT02127125|157400228|FG005|Overall Study|Lost to Follow-up|1|||
48880665|NCT02127125|157400229|FG006|Overall Study|Lost to Follow-up|0|||
48880666|NCT02127125|157400230|FG007|Overall Study|Lost to Follow-up|0|||
48880667|NCT02127125|157400231|FG008|Overall Study|Lost to Follow-up|0|||
48880668|NCT02127125|157400223|FG000|Overall Study|Withdrawal by Subject|0|||
49033760|NCT00787254|157958654|FG000|Overall Study|Lack of Efficacy|4|||
49033761|NCT00787254|157958655|FG001|Overall Study|Lack of Efficacy|15|||
49033762|NCT00787254|157958654|FG000|Overall Study|NSAIDs discontinuation|1|||
49033763|NCT00787254|157958655|FG001|Overall Study|NSAIDs discontinuation|2|||
49033764|NCT00787254|157958654|FG000|Overall Study|Institution closed|1|||
49033765|NCT00787254|157958655|FG001|Overall Study|Institution closed|0|||
49033766|NCT00787254|157958654|FG000|Overall Study|Physician Decision|4|||
49033767|NCT00787254|157958655|FG001|Overall Study|Physician Decision|8|||
48880669|NCT02127125|157400224|FG001|Overall Study|Withdrawal by Subject|0|||
48880670|NCT02127125|157400225|FG002|Overall Study|Withdrawal by Subject|0|||
48880671|NCT02127125|157400226|FG003|Overall Study|Withdrawal by Subject|1|||
48880672|NCT02127125|157400227|FG004|Overall Study|Withdrawal by Subject|0|||
48880673|NCT02127125|157400228|FG005|Overall Study|Withdrawal by Subject|0|||
48880674|NCT02127125|157400229|FG006|Overall Study|Withdrawal by Subject|0|||
48880675|NCT02127125|157400230|FG007|Overall Study|Withdrawal by Subject|0|||
48880676|NCT02127125|157400231|FG008|Overall Study|Withdrawal by Subject|0|||
48880677|NCT02127125|157400223|FG000|Overall Study|Physician Decision|0|||
48880678|NCT02127125|157400224|FG001|Overall Study|Physician Decision|0|||
49033768|NCT00836056|157958663|FG000|First Intervention|Adverse Event|1|||
48880679|NCT02127125|157400225|FG002|Overall Study|Physician Decision|1|||
48880680|NCT02127125|157400226|FG003|Overall Study|Physician Decision|0|||
48880681|NCT02127125|157400227|FG004|Overall Study|Physician Decision|1|||
48880682|NCT02127125|157400228|FG005|Overall Study|Physician Decision|2|||
48880683|NCT02127125|157400229|FG006|Overall Study|Physician Decision|0|||
48880684|NCT02127125|157400230|FG007|Overall Study|Physician Decision|0|||
48880685|NCT02127125|157400231|FG008|Overall Study|Physician Decision|0|||
49033769|NCT00836056|157958664|FG001|First Intervention|Adverse Event|0|||
48880686|NCT03017742|157400232|FG000|Overall Study|Protocol Violation|36|||
48880687|NCT03017742|157400232|FG000|Overall Study|Withdrawal by Subject|37|||
48880688|NCT00762476|157400239|FG000|Overall Study|Adverse Event|7|||
48880689|NCT00762476|157400240|FG001|Overall Study|Adverse Event|1|||
48880690|NCT00762476|157400239|FG000|Overall Study|Lost to Follow-up|2|||
48880691|NCT00762476|157400240|FG001|Overall Study|Lost to Follow-up|0|||
48880692|NCT00762476|157400239|FG000|Overall Study|Protocol Violation|5|||
48880693|NCT00762476|157400240|FG001|Overall Study|Protocol Violation|6|||
48880694|NCT00762476|157400239|FG000|Overall Study|Physician Decision|2|||
48880695|NCT00762476|157400240|FG001|Overall Study|Physician Decision|14|||
48880696|NCT00762476|157400239|FG000|Overall Study|Withdrawal by Subject|6|||
48880697|NCT00762476|157400240|FG001|Overall Study|Withdrawal by Subject|12|||
48880698|NCT00762476|157400239|FG000|Overall Study|antibiotic use|0|||
48880699|NCT00762476|157400240|FG001|Overall Study|antibiotic use|1|||
48880700|NCT00762476|157400239|FG000|Overall Study|non-compliance with study visits|0|||
48880701|NCT00762476|157400240|FG001|Overall Study|non-compliance with study visits|2|||
48880702|NCT00762476|157400239|FG000|Overall Study|Seasonal allergies|1|||
48880703|NCT00762476|157400240|FG001|Overall Study|Seasonal allergies|0|||
48880704|NCT02637323|157400241|FG000|Overall Study|Lost to Follow-up|2|||
48880705|NCT02637323|157400242|FG001|Overall Study|Lost to Follow-up|0|||
48880706|NCT02637323|157400241|FG000|Overall Study|Protocol Violation|0|||
48880707|NCT02637323|157400242|FG001|Overall Study|Protocol Violation|1|||
48880708|NCT00368875|157400245|FG000|Overall Study|Adverse Event|0|||
48880709|NCT00368875|157400246|FG001|Overall Study|Adverse Event|12|||
48880710|NCT00368875|157400245|FG000|Overall Study|Progressive disease|3|||
48880711|NCT00368875|157400246|FG001|Overall Study|Progressive disease|27|||
48880712|NCT00368875|157400245|FG000|Overall Study|Withdrawal by Subject|2|||
48880713|NCT00368875|157400246|FG001|Overall Study|Withdrawal by Subject|6|||
48880714|NCT00368875|157400245|FG000|Overall Study|Other Reason|0|||
48880715|NCT00368875|157400246|FG001|Overall Study|Other Reason|2|||
48880716|NCT00368875|157400245|FG000|Overall Study|Alternative Therapy|1|||
48880717|NCT00368875|157400246|FG001|Overall Study|Alternative Therapy|1|||
48880718|NCT01465763|157400247|FG000|Overall Study|Withdrawal by Subject|4|||
48880719|NCT01465763|157400248|FG001|Overall Study|Withdrawal by Subject|0|||
48880720|NCT01465763|157400249|FG002|Overall Study|Withdrawal by Subject|1|||
48880721|NCT01465763|157400247|FG000|Overall Study|Insufficient Clinical Response|11|||
48880722|NCT01465763|157400248|FG001|Overall Study|Insufficient Clinical Response|0|||
48880723|NCT01465763|157400249|FG002|Overall Study|Insufficient Clinical Response|1|||
48880724|NCT01465763|157400247|FG000|Overall Study|Adverse Event|9|||
48880725|NCT01465763|157400248|FG001|Overall Study|Adverse Event|0|||
48880726|NCT01465763|157400249|FG002|Overall Study|Adverse Event|1|||
48880727|NCT01465763|157400247|FG000|Overall Study|Other|2|||
48880728|NCT01465763|157400248|FG001|Overall Study|Other|0|||
48880729|NCT01465763|157400249|FG002|Overall Study|Other|0|||
48880730|NCT01465763|157400247|FG000|Overall Study|Protocol Violation|4|||
48880731|NCT01465763|157400248|FG001|Overall Study|Protocol Violation|1|||
48880732|NCT01465763|157400249|FG002|Overall Study|Protocol Violation|1|||
48880733|NCT01465763|157400247|FG000|Overall Study|Death|1|||
48880734|NCT01465763|157400248|FG001|Overall Study|Death|0|||
48880735|NCT01465763|157400249|FG002|Overall Study|Death|0|||
48880736|NCT03552523|157400251|FG000|Overall Study|Withdrawal by Subject|1|||
48880737|NCT03552523|157400252|FG001|Overall Study|Withdrawal by Subject|1|||
48880738|NCT01896726|157400253|FG000|Treatment Period 2 (Days 23-31)|Adverse Event|1|||
48880739|NCT01896726|157400253|FG000|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1|||
48880740|NCT01754753|157400254|FG000|Overall Study|Study close|43|||
48880741|NCT01754753|157400255|FG001|Overall Study|Study close|44|||
48880742|NCT01754753|157400254|FG000|Overall Study|Lost to Follow-up|9|||
48880743|NCT01754753|157400255|FG001|Overall Study|Lost to Follow-up|5|||
48880744|NCT01111240|157400256|FG000|Overall Study|Adverse Event|190|||
48880745|NCT01111240|157400256|FG000|Overall Study|Lack of Efficacy|545|||
48880746|NCT01111240|157400256|FG000|Overall Study|Lack of Efficacy and Adverse Event|19|||
48880747|NCT01111240|157400256|FG000|Overall Study|Other|312|||
48880748|NCT00617929|157400257|FG000|Overall Study|Physician Decision|1|||
48880749|NCT01443923|157400258|FG000|Overall Study|Adverse Event|1|||
48880750|NCT01443923|157400259|FG001|Overall Study|Adverse Event|0|||
48880751|NCT04160988|157400260|FG000|Overall Study|poor image quality|28|||
48880752|NCT00250432|157400265|FG000|Overall Study|Adverse Event|25|||
48880753|NCT00250432|157400266|FG001|Overall Study|Adverse Event|29|||
48880754|NCT00250432|157400265|FG000|Overall Study|Lack of Efficacy|2|||
48880755|NCT00250432|157400266|FG001|Overall Study|Lack of Efficacy|1|||
48880756|NCT00250432|157400265|FG000|Overall Study|Lost to Follow-up|6|||
48880757|NCT00250432|157400266|FG001|Overall Study|Lost to Follow-up|5|||
48880758|NCT00250432|157400265|FG000|Overall Study|Patient Moved|0|||
48880759|NCT00250432|157400266|FG001|Overall Study|Patient Moved|1|||
48880760|NCT00250432|157400265|FG000|Overall Study|Protocol Violation|0|||
48880761|NCT00250432|157400266|FG001|Overall Study|Protocol Violation|3|||
48880762|NCT00250432|157400265|FG000|Overall Study|Withdrawal by Subject|6|||
48880763|NCT00250432|157400266|FG001|Overall Study|Withdrawal by Subject|2|||
48880764|NCT00250432|157400265|FG000|Overall Study|Pt died out of posttherapy report period|6|||
49033770|NCT01188681|157958665|FG000|Overall Study|bladder cancer|0|||
49033771|NCT01188681|157958666|FG001|Overall Study|bladder cancer|0|||
49033772|NCT01188681|157958667|FG002|Overall Study|bladder cancer|1|||
49033773|NCT01188681|157958668|FG003|Overall Study|bladder cancer|0|||
49033774|NCT01188681|157958665|FG000|Overall Study|Withdrawal by Subject|0|||
49033775|NCT01188681|157958666|FG001|Overall Study|Withdrawal by Subject|0|||
49033776|NCT01188681|157958667|FG002|Overall Study|Withdrawal by Subject|0|||
49033777|NCT01188681|157958668|FG003|Overall Study|Withdrawal by Subject|1|||
49033778|NCT02622386|157958669|FG000|First Assignment|Withdrawal by Subject|3|||
49033779|NCT02622386|157958670|FG001|First Assignment|Withdrawal by Subject|2|||
49033780|NCT02622386|157958669|FG000|Washout|Withdrawal by Subject|4|||
49033781|NCT02622386|157958670|FG001|Washout|Withdrawal by Subject|4|||
49033782|NCT02622386|157958669|FG000|Second Assignment|Withdrawal by Subject|0|||
49033783|NCT02622386|157958670|FG001|Second Assignment|Withdrawal by Subject|2|||
49033784|NCT02890992|157958671|FG000|130 Weeks Open-Label Extension Period|Adverse Event|0|||
49033785|NCT02890992|157958672|FG001|130 Weeks Open-Label Extension Period|Adverse Event|1|||
49033786|NCT02890992|157958673|FG002|130 Weeks Open-Label Extension Period|Adverse Event|0|||
49033787|NCT02890992|157958674|FG003|130 Weeks Open-Label Extension Period|Adverse Event|0|||
49033788|NCT02890992|157958675|FG004|130 Weeks Open-Label Extension Period|Adverse Event|0|||
49033789|NCT02890992|157958676|FG005|130 Weeks Open-Label Extension Period|Adverse Event|0|||
49033790|NCT02890992|157958677|FG006|130 Weeks Open-Label Extension Period|Adverse Event|0|||
49033791|NCT02890992|157958678|FG007|130 Weeks Open-Label Extension Period|Adverse Event|0|||
49033792|NCT02890992|157958671|FG000|130 Weeks Open-Label Extension Period|Included but not treated|0|||
49033793|NCT02890992|157958672|FG001|130 Weeks Open-Label Extension Period|Included but not treated|0|||
49033794|NCT02890992|157958673|FG002|130 Weeks Open-Label Extension Period|Included but not treated|0|||
49033795|NCT02890992|157958674|FG003|130 Weeks Open-Label Extension Period|Included but not treated|0|||
49033796|NCT02890992|157958675|FG004|130 Weeks Open-Label Extension Period|Included but not treated|0|||
49033797|NCT02890992|157958676|FG005|130 Weeks Open-Label Extension Period|Included but not treated|0|||
49033798|NCT02890992|157958677|FG006|130 Weeks Open-Label Extension Period|Included but not treated|1|||
49033799|NCT02890992|157958678|FG007|130 Weeks Open-Label Extension Period|Included but not treated|1|||
49033800|NCT02890992|157958671|FG000|130 Weeks Open-Label Extension Period|Other than specified|0|||
49033801|NCT02890992|157958672|FG001|130 Weeks Open-Label Extension Period|Other than specified|2|||
49033802|NCT02890992|157958673|FG002|130 Weeks Open-Label Extension Period|Other than specified|0|||
49033803|NCT02890992|157958674|FG003|130 Weeks Open-Label Extension Period|Other than specified|0|||
49033804|NCT02890992|157958675|FG004|130 Weeks Open-Label Extension Period|Other than specified|0|||
49033805|NCT02890992|157958676|FG005|130 Weeks Open-Label Extension Period|Other than specified|0|||
49033806|NCT02890992|157958677|FG006|130 Weeks Open-Label Extension Period|Other than specified|0|||
49033807|NCT02890992|157958678|FG007|130 Weeks Open-Label Extension Period|Other than specified|0|||
49033808|NCT01353664|157958699|FG000|Overall Study|Other|3|||
49033809|NCT01353664|157958699|FG000|Overall Study|Disease Progression|16|||
49033810|NCT03503318|157958700|FG000|Overall Study|Death|1|||
49033811|NCT03503318|157958701|FG001|Overall Study|Death|0|||
49033812|NCT03503318|157958702|FG002|Overall Study|Death|4|||
49033813|NCT03503318|157958700|FG000|Overall Study|Adverse Event|3|||
49033814|NCT03503318|157958701|FG001|Overall Study|Adverse Event|4|||
49033815|NCT03503318|157958702|FG002|Overall Study|Adverse Event|2|||
49033816|NCT03503318|157958700|FG000|Overall Study|Withdrawal by Subject|12|||
49033817|NCT03503318|157958701|FG001|Overall Study|Withdrawal by Subject|17|||
49033818|NCT03503318|157958702|FG002|Overall Study|Withdrawal by Subject|16|||
49033819|NCT03503318|157958700|FG000|Overall Study|Protocol Violation|5|||
49033820|NCT03503318|157958701|FG001|Overall Study|Protocol Violation|0|||
49033821|NCT03503318|157958702|FG002|Overall Study|Protocol Violation|3|||
49033822|NCT03503318|157958700|FG000|Overall Study|Lost to Follow-up|17|||
49033823|NCT03503318|157958701|FG001|Overall Study|Lost to Follow-up|15|||
49033824|NCT03503318|157958702|FG002|Overall Study|Lost to Follow-up|12|||
49033825|NCT03503318|157958700|FG000|Overall Study|Other than specified|1|||
49033826|NCT03503318|157958701|FG001|Overall Study|Other than specified|3|||
49033827|NCT03503318|157958702|FG002|Overall Study|Other than specified|3|||
49033828|NCT01794845|157958703|FG000|Overall Study|Withdrawal by Subject|1|||
49033829|NCT03100344|157958704|FG000|Overall Study|Adverse Event|0|||
49033830|NCT03100344|157958705|FG001|Overall Study|Adverse Event|3|||
49033831|NCT03100344|157958706|FG002|Overall Study|Adverse Event|2|||
49033832|NCT03100344|157958707|FG003|Overall Study|Adverse Event|3|||
49033833|NCT03100344|157958704|FG000|Overall Study|Lack of Efficacy|2|||
49033834|NCT03100344|157958705|FG001|Overall Study|Lack of Efficacy|0|||
49033835|NCT03100344|157958706|FG002|Overall Study|Lack of Efficacy|0|||
48880765|NCT00250432|157400266|FG001|Overall Study|Pt died out of posttherapy report period|5|||
49033836|NCT03100344|157958707|FG003|Overall Study|Lack of Efficacy|0|||
49033837|NCT03100344|157958704|FG000|Overall Study|Protocol Violation|1|||
49033838|NCT03100344|157958705|FG001|Overall Study|Protocol Violation|0|||
49033839|NCT03100344|157958706|FG002|Overall Study|Protocol Violation|0|||
49033840|NCT03100344|157958707|FG003|Overall Study|Protocol Violation|0|||
49033841|NCT03100344|157958704|FG000|Overall Study|Withdrawal by Subject|10|||
48880766|NCT00250432|157400265|FG000|Overall Study|Pt was considered untreatable|0|||
48880767|NCT00250432|157400266|FG001|Overall Study|Pt was considered untreatable|1|||
48880768|NCT01228175|157400267|FG000|Overall Study|Lost to Follow-up|64|||
48880769|NCT01228175|157400268|FG001|Overall Study|Lost to Follow-up|50|||
48880770|NCT01228175|157400267|FG000|Overall Study|Withdrawal by Subject|1|||
48880771|NCT01228175|157400268|FG001|Overall Study|Withdrawal by Subject|2|||
48880772|NCT01228175|157400267|FG000|Overall Study|Physician Decision|1|||
48880773|NCT01228175|157400268|FG001|Overall Study|Physician Decision|1|||
48880774|NCT00243074|157400270|FG000|Overall Study|Ineligible|6|||
48880775|NCT00243074|157400270|FG000|Overall Study|Adverse Event|6|||
48880776|NCT00243074|157400270|FG000|Overall Study|Withdrawal by Subject|2|||
49033842|NCT03100344|157958705|FG001|Overall Study|Withdrawal by Subject|7|||
49033843|NCT03100344|157958706|FG002|Overall Study|Withdrawal by Subject|4|||
49033844|NCT03100344|157958707|FG003|Overall Study|Withdrawal by Subject|8|||
49033845|NCT03100344|157958704|FG000|Overall Study|Lost to Follow-up|1|||
48880777|NCT00243074|157400270|FG000|Overall Study|Lack of Efficacy|36|||
48880778|NCT00243074|157400270|FG000|Overall Study|Death|2|||
48880779|NCT00243074|157400270|FG000|Overall Study|not protocol specified|1|||
48880780|NCT00243074|157400270|FG000|Overall Study|Did not receive any treatment|1|||
48880781|NCT03784820|157400271|FG000|Overall Study|Lost to Follow-up|5|||
48880782|NCT03784820|157400272|FG001|Overall Study|Lost to Follow-up|5|||
48880783|NCT03784820|157400273|FG002|Overall Study|Lost to Follow-up|3|||
49033846|NCT03100344|157958705|FG001|Overall Study|Lost to Follow-up|1|||
49033847|NCT03100344|157958706|FG002|Overall Study|Lost to Follow-up|1|||
49033848|NCT03100344|157958707|FG003|Overall Study|Lost to Follow-up|1|||
48880784|NCT03784820|157400274|FG003|Overall Study|Lost to Follow-up|3|||
48880785|NCT00600613|157400275|FG000|Overall Study|Protocol Deviation|1|||
48880786|NCT00664534|157400276|FG000|Overall Study|Adverse Event|2|||
48880787|NCT00664534|157400277|FG001|Overall Study|Adverse Event|3|||
48880788|NCT00664534|157400276|FG000|Overall Study|Lost to Follow-up|6|||
48880789|NCT00664534|157400277|FG001|Overall Study|Lost to Follow-up|10|||
48880790|NCT00664534|157400276|FG000|Overall Study|Protocol Violation|10|||
48880791|NCT00664534|157400277|FG001|Overall Study|Protocol Violation|8|||
48880792|NCT00664534|157400276|FG000|Overall Study|Withdrawal by Subject|7|||
48880793|NCT00664534|157400277|FG001|Overall Study|Withdrawal by Subject|6|||
48880794|NCT00664534|157400276|FG000|Overall Study|Physician Decision|8|||
48880795|NCT00664534|157400277|FG001|Overall Study|Physician Decision|0|||
48880796|NCT00664534|157400276|FG000|Overall Study|Sponsor decision|8|||
48880797|NCT00664534|157400277|FG001|Overall Study|Sponsor decision|6|||
48880798|NCT03041792|157400279|FG000|Overall Study|Adverse Event|4|||
48880799|NCT03041792|157400280|FG001|Overall Study|Adverse Event|0|||
48880800|NCT03041792|157400279|FG000|Overall Study|Death in the family|0|||
48880801|NCT03041792|157400280|FG001|Overall Study|Death in the family|2|||
48880802|NCT03041792|157400279|FG000|Overall Study|Randomized but not treated|0|||
48880803|NCT03041792|157400280|FG001|Overall Study|Randomized but not treated|1|||
48880804|NCT02227992|157400281|FG000|Overall Study|Lost to Follow-up|1|||
48880805|NCT02227992|157400282|FG001|Overall Study|Lost to Follow-up|1|||
48880806|NCT01371708|157400283|FG000|Overall Study|Insufficient clinical response|3|||
48880807|NCT01371708|157400284|FG001|Overall Study|Insufficient clinical response|2|||
48880808|NCT01371708|157400285|FG002|Overall Study|Insufficient clinical response|0|||
48880809|NCT01371708|157400283|FG000|Overall Study|Lost to Follow-up|5|||
48880810|NCT01371708|157400284|FG001|Overall Study|Lost to Follow-up|9|||
48880811|NCT01371708|157400285|FG002|Overall Study|Lost to Follow-up|7|||
48880812|NCT01371708|157400283|FG000|Overall Study|Protocol Violation|2|||
48880813|NCT01371708|157400284|FG001|Overall Study|Protocol Violation|1|||
48880814|NCT01371708|157400285|FG002|Overall Study|Protocol Violation|2|||
48880815|NCT01371708|157400283|FG000|Overall Study|No longer willing to participate|7|||
48880816|NCT01371708|157400284|FG001|Overall Study|No longer willing to participate|7|||
48880817|NCT01371708|157400285|FG002|Overall Study|No longer willing to participate|13|||
48880818|NCT01371708|157400283|FG000|Overall Study|Medication error/not related to AE|0|||
48880819|NCT01371708|157400284|FG001|Overall Study|Medication error/not related to AE|1|||
48880820|NCT01371708|157400285|FG002|Overall Study|Medication error/not related to AE|0|||
48880821|NCT01371708|157400283|FG000|Overall Study|Other|3|||
48880822|NCT01371708|157400284|FG001|Overall Study|Other|2|||
48880823|NCT01371708|157400285|FG002|Overall Study|Other|4|||
48880824|NCT01371708|157400283|FG000|Overall Study|Adverse Event|5|||
48880825|NCT01371708|157400284|FG001|Overall Study|Adverse Event|8|||
48880826|NCT01371708|157400285|FG002|Overall Study|Adverse Event|12|||
48880827|NCT01371708|157400283|FG000|Overall Study|Started but did not receive treatment|1|||
48880828|NCT01371708|157400284|FG001|Overall Study|Started but did not receive treatment|0|||
48880829|NCT01371708|157400285|FG002|Overall Study|Started but did not receive treatment|1|||
48880830|NCT02514551|157400286|FG000|Overall Study|Lost to Follow-up|0|||
48880831|NCT02514551|157400287|FG001|Overall Study|Lost to Follow-up|1|||
49033849|NCT04198363|157958708|FG000|Overall Study|Adverse Event|1|||
49033850|NCT04198363|157958709|FG001|Overall Study|Adverse Event|1|||
48880832|NCT02514551|157400286|FG000|Overall Study|Participant Never Treated|0|||
48880833|NCT02514551|157400287|FG001|Overall Study|Participant Never Treated|2|||
48880834|NCT03197766|157400288|FG000|Overall Study|Withdrawal by Subject|2|||
48880835|NCT03197766|157400289|FG001|Overall Study|Withdrawal by Subject|0|||
48880836|NCT01607476|157400290|FG000|Overall Study|Withdrawal by Subject|1|||
48880837|NCT01607476|157400291|FG001|Overall Study|Withdrawal by Subject|0|||
48880838|NCT01607476|157400292|FG002|Overall Study|Withdrawal by Subject|1|||
48880839|NCT01607476|157400290|FG000|Overall Study|Lost to Follow-up|0|||
48880840|NCT01607476|157400291|FG001|Overall Study|Lost to Follow-up|0|||
49033851|NCT04198363|157958708|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
49033852|NCT04198363|157958709|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
49033853|NCT04198363|157958708|FG000|Overall Study|Reason not Specified|1|||
49033854|NCT04198363|157958709|FG001|Overall Study|Reason not Specified|0|||
49033855|NCT00942968|157960187|FG000|Overall Study|Adverse Event|60|||
49033856|NCT00942968|157960187|FG000|Overall Study|Death|76|||
49033857|NCT00942968|157960187|FG000|Overall Study|Protocol Violation|9|||
49033858|NCT00942968|157960187|FG000|Overall Study|Lost to Follow-up|4|||
49033859|NCT00942968|157960187|FG000|Overall Study|Withdrawal by Subject|44|||
49033860|NCT00942968|157960187|FG000|Overall Study|Sponsor request|5|||
49033861|NCT00942968|157960187|FG000|Overall Study|Physician Decision|11|||
49033862|NCT00942968|157960187|FG000|Overall Study|Progression of disease|12|||
49033863|NCT00942968|157960187|FG000|Overall Study|Inferior vena cava filter placement|4|||
49033864|NCT00942968|157960187|FG000|Overall Study|Pulmonary embolism (PE)|1|||
49033865|NCT00942968|157960187|FG000|Overall Study|Participant required pancreatic biopsy|1|||
49033866|NCT00942968|157960187|FG000|Overall Study|Deep vein thrombosis (DVT)|2|||
49033867|NCT01948258|157960190|FG000|Overall Study|Pregnancy|41|||
49033868|NCT01948258|157960190|FG000|Overall Study|Did not complete by cut-off date|35|||
49033869|NCT01948258|157960190|FG000|Overall Study|Lost to Follow-up|27|||
49033870|NCT01948258|157960190|FG000|Overall Study|Withdrawal by SPD|8|||
49033871|NCT01948258|157960190|FG000|Overall Study|Withdrawal by Subject|6|||
49033872|NCT01948258|157960190|FG000|Overall Study|Health Care Professional|43|||
49033873|NCT01948258|157960190|FG000|Overall Study|Removed from statistical analysis|2|||
49033874|NCT00834795|157960192|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
48880841|NCT01607476|157400292|FG002|Overall Study|Lost to Follow-up|2|||
48880842|NCT02980042|157402325|FG000|Overall Study|Lost to Follow-up|5|||
48880843|NCT02980042|157402326|FG001|Overall Study|Lost to Follow-up|0|||
48880844|NCT02980042|157402325|FG000|Overall Study|Insurance issues/treatment plan changes|2|||
48880845|NCT02980042|157402326|FG001|Overall Study|Insurance issues/treatment plan changes|0|||
48880846|NCT04367480|157402329|FG000|Overall Study|Adverse Event|1|||
48880847|NCT04367480|157402330|FG001|Overall Study|Adverse Event|1|||
48880848|NCT04367480|157402329|FG000|Overall Study|Death|1|||
48880849|NCT04367480|157402330|FG001|Overall Study|Death|0|||
48880850|NCT04367480|157402329|FG000|Overall Study|Lost to Follow-up|1|||
48880851|NCT04367480|157402330|FG001|Overall Study|Lost to Follow-up|1|||
48880852|NCT04367480|157402329|FG000|Overall Study|Withdrawal by Subject|0|||
48880853|NCT04367480|157402330|FG001|Overall Study|Withdrawal by Subject|3|||
48880854|NCT04367480|157402329|FG000|Overall Study|App glitch during the study|1|||
48880855|NCT04367480|157402330|FG001|Overall Study|App glitch during the study|0|||
48880856|NCT04367480|157402329|FG000|Overall Study|Device Distribution Error|0|||
48880857|NCT04367480|157402330|FG001|Overall Study|Device Distribution Error|2|||
48880858|NCT04367480|157402329|FG000|Overall Study|Ineligible after Randomization|0|||
48880859|NCT04367480|157402330|FG001|Overall Study|Ineligible after Randomization|1|||
48880860|NCT04367480|157402329|FG000|Overall Study|Other Medical Reasons|0|||
48880861|NCT04367480|157402330|FG001|Overall Study|Other Medical Reasons|2|||
48880862|NCT01131104|157402331|FG000|Overall Study|Withdrawal by Subject|3|||
48880863|NCT01131104|157402331|FG000|Overall Study|Physician Decision|4|||
48880864|NCT01131104|157402331|FG000|Overall Study|Information Not Available|5|||
48880865|NCT01131104|157402331|FG000|Overall Study|No Information on Index Date of Onset|1|||
48880866|NCT02525692|157402337|FG000|Overall Study|Withdrawal by Subject|1|||
48880867|NCT02525692|157402338|FG001|Overall Study|Withdrawal by Subject|1|||
48880868|NCT02525692|157402339|FG002|Overall Study|Withdrawal by Subject|0|||
48880869|NCT02525692|157402340|FG003|Overall Study|Withdrawal by Subject|5|||
48880870|NCT02525692|157402341|FG004|Overall Study|Withdrawal by Subject|0|||
48880871|NCT02525692|157402342|FG005|Overall Study|Withdrawal by Subject|1|||
48880872|NCT02525692|157402337|FG000|Overall Study|Death|16|||
48880873|NCT02525692|157402338|FG001|Overall Study|Death|18|||
49033875|NCT00834795|157960193|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
48880874|NCT02525692|157402339|FG002|Overall Study|Death|7|||
48880875|NCT02525692|157402340|FG003|Overall Study|Death|20|||
48880876|NCT02525692|157402341|FG004|Overall Study|Death|3|||
48880877|NCT02525692|157402342|FG005|Overall Study|Death|6|||
48880878|NCT02525692|157402337|FG000|Overall Study|Lost to Follow-up|0|||
48880879|NCT02525692|157402338|FG001|Overall Study|Lost to Follow-up|0|||
48880880|NCT02525692|157402339|FG002|Overall Study|Lost to Follow-up|1|||
48880881|NCT02525692|157402340|FG003|Overall Study|Lost to Follow-up|5|||
49033876|NCT00834795|157960192|FG000|Second Intervention|Adverse Event|1|||
48880882|NCT02525692|157402341|FG004|Overall Study|Lost to Follow-up|0|||
48880883|NCT02525692|157402342|FG005|Overall Study|Lost to Follow-up|0|||
48880884|NCT02271984|157402343|FG000|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
48880885|NCT02271984|157402344|FG001|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
48880886|NCT02271984|157402345|FG002|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
48880887|NCT02271984|157402346|FG003|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
48880888|NCT02271984|157402347|FG004|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
48880889|NCT02271984|157402348|FG005|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
48880890|NCT02271984|157402349|FG006|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
48880891|NCT02271984|157402350|FG007|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
48880892|NCT02271984|157402351|FG008|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
48880893|NCT02271984|157402352|FG009|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
48880894|NCT02271984|157402353|FG010|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
48880895|NCT02271984|157402354|FG011|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
48880896|NCT00863512|157402356|FG000|Overall Study|Adverse Event|2|||
48880897|NCT00863512|157402357|FG001|Overall Study|Adverse Event|0|||
48880898|NCT00863512|157402356|FG000|Overall Study|Withdrawal by Subject|11|||
48880899|NCT00863512|157402357|FG001|Overall Study|Withdrawal by Subject|0|||
48880900|NCT00863512|157402356|FG000|Overall Study|Physician Decision|1|||
48880901|NCT00863512|157402357|FG001|Overall Study|Physician Decision|0|||
48880902|NCT01107899|157402362|FG000|Overall Study|Physician Decision|5|||
48880903|NCT01107899|157402363|FG001|Overall Study|Physician Decision|0|||
48880904|NCT01107899|157402364|FG002|Overall Study|Physician Decision|3|||
48880905|NCT01107899|157402362|FG000|Overall Study|Withdrawal by Subject|0|||
48880906|NCT01107899|157402363|FG001|Overall Study|Withdrawal by Subject|0|||
48880907|NCT01107899|157402364|FG002|Overall Study|Withdrawal by Subject|1|||
48880908|NCT01454739|157402366|FG000|Overall Study|Protocol Violation|2|||
48880909|NCT01454739|157402367|FG001|Overall Study|Protocol Violation|3|||
48880910|NCT01454739|157402366|FG000|Overall Study|Withdrawal by Subject|2|||
48880911|NCT01454739|157402367|FG001|Overall Study|Withdrawal by Subject|6|||
48880912|NCT01454739|157402366|FG000|Overall Study|Other|3|||
48880913|NCT01454739|157402367|FG001|Overall Study|Other|5|||
48880914|NCT01454739|157402366|FG000|Overall Study|Physician Decision|0|||
48880915|NCT01454739|157402367|FG001|Overall Study|Physician Decision|5|||
48880916|NCT01454739|157402366|FG000|Overall Study|Lost to Follow-up|0|||
48880917|NCT01454739|157402367|FG001|Overall Study|Lost to Follow-up|1|||
48880918|NCT01454739|157402366|FG000|Overall Study|Adverse Event|0|||
48880919|NCT01454739|157402367|FG001|Overall Study|Adverse Event|1|||
48880920|NCT01810939|157402368|FG000|Part A Treatment Period|Non-compliance with Study Drug|1|||
48880921|NCT01810939|157402369|FG001|Part A Treatment Period|Non-compliance with Study Drug|0|||
48880922|NCT01810939|157402370|FG002|Part A Treatment Period|Non-compliance with Study Drug|0|||
48880923|NCT01810939|157402368|FG000|Part A Treatment Period|Protocol Violation|2|||
48880924|NCT01810939|157402369|FG001|Part A Treatment Period|Protocol Violation|0|||
48880925|NCT01810939|157402370|FG002|Part A Treatment Period|Protocol Violation|0|||
48880926|NCT01810939|157402368|FG000|Part A Treatment Period|Adverse Event|10|||
48880927|NCT01810939|157402369|FG001|Part A Treatment Period|Adverse Event|0|||
48880928|NCT01810939|157402370|FG002|Part A Treatment Period|Adverse Event|0|||
48880929|NCT01810939|157402368|FG000|Part A Treatment Period|Withdrawal by Subject|5|||
48880930|NCT01810939|157402369|FG001|Part A Treatment Period|Withdrawal by Subject|0|||
48880931|NCT01810939|157402370|FG002|Part A Treatment Period|Withdrawal by Subject|0|||
48880932|NCT01810939|157402368|FG000|Part A Treatment Period|Protocol-specified (eGFR)|2|||
48880933|NCT01810939|157402369|FG001|Part A Treatment Period|Protocol-specified (eGFR)|0|||
48880934|NCT01810939|157402370|FG002|Part A Treatment Period|Protocol-specified (eGFR)|0|||
48880935|NCT01810939|157402368|FG000|Part A Treatment Period|Protocol-specified (High K+)|3|||
48880936|NCT01810939|157402369|FG001|Part A Treatment Period|Protocol-specified (High K+)|0|||
48880937|NCT01810939|157402370|FG002|Part A Treatment Period|Protocol-specified (High K+)|0|||
48880938|NCT01810939|157402368|FG000|Part A Treatment Period|Protocol-specified (Low K+)|1|||
48880939|NCT01810939|157402369|FG001|Part A Treatment Period|Protocol-specified (Low K+)|0|||
48880940|NCT01810939|157402370|FG002|Part A Treatment Period|Protocol-specified (Low K+)|0|||
48880941|NCT01810939|157402368|FG000|Part B Placebo-Controlled Withdrawal|Physician Decision|0|||
48880942|NCT01810939|157402369|FG001|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
48880943|NCT01810939|157402370|FG002|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
48880944|NCT01810939|157402368|FG000|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
48880945|NCT01810939|157402369|FG001|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1|||
48880946|NCT01810939|157402370|FG002|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
48880947|NCT01810939|157402368|FG000|Part B Placebo-Controlled Withdrawal|Adverse Event|0|||
48880948|NCT01810939|157402369|FG001|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
48880949|NCT01810939|157402370|FG002|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
48880950|NCT01810939|157402368|FG000|Part B Placebo-Controlled Withdrawal|Death|0|||
48880951|NCT01810939|157402369|FG001|Part B Placebo-Controlled Withdrawal|Death|0|||
48880952|NCT01810939|157402370|FG002|Part B Placebo-Controlled Withdrawal|Death|1|||
48880953|NCT01810939|157402368|FG000|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
48880954|NCT01810939|157402369|FG001|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
48880955|NCT01810939|157402370|FG002|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1|||
48880956|NCT01810939|157402368|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0|||
48880957|NCT01810939|157402369|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
48880958|NCT01810939|157402370|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
48880959|NCT01810939|157402368|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0|||
48880960|NCT01810939|157402369|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1|||
48880961|NCT01810939|157402370|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2|||
48880962|NCT01810939|157402368|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0|||
48880963|NCT01810939|157402369|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2|||
48880964|NCT01810939|157402370|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14|||
48880965|NCT01810939|157402368|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0|||
48880966|NCT01810939|157402369|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2|||
48880967|NCT01810939|157402370|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1|||
48880968|NCT01810939|157402368|FG000|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
48880969|NCT01810939|157402369|FG001|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1|||
48880970|NCT01810939|157402370|FG002|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
48880971|NCT02870972|157402374|FG000|Overall Study|Adverse Event|1|||
48880972|NCT02870972|157402375|FG001|Overall Study|Adverse Event|0|||
48880973|NCT02870972|157402376|FG002|Overall Study|Adverse Event|0|||
48880974|NCT02870972|157402377|FG003|Overall Study|Adverse Event|0|||
48880975|NCT02870972|157402378|FG004|Overall Study|Adverse Event|0|||
48880976|NCT01907906|157402379|FG000|Overall Study|Withdrawal by Subject|1|||
48880977|NCT01907906|157402380|FG001|Overall Study|Withdrawal by Subject|0|||
48880978|NCT01907906|157402379|FG000|Overall Study|Physician Decision|3|||
48880979|NCT01907906|157402380|FG001|Overall Study|Physician Decision|1|||
48880980|NCT00979953|157402381|FG000|Overall Study|Adverse Event|5|||
48880981|NCT00979953|157402382|FG001|Overall Study|Adverse Event|2|||
48880982|NCT00979953|157402383|FG002|Overall Study|Adverse Event|17|||
48880983|NCT00979953|157402384|FG003|Overall Study|Adverse Event|4|||
48880984|NCT00979953|157402381|FG000|Overall Study|Lack of Efficacy|1|||
48880985|NCT00979953|157402382|FG001|Overall Study|Lack of Efficacy|2|||
48880986|NCT00979953|157402383|FG002|Overall Study|Lack of Efficacy|0|||
48880987|NCT00979953|157402384|FG003|Overall Study|Lack of Efficacy|0|||
48880988|NCT00979953|157402381|FG000|Overall Study|Lost to Follow-up|1|||
48880989|NCT00979953|157402382|FG001|Overall Study|Lost to Follow-up|1|||
48880990|NCT00979953|157402383|FG002|Overall Study|Lost to Follow-up|1|||
48880991|NCT00979953|157402384|FG003|Overall Study|Lost to Follow-up|0|||
48880992|NCT00979953|157402381|FG000|Overall Study|Withdrawal by Subject|0|||
48880993|NCT00979953|157402382|FG001|Overall Study|Withdrawal by Subject|0|||
48880994|NCT00979953|157402383|FG002|Overall Study|Withdrawal by Subject|2|||
48880995|NCT00979953|157402384|FG003|Overall Study|Withdrawal by Subject|1|||
48880996|NCT00979953|157402381|FG000|Overall Study|Protocol Violation|1|||
48880997|NCT00979953|157402382|FG001|Overall Study|Protocol Violation|0|||
48880998|NCT00979953|157402383|FG002|Overall Study|Protocol Violation|2|||
48880999|NCT00979953|157402384|FG003|Overall Study|Protocol Violation|2|||
48881000|NCT01174446|157402385|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
48881001|NCT01174446|157402386|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
48881002|NCT01174446|157402387|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1|||
48881003|NCT01174446|157402388|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
48881004|NCT01174446|157402385|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
48881005|NCT01174446|157402386|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
48881006|NCT01174446|157402387|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1|||
48881007|NCT01174446|157402388|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
48881008|NCT01174446|157402385|FG000|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1|||
48881009|NCT01174446|157402386|FG001|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
48881010|NCT01174446|157402387|FG002|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
48881011|NCT01174446|157402388|FG003|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
48881012|NCT01174446|157402385|FG000|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
48881013|NCT01174446|157402386|FG001|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1|||
48881014|NCT01174446|157402387|FG002|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
48881015|NCT01174446|157402388|FG003|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
48881016|NCT01271504|157402389|FG000|Overall Study|Death|7|||
48881017|NCT01271504|157402390|FG001|Overall Study|Death|6|||
48881018|NCT01271504|157402391|FG002|Overall Study|Death|32|||
48881019|NCT01271504|157402392|FG003|Overall Study|Death|32|||
48881020|NCT01271504|157402389|FG000|Overall Study|Lost to Follow-up|0|||
48881021|NCT01271504|157402390|FG001|Overall Study|Lost to Follow-up|1|||
48881022|NCT01271504|157402391|FG002|Overall Study|Lost to Follow-up|3|||
48881023|NCT01271504|157402392|FG003|Overall Study|Lost to Follow-up|1|||
48881024|NCT01271504|157402389|FG000|Overall Study|Protocol Violation|0|||
48881025|NCT01271504|157402390|FG001|Overall Study|Protocol Violation|0|||
49033877|NCT00834795|157960193|FG001|Second Intervention|Adverse Event|0|||
48881026|NCT01271504|157402391|FG002|Overall Study|Protocol Violation|0|||
49033878|NCT00218257|157960197|FG000|Period Between Visit 1 and 2|Lost to Follow-up|4|||
48881027|NCT01271504|157402392|FG003|Overall Study|Protocol Violation|2|||
48881028|NCT01271504|157402389|FG000|Overall Study|Administrative Reasons|0|||
48881029|NCT01271504|157402390|FG001|Overall Study|Administrative Reasons|0|||
48881030|NCT01271504|157402391|FG002|Overall Study|Administrative Reasons|6|||
48881031|NCT01271504|157402392|FG003|Overall Study|Administrative Reasons|5|||
48881032|NCT01271504|157402389|FG000|Overall Study|Withdrawal by Subject|0|||
48881033|NCT01271504|157402390|FG001|Overall Study|Withdrawal by Subject|0|||
48881034|NCT01271504|157402391|FG002|Overall Study|Withdrawal by Subject|1|||
48881035|NCT01271504|157402392|FG003|Overall Study|Withdrawal by Subject|3|||
48881036|NCT01271504|157402389|FG000|Overall Study|Other|0|||
48881037|NCT01271504|157402390|FG001|Overall Study|Other|1|||
48881038|NCT01271504|157402391|FG002|Overall Study|Other|2|||
48881039|NCT01271504|157402392|FG003|Overall Study|Other|0|||
48881040|NCT00193479|157402393|FG000|Induction Chemotherapy|Adverse Event|2|||
48881041|NCT00193479|157402393|FG000|Induction Chemotherapy|Disease Progression|1|||
48881042|NCT00193479|157402393|FG000|Maintenance Rituximab|Opted for full course rituximab/chemotherapy|2|||
48881043|NCT00193479|157402393|FG000|Maintenance Rituximab|Withdrawal by Subject|2|||
48881044|NCT03853551|157402398|FG000|Overall Study|Death|2|||
48881045|NCT03853551|157402398|FG000|Overall Study|7 patients discontinued the study because of disease progression.|7|||
48881046|NCT02406248|157402399|FG000|Overall Study|Death|7|||
48881047|NCT02406248|157402399|FG000|Overall Study|Withdrawal by Subject|2|||
48881048|NCT01777334|157402400|FG000|Overall Study|Adverse Event|18|||
48881049|NCT01777334|157402401|FG001|Overall Study|Adverse Event|14|||
48881050|NCT01777334|157402400|FG000|Overall Study|Lack of Efficacy|15|||
48881051|NCT01777334|157402401|FG001|Overall Study|Lack of Efficacy|29|||
48881052|NCT01777334|157402400|FG000|Overall Study|Protocol Violation|3|||
48881053|NCT01777334|157402401|FG001|Overall Study|Protocol Violation|7|||
48881054|NCT01777334|157402400|FG000|Overall Study|Lost to Follow-up|3|||
48881055|NCT01777334|157402401|FG001|Overall Study|Lost to Follow-up|2|||
48881056|NCT01777334|157402400|FG000|Overall Study|Withdrawal by Subject|14|||
48881057|NCT01777334|157402401|FG001|Overall Study|Withdrawal by Subject|11|||
48881058|NCT02417441|157402402|FG000|Overall Study|Inconclusive due to missing data|52|||
48881059|NCT02417441|157402403|FG001|Overall Study|Inconclusive due to missing data|19|||
49033879|NCT00218257|157960198|FG001|Period Between Visit 1 and 2|Lost to Follow-up|3|||
49033880|NCT00579345|157960201|FG000|Overall Study|Withdrawal by Subject|2|||
48881060|NCT00643617|157402407|FG000|Overall Study|Death|6|||
48881061|NCT00643617|157402408|FG001|Overall Study|Death|9|||
48881062|NCT00643617|157402407|FG000|Overall Study|Lost to Follow-up|42|||
48881063|NCT00643617|157402408|FG001|Overall Study|Lost to Follow-up|51|||
48881064|NCT03933462|157402411|FG000|Overall Study|Adverse Event|2|||
48881065|NCT03933462|157402412|FG001|Overall Study|Adverse Event|0|||
48881066|NCT03126110|157402416|FG000|Phase 1|Death|2|||
48881067|NCT03126110|157402417|FG001|Phase 1|Death|2|||
48881068|NCT03126110|157402418|FG002|Phase 1|Death|4|||
48881069|NCT03126110|157402419|FG003|Phase 1|Death|3|||
48881070|NCT03126110|157402420|FG004|Phase 1|Death|4|||
48881071|NCT03126110|157402421|FG005|Phase 1|Death|4|||
48881072|NCT03126110|157402422|FG006|Phase 1|Death|3|||
48881073|NCT03126110|157402423|FG007|Phase 1|Death|4|||
48881074|NCT03126110|157402424|FG008|Phase 1|Death|5|||
48881075|NCT03126110|157402425|FG009|Phase 1|Death|2|||
48881076|NCT03126110|157402426|FG010|Phase 1|Death|6|||
48881077|NCT03126110|157402427|FG011|Phase 1|Death|0|||
48881078|NCT03126110|157402428|FG012|Phase 1|Death|0|||
48881079|NCT03126110|157402429|FG013|Phase 1|Death|0|||
48881080|NCT03126110|157402430|FG014|Phase 1|Death|0|||
48881081|NCT03126110|157402431|FG015|Phase 1|Death|0|||
48881082|NCT03126110|157402432|FG016|Phase 1|Death|0|||
48881083|NCT03126110|157402416|FG000|Phase 1|Lost to Follow-up|0|||
48881084|NCT03126110|157402417|FG001|Phase 1|Lost to Follow-up|1|||
48881085|NCT03126110|157402418|FG002|Phase 1|Lost to Follow-up|0|||
48881086|NCT03126110|157402419|FG003|Phase 1|Lost to Follow-up|0|||
48881087|NCT03126110|157402420|FG004|Phase 1|Lost to Follow-up|0|||
48881088|NCT03126110|157402421|FG005|Phase 1|Lost to Follow-up|0|||
48881089|NCT03126110|157402422|FG006|Phase 1|Lost to Follow-up|0|||
48881090|NCT03126110|157402423|FG007|Phase 1|Lost to Follow-up|0|||
48881091|NCT03126110|157402424|FG008|Phase 1|Lost to Follow-up|1|||
48881092|NCT03126110|157402425|FG009|Phase 1|Lost to Follow-up|0|||
48881093|NCT03126110|157402426|FG010|Phase 1|Lost to Follow-up|0|||
48881094|NCT03126110|157402427|FG011|Phase 1|Lost to Follow-up|0|||
48881095|NCT03126110|157402428|FG012|Phase 1|Lost to Follow-up|0|||
48881096|NCT03126110|157402429|FG013|Phase 1|Lost to Follow-up|0|||
49033881|NCT00579345|157960202|FG001|Overall Study|Withdrawal by Subject|0|||
48881097|NCT03126110|157402430|FG014|Phase 1|Lost to Follow-up|0|||
48881098|NCT03126110|157402431|FG015|Phase 1|Lost to Follow-up|0|||
48881099|NCT03126110|157402432|FG016|Phase 1|Lost to Follow-up|0|||
48881100|NCT03126110|157402416|FG000|Phase 1|Withdrawal by Subject|1|||
48881101|NCT03126110|157402417|FG001|Phase 1|Withdrawal by Subject|0|||
48881102|NCT03126110|157402418|FG002|Phase 1|Withdrawal by Subject|0|||
48881103|NCT03126110|157402419|FG003|Phase 1|Withdrawal by Subject|1|||
48881104|NCT03126110|157402420|FG004|Phase 1|Withdrawal by Subject|1|||
48881105|NCT03126110|157402421|FG005|Phase 1|Withdrawal by Subject|0|||
48881106|NCT03126110|157402422|FG006|Phase 1|Withdrawal by Subject|0|||
48881107|NCT03126110|157402423|FG007|Phase 1|Withdrawal by Subject|0|||
48881108|NCT03126110|157402424|FG008|Phase 1|Withdrawal by Subject|2|||
48881109|NCT03126110|157402425|FG009|Phase 1|Withdrawal by Subject|1|||
48881110|NCT03126110|157402426|FG010|Phase 1|Withdrawal by Subject|0|||
48881111|NCT03126110|157402427|FG011|Phase 1|Withdrawal by Subject|0|||
48881112|NCT03126110|157402428|FG012|Phase 1|Withdrawal by Subject|0|||
48881113|NCT03126110|157402429|FG013|Phase 1|Withdrawal by Subject|0|||
48881114|NCT03126110|157402430|FG014|Phase 1|Withdrawal by Subject|0|||
48881115|NCT03126110|157402431|FG015|Phase 1|Withdrawal by Subject|0|||
48881116|NCT03126110|157402432|FG016|Phase 1|Withdrawal by Subject|0|||
48881117|NCT03126110|157402416|FG000|Phase 1|Safety follow-up no longer necessary|1|||
48881118|NCT03126110|157402417|FG001|Phase 1|Safety follow-up no longer necessary|0|||
48881119|NCT03126110|157402418|FG002|Phase 1|Safety follow-up no longer necessary|0|||
48881120|NCT03126110|157402419|FG003|Phase 1|Safety follow-up no longer necessary|0|||
48881121|NCT03126110|157402420|FG004|Phase 1|Safety follow-up no longer necessary|0|||
48881122|NCT03126110|157402421|FG005|Phase 1|Safety follow-up no longer necessary|0|||
48881123|NCT03126110|157402422|FG006|Phase 1|Safety follow-up no longer necessary|0|||
48881124|NCT03126110|157402423|FG007|Phase 1|Safety follow-up no longer necessary|0|||
48881125|NCT03126110|157402424|FG008|Phase 1|Safety follow-up no longer necessary|0|||
48881126|NCT03126110|157402425|FG009|Phase 1|Safety follow-up no longer necessary|0|||
48881127|NCT03126110|157402426|FG010|Phase 1|Safety follow-up no longer necessary|0|||
48881128|NCT03126110|157402427|FG011|Phase 1|Safety follow-up no longer necessary|0|||
48881129|NCT03126110|157402428|FG012|Phase 1|Safety follow-up no longer necessary|0|||
48881130|NCT03126110|157402429|FG013|Phase 1|Safety follow-up no longer necessary|0|||
48881131|NCT03126110|157402430|FG014|Phase 1|Safety follow-up no longer necessary|0|||
48881132|NCT03126110|157402431|FG015|Phase 1|Safety follow-up no longer necessary|0|||
48881133|NCT03126110|157402432|FG016|Phase 1|Safety follow-up no longer necessary|0|||
48881134|NCT03126110|157402416|FG000|Phase 1|Survival follow-up no longer necessary|0|||
48881135|NCT03126110|157402417|FG001|Phase 1|Survival follow-up no longer necessary|0|||
48881136|NCT03126110|157402418|FG002|Phase 1|Survival follow-up no longer necessary|1|||
48881137|NCT03126110|157402419|FG003|Phase 1|Survival follow-up no longer necessary|0|||
48881138|NCT03126110|157402420|FG004|Phase 1|Survival follow-up no longer necessary|0|||
49033882|NCT00579345|157960203|FG002|Overall Study|Withdrawal by Subject|0|||
49033883|NCT00579345|157960204|FG003|Overall Study|Withdrawal by Subject|0|||
49033884|NCT00579345|157960205|FG004|Overall Study|Withdrawal by Subject|0|||
49033885|NCT00579345|157960206|FG005|Overall Study|Withdrawal by Subject|0|||
49033886|NCT00579345|157960207|FG006|Overall Study|Withdrawal by Subject|0|||
49033887|NCT00579345|157960208|FG007|Overall Study|Withdrawal by Subject|1|||
49033888|NCT00579345|157960201|FG000|Overall Study|Lost to Follow-up|1|||
49033889|NCT00579345|157960202|FG001|Overall Study|Lost to Follow-up|0|||
49033890|NCT00579345|157960203|FG002|Overall Study|Lost to Follow-up|0|||
49033891|NCT00579345|157960204|FG003|Overall Study|Lost to Follow-up|0|||
49033892|NCT00579345|157960205|FG004|Overall Study|Lost to Follow-up|0|||
49033893|NCT00579345|157960206|FG005|Overall Study|Lost to Follow-up|0|||
49033894|NCT00579345|157960207|FG006|Overall Study|Lost to Follow-up|0|||
49033895|NCT00579345|157960208|FG007|Overall Study|Lost to Follow-up|0|||
49033896|NCT00579345|157960201|FG000|Overall Study|Adverse Event|0|||
49033897|NCT00579345|157960202|FG001|Overall Study|Adverse Event|0|||
49033898|NCT00579345|157960203|FG002|Overall Study|Adverse Event|1|||
49033899|NCT00579345|157960204|FG003|Overall Study|Adverse Event|0|||
49033900|NCT00579345|157960205|FG004|Overall Study|Adverse Event|0|||
49033901|NCT00579345|157960206|FG005|Overall Study|Adverse Event|0|||
49033902|NCT00579345|157960207|FG006|Overall Study|Adverse Event|0|||
49033903|NCT00579345|157960208|FG007|Overall Study|Adverse Event|0|||
49033904|NCT00579345|157960201|FG000|Overall Study|Protocol Violation|1|||
49033905|NCT00579345|157960202|FG001|Overall Study|Protocol Violation|0|||
49033906|NCT00579345|157960203|FG002|Overall Study|Protocol Violation|0|||
49033907|NCT00579345|157960204|FG003|Overall Study|Protocol Violation|0|||
49033908|NCT00579345|157960205|FG004|Overall Study|Protocol Violation|0|||
49033909|NCT00579345|157960206|FG005|Overall Study|Protocol Violation|0|||
49033910|NCT00579345|157960207|FG006|Overall Study|Protocol Violation|0|||
49033911|NCT00579345|157960208|FG007|Overall Study|Protocol Violation|1|||
49033912|NCT00579345|157960201|FG000|Overall Study|Death|1|||
48881139|NCT03126110|157402421|FG005|Phase 1|Survival follow-up no longer necessary|0|||
48881140|NCT03126110|157402422|FG006|Phase 1|Survival follow-up no longer necessary|0|||
48881141|NCT03126110|157402423|FG007|Phase 1|Survival follow-up no longer necessary|0|||
48881142|NCT03126110|157402424|FG008|Phase 1|Survival follow-up no longer necessary|0|||
48881143|NCT03126110|157402425|FG009|Phase 1|Survival follow-up no longer necessary|0|||
48881144|NCT03126110|157402426|FG010|Phase 1|Survival follow-up no longer necessary|0|||
49033913|NCT00579345|157960202|FG001|Overall Study|Death|1|||
48881145|NCT03126110|157402427|FG011|Phase 1|Survival follow-up no longer necessary|0|||
48881146|NCT03126110|157402428|FG012|Phase 1|Survival follow-up no longer necessary|0|||
48881147|NCT03126110|157402429|FG013|Phase 1|Survival follow-up no longer necessary|0|||
48881148|NCT03126110|157402430|FG014|Phase 1|Survival follow-up no longer necessary|0|||
49033914|NCT00579345|157960203|FG002|Overall Study|Death|1|||
49033915|NCT00579345|157960204|FG003|Overall Study|Death|1|||
49033916|NCT00579345|157960205|FG004|Overall Study|Death|0|||
49033917|NCT00579345|157960206|FG005|Overall Study|Death|0|||
49033918|NCT00579345|157960207|FG006|Overall Study|Death|0|||
49033919|NCT00579345|157960208|FG007|Overall Study|Death|0|||
49033920|NCT02956460|157960209|FG000|Lens 1|Lost to Follow-up|1|||
49033921|NCT02956460|157960210|FG001|Lens 1|Lost to Follow-up|0|||
49033922|NCT01171989|157960213|FG000|Overall Study|Lost to Follow-up|0|||
49033923|NCT01171989|157960214|FG001|Overall Study|Lost to Follow-up|0|||
49033924|NCT01171989|157960215|FG002|Overall Study|Lost to Follow-up|1|||
49033925|NCT00620074|157960216|FG000|Overall Study|Adverse Event|1|||
49033926|NCT00829673|157960219|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
49033927|NCT00829673|157960220|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
49033928|NCT04166630|157960221|FG000|Overall Study|Withdrawal by Subject|0|||
49033929|NCT04166630|157960222|FG001|Overall Study|Withdrawal by Subject|1|||
49033930|NCT02979522|157960223|FG000|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|0|||
49033931|NCT02979522|157960224|FG001|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|28|||
49033932|NCT02979522|157960223|FG000|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|8|||
49033933|NCT02979522|157960224|FG001|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|23|||
49033934|NCT02832063|157960225|FG000|Overall Study|Adverse Event|2|||
49033935|NCT02832063|157960226|FG001|Overall Study|Adverse Event|1|||
49033936|NCT02832063|157960225|FG000|Overall Study|Physician Decision|5|||
49033937|NCT02832063|157960226|FG001|Overall Study|Physician Decision|7|||
49033938|NCT02832063|157960225|FG000|Overall Study|Lost to Follow-up|15|||
49033939|NCT02832063|157960226|FG001|Overall Study|Lost to Follow-up|8|||
49033940|NCT02832063|157960225|FG000|Overall Study|Withdrawal by Subject|10|||
49033941|NCT02832063|157960226|FG001|Overall Study|Withdrawal by Subject|21|||
49033942|NCT02832063|157960225|FG000|Overall Study|Other|2|||
49033943|NCT02832063|157960226|FG001|Overall Study|Other|1|||
49033944|NCT02378935|157960227|FG000|Overall Study|Lack of Efficacy|10|||
49033945|NCT02378935|157960228|FG001|Overall Study|Lack of Efficacy|0|||
49033946|NCT02378935|157960229|FG002|Overall Study|Lack of Efficacy|2|||
49033947|NCT02378935|157960230|FG003|Overall Study|Lack of Efficacy|6|||
49033948|NCT02378935|157960231|FG004|Overall Study|Lack of Efficacy|0|||
49033949|NCT02378935|157960232|FG005|Overall Study|Lack of Efficacy|0|||
49033950|NCT02378935|157960233|FG006|Overall Study|Lack of Efficacy|0|||
49033951|NCT02378935|157960227|FG000|Overall Study|Death|0|||
49033952|NCT02378935|157960228|FG001|Overall Study|Death|0|||
49033953|NCT02378935|157960229|FG002|Overall Study|Death|1|||
49033954|NCT02378935|157960230|FG003|Overall Study|Death|0|||
49033955|NCT02378935|157960231|FG004|Overall Study|Death|0|||
49033956|NCT02378935|157960232|FG005|Overall Study|Death|0|||
49033957|NCT02378935|157960233|FG006|Overall Study|Death|0|||
49033958|NCT00440518|157960234|FG000|Randomized /Titration Period|Lack of Efficacy|1|||
49033959|NCT00440518|157960235|FG001|Randomized /Titration Period|Lack of Efficacy|0|||
49033960|NCT00440518|157960236|FG002|Randomized /Titration Period|Lack of Efficacy|1|||
49033961|NCT00440518|157960234|FG000|Randomized /Titration Period|Subject Withdrew Consent|4|||
49033962|NCT00440518|157960235|FG001|Randomized /Titration Period|Subject Withdrew Consent|1|||
49033963|NCT00440518|157960236|FG002|Randomized /Titration Period|Subject Withdrew Consent|0|||
48881149|NCT03126110|157402431|FG015|Phase 1|Survival follow-up no longer necessary|0|||
48881150|NCT03126110|157402432|FG016|Phase 1|Survival follow-up no longer necessary|0|||
48881151|NCT03126110|157402416|FG000|Phase 2|Study terminated by the sponsor|0|||
48881152|NCT03126110|157402417|FG001|Phase 2|Study terminated by the sponsor|0|||
48881153|NCT03126110|157402418|FG002|Phase 2|Study terminated by the sponsor|0|||
48881154|NCT03126110|157402419|FG003|Phase 2|Study terminated by the sponsor|0|||
48881155|NCT03126110|157402420|FG004|Phase 2|Study terminated by the sponsor|0|||
48881156|NCT03126110|157402421|FG005|Phase 2|Study terminated by the sponsor|0|||
48881157|NCT03126110|157402422|FG006|Phase 2|Study terminated by the sponsor|0|||
48881158|NCT03126110|157402423|FG007|Phase 2|Study terminated by the sponsor|0|||
48881159|NCT03126110|157402424|FG008|Phase 2|Study terminated by the sponsor|0|||
48881160|NCT03126110|157402425|FG009|Phase 2|Study terminated by the sponsor|0|||
48881161|NCT03126110|157402426|FG010|Phase 2|Study terminated by the sponsor|0|||
48881162|NCT03126110|157402427|FG011|Phase 2|Study terminated by the sponsor|0|||
48881163|NCT03126110|157402428|FG012|Phase 2|Study terminated by the sponsor|0|||
48881164|NCT03126110|157402429|FG013|Phase 2|Study terminated by the sponsor|4|||
48881165|NCT03126110|157402430|FG014|Phase 2|Study terminated by the sponsor|0|||
48881166|NCT03126110|157402431|FG015|Phase 2|Study terminated by the sponsor|0|||
48881167|NCT03126110|157402432|FG016|Phase 2|Study terminated by the sponsor|0|||
48881168|NCT03126110|157402416|FG000|Phase 2|Withdrawal by Subject|0|||
48881169|NCT03126110|157402417|FG001|Phase 2|Withdrawal by Subject|0|||
48881170|NCT03126110|157402418|FG002|Phase 2|Withdrawal by Subject|0|||
48881171|NCT03126110|157402419|FG003|Phase 2|Withdrawal by Subject|0|||
48881172|NCT03126110|157402420|FG004|Phase 2|Withdrawal by Subject|0|||
48881173|NCT03126110|157402421|FG005|Phase 2|Withdrawal by Subject|0|||
48881174|NCT03126110|157402422|FG006|Phase 2|Withdrawal by Subject|0|||
49033964|NCT00440518|157960234|FG000|Randomized /Titration Period|Protocol Deviation|1|||
49033965|NCT00440518|157960235|FG001|Randomized /Titration Period|Protocol Deviation|0|||
49033966|NCT00440518|157960236|FG002|Randomized /Titration Period|Protocol Deviation|0|||
48881175|NCT03126110|157402423|FG007|Phase 2|Withdrawal by Subject|0|||
48881176|NCT03126110|157402424|FG008|Phase 2|Withdrawal by Subject|0|||
48881177|NCT03126110|157402425|FG009|Phase 2|Withdrawal by Subject|0|||
48881178|NCT03126110|157402426|FG010|Phase 2|Withdrawal by Subject|0|||
48881179|NCT03126110|157402427|FG011|Phase 2|Withdrawal by Subject|1|||
48881180|NCT03126110|157402428|FG012|Phase 2|Withdrawal by Subject|3|||
48881181|NCT03126110|157402429|FG013|Phase 2|Withdrawal by Subject|3|||
48881182|NCT03126110|157402430|FG014|Phase 2|Withdrawal by Subject|2|||
48881183|NCT03126110|157402431|FG015|Phase 2|Withdrawal by Subject|1|||
48881184|NCT03126110|157402432|FG016|Phase 2|Withdrawal by Subject|0|||
48881185|NCT03126110|157402416|FG000|Phase 2|Lost to Follow-up|0|||
48881186|NCT03126110|157402417|FG001|Phase 2|Lost to Follow-up|0|||
48881187|NCT03126110|157402418|FG002|Phase 2|Lost to Follow-up|0|||
48881188|NCT03126110|157402419|FG003|Phase 2|Lost to Follow-up|0|||
48881189|NCT03126110|157402420|FG004|Phase 2|Lost to Follow-up|0|||
48881190|NCT03126110|157402421|FG005|Phase 2|Lost to Follow-up|0|||
48881191|NCT03126110|157402422|FG006|Phase 2|Lost to Follow-up|0|||
48881192|NCT03126110|157402423|FG007|Phase 2|Lost to Follow-up|0|||
48881193|NCT03126110|157402424|FG008|Phase 2|Lost to Follow-up|0|||
49033967|NCT00440518|157960234|FG000|Randomized /Titration Period|Unsatisfactory Compliance|2|||
49033968|NCT00440518|157960235|FG001|Randomized /Titration Period|Unsatisfactory Compliance|3|||
49033969|NCT00440518|157960236|FG002|Randomized /Titration Period|Unsatisfactory Compliance|2|||
49033970|NCT00440518|157960234|FG000|Randomized /Titration Period|Other|1|||
49033971|NCT00440518|157960235|FG001|Randomized /Titration Period|Other|0|||
48881194|NCT03126110|157402425|FG009|Phase 2|Lost to Follow-up|0|||
48881195|NCT03126110|157402426|FG010|Phase 2|Lost to Follow-up|0|||
48881196|NCT03126110|157402427|FG011|Phase 2|Lost to Follow-up|1|||
48881197|NCT03126110|157402428|FG012|Phase 2|Lost to Follow-up|1|||
48881198|NCT03126110|157402429|FG013|Phase 2|Lost to Follow-up|1|||
48881199|NCT03126110|157402430|FG014|Phase 2|Lost to Follow-up|2|||
48881200|NCT03126110|157402431|FG015|Phase 2|Lost to Follow-up|0|||
48881201|NCT03126110|157402432|FG016|Phase 2|Lost to Follow-up|0|||
48881202|NCT03126110|157402416|FG000|Phase 2|Death|0|||
48881203|NCT03126110|157402417|FG001|Phase 2|Death|0|||
48881204|NCT03126110|157402418|FG002|Phase 2|Death|0|||
48881205|NCT03126110|157402419|FG003|Phase 2|Death|0|||
48881206|NCT03126110|157402420|FG004|Phase 2|Death|0|||
48881207|NCT03126110|157402421|FG005|Phase 2|Death|0|||
48881208|NCT03126110|157402422|FG006|Phase 2|Death|0|||
48881209|NCT03126110|157402423|FG007|Phase 2|Death|0|||
48881210|NCT03126110|157402424|FG008|Phase 2|Death|0|||
48881211|NCT03126110|157402425|FG009|Phase 2|Death|0|||
48881212|NCT03126110|157402426|FG010|Phase 2|Death|0|||
48881213|NCT03126110|157402427|FG011|Phase 2|Death|6|||
48881214|NCT03126110|157402428|FG012|Phase 2|Death|12|||
48881215|NCT03126110|157402429|FG013|Phase 2|Death|25|||
48881216|NCT03126110|157402430|FG014|Phase 2|Death|11|||
48881217|NCT03126110|157402431|FG015|Phase 2|Death|3|||
48881218|NCT03126110|157402432|FG016|Phase 2|Death|2|||
48881219|NCT03126110|157402416|FG000|Phase 2|Progressive Disease|0|||
48881220|NCT03126110|157402417|FG001|Phase 2|Progressive Disease|0|||
48881221|NCT03126110|157402418|FG002|Phase 2|Progressive Disease|0|||
48881222|NCT03126110|157402419|FG003|Phase 2|Progressive Disease|0|||
48881223|NCT03126110|157402420|FG004|Phase 2|Progressive Disease|0|||
48881224|NCT03126110|157402421|FG005|Phase 2|Progressive Disease|0|||
48881225|NCT03126110|157402422|FG006|Phase 2|Progressive Disease|0|||
48881226|NCT03126110|157402423|FG007|Phase 2|Progressive Disease|0|||
48881227|NCT03126110|157402424|FG008|Phase 2|Progressive Disease|0|||
48881228|NCT03126110|157402425|FG009|Phase 2|Progressive Disease|0|||
48881229|NCT03126110|157402426|FG010|Phase 2|Progressive Disease|0|||
48881230|NCT03126110|157402427|FG011|Phase 2|Progressive Disease|0|||
48881231|NCT03126110|157402428|FG012|Phase 2|Progressive Disease|0|||
48881232|NCT03126110|157402429|FG013|Phase 2|Progressive Disease|1|||
48881233|NCT03126110|157402430|FG014|Phase 2|Progressive Disease|0|||
48881234|NCT03126110|157402431|FG015|Phase 2|Progressive Disease|0|||
48881235|NCT03126110|157402432|FG016|Phase 2|Progressive Disease|0|||
48881236|NCT03126110|157402416|FG000|Phase 2|Started new treatment|0|||
48881237|NCT03126110|157402417|FG001|Phase 2|Started new treatment|0|||
48881238|NCT03126110|157402418|FG002|Phase 2|Started new treatment|0|||
48881239|NCT03126110|157402419|FG003|Phase 2|Started new treatment|0|||
48881240|NCT03126110|157402420|FG004|Phase 2|Started new treatment|0|||
48881241|NCT03126110|157402421|FG005|Phase 2|Started new treatment|0|||
48881242|NCT03126110|157402422|FG006|Phase 2|Started new treatment|0|||
48881243|NCT03126110|157402423|FG007|Phase 2|Started new treatment|0|||
48881244|NCT03126110|157402424|FG008|Phase 2|Started new treatment|0|||
48881245|NCT03126110|157402425|FG009|Phase 2|Started new treatment|0|||
48881246|NCT03126110|157402426|FG010|Phase 2|Started new treatment|0|||
48881247|NCT03126110|157402427|FG011|Phase 2|Started new treatment|0|||
48881248|NCT03126110|157402428|FG012|Phase 2|Started new treatment|0|||
48881249|NCT03126110|157402429|FG013|Phase 2|Started new treatment|0|||
48881250|NCT03126110|157402430|FG014|Phase 2|Started new treatment|1|||
48881251|NCT03126110|157402431|FG015|Phase 2|Started new treatment|0|||
48881252|NCT03126110|157402432|FG016|Phase 2|Started new treatment|0|||
48881253|NCT02844777|157402433|FG000|Overall Study|Withdrawal by Subject|2|||
48881254|NCT02844777|157402434|FG001|Overall Study|Withdrawal by Subject|0|||
48881255|NCT02844777|157402435|FG002|Overall Study|Withdrawal by Subject|0|||
48881256|NCT00150618|157402436|FG000|Overall Study|Adverse Event|2|||
48881257|NCT00150618|157402437|FG001|Overall Study|Adverse Event|2|||
48881258|NCT00150618|157402438|FG002|Overall Study|Adverse Event|6|||
48881259|NCT00150618|157402439|FG003|Overall Study|Adverse Event|9|||
49033972|NCT00440518|157960236|FG002|Randomized /Titration Period|Other|0|||
49033973|NCT00440518|157960234|FG000|Randomized /Titration Period|Lost to Follow-up|2|||
49033974|NCT00440518|157960235|FG001|Randomized /Titration Period|Lost to Follow-up|2|||
49033975|NCT00440518|157960236|FG002|Randomized /Titration Period|Lost to Follow-up|1|||
49033976|NCT00440518|157960234|FG000|Randomized /Titration Period|Adverse Event|2|||
49033977|NCT00440518|157960235|FG001|Randomized /Titration Period|Adverse Event|3|||
49033978|NCT00440518|157960236|FG002|Randomized /Titration Period|Adverse Event|0|||
48881260|NCT00150618|157402440|FG004|Overall Study|Adverse Event|5|||
48881261|NCT00150618|157402436|FG000|Overall Study|Withdrawal by Subject|6|||
48881262|NCT00150618|157402437|FG001|Overall Study|Withdrawal by Subject|8|||
48881263|NCT00150618|157402438|FG002|Overall Study|Withdrawal by Subject|8|||
48881264|NCT00150618|157402439|FG003|Overall Study|Withdrawal by Subject|4|||
48881265|NCT00150618|157402440|FG004|Overall Study|Withdrawal by Subject|5|||
48881266|NCT00150618|157402436|FG000|Overall Study|Lost to Follow-up|4|||
48881267|NCT00150618|157402437|FG001|Overall Study|Lost to Follow-up|1|||
48881268|NCT00150618|157402438|FG002|Overall Study|Lost to Follow-up|5|||
48881269|NCT00150618|157402439|FG003|Overall Study|Lost to Follow-up|8|||
48881270|NCT00150618|157402440|FG004|Overall Study|Lost to Follow-up|4|||
48881271|NCT00150618|157402436|FG000|Overall Study|Protocol Violation|1|||
48881272|NCT00150618|157402437|FG001|Overall Study|Protocol Violation|0|||
48881273|NCT00150618|157402438|FG002|Overall Study|Protocol Violation|0|||
48881274|NCT00150618|157402439|FG003|Overall Study|Protocol Violation|0|||
48881275|NCT00150618|157402440|FG004|Overall Study|Protocol Violation|1|||
48881276|NCT00150618|157402436|FG000|Overall Study|Lack of Efficacy|1|||
48881277|NCT00150618|157402437|FG001|Overall Study|Lack of Efficacy|4|||
48881278|NCT00150618|157402438|FG002|Overall Study|Lack of Efficacy|7|||
48881279|NCT00150618|157402439|FG003|Overall Study|Lack of Efficacy|4|||
48881280|NCT00150618|157402440|FG004|Overall Study|Lack of Efficacy|6|||
48881281|NCT00150618|157402436|FG000|Overall Study|No study meds|0|||
48881282|NCT00150618|157402437|FG001|Overall Study|No study meds|0|||
48881283|NCT00150618|157402438|FG002|Overall Study|No study meds|0|||
48881284|NCT00150618|157402439|FG003|Overall Study|No study meds|0|||
48881285|NCT00150618|157402440|FG004|Overall Study|No study meds|2|||
48881286|NCT00150618|157402436|FG000|Overall Study|Physician Decision|0|||
48881287|NCT00150618|157402437|FG001|Overall Study|Physician Decision|2|||
48881288|NCT00150618|157402438|FG002|Overall Study|Physician Decision|0|||
48881289|NCT00150618|157402439|FG003|Overall Study|Physician Decision|0|||
48881290|NCT00150618|157402440|FG004|Overall Study|Physician Decision|1|||
48881291|NCT00150618|157402436|FG000|Overall Study|Lack of compliance|2|||
48881292|NCT00150618|157402437|FG001|Overall Study|Lack of compliance|1|||
48881293|NCT00150618|157402438|FG002|Overall Study|Lack of compliance|1|||
48881294|NCT00150618|157402439|FG003|Overall Study|Lack of compliance|0|||
49033979|NCT00440518|157960234|FG000|Maintenance and Safety Follow-up Periods|Adverse Event|3|||
49033980|NCT00440518|157960235|FG001|Maintenance and Safety Follow-up Periods|Adverse Event|4|||
49033981|NCT00440518|157960236|FG002|Maintenance and Safety Follow-up Periods|Adverse Event|2|||
49033982|NCT00440518|157960234|FG000|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0|||
48881295|NCT00150618|157402440|FG004|Overall Study|Lack of compliance|1|||
49033983|NCT00440518|157960235|FG001|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
49033984|NCT00440518|157960236|FG002|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
49033985|NCT00440518|157960234|FG000|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3|||
49033986|NCT00440518|157960235|FG001|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2|||
49033987|NCT00440518|157960236|FG002|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4|||
49033988|NCT00440518|157960234|FG000|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0|||
48881296|NCT00150618|157402436|FG000|Overall Study|Abnormal ECG|1|||
48881297|NCT00150618|157402437|FG001|Overall Study|Abnormal ECG|0|||
48881298|NCT00150618|157402438|FG002|Overall Study|Abnormal ECG|0|||
48881299|NCT00150618|157402439|FG003|Overall Study|Abnormal ECG|0|||
48881300|NCT00150618|157402440|FG004|Overall Study|Abnormal ECG|0|||
48881301|NCT00150618|157402436|FG000|Overall Study|Sponsor's decision|0|||
48881302|NCT00150618|157402437|FG001|Overall Study|Sponsor's decision|0|||
48881303|NCT00150618|157402438|FG002|Overall Study|Sponsor's decision|0|||
48881304|NCT00150618|157402439|FG003|Overall Study|Sponsor's decision|1|||
48881305|NCT00150618|157402440|FG004|Overall Study|Sponsor's decision|0|||
48881306|NCT01099917|157402441|FG000|Overall Study|Adverse Event|3|||
48881307|NCT01099917|157402441|FG000|Overall Study|Not Treated|24|||
48881308|NCT02567708|157402442|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
48881309|NCT02567708|157402443|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2|||
48881310|NCT02567708|157402442|FG000|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0|||
48881311|NCT02567708|157402443|FG001|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1|||
48881312|NCT02567708|157402442|FG000|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2|||
48881313|NCT02567708|157402443|FG001|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
48881314|NCT02567708|157402442|FG000|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
48881315|NCT02567708|157402443|FG001|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3|||
48881316|NCT01575873|157402444|FG000|Overall Study|Withdrawal by Subject|15|||
48881317|NCT01575873|157402445|FG001|Overall Study|Withdrawal by Subject|20|||
48881318|NCT01575873|157402446|FG002|Overall Study|Withdrawal by Subject|34|||
48881319|NCT01575873|157402447|FG003|Overall Study|Withdrawal by Subject|34|||
48881320|NCT01575873|157402444|FG000|Overall Study|Adverse Event|7|||
48881321|NCT01575873|157402445|FG001|Overall Study|Adverse Event|7|||
48881322|NCT01575873|157402446|FG002|Overall Study|Adverse Event|9|||
48881323|NCT01575873|157402447|FG003|Overall Study|Adverse Event|12|||
48881324|NCT01575873|157402444|FG000|Overall Study|Lost to Follow-up|1|||
48881325|NCT01575873|157402445|FG001|Overall Study|Lost to Follow-up|3|||
48881326|NCT01575873|157402446|FG002|Overall Study|Lost to Follow-up|13|||
48881327|NCT01575873|157402447|FG003|Overall Study|Lost to Follow-up|5|||
48881328|NCT01575873|157402444|FG000|Overall Study|Death|3|||
48881329|NCT01575873|157402445|FG001|Overall Study|Death|2|||
48881330|NCT01575873|157402446|FG002|Overall Study|Death|8|||
48881331|NCT01575873|157402447|FG003|Overall Study|Death|9|||
48881332|NCT01575873|157402444|FG000|Overall Study|Noncompliance|1|||
48881333|NCT01575873|157402445|FG001|Overall Study|Noncompliance|2|||
48881334|NCT01575873|157402446|FG002|Overall Study|Noncompliance|4|||
48881335|NCT01575873|157402447|FG003|Overall Study|Noncompliance|3|||
48881336|NCT01575873|157402444|FG000|Overall Study|Administrative decision|1|||
48881337|NCT01575873|157402445|FG001|Overall Study|Administrative decision|1|||
48881338|NCT01575873|157402446|FG002|Overall Study|Administrative decision|1|||
48881339|NCT01575873|157402447|FG003|Overall Study|Administrative decision|0|||
48881340|NCT01575873|157402444|FG000|Overall Study|Protocol deviation|0|||
48881341|NCT01575873|157402445|FG001|Overall Study|Protocol deviation|1|||
48881342|NCT01575873|157402446|FG002|Overall Study|Protocol deviation|0|||
48881343|NCT01575873|157402447|FG003|Overall Study|Protocol deviation|1|||
48881344|NCT01575873|157402444|FG000|Overall Study|Requirement for Alternative Therapy|0|||
48881345|NCT01575873|157402445|FG001|Overall Study|Requirement for Alternative Therapy|0|||
48881346|NCT01575873|157402446|FG002|Overall Study|Requirement for Alternative Therapy|1|||
48881347|NCT01575873|157402447|FG003|Overall Study|Requirement for Alternative Therapy|1|||
48881348|NCT01575873|157402444|FG000|Overall Study|Other|0|||
48881349|NCT01575873|157402445|FG001|Overall Study|Other|0|||
48881350|NCT01575873|157402446|FG002|Overall Study|Other|4|||
48881351|NCT01575873|157402447|FG003|Overall Study|Other|2|||
48881352|NCT04936685|157402448|FG000|Overall Study|Protocol Violation|1|||
48881353|NCT04936685|157402449|FG001|Overall Study|Protocol Violation|0|||
48881354|NCT00706654|157402450|FG000|Conversion Phase|Lost to Follow-up|4|||
48881355|NCT00706654|157402451|FG001|Conversion Phase|Lost to Follow-up|0|||
48881356|NCT00706654|157402452|FG002|Conversion Phase|Lost to Follow-up|0|||
48881357|NCT00706654|157402453|FG003|Conversion Phase|Lost to Follow-up|0|||
48881358|NCT00706654|157402450|FG000|Conversion Phase|Sponsor Discontinued Trial|8|||
48881359|NCT00706654|157402451|FG001|Conversion Phase|Sponsor Discontinued Trial|0|||
48881360|NCT00706654|157402452|FG002|Conversion Phase|Sponsor Discontinued Trial|0|||
49033989|NCT00440518|157960235|FG001|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3|||
49033990|NCT00440518|157960236|FG002|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6|||
49033991|NCT00440518|157960234|FG000|Maintenance and Safety Follow-up Periods|Other|0|||
49033992|NCT00440518|157960235|FG001|Maintenance and Safety Follow-up Periods|Other|0|||
49033993|NCT00440518|157960236|FG002|Maintenance and Safety Follow-up Periods|Other|2|||
49033994|NCT00440518|157960234|FG000|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1|||
49033995|NCT00440518|157960235|FG001|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2|||
49033996|NCT00440518|157960236|FG002|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0|||
49033997|NCT00163657|157960238|FG000|Overall Study|Death|12|||
49033998|NCT00163657|157960239|FG001|Overall Study|Death|14|||
49033999|NCT00163657|157960240|FG002|Overall Study|Death|19|||
49034000|NCT00163657|157960238|FG000|Overall Study|graft loss|4|||
49034001|NCT00163657|157960239|FG001|Overall Study|graft loss|1|||
49034002|NCT00163657|157960240|FG002|Overall Study|graft loss|2|||
49034003|NCT00163657|157960238|FG000|Overall Study|Withdrawal by Subject|2|||
49034004|NCT00163657|157960239|FG001|Overall Study|Withdrawal by Subject|3|||
48881361|NCT00706654|157402453|FG003|Conversion Phase|Sponsor Discontinued Trial|0|||
48881362|NCT00706654|157402450|FG000|Conversion Phase|Met Withdrawal Criteria|2|||
48881363|NCT00706654|157402451|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
48881364|NCT00706654|157402452|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
48881365|NCT00706654|157402453|FG003|Conversion Phase|Met Withdrawal Criteria|0|||
48881366|NCT00706654|157402450|FG000|Conversion Phase|Withdrawn by Investigator|14|||
48881367|NCT00706654|157402451|FG001|Conversion Phase|Withdrawn by Investigator|0|||
48881368|NCT00706654|157402452|FG002|Conversion Phase|Withdrawn by Investigator|0|||
48881369|NCT00706654|157402453|FG003|Conversion Phase|Withdrawn by Investigator|0|||
48881370|NCT00706654|157402450|FG000|Conversion Phase|Withdrew Consent|38|||
49034005|NCT00163657|157960240|FG002|Overall Study|Withdrawal by Subject|2|||
48881371|NCT00706654|157402451|FG001|Conversion Phase|Withdrew Consent|0|||
49034006|NCT00163657|157960238|FG000|Overall Study|Physician Decision|0|||
49034007|NCT00163657|157960239|FG001|Overall Study|Physician Decision|1|||
49034008|NCT00163657|157960240|FG002|Overall Study|Physician Decision|1|||
49034009|NCT00163657|157960238|FG000|Overall Study|Non Compliance|1|||
49034010|NCT00163657|157960239|FG001|Overall Study|Non Compliance|0|||
49034011|NCT00163657|157960240|FG002|Overall Study|Non Compliance|0|||
49034012|NCT00163657|157960238|FG000|Overall Study|Lost to Follow-up|1|||
49034013|NCT00163657|157960239|FG001|Overall Study|Lost to Follow-up|3|||
49034014|NCT00163657|157960240|FG002|Overall Study|Lost to Follow-up|10|||
49034015|NCT00163657|157960238|FG000|Overall Study|Other reason|0|||
49034016|NCT00163657|157960239|FG001|Overall Study|Other reason|1|||
49034017|NCT00163657|157960240|FG002|Overall Study|Other reason|3|||
49034018|NCT01319383|157960245|FG000|Overall Study|No ex vivo or in vivo response|4|||
49034019|NCT01319383|157960246|FG001|Overall Study|No ex vivo or in vivo response|0|||
49034020|NCT01319383|157960245|FG000|Overall Study|Physician Decision|3|||
49034021|NCT01319383|157960246|FG001|Overall Study|Physician Decision|0|||
49034022|NCT01319383|157960245|FG000|Overall Study|Lack of Efficacy|5|||
49034023|NCT01319383|157960246|FG001|Overall Study|Lack of Efficacy|9|||
49034024|NCT01319383|157960245|FG000|Overall Study|No in vivo response to interval doses|0|||
49034025|NCT01319383|157960246|FG001|Overall Study|No in vivo response to interval doses|1|||
49034026|NCT05755282|157960247|FG000|Overall Study|Protocol Violation|0|||
49034027|NCT05755282|157960248|FG001|Overall Study|Protocol Violation|1|||
49034028|NCT04129346|157960249|FG000|Overall Study|Death|1|||
49034029|NCT04129346|157960250|FG001|Overall Study|Death|0|||
49034030|NCT01034358|157960252|FG000|Overall Study|Withdrawal by Subject|1|||
49034031|NCT01034358|157960252|FG000|Overall Study|Protocol Violation|1|||
49034032|NCT02822235|157960255|FG000|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144|||
49034033|NCT02822235|157960256|FG001|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107|||
49034034|NCT02822235|157960255|FG000|Cross-sectional Phase (Day 1)|Reason Not Specified|2|||
49034035|NCT02822235|157960256|FG001|Cross-sectional Phase (Day 1)|Reason Not Specified|0|||
49034036|NCT02822235|157960255|FG000|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0|||
49034037|NCT02822235|157960256|FG001|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1|||
49034038|NCT02822235|157960255|FG000|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4|||
49034039|NCT02822235|157960256|FG001|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0|||
48881372|NCT00706654|157402452|FG002|Conversion Phase|Withdrew Consent|0|||
49034040|NCT02822235|157960255|FG000|Prospective Phase (Day 1 up to Month 12)|Death|1|||
49034041|NCT02822235|157960256|FG001|Prospective Phase (Day 1 up to Month 12)|Death|0|||
49034042|NCT02822235|157960255|FG000|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6|||
49034043|NCT02822235|157960256|FG001|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1|||
49034044|NCT00829790|157960260|FG000|Washout of 14 Days|Withdrawal by Subject|0|||
49034045|NCT00829790|157960261|FG001|Washout of 14 Days|Withdrawal by Subject|1|||
49034046|NCT03214952|157960262|FG000|Overall Study|Protocol Deviation|45|||
49034047|NCT03214952|157960262|FG000|Overall Study|Case Report Forms Uncollected|13|||
49034048|NCT01987765|157960263|FG000|Overall Study|Protocol Violation|65|||
49034049|NCT01987765|157960263|FG000|Overall Study|Lost to Follow-up|37|||
49034050|NCT02246166|157960266|FG000|Overall Study|Protocol Violation|1|||
49034051|NCT02246166|157960267|FG001|Overall Study|Protocol Violation|0|||
49034052|NCT03600805|157960268|FG000|Overall Study|Adverse Event|2|||
49034053|NCT03600805|157960269|FG001|Overall Study|Adverse Event|1|||
49034054|NCT03600805|157960270|FG002|Overall Study|Adverse Event|1|||
49034055|NCT03600805|157960271|FG003|Overall Study|Adverse Event|7|||
49034056|NCT03600805|157960268|FG000|Overall Study|Lack of Efficacy|2|||
49034057|NCT03600805|157960269|FG001|Overall Study|Lack of Efficacy|1|||
49034058|NCT03600805|157960270|FG002|Overall Study|Lack of Efficacy|0|||
49034059|NCT03600805|157960271|FG003|Overall Study|Lack of Efficacy|0|||
49034060|NCT03600805|157960268|FG000|Overall Study|Withdrawal by Subject|1|||
49034061|NCT03600805|157960269|FG001|Overall Study|Withdrawal by Subject|0|||
49034062|NCT03600805|157960270|FG002|Overall Study|Withdrawal by Subject|0|||
49034063|NCT03600805|157960271|FG003|Overall Study|Withdrawal by Subject|1|||
48881373|NCT00706654|157402453|FG003|Conversion Phase|Withdrew Consent|0|||
48881374|NCT00706654|157402450|FG000|Conversion Phase|Adverse Event|18|||
48881375|NCT00706654|157402451|FG001|Conversion Phase|Adverse Event|0|||
49034064|NCT03600805|157960268|FG000|Overall Study|Other unspecified|14|||
49034065|NCT03600805|157960269|FG001|Overall Study|Other unspecified|6|||
49034066|NCT03600805|157960270|FG002|Overall Study|Other unspecified|7|||
49034067|NCT03600805|157960271|FG003|Overall Study|Other unspecified|11|||
49034068|NCT00245063|157960272|FG000|Overall Study|Adverse Event|6|||
49034069|NCT00245063|157960273|FG001|Overall Study|Adverse Event|5|||
48881376|NCT00706654|157402452|FG002|Conversion Phase|Adverse Event|0|||
48881377|NCT00706654|157402453|FG003|Conversion Phase|Adverse Event|0|||
48881378|NCT00706654|157402450|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|9|||
48881379|NCT00706654|157402451|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
49034070|NCT00245063|157960272|FG000|Overall Study|Death|1|||
49034071|NCT00245063|157960273|FG001|Overall Study|Death|0|||
49034072|NCT03500341|157960274|FG000|Overall Study|Withdrawn prior to Completion|2|||
48881380|NCT00706654|157402452|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
48881381|NCT00706654|157402453|FG003|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
48881382|NCT00706654|157402450|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|2|||
48881383|NCT00706654|157402451|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
48881384|NCT00706654|157402452|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
48881385|NCT00706654|157402453|FG003|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
48881386|NCT00706654|157402450|FG000|Oral Stabilization Phase|Lost to Follow-up|17|||
48881387|NCT00706654|157402451|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
48881388|NCT00706654|157402452|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
48881389|NCT00706654|157402453|FG003|Oral Stabilization Phase|Lost to Follow-up|0|||
48881390|NCT00706654|157402450|FG000|Oral Stabilization Phase|Sponsor Discontinue Trial|19|||
48881391|NCT00706654|157402451|FG001|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
48881392|NCT00706654|157402452|FG002|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
48881393|NCT00706654|157402453|FG003|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
48881394|NCT00706654|157402450|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|15|||
48881395|NCT00706654|157402451|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
48881396|NCT00706654|157402452|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
48881397|NCT00706654|157402453|FG003|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
48881398|NCT00706654|157402450|FG000|Oral Stabilization Phase|Withdrawn by Investigator|21|||
48881399|NCT00706654|157402451|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
48881400|NCT00706654|157402452|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
48881401|NCT00706654|157402453|FG003|Oral Stabilization Phase|Withdrawn by Investigator|0|||
48881402|NCT00706654|157402450|FG000|Oral Stabilization Phase|Withdrew consent|55|||
48881403|NCT00706654|157402451|FG001|Oral Stabilization Phase|Withdrew consent|0|||
48881404|NCT00706654|157402452|FG002|Oral Stabilization Phase|Withdrew consent|0|||
48881405|NCT00706654|157402453|FG003|Oral Stabilization Phase|Withdrew consent|0|||
48881406|NCT00706654|157402450|FG000|Oral Stabilization Phase|Protocol Deviation|2|||
48881407|NCT00706654|157402451|FG001|Oral Stabilization Phase|Protocol Deviation|0|||
48881408|NCT00706654|157402452|FG002|Oral Stabilization Phase|Protocol Deviation|0|||
48881409|NCT00706654|157402453|FG003|Oral Stabilization Phase|Protocol Deviation|0|||
48881410|NCT00706654|157402450|FG000|Oral Stabilization Phase|Adverse Event|21|||
48881411|NCT00706654|157402451|FG001|Oral Stabilization Phase|Adverse Event|0|||
48881412|NCT00706654|157402452|FG002|Oral Stabilization Phase|Adverse Event|0|||
48881413|NCT00706654|157402453|FG003|Oral Stabilization Phase|Adverse Event|0|||
48881414|NCT00706654|157402450|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20|||
48881415|NCT00706654|157402451|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
48881416|NCT00706654|157402452|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
48881417|NCT00706654|157402453|FG003|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
48881418|NCT00706654|157402450|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10|||
48881419|NCT00706654|157402451|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
48881420|NCT00706654|157402452|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
48881421|NCT00706654|157402453|FG003|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
48881422|NCT00706654|157402450|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
48881423|NCT00706654|157402451|FG001|Depot Maintenance Phase|Lost to Follow-up|4|||
48881424|NCT00706654|157402452|FG002|Depot Maintenance Phase|Lost to Follow-up|10|||
48881425|NCT00706654|157402453|FG003|Depot Maintenance Phase|Lost to Follow-up|6|||
48881426|NCT00706654|157402450|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
48881427|NCT00706654|157402451|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|4|||
48881428|NCT00706654|157402452|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|6|||
48881429|NCT00706654|157402453|FG003|Depot Maintenance Phase|Met Withdrawal Criteria|5|||
48881430|NCT00706654|157402450|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
48881431|NCT00706654|157402451|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
48881432|NCT00706654|157402452|FG002|Depot Maintenance Phase|Withdrawn by Investigator|12|||
48983620|NCT00355615|157772317|FG002|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
48983621|NCT00355615|157772318|FG003|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
48983622|NCT00355615|157772319|FG004|40-week Rosuvastatin Open Label Period|Protocol Violation|1|||
48983623|NCT00355615|157772315|FG000|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
48983624|NCT00355615|157772316|FG001|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
48881433|NCT00706654|157402453|FG003|Depot Maintenance Phase|Withdrawn by Investigator|8|||
48881434|NCT00706654|157402450|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
48881435|NCT00706654|157402451|FG001|Depot Maintenance Phase|Withdrew Consent|21|||
48881436|NCT00706654|157402452|FG002|Depot Maintenance Phase|Withdrew Consent|29|||
48881437|NCT00706654|157402453|FG003|Depot Maintenance Phase|Withdrew Consent|14|||
48881438|NCT00706654|157402450|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
48881439|NCT00706654|157402451|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
48881440|NCT00706654|157402452|FG002|Depot Maintenance Phase|Protocol Deviation|3|||
48881441|NCT00706654|157402453|FG003|Depot Maintenance Phase|Protocol Deviation|1|||
48881442|NCT00706654|157402450|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
48881443|NCT00706654|157402451|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|8|||
48881444|NCT00706654|157402452|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
48881445|NCT00706654|157402453|FG003|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
48881446|NCT00706654|157402450|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
48881447|NCT00706654|157402451|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
48881448|NCT00706654|157402452|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|12|||
48881449|NCT00706654|157402453|FG003|Depot Maintenance Phase|Impending Relapse with Adverse Event|17|||
48881450|NCT00706654|157402450|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
48881451|NCT00706654|157402451|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
48881452|NCT00706654|157402452|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
48881453|NCT00706654|157402453|FG003|Depot Maintenance Phase|Impending Relapse without Adverse Event|12|||
48881454|NCT01647542|157402454|FG000|Overall Study|Major Protocol Deviation|1|||
48881455|NCT01647542|157402455|FG001|Overall Study|Major Protocol Deviation|0|||
48881456|NCT01647542|157402456|FG002|Overall Study|Major Protocol Deviation|0|||
48881457|NCT01647542|157402454|FG000|Overall Study|Adverse Event|4|||
48881458|NCT01647542|157402455|FG001|Overall Study|Adverse Event|5|||
48881459|NCT01647542|157402456|FG002|Overall Study|Adverse Event|4|||
48881460|NCT01647542|157402454|FG000|Overall Study|Lost to Follow-up|0|||
48881461|NCT01647542|157402455|FG001|Overall Study|Lost to Follow-up|2|||
48881462|NCT01647542|157402456|FG002|Overall Study|Lost to Follow-up|2|||
48881463|NCT01647542|157402454|FG000|Overall Study|Withdrawal by Subject|6|||
48881464|NCT01647542|157402455|FG001|Overall Study|Withdrawal by Subject|4|||
48881465|NCT01647542|157402456|FG002|Overall Study|Withdrawal by Subject|0|||
48881466|NCT01647542|157402454|FG000|Overall Study|Study Termination|64|||
48881467|NCT01647542|157402455|FG001|Overall Study|Study Termination|61|||
48881468|NCT01647542|157402456|FG002|Overall Study|Study Termination|65|||
48881469|NCT01647542|157402454|FG000|Overall Study|Lack of Efficacy|1|||
48881470|NCT01647542|157402455|FG001|Overall Study|Lack of Efficacy|1|||
48881471|NCT01647542|157402456|FG002|Overall Study|Lack of Efficacy|0|||
48881472|NCT01647542|157402454|FG000|Overall Study|Death|0|||
48881473|NCT01647542|157402455|FG001|Overall Study|Death|0|||
48881474|NCT01647542|157402456|FG002|Overall Study|Death|1|||
48881475|NCT01001390|157402463|FG000|Overall Study|Failure to wear AFO device|2|||
48881476|NCT01001390|157402464|FG001|Overall Study|Failure to wear AFO device|0|||
48881477|NCT02956837|157402465|FG000|Overall Study|Serious Adverse Events|0|||
48881478|NCT02956837|157402466|FG001|Overall Study|Serious Adverse Events|1|||
48881479|NCT02956837|157402467|FG002|Overall Study|Serious Adverse Events|0|||
48881480|NCT02956837|157402468|FG003|Overall Study|Serious Adverse Events|0|||
48881481|NCT02956837|157402465|FG000|Overall Study|Withdrawal by Subject|0|||
48881482|NCT02956837|157402466|FG001|Overall Study|Withdrawal by Subject|1|||
48881483|NCT02956837|157402467|FG002|Overall Study|Withdrawal by Subject|0|||
48881484|NCT02956837|157402468|FG003|Overall Study|Withdrawal by Subject|3|||
48881485|NCT02956837|157402465|FG000|Overall Study|Lost to Follow-up|0|||
48881486|NCT02956837|157402466|FG001|Overall Study|Lost to Follow-up|1|||
48881487|NCT02956837|157402467|FG002|Overall Study|Lost to Follow-up|2|||
48881488|NCT02956837|157402468|FG003|Overall Study|Lost to Follow-up|0|||
48881489|NCT02638103|157402469|FG000|Overall Study|Adverse Event|13|||
48881490|NCT02638103|157402470|FG001|Overall Study|Adverse Event|12|||
48881491|NCT02638103|157402471|FG002|Overall Study|Adverse Event|19|||
48881492|NCT02638103|157402472|FG003|Overall Study|Adverse Event|12|||
48881493|NCT02638103|157402469|FG000|Overall Study|Withdrawal by Subject|43|||
48881494|NCT02638103|157402470|FG001|Overall Study|Withdrawal by Subject|53|||
48881495|NCT02638103|157402471|FG002|Overall Study|Withdrawal by Subject|30|||
48881496|NCT02638103|157402472|FG003|Overall Study|Withdrawal by Subject|61|||
48881497|NCT02638103|157402469|FG000|Overall Study|Protocol Violation|1|||
48881498|NCT02638103|157402470|FG001|Overall Study|Protocol Violation|2|||
48881499|NCT02638103|157402471|FG002|Overall Study|Protocol Violation|1|||
48881500|NCT02638103|157402472|FG003|Overall Study|Protocol Violation|4|||
48881501|NCT02638103|157402469|FG000|Overall Study|Pregnancy|2|||
48881502|NCT02638103|157402470|FG001|Overall Study|Pregnancy|3|||
48881503|NCT02638103|157402471|FG002|Overall Study|Pregnancy|0|||
48983625|NCT00355615|157772317|FG002|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
48881504|NCT02638103|157402472|FG003|Overall Study|Pregnancy|1|||
48881505|NCT02638103|157402469|FG000|Overall Study|Non-compliance to Study Procedures|2|||
48881506|NCT02638103|157402470|FG001|Overall Study|Non-compliance to Study Procedures|1|||
48881507|NCT02638103|157402471|FG002|Overall Study|Non-compliance to Study Procedures|1|||
48881508|NCT02638103|157402472|FG003|Overall Study|Non-compliance to Study Procedures|1|||
48881509|NCT02638103|157402469|FG000|Overall Study|Lost to Follow-up|26|||
48881510|NCT02638103|157402470|FG001|Overall Study|Lost to Follow-up|33|||
48881511|NCT02638103|157402471|FG002|Overall Study|Lost to Follow-up|20|||
48881512|NCT02638103|157402472|FG003|Overall Study|Lost to Follow-up|37|||
48881513|NCT02638103|157402469|FG000|Overall Study|Lack of Efficacy|14|||
48881514|NCT02638103|157402470|FG001|Overall Study|Lack of Efficacy|10|||
48881515|NCT02638103|157402471|FG002|Overall Study|Lack of Efficacy|12|||
48881516|NCT02638103|157402472|FG003|Overall Study|Lack of Efficacy|22|||
48881517|NCT02638103|157402469|FG000|Overall Study|Other than specified|5|||
49034073|NCT02392195|157960276|FG000|Overall Study|Lost to Follow-up|4|||
49034074|NCT02392195|157960276|FG000|Overall Study|Withdrawal by Subject|4|||
49034075|NCT00840216|157960277|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
49034076|NCT00840216|157960278|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
49034077|NCT02937870|157960279|FG000|Overall Study|Adverse Event|1|||
49034078|NCT02937870|157960279|FG000|Overall Study|Protocol Deviation|2|||
49034079|NCT03673670|157960280|FG000|Treatment Period 1 (3 Days)|Withdrawal by Subject|1|||
49034080|NCT03673670|157960281|FG001|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
49034081|NCT03673670|157960282|FG002|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
49034082|NCT03673670|157960283|FG003|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
49034083|NCT03673670|157960284|FG004|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
49034084|NCT03673670|157960285|FG005|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
49034085|NCT03673670|157960280|FG000|Treatment Period 1 (3 Days)|Physician Decision|0|||
49034086|NCT03673670|157960281|FG001|Treatment Period 1 (3 Days)|Physician Decision|0|||
49034087|NCT03673670|157960282|FG002|Treatment Period 1 (3 Days)|Physician Decision|1|||
49034088|NCT03673670|157960283|FG003|Treatment Period 1 (3 Days)|Physician Decision|0|||
49034089|NCT03673670|157960284|FG004|Treatment Period 1 (3 Days)|Physician Decision|0|||
49034090|NCT03673670|157960285|FG005|Treatment Period 1 (3 Days)|Physician Decision|0|||
49034091|NCT03673670|157960280|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
49034092|NCT03673670|157960281|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
49034093|NCT03673670|157960282|FG002|Treatment Period 1 (3 Days)|Adverse Event|0|||
49034094|NCT03673670|157960283|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
49034095|NCT03673670|157960284|FG004|Treatment Period 1 (3 Days)|Adverse Event|0|||
49034096|NCT03673670|157960285|FG005|Treatment Period 1 (3 Days)|Adverse Event|1|||
49034097|NCT03673670|157960280|FG000|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
49034098|NCT03673670|157960281|FG001|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
49034099|NCT03673670|157960282|FG002|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
49034100|NCT03673670|157960283|FG003|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
49034101|NCT03673670|157960284|FG004|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
49034102|NCT03673670|157960285|FG005|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1|||
49034103|NCT03673670|157960280|FG000|Treatment Period 2 (3 Days)|Adverse Event|0|||
49034104|NCT03673670|157960281|FG001|Treatment Period 2 (3 Days)|Adverse Event|0|||
49034105|NCT03673670|157960282|FG002|Treatment Period 2 (3 Days)|Adverse Event|1|||
49034106|NCT03673670|157960283|FG003|Treatment Period 2 (3 Days)|Adverse Event|0|||
49034107|NCT03673670|157960284|FG004|Treatment Period 2 (3 Days)|Adverse Event|1|||
49034108|NCT03673670|157960285|FG005|Treatment Period 2 (3 Days)|Adverse Event|0|||
49034109|NCT03673670|157960280|FG000|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
49034110|NCT03673670|157960281|FG001|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
49034111|NCT03673670|157960282|FG002|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
49034112|NCT03673670|157960283|FG003|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
49034113|NCT03673670|157960284|FG004|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1|||
49034114|NCT03673670|157960285|FG005|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
49034115|NCT03673670|157960280|FG000|Treatment Period 3 (3 Days)|Adverse Event|0|||
49034116|NCT03673670|157960281|FG001|Treatment Period 3 (3 Days)|Adverse Event|0|||
49034117|NCT03673670|157960282|FG002|Treatment Period 3 (3 Days)|Adverse Event|0|||
49034118|NCT03673670|157960283|FG003|Treatment Period 3 (3 Days)|Adverse Event|0|||
49034119|NCT03673670|157960284|FG004|Treatment Period 3 (3 Days)|Adverse Event|1|||
49034120|NCT03673670|157960285|FG005|Treatment Period 3 (3 Days)|Adverse Event|0|||
48881518|NCT02638103|157402470|FG001|Overall Study|Other than specified|4|||
48881519|NCT02638103|157402471|FG002|Overall Study|Other than specified|2|||
49034121|NCT00609674|157960289|FG000|Overall Study|Adverse Event|1|||
49034122|NCT00609674|157960290|FG001|Overall Study|Adverse Event|1|||
49034123|NCT00609674|157960289|FG000|Overall Study|Protocol Violation|3|||
49034124|NCT00609674|157960290|FG001|Overall Study|Protocol Violation|5|||
49034125|NCT00609674|157960289|FG000|Overall Study|Lost to Follow-up|1|||
49034126|NCT00609674|157960290|FG001|Overall Study|Lost to Follow-up|0|||
49034127|NCT00609674|157960289|FG000|Overall Study|Withdrew consent|2|||
49034128|NCT00609674|157960290|FG001|Overall Study|Withdrew consent|1|||
49034129|NCT02815566|157960292|FG000|Overall Study|Adverse Event|1|||
49034130|NCT02815566|157960293|FG001|Overall Study|Adverse Event|1|||
49034131|NCT02815566|157960292|FG000|Overall Study|Withdrawal by Subject|1|||
48881520|NCT02638103|157402472|FG003|Overall Study|Other than specified|4|||
48881521|NCT00246090|157402473|FG000|Overall Study|Adverse Event|25|||
49034132|NCT02815566|157960293|FG001|Overall Study|Withdrawal by Subject|0|||
49034133|NCT02815566|157960292|FG000|Overall Study|Lost to Follow-up|0|||
49034134|NCT02815566|157960293|FG001|Overall Study|Lost to Follow-up|1|||
49034135|NCT00316277|157960294|FG000|Phase 1 (12 Weeks)|Lost to Follow-up|88|||
49034136|NCT00316277|157960295|FG001|Phase 1 (12 Weeks)|Lost to Follow-up|75|||
49034137|NCT00316277|157960294|FG000|Phase 1 (12 Weeks)|Investigator-initiated termination|2|||
49034138|NCT00316277|157960295|FG001|Phase 1 (12 Weeks)|Investigator-initiated termination|0|||
49034139|NCT00316277|157960294|FG000|Phase 1 (12 Weeks)|Eligible for Phase 2|220|||
48881522|NCT00246090|157402473|FG000|Overall Study|Withdrawal by Subject|7|||
48881523|NCT00246090|157402473|FG000|Overall Study|Progressive Disease|212|||
48881524|NCT00246090|157402473|FG000|Overall Study|Clinical Progression|30|||
48881525|NCT00246090|157402473|FG000|Overall Study|Physician Decision|11|||
48881526|NCT00246090|157402473|FG000|Overall Study|Not Otherwise Specified|10|||
48881527|NCT02920970|157402474|FG000|First Intervention|Protocol Violation|0|||
48881528|NCT02920970|157402475|FG001|First Intervention|Protocol Violation|1|||
48881529|NCT02920970|157402474|FG000|First Intervention|Adverse Event|0|||
48881530|NCT02920970|157402475|FG001|First Intervention|Adverse Event|1|||
48881531|NCT02920970|157402474|FG000|Second Intervention|Poor Lens Fit|1|||
48881532|NCT02920970|157402475|FG001|Second Intervention|Poor Lens Fit|0|||
48881533|NCT01969851|157402476|FG000|Overall Study|Adverse Event|0|||
48881534|NCT01969851|157402477|FG001|Overall Study|Adverse Event|0|||
48881535|NCT01969851|157402478|FG002|Overall Study|Adverse Event|3|||
48881536|NCT01969851|157402476|FG000|Overall Study|Lack of Efficacy|0|||
48881537|NCT01969851|157402477|FG001|Overall Study|Lack of Efficacy|3|||
48881538|NCT01969851|157402478|FG002|Overall Study|Lack of Efficacy|1|||
48881539|NCT01969851|157402476|FG000|Overall Study|Withdrawal by Subject|1|||
48881540|NCT01969851|157402477|FG001|Overall Study|Withdrawal by Subject|0|||
48881541|NCT01969851|157402478|FG002|Overall Study|Withdrawal by Subject|1|||
48881542|NCT01969851|157402476|FG000|Overall Study|No effective dose in Titration period|0|||
48881543|NCT01969851|157402477|FG001|Overall Study|No effective dose in Titration period|0|||
48881544|NCT01969851|157402478|FG002|Overall Study|No effective dose in Titration period|1|||
48881545|NCT01969851|157402476|FG000|Overall Study|Sponsor decision|0|||
48881546|NCT01969851|157402477|FG001|Overall Study|Sponsor decision|0|||
48881547|NCT01969851|157402478|FG002|Overall Study|Sponsor decision|1|||
48881548|NCT00208325|157402479|FG000|Overall Study|Death|18|||
48881549|NCT00208325|157402480|FG001|Overall Study|Death|19|||
48881550|NCT00208325|157402481|FG002|Overall Study|Death|7|||
48881551|NCT00208325|157402482|FG003|Overall Study|Death|5|||
48881552|NCT00208325|157402479|FG000|Overall Study|Withdrawal by Subject|0|||
48881553|NCT00208325|157402480|FG001|Overall Study|Withdrawal by Subject|1|||
48881554|NCT00208325|157402481|FG002|Overall Study|Withdrawal by Subject|0|||
48881555|NCT00208325|157402482|FG003|Overall Study|Withdrawal by Subject|0|||
48881556|NCT00208325|157402479|FG000|Overall Study|Revision|4|||
48881557|NCT00208325|157402480|FG001|Overall Study|Revision|1|||
48881558|NCT00208325|157402481|FG002|Overall Study|Revision|0|||
48881559|NCT00208325|157402482|FG003|Overall Study|Revision|4|||
48881560|NCT00208325|157402479|FG000|Overall Study|Lost to Follow-up|1|||
48881561|NCT00208325|157402480|FG001|Overall Study|Lost to Follow-up|0|||
48881562|NCT00208325|157402481|FG002|Overall Study|Lost to Follow-up|2|||
48881563|NCT00208325|157402482|FG003|Overall Study|Lost to Follow-up|0|||
48881564|NCT00208325|157402479|FG000|Overall Study|Unsurfaced to Resurfaced Patella|4|||
48881565|NCT00208325|157402480|FG001|Overall Study|Unsurfaced to Resurfaced Patella|4|||
48881566|NCT00208325|157402481|FG002|Overall Study|Unsurfaced to Resurfaced Patella|1|||
48881567|NCT00208325|157402482|FG003|Overall Study|Unsurfaced to Resurfaced Patella|3|||
48881568|NCT00208325|157402479|FG000|Overall Study|Does not wish to Continue in Study|5|||
48881569|NCT00208325|157402480|FG001|Overall Study|Does not wish to Continue in Study|8|||
48881570|NCT00208325|157402481|FG002|Overall Study|Does not wish to Continue in Study|3|||
48881571|NCT00208325|157402482|FG003|Overall Study|Does not wish to Continue in Study|2|||
48881572|NCT00208325|157402479|FG000|Overall Study|Other|2|||
48881573|NCT00208325|157402480|FG001|Overall Study|Other|1|||
48881574|NCT00208325|157402481|FG002|Overall Study|Other|1|||
48881575|NCT00208325|157402482|FG003|Overall Study|Other|0|||
48881576|NCT00208325|157402479|FG000|Overall Study|Mis-Randomized|17|||
48881577|NCT00208325|157402480|FG001|Overall Study|Mis-Randomized|20|||
48881578|NCT00208325|157402481|FG002|Overall Study|Mis-Randomized|0|||
48881579|NCT00208325|157402482|FG003|Overall Study|Mis-Randomized|0|||
48881580|NCT00108745|157402483|FG000|Overall Study|Withdrawal by Subject|19|||
48881581|NCT00108745|157402484|FG001|Overall Study|Withdrawal by Subject|12|||
48881582|NCT00108745|157402485|FG002|Overall Study|Withdrawal by Subject|12|||
48881583|NCT00108745|157402483|FG000|Overall Study|Never Treated|8|||
48881584|NCT00108745|157402484|FG001|Overall Study|Never Treated|10|||
48881585|NCT00108745|157402485|FG002|Overall Study|Never Treated|12|||
48881586|NCT00108745|157402483|FG000|Overall Study|Ineligible|7|||
48881587|NCT00108745|157402484|FG001|Overall Study|Ineligible|13|||
48881588|NCT00108745|157402485|FG002|Overall Study|Ineligible|13|||
48881589|NCT00203268|157402486|FG000|Early Treatment|only treated one headache|2|||
48881590|NCT00203268|157402486|FG000|Early Treatment|Lost to Follow-up|1|||
48881591|NCT00203268|157402486|FG000|Early Treatment|Withdrawal by Subject|1|||
48881592|NCT01495598|157402490|FG000|Overall Study|Death during follow up period|2|||
48881593|NCT01495598|157402490|FG000|Overall Study|Death on study|1|||
48881594|NCT01495598|157402490|FG000|Overall Study|Lost to Follow-up|3|||
48881595|NCT01495598|157402490|FG000|Overall Study|Physician Decision|8|||
48881596|NCT01213524|157402492|FG000|Baseline|Withdrawal by Subject|5|||
48881597|NCT01213524|157402492|FG000|Baseline|high breath alcohol levels|1|||
48881598|NCT01213524|157402492|FG000|Baseline|Physician Decision|1|||
48881599|NCT01213524|157402492|FG000|Session 2|Withdrawal by Subject|5|||
48881600|NCT01213524|157402492|FG000|Session 3|Withdrawal by Subject|4|||
48881601|NCT01213524|157402492|FG000|Session 4|Physician Decision|1|||
48881602|NCT01213524|157402492|FG000|Session 4|Withdrawal by Subject|2|||
48881603|NCT02671500|157402493|FG000|Overall Study|Lack of Efficacy|12|||
48881604|NCT02671500|157402493|FG000|Overall Study|Lost to Follow-up|2|||
48881605|NCT00475228|157402494|FG000|Overall Study|Lost to Follow-up|17|||
48881606|NCT00475228|157402495|FG001|Overall Study|Lost to Follow-up|17|||
48881607|NCT03551691|157402496|FG000|Overall Study|Withdrawal by Subject|3|||
48881608|NCT03551691|157402497|FG001|Overall Study|Withdrawal by Subject|3|||
48881609|NCT04411056|157404995|FG000|Overall Study|surgery cancelled|1|||
48881610|NCT04411056|157404996|FG001|Overall Study|surgery cancelled|0|||
48881611|NCT04411056|157404995|FG000|Overall Study|Equipment problem during intubation|0|||
48881612|NCT04411056|157404996|FG001|Overall Study|Equipment problem during intubation|1|||
48881613|NCT00903760|157404999|FG000|Overall Study|Disease Progression/Death|8|||
48881614|NCT00903760|157405000|FG001|Overall Study|Disease Progression/Death|6|||
48881615|NCT00903760|157404999|FG000|Overall Study|Stem Cell Transplant|8|||
48881616|NCT00903760|157405000|FG001|Overall Study|Stem Cell Transplant|4|||
48881617|NCT00903760|157404999|FG000|Overall Study|Physician Decision|1|||
48881618|NCT00903760|157405000|FG001|Overall Study|Physician Decision|2|||
48881619|NCT00903760|157404999|FG000|Overall Study|Death|0|||
48881620|NCT00903760|157405000|FG001|Overall Study|Death|1|||
48881621|NCT00903760|157404999|FG000|Overall Study|Lost to Follow-up|1|||
48881622|NCT00903760|157405000|FG001|Overall Study|Lost to Follow-up|0|||
48881623|NCT00903760|157404999|FG000|Overall Study|Withdrawal by Subject|1|||
48881624|NCT00903760|157405000|FG001|Overall Study|Withdrawal by Subject|2|||
48881625|NCT00903760|157404999|FG000|Overall Study|Off treatment for long period|0|||
48881626|NCT00903760|157405000|FG001|Overall Study|Off treatment for long period|1|||
48881627|NCT02388347|157405001|FG000|Overall Study|Withdrawal by Subject|0|||
48881628|NCT02388347|157405002|FG001|Overall Study|Withdrawal by Subject|0|||
48881629|NCT02388347|157405003|FG002|Overall Study|Withdrawal by Subject|1|||
48881630|NCT02388347|157405004|FG003|Overall Study|Withdrawal by Subject|0|||
48881631|NCT02388347|157405005|FG004|Overall Study|Withdrawal by Subject|0|||
48881632|NCT02473965|157405007|FG000|Overall Study|Adverse Event|6|||
48881633|NCT02473965|157405008|FG001|Overall Study|Adverse Event|4|||
48881634|NCT02473965|157405007|FG000|Overall Study|MG worsening|4|||
48881635|NCT02473965|157405008|FG001|Overall Study|MG worsening|1|||
48881636|NCT02473965|157405007|FG000|Overall Study|Withdrawal by Subject|2|||
48881637|NCT02473965|157405008|FG001|Overall Study|Withdrawal by Subject|3|||
48881638|NCT02473965|157405007|FG000|Overall Study|Physician Decision|0|||
48881639|NCT02473965|157405008|FG001|Overall Study|Physician Decision|2|||
48881640|NCT01183390|157405009|FG000|First Intervention|Adverse Event|0|||
48881641|NCT01183390|157405010|FG001|First Intervention|Adverse Event|1|||
48881642|NCT00487825|157405014|FG000|Overall Study|Adverse Event|2|||
48881643|NCT00487825|157405015|FG001|Overall Study|Adverse Event|2|||
48881644|NCT00487825|157405014|FG000|Overall Study|Lack of Efficacy|1|||
48881645|NCT00487825|157405015|FG001|Overall Study|Lack of Efficacy|1|||
48881646|NCT00487825|157405014|FG000|Overall Study|Other|3|||
48881647|NCT00487825|157405015|FG001|Overall Study|Other|2|||
48881648|NCT02358668|157405016|FG000|Overall Study|Adverse Event|2|||
48881649|NCT02358668|157405017|FG001|Overall Study|Adverse Event|0|||
48881650|NCT02358668|157405018|FG002|Overall Study|Adverse Event|0|||
48881651|NCT02358668|157405016|FG000|Overall Study|Withdrawal by Subject|0|||
48881652|NCT02358668|157405017|FG001|Overall Study|Withdrawal by Subject|1|||
48881653|NCT02358668|157405018|FG002|Overall Study|Withdrawal by Subject|0|||
48881654|NCT03246347|157405019|FG000|Overall Study|On Study|23|||
48881655|NCT02419417|157405020|FG000|Overall Study|Disease progression|5|||
48881656|NCT02419417|157405021|FG001|Overall Study|Disease progression|4|||
48881657|NCT02419417|157405022|FG002|Overall Study|Disease progression|13|||
48881658|NCT02419417|157405023|FG003|Overall Study|Disease progression|10|||
48881659|NCT02419417|157405024|FG004|Overall Study|Disease progression|10|||
48881660|NCT02419417|157405025|FG005|Overall Study|Disease progression|3|||
48881661|NCT02419417|157405026|FG006|Overall Study|Disease progression|4|||
48881662|NCT02419417|157405027|FG007|Overall Study|Disease progression|5|||
48881663|NCT02419417|157405028|FG008|Overall Study|Disease progression|13|||
48881664|NCT02419417|157405029|FG009|Overall Study|Disease progression|9|||
48881665|NCT02419417|157405030|FG010|Overall Study|Disease progression|0|||
48881666|NCT02419417|157405020|FG000|Overall Study|Study drug toxicity|0|||
48881667|NCT02419417|157405021|FG001|Overall Study|Study drug toxicity|0|||
48881668|NCT02419417|157405022|FG002|Overall Study|Study drug toxicity|0|||
48881669|NCT02419417|157405023|FG003|Overall Study|Study drug toxicity|0|||
48881670|NCT02419417|157405024|FG004|Overall Study|Study drug toxicity|1|||
48881671|NCT02419417|157405025|FG005|Overall Study|Study drug toxicity|0|||
48881672|NCT02419417|157405026|FG006|Overall Study|Study drug toxicity|0|||
48881673|NCT02419417|157405027|FG007|Overall Study|Study drug toxicity|0|||
48881674|NCT02419417|157405028|FG008|Overall Study|Study drug toxicity|0|||
48881675|NCT02419417|157405029|FG009|Overall Study|Study drug toxicity|0|||
48881676|NCT02419417|157405030|FG010|Overall Study|Study drug toxicity|0|||
48881677|NCT02419417|157405020|FG000|Overall Study|Adverse event unrelated to study drug|0|||
48881678|NCT02419417|157405021|FG001|Overall Study|Adverse event unrelated to study drug|0|||
48881679|NCT02419417|157405022|FG002|Overall Study|Adverse event unrelated to study drug|0|||
48881680|NCT02419417|157405023|FG003|Overall Study|Adverse event unrelated to study drug|0|||
48881681|NCT02419417|157405024|FG004|Overall Study|Adverse event unrelated to study drug|2|||
48881682|NCT02419417|157405025|FG005|Overall Study|Adverse event unrelated to study drug|1|||
48881683|NCT02419417|157405026|FG006|Overall Study|Adverse event unrelated to study drug|0|||
48881684|NCT02419417|157405027|FG007|Overall Study|Adverse event unrelated to study drug|1|||
48881685|NCT02419417|157405028|FG008|Overall Study|Adverse event unrelated to study drug|0|||
48881686|NCT02419417|157405029|FG009|Overall Study|Adverse event unrelated to study drug|0|||
48881687|NCT02419417|157405030|FG010|Overall Study|Adverse event unrelated to study drug|0|||
48881688|NCT02419417|157405020|FG000|Overall Study|Participant request to discontinue|0|||
48881689|NCT02419417|157405021|FG001|Overall Study|Participant request to discontinue|0|||
48881690|NCT02419417|157405022|FG002|Overall Study|Participant request to discontinue|0|||
48881691|NCT02419417|157405023|FG003|Overall Study|Participant request to discontinue|0|||
48881692|NCT02419417|157405024|FG004|Overall Study|Participant request to discontinue|0|||
48881693|NCT02419417|157405025|FG005|Overall Study|Participant request to discontinue|0|||
48881694|NCT02419417|157405026|FG006|Overall Study|Participant request to discontinue|0|||
48881695|NCT02419417|157405027|FG007|Overall Study|Participant request to discontinue|0|||
48881696|NCT02419417|157405028|FG008|Overall Study|Participant request to discontinue|0|||
48881697|NCT02419417|157405029|FG009|Overall Study|Participant request to discontinue|1|||
48881698|NCT02419417|157405030|FG010|Overall Study|Participant request to discontinue|0|||
48881699|NCT02419417|157405020|FG000|Overall Study|Withdrawal by Subject|0|||
48881700|NCT02419417|157405021|FG001|Overall Study|Withdrawal by Subject|0|||
48881701|NCT02419417|157405022|FG002|Overall Study|Withdrawal by Subject|0|||
48881702|NCT02419417|157405023|FG003|Overall Study|Withdrawal by Subject|0|||
48881703|NCT02419417|157405024|FG004|Overall Study|Withdrawal by Subject|0|||
48881704|NCT02419417|157405025|FG005|Overall Study|Withdrawal by Subject|0|||
48881705|NCT02419417|157405026|FG006|Overall Study|Withdrawal by Subject|0|||
48881706|NCT02419417|157405027|FG007|Overall Study|Withdrawal by Subject|0|||
48881707|NCT02419417|157405028|FG008|Overall Study|Withdrawal by Subject|0|||
48881708|NCT02419417|157405029|FG009|Overall Study|Withdrawal by Subject|0|||
48881709|NCT02419417|157405030|FG010|Overall Study|Withdrawal by Subject|1|||
49034140|NCT00316277|157960295|FG001|Phase 1 (12 Weeks)|Eligible for Phase 2|225|||
49034141|NCT00316277|157960294|FG000|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19|||
49034142|NCT00316277|157960295|FG001|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18|||
49034143|NCT00316277|157960294|FG000|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0|||
49034144|NCT00316277|157960295|FG001|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1|||
49034145|NCT03679598|157960296|FG000|Overall Study|Adverse Event|2|||
49034146|NCT03679598|157960297|FG001|Overall Study|Adverse Event|0|||
49034147|NCT00207090|157960308|FG000|Overall Study|Study drug toxicity|3|||
49034148|NCT00207090|157960308|FG000|Overall Study|Chest wall mass larger|1|||
49034149|NCT00207090|157960308|FG000|Overall Study|Disease progression/relapse|2|||
49034150|NCT00207090|157960308|FG000|Overall Study|Physician Decision|1|||
49034151|NCT00838279|157960311|FG000|Washout|Protocol Violation|1|||
49034152|NCT00838279|157960312|FG001|Washout|Protocol Violation|0|||
49034153|NCT00838279|157960311|FG000|Washout|Withdrawal by Subject|0|||
49034154|NCT00838279|157960312|FG001|Washout|Withdrawal by Subject|1|||
49034155|NCT00185458|157960315|FG000|Contraception Phase|Adverse Event|37|||
49034156|NCT00185458|157960315|FG000|Contraception Phase|Lost to Follow-up|10|||
49034157|NCT00185458|157960315|FG000|Contraception Phase|Protocol Violation|2|||
49034158|NCT00185458|157960315|FG000|Contraception Phase|Physician Decision|2|||
49034159|NCT00185458|157960315|FG000|Contraception Phase|Withdrawal by Subject|7|||
49034160|NCT00185458|157960315|FG000|HRT Phase|Adverse Event|18|||
49034161|NCT00185458|157960315|FG000|HRT Phase|Lost to Follow-up|4|||
49034162|NCT00185458|157960315|FG000|HRT Phase|Protocol Violation|2|||
49034163|NCT00185458|157960315|FG000|HRT Phase|Withdrawal by Subject|3|||
49034164|NCT04499963|157960322|FG000|Overall Study|Adverse Event|3|||
49034165|NCT04499963|157960323|FG001|Overall Study|Adverse Event|0|||
49034166|NCT04499963|157960322|FG000|Overall Study|Death|3|||
49034167|NCT04499963|157960323|FG001|Overall Study|Death|0|||
49034168|NCT04499963|157960322|FG000|Overall Study|Lack of Efficacy|7|||
49034169|NCT04499963|157960323|FG001|Overall Study|Lack of Efficacy|0|||
49034170|NCT04499963|157960322|FG000|Overall Study|Lost to Follow-up|2|||
49034171|NCT04499963|157960323|FG001|Overall Study|Lost to Follow-up|0|||
48881710|NCT02568397|157405031|FG000|Period 2|Withdrawal by Subject|0|||
48881711|NCT02568397|157405032|FG001|Period 2|Withdrawal by Subject|1|||
48881712|NCT02568397|157405031|FG000|Period 2|Physician Decision|0|||
48881713|NCT02568397|157405032|FG001|Period 2|Physician Decision|1|||
48881714|NCT04843579|157405033|FG000|Overall Study|Adverse Event|1|||
48881715|NCT04843579|157405033|FG000|Overall Study|Disease Progression|1|||
48881716|NCT01443403|157405034|FG000|Overall Study|Adverse Event|1|||
49034172|NCT01566721|157960324|FG000|Treatment Period|Withdrawal by Subject|35|||
49034173|NCT01566721|157960325|FG001|Treatment Period|Withdrawal by Subject|9|||
49034174|NCT01566721|157960324|FG000|Treatment Period|Disease Progression/Recurrence|37|||
49034175|NCT01566721|157960325|FG001|Treatment Period|Disease Progression/Recurrence|13|||
49034176|NCT01566721|157960324|FG000|Treatment Period|Investigator/Sponsor Decision|6|||
49034177|NCT01566721|157960325|FG001|Treatment Period|Investigator/Sponsor Decision|3|||
49034178|NCT01566721|157960324|FG000|Treatment Period|Other|13|||
48881717|NCT01443403|157405035|FG001|Overall Study|Adverse Event|1|||
48881718|NCT01443403|157405036|FG002|Overall Study|Adverse Event|4|||
48881719|NCT01443403|157405037|FG003|Overall Study|Adverse Event|5|||
48881720|NCT01443403|157405034|FG000|Overall Study|Withdrawal by Subject|0|||
48881721|NCT01443403|157405035|FG001|Overall Study|Withdrawal by Subject|1|||
48881722|NCT01443403|157405036|FG002|Overall Study|Withdrawal by Subject|2|||
48881723|NCT01443403|157405037|FG003|Overall Study|Withdrawal by Subject|1|||
48881724|NCT01443403|157405034|FG000|Overall Study|Lost to Follow-up|0|||
48881725|NCT01443403|157405035|FG001|Overall Study|Lost to Follow-up|0|||
48881726|NCT01443403|157405036|FG002|Overall Study|Lost to Follow-up|0|||
48881727|NCT01443403|157405037|FG003|Overall Study|Lost to Follow-up|1|||
48881728|NCT01443403|157405034|FG000|Overall Study|Protocol Violation|2|||
48881729|NCT01443403|157405035|FG001|Overall Study|Protocol Violation|1|||
48881730|NCT01443403|157405036|FG002|Overall Study|Protocol Violation|1|||
48881731|NCT01443403|157405037|FG003|Overall Study|Protocol Violation|1|||
48881732|NCT01443403|157405034|FG000|Overall Study|Use of Prohibited Treatment|2|||
48881733|NCT01443403|157405035|FG001|Overall Study|Use of Prohibited Treatment|3|||
48881734|NCT01443403|157405036|FG002|Overall Study|Use of Prohibited Treatment|0|||
48881735|NCT01443403|157405037|FG003|Overall Study|Use of Prohibited Treatment|0|||
48881736|NCT01443403|157405034|FG000|Overall Study|Other - Miscellaneous|1|||
48881737|NCT01443403|157405035|FG001|Overall Study|Other - Miscellaneous|0|||
48881738|NCT01443403|157405036|FG002|Overall Study|Other - Miscellaneous|0|||
48881739|NCT01443403|157405037|FG003|Overall Study|Other - Miscellaneous|1|||
48881740|NCT01367847|157405038|FG000|Overall Study|Withdrawal by Subject|2|||
48881741|NCT01367847|157405039|FG001|Overall Study|Withdrawal by Subject|2|||
48881742|NCT01439867|157405040|FG000|Overall Study|Non-compliance|0|||
48881743|NCT01439867|157405041|FG001|Overall Study|Non-compliance|1|||
48881744|NCT01439867|157405040|FG000|Overall Study|Withdrawal by Subject|1|||
48881745|NCT01439867|157405041|FG001|Overall Study|Withdrawal by Subject|2|||
48881746|NCT01439867|157405040|FG000|Overall Study|Administrative Decision|4|||
48881747|NCT01439867|157405041|FG001|Overall Study|Administrative Decision|5|||
48881748|NCT01439867|157405040|FG000|Overall Study|Protocol-specified Criteria|1|||
48881749|NCT01439867|157405041|FG001|Overall Study|Protocol-specified Criteria|0|||
48881750|NCT01888874|157405042|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
48881751|NCT01888874|157405043|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
48881752|NCT01888874|157405044|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
48881753|NCT01888874|157405045|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4|||
48881754|NCT01888874|157405046|FG004|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
48881755|NCT01888874|157405047|FG005|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
48881756|NCT01888874|157405048|FG006|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
48881757|NCT01888874|157405042|FG000|Period 1 (Baseline up to Week 12)|Other|1|||
48881758|NCT01888874|157405043|FG001|Period 1 (Baseline up to Week 12)|Other|0|||
48881759|NCT01888874|157405044|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
48881760|NCT01888874|157405045|FG003|Period 1 (Baseline up to Week 12)|Other|1|||
48881761|NCT01888874|157405046|FG004|Period 1 (Baseline up to Week 12)|Other|3|||
48881762|NCT01888874|157405047|FG005|Period 1 (Baseline up to Week 12)|Other|3|||
48881763|NCT01888874|157405048|FG006|Period 1 (Baseline up to Week 12)|Other|0|||
48881764|NCT01888874|157405042|FG000|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
48881765|NCT01888874|157405043|FG001|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
48881766|NCT01888874|157405044|FG002|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
48881767|NCT01888874|157405045|FG003|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
48881768|NCT01888874|157405046|FG004|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
48881769|NCT01888874|157405047|FG005|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
48881770|NCT01888874|157405048|FG006|Period 1 (Baseline up to Week 12)|Physician Decision|1|||
48881771|NCT01888874|157405042|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
48881772|NCT01888874|157405043|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
48881773|NCT01888874|157405044|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|3|||
48881774|NCT01888874|157405045|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
48881775|NCT01888874|157405046|FG004|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
48881776|NCT01888874|157405047|FG005|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
48881777|NCT01888874|157405048|FG006|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
48881778|NCT01888874|157405042|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
48881779|NCT01888874|157405043|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
48881780|NCT01888874|157405044|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
48881781|NCT01888874|157405045|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
48881782|NCT01888874|157405046|FG004|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1|||
48881783|NCT01888874|157405047|FG005|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
48881784|NCT01888874|157405048|FG006|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
48881785|NCT01888874|157405042|FG000|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
48881786|NCT01888874|157405043|FG001|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1|||
49034179|NCT01566721|157960325|FG001|Treatment Period|Other|2|||
48881787|NCT01888874|157405044|FG002|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
48881788|NCT01888874|157405045|FG003|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
48881789|NCT01888874|157405046|FG004|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
48881790|NCT01888874|157405047|FG005|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
48881791|NCT01888874|157405048|FG006|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
48881792|NCT01888874|157405042|FG000|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
48881793|NCT01888874|157405043|FG001|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
48881794|NCT01888874|157405044|FG002|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
48881795|NCT01888874|157405045|FG003|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
48881796|NCT01888874|157405046|FG004|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
48881797|NCT01888874|157405047|FG005|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
48881798|NCT01888874|157405048|FG006|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
48881799|NCT01888874|157405042|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
48881800|NCT01888874|157405043|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
48881801|NCT01888874|157405044|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
48881802|NCT01888874|157405045|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
48881803|NCT01888874|157405046|FG004|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
48881804|NCT01888874|157405047|FG005|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
48881805|NCT01888874|157405048|FG006|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
48881806|NCT01888874|157405042|FG000|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
48881807|NCT01888874|157405043|FG001|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
48881808|NCT01888874|157405044|FG002|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
48881809|NCT01888874|157405045|FG003|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
48881810|NCT01888874|157405046|FG004|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1|||
48881811|NCT01888874|157405047|FG005|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
48881812|NCT01888874|157405048|FG006|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
48881813|NCT01888874|157405042|FG000|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
48881814|NCT01888874|157405043|FG001|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
48881815|NCT01888874|157405044|FG002|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2|||
48881816|NCT01888874|157405045|FG003|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
48881817|NCT01888874|157405046|FG004|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
48881818|NCT01888874|157405047|FG005|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1|||
48881819|NCT01888874|157405048|FG006|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
48881820|NCT01888874|157405042|FG000|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
48881821|NCT01888874|157405043|FG001|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
48881822|NCT01888874|157405044|FG002|Period 2 (Week 13 to Week 24)|Treatment failure|1|||
48881823|NCT01888874|157405045|FG003|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
48881824|NCT01888874|157405046|FG004|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
48881825|NCT01888874|157405047|FG005|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
48881826|NCT01888874|157405048|FG006|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
48881827|NCT01888874|157405042|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
48881828|NCT01888874|157405043|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
48881829|NCT01888874|157405044|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
48881830|NCT01888874|157405045|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
48881831|NCT01888874|157405046|FG004|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
48881832|NCT01888874|157405047|FG005|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
48881833|NCT01888874|157405048|FG006|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
48881834|NCT01888874|157405042|FG000|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
48881835|NCT01888874|157405043|FG001|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
48881836|NCT01888874|157405044|FG002|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
48881837|NCT01888874|157405045|FG003|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
48881838|NCT01888874|157405046|FG004|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
48881839|NCT01888874|157405047|FG005|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
48881840|NCT01888874|157405048|FG006|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
48881841|NCT03768336|157405049|FG000|Overall Study|Lost to Follow-up|3|||
48881842|NCT03768336|157405050|FG001|Overall Study|Lost to Follow-up|2|||
48881843|NCT03768336|157405049|FG000|Overall Study|Became Ineligible|2|||
48881844|NCT03768336|157405050|FG001|Overall Study|Became Ineligible|0|||
48881845|NCT03768336|157405049|FG000|Overall Study|Missed final survey (3-month follow-up)|1|||
48881846|NCT03768336|157405050|FG001|Overall Study|Missed final survey (3-month follow-up)|0|||
48881847|NCT03768336|157405049|FG000|Overall Study|Missed final survey (post-treatment|0|||
48881848|NCT03768336|157405050|FG001|Overall Study|Missed final survey (post-treatment|1|||
48881849|NCT03258723|157405051|FG000|Overall Study|COVID Interruption of study|54|||
48881850|NCT03258723|157405051|FG000|Overall Study|Lost to Follow-up|8|||
48881851|NCT02000622|157405053|FG000|Overall Study|Withdrawal by Subject|5|||
48881852|NCT02000622|157405054|FG001|Overall Study|Withdrawal by Subject|7|||
48881853|NCT02000622|157405053|FG000|Overall Study|Lost to Follow-up|4|||
48881854|NCT02000622|157405054|FG001|Overall Study|Lost to Follow-up|0|||
48881855|NCT02000622|157405053|FG000|Overall Study|Death|159|||
48881856|NCT02000622|157405054|FG001|Overall Study|Death|73|||
48881857|NCT02000622|157405053|FG000|Overall Study|Withdrawn due to site closure|1|||
48881858|NCT02000622|157405054|FG001|Overall Study|Withdrawn due to site closure|0|||
48881859|NCT01234883|157405055|FG000|Overall Study|Early treatment release|8|||
48881860|NCT01234883|157405056|FG001|Overall Study|Early treatment release|10|||
48881861|NCT01234883|157405055|FG000|Overall Study|Parent/guardian withdrew consent|1|||
48881862|NCT01234883|157405056|FG001|Overall Study|Parent/guardian withdrew consent|2|||
48881863|NCT01234883|157405055|FG000|Overall Study|Technical difficulties with IV infusion|0|||
48881864|NCT01234883|157405056|FG001|Overall Study|Technical difficulties with IV infusion|1|||
48881865|NCT01234883|157405055|FG000|Overall Study|Inclusion/exclusion failure|1|||
48881866|NCT01234883|157405056|FG001|Overall Study|Inclusion/exclusion failure|0|||
48881867|NCT02270671|157405059|FG000|Overall Study|Withdrawal by Subject|1|||
48881868|NCT02270671|157405060|FG001|Overall Study|Withdrawal by Subject|1|||
48881869|NCT02270671|157405059|FG000|Overall Study|Protocol Violation|0|||
48881870|NCT02270671|157405060|FG001|Overall Study|Protocol Violation|1|||
48881871|NCT02270671|157405059|FG000|Overall Study|Missed Post-intervention Data Collection|2|||
48881872|NCT02270671|157405060|FG001|Overall Study|Missed Post-intervention Data Collection|2|||
48881873|NCT02270671|157405059|FG000|Overall Study|Lost to Follow-up|2|||
48881874|NCT02270671|157405060|FG001|Overall Study|Lost to Follow-up|1|||
48881875|NCT02563548|157405061|FG000|Dose Escalation (Up to 46 Weeks)|Adverse Event|2|||
48881876|NCT02563548|157405062|FG001|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
48881877|NCT02563548|157405063|FG002|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
48881878|NCT02563548|157405064|FG003|Dose Escalation (Up to 46 Weeks)|Adverse Event|1|||
48881879|NCT02563548|157405065|FG004|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
48881880|NCT02563548|157405066|FG005|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
48881881|NCT02563548|157405061|FG000|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1|||
48881882|NCT02563548|157405062|FG001|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
48881883|NCT02563548|157405063|FG002|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
48881884|NCT02563548|157405064|FG003|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
48881885|NCT02563548|157405065|FG004|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
48881886|NCT02563548|157405066|FG005|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
48881887|NCT02563548|157405061|FG000|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
48881888|NCT02563548|157405062|FG001|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
48881889|NCT02563548|157405063|FG002|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3|||
48881890|NCT02563548|157405064|FG003|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
48881891|NCT02563548|157405065|FG004|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
48881892|NCT02563548|157405066|FG005|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
48881893|NCT02563548|157405061|FG000|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
48881894|NCT02563548|157405062|FG001|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
48881895|NCT02563548|157405063|FG002|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2|||
48881896|NCT02563548|157405064|FG003|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1|||
48881897|NCT02563548|157405065|FG004|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
48881898|NCT02563548|157405066|FG005|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
48881899|NCT02563548|157405061|FG000|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
48881900|NCT02563548|157405062|FG001|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
48881901|NCT02563548|157405063|FG002|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
48881902|NCT02563548|157405064|FG003|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
48881903|NCT02563548|157405065|FG004|Dose Expansion (Up to 60 Weeks)|Adverse Event|1|||
48881904|NCT02563548|157405066|FG005|Dose Expansion (Up to 60 Weeks)|Adverse Event|8|||
48881905|NCT02563548|157405061|FG000|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
48881906|NCT02563548|157405062|FG001|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
48881907|NCT02563548|157405063|FG002|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
48881908|NCT02563548|157405064|FG003|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
48881909|NCT02563548|157405065|FG004|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15|||
48881910|NCT02563548|157405066|FG005|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3|||
48881911|NCT02563548|157405061|FG000|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
48881912|NCT02563548|157405062|FG001|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
48881913|NCT02563548|157405063|FG002|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
48881914|NCT02563548|157405064|FG003|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
48881915|NCT02563548|157405065|FG004|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6|||
48881916|NCT02563548|157405066|FG005|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
48881917|NCT02563548|157405061|FG000|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
48881918|NCT02563548|157405062|FG001|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
48881919|NCT02563548|157405063|FG002|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
48881920|NCT02563548|157405064|FG003|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
48881921|NCT02563548|157405065|FG004|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2|||
49034180|NCT01566721|157960324|FG000|Treatment Period|Lack of Compliance|5|||
49034181|NCT01566721|157960325|FG001|Treatment Period|Lack of Compliance|1|||
49034182|NCT01566721|157960324|FG000|Treatment Period|Adverse Event|100|||
49034183|NCT01566721|157960325|FG001|Treatment Period|Adverse Event|30|||
49034184|NCT01566721|157960324|FG000|Treatment Period|Pregnancy|1|||
49034185|NCT01566721|157960325|FG001|Treatment Period|Pregnancy|0|||
49034186|NCT01566721|157960324|FG000|Safety Follow-up|Physician Decision|6|||
49034187|NCT01566721|157960325|FG001|Safety Follow-up|Physician Decision|4|||
49034188|NCT01566721|157960324|FG000|Safety Follow-up|Lost to Follow-up|101|||
49034189|NCT01566721|157960325|FG001|Safety Follow-up|Lost to Follow-up|48|||
49034190|NCT01566721|157960324|FG000|Safety Follow-up|Withdrawal by Subject|155|||
49034191|NCT01566721|157960325|FG001|Safety Follow-up|Withdrawal by Subject|49|||
49034192|NCT01566721|157960324|FG000|Safety Follow-up|Death|28|||
49034193|NCT01566721|157960325|FG001|Safety Follow-up|Death|4|||
49034194|NCT01566721|157960324|FG000|Safety Follow-up|Non-compliance|7|||
49034195|NCT01566721|157960325|FG001|Safety Follow-up|Non-compliance|3|||
49034196|NCT01566721|157960324|FG000|Safety Follow-up|Protocol Violation|7|||
49034197|NCT01566721|157960325|FG001|Safety Follow-up|Protocol Violation|0|||
49034198|NCT01566721|157960324|FG000|Safety Follow-up|Site closure|2|||
49034199|NCT01566721|157960325|FG001|Safety Follow-up|Site closure|3|||
49034200|NCT01566721|157960324|FG000|Safety Follow-up|Erroneous reporting or late reporting|2|||
49034201|NCT01566721|157960325|FG001|Safety Follow-up|Erroneous reporting or late reporting|0|||
49034202|NCT01566721|157960324|FG000|Safety Follow-up|Missing|7|||
49034203|NCT01566721|157960325|FG001|Safety Follow-up|Missing|2|||
49034204|NCT01566721|157960324|FG000|Safety Follow-up|Disease progression /disease recurrence|223|||
49034205|NCT01566721|157960325|FG001|Safety Follow-up|Disease progression /disease recurrence|90|||
49034206|NCT01566721|157960324|FG000|Safety Follow-up|Sponsor decision|1|||
49034207|NCT01566721|157960325|FG001|Safety Follow-up|Sponsor decision|0|||
49034208|NCT01566721|157960324|FG000|Safety Follow-up|Adverse Event|8|||
49034209|NCT01566721|157960325|FG001|Safety Follow-up|Adverse Event|4|||
49034210|NCT00446563|157960328|FG000|Overall Study|Adverse Event|4|||
49034211|NCT00446563|157960329|FG001|Overall Study|Adverse Event|3|||
49034212|NCT00446563|157960328|FG000|Overall Study|Abnormal laboratory value(s)|0|||
49034213|NCT00446563|157960329|FG001|Overall Study|Abnormal laboratory value(s)|1|||
49034214|NCT00446563|157960328|FG000|Overall Study|Abnormal test procedure result(s)|1|||
49034215|NCT00446563|157960329|FG001|Overall Study|Abnormal test procedure result(s)|0|||
49034216|NCT00446563|157960328|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
49034217|NCT00446563|157960329|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
49034218|NCT00446563|157960328|FG000|Overall Study|Withdrawal by Subject|2|||
49034219|NCT00446563|157960329|FG001|Overall Study|Withdrawal by Subject|1|||
49034220|NCT00446563|157960328|FG000|Overall Study|Administrative problems|0|||
48881922|NCT02563548|157405066|FG005|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1|||
48881923|NCT02563548|157405061|FG000|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
48881924|NCT02563548|157405062|FG001|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
48881925|NCT02563548|157405063|FG002|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
48881926|NCT02563548|157405064|FG003|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
48881927|NCT02563548|157405065|FG004|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
48881928|NCT02563548|157405066|FG005|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2|||
48881929|NCT02563548|157405061|FG000|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
48881930|NCT02563548|157405062|FG001|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
48881931|NCT02563548|157405063|FG002|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
48881932|NCT02563548|157405064|FG003|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
49034221|NCT00446563|157960329|FG001|Overall Study|Administrative problems|1|||
49034222|NCT01863745|157960335|FG000|Overall Study|Disease Progression|9|||
49034223|NCT01863745|157960335|FG000|Overall Study|Adverse Event|2|||
49034224|NCT01863745|157960335|FG000|Overall Study|Death|1|||
48881933|NCT02563548|157405065|FG004|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
48881934|NCT02563548|157405066|FG005|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2|||
48881935|NCT02563548|157405061|FG000|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
48881936|NCT02563548|157405062|FG001|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
48881937|NCT02563548|157405063|FG002|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
48881938|NCT02563548|157405064|FG003|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
48881939|NCT02563548|157405065|FG004|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
48881940|NCT02563548|157405066|FG005|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1|||
48881941|NCT02563548|157405061|FG000|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
49034225|NCT01863745|157960335|FG000|Overall Study|Withdrawal by Subject|1|||
49034226|NCT03818581|157961932|FG000|Overall Study|Adverse Event|1|||
49034227|NCT03818581|157961933|FG001|Overall Study|Adverse Event|0|||
49034228|NCT03818581|157961934|FG002|Overall Study|Adverse Event|0|||
49034229|NCT03818581|157961935|FG003|Overall Study|Adverse Event|0|||
49034230|NCT03818581|157961936|FG004|Overall Study|Adverse Event|0|||
49034231|NCT03818581|157961932|FG000|Overall Study|Covid-19|2|||
49034232|NCT03818581|157961933|FG001|Overall Study|Covid-19|0|||
48881942|NCT02563548|157405062|FG001|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
48881943|NCT02563548|157405063|FG002|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
48881944|NCT02563548|157405064|FG003|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
48881945|NCT02563548|157405065|FG004|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1|||
49034233|NCT03818581|157961934|FG002|Overall Study|Covid-19|0|||
49034234|NCT03818581|157961935|FG003|Overall Study|Covid-19|0|||
49034235|NCT03818581|157961936|FG004|Overall Study|Covid-19|1|||
48881946|NCT02563548|157405066|FG005|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
48881947|NCT00847626|157405069|FG000|Overall Study|Adverse Event|10|||
48881948|NCT00847626|157405070|FG001|Overall Study|Adverse Event|10|||
48881949|NCT00847626|157405071|FG002|Overall Study|Adverse Event|6|||
48881950|NCT00847626|157405072|FG003|Overall Study|Adverse Event|19|||
48881951|NCT00847626|157405073|FG004|Overall Study|Adverse Event|11|||
48881952|NCT00847626|157405074|FG005|Overall Study|Adverse Event|22|||
48881953|NCT00847626|157405075|FG006|Overall Study|Adverse Event|4|||
48881954|NCT00847626|157405076|FG007|Overall Study|Adverse Event|6|||
48881955|NCT00847626|157405077|FG008|Overall Study|Adverse Event|3|||
48881956|NCT00847626|157405078|FG009|Overall Study|Adverse Event|6|||
48881957|NCT00847626|157405079|FG010|Overall Study|Adverse Event|6|||
48881958|NCT00847626|157405069|FG000|Overall Study|Protocol Violation|2|||
48881959|NCT00847626|157405070|FG001|Overall Study|Protocol Violation|1|||
48881960|NCT00847626|157405071|FG002|Overall Study|Protocol Violation|2|||
48881961|NCT00847626|157405072|FG003|Overall Study|Protocol Violation|1|||
48881962|NCT00847626|157405073|FG004|Overall Study|Protocol Violation|1|||
48881963|NCT00847626|157405074|FG005|Overall Study|Protocol Violation|1|||
48881964|NCT00847626|157405075|FG006|Overall Study|Protocol Violation|1|||
48881965|NCT00847626|157405076|FG007|Overall Study|Protocol Violation|1|||
48881966|NCT00847626|157405077|FG008|Overall Study|Protocol Violation|0|||
48881967|NCT00847626|157405078|FG009|Overall Study|Protocol Violation|1|||
48881968|NCT00847626|157405079|FG010|Overall Study|Protocol Violation|1|||
48881969|NCT00847626|157405069|FG000|Overall Study|Lost to Follow-up|0|||
48881970|NCT00847626|157405070|FG001|Overall Study|Lost to Follow-up|1|||
48881971|NCT00847626|157405071|FG002|Overall Study|Lost to Follow-up|1|||
48881972|NCT00847626|157405072|FG003|Overall Study|Lost to Follow-up|1|||
48881973|NCT00847626|157405073|FG004|Overall Study|Lost to Follow-up|0|||
48881974|NCT00847626|157405074|FG005|Overall Study|Lost to Follow-up|3|||
48881975|NCT00847626|157405075|FG006|Overall Study|Lost to Follow-up|1|||
48881976|NCT00847626|157405076|FG007|Overall Study|Lost to Follow-up|3|||
48881977|NCT00847626|157405077|FG008|Overall Study|Lost to Follow-up|1|||
48881978|NCT00847626|157405078|FG009|Overall Study|Lost to Follow-up|0|||
48881979|NCT00847626|157405079|FG010|Overall Study|Lost to Follow-up|1|||
48881980|NCT00847626|157405069|FG000|Overall Study|Withdrawal by Subject|5|||
48881981|NCT00847626|157405070|FG001|Overall Study|Withdrawal by Subject|5|||
48881982|NCT00847626|157405071|FG002|Overall Study|Withdrawal by Subject|3|||
48881983|NCT00847626|157405072|FG003|Overall Study|Withdrawal by Subject|8|||
48881984|NCT00847626|157405073|FG004|Overall Study|Withdrawal by Subject|12|||
48881985|NCT00847626|157405074|FG005|Overall Study|Withdrawal by Subject|9|||
48881986|NCT00847626|157405075|FG006|Overall Study|Withdrawal by Subject|8|||
48881987|NCT00847626|157405076|FG007|Overall Study|Withdrawal by Subject|4|||
48881988|NCT00847626|157405077|FG008|Overall Study|Withdrawal by Subject|4|||
48881989|NCT00847626|157405078|FG009|Overall Study|Withdrawal by Subject|5|||
48881990|NCT00847626|157405079|FG010|Overall Study|Withdrawal by Subject|2|||
49034236|NCT03818581|157961932|FG000|Overall Study|Withdrawal by Subject|0|||
49034237|NCT03818581|157961933|FG001|Overall Study|Withdrawal by Subject|0|||
49034238|NCT03818581|157961934|FG002|Overall Study|Withdrawal by Subject|0|||
49034239|NCT03818581|157961935|FG003|Overall Study|Withdrawal by Subject|0|||
48881991|NCT00847626|157405069|FG000|Overall Study|Lack of Efficacy|3|||
48881992|NCT00847626|157405070|FG001|Overall Study|Lack of Efficacy|1|||
48881993|NCT00847626|157405071|FG002|Overall Study|Lack of Efficacy|0|||
48881994|NCT00847626|157405072|FG003|Overall Study|Lack of Efficacy|1|||
48881995|NCT00847626|157405073|FG004|Overall Study|Lack of Efficacy|2|||
48881996|NCT00847626|157405074|FG005|Overall Study|Lack of Efficacy|0|||
48881997|NCT00847626|157405075|FG006|Overall Study|Lack of Efficacy|6|||
48881998|NCT00847626|157405076|FG007|Overall Study|Lack of Efficacy|2|||
48881999|NCT00847626|157405077|FG008|Overall Study|Lack of Efficacy|5|||
48882000|NCT00847626|157405078|FG009|Overall Study|Lack of Efficacy|1|||
48882001|NCT00847626|157405079|FG010|Overall Study|Lack of Efficacy|7|||
48882002|NCT00847626|157405069|FG000|Overall Study|Other|1|||
48882003|NCT00847626|157405070|FG001|Overall Study|Other|5|||
49034240|NCT03818581|157961936|FG004|Overall Study|Withdrawal by Subject|1|||
48882004|NCT00847626|157405071|FG002|Overall Study|Other|4|||
48882005|NCT00847626|157405072|FG003|Overall Study|Other|1|||
48882006|NCT00847626|157405073|FG004|Overall Study|Other|2|||
48882007|NCT00847626|157405074|FG005|Overall Study|Other|2|||
48882008|NCT00847626|157405075|FG006|Overall Study|Other|2|||
48882009|NCT00847626|157405076|FG007|Overall Study|Other|3|||
48882010|NCT00847626|157405077|FG008|Overall Study|Other|1|||
48882011|NCT00847626|157405078|FG009|Overall Study|Other|1|||
49034241|NCT03818581|157961932|FG000|Overall Study|No longer met study criteria|0|||
49034242|NCT03818581|157961933|FG001|Overall Study|No longer met study criteria|0|||
49034243|NCT03818581|157961934|FG002|Overall Study|No longer met study criteria|0|||
49034244|NCT03818581|157961935|FG003|Overall Study|No longer met study criteria|0|||
48882012|NCT00847626|157405079|FG010|Overall Study|Other|3|||
48882013|NCT00203047|157405080|FG000|Overall Study|Ongoing: in database - January 29, 2009|131|||
48882014|NCT00203047|157405081|FG001|Overall Study|Ongoing: in database - January 29, 2009|109|||
48882015|NCT00203047|157405080|FG000|Overall Study|Ongoing: not in database - Jan 29, 2009|5|||
48882016|NCT00203047|157405081|FG001|Overall Study|Ongoing: not in database - Jan 29, 2009|1|||
48882017|NCT00203047|157405080|FG000|Overall Study|Withdrawal by Subject|13|||
48882018|NCT00203047|157405081|FG001|Overall Study|Withdrawal by Subject|47|||
48882019|NCT00203047|157405080|FG000|Overall Study|Teva requested participant withdrawal|1|||
48882020|NCT00203047|157405081|FG001|Overall Study|Teva requested participant withdrawal|1|||
48882021|NCT00203047|157405080|FG000|Overall Study|Physician Decision|8|||
48882022|NCT00203047|157405081|FG001|Overall Study|Physician Decision|7|||
48882023|NCT00203047|157405080|FG000|Overall Study|Non-compliance|4|||
48882024|NCT00203047|157405081|FG001|Overall Study|Non-compliance|8|||
48882025|NCT00203047|157405080|FG000|Overall Study|Protocol Violation|1|||
48882026|NCT00203047|157405081|FG001|Overall Study|Protocol Violation|0|||
48882027|NCT00203047|157405080|FG000|Overall Study|Lost to Follow-up|11|||
48882028|NCT00203047|157405081|FG001|Overall Study|Lost to Follow-up|5|||
48882029|NCT00203047|157405080|FG000|Overall Study|Adverse Event|8|||
48882030|NCT00203047|157405081|FG001|Overall Study|Adverse Event|18|||
48882031|NCT00203047|157405080|FG000|Overall Study|Death|1|||
48882032|NCT00203047|157405081|FG001|Overall Study|Death|2|||
48882033|NCT00203047|157405080|FG000|Overall Study|Pregnancy|3|||
48882034|NCT00203047|157405081|FG001|Overall Study|Pregnancy|0|||
48882035|NCT00203047|157405080|FG000|Overall Study|Other|5|||
48882036|NCT00203047|157405081|FG001|Overall Study|Other|5|||
48882037|NCT03057847|157405082|FG000|Overall Study|Lost to Follow-up|16|||
48882038|NCT02879383|157405085|FG000|First 24 Weeks|Physician Decision|0|||
48882039|NCT02879383|157405086|FG001|First 24 Weeks|Physician Decision|1|||
48882040|NCT02879383|157405087|FG002|First 24 Weeks|Physician Decision|0|||
48882041|NCT02879383|157405088|FG003|First 24 Weeks|Physician Decision|0|||
48882042|NCT02125279|157405091|FG000|Overall Study|Lack of Efficacy|2|||
48882043|NCT02125279|157405091|FG000|Overall Study|Withdrawal by Subject|6|||
48882044|NCT02125279|157405091|FG000|Overall Study|Protocol Violation|1|||
48882045|NCT02125279|157405091|FG000|Overall Study|Lost to Follow-up|4|||
48882046|NCT00968526|157405092|FG000|Overall Study|Adverse Event|2|||
48882047|NCT00968526|157405093|FG001|Overall Study|Adverse Event|0|||
48882048|NCT00968526|157405092|FG000|Overall Study|Migrated/moved from study area|1|||
48882049|NCT00968526|157405093|FG001|Overall Study|Migrated/moved from study area|0|||
48882050|NCT00945672|157405094|FG000|Overall Study|Withdrawal by Subject|0|||
48882051|NCT00945672|157405095|FG001|Overall Study|Withdrawal by Subject|0|||
48882052|NCT00945672|157405096|FG002|Overall Study|Withdrawal by Subject|0|||
48882053|NCT00945672|157405097|FG003|Overall Study|Withdrawal by Subject|1|||
48882054|NCT00504075|157405101|FG000|Overall Study|Adverse Event|1|||
48882055|NCT00504075|157405101|FG000|Overall Study|Lost to Follow-up|5|||
48882056|NCT00504075|157405101|FG000|Overall Study|Withdrawal by Subject|1|||
48882057|NCT00504075|157405101|FG000|Overall Study|Required other therapeutic intervention|1|||
48882058|NCT01240915|157405103|FG000|Overall Study|Adverse Event|0|||
48882059|NCT01240915|157405104|FG001|Overall Study|Adverse Event|0|||
48882060|NCT01240915|157405105|FG002|Overall Study|Adverse Event|0|||
48882061|NCT01240915|157405106|FG003|Overall Study|Adverse Event|1|||
48882062|NCT01240915|157405107|FG004|Overall Study|Adverse Event|0|||
48882063|NCT01240915|157405108|FG005|Overall Study|Adverse Event|2|||
48882064|NCT01240915|157405109|FG006|Overall Study|Adverse Event|0|||
48882065|NCT01240915|157405110|FG007|Overall Study|Adverse Event|0|||
48882066|NCT01240915|157405111|FG008|Overall Study|Adverse Event|1|||
48882067|NCT01240915|157405103|FG000|Overall Study|Lost to Follow-up|0|||
48882068|NCT01240915|157405104|FG001|Overall Study|Lost to Follow-up|0|||
48882069|NCT01240915|157405105|FG002|Overall Study|Lost to Follow-up|0|||
48882070|NCT01240915|157405106|FG003|Overall Study|Lost to Follow-up|0|||
48882071|NCT01240915|157405107|FG004|Overall Study|Lost to Follow-up|1|||
48882072|NCT01240915|157405108|FG005|Overall Study|Lost to Follow-up|1|||
49034245|NCT03818581|157961936|FG004|Overall Study|No longer met study criteria|1|||
49034246|NCT00520130|157961939|FG000|Overall Study|Disease progression on study|4|||
48882073|NCT01240915|157405109|FG006|Overall Study|Lost to Follow-up|0|||
48882074|NCT01240915|157405110|FG007|Overall Study|Lost to Follow-up|1|||
48882075|NCT01240915|157405111|FG008|Overall Study|Lost to Follow-up|1|||
48882076|NCT01240915|157405103|FG000|Overall Study|Withdrawal by Subject|2|||
48882077|NCT01240915|157405104|FG001|Overall Study|Withdrawal by Subject|1|||
49034247|NCT00520130|157961940|FG001|Overall Study|Disease progression on study|0|||
49034248|NCT00520130|157961939|FG000|Overall Study|Physician Decision|1|||
48882078|NCT01240915|157405105|FG002|Overall Study|Withdrawal by Subject|0|||
48882079|NCT01240915|157405106|FG003|Overall Study|Withdrawal by Subject|2|||
48882080|NCT01240915|157405107|FG004|Overall Study|Withdrawal by Subject|0|||
48882081|NCT01240915|157405108|FG005|Overall Study|Withdrawal by Subject|4|||
49034249|NCT00520130|157961940|FG001|Overall Study|Physician Decision|1|||
48882082|NCT01240915|157405109|FG006|Overall Study|Withdrawal by Subject|2|||
48882083|NCT01240915|157405110|FG007|Overall Study|Withdrawal by Subject|3|||
48882084|NCT01240915|157405111|FG008|Overall Study|Withdrawal by Subject|3|||
48882085|NCT01240915|157405103|FG000|Overall Study|Other|0|||
48882086|NCT01240915|157405104|FG001|Overall Study|Other|0|||
48882087|NCT01240915|157405105|FG002|Overall Study|Other|0|||
48882088|NCT01240915|157405106|FG003|Overall Study|Other|0|||
48882089|NCT01240915|157405107|FG004|Overall Study|Other|2|||
48882090|NCT01240915|157405108|FG005|Overall Study|Other|0|||
48882091|NCT01240915|157405109|FG006|Overall Study|Other|0|||
48882092|NCT01240915|157405110|FG007|Overall Study|Other|0|||
48882093|NCT01240915|157405111|FG008|Overall Study|Other|0|||
48882094|NCT01240915|157405103|FG000|Overall Study|Insufficient Clinical Response|0|||
48882095|NCT01240915|157405104|FG001|Overall Study|Insufficient Clinical Response|0|||
48882096|NCT01240915|157405105|FG002|Overall Study|Insufficient Clinical Response|0|||
48882097|NCT01240915|157405106|FG003|Overall Study|Insufficient Clinical Response|0|||
48882098|NCT01240915|157405107|FG004|Overall Study|Insufficient Clinical Response|1|||
48882099|NCT01240915|157405108|FG005|Overall Study|Insufficient Clinical Response|3|||
48882100|NCT01240915|157405109|FG006|Overall Study|Insufficient Clinical Response|6|||
48882101|NCT01240915|157405110|FG007|Overall Study|Insufficient Clinical Response|0|||
48882102|NCT01240915|157405111|FG008|Overall Study|Insufficient Clinical Response|3|||
48882103|NCT02947100|157405112|FG000|Overall Study|study terminated early|3|||
48882104|NCT02947100|157405112|FG000|Overall Study|did not meet inclusion criteria|1|||
48882105|NCT00822770|157405113|FG000|Overall Study|Not treated|1|||
48882106|NCT00822770|157405114|FG001|Overall Study|Not treated|0|||
48882107|NCT00822770|157405113|FG000|Overall Study|Complication/Incomplete treatment|1|||
48882108|NCT00822770|157405114|FG001|Overall Study|Complication/Incomplete treatment|0|||
48882109|NCT00822770|157405113|FG000|Overall Study|Death|1|||
48882110|NCT00822770|157405114|FG001|Overall Study|Death|1|||
48882111|NCT02472145|157405115|FG000|Overall Study|Death|10|||
49034250|NCT03086460|157961945|FG000|Study Participants|Lost to Follow-up|2|||
48882112|NCT02472145|157405116|FG001|Overall Study|Death|101|||
49034251|NCT03086460|157961945|FG000|Study Participants|Protocol Violation|1|||
49034252|NCT03086460|157961945|FG000|Study Participants|Withdrawal by Subject|6|||
49034253|NCT03086460|157961945|FG000|Treatment A|Lost to Follow-up|1|||
49034254|NCT03086460|157961945|FG000|Treatment A|Protocol Violation|1|||
49034255|NCT03086460|157961945|FG000|Treatment A|Withdrawal by Subject|2|||
49034256|NCT03086460|157961945|FG000|Treatment C|Withdrawal by Subject|2|||
49034257|NCT03086460|157961945|FG000|Treatment E|Lost to Follow-up|1|||
49034258|NCT03086460|157961945|FG000|Treatment E|Withdrawal by Subject|3|||
49034259|NCT02476994|157961946|FG000|Overall Study|Based on feedback from FDA|1|||
49034260|NCT02476994|157961947|FG001|Overall Study|Based on feedback from FDA|0|||
49034261|NCT05292365|157961948|FG000|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
49034262|NCT05292365|157961949|FG001|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
49034263|NCT05292365|157961950|FG002|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
49034264|NCT05292365|157961951|FG003|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
49034265|NCT00834743|157961952|FG000|Second Intervention|Withdrawal by Subject|1|||
49034266|NCT00834743|157961953|FG001|Second Intervention|Withdrawal by Subject|0|||
48882113|NCT02472145|157405117|FG002|Overall Study|Death|99|||
48882114|NCT02472145|157405115|FG000|Overall Study|Lost to Follow-up|0|||
48882115|NCT02472145|157405116|FG001|Overall Study|Lost to Follow-up|1|||
48882116|NCT02472145|157405117|FG002|Overall Study|Lost to Follow-up|0|||
48882117|NCT02472145|157405115|FG000|Overall Study|Withdrawal by Subject|0|||
48882118|NCT02472145|157405116|FG001|Overall Study|Withdrawal by Subject|9|||
48882119|NCT02472145|157405117|FG002|Overall Study|Withdrawal by Subject|13|||
48882120|NCT02472145|157405115|FG000|Overall Study|Sponsor decision|0|||
48882121|NCT02472145|157405116|FG001|Overall Study|Sponsor decision|3|||
48882122|NCT02472145|157405117|FG002|Overall Study|Sponsor decision|2|||
48882123|NCT02472145|157405115|FG000|Overall Study|Other|0|||
48882124|NCT02472145|157405116|FG001|Overall Study|Other|45|||
48882125|NCT02472145|157405117|FG002|Overall Study|Other|43|||
48882126|NCT01031628|157405118|FG000|Overall Study|Study terminated early|0|||
48882127|NCT01031628|157405119|FG001|Overall Study|Study terminated early|1|||
48882128|NCT01031628|157405120|FG002|Overall Study|Study terminated early|3|||
49034267|NCT00772603|157961954|FG000|Overall Study|Withdrawal by Subject|11|||
48882129|NCT01031628|157405121|FG003|Overall Study|Study terminated early|0|||
48882130|NCT03080493|157405122|FG000|Overall Study|Did not provide NRS pain results|1|||
48882131|NCT03080493|157405123|FG001|Overall Study|Did not provide NRS pain results|0|||
48882132|NCT03080493|157405122|FG000|Overall Study|Adverse Event|0|||
48882133|NCT03080493|157405123|FG001|Overall Study|Adverse Event|1|||
48882134|NCT03080493|157405122|FG000|Overall Study|Randomization error (parity group)|0|||
48882135|NCT03080493|157405123|FG001|Overall Study|Randomization error (parity group)|1|||
48882136|NCT03332784|157405124|FG000|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
48882137|NCT03332784|157405125|FG001|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
49034268|NCT00772603|157961955|FG001|Overall Study|Withdrawal by Subject|10|||
49034269|NCT00772603|157961956|FG002|Overall Study|Withdrawal by Subject|6|||
48882138|NCT03332784|157405126|FG002|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
48882139|NCT03332784|157405127|FG003|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
48882140|NCT03332784|157405128|FG004|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
48882141|NCT03332784|157405129|FG005|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
48882142|NCT03332784|157405130|FG006|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
48882143|NCT03332784|157405131|FG007|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
48882144|NCT03332784|157405132|FG008|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
48882145|NCT03332784|157405133|FG009|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
48882146|NCT03332784|157405134|FG010|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
48882147|NCT03332784|157405135|FG011|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
48882148|NCT03332784|157405136|FG012|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
48882149|NCT03332784|157405137|FG013|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
48882150|NCT03332784|157405138|FG014|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
48882151|NCT03332784|157405139|FG015|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
48882152|NCT03332784|157405140|FG016|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
48882153|NCT03332784|157405141|FG017|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
48882154|NCT03332784|157405142|FG018|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
48882155|NCT03332784|157405143|FG019|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
48882156|NCT03238963|157405148|FG000|Overall Study|Prohibited medication given due to hospital stay|1|||
48882157|NCT03238963|157405149|FG001|Overall Study|Prohibited medication given due to hospital stay|0|||
48882158|NCT03238963|157405148|FG000|Overall Study|Withdrawal by Subject|1|||
48882159|NCT03238963|157405149|FG001|Overall Study|Withdrawal by Subject|1|||
48882160|NCT03238963|157405148|FG000|Overall Study|Lost to Follow-up|1|||
48882161|NCT03238963|157405149|FG001|Overall Study|Lost to Follow-up|0|||
48882162|NCT03238963|157405148|FG000|Overall Study|Protocol Violation|1|||
48882163|NCT03238963|157405149|FG001|Overall Study|Protocol Violation|1|||
48882164|NCT03238963|157405148|FG000|Overall Study|Adverse Event|1|||
49034270|NCT00772603|157961954|FG000|Overall Study|Adverse Event|37|||
48882165|NCT03238963|157405149|FG001|Overall Study|Adverse Event|0|||
48882166|NCT00490698|157405152|FG000|Overall Study|Withdrawal by Subject|1|||
48882167|NCT00490698|157405152|FG000|Overall Study|Disease Progression|7|||
48882168|NCT00490698|157405152|FG000|Overall Study|Physician Decision|2|||
49034271|NCT00772603|157961955|FG001|Overall Study|Adverse Event|18|||
49034272|NCT00772603|157961956|FG002|Overall Study|Adverse Event|10|||
49034273|NCT00772603|157961954|FG000|Overall Study|Subject Non-compliance|1|||
49034274|NCT00772603|157961955|FG001|Overall Study|Subject Non-compliance|6|||
49034275|NCT00772603|157961956|FG002|Overall Study|Subject Non-compliance|4|||
49034276|NCT00772603|157961954|FG000|Overall Study|Protocol Violation|0|||
49034277|NCT00772603|157961955|FG001|Overall Study|Protocol Violation|1|||
49034278|NCT00772603|157961956|FG002|Overall Study|Protocol Violation|1|||
49034279|NCT00772603|157961954|FG000|Overall Study|Lost to Follow-up|1|||
49034280|NCT00772603|157961955|FG001|Overall Study|Lost to Follow-up|5|||
49034281|NCT00772603|157961956|FG002|Overall Study|Lost to Follow-up|2|||
49034282|NCT00772603|157961954|FG000|Overall Study|Physician Decision|0|||
49034283|NCT00772603|157961955|FG001|Overall Study|Physician Decision|0|||
49034284|NCT00772603|157961956|FG002|Overall Study|Physician Decision|1|||
49034285|NCT00772603|157961954|FG000|Overall Study|Other|2|||
49034286|NCT00772603|157961955|FG001|Overall Study|Other|0|||
49034287|NCT00772603|157961956|FG002|Overall Study|Other|2|||
49034288|NCT02563561|157961965|FG000|Overall Study|Histology Other than Ta, G1-G2|3|||
49034289|NCT02563561|157961966|FG001|Overall Study|Histology Other than Ta, G1-G2|6|||
49034290|NCT02563561|157961967|FG002|Overall Study|Histology Other than Ta, G1-G2|6|||
49034291|NCT02563561|157961965|FG000|Overall Study|Withdrew of Consent|1|||
49034292|NCT02563561|157961966|FG001|Overall Study|Withdrew of Consent|1|||
49034293|NCT02563561|157961967|FG002|Overall Study|Withdrew of Consent|2|||
48882169|NCT01040169|157405153|FG000|Overall Study|Lost to Follow-up|3|||
48882170|NCT01040169|157405154|FG001|Overall Study|Lost to Follow-up|8|||
49034294|NCT02563561|157961965|FG000|Overall Study|Lost to Follow-up|1|||
49034295|NCT02563561|157961966|FG001|Overall Study|Lost to Follow-up|1|||
49034296|NCT02563561|157961967|FG002|Overall Study|Lost to Follow-up|0|||
49034297|NCT02563561|157961965|FG000|Overall Study|Participant Had Recurrence and Received Therapy|4|||
49034298|NCT02563561|157961966|FG001|Overall Study|Participant Had Recurrence and Received Therapy|2|||
49034299|NCT02563561|157961967|FG002|Overall Study|Participant Had Recurrence and Received Therapy|1|||
49034300|NCT02563561|157961965|FG000|Overall Study|Investigator Decision|3|||
49034301|NCT02563561|157961966|FG001|Overall Study|Investigator Decision|4|||
49034302|NCT02563561|157961967|FG002|Overall Study|Investigator Decision|2|||
48882171|NCT00350727|157405157|FG000|Phase I: Dose Escalation|Adverse Event|4|||
48882172|NCT00350727|157405158|FG001|Phase I: Dose Escalation|Adverse Event|0|||
48882173|NCT00350727|157405159|FG002|Phase I: Dose Escalation|Adverse Event|0|||
49034303|NCT02563561|157961965|FG000|Overall Study|Sponsor Decision|5|||
49034304|NCT02563561|157961966|FG001|Overall Study|Sponsor Decision|2|||
49034305|NCT02563561|157961967|FG002|Overall Study|Sponsor Decision|4|||
49034306|NCT02563561|157961965|FG000|Overall Study|Other|1|||
49034307|NCT02563561|157961966|FG001|Overall Study|Other|5|||
49034308|NCT02563561|157961967|FG002|Overall Study|Other|2|||
49034309|NCT03769896|157961970|FG000|Open-label Phase|Lack of Efficacy|5|||
49034310|NCT03769896|157961971|FG001|Open-label Phase|Lack of Efficacy|0|||
49034311|NCT03769896|157961970|FG000|Open-label Phase|Adverse Event|3|||
49034312|NCT03769896|157961971|FG001|Open-label Phase|Adverse Event|0|||
49034313|NCT03769896|157961970|FG000|Open-label Phase|Withdrawal by Subject|1|||
49034314|NCT03769896|157961971|FG001|Open-label Phase|Withdrawal by Subject|0|||
48882174|NCT00350727|157405157|FG000|Phase I: Dose Escalation|Lack of Efficacy|25|||
48882175|NCT00350727|157405158|FG001|Phase I: Dose Escalation|Lack of Efficacy|0|||
48882176|NCT00350727|157405159|FG002|Phase I: Dose Escalation|Lack of Efficacy|0|||
48882177|NCT00350727|157405157|FG000|Phase I: Dose Escalation|Death|1|||
48882178|NCT00350727|157405158|FG001|Phase I: Dose Escalation|Death|0|||
48882179|NCT00350727|157405159|FG002|Phase I: Dose Escalation|Death|0|||
48882180|NCT00350727|157405157|FG000|Phase I: Dose Escalation|Physician Decision|1|||
48882181|NCT00350727|157405158|FG001|Phase I: Dose Escalation|Physician Decision|0|||
48882182|NCT00350727|157405159|FG002|Phase I: Dose Escalation|Physician Decision|0|||
48882183|NCT00350727|157405157|FG000|Phase I: Dose Escalation|Transition to Extension Phase|3|||
48882184|NCT00350727|157405158|FG001|Phase I: Dose Escalation|Transition to Extension Phase|0|||
48882185|NCT00350727|157405159|FG002|Phase I: Dose Escalation|Transition to Extension Phase|0|||
48882186|NCT00350727|157405157|FG000|Phase II|Disease Progression|0|||
48882187|NCT00350727|157405158|FG001|Phase II|Disease Progression|15|||
48882188|NCT00350727|157405159|FG002|Phase II|Disease Progression|16|||
48882189|NCT00350727|157405157|FG000|Phase II|Clinical Deterioration|0|||
49034315|NCT01015703|157961976|FG000|Overall Study|Withdrawal by Subject|0|||
49034316|NCT01015703|157961977|FG001|Overall Study|Withdrawal by Subject|1|||
49034317|NCT01015703|157961978|FG002|Overall Study|Withdrawal by Subject|0|||
49034318|NCT01015703|157961979|FG003|Overall Study|Withdrawal by Subject|0|||
49034319|NCT01015703|157961980|FG004|Overall Study|Withdrawal by Subject|0|||
49034320|NCT01015703|157961976|FG000|Overall Study|Adverse Event|1|||
49034321|NCT01015703|157961977|FG001|Overall Study|Adverse Event|0|||
49034322|NCT01015703|157961978|FG002|Overall Study|Adverse Event|0|||
49034323|NCT01015703|157961979|FG003|Overall Study|Adverse Event|0|||
49034324|NCT01015703|157961980|FG004|Overall Study|Adverse Event|0|||
49034325|NCT01015703|157961976|FG000|Overall Study|Protocol Violation|1|||
49034326|NCT01015703|157961977|FG001|Overall Study|Protocol Violation|0|||
49034327|NCT01015703|157961978|FG002|Overall Study|Protocol Violation|0|||
49034328|NCT01015703|157961979|FG003|Overall Study|Protocol Violation|0|||
49034329|NCT01015703|157961980|FG004|Overall Study|Protocol Violation|0|||
49034330|NCT01534663|157961981|FG000|Overall Study|Lost to Follow-up|0|||
49034331|NCT01534663|157961982|FG001|Overall Study|Lost to Follow-up|2|||
49034332|NCT01534663|157961981|FG000|Overall Study|Adverse Event|2|||
49034333|NCT01534663|157961982|FG001|Overall Study|Adverse Event|1|||
49034334|NCT02646124|157961986|FG000|Overall Study|Lost to Follow-up|0|||
49034335|NCT02646124|157961987|FG001|Overall Study|Lost to Follow-up|2|||
49034336|NCT01528696|157961988|FG000|Overall Study|See detailed description|18|||
48882190|NCT00350727|157405158|FG001|Phase II|Clinical Deterioration|1|||
48882191|NCT00350727|157405159|FG002|Phase II|Clinical Deterioration|0|||
48882192|NCT00350727|157405157|FG000|Phase II|Withdrawal by Subject|0|||
48882193|NCT00350727|157405158|FG001|Phase II|Withdrawal by Subject|2|||
48882194|NCT00350727|157405159|FG002|Phase II|Withdrawal by Subject|1|||
48882195|NCT00350727|157405157|FG000|Phase II|Adverse Event|0|||
48882196|NCT00350727|157405158|FG001|Phase II|Adverse Event|1|||
48882197|NCT00350727|157405159|FG002|Phase II|Adverse Event|1|||
48882198|NCT00350727|157405157|FG000|Phase II|Death|0|||
48882199|NCT00350727|157405158|FG001|Phase II|Death|0|||
48882200|NCT00350727|157405159|FG002|Phase II|Death|2|||
48882201|NCT00350727|157405157|FG000|Phase II|Sponsor Terminated Study|0|||
48882202|NCT00350727|157405158|FG001|Phase II|Sponsor Terminated Study|0|||
48882203|NCT00350727|157405159|FG002|Phase II|Sponsor Terminated Study|1|||
48882204|NCT00350727|157405157|FG000|Phase II|Enrolled in Rollover Study|0|||
48882205|NCT00350727|157405158|FG001|Phase II|Enrolled in Rollover Study|0|||
48882206|NCT00350727|157405159|FG002|Phase II|Enrolled in Rollover Study|1|||
48882207|NCT03682185|157405160|FG000|Overall Study|Lost to Follow-up|4|||
48882208|NCT03682185|157405161|FG001|Overall Study|Lost to Follow-up|7|||
49034337|NCT01528696|157961989|FG001|Overall Study|See detailed description|19|||
49034338|NCT03154047|157961995|FG000|Overall Study|Death|1|||
49034339|NCT03154047|157961995|FG000|Overall Study|Study terminated by sponsor|76|||
48882209|NCT03682185|157405162|FG002|Overall Study|Lost to Follow-up|4|||
48882210|NCT03682185|157405163|FG003|Overall Study|Lost to Follow-up|7|||
48882211|NCT03682185|157405164|FG004|Overall Study|Lost to Follow-up|1|||
48882212|NCT03682185|157405160|FG000|Overall Study|Withdrawal by Subject|7|||
49034340|NCT03154047|157961995|FG000|Overall Study|Withdrawal by Subject|3|||
48882213|NCT03682185|157405161|FG001|Overall Study|Withdrawal by Subject|3|||
48882214|NCT03682185|157405162|FG002|Overall Study|Withdrawal by Subject|7|||
48882215|NCT03682185|157405163|FG003|Overall Study|Withdrawal by Subject|3|||
48882216|NCT03682185|157405164|FG004|Overall Study|Withdrawal by Subject|0|||
49034341|NCT00857454|157961998|FG000|Overall Study|Withdrawal by Subject|2|||
49034342|NCT00857454|157961998|FG000|Overall Study|Lost to Follow-up|1|||
49034343|NCT00857454|157961998|FG000|Overall Study|Adverse Event|2|||
49034344|NCT00857454|157961998|FG000|Overall Study|Total Testosterone >1050 ng/dL|1|||
49034345|NCT00857454|157961998|FG000|Overall Study|Total Testosterone <300 ng/dL|8|||
48882217|NCT01825798|157405174|FG000|Overall Study|Adverse Event|1|||
48882218|NCT01825798|157405175|FG001|Overall Study|Adverse Event|5|||
48882219|NCT01825798|157405174|FG000|Overall Study|Lost to Follow-up|1|||
48882220|NCT01825798|157405175|FG001|Overall Study|Lost to Follow-up|0|||
48882221|NCT00971997|157406492|FG000|Overall Study|Adverse Event|2|||
48882222|NCT00971997|157406492|FG000|Overall Study|Death|1|||
48882223|NCT00971997|157406492|FG000|Overall Study|Protocol Violation|4|||
48882224|NCT00971997|157406492|FG000|Overall Study|Withdrawal by Subject|5|||
48882225|NCT00971997|157406492|FG000|Overall Study|Physician Decision|7|||
48882226|NCT02808975|157406493|FG000|Overall Study|Adverse Event|3|||
48882227|NCT02808975|157406494|FG001|Overall Study|Adverse Event|4|||
48882228|NCT02808975|157406493|FG000|Overall Study|Withdrew consent|9|||
48882229|NCT02808975|157406494|FG001|Overall Study|Withdrew consent|8|||
48882230|NCT02808975|157406493|FG000|Overall Study|Lost to Follow-up|4|||
48882231|NCT02808975|157406494|FG001|Overall Study|Lost to Follow-up|6|||
48882232|NCT02808975|157406493|FG000|Overall Study|Planned HS surgery performed prior Wk 13|1|||
48882233|NCT02808975|157406494|FG001|Overall Study|Planned HS surgery performed prior Wk 13|0|||
48882234|NCT02808975|157406493|FG000|Overall Study|Other, not specified|5|||
48882235|NCT02808975|157406494|FG001|Overall Study|Other, not specified|1|||
48882236|NCT00790400|157406497|FG000|Double-blind Period (Core Phase)|Protocol Violation|1|||
48882237|NCT00790400|157406498|FG001|Double-blind Period (Core Phase)|Protocol Violation|0|||
48882238|NCT00790400|157406497|FG000|Double-blind Period (Core Phase)|Progressive disease|0|||
48882239|NCT00790400|157406498|FG001|Double-blind Period (Core Phase)|Progressive disease|9|||
48882240|NCT00790400|157406497|FG000|Double-blind Period (Core Phase)|Adverse Event|2|||
48882241|NCT00790400|157406498|FG001|Double-blind Period (Core Phase)|Adverse Event|4|||
48882242|NCT00790400|157406497|FG000|Double-blind Period (Core Phase)|Abnormal lab value (s)|1|||
48882243|NCT00790400|157406498|FG001|Double-blind Period (Core Phase)|Abnormal lab value (s)|0|||
48882244|NCT00790400|157406497|FG000|Double-blind Period (Core Phase)|Withdrawal by Subject|1|||
48882245|NCT00790400|157406498|FG001|Double-blind Period (Core Phase)|Withdrawal by Subject|0|||
48882246|NCT00790400|157406497|FG000|Double-blind Period (Core Phase)|Administrative problems|1|||
48882247|NCT00790400|157406498|FG001|Double-blind Period (Core Phase)|Administrative problems|0|||
48882248|NCT00790400|157406497|FG000|Double-blind Period (Core Phase)|Death|1|||
48882249|NCT00790400|157406498|FG001|Double-blind Period (Core Phase)|Death|0|||
48882250|NCT00790400|157406497|FG000|Everolimus Period (Core or Extension)|Adverse Event|9|||
48882251|NCT00790400|157406498|FG001|Everolimus Period (Core or Extension)|Adverse Event|0|||
48882252|NCT00790400|157406497|FG000|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1|||
48882253|NCT00790400|157406498|FG001|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0|||
48882254|NCT00790400|157406497|FG000|Everolimus Period (Core or Extension)|Withdrawal by Subject|7|||
48882255|NCT00790400|157406498|FG001|Everolimus Period (Core or Extension)|Withdrawal by Subject|0|||
48882256|NCT00790400|157406497|FG000|Everolimus Period (Core or Extension)|Lost to Follow-up|1|||
48882257|NCT00790400|157406498|FG001|Everolimus Period (Core or Extension)|Lost to Follow-up|0|||
48882258|NCT00790400|157406497|FG000|Everolimus Period (Core or Extension)|Administrative problems|2|||
48882259|NCT00790400|157406498|FG001|Everolimus Period (Core or Extension)|Administrative problems|0|||
48882260|NCT00790400|157406497|FG000|Everolimus Period (Core or Extension)|Death|1|||
48882261|NCT00790400|157406498|FG001|Everolimus Period (Core or Extension)|Death|0|||
48882262|NCT00790400|157406497|FG000|Everolimus Period (Core or Extension)|Disease progression|5|||
48882263|NCT00790400|157406498|FG001|Everolimus Period (Core or Extension)|Disease progression|0|||
48882264|NCT00790400|157406497|FG000|Everolimus Period (Core or Extension)|Protocol Violation|1|||
48882265|NCT00790400|157406498|FG001|Everolimus Period (Core or Extension)|Protocol Violation|0|||
48882266|NCT00790400|157406497|FG000|Everolimus Period (Core or Extension)|New treatment|2|||
48882267|NCT00790400|157406498|FG001|Everolimus Period (Core or Extension)|New treatment|0|||
48882268|NCT00078338|157406499|FG000|Overall Study|Adverse Event|31|||
48882269|NCT00078338|157406500|FG001|Overall Study|Adverse Event|24|||
48882270|NCT00078338|157406499|FG000|Overall Study|Lost to Follow-up|17|||
48882271|NCT00078338|157406500|FG001|Overall Study|Lost to Follow-up|2|||
48882272|NCT00078338|157406499|FG000|Overall Study|Protocol Violation|2|||
48882273|NCT00078338|157406500|FG001|Overall Study|Protocol Violation|2|||
48882274|NCT00078338|157406499|FG000|Overall Study|Disease Progression|4|||
48882275|NCT00078338|157406500|FG001|Overall Study|Disease Progression|7|||
48882276|NCT00078338|157406499|FG000|Overall Study|Other|28|||
48882277|NCT00078338|157406500|FG001|Overall Study|Other|16|||
48882278|NCT00078338|157406499|FG000|Overall Study|Subjects randomized, but not treated|3|||
48882279|NCT00078338|157406500|FG001|Overall Study|Subjects randomized, but not treated|3|||
48882280|NCT01245140|157406501|FG000|Overall Study|Adverse Event|1|||
48882281|NCT01245140|157406502|FG001|Overall Study|Adverse Event|3|||
48882282|NCT01245140|157406501|FG000|Overall Study|Lack of Efficacy|2|||
48882283|NCT01245140|157406502|FG001|Overall Study|Lack of Efficacy|4|||
48882284|NCT01245140|157406501|FG000|Overall Study|Protocol Violation|0|||
48882285|NCT01245140|157406502|FG001|Overall Study|Protocol Violation|1|||
48882286|NCT01245140|157406501|FG000|Overall Study|Withdrawal by Subject|0|||
48882287|NCT01245140|157406502|FG001|Overall Study|Withdrawal by Subject|1|||
48882288|NCT01245140|157406501|FG000|Overall Study|Refused Treatment/Did Not Coopera|0|||
48882289|NCT01245140|157406502|FG001|Overall Study|Refused Treatment/Did Not Coopera|1|||
48882290|NCT02615509|157406505|FG000|Overall Study|Lost to Follow-up|134|||
48882291|NCT02615509|157406505|FG000|Overall Study|Death|4|||
48882292|NCT02615509|157406505|FG000|Overall Study|Withdrawal by Subject|8|||
48882293|NCT00340704|157406506|FG000|PK Study|Adverse Event|0|||
48882294|NCT00340704|157406507|FG001|PK Study|Adverse Event|1|||
49034346|NCT00857454|157961998|FG000|Overall Study|MTE09 enrollment criteria not met|6|||
48882295|NCT00340704|157406508|FG002|PK Study|Adverse Event|0|||
48882296|NCT00340704|157406509|FG003|PK Study|Adverse Event|0|||
48882297|NCT00340704|157406510|FG004|PK Study|Adverse Event|0|||
48882298|NCT00340704|157406511|FG005|PK Study|Adverse Event|0|||
49034347|NCT03904147|157962003|FG000|Overall Study|Death|15|||
49034348|NCT03904147|157962004|FG001|Overall Study|Death|13|||
49034349|NCT03904147|157962005|FG002|Overall Study|Death|15|||
49034350|NCT03904147|157962003|FG000|Overall Study|Withdrawal by Subject|7|||
49034351|NCT03904147|157962004|FG001|Overall Study|Withdrawal by Subject|12|||
49034352|NCT03904147|157962005|FG002|Overall Study|Withdrawal by Subject|1|||
49034353|NCT03904147|157962003|FG000|Overall Study|1Y visit completed after 365 days|1|||
49034354|NCT03904147|157962004|FG001|Overall Study|1Y visit completed after 365 days|1|||
49034355|NCT03904147|157962005|FG002|Overall Study|1Y visit completed after 365 days|0|||
49034356|NCT05099380|157962006|FG000|Overall Study|Subject enrolled in error|1|||
49034357|NCT05099380|157962007|FG001|Overall Study|Subject enrolled in error|0|||
49034358|NCT05099380|157962006|FG000|Overall Study|Study Procedure|1|||
49034359|NCT05099380|157962007|FG001|Overall Study|Study Procedure|0|||
49034360|NCT05099380|157962006|FG000|Overall Study|Protocol Violation|1|||
49034361|NCT05099380|157962007|FG001|Overall Study|Protocol Violation|0|||
49034362|NCT05099380|157962006|FG000|Overall Study|Adverse Event|1|||
49034363|NCT05099380|157962007|FG001|Overall Study|Adverse Event|1|||
49034364|NCT05099380|157962006|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
48882299|NCT00340704|157406512|FG006|PK Study|Adverse Event|0|||
48882300|NCT00340704|157406513|FG007|PK Study|Adverse Event|0|||
48882301|NCT00340704|157406514|FG008|PK Study|Adverse Event|0|||
48882302|NCT00340704|157406506|FG000|PK Study|Not treated|0|||
48882303|NCT00340704|157406507|FG001|PK Study|Not treated|0|||
48882304|NCT00340704|157406508|FG002|PK Study|Not treated|1|||
48882305|NCT00340704|157406509|FG003|PK Study|Not treated|0|||
48882306|NCT00340704|157406510|FG004|PK Study|Not treated|0|||
48882307|NCT00340704|157406511|FG005|PK Study|Not treated|0|||
48882308|NCT00340704|157406512|FG006|PK Study|Not treated|0|||
48882309|NCT00340704|157406513|FG007|PK Study|Not treated|0|||
48882310|NCT00340704|157406514|FG008|PK Study|Not treated|0|||
48882311|NCT00340704|157406506|FG000|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
48882312|NCT00340704|157406507|FG001|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
48882313|NCT00340704|157406508|FG002|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
48882314|NCT00340704|157406509|FG003|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2|||
48882315|NCT00340704|157406510|FG004|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4|||
49034365|NCT05099380|157962007|FG001|Overall Study|Subject no longer meets eligibility criteria|0|||
49034366|NCT00838630|157962008|FG000|First Intervention|Adverse Event|1|||
49034367|NCT00838630|157962009|FG001|First Intervention|Adverse Event|0|||
49034368|NCT00838630|157962008|FG000|Washout: 7 Days|Protocol Violation|1|||
49034369|NCT00838630|157962009|FG001|Washout: 7 Days|Protocol Violation|0|||
49034370|NCT00834340|157962012|FG000|Washout|Adverse Event|1|||
49034371|NCT00834340|157962013|FG001|Washout|Adverse Event|0|||
49034372|NCT00834340|157962012|FG000|Washout|Withdrawal by Subject|1|||
49034373|NCT00834340|157962013|FG001|Washout|Withdrawal by Subject|0|||
49034374|NCT00395694|157962014|FG000|Escalation Phase + Maintenance Phase|Adverse Event|1|||
49034375|NCT00395694|157962015|FG001|Escalation Phase + Maintenance Phase|Adverse Event|2|||
49034376|NCT00395694|157962014|FG000|Continuation Phase|Adverse Event|1|||
49034377|NCT00395694|157962015|FG001|Continuation Phase|Adverse Event|0|||
49034378|NCT00395694|157962014|FG000|Continuation Phase|Lack of Efficacy|12|||
49034379|NCT00395694|157962015|FG001|Continuation Phase|Lack of Efficacy|11|||
49034380|NCT00395694|157962014|FG000|Continuation Phase|Withdrawal Due to Wishes of Family|1|||
49034381|NCT00395694|157962015|FG001|Continuation Phase|Withdrawal Due to Wishes of Family|0|||
48882316|NCT00340704|157406511|FG005|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
48882317|NCT00340704|157406512|FG006|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
48882318|NCT00340704|157406513|FG007|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
48882319|NCT00340704|157406514|FG008|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
48882320|NCT00340704|157406506|FG000|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
48882321|NCT00340704|157406507|FG001|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
48882322|NCT00340704|157406508|FG002|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
49034382|NCT00395694|157962014|FG000|Continuation Phase|Poor Compliance|1|||
49034383|NCT00395694|157962015|FG001|Continuation Phase|Poor Compliance|0|||
49034384|NCT00395694|157962014|FG000|Continuation Phase|Withdrawal by Subject|0|||
49034385|NCT00395694|157962015|FG001|Continuation Phase|Withdrawal by Subject|2|||
49034386|NCT01648582|157962016|FG000|Overall Study|Adverse Event|6|||
49034387|NCT01648582|157962017|FG001|Overall Study|Adverse Event|11|||
48882323|NCT00340704|157406509|FG003|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
48882324|NCT00340704|157406510|FG004|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
48882325|NCT00340704|157406511|FG005|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1|||
48882326|NCT00340704|157406512|FG006|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
48882327|NCT00340704|157406513|FG007|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
48882328|NCT00340704|157406514|FG008|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
48882329|NCT00340704|157406506|FG000|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
48882330|NCT00340704|157406507|FG001|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
48882331|NCT00340704|157406508|FG002|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
48882332|NCT00340704|157406509|FG003|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
48882333|NCT00340704|157406510|FG004|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1|||
48882334|NCT00340704|157406511|FG005|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3|||
48882335|NCT00340704|157406512|FG006|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
48882336|NCT00340704|157406513|FG007|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
48882337|NCT00340704|157406514|FG008|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
48882338|NCT00340704|157406506|FG000|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
48882339|NCT00340704|157406507|FG001|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
48882340|NCT00340704|157406508|FG002|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
48882341|NCT00340704|157406509|FG003|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
48882342|NCT00340704|157406510|FG004|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
48882343|NCT00340704|157406511|FG005|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3|||
48882344|NCT00340704|157406512|FG006|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53|||
48882345|NCT00340704|157406513|FG007|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11|||
48882346|NCT00340704|157406514|FG008|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28|||
49034388|NCT01648582|157962018|FG002|Overall Study|Adverse Event|2|||
49034389|NCT01648582|157962016|FG000|Overall Study|Lost to Follow-up|9|||
49034390|NCT01648582|157962017|FG001|Overall Study|Lost to Follow-up|6|||
48882347|NCT04071301|157406515|FG000|Overall Study|Withdrawal by Subject|6|||
48882348|NCT04071301|157406515|FG000|Overall Study|Death|1|||
48882349|NCT01592045|157406518|FG000|Overall Study|Disease Progression|1|||
48882350|NCT01592045|157406519|FG001|Overall Study|Disease Progression|1|||
48882351|NCT01592045|157406518|FG000|Overall Study|Adverse Event|1|||
48882352|NCT01592045|157406519|FG001|Overall Study|Adverse Event|1|||
48882353|NCT01592045|157406518|FG000|Overall Study|Withdrawal by Subject|1|||
49034391|NCT01648582|157962018|FG002|Overall Study|Lost to Follow-up|8|||
49034392|NCT01648582|157962016|FG000|Overall Study|Protocol Violation|1|||
49034393|NCT01648582|157962017|FG001|Overall Study|Protocol Violation|2|||
49034394|NCT01648582|157962018|FG002|Overall Study|Protocol Violation|1|||
49034395|NCT01648582|157962016|FG000|Overall Study|Withdrawal by Subject|15|||
49034396|NCT01648582|157962017|FG001|Overall Study|Withdrawal by Subject|17|||
49034397|NCT01648582|157962018|FG002|Overall Study|Withdrawal by Subject|17|||
49034398|NCT01648582|157962016|FG000|Overall Study|Physician Decision|0|||
49034399|NCT01648582|157962017|FG001|Overall Study|Physician Decision|1|||
49034400|NCT01648582|157962018|FG002|Overall Study|Physician Decision|3|||
49034401|NCT01648582|157962016|FG000|Overall Study|Death|1|||
49034402|NCT01648582|157962017|FG001|Overall Study|Death|0|||
49034403|NCT01648582|157962018|FG002|Overall Study|Death|0|||
49034404|NCT01648582|157962016|FG000|Overall Study|Sponsor Decision|0|||
49034405|NCT01648582|157962017|FG001|Overall Study|Sponsor Decision|1|||
49034406|NCT01648582|157962018|FG002|Overall Study|Sponsor Decision|1|||
49034407|NCT02849457|157962019|FG000|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
49034408|NCT02849457|157962020|FG001|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
49034409|NCT02849457|157962021|FG002|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|12|||
49034410|NCT02849457|157962022|FG003|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
49034411|NCT00392665|157962023|FG000|Overall Study|Death|16|||
49034412|NCT00392665|157962024|FG001|Overall Study|Death|14|||
49034413|NCT00392665|157962023|FG000|Overall Study|Lost to Follow-up|1|||
49034414|NCT00392665|157962024|FG001|Overall Study|Lost to Follow-up|1|||
49034415|NCT01959672|157962028|FG000|Overall Study|Death|1|||
49034416|NCT01058668|157962032|FG000|Double-blind Treatment Phase|Adverse Event|8|||
49034417|NCT01058668|157962033|FG001|Double-blind Treatment Phase|Adverse Event|15|||
49034418|NCT01058668|157962034|FG002|Double-blind Treatment Phase|Adverse Event|25|||
48882354|NCT01592045|157406519|FG001|Overall Study|Withdrawal by Subject|0|||
49034419|NCT01058668|157962032|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|15|||
49034420|NCT01058668|157962033|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|2|||
49034421|NCT01058668|157962034|FG002|Double-blind Treatment Phase|Insufficient Therapeutic Response|5|||
49034422|NCT01058668|157962032|FG000|Double-blind Treatment Phase|Protocol Violation|1|||
48882355|NCT01592045|157406518|FG000|Overall Study|Moved out of country|2|||
48882356|NCT01592045|157406519|FG001|Overall Study|Moved out of country|0|||
48882357|NCT03994731|157406520|FG000|Pegloticase + IMM Period|Death|2|||
48882358|NCT03994731|157406521|FG001|Pegloticase + IMM Period|Death|0|||
48882359|NCT03994731|157406520|FG000|Pegloticase + IMM Period|Lost to Follow-up|3|||
48882360|NCT03994731|157406521|FG001|Pegloticase + IMM Period|Lost to Follow-up|6|||
48882361|NCT03994731|157406520|FG000|Pegloticase + IMM Period|Withdrawal by Subject|15|||
48882362|NCT03994731|157406521|FG001|Pegloticase + IMM Period|Withdrawal by Subject|9|||
48882363|NCT01252355|157406526|FG000|Overall Study|Adverse Event|9|||
48882364|NCT01252355|157406527|FG001|Overall Study|Adverse Event|17|||
48882365|NCT01252355|157406528|FG002|Overall Study|Adverse Event|22|||
48882366|NCT01252355|157406526|FG000|Overall Study|Lack of Efficacy|6|||
48882367|NCT01252355|157406527|FG001|Overall Study|Lack of Efficacy|4|||
48882368|NCT01252355|157406528|FG002|Overall Study|Lack of Efficacy|2|||
48882369|NCT01252355|157406526|FG000|Overall Study|Lost to Follow-up|0|||
48882370|NCT01252355|157406527|FG001|Overall Study|Lost to Follow-up|0|||
48882371|NCT01252355|157406528|FG002|Overall Study|Lost to Follow-up|1|||
48882372|NCT01252355|157406526|FG000|Overall Study|Poor Compliance to Protocol|1|||
48882373|NCT01252355|157406527|FG001|Overall Study|Poor Compliance to Protocol|1|||
48882374|NCT01252355|157406528|FG002|Overall Study|Poor Compliance to Protocol|1|||
48882375|NCT01252355|157406526|FG000|Overall Study|Progressive Disease|2|||
48882376|NCT01252355|157406527|FG001|Overall Study|Progressive Disease|0|||
48882377|NCT01252355|157406528|FG002|Overall Study|Progressive Disease|0|||
48882378|NCT01252355|157406526|FG000|Overall Study|Sponsor Early Termination of Study|149|||
48882379|NCT01252355|157406527|FG001|Overall Study|Sponsor Early Termination of Study|149|||
48882380|NCT01252355|157406528|FG002|Overall Study|Sponsor Early Termination of Study|146|||
48882381|NCT01252355|157406526|FG000|Overall Study|Randomized but not Treated|2|||
48882382|NCT01252355|157406527|FG001|Overall Study|Randomized but not Treated|0|||
48882383|NCT01252355|157406528|FG002|Overall Study|Randomized but not Treated|0|||
48882384|NCT01252355|157406526|FG000|Overall Study|Other Than Above|8|||
48882385|NCT01252355|157406527|FG001|Overall Study|Other Than Above|7|||
48882386|NCT01252355|157406528|FG002|Overall Study|Other Than Above|7|||
48882387|NCT00955708|157406529|FG000|Overall Study|Death|269|||
48882388|NCT00955708|157406529|FG000|Overall Study|Lost to Follow-up|72|||
48882389|NCT00955708|157406529|FG000|Overall Study|Physician Decision|36|||
48882390|NCT00955708|157406529|FG000|Overall Study|Protocol Violation|134|||
48882391|NCT00955708|157406529|FG000|Overall Study|Registry Conclusion|186|||
48882392|NCT00955708|157406529|FG000|Overall Study|Product removed from service|94|||
48882393|NCT00955708|157406529|FG000|Overall Study|Patient Refused to participate further|116|||
48882394|NCT00955708|157406529|FG000|Overall Study|Closure of study location|60|||
48882395|NCT00955708|157406529|FG000|Overall Study|Patient changed care provider/moved|91|||
48882396|NCT01736540|157406530|FG000|Overall Study|Did not complete scan within 45 days|2|||
48882397|NCT01736540|157406530|FG000|Overall Study|Death|1|||
48882398|NCT01736540|157406530|FG000|Overall Study|Abnormal test procedure|1|||
48882399|NCT01736540|157406530|FG000|Overall Study|Withdrawal by Subject|5|||
48882400|NCT01736540|157406530|FG000|Overall Study|Protocol Violation|1|||
48882401|NCT01736540|157406530|FG000|Overall Study|Unable to tolerate MRI; claustrophobic|1|||
48882402|NCT01736540|157406530|FG000|Overall Study|No show for MRI appointment|1|||
48882403|NCT01736540|157406530|FG000|Overall Study|Unable to make MRI appointment|3|||
48882404|NCT02993523|157406537|FG000|Overall Study|Withdrew Consent|0|||
48882405|NCT02993523|157406538|FG001|Overall Study|Withdrew Consent|0|||
48882406|NCT02993523|157406539|FG002|Overall Study|Withdrew Consent|2|||
48882407|NCT02993523|157406540|FG003|Overall Study|Withdrew Consent|9|||
48882408|NCT02993523|157406541|FG004|Overall Study|Withdrew Consent|0|||
48882409|NCT02993523|157406537|FG000|Overall Study|Lost to Follow-up|0|||
48882410|NCT02993523|157406538|FG001|Overall Study|Lost to Follow-up|0|||
48882411|NCT02993523|157406539|FG002|Overall Study|Lost to Follow-up|3|||
48882412|NCT02993523|157406540|FG003|Overall Study|Lost to Follow-up|6|||
48882413|NCT02993523|157406541|FG004|Overall Study|Lost to Follow-up|0|||
48882414|NCT02993523|157406537|FG000|Overall Study|Death|1|||
48882415|NCT02993523|157406538|FG001|Overall Study|Death|1|||
48882416|NCT02993523|157406539|FG002|Overall Study|Death|138|||
48882417|NCT02993523|157406540|FG003|Overall Study|Death|222|||
48882418|NCT02993523|157406541|FG004|Overall Study|Death|6|||
48882419|NCT02993523|157406537|FG000|Overall Study|Reason not Specified|0|||
48882420|NCT02993523|157406538|FG001|Overall Study|Reason not Specified|0|||
48882421|NCT02993523|157406539|FG002|Overall Study|Reason not Specified|1|||
48882422|NCT02993523|157406540|FG003|Overall Study|Reason not Specified|1|||
48882423|NCT02993523|157406541|FG004|Overall Study|Reason not Specified|0|||
48882424|NCT00790205|157406542|FG000|Overall Study|Lost to Follow-up|61|||
48882425|NCT00790205|157406543|FG001|Overall Study|Lost to Follow-up|71|||
48882426|NCT00790205|157406542|FG000|Overall Study|Withdrawal by Subject|299|||
48882427|NCT00790205|157406543|FG001|Overall Study|Withdrawal by Subject|363|||
48882428|NCT01712061|157406544|FG000|Overall Study|Adverse Event|4|||
48882429|NCT01712061|157406545|FG001|Overall Study|Adverse Event|9|||
48882430|NCT01712061|157406546|FG002|Overall Study|Adverse Event|5|||
48882431|NCT01712061|157406544|FG000|Overall Study|Death|0|||
48882432|NCT01712061|157406545|FG001|Overall Study|Death|0|||
48882433|NCT01712061|157406546|FG002|Overall Study|Death|1|||
48882434|NCT01712061|157406544|FG000|Overall Study|Lost to Follow-up|1|||
48882435|NCT01712061|157406545|FG001|Overall Study|Lost to Follow-up|0|||
48882436|NCT01712061|157406546|FG002|Overall Study|Lost to Follow-up|1|||
48882437|NCT01712061|157406544|FG000|Overall Study|Did Not Meet Entrance Criteria|4|||
48882438|NCT01712061|157406545|FG001|Overall Study|Did Not Meet Entrance Criteria|6|||
48882439|NCT01712061|157406546|FG002|Overall Study|Did Not Meet Entrance Criteria|3|||
48882440|NCT01712061|157406544|FG000|Overall Study|Medication Error Without Associated AE|0|||
48882441|NCT01712061|157406545|FG001|Overall Study|Medication Error Without Associated AE|1|||
48882442|NCT01712061|157406546|FG002|Overall Study|Medication Error Without Associated AE|0|||
48882443|NCT01712061|157406544|FG000|Overall Study|Withdrawal by Subject|1|||
48882444|NCT01712061|157406545|FG001|Overall Study|Withdrawal by Subject|7|||
48882445|NCT01712061|157406546|FG002|Overall Study|Withdrawal by Subject|1|||
48882446|NCT01712061|157406544|FG000|Overall Study|Other|0|||
48882447|NCT01712061|157406545|FG001|Overall Study|Other|3|||
48882448|NCT01712061|157406546|FG002|Overall Study|Other|0|||
48882449|NCT02593123|157406547|FG000|Overall Study|Physician Decision|2|||
48882450|NCT02593123|157406548|FG001|Overall Study|Physician Decision|1|||
48882451|NCT02593123|157406547|FG000|Overall Study|Relapse|1|||
48882452|NCT02593123|157406548|FG001|Overall Study|Relapse|1|||
48882453|NCT01081886|157406550|FG000|Overall Study|Study termination|11|||
48882454|NCT01081886|157406551|FG001|Overall Study|Study termination|13|||
48882455|NCT01371825|157406556|FG000|Overall Study|Death|4|||
48882456|NCT02614183|157406557|FG000|Double Blind Treatment Phase|Adverse Event|10|||
48882457|NCT02614183|157406558|FG001|Double Blind Treatment Phase|Adverse Event|9|||
48882458|NCT02614183|157406559|FG002|Double Blind Treatment Phase|Adverse Event|7|||
48882459|NCT02614183|157406557|FG000|Double Blind Treatment Phase|Lack of Efficacy|10|||
48882460|NCT02614183|157406558|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
48882461|NCT02614183|157406559|FG002|Double Blind Treatment Phase|Lack of Efficacy|2|||
48882462|NCT02614183|157406557|FG000|Double Blind Treatment Phase|Lost to Follow-up|18|||
48882463|NCT02614183|157406558|FG001|Double Blind Treatment Phase|Lost to Follow-up|9|||
48882464|NCT02614183|157406559|FG002|Double Blind Treatment Phase|Lost to Follow-up|5|||
48882465|NCT02614183|157406557|FG000|Double Blind Treatment Phase|Physician Decision|7|||
48882466|NCT02614183|157406558|FG001|Double Blind Treatment Phase|Physician Decision|3|||
48882467|NCT02614183|157406559|FG002|Double Blind Treatment Phase|Physician Decision|2|||
48882468|NCT02614183|157406557|FG000|Double Blind Treatment Phase|Pregnancy|2|||
48882469|NCT02614183|157406558|FG001|Double Blind Treatment Phase|Pregnancy|1|||
48882470|NCT02614183|157406559|FG002|Double Blind Treatment Phase|Pregnancy|3|||
48882471|NCT02614183|157406557|FG000|Double Blind Treatment Phase|Protocol Violation|2|||
48882472|NCT02614183|157406558|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
48882473|NCT02614183|157406559|FG002|Double Blind Treatment Phase|Protocol Violation|2|||
48882474|NCT02614183|157406557|FG000|Double Blind Treatment Phase|Withdrawal by Subject|33|||
48882475|NCT02614183|157406558|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
48882476|NCT02614183|157406559|FG002|Double Blind Treatment Phase|Withdrawal by Subject|16|||
48882477|NCT02614183|157406557|FG000|Double Blind Treatment Phase|Did not receive study drug|1|||
48882478|NCT02614183|157406558|FG001|Double Blind Treatment Phase|Did not receive study drug|1|||
48882479|NCT02614183|157406559|FG002|Double Blind Treatment Phase|Did not receive study drug|2|||
48882480|NCT02614183|157406557|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
48882481|NCT02614183|157406558|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
48882482|NCT02614183|157406559|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
48882483|NCT02614183|157406557|FG000|Post Treatment Follow-up Phase|Physician Decision|5|||
48882484|NCT02614183|157406558|FG001|Post Treatment Follow-up Phase|Physician Decision|1|||
48882485|NCT02614183|157406559|FG002|Post Treatment Follow-up Phase|Physician Decision|2|||
48882486|NCT02614183|157406557|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
48882487|NCT02614183|157406558|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
48882488|NCT02614183|157406559|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
48882489|NCT02614183|157406557|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|7|||
48882490|NCT02614183|157406558|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|2|||
48882491|NCT02614183|157406559|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
48882492|NCT05262751|157406560|FG000|Washout Period 2|Adverse Event|1|||
48882493|NCT05262751|157406561|FG001|Washout Period 2|Adverse Event|0|||
48882494|NCT05262751|157406562|FG002|Washout Period 2|Adverse Event|0|||
48882495|NCT05262751|157406563|FG003|Washout Period 2|Adverse Event|0|||
48882496|NCT05262751|157406564|FG004|Washout Period 2|Adverse Event|0|||
48882497|NCT05262751|157406565|FG005|Washout Period 2|Adverse Event|0|||
48882498|NCT05262751|157406560|FG000|Treatment Period 3|Not treated because of an adverse event|0|||
48882499|NCT05262751|157406561|FG001|Treatment Period 3|Not treated because of an adverse event|1|||
48882500|NCT05262751|157406562|FG002|Treatment Period 3|Not treated because of an adverse event|0|||
48882501|NCT05262751|157406563|FG003|Treatment Period 3|Not treated because of an adverse event|0|||
48882502|NCT05262751|157406564|FG004|Treatment Period 3|Not treated because of an adverse event|0|||
48882503|NCT05262751|157406565|FG005|Treatment Period 3|Not treated because of an adverse event|0|||
48882504|NCT03819634|157406566|FG000|Overall Study|Physician Decision|2|||
48882505|NCT01261000|157406567|FG000|Overall Study|Screen failure|1|||
48882506|NCT03690427|157406568|FG000|Overall Study|Requested by subject not to complete traditional hookah|0|||
48882507|NCT03690427|157406569|FG001|Overall Study|Requested by subject not to complete traditional hookah|2|||
48882508|NCT01727505|157406570|FG000|First 24 Hours|Adverse Event|0|||
48882509|NCT01727505|157406571|FG001|First 24 Hours|Adverse Event|1|||
48882510|NCT01727505|157406570|FG000|Second 24 Hours|Missing data|0|||
48882511|NCT01727505|157406571|FG001|Second 24 Hours|Missing data|1|||
48882512|NCT00504777|157406572|FG000|Overall Study|Adverse Event|1|||
48882513|NCT02878603|157406574|FG000|Overall Study|Lost to Follow-up|4|||
48882514|NCT02878603|157406575|FG001|Overall Study|Lost to Follow-up|1|||
48882515|NCT02878603|157406574|FG000|Overall Study|Withdrawal by Subject|1|||
48882516|NCT02878603|157406575|FG001|Overall Study|Withdrawal by Subject|1|||
48882517|NCT02878603|157406574|FG000|Overall Study|Death|1|||
48882518|NCT02878603|157406575|FG001|Overall Study|Death|0|||
48882519|NCT02878603|157406574|FG000|Overall Study|Physician Decision|0|||
48882520|NCT02878603|157406575|FG001|Overall Study|Physician Decision|3|||
48882521|NCT00416195|157406576|FG000|Overall Study|Adverse Event|1|||
48882522|NCT00416195|157406577|FG001|Overall Study|Adverse Event|2|||
48882523|NCT00416195|157406576|FG000|Overall Study|Protocol Violation|1|||
48882524|NCT00416195|157406577|FG001|Overall Study|Protocol Violation|1|||
48882525|NCT00416195|157406576|FG000|Overall Study|Other|0|||
48882526|NCT00416195|157406577|FG001|Overall Study|Other|1|||
48882527|NCT04674189|157406579|FG000|Overall Study|Adverse Event|0|||
48882528|NCT04674189|157406580|FG001|Overall Study|Adverse Event|0|||
48882529|NCT04674189|157406581|FG002|Overall Study|Adverse Event|1|||
48882530|NCT04674189|157406579|FG000|Overall Study|Received Alternative Authorized Vaccine|0|||
48882531|NCT04674189|157406580|FG001|Overall Study|Received Alternative Authorized Vaccine|1|||
48882532|NCT04674189|157406581|FG002|Overall Study|Received Alternative Authorized Vaccine|17|||
48882533|NCT04674189|157406579|FG000|Overall Study|Physician Decision|1|||
48882534|NCT04674189|157406580|FG001|Overall Study|Physician Decision|0|||
48882535|NCT04674189|157406581|FG002|Overall Study|Physician Decision|0|||
48882536|NCT04674189|157406579|FG000|Overall Study|Withdrawal by Participant|83|||
48882537|NCT04674189|157406580|FG001|Overall Study|Withdrawal by Participant|71|||
48882538|NCT04674189|157406581|FG002|Overall Study|Withdrawal by Participant|142|||
48882539|NCT04674189|157406579|FG000|Overall Study|Lost to Follow-up|55|||
48882540|NCT04674189|157406580|FG001|Overall Study|Lost to Follow-up|53|||
48882541|NCT04674189|157406581|FG002|Overall Study|Lost to Follow-up|44|||
48882542|NCT04674189|157406579|FG000|Overall Study|Miscellaneous|27|||
48882543|NCT04674189|157406580|FG001|Overall Study|Miscellaneous|23|||
48882544|NCT04674189|157406581|FG002|Overall Study|Miscellaneous|207|||
48882545|NCT04674189|157406579|FG000|Overall Study|Did Not Receive Treatment|3|||
48882546|NCT04674189|157406580|FG001|Overall Study|Did Not Receive Treatment|1|||
48882547|NCT04674189|157406581|FG002|Overall Study|Did Not Receive Treatment|2|||
48882548|NCT01564277|157406582|FG000|Overall Study|Protocol Violation|0|||
48882549|NCT01564277|157406583|FG001|Overall Study|Protocol Violation|1|||
48882550|NCT01564277|157406582|FG000|Overall Study|Physician Decision|1|||
48882551|NCT01564277|157406583|FG001|Overall Study|Physician Decision|0|||
48882552|NCT01637077|157406584|FG000|Overall Study|Cancel|1|||
48882553|NCT01637077|157406585|FG001|Overall Study|Cancel|1|||
48882554|NCT01637077|157406584|FG000|Overall Study|Withdrawal by Subject|1|||
48882555|NCT01637077|157406585|FG001|Overall Study|Withdrawal by Subject|0|||
48882556|NCT01637077|157406584|FG000|Overall Study|No cycle 1 questionnaire data|2|||
48882557|NCT01637077|157406585|FG001|Overall Study|No cycle 1 questionnaire data|0|||
48882558|NCT01572740|157406586|FG000|Overall Study|Adverse Event|1|||
48882559|NCT01572740|157406587|FG001|Overall Study|Adverse Event|1|||
48882560|NCT01572740|157406586|FG000|Overall Study|Withdrawal by Subject|1|||
48882561|NCT01572740|157406587|FG001|Overall Study|Withdrawal by Subject|1|||
48882562|NCT01572740|157406586|FG000|Overall Study|unclassified|4|||
48882563|NCT01572740|157406587|FG001|Overall Study|unclassified|3|||
48882564|NCT00401258|157406590|FG000|Overall Study|Adverse Event|7|||
48882565|NCT00757627|157406591|FG000|Overall Study|Adverse Event|15|||
48882566|NCT00757627|157406591|FG000|Overall Study|Lack of Efficacy|10|||
48882567|NCT00757627|157406591|FG000|Overall Study|Lost to Follow-up|28|||
48983626|NCT00355615|157772318|FG003|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
48983627|NCT00355615|157772319|FG004|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3|||
48983628|NCT00355615|157772315|FG000|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
48983629|NCT00355615|157772316|FG001|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
48983630|NCT00355615|157772317|FG002|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
48983631|NCT00355615|157772318|FG003|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
48882568|NCT00757627|157406591|FG000|Overall Study|Withdrawal by Subject|27|||
48882569|NCT00757627|157406591|FG000|Overall Study|Other|1|||
48882570|NCT02336425|157406593|FG000|Overall Study|Study terminated.|2|||
48882571|NCT02336425|157406594|FG001|Overall Study|Study terminated.|2|||
48882572|NCT02336425|157406595|FG002|Overall Study|Study terminated.|3|||
48882573|NCT02336425|157406596|FG003|Overall Study|Study terminated.|3|||
48882574|NCT01067846|157406597|FG000|Overall Study|Lost to Follow-up|17|||
48882575|NCT01067846|157406598|FG001|Overall Study|Lost to Follow-up|19|||
48882576|NCT01067846|157406597|FG000|Overall Study|Withdrawal by Subject|1|||
48882577|NCT01067846|157406598|FG001|Overall Study|Withdrawal by Subject|0|||
48882578|NCT01067846|157406597|FG000|Overall Study|participation in other tx study|1|||
48882579|NCT01067846|157406598|FG001|Overall Study|participation in other tx study|0|||
48882580|NCT02833077|157406600|FG000|Overall Study|Adverse Event|1|||
48882581|NCT02833077|157406601|FG001|Overall Study|Adverse Event|2|||
48882582|NCT02833077|157406600|FG000|Overall Study|Lost to Follow-up|10|||
48882583|NCT02833077|157406601|FG001|Overall Study|Lost to Follow-up|1|||
48882584|NCT02833077|157406600|FG000|Overall Study|Personal Reasons|6|||
48882585|NCT02833077|157406601|FG001|Overall Study|Personal Reasons|4|||
48882586|NCT02833077|157406600|FG000|Overall Study|Protocol Deviation|0|||
48882587|NCT02833077|157406601|FG001|Overall Study|Protocol Deviation|1|||
48882588|NCT01782690|157406602|FG000|Overall Study|Not reported|7|||
48882589|NCT01782690|157406602|FG000|Overall Study|Toxicity of gemcitabine|1|||
48882590|NCT01782690|157406602|FG000|Overall Study|Toxicity of erlotinib|1|||
48882591|NCT01782690|157406602|FG000|Overall Study|Lost to Follow-up|31|||
48882592|NCT01782690|157406602|FG000|Overall Study|Withdrawal of informed consent|2|||
48882593|NCT01782690|157406602|FG000|Overall Study|Absent rash|9|||
48882594|NCT01782690|157406602|FG000|Overall Study|Physician Decision|13|||
48882595|NCT01782690|157406602|FG000|Overall Study|Patient's wish|21|||
48882596|NCT01782690|157406602|FG000|Overall Study|Tumor progression|74|||
48882597|NCT01782690|157406602|FG000|Overall Study|Death|133|||
48882598|NCT01782690|157406602|FG000|Overall Study|Study completion unknown|7|||
48882599|NCT00277095|157406603|FG000|Overall Study|Death|2|||
48882600|NCT00277095|157406603|FG000|Overall Study|Explanted|7|||
48882601|NCT00277095|157406603|FG000|Overall Study|Lost to Follow-up|2|||
48882602|NCT00277095|157406603|FG000|Overall Study|Missed Follow-up|9|||
48882603|NCT00277095|157406603|FG000|Overall Study|Physician Decision|1|||
48882604|NCT02592876|157406606|FG000|Overall Study|Withdrawal by Subject|3|||
48882605|NCT02592876|157406607|FG001|Overall Study|Withdrawal by Subject|3|||
48882606|NCT02592876|157406606|FG000|Overall Study|Study Termination by Sponsor|32|||
48882607|NCT02592876|157406607|FG001|Overall Study|Study Termination by Sponsor|27|||
48882608|NCT02592876|157406606|FG000|Overall Study|Lost to Follow-up|0|||
49034423|NCT01058668|157962033|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
48882609|NCT02592876|157406607|FG001|Overall Study|Lost to Follow-up|1|||
48882610|NCT02592876|157406606|FG000|Overall Study|Death|6|||
48882611|NCT02592876|157406607|FG001|Overall Study|Death|9|||
48882612|NCT01638390|157407721|FG000|Overall Study|screening failures|21|||
48882613|NCT00078377|157407722|FG000|Overall Study|Adverse Event|2|||
48882614|NCT00078377|157407723|FG001|Overall Study|Adverse Event|5|||
48882615|NCT00078377|157407724|FG002|Overall Study|Adverse Event|1|||
48882616|NCT00078377|157407722|FG000|Overall Study|Lack of Efficacy|2|||
48882617|NCT00078377|157407723|FG001|Overall Study|Lack of Efficacy|0|||
48882618|NCT00078377|157407724|FG002|Overall Study|Lack of Efficacy|2|||
48882619|NCT00078377|157407722|FG000|Overall Study|Lost to Follow-up|0|||
48882620|NCT00078377|157407723|FG001|Overall Study|Lost to Follow-up|1|||
48882621|NCT00078377|157407724|FG002|Overall Study|Lost to Follow-up|1|||
48882622|NCT00078377|157407722|FG000|Overall Study|Physician Decision|2|||
48882623|NCT00078377|157407723|FG001|Overall Study|Physician Decision|0|||
48882624|NCT00078377|157407724|FG002|Overall Study|Physician Decision|0|||
48882625|NCT00078377|157407722|FG000|Overall Study|Withdrawal by Subject|3|||
48882626|NCT00078377|157407723|FG001|Overall Study|Withdrawal by Subject|4|||
48882627|NCT00078377|157407724|FG002|Overall Study|Withdrawal by Subject|4|||
48882628|NCT00078377|157407722|FG000|Overall Study|Miscellaneous|2|||
48882629|NCT00078377|157407723|FG001|Overall Study|Miscellaneous|6|||
48882630|NCT00078377|157407724|FG002|Overall Study|Miscellaneous|1|||
48882631|NCT00129935|157407725|FG000|Overall Study|Adverse Event|18|||
48882632|NCT00129935|157407726|FG001|Overall Study|Adverse Event|56|||
48882633|NCT00129935|157407725|FG000|Overall Study|Death|1|||
48882634|NCT00129935|157407726|FG001|Overall Study|Death|1|||
48882635|NCT00129935|157407725|FG000|Overall Study|Withdrawal by Subject|7|||
48882636|NCT00129935|157407726|FG001|Overall Study|Withdrawal by Subject|20|||
48882637|NCT00129935|157407725|FG000|Overall Study|Protocol Violation|0|||
48882638|NCT00129935|157407726|FG001|Overall Study|Protocol Violation|4|||
48882639|NCT00129935|157407725|FG000|Overall Study|Physician Decision|3|||
48882640|NCT00129935|157407726|FG001|Overall Study|Physician Decision|4|||
48882641|NCT00129935|157407725|FG000|Overall Study|Recurrence|1|||
49034424|NCT01058668|157962034|FG002|Double-blind Treatment Phase|Protocol Violation|2|||
48882642|NCT00129935|157407726|FG001|Overall Study|Recurrence|3|||
48882643|NCT00129935|157407725|FG000|Overall Study|Second primary|0|||
48882644|NCT00129935|157407726|FG001|Overall Study|Second primary|1|||
48882645|NCT00129935|157407725|FG000|Overall Study|Other|3|||
48882646|NCT00129935|157407726|FG001|Overall Study|Other|2|||
48882647|NCT00129935|157407725|FG000|Overall Study|Crossed to the other arm|2|||
48882648|NCT00129935|157407726|FG001|Overall Study|Crossed to the other arm|1|||
48882649|NCT00129935|157407725|FG000|Overall Study|Incorrect study treatment|1|||
48882650|NCT00129935|157407726|FG001|Overall Study|Incorrect study treatment|0|||
48882651|NCT02354651|157407727|FG000|Overall Study|Withdrawal by Subject|2|||
49034425|NCT01058668|157962032|FG000|Double-blind Treatment Phase|Withdrawal of Consent|14|||
49034426|NCT01058668|157962033|FG001|Double-blind Treatment Phase|Withdrawal of Consent|18|||
49034427|NCT01058668|157962034|FG002|Double-blind Treatment Phase|Withdrawal of Consent|17|||
49034428|NCT01058668|157962032|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
49034429|NCT01058668|157962033|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
49034430|NCT01058668|157962034|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
49034431|NCT01058668|157962032|FG000|Double-blind Treatment Phase|Other Unspecified|1|||
49034432|NCT01058668|157962033|FG001|Double-blind Treatment Phase|Other Unspecified|1|||
49034433|NCT01058668|157962034|FG002|Double-blind Treatment Phase|Other Unspecified|0|||
48882652|NCT02354651|157407727|FG000|Overall Study|Physician Decision|1|||
48882653|NCT01381575|157407731|FG000|Overall Study|Serious Adverse Event|1|||
48882654|NCT01381575|157407732|FG001|Overall Study|Serious Adverse Event|0|||
48882655|NCT01381575|157407733|FG002|Overall Study|Serious Adverse Event|0|||
48882656|NCT01381575|157407731|FG000|Overall Study|Non-Serious Adverse Event|0|||
48882657|NCT01381575|157407732|FG001|Overall Study|Non-Serious Adverse Event|0|||
48882658|NCT01381575|157407733|FG002|Overall Study|Non-Serious Adverse Event|1|||
48882659|NCT01381575|157407731|FG000|Overall Study|Protocol Violation|0|||
48882660|NCT01381575|157407732|FG001|Overall Study|Protocol Violation|1|||
48882661|NCT01381575|157407733|FG002|Overall Study|Protocol Violation|1|||
48882662|NCT01381575|157407731|FG000|Overall Study|Withdrawal by Subject|15|||
48882663|NCT01381575|157407732|FG001|Overall Study|Withdrawal by Subject|9|||
48882664|NCT01381575|157407733|FG002|Overall Study|Withdrawal by Subject|7|||
48882665|NCT01381575|157407731|FG000|Overall Study|Migrated/moved from study area|2|||
48882666|NCT01381575|157407732|FG001|Overall Study|Migrated/moved from study area|12|||
48882667|NCT01381575|157407733|FG002|Overall Study|Migrated/moved from study area|2|||
48882668|NCT01381575|157407731|FG000|Overall Study|Lost to Follow-up|8|||
48882669|NCT01381575|157407732|FG001|Overall Study|Lost to Follow-up|17|||
48882670|NCT01381575|157407733|FG002|Overall Study|Lost to Follow-up|9|||
48882671|NCT00725712|157407734|FG000|Overall Study|Withdrawal by Subject|2|||
48882672|NCT00725712|157407735|FG001|Overall Study|Withdrawal by Subject|1|||
48882673|NCT00725712|157407734|FG000|Overall Study|Protocol Violation|1|||
48882674|NCT00725712|157407735|FG001|Overall Study|Protocol Violation|0|||
48882675|NCT00725712|157407734|FG000|Overall Study|Progressive disease|37|||
48882676|NCT00725712|157407735|FG001|Overall Study|Progressive disease|16|||
48882677|NCT00725712|157407734|FG000|Overall Study|Clinical progression not based on RECIST|0|||
48882678|NCT00725712|157407735|FG001|Overall Study|Clinical progression not based on RECIST|3|||
48882679|NCT00725712|157407734|FG000|Overall Study|Adverse Event|5|||
48882680|NCT00725712|157407735|FG001|Overall Study|Adverse Event|5|||
48882681|NCT00725712|157407734|FG000|Overall Study|Death|2|||
48882682|NCT00725712|157407735|FG001|Overall Study|Death|0|||
48882683|NCT00725712|157407734|FG000|Overall Study|Other: Death|1|||
48882684|NCT00725712|157407735|FG001|Overall Study|Other: Death|0|||
48882685|NCT00725712|157407734|FG000|Overall Study|Hospitalized, unable to continue|0|||
48882686|NCT00725712|157407735|FG001|Overall Study|Hospitalized, unable to continue|1|||
48882687|NCT00132678|157407736|FG000|Period II (Open-Label Oral Risperidone)|Death|0|||
48882688|NCT00132678|157407737|FG001|Period II (Open-Label Oral Risperidone)|Death|0|||
48882689|NCT00132678|157407738|FG002|Period II (Open-Label Oral Risperidone)|Death|1|||
48882690|NCT00132678|157407736|FG000|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
48882691|NCT00132678|157407737|FG001|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
48882692|NCT00132678|157407738|FG002|Period II (Open-Label Oral Risperidone)|Adverse Event|13|||
48882693|NCT00132678|157407736|FG000|Period II (Open-Label Oral Risperidone)|Non responder|0|||
48882694|NCT00132678|157407737|FG001|Period II (Open-Label Oral Risperidone)|Non responder|0|||
48882695|NCT00132678|157407738|FG002|Period II (Open-Label Oral Risperidone)|Non responder|6|||
48882696|NCT00132678|157407736|FG000|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
48882697|NCT00132678|157407737|FG001|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
49034434|NCT00545792|157962037|FG000|Overall Study|Withdrawal by Subject|1|||
49034435|NCT03437265|157962038|FG000|Overall Study|Protocol Violation|6|||
48882698|NCT00132678|157407738|FG002|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7|||
48882699|NCT00132678|157407736|FG000|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
48882700|NCT00132678|157407737|FG001|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
48882701|NCT00132678|157407738|FG002|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14|||
48882702|NCT00132678|157407736|FG000|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
48882703|NCT00132678|157407737|FG001|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
48882704|NCT00132678|157407738|FG002|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16|||
48882705|NCT00132678|157407736|FG000|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
48882706|NCT00132678|157407737|FG001|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
48882707|NCT00132678|157407738|FG002|Period II (Open-Label Oral Risperidone)|Physician Decision|1|||
48882708|NCT00132678|157407736|FG000|Period III (Open-Label Stabilization)|Death|2|||
48882709|NCT00132678|157407737|FG001|Period III (Open-Label Stabilization)|Death|0|||
49034436|NCT02294786|157962041|FG000|Overall Study|Withdrawal by Subject|0|||
49034437|NCT02294786|157962042|FG001|Overall Study|Withdrawal by Subject|1|||
48882710|NCT00132678|157407738|FG002|Period III (Open-Label Stabilization)|Death|0|||
48882711|NCT00132678|157407736|FG000|Period III (Open-Label Stabilization)|Adverse Event|12|||
48882712|NCT00132678|157407737|FG001|Period III (Open-Label Stabilization)|Adverse Event|0|||
48882713|NCT00132678|157407738|FG002|Period III (Open-Label Stabilization)|Adverse Event|0|||
48882714|NCT00132678|157407736|FG000|Period III (Open-Label Stabilization)|Non responder|107|||
48882715|NCT00132678|157407737|FG001|Period III (Open-Label Stabilization)|Non responder|0|||
48882716|NCT00132678|157407738|FG002|Period III (Open-Label Stabilization)|Non responder|0|||
48882717|NCT00132678|157407736|FG000|Period III (Open-Label Stabilization)|Ineligible to continue trial|5|||
48882718|NCT00132678|157407737|FG001|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
48882719|NCT00132678|157407738|FG002|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
48882720|NCT00132678|157407736|FG000|Period III (Open-Label Stabilization)|Lost to Follow-up|19|||
48882721|NCT00132678|157407737|FG001|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
48882722|NCT00132678|157407738|FG002|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
48882723|NCT00132678|157407736|FG000|Period III (Open-Label Stabilization)|Withdrawal by Subject|49|||
48882724|NCT00132678|157407737|FG001|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
48882725|NCT00132678|157407738|FG002|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
48882726|NCT00132678|157407736|FG000|Period III (Open-Label Stabilization)|Subject non-compliant|1|||
48882727|NCT00132678|157407737|FG001|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
48882728|NCT00132678|157407738|FG002|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
48882729|NCT00132678|157407736|FG000|Period III (Open-Label Stabilization)|Physician Decision|1|||
48882730|NCT00132678|157407737|FG001|Period III (Open-Label Stabilization)|Physician Decision|0|||
48882731|NCT00132678|157407738|FG002|Period III (Open-Label Stabilization)|Physician Decision|0|||
48882732|NCT00132678|157407736|FG000|Period III (Open-Label Stabilization)|Pregnancy|2|||
48882733|NCT00132678|157407737|FG001|Period III (Open-Label Stabilization)|Pregnancy|0|||
48882734|NCT00132678|157407738|FG002|Period III (Open-Label Stabilization)|Pregnancy|0|||
48882735|NCT00132678|157407736|FG000|Period IV (Double-Blind Treatment)|Adverse Event|1|||
48882736|NCT00132678|157407737|FG001|Period IV (Double-Blind Treatment)|Adverse Event|1|||
48882737|NCT00132678|157407738|FG002|Period IV (Double-Blind Treatment)|Adverse Event|0|||
48882738|NCT00132678|157407736|FG000|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
48882739|NCT00132678|157407737|FG001|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
48882740|NCT00132678|157407738|FG002|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0|||
48882741|NCT00132678|157407736|FG000|Period IV (Double-Blind Treatment)|Lost to Follow-up|6|||
48882742|NCT00132678|157407737|FG001|Period IV (Double-Blind Treatment)|Lost to Follow-up|3|||
48882743|NCT00132678|157407738|FG002|Period IV (Double-Blind Treatment)|Lost to Follow-up|0|||
48882744|NCT00132678|157407736|FG000|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14|||
48882745|NCT00132678|157407737|FG001|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15|||
48882746|NCT00132678|157407738|FG002|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0|||
48882747|NCT00132678|157407736|FG000|Period IV (Double-Blind Treatment)|Physician Decision|10|||
48882748|NCT00132678|157407737|FG001|Period IV (Double-Blind Treatment)|Physician Decision|14|||
48882749|NCT00132678|157407738|FG002|Period IV (Double-Blind Treatment)|Physician Decision|0|||
48882750|NCT00132678|157407736|FG000|Period IV (Double-Blind Treatment)|Subject Non-compliant|2|||
48882751|NCT00132678|157407737|FG001|Period IV (Double-Blind Treatment)|Subject Non-compliant|1|||
48882752|NCT00132678|157407738|FG002|Period IV (Double-Blind Treatment)|Subject Non-compliant|0|||
48882753|NCT00132678|157407736|FG000|Period IV (Double-Blind Treatment)|Pregnancy|0|||
48882754|NCT00132678|157407737|FG001|Period IV (Double-Blind Treatment)|Pregnancy|2|||
48882755|NCT00132678|157407738|FG002|Period IV (Double-Blind Treatment)|Pregnancy|0|||
48882756|NCT03896581|157407741|FG000|Overall Study|Other (Covid-19 Pandemic Circumstances)|1|||
48882757|NCT03896581|157407742|FG001|Overall Study|Other (Covid-19 Pandemic Circumstances)|0|||
48882758|NCT03896581|157407741|FG000|Overall Study|Withdrawal by Subject|4|||
48882759|NCT03896581|157407742|FG001|Overall Study|Withdrawal by Subject|1|||
48882760|NCT03896581|157407741|FG000|Overall Study|Lost to Follow-up|1|||
48882761|NCT03896581|157407742|FG001|Overall Study|Lost to Follow-up|0|||
48882762|NCT03896581|157407741|FG000|Overall Study|Lack of Efficacy|2|||
48882763|NCT03896581|157407742|FG001|Overall Study|Lack of Efficacy|1|||
48882764|NCT03896581|157407741|FG000|Overall Study|Adverse event, non-fatal|0|||
48882765|NCT03896581|157407742|FG001|Overall Study|Adverse event, non-fatal|2|||
48882766|NCT02522728|157407746|FG000|Overall Study|Withdrawal by Subject|6|||
48882767|NCT02522728|157407747|FG001|Overall Study|Withdrawal by Subject|6|||
48882768|NCT02522728|157407746|FG000|Overall Study|Death|4|||
48882769|NCT02522728|157407747|FG001|Overall Study|Death|3|||
48882770|NCT02522728|157407746|FG000|Overall Study|Adverse Event|2|||
48882771|NCT02522728|157407747|FG001|Overall Study|Adverse Event|1|||
48882772|NCT02522728|157407746|FG000|Overall Study|Did not receive randomized study device|0|||
49034438|NCT02294786|157962041|FG000|Overall Study|Physician Decision|6|||
49034439|NCT02294786|157962042|FG001|Overall Study|Physician Decision|7|||
48882773|NCT02522728|157407747|FG001|Overall Study|Did not receive randomized study device|1|||
48882774|NCT00879775|157407748|FG000|Overall Study|Lost to Follow-up|2|||
48882775|NCT00879775|157407749|FG001|Overall Study|Lost to Follow-up|1|||
48882776|NCT03019640|157407750|FG000|Overall Study|Screen Failures|4|||
48882777|NCT03019640|157407750|FG000|Overall Study|Adverse Event|3|||
48882778|NCT03019640|157407750|FG000|Overall Study|Participant Relapsed|1|||
48882779|NCT02609672|157407751|FG000|Overall Study|Lost to Follow-up|3|||
48882780|NCT02609672|157407752|FG001|Overall Study|Lost to Follow-up|1|||
48882781|NCT01154140|157407753|FG000|Overall Study|Death|71|||
48882782|NCT01154140|157407754|FG001|Overall Study|Death|81|||
48882783|NCT01154140|157407753|FG000|Overall Study|Lost to Follow-up|4|||
48882784|NCT01154140|157407754|FG001|Overall Study|Lost to Follow-up|5|||
48882785|NCT01154140|157407753|FG000|Overall Study|Withdrawal by Subject|12|||
48882786|NCT01154140|157407754|FG001|Overall Study|Withdrawal by Subject|13|||
48882787|NCT01154140|157407753|FG000|Overall Study|Other|3|||
48882788|NCT01154140|157407754|FG001|Overall Study|Other|1|||
48882789|NCT01154140|157407753|FG000|Overall Study|Randomized but not treated|1|||
48882790|NCT01154140|157407754|FG001|Overall Study|Randomized but not treated|2|||
48882791|NCT01424813|157407755|FG000|Overall Study|Withdrawal by Subject|3|||
48882792|NCT01424813|157407756|FG001|Overall Study|Withdrawal by Subject|0|||
48882793|NCT01424813|157407755|FG000|Overall Study|Protocol Violation|1|||
48882794|NCT01424813|157407756|FG001|Overall Study|Protocol Violation|0|||
48882795|NCT01424813|157407755|FG000|Overall Study|Other|1|||
48882796|NCT01424813|157407756|FG001|Overall Study|Other|2|||
48882797|NCT01358331|157407757|FG000|Overall Study|Lost to Follow-up|0|||
48882798|NCT01358331|157407758|FG001|Overall Study|Lost to Follow-up|0|||
48882799|NCT01358331|157407759|FG002|Overall Study|Lost to Follow-up|0|||
48882800|NCT01358331|157407760|FG003|Overall Study|Lost to Follow-up|1|||
48882801|NCT01358331|157407761|FG004|Overall Study|Lost to Follow-up|0|||
48882802|NCT01358331|157407762|FG005|Overall Study|Lost to Follow-up|0|||
48882803|NCT01358331|157407757|FG000|Overall Study|Withdrawal by Subject|0|||
48882804|NCT01358331|157407758|FG001|Overall Study|Withdrawal by Subject|0|||
48882805|NCT01358331|157407759|FG002|Overall Study|Withdrawal by Subject|0|||
48882806|NCT01358331|157407760|FG003|Overall Study|Withdrawal by Subject|1|||
48882807|NCT01358331|157407761|FG004|Overall Study|Withdrawal by Subject|1|||
48882808|NCT01358331|157407762|FG005|Overall Study|Withdrawal by Subject|1|||
48882809|NCT01358331|157407757|FG000|Overall Study|Adverse Events|1|||
48882810|NCT01358331|157407758|FG001|Overall Study|Adverse Events|1|||
48882811|NCT01358331|157407759|FG002|Overall Study|Adverse Events|1|||
48882812|NCT01358331|157407760|FG003|Overall Study|Adverse Events|0|||
48882813|NCT01358331|157407761|FG004|Overall Study|Adverse Events|1|||
48882814|NCT01358331|157407762|FG005|Overall Study|Adverse Events|5|||
48882815|NCT01358331|157407757|FG000|Overall Study|Symptomatic Deterioration|0|||
48882816|NCT01358331|157407758|FG001|Overall Study|Symptomatic Deterioration|0|||
48882817|NCT01358331|157407759|FG002|Overall Study|Symptomatic Deterioration|0|||
48882818|NCT01358331|157407760|FG003|Overall Study|Symptomatic Deterioration|0|||
48882819|NCT01358331|157407761|FG004|Overall Study|Symptomatic Deterioration|1|||
48882820|NCT01358331|157407762|FG005|Overall Study|Symptomatic Deterioration|0|||
48882821|NCT01358331|157407757|FG000|Overall Study|Participants did not wish to continue|0|||
48882822|NCT01358331|157407758|FG001|Overall Study|Participants did not wish to continue|0|||
48882823|NCT01358331|157407759|FG002|Overall Study|Participants did not wish to continue|0|||
48882824|NCT01358331|157407760|FG003|Overall Study|Participants did not wish to continue|0|||
48882825|NCT01358331|157407761|FG004|Overall Study|Participants did not wish to continue|1|||
48882826|NCT01358331|157407762|FG005|Overall Study|Participants did not wish to continue|0|||
48882827|NCT01358331|157407757|FG000|Overall Study|Progress of disease under investigation|1|||
48882828|NCT01358331|157407758|FG001|Overall Study|Progress of disease under investigation|2|||
48882829|NCT01358331|157407759|FG002|Overall Study|Progress of disease under investigation|3|||
48882830|NCT01358331|157407760|FG003|Overall Study|Progress of disease under investigation|1|||
48882831|NCT01358331|157407761|FG004|Overall Study|Progress of disease under investigation|3|||
48882832|NCT01358331|157407762|FG005|Overall Study|Progress of disease under investigation|0|||
48882833|NCT01417104|157407763|FG000|Overall Study|Withdrawal by Subject|5|||
48882834|NCT01417104|157407764|FG001|Overall Study|Withdrawal by Subject|1|||
48882835|NCT01417104|157407763|FG000|Overall Study|Failure to make contact|0|||
48882836|NCT01417104|157407764|FG001|Overall Study|Failure to make contact|1|||
48882837|NCT01417104|157407763|FG000|Overall Study|Adverse Event|1|||
48882838|NCT01417104|157407764|FG001|Overall Study|Adverse Event|0|||
48882839|NCT00513708|157407765|FG000|Overall Study|Lost to Follow-up|4|||
48882840|NCT00513708|157407766|FG001|Overall Study|Lost to Follow-up|4|||
48882841|NCT00513708|157407767|FG002|Overall Study|Lost to Follow-up|4|||
48882842|NCT00953615|157407771|FG000|Overall Study|Adverse Event|1|||
48882843|NCT01110408|157407778|FG000|Overall Study|Protocol Violation|1|||
48882844|NCT01110408|157407779|FG001|Overall Study|Protocol Violation|0|||
48882845|NCT01038427|157407782|FG000|Overall Study|Lost to follow up|1|||
48882846|NCT01038427|157407783|FG001|Overall Study|Lost to follow up|1|||
48882847|NCT01038427|157407784|FG002|Overall Study|Lost to follow up|0|||
48882848|NCT01038427|157407782|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
48882849|NCT01038427|157407783|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
48882850|NCT01038427|157407784|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
48882851|NCT01038427|157407782|FG000|Overall Study|Withdrew consent|0|||
48882852|NCT01038427|157407783|FG001|Overall Study|Withdrew consent|0|||
48882853|NCT01038427|157407784|FG002|Overall Study|Withdrew consent|1|||
48882854|NCT01038427|157407782|FG000|Overall Study|Adverse Event|2|||
48882855|NCT01038427|157407783|FG001|Overall Study|Adverse Event|2|||
48882856|NCT01038427|157407784|FG002|Overall Study|Adverse Event|1|||
48882857|NCT01038427|157407782|FG000|Overall Study|Enrolled in error|0|||
48882858|NCT01038427|157407783|FG001|Overall Study|Enrolled in error|1|||
48882859|NCT01038427|157407784|FG002|Overall Study|Enrolled in error|1|||
48882860|NCT01038427|157407782|FG000|Overall Study|Other|0|||
48882861|NCT01038427|157407783|FG001|Overall Study|Other|2|||
48882862|NCT01038427|157407784|FG002|Overall Study|Other|0|||
48882863|NCT00604708|157407787|FG000|Overall Study|Withdrawal by Subject|9|||
48882864|NCT00604708|157407788|FG001|Overall Study|Withdrawal by Subject|10|||
48882865|NCT00604708|157407787|FG000|Overall Study|Protocol Violation|2|||
48882866|NCT00604708|157407788|FG001|Overall Study|Protocol Violation|8|||
48882867|NCT00604708|157407787|FG000|Overall Study|Lost to Follow-up|5|||
48882868|NCT00604708|157407788|FG001|Overall Study|Lost to Follow-up|5|||
48882869|NCT00604708|157407787|FG000|Overall Study|administrative reasons|9|||
48882870|NCT00604708|157407788|FG001|Overall Study|administrative reasons|11|||
48882871|NCT00604708|157407787|FG000|Overall Study|Adverse Event|6|||
48882872|NCT00604708|157407788|FG001|Overall Study|Adverse Event|6|||
48882873|NCT02202785|157407790|FG000|Overall Study|Study Terminated by Sponsor|1|||
48882874|NCT02202785|157407791|FG001|Overall Study|Study Terminated by Sponsor|6|||
48882875|NCT02202785|157407792|FG002|Overall Study|Study Terminated by Sponsor|4|||
48882876|NCT02202785|157407790|FG000|Overall Study|Withdrawal by Subject|0|||
48882877|NCT02202785|157407791|FG001|Overall Study|Withdrawal by Subject|1|||
48882878|NCT02202785|157407792|FG002|Overall Study|Withdrawal by Subject|0|||
48882879|NCT02202785|157407790|FG000|Overall Study|Lost to Follow-up|0|||
48882880|NCT02202785|157407791|FG001|Overall Study|Lost to Follow-up|1|||
48882881|NCT02202785|157407792|FG002|Overall Study|Lost to Follow-up|0|||
48882882|NCT02202785|157407790|FG000|Overall Study|Reason not Specified|10|||
48882883|NCT02202785|157407791|FG001|Overall Study|Reason not Specified|7|||
48882884|NCT02202785|157407792|FG002|Overall Study|Reason not Specified|13|||
48882885|NCT02807883|157407802|FG000|Overall Study|Withdrawal by Subject|2|||
48882886|NCT00846807|157407805|FG000|Overall Study|Adverse Event|270|||
48882887|NCT00846807|157407805|FG000|Overall Study|Lost to Follow-up|94|||
48882888|NCT00846807|157407805|FG000|Overall Study|Withdrawal by Subject|56|||
48882889|NCT00846807|157407805|FG000|Overall Study|Non compliant with European label|7|||
48882890|NCT00846807|157407805|FG000|Overall Study|Switch to other anticoagulants|89|||
48882891|NCT00846807|157407805|FG000|Overall Study|No prescription after hospital discharge|56|||
48882892|NCT00846807|157407805|FG000|Overall Study|Other|60|||
48882893|NCT00996606|157407806|FG000|Overall Study|Adverse Event or Intercurrent Illness|2|||
48882894|NCT00996606|157407806|FG000|Overall Study|Insufficient Therapeutic Response|2|||
48882895|NCT00996606|157407806|FG000|Overall Study|Protocol Violation|1|||
48882896|NCT00996606|157407806|FG000|Overall Study|Withdrawal by Subject|3|||
48882897|NCT00972322|157407807|FG000|Overall Study|Adverse Event|2|||
48882898|NCT00972322|157407808|FG001|Overall Study|Adverse Event|1|||
48882899|NCT00972322|157407807|FG000|Overall Study|Positive drug screen|0|||
48882900|NCT00972322|157407808|FG001|Overall Study|Positive drug screen|1|||
48882901|NCT00972322|157407807|FG000|Overall Study|Lost to Follow-up|0|||
48882902|NCT00972322|157407808|FG001|Overall Study|Lost to Follow-up|1|||
48882903|NCT00972322|157407807|FG000|Overall Study|Consistently high glucose values|1|||
48882904|NCT00972322|157407808|FG001|Overall Study|Consistently high glucose values|0|||
48882905|NCT00607724|157407817|FG000|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7|||
48882906|NCT00607724|157407818|FG001|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8|||
48882907|NCT00607724|157407819|FG002|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4|||
48882908|NCT00607724|157407820|FG003|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
48882909|NCT00607724|157407821|FG004|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
48882910|NCT00607724|157407822|FG005|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
48882911|NCT00607724|157407823|FG006|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
48882912|NCT00607724|157407817|FG000|Stage 2: Expanded Cohort|Adverse Event|0|||
48882913|NCT00607724|157407818|FG001|Stage 2: Expanded Cohort|Adverse Event|0|||
48882914|NCT00607724|157407819|FG002|Stage 2: Expanded Cohort|Adverse Event|0|||
48882915|NCT00607724|157407820|FG003|Stage 2: Expanded Cohort|Adverse Event|0|||
48882916|NCT00607724|157407821|FG004|Stage 2: Expanded Cohort|Adverse Event|0|||
48882917|NCT00607724|157407822|FG005|Stage 2: Expanded Cohort|Adverse Event|0|||
48882918|NCT00607724|157407823|FG006|Stage 2: Expanded Cohort|Adverse Event|1|||
48882919|NCT00607724|157407817|FG000|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
48882920|NCT00607724|157407818|FG001|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
48882921|NCT00607724|157407819|FG002|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
48882922|NCT00607724|157407820|FG003|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4|||
48882923|NCT00607724|157407821|FG004|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8|||
49034440|NCT02294786|157962041|FG000|Overall Study|Lost to Follow-up|1|||
48882924|NCT00607724|157407822|FG005|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11|||
48882925|NCT00607724|157407823|FG006|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10|||
48882926|NCT00607724|157407817|FG000|Stage 2: Expanded Cohort|Physician Decision|0|||
48882927|NCT00607724|157407818|FG001|Stage 2: Expanded Cohort|Physician Decision|0|||
48882928|NCT00607724|157407819|FG002|Stage 2: Expanded Cohort|Physician Decision|0|||
48882929|NCT00607724|157407820|FG003|Stage 2: Expanded Cohort|Physician Decision|0|||
48882930|NCT00607724|157407821|FG004|Stage 2: Expanded Cohort|Physician Decision|1|||
48882931|NCT00607724|157407822|FG005|Stage 2: Expanded Cohort|Physician Decision|1|||
48882932|NCT00607724|157407823|FG006|Stage 2: Expanded Cohort|Physician Decision|0|||
48882933|NCT00607724|157407817|FG000|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
48882934|NCT00607724|157407818|FG001|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
48882935|NCT00607724|157407819|FG002|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
48882936|NCT00607724|157407820|FG003|Stage 2: Expanded Cohort|Withdrawal by Subject|1|||
48882937|NCT00607724|157407821|FG004|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
48882938|NCT00607724|157407822|FG005|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
48882939|NCT00607724|157407823|FG006|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
48882940|NCT01241604|157407824|FG000|Screening Period|Screen Failure|3|||
48882941|NCT01241604|157407825|FG001|Screening Period|Screen Failure|0|||
48882942|NCT01241604|157407826|FG002|Screening Period|Screen Failure|0|||
48882943|NCT03548220|157407827|FG000|Overall Study|Lost to Follow-up|1|||
48882944|NCT03548220|157407828|FG001|Overall Study|Lost to Follow-up|0|||
48882945|NCT03548220|157407829|FG002|Overall Study|Lost to Follow-up|0|||
48882946|NCT03548220|157407830|FG003|Overall Study|Lost to Follow-up|0|||
48882947|NCT00611975|157407831|FG000|Overall Study|Withdrawal by Subject|3|||
48882948|NCT00611975|157407832|FG001|Overall Study|Withdrawal by Subject|7|||
48882949|NCT00611975|157407831|FG000|Overall Study|Pregnancy|2|||
48882950|NCT00611975|157407832|FG001|Overall Study|Pregnancy|1|||
48882951|NCT01435772|157407833|FG000|Overall Study|Adverse Event|1|||
48882952|NCT01435772|157407834|FG001|Overall Study|Adverse Event|0|||
48882953|NCT01435772|157407835|FG002|Overall Study|Adverse Event|2|||
48882954|NCT01435772|157407833|FG000|Overall Study|Withdrawal by Subject|0|||
48882955|NCT01435772|157407834|FG001|Overall Study|Withdrawal by Subject|1|||
48882956|NCT01435772|157407835|FG002|Overall Study|Withdrawal by Subject|3|||
48882957|NCT01435772|157407833|FG000|Overall Study|Other - study termination|2|||
48882958|NCT01435772|157407834|FG001|Overall Study|Other - study termination|2|||
48882959|NCT01435772|157407835|FG002|Overall Study|Other - study termination|10|||
48882960|NCT01008553|157408924|FG000|Period 1 (Titration Period)|Physician Decision|2|||
48882961|NCT01008553|157408925|FG001|Period 1 (Titration Period)|Physician Decision|0|||
48882962|NCT01008553|157408926|FG002|Period 1 (Titration Period)|Physician Decision|0|||
48882963|NCT01008553|157408924|FG000|Period 1 (Titration Period)|Adverse Event|33|||
48882964|NCT01008553|157408925|FG001|Period 1 (Titration Period)|Adverse Event|0|||
48882965|NCT01008553|157408926|FG002|Period 1 (Titration Period)|Adverse Event|0|||
48882966|NCT01008553|157408924|FG000|Period 1 (Titration Period)|Withdrawal by Subject|6|||
48882967|NCT01008553|157408925|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
48882968|NCT01008553|157408926|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
48882969|NCT01008553|157408924|FG000|Period 1 (Titration Period)|Determined to increase dosage|3|||
48882970|NCT01008553|157408925|FG001|Period 1 (Titration Period)|Determined to increase dosage|0|||
48882971|NCT01008553|157408926|FG002|Period 1 (Titration Period)|Determined to increase dosage|0|||
48882972|NCT01008553|157408924|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50|||
48882973|NCT01008553|157408925|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
48882974|NCT01008553|157408926|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
48882975|NCT01008553|157408924|FG000|Period 1 (Titration Period)|Not appropriate for this study|1|||
48882976|NCT01008553|157408925|FG001|Period 1 (Titration Period)|Not appropriate for this study|0|||
48882977|NCT01008553|157408926|FG002|Period 1 (Titration Period)|Not appropriate for this study|0|||
48882978|NCT01008553|157408924|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
48882979|NCT01008553|157408925|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
48882980|NCT01008553|157408926|FG002|Period 2 (Double-Blind Period)|Physician Decision|2|||
48882981|NCT01008553|157408924|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
48882982|NCT01008553|157408925|FG001|Period 2 (Double-Blind Period)|Adverse Event|14|||
48882983|NCT01008553|157408926|FG002|Period 2 (Double-Blind Period)|Adverse Event|4|||
48882984|NCT01008553|157408924|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
48882985|NCT01008553|157408925|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
48882986|NCT01008553|157408926|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
48882987|NCT01008553|157408924|FG000|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
48882988|NCT01008553|157408925|FG001|Period 2 (Double-Blind Period)|Impossible to perform required tests|1|||
48882989|NCT01008553|157408926|FG002|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
48882990|NCT01008553|157408924|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
48882991|NCT01008553|157408925|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1|||
48882992|NCT01008553|157408926|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4|||
48882993|NCT01008553|157408924|FG000|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
49034441|NCT02294786|157962042|FG001|Overall Study|Lost to Follow-up|2|||
48882994|NCT01008553|157408925|FG001|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
48882995|NCT01008553|157408926|FG002|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3|||
48882996|NCT01008553|157408924|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
48882997|NCT01008553|157408925|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
48882998|NCT01008553|157408926|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
48882999|NCT01008553|157408924|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
48883000|NCT01008553|157408925|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18|||
48883001|NCT01008553|157408926|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35|||
48883002|NCT03563716|157408930|FG000|Overall Study|Death|20|||
48883003|NCT03563716|157408931|FG001|Overall Study|Death|14|||
48883004|NCT03563716|157408930|FG000|Overall Study|Withdrawal by Subject|3|||
48883005|NCT03563716|157408931|FG001|Overall Study|Withdrawal by Subject|3|||
48883006|NCT03563716|157408930|FG000|Overall Study|Still on Study|45|||
48883007|NCT03563716|157408931|FG001|Overall Study|Still on Study|50|||
48883008|NCT05816551|157408934|FG000|Overall Study|Withdrawal by Subject|0|||
48883009|NCT05816551|157408935|FG001|Overall Study|Withdrawal by Subject|1|||
48883010|NCT05816551|157408934|FG000|Overall Study|Withdrawn by Primary Investigator|3|||
48883011|NCT05816551|157408935|FG001|Overall Study|Withdrawn by Primary Investigator|0|||
48883012|NCT04783935|157408938|FG000|Overall Study|Withdrawal by Subject|6|||
48883013|NCT04783935|157408938|FG000|Overall Study|PROGRESSIVE DISEASE|2|||
48883014|NCT04783935|157408938|FG000|Overall Study|PATIENT HAS MOVED AND GOES TO ANOTHER HOSPITAL|1|||
48883015|NCT04783935|157408938|FG000|Overall Study|Lost to Follow-up|3|||
48883016|NCT04783935|157408938|FG000|Overall Study|PROTOCOL NON-COMPLIANCE|1|||
48883017|NCT05273749|157408939|FG000|Overall Study|Adverse Event|14|||
48883018|NCT05273749|157408940|FG001|Overall Study|Adverse Event|8|||
48883019|NCT05273749|157408939|FG000|Overall Study|Lack of Efficacy|2|||
48883020|NCT05273749|157408940|FG001|Overall Study|Lack of Efficacy|8|||
48883021|NCT05273749|157408939|FG000|Overall Study|Physician Decision|0|||
48883022|NCT05273749|157408940|FG001|Overall Study|Physician Decision|2|||
48883023|NCT05273749|157408939|FG000|Overall Study|Withdrawal by Subject|14|||
48883024|NCT05273749|157408940|FG001|Overall Study|Withdrawal by Subject|16|||
48883025|NCT05273749|157408939|FG000|Overall Study|Lost to Follow-up|10|||
48883026|NCT05273749|157408940|FG001|Overall Study|Lost to Follow-up|10|||
48883027|NCT05273749|157408939|FG000|Overall Study|Pregnancy|1|||
48883028|NCT05273749|157408940|FG001|Overall Study|Pregnancy|0|||
48883029|NCT05273749|157408939|FG000|Overall Study|Non-Compliance|3|||
48883030|NCT05273749|157408940|FG001|Overall Study|Non-Compliance|2|||
48883031|NCT05273749|157408939|FG000|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|0|||
48883032|NCT05273749|157408940|FG001|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|1|||
48883033|NCT01594827|157408943|FG000|Overall Study|Adverse Event|1|||
48883034|NCT01594827|157408944|FG001|Overall Study|Adverse Event|0|||
48883035|NCT01594827|157408943|FG000|Overall Study|Physician Decision|3|||
48883036|NCT01594827|157408944|FG001|Overall Study|Physician Decision|0|||
48883037|NCT01736189|157408945|FG000|Overall Study|Violation of registration criteria|41|||
48883038|NCT01736189|157408945|FG000|Overall Study|Protocol Violation|4|||
48883039|NCT01736189|157408945|FG000|Overall Study|Criteria and protocol violations|1|||
48883040|NCT04179500|157408946|FG000|Treatment|Withdrawal by Subject|1|||
48883041|NCT04179500|157408946|FG000|Treatment|Adverse Event|2|||
48883042|NCT04179500|157408946|FG000|Treatment|pyrazinamide resistance|1|||
48883043|NCT03274453|157408956|FG000|Overall Study|Lost to Follow-up|2|||
48883044|NCT03274453|157408957|FG001|Overall Study|Lost to Follow-up|5|||
48883045|NCT03274453|157408958|FG002|Overall Study|Lost to Follow-up|4|||
48883046|NCT03274453|157408959|FG003|Overall Study|Lost to Follow-up|1|||
48883047|NCT03274453|157408956|FG000|Overall Study|Physician Decision|2|||
48883048|NCT03274453|157408957|FG001|Overall Study|Physician Decision|0|||
48883049|NCT03274453|157408958|FG002|Overall Study|Physician Decision|0|||
48883050|NCT03274453|157408959|FG003|Overall Study|Physician Decision|3|||
48883051|NCT03274453|157408956|FG000|Overall Study|Surgery Cancelled|0|||
48883052|NCT03274453|157408957|FG001|Overall Study|Surgery Cancelled|1|||
48883053|NCT03274453|157408958|FG002|Overall Study|Surgery Cancelled|0|||
48883054|NCT03274453|157408959|FG003|Overall Study|Surgery Cancelled|0|||
48883055|NCT01661205|157408965|FG000|Overall Study|Physician Decision|2|||
48883056|NCT05875142|157408966|FG000|Overall Study|Lost to Follow-up|0|||
48883057|NCT05875142|157408967|FG001|Overall Study|Lost to Follow-up|1|||
48883058|NCT05875142|157408968|FG002|Overall Study|Lost to Follow-up|1|||
48883059|NCT01939353|157408969|FG000|Placebo Run-in (1 Week)|Withdrew Consent|3|||
48883060|NCT01939353|157408969|FG000|Placebo Run-in (1 Week)|Lost to Follow-up|1|||
48883061|NCT01939353|157408969|FG000|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2|||
48883062|NCT01939353|157408969|FG000|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
48883063|NCT01939353|157408969|FG000|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1|||
48883064|NCT01689857|157408972|FG000|Overall Study|Lost to Follow-up|5|||
48883065|NCT01689857|157408973|FG001|Overall Study|Lost to Follow-up|2|||
48883066|NCT01730378|157408974|FG000|Overall Study|Lost to Follow-up|1|||
48883067|NCT01730378|157408975|FG001|Overall Study|Lost to Follow-up|0|||
48883068|NCT00983853|157408976|FG000|Overall Study|Lost to Follow-up|1|||
48883069|NCT00983853|157408977|FG001|Overall Study|Lost to Follow-up|1|||
48883070|NCT00983853|157408978|FG002|Overall Study|Lost to Follow-up|2|||
48883071|NCT00983853|157408979|FG003|Overall Study|Lost to Follow-up|2|||
48883072|NCT00983853|157408980|FG004|Overall Study|Lost to Follow-up|2|||
48883073|NCT00983853|157408981|FG005|Overall Study|Lost to Follow-up|1|||
48883074|NCT00983853|157408976|FG000|Overall Study|Withdrawal by Subject|0|||
48883075|NCT00983853|157408977|FG001|Overall Study|Withdrawal by Subject|0|||
48883076|NCT00983853|157408978|FG002|Overall Study|Withdrawal by Subject|1|||
48883077|NCT00983853|157408979|FG003|Overall Study|Withdrawal by Subject|0|||
48883078|NCT00983853|157408980|FG004|Overall Study|Withdrawal by Subject|1|||
48883079|NCT00983853|157408981|FG005|Overall Study|Withdrawal by Subject|0|||
48883080|NCT00983853|157408976|FG000|Overall Study|Unable to come to study follow-up visits|0|||
48883081|NCT00983853|157408977|FG001|Overall Study|Unable to come to study follow-up visits|1|||
48883082|NCT00983853|157408978|FG002|Overall Study|Unable to come to study follow-up visits|0|||
48883083|NCT00983853|157408979|FG003|Overall Study|Unable to come to study follow-up visits|0|||
48883084|NCT00983853|157408980|FG004|Overall Study|Unable to come to study follow-up visits|0|||
48883085|NCT00983853|157408981|FG005|Overall Study|Unable to come to study follow-up visits|0|||
48883086|NCT00737477|157408984|FG000|Overall Study|Adverse Event|9|||
48883087|NCT00737477|157408984|FG000|Overall Study|Death|9|||
48883088|NCT00737477|157408984|FG000|Overall Study|Treatment Refusal|1|||
48883089|NCT00737477|157408984|FG000|Overall Study|Withdrawal by Subject|1|||
48883090|NCT00737477|157408984|FG000|Overall Study|Renal Transplantation|10|||
48883091|NCT00737477|157408984|FG000|Overall Study|Other|4|||
48883092|NCT01370655|157408985|FG000|Period 1|Adverse Event|2|||
48883093|NCT01370655|157408986|FG001|Period 1|Adverse Event|0|||
48883094|NCT01370655|157408987|FG002|Period 1|Adverse Event|0|||
48883095|NCT01370655|157408988|FG003|Period 1|Adverse Event|0|||
48883096|NCT01370655|157408989|FG004|Period 1|Adverse Event|0|||
48883097|NCT01370655|157408990|FG005|Period 1|Adverse Event|0|||
48883098|NCT01370655|157408991|FG006|Period 1|Adverse Event|1|||
48883099|NCT01370655|157408992|FG007|Period 1|Adverse Event|0|||
48883100|NCT01370655|157408993|FG008|Period 1|Adverse Event|0|||
48883101|NCT01370655|157408994|FG009|Period 1|Adverse Event|0|||
48883102|NCT01370655|157408995|FG010|Period 1|Adverse Event|0|||
48883103|NCT01370655|157408996|FG011|Period 1|Adverse Event|0|||
48883104|NCT01370655|157408985|FG000|Period 2|Adverse Event|0|||
48883105|NCT01370655|157408986|FG001|Period 2|Adverse Event|0|||
48883106|NCT01370655|157408987|FG002|Period 2|Adverse Event|1|||
48883107|NCT01370655|157408988|FG003|Period 2|Adverse Event|0|||
48883108|NCT01370655|157408989|FG004|Period 2|Adverse Event|1|||
48883109|NCT01370655|157408990|FG005|Period 2|Adverse Event|0|||
48883110|NCT01370655|157408991|FG006|Period 2|Adverse Event|0|||
48883111|NCT01370655|157408992|FG007|Period 2|Adverse Event|1|||
48883112|NCT01370655|157408993|FG008|Period 2|Adverse Event|0|||
48883113|NCT01370655|157408994|FG009|Period 2|Adverse Event|0|||
48883114|NCT01370655|157408995|FG010|Period 2|Adverse Event|0|||
48883115|NCT01370655|157408996|FG011|Period 2|Adverse Event|0|||
48883116|NCT01370655|157408985|FG000|Period 2|met protocol specified stopping criteria|0|||
48883117|NCT01370655|157408986|FG001|Period 2|met protocol specified stopping criteria|0|||
48883118|NCT01370655|157408987|FG002|Period 2|met protocol specified stopping criteria|1|||
48883119|NCT01370655|157408988|FG003|Period 2|met protocol specified stopping criteria|0|||
48883120|NCT01370655|157408989|FG004|Period 2|met protocol specified stopping criteria|0|||
48883121|NCT01370655|157408990|FG005|Period 2|met protocol specified stopping criteria|0|||
48883122|NCT01370655|157408991|FG006|Period 2|met protocol specified stopping criteria|1|||
48883123|NCT01370655|157408992|FG007|Period 2|met protocol specified stopping criteria|0|||
48883124|NCT01370655|157408993|FG008|Period 2|met protocol specified stopping criteria|1|||
48883125|NCT01370655|157408994|FG009|Period 2|met protocol specified stopping criteria|0|||
48883126|NCT01370655|157408995|FG010|Period 2|met protocol specified stopping criteria|1|||
49034442|NCT02294786|157962041|FG000|Overall Study|Protocol Violation|1|||
49034443|NCT02294786|157962042|FG001|Overall Study|Protocol Violation|0|||
48883127|NCT01370655|157408996|FG011|Period 2|met protocol specified stopping criteria|0|||
48883128|NCT01370655|157408985|FG000|Period 2|Withdrawal by Subject|0|||
48883129|NCT01370655|157408986|FG001|Period 2|Withdrawal by Subject|0|||
49034444|NCT02294786|157962041|FG000|Overall Study|Adverse Event|1|||
49034445|NCT02294786|157962042|FG001|Overall Study|Adverse Event|1|||
48883130|NCT01370655|157408987|FG002|Period 2|Withdrawal by Subject|0|||
48883131|NCT01370655|157408988|FG003|Period 2|Withdrawal by Subject|0|||
48883132|NCT01370655|157408989|FG004|Period 2|Withdrawal by Subject|0|||
48883133|NCT01370655|157408990|FG005|Period 2|Withdrawal by Subject|0|||
48883134|NCT01370655|157408991|FG006|Period 2|Withdrawal by Subject|0|||
48883135|NCT01370655|157408992|FG007|Period 2|Withdrawal by Subject|0|||
48883136|NCT01370655|157408993|FG008|Period 2|Withdrawal by Subject|1|||
48883137|NCT01370655|157408994|FG009|Period 2|Withdrawal by Subject|0|||
48883138|NCT01370655|157408995|FG010|Period 2|Withdrawal by Subject|0|||
48883139|NCT01370655|157408996|FG011|Period 2|Withdrawal by Subject|0|||
48883140|NCT00581477|157408997|FG000|Overall Study|Physician Decision|2|||
48883141|NCT01080326|157408998|FG000|Overall Study|Patient deterioration prior to procedure|3|||
48883142|NCT01080326|157408998|FG000|Overall Study|Surgeon decision|1|||
48883143|NCT02975102|157408999|FG000|Overall Study|Adverse Event|2|||
48883144|NCT02975102|157409000|FG001|Overall Study|Adverse Event|1|||
48883145|NCT04276051|157409004|FG000|Overall Study|Lost to Follow-up|0|||
48883146|NCT04276051|157409005|FG001|Overall Study|Lost to Follow-up|1|||
48883147|NCT04276051|157409004|FG000|Overall Study|Physician Decision|0|||
48883148|NCT04276051|157409005|FG001|Overall Study|Physician Decision|1|||
48883149|NCT04276051|157409004|FG000|Overall Study|Withdrawal by Subject|1|||
48883150|NCT04276051|157409005|FG001|Overall Study|Withdrawal by Subject|1|||
48883151|NCT01912404|157409006|FG000|Overall Study|Due to personal reasons|1|||
48883152|NCT01912404|157409007|FG001|Overall Study|Due to personal reasons|0|||
48883153|NCT01827046|157409008|FG000|Overall Study|Lost to Follow-up|1|||
48883154|NCT01827046|157409009|FG001|Overall Study|Lost to Follow-up|5|||
48883155|NCT01827046|157409008|FG000|Overall Study|Withdrawal by Subject|0|||
48883156|NCT01827046|157409009|FG001|Overall Study|Withdrawal by Subject|4|||
48883157|NCT02269423|157409010|FG000|Overall Study|Discontinued due to change in residence|0|||
48883158|NCT02269423|157409011|FG001|Overall Study|Discontinued due to change in residence|1|||
48883159|NCT02269423|157409012|FG002|Overall Study|Discontinued due to change in residence|0|||
48883160|NCT02269423|157409013|FG003|Overall Study|Discontinued due to change in residence|1|||
48883161|NCT02389764|157409015|FG000|Overall Study|Lack of Efficacy|9|||
48883162|NCT00780559|157409016|FG000|Overall Study|Lost to Follow-up|2|||
48883163|NCT00780559|157409017|FG001|Overall Study|Lost to Follow-up|7|||
48883164|NCT00780559|157409016|FG000|Overall Study|Death|1|||
48883165|NCT00780559|157409017|FG001|Overall Study|Death|0|||
48883166|NCT04676763|157409018|FG000|Part 1 (Up to Day 1)|Protocol Violation|0|||
48883167|NCT04676763|157409019|FG001|Part 1 (Up to Day 1)|Protocol Violation|1|||
48883168|NCT04676763|157409020|FG002|Part 1 (Up to Day 1)|Protocol Violation|0|||
48883169|NCT04676763|157409018|FG000|Part 1 (Up to Day 1)|Physician Decision|0|||
48883170|NCT04676763|157409019|FG001|Part 1 (Up to Day 1)|Physician Decision|1|||
48883171|NCT04676763|157409020|FG002|Part 1 (Up to Day 1)|Physician Decision|0|||
48883172|NCT04676763|157409018|FG000|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
48883173|NCT04676763|157409019|FG001|Part 1 (Up to Day 1)|Withdrawal by Subject|1|||
48883174|NCT04676763|157409020|FG002|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
48883175|NCT01327846|157409021|FG000|Core Phase|Subject decision (vital status: missing)|1|||
48883176|NCT01327846|157409022|FG001|Core Phase|Subject decision (vital status: missing)|2|||
48883177|NCT01327846|157409023|FG002|Core Phase|Subject decision (vital status: missing)|2|||
48883178|NCT01327846|157409024|FG003|Core Phase|Subject decision (vital status: missing)|1|||
48883179|NCT01327846|157409021|FG000|Core Phase|Subject decision (vital stat: unkn)|0|||
48883180|NCT01327846|157409022|FG001|Core Phase|Subject decision (vital stat: unkn)|0|||
48883181|NCT01327846|157409023|FG002|Core Phase|Subject decision (vital stat: unkn)|3|||
48883182|NCT01327846|157409024|FG003|Core Phase|Subject decision (vital stat: unkn)|3|||
48883183|NCT01327846|157409021|FG000|Core Phase|Subject decision (vital stat: dead)|1|||
48883184|NCT01327846|157409022|FG001|Core Phase|Subject decision (vital stat: dead)|3|||
48883185|NCT01327846|157409023|FG002|Core Phase|Subject decision (vital stat: dead)|4|||
48883186|NCT01327846|157409024|FG003|Core Phase|Subject decision (vital stat: dead)|4|||
48883187|NCT01327846|157409021|FG000|Core Phase|Subject decision (vital stat: alive)|23|||
48883188|NCT01327846|157409022|FG001|Core Phase|Subject decision (vital stat: alive)|24|||
48883189|NCT01327846|157409023|FG002|Core Phase|Subject decision (vital stat: alive)|13|||
48883190|NCT01327846|157409024|FG003|Core Phase|Subject decision (vital stat: alive)|20|||
48883191|NCT01327846|157409021|FG000|Core Phase|Lost to Follow-up|3|||
48883192|NCT01327846|157409022|FG001|Core Phase|Lost to Follow-up|3|||
48883193|NCT01327846|157409023|FG002|Core Phase|Lost to Follow-up|4|||
48883194|NCT01327846|157409024|FG003|Core Phase|Lost to Follow-up|5|||
48883195|NCT01327846|157409021|FG000|Extension Phase|Study terminated by sponsor|1073|||
48883196|NCT01327846|157409022|FG001|Extension Phase|Study terminated by sponsor|1124|||
48883197|NCT01327846|157409023|FG002|Extension Phase|Study terminated by sponsor|1067|||
48883198|NCT01327846|157409024|FG003|Extension Phase|Study terminated by sponsor|1660|||
48883199|NCT01327846|157409021|FG000|Extension Phase|Withdrawal by Subject|20|||
48883200|NCT01327846|157409022|FG001|Extension Phase|Withdrawal by Subject|13|||
48883201|NCT01327846|157409023|FG002|Extension Phase|Withdrawal by Subject|19|||
48883202|NCT01327846|157409024|FG003|Extension Phase|Withdrawal by Subject|37|||
48883203|NCT01327846|157409021|FG000|Extension Phase|Lost to Follow-up|4|||
48883204|NCT01327846|157409022|FG001|Extension Phase|Lost to Follow-up|3|||
49034446|NCT02294786|157962041|FG000|Overall Study|Death|2|||
48883205|NCT01327846|157409023|FG002|Extension Phase|Lost to Follow-up|4|||
48883206|NCT01327846|157409024|FG003|Extension Phase|Lost to Follow-up|7|||
48883207|NCT01327846|157409021|FG000|Extension Phase|Technical Problems|2|||
48883208|NCT01327846|157409022|FG001|Extension Phase|Technical Problems|4|||
48883209|NCT01327846|157409023|FG002|Extension Phase|Technical Problems|2|||
48883210|NCT01327846|157409024|FG003|Extension Phase|Technical Problems|2|||
48883211|NCT01250509|157409025|FG000|Overall Study|Lost to Follow-up|5|||
48883212|NCT01250509|157409026|FG001|Overall Study|Lost to Follow-up|2|||
48883213|NCT00694109|157409028|FG000|Overall Study|Physician Decision|3|||
49034447|NCT02294786|157962042|FG001|Overall Study|Death|3|||
49034448|NCT00571064|157962045|FG000|Overall Study|Adverse Event|13|||
49034449|NCT00571064|157962045|FG000|Overall Study|Protocol Violation|4|||
48883214|NCT00694109|157409028|FG000|Overall Study|Adverse Event|74|||
48883215|NCT00694109|157409028|FG000|Overall Study|Not consent of more 2 years of treatment|18|||
48883216|NCT00694109|157409028|FG000|Overall Study|Lack of Efficacy|2|||
48883217|NCT00694109|157409028|FG000|Overall Study|Withdrawal by Subject|13|||
48883218|NCT00694109|157409028|FG000|Overall Study|Pregnancy|1|||
48883219|NCT00694109|157409028|FG000|Overall Study|Enrolled but not treated|1|||
48883220|NCT00694109|157409028|FG000|Overall Study|Other|2|||
48883221|NCT00694109|157409028|FG000|Overall Study|Consented but no additional treatment|3|||
48883222|NCT01420237|157409041|FG000|Overall Study|Death|13|||
48883223|NCT01420237|157409041|FG000|Overall Study|Withdrawal by Subject|41|||
48883224|NCT01420237|157409041|FG000|Overall Study|Lost to Follow-up|32|||
48883225|NCT01420237|157409041|FG000|Overall Study|Adverse Event|10|||
48883226|NCT01420237|157409041|FG000|Overall Study|Investigative Site Termination|43|||
48883227|NCT01420237|157409041|FG000|Overall Study|Censored because study device not implanted|21|||
48883228|NCT01420237|157409041|FG000|Overall Study|Censored because surgery not performed|2|||
48883229|NCT01420237|157409041|FG000|Overall Study|Censored because of Inclusion Exclusion Violation|11|||
48883230|NCT01420237|157409041|FG000|Overall Study|Sponsor terminated study early|127|||
48883231|NCT05034328|157409044|FG000|Overall Study|Protocol Violation|1|||
48883232|NCT05034328|157409045|FG001|Overall Study|Protocol Violation|0|||
48883233|NCT05034328|157409044|FG000|Overall Study|Lost to Follow-up|0|||
48883234|NCT05034328|157409045|FG001|Overall Study|Lost to Follow-up|10|||
48883235|NCT01246999|157409828|FG000|Overall Study|Lost to Follow-up|0|||
48883236|NCT01246999|157409829|FG001|Overall Study|Lost to Follow-up|1|||
48883237|NCT01246999|157409830|FG002|Overall Study|Lost to Follow-up|0|||
48883238|NCT01246999|157409831|FG003|Overall Study|Lost to Follow-up|0|||
48883239|NCT01246999|157409828|FG000|Overall Study|Withdrawal by Subject|0|||
48883240|NCT01246999|157409829|FG001|Overall Study|Withdrawal by Subject|0|||
48883241|NCT01246999|157409830|FG002|Overall Study|Withdrawal by Subject|0|||
48883242|NCT01246999|157409831|FG003|Overall Study|Withdrawal by Subject|2|||
48883243|NCT01240551|157409832|FG000|Overall Study|Refused further treatment|3|||
48883244|NCT01240551|157409833|FG001|Overall Study|Refused further treatment|2|||
48883245|NCT01240551|157409832|FG000|Overall Study|Lost to Follow-up|1|||
48883246|NCT01240551|157409833|FG001|Overall Study|Lost to Follow-up|1|||
48883247|NCT04869982|157409838|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
48883248|NCT04869982|157409839|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
48883249|NCT04869982|157409838|FG000|Overall Study|Migrated / moved from the study area|1|||
48883250|NCT04869982|157409839|FG001|Overall Study|Migrated / moved from the study area|1|||
48883251|NCT04869982|157409838|FG000|Overall Study|Adverse event requiring expedited reporting|13|||
48883252|NCT04869982|157409839|FG001|Overall Study|Adverse event requiring expedited reporting|11|||
48883253|NCT04869982|157409838|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
48883254|NCT04869982|157409839|FG001|Overall Study|Unsolicited non-serious adverse event|1|||
48883255|NCT04869982|157409838|FG000|Overall Study|Solicited adverse event|2|||
48883256|NCT04869982|157409839|FG001|Overall Study|Solicited adverse event|1|||
49034450|NCT00571064|157962045|FG000|Overall Study|Withdrawal by Subject|2|||
49034451|NCT00571064|157962045|FG000|Overall Study|Other|2|||
48883257|NCT04247542|157409840|FG000|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
48883258|NCT04247542|157409841|FG001|2B: Double-Blind Active-Controlled|Did not receive study drug|1|||
48883259|NCT04247542|157409842|FG002|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
48883260|NCT04247542|157409840|FG000|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|0|||
48883261|NCT04247542|157409841|FG001|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
48883262|NCT04247542|157409842|FG002|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
48883263|NCT04842643|157409843|FG000|Overall Study|Physician Decision|1|||
48883264|NCT04842643|157409843|FG000|Overall Study|Other|1|||
48883265|NCT05592418|157409846|FG000|Overall Study|Adverse Event|1|||
48883266|NCT05592418|157409847|FG001|Overall Study|Adverse Event|0|||
48883267|NCT05592418|157409846|FG000|Overall Study|Lost to Follow-up|1|||
48883268|NCT05592418|157409847|FG001|Overall Study|Lost to Follow-up|3|||
48883269|NCT05592418|157409846|FG000|Overall Study|Withdrawal by Subject|2|||
48883270|NCT05592418|157409847|FG001|Overall Study|Withdrawal by Subject|7|||
48883271|NCT01016262|157409848|FG000|Double-blind Phase|Adverse Event|0|||
48883272|NCT01016262|157409849|FG001|Double-blind Phase|Adverse Event|0|||
48883273|NCT01016262|157409850|FG002|Double-blind Phase|Adverse Event|1|||
49034452|NCT00244764|157962046|FG000|Overall Study|Adverse Event|37|||
48883274|NCT01016262|157409851|FG003|Double-blind Phase|Adverse Event|0|||
48883275|NCT01016262|157409852|FG004|Double-blind Phase|Adverse Event|0|||
48883276|NCT01016262|157409853|FG005|Double-blind Phase|Adverse Event|0|||
48883277|NCT01016262|157409848|FG000|Double-blind Phase|Lack of Efficacy|1|||
48883278|NCT01016262|157409849|FG001|Double-blind Phase|Lack of Efficacy|0|||
48883279|NCT01016262|157409850|FG002|Double-blind Phase|Lack of Efficacy|5|||
48883280|NCT01016262|157409851|FG003|Double-blind Phase|Lack of Efficacy|0|||
48883281|NCT01016262|157409852|FG004|Double-blind Phase|Lack of Efficacy|0|||
48883282|NCT01016262|157409853|FG005|Double-blind Phase|Lack of Efficacy|0|||
49034453|NCT00244764|157962046|FG000|Overall Study|Lost to Follow-up|23|||
49034454|NCT00244764|157962046|FG000|Overall Study|Withdrawal by Subject|12|||
49034455|NCT00244764|157962046|FG000|Overall Study|Disease Progression|13|||
49034456|NCT00244764|157962046|FG000|Overall Study|Protocol Violation|2|||
49034457|NCT00244764|157962046|FG000|Overall Study|Death|1|||
49034458|NCT00244764|157962046|FG000|Overall Study|Off Study Medication for >21 Days|1|||
49034459|NCT00244764|157962046|FG000|Overall Study|Declining Performance Status|1|||
49034460|NCT00244764|157962046|FG000|Overall Study|Participant was Hospitalized until Death|1|||
49034461|NCT00244764|157962046|FG000|Overall Study|Primary Investigator Discretion|2|||
49034462|NCT00244764|157962046|FG000|Overall Study|Sponsor Terminated Study|2|||
49034463|NCT00244764|157962046|FG000|Overall Study|Developed Secondary Malignancy|1|||
49034464|NCT01642277|157962049|FG000|Overall Study|Adverse Event|10|||
49034465|NCT01642277|157962050|FG001|Overall Study|Adverse Event|0|||
48883283|NCT01016262|157409848|FG000|Double-blind Phase|Disease Progression|0|||
48883284|NCT01016262|157409849|FG001|Double-blind Phase|Disease Progression|1|||
48883285|NCT01016262|157409850|FG002|Double-blind Phase|Disease Progression|2|||
48883286|NCT01016262|157409851|FG003|Double-blind Phase|Disease Progression|0|||
48883287|NCT01016262|157409852|FG004|Double-blind Phase|Disease Progression|0|||
48883288|NCT01016262|157409853|FG005|Double-blind Phase|Disease Progression|0|||
48883289|NCT01016262|157409848|FG000|Double-blind Phase|Withdrawal of Informed Consent|0|||
48883290|NCT01016262|157409849|FG001|Double-blind Phase|Withdrawal of Informed Consent|0|||
48883291|NCT01016262|157409850|FG002|Double-blind Phase|Withdrawal of Informed Consent|1|||
48883292|NCT01016262|157409851|FG003|Double-blind Phase|Withdrawal of Informed Consent|0|||
48883293|NCT01016262|157409852|FG004|Double-blind Phase|Withdrawal of Informed Consent|0|||
48883294|NCT01016262|157409853|FG005|Double-blind Phase|Withdrawal of Informed Consent|0|||
48883295|NCT01016262|157409848|FG000|Open-Label Phase|Adverse Event|0|||
48883296|NCT01016262|157409849|FG001|Open-Label Phase|Adverse Event|0|||
48883297|NCT01016262|157409850|FG002|Open-Label Phase|Adverse Event|0|||
48883298|NCT01016262|157409851|FG003|Open-Label Phase|Adverse Event|1|||
48883299|NCT01016262|157409852|FG004|Open-Label Phase|Adverse Event|0|||
48883300|NCT01016262|157409853|FG005|Open-Label Phase|Adverse Event|0|||
48883301|NCT01016262|157409848|FG000|Open-Label Phase|Lost to Follow-up|0|||
48883302|NCT01016262|157409849|FG001|Open-Label Phase|Lost to Follow-up|0|||
48883303|NCT01016262|157409850|FG002|Open-Label Phase|Lost to Follow-up|0|||
48883304|NCT01016262|157409851|FG003|Open-Label Phase|Lost to Follow-up|0|||
48883305|NCT01016262|157409852|FG004|Open-Label Phase|Lost to Follow-up|1|||
48883306|NCT01016262|157409853|FG005|Open-Label Phase|Lost to Follow-up|0|||
48883307|NCT01016262|157409848|FG000|Open-Label Phase|Lack of Efficacy|0|||
48883308|NCT01016262|157409849|FG001|Open-Label Phase|Lack of Efficacy|0|||
48883309|NCT01016262|157409850|FG002|Open-Label Phase|Lack of Efficacy|0|||
48883310|NCT01016262|157409851|FG003|Open-Label Phase|Lack of Efficacy|1|||
48883311|NCT01016262|157409852|FG004|Open-Label Phase|Lack of Efficacy|0|||
48883312|NCT01016262|157409853|FG005|Open-Label Phase|Lack of Efficacy|0|||
48883313|NCT01016262|157409848|FG000|Open-Label Phase|Withdrawal of Informed Consent|0|||
48883314|NCT01016262|157409849|FG001|Open-Label Phase|Withdrawal of Informed Consent|0|||
48883315|NCT01016262|157409850|FG002|Open-Label Phase|Withdrawal of Informed Consent|0|||
48883316|NCT01016262|157409851|FG003|Open-Label Phase|Withdrawal of Informed Consent|0|||
48883317|NCT01016262|157409852|FG004|Open-Label Phase|Withdrawal of Informed Consent|1|||
48883318|NCT01016262|157409853|FG005|Open-Label Phase|Withdrawal of Informed Consent|0|||
48883319|NCT03812029|157409854|FG000|Overall Study|Protocol Violation|1|||
48883320|NCT03812029|157409855|FG001|Overall Study|Protocol Violation|0|||
48883321|NCT03812029|157409856|FG002|Overall Study|Protocol Violation|0|||
48883322|NCT03812029|157409857|FG003|Overall Study|Protocol Violation|1|||
48883323|NCT03812029|157409858|FG004|Overall Study|Protocol Violation|0|||
48883324|NCT03812029|157409854|FG000|Overall Study|Withdrawal by Subject|1|||
48883325|NCT03812029|157409855|FG001|Overall Study|Withdrawal by Subject|0|||
48883326|NCT03812029|157409856|FG002|Overall Study|Withdrawal by Subject|0|||
48883327|NCT03812029|157409857|FG003|Overall Study|Withdrawal by Subject|2|||
48883328|NCT03812029|157409858|FG004|Overall Study|Withdrawal by Subject|2|||
48883329|NCT03812029|157409854|FG000|Overall Study|Stopping rules|0|||
48883330|NCT03812029|157409855|FG001|Overall Study|Stopping rules|1|||
48883331|NCT03812029|157409856|FG002|Overall Study|Stopping rules|0|||
48883332|NCT03812029|157409857|FG003|Overall Study|Stopping rules|0|||
48883333|NCT03812029|157409858|FG004|Overall Study|Stopping rules|0|||
48883334|NCT03812029|157409854|FG000|Overall Study|Adverse Event|0|||
48883335|NCT03812029|157409855|FG001|Overall Study|Adverse Event|9|||
48883336|NCT03812029|157409856|FG002|Overall Study|Adverse Event|0|||
48883337|NCT03812029|157409857|FG003|Overall Study|Adverse Event|3|||
48883338|NCT03812029|157409858|FG004|Overall Study|Adverse Event|5|||
48883339|NCT03812029|157409854|FG000|Overall Study|Lost to Follow-up|0|||
48883340|NCT03812029|157409855|FG001|Overall Study|Lost to Follow-up|0|||
48883341|NCT03812029|157409856|FG002|Overall Study|Lost to Follow-up|0|||
48883342|NCT03812029|157409857|FG003|Overall Study|Lost to Follow-up|0|||
49034466|NCT01642277|157962049|FG000|Overall Study|Physician Decision|2|||
49034467|NCT01642277|157962050|FG001|Overall Study|Physician Decision|0|||
48883343|NCT03812029|157409858|FG004|Overall Study|Lost to Follow-up|3|||
48883344|NCT03361306|157409859|FG000|Overall Study|Death|5|||
48883345|NCT03361306|157409859|FG000|Overall Study|Still On Study (on study treatment)|3|||
48883346|NCT03361306|157409859|FG000|Overall Study|Still On Study (in follow up)|7|||
49034468|NCT01642277|157962049|FG000|Overall Study|Protocol Violation|1|||
49034469|NCT01642277|157962050|FG001|Overall Study|Protocol Violation|0|||
49034470|NCT01642277|157962049|FG000|Overall Study|Withdrawal by Subject|11|||
49034471|NCT01642277|157962050|FG001|Overall Study|Withdrawal by Subject|0|||
49034472|NCT04238754|157962051|FG000|Washout - 1 Week|Lost to Follow-up|1|||
49034473|NCT04238754|157962052|FG001|Washout - 1 Week|Lost to Follow-up|0|||
49034474|NCT00834431|157962053|FG000|First Intervention|Adverse Event|0|||
49034475|NCT00834431|157962054|FG001|First Intervention|Adverse Event|1|||
49034476|NCT00834431|157962053|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
49034477|NCT00834431|157962054|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
49034478|NCT01208337|157962057|FG000|Overall Study|Death|3|||
49034479|NCT00505622|157962058|FG000|Overall Study|Adverse Event|5|||
49034480|NCT00505622|157962059|FG001|Overall Study|Adverse Event|6|||
49034481|NCT00505622|157962060|FG002|Overall Study|Adverse Event|4|||
48883347|NCT00667394|157409860|FG000|Overall Study|Adverse Event|3|||
48883348|NCT00667394|157409861|FG001|Overall Study|Adverse Event|0|||
48883349|NCT00667394|157409860|FG000|Overall Study|Progressive disease|1|||
48883350|NCT00667394|157409861|FG001|Overall Study|Progressive disease|0|||
48883351|NCT04924660|157409862|FG000|United States|Death|29|||
48883352|NCT04924660|157409863|FG001|United States|Death|32|||
48883353|NCT04924660|157409864|FG002|United States|Death|34|||
48883354|NCT04924660|157409865|FG003|United States|Death|25|||
48883355|NCT04924660|157409866|FG004|United States|Death|26|||
48883356|NCT04924660|157409867|FG005|United States|Death|23|||
48883357|NCT04924660|157409862|FG000|United States|Lost to Follow-up|15|||
48883358|NCT04924660|157409863|FG001|United States|Lost to Follow-up|10|||
48883359|NCT04924660|157409864|FG002|United States|Lost to Follow-up|13|||
48883360|NCT04924660|157409865|FG003|United States|Lost to Follow-up|5|||
48883361|NCT04924660|157409866|FG004|United States|Lost to Follow-up|19|||
48883362|NCT04924660|157409867|FG005|United States|Lost to Follow-up|20|||
48883363|NCT04924660|157409862|FG000|United States|Withdrawal by Subject|8|||
48883364|NCT04924660|157409863|FG001|United States|Withdrawal by Subject|3|||
48883365|NCT04924660|157409864|FG002|United States|Withdrawal by Subject|3|||
48883366|NCT04924660|157409865|FG003|United States|Withdrawal by Subject|3|||
48883367|NCT04924660|157409866|FG004|United States|Withdrawal by Subject|8|||
48883368|NCT04924660|157409867|FG005|United States|Withdrawal by Subject|4|||
48883369|NCT04924660|157409862|FG000|Spain|Death|0|||
48883370|NCT04924660|157409863|FG001|Spain|Death|0|||
48883371|NCT04924660|157409864|FG002|Spain|Death|0|||
48883372|NCT04924660|157409865|FG003|Spain|Death|0|||
48883373|NCT04924660|157409866|FG004|Spain|Death|0|||
48883374|NCT04924660|157409867|FG005|Spain|Death|2|||
48883375|NCT04924660|157409862|FG000|Spain|Lost to Follow-up|0|||
48883376|NCT04924660|157409863|FG001|Spain|Lost to Follow-up|0|||
48883377|NCT04924660|157409864|FG002|Spain|Lost to Follow-up|0|||
48883378|NCT04924660|157409865|FG003|Spain|Lost to Follow-up|0|||
48883379|NCT04924660|157409866|FG004|Spain|Lost to Follow-up|1|||
48883380|NCT04924660|157409867|FG005|Spain|Lost to Follow-up|0|||
48883381|NCT04924660|157409862|FG000|Brazil|Death|0|||
48883382|NCT04924660|157409863|FG001|Brazil|Death|0|||
48883383|NCT04924660|157409864|FG002|Brazil|Death|0|||
48883384|NCT04924660|157409865|FG003|Brazil|Death|0|||
48883385|NCT04924660|157409866|FG004|Brazil|Death|1|||
48883386|NCT04924660|157409867|FG005|Brazil|Death|0|||
48883387|NCT04924660|157409862|FG000|Italy|Lost to Follow-up|0|||
48883388|NCT04924660|157409863|FG001|Italy|Lost to Follow-up|0|||
48883389|NCT04924660|157409864|FG002|Italy|Lost to Follow-up|0|||
48883390|NCT04924660|157409865|FG003|Italy|Lost to Follow-up|0|||
49034482|NCT00505622|157962058|FG000|Overall Study|Protocol Violation|1|||
49034483|NCT00505622|157962059|FG001|Overall Study|Protocol Violation|1|||
48883391|NCT04924660|157409866|FG004|Italy|Lost to Follow-up|0|||
48883392|NCT04924660|157409867|FG005|Italy|Lost to Follow-up|1|||
48883393|NCT04924660|157409862|FG000|South Africa|Death|0|||
48883394|NCT04924660|157409863|FG001|South Africa|Death|0|||
48883395|NCT04924660|157409864|FG002|South Africa|Death|0|||
48883396|NCT04924660|157409865|FG003|South Africa|Death|0|||
48883397|NCT04924660|157409866|FG004|South Africa|Death|0|||
49034484|NCT00505622|157962060|FG002|Overall Study|Protocol Violation|0|||
49034485|NCT00505622|157962058|FG000|Overall Study|Withdrawal by Subject|0|||
49034486|NCT00505622|157962059|FG001|Overall Study|Withdrawal by Subject|3|||
48883398|NCT04924660|157409867|FG005|South Africa|Death|1|||
48883399|NCT04924660|157409862|FG000|South Africa|Lost to Follow-up|0|||
48883400|NCT04924660|157409863|FG001|South Africa|Lost to Follow-up|0|||
48883401|NCT04924660|157409864|FG002|South Africa|Lost to Follow-up|0|||
48883402|NCT04924660|157409865|FG003|South Africa|Lost to Follow-up|0|||
48883403|NCT04924660|157409866|FG004|South Africa|Lost to Follow-up|0|||
49034487|NCT00505622|157962060|FG002|Overall Study|Withdrawal by Subject|2|||
48883404|NCT04924660|157409867|FG005|South Africa|Lost to Follow-up|1|||
48883405|NCT02979249|157409868|FG000|Overall Study|Lost to Follow-up|2|||
48883406|NCT02979249|157409868|FG000|Overall Study|Withdrawal by Subject|4|||
48883407|NCT04993677|157409870|FG000|Overall Study|Lost to Follow-up|1|||
48883408|NCT04993677|157409871|FG001|Overall Study|Lost to Follow-up|0|||
48883409|NCT04993677|157409872|FG002|Overall Study|Lost to Follow-up|0|||
48883410|NCT04993677|157409873|FG003|Overall Study|Lost to Follow-up|0|||
48883411|NCT04993677|157409870|FG000|Overall Study|Death|11|||
48883412|NCT04993677|157409871|FG001|Overall Study|Death|8|||
48883413|NCT04993677|157409872|FG002|Overall Study|Death|3|||
48883414|NCT04993677|157409873|FG003|Overall Study|Death|1|||
48883415|NCT04993677|157409870|FG000|Overall Study|Subject withdrawal of consent|4|||
48883416|NCT04993677|157409871|FG001|Overall Study|Subject withdrawal of consent|3|||
48883417|NCT04993677|157409872|FG002|Overall Study|Subject withdrawal of consent|0|||
48883418|NCT04993677|157409873|FG003|Overall Study|Subject withdrawal of consent|2|||
48883419|NCT04993677|157409870|FG000|Overall Study|Study termination by sponsor|3|||
48883420|NCT04993677|157409871|FG001|Overall Study|Study termination by sponsor|22|||
48883421|NCT04993677|157409872|FG002|Overall Study|Study termination by sponsor|3|||
48883422|NCT04993677|157409873|FG003|Overall Study|Study termination by sponsor|3|||
48883423|NCT04993677|157409870|FG000|Overall Study|Other|2|||
48883424|NCT04993677|157409871|FG001|Overall Study|Other|2|||
48883425|NCT04993677|157409872|FG002|Overall Study|Other|3|||
48883426|NCT04993677|157409873|FG003|Overall Study|Other|2|||
48883427|NCT01931098|157409874|FG000|Overall Study|Withdrawal by Subject|0|||
48883428|NCT01931098|157409875|FG001|Overall Study|Withdrawal by Subject|1|||
48883429|NCT01931098|157409874|FG000|Overall Study|Enrolled in different protocol|0|||
48883430|NCT01931098|157409875|FG001|Overall Study|Enrolled in different protocol|1|||
48883431|NCT01931098|157409874|FG000|Overall Study|Unable to begin trmt:active infection|0|||
48883432|NCT01931098|157409875|FG001|Overall Study|Unable to begin trmt:active infection|1|||
48883433|NCT01931098|157409874|FG000|Overall Study|Refused further treatment|0|||
48883434|NCT01931098|157409875|FG001|Overall Study|Refused further treatment|1|||
48883435|NCT04149704|157409878|FG000|Three Month Follow-up|Death|2|||
48883436|NCT04149704|157409879|FG001|Three Month Follow-up|Death|0|||
48883437|NCT04149704|157409880|FG002|Three Month Follow-up|Death|0|||
48883438|NCT04149704|157409881|FG003|Three Month Follow-up|Death|0|||
48883439|NCT04149704|157409878|FG000|Three Month Follow-up|Lost to Follow-up|1|||
48883440|NCT04149704|157409879|FG001|Three Month Follow-up|Lost to Follow-up|4|||
48883441|NCT04149704|157409880|FG002|Three Month Follow-up|Lost to Follow-up|5|||
48883442|NCT04149704|157409881|FG003|Three Month Follow-up|Lost to Follow-up|5|||
48883443|NCT04149704|157409878|FG000|Three Month Follow-up|Withdrawal by Subject|1|||
48883444|NCT04149704|157409879|FG001|Three Month Follow-up|Withdrawal by Subject|0|||
48883445|NCT04149704|157409880|FG002|Three Month Follow-up|Withdrawal by Subject|0|||
48883446|NCT04149704|157409881|FG003|Three Month Follow-up|Withdrawal by Subject|0|||
48883447|NCT04149704|157409878|FG000|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
48883448|NCT04149704|157409879|FG001|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
48883449|NCT04149704|157409880|FG002|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
48883450|NCT04149704|157409881|FG003|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
48883451|NCT03101462|157409882|FG000|Overall Study|Missed Visit 02 and/or Visit 03|1|||
48883452|NCT03101462|157409883|FG001|Overall Study|Missed Visit 02 and/or Visit 03|1|||
48883453|NCT01594970|157409884|FG000|Overall Study|Non-Adverse Event Related|4|||
48883454|NCT01594970|157409885|FG001|Overall Study|Non-Adverse Event Related|5|||
48883455|NCT01594970|157409886|FG002|Overall Study|Non-Adverse Event Related|6|||
48883456|NCT01594970|157409884|FG000|Overall Study|Adverse Event|17|||
48883457|NCT01594970|157409885|FG001|Overall Study|Adverse Event|23|||
48883458|NCT01594970|157409886|FG002|Overall Study|Adverse Event|23|||
48883459|NCT01594970|157409884|FG000|Overall Study|Lost to Follow-up|54|||
48883460|NCT01594970|157409885|FG001|Overall Study|Lost to Follow-up|54|||
48883461|NCT01594970|157409886|FG002|Overall Study|Lost to Follow-up|37|||
48883462|NCT03192475|157409889|FG000|Overall Study|Death|0|||
48883463|NCT03192475|157409890|FG001|Overall Study|Death|1|||
48883464|NCT03192475|157409889|FG000|Overall Study|Lost to Follow-up|13|||
48883465|NCT03192475|157409890|FG001|Overall Study|Lost to Follow-up|8|||
48883466|NCT01989169|157409894|FG000|Period 2|Adverse Event|0|||
48883467|NCT01989169|157409895|FG001|Period 2|Adverse Event|1|||
48883468|NCT05583578|157409898|FG000|Overall Study|Withdrawal by Subject|2|||
48883469|NCT05583578|157409899|FG001|Overall Study|Withdrawal by Subject|0|||
48883470|NCT03924635|157409900|FG000|Overall Study|Withdrawal by Subject|2|||
48883471|NCT03924635|157409901|FG001|Overall Study|Withdrawal by Subject|4|||
48883472|NCT04294641|157409902|FG000|Overall Study|Screen failure|4|||
48883473|NCT04685135|157409903|FG000|Overall Study|Death|126|||
48883474|NCT04685135|157409904|FG001|Overall Study|Death|53|||
48883475|NCT04685135|157409903|FG000|Overall Study|Withdrawal by Subject|12|||
48883476|NCT04685135|157409904|FG001|Overall Study|Withdrawal by Subject|16|||
48883477|NCT03547271|157409905|FG000|Overall Study|Adverse Event|1|||
48883478|NCT03547271|157409906|FG001|Overall Study|Adverse Event|1|||
48883479|NCT03547271|157409907|FG002|Overall Study|Adverse Event|0|||
48883480|NCT03547271|157409908|FG003|Overall Study|Adverse Event|0|||
48883481|NCT03547271|157409905|FG000|Overall Study|Protocol deviation|5|||
48883482|NCT03547271|157409906|FG001|Overall Study|Protocol deviation|7|||
48883483|NCT03547271|157409907|FG002|Overall Study|Protocol deviation|3|||
48883484|NCT03547271|157409908|FG003|Overall Study|Protocol deviation|0|||
48883485|NCT03547271|157409905|FG000|Overall Study|Withdrawal by Parent/Guardian|24|||
48883486|NCT03547271|157409906|FG001|Overall Study|Withdrawal by Parent/Guardian|24|||
48883487|NCT03547271|157409907|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
48883488|NCT03547271|157409908|FG003|Overall Study|Withdrawal by Parent/Guardian|4|||
48883489|NCT03547271|157409905|FG000|Overall Study|Lost to Follow-up|3|||
48883490|NCT03547271|157409906|FG001|Overall Study|Lost to Follow-up|3|||
48883491|NCT03547271|157409907|FG002|Overall Study|Lost to Follow-up|1|||
48883492|NCT03547271|157409908|FG003|Overall Study|Lost to Follow-up|0|||
48883493|NCT03073941|157411173|FG000|Overall Study|Received non-study device intraoperatively|0|||
48883494|NCT03073941|157411174|FG001|Overall Study|Received non-study device intraoperatively|2|||
48883495|NCT03073941|157411173|FG000|Overall Study|Death|1|||
48883496|NCT03073941|157411174|FG001|Overall Study|Death|0|||
48883497|NCT03073941|157411173|FG000|Overall Study|Withdrawal by Subject|1|||
48883498|NCT03073941|157411174|FG001|Overall Study|Withdrawal by Subject|3|||
48883499|NCT03073941|157411173|FG000|Overall Study|Lost to Follow-up|5|||
48883500|NCT03073941|157411174|FG001|Overall Study|Lost to Follow-up|4|||
48883501|NCT03073941|157411173|FG000|Overall Study|Adverse Event|4|||
48883502|NCT03073941|157411174|FG001|Overall Study|Adverse Event|2|||
48883503|NCT03073941|157411173|FG000|Overall Study|Met an exclusion criterion|0|||
48883504|NCT03073941|157411174|FG001|Overall Study|Met an exclusion criterion|1|||
48883505|NCT00667459|157411179|FG000|Overall Study|Death|0|||
48883506|NCT00667459|157411180|FG001|Overall Study|Death|2|||
48883507|NCT00667459|157411179|FG000|Overall Study|Lost to Follow-up|8|||
48883508|NCT00667459|157411180|FG001|Overall Study|Lost to Follow-up|43|||
48883509|NCT02797522|157411181|FG000|Overall Study|Study Terminated by Sponsor|0|||
48883510|NCT02797522|157411182|FG001|Overall Study|Study Terminated by Sponsor|0|||
48883511|NCT02797522|157411183|FG002|Overall Study|Study Terminated by Sponsor|0|||
48883512|NCT02797522|157411184|FG003|Overall Study|Study Terminated by Sponsor|0|||
48883513|NCT02797522|157411185|FG004|Overall Study|Study Terminated by Sponsor|0|||
48883514|NCT02797522|157411186|FG005|Overall Study|Study Terminated by Sponsor|0|||
48883515|NCT02797522|157411187|FG006|Overall Study|Study Terminated by Sponsor|0|||
48883516|NCT02797522|157411188|FG007|Overall Study|Study Terminated by Sponsor|4|||
48883517|NCT02797522|157411189|FG008|Overall Study|Study Terminated by Sponsor|2|||
48883518|NCT02797522|157411190|FG009|Overall Study|Study Terminated by Sponsor|4|||
48883519|NCT02797522|157411191|FG010|Overall Study|Study Terminated by Sponsor|1|||
48883520|NCT03838731|157411192|FG000|Overall Study|Pregnancy|0|||
48883521|NCT03838731|157411193|FG001|Overall Study|Pregnancy|1|||
48883522|NCT03838731|157411192|FG000|Overall Study|Withdrawal of consent|1|||
48883523|NCT03838731|157411193|FG001|Overall Study|Withdrawal of consent|0|||
49034488|NCT00505622|157962058|FG000|Overall Study|Study termination by sponsor|115|||
49034489|NCT00505622|157962059|FG001|Overall Study|Study termination by sponsor|98|||
49034490|NCT00505622|157962060|FG002|Overall Study|Study termination by sponsor|90|||
49034491|NCT02601625|157962061|FG000|Overall Study|Lost to Follow-up|0|||
49034492|NCT02601625|157962062|FG001|Overall Study|Lost to Follow-up|0|||
49034493|NCT02601625|157962063|FG002|Overall Study|Lost to Follow-up|1|||
49034494|NCT02601625|157962064|FG003|Overall Study|Lost to Follow-up|1|||
49034495|NCT04887415|157962067|FG000|Overall Study|Lost to Follow-up|2|||
49034496|NCT00841698|157962068|FG000|First Intervention|Withdrawal by Subject|1|||
48883524|NCT04878354|157411194|FG000|Overall Study|Adverse Event|4|||
48883525|NCT04878354|157411195|FG001|Overall Study|Adverse Event|13|||
48883526|NCT04878354|157411194|FG000|Overall Study|Withdrawal by Subject|14|||
48883527|NCT04878354|157411195|FG001|Overall Study|Withdrawal by Subject|12|||
48883528|NCT04878354|157411194|FG000|Overall Study|Lost to Follow-up|4|||
48883529|NCT04878354|157411195|FG001|Overall Study|Lost to Follow-up|1|||
48883530|NCT04878354|157411194|FG000|Overall Study|Lack of Efficacy|1|||
48883531|NCT04878354|157411195|FG001|Overall Study|Lack of Efficacy|0|||
48883532|NCT04878354|157411194|FG000|Overall Study|Protocol Violation|0|||
48883533|NCT04878354|157411195|FG001|Overall Study|Protocol Violation|1|||
48883534|NCT04878354|157411194|FG000|Overall Study|"Reason stated as other in CRF"|2|||
48883535|NCT04878354|157411195|FG001|Overall Study|"Reason stated as other in CRF"|3|||
48883536|NCT05307783|157411196|FG000|Overall Study|Death|7|||
48883537|NCT05307783|157411196|FG000|Overall Study|Lost to Follow-up|4|||
49034497|NCT00841698|157962069|FG001|First Intervention|Withdrawal by Subject|0|||
49034498|NCT00418145|157962072|FG000|Overall Study|study terminated|6|||
49034499|NCT01316055|157962077|FG000|Overall Study|Lost to Follow-up|1|||
48883538|NCT02728076|157411198|FG000|Overall Study|Physician Decision|4|||
48883539|NCT00527787|157411199|FG000|Overall Study|Adverse Event|14|||
48883540|NCT00527787|157411200|FG001|Overall Study|Adverse Event|24|||
48883541|NCT00527787|157411199|FG000|Overall Study|Withdrawal by Subject|13|||
48883542|NCT00527787|157411200|FG001|Overall Study|Withdrawal by Subject|25|||
48883543|NCT00527787|157411199|FG000|Overall Study|Lost to Follow-up|5|||
48883544|NCT00527787|157411200|FG001|Overall Study|Lost to Follow-up|2|||
48883545|NCT00527787|157411199|FG000|Overall Study|Duodenal Ulcer|1|||
48883546|NCT00527787|157411200|FG001|Overall Study|Duodenal Ulcer|10|||
48883547|NCT00527787|157411199|FG000|Overall Study|misc|5|||
48883548|NCT00527787|157411200|FG001|Overall Study|misc|2|||
49034500|NCT01316055|157962078|FG001|Overall Study|Lost to Follow-up|0|||
49034501|NCT01316055|157962079|FG002|Overall Study|Lost to Follow-up|0|||
48883549|NCT02312557|157411201|FG000|Overall Study|Survival follow-up|4|||
48883550|NCT03106753|157411206|FG000|Overall Study|Withdrawal by Subject|0|||
48883551|NCT03106753|157411207|FG001|Overall Study|Withdrawal by Subject|1|||
48883552|NCT01735175|157411212|FG000|Overall Study|Withdrawal by Subject|9|||
48883553|NCT01735175|157411213|FG001|Overall Study|Withdrawal by Subject|2|||
48883554|NCT01735175|157411212|FG000|Overall Study|Lost to Follow-up|4|||
48883555|NCT01735175|157411213|FG001|Overall Study|Lost to Follow-up|2|||
48883556|NCT01735175|157411212|FG000|Overall Study|Death|3|||
48883557|NCT01735175|157411213|FG001|Overall Study|Death|2|||
48883558|NCT01735175|157411212|FG000|Overall Study|Other (mostly EOS/EOT visit missing)|13|||
48883559|NCT01735175|157411213|FG001|Overall Study|Other (mostly EOS/EOT visit missing)|7|||
48883560|NCT05877976|157411223|FG000|Overall Study|Lost to Follow-up|31|||
48883561|NCT02844816|157411240|FG000|Overall Study|No protocol treatment received|5|||
48883562|NCT02844816|157411241|FG001|Overall Study|No protocol treatment received|1|||
48883563|NCT02844816|157411240|FG000|Overall Study|Ineligible|22|||
48883564|NCT02844816|157411241|FG001|Overall Study|Ineligible|15|||
48883565|NCT02844816|157411240|FG000|Overall Study|Participant refusal|5|||
48883566|NCT02844816|157411241|FG001|Overall Study|Participant refusal|5|||
48883567|NCT02844816|157411240|FG000|Overall Study|Adverse Event|5|||
48883568|NCT02844816|157411241|FG001|Overall Study|Adverse Event|4|||
48883569|NCT02844816|157411240|FG000|Overall Study|Death|0|||
48883570|NCT02844816|157411241|FG001|Overall Study|Death|1|||
48883571|NCT02844816|157411240|FG000|Overall Study|Disease progression/recurrence|50|||
48883572|NCT02844816|157411241|FG001|Overall Study|Disease progression/recurrence|24|||
48883573|NCT02844816|157411240|FG000|Overall Study|Physician Decision|1|||
48883574|NCT02844816|157411241|FG001|Overall Study|Physician Decision|1|||
48883575|NCT05645757|157411242|FG000|Overall Study|Enrolled but treatment not administered|0|||
48883576|NCT05645757|157411243|FG001|Overall Study|Enrolled but treatment not administered|0|||
48883577|NCT05645757|157411244|FG002|Overall Study|Enrolled but treatment not administered|0|||
48883578|NCT05645757|157411245|FG003|Overall Study|Enrolled but treatment not administered|0|||
48883579|NCT05645757|157411246|FG004|Overall Study|Enrolled but treatment not administered|1|||
48883580|NCT05645757|157411247|FG005|Overall Study|Enrolled but treatment not administered|1|||
48883581|NCT05645757|157411248|FG006|Overall Study|Enrolled but treatment not administered|0|||
48883582|NCT05645757|157411249|FG007|Overall Study|Enrolled but treatment not administered|0|||
48883583|NCT00539591|157411250|FG000|Overall Study|Toxicity|3|||
48883584|NCT00539591|157411251|FG001|Overall Study|Toxicity|0|||
48883585|NCT00539591|157411252|FG002|Overall Study|Toxicity|0|||
48883586|NCT00539591|157411250|FG000|Overall Study|Disease progression|2|||
48883587|NCT00539591|157411251|FG001|Overall Study|Disease progression|2|||
48883588|NCT00539591|157411252|FG002|Overall Study|Disease progression|3|||
48883589|NCT04471246|157411253|FG000|Overall Study|Lost to Follow-up|2|||
48883590|NCT04471246|157411254|FG001|Overall Study|Lost to Follow-up|2|||
48883591|NCT02626455|157411255|FG000|Overall Study|Other|1|||
48883592|NCT02626455|157411256|FG001|Overall Study|Other|1|||
48883593|NCT02626455|157411257|FG002|Overall Study|Other|0|||
48883594|NCT02626455|157411258|FG003|Overall Study|Other|0|||
48883595|NCT02626455|157411259|FG004|Overall Study|Other|0|||
48883596|NCT02626455|157411260|FG005|Overall Study|Other|17|||
48883597|NCT02626455|157411261|FG006|Overall Study|Other|23|||
48883598|NCT02626455|157411255|FG000|Overall Study|Withdrawal by Subject|1|||
48883599|NCT02626455|157411256|FG001|Overall Study|Withdrawal by Subject|0|||
48883600|NCT02626455|157411257|FG002|Overall Study|Withdrawal by Subject|0|||
48883601|NCT02626455|157411258|FG003|Overall Study|Withdrawal by Subject|0|||
48883602|NCT02626455|157411259|FG004|Overall Study|Withdrawal by Subject|0|||
48883603|NCT02626455|157411260|FG005|Overall Study|Withdrawal by Subject|10|||
48883604|NCT02626455|157411261|FG006|Overall Study|Withdrawal by Subject|6|||
48883605|NCT02626455|157411255|FG000|Overall Study|Physician Decision|0|||
48883606|NCT02626455|157411256|FG001|Overall Study|Physician Decision|2|||
48692482|NCT03287791|156724500|FG000|Overall Study|Protocol Violation|7|||
48692483|NCT03287791|156724501|FG001|Overall Study|Protocol Violation|2|||
48692484|NCT03287791|156724502|FG002|Overall Study|Protocol Violation|1|||
48692485|NCT03287791|156724500|FG000|Overall Study|Participant was enrolled at 2 sites|1|||
48692486|NCT03287791|156724501|FG001|Overall Study|Participant was enrolled at 2 sites|0|||
48692487|NCT03287791|156724502|FG002|Overall Study|Participant was enrolled at 2 sites|1|||
48692488|NCT03287791|156724500|FG000|Overall Study|Too much time between 2 visits|0|||
48692489|NCT03287791|156724501|FG001|Overall Study|Too much time between 2 visits|1|||
48692490|NCT03287791|156724502|FG002|Overall Study|Too much time between 2 visits|0|||
48692491|NCT03287791|156724500|FG000|Overall Study|Non-compliance|0|||
48692492|NCT03287791|156724501|FG001|Overall Study|Non-compliance|1|||
48692493|NCT03287791|156724502|FG002|Overall Study|Non-compliance|0|||
48692494|NCT03287791|156724500|FG000|Overall Study|Did not meet inclusion criteria|1|||
48692495|NCT03287791|156724501|FG001|Overall Study|Did not meet inclusion criteria|0|||
48692496|NCT03287791|156724502|FG002|Overall Study|Did not meet inclusion criteria|0|||
48692497|NCT00453154|156724503|FG000|Double BIind Maintenance|Adverse Event|0|||
48692498|NCT00453154|156724504|FG001|Double BIind Maintenance|Adverse Event|0|||
48692499|NCT00453154|156724505|FG002|Double BIind Maintenance|Adverse Event|3|||
48883607|NCT02626455|157411257|FG002|Overall Study|Physician Decision|2|||
49034502|NCT01929863|157962080|FG000|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1|||
49034503|NCT01929863|157962081|FG001|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0|||
48883608|NCT02626455|157411258|FG003|Overall Study|Physician Decision|2|||
48883609|NCT02626455|157411259|FG004|Overall Study|Physician Decision|1|||
48883610|NCT02626455|157411260|FG005|Overall Study|Physician Decision|10|||
48883611|NCT02626455|157411261|FG006|Overall Study|Physician Decision|3|||
48883612|NCT02626455|157411255|FG000|Overall Study|Patient decision: COVID-19 pandemic related|0|||
48883613|NCT02626455|157411256|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
48883614|NCT02626455|157411257|FG002|Overall Study|Patient decision: COVID-19 pandemic related|0|||
48883615|NCT02626455|157411258|FG003|Overall Study|Patient decision: COVID-19 pandemic related|0|||
48883616|NCT02626455|157411259|FG004|Overall Study|Patient decision: COVID-19 pandemic related|0|||
48883617|NCT02626455|157411260|FG005|Overall Study|Patient decision: COVID-19 pandemic related|0|||
48883618|NCT02626455|157411261|FG006|Overall Study|Patient decision: COVID-19 pandemic related|1|||
48883619|NCT02626455|157411255|FG000|Overall Study|Physician decision: COVID-19 pandemic related|0|||
48883620|NCT02626455|157411256|FG001|Overall Study|Physician decision: COVID-19 pandemic related|0|||
48883621|NCT02626455|157411257|FG002|Overall Study|Physician decision: COVID-19 pandemic related|0|||
48883622|NCT02626455|157411258|FG003|Overall Study|Physician decision: COVID-19 pandemic related|0|||
48883623|NCT02626455|157411259|FG004|Overall Study|Physician decision: COVID-19 pandemic related|0|||
48883624|NCT02626455|157411260|FG005|Overall Study|Physician decision: COVID-19 pandemic related|0|||
48883625|NCT02626455|157411261|FG006|Overall Study|Physician decision: COVID-19 pandemic related|2|||
48883626|NCT02626455|157411255|FG000|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
48883627|NCT02626455|157411256|FG001|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
48883628|NCT02626455|157411257|FG002|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
48883629|NCT02626455|157411258|FG003|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
48883630|NCT02626455|157411259|FG004|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
48883631|NCT02626455|157411260|FG005|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
48883632|NCT02626455|157411261|FG006|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
48883633|NCT02626455|157411255|FG000|Overall Study|Patient decision|0|||
48883634|NCT02626455|157411256|FG001|Overall Study|Patient decision|1|||
48883635|NCT02626455|157411257|FG002|Overall Study|Patient decision|0|||
48883636|NCT02626455|157411258|FG003|Overall Study|Patient decision|0|||
48883637|NCT02626455|157411259|FG004|Overall Study|Patient decision|1|||
48883638|NCT02626455|157411260|FG005|Overall Study|Patient decision|36|||
48883639|NCT02626455|157411261|FG006|Overall Study|Patient decision|22|||
48883640|NCT02626455|157411255|FG000|Overall Study|Protocol Violation|0|||
48883641|NCT02626455|157411256|FG001|Overall Study|Protocol Violation|0|||
49034504|NCT01929863|157962080|FG000|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0|||
48883642|NCT02626455|157411257|FG002|Overall Study|Protocol Violation|0|||
48883643|NCT02626455|157411258|FG003|Overall Study|Protocol Violation|0|||
48883644|NCT02626455|157411259|FG004|Overall Study|Protocol Violation|0|||
48883645|NCT02626455|157411260|FG005|Overall Study|Protocol Violation|0|||
48883646|NCT02626455|157411261|FG006|Overall Study|Protocol Violation|1|||
48883647|NCT02626455|157411255|FG000|Overall Study|Progressive disease - radiological progression|0|||
48883648|NCT02626455|157411256|FG001|Overall Study|Progressive disease - radiological progression|0|||
48883649|NCT02626455|157411257|FG002|Overall Study|Progressive disease - radiological progression|0|||
48883650|NCT02626455|157411258|FG003|Overall Study|Progressive disease - radiological progression|0|||
48883651|NCT02626455|157411259|FG004|Overall Study|Progressive disease - radiological progression|0|||
48883652|NCT02626455|157411260|FG005|Overall Study|Progressive disease - radiological progression|11|||
48883653|NCT02626455|157411261|FG006|Overall Study|Progressive disease - radiological progression|22|||
48883654|NCT02626455|157411255|FG000|Overall Study|Progressive disease - clinical progression|0|||
48883655|NCT02626455|157411256|FG001|Overall Study|Progressive disease - clinical progression|0|||
48883656|NCT02626455|157411257|FG002|Overall Study|Progressive disease - clinical progression|0|||
48883657|NCT02626455|157411258|FG003|Overall Study|Progressive disease - clinical progression|0|||
48883658|NCT02626455|157411259|FG004|Overall Study|Progressive disease - clinical progression|0|||
48883659|NCT02626455|157411260|FG005|Overall Study|Progressive disease - clinical progression|1|||
48883660|NCT02626455|157411261|FG006|Overall Study|Progressive disease - clinical progression|2|||
48883661|NCT02626455|157411255|FG000|Overall Study|Lost to Follow-up|0|||
48883662|NCT02626455|157411256|FG001|Overall Study|Lost to Follow-up|0|||
48883663|NCT02626455|157411257|FG002|Overall Study|Lost to Follow-up|0|||
48883664|NCT02626455|157411258|FG003|Overall Study|Lost to Follow-up|0|||
48883665|NCT02626455|157411259|FG004|Overall Study|Lost to Follow-up|0|||
48883666|NCT02626455|157411260|FG005|Overall Study|Lost to Follow-up|1|||
48883667|NCT02626455|157411261|FG006|Overall Study|Lost to Follow-up|0|||
48883668|NCT02626455|157411255|FG000|Overall Study|AE not associated with clinical disease progression|1|||
48883669|NCT02626455|157411256|FG001|Overall Study|AE not associated with clinical disease progression|1|||
48883670|NCT02626455|157411257|FG002|Overall Study|AE not associated with clinical disease progression|0|||
48883671|NCT02626455|157411258|FG003|Overall Study|AE not associated with clinical disease progression|2|||
48883672|NCT02626455|157411259|FG004|Overall Study|AE not associated with clinical disease progression|1|||
49034505|NCT01929863|157962081|FG001|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1|||
49034506|NCT01929863|157962080|FG000|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0|||
49034507|NCT01929863|157962081|FG001|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1|||
49034508|NCT03769025|157962083|FG000|Overall Study|Withdrawal by Subject|1|||
49034509|NCT03769025|157962084|FG001|Overall Study|Withdrawal by Subject|1|||
49034510|NCT03769025|157962083|FG000|Overall Study|Lost to Follow-up|4|||
49034511|NCT03769025|157962084|FG001|Overall Study|Lost to Follow-up|3|||
49034512|NCT01302548|157962085|FG000|Overall Study|Lost to Follow-up|2|||
49034513|NCT01302548|157962086|FG001|Overall Study|Lost to Follow-up|1|||
49034514|NCT00745420|157963425|FG000|Overall Study|Ineligible|1|||
49034515|NCT01466166|157963426|FG000|Overall Study|Death|1|||
49034516|NCT01466166|157963426|FG000|Overall Study|Lost to Follow-up|7|||
49034517|NCT01466166|157963426|FG000|Overall Study|Infusion Reaction (IR)|27|||
49034518|NCT01466166|157963426|FG000|Overall Study|Adverse Event (Other than IR)|11|||
49034519|NCT01466166|157963426|FG000|Overall Study|Elevated Serum Uric Acid|78|||
49034520|NCT01466166|157963426|FG000|Overall Study|Withdrawal by Subject|13|||
49034521|NCT01466166|157963426|FG000|Overall Study|Sponsor Decision|4|||
49034522|NCT01466166|157963426|FG000|Overall Study|Protocol Violation/Noncompliance|2|||
49034523|NCT01466166|157963426|FG000|Overall Study|Other|20|||
49034524|NCT02566850|157963432|FG000|Overall Study|Protocol Violation|1|||
49034525|NCT03447353|157963433|FG000|Overall Study|Failure at Screening Visit|2|||
49034526|NCT03447353|157963433|FG000|Overall Study|Lost to Follow-up|4|||
49034527|NCT03447353|157963433|FG000|Overall Study|Scheduling Conflicts|3|||
49034528|NCT03447353|157963433|FG000|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1|||
49034529|NCT02175095|157963434|FG000|Overall Study|Withdrawal by Subject|3|||
49034530|NCT01857934|157963435|FG000|Overall Study|Relapse or progression|2|||
49034531|NCT01857934|157963435|FG000|Overall Study|Unacceptable toxicity|3|||
49034532|NCT01857934|157963435|FG000|Overall Study|Unwillingness or inability to comply|2|||
49034533|NCT01857934|157963435|FG000|Overall Study|Physician Decision|3|||
49034534|NCT02635750|157963436|FG000|Part 1, Period 2|Adverse Event|1|||
49034535|NCT02635750|157963437|FG001|Part 1, Period 2|Adverse Event|0|||
49034536|NCT02635750|157963438|FG002|Part 1, Period 2|Adverse Event|0|||
49034537|NCT02028715|157963441|FG000|Overall Study|Adverse Event|2|||
49034538|NCT02028715|157963442|FG001|Overall Study|Adverse Event|2|||
49034539|NCT02028715|157963441|FG000|Overall Study|Physician Decision|1|||
49034540|NCT02028715|157963442|FG001|Overall Study|Physician Decision|0|||
49034541|NCT02028715|157963441|FG000|Overall Study|Did not complete satisfaction surveys|2|||
49034542|NCT02028715|157963442|FG001|Overall Study|Did not complete satisfaction surveys|2|||
49034543|NCT00371839|157963443|FG000|Overall Study|Death|4|||
49034544|NCT00371839|157963444|FG001|Overall Study|Death|0|||
49034545|NCT00371839|157963445|FG002|Overall Study|Death|0|||
49034546|NCT00371839|157963443|FG000|Overall Study|Withdrawal by Subject|7|||
49034547|NCT00371839|157963444|FG001|Overall Study|Withdrawal by Subject|4|||
49034548|NCT00371839|157963445|FG002|Overall Study|Withdrawal by Subject|0|||
49034549|NCT00371839|157963443|FG000|Overall Study|Lost to Follow-up|6|||
49034550|NCT00371839|157963444|FG001|Overall Study|Lost to Follow-up|3|||
49034551|NCT00371839|157963445|FG002|Overall Study|Lost to Follow-up|2|||
49034552|NCT03935880|157963446|FG000|Overall Study|Lost to Follow-up|0|||
49034553|NCT03935880|157963447|FG001|Overall Study|Lost to Follow-up|1|||
49034554|NCT01531894|157963448|FG000|Overall Study|Physician Decision|8|||
49034555|NCT01531894|157963448|FG000|Overall Study|Death|1|||
49034556|NCT02718326|157963449|FG000|Overall Study|Adverse Event|4|||
49034557|NCT02718326|157963450|FG001|Overall Study|Adverse Event|9|||
49034558|NCT02718326|157963451|FG002|Overall Study|Adverse Event|0|||
49034559|NCT02718326|157963449|FG000|Overall Study|Death|8|||
49034560|NCT02718326|157963450|FG001|Overall Study|Death|1|||
49034561|NCT02718326|157963451|FG002|Overall Study|Death|2|||
49034562|NCT02718326|157963449|FG000|Overall Study|Withdrawal by Subject|4|||
49034563|NCT02718326|157963450|FG001|Overall Study|Withdrawal by Subject|9|||
49034564|NCT02718326|157963451|FG002|Overall Study|Withdrawal by Subject|6|||
49034565|NCT02718326|157963449|FG000|Overall Study|Lost to Follow-up|18|||
49034566|NCT02718326|157963450|FG001|Overall Study|Lost to Follow-up|5|||
49034567|NCT02718326|157963451|FG002|Overall Study|Lost to Follow-up|14|||
49034568|NCT02718326|157963449|FG000|Overall Study|Protocol Deviation|1|||
49034569|NCT02718326|157963450|FG001|Overall Study|Protocol Deviation|0|||
49034570|NCT02718326|157963451|FG002|Overall Study|Protocol Deviation|0|||
49034571|NCT02718326|157963449|FG000|Overall Study|Pregnancy|1|||
49034572|NCT02718326|157963450|FG001|Overall Study|Pregnancy|0|||
49034573|NCT02718326|157963451|FG002|Overall Study|Pregnancy|0|||
49034574|NCT03122535|157963452|FG000|Overall Study|Lost to Follow-up|68|||
49034575|NCT03122535|157963453|FG001|Overall Study|Lost to Follow-up|68|||
49034576|NCT03122535|157963452|FG000|Overall Study|Physician Decision|3|||
49034577|NCT03122535|157963453|FG001|Overall Study|Physician Decision|3|||
49034578|NCT03122535|157963452|FG000|Overall Study|Withdrawal by Subject|2|||
49034579|NCT03122535|157963453|FG001|Overall Study|Withdrawal by Subject|2|||
49034580|NCT00627016|157963454|FG000|Overall Study|Adverse Event|1|||
49034581|NCT00627016|157963455|FG001|Overall Study|Adverse Event|1|||
49034582|NCT00627016|157963454|FG000|Overall Study|Protocol Violation|0|||
49034583|NCT00627016|157963455|FG001|Overall Study|Protocol Violation|2|||
49034584|NCT00627016|157963454|FG000|Overall Study|Lost to Follow-up|0|||
49034585|NCT00627016|157963455|FG001|Overall Study|Lost to Follow-up|1|||
49034586|NCT00627016|157963454|FG000|Overall Study|Withdrawal by Subject|2|||
49034587|NCT00627016|157963455|FG001|Overall Study|Withdrawal by Subject|1|||
49034588|NCT00627016|157963454|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
49034589|NCT00627016|157963455|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
49034590|NCT00627016|157963454|FG000|Overall Study|Lack of Efficacy|1|||
49034591|NCT00627016|157963455|FG001|Overall Study|Lack of Efficacy|0|||
49034592|NCT00627016|157963454|FG000|Overall Study|Placed on Excluded Drugs|1|||
49034593|NCT00627016|157963455|FG001|Overall Study|Placed on Excluded Drugs|0|||
49034594|NCT00627016|157963454|FG000|Overall Study|Pregnancy|1|||
49034595|NCT00627016|157963455|FG001|Overall Study|Pregnancy|0|||
48883673|NCT02626455|157411260|FG005|Overall Study|AE not associated with clinical disease progression|65|||
48883674|NCT02626455|157411261|FG006|Overall Study|AE not associated with clinical disease progression|21|||
48883675|NCT02626455|157411255|FG000|Overall Study|AE associated with clinical disease progression|0|||
48883676|NCT02626455|157411256|FG001|Overall Study|AE associated with clinical disease progression|0|||
48883677|NCT02626455|157411257|FG002|Overall Study|AE associated with clinical disease progression|0|||
48883678|NCT02626455|157411258|FG003|Overall Study|AE associated with clinical disease progression|0|||
48883679|NCT02626455|157411259|FG004|Overall Study|AE associated with clinical disease progression|0|||
48883680|NCT02626455|157411260|FG005|Overall Study|AE associated with clinical disease progression|1|||
48883681|NCT02626455|157411261|FG006|Overall Study|AE associated with clinical disease progression|2|||
48883682|NCT02626455|157411255|FG000|Overall Study|Study intervention never administered|0|||
48883683|NCT02626455|157411256|FG001|Overall Study|Study intervention never administered|0|||
48883684|NCT02626455|157411257|FG002|Overall Study|Study intervention never administered|0|||
48883685|NCT02626455|157411258|FG003|Overall Study|Study intervention never administered|0|||
48883686|NCT02626455|157411259|FG004|Overall Study|Study intervention never administered|0|||
49034596|NCT00377260|157963456|FG000|Overall Study|Lost to Follow-up|0|||
49034597|NCT00377260|157963457|FG001|Overall Study|Lost to Follow-up|1|||
49034598|NCT00377260|157963456|FG000|Overall Study|Withdrawal by Subject|2|||
49034599|NCT00377260|157963457|FG001|Overall Study|Withdrawal by Subject|4|||
49034600|NCT00829530|157963460|FG000|First Intervention|Adverse Event|0|||
49034601|NCT00829530|157963461|FG001|First Intervention|Adverse Event|1|||
49034602|NCT00829530|157963460|FG000|First Intervention|Intolerance to Venopuncture|0|||
49034603|NCT00829530|157963461|FG001|First Intervention|Intolerance to Venopuncture|1|||
49034604|NCT00829530|157963460|FG000|Second Intervention|Intolerance to Venopuncture|1|||
49034605|NCT00829530|157963461|FG001|Second Intervention|Intolerance to Venopuncture|0|||
49034606|NCT06195579|157963462|FG000|Overall Study|Withdrawal by Subject|1|||
49034607|NCT02436005|157963463|FG000|Second Intervention|Adverse Event|0|||
49034608|NCT02436005|157963464|FG001|Second Intervention|Adverse Event|1|||
49034609|NCT04112823|157963469|FG000|Overall Study|Lost to Follow-up|2|||
49034610|NCT04112823|157963470|FG001|Overall Study|Lost to Follow-up|3|||
49034611|NCT04408794|157963471|FG000|Overall Study|Adverse Event|43|||
49034612|NCT04408794|157963471|FG000|Overall Study|Infrequent study drug usage|43|||
49034613|NCT04408794|157963471|FG000|Overall Study|Lack of Efficacy|61|||
49034614|NCT04408794|157963471|FG000|Overall Study|Lost to Follow-up|33|||
49034615|NCT04408794|157963471|FG000|Overall Study|Non-compliance|6|||
49034616|NCT04408794|157963471|FG000|Overall Study|Physician Decision|1|||
49034617|NCT04408794|157963471|FG000|Overall Study|Pregnancy|6|||
49034618|NCT04408794|157963471|FG000|Overall Study|Protocol Deviation|9|||
49034619|NCT04408794|157963471|FG000|Overall Study|Sheehan-STS Result|1|||
49034620|NCT04408794|157963471|FG000|Overall Study|Withdrawal by Subject|57|||
49034621|NCT04408794|157963471|FG000|Overall Study|Terminated study prematurely due to COVID-19 - Adverse Event|2|||
49034622|NCT04408794|157963471|FG000|Overall Study|Never Treated Migraine|5|||
49034623|NCT01778010|157963473|FG000|Overall Study|Withdrawal by Subject|2|||
49034624|NCT01778010|157963473|FG000|Overall Study|abnormal ECG before meds|1|||
49034625|NCT01778010|157963473|FG000|Overall Study|Arrested|1|||
49034626|NCT01778010|157963473|FG000|Overall Study|rash while on placebo|1|||
49034627|NCT05041361|157963481|FG000|Overall Study|Lost to Follow-up|1|||
48883687|NCT02626455|157411260|FG005|Overall Study|Study intervention never administered|1|||
48883688|NCT02626455|157411261|FG006|Overall Study|Study intervention never administered|3|||
48883689|NCT02240238|157411262|FG000|Phase 1|Adverse Event|0|||
48883690|NCT02240238|157411263|FG001|Phase 1|Adverse Event|0|||
48883691|NCT02240238|157411264|FG002|Phase 1|Adverse Event|0|||
49034628|NCT05041361|157963482|FG001|Overall Study|Lost to Follow-up|3|||
49034629|NCT03138967|157963488|FG000|Overall Study|Death|0|||
49034630|NCT03138967|157963489|FG001|Overall Study|Death|1|||
49034631|NCT03138967|157963488|FG000|Overall Study|Physician Decision|1|||
49034632|NCT03138967|157963489|FG001|Overall Study|Physician Decision|3|||
49034633|NCT02588339|157963490|FG000|Overall Study|Withdrawal by Subject|1|||
49034634|NCT02588339|157963490|FG000|Overall Study|GVHD Progression prior to treatment|2|||
49034635|NCT01686438|157963493|FG000|Overall Study|Lost to Follow-up|8|||
48883692|NCT02240238|157411265|FG003|Phase 1|Adverse Event|0|||
49034636|NCT01686438|157963494|FG001|Overall Study|Lost to Follow-up|9|||
49034637|NCT01686438|157963495|FG002|Overall Study|Lost to Follow-up|10|||
49034638|NCT01686438|157963493|FG000|Overall Study|Adverse Event|0|||
49034639|NCT01686438|157963494|FG001|Overall Study|Adverse Event|0|||
49034640|NCT01686438|157963495|FG002|Overall Study|Adverse Event|1|||
49034641|NCT01686438|157963493|FG000|Overall Study|Protocol Violation|0|||
49034642|NCT01686438|157963494|FG001|Overall Study|Protocol Violation|0|||
48796295|NCT00322348|157091531|FG001|Overall Study|Lost to Follow-up|0|||
48796296|NCT00322348|157091530|FG000|Overall Study|Death|0|||
48796297|NCT00322348|157091531|FG001|Overall Study|Death|2|||
48796298|NCT00322348|157091530|FG000|Overall Study|Disease Progression|30|||
48796299|NCT00322348|157091531|FG001|Overall Study|Disease Progression|25|||
48796300|NCT00322348|157091530|FG000|Overall Study|Reasons not specified|5|||
48796301|NCT00322348|157091531|FG001|Overall Study|Reasons not specified|1|||
48796302|NCT04958109|157091532|FG000|Overall Study|Withdrawal by Subject|0|||
48796303|NCT04958109|157091533|FG001|Overall Study|Withdrawal by Subject|1|||
48796304|NCT04958109|157091532|FG000|Overall Study|Lost to Follow-up|0|||
48796305|NCT04958109|157091533|FG001|Overall Study|Lost to Follow-up|1|||
48796306|NCT01292239|157091536|FG000|Overall Study|Other|1|||
48796307|NCT01292239|157091537|FG001|Overall Study|Other|1|||
48796308|NCT01292239|157091536|FG000|Overall Study|Withdrawal by Subject|3|||
48796309|NCT01292239|157091537|FG001|Overall Study|Withdrawal by Subject|6|||
48796310|NCT01939548|157091541|FG000|Overall Study|Non compliance|0|||
48796311|NCT01939548|157091542|FG001|Overall Study|Non compliance|2|||
48796312|NCT01939548|157091543|FG002|Overall Study|Non compliance|0|||
48796313|NCT01939548|157091541|FG000|Overall Study|Study Terminated by Sponsor|17|||
48796314|NCT01939548|157091542|FG001|Overall Study|Study Terminated by Sponsor|19|||
48796315|NCT01939548|157091543|FG002|Overall Study|Study Terminated by Sponsor|12|||
48796316|NCT01939548|157091541|FG000|Overall Study|Insufficient Clinical Response|1|||
48796317|NCT01939548|157091542|FG001|Overall Study|Insufficient Clinical Response|0|||
48796318|NCT01939548|157091543|FG002|Overall Study|Insufficient Clinical Response|0|||
48796319|NCT01939548|157091541|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
48796320|NCT01939548|157091542|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
48796321|NCT01939548|157091543|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
48796322|NCT01939548|157091541|FG000|Overall Study|Withdrawal by Subject|4|||
48796323|NCT01939548|157091542|FG001|Overall Study|Withdrawal by Subject|4|||
48796324|NCT01939548|157091543|FG002|Overall Study|Withdrawal by Subject|1|||
48796325|NCT01939548|157091541|FG000|Overall Study|Protocol Violation|7|||
48796326|NCT01939548|157091542|FG001|Overall Study|Protocol Violation|6|||
48796327|NCT01939548|157091543|FG002|Overall Study|Protocol Violation|5|||
48796328|NCT01939548|157091541|FG000|Overall Study|Lost to Follow-up|5|||
48796329|NCT01939548|157091542|FG001|Overall Study|Lost to Follow-up|5|||
48796330|NCT01939548|157091543|FG002|Overall Study|Lost to Follow-up|3|||
48796331|NCT01939548|157091541|FG000|Overall Study|Adverse Event|2|||
48796332|NCT01939548|157091542|FG001|Overall Study|Adverse Event|9|||
48796333|NCT01939548|157091543|FG002|Overall Study|Adverse Event|7|||
48796334|NCT01939548|157091541|FG000|Overall Study|Death|0|||
48796335|NCT01939548|157091542|FG001|Overall Study|Death|0|||
48796336|NCT01939548|157091543|FG002|Overall Study|Death|1|||
48796337|NCT01939548|157091541|FG000|Overall Study|Participant dropped|0|||
48796338|NCT01939548|157091542|FG001|Overall Study|Participant dropped|0|||
48796339|NCT01939548|157091543|FG002|Overall Study|Participant dropped|1|||
48796340|NCT01939548|157091541|FG000|Overall Study|Participant unwilling to continue|0|||
48796341|NCT01939548|157091542|FG001|Overall Study|Participant unwilling to continue|1|||
48796342|NCT01939548|157091543|FG002|Overall Study|Participant unwilling to continue|0|||
48796343|NCT01939548|157091541|FG000|Overall Study|Participant withdrew consent|0|||
48796344|NCT01939548|157091542|FG001|Overall Study|Participant withdrew consent|2|||
48796345|NCT01939548|157091543|FG002|Overall Study|Participant withdrew consent|0|||
48796346|NCT01939548|157091541|FG000|Overall Study|Did not complete follow-up|0|||
48796347|NCT01939548|157091542|FG001|Overall Study|Did not complete follow-up|1|||
48796348|NCT01939548|157091543|FG002|Overall Study|Did not complete follow-up|0|||
48796349|NCT01400503|157091549|FG000|Overall Study|Withdrawal by Subject|1|||
48796350|NCT01400503|157091549|FG000|Overall Study|Study Terminated by Sponsor|58|||
48796351|NCT01400503|157091549|FG000|Overall Study|Other|1|||
48796352|NCT00344461|157091552|FG000|Overall Study|Adverse Event|6|||
48796353|NCT00344461|157091552|FG000|Overall Study|Death|1|||
48796354|NCT00344461|157091552|FG000|Overall Study|Lack of Efficacy|2|||
48796355|NCT00344461|157091552|FG000|Overall Study|Lost to Follow-up|2|||
48796356|NCT00344461|157091552|FG000|Overall Study|Physician Decision|2|||
48796357|NCT00344461|157091552|FG000|Overall Study|Protocol Violation|6|||
48796358|NCT00344461|157091552|FG000|Overall Study|Withdrawal by Subject|2|||
48796359|NCT01261338|157091556|FG000|Overall Study|Withdrawal by Subject|3|||
48796360|NCT01261338|157091557|FG001|Overall Study|Withdrawal by Subject|2|||
48796361|NCT01515748|157091560|FG000|Overall Study|Withdrawal by Subject|32|||
48796362|NCT01515748|157091561|FG001|Overall Study|Withdrawal by Subject|41|||
48796363|NCT01515748|157091560|FG000|Overall Study|Lost to Follow-up|2|||
48796364|NCT01515748|157091561|FG001|Overall Study|Lost to Follow-up|4|||
48796365|NCT01515748|157091560|FG000|Overall Study|Other than specified above|5|||
49034643|NCT01686438|157963495|FG002|Overall Study|Protocol Violation|1|||
49034644|NCT01686438|157963493|FG000|Overall Study|Withdrawal by Subject|0|||
49034645|NCT01686438|157963494|FG001|Overall Study|Withdrawal by Subject|0|||
49034646|NCT01686438|157963495|FG002|Overall Study|Withdrawal by Subject|1|||
49034647|NCT00463684|157963496|FG000|Overall Study|Withdrawal by Subject|1|||
49034648|NCT00463684|157963496|FG000|Overall Study|Lost to Follow-up|3|||
49034649|NCT00906399|157963497|FG000|Year 1|Randomized But Not Treated|0|||
49034650|NCT00906399|157963498|FG001|Year 1|Randomized But Not Treated|1|||
49034651|NCT00906399|157963499|FG002|Year 1|Randomized But Not Treated|3|||
49034652|NCT00906399|157963500|FG003|Year 1|Randomized But Not Treated|0|||
49034653|NCT00906399|157963501|FG004|Year 1|Randomized But Not Treated|0|||
49034654|NCT00906399|157963502|FG005|Year 1|Randomized But Not Treated|0|||
49034655|NCT00906399|157963503|FG006|Year 1|Randomized But Not Treated|0|||
49034656|NCT00906399|157963497|FG000|Year 1|Adverse Event|4|||
49034657|NCT00906399|157963498|FG001|Year 1|Adverse Event|22|||
49034658|NCT00906399|157963499|FG002|Year 1|Adverse Event|24|||
49034659|NCT00906399|157963500|FG003|Year 1|Adverse Event|0|||
49034660|NCT00906399|157963501|FG004|Year 1|Adverse Event|0|||
49034661|NCT00906399|157963502|FG005|Year 1|Adverse Event|0|||
49034662|NCT00906399|157963503|FG006|Year 1|Adverse Event|0|||
49034663|NCT00906399|157963497|FG000|Year 1|Lost to Follow-up|4|||
49034664|NCT00906399|157963498|FG001|Year 1|Lost to Follow-up|4|||
49034665|NCT00906399|157963499|FG002|Year 1|Lost to Follow-up|2|||
49034666|NCT00906399|157963500|FG003|Year 1|Lost to Follow-up|0|||
49034667|NCT00906399|157963501|FG004|Year 1|Lost to Follow-up|0|||
49034668|NCT00906399|157963502|FG005|Year 1|Lost to Follow-up|0|||
49034669|NCT00906399|157963503|FG006|Year 1|Lost to Follow-up|0|||
49034670|NCT00906399|157963497|FG000|Year 1|Withdrawal by Subject|30|||
49034671|NCT00906399|157963498|FG001|Year 1|Withdrawal by Subject|32|||
49034672|NCT00906399|157963499|FG002|Year 1|Withdrawal by Subject|36|||
49034673|NCT00906399|157963500|FG003|Year 1|Withdrawal by Subject|0|||
49034674|NCT00906399|157963501|FG004|Year 1|Withdrawal by Subject|0|||
49034675|NCT00906399|157963502|FG005|Year 1|Withdrawal by Subject|0|||
49034676|NCT00906399|157963503|FG006|Year 1|Withdrawal by Subject|0|||
49034677|NCT00906399|157963497|FG000|Year 1|Physician Decision|0|||
49034678|NCT00906399|157963498|FG001|Year 1|Physician Decision|1|||
49034679|NCT00906399|157963499|FG002|Year 1|Physician Decision|3|||
49034680|NCT00906399|157963500|FG003|Year 1|Physician Decision|0|||
49034681|NCT00906399|157963501|FG004|Year 1|Physician Decision|0|||
49034682|NCT00906399|157963502|FG005|Year 1|Physician Decision|0|||
49034683|NCT00906399|157963503|FG006|Year 1|Physician Decision|0|||
49034684|NCT00906399|157963497|FG000|Year 1|Death|2|||
49034685|NCT00906399|157963498|FG001|Year 1|Death|1|||
49034686|NCT00906399|157963499|FG002|Year 1|Death|1|||
49034687|NCT00906399|157963500|FG003|Year 1|Death|0|||
49034688|NCT00906399|157963501|FG004|Year 1|Death|0|||
49034689|NCT00906399|157963502|FG005|Year 1|Death|0|||
49034690|NCT00906399|157963503|FG006|Year 1|Death|0|||
49034691|NCT00906399|157963497|FG000|Year 1|Other|4|||
49034692|NCT00906399|157963498|FG001|Year 1|Other|2|||
49034693|NCT00906399|157963499|FG002|Year 1|Other|7|||
49034694|NCT00906399|157963500|FG003|Year 1|Other|0|||
49034695|NCT00906399|157963501|FG004|Year 1|Other|0|||
49034696|NCT00906399|157963502|FG005|Year 1|Other|0|||
49034697|NCT00906399|157963503|FG006|Year 1|Other|0|||
49034698|NCT00906399|157963497|FG000|Year 2|Adverse Event|0|||
49034699|NCT00906399|157963498|FG001|Year 2|Adverse Event|0|||
49034700|NCT00906399|157963499|FG002|Year 2|Adverse Event|0|||
49034701|NCT00906399|157963500|FG003|Year 2|Adverse Event|9|||
49034702|NCT00906399|157963501|FG004|Year 2|Adverse Event|8|||
48883693|NCT02240238|157411266|FG004|Phase 1|Adverse Event|0|||
48883694|NCT02240238|157411267|FG005|Phase 1|Adverse Event|0|||
48883695|NCT02240238|157411268|FG006|Phase 1|Adverse Event|3|||
48883696|NCT02240238|157411269|FG007|Phase 1|Adverse Event|1|||
48883697|NCT02240238|157411270|FG008|Phase 1|Adverse Event|0|||
49034703|NCT00906399|157963502|FG005|Year 2|Adverse Event|11|||
49034704|NCT00906399|157963503|FG006|Year 2|Adverse Event|6|||
49034705|NCT00906399|157963497|FG000|Year 2|Lost to Follow-up|0|||
49034706|NCT00906399|157963498|FG001|Year 2|Lost to Follow-up|0|||
49034707|NCT00906399|157963499|FG002|Year 2|Lost to Follow-up|0|||
49034708|NCT00906399|157963500|FG003|Year 2|Lost to Follow-up|1|||
49034709|NCT00906399|157963501|FG004|Year 2|Lost to Follow-up|4|||
49034710|NCT00906399|157963502|FG005|Year 2|Lost to Follow-up|2|||
49034711|NCT00906399|157963503|FG006|Year 2|Lost to Follow-up|4|||
48883698|NCT02240238|157411271|FG009|Phase 1|Adverse Event|0|||
48883699|NCT02240238|157411272|FG010|Phase 1|Adverse Event|0|||
49034712|NCT00906399|157963497|FG000|Year 2|Withdrawal by Subject|0|||
49034713|NCT00906399|157963498|FG001|Year 2|Withdrawal by Subject|0|||
49034714|NCT00906399|157963499|FG002|Year 2|Withdrawal by Subject|0|||
49034715|NCT00906399|157963500|FG003|Year 2|Withdrawal by Subject|17|||
49034716|NCT00906399|157963501|FG004|Year 2|Withdrawal by Subject|18|||
49034717|NCT00906399|157963502|FG005|Year 2|Withdrawal by Subject|27|||
49034718|NCT00906399|157963503|FG006|Year 2|Withdrawal by Subject|13|||
49034719|NCT00906399|157963497|FG000|Year 2|Physician Decision|0|||
49034720|NCT00906399|157963498|FG001|Year 2|Physician Decision|0|||
49034721|NCT00906399|157963499|FG002|Year 2|Physician Decision|0|||
49034722|NCT00906399|157963500|FG003|Year 2|Physician Decision|0|||
48883700|NCT02240238|157411273|FG011|Phase 1|Adverse Event|0|||
48883701|NCT02240238|157411262|FG000|Phase 1|Death|0|||
48883702|NCT02240238|157411263|FG001|Phase 1|Death|0|||
48883703|NCT02240238|157411264|FG002|Phase 1|Death|0|||
48883704|NCT02240238|157411265|FG003|Phase 1|Death|0|||
48883705|NCT02240238|157411266|FG004|Phase 1|Death|0|||
48883706|NCT02240238|157411267|FG005|Phase 1|Death|1|||
48883707|NCT02240238|157411268|FG006|Phase 1|Death|0|||
48883708|NCT02240238|157411269|FG007|Phase 1|Death|0|||
48883709|NCT02240238|157411270|FG008|Phase 1|Death|0|||
48883710|NCT02240238|157411271|FG009|Phase 1|Death|0|||
48883711|NCT02240238|157411272|FG010|Phase 1|Death|0|||
48883712|NCT02240238|157411273|FG011|Phase 1|Death|0|||
48883713|NCT02240238|157411262|FG000|Phase 1|Sponsor termination|0|||
48883714|NCT02240238|157411263|FG001|Phase 1|Sponsor termination|0|||
48883715|NCT02240238|157411264|FG002|Phase 1|Sponsor termination|0|||
48883716|NCT02240238|157411265|FG003|Phase 1|Sponsor termination|0|||
48883717|NCT02240238|157411266|FG004|Phase 1|Sponsor termination|0|||
48883718|NCT02240238|157411267|FG005|Phase 1|Sponsor termination|1|||
48883719|NCT02240238|157411268|FG006|Phase 1|Sponsor termination|0|||
48883720|NCT02240238|157411269|FG007|Phase 1|Sponsor termination|0|||
48883721|NCT02240238|157411270|FG008|Phase 1|Sponsor termination|0|||
48883722|NCT02240238|157411271|FG009|Phase 1|Sponsor termination|0|||
48883723|NCT02240238|157411272|FG010|Phase 1|Sponsor termination|0|||
48883724|NCT02240238|157411273|FG011|Phase 1|Sponsor termination|0|||
48883725|NCT02240238|157411262|FG000|Phase 1|Withdrawal by Subject|0|||
48883726|NCT02240238|157411263|FG001|Phase 1|Withdrawal by Subject|0|||
48883727|NCT02240238|157411264|FG002|Phase 1|Withdrawal by Subject|0|||
48883728|NCT02240238|157411265|FG003|Phase 1|Withdrawal by Subject|0|||
48883729|NCT02240238|157411266|FG004|Phase 1|Withdrawal by Subject|0|||
48883730|NCT02240238|157411267|FG005|Phase 1|Withdrawal by Subject|2|||
48883731|NCT02240238|157411268|FG006|Phase 1|Withdrawal by Subject|0|||
48883732|NCT02240238|157411269|FG007|Phase 1|Withdrawal by Subject|0|||
48883733|NCT02240238|157411270|FG008|Phase 1|Withdrawal by Subject|0|||
48883734|NCT02240238|157411271|FG009|Phase 1|Withdrawal by Subject|0|||
48883735|NCT02240238|157411272|FG010|Phase 1|Withdrawal by Subject|0|||
48883736|NCT02240238|157411273|FG011|Phase 1|Withdrawal by Subject|0|||
48883737|NCT02240238|157411262|FG000|Phase 1|Physician Decision|0|||
48883738|NCT02240238|157411263|FG001|Phase 1|Physician Decision|0|||
48883739|NCT02240238|157411264|FG002|Phase 1|Physician Decision|0|||
48883740|NCT02240238|157411265|FG003|Phase 1|Physician Decision|0|||
48883741|NCT02240238|157411266|FG004|Phase 1|Physician Decision|0|||
48883742|NCT02240238|157411267|FG005|Phase 1|Physician Decision|2|||
48883743|NCT02240238|157411268|FG006|Phase 1|Physician Decision|0|||
48883744|NCT02240238|157411269|FG007|Phase 1|Physician Decision|0|||
48883745|NCT02240238|157411270|FG008|Phase 1|Physician Decision|0|||
48883746|NCT02240238|157411271|FG009|Phase 1|Physician Decision|0|||
48883747|NCT02240238|157411272|FG010|Phase 1|Physician Decision|0|||
48883748|NCT02240238|157411273|FG011|Phase 1|Physician Decision|0|||
48883749|NCT02240238|157411262|FG000|Phase 2|Adverse Event|0|||
48883750|NCT02240238|157411263|FG001|Phase 2|Adverse Event|0|||
48883751|NCT02240238|157411264|FG002|Phase 2|Adverse Event|0|||
48883752|NCT02240238|157411265|FG003|Phase 2|Adverse Event|0|||
48883753|NCT02240238|157411266|FG004|Phase 2|Adverse Event|0|||
48883754|NCT02240238|157411267|FG005|Phase 2|Adverse Event|0|||
48883755|NCT02240238|157411268|FG006|Phase 2|Adverse Event|0|||
48883756|NCT02240238|157411269|FG007|Phase 2|Adverse Event|0|||
48883757|NCT02240238|157411270|FG008|Phase 2|Adverse Event|0|||
48883758|NCT02240238|157411271|FG009|Phase 2|Adverse Event|7|||
48883759|NCT02240238|157411272|FG010|Phase 2|Adverse Event|14|||
48883760|NCT02240238|157411273|FG011|Phase 2|Adverse Event|2|||
48883761|NCT02240238|157411262|FG000|Phase 2|Death|0|||
48883762|NCT02240238|157411263|FG001|Phase 2|Death|0|||
48883763|NCT02240238|157411264|FG002|Phase 2|Death|0|||
48883764|NCT02240238|157411265|FG003|Phase 2|Death|0|||
48883765|NCT02240238|157411266|FG004|Phase 2|Death|0|||
48883766|NCT02240238|157411267|FG005|Phase 2|Death|0|||
48883767|NCT02240238|157411268|FG006|Phase 2|Death|0|||
48883768|NCT02240238|157411269|FG007|Phase 2|Death|0|||
48692500|NCT00453154|156724506|FG003|Double BIind Maintenance|Adverse Event|12|||
48883769|NCT02240238|157411270|FG008|Phase 2|Death|0|||
48883770|NCT02240238|157411271|FG009|Phase 2|Death|3|||
48883771|NCT02240238|157411272|FG010|Phase 2|Death|2|||
48883772|NCT02240238|157411273|FG011|Phase 2|Death|1|||
48883773|NCT02240238|157411262|FG000|Phase 2|Disease progression|0|||
48883774|NCT02240238|157411263|FG001|Phase 2|Disease progression|0|||
48883775|NCT02240238|157411264|FG002|Phase 2|Disease progression|0|||
48883776|NCT02240238|157411265|FG003|Phase 2|Disease progression|0|||
48883777|NCT02240238|157411266|FG004|Phase 2|Disease progression|0|||
48883778|NCT02240238|157411267|FG005|Phase 2|Disease progression|0|||
48883779|NCT02240238|157411268|FG006|Phase 2|Disease progression|0|||
48883780|NCT02240238|157411269|FG007|Phase 2|Disease progression|0|||
48883781|NCT02240238|157411270|FG008|Phase 2|Disease progression|0|||
48883782|NCT02240238|157411271|FG009|Phase 2|Disease progression|5|||
48883783|NCT02240238|157411272|FG010|Phase 2|Disease progression|11|||
48883784|NCT02240238|157411273|FG011|Phase 2|Disease progression|1|||
48883785|NCT02240238|157411262|FG000|Phase 2|Withdrawal by Subject|0|||
48883786|NCT02240238|157411263|FG001|Phase 2|Withdrawal by Subject|0|||
48883787|NCT02240238|157411264|FG002|Phase 2|Withdrawal by Subject|0|||
48883788|NCT02240238|157411265|FG003|Phase 2|Withdrawal by Subject|0|||
48883789|NCT02240238|157411266|FG004|Phase 2|Withdrawal by Subject|0|||
48883790|NCT02240238|157411267|FG005|Phase 2|Withdrawal by Subject|0|||
48883791|NCT02240238|157411268|FG006|Phase 2|Withdrawal by Subject|0|||
48883792|NCT02240238|157411269|FG007|Phase 2|Withdrawal by Subject|0|||
48883793|NCT02240238|157411270|FG008|Phase 2|Withdrawal by Subject|0|||
48883794|NCT02240238|157411271|FG009|Phase 2|Withdrawal by Subject|1|||
48883795|NCT02240238|157411272|FG010|Phase 2|Withdrawal by Subject|1|||
48883796|NCT02240238|157411273|FG011|Phase 2|Withdrawal by Subject|0|||
48883797|NCT02240238|157411262|FG000|Phase 2|Physician Decision|0|||
48883798|NCT02240238|157411263|FG001|Phase 2|Physician Decision|0|||
48883799|NCT02240238|157411264|FG002|Phase 2|Physician Decision|0|||
48883800|NCT02240238|157411265|FG003|Phase 2|Physician Decision|0|||
48883801|NCT02240238|157411266|FG004|Phase 2|Physician Decision|0|||
48883802|NCT02240238|157411267|FG005|Phase 2|Physician Decision|0|||
48883803|NCT02240238|157411268|FG006|Phase 2|Physician Decision|0|||
48883804|NCT02240238|157411269|FG007|Phase 2|Physician Decision|0|||
49034723|NCT00906399|157963501|FG004|Year 2|Physician Decision|2|||
48883805|NCT02240238|157411270|FG008|Phase 2|Physician Decision|0|||
48883806|NCT02240238|157411271|FG009|Phase 2|Physician Decision|1|||
48883807|NCT02240238|157411272|FG010|Phase 2|Physician Decision|3|||
48883808|NCT02240238|157411273|FG011|Phase 2|Physician Decision|0|||
48883809|NCT02240238|157411262|FG000|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
48883810|NCT02240238|157411263|FG001|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
48883811|NCT02240238|157411264|FG002|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
48883812|NCT02240238|157411265|FG003|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
48883813|NCT02240238|157411266|FG004|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
48883814|NCT02240238|157411267|FG005|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
48883815|NCT02240238|157411268|FG006|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
48883816|NCT02240238|157411269|FG007|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
48883817|NCT02240238|157411270|FG008|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
48883818|NCT02240238|157411271|FG009|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|1|||
48883819|NCT02240238|157411272|FG010|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
48883820|NCT02240238|157411273|FG011|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
48883821|NCT02240238|157411262|FG000|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
48883822|NCT02240238|157411263|FG001|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
48883823|NCT02240238|157411264|FG002|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
49034724|NCT00906399|157963502|FG005|Year 2|Physician Decision|6|||
49034725|NCT00906399|157963503|FG006|Year 2|Physician Decision|3|||
48883824|NCT02240238|157411265|FG003|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
49034726|NCT00906399|157963497|FG000|Year 2|Death|0|||
49034727|NCT00906399|157963498|FG001|Year 2|Death|0|||
49034728|NCT00906399|157963499|FG002|Year 2|Death|0|||
49034729|NCT00906399|157963500|FG003|Year 2|Death|1|||
49034730|NCT00906399|157963501|FG004|Year 2|Death|0|||
49034731|NCT00906399|157963502|FG005|Year 2|Death|0|||
49034732|NCT00906399|157963503|FG006|Year 2|Death|3|||
49034733|NCT00906399|157963497|FG000|Year 2|Other|0|||
49034734|NCT00906399|157963498|FG001|Year 2|Other|0|||
49034735|NCT00906399|157963499|FG002|Year 2|Other|0|||
49034736|NCT00906399|157963500|FG003|Year 2|Other|2|||
49034737|NCT00906399|157963501|FG004|Year 2|Other|3|||
49034738|NCT00906399|157963502|FG005|Year 2|Other|1|||
49034739|NCT00906399|157963503|FG006|Year 2|Other|0|||
49034740|NCT01168856|157963504|FG000|Overall Study|Lost to Follow-up|4|||
49034741|NCT01168856|157963505|FG001|Overall Study|Lost to Follow-up|34|||
49034742|NCT01168856|157963504|FG000|Overall Study|Withdrawal by Subject|6|||
49034743|NCT01168856|157963505|FG001|Overall Study|Withdrawal by Subject|8|||
49034744|NCT01168856|157963504|FG000|Overall Study|Physician Decision|2|||
49034745|NCT01168856|157963505|FG001|Overall Study|Physician Decision|1|||
49034746|NCT01168856|157963504|FG000|Overall Study|Confirmed Quantifiable HCV RNA|0|||
49034747|NCT01168856|157963505|FG001|Overall Study|Confirmed Quantifiable HCV RNA|1|||
49034748|NCT01168856|157963504|FG000|Overall Study|Participant received anti-HCV treatment|1|||
49034749|NCT01168856|157963505|FG001|Overall Study|Participant received anti-HCV treatment|0|||
49034750|NCT01168856|157963504|FG000|Overall Study|Death|0|||
49034751|NCT01168856|157963505|FG001|Overall Study|Death|2|||
49034752|NCT01168856|157963504|FG000|Overall Study|Other|1|||
49034753|NCT01168856|157963505|FG001|Overall Study|Other|291|||
49034754|NCT01168856|157963504|FG000|Overall Study|Protocol Violation|4|||
49034755|NCT01168856|157963505|FG001|Overall Study|Protocol Violation|6|||
48883825|NCT02240238|157411266|FG004|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
48883826|NCT02240238|157411267|FG005|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
48883827|NCT02240238|157411268|FG006|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
48883828|NCT02240238|157411269|FG007|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
48883829|NCT02240238|157411270|FG008|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
48883830|NCT02240238|157411271|FG009|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|1|||
48883831|NCT02240238|157411272|FG010|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
48883832|NCT02240238|157411273|FG011|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
48883833|NCT02240238|157411262|FG000|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
48883834|NCT02240238|157411263|FG001|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
48883835|NCT02240238|157411264|FG002|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
48883836|NCT02240238|157411265|FG003|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
48883837|NCT02240238|157411266|FG004|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
48883838|NCT02240238|157411267|FG005|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
48883839|NCT02240238|157411268|FG006|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
48883840|NCT02240238|157411269|FG007|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
48883841|NCT02240238|157411270|FG008|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
48883842|NCT02240238|157411271|FG009|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
48883843|NCT02240238|157411272|FG010|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|1|||
48883844|NCT02240238|157411273|FG011|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
48883845|NCT02240238|157411262|FG000|Phase 2|TREATMENT DELAY >14 DAYS|0|||
48883846|NCT02240238|157411263|FG001|Phase 2|TREATMENT DELAY >14 DAYS|0|||
48883847|NCT02240238|157411264|FG002|Phase 2|TREATMENT DELAY >14 DAYS|0|||
48883848|NCT02240238|157411265|FG003|Phase 2|TREATMENT DELAY >14 DAYS|0|||
48883849|NCT02240238|157411266|FG004|Phase 2|TREATMENT DELAY >14 DAYS|0|||
48883850|NCT02240238|157411267|FG005|Phase 2|TREATMENT DELAY >14 DAYS|0|||
48883851|NCT02240238|157411268|FG006|Phase 2|TREATMENT DELAY >14 DAYS|0|||
48883852|NCT02240238|157411269|FG007|Phase 2|TREATMENT DELAY >14 DAYS|0|||
48883853|NCT02240238|157411270|FG008|Phase 2|TREATMENT DELAY >14 DAYS|0|||
48883854|NCT02240238|157411271|FG009|Phase 2|TREATMENT DELAY >14 DAYS|0|||
48883855|NCT02240238|157411272|FG010|Phase 2|TREATMENT DELAY >14 DAYS|1|||
48883856|NCT02240238|157411273|FG011|Phase 2|TREATMENT DELAY >14 DAYS|0|||
48883857|NCT02240238|157411262|FG000|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
48883858|NCT02240238|157411263|FG001|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
48883859|NCT02240238|157411264|FG002|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
48883860|NCT02240238|157411265|FG003|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
48883861|NCT02240238|157411266|FG004|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
48883862|NCT02240238|157411267|FG005|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
48883863|NCT02240238|157411268|FG006|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
48883864|NCT02240238|157411269|FG007|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
48883865|NCT02240238|157411270|FG008|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
48883866|NCT02240238|157411271|FG009|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
48883867|NCT02240238|157411272|FG010|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|1|||
48883868|NCT02240238|157411273|FG011|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
48883869|NCT02240238|157411262|FG000|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
48883870|NCT02240238|157411263|FG001|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
48883871|NCT02240238|157411264|FG002|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
48883872|NCT02240238|157411265|FG003|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
48883873|NCT02240238|157411266|FG004|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
48883874|NCT02240238|157411267|FG005|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
48883875|NCT02240238|157411268|FG006|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
48883876|NCT02240238|157411269|FG007|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
48883877|NCT02240238|157411270|FG008|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
48883878|NCT02240238|157411271|FG009|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
48883879|NCT02240238|157411272|FG010|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|1|||
48883880|NCT02240238|157411273|FG011|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
48883881|NCT02240238|157411262|FG000|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
48883882|NCT02240238|157411263|FG001|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
48883883|NCT02240238|157411264|FG002|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
48883884|NCT02240238|157411265|FG003|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
48883885|NCT02240238|157411266|FG004|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
48883886|NCT02240238|157411267|FG005|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
48883887|NCT02240238|157411268|FG006|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
48883888|NCT02240238|157411269|FG007|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
48883889|NCT02240238|157411270|FG008|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
48883890|NCT02240238|157411271|FG009|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
48883891|NCT02240238|157411272|FG010|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|1|||
48883892|NCT02240238|157411273|FG011|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
48883893|NCT02240238|157411262|FG000|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
48883894|NCT02240238|157411263|FG001|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
48883895|NCT02240238|157411264|FG002|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
48883896|NCT02240238|157411265|FG003|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
49034756|NCT00833937|157963508|FG000|Washout|Withdrawal by Subject|1|||
49034757|NCT00833937|157963509|FG001|Washout|Withdrawal by Subject|0|||
49034758|NCT04631562|157963510|FG000|Overall Study|Withdrawal by Subject|0|||
49034759|NCT04631562|157963511|FG001|Overall Study|Withdrawal by Subject|0|||
48883897|NCT02240238|157411266|FG004|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
48883898|NCT02240238|157411267|FG005|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
48883899|NCT02240238|157411268|FG006|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
48883900|NCT02240238|157411269|FG007|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
48883901|NCT02240238|157411270|FG008|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
48883902|NCT02240238|157411271|FG009|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
48883903|NCT02240238|157411272|FG010|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
48883904|NCT02240238|157411273|FG011|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|1|||
48883905|NCT03626220|157411274|FG000|Overall Study|Withdrawal by Subject|2|||
48883906|NCT03626220|157411275|FG001|Overall Study|Withdrawal by Subject|0|||
48883907|NCT00681668|157411276|FG000|Overall Study|Protocol Violation|1|||
48883908|NCT00681668|157411276|FG000|Overall Study|Withdrawal by Subject|1|||
48883909|NCT01200290|157411277|FG000|Treatment Period|Adverse Event|1|||
48883910|NCT01200290|157411277|FG000|Post-Treatment Follow-Up Period|Death|2|||
48883911|NCT01217437|157411278|FG000|Overall Study|Adverse Event|0|||
49034760|NCT04631562|157963512|FG002|Overall Study|Withdrawal by Subject|0|||
49034761|NCT04631562|157963513|FG003|Overall Study|Withdrawal by Subject|0|||
49034762|NCT04631562|157963514|FG004|Overall Study|Withdrawal by Subject|0|||
49034763|NCT04631562|157963515|FG005|Overall Study|Withdrawal by Subject|0|||
49034764|NCT04631562|157963516|FG006|Overall Study|Withdrawal by Subject|0|||
49034765|NCT04631562|157963517|FG007|Overall Study|Withdrawal by Subject|1|||
49034766|NCT04631562|157963518|FG008|Overall Study|Withdrawal by Subject|0|||
49034767|NCT04631562|157963510|FG000|Overall Study|Other|0|||
49034768|NCT04631562|157963511|FG001|Overall Study|Other|0|||
49034769|NCT04631562|157963512|FG002|Overall Study|Other|0|||
49034770|NCT04631562|157963513|FG003|Overall Study|Other|0|||
49034771|NCT04631562|157963514|FG004|Overall Study|Other|0|||
49034772|NCT04631562|157963515|FG005|Overall Study|Other|0|||
49034773|NCT04631562|157963516|FG006|Overall Study|Other|0|||
49034774|NCT04631562|157963517|FG007|Overall Study|Other|0|||
49034775|NCT04631562|157963518|FG008|Overall Study|Other|1|||
49034776|NCT04631562|157963510|FG000|Overall Study|Lost to Follow-up|0|||
48883912|NCT01217437|157411279|FG001|Overall Study|Adverse Event|8|||
48883913|NCT01217437|157411278|FG000|Overall Study|Death|5|||
48883914|NCT01217437|157411279|FG001|Overall Study|Death|0|||
48883915|NCT01217437|157411278|FG000|Overall Study|Lack of Efficacy|29|||
48883916|NCT01217437|157411279|FG001|Overall Study|Lack of Efficacy|25|||
48883917|NCT01217437|157411278|FG000|Overall Study|Physician Decision|8|||
48883918|NCT01217437|157411279|FG001|Overall Study|Physician Decision|5|||
48883919|NCT01217437|157411278|FG000|Overall Study|Withdrawal by Subject|0|||
48883920|NCT01217437|157411279|FG001|Overall Study|Withdrawal by Subject|2|||
48883921|NCT01217437|157411278|FG000|Overall Study|Ineligible|1|||
48883922|NCT01217437|157411279|FG001|Overall Study|Ineligible|1|||
48883923|NCT00862836|157411280|FG000|Overall Study|Withdrawal by Subject|1|||
48883924|NCT01144377|157411281|FG000|52 Week Treatment Period|Adverse Event|0|||
48883925|NCT01144377|157411282|FG001|52 Week Treatment Period|Adverse Event|0|||
48883926|NCT01144377|157411283|FG002|52 Week Treatment Period|Adverse Event|3|||
48883927|NCT01144377|157411284|FG003|52 Week Treatment Period|Adverse Event|2|||
49034777|NCT04631562|157963511|FG001|Overall Study|Lost to Follow-up|0|||
48883928|NCT01144377|157411285|FG004|52 Week Treatment Period|Adverse Event|1|||
48883929|NCT01144377|157411281|FG000|52 Week Treatment Period|Entry Criteria Not Met|0|||
48883930|NCT01144377|157411282|FG001|52 Week Treatment Period|Entry Criteria Not Met|0|||
48883931|NCT01144377|157411283|FG002|52 Week Treatment Period|Entry Criteria Not Met|1|||
48883932|NCT01144377|157411284|FG003|52 Week Treatment Period|Entry Criteria Not Met|1|||
48883933|NCT01144377|157411285|FG004|52 Week Treatment Period|Entry Criteria Not Met|0|||
49034778|NCT04631562|157963512|FG002|Overall Study|Lost to Follow-up|0|||
49034779|NCT04631562|157963513|FG003|Overall Study|Lost to Follow-up|1|||
49034780|NCT04631562|157963514|FG004|Overall Study|Lost to Follow-up|0|||
49034781|NCT04631562|157963515|FG005|Overall Study|Lost to Follow-up|0|||
49034782|NCT04631562|157963516|FG006|Overall Study|Lost to Follow-up|0|||
48883934|NCT01144377|157411281|FG000|52 Week Treatment Period|Protocol Violation|0|||
48883935|NCT01144377|157411282|FG001|52 Week Treatment Period|Protocol Violation|0|||
48883936|NCT01144377|157411283|FG002|52 Week Treatment Period|Protocol Violation|0|||
48883937|NCT01144377|157411284|FG003|52 Week Treatment Period|Protocol Violation|0|||
48883938|NCT01144377|157411285|FG004|52 Week Treatment Period|Protocol Violation|1|||
48883939|NCT01144377|157411281|FG000|52 Week Treatment Period|Lost to Follow-up|1|||
48883940|NCT01144377|157411282|FG001|52 Week Treatment Period|Lost to Follow-up|0|||
48883941|NCT01144377|157411283|FG002|52 Week Treatment Period|Lost to Follow-up|0|||
48883942|NCT01144377|157411284|FG003|52 Week Treatment Period|Lost to Follow-up|0|||
48883943|NCT01144377|157411285|FG004|52 Week Treatment Period|Lost to Follow-up|0|||
48883944|NCT01144377|157411281|FG000|52 Week Treatment Period|Withdrawal by Subject|4|||
48883945|NCT01144377|157411282|FG001|52 Week Treatment Period|Withdrawal by Subject|1|||
48883946|NCT01144377|157411283|FG002|52 Week Treatment Period|Withdrawal by Subject|1|||
48883947|NCT01144377|157411284|FG003|52 Week Treatment Period|Withdrawal by Subject|1|||
48883948|NCT01144377|157411285|FG004|52 Week Treatment Period|Withdrawal by Subject|0|||
48883949|NCT01144377|157411281|FG000|52 Week Treatment Period|Sponsor Decision|0|||
48883950|NCT01144377|157411282|FG001|52 Week Treatment Period|Sponsor Decision|0|||
48883951|NCT01144377|157411283|FG002|52 Week Treatment Period|Sponsor Decision|0|||
48883952|NCT01144377|157411284|FG003|52 Week Treatment Period|Sponsor Decision|0|||
48883953|NCT01144377|157411285|FG004|52 Week Treatment Period|Sponsor Decision|1|||
48883954|NCT01144377|157411281|FG000|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
48883955|NCT01144377|157411282|FG001|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
48883956|NCT01144377|157411283|FG002|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
48883957|NCT01144377|157411284|FG003|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
48883958|NCT01144377|157411285|FG004|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
48883959|NCT01144377|157411281|FG000|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
48883960|NCT01144377|157411282|FG001|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
48883961|NCT01144377|157411283|FG002|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
48883962|NCT01144377|157411284|FG003|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
48883963|NCT01144377|157411285|FG004|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1|||
48883964|NCT01144377|157411281|FG000|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1|||
48883965|NCT01144377|157411282|FG001|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
48883966|NCT01144377|157411283|FG002|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
48883967|NCT01144377|157411284|FG003|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
48883968|NCT01144377|157411285|FG004|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
48883969|NCT02951052|157412403|FG000|Overall Study|Adverse Event|13|||
48883970|NCT02951052|157412404|FG001|Overall Study|Adverse Event|5|||
48883971|NCT02951052|157412403|FG000|Overall Study|Withdrawal by Subject|1|||
48883972|NCT02951052|157412404|FG001|Overall Study|Withdrawal by Subject|5|||
48883973|NCT02951052|157412403|FG000|Overall Study|Physician Decision|2|||
48883974|NCT02951052|157412404|FG001|Overall Study|Physician Decision|0|||
48883975|NCT02951052|157412403|FG000|Overall Study|Lost to Follow-up|1|||
48883976|NCT02951052|157412404|FG001|Overall Study|Lost to Follow-up|1|||
48883977|NCT02951052|157412403|FG000|Overall Study|Protocol-specified withdrawal criterion|1|||
48883978|NCT02951052|157412404|FG001|Overall Study|Protocol-specified withdrawal criterion|0|||
48883979|NCT02951052|157412403|FG000|Overall Study|Protocol Violation|5|||
48883980|NCT02951052|157412404|FG001|Overall Study|Protocol Violation|3|||
48883981|NCT02951052|157412403|FG000|Overall Study|Lack of Efficacy|3|||
48883982|NCT02951052|157412404|FG001|Overall Study|Lack of Efficacy|4|||
48883983|NCT02951052|157412403|FG000|Overall Study|Ongoing|1|||
48883984|NCT02951052|157412404|FG001|Overall Study|Ongoing|0|||
48883985|NCT04710576|157412405|FG000|Overall Study|Participants still in the study|73|||
48883986|NCT04710576|157412406|FG001|Overall Study|Participants still in the study|70|||
48883987|NCT04710576|157412407|FG002|Overall Study|Participants still in the study|60|||
48883988|NCT04710576|157412405|FG000|Overall Study|Death|2|||
48883989|NCT04710576|157412406|FG001|Overall Study|Death|7|||
48883990|NCT04710576|157412407|FG002|Overall Study|Death|12|||
48883991|NCT04710576|157412405|FG000|Overall Study|Withdrawal by Subject|4|||
48883992|NCT04710576|157412406|FG001|Overall Study|Withdrawal by Subject|3|||
48883993|NCT04710576|157412407|FG002|Overall Study|Withdrawal by Subject|7|||
49034783|NCT04631562|157963517|FG007|Overall Study|Lost to Follow-up|0|||
48883994|NCT04710576|157412405|FG000|Overall Study|Sponsor decision|1|||
48883995|NCT04710576|157412406|FG001|Overall Study|Sponsor decision|0|||
48883996|NCT04710576|157412407|FG002|Overall Study|Sponsor decision|0|||
48883997|NCT01850589|157412410|FG000|Overall Study|Withdrawal by Subject|8|||
48883998|NCT01850589|157412411|FG001|Overall Study|Withdrawal by Subject|0|||
48883999|NCT01250925|157412421|FG000|Overall Study|Lost to Follow-up|1|||
48884000|NCT01250925|157412422|FG001|Overall Study|Lost to Follow-up|1|||
48884001|NCT01250925|157412423|FG002|Overall Study|Lost to Follow-up|0|||
48884002|NCT01250925|157412421|FG000|Overall Study|Withdrawal by Subject|2|||
48884003|NCT01250925|157412422|FG001|Overall Study|Withdrawal by Subject|0|||
49034784|NCT04631562|157963518|FG008|Overall Study|Lost to Follow-up|0|||
49034785|NCT04631562|157963510|FG000|Overall Study|Adverse Event|0|||
48884004|NCT01250925|157412423|FG002|Overall Study|Withdrawal by Subject|0|||
48884005|NCT01250925|157412421|FG000|Overall Study|Protocol Violation|2|||
48884006|NCT01250925|157412422|FG001|Overall Study|Protocol Violation|0|||
48884007|NCT01250925|157412423|FG002|Overall Study|Protocol Violation|0|||
48884008|NCT01250925|157412421|FG000|Overall Study|Physician Decision|0|||
48884009|NCT01250925|157412422|FG001|Overall Study|Physician Decision|2|||
48884010|NCT01250925|157412423|FG002|Overall Study|Physician Decision|1|||
48884011|NCT01250925|157412421|FG000|Overall Study|Adverse Event|0|||
48884012|NCT01250925|157412422|FG001|Overall Study|Adverse Event|0|||
48884013|NCT01250925|157412423|FG002|Overall Study|Adverse Event|1|||
48884014|NCT03895203|157412424|FG000|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
48884015|NCT03895203|157412425|FG001|Double-Blind Treatment Period: 16 Weeks|Adverse Event|8|||
48884016|NCT03895203|157412426|FG002|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
48884017|NCT03895203|157412427|FG003|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
48884018|NCT03895203|157412428|FG004|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
48884019|NCT03895203|157412429|FG005|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
48884020|NCT03895203|157412424|FG000|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|2|||
48884021|NCT03895203|157412425|FG001|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
48884022|NCT03895203|157412426|FG002|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
48884023|NCT03895203|157412427|FG003|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
48884024|NCT03895203|157412428|FG004|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
48884025|NCT03895203|157412429|FG005|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
48884026|NCT03895203|157412424|FG000|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|2|||
48884027|NCT03895203|157412425|FG001|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
48884028|NCT03895203|157412426|FG002|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
48884029|NCT03895203|157412427|FG003|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
48884030|NCT03895203|157412428|FG004|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
48884031|NCT03895203|157412429|FG005|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
48884032|NCT03895203|157412424|FG000|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|4|||
48884033|NCT03895203|157412425|FG001|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|6|||
48884034|NCT03895203|157412426|FG002|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|1|||
48884035|NCT03895203|157412427|FG003|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
48884036|NCT03895203|157412428|FG004|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
48884037|NCT03895203|157412429|FG005|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
48884038|NCT03895203|157412424|FG000|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
48884039|NCT03895203|157412425|FG001|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|1|||
48884040|NCT03895203|157412426|FG002|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
48884041|NCT03895203|157412427|FG003|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
48884042|NCT03895203|157412428|FG004|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
48884043|NCT03895203|157412429|FG005|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
48884044|NCT03895203|157412424|FG000|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
48884045|NCT03895203|157412425|FG001|Double-Blind Treatment Period: 16 Weeks|Site terminated|1|||
48884046|NCT03895203|157412426|FG002|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
48884047|NCT03895203|157412427|FG003|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
48884048|NCT03895203|157412428|FG004|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
48884049|NCT03895203|157412429|FG005|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
48884050|NCT03895203|157412424|FG000|Active Treatment-Blind Period: 36 Weeks|Death|0|||
48884051|NCT03895203|157412425|FG001|Active Treatment-Blind Period: 36 Weeks|Death|0|||
48884052|NCT03895203|157412426|FG002|Active Treatment-Blind Period: 36 Weeks|Death|0|||
48884053|NCT03895203|157412427|FG003|Active Treatment-Blind Period: 36 Weeks|Death|1|||
48884054|NCT03895203|157412428|FG004|Active Treatment-Blind Period: 36 Weeks|Death|0|||
48884055|NCT03895203|157412429|FG005|Active Treatment-Blind Period: 36 Weeks|Death|0|||
48884056|NCT03895203|157412424|FG000|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
48884057|NCT03895203|157412425|FG001|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
48884058|NCT03895203|157412426|FG002|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
48884059|NCT03895203|157412427|FG003|Active Treatment-Blind Period: 36 Weeks|Adverse Event|5|||
48884060|NCT03895203|157412428|FG004|Active Treatment-Blind Period: 36 Weeks|Adverse Event|9|||
48884061|NCT03895203|157412429|FG005|Active Treatment-Blind Period: 36 Weeks|Adverse Event|4|||
48884062|NCT03895203|157412424|FG000|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
48884063|NCT03895203|157412425|FG001|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
48884064|NCT03895203|157412426|FG002|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
48884065|NCT03895203|157412427|FG003|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|1|||
48884066|NCT03895203|157412428|FG004|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|6|||
48884067|NCT03895203|157412429|FG005|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|4|||
48884068|NCT03895203|157412424|FG000|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
48884069|NCT03895203|157412425|FG001|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
48884070|NCT03895203|157412426|FG002|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
48884071|NCT03895203|157412427|FG003|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|1|||
48884072|NCT03895203|157412428|FG004|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|3|||
49034786|NCT04631562|157963511|FG001|Overall Study|Adverse Event|0|||
49034787|NCT04631562|157963512|FG002|Overall Study|Adverse Event|0|||
49034788|NCT04631562|157963513|FG003|Overall Study|Adverse Event|0|||
49034789|NCT04631562|157963514|FG004|Overall Study|Adverse Event|0|||
49034790|NCT04631562|157963515|FG005|Overall Study|Adverse Event|0|||
48884073|NCT03895203|157412429|FG005|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
49034791|NCT04631562|157963516|FG006|Overall Study|Adverse Event|1|||
49034792|NCT04631562|157963517|FG007|Overall Study|Adverse Event|0|||
49034793|NCT04631562|157963518|FG008|Overall Study|Adverse Event|0|||
49034794|NCT00835536|157963519|FG000|Washout of 5 Weeks|Withdrawal by Subject|1|||
49034795|NCT00835536|157963520|FG001|Washout of 5 Weeks|Withdrawal by Subject|0|||
49034796|NCT02139826|157963523|FG000|Overall Study|Adverse Event|1|||
49034797|NCT02911701|157963526|FG000|Overall Study|Withdrawal by Subject|2|||
49034798|NCT02911701|157963527|FG001|Overall Study|Withdrawal by Subject|4|||
49034799|NCT02911701|157963526|FG000|Overall Study|Adverse Event|1|||
49034800|NCT02911701|157963527|FG001|Overall Study|Adverse Event|0|||
49034801|NCT00489307|157963530|FG000|Overall Study|Death|1|||
49034802|NCT00489307|157963531|FG001|Overall Study|Death|1|||
49034803|NCT00489307|157963530|FG000|Overall Study|Lost to Follow-up|2|||
49034804|NCT00489307|157963531|FG001|Overall Study|Lost to Follow-up|2|||
49034805|NCT00489307|157963530|FG000|Overall Study|Physician Decision|1|||
49034806|NCT00489307|157963531|FG001|Overall Study|Physician Decision|0|||
49034807|NCT00489307|157963530|FG000|Overall Study|Withdrawal by Subject|2|||
48884074|NCT03895203|157412424|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
48884075|NCT03895203|157412425|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
48884076|NCT03895203|157412426|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
48884077|NCT03895203|157412427|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|4|||
48884078|NCT03895203|157412428|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|9|||
48884079|NCT03895203|157412429|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|2|||
48884080|NCT03895203|157412424|FG000|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
48884081|NCT03895203|157412425|FG001|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
48884082|NCT03895203|157412426|FG002|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
48884083|NCT03895203|157412427|FG003|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|1|||
48884084|NCT03895203|157412428|FG004|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
48884085|NCT03895203|157412429|FG005|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
48884086|NCT03895203|157412424|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
48884087|NCT03895203|157412425|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
48884088|NCT03895203|157412426|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
48884089|NCT03895203|157412427|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|1|||
48884090|NCT03895203|157412428|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
48884091|NCT03895203|157412429|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
48884092|NCT03895203|157412424|FG000|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
48884093|NCT03895203|157412425|FG001|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
48884094|NCT03895203|157412426|FG002|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
48884095|NCT03895203|157412427|FG003|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
48884096|NCT03895203|157412428|FG004|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
48884097|NCT03895203|157412429|FG005|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|1|||
48884098|NCT03738475|157412431|FG000|Overall Study|Participant Non-Compliance|1|||
48884099|NCT03738475|157412432|FG001|Overall Study|Participant Non-Compliance|0|||
48884100|NCT00332462|157412435|FG000|Overall Study|Adverse Event|5|||
48884101|NCT00332462|157412435|FG000|Overall Study|Abnormal Lab Value|1|||
48884102|NCT00332462|157412435|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
48884103|NCT00332462|157412435|FG000|Overall Study|no longer requires study drug|1|||
49034808|NCT00489307|157963531|FG001|Overall Study|Withdrawal by Subject|4|||
49034809|NCT00489307|157963530|FG000|Overall Study|Hospitalization unrelated to treatment|10|||
49034810|NCT00489307|157963531|FG001|Overall Study|Hospitalization unrelated to treatment|7|||
48884104|NCT00332462|157412435|FG000|Overall Study|Death|3|||
48884105|NCT00332462|157412435|FG000|Overall Study|Graft Loss|2|||
48884106|NCT03046121|157412436|FG000|Overall Study|Death|32|||
48884107|NCT03046121|157412437|FG001|Overall Study|Death|60|||
48884108|NCT03046121|157412436|FG000|Overall Study|Withdrawal by Subject|14|||
48884109|NCT03046121|157412437|FG001|Overall Study|Withdrawal by Subject|12|||
49034811|NCT00489307|157963530|FG000|Overall Study|Surgery after assignment|1|||
49034812|NCT00489307|157963531|FG001|Overall Study|Surgery after assignment|0|||
49034813|NCT00489307|157963530|FG000|Overall Study|Did not fill up the forms|2|||
49034814|NCT00489307|157963531|FG001|Overall Study|Did not fill up the forms|1|||
49034815|NCT00489307|157963530|FG000|Overall Study|Patient or family refusal|5|||
48884110|NCT02159040|157412440|FG000|Overall Study|Death|1|||
48884111|NCT01886287|157412441|FG000|Overall Study|Radiographic disease progression|1|||
48884112|NCT01886287|157412441|FG000|Overall Study|Clinical progression due to disease|1|||
48884113|NCT04019873|157412442|FG000|Overall Study|Discontinued from the treatment|1|||
48884114|NCT04019873|157412443|FG001|Overall Study|Discontinued from the treatment|39|||
48884115|NCT04019873|157412444|FG002|Overall Study|Discontinued from the treatment|2|||
48884116|NCT03392168|157412445|FG000|Period 2: Cohort 2|Lost to Follow-up|0|||
48884117|NCT03392168|157412446|FG001|Period 2: Cohort 2|Lost to Follow-up|1|||
48884118|NCT03392168|157412447|FG002|Period 2: Cohort 2|Lost to Follow-up|1|||
48884119|NCT03392168|157412448|FG003|Period 2: Cohort 2|Lost to Follow-up|1|||
48884120|NCT03392168|157412445|FG000|Period 2: Cohort 2|Other|0|||
48884121|NCT03392168|157412446|FG001|Period 2: Cohort 2|Other|1|||
48884122|NCT03392168|157412447|FG002|Period 2: Cohort 2|Other|0|||
48884123|NCT03392168|157412448|FG003|Period 2: Cohort 2|Other|0|||
48884124|NCT04350463|157412449|FG000|Overall Study|Other reason|0|||
48884125|NCT04350463|157412450|FG001|Overall Study|Other reason|0|||
48884126|NCT04350463|157412451|FG002|Overall Study|Other reason|0|||
49034816|NCT00489307|157963531|FG001|Overall Study|Patient or family refusal|9|||
49034817|NCT03114891|157963534|FG000|First Treatment Round|Lost to Follow-up|0|||
48884127|NCT04350463|157412452|FG003|Overall Study|Other reason|1|||
48884128|NCT04350463|157412449|FG000|Overall Study|Lost to Follow-up|0|||
48884129|NCT04350463|157412450|FG001|Overall Study|Lost to Follow-up|0|||
48884130|NCT04350463|157412451|FG002|Overall Study|Lost to Follow-up|0|||
48884131|NCT04350463|157412452|FG003|Overall Study|Lost to Follow-up|2|||
48884132|NCT04350463|157412449|FG000|Overall Study|Withdrawal by Subject|4|||
48884133|NCT04350463|157412450|FG001|Overall Study|Withdrawal by Subject|0|||
49034818|NCT03114891|157963535|FG001|First Treatment Round|Lost to Follow-up|1|||
48884134|NCT04350463|157412451|FG002|Overall Study|Withdrawal by Subject|1|||
48884135|NCT04350463|157412452|FG003|Overall Study|Withdrawal by Subject|4|||
48884136|NCT04350463|157412449|FG000|Overall Study|Adverse Event|0|||
48884137|NCT04350463|157412450|FG001|Overall Study|Adverse Event|0|||
48884138|NCT04350463|157412451|FG002|Overall Study|Adverse Event|0|||
48884139|NCT04350463|157412452|FG003|Overall Study|Adverse Event|2|||
48884140|NCT04350463|157412449|FG000|Overall Study|Death|27|||
48884141|NCT04350463|157412450|FG001|Overall Study|Death|2|||
48884142|NCT04350463|157412451|FG002|Overall Study|Death|13|||
48884143|NCT04350463|157412452|FG003|Overall Study|Death|26|||
48884144|NCT02683447|157412454|FG000|Overall Study|Lost to Follow-up|2|||
48884145|NCT01399918|157412455|FG000|Overall Study|Not eligible and not enrolled in the study|2|||
48884146|NCT03026075|157412457|FG000|Overall Study|Physician Decision|1|||
48884147|NCT01436253|157412458|FG000|Overall Study|Lost to Follow-up|182|||
48884148|NCT01436253|157412458|FG000|Overall Study|Not meeting all eligibility criteria|117|||
48884149|NCT05269667|157412459|FG000|Overall Study|Study Terminated by Sponsor|4|||
48884150|NCT00623805|157412460|FG000|Overall Study|Adverse Event|9|||
48884151|NCT00623805|157412461|FG001|Overall Study|Adverse Event|6|||
48884152|NCT00623805|157412460|FG000|Overall Study|Death|2|||
48884153|NCT00623805|157412461|FG001|Overall Study|Death|0|||
48884154|NCT00623805|157412460|FG000|Overall Study|Lack of Efficacy|3|||
48884155|NCT00623805|157412461|FG001|Overall Study|Lack of Efficacy|7|||
48884156|NCT00623805|157412460|FG000|Overall Study|Lost to Follow-up|2|||
48884157|NCT00623805|157412461|FG001|Overall Study|Lost to Follow-up|2|||
48884158|NCT00623805|157412460|FG000|Overall Study|Protocol Violation|1|||
48884159|NCT00623805|157412461|FG001|Overall Study|Protocol Violation|1|||
48884160|NCT00623805|157412460|FG000|Overall Study|Reason not Specified|3|||
48884161|NCT00623805|157412461|FG001|Overall Study|Reason not Specified|6|||
48884162|NCT04524364|157412462|FG000|Overall Study|Physician Decision|3|||
48884163|NCT04524364|157412463|FG001|Overall Study|Physician Decision|6|||
48884164|NCT04524364|157412462|FG000|Overall Study|Adverse Event|0|||
48884165|NCT04524364|157412463|FG001|Overall Study|Adverse Event|1|||
48884166|NCT04524364|157412462|FG000|Overall Study|Investigational device deficiency|0|||
48884167|NCT04524364|157412463|FG001|Overall Study|Investigational device deficiency|1|||
48884168|NCT04524364|157412462|FG000|Overall Study|Implantable cardioverter device (ICD) discovered|0|||
48884169|NCT04524364|157412463|FG001|Overall Study|Implantable cardioverter device (ICD) discovered|1|||
48884170|NCT04524364|157412462|FG000|Overall Study|Device unavailability|0|||
48884171|NCT04524364|157412463|FG001|Overall Study|Device unavailability|2|||
48884172|NCT04524364|157412462|FG000|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|1|||
48884173|NCT04524364|157412463|FG001|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|0|||
48884174|NCT04524364|157412462|FG000|Overall Study|Low International normalized ratio (INR)|1|||
48884175|NCT04524364|157412463|FG001|Overall Study|Low International normalized ratio (INR)|0|||
48884176|NCT01946789|157412465|FG000|Overall Study|Death|0|||
48884177|NCT01946789|157412466|FG001|Overall Study|Death|2|||
48884178|NCT01946789|157412467|FG002|Overall Study|Death|1|||
48884179|NCT01946789|157412468|FG003|Overall Study|Death|1|||
48884180|NCT01946789|157412469|FG004|Overall Study|Death|1|||
48884181|NCT01946789|157412470|FG005|Overall Study|Death|1|||
48884182|NCT01946789|157412471|FG006|Overall Study|Death|3|||
48884183|NCT01946789|157412472|FG007|Overall Study|Death|1|||
48884184|NCT01946789|157412473|FG008|Overall Study|Death|2|||
48884185|NCT01946789|157412465|FG000|Overall Study|Progressive Disease|0|||
48884186|NCT01946789|157412466|FG001|Overall Study|Progressive Disease|0|||
48884187|NCT01946789|157412467|FG002|Overall Study|Progressive Disease|1|||
48884188|NCT01946789|157412468|FG003|Overall Study|Progressive Disease|0|||
48983632|NCT00355615|157772319|FG004|40-week Rosuvastatin Open Label Period|investigational site closed|1|||
48983633|NCT01603628|157772320|FG000|Overall Study|Personal Reasons|1|||
48983634|NCT01603628|157772321|FG001|Overall Study|Personal Reasons|1|||
48983635|NCT01603628|157772322|FG002|Overall Study|Personal Reasons|2|||
48983636|NCT01603628|157772320|FG000|Overall Study|Protocol Violation|1|||
48983637|NCT01603628|157772321|FG001|Overall Study|Protocol Violation|1|||
48983638|NCT01603628|157772322|FG002|Overall Study|Protocol Violation|0|||
48983639|NCT01603628|157772320|FG000|Overall Study|Lost to Follow-up|0|||
48884189|NCT01946789|157412469|FG004|Overall Study|Progressive Disease|0|||
48884190|NCT01946789|157412470|FG005|Overall Study|Progressive Disease|2|||
48884191|NCT01946789|157412471|FG006|Overall Study|Progressive Disease|0|||
48884192|NCT01946789|157412472|FG007|Overall Study|Progressive Disease|0|||
48884193|NCT01946789|157412473|FG008|Overall Study|Progressive Disease|0|||
48884194|NCT01946789|157412465|FG000|Overall Study|Withdrawal by Subject|0|||
48884195|NCT01946789|157412466|FG001|Overall Study|Withdrawal by Subject|0|||
48884196|NCT01946789|157412467|FG002|Overall Study|Withdrawal by Subject|0|||
48884197|NCT01946789|157412468|FG003|Overall Study|Withdrawal by Subject|2|||
48884198|NCT01946789|157412469|FG004|Overall Study|Withdrawal by Subject|1|||
48884199|NCT01946789|157412470|FG005|Overall Study|Withdrawal by Subject|0|||
48884200|NCT01946789|157412471|FG006|Overall Study|Withdrawal by Subject|1|||
48884201|NCT01946789|157412472|FG007|Overall Study|Withdrawal by Subject|0|||
48884202|NCT01946789|157412473|FG008|Overall Study|Withdrawal by Subject|0|||
48884203|NCT03517449|157412474|FG000|Overall Study|Death|184|||
48884204|NCT03517449|157412475|FG001|Overall Study|Death|236|||
48884205|NCT03517449|157412474|FG000|Overall Study|Lost to Follow-up|0|||
48884206|NCT03517449|157412475|FG001|Overall Study|Lost to Follow-up|2|||
48884207|NCT03517449|157412474|FG000|Overall Study|Withdrawal by Subject|7|||
48884208|NCT03517449|157412475|FG001|Overall Study|Withdrawal by Subject|26|||
48884209|NCT03517449|157412474|FG000|Overall Study|Participants Ongoing|220|||
48884210|NCT03517449|157412475|FG001|Overall Study|Participants Ongoing|152|||
48884211|NCT01147536|157412480|FG000|Overall Study|Administrative study close|2|||
48884212|NCT01147536|157412480|FG000|Overall Study|Death|1|||
48884213|NCT03762200|157412481|FG000|Overall Study|Death|2|||
48884214|NCT04577001|157412482|FG000|Overall Study|Subject became ineligible|0|||
48884215|NCT04577001|157412483|FG001|Overall Study|Subject became ineligible|1|||
48884216|NCT01214642|157412484|FG000|Overall Study|Progressive Disease|3|||
48884217|NCT01214642|157412485|FG001|Overall Study|Progressive Disease|2|||
48884218|NCT01214642|157412486|FG002|Overall Study|Progressive Disease|3|||
48884219|NCT01214642|157412487|FG003|Overall Study|Progressive Disease|5|||
48884220|NCT01214642|157412488|FG004|Overall Study|Progressive Disease|5|||
48884221|NCT01214642|157412489|FG005|Overall Study|Progressive Disease|3|||
48884222|NCT01214642|157412490|FG006|Overall Study|Progressive Disease|5|||
48884223|NCT01214642|157412491|FG007|Overall Study|Progressive Disease|3|||
48884224|NCT01214642|157412492|FG008|Overall Study|Progressive Disease|10|||
48884225|NCT01214642|157412493|FG009|Overall Study|Progressive Disease|2|||
48884226|NCT01214642|157412494|FG010|Overall Study|Progressive Disease|1|||
48884227|NCT01214642|157412495|FG011|Overall Study|Progressive Disease|4|||
48884228|NCT01214642|157412484|FG000|Overall Study|Adverse Event|0|||
48884229|NCT01214642|157412485|FG001|Overall Study|Adverse Event|1|||
48884230|NCT01214642|157412486|FG002|Overall Study|Adverse Event|0|||
48884231|NCT01214642|157412487|FG003|Overall Study|Adverse Event|0|||
48884232|NCT01214642|157412488|FG004|Overall Study|Adverse Event|0|||
48884233|NCT01214642|157412489|FG005|Overall Study|Adverse Event|0|||
48884234|NCT01214642|157412490|FG006|Overall Study|Adverse Event|1|||
48884235|NCT01214642|157412491|FG007|Overall Study|Adverse Event|0|||
48884236|NCT01214642|157412492|FG008|Overall Study|Adverse Event|0|||
48884237|NCT01214642|157412493|FG009|Overall Study|Adverse Event|1|||
48884238|NCT01214642|157412494|FG010|Overall Study|Adverse Event|1|||
48884239|NCT01214642|157412495|FG011|Overall Study|Adverse Event|0|||
48884240|NCT01214642|157412484|FG000|Overall Study|Death|0|||
48884241|NCT01214642|157412485|FG001|Overall Study|Death|0|||
48884242|NCT01214642|157412486|FG002|Overall Study|Death|1|||
48884243|NCT01214642|157412487|FG003|Overall Study|Death|0|||
48884244|NCT01214642|157412488|FG004|Overall Study|Death|0|||
48884245|NCT01214642|157412489|FG005|Overall Study|Death|0|||
48884246|NCT01214642|157412490|FG006|Overall Study|Death|0|||
48884247|NCT01214642|157412491|FG007|Overall Study|Death|0|||
48983640|NCT01603628|157772321|FG001|Overall Study|Lost to Follow-up|1|||
48983641|NCT01603628|157772322|FG002|Overall Study|Lost to Follow-up|0|||
48983642|NCT01603628|157772320|FG000|Overall Study|Other Miscellaneous Reason|1|||
48884248|NCT01214642|157412492|FG008|Overall Study|Death|0|||
48884249|NCT01214642|157412493|FG009|Overall Study|Death|0|||
48884250|NCT01214642|157412494|FG010|Overall Study|Death|1|||
48884251|NCT01214642|157412495|FG011|Overall Study|Death|0|||
48884252|NCT01214642|157412484|FG000|Overall Study|Withdrawal by Subject|0|||
48884253|NCT01214642|157412485|FG001|Overall Study|Withdrawal by Subject|0|||
48884254|NCT01214642|157412486|FG002|Overall Study|Withdrawal by Subject|1|||
48884255|NCT01214642|157412487|FG003|Overall Study|Withdrawal by Subject|0|||
48884256|NCT01214642|157412488|FG004|Overall Study|Withdrawal by Subject|0|||
48884257|NCT01214642|157412489|FG005|Overall Study|Withdrawal by Subject|0|||
48884258|NCT01214642|157412490|FG006|Overall Study|Withdrawal by Subject|0|||
48884259|NCT01214642|157412491|FG007|Overall Study|Withdrawal by Subject|0|||
48884260|NCT01214642|157412492|FG008|Overall Study|Withdrawal by Subject|3|||
48884261|NCT01214642|157412493|FG009|Overall Study|Withdrawal by Subject|1|||
48884262|NCT01214642|157412494|FG010|Overall Study|Withdrawal by Subject|1|||
48884263|NCT01214642|157412495|FG011|Overall Study|Withdrawal by Subject|0|||
48884264|NCT01214642|157412484|FG000|Overall Study|Physician Decision|0|||
48884265|NCT01214642|157412485|FG001|Overall Study|Physician Decision|0|||
48884266|NCT01214642|157412486|FG002|Overall Study|Physician Decision|1|||
48884267|NCT01214642|157412487|FG003|Overall Study|Physician Decision|1|||
48884268|NCT01214642|157412488|FG004|Overall Study|Physician Decision|1|||
48884269|NCT01214642|157412489|FG005|Overall Study|Physician Decision|0|||
48884270|NCT01214642|157412490|FG006|Overall Study|Physician Decision|0|||
48884271|NCT01214642|157412491|FG007|Overall Study|Physician Decision|0|||
48884272|NCT01214642|157412492|FG008|Overall Study|Physician Decision|0|||
48884273|NCT01214642|157412493|FG009|Overall Study|Physician Decision|0|||
48884274|NCT01214642|157412494|FG010|Overall Study|Physician Decision|0|||
48884275|NCT01214642|157412495|FG011|Overall Study|Physician Decision|2|||
48884276|NCT01064648|157412509|FG000|Phase I Cohort1: Dose Level 1|Progression|5|||
48884277|NCT01064648|157412510|FG001|Phase I Cohort1: Dose Level 1|Progression|0|||
48884278|NCT01064648|157412511|FG002|Phase I Cohort1: Dose Level 1|Progression|0|||
48884279|NCT01064648|157412512|FG003|Phase I Cohort1: Dose Level 1|Progression|0|||
48884280|NCT01064648|157412509|FG000|Phase I Cohort1: Dose Level 1|Non-protocol specified|2|||
48884281|NCT01064648|157412510|FG001|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
48884282|NCT01064648|157412511|FG002|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
48884283|NCT01064648|157412512|FG003|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
48884284|NCT01064648|157412509|FG000|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
48884285|NCT01064648|157412510|FG001|Phase I Cohort 2: Dose Level 2|Adverse Event|3|||
48884286|NCT01064648|157412511|FG002|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
48884287|NCT01064648|157412512|FG003|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
48884288|NCT01064648|157412509|FG000|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
48884289|NCT01064648|157412510|FG001|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1|||
48884290|NCT01064648|157412511|FG002|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
48884291|NCT01064648|157412512|FG003|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
48884292|NCT01064648|157412509|FG000|Phase I Cohort 2: Dose Level 2|Progression|0|||
48884293|NCT01064648|157412510|FG001|Phase I Cohort 2: Dose Level 2|Progression|5|||
48884294|NCT01064648|157412511|FG002|Phase I Cohort 2: Dose Level 2|Progression|0|||
48884295|NCT01064648|157412512|FG003|Phase I Cohort 2: Dose Level 2|Progression|0|||
48884296|NCT01064648|157412509|FG000|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
49034819|NCT03114891|157963536|FG002|First Treatment Round|Lost to Follow-up|1|||
49034820|NCT03114891|157963537|FG003|First Treatment Round|Lost to Follow-up|0|||
49034821|NCT03114891|157963534|FG000|First Treatment Round|Withdrawal by Subject|0|||
49034822|NCT03114891|157963535|FG001|First Treatment Round|Withdrawal by Subject|2|||
49034823|NCT03114891|157963536|FG002|First Treatment Round|Withdrawal by Subject|0|||
49034824|NCT03114891|157963537|FG003|First Treatment Round|Withdrawal by Subject|1|||
49034825|NCT03114891|157963534|FG000|3 Week Break|Lost to Follow-up|1|||
49034826|NCT03114891|157963535|FG001|3 Week Break|Lost to Follow-up|0|||
49034827|NCT03114891|157963536|FG002|3 Week Break|Lost to Follow-up|0|||
49034828|NCT03114891|157963537|FG003|3 Week Break|Lost to Follow-up|1|||
49034829|NCT03114891|157963534|FG000|3 Week Break|Withdrawal by Subject|0|||
49034830|NCT03114891|157963535|FG001|3 Week Break|Withdrawal by Subject|1|||
49034831|NCT03114891|157963536|FG002|3 Week Break|Withdrawal by Subject|0|||
49034832|NCT03114891|157963537|FG003|3 Week Break|Withdrawal by Subject|0|||
49034833|NCT03114891|157963534|FG000|Second Treatment Round|Lost to Follow-up|1|||
49034834|NCT03114891|157963535|FG001|Second Treatment Round|Lost to Follow-up|0|||
49034835|NCT03114891|157963536|FG002|Second Treatment Round|Lost to Follow-up|0|||
49034836|NCT03114891|157963537|FG003|Second Treatment Round|Lost to Follow-up|0|||
49034837|NCT03114891|157963534|FG000|Second Treatment Round|Physician Decision|1|||
49034838|NCT03114891|157963535|FG001|Second Treatment Round|Physician Decision|0|||
48884297|NCT01064648|157412510|FG001|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4|||
48884298|NCT01064648|157412511|FG002|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
48884299|NCT01064648|157412512|FG003|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
48884300|NCT01064648|157412509|FG000|Phase II|Adverse Event|0|||
48884301|NCT01064648|157412510|FG001|Phase II|Adverse Event|0|||
48884302|NCT01064648|157412511|FG002|Phase II|Adverse Event|15|||
49034839|NCT03114891|157963536|FG002|Second Treatment Round|Physician Decision|0|||
49034840|NCT03114891|157963537|FG003|Second Treatment Round|Physician Decision|0|||
49034841|NCT02281084|157963540|FG000|Overall Study|Death|21|||
49034842|NCT02281084|157963541|FG001|Overall Study|Death|18|||
49034843|NCT02281084|157963542|FG002|Overall Study|Death|3|||
49034844|NCT02281084|157963543|FG003|Overall Study|Death|5|||
49034845|NCT02281084|157963540|FG000|Overall Study|Adverse Event|1|||
49034846|NCT02281084|157963541|FG001|Overall Study|Adverse Event|0|||
49034847|NCT02281084|157963542|FG002|Overall Study|Adverse Event|0|||
49034848|NCT02281084|157963543|FG003|Overall Study|Adverse Event|0|||
49034849|NCT02281084|157963540|FG000|Overall Study|Withdrawal by Subject|2|||
49034850|NCT02281084|157963541|FG001|Overall Study|Withdrawal by Subject|2|||
49034851|NCT02281084|157963542|FG002|Overall Study|Withdrawal by Subject|0|||
49034852|NCT02281084|157963543|FG003|Overall Study|Withdrawal by Subject|0|||
49034853|NCT02281084|157963540|FG000|Overall Study|Site Closure by Sponsor|5|||
49034854|NCT02281084|157963541|FG001|Overall Study|Site Closure by Sponsor|1|||
49034855|NCT02281084|157963542|FG002|Overall Study|Site Closure by Sponsor|2|||
49034856|NCT02281084|157963543|FG003|Overall Study|Site Closure by Sponsor|0|||
49034857|NCT04633564|157963544|FG000|Period 1|Adverse Event|28|||
49034858|NCT04633564|157963545|FG001|Period 1|Adverse Event|19|||
49034859|NCT04633564|157963544|FG000|Period 1|Death|8|||
49034860|NCT04633564|157963545|FG001|Period 1|Death|7|||
49034861|NCT04633564|157963544|FG000|Period 1|Lost to Follow-up|3|||
49034862|NCT04633564|157963545|FG001|Period 1|Lost to Follow-up|5|||
49034863|NCT04633564|157963544|FG000|Period 1|Physician Decision|4|||
49034864|NCT04633564|157963545|FG001|Period 1|Physician Decision|12|||
49034865|NCT04633564|157963544|FG000|Period 1|Protocol Violation|0|||
49034866|NCT04633564|157963545|FG001|Period 1|Protocol Violation|1|||
49034867|NCT04633564|157963544|FG000|Period 1|Withdrawal by Subject|10|||
49034868|NCT04633564|157963545|FG001|Period 1|Withdrawal by Subject|8|||
49034869|NCT04633564|157963544|FG000|Period 1|Progressive disease|47|||
49034870|NCT04633564|157963545|FG001|Period 1|Progressive disease|51|||
48884303|NCT01064648|157412512|FG003|Phase II|Adverse Event|8|||
48884304|NCT01064648|157412509|FG000|Phase II|Death|0|||
48884305|NCT01064648|157412510|FG001|Phase II|Death|0|||
48884306|NCT01064648|157412511|FG002|Phase II|Death|4|||
48884307|NCT01064648|157412512|FG003|Phase II|Death|5|||
48884308|NCT01064648|157412509|FG000|Phase II|Withdrawal by Subject|0|||
48884309|NCT01064648|157412510|FG001|Phase II|Withdrawal by Subject|0|||
48884310|NCT01064648|157412511|FG002|Phase II|Withdrawal by Subject|2|||
48884311|NCT01064648|157412512|FG003|Phase II|Withdrawal by Subject|5|||
48884312|NCT01064648|157412509|FG000|Phase II|Progression|0|||
48884313|NCT01064648|157412510|FG001|Phase II|Progression|0|||
48884314|NCT01064648|157412511|FG002|Phase II|Progression|21|||
48884315|NCT01064648|157412512|FG003|Phase II|Progression|27|||
48884316|NCT01064648|157412509|FG000|Phase II|Non-protocol specified|0|||
48884317|NCT01064648|157412510|FG001|Phase II|Non-protocol specified|0|||
48884318|NCT01064648|157412511|FG002|Phase II|Non-protocol specified|5|||
48884319|NCT01064648|157412512|FG003|Phase II|Non-protocol specified|3|||
48884320|NCT01064648|157412509|FG000|Phase II|Under Review|0|||
48884321|NCT01064648|157412510|FG001|Phase II|Under Review|0|||
48884322|NCT01064648|157412511|FG002|Phase II|Under Review|2|||
48884323|NCT01064648|157412512|FG003|Phase II|Under Review|0|||
48884324|NCT02783573|157413773|FG000|Placebo-Controlled Treatment Period|Adverse Event|13|||
48884325|NCT02783573|157413774|FG001|Placebo-Controlled Treatment Period|Adverse Event|17|||
48884326|NCT02783573|157413775|FG002|Placebo-Controlled Treatment Period|Adverse Event|13|||
48884327|NCT02783573|157413773|FG000|Placebo-Controlled Treatment Period|Death|4|||
48884328|NCT02783573|157413774|FG001|Placebo-Controlled Treatment Period|Death|2|||
48884329|NCT02783573|157413775|FG002|Placebo-Controlled Treatment Period|Death|3|||
48884330|NCT02783573|157413773|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
48884331|NCT02783573|157413774|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
48884332|NCT02783573|157413775|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
48884333|NCT02783573|157413773|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
48884334|NCT02783573|157413774|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
48884335|NCT02783573|157413775|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
48884336|NCT02783573|157413773|FG000|Placebo-Controlled Treatment Period|Non-Compliance|0|||
48884337|NCT02783573|157413774|FG001|Placebo-Controlled Treatment Period|Non-Compliance|1|||
48884338|NCT02783573|157413775|FG002|Placebo-Controlled Treatment Period|Non-Compliance|0|||
49034871|NCT04633564|157963544|FG000|Period 1|Terminated by Sponsor|8|||
49034872|NCT04633564|157963545|FG001|Period 1|Terminated by Sponsor|6|||
49034873|NCT04633564|157963544|FG000|Period 2|Adverse Event|3|||
49034874|NCT04633564|157963545|FG001|Period 2|Adverse Event|4|||
49034875|NCT04633564|157963544|FG000|Period 2|Death|0|||
49034876|NCT04633564|157963545|FG001|Period 2|Death|2|||
49034877|NCT04633564|157963544|FG000|Period 2|Lost to Follow-up|0|||
48884339|NCT02783573|157413773|FG000|Placebo-Controlled Treatment Period|Other-determined by Investigator|0|||
48884340|NCT02783573|157413774|FG001|Placebo-Controlled Treatment Period|Other-determined by Investigator|1|||
48884341|NCT02783573|157413775|FG002|Placebo-Controlled Treatment Period|Other-determined by Investigator|2|||
48884342|NCT02783573|157413773|FG000|Placebo-Controlled Treatment Period|Physician Decision|3|||
48884343|NCT02783573|157413774|FG001|Placebo-Controlled Treatment Period|Physician Decision|1|||
48884344|NCT02783573|157413775|FG002|Placebo-Controlled Treatment Period|Physician Decision|3|||
49034878|NCT04633564|157963545|FG001|Period 2|Lost to Follow-up|1|||
49034879|NCT04633564|157963544|FG000|Period 2|Physician Decision|2|||
49034880|NCT04633564|157963545|FG001|Period 2|Physician Decision|4|||
49034881|NCT04633564|157963544|FG000|Period 2|Withdrawal by Subject|5|||
49034882|NCT04633564|157963545|FG001|Period 2|Withdrawal by Subject|1|||
49034883|NCT04633564|157963544|FG000|Period 2|Progressive Disease|74|||
49034884|NCT04633564|157963545|FG001|Period 2|Progressive Disease|82|||
49034885|NCT04633564|157963544|FG000|Period 2|Terminated by Sponsor|9|||
49034886|NCT04633564|157963545|FG001|Period 2|Terminated by Sponsor|3|||
49034887|NCT03238781|157963546|FG000|Overall Study|Adverse Event|1|||
49034888|NCT03238781|157963547|FG001|Overall Study|Adverse Event|1|||
48884345|NCT02783573|157413773|FG000|Placebo-Controlled Treatment Period|Protocol Violation|1|||
48884346|NCT02783573|157413774|FG001|Placebo-Controlled Treatment Period|Protocol Violation|2|||
48884347|NCT02783573|157413775|FG002|Placebo-Controlled Treatment Period|Protocol Violation|0|||
49034889|NCT03238781|157963548|FG002|Overall Study|Adverse Event|2|||
49034890|NCT03238781|157963546|FG000|Overall Study|Lost to Follow-up|2|||
49034891|NCT03238781|157963547|FG001|Overall Study|Lost to Follow-up|1|||
48884348|NCT02783573|157413773|FG000|Placebo-Controlled Treatment Period|Withdrawal by Subject|15|||
48884349|NCT02783573|157413774|FG001|Placebo-Controlled Treatment Period|Withdrawal by Subject|20|||
48884350|NCT02783573|157413775|FG002|Placebo-Controlled Treatment Period|Withdrawal by Subject|23|||
48884351|NCT02783573|157413773|FG000|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
48884352|NCT02783573|157413774|FG001|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
48884353|NCT02783573|157413775|FG002|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9|||
48884354|NCT02783573|157413773|FG000|Placebo-Controlled Treatment Period|Sponsor Decision|494|||
48884355|NCT02783573|157413774|FG001|Placebo-Controlled Treatment Period|Sponsor Decision|512|||
48884356|NCT02783573|157413775|FG002|Placebo-Controlled Treatment Period|Sponsor Decision|492|||
48884357|NCT02783573|157413773|FG000|Delayed-Start Period|Sponsor Decision|0|||
48884358|NCT02783573|157413774|FG001|Delayed-Start Period|Sponsor Decision|17|||
48884359|NCT02783573|157413775|FG002|Delayed-Start Period|Sponsor Decision|12|||
48884360|NCT01200342|157413776|FG000|Overall Study|Disease Progression|1|||
48884361|NCT01251770|157413777|FG000|Overall Study|Protocol Violation|13|||
48884362|NCT01251770|157413778|FG001|Overall Study|Protocol Violation|7|||
48884363|NCT02412735|157413779|FG000|Overall Study|Adverse Event|0|||
48884364|NCT02412735|157413780|FG001|Overall Study|Adverse Event|1|||
48884365|NCT02412735|157413781|FG002|Overall Study|Adverse Event|2|||
48884366|NCT02412735|157413779|FG000|Overall Study|Withdrawal by Subject|23|||
48884367|NCT02412735|157413780|FG001|Overall Study|Withdrawal by Subject|27|||
48884368|NCT02412735|157413781|FG002|Overall Study|Withdrawal by Subject|22|||
48884369|NCT02412735|157413779|FG000|Overall Study|Investigator Decision|3|||
48884370|NCT02412735|157413780|FG001|Overall Study|Investigator Decision|3|||
48884371|NCT02412735|157413781|FG002|Overall Study|Investigator Decision|2|||
48884372|NCT02412735|157413779|FG000|Overall Study|Lost to Follow-up|17|||
48884373|NCT02412735|157413780|FG001|Overall Study|Lost to Follow-up|11|||
48884374|NCT02412735|157413781|FG002|Overall Study|Lost to Follow-up|18|||
48884375|NCT02412735|157413779|FG000|Overall Study|Reason not Specified|3|||
48884376|NCT02412735|157413780|FG001|Overall Study|Reason not Specified|2|||
48884377|NCT02412735|157413781|FG002|Overall Study|Reason not Specified|2|||
48884378|NCT02963090|157413783|FG000|Non-cross Over Phase|Patient deterioration before starting protocol treatment|1|||
48884379|NCT02963090|157413784|FG001|Non-cross Over Phase|Patient deterioration before starting protocol treatment|0|||
48884380|NCT03175029|157413787|FG000|Overall Study|Withdrawal by Subject|2|||
48884381|NCT03175029|157413788|FG001|Overall Study|Withdrawal by Subject|1|||
48884382|NCT03175029|157413787|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
48884383|NCT03175029|157413788|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
48884384|NCT02179177|157413789|FG000|Overall Study|Lost to Follow-up|1|||
48884385|NCT02179177|157413790|FG001|Overall Study|Lost to Follow-up|1|||
48884386|NCT02179177|157413789|FG000|Overall Study|Withdrawal by Subject|1|||
48884387|NCT02179177|157413790|FG001|Overall Study|Withdrawal by Subject|1|||
48884388|NCT04089371|157413793|FG000|Overall Study|Withdrawal by Subject|0|||
48884389|NCT04089371|157413794|FG001|Overall Study|Withdrawal by Subject|1|||
48884390|NCT04089371|157413793|FG000|Overall Study|Study terminated early|0|||
48884391|NCT04089371|157413794|FG001|Overall Study|Study terminated early|9|||
48884392|NCT00678301|157413796|FG000|Overall Study|Non-compliance with study procedures|0|||
48884393|NCT00678301|157413797|FG001|Overall Study|Non-compliance with study procedures|1|||
48884394|NCT00678301|157413796|FG000|Overall Study|Adverse Event|1|||
48884395|NCT00678301|157413797|FG001|Overall Study|Adverse Event|0|||
48884396|NCT00678301|157413796|FG000|Overall Study|Withdrawal by Subject|4|||
48884397|NCT00678301|157413797|FG001|Overall Study|Withdrawal by Subject|0|||
48884398|NCT00678301|157413796|FG000|Overall Study|Lost to Follow-up|3|||
48884399|NCT00678301|157413797|FG001|Overall Study|Lost to Follow-up|1|||
48884400|NCT00702962|157413798|FG000|Overall Study|Progressive disease|0|||
48884401|NCT00702962|157413799|FG001|Overall Study|Progressive disease|1|||
48884402|NCT00702962|157413798|FG000|Overall Study|Hospitalized for other health disorder|1|||
48884403|NCT00702962|157413799|FG001|Overall Study|Hospitalized for other health disorder|0|||
48884404|NCT00335140|157413802|FG000|Overall Study|Ineligible|1|||
49034892|NCT03238781|157963548|FG002|Overall Study|Lost to Follow-up|2|||
48884405|NCT01132820|157413804|FG000|Overall Study|Ineligible: wrong cell type|1|||
48884406|NCT01132820|157413804|FG000|Overall Study|Ineligible:Improper pre-protocol therapy|1|||
48884407|NCT01132820|157413804|FG000|Overall Study|Ineligible:Inadequate pathology|1|||
48884408|NCT01132820|157413804|FG000|Overall Study|Never treated|1|||
48884409|NCT01132820|157413804|FG000|Overall Study|Inadequate data|1|||
48884410|NCT00677534|157413805|FG000|Washout (Weeks 1-4)|did not qualify after signing consent|1|||
48884411|NCT00677534|157413805|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
48884412|NCT00677534|157413805|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
48884413|NCT01923467|157413806|FG000|Overall Study|Lost to Follow-up|62|||
48884414|NCT01923467|157413806|FG000|Overall Study|Subject non-interest|479|||
48884415|NCT02687035|157413807|FG000|Overall Study|Withdrawal by Subject|1|||
48884416|NCT02687035|157413807|FG000|Overall Study|Death|87|||
48884417|NCT02687035|157413807|FG000|Overall Study|Lost to Follow-up|1|||
48884418|NCT02687035|157413807|FG000|Overall Study|Missed Visit|87|||
48884419|NCT02687035|157413807|FG000|Overall Study|Did not receive Study Device|8|||
48884421|NCT03149042|157413809|FG000|Overall Study|Invasive FFR not performed|21|||
48884422|NCT03149042|157413809|FG000|Overall Study|Poor CT Image Quality|1|||
48884423|NCT03149042|157413809|FG000|Overall Study|Invasive FFR Measurement cancelled|1|||
48884424|NCT01023958|157413810|FG000|Overall Study|Progressive disease|48|||
48884425|NCT01023958|157413810|FG000|Overall Study|Other adverse event|1|||
48884426|NCT01023958|157413810|FG000|Overall Study|Refused to continue medication|1|||
48884427|NCT01195623|157413811|FG000|Overall Study|Lost to Follow-up|35|||
48884428|NCT01195623|157413812|FG001|Overall Study|Lost to Follow-up|37|||
48884429|NCT00842244|157413816|FG000|Overall Study|Death|3|||
48884430|NCT00842244|157413816|FG000|Overall Study|Withdrawal by Subject|1|||
48884431|NCT00842244|157413816|FG000|Overall Study|Other|17|||
48884432|NCT03846453|157413817|FG000|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|465|||
48884433|NCT03846453|157413818|FG001|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
48884434|NCT03846453|157413819|FG002|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
48884435|NCT03846453|157413817|FG000|Placebo Run-in (14 Days)|Withdrawal by Subject|3|||
48884436|NCT03846453|157413818|FG001|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
48884437|NCT03846453|157413819|FG002|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
48884438|NCT03846453|157413817|FG000|Placebo Run-in (14 Days)|Physician Decision|1|||
48884439|NCT03846453|157413818|FG001|Placebo Run-in (14 Days)|Physician Decision|0|||
48884440|NCT03846453|157413819|FG002|Placebo Run-in (14 Days)|Physician Decision|0|||
48884441|NCT03846453|157413817|FG000|Placebo Run-in (14 Days)|Other|2|||
48884442|NCT03846453|157413818|FG001|Placebo Run-in (14 Days)|Other|0|||
48884443|NCT03846453|157413819|FG002|Placebo Run-in (14 Days)|Other|0|||
48884444|NCT03846453|157413817|FG000|Randomized Treatment Period (Days 57±3)|Adverse Event|0|||
48884445|NCT03846453|157413818|FG001|Randomized Treatment Period (Days 57±3)|Adverse Event|16|||
48983643|NCT01603628|157772321|FG001|Overall Study|Other Miscellaneous Reason|0|||
48983644|NCT01603628|157772322|FG002|Overall Study|Other Miscellaneous Reason|0|||
48983645|NCT00242710|157772323|FG000|Core Study (up to Year 1)|Adverse Event|30|||
48983646|NCT00242710|157772324|FG001|Core Study (up to Year 1)|Adverse Event|25|||
48983647|NCT00242710|157772325|FG002|Core Study (up to Year 1)|Adverse Event|23|||
48983648|NCT00242710|157772326|FG003|Core Study (up to Year 1)|Adverse Event|14|||
48983649|NCT00242710|157772323|FG000|Core Study (up to Year 1)|Death|0|||
48983650|NCT00242710|157772324|FG001|Core Study (up to Year 1)|Death|0|||
48983651|NCT00242710|157772325|FG002|Core Study (up to Year 1)|Death|1|||
48983652|NCT00242710|157772326|FG003|Core Study (up to Year 1)|Death|0|||
48983653|NCT00242710|157772323|FG000|Core Study (up to Year 1)|Physician Decision|0|||
48983654|NCT00242710|157772324|FG001|Core Study (up to Year 1)|Physician Decision|1|||
48983655|NCT00242710|157772325|FG002|Core Study (up to Year 1)|Physician Decision|0|||
48983656|NCT00242710|157772326|FG003|Core Study (up to Year 1)|Physician Decision|1|||
48983657|NCT00242710|157772323|FG000|Core Study (up to Year 1)|Lost to Follow-up|8|||
48983658|NCT00242710|157772324|FG001|Core Study (up to Year 1)|Lost to Follow-up|8|||
48983659|NCT00242710|157772325|FG002|Core Study (up to Year 1)|Lost to Follow-up|7|||
48983660|NCT00242710|157772326|FG003|Core Study (up to Year 1)|Lost to Follow-up|3|||
48983661|NCT00242710|157772323|FG000|Core Study (up to Year 1)|Other|6|||
48983662|NCT00242710|157772324|FG001|Core Study (up to Year 1)|Other|1|||
48983663|NCT00242710|157772325|FG002|Core Study (up to Year 1)|Other|0|||
48983664|NCT00242710|157772326|FG003|Core Study (up to Year 1)|Other|2|||
48884446|NCT03846453|157413819|FG002|Randomized Treatment Period (Days 57±3)|Adverse Event|8|||
48884447|NCT03846453|157413817|FG000|Randomized Treatment Period (Days 57±3)|Protocol Violation|0|||
48983665|NCT00242710|157772323|FG000|Core Study (up to Year 1)|Protocol Violation|2|||
48983666|NCT00242710|157772324|FG001|Core Study (up to Year 1)|Protocol Violation|9|||
48884448|NCT03846453|157413818|FG001|Randomized Treatment Period (Days 57±3)|Protocol Violation|6|||
48884449|NCT03846453|157413819|FG002|Randomized Treatment Period (Days 57±3)|Protocol Violation|5|||
48884450|NCT03846453|157413817|FG000|Randomized Treatment Period (Days 57±3)|Administrative Reasons|0|||
48884451|NCT03846453|157413818|FG001|Randomized Treatment Period (Days 57±3)|Administrative Reasons|2|||
48884452|NCT03846453|157413819|FG002|Randomized Treatment Period (Days 57±3)|Administrative Reasons|4|||
48884453|NCT03846453|157413817|FG000|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|0|||
48884454|NCT03846453|157413818|FG001|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|2|||
48884455|NCT03846453|157413819|FG002|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|4|||
48884456|NCT03846453|157413817|FG000|Randomized Treatment Period (Days 57±3)|Other|0|||
48884457|NCT03846453|157413818|FG001|Randomized Treatment Period (Days 57±3)|Other|1|||
48884458|NCT03846453|157413819|FG002|Randomized Treatment Period (Days 57±3)|Other|4|||
48884459|NCT01711853|157413821|FG000|Overall Study|Not treated|3|||
48884460|NCT01606670|157413822|FG000|Overall Study|Adverse Event|6|||
48884461|NCT01606670|157413822|FG000|Overall Study|Lack of Efficacy|2|||
48884462|NCT01606670|157413822|FG000|Overall Study|Lost to Follow-up|3|||
48884463|NCT01606670|157413822|FG000|Overall Study|Withdrawal by Subject|3|||
48884464|NCT01606670|157413822|FG000|Overall Study|Other Reason|2|||
48884465|NCT01886872|157413825|FG000|Overall Study|Ineligible|7|||
48884466|NCT01886872|157413826|FG001|Overall Study|Ineligible|4|||
48884467|NCT01886872|157413827|FG002|Overall Study|Ineligible|12|||
48884468|NCT04499924|157413828|FG000|Overall Study|Study termination by sponsor|4|||
48884469|NCT04499924|157413829|FG001|Overall Study|Study termination by sponsor|6|||
48884470|NCT04499924|157413828|FG000|Overall Study|Withdrawal by Subject|1|||
48884471|NCT04499924|157413829|FG001|Overall Study|Withdrawal by Subject|3|||
48884472|NCT01011868|157413833|FG000|After Week 18 Follow-up|Adverse Event|8|||
48884473|NCT01011868|157413834|FG001|After Week 18 Follow-up|Adverse Event|6|||
48884474|NCT01011868|157413835|FG002|After Week 18 Follow-up|Adverse Event|13|||
48884475|NCT01011868|157413833|FG000|After Week 18 Follow-up|Lack of Efficacy|1|||
48884476|NCT01011868|157413834|FG001|After Week 18 Follow-up|Lack of Efficacy|0|||
48884477|NCT01011868|157413835|FG002|After Week 18 Follow-up|Lack of Efficacy|0|||
48884478|NCT01011868|157413833|FG000|After Week 18 Follow-up|Protocol Violation|1|||
48884479|NCT01011868|157413834|FG001|After Week 18 Follow-up|Protocol Violation|1|||
48884480|NCT01011868|157413835|FG002|After Week 18 Follow-up|Protocol Violation|1|||
48884481|NCT01011868|157413833|FG000|After Week 18 Follow-up|Lost to Follow-up|5|||
48884482|NCT01011868|157413834|FG001|After Week 18 Follow-up|Lost to Follow-up|3|||
48884483|NCT01011868|157413835|FG002|After Week 18 Follow-up|Lost to Follow-up|0|||
48884484|NCT01011868|157413833|FG000|After Week 18 Follow-up|Withdrawal by Subject|6|||
48884485|NCT01011868|157413834|FG001|After Week 18 Follow-up|Withdrawal by Subject|3|||
48884486|NCT01011868|157413835|FG002|After Week 18 Follow-up|Withdrawal by Subject|0|||
48884487|NCT01011868|157413833|FG000|After Week 18 Follow-up|Other reason not defined above|2|||
48884488|NCT01011868|157413834|FG001|After Week 18 Follow-up|Other reason not defined above|3|||
48884489|NCT01011868|157413835|FG002|After Week 18 Follow-up|Other reason not defined above|12|||
48884490|NCT01011868|157413833|FG000|After Week 78 Follow-up|Adverse Event|14|||
48884491|NCT01011868|157413834|FG001|After Week 78 Follow-up|Adverse Event|18|||
48884492|NCT01011868|157413835|FG002|After Week 78 Follow-up|Adverse Event|21|||
48884493|NCT01011868|157413833|FG000|After Week 78 Follow-up|Lack of Efficacy|4|||
48884494|NCT01011868|157413834|FG001|After Week 78 Follow-up|Lack of Efficacy|0|||
48884495|NCT01011868|157413835|FG002|After Week 78 Follow-up|Lack of Efficacy|0|||
48884496|NCT01011868|157413833|FG000|After Week 78 Follow-up|Protocol Violation|9|||
48884497|NCT01011868|157413834|FG001|After Week 78 Follow-up|Protocol Violation|1|||
48884498|NCT01011868|157413835|FG002|After Week 78 Follow-up|Protocol Violation|2|||
48884499|NCT01011868|157413833|FG000|After Week 78 Follow-up|Lost to Follow-up|11|||
48884500|NCT01011868|157413834|FG001|After Week 78 Follow-up|Lost to Follow-up|6|||
48884501|NCT01011868|157413835|FG002|After Week 78 Follow-up|Lost to Follow-up|4|||
48884502|NCT01011868|157413833|FG000|After Week 78 Follow-up|Withdrawal by Subject|9|||
48884503|NCT01011868|157413834|FG001|After Week 78 Follow-up|Withdrawal by Subject|8|||
48884504|NCT01011868|157413835|FG002|After Week 78 Follow-up|Withdrawal by Subject|1|||
48884505|NCT01011868|157413833|FG000|After Week 78 Follow-up|Other reason not defined above|5|||
48884506|NCT01011868|157413834|FG001|After Week 78 Follow-up|Other reason not defined above|5|||
48884507|NCT01011868|157413835|FG002|After Week 78 Follow-up|Other reason not defined above|16|||
48884508|NCT01509547|157413843|FG000|Overall Study|Lost to Follow-up|24|||
48884509|NCT01509547|157413844|FG001|Overall Study|Lost to Follow-up|14|||
48884510|NCT01509547|157413843|FG000|Overall Study|Withdrawal by Subject|11|||
48884511|NCT01509547|157413844|FG001|Overall Study|Withdrawal by Subject|24|||
48884512|NCT01509547|157413843|FG000|Overall Study|Physician Decision|0|||
48884513|NCT01509547|157413844|FG001|Overall Study|Physician Decision|1|||
48884514|NCT00594880|157413845|FG000|Overall Study|Withdrawal by Subject|1|||
48884515|NCT00594880|157413846|FG001|Overall Study|Withdrawal by Subject|1|||
48884516|NCT00594880|157413845|FG000|Overall Study|Lost to Follow-up|1|||
48884517|NCT00594880|157413846|FG001|Overall Study|Lost to Follow-up|0|||
48884518|NCT02206061|157413847|FG000|Overall Study|Withdrawal by Subject|4|||
48884519|NCT02206061|157413848|FG001|Overall Study|Withdrawal by Subject|7|||
48884520|NCT02206061|157413849|FG002|Overall Study|Withdrawal by Subject|1|||
48884521|NCT02206061|157413847|FG000|Overall Study|Lost to Follow-up|14|||
49034893|NCT03238781|157963546|FG000|Overall Study|Withdrawal by Subject|23|||
48884522|NCT02206061|157413848|FG001|Overall Study|Lost to Follow-up|7|||
48884523|NCT02206061|157413849|FG002|Overall Study|Lost to Follow-up|20|||
48884524|NCT01254747|157413850|FG000|Overall Study|Unacceptable subjective vision|0|||
48884525|NCT01254747|157413851|FG001|Overall Study|Unacceptable subjective vision|0|||
48884526|NCT01254747|157413852|FG002|Overall Study|Unacceptable subjective vision|0|||
48884527|NCT01254747|157413853|FG003|Overall Study|Unacceptable subjective vision|2|||
48884528|NCT01254747|157413850|FG000|Overall Study|Difficult removal handling|0|||
48884529|NCT01254747|157413851|FG001|Overall Study|Difficult removal handling|0|||
48884530|NCT01254747|157413852|FG002|Overall Study|Difficult removal handling|1|||
48884531|NCT01254747|157413853|FG003|Overall Study|Difficult removal handling|0|||
48884532|NCT01254747|157413850|FG000|Overall Study|Symptoms and problems|0|||
48884533|NCT01254747|157413851|FG001|Overall Study|Symptoms and problems|2|||
48884534|NCT01254747|157413852|FG002|Overall Study|Symptoms and problems|1|||
48884535|NCT01254747|157413853|FG003|Overall Study|Symptoms and problems|0|||
48884536|NCT01254747|157413850|FG000|Overall Study|Lost to Follow-up|0|||
48884537|NCT01254747|157413851|FG001|Overall Study|Lost to Follow-up|0|||
48884538|NCT01254747|157413852|FG002|Overall Study|Lost to Follow-up|1|||
48884539|NCT01254747|157413853|FG003|Overall Study|Lost to Follow-up|0|||
48884540|NCT01254747|157413850|FG000|Overall Study|Biomicroscopy|0|||
48884541|NCT01254747|157413851|FG001|Overall Study|Biomicroscopy|0|||
48884542|NCT01254747|157413852|FG002|Overall Study|Biomicroscopy|1|||
48884543|NCT01254747|157413853|FG003|Overall Study|Biomicroscopy|0|||
48884544|NCT01254747|157413850|FG000|Overall Study|Discomfort|0|||
48884545|NCT01254747|157413851|FG001|Overall Study|Discomfort|4|||
48884546|NCT01254747|157413852|FG002|Overall Study|Discomfort|0|||
48884547|NCT01254747|157413853|FG003|Overall Study|Discomfort|0|||
48884548|NCT02817906|157413854|FG000|Overall Study|Adverse Event|3|||
48884549|NCT02817906|157413855|FG001|Overall Study|Adverse Event|0|||
48884550|NCT02817906|157413854|FG000|Overall Study|Lack of Efficacy|1|||
48884551|NCT02817906|157413855|FG001|Overall Study|Lack of Efficacy|0|||
48884552|NCT02817906|157413854|FG000|Overall Study|Protocol Violation|1|||
48884553|NCT02817906|157413855|FG001|Overall Study|Protocol Violation|1|||
48884554|NCT02817906|157413854|FG000|Overall Study|Study Terminated by Sponsor|2|||
48884555|NCT02817906|157413855|FG001|Overall Study|Study Terminated by Sponsor|2|||
48884556|NCT02817906|157413854|FG000|Overall Study|Withdrawal by Subject|7|||
48884557|NCT02817906|157413855|FG001|Overall Study|Withdrawal by Subject|0|||
48884558|NCT02817906|157413854|FG000|Overall Study|Other|2|||
48884559|NCT02817906|157413855|FG001|Overall Study|Other|2|||
48884560|NCT03381339|157413858|FG000|Overall Study|Protocol Violation|4|||
48884561|NCT03381339|157413859|FG001|Overall Study|Protocol Violation|3|||
48884562|NCT03381339|157413858|FG000|Overall Study|Lost to Follow-up|0|||
48884563|NCT03381339|157413859|FG001|Overall Study|Lost to Follow-up|1|||
48884564|NCT02108964|157413860|FG000|Overall Study|Progressive disease|15|||
48884565|NCT02108964|157413861|FG001|Overall Study|Progressive disease|31|||
48884566|NCT02108964|157413862|FG002|Overall Study|Progressive disease|54|||
48884567|NCT02108964|157413863|FG003|Overall Study|Progressive disease|7|||
48884568|NCT02108964|157413864|FG004|Overall Study|Progressive disease|20|||
48884569|NCT02108964|157413865|FG005|Overall Study|Progressive disease|4|||
48884570|NCT02108964|157413866|FG006|Overall Study|Progressive disease|6|||
48884571|NCT02108964|157413867|FG007|Overall Study|Progressive disease|33|||
48884572|NCT02108964|157413860|FG000|Overall Study|Physician Decision|1|||
48884573|NCT02108964|157413861|FG001|Overall Study|Physician Decision|5|||
48884574|NCT02108964|157413862|FG002|Overall Study|Physician Decision|7|||
49034894|NCT03238781|157963547|FG001|Overall Study|Withdrawal by Subject|14|||
49034895|NCT03238781|157963548|FG002|Overall Study|Withdrawal by Subject|16|||
49034896|NCT03238781|157963546|FG000|Overall Study|Decision by sponsor|0|||
49034897|NCT03238781|157963547|FG001|Overall Study|Decision by sponsor|1|||
49034898|NCT03238781|157963548|FG002|Overall Study|Decision by sponsor|0|||
49098995|NCT01744184|158197013|FG000|Overall Study|Withdrawal by Subject|0|||
49098996|NCT01744184|158197014|FG001|Overall Study|Withdrawal by Subject|1|||
49098997|NCT02419612|158197015|FG000|Short-term Treatment Period|Adverse Event|1|||
49098998|NCT02419612|158197016|FG001|Short-term Treatment Period|Adverse Event|1|||
49098999|NCT02419612|158197015|FG000|Short-term Treatment Period|Death|0|||
49099000|NCT02419612|158197016|FG001|Short-term Treatment Period|Death|2|||
48884575|NCT02108964|157413863|FG003|Overall Study|Physician Decision|1|||
48884576|NCT02108964|157413864|FG004|Overall Study|Physician Decision|2|||
48884577|NCT02108964|157413865|FG005|Overall Study|Physician Decision|1|||
48884578|NCT02108964|157413866|FG006|Overall Study|Physician Decision|1|||
48884579|NCT02108964|157413867|FG007|Overall Study|Physician Decision|3|||
48884580|NCT02108964|157413860|FG000|Overall Study|Adverse Event|0|||
48884581|NCT02108964|157413861|FG001|Overall Study|Adverse Event|0|||
48884582|NCT02108964|157413862|FG002|Overall Study|Adverse Event|4|||
48884583|NCT02108964|157413863|FG003|Overall Study|Adverse Event|0|||
48884584|NCT02108964|157413864|FG004|Overall Study|Adverse Event|1|||
48884585|NCT02108964|157413865|FG005|Overall Study|Adverse Event|0|||
48884586|NCT02108964|157413866|FG006|Overall Study|Adverse Event|3|||
48884587|NCT02108964|157413867|FG007|Overall Study|Adverse Event|2|||
49099001|NCT02419612|158197015|FG000|Short-term Treatment Period|Lost to Follow-up|6|||
49099002|NCT02419612|158197016|FG001|Short-term Treatment Period|Lost to Follow-up|6|||
48884588|NCT02108964|157413860|FG000|Overall Study|Death|1|||
48884589|NCT02108964|157413861|FG001|Overall Study|Death|1|||
48884590|NCT02108964|157413862|FG002|Overall Study|Death|4|||
48884591|NCT02108964|157413863|FG003|Overall Study|Death|0|||
48884592|NCT02108964|157413864|FG004|Overall Study|Death|3|||
48884593|NCT02108964|157413865|FG005|Overall Study|Death|0|||
48884594|NCT02108964|157413866|FG006|Overall Study|Death|0|||
48884595|NCT02108964|157413867|FG007|Overall Study|Death|2|||
48884596|NCT02108964|157413860|FG000|Overall Study|Subject/Guardian decision|0|||
48884597|NCT02108964|157413861|FG001|Overall Study|Subject/Guardian decision|1|||
48884598|NCT02108964|157413862|FG002|Overall Study|Subject/Guardian decision|4|||
48884599|NCT02108964|157413863|FG003|Overall Study|Subject/Guardian decision|0|||
48884600|NCT02108964|157413864|FG004|Overall Study|Subject/Guardian decision|2|||
48884601|NCT02108964|157413865|FG005|Overall Study|Subject/Guardian decision|0|||
48884602|NCT02108964|157413866|FG006|Overall Study|Subject/Guardian decision|1|||
48884603|NCT02108964|157413867|FG007|Overall Study|Subject/Guardian decision|2|||
48884604|NCT02108964|157413860|FG000|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
48884605|NCT02108964|157413861|FG001|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
48884606|NCT02108964|157413862|FG002|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
48884607|NCT02108964|157413863|FG003|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
48884608|NCT02108964|157413864|FG004|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
48884609|NCT02108964|157413865|FG005|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
48884610|NCT02108964|157413866|FG006|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
48884611|NCT02108964|157413867|FG007|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|3|||
48884616|NCT04850898|157413870|FG000|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
48884617|NCT04850898|157413871|FG001|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
48884618|NCT04949841|157413873|FG000|Overall Study|Adverse Event|7|||
48884619|NCT04949841|157413873|FG000|Overall Study|Death|1|||
48884620|NCT04949841|157413873|FG000|Overall Study|Withdrawal by Subject|52|||
48884621|NCT04949841|157413873|FG000|Overall Study|Pregnancy|4|||
48884622|NCT04949841|157413873|FG000|Overall Study|Lost to Follow-up|9|||
48884623|NCT04949841|157413873|FG000|Overall Study|Lack of Efficacy|55|||
48884624|NCT04949841|157413873|FG000|Overall Study|Various reasons|9|||
48884625|NCT00552929|157413876|FG000|Overall Study|Lost to Follow-up|0|||
48884626|NCT00552929|157413877|FG001|Overall Study|Lost to Follow-up|0|||
48884627|NCT00552929|157413878|FG002|Overall Study|Lost to Follow-up|0|||
48884628|NCT00552929|157413879|FG003|Overall Study|Lost to Follow-up|0|||
48884629|NCT00552929|157413880|FG004|Overall Study|Lost to Follow-up|0|||
48884630|NCT00552929|157413881|FG005|Overall Study|Lost to Follow-up|0|||
48884631|NCT00552929|157413882|FG006|Overall Study|Lost to Follow-up|0|||
48884632|NCT00552929|157413883|FG007|Overall Study|Lost to Follow-up|0|||
48884633|NCT00552929|157413884|FG008|Overall Study|Lost to Follow-up|1|||
48884634|NCT00552929|157413885|FG009|Overall Study|Lost to Follow-up|0|||
48884635|NCT00552929|157413876|FG000|Overall Study|Not Eligible|0|||
48884636|NCT00552929|157413877|FG001|Overall Study|Not Eligible|0|||
48884637|NCT00552929|157413878|FG002|Overall Study|Not Eligible|0|||
48884638|NCT00552929|157413879|FG003|Overall Study|Not Eligible|0|||
48884639|NCT00552929|157413880|FG004|Overall Study|Not Eligible|0|||
48884640|NCT00552929|157413881|FG005|Overall Study|Not Eligible|1|||
48884641|NCT00552929|157413882|FG006|Overall Study|Not Eligible|0|||
48884642|NCT00552929|157413883|FG007|Overall Study|Not Eligible|0|||
48983667|NCT00242710|157772325|FG002|Core Study (up to Year 1)|Protocol Violation|1|||
48983668|NCT00242710|157772326|FG003|Core Study (up to Year 1)|Protocol Violation|3|||
48983669|NCT00242710|157772323|FG000|Core Study (up to Year 1)|Withdrawal by Subject|27|||
48983670|NCT00242710|157772324|FG001|Core Study (up to Year 1)|Withdrawal by Subject|16|||
48983671|NCT00242710|157772325|FG002|Core Study (up to Year 1)|Withdrawal by Subject|15|||
48983672|NCT00242710|157772326|FG003|Core Study (up to Year 1)|Withdrawal by Subject|6|||
48983673|NCT00242710|157772323|FG000|Core Study (up to Year 1)|Lack of Efficacy|1|||
48983674|NCT00242710|157772324|FG001|Core Study (up to Year 1)|Lack of Efficacy|0|||
48983675|NCT00242710|157772325|FG002|Core Study (up to Year 1)|Lack of Efficacy|0|||
48983676|NCT00242710|157772326|FG003|Core Study (up to Year 1)|Lack of Efficacy|0|||
48983677|NCT00242710|157772323|FG000|Core Study (up to Year 1)|Randomized but not Treated|12|||
48983678|NCT00242710|157772324|FG001|Core Study (up to Year 1)|Randomized but not Treated|4|||
48983679|NCT00242710|157772325|FG002|Core Study (up to Year 1)|Randomized but not Treated|4|||
48983680|NCT00242710|157772326|FG003|Core Study (up to Year 1)|Randomized but not Treated|2|||
48983681|NCT00242710|157772323|FG000|Period Between Core Study and Extension|Adverse Event|2|||
48983682|NCT00242710|157772324|FG001|Period Between Core Study and Extension|Adverse Event|3|||
48884643|NCT00552929|157413884|FG008|Overall Study|Not Eligible|0|||
48884644|NCT00552929|157413885|FG009|Overall Study|Not Eligible|0|||
48884645|NCT01865747|157413888|FG000|Overall Study (ITT)|Adverse Event|32|||
48884646|NCT01865747|157413889|FG001|Overall Study (ITT)|Adverse Event|31|||
48983683|NCT00242710|157772325|FG002|Period Between Core Study and Extension|Adverse Event|5|||
48884647|NCT01865747|157413888|FG000|Overall Study (ITT)|Clinical Deterioration|29|||
48884648|NCT01865747|157413889|FG001|Overall Study (ITT)|Clinical Deterioration|50|||
48884649|NCT01865747|157413888|FG000|Overall Study (ITT)|Lack of Efficacy|3|||
48884650|NCT01865747|157413889|FG001|Overall Study (ITT)|Lack of Efficacy|0|||
48884651|NCT01865747|157413888|FG000|Overall Study (ITT)|Protocol Violation|1|||
48884652|NCT01865747|157413889|FG001|Overall Study (ITT)|Protocol Violation|1|||
48884653|NCT01865747|157413888|FG000|Overall Study (ITT)|Physician Decision|5|||
48884654|NCT01865747|157413889|FG001|Overall Study (ITT)|Physician Decision|2|||
48884655|NCT01865747|157413888|FG000|Overall Study (ITT)|Withdrawal by Subject|6|||
48884656|NCT01865747|157413889|FG001|Overall Study (ITT)|Withdrawal by Subject|11|||
48884657|NCT01865747|157413888|FG000|Overall Study (ITT)|Sponsor Decision|0|||
48884658|NCT01865747|157413889|FG001|Overall Study (ITT)|Sponsor Decision|1|||
48884659|NCT01865747|157413888|FG000|Overall Study (ITT)|Progressive Disease|122|||
48884660|NCT01865747|157413889|FG001|Overall Study (ITT)|Progressive Disease|158|||
48884661|NCT01865747|157413888|FG000|Overall Study (ITT)|Reason Not Provided|0|||
48884662|NCT01865747|157413889|FG001|Overall Study (ITT)|Reason Not Provided|1|||
48884663|NCT01865747|157413888|FG000|Primary Intent to Treat (PITT)|Adverse Event|21|||
48884664|NCT01865747|157413889|FG001|Primary Intent to Treat (PITT)|Adverse Event|20|||
48884665|NCT01865747|157413888|FG000|Primary Intent to Treat (PITT)|Clinical Deterioration|18|||
48884666|NCT01865747|157413889|FG001|Primary Intent to Treat (PITT)|Clinical Deterioration|29|||
48884667|NCT01865747|157413888|FG000|Primary Intent to Treat (PITT)|Lack of Efficacy|2|||
48884668|NCT01865747|157413889|FG001|Primary Intent to Treat (PITT)|Lack of Efficacy|0|||
48884669|NCT01865747|157413888|FG000|Primary Intent to Treat (PITT)|Protocol Violation|1|||
48884670|NCT01865747|157413889|FG001|Primary Intent to Treat (PITT)|Protocol Violation|1|||
48884671|NCT01865747|157413888|FG000|Primary Intent to Treat (PITT)|Physician Decision|4|||
48884672|NCT01865747|157413889|FG001|Primary Intent to Treat (PITT)|Physician Decision|2|||
48884673|NCT01865747|157413888|FG000|Primary Intent to Treat (PITT)|Withdrawal by Subject|3|||
48884674|NCT01865747|157413889|FG001|Primary Intent to Treat (PITT)|Withdrawal by Subject|7|||
48884675|NCT01865747|157413888|FG000|Primary Intent to Treat (PITT)|Progressive Disease|82|||
48884676|NCT01865747|157413889|FG001|Primary Intent to Treat (PITT)|Progressive Disease|92|||
48884677|NCT01865747|157413888|FG000|Primary Intent to Treat (PITT)|Other|0|||
48884678|NCT01865747|157413889|FG001|Primary Intent to Treat (PITT)|Other|1|||
48884679|NCT01133418|157413890|FG000|Overall Study|Lost to Follow-up|5|||
48884680|NCT01133418|157413891|FG001|Overall Study|Lost to Follow-up|6|||
48884681|NCT04469270|157413892|FG000|Overall Study|Adverse Event|2|||
48884682|NCT04469270|157413893|FG001|Overall Study|Adverse Event|0|||
48884683|NCT04469270|157413892|FG000|Overall Study|Lost to Follow-up|4|||
48884684|NCT04469270|157413893|FG001|Overall Study|Lost to Follow-up|3|||
48884685|NCT04469270|157413892|FG000|Overall Study|Withdrawal by Subject|7|||
48884686|NCT04469270|157413893|FG001|Overall Study|Withdrawal by Subject|3|||
48884687|NCT04469270|157413892|FG000|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|2|||
48884688|NCT04469270|157413893|FG001|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|0|||
48884689|NCT04469270|157413892|FG000|Overall Study|missing|1|||
48884690|NCT04469270|157413893|FG001|Overall Study|missing|0|||
48884691|NCT04820322|157413894|FG000|Overall Study|Adverse Event|1|||
48884692|NCT04820322|157413895|FG001|Overall Study|Adverse Event|0|||
48884693|NCT01820611|157413898|FG000|Overall Study|Death|8|||
48884694|NCT01820611|157413898|FG000|Overall Study|Adverse Event|1|||
48884695|NCT01820611|157413898|FG000|Overall Study|Withdrawal by Subject|9|||
48884696|NCT03043872|157413899|FG000|Overall Study|Withdrawal by Subject|6|||
48884697|NCT03043872|157413900|FG001|Overall Study|Withdrawal by Subject|6|||
48884698|NCT03043872|157413901|FG002|Overall Study|Withdrawal by Subject|15|||
48884699|NCT03043872|157413899|FG000|Overall Study|Lost to Follow-up|2|||
48884700|NCT03043872|157413900|FG001|Overall Study|Lost to Follow-up|1|||
48884701|NCT03043872|157413901|FG002|Overall Study|Lost to Follow-up|1|||
48884702|NCT03043872|157413899|FG000|Overall Study|Death|270|||
48884703|NCT03043872|157413900|FG001|Overall Study|Death|269|||
48884704|NCT03043872|157413901|FG002|Overall Study|Death|296|||
48884705|NCT01706705|157415546|FG000|Overall Study|Death|1|||
48884706|NCT01706705|157415546|FG000|Overall Study|Lack of Efficacy|13|||
48884707|NCT01706705|157415546|FG000|Overall Study|Non-clinical|6|||
48884708|NCT00863681|157415547|FG000|Overall Study|Other|2|||
48884709|NCT00863681|157415548|FG001|Overall Study|Other|0|||
48884710|NCT00863681|157415549|FG002|Overall Study|Other|0|||
48884711|NCT00863681|157415547|FG000|Overall Study|Missing|1|||
48884712|NCT00863681|157415548|FG001|Overall Study|Missing|0|||
48884713|NCT00863681|157415549|FG002|Overall Study|Missing|0|||
48884714|NCT00863681|157415547|FG000|Overall Study|Death|40|||
48884715|NCT00863681|157415548|FG001|Overall Study|Death|23|||
48884716|NCT00863681|157415549|FG002|Overall Study|Death|6|||
48884717|NCT00863681|157415547|FG000|Overall Study|Withdrawal by Subject|12|||
48884718|NCT00863681|157415548|FG001|Overall Study|Withdrawal by Subject|5|||
48884719|NCT00863681|157415549|FG002|Overall Study|Withdrawal by Subject|2|||
48884720|NCT00863681|157415547|FG000|Overall Study|Protocol Violation|2|||
48884721|NCT00863681|157415548|FG001|Overall Study|Protocol Violation|0|||
48884722|NCT00863681|157415549|FG002|Overall Study|Protocol Violation|0|||
48884723|NCT00863681|157415547|FG000|Overall Study|Lost to Follow-up|3|||
48884724|NCT00863681|157415548|FG001|Overall Study|Lost to Follow-up|0|||
48884725|NCT00863681|157415549|FG002|Overall Study|Lost to Follow-up|3|||
48884726|NCT00863681|157415547|FG000|Overall Study|Adverse Event|28|||
48884727|NCT00863681|157415548|FG001|Overall Study|Adverse Event|10|||
49034899|NCT03873272|157965419|FG000|Overall Study|Withdrawal by Subject|2|||
49034900|NCT03873272|157965420|FG001|Overall Study|Withdrawal by Subject|0|||
48884728|NCT00863681|157415549|FG002|Overall Study|Adverse Event|6|||
48884729|NCT00863681|157415547|FG000|Overall Study|Lack of Efficacy|2|||
48884730|NCT00863681|157415548|FG001|Overall Study|Lack of Efficacy|2|||
48884731|NCT00863681|157415549|FG002|Overall Study|Lack of Efficacy|1|||
48884732|NCT00863681|157415547|FG000|Overall Study|Non-compliance with study drug|1|||
48884733|NCT00863681|157415548|FG001|Overall Study|Non-compliance with study drug|3|||
48884734|NCT00863681|157415549|FG002|Overall Study|Non-compliance with study drug|0|||
48884735|NCT00338962|157415550|FG000|Overall Study|Lost to Follow-up|3|||
48884736|NCT00338962|157415551|FG001|Overall Study|Lost to Follow-up|3|||
48884737|NCT00338962|157415552|FG002|Overall Study|Lost to Follow-up|2|||
48884738|NCT00338962|157415553|FG003|Overall Study|Lost to Follow-up|3|||
48884739|NCT00338962|157415550|FG000|Overall Study|Withdrawal by Subject|1|||
48884740|NCT00338962|157415551|FG001|Overall Study|Withdrawal by Subject|0|||
48884741|NCT00338962|157415552|FG002|Overall Study|Withdrawal by Subject|0|||
48884742|NCT00338962|157415553|FG003|Overall Study|Withdrawal by Subject|0|||
48884743|NCT00338962|157415550|FG000|Overall Study|No Transportation|2|||
48884744|NCT00338962|157415551|FG001|Overall Study|No Transportation|0|||
48884745|NCT00338962|157415552|FG002|Overall Study|No Transportation|0|||
48884746|NCT00338962|157415553|FG003|Overall Study|No Transportation|0|||
48884747|NCT00338962|157415550|FG000|Overall Study|Time Constraint|2|||
48884748|NCT00338962|157415551|FG001|Overall Study|Time Constraint|0|||
48884749|NCT00338962|157415552|FG002|Overall Study|Time Constraint|0|||
48884750|NCT00338962|157415553|FG003|Overall Study|Time Constraint|0|||
48884751|NCT00338962|157415550|FG000|Overall Study|Moved|0|||
48884752|NCT00338962|157415551|FG001|Overall Study|Moved|1|||
48884753|NCT00338962|157415552|FG002|Overall Study|Moved|0|||
48884754|NCT00338962|157415553|FG003|Overall Study|Moved|0|||
48884755|NCT00338962|157415550|FG000|Overall Study|Adverse Event|0|||
48884756|NCT00338962|157415551|FG001|Overall Study|Adverse Event|0|||
48884757|NCT00338962|157415552|FG002|Overall Study|Adverse Event|2|||
48884758|NCT00338962|157415553|FG003|Overall Study|Adverse Event|0|||
48884759|NCT00338962|157415550|FG000|Overall Study|Poor Compliance|0|||
49034901|NCT03873272|157965421|FG002|Overall Study|Withdrawal by Subject|1|||
49034902|NCT03873272|157965419|FG000|Overall Study|Death|0|||
49034903|NCT03873272|157965420|FG001|Overall Study|Death|2|||
49034904|NCT03873272|157965421|FG002|Overall Study|Death|1|||
49034905|NCT02653664|157965422|FG000|Post-Treatment|Withdrawal by Subject|6|||
49034906|NCT02653664|157965423|FG001|Post-Treatment|Withdrawal by Subject|5|||
49034907|NCT02653664|157965424|FG002|Post-Treatment|Withdrawal by Subject|7|||
49034908|NCT02653664|157965422|FG000|Post-Treatment|Lost to Follow-up|8|||
49034909|NCT02653664|157965423|FG001|Post-Treatment|Lost to Follow-up|1|||
49034910|NCT02653664|157965424|FG002|Post-Treatment|Lost to Follow-up|7|||
49034911|NCT02653664|157965422|FG000|3 Month Follow-Up|Withdrawal by Subject|9|||
49034912|NCT02653664|157965423|FG001|3 Month Follow-Up|Withdrawal by Subject|5|||
49034913|NCT02653664|157965424|FG002|3 Month Follow-Up|Withdrawal by Subject|9|||
49034914|NCT02653664|157965422|FG000|3 Month Follow-Up|Lost to Follow-up|9|||
49034915|NCT02653664|157965423|FG001|3 Month Follow-Up|Lost to Follow-up|8|||
49034916|NCT02653664|157965424|FG002|3 Month Follow-Up|Lost to Follow-up|16|||
49034917|NCT02653664|157965422|FG000|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
49034918|NCT02653664|157965423|FG001|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
49034919|NCT02653664|157965424|FG002|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
49034920|NCT02653664|157965422|FG000|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3|||
49034921|NCT02653664|157965423|FG001|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
49034922|NCT02653664|157965424|FG002|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
49034923|NCT02653664|157965422|FG000|6 Month Follow-Up|Withdrawal by Subject|13|||
49034924|NCT02653664|157965423|FG001|6 Month Follow-Up|Withdrawal by Subject|7|||
48884760|NCT00338962|157415551|FG001|Overall Study|Poor Compliance|0|||
48884761|NCT00338962|157415552|FG002|Overall Study|Poor Compliance|2|||
49034925|NCT02653664|157965424|FG002|6 Month Follow-Up|Withdrawal by Subject|14|||
49034926|NCT02653664|157965422|FG000|6 Month Follow-Up|Lost to Follow-up|10|||
49034927|NCT02653664|157965423|FG001|6 Month Follow-Up|Lost to Follow-up|11|||
49034928|NCT02653664|157965424|FG002|6 Month Follow-Up|Lost to Follow-up|9|||
48884762|NCT00338962|157415553|FG003|Overall Study|Poor Compliance|0|||
48884763|NCT00742326|157415554|FG000|Overall Study|Physician Decision|0|||
48884764|NCT00742326|157415555|FG001|Overall Study|Physician Decision|1|||
48884765|NCT01441635|157415556|FG000|Overall Study|Adverse Event|4|||
48884766|NCT01441635|157415557|FG001|Overall Study|Adverse Event|3|||
48884767|NCT01441635|157415558|FG002|Overall Study|Adverse Event|1|||
48884768|NCT01441635|157415559|FG003|Overall Study|Adverse Event|5|||
48884769|NCT01441635|157415560|FG004|Overall Study|Adverse Event|1|||
48884770|NCT01441635|157415561|FG005|Overall Study|Adverse Event|2|||
48884771|NCT01441635|157415562|FG006|Overall Study|Adverse Event|2|||
48884772|NCT01441635|157415563|FG007|Overall Study|Adverse Event|2|||
48884773|NCT01441635|157415564|FG008|Overall Study|Adverse Event|1|||
48884774|NCT01441635|157415565|FG009|Overall Study|Adverse Event|0|||
48884775|NCT01441635|157415556|FG000|Overall Study|Withdrawal by Subject|1|||
48884776|NCT01441635|157415557|FG001|Overall Study|Withdrawal by Subject|1|||
48884777|NCT01441635|157415558|FG002|Overall Study|Withdrawal by Subject|0|||
48884778|NCT01441635|157415559|FG003|Overall Study|Withdrawal by Subject|1|||
49034929|NCT02653664|157965422|FG000|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
49034930|NCT02653664|157965423|FG001|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
49034931|NCT02653664|157965424|FG002|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
49034932|NCT02653664|157965422|FG000|6 Month Follow-Up|Subject Declined Assessment Period|0|||
49034933|NCT02653664|157965423|FG001|6 Month Follow-Up|Subject Declined Assessment Period|1|||
49034934|NCT02653664|157965424|FG002|6 Month Follow-Up|Subject Declined Assessment Period|0|||
49034935|NCT00462345|157965427|FG000|Overall Study|Withdrawal by Subject|2|||
49034936|NCT00462345|157965427|FG000|Overall Study|Did not complete second course|1|||
49034937|NCT02642653|157965429|FG000|Overall Study|Adverse Event|2|||
48884779|NCT01441635|157415560|FG004|Overall Study|Withdrawal by Subject|0|||
48884780|NCT01441635|157415561|FG005|Overall Study|Withdrawal by Subject|0|||
48884781|NCT01441635|157415562|FG006|Overall Study|Withdrawal by Subject|2|||
48884782|NCT01441635|157415563|FG007|Overall Study|Withdrawal by Subject|0|||
48884783|NCT01441635|157415564|FG008|Overall Study|Withdrawal by Subject|1|||
48884784|NCT01441635|157415565|FG009|Overall Study|Withdrawal by Subject|1|||
48884785|NCT01441635|157415556|FG000|Overall Study|Lost to Follow-up|0|||
48884786|NCT01441635|157415557|FG001|Overall Study|Lost to Follow-up|1|||
48884787|NCT01441635|157415558|FG002|Overall Study|Lost to Follow-up|1|||
48884788|NCT01441635|157415559|FG003|Overall Study|Lost to Follow-up|1|||
48884789|NCT01441635|157415560|FG004|Overall Study|Lost to Follow-up|1|||
48884790|NCT01441635|157415561|FG005|Overall Study|Lost to Follow-up|3|||
48884791|NCT01441635|157415562|FG006|Overall Study|Lost to Follow-up|1|||
48884792|NCT01441635|157415563|FG007|Overall Study|Lost to Follow-up|1|||
48884793|NCT01441635|157415564|FG008|Overall Study|Lost to Follow-up|0|||
48884794|NCT01441635|157415565|FG009|Overall Study|Lost to Follow-up|1|||
48884795|NCT01441635|157415556|FG000|Overall Study|Noncompliance|0|||
48884796|NCT01441635|157415557|FG001|Overall Study|Noncompliance|1|||
48884797|NCT01441635|157415558|FG002|Overall Study|Noncompliance|0|||
48884798|NCT01441635|157415559|FG003|Overall Study|Noncompliance|0|||
49034938|NCT02642653|157965430|FG001|Overall Study|Adverse Event|0|||
49034939|NCT01056484|157965431|FG000|Randomized Controlled Trial|Withdrawal by Subject|6|||
49034940|NCT01056484|157965432|FG001|Randomized Controlled Trial|Withdrawal by Subject|1|||
49034941|NCT01056484|157965431|FG000|Randomized Controlled Trial|Physician Decision|1|||
49034942|NCT01056484|157965432|FG001|Randomized Controlled Trial|Physician Decision|0|||
49034943|NCT01056484|157965431|FG000|Follow up - Non-randomized|Withdrawal by Subject|0|||
49034944|NCT01056484|157965432|FG001|Follow up - Non-randomized|Withdrawal by Subject|2|||
49034945|NCT02545283|157965435|FG000|Overall Study|Lost to Follow-up|2|||
49034946|NCT02545283|157965436|FG001|Overall Study|Lost to Follow-up|4|||
49034947|NCT02545283|157965435|FG000|Overall Study|Withdrawal by Subject|5|||
49034948|NCT02545283|157965436|FG001|Overall Study|Withdrawal by Subject|9|||
49034949|NCT02545283|157965435|FG000|Overall Study|Death|109|||
49034950|NCT02545283|157965436|FG001|Overall Study|Death|211|||
49034951|NCT02545283|157965435|FG000|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0|||
49034952|NCT02545283|157965436|FG001|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3|||
49034953|NCT02545283|157965435|FG000|Overall Study|Study Terminated By Sponsor|33|||
49034954|NCT02545283|157965436|FG001|Overall Study|Study Terminated By Sponsor|71|||
49034955|NCT00583453|157965437|FG000|Overall Study|discontinued intervention|0|||
49034956|NCT00583453|157965438|FG001|Overall Study|discontinued intervention|2|||
49034957|NCT03106415|157965439|FG000|Phase 1|Withdrawal by Subject|1|||
49034958|NCT03106415|157965440|FG001|Phase 1|Withdrawal by Subject|0|||
49034959|NCT03106415|157965441|FG002|Phase 1|Withdrawal by Subject|0|||
48884799|NCT01441635|157415560|FG004|Overall Study|Noncompliance|0|||
48884800|NCT01441635|157415561|FG005|Overall Study|Noncompliance|0|||
49034960|NCT03106415|157965439|FG000|Phase 1|Adverse Event|1|||
49034961|NCT03106415|157965440|FG001|Phase 1|Adverse Event|1|||
49034962|NCT03106415|157965441|FG002|Phase 1|Adverse Event|0|||
49034963|NCT03106415|157965439|FG000|Phase 1|Protocol Violation|0|||
49034964|NCT03106415|157965440|FG001|Phase 1|Protocol Violation|1|||
49034965|NCT03106415|157965441|FG002|Phase 1|Protocol Violation|0|||
49034966|NCT00365365|157965442|FG000|Overall Study|Randomized but not treated|0|||
48884801|NCT01441635|157415562|FG006|Overall Study|Noncompliance|1|||
48884802|NCT01441635|157415563|FG007|Overall Study|Noncompliance|0|||
48884803|NCT01441635|157415564|FG008|Overall Study|Noncompliance|0|||
48884804|NCT01441635|157415565|FG009|Overall Study|Noncompliance|0|||
48884805|NCT01441635|157415556|FG000|Overall Study|Surgery or Invasive Intervention|0|||
48884806|NCT01441635|157415557|FG001|Overall Study|Surgery or Invasive Intervention|0|||
48884807|NCT01441635|157415558|FG002|Overall Study|Surgery or Invasive Intervention|1|||
48884808|NCT01441635|157415559|FG003|Overall Study|Surgery or Invasive Intervention|0|||
48884809|NCT01441635|157415560|FG004|Overall Study|Surgery or Invasive Intervention|0|||
48884810|NCT01441635|157415561|FG005|Overall Study|Surgery or Invasive Intervention|0|||
48884811|NCT01441635|157415562|FG006|Overall Study|Surgery or Invasive Intervention|0|||
48884812|NCT01441635|157415563|FG007|Overall Study|Surgery or Invasive Intervention|0|||
48884813|NCT01441635|157415564|FG008|Overall Study|Surgery or Invasive Intervention|0|||
48884814|NCT01441635|157415565|FG009|Overall Study|Surgery or Invasive Intervention|0|||
48884815|NCT01441635|157415556|FG000|Overall Study|Received Exclusionary Medication|1|||
48884816|NCT01441635|157415557|FG001|Overall Study|Received Exclusionary Medication|0|||
48884817|NCT01441635|157415558|FG002|Overall Study|Received Exclusionary Medication|0|||
48884818|NCT01441635|157415559|FG003|Overall Study|Received Exclusionary Medication|0|||
48884819|NCT01441635|157415560|FG004|Overall Study|Received Exclusionary Medication|0|||
48884820|NCT01441635|157415561|FG005|Overall Study|Received Exclusionary Medication|0|||
48884821|NCT01441635|157415562|FG006|Overall Study|Received Exclusionary Medication|0|||
48884822|NCT01441635|157415563|FG007|Overall Study|Received Exclusionary Medication|0|||
48884823|NCT01441635|157415564|FG008|Overall Study|Received Exclusionary Medication|0|||
48884824|NCT01441635|157415565|FG009|Overall Study|Received Exclusionary Medication|0|||
48884825|NCT01441635|157415556|FG000|Overall Study|Other|0|||
48884826|NCT01441635|157415557|FG001|Overall Study|Other|0|||
48884827|NCT01441635|157415558|FG002|Overall Study|Other|0|||
48884828|NCT01441635|157415559|FG003|Overall Study|Other|0|||
48884829|NCT01441635|157415560|FG004|Overall Study|Other|0|||
48884830|NCT01441635|157415561|FG005|Overall Study|Other|0|||
48884831|NCT01441635|157415562|FG006|Overall Study|Other|0|||
48884832|NCT01441635|157415563|FG007|Overall Study|Other|1|||
48884833|NCT01441635|157415564|FG008|Overall Study|Other|0|||
48884834|NCT01441635|157415565|FG009|Overall Study|Other|0|||
48884835|NCT01818531|157415568|FG000|Overall Study|Withdrawn for case delay after block|1|||
48884836|NCT01818531|157415569|FG001|Overall Study|Withdrawn for case delay after block|0|||
48884837|NCT01818531|157415568|FG000|Overall Study|Withdrawn for long-acting opioid patch|0|||
48884838|NCT01818531|157415569|FG001|Overall Study|Withdrawn for long-acting opioid patch|1|||
48884839|NCT01818531|157415568|FG000|Overall Study|Withdrawn for failure to place block|0|||
48884840|NCT01818531|157415569|FG001|Overall Study|Withdrawn for failure to place block|1|||
48884841|NCT03274895|157415574|FG000|Overall Study|Lack of Efficacy|1|||
48884842|NCT03274895|157415575|FG001|Overall Study|Lack of Efficacy|0|||
48884843|NCT03274895|157415574|FG000|Overall Study|Adverse Event|8|||
48884844|NCT03274895|157415575|FG001|Overall Study|Adverse Event|7|||
48884845|NCT03274895|157415574|FG000|Overall Study|Lost to Follow-up|1|||
48884846|NCT03274895|157415575|FG001|Overall Study|Lost to Follow-up|0|||
49034967|NCT00365365|157965443|FG001|Overall Study|Randomized but not treated|2|||
49034968|NCT00365365|157965444|FG002|Overall Study|Randomized but not treated|0|||
49034969|NCT00365365|157965442|FG000|Overall Study|Poor compliance to protocol|0|||
49034970|NCT00365365|157965443|FG001|Overall Study|Poor compliance to protocol|1|||
49034971|NCT00365365|157965444|FG002|Overall Study|Poor compliance to protocol|0|||
49034972|NCT00365365|157965442|FG000|Overall Study|Lost to Follow-up|3|||
49034973|NCT00365365|157965443|FG001|Overall Study|Lost to Follow-up|3|||
49034974|NCT00365365|157965444|FG002|Overall Study|Lost to Follow-up|3|||
49034975|NCT00365365|157965442|FG000|Overall Study|Death|1|||
49034976|NCT00365365|157965443|FG001|Overall Study|Death|3|||
49034977|NCT00365365|157965444|FG002|Overall Study|Death|0|||
49034978|NCT00365365|157965442|FG000|Overall Study|Subject's request|11|||
49034979|NCT00365365|157965443|FG001|Overall Study|Subject's request|13|||
49034980|NCT00365365|157965444|FG002|Overall Study|Subject's request|1|||
49034981|NCT00365365|157965442|FG000|Overall Study|Disease progression/relapse|9|||
49034982|NCT00365365|157965443|FG001|Overall Study|Disease progression/relapse|6|||
49034983|NCT00365365|157965444|FG002|Overall Study|Disease progression/relapse|7|||
49034984|NCT00365365|157965442|FG000|Overall Study|Adverse Event|6|||
49034985|NCT00365365|157965443|FG001|Overall Study|Adverse Event|6|||
48884847|NCT03274895|157415574|FG000|Overall Study|Diagnosis not confirmed|3|||
48884848|NCT03274895|157415575|FG001|Overall Study|Diagnosis not confirmed|4|||
48884849|NCT00477490|157415576|FG000|Part I: 4 Week Efficacy|Adverse Event|1|||
48884850|NCT00477490|157415577|FG001|Part I: 4 Week Efficacy|Adverse Event|4|||
48884851|NCT00477490|157415578|FG002|Part I: 4 Week Efficacy|Adverse Event|0|||
48884852|NCT00477490|157415579|FG003|Part I: 4 Week Efficacy|Adverse Event|5|||
48884853|NCT00477490|157415580|FG004|Part I: 4 Week Efficacy|Adverse Event|6|||
48884854|NCT00477490|157415581|FG005|Part I: 4 Week Efficacy|Adverse Event|0|||
48884855|NCT00477490|157415582|FG006|Part I: 4 Week Efficacy|Adverse Event|0|||
49034986|NCT00365365|157965444|FG002|Overall Study|Adverse Event|3|||
49034987|NCT00365365|157965442|FG000|Overall Study|Moved|2|||
49034988|NCT00365365|157965443|FG001|Overall Study|Moved|0|||
48884856|NCT00477490|157415583|FG007|Part I: 4 Week Efficacy|Adverse Event|0|||
48884857|NCT00477490|157415584|FG008|Part I: 4 Week Efficacy|Adverse Event|0|||
48884858|NCT00477490|157415576|FG000|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1|||
48884859|NCT00477490|157415577|FG001|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
49034989|NCT00365365|157965444|FG002|Overall Study|Moved|0|||
49034990|NCT00365365|157965442|FG000|Overall Study|New cancer|1|||
49034991|NCT00365365|157965443|FG001|Overall Study|New cancer|0|||
48884860|NCT00477490|157415578|FG002|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
48884861|NCT00477490|157415579|FG003|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5|||
48884862|NCT00477490|157415580|FG004|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4|||
48884863|NCT00477490|157415581|FG005|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
48884864|NCT00477490|157415582|FG006|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
48884865|NCT00477490|157415583|FG007|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
48884866|NCT00477490|157415584|FG008|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
48884867|NCT00477490|157415576|FG000|Part I: 4 Week Efficacy|Protocol Violation|2|||
48884868|NCT00477490|157415577|FG001|Part I: 4 Week Efficacy|Protocol Violation|0|||
48884869|NCT00477490|157415578|FG002|Part I: 4 Week Efficacy|Protocol Violation|0|||
48884870|NCT00477490|157415579|FG003|Part I: 4 Week Efficacy|Protocol Violation|0|||
48884871|NCT00477490|157415580|FG004|Part I: 4 Week Efficacy|Protocol Violation|1|||
48884872|NCT00477490|157415581|FG005|Part I: 4 Week Efficacy|Protocol Violation|0|||
48884873|NCT00477490|157415582|FG006|Part I: 4 Week Efficacy|Protocol Violation|0|||
48884874|NCT00477490|157415583|FG007|Part I: 4 Week Efficacy|Protocol Violation|0|||
48884875|NCT00477490|157415584|FG008|Part I: 4 Week Efficacy|Protocol Violation|0|||
48884876|NCT00477490|157415576|FG000|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
48884877|NCT00477490|157415577|FG001|Part I: 4 Week Efficacy|Withdrawal by Subject|5|||
48884878|NCT00477490|157415578|FG002|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
48884879|NCT00477490|157415579|FG003|Part I: 4 Week Efficacy|Withdrawal by Subject|4|||
48884880|NCT00477490|157415580|FG004|Part I: 4 Week Efficacy|Withdrawal by Subject|9|||
48884881|NCT00477490|157415581|FG005|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
48884882|NCT00477490|157415582|FG006|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
48884883|NCT00477490|157415583|FG007|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
48884884|NCT00477490|157415584|FG008|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
48884885|NCT00477490|157415576|FG000|Part I: 4 Week Efficacy|Lost to Follow-up|2|||
48884886|NCT00477490|157415577|FG001|Part I: 4 Week Efficacy|Lost to Follow-up|4|||
48884887|NCT00477490|157415578|FG002|Part I: 4 Week Efficacy|Lost to Follow-up|1|||
48884888|NCT00477490|157415579|FG003|Part I: 4 Week Efficacy|Lost to Follow-up|5|||
48884889|NCT00477490|157415580|FG004|Part I: 4 Week Efficacy|Lost to Follow-up|3|||
48884890|NCT00477490|157415581|FG005|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
48884891|NCT00477490|157415582|FG006|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
48884892|NCT00477490|157415583|FG007|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
48884893|NCT00477490|157415584|FG008|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
48884894|NCT00477490|157415576|FG000|Part I: 4 Week Efficacy|Other, not specified|2|||
48884895|NCT00477490|157415577|FG001|Part I: 4 Week Efficacy|Other, not specified|4|||
48884896|NCT00477490|157415578|FG002|Part I: 4 Week Efficacy|Other, not specified|0|||
48884897|NCT00477490|157415579|FG003|Part I: 4 Week Efficacy|Other, not specified|1|||
48884898|NCT00477490|157415580|FG004|Part I: 4 Week Efficacy|Other, not specified|1|||
48884899|NCT00477490|157415581|FG005|Part I: 4 Week Efficacy|Other, not specified|0|||
48884900|NCT00477490|157415582|FG006|Part I: 4 Week Efficacy|Other, not specified|0|||
48884901|NCT00477490|157415583|FG007|Part I: 4 Week Efficacy|Other, not specified|0|||
48884902|NCT00477490|157415584|FG008|Part I: 4 Week Efficacy|Other, not specified|0|||
48884903|NCT00477490|157415576|FG000|Part I: 4 Week Efficacy|Not Reported|1|||
48884904|NCT00477490|157415577|FG001|Part I: 4 Week Efficacy|Not Reported|2|||
48884905|NCT00477490|157415578|FG002|Part I: 4 Week Efficacy|Not Reported|3|||
48884906|NCT00477490|157415579|FG003|Part I: 4 Week Efficacy|Not Reported|0|||
48884907|NCT00477490|157415580|FG004|Part I: 4 Week Efficacy|Not Reported|1|||
48884908|NCT00477490|157415581|FG005|Part I: 4 Week Efficacy|Not Reported|0|||
48884909|NCT00477490|157415582|FG006|Part I: 4 Week Efficacy|Not Reported|0|||
48983684|NCT00242710|157772326|FG003|Period Between Core Study and Extension|Adverse Event|2|||
48983685|NCT00242710|157772323|FG000|Period Between Core Study and Extension|Physician Decision|1|||
48983686|NCT00242710|157772324|FG001|Period Between Core Study and Extension|Physician Decision|1|||
48983687|NCT00242710|157772325|FG002|Period Between Core Study and Extension|Physician Decision|0|||
48983688|NCT00242710|157772326|FG003|Period Between Core Study and Extension|Physician Decision|0|||
48983689|NCT00242710|157772323|FG000|Period Between Core Study and Extension|Other|24|||
48983690|NCT00242710|157772324|FG001|Period Between Core Study and Extension|Other|24|||
48983691|NCT00242710|157772325|FG002|Period Between Core Study and Extension|Other|9|||
48983692|NCT00242710|157772326|FG003|Period Between Core Study and Extension|Other|11|||
48983693|NCT00242710|157772323|FG000|Period Between Core Study and Extension|Extension not Available|17|||
48983694|NCT00242710|157772324|FG001|Period Between Core Study and Extension|Extension not Available|21|||
48983695|NCT00242710|157772325|FG002|Period Between Core Study and Extension|Extension not Available|8|||
48983696|NCT00242710|157772326|FG003|Period Between Core Study and Extension|Extension not Available|7|||
48983697|NCT00242710|157772323|FG000|Period Between Core Study and Extension|Protocol Violation|0|||
48983698|NCT00242710|157772324|FG001|Period Between Core Study and Extension|Protocol Violation|0|||
48983699|NCT00242710|157772325|FG002|Period Between Core Study and Extension|Protocol Violation|2|||
48983700|NCT00242710|157772326|FG003|Period Between Core Study and Extension|Protocol Violation|1|||
48884910|NCT00477490|157415583|FG007|Part I: 4 Week Efficacy|Not Reported|0|||
48983701|NCT00242710|157772323|FG000|Period Between Core Study and Extension|Withdrawal by Subject|75|||
48884911|NCT00477490|157415584|FG008|Part I: 4 Week Efficacy|Not Reported|0|||
48884912|NCT00477490|157415576|FG000|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0|||
48884913|NCT00477490|157415577|FG001|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15|||
48884914|NCT00477490|157415578|FG002|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
48884915|NCT00477490|157415579|FG003|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
48884916|NCT00477490|157415580|FG004|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10|||
48884917|NCT00477490|157415581|FG005|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4|||
48884918|NCT00477490|157415582|FG006|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
48884919|NCT00477490|157415583|FG007|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3|||
48884920|NCT00477490|157415584|FG008|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
48884921|NCT00477490|157415576|FG000|Part II: Extension Week 5 up to Day 169|Adverse Event|0|||
48884922|NCT00477490|157415577|FG001|Part II: Extension Week 5 up to Day 169|Adverse Event|2|||
48884923|NCT00477490|157415578|FG002|Part II: Extension Week 5 up to Day 169|Adverse Event|3|||
48884924|NCT00477490|157415579|FG003|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
48884925|NCT00477490|157415580|FG004|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
48884926|NCT00477490|157415581|FG005|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
48884927|NCT00477490|157415582|FG006|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
48884928|NCT00477490|157415583|FG007|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
48884929|NCT00477490|157415584|FG008|Part II: Extension Week 5 up to Day 169|Adverse Event|4|||
48884930|NCT00477490|157415576|FG000|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
48884931|NCT00477490|157415577|FG001|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3|||
48884932|NCT00477490|157415578|FG002|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2|||
48884933|NCT00477490|157415579|FG003|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
48884934|NCT00477490|157415580|FG004|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5|||
48884935|NCT00477490|157415581|FG005|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
48884936|NCT00477490|157415582|FG006|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1|||
48884937|NCT00477490|157415583|FG007|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
48884938|NCT00477490|157415584|FG008|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
48884939|NCT00477490|157415576|FG000|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
48884940|NCT00477490|157415577|FG001|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
48884941|NCT00477490|157415578|FG002|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
48884942|NCT00477490|157415579|FG003|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
48884943|NCT00477490|157415580|FG004|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
48884944|NCT00477490|157415581|FG005|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
48884945|NCT00477490|157415582|FG006|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
48884946|NCT00477490|157415583|FG007|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
48884947|NCT00477490|157415584|FG008|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
48884948|NCT00477490|157415576|FG000|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
48884949|NCT00477490|157415577|FG001|Part II: Extension Week 5 up to Day 169|Excluded medication|1|||
48884950|NCT00477490|157415578|FG002|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
48884951|NCT00477490|157415579|FG003|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
48884952|NCT00477490|157415580|FG004|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
48884953|NCT00477490|157415581|FG005|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
48884954|NCT00477490|157415582|FG006|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
48884955|NCT00477490|157415583|FG007|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
48884956|NCT00477490|157415584|FG008|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
48884957|NCT00477490|157415576|FG000|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
48884958|NCT00477490|157415577|FG001|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
48884959|NCT00477490|157415578|FG002|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
48884960|NCT00477490|157415579|FG003|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
48884961|NCT00477490|157415580|FG004|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
48884962|NCT00477490|157415581|FG005|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
48884963|NCT00477490|157415582|FG006|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
48884964|NCT00477490|157415583|FG007|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
48884965|NCT00477490|157415584|FG008|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
48884966|NCT00477490|157415576|FG000|Part II: Extension Week 5 up to Day 169|Not reported|0|||
48884967|NCT00477490|157415577|FG001|Part II: Extension Week 5 up to Day 169|Not reported|3|||
48884968|NCT00477490|157415578|FG002|Part II: Extension Week 5 up to Day 169|Not reported|1|||
48884969|NCT00477490|157415579|FG003|Part II: Extension Week 5 up to Day 169|Not reported|0|||
48884970|NCT00477490|157415580|FG004|Part II: Extension Week 5 up to Day 169|Not reported|1|||
48884971|NCT00477490|157415581|FG005|Part II: Extension Week 5 up to Day 169|Not reported|0|||
48884972|NCT00477490|157415582|FG006|Part II: Extension Week 5 up to Day 169|Not reported|0|||
48884973|NCT00477490|157415583|FG007|Part II: Extension Week 5 up to Day 169|Not reported|0|||
48884974|NCT00477490|157415584|FG008|Part II: Extension Week 5 up to Day 169|Not reported|0|||
48884975|NCT01646177|157415585|FG000|Blinded Induction Dosing (Week 0-12)|Adverse Event|2|||
48884976|NCT01646177|157415586|FG001|Blinded Induction Dosing (Week 0-12)|Adverse Event|4|||
48884977|NCT01646177|157415587|FG002|Blinded Induction Dosing (Week 0-12)|Adverse Event|9|||
48884978|NCT01646177|157415588|FG003|Blinded Induction Dosing (Week 0-12)|Adverse Event|8|||
48884979|NCT01646177|157415589|FG004|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
48884980|NCT01646177|157415590|FG005|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
48884981|NCT01646177|157415591|FG006|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
48884982|NCT01646177|157415592|FG007|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
48884983|NCT01646177|157415593|FG008|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
48884984|NCT01646177|157415594|FG009|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
48884985|NCT01646177|157415595|FG010|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
48884986|NCT01646177|157415596|FG011|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
48884987|NCT01646177|157415585|FG000|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1|||
48884988|NCT01646177|157415586|FG001|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3|||
48884989|NCT01646177|157415587|FG002|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8|||
49034992|NCT00365365|157965444|FG002|Overall Study|New cancer|0|||
49034993|NCT00365365|157965442|FG000|Overall Study|Withdrew consent|1|||
49034994|NCT00365365|157965443|FG001|Overall Study|Withdrew consent|1|||
49034995|NCT00365365|157965444|FG002|Overall Study|Withdrew consent|0|||
49034996|NCT00365365|157965442|FG000|Overall Study|Second malignancy|0|||
49034997|NCT00365365|157965443|FG001|Overall Study|Second malignancy|1|||
49034998|NCT00365365|157965444|FG002|Overall Study|Second malignancy|0|||
49034999|NCT00365365|157965442|FG000|Overall Study|Patient/physician decision|0|||
49035000|NCT00365365|157965443|FG001|Overall Study|Patient/physician decision|0|||
48884990|NCT01646177|157415588|FG003|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7|||
48884991|NCT01646177|157415589|FG004|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
48884992|NCT01646177|157415590|FG005|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
48884993|NCT01646177|157415591|FG006|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
48884994|NCT01646177|157415592|FG007|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
48884995|NCT01646177|157415593|FG008|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
48884996|NCT01646177|157415594|FG009|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
48884997|NCT01646177|157415595|FG010|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
48884998|NCT01646177|157415596|FG011|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
48884999|NCT01646177|157415585|FG000|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3|||
48885000|NCT01646177|157415586|FG001|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2|||
48885001|NCT01646177|157415587|FG002|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
48885002|NCT01646177|157415588|FG003|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
48885003|NCT01646177|157415589|FG004|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
48885004|NCT01646177|157415590|FG005|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
48885005|NCT01646177|157415591|FG006|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
48885006|NCT01646177|157415592|FG007|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
48885007|NCT01646177|157415593|FG008|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
48885008|NCT01646177|157415594|FG009|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
48885009|NCT01646177|157415595|FG010|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
48885010|NCT01646177|157415596|FG011|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
48885011|NCT01646177|157415585|FG000|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
48885012|NCT01646177|157415586|FG001|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
48885013|NCT01646177|157415587|FG002|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
49035001|NCT00365365|157965444|FG002|Overall Study|Patient/physician decision|1|||
48885014|NCT01646177|157415588|FG003|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
48885015|NCT01646177|157415589|FG004|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
48885016|NCT01646177|157415590|FG005|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
48885017|NCT01646177|157415591|FG006|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
48885018|NCT01646177|157415592|FG007|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
48885019|NCT01646177|157415593|FG008|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
48885020|NCT01646177|157415594|FG009|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
49035002|NCT00984022|157965445|FG000|Overall Study|Lost to Follow-up|10|||
49035003|NCT00984022|157965446|FG001|Overall Study|Lost to Follow-up|14|||
49035004|NCT00573443|157965447|FG000|Double-Blind Phase|Lost to Follow-up|1|||
49035005|NCT00573443|157965448|FG001|Double-Blind Phase|Lost to Follow-up|3|||
49035006|NCT00573443|157965449|FG002|Double-Blind Phase|Lost to Follow-up|2|||
49035007|NCT00573443|157965447|FG000|Double-Blind Phase|Exacerbation of MS symptoms|1|||
49035008|NCT00573443|157965448|FG001|Double-Blind Phase|Exacerbation of MS symptoms|0|||
49035009|NCT00573443|157965449|FG002|Double-Blind Phase|Exacerbation of MS symptoms|1|||
49035010|NCT00573443|157965447|FG000|Double-Blind Phase|Adverse Event|1|||
49035011|NCT00573443|157965448|FG001|Double-Blind Phase|Adverse Event|5|||
49035012|NCT00573443|157965449|FG002|Double-Blind Phase|Adverse Event|0|||
48692501|NCT00453154|156724503|FG000|Double BIind Maintenance|Death|0|||
49035013|NCT00573443|157965447|FG000|Double-Blind Phase|Serious Adverse Event (AE)|2|||
48885021|NCT01646177|157415595|FG010|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
48885022|NCT01646177|157415596|FG011|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
48885023|NCT01646177|157415585|FG000|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
48885024|NCT01646177|157415586|FG001|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
48885025|NCT01646177|157415587|FG002|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2|||
48885026|NCT01646177|157415588|FG003|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1|||
48885027|NCT01646177|157415589|FG004|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
48885028|NCT01646177|157415590|FG005|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
48885029|NCT01646177|157415591|FG006|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
48885030|NCT01646177|157415592|FG007|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
48885031|NCT01646177|157415593|FG008|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
48885032|NCT01646177|157415594|FG009|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
48885033|NCT01646177|157415595|FG010|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
48885034|NCT01646177|157415596|FG011|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
48885035|NCT01646177|157415585|FG000|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3|||
48885036|NCT01646177|157415586|FG001|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
48885037|NCT01646177|157415587|FG002|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
48885038|NCT01646177|157415588|FG003|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
48885039|NCT01646177|157415589|FG004|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
48885040|NCT01646177|157415590|FG005|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
48885041|NCT01646177|157415591|FG006|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
48885042|NCT01646177|157415592|FG007|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
48885043|NCT01646177|157415593|FG008|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
48885044|NCT01646177|157415594|FG009|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
48885045|NCT01646177|157415595|FG010|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
48885046|NCT01646177|157415596|FG011|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
48885047|NCT01646177|157415585|FG000|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
48885048|NCT01646177|157415586|FG001|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
48885049|NCT01646177|157415587|FG002|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
48885050|NCT01646177|157415588|FG003|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
48885051|NCT01646177|157415589|FG004|Long-Term Extension Period (Week 12-264)|Adverse Event|16|||
48885052|NCT01646177|157415590|FG005|Long-Term Extension Period (Week 12-264)|Adverse Event|34|||
48983702|NCT00242710|157772324|FG001|Period Between Core Study and Extension|Withdrawal by Subject|63|||
48983703|NCT00242710|157772325|FG002|Period Between Core Study and Extension|Withdrawal by Subject|24|||
48983704|NCT00242710|157772326|FG003|Period Between Core Study and Extension|Withdrawal by Subject|28|||
48983705|NCT00242710|157772323|FG000|Study Extension (up to Year 2)|Adverse Event|7|||
48983706|NCT00242710|157772324|FG001|Study Extension (up to Year 2)|Adverse Event|9|||
48983707|NCT00242710|157772325|FG002|Study Extension (up to Year 2)|Adverse Event|2|||
48983708|NCT00242710|157772326|FG003|Study Extension (up to Year 2)|Adverse Event|4|||
48983709|NCT00242710|157772323|FG000|Study Extension (up to Year 2)|Death|0|||
48983710|NCT00242710|157772324|FG001|Study Extension (up to Year 2)|Death|0|||
48983711|NCT00242710|157772325|FG002|Study Extension (up to Year 2)|Death|0|||
48983712|NCT00242710|157772326|FG003|Study Extension (up to Year 2)|Death|1|||
48983713|NCT00242710|157772323|FG000|Study Extension (up to Year 2)|Lost to Follow-up|7|||
48983714|NCT00242710|157772324|FG001|Study Extension (up to Year 2)|Lost to Follow-up|7|||
48983715|NCT00242710|157772325|FG002|Study Extension (up to Year 2)|Lost to Follow-up|5|||
48983716|NCT00242710|157772326|FG003|Study Extension (up to Year 2)|Lost to Follow-up|0|||
48983717|NCT00242710|157772323|FG000|Study Extension (up to Year 2)|Other|3|||
48983718|NCT00242710|157772324|FG001|Study Extension (up to Year 2)|Other|5|||
48983719|NCT00242710|157772325|FG002|Study Extension (up to Year 2)|Other|4|||
48983720|NCT00242710|157772326|FG003|Study Extension (up to Year 2)|Other|3|||
48983721|NCT00242710|157772323|FG000|Study Extension (up to Year 2)|Protocol Violation|0|||
48983722|NCT00242710|157772324|FG001|Study Extension (up to Year 2)|Protocol Violation|2|||
48983723|NCT00242710|157772325|FG002|Study Extension (up to Year 2)|Protocol Violation|0|||
48983724|NCT00242710|157772326|FG003|Study Extension (up to Year 2)|Protocol Violation|1|||
48983725|NCT00242710|157772323|FG000|Study Extension (up to Year 2)|Withdrawal by Subject|10|||
48983726|NCT00242710|157772324|FG001|Study Extension (up to Year 2)|Withdrawal by Subject|6|||
48983727|NCT00242710|157772325|FG002|Study Extension (up to Year 2)|Withdrawal by Subject|4|||
48983728|NCT00242710|157772326|FG003|Study Extension (up to Year 2)|Withdrawal by Subject|1|||
48983729|NCT03083470|157772327|FG000|Overall Study|Lost to Follow-up|0|||
48983730|NCT03083470|157772328|FG001|Overall Study|Lost to Follow-up|0|||
48983731|NCT03083470|157772329|FG002|Overall Study|Lost to Follow-up|0|||
48983732|NCT03083470|157772330|FG003|Overall Study|Lost to Follow-up|0|||
48692502|NCT00453154|156724504|FG001|Double BIind Maintenance|Death|0|||
48885053|NCT01646177|157415591|FG006|Long-Term Extension Period (Week 12-264)|Adverse Event|43|||
48885054|NCT01646177|157415592|FG007|Long-Term Extension Period (Week 12-264)|Adverse Event|30|||
48983733|NCT03083470|157772331|FG004|Overall Study|Lost to Follow-up|1|||
48885055|NCT01646177|157415593|FG008|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
48885056|NCT01646177|157415594|FG009|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
48885057|NCT01646177|157415595|FG010|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
48885058|NCT01646177|157415596|FG011|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
48885059|NCT01646177|157415585|FG000|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
48885060|NCT01646177|157415586|FG001|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
48885061|NCT01646177|157415587|FG002|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
48885062|NCT01646177|157415588|FG003|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
48885063|NCT01646177|157415589|FG004|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11|||
48885064|NCT01646177|157415590|FG005|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30|||
48885065|NCT01646177|157415591|FG006|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29|||
48885066|NCT01646177|157415592|FG007|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27|||
48885067|NCT01646177|157415593|FG008|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
48885068|NCT01646177|157415594|FG009|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
48885069|NCT01646177|157415595|FG010|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
48885070|NCT01646177|157415596|FG011|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
48885071|NCT01646177|157415585|FG000|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
48885072|NCT01646177|157415586|FG001|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
48885073|NCT01646177|157415587|FG002|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
48885074|NCT01646177|157415588|FG003|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
48885075|NCT01646177|157415589|FG004|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6|||
48885076|NCT01646177|157415590|FG005|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17|||
48885077|NCT01646177|157415591|FG006|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23|||
48885078|NCT01646177|157415592|FG007|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18|||
48885079|NCT01646177|157415593|FG008|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
48885080|NCT01646177|157415594|FG009|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
48885081|NCT01646177|157415595|FG010|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
48885082|NCT01646177|157415596|FG011|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
48885083|NCT01646177|157415585|FG000|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
48885084|NCT01646177|157415586|FG001|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
48885085|NCT01646177|157415587|FG002|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
48885086|NCT01646177|157415588|FG003|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
48885087|NCT01646177|157415589|FG004|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6|||
48885088|NCT01646177|157415590|FG005|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14|||
48885089|NCT01646177|157415591|FG006|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10|||
48885090|NCT01646177|157415592|FG007|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11|||
48885091|NCT01646177|157415593|FG008|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
48885092|NCT01646177|157415594|FG009|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
48885093|NCT01646177|157415595|FG010|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
48885094|NCT01646177|157415596|FG011|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
48885095|NCT01646177|157415585|FG000|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
48885096|NCT01646177|157415586|FG001|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
48885097|NCT01646177|157415587|FG002|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
48885098|NCT01646177|157415588|FG003|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
48885099|NCT01646177|157415589|FG004|Long-Term Extension Period (Week 12-264)|Physician Decision|3|||
48885100|NCT01646177|157415590|FG005|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
48885101|NCT01646177|157415591|FG006|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
48885102|NCT01646177|157415592|FG007|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
48885103|NCT01646177|157415593|FG008|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
48885104|NCT01646177|157415594|FG009|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
48885105|NCT01646177|157415595|FG010|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
48885106|NCT01646177|157415596|FG011|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
48885107|NCT01646177|157415585|FG000|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
48885108|NCT01646177|157415586|FG001|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
48885109|NCT01646177|157415587|FG002|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
48885110|NCT01646177|157415588|FG003|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
48885111|NCT01646177|157415589|FG004|Long-Term Extension Period (Week 12-264)|Protocol Violation|1|||
48983734|NCT03083470|157772327|FG000|Overall Study|Withdrawal by Subject|0|||
48983735|NCT03083470|157772328|FG001|Overall Study|Withdrawal by Subject|0|||
48983736|NCT03083470|157772329|FG002|Overall Study|Withdrawal by Subject|0|||
48983737|NCT03083470|157772330|FG003|Overall Study|Withdrawal by Subject|0|||
48983738|NCT03083470|157772331|FG004|Overall Study|Withdrawal by Subject|1|||
48983739|NCT00256204|157772332|FG000|Overall Study|Adverse Event|10|||
48983740|NCT00256204|157772333|FG001|Overall Study|Adverse Event|14|||
48885112|NCT01646177|157415590|FG005|Long-Term Extension Period (Week 12-264)|Protocol Violation|4|||
48885113|NCT01646177|157415591|FG006|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
48885114|NCT01646177|157415592|FG007|Long-Term Extension Period (Week 12-264)|Protocol Violation|5|||
48885115|NCT01646177|157415593|FG008|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
48885116|NCT01646177|157415594|FG009|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
48885117|NCT01646177|157415595|FG010|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
48885118|NCT01646177|157415596|FG011|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
48885119|NCT01646177|157415585|FG000|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
49035014|NCT00573443|157965448|FG001|Double-Blind Phase|Serious Adverse Event (AE)|3|||
49035015|NCT00573443|157965449|FG002|Double-Blind Phase|Serious Adverse Event (AE)|1|||
49035016|NCT00573443|157965447|FG000|Double-Blind Phase|Medication refusal due to AE|2|||
49035017|NCT00573443|157965448|FG001|Double-Blind Phase|Medication refusal due to AE|2|||
49035018|NCT00573443|157965449|FG002|Double-Blind Phase|Medication refusal due to AE|0|||
49035019|NCT00573443|157965447|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
49035020|NCT00573443|157965448|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
49035021|NCT00573443|157965449|FG002|Double-Blind Phase|Withdrawal by Subject|7|||
49035022|NCT00573443|157965447|FG000|Double-Blind Phase|Protocol Violation|0|||
49035023|NCT00573443|157965448|FG001|Double-Blind Phase|Protocol Violation|2|||
49035024|NCT00573443|157965449|FG002|Double-Blind Phase|Protocol Violation|1|||
49035025|NCT00573443|157965447|FG000|Double-Blind Phase|Other|0|||
49035026|NCT00573443|157965448|FG001|Double-Blind Phase|Other|2|||
49035027|NCT00573443|157965449|FG002|Double-Blind Phase|Other|3|||
49035028|NCT00573443|157965447|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
49035029|NCT00573443|157965448|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
49035030|NCT00573443|157965449|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
49035031|NCT00573443|157965447|FG000|Open-Label Extension Phase|Exacerbation of MS symptoms|2|||
49035032|NCT00573443|157965448|FG001|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
49035033|NCT00573443|157965449|FG002|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
49035034|NCT00573443|157965447|FG000|Open-Label Extension Phase|Adverse Event|3|||
49035035|NCT00573443|157965448|FG001|Open-Label Extension Phase|Adverse Event|0|||
49035036|NCT00573443|157965449|FG002|Open-Label Extension Phase|Adverse Event|0|||
48885120|NCT01646177|157415586|FG001|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
48885121|NCT01646177|157415587|FG002|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
48885122|NCT01646177|157415588|FG003|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
48885123|NCT01646177|157415589|FG004|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3|||
48885124|NCT01646177|157415590|FG005|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
48885125|NCT01646177|157415591|FG006|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
48885126|NCT01646177|157415592|FG007|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
49035037|NCT00573443|157965447|FG000|Open-Label Extension Phase|Serious Adverse Event|5|||
49035038|NCT00573443|157965448|FG001|Open-Label Extension Phase|Serious Adverse Event|0|||
49035039|NCT00573443|157965449|FG002|Open-Label Extension Phase|Serious Adverse Event|0|||
49035040|NCT00573443|157965447|FG000|Open-Label Extension Phase|Withdrawal by Subject|3|||
49035041|NCT00573443|157965448|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
49035042|NCT00573443|157965449|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
49035043|NCT00573443|157965447|FG000|Open-Label Extension Phase|Protocol Violation|2|||
49035044|NCT00573443|157965448|FG001|Open-Label Extension Phase|Protocol Violation|0|||
49035045|NCT00573443|157965449|FG002|Open-Label Extension Phase|Protocol Violation|0|||
49035046|NCT00573443|157965447|FG000|Open-Label Extension Phase|Other|2|||
49035047|NCT00573443|157965448|FG001|Open-Label Extension Phase|Other|0|||
49035048|NCT00573443|157965449|FG002|Open-Label Extension Phase|Other|0|||
49035049|NCT02300103|157965450|FG000|Overall Study|Lack of Efficacy|3|||
49035050|NCT02300103|157965450|FG000|Overall Study|Protocol Violation|1|||
49035051|NCT02300103|157965450|FG000|Overall Study|Withdrew Consent|2|||
49035052|NCT00905606|157965454|FG000|Period 1|Adverse Event|0|||
49035053|NCT00905606|157965455|FG001|Period 1|Adverse Event|1|||
49035054|NCT00905606|157965454|FG000|Washout|Withdrawal by Subject|1|||
49035055|NCT00905606|157965455|FG001|Washout|Withdrawal by Subject|0|||
49035056|NCT03635320|157965456|FG000|Overall Study|not implanted the device|1|||
48885127|NCT01646177|157415593|FG008|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
48885128|NCT01646177|157415594|FG009|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
48885129|NCT01646177|157415595|FG010|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
48885130|NCT01646177|157415596|FG011|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
49035057|NCT03635320|157965457|FG001|Overall Study|not implanted the device|2|||
49035058|NCT03635320|157965456|FG000|Overall Study|Withdrawal by Subject|11|||
49035059|NCT03635320|157965457|FG001|Overall Study|Withdrawal by Subject|6|||
49035060|NCT01015625|157965459|FG000|Overall Study|Lost to Follow-up|3|||
49035061|NCT01015625|157965460|FG001|Overall Study|Lost to Follow-up|1|||
49035062|NCT01015625|157965459|FG000|Overall Study|Withdrawal by Subject|2|||
49035063|NCT01015625|157965460|FG001|Overall Study|Withdrawal by Subject|3|||
49035064|NCT01015625|157965459|FG000|Overall Study|Physician Decision|2|||
49035065|NCT01015625|157965460|FG001|Overall Study|Physician Decision|0|||
49035066|NCT01015625|157965459|FG000|Overall Study|Death|30|||
48885131|NCT01646177|157415585|FG000|Long-Term Extension Period (Week 12-264)|Death|0|||
48885132|NCT01646177|157415586|FG001|Long-Term Extension Period (Week 12-264)|Death|0|||
48885133|NCT01646177|157415587|FG002|Long-Term Extension Period (Week 12-264)|Death|0|||
48885134|NCT01646177|157415588|FG003|Long-Term Extension Period (Week 12-264)|Death|0|||
48885135|NCT01646177|157415589|FG004|Long-Term Extension Period (Week 12-264)|Death|1|||
48885136|NCT01646177|157415590|FG005|Long-Term Extension Period (Week 12-264)|Death|3|||
48885137|NCT01646177|157415591|FG006|Long-Term Extension Period (Week 12-264)|Death|1|||
48885138|NCT01646177|157415592|FG007|Long-Term Extension Period (Week 12-264)|Death|3|||
48885139|NCT01646177|157415593|FG008|Long-Term Extension Period (Week 12-264)|Death|0|||
48885140|NCT01646177|157415594|FG009|Long-Term Extension Period (Week 12-264)|Death|0|||
48885141|NCT01646177|157415595|FG010|Long-Term Extension Period (Week 12-264)|Death|0|||
48885142|NCT01646177|157415596|FG011|Long-Term Extension Period (Week 12-264)|Death|0|||
48885143|NCT01646177|157415585|FG000|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
48885144|NCT01646177|157415586|FG001|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
48885145|NCT01646177|157415587|FG002|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
48885146|NCT01646177|157415588|FG003|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
48885147|NCT01646177|157415589|FG004|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
48885148|NCT01646177|157415590|FG005|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
48885149|NCT01646177|157415591|FG006|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
48885150|NCT01646177|157415592|FG007|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4|||
48885151|NCT01646177|157415593|FG008|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
48885152|NCT01646177|157415594|FG009|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
48885153|NCT01646177|157415595|FG010|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
48885154|NCT01646177|157415596|FG011|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
48885155|NCT01646177|157415585|FG000|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
48885156|NCT01646177|157415586|FG001|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
48885157|NCT01646177|157415587|FG002|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
48885158|NCT01646177|157415588|FG003|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
48885159|NCT01646177|157415589|FG004|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
48885160|NCT01646177|157415590|FG005|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
48885161|NCT01646177|157415591|FG006|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
48885162|NCT01646177|157415592|FG007|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1|||
48885163|NCT01646177|157415593|FG008|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
48885164|NCT01646177|157415594|FG009|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
48885165|NCT01646177|157415595|FG010|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
48885166|NCT01646177|157415596|FG011|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
48885167|NCT01646177|157415585|FG000|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
48885168|NCT01646177|157415586|FG001|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
48885169|NCT01646177|157415587|FG002|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
48885170|NCT01646177|157415588|FG003|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
48885171|NCT01646177|157415589|FG004|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
48885172|NCT01646177|157415590|FG005|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3|||
48885173|NCT01646177|157415591|FG006|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2|||
48885174|NCT01646177|157415592|FG007|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1|||
48885175|NCT01646177|157415593|FG008|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
48885176|NCT01646177|157415594|FG009|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
48885177|NCT01646177|157415595|FG010|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
48885178|NCT01646177|157415596|FG011|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
48885179|NCT01646177|157415585|FG000|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
48885180|NCT01646177|157415586|FG001|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
48885181|NCT01646177|157415587|FG002|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
48885182|NCT01646177|157415588|FG003|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
48885183|NCT01646177|157415589|FG004|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
48885184|NCT01646177|157415590|FG005|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
48885185|NCT01646177|157415591|FG006|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
48885186|NCT01646177|157415592|FG007|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
48885187|NCT01646177|157415593|FG008|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13|||
48885188|NCT01646177|157415594|FG009|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28|||
48885189|NCT01646177|157415595|FG010|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34|||
48983741|NCT00256204|157772334|FG002|Overall Study|Adverse Event|16|||
48983742|NCT00256204|157772335|FG003|Overall Study|Adverse Event|14|||
48983743|NCT00256204|157772332|FG000|Overall Study|Death|0|||
48983744|NCT00256204|157772333|FG001|Overall Study|Death|1|||
48983745|NCT00256204|157772334|FG002|Overall Study|Death|0|||
48983746|NCT00256204|157772335|FG003|Overall Study|Death|0|||
48885190|NCT01646177|157415596|FG011|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30|||
48885191|NCT01646177|157415585|FG000|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
48885192|NCT01646177|157415586|FG001|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
48885193|NCT01646177|157415587|FG002|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
48885194|NCT01646177|157415588|FG003|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
48885195|NCT01646177|157415589|FG004|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
48885196|NCT01646177|157415590|FG005|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
48885197|NCT01646177|157415591|FG006|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
48885198|NCT01646177|157415592|FG007|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
48885199|NCT01646177|157415593|FG008|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7|||
48885200|NCT01646177|157415594|FG009|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21|||
48885201|NCT01646177|157415595|FG010|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
48885202|NCT01646177|157415596|FG011|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
48885203|NCT01646177|157415585|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
48885204|NCT01646177|157415586|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
48885205|NCT01646177|157415587|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
48885206|NCT01646177|157415588|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
48885207|NCT01646177|157415589|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
48885208|NCT01646177|157415590|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
48885209|NCT01646177|157415591|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
48885210|NCT01646177|157415592|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
48885211|NCT01646177|157415593|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4|||
48885212|NCT01646177|157415594|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8|||
48885213|NCT01646177|157415595|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
48885214|NCT01646177|157415596|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
48885215|NCT01646177|157415585|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
48885216|NCT01646177|157415586|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
48885217|NCT01646177|157415587|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
48885218|NCT01646177|157415588|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
48885219|NCT01646177|157415589|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
48885220|NCT01646177|157415590|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
48885221|NCT01646177|157415591|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
48885222|NCT01646177|157415592|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
48885223|NCT01646177|157415593|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4|||
48885224|NCT01646177|157415594|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
48885225|NCT01646177|157415595|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8|||
48885226|NCT01646177|157415596|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
48885227|NCT01646177|157415585|FG000|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
48885228|NCT01646177|157415586|FG001|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
48885229|NCT01646177|157415587|FG002|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
48885230|NCT01646177|157415588|FG003|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
48885231|NCT01646177|157415589|FG004|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
48885232|NCT01646177|157415590|FG005|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
48885233|NCT01646177|157415591|FG006|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
48885234|NCT01646177|157415592|FG007|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
48885235|NCT01646177|157415593|FG008|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1|||
48885236|NCT01646177|157415594|FG009|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6|||
48885237|NCT01646177|157415595|FG010|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4|||
48885238|NCT01646177|157415596|FG011|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7|||
48885239|NCT01646177|157415585|FG000|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
48885240|NCT01646177|157415586|FG001|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
48885241|NCT01646177|157415587|FG002|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
48885242|NCT01646177|157415588|FG003|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
48885243|NCT01646177|157415589|FG004|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
48885244|NCT01646177|157415590|FG005|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
48885245|NCT01646177|157415591|FG006|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
48885246|NCT01646177|157415592|FG007|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
48885247|NCT01646177|157415593|FG008|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1|||
48885248|NCT01646177|157415594|FG009|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
48885249|NCT01646177|157415595|FG010|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
48885250|NCT01646177|157415596|FG011|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3|||
48885251|NCT01646177|157415585|FG000|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
48885252|NCT01646177|157415586|FG001|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
48885253|NCT01646177|157415587|FG002|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
48885254|NCT01646177|157415588|FG003|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
48885255|NCT01646177|157415589|FG004|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
48885256|NCT01646177|157415590|FG005|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
48885257|NCT01646177|157415591|FG006|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
48885258|NCT01646177|157415592|FG007|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
48885259|NCT01646177|157415593|FG008|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
48885260|NCT01646177|157415594|FG009|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
48885261|NCT01646177|157415595|FG010|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
48885262|NCT01646177|157415596|FG011|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3|||
48885263|NCT01646177|157415585|FG000|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
48885264|NCT01646177|157415586|FG001|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
48885265|NCT01646177|157415587|FG002|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
48885266|NCT01646177|157415588|FG003|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
48885267|NCT01646177|157415589|FG004|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
48885268|NCT01646177|157415590|FG005|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
48885269|NCT01646177|157415591|FG006|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
48885270|NCT01646177|157415592|FG007|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
48885271|NCT01646177|157415593|FG008|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
48885272|NCT01646177|157415594|FG009|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
48885273|NCT01646177|157415595|FG010|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
48885274|NCT01646177|157415596|FG011|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
48885275|NCT01646177|157415585|FG000|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
48885276|NCT01646177|157415586|FG001|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
48885277|NCT01646177|157415587|FG002|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
48885278|NCT01646177|157415588|FG003|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
48885279|NCT01646177|157415589|FG004|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
48885280|NCT01646177|157415590|FG005|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
48885281|NCT01646177|157415591|FG006|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
48885282|NCT01646177|157415592|FG007|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
48885283|NCT01646177|157415593|FG008|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
48885284|NCT01646177|157415594|FG009|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
48885285|NCT01646177|157415595|FG010|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
48885286|NCT01646177|157415596|FG011|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
48885287|NCT01646177|157415585|FG000|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
48885288|NCT01646177|157415586|FG001|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
48885289|NCT01646177|157415587|FG002|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
48885290|NCT01646177|157415588|FG003|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
48885291|NCT01646177|157415589|FG004|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
48885292|NCT01646177|157415590|FG005|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
48885293|NCT01646177|157415591|FG006|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
48885294|NCT01646177|157415592|FG007|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
48885295|NCT01646177|157415593|FG008|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
48885296|NCT01646177|157415594|FG009|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
48885297|NCT01646177|157415595|FG010|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
48983747|NCT00256204|157772332|FG000|Overall Study|Lost to Follow-up|1|||
48983748|NCT00256204|157772333|FG001|Overall Study|Lost to Follow-up|1|||
48983749|NCT00256204|157772334|FG002|Overall Study|Lost to Follow-up|1|||
48885298|NCT01646177|157415596|FG011|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
48885299|NCT02807272|157415598|FG000|Overall Study|Death|9|||
48885300|NCT02807272|157415599|FG001|Overall Study|Death|5|||
48885301|NCT02807272|157415600|FG002|Overall Study|Death|2|||
48885302|NCT02807272|157415601|FG003|Overall Study|Death|0|||
48885303|NCT02807272|157415602|FG004|Overall Study|Death|1|||
48885304|NCT02807272|157415598|FG000|Overall Study|Lost to Follow-up|1|||
48885305|NCT02807272|157415599|FG001|Overall Study|Lost to Follow-up|0|||
48983750|NCT00256204|157772335|FG003|Overall Study|Lost to Follow-up|2|||
48983751|NCT00256204|157772332|FG000|Overall Study|Protocol Violation|1|||
48983752|NCT00256204|157772333|FG001|Overall Study|Protocol Violation|0|||
48983753|NCT00256204|157772334|FG002|Overall Study|Protocol Violation|2|||
48983754|NCT00256204|157772335|FG003|Overall Study|Protocol Violation|1|||
48983755|NCT00256204|157772332|FG000|Overall Study|Physician Decision|0|||
48983756|NCT00256204|157772333|FG001|Overall Study|Physician Decision|0|||
48983757|NCT00256204|157772334|FG002|Overall Study|Physician Decision|1|||
48983758|NCT00256204|157772335|FG003|Overall Study|Physician Decision|2|||
48983759|NCT00256204|157772332|FG000|Overall Study|Withdrawal by Subject|17|||
48983760|NCT00256204|157772333|FG001|Overall Study|Withdrawal by Subject|6|||
48983761|NCT00256204|157772334|FG002|Overall Study|Withdrawal by Subject|7|||
48983762|NCT00256204|157772335|FG003|Overall Study|Withdrawal by Subject|5|||
48983763|NCT00256204|157772332|FG000|Overall Study|Need for additional prohibited treatment|38|||
49035067|NCT01015625|157965460|FG001|Overall Study|Death|22|||
49035068|NCT01796171|157965465|FG000|Enrolled|Death|0|||
49035069|NCT01796171|157965466|FG001|Enrolled|Death|0|||
48885306|NCT02807272|157415600|FG002|Overall Study|Lost to Follow-up|0|||
48885307|NCT02807272|157415601|FG003|Overall Study|Lost to Follow-up|0|||
48885308|NCT02807272|157415602|FG004|Overall Study|Lost to Follow-up|0|||
48885309|NCT02807272|157415598|FG000|Overall Study|Permanent Withdrawal of Consent|8|||
48885310|NCT02807272|157415599|FG001|Overall Study|Permanent Withdrawal of Consent|2|||
48885311|NCT02807272|157415600|FG002|Overall Study|Permanent Withdrawal of Consent|0|||
48885312|NCT02807272|157415601|FG003|Overall Study|Permanent Withdrawal of Consent|2|||
48885313|NCT02807272|157415602|FG004|Overall Study|Permanent Withdrawal of Consent|1|||
48885314|NCT02807272|157415598|FG000|Overall Study|Protocol-defined Disease Progression|0|||
48885315|NCT02807272|157415599|FG001|Overall Study|Protocol-defined Disease Progression|1|||
48885316|NCT02807272|157415600|FG002|Overall Study|Protocol-defined Disease Progression|0|||
48885317|NCT02807272|157415601|FG003|Overall Study|Protocol-defined Disease Progression|0|||
48885318|NCT02807272|157415602|FG004|Overall Study|Protocol-defined Disease Progression|1|||
48885319|NCT02807272|157415598|FG000|Overall Study|Study Terminated by Sponsor|1|||
48885320|NCT02807272|157415599|FG001|Overall Study|Study Terminated by Sponsor|0|||
48885321|NCT02807272|157415600|FG002|Overall Study|Study Terminated by Sponsor|0|||
48885322|NCT02807272|157415601|FG003|Overall Study|Study Terminated by Sponsor|1|||
48885323|NCT02807272|157415602|FG004|Overall Study|Study Terminated by Sponsor|0|||
48885324|NCT02807272|157415598|FG000|Overall Study|Other|1|||
48885325|NCT02807272|157415599|FG001|Overall Study|Other|0|||
48885326|NCT02807272|157415600|FG002|Overall Study|Other|0|||
48885327|NCT02807272|157415601|FG003|Overall Study|Other|0|||
48885328|NCT02807272|157415602|FG004|Overall Study|Other|1|||
48885329|NCT00820170|157415611|FG000|Overall Study|Adverse Event|0|||
48885330|NCT00820170|157415612|FG001|Overall Study|Adverse Event|0|||
48885331|NCT00820170|157415613|FG002|Overall Study|Adverse Event|0|||
48885332|NCT00820170|157415614|FG003|Overall Study|Adverse Event|0|||
48885333|NCT00820170|157415615|FG004|Overall Study|Adverse Event|2|||
48885334|NCT00820170|157415611|FG000|Overall Study|Progressive Disease|0|||
48885335|NCT00820170|157415612|FG001|Overall Study|Progressive Disease|0|||
48885336|NCT00820170|157415613|FG002|Overall Study|Progressive Disease|0|||
48885337|NCT00820170|157415614|FG003|Overall Study|Progressive Disease|0|||
48885338|NCT00820170|157415615|FG004|Overall Study|Progressive Disease|2|||
48885339|NCT00902746|157415622|FG000|Overall Study|Protocol Violation|7|||
48885340|NCT00902746|157415622|FG000|Overall Study|Withdrawal by Subject|16|||
48885341|NCT00902746|157415622|FG000|Overall Study|Adverse Event|8|||
48885342|NCT00902746|157415622|FG000|Overall Study|Lost to Follow-up|3|||
49035070|NCT01796171|157965467|FG002|Enrolled|Death|0|||
49035071|NCT01796171|157965468|FG003|Enrolled|Death|0|||
49035072|NCT01796171|157965469|FG004|Enrolled|Death|0|||
49035073|NCT01796171|157965470|FG005|Enrolled|Death|0|||
49035074|NCT01796171|157965471|FG006|Enrolled|Death|0|||
49035075|NCT01796171|157965472|FG007|Enrolled|Death|0|||
49035076|NCT01796171|157965473|FG008|Enrolled|Death|0|||
49035077|NCT01796171|157965474|FG009|Enrolled|Death|0|||
49035078|NCT01796171|157965475|FG010|Enrolled|Death|0|||
49035079|NCT01796171|157965476|FG011|Enrolled|Death|0|||
49035080|NCT01796171|157965477|FG012|Enrolled|Death|0|||
49035081|NCT01796171|157965478|FG013|Enrolled|Death|0|||
49035082|NCT01796171|157965479|FG014|Enrolled|Death|1|||
49035083|NCT01796171|157965465|FG000|Pre-reatment With Rituximab|Adverse Event|0|||
49035084|NCT01796171|157965466|FG001|Pre-reatment With Rituximab|Adverse Event|0|||
49035085|NCT01796171|157965467|FG002|Pre-reatment With Rituximab|Adverse Event|0|||
49035086|NCT01796171|157965468|FG003|Pre-reatment With Rituximab|Adverse Event|0|||
49035087|NCT01796171|157965469|FG004|Pre-reatment With Rituximab|Adverse Event|0|||
49035088|NCT01796171|157965470|FG005|Pre-reatment With Rituximab|Adverse Event|0|||
49035089|NCT01796171|157965471|FG006|Pre-reatment With Rituximab|Adverse Event|0|||
49035090|NCT01796171|157965472|FG007|Pre-reatment With Rituximab|Adverse Event|0|||
49035091|NCT01796171|157965473|FG008|Pre-reatment With Rituximab|Adverse Event|0|||
49035092|NCT01796171|157965474|FG009|Pre-reatment With Rituximab|Adverse Event|2|||
49035093|NCT01796171|157965475|FG010|Pre-reatment With Rituximab|Adverse Event|0|||
49035094|NCT01796171|157965476|FG011|Pre-reatment With Rituximab|Adverse Event|0|||
49035095|NCT01796171|157965477|FG012|Pre-reatment With Rituximab|Adverse Event|0|||
49035096|NCT01796171|157965478|FG013|Pre-reatment With Rituximab|Adverse Event|0|||
49035097|NCT01796171|157965479|FG014|Pre-reatment With Rituximab|Adverse Event|0|||
48885343|NCT00902746|157415622|FG000|Overall Study|Physician Decision|2|||
48885344|NCT00755105|157415625|FG000|Overall Study|Withdrawal by Subject|9|||
48885345|NCT00755105|157415626|FG001|Overall Study|Withdrawal by Subject|11|||
48885346|NCT00755105|157415627|FG002|Overall Study|Withdrawal by Subject|4|||
49035098|NCT01796171|157965465|FG000|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
48885347|NCT01277887|157415629|FG000|Pre-Quit Treatment Phase|No longer interested in treatment|1|||
48885348|NCT01277887|157415630|FG001|Pre-Quit Treatment Phase|No longer interested in treatment|0|||
48885349|NCT01277887|157415629|FG000|Pre-Quit Treatment Phase|Withdrawal by Subject|2|||
49035099|NCT01796171|157965466|FG001|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
49035100|NCT01796171|157965467|FG002|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
49035101|NCT01796171|157965468|FG003|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
49035102|NCT01796171|157965469|FG004|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
49035103|NCT01796171|157965470|FG005|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
48885350|NCT01277887|157415630|FG001|Pre-Quit Treatment Phase|Withdrawal by Subject|0|||
48885351|NCT01277887|157415629|FG000|Post-Quit Treatment Phase|No longer interested in treatment|3|||
48885352|NCT01277887|157415630|FG001|Post-Quit Treatment Phase|No longer interested in treatment|5|||
48885353|NCT02416453|157415631|FG000|Overall Study|Adverse Event|0|||
48885354|NCT02416453|157415632|FG001|Overall Study|Adverse Event|0|||
48885355|NCT02416453|157415633|FG002|Overall Study|Adverse Event|0|||
48885356|NCT02416453|157415634|FG003|Overall Study|Adverse Event|2|||
48885357|NCT02416453|157415635|FG004|Overall Study|Adverse Event|0|||
48885358|NCT02416453|157415636|FG005|Overall Study|Adverse Event|1|||
48885359|NCT02416453|157415637|FG006|Overall Study|Adverse Event|0|||
48885360|NCT02416453|157415638|FG007|Overall Study|Adverse Event|0|||
48885361|NCT02416453|157415639|FG008|Overall Study|Adverse Event|0|||
48885362|NCT02416453|157415640|FG009|Overall Study|Adverse Event|0|||
48885363|NCT02416453|157415641|FG010|Overall Study|Adverse Event|0|||
48885364|NCT02416453|157415631|FG000|Overall Study|Lost to Follow-up|1|||
48885365|NCT02416453|157415632|FG001|Overall Study|Lost to Follow-up|3|||
48885366|NCT02416453|157415633|FG002|Overall Study|Lost to Follow-up|0|||
48885367|NCT02416453|157415634|FG003|Overall Study|Lost to Follow-up|8|||
48885368|NCT02416453|157415635|FG004|Overall Study|Lost to Follow-up|0|||
48885369|NCT02416453|157415636|FG005|Overall Study|Lost to Follow-up|5|||
48885370|NCT02416453|157415637|FG006|Overall Study|Lost to Follow-up|1|||
48885371|NCT02416453|157415638|FG007|Overall Study|Lost to Follow-up|3|||
48885372|NCT02416453|157415639|FG008|Overall Study|Lost to Follow-up|1|||
48885373|NCT02416453|157415640|FG009|Overall Study|Lost to Follow-up|0|||
48885374|NCT02416453|157415641|FG010|Overall Study|Lost to Follow-up|0|||
48885375|NCT02416453|157415631|FG000|Overall Study|Physician Decision|0|||
48885376|NCT02416453|157415632|FG001|Overall Study|Physician Decision|0|||
48885377|NCT02416453|157415633|FG002|Overall Study|Physician Decision|0|||
48885378|NCT02416453|157415634|FG003|Overall Study|Physician Decision|0|||
48885379|NCT02416453|157415635|FG004|Overall Study|Physician Decision|0|||
48885380|NCT02416453|157415636|FG005|Overall Study|Physician Decision|1|||
48885381|NCT02416453|157415637|FG006|Overall Study|Physician Decision|1|||
48885382|NCT02416453|157415638|FG007|Overall Study|Physician Decision|1|||
48885383|NCT02416453|157415639|FG008|Overall Study|Physician Decision|0|||
48885384|NCT02416453|157415640|FG009|Overall Study|Physician Decision|0|||
48885385|NCT02416453|157415641|FG010|Overall Study|Physician Decision|0|||
48885386|NCT02416453|157415631|FG000|Overall Study|Withdrawal by Subject|2|||
48885387|NCT02416453|157415632|FG001|Overall Study|Withdrawal by Subject|0|||
48885388|NCT02416453|157415633|FG002|Overall Study|Withdrawal by Subject|0|||
48885389|NCT02416453|157415634|FG003|Overall Study|Withdrawal by Subject|5|||
48885390|NCT02416453|157415635|FG004|Overall Study|Withdrawal by Subject|1|||
48885391|NCT02416453|157415636|FG005|Overall Study|Withdrawal by Subject|8|||
48885392|NCT02416453|157415637|FG006|Overall Study|Withdrawal by Subject|0|||
48885393|NCT02416453|157415638|FG007|Overall Study|Withdrawal by Subject|8|||
48885394|NCT02416453|157415639|FG008|Overall Study|Withdrawal by Subject|4|||
48885395|NCT02416453|157415640|FG009|Overall Study|Withdrawal by Subject|0|||
48885396|NCT02416453|157415641|FG010|Overall Study|Withdrawal by Subject|0|||
48885397|NCT02416453|157415631|FG000|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
48885398|NCT02416453|157415632|FG001|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
48885399|NCT02416453|157415633|FG002|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1|||
48885400|NCT02416453|157415634|FG003|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
48885401|NCT02416453|157415635|FG004|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
48885402|NCT02416453|157415636|FG005|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
49035104|NCT01796171|157965471|FG006|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
49035105|NCT01796171|157965472|FG007|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
49035106|NCT01796171|157965473|FG008|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
48885403|NCT02416453|157415637|FG006|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
48885404|NCT02416453|157415638|FG007|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
48885405|NCT02416453|157415639|FG008|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
48885406|NCT02416453|157415640|FG009|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
48885407|NCT02416453|157415641|FG010|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
48885408|NCT02416453|157415631|FG000|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
48885409|NCT02416453|157415632|FG001|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
48885410|NCT02416453|157415633|FG002|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
48885411|NCT02416453|157415634|FG003|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
48885412|NCT02416453|157415635|FG004|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
48885413|NCT02416453|157415636|FG005|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1|||
48885414|NCT02416453|157415637|FG006|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
48885415|NCT02416453|157415638|FG007|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
48885416|NCT02416453|157415639|FG008|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
48885417|NCT02416453|157415640|FG009|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
48885418|NCT02416453|157415641|FG010|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
48885419|NCT00368927|157415642|FG000|Overall Study|Lost to Follow-up|2|||
48885420|NCT00368927|157415643|FG001|Overall Study|Lost to Follow-up|0|||
48885421|NCT00368927|157415642|FG000|Overall Study|Adverse Event|1|||
48885422|NCT00368927|157415643|FG001|Overall Study|Adverse Event|1|||
48885423|NCT00368927|157415642|FG000|Overall Study|Withdrawal by Subject|1|||
48885424|NCT00368927|157415643|FG001|Overall Study|Withdrawal by Subject|2|||
48885425|NCT00368927|157415642|FG000|Overall Study|Physician Decision|1|||
48885426|NCT00368927|157415643|FG001|Overall Study|Physician Decision|0|||
48885427|NCT04145700|157415649|FG000|Overall Study|Withdrawal by Subject|8|||
48885428|NCT04145700|157415650|FG001|Overall Study|Withdrawal by Subject|3|||
48885429|NCT01259089|157415651|FG000|Reached First Response at 4 Weeks|Patient not treated on study|0|||
48885430|NCT01259089|157415652|FG001|Reached First Response at 4 Weeks|Patient not treated on study|0|||
48885431|NCT01259089|157415653|FG002|Reached First Response at 4 Weeks|Patient not treated on study|0|||
48885432|NCT01259089|157415654|FG003|Reached First Response at 4 Weeks|Patient not treated on study|0|||
48885433|NCT01259089|157415655|FG004|Reached First Response at 4 Weeks|Patient not treated on study|0|||
48885434|NCT01259089|157415656|FG005|Reached First Response at 4 Weeks|Patient not treated on study|1|||
48885435|NCT01259089|157415651|FG000|Reached First Response at 4 Weeks|Adverse Event|0|||
48885436|NCT01259089|157415652|FG001|Reached First Response at 4 Weeks|Adverse Event|0|||
48885437|NCT01259089|157415653|FG002|Reached First Response at 4 Weeks|Adverse Event|0|||
48885438|NCT01259089|157415654|FG003|Reached First Response at 4 Weeks|Adverse Event|0|||
48885439|NCT01259089|157415655|FG004|Reached First Response at 4 Weeks|Adverse Event|0|||
48885440|NCT01259089|157415656|FG005|Reached First Response at 4 Weeks|Adverse Event|1|||
48885441|NCT01259089|157415651|FG000|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
48885442|NCT01259089|157415652|FG001|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
48885443|NCT01259089|157415653|FG002|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
48885444|NCT01259089|157415654|FG003|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
48885445|NCT01259089|157415655|FG004|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
48885446|NCT01259089|157415656|FG005|Confirmed Response at 8 Weeks|Withdrawal by Subject|1|||
48885447|NCT01259089|157415651|FG000|Confirmed Response at 8 Weeks|Adverse Event|0|||
48885448|NCT01259089|157415652|FG001|Confirmed Response at 8 Weeks|Adverse Event|0|||
48885449|NCT01259089|157415653|FG002|Confirmed Response at 8 Weeks|Adverse Event|0|||
48885450|NCT01259089|157415654|FG003|Confirmed Response at 8 Weeks|Adverse Event|0|||
48885451|NCT01259089|157415655|FG004|Confirmed Response at 8 Weeks|Adverse Event|1|||
48885452|NCT01259089|157415656|FG005|Confirmed Response at 8 Weeks|Adverse Event|2|||
48885453|NCT01259089|157415651|FG000|Confirmed Response at 8 Weeks|Progressive disease|0|||
48885454|NCT01259089|157415652|FG001|Confirmed Response at 8 Weeks|Progressive disease|0|||
48885455|NCT01259089|157415653|FG002|Confirmed Response at 8 Weeks|Progressive disease|1|||
48885456|NCT01259089|157415654|FG003|Confirmed Response at 8 Weeks|Progressive disease|1|||
48885457|NCT01259089|157415655|FG004|Confirmed Response at 8 Weeks|Progressive disease|3|||
48885458|NCT01259089|157415656|FG005|Confirmed Response at 8 Weeks|Progressive disease|7|||
48885459|NCT01259089|157415651|FG000|Continued Treatment After 8 Weeks|Withdrawal by Subject|1|||
48885460|NCT01259089|157415652|FG001|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
48885461|NCT01259089|157415653|FG002|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
48885462|NCT01259089|157415654|FG003|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
48885463|NCT01259089|157415655|FG004|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
48885464|NCT01259089|157415656|FG005|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
48885465|NCT01259089|157415651|FG000|Continued Treatment After 8 Weeks|Adverse Event|0|||
48885466|NCT01259089|157415652|FG001|Continued Treatment After 8 Weeks|Adverse Event|0|||
48885467|NCT01259089|157415653|FG002|Continued Treatment After 8 Weeks|Adverse Event|0|||
48885468|NCT01259089|157415654|FG003|Continued Treatment After 8 Weeks|Adverse Event|0|||
48885469|NCT01259089|157415655|FG004|Continued Treatment After 8 Weeks|Adverse Event|2|||
48885470|NCT01259089|157415656|FG005|Continued Treatment After 8 Weeks|Adverse Event|1|||
48885471|NCT01259089|157415651|FG000|Continued Treatment After 8 Weeks|Progressive disease|1|||
48885472|NCT01259089|157415652|FG001|Continued Treatment After 8 Weeks|Progressive disease|1|||
48885473|NCT01259089|157415653|FG002|Continued Treatment After 8 Weeks|Progressive disease|1|||
48885474|NCT01259089|157415654|FG003|Continued Treatment After 8 Weeks|Progressive disease|1|||
48885475|NCT01259089|157415655|FG004|Continued Treatment After 8 Weeks|Progressive disease|0|||
48885476|NCT01259089|157415656|FG005|Continued Treatment After 8 Weeks|Progressive disease|0|||
48885477|NCT01259089|157415651|FG000|Survival Follow up for Two Years|Death|3|||
48885478|NCT01259089|157415652|FG001|Survival Follow up for Two Years|Death|2|||
48885479|NCT01259089|157415653|FG002|Survival Follow up for Two Years|Death|2|||
48885480|NCT01259089|157415654|FG003|Survival Follow up for Two Years|Death|3|||
48885481|NCT01259089|157415655|FG004|Survival Follow up for Two Years|Death|6|||
48885482|NCT01259089|157415656|FG005|Survival Follow up for Two Years|Death|13|||
48885483|NCT01259089|157415651|FG000|Survival Follow up for Two Years|Lost to Follow-up|0|||
48885484|NCT01259089|157415652|FG001|Survival Follow up for Two Years|Lost to Follow-up|0|||
48885485|NCT01259089|157415653|FG002|Survival Follow up for Two Years|Lost to Follow-up|0|||
48885486|NCT01259089|157415654|FG003|Survival Follow up for Two Years|Lost to Follow-up|0|||
48885487|NCT01259089|157415655|FG004|Survival Follow up for Two Years|Lost to Follow-up|0|||
48885488|NCT01259089|157415656|FG005|Survival Follow up for Two Years|Lost to Follow-up|2|||
48885489|NCT01259089|157415651|FG000|Survival Follow up for Two Years|stopped being followed as study closed|0|||
48885490|NCT01259089|157415652|FG001|Survival Follow up for Two Years|stopped being followed as study closed|0|||
48885491|NCT01259089|157415653|FG002|Survival Follow up for Two Years|stopped being followed as study closed|0|||
48885492|NCT01259089|157415654|FG003|Survival Follow up for Two Years|stopped being followed as study closed|0|||
48885493|NCT01259089|157415655|FG004|Survival Follow up for Two Years|stopped being followed as study closed|0|||
48885494|NCT01259089|157415656|FG005|Survival Follow up for Two Years|stopped being followed as study closed|4|||
48885495|NCT01245374|157415661|FG000|Overall Study|Protocol Violation|1|||
48885496|NCT01245374|157415661|FG000|Overall Study|Withdrawal by Subject|3|||
48885497|NCT01840410|157415662|FG000|Overall Study|Physician Decision|1|||
48885498|NCT01840410|157415663|FG001|Overall Study|Physician Decision|2|||
48885499|NCT01840410|157415662|FG000|Overall Study|Pregnancy|1|||
48885500|NCT01840410|157415663|FG001|Overall Study|Pregnancy|0|||
48885501|NCT01840410|157415662|FG000|Overall Study|Protocol deviation|1|||
48885502|NCT01840410|157415663|FG001|Overall Study|Protocol deviation|0|||
48885503|NCT01840410|157415662|FG000|Overall Study|Lost to Follow-up|1|||
48885504|NCT01840410|157415663|FG001|Overall Study|Lost to Follow-up|0|||
48885505|NCT01840410|157415662|FG000|Overall Study|Withdrawal by Subject|2|||
48885506|NCT01840410|157415663|FG001|Overall Study|Withdrawal by Subject|1|||
48885507|NCT01840410|157415662|FG000|Overall Study|Adverse Event|1|||
48885508|NCT01840410|157415663|FG001|Overall Study|Adverse Event|1|||
48885509|NCT01747551|157415664|FG000|Overall Study|Progressive Disease|24|||
48885510|NCT01747551|157415665|FG001|Overall Study|Progressive Disease|17|||
48885511|NCT01747551|157415664|FG000|Overall Study|Death|3|||
48885512|NCT01747551|157415665|FG001|Overall Study|Death|1|||
49035107|NCT01796171|157965474|FG009|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
49035108|NCT01796171|157965475|FG010|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
49035109|NCT01796171|157965476|FG011|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
49035110|NCT01796171|157965477|FG012|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
49035111|NCT01796171|157965478|FG013|Pre-reatment With Rituximab|Withdrawal by Subject|1|||
49035112|NCT01796171|157965479|FG014|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
49035113|NCT01796171|157965465|FG000|Treatment Period With Betalutin|Progressive disease|0|||
49035114|NCT01796171|157965466|FG001|Treatment Period With Betalutin|Progressive disease|1|||
49035115|NCT01796171|157965467|FG002|Treatment Period With Betalutin|Progressive disease|0|||
48885513|NCT01747551|157415664|FG000|Overall Study|Adverse Event|7|||
48885514|NCT01747551|157415665|FG001|Overall Study|Adverse Event|1|||
48885515|NCT01747551|157415664|FG000|Overall Study|Prolonged Treatment Delay|2|||
48885516|NCT01747551|157415665|FG001|Overall Study|Prolonged Treatment Delay|0|||
48885517|NCT01747551|157415664|FG000|Overall Study|Withdrawal by Subject|3|||
48885518|NCT01747551|157415665|FG001|Overall Study|Withdrawal by Subject|1|||
48885519|NCT01747551|157415664|FG000|Overall Study|Physician Decision|2|||
48885520|NCT01747551|157415665|FG001|Overall Study|Physician Decision|1|||
48885521|NCT01747551|157415664|FG000|Overall Study|Other|2|||
48885522|NCT01747551|157415665|FG001|Overall Study|Other|0|||
48885523|NCT01413503|157415666|FG000|Overall Study|Lost to Follow-up|1|||
48885524|NCT02406677|157415667|FG000|Overall Study|Death|16|||
48885525|NCT02406677|157415668|FG001|Overall Study|Death|8|||
48885526|NCT02406677|157415667|FG000|Overall Study|Discharged without P2Y12|1|||
48885527|NCT02406677|157415668|FG001|Overall Study|Discharged without P2Y12|3|||
49035116|NCT01796171|157965468|FG003|Treatment Period With Betalutin|Progressive disease|0|||
49035117|NCT01796171|157965469|FG004|Treatment Period With Betalutin|Progressive disease|0|||
49035118|NCT01796171|157965470|FG005|Treatment Period With Betalutin|Progressive disease|0|||
49035119|NCT01796171|157965471|FG006|Treatment Period With Betalutin|Progressive disease|0|||
49035120|NCT01796171|157965472|FG007|Treatment Period With Betalutin|Progressive disease|0|||
49035121|NCT01796171|157965473|FG008|Treatment Period With Betalutin|Progressive disease|0|||
49035122|NCT01796171|157965474|FG009|Treatment Period With Betalutin|Progressive disease|0|||
49035123|NCT01796171|157965475|FG010|Treatment Period With Betalutin|Progressive disease|0|||
49035124|NCT01796171|157965476|FG011|Treatment Period With Betalutin|Progressive disease|0|||
48885528|NCT02406677|157415667|FG000|Overall Study|Discharged on prasugrel|283|||
48885529|NCT02406677|157415668|FG001|Overall Study|Discharged on prasugrel|587|||
48885530|NCT02406677|157415667|FG000|Overall Study|Withdrawal by Subject|1|||
48885531|NCT02406677|157415668|FG001|Overall Study|Withdrawal by Subject|0|||
48885532|NCT01114880|157415669|FG000|Period 1 (Week 0 to Week 12)|Adverse Event|4|||
48885533|NCT01114880|157415670|FG001|Period 1 (Week 0 to Week 12)|Adverse Event|0|||
48885534|NCT01114880|157415669|FG000|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1|||
48885535|NCT01114880|157415670|FG001|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0|||
49035125|NCT01796171|157965477|FG012|Treatment Period With Betalutin|Progressive disease|0|||
48885536|NCT01114880|157415669|FG000|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0|||
48885537|NCT01114880|157415670|FG001|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1|||
48885538|NCT01114880|157415669|FG000|Period 1 (Week 0 to Week 12)|Poor subject compliance|0|||
48885539|NCT01114880|157415670|FG001|Period 1 (Week 0 to Week 12)|Poor subject compliance|1|||
48885540|NCT01114880|157415669|FG000|Period 2 (Week 12 to Week 24)|Adverse Event|3|||
48885541|NCT01114880|157415670|FG001|Period 2 (Week 12 to Week 24)|Adverse Event|0|||
48885542|NCT01114880|157415669|FG000|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0|||
49035126|NCT01796171|157965478|FG013|Treatment Period With Betalutin|Progressive disease|0|||
49035127|NCT01796171|157965479|FG014|Treatment Period With Betalutin|Progressive disease|0|||
49035128|NCT01796171|157965465|FG000|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
49035129|NCT01796171|157965466|FG001|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
49035130|NCT01796171|157965467|FG002|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
49035131|NCT01796171|157965468|FG003|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
49035132|NCT01796171|157965469|FG004|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
49035133|NCT01796171|157965470|FG005|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
49035134|NCT01796171|157965471|FG006|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
49035135|NCT01796171|157965472|FG007|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
49035136|NCT01796171|157965473|FG008|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
49035137|NCT01796171|157965474|FG009|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
49035138|NCT01796171|157965475|FG010|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
49035139|NCT01796171|157965476|FG011|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
49035140|NCT01796171|157965477|FG012|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
49035141|NCT01796171|157965478|FG013|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
49035142|NCT01796171|157965479|FG014|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
49035143|NCT01796171|157965465|FG000|Treatment Period With Betalutin|Physician Decision|0|||
49035144|NCT01796171|157965466|FG001|Treatment Period With Betalutin|Physician Decision|0|||
49035145|NCT01796171|157965467|FG002|Treatment Period With Betalutin|Physician Decision|0|||
49035146|NCT01796171|157965468|FG003|Treatment Period With Betalutin|Physician Decision|0|||
49035147|NCT01796171|157965469|FG004|Treatment Period With Betalutin|Physician Decision|0|||
49035148|NCT01796171|157965470|FG005|Treatment Period With Betalutin|Physician Decision|0|||
49035149|NCT01796171|157965471|FG006|Treatment Period With Betalutin|Physician Decision|0|||
49035150|NCT01796171|157965472|FG007|Treatment Period With Betalutin|Physician Decision|0|||
49035151|NCT01796171|157965473|FG008|Treatment Period With Betalutin|Physician Decision|0|||
49035152|NCT01796171|157965474|FG009|Treatment Period With Betalutin|Physician Decision|0|||
49035153|NCT01796171|157965475|FG010|Treatment Period With Betalutin|Physician Decision|5|||
49035154|NCT01796171|157965476|FG011|Treatment Period With Betalutin|Physician Decision|1|||
49035155|NCT01796171|157965477|FG012|Treatment Period With Betalutin|Physician Decision|1|||
49035156|NCT01796171|157965478|FG013|Treatment Period With Betalutin|Physician Decision|0|||
49035157|NCT01796171|157965479|FG014|Treatment Period With Betalutin|Physician Decision|0|||
49035158|NCT01796171|157965465|FG000|Treatment Period With Betalutin|Death|0|||
49035159|NCT01796171|157965466|FG001|Treatment Period With Betalutin|Death|0|||
49035160|NCT01796171|157965467|FG002|Treatment Period With Betalutin|Death|0|||
49035161|NCT01796171|157965468|FG003|Treatment Period With Betalutin|Death|0|||
49035162|NCT01796171|157965469|FG004|Treatment Period With Betalutin|Death|0|||
49035163|NCT01796171|157965470|FG005|Treatment Period With Betalutin|Death|0|||
48885543|NCT01114880|157415670|FG001|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2|||
48885544|NCT00283244|157415676|FG000|Overall Study|Adverse Event|0|||
48885545|NCT00283244|157415677|FG001|Overall Study|Adverse Event|8|||
48885546|NCT00283244|157415678|FG002|Overall Study|Adverse Event|11|||
48885547|NCT00283244|157415676|FG000|Overall Study|Death|4|||
48885548|NCT00283244|157415677|FG001|Overall Study|Death|3|||
48885549|NCT00283244|157415678|FG002|Overall Study|Death|2|||
48885550|NCT00283244|157415676|FG000|Overall Study|Lack of Efficacy|8|||
48885551|NCT00283244|157415677|FG001|Overall Study|Lack of Efficacy|32|||
48885552|NCT00283244|157415678|FG002|Overall Study|Lack of Efficacy|26|||
48885553|NCT00283244|157415676|FG000|Overall Study|Withdrawal by Subject|1|||
48885554|NCT00283244|157415677|FG001|Overall Study|Withdrawal by Subject|2|||
48885555|NCT00283244|157415678|FG002|Overall Study|Withdrawal by Subject|2|||
48885556|NCT00283244|157415676|FG000|Overall Study|Physician Decision|0|||
48885557|NCT00283244|157415677|FG001|Overall Study|Physician Decision|0|||
48885558|NCT00283244|157415678|FG002|Overall Study|Physician Decision|1|||
48885559|NCT00283244|157415676|FG000|Overall Study|Medical illness (other complicating dz)|4|||
48885560|NCT00283244|157415677|FG001|Overall Study|Medical illness (other complicating dz)|3|||
48885561|NCT00283244|157415678|FG002|Overall Study|Medical illness (other complicating dz)|6|||
48885562|NCT00283244|157415676|FG000|Overall Study|Clinical deterioration|1|||
48885563|NCT00283244|157415677|FG001|Overall Study|Clinical deterioration|3|||
48885564|NCT00283244|157415678|FG002|Overall Study|Clinical deterioration|3|||
48885565|NCT02145468|157415679|FG000|Overall Study|Withdrawal by Subject|5|||
48885566|NCT02145468|157415680|FG001|Overall Study|Withdrawal by Subject|8|||
48885567|NCT01609062|157415682|FG000|Extension Phase|Terminated by Sponsor|14|||
48885568|NCT01609062|157415683|FG001|Extension Phase|Terminated by Sponsor|9|||
48885569|NCT01609062|157415682|FG000|Extension Phase|Discontinued drug and then was pregnant|1|||
49035164|NCT01796171|157965471|FG006|Treatment Period With Betalutin|Death|0|||
48885570|NCT01609062|157415683|FG001|Extension Phase|Discontinued drug and then was pregnant|0|||
48885571|NCT01609062|157415682|FG000|Extension Phase|Anticipated surgery & transition to EAP|0|||
49035165|NCT01796171|157965472|FG007|Treatment Period With Betalutin|Death|0|||
49035166|NCT01796171|157965473|FG008|Treatment Period With Betalutin|Death|0|||
49035167|NCT01796171|157965474|FG009|Treatment Period With Betalutin|Death|0|||
49035168|NCT01796171|157965475|FG010|Treatment Period With Betalutin|Death|2|||
49035169|NCT01796171|157965476|FG011|Treatment Period With Betalutin|Death|0|||
49035170|NCT01796171|157965477|FG012|Treatment Period With Betalutin|Death|0|||
49035171|NCT01796171|157965478|FG013|Treatment Period With Betalutin|Death|0|||
49035172|NCT01796171|157965479|FG014|Treatment Period With Betalutin|Death|0|||
49035173|NCT01796171|157965465|FG000|Treatment Period With Betalutin|Sponsor Decision|0|||
49035174|NCT01796171|157965466|FG001|Treatment Period With Betalutin|Sponsor Decision|0|||
49035175|NCT01796171|157965467|FG002|Treatment Period With Betalutin|Sponsor Decision|0|||
49035176|NCT01796171|157965468|FG003|Treatment Period With Betalutin|Sponsor Decision|0|||
49035177|NCT01796171|157965469|FG004|Treatment Period With Betalutin|Sponsor Decision|0|||
49035178|NCT01796171|157965470|FG005|Treatment Period With Betalutin|Sponsor Decision|0|||
48885572|NCT01609062|157415683|FG001|Extension Phase|Anticipated surgery & transition to EAP|1|||
48885573|NCT00680992|157415684|FG000|Overall Study|Complete Resection (as per protocol)|25|||
48885574|NCT00680992|157415685|FG001|Overall Study|Complete Resection (as per protocol)|121|||
48885575|NCT00680992|157415686|FG002|Overall Study|Complete Resection (as per protocol)|0|||
48885576|NCT00680992|157415684|FG000|Overall Study|Administrative Decision|83|||
48885577|NCT00680992|157415685|FG001|Overall Study|Administrative Decision|42|||
48885578|NCT00680992|157415686|FG002|Overall Study|Administrative Decision|5|||
48885579|NCT00680992|157415684|FG000|Overall Study|End of Trial|32|||
48885580|NCT00680992|157415685|FG001|Overall Study|End of Trial|12|||
48885581|NCT00680992|157415686|FG002|Overall Study|End of Trial|3|||
48885582|NCT00680992|157415684|FG000|Overall Study|Withdrawal by Subject|33|||
48885583|NCT00680992|157415685|FG001|Overall Study|Withdrawal by Subject|11|||
48885584|NCT00680992|157415686|FG002|Overall Study|Withdrawal by Subject|1|||
48885585|NCT00680992|157415684|FG000|Overall Study|Adverse Event|21|||
48885586|NCT00680992|157415685|FG001|Overall Study|Adverse Event|19|||
48885587|NCT00680992|157415686|FG002|Overall Study|Adverse Event|1|||
48885588|NCT00680992|157415684|FG000|Overall Study|Other|19|||
48885589|NCT00680992|157415685|FG001|Overall Study|Other|14|||
48885590|NCT00680992|157415686|FG002|Overall Study|Other|1|||
48885591|NCT00680992|157415684|FG000|Overall Study|Disease Progression|21|||
48885592|NCT00680992|157415685|FG001|Overall Study|Disease Progression|9|||
48885593|NCT00680992|157415686|FG002|Overall Study|Disease Progression|0|||
48885594|NCT00680992|157415684|FG000|Overall Study|Lost to Follow-up|12|||
48885595|NCT00680992|157415685|FG001|Overall Study|Lost to Follow-up|14|||
48885596|NCT00680992|157415686|FG002|Overall Study|Lost to Follow-up|0|||
48885597|NCT00680992|157415684|FG000|Overall Study|Noncompliance|4|||
48885598|NCT00680992|157415685|FG001|Overall Study|Noncompliance|6|||
48885599|NCT00680992|157415686|FG002|Overall Study|Noncompliance|0|||
48885600|NCT00680992|157415684|FG000|Overall Study|Requirement for Alternative Therapy|8|||
48885601|NCT00680992|157415685|FG001|Overall Study|Requirement for Alternative Therapy|2|||
48885602|NCT00680992|157415686|FG002|Overall Study|Requirement for Alternative Therapy|0|||
48885603|NCT00680992|157415684|FG000|Overall Study|Pregnancy|5|||
48885604|NCT00680992|157415685|FG001|Overall Study|Pregnancy|0|||
48885605|NCT00680992|157415686|FG002|Overall Study|Pregnancy|1|||
48885606|NCT00680992|157415684|FG000|Overall Study|Death|5|||
48885607|NCT00680992|157415685|FG001|Overall Study|Death|1|||
48885608|NCT00680992|157415686|FG002|Overall Study|Death|0|||
48885609|NCT00680992|157415684|FG000|Overall Study|Ineligibility Determined|0|||
48885610|NCT00680992|157415685|FG001|Overall Study|Ineligibility Determined|1|||
48885611|NCT00680992|157415686|FG002|Overall Study|Ineligibility Determined|0|||
48885612|NCT00513305|157415687|FG000|Overall Study|Adverse Event|6|||
48885613|NCT00513305|157415688|FG001|Overall Study|Adverse Event|2|||
48885614|NCT00513305|157415687|FG000|Overall Study|Death (through Consolidation Treatment)|2|||
48885615|NCT00513305|157415688|FG001|Overall Study|Death (through Consolidation Treatment)|2|||
48885616|NCT00513305|157415687|FG000|Overall Study|Lack of Efficacy|8|||
48885617|NCT00513305|157415688|FG001|Overall Study|Lack of Efficacy|13|||
48885618|NCT00513305|157415687|FG000|Overall Study|Withdrawal by Subject|1|||
48885619|NCT00513305|157415688|FG001|Overall Study|Withdrawal by Subject|2|||
48885620|NCT00513305|157415687|FG000|Overall Study|Disease progression|8|||
48885621|NCT00513305|157415688|FG001|Overall Study|Disease progression|5|||
48885622|NCT00513305|157415687|FG000|Overall Study|Eligible for stem cell transplant|1|||
48885623|NCT00513305|157415688|FG001|Overall Study|Eligible for stem cell transplant|0|||
48885624|NCT00513305|157415687|FG000|Overall Study|Hematologic counts did not recover|1|||
48885625|NCT00513305|157415688|FG001|Overall Study|Hematologic counts did not recover|0|||
49035179|NCT01796171|157965471|FG006|Treatment Period With Betalutin|Sponsor Decision|0|||
49035180|NCT01796171|157965472|FG007|Treatment Period With Betalutin|Sponsor Decision|0|||
48885626|NCT00513305|157415687|FG000|Overall Study|Physician Decision|1|||
48885627|NCT00513305|157415688|FG001|Overall Study|Physician Decision|0|||
48885628|NCT00513305|157415687|FG000|Overall Study|Persistent hypocellularity|0|||
48885629|NCT00513305|157415688|FG001|Overall Study|Persistent hypocellularity|1|||
48885630|NCT00513305|157415687|FG000|Overall Study|Sponsor Decision|0|||
48885631|NCT00513305|157415688|FG001|Overall Study|Sponsor Decision|2|||
49035181|NCT01796171|157965473|FG008|Treatment Period With Betalutin|Sponsor Decision|0|||
49035182|NCT01796171|157965474|FG009|Treatment Period With Betalutin|Sponsor Decision|0|||
49035183|NCT01796171|157965475|FG010|Treatment Period With Betalutin|Sponsor Decision|2|||
49035184|NCT01796171|157965476|FG011|Treatment Period With Betalutin|Sponsor Decision|0|||
49035185|NCT01796171|157965477|FG012|Treatment Period With Betalutin|Sponsor Decision|0|||
49035186|NCT01796171|157965478|FG013|Treatment Period With Betalutin|Sponsor Decision|0|||
49035187|NCT01796171|157965479|FG014|Treatment Period With Betalutin|Sponsor Decision|0|||
49035188|NCT01796171|157965465|FG000|Treatment Period With Betalutin|Withdrawal by Subject|0|||
49035189|NCT01796171|157965466|FG001|Treatment Period With Betalutin|Withdrawal by Subject|0|||
49035190|NCT01796171|157965467|FG002|Treatment Period With Betalutin|Withdrawal by Subject|0|||
49035191|NCT01796171|157965468|FG003|Treatment Period With Betalutin|Withdrawal by Subject|0|||
49035192|NCT01796171|157965469|FG004|Treatment Period With Betalutin|Withdrawal by Subject|0|||
49035193|NCT01796171|157965470|FG005|Treatment Period With Betalutin|Withdrawal by Subject|0|||
49035194|NCT01796171|157965471|FG006|Treatment Period With Betalutin|Withdrawal by Subject|0|||
49035195|NCT01796171|157965472|FG007|Treatment Period With Betalutin|Withdrawal by Subject|0|||
49035196|NCT01796171|157965473|FG008|Treatment Period With Betalutin|Withdrawal by Subject|0|||
49035197|NCT01796171|157965474|FG009|Treatment Period With Betalutin|Withdrawal by Subject|0|||
49035198|NCT01796171|157965475|FG010|Treatment Period With Betalutin|Withdrawal by Subject|1|||
49035199|NCT01796171|157965476|FG011|Treatment Period With Betalutin|Withdrawal by Subject|1|||
49035200|NCT01796171|157965477|FG012|Treatment Period With Betalutin|Withdrawal by Subject|0|||
49035201|NCT01796171|157965478|FG013|Treatment Period With Betalutin|Withdrawal by Subject|0|||
48885632|NCT04177394|157415710|FG000|Overall Study|Death|16|||
48885633|NCT04177394|157415710|FG000|Overall Study|Withdrawal by Subject|19|||
48885634|NCT04177394|157415710|FG000|Overall Study|Missed visits|61|||
48885635|NCT04177394|157415710|FG000|Overall Study|Expected Visits|15|||
48885636|NCT05123586|157415711|FG000|Overall Study|Physician Decision|1|||
48885637|NCT05123586|157415712|FG001|Overall Study|Physician Decision|1|||
48885638|NCT05123586|157415711|FG000|Overall Study|Withdrawal by Subject|0|||
48885639|NCT05123586|157415712|FG001|Overall Study|Withdrawal by Subject|3|||
48885640|NCT01934790|157415713|FG000|Treatment|Adverse Event|3|||
48885641|NCT01934790|157415713|FG000|Treatment|Clinical progression|6|||
48885642|NCT01934790|157415713|FG000|Treatment|Radiological progression|4|||
48885643|NCT01934790|157415713|FG000|Treatment|Withdrawal by Subject|2|||
48885644|NCT01934790|157415713|FG000|Treatment|Study drug never administered|1|||
48885645|NCT01934790|157415713|FG000|Active Follow up|Death|20|||
48885646|NCT01934790|157415713|FG000|Active Follow up|Physician Decision|2|||
48885647|NCT01934790|157415713|FG000|Active Follow up|Progressive disease|1|||
48885648|NCT01934790|157415713|FG000|Active Follow up|Other reason|1|||
48885649|NCT05167864|157415714|FG000|Overall Study|Lost to Follow-up|7|||
48885650|NCT05167864|157415715|FG001|Overall Study|Lost to Follow-up|6|||
48885651|NCT05167864|157415716|FG002|Overall Study|Lost to Follow-up|7|||
48885652|NCT05167864|157415717|FG003|Overall Study|Lost to Follow-up|9|||
48885653|NCT04862234|157415722|FG000|Overall Study|Surgery cancellation|1|||
48885654|NCT04862234|157415723|FG001|Overall Study|Surgery cancellation|2|||
48885655|NCT04862234|157415722|FG000|Overall Study|Early discharge (<48 hours) - no CGM data collected|0|||
48885656|NCT04862234|157415723|FG001|Overall Study|Early discharge (<48 hours) - no CGM data collected|1|||
48885657|NCT04862234|157415722|FG000|Overall Study|Early discharge (<48 hours) - CGM data collected|0|||
48885658|NCT04862234|157415723|FG001|Overall Study|Early discharge (<48 hours) - CGM data collected|1|||
48885659|NCT00384397|157415725|FG000|Overall Study|Adverse Event|0|||
48885660|NCT00384397|157415726|FG001|Overall Study|Adverse Event|1|||
48885661|NCT00384397|157415727|FG002|Overall Study|Adverse Event|2|||
48885662|NCT00384397|157415725|FG000|Overall Study|Protocol Violation|7|||
48885663|NCT00384397|157415726|FG001|Overall Study|Protocol Violation|15|||
48885664|NCT00384397|157415727|FG002|Overall Study|Protocol Violation|13|||
48885665|NCT00384397|157415725|FG000|Overall Study|Lost to Follow-up|11|||
48885666|NCT00384397|157415726|FG001|Overall Study|Lost to Follow-up|13|||
48885667|NCT00384397|157415727|FG002|Overall Study|Lost to Follow-up|3|||
48885668|NCT00384397|157415725|FG000|Overall Study|Withdrawal by Subject|14|||
48885669|NCT00384397|157415726|FG001|Overall Study|Withdrawal by Subject|17|||
48885670|NCT00384397|157415727|FG002|Overall Study|Withdrawal by Subject|15|||
48885671|NCT02489968|157415728|FG000|Open-label Treatment Period|Adverse Event|14|||
48885672|NCT02489968|157415729|FG001|Open-label Treatment Period|Adverse Event|7|||
48885673|NCT02489968|157415730|FG002|Open-label Treatment Period|Adverse Event|0|||
48885674|NCT02489968|157415731|FG003|Open-label Treatment Period|Adverse Event|0|||
48885675|NCT02489968|157415732|FG004|Open-label Treatment Period|Adverse Event|0|||
48885676|NCT02489968|157415733|FG005|Open-label Treatment Period|Adverse Event|0|||
48885677|NCT02489968|157415728|FG000|Open-label Treatment Period|Protocol Violation|2|||
48885678|NCT02489968|157415729|FG001|Open-label Treatment Period|Protocol Violation|2|||
48885679|NCT02489968|157415730|FG002|Open-label Treatment Period|Protocol Violation|0|||
48885680|NCT02489968|157415731|FG003|Open-label Treatment Period|Protocol Violation|0|||
48885681|NCT02489968|157415732|FG004|Open-label Treatment Period|Protocol Violation|0|||
48885682|NCT02489968|157415733|FG005|Open-label Treatment Period|Protocol Violation|0|||
49035202|NCT01796171|157965479|FG014|Treatment Period With Betalutin|Withdrawal by Subject|0|||
48885683|NCT02489968|157415728|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
48885684|NCT02489968|157415729|FG001|Open-label Treatment Period|Lost to Follow-up|3|||
48885685|NCT02489968|157415730|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
48885686|NCT02489968|157415731|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
48885687|NCT02489968|157415732|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
48885688|NCT02489968|157415733|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
48885689|NCT02489968|157415728|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
48885690|NCT02489968|157415729|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
48885691|NCT02489968|157415730|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
48885692|NCT02489968|157415731|FG003|Open-label Treatment Period|Withdrawal by Subject|0|||
48885693|NCT02489968|157415732|FG004|Open-label Treatment Period|Withdrawal by Subject|0|||
48885694|NCT02489968|157415733|FG005|Open-label Treatment Period|Withdrawal by Subject|0|||
48885695|NCT02489968|157415728|FG000|Open-label Treatment Period|Other than specified above|204|||
48885696|NCT02489968|157415729|FG001|Open-label Treatment Period|Other than specified above|189|||
48885697|NCT02489968|157415730|FG002|Open-label Treatment Period|Other than specified above|0|||
48885698|NCT02489968|157415731|FG003|Open-label Treatment Period|Other than specified above|0|||
48885699|NCT02489968|157415732|FG004|Open-label Treatment Period|Other than specified above|0|||
48885700|NCT02489968|157415733|FG005|Open-label Treatment Period|Other than specified above|0|||
48885701|NCT02489968|157415728|FG000|Double-blind Treatment Period|Adverse Event|0|||
48885702|NCT02489968|157415729|FG001|Double-blind Treatment Period|Adverse Event|0|||
48885703|NCT02489968|157415730|FG002|Double-blind Treatment Period|Adverse Event|2|||
48885704|NCT02489968|157415731|FG003|Double-blind Treatment Period|Adverse Event|6|||
48885705|NCT02489968|157415732|FG004|Double-blind Treatment Period|Adverse Event|4|||
48885706|NCT02489968|157415733|FG005|Double-blind Treatment Period|Adverse Event|5|||
48885707|NCT02489968|157415728|FG000|Double-blind Treatment Period|Protocol Violation|0|||
48885708|NCT02489968|157415729|FG001|Double-blind Treatment Period|Protocol Violation|0|||
48885709|NCT02489968|157415730|FG002|Double-blind Treatment Period|Protocol Violation|0|||
48885710|NCT02489968|157415731|FG003|Double-blind Treatment Period|Protocol Violation|0|||
48885711|NCT02489968|157415732|FG004|Double-blind Treatment Period|Protocol Violation|1|||
48885712|NCT02489968|157415733|FG005|Double-blind Treatment Period|Protocol Violation|1|||
48885713|NCT02489968|157415728|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
48885714|NCT02489968|157415729|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
48885715|NCT02489968|157415730|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
48885716|NCT02489968|157415731|FG003|Double-blind Treatment Period|Withdrawal by Subject|2|||
48885717|NCT02489968|157415732|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
48885718|NCT02489968|157415733|FG005|Double-blind Treatment Period|Withdrawal by Subject|2|||
48885719|NCT02489968|157415728|FG000|Double-blind Treatment Period|Other than specified above|0|||
48885720|NCT02489968|157415729|FG001|Double-blind Treatment Period|Other than specified above|0|||
48885721|NCT02489968|157415730|FG002|Double-blind Treatment Period|Other than specified above|0|||
48885722|NCT02489968|157415731|FG003|Double-blind Treatment Period|Other than specified above|0|||
48885723|NCT02489968|157415732|FG004|Double-blind Treatment Period|Other than specified above|1|||
48885724|NCT02489968|157415733|FG005|Double-blind Treatment Period|Other than specified above|0|||
48885725|NCT01593787|157415734|FG000|Overall Study|Adverse Event|1|||
48885726|NCT01593787|157415735|FG001|Overall Study|Adverse Event|0|||
48885727|NCT01593787|157415736|FG002|Overall Study|Adverse Event|0|||
48885728|NCT03192462|157417098|FG000|Overall Study|Death|13|||
48885729|NCT03192462|157417099|FG001|Overall Study|Death|11|||
48885730|NCT03192462|157417100|FG002|Overall Study|Death|9|||
48885731|NCT03192462|157417098|FG000|Overall Study|Lost to Follow-up|0|||
48885732|NCT03192462|157417099|FG001|Overall Study|Lost to Follow-up|1|||
48885733|NCT03192462|157417100|FG002|Overall Study|Lost to Follow-up|0|||
48885734|NCT03192462|157417098|FG000|Overall Study|On follow up|0|||
48885735|NCT03192462|157417099|FG001|Overall Study|On follow up|0|||
48885736|NCT03192462|157417100|FG002|Overall Study|On follow up|3|||
48885737|NCT01385748|157417102|FG000|Overall Study|Withdrawal by Subject|7|||
48885738|NCT01385748|157417103|FG001|Overall Study|Withdrawal by Subject|4|||
48885739|NCT01385748|157417104|FG002|Overall Study|Withdrawal by Subject|5|||
48885740|NCT01385748|157417102|FG000|Overall Study|Noncompliance|3|||
48885741|NCT01385748|157417103|FG001|Overall Study|Noncompliance|1|||
48885742|NCT01385748|157417104|FG002|Overall Study|Noncompliance|6|||
48885743|NCT01385748|157417102|FG000|Overall Study|Other|1|||
48885744|NCT01385748|157417103|FG001|Overall Study|Other|7|||
48885745|NCT01385748|157417104|FG002|Overall Study|Other|1|||
48885746|NCT01385748|157417102|FG000|Overall Study|Adverse Event|4|||
48885747|NCT01385748|157417103|FG001|Overall Study|Adverse Event|2|||
48885748|NCT01385748|157417104|FG002|Overall Study|Adverse Event|1|||
48885749|NCT03232931|157417105|FG000|Overall Study|Physician Decision|1|||
48885750|NCT03232931|157417106|FG001|Overall Study|Physician Decision|1|||
48885751|NCT03232931|157417105|FG000|Overall Study|Withdrawal by Subject|6|||
48885752|NCT03232931|157417106|FG001|Overall Study|Withdrawal by Subject|0|||
48885753|NCT03232931|157417105|FG000|Overall Study|Discharged before completing study activities per protocol|4|||
48885754|NCT03232931|157417106|FG001|Overall Study|Discharged before completing study activities per protocol|2|||
48885755|NCT03232931|157417105|FG000|Overall Study|Parent did not record voice|1|||
48885756|NCT03232931|157417106|FG001|Overall Study|Parent did not record voice|2|||
48885757|NCT03232931|157417105|FG000|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|2|||
48885758|NCT03232931|157417106|FG001|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|1|||
48885759|NCT01681277|157417109|FG000|Overall Study|Adverse Event|1|||
48885760|NCT01681277|157417110|FG001|Overall Study|Adverse Event|0|||
48885761|NCT01681277|157417111|FG002|Overall Study|Adverse Event|0|||
48885762|NCT01681277|157417112|FG003|Overall Study|Adverse Event|0|||
48885763|NCT01681277|157417113|FG004|Overall Study|Adverse Event|0|||
48885764|NCT04707664|157417122|FG000|Overall Study|Adverse Event|2|||
48885765|NCT04707664|157417123|FG001|Overall Study|Adverse Event|0|||
48885766|NCT04707664|157417122|FG000|Overall Study|Death|1|||
48885767|NCT04707664|157417123|FG001|Overall Study|Death|2|||
48885768|NCT04707664|157417122|FG000|Overall Study|Withdrawal by Subject|13|||
48885769|NCT04707664|157417123|FG001|Overall Study|Withdrawal by Subject|21|||
48885770|NCT04707664|157417122|FG000|Overall Study|Lost to Follow-up|11|||
48885771|NCT04707664|157417123|FG001|Overall Study|Lost to Follow-up|13|||
48885772|NCT04707664|157417122|FG000|Overall Study|Not treated|2|||
48885773|NCT04707664|157417123|FG001|Overall Study|Not treated|0|||
48885774|NCT02056626|157417124|FG000|Overall Study|patient did not follow directions|3|||
48885775|NCT02056626|157417125|FG001|Overall Study|patient did not follow directions|1|||
48885776|NCT02056626|157417126|FG002|Overall Study|patient did not follow directions|0|||
48885777|NCT02056626|157417127|FG003|Overall Study|patient did not follow directions|0|||
48885778|NCT02460575|157417128|FG000|Overall Study|Lost to Follow-up|1|||
48885779|NCT02460575|157417129|FG001|Overall Study|Lost to Follow-up|0|||
48885780|NCT04307940|157417130|FG000|Overall Study|Adverse Event|1|||
48885781|NCT04307940|157417131|FG001|Overall Study|Adverse Event|0|||
48885782|NCT04307940|157417132|FG002|Overall Study|Adverse Event|0|||
48885783|NCT04307940|157417130|FG000|Overall Study|Withdrawal by Subject|2|||
48885784|NCT04307940|157417131|FG001|Overall Study|Withdrawal by Subject|3|||
48885785|NCT04307940|157417132|FG002|Overall Study|Withdrawal by Subject|1|||
48885786|NCT04307940|157417130|FG000|Overall Study|Lost to Follow-up|2|||
48885787|NCT04307940|157417131|FG001|Overall Study|Lost to Follow-up|0|||
48885788|NCT04307940|157417132|FG002|Overall Study|Lost to Follow-up|1|||
48885789|NCT04400487|157417137|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
48885790|NCT04400487|157417137|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
48885791|NCT04400487|157417137|FG000|Follow-up Period (28 Days)|Started commercial product|2|||
48885792|NCT00127205|157417142|FG000|Overall Study|Adverse Event|228|||
48885793|NCT00127205|157417143|FG001|Overall Study|Adverse Event|387|||
48885794|NCT00127205|157417144|FG002|Overall Study|Adverse Event|273|||
48885795|NCT00127205|157417142|FG000|Overall Study|Death|8|||
48885796|NCT00127205|157417143|FG001|Overall Study|Death|6|||
48885797|NCT00127205|157417144|FG002|Overall Study|Death|5|||
48885798|NCT00127205|157417142|FG000|Overall Study|Withdrawal by Subject|318|||
48885799|NCT00127205|157417143|FG001|Overall Study|Withdrawal by Subject|310|||
48885800|NCT00127205|157417144|FG002|Overall Study|Withdrawal by Subject|172|||
48885801|NCT00127205|157417142|FG000|Overall Study|Other-non protocol specified|142|||
48885802|NCT00127205|157417143|FG001|Overall Study|Other-non protocol specified|129|||
48885803|NCT00127205|157417144|FG002|Overall Study|Other-non protocol specified|77|||
48885804|NCT00127205|157417142|FG000|Overall Study|Data not reported|6|||
48885805|NCT00127205|157417143|FG001|Overall Study|Data not reported|10|||
48885806|NCT00127205|157417144|FG002|Overall Study|Data not reported|1|||
48885807|NCT00127205|157417142|FG000|Overall Study|Progression|127|||
48885808|NCT00127205|157417143|FG001|Overall Study|Progression|131|||
48885809|NCT00127205|157417144|FG002|Overall Study|Progression|84|||
48885810|NCT00734591|157417145|FG000|Screening for Prospective Period|Site did not participate|1604|||
48885811|NCT00734591|157417146|FG001|Screening for Prospective Period|Site did not participate|1488|||
48885812|NCT00734591|157417145|FG000|Screening for Prospective Period|Patient at partic. site not enrolled|913|||
48885813|NCT00734591|157417146|FG001|Screening for Prospective Period|Patient at partic. site not enrolled|803|||
48885814|NCT00734591|157417145|FG000|Prospective Period|Withdrawal by Subject|11|||
48885815|NCT00734591|157417146|FG001|Prospective Period|Withdrawal by Subject|9|||
48885816|NCT00734591|157417145|FG000|Prospective Period|Lost to Follow-up|37|||
48885817|NCT00734591|157417146|FG001|Prospective Period|Lost to Follow-up|33|||
48885818|NCT00734591|157417145|FG000|Prospective Period|Study Terminated|1|||
48885819|NCT00734591|157417146|FG001|Prospective Period|Study Terminated|0|||
48885820|NCT00734591|157417145|FG000|Prospective Period|Other|2|||
48885821|NCT00734591|157417146|FG001|Prospective Period|Other|2|||
48885822|NCT02493062|157417147|FG000|Overall Study|Physician Decision|12|||
48885823|NCT02138786|157417148|FG000|Overall Study|Adverse Event|0|||
48885824|NCT02138786|157417149|FG001|Overall Study|Adverse Event|2|||
48885825|NCT02138786|157417150|FG002|Overall Study|Adverse Event|1|||
48885826|NCT02138786|157417148|FG000|Overall Study|Death|1|||
48885827|NCT02138786|157417149|FG001|Overall Study|Death|7|||
48885828|NCT02138786|157417150|FG002|Overall Study|Death|2|||
48885829|NCT02138786|157417148|FG000|Overall Study|Disease Progression|1|||
48885830|NCT02138786|157417149|FG001|Overall Study|Disease Progression|1|||
48885831|NCT02138786|157417150|FG002|Overall Study|Disease Progression|3|||
48885832|NCT02138786|157417148|FG000|Overall Study|Withdrawal by Subject|1|||
48885833|NCT02138786|157417149|FG001|Overall Study|Withdrawal by Subject|2|||
48885834|NCT02138786|157417150|FG002|Overall Study|Withdrawal by Subject|0|||
48885835|NCT02138786|157417148|FG000|Overall Study|Patient's Wish|0|||
48885836|NCT02138786|157417149|FG001|Overall Study|Patient's Wish|2|||
48885837|NCT02138786|157417150|FG002|Overall Study|Patient's Wish|0|||
48885838|NCT02138786|157417148|FG000|Overall Study|Sponsor Terminated Study|0|||
48885839|NCT02138786|157417149|FG001|Overall Study|Sponsor Terminated Study|1|||
48885840|NCT02138786|157417150|FG002|Overall Study|Sponsor Terminated Study|1|||
48885841|NCT02138786|157417148|FG000|Overall Study|Non-Compliance|0|||
48885842|NCT02138786|157417149|FG001|Overall Study|Non-Compliance|0|||
48885843|NCT02138786|157417150|FG002|Overall Study|Non-Compliance|1|||
48885844|NCT01681992|157417151|FG000|Overall Study|Adverse Event|3|||
48885845|NCT01681992|157417152|FG001|Overall Study|Adverse Event|2|||
48885846|NCT01681992|157417153|FG002|Overall Study|Adverse Event|3|||
49035203|NCT01796171|157965465|FG000|Follow-up Period|Start of further anticancer therapy|4|||
49035204|NCT01796171|157965466|FG001|Follow-up Period|Start of further anticancer therapy|25|||
49035205|NCT01796171|157965467|FG002|Follow-up Period|Start of further anticancer therapy|2|||
49035206|NCT01796171|157965468|FG003|Follow-up Period|Start of further anticancer therapy|1|||
49035207|NCT01796171|157965469|FG004|Follow-up Period|Start of further anticancer therapy|2|||
49035208|NCT01796171|157965470|FG005|Follow-up Period|Start of further anticancer therapy|2|||
49035209|NCT01796171|157965471|FG006|Follow-up Period|Start of further anticancer therapy|1|||
49035210|NCT01796171|157965472|FG007|Follow-up Period|Start of further anticancer therapy|15|||
49035211|NCT01796171|157965473|FG008|Follow-up Period|Start of further anticancer therapy|2|||
49035212|NCT01796171|157965474|FG009|Follow-up Period|Start of further anticancer therapy|0|||
49035213|NCT01796171|157965475|FG010|Follow-up Period|Start of further anticancer therapy|0|||
49035214|NCT01796171|157965476|FG011|Follow-up Period|Start of further anticancer therapy|0|||
49035215|NCT01796171|157965477|FG012|Follow-up Period|Start of further anticancer therapy|0|||
49035216|NCT01796171|157965478|FG013|Follow-up Period|Start of further anticancer therapy|0|||
49035217|NCT01796171|157965479|FG014|Follow-up Period|Start of further anticancer therapy|0|||
49035218|NCT01796171|157965465|FG000|Follow-up Period|Progressive disease|0|||
49035219|NCT01796171|157965466|FG001|Follow-up Period|Progressive disease|1|||
49035220|NCT01796171|157965467|FG002|Follow-up Period|Progressive disease|0|||
49035221|NCT01796171|157965468|FG003|Follow-up Period|Progressive disease|0|||
49035222|NCT01796171|157965469|FG004|Follow-up Period|Progressive disease|0|||
49035223|NCT01796171|157965470|FG005|Follow-up Period|Progressive disease|0|||
49035224|NCT01796171|157965471|FG006|Follow-up Period|Progressive disease|0|||
49035225|NCT01796171|157965472|FG007|Follow-up Period|Progressive disease|3|||
49035226|NCT01796171|157965473|FG008|Follow-up Period|Progressive disease|0|||
49035227|NCT01796171|157965474|FG009|Follow-up Period|Progressive disease|0|||
49035228|NCT01796171|157965475|FG010|Follow-up Period|Progressive disease|0|||
48885847|NCT01681992|157417151|FG000|Overall Study|Lost to Follow-up|36|||
48885848|NCT01681992|157417152|FG001|Overall Study|Lost to Follow-up|38|||
48885849|NCT01681992|157417153|FG002|Overall Study|Lost to Follow-up|53|||
48885850|NCT01681992|157417151|FG000|Overall Study|As Per Sponsor Decision|0|||
48885851|NCT01681992|157417152|FG001|Overall Study|As Per Sponsor Decision|0|||
48885852|NCT01681992|157417153|FG002|Overall Study|As Per Sponsor Decision|1|||
48885853|NCT01681992|157417151|FG000|Overall Study|Protocol Violation|0|||
48885854|NCT01681992|157417152|FG001|Overall Study|Protocol Violation|0|||
48885855|NCT01681992|157417153|FG002|Overall Study|Protocol Violation|1|||
48885856|NCT01681992|157417151|FG000|Overall Study|Withdrawal by Subject|27|||
48885857|NCT01681992|157417152|FG001|Overall Study|Withdrawal by Subject|30|||
48885858|NCT01681992|157417153|FG002|Overall Study|Withdrawal by Subject|25|||
48885859|NCT01294397|157417157|FG000|Overall Study|Withdrawal by Subject|1|||
48885860|NCT01294397|157417157|FG000|Overall Study|Administrative Decision|1|||
48885861|NCT00426127|157417158|FG000|Overall Study|Adverse Event|1|||
48885862|NCT00426127|157417158|FG000|Overall Study|Removed due to disease progression|1|||
48885863|NCT02476175|157417159|FG000|Overall Study|Adverse Event|2|||
48885864|NCT02242097|157417164|FG000|Ibrutinib Treatment|Adverse Event|16|||
48885865|NCT02242097|157417164|FG000|Ibrutinib Treatment|Physician Decision|1|||
48885866|NCT02242097|157417164|FG000|Ibrutinib Treatment|Lack of Efficacy|1|||
48885867|NCT02242097|157417164|FG000|Ibrutinib Treatment|Death|1|||
48885868|NCT02242097|157417164|FG000|Ibrutinib Treatment|Patient Ineligible to start treatment|1|||
48885869|NCT02242097|157417164|FG000|Post Therapy Follow Up|Death|3|||
48885870|NCT02242097|157417164|FG000|Post Therapy Follow Up|Lost to Follow-up|1|||
48885871|NCT02922023|157417165|FG000|Overall Study|Lost to Follow-up|2|||
48885872|NCT02922023|157417166|FG001|Overall Study|Lost to Follow-up|0|||
49035229|NCT01796171|157965476|FG011|Follow-up Period|Progressive disease|0|||
49035230|NCT01796171|157965477|FG012|Follow-up Period|Progressive disease|0|||
49035231|NCT01796171|157965478|FG013|Follow-up Period|Progressive disease|0|||
48885873|NCT01685229|157417170|FG000|Overall Study|Subjects missing Study Exit form|3|||
48885874|NCT01685229|157417171|FG001|Overall Study|Subjects missing Study Exit form|1|||
48885875|NCT01685229|157417170|FG000|Overall Study|Lost to Follow-up|16|||
48885876|NCT01685229|157417171|FG001|Overall Study|Lost to Follow-up|10|||
48885877|NCT01685229|157417170|FG000|Overall Study|Withdrawal by Subject|6|||
48885878|NCT01685229|157417171|FG001|Overall Study|Withdrawal by Subject|5|||
48885879|NCT01685229|157417170|FG000|Overall Study|Death|1|||
48885880|NCT01685229|157417171|FG001|Overall Study|Death|0|||
48885881|NCT02597712|157417180|FG000|Overall Study|Baseline biopsies showed indefinite for dysplasia|2|||
48885882|NCT02597712|157417181|FG001|Overall Study|Baseline biopsies showed indefinite for dysplasia|0|||
48885883|NCT02597712|157417180|FG000|Overall Study|Baseline biopsies showed low grade dysplasia|1|||
48885884|NCT02597712|157417181|FG001|Overall Study|Baseline biopsies showed low grade dysplasia|0|||
48885885|NCT02597712|157417180|FG000|Overall Study|Recurrent metastatic prostate cancer|0|||
48885886|NCT02597712|157417181|FG001|Overall Study|Recurrent metastatic prostate cancer|1|||
48885887|NCT01162486|157417182|FG000|Overall Study|low ANC|1|||
48885888|NCT01162486|157417183|FG001|Overall Study|low ANC|0|||
48885889|NCT01162486|157417184|FG002|Overall Study|low ANC|0|||
48885890|NCT01162486|157417185|FG003|Overall Study|low ANC|0|||
48885891|NCT01162486|157417186|FG004|Overall Study|low ANC|0|||
48885892|NCT01162486|157417182|FG000|Overall Study|vomited Rifampin/ gagged with midazolam|1|||
48885893|NCT01162486|157417183|FG001|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
48885894|NCT01162486|157417184|FG002|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
48885895|NCT01162486|157417185|FG003|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
48885896|NCT01162486|157417186|FG004|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
48885897|NCT01162486|157417182|FG000|Overall Study|elevated LFTs|0|||
48885898|NCT01162486|157417183|FG001|Overall Study|elevated LFTs|0|||
48885899|NCT01162486|157417184|FG002|Overall Study|elevated LFTs|1|||
48885900|NCT01162486|157417185|FG003|Overall Study|elevated LFTs|0|||
48885901|NCT01162486|157417186|FG004|Overall Study|elevated LFTs|0|||
48885902|NCT01162486|157417182|FG000|Overall Study|Pregnancy|0|||
48885903|NCT01162486|157417183|FG001|Overall Study|Pregnancy|0|||
48885904|NCT01162486|157417184|FG002|Overall Study|Pregnancy|0|||
48885905|NCT01162486|157417185|FG003|Overall Study|Pregnancy|1|||
48885906|NCT01162486|157417186|FG004|Overall Study|Pregnancy|0|||
48885907|NCT01305408|157417187|FG000|Overall Study|Adverse Event|10|||
48885908|NCT01305408|157417188|FG001|Overall Study|Adverse Event|7|||
48885909|NCT01305408|157417187|FG000|Overall Study|Lack of Efficacy|3|||
48885910|NCT01305408|157417188|FG001|Overall Study|Lack of Efficacy|4|||
48885911|NCT01305408|157417187|FG000|Overall Study|Withdrawal by Subject|9|||
48885912|NCT01305408|157417188|FG001|Overall Study|Withdrawal by Subject|9|||
48885913|NCT01305408|157417187|FG000|Overall Study|Protocol Violation|4|||
48885914|NCT01305408|157417188|FG001|Overall Study|Protocol Violation|6|||
48885915|NCT01305408|157417187|FG000|Overall Study|Lost to Follow-up|5|||
48983764|NCT00256204|157772333|FG001|Overall Study|Need for additional prohibited treatment|28|||
48983765|NCT00256204|157772334|FG002|Overall Study|Need for additional prohibited treatment|27|||
48983766|NCT00256204|157772335|FG003|Overall Study|Need for additional prohibited treatment|25|||
48983767|NCT01766401|157772336|FG000|Overall Study|Adverse Event|7|||
48983768|NCT01766401|157772337|FG001|Overall Study|Adverse Event|22|||
48983769|NCT01766401|157772336|FG000|Overall Study|Lack of Efficacy|1|||
48983770|NCT01766401|157772337|FG001|Overall Study|Lack of Efficacy|2|||
48983771|NCT01766401|157772336|FG000|Overall Study|Protocol Violation|3|||
48983772|NCT01766401|157772337|FG001|Overall Study|Protocol Violation|8|||
48983773|NCT01766401|157772336|FG000|Overall Study|Withdrawal by Subject|15|||
48983774|NCT01766401|157772337|FG001|Overall Study|Withdrawal by Subject|12|||
48983775|NCT01766401|157772336|FG000|Overall Study|Lost to Follow-up|10|||
48983776|NCT01766401|157772337|FG001|Overall Study|Lost to Follow-up|11|||
48983777|NCT01766401|157772336|FG000|Overall Study|Pregnancy|1|||
48983778|NCT01766401|157772337|FG001|Overall Study|Pregnancy|1|||
48983779|NCT04430036|157772343|FG000|Safety Run in Phase|Progression of disease|2|||
48983780|NCT01526928|157772344|FG000|Overall Study|Progressive Disease|35|||
48983781|NCT01526928|157772345|FG001|Overall Study|Progressive Disease|17|||
48983782|NCT01526928|157772346|FG002|Overall Study|Progressive Disease|150|||
48983783|NCT01526928|157772347|FG003|Overall Study|Progressive Disease|182|||
48983784|NCT01526928|157772348|FG004|Overall Study|Progressive Disease|76|||
48983785|NCT01526928|157772349|FG005|Overall Study|Progressive Disease|4|||
48983786|NCT01526928|157772344|FG000|Overall Study|Adverse Event|2|||
48983787|NCT01526928|157772345|FG001|Overall Study|Adverse Event|1|||
48983788|NCT01526928|157772346|FG002|Overall Study|Adverse Event|29|||
48983789|NCT01526928|157772347|FG003|Overall Study|Adverse Event|40|||
48983790|NCT01526928|157772348|FG004|Overall Study|Adverse Event|13|||
48983791|NCT01526928|157772349|FG005|Overall Study|Adverse Event|2|||
48885916|NCT01305408|157417188|FG001|Overall Study|Lost to Follow-up|3|||
48885917|NCT01305408|157417187|FG000|Overall Study|Noncompliance with study medication|0|||
48983792|NCT01526928|157772344|FG000|Overall Study|Death|0|||
48983793|NCT01526928|157772345|FG001|Overall Study|Death|0|||
48983794|NCT01526928|157772346|FG002|Overall Study|Death|3|||
48983795|NCT01526928|157772347|FG003|Overall Study|Death|0|||
48983796|NCT01526928|157772348|FG004|Overall Study|Death|0|||
48983797|NCT01526928|157772349|FG005|Overall Study|Death|0|||
48885918|NCT01305408|157417188|FG001|Overall Study|Noncompliance with study medication|1|||
48983798|NCT01526928|157772344|FG000|Overall Study|Withdrawal by Subject|1|||
48885919|NCT01305408|157417187|FG000|Overall Study|Noncompliance with study procedures|0|||
48885920|NCT01305408|157417188|FG001|Overall Study|Noncompliance with study procedures|1|||
48885921|NCT01305408|157417187|FG000|Overall Study|Other|1|||
48885922|NCT01305408|157417188|FG001|Overall Study|Other|0|||
48885923|NCT00669877|157417191|FG000|Overall Study|Disease Progression/Death|4|||
48885924|NCT03635099|157417192|FG000|Period 1|Adverse Event|1|||
48885925|NCT03635099|157417193|FG001|Period 1|Adverse Event|0|||
48885926|NCT03635099|157417194|FG002|Period 1|Adverse Event|0|||
48885927|NCT03635099|157417195|FG003|Period 1|Adverse Event|1|||
48885928|NCT03635099|157417196|FG004|Period 1|Adverse Event|0|||
48885929|NCT03635099|157417197|FG005|Period 1|Adverse Event|0|||
48885930|NCT03635099|157417198|FG006|Period 1|Adverse Event|0|||
48885931|NCT03635099|157417199|FG007|Period 1|Adverse Event|0|||
48885932|NCT03635099|157417192|FG000|Period 1|Protocol Violation|0|||
48885933|NCT03635099|157417193|FG001|Period 1|Protocol Violation|0|||
48885934|NCT03635099|157417194|FG002|Period 1|Protocol Violation|1|||
48885935|NCT03635099|157417195|FG003|Period 1|Protocol Violation|0|||
48885936|NCT03635099|157417196|FG004|Period 1|Protocol Violation|0|||
48885937|NCT03635099|157417197|FG005|Period 1|Protocol Violation|0|||
48885938|NCT03635099|157417198|FG006|Period 1|Protocol Violation|0|||
48885939|NCT03635099|157417199|FG007|Period 1|Protocol Violation|0|||
48885940|NCT03635099|157417192|FG000|Period 1|Lost to Follow-up|0|||
48885941|NCT03635099|157417193|FG001|Period 1|Lost to Follow-up|0|||
48885942|NCT03635099|157417194|FG002|Period 1|Lost to Follow-up|1|||
48885943|NCT03635099|157417195|FG003|Period 1|Lost to Follow-up|2|||
48885944|NCT03635099|157417196|FG004|Period 1|Lost to Follow-up|1|||
48885945|NCT03635099|157417197|FG005|Period 1|Lost to Follow-up|0|||
48885946|NCT03635099|157417198|FG006|Period 1|Lost to Follow-up|1|||
48885947|NCT03635099|157417199|FG007|Period 1|Lost to Follow-up|2|||
48885948|NCT03635099|157417192|FG000|Period 1|Withdrawal by Subject|3|||
48885949|NCT03635099|157417193|FG001|Period 1|Withdrawal by Subject|3|||
48885950|NCT03635099|157417194|FG002|Period 1|Withdrawal by Subject|5|||
48885951|NCT03635099|157417195|FG003|Period 1|Withdrawal by Subject|2|||
48885952|NCT03635099|157417196|FG004|Period 1|Withdrawal by Subject|2|||
48885953|NCT03635099|157417197|FG005|Period 1|Withdrawal by Subject|0|||
48885954|NCT03635099|157417198|FG006|Period 1|Withdrawal by Subject|3|||
48885955|NCT03635099|157417199|FG007|Period 1|Withdrawal by Subject|0|||
48885956|NCT03635099|157417192|FG000|Period 1|History of suicidal ideation|0|||
48885957|NCT03635099|157417193|FG001|Period 1|History of suicidal ideation|0|||
49035232|NCT01796171|157965479|FG014|Follow-up Period|Progressive disease|0|||
49035233|NCT01796171|157965465|FG000|Follow-up Period|Physician Decision|0|||
49035234|NCT01796171|157965466|FG001|Follow-up Period|Physician Decision|2|||
49035235|NCT01796171|157965467|FG002|Follow-up Period|Physician Decision|0|||
49035236|NCT01796171|157965468|FG003|Follow-up Period|Physician Decision|0|||
49035237|NCT01796171|157965469|FG004|Follow-up Period|Physician Decision|0|||
49035238|NCT01796171|157965470|FG005|Follow-up Period|Physician Decision|0|||
49035239|NCT01796171|157965471|FG006|Follow-up Period|Physician Decision|0|||
49035240|NCT01796171|157965472|FG007|Follow-up Period|Physician Decision|0|||
49035241|NCT01796171|157965473|FG008|Follow-up Period|Physician Decision|0|||
48885958|NCT03635099|157417194|FG002|Period 1|History of suicidal ideation|1|||
48885959|NCT03635099|157417195|FG003|Period 1|History of suicidal ideation|0|||
48885960|NCT03635099|157417196|FG004|Period 1|History of suicidal ideation|0|||
48885961|NCT03635099|157417197|FG005|Period 1|History of suicidal ideation|0|||
48885962|NCT03635099|157417198|FG006|Period 1|History of suicidal ideation|0|||
48885963|NCT03635099|157417199|FG007|Period 1|History of suicidal ideation|0|||
48885964|NCT03635099|157417192|FG000|Period 1|pursue other treatment options|0|||
48885965|NCT03635099|157417193|FG001|Period 1|pursue other treatment options|0|||
48885966|NCT03635099|157417194|FG002|Period 1|pursue other treatment options|0|||
48885967|NCT03635099|157417195|FG003|Period 1|pursue other treatment options|0|||
48885968|NCT03635099|157417196|FG004|Period 1|pursue other treatment options|0|||
48885969|NCT03635099|157417197|FG005|Period 1|pursue other treatment options|1|||
48885970|NCT03635099|157417198|FG006|Period 1|pursue other treatment options|0|||
48885971|NCT03635099|157417199|FG007|Period 1|pursue other treatment options|0|||
48885972|NCT03635099|157417192|FG000|Not Eligible for Period 2|Pregnancy|0|||
48885973|NCT03635099|157417193|FG001|Not Eligible for Period 2|Pregnancy|0|||
48885974|NCT03635099|157417194|FG002|Not Eligible for Period 2|Pregnancy|0|||
48885975|NCT03635099|157417195|FG003|Not Eligible for Period 2|Pregnancy|1|||
48885976|NCT03635099|157417196|FG004|Not Eligible for Period 2|Pregnancy|0|||
48885977|NCT03635099|157417197|FG005|Not Eligible for Period 2|Pregnancy|0|||
48885978|NCT03635099|157417198|FG006|Not Eligible for Period 2|Pregnancy|0|||
48885979|NCT03635099|157417199|FG007|Not Eligible for Period 2|Pregnancy|0|||
48885980|NCT03635099|157417192|FG000|Not Eligible for Period 2|Withdrawal by Subject|1|||
48885981|NCT03635099|157417193|FG001|Not Eligible for Period 2|Withdrawal by Subject|0|||
48885982|NCT03635099|157417194|FG002|Not Eligible for Period 2|Withdrawal by Subject|0|||
48885983|NCT03635099|157417195|FG003|Not Eligible for Period 2|Withdrawal by Subject|0|||
48885984|NCT03635099|157417196|FG004|Not Eligible for Period 2|Withdrawal by Subject|0|||
49035242|NCT01796171|157965474|FG009|Follow-up Period|Physician Decision|0|||
49035243|NCT01796171|157965475|FG010|Follow-up Period|Physician Decision|5|||
48885985|NCT03635099|157417197|FG005|Not Eligible for Period 2|Withdrawal by Subject|0|||
48885986|NCT03635099|157417198|FG006|Not Eligible for Period 2|Withdrawal by Subject|0|||
48885987|NCT03635099|157417199|FG007|Not Eligible for Period 2|Withdrawal by Subject|0|||
48885988|NCT03635099|157417192|FG000|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
48885989|NCT03635099|157417193|FG001|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
48885990|NCT03635099|157417194|FG002|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
48885991|NCT03635099|157417195|FG003|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
48885992|NCT03635099|157417196|FG004|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
48885993|NCT03635099|157417197|FG005|Not Eligible for Period 2|Part II subjects did not have a period 2.|9|||
48885994|NCT03635099|157417198|FG006|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
48885995|NCT03635099|157417199|FG007|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
48885996|NCT03635099|157417192|FG000|Eligible for Period 2|Switch to higher dose at end of period 1|15|||
48885997|NCT03635099|157417193|FG001|Eligible for Period 2|Switch to higher dose at end of period 1|35|||
48885998|NCT03635099|157417194|FG002|Eligible for Period 2|Switch to higher dose at end of period 1|21|||
48885999|NCT03635099|157417195|FG003|Eligible for Period 2|Switch to higher dose at end of period 1|25|||
48886000|NCT03635099|157417196|FG004|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
48886001|NCT03635099|157417197|FG005|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
48886002|NCT03635099|157417198|FG006|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
48886003|NCT03635099|157417199|FG007|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
48886004|NCT03635099|157417192|FG000|Period 2|Adverse Event|0|||
48886005|NCT03635099|157417193|FG001|Period 2|Adverse Event|0|||
48886006|NCT03635099|157417194|FG002|Period 2|Adverse Event|1|||
48886007|NCT03635099|157417195|FG003|Period 2|Adverse Event|0|||
48886008|NCT03635099|157417196|FG004|Period 2|Adverse Event|1|||
48886009|NCT03635099|157417197|FG005|Period 2|Adverse Event|0|||
48886010|NCT03635099|157417198|FG006|Period 2|Adverse Event|0|||
48886011|NCT03635099|157417199|FG007|Period 2|Adverse Event|0|||
48886012|NCT03635099|157417192|FG000|Period 2|Lost to Follow-up|0|||
48886013|NCT03635099|157417193|FG001|Period 2|Lost to Follow-up|0|||
48886014|NCT03635099|157417194|FG002|Period 2|Lost to Follow-up|1|||
48886015|NCT03635099|157417195|FG003|Period 2|Lost to Follow-up|0|||
48886016|NCT03635099|157417196|FG004|Period 2|Lost to Follow-up|4|||
48886017|NCT03635099|157417197|FG005|Period 2|Lost to Follow-up|0|||
48886018|NCT03635099|157417198|FG006|Period 2|Lost to Follow-up|0|||
48886019|NCT03635099|157417199|FG007|Period 2|Lost to Follow-up|0|||
48886020|NCT03635099|157417192|FG000|Period 2|Withdrawal by Subject|0|||
48886021|NCT03635099|157417193|FG001|Period 2|Withdrawal by Subject|0|||
48886022|NCT03635099|157417194|FG002|Period 2|Withdrawal by Subject|7|||
48886023|NCT03635099|157417195|FG003|Period 2|Withdrawal by Subject|4|||
48886024|NCT03635099|157417196|FG004|Period 2|Withdrawal by Subject|7|||
48886025|NCT03635099|157417197|FG005|Period 2|Withdrawal by Subject|0|||
48886026|NCT03635099|157417198|FG006|Period 2|Withdrawal by Subject|0|||
48886027|NCT03635099|157417199|FG007|Period 2|Withdrawal by Subject|0|||
48886028|NCT01068665|157417200|FG000|Overall Study|Adverse Event|5|||
48886029|NCT01068665|157417201|FG001|Overall Study|Adverse Event|4|||
48886030|NCT01068665|157417200|FG000|Overall Study|Lack of Efficacy|0|||
48886031|NCT01068665|157417201|FG001|Overall Study|Lack of Efficacy|2|||
48886032|NCT01068665|157417200|FG000|Overall Study|Protocol Violation|5|||
48886033|NCT01068665|157417201|FG001|Overall Study|Protocol Violation|2|||
48886034|NCT01068665|157417200|FG000|Overall Study|Withdrawal Criteria|3|||
48886035|NCT01068665|157417201|FG001|Overall Study|Withdrawal Criteria|9|||
48886036|NCT01068665|157417200|FG000|Overall Study|Other|17|||
48886037|NCT01068665|157417201|FG001|Overall Study|Other|12|||
48886038|NCT01162863|157417209|FG000|Overall Study|Lack of Efficacy|1|||
48886039|NCT01162863|157417210|FG001|Overall Study|Lack of Efficacy|0|||
48886040|NCT01162863|157417211|FG002|Overall Study|Lack of Efficacy|0|||
48886041|NCT01162863|157417209|FG000|Overall Study|Adverse Event|0|||
48886042|NCT01162863|157417210|FG001|Overall Study|Adverse Event|1|||
48886043|NCT01162863|157417211|FG002|Overall Study|Adverse Event|0|||
48886044|NCT04230122|157417213|FG000|Overall Study|Lost to Follow-up|1|||
48886045|NCT04230122|157417214|FG001|Overall Study|Lost to Follow-up|0|||
48886046|NCT01696955|157417215|FG000|Main Study|Protocol Violation|1|||
48886047|NCT01696955|157417216|FG001|Main Study|Protocol Violation|0|||
48886048|NCT01696955|157417215|FG000|Main Study|Withdrawal by Subject|1|||
48886049|NCT01696955|157417216|FG001|Main Study|Withdrawal by Subject|1|||
48886050|NCT03752970|157417217|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
48886051|NCT03752970|157417218|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|1|||
48886052|NCT03752970|157417219|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
48886053|NCT03752970|157417217|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
48886054|NCT03752970|157417218|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
48886055|NCT03752970|157417219|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|1|||
48886056|NCT03752970|157417217|FG000|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
48886057|NCT03752970|157417218|FG001|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
48886058|NCT03752970|157417219|FG002|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|1|||
48886059|NCT03752970|157417217|FG000|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
48886060|NCT03752970|157417218|FG001|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|4|||
48886061|NCT03752970|157417219|FG002|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
48886062|NCT03752970|157417217|FG000|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
48886063|NCT03752970|157417218|FG001|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
48886064|NCT03752970|157417219|FG002|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|1|||
48886065|NCT04531904|157417227|FG000|Overall Study|Lost to Follow-up|1|||
48886066|NCT04531904|157417227|FG000|Overall Study|Death|14|||
48886067|NCT02628028|157417228|FG000|Dosing Period|Withdrawal by Subject|0|||
48886068|NCT02628028|157417229|FG001|Dosing Period|Withdrawal by Subject|0|||
48886069|NCT02628028|157417230|FG002|Dosing Period|Withdrawal by Subject|1|||
48886070|NCT02628028|157417231|FG003|Dosing Period|Withdrawal by Subject|0|||
48886071|NCT02628028|157417232|FG004|Dosing Period|Withdrawal by Subject|2|||
48886072|NCT02628028|157417233|FG005|Dosing Period|Withdrawal by Subject|4|||
48886073|NCT02628028|157417234|FG006|Dosing Period|Withdrawal by Subject|1|||
48886074|NCT02628028|157417235|FG007|Dosing Period|Withdrawal by Subject|1|||
48886075|NCT02628028|157417228|FG000|Dosing Period|Adverse Event|0|||
48886076|NCT02628028|157417229|FG001|Dosing Period|Adverse Event|0|||
48886077|NCT02628028|157417230|FG002|Dosing Period|Adverse Event|0|||
48886078|NCT02628028|157417231|FG003|Dosing Period|Adverse Event|0|||
48886079|NCT02628028|157417232|FG004|Dosing Period|Adverse Event|2|||
48886080|NCT02628028|157417233|FG005|Dosing Period|Adverse Event|1|||
48886081|NCT02628028|157417234|FG006|Dosing Period|Adverse Event|3|||
48886082|NCT02628028|157417235|FG007|Dosing Period|Adverse Event|2|||
48886083|NCT02628028|157417228|FG000|Dosing Period|Death|0|||
48886084|NCT02628028|157417229|FG001|Dosing Period|Death|0|||
48886085|NCT02628028|157417230|FG002|Dosing Period|Death|0|||
48886086|NCT02628028|157417231|FG003|Dosing Period|Death|0|||
48886087|NCT02628028|157417232|FG004|Dosing Period|Death|0|||
48886088|NCT02628028|157417233|FG005|Dosing Period|Death|0|||
48886089|NCT02628028|157417234|FG006|Dosing Period|Death|0|||
48886090|NCT02628028|157417235|FG007|Dosing Period|Death|1|||
48886091|NCT02628028|157417228|FG000|Dosing Period|Lack of Efficacy|0|||
48886092|NCT02628028|157417229|FG001|Dosing Period|Lack of Efficacy|0|||
48886093|NCT02628028|157417230|FG002|Dosing Period|Lack of Efficacy|0|||
48886094|NCT02628028|157417231|FG003|Dosing Period|Lack of Efficacy|0|||
48886095|NCT02628028|157417232|FG004|Dosing Period|Lack of Efficacy|3|||
48886096|NCT02628028|157417233|FG005|Dosing Period|Lack of Efficacy|0|||
48886097|NCT02628028|157417234|FG006|Dosing Period|Lack of Efficacy|1|||
48886098|NCT02628028|157417235|FG007|Dosing Period|Lack of Efficacy|0|||
48886099|NCT02628028|157417228|FG000|Dosing Period|Study Terminated by Sponsor|0|||
48886100|NCT02628028|157417229|FG001|Dosing Period|Study Terminated by Sponsor|0|||
48886101|NCT02628028|157417230|FG002|Dosing Period|Study Terminated by Sponsor|0|||
48886102|NCT02628028|157417231|FG003|Dosing Period|Study Terminated by Sponsor|0|||
48886103|NCT02628028|157417232|FG004|Dosing Period|Study Terminated by Sponsor|7|||
48886104|NCT02628028|157417233|FG005|Dosing Period|Study Terminated by Sponsor|6|||
48886105|NCT02628028|157417234|FG006|Dosing Period|Study Terminated by Sponsor|7|||
48886106|NCT02628028|157417235|FG007|Dosing Period|Study Terminated by Sponsor|7|||
48886107|NCT02628028|157417228|FG000|Dosing Period|Physician Decision|0|||
48886108|NCT02628028|157417229|FG001|Dosing Period|Physician Decision|0|||
48886109|NCT02628028|157417230|FG002|Dosing Period|Physician Decision|0|||
48886110|NCT02628028|157417231|FG003|Dosing Period|Physician Decision|0|||
48886111|NCT02628028|157417232|FG004|Dosing Period|Physician Decision|0|||
48886112|NCT02628028|157417233|FG005|Dosing Period|Physician Decision|1|||
48886113|NCT02628028|157417234|FG006|Dosing Period|Physician Decision|0|||
48886114|NCT02628028|157417235|FG007|Dosing Period|Physician Decision|0|||
48886115|NCT02628028|157417228|FG000|Dosing Period|Site Terminated by Sponsor|0|||
48886116|NCT02628028|157417229|FG001|Dosing Period|Site Terminated by Sponsor|0|||
48886117|NCT02628028|157417230|FG002|Dosing Period|Site Terminated by Sponsor|0|||
48886118|NCT02628028|157417231|FG003|Dosing Period|Site Terminated by Sponsor|0|||
48886119|NCT02628028|157417232|FG004|Dosing Period|Site Terminated by Sponsor|0|||
48886120|NCT02628028|157417233|FG005|Dosing Period|Site Terminated by Sponsor|1|||
48886121|NCT02628028|157417234|FG006|Dosing Period|Site Terminated by Sponsor|1|||
48886122|NCT02628028|157417235|FG007|Dosing Period|Site Terminated by Sponsor|0|||
48886123|NCT02628028|157417228|FG000|Dosing Period|Lost to Follow-up|0|||
48886124|NCT02628028|157417229|FG001|Dosing Period|Lost to Follow-up|0|||
48886125|NCT02628028|157417230|FG002|Dosing Period|Lost to Follow-up|0|||
48886126|NCT02628028|157417231|FG003|Dosing Period|Lost to Follow-up|0|||
48886127|NCT02628028|157417232|FG004|Dosing Period|Lost to Follow-up|0|||
48886128|NCT02628028|157417233|FG005|Dosing Period|Lost to Follow-up|0|||
48886129|NCT02628028|157417234|FG006|Dosing Period|Lost to Follow-up|1|||
48886130|NCT02628028|157417235|FG007|Dosing Period|Lost to Follow-up|0|||
48886131|NCT02628028|157417228|FG000|Dosing Period|Other|0|||
48886132|NCT02628028|157417229|FG001|Dosing Period|Other|0|||
48886133|NCT02628028|157417230|FG002|Dosing Period|Other|0|||
48886134|NCT02628028|157417231|FG003|Dosing Period|Other|0|||
48886135|NCT02628028|157417232|FG004|Dosing Period|Other|2|||
48886136|NCT02628028|157417233|FG005|Dosing Period|Other|1|||
48886137|NCT02628028|157417234|FG006|Dosing Period|Other|2|||
48886138|NCT02628028|157417235|FG007|Dosing Period|Other|4|||
48886139|NCT02628028|157417228|FG000|Long-term Extension (LTE) Period|Adverse Event|0|||
48886140|NCT02628028|157417229|FG001|Long-term Extension (LTE) Period|Adverse Event|0|||
48886141|NCT02628028|157417230|FG002|Long-term Extension (LTE) Period|Adverse Event|0|||
48886142|NCT02628028|157417231|FG003|Long-term Extension (LTE) Period|Adverse Event|0|||
48886143|NCT02628028|157417232|FG004|Long-term Extension (LTE) Period|Adverse Event|0|||
48886144|NCT02628028|157417233|FG005|Long-term Extension (LTE) Period|Adverse Event|1|||
48886145|NCT02628028|157417234|FG006|Long-term Extension (LTE) Period|Adverse Event|0|||
48886146|NCT02628028|157417235|FG007|Long-term Extension (LTE) Period|Adverse Event|3|||
48886147|NCT02628028|157417228|FG000|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
48886148|NCT02628028|157417229|FG001|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
48886149|NCT02628028|157417230|FG002|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
48886150|NCT02628028|157417231|FG003|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
48886151|NCT02628028|157417232|FG004|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
48886152|NCT02628028|157417233|FG005|Long-term Extension (LTE) Period|Lack of Efficacy|2|||
48886153|NCT02628028|157417234|FG006|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
48886154|NCT02628028|157417235|FG007|Long-term Extension (LTE) Period|Lack of Efficacy|1|||
48886155|NCT02628028|157417228|FG000|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
48886156|NCT02628028|157417229|FG001|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
48886157|NCT02628028|157417230|FG002|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
48886158|NCT02628028|157417231|FG003|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
48886159|NCT02628028|157417232|FG004|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
48886160|NCT02628028|157417233|FG005|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52|||
48886161|NCT02628028|157417234|FG006|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
48886162|NCT02628028|157417235|FG007|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
48886163|NCT02628028|157417228|FG000|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
48886164|NCT02628028|157417229|FG001|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
48886165|NCT02628028|157417230|FG002|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
48886166|NCT02628028|157417231|FG003|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
48886167|NCT02628028|157417232|FG004|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
48886168|NCT02628028|157417233|FG005|Long-term Extension (LTE) Period|Withdrawal by Subject|2|||
48886169|NCT02628028|157417234|FG006|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
48886170|NCT02628028|157417235|FG007|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
48886171|NCT02628028|157417228|FG000|Long-term Extension (LTE) Period|Other|0|||
48886172|NCT02628028|157417229|FG001|Long-term Extension (LTE) Period|Other|0|||
48886173|NCT02628028|157417230|FG002|Long-term Extension (LTE) Period|Other|0|||
48886174|NCT02628028|157417231|FG003|Long-term Extension (LTE) Period|Other|0|||
48886175|NCT02628028|157417232|FG004|Long-term Extension (LTE) Period|Other|0|||
48886176|NCT02628028|157417233|FG005|Long-term Extension (LTE) Period|Other|3|||
48886177|NCT02628028|157417234|FG006|Long-term Extension (LTE) Period|Other|4|||
48886178|NCT02628028|157417235|FG007|Long-term Extension (LTE) Period|Other|3|||
48886179|NCT03835754|157417238|FG000|Overall Study|Death|4|||
48886180|NCT02737826|157419661|FG000|Phase II - Randomization + Taper|Withdrawal by Subject|0|||
48886181|NCT02737826|157419662|FG001|Phase II - Randomization + Taper|Withdrawal by Subject|12|||
48886182|NCT02737826|157419663|FG002|Phase II - Randomization + Taper|Withdrawal by Subject|14|||
48886183|NCT02666664|157419664|FG000|Overall Study|Physician Decision|0|||
48886184|NCT02666664|157419665|FG001|Overall Study|Physician Decision|1|||
48886185|NCT02666664|157419664|FG000|Overall Study|Protocol Violation|0|||
48886186|NCT02666664|157419665|FG001|Overall Study|Protocol Violation|2|||
48886187|NCT02666664|157419664|FG000|Overall Study|Other|0|||
48886188|NCT02666664|157419665|FG001|Overall Study|Other|1|||
48886189|NCT02666664|157419664|FG000|Overall Study|Adverse Event|12|||
48886190|NCT02666664|157419665|FG001|Overall Study|Adverse Event|37|||
48886191|NCT02666664|157419664|FG000|Overall Study|Withdrawal by participant|23|||
48886192|NCT02666664|157419665|FG001|Overall Study|Withdrawal by participant|40|||
48886193|NCT02666664|157419664|FG000|Overall Study|Sponsor decision|0|||
48886194|NCT02666664|157419665|FG001|Overall Study|Sponsor decision|1|||
48886195|NCT02666664|157419664|FG000|Overall Study|Lost to Follow-up|1|||
48886196|NCT02666664|157419665|FG001|Overall Study|Lost to Follow-up|2|||
48886197|NCT02550938|157419666|FG000|Overall Study|Lost to Follow-up|8|||
48886198|NCT02550938|157419667|FG001|Overall Study|Lost to Follow-up|7|||
48886199|NCT02550938|157419668|FG002|Overall Study|Lost to Follow-up|12|||
48886200|NCT02550938|157419669|FG003|Overall Study|Lost to Follow-up|11|||
48886201|NCT01182441|157419670|FG000|Overall Study|Patient Still in Follow-up|152|||
48886202|NCT01182441|157419671|FG001|Overall Study|Patient Still in Follow-up|72|||
48886203|NCT01182441|157419670|FG000|Overall Study|Death|37|||
48886204|NCT01182441|157419671|FG001|Overall Study|Death|25|||
48886205|NCT01182441|157419670|FG000|Overall Study|Implant Attempt Unsuccessful|13|||
48886206|NCT01182441|157419671|FG001|Overall Study|Implant Attempt Unsuccessful|0|||
48886207|NCT01182441|157419670|FG000|Overall Study|Lost to Follow-up|5|||
48886208|NCT01182441|157419671|FG001|Overall Study|Lost to Follow-up|8|||
48886209|NCT01182441|157419670|FG000|Overall Study|Withdrawal by Subject|6|||
48886210|NCT01182441|157419671|FG001|Overall Study|Withdrawal by Subject|13|||
48886211|NCT01182441|157419670|FG000|Overall Study|Implant Not Attempted|4|||
48886212|NCT01182441|157419671|FG001|Overall Study|Implant Not Attempted|0|||
48886213|NCT01182441|157419670|FG000|Overall Study|Adverse Event|2|||
48886214|NCT01182441|157419671|FG001|Overall Study|Adverse Event|0|||
48886215|NCT01182441|157419670|FG000|Overall Study|Physician Decision|1|||
48886216|NCT01182441|157419671|FG001|Overall Study|Physician Decision|1|||
48886217|NCT02815579|157419672|FG000|Overall Study|Non-payment of loan down-payment|16|||
48886218|NCT02815579|157419673|FG001|Overall Study|Non-payment of loan down-payment|0|||
48886219|NCT02815579|157419672|FG000|Overall Study|Withdrawal by Subject|7|||
48886220|NCT02815579|157419673|FG001|Overall Study|Withdrawal by Subject|1|||
48886221|NCT02815579|157419672|FG000|Overall Study|Moved out of study area before receiving any study activities|9|||
48886222|NCT02815579|157419673|FG001|Overall Study|Moved out of study area before receiving any study activities|11|||
48886223|NCT02815579|157419672|FG000|Overall Study|Lost to Follow-up|7|||
48886224|NCT02815579|157419673|FG001|Overall Study|Lost to Follow-up|4|||
48886225|NCT02815579|157419672|FG000|Overall Study|Hospitalized before receipt of any study activities|1|||
48886226|NCT02815579|157419673|FG001|Overall Study|Hospitalized before receipt of any study activities|0|||
48886227|NCT02815579|157419672|FG000|Overall Study|Uncomfortable with MEMS adherence monitoring cap|1|||
48886228|NCT02815579|157419673|FG001|Overall Study|Uncomfortable with MEMS adherence monitoring cap|0|||
48886229|NCT02815579|157419672|FG000|Overall Study|Death|5|||
48886230|NCT02815579|157419673|FG001|Overall Study|Death|4|||
48886231|NCT02815579|157419672|FG000|Overall Study|Imprisoned|0|||
48886232|NCT02815579|157419673|FG001|Overall Study|Imprisoned|2|||
48886233|NCT02815579|157419672|FG000|Overall Study|Did not meet enrollment criteria|0|||
48886234|NCT02815579|157419673|FG001|Overall Study|Did not meet enrollment criteria|1|||
48886235|NCT03480932|157419674|FG000|Overall Study|Death|1|||
48886236|NCT03480932|157419675|FG001|Overall Study|Death|1|||
48886237|NCT03480932|157419676|FG002|Overall Study|Death|0|||
48886238|NCT03480932|157419674|FG000|Overall Study|Lost to Follow-up|0|||
48886239|NCT03480932|157419675|FG001|Overall Study|Lost to Follow-up|2|||
48886240|NCT03480932|157419676|FG002|Overall Study|Lost to Follow-up|3|||
48886241|NCT03480932|157419674|FG000|Overall Study|Incarcerated|2|||
48886242|NCT03480932|157419675|FG001|Overall Study|Incarcerated|2|||
48886243|NCT03480932|157419676|FG002|Overall Study|Incarcerated|2|||
48886244|NCT00667225|157419682|FG000|Overall Study|Subject had no more lesions to treat.|1|||
48886245|NCT00667225|157419683|FG001|Overall Study|Subject had no more lesions to treat.|0|||
48886246|NCT00667225|157419682|FG000|Overall Study|Lost to Follow-up|0|||
48886247|NCT00667225|157419683|FG001|Overall Study|Lost to Follow-up|1|||
48886248|NCT02248818|157419684|FG000|Screening|Protocol Violation|0|||
48886249|NCT02248818|157419685|FG001|Screening|Protocol Violation|0|||
48886250|NCT02248818|157419686|FG002|Screening|Protocol Violation|0|||
48886251|NCT02248818|157419687|FG003|Screening|Protocol Violation|0|||
48886252|NCT02248818|157419688|FG004|Screening|Protocol Violation|0|||
48886253|NCT02248818|157419689|FG005|Screening|Protocol Violation|0|||
48886254|NCT02248818|157419690|FG006|Screening|Protocol Violation|0|||
48886255|NCT02248818|157419691|FG007|Screening|Protocol Violation|0|||
48886256|NCT02248818|157419692|FG008|Screening|Protocol Violation|7|||
48886257|NCT02248818|157419684|FG000|Screening|Study fully enrolled|0|||
48886258|NCT02248818|157419685|FG001|Screening|Study fully enrolled|0|||
48886259|NCT02248818|157419686|FG002|Screening|Study fully enrolled|0|||
48886260|NCT02248818|157419687|FG003|Screening|Study fully enrolled|0|||
48886261|NCT02248818|157419688|FG004|Screening|Study fully enrolled|0|||
48886262|NCT02248818|157419689|FG005|Screening|Study fully enrolled|0|||
48886263|NCT02248818|157419690|FG006|Screening|Study fully enrolled|0|||
48886264|NCT02248818|157419691|FG007|Screening|Study fully enrolled|0|||
48886265|NCT02248818|157419692|FG008|Screening|Study fully enrolled|14|||
48886266|NCT02248818|157419684|FG000|Screening|Physician Decision|0|||
48886267|NCT02248818|157419685|FG001|Screening|Physician Decision|0|||
48886268|NCT02248818|157419686|FG002|Screening|Physician Decision|0|||
48886269|NCT02248818|157419687|FG003|Screening|Physician Decision|0|||
48886270|NCT02248818|157419688|FG004|Screening|Physician Decision|0|||
48886271|NCT02248818|157419689|FG005|Screening|Physician Decision|0|||
48886272|NCT02248818|157419690|FG006|Screening|Physician Decision|0|||
48886273|NCT02248818|157419691|FG007|Screening|Physician Decision|0|||
48886274|NCT02248818|157419692|FG008|Screening|Physician Decision|73|||
48886275|NCT02248818|157419684|FG000|Screening|Withdrawal by Subject|0|||
48886276|NCT02248818|157419685|FG001|Screening|Withdrawal by Subject|0|||
48886277|NCT02248818|157419686|FG002|Screening|Withdrawal by Subject|0|||
48886278|NCT02248818|157419687|FG003|Screening|Withdrawal by Subject|0|||
48886279|NCT02248818|157419688|FG004|Screening|Withdrawal by Subject|0|||
48886280|NCT02248818|157419689|FG005|Screening|Withdrawal by Subject|0|||
48886281|NCT02248818|157419690|FG006|Screening|Withdrawal by Subject|0|||
48886282|NCT02248818|157419691|FG007|Screening|Withdrawal by Subject|0|||
48886283|NCT02248818|157419692|FG008|Screening|Withdrawal by Subject|6|||
48886284|NCT02248818|157419684|FG000|Screening|Lost to Follow-up|0|||
48886285|NCT02248818|157419685|FG001|Screening|Lost to Follow-up|0|||
48886286|NCT02248818|157419686|FG002|Screening|Lost to Follow-up|0|||
48886287|NCT02248818|157419687|FG003|Screening|Lost to Follow-up|0|||
48886288|NCT02248818|157419688|FG004|Screening|Lost to Follow-up|0|||
48886289|NCT02248818|157419689|FG005|Screening|Lost to Follow-up|0|||
48886290|NCT02248818|157419690|FG006|Screening|Lost to Follow-up|0|||
48886291|NCT02248818|157419691|FG007|Screening|Lost to Follow-up|0|||
48886292|NCT02248818|157419692|FG008|Screening|Lost to Follow-up|7|||
48886293|NCT02248818|157419684|FG000|Randomised Study|Administrative - randomization error|0|||
48886294|NCT02248818|157419685|FG001|Randomised Study|Administrative - randomization error|0|||
48886295|NCT02248818|157419686|FG002|Randomised Study|Administrative - randomization error|0|||
48886296|NCT02248818|157419687|FG003|Randomised Study|Administrative - randomization error|0|||
48886297|NCT02248818|157419688|FG004|Randomised Study|Administrative - randomization error|0|||
48886298|NCT02248818|157419689|FG005|Randomised Study|Administrative - randomization error|8|||
48886299|NCT02248818|157419690|FG006|Randomised Study|Administrative - randomization error|0|||
48886300|NCT02248818|157419691|FG007|Randomised Study|Administrative - randomization error|0|||
48886301|NCT02248818|157419692|FG008|Randomised Study|Administrative - randomization error|0|||
48886302|NCT05262517|157419693|FG000|Overall Study|Randomized but not treated|5|||
48886303|NCT05262517|157419694|FG001|Overall Study|Randomized but not treated|11|||
48886304|NCT01896557|157419699|FG000|Clopidogrel Alone|Adverse Event|1|||
48886305|NCT01896557|157419700|FG001|Clopidogrel Alone|Adverse Event|0|||
48886306|NCT01896557|157419699|FG000|Clopidogrel + GI Protector|low adherence|1|||
48886307|NCT01896557|157419700|FG001|Clopidogrel + GI Protector|low adherence|1|||
48886308|NCT01896557|157419699|FG000|Clopidogrel + GI Protector|Reading error|1|||
48886309|NCT01896557|157419700|FG001|Clopidogrel + GI Protector|Reading error|3|||
48886310|NCT03301155|157419701|FG000|Overall Study|Сompliance with exclusion criteria|8|||
48886311|NCT03301155|157419702|FG001|Overall Study|Сompliance with exclusion criteria|7|||
48886312|NCT04939701|157419708|FG000|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
48886313|NCT04939701|157419709|FG001|Phase 1: Dose Escalation (168 Days)|Progressive disease|5|||
48886314|NCT04939701|157419710|FG002|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
48886315|NCT04939701|157419708|FG000|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
48886316|NCT04939701|157419709|FG001|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|1|||
48886317|NCT04939701|157419710|FG002|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
48886318|NCT04939701|157419708|FG000|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|2|||
48886319|NCT04939701|157419709|FG001|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
48886320|NCT04939701|157419710|FG002|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
48886321|NCT04939701|157419708|FG000|Phase 1: Dose Escalation (168 Days)|Death|1|||
48886322|NCT04939701|157419709|FG001|Phase 1: Dose Escalation (168 Days)|Death|0|||
48886323|NCT04939701|157419710|FG002|Phase 1: Dose Escalation (168 Days)|Death|0|||
48886324|NCT04939701|157419708|FG000|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
48886325|NCT04939701|157419709|FG001|Phase 1: Dose Escalation (168 Days)|Adverse Event|1|||
48886326|NCT04939701|157419710|FG002|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
48886327|NCT04939701|157419708|FG000|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
48886328|NCT04939701|157419709|FG001|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
48886329|NCT04939701|157419710|FG002|Phase 2: Dose Expansion (168 Days)|Progressive disease|3|||
48886330|NCT04939701|157419708|FG000|Phase 2: Dose Expansion (168 Days)|Death|0|||
48886331|NCT04939701|157419709|FG001|Phase 2: Dose Expansion (168 Days)|Death|0|||
48886332|NCT04939701|157419710|FG002|Phase 2: Dose Expansion (168 Days)|Death|1|||
48886333|NCT01519089|157419711|FG000|Overall Study|Adverse Event|4|||
48886334|NCT01519089|157419712|FG001|Overall Study|Adverse Event|4|||
48886335|NCT01519089|157419711|FG000|Overall Study|Lack of Efficacy|0|||
48983799|NCT01526928|157772345|FG001|Overall Study|Withdrawal by Subject|0|||
48983800|NCT01526928|157772346|FG002|Overall Study|Withdrawal by Subject|13|||
48983801|NCT01526928|157772347|FG003|Overall Study|Withdrawal by Subject|11|||
48983802|NCT01526928|157772348|FG004|Overall Study|Withdrawal by Subject|3|||
48983803|NCT01526928|157772349|FG005|Overall Study|Withdrawal by Subject|0|||
48983804|NCT01526928|157772344|FG000|Overall Study|Physician Decision|0|||
48983805|NCT01526928|157772345|FG001|Overall Study|Physician Decision|0|||
48983806|NCT01526928|157772346|FG002|Overall Study|Physician Decision|2|||
48983807|NCT01526928|157772347|FG003|Overall Study|Physician Decision|5|||
48983808|NCT01526928|157772348|FG004|Overall Study|Physician Decision|0|||
48983809|NCT01526928|157772349|FG005|Overall Study|Physician Decision|0|||
48983810|NCT01526928|157772344|FG000|Overall Study|Other Reason|0|||
48983811|NCT01526928|157772345|FG001|Overall Study|Other Reason|1|||
48983812|NCT01526928|157772346|FG002|Overall Study|Other Reason|11|||
48983813|NCT01526928|157772347|FG003|Overall Study|Other Reason|4|||
48983814|NCT01526928|157772348|FG004|Overall Study|Other Reason|1|||
48983815|NCT01526928|157772349|FG005|Overall Study|Other Reason|0|||
48983816|NCT01526928|157772344|FG000|Overall Study|Lost to Follow-up|0|||
49035244|NCT01796171|157965476|FG011|Follow-up Period|Physician Decision|0|||
48886336|NCT01519089|157419712|FG001|Overall Study|Lack of Efficacy|2|||
48886337|NCT01519089|157419711|FG000|Overall Study|Lost to Follow-up|1|||
48886338|NCT01519089|157419712|FG001|Overall Study|Lost to Follow-up|0|||
48983817|NCT01526928|157772345|FG001|Overall Study|Lost to Follow-up|0|||
48983818|NCT01526928|157772346|FG002|Overall Study|Lost to Follow-up|0|||
48983819|NCT01526928|157772347|FG003|Overall Study|Lost to Follow-up|1|||
48886339|NCT01519089|157419711|FG000|Overall Study|Withdrawal by Subject|0|||
48886340|NCT01519089|157419712|FG001|Overall Study|Withdrawal by Subject|2|||
48886341|NCT01519089|157419711|FG000|Overall Study|Other|2|||
48886342|NCT01519089|157419712|FG001|Overall Study|Other|6|||
48886343|NCT01519089|157419711|FG000|Overall Study|Not received study drug|0|||
48886344|NCT01519089|157419712|FG001|Overall Study|Not received study drug|1|||
48886345|NCT01607879|157419713|FG000|Overall Study|Death|1|||
48886346|NCT01607879|157419714|FG001|Overall Study|Death|0|||
48886347|NCT00384189|157419715|FG000|Overall Study|Reason Not Specified|50|||
48886348|NCT00384189|157419716|FG001|Overall Study|Reason Not Specified|57|||
48886349|NCT00384189|157419717|FG002|Overall Study|Reason Not Specified|58|||
48886350|NCT00384189|157419718|FG003|Overall Study|Reason Not Specified|40|||
48886351|NCT03926195|157419721|FG000|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|0|||
48886352|NCT03926195|157419722|FG001|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|2|||
48886353|NCT03926195|157419721|FG000|EXT Phase (Through Week 156)|Adverse Event|5|||
48886354|NCT03926195|157419722|FG001|EXT Phase (Through Week 156)|Adverse Event|1|||
48886355|NCT03926195|157419721|FG000|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|16|||
48886356|NCT03926195|157419722|FG001|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|17|||
49035245|NCT01796171|157965477|FG012|Follow-up Period|Physician Decision|0|||
49035246|NCT01796171|157965478|FG013|Follow-up Period|Physician Decision|0|||
49035247|NCT01796171|157965479|FG014|Follow-up Period|Physician Decision|0|||
49035248|NCT01796171|157965465|FG000|Follow-up Period|Withdrawal by Subject|0|||
49035249|NCT01796171|157965466|FG001|Follow-up Period|Withdrawal by Subject|1|||
49035250|NCT01796171|157965467|FG002|Follow-up Period|Withdrawal by Subject|0|||
49035251|NCT01796171|157965468|FG003|Follow-up Period|Withdrawal by Subject|0|||
48886357|NCT03926195|157419721|FG000|EXT Phase (Through Week 156)|Withdrawal by Subject|1|||
48886358|NCT03926195|157419722|FG001|EXT Phase (Through Week 156)|Withdrawal by Subject|3|||
49035252|NCT01796171|157965469|FG004|Follow-up Period|Withdrawal by Subject|0|||
49035253|NCT01796171|157965470|FG005|Follow-up Period|Withdrawal by Subject|1|||
49035254|NCT01796171|157965471|FG006|Follow-up Period|Withdrawal by Subject|0|||
49035255|NCT01796171|157965472|FG007|Follow-up Period|Withdrawal by Subject|0|||
49035256|NCT01796171|157965473|FG008|Follow-up Period|Withdrawal by Subject|0|||
49035257|NCT01796171|157965474|FG009|Follow-up Period|Withdrawal by Subject|0|||
49035258|NCT01796171|157965475|FG010|Follow-up Period|Withdrawal by Subject|3|||
49035259|NCT01796171|157965476|FG011|Follow-up Period|Withdrawal by Subject|1|||
49035260|NCT01796171|157965477|FG012|Follow-up Period|Withdrawal by Subject|0|||
49035261|NCT01796171|157965478|FG013|Follow-up Period|Withdrawal by Subject|0|||
49035262|NCT01796171|157965479|FG014|Follow-up Period|Withdrawal by Subject|0|||
48886359|NCT03926195|157419721|FG000|EXT Phase (Through Week 156)|Physician Decision|0|||
48886360|NCT03926195|157419722|FG001|EXT Phase (Through Week 156)|Physician Decision|2|||
48886361|NCT03926195|157419721|FG000|Monitoring Phase (52 Weeks)|Withdrawal by Subject|0|||
48886362|NCT03926195|157419722|FG001|Monitoring Phase (52 Weeks)|Withdrawal by Subject|1|||
48886363|NCT02088957|157419723|FG000|Overall Study|Lack of Efficacy|1|||
48886364|NCT02088957|157419724|FG001|Overall Study|Lack of Efficacy|0|||
48886365|NCT02071290|157419725|FG000|Overall Study|Death|1|||
48886366|NCT02071290|157419726|FG001|Overall Study|Death|0|||
48886367|NCT02071290|157419725|FG000|Overall Study|Withdrawal by Subject|0|||
48886368|NCT02071290|157419726|FG001|Overall Study|Withdrawal by Subject|1|||
48886369|NCT02071290|157419725|FG000|Overall Study|Protocol Violation|3|||
48886370|NCT02071290|157419726|FG001|Overall Study|Protocol Violation|5|||
48886371|NCT02071290|157419725|FG000|Overall Study|Physician Decision|0|||
48886372|NCT02071290|157419726|FG001|Overall Study|Physician Decision|1|||
48886373|NCT03338296|157419727|FG000|Overall Study|Adverse Event|0|||
48886374|NCT03338296|157419728|FG001|Overall Study|Adverse Event|1|||
48886375|NCT03338296|157419727|FG000|Overall Study|Withdrawal by Subject|14|||
48886376|NCT03338296|157419728|FG001|Overall Study|Withdrawal by Subject|13|||
48886377|NCT03338296|157419727|FG000|Overall Study|Lost to Follow-up|10|||
48886378|NCT03338296|157419728|FG001|Overall Study|Lost to Follow-up|10|||
48886379|NCT03338296|157419727|FG000|Overall Study|Study Terminated by Sponsor|77|||
48886380|NCT03338296|157419728|FG001|Overall Study|Study Terminated by Sponsor|76|||
48886381|NCT03338296|157419727|FG000|Overall Study|Other|2|||
48886382|NCT03338296|157419728|FG001|Overall Study|Other|7|||
48886383|NCT03338296|157419727|FG000|Overall Study|Missing|0|||
48886384|NCT03338296|157419728|FG001|Overall Study|Missing|1|||
49035263|NCT01796171|157965465|FG000|Follow-up Period|Death|0|||
48886385|NCT02175641|157419731|FG000|Overall Study|Death|3|||
48886386|NCT02175641|157419732|FG001|Overall Study|Death|4|||
48886387|NCT02175641|157419731|FG000|Overall Study|Lost to Follow-up|4|||
48886388|NCT02175641|157419732|FG001|Overall Study|Lost to Follow-up|4|||
48886389|NCT02175641|157419731|FG000|Overall Study|Withdrawal by Subject|7|||
48886390|NCT02175641|157419732|FG001|Overall Study|Withdrawal by Subject|4|||
48886391|NCT02175641|157419731|FG000|Overall Study|Discharged from Supportive Housing Agenc|13|||
48886392|NCT02175641|157419732|FG001|Overall Study|Discharged from Supportive Housing Agenc|15|||
48886393|NCT02175641|157419731|FG000|Overall Study|Developed Contraindicated Condition|8|||
49035264|NCT01796171|157965466|FG001|Follow-up Period|Death|0|||
49035265|NCT01796171|157965467|FG002|Follow-up Period|Death|0|||
48886394|NCT02175641|157419732|FG001|Overall Study|Developed Contraindicated Condition|0|||
48886395|NCT01725126|157419733|FG000|Overall Study|Protocol Violation|0|||
48886396|NCT01725126|157419734|FG001|Overall Study|Protocol Violation|1|||
48886397|NCT01725126|157419735|FG002|Overall Study|Protocol Violation|0|||
48886398|NCT01725126|157419736|FG003|Overall Study|Protocol Violation|0|||
48886399|NCT01725126|157419737|FG004|Overall Study|Protocol Violation|0|||
48886400|NCT01725126|157419738|FG005|Overall Study|Protocol Violation|0|||
48886401|NCT01725126|157419733|FG000|Overall Study|Withdrawal by Subject|0|||
48886402|NCT01725126|157419734|FG001|Overall Study|Withdrawal by Subject|0|||
48886403|NCT01725126|157419735|FG002|Overall Study|Withdrawal by Subject|0|||
48886404|NCT01725126|157419736|FG003|Overall Study|Withdrawal by Subject|1|||
48886405|NCT01725126|157419737|FG004|Overall Study|Withdrawal by Subject|0|||
48886406|NCT01725126|157419738|FG005|Overall Study|Withdrawal by Subject|0|||
48886407|NCT00479882|157419743|FG000|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96|||
48886408|NCT00479882|157419744|FG001|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99|||
48886409|NCT00479882|157419745|FG002|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98|||
48886410|NCT00479882|157419746|FG003|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87|||
48886411|NCT00479882|157419743|FG000|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0|||
48886412|NCT00479882|157419744|FG001|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
48886413|NCT00479882|157419745|FG002|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
48886414|NCT00479882|157419746|FG003|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
48886415|NCT00479882|157419743|FG000|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12|||
48886416|NCT00479882|157419744|FG001|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
48886417|NCT00479882|157419745|FG002|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
48886418|NCT00479882|157419746|FG003|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11|||
48886419|NCT00479882|157419743|FG000|Precrossover: Periods I/II (Weeks 1-12)|Other|4|||
48886420|NCT00479882|157419744|FG001|Precrossover: Periods I/II (Weeks 1-12)|Other|6|||
48886421|NCT00479882|157419745|FG002|Precrossover: Periods I/II (Weeks 1-12)|Other|9|||
48886422|NCT00479882|157419746|FG003|Precrossover: Periods I/II (Weeks 1-12)|Other|5|||
48886423|NCT00479882|157419743|FG000|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0|||
48886424|NCT00479882|157419744|FG001|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4|||
48886425|NCT00479882|157419745|FG002|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2|||
48886426|NCT00479882|157419746|FG003|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1|||
48886427|NCT00479882|157419743|FG000|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24|||
48886428|NCT00479882|157419744|FG001|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33|||
48886429|NCT00479882|157419745|FG002|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30|||
48886430|NCT00479882|157419746|FG003|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25|||
48886431|NCT00479882|157419743|FG000|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2|||
48886432|NCT00479882|157419744|FG001|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
48886433|NCT00479882|157419745|FG002|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5|||
48886434|NCT00479882|157419746|FG003|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
48886435|NCT00479882|157419743|FG000|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
48886436|NCT00479882|157419744|FG001|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13|||
48886437|NCT00479882|157419745|FG002|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
48886438|NCT00479882|157419746|FG003|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10|||
48886439|NCT00479882|157419743|FG000|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3|||
48886440|NCT00479882|157419744|FG001|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1|||
48886441|NCT00479882|157419745|FG002|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
48886442|NCT00479882|157419746|FG003|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
48886443|NCT00479882|157419743|FG000|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
48886444|NCT00479882|157419744|FG001|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2|||
48886445|NCT00479882|157419745|FG002|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
48886446|NCT00479882|157419746|FG003|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
48886447|NCT00479882|157419743|FG000|Crossover: Period III (Weeks 13-20)|Other|5|||
48886448|NCT00479882|157419744|FG001|Crossover: Period III (Weeks 13-20)|Other|0|||
48886449|NCT00479882|157419745|FG002|Crossover: Period III (Weeks 13-20)|Other|2|||
48886450|NCT00479882|157419746|FG003|Crossover: Period III (Weeks 13-20)|Other|2|||
48886451|NCT00479882|157419743|FG000|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
48886452|NCT00479882|157419744|FG001|Crossover: Period III (Weeks 13-20)|Participant moved|2|||
48886453|NCT00479882|157419745|FG002|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
48886454|NCT00479882|157419746|FG003|Crossover: Period III (Weeks 13-20)|Participant moved|0|||
48886455|NCT00479882|157419743|FG000|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
48886456|NCT00479882|157419744|FG001|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
48886457|NCT00479882|157419745|FG002|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1|||
48886458|NCT00479882|157419746|FG003|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
48886459|NCT00479882|157419743|FG000|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
48886460|NCT00479882|157419744|FG001|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
49035266|NCT01796171|157965468|FG003|Follow-up Period|Death|0|||
49035267|NCT01796171|157965469|FG004|Follow-up Period|Death|0|||
49035268|NCT01796171|157965470|FG005|Follow-up Period|Death|0|||
49035269|NCT01796171|157965471|FG006|Follow-up Period|Death|1|||
49035270|NCT01796171|157965472|FG007|Follow-up Period|Death|0|||
49035271|NCT01796171|157965473|FG008|Follow-up Period|Death|0|||
49035272|NCT01796171|157965474|FG009|Follow-up Period|Death|0|||
49035273|NCT01796171|157965475|FG010|Follow-up Period|Death|17|||
49035274|NCT01796171|157965476|FG011|Follow-up Period|Death|9|||
49035275|NCT01796171|157965477|FG012|Follow-up Period|Death|1|||
49035276|NCT01796171|157965478|FG013|Follow-up Period|Death|0|||
49035277|NCT01796171|157965479|FG014|Follow-up Period|Death|0|||
49035278|NCT01796171|157965465|FG000|Follow-up Period|Patient transferred to other hospital|0|||
49035279|NCT01796171|157965466|FG001|Follow-up Period|Patient transferred to other hospital|1|||
49035280|NCT01796171|157965467|FG002|Follow-up Period|Patient transferred to other hospital|0|||
49035281|NCT01796171|157965468|FG003|Follow-up Period|Patient transferred to other hospital|0|||
49035282|NCT01796171|157965469|FG004|Follow-up Period|Patient transferred to other hospital|0|||
49035283|NCT01796171|157965470|FG005|Follow-up Period|Patient transferred to other hospital|0|||
49035284|NCT01796171|157965471|FG006|Follow-up Period|Patient transferred to other hospital|0|||
49035285|NCT01796171|157965472|FG007|Follow-up Period|Patient transferred to other hospital|0|||
49035286|NCT01796171|157965473|FG008|Follow-up Period|Patient transferred to other hospital|0|||
49035287|NCT01796171|157965474|FG009|Follow-up Period|Patient transferred to other hospital|0|||
49035288|NCT01796171|157965475|FG010|Follow-up Period|Patient transferred to other hospital|0|||
49035289|NCT01796171|157965476|FG011|Follow-up Period|Patient transferred to other hospital|0|||
49035290|NCT01796171|157965477|FG012|Follow-up Period|Patient transferred to other hospital|0|||
49035291|NCT01796171|157965478|FG013|Follow-up Period|Patient transferred to other hospital|0|||
49035292|NCT01796171|157965479|FG014|Follow-up Period|Patient transferred to other hospital|0|||
49035293|NCT01796171|157965465|FG000|Follow-up Period|Sponsor Decision|0|||
49035294|NCT01796171|157965466|FG001|Follow-up Period|Sponsor Decision|0|||
49035295|NCT01796171|157965467|FG002|Follow-up Period|Sponsor Decision|0|||
49035296|NCT01796171|157965468|FG003|Follow-up Period|Sponsor Decision|0|||
49035297|NCT01796171|157965469|FG004|Follow-up Period|Sponsor Decision|0|||
49035298|NCT01796171|157965470|FG005|Follow-up Period|Sponsor Decision|0|||
49035299|NCT01796171|157965471|FG006|Follow-up Period|Sponsor Decision|0|||
49035300|NCT01796171|157965472|FG007|Follow-up Period|Sponsor Decision|0|||
49035301|NCT01796171|157965473|FG008|Follow-up Period|Sponsor Decision|0|||
49035302|NCT01796171|157965474|FG009|Follow-up Period|Sponsor Decision|0|||
49035303|NCT01796171|157965475|FG010|Follow-up Period|Sponsor Decision|40|||
49035304|NCT01796171|157965476|FG011|Follow-up Period|Sponsor Decision|15|||
49035305|NCT01796171|157965477|FG012|Follow-up Period|Sponsor Decision|7|||
49035306|NCT01796171|157965478|FG013|Follow-up Period|Sponsor Decision|0|||
49035307|NCT01796171|157965479|FG014|Follow-up Period|Sponsor Decision|0|||
49035308|NCT01000961|157965480|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
49035309|NCT01000961|157965481|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
48886461|NCT00479882|157419745|FG002|Crossover: Period III (Weeks 13-20)|Protocol Violation|1|||
48886462|NCT00479882|157419746|FG003|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
48886463|NCT02224703|157419750|FG000|Overall Study|Adverse Event|0|||
48886464|NCT02224703|157419751|FG001|Overall Study|Adverse Event|5|||
48886465|NCT02224703|157419752|FG002|Overall Study|Adverse Event|0|||
48886466|NCT02224703|157419750|FG000|Overall Study|Withdrawn by investigator|1|||
48886467|NCT02224703|157419751|FG001|Overall Study|Withdrawn by investigator|0|||
48886468|NCT02224703|157419752|FG002|Overall Study|Withdrawn by investigator|0|||
48886469|NCT02224703|157419750|FG000|Overall Study|Advised by medical monitor|1|||
48886470|NCT02224703|157419751|FG001|Overall Study|Advised by medical monitor|0|||
48886471|NCT02224703|157419752|FG002|Overall Study|Advised by medical monitor|0|||
48886472|NCT02224703|157419750|FG000|Overall Study|Withdrawn by parent/guardian|0|||
48886473|NCT02224703|157419751|FG001|Overall Study|Withdrawn by parent/guardian|1|||
48886474|NCT02224703|157419752|FG002|Overall Study|Withdrawn by parent/guardian|0|||
48886475|NCT02224703|157419750|FG000|Overall Study|Lack of Efficacy|1|||
48886476|NCT02224703|157419751|FG001|Overall Study|Lack of Efficacy|0|||
48886477|NCT02224703|157419752|FG002|Overall Study|Lack of Efficacy|0|||
48886478|NCT01643044|157419753|FG000|Overall Study|Lost to Follow-up|1|||
48886479|NCT01643044|157419754|FG001|Overall Study|Lost to Follow-up|1|||
48886480|NCT01643044|157419753|FG000|Overall Study|Miscarried baby|2|||
48886481|NCT01643044|157419754|FG001|Overall Study|Miscarried baby|2|||
48886482|NCT01643044|157419753|FG000|Overall Study|Delivered outside of hospital|1|||
48886483|NCT01643044|157419754|FG001|Overall Study|Delivered outside of hospital|2|||
48886484|NCT03031496|157419757|FG000|Period 1|Adverse Event|2|||
48886485|NCT03031496|157419758|FG001|Period 1|Adverse Event|0|||
48886486|NCT03031496|157419757|FG000|Period 1|Withdrawal by Subject|0|||
48886487|NCT03031496|157419758|FG001|Period 1|Withdrawal by Subject|2|||
49035310|NCT01000961|157965480|FG000|First Intervention (3 Weeks)|Infection after pre-planned surgery|0|||
49035311|NCT01000961|157965481|FG001|First Intervention (3 Weeks)|Infection after pre-planned surgery|1|||
48886488|NCT02574845|157419764|FG000|Overall Study|Consent withdrawn further participation|0|||
48886489|NCT02574845|157419765|FG001|Overall Study|Consent withdrawn further participation|0|||
48886490|NCT02574845|157419766|FG002|Overall Study|Consent withdrawn further participation|0|||
48886491|NCT02574845|157419767|FG003|Overall Study|Consent withdrawn further participation|0|||
48886492|NCT02574845|157419768|FG004|Overall Study|Consent withdrawn further participation|1|||
48886493|NCT02574845|157419769|FG005|Overall Study|Consent withdrawn further participation|0|||
48886494|NCT02574845|157419764|FG000|Overall Study|Adverse Event|0|||
49035312|NCT00418561|157965482|FG000|Overall Study|Participant's (guardian's) decision|0|||
49035313|NCT00418561|157965483|FG001|Overall Study|Participant's (guardian's) decision|1|||
49035314|NCT00418561|157965484|FG002|Overall Study|Participant's (guardian's) decision|0|||
49035315|NCT00829309|157965485|FG000|Washout: 7 Days|Protocol Violation|1|||
49035316|NCT00829309|157965486|FG001|Washout: 7 Days|Protocol Violation|0|||
49035317|NCT01083693|157965491|FG000|Overall Study|Adverse Event|1|||
49035318|NCT01083693|157965492|FG001|Overall Study|Adverse Event|1|||
49035319|NCT01083693|157965493|FG002|Overall Study|Adverse Event|0|||
49035320|NCT01083693|157965491|FG000|Overall Study|Lost to Follow-up|2|||
49035321|NCT01083693|157965492|FG001|Overall Study|Lost to Follow-up|0|||
49035322|NCT01083693|157965493|FG002|Overall Study|Lost to Follow-up|2|||
49035323|NCT01083693|157965491|FG000|Overall Study|Lack of effectiveness|13|||
49035324|NCT01083693|157965492|FG001|Overall Study|Lack of effectiveness|2|||
49035325|NCT01083693|157965493|FG002|Overall Study|Lack of effectiveness|2|||
49035326|NCT01083693|157965491|FG000|Overall Study|Patient Moved|0|||
49035327|NCT01083693|157965492|FG001|Overall Study|Patient Moved|1|||
49035328|NCT01083693|157965493|FG002|Overall Study|Patient Moved|0|||
49035329|NCT01083693|157965491|FG000|Overall Study|Complete remission|0|||
49035330|NCT01083693|157965492|FG001|Overall Study|Complete remission|1|||
49035331|NCT01083693|157965493|FG002|Overall Study|Complete remission|0|||
49035332|NCT01083693|157965491|FG000|Overall Study|Other medical condition/surgery|1|||
49035333|NCT01083693|157965492|FG001|Overall Study|Other medical condition/surgery|1|||
49035334|NCT01083693|157965493|FG002|Overall Study|Other medical condition/surgery|0|||
49035335|NCT01083693|157965491|FG000|Overall Study|Withdrawal by Subject|3|||
49035336|NCT01083693|157965492|FG001|Overall Study|Withdrawal by Subject|0|||
49035337|NCT01083693|157965493|FG002|Overall Study|Withdrawal by Subject|2|||
49035338|NCT01083693|157965491|FG000|Overall Study|Reason unknown|0|||
49035339|NCT01083693|157965492|FG001|Overall Study|Reason unknown|0|||
49035340|NCT01083693|157965493|FG002|Overall Study|Reason unknown|1|||
48886495|NCT02574845|157419765|FG001|Overall Study|Adverse Event|1|||
48886496|NCT02574845|157419766|FG002|Overall Study|Adverse Event|0|||
48886497|NCT02574845|157419767|FG003|Overall Study|Adverse Event|0|||
48886498|NCT02574845|157419768|FG004|Overall Study|Adverse Event|0|||
48886499|NCT02574845|157419769|FG005|Overall Study|Adverse Event|1|||
48886500|NCT03174431|157419781|FG000|Overall Study|Withdrawal by Subject|14|||
48886501|NCT03174431|157419782|FG001|Overall Study|Withdrawal by Subject|11|||
48886502|NCT03174431|157419781|FG000|Overall Study|alternative treatment|2|||
48886503|NCT03174431|157419782|FG001|Overall Study|alternative treatment|0|||
48886504|NCT03174431|157419781|FG000|Overall Study|Lost to Follow-up|1|||
48886505|NCT03174431|157419782|FG001|Overall Study|Lost to Follow-up|5|||
48886506|NCT02797080|157419783|FG000|Overall Study|Lost to Follow-up|1|||
48886507|NCT02797080|157419783|FG000|Overall Study|Withdrawal by Subject|1|||
48886508|NCT04148651|157419785|FG000|Overall Study|Lost to Follow-up|2|||
48886509|NCT03519204|157419786|FG000|Overall Study|Lost to Follow-up|3|||
48886510|NCT03519204|157419787|FG001|Overall Study|Lost to Follow-up|8|||
48886511|NCT03519204|157419786|FG000|Overall Study|Withdrawal by Subject|9|||
48886512|NCT03519204|157419787|FG001|Overall Study|Withdrawal by Subject|7|||
48886513|NCT03519204|157419786|FG000|Overall Study|Other Miscellaneous Reasons|1|||
48886514|NCT03519204|157419787|FG001|Overall Study|Other Miscellaneous Reasons|0|||
48886515|NCT02683785|157419788|FG000|Overall Study|Withdrawal by Subject|1|||
48886516|NCT02683785|157419789|FG001|Overall Study|Withdrawal by Subject|1|||
48886517|NCT02683785|157419788|FG000|Overall Study|Lost to Follow-up|0|||
48886518|NCT02683785|157419789|FG001|Overall Study|Lost to Follow-up|1|||
48886519|NCT02683785|157419788|FG000|Overall Study|Adverse Event|0|||
48886520|NCT02683785|157419789|FG001|Overall Study|Adverse Event|2|||
48983820|NCT01526928|157772348|FG004|Overall Study|Lost to Follow-up|0|||
48983821|NCT01526928|157772349|FG005|Overall Study|Lost to Follow-up|0|||
48983822|NCT01526928|157772344|FG000|Overall Study|Protocol Deviation|0|||
48983823|NCT01526928|157772345|FG001|Overall Study|Protocol Deviation|0|||
48983824|NCT01526928|157772346|FG002|Overall Study|Protocol Deviation|0|||
48983825|NCT01526928|157772347|FG003|Overall Study|Protocol Deviation|2|||
48983826|NCT01526928|157772348|FG004|Overall Study|Protocol Deviation|0|||
48983827|NCT01526928|157772349|FG005|Overall Study|Protocol Deviation|0|||
48983828|NCT01526928|157772344|FG000|Overall Study|Missing|0|||
48983829|NCT01526928|157772345|FG001|Overall Study|Missing|0|||
48983830|NCT01526928|157772346|FG002|Overall Study|Missing|1|||
48983831|NCT01526928|157772347|FG003|Overall Study|Missing|0|||
48983832|NCT01526928|157772348|FG004|Overall Study|Missing|2|||
48983833|NCT01526928|157772349|FG005|Overall Study|Missing|0|||
48983834|NCT00836953|157772350|FG000|Overall Study|Withdrawal by Subject|1|||
48983835|NCT00836953|157772350|FG000|Overall Study|Lost to Follow-up|1|||
48983836|NCT01842334|157772357|FG000|Overall Study|Withdrawal by Subject|3|||
49035341|NCT03107091|157965494|FG000|Overall Study|Physician Decision|1|||
49035342|NCT01444378|157965501|FG000|Overall Study|Lost to Follow-up|1|||
49035343|NCT01444378|157965501|FG000|Overall Study|Withdrawal by Subject|1|||
49035344|NCT01444378|157965501|FG000|Overall Study|Death|3|||
49035345|NCT01444378|157965501|FG000|Overall Study|Administrative Closure Of The Study|2|||
49035346|NCT01444378|157965501|FG000|Overall Study|Missed Visits|10|||
49035347|NCT04022954|157965504|FG000|Consented to Completed Procedure|Consented Screen Failure|1|||
49035348|NCT04022954|157965504|FG000|Completed 12-month Follow-up|Lost to Follow-up|5|||
49035349|NCT04022954|157965504|FG000|Completed 12-month Follow-up|Withdrawal by Subject|3|||
49035350|NCT03285594|157965507|FG000|Overall Study|At the Participant's Own Request|10|||
49035351|NCT03285594|157965508|FG001|Overall Study|At the Participant's Own Request|5|||
49035352|NCT03285594|157965509|FG002|Overall Study|At the Participant's Own Request|21|||
49035353|NCT03285594|157965507|FG000|Overall Study|Adverse Event|2|||
49035354|NCT03285594|157965508|FG001|Overall Study|Adverse Event|2|||
48886521|NCT00534495|157419795|FG000|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
48886522|NCT00534495|157419796|FG001|Double Blind Placebo Phase Week 0-4|randomized in error|1|||
48886523|NCT00534495|157419797|FG002|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
48886524|NCT00534495|157419795|FG000|All Active Treatment Phase Week 4-24|Adverse Event|1|||
48886525|NCT00534495|157419796|FG001|All Active Treatment Phase Week 4-24|Adverse Event|0|||
48886526|NCT00534495|157419797|FG002|All Active Treatment Phase Week 4-24|Adverse Event|0|||
48886527|NCT00534495|157419795|FG000|All Active Treatment Phase Week 4-24|Lack of Efficacy|1|||
48886528|NCT00534495|157419796|FG001|All Active Treatment Phase Week 4-24|Lack of Efficacy|7|||
48886529|NCT00534495|157419797|FG002|All Active Treatment Phase Week 4-24|Lack of Efficacy|0|||
48886530|NCT00534495|157419795|FG000|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
48886531|NCT00534495|157419796|FG001|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
48886532|NCT00534495|157419797|FG002|All Active Treatment Phase Week 4-24|Lost to Follow-up|0|||
48886533|NCT00534495|157419795|FG000|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
48886534|NCT00534495|157419796|FG001|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
48886535|NCT00534495|157419797|FG002|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0|||
48886536|NCT00534495|157419795|FG000|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
48886537|NCT00534495|157419796|FG001|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
48886538|NCT00534495|157419797|FG002|Long Term Ext. Phase Week 24-month 21|Adverse Event|1|||
48886539|NCT00534495|157419795|FG000|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
48886540|NCT00534495|157419796|FG001|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
48886541|NCT00534495|157419797|FG002|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5|||
48886542|NCT00534495|157419795|FG000|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
48886543|NCT00534495|157419796|FG001|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
49035355|NCT03285594|157965509|FG002|Overall Study|Adverse Event|6|||
49035356|NCT03285594|157965507|FG000|Overall Study|Poor Compliance to Protocol|0|||
49035357|NCT03285594|157965508|FG001|Overall Study|Poor Compliance to Protocol|0|||
49035358|NCT03285594|157965509|FG002|Overall Study|Poor Compliance to Protocol|1|||
49035359|NCT03285594|157965507|FG000|Overall Study|Lost to Follow-up|0|||
49035360|NCT03285594|157965508|FG001|Overall Study|Lost to Follow-up|0|||
49035361|NCT03285594|157965509|FG002|Overall Study|Lost to Follow-up|1|||
49035362|NCT03285594|157965507|FG000|Overall Study|Reason Not Specified|3|||
49035363|NCT03285594|157965508|FG001|Overall Study|Reason Not Specified|4|||
49035364|NCT03285594|157965509|FG002|Overall Study|Reason Not Specified|8|||
49035365|NCT02558491|157965511|FG000|First Invention|Withdrawal by Subject|3|||
49035366|NCT02558491|157965512|FG001|First Invention|Withdrawal by Subject|1|||
49035367|NCT02558491|157965511|FG000|First Invention|Data collection issues|1|||
49035368|NCT02558491|157965512|FG001|First Invention|Data collection issues|0|||
49035369|NCT02558491|157965511|FG000|First Invention|Stopping criteria|0|||
49035370|NCT02558491|157965512|FG001|First Invention|Stopping criteria|1|||
49035371|NCT02558491|157965511|FG000|First Invention|Changed parameters during trial|1|||
49035372|NCT02558491|157965512|FG001|First Invention|Changed parameters during trial|0|||
49035373|NCT02558491|157965511|FG000|Second Intervention|Withdrawal by Subject|1|||
48886544|NCT00534495|157419797|FG002|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3|||
48886545|NCT00534495|157419795|FG000|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
48886546|NCT00534495|157419796|FG001|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
48886547|NCT00534495|157419797|FG002|Long Term Ext. Phase Week 24-month 21|non compliance|2|||
49035374|NCT02558491|157965512|FG001|Second Intervention|Withdrawal by Subject|0|||
49035375|NCT02558491|157965511|FG000|Second Intervention|Stopping Criteria|1|||
49035376|NCT02558491|157965512|FG001|Second Intervention|Stopping Criteria|0|||
49035377|NCT00556322|157965513|FG000|Overall Study|Insufficient therapeutic response|158|||
49035378|NCT00556322|157965514|FG001|Overall Study|Insufficient therapeutic response|168|||
49035379|NCT00556322|157965513|FG000|Overall Study|Adverse Event|7|||
49035380|NCT00556322|157965514|FG001|Overall Study|Adverse Event|4|||
49035381|NCT00556322|157965513|FG000|Overall Study|Other|4|||
49035382|NCT00556322|157965514|FG001|Overall Study|Other|1|||
49035383|NCT00556322|157965513|FG000|Overall Study|Lost to Follow-up|5|||
49035384|NCT00556322|157965514|FG001|Overall Study|Lost to Follow-up|3|||
49035385|NCT00556322|157965513|FG000|Overall Study|Withdrawal by Subject|19|||
49035386|NCT00556322|157965514|FG001|Overall Study|Withdrawal by Subject|7|||
49035387|NCT00556322|157965513|FG000|Overall Study|Protocol Violation|5|||
49035388|NCT00556322|157965514|FG001|Overall Study|Protocol Violation|1|||
49035389|NCT00556322|157965513|FG000|Overall Study|Ongoing at data cutoff|3|||
49035390|NCT00556322|157965514|FG001|Overall Study|Ongoing at data cutoff|5|||
49035391|NCT00556322|157965513|FG000|Overall Study|Death|20|||
49035392|NCT00556322|157965514|FG001|Overall Study|Death|14|||
49035393|NCT02488408|157965518|FG000|Part A|Adverse Event|2|||
49035394|NCT02488408|157965519|FG001|Part A|Adverse Event|0|||
49035395|NCT02488408|157965520|FG002|Part A|Adverse Event|0|||
49035396|NCT02488408|157965521|FG003|Part A|Adverse Event|0|||
49035397|NCT02488408|157965522|FG004|Part A|Adverse Event|0|||
49035398|NCT02488408|157965523|FG005|Part A|Adverse Event|0|||
49035399|NCT02488408|157965524|FG006|Part A|Adverse Event|0|||
49035400|NCT02488408|157965525|FG007|Part A|Adverse Event|0|||
49035401|NCT02488408|157965526|FG008|Part A|Adverse Event|0|||
49035402|NCT02488408|157965527|FG009|Part A|Adverse Event|0|||
49035403|NCT02488408|157965518|FG000|Part A|Death|1|||
49035404|NCT02488408|157965519|FG001|Part A|Death|5|||
49035405|NCT02488408|157965520|FG002|Part A|Death|0|||
49035406|NCT02488408|157965521|FG003|Part A|Death|0|||
49035407|NCT02488408|157965522|FG004|Part A|Death|3|||
49035408|NCT02488408|157965523|FG005|Part A|Death|0|||
49035409|NCT02488408|157965524|FG006|Part A|Death|0|||
49035410|NCT02488408|157965525|FG007|Part A|Death|0|||
49035411|NCT02488408|157965526|FG008|Part A|Death|0|||
49035412|NCT02488408|157965527|FG009|Part A|Death|0|||
49035413|NCT02488408|157965518|FG000|Part A|Disease Progression|2|||
49035414|NCT02488408|157965519|FG001|Part A|Disease Progression|8|||
49035415|NCT02488408|157965520|FG002|Part A|Disease Progression|2|||
49035416|NCT02488408|157965521|FG003|Part A|Disease Progression|3|||
49035417|NCT02488408|157965522|FG004|Part A|Disease Progression|4|||
49035418|NCT02488408|157965523|FG005|Part A|Disease Progression|0|||
49035419|NCT02488408|157965524|FG006|Part A|Disease Progression|0|||
49035420|NCT02488408|157965525|FG007|Part A|Disease Progression|0|||
49035421|NCT02488408|157965526|FG008|Part A|Disease Progression|0|||
49035422|NCT02488408|157965527|FG009|Part A|Disease Progression|0|||
49035423|NCT02488408|157965518|FG000|Part A|Initiation of Alternative Cancer Therapy|0|||
49035424|NCT02488408|157965519|FG001|Part A|Initiation of Alternative Cancer Therapy|0|||
49035425|NCT02488408|157965520|FG002|Part A|Initiation of Alternative Cancer Therapy|0|||
49035426|NCT02488408|157965521|FG003|Part A|Initiation of Alternative Cancer Therapy|1|||
49035427|NCT02488408|157965522|FG004|Part A|Initiation of Alternative Cancer Therapy|0|||
49035428|NCT02488408|157965523|FG005|Part A|Initiation of Alternative Cancer Therapy|0|||
49035429|NCT02488408|157965524|FG006|Part A|Initiation of Alternative Cancer Therapy|0|||
49035430|NCT02488408|157965525|FG007|Part A|Initiation of Alternative Cancer Therapy|0|||
49035431|NCT02488408|157965526|FG008|Part A|Initiation of Alternative Cancer Therapy|0|||
49035432|NCT02488408|157965527|FG009|Part A|Initiation of Alternative Cancer Therapy|0|||
49035433|NCT02488408|157965518|FG000|Part A|Investigator Decision|0|||
49035434|NCT02488408|157965519|FG001|Part A|Investigator Decision|1|||
49035435|NCT02488408|157965520|FG002|Part A|Investigator Decision|1|||
49035436|NCT02488408|157965521|FG003|Part A|Investigator Decision|0|||
49035437|NCT02488408|157965522|FG004|Part A|Investigator Decision|0|||
48886548|NCT02440425|157419798|FG000|Overall Study|Death likely due to disease progression|1|||
48886549|NCT02440425|157419798|FG000|Overall Study|Withdrawal by Subject|2|||
48886550|NCT02440425|157419798|FG000|Overall Study|Adverse Event|1|||
48886551|NCT02440425|157419798|FG000|Overall Study|Adverse Event/Ineligible|1|||
48886552|NCT01430468|157419799|FG000|Overall Study|Physician Decision|2|||
48886553|NCT01430468|157419800|FG001|Overall Study|Physician Decision|1|||
48886554|NCT01430468|157419799|FG000|Overall Study|Withdrawal by Subject|5|||
48886555|NCT01430468|157419800|FG001|Overall Study|Withdrawal by Subject|5|||
48886556|NCT03538938|157419801|FG000|Overall Study|Death|0|||
48886557|NCT03538938|157419802|FG001|Overall Study|Death|0|||
48886558|NCT03538938|157419803|FG002|Overall Study|Death|2|||
48886559|NCT03538938|157419804|FG003|Overall Study|Death|0|||
48886560|NCT03538938|157419805|FG004|Overall Study|Death|0|||
48886561|NCT03538938|157419806|FG005|Overall Study|Death|1|||
49035438|NCT02488408|157965523|FG005|Part A|Investigator Decision|0|||
49035439|NCT02488408|157965524|FG006|Part A|Investigator Decision|0|||
49035440|NCT02488408|157965525|FG007|Part A|Investigator Decision|0|||
49035441|NCT02488408|157965526|FG008|Part A|Investigator Decision|0|||
49035442|NCT02488408|157965527|FG009|Part A|Investigator Decision|0|||
49035443|NCT02488408|157965518|FG000|Part A|Withdrawal by Subject|0|||
49035444|NCT02488408|157965519|FG001|Part A|Withdrawal by Subject|0|||
49035445|NCT02488408|157965520|FG002|Part A|Withdrawal by Subject|2|||
48886562|NCT03538938|157419807|FG006|Overall Study|Death|0|||
48886563|NCT03538938|157419808|FG007|Overall Study|Death|1|||
48886564|NCT03538938|157419809|FG008|Overall Study|Death|1|||
49035446|NCT02488408|157965521|FG003|Part A|Withdrawal by Subject|0|||
49035447|NCT02488408|157965522|FG004|Part A|Withdrawal by Subject|0|||
49035448|NCT02488408|157965523|FG005|Part A|Withdrawal by Subject|0|||
49035449|NCT02488408|157965524|FG006|Part A|Withdrawal by Subject|0|||
48886565|NCT03538938|157419810|FG009|Overall Study|Death|1|||
48886566|NCT03538938|157419811|FG010|Overall Study|Death|0|||
48886567|NCT03538938|157419812|FG011|Overall Study|Death|0|||
48886568|NCT03538938|157419813|FG012|Overall Study|Death|1|||
48886569|NCT03538938|157419814|FG013|Overall Study|Death|1|||
48886570|NCT03538938|157419815|FG014|Overall Study|Death|0|||
48886571|NCT03538938|157419816|FG015|Overall Study|Death|1|||
48886572|NCT03538938|157419801|FG000|Overall Study|Withdrawal by Subject|4|||
48886573|NCT03538938|157419802|FG001|Overall Study|Withdrawal by Subject|6|||
48886574|NCT03538938|157419803|FG002|Overall Study|Withdrawal by Subject|5|||
48886575|NCT03538938|157419804|FG003|Overall Study|Withdrawal by Subject|3|||
48886576|NCT03538938|157419805|FG004|Overall Study|Withdrawal by Subject|0|||
48886577|NCT03538938|157419806|FG005|Overall Study|Withdrawal by Subject|0|||
48886578|NCT03538938|157419807|FG006|Overall Study|Withdrawal by Subject|3|||
48886579|NCT03538938|157419808|FG007|Overall Study|Withdrawal by Subject|1|||
48886580|NCT03538938|157419809|FG008|Overall Study|Withdrawal by Subject|5|||
48886581|NCT03538938|157419810|FG009|Overall Study|Withdrawal by Subject|1|||
48886582|NCT03538938|157419811|FG010|Overall Study|Withdrawal by Subject|2|||
48886583|NCT03538938|157419812|FG011|Overall Study|Withdrawal by Subject|1|||
48886584|NCT03538938|157419813|FG012|Overall Study|Withdrawal by Subject|3|||
48886585|NCT03538938|157419814|FG013|Overall Study|Withdrawal by Subject|0|||
48886586|NCT03538938|157419815|FG014|Overall Study|Withdrawal by Subject|2|||
48886587|NCT03538938|157419816|FG015|Overall Study|Withdrawal by Subject|4|||
48886588|NCT03538938|157419801|FG000|Overall Study|Incarcerated|0|||
48886589|NCT03538938|157419802|FG001|Overall Study|Incarcerated|0|||
48886590|NCT03538938|157419803|FG002|Overall Study|Incarcerated|0|||
48886591|NCT03538938|157419804|FG003|Overall Study|Incarcerated|0|||
48886592|NCT03538938|157419805|FG004|Overall Study|Incarcerated|0|||
48886593|NCT03538938|157419806|FG005|Overall Study|Incarcerated|0|||
48886594|NCT03538938|157419807|FG006|Overall Study|Incarcerated|0|||
48886595|NCT03538938|157419808|FG007|Overall Study|Incarcerated|0|||
48886596|NCT03538938|157419809|FG008|Overall Study|Incarcerated|0|||
48886597|NCT03538938|157419810|FG009|Overall Study|Incarcerated|0|||
48886598|NCT03538938|157419811|FG010|Overall Study|Incarcerated|0|||
48886599|NCT03538938|157419812|FG011|Overall Study|Incarcerated|1|||
48886600|NCT03538938|157419813|FG012|Overall Study|Incarcerated|0|||
48886601|NCT03538938|157419814|FG013|Overall Study|Incarcerated|0|||
48886602|NCT03538938|157419815|FG014|Overall Study|Incarcerated|0|||
48886603|NCT03538938|157419816|FG015|Overall Study|Incarcerated|0|||
48886604|NCT03653208|157419819|FG000|Overall Study|Withdrawal by Subject|0|||
48886605|NCT03653208|157419820|FG001|Overall Study|Withdrawal by Subject|0|||
48886606|NCT03653208|157419821|FG002|Overall Study|Withdrawal by Subject|0|||
48886607|NCT03653208|157419822|FG003|Overall Study|Withdrawal by Subject|0|||
48886608|NCT03653208|157419823|FG004|Overall Study|Withdrawal by Subject|1|||
48886609|NCT03653208|157419824|FG005|Overall Study|Withdrawal by Subject|0|||
48886610|NCT03653208|157419825|FG006|Overall Study|Withdrawal by Subject|0|||
48886611|NCT03653208|157419826|FG007|Overall Study|Withdrawal by Subject|1|||
48886612|NCT03653208|157419827|FG008|Overall Study|Withdrawal by Subject|1|||
48886613|NCT01281839|157419828|FG000|Overall Study|Lost to Follow-up|6|||
48886614|NCT01281839|157419829|FG001|Overall Study|Lost to Follow-up|3|||
48886615|NCT01281839|157419828|FG000|Overall Study|Withdrawal by Subject|4|||
48886616|NCT01281839|157419829|FG001|Overall Study|Withdrawal by Subject|10|||
48886617|NCT01281839|157419828|FG000|Overall Study|Reason not specified|0|||
48886618|NCT01281839|157419829|FG001|Overall Study|Reason not specified|1|||
48886619|NCT03449901|157419830|FG000|Overall Study|Progression|57|||
48886620|NCT03449901|157419831|FG001|Overall Study|Progression|12|||
48886621|NCT03449901|157419830|FG000|Overall Study|Adverse Event|3|||
48886622|NCT03449901|157419831|FG001|Overall Study|Adverse Event|0|||
48886623|NCT03449901|157419830|FG000|Overall Study|Death|6|||
48886624|NCT03449901|157419831|FG001|Overall Study|Death|2|||
48886625|NCT03449901|157419830|FG000|Overall Study|Withdrawal by Subject|12|||
48886626|NCT03449901|157419831|FG001|Overall Study|Withdrawal by Subject|1|||
48886627|NCT03449901|157419830|FG000|Overall Study|Physician Decision|1|||
48886628|NCT03449901|157419831|FG001|Overall Study|Physician Decision|0|||
48886629|NCT03449901|157419830|FG000|Overall Study|Patient elected for surgical intervention|1|||
48886630|NCT03449901|157419831|FG001|Overall Study|Patient elected for surgical intervention|0|||
48886631|NCT03449901|157419830|FG000|Overall Study|Patient off for other complicating disease|1|||
48886632|NCT03449901|157419831|FG001|Overall Study|Patient off for other complicating disease|0|||
48886633|NCT00743431|157419833|FG000|Overall Study|Toxicity|6|||
48886634|NCT00743431|157419833|FG000|Overall Study|Tumor progression|56|||
48886635|NCT00743431|157419833|FG000|Overall Study|Withdrawal by Subject|13|||
48886636|NCT00743431|157419833|FG000|Overall Study|Death|9|||
48886637|NCT00743431|157419833|FG000|Overall Study|Reason for discontinuation not specified|29|||
48886638|NCT00743431|157419833|FG000|Overall Study|No documentation available|13|||
48886639|NCT04343976|157419834|FG000|Overall Study|Withdrawal by Subject|0|||
48886640|NCT04343976|157419835|FG001|Overall Study|Withdrawal by Subject|1|||
48886641|NCT00737698|157419836|FG000|Overall Study|Withdrawal by Subject|6|||
48886642|NCT00737698|157419837|FG001|Overall Study|Withdrawal by Subject|5|||
49035450|NCT02488408|157965525|FG007|Part A|Withdrawal by Subject|0|||
49035451|NCT02488408|157965526|FG008|Part A|Withdrawal by Subject|0|||
49035452|NCT02488408|157965527|FG009|Part A|Withdrawal by Subject|0|||
49035453|NCT02488408|157965518|FG000|Part A|Other|1|||
49035454|NCT02488408|157965519|FG001|Part A|Other|0|||
49035455|NCT02488408|157965520|FG002|Part A|Other|0|||
49035456|NCT02488408|157965521|FG003|Part A|Other|0|||
49035457|NCT02488408|157965522|FG004|Part A|Other|0|||
49035458|NCT02488408|157965523|FG005|Part A|Other|0|||
49035459|NCT02488408|157965524|FG006|Part A|Other|0|||
49035460|NCT02488408|157965525|FG007|Part A|Other|0|||
49035461|NCT02488408|157965526|FG008|Part A|Other|0|||
49035462|NCT02488408|157965527|FG009|Part A|Other|0|||
49035463|NCT02488408|157965518|FG000|Part B|Adverse Event|0|||
49035464|NCT02488408|157965519|FG001|Part B|Adverse Event|0|||
49035465|NCT02488408|157965520|FG002|Part B|Adverse Event|0|||
49035466|NCT02488408|157965521|FG003|Part B|Adverse Event|0|||
49035467|NCT02488408|157965522|FG004|Part B|Adverse Event|0|||
49035468|NCT02488408|157965523|FG005|Part B|Adverse Event|2|||
49035469|NCT02488408|157965524|FG006|Part B|Adverse Event|2|||
49035470|NCT02488408|157965525|FG007|Part B|Adverse Event|7|||
49035471|NCT02488408|157965526|FG008|Part B|Adverse Event|2|||
49035472|NCT02488408|157965527|FG009|Part B|Adverse Event|2|||
49035473|NCT02488408|157965518|FG000|Part B|Death|0|||
49035474|NCT02488408|157965519|FG001|Part B|Death|0|||
49035475|NCT02488408|157965520|FG002|Part B|Death|0|||
49035476|NCT02488408|157965521|FG003|Part B|Death|0|||
48886643|NCT00737698|157419838|FG002|Overall Study|Withdrawal by Subject|3|||
48886644|NCT00737698|157419836|FG000|Overall Study|Death|0|||
48886645|NCT00737698|157419837|FG001|Overall Study|Death|0|||
48886646|NCT00737698|157419838|FG002|Overall Study|Death|1|||
48886647|NCT03406078|157419839|FG000|Overall Study|Death|1|||
48886648|NCT03406078|157419840|FG001|Overall Study|Death|0|||
48886649|NCT03406078|157419839|FG000|Overall Study|Lost to Follow-up|0|||
48886650|NCT03406078|157419840|FG001|Overall Study|Lost to Follow-up|1|||
48886651|NCT03406078|157419839|FG000|Overall Study|Withdrawal by Subject|5|||
48886652|NCT03406078|157419840|FG001|Overall Study|Withdrawal by Subject|2|||
48886653|NCT03686423|157419841|FG000|Overall Study|Withdrawal by Subject|9|||
48886654|NCT03686423|157419841|FG000|Overall Study|lost to follow up (study interrupted by COVID)|6|||
48886655|NCT04531098|157419844|FG000|Stage I|Adverse Event|0|||
48886656|NCT04531098|157419845|FG001|Stage I|Adverse Event|0|||
48886657|NCT04531098|157419846|FG002|Stage I|Adverse Event|3|||
48886658|NCT04531098|157419844|FG000|Stage I|Protocol Violation|0|||
48886659|NCT04531098|157419845|FG001|Stage I|Protocol Violation|0|||
48886660|NCT04531098|157419846|FG002|Stage I|Protocol Violation|5|||
48886661|NCT04531098|157419844|FG000|Stage I|Withdrawal by Subject|0|||
48886662|NCT04531098|157419845|FG001|Stage I|Withdrawal by Subject|5|||
48886663|NCT04531098|157419846|FG002|Stage I|Withdrawal by Subject|10|||
48886664|NCT04531098|157419844|FG000|Stage II|Adverse Event|1|||
48886665|NCT04531098|157419845|FG001|Stage II|Adverse Event|2|||
48886666|NCT04531098|157419846|FG002|Stage II|Adverse Event|0|||
48886667|NCT04531098|157419844|FG000|Stage II|Protocol Violation|1|||
48886668|NCT04531098|157419845|FG001|Stage II|Protocol Violation|2|||
48886669|NCT04531098|157419846|FG002|Stage II|Protocol Violation|0|||
48886670|NCT04531098|157419844|FG000|Stage II|Withdrawal by Subject|3|||
48886671|NCT04531098|157419845|FG001|Stage II|Withdrawal by Subject|1|||
48886672|NCT04531098|157419846|FG002|Stage II|Withdrawal by Subject|0|||
48886673|NCT04531098|157419844|FG000|Stage II|Moved from study area|8|||
48886674|NCT04531098|157419845|FG001|Stage II|Moved from study area|5|||
48886675|NCT04531098|157419846|FG002|Stage II|Moved from study area|0|||
48886676|NCT02001064|157419847|FG000|Overall Study|Withdrawal by Subject|2|||
48886677|NCT02001064|157419848|FG001|Overall Study|Withdrawal by Subject|1|||
49035477|NCT02488408|157965522|FG004|Part B|Death|0|||
49035478|NCT02488408|157965523|FG005|Part B|Death|3|||
49035479|NCT02488408|157965524|FG006|Part B|Death|1|||
49035480|NCT02488408|157965525|FG007|Part B|Death|2|||
49035481|NCT02488408|157965526|FG008|Part B|Death|2|||
49035482|NCT02488408|157965527|FG009|Part B|Death|2|||
49035483|NCT02488408|157965518|FG000|Part B|Death due to Disease Progression|0|||
49035484|NCT02488408|157965519|FG001|Part B|Death due to Disease Progression|0|||
48886678|NCT00438672|157419849|FG000|Overall Study|Lost to Follow-up|7|||
48886679|NCT00438672|157419850|FG001|Overall Study|Lost to Follow-up|9|||
48886680|NCT00316017|157419852|FG000|Overall Study|Protocol Violation|11|||
48886681|NCT00316017|157419853|FG001|Overall Study|Protocol Violation|13|||
48886682|NCT00316017|157419854|FG002|Overall Study|Protocol Violation|19|||
48886683|NCT00320528|157419855|FG000|Study Period II|Adverse Event|3|||
48886684|NCT00320528|157419856|FG001|Study Period II|Adverse Event|4|||
48886685|NCT00320528|157419857|FG002|Study Period II|Adverse Event|8|||
48886686|NCT00320528|157419855|FG000|Study Period II|Parent/Caregiver Decision|8|||
48886687|NCT00320528|157419856|FG001|Study Period II|Parent/Caregiver Decision|3|||
48886688|NCT00320528|157419857|FG002|Study Period II|Parent/Caregiver Decision|11|||
49035485|NCT02488408|157965520|FG002|Part B|Death due to Disease Progression|0|||
49035486|NCT02488408|157965521|FG003|Part B|Death due to Disease Progression|0|||
49035487|NCT02488408|157965522|FG004|Part B|Death due to Disease Progression|0|||
49035488|NCT02488408|157965523|FG005|Part B|Death due to Disease Progression|2|||
48886689|NCT00320528|157419855|FG000|Study Period II|Withdrawal by Subject|0|||
48886690|NCT00320528|157419856|FG001|Study Period II|Withdrawal by Subject|1|||
48886691|NCT00320528|157419857|FG002|Study Period II|Withdrawal by Subject|1|||
48886692|NCT00320528|157419855|FG000|Study Period II|Entry Criteria Exclusion|0|||
48886693|NCT00320528|157419856|FG001|Study Period II|Entry Criteria Exclusion|2|||
48886694|NCT00320528|157419857|FG002|Study Period II|Entry Criteria Exclusion|2|||
48886695|NCT00320528|157419855|FG000|Study Period III|Adverse Event|1|||
48886696|NCT00320528|157419856|FG001|Study Period III|Adverse Event|0|||
48886697|NCT00320528|157419857|FG002|Study Period III|Adverse Event|0|||
48886698|NCT00320528|157419855|FG000|Study Period III|Lost to Follow-up|1|||
48886699|NCT00320528|157419856|FG001|Study Period III|Lost to Follow-up|0|||
48886700|NCT00320528|157419857|FG002|Study Period III|Lost to Follow-up|0|||
48886701|NCT00320528|157419855|FG000|Study Period III|Withdrawal by Subject|1|||
48886702|NCT00320528|157419856|FG001|Study Period III|Withdrawal by Subject|1|||
48886703|NCT00320528|157419857|FG002|Study Period III|Withdrawal by Subject|2|||
48886704|NCT00320528|157419855|FG000|Study Period III|Lack of Efficacy|2|||
48886705|NCT00320528|157419856|FG001|Study Period III|Lack of Efficacy|0|||
48886706|NCT00320528|157419857|FG002|Study Period III|Lack of Efficacy|0|||
48886707|NCT00320528|157419855|FG000|Study Period III|Parent/Caregiver Decision|14|||
48886708|NCT00320528|157419856|FG001|Study Period III|Parent/Caregiver Decision|3|||
48886709|NCT00320528|157419857|FG002|Study Period III|Parent/Caregiver Decision|11|||
48886710|NCT00320528|157419855|FG000|Study Period III|Protocol Violation|0|||
48886711|NCT00320528|157419856|FG001|Study Period III|Protocol Violation|1|||
48886712|NCT00320528|157419857|FG002|Study Period III|Protocol Violation|0|||
49035489|NCT02488408|157965524|FG006|Part B|Death due to Disease Progression|2|||
49035490|NCT02488408|157965525|FG007|Part B|Death due to Disease Progression|1|||
49035491|NCT02488408|157965526|FG008|Part B|Death due to Disease Progression|1|||
48886713|NCT00320528|157419855|FG000|Study Period III|Physician Decision|0|||
48886714|NCT00320528|157419856|FG001|Study Period III|Physician Decision|1|||
48886715|NCT00320528|157419857|FG002|Study Period III|Physician Decision|2|||
48886716|NCT00320528|157419855|FG000|Study Period III|Sponsor Decision|0|||
48886717|NCT00320528|157419856|FG001|Study Period III|Sponsor Decision|0|||
48886718|NCT00320528|157419857|FG002|Study Period III|Sponsor Decision|1|||
48886719|NCT00320528|157419855|FG000|Study Period III|Atomoxetine Commercially Available|68|||
48886720|NCT00320528|157419856|FG001|Study Period III|Atomoxetine Commercially Available|25|||
48886721|NCT00320528|157419857|FG002|Study Period III|Atomoxetine Commercially Available|90|||
48886722|NCT01468181|157419858|FG000|Overall Study|Adverse Event|8|||
49035492|NCT02488408|157965527|FG009|Part B|Death due to Disease Progression|1|||
48886723|NCT01468181|157419859|FG001|Overall Study|Adverse Event|1|||
48886724|NCT01468181|157419860|FG002|Overall Study|Adverse Event|6|||
48886725|NCT01468181|157419861|FG003|Overall Study|Adverse Event|2|||
48886726|NCT01468181|157419862|FG004|Overall Study|Adverse Event|2|||
48886727|NCT01468181|157419858|FG000|Overall Study|Protocol Violation|2|||
48886728|NCT01468181|157419859|FG001|Overall Study|Protocol Violation|0|||
48886729|NCT01468181|157419860|FG002|Overall Study|Protocol Violation|1|||
48886730|NCT01468181|157419861|FG003|Overall Study|Protocol Violation|0|||
48886731|NCT01468181|157419862|FG004|Overall Study|Protocol Violation|1|||
48886732|NCT01468181|157419858|FG000|Overall Study|Physician Decision|0|||
48886733|NCT01468181|157419859|FG001|Overall Study|Physician Decision|0|||
48886734|NCT01468181|157419860|FG002|Overall Study|Physician Decision|0|||
48886735|NCT01468181|157419861|FG003|Overall Study|Physician Decision|1|||
49035493|NCT02488408|157965518|FG000|Part B|Disease Progression|0|||
49035494|NCT02488408|157965519|FG001|Part B|Disease Progression|0|||
49035495|NCT02488408|157965520|FG002|Part B|Disease Progression|0|||
49035496|NCT02488408|157965521|FG003|Part B|Disease Progression|0|||
49035497|NCT02488408|157965522|FG004|Part B|Disease Progression|0|||
49035498|NCT02488408|157965523|FG005|Part B|Disease Progression|6|||
49035499|NCT02488408|157965524|FG006|Part B|Disease Progression|9|||
49035500|NCT02488408|157965525|FG007|Part B|Disease Progression|7|||
49035501|NCT02488408|157965526|FG008|Part B|Disease Progression|9|||
48886736|NCT01468181|157419862|FG004|Overall Study|Physician Decision|1|||
48886737|NCT01468181|157419858|FG000|Overall Study|Lost to Follow-up|0|||
49035502|NCT02488408|157965527|FG009|Part B|Disease Progression|11|||
49035503|NCT02488408|157965518|FG000|Part B|Initiation of Alternative Cancer Therapy|0|||
49035504|NCT02488408|157965519|FG001|Part B|Initiation of Alternative Cancer Therapy|0|||
48886738|NCT01468181|157419859|FG001|Overall Study|Lost to Follow-up|0|||
48886739|NCT01468181|157419860|FG002|Overall Study|Lost to Follow-up|1|||
48886740|NCT01468181|157419861|FG003|Overall Study|Lost to Follow-up|0|||
48886741|NCT01468181|157419862|FG004|Overall Study|Lost to Follow-up|1|||
48886742|NCT01468181|157419858|FG000|Overall Study|Withdrawal by Subject|0|||
48886743|NCT01468181|157419859|FG001|Overall Study|Withdrawal by Subject|1|||
48886744|NCT01468181|157419860|FG002|Overall Study|Withdrawal by Subject|0|||
48886745|NCT01468181|157419861|FG003|Overall Study|Withdrawal by Subject|0|||
48886746|NCT01468181|157419862|FG004|Overall Study|Withdrawal by Subject|0|||
48886747|NCT03816761|157421879|FG000|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
49035505|NCT02488408|157965520|FG002|Part B|Initiation of Alternative Cancer Therapy|0|||
49035506|NCT02488408|157965521|FG003|Part B|Initiation of Alternative Cancer Therapy|0|||
48886748|NCT03816761|157421880|FG001|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
48886749|NCT03816761|157421881|FG002|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
48886750|NCT03816761|157421882|FG003|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
48886751|NCT03816761|157421883|FG004|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
48886752|NCT03816761|157421884|FG005|First Treatment Period (7 Days)|Withdrawal by Subject|1|||
48886753|NCT03816761|157421879|FG000|Second Treatment Period (7 Days)|Unclassified|0|||
48886754|NCT03816761|157421880|FG001|Second Treatment Period (7 Days)|Unclassified|0|||
48886755|NCT03816761|157421881|FG002|Second Treatment Period (7 Days)|Unclassified|0|||
48886756|NCT03816761|157421882|FG003|Second Treatment Period (7 Days)|Unclassified|1|||
48886757|NCT03816761|157421883|FG004|Second Treatment Period (7 Days)|Unclassified|0|||
48886758|NCT03816761|157421884|FG005|Second Treatment Period (7 Days)|Unclassified|0|||
48886759|NCT01730950|157421892|FG000|Overall Study|Protocol Violation|6|||
48886760|NCT01730950|157421893|FG001|Overall Study|Protocol Violation|6|||
48886761|NCT00233480|157421896|FG000|Overall Study|Underwent status II heart transplant|0|||
48886762|NCT00233480|157421897|FG001|Overall Study|Underwent status II heart transplant|1|||
48886763|NCT00581893|157421898|FG000|Second Intervention (1 Month)|Lost to Follow-up|3|||
48886764|NCT00581893|157421899|FG001|Second Intervention (1 Month)|Lost to Follow-up|2|||
48886765|NCT04942366|157421906|FG000|Overall Study|Withdrawal by Subject|5|||
48886766|NCT04942366|157421907|FG001|Overall Study|Withdrawal by Subject|5|||
48886767|NCT01484431|157421909|FG000|Period 1: High Dose|Physician Decision|0|||
48886768|NCT01484431|157421910|FG001|Period 1: High Dose|Physician Decision|1|||
49035507|NCT02488408|157965522|FG004|Part B|Initiation of Alternative Cancer Therapy|0|||
49035508|NCT02488408|157965523|FG005|Part B|Initiation of Alternative Cancer Therapy|1|||
49035509|NCT02488408|157965524|FG006|Part B|Initiation of Alternative Cancer Therapy|1|||
49035510|NCT02488408|157965525|FG007|Part B|Initiation of Alternative Cancer Therapy|1|||
49035511|NCT02488408|157965526|FG008|Part B|Initiation of Alternative Cancer Therapy|2|||
49035512|NCT02488408|157965527|FG009|Part B|Initiation of Alternative Cancer Therapy|3|||
49035513|NCT02488408|157965518|FG000|Part B|Investigator Decision|0|||
49035514|NCT02488408|157965519|FG001|Part B|Investigator Decision|0|||
48886769|NCT01484431|157421911|FG002|Period 1: High Dose|Physician Decision|0|||
48886770|NCT01484431|157421909|FG000|Period 2|Death|0|||
48886771|NCT01484431|157421910|FG001|Period 2|Death|1|||
48886772|NCT01484431|157421911|FG002|Period 2|Death|1|||
48886773|NCT01484431|157421909|FG000|Period 2|Physician Decision|0|||
48886774|NCT01484431|157421910|FG001|Period 2|Physician Decision|0|||
48886775|NCT01484431|157421911|FG002|Period 2|Physician Decision|1|||
48886776|NCT01484431|157421909|FG000|Period 2|Non-Compliance with Study Drug|1|||
48886777|NCT01484431|157421910|FG001|Period 2|Non-Compliance with Study Drug|0|||
48886778|NCT01484431|157421911|FG002|Period 2|Non-Compliance with Study Drug|0|||
48886779|NCT00918879|157421916|FG000|Overall Study|Withdrawal by Subject|4|||
48886780|NCT00918879|157421917|FG001|Overall Study|Withdrawal by Subject|4|||
48886781|NCT00918879|157421916|FG000|Overall Study|Lost to Follow-up|1|||
48886782|NCT00918879|157421917|FG001|Overall Study|Lost to Follow-up|1|||
48886783|NCT00918879|157421916|FG000|Overall Study|Severe non-compliance to protocol|1|||
48886784|NCT00918879|157421917|FG001|Overall Study|Severe non-compliance to protocol|1|||
48886785|NCT04491877|157421918|FG000|Overall Study|Protocol Deviation|1|||
48886786|NCT04491877|157421919|FG001|Overall Study|Protocol Deviation|0|||
48886787|NCT04491877|157421920|FG002|Overall Study|Protocol Deviation|2|||
48886788|NCT04491877|157421921|FG003|Overall Study|Protocol Deviation|0|||
48886789|NCT04491877|157421922|FG004|Overall Study|Protocol Deviation|0|||
48886790|NCT04491877|157421923|FG005|Overall Study|Protocol Deviation|0|||
48886791|NCT04491877|157421924|FG006|Overall Study|Protocol Deviation|1|||
48886792|NCT04491877|157421925|FG007|Overall Study|Protocol Deviation|1|||
48886793|NCT04491877|157421926|FG008|Overall Study|Protocol Deviation|0|||
48886794|NCT04491877|157421918|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
48886795|NCT04491877|157421919|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
48886796|NCT04491877|157421920|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
48886797|NCT04491877|157421921|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
48886798|NCT04491877|157421922|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
48886799|NCT04491877|157421923|FG005|Overall Study|Withdrawal by Parent/Guardian|2|||
48886800|NCT04491877|157421924|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
48886801|NCT04491877|157421925|FG007|Overall Study|Withdrawal by Parent/Guardian|5|||
48886802|NCT04491877|157421926|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
48886803|NCT04491877|157421918|FG000|Overall Study|Lost to Follow-up|0|||
48886804|NCT04491877|157421919|FG001|Overall Study|Lost to Follow-up|2|||
49035515|NCT02488408|157965520|FG002|Part B|Investigator Decision|0|||
48886805|NCT04491877|157421920|FG002|Overall Study|Lost to Follow-up|0|||
48886806|NCT04491877|157421921|FG003|Overall Study|Lost to Follow-up|0|||
48886807|NCT04491877|157421922|FG004|Overall Study|Lost to Follow-up|0|||
48886808|NCT04491877|157421923|FG005|Overall Study|Lost to Follow-up|0|||
48886809|NCT04491877|157421924|FG006|Overall Study|Lost to Follow-up|2|||
48886810|NCT04491877|157421925|FG007|Overall Study|Lost to Follow-up|1|||
48886811|NCT04491877|157421926|FG008|Overall Study|Lost to Follow-up|1|||
48886812|NCT02993406|157421932|FG000|Overall Study|Withdrawal by Subject|170|||
49035516|NCT02488408|157965521|FG003|Part B|Investigator Decision|0|||
48886813|NCT02993406|157421933|FG001|Overall Study|Withdrawal by Subject|196|||
48886814|NCT02993406|157421932|FG000|Overall Study|Physician Decision|3|||
48886815|NCT02993406|157421933|FG001|Overall Study|Physician Decision|5|||
48886816|NCT02993406|157421932|FG000|Overall Study|Lost to Follow-up|12|||
49035517|NCT02488408|157965522|FG004|Part B|Investigator Decision|0|||
49035518|NCT02488408|157965523|FG005|Part B|Investigator Decision|0|||
48886817|NCT02993406|157421933|FG001|Overall Study|Lost to Follow-up|13|||
48886818|NCT02993406|157421932|FG000|Overall Study|Unclassifiable Response|105|||
48886819|NCT02993406|157421933|FG001|Overall Study|Unclassifiable Response|139|||
48886820|NCT02993406|157421932|FG000|Overall Study|Administrative decision|1|||
48886821|NCT02993406|157421933|FG001|Overall Study|Administrative decision|0|||
48886822|NCT02993406|157421932|FG000|Overall Study|Sponsor decision|4|||
48886823|NCT02993406|157421933|FG001|Overall Study|Sponsor decision|5|||
48886824|NCT02706405|157421945|FG000|Overall Study|Death|3|||
48886825|NCT02706405|157421946|FG001|Overall Study|Death|2|||
48886826|NCT02706405|157421947|FG002|Overall Study|Death|0|||
48886827|NCT02706405|157421948|FG003|Overall Study|Death|1|||
48886828|NCT02706405|157421949|FG004|Overall Study|Death|0|||
48886829|NCT02706405|157421950|FG005|Overall Study|Death|0|||
48886830|NCT02706405|157421951|FG006|Overall Study|Death|3|||
48886831|NCT02706405|157421952|FG007|Overall Study|Death|4|||
49035519|NCT02488408|157965524|FG006|Part B|Investigator Decision|1|||
49035520|NCT02488408|157965525|FG007|Part B|Investigator Decision|0|||
49035521|NCT02488408|157965526|FG008|Part B|Investigator Decision|2|||
49035522|NCT02488408|157965527|FG009|Part B|Investigator Decision|1|||
48886832|NCT02706405|157421945|FG000|Overall Study|Disease progression|0|||
48886833|NCT02706405|157421946|FG001|Overall Study|Disease progression|0|||
48886834|NCT02706405|157421947|FG002|Overall Study|Disease progression|0|||
48886835|NCT02706405|157421948|FG003|Overall Study|Disease progression|0|||
48886836|NCT02706405|157421949|FG004|Overall Study|Disease progression|0|||
48886837|NCT02706405|157421950|FG005|Overall Study|Disease progression|0|||
48886838|NCT02706405|157421951|FG006|Overall Study|Disease progression|0|||
48886839|NCT02706405|157421952|FG007|Overall Study|Disease progression|1|||
48886840|NCT02706405|157421945|FG000|Overall Study|Pt moved to new therapy|0|||
48886841|NCT02706405|157421946|FG001|Overall Study|Pt moved to new therapy|0|||
48886842|NCT02706405|157421947|FG002|Overall Study|Pt moved to new therapy|0|||
48886843|NCT02706405|157421948|FG003|Overall Study|Pt moved to new therapy|0|||
48886844|NCT02706405|157421949|FG004|Overall Study|Pt moved to new therapy|0|||
48886845|NCT02706405|157421950|FG005|Overall Study|Pt moved to new therapy|1|||
48886846|NCT02706405|157421951|FG006|Overall Study|Pt moved to new therapy|0|||
48886847|NCT02706405|157421952|FG007|Overall Study|Pt moved to new therapy|1|||
48886848|NCT02706405|157421945|FG000|Overall Study|Physician Decision|1|||
48886849|NCT02706405|157421946|FG001|Overall Study|Physician Decision|0|||
48886850|NCT02706405|157421947|FG002|Overall Study|Physician Decision|0|||
48886851|NCT02706405|157421948|FG003|Overall Study|Physician Decision|0|||
48886852|NCT02706405|157421949|FG004|Overall Study|Physician Decision|0|||
48886853|NCT02706405|157421950|FG005|Overall Study|Physician Decision|0|||
48886854|NCT02706405|157421951|FG006|Overall Study|Physician Decision|0|||
48886855|NCT02706405|157421952|FG007|Overall Study|Physician Decision|0|||
48886856|NCT01228318|157421953|FG000|Overall Study|Clinic no show to receive intervention|1|||
48886857|NCT01228318|157421954|FG001|Overall Study|Clinic no show to receive intervention|0|||
48886858|NCT01228318|157421953|FG000|Overall Study|Unable to contact|2|||
48886859|NCT01228318|157421954|FG001|Overall Study|Unable to contact|5|||
48886860|NCT01228318|157421953|FG000|Overall Study|Moved|0|||
48886861|NCT01228318|157421954|FG001|Overall Study|Moved|2|||
48886862|NCT01228318|157421953|FG000|Overall Study|Incarcerated|1|||
48886863|NCT01228318|157421954|FG001|Overall Study|Incarcerated|0|||
48886864|NCT02037477|157421955|FG000|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
48886865|NCT02037477|157421956|FG001|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
48886866|NCT02037477|157421957|FG002|Treatment Period 1|Pre-treatment Event/Adverse Event|1|||
48886867|NCT02037477|157421958|FG003|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
48886868|NCT00603525|157421963|FG000|DB Treatment Period (24 Weeks)|Adverse Event|3|||
48886869|NCT00603525|157421964|FG001|DB Treatment Period (24 Weeks)|Adverse Event|9|||
49035523|NCT01788423|157965528|FG000|Overall Study|See Comments in Completed (above)|0|||
49035524|NCT01788423|157965529|FG001|Overall Study|See Comments in Completed (above)|4|||
49035525|NCT01788423|157965530|FG002|Overall Study|See Comments in Completed (above)|5|||
48886870|NCT00603525|157421965|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
48886871|NCT00603525|157421963|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|7|||
48886872|NCT00603525|157421964|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
48886873|NCT00603525|157421965|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
48886874|NCT00603525|157421963|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
48886875|NCT00603525|157421964|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|2|||
48886876|NCT00603525|157421965|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
48886877|NCT00603525|157421963|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
48886878|NCT00603525|157421964|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|3|||
48886879|NCT00603525|157421965|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
49035526|NCT01501955|157965531|FG000|Overall Study|Withdrawal by Subject|1|||
48886880|NCT00603525|157421963|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
48886881|NCT00603525|157421964|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6|||
48886882|NCT00603525|157421965|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
48886883|NCT00603525|157421963|FG000|DB Treatment Period (24 Weeks)|Physician Decision|0|||
48886884|NCT00603525|157421964|FG001|DB Treatment Period (24 Weeks)|Physician Decision|1|||
48886885|NCT00603525|157421965|FG002|DB Treatment Period (24 Weeks)|Physician Decision|0|||
48886886|NCT00603525|157421963|FG000|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
48886887|NCT00603525|157421964|FG001|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1|||
48886888|NCT00603525|157421965|FG002|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
48886889|NCT00603525|157421963|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
48886890|NCT00603525|157421964|FG001|OL Treatment Period (120 Weeks)|Adverse Event|12|||
48886891|NCT00603525|157421965|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
48886892|NCT00603525|157421963|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
48886893|NCT00603525|157421964|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|13|||
48886894|NCT00603525|157421965|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
48886895|NCT00603525|157421963|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
48886896|NCT00603525|157421964|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|1|||
48886897|NCT00603525|157421965|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
48886898|NCT00603525|157421963|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
48886899|NCT00603525|157421964|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5|||
48886900|NCT00603525|157421965|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
48886901|NCT00603525|157421963|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
48886902|NCT00603525|157421964|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71|||
48886903|NCT00603525|157421965|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
48886904|NCT00603525|157421963|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
48886905|NCT00603525|157421964|FG001|OL Treatment Period (120 Weeks)|Physician Decision|2|||
48886906|NCT00603525|157421965|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
48886907|NCT00603525|157421963|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
48886908|NCT00603525|157421964|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8|||
48886909|NCT00603525|157421965|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
48886910|NCT00603525|157421963|FG000|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
48886911|NCT00603525|157421964|FG001|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
48886912|NCT00603525|157421965|FG002|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111|||
48886913|NCT02311673|157421966|FG000|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
48886914|NCT02311673|157421967|FG001|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
48886915|NCT02311673|157421968|FG002|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|1|||
48886916|NCT02311673|157421969|FG003|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
48886917|NCT04043143|157421970|FG000|Overall Study|Lost to Follow-up|5|||
48886918|NCT04043143|157421971|FG001|Overall Study|Lost to Follow-up|5|||
48886919|NCT04043143|157421970|FG000|Overall Study|screen failure|1|||
48886920|NCT04043143|157421971|FG001|Overall Study|screen failure|0|||
48886921|NCT01977677|157421972|FG000|Overall Study|Unrelated Adverse Event|0|||
48886922|NCT01977677|157421973|FG001|Overall Study|Unrelated Adverse Event|0|||
48886923|NCT01977677|157421974|FG002|Overall Study|Unrelated Adverse Event|1|||
48886924|NCT00953771|157421977|FG000|Overall Study|Death|1|||
48886925|NCT00953771|157421978|FG001|Overall Study|Death|0|||
48886926|NCT00567567|157421979|FG000|Overall Study|Adverse Event|0|||
48886927|NCT00567567|157421980|FG001|Overall Study|Adverse Event|2|||
48886928|NCT00567567|157421981|FG002|Overall Study|Adverse Event|5|||
48886929|NCT00567567|157421979|FG000|Overall Study|Death|8|||
48886930|NCT00567567|157421980|FG001|Overall Study|Death|1|||
48886931|NCT00567567|157421981|FG002|Overall Study|Death|5|||
48886932|NCT00567567|157421979|FG000|Overall Study|Lack of Efficacy|16|||
48886933|NCT00567567|157421980|FG001|Overall Study|Lack of Efficacy|17|||
48886934|NCT00567567|157421981|FG002|Overall Study|Lack of Efficacy|48|||
48886935|NCT00567567|157421979|FG000|Overall Study|Lost to Follow-up|0|||
48886936|NCT00567567|157421980|FG001|Overall Study|Lost to Follow-up|0|||
48886937|NCT00567567|157421981|FG002|Overall Study|Lost to Follow-up|1|||
48886938|NCT00567567|157421979|FG000|Overall Study|Physician Decision|16|||
48886939|NCT00567567|157421980|FG001|Overall Study|Physician Decision|18|||
48886940|NCT00567567|157421981|FG002|Overall Study|Physician Decision|84|||
48886941|NCT00567567|157421979|FG000|Overall Study|Withdrawal by Subject|0|||
48886942|NCT00567567|157421980|FG001|Overall Study|Withdrawal by Subject|0|||
48886943|NCT00567567|157421981|FG002|Overall Study|Withdrawal by Subject|2|||
48886944|NCT00567567|157421979|FG000|Overall Study|Ineligible|4|||
48886945|NCT00567567|157421980|FG001|Overall Study|Ineligible|0|||
48886946|NCT00567567|157421981|FG002|Overall Study|Ineligible|9|||
48886947|NCT00567567|157421979|FG000|Overall Study|Refusal by patient/parent/guardian|9|||
48886948|NCT00567567|157421980|FG001|Overall Study|Refusal by patient/parent/guardian|16|||
48886949|NCT00567567|157421981|FG002|Overall Study|Refusal by patient/parent/guardian|122|||
48886950|NCT00567567|157421979|FG000|Overall Study|Enrolled another COG therapeutic study|99|||
48886951|NCT00567567|157421980|FG001|Overall Study|Enrolled another COG therapeutic study|80|||
48886952|NCT00567567|157421981|FG002|Overall Study|Enrolled another COG therapeutic study|0|||
48886953|NCT00567567|157421979|FG000|Overall Study|Unable adequate stem cell for transplant|0|||
48886954|NCT00567567|157421980|FG001|Overall Study|Unable adequate stem cell for transplant|0|||
48886955|NCT00567567|157421981|FG002|Overall Study|Unable adequate stem cell for transplant|2|||
48886956|NCT03433677|157421982|FG000|Period 1|Protocol Violation|1|||
48886957|NCT03433677|157421983|FG001|Period 1|Protocol Violation|0|||
48886958|NCT03433677|157421982|FG000|Period 2|Withdrawal by Subject|1|||
48886959|NCT03433677|157421983|FG001|Period 2|Withdrawal by Subject|1|||
48886960|NCT00709228|157421984|FG000|Overall Study|Not treated|14|||
48886961|NCT00709228|157421984|FG000|Overall Study|Eligibility criteria not met|281|||
48886962|NCT00709228|157421984|FG000|Overall Study|Adverse events|2|||
48886963|NCT00709228|157421984|FG000|Overall Study|Discontinued treatment|14|||
48886964|NCT00709228|157421984|FG000|Overall Study|Did not enter follow-up|4|||
48886965|NCT00709228|157421984|FG000|Overall Study|Discontinued follow-up|5|||
48886966|NCT00709228|157421984|FG000|Overall Study|Disease progression|1|||
49035527|NCT01501955|157965532|FG001|Overall Study|Withdrawal by Subject|0|||
49035528|NCT01501955|157965531|FG000|Overall Study|Adverse Event|1|||
48886967|NCT00709228|157421984|FG000|Overall Study|Lost to Follow-up|6|||
48886968|NCT00709228|157421984|FG000|Overall Study|Non-compliance|5|||
48886969|NCT04497389|157421985|FG000|Overall Study|Withdrawal by Subject|1|||
48886970|NCT04497389|157421986|FG001|Overall Study|Withdrawal by Subject|0|||
48886971|NCT00789360|157421987|FG000|Overall Study|Protocol Violation|3|||
48886972|NCT00789360|157421988|FG001|Overall Study|Protocol Violation|1|||
48886973|NCT03139604|157421989|FG000|Overall Study|Other|7|||
48886974|NCT03139604|157421990|FG001|Overall Study|Other|3|||
48886975|NCT03139604|157421989|FG000|Overall Study|Withdrawal by Subject|16|||
48886976|NCT03139604|157421990|FG001|Overall Study|Withdrawal by Subject|17|||
48886977|NCT03139604|157421989|FG000|Overall Study|Physician Decision|1|||
48886978|NCT03139604|157421990|FG001|Overall Study|Physician Decision|2|||
48886979|NCT03139604|157421989|FG000|Overall Study|Lost to Follow-up|3|||
48886980|NCT03139604|157421990|FG001|Overall Study|Lost to Follow-up|1|||
48886981|NCT03139604|157421989|FG000|Overall Study|Death|65|||
48886982|NCT03139604|157421990|FG001|Overall Study|Death|67|||
48886983|NCT03139604|157421989|FG000|Overall Study|Study Terminated by Sponsor|122|||
48886984|NCT03139604|157421990|FG001|Overall Study|Study Terminated by Sponsor|127|||
48886985|NCT03139604|157421989|FG000|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5|||
48886986|NCT03139604|157421990|FG001|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3|||
48886987|NCT03559062|157421991|FG000|Overall Study|Other|0|||
48886988|NCT03559062|157421992|FG001|Overall Study|Other|1|||
48886989|NCT03559062|157421993|FG002|Overall Study|Other|0|||
48886990|NCT01940939|157421994|FG000|Overall Study|Withdrawal by Subject|2|||
48886991|NCT01940939|157421995|FG001|Overall Study|Withdrawal by Subject|8|||
48886992|NCT01144052|157421996|FG000|Overall Study|Withdrawal by Subject|1|||
48886993|NCT01144052|157421997|FG001|Overall Study|Withdrawal by Subject|1|||
49035529|NCT01501955|157965532|FG001|Overall Study|Adverse Event|3|||
49035530|NCT02087423|157965533|FG000|Overall Study|Withdrawal by Subject|20|||
49035531|NCT02087423|157965534|FG001|Overall Study|Withdrawal by Subject|20|||
48886994|NCT02591953|157421998|FG000|Overall Study|Lost to Follow-up|6|||
48886995|NCT02591953|157421999|FG001|Overall Study|Lost to Follow-up|6|||
48886996|NCT01499303|157422001|FG000|Overall Study|Ongoing|2|||
48886997|NCT01499303|157422002|FG001|Overall Study|Ongoing|1|||
48886998|NCT01499303|157422001|FG000|Overall Study|Withdrawal by Subject|0|||
48886999|NCT01499303|157422002|FG001|Overall Study|Withdrawal by Subject|1|||
48887000|NCT01499303|157422001|FG000|Overall Study|Adverse Event|1|||
48887001|NCT01499303|157422002|FG001|Overall Study|Adverse Event|4|||
48887002|NCT01499303|157422001|FG000|Overall Study|Other|0|||
48887003|NCT01499303|157422002|FG001|Overall Study|Other|1|||
48887004|NCT00461981|157422003|FG000|Overall Study|Lost to Follow-up|9|||
49035532|NCT02087423|157965535|FG002|Overall Study|Withdrawal by Subject|3|||
48887005|NCT00461981|157422004|FG001|Overall Study|Lost to Follow-up|6|||
48887006|NCT00461981|157422003|FG000|Overall Study|Withdrawal by Subject|2|||
48887007|NCT00461981|157422004|FG001|Overall Study|Withdrawal by Subject|3|||
48887008|NCT00874731|157422012|FG000|Part 1, Day 1: Placebo|Disease Progression|1|||
48887009|NCT00874731|157422013|FG001|Part 1, Day 1: Placebo|Disease Progression|0|||
48887010|NCT00874731|157422014|FG002|Part 1, Day 1: Placebo|Disease Progression|0|||
48887011|NCT00874731|157422012|FG000|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
49035533|NCT02087423|157965533|FG000|Overall Study|Death|68|||
48887012|NCT00874731|157422013|FG001|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
48887013|NCT00874731|157422014|FG002|Part 2: Ridaforolimus 40 mg|Adverse Event|3|||
48887014|NCT00874731|157422012|FG000|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
48887015|NCT00874731|157422013|FG001|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
48887016|NCT00874731|157422014|FG002|Part 2: Ridaforolimus 40 mg|Disease Progression|19|||
48887017|NCT03015129|157422015|FG000|Overall Study|Death|2|||
49035534|NCT02087423|157965534|FG001|Overall Study|Death|207|||
49035535|NCT02087423|157965535|FG002|Overall Study|Death|40|||
48887018|NCT03015129|157422016|FG001|Overall Study|Death|2|||
49035536|NCT02087423|157965533|FG000|Overall Study|Lost to Follow-up|0|||
49035537|NCT02087423|157965534|FG001|Overall Study|Lost to Follow-up|2|||
49035538|NCT02087423|157965535|FG002|Overall Study|Lost to Follow-up|0|||
49035539|NCT02087423|157965533|FG000|Overall Study|Terminated from study at final DCO|23|||
49035540|NCT02087423|157965534|FG001|Overall Study|Terminated from study at final DCO|36|||
49035541|NCT02087423|157965535|FG002|Overall Study|Terminated from study at final DCO|25|||
48887019|NCT03015129|157422015|FG000|Overall Study|Lost to Follow-up|0|||
48887020|NCT03015129|157422016|FG001|Overall Study|Lost to Follow-up|1|||
48887021|NCT03015129|157422015|FG000|Overall Study|Progression of disease|38|||
48887022|NCT03015129|157422016|FG001|Overall Study|Progression of disease|33|||
48887023|NCT03015129|157422015|FG000|Overall Study|Adverse Event|0|||
48887024|NCT03015129|157422016|FG001|Overall Study|Adverse Event|4|||
48887025|NCT01022112|157422019|FG000|Overall Study|Adverse Event|1|||
48887026|NCT01022112|157422020|FG001|Overall Study|Adverse Event|2|||
48887027|NCT01022112|157422021|FG002|Overall Study|Adverse Event|0|||
48887028|NCT01022112|157422022|FG003|Overall Study|Adverse Event|1|||
48887029|NCT01022112|157422023|FG004|Overall Study|Adverse Event|0|||
48887030|NCT01022112|157422019|FG000|Overall Study|Lack of Efficacy|1|||
48887031|NCT01022112|157422020|FG001|Overall Study|Lack of Efficacy|0|||
48887032|NCT01022112|157422021|FG002|Overall Study|Lack of Efficacy|0|||
49035542|NCT03637764|157965536|FG000|Overall Study|Adverse Event|2|||
49035543|NCT03637764|157965537|FG001|Overall Study|Adverse Event|0|||
49035544|NCT03637764|157965538|FG002|Overall Study|Adverse Event|0|||
49035545|NCT03637764|157965539|FG003|Overall Study|Adverse Event|1|||
49035546|NCT03637764|157965536|FG000|Overall Study|Progressive Disease|23|||
49035547|NCT03637764|157965537|FG001|Overall Study|Progressive Disease|23|||
49035548|NCT03637764|157965538|FG002|Overall Study|Progressive Disease|18|||
49035549|NCT03637764|157965539|FG003|Overall Study|Progressive Disease|31|||
49035550|NCT03637764|157965536|FG000|Overall Study|Withdrawal by Subject|1|||
49035551|NCT03637764|157965537|FG001|Overall Study|Withdrawal by Subject|3|||
49035552|NCT03637764|157965538|FG002|Overall Study|Withdrawal by Subject|0|||
49035553|NCT03637764|157965539|FG003|Overall Study|Withdrawal by Subject|1|||
49035554|NCT02648438|157965540|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
49035555|NCT02648438|157965541|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
49035556|NCT02648438|157965542|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
49035557|NCT02648438|157965540|FG000|Overall Study|Protocol Violation|2|||
49035558|NCT02648438|157965541|FG001|Overall Study|Protocol Violation|0|||
49035559|NCT02648438|157965542|FG002|Overall Study|Protocol Violation|0|||
49035560|NCT02648438|157965540|FG000|Overall Study|Withdrawal by Subject|1|||
49035561|NCT02648438|157965541|FG001|Overall Study|Withdrawal by Subject|1|||
49035562|NCT02648438|157965542|FG002|Overall Study|Withdrawal by Subject|0|||
49035563|NCT03249454|157965543|FG000|Overall Study|Withdrawal by Subject|0|||
49035564|NCT03249454|157965544|FG001|Overall Study|Withdrawal by Subject|0|||
49035565|NCT03249454|157965545|FG002|Overall Study|Withdrawal by Subject|0|||
49035566|NCT03249454|157965546|FG003|Overall Study|Withdrawal by Subject|0|||
49035567|NCT03249454|157965547|FG004|Overall Study|Withdrawal by Subject|0|||
48887033|NCT01022112|157422022|FG003|Overall Study|Lack of Efficacy|0|||
48887034|NCT01022112|157422023|FG004|Overall Study|Lack of Efficacy|1|||
48887035|NCT01022112|157422019|FG000|Overall Study|Physician Decision|0|||
48887036|NCT01022112|157422020|FG001|Overall Study|Physician Decision|0|||
48887037|NCT01022112|157422021|FG002|Overall Study|Physician Decision|1|||
48887038|NCT01022112|157422022|FG003|Overall Study|Physician Decision|0|||
48887039|NCT01022112|157422023|FG004|Overall Study|Physician Decision|1|||
48887040|NCT01022112|157422019|FG000|Overall Study|Withdrawal by Subject|0|||
48887041|NCT01022112|157422020|FG001|Overall Study|Withdrawal by Subject|1|||
48887042|NCT01022112|157422021|FG002|Overall Study|Withdrawal by Subject|2|||
48887043|NCT01022112|157422022|FG003|Overall Study|Withdrawal by Subject|2|||
48887044|NCT01022112|157422023|FG004|Overall Study|Withdrawal by Subject|1|||
48887045|NCT01022112|157422019|FG000|Overall Study|Fasting plasma glucose level increased|1|||
48887046|NCT01022112|157422020|FG001|Overall Study|Fasting plasma glucose level increased|0|||
48887047|NCT01022112|157422021|FG002|Overall Study|Fasting plasma glucose level increased|0|||
48887048|NCT01022112|157422022|FG003|Overall Study|Fasting plasma glucose level increased|0|||
48887049|NCT01022112|157422023|FG004|Overall Study|Fasting plasma glucose level increased|7|||
48887050|NCT01803282|157422026|FG000|Overall Study|Progressive Disease|4|||
48887051|NCT01803282|157422027|FG001|Overall Study|Progressive Disease|3|||
49035568|NCT03249454|157965548|FG005|Overall Study|Withdrawal by Subject|0|||
49035569|NCT03249454|157965549|FG006|Overall Study|Withdrawal by Subject|0|||
49035570|NCT03249454|157965550|FG007|Overall Study|Withdrawal by Subject|0|||
49035571|NCT03249454|157965551|FG008|Overall Study|Withdrawal by Subject|0|||
49035572|NCT03249454|157965552|FG009|Overall Study|Withdrawal by Subject|1|||
49035573|NCT03249454|157965553|FG010|Overall Study|Withdrawal by Subject|1|||
48887052|NCT01803282|157422028|FG002|Overall Study|Progressive Disease|6|||
48887053|NCT01803282|157422029|FG003|Overall Study|Progressive Disease|22|||
49035574|NCT01175135|157965554|FG000|Overall Study|Adverse Event|2|||
48887054|NCT01803282|157422030|FG004|Overall Study|Progressive Disease|5|||
48887055|NCT01803282|157422031|FG005|Overall Study|Progressive Disease|8|||
48887056|NCT01803282|157422032|FG006|Overall Study|Progressive Disease|23|||
48887057|NCT01803282|157422033|FG007|Overall Study|Progressive Disease|24|||
48887058|NCT01803282|157422034|FG008|Overall Study|Progressive Disease|3|||
48887059|NCT01803282|157422035|FG009|Overall Study|Progressive Disease|29|||
48887060|NCT01803282|157422036|FG010|Overall Study|Progressive Disease|6|||
48887061|NCT01803282|157422037|FG011|Overall Study|Progressive Disease|11|||
48887062|NCT01803282|157422026|FG000|Overall Study|Death|0|||
48887063|NCT01803282|157422027|FG001|Overall Study|Death|0|||
48887064|NCT01803282|157422028|FG002|Overall Study|Death|0|||
48887065|NCT01803282|157422029|FG003|Overall Study|Death|0|||
48887066|NCT01803282|157422030|FG004|Overall Study|Death|2|||
48887067|NCT01803282|157422031|FG005|Overall Study|Death|1|||
48887068|NCT01803282|157422032|FG006|Overall Study|Death|1|||
48887069|NCT01803282|157422033|FG007|Overall Study|Death|5|||
48887070|NCT01803282|157422034|FG008|Overall Study|Death|1|||
48887071|NCT01803282|157422035|FG009|Overall Study|Death|1|||
48887072|NCT01803282|157422036|FG010|Overall Study|Death|0|||
48887073|NCT01803282|157422037|FG011|Overall Study|Death|0|||
48887074|NCT01803282|157422026|FG000|Overall Study|Withdrew Consent|0|||
48887075|NCT01803282|157422027|FG001|Overall Study|Withdrew Consent|0|||
48887076|NCT01803282|157422028|FG002|Overall Study|Withdrew Consent|0|||
48887077|NCT01803282|157422029|FG003|Overall Study|Withdrew Consent|6|||
48887078|NCT01803282|157422030|FG004|Overall Study|Withdrew Consent|1|||
48887079|NCT01803282|157422031|FG005|Overall Study|Withdrew Consent|0|||
48887080|NCT01803282|157422032|FG006|Overall Study|Withdrew Consent|8|||
48887081|NCT01803282|157422033|FG007|Overall Study|Withdrew Consent|3|||
48887082|NCT01803282|157422034|FG008|Overall Study|Withdrew Consent|1|||
48887083|NCT01803282|157422035|FG009|Overall Study|Withdrew Consent|5|||
48887084|NCT01803282|157422036|FG010|Overall Study|Withdrew Consent|0|||
48887085|NCT01803282|157422037|FG011|Overall Study|Withdrew Consent|1|||
48887086|NCT01803282|157422026|FG000|Overall Study|Investigator's Discretion|0|||
48887087|NCT01803282|157422027|FG001|Overall Study|Investigator's Discretion|0|||
48887088|NCT01803282|157422028|FG002|Overall Study|Investigator's Discretion|0|||
48887089|NCT01803282|157422029|FG003|Overall Study|Investigator's Discretion|7|||
48887090|NCT01803282|157422030|FG004|Overall Study|Investigator's Discretion|2|||
48887091|NCT01803282|157422031|FG005|Overall Study|Investigator's Discretion|1|||
48887092|NCT01803282|157422032|FG006|Overall Study|Investigator's Discretion|7|||
48887093|NCT01803282|157422033|FG007|Overall Study|Investigator's Discretion|10|||
48887094|NCT01803282|157422034|FG008|Overall Study|Investigator's Discretion|6|||
48887095|NCT01803282|157422035|FG009|Overall Study|Investigator's Discretion|7|||
48887096|NCT01803282|157422036|FG010|Overall Study|Investigator's Discretion|1|||
48887097|NCT01803282|157422037|FG011|Overall Study|Investigator's Discretion|0|||
48887098|NCT01803282|157422026|FG000|Overall Study|Adverse Event|0|||
48887099|NCT01803282|157422027|FG001|Overall Study|Adverse Event|0|||
48887100|NCT01803282|157422028|FG002|Overall Study|Adverse Event|0|||
48887101|NCT01803282|157422029|FG003|Overall Study|Adverse Event|0|||
48887102|NCT01803282|157422030|FG004|Overall Study|Adverse Event|0|||
48887103|NCT01803282|157422031|FG005|Overall Study|Adverse Event|0|||
48887104|NCT01803282|157422032|FG006|Overall Study|Adverse Event|1|||
48887105|NCT01803282|157422033|FG007|Overall Study|Adverse Event|2|||
48887106|NCT01803282|157422034|FG008|Overall Study|Adverse Event|0|||
48887107|NCT01803282|157422035|FG009|Overall Study|Adverse Event|1|||
48887108|NCT01803282|157422036|FG010|Overall Study|Adverse Event|0|||
48887109|NCT01803282|157422037|FG011|Overall Study|Adverse Event|3|||
48887110|NCT01803282|157422026|FG000|Overall Study|Non-Compliance with Study Drug|0|||
48887111|NCT01803282|157422027|FG001|Overall Study|Non-Compliance with Study Drug|0|||
48887112|NCT01803282|157422028|FG002|Overall Study|Non-Compliance with Study Drug|0|||
48887113|NCT01803282|157422029|FG003|Overall Study|Non-Compliance with Study Drug|1|||
48887114|NCT01803282|157422030|FG004|Overall Study|Non-Compliance with Study Drug|0|||
48887115|NCT01803282|157422031|FG005|Overall Study|Non-Compliance with Study Drug|0|||
48887116|NCT01803282|157422032|FG006|Overall Study|Non-Compliance with Study Drug|0|||
48887117|NCT01803282|157422033|FG007|Overall Study|Non-Compliance with Study Drug|0|||
48887118|NCT01803282|157422034|FG008|Overall Study|Non-Compliance with Study Drug|0|||
48887119|NCT01803282|157422035|FG009|Overall Study|Non-Compliance with Study Drug|0|||
49035575|NCT01175135|157965555|FG001|Overall Study|Adverse Event|5|||
48887120|NCT01803282|157422036|FG010|Overall Study|Non-Compliance with Study Drug|0|||
48887121|NCT01803282|157422037|FG011|Overall Study|Non-Compliance with Study Drug|0|||
48887122|NCT01803282|157422026|FG000|Overall Study|Unknown Reason|0|||
48887123|NCT01803282|157422027|FG001|Overall Study|Unknown Reason|0|||
48887124|NCT01803282|157422028|FG002|Overall Study|Unknown Reason|0|||
48887125|NCT01803282|157422029|FG003|Overall Study|Unknown Reason|0|||
48887126|NCT01803282|157422030|FG004|Overall Study|Unknown Reason|0|||
48887127|NCT01803282|157422031|FG005|Overall Study|Unknown Reason|0|||
48887128|NCT01803282|157422032|FG006|Overall Study|Unknown Reason|0|||
48887129|NCT01803282|157422033|FG007|Overall Study|Unknown Reason|1|||
48887130|NCT01803282|157422034|FG008|Overall Study|Unknown Reason|0|||
48887131|NCT01803282|157422035|FG009|Overall Study|Unknown Reason|0|||
48887132|NCT01803282|157422036|FG010|Overall Study|Unknown Reason|0|||
48887133|NCT01803282|157422037|FG011|Overall Study|Unknown Reason|0|||
48887134|NCT01803282|157422026|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
48887135|NCT01803282|157422027|FG001|Overall Study|Specified Criteria for Withdrawal|0|||
48887136|NCT01803282|157422028|FG002|Overall Study|Specified Criteria for Withdrawal|0|||
48887137|NCT01803282|157422029|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
48887138|NCT01803282|157422030|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
48887139|NCT01803282|157422031|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
48887140|NCT01803282|157422032|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
48887141|NCT01803282|157422033|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
48887142|NCT01803282|157422034|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
48887143|NCT01803282|157422035|FG009|Overall Study|Specified Criteria for Withdrawal|1|||
48887144|NCT01803282|157422036|FG010|Overall Study|Specified Criteria for Withdrawal|1|||
48887145|NCT01803282|157422037|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
48887146|NCT01803282|157422026|FG000|Overall Study|Enrolled but Never Treated|0|||
48887147|NCT01803282|157422027|FG001|Overall Study|Enrolled but Never Treated|0|||
48887148|NCT01803282|157422028|FG002|Overall Study|Enrolled but Never Treated|0|||
48887149|NCT01803282|157422029|FG003|Overall Study|Enrolled but Never Treated|0|||
48887150|NCT01803282|157422030|FG004|Overall Study|Enrolled but Never Treated|1|||
48887151|NCT01803282|157422031|FG005|Overall Study|Enrolled but Never Treated|0|||
48887152|NCT01803282|157422032|FG006|Overall Study|Enrolled but Never Treated|1|||
48887153|NCT01803282|157422033|FG007|Overall Study|Enrolled but Never Treated|1|||
48887154|NCT01803282|157422034|FG008|Overall Study|Enrolled but Never Treated|0|||
48887155|NCT01803282|157422035|FG009|Overall Study|Enrolled but Never Treated|1|||
48887156|NCT01803282|157422036|FG010|Overall Study|Enrolled but Never Treated|0|||
48887157|NCT01803282|157422037|FG011|Overall Study|Enrolled but Never Treated|0|||
48887158|NCT01743989|157422040|FG000|Treatment Phase|Unstable MR4.0|0|||
48887159|NCT01743989|157422041|FG001|Treatment Phase|Unstable MR4.0|6|||
48887160|NCT01743989|157422042|FG002|Treatment Phase|Unstable MR4.0|263|||
48887161|NCT01743989|157422040|FG000|Treatment Phase|Adverse Event|0|||
48887162|NCT01743989|157422041|FG001|Treatment Phase|Adverse Event|4|||
48887163|NCT01743989|157422042|FG002|Treatment Phase|Adverse Event|67|||
48887164|NCT01743989|157422040|FG000|Treatment Phase|Withdrawal by Subject|1|||
48887165|NCT01743989|157422041|FG001|Treatment Phase|Withdrawal by Subject|3|||
48887166|NCT01743989|157422042|FG002|Treatment Phase|Withdrawal by Subject|28|||
48887167|NCT01743989|157422040|FG000|Treatment Phase|Death|0|||
48887168|NCT01743989|157422041|FG001|Treatment Phase|Death|1|||
48887169|NCT01743989|157422042|FG002|Treatment Phase|Death|3|||
48887170|NCT01743989|157422040|FG000|Treatment Phase|Abnormal laboratory value(s)|0|||
48887171|NCT01743989|157422041|FG001|Treatment Phase|Abnormal laboratory value(s)|0|||
48887172|NCT01743989|157422042|FG002|Treatment Phase|Abnormal laboratory value(s)|3|||
48887173|NCT01743989|157422040|FG000|Treatment Phase|Protocol deviation|0|||
48887174|NCT01743989|157422041|FG001|Treatment Phase|Protocol deviation|0|||
48887175|NCT01743989|157422042|FG002|Treatment Phase|Protocol deviation|3|||
48887176|NCT01743989|157422040|FG000|Treatment Phase|Pregnancy|0|||
48887177|NCT01743989|157422041|FG001|Treatment Phase|Pregnancy|0|||
48887178|NCT01743989|157422042|FG002|Treatment Phase|Pregnancy|2|||
48887179|NCT01743989|157422040|FG000|Treatment Phase|Lost to Follow-up|0|||
48887180|NCT01743989|157422041|FG001|Treatment Phase|Lost to Follow-up|0|||
48887181|NCT01743989|157422042|FG002|Treatment Phase|Lost to Follow-up|2|||
48887182|NCT01743989|157422040|FG000|Treatment Phase|Abnormal test procedure result(s)|0|||
48887183|NCT01743989|157422041|FG001|Treatment Phase|Abnormal test procedure result(s)|0|||
48887184|NCT01743989|157422042|FG002|Treatment Phase|Abnormal test procedure result(s)|1|||
48887185|NCT01743989|157422040|FG000|Treatment Phase|Administrative problems|0|||
48887186|NCT01743989|157422041|FG001|Treatment Phase|Administrative problems|0|||
48887187|NCT01743989|157422042|FG002|Treatment Phase|Administrative problems|1|||
48887188|NCT01743989|157422040|FG000|Treatment Phase|New cancer (CML) therapy|0|||
48887189|NCT01743989|157422041|FG001|Treatment Phase|New cancer (CML) therapy|1|||
48887190|NCT01743989|157422042|FG002|Treatment Phase|New cancer (CML) therapy|0|||
48887191|NCT01743989|157422040|FG000|Treatment Phase|Physician Decision|0|||
48887192|NCT01743989|157422041|FG001|Treatment Phase|Physician Decision|0|||
48887193|NCT01743989|157422042|FG002|Treatment Phase|Physician Decision|3|||
48887194|NCT01743989|157422040|FG000|Treatment Phase|Patient non-compliance to treatment|0|||
48887195|NCT01743989|157422041|FG001|Treatment Phase|Patient non-compliance to treatment|0|||
48887196|NCT01743989|157422042|FG002|Treatment Phase|Patient non-compliance to treatment|3|||
48887197|NCT01743989|157422040|FG000|Treatment Phase|Not randomized by mistake|0|||
48887198|NCT01743989|157422041|FG001|Treatment Phase|Not randomized by mistake|0|||
48887199|NCT01743989|157422042|FG002|Treatment Phase|Not randomized by mistake|1|||
48887200|NCT01743989|157422040|FG000|Treatment Phase|Included by mistake|0|||
48887201|NCT01743989|157422041|FG001|Treatment Phase|Included by mistake|0|||
48887202|NCT01743989|157422042|FG002|Treatment Phase|Included by mistake|1|||
48887203|NCT01743989|157422040|FG000|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82|||
48887204|NCT01743989|157422041|FG001|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59|||
48887205|NCT01743989|157422042|FG002|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0|||
48887206|NCT01743989|157422040|FG000|TFR Phase|Adverse Event|0|||
48887207|NCT01743989|157422041|FG001|TFR Phase|Adverse Event|1|||
48887208|NCT01743989|157422042|FG002|TFR Phase|Adverse Event|0|||
48887209|NCT01743989|157422040|FG000|TFR Phase|Lost to Follow-up|0|||
48887210|NCT01743989|157422041|FG001|TFR Phase|Lost to Follow-up|2|||
48887211|NCT01743989|157422042|FG002|TFR Phase|Lost to Follow-up|0|||
48887212|NCT01743989|157422040|FG000|TFR Phase|Physician Decision|0|||
48887213|NCT01743989|157422041|FG001|TFR Phase|Physician Decision|1|||
48887214|NCT01743989|157422042|FG002|TFR Phase|Physician Decision|0|||
48887215|NCT01743989|157422040|FG000|TFR Phase|Logistical problems|0|||
48887216|NCT01743989|157422041|FG001|TFR Phase|Logistical problems|2|||
48887217|NCT01743989|157422042|FG002|TFR Phase|Logistical problems|0|||
48887218|NCT01743989|157422040|FG000|TFR Phase|Protocol deviation|0|||
48887219|NCT01743989|157422041|FG001|TFR Phase|Protocol deviation|1|||
48887220|NCT01743989|157422042|FG002|TFR Phase|Protocol deviation|0|||
48887221|NCT01743989|157422040|FG000|TFR Phase|Withdrawal by Subject|0|||
48887222|NCT01743989|157422041|FG001|TFR Phase|Withdrawal by Subject|2|||
48887223|NCT01743989|157422042|FG002|TFR Phase|Withdrawal by Subject|0|||
48887224|NCT01743989|157422040|FG000|Re-treatment Phase|Adverse Event|8|||
48887225|NCT01743989|157422041|FG001|Re-treatment Phase|Adverse Event|4|||
48887226|NCT01743989|157422042|FG002|Re-treatment Phase|Adverse Event|0|||
48887227|NCT01743989|157422040|FG000|Re-treatment Phase|Death|1|||
48887228|NCT01743989|157422041|FG001|Re-treatment Phase|Death|1|||
48887229|NCT01743989|157422042|FG002|Re-treatment Phase|Death|0|||
48887230|NCT01743989|157422040|FG000|Re-treatment Phase|Administrative problems|1|||
49035576|NCT01175135|157965556|FG002|Overall Study|Adverse Event|3|||
49035577|NCT01175135|157965557|FG003|Overall Study|Adverse Event|4|||
49035578|NCT01175135|157965554|FG000|Overall Study|Death|1|||
49035579|NCT01175135|157965555|FG001|Overall Study|Death|0|||
49035580|NCT01175135|157965556|FG002|Overall Study|Death|0|||
49035581|NCT01175135|157965557|FG003|Overall Study|Death|0|||
49035582|NCT01175135|157965554|FG000|Overall Study|Lack of Efficacy|4|||
49035583|NCT01175135|157965555|FG001|Overall Study|Lack of Efficacy|5|||
49035584|NCT01175135|157965556|FG002|Overall Study|Lack of Efficacy|0|||
49035585|NCT01175135|157965557|FG003|Overall Study|Lack of Efficacy|5|||
49035586|NCT01175135|157965554|FG000|Overall Study|Lost to Follow-up|1|||
49035587|NCT01175135|157965555|FG001|Overall Study|Lost to Follow-up|2|||
49035588|NCT01175135|157965556|FG002|Overall Study|Lost to Follow-up|0|||
49035589|NCT01175135|157965557|FG003|Overall Study|Lost to Follow-up|0|||
49035590|NCT01175135|157965554|FG000|Overall Study|Protocol Violation|1|||
49035591|NCT01175135|157965555|FG001|Overall Study|Protocol Violation|1|||
49035592|NCT01175135|157965556|FG002|Overall Study|Protocol Violation|0|||
49035593|NCT01175135|157965557|FG003|Overall Study|Protocol Violation|0|||
49035594|NCT01175135|157965554|FG000|Overall Study|Withdrawal by Subject|4|||
49035595|NCT01175135|157965555|FG001|Overall Study|Withdrawal by Subject|8|||
49035596|NCT01175135|157965556|FG002|Overall Study|Withdrawal by Subject|5|||
49035597|NCT01175135|157965557|FG003|Overall Study|Withdrawal by Subject|5|||
49035598|NCT01175135|157965554|FG000|Overall Study|Other|3|||
49035599|NCT01175135|157965555|FG001|Overall Study|Other|1|||
49035600|NCT01175135|157965556|FG002|Overall Study|Other|3|||
49035601|NCT01175135|157965557|FG003|Overall Study|Other|0|||
49035602|NCT01175135|157965554|FG000|Overall Study|Randomized But Not Treated|0|||
49035603|NCT01175135|157965555|FG001|Overall Study|Randomized But Not Treated|0|||
49035604|NCT01175135|157965556|FG002|Overall Study|Randomized But Not Treated|1|||
49035605|NCT01175135|157965557|FG003|Overall Study|Randomized But Not Treated|0|||
49035606|NCT05169710|157965558|FG000|Overall Study|Adverse Event|1|||
49035607|NCT05169710|157965559|FG001|Overall Study|Adverse Event|2|||
49035608|NCT05169710|157965560|FG002|Overall Study|Adverse Event|2|||
49035609|NCT05169710|157965558|FG000|Overall Study|Lost to Follow-up|0|||
49035610|NCT05169710|157965559|FG001|Overall Study|Lost to Follow-up|0|||
49035611|NCT05169710|157965560|FG002|Overall Study|Lost to Follow-up|1|||
49035612|NCT05169710|157965558|FG000|Overall Study|Withdrawal by Subject|2|||
49035613|NCT05169710|157965559|FG001|Overall Study|Withdrawal by Subject|1|||
49035614|NCT05169710|157965560|FG002|Overall Study|Withdrawal by Subject|0|||
48887231|NCT01743989|157422041|FG001|Re-treatment Phase|Administrative problems|1|||
48887232|NCT01743989|157422042|FG002|Re-treatment Phase|Administrative problems|0|||
48887233|NCT01743989|157422040|FG000|Re-treatment Phase|Withdrawal by Subject|5|||
48887234|NCT01743989|157422041|FG001|Re-treatment Phase|Withdrawal by Subject|1|||
49035615|NCT05169710|157965558|FG000|Overall Study|Other Study Discontinuation Reason|0|||
49035616|NCT05169710|157965559|FG001|Overall Study|Other Study Discontinuation Reason|2|||
49035617|NCT05169710|157965560|FG002|Overall Study|Other Study Discontinuation Reason|0|||
49035618|NCT04400890|157965561|FG000|Overall Study|Withdrawal by Subject|3|||
49035619|NCT04400890|157965562|FG001|Overall Study|Withdrawal by Subject|2|||
49035620|NCT00466167|157965567|FG000|Overall Study|Adverse Event|8|||
49035621|NCT00466167|157965568|FG001|Overall Study|Adverse Event|8|||
49035622|NCT00466167|157965569|FG002|Overall Study|Adverse Event|7|||
49035623|NCT00466167|157965567|FG000|Overall Study|Lack of Efficacy|2|||
49035624|NCT00466167|157965568|FG001|Overall Study|Lack of Efficacy|0|||
49035625|NCT00466167|157965569|FG002|Overall Study|Lack of Efficacy|3|||
48887235|NCT01743989|157422042|FG002|Re-treatment Phase|Withdrawal by Subject|0|||
48887236|NCT01743989|157422040|FG000|Re-treatment Phase|Unstable MR|1|||
48887237|NCT01743989|157422041|FG001|Re-treatment Phase|Unstable MR|0|||
49035626|NCT00466167|157965567|FG000|Overall Study|Protocol Violation|1|||
49035627|NCT00466167|157965568|FG001|Overall Study|Protocol Violation|1|||
49035628|NCT00466167|157965569|FG002|Overall Study|Protocol Violation|2|||
49035629|NCT00466167|157965567|FG000|Overall Study|Lost to Follow-up|3|||
49035630|NCT00466167|157965568|FG001|Overall Study|Lost to Follow-up|2|||
49035631|NCT00466167|157965569|FG002|Overall Study|Lost to Follow-up|2|||
49035632|NCT00466167|157965567|FG000|Overall Study|Withdrawal by Subject|4|||
49035633|NCT00466167|157965568|FG001|Overall Study|Withdrawal by Subject|1|||
49035634|NCT00466167|157965569|FG002|Overall Study|Withdrawal by Subject|6|||
49035635|NCT00466167|157965567|FG000|Overall Study|patient did not meet inclusion criteria|1|||
49035636|NCT00466167|157965568|FG001|Overall Study|patient did not meet inclusion criteria|0|||
49035637|NCT00466167|157965569|FG002|Overall Study|patient did not meet inclusion criteria|1|||
49035638|NCT00466167|157965567|FG000|Overall Study|Not treated|1|||
48887238|NCT01743989|157422042|FG002|Re-treatment Phase|Unstable MR|0|||
48887239|NCT01743989|157422040|FG000|Re-treatment Phase|Physician Decision|0|||
48887240|NCT01743989|157422041|FG001|Re-treatment Phase|Physician Decision|1|||
48887241|NCT01743989|157422042|FG002|Re-treatment Phase|Physician Decision|0|||
48887242|NCT01743989|157422040|FG000|Re-treatment Phase|Lost to Follow-up|0|||
48887243|NCT01743989|157422041|FG001|Re-treatment Phase|Lost to Follow-up|1|||
48887244|NCT01743989|157422042|FG002|Re-treatment Phase|Lost to Follow-up|0|||
48887245|NCT02235311|157422046|FG000|Overall Study|Lost to Follow-up|0|||
48887246|NCT02235311|157422047|FG001|Overall Study|Lost to Follow-up|1|||
48887247|NCT02235311|157422046|FG000|Overall Study|Protocol Violation|0|||
48887248|NCT02235311|157422047|FG001|Overall Study|Protocol Violation|1|||
48887249|NCT04655027|157422049|FG000|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|1|||
48887250|NCT04655027|157422050|FG001|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|0|||
48887251|NCT03014479|157422055|FG000|Overall Study|Adverse Event|0|||
48887252|NCT03014479|157422056|FG001|Overall Study|Adverse Event|1|||
48887253|NCT03014479|157422055|FG000|Overall Study|Voluntary Withdrawal|0|||
48887254|NCT03014479|157422056|FG001|Overall Study|Voluntary Withdrawal|2|||
48887255|NCT03014479|157422055|FG000|Overall Study|Unacceptable Inability of Site Visit|0|||
48887256|NCT03014479|157422056|FG001|Overall Study|Unacceptable Inability of Site Visit|1|||
48887257|NCT05597787|157422057|FG000|Overall Study|Withdrawal by Subject|0|||
48887258|NCT05597787|157422058|FG001|Overall Study|Withdrawal by Subject|0|||
48887259|NCT05597787|157422059|FG002|Overall Study|Withdrawal by Subject|1|||
49035639|NCT00466167|157965568|FG001|Overall Study|Not treated|0|||
49035640|NCT00466167|157965569|FG002|Overall Study|Not treated|0|||
49035641|NCT03199963|157965570|FG000|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
49035642|NCT03199963|157965571|FG001|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
49035643|NCT03199963|157965570|FG000|Blinded Phase - Overall Study|Lost to Follow-up|9|||
49035644|NCT03199963|157965571|FG001|Blinded Phase - Overall Study|Lost to Follow-up|2|||
49035645|NCT03199963|157965570|FG000|Blinded Phase - Overall Study|Adverse Event|10|||
49035646|NCT03199963|157965571|FG001|Blinded Phase - Overall Study|Adverse Event|5|||
48887260|NCT05215054|157422060|FG000|Overall Study|Lost to Follow-up|1|||
48887261|NCT05215054|157422061|FG001|Overall Study|Lost to Follow-up|1|||
48887262|NCT05215054|157422060|FG000|Overall Study|Protocol Violation|1|||
48887263|NCT05215054|157422061|FG001|Overall Study|Protocol Violation|1|||
48887264|NCT05215054|157422060|FG000|Overall Study|Withdrawal by Subject|4|||
48887265|NCT05215054|157422061|FG001|Overall Study|Withdrawal by Subject|4|||
48887266|NCT01920477|157424123|FG000|Overall Study|Adverse Event|0|||
48887267|NCT01920477|157424124|FG001|Overall Study|Adverse Event|1|||
48887268|NCT01920477|157424123|FG000|Overall Study|Lack of Efficacy|1|||
48887269|NCT01920477|157424124|FG001|Overall Study|Lack of Efficacy|0|||
48887270|NCT01920477|157424123|FG000|Overall Study|Study closed/terminated|14|||
48887271|NCT01920477|157424124|FG001|Overall Study|Study closed/terminated|15|||
48887272|NCT01920477|157424123|FG000|Overall Study|Withdrawal by Subject|0|||
48887273|NCT01920477|157424124|FG001|Overall Study|Withdrawal by Subject|1|||
48887274|NCT00387426|157424127|FG000|Overall Study|Lack of Response|7|||
48887275|NCT00387426|157424127|FG000|Overall Study|Toxicities|4|||
48887276|NCT00387426|157424127|FG000|Overall Study|Disease Progression|3|||
48887277|NCT00747227|157424128|FG000|Overall Study|Death|3|||
48887278|NCT00747227|157424129|FG001|Overall Study|Death|1|||
48887279|NCT00747227|157424128|FG000|Overall Study|Withdrawal by Subject|1|||
48887280|NCT00747227|157424129|FG001|Overall Study|Withdrawal by Subject|0|||
48887281|NCT00747227|157424128|FG000|Overall Study|Lost to Follow-up|1|||
48887282|NCT00747227|157424129|FG001|Overall Study|Lost to Follow-up|2|||
48887283|NCT00747227|157424128|FG000|Overall Study|Illness|1|||
48887284|NCT00747227|157424129|FG001|Overall Study|Illness|1|||
48887285|NCT01253135|157424130|FG000|Original Protocol|Protocol Amendment|15|||
48887286|NCT01253135|157424130|FG000|Amended Protocol|Non-compliance|1|||
49035647|NCT03199963|157965570|FG000|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|109|||
49035648|NCT03199963|157965571|FG001|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|54|||
48887287|NCT00974259|157424131|FG000|Overall Study|Technically inadequate PbtO2 recordings|2|||
48887288|NCT00974259|157424132|FG001|Overall Study|Technically inadequate PbtO2 recordings|1|||
48887289|NCT02787044|157424133|FG000|Overall Study|Lost to Follow-up|15|||
48887290|NCT02787044|157424134|FG001|Overall Study|Lost to Follow-up|19|||
48887291|NCT00943852|157424137|FG000|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
48887292|NCT00943852|157424138|FG001|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
48887293|NCT00943852|157424139|FG002|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
48887294|NCT00943852|157424140|FG003|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1|||
48887295|NCT00943852|157424141|FG004|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
48887296|NCT00943852|157424142|FG005|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
48887297|NCT00943852|157424143|FG006|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
48887298|NCT00943852|157424144|FG007|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
48887299|NCT00943852|157424145|FG008|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
48887300|NCT00943852|157424146|FG009|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
48887301|NCT00943852|157424137|FG000|Washout Period After Period 2 Treatment|Trial stopped early|0|||
48887302|NCT00943852|157424138|FG001|Washout Period After Period 2 Treatment|Trial stopped early|0|||
48887303|NCT00943852|157424139|FG002|Washout Period After Period 2 Treatment|Trial stopped early|0|||
48887304|NCT00943852|157424140|FG003|Washout Period After Period 2 Treatment|Trial stopped early|0|||
48887305|NCT00943852|157424141|FG004|Washout Period After Period 2 Treatment|Trial stopped early|0|||
48887306|NCT00943852|157424142|FG005|Washout Period After Period 2 Treatment|Trial stopped early|1|||
48887307|NCT00943852|157424143|FG006|Washout Period After Period 2 Treatment|Trial stopped early|0|||
48887308|NCT00943852|157424144|FG007|Washout Period After Period 2 Treatment|Trial stopped early|0|||
48887309|NCT00943852|157424145|FG008|Washout Period After Period 2 Treatment|Trial stopped early|0|||
48887310|NCT00943852|157424146|FG009|Washout Period After Period 2 Treatment|Trial stopped early|0|||
48887311|NCT00943852|157424137|FG000|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
48887312|NCT00943852|157424138|FG001|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
48887313|NCT00943852|157424139|FG002|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
48887314|NCT00943852|157424140|FG003|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
48887315|NCT00943852|157424141|FG004|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
48887316|NCT00943852|157424142|FG005|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
48887317|NCT00943852|157424143|FG006|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1|||
48887318|NCT00943852|157424144|FG007|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
48887319|NCT00943852|157424145|FG008|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
48887320|NCT00943852|157424146|FG009|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
48887321|NCT00943852|157424137|FG000|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
48887322|NCT00943852|157424138|FG001|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
48887323|NCT00943852|157424139|FG002|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
48887324|NCT00943852|157424140|FG003|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
48887325|NCT00943852|157424141|FG004|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
48887326|NCT00943852|157424142|FG005|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
48887327|NCT00943852|157424143|FG006|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
48887328|NCT00943852|157424144|FG007|Washout Period After Period 4 Treatment|Not taking medication per protocol|1|||
48887329|NCT00943852|157424145|FG008|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
48887330|NCT00943852|157424146|FG009|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
48887331|NCT00943852|157424137|FG000|Washout Period After Period 4 Treatment|Trial stopped early|1|||
48887332|NCT00943852|157424138|FG001|Washout Period After Period 4 Treatment|Trial stopped early|0|||
48887333|NCT00943852|157424139|FG002|Washout Period After Period 4 Treatment|Trial stopped early|1|||
48887334|NCT00943852|157424140|FG003|Washout Period After Period 4 Treatment|Trial stopped early|1|||
48887335|NCT00943852|157424141|FG004|Washout Period After Period 4 Treatment|Trial stopped early|0|||
48887336|NCT00943852|157424142|FG005|Washout Period After Period 4 Treatment|Trial stopped early|0|||
48887337|NCT00943852|157424143|FG006|Washout Period After Period 4 Treatment|Trial stopped early|1|||
48887338|NCT00943852|157424144|FG007|Washout Period After Period 4 Treatment|Trial stopped early|0|||
48887339|NCT00943852|157424145|FG008|Washout Period After Period 4 Treatment|Trial stopped early|0|||
48887340|NCT00943852|157424146|FG009|Washout Period After Period 4 Treatment|Trial stopped early|0|||
48887341|NCT02383940|157424151|FG000|Overall Study|Adverse Event|1|||
48887342|NCT02383940|157424152|FG001|Overall Study|Adverse Event|0|||
48887343|NCT02383940|157424151|FG000|Overall Study|Lost to Follow-up|2|||
48887344|NCT02383940|157424152|FG001|Overall Study|Lost to Follow-up|2|||
48887345|NCT02383940|157424151|FG000|Overall Study|Physician Decision|2|||
48887346|NCT02383940|157424152|FG001|Overall Study|Physician Decision|0|||
48887347|NCT02383940|157424151|FG000|Overall Study|Withdrawal by Subject|1|||
48887348|NCT02383940|157424152|FG001|Overall Study|Withdrawal by Subject|1|||
48887349|NCT02383940|157424151|FG000|Overall Study|Randomized but not treated|2|||
48887350|NCT02383940|157424152|FG001|Overall Study|Randomized but not treated|0|||
48887351|NCT02383940|157424151|FG000|Overall Study|Other than specified above|1|||
48887352|NCT02383940|157424152|FG001|Overall Study|Other than specified above|0|||
48887353|NCT00685698|157424153|FG000|Overall Study|Withdrawal by Subject|1|||
48887354|NCT00685698|157424153|FG000|Overall Study|Protocol Violation|6|||
48887355|NCT00685698|157424153|FG000|Overall Study|Adverse Event|3|||
48887356|NCT00685698|157424153|FG000|Overall Study|CULTURE GRAM NEG SPECIES|1|||
48887357|NCT00685698|157424153|FG000|Overall Study|CULTURE RESULTS: GRAM-VE|1|||
48887358|NCT00685698|157424153|FG000|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1|||
48887359|NCT05383508|157424157|FG000|Overall Study|Withdrawal by Subject|1|||
48887360|NCT05383508|157424158|FG001|Overall Study|Withdrawal by Subject|0|||
48887361|NCT05383508|157424159|FG002|Overall Study|Withdrawal by Subject|1|||
48887362|NCT05383508|157424160|FG003|Overall Study|Withdrawal by Subject|1|||
48887363|NCT05383508|157424161|FG004|Overall Study|Withdrawal by Subject|2|||
48887364|NCT05383508|157424162|FG005|Overall Study|Withdrawal by Subject|0|||
48887365|NCT02949362|157424172|FG000|Retrospective Period|Inform consent not signed by participant|4|||
48887366|NCT02949362|157424173|FG001|Retrospective Period|Inform consent not signed by participant|1|||
48887367|NCT02949362|157424174|FG002|Retrospective Period|Inform consent not signed by participant|0|||
48887368|NCT02949362|157424175|FG003|Retrospective Period|Inform consent not signed by participant|0|||
48887369|NCT02949362|157424172|FG000|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
48887370|NCT02949362|157424173|FG001|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
48887371|NCT02949362|157424174|FG002|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|1|||
48887372|NCT02949362|157424175|FG003|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
49035649|NCT03199963|157965570|FG000|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|7|||
49035650|NCT03199963|157965571|FG001|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|5|||
48887373|NCT02949362|157424172|FG000|Prospective Period|Other|0|||
48887374|NCT02949362|157424173|FG001|Prospective Period|Other|0|||
48887375|NCT02949362|157424174|FG002|Prospective Period|Other|0|||
48887376|NCT02949362|157424175|FG003|Prospective Period|Other|4|||
48887377|NCT01853475|157424176|FG000|Overall Study|Withdrawal by Subject|0|||
48887378|NCT01853475|157424177|FG001|Overall Study|Withdrawal by Subject|1|||
48887379|NCT01853475|157424178|FG002|Overall Study|Withdrawal by Subject|0|||
48887380|NCT02766777|157424179|FG000|Overall Study|Adverse Event|12|||
48887381|NCT02766777|157424179|FG000|Overall Study|Lost to Follow-up|16|||
48887382|NCT02766777|157424179|FG000|Overall Study|Non-Compliance With Study Drug|1|||
48887383|NCT02766777|157424179|FG000|Overall Study|Protocol Violation|1|||
48887384|NCT02766777|157424179|FG000|Overall Study|Withdrawal by Subject|4|||
49035651|NCT03199963|157965570|FG000|Optional Open-Label Phase - BHR-700|Adverse Event|0|||
48887385|NCT00406692|157424180|FG000|Overall Study|Withdrawal by Subject|4|||
48887386|NCT00406692|157424180|FG000|Overall Study|Physician Decision|1|||
48887387|NCT00406692|157424180|FG000|Overall Study|Adverse Event|1|||
48887388|NCT00406692|157424180|FG000|Overall Study|Lack of Efficacy|1|||
48887389|NCT03596762|157424181|FG000|Overall Study|Protocol Violation|0|||
48887390|NCT03596762|157424182|FG001|Overall Study|Protocol Violation|0|||
48887391|NCT03596762|157424183|FG002|Overall Study|Protocol Violation|0|||
48887392|NCT03596762|157424184|FG003|Overall Study|Protocol Violation|0|||
49035652|NCT03199963|157965571|FG001|Optional Open-Label Phase - BHR-700|Adverse Event|1|||
49035653|NCT02213263|157965572|FG000|Overall Study|Insufficient clinical response|4|||
49035654|NCT02213263|157965573|FG001|Overall Study|Insufficient clinical response|3|||
49035655|NCT02213263|157965572|FG000|Overall Study|Lost to Follow-up|0|||
49035656|NCT02213263|157965573|FG001|Overall Study|Lost to Follow-up|1|||
49035657|NCT02213263|157965572|FG000|Overall Study|No longer willing to participate|3|||
49035658|NCT02213263|157965573|FG001|Overall Study|No longer willing to participate|4|||
49035659|NCT02213263|157965572|FG000|Overall Study|Progressive disease|20|||
49035660|NCT02213263|157965573|FG001|Overall Study|Progressive disease|14|||
49035661|NCT02213263|157965572|FG000|Overall Study|Protocol Violation|0|||
49035662|NCT02213263|157965573|FG001|Overall Study|Protocol Violation|1|||
49035663|NCT02213263|157965572|FG000|Overall Study|Adverse Event|1|||
49035664|NCT02213263|157965573|FG001|Overall Study|Adverse Event|3|||
49035665|NCT00263588|157965574|FG000|Overall Study|Death|54|||
49035666|NCT00263588|157965575|FG001|Overall Study|Death|90|||
49035667|NCT00263588|157965574|FG000|Overall Study|disease progression, coma, 1 unknown|10|||
49035668|NCT00263588|157965575|FG001|Overall Study|disease progression, coma, 1 unknown|11|||
49035669|NCT00263588|157965574|FG000|Overall Study|Lost to Follow-up|7|||
49035670|NCT00263588|157965575|FG001|Overall Study|Lost to Follow-up|10|||
49035671|NCT00263588|157965574|FG000|Overall Study|Withdrawal by Subject|3|||
49035672|NCT00263588|157965575|FG001|Overall Study|Withdrawal by Subject|4|||
49035673|NCT00263588|157965574|FG000|Overall Study|Protocol Violation|0|||
49035674|NCT00263588|157965575|FG001|Overall Study|Protocol Violation|1|||
49035675|NCT00263588|157965574|FG000|Overall Study|Investigator decision|7|||
49035676|NCT00263588|157965575|FG001|Overall Study|Investigator decision|15|||
48887393|NCT03596762|157424185|FG004|Overall Study|Protocol Violation|1|||
48887394|NCT03596762|157424181|FG000|Overall Study|Adverse Event|2|||
49035677|NCT00263588|157965574|FG000|Overall Study|Sponsor terminated study|0|||
49035678|NCT00263588|157965575|FG001|Overall Study|Sponsor terminated study|1|||
49035679|NCT00835692|157965576|FG000|First Intervention|Withdrawal by Subject|1|||
49035680|NCT00835692|157965577|FG001|First Intervention|Withdrawal by Subject|0|||
49035681|NCT00003470|157965578|FG000|Overall Study|Not evaluable|6|||
49035682|NCT01169558|157965580|FG000|Overall Study|Disease progression|98|||
49035683|NCT01169558|157965580|FG000|Overall Study|Adverse Event|25|||
49035684|NCT01169558|157965580|FG000|Overall Study|Withdrawal of Consent|8|||
49035685|NCT01169558|157965580|FG000|Overall Study|Medical Decision|7|||
49035686|NCT01169558|157965580|FG000|Overall Study|Stable Disease|4|||
49035687|NCT01169558|157965580|FG000|Overall Study|Lost to Follow-up|4|||
49035688|NCT01169558|157965580|FG000|Overall Study|Need for Surgery|4|||
49035689|NCT01169558|157965580|FG000|Overall Study|Non-compliance|2|||
49035690|NCT01169558|157965580|FG000|Overall Study|Protocol Violation|2|||
49035691|NCT01169558|157965580|FG000|Overall Study|Partial response|2|||
49035692|NCT01190865|157965583|FG000|Overall Study|Withdrawal by Subject|1|||
49035693|NCT01190865|157965583|FG000|Overall Study|Non-compliance|2|||
49035694|NCT03292484|157965584|FG000|Overall Study|Participants did not have Disposition - Study Exit forms|415|||
49035695|NCT03292484|157965584|FG000|Overall Study|Withdrew consent (unrelated to adverse event [AE])|86|||
49035696|NCT03292484|157965584|FG000|Overall Study|Protocol Violation|2|||
49035697|NCT03292484|157965584|FG000|Overall Study|Investigator decision (unrelated to AE)|13|||
49035698|NCT03292484|157965584|FG000|Overall Study|Sponsor decision|349|||
49035699|NCT03292484|157965584|FG000|Overall Study|Lost to Follow-up|7|||
49035700|NCT03292484|157965584|FG000|Overall Study|Coronavirus Disease 2019|1|||
49035701|NCT03292484|157965584|FG000|Overall Study|Other|20|||
49035702|NCT01983969|157965585|FG000|Overall Study|Disease Progression|0|||
49035703|NCT01983969|157965586|FG001|Overall Study|Disease Progression|1|||
49035704|NCT01983969|157965587|FG002|Overall Study|Disease Progression|0|||
49035705|NCT04173247|157965588|FG000|Overall Study|Withdrawal by Subject|0|||
49035706|NCT04173247|157965589|FG001|Overall Study|Withdrawal by Subject|2|||
49035707|NCT04173247|157965588|FG000|Overall Study|Death|1|||
49035708|NCT04173247|157965589|FG001|Overall Study|Death|0|||
49035709|NCT04173247|157965588|FG000|Overall Study|Physician Decision|1|||
49035710|NCT04173247|157965589|FG001|Overall Study|Physician Decision|0|||
49035711|NCT01010503|157965592|FG000|Overall Study|Adverse Event|1|||
48796366|NCT01515748|157091561|FG001|Overall Study|Other than specified above|10|||
48796367|NCT04197713|157091562|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|0|||
48796368|NCT04197713|157091563|FG001|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|1|||
48796369|NCT04981678|157091568|FG000|Overall Study|Lost to Follow-up|0|||
48796370|NCT04981678|157091569|FG001|Overall Study|Lost to Follow-up|1|||
48796371|NCT01791725|157093641|FG000|Overall Study|Withdrawal by Subject|0|||
48796372|NCT01791725|157093642|FG001|Overall Study|Withdrawal by Subject|1|||
48796373|NCT01791725|157093643|FG002|Overall Study|Withdrawal by Subject|0|||
48796374|NCT03393000|157093646|FG000|Overall Study|Death|11|||
48796375|NCT03393000|157093646|FG000|Overall Study|Withdrawal by Subject|2|||
48796376|NCT03393000|157093646|FG000|Overall Study|Physician Decision|1|||
48796377|NCT01773070|157093647|FG000|Overall Study|Withdrawal by Subject|24|||
48796378|NCT01773070|157093647|FG000|Overall Study|Lost to Follow-up|39|||
48796379|NCT01773070|157093647|FG000|Overall Study|Other|15|||
48796380|NCT01773070|157093647|FG000|Overall Study|Death (unrelated to study procedures)|3|||
48796381|NCT01559844|157093648|FG000|Overall Study|Consent Withdrawn|7|||
48796382|NCT01559844|157093648|FG000|Overall Study|Death|5|||
48796383|NCT01559844|157093648|FG000|Overall Study|Efficacy Failure|10|||
48796384|NCT01559844|157093648|FG000|Overall Study|No Longer A Transplant Candidate|3|||
48796385|NCT02181803|157093649|FG000|Overall Study|Withdrawal by Subject|0|||
48796386|NCT02181803|157093650|FG001|Overall Study|Withdrawal by Subject|2|||
48796387|NCT02181803|157093651|FG002|Overall Study|Withdrawal by Subject|0|||
48796388|NCT02181803|157093652|FG003|Overall Study|Withdrawal by Subject|0|||
48796389|NCT02181803|157093653|FG004|Overall Study|Withdrawal by Subject|0|||
48796390|NCT02181803|157093654|FG005|Overall Study|Withdrawal by Subject|0|||
48796391|NCT02181803|157093655|FG006|Overall Study|Withdrawal by Subject|0|||
48796392|NCT02181803|157093656|FG007|Overall Study|Withdrawal by Subject|0|||
48796393|NCT02181803|157093657|FG008|Overall Study|Withdrawal by Subject|0|||
48796394|NCT02181803|157093649|FG000|Overall Study|Physician Decision|0|||
48796395|NCT02181803|157093650|FG001|Overall Study|Physician Decision|0|||
48796396|NCT02181803|157093651|FG002|Overall Study|Physician Decision|0|||
48796397|NCT02181803|157093652|FG003|Overall Study|Physician Decision|1|||
48796398|NCT02181803|157093653|FG004|Overall Study|Physician Decision|0|||
48796399|NCT02181803|157093654|FG005|Overall Study|Physician Decision|0|||
48796400|NCT02181803|157093655|FG006|Overall Study|Physician Decision|0|||
48796401|NCT02181803|157093656|FG007|Overall Study|Physician Decision|1|||
49035712|NCT01010503|157965592|FG000|Overall Study|Death|1|||
49035713|NCT02057835|157966870|FG000|Overall Study|Withdrawal by Subject|0|||
49035714|NCT02057835|157966871|FG001|Overall Study|Withdrawal by Subject|2|||
49035715|NCT02057835|157966872|FG002|Overall Study|Withdrawal by Subject|0|||
48796402|NCT02181803|157093657|FG008|Overall Study|Physician Decision|0|||
48796403|NCT02181803|157093649|FG000|Overall Study|Adverse Event|0|||
49035716|NCT02057835|157966873|FG003|Overall Study|Withdrawal by Subject|0|||
49035717|NCT02057835|157966874|FG004|Overall Study|Withdrawal by Subject|0|||
49035718|NCT02057835|157966875|FG005|Overall Study|Withdrawal by Subject|0|||
49035719|NCT02057835|157966876|FG006|Overall Study|Withdrawal by Subject|0|||
49035720|NCT02057835|157966877|FG007|Overall Study|Withdrawal by Subject|0|||
49035721|NCT02057835|157966878|FG008|Overall Study|Withdrawal by Subject|0|||
49035722|NCT02057835|157966879|FG009|Overall Study|Withdrawal by Subject|0|||
49035723|NCT00830258|157966880|FG000|First Intervention|Adverse Event|1|||
49035724|NCT00830258|157966881|FG001|First Intervention|Adverse Event|0|||
49035725|NCT00830258|157966880|FG000|Washout: 7 Days|Protocol Violation|1|||
49035726|NCT00830258|157966881|FG001|Washout: 7 Days|Protocol Violation|0|||
49035727|NCT00124618|157966882|FG000|Overall Study|Ineligible|1|||
49035728|NCT00003659|157966890|FG000|Overall Study|Withdrawal by Subject|3|||
49035729|NCT03605342|157966895|FG000|Overall Study|Withdrawal by Subject|9|||
49035730|NCT03605342|157966896|FG001|Overall Study|Withdrawal by Subject|7|||
49035731|NCT03605342|157966895|FG000|Overall Study|Lost to Follow-up|1|||
49035732|NCT03605342|157966896|FG001|Overall Study|Lost to Follow-up|1|||
49035733|NCT02861300|157966897|FG000|Overall Study|Death|0|||
49035734|NCT02861300|157966898|FG001|Overall Study|Death|0|||
49035735|NCT02861300|157966899|FG002|Overall Study|Death|0|||
49035736|NCT02861300|157966900|FG003|Overall Study|Death|0|||
49035737|NCT02861300|157966901|FG004|Overall Study|Death|0|||
48887395|NCT03596762|157424182|FG001|Overall Study|Adverse Event|0|||
48887396|NCT03596762|157424183|FG002|Overall Study|Adverse Event|1|||
48887397|NCT03596762|157424184|FG003|Overall Study|Adverse Event|0|||
48887398|NCT03596762|157424185|FG004|Overall Study|Adverse Event|5|||
48887399|NCT03596762|157424181|FG000|Overall Study|Withdrawal by Subject|2|||
48887400|NCT03596762|157424182|FG001|Overall Study|Withdrawal by Subject|1|||
48887401|NCT03596762|157424183|FG002|Overall Study|Withdrawal by Subject|0|||
48887402|NCT03596762|157424184|FG003|Overall Study|Withdrawal by Subject|1|||
48887403|NCT03596762|157424185|FG004|Overall Study|Withdrawal by Subject|1|||
48887404|NCT02510040|157424186|FG000|Overall Study|Deemed no longer eligible|18|||
48887405|NCT02510040|157424187|FG001|Overall Study|Deemed no longer eligible|3|||
48887406|NCT02510040|157424188|FG002|Overall Study|Deemed no longer eligible|1|||
48887407|NCT01129102|157424189|FG000|Overall Study|No study drug treatment|2|||
48887408|NCT01129102|157424190|FG001|Overall Study|No study drug treatment|3|||
48887409|NCT01129102|157424191|FG002|Overall Study|No study drug treatment|1|||
48887410|NCT01129102|157424189|FG000|Overall Study|Withdrawal by Subject|2|||
48887411|NCT01129102|157424190|FG001|Overall Study|Withdrawal by Subject|0|||
48887412|NCT01129102|157424191|FG002|Overall Study|Withdrawal by Subject|3|||
48887413|NCT01129102|157424189|FG000|Overall Study|Protocol Violation|0|||
48887414|NCT01129102|157424190|FG001|Overall Study|Protocol Violation|1|||
48887415|NCT01129102|157424191|FG002|Overall Study|Protocol Violation|1|||
48887416|NCT01129102|157424189|FG000|Overall Study|Pregnancy|0|||
48887417|NCT01129102|157424190|FG001|Overall Study|Pregnancy|0|||
48887418|NCT01129102|157424191|FG002|Overall Study|Pregnancy|1|||
48887419|NCT01129102|157424189|FG000|Overall Study|Adverse Event|2|||
48887420|NCT01129102|157424190|FG001|Overall Study|Adverse Event|2|||
48887421|NCT01129102|157424191|FG002|Overall Study|Adverse Event|1|||
48887422|NCT01129102|157424189|FG000|Overall Study|Lost to Follow-up|2|||
48887423|NCT01129102|157424190|FG001|Overall Study|Lost to Follow-up|0|||
48887424|NCT01129102|157424191|FG002|Overall Study|Lost to Follow-up|0|||
48887425|NCT00951015|157424192|FG000|Randomization Phase 96 Week|Adverse Event|1|||
48887426|NCT00951015|157424193|FG001|Randomization Phase 96 Week|Adverse Event|1|||
48887427|NCT00951015|157424194|FG002|Randomization Phase 96 Week|Adverse Event|2|||
48887428|NCT00951015|157424195|FG003|Randomization Phase 96 Week|Adverse Event|5|||
48887429|NCT00951015|157424196|FG004|Randomization Phase 96 Week|Adverse Event|0|||
48887430|NCT00951015|157424192|FG000|Randomization Phase 96 Week|Lack of Efficacy|1|||
48887431|NCT00951015|157424193|FG001|Randomization Phase 96 Week|Lack of Efficacy|1|||
48887432|NCT00951015|157424194|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
48887433|NCT00951015|157424195|FG003|Randomization Phase 96 Week|Lack of Efficacy|0|||
49035738|NCT02861300|157966902|FG005|Overall Study|Death|0|||
49035739|NCT02861300|157966903|FG006|Overall Study|Death|24|||
49035740|NCT02861300|157966897|FG000|Overall Study|Delay in treatment|0|||
48887434|NCT00951015|157424196|FG004|Randomization Phase 96 Week|Lack of Efficacy|0|||
49035741|NCT02861300|157966898|FG001|Overall Study|Delay in treatment|0|||
49035742|NCT02861300|157966899|FG002|Overall Study|Delay in treatment|0|||
49035743|NCT02861300|157966900|FG003|Overall Study|Delay in treatment|0|||
49035744|NCT02861300|157966901|FG004|Overall Study|Delay in treatment|0|||
48887435|NCT00951015|157424192|FG000|Randomization Phase 96 Week|Protocol Violation|1|||
48887436|NCT00951015|157424193|FG001|Randomization Phase 96 Week|Protocol Violation|1|||
48887437|NCT00951015|157424194|FG002|Randomization Phase 96 Week|Protocol Violation|1|||
48887438|NCT00951015|157424195|FG003|Randomization Phase 96 Week|Protocol Violation|0|||
48887439|NCT00951015|157424196|FG004|Randomization Phase 96 Week|Protocol Violation|0|||
49035745|NCT02861300|157966902|FG005|Overall Study|Delay in treatment|1|||
49035746|NCT02861300|157966903|FG006|Overall Study|Delay in treatment|0|||
49035747|NCT02861300|157966897|FG000|Overall Study|Disease Progression|0|||
49035748|NCT02861300|157966898|FG001|Overall Study|Disease Progression|1|||
48887440|NCT00951015|157424192|FG000|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
48887441|NCT00951015|157424193|FG001|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
48887442|NCT00951015|157424194|FG002|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
48887443|NCT00951015|157424195|FG003|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1|||
48887444|NCT00951015|157424196|FG004|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
48887445|NCT00951015|157424192|FG000|Randomization Phase 96 Week|Lost to Follow-up|0|||
48887446|NCT00951015|157424193|FG001|Randomization Phase 96 Week|Lost to Follow-up|3|||
48887447|NCT00951015|157424194|FG002|Randomization Phase 96 Week|Lost to Follow-up|1|||
48887448|NCT00951015|157424195|FG003|Randomization Phase 96 Week|Lost to Follow-up|2|||
48887449|NCT00951015|157424196|FG004|Randomization Phase 96 Week|Lost to Follow-up|0|||
48887450|NCT00951015|157424192|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
48887451|NCT00951015|157424193|FG001|Randomization Phase 96 Week|Withdrawal by Subject|1|||
48887452|NCT00951015|157424194|FG002|Randomization Phase 96 Week|Withdrawal by Subject|1|||
48887453|NCT00951015|157424195|FG003|Randomization Phase 96 Week|Withdrawal by Subject|2|||
48887454|NCT00951015|157424196|FG004|Randomization Phase 96 Week|Withdrawal by Subject|0|||
48887455|NCT00951015|157424192|FG000|Open-label Phase|Adverse Event|0|||
48887456|NCT00951015|157424193|FG001|Open-label Phase|Adverse Event|0|||
48887457|NCT00951015|157424194|FG002|Open-label Phase|Adverse Event|0|||
48887458|NCT00951015|157424195|FG003|Open-label Phase|Adverse Event|0|||
48887459|NCT00951015|157424196|FG004|Open-label Phase|Adverse Event|3|||
48887460|NCT00951015|157424192|FG000|Open-label Phase|Lack of Efficacy|0|||
48887461|NCT00951015|157424193|FG001|Open-label Phase|Lack of Efficacy|0|||
48887462|NCT00951015|157424194|FG002|Open-label Phase|Lack of Efficacy|0|||
48887463|NCT00951015|157424195|FG003|Open-label Phase|Lack of Efficacy|0|||
48887464|NCT00951015|157424196|FG004|Open-label Phase|Lack of Efficacy|1|||
48887465|NCT00951015|157424192|FG000|Open-label Phase|Protocol Violation|0|||
48887466|NCT00951015|157424193|FG001|Open-label Phase|Protocol Violation|0|||
48887467|NCT00951015|157424194|FG002|Open-label Phase|Protocol Violation|0|||
48887468|NCT00951015|157424195|FG003|Open-label Phase|Protocol Violation|0|||
48887469|NCT00951015|157424196|FG004|Open-label Phase|Protocol Violation|12|||
48887470|NCT00951015|157424192|FG000|Open-label Phase|Lost to Follow-up|0|||
48887471|NCT00951015|157424193|FG001|Open-label Phase|Lost to Follow-up|0|||
48887472|NCT00951015|157424194|FG002|Open-label Phase|Lost to Follow-up|0|||
48887473|NCT00951015|157424195|FG003|Open-label Phase|Lost to Follow-up|0|||
48887474|NCT00951015|157424196|FG004|Open-label Phase|Lost to Follow-up|12|||
48887475|NCT00951015|157424192|FG000|Open-label Phase|Withdrawal by Subject|0|||
48887476|NCT00951015|157424193|FG001|Open-label Phase|Withdrawal by Subject|0|||
48887477|NCT00951015|157424194|FG002|Open-label Phase|Withdrawal by Subject|0|||
48887478|NCT00951015|157424195|FG003|Open-label Phase|Withdrawal by Subject|0|||
48887479|NCT00951015|157424196|FG004|Open-label Phase|Withdrawal by Subject|14|||
48887480|NCT00951015|157424192|FG000|Open-label Phase|Physician Decision|0|||
48887481|NCT00951015|157424193|FG001|Open-label Phase|Physician Decision|0|||
48887482|NCT00951015|157424194|FG002|Open-label Phase|Physician Decision|0|||
48887483|NCT00951015|157424195|FG003|Open-label Phase|Physician Decision|0|||
48887484|NCT00951015|157424196|FG004|Open-label Phase|Physician Decision|8|||
48887485|NCT00299494|157424199|FG000|Overall Study|Withdrawal by Subject|0|||
48887486|NCT00299494|157424200|FG001|Overall Study|Withdrawal by Subject|0|||
48887487|NCT00299494|157424201|FG002|Overall Study|Withdrawal by Subject|0|||
48887488|NCT00299494|157424202|FG003|Overall Study|Withdrawal by Subject|3|||
48887489|NCT00299494|157424203|FG004|Overall Study|Withdrawal by Subject|1|||
48887490|NCT00299494|157424204|FG005|Overall Study|Withdrawal by Subject|4|||
48887491|NCT00299494|157424199|FG000|Overall Study|Physician Decision|0|||
48887492|NCT00299494|157424200|FG001|Overall Study|Physician Decision|0|||
48887493|NCT00299494|157424201|FG002|Overall Study|Physician Decision|0|||
48887494|NCT00299494|157424202|FG003|Overall Study|Physician Decision|0|||
48887495|NCT00299494|157424203|FG004|Overall Study|Physician Decision|1|||
48887496|NCT00299494|157424204|FG005|Overall Study|Physician Decision|0|||
48887497|NCT00299494|157424199|FG000|Overall Study|Death|3|||
48887498|NCT00299494|157424200|FG001|Overall Study|Death|1|||
48887499|NCT00299494|157424201|FG002|Overall Study|Death|4|||
48887500|NCT00299494|157424202|FG003|Overall Study|Death|6|||
48887501|NCT00299494|157424203|FG004|Overall Study|Death|18|||
48887502|NCT00299494|157424204|FG005|Overall Study|Death|19|||
48887503|NCT00299494|157424199|FG000|Overall Study|Lost to Follow-up|0|||
48887504|NCT00299494|157424200|FG001|Overall Study|Lost to Follow-up|0|||
48887505|NCT00299494|157424201|FG002|Overall Study|Lost to Follow-up|0|||
48887506|NCT00299494|157424202|FG003|Overall Study|Lost to Follow-up|0|||
48887507|NCT00299494|157424203|FG004|Overall Study|Lost to Follow-up|3|||
48887508|NCT00299494|157424204|FG005|Overall Study|Lost to Follow-up|1|||
48887509|NCT00299494|157424199|FG000|Overall Study|Other - Unspecified|0|||
48887510|NCT00299494|157424200|FG001|Overall Study|Other - Unspecified|0|||
48887511|NCT00299494|157424201|FG002|Overall Study|Other - Unspecified|0|||
48887512|NCT00299494|157424202|FG003|Overall Study|Other - Unspecified|0|||
48887513|NCT00299494|157424203|FG004|Overall Study|Other - Unspecified|3|||
48887514|NCT00299494|157424204|FG005|Overall Study|Other - Unspecified|1|||
48887515|NCT00299494|157424199|FG000|Overall Study|Other - site closure|0|||
49035749|NCT02861300|157966899|FG002|Overall Study|Disease Progression|0|||
49035750|NCT02861300|157966900|FG003|Overall Study|Disease Progression|0|||
49035751|NCT02861300|157966901|FG004|Overall Study|Disease Progression|0|||
49035752|NCT02861300|157966902|FG005|Overall Study|Disease Progression|0|||
49035753|NCT02861300|157966903|FG006|Overall Study|Disease Progression|2|||
49035754|NCT02861300|157966897|FG000|Overall Study|Patient decision/withdrawal/refusal|0|||
49035755|NCT02861300|157966898|FG001|Overall Study|Patient decision/withdrawal/refusal|0|||
49035756|NCT02861300|157966899|FG002|Overall Study|Patient decision/withdrawal/refusal|0|||
49035757|NCT02861300|157966900|FG003|Overall Study|Patient decision/withdrawal/refusal|0|||
49035758|NCT02861300|157966901|FG004|Overall Study|Patient decision/withdrawal/refusal|0|||
49035759|NCT02861300|157966902|FG005|Overall Study|Patient decision/withdrawal/refusal|0|||
49035760|NCT02861300|157966903|FG006|Overall Study|Patient decision/withdrawal/refusal|2|||
49035761|NCT02861300|157966897|FG000|Overall Study|Clinical Complications|0|||
49035762|NCT02861300|157966898|FG001|Overall Study|Clinical Complications|0|||
49035763|NCT02861300|157966899|FG002|Overall Study|Clinical Complications|0|||
49035764|NCT02861300|157966900|FG003|Overall Study|Clinical Complications|0|||
49035765|NCT02861300|157966901|FG004|Overall Study|Clinical Complications|0|||
49035766|NCT02861300|157966902|FG005|Overall Study|Clinical Complications|0|||
49035767|NCT02861300|157966903|FG006|Overall Study|Clinical Complications|1|||
49035768|NCT03733444|157966908|FG000|Overall Study|Adverse Event|8|||
49035769|NCT03733444|157966909|FG001|Overall Study|Adverse Event|10|||
49035770|NCT03733444|157966910|FG002|Overall Study|Adverse Event|5|||
49035771|NCT03733444|157966908|FG000|Overall Study|Death|20|||
49035772|NCT03733444|157966909|FG001|Overall Study|Death|19|||
49035773|NCT03733444|157966910|FG002|Overall Study|Death|11|||
49035774|NCT03733444|157966908|FG000|Overall Study|Lost to Follow-up|3|||
49035775|NCT03733444|157966909|FG001|Overall Study|Lost to Follow-up|0|||
49035776|NCT03733444|157966910|FG002|Overall Study|Lost to Follow-up|1|||
49035777|NCT03733444|157966908|FG000|Overall Study|Lack of Efficacy|0|||
49035778|NCT03733444|157966909|FG001|Overall Study|Lack of Efficacy|1|||
49035779|NCT03733444|157966910|FG002|Overall Study|Lack of Efficacy|1|||
48796404|NCT02181803|157093650|FG001|Overall Study|Adverse Event|2|||
48796405|NCT02181803|157093651|FG002|Overall Study|Adverse Event|0|||
48796406|NCT02181803|157093652|FG003|Overall Study|Adverse Event|1|||
48796407|NCT02181803|157093653|FG004|Overall Study|Adverse Event|0|||
48796408|NCT02181803|157093654|FG005|Overall Study|Adverse Event|0|||
48796409|NCT02181803|157093655|FG006|Overall Study|Adverse Event|1|||
48796410|NCT02181803|157093656|FG007|Overall Study|Adverse Event|0|||
48796411|NCT02181803|157093657|FG008|Overall Study|Adverse Event|0|||
48796412|NCT01514448|157093658|FG000|Overall Study|Death|7|||
48796413|NCT01514448|157093659|FG001|Overall Study|Death|8|||
48796414|NCT01514448|157093658|FG000|Overall Study|Withdrawal by Subject|2|||
48796415|NCT01514448|157093659|FG001|Overall Study|Withdrawal by Subject|0|||
48796416|NCT01514448|157093658|FG000|Overall Study|Lost to Follow-up|2|||
48796417|NCT01514448|157093659|FG001|Overall Study|Lost to Follow-up|0|||
48796418|NCT01514448|157093658|FG000|Overall Study|New Cancer Therapy|1|||
48796419|NCT01514448|157093659|FG001|Overall Study|New Cancer Therapy|0|||
48796420|NCT03151005|157093665|FG000|Overall Study|Lost to Follow-up|5|||
48796421|NCT03151005|157093666|FG001|Overall Study|Lost to Follow-up|5|||
48796422|NCT02723864|157093669|FG000|Overall Study|Refused further treatment|1|||
48796423|NCT02723864|157093670|FG001|Overall Study|Refused further treatment|0|||
48796424|NCT02723864|157093671|FG002|Overall Study|Refused further treatment|0|||
48796425|NCT02723864|157093672|FG003|Overall Study|Refused further treatment|0|||
48796426|NCT02723864|157093673|FG004|Overall Study|Refused further treatment|1|||
48796427|NCT02723864|157093674|FG005|Overall Study|Refused further treatment|2|||
48796428|NCT02723864|157093675|FG006|Overall Study|Refused further treatment|0|||
48796429|NCT02723864|157093669|FG000|Overall Study|Exceed treatment hold time|0|||
48796430|NCT02723864|157093670|FG001|Overall Study|Exceed treatment hold time|1|||
48796431|NCT02723864|157093671|FG002|Overall Study|Exceed treatment hold time|0|||
48796432|NCT02723864|157093672|FG003|Overall Study|Exceed treatment hold time|0|||
48796433|NCT02723864|157093673|FG004|Overall Study|Exceed treatment hold time|0|||
48796434|NCT02723864|157093674|FG005|Overall Study|Exceed treatment hold time|0|||
48796435|NCT02723864|157093675|FG006|Overall Study|Exceed treatment hold time|0|||
48796436|NCT02723864|157093669|FG000|Overall Study|Clinical progression|0|||
48796437|NCT02723864|157093670|FG001|Overall Study|Clinical progression|0|||
48796438|NCT02723864|157093671|FG002|Overall Study|Clinical progression|1|||
48796439|NCT02723864|157093672|FG003|Overall Study|Clinical progression|0|||
48796440|NCT02723864|157093673|FG004|Overall Study|Clinical progression|0|||
48796441|NCT02723864|157093674|FG005|Overall Study|Clinical progression|3|||
48796442|NCT02723864|157093675|FG006|Overall Study|Clinical progression|1|||
48796443|NCT02723864|157093669|FG000|Overall Study|Physician Decision|0|||
48796444|NCT02723864|157093670|FG001|Overall Study|Physician Decision|0|||
48796445|NCT02723864|157093671|FG002|Overall Study|Physician Decision|0|||
48796446|NCT02723864|157093672|FG003|Overall Study|Physician Decision|0|||
48796447|NCT02723864|157093673|FG004|Overall Study|Physician Decision|0|||
49035780|NCT03733444|157966908|FG000|Overall Study|Physician Decision|2|||
49035781|NCT03733444|157966909|FG001|Overall Study|Physician Decision|1|||
49035782|NCT03733444|157966910|FG002|Overall Study|Physician Decision|0|||
48983837|NCT01842334|157772358|FG001|Overall Study|Withdrawal by Subject|3|||
48983838|NCT01842334|157772357|FG000|Overall Study|Moved away mid-study|0|||
48983839|NCT01842334|157772358|FG001|Overall Study|Moved away mid-study|1|||
48796448|NCT02723864|157093674|FG005|Overall Study|Physician Decision|0|||
48796449|NCT02723864|157093675|FG006|Overall Study|Physician Decision|1|||
48983840|NCT01425528|157772359|FG000|Overall Study|Withdrawal by Subject|1|||
48983841|NCT01425528|157772360|FG001|Overall Study|Withdrawal by Subject|1|||
48983842|NCT01948791|157772361|FG000|Overall Study|Adverse Event|12|||
48983843|NCT01948791|157772361|FG000|Overall Study|Lack of Efficacy|3|||
48983844|NCT01948791|157772361|FG000|Overall Study|Protocol Violation|2|||
48983845|NCT01948791|157772361|FG000|Overall Study|Withdrawal by Subject|5|||
48983846|NCT01948791|157772361|FG000|Overall Study|Lost to Follow-up|6|||
48983847|NCT01948791|157772361|FG000|Overall Study|Management issues|1|||
48983848|NCT01948791|157772361|FG000|Overall Study|Others|7|||
48983849|NCT01948791|157772361|FG000|Overall Study|Screening failure|35|||
48983850|NCT03323385|157772366|FG000|Overall Study|Withdrawal by Subject|1|||
48983851|NCT03323385|157772367|FG001|Overall Study|Withdrawal by Subject|2|||
48983852|NCT03323385|157772366|FG000|Overall Study|Noncompliance|0|||
48983853|NCT03323385|157772367|FG001|Overall Study|Noncompliance|1|||
48983854|NCT00935701|157772368|FG000|Overall Study|Failure to Transition to Acupuncture|1|||
48983855|NCT01426009|157772369|FG000|Period 1-First Intervention (7 Days)|Adverse Event|1|||
48983856|NCT01426009|157772369|FG000|Period 1-First Intervention (7 Days)|Personal Reasons|1|||
48983857|NCT01426009|157772369|FG000|Washout 1|Withdrawal by Subject|1|||
48983858|NCT01426009|157772369|FG000|Washout 1|Personal Reasons|1|||
48983859|NCT01426009|157772369|FG000|Period 2-Second Intervention (7 Days)|Adverse Event|4|||
48983860|NCT01426009|157772369|FG000|Period 2-Second Intervention (7 Days)|personal reasons|1|||
48983861|NCT01426009|157772369|FG000|Washout 2|electrive surgery|1|||
48983862|NCT01426009|157772369|FG000|Washout 3|personal reasons|1|||
48983863|NCT01426009|157772369|FG000|Period 4-Fourth Intervention (7 Days)|personal reasons|1|||
48983864|NCT01426009|157772369|FG000|Washout 4|Lost to Follow-up|1|||
48983865|NCT02178592|157772370|FG000|Randomized Phase (Up to Week 52)|Adverse Event|0|||
48983866|NCT02178592|157772371|FG001|Randomized Phase (Up to Week 52)|Adverse Event|2|||
48983867|NCT02178592|157772370|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
48983868|NCT02178592|157772371|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
48983869|NCT02178592|157772370|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|3|||
48983870|NCT02178592|157772371|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|2|||
48983871|NCT02178592|157772370|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3|||
48983872|NCT02178592|157772371|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1|||
48983873|NCT02178592|157772370|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|11|||
48983874|NCT02178592|157772371|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|3|||
48983875|NCT02178592|157772370|FG000|Randomized Phase (Up to Week 52)|Physician Decision|1|||
48983876|NCT02178592|157772371|FG001|Randomized Phase (Up to Week 52)|Physician Decision|0|||
48983877|NCT02178592|157772370|FG000|OLE Phase (Week 52 to Week 252)|Adverse Event|1|||
48983878|NCT02178592|157772371|FG001|OLE Phase (Week 52 to Week 252)|Adverse Event|0|||
48983879|NCT02178592|157772370|FG000|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0|||
48983880|NCT02178592|157772371|FG001|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1|||
48796450|NCT02723864|157093669|FG000|Overall Study|Changes in patient condition|0|||
48796451|NCT02723864|157093670|FG001|Overall Study|Changes in patient condition|0|||
48796452|NCT02723864|157093671|FG002|Overall Study|Changes in patient condition|0|||
48796453|NCT02723864|157093672|FG003|Overall Study|Changes in patient condition|0|||
48796454|NCT02723864|157093673|FG004|Overall Study|Changes in patient condition|0|||
48796455|NCT02723864|157093674|FG005|Overall Study|Changes in patient condition|1|||
48796456|NCT02723864|157093675|FG006|Overall Study|Changes in patient condition|0|||
48796457|NCT02723864|157093669|FG000|Overall Study|Patient choice|0|||
48796458|NCT02723864|157093670|FG001|Overall Study|Patient choice|0|||
48796459|NCT02723864|157093671|FG002|Overall Study|Patient choice|0|||
48796460|NCT02723864|157093672|FG003|Overall Study|Patient choice|0|||
48796461|NCT02723864|157093673|FG004|Overall Study|Patient choice|0|||
48796462|NCT02723864|157093674|FG005|Overall Study|Patient choice|1|||
48796463|NCT02723864|157093675|FG006|Overall Study|Patient choice|0|||
48796464|NCT02723864|157093669|FG000|Overall Study|Adverse Event|0|||
48796465|NCT02723864|157093670|FG001|Overall Study|Adverse Event|0|||
48796466|NCT02723864|157093671|FG002|Overall Study|Adverse Event|0|||
48796467|NCT02723864|157093672|FG003|Overall Study|Adverse Event|0|||
48796468|NCT02723864|157093673|FG004|Overall Study|Adverse Event|0|||
48796469|NCT02723864|157093674|FG005|Overall Study|Adverse Event|1|||
48796470|NCT02723864|157093675|FG006|Overall Study|Adverse Event|0|||
48796471|NCT02723864|157093669|FG000|Overall Study|Started new treatment|0|||
48796472|NCT02723864|157093670|FG001|Overall Study|Started new treatment|0|||
48796473|NCT02723864|157093671|FG002|Overall Study|Started new treatment|0|||
48796474|NCT02723864|157093672|FG003|Overall Study|Started new treatment|0|||
48796475|NCT02723864|157093673|FG004|Overall Study|Started new treatment|0|||
48796476|NCT02723864|157093674|FG005|Overall Study|Started new treatment|1|||
48796477|NCT02723864|157093675|FG006|Overall Study|Started new treatment|0|||
48887516|NCT00299494|157424200|FG001|Overall Study|Other - site closure|0|||
48887517|NCT00299494|157424201|FG002|Overall Study|Other - site closure|0|||
48887518|NCT00299494|157424202|FG003|Overall Study|Other - site closure|1|||
48887519|NCT00299494|157424203|FG004|Overall Study|Other - site closure|1|||
48887520|NCT00299494|157424204|FG005|Overall Study|Other - site closure|1|||
48887521|NCT00214019|157424205|FG000|Overall Study|Lost to Follow-up|11|||
48887522|NCT00214019|157424205|FG000|Overall Study|Withdrawal by Subject|2|||
48887523|NCT00214019|157424205|FG000|Overall Study|Screen Failed prior to randomization|17|||
48887524|NCT01677767|157424206|FG000|Overall Study|Adverse Event|1|||
48887525|NCT01677767|157424206|FG000|Overall Study|Death|4|||
48887526|NCT01677767|157424206|FG000|Overall Study|Protocol Violation|4|||
48887527|NCT01677767|157424206|FG000|Overall Study|Withdrawal by Subject|10|||
48887528|NCT01677767|157424206|FG000|Overall Study|Non-compliance by the participants|3|||
48887529|NCT00468143|157424210|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|3|||
48887530|NCT00468143|157424211|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|4|||
48887531|NCT00468143|157424210|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
48887532|NCT00468143|157424211|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
48887533|NCT02992691|157424212|FG000|Overall Study|Adverse Event|2|||
48887534|NCT02992691|157424212|FG000|Overall Study|Withdrawal by Subject|1|||
48887535|NCT00588692|157424213|FG000|Overall Study|Withdrawal by Subject|4|||
48887536|NCT00588692|157424214|FG001|Overall Study|Withdrawal by Subject|2|||
48887537|NCT00588692|157424213|FG000|Overall Study|Hip Surgery|0|||
48887538|NCT00588692|157424214|FG001|Overall Study|Hip Surgery|1|||
48887539|NCT00588692|157424213|FG000|Overall Study|Severe Peptic Ulcer Disease|1|||
48887540|NCT00588692|157424214|FG001|Overall Study|Severe Peptic Ulcer Disease|0|||
48887541|NCT00588692|157424213|FG000|Overall Study|Cancer|1|||
48887542|NCT00588692|157424214|FG001|Overall Study|Cancer|0|||
48887543|NCT00588692|157424213|FG000|Overall Study|Death|1|||
48887544|NCT00588692|157424214|FG001|Overall Study|Death|0|||
48887545|NCT01374568|157424215|FG000|Overall Study|Lab unable to analyze BTM|0|||
48887546|NCT01374568|157424216|FG001|Overall Study|Lab unable to analyze BTM|2|||
48887547|NCT00392925|157424219|FG000|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11|||
48887548|NCT00392925|157424220|FG001|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
48887549|NCT00392925|157424221|FG002|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
48887550|NCT00392925|157424222|FG003|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
48887551|NCT00392925|157424219|FG000|4 Week Lead-In Period - Non-Randomized|Adverse Event|5|||
48887552|NCT00392925|157424220|FG001|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
48887553|NCT00392925|157424221|FG002|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
48887554|NCT00392925|157424222|FG003|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
48887555|NCT00392925|157424219|FG000|4 Week Lead-In Period - Non-Randomized|Physician Decision|1|||
48887556|NCT00392925|157424220|FG001|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
48887557|NCT00392925|157424221|FG002|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
48887558|NCT00392925|157424222|FG003|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
48887559|NCT00392925|157424219|FG000|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5|||
48887560|NCT00392925|157424220|FG001|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
48887561|NCT00392925|157424221|FG002|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
48887562|NCT00392925|157424222|FG003|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
48887563|NCT00392925|157424219|FG000|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16|||
48887564|NCT00392925|157424220|FG001|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
48887565|NCT00392925|157424221|FG002|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
48887566|NCT00392925|157424222|FG003|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
48887567|NCT00392925|157424219|FG000|Randomization to Treatment Group Period|Withdrawal by Subject|0|||
48887568|NCT00392925|157424220|FG001|Randomization to Treatment Group Period|Withdrawal by Subject|2|||
48887569|NCT00392925|157424221|FG002|Randomization to Treatment Group Period|Withdrawal by Subject|6|||
48887570|NCT00392925|157424222|FG003|Randomization to Treatment Group Period|Withdrawal by Subject|8|||
48887571|NCT00392925|157424219|FG000|Randomization to Treatment Group Period|Adverse Event|0|||
48887572|NCT00392925|157424220|FG001|Randomization to Treatment Group Period|Adverse Event|3|||
48887573|NCT00392925|157424221|FG002|Randomization to Treatment Group Period|Adverse Event|3|||
48887574|NCT00392925|157424222|FG003|Randomization to Treatment Group Period|Adverse Event|5|||
48887575|NCT00392925|157424219|FG000|Randomization to Treatment Group Period|Protocol Violation|0|||
48887576|NCT00392925|157424220|FG001|Randomization to Treatment Group Period|Protocol Violation|0|||
48887577|NCT00392925|157424221|FG002|Randomization to Treatment Group Period|Protocol Violation|2|||
48887578|NCT00392925|157424222|FG003|Randomization to Treatment Group Period|Protocol Violation|1|||
48887579|NCT00392925|157424219|FG000|Randomization to Treatment Group Period|Lost to Follow-up|0|||
48887580|NCT00392925|157424220|FG001|Randomization to Treatment Group Period|Lost to Follow-up|3|||
48887581|NCT00392925|157424221|FG002|Randomization to Treatment Group Period|Lost to Follow-up|8|||
48887582|NCT00392925|157424222|FG003|Randomization to Treatment Group Period|Lost to Follow-up|4|||
48887583|NCT00403767|157424226|FG000|Overall Study|Adverse Event|993|||
48983881|NCT02178592|157772370|FG000|OLE Phase (Week 52 to Week 252)|Protocol Violation|2|||
48887584|NCT00403767|157424227|FG001|Overall Study|Adverse Event|919|||
48887585|NCT00403767|157424226|FG000|Overall Study|Non-compliant with study medication|134|||
48887586|NCT00403767|157424227|FG001|Overall Study|Non-compliant with study medication|164|||
48887587|NCT00403767|157424226|FG000|Overall Study|Consent withdrawn|671|||
48887588|NCT00403767|157424227|FG001|Overall Study|Consent withdrawn|673|||
48887589|NCT00403767|157424226|FG000|Overall Study|Investigator dec./not protocol-related|191|||
49035783|NCT03733444|157966908|FG000|Overall Study|Protocol Violation|2|||
49035784|NCT03733444|157966909|FG001|Overall Study|Protocol Violation|1|||
49035785|NCT03733444|157966910|FG002|Overall Study|Protocol Violation|0|||
49035786|NCT03733444|157966908|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
49035787|NCT03733444|157966909|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
49035788|NCT03733444|157966910|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|2|||
49035789|NCT03733444|157966908|FG000|Overall Study|Study Terminated by Sponsor|203|||
49035790|NCT03733444|157966909|FG001|Overall Study|Study Terminated by Sponsor|209|||
49035791|NCT03733444|157966910|FG002|Overall Study|Study Terminated by Sponsor|221|||
49035792|NCT03733444|157966908|FG000|Overall Study|Withdrawal by Subject|19|||
49035793|NCT03733444|157966909|FG001|Overall Study|Withdrawal by Subject|18|||
49035794|NCT03733444|157966910|FG002|Overall Study|Withdrawal by Subject|16|||
49035795|NCT03733444|157966908|FG000|Overall Study|Miscellaneous|1|||
49035796|NCT03733444|157966909|FG001|Overall Study|Miscellaneous|0|||
49035797|NCT03733444|157966910|FG002|Overall Study|Miscellaneous|1|||
49035798|NCT03733444|157966908|FG000|Overall Study|Not Treated|1|||
49035799|NCT03733444|157966909|FG001|Overall Study|Not Treated|2|||
49035800|NCT03733444|157966910|FG002|Overall Study|Not Treated|1|||
49035801|NCT00835263|157966911|FG000|Second Intervention|Adverse Event|1|||
49035802|NCT00835263|157966912|FG001|Second Intervention|Adverse Event|0|||
49035803|NCT04230681|157966913|FG000|Overall Study|Physician Decision|2|||
49035804|NCT04230681|157966914|FG001|Overall Study|Physician Decision|3|||
49035805|NCT04230681|157966913|FG000|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
49035806|NCT04230681|157966914|FG001|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
49035807|NCT04230681|157966913|FG000|Overall Study|IV inadvertently removed|0|||
49035808|NCT04230681|157966914|FG001|Overall Study|IV inadvertently removed|1|||
49035809|NCT00848536|157966915|FG000|Overall Study|Adverse Event|2|||
48887590|NCT00403767|157424227|FG001|Overall Study|Investigator dec./not protocol-related|178|||
48887591|NCT00403767|157424226|FG000|Overall Study|Lost to Follow-up|6|||
48887592|NCT00403767|157424227|FG001|Overall Study|Lost to Follow-up|8|||
48887593|NCT00403767|157424226|FG000|Overall Study|Protocol Violation|142|||
48887594|NCT00403767|157424227|FG001|Overall Study|Protocol Violation|124|||
48887595|NCT00403767|157424226|FG000|Overall Study|Clinical efficacy endpoint reached|300|||
48887596|NCT00403767|157424227|FG001|Overall Study|Clinical efficacy endpoint reached|332|||
48887597|NCT00403767|157424226|FG000|Overall Study|Study terminated by sponsor|82|||
48887598|NCT00403767|157424227|FG001|Overall Study|Study terminated by sponsor|69|||
48887599|NCT00403767|157424226|FG000|Overall Study|Missing/incomplete data|1|||
48887600|NCT00403767|157424227|FG001|Overall Study|Missing/incomplete data|1|||
48887601|NCT01137578|157424234|FG000|Overall Study|Participant requested to Discontinue|3|||
48887602|NCT01137578|157424235|FG001|Overall Study|Participant requested to Discontinue|0|||
48887603|NCT01137578|157424236|FG002|Overall Study|Participant requested to Discontinue|0|||
48887604|NCT01137578|157424234|FG000|Overall Study|Withdrawal by Subject|1|||
48887605|NCT01137578|157424235|FG001|Overall Study|Withdrawal by Subject|0|||
48887606|NCT01137578|157424236|FG002|Overall Study|Withdrawal by Subject|0|||
48887607|NCT01137578|157424234|FG000|Overall Study|Other|12|||
48887608|NCT01137578|157424235|FG001|Overall Study|Other|2|||
48887609|NCT01137578|157424236|FG002|Overall Study|Other|6|||
48887610|NCT01152814|157424241|FG000|Overall Study|Lost to Follow-up|2|||
48887611|NCT03284203|157424242|FG000|Overall Study|Lost to Follow-up|3|||
48887612|NCT02229851|157424243|FG000|Main Phase (Double-blind Phase)|Unclassified|1|||
48887613|NCT02229851|157424244|FG001|Main Phase (Double-blind Phase)|Unclassified|2|||
48887614|NCT02229851|157424245|FG002|Main Phase (Double-blind Phase)|Unclassified|0|||
49035810|NCT00848536|157966916|FG001|Overall Study|Adverse Event|2|||
49035811|NCT00848536|157966915|FG000|Overall Study|Withdrawal by Subject|0|||
49035812|NCT00848536|157966916|FG001|Overall Study|Withdrawal by Subject|1|||
48887615|NCT02229851|157424246|FG003|Main Phase (Double-blind Phase)|Unclassified|0|||
48887616|NCT02229851|157424247|FG004|Main Phase (Double-blind Phase)|Unclassified|0|||
48887617|NCT02229851|157424248|FG005|Main Phase (Double-blind Phase)|Unclassified|0|||
48887618|NCT02229851|157424249|FG006|Main Phase (Double-blind Phase)|Unclassified|0|||
49035813|NCT00848536|157966915|FG000|Overall Study|Protocol Violation|0|||
49035814|NCT00848536|157966916|FG001|Overall Study|Protocol Violation|1|||
49035815|NCT00848536|157966915|FG000|Overall Study|Noncompliance|1|||
49035816|NCT00848536|157966916|FG001|Overall Study|Noncompliance|0|||
49035817|NCT00848536|157966915|FG000|Overall Study|Inadequate Control of IOP|1|||
49035818|NCT00848536|157966916|FG001|Overall Study|Inadequate Control of IOP|1|||
49035819|NCT00848536|157966915|FG000|Overall Study|Patient Moved|0|||
49035820|NCT00848536|157966916|FG001|Overall Study|Patient Moved|2|||
49035821|NCT02993159|157966917|FG000|Overall Study|Withdrawal by Subject|1|||
48887619|NCT02229851|157424243|FG000|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
48887620|NCT02229851|157424244|FG001|Main Phase (Double-blind Phase)|Lost to Follow-up|1|||
48887621|NCT02229851|157424245|FG002|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
48887622|NCT02229851|157424246|FG003|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
48887623|NCT02229851|157424247|FG004|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
48887624|NCT02229851|157424248|FG005|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
48887625|NCT02229851|157424249|FG006|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
48887626|NCT02229851|157424243|FG000|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
49035822|NCT02993159|157966918|FG001|Overall Study|Withdrawal by Subject|3|||
49035823|NCT02993159|157966917|FG000|Overall Study|Protocol Violation|1|||
48887627|NCT02229851|157424244|FG001|Main Phase (Double-blind Phase)|Withdrawal by Subject|12|||
48887628|NCT02229851|157424245|FG002|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
48887629|NCT02229851|157424246|FG003|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
48887630|NCT02229851|157424247|FG004|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
48887631|NCT02229851|157424248|FG005|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
48887632|NCT02229851|157424249|FG006|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
48887633|NCT02229851|157424243|FG000|Main Phase (Double-blind Phase)|Protocol Violation|0|||
48887634|NCT02229851|157424244|FG001|Main Phase (Double-blind Phase)|Protocol Violation|0|||
48887635|NCT02229851|157424245|FG002|Main Phase (Double-blind Phase)|Protocol Violation|2|||
48887636|NCT02229851|157424246|FG003|Main Phase (Double-blind Phase)|Protocol Violation|0|||
48887637|NCT02229851|157424247|FG004|Main Phase (Double-blind Phase)|Protocol Violation|0|||
48887638|NCT02229851|157424248|FG005|Main Phase (Double-blind Phase)|Protocol Violation|0|||
48887639|NCT02229851|157424249|FG006|Main Phase (Double-blind Phase)|Protocol Violation|0|||
48887640|NCT02229851|157424243|FG000|Main Phase (Double-blind Phase)|Death|1|||
48887641|NCT02229851|157424244|FG001|Main Phase (Double-blind Phase)|Death|1|||
48887642|NCT02229851|157424245|FG002|Main Phase (Double-blind Phase)|Death|0|||
48887643|NCT02229851|157424246|FG003|Main Phase (Double-blind Phase)|Death|0|||
48887644|NCT02229851|157424247|FG004|Main Phase (Double-blind Phase)|Death|0|||
48887645|NCT02229851|157424248|FG005|Main Phase (Double-blind Phase)|Death|0|||
48887646|NCT02229851|157424249|FG006|Main Phase (Double-blind Phase)|Death|0|||
48887647|NCT02229851|157424243|FG000|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
48887648|NCT02229851|157424244|FG001|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
49035824|NCT02993159|157966918|FG001|Overall Study|Protocol Violation|0|||
49035825|NCT02993159|157966917|FG000|Overall Study|Opted out of surgery|2|||
49035826|NCT02993159|157966918|FG001|Overall Study|Opted out of surgery|0|||
49035827|NCT02993159|157966917|FG000|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
49035828|NCT02993159|157966918|FG001|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
49035829|NCT02993159|157966917|FG000|Overall Study|Physician Decision|0|||
49035830|NCT02993159|157966918|FG001|Overall Study|Physician Decision|1|||
49035831|NCT00796328|157966921|FG000|Overall Study|experienced hypotension requiring tx|6|||
49035832|NCT01380782|157966922|FG000|Overall Study|Adverse Event|0|||
49035833|NCT01380782|157966923|FG001|Overall Study|Adverse Event|1|||
49035834|NCT01380782|157966924|FG002|Overall Study|Adverse Event|0|||
49035835|NCT01380782|157966925|FG003|Overall Study|Adverse Event|0|||
49035836|NCT01380782|157966922|FG000|Overall Study|Death|1|||
49035837|NCT01380782|157966923|FG001|Overall Study|Death|0|||
49035838|NCT01380782|157966924|FG002|Overall Study|Death|0|||
49035839|NCT01380782|157966925|FG003|Overall Study|Death|0|||
49035840|NCT01380782|157966922|FG000|Overall Study|Lack of Efficacy|10|||
49035841|NCT01380782|157966923|FG001|Overall Study|Lack of Efficacy|9|||
49035842|NCT01380782|157966924|FG002|Overall Study|Lack of Efficacy|10|||
49035843|NCT01380782|157966925|FG003|Overall Study|Lack of Efficacy|3|||
49035844|NCT01380782|157966922|FG000|Overall Study|Physician Decision|1|||
49035845|NCT01380782|157966923|FG001|Overall Study|Physician Decision|0|||
49035846|NCT01380782|157966924|FG002|Overall Study|Physician Decision|0|||
49035847|NCT01380782|157966925|FG003|Overall Study|Physician Decision|0|||
49035848|NCT01380782|157966922|FG000|Overall Study|Withdrawal by Subject|0|||
49035849|NCT01380782|157966923|FG001|Overall Study|Withdrawal by Subject|0|||
49035850|NCT01380782|157966924|FG002|Overall Study|Withdrawal by Subject|1|||
49035851|NCT01380782|157966925|FG003|Overall Study|Withdrawal by Subject|1|||
49035852|NCT01403194|157966931|FG000|Overall Study|Screen Failure|2|||
49035853|NCT01403194|157966931|FG000|Overall Study|Lost to Follow-up|8|||
49035854|NCT00477594|157966932|FG000|Year 1 and Year 2|Adverse Event|4|||
49035855|NCT00477594|157966933|FG001|Year 1 and Year 2|Adverse Event|2|||
49035856|NCT00477594|157966932|FG000|Year 1 and Year 2|Physician Decision|2|||
49035857|NCT00477594|157966933|FG001|Year 1 and Year 2|Physician Decision|1|||
49035858|NCT00477594|157966932|FG000|Year 1 and Year 2|Withdrawal by Subject|2|||
49035859|NCT00477594|157966933|FG001|Year 1 and Year 2|Withdrawal by Subject|1|||
49035860|NCT00477594|157966932|FG000|Year 1 and Year 2|Other|1|||
49035861|NCT00477594|157966933|FG001|Year 1 and Year 2|Other|0|||
49035862|NCT00477594|157966932|FG000|Year 3|Adverse Event|1|||
49035863|NCT00477594|157966933|FG001|Year 3|Adverse Event|0|||
49035864|NCT00477594|157966932|FG000|Year 3|Withdrawal by Subject|1|||
49035865|NCT00477594|157966933|FG001|Year 3|Withdrawal by Subject|0|||
49035866|NCT00477594|157966932|FG000|Follow-up Period|Withdrawal by Subject|2|||
49035867|NCT00477594|157966933|FG001|Follow-up Period|Withdrawal by Subject|1|||
48887649|NCT02229851|157424245|FG002|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
48887650|NCT02229851|157424246|FG003|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
48887651|NCT02229851|157424247|FG004|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
48887652|NCT02229851|157424248|FG005|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
48887653|NCT02229851|157424249|FG006|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
48887654|NCT02229851|157424243|FG000|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
48887655|NCT02229851|157424244|FG001|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
48887656|NCT02229851|157424245|FG002|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
48887657|NCT02229851|157424246|FG003|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
48887658|NCT02229851|157424247|FG004|Extension Phase (Open-label Phase)|Withdrawal by Subject|4|||
48887659|NCT02229851|157424248|FG005|Extension Phase (Open-label Phase)|Withdrawal by Subject|3|||
48887660|NCT02229851|157424249|FG006|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
48887661|NCT02229851|157424243|FG000|Extension Phase (Open-label Phase)|Death|0|||
48887662|NCT02229851|157424244|FG001|Extension Phase (Open-label Phase)|Death|0|||
48887663|NCT02229851|157424245|FG002|Extension Phase (Open-label Phase)|Death|0|||
48887664|NCT02229851|157424246|FG003|Extension Phase (Open-label Phase)|Death|1|||
48887665|NCT02229851|157424247|FG004|Extension Phase (Open-label Phase)|Death|0|||
48887666|NCT02229851|157424248|FG005|Extension Phase (Open-label Phase)|Death|1|||
48887667|NCT02229851|157424249|FG006|Extension Phase (Open-label Phase)|Death|1|||
48887668|NCT02310100|157424250|FG000|Overall Study|Physician Decision|3|||
48887669|NCT02310100|157424250|FG000|Overall Study|Withdrawal by Subject|10|||
48887670|NCT02310100|157424250|FG000|Overall Study|Enrollment closure|1|||
48887671|NCT02310100|157424250|FG000|Overall Study|Unapproved ablation operator|1|||
48887672|NCT02310100|157424250|FG000|Overall Study|Visit compliance|1|||
48887673|NCT02310100|157424250|FG000|Overall Study|Lost to Follow-up|2|||
48887674|NCT01518153|157424251|FG000|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5|||
48887675|NCT01518153|157424252|FG001|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
48887676|NCT01518153|157424253|FG002|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
48887677|NCT01518153|157424251|FG000|Stem Cell Transplant|Death|2|||
48887678|NCT01518153|157424252|FG001|Stem Cell Transplant|Death|0|||
48887679|NCT01518153|157424253|FG002|Stem Cell Transplant|Death|0|||
48887680|NCT01518153|157424251|FG000|Stem Cell Transplant|Secondary graft failure|1|||
48887681|NCT01518153|157424252|FG001|Stem Cell Transplant|Secondary graft failure|0|||
48887682|NCT01518153|157424253|FG002|Stem Cell Transplant|Secondary graft failure|0|||
48887683|NCT01518153|157424251|FG000|Stem Cell Transplant|Adverse Event|1|||
48887684|NCT01518153|157424252|FG001|Stem Cell Transplant|Adverse Event|0|||
48887685|NCT01518153|157424253|FG002|Stem Cell Transplant|Adverse Event|0|||
48887686|NCT01518153|157424251|FG000|Donor Lymphocyte Infusion|Death|0|||
48887687|NCT01518153|157424252|FG001|Donor Lymphocyte Infusion|Death|2|||
48887688|NCT01518153|157424253|FG002|Donor Lymphocyte Infusion|Death|1|||
48887689|NCT00911768|157424254|FG000|Overall Study|Protocol Violation|5|||
48887690|NCT00911768|157424255|FG001|Overall Study|Protocol Violation|4|||
48887691|NCT00911768|157424254|FG000|Overall Study|Withdrawal by Subject|1|||
48887692|NCT00911768|157424255|FG001|Overall Study|Withdrawal by Subject|0|||
48887693|NCT04157400|157424260|FG000|Overall Study|Withdrawal by Subject|1|||
48887694|NCT04157400|157424260|FG000|Overall Study|Lost to Follow-up|3|||
48887695|NCT01397422|157424266|FG000|Overall Study|Adverse Event|0|||
48887696|NCT01397422|157424267|FG001|Overall Study|Adverse Event|3|||
48887697|NCT01397422|157424268|FG002|Overall Study|Adverse Event|3|||
48887698|NCT01397422|157424269|FG003|Overall Study|Adverse Event|8|||
48887699|NCT01397422|157424266|FG000|Overall Study|Withdrawal by Subject|1|||
48887700|NCT01397422|157424267|FG001|Overall Study|Withdrawal by Subject|0|||
48887701|NCT01397422|157424268|FG002|Overall Study|Withdrawal by Subject|0|||
48887702|NCT01397422|157424269|FG003|Overall Study|Withdrawal by Subject|0|||
48887703|NCT01397422|157424266|FG000|Overall Study|Increased bradykinesia related to PD|1|||
48887704|NCT01397422|157424267|FG001|Overall Study|Increased bradykinesia related to PD|0|||
48887705|NCT01397422|157424268|FG002|Overall Study|Increased bradykinesia related to PD|0|||
48887706|NCT01397422|157424269|FG003|Overall Study|Increased bradykinesia related to PD|0|||
48887707|NCT00925353|157424270|FG000|Overall Study|Failed preliminary EKG or lab criteria.|3|||
48887708|NCT05543707|157424276|FG000|Overall Study|Study drug non-compliance/|5|||
49035868|NCT00477594|157966932|FG000|Follow-up Period|Other|1|||
49035869|NCT00477594|157966933|FG001|Follow-up Period|Other|0|||
49035870|NCT04827394|157966934|FG000|Overall Study|Physician Decision|0|||
48887709|NCT05543707|157424277|FG001|Overall Study|Study drug non-compliance/|0|||
48887710|NCT05543707|157424276|FG000|Overall Study|Withdrawal by Subject|1|||
48887711|NCT05543707|157424277|FG001|Overall Study|Withdrawal by Subject|1|||
48887712|NCT05543707|157424276|FG000|Overall Study|Adverse Event|1|||
48887713|NCT05543707|157424277|FG001|Overall Study|Adverse Event|0|||
48887714|NCT05543707|157424276|FG000|Overall Study|concurrent illness|0|||
48887715|NCT05543707|157424277|FG001|Overall Study|concurrent illness|1|||
48887716|NCT05543707|157424276|FG000|Overall Study|Pregnancy|1|||
48887717|NCT05543707|157424277|FG001|Overall Study|Pregnancy|1|||
48887718|NCT05384938|157424278|FG000|Overall Study|Withdrawal by Subject|8|||
48887719|NCT05384938|157424278|FG000|Overall Study|Lost to Follow-up|6|||
48887720|NCT05384938|157424278|FG000|Overall Study|One participant included in study but not included in analysis as did not meet eligibility criteria|1|||
48887721|NCT01905150|157424279|FG000|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|2|||
48887722|NCT01905150|157424280|FG001|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|0|||
48887723|NCT01123070|157425900|FG000|Part B Double Blind Period|Protocol Violation|0|||
48887724|NCT01123070|157425901|FG001|Part B Double Blind Period|Protocol Violation|0|||
48887725|NCT01123070|157425902|FG002|Part B Double Blind Period|Protocol Violation|0|||
48887726|NCT01123070|157425903|FG003|Part B Double Blind Period|Protocol Violation|1|||
48887727|NCT01123070|157425900|FG000|Part B Double Blind Period|Adverse Event|0|||
48887728|NCT01123070|157425901|FG001|Part B Double Blind Period|Adverse Event|0|||
48887729|NCT01123070|157425902|FG002|Part B Double Blind Period|Adverse Event|2|||
48887730|NCT01123070|157425903|FG003|Part B Double Blind Period|Adverse Event|0|||
48887731|NCT01123070|157425900|FG000|Part B Double Blind Period|Sponsor's Decision|0|||
48887732|NCT01123070|157425901|FG001|Part B Double Blind Period|Sponsor's Decision|0|||
48887733|NCT01123070|157425902|FG002|Part B Double Blind Period|Sponsor's Decision|2|||
48887734|NCT01123070|157425903|FG003|Part B Double Blind Period|Sponsor's Decision|2|||
48887735|NCT02218606|157425904|FG000|Overall Study|Adverse Event|1|||
48887736|NCT02218606|157425905|FG001|Overall Study|Adverse Event|1|||
48887737|NCT02218606|157425904|FG000|Overall Study|Death|15|||
48887738|NCT02218606|157425905|FG001|Overall Study|Death|28|||
48887739|NCT02218606|157425904|FG000|Overall Study|Physician Decision|0|||
48887740|NCT02218606|157425905|FG001|Overall Study|Physician Decision|1|||
48887741|NCT02218606|157425904|FG000|Overall Study|Withdrawal by Subject|4|||
48887742|NCT02218606|157425905|FG001|Overall Study|Withdrawal by Subject|0|||
48887743|NCT02218606|157425904|FG000|Overall Study|Noncompliance|1|||
48887744|NCT02218606|157425905|FG001|Overall Study|Noncompliance|0|||
48887745|NCT02218606|157425904|FG000|Overall Study|Initiation of new drug for prostate cancer|2|||
49035871|NCT04827394|157966935|FG001|Overall Study|Physician Decision|2|||
49035872|NCT01020474|157966936|FG000|Overall Study|Adverse Event|4|||
49035873|NCT01020474|157966937|FG001|Overall Study|Adverse Event|4|||
49035874|NCT01020474|157966936|FG000|Overall Study|Protocol Violation|0|||
49035875|NCT01020474|157966937|FG001|Overall Study|Protocol Violation|2|||
49035876|NCT01020474|157966936|FG000|Overall Study|Withdrawal by Subject|5|||
49035877|NCT01020474|157966937|FG001|Overall Study|Withdrawal by Subject|7|||
49035878|NCT01020474|157966936|FG000|Overall Study|Other Reasons|1|||
49035879|NCT01020474|157966937|FG001|Overall Study|Other Reasons|1|||
49035880|NCT01020474|157966936|FG000|Overall Study|Insufficient Clinical Response|0|||
49035881|NCT01020474|157966937|FG001|Overall Study|Insufficient Clinical Response|3|||
49035882|NCT03987191|157966938|FG000|Overall Study|COVID-19 related research disruption|0|||
49035883|NCT03987191|157966939|FG001|Overall Study|COVID-19 related research disruption|2|||
49035884|NCT01919112|157966940|FG000|Secondary Analysis-day 30|Death|1|||
49035885|NCT01919112|157966941|FG001|Secondary Analysis-day 30|Death|1|||
48887746|NCT02218606|157425905|FG001|Overall Study|Initiation of new drug for prostate cancer|0|||
48887747|NCT02218606|157425904|FG000|Overall Study|Other|2|||
48887748|NCT02218606|157425905|FG001|Overall Study|Other|1|||
48887749|NCT02218606|157425904|FG000|Overall Study|Never started treatment|0|||
48887750|NCT02218606|157425905|FG001|Overall Study|Never started treatment|1|||
48887751|NCT01020877|157425906|FG000|Second Intervention|Withdrawal by Subject|1|||
48887752|NCT01020877|157425907|FG001|Second Intervention|Withdrawal by Subject|0|||
48887753|NCT01088984|157425908|FG000|Phase 1|Death|2|||
49035886|NCT01919112|157966942|FG002|Secondary Analysis-day 30|Death|1|||
49035887|NCT01919112|157966940|FG000|Secondary Analysis-day 30|Lost to Follow-up|1|||
49035888|NCT01919112|157966941|FG001|Secondary Analysis-day 30|Lost to Follow-up|0|||
49035889|NCT01919112|157966942|FG002|Secondary Analysis-day 30|Lost to Follow-up|0|||
49035890|NCT04692155|157966945|FG000|Overall Study|Death|1|||
49035891|NCT02043132|157966946|FG000|Overall Study|Lost to Follow-up|1|||
49035892|NCT02043132|157966947|FG001|Overall Study|Lost to Follow-up|1|||
49035893|NCT02043132|157966946|FG000|Overall Study|screen failures|4|||
49035894|NCT02043132|157966947|FG001|Overall Study|screen failures|8|||
49035895|NCT02280863|157966950|FG000|Integrated Platform|Met stopping criteria|0|||
49035896|NCT02280863|157966951|FG001|Integrated Platform|Met stopping criteria|1|||
48887754|NCT01088984|157425909|FG001|Phase 1|Death|1|||
48887755|NCT01088984|157425908|FG000|Phase 1|Disease Progression|2|||
48887756|NCT01088984|157425909|FG001|Phase 1|Disease Progression|4|||
49035897|NCT03419403|157966952|FG000|Overall Study|Withdrawal by Subject|5|||
49035898|NCT03419403|157966953|FG001|Overall Study|Withdrawal by Subject|2|||
48887757|NCT01088984|157425908|FG000|Phase 1|Other|1|||
48887758|NCT01088984|157425909|FG001|Phase 1|Other|1|||
48887759|NCT01088984|157425908|FG000|Phase 2|Death|0|||
48887760|NCT01088984|157425909|FG001|Phase 2|Death|5|||
48887761|NCT01088984|157425908|FG000|Phase 2|Withdrawal by Subject|0|||
48887762|NCT01088984|157425909|FG001|Phase 2|Withdrawal by Subject|1|||
48887763|NCT01088984|157425908|FG000|Phase 2|DIsease Progression|0|||
48887764|NCT01088984|157425909|FG001|Phase 2|DIsease Progression|25|||
48887765|NCT01088984|157425908|FG000|Phase 2|Other|0|||
49035899|NCT03419403|157966954|FG002|Overall Study|Withdrawal by Subject|5|||
49035900|NCT03419403|157966955|FG003|Overall Study|Withdrawal by Subject|1|||
49035901|NCT03419403|157966952|FG000|Overall Study|Progressive disease (per protocol)|0|||
49035902|NCT03419403|157966953|FG001|Overall Study|Progressive disease (per protocol)|2|||
49035903|NCT03419403|157966954|FG002|Overall Study|Progressive disease (per protocol)|2|||
49035904|NCT03419403|157966955|FG003|Overall Study|Progressive disease (per protocol)|0|||
49035905|NCT03419403|157966952|FG000|Overall Study|Other, not specified|6|||
49035906|NCT03419403|157966953|FG001|Overall Study|Other, not specified|4|||
49035907|NCT03419403|157966954|FG002|Overall Study|Other, not specified|5|||
49035908|NCT03419403|157966955|FG003|Overall Study|Other, not specified|1|||
49035909|NCT03419403|157966952|FG000|Overall Study|Left study due to COVID-19 restrictions|1|||
49035910|NCT03419403|157966953|FG001|Overall Study|Left study due to COVID-19 restrictions|1|||
49035911|NCT03419403|157966954|FG002|Overall Study|Left study due to COVID-19 restrictions|0|||
49035912|NCT03419403|157966955|FG003|Overall Study|Left study due to COVID-19 restrictions|0|||
49035913|NCT01415986|157966956|FG000|Overall Study|Lost to Follow-up|1|||
49035914|NCT00830024|157966959|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
49035915|NCT00830024|157966960|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
49035916|NCT00838539|157966967|FG000|Overall Study|Disease Progression|2|||
49035917|NCT00838539|157966968|FG001|Overall Study|Disease Progression|4|||
49035918|NCT00838539|157966969|FG002|Overall Study|Disease Progression|3|||
49035919|NCT00838539|157966970|FG003|Overall Study|Disease Progression|2|||
49035920|NCT00838539|157966971|FG004|Overall Study|Disease Progression|4|||
49035921|NCT00838539|157966972|FG005|Overall Study|Disease Progression|2|||
49035922|NCT00838539|157966973|FG006|Overall Study|Disease Progression|3|||
49035923|NCT00838539|157966974|FG007|Overall Study|Disease Progression|4|||
49035924|NCT00838539|157966975|FG008|Overall Study|Disease Progression|4|||
49035925|NCT00838539|157966976|FG009|Overall Study|Disease Progression|5|||
49035926|NCT00838539|157966977|FG010|Overall Study|Disease Progression|1|||
49035927|NCT00838539|157966978|FG011|Overall Study|Disease Progression|4|||
49035928|NCT00838539|157966967|FG000|Overall Study|Adverse Event|1|||
49035929|NCT00838539|157966968|FG001|Overall Study|Adverse Event|1|||
48887766|NCT01088984|157425909|FG001|Phase 2|Other|1|||
48887767|NCT00699153|157425911|FG000|Overall Study|Lost to Follow-up|1|||
48887768|NCT00699153|157425912|FG001|Overall Study|Lost to Follow-up|0|||
48887769|NCT00699153|157425911|FG000|Overall Study|Adverse Event|0|||
48887770|NCT00699153|157425912|FG001|Overall Study|Adverse Event|2|||
48887771|NCT00699153|157425911|FG000|Overall Study|Protocol Violation|1|||
48887772|NCT00699153|157425912|FG001|Overall Study|Protocol Violation|0|||
48887773|NCT00699153|157425911|FG000|Overall Study|Travel Problem|1|||
48887774|NCT00699153|157425912|FG001|Overall Study|Travel Problem|0|||
48887775|NCT00357110|157425915|FG000|Overall Study|Early study termination|5|||
48887776|NCT00357110|157425916|FG001|Overall Study|Early study termination|5|||
49035930|NCT00838539|157966969|FG002|Overall Study|Adverse Event|1|||
49035931|NCT00838539|157966970|FG003|Overall Study|Adverse Event|1|||
49035932|NCT00838539|157966971|FG004|Overall Study|Adverse Event|2|||
49035933|NCT00838539|157966972|FG005|Overall Study|Adverse Event|1|||
49035934|NCT00838539|157966973|FG006|Overall Study|Adverse Event|0|||
49035935|NCT00838539|157966974|FG007|Overall Study|Adverse Event|2|||
49035936|NCT00838539|157966975|FG008|Overall Study|Adverse Event|0|||
49035937|NCT00838539|157966976|FG009|Overall Study|Adverse Event|1|||
49035938|NCT00838539|157966977|FG010|Overall Study|Adverse Event|2|||
49035939|NCT00838539|157966978|FG011|Overall Study|Adverse Event|0|||
49035940|NCT00838539|157966967|FG000|Overall Study|Withdrawal by Subject|0|||
49035941|NCT00838539|157966968|FG001|Overall Study|Withdrawal by Subject|1|||
49035942|NCT00838539|157966969|FG002|Overall Study|Withdrawal by Subject|0|||
49035943|NCT00838539|157966970|FG003|Overall Study|Withdrawal by Subject|0|||
49035944|NCT00838539|157966971|FG004|Overall Study|Withdrawal by Subject|0|||
49035945|NCT00838539|157966972|FG005|Overall Study|Withdrawal by Subject|0|||
49035946|NCT00838539|157966973|FG006|Overall Study|Withdrawal by Subject|0|||
49035947|NCT00838539|157966974|FG007|Overall Study|Withdrawal by Subject|0|||
49035948|NCT00838539|157966975|FG008|Overall Study|Withdrawal by Subject|0|||
49035949|NCT00838539|157966976|FG009|Overall Study|Withdrawal by Subject|1|||
49035950|NCT00838539|157966977|FG010|Overall Study|Withdrawal by Subject|2|||
49035951|NCT00838539|157966978|FG011|Overall Study|Withdrawal by Subject|0|||
49035952|NCT00838539|157966967|FG000|Overall Study|Death|0|||
49035953|NCT00838539|157966968|FG001|Overall Study|Death|0|||
48887777|NCT00515671|157425922|FG000|Overall Study|Lost to Follow-up|13|||
48887778|NCT00515671|157425923|FG001|Overall Study|Lost to Follow-up|10|||
49035954|NCT00838539|157966969|FG002|Overall Study|Death|0|||
48887779|NCT00515671|157425922|FG000|Overall Study|Withdrawal by Subject|3|||
48887780|NCT00515671|157425923|FG001|Overall Study|Withdrawal by Subject|5|||
48887781|NCT00515671|157425922|FG000|Overall Study|incarcerated|1|||
48887782|NCT00515671|157425923|FG001|Overall Study|incarcerated|2|||
48887783|NCT00545753|157425924|FG000|Overall Study|Withdrawal by Subject|0|||
49035955|NCT00838539|157966970|FG003|Overall Study|Death|0|||
49035956|NCT00838539|157966971|FG004|Overall Study|Death|0|||
49035957|NCT00838539|157966972|FG005|Overall Study|Death|0|||
48887784|NCT00545753|157425925|FG001|Overall Study|Withdrawal by Subject|1|||
49035958|NCT00838539|157966973|FG006|Overall Study|Death|1|||
49035959|NCT00838539|157966974|FG007|Overall Study|Death|0|||
49035960|NCT00838539|157966975|FG008|Overall Study|Death|0|||
48887785|NCT00545753|157425926|FG002|Overall Study|Withdrawal by Subject|10|||
48887786|NCT00545753|157425924|FG000|Overall Study|Lost to Follow-up|13|||
48887787|NCT00545753|157425925|FG001|Overall Study|Lost to Follow-up|3|||
48887788|NCT00545753|157425926|FG002|Overall Study|Lost to Follow-up|12|||
48887789|NCT00545753|157425924|FG000|Overall Study|Protocol Violation|3|||
48887790|NCT00545753|157425925|FG001|Overall Study|Protocol Violation|1|||
48887791|NCT00545753|157425926|FG002|Overall Study|Protocol Violation|4|||
48887792|NCT01531673|157425929|FG000|Overall Study|Non-Compliance|0|||
48887793|NCT01531673|157425930|FG001|Overall Study|Non-Compliance|0|||
48887794|NCT01531673|157425931|FG002|Overall Study|Non-Compliance|0|||
48887795|NCT01531673|157425932|FG003|Overall Study|Non-Compliance|0|||
48887796|NCT01531673|157425933|FG004|Overall Study|Non-Compliance|0|||
48887797|NCT01531673|157425934|FG005|Overall Study|Non-Compliance|1|||
48887798|NCT01531673|157425935|FG006|Overall Study|Non-Compliance|0|||
48887799|NCT01531673|157425936|FG007|Overall Study|Non-Compliance|0|||
48887800|NCT01531673|157425937|FG008|Overall Study|Non-Compliance|0|||
48887801|NCT01531673|157425938|FG009|Overall Study|Non-Compliance|0|||
48887802|NCT01531673|157425939|FG010|Overall Study|Non-Compliance|0|||
48887803|NCT01531673|157425940|FG011|Overall Study|Non-Compliance|0|||
48887804|NCT01531673|157425941|FG012|Overall Study|Non-Compliance|0|||
48887805|NCT01531673|157425929|FG000|Overall Study|Adverse Event|0|||
48887806|NCT01531673|157425930|FG001|Overall Study|Adverse Event|1|||
48887807|NCT01531673|157425931|FG002|Overall Study|Adverse Event|0|||
48887808|NCT01531673|157425932|FG003|Overall Study|Adverse Event|0|||
48887809|NCT01531673|157425933|FG004|Overall Study|Adverse Event|0|||
48887810|NCT01531673|157425934|FG005|Overall Study|Adverse Event|0|||
48887811|NCT01531673|157425935|FG006|Overall Study|Adverse Event|0|||
48887812|NCT01531673|157425936|FG007|Overall Study|Adverse Event|0|||
48887813|NCT01531673|157425937|FG008|Overall Study|Adverse Event|0|||
48887814|NCT01531673|157425938|FG009|Overall Study|Adverse Event|0|||
48887815|NCT01531673|157425939|FG010|Overall Study|Adverse Event|0|||
48887816|NCT01531673|157425940|FG011|Overall Study|Adverse Event|0|||
48887817|NCT01531673|157425941|FG012|Overall Study|Adverse Event|0|||
48887818|NCT01531673|157425929|FG000|Overall Study|Lost to Follow-up|0|||
48887819|NCT01531673|157425930|FG001|Overall Study|Lost to Follow-up|0|||
48887820|NCT01531673|157425931|FG002|Overall Study|Lost to Follow-up|0|||
48887821|NCT01531673|157425932|FG003|Overall Study|Lost to Follow-up|0|||
49035961|NCT00838539|157966976|FG009|Overall Study|Death|0|||
49035962|NCT00838539|157966977|FG010|Overall Study|Death|0|||
49035963|NCT00838539|157966978|FG011|Overall Study|Death|0|||
49035964|NCT00838539|157966967|FG000|Overall Study|Physician Decision|0|||
49035965|NCT00838539|157966968|FG001|Overall Study|Physician Decision|0|||
49035966|NCT00838539|157966969|FG002|Overall Study|Physician Decision|0|||
49035967|NCT00838539|157966970|FG003|Overall Study|Physician Decision|0|||
49035968|NCT00838539|157966971|FG004|Overall Study|Physician Decision|0|||
49035969|NCT00838539|157966972|FG005|Overall Study|Physician Decision|0|||
49035970|NCT00838539|157966973|FG006|Overall Study|Physician Decision|0|||
49035971|NCT00838539|157966974|FG007|Overall Study|Physician Decision|0|||
49035972|NCT00838539|157966975|FG008|Overall Study|Physician Decision|1|||
49035973|NCT00838539|157966976|FG009|Overall Study|Physician Decision|0|||
48887822|NCT01531673|157425933|FG004|Overall Study|Lost to Follow-up|1|||
49035974|NCT00838539|157966977|FG010|Overall Study|Physician Decision|0|||
48887823|NCT01531673|157425934|FG005|Overall Study|Lost to Follow-up|0|||
48887824|NCT01531673|157425935|FG006|Overall Study|Lost to Follow-up|0|||
48887825|NCT01531673|157425936|FG007|Overall Study|Lost to Follow-up|0|||
48887826|NCT01531673|157425937|FG008|Overall Study|Lost to Follow-up|0|||
48887827|NCT01531673|157425938|FG009|Overall Study|Lost to Follow-up|0|||
48887828|NCT01531673|157425939|FG010|Overall Study|Lost to Follow-up|0|||
48887829|NCT01531673|157425940|FG011|Overall Study|Lost to Follow-up|0|||
48887830|NCT01531673|157425941|FG012|Overall Study|Lost to Follow-up|0|||
48887831|NCT01531673|157425929|FG000|Overall Study|Other|0|||
48887832|NCT01531673|157425930|FG001|Overall Study|Other|0|||
48887833|NCT01531673|157425931|FG002|Overall Study|Other|0|||
49035975|NCT00838539|157966978|FG011|Overall Study|Physician Decision|0|||
49035976|NCT00838539|157966967|FG000|Overall Study|Clinical Progression|0|||
48887834|NCT01531673|157425932|FG003|Overall Study|Other|1|||
48887835|NCT01531673|157425933|FG004|Overall Study|Other|0|||
48887836|NCT01531673|157425934|FG005|Overall Study|Other|0|||
48887837|NCT01531673|157425935|FG006|Overall Study|Other|0|||
48887838|NCT01531673|157425936|FG007|Overall Study|Other|0|||
48887839|NCT01531673|157425937|FG008|Overall Study|Other|0|||
48887840|NCT01531673|157425938|FG009|Overall Study|Other|1|||
48887841|NCT01531673|157425939|FG010|Overall Study|Other|0|||
48887842|NCT01531673|157425940|FG011|Overall Study|Other|0|||
48887843|NCT01531673|157425941|FG012|Overall Study|Other|0|||
48887844|NCT00568178|157425942|FG000|Double Blind Base Study|Adverse Event|0|||
48887845|NCT00568178|157425943|FG001|Double Blind Base Study|Adverse Event|2|||
48887846|NCT00568178|157425944|FG002|Double Blind Base Study|Adverse Event|1|||
49035977|NCT00838539|157966968|FG001|Overall Study|Clinical Progression|0|||
49035978|NCT00838539|157966969|FG002|Overall Study|Clinical Progression|0|||
48887847|NCT00568178|157425945|FG003|Double Blind Base Study|Adverse Event|2|||
49035979|NCT00838539|157966970|FG003|Overall Study|Clinical Progression|0|||
49035980|NCT00838539|157966971|FG004|Overall Study|Clinical Progression|0|||
49035981|NCT00838539|157966972|FG005|Overall Study|Clinical Progression|0|||
49035982|NCT00838539|157966973|FG006|Overall Study|Clinical Progression|1|||
49035983|NCT00838539|157966974|FG007|Overall Study|Clinical Progression|0|||
49035984|NCT00838539|157966975|FG008|Overall Study|Clinical Progression|0|||
49035985|NCT00838539|157966976|FG009|Overall Study|Clinical Progression|0|||
49035986|NCT00838539|157966977|FG010|Overall Study|Clinical Progression|0|||
49035987|NCT00838539|157966978|FG011|Overall Study|Clinical Progression|0|||
49035988|NCT00838539|157966967|FG000|Overall Study|Symptomatic Deterioration|0|||
49035989|NCT00838539|157966968|FG001|Overall Study|Symptomatic Deterioration|0|||
49035990|NCT00838539|157966969|FG002|Overall Study|Symptomatic Deterioration|1|||
49035991|NCT00838539|157966970|FG003|Overall Study|Symptomatic Deterioration|1|||
49035992|NCT00838539|157966971|FG004|Overall Study|Symptomatic Deterioration|0|||
49035993|NCT00838539|157966972|FG005|Overall Study|Symptomatic Deterioration|1|||
49035994|NCT00838539|157966973|FG006|Overall Study|Symptomatic Deterioration|0|||
49035995|NCT00838539|157966974|FG007|Overall Study|Symptomatic Deterioration|0|||
49035996|NCT00838539|157966975|FG008|Overall Study|Symptomatic Deterioration|0|||
49035997|NCT00838539|157966976|FG009|Overall Study|Symptomatic Deterioration|1|||
49035998|NCT00838539|157966977|FG010|Overall Study|Symptomatic Deterioration|0|||
49035999|NCT00838539|157966978|FG011|Overall Study|Symptomatic Deterioration|0|||
49036000|NCT03719040|157966979|FG000|Overall Study|Withdrawal by Subject|177|||
49036001|NCT03719040|157966979|FG000|Overall Study|Lost to Follow-up|26|||
49036002|NCT02358538|157966985|FG000|Through Week 26|Adverse Event|0|||
49036003|NCT02358538|157966986|FG001|Through Week 26|Adverse Event|1|||
49036004|NCT02358538|157966987|FG002|Through Week 26|Adverse Event|1|||
49036005|NCT02358538|157966988|FG003|Through Week 26|Adverse Event|2|||
49036006|NCT02358538|157966985|FG000|Through Week 26|Lack of Efficacy|1|||
49036007|NCT02358538|157966986|FG001|Through Week 26|Lack of Efficacy|1|||
49036008|NCT02358538|157966987|FG002|Through Week 26|Lack of Efficacy|3|||
49036009|NCT02358538|157966988|FG003|Through Week 26|Lack of Efficacy|3|||
49036010|NCT02358538|157966985|FG000|Through Week 26|Withdrawal by Subject|1|||
49036011|NCT02358538|157966986|FG001|Through Week 26|Withdrawal by Subject|0|||
49036012|NCT02358538|157966987|FG002|Through Week 26|Withdrawal by Subject|0|||
49036013|NCT02358538|157966988|FG003|Through Week 26|Withdrawal by Subject|0|||
49036014|NCT02358538|157966985|FG000|Through Week 26|Non-Compliance|0|||
49036015|NCT02358538|157966986|FG001|Through Week 26|Non-Compliance|0|||
49036016|NCT02358538|157966987|FG002|Through Week 26|Non-Compliance|1|||
49036017|NCT02358538|157966988|FG003|Through Week 26|Non-Compliance|0|||
49036018|NCT02358538|157966985|FG000|Through Week 26|Family did not see benefit from IP|1|||
49036019|NCT02358538|157966986|FG001|Through Week 26|Family did not see benefit from IP|0|||
49036020|NCT02358538|157966987|FG002|Through Week 26|Family did not see benefit from IP|0|||
49036021|NCT02358538|157966988|FG003|Through Week 26|Family did not see benefit from IP|0|||
49036022|NCT02358538|157966985|FG000|52 Week Extension Period|Lack of Efficacy|0|||
49036023|NCT02358538|157966986|FG001|52 Week Extension Period|Lack of Efficacy|0|||
49036024|NCT02358538|157966987|FG002|52 Week Extension Period|Lack of Efficacy|2|||
49036025|NCT02358538|157966988|FG003|52 Week Extension Period|Lack of Efficacy|4|||
49036026|NCT00829764|157966998|FG000|First Intervention|Adverse Event|1|||
49036027|NCT00829764|157966999|FG001|First Intervention|Adverse Event|0|||
49036028|NCT00829764|157966998|FG000|First Intervention|Withdrawal by Subject|1|||
48887848|NCT00568178|157425946|FG004|Double Blind Base Study|Adverse Event|0|||
48887849|NCT00568178|157425947|FG005|Double Blind Base Study|Adverse Event|0|||
48887850|NCT00568178|157425942|FG000|Double Blind Base Study|Lost to Follow-up|1|||
48887851|NCT00568178|157425943|FG001|Double Blind Base Study|Lost to Follow-up|0|||
48887852|NCT00568178|157425944|FG002|Double Blind Base Study|Lost to Follow-up|0|||
48887853|NCT00568178|157425945|FG003|Double Blind Base Study|Lost to Follow-up|1|||
48887854|NCT00568178|157425946|FG004|Double Blind Base Study|Lost to Follow-up|0|||
48887855|NCT00568178|157425947|FG005|Double Blind Base Study|Lost to Follow-up|0|||
48887856|NCT00568178|157425942|FG000|Double Blind Base Study|Physician Decision|1|||
48887857|NCT00568178|157425943|FG001|Double Blind Base Study|Physician Decision|1|||
48887858|NCT00568178|157425944|FG002|Double Blind Base Study|Physician Decision|0|||
48887859|NCT00568178|157425945|FG003|Double Blind Base Study|Physician Decision|1|||
48887860|NCT00568178|157425946|FG004|Double Blind Base Study|Physician Decision|0|||
48887861|NCT00568178|157425947|FG005|Double Blind Base Study|Physician Decision|0|||
48887862|NCT00568178|157425942|FG000|Double Blind Base Study|Protocol Violation|3|||
48887863|NCT00568178|157425943|FG001|Double Blind Base Study|Protocol Violation|2|||
49036029|NCT00829764|157966999|FG001|First Intervention|Withdrawal by Subject|1|||
49036030|NCT04594252|157967000|FG000|Overall Study|Adverse Event|0|||
49036031|NCT04594252|157967001|FG001|Overall Study|Adverse Event|2|||
48887864|NCT00568178|157425944|FG002|Double Blind Base Study|Protocol Violation|0|||
48887865|NCT00568178|157425945|FG003|Double Blind Base Study|Protocol Violation|0|||
49036032|NCT01180634|157968145|FG000|Overall Study|Adverse Event|4|||
49036033|NCT01180634|157968146|FG001|Overall Study|Adverse Event|1|||
49036034|NCT01180634|157968145|FG000|Overall Study|Miscellaneous|2|||
49036035|NCT01180634|157968146|FG001|Overall Study|Miscellaneous|0|||
49036036|NCT01180634|157968145|FG000|Overall Study|Withdrawal by Subject|4|||
49036037|NCT01180634|157968146|FG001|Overall Study|Withdrawal by Subject|0|||
49036038|NCT02267187|157968148|FG000|Overall Study|Physician Decision|2|||
49036039|NCT02267187|157968148|FG000|Overall Study|Screen fail|3|||
49036040|NCT03713086|157968149|FG000|Overall Study|Withdrawal by Subject|0|||
49036041|NCT03713086|157968150|FG001|Overall Study|Withdrawal by Subject|2|||
49036042|NCT03713086|157968151|FG002|Overall Study|Withdrawal by Subject|1|||
49036043|NCT03713086|157968152|FG003|Overall Study|Withdrawal by Subject|0|||
49036044|NCT03713086|157968149|FG000|Overall Study|Lost to Follow-up|0|||
49036045|NCT03713086|157968150|FG001|Overall Study|Lost to Follow-up|1|||
49036046|NCT03713086|157968151|FG002|Overall Study|Lost to Follow-up|0|||
49036047|NCT03713086|157968152|FG003|Overall Study|Lost to Follow-up|1|||
49036048|NCT01340495|157968158|FG000|Overall Study|Withdrawal by Subject|1|||
48887866|NCT00568178|157425946|FG004|Double Blind Base Study|Protocol Violation|0|||
48887867|NCT00568178|157425947|FG005|Double Blind Base Study|Protocol Violation|0|||
48887868|NCT00568178|157425942|FG000|Double Blind Base Study|Withdrawal by Subject|1|||
48887869|NCT00568178|157425943|FG001|Double Blind Base Study|Withdrawal by Subject|1|||
48887870|NCT00568178|157425944|FG002|Double Blind Base Study|Withdrawal by Subject|0|||
48887871|NCT00568178|157425945|FG003|Double Blind Base Study|Withdrawal by Subject|0|||
48887872|NCT00568178|157425946|FG004|Double Blind Base Study|Withdrawal by Subject|0|||
48887873|NCT00568178|157425947|FG005|Double Blind Base Study|Withdrawal by Subject|0|||
48887874|NCT00568178|157425942|FG000|Double Blind Base Study|Progressive Disease|0|||
48887875|NCT00568178|157425943|FG001|Double Blind Base Study|Progressive Disease|0|||
48887876|NCT00568178|157425944|FG002|Double Blind Base Study|Progressive Disease|0|||
48887877|NCT00568178|157425945|FG003|Double Blind Base Study|Progressive Disease|1|||
48887878|NCT00568178|157425946|FG004|Double Blind Base Study|Progressive Disease|0|||
48887879|NCT00568178|157425947|FG005|Double Blind Base Study|Progressive Disease|0|||
48887880|NCT00568178|157425942|FG000|Open Label Extension|Adverse Event|0|||
48887881|NCT00568178|157425943|FG001|Open Label Extension|Adverse Event|0|||
48887882|NCT00568178|157425944|FG002|Open Label Extension|Adverse Event|0|||
48887883|NCT00568178|157425945|FG003|Open Label Extension|Adverse Event|0|||
48887884|NCT00568178|157425946|FG004|Open Label Extension|Adverse Event|11|||
48887885|NCT00568178|157425947|FG005|Open Label Extension|Adverse Event|8|||
48887886|NCT00568178|157425942|FG000|Open Label Extension|Protocol Violation|0|||
48887887|NCT00568178|157425943|FG001|Open Label Extension|Protocol Violation|0|||
48887888|NCT00568178|157425944|FG002|Open Label Extension|Protocol Violation|0|||
48887889|NCT00568178|157425945|FG003|Open Label Extension|Protocol Violation|0|||
48887890|NCT00568178|157425946|FG004|Open Label Extension|Protocol Violation|1|||
48887891|NCT00568178|157425947|FG005|Open Label Extension|Protocol Violation|0|||
48887892|NCT00568178|157425942|FG000|Open Label Extension|Lost to Follow-up|0|||
48887893|NCT00568178|157425943|FG001|Open Label Extension|Lost to Follow-up|0|||
48887894|NCT00568178|157425944|FG002|Open Label Extension|Lost to Follow-up|0|||
48887895|NCT00568178|157425945|FG003|Open Label Extension|Lost to Follow-up|0|||
48887896|NCT00568178|157425946|FG004|Open Label Extension|Lost to Follow-up|6|||
48887897|NCT00568178|157425947|FG005|Open Label Extension|Lost to Follow-up|11|||
48887898|NCT00568178|157425942|FG000|Open Label Extension|Physician Decision|0|||
48887899|NCT00568178|157425943|FG001|Open Label Extension|Physician Decision|0|||
48887900|NCT00568178|157425944|FG002|Open Label Extension|Physician Decision|0|||
49036049|NCT02957942|157968162|FG000|Overall Study|Withdrawal by Subject|0|||
48887901|NCT00568178|157425945|FG003|Open Label Extension|Physician Decision|0|||
48887902|NCT00568178|157425946|FG004|Open Label Extension|Physician Decision|9|||
48887903|NCT00568178|157425947|FG005|Open Label Extension|Physician Decision|8|||
48887904|NCT00568178|157425942|FG000|Open Label Extension|Pregnancy|0|||
48887905|NCT00568178|157425943|FG001|Open Label Extension|Pregnancy|0|||
48887906|NCT00568178|157425944|FG002|Open Label Extension|Pregnancy|0|||
48887907|NCT00568178|157425945|FG003|Open Label Extension|Pregnancy|0|||
49036050|NCT02957942|157968163|FG001|Overall Study|Withdrawal by Subject|1|||
49036051|NCT02957942|157968162|FG000|Overall Study|Practicing experiment protocol|0|||
49036052|NCT02957942|157968163|FG001|Overall Study|Practicing experiment protocol|6|||
49036053|NCT00804856|157968164|FG000|Overall Study|Progressive Disease|3|||
49036054|NCT00804856|157968165|FG001|Overall Study|Progressive Disease|2|||
49036055|NCT00804856|157968166|FG002|Overall Study|Progressive Disease|4|||
49036056|NCT00804856|157968167|FG003|Overall Study|Progressive Disease|6|||
49036057|NCT00804856|157968168|FG004|Overall Study|Progressive Disease|4|||
49036058|NCT00804856|157968169|FG005|Overall Study|Progressive Disease|1|||
48887908|NCT00568178|157425946|FG004|Open Label Extension|Pregnancy|0|||
48887909|NCT00568178|157425947|FG005|Open Label Extension|Pregnancy|1|||
48887910|NCT00568178|157425942|FG000|Open Label Extension|Progressive Disease|0|||
49036059|NCT00804856|157968170|FG006|Overall Study|Progressive Disease|8|||
49036060|NCT00804856|157968171|FG007|Overall Study|Progressive Disease|2|||
49036061|NCT00804856|157968172|FG008|Overall Study|Progressive Disease|4|||
49036062|NCT00804856|157968173|FG009|Overall Study|Progressive Disease|5|||
49036063|NCT00804856|157968174|FG010|Overall Study|Progressive Disease|12|||
49036064|NCT00804856|157968175|FG011|Overall Study|Progressive Disease|2|||
49036065|NCT00804856|157968176|FG012|Overall Study|Progressive Disease|2|||
49036066|NCT00804856|157968177|FG013|Overall Study|Progressive Disease|26|||
49036067|NCT00804856|157968178|FG014|Overall Study|Progressive Disease|20|||
49036068|NCT00804856|157968164|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
49036069|NCT00804856|157968165|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
49036070|NCT00804856|157968166|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
49036071|NCT00804856|157968167|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
49036072|NCT00804856|157968168|FG004|Overall Study|Dose Limiting Toxicity (DLT)|1|||
49036073|NCT00804856|157968169|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
49036074|NCT00804856|157968170|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
49036075|NCT00804856|157968171|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
49036076|NCT00804856|157968172|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
49036077|NCT00804856|157968173|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
49036078|NCT00804856|157968174|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
49036079|NCT00804856|157968175|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
49036080|NCT00804856|157968176|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
49036081|NCT00804856|157968177|FG013|Overall Study|Dose Limiting Toxicity (DLT)|0|||
49036082|NCT00804856|157968178|FG014|Overall Study|Dose Limiting Toxicity (DLT)|1|||
49036083|NCT00804856|157968164|FG000|Overall Study|Other Adverse Event|1|||
49036084|NCT00804856|157968165|FG001|Overall Study|Other Adverse Event|1|||
49036085|NCT00804856|157968166|FG002|Overall Study|Other Adverse Event|1|||
49036086|NCT00804856|157968167|FG003|Overall Study|Other Adverse Event|2|||
49036087|NCT00804856|157968168|FG004|Overall Study|Other Adverse Event|2|||
49036088|NCT00804856|157968169|FG005|Overall Study|Other Adverse Event|1|||
49036089|NCT00804856|157968170|FG006|Overall Study|Other Adverse Event|3|||
49036090|NCT00804856|157968171|FG007|Overall Study|Other Adverse Event|0|||
49036091|NCT00804856|157968172|FG008|Overall Study|Other Adverse Event|0|||
49036092|NCT00804856|157968173|FG009|Overall Study|Other Adverse Event|1|||
49036093|NCT00804856|157968174|FG010|Overall Study|Other Adverse Event|5|||
49036094|NCT00804856|157968175|FG011|Overall Study|Other Adverse Event|2|||
49036095|NCT00804856|157968176|FG012|Overall Study|Other Adverse Event|0|||
49036096|NCT00804856|157968177|FG013|Overall Study|Other Adverse Event|6|||
49036097|NCT00804856|157968178|FG014|Overall Study|Other Adverse Event|13|||
49036098|NCT00804856|157968164|FG000|Overall Study|Non compliance with protocol|0|||
49036099|NCT00804856|157968165|FG001|Overall Study|Non compliance with protocol|0|||
49036100|NCT00804856|157968166|FG002|Overall Study|Non compliance with protocol|0|||
49036101|NCT00804856|157968167|FG003|Overall Study|Non compliance with protocol|0|||
49036102|NCT00804856|157968168|FG004|Overall Study|Non compliance with protocol|0|||
48796478|NCT02723864|157093669|FG000|Overall Study|Switched to alternative treatment|0|||
49036103|NCT00804856|157968169|FG005|Overall Study|Non compliance with protocol|0|||
49036104|NCT00804856|157968170|FG006|Overall Study|Non compliance with protocol|0|||
49036105|NCT00804856|157968171|FG007|Overall Study|Non compliance with protocol|0|||
49036106|NCT00804856|157968172|FG008|Overall Study|Non compliance with protocol|0|||
49036107|NCT00804856|157968173|FG009|Overall Study|Non compliance with protocol|0|||
49036108|NCT00804856|157968174|FG010|Overall Study|Non compliance with protocol|0|||
49036109|NCT00804856|157968175|FG011|Overall Study|Non compliance with protocol|0|||
48796479|NCT02723864|157093670|FG001|Overall Study|Switched to alternative treatment|0|||
48796480|NCT02723864|157093671|FG002|Overall Study|Switched to alternative treatment|0|||
48796481|NCT02723864|157093672|FG003|Overall Study|Switched to alternative treatment|0|||
48796482|NCT02723864|157093673|FG004|Overall Study|Switched to alternative treatment|0|||
48796483|NCT02723864|157093674|FG005|Overall Study|Switched to alternative treatment|1|||
48796484|NCT02723864|157093675|FG006|Overall Study|Switched to alternative treatment|0|||
48796485|NCT02723864|157093669|FG000|Overall Study|Late determination of ineligibility|0|||
48796486|NCT02723864|157093670|FG001|Overall Study|Late determination of ineligibility|0|||
48796487|NCT02723864|157093671|FG002|Overall Study|Late determination of ineligibility|0|||
48796488|NCT02723864|157093672|FG003|Overall Study|Late determination of ineligibility|0|||
48796489|NCT02723864|157093673|FG004|Overall Study|Late determination of ineligibility|0|||
48796490|NCT02723864|157093674|FG005|Overall Study|Late determination of ineligibility|1|||
48796491|NCT02723864|157093675|FG006|Overall Study|Late determination of ineligibility|0|||
48796492|NCT02548455|157093676|FG000|Overall Study|Withdrawal by Subject|27|||
48796493|NCT02548455|157093676|FG000|Overall Study|Death|26|||
48796494|NCT02548455|157093676|FG000|Overall Study|Lost to Follow-up|14|||
48796495|NCT02548455|157093676|FG000|Overall Study|Visit not completed|173|||
48796496|NCT04528069|157093677|FG000|Overall Study|Adverse Event|1|||
48796497|NCT04528069|157093677|FG000|Overall Study|Lost to Follow-up|1|||
48796498|NCT04528069|157093677|FG000|Overall Study|Patient Unable to Come|1|||
48796499|NCT04528069|157093677|FG000|Overall Study|Patient Unable to Attend|1|||
48796500|NCT01137474|157093678|FG000|Overall Study|Adverse Event|3|||
48796501|NCT01137474|157093679|FG001|Overall Study|Adverse Event|5|||
48796502|NCT01137474|157093680|FG002|Overall Study|Adverse Event|1|||
48796503|NCT01137474|157093681|FG003|Overall Study|Adverse Event|3|||
48796504|NCT01137474|157093678|FG000|Overall Study|Withdrawal by Subject|7|||
48796505|NCT01137474|157093679|FG001|Overall Study|Withdrawal by Subject|2|||
48796506|NCT01137474|157093680|FG002|Overall Study|Withdrawal by Subject|6|||
48796507|NCT01137474|157093681|FG003|Overall Study|Withdrawal by Subject|9|||
48796508|NCT01137474|157093678|FG000|Overall Study|No longer met study criteria|6|||
48796509|NCT01137474|157093679|FG001|Overall Study|No longer met study criteria|1|||
48887911|NCT00568178|157425943|FG001|Open Label Extension|Progressive Disease|0|||
48887912|NCT00568178|157425944|FG002|Open Label Extension|Progressive Disease|0|||
48887913|NCT00568178|157425945|FG003|Open Label Extension|Progressive Disease|0|||
48887914|NCT00568178|157425946|FG004|Open Label Extension|Progressive Disease|3|||
48887915|NCT00568178|157425947|FG005|Open Label Extension|Progressive Disease|1|||
48887916|NCT00568178|157425942|FG000|Open Label Extension|Termination of Trial|0|||
48887917|NCT00568178|157425943|FG001|Open Label Extension|Termination of Trial|0|||
48887918|NCT00568178|157425944|FG002|Open Label Extension|Termination of Trial|0|||
49036110|NCT00804856|157968176|FG012|Overall Study|Non compliance with protocol|0|||
49036111|NCT00804856|157968177|FG013|Overall Study|Non compliance with protocol|2|||
49036112|NCT00804856|157968178|FG014|Overall Study|Non compliance with protocol|0|||
49036113|NCT00804856|157968164|FG000|Overall Study|Refused to continue medication|0|||
49036114|NCT00804856|157968165|FG001|Overall Study|Refused to continue medication|0|||
49036115|NCT00804856|157968166|FG002|Overall Study|Refused to continue medication|0|||
49036116|NCT00804856|157968167|FG003|Overall Study|Refused to continue medication|1|||
49036117|NCT00804856|157968168|FG004|Overall Study|Refused to continue medication|1|||
49036118|NCT00804856|157968169|FG005|Overall Study|Refused to continue medication|0|||
49036119|NCT00804856|157968170|FG006|Overall Study|Refused to continue medication|0|||
48887919|NCT00568178|157425945|FG003|Open Label Extension|Termination of Trial|0|||
48887920|NCT00568178|157425946|FG004|Open Label Extension|Termination of Trial|45|||
48887921|NCT00568178|157425947|FG005|Open Label Extension|Termination of Trial|47|||
48887922|NCT00568178|157425942|FG000|Open Label Extension|Withdrawal by Subject|0|||
48887923|NCT00568178|157425943|FG001|Open Label Extension|Withdrawal by Subject|0|||
48887924|NCT00568178|157425944|FG002|Open Label Extension|Withdrawal by Subject|0|||
48887925|NCT00568178|157425945|FG003|Open Label Extension|Withdrawal by Subject|0|||
48887926|NCT00568178|157425946|FG004|Open Label Extension|Withdrawal by Subject|4|||
48887927|NCT00568178|157425947|FG005|Open Label Extension|Withdrawal by Subject|4|||
48887928|NCT00288639|157425948|FG000|Overall Study|Adverse Event|5|||
48887929|NCT00288639|157425948|FG000|Overall Study|Lack of Efficacy|4|||
48887930|NCT00288639|157425948|FG000|Overall Study|Withdrawal by Subject|2|||
48887931|NCT00288639|157425948|FG000|Overall Study|Other|1|||
48887932|NCT00264303|157425949|FG000|Overall Study|Adverse Event|4|||
48887933|NCT00264303|157425950|FG001|Overall Study|Adverse Event|3|||
48887934|NCT00264303|157425949|FG000|Overall Study|Lack of Efficacy|10|||
48887935|NCT00264303|157425950|FG001|Overall Study|Lack of Efficacy|13|||
49036120|NCT00804856|157968171|FG007|Overall Study|Refused to continue medication|0|||
49036121|NCT00804856|157968172|FG008|Overall Study|Refused to continue medication|0|||
49036122|NCT00804856|157968173|FG009|Overall Study|Refused to continue medication|0|||
48796510|NCT01137474|157093680|FG002|Overall Study|No longer met study criteria|0|||
48796511|NCT01137474|157093681|FG003|Overall Study|No longer met study criteria|5|||
48796512|NCT01137474|157093678|FG000|Overall Study|Lost to Follow-up|5|||
48796513|NCT01137474|157093679|FG001|Overall Study|Lost to Follow-up|1|||
48796514|NCT01137474|157093680|FG002|Overall Study|Lost to Follow-up|0|||
48796515|NCT01137474|157093681|FG003|Overall Study|Lost to Follow-up|2|||
48796516|NCT01137474|157093678|FG000|Overall Study|Lack of Efficacy|0|||
48796517|NCT01137474|157093679|FG001|Overall Study|Lack of Efficacy|0|||
48796518|NCT01137474|157093680|FG002|Overall Study|Lack of Efficacy|0|||
48796519|NCT01137474|157093681|FG003|Overall Study|Lack of Efficacy|2|||
48796520|NCT01137474|157093678|FG000|Overall Study|Other|3|||
48796521|NCT01137474|157093679|FG001|Overall Study|Other|1|||
48796522|NCT01137474|157093680|FG002|Overall Study|Other|0|||
48796523|NCT01137474|157093681|FG003|Overall Study|Other|0|||
48796524|NCT01137474|157093678|FG000|Overall Study|Pregnancy|0|||
48796525|NCT01137474|157093679|FG001|Overall Study|Pregnancy|1|||
48796526|NCT01137474|157093680|FG002|Overall Study|Pregnancy|0|||
48796527|NCT01137474|157093681|FG003|Overall Study|Pregnancy|0|||
48796528|NCT01137474|157093678|FG000|Overall Study|Administrative reason by sponsor|0|||
48796529|NCT01137474|157093679|FG001|Overall Study|Administrative reason by sponsor|1|||
48796530|NCT01137474|157093680|FG002|Overall Study|Administrative reason by sponsor|0|||
48796531|NCT01137474|157093681|FG003|Overall Study|Administrative reason by sponsor|0|||
48796532|NCT04683926|157093683|FG000|Intervention 2 (1 Day)|Adverse Event|0|||
48796533|NCT04683926|157093684|FG001|Intervention 2 (1 Day)|Adverse Event|0|||
48796534|NCT04683926|157093685|FG002|Intervention 2 (1 Day)|Adverse Event|0|||
48796535|NCT04683926|157093686|FG003|Intervention 2 (1 Day)|Adverse Event|1|||
48796536|NCT04385368|157093688|FG000|Overall Study|Death|5|||
48796537|NCT04385368|157093689|FG001|Overall Study|Death|5|||
48796538|NCT04385368|157093688|FG000|Overall Study|Physician Decision|3|||
48796539|NCT04385368|157093689|FG001|Overall Study|Physician Decision|0|||
48796540|NCT04385368|157093688|FG000|Overall Study|Withdrawal by Subject|4|||
48796541|NCT04385368|157093689|FG001|Overall Study|Withdrawal by Subject|3|||
48796542|NCT04052204|157093690|FG000|Overall Study|Death|1|||
48796543|NCT04052204|157093691|FG001|Overall Study|Death|0|||
48796544|NCT04052204|157093692|FG002|Overall Study|Death|0|||
48796545|NCT04052204|157093690|FG000|Overall Study|Progressive disease|1|||
48796546|NCT04052204|157093691|FG001|Overall Study|Progressive disease|0|||
48796547|NCT04052204|157093692|FG002|Overall Study|Progressive disease|0|||
48887936|NCT00264303|157425949|FG000|Overall Study|Lost to Follow-up|3|||
48887937|NCT00264303|157425950|FG001|Overall Study|Lost to Follow-up|3|||
48887938|NCT00264303|157425949|FG000|Overall Study|Withdrawal by Subject|2|||
48887939|NCT00264303|157425950|FG001|Overall Study|Withdrawal by Subject|3|||
48887940|NCT00264303|157425949|FG000|Overall Study|Various reasons listed in study report|6|||
48887941|NCT00264303|157425950|FG001|Overall Study|Various reasons listed in study report|7|||
48887942|NCT02304705|157425956|FG000|Overall Study|Withdrawal by Subject|2|||
48887943|NCT02304705|157425957|FG001|Overall Study|Withdrawal by Subject|0|||
48887944|NCT02304705|157425956|FG000|Overall Study|Physician Decision|2|||
48887945|NCT02304705|157425957|FG001|Overall Study|Physician Decision|4|||
48887946|NCT02304705|157425956|FG000|Overall Study|Death|0|||
48887947|NCT02304705|157425957|FG001|Overall Study|Death|1|||
48887948|NCT02304705|157425956|FG000|Overall Study|Lost to Follow-up|0|||
48887949|NCT02304705|157425957|FG001|Overall Study|Lost to Follow-up|2|||
48887950|NCT00095056|157425958|FG000|Phase A (Weeks 0-12)|Adverse Event|1|||
48887951|NCT00095056|157425959|FG001|Phase A (Weeks 0-12)|Adverse Event|1|||
48887952|NCT00095056|157425958|FG000|Phase A (Weeks 0-12)|Withdrawal by Subject|3|||
48887953|NCT00095056|157425959|FG001|Phase A (Weeks 0-12)|Withdrawal by Subject|0|||
48887954|NCT00095056|157425958|FG000|Phase A (Weeks 0-12)|Death|1|||
48887955|NCT00095056|157425959|FG001|Phase A (Weeks 0-12)|Death|0|||
48887956|NCT00095056|157425958|FG000|Phase A (Weeks 0-12)|Protocol specific criteria|2|||
48887957|NCT00095056|157425959|FG001|Phase A (Weeks 0-12)|Protocol specific criteria|0|||
48887958|NCT00095056|157425958|FG000|Phase B (Weeks 12-54)|Adverse Event|2|||
48887959|NCT00095056|157425959|FG001|Phase B (Weeks 12-54)|Adverse Event|2|||
48887960|NCT00095056|157425958|FG000|Phase B (Weeks 12-54)|Lost to Follow-up|1|||
48887961|NCT00095056|157425959|FG001|Phase B (Weeks 12-54)|Lost to Follow-up|0|||
48887962|NCT00095056|157425958|FG000|Phase B (Weeks 12-54)|Withdrawal by Subject|2|||
48887963|NCT00095056|157425959|FG001|Phase B (Weeks 12-54)|Withdrawal by Subject|1|||
48887964|NCT00095056|157425958|FG000|Phase B (Weeks 12-54)|Patient Moved|1|||
48887965|NCT00095056|157425959|FG001|Phase B (Weeks 12-54)|Patient Moved|0|||
48887966|NCT00095056|157425958|FG000|Phase B (Weeks 12-54)|Death|3|||
48887967|NCT00095056|157425959|FG001|Phase B (Weeks 12-54)|Death|1|||
48887968|NCT00095056|157425958|FG000|Phase B (Weeks 12-54)|Protocol specific criteria|1|||
48887969|NCT00095056|157425959|FG001|Phase B (Weeks 12-54)|Protocol specific criteria|0|||
48887970|NCT00095056|157425958|FG000|Phase B (Weeks 12-54)|Protocol Violation|0|||
48887971|NCT00095056|157425959|FG001|Phase B (Weeks 12-54)|Protocol Violation|1|||
48887972|NCT00979576|157425960|FG000|Combination Treatment Phase|Progressive disease|3|||
48887973|NCT00979576|157425961|FG001|Combination Treatment Phase|Progressive disease|1|||
48887974|NCT00979576|157425962|FG002|Combination Treatment Phase|Progressive disease|5|||
48887975|NCT00979576|157425960|FG000|Combination Treatment Phase|Dose limiting toxicity|0|||
48887976|NCT00979576|157425961|FG001|Combination Treatment Phase|Dose limiting toxicity|3|||
48887977|NCT00979576|157425962|FG002|Combination Treatment Phase|Dose limiting toxicity|2|||
48887978|NCT00979576|157425960|FG000|Combination Treatment Phase|Adverse Event|0|||
48887979|NCT00979576|157425961|FG001|Combination Treatment Phase|Adverse Event|2|||
48887980|NCT00979576|157425962|FG002|Combination Treatment Phase|Adverse Event|2|||
48887981|NCT00979576|157425960|FG000|Combination Followed by Monotherapy|Progressive Disease|0|||
48887982|NCT00979576|157425961|FG001|Combination Followed by Monotherapy|Progressive Disease|2|||
48887983|NCT00979576|157425962|FG002|Combination Followed by Monotherapy|Progressive Disease|1|||
48887984|NCT00616902|157425965|FG000|Overall Study|Termination of study|6|||
48887985|NCT00616902|157425966|FG001|Overall Study|Termination of study|6|||
48887986|NCT02530970|157425969|FG000|Overall Study|Adverse Event|8|||
48887987|NCT02530970|157425969|FG000|Overall Study|Lost to Follow-up|88|||
48887988|NCT02530970|157425969|FG000|Overall Study|Physician Decision|5|||
48887989|NCT02530970|157425969|FG000|Overall Study|Withdrawal by Subject|14|||
48887990|NCT02530970|157425969|FG000|Overall Study|Death|6|||
48887991|NCT02530970|157425969|FG000|Overall Study|Hospitalization|1|||
48887992|NCT02530970|157425969|FG000|Overall Study|Insurance|2|||
48887993|NCT02530970|157425969|FG000|Overall Study|Explant|2|||
48887994|NCT02530970|157425969|FG000|Overall Study|Change in Provider|5|||
48887995|NCT02530970|157425969|FG000|Overall Study|Relocation|3|||
48887996|NCT02233803|157425972|FG000|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1|||
48887997|NCT02233803|157425973|FG001|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0|||
48887998|NCT02233803|157425972|FG000|Treatment Period 1 (4-Wks)|Adverse Event|0|||
48887999|NCT02233803|157425973|FG001|Treatment Period 1 (4-Wks)|Adverse Event|1|||
48888000|NCT02233803|157425972|FG000|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
48888001|NCT02233803|157425973|FG001|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
48888002|NCT02233803|157425972|FG000|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0|||
48888003|NCT02233803|157425973|FG001|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1|||
48888004|NCT02233803|157425972|FG000|Washout Period (4-Wks)|Lost to Follow-up|0|||
48983882|NCT02178592|157772371|FG001|OLE Phase (Week 52 to Week 252)|Protocol Violation|0|||
48888005|NCT02233803|157425973|FG001|Washout Period (4-Wks)|Lost to Follow-up|1|||
48888006|NCT02233803|157425972|FG000|Washout Period (4-Wks)|Physician Decision|1|||
48888007|NCT02233803|157425973|FG001|Washout Period (4-Wks)|Physician Decision|0|||
48888008|NCT02233803|157425972|FG000|Washout Period (4-Wks)|Withdrawal by Subject|1|||
48888009|NCT02233803|157425973|FG001|Washout Period (4-Wks)|Withdrawal by Subject|1|||
48888010|NCT02233803|157425972|FG000|Treatment Period 2 (4-Wks)|Lost to Follow-up|1|||
48888011|NCT02233803|157425973|FG001|Treatment Period 2 (4-Wks)|Lost to Follow-up|0|||
48888012|NCT02233803|157425972|FG000|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1|||
48888013|NCT02233803|157425973|FG001|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2|||
48888014|NCT01365481|157425976|FG000|Overall Study|Adverse Event|6|||
48888015|NCT01365481|157425977|FG001|Overall Study|Adverse Event|9|||
48888016|NCT01365481|157425978|FG002|Overall Study|Adverse Event|0|||
48888017|NCT01365481|157425979|FG003|Overall Study|Adverse Event|2|||
48888018|NCT01365481|157425976|FG000|Overall Study|Withdrawal by Subject|0|||
48888019|NCT01365481|157425977|FG001|Overall Study|Withdrawal by Subject|2|||
48888020|NCT01365481|157425978|FG002|Overall Study|Withdrawal by Subject|1|||
48888021|NCT01365481|157425979|FG003|Overall Study|Withdrawal by Subject|1|||
48888022|NCT01365481|157425976|FG000|Overall Study|Lost to Follow-up|1|||
48888023|NCT01365481|157425977|FG001|Overall Study|Lost to Follow-up|1|||
48888024|NCT01365481|157425978|FG002|Overall Study|Lost to Follow-up|2|||
48888025|NCT01365481|157425979|FG003|Overall Study|Lost to Follow-up|3|||
48888026|NCT01365481|157425976|FG000|Overall Study|Abnormal laboratory value(s)|0|||
48888027|NCT01365481|157425977|FG001|Overall Study|Abnormal laboratory value(s)|1|||
48888028|NCT01365481|157425978|FG002|Overall Study|Abnormal laboratory value(s)|0|||
48888029|NCT01365481|157425979|FG003|Overall Study|Abnormal laboratory value(s)|0|||
48888030|NCT01365481|157425976|FG000|Overall Study|Administrative problems|0|||
48888031|NCT01365481|157425977|FG001|Overall Study|Administrative problems|1|||
48888032|NCT01365481|157425978|FG002|Overall Study|Administrative problems|0|||
48888033|NCT01365481|157425979|FG003|Overall Study|Administrative problems|0|||
48888034|NCT01365481|157425976|FG000|Overall Study|Protocol deviation|0|||
48888035|NCT01365481|157425977|FG001|Overall Study|Protocol deviation|1|||
48888036|NCT01365481|157425978|FG002|Overall Study|Protocol deviation|0|||
48888037|NCT01365481|157425979|FG003|Overall Study|Protocol deviation|1|||
48888038|NCT01365481|157425976|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
48888039|NCT01365481|157425977|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
48888040|NCT01365481|157425978|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
48888041|NCT01365481|157425979|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
48888042|NCT00635661|157425980|FG000|Overall Study|Withdrawal by Subject|4|||
48888043|NCT01427725|157425989|FG000|Overall Study|Lost to Follow-up|17|||
48888044|NCT01427725|157425989|FG000|Overall Study|Protocol Violation|1|||
48888045|NCT01427725|157425989|FG000|Overall Study|Drug not administered|1|||
48888046|NCT01427725|157425989|FG000|Overall Study|Failure to visit|7|||
48888047|NCT01427725|157425989|FG000|Overall Study|Adverse Event|46|||
48888048|NCT01427725|157425989|FG000|Overall Study|Failure to visit after administration|40|||
48888049|NCT01427725|157425989|FG000|Overall Study|Patient's rejection|27|||
48888050|NCT01427725|157425989|FG000|Overall Study|Transfer to a different hospital|17|||
48888051|NCT01427725|157425989|FG000|Overall Study|Lack of Efficacy|8|||
48888052|NCT01427725|157425989|FG000|Overall Study|Death|7|||
48888053|NCT01427725|157425989|FG000|Overall Study|Symptom improvement|6|||
48888054|NCT01427725|157425989|FG000|Overall Study|AE and Patient's rejection|5|||
48888055|NCT01427725|157425989|FG000|Overall Study|Physician Decision|5|||
48888056|NCT01427725|157425989|FG000|Overall Study|Exacerbation of underlying disease|5|||
48888057|NCT01427725|157425989|FG000|Overall Study|Oral feeding difficulty|5|||
48888058|NCT01427725|157425989|FG000|Overall Study|Lack of Efficacy and Patient's rejection|1|||
48888059|NCT01427725|157425989|FG000|Overall Study|Forgetting prescription|1|||
48888060|NCT01427725|157425989|FG000|Overall Study|Other|2|||
48888061|NCT00468559|157425990|FG000|Open-label Treatment Phase|Adverse Event|5|||
48888062|NCT00468559|157425991|FG001|Open-label Treatment Phase|Adverse Event|0|||
48888063|NCT00468559|157425992|FG002|Open-label Treatment Phase|Adverse Event|0|||
48888064|NCT00468559|157425990|FG000|Open-label Treatment Phase|Lack of Efficacy|9|||
48888065|NCT00468559|157425991|FG001|Open-label Treatment Phase|Lack of Efficacy|0|||
48888066|NCT00468559|157425992|FG002|Open-label Treatment Phase|Lack of Efficacy|0|||
48888067|NCT00468559|157425990|FG000|Open-label Treatment Phase|Withdrawal by Subject|4|||
48888068|NCT00468559|157425991|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
48888069|NCT00468559|157425992|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
48888070|NCT00468559|157425990|FG000|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0|||
48888071|NCT00468559|157425991|FG001|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8|||
48888072|NCT00468559|157425992|FG002|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17|||
48888073|NCT00468559|157425990|FG000|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
48888074|NCT00468559|157425991|FG001|Double-blind, Treatment-withdrawal Phase|Adverse Event|2|||
48888075|NCT00468559|157425992|FG002|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
48888076|NCT01641159|157425993|FG000|Overall Study|Lost to Follow-up|2|||
48888077|NCT01641159|157425994|FG001|Overall Study|Lost to Follow-up|1|||
48888078|NCT01641159|157425993|FG000|Overall Study|Withdrawal by Subject|0|||
48888079|NCT01641159|157425994|FG001|Overall Study|Withdrawal by Subject|1|||
48888080|NCT00436605|157425995|FG000|Overall Study|Protocol Violation|3|||
48888081|NCT01696045|157425998|FG000|Overall Study|Study drug toxicity|1|||
48888082|NCT01696045|157425999|FG001|Overall Study|Study drug toxicity|5|||
48888083|NCT01696045|157425998|FG000|Overall Study|Disease progression|2|||
48888084|NCT01696045|157425999|FG001|Overall Study|Disease progression|2|||
48888085|NCT00573859|157426000|FG000|Medication Versus Placebo|Scheduling conflicts|12|||
48888086|NCT00573859|157426000|FG000|Smoking Versus Abstinence|Scheduling conflicts|12|||
48888087|NCT00415051|157426001|FG000|Overall Study|Protocol Violation|1|||
48888088|NCT01163292|157426003|FG000|Overall Study|Lack of Efficacy|9|||
48888089|NCT01163292|157426004|FG001|Overall Study|Lack of Efficacy|0|||
48888090|NCT01163292|157426003|FG000|Overall Study|Adverse Event|6|||
48888091|NCT01163292|157426004|FG001|Overall Study|Adverse Event|0|||
48888092|NCT01163292|157426003|FG000|Overall Study|Initiation of biological therapy|0|||
48888093|NCT01163292|157426004|FG001|Overall Study|Initiation of biological therapy|15|||
48888094|NCT01163292|157426003|FG000|Overall Study|Sufficient response to adalimumab|8|||
48888095|NCT01163292|157426004|FG001|Overall Study|Sufficient response to adalimumab|0|||
48888096|NCT01163292|157426003|FG000|Overall Study|Refusal to receive adalimumab|7|||
48888097|NCT01163292|157426004|FG001|Overall Study|Refusal to receive adalimumab|0|||
48888098|NCT01163292|157426003|FG000|Overall Study|Economic reasons|6|||
48888099|NCT01163292|157426004|FG001|Overall Study|Economic reasons|0|||
48888100|NCT01163292|157426003|FG000|Overall Study|No further visits|5|||
48888101|NCT01163292|157426004|FG001|Overall Study|No further visits|7|||
48888102|NCT00886795|157426008|FG000|Overall Study|Lack of Efficacy|1|||
48888103|NCT05132127|157426011|FG000|Overall Study|Adverse Event|1|||
49036123|NCT00804856|157968174|FG010|Overall Study|Refused to continue medication|3|||
48888104|NCT04276415|157426012|FG000|Overall Study|Adverse Event|0|||
49036124|NCT00804856|157968175|FG011|Overall Study|Refused to continue medication|0|||
49036125|NCT00804856|157968176|FG012|Overall Study|Refused to continue medication|1|||
49036126|NCT00804856|157968177|FG013|Overall Study|Refused to continue medication|1|||
49036127|NCT00804856|157968178|FG014|Overall Study|Refused to continue medication|5|||
48888105|NCT04276415|157426013|FG001|Overall Study|Adverse Event|0|||
48888106|NCT04276415|157426014|FG002|Overall Study|Adverse Event|0|||
48888107|NCT04276415|157426015|FG003|Overall Study|Adverse Event|3|||
48888108|NCT04276415|157426016|FG004|Overall Study|Adverse Event|0|||
48888109|NCT04276415|157426017|FG005|Overall Study|Adverse Event|0|||
48888110|NCT04276415|157426012|FG000|Overall Study|Clinical progression|1|||
48888111|NCT04276415|157426013|FG001|Overall Study|Clinical progression|1|||
48888112|NCT04276415|157426014|FG002|Overall Study|Clinical progression|0|||
48888113|NCT04276415|157426015|FG003|Overall Study|Clinical progression|0|||
48888114|NCT04276415|157426016|FG004|Overall Study|Clinical progression|1|||
48888115|NCT04276415|157426017|FG005|Overall Study|Clinical progression|0|||
48888116|NCT04276415|157426012|FG000|Overall Study|Other|0|||
48888117|NCT04276415|157426013|FG001|Overall Study|Other|0|||
48888118|NCT04276415|157426014|FG002|Overall Study|Other|0|||
48888119|NCT04276415|157426015|FG003|Overall Study|Other|1|||
48888120|NCT04276415|157426016|FG004|Overall Study|Other|0|||
48888121|NCT04276415|157426017|FG005|Overall Study|Other|0|||
48888122|NCT04276415|157426012|FG000|Overall Study|Physician Decision|0|||
48888123|NCT04276415|157426013|FG001|Overall Study|Physician Decision|0|||
48888124|NCT04276415|157426014|FG002|Overall Study|Physician Decision|1|||
48888125|NCT04276415|157426015|FG003|Overall Study|Physician Decision|3|||
48888126|NCT04276415|157426016|FG004|Overall Study|Physician Decision|2|||
48888127|NCT04276415|157426017|FG005|Overall Study|Physician Decision|0|||
48888128|NCT04276415|157426012|FG000|Overall Study|Progressive disease|3|||
48888129|NCT04276415|157426013|FG001|Overall Study|Progressive disease|3|||
48888130|NCT04276415|157426014|FG002|Overall Study|Progressive disease|4|||
48888131|NCT04276415|157426015|FG003|Overall Study|Progressive disease|5|||
48888132|NCT04276415|157426016|FG004|Overall Study|Progressive disease|1|||
48888133|NCT04276415|157426017|FG005|Overall Study|Progressive disease|2|||
48888134|NCT04276415|157426012|FG000|Overall Study|Withdrawal by patient|0|||
48888135|NCT04276415|157426013|FG001|Overall Study|Withdrawal by patient|0|||
49036128|NCT00804856|157968164|FG000|Overall Study|Other reason than listed above|0|||
49036129|NCT00804856|157968165|FG001|Overall Study|Other reason than listed above|0|||
49036130|NCT00804856|157968166|FG002|Overall Study|Other reason than listed above|0|||
49036131|NCT00804856|157968167|FG003|Overall Study|Other reason than listed above|0|||
48888136|NCT04276415|157426014|FG002|Overall Study|Withdrawal by patient|0|||
48888137|NCT04276415|157426015|FG003|Overall Study|Withdrawal by patient|1|||
48888138|NCT04276415|157426016|FG004|Overall Study|Withdrawal by patient|2|||
49036132|NCT00804856|157968168|FG004|Overall Study|Other reason than listed above|0|||
48888139|NCT04276415|157426017|FG005|Overall Study|Withdrawal by patient|0|||
48888140|NCT01373151|157426018|FG000|Period 1|Lack of Efficacy|3|||
48888141|NCT01373151|157426019|FG001|Period 1|Lack of Efficacy|0|||
48888142|NCT01373151|157426020|FG002|Period 1|Lack of Efficacy|0|||
48888143|NCT01373151|157426021|FG003|Period 1|Lack of Efficacy|0|||
48888144|NCT01373151|157426022|FG004|Period 1|Lack of Efficacy|1|||
48888145|NCT01373151|157426023|FG005|Period 1|Lack of Efficacy|0|||
48888146|NCT01373151|157426024|FG006|Period 1|Lack of Efficacy|0|||
48888147|NCT01373151|157426018|FG000|Period 1|Adverse Event|0|||
48888148|NCT01373151|157426019|FG001|Period 1|Adverse Event|0|||
48888149|NCT01373151|157426020|FG002|Period 1|Adverse Event|1|||
48888150|NCT01373151|157426021|FG003|Period 1|Adverse Event|0|||
48888151|NCT01373151|157426022|FG004|Period 1|Adverse Event|4|||
48888152|NCT01373151|157426023|FG005|Period 1|Adverse Event|3|||
48888153|NCT01373151|157426024|FG006|Period 1|Adverse Event|0|||
48888154|NCT01373151|157426018|FG000|Period 1|Withdrawal by Subject|2|||
48888155|NCT01373151|157426019|FG001|Period 1|Withdrawal by Subject|0|||
48888156|NCT01373151|157426020|FG002|Period 1|Withdrawal by Subject|3|||
48888157|NCT01373151|157426021|FG003|Period 1|Withdrawal by Subject|1|||
48888158|NCT01373151|157426022|FG004|Period 1|Withdrawal by Subject|0|||
48888159|NCT01373151|157426023|FG005|Period 1|Withdrawal by Subject|1|||
48888160|NCT01373151|157426024|FG006|Period 1|Withdrawal by Subject|0|||
48888161|NCT01373151|157426018|FG000|Period 2|Lack of Efficacy|9|||
48888162|NCT01373151|157426019|FG001|Period 2|Lack of Efficacy|0|||
48888163|NCT01373151|157426020|FG002|Period 2|Lack of Efficacy|0|||
48888164|NCT01373151|157426021|FG003|Period 2|Lack of Efficacy|1|||
48888165|NCT01373151|157426022|FG004|Period 2|Lack of Efficacy|2|||
48888166|NCT01373151|157426023|FG005|Period 2|Lack of Efficacy|0|||
48888167|NCT01373151|157426024|FG006|Period 2|Lack of Efficacy|3|||
48888168|NCT01373151|157426018|FG000|Period 2|Adverse Event|0|||
48888169|NCT01373151|157426019|FG001|Period 2|Adverse Event|0|||
48888170|NCT01373151|157426020|FG002|Period 2|Adverse Event|3|||
48888171|NCT01373151|157426021|FG003|Period 2|Adverse Event|3|||
48888172|NCT01373151|157426022|FG004|Period 2|Adverse Event|0|||
48888173|NCT01373151|157426023|FG005|Period 2|Adverse Event|0|||
48888174|NCT01373151|157426024|FG006|Period 2|Adverse Event|1|||
48888175|NCT01373151|157426018|FG000|Period 2|subject request to discontinue|0|||
48888176|NCT01373151|157426019|FG001|Period 2|subject request to discontinue|1|||
48888177|NCT01373151|157426020|FG002|Period 2|subject request to discontinue|0|||
48888178|NCT01373151|157426021|FG003|Period 2|subject request to discontinue|0|||
48888179|NCT01373151|157426022|FG004|Period 2|subject request to discontinue|0|||
48888180|NCT01373151|157426023|FG005|Period 2|subject request to discontinue|0|||
48888181|NCT01373151|157426024|FG006|Period 2|subject request to discontinue|0|||
48888182|NCT01373151|157426018|FG000|Period 2|Withdrawal by Subject|0|||
48888183|NCT01373151|157426019|FG001|Period 2|Withdrawal by Subject|0|||
48888184|NCT01373151|157426020|FG002|Period 2|Withdrawal by Subject|0|||
48888185|NCT01373151|157426021|FG003|Period 2|Withdrawal by Subject|1|||
48888186|NCT01373151|157426022|FG004|Period 2|Withdrawal by Subject|0|||
48888187|NCT01373151|157426023|FG005|Period 2|Withdrawal by Subject|0|||
48888188|NCT01373151|157426024|FG006|Period 2|Withdrawal by Subject|0|||
48888189|NCT01373151|157426018|FG000|Period 2|Other|0|||
48888190|NCT01373151|157426019|FG001|Period 2|Other|0|||
48888191|NCT01373151|157426020|FG002|Period 2|Other|1|||
48888192|NCT01373151|157426021|FG003|Period 2|Other|0|||
48888193|NCT01373151|157426022|FG004|Period 2|Other|0|||
48888194|NCT01373151|157426023|FG005|Period 2|Other|0|||
48888195|NCT01373151|157426024|FG006|Period 2|Other|1|||
48888196|NCT04958200|157426028|FG000|Overall Study|Withdrawal by Subject|0|||
48888197|NCT04958200|157426029|FG001|Overall Study|Withdrawal by Subject|2|||
48888198|NCT04958200|157426028|FG000|Overall Study|Lost to Follow-up|3|||
48888199|NCT04958200|157426029|FG001|Overall Study|Lost to Follow-up|2|||
48888200|NCT02387970|157426030|FG000|Overall Study|Did not complete 1-year follow up|1|||
48888201|NCT02387970|157426031|FG001|Overall Study|Did not complete 1-year follow up|2|||
48888202|NCT03117998|157426032|FG000|Overall Study|Adverse Event|1|||
48888203|NCT03117998|157426033|FG001|Overall Study|Adverse Event|0|||
48888204|NCT03117998|157426034|FG002|Overall Study|Adverse Event|0|||
48888205|NCT03117998|157426035|FG003|Overall Study|Adverse Event|0|||
48888206|NCT03117998|157426036|FG004|Overall Study|Adverse Event|0|||
48888207|NCT03117998|157426037|FG005|Overall Study|Adverse Event|0|||
48888208|NCT03117998|157426032|FG000|Overall Study|Withdrawal by Subject|0|||
48888209|NCT03117998|157426033|FG001|Overall Study|Withdrawal by Subject|0|||
48888210|NCT03117998|157426034|FG002|Overall Study|Withdrawal by Subject|2|||
48888211|NCT03117998|157426035|FG003|Overall Study|Withdrawal by Subject|3|||
48888212|NCT03117998|157426036|FG004|Overall Study|Withdrawal by Subject|3|||
48888213|NCT03117998|157426037|FG005|Overall Study|Withdrawal by Subject|0|||
48888214|NCT03117998|157426032|FG000|Overall Study|Physician Decision|0|||
48888215|NCT03117998|157426033|FG001|Overall Study|Physician Decision|1|||
48888216|NCT03117998|157426034|FG002|Overall Study|Physician Decision|1|||
48888217|NCT03117998|157426035|FG003|Overall Study|Physician Decision|0|||
48888218|NCT03117998|157426036|FG004|Overall Study|Physician Decision|0|||
48888219|NCT03117998|157426037|FG005|Overall Study|Physician Decision|0|||
48888220|NCT03117998|157426032|FG000|Overall Study|Lost to Follow-up|0|||
48888221|NCT03117998|157426033|FG001|Overall Study|Lost to Follow-up|0|||
48888222|NCT03117998|157426034|FG002|Overall Study|Lost to Follow-up|0|||
48888223|NCT03117998|157426035|FG003|Overall Study|Lost to Follow-up|1|||
48888224|NCT03117998|157426036|FG004|Overall Study|Lost to Follow-up|4|||
48888225|NCT03117998|157426037|FG005|Overall Study|Lost to Follow-up|0|||
48888226|NCT03117998|157426032|FG000|Overall Study|Subject noncompliance|0|||
48888227|NCT03117998|157426033|FG001|Overall Study|Subject noncompliance|0|||
48888228|NCT03117998|157426034|FG002|Overall Study|Subject noncompliance|1|||
48888229|NCT03117998|157426035|FG003|Overall Study|Subject noncompliance|0|||
48888230|NCT03117998|157426036|FG004|Overall Study|Subject noncompliance|0|||
48888231|NCT03117998|157426037|FG005|Overall Study|Subject noncompliance|2|||
48888232|NCT03117998|157426032|FG000|Overall Study|Protocol Violation|0|||
48888233|NCT03117998|157426033|FG001|Overall Study|Protocol Violation|0|||
48888234|NCT03117998|157426034|FG002|Overall Study|Protocol Violation|0|||
49036133|NCT00804856|157968169|FG005|Overall Study|Other reason than listed above|1|||
48888235|NCT03117998|157426035|FG003|Overall Study|Protocol Violation|0|||
48888236|NCT03117998|157426036|FG004|Overall Study|Protocol Violation|0|||
48888237|NCT03117998|157426037|FG005|Overall Study|Protocol Violation|1|||
48888238|NCT00293059|157426038|FG000|Overall Study|Adverse Event|12|||
48888239|NCT00293059|157426039|FG001|Overall Study|Adverse Event|4|||
49036134|NCT00804856|157968170|FG006|Overall Study|Other reason than listed above|0|||
49036135|NCT00804856|157968171|FG007|Overall Study|Other reason than listed above|0|||
49036136|NCT00804856|157968172|FG008|Overall Study|Other reason than listed above|1|||
49036137|NCT00804856|157968173|FG009|Overall Study|Other reason than listed above|0|||
49036138|NCT00804856|157968174|FG010|Overall Study|Other reason than listed above|3|||
49036139|NCT00804856|157968175|FG011|Overall Study|Other reason than listed above|1|||
48888240|NCT00293059|157426038|FG000|Overall Study|Lack of Efficacy|2|||
48888241|NCT00293059|157426039|FG001|Overall Study|Lack of Efficacy|0|||
48888242|NCT00293059|157426038|FG000|Overall Study|Lost to Follow-up|2|||
48888243|NCT00293059|157426039|FG001|Overall Study|Lost to Follow-up|3|||
48888244|NCT00293059|157426038|FG000|Overall Study|Pregnancy|1|||
48888245|NCT00293059|157426039|FG001|Overall Study|Pregnancy|1|||
48888246|NCT00293059|157426038|FG000|Overall Study|Protocol Violation|2|||
48888247|NCT00293059|157426039|FG001|Overall Study|Protocol Violation|0|||
48888248|NCT00293059|157426038|FG000|Overall Study|Withdrawal by Subject|11|||
48888249|NCT00293059|157426039|FG001|Overall Study|Withdrawal by Subject|5|||
48888250|NCT00293059|157426038|FG000|Overall Study|Participant moved out of state|1|||
48888251|NCT00293059|157426039|FG001|Overall Study|Participant moved out of state|0|||
48888252|NCT00293059|157426038|FG000|Overall Study|Participant stopped study drug|1|||
48888253|NCT00293059|157426039|FG001|Overall Study|Participant stopped study drug|0|||
48888254|NCT00293059|157426038|FG000|Overall Study|Noncompliant - sanitary pads collection|0|||
48888255|NCT00293059|157426039|FG001|Overall Study|Noncompliant - sanitary pads collection|1|||
48888256|NCT00293059|157426038|FG000|Overall Study|missing|3|||
48888257|NCT00293059|157426039|FG001|Overall Study|missing|5|||
48888258|NCT00586612|157426040|FG000|Primary Phase|Protocol Violation|1|||
48888259|NCT00586612|157426041|FG001|Primary Phase|Protocol Violation|0|||
48888260|NCT00586612|157426040|FG000|Primary Phase|Lost to Follow-up|0|||
48888261|NCT00586612|157426041|FG001|Primary Phase|Lost to Follow-up|1|||
48888262|NCT00586612|157426040|FG000|Primary Phase|Withdrawal by Subject|0|||
48888263|NCT00586612|157426041|FG001|Primary Phase|Withdrawal by Subject|2|||
48888264|NCT00586612|157426040|FG000|Booster Phase|Lost to Follow-up|3|||
48888265|NCT00586612|157426041|FG001|Booster Phase|Lost to Follow-up|1|||
48888266|NCT01879553|157426042|FG000|Overall Study|Withdrawal by Subject|1|||
48888267|NCT01879553|157426043|FG001|Overall Study|Withdrawal by Subject|0|||
48888268|NCT02738853|157426044|FG000|Enrollment|Inclusion/Exclusion not met|21|||
48888269|NCT02738853|157426044|FG000|Enrollment|Withdrawal by Subject|3|||
48888270|NCT02738853|157426044|FG000|Enrollment|Subject treated with commercially available device|6|||
48888271|NCT02738853|157426044|FG000|Enrollment|Study Enrollment Closed|3|||
48888272|NCT02738853|157426044|FG000|Procedure|Death|1|||
48888273|NCT02738853|157426044|FG000|1 Month|Death|2|||
48888274|NCT02738853|157426044|FG000|6 Month|Death|4|||
48888275|NCT02738853|157426044|FG000|6 Month|Withdrawal by Subject|2|||
48888276|NCT02738853|157426044|FG000|1 Year|Death|6|||
48888277|NCT02738853|157426044|FG000|1 Year|Withdrawal by Subject|1|||
48888278|NCT02738853|157426044|FG000|2 Year|Death|2|||
48888279|NCT02738853|157426044|FG000|2 Year|Lost to Follow-up|1|||
48888280|NCT02738853|157426044|FG000|3 Year|Death|2|||
48888281|NCT02738853|157426044|FG000|3 Year|Withdrawal by Subject|1|||
48888282|NCT02738853|157426044|FG000|4 Year|Death|9|||
48888283|NCT02738853|157426044|FG000|5 Year|Lost to Follow-up|4|||
48888284|NCT01585155|157426045|FG000|Overall Study|Adverse Event|1|||
48888285|NCT01585155|157426045|FG000|Overall Study|Lack of Efficacy|2|||
49036140|NCT00804856|157968176|FG012|Overall Study|Other reason than listed above|1|||
49036141|NCT00804856|157968177|FG013|Overall Study|Other reason than listed above|10|||
48888286|NCT01585155|157426045|FG000|Overall Study|Worsening ulcerative colitis|2|||
48888287|NCT03772587|157426048|FG000|Overall Study|COVID-19|0|||
48888288|NCT03772587|157426049|FG001|Overall Study|COVID-19|0|||
48888289|NCT03772587|157426050|FG002|Overall Study|COVID-19|1|||
48888290|NCT03772587|157426051|FG003|Overall Study|COVID-19|1|||
48888291|NCT03772587|157426052|FG004|Overall Study|COVID-19|0|||
48888292|NCT03772587|157426048|FG000|Overall Study|Withdrawal by Subject|1|||
49036142|NCT00804856|157968178|FG014|Overall Study|Other reason than listed above|3|||
48888293|NCT03772587|157426049|FG001|Overall Study|Withdrawal by Subject|0|||
48888294|NCT03772587|157426050|FG002|Overall Study|Withdrawal by Subject|0|||
48888295|NCT03772587|157426051|FG003|Overall Study|Withdrawal by Subject|0|||
48888296|NCT03772587|157426052|FG004|Overall Study|Withdrawal by Subject|0|||
48888297|NCT00126503|157426053|FG000|Overall Study|disease progression|23|||
48888298|NCT00126503|157426054|FG001|Overall Study|disease progression|14|||
48888299|NCT00126503|157426053|FG000|Overall Study|Withdrawal by Subject|0|||
48888300|NCT00126503|157426054|FG001|Overall Study|Withdrawal by Subject|1|||
48888301|NCT00126503|157426053|FG000|Overall Study|alternative therapy|1|||
48888302|NCT00126503|157426054|FG001|Overall Study|alternative therapy|1|||
49036143|NCT00446966|157968181|FG000|Overall Study|Lost to Follow-up|10|||
49036144|NCT00446966|157968182|FG001|Overall Study|Lost to Follow-up|7|||
48888303|NCT00126503|157426053|FG000|Overall Study|other complicating disease|4|||
48888304|NCT00126503|157426054|FG001|Overall Study|other complicating disease|1|||
48888305|NCT00126503|157426053|FG000|Overall Study|Death|3|||
48888306|NCT00126503|157426054|FG001|Overall Study|Death|0|||
48888307|NCT00126503|157426053|FG000|Overall Study|Adverse Event|13|||
48888308|NCT00126503|157426054|FG001|Overall Study|Adverse Event|3|||
48888309|NCT00126503|157426053|FG000|Overall Study|non-compliant|1|||
48888310|NCT00126503|157426054|FG001|Overall Study|non-compliant|0|||
48888311|NCT00126503|157426053|FG000|Overall Study|Physician Decision|2|||
48888312|NCT00126503|157426054|FG001|Overall Study|Physician Decision|1|||
48888313|NCT05000931|157426055|FG000|Overall Study|Lost to Follow-up|1|||
48888314|NCT03345576|157426056|FG000|Overall Study|Withdrawal by Subject|2|||
48888315|NCT03345576|157426057|FG001|Overall Study|Withdrawal by Subject|2|||
48888316|NCT03345576|157426056|FG000|Overall Study|Adverse Event|1|||
48888317|NCT03345576|157426057|FG001|Overall Study|Adverse Event|0|||
48888318|NCT05602727|157428494|FG000|Overall Study|Physician Decision|0|||
48888319|NCT05602727|157428495|FG001|Overall Study|Physician Decision|1|||
48888320|NCT05602727|157428496|FG002|Overall Study|Physician Decision|0|||
48888321|NCT05602727|157428494|FG000|Overall Study|Randomized by mistake without study medication|1|||
48888322|NCT05602727|157428495|FG001|Overall Study|Randomized by mistake without study medication|0|||
48888323|NCT05602727|157428496|FG002|Overall Study|Randomized by mistake without study medication|0|||
48888324|NCT05602727|157428494|FG000|Overall Study|Study termination by Sponsor|18|||
48888325|NCT05602727|157428495|FG001|Overall Study|Study termination by Sponsor|15|||
48888326|NCT05602727|157428496|FG002|Overall Study|Study termination by Sponsor|19|||
48888327|NCT05602727|157428494|FG000|Overall Study|Withdrawal by Subject|2|||
48888328|NCT05602727|157428495|FG001|Overall Study|Withdrawal by Subject|1|||
48888329|NCT05602727|157428496|FG002|Overall Study|Withdrawal by Subject|1|||
48888330|NCT05602727|157428494|FG000|Overall Study|Various reasons|1|||
48888331|NCT05602727|157428495|FG001|Overall Study|Various reasons|6|||
48888332|NCT05602727|157428496|FG002|Overall Study|Various reasons|1|||
48888333|NCT01283152|157428497|FG000|Overall Study|Discharged prior to 24 hr assessment|1|||
48888334|NCT01283152|157428498|FG001|Overall Study|Discharged prior to 24 hr assessment|0|||
48888335|NCT01283152|157428497|FG000|Overall Study|Refused HESA|1|||
48888336|NCT01283152|157428498|FG001|Overall Study|Refused HESA|0|||
48888337|NCT04833127|157428499|FG000|Overall Study|Lost to Follow-up|1|||
48888338|NCT04833127|157428500|FG001|Overall Study|Lost to Follow-up|1|||
48888339|NCT00772330|157428503|FG000|Overall Study|Lost to Follow-up|3|||
48888340|NCT00224887|157428505|FG000|Overall Study|Pregnancy|6|||
48888341|NCT00224887|157428506|FG001|Overall Study|Pregnancy|6|||
48888342|NCT02672852|157428507|FG000|Part A1|Disease Worsening|1|||
48888343|NCT02672852|157428508|FG001|Part A1|Disease Worsening|0|||
48888344|NCT02672852|157428509|FG002|Part A1|Disease Worsening|0|||
48888345|NCT02672852|157428510|FG003|Part A1|Disease Worsening|0|||
48888346|NCT02672852|157428511|FG004|Part A1|Disease Worsening|0|||
48888347|NCT02672852|157428512|FG005|Part A1|Disease Worsening|0|||
48888348|NCT02672852|157428513|FG006|Part A1|Disease Worsening|0|||
48888349|NCT02672852|157428507|FG000|Part A1|Adverse Event|0|||
48888350|NCT02672852|157428508|FG001|Part A1|Adverse Event|1|||
49036145|NCT01558635|157968184|FG000|Overall Study|Death|1|||
49036146|NCT01558635|157968184|FG000|Overall Study|Withdrawal by Subject|2|||
49036147|NCT01558635|157968184|FG000|Overall Study|Physician Decision|1|||
49036148|NCT01558635|157968184|FG000|Overall Study|Subject received other treatment|1|||
49036149|NCT01558635|157968184|FG000|Overall Study|Reveal XT was explanted|1|||
49036150|NCT00835575|157968185|FG000|Washout of 14 Days|Withdrawal by Subject|1|||
49036151|NCT00835575|157968186|FG001|Washout of 14 Days|Withdrawal by Subject|0|||
49036152|NCT01440803|157968189|FG000|Overall Study|Met study stopping rule|2|||
48888351|NCT02672852|157428509|FG002|Part A1|Adverse Event|0|||
48888352|NCT02672852|157428510|FG003|Part A1|Adverse Event|0|||
48888353|NCT02672852|157428511|FG004|Part A1|Adverse Event|0|||
48888354|NCT02672852|157428512|FG005|Part A1|Adverse Event|0|||
48888355|NCT02672852|157428513|FG006|Part A1|Adverse Event|0|||
48888356|NCT02672852|157428507|FG000|Part A1|Lost to Follow-up|1|||
48888357|NCT02672852|157428508|FG001|Part A1|Lost to Follow-up|2|||
48888358|NCT02672852|157428509|FG002|Part A1|Lost to Follow-up|0|||
48888359|NCT02672852|157428510|FG003|Part A1|Lost to Follow-up|0|||
48888360|NCT02672852|157428511|FG004|Part A1|Lost to Follow-up|0|||
48888361|NCT02672852|157428512|FG005|Part A1|Lost to Follow-up|0|||
48888362|NCT02672852|157428513|FG006|Part A1|Lost to Follow-up|0|||
48888363|NCT02672852|157428507|FG000|Part A1|Withdrawal by Subject|1|||
48888364|NCT02672852|157428508|FG001|Part A1|Withdrawal by Subject|1|||
48888365|NCT02672852|157428509|FG002|Part A1|Withdrawal by Subject|0|||
48888366|NCT02672852|157428510|FG003|Part A1|Withdrawal by Subject|0|||
48888367|NCT02672852|157428511|FG004|Part A1|Withdrawal by Subject|0|||
48888368|NCT02672852|157428512|FG005|Part A1|Withdrawal by Subject|0|||
48888369|NCT02672852|157428513|FG006|Part A1|Withdrawal by Subject|0|||
48888370|NCT02672852|157428507|FG000|Part A2|Disease worsening|0|||
48888371|NCT02672852|157428508|FG001|Part A2|Disease worsening|0|||
49036153|NCT01440803|157968190|FG001|Overall Study|Met study stopping rule|1|||
49036154|NCT01440803|157968189|FG000|Overall Study|Lost to Follow-up|0|||
48888372|NCT02672852|157428509|FG002|Part A2|Disease worsening|1|||
48888373|NCT02672852|157428510|FG003|Part A2|Disease worsening|0|||
48888374|NCT02672852|157428511|FG004|Part A2|Disease worsening|0|||
48888375|NCT02672852|157428512|FG005|Part A2|Disease worsening|0|||
48888376|NCT02672852|157428513|FG006|Part A2|Disease worsening|0|||
48888377|NCT02672852|157428507|FG000|Part A2|Adverse Event|0|||
48888378|NCT02672852|157428508|FG001|Part A2|Adverse Event|0|||
48888379|NCT02672852|157428509|FG002|Part A2|Adverse Event|3|||
48888380|NCT02672852|157428510|FG003|Part A2|Adverse Event|0|||
48888381|NCT02672852|157428511|FG004|Part A2|Adverse Event|0|||
48888382|NCT02672852|157428512|FG005|Part A2|Adverse Event|0|||
48888383|NCT02672852|157428513|FG006|Part A2|Adverse Event|0|||
48888384|NCT02672852|157428507|FG000|Part A2|Lost to Follow-up|0|||
48888385|NCT02672852|157428508|FG001|Part A2|Lost to Follow-up|0|||
48888386|NCT02672852|157428509|FG002|Part A2|Lost to Follow-up|2|||
48888387|NCT02672852|157428510|FG003|Part A2|Lost to Follow-up|0|||
48888388|NCT02672852|157428511|FG004|Part A2|Lost to Follow-up|0|||
48888389|NCT02672852|157428512|FG005|Part A2|Lost to Follow-up|0|||
48888390|NCT02672852|157428513|FG006|Part A2|Lost to Follow-up|0|||
48888391|NCT02672852|157428507|FG000|Part A2|Withdrawal by Subject|0|||
48888392|NCT02672852|157428508|FG001|Part A2|Withdrawal by Subject|0|||
48888393|NCT02672852|157428509|FG002|Part A2|Withdrawal by Subject|1|||
48888394|NCT02672852|157428510|FG003|Part A2|Withdrawal by Subject|0|||
48888395|NCT02672852|157428511|FG004|Part A2|Withdrawal by Subject|0|||
48888396|NCT02672852|157428512|FG005|Part A2|Withdrawal by Subject|0|||
48888397|NCT02672852|157428513|FG006|Part A2|Withdrawal by Subject|0|||
48888398|NCT02672852|157428507|FG000|Part A2|Other|0|||
48888399|NCT02672852|157428508|FG001|Part A2|Other|0|||
48888400|NCT02672852|157428509|FG002|Part A2|Other|3|||
48888401|NCT02672852|157428510|FG003|Part A2|Other|0|||
48888402|NCT02672852|157428511|FG004|Part A2|Other|0|||
48888403|NCT02672852|157428512|FG005|Part A2|Other|0|||
48888404|NCT02672852|157428513|FG006|Part A2|Other|0|||
48888405|NCT02672852|157428507|FG000|Part A2|Not entered in Part B|0|||
48888406|NCT02672852|157428508|FG001|Part A2|Not entered in Part B|0|||
48888407|NCT02672852|157428509|FG002|Part A2|Not entered in Part B|0|||
48888408|NCT02672852|157428510|FG003|Part A2|Not entered in Part B|4|||
48888409|NCT02672852|157428511|FG004|Part A2|Not entered in Part B|0|||
48888410|NCT02672852|157428512|FG005|Part A2|Not entered in Part B|0|||
48888411|NCT02672852|157428513|FG006|Part A2|Not entered in Part B|0|||
48888412|NCT02672852|157428507|FG000|Part B|Disease worsening|0|||
48888413|NCT02672852|157428508|FG001|Part B|Disease worsening|0|||
48888414|NCT02672852|157428509|FG002|Part B|Disease worsening|0|||
48888415|NCT02672852|157428510|FG003|Part B|Disease worsening|0|||
48888416|NCT02672852|157428511|FG004|Part B|Disease worsening|1|||
48888417|NCT02672852|157428512|FG005|Part B|Disease worsening|0|||
48888418|NCT02672852|157428513|FG006|Part B|Disease worsening|1|||
48888419|NCT02672852|157428507|FG000|Part B|Worsening pre-existing condition|0|||
48888420|NCT02672852|157428508|FG001|Part B|Worsening pre-existing condition|0|||
48888421|NCT02672852|157428509|FG002|Part B|Worsening pre-existing condition|0|||
48888422|NCT02672852|157428510|FG003|Part B|Worsening pre-existing condition|0|||
48888423|NCT02672852|157428511|FG004|Part B|Worsening pre-existing condition|0|||
48888424|NCT02672852|157428512|FG005|Part B|Worsening pre-existing condition|1|||
48888425|NCT02672852|157428513|FG006|Part B|Worsening pre-existing condition|0|||
48888426|NCT02672852|157428507|FG000|Part B|Other adverse event|0|||
48888427|NCT02672852|157428508|FG001|Part B|Other adverse event|0|||
48888428|NCT02672852|157428509|FG002|Part B|Other adverse event|0|||
48888429|NCT02672852|157428510|FG003|Part B|Other adverse event|0|||
48888430|NCT02672852|157428511|FG004|Part B|Other adverse event|3|||
48888431|NCT02672852|157428512|FG005|Part B|Other adverse event|5|||
48888432|NCT02672852|157428513|FG006|Part B|Other adverse event|1|||
48888433|NCT02672852|157428507|FG000|Part B|Lost to Follow-up|0|||
48888434|NCT02672852|157428508|FG001|Part B|Lost to Follow-up|0|||
48888435|NCT02672852|157428509|FG002|Part B|Lost to Follow-up|0|||
48888436|NCT02672852|157428510|FG003|Part B|Lost to Follow-up|0|||
48888437|NCT02672852|157428511|FG004|Part B|Lost to Follow-up|3|||
48888438|NCT02672852|157428512|FG005|Part B|Lost to Follow-up|4|||
48888439|NCT02672852|157428513|FG006|Part B|Lost to Follow-up|1|||
48888440|NCT02672852|157428507|FG000|Part B|Withdrawal by Subject|0|||
48888441|NCT02672852|157428508|FG001|Part B|Withdrawal by Subject|0|||
48888442|NCT02672852|157428509|FG002|Part B|Withdrawal by Subject|0|||
48888443|NCT02672852|157428510|FG003|Part B|Withdrawal by Subject|0|||
48888444|NCT02672852|157428511|FG004|Part B|Withdrawal by Subject|5|||
48888445|NCT02672852|157428512|FG005|Part B|Withdrawal by Subject|0|||
48888446|NCT02672852|157428513|FG006|Part B|Withdrawal by Subject|7|||
48888447|NCT02672852|157428507|FG000|Part B|Other|0|||
48888448|NCT02672852|157428508|FG001|Part B|Other|0|||
48888449|NCT02672852|157428509|FG002|Part B|Other|0|||
48888450|NCT02672852|157428510|FG003|Part B|Other|0|||
48888451|NCT02672852|157428511|FG004|Part B|Other|4|||
48888452|NCT02672852|157428512|FG005|Part B|Other|1|||
48888453|NCT02672852|157428513|FG006|Part B|Other|2|||
48888454|NCT03845140|157428514|FG000|Overall Study|Participant travelled outside study area|0|||
48888455|NCT03845140|157428515|FG001|Overall Study|Participant travelled outside study area|1|||
48888456|NCT03845140|157428516|FG002|Overall Study|Participant travelled outside study area|0|||
48888457|NCT03845140|157428517|FG003|Overall Study|Participant travelled outside study area|0|||
48888458|NCT03845140|157428518|FG004|Overall Study|Participant travelled outside study area|0|||
48888459|NCT03845140|157428519|FG005|Overall Study|Participant travelled outside study area|0|||
48888460|NCT04958642|157428520|FG000|Overall Study|Transferred to OLEX program|3|||
48888461|NCT04958642|157428521|FG001|Overall Study|Transferred to OLEX program|0|||
48888462|NCT04958642|157428522|FG002|Overall Study|Transferred to OLEX program|5|||
48888463|NCT04958642|157428520|FG000|Overall Study|Death|0|||
48888464|NCT04958642|157428521|FG001|Overall Study|Death|0|||
48888465|NCT04958642|157428522|FG002|Overall Study|Death|1|||
48888466|NCT04958642|157428520|FG000|Overall Study|Withdrawal by Subject|4|||
48888467|NCT04958642|157428521|FG001|Overall Study|Withdrawal by Subject|9|||
48888468|NCT04958642|157428522|FG002|Overall Study|Withdrawal by Subject|13|||
48888469|NCT04958642|157428520|FG000|Overall Study|Investigator's Decision|0|||
48888470|NCT04958642|157428521|FG001|Overall Study|Investigator's Decision|0|||
48888471|NCT04958642|157428522|FG002|Overall Study|Investigator's Decision|1|||
48888472|NCT04958642|157428520|FG000|Overall Study|Adverse Event|1|||
48888473|NCT04958642|157428521|FG001|Overall Study|Adverse Event|0|||
48888474|NCT04958642|157428522|FG002|Overall Study|Adverse Event|1|||
48888475|NCT04958642|157428520|FG000|Overall Study|Termination by Sponsor/Regulatory Authorities|8|||
48888476|NCT04958642|157428521|FG001|Overall Study|Termination by Sponsor/Regulatory Authorities|4|||
48888477|NCT04958642|157428522|FG002|Overall Study|Termination by Sponsor/Regulatory Authorities|13|||
48888478|NCT04958642|157428520|FG000|Overall Study|Lost to Follow-up|1|||
48888479|NCT04958642|157428521|FG001|Overall Study|Lost to Follow-up|0|||
48888480|NCT04958642|157428522|FG002|Overall Study|Lost to Follow-up|0|||
48888481|NCT04958642|157428520|FG000|Overall Study|Transferred to EAP following study termination|0|||
48888482|NCT04958642|157428521|FG001|Overall Study|Transferred to EAP following study termination|0|||
48888483|NCT04958642|157428522|FG002|Overall Study|Transferred to EAP following study termination|1|||
48888484|NCT04958642|157428520|FG000|Overall Study|Transferred to Expanded Access Program|1|||
48888485|NCT04958642|157428521|FG001|Overall Study|Transferred to Expanded Access Program|0|||
48888486|NCT04958642|157428522|FG002|Overall Study|Transferred to Expanded Access Program|0|||
48888487|NCT01656200|157428523|FG000|Overall Study|Withdrawal by Subject|1|||
48888488|NCT01156376|157428524|FG000|Overall Study|Adverse Event|1|||
48888489|NCT01156376|157428525|FG001|Overall Study|Adverse Event|0|||
48888490|NCT01156376|157428526|FG002|Overall Study|Adverse Event|1|||
48888491|NCT01156376|157428524|FG000|Overall Study|Withdrawal by Subject|0|||
48888492|NCT01156376|157428525|FG001|Overall Study|Withdrawal by Subject|0|||
48888493|NCT01156376|157428526|FG002|Overall Study|Withdrawal by Subject|3|||
48888494|NCT00565773|157428527|FG000|Overall Study|Withdrawal by Subject|1|||
48888495|NCT00565773|157428527|FG000|Overall Study|Physician Decision|1|||
48888496|NCT04546425|157428528|FG000|Overall Study|Protocol Violation|1|||
48888497|NCT04546425|157428529|FG001|Overall Study|Protocol Violation|1|||
48888498|NCT04546425|157428530|FG002|Overall Study|Protocol Violation|0|||
48888499|NCT04546425|157428531|FG003|Overall Study|Protocol Violation|0|||
48888500|NCT04546425|157428528|FG000|Overall Study|Adverse Event|3|||
48888501|NCT04546425|157428529|FG001|Overall Study|Adverse Event|0|||
48888502|NCT04546425|157428530|FG002|Overall Study|Adverse Event|0|||
48888503|NCT04546425|157428531|FG003|Overall Study|Adverse Event|0|||
48888504|NCT04546425|157428528|FG000|Overall Study|Lost to Follow-up|5|||
48888505|NCT04546425|157428529|FG001|Overall Study|Lost to Follow-up|4|||
48888506|NCT04546425|157428530|FG002|Overall Study|Lost to Follow-up|0|||
48888507|NCT04546425|157428531|FG003|Overall Study|Lost to Follow-up|0|||
48888508|NCT04546425|157428528|FG000|Overall Study|No Longer met eligibility criteria|3|||
48888509|NCT04546425|157428529|FG001|Overall Study|No Longer met eligibility criteria|3|||
48888510|NCT04546425|157428530|FG002|Overall Study|No Longer met eligibility criteria|1|||
48888511|NCT04546425|157428531|FG003|Overall Study|No Longer met eligibility criteria|1|||
48888512|NCT04546425|157428528|FG000|Overall Study|Withdrawal by parent/guardian|6|||
48888513|NCT04546425|157428529|FG001|Overall Study|Withdrawal by parent/guardian|5|||
48888514|NCT04546425|157428530|FG002|Overall Study|Withdrawal by parent/guardian|1|||
48888515|NCT04546425|157428531|FG003|Overall Study|Withdrawal by parent/guardian|1|||
48888516|NCT03921723|157428534|FG000|Period 2 (4 Days)|Withdrawal by Subject|3|||
48888517|NCT03921723|157428534|FG000|Period 3 (4 Days)|Withdrawal by Subject|1|||
48888518|NCT01461811|157428535|FG000|Overall Study|Adverse Event|2|||
48888519|NCT01461811|157428536|FG001|Overall Study|Adverse Event|1|||
48888520|NCT01461811|157428535|FG000|Overall Study|Subject decision unrelated to an AE|1|||
48888521|NCT01461811|157428536|FG001|Overall Study|Subject decision unrelated to an AE|1|||
48888522|NCT01461811|157428535|FG000|Overall Study|Noncompliance|1|||
48888523|NCT01461811|157428536|FG001|Overall Study|Noncompliance|1|||
48888524|NCT04076943|157428539|FG000|Overall Study|Withdrawal by Subject|12|||
48888525|NCT04076943|157428539|FG000|Overall Study|Adverse Event|1|||
48888526|NCT04076943|157428539|FG000|Overall Study|Progressive Disease|2|||
48888527|NCT04076943|157428539|FG000|Overall Study|Death|13|||
48888528|NCT04076943|157428539|FG000|Overall Study|Other than specified|6|||
48888529|NCT03047395|157428540|FG000|Overall Study|Adverse Event|142|||
48888530|NCT03047395|157428540|FG000|Overall Study|Withdrawal by Subject|155|||
48888531|NCT03047395|157428540|FG000|Overall Study|Lost to Follow-up|144|||
49036155|NCT01440803|157968190|FG001|Overall Study|Lost to Follow-up|2|||
49036156|NCT01440803|157968189|FG000|Overall Study|Withdrawal by Subject|0|||
49036157|NCT01440803|157968190|FG001|Overall Study|Withdrawal by Subject|1|||
49036158|NCT05746455|157968191|FG000|Overall Study|Discharged from Clinical Service|1|||
49036159|NCT05746455|157968191|FG000|Overall Study|Lost to Follow-up|1|||
49036160|NCT01693523|157968192|FG000|Overall Study|Adverse Event|2|||
49036161|NCT01693523|157968193|FG001|Overall Study|Adverse Event|1|||
49036162|NCT01693523|157968194|FG002|Overall Study|Adverse Event|0|||
49036163|NCT01693523|157968192|FG000|Overall Study|Death|0|||
49036164|NCT01693523|157968193|FG001|Overall Study|Death|1|||
49036165|NCT01693523|157968194|FG002|Overall Study|Death|1|||
49036166|NCT01693523|157968192|FG000|Overall Study|Lost to Follow-up|0|||
49036167|NCT01693523|157968193|FG001|Overall Study|Lost to Follow-up|0|||
49036168|NCT01693523|157968194|FG002|Overall Study|Lost to Follow-up|4|||
49036169|NCT01693523|157968192|FG000|Overall Study|Physician Decision|0|||
48888532|NCT03047395|157428540|FG000|Overall Study|COVID-19 Infection|2|||
48888533|NCT03047395|157428540|FG000|Overall Study|COVID-19 Logistical Restrictions|9|||
48888534|NCT03047395|157428540|FG000|Overall Study|Other, Not Specified|117|||
48888535|NCT01075958|157428543|FG000|Overall Study|Blood sample could not be obtained|44|||
48888536|NCT01232738|157428548|FG000|Overall Study|Death|3|||
48888537|NCT01232738|157428548|FG000|Overall Study|Physician Decision|2|||
48888538|NCT01232738|157428548|FG000|Overall Study|Lost to Follow-up|1|||
48888539|NCT01232738|157428548|FG000|Overall Study|Withdrawal by Subject|2|||
48888540|NCT01232738|157428548|FG000|Overall Study|Adverse Event|5|||
48888541|NCT01125046|157428549|FG000|First 6 Months of Treatment|Death|1|||
48888542|NCT01125046|157428549|FG000|First 6 Months of Treatment|Withdrawal by Subject|2|||
48888543|NCT01125046|157428549|FG000|First 6 Months of Treatment|Non-compliance|1|||
48888544|NCT01125046|157428549|FG000|First 6 Months of Treatment|Surgery|1|||
48888545|NCT01125046|157428549|FG000|First 6 Months of Treatment|Progressive Disease|7|||
48888546|NCT01125046|157428549|FG000|First 6 Months of Treatment|Adverse Event|2|||
48888547|NCT01125046|157428549|FG000|Continued Treatment After 6 Months|Progressive Disease|2|||
48888548|NCT01125046|157428549|FG000|Continued Treatment After 6 Months|Adverse Event|1|||
48888549|NCT01125046|157428549|FG000|Follow-up/Data Cut Off Point|Death|29|||
48888550|NCT01125046|157428549|FG000|Follow-up/Data Cut Off Point|Lost to Follow-up|4|||
48888551|NCT03868787|157428550|FG000|Overall Study|Withdrawal by Subject|2|||
48888552|NCT03868787|157428551|FG001|Overall Study|Withdrawal by Subject|1|||
48888553|NCT00659880|157428552|FG000|Overall Study|Lost to Follow-up|5|||
48888554|NCT00941070|157428553|FG000|Overall Study|Patient non-compliant|1|||
48888555|NCT04488770|157428554|FG000|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
48888556|NCT04488770|157428555|FG001|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
48888557|NCT04488770|157428556|FG002|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
48888558|NCT04488770|157428557|FG003|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|1|||
48888559|NCT04488770|157428558|FG004|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
48888560|NCT04488770|157428559|FG005|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
48888561|NCT04488770|157428560|FG006|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
48888562|NCT04488770|157428561|FG007|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
48888563|NCT04488770|157428562|FG008|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
48888564|NCT04488770|157428563|FG009|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
48888565|NCT04488770|157428564|FG010|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
48888566|NCT04488770|157428565|FG011|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
48888567|NCT04488770|157428566|FG012|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
48888568|NCT04488770|157428554|FG000|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|1|||
48888569|NCT04488770|157428555|FG001|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
48888570|NCT04488770|157428556|FG002|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
48888571|NCT04488770|157428557|FG003|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
48888572|NCT04488770|157428558|FG004|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
48888573|NCT04488770|157428559|FG005|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
48888574|NCT04488770|157428560|FG006|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
48888575|NCT04488770|157428561|FG007|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
48888576|NCT04488770|157428562|FG008|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
48888577|NCT04488770|157428563|FG009|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
48888578|NCT04488770|157428564|FG010|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
48888579|NCT04488770|157428565|FG011|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
48888580|NCT04488770|157428566|FG012|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
48888581|NCT04488770|157428554|FG000|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
48888582|NCT04488770|157428555|FG001|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
48888583|NCT04488770|157428556|FG002|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
48888584|NCT04488770|157428557|FG003|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
49036170|NCT01693523|157968193|FG001|Overall Study|Physician Decision|0|||
49036171|NCT01693523|157968194|FG002|Overall Study|Physician Decision|1|||
49036172|NCT01693523|157968192|FG000|Overall Study|Withdrawal by Subject|1|||
49036173|NCT01693523|157968193|FG001|Overall Study|Withdrawal by Subject|2|||
48888585|NCT04488770|157428558|FG004|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
48888586|NCT04488770|157428559|FG005|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
48888587|NCT04488770|157428560|FG006|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
48888588|NCT04488770|157428561|FG007|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
49036174|NCT01693523|157968194|FG002|Overall Study|Withdrawal by Subject|2|||
49036175|NCT01693523|157968192|FG000|Overall Study|Lack of compliance study medication|1|||
49036176|NCT01693523|157968193|FG001|Overall Study|Lack of compliance study medication|2|||
49036177|NCT01693523|157968194|FG002|Overall Study|Lack of compliance study medication|0|||
49036178|NCT01693523|157968192|FG000|Overall Study|Chemotherapy was held|1|||
49036179|NCT01693523|157968193|FG001|Overall Study|Chemotherapy was held|2|||
49036180|NCT01693523|157968194|FG002|Overall Study|Chemotherapy was held|0|||
49036181|NCT03343535|157968195|FG000|Overall Study|Lost to Follow-up|1|||
49036182|NCT03343535|157968195|FG000|Overall Study|Subject Discontinued Due to Re-transplant|1|||
49036183|NCT03343535|157968195|FG000|Overall Study|Death|12|||
49036184|NCT00834418|157968198|FG000|Overall Study|Adverse Event|0|||
49036185|NCT00834418|157968199|FG001|Overall Study|Adverse Event|2|||
49036186|NCT00443651|157968200|FG000|Overall Study|Death|1|||
49036187|NCT00443651|157968201|FG001|Overall Study|Death|5|||
49036188|NCT00443651|157968200|FG000|Overall Study|Adverse Event|5|||
49036189|NCT00443651|157968201|FG001|Overall Study|Adverse Event|6|||
49036190|NCT00443651|157968200|FG000|Overall Study|Lost to Follow-up|18|||
49036191|NCT00443651|157968201|FG001|Overall Study|Lost to Follow-up|12|||
49036192|NCT00443651|157968200|FG000|Overall Study|Patient's/Guardian's Decision|58|||
49036193|NCT00443651|157968201|FG001|Overall Study|Patient's/Guardian's Decision|30|||
49036194|NCT00443651|157968200|FG000|Overall Study|Physician Decision|13|||
48888589|NCT04488770|157428562|FG008|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
49036195|NCT00443651|157968201|FG001|Overall Study|Physician Decision|4|||
49036196|NCT00443651|157968200|FG000|Overall Study|Pregnancy|0|||
49036197|NCT00443651|157968201|FG001|Overall Study|Pregnancy|1|||
48888590|NCT04488770|157428563|FG009|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
48888591|NCT04488770|157428564|FG010|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
48888592|NCT04488770|157428565|FG011|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
48888593|NCT04488770|157428566|FG012|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
48888594|NCT04488770|157428554|FG000|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
48888595|NCT04488770|157428555|FG001|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
48888596|NCT04488770|157428556|FG002|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
48888597|NCT04488770|157428557|FG003|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
48888598|NCT04488770|157428558|FG004|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|1|||
48888599|NCT04488770|157428559|FG005|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
48888600|NCT04488770|157428560|FG006|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
48888601|NCT04488770|157428561|FG007|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
48888602|NCT04488770|157428562|FG008|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
48888603|NCT04488770|157428563|FG009|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
48888604|NCT04488770|157428564|FG010|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
48888605|NCT04488770|157428565|FG011|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
48888606|NCT04488770|157428566|FG012|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
49036198|NCT02125461|157968206|FG000|Overall Study|Withdrawal by Subject|30|||
49036199|NCT02125461|157968207|FG001|Overall Study|Withdrawal by Subject|16|||
49036200|NCT02125461|157968206|FG000|Overall Study|Lost to Follow-up|8|||
49036201|NCT02125461|157968207|FG001|Overall Study|Lost to Follow-up|3|||
49036202|NCT02125461|157968206|FG000|Overall Study|Death|260|||
49036203|NCT02125461|157968207|FG001|Overall Study|Death|149|||
49036204|NCT02125461|157968206|FG000|Overall Study|Missing Termination Reason|0|||
49036205|NCT02125461|157968207|FG001|Overall Study|Missing Termination Reason|1|||
49036206|NCT02888756|157968209|FG000|Analytical Treatment Interruption|Physician Decision|10|||
49036207|NCT02888756|157968210|FG001|Analytical Treatment Interruption|Physician Decision|6|||
49036208|NCT02888756|157968211|FG002|Analytical Treatment Interruption|Physician Decision|5|||
49036209|NCT02842853|157968214|FG000|Overall Study|Non-compliance with the protocol|3|||
49036210|NCT02842853|157968215|FG001|Overall Study|Non-compliance with the protocol|7|||
49036211|NCT02842853|157968216|FG002|Overall Study|Non-compliance with the protocol|2|||
49036212|NCT02842853|157968217|FG003|Overall Study|Non-compliance with the protocol|5|||
49036213|NCT02842853|157968214|FG000|Overall Study|Subject met exclusion criteria|0|||
49036214|NCT02842853|157968215|FG001|Overall Study|Subject met exclusion criteria|1|||
49036215|NCT02842853|157968216|FG002|Overall Study|Subject met exclusion criteria|0|||
49036216|NCT02842853|157968217|FG003|Overall Study|Subject met exclusion criteria|0|||
49036217|NCT02842853|157968214|FG000|Overall Study|Withdrawal by Subject|11|||
49036218|NCT02842853|157968215|FG001|Overall Study|Withdrawal by Subject|13|||
49036219|NCT02842853|157968216|FG002|Overall Study|Withdrawal by Subject|9|||
49036220|NCT02842853|157968217|FG003|Overall Study|Withdrawal by Subject|8|||
49036221|NCT02842853|157968214|FG000|Overall Study|Lost to Follow-up|9|||
49036222|NCT02842853|157968215|FG001|Overall Study|Lost to Follow-up|13|||
49036223|NCT02842853|157968216|FG002|Overall Study|Lost to Follow-up|10|||
49036224|NCT02842853|157968217|FG003|Overall Study|Lost to Follow-up|11|||
49036225|NCT03261167|157968218|FG000|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0|||
49036226|NCT03261167|157968219|FG001|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3|||
49036227|NCT03261167|157968218|FG000|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3|||
49036228|NCT03261167|157968219|FG001|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1|||
49036229|NCT03261167|157968218|FG000|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1|||
49036230|NCT03261167|157968219|FG001|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0|||
49036231|NCT03261167|157968218|FG000|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1|||
49036232|NCT03261167|157968219|FG001|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0|||
49036233|NCT03261167|157968218|FG000|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
49036234|NCT03261167|157968219|FG001|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
49036235|NCT01701063|157968222|FG000|Overall Study|Lost to Follow-up|0|||
49036236|NCT01701063|157968223|FG001|Overall Study|Lost to Follow-up|1|||
49036237|NCT01701063|157968224|FG002|Overall Study|Lost to Follow-up|0|||
49036238|NCT01701063|157968222|FG000|Overall Study|Withdrawal by Subject|0|||
49036239|NCT01701063|157968223|FG001|Overall Study|Withdrawal by Subject|0|||
49036240|NCT01701063|157968224|FG002|Overall Study|Withdrawal by Subject|1|||
49036241|NCT01701063|157968222|FG000|Overall Study|Other|0|||
49036242|NCT01701063|157968223|FG001|Overall Study|Other|0|||
49036243|NCT01701063|157968224|FG002|Overall Study|Other|1|||
49036244|NCT05387408|157968227|FG000|Overall Study|Lack of time and access to participants to complete the survey by the health fund administrators|4939|||
49036245|NCT03364192|157968234|FG000|Overall Study|Ineligible|10|||
49036246|NCT03364192|157968234|FG000|Overall Study|Withdrawal by Subject|5|||
49036247|NCT03364192|157968234|FG000|Overall Study|Lost to Follow-up|1|||
49036248|NCT02554877|157968241|FG000|Overall Study|Adverse Event|2|||
49036249|NCT02554877|157968242|FG001|Overall Study|Adverse Event|0|||
49036250|NCT02554877|157968243|FG002|Overall Study|Adverse Event|0|||
49036251|NCT02554877|157968244|FG003|Overall Study|Adverse Event|1|||
49036252|NCT02554877|157968241|FG000|Overall Study|Lost to Follow-up|1|||
49036253|NCT02554877|157968242|FG001|Overall Study|Lost to Follow-up|1|||
49036254|NCT02554877|157968243|FG002|Overall Study|Lost to Follow-up|1|||
49036255|NCT02554877|157968244|FG003|Overall Study|Lost to Follow-up|2|||
49036256|NCT02554877|157968241|FG000|Overall Study|Did not meet entrance criteria|0|||
49036257|NCT02554877|157968242|FG001|Overall Study|Did not meet entrance criteria|0|||
49036258|NCT02554877|157968243|FG002|Overall Study|Did not meet entrance criteria|1|||
49036259|NCT02554877|157968244|FG003|Overall Study|Did not meet entrance criteria|0|||
49036260|NCT02554877|157968241|FG000|Overall Study|No longer met eligibility criteria|1|||
49036261|NCT02554877|157968242|FG001|Overall Study|No longer met eligibility criteria|0|||
49036262|NCT02554877|157968243|FG002|Overall Study|No longer met eligibility criteria|1|||
49036263|NCT02554877|157968244|FG003|Overall Study|No longer met eligibility criteria|1|||
49036264|NCT02554877|157968241|FG000|Overall Study|Protocol Violation|3|||
49036265|NCT02554877|157968242|FG001|Overall Study|Protocol Violation|1|||
49036266|NCT02554877|157968243|FG002|Overall Study|Protocol Violation|1|||
49036267|NCT02554877|157968244|FG003|Overall Study|Protocol Violation|0|||
49036268|NCT02554877|157968241|FG000|Overall Study|Other|1|||
49036269|NCT02554877|157968242|FG001|Overall Study|Other|3|||
49036270|NCT02554877|157968243|FG002|Overall Study|Other|0|||
49036271|NCT02554877|157968244|FG003|Overall Study|Other|3|||
49036272|NCT02554877|157968241|FG000|Overall Study|Insufficient clinical response|4|||
49036273|NCT02554877|157968242|FG001|Overall Study|Insufficient clinical response|0|||
49036274|NCT02554877|157968243|FG002|Overall Study|Insufficient clinical response|0|||
49036275|NCT02554877|157968244|FG003|Overall Study|Insufficient clinical response|0|||
49036276|NCT02554877|157968241|FG000|Overall Study|No longer willing to participate|0|||
49036277|NCT02554877|157968242|FG001|Overall Study|No longer willing to participate|2|||
49036278|NCT02554877|157968243|FG002|Overall Study|No longer willing to participate|2|||
49036279|NCT02554877|157968244|FG003|Overall Study|No longer willing to participate|0|||
49036280|NCT04474405|157968245|FG000|Overall Study|Withdrawal by Subject|0|||
49036281|NCT04474405|157968246|FG001|Overall Study|Withdrawal by Subject|0|||
49036282|NCT04474405|157968247|FG002|Overall Study|Withdrawal by Subject|1|||
49036283|NCT04474405|157968248|FG003|Overall Study|Withdrawal by Subject|0|||
49036284|NCT04474405|157968249|FG004|Overall Study|Withdrawal by Subject|1|||
49036285|NCT04474405|157968250|FG005|Overall Study|Withdrawal by Subject|0|||
49036286|NCT04474405|157968245|FG000|Overall Study|Other|0|||
49036287|NCT04474405|157968246|FG001|Overall Study|Other|0|||
49036288|NCT04474405|157968247|FG002|Overall Study|Other|0|||
49036289|NCT04474405|157968248|FG003|Overall Study|Other|0|||
49036290|NCT04474405|157968249|FG004|Overall Study|Other|3|||
48888607|NCT03361605|157428570|FG000|Overall Study|Analyzable data not available|3|||
49036291|NCT04474405|157968250|FG005|Overall Study|Other|0|||
49036292|NCT00274651|157968251|FG000|Overall Study|Adverse Event|6|||
49036293|NCT00274651|157968252|FG001|Overall Study|Adverse Event|3|||
49036294|NCT00274651|157968251|FG000|Overall Study|Lack of Efficacy|13|||
49036295|NCT00274651|157968252|FG001|Overall Study|Lack of Efficacy|6|||
49036296|NCT00274651|157968251|FG000|Overall Study|Death|1|||
49036297|NCT00274651|157968252|FG001|Overall Study|Death|3|||
49036298|NCT00274651|157968251|FG000|Overall Study|Withdrawal by Subject|0|||
49036299|NCT00274651|157968252|FG001|Overall Study|Withdrawal by Subject|1|||
49036300|NCT00274651|157968251|FG000|Overall Study|Physician Decision|8|||
49036301|NCT00274651|157968252|FG001|Overall Study|Physician Decision|7|||
49036302|NCT05133180|157968255|FG000|Overall Study|Withdrawal of consent|1|||
49036303|NCT05133180|157968256|FG001|Overall Study|Withdrawal of consent|1|||
49036304|NCT05133180|157968255|FG000|Overall Study|Lost to Follow-up|1|||
49036305|NCT05133180|157968256|FG001|Overall Study|Lost to Follow-up|1|||
49036306|NCT05133180|157968255|FG000|Overall Study|Documented disease progression|0|||
49036307|NCT05133180|157968256|FG001|Overall Study|Documented disease progression|1|||
49036308|NCT04345653|157968257|FG000|Overall Study|Withdrawal by Subject|2|||
49036309|NCT01895335|157968258|FG000|Overall Study|Adverse Event|106|||
49036310|NCT01895335|157968258|FG000|Overall Study|Lack of Efficacy|53|||
49036311|NCT01895335|157968258|FG000|Overall Study|Poor Compliance to Protocol|11|||
49036312|NCT01895335|157968258|FG000|Overall Study|Included But Not treated|1|||
49036313|NCT01895335|157968258|FG000|Overall Study|Other than Specified Above|44|||
49036314|NCT00191815|157968259|FG000|Overall Study|Adverse Event|2|||
49036315|NCT00191815|157968259|FG000|Overall Study|Disease progression or relapse|24|||
49036316|NCT00191815|157968259|FG000|Overall Study|Death|2|||
49036317|NCT00191815|157968259|FG000|Overall Study|Protocol Violation|3|||
49036318|NCT00191815|157968259|FG000|Overall Study|Physician Decision|2|||
49036319|NCT00191815|157968259|FG000|Overall Study|Withdrawal by Subject|7|||
49036320|NCT00700739|157968260|FG000|Overall Study|Lost to Follow-up|4|||
49036321|NCT00700739|157968261|FG001|Overall Study|Lost to Follow-up|4|||
49036322|NCT00875524|157968262|FG000|Overall Study|Serious adverse event|0|||
49036323|NCT00875524|157968263|FG001|Overall Study|Serious adverse event|1|||
49036324|NCT00875524|157968262|FG000|Overall Study|Protocol Violation|4|||
49036325|NCT00875524|157968263|FG001|Overall Study|Protocol Violation|0|||
49036326|NCT00875524|157968262|FG000|Overall Study|Lost to Follow-up|1|||
49036327|NCT00875524|157968263|FG001|Overall Study|Lost to Follow-up|0|||
49036328|NCT00875524|157968262|FG000|Overall Study|Withdrawal by Subject|3|||
48888608|NCT01559129|157428574|FG000|Treatment Phase|Adverse Event|0|||
48888609|NCT01559129|157428575|FG001|Treatment Phase|Adverse Event|2|||
48888610|NCT01559129|157428574|FG000|Treatment Phase|Progressive Disease|1|||
49036329|NCT00875524|157968263|FG001|Overall Study|Withdrawal by Subject|5|||
48888611|NCT01559129|157428575|FG001|Treatment Phase|Progressive Disease|1|||
48888612|NCT01559129|157428574|FG000|Treatment Phase|Lack of Efficacy|0|||
48888613|NCT01559129|157428575|FG001|Treatment Phase|Lack of Efficacy|1|||
48888614|NCT01559129|157428574|FG000|Treatment Phase|Study Terminated by Sponsor|3|||
48888615|NCT01559129|157428575|FG001|Treatment Phase|Study Terminated by Sponsor|2|||
48888616|NCT01559129|157428574|FG000|Treatment Phase|Protocol Exclusion Criteria|1|||
48888617|NCT01559129|157428575|FG001|Treatment Phase|Protocol Exclusion Criteria|0|||
48888618|NCT01559129|157428574|FG000|Treatment Phase|Did Not Receive Study Drug|0|||
48888619|NCT01559129|157428575|FG001|Treatment Phase|Did Not Receive Study Drug|1|||
48888620|NCT01559129|157428574|FG000|Open-label Extension Period|Adverse Event|1|||
48888621|NCT01559129|157428575|FG001|Open-label Extension Period|Adverse Event|0|||
49036330|NCT00429416|157968264|FG000|Overall Study|Death|1|||
49036331|NCT02615249|157968265|FG000|Overall Study|Withdrawal by Subject|1|||
49036332|NCT00829452|157968266|FG000|First Intervention|Withdrawal by Subject|0|||
49036333|NCT00829452|157968267|FG001|First Intervention|Withdrawal by Subject|1|||
49036334|NCT00829452|157968266|FG000|Washout of 42 Days|Withdrawal by Subject|0|||
48888622|NCT01559129|157428574|FG000|Open-label Extension Period|Study Terminated by Sponsor|5|||
48888623|NCT01559129|157428575|FG001|Open-label Extension Period|Study Terminated by Sponsor|2|||
48888624|NCT00818779|157428576|FG000|Overall Study|Protocol Violation|1|||
48888625|NCT00818779|157428577|FG001|Overall Study|Protocol Violation|0|||
48888626|NCT00818779|157428576|FG000|Overall Study|Lost to Follow-up|1|||
48888627|NCT00818779|157428577|FG001|Overall Study|Lost to Follow-up|0|||
48888628|NCT00818779|157428576|FG000|Overall Study|Adverse Event|4|||
48888629|NCT00818779|157428577|FG001|Overall Study|Adverse Event|1|||
48888630|NCT03682302|157428578|FG000|Overall Study|Lost to Follow-up|1|||
48888631|NCT03682302|157428579|FG001|Overall Study|Lost to Follow-up|2|||
48888632|NCT03682302|157428580|FG002|Overall Study|Lost to Follow-up|0|||
48888633|NCT03682302|157428581|FG003|Overall Study|Lost to Follow-up|1|||
48888634|NCT03682302|157428578|FG000|Overall Study|Study drug was not administered|0|||
48888635|NCT03682302|157428579|FG001|Overall Study|Study drug was not administered|0|||
48888636|NCT03682302|157428580|FG002|Overall Study|Study drug was not administered|1|||
48888637|NCT03682302|157428581|FG003|Overall Study|Study drug was not administered|1|||
48888638|NCT04608773|157428588|FG000|First Wash Out (1 Week)|Withdrawal by Subject|12|||
49036335|NCT00829452|157968267|FG001|Washout of 42 Days|Withdrawal by Subject|1|||
49036336|NCT00829452|157968266|FG000|Second Intervention|Physician Decision|0|||
49036337|NCT00829452|157968267|FG001|Second Intervention|Physician Decision|1|||
49036338|NCT00682461|157969404|FG000|Overall Study|Adverse Event|5|||
49036339|NCT00682461|157969405|FG001|Overall Study|Adverse Event|7|||
49036340|NCT00682461|157969404|FG000|Overall Study|Lost to Follow-up|8|||
49036341|NCT00682461|157969405|FG001|Overall Study|Lost to Follow-up|5|||
49036342|NCT00682461|157969404|FG000|Overall Study|Withdrawal by Subject|12|||
49036343|NCT00682461|157969405|FG001|Overall Study|Withdrawal by Subject|19|||
49036344|NCT02875392|157969406|FG000|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7|||
49036345|NCT02875392|157969407|FG001|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8|||
49036346|NCT03599193|157969410|FG000|Overall Study|Adverse Event|0|||
49036347|NCT03599193|157969411|FG001|Overall Study|Adverse Event|2|||
49036348|NCT03599193|157969410|FG000|Overall Study|Withdrawal by Subject|1|||
49036349|NCT03599193|157969411|FG001|Overall Study|Withdrawal by Subject|0|||
49036350|NCT03599193|157969410|FG000|Overall Study|Protocol Violation|1|||
49036351|NCT03599193|157969411|FG001|Overall Study|Protocol Violation|0|||
49036352|NCT03599193|157969410|FG000|Overall Study|Lost to Follow-up|0|||
49036353|NCT03599193|157969411|FG001|Overall Study|Lost to Follow-up|1|||
49036354|NCT00834717|157969412|FG000|First Intervention|Adverse Event|1|||
49036355|NCT00834717|157969413|FG001|First Intervention|Adverse Event|0|||
49036356|NCT00834717|157969412|FG000|First Intervention|Withdrawal by Subject|0|||
49036357|NCT00834717|157969413|FG001|First Intervention|Withdrawal by Subject|1|||
49036358|NCT02222818|157969414|FG000|Period 1|Eligibility criteria not met|0|||
49036359|NCT02222818|157969415|FG001|Period 1|Eligibility criteria not met|3|||
49036360|NCT01811953|157969416|FG000|Overall Study|Adverse Event|0|||
49036361|NCT01811953|157969417|FG001|Overall Study|Adverse Event|0|||
49036362|NCT01811953|157969418|FG002|Overall Study|Adverse Event|0|||
49036363|NCT01811953|157969419|FG003|Overall Study|Adverse Event|1|||
49036364|NCT01811953|157969420|FG004|Overall Study|Adverse Event|0|||
49036365|NCT01811953|157969421|FG005|Overall Study|Adverse Event|1|||
49036366|NCT01811953|157969416|FG000|Overall Study|Protocol Violation|0|||
49036367|NCT01811953|157969417|FG001|Overall Study|Protocol Violation|0|||
49036368|NCT01811953|157969418|FG002|Overall Study|Protocol Violation|0|||
49036369|NCT01811953|157969419|FG003|Overall Study|Protocol Violation|0|||
49036370|NCT01811953|157969420|FG004|Overall Study|Protocol Violation|1|||
49036371|NCT01811953|157969421|FG005|Overall Study|Protocol Violation|0|||
49036372|NCT02611687|157969422|FG000|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|2|||
49036373|NCT02611687|157969423|FG001|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|1|||
49036374|NCT00455312|157969427|FG000|Overall Study|Death|0|||
49036375|NCT00455312|157969428|FG001|Overall Study|Death|1|||
49036376|NCT04466111|157969431|FG000|Prior to Trial Phase|Physician Decision|1|||
49036377|NCT00849797|157969432|FG000|First Intervention|bad veins|1|||
49036378|NCT00849797|157969433|FG001|First Intervention|bad veins|0|||
49036379|NCT00849797|157969432|FG000|First Intervention|Adverse Event|0|||
49036380|NCT00849797|157969433|FG001|First Intervention|Adverse Event|1|||
49036381|NCT00849797|157969432|FG000|Washout: One Week|Withdrawal by Subject|0|||
49036382|NCT00849797|157969433|FG001|Washout: One Week|Withdrawal by Subject|2|||
49036383|NCT01913405|157969436|FG000|Overall Study|Withdrawal by Subject|1|||
49036384|NCT01913405|157969436|FG000|Overall Study|Adverse Event|1|||
49036385|NCT04089553|157969437|FG000|Overall Study|Death|1|||
49036386|NCT04089553|157969438|FG001|Overall Study|Death|1|||
49036387|NCT04089553|157969437|FG000|Overall Study|Progressive disease - objective (AZD4635)|13|||
49036388|NCT04089553|157969438|FG001|Overall Study|Progressive disease - objective (AZD4635)|20|||
49036389|NCT04089553|157969437|FG000|Overall Study|Withdrawal by Subject|3|||
49036390|NCT04089553|157969438|FG001|Overall Study|Withdrawal by Subject|3|||
49036391|NCT04089553|157969437|FG000|Overall Study|Physician Decision|1|||
48888639|NCT04608773|157428589|FG001|First Wash Out (1 Week)|Withdrawal by Subject|6|||
48888640|NCT04608773|157428588|FG000|First Intervention (2 Weeks)|Lost to Follow-up|3|||
48888641|NCT04608773|157428589|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
48888642|NCT04608773|157428588|FG000|First Intervention (2 Weeks)|mild adverse effects|1|||
48888643|NCT04608773|157428589|FG001|First Intervention (2 Weeks)|mild adverse effects|3|||
48888644|NCT04608773|157428588|FG000|Second Intervention (2 Week)|Lost to Follow-up|2|||
48888645|NCT04608773|157428589|FG001|Second Intervention (2 Week)|Lost to Follow-up|4|||
48888646|NCT04608773|157428588|FG000|Second Intervention (2 Week)|mild adverse effect|0|||
48888647|NCT04608773|157428589|FG001|Second Intervention (2 Week)|mild adverse effect|1|||
48888648|NCT04806373|157428591|FG000|Overall Study|Withdrawal by Subject|1|||
48888649|NCT04806373|157428592|FG001|Overall Study|Withdrawal by Subject|1|||
48888650|NCT05269966|157428593|FG000|Overall Study|Adverse Event|4|||
48888651|NCT05269966|157428593|FG000|Overall Study|Withdrawal by Subject|1|||
48888652|NCT05269966|157428593|FG000|Overall Study|Lost to Follow-up|4|||
48888653|NCT05269966|157428593|FG000|Overall Study|Physician Decision|1|||
48888654|NCT01525238|157428598|FG000|Overall Study|Withdrawal by Subject|1|||
48888655|NCT01525238|157428599|FG001|Overall Study|Withdrawal by Subject|0|||
48888656|NCT01525238|157428600|FG002|Overall Study|Withdrawal by Subject|0|||
49036392|NCT04089553|157969438|FG001|Overall Study|Physician Decision|0|||
49036393|NCT04089553|157969437|FG000|Overall Study|Progressive disease - subjective (AZD4635)|6|||
49036394|NCT04089553|157969438|FG001|Overall Study|Progressive disease - subjective (AZD4635)|3|||
49036395|NCT04089553|157969437|FG000|Overall Study|Other|1|||
49036396|NCT04089553|157969438|FG001|Overall Study|Other|0|||
49036397|NCT04089553|157969437|FG000|Overall Study|Adverse Event|1|||
49036398|NCT04089553|157969438|FG001|Overall Study|Adverse Event|1|||
49036399|NCT01030133|157969439|FG000|Overall Study|failed to experience pain at level 7/10|2|||
48888657|NCT03738423|157428601|FG000|Overall Study|Withdrawal by Subject|9|||
48888658|NCT03738423|157428602|FG001|Overall Study|Withdrawal by Subject|12|||
48888659|NCT03738423|157428603|FG002|Overall Study|Withdrawal by Subject|9|||
48888660|NCT03738423|157428604|FG003|Overall Study|Withdrawal by Subject|12|||
49036400|NCT01030133|157969440|FG001|Overall Study|failed to experience pain at level 7/10|2|||
49036401|NCT00835666|157969441|FG000|Washout|Protocol Violation|1|||
49036402|NCT00835666|157969442|FG001|Washout|Protocol Violation|0|||
49036403|NCT00835666|157969441|FG000|Washout|Withdrawal by Subject|1|||
49036404|NCT00835666|157969442|FG001|Washout|Withdrawal by Subject|0|||
48888661|NCT03738423|157428605|FG004|Overall Study|Withdrawal by Subject|10|||
48888662|NCT03738423|157428601|FG000|Overall Study|Lack of Efficacy|3|||
48888663|NCT03738423|157428602|FG001|Overall Study|Lack of Efficacy|1|||
48888664|NCT03738423|157428603|FG002|Overall Study|Lack of Efficacy|1|||
48888665|NCT03738423|157428604|FG003|Overall Study|Lack of Efficacy|1|||
48888666|NCT03738423|157428605|FG004|Overall Study|Lack of Efficacy|2|||
48888667|NCT03738423|157428601|FG000|Overall Study|Lost to Follow-up|1|||
48888668|NCT03738423|157428602|FG001|Overall Study|Lost to Follow-up|0|||
49036405|NCT03446768|157969443|FG000|Overall Study|Withdrawal by Subject|0|||
49036406|NCT03446768|157969444|FG001|Overall Study|Withdrawal by Subject|1|||
49036407|NCT00107991|157969445|FG000|Eligibility Assessment|Disease not severe enough|7|||
49036408|NCT00107991|157969445|FG000|Eligibility Assessment|Unwilling to participate|7|||
49036409|NCT00107991|157969445|FG000|Eligibility Assessment|Positive purified protein derivative|4|||
49036410|NCT00107991|157969445|FG000|Eligibility Assessment|Abnormal labs|2|||
49036411|NCT00107991|157969445|FG000|Eligibility Assessment|Ongoing treatment with antibiotics|1|||
49036412|NCT00107991|157969445|FG000|Eligibility Assessment|chronic uncontrolled asthma|1|||
49036413|NCT00107991|157969445|FG000|Eligibility Assessment|hx of alcohol abuse in past 12 months|1|||
49036414|NCT00107991|157969445|FG000|12 Week Treatment Period|Lack of Efficacy|2|||
49036415|NCT00107991|157969445|FG000|12 Week Treatment Period|Adverse Event|1|||
49036416|NCT00107991|157969445|FG000|12 Week Treatment Period|Protocol Violation|1|||
49036417|NCT00107991|157969445|FG000|12 Week Treatment Period|Incarcerated|1|||
49036418|NCT00107991|157969445|FG000|18-Week Post Treatment Assessment|Adverse Event|2|||
49036419|NCT00935012|157969448|FG000|Overall Study|Death|19|||
49036420|NCT00935012|157969448|FG000|Overall Study|Withdrawal by Subject|3|||
49036421|NCT00935012|157969448|FG000|Overall Study|Other|5|||
49036422|NCT00935012|157969448|FG000|Overall Study|Adverse Event|2|||
49036423|NCT03827395|157969449|FG000|Overall Study|Lost to Follow-up|1|||
49036424|NCT03827395|157969450|FG001|Overall Study|Lost to Follow-up|0|||
49036425|NCT03827395|157969449|FG000|Overall Study|Protocol Violation|1|||
49036426|NCT03827395|157969450|FG001|Overall Study|Protocol Violation|0|||
48888669|NCT03738423|157428603|FG002|Overall Study|Lost to Follow-up|1|||
48888670|NCT03738423|157428604|FG003|Overall Study|Lost to Follow-up|1|||
48888671|NCT03738423|157428605|FG004|Overall Study|Lost to Follow-up|0|||
48888672|NCT03738423|157428601|FG000|Overall Study|Protocol Violation|1|||
48888673|NCT03738423|157428602|FG001|Overall Study|Protocol Violation|0|||
48888674|NCT03738423|157428603|FG002|Overall Study|Protocol Violation|0|||
48888675|NCT03738423|157428604|FG003|Overall Study|Protocol Violation|0|||
48888676|NCT03738423|157428605|FG004|Overall Study|Protocol Violation|1|||
48888677|NCT03738423|157428601|FG000|Overall Study|Physician Decision|0|||
48888678|NCT03738423|157428602|FG001|Overall Study|Physician Decision|0|||
48888679|NCT03738423|157428603|FG002|Overall Study|Physician Decision|1|||
48888680|NCT03738423|157428604|FG003|Overall Study|Physician Decision|0|||
48888681|NCT03738423|157428605|FG004|Overall Study|Physician Decision|1|||
48888682|NCT03738423|157428601|FG000|Overall Study|Death|0|||
48888683|NCT03738423|157428602|FG001|Overall Study|Death|0|||
48888684|NCT03738423|157428603|FG002|Overall Study|Death|0|||
48888685|NCT03738423|157428604|FG003|Overall Study|Death|0|||
48888686|NCT03738423|157428605|FG004|Overall Study|Death|1|||
48888687|NCT03738423|157428601|FG000|Overall Study|Randomized but never treated|0|||
48888688|NCT03738423|157428602|FG001|Overall Study|Randomized but never treated|0|||
48888689|NCT03738423|157428603|FG002|Overall Study|Randomized but never treated|1|||
48888690|NCT03738423|157428604|FG003|Overall Study|Randomized but never treated|1|||
48888691|NCT03738423|157428605|FG004|Overall Study|Randomized but never treated|0|||
48888692|NCT01370590|157428606|FG000|Period 1|Adverse Event|8|||
48888693|NCT01370590|157428607|FG001|Period 1|Adverse Event|4|||
48888694|NCT01370590|157428606|FG000|Period 1|Lost to Follow-up|2|||
48888695|NCT01370590|157428607|FG001|Period 1|Lost to Follow-up|2|||
48888696|NCT01370590|157428606|FG000|Period 1|Protocol Violation|2|||
48888697|NCT01370590|157428607|FG001|Period 1|Protocol Violation|2|||
48888698|NCT01370590|157428606|FG000|Period 1|Withdrawal by Subject|4|||
48888699|NCT01370590|157428607|FG001|Period 1|Withdrawal by Subject|2|||
48888700|NCT01370590|157428606|FG000|Period 1|Could not access randomization system|0|||
48888701|NCT01370590|157428607|FG001|Period 1|Could not access randomization system|1|||
48888702|NCT01370590|157428606|FG000|Crossover Washout Period|Adverse Event|1|||
49036427|NCT03827395|157969449|FG000|Overall Study|Became ineligible after enrollment|1|||
49036428|NCT03827395|157969450|FG001|Overall Study|Became ineligible after enrollment|2|||
49036429|NCT01537887|157969451|FG000|Period 1|Physician Decision|0|||
48888703|NCT01370590|157428607|FG001|Crossover Washout Period|Adverse Event|4|||
48888704|NCT01370590|157428606|FG000|Crossover Washout Period|Lost to Follow-up|2|||
48888705|NCT01370590|157428607|FG001|Crossover Washout Period|Lost to Follow-up|0|||
48888706|NCT01370590|157428606|FG000|Crossover Washout Period|Non-compliance with Study Drug|1|||
48888707|NCT01370590|157428607|FG001|Crossover Washout Period|Non-compliance with Study Drug|0|||
48888708|NCT01370590|157428606|FG000|Crossover Washout Period|Withdrawal by Subject|2|||
48888709|NCT01370590|157428607|FG001|Crossover Washout Period|Withdrawal by Subject|2|||
48888710|NCT01370590|157428606|FG000|Period 2|Adverse Event|0|||
48888711|NCT01370590|157428607|FG001|Period 2|Adverse Event|1|||
48888712|NCT01370590|157428606|FG000|Period 2|Withdrawal by Subject|1|||
48888713|NCT01370590|157428607|FG001|Period 2|Withdrawal by Subject|1|||
48888714|NCT05172050|157428608|FG000|Overall Study|Negative Nasopharyngeal swab|5|||
48888715|NCT05172050|157428609|FG001|Overall Study|Negative Nasopharyngeal swab|5|||
48888716|NCT05172050|157428610|FG002|Overall Study|Negative Nasopharyngeal swab|3|||
49036430|NCT01537887|157969452|FG001|Period 1|Physician Decision|0|||
49036431|NCT01537887|157969453|FG002|Period 1|Physician Decision|0|||
49036432|NCT01537887|157969454|FG003|Period 1|Physician Decision|0|||
48888717|NCT05172050|157428608|FG000|Overall Study|Development of AE or unacceptable toxicity|5|||
48888718|NCT05172050|157428609|FG001|Overall Study|Development of AE or unacceptable toxicity|4|||
48888719|NCT05172050|157428610|FG002|Overall Study|Development of AE or unacceptable toxicity|7|||
48888720|NCT05172050|157428608|FG000|Overall Study|Other|2|||
48888721|NCT05172050|157428609|FG001|Overall Study|Other|2|||
48888722|NCT05172050|157428610|FG002|Overall Study|Other|1|||
48888723|NCT00867308|157428617|FG000|Overall Study|Death|1|||
49036433|NCT01537887|157969455|FG004|Period 1|Physician Decision|1|||
49036434|NCT01537887|157969456|FG005|Period 1|Physician Decision|1|||
49036435|NCT01537887|157969451|FG000|Period 1|Did not receive treatment|0|||
49036436|NCT01537887|157969452|FG001|Period 1|Did not receive treatment|0|||
49036437|NCT01537887|157969453|FG002|Period 1|Did not receive treatment|1|||
49036438|NCT01537887|157969454|FG003|Period 1|Did not receive treatment|0|||
49036439|NCT01537887|157969455|FG004|Period 1|Did not receive treatment|0|||
49036440|NCT01537887|157969456|FG005|Period 1|Did not receive treatment|0|||
49036441|NCT01537887|157969451|FG000|Period 2|Withdrawal by Subject|0|||
49036442|NCT01537887|157969452|FG001|Period 2|Withdrawal by Subject|1|||
49036443|NCT01537887|157969453|FG002|Period 2|Withdrawal by Subject|0|||
49036444|NCT01537887|157969454|FG003|Period 2|Withdrawal by Subject|0|||
49036445|NCT01537887|157969455|FG004|Period 2|Withdrawal by Subject|0|||
49036446|NCT01537887|157969456|FG005|Period 2|Withdrawal by Subject|0|||
49036447|NCT01537887|157969451|FG000|Period 3|Adverse Event|0|||
49036448|NCT01537887|157969452|FG001|Period 3|Adverse Event|0|||
49036449|NCT01537887|157969453|FG002|Period 3|Adverse Event|1|||
49036450|NCT01537887|157969454|FG003|Period 3|Adverse Event|0|||
49036451|NCT01537887|157969455|FG004|Period 3|Adverse Event|0|||
49036452|NCT01537887|157969456|FG005|Period 3|Adverse Event|0|||
49036453|NCT01537887|157969451|FG000|Period 3|Withdrawal by Subject|0|||
49036454|NCT01537887|157969452|FG001|Period 3|Withdrawal by Subject|1|||
49036455|NCT01537887|157969453|FG002|Period 3|Withdrawal by Subject|0|||
49036456|NCT01537887|157969454|FG003|Period 3|Withdrawal by Subject|0|||
49036457|NCT01537887|157969455|FG004|Period 3|Withdrawal by Subject|0|||
49036458|NCT01537887|157969456|FG005|Period 3|Withdrawal by Subject|0|||
49036459|NCT04723693|157969457|FG000|Overall Study|Withdrawal by Subject|2|||
49036460|NCT03669861|157969458|FG000|Overall Study|Disease Flare|5|||
49036461|NCT03669861|157969458|FG000|Overall Study|Lack of Efficacy|2|||
49036462|NCT02157974|157969464|FG000|Overall Study|Withdrawal by Subject|0|||
49036463|NCT02157974|157969465|FG001|Overall Study|Withdrawal by Subject|1|||
49036464|NCT02157974|157969466|FG002|Overall Study|Withdrawal by Subject|0|||
49036465|NCT02157974|157969467|FG003|Overall Study|Withdrawal by Subject|0|||
49036466|NCT02157974|157969468|FG004|Overall Study|Withdrawal by Subject|0|||
48888724|NCT00867308|157428618|FG001|Overall Study|Death|0|||
48888725|NCT00867308|157428617|FG000|Overall Study|Adverse Event|1|||
48888726|NCT00867308|157428618|FG001|Overall Study|Adverse Event|4|||
48888727|NCT00867308|157428617|FG000|Overall Study|Lack of Efficacy|6|||
48888728|NCT00867308|157428618|FG001|Overall Study|Lack of Efficacy|12|||
49036467|NCT02157974|157969464|FG000|Overall Study|Screen Failure|0|||
49036468|NCT02157974|157969465|FG001|Overall Study|Screen Failure|1|||
49036469|NCT02157974|157969466|FG002|Overall Study|Screen Failure|0|||
49036470|NCT02157974|157969467|FG003|Overall Study|Screen Failure|0|||
49036471|NCT02157974|157969468|FG004|Overall Study|Screen Failure|0|||
49036472|NCT02157974|157969464|FG000|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
48888729|NCT00867308|157428617|FG000|Overall Study|Withdrawal by Subject|1|||
48888730|NCT00867308|157428618|FG001|Overall Study|Withdrawal by Subject|2|||
48888731|NCT00604825|157428619|FG000|Overall Study|Adverse Event|2|||
49036473|NCT02157974|157969465|FG001|Overall Study|Nurse not able to place IV so unable to complete visit|1|||
48888732|NCT00604825|157428620|FG001|Overall Study|Adverse Event|6|||
48888733|NCT00604825|157428621|FG002|Overall Study|Adverse Event|7|||
48888734|NCT00604825|157428622|FG003|Overall Study|Adverse Event|4|||
49036474|NCT02157974|157969466|FG002|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
49036475|NCT02157974|157969467|FG003|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
48888735|NCT00604825|157428619|FG000|Overall Study|Lost to Follow-up|0|||
48888736|NCT00604825|157428620|FG001|Overall Study|Lost to Follow-up|3|||
48888737|NCT00604825|157428621|FG002|Overall Study|Lost to Follow-up|1|||
48888738|NCT00604825|157428622|FG003|Overall Study|Lost to Follow-up|0|||
48888739|NCT00604825|157428619|FG000|Overall Study|Protocol Violation|0|||
48888740|NCT00604825|157428620|FG001|Overall Study|Protocol Violation|1|||
48888741|NCT00604825|157428621|FG002|Overall Study|Protocol Violation|0|||
48888742|NCT00604825|157428622|FG003|Overall Study|Protocol Violation|0|||
48888743|NCT00604825|157428619|FG000|Overall Study|Withdrawal by Subject|4|||
48888744|NCT00604825|157428620|FG001|Overall Study|Withdrawal by Subject|3|||
48888745|NCT00604825|157428621|FG002|Overall Study|Withdrawal by Subject|5|||
48888746|NCT00604825|157428622|FG003|Overall Study|Withdrawal by Subject|5|||
48888747|NCT00604825|157428619|FG000|Overall Study|Lack of Efficacy|3|||
48888748|NCT00604825|157428620|FG001|Overall Study|Lack of Efficacy|2|||
48888749|NCT00604825|157428621|FG002|Overall Study|Lack of Efficacy|1|||
48888750|NCT00604825|157428622|FG003|Overall Study|Lack of Efficacy|0|||
48888751|NCT00604825|157428619|FG000|Overall Study|Did not meet eligibility criteria|0|||
48888752|NCT00604825|157428620|FG001|Overall Study|Did not meet eligibility criteria|0|||
49036476|NCT02157974|157969468|FG004|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
49036477|NCT01590563|157969470|FG000|Overall Study|simple uterine hyperplasia - not related|1|||
48888753|NCT00604825|157428621|FG002|Overall Study|Did not meet eligibility criteria|2|||
48888754|NCT00604825|157428622|FG003|Overall Study|Did not meet eligibility criteria|0|||
49036478|NCT03256695|157969473|FG000|Overall Study|Adverse Event|8|||
48888755|NCT00604825|157428619|FG000|Overall Study|Physician Decision|0|||
48888756|NCT00604825|157428620|FG001|Overall Study|Physician Decision|0|||
48888757|NCT00604825|157428621|FG002|Overall Study|Physician Decision|0|||
48888758|NCT00604825|157428622|FG003|Overall Study|Physician Decision|1|||
48888759|NCT00604825|157428619|FG000|Overall Study|Exclusion criterion met|0|||
48888760|NCT00604825|157428620|FG001|Overall Study|Exclusion criterion met|0|||
48888761|NCT00604825|157428621|FG002|Overall Study|Exclusion criterion met|0|||
48888762|NCT00604825|157428622|FG003|Overall Study|Exclusion criterion met|1|||
48888763|NCT04617275|157428623|FG000|Treatment Period|Adverse Event|1|||
48888764|NCT04617275|157428624|FG001|Treatment Period|Adverse Event|6|||
48888765|NCT04617275|157428625|FG002|Treatment Period|Adverse Event|4|||
48888766|NCT04617275|157428626|FG003|Treatment Period|Adverse Event|6|||
48888767|NCT04617275|157428627|FG004|Treatment Period|Adverse Event|7|||
48888768|NCT04617275|157428628|FG005|Treatment Period|Adverse Event|8|||
48888769|NCT04617275|157428629|FG006|Treatment Period|Adverse Event|0|||
48888770|NCT04617275|157428630|FG007|Treatment Period|Adverse Event|12|||
48888771|NCT04617275|157428623|FG000|Treatment Period|Lost to Follow-up|0|||
48888772|NCT04617275|157428624|FG001|Treatment Period|Lost to Follow-up|0|||
48888773|NCT04617275|157428625|FG002|Treatment Period|Lost to Follow-up|2|||
48888774|NCT04617275|157428626|FG003|Treatment Period|Lost to Follow-up|0|||
48888775|NCT04617275|157428627|FG004|Treatment Period|Lost to Follow-up|0|||
48888776|NCT04617275|157428628|FG005|Treatment Period|Lost to Follow-up|3|||
48888777|NCT04617275|157428629|FG006|Treatment Period|Lost to Follow-up|0|||
49036479|NCT03256695|157969473|FG000|Overall Study|Death|2|||
49036480|NCT03256695|157969473|FG000|Overall Study|Withdrawal by Subject|14|||
49036481|NCT03256695|157969473|FG000|Overall Study|Non-compliance with study drug|1|||
49036482|NCT03256695|157969473|FG000|Overall Study|Lost to Follow-up|3|||
49036483|NCT03256695|157969473|FG000|Overall Study|Lack of Efficacy|3|||
49036484|NCT03256695|157969473|FG000|Overall Study|Protocol Violation|5|||
49036485|NCT03256695|157969473|FG000|Overall Study|Other than specified|3|||
49036486|NCT03322267|157969474|FG000|Overall Study|Lack of Efficacy|11|||
49036487|NCT03322267|157969474|FG000|Overall Study|Adverse Event|1|||
49036488|NCT03322267|157969474|FG000|Overall Study|Withdrawal by Subject|2|||
49036489|NCT00909753|157969477|FG000|Period: Washout of 28 Days|Protocol Violation|2|||
49036490|NCT00909753|157969478|FG001|Period: Washout of 28 Days|Protocol Violation|3|||
49036491|NCT00909753|157969477|FG000|Period: Second Intervention|Protocol Violation|1|||
49036492|NCT00909753|157969478|FG001|Period: Second Intervention|Protocol Violation|0|||
48888778|NCT04617275|157428630|FG007|Treatment Period|Lost to Follow-up|2|||
48888779|NCT04617275|157428623|FG000|Treatment Period|No longer meets eligibility criteria|0|||
48888780|NCT04617275|157428624|FG001|Treatment Period|No longer meets eligibility criteria|0|||
48888781|NCT04617275|157428625|FG002|Treatment Period|No longer meets eligibility criteria|0|||
49036493|NCT00472212|157969479|FG000|Overall Study|Lost to Follow-up|6|||
48888782|NCT04617275|157428626|FG003|Treatment Period|No longer meets eligibility criteria|1|||
48888783|NCT04617275|157428627|FG004|Treatment Period|No longer meets eligibility criteria|0|||
48888784|NCT04617275|157428628|FG005|Treatment Period|No longer meets eligibility criteria|0|||
48888785|NCT04617275|157428629|FG006|Treatment Period|No longer meets eligibility criteria|0|||
48888786|NCT04617275|157428630|FG007|Treatment Period|No longer meets eligibility criteria|0|||
48888787|NCT04617275|157428623|FG000|Treatment Period|Other|0|||
48888788|NCT04617275|157428624|FG001|Treatment Period|Other|1|||
49036494|NCT00472212|157969480|FG001|Overall Study|Lost to Follow-up|4|||
49036495|NCT03480763|157969481|FG000|Overall Study|Withdrawal by Subject|18|||
49036496|NCT03480763|157969482|FG001|Overall Study|Withdrawal by Subject|10|||
49036497|NCT03480763|157969481|FG000|Overall Study|Lost to Follow-up|4|||
48888789|NCT04617275|157428625|FG002|Treatment Period|Other|0|||
48888790|NCT04617275|157428626|FG003|Treatment Period|Other|0|||
48888791|NCT04617275|157428627|FG004|Treatment Period|Other|0|||
48888792|NCT04617275|157428628|FG005|Treatment Period|Other|0|||
48888793|NCT04617275|157428629|FG006|Treatment Period|Other|0|||
48888794|NCT04617275|157428630|FG007|Treatment Period|Other|0|||
48888795|NCT04617275|157428623|FG000|Treatment Period|Withdrawal by Subject|2|||
48888796|NCT04617275|157428624|FG001|Treatment Period|Withdrawal by Subject|0|||
48888797|NCT04617275|157428625|FG002|Treatment Period|Withdrawal by Subject|0|||
48888798|NCT04617275|157428626|FG003|Treatment Period|Withdrawal by Subject|2|||
48888799|NCT04617275|157428627|FG004|Treatment Period|Withdrawal by Subject|2|||
48888800|NCT04617275|157428628|FG005|Treatment Period|Withdrawal by Subject|0|||
48888801|NCT04617275|157428629|FG006|Treatment Period|Withdrawal by Subject|1|||
48888802|NCT04617275|157428630|FG007|Treatment Period|Withdrawal by Subject|2|||
48888803|NCT04617275|157428623|FG000|Follow-up Period|Adverse Event|1|||
48888804|NCT04617275|157428624|FG001|Follow-up Period|Adverse Event|1|||
48888805|NCT04617275|157428625|FG002|Follow-up Period|Adverse Event|2|||
48888806|NCT04617275|157428626|FG003|Follow-up Period|Adverse Event|3|||
48888807|NCT04617275|157428627|FG004|Follow-up Period|Adverse Event|4|||
48888808|NCT04617275|157428628|FG005|Follow-up Period|Adverse Event|3|||
48888809|NCT04617275|157428629|FG006|Follow-up Period|Adverse Event|0|||
48888810|NCT04617275|157428630|FG007|Follow-up Period|Adverse Event|3|||
48888811|NCT04617275|157428623|FG000|Follow-up Period|Lost to Follow-up|0|||
48888812|NCT04617275|157428624|FG001|Follow-up Period|Lost to Follow-up|1|||
48888813|NCT04617275|157428625|FG002|Follow-up Period|Lost to Follow-up|2|||
48888814|NCT04617275|157428626|FG003|Follow-up Period|Lost to Follow-up|0|||
48888815|NCT04617275|157428627|FG004|Follow-up Period|Lost to Follow-up|0|||
48888816|NCT04617275|157428628|FG005|Follow-up Period|Lost to Follow-up|4|||
48888817|NCT04617275|157428629|FG006|Follow-up Period|Lost to Follow-up|0|||
48888818|NCT04617275|157428630|FG007|Follow-up Period|Lost to Follow-up|3|||
48888819|NCT04617275|157428623|FG000|Follow-up Period|No longer meets eligibility criteria|0|||
48888820|NCT04617275|157428624|FG001|Follow-up Period|No longer meets eligibility criteria|0|||
48888821|NCT04617275|157428625|FG002|Follow-up Period|No longer meets eligibility criteria|0|||
48888822|NCT04617275|157428626|FG003|Follow-up Period|No longer meets eligibility criteria|1|||
48888823|NCT04617275|157428627|FG004|Follow-up Period|No longer meets eligibility criteria|0|||
48888824|NCT04617275|157428628|FG005|Follow-up Period|No longer meets eligibility criteria|0|||
48888825|NCT04617275|157428629|FG006|Follow-up Period|No longer meets eligibility criteria|0|||
48888826|NCT04617275|157428630|FG007|Follow-up Period|No longer meets eligibility criteria|0|||
48888827|NCT04617275|157428623|FG000|Follow-up Period|Other|0|||
48888828|NCT04617275|157428624|FG001|Follow-up Period|Other|1|||
48888829|NCT04617275|157428625|FG002|Follow-up Period|Other|0|||
48888830|NCT04617275|157428626|FG003|Follow-up Period|Other|0|||
48888831|NCT04617275|157428627|FG004|Follow-up Period|Other|0|||
48888832|NCT04617275|157428628|FG005|Follow-up Period|Other|0|||
48888833|NCT04617275|157428629|FG006|Follow-up Period|Other|0|||
48888834|NCT04617275|157428630|FG007|Follow-up Period|Other|0|||
48888835|NCT04617275|157428623|FG000|Follow-up Period|Withdrawal by Subject|2|||
48888836|NCT04617275|157428624|FG001|Follow-up Period|Withdrawal by Subject|0|||
48888837|NCT04617275|157428625|FG002|Follow-up Period|Withdrawal by Subject|0|||
48888838|NCT04617275|157428626|FG003|Follow-up Period|Withdrawal by Subject|2|||
48888839|NCT04617275|157428627|FG004|Follow-up Period|Withdrawal by Subject|2|||
48888840|NCT04617275|157428628|FG005|Follow-up Period|Withdrawal by Subject|0|||
48888841|NCT04617275|157428629|FG006|Follow-up Period|Withdrawal by Subject|1|||
48888842|NCT04617275|157428630|FG007|Follow-up Period|Withdrawal by Subject|2|||
48888843|NCT04927884|157428641|FG000|Overall Study|Progressive Disease|2|||
48888844|NCT05618912|157428642|FG000|Overall Study|Lost to Follow-up|14|||
48888845|NCT05618912|157428643|FG001|Overall Study|Lost to Follow-up|19|||
48888846|NCT05038800|157428644|FG000|Overall Study|Death|1|||
48888847|NCT05038800|157428645|FG001|Overall Study|Death|1|||
48888848|NCT05038800|157428646|FG002|Overall Study|Death|5|||
48888849|NCT05038800|157428647|FG003|Overall Study|Death|3|||
48888850|NCT05038800|157428648|FG004|Overall Study|Death|1|||
48888851|NCT05038800|157428644|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
48888852|NCT05038800|157428645|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
48888853|NCT05038800|157428646|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
48888854|NCT05038800|157428647|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
48888855|NCT05038800|157428648|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
48888856|NCT05038800|157428644|FG000|Overall Study|Lack of Efficacy|0|||
48888857|NCT05038800|157428645|FG001|Overall Study|Lack of Efficacy|0|||
48888858|NCT05038800|157428646|FG002|Overall Study|Lack of Efficacy|0|||
48888859|NCT05038800|157428647|FG003|Overall Study|Lack of Efficacy|0|||
48888860|NCT05038800|157428648|FG004|Overall Study|Lack of Efficacy|1|||
48888861|NCT04500769|157430042|FG000|Overall Study|Withdrawal by Subject|5|||
48888862|NCT01012817|157430043|FG000|Overall Study|Withdrawal by Subject|0|||
48888863|NCT01012817|157430044|FG001|Overall Study|Withdrawal by Subject|0|||
48888864|NCT01012817|157430045|FG002|Overall Study|Withdrawal by Subject|0|||
48888865|NCT01012817|157430046|FG003|Overall Study|Withdrawal by Subject|1|||
48888866|NCT01012817|157430047|FG004|Overall Study|Withdrawal by Subject|0|||
48888867|NCT01012817|157430048|FG005|Overall Study|Withdrawal by Subject|0|||
48888868|NCT01012817|157430049|FG006|Overall Study|Withdrawal by Subject|0|||
48888869|NCT01012817|157430050|FG007|Overall Study|Withdrawal by Subject|1|||
48888870|NCT01012817|157430051|FG008|Overall Study|Withdrawal by Subject|0|||
48888871|NCT01012817|157430052|FG009|Overall Study|Withdrawal by Subject|0|||
48888872|NCT01012817|157430053|FG010|Overall Study|Withdrawal by Subject|1|||
48888873|NCT01012817|157430054|FG011|Overall Study|Withdrawal by Subject|1|||
48888874|NCT01012817|157430055|FG012|Overall Study|Withdrawal by Subject|0|||
48888875|NCT01012817|157430056|FG013|Overall Study|Withdrawal by Subject|1|||
48888876|NCT01012817|157430043|FG000|Overall Study|Adverse Event|0|||
48888877|NCT01012817|157430044|FG001|Overall Study|Adverse Event|0|||
48888878|NCT01012817|157430045|FG002|Overall Study|Adverse Event|0|||
48888879|NCT01012817|157430046|FG003|Overall Study|Adverse Event|0|||
48888880|NCT01012817|157430047|FG004|Overall Study|Adverse Event|0|||
48888881|NCT01012817|157430048|FG005|Overall Study|Adverse Event|1|||
48888882|NCT01012817|157430049|FG006|Overall Study|Adverse Event|0|||
48888883|NCT01012817|157430050|FG007|Overall Study|Adverse Event|0|||
48888884|NCT01012817|157430051|FG008|Overall Study|Adverse Event|0|||
48888885|NCT01012817|157430052|FG009|Overall Study|Adverse Event|0|||
48888886|NCT01012817|157430053|FG010|Overall Study|Adverse Event|1|||
48888887|NCT01012817|157430054|FG011|Overall Study|Adverse Event|0|||
48888888|NCT01012817|157430055|FG012|Overall Study|Adverse Event|0|||
48888889|NCT01012817|157430056|FG013|Overall Study|Adverse Event|1|||
49036498|NCT03480763|157969482|FG001|Overall Study|Lost to Follow-up|7|||
49036499|NCT03480763|157969481|FG000|Overall Study|non-study pneumococcal vaccine|1|||
49036500|NCT03480763|157969482|FG001|Overall Study|non-study pneumococcal vaccine|0|||
49036501|NCT03480763|157969481|FG000|Overall Study|oncological treatment|0|||
49036502|NCT03480763|157969482|FG001|Overall Study|oncological treatment|2|||
49036503|NCT03480763|157969481|FG000|Overall Study|pain with vaccination|1|||
49036504|NCT03480763|157969482|FG001|Overall Study|pain with vaccination|0|||
49036505|NCT00418938|157969487|FG000|Overall Study|Reimbursement|1|||
49036506|NCT00418938|157969488|FG001|Overall Study|Reimbursement|0|||
49036507|NCT00418938|157969487|FG000|Overall Study|Administrative decision|3|||
49036508|NCT00418938|157969488|FG001|Overall Study|Administrative decision|3|||
49036509|NCT00418938|157969487|FG000|Overall Study|Withdrawal by Subject|16|||
49036510|NCT00418938|157969488|FG001|Overall Study|Withdrawal by Subject|15|||
49036511|NCT00418938|157969487|FG000|Overall Study|Lost to Follow-up|1|||
49036512|NCT00418938|157969488|FG001|Overall Study|Lost to Follow-up|3|||
49036513|NCT00418938|157969487|FG000|Overall Study|Adverse Event|1|||
49036514|NCT00418938|157969488|FG001|Overall Study|Adverse Event|1|||
49036515|NCT00418938|157969487|FG000|Overall Study|On-going|1|||
49036516|NCT00418938|157969488|FG001|Overall Study|On-going|1|||
49036517|NCT00418938|157969487|FG000|Overall Study|Ineligibility Determined|1|||
49036518|NCT00418938|157969488|FG001|Overall Study|Ineligibility Determined|0|||
49036519|NCT00115063|157969489|FG000|Overall Study|Lost to Follow-up|98|||
49036520|NCT00115063|157969490|FG001|Overall Study|Lost to Follow-up|104|||
49036521|NCT00115063|157969489|FG000|Overall Study|Death|1|||
49036522|NCT00115063|157969490|FG001|Overall Study|Death|0|||
49036523|NCT00574847|157969491|FG000|Overall Study|Adverse Event|2|||
49036524|NCT00574847|157969492|FG001|Overall Study|Adverse Event|0|||
49036525|NCT00574847|157969491|FG000|Overall Study|Death|1|||
48888890|NCT01006980|157430061|FG000|Vemurafenib and Dacarbazine|Randomized but Not Treated|1|||
48888891|NCT01006980|157430062|FG001|Vemurafenib and Dacarbazine|Randomized but Not Treated|45|||
48888892|NCT01006980|157430061|FG000|Vemurafenib and Dacarbazine|Adverse Event|25|||
48888893|NCT01006980|157430062|FG001|Vemurafenib and Dacarbazine|Adverse Event|5|||
48888894|NCT01006980|157430061|FG000|Vemurafenib and Dacarbazine|Death|13|||
48888895|NCT01006980|157430062|FG001|Vemurafenib and Dacarbazine|Death|12|||
48888896|NCT01006980|157430061|FG000|Vemurafenib and Dacarbazine|Progression|257|||
48888897|NCT01006980|157430062|FG001|Vemurafenib and Dacarbazine|Progression|218|||
48888898|NCT01006980|157430061|FG000|Vemurafenib and Dacarbazine|Withdrawal of Consent|4|||
48888899|NCT01006980|157430062|FG001|Vemurafenib and Dacarbazine|Withdrawal of Consent|6|||
48888900|NCT01006980|157430061|FG000|Vemurafenib and Dacarbazine|Refuse Treatment|9|||
48888901|NCT01006980|157430062|FG001|Vemurafenib and Dacarbazine|Refuse Treatment|6|||
48888902|NCT01006980|157430061|FG000|Vemurafenib and Dacarbazine|Protocol Violation|2|||
48888903|NCT01006980|157430062|FG001|Vemurafenib and Dacarbazine|Protocol Violation|3|||
48888904|NCT01006980|157430061|FG000|Vemurafenib and Dacarbazine|Reason Not Specified|26|||
48888905|NCT01006980|157430062|FG001|Vemurafenib and Dacarbazine|Reason Not Specified|43|||
48888906|NCT01006980|157430061|FG000|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0|||
48888907|NCT01006980|157430062|FG001|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4|||
49036526|NCT00574847|157969492|FG001|Overall Study|Death|0|||
49036527|NCT00574847|157969491|FG000|Overall Study|Withdrawal by Subject|2|||
49036528|NCT00574847|157969492|FG001|Overall Study|Withdrawal by Subject|2|||
49036529|NCT00574847|157969491|FG000|Overall Study|Physician Decision|1|||
49036530|NCT00574847|157969492|FG001|Overall Study|Physician Decision|0|||
49036531|NCT00574847|157969491|FG000|Overall Study|Did not receive medication (declined)|2|||
49036532|NCT00574847|157969492|FG001|Overall Study|Did not receive medication (declined)|5|||
49036533|NCT00881751|157969493|FG000|Overall Study|Physician Decision|0|||
49036534|NCT00881751|157969494|FG001|Overall Study|Physician Decision|1|||
49036535|NCT00881751|157969493|FG000|Overall Study|Adverse Event|0|||
49036536|NCT00881751|157969494|FG001|Overall Study|Adverse Event|2|||
49036537|NCT00881751|157969493|FG000|Overall Study|Withdrawal by Subject|0|||
49036538|NCT00881751|157969494|FG001|Overall Study|Withdrawal by Subject|2|||
49036539|NCT03273153|157969495|FG000|Overall Study|Adverse Event|1|||
49036540|NCT03273153|157969496|FG001|Overall Study|Adverse Event|2|||
49036541|NCT03273153|157969495|FG000|Overall Study|Missing|0|||
49036542|NCT03273153|157969496|FG001|Overall Study|Missing|2|||
49036543|NCT03273153|157969495|FG000|Overall Study|Other|3|||
49036544|NCT03273153|157969496|FG001|Overall Study|Other|2|||
49036545|NCT03273153|157969495|FG000|Overall Study|Symptomatic Deterioration|0|||
49036546|NCT03273153|157969496|FG001|Overall Study|Symptomatic Deterioration|1|||
49036547|NCT03273153|157969495|FG000|Overall Study|Progressive Disease|6|||
49036548|NCT03273153|157969496|FG001|Overall Study|Progressive Disease|5|||
49036549|NCT03273153|157969495|FG000|Overall Study|Physician Decision|1|||
49036550|NCT03273153|157969496|FG001|Overall Study|Physician Decision|3|||
49036551|NCT03273153|157969495|FG000|Overall Study|Study Terminated by Sponsor|112|||
49036552|NCT03273153|157969496|FG001|Overall Study|Study Terminated by Sponsor|102|||
49036553|NCT03273153|157969495|FG000|Overall Study|Withdrawal by Subject|26|||
49036554|NCT03273153|157969496|FG001|Overall Study|Withdrawal by Subject|25|||
49036555|NCT03273153|157969495|FG000|Overall Study|Protocol Deviation|3|||
49036556|NCT03273153|157969496|FG001|Overall Study|Protocol Deviation|0|||
49036557|NCT03273153|157969495|FG000|Overall Study|Lost to Follow-up|6|||
49036558|NCT03273153|157969496|FG001|Overall Study|Lost to Follow-up|11|||
49036559|NCT03273153|157969495|FG000|Overall Study|Death|66|||
49036560|NCT03273153|157969496|FG001|Overall Study|Death|69|||
49036561|NCT02436200|157969497|FG000|Overall Study|Significant outlier|1|||
49036562|NCT01838681|157969508|FG000|Period A|Adverse Event|39|||
49036563|NCT01838681|157969509|FG001|Period A|Adverse Event|0|||
49036564|NCT01838681|157969510|FG002|Period A|Adverse Event|0|||
49036565|NCT01838681|157969511|FG003|Period A|Adverse Event|0|||
49036566|NCT01838681|157969508|FG000|Period A|Lack of Efficacy|21|||
49036567|NCT01838681|157969509|FG001|Period A|Lack of Efficacy|0|||
49036568|NCT01838681|157969510|FG002|Period A|Lack of Efficacy|0|||
48796548|NCT04052204|157093690|FG000|Overall Study|Other|1|||
48796549|NCT04052204|157093691|FG001|Overall Study|Other|0|||
48796550|NCT04052204|157093692|FG002|Overall Study|Other|0|||
48796551|NCT02384759|157093693|FG000|Overall Study|Patients not treated|3|||
48796552|NCT02384759|157093694|FG001|Overall Study|Patients not treated|2|||
48796553|NCT01433354|157093695|FG000|Overall Study|Adverse Event|6|||
48796554|NCT01433354|157093695|FG000|Overall Study|Lost to Follow-up|1|||
48796555|NCT01433354|157093695|FG000|Overall Study|Administrative problems|90|||
48796556|NCT01433354|157093695|FG000|Overall Study|Protocol Violation|2|||
48796557|NCT01433354|157093695|FG000|Overall Study|Lack of Efficacy|17|||
48796558|NCT01433354|157093695|FG000|Overall Study|Subject Withdrew Consent|3|||
48796559|NCT04570436|157093711|FG000|Overall Study|Adverse Event|0|||
48796560|NCT04570436|157093712|FG001|Overall Study|Adverse Event|0|||
48796561|NCT04570436|157093713|FG002|Overall Study|Adverse Event|1|||
48796562|NCT04570436|157093714|FG003|Overall Study|Adverse Event|0|||
48796563|NCT04570436|157093715|FG004|Overall Study|Adverse Event|0|||
48796564|NCT04570436|157093716|FG005|Overall Study|Adverse Event|0|||
48796565|NCT04570436|157093717|FG006|Overall Study|Adverse Event|0|||
48796566|NCT04570436|157093718|FG007|Overall Study|Adverse Event|0|||
48796567|NCT04570436|157093719|FG008|Overall Study|Adverse Event|0|||
48796568|NCT04570436|157093720|FG009|Overall Study|Adverse Event|0|||
48796569|NCT04570436|157093711|FG000|Overall Study|Physician Decision|1|||
48796570|NCT04570436|157093712|FG001|Overall Study|Physician Decision|0|||
48796571|NCT04570436|157093713|FG002|Overall Study|Physician Decision|0|||
48796572|NCT04570436|157093714|FG003|Overall Study|Physician Decision|0|||
48796573|NCT04570436|157093715|FG004|Overall Study|Physician Decision|0|||
48796574|NCT04570436|157093716|FG005|Overall Study|Physician Decision|0|||
48796575|NCT04570436|157093717|FG006|Overall Study|Physician Decision|0|||
48796576|NCT04570436|157093718|FG007|Overall Study|Physician Decision|0|||
48796577|NCT04570436|157093719|FG008|Overall Study|Physician Decision|0|||
48796578|NCT04570436|157093720|FG009|Overall Study|Physician Decision|0|||
48796579|NCT00224874|157093721|FG000|Overall Study|Withdrawal by Subject|0|||
48796580|NCT00224874|157093722|FG001|Overall Study|Withdrawal by Subject|0|||
48796581|NCT00224874|157093723|FG002|Overall Study|Withdrawal by Subject|1|||
48796582|NCT00224874|157093724|FG003|Overall Study|Withdrawal by Subject|0|||
49036569|NCT01838681|157969511|FG003|Period A|Lack of Efficacy|0|||
49036570|NCT01838681|157969508|FG000|Period A|Early response|148|||
49036571|NCT01838681|157969509|FG001|Period A|Early response|0|||
49036572|NCT01838681|157969510|FG002|Period A|Early response|0|||
49036573|NCT01838681|157969511|FG003|Period A|Early response|0|||
49036574|NCT01838681|157969508|FG000|Period A|Withdrawal by Subject|70|||
49036575|NCT01838681|157969509|FG001|Period A|Withdrawal by Subject|0|||
49036576|NCT01838681|157969510|FG002|Period A|Withdrawal by Subject|0|||
49036577|NCT01838681|157969511|FG003|Period A|Withdrawal by Subject|0|||
49036578|NCT01838681|157969508|FG000|Period A|Protocol Violation|16|||
49036579|NCT01838681|157969509|FG001|Period A|Protocol Violation|0|||
48888908|NCT01006980|157430061|FG000|Crossover: Dacarbazine to Vemurafenib|Death|0|||
48888909|NCT01006980|157430062|FG001|Crossover: Dacarbazine to Vemurafenib|Death|4|||
48888910|NCT01006980|157430061|FG000|Crossover: Dacarbazine to Vemurafenib|Progression|0|||
48888911|NCT01006980|157430062|FG001|Crossover: Dacarbazine to Vemurafenib|Progression|65|||
48888912|NCT01006980|157430061|FG000|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0|||
48888913|NCT01006980|157430062|FG001|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1|||
48888914|NCT01006980|157430061|FG000|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0|||
48888915|NCT01006980|157430062|FG001|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10|||
48888916|NCT04828837|157430070|FG000|Overall Study|Stay-at-home during a COVID-19 outbreak|1|||
48888917|NCT04828837|157430071|FG001|Overall Study|Stay-at-home during a COVID-19 outbreak|3|||
48888918|NCT04828837|157430070|FG000|Overall Study|Lost to Follow-up|2|||
49036580|NCT01838681|157969510|FG002|Period A|Protocol Violation|0|||
49036581|NCT01838681|157969511|FG003|Period A|Protocol Violation|0|||
48888919|NCT04828837|157430071|FG001|Overall Study|Lost to Follow-up|6|||
48888920|NCT04828837|157430070|FG000|Overall Study|Lack of Efficacy|1|||
48888921|NCT04828837|157430071|FG001|Overall Study|Lack of Efficacy|0|||
48888922|NCT04828837|157430070|FG000|Overall Study|Admitted due to pneumothorax.|1|||
48888923|NCT04828837|157430071|FG001|Overall Study|Admitted due to pneumothorax.|0|||
48888924|NCT04828837|157430070|FG000|Overall Study|Admitted due to HIVD for operation.|0|||
48888925|NCT04828837|157430071|FG001|Overall Study|Admitted due to HIVD for operation.|1|||
48888926|NCT00837694|157430074|FG000|Overall Study|Lost to Follow-up|2|||
48888927|NCT00837694|157430075|FG001|Overall Study|Lost to Follow-up|0|||
48888928|NCT00837694|157430076|FG002|Overall Study|Lost to Follow-up|2|||
48888929|NCT00837694|157430077|FG003|Overall Study|Lost to Follow-up|1|||
48888930|NCT00837694|157430078|FG004|Overall Study|Lost to Follow-up|1|||
48888931|NCT00837694|157430079|FG005|Overall Study|Lost to Follow-up|1|||
48888932|NCT04996004|157430084|FG000|Phase I|Death|1|||
48888933|NCT04996004|157430085|FG001|Phase I|Death|2|||
48888934|NCT04996004|157430086|FG002|Phase I|Death|1|||
48888935|NCT04996004|157430087|FG003|Phase I|Death|0|||
48888936|NCT04996004|157430088|FG004|Phase I|Death|0|||
48888937|NCT04996004|157430089|FG005|Phase I|Death|0|||
48888938|NCT04996004|157430084|FG000|Phase I|Study terminated by sponsor|2|||
48888939|NCT04996004|157430085|FG001|Phase I|Study terminated by sponsor|1|||
48888940|NCT04996004|157430086|FG002|Phase I|Study terminated by sponsor|2|||
48888941|NCT04996004|157430087|FG003|Phase I|Study terminated by sponsor|0|||
48888942|NCT04996004|157430088|FG004|Phase I|Study terminated by sponsor|0|||
49036582|NCT01838681|157969508|FG000|Period A|Non-compliance with IMP|6|||
49036583|NCT01838681|157969509|FG001|Period A|Non-compliance with IMP|0|||
49036584|NCT01838681|157969510|FG002|Period A|Non-compliance with IMP|0|||
49036585|NCT01838681|157969511|FG003|Period A|Non-compliance with IMP|0|||
49036586|NCT01838681|157969508|FG000|Period A|Lost to Follow-up|4|||
49036587|NCT01838681|157969509|FG001|Period A|Lost to Follow-up|0|||
49036588|NCT01838681|157969510|FG002|Period A|Lost to Follow-up|0|||
49036589|NCT01838681|157969511|FG003|Period A|Lost to Follow-up|0|||
48888943|NCT04996004|157430089|FG005|Phase I|Study terminated by sponsor|0|||
49036590|NCT01838681|157969508|FG000|Period A|Withdrawal before treatment|4|||
49036591|NCT01838681|157969509|FG001|Period A|Withdrawal before treatment|0|||
49036592|NCT01838681|157969510|FG002|Period A|Withdrawal before treatment|0|||
49036593|NCT01838681|157969511|FG003|Period A|Withdrawal before treatment|0|||
49036594|NCT01838681|157969508|FG000|Period A|Administrative or other reasons|17|||
49036595|NCT01838681|157969509|FG001|Period A|Administrative or other reasons|0|||
49036596|NCT01838681|157969510|FG002|Period A|Administrative or other reasons|0|||
49036597|NCT01838681|157969511|FG003|Period A|Administrative or other reasons|0|||
49036598|NCT01838681|157969508|FG000|Period B/A+|Adverse Event|0|||
49036599|NCT01838681|157969509|FG001|Period B/A+|Adverse Event|13|||
49036600|NCT01838681|157969510|FG002|Period B/A+|Adverse Event|27|||
49036601|NCT01838681|157969511|FG003|Period B/A+|Adverse Event|16|||
48888944|NCT04996004|157430084|FG000|Phase II|Study terminated by sponsor|0|||
48888945|NCT04996004|157430085|FG001|Phase II|Study terminated by sponsor|0|||
48888946|NCT04996004|157430086|FG002|Phase II|Study terminated by sponsor|0|||
48888947|NCT04996004|157430087|FG003|Phase II|Study terminated by sponsor|20|||
48888948|NCT04996004|157430088|FG004|Phase II|Study terminated by sponsor|10|||
48888949|NCT04996004|157430089|FG005|Phase II|Study terminated by sponsor|10|||
48888950|NCT04996004|157430084|FG000|Phase II|Withdrawal by Subject|0|||
48888951|NCT04996004|157430085|FG001|Phase II|Withdrawal by Subject|0|||
48888952|NCT04996004|157430086|FG002|Phase II|Withdrawal by Subject|0|||
48888953|NCT04996004|157430087|FG003|Phase II|Withdrawal by Subject|0|||
48888954|NCT04996004|157430088|FG004|Phase II|Withdrawal by Subject|1|||
48888955|NCT04996004|157430089|FG005|Phase II|Withdrawal by Subject|2|||
48888956|NCT04996004|157430084|FG000|Phase II|Death|0|||
49036602|NCT01838681|157969508|FG000|Period B/A+|Lack of Efficacy|0|||
49036603|NCT01838681|157969509|FG001|Period B/A+|Lack of Efficacy|9|||
49036604|NCT01838681|157969510|FG002|Period B/A+|Lack of Efficacy|11|||
49036605|NCT01838681|157969511|FG003|Period B/A+|Lack of Efficacy|6|||
49036606|NCT01838681|157969508|FG000|Period B/A+|Withdrawal by Subject|0|||
49036607|NCT01838681|157969509|FG001|Period B/A+|Withdrawal by Subject|28|||
49036608|NCT01838681|157969510|FG002|Period B/A+|Withdrawal by Subject|35|||
48888957|NCT04996004|157430085|FG001|Phase II|Death|0|||
48888958|NCT04996004|157430086|FG002|Phase II|Death|0|||
48888959|NCT04996004|157430087|FG003|Phase II|Death|12|||
48888960|NCT04996004|157430088|FG004|Phase II|Death|2|||
48888961|NCT04996004|157430089|FG005|Phase II|Death|9|||
48888962|NCT04996004|157430084|FG000|Phase II|Other|0|||
48888963|NCT04996004|157430085|FG001|Phase II|Other|0|||
48888964|NCT04996004|157430086|FG002|Phase II|Other|0|||
48888965|NCT04996004|157430087|FG003|Phase II|Other|0|||
48888966|NCT04996004|157430088|FG004|Phase II|Other|0|||
48888967|NCT04996004|157430089|FG005|Phase II|Other|1|||
48888968|NCT05110690|157430090|FG000|Eligible for Consent and Enrollment|Did not consent|5|||
48888969|NCT05110690|157430090|FG000|Started Intervention|Ineligible due to canceled surgery|1|||
48888970|NCT05110690|157430090|FG000|Completion of Intervention|Lost to Follow-up|1|||
48888971|NCT05110690|157430090|FG000|Completion of Intervention|Death|1|||
48888972|NCT05110690|157430090|FG000|Completion of Intervention|Withdrawal by Subject|2|||
48888973|NCT01638429|157430096|FG000|Overall Study|Withdrawal by Subject|1|||
48888974|NCT03889704|157430097|FG000|Overall Study|Study terminated due to pandemic|1|||
49036609|NCT01838681|157969511|FG003|Period B/A+|Withdrawal by Subject|47|||
48888975|NCT02060370|157430098|FG000|Overall Study|Physician Decision|1|||
48888976|NCT03377699|157430101|FG000|Overall Study|Withdrawal by Subject|2|||
48888977|NCT03377699|157430102|FG001|Overall Study|Withdrawal by Subject|9|||
48888978|NCT03377699|157430101|FG000|Overall Study|Lost to Follow-up|1|||
48888979|NCT03377699|157430102|FG001|Overall Study|Lost to Follow-up|1|||
48888980|NCT03377699|157430101|FG000|Overall Study|Commencement of medical infertility treatment during the course of the trial|1|||
48983883|NCT02178592|157772370|FG000|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4|||
48983884|NCT02178592|157772371|FG001|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1|||
48983885|NCT02178592|157772370|FG000|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2|||
48983886|NCT02178592|157772371|FG001|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0|||
48983887|NCT02178592|157772370|FG000|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3|||
48983888|NCT02178592|157772371|FG001|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1|||
48983889|NCT01468844|157772372|FG000|Overall Study|Adverse Event|1|||
48983890|NCT01468844|157772373|FG001|Overall Study|Adverse Event|0|||
48983891|NCT01468844|157772372|FG000|Overall Study|Withdrawal by Subject|1|||
48983892|NCT01468844|157772373|FG001|Overall Study|Withdrawal by Subject|0|||
48983893|NCT00783263|157772385|FG000|Overall Study|Adverse Event|3|||
48983894|NCT00783263|157772386|FG001|Overall Study|Adverse Event|0|||
48983895|NCT00783263|157772387|FG002|Overall Study|Adverse Event|2|||
48983896|NCT00783263|157772388|FG003|Overall Study|Adverse Event|1|||
48983897|NCT00783263|157772385|FG000|Overall Study|Lost to Follow-up|1|||
48983898|NCT00783263|157772386|FG001|Overall Study|Lost to Follow-up|1|||
48983899|NCT00783263|157772387|FG002|Overall Study|Lost to Follow-up|0|||
48983900|NCT00783263|157772388|FG003|Overall Study|Lost to Follow-up|0|||
48983901|NCT00783263|157772385|FG000|Overall Study|Withdrawal by Subject|0|||
48983902|NCT00783263|157772386|FG001|Overall Study|Withdrawal by Subject|1|||
48983903|NCT00783263|157772387|FG002|Overall Study|Withdrawal by Subject|1|||
48983904|NCT00783263|157772388|FG003|Overall Study|Withdrawal by Subject|2|||
48983905|NCT00081263|157772389|FG000|Overall Study|clerical error|1|||
48983906|NCT00081263|157772390|FG001|Overall Study|clerical error|0|||
48983907|NCT00081263|157772389|FG000|Overall Study|wrong cell type|7|||
48983908|NCT00081263|157772390|FG001|Overall Study|wrong cell type|5|||
48983909|NCT00081263|157772389|FG000|Overall Study|improper pre-protocol therapy|0|||
48983910|NCT00081263|157772390|FG001|Overall Study|improper pre-protocol therapy|1|||
48983911|NCT00081263|157772389|FG000|Overall Study|Inadequate pathology|0|||
48983912|NCT00081263|157772390|FG001|Overall Study|Inadequate pathology|1|||
48983913|NCT00081263|157772389|FG000|Overall Study|Never treated|4|||
48983914|NCT00081263|157772390|FG001|Overall Study|Never treated|5|||
48983915|NCT00081263|157772389|FG000|Overall Study|Inadequate data|5|||
48983916|NCT00081263|157772390|FG001|Overall Study|Inadequate data|10|||
48983917|NCT00508820|157772396|FG000|Overall Study|Adverse Event|6|||
48983918|NCT00508820|157772397|FG001|Overall Study|Adverse Event|10|||
48983919|NCT00508820|157772396|FG000|Overall Study|Death|6|||
48983920|NCT00508820|157772397|FG001|Overall Study|Death|8|||
48983921|NCT00508820|157772396|FG000|Overall Study|Lost to Follow-up|1|||
48983922|NCT00508820|157772397|FG001|Overall Study|Lost to Follow-up|1|||
48983923|NCT00508820|157772396|FG000|Overall Study|Physician Decision|8|||
48983924|NCT00508820|157772397|FG001|Overall Study|Physician Decision|2|||
48983925|NCT00508820|157772396|FG000|Overall Study|Pregnancy|0|||
48983926|NCT00508820|157772397|FG001|Overall Study|Pregnancy|2|||
48983927|NCT00508820|157772396|FG000|Overall Study|Protocol Violation|2|||
48983928|NCT00508820|157772397|FG001|Overall Study|Protocol Violation|0|||
48983929|NCT00508820|157772396|FG000|Overall Study|Withdrawal by Subject|10|||
48983930|NCT00508820|157772397|FG001|Overall Study|Withdrawal by Subject|12|||
48983931|NCT00508820|157772396|FG000|Overall Study|Other|11|||
48983932|NCT00508820|157772397|FG001|Overall Study|Other|2|||
48983933|NCT00508820|157772396|FG000|Overall Study|Noncompliance|1|||
48983934|NCT00508820|157772397|FG001|Overall Study|Noncompliance|0|||
49036610|NCT01838681|157969508|FG000|Period B/A+|Protocol Violation|0|||
49036611|NCT01838681|157969509|FG001|Period B/A+|Protocol Violation|1|||
49036612|NCT01838681|157969510|FG002|Period B/A+|Protocol Violation|4|||
48796583|NCT03280121|157093725|FG000|Overall Study|Physician Decision|1|||
48796584|NCT03280121|157093725|FG000|Overall Study|Lost to Follow-up|1|||
48796585|NCT03280121|157093725|FG000|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4|||
48796586|NCT00911534|157093728|FG000|Overall Study|Adverse Event|4|||
48796587|NCT00911534|157093729|FG001|Overall Study|Adverse Event|4|||
48796588|NCT00911534|157093728|FG000|Overall Study|Lost to Follow-up|2|||
48796589|NCT00911534|157093729|FG001|Overall Study|Lost to Follow-up|4|||
48796590|NCT00911534|157093728|FG000|Overall Study|Withdrawal by Subject|2|||
48796591|NCT00911534|157093729|FG001|Overall Study|Withdrawal by Subject|1|||
48796592|NCT00911534|157093728|FG000|Overall Study|Lack of Efficacy|4|||
48796593|NCT00911534|157093729|FG001|Overall Study|Lack of Efficacy|1|||
48796594|NCT00911534|157093728|FG000|Overall Study|Withdrawal of consent|1|||
48796595|NCT00911534|157093729|FG001|Overall Study|Withdrawal of consent|4|||
48796596|NCT00911534|157093728|FG000|Overall Study|Other|2|||
48796597|NCT00911534|157093729|FG001|Overall Study|Other|2|||
48796598|NCT02807558|157093735|FG000|Overall Study|Consent withdrawn by participant|4|||
48796599|NCT02807558|157093736|FG001|Overall Study|Consent withdrawn by participant|0|||
48796600|NCT02807558|157093737|FG002|Overall Study|Consent withdrawn by participant|4|||
48796601|NCT02807558|157093738|FG003|Overall Study|Consent withdrawn by participant|2|||
48796602|NCT02807558|157093739|FG004|Overall Study|Consent withdrawn by participant|1|||
48796603|NCT02807558|157093740|FG005|Overall Study|Consent withdrawn by participant|0|||
48796604|NCT02807558|157093735|FG000|Overall Study|Non-compliance with Study Drug|0|||
48796605|NCT02807558|157093736|FG001|Overall Study|Non-compliance with Study Drug|0|||
48796606|NCT02807558|157093737|FG002|Overall Study|Non-compliance with Study Drug|1|||
48796607|NCT02807558|157093738|FG003|Overall Study|Non-compliance with Study Drug|0|||
48796608|NCT02807558|157093739|FG004|Overall Study|Non-compliance with Study Drug|0|||
48796609|NCT02807558|157093740|FG005|Overall Study|Non-compliance with Study Drug|0|||
48796610|NCT02807558|157093735|FG000|Overall Study|Adverse Event|0|||
48796611|NCT02807558|157093736|FG001|Overall Study|Adverse Event|0|||
48796612|NCT02807558|157093737|FG002|Overall Study|Adverse Event|9|||
48796613|NCT02807558|157093738|FG003|Overall Study|Adverse Event|0|||
48796614|NCT02807558|157093739|FG004|Overall Study|Adverse Event|0|||
48796615|NCT02807558|157093740|FG005|Overall Study|Adverse Event|0|||
48796616|NCT02807558|157093735|FG000|Overall Study|Death|23|||
48796617|NCT02807558|157093736|FG001|Overall Study|Death|2|||
48796618|NCT02807558|157093737|FG002|Overall Study|Death|3|||
48796619|NCT02807558|157093738|FG003|Overall Study|Death|43|||
48796620|NCT02807558|157093739|FG004|Overall Study|Death|24|||
48796621|NCT02807558|157093740|FG005|Overall Study|Death|15|||
48796622|NCT02807558|157093735|FG000|Overall Study|Progressive Disease|0|||
48796623|NCT02807558|157093736|FG001|Overall Study|Progressive Disease|0|||
48796624|NCT02807558|157093737|FG002|Overall Study|Progressive Disease|1|||
48796625|NCT02807558|157093738|FG003|Overall Study|Progressive Disease|0|||
48796626|NCT02807558|157093739|FG004|Overall Study|Progressive Disease|0|||
48796627|NCT02807558|157093740|FG005|Overall Study|Progressive Disease|0|||
48796628|NCT02807558|157093735|FG000|Overall Study|Other than specified|1|||
48796629|NCT02807558|157093736|FG001|Overall Study|Other than specified|0|||
48796630|NCT02807558|157093737|FG002|Overall Study|Other than specified|2|||
48796631|NCT02807558|157093738|FG003|Overall Study|Other than specified|0|||
48796632|NCT02807558|157093739|FG004|Overall Study|Other than specified|1|||
48796633|NCT02807558|157093740|FG005|Overall Study|Other than specified|1|||
48796634|NCT02807558|157093735|FG000|Overall Study|Lack of Efficacy|0|||
48796635|NCT02807558|157093736|FG001|Overall Study|Lack of Efficacy|0|||
48796636|NCT02807558|157093737|FG002|Overall Study|Lack of Efficacy|9|||
48796637|NCT02807558|157093738|FG003|Overall Study|Lack of Efficacy|0|||
48796638|NCT02807558|157093739|FG004|Overall Study|Lack of Efficacy|0|||
48796639|NCT02807558|157093740|FG005|Overall Study|Lack of Efficacy|0|||
48796640|NCT01994954|157093745|FG000|Overall Study|Death|1|||
48796641|NCT01994954|157093746|FG001|Overall Study|Death|0|||
48796642|NCT01994954|157093745|FG000|Overall Study|Withdrawal by Subject|9|||
48796643|NCT01994954|157093746|FG001|Overall Study|Withdrawal by Subject|14|||
48796644|NCT01994954|157093745|FG000|Overall Study|Physician Decision|2|||
48796645|NCT01994954|157093746|FG001|Overall Study|Physician Decision|2|||
48796646|NCT01994954|157093745|FG000|Overall Study|Lost to Follow-up|8|||
48796647|NCT01994954|157093746|FG001|Overall Study|Lost to Follow-up|10|||
48796648|NCT01994954|157093745|FG000|Overall Study|6 Month Follow-up Not Complete|5|||
48796649|NCT01994954|157093746|FG001|Overall Study|6 Month Follow-up Not Complete|4|||
48796650|NCT04198805|157093747|FG000|Overall Study|Death|0|||
48796651|NCT04198805|157093748|FG001|Overall Study|Death|0|||
48796652|NCT04198805|157093749|FG002|Overall Study|Death|0|||
48796653|NCT04198805|157093750|FG003|Overall Study|Death|1|||
48796654|NCT04198805|157093747|FG000|Overall Study|Early Termination|8|||
48796655|NCT04198805|157093748|FG001|Overall Study|Early Termination|4|||
48796656|NCT04198805|157093749|FG002|Overall Study|Early Termination|6|||
49036613|NCT01838681|157969511|FG003|Period B/A+|Protocol Violation|6|||
49036614|NCT01838681|157969508|FG000|Period B/A+|Non-compliance with IMP|0|||
48796657|NCT04198805|157093750|FG003|Overall Study|Early Termination|9|||
48796658|NCT00683644|157093751|FG000|Overall Study|Withdrawal by Subject|4|||
48796659|NCT00683644|157093752|FG001|Overall Study|Withdrawal by Subject|2|||
48796660|NCT00683644|157093751|FG000|Overall Study|Lost to Follow-up|1|||
48796661|NCT00683644|157093752|FG001|Overall Study|Lost to Follow-up|4|||
48796662|NCT00683644|157093751|FG000|Overall Study|Adverse Event|1|||
48796663|NCT00683644|157093752|FG001|Overall Study|Adverse Event|2|||
48796664|NCT00683644|157093751|FG000|Overall Study|Low copper, other health problems,|7|||
48796665|NCT00683644|157093752|FG001|Overall Study|Low copper, other health problems,|6|||
48796666|NCT01441102|157093753|FG000|Overall Study|Adverse Event|1|||
48796667|NCT01441102|157093753|FG000|Overall Study|Withdrawal by Subject|2|||
48796668|NCT04084314|157093755|FG000|Overall Study|Subject/guardian decision|91|||
48796669|NCT04084314|157093755|FG000|Overall Study|Adverse Event|24|||
48796670|NCT04084314|157093755|FG000|Overall Study|Lost to Follow-up|19|||
48796671|NCT04084314|157093755|FG000|Overall Study|New therapy for study indication|9|||
48796672|NCT04084314|157093755|FG000|Overall Study|Pregnancy|9|||
48796673|NCT04084314|157093755|FG000|Overall Study|Withdrawal of informed consent|8|||
48796674|NCT04084314|157093755|FG000|Overall Study|Physician Decision|4|||
48796675|NCT04084314|157093755|FG000|Overall Study|Protocol Deviation|3|||
48796676|NCT01218126|157093756|FG000|Overall Study|Adverse Event|8|||
48796677|NCT01218126|157093757|FG001|Overall Study|Adverse Event|10|||
48796678|NCT01218126|157093758|FG002|Overall Study|Adverse Event|12|||
48796679|NCT01218126|157093759|FG003|Overall Study|Adverse Event|16|||
48796680|NCT01218126|157093756|FG000|Overall Study|Lack of Efficacy|7|||
48796681|NCT01218126|157093757|FG001|Overall Study|Lack of Efficacy|2|||
48796682|NCT01218126|157093758|FG002|Overall Study|Lack of Efficacy|2|||
48796683|NCT01218126|157093759|FG003|Overall Study|Lack of Efficacy|6|||
48796684|NCT01218126|157093756|FG000|Overall Study|Protocol Violation|5|||
48796685|NCT01218126|157093757|FG001|Overall Study|Protocol Violation|2|||
48796686|NCT01218126|157093758|FG002|Overall Study|Protocol Violation|2|||
48796687|NCT01218126|157093759|FG003|Overall Study|Protocol Violation|3|||
48796688|NCT01218126|157093756|FG000|Overall Study|Protocol-defined stopping criteria|1|||
48796689|NCT01218126|157093757|FG001|Overall Study|Protocol-defined stopping criteria|1|||
48796690|NCT01218126|157093758|FG002|Overall Study|Protocol-defined stopping criteria|0|||
48796691|NCT01218126|157093759|FG003|Overall Study|Protocol-defined stopping criteria|0|||
48796692|NCT01218126|157093756|FG000|Overall Study|Lost to Follow-up|0|||
48796693|NCT01218126|157093757|FG001|Overall Study|Lost to Follow-up|0|||
48796694|NCT01218126|157093758|FG002|Overall Study|Lost to Follow-up|0|||
48796695|NCT01218126|157093759|FG003|Overall Study|Lost to Follow-up|2|||
48796696|NCT01218126|157093756|FG000|Overall Study|Physician Decision|1|||
48796697|NCT01218126|157093757|FG001|Overall Study|Physician Decision|2|||
48796698|NCT01218126|157093758|FG002|Overall Study|Physician Decision|4|||
48796699|NCT01218126|157093759|FG003|Overall Study|Physician Decision|2|||
48796700|NCT01218126|157093756|FG000|Overall Study|Withdrawal by Subject|2|||
48796701|NCT01218126|157093757|FG001|Overall Study|Withdrawal by Subject|5|||
48796702|NCT01218126|157093758|FG002|Overall Study|Withdrawal by Subject|4|||
48796703|NCT01218126|157093759|FG003|Overall Study|Withdrawal by Subject|6|||
48796704|NCT00810264|157093761|FG000|Overall Study|Lost to Follow-up|191|||
48796705|NCT00810264|157093761|FG000|Overall Study|Withdrawal by subject or physician|721|||
48796706|NCT00810264|157093761|FG000|Overall Study|Death|641|||
48796707|NCT01830127|157093762|FG000|Overall Study|Adverse Event|1|||
48796708|NCT01830127|157093763|FG001|Overall Study|Adverse Event|6|||
48796709|NCT01830127|157093762|FG000|Overall Study|Lack of Efficacy|3|||
48796710|NCT01830127|157093763|FG001|Overall Study|Lack of Efficacy|0|||
48796711|NCT01830127|157093762|FG000|Overall Study|Withdrawal by Subject|1|||
48796712|NCT01830127|157093763|FG001|Overall Study|Withdrawal by Subject|1|||
48796713|NCT01830127|157093762|FG000|Overall Study|Other reason not defined above|0|||
48796714|NCT01830127|157093763|FG001|Overall Study|Other reason not defined above|2|||
48796715|NCT00500903|157093774|FG000|Overall Study|Occurrence of Adverse Event(s)|10|||
48796716|NCT00500903|157093775|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
48796717|NCT00500903|157093776|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
48796718|NCT00500903|157093774|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
48796719|NCT00500903|157093775|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
48796720|NCT00500903|157093776|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
48796721|NCT00500903|157093774|FG000|Overall Study|Progressive Disease|41|||
48796722|NCT00500903|157093775|FG001|Overall Study|Progressive Disease|2|||
48796723|NCT00500903|157093776|FG002|Overall Study|Progressive Disease|15|||
48796724|NCT00500903|157093774|FG000|Overall Study|Patient Declined Further Treatment|0|||
48796725|NCT00500903|157093775|FG001|Overall Study|Patient Declined Further Treatment|0|||
48796726|NCT00500903|157093776|FG002|Overall Study|Patient Declined Further Treatment|3|||
48796727|NCT00500903|157093774|FG000|Overall Study|Symptomatic Deterioration|2|||
48796728|NCT00500903|157093775|FG001|Overall Study|Symptomatic Deterioration|0|||
48796729|NCT00500903|157093776|FG002|Overall Study|Symptomatic Deterioration|0|||
48796730|NCT00500903|157093774|FG000|Overall Study|Reason Not Specified|10|||
48796731|NCT00500903|157093775|FG001|Overall Study|Reason Not Specified|0|||
48796732|NCT00500903|157093776|FG002|Overall Study|Reason Not Specified|2|||
48796733|NCT00698646|157093780|FG000|Overall Study|Adverse Event|8|||
48888981|NCT03377699|157430102|FG001|Overall Study|Commencement of medical infertility treatment during the course of the trial|0|||
48888982|NCT03377699|157430101|FG000|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
48888983|NCT03377699|157430102|FG001|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
48888984|NCT03377699|157430101|FG000|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|11|||
48888985|NCT03377699|157430102|FG001|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|8|||
48888986|NCT03377699|157430101|FG000|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
48888987|NCT03377699|157430102|FG001|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
48888988|NCT03248882|157430103|FG000|Overall Study|Adverse Event|3|||
48888989|NCT03248882|157430104|FG001|Overall Study|Adverse Event|3|||
48888990|NCT03248882|157430105|FG002|Overall Study|Adverse Event|2|||
48888991|NCT03248882|157430106|FG003|Overall Study|Adverse Event|6|||
48888992|NCT03248882|157430107|FG004|Overall Study|Adverse Event|9|||
48888993|NCT03248882|157430103|FG000|Overall Study|Lost to Follow-up|0|||
48888994|NCT03248882|157430104|FG001|Overall Study|Lost to Follow-up|0|||
48888995|NCT03248882|157430105|FG002|Overall Study|Lost to Follow-up|0|||
48888996|NCT03248882|157430106|FG003|Overall Study|Lost to Follow-up|0|||
48888997|NCT03248882|157430107|FG004|Overall Study|Lost to Follow-up|1|||
48888998|NCT03248882|157430103|FG000|Overall Study|Protocol Violation|2|||
48888999|NCT03248882|157430104|FG001|Overall Study|Protocol Violation|0|||
48889000|NCT03248882|157430105|FG002|Overall Study|Protocol Violation|2|||
48889001|NCT03248882|157430106|FG003|Overall Study|Protocol Violation|0|||
48889002|NCT03248882|157430107|FG004|Overall Study|Protocol Violation|1|||
48889003|NCT03248882|157430103|FG000|Overall Study|Withdrawal by Subject|2|||
48889004|NCT03248882|157430104|FG001|Overall Study|Withdrawal by Subject|2|||
48889005|NCT03248882|157430105|FG002|Overall Study|Withdrawal by Subject|3|||
48889006|NCT03248882|157430106|FG003|Overall Study|Withdrawal by Subject|4|||
48889007|NCT03248882|157430107|FG004|Overall Study|Withdrawal by Subject|2|||
48889008|NCT02182947|157430108|FG000|Overall Study|Withdrawal by Subject|7|||
48889009|NCT02182947|157430108|FG000|Overall Study|Lost to Follow-up|3|||
48889010|NCT02182947|157430108|FG000|Overall Study|Failed screening activities|8|||
48889011|NCT02030002|157430109|FG000|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1|||
48889012|NCT02030002|157430109|FG000|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4|||
48889013|NCT02030002|157430109|FG000|Follow-up|Lost to Follow-up|2|||
48889014|NCT01598662|157430111|FG000|Overall Study|Lost to Follow-up|10|||
48889015|NCT01598662|157430112|FG001|Overall Study|Lost to Follow-up|17|||
48889016|NCT01598662|157430111|FG000|Overall Study|Physician Decision|1|||
48889017|NCT01598662|157430112|FG001|Overall Study|Physician Decision|2|||
48889018|NCT01598662|157430111|FG000|Overall Study|IUD expelled before month 6|0|||
48889019|NCT01598662|157430112|FG001|Overall Study|IUD expelled before month 6|2|||
48889020|NCT01399697|157430114|FG000|Overall Study|Adverse Event|13|||
48889021|NCT01399697|157430115|FG001|Overall Study|Adverse Event|3|||
48889022|NCT01399697|157430116|FG002|Overall Study|Adverse Event|1|||
48889023|NCT01399697|157430114|FG000|Overall Study|Lost to Follow-up|2|||
48889024|NCT01399697|157430115|FG001|Overall Study|Lost to Follow-up|0|||
48889025|NCT01399697|157430116|FG002|Overall Study|Lost to Follow-up|0|||
48889026|NCT01399697|157430114|FG000|Overall Study|Withdrawal by Subject|8|||
48889027|NCT01399697|157430115|FG001|Overall Study|Withdrawal by Subject|0|||
48889028|NCT01399697|157430116|FG002|Overall Study|Withdrawal by Subject|0|||
48889029|NCT01399697|157430114|FG000|Overall Study|Investigator Decisión|1|||
48889030|NCT01399697|157430115|FG001|Overall Study|Investigator Decisión|0|||
48889031|NCT01399697|157430116|FG002|Overall Study|Investigator Decisión|2|||
48889032|NCT01399697|157430114|FG000|Overall Study|Lack of Efficacy|9|||
48889033|NCT01399697|157430115|FG001|Overall Study|Lack of Efficacy|0|||
48889034|NCT01399697|157430116|FG002|Overall Study|Lack of Efficacy|1|||
48889035|NCT01399697|157430114|FG000|Overall Study|Protocol Violation|2|||
48889036|NCT01399697|157430115|FG001|Overall Study|Protocol Violation|0|||
48889037|NCT01399697|157430116|FG002|Overall Study|Protocol Violation|0|||
48889038|NCT01399697|157430114|FG000|Overall Study|Non-Compliant|1|||
48889039|NCT01399697|157430115|FG001|Overall Study|Non-Compliant|0|||
48889040|NCT01399697|157430116|FG002|Overall Study|Non-Compliant|0|||
48889041|NCT01399697|157430114|FG000|Overall Study|Inclusion Error|2|||
48889042|NCT01399697|157430115|FG001|Overall Study|Inclusion Error|0|||
48889043|NCT01399697|157430116|FG002|Overall Study|Inclusion Error|0|||
48889044|NCT01399697|157430114|FG000|Overall Study|Positive result for hepatitis B|1|||
48889045|NCT01399697|157430115|FG001|Overall Study|Positive result for hepatitis B|0|||
48889046|NCT01399697|157430116|FG002|Overall Study|Positive result for hepatitis B|0|||
48889047|NCT01399697|157430114|FG000|Overall Study|Clinical RA remission|1|||
48889048|NCT01399697|157430115|FG001|Overall Study|Clinical RA remission|0|||
48889049|NCT01399697|157430116|FG002|Overall Study|Clinical RA remission|0|||
48889050|NCT01399697|157430114|FG000|Overall Study|Sponsor Decision|1|||
48889051|NCT01399697|157430115|FG001|Overall Study|Sponsor Decision|0|||
48889052|NCT01399697|157430116|FG002|Overall Study|Sponsor Decision|0|||
49036615|NCT01838681|157969509|FG001|Period B/A+|Non-compliance with IMP|2|||
49036616|NCT01838681|157969510|FG002|Period B/A+|Non-compliance with IMP|3|||
48889053|NCT03435692|157430119|FG000|Overall Study|Lack of Efficacy|2|||
48889054|NCT03435692|157430120|FG001|Overall Study|Lack of Efficacy|2|||
48889055|NCT03435692|157430121|FG002|Overall Study|Lack of Efficacy|0|||
48889056|NCT03231800|157430123|FG000|Overall Study|Lost to Follow-up|0|||
48889057|NCT03231800|157430124|FG001|Overall Study|Lost to Follow-up|2|||
48889058|NCT03231800|157430123|FG000|Overall Study|Protocol Violation|1|||
48889059|NCT03231800|157430124|FG001|Overall Study|Protocol Violation|1|||
48889060|NCT03231800|157430123|FG000|Overall Study|reason not provided|2|||
48889061|NCT03231800|157430124|FG001|Overall Study|reason not provided|0|||
48889062|NCT00859222|157430128|FG000|Overall Study|Adverse Event|2|||
48889063|NCT00859222|157430129|FG001|Overall Study|Adverse Event|3|||
48889064|NCT00859222|157430130|FG002|Overall Study|Adverse Event|6|||
48889065|NCT00859222|157430131|FG003|Overall Study|Adverse Event|24|||
48889066|NCT00859222|157430132|FG004|Overall Study|Adverse Event|15|||
48889067|NCT00859222|157430128|FG000|Overall Study|DLT|1|||
48889068|NCT00859222|157430129|FG001|Overall Study|DLT|0|||
48889069|NCT00859222|157430130|FG002|Overall Study|DLT|0|||
48889070|NCT00859222|157430131|FG003|Overall Study|DLT|0|||
48889071|NCT00859222|157430132|FG004|Overall Study|DLT|0|||
48889072|NCT00488475|157430133|FG000|Overall Study|Other|1754|||
48889073|NCT00821587|157430134|FG000|Overall Study|Physician Decision|0|||
48889074|NCT00821587|157430135|FG001|Overall Study|Physician Decision|1|||
48889075|NCT02781090|157430140|FG000|3-Month Follow-Up|Missed Visit|20|||
48889076|NCT02781090|157430141|FG001|3-Month Follow-Up|Missed Visit|20|||
48889077|NCT02781090|157430140|FG000|3-Month Follow-Up|Lost to Follow-up|40|||
48889078|NCT02781090|157430141|FG001|3-Month Follow-Up|Lost to Follow-up|34|||
48889079|NCT02781090|157430140|FG000|3-Month Follow-Up|Withdrawal by Subject|4|||
48889080|NCT02781090|157430141|FG001|3-Month Follow-Up|Withdrawal by Subject|3|||
48889081|NCT02781090|157430140|FG000|3-Month Follow-Up|Death|1|||
48889082|NCT02781090|157430141|FG001|3-Month Follow-Up|Death|0|||
48889083|NCT02781090|157430140|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
48889084|NCT02781090|157430141|FG001|6-Month Follow-Up|Withdrawal by Subject|2|||
48889085|NCT02781090|157430140|FG000|6-Month Follow-Up|Lost to Follow-up|20|||
48889086|NCT02781090|157430141|FG001|6-Month Follow-Up|Lost to Follow-up|22|||
48889087|NCT02781090|157430140|FG000|6-Month Follow-Up|Death|0|||
48889088|NCT02781090|157430141|FG001|6-Month Follow-Up|Death|1|||
48889089|NCT01208103|157430142|FG000|Overall Study|Adverse Event|1|||
48889090|NCT01208103|157430142|FG000|Overall Study|Withdrawal by Subject|1|||
48889091|NCT01401153|157430143|FG000|First Test Day|Learning disabilities; illness|1|||
48889092|NCT01401153|157430144|FG001|First Test Day|Learning disabilities; illness|10|||
48889093|NCT01401153|157430143|FG000|Second Test Day|illness|0|||
48889094|NCT01401153|157430144|FG001|Second Test Day|illness|5|||
48889095|NCT01605019|157430145|FG000|Overall Study|pt did not meet transplant endpoint|3|||
48889096|NCT01605019|157430146|FG001|Overall Study|pt did not meet transplant endpoint|0|||
48889097|NCT02770612|157430147|FG000|Overall Study|Met exclusion criteria (postop LOS>7d)|1|||
48889098|NCT02636725|157430151|FG000|Overall Study|Adverse Event|1|||
48889099|NCT02180243|157430152|FG000|Overall Study|Withdrawal by Subject|12|||
48889100|NCT02180243|157430153|FG001|Overall Study|Withdrawal by Subject|12|||
48889101|NCT02180243|157430152|FG000|Overall Study|Lost to Follow-up|12|||
48889102|NCT02180243|157430153|FG001|Overall Study|Lost to Follow-up|2|||
48889103|NCT02535091|157430154|FG000|Overall Study|Entered Expanded Access Program (EAP)/Navigator|34|||
48889104|NCT02535091|157430155|FG001|Overall Study|Entered Expanded Access Program (EAP)/Navigator|18|||
48889105|NCT02535091|157430156|FG002|Overall Study|Entered Expanded Access Program (EAP)/Navigator|575|||
48889106|NCT02535091|157430154|FG000|Overall Study|Withdrawal by Subject|14|||
48889107|NCT02535091|157430155|FG001|Overall Study|Withdrawal by Subject|5|||
48889108|NCT02535091|157430156|FG002|Overall Study|Withdrawal by Subject|121|||
48889109|NCT02535091|157430154|FG000|Overall Study|Adverse Event|9|||
48983935|NCT00508820|157772396|FG000|Overall Study|Requirement for alternative therapy|7|||
48983936|NCT00508820|157772397|FG001|Overall Study|Requirement for alternative therapy|15|||
48983937|NCT00508820|157772396|FG000|Overall Study|Protocol-specified Criteria|3|||
48983938|NCT00508820|157772397|FG001|Overall Study|Protocol-specified Criteria|12|||
48889110|NCT02535091|157430155|FG001|Overall Study|Adverse Event|4|||
48889111|NCT02535091|157430156|FG002|Overall Study|Adverse Event|170|||
48889112|NCT02535091|157430154|FG000|Overall Study|Other|4|||
48983939|NCT02036476|157772398|FG000|Overall Study|Withdrawal by Subject|2|||
48983940|NCT02036476|157772398|FG000|Overall Study|Progressive Disease|4|||
48983941|NCT02036476|157772398|FG000|Overall Study|Unacceptable Toxicity|2|||
48983942|NCT01225211|157772399|FG000|Overall Study|Adverse Event|0|||
48983943|NCT01225211|157772400|FG001|Overall Study|Adverse Event|0|||
48983944|NCT01225211|157772401|FG002|Overall Study|Adverse Event|1|||
48983945|NCT01225211|157772402|FG003|Overall Study|Adverse Event|0|||
48983946|NCT01225211|157772403|FG004|Overall Study|Adverse Event|0|||
48889113|NCT02535091|157430155|FG001|Overall Study|Other|3|||
48889114|NCT02535091|157430156|FG002|Overall Study|Other|81|||
48983947|NCT01225211|157772404|FG005|Overall Study|Adverse Event|0|||
48889115|NCT02535091|157430154|FG000|Overall Study|Lost to Follow-up|0|||
48889116|NCT02535091|157430155|FG001|Overall Study|Lost to Follow-up|1|||
48983948|NCT01225211|157772405|FG006|Overall Study|Adverse Event|0|||
48983949|NCT01225211|157772406|FG007|Overall Study|Adverse Event|0|||
49036617|NCT01838681|157969511|FG003|Period B/A+|Non-compliance with IMP|3|||
49036618|NCT01838681|157969508|FG000|Period B/A+|Lost to Follow-up|0|||
49036619|NCT01838681|157969509|FG001|Period B/A+|Lost to Follow-up|2|||
49036620|NCT01838681|157969510|FG002|Period B/A+|Lost to Follow-up|5|||
49036621|NCT01838681|157969511|FG003|Period B/A+|Lost to Follow-up|11|||
49036622|NCT01838681|157969508|FG000|Period B/A+|Withdrawal before treatment|0|||
49036623|NCT01838681|157969509|FG001|Period B/A+|Withdrawal before treatment|1|||
49036624|NCT01838681|157969510|FG002|Period B/A+|Withdrawal before treatment|0|||
49036625|NCT01838681|157969511|FG003|Period B/A+|Withdrawal before treatment|0|||
49036626|NCT01838681|157969508|FG000|Period B/A+|Administrative or other reasons|0|||
49036627|NCT01838681|157969509|FG001|Period B/A+|Administrative or other reasons|6|||
49036628|NCT01838681|157969510|FG002|Period B/A+|Administrative or other reasons|10|||
49036629|NCT01838681|157969511|FG003|Period B/A+|Administrative or other reasons|28|||
49036630|NCT03681470|157969512|FG000|Overall Study|Lack of Efficacy|3|||
49036631|NCT03681470|157969512|FG000|Overall Study|Lost to Follow-up|1|||
49036632|NCT03681470|157969512|FG000|Overall Study|Protocol Violation|3|||
49036633|NCT03681470|157969512|FG000|Overall Study|Withdrawal by Subject|1|||
49036634|NCT00835081|157969516|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
48889117|NCT02535091|157430156|FG002|Overall Study|Lost to Follow-up|19|||
48889118|NCT02535091|157430154|FG000|Overall Study|Protocol Violation|0|||
48889119|NCT02535091|157430155|FG001|Overall Study|Protocol Violation|1|||
48889120|NCT02535091|157430156|FG002|Overall Study|Protocol Violation|11|||
48889121|NCT02535091|157430154|FG000|Overall Study|Pregnancy|0|||
48889122|NCT02535091|157430155|FG001|Overall Study|Pregnancy|0|||
48889123|NCT02535091|157430156|FG002|Overall Study|Pregnancy|7|||
48889124|NCT01280357|157430157|FG000|Overall Study|Excluded no internal monitoring|14|||
48889125|NCT01280357|157430157|FG000|Overall Study|IInsufficient data/No data supplied|12|||
48889126|NCT02643472|157430158|FG000|Overall Study|Death|2|||
48889127|NCT02643472|157430159|FG001|Overall Study|Death|5|||
48889128|NCT02643472|157430158|FG000|Overall Study|Withdrawal by Subject|3|||
48889129|NCT02643472|157430159|FG001|Overall Study|Withdrawal by Subject|2|||
48889130|NCT02643472|157430158|FG000|Overall Study|Protocol Violation|0|||
48889131|NCT02643472|157430159|FG001|Overall Study|Protocol Violation|1|||
48889132|NCT02643472|157430158|FG000|Overall Study|Lost to Follow-up|22|||
48889133|NCT02643472|157430159|FG001|Overall Study|Lost to Follow-up|26|||
48889134|NCT01258595|157430162|FG000|Overall Study|Lost to Follow-up|1|||
48889135|NCT01258595|157430163|FG001|Overall Study|Lost to Follow-up|0|||
48889136|NCT01258595|157430162|FG000|Overall Study|Withdrawal by Subject|0|||
48889137|NCT01258595|157430163|FG001|Overall Study|Withdrawal by Subject|1|||
48889138|NCT00506441|157430164|FG000|Period 1; Open-label Period|Adverse Event|21|||
48889139|NCT00506441|157430165|FG001|Period 1; Open-label Period|Adverse Event|0|||
48889140|NCT00506441|157430164|FG000|Period 1; Open-label Period|Lack of Efficacy|13|||
48889141|NCT00506441|157430165|FG001|Period 1; Open-label Period|Lack of Efficacy|0|||
48889142|NCT00506441|157430164|FG000|Period 1; Open-label Period|Lost to Follow-up|2|||
48889143|NCT00506441|157430165|FG001|Period 1; Open-label Period|Lost to Follow-up|0|||
48889144|NCT00506441|157430164|FG000|Period 1; Open-label Period|Physician Decision|5|||
48889145|NCT00506441|157430165|FG001|Period 1; Open-label Period|Physician Decision|0|||
48889146|NCT00506441|157430164|FG000|Period 1; Open-label Period|Protocol Violation|9|||
48889147|NCT00506441|157430165|FG001|Period 1; Open-label Period|Protocol Violation|0|||
48889148|NCT00506441|157430164|FG000|Period 1; Open-label Period|Withdrawal by Subject|13|||
48889149|NCT00506441|157430165|FG001|Period 1; Open-label Period|Withdrawal by Subject|0|||
48889150|NCT00506441|157430164|FG000|Period 1; Open-label Period|Other Reasons|13|||
48889151|NCT00506441|157430165|FG001|Period 1; Open-label Period|Other Reasons|0|||
48889152|NCT00506441|157430164|FG000|Period 2; Double-blind Period|Adverse Event|0|||
48889153|NCT00506441|157430165|FG001|Period 2; Double-blind Period|Adverse Event|1|||
48889154|NCT00506441|157430164|FG000|Period 2; Double-blind Period|Lack of Efficacy|0|||
48889155|NCT00506441|157430165|FG001|Period 2; Double-blind Period|Lack of Efficacy|2|||
48889156|NCT00506441|157430164|FG000|Period 2; Double-blind Period|Physician Decision|1|||
49036635|NCT00835081|157969517|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
49036636|NCT02535923|157969520|FG000|Overall Study|Lost to Follow-up|5|||
49036637|NCT02535923|157969521|FG001|Overall Study|Lost to Follow-up|5|||
49036638|NCT02535923|157969520|FG000|Overall Study|Withdrawal by Subject|4|||
49036639|NCT02535923|157969521|FG001|Overall Study|Withdrawal by Subject|3|||
49036640|NCT01018862|157969524|FG000|Overall Study|Adverse Event|2|||
49036641|NCT01018862|157969525|FG001|Overall Study|Adverse Event|0|||
49036642|NCT01018862|157969526|FG002|Overall Study|Adverse Event|6|||
49036643|NCT01018862|157969524|FG000|Overall Study|Lack of Efficacy|1|||
49036644|NCT01018862|157969525|FG001|Overall Study|Lack of Efficacy|0|||
49036645|NCT01018862|157969526|FG002|Overall Study|Lack of Efficacy|2|||
48889157|NCT00506441|157430165|FG001|Period 2; Double-blind Period|Physician Decision|1|||
48889158|NCT00506441|157430164|FG000|Period 2; Double-blind Period|Withdrawal by Subject|1|||
48889159|NCT00506441|157430165|FG001|Period 2; Double-blind Period|Withdrawal by Subject|0|||
48889160|NCT00506441|157430164|FG000|Period 2; Double-blind Period|Other Reason|1|||
48889161|NCT00506441|157430165|FG001|Period 2; Double-blind Period|Other Reason|1|||
48889162|NCT03541200|157430166|FG000|Overall Study|Adverse Event|19|||
49036646|NCT01018862|157969524|FG000|Overall Study|Lost to Follow-up|3|||
49036647|NCT01018862|157969525|FG001|Overall Study|Lost to Follow-up|1|||
49036648|NCT01018862|157969526|FG002|Overall Study|Lost to Follow-up|0|||
49036649|NCT01018862|157969524|FG000|Overall Study|Protocol Violation|1|||
49036650|NCT01018862|157969525|FG001|Overall Study|Protocol Violation|3|||
49036651|NCT01018862|157969526|FG002|Overall Study|Protocol Violation|3|||
49036652|NCT01018862|157969524|FG000|Overall Study|Withdrawal by Subject|1|||
49036653|NCT01018862|157969525|FG001|Overall Study|Withdrawal by Subject|2|||
49036654|NCT01018862|157969526|FG002|Overall Study|Withdrawal by Subject|1|||
49036655|NCT01018862|157969524|FG000|Overall Study|administrative problems|5|||
49036656|NCT01018862|157969525|FG001|Overall Study|administrative problems|4|||
49036657|NCT01018862|157969526|FG002|Overall Study|administrative problems|4|||
49036658|NCT03279978|157969527|FG000|Overall Study|Withdrawal by Subject|0|||
49036659|NCT03279978|157969528|FG001|Overall Study|Withdrawal by Subject|1|||
49036660|NCT03279978|157969529|FG002|Overall Study|Withdrawal by Subject|0|||
49036661|NCT03279978|157969530|FG003|Overall Study|Withdrawal by Subject|0|||
49036662|NCT03279978|157969531|FG004|Overall Study|Withdrawal by Subject|0|||
49036663|NCT03279978|157969532|FG005|Overall Study|Withdrawal by Subject|0|||
49036664|NCT03279978|157969533|FG006|Overall Study|Withdrawal by Subject|0|||
49036665|NCT03279978|157969534|FG007|Overall Study|Withdrawal by Subject|0|||
49036666|NCT03279978|157969535|FG008|Overall Study|Withdrawal by Subject|0|||
49036667|NCT03279978|157969536|FG009|Overall Study|Withdrawal by Subject|1|||
49036668|NCT03279978|157969527|FG000|Overall Study|Lost to Follow-up|1|||
49036669|NCT03279978|157969528|FG001|Overall Study|Lost to Follow-up|0|||
49036670|NCT03279978|157969529|FG002|Overall Study|Lost to Follow-up|1|||
49036671|NCT03279978|157969530|FG003|Overall Study|Lost to Follow-up|0|||
49036672|NCT03279978|157969531|FG004|Overall Study|Lost to Follow-up|0|||
49036673|NCT03279978|157969532|FG005|Overall Study|Lost to Follow-up|0|||
49036674|NCT03279978|157969533|FG006|Overall Study|Lost to Follow-up|0|||
49036675|NCT03279978|157969534|FG007|Overall Study|Lost to Follow-up|0|||
49036676|NCT03279978|157969535|FG008|Overall Study|Lost to Follow-up|0|||
49036677|NCT03279978|157969536|FG009|Overall Study|Lost to Follow-up|0|||
49036678|NCT03279978|157969527|FG000|Overall Study|Other than stated above|0|||
49036679|NCT03279978|157969528|FG001|Overall Study|Other than stated above|0|||
49036680|NCT03279978|157969529|FG002|Overall Study|Other than stated above|0|||
49036681|NCT03279978|157969530|FG003|Overall Study|Other than stated above|0|||
49036682|NCT03279978|157969531|FG004|Overall Study|Other than stated above|0|||
49036683|NCT03279978|157969532|FG005|Overall Study|Other than stated above|0|||
48889163|NCT03541200|157430166|FG000|Overall Study|Death|1|||
48889164|NCT03541200|157430166|FG000|Overall Study|Lost to Follow-up|10|||
48889165|NCT03541200|157430166|FG000|Overall Study|Physician Decision|1|||
48889166|NCT03541200|157430166|FG000|Overall Study|Protocol Violation|51|||
48889167|NCT03541200|157430166|FG000|Overall Study|Withdrawal by Subject|23|||
48889168|NCT03541200|157430166|FG000|Overall Study|other|8|||
48889169|NCT00528931|157430171|FG000|Overall Study|Lost to Follow-up|1|||
48889170|NCT01253018|157430172|FG000|Overall Study|Lost to Follow-up|1|||
48889171|NCT01253018|157430173|FG001|Overall Study|Lost to Follow-up|1|||
48889172|NCT01253018|157430172|FG000|Overall Study|Robot Repair Issues|2|||
48889173|NCT01253018|157430173|FG001|Overall Study|Robot Repair Issues|0|||
48889174|NCT01253018|157430172|FG000|Overall Study|Withdrawal by Subject|1|||
48889175|NCT01253018|157430173|FG001|Overall Study|Withdrawal by Subject|1|||
48889176|NCT01204710|157430183|FG000|Randomization Treatment|Lost to Follow-up|1|||
49036684|NCT03279978|157969533|FG006|Overall Study|Other than stated above|1|||
49036685|NCT03279978|157969534|FG007|Overall Study|Other than stated above|0|||
49036686|NCT03279978|157969535|FG008|Overall Study|Other than stated above|0|||
49036687|NCT03279978|157969536|FG009|Overall Study|Other than stated above|0|||
49036688|NCT00840879|157969537|FG000|Second Intervention|Withdrawal by Subject|1|||
49036689|NCT00840879|157969538|FG001|Second Intervention|Withdrawal by Subject|0|||
49036690|NCT04236596|157969539|FG000|Overall Study|Withdrawal by Subject|1|||
49036691|NCT04236596|157969539|FG000|Overall Study|Participants did not retain implant for entire trial|3|||
49036692|NCT04236596|157969539|FG000|Overall Study|Participants did not receive implant at all|4|||
49036693|NCT03255733|157971129|FG000|Overall Study|Lost to Follow-up|4|||
49036694|NCT03868891|157971132|FG000|Overall Study|Adverse Event|1|||
49036695|NCT03868891|157971133|FG001|Overall Study|Adverse Event|0|||
49036696|NCT03868891|157971132|FG000|Overall Study|Lost to Follow-up|2|||
49036697|NCT03868891|157971133|FG001|Overall Study|Lost to Follow-up|1|||
49036698|NCT03868891|157971132|FG000|Overall Study|COVID-19 Restrictions|1|||
48889177|NCT01204710|157430184|FG001|Randomization Treatment|Lost to Follow-up|0|||
49036699|NCT03868891|157971133|FG001|Overall Study|COVID-19 Restrictions|2|||
48889178|NCT01204710|157430183|FG000|Randomization Treatment|Withdrawal by Subject|6|||
48889179|NCT01204710|157430184|FG001|Randomization Treatment|Withdrawal by Subject|5|||
48889180|NCT01204710|157430183|FG000|Randomization Treatment|Physician Decision|3|||
49036700|NCT01564394|157971136|FG000|Overall Study|Withdrawal by Subject|6|||
49036701|NCT01564394|157971137|FG001|Overall Study|Withdrawal by Subject|10|||
49036702|NCT01705574|157971138|FG000|Double-Blind Phase|Lost to Follow-up|12|||
49036703|NCT01705574|157971139|FG001|Double-Blind Phase|Lost to Follow-up|16|||
49036704|NCT01705574|157971140|FG002|Double-Blind Phase|Lost to Follow-up|0|||
49036705|NCT01705574|157971141|FG003|Double-Blind Phase|Lost to Follow-up|0|||
49036706|NCT01705574|157971138|FG000|Double-Blind Phase|Adverse Event|3|||
49036707|NCT01705574|157971139|FG001|Double-Blind Phase|Adverse Event|10|||
49036708|NCT01705574|157971140|FG002|Double-Blind Phase|Adverse Event|0|||
49036709|NCT01705574|157971141|FG003|Double-Blind Phase|Adverse Event|0|||
49036710|NCT01705574|157971138|FG000|Double-Blind Phase|Withdrew Consent|8|||
49036711|NCT01705574|157971139|FG001|Double-Blind Phase|Withdrew Consent|5|||
49036712|NCT01705574|157971140|FG002|Double-Blind Phase|Withdrew Consent|0|||
49036713|NCT01705574|157971141|FG003|Double-Blind Phase|Withdrew Consent|0|||
49036714|NCT01705574|157971138|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
49036715|NCT01705574|157971139|FG001|Double-Blind Phase|Non-Compliance with Study Drug|5|||
49036716|NCT01705574|157971140|FG002|Double-Blind Phase|Non-Compliance with Study Drug|0|||
49036717|NCT01705574|157971141|FG003|Double-Blind Phase|Non-Compliance with Study Drug|0|||
49036718|NCT01705574|157971138|FG000|Double-Blind Phase|Pregnancy|1|||
49036719|NCT01705574|157971139|FG001|Double-Blind Phase|Pregnancy|1|||
49036720|NCT01705574|157971140|FG002|Double-Blind Phase|Pregnancy|0|||
49036721|NCT01705574|157971141|FG003|Double-Blind Phase|Pregnancy|0|||
49036722|NCT01705574|157971138|FG000|Double-Blind Phase|Protocol Violation|1|||
49036723|NCT01705574|157971139|FG001|Double-Blind Phase|Protocol Violation|0|||
49036724|NCT01705574|157971140|FG002|Double-Blind Phase|Protocol Violation|0|||
49036725|NCT01705574|157971141|FG003|Double-Blind Phase|Protocol Violation|0|||
49036726|NCT01705574|157971138|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
49036727|NCT01705574|157971139|FG001|Double-Blind Phase|Randomized but Not Treated|4|||
49036728|NCT01705574|157971140|FG002|Double-Blind Phase|Randomized but Not Treated|0|||
49036729|NCT01705574|157971141|FG003|Double-Blind Phase|Randomized but Not Treated|0|||
49036730|NCT01705574|157971138|FG000|Open-Label Extension Phase|Lost to Follow-up|6|||
49036731|NCT01705574|157971139|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
49036732|NCT01705574|157971140|FG002|Open-Label Extension Phase|Lost to Follow-up|2|||
49036733|NCT01705574|157971141|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
49036734|NCT01705574|157971138|FG000|Open-Label Extension Phase|Withdrew Consent|4|||
49036735|NCT01705574|157971139|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
49036736|NCT01705574|157971140|FG002|Open-Label Extension Phase|Withdrew Consent|4|||
49036737|NCT01705574|157971141|FG003|Open-Label Extension Phase|Withdrew Consent|1|||
49036738|NCT01705574|157971138|FG000|Open-Label Extension Phase|Adverse Event|3|||
49036739|NCT01705574|157971139|FG001|Open-Label Extension Phase|Adverse Event|0|||
49036740|NCT01705574|157971140|FG002|Open-Label Extension Phase|Adverse Event|0|||
49036741|NCT01705574|157971141|FG003|Open-Label Extension Phase|Adverse Event|1|||
49036742|NCT01705574|157971138|FG000|Open-Label Extension Phase|Death|2|||
49036743|NCT01705574|157971139|FG001|Open-Label Extension Phase|Death|0|||
49036744|NCT01705574|157971140|FG002|Open-Label Extension Phase|Death|1|||
49036745|NCT01705574|157971141|FG003|Open-Label Extension Phase|Death|0|||
49036746|NCT01705574|157971138|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
48889181|NCT01204710|157430184|FG001|Randomization Treatment|Physician Decision|2|||
48889182|NCT01204710|157430183|FG000|Randomization Treatment|Entry criteria not met|0|||
48889183|NCT01204710|157430184|FG001|Randomization Treatment|Entry criteria not met|1|||
48889184|NCT01204710|157430183|FG000|Randomization Treatment|Adverse Event|4|||
48889185|NCT01204710|157430184|FG001|Randomization Treatment|Adverse Event|2|||
48889186|NCT01204710|157430183|FG000|Randomization Treatment|Sponsor Decision|0|||
48889187|NCT01204710|157430184|FG001|Randomization Treatment|Sponsor Decision|1|||
48889188|NCT01204710|157430183|FG000|Randomization Treatment|Worsening of General condition|0|||
48889189|NCT01204710|157430184|FG001|Randomization Treatment|Worsening of General condition|1|||
48889190|NCT01204710|157430183|FG000|Randomization Treatment|Moved and Followed for Survival|0|||
48889191|NCT01204710|157430184|FG001|Randomization Treatment|Moved and Followed for Survival|1|||
48889192|NCT01204710|157430183|FG000|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0|||
48889193|NCT01204710|157430184|FG001|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1|||
48889194|NCT01204710|157430183|FG000|Optional Olaratumab Monotherapy|Physician Decision|0|||
48889195|NCT01204710|157430184|FG001|Optional Olaratumab Monotherapy|Physician Decision|1|||
48889196|NCT01204710|157430183|FG000|Optional Olaratumab Monotherapy|Withdrawal by Subject|0|||
49036747|NCT01705574|157971139|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
49036748|NCT01705574|157971140|FG002|Open-Label Extension Phase|Non-Compliance with Study Drug|1|||
49036749|NCT01705574|157971141|FG003|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
49036750|NCT01705574|157971138|FG000|Open-Label Extension Phase|Physician Decision|0|||
49036751|NCT01705574|157971139|FG001|Open-Label Extension Phase|Physician Decision|0|||
49036752|NCT01705574|157971140|FG002|Open-Label Extension Phase|Physician Decision|2|||
49036753|NCT01705574|157971141|FG003|Open-Label Extension Phase|Physician Decision|0|||
48889197|NCT01204710|157430184|FG001|Optional Olaratumab Monotherapy|Withdrawal by Subject|1|||
49036754|NCT01705574|157971138|FG000|Open-Label Extension Phase|Pregnancy|0|||
49036755|NCT01705574|157971139|FG001|Open-Label Extension Phase|Pregnancy|0|||
49036756|NCT01705574|157971140|FG002|Open-Label Extension Phase|Pregnancy|1|||
49036757|NCT01705574|157971141|FG003|Open-Label Extension Phase|Pregnancy|1|||
49036758|NCT03606174|157971142|FG000|Overall Study|Death|37|||
49036759|NCT03606174|157971143|FG001|Overall Study|Death|15|||
49036760|NCT03606174|157971144|FG002|Overall Study|Death|15|||
49036761|NCT03606174|157971145|FG003|Overall Study|Death|7|||
48889198|NCT02996474|157430185|FG000|Overall Study|Physician Decision|5|||
48889199|NCT01142115|157430187|FG000|First Intervention|Lack of Efficacy|1|||
48889200|NCT01142115|157430188|FG001|First Intervention|Lack of Efficacy|1|||
48889201|NCT01142115|157430187|FG000|First Intervention|Adverse Event|1|||
48889202|NCT01142115|157430188|FG001|First Intervention|Adverse Event|0|||
48889203|NCT00633880|157430189|FG000|Open Label Titration|Lack of Efficacy|1|||
48889204|NCT00633880|157430190|FG001|Open Label Titration|Lack of Efficacy|0|||
48889205|NCT00633880|157430191|FG002|Open Label Titration|Lack of Efficacy|0|||
48889206|NCT00633880|157430189|FG000|Open Label Titration|Adverse Event|13|||
48889207|NCT00633880|157430190|FG001|Open Label Titration|Adverse Event|0|||
48889208|NCT00633880|157430191|FG002|Open Label Titration|Adverse Event|0|||
48889209|NCT00633880|157430189|FG000|Open Label Titration|Treatment Failure|55|||
48889210|NCT00633880|157430190|FG001|Open Label Titration|Treatment Failure|0|||
48889211|NCT00633880|157430191|FG002|Open Label Titration|Treatment Failure|0|||
48889212|NCT00633880|157430189|FG000|Open Label Titration|Protocol Violation|6|||
48889213|NCT00633880|157430190|FG001|Open Label Titration|Protocol Violation|0|||
48889214|NCT00633880|157430191|FG002|Open Label Titration|Protocol Violation|0|||
48889215|NCT00633880|157430189|FG000|Open Label Titration|Physician Decision|1|||
48889216|NCT00633880|157430190|FG001|Open Label Titration|Physician Decision|0|||
48889217|NCT00633880|157430191|FG002|Open Label Titration|Physician Decision|0|||
48889218|NCT00633880|157430189|FG000|Open Label Titration|Withdrawal by Subject|4|||
48889219|NCT00633880|157430190|FG001|Open Label Titration|Withdrawal by Subject|0|||
48889220|NCT00633880|157430191|FG002|Open Label Titration|Withdrawal by Subject|0|||
48889221|NCT04445987|157430192|FG000|Overall Study|Adverse Event|0|||
48889222|NCT04445987|157430193|FG001|Overall Study|Adverse Event|0|||
48889223|NCT04445987|157430194|FG002|Overall Study|Adverse Event|1|||
48889224|NCT04445987|157430195|FG003|Overall Study|Adverse Event|0|||
48889225|NCT04445987|157430196|FG004|Overall Study|Adverse Event|4|||
48889226|NCT04445987|157430197|FG005|Overall Study|Adverse Event|0|||
49036762|NCT03606174|157971146|FG004|Overall Study|Death|35|||
49036763|NCT03606174|157971147|FG005|Overall Study|Death|12|||
49036764|NCT03606174|157971148|FG006|Overall Study|Death|35|||
49036765|NCT03606174|157971149|FG007|Overall Study|Death|8|||
49036766|NCT03606174|157971150|FG008|Overall Study|Death|5|||
49036767|NCT03606174|157971151|FG009|Overall Study|Death|3|||
48889227|NCT04445987|157430192|FG000|Overall Study|Lost to Follow-up|4|||
48889228|NCT04445987|157430193|FG001|Overall Study|Lost to Follow-up|3|||
48889229|NCT04445987|157430194|FG002|Overall Study|Lost to Follow-up|1|||
48889230|NCT04445987|157430195|FG003|Overall Study|Lost to Follow-up|1|||
48889231|NCT04445987|157430196|FG004|Overall Study|Lost to Follow-up|29|||
48889232|NCT04445987|157430197|FG005|Overall Study|Lost to Follow-up|0|||
48889233|NCT04445987|157430192|FG000|Overall Study|Physician Decision|0|||
48889234|NCT04445987|157430193|FG001|Overall Study|Physician Decision|0|||
48889235|NCT04445987|157430194|FG002|Overall Study|Physician Decision|0|||
48889236|NCT04445987|157430195|FG003|Overall Study|Physician Decision|0|||
48889237|NCT04445987|157430196|FG004|Overall Study|Physician Decision|1|||
48889238|NCT04445987|157430197|FG005|Overall Study|Physician Decision|0|||
48889239|NCT04445987|157430192|FG000|Overall Study|Protocol Violation|1|||
48889240|NCT04445987|157430193|FG001|Overall Study|Protocol Violation|0|||
48889241|NCT04445987|157430194|FG002|Overall Study|Protocol Violation|0|||
48889242|NCT04445987|157430195|FG003|Overall Study|Protocol Violation|0|||
48889243|NCT04445987|157430196|FG004|Overall Study|Protocol Violation|2|||
48889244|NCT04445987|157430197|FG005|Overall Study|Protocol Violation|0|||
48889245|NCT04445987|157430192|FG000|Overall Study|Withdrawal by Subject|4|||
48889246|NCT04445987|157430193|FG001|Overall Study|Withdrawal by Subject|0|||
48889247|NCT04445987|157430194|FG002|Overall Study|Withdrawal by Subject|1|||
48889248|NCT04445987|157430195|FG003|Overall Study|Withdrawal by Subject|0|||
48889249|NCT04445987|157430196|FG004|Overall Study|Withdrawal by Subject|18|||
48889250|NCT04445987|157430197|FG005|Overall Study|Withdrawal by Subject|1|||
48889251|NCT04445987|157430192|FG000|Overall Study|Other reason|0|||
48889252|NCT04445987|157430193|FG001|Overall Study|Other reason|0|||
48889253|NCT04445987|157430194|FG002|Overall Study|Other reason|1|||
48889254|NCT04445987|157430195|FG003|Overall Study|Other reason|0|||
48889255|NCT04445987|157430196|FG004|Overall Study|Other reason|2|||
48889256|NCT04445987|157430197|FG005|Overall Study|Other reason|0|||
48889257|NCT02412371|157430198|FG000|Overall Study|Withdrawal by Subject|0|||
48889258|NCT02412371|157430199|FG001|Overall Study|Withdrawal by Subject|2|||
48889259|NCT02412371|157430200|FG002|Overall Study|Withdrawal by Subject|0|||
48889260|NCT02412371|157430201|FG003|Overall Study|Withdrawal by Subject|1|||
48889261|NCT02412371|157430202|FG004|Overall Study|Withdrawal by Subject|1|||
48889262|NCT02412371|157430203|FG005|Overall Study|Withdrawal by Subject|0|||
48889263|NCT02412371|157430198|FG000|Overall Study|Sponsor Discontinued Study|1|||
48889264|NCT02412371|157430199|FG001|Overall Study|Sponsor Discontinued Study|4|||
48889265|NCT02412371|157430200|FG002|Overall Study|Sponsor Discontinued Study|6|||
49036768|NCT03606174|157971152|FG010|Overall Study|Death|0|||
49036769|NCT03606174|157971142|FG000|Overall Study|Lost to Follow-up|0|||
49036770|NCT03606174|157971143|FG001|Overall Study|Lost to Follow-up|0|||
48889266|NCT02412371|157430201|FG003|Overall Study|Sponsor Discontinued Study|4|||
49036771|NCT03606174|157971144|FG002|Overall Study|Lost to Follow-up|0|||
48889267|NCT02412371|157430202|FG004|Overall Study|Sponsor Discontinued Study|5|||
48889268|NCT02412371|157430203|FG005|Overall Study|Sponsor Discontinued Study|0|||
48889269|NCT02412371|157430198|FG000|Overall Study|Death|4|||
48889270|NCT02412371|157430199|FG001|Overall Study|Death|2|||
48889271|NCT02412371|157430200|FG002|Overall Study|Death|1|||
48889272|NCT02412371|157430201|FG003|Overall Study|Death|3|||
48889273|NCT02412371|157430202|FG004|Overall Study|Death|5|||
48889274|NCT02412371|157430203|FG005|Overall Study|Death|2|||
48889275|NCT02412371|157430198|FG000|Overall Study|Other|2|||
48889276|NCT02412371|157430199|FG001|Overall Study|Other|1|||
48889277|NCT02412371|157430200|FG002|Overall Study|Other|0|||
48889278|NCT02412371|157430201|FG003|Overall Study|Other|0|||
48889279|NCT02412371|157430202|FG004|Overall Study|Other|1|||
48889280|NCT02412371|157430203|FG005|Overall Study|Other|3|||
48889281|NCT02053792|157430204|FG000|Overall Study|Physician Decision|0|||
48889282|NCT02053792|157430205|FG001|Overall Study|Physician Decision|1|||
48889283|NCT02053792|157430204|FG000|Overall Study|Development of High titer FIX inhibitor|0|||
48889284|NCT02053792|157430205|FG001|Overall Study|Development of High titer FIX inhibitor|1|||
48889285|NCT02053792|157430204|FG000|Overall Study|Lack of Efficacy|1|||
48889286|NCT02053792|157430205|FG001|Overall Study|Lack of Efficacy|0|||
48889287|NCT02053792|157430204|FG000|Overall Study|Adverse Event|1|||
48889288|NCT02053792|157430205|FG001|Overall Study|Adverse Event|0|||
48889289|NCT02053792|157430204|FG000|Overall Study|Withdrawal by Subject|2|||
48889290|NCT02053792|157430205|FG001|Overall Study|Withdrawal by Subject|2|||
48889291|NCT02053792|157430204|FG000|Overall Study|The patient was not compliant to the study procedure|1|||
48889292|NCT02053792|157430205|FG001|Overall Study|The patient was not compliant to the study procedure|0|||
48889293|NCT02053792|157430204|FG000|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|1|||
48889294|NCT02053792|157430205|FG001|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|0|||
48889295|NCT04869358|157430206|FG000|Overall Study|Wish to have children.|1|||
48889296|NCT04869358|157430207|FG001|Overall Study|Wish to have children.|0|||
48889297|NCT04869358|157430208|FG002|Overall Study|Wish to have children.|0|||
48889298|NCT04869358|157430209|FG003|Overall Study|Wish to have children.|0|||
48889299|NCT00474526|157432014|FG000|Overall Study|ADMINISTRATIVE REASON|11|||
48889300|NCT00474526|157432015|FG001|Overall Study|ADMINISTRATIVE REASON|9|||
48889301|NCT00474526|157432016|FG002|Overall Study|ADMINISTRATIVE REASON|9|||
48889302|NCT00474526|157432017|FG003|Overall Study|ADMINISTRATIVE REASON|20|||
48889303|NCT00474526|157432018|FG004|Overall Study|ADMINISTRATIVE REASON|9|||
48889304|NCT00474526|157432019|FG005|Overall Study|ADMINISTRATIVE REASON|1|||
48889305|NCT00474526|157432020|FG006|Overall Study|ADMINISTRATIVE REASON|1|||
48889306|NCT00474526|157432021|FG007|Overall Study|ADMINISTRATIVE REASON|0|||
48889307|NCT00474526|157432022|FG008|Overall Study|ADMINISTRATIVE REASON|2|||
48889308|NCT00474526|157432023|FG009|Overall Study|ADMINISTRATIVE REASON|1|||
48889309|NCT00474526|157432024|FG010|Overall Study|ADMINISTRATIVE REASON|1|||
48889310|NCT00474526|157432025|FG011|Overall Study|ADMINISTRATIVE REASON|1|||
48889311|NCT00474526|157432026|FG012|Overall Study|ADMINISTRATIVE REASON|1|||
48889312|NCT00474526|157432027|FG013|Overall Study|ADMINISTRATIVE REASON|1|||
48889313|NCT00474526|157432028|FG014|Overall Study|ADMINISTRATIVE REASON|2|||
48889314|NCT00474526|157432029|FG015|Overall Study|ADMINISTRATIVE REASON|0|||
48889315|NCT00474526|157432030|FG016|Overall Study|ADMINISTRATIVE REASON|0|||
48889316|NCT00474526|157432014|FG000|Overall Study|Adverse Event|2|||
48889317|NCT00474526|157432015|FG001|Overall Study|Adverse Event|0|||
48889318|NCT00474526|157432016|FG002|Overall Study|Adverse Event|2|||
48889319|NCT00474526|157432017|FG003|Overall Study|Adverse Event|4|||
48889320|NCT00474526|157432018|FG004|Overall Study|Adverse Event|2|||
48889321|NCT00474526|157432019|FG005|Overall Study|Adverse Event|1|||
48889322|NCT00474526|157432020|FG006|Overall Study|Adverse Event|1|||
48889323|NCT00474526|157432021|FG007|Overall Study|Adverse Event|0|||
48889324|NCT00474526|157432022|FG008|Overall Study|Adverse Event|0|||
48889325|NCT00474526|157432023|FG009|Overall Study|Adverse Event|0|||
48889326|NCT00474526|157432024|FG010|Overall Study|Adverse Event|0|||
48889327|NCT00474526|157432025|FG011|Overall Study|Adverse Event|0|||
48889328|NCT00474526|157432026|FG012|Overall Study|Adverse Event|0|||
48889329|NCT00474526|157432027|FG013|Overall Study|Adverse Event|0|||
48889330|NCT00474526|157432028|FG014|Overall Study|Adverse Event|1|||
48889331|NCT00474526|157432029|FG015|Overall Study|Adverse Event|1|||
48889332|NCT00474526|157432030|FG016|Overall Study|Adverse Event|0|||
48889333|NCT00474526|157432014|FG000|Overall Study|Death|0|||
48889334|NCT00474526|157432015|FG001|Overall Study|Death|0|||
48889335|NCT00474526|157432016|FG002|Overall Study|Death|0|||
48889336|NCT00474526|157432017|FG003|Overall Study|Death|0|||
48889337|NCT00474526|157432018|FG004|Overall Study|Death|0|||
48889338|NCT00474526|157432019|FG005|Overall Study|Death|0|||
48889339|NCT00474526|157432020|FG006|Overall Study|Death|0|||
48889340|NCT00474526|157432021|FG007|Overall Study|Death|0|||
48889341|NCT00474526|157432022|FG008|Overall Study|Death|0|||
48889342|NCT00474526|157432023|FG009|Overall Study|Death|0|||
48889343|NCT00474526|157432024|FG010|Overall Study|Death|0|||
48889344|NCT00474526|157432025|FG011|Overall Study|Death|0|||
48889345|NCT00474526|157432026|FG012|Overall Study|Death|0|||
48889346|NCT00474526|157432027|FG013|Overall Study|Death|3|||
48889347|NCT00474526|157432028|FG014|Overall Study|Death|0|||
48889348|NCT00474526|157432029|FG015|Overall Study|Death|0|||
48889349|NCT00474526|157432030|FG016|Overall Study|Death|0|||
48889350|NCT00474526|157432014|FG000|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
48889351|NCT00474526|157432015|FG001|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
48889352|NCT00474526|157432016|FG002|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
48889353|NCT00474526|157432017|FG003|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
48889354|NCT00474526|157432018|FG004|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
48889355|NCT00474526|157432019|FG005|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
48889356|NCT00474526|157432020|FG006|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
48889357|NCT00474526|157432021|FG007|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
48889358|NCT00474526|157432022|FG008|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
48889359|NCT00474526|157432023|FG009|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
48889360|NCT00474526|157432024|FG010|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
48889361|NCT00474526|157432025|FG011|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
48889362|NCT00474526|157432026|FG012|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
48889363|NCT00474526|157432027|FG013|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
48889364|NCT00474526|157432028|FG014|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
48889365|NCT00474526|157432029|FG015|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
48889366|NCT00474526|157432030|FG016|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
48889367|NCT00474526|157432014|FG000|Overall Study|Lost to Follow-up|8|||
48889368|NCT00474526|157432015|FG001|Overall Study|Lost to Follow-up|6|||
48889369|NCT00474526|157432016|FG002|Overall Study|Lost to Follow-up|13|||
48889370|NCT00474526|157432017|FG003|Overall Study|Lost to Follow-up|29|||
48889371|NCT00474526|157432018|FG004|Overall Study|Lost to Follow-up|11|||
48889372|NCT00474526|157432019|FG005|Overall Study|Lost to Follow-up|5|||
48889373|NCT00474526|157432020|FG006|Overall Study|Lost to Follow-up|8|||
48889374|NCT00474526|157432021|FG007|Overall Study|Lost to Follow-up|1|||
48889375|NCT00474526|157432022|FG008|Overall Study|Lost to Follow-up|0|||
48889376|NCT00474526|157432023|FG009|Overall Study|Lost to Follow-up|6|||
48889377|NCT00474526|157432024|FG010|Overall Study|Lost to Follow-up|2|||
48889378|NCT00474526|157432025|FG011|Overall Study|Lost to Follow-up|4|||
48889379|NCT00474526|157432026|FG012|Overall Study|Lost to Follow-up|6|||
48889380|NCT00474526|157432027|FG013|Overall Study|Lost to Follow-up|74|||
48889381|NCT00474526|157432028|FG014|Overall Study|Lost to Follow-up|29|||
48889382|NCT00474526|157432029|FG015|Overall Study|Lost to Follow-up|4|||
48889383|NCT00474526|157432030|FG016|Overall Study|Lost to Follow-up|5|||
48889384|NCT00474526|157432014|FG000|Overall Study|Protocol Violation|2|||
48889385|NCT00474526|157432015|FG001|Overall Study|Protocol Violation|6|||
48889386|NCT00474526|157432016|FG002|Overall Study|Protocol Violation|4|||
48889387|NCT00474526|157432017|FG003|Overall Study|Protocol Violation|12|||
48889388|NCT00474526|157432018|FG004|Overall Study|Protocol Violation|3|||
48889389|NCT00474526|157432019|FG005|Overall Study|Protocol Violation|1|||
48889390|NCT00474526|157432020|FG006|Overall Study|Protocol Violation|3|||
48889391|NCT00474526|157432021|FG007|Overall Study|Protocol Violation|0|||
48889392|NCT00474526|157432022|FG008|Overall Study|Protocol Violation|0|||
48889393|NCT00474526|157432023|FG009|Overall Study|Protocol Violation|4|||
48889394|NCT00474526|157432024|FG010|Overall Study|Protocol Violation|2|||
48889395|NCT00474526|157432025|FG011|Overall Study|Protocol Violation|2|||
48889396|NCT00474526|157432026|FG012|Overall Study|Protocol Violation|4|||
48889397|NCT00474526|157432027|FG013|Overall Study|Protocol Violation|19|||
48889398|NCT00474526|157432028|FG014|Overall Study|Protocol Violation|9|||
48889399|NCT00474526|157432029|FG015|Overall Study|Protocol Violation|6|||
48889400|NCT00474526|157432030|FG016|Overall Study|Protocol Violation|2|||
48889401|NCT00474526|157432014|FG000|Overall Study|UNABLE TO CLASSIFY|1|||
48889402|NCT00474526|157432015|FG001|Overall Study|UNABLE TO CLASSIFY|0|||
48889403|NCT00474526|157432016|FG002|Overall Study|UNABLE TO CLASSIFY|0|||
48889404|NCT00474526|157432017|FG003|Overall Study|UNABLE TO CLASSIFY|1|||
48889405|NCT00474526|157432018|FG004|Overall Study|UNABLE TO CLASSIFY|3|||
48889406|NCT00474526|157432019|FG005|Overall Study|UNABLE TO CLASSIFY|2|||
48889407|NCT00474526|157432020|FG006|Overall Study|UNABLE TO CLASSIFY|0|||
48889408|NCT00474526|157432021|FG007|Overall Study|UNABLE TO CLASSIFY|1|||
48889409|NCT00474526|157432022|FG008|Overall Study|UNABLE TO CLASSIFY|0|||
48889410|NCT00474526|157432023|FG009|Overall Study|UNABLE TO CLASSIFY|3|||
48889411|NCT00474526|157432024|FG010|Overall Study|UNABLE TO CLASSIFY|0|||
48889412|NCT00474526|157432025|FG011|Overall Study|UNABLE TO CLASSIFY|0|||
48889413|NCT00474526|157432026|FG012|Overall Study|UNABLE TO CLASSIFY|0|||
48889414|NCT00474526|157432027|FG013|Overall Study|UNABLE TO CLASSIFY|20|||
48889415|NCT00474526|157432028|FG014|Overall Study|UNABLE TO CLASSIFY|12|||
48889416|NCT00474526|157432029|FG015|Overall Study|UNABLE TO CLASSIFY|6|||
48889417|NCT00474526|157432030|FG016|Overall Study|UNABLE TO CLASSIFY|1|||
48889418|NCT00474526|157432014|FG000|Overall Study|Withdrawal by Subject|9|||
48889419|NCT00474526|157432015|FG001|Overall Study|Withdrawal by Subject|24|||
48889420|NCT00474526|157432016|FG002|Overall Study|Withdrawal by Subject|21|||
48889421|NCT00474526|157432017|FG003|Overall Study|Withdrawal by Subject|52|||
48889422|NCT00474526|157432018|FG004|Overall Study|Withdrawal by Subject|38|||
48889423|NCT00474526|157432019|FG005|Overall Study|Withdrawal by Subject|6|||
48889424|NCT00474526|157432020|FG006|Overall Study|Withdrawal by Subject|12|||
48889425|NCT00474526|157432021|FG007|Overall Study|Withdrawal by Subject|4|||
48889426|NCT00474526|157432022|FG008|Overall Study|Withdrawal by Subject|4|||
48889427|NCT00474526|157432023|FG009|Overall Study|Withdrawal by Subject|13|||
48889428|NCT00474526|157432024|FG010|Overall Study|Withdrawal by Subject|5|||
48889429|NCT00474526|157432025|FG011|Overall Study|Withdrawal by Subject|4|||
48889430|NCT00474526|157432026|FG012|Overall Study|Withdrawal by Subject|4|||
48889431|NCT00474526|157432027|FG013|Overall Study|Withdrawal by Subject|37|||
48889432|NCT00474526|157432028|FG014|Overall Study|Withdrawal by Subject|22|||
48889433|NCT00474526|157432029|FG015|Overall Study|Withdrawal by Subject|1|||
48889434|NCT00474526|157432030|FG016|Overall Study|Withdrawal by Subject|1|||
48889435|NCT04546217|157432032|FG000|Overall Study|Withdrawal by Subject|2|||
48889436|NCT04546217|157432033|FG001|Overall Study|Withdrawal by Subject|0|||
48889437|NCT04546217|157432032|FG000|Overall Study|Uncontrolled hypertension|1|||
48889438|NCT04546217|157432033|FG001|Overall Study|Uncontrolled hypertension|0|||
48889439|NCT00890695|157432040|FG000|Overall Study|Protocol Violation|1|||
48889440|NCT00890695|157432041|FG001|Overall Study|Protocol Violation|0|||
48889441|NCT02113124|157432042|FG000|Overall Study|Unable to retrieve blood sample|1|||
48889442|NCT02113124|157432043|FG001|Overall Study|Unable to retrieve blood sample|1|||
48889443|NCT01732822|157432046|FG000|Overall Study|Withdrawal by Subject|123|||
48889444|NCT01732822|157432047|FG001|Overall Study|Withdrawal by Subject|113|||
48889445|NCT03002220|157432050|FG000|Overall Study|Lack of Efficacy|2|||
48889446|NCT03002220|157432050|FG000|Overall Study|Withdrawal by Subject|3|||
48889447|NCT03002220|157432050|FG000|Overall Study|Adverse Event|2|||
48889448|NCT03002220|157432050|FG000|Overall Study|Disease progression|13|||
49036772|NCT03606174|157971145|FG003|Overall Study|Lost to Follow-up|0|||
49036773|NCT03606174|157971146|FG004|Overall Study|Lost to Follow-up|1|||
49036774|NCT03606174|157971147|FG005|Overall Study|Lost to Follow-up|1|||
48889449|NCT03002220|157432050|FG000|Overall Study|Physician Decision|1|||
48889450|NCT00128102|157432051|FG000|Overall Study|Site Discontinued|3|||
48889451|NCT00128102|157432052|FG001|Overall Study|Site Discontinued|6|||
48889452|NCT00128102|157432051|FG000|Overall Study|Other|0|||
48889453|NCT00128102|157432052|FG001|Overall Study|Other|1|||
48889454|NCT00128102|157432051|FG000|Overall Study|Progressive Disease|255|||
48889455|NCT00128102|157432052|FG001|Overall Study|Progressive Disease|285|||
48889456|NCT00128102|157432051|FG000|Overall Study|Adverse Event|34|||
48889457|NCT00128102|157432052|FG001|Overall Study|Adverse Event|11|||
48889458|NCT00128102|157432051|FG000|Overall Study|Death|12|||
48889459|NCT00128102|157432052|FG001|Overall Study|Death|13|||
48889460|NCT00128102|157432051|FG000|Overall Study|Physician Decision|3|||
48889461|NCT00128102|157432052|FG001|Overall Study|Physician Decision|3|||
48889462|NCT00128102|157432051|FG000|Overall Study|Withdrawal by Subject|19|||
48889463|NCT00128102|157432052|FG001|Overall Study|Withdrawal by Subject|11|||
48889464|NCT00128102|157432051|FG000|Overall Study|Protocol Violation|2|||
48889465|NCT00128102|157432052|FG001|Overall Study|Protocol Violation|2|||
48889466|NCT01202903|157432055|FG000|Overall Study|Administrative Probelms|1|||
48889467|NCT01202903|157432056|FG001|Overall Study|Administrative Probelms|4|||
48889468|NCT01202903|157432055|FG000|Overall Study|Protocol Violation|0|||
48889469|NCT01202903|157432056|FG001|Overall Study|Protocol Violation|1|||
48889470|NCT01202903|157432055|FG000|Overall Study|Death|1|||
48889471|NCT01202903|157432056|FG001|Overall Study|Death|0|||
48889472|NCT01202903|157432055|FG000|Overall Study|Lost to Follow-up|1|||
48889473|NCT01202903|157432056|FG001|Overall Study|Lost to Follow-up|1|||
48889474|NCT01202903|157432055|FG000|Overall Study|Lack of Efficacy|1|||
48889475|NCT01202903|157432056|FG001|Overall Study|Lack of Efficacy|3|||
48889476|NCT01202903|157432055|FG000|Overall Study|Adverse Event|3|||
48889477|NCT01202903|157432056|FG001|Overall Study|Adverse Event|3|||
48889478|NCT01202903|157432055|FG000|Overall Study|Withdrawal by Subject|4|||
48889479|NCT01202903|157432056|FG001|Overall Study|Withdrawal by Subject|4|||
48889480|NCT01302080|157432057|FG000|Overall Study|Withdrew Consent|92|||
48889481|NCT01302080|157432058|FG001|Overall Study|Withdrew Consent|39|||
48889482|NCT01302080|157432057|FG000|Overall Study|Patient/Family Moved|28|||
48889483|NCT01302080|157432058|FG001|Overall Study|Patient/Family Moved|3|||
49036775|NCT03606174|157971148|FG006|Overall Study|Lost to Follow-up|0|||
49036776|NCT03606174|157971149|FG007|Overall Study|Lost to Follow-up|0|||
48889484|NCT01302080|157432057|FG000|Overall Study|Lost to Follow-up|192|||
48889485|NCT01302080|157432058|FG001|Overall Study|Lost to Follow-up|93|||
48889486|NCT01302080|157432057|FG000|Overall Study|Death|1|||
48889487|NCT01302080|157432058|FG001|Overall Study|Death|0|||
48889488|NCT01302080|157432057|FG000|Overall Study|Other|52|||
48889489|NCT01302080|157432058|FG001|Overall Study|Other|8|||
48889490|NCT01302080|157432057|FG000|Overall Study|Reason Missing For Discontinuation|1|||
48889491|NCT01302080|157432058|FG001|Overall Study|Reason Missing For Discontinuation|0|||
48889492|NCT01255631|157432059|FG000|Overall Study|poor enrollment, no data analyzed|9|||
48889493|NCT01255631|157432060|FG001|Overall Study|poor enrollment, no data analyzed|6|||
48889494|NCT03339245|157432061|FG000|Overall Study|Adverse Event|1|||
48889495|NCT03339245|157432062|FG001|Overall Study|Adverse Event|1|||
48889496|NCT03339245|157432061|FG000|Overall Study|Withdrawal by Subject|1|||
48889497|NCT03339245|157432062|FG001|Overall Study|Withdrawal by Subject|0|||
48889498|NCT02124811|157432080|FG000|Overall Study|Early termination|2|||
48889499|NCT02124811|157432081|FG001|Overall Study|Early termination|2|||
48889500|NCT02124811|157432080|FG000|Overall Study|Withdrawal by Subject|1|||
48889501|NCT02124811|157432081|FG001|Overall Study|Withdrawal by Subject|0|||
49036777|NCT03606174|157971150|FG008|Overall Study|Lost to Follow-up|0|||
49036778|NCT03606174|157971151|FG009|Overall Study|Lost to Follow-up|0|||
49036779|NCT03606174|157971152|FG010|Overall Study|Lost to Follow-up|0|||
48889502|NCT02731690|157432084|FG000|Overall Study|Adverse Event|1|||
48889503|NCT02731690|157432084|FG000|Overall Study|Withdrawal by Subject|3|||
48889504|NCT02731690|157432084|FG000|Overall Study|Discontinuation of Study by Sponsor|26|||
48889505|NCT02735577|157432085|FG000|Disulfiram Treatment|Lost to Follow-up|1|||
48889506|NCT02735577|157432085|FG000|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2|||
48889507|NCT01332630|157432088|FG000|Overall Study|Withdrawal by Subject|3|||
48889508|NCT01552603|157432092|FG000|Overall Study|Physician Decision|1|||
48889509|NCT04020185|157432093|FG000|Overall Study|Death|0|||
48889510|NCT04020185|157432094|FG001|Overall Study|Death|0|||
48889511|NCT04020185|157432095|FG002|Overall Study|Death|1|||
48889512|NCT04020185|157432096|FG003|Overall Study|Death|2|||
48889513|NCT04020185|157432097|FG004|Overall Study|Death|1|||
48889514|NCT04020185|157432098|FG005|Overall Study|Death|0|||
48889515|NCT04020185|157432099|FG006|Overall Study|Death|1|||
48889516|NCT04020185|157432100|FG007|Overall Study|Death|0|||
48889517|NCT04020185|157432093|FG000|Overall Study|Consent withdrawn|1|||
48889518|NCT04020185|157432094|FG001|Overall Study|Consent withdrawn|0|||
48889519|NCT04020185|157432095|FG002|Overall Study|Consent withdrawn|0|||
48889520|NCT04020185|157432096|FG003|Overall Study|Consent withdrawn|0|||
48889521|NCT04020185|157432097|FG004|Overall Study|Consent withdrawn|2|||
48889522|NCT04020185|157432098|FG005|Overall Study|Consent withdrawn|0|||
48889523|NCT04020185|157432099|FG006|Overall Study|Consent withdrawn|1|||
48889524|NCT04020185|157432100|FG007|Overall Study|Consent withdrawn|1|||
48889525|NCT04020185|157432093|FG000|Overall Study|Patient in hospice|0|||
48889526|NCT04020185|157432094|FG001|Overall Study|Patient in hospice|1|||
48889527|NCT04020185|157432095|FG002|Overall Study|Patient in hospice|0|||
48889528|NCT04020185|157432096|FG003|Overall Study|Patient in hospice|0|||
48889529|NCT04020185|157432097|FG004|Overall Study|Patient in hospice|0|||
48889530|NCT04020185|157432098|FG005|Overall Study|Patient in hospice|0|||
48889531|NCT04020185|157432099|FG006|Overall Study|Patient in hospice|0|||
48889532|NCT04020185|157432100|FG007|Overall Study|Patient in hospice|0|||
48889533|NCT04020185|157432093|FG000|Overall Study|Continuing on expanded access|0|||
48889534|NCT04020185|157432094|FG001|Overall Study|Continuing on expanded access|0|||
48889535|NCT04020185|157432095|FG002|Overall Study|Continuing on expanded access|0|||
48889536|NCT04020185|157432096|FG003|Overall Study|Continuing on expanded access|0|||
48889537|NCT04020185|157432097|FG004|Overall Study|Continuing on expanded access|0|||
48889538|NCT04020185|157432098|FG005|Overall Study|Continuing on expanded access|0|||
48889539|NCT04020185|157432099|FG006|Overall Study|Continuing on expanded access|1|||
48889540|NCT04020185|157432100|FG007|Overall Study|Continuing on expanded access|1|||
48889541|NCT02898077|157432101|FG000|Overall Study|Enrolled/randomized, but never treated|1|||
48889542|NCT02898077|157432102|FG001|Overall Study|Enrolled/randomized, but never treated|1|||
48889543|NCT02898077|157432101|FG000|Overall Study|Lost to Follow-up|4|||
48889544|NCT02898077|157432102|FG001|Overall Study|Lost to Follow-up|3|||
48889545|NCT02898077|157432101|FG000|Overall Study|Physician Decision|0|||
48889546|NCT02898077|157432102|FG001|Overall Study|Physician Decision|2|||
49036780|NCT03606174|157971142|FG000|Overall Study|Withdrawal by Subject|6|||
49036781|NCT03606174|157971143|FG001|Overall Study|Withdrawal by Subject|0|||
49036782|NCT03606174|157971144|FG002|Overall Study|Withdrawal by Subject|0|||
49036783|NCT03606174|157971145|FG003|Overall Study|Withdrawal by Subject|1|||
49036784|NCT03606174|157971146|FG004|Overall Study|Withdrawal by Subject|2|||
49036785|NCT03606174|157971147|FG005|Overall Study|Withdrawal by Subject|1|||
48889547|NCT02898077|157432101|FG000|Overall Study|Sponsor Decision|32|||
48889548|NCT02898077|157432102|FG001|Overall Study|Sponsor Decision|13|||
48889549|NCT02898077|157432101|FG000|Overall Study|Withdrawal by Subject|6|||
48889550|NCT02898077|157432102|FG001|Overall Study|Withdrawal by Subject|3|||
48889551|NCT02898077|157432101|FG000|Overall Study|Discontinued from treatment but refused follow-up|2|||
48889552|NCT02898077|157432102|FG001|Overall Study|Discontinued from treatment but refused follow-up|1|||
48889553|NCT02898077|157432101|FG000|Overall Study|Ended extension period|3|||
48889554|NCT02898077|157432102|FG001|Overall Study|Ended extension period|0|||
48889555|NCT03330405|157432103|FG000|Overall Study|Other|1|||
48889556|NCT03330405|157432104|FG001|Overall Study|Other|3|||
48889557|NCT03330405|157432105|FG002|Overall Study|Other|1|||
48889558|NCT03330405|157432106|FG003|Overall Study|Other|0|||
48889559|NCT03330405|157432107|FG004|Overall Study|Other|2|||
48889560|NCT03330405|157432108|FG005|Overall Study|Other|0|||
48889561|NCT03330405|157432109|FG006|Overall Study|Other|1|||
48889562|NCT03330405|157432110|FG007|Overall Study|Other|0|||
48889563|NCT03330405|157432111|FG008|Overall Study|Other|0|||
48889564|NCT03330405|157432112|FG009|Overall Study|Other|0|||
48889565|NCT03330405|157432113|FG010|Overall Study|Other|0|||
48889566|NCT03330405|157432103|FG000|Overall Study|Progressive disease|8|||
48889567|NCT03330405|157432104|FG001|Overall Study|Progressive disease|27|||
48889568|NCT03330405|157432105|FG002|Overall Study|Progressive disease|4|||
48889569|NCT03330405|157432106|FG003|Overall Study|Progressive disease|18|||
48889570|NCT03330405|157432107|FG004|Overall Study|Progressive disease|16|||
48889571|NCT03330405|157432108|FG005|Overall Study|Progressive disease|14|||
48889572|NCT03330405|157432109|FG006|Overall Study|Progressive disease|7|||
48889573|NCT03330405|157432110|FG007|Overall Study|Progressive disease|29|||
48889574|NCT03330405|157432111|FG008|Overall Study|Progressive disease|9|||
48889575|NCT03330405|157432112|FG009|Overall Study|Progressive disease|11|||
48889576|NCT03330405|157432113|FG010|Overall Study|Progressive disease|5|||
48889577|NCT03330405|157432103|FG000|Overall Study|Withdrawal by Subject|1|||
48889578|NCT03330405|157432104|FG001|Overall Study|Withdrawal by Subject|4|||
48889579|NCT03330405|157432105|FG002|Overall Study|Withdrawal by Subject|0|||
48889580|NCT03330405|157432106|FG003|Overall Study|Withdrawal by Subject|1|||
48889581|NCT03330405|157432107|FG004|Overall Study|Withdrawal by Subject|1|||
48889582|NCT03330405|157432108|FG005|Overall Study|Withdrawal by Subject|1|||
48889583|NCT03330405|157432109|FG006|Overall Study|Withdrawal by Subject|0|||
48889584|NCT03330405|157432110|FG007|Overall Study|Withdrawal by Subject|2|||
48889585|NCT03330405|157432111|FG008|Overall Study|Withdrawal by Subject|2|||
48889586|NCT03330405|157432112|FG009|Overall Study|Withdrawal by Subject|1|||
48889587|NCT03330405|157432113|FG010|Overall Study|Withdrawal by Subject|1|||
48889588|NCT03330405|157432103|FG000|Overall Study|Global deterioration of health status|2|||
48889589|NCT03330405|157432104|FG001|Overall Study|Global deterioration of health status|3|||
48889590|NCT03330405|157432105|FG002|Overall Study|Global deterioration of health status|0|||
48889591|NCT03330405|157432106|FG003|Overall Study|Global deterioration of health status|2|||
48889592|NCT03330405|157432107|FG004|Overall Study|Global deterioration of health status|3|||
48889593|NCT03330405|157432108|FG005|Overall Study|Global deterioration of health status|3|||
48889594|NCT03330405|157432109|FG006|Overall Study|Global deterioration of health status|0|||
48889595|NCT03330405|157432110|FG007|Overall Study|Global deterioration of health status|2|||
48889596|NCT03330405|157432111|FG008|Overall Study|Global deterioration of health status|8|||
48889597|NCT03330405|157432112|FG009|Overall Study|Global deterioration of health status|4|||
48889598|NCT03330405|157432113|FG010|Overall Study|Global deterioration of health status|1|||
48889599|NCT03330405|157432103|FG000|Overall Study|Adverse Event|0|||
48889600|NCT03330405|157432104|FG001|Overall Study|Adverse Event|1|||
48889601|NCT03330405|157432105|FG002|Overall Study|Adverse Event|0|||
48889602|NCT03330405|157432106|FG003|Overall Study|Adverse Event|1|||
48889603|NCT03330405|157432107|FG004|Overall Study|Adverse Event|1|||
48889604|NCT03330405|157432108|FG005|Overall Study|Adverse Event|1|||
48889605|NCT03330405|157432109|FG006|Overall Study|Adverse Event|3|||
48889606|NCT03330405|157432110|FG007|Overall Study|Adverse Event|4|||
48889607|NCT03330405|157432111|FG008|Overall Study|Adverse Event|2|||
48889608|NCT03330405|157432112|FG009|Overall Study|Adverse Event|2|||
48889609|NCT03330405|157432113|FG010|Overall Study|Adverse Event|2|||
48889610|NCT03330405|157432103|FG000|Overall Study|Death|0|||
48889611|NCT03330405|157432104|FG001|Overall Study|Death|4|||
48889612|NCT03330405|157432105|FG002|Overall Study|Death|0|||
48889613|NCT03330405|157432106|FG003|Overall Study|Death|0|||
48889614|NCT03330405|157432107|FG004|Overall Study|Death|0|||
48889615|NCT03330405|157432108|FG005|Overall Study|Death|1|||
48889616|NCT03330405|157432109|FG006|Overall Study|Death|0|||
48889617|NCT03330405|157432110|FG007|Overall Study|Death|2|||
48889618|NCT03330405|157432111|FG008|Overall Study|Death|0|||
48889619|NCT03330405|157432112|FG009|Overall Study|Death|0|||
48889620|NCT03330405|157432113|FG010|Overall Study|Death|0|||
48889621|NCT03330405|157432103|FG000|Overall Study|Physician Decision|0|||
48889622|NCT03330405|157432104|FG001|Overall Study|Physician Decision|0|||
48889623|NCT03330405|157432105|FG002|Overall Study|Physician Decision|0|||
48889624|NCT03330405|157432106|FG003|Overall Study|Physician Decision|0|||
48889625|NCT03330405|157432107|FG004|Overall Study|Physician Decision|0|||
49036786|NCT03606174|157971148|FG006|Overall Study|Withdrawal by Subject|4|||
49036787|NCT03606174|157971149|FG007|Overall Study|Withdrawal by Subject|0|||
48889626|NCT03330405|157432108|FG005|Overall Study|Physician Decision|0|||
48889627|NCT03330405|157432109|FG006|Overall Study|Physician Decision|0|||
48889628|NCT03330405|157432110|FG007|Overall Study|Physician Decision|1|||
48889629|NCT03330405|157432111|FG008|Overall Study|Physician Decision|0|||
48889630|NCT03330405|157432112|FG009|Overall Study|Physician Decision|0|||
49036788|NCT03606174|157971150|FG008|Overall Study|Withdrawal by Subject|0|||
48889631|NCT03330405|157432113|FG010|Overall Study|Physician Decision|0|||
48889632|NCT00626197|157432114|FG000|Overall Study|Did not cooperate|2|||
48889633|NCT00626197|157432115|FG001|Overall Study|Did not cooperate|6|||
48889634|NCT00626197|157432116|FG002|Overall Study|Did not cooperate|1|||
48889635|NCT00626197|157432114|FG000|Overall Study|Failure to return|6|||
48889636|NCT00626197|157432115|FG001|Overall Study|Failure to return|5|||
48889637|NCT00626197|157432116|FG002|Overall Study|Failure to return|6|||
48889638|NCT00626197|157432114|FG000|Overall Study|Adverse event, serious fatal|3|||
48889639|NCT00626197|157432115|FG001|Overall Study|Adverse event, serious fatal|6|||
48889640|NCT00626197|157432116|FG002|Overall Study|Adverse event, serious fatal|6|||
48889641|NCT00626197|157432114|FG000|Overall Study|Adverse Event|1|||
48889642|NCT00626197|157432115|FG001|Overall Study|Adverse Event|1|||
48889643|NCT00626197|157432116|FG002|Overall Study|Adverse Event|2|||
48889644|NCT00626197|157432114|FG000|Overall Study|Withdrawal by Subject|17|||
48889645|NCT00626197|157432115|FG001|Overall Study|Withdrawal by Subject|17|||
48889646|NCT00626197|157432116|FG002|Overall Study|Withdrawal by Subject|7|||
48889647|NCT00626197|157432114|FG000|Overall Study|Administrative reasons|15|||
48889648|NCT00626197|157432115|FG001|Overall Study|Administrative reasons|19|||
48889649|NCT00626197|157432116|FG002|Overall Study|Administrative reasons|55|||
48889650|NCT00022659|157432117|FG000|Overall Study|Ineligible: wrong primary|1|||
48889651|NCT00022659|157432117|FG000|Overall Study|Never treated|1|||
48889652|NCT01757197|157432118|FG000|Overall Study|Death|2|||
48889653|NCT02236988|157432119|FG000|Overall Study|Lost to Follow-up|0|||
48889654|NCT02236988|157432120|FG001|Overall Study|Lost to Follow-up|0|||
48889655|NCT02236988|157432121|FG002|Overall Study|Lost to Follow-up|0|||
48889656|NCT02236988|157432122|FG003|Overall Study|Lost to Follow-up|1|||
48889657|NCT02236988|157432119|FG000|Overall Study|Unable to Comply with Study Visits|0|||
48889658|NCT02236988|157432120|FG001|Overall Study|Unable to Comply with Study Visits|0|||
48889659|NCT02236988|157432121|FG002|Overall Study|Unable to Comply with Study Visits|0|||
48889660|NCT02236988|157432122|FG003|Overall Study|Unable to Comply with Study Visits|2|||
48889661|NCT00608868|157432123|FG000|Overall Study|Withdrawal by Subject|7|||
48889662|NCT00608868|157432123|FG000|Overall Study|Protocol Violation|3|||
48889663|NCT00608868|157432123|FG000|Overall Study|Lost to Follow-up|2|||
48889664|NCT00608868|157432123|FG000|Overall Study|Adverse Event|1|||
48889665|NCT00608868|157432123|FG000|Overall Study|Physician Decision|2|||
48889666|NCT04032613|157432124|FG000|Overall Study|Did not complete post-program assessment|5|||
48889667|NCT04032613|157432125|FG001|Overall Study|Did not complete post-program assessment|2|||
48889668|NCT00523640|157432127|FG000|Overall Study|Death|1|||
48889669|NCT05032872|157432128|FG000|Overall Study|Adverse Event|1|||
48889670|NCT05032872|157432129|FG001|Overall Study|Adverse Event|0|||
48889671|NCT05032872|157432128|FG000|Overall Study|Lost to Follow-up|2|||
48889672|NCT05032872|157432129|FG001|Overall Study|Lost to Follow-up|4|||
48889673|NCT05032872|157432128|FG000|Overall Study|Withdrawal by Subject|4|||
48889674|NCT05032872|157432129|FG001|Overall Study|Withdrawal by Subject|3|||
48889675|NCT04514510|157432132|FG000|Overall Study|Lost to Follow-up|0|||
48889676|NCT04514510|157432133|FG001|Overall Study|Lost to Follow-up|1|||
48889677|NCT04514510|157432132|FG000|Overall Study|Randomized but did not receive Isoquercetin|1|||
48889678|NCT04514510|157432133|FG001|Overall Study|Randomized but did not receive Isoquercetin|0|||
48889679|NCT02964325|157432140|FG000|Overall Study|Lost to Follow-up|3|||
48889680|NCT02964325|157432141|FG001|Overall Study|Lost to Follow-up|3|||
48889681|NCT02964325|157432140|FG000|Overall Study|Physician Decision|5|||
48889682|NCT02964325|157432141|FG001|Overall Study|Physician Decision|4|||
48889683|NCT02964325|157432140|FG000|Overall Study|Death|1|||
48889684|NCT02964325|157432141|FG001|Overall Study|Death|3|||
48889685|NCT02964325|157432140|FG000|Overall Study|Withdrawal by Subject|2|||
48889686|NCT02964325|157432141|FG001|Overall Study|Withdrawal by Subject|1|||
48889687|NCT02964325|157432140|FG000|Overall Study|Did not require PLT transfusion, had HLA positive|10|||
48889688|NCT02964325|157432141|FG001|Overall Study|Did not require PLT transfusion, had HLA positive|12|||
49036789|NCT03606174|157971151|FG009|Overall Study|Withdrawal by Subject|0|||
49036790|NCT03606174|157971152|FG010|Overall Study|Withdrawal by Subject|1|||
49036791|NCT03606174|157971142|FG000|Overall Study|Study Terminated by Sponsor|5|||
48889689|NCT01867333|157432142|FG000|Overall Study|Withdrawal by Subject|1|||
48889690|NCT01867333|157432143|FG001|Overall Study|Withdrawal by Subject|0|||
48889691|NCT01867333|157432142|FG000|Overall Study|Adverse Event|1|||
48889692|NCT01867333|157432143|FG001|Overall Study|Adverse Event|0|||
48889693|NCT01867333|157432142|FG000|Overall Study|Participant choice|1|||
48889694|NCT01867333|157432143|FG001|Overall Study|Participant choice|2|||
48889695|NCT01867333|157432142|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
48889696|NCT01867333|157432143|FG001|Overall Study|Complicating disease/intercurrent illness|0|||
48889697|NCT01867333|157432142|FG000|Overall Study|Death|0|||
48889698|NCT01867333|157432143|FG001|Overall Study|Death|1|||
48889699|NCT01867333|157432142|FG000|Overall Study|Physician Decision|3|||
49036792|NCT03606174|157971143|FG001|Overall Study|Study Terminated by Sponsor|7|||
48889700|NCT01867333|157432143|FG001|Overall Study|Physician Decision|2|||
48889701|NCT01867333|157432142|FG000|Overall Study|Switched to alternative treatment|1|||
48889702|NCT01867333|157432143|FG001|Overall Study|Switched to alternative treatment|0|||
48889703|NCT04075994|157432144|FG000|Overall Study|Withdrawal by Subject|8|||
48889704|NCT04075994|157432145|FG001|Overall Study|Withdrawal by Subject|9|||
48889705|NCT04075994|157432144|FG000|Overall Study|Adverse Event|2|||
48889706|NCT04075994|157432145|FG001|Overall Study|Adverse Event|2|||
48889707|NCT04075994|157432144|FG000|Overall Study|Investigator withdrew|3|||
48889708|NCT04075994|157432145|FG001|Overall Study|Investigator withdrew|1|||
48889709|NCT05330676|157432147|FG000|Overall Study|Inadequate imaging quality for final analysis|2|||
48889710|NCT05330676|157432148|FG001|Overall Study|Inadequate imaging quality for final analysis|9|||
48889711|NCT01305239|157432150|FG000|Overall Study|Adverse Event|22|||
48889712|NCT01305239|157432150|FG000|Overall Study|Exemestane taken prior to inclusion only|1|||
48889713|NCT01361594|157432153|FG000|Overall Study|Withdrawal by Subject|1|||
48889714|NCT01361594|157432154|FG001|Overall Study|Withdrawal by Subject|2|||
48889715|NCT03525392|157432165|FG000|Overall Study|Adverse Event|1|||
48889716|NCT03525392|157432166|FG001|Overall Study|Adverse Event|0|||
48889717|NCT03525392|157432167|FG002|Overall Study|Adverse Event|2|||
48889718|NCT03525392|157432168|FG003|Overall Study|Adverse Event|0|||
48889719|NCT03525392|157432169|FG004|Overall Study|Adverse Event|0|||
48889720|NCT03525392|157432165|FG000|Overall Study|Progressive disease|0|||
48889721|NCT03525392|157432166|FG001|Overall Study|Progressive disease|1|||
48889722|NCT03525392|157432167|FG002|Overall Study|Progressive disease|1|||
48889723|NCT03525392|157432168|FG003|Overall Study|Progressive disease|3|||
48889724|NCT03525392|157432169|FG004|Overall Study|Progressive disease|1|||
48889725|NCT02703259|157432174|FG000|24 Hours Postoperative Assessment|Lost to Follow-up|1|||
48889726|NCT02703259|157432175|FG001|24 Hours Postoperative Assessment|Lost to Follow-up|4|||
48889727|NCT02703259|157432174|FG000|24 Hours Postoperative Assessment|excluded from analysis per protocol|1|||
48889728|NCT02703259|157432175|FG001|24 Hours Postoperative Assessment|excluded from analysis per protocol|2|||
48889729|NCT02703259|157432174|FG000|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
48889730|NCT02703259|157432175|FG001|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
48889731|NCT01012414|157432176|FG000|Overall Study|Withdrawal by Subject|2|||
48889732|NCT01012414|157432176|FG000|Overall Study|Lost to Follow-up|1|||
48889733|NCT01012414|157432176|FG000|Overall Study|Trial was stopped before completed|7|||
48889734|NCT05917470|157432177|FG000|Overall Study|Progressive Disease|1|||
48889735|NCT05917470|157432178|FG001|Overall Study|Progressive Disease|1|||
48889736|NCT05917470|157432179|FG002|Overall Study|Progressive Disease|2|||
48889737|NCT05917470|157432180|FG003|Overall Study|Progressive Disease|3|||
48889738|NCT05917470|157432181|FG004|Overall Study|Progressive Disease|1|||
48889739|NCT05917470|157432182|FG005|Overall Study|Progressive Disease|1|||
48889740|NCT05917470|157432183|FG006|Overall Study|Progressive Disease|0|||
48889741|NCT05917470|157432184|FG007|Overall Study|Progressive Disease|0|||
48889742|NCT05917470|157432177|FG000|Overall Study|Withdrawal by Subject|0|||
48889743|NCT05917470|157432178|FG001|Overall Study|Withdrawal by Subject|0|||
48889744|NCT05917470|157432179|FG002|Overall Study|Withdrawal by Subject|1|||
48889745|NCT05917470|157432180|FG003|Overall Study|Withdrawal by Subject|0|||
48889746|NCT05917470|157432181|FG004|Overall Study|Withdrawal by Subject|0|||
48889747|NCT05917470|157432182|FG005|Overall Study|Withdrawal by Subject|0|||
48889748|NCT05917470|157432183|FG006|Overall Study|Withdrawal by Subject|0|||
48889749|NCT05917470|157432184|FG007|Overall Study|Withdrawal by Subject|0|||
48889750|NCT05917470|157432177|FG000|Overall Study|Sponsor Decision|0|||
48889751|NCT05917470|157432178|FG001|Overall Study|Sponsor Decision|0|||
48889752|NCT05917470|157432179|FG002|Overall Study|Sponsor Decision|1|||
48889753|NCT05917470|157432180|FG003|Overall Study|Sponsor Decision|0|||
48889754|NCT05917470|157432181|FG004|Overall Study|Sponsor Decision|2|||
48889755|NCT05917470|157432182|FG005|Overall Study|Sponsor Decision|1|||
48889756|NCT05917470|157432183|FG006|Overall Study|Sponsor Decision|3|||
48889757|NCT05917470|157432184|FG007|Overall Study|Sponsor Decision|3|||
48889758|NCT05917470|157432177|FG000|Overall Study|Adverse Event|0|||
48889759|NCT05917470|157432178|FG001|Overall Study|Adverse Event|0|||
48889760|NCT05917470|157432179|FG002|Overall Study|Adverse Event|0|||
48889761|NCT05917470|157432180|FG003|Overall Study|Adverse Event|0|||
48889762|NCT05917470|157432181|FG004|Overall Study|Adverse Event|0|||
48889763|NCT05917470|157432182|FG005|Overall Study|Adverse Event|1|||
48889764|NCT05917470|157432183|FG006|Overall Study|Adverse Event|0|||
48889765|NCT05917470|157432184|FG007|Overall Study|Adverse Event|0|||
48889766|NCT00316602|157434053|FG000|Overall Study|Withdrawal by Subject|3|||
48889767|NCT00316602|157434054|FG001|Overall Study|Withdrawal by Subject|2|||
48889768|NCT00316602|157434053|FG000|Overall Study|Subject unwilling/unable to comply with|3|||
48889769|NCT00316602|157434054|FG001|Overall Study|Subject unwilling/unable to comply with|17|||
48889770|NCT00316602|157434053|FG000|Overall Study|Adverse Event|1|||
48889771|NCT00316602|157434054|FG001|Overall Study|Adverse Event|0|||
48889772|NCT00316602|157434053|FG000|Overall Study|Other|3|||
48889773|NCT00316602|157434054|FG001|Overall Study|Other|6|||
48889774|NCT01008410|157434055|FG000|Overall Study|Adverse Event|13|||
48889775|NCT01008410|157434056|FG001|Overall Study|Adverse Event|7|||
48889776|NCT01008410|157434055|FG000|Overall Study|Withdrawal by Subject|6|||
48889777|NCT01008410|157434056|FG001|Overall Study|Withdrawal by Subject|2|||
48889778|NCT01008410|157434055|FG000|Overall Study|Lost to Follow-up|1|||
48889779|NCT01008410|157434056|FG001|Overall Study|Lost to Follow-up|0|||
48889780|NCT01008410|157434055|FG000|Overall Study|Noncompliance|1|||
48889781|NCT01008410|157434056|FG001|Overall Study|Noncompliance|0|||
48889782|NCT01008410|157434055|FG000|Overall Study|Low Cortisol|2|||
48889783|NCT01008410|157434056|FG001|Overall Study|Low Cortisol|0|||
48889784|NCT01008410|157434055|FG000|Overall Study|Lack of Efficacy|2|||
48889785|NCT01008410|157434056|FG001|Overall Study|Lack of Efficacy|6|||
48889786|NCT01008410|157434055|FG000|Overall Study|Met Exclusion Criterion|0|||
48889787|NCT01008410|157434056|FG001|Overall Study|Met Exclusion Criterion|1|||
48889788|NCT01302067|157434057|FG000|Overall Study|Death|0|||
48889789|NCT01302067|157434058|FG001|Overall Study|Death|0|||
48889790|NCT01302067|157434059|FG002|Overall Study|Death|1|||
48889791|NCT01302067|157434057|FG000|Overall Study|Physician Decision|9|||
48889792|NCT01302067|157434058|FG001|Overall Study|Physician Decision|5|||
48889793|NCT01302067|157434059|FG002|Overall Study|Physician Decision|14|||
48889794|NCT01302067|157434057|FG000|Overall Study|Lack of Efficacy|8|||
48889795|NCT01302067|157434058|FG001|Overall Study|Lack of Efficacy|4|||
48889796|NCT01302067|157434059|FG002|Overall Study|Lack of Efficacy|2|||
48889797|NCT01302067|157434057|FG000|Overall Study|Lost to Follow-up|9|||
48889798|NCT01302067|157434058|FG001|Overall Study|Lost to Follow-up|4|||
48889799|NCT01302067|157434059|FG002|Overall Study|Lost to Follow-up|15|||
48889800|NCT01302067|157434057|FG000|Overall Study|Withdrawal by Subject|13|||
48889801|NCT01302067|157434058|FG001|Overall Study|Withdrawal by Subject|6|||
48889802|NCT01302067|157434059|FG002|Overall Study|Withdrawal by Subject|10|||
48889803|NCT01302067|157434057|FG000|Overall Study|Other|1|||
48889804|NCT01302067|157434058|FG001|Overall Study|Other|1|||
48889805|NCT01302067|157434059|FG002|Overall Study|Other|3|||
48889806|NCT01302067|157434057|FG000|Overall Study|Protocol Violation|11|||
48889807|NCT01302067|157434058|FG001|Overall Study|Protocol Violation|0|||
48889808|NCT01302067|157434059|FG002|Overall Study|Protocol Violation|8|||
48889809|NCT01302067|157434057|FG000|Overall Study|Adverse Event|27|||
48889810|NCT01302067|157434058|FG001|Overall Study|Adverse Event|14|||
48889811|NCT01302067|157434059|FG002|Overall Study|Adverse Event|45|||
48889812|NCT02349425|157434060|FG000|Period 1|Adverse Event|1|||
48889813|NCT02349425|157434061|FG001|Period 1|Adverse Event|1|||
48889814|NCT02349425|157434062|FG002|Period 1|Adverse Event|0|||
48889815|NCT02349425|157434063|FG003|Period 1|Adverse Event|0|||
48889816|NCT02349425|157434060|FG000|Period 2|Adverse Event|0|||
48889817|NCT02349425|157434061|FG001|Period 2|Adverse Event|1|||
48889818|NCT02349425|157434062|FG002|Period 2|Adverse Event|1|||
48889819|NCT02349425|157434063|FG003|Period 2|Adverse Event|0|||
48889820|NCT01498887|157434064|FG000|Overall Study|Administrative problems|1|||
48889821|NCT01498887|157434065|FG001|Overall Study|Administrative problems|0|||
49036793|NCT03606174|157971144|FG002|Overall Study|Study Terminated by Sponsor|3|||
49036794|NCT03606174|157971145|FG003|Overall Study|Study Terminated by Sponsor|0|||
48889822|NCT01498887|157434064|FG000|Overall Study|Lost to Follow-up|1|||
48889823|NCT01498887|157434065|FG001|Overall Study|Lost to Follow-up|1|||
48889824|NCT01498887|157434064|FG000|Overall Study|Withdrawal by Subject|1|||
48889825|NCT01498887|157434065|FG001|Overall Study|Withdrawal by Subject|0|||
48889826|NCT01498887|157434064|FG000|Overall Study|Protocol Violation|1|||
48889827|NCT01498887|157434065|FG001|Overall Study|Protocol Violation|3|||
48889828|NCT01498887|157434064|FG000|Overall Study|Lack of Efficacy|5|||
48889829|NCT01498887|157434065|FG001|Overall Study|Lack of Efficacy|3|||
48889830|NCT01498887|157434064|FG000|Overall Study|Abnormal result from test procedure|1|||
48889831|NCT01498887|157434065|FG001|Overall Study|Abnormal result from test procedure|1|||
48889832|NCT01498887|157434064|FG000|Overall Study|Abnormal laboratory value|2|||
48889833|NCT01498887|157434065|FG001|Overall Study|Abnormal laboratory value|2|||
48889834|NCT01498887|157434064|FG000|Overall Study|Adverse Event|4|||
48889835|NCT01498887|157434065|FG001|Overall Study|Adverse Event|1|||
48889836|NCT02738203|157434066|FG000|Overall Study|Failed IUD Insertion|2|||
48889837|NCT02738203|157434067|FG001|Overall Study|Failed IUD Insertion|2|||
48889838|NCT02738203|157434066|FG000|Overall Study|Protocol Violation|0|||
48889839|NCT02738203|157434067|FG001|Overall Study|Protocol Violation|1|||
48889840|NCT00297427|157434068|FG000|Phase 1: Initial Intervention|Withdrawal by Subject|8|||
48889841|NCT00297427|157434069|FG001|Phase 1: Initial Intervention|Withdrawal by Subject|5|||
48889842|NCT00297427|157434068|FG000|Phase 1: Initial Intervention|Lost to Follow-up|0|||
48889843|NCT00297427|157434069|FG001|Phase 1: Initial Intervention|Lost to Follow-up|3|||
48889844|NCT00297427|157434068|FG000|Phase 1: Initial Intervention|Death|0|||
48889845|NCT00297427|157434069|FG001|Phase 1: Initial Intervention|Death|1|||
48889846|NCT00297427|157434068|FG000|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15|||
48889847|NCT00297427|157434069|FG001|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0|||
48889848|NCT00297427|157434068|FG000|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1|||
48889849|NCT00297427|157434069|FG001|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0|||
49036795|NCT03606174|157971146|FG004|Overall Study|Study Terminated by Sponsor|11|||
48889850|NCT00297427|157434068|FG000|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29|||
48889851|NCT00297427|157434069|FG001|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0|||
48889852|NCT00297427|157434068|FG000|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3|||
48889853|NCT00297427|157434069|FG001|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0|||
48889854|NCT00297427|157434068|FG000|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2|||
49036796|NCT03606174|157971147|FG005|Overall Study|Study Terminated by Sponsor|6|||
49036797|NCT03606174|157971148|FG006|Overall Study|Study Terminated by Sponsor|12|||
48889855|NCT00297427|157434069|FG001|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0|||
48889856|NCT03241927|157434071|FG000|Overall Study|study terminated|1|||
48889857|NCT03241927|157434072|FG001|Overall Study|study terminated|0|||
48889858|NCT03056300|157434073|FG000|Overall Study|Surgical reason per study protocol|3|||
48889859|NCT03563157|157434076|FG000|Overall Study|Progressive Disease|2|||
48889860|NCT03245151|157434077|FG000|Overall Study|Withdrawal by Subject|2|||
48889861|NCT03245151|157434078|FG001|Overall Study|Withdrawal by Subject|0|||
48889862|NCT03245151|157434079|FG002|Overall Study|Withdrawal by Subject|0|||
48889863|NCT03245151|157434080|FG003|Overall Study|Withdrawal by Subject|2|||
48889864|NCT03245151|157434081|FG004|Overall Study|Withdrawal by Subject|1|||
48889865|NCT03245151|157434077|FG000|Overall Study|Death|3|||
48889866|NCT03245151|157434078|FG001|Overall Study|Death|14|||
48889867|NCT03245151|157434079|FG002|Overall Study|Death|9|||
48889868|NCT03245151|157434080|FG003|Overall Study|Death|16|||
48889869|NCT03245151|157434081|FG004|Overall Study|Death|7|||
48889870|NCT03245151|157434077|FG000|Overall Study|Sponsor's decision|0|||
48889871|NCT03245151|157434078|FG001|Overall Study|Sponsor's decision|1|||
48889872|NCT03245151|157434079|FG002|Overall Study|Sponsor's decision|0|||
48889873|NCT03245151|157434080|FG003|Overall Study|Sponsor's decision|0|||
48889874|NCT03245151|157434081|FG004|Overall Study|Sponsor's decision|0|||
48889875|NCT02942277|157434084|FG000|Year 1|Withdrawal by Subject|0|||
48889876|NCT02942277|157434085|FG001|Year 1|Withdrawal by Subject|0|||
48889877|NCT02942277|157434086|FG002|Year 1|Withdrawal by Subject|0|||
48889878|NCT02942277|157434087|FG003|Year 1|Withdrawal by Subject|0|||
48889879|NCT02942277|157434088|FG004|Year 1|Withdrawal by Subject|1|||
48889880|NCT02942277|157434089|FG005|Year 1|Withdrawal by Subject|3|||
48889881|NCT02942277|157434090|FG006|Year 1|Withdrawal by Subject|0|||
48889882|NCT02942277|157434091|FG007|Year 1|Withdrawal by Subject|1|||
48889883|NCT02942277|157434092|FG008|Year 1|Withdrawal by Subject|0|||
48889884|NCT02942277|157434093|FG009|Year 1|Withdrawal by Subject|0|||
48889885|NCT02942277|157434094|FG010|Year 1|Withdrawal by Subject|3|||
48889886|NCT02942277|157434084|FG000|Year 1|Travel|0|||
48889887|NCT02942277|157434085|FG001|Year 1|Travel|1|||
48889888|NCT02942277|157434086|FG002|Year 1|Travel|0|||
48889889|NCT02942277|157434087|FG003|Year 1|Travel|0|||
48889890|NCT02942277|157434088|FG004|Year 1|Travel|4|||
48889891|NCT02942277|157434089|FG005|Year 1|Travel|5|||
48889892|NCT02942277|157434090|FG006|Year 1|Travel|0|||
48889893|NCT02942277|157434091|FG007|Year 1|Travel|0|||
48889894|NCT02942277|157434092|FG008|Year 1|Travel|0|||
48889895|NCT02942277|157434093|FG009|Year 1|Travel|0|||
48889896|NCT02942277|157434094|FG010|Year 1|Travel|8|||
48889897|NCT02942277|157434084|FG000|Year 1|Joined Army|0|||
48889898|NCT02942277|157434085|FG001|Year 1|Joined Army|1|||
48889899|NCT02942277|157434086|FG002|Year 1|Joined Army|0|||
48889900|NCT02942277|157434087|FG003|Year 1|Joined Army|0|||
48889901|NCT02942277|157434088|FG004|Year 1|Joined Army|0|||
48889902|NCT02942277|157434089|FG005|Year 1|Joined Army|0|||
48889903|NCT02942277|157434090|FG006|Year 1|Joined Army|0|||
48889904|NCT02942277|157434091|FG007|Year 1|Joined Army|0|||
48889905|NCT02942277|157434092|FG008|Year 1|Joined Army|0|||
48889906|NCT02942277|157434093|FG009|Year 1|Joined Army|0|||
48889907|NCT02942277|157434094|FG010|Year 1|Joined Army|0|||
48889908|NCT02942277|157434084|FG000|Year 1|Subject met withdrawal criteria|0|||
48889909|NCT02942277|157434085|FG001|Year 1|Subject met withdrawal criteria|0|||
48889910|NCT02942277|157434086|FG002|Year 1|Subject met withdrawal criteria|0|||
48889911|NCT02942277|157434087|FG003|Year 1|Subject met withdrawal criteria|1|||
48889912|NCT02942277|157434088|FG004|Year 1|Subject met withdrawal criteria|0|||
48889913|NCT02942277|157434089|FG005|Year 1|Subject met withdrawal criteria|0|||
48889914|NCT02942277|157434090|FG006|Year 1|Subject met withdrawal criteria|0|||
48889915|NCT02942277|157434091|FG007|Year 1|Subject met withdrawal criteria|0|||
48889916|NCT02942277|157434092|FG008|Year 1|Subject met withdrawal criteria|0|||
48889917|NCT02942277|157434093|FG009|Year 1|Subject met withdrawal criteria|0|||
48889918|NCT02942277|157434094|FG010|Year 1|Subject met withdrawal criteria|0|||
48889919|NCT02942277|157434084|FG000|Year 1|Lost to Follow-up|0|||
48889920|NCT02942277|157434085|FG001|Year 1|Lost to Follow-up|0|||
48889921|NCT02942277|157434086|FG002|Year 1|Lost to Follow-up|0|||
48889922|NCT02942277|157434087|FG003|Year 1|Lost to Follow-up|0|||
48889923|NCT02942277|157434088|FG004|Year 1|Lost to Follow-up|1|||
48889924|NCT02942277|157434089|FG005|Year 1|Lost to Follow-up|0|||
48889925|NCT02942277|157434090|FG006|Year 1|Lost to Follow-up|0|||
48889926|NCT02942277|157434091|FG007|Year 1|Lost to Follow-up|0|||
48889927|NCT02942277|157434092|FG008|Year 1|Lost to Follow-up|0|||
48889928|NCT02942277|157434093|FG009|Year 1|Lost to Follow-up|0|||
48889929|NCT02942277|157434094|FG010|Year 1|Lost to Follow-up|2|||
48889930|NCT02942277|157434084|FG000|Year 1|Protocol Violation|0|||
48889931|NCT02942277|157434085|FG001|Year 1|Protocol Violation|0|||
48889932|NCT02942277|157434086|FG002|Year 1|Protocol Violation|0|||
48889933|NCT02942277|157434087|FG003|Year 1|Protocol Violation|0|||
48889934|NCT02942277|157434088|FG004|Year 1|Protocol Violation|1|||
48889935|NCT02942277|157434089|FG005|Year 1|Protocol Violation|1|||
48889936|NCT02942277|157434090|FG006|Year 1|Protocol Violation|0|||
48889937|NCT02942277|157434091|FG007|Year 1|Protocol Violation|0|||
48889938|NCT02942277|157434092|FG008|Year 1|Protocol Violation|0|||
48889939|NCT02942277|157434093|FG009|Year 1|Protocol Violation|0|||
48889940|NCT02942277|157434094|FG010|Year 1|Protocol Violation|2|||
49036798|NCT03606174|157971149|FG007|Overall Study|Study Terminated by Sponsor|1|||
49036799|NCT03606174|157971150|FG008|Overall Study|Study Terminated by Sponsor|3|||
49036800|NCT03606174|157971151|FG009|Overall Study|Study Terminated by Sponsor|1|||
49036801|NCT03606174|157971152|FG010|Overall Study|Study Terminated by Sponsor|2|||
49036802|NCT03606174|157971142|FG000|Overall Study|Miscellaneous|1|||
49036803|NCT03606174|157971143|FG001|Overall Study|Miscellaneous|1|||
49036804|NCT03606174|157971144|FG002|Overall Study|Miscellaneous|0|||
49036805|NCT03606174|157971145|FG003|Overall Study|Miscellaneous|1|||
49036806|NCT03606174|157971146|FG004|Overall Study|Miscellaneous|4|||
49036807|NCT03606174|157971147|FG005|Overall Study|Miscellaneous|7|||
49036808|NCT03606174|157971148|FG006|Overall Study|Miscellaneous|5|||
49036809|NCT03606174|157971149|FG007|Overall Study|Miscellaneous|0|||
49036810|NCT03606174|157971150|FG008|Overall Study|Miscellaneous|0|||
49036811|NCT03606174|157971151|FG009|Overall Study|Miscellaneous|0|||
49036812|NCT03606174|157971152|FG010|Overall Study|Miscellaneous|1|||
49036813|NCT00859521|157971153|FG000|Washout|Withdrawal by Subject|0|||
49036814|NCT00859521|157971154|FG001|Washout|Withdrawal by Subject|1|||
49036815|NCT01609257|157971158|FG000|Overall Study|Lost to Follow-up|2|||
49036816|NCT01609257|157971159|FG001|Overall Study|Lost to Follow-up|1|||
49036817|NCT01609257|157971158|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
49036818|NCT01609257|157971159|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
49036819|NCT01609257|157971158|FG000|Overall Study|Non-compliance/Protocol deviation|4|||
49036820|NCT01609257|157971159|FG001|Overall Study|Non-compliance/Protocol deviation|6|||
49036821|NCT04639219|157971160|FG000|Overall Study|Withdrawal by Subject|8|||
49036822|NCT04639219|157971160|FG000|Overall Study|Lost to Follow-up|6|||
49036823|NCT04639219|157971160|FG000|Overall Study|Death|55|||
49036824|NCT00777023|157971161|FG000|Overall Study|Adverse Event|15|||
49036825|NCT00777023|157971162|FG001|Overall Study|Adverse Event|21|||
49036826|NCT00777023|157971163|FG002|Overall Study|Adverse Event|8|||
49036827|NCT00777023|157971161|FG000|Overall Study|Lack of Efficacy|1|||
49036828|NCT00777023|157971162|FG001|Overall Study|Lack of Efficacy|0|||
49036829|NCT00777023|157971163|FG002|Overall Study|Lack of Efficacy|14|||
49036830|NCT00777023|157971161|FG000|Overall Study|Protocol Violation|2|||
49036831|NCT00777023|157971162|FG001|Overall Study|Protocol Violation|1|||
49036832|NCT00777023|157971163|FG002|Overall Study|Protocol Violation|1|||
49036833|NCT00777023|157971161|FG000|Overall Study|Lost to Follow-up|2|||
49036834|NCT00777023|157971162|FG001|Overall Study|Lost to Follow-up|3|||
49036835|NCT00777023|157971163|FG002|Overall Study|Lost to Follow-up|3|||
49036836|NCT00777023|157971161|FG000|Overall Study|Death|0|||
49036837|NCT00777023|157971162|FG001|Overall Study|Death|1|||
49036838|NCT00777023|157971163|FG002|Overall Study|Death|0|||
49036839|NCT00777023|157971161|FG000|Overall Study|Withdrawal by Subject|7|||
49036840|NCT00777023|157971162|FG001|Overall Study|Withdrawal by Subject|7|||
49036841|NCT00777023|157971163|FG002|Overall Study|Withdrawal by Subject|8|||
49036842|NCT00777023|157971161|FG000|Overall Study|Missing data|1|||
49036843|NCT00777023|157971162|FG001|Overall Study|Missing data|1|||
49036844|NCT00777023|157971163|FG002|Overall Study|Missing data|0|||
49036845|NCT00777023|157971161|FG000|Overall Study|Reasons not specified|4|||
49036846|NCT00777023|157971162|FG001|Overall Study|Reasons not specified|4|||
49036847|NCT00777023|157971163|FG002|Overall Study|Reasons not specified|2|||
49036848|NCT00777023|157971161|FG000|Overall Study|Last dose date unknown|3|||
49036849|NCT00777023|157971162|FG001|Overall Study|Last dose date unknown|3|||
49036850|NCT00777023|157971163|FG002|Overall Study|Last dose date unknown|1|||
49036851|NCT03049748|157971170|FG000|Overall Study|Lost to Follow-up|1|||
48889941|NCT02942277|157434084|FG000|Year 1|Pregnancy|0|||
48889942|NCT02942277|157434085|FG001|Year 1|Pregnancy|0|||
49036852|NCT03049748|157971171|FG001|Overall Study|Lost to Follow-up|0|||
49036853|NCT03049748|157971170|FG000|Overall Study|Death|3|||
49036854|NCT03049748|157971171|FG001|Overall Study|Death|0|||
49036855|NCT03049748|157971170|FG000|Overall Study|Withdrawal by Subject|0|||
49036856|NCT03049748|157971171|FG001|Overall Study|Withdrawal by Subject|3|||
49036857|NCT03049748|157971170|FG000|Overall Study|Protocol Violation|0|||
48889943|NCT02942277|157434086|FG002|Year 1|Pregnancy|0|||
48889944|NCT02942277|157434087|FG003|Year 1|Pregnancy|0|||
49036858|NCT03049748|157971171|FG001|Overall Study|Protocol Violation|2|||
49036859|NCT03049748|157971170|FG000|Overall Study|Moved out of state (relocation)|0|||
49036860|NCT03049748|157971171|FG001|Overall Study|Moved out of state (relocation)|1|||
49036861|NCT01547286|157971172|FG000|Overall Study|Did not meet all eligibility criteria|1|||
48889945|NCT02942277|157434088|FG004|Year 1|Pregnancy|0|||
49036862|NCT01547286|157971172|FG000|Overall Study|Physician Decision|1|||
49036863|NCT03415308|157971173|FG000|Overall Study|Lost to Follow-up|0|||
48889946|NCT02942277|157434089|FG005|Year 1|Pregnancy|1|||
48889947|NCT02942277|157434090|FG006|Year 1|Pregnancy|0|||
48889948|NCT02942277|157434091|FG007|Year 1|Pregnancy|0|||
49036864|NCT03415308|157971174|FG001|Overall Study|Lost to Follow-up|0|||
48889949|NCT02942277|157434092|FG008|Year 1|Pregnancy|0|||
48889950|NCT02942277|157434093|FG009|Year 1|Pregnancy|0|||
48889951|NCT02942277|157434094|FG010|Year 1|Pregnancy|0|||
48889952|NCT02942277|157434084|FG000|Year 2|Lost to Follow-up|0|||
48889953|NCT02942277|157434085|FG001|Year 2|Lost to Follow-up|0|||
48889954|NCT02942277|157434086|FG002|Year 2|Lost to Follow-up|0|||
48889955|NCT02942277|157434087|FG003|Year 2|Lost to Follow-up|0|||
48889956|NCT02942277|157434088|FG004|Year 2|Lost to Follow-up|2|||
48889957|NCT02942277|157434089|FG005|Year 2|Lost to Follow-up|1|||
48889958|NCT02942277|157434090|FG006|Year 2|Lost to Follow-up|0|||
48889959|NCT02942277|157434091|FG007|Year 2|Lost to Follow-up|0|||
48889960|NCT02942277|157434092|FG008|Year 2|Lost to Follow-up|0|||
48889961|NCT02942277|157434093|FG009|Year 2|Lost to Follow-up|0|||
48889962|NCT02942277|157434094|FG010|Year 2|Lost to Follow-up|0|||
48889963|NCT02942277|157434084|FG000|Year 2|Did not rescreen|0|||
48889964|NCT02942277|157434085|FG001|Year 2|Did not rescreen|0|||
48889965|NCT02942277|157434086|FG002|Year 2|Did not rescreen|1|||
48889966|NCT02942277|157434087|FG003|Year 2|Did not rescreen|1|||
48889967|NCT02942277|157434088|FG004|Year 2|Did not rescreen|9|||
48889968|NCT02942277|157434089|FG005|Year 2|Did not rescreen|6|||
48889969|NCT02942277|157434090|FG006|Year 2|Did not rescreen|0|||
48889970|NCT02942277|157434091|FG007|Year 2|Did not rescreen|1|||
48889971|NCT02942277|157434092|FG008|Year 2|Did not rescreen|0|||
48889972|NCT02942277|157434093|FG009|Year 2|Did not rescreen|0|||
48889973|NCT02942277|157434094|FG010|Year 2|Did not rescreen|21|||
48889974|NCT02942277|157434084|FG000|Year 2|Met withdrawal criteria|0|||
48889975|NCT02942277|157434085|FG001|Year 2|Met withdrawal criteria|0|||
48889976|NCT02942277|157434086|FG002|Year 2|Met withdrawal criteria|0|||
48889977|NCT02942277|157434087|FG003|Year 2|Met withdrawal criteria|0|||
48889978|NCT02942277|157434088|FG004|Year 2|Met withdrawal criteria|1|||
48889979|NCT02942277|157434089|FG005|Year 2|Met withdrawal criteria|2|||
48889980|NCT02942277|157434090|FG006|Year 2|Met withdrawal criteria|0|||
48889981|NCT02942277|157434091|FG007|Year 2|Met withdrawal criteria|0|||
48889982|NCT02942277|157434092|FG008|Year 2|Met withdrawal criteria|0|||
48889983|NCT02942277|157434093|FG009|Year 2|Met withdrawal criteria|0|||
48889984|NCT02942277|157434094|FG010|Year 2|Met withdrawal criteria|1|||
48889985|NCT02942277|157434084|FG000|Year 2|Travel|0|||
48889986|NCT02942277|157434085|FG001|Year 2|Travel|1|||
48889987|NCT02942277|157434086|FG002|Year 2|Travel|0|||
48889988|NCT02942277|157434087|FG003|Year 2|Travel|0|||
48889989|NCT02942277|157434088|FG004|Year 2|Travel|0|||
48889990|NCT02942277|157434089|FG005|Year 2|Travel|1|||
48889991|NCT02942277|157434090|FG006|Year 2|Travel|0|||
48889992|NCT02942277|157434091|FG007|Year 2|Travel|0|||
48889993|NCT02942277|157434092|FG008|Year 2|Travel|0|||
48889994|NCT02942277|157434093|FG009|Year 2|Travel|1|||
48889995|NCT02942277|157434094|FG010|Year 2|Travel|3|||
48889996|NCT02942277|157434084|FG000|Year 2|Non-compliant|0|||
48889997|NCT02942277|157434085|FG001|Year 2|Non-compliant|0|||
48889998|NCT02942277|157434086|FG002|Year 2|Non-compliant|0|||
48889999|NCT02942277|157434087|FG003|Year 2|Non-compliant|0|||
48890000|NCT02942277|157434088|FG004|Year 2|Non-compliant|1|||
48890001|NCT02942277|157434089|FG005|Year 2|Non-compliant|1|||
48890002|NCT02942277|157434090|FG006|Year 2|Non-compliant|0|||
48890003|NCT02942277|157434091|FG007|Year 2|Non-compliant|0|||
48890004|NCT02942277|157434092|FG008|Year 2|Non-compliant|0|||
48890005|NCT02942277|157434093|FG009|Year 2|Non-compliant|0|||
48890006|NCT02942277|157434094|FG010|Year 2|Non-compliant|0|||
48890007|NCT02942277|157434084|FG000|Year 2|Withdrawal by Subject|0|||
48890008|NCT02942277|157434085|FG001|Year 2|Withdrawal by Subject|0|||
48890009|NCT02942277|157434086|FG002|Year 2|Withdrawal by Subject|0|||
48890010|NCT02942277|157434087|FG003|Year 2|Withdrawal by Subject|0|||
48890011|NCT02942277|157434088|FG004|Year 2|Withdrawal by Subject|0|||
48890012|NCT02942277|157434089|FG005|Year 2|Withdrawal by Subject|0|||
48890013|NCT02942277|157434090|FG006|Year 2|Withdrawal by Subject|1|||
48890014|NCT02942277|157434091|FG007|Year 2|Withdrawal by Subject|0|||
48890015|NCT02942277|157434092|FG008|Year 2|Withdrawal by Subject|0|||
48890016|NCT02942277|157434093|FG009|Year 2|Withdrawal by Subject|0|||
48890017|NCT02942277|157434094|FG010|Year 2|Withdrawal by Subject|0|||
48890018|NCT00836745|157434097|FG000|Overall Study|Death|2|||
48890019|NCT00836745|157434097|FG000|Overall Study|Lost to Follow-up|10|||
48890020|NCT00836745|157434097|FG000|Overall Study|Adverse Event|3|||
48890021|NCT00836745|157434097|FG000|Overall Study|Objective progression or relapse|4|||
48890022|NCT00836745|157434097|FG000|Overall Study|Other|2|||
48890023|NCT05096221|157434103|FG000|Part 2|Ongoing in Part 2 of the Study|63|||
48890024|NCT05096221|157434104|FG001|Part 2|Ongoing in Part 2 of the Study|62|||
48890025|NCT01669577|157434105|FG000|Overall Study|Death|22|||
48890026|NCT01669577|157434105|FG000|Overall Study|Lost to Follow-up|78|||
48890027|NCT01669577|157434105|FG000|Overall Study|Physician Decision|34|||
48890028|NCT01769326|157434106|FG000|Overall Study|Lost to Follow-up|1|||
48890029|NCT01769326|157434107|FG001|Overall Study|Lost to Follow-up|2|||
48890030|NCT01769326|157434108|FG002|Overall Study|Lost to Follow-up|0|||
48890031|NCT01769326|157434109|FG003|Overall Study|Lost to Follow-up|0|||
48890032|NCT01769326|157434106|FG000|Overall Study|unrelated injry|1|||
48890033|NCT01769326|157434107|FG001|Overall Study|unrelated injry|1|||
48890034|NCT01769326|157434108|FG002|Overall Study|unrelated injry|0|||
48890035|NCT01769326|157434109|FG003|Overall Study|unrelated injry|0|||
48890036|NCT01769326|157434106|FG000|Overall Study|got a job|0|||
48890037|NCT01769326|157434107|FG001|Overall Study|got a job|1|||
48890038|NCT01769326|157434108|FG002|Overall Study|got a job|0|||
48890039|NCT01769326|157434109|FG003|Overall Study|got a job|0|||
48890040|NCT01769326|157434106|FG000|Overall Study|Got sick and could not complete study|0|||
48890041|NCT01769326|157434107|FG001|Overall Study|Got sick and could not complete study|0|||
48890042|NCT01769326|157434108|FG002|Overall Study|Got sick and could not complete study|1|||
49036865|NCT03415308|157971175|FG002|Overall Study|Lost to Follow-up|1|||
49036866|NCT03415308|157971173|FG000|Overall Study|Scheduling Conflicts|0|||
48890043|NCT01769326|157434109|FG003|Overall Study|Got sick and could not complete study|0|||
48890044|NCT02546921|157434112|FG000|Overall Study|Adverse Event|0|||
48890045|NCT02546921|157434113|FG001|Overall Study|Adverse Event|5|||
48890046|NCT02546921|157434114|FG002|Overall Study|Adverse Event|2|||
48890047|NCT02546921|157434115|FG003|Overall Study|Adverse Event|0|||
48890048|NCT02546921|157434116|FG004|Overall Study|Adverse Event|0|||
48890049|NCT02546921|157434117|FG005|Overall Study|Adverse Event|0|||
48890050|NCT02546921|157434118|FG006|Overall Study|Adverse Event|0|||
48890051|NCT02546921|157434112|FG000|Overall Study|Evidence of Disease Progression|1|||
48890052|NCT02546921|157434113|FG001|Overall Study|Evidence of Disease Progression|0|||
48890053|NCT02546921|157434114|FG002|Overall Study|Evidence of Disease Progression|0|||
48890054|NCT02546921|157434115|FG003|Overall Study|Evidence of Disease Progression|0|||
48890055|NCT02546921|157434116|FG004|Overall Study|Evidence of Disease Progression|1|||
48890056|NCT02546921|157434117|FG005|Overall Study|Evidence of Disease Progression|0|||
48890057|NCT02546921|157434118|FG006|Overall Study|Evidence of Disease Progression|0|||
48890058|NCT02546921|157434112|FG000|Overall Study|Patient Choice|0|||
48890059|NCT02546921|157434113|FG001|Overall Study|Patient Choice|1|||
48890060|NCT02546921|157434114|FG002|Overall Study|Patient Choice|0|||
48890061|NCT02546921|157434115|FG003|Overall Study|Patient Choice|0|||
48890062|NCT02546921|157434116|FG004|Overall Study|Patient Choice|0|||
48890063|NCT02546921|157434117|FG005|Overall Study|Patient Choice|1|||
48890064|NCT02546921|157434118|FG006|Overall Study|Patient Choice|0|||
48890065|NCT02091206|157434119|FG000|Treatment Period|Adverse Event|0|||
48890066|NCT02091206|157434120|FG001|Treatment Period|Adverse Event|1|||
48890067|NCT02091206|157434121|FG002|Treatment Period|Adverse Event|0|||
48890068|NCT02091206|157434122|FG003|Treatment Period|Adverse Event|0|||
48890069|NCT02091206|157434119|FG000|Treatment Period|Met withdrawal criteria|0|||
48890070|NCT02091206|157434120|FG001|Treatment Period|Met withdrawal criteria|0|||
48890071|NCT02091206|157434121|FG002|Treatment Period|Met withdrawal criteria|1|||
48890072|NCT02091206|157434122|FG003|Treatment Period|Met withdrawal criteria|0|||
48890073|NCT02091206|157434119|FG000|Taper Period|Participant refused study drug|1|||
48890074|NCT02091206|157434120|FG001|Taper Period|Participant refused study drug|0|||
48890075|NCT02091206|157434121|FG002|Taper Period|Participant refused study drug|0|||
48890076|NCT02091206|157434122|FG003|Taper Period|Participant refused study drug|1|||
48890077|NCT02091206|157434119|FG000|Taper Period|Lost to Follow-up|0|||
48890078|NCT02091206|157434120|FG001|Taper Period|Lost to Follow-up|0|||
48890079|NCT02091206|157434121|FG002|Taper Period|Lost to Follow-up|0|||
48890080|NCT02091206|157434122|FG003|Taper Period|Lost to Follow-up|1|||
48890081|NCT03538301|157434123|FG000|Overall Study|Adverse Event|1|||
49036867|NCT03415308|157971174|FG001|Overall Study|Scheduling Conflicts|0|||
49036868|NCT03415308|157971175|FG002|Overall Study|Scheduling Conflicts|7|||
49036869|NCT03307343|157971176|FG000|Overall Study|Withdrawal by Subject|1|||
49036870|NCT03307343|157971177|FG001|Overall Study|Withdrawal by Subject|2|||
49036871|NCT03307343|157971176|FG000|Overall Study|Pregnancy|0|||
49036872|NCT03307343|157971177|FG001|Overall Study|Pregnancy|2|||
49036873|NCT03307343|157971176|FG000|Overall Study|Physician Decision|1|||
49036874|NCT03307343|157971177|FG001|Overall Study|Physician Decision|0|||
49036875|NCT03307343|157971176|FG000|Overall Study|Lost to Follow-up|0|||
48890082|NCT03538301|157434124|FG001|Overall Study|Adverse Event|4|||
48890083|NCT03538301|157434125|FG002|Overall Study|Adverse Event|4|||
48890084|NCT03538301|157434123|FG000|Overall Study|Death|1|||
48890085|NCT03538301|157434124|FG001|Overall Study|Death|1|||
48890086|NCT03538301|157434125|FG002|Overall Study|Death|0|||
48890087|NCT03538301|157434123|FG000|Overall Study|Physician Decision|0|||
48890088|NCT03538301|157434124|FG001|Overall Study|Physician Decision|1|||
48890089|NCT03538301|157434125|FG002|Overall Study|Physician Decision|0|||
48890090|NCT03538301|157434123|FG000|Overall Study|Protocol Violation|0|||
48890091|NCT03538301|157434124|FG001|Overall Study|Protocol Violation|0|||
48890092|NCT03538301|157434125|FG002|Overall Study|Protocol Violation|1|||
48890093|NCT03538301|157434123|FG000|Overall Study|Terminated Early from the Study due to COVID-19 Impact|9|||
48890094|NCT03538301|157434124|FG001|Overall Study|Terminated Early from the Study due to COVID-19 Impact|6|||
48890095|NCT03538301|157434125|FG002|Overall Study|Terminated Early from the Study due to COVID-19 Impact|7|||
49036876|NCT03307343|157971177|FG001|Overall Study|Lost to Follow-up|2|||
49036877|NCT01471353|157971183|FG000|Overall Study|remain on study|3|||
48890096|NCT00350103|157434130|FG000|Overall Study|Adverse Event|12|||
48890097|NCT00350103|157434131|FG001|Overall Study|Adverse Event|29|||
48890098|NCT00350103|157434132|FG002|Overall Study|Adverse Event|17|||
48890099|NCT00350103|157434130|FG000|Overall Study|Lack of Efficacy|5|||
48890100|NCT00350103|157434131|FG001|Overall Study|Lack of Efficacy|1|||
48890101|NCT00350103|157434132|FG002|Overall Study|Lack of Efficacy|3|||
48890102|NCT00350103|157434130|FG000|Overall Study|Withdrawal by Subject|6|||
48890103|NCT00350103|157434131|FG001|Overall Study|Withdrawal by Subject|6|||
48890104|NCT00350103|157434132|FG002|Overall Study|Withdrawal by Subject|8|||
48890105|NCT00350103|157434130|FG000|Overall Study|Protocol Violation|0|||
48890106|NCT00350103|157434131|FG001|Overall Study|Protocol Violation|0|||
48890107|NCT00350103|157434132|FG002|Overall Study|Protocol Violation|1|||
48890108|NCT00350103|157434130|FG000|Overall Study|Unsatisfactory Compliance|2|||
48890109|NCT00350103|157434131|FG001|Overall Study|Unsatisfactory Compliance|2|||
48890110|NCT00350103|157434132|FG002|Overall Study|Unsatisfactory Compliance|1|||
48890111|NCT00350103|157434130|FG000|Overall Study|Investigator´s decision|1|||
48890112|NCT00350103|157434131|FG001|Overall Study|Investigator´s decision|1|||
48890113|NCT00350103|157434132|FG002|Overall Study|Investigator´s decision|0|||
48890114|NCT00350103|157434130|FG000|Overall Study|Exclusion criteria met|0|||
48890115|NCT00350103|157434131|FG001|Overall Study|Exclusion criteria met|0|||
48890116|NCT00350103|157434132|FG002|Overall Study|Exclusion criteria met|1|||
48890117|NCT00350103|157434130|FG000|Overall Study|Patient relocated|0|||
48890118|NCT00350103|157434131|FG001|Overall Study|Patient relocated|0|||
48890119|NCT00350103|157434132|FG002|Overall Study|Patient relocated|1|||
48890120|NCT00350103|157434130|FG000|Overall Study|Need for prohibited medication|1|||
48890121|NCT00350103|157434131|FG001|Overall Study|Need for prohibited medication|0|||
48890122|NCT00350103|157434132|FG002|Overall Study|Need for prohibited medication|0|||
48890123|NCT00350103|157434130|FG000|Overall Study|Personal reasons|0|||
48890124|NCT00350103|157434131|FG001|Overall Study|Personal reasons|0|||
48890125|NCT00350103|157434132|FG002|Overall Study|Personal reasons|1|||
48890126|NCT00350103|157434130|FG000|Overall Study|Patient stopped feeling pain|1|||
48890127|NCT00350103|157434131|FG001|Overall Study|Patient stopped feeling pain|0|||
48890128|NCT00350103|157434132|FG002|Overall Study|Patient stopped feeling pain|0|||
48890129|NCT00350103|157434130|FG000|Overall Study|PR greater than 250ms|0|||
48890130|NCT00350103|157434131|FG001|Overall Study|PR greater than 250ms|0|||
48890131|NCT00350103|157434132|FG002|Overall Study|PR greater than 250ms|1|||
48890132|NCT00350103|157434130|FG000|Overall Study|Wrong calculation of QT interval|0|||
48890133|NCT00350103|157434131|FG001|Overall Study|Wrong calculation of QT interval|0|||
48890134|NCT00350103|157434132|FG002|Overall Study|Wrong calculation of QT interval|1|||
48890135|NCT00350103|157434130|FG000|Overall Study|Sponsor mistake|1|||
48890136|NCT00350103|157434131|FG001|Overall Study|Sponsor mistake|0|||
48890137|NCT00350103|157434132|FG002|Overall Study|Sponsor mistake|0|||
48890138|NCT00350103|157434130|FG000|Overall Study|Randomization mistake|0|||
48890139|NCT00350103|157434131|FG001|Overall Study|Randomization mistake|1|||
48890140|NCT00350103|157434132|FG002|Overall Study|Randomization mistake|1|||
48890141|NCT00350103|157434130|FG000|Overall Study|Sponsor´s decision|0|||
48890142|NCT00350103|157434131|FG001|Overall Study|Sponsor´s decision|1|||
48890143|NCT00350103|157434132|FG002|Overall Study|Sponsor´s decision|0|||
48890144|NCT00350103|157434130|FG000|Overall Study|Lost, Reason unknown|1|||
48890145|NCT00350103|157434131|FG001|Overall Study|Lost, Reason unknown|1|||
48890146|NCT00350103|157434132|FG002|Overall Study|Lost, Reason unknown|0|||
48890147|NCT02842151|157434133|FG000|Overall Study|Adverse Event|1|||
48890148|NCT02842151|157434133|FG000|Overall Study|Subject moved too far away|1|||
48890149|NCT02559895|157434134|FG000|Overall Study|Adverse Event|3|||
48890150|NCT02559895|157434135|FG001|Overall Study|Adverse Event|3|||
48890151|NCT02559895|157434136|FG002|Overall Study|Adverse Event|2|||
48890152|NCT02559895|157434137|FG003|Overall Study|Adverse Event|1|||
48890153|NCT02559895|157434134|FG000|Overall Study|Lack of Efficacy|2|||
48890154|NCT02559895|157434135|FG001|Overall Study|Lack of Efficacy|3|||
48890155|NCT02559895|157434136|FG002|Overall Study|Lack of Efficacy|2|||
48890156|NCT02559895|157434137|FG003|Overall Study|Lack of Efficacy|8|||
48890157|NCT02559895|157434134|FG000|Overall Study|Lost to Follow-up|22|||
48890158|NCT02559895|157434135|FG001|Overall Study|Lost to Follow-up|16|||
48890159|NCT02559895|157434136|FG002|Overall Study|Lost to Follow-up|12|||
48890160|NCT02559895|157434137|FG003|Overall Study|Lost to Follow-up|17|||
48890161|NCT02559895|157434134|FG000|Overall Study|Physician Decision|1|||
48890162|NCT02559895|157434135|FG001|Overall Study|Physician Decision|1|||
48890163|NCT02559895|157434136|FG002|Overall Study|Physician Decision|3|||
48890164|NCT02559895|157434137|FG003|Overall Study|Physician Decision|0|||
48890165|NCT02559895|157434134|FG000|Overall Study|Withdrawal by Subject|16|||
48890166|NCT02559895|157434135|FG001|Overall Study|Withdrawal by Subject|9|||
48890167|NCT02559895|157434136|FG002|Overall Study|Withdrawal by Subject|20|||
48890168|NCT02559895|157434137|FG003|Overall Study|Withdrawal by Subject|9|||
48890169|NCT02559895|157434134|FG000|Overall Study|Study Burden|10|||
48983950|NCT01225211|157772407|FG008|Overall Study|Adverse Event|0|||
48890170|NCT02559895|157434135|FG001|Overall Study|Study Burden|16|||
48890171|NCT02559895|157434136|FG002|Overall Study|Study Burden|12|||
48890172|NCT02559895|157434137|FG003|Overall Study|Study Burden|22|||
48890173|NCT02559895|157434134|FG000|Overall Study|Other|1|||
48890174|NCT02559895|157434135|FG001|Overall Study|Other|5|||
48890175|NCT02559895|157434136|FG002|Overall Study|Other|3|||
48890176|NCT02559895|157434137|FG003|Overall Study|Other|3|||
48890177|NCT02712905|157434138|FG000|Monotherapy|Death|2|||
48890178|NCT02712905|157434139|FG001|Monotherapy|Death|5|||
48890179|NCT02712905|157434140|FG002|Monotherapy|Death|0|||
48890180|NCT02712905|157434141|FG003|Monotherapy|Death|3|||
48890181|NCT02712905|157434142|FG004|Monotherapy|Death|15|||
48890182|NCT02712905|157434143|FG005|Monotherapy|Death|1|||
48890183|NCT02712905|157434144|FG006|Monotherapy|Death|3|||
48890184|NCT02712905|157434145|FG007|Monotherapy|Death|3|||
48890185|NCT02712905|157434146|FG008|Monotherapy|Death|0|||
48890186|NCT02712905|157434147|FG009|Monotherapy|Death|27|||
48890187|NCT02712905|157434148|FG010|Monotherapy|Death|2|||
48890188|NCT02712905|157434149|FG011|Monotherapy|Death|5|||
48890189|NCT02712905|157434150|FG012|Monotherapy|Death|0|||
48890190|NCT02712905|157434151|FG013|Monotherapy|Death|0|||
48890191|NCT02712905|157434152|FG014|Monotherapy|Death|0|||
48890192|NCT02712905|157434153|FG015|Monotherapy|Death|0|||
48890193|NCT02712905|157434154|FG016|Monotherapy|Death|0|||
48890194|NCT02712905|157434155|FG017|Monotherapy|Death|0|||
48890195|NCT02712905|157434138|FG000|Monotherapy|Lost to Follow-up|0|||
48890196|NCT02712905|157434139|FG001|Monotherapy|Lost to Follow-up|1|||
48890197|NCT02712905|157434140|FG002|Monotherapy|Lost to Follow-up|0|||
48890198|NCT02712905|157434141|FG003|Monotherapy|Lost to Follow-up|1|||
48890199|NCT02712905|157434142|FG004|Monotherapy|Lost to Follow-up|0|||
48890200|NCT02712905|157434143|FG005|Monotherapy|Lost to Follow-up|0|||
48890201|NCT02712905|157434144|FG006|Monotherapy|Lost to Follow-up|0|||
48890202|NCT02712905|157434145|FG007|Monotherapy|Lost to Follow-up|0|||
48890203|NCT02712905|157434146|FG008|Monotherapy|Lost to Follow-up|0|||
48890204|NCT02712905|157434147|FG009|Monotherapy|Lost to Follow-up|2|||
48890205|NCT02712905|157434148|FG010|Monotherapy|Lost to Follow-up|0|||
48890206|NCT02712905|157434149|FG011|Monotherapy|Lost to Follow-up|0|||
48890207|NCT02712905|157434150|FG012|Monotherapy|Lost to Follow-up|0|||
48890208|NCT02712905|157434151|FG013|Monotherapy|Lost to Follow-up|0|||
48890209|NCT02712905|157434152|FG014|Monotherapy|Lost to Follow-up|0|||
48890210|NCT02712905|157434153|FG015|Monotherapy|Lost to Follow-up|0|||
48890211|NCT02712905|157434154|FG016|Monotherapy|Lost to Follow-up|0|||
48890212|NCT02712905|157434155|FG017|Monotherapy|Lost to Follow-up|0|||
48890213|NCT02712905|157434138|FG000|Monotherapy|Physician Decision|1|||
48890214|NCT02712905|157434139|FG001|Monotherapy|Physician Decision|0|||
48890215|NCT02712905|157434140|FG002|Monotherapy|Physician Decision|0|||
48890216|NCT02712905|157434141|FG003|Monotherapy|Physician Decision|1|||
48890217|NCT02712905|157434142|FG004|Monotherapy|Physician Decision|0|||
48890218|NCT02712905|157434143|FG005|Monotherapy|Physician Decision|0|||
48890219|NCT02712905|157434144|FG006|Monotherapy|Physician Decision|0|||
48890220|NCT02712905|157434145|FG007|Monotherapy|Physician Decision|0|||
48890221|NCT02712905|157434146|FG008|Monotherapy|Physician Decision|0|||
48890222|NCT02712905|157434147|FG009|Monotherapy|Physician Decision|1|||
48890223|NCT02712905|157434148|FG010|Monotherapy|Physician Decision|0|||
48890224|NCT02712905|157434149|FG011|Monotherapy|Physician Decision|0|||
48890225|NCT02712905|157434150|FG012|Monotherapy|Physician Decision|0|||
48890226|NCT02712905|157434151|FG013|Monotherapy|Physician Decision|0|||
48890227|NCT02712905|157434152|FG014|Monotherapy|Physician Decision|0|||
48890228|NCT02712905|157434153|FG015|Monotherapy|Physician Decision|0|||
48890229|NCT02712905|157434154|FG016|Monotherapy|Physician Decision|0|||
48890230|NCT02712905|157434155|FG017|Monotherapy|Physician Decision|0|||
48890231|NCT02712905|157434138|FG000|Monotherapy|Study Terminated by Sponsor|0|||
48890232|NCT02712905|157434139|FG001|Monotherapy|Study Terminated by Sponsor|0|||
48890233|NCT02712905|157434140|FG002|Monotherapy|Study Terminated by Sponsor|0|||
48890234|NCT02712905|157434141|FG003|Monotherapy|Study Terminated by Sponsor|0|||
48890235|NCT02712905|157434142|FG004|Monotherapy|Study Terminated by Sponsor|1|||
48890236|NCT02712905|157434143|FG005|Monotherapy|Study Terminated by Sponsor|0|||
48890237|NCT02712905|157434144|FG006|Monotherapy|Study Terminated by Sponsor|0|||
48890238|NCT02712905|157434145|FG007|Monotherapy|Study Terminated by Sponsor|0|||
48890239|NCT02712905|157434146|FG008|Monotherapy|Study Terminated by Sponsor|0|||
48890240|NCT02712905|157434147|FG009|Monotherapy|Study Terminated by Sponsor|2|||
48890241|NCT02712905|157434148|FG010|Monotherapy|Study Terminated by Sponsor|0|||
48890242|NCT02712905|157434149|FG011|Monotherapy|Study Terminated by Sponsor|0|||
48890243|NCT02712905|157434150|FG012|Monotherapy|Study Terminated by Sponsor|0|||
48890244|NCT02712905|157434151|FG013|Monotherapy|Study Terminated by Sponsor|0|||
48890245|NCT02712905|157434152|FG014|Monotherapy|Study Terminated by Sponsor|0|||
48890246|NCT02712905|157434153|FG015|Monotherapy|Study Terminated by Sponsor|0|||
48890247|NCT02712905|157434154|FG016|Monotherapy|Study Terminated by Sponsor|0|||
48890248|NCT02712905|157434155|FG017|Monotherapy|Study Terminated by Sponsor|0|||
48890249|NCT02712905|157434138|FG000|Monotherapy|Withdrawal by Subject|0|||
48890250|NCT02712905|157434139|FG001|Monotherapy|Withdrawal by Subject|0|||
48890251|NCT02712905|157434140|FG002|Monotherapy|Withdrawal by Subject|1|||
48890252|NCT02712905|157434141|FG003|Monotherapy|Withdrawal by Subject|0|||
48890253|NCT02712905|157434142|FG004|Monotherapy|Withdrawal by Subject|2|||
48890254|NCT02712905|157434143|FG005|Monotherapy|Withdrawal by Subject|0|||
48890255|NCT02712905|157434144|FG006|Monotherapy|Withdrawal by Subject|0|||
48890256|NCT02712905|157434145|FG007|Monotherapy|Withdrawal by Subject|0|||
48890257|NCT02712905|157434146|FG008|Monotherapy|Withdrawal by Subject|0|||
48890258|NCT02712905|157434147|FG009|Monotherapy|Withdrawal by Subject|4|||
49036878|NCT00836472|157971184|FG000|Washout|Adverse Event|1|||
49036879|NCT00836472|157971185|FG001|Washout|Adverse Event|2|||
49036880|NCT00836472|157971184|FG000|Washout|Withdrawal by Subject|1|||
49036881|NCT00836472|157971185|FG001|Washout|Withdrawal by Subject|1|||
49036882|NCT03913377|157971186|FG000|Period 1|Test Article no longer available|0|||
49036883|NCT03913377|157971187|FG001|Period 1|Test Article no longer available|1|||
49036884|NCT03913377|157971188|FG002|Period 1|Test Article no longer available|0|||
49036885|NCT03913377|157971186|FG000|Period 1|No Longer Meets Eligibility Criteria|0|||
49036886|NCT03913377|157971187|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
49036887|NCT03913377|157971188|FG002|Period 1|No Longer Meets Eligibility Criteria|1|||
49036888|NCT00918645|157971193|FG000|Overall Study|Withdrawal by Subject|1|||
49036889|NCT03599362|157971194|FG000|Overall Study|Screen Failure|3|||
49036890|NCT04547192|157971195|FG000|Period 1: 0-14 Weeks|Incomplete Data|7|||
49036891|NCT04547192|157971196|FG001|Period 1: 0-14 Weeks|Incomplete Data|2|||
49036892|NCT04547192|157971197|FG002|Period 1: 0-14 Weeks|Incomplete Data|5|||
48890259|NCT02712905|157434148|FG010|Monotherapy|Withdrawal by Subject|1|||
48890260|NCT02712905|157434149|FG011|Monotherapy|Withdrawal by Subject|2|||
48890261|NCT02712905|157434150|FG012|Monotherapy|Withdrawal by Subject|0|||
48890262|NCT02712905|157434151|FG013|Monotherapy|Withdrawal by Subject|0|||
48890263|NCT02712905|157434152|FG014|Monotherapy|Withdrawal by Subject|0|||
48890264|NCT02712905|157434153|FG015|Monotherapy|Withdrawal by Subject|0|||
48890265|NCT02712905|157434154|FG016|Monotherapy|Withdrawal by Subject|0|||
48890266|NCT02712905|157434155|FG017|Monotherapy|Withdrawal by Subject|0|||
48890267|NCT02712905|157434138|FG000|Monotherapy|Started New Cancer Drug|0|||
48890268|NCT02712905|157434139|FG001|Monotherapy|Started New Cancer Drug|0|||
48890269|NCT02712905|157434140|FG002|Monotherapy|Started New Cancer Drug|0|||
48890270|NCT02712905|157434141|FG003|Monotherapy|Started New Cancer Drug|0|||
48890271|NCT02712905|157434142|FG004|Monotherapy|Started New Cancer Drug|0|||
48890272|NCT02712905|157434143|FG005|Monotherapy|Started New Cancer Drug|1|||
48890273|NCT02712905|157434144|FG006|Monotherapy|Started New Cancer Drug|0|||
48890274|NCT02712905|157434145|FG007|Monotherapy|Started New Cancer Drug|0|||
48890275|NCT02712905|157434146|FG008|Monotherapy|Started New Cancer Drug|0|||
48890276|NCT02712905|157434147|FG009|Monotherapy|Started New Cancer Drug|0|||
48890277|NCT02712905|157434148|FG010|Monotherapy|Started New Cancer Drug|0|||
48890278|NCT02712905|157434149|FG011|Monotherapy|Started New Cancer Drug|0|||
48890279|NCT02712905|157434150|FG012|Monotherapy|Started New Cancer Drug|0|||
48890280|NCT02712905|157434151|FG013|Monotherapy|Started New Cancer Drug|0|||
48890281|NCT02712905|157434152|FG014|Monotherapy|Started New Cancer Drug|0|||
48890282|NCT02712905|157434153|FG015|Monotherapy|Started New Cancer Drug|0|||
48890283|NCT02712905|157434154|FG016|Monotherapy|Started New Cancer Drug|0|||
48890284|NCT02712905|157434155|FG017|Monotherapy|Started New Cancer Drug|0|||
48890285|NCT02712905|157434138|FG000|Monotherapy|Adverse Event|0|||
48890286|NCT02712905|157434139|FG001|Monotherapy|Adverse Event|0|||
48890287|NCT02712905|157434140|FG002|Monotherapy|Adverse Event|0|||
48890288|NCT02712905|157434141|FG003|Monotherapy|Adverse Event|0|||
48890289|NCT02712905|157434142|FG004|Monotherapy|Adverse Event|0|||
48890290|NCT02712905|157434143|FG005|Monotherapy|Adverse Event|0|||
48890291|NCT02712905|157434144|FG006|Monotherapy|Adverse Event|0|||
48890292|NCT02712905|157434145|FG007|Monotherapy|Adverse Event|0|||
49036893|NCT04547192|157971198|FG003|Period 1: 0-14 Weeks|Incomplete Data|1|||
48890293|NCT02712905|157434146|FG008|Monotherapy|Adverse Event|1|||
48890294|NCT02712905|157434147|FG009|Monotherapy|Adverse Event|0|||
48890295|NCT02712905|157434148|FG010|Monotherapy|Adverse Event|0|||
48890296|NCT02712905|157434149|FG011|Monotherapy|Adverse Event|0|||
48890297|NCT02712905|157434150|FG012|Monotherapy|Adverse Event|0|||
48890298|NCT02712905|157434151|FG013|Monotherapy|Adverse Event|0|||
48890299|NCT02712905|157434152|FG014|Monotherapy|Adverse Event|0|||
48890300|NCT02712905|157434153|FG015|Monotherapy|Adverse Event|0|||
49036894|NCT04547192|157971195|FG000|Period 2: 14-28 Weeks|Incomplete Data|0|||
49036895|NCT04547192|157971196|FG001|Period 2: 14-28 Weeks|Incomplete Data|1|||
49036896|NCT04547192|157971197|FG002|Period 2: 14-28 Weeks|Incomplete Data|1|||
49036897|NCT04547192|157971198|FG003|Period 2: 14-28 Weeks|Incomplete Data|0|||
49036898|NCT04547192|157971195|FG000|Period 3: 28-42 Weeks|Incomplete Data|2|||
49036899|NCT04547192|157971196|FG001|Period 3: 28-42 Weeks|Incomplete Data|0|||
49036900|NCT04547192|157971197|FG002|Period 3: 28-42 Weeks|Incomplete Data|6|||
49036901|NCT04547192|157971198|FG003|Period 3: 28-42 Weeks|Incomplete Data|0|||
48890301|NCT02712905|157434154|FG016|Monotherapy|Adverse Event|0|||
48890302|NCT02712905|157434155|FG017|Monotherapy|Adverse Event|0|||
48890303|NCT02712905|157434138|FG000|Combination Therapy|Death|0|||
48890304|NCT02712905|157434139|FG001|Combination Therapy|Death|0|||
48890305|NCT02712905|157434140|FG002|Combination Therapy|Death|0|||
48890306|NCT02712905|157434141|FG003|Combination Therapy|Death|0|||
49036902|NCT04547192|157971195|FG000|Period 4: 42-56 Weeks|Incomplete Data|2|||
48890307|NCT02712905|157434142|FG004|Combination Therapy|Death|0|||
48890308|NCT02712905|157434143|FG005|Combination Therapy|Death|0|||
48890309|NCT02712905|157434144|FG006|Combination Therapy|Death|0|||
48890310|NCT02712905|157434145|FG007|Combination Therapy|Death|0|||
48890311|NCT02712905|157434146|FG008|Combination Therapy|Death|0|||
48890312|NCT02712905|157434147|FG009|Combination Therapy|Death|0|||
48890313|NCT02712905|157434148|FG010|Combination Therapy|Death|0|||
48890314|NCT02712905|157434149|FG011|Combination Therapy|Death|0|||
48890315|NCT02712905|157434150|FG012|Combination Therapy|Death|5|||
48890316|NCT02712905|157434151|FG013|Combination Therapy|Death|6|||
48890317|NCT02712905|157434152|FG014|Combination Therapy|Death|1|||
48890318|NCT02712905|157434153|FG015|Combination Therapy|Death|3|||
48890319|NCT02712905|157434154|FG016|Combination Therapy|Death|1|||
49036903|NCT04547192|157971196|FG001|Period 4: 42-56 Weeks|Incomplete Data|0|||
49036904|NCT04547192|157971197|FG002|Period 4: 42-56 Weeks|Incomplete Data|0|||
49036905|NCT04547192|157971198|FG003|Period 4: 42-56 Weeks|Incomplete Data|0|||
49036906|NCT04547192|157971195|FG000|Period 5: 56-70 Weeks|Incomplete Data|0|||
49036907|NCT04547192|157971196|FG001|Period 5: 56-70 Weeks|Incomplete Data|0|||
49036908|NCT04547192|157971197|FG002|Period 5: 56-70 Weeks|Incomplete Data|1|||
49036909|NCT04547192|157971198|FG003|Period 5: 56-70 Weeks|Incomplete Data|0|||
49036910|NCT04194801|157971199|FG000|Part Ib/II End Of Treatment-BLU554|Adverse Event|0|||
49036911|NCT04194801|157971200|FG001|Part Ib/II End Of Treatment-BLU554|Adverse Event|2|||
49036912|NCT04194801|157971201|FG002|Part Ib/II End Of Treatment-BLU554|Adverse Event|1|||
49036913|NCT04194801|157971199|FG000|Part Ib/II End Of Treatment-BLU554|Death|0|||
49036914|NCT04194801|157971200|FG001|Part Ib/II End Of Treatment-BLU554|Death|0|||
49036915|NCT04194801|157971201|FG002|Part Ib/II End Of Treatment-BLU554|Death|1|||
49036916|NCT04194801|157971199|FG000|Part Ib/II End Of Treatment-BLU554|Physician Decision|1|||
49036917|NCT04194801|157971200|FG001|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
49036918|NCT04194801|157971201|FG002|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
49036919|NCT04194801|157971199|FG000|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|3|||
49036920|NCT04194801|157971200|FG001|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|4|||
49036921|NCT04194801|157971201|FG002|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|9|||
49036922|NCT04194801|157971199|FG000|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
49036923|NCT04194801|157971200|FG001|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|1|||
49036924|NCT04194801|157971201|FG002|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
49036925|NCT04194801|157971199|FG000|Part Ib/II End Of Treatment-BLU554|Other|0|||
49036926|NCT04194801|157971200|FG001|Part Ib/II End Of Treatment-BLU554|Other|0|||
49036927|NCT04194801|157971201|FG002|Part Ib/II End Of Treatment-BLU554|Other|2|||
48890320|NCT02712905|157434155|FG017|Combination Therapy|Death|3|||
48890321|NCT02712905|157434138|FG000|Combination Therapy|Study Terminated by Sponsor|0|||
48890322|NCT02712905|157434139|FG001|Combination Therapy|Study Terminated by Sponsor|0|||
48890323|NCT02712905|157434140|FG002|Combination Therapy|Study Terminated by Sponsor|0|||
48890324|NCT02712905|157434141|FG003|Combination Therapy|Study Terminated by Sponsor|0|||
48890325|NCT02712905|157434142|FG004|Combination Therapy|Study Terminated by Sponsor|0|||
48890326|NCT02712905|157434143|FG005|Combination Therapy|Study Terminated by Sponsor|0|||
48890327|NCT02712905|157434144|FG006|Combination Therapy|Study Terminated by Sponsor|0|||
48890328|NCT02712905|157434145|FG007|Combination Therapy|Study Terminated by Sponsor|0|||
48890329|NCT02712905|157434146|FG008|Combination Therapy|Study Terminated by Sponsor|0|||
48890330|NCT02712905|157434147|FG009|Combination Therapy|Study Terminated by Sponsor|0|||
48890331|NCT02712905|157434148|FG010|Combination Therapy|Study Terminated by Sponsor|0|||
48890332|NCT02712905|157434149|FG011|Combination Therapy|Study Terminated by Sponsor|0|||
48890333|NCT02712905|157434150|FG012|Combination Therapy|Study Terminated by Sponsor|0|||
48890334|NCT02712905|157434151|FG013|Combination Therapy|Study Terminated by Sponsor|1|||
48890335|NCT02712905|157434152|FG014|Combination Therapy|Study Terminated by Sponsor|0|||
48890336|NCT02712905|157434153|FG015|Combination Therapy|Study Terminated by Sponsor|2|||
48890337|NCT02712905|157434154|FG016|Combination Therapy|Study Terminated by Sponsor|0|||
48890338|NCT02712905|157434155|FG017|Combination Therapy|Study Terminated by Sponsor|1|||
48890339|NCT02712905|157434138|FG000|Combination Therapy|Withdrawal by Subject|0|||
48890340|NCT02712905|157434139|FG001|Combination Therapy|Withdrawal by Subject|0|||
48890341|NCT02712905|157434140|FG002|Combination Therapy|Withdrawal by Subject|0|||
48890342|NCT02712905|157434141|FG003|Combination Therapy|Withdrawal by Subject|0|||
48890343|NCT02712905|157434142|FG004|Combination Therapy|Withdrawal by Subject|0|||
48890344|NCT02712905|157434143|FG005|Combination Therapy|Withdrawal by Subject|0|||
48890345|NCT02712905|157434144|FG006|Combination Therapy|Withdrawal by Subject|0|||
48890346|NCT02712905|157434145|FG007|Combination Therapy|Withdrawal by Subject|0|||
48890347|NCT02712905|157434146|FG008|Combination Therapy|Withdrawal by Subject|0|||
48890348|NCT02712905|157434147|FG009|Combination Therapy|Withdrawal by Subject|0|||
48890349|NCT02712905|157434148|FG010|Combination Therapy|Withdrawal by Subject|0|||
48890350|NCT02712905|157434149|FG011|Combination Therapy|Withdrawal by Subject|0|||
48890351|NCT02712905|157434150|FG012|Combination Therapy|Withdrawal by Subject|0|||
48890352|NCT02712905|157434151|FG013|Combination Therapy|Withdrawal by Subject|0|||
48890353|NCT02712905|157434152|FG014|Combination Therapy|Withdrawal by Subject|0|||
48890354|NCT02712905|157434153|FG015|Combination Therapy|Withdrawal by Subject|1|||
48890355|NCT02712905|157434154|FG016|Combination Therapy|Withdrawal by Subject|0|||
48890356|NCT02712905|157434155|FG017|Combination Therapy|Withdrawal by Subject|2|||
48890357|NCT02712905|157434138|FG000|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
48890358|NCT02712905|157434139|FG001|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
48890359|NCT02712905|157434140|FG002|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
48890360|NCT02712905|157434141|FG003|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
48890361|NCT02712905|157434142|FG004|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
48890362|NCT02712905|157434143|FG005|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
48890363|NCT02712905|157434144|FG006|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
48890364|NCT02712905|157434145|FG007|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
48890365|NCT02712905|157434146|FG008|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
48890366|NCT02712905|157434147|FG009|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
48890367|NCT02712905|157434148|FG010|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
48890368|NCT02712905|157434149|FG011|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
48890369|NCT02712905|157434150|FG012|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
48890370|NCT02712905|157434151|FG013|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
49036928|NCT04194801|157971199|FG000|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
49036929|NCT04194801|157971200|FG001|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
49036930|NCT04194801|157971201|FG002|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|2|||
49036931|NCT04194801|157971199|FG000|Part Ib/II End Of Treatment-CS1001|Adverse Event|1|||
49036932|NCT04194801|157971200|FG001|Part Ib/II End Of Treatment-CS1001|Adverse Event|0|||
49036933|NCT04194801|157971201|FG002|Part Ib/II End Of Treatment-CS1001|Adverse Event|2|||
49036934|NCT04194801|157971199|FG000|Part Ib/II End Of Treatment-CS1001|Death|0|||
49036935|NCT04194801|157971200|FG001|Part Ib/II End Of Treatment-CS1001|Death|0|||
49036936|NCT04194801|157971201|FG002|Part Ib/II End Of Treatment-CS1001|Death|1|||
49036937|NCT04194801|157971199|FG000|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|3|||
49036938|NCT04194801|157971200|FG001|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|6|||
48890371|NCT02712905|157434152|FG014|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
48890372|NCT02712905|157434153|FG015|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|1|||
48890373|NCT02712905|157434154|FG016|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
48890374|NCT02712905|157434155|FG017|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
48890375|NCT04664400|157434156|FG000|Overall Study|Withdrawal by Subject|2|||
48890376|NCT00515853|157434157|FG000|Overall Study|Lost to Follow-up|9|||
48890377|NCT00515853|157434158|FG001|Overall Study|Lost to Follow-up|13|||
48890378|NCT00515853|157434157|FG000|Overall Study|Withdrawal by Subject|6|||
48890379|NCT00515853|157434158|FG001|Overall Study|Withdrawal by Subject|4|||
48890380|NCT00490724|157434163|FG000|Period I|Physician Decision|0|||
48890381|NCT00490724|157434164|FG001|Period I|Physician Decision|0|||
48890382|NCT00490724|157434165|FG002|Period I|Physician Decision|1|||
48890383|NCT00490724|157434163|FG000|Period II|Treatment Discontinuation|3|||
48890384|NCT00490724|157434164|FG001|Period II|Treatment Discontinuation|1|||
48890385|NCT00490724|157434165|FG002|Period II|Treatment Discontinuation|3|||
49036939|NCT04194801|157971201|FG002|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|9|||
49036940|NCT04194801|157971199|FG000|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
49036941|NCT04194801|157971200|FG001|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|1|||
49036942|NCT04194801|157971201|FG002|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
49036943|NCT04194801|157971199|FG000|Part Ib/II End Of Treatment-CS1001|Other|0|||
49036944|NCT04194801|157971200|FG001|Part Ib/II End Of Treatment-CS1001|Other|0|||
49036945|NCT04194801|157971201|FG002|Part Ib/II End Of Treatment-CS1001|Other|1|||
49036946|NCT04194801|157971199|FG000|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
49036947|NCT04194801|157971200|FG001|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
49036948|NCT04194801|157971201|FG002|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|2|||
49036949|NCT04194801|157971199|FG000|Part Ib/II End of Study|Death|2|||
49036950|NCT04194801|157971200|FG001|Part Ib/II End of Study|Death|3|||
49036951|NCT04194801|157971201|FG002|Part Ib/II End of Study|Death|3|||
49036952|NCT04194801|157971199|FG000|Part Ib/II End of Study|Lost to Follow-up|0|||
49036953|NCT04194801|157971200|FG001|Part Ib/II End of Study|Lost to Follow-up|1|||
49036954|NCT04194801|157971201|FG002|Part Ib/II End of Study|Lost to Follow-up|0|||
49036955|NCT04194801|157971199|FG000|Part Ib/II End of Study|Withdrawal by Subject|1|||
49036956|NCT04194801|157971200|FG001|Part Ib/II End of Study|Withdrawal by Subject|0|||
49036957|NCT04194801|157971201|FG002|Part Ib/II End of Study|Withdrawal by Subject|2|||
49036958|NCT04194801|157971199|FG000|Part Ib/II End of Study|Study ended by sponsor|1|||
49036959|NCT04194801|157971200|FG001|Part Ib/II End of Study|Study ended by sponsor|3|||
49036960|NCT04194801|157971201|FG002|Part Ib/II End of Study|Study ended by sponsor|8|||
49036961|NCT04194801|157971199|FG000|Part Ib/II End of Study|Ongoing treatment|0|||
49036962|NCT04194801|157971200|FG001|Part Ib/II End of Study|Ongoing treatment|0|||
49036963|NCT04194801|157971201|FG002|Part Ib/II End of Study|Ongoing treatment|2|||
49036964|NCT01442155|157971208|FG000|Overall Study|Complete remission|35|||
49036965|NCT01442155|157971208|FG000|Overall Study|Recurrence|26|||
49036966|NCT01442155|157971208|FG000|Overall Study|Adverse Event|2|||
49036967|NCT01442155|157971208|FG000|Overall Study|Lost to Follow-up|2|||
49036968|NCT03707587|157971209|FG000|Overall Study|Death|0|||
48890386|NCT01011153|157434166|FG000|Overall Study|Less than 78 cases completed|8|||
49036969|NCT03707587|157971210|FG001|Overall Study|Death|1|||
49036970|NCT01370083|157971211|FG000|Overall Study|Lost to Follow-up|2|||
49036971|NCT01370083|157971212|FG001|Overall Study|Lost to Follow-up|0|||
49036972|NCT01370083|157971211|FG000|Overall Study|Adverse Event|0|||
48890387|NCT01011153|157434167|FG001|Overall Study|Less than 78 cases completed|11|||
48890388|NCT01011153|157434168|FG002|Overall Study|Less than 78 cases completed|9|||
48890389|NCT05038163|157434170|FG000|Stage 1|Did not complete survey|374|||
48890390|NCT05038163|157434171|FG001|Stage 1|Did not complete survey|0|||
48890391|NCT05038163|157434172|FG002|Stage 1|Did not complete survey|0|||
48890392|NCT05038163|157434173|FG003|Stage 1|Did not complete survey|0|||
48890393|NCT05038163|157434174|FG004|Stage 1|Did not complete survey|0|||
48890394|NCT05038163|157434175|FG005|Stage 1|Did not complete survey|0|||
48890395|NCT05038163|157434170|FG000|Stage 2|Did not complete Stage 2 survey|0|||
48890396|NCT05038163|157434171|FG001|Stage 2|Did not complete Stage 2 survey|29|||
48890397|NCT05038163|157434172|FG002|Stage 2|Did not complete Stage 2 survey|30|||
48890398|NCT05038163|157434173|FG003|Stage 2|Did not complete Stage 2 survey|24|||
48890399|NCT05038163|157434174|FG004|Stage 2|Did not complete Stage 2 survey|21|||
48890400|NCT05038163|157434175|FG005|Stage 2|Did not complete Stage 2 survey|100|||
48890401|NCT02656706|157434178|FG000|Overall Study|Insurance Denial|1|||
48890402|NCT03149549|157434181|FG000|Study Discontinuation--Treatment Period|Death|0|||
48890403|NCT03149549|157434182|FG001|Study Discontinuation--Treatment Period|Death|0|||
48890404|NCT03149549|157434183|FG002|Study Discontinuation--Treatment Period|Death|0|||
48890405|NCT03149549|157434184|FG003|Study Discontinuation--Treatment Period|Death|1|||
48890406|NCT03149549|157434185|FG004|Study Discontinuation--Treatment Period|Death|2|||
48890407|NCT03149549|157434186|FG005|Study Discontinuation--Treatment Period|Death|1|||
48890408|NCT03149549|157434187|FG006|Study Discontinuation--Treatment Period|Death|1|||
48890409|NCT03149549|157434188|FG007|Study Discontinuation--Treatment Period|Death|2|||
48890410|NCT03149549|157434189|FG008|Study Discontinuation--Treatment Period|Death|4|||
48890411|NCT03149549|157434190|FG009|Study Discontinuation--Treatment Period|Death|1|||
48890412|NCT03149549|157434191|FG010|Study Discontinuation--Treatment Period|Death|0|||
48890413|NCT03149549|157434192|FG011|Study Discontinuation--Treatment Period|Death|0|||
48890414|NCT03149549|157434193|FG012|Study Discontinuation--Treatment Period|Death|1|||
48890415|NCT03149549|157434181|FG000|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
48890416|NCT03149549|157434182|FG001|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
48890417|NCT03149549|157434183|FG002|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
48890418|NCT03149549|157434184|FG003|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
48890419|NCT03149549|157434185|FG004|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
48890420|NCT03149549|157434186|FG005|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
48890421|NCT03149549|157434187|FG006|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
48890422|NCT03149549|157434188|FG007|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
48890423|NCT03149549|157434189|FG008|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
48890424|NCT03149549|157434190|FG009|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
48890425|NCT03149549|157434191|FG010|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
48890426|NCT03149549|157434192|FG011|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
48890427|NCT03149549|157434193|FG012|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
48890428|NCT03149549|157434181|FG000|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
48890429|NCT03149549|157434182|FG001|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
48890430|NCT03149549|157434183|FG002|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
48890431|NCT03149549|157434184|FG003|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
48890432|NCT03149549|157434185|FG004|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
48890433|NCT03149549|157434186|FG005|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
48890434|NCT03149549|157434187|FG006|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
48890435|NCT03149549|157434188|FG007|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
48890436|NCT03149549|157434189|FG008|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
48890437|NCT03149549|157434190|FG009|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
49036973|NCT01370083|157971212|FG001|Overall Study|Adverse Event|1|||
48890438|NCT03149549|157434191|FG010|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
48890439|NCT03149549|157434192|FG011|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
48890440|NCT03149549|157434193|FG012|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
48890441|NCT03149549|157434181|FG000|Study Discontinuation--Treatment Period|Other|0|||
48890442|NCT03149549|157434182|FG001|Study Discontinuation--Treatment Period|Other|0|||
48890443|NCT03149549|157434183|FG002|Study Discontinuation--Treatment Period|Other|0|||
49036974|NCT00294047|157971213|FG000|Month 48|Adverse Event|28|||
49036975|NCT00294047|157971214|FG001|Month 48|Adverse Event|13|||
49036976|NCT00294047|157971213|FG000|Month 48|Protocol Violation|4|||
48890444|NCT03149549|157434184|FG003|Study Discontinuation--Treatment Period|Other|0|||
48890445|NCT03149549|157434185|FG004|Study Discontinuation--Treatment Period|Other|0|||
48890446|NCT03149549|157434186|FG005|Study Discontinuation--Treatment Period|Other|0|||
48890447|NCT03149549|157434187|FG006|Study Discontinuation--Treatment Period|Other|0|||
48890448|NCT03149549|157434188|FG007|Study Discontinuation--Treatment Period|Other|1|||
48890449|NCT03149549|157434189|FG008|Study Discontinuation--Treatment Period|Other|0|||
48890450|NCT03149549|157434190|FG009|Study Discontinuation--Treatment Period|Other|1|||
49036977|NCT00294047|157971214|FG001|Month 48|Protocol Violation|4|||
49036978|NCT00294047|157971213|FG000|Month 48|Withdrawal by Subject|111|||
49036979|NCT00294047|157971214|FG001|Month 48|Withdrawal by Subject|115|||
49036980|NCT00294047|157971213|FG000|Month 48|Lost to Follow-up|272|||
49036981|NCT00294047|157971214|FG001|Month 48|Lost to Follow-up|287|||
49036982|NCT00294047|157971213|FG000|Month 48|Other|10|||
49036983|NCT00294047|157971214|FG001|Month 48|Other|14|||
48890451|NCT03149549|157434191|FG010|Study Discontinuation--Treatment Period|Other|0|||
48890452|NCT03149549|157434192|FG011|Study Discontinuation--Treatment Period|Other|0|||
49036984|NCT00294047|157971213|FG000|Month 84|Adverse Event|4|||
49036985|NCT00294047|157971214|FG001|Month 84|Adverse Event|2|||
49036986|NCT00294047|157971213|FG000|Month 84|Protocol Violation|1|||
49036987|NCT00294047|157971214|FG001|Month 84|Protocol Violation|1|||
49036988|NCT00294047|157971213|FG000|Month 84|Withdrawal by Subject|33|||
49036989|NCT00294047|157971214|FG001|Month 84|Withdrawal by Subject|31|||
49036990|NCT00294047|157971213|FG000|Month 84|Lost to Follow-up|187|||
49036991|NCT00294047|157971214|FG001|Month 84|Lost to Follow-up|190|||
49036992|NCT00294047|157971213|FG000|Month 84|Absent Cervix|2|||
49036993|NCT00294047|157971214|FG001|Month 84|Absent Cervix|0|||
49036994|NCT00294047|157971213|FG000|Month 84|Work related reasons|4|||
49036995|NCT00294047|157971214|FG001|Month 84|Work related reasons|2|||
49036996|NCT00294047|157971213|FG000|Month 84|Center closed, subject did not transfer|1|||
49036997|NCT00294047|157971214|FG001|Month 84|Center closed, subject did not transfer|0|||
49036998|NCT00294047|157971213|FG000|Month 84|Family problems|2|||
49036999|NCT00294047|157971214|FG001|Month 84|Family problems|2|||
49037000|NCT00294047|157971213|FG000|Month 84|Lack of time|3|||
49037001|NCT00294047|157971214|FG001|Month 84|Lack of time|1|||
49037002|NCT00294047|157971213|FG000|Month 84|Personal reason|2|||
49037003|NCT00294047|157971214|FG001|Month 84|Personal reason|4|||
49037004|NCT00294047|157971213|FG000|Month 84|Subject does not want male physician|1|||
48890453|NCT03149549|157434193|FG012|Study Discontinuation--Treatment Period|Other|0|||
48890454|NCT03149549|157434181|FG000|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
48890455|NCT03149549|157434182|FG001|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
48890456|NCT03149549|157434183|FG002|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
48890457|NCT03149549|157434184|FG003|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
48890458|NCT03149549|157434185|FG004|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
48890459|NCT03149549|157434186|FG005|Study Discontinuation--Follow-Up Period|Lost to Follow-up|4|||
48890460|NCT03149549|157434187|FG006|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
48890461|NCT03149549|157434188|FG007|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
48890462|NCT03149549|157434189|FG008|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
48890463|NCT03149549|157434190|FG009|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
48890464|NCT03149549|157434191|FG010|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
48890465|NCT03149549|157434192|FG011|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
48890466|NCT03149549|157434193|FG012|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
48890467|NCT03149549|157434181|FG000|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
48890468|NCT03149549|157434182|FG001|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
48890469|NCT03149549|157434183|FG002|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
48890470|NCT03149549|157434184|FG003|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
48890471|NCT03149549|157434185|FG004|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
48890472|NCT03149549|157434186|FG005|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
48890473|NCT03149549|157434187|FG006|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
48890474|NCT03149549|157434188|FG007|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
48890475|NCT03149549|157434189|FG008|Study Discontinuation--Follow-Up Period|Termination by Sponsor|5|||
48890476|NCT03149549|157434190|FG009|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
48890477|NCT03149549|157434191|FG010|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
49037005|NCT00294047|157971214|FG001|Month 84|Subject does not want male physician|0|||
49037006|NCT00294047|157971213|FG000|Month 84|Transport reimbursement delayed|0|||
49037007|NCT00294047|157971214|FG001|Month 84|Transport reimbursement delayed|1|||
48890478|NCT03149549|157434192|FG011|Study Discontinuation--Follow-Up Period|Termination by Sponsor|3|||
48890479|NCT03149549|157434193|FG012|Study Discontinuation--Follow-Up Period|Termination by Sponsor|2|||
49037008|NCT00294047|157971213|FG000|Month 84|Unable to reach study site|1|||
49037009|NCT00294047|157971214|FG001|Month 84|Unable to reach study site|0|||
49037010|NCT00294047|157971213|FG000|Month 84|Under investigation locally|1|||
49037011|NCT00294047|157971214|FG001|Month 84|Under investigation locally|0|||
49037012|NCT00294047|157971213|FG000|Month 84|Visit missed|0|||
48890480|NCT03149549|157434181|FG000|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
48890481|NCT03149549|157434182|FG001|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
48890482|NCT03149549|157434183|FG002|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
48890483|NCT03149549|157434184|FG003|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
48890484|NCT03149549|157434185|FG004|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
48890485|NCT03149549|157434186|FG005|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
48890486|NCT03149549|157434187|FG006|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
48890487|NCT03149549|157434188|FG007|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|4|||
48890488|NCT03149549|157434189|FG008|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
48890489|NCT03149549|157434190|FG009|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
48890490|NCT03149549|157434191|FG010|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|3|||
48890491|NCT03149549|157434192|FG011|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
48890492|NCT03149549|157434193|FG012|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
48890493|NCT03149549|157434181|FG000|Study Discontinuation--Follow-Up Period|Other|0|||
48890494|NCT03149549|157434182|FG001|Study Discontinuation--Follow-Up Period|Other|0|||
48890495|NCT03149549|157434183|FG002|Study Discontinuation--Follow-Up Period|Other|0|||
48890496|NCT03149549|157434184|FG003|Study Discontinuation--Follow-Up Period|Other|0|||
48890497|NCT03149549|157434185|FG004|Study Discontinuation--Follow-Up Period|Other|0|||
48890498|NCT03149549|157434186|FG005|Study Discontinuation--Follow-Up Period|Other|0|||
48890499|NCT03149549|157434187|FG006|Study Discontinuation--Follow-Up Period|Other|0|||
48890500|NCT03149549|157434188|FG007|Study Discontinuation--Follow-Up Period|Other|0|||
48890501|NCT03149549|157434189|FG008|Study Discontinuation--Follow-Up Period|Other|0|||
48890502|NCT03149549|157434190|FG009|Study Discontinuation--Follow-Up Period|Other|1|||
48890503|NCT03149549|157434191|FG010|Study Discontinuation--Follow-Up Period|Other|0|||
48890504|NCT03149549|157434192|FG011|Study Discontinuation--Follow-Up Period|Other|0|||
48890505|NCT03149549|157434193|FG012|Study Discontinuation--Follow-Up Period|Other|0|||
48890506|NCT03149549|157434181|FG000|Study Discontinuation--Follow-Up Period|Death|1|||
48890507|NCT03149549|157434182|FG001|Study Discontinuation--Follow-Up Period|Death|3|||
48890508|NCT03149549|157434183|FG002|Study Discontinuation--Follow-Up Period|Death|3|||
48890509|NCT03149549|157434184|FG003|Study Discontinuation--Follow-Up Period|Death|1|||
48890510|NCT03149549|157434185|FG004|Study Discontinuation--Follow-Up Period|Death|4|||
48890511|NCT03149549|157434186|FG005|Study Discontinuation--Follow-Up Period|Death|3|||
48890512|NCT03149549|157434187|FG006|Study Discontinuation--Follow-Up Period|Death|5|||
48890513|NCT03149549|157434188|FG007|Study Discontinuation--Follow-Up Period|Death|3|||
48890514|NCT03149549|157434189|FG008|Study Discontinuation--Follow-Up Period|Death|9|||
48890515|NCT03149549|157434190|FG009|Study Discontinuation--Follow-Up Period|Death|5|||
48890516|NCT03149549|157434191|FG010|Study Discontinuation--Follow-Up Period|Death|5|||
48890517|NCT03149549|157434192|FG011|Study Discontinuation--Follow-Up Period|Death|1|||
48890518|NCT03149549|157434193|FG012|Study Discontinuation--Follow-Up Period|Death|1|||
48890519|NCT02631577|157434196|FG000|Overall Study|Death|1|||
48890520|NCT02631577|157434197|FG001|Overall Study|Death|7|||
48890521|NCT02631577|157434196|FG000|Overall Study|Withdrawal by Subject|0|||
48890522|NCT02631577|157434197|FG001|Overall Study|Withdrawal by Subject|3|||
48890523|NCT01892540|157434198|FG000|Overall Study|Did not complete PET/MRI|0|||
48890524|NCT01892540|157434199|FG001|Overall Study|Did not complete PET/MRI|0|||
48890525|NCT01892540|157434200|FG002|Overall Study|Did not complete PET/MRI|2|||
48890526|NCT01892540|157434198|FG000|Overall Study|Did not fit in scanner|0|||
48890527|NCT01892540|157434199|FG001|Overall Study|Did not fit in scanner|0|||
48890528|NCT01892540|157434200|FG002|Overall Study|Did not fit in scanner|1|||
48890529|NCT01342341|157435862|FG000|Overall Study|Lost to Follow-up|4|||
48890530|NCT01342341|157435863|FG001|Overall Study|Lost to Follow-up|4|||
48890531|NCT02075476|157435869|FG000|Overall Study|Death|2|||
48890532|NCT02075476|157435870|FG001|Overall Study|Death|2|||
48890533|NCT02075476|157435869|FG000|Overall Study|Lost to Follow-up|1|||
48890534|NCT02075476|157435870|FG001|Overall Study|Lost to Follow-up|3|||
48890535|NCT02389452|157435871|FG000|Overall Study|Lost to Follow-up|13|||
48890536|NCT02389452|157435871|FG000|Overall Study|Adverse Event|1|||
48890537|NCT02389452|157435871|FG000|Overall Study|Withdrawal by Subject|5|||
49037013|NCT00294047|157971214|FG001|Month 84|Visit missed|1|||
49037014|NCT00294047|157971213|FG000|Month 84|No consent for Month 84 Follow-up|731|||
49037015|NCT00294047|157971214|FG001|Month 84|No consent for Month 84 Follow-up|754|||
48890538|NCT02389452|157435871|FG000|Overall Study|Enrolled but Not Eligible for Study|6|||
48890539|NCT01195948|157435872|FG000|Overall Study|Lost to Follow-up|0|||
49037016|NCT02760927|157971215|FG000|Overall Study|Tube Slippage from Device|1|||
49037017|NCT01604941|157971218|FG000|Overall Study|Adverse Event|1|||
48890540|NCT01195948|157435873|FG001|Overall Study|Lost to Follow-up|1|||
48890541|NCT01195948|157435874|FG002|Overall Study|Lost to Follow-up|2|||
48890542|NCT00414908|157435875|FG000|Overall Study|Protocol Violation|1|||
48890543|NCT00414908|157435876|FG001|Overall Study|Protocol Violation|1|||
48890544|NCT04165031|157435877|FG000|Overall Study|Adverse Event|1|||
48890545|NCT04165031|157435878|FG001|Overall Study|Adverse Event|1|||
49037018|NCT01604941|157971219|FG001|Overall Study|Adverse Event|2|||
48890546|NCT04165031|157435879|FG002|Overall Study|Adverse Event|0|||
48890547|NCT04165031|157435880|FG003|Overall Study|Adverse Event|0|||
48890548|NCT04165031|157435881|FG004|Overall Study|Adverse Event|0|||
49037019|NCT01604941|157971220|FG002|Overall Study|Adverse Event|0|||
49037020|NCT01604941|157971221|FG003|Overall Study|Adverse Event|0|||
49037021|NCT01604941|157971222|FG004|Overall Study|Adverse Event|1|||
49037022|NCT01604941|157971223|FG005|Overall Study|Adverse Event|5|||
49037023|NCT01604941|157971218|FG000|Overall Study|Non-compliance|1|||
49037024|NCT01604941|157971219|FG001|Overall Study|Non-compliance|0|||
49037025|NCT01604941|157971220|FG002|Overall Study|Non-compliance|0|||
49037026|NCT01604941|157971221|FG003|Overall Study|Non-compliance|0|||
49037027|NCT01604941|157971222|FG004|Overall Study|Non-compliance|0|||
49037028|NCT01604941|157971223|FG005|Overall Study|Non-compliance|0|||
49037029|NCT01604941|157971218|FG000|Overall Study|Participant Decision|0|||
49037030|NCT01604941|157971219|FG001|Overall Study|Participant Decision|0|||
49037031|NCT01604941|157971220|FG002|Overall Study|Participant Decision|0|||
49037032|NCT01604941|157971221|FG003|Overall Study|Participant Decision|0|||
49037033|NCT01604941|157971222|FG004|Overall Study|Participant Decision|0|||
49037034|NCT01604941|157971223|FG005|Overall Study|Participant Decision|2|||
49037035|NCT01604941|157971218|FG000|Overall Study|Early Study Termination|9|||
49037036|NCT01604941|157971219|FG001|Overall Study|Early Study Termination|2|||
49037037|NCT01604941|157971220|FG002|Overall Study|Early Study Termination|3|||
49037038|NCT01604941|157971221|FG003|Overall Study|Early Study Termination|3|||
49037039|NCT01604941|157971222|FG004|Overall Study|Early Study Termination|0|||
49037040|NCT01604941|157971223|FG005|Overall Study|Early Study Termination|0|||
49037041|NCT03930732|157971227|FG000|Overall Study|Adverse Event|9|||
49037042|NCT03930732|157971228|FG001|Overall Study|Adverse Event|7|||
49037043|NCT03930732|157971227|FG000|Overall Study|Poor compliance to protocol|0|||
49037044|NCT03930732|157971228|FG001|Overall Study|Poor compliance to protocol|1|||
49037045|NCT03930732|157971227|FG000|Overall Study|Withdrawal by Subject|23|||
49037046|NCT03930732|157971228|FG001|Overall Study|Withdrawal by Subject|11|||
49037047|NCT03930732|157971227|FG000|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|0|||
49037048|NCT03930732|157971228|FG001|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|1|||
49037049|NCT03930732|157971227|FG000|Overall Study|Other reason not related to COVID-19|5|||
49037050|NCT03930732|157971228|FG001|Overall Study|Other reason not related to COVID-19|8|||
49037051|NCT01075282|157971229|FG000|Overall Study|Withdrawal by Subject|11|||
48890549|NCT04165031|157435882|FG005|Overall Study|Adverse Event|0|||
48890550|NCT04165031|157435877|FG000|Overall Study|Withdrawal by Subject|0|||
48890551|NCT04165031|157435878|FG001|Overall Study|Withdrawal by Subject|0|||
48890552|NCT04165031|157435879|FG002|Overall Study|Withdrawal by Subject|1|||
48890553|NCT04165031|157435880|FG003|Overall Study|Withdrawal by Subject|0|||
48890554|NCT04165031|157435881|FG004|Overall Study|Withdrawal by Subject|0|||
48890555|NCT04165031|157435882|FG005|Overall Study|Withdrawal by Subject|0|||
48890556|NCT03140280|157435883|FG000|Overall Study|Physician Decision|5|||
48890557|NCT04476251|157435886|FG000|Overall Study|Not treated|1|||
48890558|NCT00663702|157435892|FG000|Overall Study|Adverse Event|8|||
48890559|NCT00663702|157435893|FG001|Overall Study|Adverse Event|4|||
48890560|NCT00663702|157435892|FG000|Overall Study|Withdrawal by Subject|3|||
48890561|NCT00663702|157435893|FG001|Overall Study|Withdrawal by Subject|1|||
48890562|NCT00663702|157435892|FG000|Overall Study|Pregnancy|0|||
48890563|NCT00663702|157435893|FG001|Overall Study|Pregnancy|1|||
48890564|NCT00663702|157435892|FG000|Overall Study|Lost to Follow-up|3|||
48890565|NCT00663702|157435893|FG001|Overall Study|Lost to Follow-up|0|||
48890566|NCT00663702|157435892|FG000|Overall Study|Death|1|||
48890567|NCT00663702|157435893|FG001|Overall Study|Death|1|||
48890568|NCT00663702|157435892|FG000|Overall Study|Lack of Efficacy|3|||
48890569|NCT00663702|157435893|FG001|Overall Study|Lack of Efficacy|3|||
48890570|NCT00626990|157435894|FG000|Overall Study|Lack of Efficacy|6|||
48890571|NCT00626990|157435895|FG001|Overall Study|Lack of Efficacy|7|||
48890572|NCT00626990|157435896|FG002|Overall Study|Lack of Efficacy|49|||
48890573|NCT00626990|157435897|FG003|Overall Study|Lack of Efficacy|40|||
48890574|NCT00626990|157435894|FG000|Overall Study|Adverse Event|1|||
48890575|NCT00626990|157435895|FG001|Overall Study|Adverse Event|7|||
48890576|NCT00626990|157435896|FG002|Overall Study|Adverse Event|14|||
48890577|NCT00626990|157435897|FG003|Overall Study|Adverse Event|28|||
48890578|NCT00626990|157435894|FG000|Overall Study|Death|0|||
49037052|NCT01075282|157971230|FG001|Overall Study|Withdrawal by Subject|7|||
49037053|NCT01075282|157971231|FG002|Overall Study|Withdrawal by Subject|11|||
49037054|NCT01075282|157971229|FG000|Overall Study|Adverse Event|9|||
48890579|NCT00626990|157435895|FG001|Overall Study|Death|1|||
49037055|NCT01075282|157971230|FG001|Overall Study|Adverse Event|8|||
48890580|NCT00626990|157435896|FG002|Overall Study|Death|0|||
48890581|NCT00626990|157435897|FG003|Overall Study|Death|0|||
48890582|NCT00626990|157435894|FG000|Overall Study|Withdrawal by Subject|3|||
48890583|NCT00626990|157435895|FG001|Overall Study|Withdrawal by Subject|1|||
48890584|NCT00626990|157435896|FG002|Overall Study|Withdrawal by Subject|5|||
48890585|NCT00626990|157435897|FG003|Overall Study|Withdrawal by Subject|11|||
48890586|NCT00626990|157435894|FG000|Overall Study|Protocol Violation|0|||
49037056|NCT01075282|157971231|FG002|Overall Study|Adverse Event|5|||
49037057|NCT01075282|157971229|FG000|Overall Study|Entry Criteria Not Met|3|||
49037058|NCT01075282|157971230|FG001|Overall Study|Entry Criteria Not Met|2|||
49037059|NCT01075282|157971231|FG002|Overall Study|Entry Criteria Not Met|0|||
49037060|NCT01075282|157971229|FG000|Overall Study|Lost to Follow-up|3|||
49037061|NCT01075282|157971230|FG001|Overall Study|Lost to Follow-up|3|||
49037062|NCT01075282|157971231|FG002|Overall Study|Lost to Follow-up|3|||
49037063|NCT01075282|157971229|FG000|Overall Study|Physician Decision|3|||
49037064|NCT01075282|157971230|FG001|Overall Study|Physician Decision|3|||
49037065|NCT01075282|157971231|FG002|Overall Study|Physician Decision|3|||
49037066|NCT01075282|157971229|FG000|Overall Study|Lack of Efficacy|1|||
49037067|NCT01075282|157971230|FG001|Overall Study|Lack of Efficacy|1|||
49037068|NCT01075282|157971231|FG002|Overall Study|Lack of Efficacy|0|||
49037069|NCT01075282|157971229|FG000|Overall Study|Treatment Non-compliance|1|||
49037070|NCT01075282|157971230|FG001|Overall Study|Treatment Non-compliance|2|||
49037071|NCT01075282|157971231|FG002|Overall Study|Treatment Non-compliance|2|||
49037072|NCT01075282|157971229|FG000|Overall Study|Protocol Violation|0|||
49037073|NCT01075282|157971230|FG001|Overall Study|Protocol Violation|2|||
49037074|NCT01075282|157971231|FG002|Overall Study|Protocol Violation|1|||
49037075|NCT01075282|157971229|FG000|Overall Study|Death|0|||
49037076|NCT01075282|157971230|FG001|Overall Study|Death|1|||
49037077|NCT01075282|157971231|FG002|Overall Study|Death|2|||
49037078|NCT01559363|157971243|FG000|Phase 1b: Up to 36 Months|Withdrawal by Subject|2|||
49037079|NCT01559363|157971244|FG001|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
49037080|NCT01559363|157971245|FG002|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
49037081|NCT01559363|157971246|FG003|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
49037082|NCT01559363|157971247|FG004|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
49037083|NCT01559363|157971248|FG005|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
49037084|NCT01559363|157971243|FG000|Phase 1b: Up to 36 Months|Investigator decision|1|||
49037085|NCT01559363|157971244|FG001|Phase 1b: Up to 36 Months|Investigator decision|0|||
49037086|NCT01559363|157971245|FG002|Phase 1b: Up to 36 Months|Investigator decision|0|||
49037087|NCT01559363|157971246|FG003|Phase 1b: Up to 36 Months|Investigator decision|0|||
49037088|NCT01559363|157971247|FG004|Phase 1b: Up to 36 Months|Investigator decision|0|||
49037089|NCT01559363|157971248|FG005|Phase 1b: Up to 36 Months|Investigator decision|0|||
48890587|NCT00626990|157435895|FG001|Overall Study|Protocol Violation|1|||
48890588|NCT00626990|157435896|FG002|Overall Study|Protocol Violation|1|||
48890589|NCT00626990|157435897|FG003|Overall Study|Protocol Violation|0|||
48890590|NCT00626990|157435894|FG000|Overall Study|Various different reasons/missing|4|||
48890591|NCT00626990|157435895|FG001|Overall Study|Various different reasons/missing|8|||
48890592|NCT00626990|157435896|FG002|Overall Study|Various different reasons/missing|8|||
48890593|NCT00626990|157435897|FG003|Overall Study|Various different reasons/missing|16|||
48890594|NCT02187159|157435898|FG000|Overall Study|Protocol Violation|4|||
48890595|NCT02187159|157435899|FG001|Overall Study|Protocol Violation|6|||
48890596|NCT02187159|157435900|FG002|Overall Study|Protocol Violation|3|||
48890597|NCT02187159|157435901|FG003|Overall Study|Protocol Violation|4|||
48890598|NCT02187159|157435898|FG000|Overall Study|Lack of Efficacy|10|||
48890599|NCT02187159|157435899|FG001|Overall Study|Lack of Efficacy|5|||
48890600|NCT02187159|157435900|FG002|Overall Study|Lack of Efficacy|4|||
48890601|NCT02187159|157435901|FG003|Overall Study|Lack of Efficacy|7|||
48890602|NCT02187159|157435898|FG000|Overall Study|Adverse Event|28|||
48890603|NCT02187159|157435899|FG001|Overall Study|Adverse Event|33|||
48890604|NCT02187159|157435900|FG002|Overall Study|Adverse Event|42|||
48890605|NCT02187159|157435901|FG003|Overall Study|Adverse Event|50|||
48890606|NCT02187159|157435898|FG000|Overall Study|Withdrawal by Subject|24|||
48890607|NCT02187159|157435899|FG001|Overall Study|Withdrawal by Subject|28|||
48890608|NCT02187159|157435900|FG002|Overall Study|Withdrawal by Subject|25|||
48890609|NCT02187159|157435901|FG003|Overall Study|Withdrawal by Subject|26|||
48890610|NCT02187159|157435898|FG000|Overall Study|Other|3|||
48890611|NCT02187159|157435899|FG001|Overall Study|Other|7|||
48890612|NCT02187159|157435900|FG002|Overall Study|Other|3|||
48890613|NCT02187159|157435901|FG003|Overall Study|Other|9|||
48890614|NCT03482466|157435904|FG000|Overall Study|Protocol Violation|2|||
48890615|NCT03896152|157435909|FG000|Overall Study|Patient/guardian decision|1|||
49037090|NCT01559363|157971243|FG000|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
49037091|NCT01559363|157971244|FG001|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
49037092|NCT01559363|157971245|FG002|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
49037093|NCT01559363|157971246|FG003|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
49037094|NCT01559363|157971247|FG004|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
49037095|NCT01559363|157971248|FG005|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
49037096|NCT01559363|157971243|FG000|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|2|||
48890616|NCT03896152|157435910|FG001|Overall Study|Patient/guardian decision|1|||
48890617|NCT03896152|157435909|FG000|Overall Study|Adverse Event|0|||
48890618|NCT03896152|157435910|FG001|Overall Study|Adverse Event|1|||
48890619|NCT03896152|157435909|FG000|Overall Study|Physician Decision|1|||
48890620|NCT03896152|157435910|FG001|Overall Study|Physician Decision|0|||
48890621|NCT03896152|157435909|FG000|Overall Study|Technical problems|1|||
48890622|NCT03896152|157435910|FG001|Overall Study|Technical problems|0|||
48890623|NCT00436852|157435911|FG000|Overall Study|Death|23|||
48890624|NCT00436852|157435912|FG001|Overall Study|Death|34|||
48890625|NCT00436852|157435911|FG000|Overall Study|Lack of Efficacy|9|||
48890626|NCT00436852|157435912|FG001|Overall Study|Lack of Efficacy|7|||
48890627|NCT00436852|157435911|FG000|Overall Study|Withdrawal by Subject|2|||
48890628|NCT00436852|157435912|FG001|Overall Study|Withdrawal by Subject|4|||
48890629|NCT00436852|157435911|FG000|Overall Study|Ineligible|1|||
48890630|NCT00436852|157435912|FG001|Overall Study|Ineligible|0|||
48890631|NCT03167359|157435913|FG000|Overall Study|Physician Decision|1|||
48890632|NCT03167359|157435913|FG000|Overall Study|Lost to Follow-up|1|||
48890633|NCT03339583|157435914|FG000|First Intervention (14 Days)|Adverse Event|1|||
48890634|NCT03339583|157435915|FG001|First Intervention (14 Days)|Adverse Event|0|||
48890635|NCT03339583|157435914|FG000|Second Intervention (14 Days)|unrelated acute exacerbation|0|||
48890636|NCT03339583|157435915|FG001|Second Intervention (14 Days)|unrelated acute exacerbation|1|||
48890637|NCT03339583|157435914|FG000|Second Intervention (14 Days)|Adverse Event|0|||
48890638|NCT03339583|157435915|FG001|Second Intervention (14 Days)|Adverse Event|1|||
48890639|NCT03339583|157435914|FG000|Follow-up (14 Days)|Physician Decision|6|||
48890640|NCT03339583|157435915|FG001|Follow-up (14 Days)|Physician Decision|3|||
48890641|NCT02141620|157435916|FG000|Treatment Condition 1 (7 Days)|Adverse Event|1|||
48890642|NCT02141620|157435917|FG001|Treatment Condition 1 (7 Days)|Adverse Event|0|||
48890643|NCT01004848|157435922|FG000|Overall Study|Lost to Follow-up|55|||
48890644|NCT01004848|157435923|FG001|Overall Study|Lost to Follow-up|45|||
48890645|NCT03582943|157435924|FG000|Allocated to Groups|Withdrawal by Subject|1|||
48890646|NCT03582943|157435925|FG001|Allocated to Groups|Withdrawal by Subject|1|||
48890647|NCT03582943|157435924|FG000|Intervention and Follow up|Withdrawal by Subject|4|||
48890648|NCT03582943|157435925|FG001|Intervention and Follow up|Withdrawal by Subject|2|||
48890649|NCT03582943|157435924|FG000|Analyzed|Protocol Violation|4|||
48890650|NCT03582943|157435925|FG001|Analyzed|Protocol Violation|1|||
48890651|NCT01416389|157435928|FG000|Overall Study|Lost to Follow-up|1|||
48890652|NCT01416389|157435929|FG001|Overall Study|Lost to Follow-up|0|||
48890653|NCT01416389|157435928|FG000|Overall Study|Started New Therapy|2|||
48890654|NCT01416389|157435929|FG001|Overall Study|Started New Therapy|0|||
48890655|NCT01127763|157435930|FG000|Overall Study|Adverse Event|2|||
48890656|NCT01127763|157435930|FG000|Overall Study|Withdrawal by Subject|1|||
48890657|NCT01127763|157435930|FG000|Overall Study|Physician Decision|2|||
48890658|NCT01528345|157435934|FG000|Overall Study|Adverse Event|10|||
48890659|NCT01528345|157435935|FG001|Overall Study|Adverse Event|1|||
48890660|NCT01528345|157435934|FG000|Overall Study|Death|1|||
48890661|NCT01528345|157435935|FG001|Overall Study|Death|1|||
48890662|NCT01528345|157435934|FG000|Overall Study|Non-compliance with study treatment|1|||
48890663|NCT01528345|157435935|FG001|Overall Study|Non-compliance with study treatment|0|||
48890664|NCT01528345|157435934|FG000|Overall Study|Progressive Disease|26|||
48890665|NCT01528345|157435935|FG001|Overall Study|Progressive Disease|40|||
48890666|NCT01528345|157435934|FG000|Overall Study|Study Terminated by Sponsor|4|||
48890667|NCT01528345|157435935|FG001|Overall Study|Study Terminated by Sponsor|8|||
48890668|NCT01528345|157435934|FG000|Overall Study|Subject/Guardian Decision|5|||
48890669|NCT01528345|157435935|FG001|Overall Study|Subject/Guardian Decision|0|||
48890670|NCT02971761|157435938|FG000|Overall Study|GTx-024 drug supply was withdrawn|2|||
48890671|NCT00735475|157435940|FG000|Overall Study|Adverse Event|0|||
48890672|NCT00735475|157435941|FG001|Overall Study|Adverse Event|1|||
48890673|NCT00735475|157435940|FG000|Overall Study|Death|1|||
48890674|NCT00735475|157435941|FG001|Overall Study|Death|1|||
48890675|NCT00735475|157435940|FG000|Overall Study|Lost to Follow-up|3|||
48890676|NCT00735475|157435941|FG001|Overall Study|Lost to Follow-up|3|||
48890677|NCT00735475|157435940|FG000|Overall Study|Physician Decision|0|||
48890678|NCT00735475|157435941|FG001|Overall Study|Physician Decision|1|||
48890679|NCT00735475|157435940|FG000|Overall Study|Withdrawal by Subject|4|||
48890680|NCT00735475|157435941|FG001|Overall Study|Withdrawal by Subject|5|||
48890681|NCT00548262|157435942|FG000|Overall Study|Death|21|||
48890682|NCT00548262|157435942|FG000|Overall Study|Adverse Event|2|||
48890683|NCT00548262|157435942|FG000|Overall Study|Lack of Efficacy|4|||
48890684|NCT00548262|157435942|FG000|Overall Study|Lost to Follow-up|1|||
48890685|NCT00548262|157435942|FG000|Overall Study|Other|3|||
48890686|NCT00548262|157435942|FG000|Overall Study|Withdrawal by Subject|1|||
48890687|NCT02285153|157435943|FG000|Overall Study|Adverse Event|1|||
48890688|NCT02285153|157435944|FG001|Overall Study|Adverse Event|0|||
48890689|NCT01283516|157435950|FG000|Overall Study|Adverse Event|0|||
48890690|NCT01283516|157435951|FG001|Overall Study|Adverse Event|0|||
48890691|NCT01283516|157435952|FG002|Overall Study|Adverse Event|0|||
48890692|NCT01283516|157435953|FG003|Overall Study|Adverse Event|0|||
48890693|NCT01283516|157435954|FG004|Overall Study|Adverse Event|0|||
48890694|NCT01283516|157435955|FG005|Overall Study|Adverse Event|0|||
48890695|NCT01283516|157435956|FG006|Overall Study|Adverse Event|2|||
48890696|NCT01283516|157435957|FG007|Overall Study|Adverse Event|0|||
48890697|NCT01283516|157435958|FG008|Overall Study|Adverse Event|28|||
48890698|NCT01283516|157435950|FG000|Overall Study|Death|0|||
48890699|NCT01283516|157435951|FG001|Overall Study|Death|0|||
48890700|NCT01283516|157435952|FG002|Overall Study|Death|0|||
48890701|NCT01283516|157435953|FG003|Overall Study|Death|0|||
48890702|NCT01283516|157435954|FG004|Overall Study|Death|0|||
48890703|NCT01283516|157435955|FG005|Overall Study|Death|1|||
48890704|NCT01283516|157435956|FG006|Overall Study|Death|0|||
48890705|NCT01283516|157435957|FG007|Overall Study|Death|1|||
48890706|NCT01283516|157435958|FG008|Overall Study|Death|12|||
48890707|NCT01283516|157435950|FG000|Overall Study|Disease Progression|2|||
48890708|NCT01283516|157435951|FG001|Overall Study|Disease Progression|2|||
48890709|NCT01283516|157435952|FG002|Overall Study|Disease Progression|3|||
48890710|NCT01283516|157435953|FG003|Overall Study|Disease Progression|3|||
48890711|NCT01283516|157435954|FG004|Overall Study|Disease Progression|13|||
48890712|NCT01283516|157435955|FG005|Overall Study|Disease Progression|8|||
48890713|NCT01283516|157435956|FG006|Overall Study|Disease Progression|6|||
48890714|NCT01283516|157435957|FG007|Overall Study|Disease Progression|3|||
48890715|NCT01283516|157435958|FG008|Overall Study|Disease Progression|139|||
48890716|NCT01283516|157435950|FG000|Overall Study|Withdrawal by Subject|0|||
48890717|NCT01283516|157435951|FG001|Overall Study|Withdrawal by Subject|0|||
48890718|NCT01283516|157435952|FG002|Overall Study|Withdrawal by Subject|0|||
48890719|NCT01283516|157435953|FG003|Overall Study|Withdrawal by Subject|0|||
48890720|NCT01283516|157435954|FG004|Overall Study|Withdrawal by Subject|1|||
48890721|NCT01283516|157435955|FG005|Overall Study|Withdrawal by Subject|0|||
48890722|NCT01283516|157435956|FG006|Overall Study|Withdrawal by Subject|1|||
48890723|NCT01283516|157435957|FG007|Overall Study|Withdrawal by Subject|0|||
48890724|NCT01283516|157435958|FG008|Overall Study|Withdrawal by Subject|36|||
48890725|NCT01283516|157435950|FG000|Overall Study|Administrative problems|0|||
48890726|NCT01283516|157435951|FG001|Overall Study|Administrative problems|0|||
48890727|NCT01283516|157435952|FG002|Overall Study|Administrative problems|0|||
48890728|NCT01283516|157435953|FG003|Overall Study|Administrative problems|0|||
48890729|NCT01283516|157435954|FG004|Overall Study|Administrative problems|0|||
48890730|NCT01283516|157435955|FG005|Overall Study|Administrative problems|1|||
48890731|NCT01283516|157435956|FG006|Overall Study|Administrative problems|1|||
48890732|NCT01283516|157435957|FG007|Overall Study|Administrative problems|1|||
48890733|NCT01283516|157435958|FG008|Overall Study|Administrative problems|39|||
48890734|NCT01283516|157435950|FG000|Overall Study|Lost to Follow-up|0|||
48890735|NCT01283516|157435951|FG001|Overall Study|Lost to Follow-up|0|||
48890736|NCT01283516|157435952|FG002|Overall Study|Lost to Follow-up|0|||
48890737|NCT01283516|157435953|FG003|Overall Study|Lost to Follow-up|0|||
48890738|NCT01283516|157435954|FG004|Overall Study|Lost to Follow-up|0|||
48890739|NCT01283516|157435955|FG005|Overall Study|Lost to Follow-up|0|||
48890740|NCT01283516|157435956|FG006|Overall Study|Lost to Follow-up|0|||
48890741|NCT01283516|157435957|FG007|Overall Study|Lost to Follow-up|0|||
48890742|NCT01283516|157435958|FG008|Overall Study|Lost to Follow-up|1|||
48890743|NCT00998790|157435961|FG000|Overall Study|Withdrawal by Subject|21|||
48890744|NCT02576587|157435962|FG000|Baseline|Equipment failure|0|||
48890745|NCT02576587|157435963|FG001|Baseline|Equipment failure|1|||
48890746|NCT02576587|157435962|FG000|Follow up Period (Case Only)|Withdrawal by Subject|25|||
48890747|NCT02576587|157435963|FG001|Follow up Period (Case Only)|Withdrawal by Subject|0|||
48890748|NCT02576587|157435962|FG000|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92|||
48890749|NCT02576587|157435963|FG001|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0|||
48890750|NCT02576587|157435962|FG000|Follow up Period (Case Only)|Controls not eligible for followup|0|||
48890751|NCT02576587|157435963|FG001|Follow up Period (Case Only)|Controls not eligible for followup|155|||
48890752|NCT00532493|157435966|FG000|Overall Study|Death|1|||
48890753|NCT00532493|157435967|FG001|Overall Study|Death|1|||
48890754|NCT00532493|157435966|FG000|Overall Study|Lost to Follow-up|10|||
48890755|NCT00532493|157435967|FG001|Overall Study|Lost to Follow-up|7|||
48890756|NCT00532493|157435966|FG000|Overall Study|Withdrawal by Subject|7|||
48890757|NCT00532493|157435967|FG001|Overall Study|Withdrawal by Subject|9|||
48890758|NCT00532493|157435966|FG000|Overall Study|Physician Decision|1|||
49037097|NCT01559363|157971244|FG001|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
49037098|NCT01559363|157971245|FG002|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|1|||
49037099|NCT01559363|157971246|FG003|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
49037100|NCT01559363|157971247|FG004|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
49037101|NCT01559363|157971248|FG005|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
49037102|NCT01559363|157971243|FG000|Phase 1b: Up to 36 Months|Unspecified reason|0|||
48890759|NCT00532493|157435967|FG001|Overall Study|Physician Decision|6|||
48890760|NCT00532493|157435966|FG000|Overall Study|Adverse Event|6|||
48890761|NCT00532493|157435967|FG001|Overall Study|Adverse Event|5|||
48890762|NCT00532493|157435966|FG000|Overall Study|Protocol Deviation|1|||
48890763|NCT00532493|157435967|FG001|Overall Study|Protocol Deviation|0|||
48890764|NCT00532493|157435966|FG000|Overall Study|Subject Moved Away|3|||
48890765|NCT00532493|157435967|FG001|Overall Study|Subject Moved Away|1|||
48890766|NCT00532493|157435966|FG000|Overall Study|Contraindicative Medication|1|||
48890767|NCT00532493|157435967|FG001|Overall Study|Contraindicative Medication|0|||
48890768|NCT00444275|157435968|FG000|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
48890769|NCT00444275|157435969|FG001|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
48890770|NCT00444275|157435970|FG002|Maintenance Treatment Phase|Didn'r receive the treatment|22|||
48890771|NCT00444275|157435971|FG003|Maintenance Treatment Phase|Didn'r receive the treatment|17|||
48890772|NCT00444275|157435972|FG004|Maintenance Treatment Phase|Didn'r receive the treatment|29|||
48890773|NCT00444275|157435968|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
48890774|NCT00444275|157435969|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
48890775|NCT00444275|157435970|FG002|Maintenance Treatment Phase|Lost to Follow-up|8|||
48890776|NCT00444275|157435971|FG003|Maintenance Treatment Phase|Lost to Follow-up|14|||
48890777|NCT00444275|157435972|FG004|Maintenance Treatment Phase|Lost to Follow-up|10|||
48890778|NCT00444275|157435968|FG000|Maintenance Treatment Phase|Adverse Event|0|||
48890779|NCT00444275|157435969|FG001|Maintenance Treatment Phase|Adverse Event|0|||
48890780|NCT00444275|157435970|FG002|Maintenance Treatment Phase|Adverse Event|3|||
48890781|NCT00444275|157435971|FG003|Maintenance Treatment Phase|Adverse Event|2|||
48890782|NCT00444275|157435972|FG004|Maintenance Treatment Phase|Adverse Event|13|||
48890783|NCT00444275|157435968|FG000|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
48890784|NCT00444275|157435969|FG001|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
48890785|NCT00444275|157435970|FG002|Maintenance Treatment Phase|Protocol specific criteria's development|1|||
48890786|NCT00444275|157435971|FG003|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
48890787|NCT00444275|157435972|FG004|Maintenance Treatment Phase|Protocol specific criteria's development|6|||
48890788|NCT00444275|157435968|FG000|Maintenance Treatment Phase|Patient's wish|0|||
48890789|NCT00444275|157435969|FG001|Maintenance Treatment Phase|Patient's wish|0|||
48890790|NCT00444275|157435970|FG002|Maintenance Treatment Phase|Patient's wish|19|||
48890791|NCT00444275|157435971|FG003|Maintenance Treatment Phase|Patient's wish|9|||
48890792|NCT00444275|157435972|FG004|Maintenance Treatment Phase|Patient's wish|20|||
48890793|NCT00444275|157435968|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
48890794|NCT00444275|157435969|FG001|Maintenance Treatment Phase|Protocol Violation|0|||
48890795|NCT00444275|157435970|FG002|Maintenance Treatment Phase|Protocol Violation|103|||
48890796|NCT00444275|157435971|FG003|Maintenance Treatment Phase|Protocol Violation|88|||
48890797|NCT00444275|157435972|FG004|Maintenance Treatment Phase|Protocol Violation|87|||
48890798|NCT00444275|157435968|FG000|Maintenance Treatment Phase|Ineffectiveness|0|||
48890799|NCT00444275|157435969|FG001|Maintenance Treatment Phase|Ineffectiveness|0|||
48890800|NCT00444275|157435970|FG002|Maintenance Treatment Phase|Ineffectiveness|5|||
48890801|NCT00444275|157435971|FG003|Maintenance Treatment Phase|Ineffectiveness|3|||
48890802|NCT00444275|157435972|FG004|Maintenance Treatment Phase|Ineffectiveness|14|||
48890803|NCT02045875|157435973|FG000|Overall Study|Lost to Follow-up|3|||
48890804|NCT02045875|157435974|FG001|Overall Study|Lost to Follow-up|0|||
48890805|NCT02045875|157435973|FG000|Overall Study|Withdrawal by Subject|4|||
48890806|NCT02045875|157435974|FG001|Overall Study|Withdrawal by Subject|3|||
48890807|NCT02153073|157435975|FG000|Overall Study|Case Report Forms Uncollected|230|||
48890808|NCT02153073|157435975|FG000|Overall Study|Protocol Deviation|68|||
48890809|NCT03291288|157435976|FG000|Drug-drug Interaction Phase|Adverse Event|2|||
48890810|NCT03291288|157435977|FG001|Drug-drug Interaction Phase|Adverse Event|0|||
48890811|NCT03291288|157435976|FG000|Drug-drug Interaction Phase|Disease progression|1|||
48890812|NCT03291288|157435977|FG001|Drug-drug Interaction Phase|Disease progression|0|||
48890813|NCT03291288|157435976|FG000|Drug-drug Interaction Phase|Other|3|||
48890814|NCT03291288|157435977|FG001|Drug-drug Interaction Phase|Other|0|||
48890815|NCT03291288|157435976|FG000|Pexidartinib Only|Ongoing|0|||
48890816|NCT03291288|157435977|FG001|Pexidartinib Only|Ongoing|2|||
48890817|NCT01080716|157435978|FG000|Part 1|Physician Decision|1|||
48890818|NCT01080716|157435979|FG001|Part 1|Physician Decision|0|||
48890819|NCT01080716|157435980|FG002|Part 1|Physician Decision|0|||
48890820|NCT01080716|157435981|FG003|Part 1|Physician Decision|0|||
48890821|NCT01056718|157435982|FG000|Overall Study|Withdrawal by Subject|2|||
48890822|NCT01056718|157435982|FG000|Overall Study|Ischemia on baseline stress test|1|||
48890823|NCT01276379|157435983|FG000|Overall Study|Screening failure|40|||
48890824|NCT00287690|157435984|FG000|Overall Study|Protocol Violation|20|||
48890825|NCT00287690|157435985|FG001|Overall Study|Protocol Violation|26|||
48890826|NCT03592745|157435986|FG000|Overall Study|Adverse Event|0|||
48890827|NCT03592745|157435987|FG001|Overall Study|Adverse Event|2|||
48890828|NCT03592745|157435986|FG000|Overall Study|Lost to Follow-up|2|||
48890829|NCT03592745|157435987|FG001|Overall Study|Lost to Follow-up|0|||
48890830|NCT03592745|157435986|FG000|Overall Study|study temporary closure due to covid-19 pandemic|1|||
48890831|NCT03592745|157435987|FG001|Overall Study|study temporary closure due to covid-19 pandemic|1|||
48890832|NCT00864253|157435988|FG000|Overall Study|Adverse Event|56|||
48890833|NCT00864253|157435989|FG001|Overall Study|Adverse Event|11|||
48890834|NCT00864253|157435988|FG000|Overall Study|Unrelated Adverse Event|3|||
48890835|NCT00864253|157435989|FG001|Overall Study|Unrelated Adverse Event|1|||
48890836|NCT00864253|157435988|FG000|Overall Study|Physician Decision|11|||
48890837|NCT00864253|157435989|FG001|Overall Study|Physician Decision|15|||
48890838|NCT00864253|157435988|FG000|Overall Study|Protocol Violation|0|||
48890839|NCT00864253|157435989|FG001|Overall Study|Protocol Violation|2|||
48890840|NCT00864253|157435988|FG000|Overall Study|Lost to Follow-up|1|||
48890841|NCT00864253|157435989|FG001|Overall Study|Lost to Follow-up|1|||
48890842|NCT00864253|157435988|FG000|Overall Study|Withdrawal by Subject|18|||
48890843|NCT00864253|157435989|FG001|Overall Study|Withdrawal by Subject|18|||
48890844|NCT00864253|157435988|FG000|Overall Study|Death|1|||
48890845|NCT00864253|157435989|FG001|Overall Study|Death|0|||
48890846|NCT00864253|157435988|FG000|Overall Study|Ongoing|2|||
48890847|NCT00864253|157435989|FG001|Overall Study|Ongoing|3|||
48890848|NCT00864253|157435988|FG000|Overall Study|Untreated|7|||
48890849|NCT00864253|157435989|FG001|Overall Study|Untreated|7|||
48890850|NCT03590366|157435990|FG000|Overall Study|Adverse Event|0|||
48890851|NCT03590366|157435991|FG001|Overall Study|Adverse Event|3|||
48890852|NCT03590366|157435990|FG000|Overall Study|Lost to Follow-up|3|||
48890853|NCT03590366|157435991|FG001|Overall Study|Lost to Follow-up|3|||
48890854|NCT03590366|157435990|FG000|Overall Study|Withdrawal by Subject|0|||
48890855|NCT03590366|157435991|FG001|Overall Study|Withdrawal by Subject|2|||
48890856|NCT03309813|157435992|FG000|Main Randomized Study|Withdrawal by Subject|1|||
48890857|NCT03309813|157435993|FG001|Main Randomized Study|Withdrawal by Subject|0|||
48890858|NCT00738894|157435994|FG000|Overall Study|Lost to Follow-up|23|||
48890859|NCT00738894|157435995|FG001|Overall Study|Lost to Follow-up|13|||
48890860|NCT00738894|157435994|FG000|Overall Study|Withdrawal by Subject|10|||
48890861|NCT00738894|157435995|FG001|Overall Study|Withdrawal by Subject|15|||
48890862|NCT00738894|157435994|FG000|Overall Study|Physician Decision|4|||
48890863|NCT00738894|157435995|FG001|Overall Study|Physician Decision|5|||
48890864|NCT00738894|157435994|FG000|Overall Study|Death|2|||
48890865|NCT00738894|157435995|FG001|Overall Study|Death|0|||
48890866|NCT02656329|157435999|FG000|Overall Study|Lost to Follow-up|2|||
48890867|NCT02656329|157436000|FG001|Overall Study|Lost to Follow-up|3|||
48890868|NCT02656329|157435999|FG000|Overall Study|Withdrawal by Subject|7|||
48890869|NCT02656329|157436000|FG001|Overall Study|Withdrawal by Subject|6|||
48890870|NCT02656329|157435999|FG000|Overall Study|Study termination by Sponsor|150|||
48890871|NCT02656329|157436000|FG001|Overall Study|Study termination by Sponsor|142|||
48890872|NCT02656329|157435999|FG000|Overall Study|Other than specified above|5|||
48890873|NCT02656329|157436000|FG001|Overall Study|Other than specified above|6|||
48890874|NCT03208036|157436001|FG000|Baseline Assessment|Withdrawal by Subject|1|||
48890875|NCT03208036|157436002|FG001|Baseline Assessment|Withdrawal by Subject|1|||
48890876|NCT03208036|157436001|FG000|2nd Baseline Assessment|Withdrawal by Subject|1|||
48890877|NCT03208036|157436002|FG001|2nd Baseline Assessment|Withdrawal by Subject|2|||
48890878|NCT03208036|157436001|FG000|Intervention|Withdrawal by Subject|3|||
48890879|NCT03208036|157436002|FG001|Intervention|Withdrawal by Subject|2|||
48890880|NCT03208036|157436001|FG000|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|1|||
48890881|NCT03208036|157436002|FG001|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|2|||
48890882|NCT00700778|157436003|FG000|Overall Study|Inconclusive data due to inadequate sample collection|2|||
48890883|NCT04927247|157436004|FG000|Overall Study|Other|2|||
48890884|NCT04927247|157436005|FG001|Overall Study|Other|1|||
48890885|NCT04927247|157436004|FG000|Overall Study|Physician Decision|0|||
48890886|NCT04927247|157436005|FG001|Overall Study|Physician Decision|1|||
48890887|NCT04927247|157436004|FG000|Overall Study|Adverse Event|1|||
48890888|NCT04927247|157436005|FG001|Overall Study|Adverse Event|0|||
48890889|NCT00591851|157436006|FG000|Overall Study|Withdrawal by Subject|3|||
48890890|NCT00591851|157436006|FG000|Overall Study|Adverse Event|2|||
48890891|NCT00591851|157436006|FG000|Overall Study|Progressive Disease|1|||
48890892|NCT00704405|157436007|FG000|Overall Study (NC Population)|Adverse Event|1|||
48890893|NCT00704405|157436008|FG001|Overall Study (NC Population)|Adverse Event|0|||
48890894|NCT00704405|157436009|FG002|Overall Study (NC Population)|Adverse Event|0|||
48796734|NCT00698646|157093781|FG001|Overall Study|Adverse Event|7|||
48796735|NCT00698646|157093782|FG002|Overall Study|Adverse Event|8|||
48796736|NCT00698646|157093780|FG000|Overall Study|Unsatisfactory Therapeutic Effect|11|||
48796737|NCT00698646|157093781|FG001|Overall Study|Unsatisfactory Therapeutic Effect|11|||
48796738|NCT00698646|157093782|FG002|Overall Study|Unsatisfactory Therapeutic Effect|7|||
48796739|NCT00698646|157093780|FG000|Overall Study|Protocol Deviation|6|||
48796740|NCT00698646|157093781|FG001|Overall Study|Protocol Deviation|2|||
48796741|NCT00698646|157093782|FG002|Overall Study|Protocol Deviation|3|||
48796742|NCT00698646|157093780|FG000|Overall Study|Withdrawal by Subject|10|||
48796743|NCT00698646|157093781|FG001|Overall Study|Withdrawal by Subject|11|||
48796744|NCT00698646|157093782|FG002|Overall Study|Withdrawal by Subject|8|||
48796745|NCT00698646|157093780|FG000|Overall Study|Lost to Follow-up|0|||
48796746|NCT00698646|157093781|FG001|Overall Study|Lost to Follow-up|0|||
48796747|NCT00698646|157093782|FG002|Overall Study|Lost to Follow-up|2|||
48796748|NCT00698646|157093780|FG000|Overall Study|Administrative problems|1|||
48796749|NCT00698646|157093781|FG001|Overall Study|Administrative problems|0|||
48796750|NCT00698646|157093782|FG002|Overall Study|Administrative problems|1|||
48796751|NCT02332590|157093783|FG000|DB Period (up to 24 Weeks)|Adverse Event|15|||
48796752|NCT02332590|157093784|FG001|DB Period (up to 24 Weeks)|Adverse Event|11|||
48796753|NCT02332590|157093783|FG000|DB Period (up to 24 Weeks)|Lack of Efficacy|4|||
48796754|NCT02332590|157093784|FG001|DB Period (up to 24 Weeks)|Lack of Efficacy|2|||
48890895|NCT00704405|157436010|FG003|Overall Study (NC Population)|Adverse Event|0|||
48890896|NCT00704405|157436011|FG004|Overall Study (NC Population)|Adverse Event|0|||
48890897|NCT00704405|157436007|FG000|Overall Study (NC Population)|Lost to Follow-up|2|||
48890898|NCT00704405|157436008|FG001|Overall Study (NC Population)|Lost to Follow-up|1|||
48890899|NCT00704405|157436009|FG002|Overall Study (NC Population)|Lost to Follow-up|1|||
48890900|NCT00704405|157436010|FG003|Overall Study (NC Population)|Lost to Follow-up|2|||
48890901|NCT00704405|157436011|FG004|Overall Study (NC Population)|Lost to Follow-up|2|||
48890902|NCT00704405|157436007|FG000|Overall Study (NC Population)|Withdrawal by Subject|2|||
48890903|NCT00704405|157436008|FG001|Overall Study (NC Population)|Withdrawal by Subject|3|||
48890904|NCT00704405|157436009|FG002|Overall Study (NC Population)|Withdrawal by Subject|2|||
48890905|NCT00704405|157436010|FG003|Overall Study (NC Population)|Withdrawal by Subject|2|||
48890906|NCT00704405|157436011|FG004|Overall Study (NC Population)|Withdrawal by Subject|2|||
48890907|NCT00704405|157436007|FG000|Overall Study (NC Population)|Other|0|||
48890908|NCT00704405|157436008|FG001|Overall Study (NC Population)|Other|0|||
48890909|NCT00704405|157436009|FG002|Overall Study (NC Population)|Other|0|||
48890910|NCT00704405|157436010|FG003|Overall Study (NC Population)|Other|0|||
48890911|NCT00704405|157436011|FG004|Overall Study (NC Population)|Other|1|||
48890912|NCT00704405|157436007|FG000|Overall Study (C Population)|Withdrawal by Subject|1|||
48890913|NCT00704405|157436008|FG001|Overall Study (C Population)|Withdrawal by Subject|1|||
48890914|NCT00704405|157436009|FG002|Overall Study (C Population)|Withdrawal by Subject|1|||
48890915|NCT00704405|157436010|FG003|Overall Study (C Population)|Withdrawal by Subject|1|||
48890916|NCT00704405|157436011|FG004|Overall Study (C Population)|Withdrawal by Subject|0|||
48890917|NCT00704405|157436007|FG000|Overall Study (C Population)|Lost to Follow-up|0|||
48890918|NCT00704405|157436008|FG001|Overall Study (C Population)|Lost to Follow-up|2|||
48890919|NCT00704405|157436009|FG002|Overall Study (C Population)|Lost to Follow-up|0|||
48890920|NCT00704405|157436010|FG003|Overall Study (C Population)|Lost to Follow-up|0|||
48890921|NCT00704405|157436011|FG004|Overall Study (C Population)|Lost to Follow-up|0|||
48890922|NCT02101385|157436015|FG000|Study Treatment|Disease Progression|9|||
48890923|NCT02101385|157436016|FG001|Study Treatment|Disease Progression|3|||
48890924|NCT02101385|157436015|FG000|Study Treatment|Alternative therapy|0|||
48890925|NCT02101385|157436016|FG001|Study Treatment|Alternative therapy|1|||
48890926|NCT02101385|157436015|FG000|Study Treatment|No treatment, per protocol criteria|0|||
48890927|NCT02101385|157436016|FG001|Study Treatment|No treatment, per protocol criteria|4|||
48890928|NCT02101385|157436015|FG000|Study Treatment|Patient Non compliance|0|||
48890929|NCT02101385|157436016|FG001|Study Treatment|Patient Non compliance|2|||
48890930|NCT02101385|157436015|FG000|Study Treatment|Withdrawal by Subject|5|||
48890931|NCT02101385|157436016|FG001|Study Treatment|Withdrawal by Subject|2|||
48890932|NCT02101385|157436015|FG000|Study Treatment|screen failure|1|||
48890933|NCT02101385|157436016|FG001|Study Treatment|screen failure|0|||
48890934|NCT02101385|157436015|FG000|Study Treatment|AE/Side Effects/Complications|8|||
48890935|NCT02101385|157436016|FG001|Study Treatment|AE/Side Effects/Complications|0|||
48890936|NCT02101385|157436015|FG000|Study Treatment|Lost to Follow-up|1|||
48890937|NCT02101385|157436016|FG001|Study Treatment|Lost to Follow-up|0|||
48890938|NCT02101385|157436015|FG000|Study Treatment|Disease Progression before treatment|1|||
48890939|NCT02101385|157436016|FG001|Study Treatment|Disease Progression before treatment|0|||
48890940|NCT02101385|157436015|FG000|Study Treatment|Death|1|||
48890941|NCT02101385|157436016|FG001|Study Treatment|Death|0|||
48890942|NCT02101385|157436015|FG000|Follow up|Lost to Follow-up|4|||
48890943|NCT02101385|157436016|FG001|Follow up|Lost to Follow-up|9|||
48890944|NCT02101385|157436015|FG000|Follow up|Refused to follow up|5|||
48890945|NCT02101385|157436016|FG001|Follow up|Refused to follow up|4|||
48890946|NCT02101385|157436015|FG000|Follow up|Death|21|||
48890947|NCT02101385|157436016|FG001|Follow up|Death|39|||
48890948|NCT02101385|157436015|FG000|Follow up|study completed|33|||
48890949|NCT02101385|157436016|FG001|Follow up|study completed|52|||
48890950|NCT02101385|157436015|FG000|Follow up|screen failure|2|||
48890951|NCT02101385|157436016|FG001|Follow up|screen failure|0|||
48890952|NCT02101385|157436015|FG000|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|0|||
48890953|NCT02101385|157436016|FG001|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|1|||
48890954|NCT02101385|157436015|FG000|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|0|||
48890955|NCT02101385|157436016|FG001|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|1|||
48890956|NCT02101385|157436015|FG000|Follow up|Withdrawal by Subject|2|||
48890957|NCT02101385|157436016|FG001|Follow up|Withdrawal by Subject|2|||
48890958|NCT02101385|157436015|FG000|Follow up|PI requested closure of site|0|||
48890959|NCT02101385|157436016|FG001|Follow up|PI requested closure of site|5|||
48890960|NCT00847808|157436017|FG000|Overall Study|Adverse Event|7|||
48890961|NCT00847808|157436017|FG000|Overall Study|Protocol Violation|1|||
48890962|NCT00847808|157436017|FG000|Overall Study|Lost to Follow-up|1|||
48890963|NCT00847808|157436017|FG000|Overall Study|Withdrawal by Subject|4|||
48890964|NCT00847808|157436017|FG000|Overall Study|Participant Reported Lack of Efficacy|1|||
48890965|NCT00847808|157436017|FG000|Overall Study|Participant Took Excluded Medication|1|||
48890966|NCT02760498|157436018|FG000|Overall Study|Adverse Event|3|||
48890967|NCT02760498|157436019|FG001|Overall Study|Adverse Event|3|||
48890968|NCT02760498|157436020|FG002|Overall Study|Adverse Event|1|||
48890969|NCT02760498|157436021|FG003|Overall Study|Adverse Event|1|||
49037103|NCT01559363|157971244|FG001|Phase 1b: Up to 36 Months|Unspecified reason|1|||
49037104|NCT01559363|157971245|FG002|Phase 1b: Up to 36 Months|Unspecified reason|0|||
49037105|NCT01559363|157971246|FG003|Phase 1b: Up to 36 Months|Unspecified reason|0|||
48796755|NCT02332590|157093783|FG000|DB Period (up to 24 Weeks)|Poor compliance to protocol|3|||
48796756|NCT02332590|157093784|FG001|DB Period (up to 24 Weeks)|Poor compliance to protocol|1|||
48796757|NCT02332590|157093783|FG000|DB Period (up to 24 Weeks)|Randomized but not treated|1|||
48796758|NCT02332590|157093784|FG001|DB Period (up to 24 Weeks)|Randomized but not treated|0|||
48796759|NCT02332590|157093783|FG000|DB Period (up to 24 Weeks)|Other than specified above|6|||
48796760|NCT02332590|157093784|FG001|DB Period (up to 24 Weeks)|Other than specified above|5|||
48796761|NCT02332590|157093783|FG000|OLE Period (Week 24 up to Week 300)|Adverse Event|20|||
48796762|NCT02332590|157093784|FG001|OLE Period (Week 24 up to Week 300)|Adverse Event|23|||
48796763|NCT02332590|157093783|FG000|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|2|||
48796764|NCT02332590|157093784|FG001|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|6|||
48796765|NCT02332590|157093783|FG000|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|5|||
48796766|NCT02332590|157093784|FG001|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|1|||
48796767|NCT02332590|157093783|FG000|OLE Period (Week 24 up to Week 300)|Other Unspecified|20|||
48796768|NCT02332590|157093784|FG001|OLE Period (Week 24 up to Week 300)|Other Unspecified|15|||
48796769|NCT00981084|157093792|FG000|Post Intervention (Data Analysis)|poor effort|1|||
48796770|NCT00981084|157093793|FG001|Post Intervention (Data Analysis)|poor effort|1|||
48796771|NCT00981084|157093792|FG000|Post Intervention (Data Analysis)|imbalance in disease subtype|1|||
48796772|NCT00981084|157093793|FG001|Post Intervention (Data Analysis)|imbalance in disease subtype|0|||
48796773|NCT01112579|157093794|FG000|Overall Study|Missed Visit|1|||
48796774|NCT01112579|157093795|FG001|Overall Study|Missed Visit|1|||
48796775|NCT01112579|157093794|FG000|Overall Study|Death|0|||
48796776|NCT01112579|157093795|FG001|Overall Study|Death|2|||
48796777|NCT01951625|157093798|FG000|Treatment Period|Protocol Violation|2|||
48796778|NCT01951625|157093799|FG001|Treatment Period|Protocol Violation|0|||
48796779|NCT01951625|157093800|FG002|Treatment Period|Protocol Violation|1|||
48796780|NCT01951625|157093801|FG003|Treatment Period|Protocol Violation|3|||
48796781|NCT01951625|157093802|FG004|Treatment Period|Protocol Violation|2|||
48796782|NCT01951625|157093798|FG000|Treatment Period|Physician Decision|0|||
48796783|NCT01951625|157093799|FG001|Treatment Period|Physician Decision|0|||
48796784|NCT01951625|157093800|FG002|Treatment Period|Physician Decision|0|||
48796785|NCT01951625|157093801|FG003|Treatment Period|Physician Decision|0|||
48796786|NCT01951625|157093802|FG004|Treatment Period|Physician Decision|1|||
48796787|NCT01951625|157093798|FG000|Treatment Period|Protocol driven decision point|0|||
48796788|NCT01951625|157093799|FG001|Treatment Period|Protocol driven decision point|5|||
48796789|NCT01951625|157093800|FG002|Treatment Period|Protocol driven decision point|0|||
48796790|NCT01951625|157093801|FG003|Treatment Period|Protocol driven decision point|2|||
48796791|NCT01951625|157093802|FG004|Treatment Period|Protocol driven decision point|1|||
48796792|NCT01951625|157093798|FG000|Treatment Period|Non compliance with study drug|1|||
48796793|NCT01951625|157093799|FG001|Treatment Period|Non compliance with study drug|2|||
48796794|NCT01951625|157093800|FG002|Treatment Period|Non compliance with study drug|2|||
48796795|NCT01951625|157093801|FG003|Treatment Period|Non compliance with study drug|0|||
48796796|NCT01951625|157093802|FG004|Treatment Period|Non compliance with study drug|0|||
48796797|NCT01951625|157093798|FG000|Treatment Period|Death|3|||
48796798|NCT01951625|157093799|FG001|Treatment Period|Death|2|||
48796799|NCT01951625|157093800|FG002|Treatment Period|Death|2|||
48796800|NCT01951625|157093801|FG003|Treatment Period|Death|1|||
48796801|NCT01951625|157093802|FG004|Treatment Period|Death|2|||
48796802|NCT01951625|157093798|FG000|Treatment Period|Adverse Event|7|||
48796803|NCT01951625|157093799|FG001|Treatment Period|Adverse Event|10|||
48796804|NCT01951625|157093800|FG002|Treatment Period|Adverse Event|9|||
48796805|NCT01951625|157093801|FG003|Treatment Period|Adverse Event|8|||
48796806|NCT01951625|157093802|FG004|Treatment Period|Adverse Event|8|||
48796807|NCT01951625|157093798|FG000|Treatment Period|Withdrawal by Subject|5|||
48796808|NCT01951625|157093799|FG001|Treatment Period|Withdrawal by Subject|2|||
48796809|NCT01951625|157093800|FG002|Treatment Period|Withdrawal by Subject|1|||
48796810|NCT01951625|157093801|FG003|Treatment Period|Withdrawal by Subject|7|||
48796811|NCT01951625|157093802|FG004|Treatment Period|Withdrawal by Subject|3|||
48796812|NCT01951625|157093798|FG000|Treatment Period|Lost to Follow-up|1|||
48796813|NCT01951625|157093799|FG001|Treatment Period|Lost to Follow-up|0|||
48796814|NCT01951625|157093800|FG002|Treatment Period|Lost to Follow-up|0|||
48796815|NCT01951625|157093801|FG003|Treatment Period|Lost to Follow-up|1|||
48796816|NCT01951625|157093802|FG004|Treatment Period|Lost to Follow-up|0|||
48796817|NCT01951625|157093798|FG000|Follow Up Period|Non-compliance with study drug|1|||
48796818|NCT01951625|157093799|FG001|Follow Up Period|Non-compliance with study drug|0|||
48796819|NCT01951625|157093800|FG002|Follow Up Period|Non-compliance with study drug|0|||
48796820|NCT01951625|157093801|FG003|Follow Up Period|Non-compliance with study drug|0|||
48796821|NCT01951625|157093802|FG004|Follow Up Period|Non-compliance with study drug|0|||
48796822|NCT01951625|157093798|FG000|Follow Up Period|Death|1|||
48796823|NCT01951625|157093799|FG001|Follow Up Period|Death|3|||
48796824|NCT01951625|157093800|FG002|Follow Up Period|Death|2|||
48796825|NCT01951625|157093801|FG003|Follow Up Period|Death|2|||
48890970|NCT02760498|157436022|FG004|Overall Study|Adverse Event|0|||
48890971|NCT02760498|157436023|FG005|Overall Study|Adverse Event|6|||
48890972|NCT02760498|157436018|FG000|Overall Study|Death|7|||
48890973|NCT02760498|157436019|FG001|Overall Study|Death|5|||
49037106|NCT01559363|157971247|FG004|Phase 1b: Up to 36 Months|Unspecified reason|0|||
49037107|NCT01559363|157971248|FG005|Phase 1b: Up to 36 Months|Unspecified reason|0|||
49037108|NCT01559363|157971243|FG000|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
49037109|NCT01559363|157971244|FG001|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
49037110|NCT01559363|157971245|FG002|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
49037111|NCT01559363|157971246|FG003|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
49037112|NCT01559363|157971247|FG004|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
49037113|NCT01559363|157971248|FG005|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
49037114|NCT01559363|157971243|FG000|Phase 2a: Up to 28 Months|Unspecified reason|0|||
49037115|NCT01559363|157971244|FG001|Phase 2a: Up to 28 Months|Unspecified reason|0|||
49037116|NCT01559363|157971245|FG002|Phase 2a: Up to 28 Months|Unspecified reason|0|||
49037117|NCT01559363|157971246|FG003|Phase 2a: Up to 28 Months|Unspecified reason|1|||
49037118|NCT01559363|157971247|FG004|Phase 2a: Up to 28 Months|Unspecified reason|0|||
49037119|NCT01559363|157971248|FG005|Phase 2a: Up to 28 Months|Unspecified reason|0|||
49037120|NCT01926119|157971252|FG000|Overall Study|Withdrawal by Subject|1|||
49037121|NCT00957021|157971253|FG000|Overall Study|Death|5|||
49037122|NCT00957021|157971253|FG000|Overall Study|Lost to Follow-up|8|||
49037123|NCT00957021|157971253|FG000|Overall Study|Withdrawal by Subject|34|||
49037124|NCT00957021|157971253|FG000|Overall Study|No 2 yr ROM data|35|||
49037125|NCT00957021|157971253|FG000|Overall Study|Revised study component by 2 yr visit|8|||
49037126|NCT00957021|157971253|FG000|Overall Study|Site Termination by the 2 yr visit|16|||
48890974|NCT02760498|157436020|FG002|Overall Study|Death|5|||
48890975|NCT02760498|157436021|FG003|Overall Study|Death|7|||
48890976|NCT02760498|157436022|FG004|Overall Study|Death|0|||
48890977|NCT02760498|157436023|FG005|Overall Study|Death|23|||
48890978|NCT02760498|157436018|FG000|Overall Study|Lost to Follow-up|0|||
48890979|NCT02760498|157436019|FG001|Overall Study|Lost to Follow-up|0|||
48890980|NCT02760498|157436020|FG002|Overall Study|Lost to Follow-up|0|||
48890981|NCT02760498|157436021|FG003|Overall Study|Lost to Follow-up|0|||
48890982|NCT02760498|157436022|FG004|Overall Study|Lost to Follow-up|0|||
48890983|NCT02760498|157436023|FG005|Overall Study|Lost to Follow-up|3|||
48890984|NCT02760498|157436018|FG000|Overall Study|Non-compliance with study drug|0|||
48890985|NCT02760498|157436019|FG001|Overall Study|Non-compliance with study drug|2|||
48890986|NCT02760498|157436020|FG002|Overall Study|Non-compliance with study drug|0|||
48890987|NCT02760498|157436021|FG003|Overall Study|Non-compliance with study drug|0|||
48890988|NCT02760498|157436022|FG004|Overall Study|Non-compliance with study drug|0|||
48890989|NCT02760498|157436023|FG005|Overall Study|Non-compliance with study drug|0|||
48890990|NCT02760498|157436018|FG000|Overall Study|Participant decision|1|||
48890991|NCT02760498|157436019|FG001|Overall Study|Participant decision|4|||
48890992|NCT02760498|157436020|FG002|Overall Study|Participant decision|2|||
48890993|NCT02760498|157436021|FG003|Overall Study|Participant decision|2|||
48890994|NCT02760498|157436022|FG004|Overall Study|Participant decision|1|||
48890995|NCT02760498|157436023|FG005|Overall Study|Participant decision|6|||
48890996|NCT02760498|157436018|FG000|Overall Study|Sponsor decision|0|||
48890997|NCT02760498|157436019|FG001|Overall Study|Sponsor decision|0|||
48890998|NCT02760498|157436020|FG002|Overall Study|Sponsor decision|0|||
48890999|NCT02760498|157436021|FG003|Overall Study|Sponsor decision|3|||
48891000|NCT02760498|157436022|FG004|Overall Study|Sponsor decision|0|||
48891001|NCT02760498|157436023|FG005|Overall Study|Sponsor decision|0|||
48891002|NCT02760498|157436018|FG000|Overall Study|Physician Decision|3|||
48891003|NCT02760498|157436019|FG001|Overall Study|Physician Decision|4|||
48891004|NCT02760498|157436020|FG002|Overall Study|Physician Decision|1|||
48891005|NCT02760498|157436021|FG003|Overall Study|Physician Decision|4|||
48891006|NCT02760498|157436022|FG004|Overall Study|Physician Decision|0|||
48891007|NCT02760498|157436023|FG005|Overall Study|Physician Decision|2|||
48891008|NCT02760498|157436018|FG000|Overall Study|Disease progression|21|||
48891009|NCT02760498|157436019|FG001|Overall Study|Disease progression|19|||
48891010|NCT02760498|157436020|FG002|Overall Study|Disease progression|20|||
48891011|NCT02760498|157436021|FG003|Overall Study|Disease progression|18|||
48891012|NCT02760498|157436022|FG004|Overall Study|Disease progression|4|||
48891013|NCT02760498|157436023|FG005|Overall Study|Disease progression|55|||
48891014|NCT02760498|157436018|FG000|Overall Study|Withdrawal by Subject|4|||
48891015|NCT02760498|157436019|FG001|Overall Study|Withdrawal by Subject|7|||
48891016|NCT02760498|157436020|FG002|Overall Study|Withdrawal by Subject|5|||
48891017|NCT02760498|157436021|FG003|Overall Study|Withdrawal by Subject|1|||
48891018|NCT02760498|157436022|FG004|Overall Study|Withdrawal by Subject|0|||
48891019|NCT02760498|157436023|FG005|Overall Study|Withdrawal by Subject|6|||
48891020|NCT02760498|157436018|FG000|Overall Study|Other than specified|1|||
48891021|NCT02760498|157436019|FG001|Overall Study|Other than specified|6|||
48891022|NCT02760498|157436020|FG002|Overall Study|Other than specified|0|||
48891023|NCT02760498|157436021|FG003|Overall Study|Other than specified|3|||
48891024|NCT02760498|157436022|FG004|Overall Study|Other than specified|1|||
48891025|NCT02760498|157436023|FG005|Overall Study|Other than specified|0|||
48891026|NCT02760498|157436018|FG000|Overall Study|Not treated|0|||
48891027|NCT02760498|157436019|FG001|Overall Study|Not treated|0|||
48891028|NCT02760498|157436020|FG002|Overall Study|Not treated|0|||
48891029|NCT02760498|157436021|FG003|Overall Study|Not treated|0|||
48891030|NCT02760498|157436022|FG004|Overall Study|Not treated|0|||
48891031|NCT02760498|157436023|FG005|Overall Study|Not treated|2|||
48891032|NCT03248492|157436027|FG000|Overall Study|Ongoing|23|||
48891033|NCT03248492|157436028|FG001|Overall Study|Ongoing|26|||
48891034|NCT03248492|157436029|FG002|Overall Study|Ongoing|3|||
48891035|NCT03248492|157436030|FG003|Overall Study|Ongoing|85|||
48891036|NCT03248492|157436031|FG004|Overall Study|Ongoing|2|||
48891037|NCT03248492|157436027|FG000|Overall Study|Progressive disease per RECIST v1.1|16|||
48891038|NCT03248492|157436028|FG001|Overall Study|Progressive disease per RECIST v1.1|12|||
48891039|NCT03248492|157436029|FG002|Overall Study|Progressive disease per RECIST v1.1|9|||
48891040|NCT03248492|157436030|FG003|Overall Study|Progressive disease per RECIST v1.1|22|||
48891041|NCT03248492|157436031|FG004|Overall Study|Progressive disease per RECIST v1.1|0|||
48891042|NCT03248492|157436027|FG000|Overall Study|Adverse Event|6|||
48891043|NCT03248492|157436028|FG001|Overall Study|Adverse Event|6|||
48891044|NCT03248492|157436029|FG002|Overall Study|Adverse Event|8|||
48891045|NCT03248492|157436030|FG003|Overall Study|Adverse Event|8|||
48891046|NCT03248492|157436031|FG004|Overall Study|Adverse Event|1|||
48891047|NCT03248492|157436027|FG000|Overall Study|Withdrawal by Subject|3|||
48891048|NCT03248492|157436028|FG001|Overall Study|Withdrawal by Subject|3|||
48891049|NCT03248492|157436029|FG002|Overall Study|Withdrawal by Subject|0|||
48891050|NCT03248492|157436030|FG003|Overall Study|Withdrawal by Subject|3|||
48891051|NCT03248492|157436031|FG004|Overall Study|Withdrawal by Subject|1|||
48891052|NCT03248492|157436027|FG000|Overall Study|Physician Decision|1|||
48891053|NCT03248492|157436028|FG001|Overall Study|Physician Decision|0|||
49037127|NCT00957021|157971253|FG000|Overall Study|Surgery Cancelled|9|||
49037128|NCT00957021|157971253|FG000|Overall Study|Termination due to language issue|2|||
48891054|NCT03248492|157436029|FG002|Overall Study|Physician Decision|1|||
48891055|NCT03248492|157436030|FG003|Overall Study|Physician Decision|2|||
48891056|NCT03248492|157436031|FG004|Overall Study|Physician Decision|0|||
48891057|NCT03248492|157436027|FG000|Overall Study|Death|1|||
48891058|NCT03248492|157436028|FG001|Overall Study|Death|0|||
48891059|NCT03248492|157436029|FG002|Overall Study|Death|0|||
48891060|NCT03248492|157436030|FG003|Overall Study|Death|6|||
48891061|NCT03248492|157436031|FG004|Overall Study|Death|0|||
48891062|NCT03248492|157436027|FG000|Overall Study|Other|0|||
48891063|NCT03248492|157436028|FG001|Overall Study|Other|1|||
48891064|NCT03248492|157436029|FG002|Overall Study|Other|0|||
48891065|NCT03248492|157436030|FG003|Overall Study|Other|4|||
48891066|NCT03248492|157436031|FG004|Overall Study|Other|0|||
48891067|NCT03775486|157436032|FG000|Initial Therapy Phase|Other reason provided|0|||
48891068|NCT03775486|157436033|FG001|Initial Therapy Phase|Other reason provided|15|||
48891069|NCT03775486|157436032|FG000|Initial Therapy Phase|Condition under investigation worsened|0|||
49037129|NCT00672984|157971256|FG000|First Intervention|Adverse Event|5|||
49037130|NCT00672984|157971257|FG001|First Intervention|Adverse Event|0|||
49037131|NCT00672984|157971258|FG002|First Intervention|Adverse Event|0|||
49037132|NCT00672984|157971256|FG000|First Intervention|Withdrawal by Subject|1|||
49037133|NCT00672984|157971257|FG001|First Intervention|Withdrawal by Subject|2|||
49037134|NCT00672984|157971258|FG002|First Intervention|Withdrawal by Subject|2|||
49037135|NCT00672984|157971256|FG000|First Intervention|Sponsor decision|3|||
49037136|NCT00672984|157971257|FG001|First Intervention|Sponsor decision|0|||
49037137|NCT00672984|157971258|FG002|First Intervention|Sponsor decision|0|||
49037138|NCT00672984|157971256|FG000|Second Intervention|Non-compliance with facility policies|0|||
49037139|NCT00672984|157971257|FG001|Second Intervention|Non-compliance with facility policies|2|||
49037140|NCT00672984|157971258|FG002|Second Intervention|Non-compliance with facility policies|0|||
49037141|NCT00672984|157971256|FG000|Second Intervention|Withdrawal by Subject|0|||
48891070|NCT03775486|157436033|FG001|Initial Therapy Phase|Condition under investigation worsened|67|||
48891071|NCT03775486|157436032|FG000|Initial Therapy Phase|Protocol Violation|0|||
48891072|NCT03775486|157436033|FG001|Initial Therapy Phase|Protocol Violation|2|||
48891073|NCT03775486|157436032|FG000|Initial Therapy Phase|Adverse Event|0|||
48891074|NCT03775486|157436033|FG001|Initial Therapy Phase|Adverse Event|34|||
48891075|NCT03775486|157436032|FG000|Initial Therapy Phase|Withdrawal by Subject|0|||
48891076|NCT03775486|157436033|FG001|Initial Therapy Phase|Withdrawal by Subject|14|||
48891077|NCT03775486|157436032|FG000|Maintenance Phase|Withdrawal by Subject|13|||
48891078|NCT03775486|157436033|FG001|Maintenance Phase|Withdrawal by Subject|12|||
48891079|NCT03775486|157436032|FG000|Maintenance Phase|Death|44|||
48891080|NCT03775486|157436033|FG001|Maintenance Phase|Death|45|||
48891081|NCT01305200|157436034|FG000|Overall Study|Physician Decision|4|||
48891082|NCT01305200|157436035|FG001|Overall Study|Physician Decision|6|||
48891083|NCT01305200|157436036|FG002|Overall Study|Physician Decision|1|||
48891084|NCT01305200|157436034|FG000|Overall Study|Withdrawal by Subject|24|||
48891085|NCT01305200|157436035|FG001|Overall Study|Withdrawal by Subject|21|||
48891086|NCT01305200|157436036|FG002|Overall Study|Withdrawal by Subject|1|||
48891087|NCT01305200|157436034|FG000|Overall Study|Ineligible|1|||
49037142|NCT00672984|157971257|FG001|Second Intervention|Withdrawal by Subject|3|||
49037143|NCT00672984|157971258|FG002|Second Intervention|Withdrawal by Subject|0|||
49037144|NCT00672984|157971256|FG000|Second Intervention|Protocol Violation|0|||
49037145|NCT00672984|157971257|FG001|Second Intervention|Protocol Violation|1|||
49037146|NCT00672984|157971258|FG002|Second Intervention|Protocol Violation|1|||
49037147|NCT00672984|157971256|FG000|Third Intervention|Adverse Event|1|||
49037148|NCT00672984|157971257|FG001|Third Intervention|Adverse Event|0|||
49037149|NCT00672984|157971258|FG002|Third Intervention|Adverse Event|1|||
49037150|NCT03218787|157971267|FG000|Overall Study|Lost to Follow-up|12|||
49037151|NCT03218787|157971267|FG000|Overall Study|Withdrawal by Subject|72|||
49037152|NCT03218787|157971267|FG000|Overall Study|Physician Decision|11|||
49037153|NCT03218787|157971267|FG000|Overall Study|Death|111|||
49037154|NCT01576705|157971268|FG000|Overall Study|TSH > 7 mIU/L at baseline|3|||
49037155|NCT01576705|157971269|FG001|Overall Study|TSH > 7 mIU/L at baseline|7|||
49037156|NCT01576705|157971270|FG002|Overall Study|TSH > 7 mIU/L at baseline|5|||
49037157|NCT01576705|157971271|FG003|Overall Study|TSH > 7 mIU/L at baseline|3|||
49037158|NCT01576705|157971268|FG000|Overall Study|invalid ICF|0|||
49037159|NCT01576705|157971269|FG001|Overall Study|invalid ICF|1|||
49037160|NCT01576705|157971270|FG002|Overall Study|invalid ICF|0|||
49037161|NCT01576705|157971271|FG003|Overall Study|invalid ICF|0|||
49037162|NCT00268203|157971272|FG000|Overall Study|Lost to Follow-up|92|||
49037163|NCT00268203|157971272|FG000|Overall Study|Withdrawal by Subject|9|||
49037164|NCT00268203|157971272|FG000|Overall Study|Received Other NHL Therapy|7|||
49037165|NCT00268203|157971272|FG000|Overall Study|Progressive Disease|359|||
49037166|NCT00268203|157971272|FG000|Overall Study|Death|84|||
49037167|NCT00268203|157971272|FG000|Overall Study|Reason Not Specified|34|||
48891088|NCT01305200|157436035|FG001|Overall Study|Ineligible|2|||
48891089|NCT01305200|157436036|FG002|Overall Study|Ineligible|1|||
48891090|NCT01305200|157436034|FG000|Overall Study|Death|0|||
48891091|NCT01305200|157436035|FG001|Overall Study|Death|2|||
48891092|NCT01305200|157436036|FG002|Overall Study|Death|0|||
48891093|NCT01967147|157438165|FG000|Overall Study|Adverse Event|5|||
48891094|NCT01967147|157438166|FG001|Overall Study|Adverse Event|2|||
48891095|NCT01967147|157438165|FG000|Overall Study|Lack of Efficacy|1|||
48891096|NCT01967147|157438166|FG001|Overall Study|Lack of Efficacy|4|||
48891097|NCT01967147|157438165|FG000|Overall Study|Lost to Follow-up|1|||
48891098|NCT01967147|157438166|FG001|Overall Study|Lost to Follow-up|2|||
48891099|NCT01967147|157438165|FG000|Overall Study|Withdrawal by Subject|2|||
48891100|NCT01967147|157438166|FG001|Overall Study|Withdrawal by Subject|4|||
48891101|NCT01967147|157438165|FG000|Overall Study|Non-compliance with Study Drug|0|||
48891102|NCT01967147|157438166|FG001|Overall Study|Non-compliance with Study Drug|3|||
48891103|NCT01967147|157438165|FG000|Overall Study|Other|4|||
48891104|NCT01967147|157438166|FG001|Overall Study|Other|5|||
48891105|NCT01099215|157438167|FG000|Overall Study|Withdrawal by Subject|1|||
48891106|NCT01099215|157438168|FG001|Overall Study|Withdrawal by Subject|0|||
48891107|NCT01099215|157438167|FG000|Overall Study|Adverse Event|0|||
48891108|NCT01099215|157438168|FG001|Overall Study|Adverse Event|1|||
48891109|NCT03284229|157438173|FG000|Overall Study|Lost to Follow-up|3|||
48891110|NCT01901432|157438178|FG000|Overall Study|Adverse Event|0|||
48891111|NCT01901432|157438179|FG001|Overall Study|Adverse Event|1|||
48891112|NCT01901432|157438180|FG002|Overall Study|Adverse Event|1|||
48891113|NCT01901432|157438181|FG003|Overall Study|Adverse Event|0|||
48891114|NCT01901432|157438182|FG004|Overall Study|Adverse Event|1|||
48891115|NCT01901432|157438178|FG000|Overall Study|Withdrawal by Subject|0|||
48891116|NCT01901432|157438179|FG001|Overall Study|Withdrawal by Subject|0|||
48891117|NCT01901432|157438180|FG002|Overall Study|Withdrawal by Subject|1|||
48891118|NCT01901432|157438181|FG003|Overall Study|Withdrawal by Subject|0|||
48891119|NCT01901432|157438182|FG004|Overall Study|Withdrawal by Subject|5|||
48891120|NCT01901432|157438178|FG000|Overall Study|Physician Decision|0|||
49037168|NCT00268203|157971272|FG000|Overall Study|Completed 2 Years of Follow-up|62|||
49037169|NCT02272803|157971273|FG000|Overall Study|Disease progression|16|||
49037170|NCT02272803|157971274|FG001|Overall Study|Disease progression|8|||
49037171|NCT02272803|157971273|FG000|Overall Study|Adverse Event unrelated to study drug|3|||
48891121|NCT01901432|157438179|FG001|Overall Study|Physician Decision|0|||
48891122|NCT01901432|157438180|FG002|Overall Study|Physician Decision|0|||
48891123|NCT01901432|157438181|FG003|Overall Study|Physician Decision|0|||
48891124|NCT01901432|157438182|FG004|Overall Study|Physician Decision|2|||
48891125|NCT01901432|157438178|FG000|Overall Study|Patient decision to stop study drug|0|||
49037172|NCT02272803|157971274|FG001|Overall Study|Adverse Event unrelated to study drug|5|||
49037173|NCT02272803|157971273|FG000|Overall Study|Study drug toxicity|4|||
49037174|NCT02272803|157971274|FG001|Overall Study|Study drug toxicity|9|||
49037175|NCT02272803|157971273|FG000|Overall Study|Participant request to discontinue study treatment|3|||
48891126|NCT01901432|157438179|FG001|Overall Study|Patient decision to stop study drug|0|||
48891127|NCT01901432|157438180|FG002|Overall Study|Patient decision to stop study drug|0|||
48891128|NCT01901432|157438181|FG003|Overall Study|Patient decision to stop study drug|0|||
48891129|NCT01901432|157438182|FG004|Overall Study|Patient decision to stop study drug|1|||
49037176|NCT02272803|157971274|FG001|Overall Study|Participant request to discontinue study treatment|7|||
48891130|NCT01901419|157438183|FG000|Overall Study|Protocol Violation|2|||
49037177|NCT02272803|157971273|FG000|Overall Study|Maximum clinical benefit|4|||
49037178|NCT02272803|157971274|FG001|Overall Study|Maximum clinical benefit|2|||
49037179|NCT02272803|157971273|FG000|Overall Study|Poor/non-compliance|2|||
49037180|NCT02272803|157971274|FG001|Overall Study|Poor/non-compliance|2|||
49037181|NCT02272803|157971273|FG000|Overall Study|Withdrawal by Subject|2|||
49037182|NCT02272803|157971274|FG001|Overall Study|Withdrawal by Subject|1|||
49037183|NCT02272803|157971273|FG000|Overall Study|Death|0|||
49037184|NCT02272803|157971274|FG001|Overall Study|Death|1|||
49037185|NCT02272803|157971273|FG000|Overall Study|Other reasons|1|||
49037186|NCT02272803|157971274|FG001|Overall Study|Other reasons|3|||
49037187|NCT02272803|157971273|FG000|Overall Study|Administrative reason by sponsor|5|||
49037188|NCT02272803|157971274|FG001|Overall Study|Administrative reason by sponsor|4|||
49037189|NCT02264977|157971275|FG000|Overall Study|Death|3|||
49037190|NCT02264977|157971275|FG000|Overall Study|Physician Decision|1|||
49037191|NCT02264977|157971275|FG000|Overall Study|Refuse to return|1|||
48891131|NCT01901419|157438184|FG001|Overall Study|Protocol Violation|6|||
48891132|NCT01901419|157438183|FG000|Overall Study|unavailable researchers|6|||
48891133|NCT01901419|157438184|FG001|Overall Study|unavailable researchers|3|||
48891134|NCT00379288|157438185|FG000|Overall Study|Adverse Event|5|||
48891135|NCT00379288|157438186|FG001|Overall Study|Adverse Event|6|||
48891136|NCT00379288|157438187|FG002|Overall Study|Adverse Event|2|||
49037192|NCT00243347|157971276|FG000|Overall Study|Lack of Efficacy|4|||
49037193|NCT00243347|157971276|FG000|Overall Study|Adverse Event|2|||
49037194|NCT00243347|157971276|FG000|Overall Study|Death|1|||
49037195|NCT00243347|157971276|FG000|Overall Study|Withdrawal by Subject|5|||
49037196|NCT00243347|157971276|FG000|Overall Study|Condition worsened|7|||
49037197|NCT00796562|157971283|FG000|Overall Study|Death|49|||
49037198|NCT02452463|157971284|FG000|Overall Study|Death|1|||
49037199|NCT02452463|157971285|FG001|Overall Study|Death|0|||
49037200|NCT02452463|157971286|FG002|Overall Study|Death|0|||
49037201|NCT02452463|157971284|FG000|Overall Study|Study Suspended|1|||
49037202|NCT02452463|157971285|FG001|Overall Study|Study Suspended|0|||
49037203|NCT02452463|157971286|FG002|Overall Study|Study Suspended|0|||
49037204|NCT02452463|157971284|FG000|Overall Study|Recommended by DSMB|0|||
49037205|NCT02452463|157971285|FG001|Overall Study|Recommended by DSMB|1|||
49037206|NCT02452463|157971286|FG002|Overall Study|Recommended by DSMB|0|||
49037207|NCT02452463|157971284|FG000|Overall Study|Withdrawal by Subject|0|||
49037208|NCT02452463|157971285|FG001|Overall Study|Withdrawal by Subject|1|||
49037209|NCT02452463|157971286|FG002|Overall Study|Withdrawal by Subject|0|||
49037210|NCT05740098|157971287|FG000|Overall Study|Lost to Follow-up|26|||
49037211|NCT05740098|157971288|FG001|Overall Study|Lost to Follow-up|17|||
49037212|NCT05740098|157971289|FG002|Overall Study|Lost to Follow-up|21|||
49037213|NCT00730691|157971292|FG000|Overall Study|Adverse Event|4|||
48891137|NCT00379288|157438188|FG003|Overall Study|Adverse Event|0|||
48891138|NCT00379288|157438185|FG000|Overall Study|Treatment Failure|0|||
48891139|NCT00379288|157438186|FG001|Overall Study|Treatment Failure|1|||
48891140|NCT00379288|157438187|FG002|Overall Study|Treatment Failure|0|||
48891141|NCT00379288|157438188|FG003|Overall Study|Treatment Failure|1|||
48891142|NCT00379288|157438185|FG000|Overall Study|Lost to Follow-up|3|||
48891143|NCT00379288|157438186|FG001|Overall Study|Lost to Follow-up|3|||
48891144|NCT00379288|157438187|FG002|Overall Study|Lost to Follow-up|2|||
48891145|NCT00379288|157438188|FG003|Overall Study|Lost to Follow-up|0|||
48891146|NCT00379288|157438185|FG000|Overall Study|Subject withdrew-unrelated to study drug|0|||
48891147|NCT00379288|157438186|FG001|Overall Study|Subject withdrew-unrelated to study drug|3|||
49037214|NCT00730691|157971293|FG001|Overall Study|Adverse Event|8|||
49037215|NCT00730691|157971294|FG002|Overall Study|Adverse Event|11|||
49037216|NCT00730691|157971295|FG003|Overall Study|Adverse Event|11|||
49037217|NCT00730691|157971296|FG004|Overall Study|Adverse Event|23|||
49037218|NCT00730691|157971292|FG000|Overall Study|Lack of Efficacy|4|||
49037219|NCT00730691|157971293|FG001|Overall Study|Lack of Efficacy|4|||
49037220|NCT00730691|157971294|FG002|Overall Study|Lack of Efficacy|2|||
49037221|NCT00730691|157971295|FG003|Overall Study|Lack of Efficacy|1|||
49037222|NCT00730691|157971296|FG004|Overall Study|Lack of Efficacy|1|||
48891148|NCT00379288|157438187|FG002|Overall Study|Subject withdrew-unrelated to study drug|4|||
48891149|NCT00379288|157438188|FG003|Overall Study|Subject withdrew-unrelated to study drug|2|||
49037223|NCT00730691|157971292|FG000|Overall Study|Non-compliance with Study Drug|6|||
49037224|NCT00730691|157971293|FG001|Overall Study|Non-compliance with Study Drug|1|||
49037225|NCT00730691|157971294|FG002|Overall Study|Non-compliance with Study Drug|6|||
49037226|NCT00730691|157971295|FG003|Overall Study|Non-compliance with Study Drug|3|||
49037227|NCT00730691|157971296|FG004|Overall Study|Non-compliance with Study Drug|3|||
49037228|NCT00730691|157971292|FG000|Overall Study|Protocol Deviations|3|||
49037229|NCT00730691|157971293|FG001|Overall Study|Protocol Deviations|5|||
49037230|NCT00730691|157971294|FG002|Overall Study|Protocol Deviations|3|||
49037231|NCT00730691|157971295|FG003|Overall Study|Protocol Deviations|7|||
49037232|NCT00730691|157971296|FG004|Overall Study|Protocol Deviations|5|||
49037233|NCT00730691|157971292|FG000|Overall Study|Withdrawal of Consent|7|||
49037234|NCT00730691|157971293|FG001|Overall Study|Withdrawal of Consent|9|||
48891150|NCT00379288|157438185|FG000|Overall Study|Subject withdrew-related to study drug|1|||
48891151|NCT00379288|157438186|FG001|Overall Study|Subject withdrew-related to study drug|0|||
48891152|NCT00379288|157438187|FG002|Overall Study|Subject withdrew-related to study drug|0|||
48891153|NCT00379288|157438188|FG003|Overall Study|Subject withdrew-related to study drug|1|||
48891154|NCT00379288|157438185|FG000|Overall Study|Noncompliance with protocol|8|||
48891155|NCT00379288|157438186|FG001|Overall Study|Noncompliance with protocol|6|||
48891156|NCT00379288|157438187|FG002|Overall Study|Noncompliance with protocol|2|||
48891157|NCT00379288|157438188|FG003|Overall Study|Noncompliance with protocol|1|||
48891158|NCT00379288|157438185|FG000|Overall Study|Did not meet protocol eligibility|0|||
48891159|NCT00379288|157438186|FG001|Overall Study|Did not meet protocol eligibility|1|||
48891160|NCT00379288|157438187|FG002|Overall Study|Did not meet protocol eligibility|0|||
48891161|NCT00379288|157438188|FG003|Overall Study|Did not meet protocol eligibility|2|||
48891162|NCT00379288|157438185|FG000|Overall Study|Administrative|2|||
48891163|NCT00379288|157438186|FG001|Overall Study|Administrative|2|||
48891164|NCT00379288|157438187|FG002|Overall Study|Administrative|0|||
48891165|NCT00379288|157438188|FG003|Overall Study|Administrative|1|||
48891166|NCT03333876|157438189|FG000|Screening Period|Screen Failure|4|||
48891167|NCT03333876|157438189|FG000|Nasal Dilator|Bed Partner Lost to follow up|6|||
48891168|NCT03333876|157438189|FG000|Mandibular Advancement|Adverse Event|2|||
48891169|NCT03333876|157438189|FG000|Mandibular Advancement|Product Damage|2|||
48891170|NCT01014208|157438191|FG000|Overall Study|Lost to Follow-up|2|||
48891171|NCT01014208|157438192|FG001|Overall Study|Lost to Follow-up|5|||
48891172|NCT01014208|157438191|FG000|Overall Study|Participant Withdrew Consent|12|||
48891173|NCT01014208|157438192|FG001|Overall Study|Participant Withdrew Consent|12|||
48891174|NCT01014208|157438191|FG000|Overall Study|Did Not Receive Study Drug|2|||
48891175|NCT01014208|157438192|FG001|Overall Study|Did Not Receive Study Drug|0|||
48891176|NCT01014208|157438191|FG000|Overall Study|Study Closed/terminated|78|||
48891177|NCT01014208|157438192|FG001|Overall Study|Study Closed/terminated|83|||
48891178|NCT00818168|157438194|FG000|Overall Study|Lack of Efficacy|18|||
48891179|NCT00818168|157438194|FG000|Overall Study|Pregnancy|2|||
48891180|NCT00818168|157438194|FG000|Overall Study|Withdrawal by Subject|16|||
48891181|NCT00818168|157438194|FG000|Overall Study|Lost to Follow-up|7|||
48891182|NCT00818168|157438194|FG000|Overall Study|Adverse Event|19|||
48891183|NCT00818168|157438194|FG000|Overall Study|Reason for Non-completion Not reported|6|||
48891184|NCT00818168|157438194|FG000|Overall Study|Participant Moved|2|||
48891185|NCT02040259|157438195|FG000|Overall Study|Death|280|||
48891186|NCT02040259|157438195|FG000|Overall Study|Lost to Follow-up|76|||
49037235|NCT00730691|157971294|FG002|Overall Study|Withdrawal of Consent|3|||
49037236|NCT00730691|157971295|FG003|Overall Study|Withdrawal of Consent|6|||
49037237|NCT00730691|157971296|FG004|Overall Study|Withdrawal of Consent|3|||
49037238|NCT00730691|157971292|FG000|Overall Study|Lost to Follow-up|11|||
49037239|NCT00730691|157971293|FG001|Overall Study|Lost to Follow-up|8|||
49037240|NCT00730691|157971294|FG002|Overall Study|Lost to Follow-up|13|||
49037241|NCT00730691|157971295|FG003|Overall Study|Lost to Follow-up|15|||
49037242|NCT00730691|157971296|FG004|Overall Study|Lost to Follow-up|13|||
49037243|NCT00730691|157971292|FG000|Overall Study|Other|1|||
49037244|NCT00730691|157971293|FG001|Overall Study|Other|1|||
49037245|NCT00730691|157971294|FG002|Overall Study|Other|1|||
49037246|NCT00730691|157971295|FG003|Overall Study|Other|2|||
49037247|NCT00730691|157971296|FG004|Overall Study|Other|2|||
49037248|NCT04223791|157971297|FG000|Overall Study|Lost to Follow-up|0|||
49037249|NCT04223791|157971298|FG001|Overall Study|Lost to Follow-up|4|||
49037250|NCT04223791|157971297|FG000|Overall Study|Physician Decision|5|||
49037251|NCT04223791|157971298|FG001|Overall Study|Physician Decision|1|||
48891187|NCT02040259|157438195|FG000|Overall Study|Assessment not completed|3|||
48891188|NCT02040259|157438195|FG000|Overall Study|Withdrawal by Subject|4|||
48891189|NCT04138576|157438196|FG000|Overall Study|Due to epidemiological situation (COVID-19) patients were dropped out from the study.|16|||
48891190|NCT00266227|157438199|FG000|Initial Treatment|Adverse Event|0|||
48891191|NCT00266227|157438200|FG001|Initial Treatment|Adverse Event|0|||
48891192|NCT00266227|157438201|FG002|Initial Treatment|Adverse Event|13|||
48891193|NCT00266227|157438199|FG000|Initial Treatment|Lost to Follow-up|0|||
48891194|NCT00266227|157438200|FG001|Initial Treatment|Lost to Follow-up|0|||
48891195|NCT00266227|157438201|FG002|Initial Treatment|Lost to Follow-up|6|||
48891196|NCT00266227|157438199|FG000|Initial Treatment|Subject/Guardian decision to withdraw|0|||
48891197|NCT00266227|157438200|FG001|Initial Treatment|Subject/Guardian decision to withdraw|0|||
49037252|NCT04223791|157971297|FG000|Overall Study|Protocol Violation|1|||
49037253|NCT04223791|157971298|FG001|Overall Study|Protocol Violation|1|||
49037254|NCT04223791|157971297|FG000|Overall Study|Withdrawal by Subject|10|||
49037255|NCT04223791|157971298|FG001|Overall Study|Withdrawal by Subject|12|||
49037256|NCT04223791|157971297|FG000|Overall Study|Pregnancy|1|||
49037257|NCT04223791|157971298|FG001|Overall Study|Pregnancy|1|||
49037258|NCT04223791|157971297|FG000|Overall Study|Ongoing in Study|305|||
49037259|NCT04223791|157971298|FG001|Overall Study|Ongoing in Study|302|||
49037260|NCT04183335|157973073|FG000|Overall Study|Adverse Event|1|||
49037261|NCT04183335|157973074|FG001|Overall Study|Adverse Event|0|||
49037262|NCT04183335|157973073|FG000|Overall Study|Withdrawal by Subject|12|||
49037263|NCT04183335|157973074|FG001|Overall Study|Withdrawal by Subject|3|||
49037264|NCT01660243|157973075|FG000|Overall Study|Adverse Event|1|||
48891198|NCT00266227|157438201|FG002|Initial Treatment|Subject/Guardian decision to withdraw|45|||
48891199|NCT00266227|157438199|FG000|Initial Treatment|Physician decision to withdraw|0|||
48891200|NCT00266227|157438200|FG001|Initial Treatment|Physician decision to withdraw|0|||
48891201|NCT00266227|157438201|FG002|Initial Treatment|Physician decision to withdraw|12|||
48891202|NCT00266227|157438199|FG000|Initial Treatment|Pregnancy|0|||
48891203|NCT00266227|157438200|FG001|Initial Treatment|Pregnancy|0|||
48891204|NCT00266227|157438201|FG002|Initial Treatment|Pregnancy|1|||
48891205|NCT00266227|157438199|FG000|Retreatment: Up to Week 48|Death|1|||
48891206|NCT00266227|157438200|FG001|Retreatment: Up to Week 48|Death|0|||
48891207|NCT00266227|157438201|FG002|Retreatment: Up to Week 48|Death|0|||
48891208|NCT00266227|157438199|FG000|Retreatment: Up to Week 48|Adverse Event|7|||
48891209|NCT00266227|157438200|FG001|Retreatment: Up to Week 48|Adverse Event|7|||
48891210|NCT00266227|157438201|FG002|Retreatment: Up to Week 48|Adverse Event|0|||
48891211|NCT00266227|157438199|FG000|Retreatment: Up to Week 48|Lost to Follow-up|3|||
48891212|NCT00266227|157438200|FG001|Retreatment: Up to Week 48|Lost to Follow-up|0|||
48891213|NCT00266227|157438201|FG002|Retreatment: Up to Week 48|Lost to Follow-up|0|||
48891214|NCT00266227|157438199|FG000|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11|||
48891215|NCT00266227|157438200|FG001|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14|||
48891216|NCT00266227|157438201|FG002|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0|||
48891217|NCT00266227|157438199|FG000|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4|||
48891218|NCT00266227|157438200|FG001|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2|||
48891219|NCT00266227|157438201|FG002|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0|||
48891220|NCT00266227|157438199|FG000|Retreatment: Up to Week 48|Pregnancy|1|||
48891221|NCT00266227|157438200|FG001|Retreatment: Up to Week 48|Pregnancy|0|||
48891222|NCT00266227|157438201|FG002|Retreatment: Up to Week 48|Pregnancy|0|||
48891223|NCT00266227|157438199|FG000|Retreatment: Week 48 to Week 72|Death|1|||
48891224|NCT00266227|157438200|FG001|Retreatment: Week 48 to Week 72|Death|1|||
48891225|NCT00266227|157438201|FG002|Retreatment: Week 48 to Week 72|Death|0|||
48891226|NCT00266227|157438199|FG000|Retreatment: Week 48 to Week 72|Adverse Event|6|||
48891227|NCT00266227|157438200|FG001|Retreatment: Week 48 to Week 72|Adverse Event|2|||
48891228|NCT00266227|157438201|FG002|Retreatment: Week 48 to Week 72|Adverse Event|0|||
48891229|NCT00266227|157438199|FG000|Retreatment: Week 48 to Week 72|Lost to Follow-up|1|||
48891230|NCT00266227|157438200|FG001|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
48891231|NCT00266227|157438201|FG002|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
48891232|NCT00266227|157438199|FG000|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41|||
48891233|NCT00266227|157438200|FG001|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29|||
49037265|NCT01660243|157973076|FG001|Overall Study|Adverse Event|0|||
49037266|NCT01660243|157973077|FG002|Overall Study|Adverse Event|1|||
49037267|NCT01660243|157973078|FG003|Overall Study|Adverse Event|0|||
49037268|NCT01660243|157973075|FG000|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|1|||
48891234|NCT00266227|157438201|FG002|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0|||
48891235|NCT00266227|157438199|FG000|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15|||
48891236|NCT00266227|157438200|FG001|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10|||
48891237|NCT00266227|157438201|FG002|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0|||
48891238|NCT03900416|157438202|FG000|Six Week Follow-up|Lost to Follow-up|1|||
48891239|NCT03900416|157438203|FG001|Six Week Follow-up|Lost to Follow-up|0|||
48891240|NCT03900416|157438202|FG000|Six Week Follow-up|Withdrawal by Subject|1|||
48891241|NCT03900416|157438203|FG001|Six Week Follow-up|Withdrawal by Subject|0|||
48891242|NCT03900416|157438202|FG000|Twelve Week Follow-up|Lost to Follow-up|0|||
48891243|NCT03900416|157438203|FG001|Twelve Week Follow-up|Lost to Follow-up|2|||
48891244|NCT03900416|157438202|FG000|Twelve Week Follow-up|Withdrawal by Subject|0|||
48891245|NCT03900416|157438203|FG001|Twelve Week Follow-up|Withdrawal by Subject|1|||
48891246|NCT03900416|157438202|FG000|Twelve Week Follow-up|Adverse Event|1|||
48891247|NCT03900416|157438203|FG001|Twelve Week Follow-up|Adverse Event|1|||
48891248|NCT03900416|157438202|FG000|Six Month Follow-up|Lost to Follow-up|4|||
48891249|NCT03900416|157438203|FG001|Six Month Follow-up|Lost to Follow-up|3|||
48891250|NCT03900416|157438202|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
48891251|NCT03900416|157438203|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
48891252|NCT00201643|157438204|FG000|Overall Study|Withdrawal by Subject|5|||
48891253|NCT00201643|157438205|FG001|Overall Study|Withdrawal by Subject|4|||
48891254|NCT00727311|157438206|FG000|Overall Study|Did not receive drug|316|||
48891255|NCT00727311|157438206|FG000|Overall Study|Missing end of therapy data|205|||
48891256|NCT00727311|157438206|FG000|Overall Study|Adverse Event|58|||
48891257|NCT00727311|157438206|FG000|Overall Study|Lack of Efficacy|242|||
48891258|NCT00727311|157438206|FG000|Overall Study|Lost to Follow-up|73|||
48891259|NCT00727311|157438206|FG000|Overall Study|Withdrawal by Subject|77|||
48891260|NCT00727311|157438206|FG000|Overall Study|Other|97|||
48891261|NCT00727311|157438206|FG000|Overall Study|Multiple reasons|39|||
48891262|NCT02643303|157438210|FG000|Overall Study|Progressive Disease|4|||
48891263|NCT02643303|157438211|FG001|Overall Study|Progressive Disease|4|||
49037269|NCT01660243|157973076|FG001|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
49037270|NCT01660243|157973077|FG002|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
49037271|NCT01660243|157973078|FG003|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
49037272|NCT01660243|157973075|FG000|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
49037273|NCT01660243|157973076|FG001|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
49037274|NCT01660243|157973077|FG002|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|1|||
49037275|NCT01660243|157973078|FG003|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
49037276|NCT01660243|157973075|FG000|Overall Study|Randomization error|0|||
49037277|NCT01660243|157973076|FG001|Overall Study|Randomization error|0|||
49037278|NCT01660243|157973077|FG002|Overall Study|Randomization error|0|||
49037279|NCT01660243|157973078|FG003|Overall Study|Randomization error|1|||
49037280|NCT02475681|157973079|FG000|Overall Study|Death|16|||
49037281|NCT02475681|157973080|FG001|Overall Study|Death|6|||
49037282|NCT02475681|157973081|FG002|Overall Study|Death|9|||
49037283|NCT02475681|157973079|FG000|Overall Study|Physician Decision|0|||
49037284|NCT02475681|157973080|FG001|Overall Study|Physician Decision|3|||
48891264|NCT02643303|157438212|FG002|Overall Study|Progressive Disease|1|||
48891265|NCT02643303|157438213|FG003|Overall Study|Progressive Disease|12|||
48891266|NCT02643303|157438214|FG004|Overall Study|Progressive Disease|6|||
48891267|NCT02643303|157438215|FG005|Overall Study|Progressive Disease|4|||
48891268|NCT02643303|157438216|FG006|Overall Study|Progressive Disease|8|||
49037285|NCT02475681|157973081|FG002|Overall Study|Physician Decision|1|||
49037286|NCT02475681|157973079|FG000|Overall Study|Withdrawal by Subject|12|||
49037287|NCT02475681|157973080|FG001|Overall Study|Withdrawal by Subject|6|||
48891269|NCT02643303|157438217|FG007|Overall Study|Progressive Disease|2|||
48891270|NCT02643303|157438218|FG008|Overall Study|Progressive Disease|6|||
48891271|NCT02643303|157438210|FG000|Overall Study|Adverse Event|0|||
48891272|NCT02643303|157438211|FG001|Overall Study|Adverse Event|1|||
48891273|NCT02643303|157438212|FG002|Overall Study|Adverse Event|0|||
48891274|NCT02643303|157438213|FG003|Overall Study|Adverse Event|0|||
48891275|NCT02643303|157438214|FG004|Overall Study|Adverse Event|1|||
48891276|NCT02643303|157438215|FG005|Overall Study|Adverse Event|0|||
48891277|NCT02643303|157438216|FG006|Overall Study|Adverse Event|0|||
48891278|NCT02643303|157438217|FG007|Overall Study|Adverse Event|0|||
48891279|NCT02643303|157438218|FG008|Overall Study|Adverse Event|0|||
48891280|NCT02643303|157438210|FG000|Overall Study|Withdrawal by Subject|0|||
48891281|NCT02643303|157438211|FG001|Overall Study|Withdrawal by Subject|0|||
48891282|NCT02643303|157438212|FG002|Overall Study|Withdrawal by Subject|0|||
48891283|NCT02643303|157438213|FG003|Overall Study|Withdrawal by Subject|1|||
48891284|NCT02643303|157438214|FG004|Overall Study|Withdrawal by Subject|0|||
48891285|NCT02643303|157438215|FG005|Overall Study|Withdrawal by Subject|0|||
48891286|NCT02643303|157438216|FG006|Overall Study|Withdrawal by Subject|1|||
48891287|NCT02643303|157438217|FG007|Overall Study|Withdrawal by Subject|1|||
48891288|NCT02643303|157438218|FG008|Overall Study|Withdrawal by Subject|1|||
48891289|NCT00490490|157438219|FG000|Completed Assessment for TTP|Withdrawal by Subject|1|||
48891290|NCT00490490|157438219|FG000|Completed Assessment for TTP|Lost to Follow-up|2|||
48891291|NCT03836716|157438220|FG000|Overall Study|Adverse Event|3|||
48891292|NCT03836716|157438220|FG000|Overall Study|Death|22|||
48891293|NCT03836716|157438220|FG000|Overall Study|Withdrawal by Subject|8|||
48891294|NCT03836716|157438220|FG000|Overall Study|Study terminated by sponsor|87|||
48891295|NCT00037830|157438221|FG000|Overall Study|Adverse Event|2|||
48891296|NCT00037830|157438222|FG001|Overall Study|Adverse Event|0|||
48891297|NCT00037830|157438223|FG002|Overall Study|Adverse Event|0|||
48891298|NCT00037830|157438221|FG000|Overall Study|Withdrawal by Subject|4|||
48891299|NCT00037830|157438222|FG001|Overall Study|Withdrawal by Subject|5|||
48891300|NCT00037830|157438223|FG002|Overall Study|Withdrawal by Subject|1|||
48891301|NCT00037830|157438221|FG000|Overall Study|Protocol Violation|2|||
48891302|NCT00037830|157438222|FG001|Overall Study|Protocol Violation|2|||
48891303|NCT00037830|157438223|FG002|Overall Study|Protocol Violation|0|||
48891304|NCT00037830|157438221|FG000|Overall Study|Unrelated Medical Problem|2|||
48891305|NCT00037830|157438222|FG001|Overall Study|Unrelated Medical Problem|0|||
48891306|NCT00037830|157438223|FG002|Overall Study|Unrelated Medical Problem|0|||
48891307|NCT01097707|157438232|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
48891308|NCT01097707|157438233|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
48891309|NCT01097707|157438234|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
48891310|NCT01097707|157438235|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
48891311|NCT01097707|157438236|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
49037288|NCT02475681|157973081|FG002|Overall Study|Withdrawal by Subject|9|||
49037289|NCT02475681|157973079|FG000|Overall Study|Lost to Follow-up|2|||
49037290|NCT02475681|157973080|FG001|Overall Study|Lost to Follow-up|1|||
49037291|NCT02475681|157973081|FG002|Overall Study|Lost to Follow-up|3|||
49037292|NCT02475681|157973079|FG000|Overall Study|Ongoing in Study|0|||
48891312|NCT01097707|157438232|FG000|Overall Study|Adverse Event|4|||
48891313|NCT01097707|157438233|FG001|Overall Study|Adverse Event|2|||
48891314|NCT01097707|157438234|FG002|Overall Study|Adverse Event|3|||
48891315|NCT01097707|157438235|FG003|Overall Study|Adverse Event|1|||
48891316|NCT01097707|157438236|FG004|Overall Study|Adverse Event|3|||
48891317|NCT01097707|157438232|FG000|Overall Study|Entry Criteria Not Met|2|||
48891318|NCT01097707|157438233|FG001|Overall Study|Entry Criteria Not Met|1|||
48891319|NCT01097707|157438234|FG002|Overall Study|Entry Criteria Not Met|1|||
48891320|NCT01097707|157438235|FG003|Overall Study|Entry Criteria Not Met|0|||
48891321|NCT01097707|157438236|FG004|Overall Study|Entry Criteria Not Met|1|||
48891322|NCT01097707|157438232|FG000|Overall Study|Lack of Efficacy|1|||
48891323|NCT01097707|157438233|FG001|Overall Study|Lack of Efficacy|0|||
48891324|NCT01097707|157438234|FG002|Overall Study|Lack of Efficacy|0|||
48891325|NCT01097707|157438235|FG003|Overall Study|Lack of Efficacy|1|||
48891326|NCT01097707|157438236|FG004|Overall Study|Lack of Efficacy|0|||
48891327|NCT01097707|157438232|FG000|Overall Study|Lost to Follow-up|1|||
48891328|NCT01097707|157438233|FG001|Overall Study|Lost to Follow-up|1|||
48891329|NCT01097707|157438234|FG002|Overall Study|Lost to Follow-up|2|||
48891330|NCT01097707|157438235|FG003|Overall Study|Lost to Follow-up|0|||
48891331|NCT01097707|157438236|FG004|Overall Study|Lost to Follow-up|3|||
48891332|NCT01097707|157438232|FG000|Overall Study|Protocol Violation|2|||
48891333|NCT01097707|157438233|FG001|Overall Study|Protocol Violation|2|||
48891334|NCT01097707|157438234|FG002|Overall Study|Protocol Violation|3|||
48891335|NCT01097707|157438235|FG003|Overall Study|Protocol Violation|2|||
48891336|NCT01097707|157438236|FG004|Overall Study|Protocol Violation|2|||
48891337|NCT01097707|157438232|FG000|Overall Study|Sponsor Decision|31|||
48891338|NCT01097707|157438233|FG001|Overall Study|Sponsor Decision|31|||
48891339|NCT01097707|157438234|FG002|Overall Study|Sponsor Decision|34|||
48891340|NCT01097707|157438235|FG003|Overall Study|Sponsor Decision|35|||
48891341|NCT01097707|157438236|FG004|Overall Study|Sponsor Decision|36|||
48891342|NCT01097707|157438232|FG000|Overall Study|Withdrawal by Subject|3|||
48891343|NCT01097707|157438233|FG001|Overall Study|Withdrawal by Subject|6|||
48891344|NCT01097707|157438234|FG002|Overall Study|Withdrawal by Subject|1|||
48891345|NCT01097707|157438235|FG003|Overall Study|Withdrawal by Subject|4|||
48891346|NCT01097707|157438236|FG004|Overall Study|Withdrawal by Subject|3|||
48891347|NCT01097707|157438232|FG000|Overall Study|Reason unknown|0|||
48891348|NCT01097707|157438233|FG001|Overall Study|Reason unknown|0|||
48891349|NCT01097707|157438234|FG002|Overall Study|Reason unknown|0|||
48891350|NCT01097707|157438235|FG003|Overall Study|Reason unknown|0|||
48891351|NCT01097707|157438236|FG004|Overall Study|Reason unknown|1|||
48891352|NCT05775991|157438240|FG000|Overall Study|Withdrawal by Subject|0|||
48891353|NCT05775991|157438241|FG001|Overall Study|Withdrawal by Subject|0|||
48891354|NCT05775991|157438242|FG002|Overall Study|Withdrawal by Subject|2|||
48891355|NCT00964886|157438243|FG000|Overall Study|Lost to Follow-up|2|||
48891356|NCT00964886|157438244|FG001|Overall Study|Lost to Follow-up|2|||
48891357|NCT00964886|157438245|FG002|Overall Study|Lost to Follow-up|6|||
48891358|NCT00964886|157438246|FG003|Overall Study|Lost to Follow-up|4|||
48891359|NCT00964886|157438243|FG000|Overall Study|Withdrawal by Subject|6|||
48891360|NCT00964886|157438244|FG001|Overall Study|Withdrawal by Subject|2|||
48891361|NCT00964886|157438245|FG002|Overall Study|Withdrawal by Subject|5|||
48891362|NCT00964886|157438246|FG003|Overall Study|Withdrawal by Subject|3|||
48891363|NCT00964886|157438243|FG000|Overall Study|Adverse Event|3|||
48891364|NCT00964886|157438244|FG001|Overall Study|Adverse Event|1|||
48891365|NCT00964886|157438245|FG002|Overall Study|Adverse Event|5|||
48891366|NCT00964886|157438246|FG003|Overall Study|Adverse Event|2|||
48891367|NCT00964886|157438243|FG000|Overall Study|Protocol Violation|0|||
48891368|NCT00964886|157438244|FG001|Overall Study|Protocol Violation|2|||
48891369|NCT00964886|157438245|FG002|Overall Study|Protocol Violation|0|||
48891370|NCT00964886|157438246|FG003|Overall Study|Protocol Violation|0|||
48891371|NCT00939822|157438247|FG000|Overall Study|Lost to Follow-up|1|||
48891372|NCT00939822|157438248|FG001|Overall Study|Lost to Follow-up|0|||
48891373|NCT00939822|157438247|FG000|Overall Study|withdrew from study due to busy schedule|1|||
48891374|NCT00939822|157438248|FG001|Overall Study|withdrew from study due to busy schedule|1|||
48891375|NCT00939822|157438247|FG000|Overall Study|Mental health issues|0|||
48891376|NCT00939822|157438248|FG001|Overall Study|Mental health issues|2|||
48891377|NCT01072630|157438249|FG000|Overall Study|Adverse Event|11|||
48891378|NCT01072630|157438250|FG001|Overall Study|Adverse Event|19|||
48891379|NCT01072630|157438251|FG002|Overall Study|Adverse Event|2|||
48891380|NCT01072630|157438249|FG000|Overall Study|Lack of Efficacy|10|||
48891381|NCT01072630|157438250|FG001|Overall Study|Lack of Efficacy|10|||
48891382|NCT01072630|157438251|FG002|Overall Study|Lack of Efficacy|1|||
48891383|NCT01072630|157438249|FG000|Overall Study|Withdrawal by Subject|8|||
48891384|NCT01072630|157438250|FG001|Overall Study|Withdrawal by Subject|7|||
48891385|NCT01072630|157438251|FG002|Overall Study|Withdrawal by Subject|2|||
48891386|NCT01072630|157438249|FG000|Overall Study|Protocol Violation|10|||
48891387|NCT01072630|157438250|FG001|Overall Study|Protocol Violation|8|||
48891388|NCT01072630|157438251|FG002|Overall Study|Protocol Violation|4|||
48891389|NCT01072630|157438249|FG000|Overall Study|Lost to Follow-up|11|||
48891390|NCT01072630|157438250|FG001|Overall Study|Lost to Follow-up|11|||
48891391|NCT01072630|157438251|FG002|Overall Study|Lost to Follow-up|1|||
48891392|NCT01072630|157438249|FG000|Overall Study|Noncompliance with study medication|1|||
48891393|NCT01072630|157438250|FG001|Overall Study|Noncompliance with study medication|1|||
48891394|NCT01072630|157438251|FG002|Overall Study|Noncompliance with study medication|1|||
48891395|NCT01072630|157438249|FG000|Overall Study|Noncompliance with study procedures|1|||
48891396|NCT01072630|157438250|FG001|Overall Study|Noncompliance with study procedures|2|||
48891397|NCT01072630|157438251|FG002|Overall Study|Noncompliance with study procedures|1|||
48891398|NCT01072630|157438249|FG000|Overall Study|Other|3|||
48891399|NCT01072630|157438250|FG001|Overall Study|Other|2|||
48891400|NCT01072630|157438251|FG002|Overall Study|Other|1|||
48891401|NCT00652327|157438254|FG000|Overall Study|Adverse Event|0|||
48891402|NCT00652327|157438255|FG001|Overall Study|Adverse Event|2|||
48891403|NCT00652327|157438254|FG000|Overall Study|Lost to Follow-up|0|||
48891404|NCT00652327|157438255|FG001|Overall Study|Lost to Follow-up|3|||
48891405|NCT03214640|157438256|FG000|Overall Study|Protocol Violation|1|||
48891406|NCT03214640|157438257|FG001|Overall Study|Protocol Violation|2|||
48891407|NCT03214640|157438258|FG002|Overall Study|Protocol Violation|1|||
48891408|NCT03214640|157438259|FG003|Overall Study|Protocol Violation|4|||
48891409|NCT00910039|157438260|FG000|Overall Study|Physician Decision|1|||
48891410|NCT00400725|157438275|FG000|Initial Phase (up to 4 Weeks)|Adverse Event|1|||
48891411|NCT00400725|157438276|FG001|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
48891412|NCT00400725|157438277|FG002|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
48891413|NCT00400725|157438275|FG000|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|14|||
48891414|NCT00400725|157438276|FG001|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
48891415|NCT00400725|157438277|FG002|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
48891416|NCT00400725|157438275|FG000|Initial Phase (up to 4 Weeks)|Lost to Follow-up|1|||
48891417|NCT00400725|157438276|FG001|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
48891418|NCT00400725|157438277|FG002|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
48891419|NCT00400725|157438275|FG000|Initial Phase (up to 4 Weeks)|Other|1|||
48891420|NCT00400725|157438276|FG001|Initial Phase (up to 4 Weeks)|Other|0|||
48891421|NCT00400725|157438277|FG002|Initial Phase (up to 4 Weeks)|Other|0|||
48891422|NCT00400725|157438275|FG000|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
48891423|NCT00400725|157438276|FG001|Maintenance Phase (up to 6 Months)|Lack of Efficacy|1|||
48891424|NCT00400725|157438277|FG002|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
48891425|NCT00400725|157438275|FG000|Maintenance Phase (up to 6 Months)|Adverse Event|0|||
48891426|NCT00400725|157438276|FG001|Maintenance Phase (up to 6 Months)|Adverse Event|2|||
48891427|NCT00400725|157438277|FG002|Maintenance Phase (up to 6 Months)|Adverse Event|4|||
48891428|NCT00400725|157438275|FG000|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|0|||
48891429|NCT00400725|157438276|FG001|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|11|||
48891430|NCT00400725|157438277|FG002|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|21|||
48891431|NCT00400725|157438275|FG000|Maintenance Phase (up to 6 Months)|Lost to Follow-up|0|||
48891432|NCT00400725|157438276|FG001|Maintenance Phase (up to 6 Months)|Lost to Follow-up|1|||
48891433|NCT00400725|157438277|FG002|Maintenance Phase (up to 6 Months)|Lost to Follow-up|2|||
48891434|NCT00400725|157438275|FG000|Maintenance Phase (up to 6 Months)|Other|0|||
48891435|NCT00400725|157438276|FG001|Maintenance Phase (up to 6 Months)|Other|1|||
48891436|NCT00400725|157438277|FG002|Maintenance Phase (up to 6 Months)|Other|2|||
48891437|NCT02884908|157438278|FG000|Overall Study|Lost to Follow-up|13|||
48891438|NCT02884908|157438279|FG001|Overall Study|Lost to Follow-up|18|||
48891439|NCT04860297|157438280|FG000|Part A (Primary Series)|Withdrawal by Subject|0|||
48891440|NCT04860297|157438281|FG001|Part A (Primary Series)|Withdrawal by Subject|1|||
48891441|NCT04860297|157438282|FG002|Part A (Primary Series)|Withdrawal by Subject|0|||
48891442|NCT04860297|157438283|FG003|Part A (Primary Series)|Withdrawal by Subject|1|||
48891443|NCT04860297|157438284|FG004|Part A (Primary Series)|Withdrawal by Subject|0|||
48891444|NCT04860297|157438285|FG005|Part A (Primary Series)|Withdrawal by Subject|0|||
48891445|NCT04860297|157438286|FG006|Part A (Primary Series)|Withdrawal by Subject|0|||
48891446|NCT04860297|157438287|FG007|Part A (Primary Series)|Withdrawal by Subject|0|||
48891447|NCT04860297|157438280|FG000|Part A (Primary Series)|Lost to Follow-up|1|||
48891448|NCT04860297|157438281|FG001|Part A (Primary Series)|Lost to Follow-up|0|||
48891449|NCT04860297|157438282|FG002|Part A (Primary Series)|Lost to Follow-up|0|||
48891450|NCT04860297|157438283|FG003|Part A (Primary Series)|Lost to Follow-up|2|||
48891451|NCT04860297|157438284|FG004|Part A (Primary Series)|Lost to Follow-up|0|||
48891452|NCT04860297|157438285|FG005|Part A (Primary Series)|Lost to Follow-up|0|||
48891453|NCT04860297|157438286|FG006|Part A (Primary Series)|Lost to Follow-up|0|||
48891454|NCT04860297|157438287|FG007|Part A (Primary Series)|Lost to Follow-up|0|||
49037293|NCT02475681|157973080|FG001|Overall Study|Ongoing in Study|163|||
49037294|NCT02475681|157973081|FG002|Overall Study|Ongoing in Study|157|||
49037295|NCT02475681|157973079|FG000|Overall Study|Reasons other than above listed|2|||
49037296|NCT02475681|157973080|FG001|Overall Study|Reasons other than above listed|0|||
49037297|NCT02475681|157973081|FG002|Overall Study|Reasons other than above listed|0|||
48891455|NCT04860297|157438280|FG000|Part B (Booster Dose)|Protocol Deviation|0|||
48891456|NCT04860297|157438281|FG001|Part B (Booster Dose)|Protocol Deviation|0|||
48891457|NCT04860297|157438282|FG002|Part B (Booster Dose)|Protocol Deviation|0|||
48891458|NCT04860297|157438283|FG003|Part B (Booster Dose)|Protocol Deviation|0|||
49037298|NCT04035187|157973082|FG000|Overall Study|Withdrawal by Subject|2|||
49037299|NCT04035187|157973083|FG001|Overall Study|Withdrawal by Subject|1|||
49037300|NCT04035187|157973084|FG002|Overall Study|Withdrawal by Subject|0|||
48891459|NCT04860297|157438284|FG004|Part B (Booster Dose)|Protocol Deviation|0|||
48891460|NCT04860297|157438285|FG005|Part B (Booster Dose)|Protocol Deviation|0|||
48891461|NCT04860297|157438286|FG006|Part B (Booster Dose)|Protocol Deviation|1|||
48891462|NCT04860297|157438287|FG007|Part B (Booster Dose)|Protocol Deviation|0|||
48891463|NCT04860297|157438280|FG000|Part B (Booster Dose)|Other Than Specified|0|||
48891464|NCT04860297|157438281|FG001|Part B (Booster Dose)|Other Than Specified|0|||
48891465|NCT04860297|157438282|FG002|Part B (Booster Dose)|Other Than Specified|0|||
48891466|NCT04860297|157438283|FG003|Part B (Booster Dose)|Other Than Specified|0|||
48891467|NCT04860297|157438284|FG004|Part B (Booster Dose)|Other Than Specified|0|||
48891468|NCT04860297|157438285|FG005|Part B (Booster Dose)|Other Than Specified|1|||
48891469|NCT04860297|157438286|FG006|Part B (Booster Dose)|Other Than Specified|1|||
48891470|NCT04860297|157438287|FG007|Part B (Booster Dose)|Other Than Specified|0|||
48891471|NCT04860297|157438280|FG000|Part B (Booster Dose)|Withdrawal by Subject|0|||
48891472|NCT04860297|157438281|FG001|Part B (Booster Dose)|Withdrawal by Subject|0|||
48891473|NCT04860297|157438282|FG002|Part B (Booster Dose)|Withdrawal by Subject|0|||
48891474|NCT04860297|157438283|FG003|Part B (Booster Dose)|Withdrawal by Subject|0|||
48891475|NCT04860297|157438284|FG004|Part B (Booster Dose)|Withdrawal by Subject|0|||
48891476|NCT04860297|157438285|FG005|Part B (Booster Dose)|Withdrawal by Subject|2|||
48891477|NCT04860297|157438286|FG006|Part B (Booster Dose)|Withdrawal by Subject|0|||
48891478|NCT04860297|157438287|FG007|Part B (Booster Dose)|Withdrawal by Subject|1|||
48891479|NCT04860297|157438280|FG000|Part B (Booster Dose)|Death|0|||
48891480|NCT04860297|157438281|FG001|Part B (Booster Dose)|Death|0|||
48891481|NCT04860297|157438282|FG002|Part B (Booster Dose)|Death|0|||
48891482|NCT04860297|157438283|FG003|Part B (Booster Dose)|Death|0|||
48891483|NCT04860297|157438284|FG004|Part B (Booster Dose)|Death|1|||
48891484|NCT04860297|157438285|FG005|Part B (Booster Dose)|Death|2|||
48891485|NCT04860297|157438286|FG006|Part B (Booster Dose)|Death|1|||
48891486|NCT04860297|157438287|FG007|Part B (Booster Dose)|Death|0|||
48891487|NCT04860297|157438280|FG000|Part B (Booster Dose)|Lost to Follow-up|0|||
48891488|NCT04860297|157438281|FG001|Part B (Booster Dose)|Lost to Follow-up|0|||
48891489|NCT04860297|157438282|FG002|Part B (Booster Dose)|Lost to Follow-up|0|||
48983951|NCT01225211|157772408|FG009|Overall Study|Adverse Event|1|||
48983952|NCT01225211|157772399|FG000|Overall Study|Withdrawal by Subject|0|||
48983953|NCT01225211|157772400|FG001|Overall Study|Withdrawal by Subject|0|||
48983954|NCT01225211|157772401|FG002|Overall Study|Withdrawal by Subject|0|||
48983955|NCT01225211|157772402|FG003|Overall Study|Withdrawal by Subject|0|||
48983956|NCT01225211|157772403|FG004|Overall Study|Withdrawal by Subject|0|||
48983957|NCT01225211|157772404|FG005|Overall Study|Withdrawal by Subject|0|||
48983958|NCT01225211|157772405|FG006|Overall Study|Withdrawal by Subject|1|||
48983959|NCT01225211|157772406|FG007|Overall Study|Withdrawal by Subject|0|||
48983960|NCT01225211|157772407|FG008|Overall Study|Withdrawal by Subject|1|||
48983961|NCT01225211|157772408|FG009|Overall Study|Withdrawal by Subject|3|||
48983962|NCT01225211|157772399|FG000|Overall Study|Other|0|||
48983963|NCT01225211|157772400|FG001|Overall Study|Other|0|||
48983964|NCT01225211|157772401|FG002|Overall Study|Other|0|||
48983965|NCT01225211|157772402|FG003|Overall Study|Other|0|||
48983966|NCT01225211|157772403|FG004|Overall Study|Other|0|||
48983967|NCT01225211|157772404|FG005|Overall Study|Other|0|||
48983968|NCT01225211|157772405|FG006|Overall Study|Other|0|||
48983969|NCT01225211|157772406|FG007|Overall Study|Other|0|||
48983970|NCT01225211|157772407|FG008|Overall Study|Other|0|||
48983971|NCT01225211|157772408|FG009|Overall Study|Other|1|||
48983972|NCT02355665|157772412|FG000|Overall Study|Adverse Event|16|||
48983973|NCT02355665|157772413|FG001|Overall Study|Adverse Event|24|||
48983974|NCT02355665|157772412|FG000|Overall Study|Protocol Violation|2|||
48983975|NCT02355665|157772413|FG001|Overall Study|Protocol Violation|0|||
48983976|NCT02355665|157772412|FG000|Overall Study|Withdrawal by Subject|90|||
48983977|NCT02355665|157772413|FG001|Overall Study|Withdrawal by Subject|100|||
48983978|NCT02355665|157772412|FG000|Overall Study|Lost to Follow-up|131|||
48983979|NCT02355665|157772413|FG001|Overall Study|Lost to Follow-up|103|||
48983980|NCT02355665|157772412|FG000|Overall Study|Death|4|||
48983981|NCT02355665|157772413|FG001|Overall Study|Death|2|||
48983982|NCT02355665|157772412|FG000|Overall Study|Compliance, PI decision, move, eligible|6|||
48983983|NCT02355665|157772413|FG001|Overall Study|Compliance, PI decision, move, eligible|3|||
48983984|NCT02735044|157772414|FG000|Overall Study|Adverse Event|3|||
48983985|NCT02735044|157772415|FG001|Overall Study|Adverse Event|3|||
48983986|NCT02735044|157772414|FG000|Overall Study|Lack of Efficacy|1|||
48983987|NCT02735044|157772415|FG001|Overall Study|Lack of Efficacy|0|||
48983988|NCT02735044|157772414|FG000|Overall Study|Poor compliance to protocol|7|||
48983989|NCT02735044|157772415|FG001|Overall Study|Poor compliance to protocol|7|||
48983990|NCT02735044|157772414|FG000|Overall Study|Randomized and not treated|0|||
48983991|NCT02735044|157772415|FG001|Overall Study|Randomized and not treated|2|||
48983992|NCT02735044|157772414|FG000|Overall Study|Other, not specified above|5|||
48983993|NCT02735044|157772415|FG001|Overall Study|Other, not specified above|11|||
48983994|NCT01984294|157772416|FG000|Overall Study|Randomized but Never Treated|0|||
48983995|NCT01984294|157772417|FG001|Overall Study|Randomized but Never Treated|0|||
48983996|NCT01984294|157772418|FG002|Overall Study|Randomized but Never Treated|1|||
48891490|NCT04860297|157438283|FG003|Part B (Booster Dose)|Lost to Follow-up|0|||
48891491|NCT04860297|157438284|FG004|Part B (Booster Dose)|Lost to Follow-up|3|||
48891492|NCT04860297|157438285|FG005|Part B (Booster Dose)|Lost to Follow-up|5|||
48891493|NCT04860297|157438286|FG006|Part B (Booster Dose)|Lost to Follow-up|1|||
48891494|NCT04860297|157438287|FG007|Part B (Booster Dose)|Lost to Follow-up|2|||
48891495|NCT00862719|157438288|FG000|Overall Study|Disease Progression|5|||
48891496|NCT00862719|157438289|FG001|Overall Study|Disease Progression|0|||
48891497|NCT00862719|157438290|FG002|Overall Study|Disease Progression|1|||
48891498|NCT00862719|157438291|FG003|Overall Study|Disease Progression|0|||
48891499|NCT00862719|157438288|FG000|Overall Study|Death|5|||
48891500|NCT00862719|157438289|FG001|Overall Study|Death|6|||
48891501|NCT00862719|157438290|FG002|Overall Study|Death|1|||
48891502|NCT00862719|157438291|FG003|Overall Study|Death|1|||
48891503|NCT00862719|157438288|FG000|Overall Study|Engraftment failure|0|||
48891504|NCT00862719|157438289|FG001|Overall Study|Engraftment failure|0|||
48891505|NCT00862719|157438290|FG002|Overall Study|Engraftment failure|1|||
48891506|NCT00862719|157438291|FG003|Overall Study|Engraftment failure|0|||
48891507|NCT00862719|157438288|FG000|Overall Study|Veno-Occlusive Disease|0|||
48891508|NCT00862719|157438289|FG001|Overall Study|Veno-Occlusive Disease|0|||
48891509|NCT00862719|157438290|FG002|Overall Study|Veno-Occlusive Disease|1|||
48891510|NCT00862719|157438291|FG003|Overall Study|Veno-Occlusive Disease|0|||
48891511|NCT00798590|157438292|FG000|Overall Study|P.I, Left institution. Study terminated|11|||
48891512|NCT00798590|157438293|FG001|Overall Study|P.I, Left institution. Study terminated|8|||
48891513|NCT00324116|157438294|FG000|Overall Study|Adverse Event|5|||
48891514|NCT00324116|157438294|FG000|Overall Study|Lack of Efficacy|17|||
48891515|NCT00324116|157438294|FG000|Overall Study|Withdrawal by Subject|5|||
48891516|NCT00324116|157438294|FG000|Overall Study|Other|5|||
48891517|NCT00929110|157438297|FG000|Overall Study|Adverse Event|40|||
48891518|NCT00929110|157438298|FG001|Overall Study|Adverse Event|29|||
48891519|NCT00929110|157438299|FG002|Overall Study|Adverse Event|18|||
48891520|NCT00929110|157438297|FG000|Overall Study|Subject withdrew consent|40|||
48891521|NCT00929110|157438298|FG001|Overall Study|Subject withdrew consent|23|||
48891522|NCT00929110|157438299|FG002|Overall Study|Subject withdrew consent|26|||
48891523|NCT00929110|157438297|FG000|Overall Study|Unsatisfactory therapeutic effect|20|||
48891524|NCT00929110|157438298|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
48891525|NCT00929110|157438299|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
48891526|NCT00929110|157438297|FG000|Overall Study|Lost to Follow-up|7|||
48891527|NCT00929110|157438298|FG001|Overall Study|Lost to Follow-up|7|||
48891528|NCT00929110|157438299|FG002|Overall Study|Lost to Follow-up|3|||
48891529|NCT00929110|157438297|FG000|Overall Study|Protocol deviation|5|||
48891530|NCT00929110|157438298|FG001|Overall Study|Protocol deviation|2|||
48891531|NCT00929110|157438299|FG002|Overall Study|Protocol deviation|4|||
48891532|NCT00929110|157438297|FG000|Overall Study|Administrative problems|4|||
48891533|NCT00929110|157438298|FG001|Overall Study|Administrative problems|1|||
48891534|NCT00929110|157438299|FG002|Overall Study|Administrative problems|2|||
48891535|NCT00929110|157438297|FG000|Overall Study|Death|2|||
48891536|NCT00929110|157438298|FG001|Overall Study|Death|2|||
48891537|NCT00929110|157438299|FG002|Overall Study|Death|2|||
48891538|NCT00929110|157438297|FG000|Overall Study|Abnormal laboratory value(s)|0|||
48891539|NCT00929110|157438298|FG001|Overall Study|Abnormal laboratory value(s)|1|||
48891540|NCT00929110|157438299|FG002|Overall Study|Abnormal laboratory value(s)|0|||
48891541|NCT00929110|157438297|FG000|Overall Study|Abnormal test procedure result(s)|0|||
48891542|NCT00929110|157438298|FG001|Overall Study|Abnormal test procedure result(s)|1|||
48891543|NCT00929110|157438299|FG002|Overall Study|Abnormal test procedure result(s)|1|||
48891544|NCT00929110|157438297|FG000|Overall Study|Patient inability to use the device|0|||
48891545|NCT00929110|157438298|FG001|Overall Study|Patient inability to use the device|1|||
48891546|NCT00929110|157438299|FG002|Overall Study|Patient inability to use the device|0|||
48891547|NCT02217475|157438300|FG000|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
48891548|NCT02217475|157438301|FG001|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1|||
48891549|NCT02217475|157438302|FG002|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
48891550|NCT02217475|157438300|FG000|Treatment Period 1 (Year 1)|Adverse Event|4|||
48891551|NCT02217475|157438301|FG001|Treatment Period 1 (Year 1)|Adverse Event|5|||
48891552|NCT02217475|157438302|FG002|Treatment Period 1 (Year 1)|Adverse Event|9|||
48891553|NCT02217475|157438300|FG000|Treatment Period 1 (Year 1)|Lost to Follow-up|1|||
48891554|NCT02217475|157438301|FG001|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
48891555|NCT02217475|157438302|FG002|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
48891556|NCT02217475|157438300|FG000|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5|||
48983997|NCT01984294|157772416|FG000|Overall Study|Lack of Efficacy|4|||
48983998|NCT01984294|157772417|FG001|Overall Study|Lack of Efficacy|2|||
48983999|NCT01984294|157772418|FG002|Overall Study|Lack of Efficacy|6|||
48984000|NCT01984294|157772416|FG000|Overall Study|Adverse Event|0|||
48984001|NCT01984294|157772417|FG001|Overall Study|Adverse Event|1|||
48984002|NCT01984294|157772418|FG002|Overall Study|Adverse Event|0|||
48984003|NCT00517634|157772420|FG000|Second Treatment Period|Withdrawal by Subject|0|||
48984004|NCT00517634|157772421|FG001|Second Treatment Period|Withdrawal by Subject|0|||
49037301|NCT04035187|157973085|FG003|Overall Study|Withdrawal by Subject|0|||
49037302|NCT04035187|157973082|FG000|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
49037303|NCT04035187|157973083|FG001|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
49037304|NCT04035187|157973084|FG002|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
49037305|NCT04035187|157973085|FG003|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
49037306|NCT02659150|157973090|FG000|Subject Enrollment|Physician Decision|3|||
49037307|NCT02659150|157973090|FG000|Subject Enrollment|Withdrawal by Subject|2|||
49037308|NCT02659150|157973090|FG000|Baseline Imaging|Withdrawal by Subject|1|||
49037309|NCT02659150|157973090|FG000|Baseline Imaging|Physician Decision|1|||
49037310|NCT02659150|157973090|FG000|Study Drug Dosing|Adverse Event|1|||
49037311|NCT00679081|157973092|FG000|Overall Study|Lost to Follow-up|1|||
49037312|NCT01695239|157973094|FG000|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
49037313|NCT01695239|157973095|FG001|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
49037314|NCT01695239|157973096|FG002|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3|||
49037315|NCT01695239|157973097|FG003|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4|||
49037316|NCT01695239|157973098|FG004|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
49037317|NCT01695239|157973099|FG005|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
49037318|NCT01695239|157973100|FG006|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
49037319|NCT01695239|157973101|FG007|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
49037320|NCT01695239|157973102|FG008|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
48891557|NCT02217475|157438301|FG001|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2|||
48891558|NCT02217475|157438302|FG002|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11|||
48891559|NCT02217475|157438300|FG000|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
48891560|NCT02217475|157438301|FG001|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
48891561|NCT02217475|157438302|FG002|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1|||
48891562|NCT02217475|157438300|FG000|Discontinued After Period 1|Adverse Event|1|||
48891563|NCT02217475|157438301|FG001|Discontinued After Period 1|Adverse Event|2|||
48891564|NCT02217475|157438302|FG002|Discontinued After Period 1|Adverse Event|0|||
48891565|NCT02217475|157438300|FG000|Discontinued After Period 1|Participant Withdrew Consent|1|||
48891566|NCT02217475|157438301|FG001|Discontinued After Period 1|Participant Withdrew Consent|1|||
48891567|NCT02217475|157438302|FG002|Discontinued After Period 1|Participant Withdrew Consent|2|||
48891568|NCT02217475|157438300|FG000|Discontinued After Period 1|Physician Decision|0|||
48891569|NCT02217475|157438301|FG001|Discontinued After Period 1|Physician Decision|0|||
48891570|NCT02217475|157438302|FG002|Discontinued After Period 1|Physician Decision|1|||
48891571|NCT02217475|157438300|FG000|Treatment Period 2 (Year 2)|Adverse Event|0|||
48891572|NCT02217475|157438301|FG001|Treatment Period 2 (Year 2)|Adverse Event|1|||
48891573|NCT02217475|157438302|FG002|Treatment Period 2 (Year 2)|Adverse Event|5|||
48891574|NCT02217475|157438300|FG000|Treatment Period 2 (Year 2)|Lost to Follow-up|0|||
48891575|NCT02217475|157438301|FG001|Treatment Period 2 (Year 2)|Lost to Follow-up|1|||
48891576|NCT02217475|157438302|FG002|Treatment Period 2 (Year 2)|Lost to Follow-up|2|||
48891577|NCT02217475|157438300|FG000|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
48891578|NCT02217475|157438301|FG001|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0|||
48891579|NCT02217475|157438302|FG002|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
48891580|NCT02217475|157438300|FG000|Treatment Period 2 (Year 2)|Physician Decision|0|||
48891581|NCT02217475|157438301|FG001|Treatment Period 2 (Year 2)|Physician Decision|0|||
48891582|NCT02217475|157438302|FG002|Treatment Period 2 (Year 2)|Physician Decision|2|||
48891583|NCT02217475|157438300|FG000|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
48891584|NCT02217475|157438301|FG001|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
48891585|NCT02217475|157438302|FG002|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1|||
48891586|NCT01215188|157438303|FG000|Overall Study|Lost to Follow-up|22|||
48891587|NCT01215188|157438304|FG001|Overall Study|Lost to Follow-up|22|||
48891588|NCT01215188|157438305|FG002|Overall Study|Lost to Follow-up|16|||
48891589|NCT01215188|157438303|FG000|Overall Study|Adverse Event|1|||
48891590|NCT01215188|157438304|FG001|Overall Study|Adverse Event|1|||
48891591|NCT01215188|157438305|FG002|Overall Study|Adverse Event|3|||
48891592|NCT01215188|157438303|FG000|Overall Study|Physician Decision|2|||
48891593|NCT01215188|157438304|FG001|Overall Study|Physician Decision|1|||
48891594|NCT01215188|157438305|FG002|Overall Study|Physician Decision|0|||
48891595|NCT01215188|157438303|FG000|Overall Study|Lack of Efficacy|0|||
48891596|NCT01215188|157438304|FG001|Overall Study|Lack of Efficacy|0|||
48891597|NCT01215188|157438305|FG002|Overall Study|Lack of Efficacy|1|||
48891598|NCT01215188|157438303|FG000|Overall Study|Protocol Violation|1|||
49037321|NCT01695239|157973103|FG009|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
48891599|NCT01215188|157438304|FG001|Overall Study|Protocol Violation|1|||
48891600|NCT01215188|157438305|FG002|Overall Study|Protocol Violation|1|||
48891601|NCT01215188|157438303|FG000|Overall Study|Withdrawal by Subject|32|||
48891602|NCT01215188|157438304|FG001|Overall Study|Withdrawal by Subject|34|||
48891603|NCT01215188|157438305|FG002|Overall Study|Withdrawal by Subject|31|||
48891604|NCT00992225|157438312|FG000|Overall Study|Entry Criteria Not Met|8|||
48891605|NCT00992225|157438312|FG000|Overall Study|Adverse Event|2|||
48891606|NCT03122223|157438313|FG000|Overall Study|Withdrawal by Subject|2|||
48891607|NCT03122223|157438314|FG001|Overall Study|Withdrawal by Subject|2|||
48891608|NCT03122223|157438315|FG002|Overall Study|Withdrawal by Subject|1|||
48891609|NCT03122223|157438316|FG003|Overall Study|Withdrawal by Subject|0|||
48891610|NCT03122223|157438313|FG000|Overall Study|Lost to Follow-up|0|||
48891611|NCT03122223|157438314|FG001|Overall Study|Lost to Follow-up|2|||
48891612|NCT03122223|157438315|FG002|Overall Study|Lost to Follow-up|2|||
48891613|NCT03122223|157438316|FG003|Overall Study|Lost to Follow-up|0|||
48891614|NCT03122223|157438313|FG000|Overall Study|Participant unable to adhere|1|||
48891615|NCT03122223|157438314|FG001|Overall Study|Participant unable to adhere|1|||
48891616|NCT03122223|157438315|FG002|Overall Study|Participant unable to adhere|1|||
48891617|NCT03122223|157438316|FG003|Overall Study|Participant unable to adhere|0|||
48891618|NCT03181789|157438317|FG000|Overall Study|Withdrawal by Subject|0|||
48891619|NCT03181789|157438318|FG001|Overall Study|Withdrawal by Subject|1|||
48891620|NCT03181789|157438319|FG002|Overall Study|Withdrawal by Subject|1|||
48891621|NCT03181789|157438320|FG003|Overall Study|Withdrawal by Subject|0|||
48891622|NCT03181789|157438317|FG000|Overall Study|Lost to Follow-up|7|||
48891623|NCT03181789|157438318|FG001|Overall Study|Lost to Follow-up|1|||
48891624|NCT03181789|157438319|FG002|Overall Study|Lost to Follow-up|0|||
48891625|NCT03181789|157438320|FG003|Overall Study|Lost to Follow-up|0|||
48891626|NCT03181789|157438317|FG000|Overall Study|Participant unable to adhere to visit|0|||
48891627|NCT03181789|157438318|FG001|Overall Study|Participant unable to adhere to visit|1|||
48891628|NCT03181789|157438319|FG002|Overall Study|Participant unable to adhere to visit|0|||
48891629|NCT03181789|157438320|FG003|Overall Study|Participant unable to adhere to visit|0|||
48891630|NCT02624791|157438321|FG000|Overall Study|Withdrawal by Subject|2|||
48891631|NCT02624791|157438322|FG001|Overall Study|Withdrawal by Subject|0|||
48891632|NCT02624791|157438323|FG002|Overall Study|Withdrawal by Subject|0|||
48891633|NCT02624791|157438324|FG003|Overall Study|Withdrawal by Subject|0|||
48891634|NCT02624791|157438325|FG004|Overall Study|Withdrawal by Subject|0|||
48891635|NCT02624791|157438326|FG005|Overall Study|Withdrawal by Subject|0|||
48891636|NCT04189952|157438327|FG000|Follow-up Period|Death|1|||
48891637|NCT04189952|157438327|FG000|Follow-up Period|Withdrawal by Subject|1|||
48891638|NCT03466073|157438328|FG000|Overall Study|Death|1|||
48891639|NCT03466073|157438329|FG001|Overall Study|Death|0|||
48891640|NCT03466073|157438330|FG002|Overall Study|Death|0|||
48891641|NCT03466073|157438331|FG003|Overall Study|Death|0|||
48891642|NCT03466073|157438332|FG004|Overall Study|Death|0|||
48891643|NCT03466073|157438333|FG005|Overall Study|Death|1|||
48891644|NCT01081665|157438334|FG000|Overall Study|Death|41|||
48891645|NCT01081665|157438334|FG000|Overall Study|Lost to Follow-up|18|||
48891646|NCT01081665|157438334|FG000|Overall Study|Withdrawal by Subject|17|||
48891647|NCT01081665|157438334|FG000|Overall Study|Change of dialysis unit|10|||
48891648|NCT01081665|157438334|FG000|Overall Study|Regulation of iPTH|5|||
48891649|NCT01081665|157438334|FG000|Overall Study|Change in renal replacement therapy|2|||
48891650|NCT01081665|157438334|FG000|Overall Study|Adverse Event|1|||
48891651|NCT01081665|157438334|FG000|Overall Study|Lack of Efficacy|1|||
48891652|NCT01395888|157438339|FG000|2-week Run-in Period|Adverse Event|2|||
48891653|NCT01395888|157438340|FG001|2-week Run-in Period|Adverse Event|0|||
48891654|NCT01395888|157438341|FG002|2-week Run-in Period|Adverse Event|0|||
48891655|NCT01395888|157438339|FG000|2-week Run-in Period|Continuation Criteria Not Met|13|||
48891656|NCT01395888|157438340|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
48891657|NCT01395888|157438341|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
48891658|NCT01395888|157438339|FG000|2-week Run-in Period|Lost to Follow-up|1|||
48891659|NCT01395888|157438340|FG001|2-week Run-in Period|Lost to Follow-up|0|||
48891660|NCT01395888|157438341|FG002|2-week Run-in Period|Lost to Follow-up|0|||
48891661|NCT01395888|157438339|FG000|2-week Run-in Period|Protocol Violation|2|||
48891662|NCT01395888|157438340|FG001|2-week Run-in Period|Protocol Violation|0|||
48891663|NCT01395888|157438341|FG002|2-week Run-in Period|Protocol Violation|0|||
48891664|NCT01395888|157438339|FG000|2-week Run-in Period|Withdrawal by Subject|4|||
48891665|NCT01395888|157438340|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
48891666|NCT01395888|157438341|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
48891667|NCT01395888|157438339|FG000|Treatment Period (TP)|Adverse Event|0|||
48891668|NCT01395888|157438340|FG001|Treatment Period (TP)|Adverse Event|7|||
48891669|NCT01395888|157438341|FG002|Treatment Period (TP)|Adverse Event|6|||
48891670|NCT01395888|157438339|FG000|Treatment Period (TP)|Lack of Efficacy|0|||
48891671|NCT01395888|157438340|FG001|Treatment Period (TP)|Lack of Efficacy|4|||
48891672|NCT01395888|157438341|FG002|Treatment Period (TP)|Lack of Efficacy|3|||
48891673|NCT01395888|157438339|FG000|Treatment Period (TP)|Protocol Violation|0|||
48891674|NCT01395888|157438340|FG001|Treatment Period (TP)|Protocol Violation|1|||
48891675|NCT01395888|157438341|FG002|Treatment Period (TP)|Protocol Violation|5|||
48891676|NCT01395888|157438339|FG000|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
48891677|NCT01395888|157438340|FG001|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1|||
48891678|NCT01395888|157438341|FG002|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
48891679|NCT01395888|157438339|FG000|Treatment Period (TP)|Withdrawal by Subject|0|||
48891680|NCT01395888|157438340|FG001|Treatment Period (TP)|Withdrawal by Subject|2|||
48891681|NCT01395888|157438341|FG002|Treatment Period (TP)|Withdrawal by Subject|3|||
48891682|NCT02217501|157438348|FG000|Overall Study|Death|3|||
48891683|NCT02217501|157438349|FG001|Overall Study|Death|4|||
48891684|NCT02019667|157438352|FG000|First Intervention (6 Months)|Adverse Event|0|||
48891685|NCT02019667|157438353|FG001|First Intervention (6 Months)|Adverse Event|1|||
48891686|NCT02019667|157438352|FG000|2nd Intervention (6 Months)|Adverse Event|0|||
48891687|NCT02019667|157438353|FG001|2nd Intervention (6 Months)|Adverse Event|1|||
48891688|NCT02019667|157438352|FG000|2nd Intervention (6 Months)|Physician Decision|0|||
48891689|NCT02019667|157438353|FG001|2nd Intervention (6 Months)|Physician Decision|1|||
48891690|NCT05114473|157438354|FG000|Overall Study|Lost to Follow-up|2|||
48891691|NCT05114473|157438355|FG001|Overall Study|Lost to Follow-up|2|||
48891692|NCT05114473|157438356|FG002|Overall Study|Lost to Follow-up|0|||
48891693|NCT02495792|157438357|FG000|Overall Study|Lost to Follow-up|5|||
48891694|NCT02495792|157438358|FG001|Overall Study|Lost to Follow-up|9|||
48891695|NCT02495792|157438357|FG000|Overall Study|Protocol Violation|32|||
48891696|NCT02495792|157438358|FG001|Overall Study|Protocol Violation|31|||
48891697|NCT02432196|157438359|FG000|Overall Study|Exit - did not receive study device|1|||
48891698|NCT02432196|157438359|FG000|Overall Study|Death|2|||
48891699|NCT02432196|157438359|FG000|Overall Study|Reoperation|3|||
48891700|NCT02766465|157438362|FG000|Overall Study|Withdrawal by Subject|0|||
48891701|NCT02766465|157438363|FG001|Overall Study|Withdrawal by Subject|10|||
48891702|NCT01758900|157438366|FG000|Overall Study|difficulty for further intubation|7|||
48891703|NCT01758900|157438367|FG001|Overall Study|difficulty for further intubation|8|||
48891704|NCT00935818|157438368|FG000|Overall Study|Withdrawal by Subject|45|||
49037322|NCT01695239|157973104|FG010|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
49037323|NCT01695239|157973105|FG011|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
48891705|NCT00935818|157438369|FG001|Overall Study|Withdrawal by Subject|50|||
48891706|NCT00935818|157438368|FG000|Overall Study|Lost to Follow-up|40|||
48891707|NCT00935818|157438369|FG001|Overall Study|Lost to Follow-up|42|||
49037324|NCT01695239|157973106|FG012|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
49037325|NCT01695239|157973107|FG013|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
49037326|NCT01695239|157973094|FG000|Double-Blind (DB) Treatment Period|Adverse Event|2|||
49037327|NCT01695239|157973095|FG001|Double-Blind (DB) Treatment Period|Adverse Event|2|||
48891708|NCT00935818|157438368|FG000|Overall Study|Adverse Event|6|||
48891709|NCT00935818|157438369|FG001|Overall Study|Adverse Event|7|||
48891710|NCT00935818|157438368|FG000|Overall Study|Physician Decision|0|||
48891711|NCT00935818|157438369|FG001|Overall Study|Physician Decision|1|||
48891712|NCT01142232|157439581|FG000|Overall Study|Adverse Event|1|||
48891713|NCT01142232|157439582|FG001|Overall Study|Adverse Event|2|||
48891714|NCT01142232|157439583|FG002|Overall Study|Adverse Event|1|||
48891715|NCT01142232|157439584|FG003|Overall Study|Adverse Event|0|||
48891716|NCT01142232|157439585|FG004|Overall Study|Adverse Event|4|||
48891717|NCT01142232|157439581|FG000|Overall Study|Death|0|||
48891718|NCT01142232|157439582|FG001|Overall Study|Death|0|||
48891719|NCT01142232|157439583|FG002|Overall Study|Death|0|||
48891720|NCT01142232|157439584|FG003|Overall Study|Death|0|||
48891721|NCT01142232|157439585|FG004|Overall Study|Death|1|||
48891722|NCT01142232|157439581|FG000|Overall Study|Disease Progression|2|||
48891723|NCT01142232|157439582|FG001|Overall Study|Disease Progression|0|||
48891724|NCT01142232|157439583|FG002|Overall Study|Disease Progression|1|||
48891725|NCT01142232|157439584|FG003|Overall Study|Disease Progression|2|||
48891726|NCT01142232|157439585|FG004|Overall Study|Disease Progression|12|||
48891727|NCT01142232|157439581|FG000|Overall Study|Withdrawal by Subject|0|||
49037328|NCT01695239|157973096|FG002|Double-Blind (DB) Treatment Period|Adverse Event|2|||
49037329|NCT01695239|157973097|FG003|Double-Blind (DB) Treatment Period|Adverse Event|3|||
49037330|NCT01695239|157973098|FG004|Double-Blind (DB) Treatment Period|Adverse Event|0|||
49037331|NCT01695239|157973099|FG005|Double-Blind (DB) Treatment Period|Adverse Event|0|||
49037332|NCT01695239|157973100|FG006|Double-Blind (DB) Treatment Period|Adverse Event|0|||
48891728|NCT01142232|157439582|FG001|Overall Study|Withdrawal by Subject|0|||
48891729|NCT01142232|157439583|FG002|Overall Study|Withdrawal by Subject|0|||
48891730|NCT01142232|157439584|FG003|Overall Study|Withdrawal by Subject|1|||
48891731|NCT01142232|157439585|FG004|Overall Study|Withdrawal by Subject|3|||
48891732|NCT01142232|157439581|FG000|Overall Study|Physician Decision|0|||
49037333|NCT01695239|157973101|FG007|Double-Blind (DB) Treatment Period|Adverse Event|0|||
49037334|NCT01695239|157973102|FG008|Double-Blind (DB) Treatment Period|Adverse Event|0|||
49037335|NCT01695239|157973103|FG009|Double-Blind (DB) Treatment Period|Adverse Event|0|||
48891733|NCT01142232|157439582|FG001|Overall Study|Physician Decision|1|||
48891734|NCT01142232|157439583|FG002|Overall Study|Physician Decision|0|||
48891735|NCT01142232|157439584|FG003|Overall Study|Physician Decision|2|||
48891736|NCT01142232|157439585|FG004|Overall Study|Physician Decision|10|||
48891737|NCT01142232|157439581|FG000|Overall Study|Alternative Therapy|0|||
48891738|NCT01142232|157439582|FG001|Overall Study|Alternative Therapy|1|||
48891739|NCT01142232|157439583|FG002|Overall Study|Alternative Therapy|1|||
48891740|NCT01142232|157439584|FG003|Overall Study|Alternative Therapy|0|||
48891741|NCT01142232|157439585|FG004|Overall Study|Alternative Therapy|1|||
48891742|NCT01142232|157439581|FG000|Overall Study|Off Trt for other complicating disease|0|||
48891743|NCT01142232|157439582|FG001|Overall Study|Off Trt for other complicating disease|0|||
48891744|NCT01142232|157439583|FG002|Overall Study|Off Trt for other complicating disease|0|||
48891745|NCT01142232|157439584|FG003|Overall Study|Off Trt for other complicating disease|0|||
48891746|NCT01142232|157439585|FG004|Overall Study|Off Trt for other complicating disease|1|||
48891747|NCT01142232|157439581|FG000|Overall Study|Noncompliance|0|||
48891748|NCT01142232|157439582|FG001|Overall Study|Noncompliance|0|||
48891749|NCT01142232|157439583|FG002|Overall Study|Noncompliance|0|||
48891750|NCT01142232|157439584|FG003|Overall Study|Noncompliance|0|||
48891751|NCT01142232|157439585|FG004|Overall Study|Noncompliance|2|||
48891752|NCT03507777|157439586|FG000|Overall Study|Lost to Follow-up|5|||
48891753|NCT03507777|157439587|FG001|Overall Study|Lost to Follow-up|7|||
48891754|NCT03507777|157439586|FG000|Overall Study|Withdrawal by Subject|6|||
48891755|NCT03507777|157439587|FG001|Overall Study|Withdrawal by Subject|11|||
48891756|NCT03507777|157439586|FG000|Overall Study|Death|30|||
48891757|NCT03507777|157439587|FG001|Overall Study|Death|44|||
48891758|NCT03507777|157439586|FG000|Overall Study|Other Reasons|3|||
48891759|NCT03507777|157439587|FG001|Overall Study|Other Reasons|8|||
48891760|NCT04101318|157439588|FG000|First Intervention (42 +/- 3 Days)|Lost to Follow-up|0|||
48891761|NCT04101318|157439589|FG001|First Intervention (42 +/- 3 Days)|Lost to Follow-up|1|||
48891762|NCT04101318|157439588|FG000|First Intervention (42 +/- 3 Days)|Adverse Event|0|||
48891763|NCT04101318|157439589|FG001|First Intervention (42 +/- 3 Days)|Adverse Event|1|||
48891764|NCT04101318|157439588|FG000|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
48891765|NCT04101318|157439589|FG001|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
48891766|NCT03207451|157439590|FG000|Overall Study|scheduling conflict|1|||
48891767|NCT03207451|157439591|FG001|Overall Study|scheduling conflict|0|||
48891768|NCT03207451|157439592|FG002|Overall Study|scheduling conflict|2|||
48891769|NCT03207451|157439593|FG003|Overall Study|scheduling conflict|2|||
48891770|NCT03207451|157439590|FG000|Overall Study|Adverse Event|0|||
48891771|NCT03207451|157439591|FG001|Overall Study|Adverse Event|0|||
48891772|NCT03207451|157439592|FG002|Overall Study|Adverse Event|0|||
48891773|NCT03207451|157439593|FG003|Overall Study|Adverse Event|1|||
48891774|NCT04552899|157439594|FG000|Overall Study|Adverse Event|4|||
48891775|NCT04552899|157439595|FG001|Overall Study|Adverse Event|3|||
48891776|NCT04552899|157439594|FG000|Overall Study|Death|4|||
48891777|NCT04552899|157439595|FG001|Overall Study|Death|4|||
48891778|NCT04552899|157439594|FG000|Overall Study|Lost to Follow-up|8|||
48891779|NCT04552899|157439595|FG001|Overall Study|Lost to Follow-up|13|||
48891780|NCT04552899|157439594|FG000|Overall Study|Lung Transplant|4|||
48891781|NCT04552899|157439595|FG001|Overall Study|Lung Transplant|3|||
48891782|NCT04552899|157439594|FG000|Overall Study|Participant and physician wanted to withdraw participant from study|0|||
48891783|NCT04552899|157439595|FG001|Overall Study|Participant and physician wanted to withdraw participant from study|1|||
48891784|NCT04552899|157439594|FG000|Overall Study|Physician Decision|3|||
48891785|NCT04552899|157439595|FG001|Overall Study|Physician Decision|4|||
48891786|NCT04552899|157439594|FG000|Overall Study|Study Terminated By Sponsor|237|||
48984005|NCT00517634|157772422|FG002|Second Treatment Period|Withdrawal by Subject|0|||
48984006|NCT00517634|157772423|FG003|Second Treatment Period|Withdrawal by Subject|0|||
48984007|NCT00517634|157772424|FG004|Second Treatment Period|Withdrawal by Subject|1|||
48984008|NCT00517634|157772425|FG005|Second Treatment Period|Withdrawal by Subject|0|||
48984009|NCT01156012|157772430|FG000|Overall Study|Adverse Event|3|||
48984010|NCT01156012|157772431|FG001|Overall Study|Adverse Event|1|||
48984011|NCT01156012|157772430|FG000|Overall Study|Lost to Follow-up|1|||
48984012|NCT01156012|157772431|FG001|Overall Study|Lost to Follow-up|0|||
48984013|NCT01156012|157772430|FG000|Overall Study|Withdrawal by Subject|1|||
48984014|NCT01156012|157772431|FG001|Overall Study|Withdrawal by Subject|0|||
48984015|NCT01156012|157772430|FG000|Overall Study|use of commercial drug instead of study|0|||
48984016|NCT01156012|157772431|FG001|Overall Study|use of commercial drug instead of study|1|||
48984017|NCT01156012|157772430|FG000|Overall Study|Non respect of one of inclusion criteria|2|||
48984018|NCT01156012|157772431|FG001|Overall Study|Non respect of one of inclusion criteria|1|||
48984019|NCT00626795|157772432|FG000|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
48984020|NCT00626795|157772433|FG001|Open-label TD1414 Cream TID Treatment|Adverse Event|1|||
48984021|NCT00626795|157772434|FG002|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
48984022|NCT00626795|157772432|FG000|Blinded Treatment|Lack of Efficacy|2|||
48984023|NCT00626795|157772433|FG001|Blinded Treatment|Lack of Efficacy|0|||
48984024|NCT00626795|157772434|FG002|Blinded Treatment|Lack of Efficacy|0|||
48984025|NCT00626795|157772432|FG000|Blinded Treatment|Unacceptable adverse event|0|||
48984026|NCT00626795|157772433|FG001|Blinded Treatment|Unacceptable adverse event|0|||
48984027|NCT00626795|157772434|FG002|Blinded Treatment|Unacceptable adverse event|1|||
48984028|NCT00626795|157772432|FG000|Blinded Treatment|Protocol Violation|0|||
48984029|NCT00626795|157772433|FG001|Blinded Treatment|Protocol Violation|1|||
48984030|NCT00626795|157772434|FG002|Blinded Treatment|Protocol Violation|1|||
48984031|NCT00626795|157772432|FG000|Blinded Treatment|Withdrawal by Subject|1|||
48984032|NCT00626795|157772433|FG001|Blinded Treatment|Withdrawal by Subject|1|||
48984033|NCT00626795|157772434|FG002|Blinded Treatment|Withdrawal by Subject|0|||
48984034|NCT00626795|157772432|FG000|Blinded Treatment|Other reasons|2|||
49037336|NCT01695239|157973104|FG010|Double-Blind (DB) Treatment Period|Adverse Event|0|||
49037337|NCT01695239|157973105|FG011|Double-Blind (DB) Treatment Period|Adverse Event|0|||
49037338|NCT01695239|157973106|FG012|Double-Blind (DB) Treatment Period|Adverse Event|0|||
49037339|NCT01695239|157973107|FG013|Double-Blind (DB) Treatment Period|Adverse Event|0|||
49037340|NCT01695239|157973094|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|4|||
49037341|NCT01695239|157973095|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
49037342|NCT01695239|157973096|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
49037343|NCT01695239|157973097|FG003|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
48891787|NCT04552899|157439595|FG001|Overall Study|Study Terminated By Sponsor|239|||
48891788|NCT04552899|157439594|FG000|Overall Study|Withdrawal by Subject|15|||
48891789|NCT04552899|157439595|FG001|Overall Study|Withdrawal by Subject|17|||
48891790|NCT02929329|157439596|FG000|Overall Study|Withdrawal by Subject|24|||
48891791|NCT02929329|157439597|FG001|Overall Study|Withdrawal by Subject|21|||
48891792|NCT02929329|157439596|FG000|Overall Study|Lost to Follow-up|26|||
49037344|NCT01695239|157973098|FG004|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
49037345|NCT01695239|157973099|FG005|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
49037346|NCT01695239|157973100|FG006|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
49037347|NCT01695239|157973101|FG007|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
49037348|NCT01695239|157973102|FG008|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
49037349|NCT01695239|157973103|FG009|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
49037350|NCT01695239|157973104|FG010|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
49037351|NCT01695239|157973105|FG011|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
48891793|NCT02929329|157439597|FG001|Overall Study|Lost to Follow-up|20|||
48891794|NCT02929329|157439596|FG000|Overall Study|Death|1054|||
48891795|NCT02929329|157439597|FG001|Overall Study|Death|1051|||
48891796|NCT04772898|157439599|FG000|Overall Study|Withdrawal by Subject|0|||
48891797|NCT04772898|157439600|FG001|Overall Study|Withdrawal by Subject|1|||
48891798|NCT00473265|157439601|FG000|Overall Study|Unrelated adverse event|5|||
48891799|NCT00473265|157439601|FG000|Overall Study|Off treatment early|15|||
48891800|NCT01470001|157439602|FG000|Overall Study|Lost to Follow-up|1|||
48891801|NCT01470001|157439603|FG001|Overall Study|Lost to Follow-up|1|||
48891802|NCT01470001|157439602|FG000|Overall Study|Physician Decision|2|||
48891803|NCT01470001|157439603|FG001|Overall Study|Physician Decision|0|||
48891804|NCT01470001|157439602|FG000|Overall Study|Withdrawal by Subject|2|||
48891805|NCT01470001|157439603|FG001|Overall Study|Withdrawal by Subject|1|||
48891806|NCT01517295|157439604|FG000|Overall Study|Physician Decision|1|||
48891807|NCT01517295|157439605|FG001|Overall Study|Physician Decision|0|||
48891808|NCT01353859|157439606|FG000|Overall Study|Adverse Event|3|||
48891809|NCT01353859|157439606|FG000|Overall Study|Lack of Efficacy|1|||
48891810|NCT01631227|157439607|FG000|Overall Study|withdrawn consent|27|||
48891811|NCT01631227|157439608|FG001|Overall Study|withdrawn consent|21|||
48891812|NCT01631227|157439607|FG000|Overall Study|Adverse Event|1|||
48891813|NCT01631227|157439608|FG001|Overall Study|Adverse Event|0|||
48891814|NCT01631227|157439607|FG000|Overall Study|administrative|2|||
48891815|NCT01631227|157439608|FG001|Overall Study|administrative|1|||
48891816|NCT03053518|157439612|FG000|Overall Study|Withdrawal by Subject|3|||
48891817|NCT03053518|157439612|FG000|Overall Study|Lost to Follow-up|2|||
48891818|NCT03053518|157439612|FG000|Overall Study|Ineligible|5|||
48891819|NCT03775434|157439613|FG000|Overall Study|Adverse Event|2|||
48891820|NCT03775434|157439613|FG000|Overall Study|Withdrawal by Subject|1|||
48891821|NCT05560243|157439615|FG000|Overall Study|11 did not start the intervention, and 14 were lost to follow-up|25|||
48891822|NCT04155047|157439620|FG000|Overall Study|Adverse Event|1|||
48891823|NCT04155047|157439621|FG001|Overall Study|Adverse Event|0|||
48891824|NCT04155047|157439620|FG000|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1|||
48891825|NCT04155047|157439621|FG001|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0|||
48891826|NCT00635427|157439630|FG000|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
48891827|NCT00635427|157439631|FG001|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
48891828|NCT00635427|157439632|FG002|Overall Study|Refusal Of Required DiagnosticEvaluation|1|||
48891829|NCT00635427|157439633|FG003|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
49037352|NCT01695239|157973106|FG012|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
49037353|NCT01695239|157973107|FG013|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
49037354|NCT01695239|157973094|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
49037355|NCT01695239|157973095|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
49037356|NCT01695239|157973096|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
48891830|NCT00635427|157439634|FG004|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
48891831|NCT00635427|157439630|FG000|Overall Study|Death|0|||
48891832|NCT00635427|157439631|FG001|Overall Study|Death|0|||
48891833|NCT00635427|157439632|FG002|Overall Study|Death|0|||
48891834|NCT00635427|157439633|FG003|Overall Study|Death|1|||
48891835|NCT00635427|157439634|FG004|Overall Study|Death|0|||
48891836|NCT00635427|157439630|FG000|Overall Study|Termination Of Study By Sponsor|12|||
48891837|NCT00635427|157439631|FG001|Overall Study|Termination Of Study By Sponsor|6|||
48891838|NCT00635427|157439632|FG002|Overall Study|Termination Of Study By Sponsor|10|||
49037357|NCT01695239|157973097|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
49037358|NCT01695239|157973098|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
49037359|NCT01695239|157973099|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
49037360|NCT01695239|157973100|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
49037361|NCT01695239|157973101|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
49037362|NCT01695239|157973102|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
49037363|NCT01695239|157973103|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
49037364|NCT01695239|157973104|FG010|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
49037365|NCT01695239|157973105|FG011|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
49037366|NCT01695239|157973106|FG012|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
49037367|NCT01695239|157973107|FG013|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
49037368|NCT01695239|157973094|FG000|Double-Blind (DB) Treatment Period|Sponsor Decision|3|||
49037369|NCT01695239|157973095|FG001|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
49037370|NCT01695239|157973096|FG002|Double-Blind (DB) Treatment Period|Sponsor Decision|1|||
49037371|NCT01695239|157973097|FG003|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
48891839|NCT00635427|157439633|FG003|Overall Study|Termination Of Study By Sponsor|6|||
48891840|NCT00635427|157439634|FG004|Overall Study|Termination Of Study By Sponsor|6|||
48891841|NCT00635427|157439630|FG000|Overall Study|Withdrawal Of Consent|0|||
48891842|NCT00635427|157439631|FG001|Overall Study|Withdrawal Of Consent|0|||
48891843|NCT00635427|157439632|FG002|Overall Study|Withdrawal Of Consent|0|||
48891844|NCT00635427|157439633|FG003|Overall Study|Withdrawal Of Consent|2|||
48891845|NCT00635427|157439634|FG004|Overall Study|Withdrawal Of Consent|2|||
48891846|NCT02081417|157439635|FG000|Overall Study|Lost to Follow-up|26|||
48891847|NCT02081417|157439636|FG001|Overall Study|Lost to Follow-up|23|||
48891848|NCT02081417|157439635|FG000|Overall Study|Moved Away|1|||
48891849|NCT02081417|157439636|FG001|Overall Study|Moved Away|2|||
48891850|NCT02081417|157439635|FG000|Overall Study|Incarcerated|2|||
48891851|NCT02081417|157439636|FG001|Overall Study|Incarcerated|2|||
48891852|NCT02081417|157439635|FG000|Overall Study|Death|4|||
48891853|NCT02081417|157439636|FG001|Overall Study|Death|3|||
48891854|NCT02081417|157439635|FG000|Overall Study|Withdrawal by Subject|4|||
48891855|NCT02081417|157439636|FG001|Overall Study|Withdrawal by Subject|0|||
48891856|NCT02081417|157439635|FG000|Overall Study|Admitted to Residential Treatment|2|||
48891857|NCT02081417|157439636|FG001|Overall Study|Admitted to Residential Treatment|0|||
48891858|NCT02081417|157439635|FG000|Overall Study|Did not start treatment|17|||
48891859|NCT02081417|157439636|FG001|Overall Study|Did not start treatment|21|||
48891860|NCT01145898|157439644|FG000|3-year Treatment|medication change by treating physician|3|||
48891861|NCT01145898|157439645|FG001|3-year Treatment|medication change by treating physician|16|||
48891862|NCT04811131|157439646|FG000|Overall Study|Adverse Event|0|||
48891863|NCT04811131|157439647|FG001|Overall Study|Adverse Event|0|||
48891864|NCT04811131|157439648|FG002|Overall Study|Adverse Event|1|||
48891865|NCT04811131|157439649|FG003|Overall Study|Adverse Event|0|||
48891866|NCT04811131|157439646|FG000|Overall Study|Lack of Efficacy|0|||
48891867|NCT04811131|157439647|FG001|Overall Study|Lack of Efficacy|0|||
48891868|NCT04811131|157439648|FG002|Overall Study|Lack of Efficacy|0|||
48891869|NCT04811131|157439649|FG003|Overall Study|Lack of Efficacy|1|||
48891870|NCT04811131|157439646|FG000|Overall Study|Lost to Follow-up|0|||
48891871|NCT04811131|157439647|FG001|Overall Study|Lost to Follow-up|1|||
48891872|NCT04811131|157439648|FG002|Overall Study|Lost to Follow-up|0|||
48891873|NCT04811131|157439649|FG003|Overall Study|Lost to Follow-up|0|||
48891874|NCT04811131|157439646|FG000|Overall Study|Sponsor request|31|||
48891875|NCT04811131|157439647|FG001|Overall Study|Sponsor request|35|||
48891876|NCT04811131|157439648|FG002|Overall Study|Sponsor request|27|||
48891877|NCT04811131|157439649|FG003|Overall Study|Sponsor request|10|||
48891878|NCT04811131|157439646|FG000|Overall Study|Withdrawal by Subject|3|||
48891879|NCT04811131|157439647|FG001|Overall Study|Withdrawal by Subject|1|||
48891880|NCT04811131|157439648|FG002|Overall Study|Withdrawal by Subject|3|||
48891881|NCT04811131|157439649|FG003|Overall Study|Withdrawal by Subject|1|||
48891882|NCT02755818|157439650|FG000|Overall Study|Withdrawal by Subject|0|||
48891883|NCT02755818|157439651|FG001|Overall Study|Withdrawal by Subject|0|||
48891884|NCT02755818|157439652|FG002|Overall Study|Withdrawal by Subject|0|||
48891885|NCT02755818|157439653|FG003|Overall Study|Withdrawal by Subject|2|||
48891886|NCT02755818|157439650|FG000|Overall Study|withdrawal by PI|0|||
48891887|NCT02755818|157439651|FG001|Overall Study|withdrawal by PI|0|||
48891888|NCT02755818|157439652|FG002|Overall Study|withdrawal by PI|1|||
48891889|NCT02755818|157439653|FG003|Overall Study|withdrawal by PI|1|||
48891890|NCT03223662|157439654|FG000|Overall Study|Physician Decision|1|||
48891891|NCT03223662|157439654|FG000|Overall Study|Study closure|1|||
48891892|NCT01877239|157439657|FG000|Overall Study|Adverse Event|4|||
48891893|NCT01877239|157439657|FG000|Overall Study|Disease Remission|1|||
48891894|NCT01877239|157439657|FG000|Overall Study|Withdrawal by Subject|4|||
48891895|NCT01877239|157439657|FG000|Overall Study|Other|2|||
48891896|NCT01877239|157439657|FG000|Overall Study|Lack of Efficacy|4|||
48891897|NCT01877239|157439657|FG000|Overall Study|Data not available|35|||
48891898|NCT00291642|157439666|FG000|Overall Study|Adverse Event|1|||
49037372|NCT01695239|157973098|FG004|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
49037373|NCT01695239|157973099|FG005|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
49037374|NCT01695239|157973100|FG006|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
49037375|NCT01695239|157973101|FG007|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
49037376|NCT01695239|157973102|FG008|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
48891899|NCT00291642|157439667|FG001|Overall Study|Adverse Event|0|||
48891900|NCT00291642|157439668|FG002|Overall Study|Adverse Event|1|||
49037377|NCT01695239|157973103|FG009|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
49037378|NCT01695239|157973104|FG010|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
49037379|NCT01695239|157973105|FG011|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
49037380|NCT01695239|157973106|FG012|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
49037381|NCT01695239|157973107|FG013|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
49037382|NCT01695239|157973094|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
49037383|NCT01695239|157973095|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
49037384|NCT01695239|157973096|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
49037385|NCT01695239|157973097|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
49037386|NCT01695239|157973098|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
49037387|NCT01695239|157973099|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
49037388|NCT01695239|157973100|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
49037389|NCT01695239|157973101|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
49037390|NCT01695239|157973102|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
49037391|NCT01695239|157973103|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
49037392|NCT01695239|157973104|FG010|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
49037393|NCT01695239|157973105|FG011|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
49037394|NCT01695239|157973106|FG012|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
49037395|NCT01695239|157973107|FG013|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
49037396|NCT01695239|157973094|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|1|||
49037397|NCT01695239|157973095|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
49037398|NCT01695239|157973096|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
49037399|NCT01695239|157973097|FG003|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
49037400|NCT01695239|157973098|FG004|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
49037401|NCT01695239|157973099|FG005|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
49037402|NCT01695239|157973100|FG006|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
49037403|NCT01695239|157973101|FG007|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
49037404|NCT01695239|157973102|FG008|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
49037405|NCT01695239|157973103|FG009|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
49037406|NCT01695239|157973104|FG010|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
49037407|NCT01695239|157973105|FG011|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
49037408|NCT01695239|157973106|FG012|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
49037409|NCT01695239|157973107|FG013|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
49037410|NCT01695239|157973094|FG000|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
49037411|NCT01695239|157973095|FG001|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
48891901|NCT00291642|157439669|FG003|Overall Study|Adverse Event|0|||
48891902|NCT00291642|157439670|FG004|Overall Study|Adverse Event|1|||
48891903|NCT00291642|157439666|FG000|Overall Study|Patient missed visit|0|||
48891904|NCT00291642|157439667|FG001|Overall Study|Patient missed visit|0|||
48891905|NCT00291642|157439668|FG002|Overall Study|Patient missed visit|1|||
48891906|NCT00291642|157439669|FG003|Overall Study|Patient missed visit|0|||
48891907|NCT00291642|157439670|FG004|Overall Study|Patient missed visit|0|||
48891908|NCT00291642|157439666|FG000|Overall Study|Intake of prohibited medication|1|||
48891909|NCT00291642|157439667|FG001|Overall Study|Intake of prohibited medication|0|||
48891910|NCT00291642|157439668|FG002|Overall Study|Intake of prohibited medication|0|||
48891911|NCT00291642|157439669|FG003|Overall Study|Intake of prohibited medication|0|||
48891912|NCT00291642|157439670|FG004|Overall Study|Intake of prohibited medication|0|||
48891913|NCT01712659|157439671|FG000|Dose Escalation|Physician Decision|0|||
48891914|NCT01712659|157439672|FG001|Dose Escalation|Physician Decision|1|||
48891915|NCT01712659|157439673|FG002|Dose Escalation|Physician Decision|0|||
48891916|NCT01712659|157439674|FG003|Dose Escalation|Physician Decision|0|||
48891917|NCT01712659|157439675|FG004|Dose Escalation|Physician Decision|0|||
48891918|NCT01712659|157439671|FG000|Dose Escalation|Unable to take study drug|0|||
48891919|NCT01712659|157439672|FG001|Dose Escalation|Unable to take study drug|1|||
48891920|NCT01712659|157439673|FG002|Dose Escalation|Unable to take study drug|0|||
48891921|NCT01712659|157439674|FG003|Dose Escalation|Unable to take study drug|0|||
49037412|NCT01695239|157973096|FG002|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
49037413|NCT01695239|157973097|FG003|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
48891922|NCT01712659|157439675|FG004|Dose Escalation|Unable to take study drug|0|||
48891923|NCT01712659|157439671|FG000|Dose Expansion|Early disease progression|1|||
48891924|NCT01712659|157439672|FG001|Dose Expansion|Early disease progression|0|||
49037414|NCT01695239|157973098|FG004|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
49037415|NCT01695239|157973099|FG005|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
49037416|NCT01695239|157973100|FG006|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
49037417|NCT01695239|157973101|FG007|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9|||
49037418|NCT01695239|157973102|FG008|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
49037419|NCT01695239|157973103|FG009|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
49037420|NCT01695239|157973104|FG010|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
49037421|NCT01695239|157973105|FG011|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
49037422|NCT01695239|157973106|FG012|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
49037423|NCT01695239|157973107|FG013|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
49037424|NCT01695239|157973094|FG000|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
49037425|NCT01695239|157973095|FG001|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
49037426|NCT01695239|157973096|FG002|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
49037427|NCT01695239|157973097|FG003|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
49037428|NCT01695239|157973098|FG004|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
49037429|NCT01695239|157973099|FG005|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
49037430|NCT01695239|157973100|FG006|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
49037431|NCT01695239|157973101|FG007|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1|||
49037432|NCT01695239|157973102|FG008|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
49037433|NCT01695239|157973103|FG009|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
49037434|NCT01695239|157973104|FG010|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
49037435|NCT01695239|157973105|FG011|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
49037436|NCT01695239|157973106|FG012|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
49037437|NCT01695239|157973107|FG013|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
49037438|NCT01695239|157973094|FG000|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
49037439|NCT01695239|157973095|FG001|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
49037440|NCT01695239|157973096|FG002|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
49037441|NCT01695239|157973097|FG003|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
49037442|NCT01695239|157973098|FG004|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
49037443|NCT01695239|157973099|FG005|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
49037444|NCT01695239|157973100|FG006|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
49037445|NCT01695239|157973101|FG007|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1|||
49037446|NCT01695239|157973102|FG008|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
49037447|NCT01695239|157973103|FG009|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
49037448|NCT01695239|157973104|FG010|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
48891925|NCT01712659|157439673|FG002|Dose Expansion|Early disease progression|0|||
48891926|NCT01712659|157439674|FG003|Dose Expansion|Early disease progression|0|||
48891927|NCT01712659|157439675|FG004|Dose Expansion|Early disease progression|0|||
48891928|NCT01712659|157439671|FG000|Dose Expansion|Physician Decision|1|||
48891929|NCT01712659|157439672|FG001|Dose Expansion|Physician Decision|0|||
48891930|NCT01712659|157439673|FG002|Dose Expansion|Physician Decision|0|||
48891931|NCT01712659|157439674|FG003|Dose Expansion|Physician Decision|0|||
48891932|NCT01712659|157439675|FG004|Dose Expansion|Physician Decision|0|||
48891933|NCT02544451|157439677|FG000|Treatment Period 1 (96 Weeks)|Adverse Event|1|||
48891934|NCT02544451|157439678|FG001|Treatment Period 1 (96 Weeks)|Adverse Event|6|||
48891935|NCT02544451|157439679|FG002|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
48891936|NCT02544451|157439680|FG003|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
48891937|NCT02544451|157439677|FG000|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3|||
48891938|NCT02544451|157439678|FG001|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2|||
48891939|NCT02544451|157439679|FG002|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1|||
48891940|NCT02544451|157439680|FG003|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0|||
48891941|NCT02544451|157439677|FG000|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2|||
48891942|NCT02544451|157439678|FG001|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
48891943|NCT02544451|157439679|FG002|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
48891944|NCT02544451|157439680|FG003|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
48891945|NCT02544451|157439677|FG000|Treatment Period 1 (96 Weeks)|Physician Decision|4|||
48891946|NCT02544451|157439678|FG001|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
48891947|NCT02544451|157439679|FG002|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
48891948|NCT02544451|157439680|FG003|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
49037449|NCT01695239|157973105|FG011|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
49037450|NCT01695239|157973106|FG012|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
49037451|NCT01695239|157973107|FG013|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
49037452|NCT01695239|157973094|FG000|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
49037453|NCT01695239|157973095|FG001|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
49037454|NCT01695239|157973096|FG002|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
49037455|NCT01695239|157973097|FG003|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
49037456|NCT01695239|157973098|FG004|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
49037457|NCT01695239|157973099|FG005|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
49037458|NCT01695239|157973100|FG006|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
49037459|NCT01695239|157973101|FG007|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
48891949|NCT02544451|157439677|FG000|Treatment Period 1 (96 Weeks)|Other|4|||
48891950|NCT02544451|157439678|FG001|Treatment Period 1 (96 Weeks)|Other|4|||
48891951|NCT02544451|157439679|FG002|Treatment Period 1 (96 Weeks)|Other|0|||
48891952|NCT02544451|157439680|FG003|Treatment Period 1 (96 Weeks)|Other|0|||
48891953|NCT02544451|157439677|FG000|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
48891954|NCT02544451|157439678|FG001|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
48891955|NCT02544451|157439679|FG002|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
48891956|NCT02544451|157439680|FG003|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10|||
49037460|NCT01695239|157973102|FG008|Extension Long-Term Extension Periods|Lack of Efficacy|37|||
49037461|NCT01695239|157973103|FG009|Extension Long-Term Extension Periods|Lack of Efficacy|31|||
49037462|NCT01695239|157973104|FG010|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
49037463|NCT01695239|157973105|FG011|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
49037464|NCT01695239|157973106|FG012|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
49037465|NCT01695239|157973107|FG013|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
49037466|NCT01695239|157973094|FG000|Extension Long-Term Extension Periods|Adverse Event|0|||
49037467|NCT01695239|157973095|FG001|Extension Long-Term Extension Periods|Adverse Event|0|||
49037468|NCT01695239|157973096|FG002|Extension Long-Term Extension Periods|Adverse Event|0|||
49037469|NCT01695239|157973097|FG003|Extension Long-Term Extension Periods|Adverse Event|0|||
49037470|NCT01695239|157973098|FG004|Extension Long-Term Extension Periods|Adverse Event|0|||
49037471|NCT01695239|157973099|FG005|Extension Long-Term Extension Periods|Adverse Event|0|||
49037472|NCT01695239|157973100|FG006|Extension Long-Term Extension Periods|Adverse Event|0|||
49037473|NCT01695239|157973101|FG007|Extension Long-Term Extension Periods|Adverse Event|0|||
49037474|NCT01695239|157973102|FG008|Extension Long-Term Extension Periods|Adverse Event|15|||
49037475|NCT01695239|157973103|FG009|Extension Long-Term Extension Periods|Adverse Event|21|||
49037476|NCT01695239|157973104|FG010|Extension Long-Term Extension Periods|Adverse Event|0|||
49037477|NCT01695239|157973105|FG011|Extension Long-Term Extension Periods|Adverse Event|0|||
49037478|NCT01695239|157973106|FG012|Extension Long-Term Extension Periods|Adverse Event|0|||
49037479|NCT01695239|157973107|FG013|Extension Long-Term Extension Periods|Adverse Event|0|||
49037480|NCT01695239|157973094|FG000|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
49037481|NCT01695239|157973095|FG001|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
49037482|NCT01695239|157973096|FG002|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
49037483|NCT01695239|157973097|FG003|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
49037484|NCT01695239|157973098|FG004|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
49037485|NCT01695239|157973099|FG005|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
49037486|NCT01695239|157973100|FG006|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
49037487|NCT01695239|157973101|FG007|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
49037488|NCT01695239|157973102|FG008|Extension Long-Term Extension Periods|Withdrawal by Subject|6|||
49037489|NCT01695239|157973103|FG009|Extension Long-Term Extension Periods|Withdrawal by Subject|7|||
49037490|NCT01695239|157973104|FG010|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
49037491|NCT01695239|157973105|FG011|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
49037492|NCT01695239|157973106|FG012|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
49037493|NCT01695239|157973107|FG013|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
49037494|NCT01695239|157973094|FG000|Extension Long-Term Extension Periods|Physician Decision|0|||
49037495|NCT01695239|157973095|FG001|Extension Long-Term Extension Periods|Physician Decision|0|||
49037496|NCT01695239|157973096|FG002|Extension Long-Term Extension Periods|Physician Decision|0|||
49037497|NCT01695239|157973097|FG003|Extension Long-Term Extension Periods|Physician Decision|0|||
49037498|NCT01695239|157973098|FG004|Extension Long-Term Extension Periods|Physician Decision|0|||
49037499|NCT01695239|157973099|FG005|Extension Long-Term Extension Periods|Physician Decision|0|||
49037500|NCT01695239|157973100|FG006|Extension Long-Term Extension Periods|Physician Decision|0|||
49037501|NCT01695239|157973101|FG007|Extension Long-Term Extension Periods|Physician Decision|0|||
49037502|NCT01695239|157973102|FG008|Extension Long-Term Extension Periods|Physician Decision|3|||
49037503|NCT01695239|157973103|FG009|Extension Long-Term Extension Periods|Physician Decision|0|||
49037504|NCT01695239|157973104|FG010|Extension Long-Term Extension Periods|Physician Decision|0|||
49037505|NCT01695239|157973105|FG011|Extension Long-Term Extension Periods|Physician Decision|0|||
49037506|NCT01695239|157973106|FG012|Extension Long-Term Extension Periods|Physician Decision|0|||
48891957|NCT02581631|157439681|FG000|Overall Study|Disease progression|29|||
49037507|NCT01695239|157973107|FG013|Extension Long-Term Extension Periods|Physician Decision|0|||
49037508|NCT01695239|157973094|FG000|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
49037509|NCT01695239|157973095|FG001|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
48891958|NCT02581631|157439682|FG001|Overall Study|Disease progression|19|||
48891959|NCT02581631|157439683|FG002|Overall Study|Disease progression|13|||
49037510|NCT01695239|157973096|FG002|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
49037511|NCT01695239|157973097|FG003|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
49037512|NCT01695239|157973098|FG004|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
49037513|NCT01695239|157973099|FG005|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
49037514|NCT01695239|157973100|FG006|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
49037515|NCT01695239|157973101|FG007|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
49037516|NCT01695239|157973102|FG008|Extension Long-Term Extension Periods|Lost to Follow-up|2|||
49037517|NCT01695239|157973103|FG009|Extension Long-Term Extension Periods|Lost to Follow-up|1|||
49037518|NCT01695239|157973104|FG010|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
49037519|NCT01695239|157973105|FG011|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
49037520|NCT01695239|157973106|FG012|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
49037521|NCT01695239|157973107|FG013|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
49037522|NCT01695239|157973094|FG000|Extension Long-Term Extension Periods|Sponsor Decision|0|||
49037523|NCT01695239|157973095|FG001|Extension Long-Term Extension Periods|Sponsor Decision|0|||
49037524|NCT01695239|157973096|FG002|Extension Long-Term Extension Periods|Sponsor Decision|0|||
49037525|NCT01695239|157973097|FG003|Extension Long-Term Extension Periods|Sponsor Decision|0|||
49037526|NCT01695239|157973098|FG004|Extension Long-Term Extension Periods|Sponsor Decision|0|||
49037527|NCT01695239|157973099|FG005|Extension Long-Term Extension Periods|Sponsor Decision|0|||
49037528|NCT01695239|157973100|FG006|Extension Long-Term Extension Periods|Sponsor Decision|0|||
49037529|NCT01695239|157973101|FG007|Extension Long-Term Extension Periods|Sponsor Decision|0|||
49037530|NCT01695239|157973102|FG008|Extension Long-Term Extension Periods|Sponsor Decision|2|||
49037531|NCT01695239|157973103|FG009|Extension Long-Term Extension Periods|Sponsor Decision|1|||
49037532|NCT01695239|157973104|FG010|Extension Long-Term Extension Periods|Sponsor Decision|0|||
49037533|NCT01695239|157973105|FG011|Extension Long-Term Extension Periods|Sponsor Decision|0|||
49037534|NCT01695239|157973106|FG012|Extension Long-Term Extension Periods|Sponsor Decision|0|||
49037535|NCT01695239|157973107|FG013|Extension Long-Term Extension Periods|Sponsor Decision|0|||
49037536|NCT01695239|157973094|FG000|Extension Long-Term Extension Periods|Death|0|||
49037537|NCT01695239|157973095|FG001|Extension Long-Term Extension Periods|Death|0|||
49037538|NCT01695239|157973096|FG002|Extension Long-Term Extension Periods|Death|0|||
49037539|NCT01695239|157973097|FG003|Extension Long-Term Extension Periods|Death|0|||
49037540|NCT01695239|157973098|FG004|Extension Long-Term Extension Periods|Death|0|||
49037541|NCT01695239|157973099|FG005|Extension Long-Term Extension Periods|Death|0|||
49037542|NCT01695239|157973100|FG006|Extension Long-Term Extension Periods|Death|0|||
49037543|NCT01695239|157973101|FG007|Extension Long-Term Extension Periods|Death|0|||
49037544|NCT01695239|157973102|FG008|Extension Long-Term Extension Periods|Death|1|||
49037545|NCT01695239|157973103|FG009|Extension Long-Term Extension Periods|Death|0|||
49037546|NCT01695239|157973104|FG010|Extension Long-Term Extension Periods|Death|0|||
49037547|NCT01695239|157973105|FG011|Extension Long-Term Extension Periods|Death|0|||
49037548|NCT01695239|157973106|FG012|Extension Long-Term Extension Periods|Death|0|||
49037549|NCT01695239|157973107|FG013|Extension Long-Term Extension Periods|Death|0|||
49037550|NCT01695239|157973094|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
49037551|NCT01695239|157973095|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
49037552|NCT01695239|157973096|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
49037553|NCT01695239|157973097|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
49037554|NCT01695239|157973098|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
49037555|NCT01695239|157973099|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
49037556|NCT01695239|157973100|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
49037557|NCT01695239|157973101|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
49037558|NCT01695239|157973102|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
49037559|NCT01695239|157973103|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
49037560|NCT01695239|157973104|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
49037561|NCT01695239|157973105|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
49037562|NCT01695239|157973106|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
49037563|NCT01695239|157973107|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
49037564|NCT01695239|157973094|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
49037565|NCT01695239|157973095|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
49037566|NCT01695239|157973096|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
49037567|NCT01695239|157973097|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
49037568|NCT01695239|157973098|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
49037569|NCT01695239|157973099|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
49037570|NCT01695239|157973100|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
49037571|NCT01695239|157973101|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
49037572|NCT01695239|157973102|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
49037573|NCT01695239|157973103|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
49037574|NCT01695239|157973104|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
49037575|NCT01695239|157973105|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
49037576|NCT01695239|157973106|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
49037577|NCT01695239|157973107|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
49037578|NCT01695239|157973094|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
49037579|NCT01695239|157973095|FG001|Post-Treatment Follow-Up Period|Physician Decision|0|||
49037580|NCT01695239|157973096|FG002|Post-Treatment Follow-Up Period|Physician Decision|0|||
49037581|NCT01695239|157973097|FG003|Post-Treatment Follow-Up Period|Physician Decision|0|||
49037582|NCT01695239|157973098|FG004|Post-Treatment Follow-Up Period|Physician Decision|0|||
49037583|NCT01695239|157973099|FG005|Post-Treatment Follow-Up Period|Physician Decision|0|||
49037584|NCT01695239|157973100|FG006|Post-Treatment Follow-Up Period|Physician Decision|0|||
49037585|NCT01695239|157973101|FG007|Post-Treatment Follow-Up Period|Physician Decision|0|||
49037586|NCT01695239|157973102|FG008|Post-Treatment Follow-Up Period|Physician Decision|0|||
49037587|NCT01695239|157973103|FG009|Post-Treatment Follow-Up Period|Physician Decision|0|||
49037588|NCT01695239|157973104|FG010|Post-Treatment Follow-Up Period|Physician Decision|0|||
49037589|NCT01695239|157973105|FG011|Post-Treatment Follow-Up Period|Physician Decision|0|||
49037590|NCT01695239|157973106|FG012|Post-Treatment Follow-Up Period|Physician Decision|2|||
49037591|NCT01695239|157973107|FG013|Post-Treatment Follow-Up Period|Physician Decision|0|||
49037592|NCT01695239|157973094|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
49037593|NCT01695239|157973095|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
49037594|NCT01695239|157973096|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
49037595|NCT01695239|157973097|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
49037596|NCT01695239|157973098|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
49037597|NCT01695239|157973099|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
49037598|NCT01695239|157973100|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
49037599|NCT01695239|157973101|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
49037600|NCT01695239|157973102|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
49037601|NCT01695239|157973103|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
49037602|NCT01695239|157973104|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
49037603|NCT01695239|157973105|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
49037604|NCT01695239|157973106|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
49037605|NCT01695239|157973107|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
49037606|NCT03684928|157973109|FG000|First Intervention|Lost to Follow-up|0|||
49037607|NCT03684928|157973110|FG001|First Intervention|Lost to Follow-up|1|||
49037608|NCT03684928|157973109|FG000|First Intervention|Withdrawal by Subject|0|||
49037609|NCT03684928|157973110|FG001|First Intervention|Withdrawal by Subject|2|||
49037610|NCT03684928|157973109|FG000|Second Intervention|Soft Tissue Injury|1|||
49037611|NCT03684928|157973110|FG001|Second Intervention|Soft Tissue Injury|0|||
49037612|NCT00635648|157973111|FG000|Overall Study|Adverse Event|12|||
49037613|NCT00635648|157973111|FG000|Overall Study|Withdrawal by Subject|9|||
49037614|NCT00635648|157973111|FG000|Overall Study|Physician Decision|4|||
49037615|NCT00635648|157973111|FG000|Overall Study|Rapid progression of baseline disease|4|||
49037616|NCT00635648|157973111|FG000|Overall Study|Use of other antifungal agent needed|1|||
49037617|NCT00635648|157973111|FG000|Overall Study|No improvement after 7-10 days treatment|4|||
49037618|NCT00635648|157973111|FG000|Overall Study|Noncompliance with protocol|1|||
49037619|NCT00635648|157973111|FG000|Overall Study|Other reason|2|||
49037620|NCT01535222|157973112|FG000|Overall Study|Inclusion/exclusion|0|||
49037621|NCT01535222|157973113|FG001|Overall Study|Inclusion/exclusion|0|||
49037622|NCT01535222|157973114|FG002|Overall Study|Inclusion/exclusion|1|||
49037623|NCT01535222|157973115|FG003|Overall Study|Inclusion/exclusion|0|||
49037624|NCT01535222|157973116|FG004|Overall Study|Inclusion/exclusion|0|||
49037625|NCT01535222|157973117|FG005|Overall Study|Inclusion/exclusion|0|||
49037626|NCT03889639|157973118|FG000|Overall Study|Withdrawal by Subject|0|||
49037627|NCT03889639|157973119|FG001|Overall Study|Withdrawal by Subject|0|||
48891960|NCT02581631|157439684|FG003|Overall Study|Disease progression|5|||
48891961|NCT02581631|157439685|FG004|Overall Study|Disease progression|8|||
48891962|NCT02581631|157439681|FG000|Overall Study|Study drug toxicity|4|||
48891963|NCT02581631|157439682|FG001|Overall Study|Study drug toxicity|6|||
48891964|NCT02581631|157439683|FG002|Overall Study|Study drug toxicity|7|||
48891965|NCT02581631|157439684|FG003|Overall Study|Study drug toxicity|0|||
48891966|NCT02581631|157439685|FG004|Overall Study|Study drug toxicity|3|||
48891967|NCT02581631|157439681|FG000|Overall Study|AE unrelated to study drug|3|||
48891968|NCT02581631|157439682|FG001|Overall Study|AE unrelated to study drug|1|||
48891969|NCT02581631|157439683|FG002|Overall Study|AE unrelated to study drug|1|||
48891970|NCT02581631|157439684|FG003|Overall Study|AE unrelated to study drug|0|||
48891971|NCT02581631|157439685|FG004|Overall Study|AE unrelated to study drug|2|||
48891972|NCT02581631|157439681|FG000|Overall Study|Request to discontinue|1|||
48891973|NCT02581631|157439682|FG001|Overall Study|Request to discontinue|0|||
48891974|NCT02581631|157439683|FG002|Overall Study|Request to discontinue|3|||
48891975|NCT02581631|157439684|FG003|Overall Study|Request to discontinue|0|||
49037628|NCT03889639|157973120|FG002|Overall Study|Withdrawal by Subject|0|||
49037629|NCT03889639|157973121|FG003|Overall Study|Withdrawal by Subject|0|||
49037630|NCT03889639|157973122|FG004|Overall Study|Withdrawal by Subject|0|||
48891976|NCT02581631|157439685|FG004|Overall Study|Request to discontinue|1|||
49037631|NCT03889639|157973123|FG005|Overall Study|Withdrawal by Subject|0|||
49037632|NCT03889639|157973124|FG006|Overall Study|Withdrawal by Subject|0|||
49037633|NCT03889639|157973125|FG007|Overall Study|Withdrawal by Subject|1|||
49037634|NCT00705666|157973128|FG000|Overall Study|No post-treatment questionnaire|279|||
49037635|NCT00705666|157973128|FG000|Overall Study|Withdrawal by Subject|21|||
49037636|NCT00705666|157973128|FG000|Overall Study|Physician Decision|7|||
49037637|NCT00705666|157973128|FG000|Overall Study|Lost to Follow-up|5|||
49037638|NCT00705666|157973128|FG000|Overall Study|Death|1|||
49037639|NCT00705666|157973128|FG000|Overall Study|Adverse Event|4|||
49037640|NCT00705666|157973128|FG000|Overall Study|Other|12|||
49037641|NCT00705666|157973128|FG000|Overall Study|Other|2|||
49037642|NCT00705666|157973128|FG000|Overall Study|Lack of data|3|||
49037643|NCT00705666|157973128|FG000|Overall Study|Untreated|5|||
49037644|NCT00506831|157973129|FG000|Overall Study|Death|1|||
49037645|NCT00506831|157973129|FG000|Overall Study|Withdrawal by Subject|1|||
49037646|NCT02105272|157973130|FG000|Overall Study|Adverse Event|1|||
49037647|NCT02105272|157973131|FG001|Overall Study|Adverse Event|2|||
49037648|NCT02105272|157973130|FG000|Overall Study|Physician Decision|0|||
49037649|NCT02105272|157973131|FG001|Overall Study|Physician Decision|1|||
49037650|NCT02105272|157973130|FG000|Overall Study|Protocol Violation|2|||
49037651|NCT02105272|157973131|FG001|Overall Study|Protocol Violation|0|||
49037652|NCT02105272|157973130|FG000|Overall Study|Withdrawal by Subject|2|||
49037653|NCT02105272|157973131|FG001|Overall Study|Withdrawal by Subject|0|||
49037654|NCT01410227|157973132|FG000|Overall Study|Adverse Event|1|||
49037655|NCT01410227|157973133|FG001|Overall Study|Adverse Event|0|||
49037656|NCT01410227|157973134|FG002|Overall Study|Adverse Event|0|||
49037657|NCT01410227|157973135|FG003|Overall Study|Adverse Event|0|||
49037658|NCT01410227|157973132|FG000|Overall Study|Withdrawal by Subject|3|||
49037659|NCT01410227|157973133|FG001|Overall Study|Withdrawal by Subject|0|||
49037660|NCT01410227|157973134|FG002|Overall Study|Withdrawal by Subject|1|||
49037661|NCT01410227|157973135|FG003|Overall Study|Withdrawal by Subject|0|||
49037662|NCT01410227|157973132|FG000|Overall Study|Pregnancy|0|||
49037663|NCT01410227|157973133|FG001|Overall Study|Pregnancy|0|||
49037664|NCT01410227|157973134|FG002|Overall Study|Pregnancy|0|||
49037665|NCT01410227|157973135|FG003|Overall Study|Pregnancy|1|||
49037666|NCT01410227|157973132|FG000|Overall Study|Met Excl. Criteria After Starting Study|0|||
49037667|NCT01410227|157973133|FG001|Overall Study|Met Excl. Criteria After Starting Study|0|||
49037668|NCT01410227|157973134|FG002|Overall Study|Met Excl. Criteria After Starting Study|1|||
49037669|NCT01410227|157973135|FG003|Overall Study|Met Excl. Criteria After Starting Study|0|||
49037670|NCT02699463|157973136|FG000|Overall Study|Lost to Follow-up|11|||
48891977|NCT02581631|157439681|FG000|Overall Study|participant withdrew consent|3|||
48891978|NCT02581631|157439682|FG001|Overall Study|participant withdrew consent|0|||
48891979|NCT02581631|157439683|FG002|Overall Study|participant withdrew consent|1|||
48891980|NCT02581631|157439684|FG003|Overall Study|participant withdrew consent|0|||
48891981|NCT02581631|157439685|FG004|Overall Study|participant withdrew consent|0|||
48891982|NCT02581631|157439681|FG000|Overall Study|Maximum clinical benefit|1|||
48891983|NCT02581631|157439682|FG001|Overall Study|Maximum clinical benefit|7|||
48891984|NCT02581631|157439683|FG002|Overall Study|Maximum clinical benefit|1|||
48891985|NCT02581631|157439684|FG003|Overall Study|Maximum clinical benefit|3|||
48891986|NCT02581631|157439685|FG004|Overall Study|Maximum clinical benefit|13|||
48891987|NCT02581631|157439681|FG000|Overall Study|Other Reasons|1|||
48891988|NCT02581631|157439682|FG001|Overall Study|Other Reasons|0|||
48891989|NCT02581631|157439683|FG002|Overall Study|Other Reasons|2|||
48891990|NCT02581631|157439684|FG003|Overall Study|Other Reasons|2|||
48891991|NCT02581631|157439685|FG004|Overall Study|Other Reasons|3|||
48891992|NCT02581631|157439681|FG000|Overall Study|Poor/Non-Compliance|0|||
48891993|NCT02581631|157439682|FG001|Overall Study|Poor/Non-Compliance|0|||
48891994|NCT02581631|157439683|FG002|Overall Study|Poor/Non-Compliance|1|||
48891995|NCT02581631|157439684|FG003|Overall Study|Poor/Non-Compliance|0|||
48891996|NCT02581631|157439685|FG004|Overall Study|Poor/Non-Compliance|0|||
48891997|NCT00132873|157439686|FG000|Overall Study|Adverse Event|3|||
48891998|NCT00132873|157439686|FG000|Overall Study|Lost to Follow-up|1|||
48891999|NCT00132873|157439686|FG000|Overall Study|Lack of Efficacy|1|||
48892000|NCT00132873|157439686|FG000|Overall Study|Withdrawal by Subject|3|||
48892001|NCT00132873|157439686|FG000|Overall Study|Planned Pregnancy|1|||
49037671|NCT02699463|157973137|FG001|Overall Study|Lost to Follow-up|8|||
48892002|NCT01775124|157439687|FG000|Core Period|Disease Progression|0|||
48892003|NCT01775124|157439688|FG001|Core Period|Disease Progression|1|||
48892004|NCT01775124|157439687|FG000|Core Period|Physician Decision|1|||
49037672|NCT02699463|157973136|FG000|Overall Study|Withdrawal by Subject|4|||
49037673|NCT02699463|157973137|FG001|Overall Study|Withdrawal by Subject|1|||
49037674|NCT02488239|157973140|FG000|Overall Study|Death|3|||
49037675|NCT02488239|157973140|FG000|Overall Study|Withdrawal by Subject|3|||
49037676|NCT02488239|157973140|FG000|Overall Study|Physician Decision|2|||
48892005|NCT01775124|157439688|FG001|Core Period|Physician Decision|1|||
48892006|NCT01775124|157439687|FG000|Core Period|Death|0|||
48892007|NCT01775124|157439688|FG001|Core Period|Death|1|||
48892008|NCT01775124|157439687|FG000|Core Period|Administrative problems|1|||
49037677|NCT02488239|157973140|FG000|Overall Study|Consent ineligible|1|||
49037678|NCT02488239|157973140|FG000|Overall Study|Did not undergo implant procedure|1|||
49037679|NCT00585286|157973142|FG000|Overall Study|Lost to Follow-up|1|||
49037680|NCT01103713|157973146|FG000|Overall Study|Lost to Follow-up|2|||
49037681|NCT01103713|157973146|FG000|Overall Study|Withdrawal by Subject|8|||
49037682|NCT01103713|157973146|FG000|Overall Study|Study terminated by sponsor|2|||
49037683|NCT01103713|157973146|FG000|Overall Study|Other|1|||
49037684|NCT05752721|157973147|FG000|Overall Study|Lost to Follow-up|22|||
49037685|NCT05752721|157973148|FG001|Overall Study|Lost to Follow-up|20|||
49037686|NCT05752721|157973147|FG000|Overall Study|Withdrawal by Subject|15|||
49037687|NCT05752721|157973148|FG001|Overall Study|Withdrawal by Subject|12|||
49037688|NCT02072096|157973151|FG000|Overall Study|Lack of Efficacy|18|||
49037689|NCT02072096|157973152|FG001|Overall Study|Lack of Efficacy|29|||
49037690|NCT02072096|157973151|FG000|Overall Study|Protocol Violation|7|||
49037691|NCT02072096|157973152|FG001|Overall Study|Protocol Violation|7|||
49037692|NCT02072096|157973151|FG000|Overall Study|Withdrawal by Subject|5|||
49037693|NCT02072096|157973152|FG001|Overall Study|Withdrawal by Subject|7|||
49037694|NCT02072096|157973151|FG000|Overall Study|Adverse Event|5|||
49037695|NCT02072096|157973152|FG001|Overall Study|Adverse Event|2|||
49037696|NCT02072096|157973151|FG000|Overall Study|No Reason Provided|4|||
49037697|NCT02072096|157973152|FG001|Overall Study|No Reason Provided|2|||
49037698|NCT02072096|157973151|FG000|Overall Study|Death|2|||
49037699|NCT02072096|157973152|FG001|Overall Study|Death|0|||
49037700|NCT02072096|157973151|FG000|Overall Study|Physician Decision|0|||
49037701|NCT02072096|157973152|FG001|Overall Study|Physician Decision|1|||
49037702|NCT02072096|157973151|FG000|Overall Study|Study Terminated by Sponsor|43|||
49037703|NCT02072096|157973152|FG001|Overall Study|Study Terminated by Sponsor|30|||
49037704|NCT02072096|157973151|FG000|Overall Study|Lost to Follow-up|1|||
49037705|NCT02072096|157973152|FG001|Overall Study|Lost to Follow-up|0|||
49037706|NCT00216736|157973153|FG000|Overall Study|Lost to Follow-up|1|||
49037707|NCT00216736|157973154|FG001|Overall Study|Lost to Follow-up|1|||
49037708|NCT00152451|157973155|FG000|Overall Study|Adverse Event|4|||
49037709|NCT03644550|157973156|FG000|Overall Study|Withdrawal by Subject|3|||
49037710|NCT03644550|157973156|FG000|Overall Study|Progressive disease|15|||
49037711|NCT00367133|157973160|FG000|2 Years|Death|20|||
49037712|NCT00367133|157973161|FG001|2 Years|Death|12|||
48892009|NCT01775124|157439688|FG001|Core Period|Administrative problems|0|||
48892010|NCT01775124|157439687|FG000|Core Period|Withdrawal by Subject|4|||
48892011|NCT01775124|157439688|FG001|Core Period|Withdrawal by Subject|2|||
48892012|NCT01775124|157439687|FG000|Core Period|Adverse Event|5|||
48892013|NCT01775124|157439688|FG001|Core Period|Adverse Event|5|||
48892014|NCT01775124|157439687|FG000|Extension Period|Adverse Event|3|||
48892015|NCT01775124|157439688|FG001|Extension Period|Adverse Event|2|||
48892016|NCT01775124|157439687|FG000|Extension Period|Physician Decision|0|||
48892017|NCT01775124|157439688|FG001|Extension Period|Physician Decision|2|||
48892018|NCT01775124|157439687|FG000|Extension Period|Administrative problems|0|||
48892019|NCT01775124|157439688|FG001|Extension Period|Administrative problems|1|||
48892020|NCT01775124|157439687|FG000|Extension Period|Lost to Follow-up|0|||
48892021|NCT01775124|157439688|FG001|Extension Period|Lost to Follow-up|1|||
48892022|NCT01775124|157439687|FG000|Extension Period|Withdrawal by Subject|9|||
48892023|NCT01775124|157439688|FG001|Extension Period|Withdrawal by Subject|12|||
48892024|NCT01036438|157439689|FG000|Overall Study|Adverse Event|7|||
48892025|NCT01036438|157439690|FG001|Overall Study|Adverse Event|8|||
48892026|NCT01036438|157439689|FG000|Overall Study|Death|0|||
48892027|NCT01036438|157439690|FG001|Overall Study|Death|1|||
48892028|NCT01036438|157439689|FG000|Overall Study|No effect of study treatment|3|||
48892029|NCT01036438|157439690|FG001|Overall Study|No effect of study treatment|1|||
48892030|NCT00888927|157439691|FG000|Overall Study|Adverse Event|0|||
48892031|NCT00888927|157439692|FG001|Overall Study|Adverse Event|0|||
48892032|NCT00888927|157439693|FG002|Overall Study|Adverse Event|0|||
48892033|NCT00888927|157439694|FG003|Overall Study|Adverse Event|1|||
49037713|NCT00367133|157973162|FG002|2 Years|Death|12|||
49037714|NCT00367133|157973160|FG000|2 Years|Dropped|34|||
49037715|NCT00367133|157973161|FG001|2 Years|Dropped|19|||
49037716|NCT00367133|157973162|FG002|2 Years|Dropped|33|||
49037717|NCT00367133|157973160|FG000|2 Years|Missed visit|4|||
49037718|NCT00367133|157973161|FG001|2 Years|Missed visit|5|||
49037719|NCT00367133|157973162|FG002|2 Years|Missed visit|4|||
49037720|NCT00847535|157973168|FG000|Overall Study|Withdrawal by Subject|2|||
49037721|NCT00847535|157973169|FG001|Overall Study|Withdrawal by Subject|1|||
48892034|NCT00888927|157439691|FG000|Overall Study|Withdrawal of consent|0|||
48892035|NCT00888927|157439692|FG001|Overall Study|Withdrawal of consent|0|||
49037722|NCT00847535|157973170|FG002|Overall Study|Withdrawal by Subject|1|||
49037723|NCT00847535|157973168|FG000|Overall Study|Lost to Follow-up|0|||
49037724|NCT00847535|157973169|FG001|Overall Study|Lost to Follow-up|1|||
49037725|NCT00847535|157973170|FG002|Overall Study|Lost to Follow-up|0|||
48892036|NCT00888927|157439693|FG002|Overall Study|Withdrawal of consent|0|||
48892037|NCT00888927|157439694|FG003|Overall Study|Withdrawal of consent|1|||
48892038|NCT05086276|157439695|FG000|Overall Study|Missed visit 5/Day 60 visit|1|||
49037726|NCT02336074|157973171|FG000|Overall Study|Adverse Event|0|||
49037727|NCT02336074|157973172|FG001|Overall Study|Adverse Event|2|||
48892039|NCT05086276|157439696|FG001|Overall Study|Missed visit 5/Day 60 visit|1|||
48892040|NCT00895154|157439697|FG000|Overall Study|Lost to Follow-up|1|||
48892041|NCT00895154|157439698|FG001|Overall Study|Lost to Follow-up|1|||
48892042|NCT00895154|157439697|FG000|Overall Study|Withdrawal by Subject|0|||
48892043|NCT00895154|157439698|FG001|Overall Study|Withdrawal by Subject|1|||
48892044|NCT00777088|157439699|FG000|Overall Study|PED Treatment not attempted|1|||
48892045|NCT01278173|157439700|FG000|Overall Study|Lack of Efficacy|13|||
48892046|NCT01278173|157439700|FG000|Overall Study|Adverse Event|8|||
48892047|NCT01278173|157439700|FG000|Overall Study|Administrative or other reason|4|||
48892048|NCT01278173|157439700|FG000|Overall Study|Protocol Violation|1|||
48892049|NCT01278173|157439700|FG000|Overall Study|Withdrawal by Subject|1|||
48892050|NCT03432260|157439703|FG000|Overall Study|Lost to Follow-up|1|||
48892051|NCT03432260|157439704|FG001|Overall Study|Lost to Follow-up|1|||
48892052|NCT03432260|157439705|FG002|Overall Study|Lost to Follow-up|0|||
48892053|NCT03432260|157439706|FG003|Overall Study|Lost to Follow-up|0|||
48892054|NCT03432260|157439707|FG004|Overall Study|Lost to Follow-up|1|||
48892055|NCT02317432|157439708|FG000|Overall Study|Death|4|||
48892056|NCT02317432|157439709|FG001|Overall Study|Death|1|||
48892057|NCT02317432|157439708|FG000|Overall Study|Lost to Follow-up|0|||
48892058|NCT02317432|157439709|FG001|Overall Study|Lost to Follow-up|5|||
49037728|NCT01252953|157973173|FG000|Overall Study|Withdrawal by Subject|16|||
49037729|NCT01252953|157973174|FG001|Overall Study|Withdrawal by Subject|17|||
49037730|NCT01252953|157973173|FG000|Overall Study|Lost to Follow-up|22|||
49037731|NCT01252953|157973174|FG001|Overall Study|Lost to Follow-up|21|||
49037732|NCT05616728|157973177|FG000|Overall Study|Lost to Follow-up|0|||
49037733|NCT05616728|157973178|FG001|Overall Study|Lost to Follow-up|0|||
49037734|NCT05616728|157973179|FG002|Overall Study|Lost to Follow-up|1|||
49037735|NCT05616728|157973177|FG000|Overall Study|Withdrawal by Subject|1|||
49037736|NCT05616728|157973178|FG001|Overall Study|Withdrawal by Subject|1|||
49037737|NCT05616728|157973179|FG002|Overall Study|Withdrawal by Subject|0|||
49037738|NCT05616728|157973177|FG000|Overall Study|Physician Decision|1|||
49037739|NCT05616728|157973178|FG001|Overall Study|Physician Decision|1|||
49037740|NCT05616728|157973179|FG002|Overall Study|Physician Decision|1|||
49037741|NCT05616728|157973177|FG000|Overall Study|Other|0|||
48892059|NCT02317432|157439708|FG000|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27|||
48892060|NCT02317432|157439709|FG001|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0|||
48892061|NCT05593445|157439710|FG000|12-Week DBVC Period|Adverse Event|1|||
48892062|NCT05593445|157439711|FG001|12-Week DBVC Period|Adverse Event|0|||
48892063|NCT05593445|157439712|FG002|12-Week DBVC Period|Adverse Event|0|||
48892064|NCT05593445|157439713|FG003|12-Week DBVC Period|Adverse Event|0|||
48892065|NCT05593445|157439710|FG000|12-Week DBVC Period|Physician Decision|0|||
48892066|NCT05593445|157439711|FG001|12-Week DBVC Period|Physician Decision|1|||
48892067|NCT05593445|157439712|FG002|12-Week DBVC Period|Physician Decision|0|||
48892068|NCT05593445|157439713|FG003|12-Week DBVC Period|Physician Decision|0|||
48892069|NCT05593445|157439710|FG000|12-Week DBVC Period|Protocol Violation|0|||
48892070|NCT05593445|157439711|FG001|12-Week DBVC Period|Protocol Violation|1|||
48892071|NCT05593445|157439712|FG002|12-Week DBVC Period|Protocol Violation|0|||
48892072|NCT05593445|157439713|FG003|12-Week DBVC Period|Protocol Violation|0|||
48892073|NCT05593445|157439710|FG000|12-Week DBVC Period|Withdrawal by Subject|0|||
48892074|NCT05593445|157439711|FG001|12-Week DBVC Period|Withdrawal by Subject|1|||
48892075|NCT05593445|157439712|FG002|12-Week DBVC Period|Withdrawal by Subject|0|||
48892076|NCT05593445|157439713|FG003|12-Week DBVC Period|Withdrawal by Subject|0|||
48892077|NCT05593445|157439710|FG000|12-Week DBVC Period|Did Not Meet Eligibility Criteria|1|||
48892078|NCT05593445|157439711|FG001|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
48892079|NCT05593445|157439712|FG002|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
48892080|NCT05593445|157439713|FG003|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
48892081|NCT05593445|157439710|FG000|12-Week Open-Label Extension Period|Adverse Event|0|||
48892082|NCT05593445|157439711|FG001|12-Week Open-Label Extension Period|Adverse Event|0|||
48892083|NCT05593445|157439712|FG002|12-Week Open-Label Extension Period|Adverse Event|1|||
48892084|NCT05593445|157439713|FG003|12-Week Open-Label Extension Period|Adverse Event|1|||
48892085|NCT05593445|157439710|FG000|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
49037742|NCT05616728|157973178|FG001|Overall Study|Other|2|||
49037743|NCT05616728|157973179|FG002|Overall Study|Other|0|||
49037744|NCT00834873|157973182|FG000|First Intervention|Adverse Event|0|||
49037745|NCT00834873|157973183|FG001|First Intervention|Adverse Event|1|||
49037746|NCT00354835|157973184|FG000|Overall Study|Death|1|||
48892086|NCT05593445|157439711|FG001|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
48892087|NCT05593445|157439712|FG002|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
49037747|NCT00354835|157973185|FG001|Overall Study|Death|1|||
49037748|NCT00354835|157973184|FG000|Overall Study|Physician Decision|8|||
49037749|NCT00354835|157973185|FG001|Overall Study|Physician Decision|13|||
48892088|NCT05593445|157439713|FG003|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
48892089|NCT05593445|157439710|FG000|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
48892090|NCT05593445|157439711|FG001|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
49037750|NCT00354835|157973184|FG000|Overall Study|Withdrawal by Subject|2|||
48892091|NCT05593445|157439712|FG002|12-Week Open-Label Extension Period|Withdrawal by Subject|1|||
48892092|NCT05593445|157439713|FG003|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
48892093|NCT03981861|157439714|FG000|Overall Study|Withdrawal by Subject|3|||
48892094|NCT03554629|157441496|FG000|Overall Study|Inadequate data|6|||
48892095|NCT02514239|157441497|FG000|Overall Study|Refused to continue trial medication|0|||
48892096|NCT02514239|157441498|FG001|Overall Study|Refused to continue trial medication|0|||
48892097|NCT02514239|157441499|FG002|Overall Study|Refused to continue trial medication|0|||
48892098|NCT02514239|157441500|FG003|Overall Study|Refused to continue trial medication|0|||
48892099|NCT02514239|157441501|FG004|Overall Study|Refused to continue trial medication|0|||
48892100|NCT02514239|157441502|FG005|Overall Study|Refused to continue trial medication|0|||
48892101|NCT02514239|157441503|FG006|Overall Study|Refused to continue trial medication|0|||
48892102|NCT02514239|157441504|FG007|Overall Study|Refused to continue trial medication|0|||
48984035|NCT00626795|157772433|FG001|Blinded Treatment|Other reasons|0|||
48984036|NCT00626795|157772434|FG002|Blinded Treatment|Other reasons|2|||
48984037|NCT00626795|157772432|FG000|Blinded Treatment|Missing reason for withdrawal|5|||
48984038|NCT00626795|157772433|FG001|Blinded Treatment|Missing reason for withdrawal|3|||
48984039|NCT00626795|157772434|FG002|Blinded Treatment|Missing reason for withdrawal|5|||
48984040|NCT04129242|157772435|FG000|Overall Study|Physician Decision|1|||
48984041|NCT04129242|157772436|FG001|Overall Study|Physician Decision|1|||
48984042|NCT04129242|157772435|FG000|Overall Study|Protocol Violation|0|||
48984043|NCT04129242|157772436|FG001|Overall Study|Protocol Violation|1|||
48984044|NCT00736385|157774113|FG000|Overall Study|Withdrawal by Subject|2|||
48984045|NCT00736385|157774114|FG001|Overall Study|Withdrawal by Subject|2|||
48984046|NCT00736385|157774113|FG000|Overall Study|Adverse Event|0|||
48984047|NCT00736385|157774114|FG001|Overall Study|Adverse Event|1|||
48984048|NCT00686699|157774115|FG000|Treatment Period 1|Adverse Event|0|||
48984049|NCT00686699|157774116|FG001|Treatment Period 1|Adverse Event|2|||
48984050|NCT00908895|157774117|FG000|Overall Study|Lost to Follow-up|1|||
48984051|NCT00908895|157774118|FG001|Overall Study|Lost to Follow-up|3|||
48984052|NCT00908895|157774117|FG000|Overall Study|algodystrophy|2|||
48984053|NCT00908895|157774118|FG001|Overall Study|algodystrophy|2|||
48984054|NCT00908895|157774117|FG000|Overall Study|Adverse Event|1|||
48984055|NCT00908895|157774118|FG001|Overall Study|Adverse Event|1|||
48984056|NCT01997892|157774119|FG000|Overall Study|Physician Decision|2|||
48984057|NCT01997892|157774119|FG000|Overall Study|Lost to Follow-up|6|||
48984058|NCT01997892|157774119|FG000|Overall Study|Death|14|||
48984059|NCT01997892|157774119|FG000|Overall Study|Renal transplant|8|||
48984060|NCT01997892|157774119|FG000|Overall Study|Other|3|||
48984061|NCT01997892|157774119|FG000|Overall Study|Study completion data not recorded|35|||
48984062|NCT01693562|157774121|FG000|Escalation Phase|Withdrawal by Subject|0|||
48984063|NCT01693562|157774122|FG001|Escalation Phase|Withdrawal by Subject|1|||
48984064|NCT01693562|157774123|FG002|Escalation Phase|Withdrawal by Subject|0|||
48984065|NCT01693562|157774124|FG003|Escalation Phase|Withdrawal by Subject|0|||
48984066|NCT01693562|157774125|FG004|Escalation Phase|Withdrawal by Subject|0|||
48984067|NCT01693562|157774126|FG005|Escalation Phase|Withdrawal by Subject|2|||
48984068|NCT01693562|157774127|FG006|Escalation Phase|Withdrawal by Subject|0|||
48984069|NCT01693562|157774128|FG007|Escalation Phase|Withdrawal by Subject|0|||
48984070|NCT01693562|157774129|FG008|Escalation Phase|Withdrawal by Subject|0|||
48984071|NCT01693562|157774130|FG009|Escalation Phase|Withdrawal by Subject|0|||
48984072|NCT01693562|157774131|FG010|Escalation Phase|Withdrawal by Subject|0|||
48984073|NCT01693562|157774132|FG011|Escalation Phase|Withdrawal by Subject|0|||
48984074|NCT01693562|157774133|FG012|Escalation Phase|Withdrawal by Subject|0|||
48984075|NCT01693562|157774134|FG013|Escalation Phase|Withdrawal by Subject|0|||
48984076|NCT01693562|157774135|FG014|Escalation Phase|Withdrawal by Subject|0|||
48984077|NCT01693562|157774136|FG015|Escalation Phase|Withdrawal by Subject|0|||
48984078|NCT01693562|157774137|FG016|Escalation Phase|Withdrawal by Subject|0|||
48984079|NCT01693562|157774138|FG017|Escalation Phase|Withdrawal by Subject|0|||
48984080|NCT01693562|157774139|FG018|Escalation Phase|Withdrawal by Subject|0|||
48984081|NCT01693562|157774140|FG019|Escalation Phase|Withdrawal by Subject|0|||
48984082|NCT01693562|157774141|FG020|Escalation Phase|Withdrawal by Subject|0|||
48984083|NCT01693562|157774142|FG021|Escalation Phase|Withdrawal by Subject|0|||
48984084|NCT01693562|157774143|FG022|Escalation Phase|Withdrawal by Subject|0|||
48984085|NCT01693562|157774121|FG000|Escalation Phase|Death|4|||
48984086|NCT01693562|157774122|FG001|Escalation Phase|Death|2|||
48984087|NCT01693562|157774123|FG002|Escalation Phase|Death|0|||
48984088|NCT01693562|157774124|FG003|Escalation Phase|Death|3|||
48984089|NCT01693562|157774125|FG004|Escalation Phase|Death|6|||
48984090|NCT01693562|157774126|FG005|Escalation Phase|Death|4|||
48984091|NCT01693562|157774127|FG006|Escalation Phase|Death|0|||
48984092|NCT01693562|157774128|FG007|Escalation Phase|Death|0|||
48984093|NCT01693562|157774129|FG008|Escalation Phase|Death|0|||
48984094|NCT01693562|157774130|FG009|Escalation Phase|Death|0|||
48984095|NCT01693562|157774131|FG010|Escalation Phase|Death|0|||
48984096|NCT01693562|157774132|FG011|Escalation Phase|Death|0|||
48984097|NCT01693562|157774133|FG012|Escalation Phase|Death|0|||
49037751|NCT00354835|157973185|FG001|Overall Study|Withdrawal by Subject|1|||
49037752|NCT00354835|157973184|FG000|Overall Study|Ineligible|17|||
49037753|NCT00354835|157973185|FG001|Overall Study|Ineligible|16|||
49037754|NCT00354835|157973184|FG000|Overall Study|Disease progression or relapse|15|||
49037755|NCT00354835|157973185|FG001|Overall Study|Disease progression or relapse|22|||
49037756|NCT00354835|157973184|FG000|Overall Study|Adverse Event|6|||
49037757|NCT00354835|157973185|FG001|Overall Study|Adverse Event|0|||
49037758|NCT00354835|157973184|FG000|Overall Study|Refusal of further therapy|3|||
49037759|NCT00354835|157973185|FG001|Overall Study|Refusal of further therapy|8|||
49037760|NCT01968551|157973193|FG000|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
49037761|NCT01968551|157973194|FG001|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
49037762|NCT01968551|157973195|FG002|Open Label Phase (48 Weeks)|Randomized but Never Treated|0|||
49037763|NCT01968551|157973193|FG000|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
49037764|NCT01968551|157973194|FG001|Open Label Phase (48 Weeks)|Investigator's Discretion|1|||
48892103|NCT02514239|157441505|FG008|Overall Study|Refused to continue trial medication|0|||
48892104|NCT02514239|157441506|FG009|Overall Study|Refused to continue trial medication|1|||
48892105|NCT02514239|157441497|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
48892106|NCT02514239|157441498|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
48892107|NCT02514239|157441499|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
48892108|NCT02514239|157441500|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
48892109|NCT02514239|157441501|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
48892110|NCT02514239|157441502|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
48892111|NCT02514239|157441503|FG006|Overall Study|Dose-limiting toxicity (DLT)|0|||
48892112|NCT02514239|157441504|FG007|Overall Study|Dose-limiting toxicity (DLT)|0|||
48892113|NCT02514239|157441505|FG008|Overall Study|Dose-limiting toxicity (DLT)|1|||
48892114|NCT02514239|157441506|FG009|Overall Study|Dose-limiting toxicity (DLT)|2|||
48892115|NCT02514239|157441497|FG000|Overall Study|Not treated|0|||
48892116|NCT02514239|157441498|FG001|Overall Study|Not treated|1|||
48892117|NCT02514239|157441499|FG002|Overall Study|Not treated|0|||
48892118|NCT02514239|157441500|FG003|Overall Study|Not treated|0|||
48892119|NCT02514239|157441501|FG004|Overall Study|Not treated|0|||
48892120|NCT02514239|157441502|FG005|Overall Study|Not treated|0|||
48892121|NCT02514239|157441503|FG006|Overall Study|Not treated|0|||
48892122|NCT02514239|157441504|FG007|Overall Study|Not treated|0|||
48892123|NCT02514239|157441505|FG008|Overall Study|Not treated|0|||
48892124|NCT02514239|157441506|FG009|Overall Study|Not treated|0|||
48892125|NCT02514239|157441497|FG000|Overall Study|Other Adverse Events|2|||
48892126|NCT02514239|157441498|FG001|Overall Study|Other Adverse Events|0|||
48892127|NCT02514239|157441499|FG002|Overall Study|Other Adverse Events|0|||
48892128|NCT02514239|157441500|FG003|Overall Study|Other Adverse Events|1|||
48892129|NCT02514239|157441501|FG004|Overall Study|Other Adverse Events|0|||
48892130|NCT02514239|157441502|FG005|Overall Study|Other Adverse Events|1|||
48892131|NCT02514239|157441503|FG006|Overall Study|Other Adverse Events|0|||
48892132|NCT02514239|157441504|FG007|Overall Study|Other Adverse Events|1|||
48892133|NCT02514239|157441505|FG008|Overall Study|Other Adverse Events|2|||
48892134|NCT02514239|157441506|FG009|Overall Study|Other Adverse Events|0|||
48892135|NCT02514239|157441497|FG000|Overall Study|Progressive disease|3|||
48892136|NCT02514239|157441498|FG001|Overall Study|Progressive disease|3|||
48892137|NCT02514239|157441499|FG002|Overall Study|Progressive disease|2|||
48892138|NCT02514239|157441500|FG003|Overall Study|Progressive disease|2|||
48984098|NCT01693562|157774134|FG013|Escalation Phase|Death|0|||
48984099|NCT01693562|157774135|FG014|Escalation Phase|Death|0|||
48984100|NCT01693562|157774136|FG015|Escalation Phase|Death|0|||
48984101|NCT01693562|157774137|FG016|Escalation Phase|Death|0|||
48984102|NCT01693562|157774138|FG017|Escalation Phase|Death|0|||
48984103|NCT01693562|157774139|FG018|Escalation Phase|Death|0|||
48984104|NCT01693562|157774140|FG019|Escalation Phase|Death|0|||
48984105|NCT01693562|157774141|FG020|Escalation Phase|Death|0|||
48984106|NCT01693562|157774142|FG021|Escalation Phase|Death|0|||
48984107|NCT01693562|157774143|FG022|Escalation Phase|Death|0|||
48984108|NCT01693562|157774121|FG000|Escalation Phase|Lost to Follow-up|0|||
48984109|NCT01693562|157774122|FG001|Escalation Phase|Lost to Follow-up|1|||
48984110|NCT01693562|157774123|FG002|Escalation Phase|Lost to Follow-up|1|||
48984111|NCT01693562|157774124|FG003|Escalation Phase|Lost to Follow-up|0|||
48984112|NCT01693562|157774125|FG004|Escalation Phase|Lost to Follow-up|0|||
48984113|NCT01693562|157774126|FG005|Escalation Phase|Lost to Follow-up|0|||
48984114|NCT01693562|157774127|FG006|Escalation Phase|Lost to Follow-up|0|||
48984115|NCT01693562|157774128|FG007|Escalation Phase|Lost to Follow-up|0|||
48984116|NCT01693562|157774129|FG008|Escalation Phase|Lost to Follow-up|0|||
48984117|NCT01693562|157774130|FG009|Escalation Phase|Lost to Follow-up|0|||
48984118|NCT01693562|157774131|FG010|Escalation Phase|Lost to Follow-up|0|||
48984119|NCT01693562|157774132|FG011|Escalation Phase|Lost to Follow-up|0|||
48984120|NCT01693562|157774133|FG012|Escalation Phase|Lost to Follow-up|0|||
48984121|NCT01693562|157774134|FG013|Escalation Phase|Lost to Follow-up|0|||
48984122|NCT01693562|157774135|FG014|Escalation Phase|Lost to Follow-up|0|||
48984123|NCT01693562|157774136|FG015|Escalation Phase|Lost to Follow-up|0|||
48984124|NCT01693562|157774137|FG016|Escalation Phase|Lost to Follow-up|0|||
48892139|NCT02514239|157441501|FG004|Overall Study|Progressive disease|3|||
48892140|NCT02514239|157441502|FG005|Overall Study|Progressive disease|3|||
48892141|NCT02514239|157441503|FG006|Overall Study|Progressive disease|4|||
48892142|NCT02514239|157441504|FG007|Overall Study|Progressive disease|2|||
48892143|NCT02514239|157441505|FG008|Overall Study|Progressive disease|5|||
48892144|NCT02514239|157441506|FG009|Overall Study|Progressive disease|0|||
48892145|NCT02314780|157441507|FG000|Overall Study|organizational reasons|0|||
48892146|NCT02314780|157441508|FG001|Overall Study|organizational reasons|2|||
48892147|NCT02314780|157441509|FG002|Overall Study|organizational reasons|0|||
48892148|NCT02314780|157441507|FG000|Overall Study|Adverse Event|0|||
48892149|NCT02314780|157441508|FG001|Overall Study|Adverse Event|1|||
48892150|NCT02314780|157441509|FG002|Overall Study|Adverse Event|0|||
48892151|NCT00215137|157441510|FG000|Open Label Escitalopram|Lack of Efficacy|1|||
48892152|NCT00215137|157441511|FG001|Open Label Escitalopram|Lack of Efficacy|0|||
48892153|NCT00215137|157441512|FG002|Open Label Escitalopram|Lack of Efficacy|0|||
48892154|NCT00215137|157441510|FG000|Randomization Period|Lost to Follow-up|0|||
48892155|NCT00215137|157441511|FG001|Randomization Period|Lost to Follow-up|1|||
48892156|NCT00215137|157441512|FG002|Randomization Period|Lost to Follow-up|0|||
48892157|NCT00215137|157441510|FG000|Randomization Period|Withdrawal by Subject|0|||
48892158|NCT00215137|157441511|FG001|Randomization Period|Withdrawal by Subject|1|||
48892159|NCT00215137|157441512|FG002|Randomization Period|Withdrawal by Subject|0|||
48892160|NCT00166712|157441515|FG000|Overall Study|Death|0|||
48892161|NCT00166712|157441516|FG001|Overall Study|Death|1|||
48892162|NCT00166712|157441515|FG000|Overall Study|Adverse Event|1|||
48892163|NCT00166712|157441516|FG001|Overall Study|Adverse Event|0|||
48892164|NCT00166712|157441515|FG000|Overall Study|Withdrawal by Subject|1|||
48892165|NCT00166712|157441516|FG001|Overall Study|Withdrawal by Subject|2|||
48892166|NCT00166712|157441515|FG000|Overall Study|Physician Decision|0|||
48892167|NCT00166712|157441516|FG001|Overall Study|Physician Decision|2|||
48892168|NCT04684394|157441517|FG000|Overall Study|Death|1|||
48892169|NCT04684394|157441518|FG001|Overall Study|Death|2|||
48892170|NCT04684394|157441517|FG000|Overall Study|Lost to Follow-up|1|||
48892171|NCT04684394|157441518|FG001|Overall Study|Lost to Follow-up|0|||
48892172|NCT04684394|157441517|FG000|Overall Study|Withdrawal by Subject|2|||
48892173|NCT04684394|157441518|FG001|Overall Study|Withdrawal by Subject|0|||
48892174|NCT04684394|157441517|FG000|Overall Study|Study discontinued per Sponsor decision|25|||
48892175|NCT04684394|157441518|FG001|Overall Study|Study discontinued per Sponsor decision|13|||
48892176|NCT00969709|157441519|FG000|Overall Study|Adverse Event|3|||
48892177|NCT00969709|157441520|FG001|Overall Study|Adverse Event|13|||
48892178|NCT00969709|157441521|FG002|Overall Study|Adverse Event|26|||
48892179|NCT00969709|157441522|FG003|Overall Study|Adverse Event|12|||
48892180|NCT00969709|157441519|FG000|Overall Study|Lack of Efficacy|7|||
48892181|NCT00969709|157441520|FG001|Overall Study|Lack of Efficacy|4|||
48892182|NCT00969709|157441521|FG002|Overall Study|Lack of Efficacy|1|||
48892183|NCT00969709|157441522|FG003|Overall Study|Lack of Efficacy|3|||
48892184|NCT00969709|157441519|FG000|Overall Study|Protocol Violation|9|||
48892185|NCT00969709|157441520|FG001|Overall Study|Protocol Violation|5|||
48892186|NCT00969709|157441521|FG002|Overall Study|Protocol Violation|9|||
48892187|NCT00969709|157441522|FG003|Overall Study|Protocol Violation|10|||
48892188|NCT00969709|157441519|FG000|Overall Study|Withdrawal by Subject|9|||
48892189|NCT00969709|157441520|FG001|Overall Study|Withdrawal by Subject|12|||
48892190|NCT00969709|157441521|FG002|Overall Study|Withdrawal by Subject|11|||
48892191|NCT00969709|157441522|FG003|Overall Study|Withdrawal by Subject|23|||
48892192|NCT00969709|157441519|FG000|Overall Study|Lost to Follow-up|10|||
48892193|NCT00969709|157441520|FG001|Overall Study|Lost to Follow-up|14|||
48892194|NCT00969709|157441521|FG002|Overall Study|Lost to Follow-up|8|||
48892195|NCT00969709|157441522|FG003|Overall Study|Lost to Follow-up|15|||
48892196|NCT00969709|157441519|FG000|Overall Study|Other reasons|0|||
48892197|NCT00969709|157441520|FG001|Overall Study|Other reasons|0|||
48892198|NCT00969709|157441521|FG002|Overall Study|Other reasons|3|||
48892199|NCT00969709|157441522|FG003|Overall Study|Other reasons|0|||
48892200|NCT02980731|157441523|FG000|Overall Study|Death|63|||
48892201|NCT02980731|157441523|FG000|Overall Study|Withdrawal by Subject|6|||
48892202|NCT02980731|157441523|FG000|Overall Study|Lost to Follow-up|5|||
48892203|NCT02980731|157441523|FG000|Overall Study|Study terminated by Sponsor|4|||
49037765|NCT01968551|157973195|FG002|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
49037766|NCT01968551|157973193|FG000|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
48892204|NCT02980731|157441523|FG000|Overall Study|Completed survival follow-up period|65|||
48892205|NCT02980731|157441523|FG000|Overall Study|COVID-19 infection|1|||
48892206|NCT02980731|157441523|FG000|Overall Study|Other, not specified|66|||
48892207|NCT00774930|157441524|FG000|DB Phase|Early Roll Over (ERO) to IOL phase|11|||
48892208|NCT00774930|157441525|FG001|DB Phase|Early Roll Over (ERO) to IOL phase|12|||
48892209|NCT00774930|157441524|FG000|DB Phase|Adverse Event|1|||
48892210|NCT00774930|157441525|FG001|DB Phase|Adverse Event|2|||
48892211|NCT00774930|157441524|FG000|DB Phase|Subject Decision|1|||
48892212|NCT00774930|157441525|FG001|DB Phase|Subject Decision|5|||
48892213|NCT00774930|157441524|FG000|DB Phase|Sponsor Decision|0|||
48892214|NCT00774930|157441525|FG001|DB Phase|Sponsor Decision|1|||
48892215|NCT00774930|157441524|FG000|DB Phase|Disease Progression|1|||
48892216|NCT00774930|157441525|FG001|DB Phase|Disease Progression|1|||
48892217|NCT00774930|157441524|FG000|DB Phase|Started Nonprotocol Radiation therapy|0|||
48892218|NCT00774930|157441525|FG001|DB Phase|Started Nonprotocol Radiation therapy|1|||
48892219|NCT00774930|157441524|FG000|IOL Phase|Adverse Event|1|||
48892220|NCT00774930|157441525|FG001|IOL Phase|Adverse Event|1|||
48892221|NCT00774930|157441524|FG000|IOL Phase|Subject Decision|4|||
48892222|NCT00774930|157441525|FG001|IOL Phase|Subject Decision|3|||
48892223|NCT00774930|157441524|FG000|IOL Phase|Physician Decision|3|||
48892224|NCT00774930|157441525|FG001|IOL Phase|Physician Decision|2|||
48892225|NCT00774930|157441524|FG000|IOL Phase|Sponsor Decision|1|||
48892226|NCT00774930|157441525|FG001|IOL Phase|Sponsor Decision|0|||
48892227|NCT00774930|157441524|FG000|IOL Phase|Disease Progression|2|||
48892228|NCT00774930|157441525|FG001|IOL Phase|Disease Progression|1|||
48892229|NCT00774930|157441524|FG000|IOL Phase|Subject Consumed Prohibited Medication|1|||
48892230|NCT00774930|157441525|FG001|IOL Phase|Subject Consumed Prohibited Medication|0|||
48892231|NCT00774930|157441524|FG000|IOL Phase|Peptide Receptor Radionuclide Therapy|0|||
48892232|NCT00774930|157441525|FG001|IOL Phase|Peptide Receptor Radionuclide Therapy|1|||
48892233|NCT00774930|157441524|FG000|IOL Phase|Other|1|||
48892234|NCT00774930|157441525|FG001|IOL Phase|Other|0|||
48892235|NCT00774930|157441524|FG000|IOL Phase|Brain radiation|0|||
48892236|NCT00774930|157441525|FG001|IOL Phase|Brain radiation|1|||
48892237|NCT00774930|157441524|FG000|LTOLE Phase|Adverse Event|7|||
48892238|NCT00774930|157441525|FG001|LTOLE Phase|Adverse Event|3|||
48892239|NCT00774930|157441524|FG000|LTOLE Phase|Subject decision|0|||
48892240|NCT00774930|157441525|FG001|LTOLE Phase|Subject decision|5|||
48892241|NCT00774930|157441524|FG000|LTOLE Phase|Physician Decision|4|||
48892242|NCT00774930|157441525|FG001|LTOLE Phase|Physician Decision|1|||
48892243|NCT00774930|157441524|FG000|LTOLE Phase|Sponsor decision|2|||
48892244|NCT00774930|157441525|FG001|LTOLE Phase|Sponsor decision|1|||
48892245|NCT00774930|157441524|FG000|LTOLE Phase|Disease Progression|2|||
48892246|NCT00774930|157441525|FG001|LTOLE Phase|Disease Progression|5|||
48892247|NCT00774930|157441524|FG000|LTOLE Phase|Tumour Progression of Hepatic Metastases|0|||
48892248|NCT00774930|157441525|FG001|LTOLE Phase|Tumour Progression of Hepatic Metastases|1|||
49037767|NCT01968551|157973194|FG001|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
49037768|NCT01968551|157973195|FG002|Open Label Phase (48 Weeks)|Withdrew Consent|3|||
49037769|NCT01968551|157973193|FG000|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
49037770|NCT01968551|157973194|FG001|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
49037771|NCT01968551|157973195|FG002|Open Label Phase (48 Weeks)|Lost to Follow-up|2|||
49037772|NCT01968551|157973193|FG000|Extension Phase|Adverse Event|0|||
49037773|NCT01968551|157973194|FG001|Extension Phase|Adverse Event|0|||
49037774|NCT01968551|157973195|FG002|Extension Phase|Adverse Event|2|||
49037775|NCT01968551|157973193|FG000|Extension Phase|Death|0|||
49037776|NCT01968551|157973194|FG001|Extension Phase|Death|1|||
49037777|NCT01968551|157973195|FG002|Extension Phase|Death|0|||
49037778|NCT01968551|157973193|FG000|Extension Phase|Withdrew Consent|0|||
49037779|NCT01968551|157973194|FG001|Extension Phase|Withdrew Consent|0|||
49037780|NCT01968551|157973195|FG002|Extension Phase|Withdrew Consent|1|||
49037781|NCT01968551|157973193|FG000|Extension Phase|Lost to Follow-up|1|||
48892249|NCT00774930|157441524|FG000|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0|||
48892250|NCT00774930|157441525|FG001|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1|||
48892251|NCT00730275|157441526|FG000|Overall Study|Withdrawal by Subject|0|||
48892252|NCT00730275|157441527|FG001|Overall Study|Withdrawal by Subject|0|||
48892253|NCT00730275|157441528|FG002|Overall Study|Withdrawal by Subject|0|||
48892254|NCT00730275|157441529|FG003|Overall Study|Withdrawal by Subject|1|||
48892255|NCT03020576|157441530|FG000|Overall Study|Withdrawal by Subject|1|||
48892256|NCT03020576|157441531|FG001|Overall Study|Withdrawal by Subject|2|||
48892257|NCT01153321|157441532|FG000|Overall Study|Development of study withdrawal criteria|0|||
48892258|NCT01153321|157441533|FG001|Overall Study|Development of study withdrawal criteria|1|||
48892259|NCT01153321|157441532|FG000|Overall Study|Withdrawal by Subject|0|||
48892260|NCT01153321|157441533|FG001|Overall Study|Withdrawal by Subject|1|||
48892261|NCT01153321|157441532|FG000|Overall Study|Adverse Event|1|||
48892262|NCT01153321|157441533|FG001|Overall Study|Adverse Event|1|||
48892263|NCT01177800|157441534|FG000|Overall Study|Adverse Event|9|||
48892264|NCT01177800|157441535|FG001|Overall Study|Adverse Event|3|||
48892265|NCT01177800|157441534|FG000|Overall Study|Protocol Violation|0|||
48892266|NCT01177800|157441535|FG001|Overall Study|Protocol Violation|1|||
48892267|NCT01177800|157441534|FG000|Overall Study|Physician Decision|1|||
48892268|NCT01177800|157441535|FG001|Overall Study|Physician Decision|0|||
49037782|NCT01968551|157973194|FG001|Extension Phase|Lost to Follow-up|0|||
48892269|NCT01177800|157441534|FG000|Overall Study|Withdrawal of informed consent|0|||
48892270|NCT01177800|157441535|FG001|Overall Study|Withdrawal of informed consent|1|||
48892271|NCT00356408|157441536|FG000|Overall Study|Adverse Event|9|||
48892272|NCT00356408|157441536|FG000|Overall Study|Lack of Efficacy|36|||
49037783|NCT01968551|157973195|FG002|Extension Phase|Lost to Follow-up|1|||
49037784|NCT02625974|157973198|FG000|Part 1|Lost to Follow-up|9|||
48892273|NCT00356408|157441536|FG000|Overall Study|Lost to Follow-up|2|||
48892274|NCT00356408|157441536|FG000|Overall Study|Withdrawal by Subject|6|||
48892275|NCT00356408|157441536|FG000|Overall Study|Other: Principal investigator discretion|3|||
48892276|NCT00356408|157441536|FG000|Overall Study|Other: Sponsor request|1|||
48892277|NCT00356408|157441536|FG000|Overall Study|Other: Azathioprine stopped|1|||
48892278|NCT00356408|157441536|FG000|Overall Study|Other: Failed to meet Inc/Exc criteria|1|||
48892279|NCT00356408|157441536|FG000|Overall Study|Other: Subject chose commerical dosing|1|||
48892280|NCT03527550|157441537|FG000|Overall Study|Lost to Follow-up|4|||
48892281|NCT03527550|157441538|FG001|Overall Study|Lost to Follow-up|2|||
48892282|NCT03527550|157441537|FG000|Overall Study|Withdrawal by Subject|4|||
48892283|NCT03527550|157441538|FG001|Overall Study|Withdrawal by Subject|1|||
48892284|NCT03527550|157441537|FG000|Overall Study|Participant reported exclusion criterion after study enrollment.|1|||
48892285|NCT03527550|157441538|FG001|Overall Study|Participant reported exclusion criterion after study enrollment.|0|||
48892286|NCT00911937|157441539|FG000|Overall Study|Death|1|||
48892287|NCT00911937|157441540|FG001|Overall Study|Death|0|||
48892288|NCT00911937|157441539|FG000|Overall Study|Lost to Follow-up|8|||
48892289|NCT00911937|157441540|FG001|Overall Study|Lost to Follow-up|5|||
48892290|NCT00911937|157441539|FG000|Overall Study|Withdrawal by Subject|10|||
48892291|NCT00911937|157441540|FG001|Overall Study|Withdrawal by Subject|7|||
48892292|NCT00911937|157441539|FG000|Overall Study|Withdrawn due to pregnancy|1|||
48892293|NCT00911937|157441540|FG001|Overall Study|Withdrawn due to pregnancy|0|||
48892294|NCT00911937|157441539|FG000|Overall Study|Adverse Event|11|||
48892295|NCT00911937|157441540|FG001|Overall Study|Adverse Event|25|||
48892296|NCT00911937|157441539|FG000|Overall Study|Lack of Efficacy|11|||
48892297|NCT00911937|157441540|FG001|Overall Study|Lack of Efficacy|6|||
48892298|NCT00911937|157441539|FG000|Overall Study|Did not meet inclusion criteria|9|||
48892299|NCT00911937|157441540|FG001|Overall Study|Did not meet inclusion criteria|11|||
48892300|NCT00911937|157441539|FG000|Overall Study|Protocol Violation|14|||
48892301|NCT00911937|157441540|FG001|Overall Study|Protocol Violation|23|||
48892302|NCT00911937|157441539|FG000|Overall Study|Randomized but not treated|13|||
48892303|NCT00911937|157441540|FG001|Overall Study|Randomized but not treated|13|||
48892304|NCT00911937|157441539|FG000|Overall Study|Other|9|||
48892305|NCT00911937|157441540|FG001|Overall Study|Other|5|||
48892306|NCT00700427|157441541|FG000|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298|||
48892307|NCT00700427|157441542|FG001|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
48892308|NCT00700427|157441543|FG002|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
48892309|NCT00700427|157441544|FG003|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
48892310|NCT00700427|157441545|FG004|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
48892311|NCT00700427|157441541|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173|||
48892312|NCT00700427|157441542|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
48892313|NCT00700427|157441543|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
48892314|NCT00700427|157441544|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
48892315|NCT00700427|157441545|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
48892316|NCT00700427|157441541|FG000|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164|||
48892317|NCT00700427|157441542|FG001|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
48892318|NCT00700427|157441543|FG002|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
48892319|NCT00700427|157441544|FG003|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
48892320|NCT00700427|157441545|FG004|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
48892321|NCT00700427|157441541|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161|||
48892322|NCT00700427|157441542|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
48892323|NCT00700427|157441543|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
48892324|NCT00700427|157441544|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
48892325|NCT00700427|157441545|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
48892326|NCT00700427|157441541|FG000|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108|||
48892327|NCT00700427|157441542|FG001|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
48892328|NCT00700427|157441543|FG002|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
48892329|NCT00700427|157441544|FG003|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
48892330|NCT00700427|157441545|FG004|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
48892331|NCT00700427|157441541|FG000|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90|||
48892332|NCT00700427|157441542|FG001|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
48892333|NCT00700427|157441543|FG002|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
48892334|NCT00700427|157441544|FG003|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
48984125|NCT01693562|157774138|FG017|Escalation Phase|Lost to Follow-up|0|||
48984126|NCT01693562|157774139|FG018|Escalation Phase|Lost to Follow-up|0|||
48892335|NCT00700427|157441545|FG004|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
48892336|NCT00700427|157441541|FG000|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8|||
48892337|NCT00700427|157441542|FG001|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
48892338|NCT00700427|157441543|FG002|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
48892339|NCT00700427|157441544|FG003|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
48892340|NCT00700427|157441545|FG004|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
48892341|NCT00700427|157441541|FG000|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7|||
48892342|NCT00700427|157441542|FG001|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
49037785|NCT02625974|157973199|FG001|Part 1|Lost to Follow-up|3|||
49037786|NCT02625974|157973198|FG000|Part 2|Lost to Follow-up|4|||
48892343|NCT00700427|157441543|FG002|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
48892344|NCT00700427|157441544|FG003|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
48892345|NCT00700427|157441545|FG004|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
48892346|NCT00700427|157441541|FG000|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2|||
48892347|NCT00700427|157441542|FG001|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
48892348|NCT00700427|157441543|FG002|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
48892349|NCT00700427|157441544|FG003|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
48892350|NCT00700427|157441545|FG004|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
48892351|NCT00700427|157441541|FG000|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
48892352|NCT00700427|157441542|FG001|Study Period 3A (Blinded Maintenance)|Adverse Event|50|||
48892353|NCT00700427|157441543|FG002|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
48892354|NCT00700427|157441544|FG003|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
48892355|NCT00700427|157441545|FG004|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
48892356|NCT00700427|157441541|FG000|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
48892357|NCT00700427|157441542|FG001|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162|||
48892358|NCT00700427|157441543|FG002|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
48892359|NCT00700427|157441544|FG003|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
48892360|NCT00700427|157441545|FG004|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
48892361|NCT00700427|157441541|FG000|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
48892362|NCT00700427|157441542|FG001|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81|||
48892363|NCT00700427|157441543|FG002|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
48892364|NCT00700427|157441544|FG003|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
48892365|NCT00700427|157441545|FG004|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
48892366|NCT00700427|157441541|FG000|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
48892367|NCT00700427|157441542|FG001|Study Period 3A (Blinded Maintenance)|Protocol Violation|56|||
48892368|NCT00700427|157441543|FG002|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
48892369|NCT00700427|157441544|FG003|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
48892370|NCT00700427|157441545|FG004|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
48892371|NCT00700427|157441541|FG000|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
48892372|NCT00700427|157441542|FG001|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49|||
49037787|NCT02625974|157973199|FG001|Part 2|Lost to Follow-up|6|||
48892373|NCT00700427|157441543|FG002|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
48892374|NCT00700427|157441544|FG003|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
48892375|NCT00700427|157441545|FG004|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
48892376|NCT00700427|157441541|FG000|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
48892377|NCT00700427|157441542|FG001|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41|||
48892378|NCT00700427|157441543|FG002|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
48892379|NCT00700427|157441544|FG003|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
48892380|NCT00700427|157441545|FG004|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
48892381|NCT00700427|157441541|FG000|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
48892382|NCT00700427|157441542|FG001|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32|||
48892383|NCT00700427|157441543|FG002|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
48892384|NCT00700427|157441544|FG003|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
48892385|NCT00700427|157441545|FG004|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
48892386|NCT00700427|157441541|FG000|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
48892387|NCT00700427|157441542|FG001|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3|||
48892388|NCT00700427|157441543|FG002|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
48892389|NCT00700427|157441544|FG003|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
48892390|NCT00700427|157441545|FG004|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
49037788|NCT02625974|157973198|FG000|Part 2|Other, including due to the COVID-19 Pandemic|2|||
48892391|NCT00700427|157441541|FG000|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
48892392|NCT00700427|157441542|FG001|Study Period 3A (Blinded Maintenance)|Physician Decision|2|||
48892393|NCT00700427|157441543|FG002|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
48892394|NCT00700427|157441544|FG003|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
48892395|NCT00700427|157441545|FG004|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
48892396|NCT00700427|157441541|FG000|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
49037789|NCT02625974|157973199|FG001|Part 2|Other, including due to the COVID-19 Pandemic|1|||
49037790|NCT00725322|157973200|FG000|Washout (28 Days)|Withdrawal by Subject|2|||
49037791|NCT00725322|157973201|FG001|Washout (28 Days)|Withdrawal by Subject|0|||
48892397|NCT00700427|157441542|FG001|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5|||
48892398|NCT00700427|157441543|FG002|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
48892399|NCT00700427|157441544|FG003|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
49037792|NCT00725322|157973200|FG000|Washout (28 Days)|Protocol Violation|0|||
48892400|NCT00700427|157441545|FG004|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
48892401|NCT00700427|157441541|FG000|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
48892402|NCT00700427|157441542|FG001|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
48892403|NCT00700427|157441543|FG002|Study Period 3B (Randomized Withdrawal)|Adverse Event|8|||
48892404|NCT00700427|157441544|FG003|Study Period 3B (Randomized Withdrawal)|Adverse Event|5|||
48892405|NCT00700427|157441545|FG004|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
48892406|NCT00700427|157441541|FG000|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
48892407|NCT00700427|157441542|FG001|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
48892408|NCT00700427|157441543|FG002|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25|||
48892409|NCT00700427|157441544|FG003|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34|||
48892410|NCT00700427|157441545|FG004|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
48892411|NCT00700427|157441541|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
48892412|NCT00700427|157441542|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
48892413|NCT00700427|157441543|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23|||
48892414|NCT00700427|157441544|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25|||
48892415|NCT00700427|157441545|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
48892416|NCT00700427|157441541|FG000|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
48892417|NCT00700427|157441542|FG001|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
48892418|NCT00700427|157441543|FG002|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19|||
48892419|NCT00700427|157441544|FG003|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9|||
48892420|NCT00700427|157441545|FG004|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
48892421|NCT00700427|157441541|FG000|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
48892422|NCT00700427|157441542|FG001|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
48892423|NCT00700427|157441543|FG002|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3|||
48892424|NCT00700427|157441544|FG003|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11|||
48892425|NCT00700427|157441545|FG004|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
48892426|NCT00700427|157441541|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
48892427|NCT00700427|157441542|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
48892428|NCT00700427|157441543|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
48892429|NCT00700427|157441544|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5|||
49037793|NCT00725322|157973201|FG001|Washout (28 Days)|Protocol Violation|1|||
49037794|NCT02061280|157973202|FG000|Overall Study|Protocol Violation|12|||
48892430|NCT00700427|157441545|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
48892431|NCT00700427|157441541|FG000|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
49037795|NCT02061280|157973203|FG001|Overall Study|Protocol Violation|8|||
49037796|NCT02061280|157973202|FG000|Overall Study|moved out of state|0|||
49037797|NCT02061280|157973203|FG001|Overall Study|moved out of state|1|||
49037798|NCT02061280|157973202|FG000|Overall Study|Withdrawal by Subject|1|||
49037799|NCT02061280|157973203|FG001|Overall Study|Withdrawal by Subject|2|||
49037800|NCT02061280|157973202|FG000|Overall Study|Lost to Follow-up|5|||
49037801|NCT02061280|157973203|FG001|Overall Study|Lost to Follow-up|1|||
49037802|NCT02055547|157973204|FG000|Overall Study|Protocol Violation|0|||
49037803|NCT02055547|157973205|FG001|Overall Study|Protocol Violation|0|||
49037804|NCT02055547|157973206|FG002|Overall Study|Protocol Violation|1|||
48892432|NCT00700427|157441542|FG001|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
48892433|NCT00700427|157441543|FG002|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
48892434|NCT00700427|157441544|FG003|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3|||
48892435|NCT00700427|157441545|FG004|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
48892436|NCT00700427|157441541|FG000|Study Period 3B (Randomized Withdrawal)|Missing|0|||
48892437|NCT00700427|157441542|FG001|Study Period 3B (Randomized Withdrawal)|Missing|0|||
48892438|NCT00700427|157441543|FG002|Study Period 3B (Randomized Withdrawal)|Missing|1|||
48892439|NCT00700427|157441544|FG003|Study Period 3B (Randomized Withdrawal)|Missing|1|||
48892440|NCT00700427|157441545|FG004|Study Period 3B (Randomized Withdrawal)|Missing|0|||
48892441|NCT00700427|157441541|FG000|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
48892442|NCT00700427|157441542|FG001|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
48892443|NCT00700427|157441543|FG002|Study Period 3B (Randomized Withdrawal)|Physician Decision|2|||
48892444|NCT00700427|157441544|FG003|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
48892445|NCT00700427|157441545|FG004|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
48892446|NCT00700427|157441541|FG000|Study Period 3B (Randomized Withdrawal)|Death|0|||
48892447|NCT00700427|157441542|FG001|Study Period 3B (Randomized Withdrawal)|Death|0|||
48892448|NCT00700427|157441543|FG002|Study Period 3B (Randomized Withdrawal)|Death|1|||
48892449|NCT00700427|157441544|FG003|Study Period 3B (Randomized Withdrawal)|Death|0|||
48892450|NCT00700427|157441545|FG004|Study Period 3B (Randomized Withdrawal)|Death|0|||
48892451|NCT00700427|157441541|FG000|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
48892452|NCT00700427|157441542|FG001|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
49037805|NCT02055547|157973207|FG003|Overall Study|Protocol Violation|0|||
49037806|NCT02055547|157973208|FG004|Overall Study|Protocol Violation|0|||
48892453|NCT00700427|157441543|FG002|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
48892454|NCT00700427|157441544|FG003|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
48892455|NCT00700427|157441545|FG004|Study Period 4 (Open-Label Extension)|Adverse Event|16|||
48892456|NCT00700427|157441541|FG000|Study Period 4 (Open-Label Extension)|Death|0|||
48892457|NCT00700427|157441542|FG001|Study Period 4 (Open-Label Extension)|Death|0|||
48892458|NCT00700427|157441543|FG002|Study Period 4 (Open-Label Extension)|Death|0|||
48892459|NCT00700427|157441544|FG003|Study Period 4 (Open-Label Extension)|Death|0|||
48892460|NCT00700427|157441545|FG004|Study Period 4 (Open-Label Extension)|Death|1|||
48892461|NCT00700427|157441541|FG000|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
48892462|NCT00700427|157441542|FG001|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
48892463|NCT00700427|157441543|FG002|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
48892464|NCT00700427|157441544|FG003|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
48892465|NCT00700427|157441545|FG004|Study Period 4 (Open-Label Extension)|Protocol Violation|12|||
48892466|NCT00700427|157441541|FG000|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
48892467|NCT00700427|157441542|FG001|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
48892468|NCT00700427|157441543|FG002|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
48892469|NCT00700427|157441544|FG003|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
48892470|NCT00700427|157441545|FG004|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38|||
48892471|NCT00700427|157441541|FG000|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
48892472|NCT00700427|157441542|FG001|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
48892473|NCT00700427|157441543|FG002|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
48892474|NCT00700427|157441544|FG003|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
48892475|NCT00700427|157441545|FG004|Study Period 4 (Open-Label Extension)|Physician Decision|2|||
48892476|NCT00700427|157441541|FG000|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
48892477|NCT00700427|157441542|FG001|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
48892478|NCT00700427|157441543|FG002|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
48892479|NCT00700427|157441544|FG003|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
48892480|NCT00700427|157441545|FG004|Study Period 4 (Open-Label Extension)|Sponsor Decision|2|||
48892481|NCT00700427|157441541|FG000|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
48892482|NCT00700427|157441542|FG001|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
48892483|NCT00700427|157441543|FG002|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
48892484|NCT00700427|157441544|FG003|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
48892485|NCT00700427|157441545|FG004|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1|||
48892486|NCT00700427|157441541|FG000|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
48892487|NCT00700427|157441542|FG001|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
48892488|NCT00700427|157441543|FG002|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
48892489|NCT00700427|157441544|FG003|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
48892490|NCT00700427|157441545|FG004|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11|||
48892491|NCT00700427|157441541|FG000|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
48892492|NCT00700427|157441542|FG001|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
48892493|NCT00700427|157441543|FG002|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
48892494|NCT00700427|157441544|FG003|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
48892495|NCT00700427|157441545|FG004|Study Period 4 (Open-Label Extension)|Clinical Relapse|1|||
48892496|NCT02207569|157441550|FG000|1-Month|Death|6|||
48892497|NCT02207569|157441550|FG000|1-Month|Withdrawal by Subject|2|||
48892498|NCT02207569|157441550|FG000|1-Month|Subject anesthetized but product not onsite, for medical justification treated w/commercial device|1|||
48892499|NCT02207569|157441550|FG000|6-Month|Death|8|||
48892500|NCT02207569|157441550|FG000|6-Month|Withdrawal by Subject|2|||
48892501|NCT02207569|157441550|FG000|12-Month|Death|14|||
48892502|NCT02207569|157441550|FG000|12-Month|Withdrawal by Subject|2|||
48892503|NCT02207569|157441550|FG000|24-Month|Death|23|||
48892504|NCT02207569|157441550|FG000|24-Month|Withdrawal by Subject|3|||
48892505|NCT02207569|157441550|FG000|36-Month|Death|23|||
48892506|NCT02207569|157441550|FG000|36-Month|Withdrawal by Subject|4|||
48892507|NCT02207569|157441550|FG000|48-Month|Death|25|||
48892508|NCT02207569|157441550|FG000|48-Month|Withdrawal by Subject|2|||
48892509|NCT02207569|157441550|FG000|48-Month|Lost to Follow-up|4|||
48892510|NCT02207569|157441550|FG000|60-Month|Death|1|||
48892511|NCT02207569|157441550|FG000|60-Month|Lost to Follow-up|1|||
48892512|NCT02207569|157441550|FG000|60-Month|pt 103 years old no longer traveling for MD visits|1|||
48892513|NCT02207569|157441550|FG000|60-Month|Covid-19 pt not willing to be seen|1|||
48892514|NCT01014143|157441551|FG000|Second Intervention|Lost to Follow-up|2|||
48892515|NCT01014143|157441552|FG001|Second Intervention|Lost to Follow-up|0|||
48892516|NCT01014143|157441553|FG002|Second Intervention|Lost to Follow-up|0|||
48892517|NCT01493427|157441556|FG000|Overall Study|Adverse Event|10|||
48892518|NCT01493427|157441556|FG000|Overall Study|Personal Reasons|4|||
48892519|NCT01493427|157441556|FG000|Overall Study|Lost to Follow-up|2|||
48892520|NCT01493427|157441556|FG000|Overall Study|Inability to Follow Instructions|2|||
48892521|NCT01493427|157441556|FG000|Overall Study|Other|2|||
48892522|NCT02334423|157441559|FG000|Overall Study|Protocol Violation|10|||
48892523|NCT02334423|157441560|FG001|Overall Study|Protocol Violation|3|||
48892524|NCT01076647|157441563|FG000|Overall Study|Adverse Event|4|||
48892525|NCT01076647|157441564|FG001|Overall Study|Adverse Event|1|||
48892526|NCT01076647|157441563|FG000|Overall Study|Lack of Efficacy|0|||
48892527|NCT01076647|157441564|FG001|Overall Study|Lack of Efficacy|1|||
48892528|NCT01076647|157441563|FG000|Overall Study|Protocol Violation|7|||
48892529|NCT01076647|157441564|FG001|Overall Study|Protocol Violation|9|||
48892530|NCT01076647|157441563|FG000|Overall Study|Withdrawal criteria|2|||
48892531|NCT01076647|157441564|FG001|Overall Study|Withdrawal criteria|2|||
48892532|NCT01076647|157441563|FG000|Overall Study|Unclassified|12|||
48892533|NCT01076647|157441564|FG001|Overall Study|Unclassified|12|||
48892534|NCT04313608|157441565|FG000|Overall Study|Death|12|||
48892535|NCT04313608|157441566|FG001|Overall Study|Death|3|||
48892536|NCT00831129|157441567|FG000|Overall Study|Adverse Event|0|||
48892537|NCT00831129|157441568|FG001|Overall Study|Adverse Event|1|||
48892538|NCT00831129|157441567|FG000|Overall Study|9 lost to follow-up reasons uknown|0|||
48892539|NCT00831129|157441568|FG001|Overall Study|9 lost to follow-up reasons uknown|9|||
48892540|NCT03001076|157441571|FG000|Overall Study|Withdrawal by patient|2|||
48892541|NCT03001076|157441572|FG001|Overall Study|Withdrawal by patient|0|||
48892542|NCT03001076|157441571|FG000|Overall Study|Other|1|||
48892543|NCT03001076|157441572|FG001|Overall Study|Other|0|||
48892544|NCT03001076|157441571|FG000|Overall Study|Adverse Event|3|||
48892545|NCT03001076|157441572|FG001|Overall Study|Adverse Event|3|||
48892546|NCT03001076|157441571|FG000|Overall Study|Sponsor decision|1|||
48892547|NCT03001076|157441572|FG001|Overall Study|Sponsor decision|0|||
48892548|NCT03001076|157441571|FG000|Overall Study|Lost to Follow-up|0|||
48892549|NCT03001076|157441572|FG001|Overall Study|Lost to Follow-up|2|||
48892550|NCT00844532|157441573|FG000|Overall Study|Death|16|||
48892551|NCT00844532|157441573|FG000|Overall Study|Withdrawal by Subject|16|||
48892552|NCT00844532|157441573|FG000|Overall Study|Lost to Follow-up|7|||
48892553|NCT01993927|157441576|FG000|Overall Study|Case Report Forms Uncollected|18|||
48892554|NCT01993927|157441576|FG000|Overall Study|Protocol Violation|11|||
48892555|NCT02751320|157441584|FG000|Overall Study|Adverse Event|2|||
48892556|NCT02751320|157441584|FG000|Overall Study|Withdrawal by Subject|1|||
48892557|NCT05017103|157441585|FG000|Overall Study|Death|2|||
48892558|NCT00296400|157441586|FG000|Overall Study|Adverse Event|7|||
48892559|NCT00296400|157441587|FG001|Overall Study|Adverse Event|7|||
48892560|NCT00296400|157441588|FG002|Overall Study|Adverse Event|7|||
48892561|NCT00296400|157441586|FG000|Overall Study|Withdrawal by Subject|5|||
48892562|NCT00296400|157441587|FG001|Overall Study|Withdrawal by Subject|6|||
48892563|NCT00296400|157441588|FG002|Overall Study|Withdrawal by Subject|2|||
48892564|NCT00296400|157441586|FG000|Overall Study|Incorrect enrollment|2|||
48892565|NCT00296400|157441587|FG001|Overall Study|Incorrect enrollment|0|||
48892566|NCT00296400|157441588|FG002|Overall Study|Incorrect enrollment|0|||
48892567|NCT00296400|157441586|FG000|Overall Study|Protocol Violation|1|||
48892568|NCT00296400|157441587|FG001|Overall Study|Protocol Violation|1|||
48892569|NCT00296400|157441588|FG002|Overall Study|Protocol Violation|1|||
48892570|NCT00296400|157441586|FG000|Overall Study|Lost to Follow-up|1|||
48892571|NCT00296400|157441587|FG001|Overall Study|Lost to Follow-up|1|||
48892572|NCT00296400|157441588|FG002|Overall Study|Lost to Follow-up|2|||
48892573|NCT00296400|157441586|FG000|Overall Study|Study specific discontinuation criteria|0|||
48892574|NCT00296400|157441587|FG001|Overall Study|Study specific discontinuation criteria|0|||
48892575|NCT00296400|157441588|FG002|Overall Study|Study specific discontinuation criteria|1|||
48892576|NCT00296400|157441586|FG000|Overall Study|Visit 10 was performed earlier|0|||
48892577|NCT00296400|157441587|FG001|Overall Study|Visit 10 was performed earlier|1|||
48892578|NCT00296400|157441588|FG002|Overall Study|Visit 10 was performed earlier|0|||
48892579|NCT00296400|157441586|FG000|Overall Study|Pregnancy|1|||
48892580|NCT00296400|157441587|FG001|Overall Study|Pregnancy|2|||
48892581|NCT00296400|157441588|FG002|Overall Study|Pregnancy|0|||
48892582|NCT01242800|157441595|FG000|Overall Study|Patient refusal|0|||
48892583|NCT01242800|157441596|FG001|Overall Study|Patient refusal|10|||
48892584|NCT01242800|157441595|FG000|Overall Study|Physician Decision|0|||
48892585|NCT01242800|157441596|FG001|Overall Study|Physician Decision|1|||
48892586|NCT01242800|157441595|FG000|Overall Study|Disease progression|0|||
48892587|NCT01242800|157441596|FG001|Overall Study|Disease progression|3|||
48892588|NCT01242800|157441595|FG000|Overall Study|Lack of insurance coverage for surgery|0|||
48892589|NCT01242800|157441596|FG001|Overall Study|Lack of insurance coverage for surgery|1|||
48892590|NCT01242800|157441595|FG000|Overall Study|Reasons not reported|0|||
48892591|NCT01242800|157441596|FG001|Overall Study|Reasons not reported|4|||
48892592|NCT03683823|157441597|FG000|Post-treatment Assessment|Withdrawal by Subject|1|||
48892593|NCT03683823|157441598|FG001|Post-treatment Assessment|Withdrawal by Subject|1|||
48892594|NCT03683823|157441597|FG000|Post-treatment Assessment|Lost to Follow-up|0|||
48892595|NCT03683823|157441598|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
48984127|NCT01693562|157774140|FG019|Escalation Phase|Lost to Follow-up|0|||
48984128|NCT01693562|157774141|FG020|Escalation Phase|Lost to Follow-up|0|||
48892596|NCT03683823|157441597|FG000|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
48892597|NCT03683823|157441598|FG001|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
49037807|NCT02055547|157973209|FG005|Overall Study|Protocol Violation|0|||
48892598|NCT01262027|157441599|FG000|Overall Study|Adverse Event|1|||
48892599|NCT01262027|157441599|FG000|Overall Study|Withdrawal by Subject|3|||
48892600|NCT01262027|157441599|FG000|Overall Study|Protocol Violation|1|||
48892601|NCT01394978|157441600|FG000|Overall Study|Withdrawal by Subject|2|||
48892602|NCT01394978|157441601|FG001|Overall Study|Withdrawal by Subject|4|||
48892603|NCT01394978|157441600|FG000|Overall Study|Lost to Follow-up|13|||
48892604|NCT01394978|157441601|FG001|Overall Study|Lost to Follow-up|20|||
48892605|NCT01394978|157441600|FG000|Overall Study|Death|6|||
48892606|NCT01394978|157441601|FG001|Overall Study|Death|7|||
48892607|NCT00589121|157441602|FG000|Overall Study|Protocol Violation|2|||
48892608|NCT00589121|157441603|FG001|Overall Study|Protocol Violation|6|||
48892609|NCT00589121|157441602|FG000|Overall Study|No protocol treatment received|0|||
48892610|NCT00589121|157441603|FG001|Overall Study|No protocol treatment received|1|||
48892611|NCT01081132|157441604|FG000|Overall Study|Lack of Efficacy|25|||
48892612|NCT01081132|157441605|FG001|Overall Study|Lack of Efficacy|9|||
48892613|NCT01081132|157441604|FG000|Overall Study|Withdrawal by Subject|13|||
48892614|NCT01081132|157441605|FG001|Overall Study|Withdrawal by Subject|16|||
48892615|NCT01081132|157441604|FG000|Overall Study|Lost to Follow-up|4|||
48892616|NCT01081132|157441605|FG001|Overall Study|Lost to Follow-up|11|||
48892617|NCT01081132|157441604|FG000|Overall Study|Adverse Event|3|||
48892618|NCT01081132|157441605|FG001|Overall Study|Adverse Event|9|||
48892619|NCT01081132|157441604|FG000|Overall Study|Non Compliance|4|||
48892620|NCT01081132|157441605|FG001|Overall Study|Non Compliance|2|||
48892621|NCT01081132|157441604|FG000|Overall Study|Lack Of Compliance|0|||
48892622|NCT01081132|157441605|FG001|Overall Study|Lack Of Compliance|1|||
48892623|NCT01081132|157441604|FG000|Overall Study|Missed Visits|1|||
48892624|NCT01081132|157441605|FG001|Overall Study|Missed Visits|1|||
48892625|NCT01081132|157441604|FG000|Overall Study|Stopped Taking Meds|2|||
48892626|NCT01081132|157441605|FG001|Overall Study|Stopped Taking Meds|0|||
48892627|NCT01081132|157441604|FG000|Overall Study|Patient Did Not Complete Wk14 and 15|0|||
48892628|NCT01081132|157441605|FG001|Overall Study|Patient Did Not Complete Wk14 and 15|1|||
48892629|NCT01081132|157441604|FG000|Overall Study|Declined Taper Phase|0|||
48892630|NCT01081132|157441605|FG001|Overall Study|Declined Taper Phase|1|||
48892631|NCT01081132|157441604|FG000|Overall Study|Protocol Violation|3|||
49037808|NCT02055547|157973210|FG006|Overall Study|Protocol Violation|1|||
49037809|NCT02055547|157973211|FG007|Overall Study|Protocol Violation|0|||
49037810|NCT02055547|157973212|FG008|Overall Study|Protocol Violation|0|||
49037811|NCT02055547|157973213|FG009|Overall Study|Protocol Violation|0|||
49037812|NCT02055547|157973214|FG010|Overall Study|Protocol Violation|0|||
49037813|NCT02055547|157973215|FG011|Overall Study|Protocol Violation|0|||
49037814|NCT02055547|157973216|FG012|Overall Study|Protocol Violation|0|||
49037815|NCT02055547|157973217|FG013|Overall Study|Protocol Violation|0|||
49037816|NCT02055547|157973218|FG014|Overall Study|Protocol Violation|0|||
49037817|NCT02055547|157973219|FG015|Overall Study|Protocol Violation|0|||
49037818|NCT02055547|157973220|FG016|Overall Study|Protocol Violation|0|||
49037819|NCT02055547|157973221|FG017|Overall Study|Protocol Violation|0|||
49037820|NCT02055547|157973222|FG018|Overall Study|Protocol Violation|0|||
49037821|NCT02055547|157973204|FG000|Overall Study|Physician Decision|0|||
49037822|NCT02055547|157973205|FG001|Overall Study|Physician Decision|1|||
49037823|NCT02055547|157973206|FG002|Overall Study|Physician Decision|1|||
49037824|NCT02055547|157973207|FG003|Overall Study|Physician Decision|0|||
49037825|NCT02055547|157973208|FG004|Overall Study|Physician Decision|1|||
49037826|NCT02055547|157973209|FG005|Overall Study|Physician Decision|0|||
49037827|NCT02055547|157973210|FG006|Overall Study|Physician Decision|0|||
49037828|NCT02055547|157973211|FG007|Overall Study|Physician Decision|0|||
49037829|NCT02055547|157973212|FG008|Overall Study|Physician Decision|0|||
49037830|NCT02055547|157973213|FG009|Overall Study|Physician Decision|1|||
49037831|NCT02055547|157973214|FG010|Overall Study|Physician Decision|1|||
49037832|NCT02055547|157973215|FG011|Overall Study|Physician Decision|0|||
49037833|NCT02055547|157973216|FG012|Overall Study|Physician Decision|0|||
48892632|NCT01081132|157441605|FG001|Overall Study|Protocol Violation|1|||
48892633|NCT02297139|157441606|FG000|Overall Study|Disease progression|0|||
49037834|NCT02055547|157973217|FG013|Overall Study|Physician Decision|0|||
49037835|NCT02055547|157973218|FG014|Overall Study|Physician Decision|0|||
48892634|NCT02297139|157441607|FG001|Overall Study|Disease progression|1|||
48892635|NCT02297139|157441606|FG000|Overall Study|Study drug toxicity|0|||
48892636|NCT02297139|157441607|FG001|Overall Study|Study drug toxicity|4|||
48892637|NCT02297139|157441606|FG000|Overall Study|Participant request to discontinue study treatment|0|||
48892638|NCT02297139|157441607|FG001|Overall Study|Participant request to discontinue study treatment|1|||
48892639|NCT02297139|157441606|FG000|Overall Study|Maximum clinical benefit|1|||
49037836|NCT02055547|157973219|FG015|Overall Study|Physician Decision|0|||
49037837|NCT02055547|157973220|FG016|Overall Study|Physician Decision|0|||
49037838|NCT02055547|157973221|FG017|Overall Study|Physician Decision|0|||
49037839|NCT02055547|157973222|FG018|Overall Study|Physician Decision|0|||
49037840|NCT02055547|157973204|FG000|Overall Study|Adverse Event|0|||
48892640|NCT02297139|157441607|FG001|Overall Study|Maximum clinical benefit|0|||
48892641|NCT02297139|157441606|FG000|Overall Study|Administrative reason by sponsor|0|||
49037841|NCT02055547|157973205|FG001|Overall Study|Adverse Event|0|||
49037842|NCT02055547|157973206|FG002|Overall Study|Adverse Event|0|||
48892642|NCT02297139|157441607|FG001|Overall Study|Administrative reason by sponsor|2|||
48892643|NCT02297139|157441606|FG000|Overall Study|Other reasons|0|||
49037843|NCT02055547|157973207|FG003|Overall Study|Adverse Event|0|||
49037844|NCT02055547|157973208|FG004|Overall Study|Adverse Event|0|||
49037845|NCT02055547|157973209|FG005|Overall Study|Adverse Event|0|||
49037846|NCT02055547|157973210|FG006|Overall Study|Adverse Event|1|||
49037847|NCT02055547|157973211|FG007|Overall Study|Adverse Event|0|||
49037848|NCT02055547|157973212|FG008|Overall Study|Adverse Event|1|||
49037849|NCT02055547|157973213|FG009|Overall Study|Adverse Event|0|||
49037850|NCT02055547|157973214|FG010|Overall Study|Adverse Event|0|||
49037851|NCT02055547|157973215|FG011|Overall Study|Adverse Event|0|||
49037852|NCT02055547|157973216|FG012|Overall Study|Adverse Event|0|||
49037853|NCT02055547|157973217|FG013|Overall Study|Adverse Event|0|||
49037854|NCT02055547|157973218|FG014|Overall Study|Adverse Event|0|||
49037855|NCT02055547|157973219|FG015|Overall Study|Adverse Event|0|||
48892644|NCT02297139|157441607|FG001|Overall Study|Other reasons|8|||
48892645|NCT03562975|157441610|FG000|Overall Study|Death|1|||
48892646|NCT03562975|157441610|FG000|Overall Study|Lost to Follow-up|1|||
48892647|NCT03562975|157441610|FG000|Overall Study|Withdrawal by Subject|1|||
48892648|NCT05148962|157441611|FG000|Overall Study|Withdrawal by Subject|1|||
48892649|NCT05148962|157441612|FG001|Overall Study|Withdrawal by Subject|1|||
48892650|NCT05148962|157441613|FG002|Overall Study|Withdrawal by Subject|0|||
48892651|NCT05148962|157441614|FG003|Overall Study|Withdrawal by Subject|1|||
48892652|NCT05148962|157441615|FG004|Overall Study|Withdrawal by Subject|0|||
48892653|NCT05148962|157441611|FG000|Overall Study|Participant was early terminated per protocol|0|||
48892654|NCT05148962|157441612|FG001|Overall Study|Participant was early terminated per protocol|0|||
48892655|NCT05148962|157441613|FG002|Overall Study|Participant was early terminated per protocol|3|||
48892656|NCT05148962|157441614|FG003|Overall Study|Participant was early terminated per protocol|5|||
48892657|NCT05148962|157441615|FG004|Overall Study|Participant was early terminated per protocol|2|||
48892658|NCT05148962|157441611|FG000|Overall Study|Miscellaneous|0|||
48892659|NCT05148962|157441612|FG001|Overall Study|Miscellaneous|0|||
48892660|NCT05148962|157441613|FG002|Overall Study|Miscellaneous|0|||
48892661|NCT05148962|157441614|FG003|Overall Study|Miscellaneous|1|||
48892662|NCT05148962|157441615|FG004|Overall Study|Miscellaneous|0|||
48892663|NCT03141905|157441616|FG000|Overall Study|Death|3|||
48892664|NCT03141905|157441617|FG001|Overall Study|Death|2|||
48892665|NCT03141905|157441616|FG000|Overall Study|Withdrawal by Subject|1|||
48892666|NCT03141905|157441617|FG001|Overall Study|Withdrawal by Subject|0|||
48892667|NCT03141905|157441616|FG000|Overall Study|Lost to Follow-up|3|||
48892668|NCT03141905|157441617|FG001|Overall Study|Lost to Follow-up|7|||
48892669|NCT03141905|157441616|FG000|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17|||
48892670|NCT03141905|157441617|FG001|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10|||
48892671|NCT00151281|157441618|FG000|Overall Study|Not evaluable|3|||
48892672|NCT05180500|157441619|FG000|Overall Study|Adverse Event|1|||
48892673|NCT05180500|157441620|FG001|Overall Study|Adverse Event|0|||
48892674|NCT05180500|157441619|FG000|Overall Study|Withdrawal by Subject|2|||
48892675|NCT05180500|157441620|FG001|Overall Study|Withdrawal by Subject|0|||
48892676|NCT03668223|157441622|FG000|Overall Study|Death|10|||
48892677|NCT03668223|157441623|FG001|Overall Study|Death|5|||
48892678|NCT03668223|157441622|FG000|Overall Study|Lost to Follow-up|12|||
48892679|NCT03668223|157441623|FG001|Overall Study|Lost to Follow-up|12|||
48892680|NCT03668223|157441622|FG000|Overall Study|Withdrawal by Subject|8|||
48892681|NCT03668223|157441623|FG001|Overall Study|Withdrawal by Subject|3|||
48892682|NCT03465904|157441628|FG000|Overall Study|Withdrawal by Subject|9|||
48892683|NCT03465904|157441629|FG001|Overall Study|Withdrawal by Subject|5|||
48892684|NCT03465904|157441628|FG000|Overall Study|Lost to Follow-up|11|||
48892685|NCT03465904|157441629|FG001|Overall Study|Lost to Follow-up|9|||
48892686|NCT03465904|157441628|FG000|Overall Study|Protocol Violation|20|||
48892687|NCT03465904|157441629|FG001|Overall Study|Protocol Violation|15|||
48892688|NCT00565851|157443570|FG000|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
48892689|NCT00565851|157443571|FG001|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
48892690|NCT00565851|157443572|FG002|Chemotherapy Assignment|Never Initiated Chemotherapy|3|||
48892691|NCT00565851|157443573|FG003|Chemotherapy Assignment|Never Initiated Chemotherapy|18|||
48892692|NCT00565851|157443574|FG004|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
48892693|NCT00565851|157443575|FG005|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
48892694|NCT00565851|157443576|FG006|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
48892695|NCT00565851|157443577|FG007|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
48892696|NCT00565851|157443570|FG000|Chemotherapy Assignment|Still On Chemotherapy|0|||
48892697|NCT00565851|157443571|FG001|Chemotherapy Assignment|Still On Chemotherapy|14|||
48892698|NCT00565851|157443572|FG002|Chemotherapy Assignment|Still On Chemotherapy|0|||
48892699|NCT00565851|157443573|FG003|Chemotherapy Assignment|Still On Chemotherapy|18|||
49037856|NCT02055547|157973220|FG016|Overall Study|Adverse Event|0|||
49037857|NCT02055547|157973221|FG017|Overall Study|Adverse Event|0|||
49037858|NCT02055547|157973222|FG018|Overall Study|Adverse Event|0|||
49037859|NCT02055547|157973204|FG000|Overall Study|Withdrawal by Subject|0|||
49037860|NCT02055547|157973205|FG001|Overall Study|Withdrawal by Subject|0|||
49037861|NCT02055547|157973206|FG002|Overall Study|Withdrawal by Subject|0|||
49037862|NCT02055547|157973207|FG003|Overall Study|Withdrawal by Subject|0|||
49037863|NCT02055547|157973208|FG004|Overall Study|Withdrawal by Subject|0|||
49037864|NCT02055547|157973209|FG005|Overall Study|Withdrawal by Subject|1|||
49037865|NCT02055547|157973210|FG006|Overall Study|Withdrawal by Subject|0|||
49037866|NCT02055547|157973211|FG007|Overall Study|Withdrawal by Subject|0|||
49037867|NCT02055547|157973212|FG008|Overall Study|Withdrawal by Subject|1|||
49037868|NCT02055547|157973213|FG009|Overall Study|Withdrawal by Subject|0|||
49037869|NCT02055547|157973214|FG010|Overall Study|Withdrawal by Subject|0|||
49037870|NCT02055547|157973215|FG011|Overall Study|Withdrawal by Subject|0|||
49037871|NCT02055547|157973216|FG012|Overall Study|Withdrawal by Subject|0|||
49037872|NCT02055547|157973217|FG013|Overall Study|Withdrawal by Subject|1|||
49037873|NCT02055547|157973218|FG014|Overall Study|Withdrawal by Subject|0|||
49037874|NCT02055547|157973219|FG015|Overall Study|Withdrawal by Subject|1|||
49037875|NCT02055547|157973220|FG016|Overall Study|Withdrawal by Subject|0|||
49037876|NCT02055547|157973221|FG017|Overall Study|Withdrawal by Subject|0|||
49037877|NCT02055547|157973222|FG018|Overall Study|Withdrawal by Subject|0|||
49037878|NCT02055547|157973204|FG000|Overall Study|Lost to Follow-up|0|||
49037879|NCT02055547|157973205|FG001|Overall Study|Lost to Follow-up|0|||
49037880|NCT02055547|157973206|FG002|Overall Study|Lost to Follow-up|1|||
49037881|NCT02055547|157973207|FG003|Overall Study|Lost to Follow-up|0|||
49037882|NCT02055547|157973208|FG004|Overall Study|Lost to Follow-up|0|||
49037883|NCT02055547|157973209|FG005|Overall Study|Lost to Follow-up|0|||
49037884|NCT02055547|157973210|FG006|Overall Study|Lost to Follow-up|0|||
49037885|NCT02055547|157973211|FG007|Overall Study|Lost to Follow-up|0|||
49037886|NCT02055547|157973212|FG008|Overall Study|Lost to Follow-up|0|||
49037887|NCT02055547|157973213|FG009|Overall Study|Lost to Follow-up|0|||
49037888|NCT02055547|157973214|FG010|Overall Study|Lost to Follow-up|0|||
49037889|NCT02055547|157973215|FG011|Overall Study|Lost to Follow-up|0|||
49037890|NCT02055547|157973216|FG012|Overall Study|Lost to Follow-up|0|||
49037891|NCT02055547|157973217|FG013|Overall Study|Lost to Follow-up|0|||
49037892|NCT02055547|157973218|FG014|Overall Study|Lost to Follow-up|0|||
49037893|NCT02055547|157973219|FG015|Overall Study|Lost to Follow-up|0|||
49037894|NCT02055547|157973220|FG016|Overall Study|Lost to Follow-up|0|||
49037895|NCT02055547|157973221|FG017|Overall Study|Lost to Follow-up|0|||
49037896|NCT02055547|157973222|FG018|Overall Study|Lost to Follow-up|0|||
49037897|NCT00645853|157973223|FG000|Overall Study|Adverse Event|18|||
49037898|NCT00645853|157973224|FG001|Overall Study|Adverse Event|7|||
49037899|NCT00645853|157973223|FG000|Overall Study|AZ study closure in Hungary|60|||
49037900|NCT00645853|157973224|FG001|Overall Study|AZ study closure in Hungary|40|||
49037901|NCT00645853|157973223|FG000|Overall Study|Withdrawal by Subject|5|||
49037902|NCT00645853|157973224|FG001|Overall Study|Withdrawal by Subject|2|||
49037903|NCT00645853|157973223|FG000|Overall Study|Protocol Violation|0|||
49037904|NCT00645853|157973224|FG001|Overall Study|Protocol Violation|2|||
49037905|NCT00645853|157973223|FG000|Overall Study|Discontinuation criteria|2|||
49037906|NCT00645853|157973224|FG001|Overall Study|Discontinuation criteria|2|||
49037907|NCT00645853|157973223|FG000|Overall Study|recall of ICF, planned operation, death|7|||
49037908|NCT00645853|157973224|FG001|Overall Study|recall of ICF, planned operation, death|4|||
49037909|NCT02905435|157973225|FG000|Overall Study|Death|2|||
49037910|NCT02905435|157973225|FG000|Overall Study|Physician Decision|1|||
49037911|NCT02905435|157973225|FG000|Overall Study|Lost to Follow-up|4|||
49037912|NCT01004510|157973226|FG000|Overall Study|Adverse Event|1|||
49037913|NCT00537095|157973227|FG000|Randomized Treatment Period (433 Days)|Adverse Event|24|||
49037914|NCT00537095|157973228|FG001|Randomized Treatment Period (433 Days)|Adverse Event|4|||
49037915|NCT00537095|157973227|FG000|Randomized Treatment Period (433 Days)|Objective Disease Progression|21|||
49037916|NCT00537095|157973228|FG001|Randomized Treatment Period (433 Days)|Objective Disease Progression|48|||
49037917|NCT00537095|157973227|FG000|Randomized Treatment Period (433 Days)|Death|3|||
49037918|NCT00537095|157973228|FG001|Randomized Treatment Period (433 Days)|Death|1|||
49037919|NCT00537095|157973227|FG000|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
49037920|NCT00537095|157973228|FG001|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
49037921|NCT00537095|157973227|FG000|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|1|||
49037922|NCT00537095|157973228|FG001|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|2|||
49037923|NCT00537095|157973227|FG000|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|21|||
49037924|NCT00537095|157973228|FG001|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|16|||
49037925|NCT00537095|157973227|FG000|Open-label Period (590 Days)|Adverse Event|2|||
49037926|NCT00537095|157973228|FG001|Open-label Period (590 Days)|Adverse Event|11|||
49037927|NCT00537095|157973227|FG000|Open-label Period (590 Days)|Objective Disease Progression|2|||
49037928|NCT00537095|157973228|FG001|Open-label Period (590 Days)|Objective Disease Progression|21|||
48892700|NCT00565851|157443574|FG004|Chemotherapy Assignment|Still On Chemotherapy|0|||
48892701|NCT00565851|157443575|FG005|Chemotherapy Assignment|Still On Chemotherapy|1|||
49037929|NCT00537095|157973227|FG000|Open-label Period (590 Days)|Death|2|||
49037930|NCT00537095|157973228|FG001|Open-label Period (590 Days)|Death|2|||
48892702|NCT00565851|157443576|FG006|Chemotherapy Assignment|Still On Chemotherapy|0|||
48892703|NCT00565851|157443577|FG007|Chemotherapy Assignment|Still On Chemotherapy|1|||
48892704|NCT02516332|157443581|FG000|Overall Study|Withdrawal by Subject|2|||
48892705|NCT02516332|157443582|FG001|Overall Study|Withdrawal by Subject|1|||
48892706|NCT02516332|157443583|FG002|Overall Study|Withdrawal by Subject|2|||
48892707|NCT01015560|157443584|FG000|Overall Study|Adverse Event|1|||
48892708|NCT01015560|157443584|FG000|Overall Study|Not protocol specified|1|||
48892709|NCT01015560|157443584|FG000|Overall Study|Withdrawal by Subject|1|||
48892710|NCT00770029|157443587|FG000|Overall Study|Lost to Follow-up|2|||
48892711|NCT00770029|157443588|FG001|Overall Study|Lost to Follow-up|0|||
48892712|NCT00770029|157443587|FG000|Overall Study|Withdrawal by Subject|3|||
48892713|NCT00770029|157443588|FG001|Overall Study|Withdrawal by Subject|3|||
48892714|NCT00770029|157443587|FG000|Overall Study|Adverse Event|1|||
48892715|NCT00770029|157443588|FG001|Overall Study|Adverse Event|0|||
48892716|NCT01789567|157443589|FG000|Overall Study|Death|6|||
48892717|NCT01775475|157443590|FG000|Overall Study|Death|3|||
48892718|NCT01775475|157443591|FG001|Overall Study|Death|3|||
48892719|NCT01076153|157443592|FG000|Overall Study|Symptoms improved/resolved|10|||
48892720|NCT01076153|157443592|FG000|Overall Study|Adverse Event|1|||
48892721|NCT00503139|157443593|FG000|Overall Study|Case Report Forms were not collected|4|||
48892722|NCT00503139|157443593|FG000|Overall Study|Protocol Violation|4|||
48892723|NCT02914275|157443594|FG000|Overall Study|Lost to Follow-up|84|||
48892724|NCT02914275|157443595|FG001|Overall Study|Lost to Follow-up|29|||
48892725|NCT02914275|157443594|FG000|Overall Study|Withdrawal by Subject|26|||
48892726|NCT02914275|157443595|FG001|Overall Study|Withdrawal by Subject|10|||
48892727|NCT02914275|157443594|FG000|Overall Study|Protocol Violation|1|||
48892728|NCT02914275|157443595|FG001|Overall Study|Protocol Violation|1|||
48892729|NCT02914275|157443594|FG000|Overall Study|Physician Decision|3|||
48892730|NCT02914275|157443595|FG001|Overall Study|Physician Decision|1|||
48892731|NCT02914275|157443594|FG000|Overall Study|Other|4|||
48892732|NCT02914275|157443595|FG001|Overall Study|Other|1|||
48892733|NCT02914275|157443594|FG000|Overall Study|Excluded due to invalid informed consent|3|||
48892734|NCT02914275|157443595|FG001|Overall Study|Excluded due to invalid informed consent|0|||
48892735|NCT01994837|157443603|FG000|Overall Study|Progressive disease per protocol|23|||
48892736|NCT01994837|157443603|FG000|Overall Study|Adv event related to progressive disease|3|||
48892737|NCT01994837|157443603|FG000|Overall Study|Fatal progressive disease|2|||
48892738|NCT01994837|157443603|FG000|Overall Study|Adverse event not related to progression|1|||
48892739|NCT01994837|157443603|FG000|Overall Study|Chose palliative care|1|||
48892740|NCT01994837|157443603|FG000|Overall Study|Proceeded to transplant|1|||
48892741|NCT01994837|157443603|FG000|Overall Study|Removed from study due to no response|1|||
48892742|NCT03446781|157443604|FG000|Overall Study|Lost to Follow-up|11|||
48892743|NCT03446781|157443605|FG001|Overall Study|Lost to Follow-up|5|||
48892744|NCT03446781|157443604|FG000|Overall Study|Withdrawal by Subject|9|||
48892745|NCT03446781|157443605|FG001|Overall Study|Withdrawal by Subject|7|||
48892746|NCT03446781|157443604|FG000|Overall Study|Adverse Event|8|||
49037931|NCT00537095|157973227|FG000|Open-label Period (590 Days)|Withdrawal by Subject|1|||
49037932|NCT00537095|157973228|FG001|Open-label Period (590 Days)|Withdrawal by Subject|2|||
49037933|NCT00537095|157973227|FG000|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|5|||
49037934|NCT00537095|157973228|FG001|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|3|||
49037935|NCT02911025|157973229|FG000|Overall Study|Lost to Follow-up|3|||
49037936|NCT01960296|157973230|FG000|Overall Study|Postponed surgery|1|||
49037937|NCT01960296|157973231|FG001|Overall Study|Postponed surgery|0|||
49037938|NCT01960296|157973230|FG000|Overall Study|Received different procedure|1|||
49037939|NCT01960296|157973231|FG001|Overall Study|Received different procedure|3|||
49037940|NCT00045162|157973232|FG000|Overall Study|Ineligible|12|||
49037941|NCT00045162|157973233|FG001|Overall Study|Ineligible|8|||
49037942|NCT00045162|157973232|FG000|Overall Study|Not treated|7|||
49037943|NCT00045162|157973233|FG001|Overall Study|Not treated|2|||
49037944|NCT00045162|157973232|FG000|Overall Study|Adverse Event|55|||
49037945|NCT00045162|157973233|FG001|Overall Study|Adverse Event|50|||
48892747|NCT03446781|157443605|FG001|Overall Study|Adverse Event|2|||
48892748|NCT03446781|157443604|FG000|Overall Study|Protocol Violation|0|||
48892749|NCT03446781|157443605|FG001|Overall Study|Protocol Violation|3|||
48892750|NCT03651622|157443615|FG000|Diet Period 1 (Randomization 1)|Lost to Follow-up|0|||
48892751|NCT03651622|157443616|FG001|Diet Period 1 (Randomization 1)|Lost to Follow-up|6|||
49037946|NCT00045162|157973232|FG000|Overall Study|Lack of Efficacy|32|||
49037947|NCT00045162|157973233|FG001|Overall Study|Lack of Efficacy|29|||
49037948|NCT00045162|157973232|FG000|Overall Study|Death|10|||
48892752|NCT03651622|157443617|FG002|Diet Period 1 (Randomization 1)|Lost to Follow-up|2|||
48892753|NCT03651622|157443615|FG000|Diet Period 1 (Randomization 1)|Withdrawal by Subject|4|||
48892754|NCT03651622|157443616|FG001|Diet Period 1 (Randomization 1)|Withdrawal by Subject|1|||
49037949|NCT00045162|157973233|FG001|Overall Study|Death|10|||
48892755|NCT03651622|157443617|FG002|Diet Period 1 (Randomization 1)|Withdrawal by Subject|7|||
48892756|NCT03651622|157443615|FG000|Diet Period 2 (Randomization 2)|Lost to Follow-up|0|||
48892757|NCT03651622|157443616|FG001|Diet Period 2 (Randomization 2)|Lost to Follow-up|2|||
49037950|NCT00045162|157973232|FG000|Overall Study|Withdrawal by Subject|5|||
48892758|NCT03651622|157443617|FG002|Diet Period 2 (Randomization 2)|Lost to Follow-up|3|||
48892759|NCT03651622|157443615|FG000|Diet Period 2 (Randomization 2)|Withdrawal by Subject|2|||
48892760|NCT03651622|157443616|FG001|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
48892761|NCT03651622|157443617|FG002|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
48892762|NCT03651622|157443615|FG000|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
48892763|NCT03651622|157443616|FG001|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
48892764|NCT03651622|157443617|FG002|Diet Period 3 (Randomization 3)|Withdrawal by Subject|1|||
48892765|NCT01253304|157443618|FG000|Overall Study|Adverse Event|0|||
48892766|NCT01253304|157443619|FG001|Overall Study|Adverse Event|0|||
48892767|NCT01253304|157443620|FG002|Overall Study|Adverse Event|0|||
48892768|NCT01253304|157443621|FG003|Overall Study|Adverse Event|1|||
48892769|NCT01327495|157443622|FG000|Overall Study|Adverse Event|2|||
48892770|NCT01327495|157443623|FG001|Overall Study|Adverse Event|1|||
48892771|NCT01327495|157443624|FG002|Overall Study|Adverse Event|1|||
48892772|NCT01327495|157443625|FG003|Overall Study|Adverse Event|0|||
48892773|NCT01327495|157443626|FG004|Overall Study|Adverse Event|0|||
48892774|NCT01327495|157443627|FG005|Overall Study|Adverse Event|2|||
48892775|NCT01327495|157443622|FG000|Overall Study|Withdrawal by Subject|0|||
48892776|NCT01327495|157443623|FG001|Overall Study|Withdrawal by Subject|1|||
48892777|NCT01327495|157443624|FG002|Overall Study|Withdrawal by Subject|1|||
48892778|NCT01327495|157443625|FG003|Overall Study|Withdrawal by Subject|0|||
48892779|NCT01327495|157443626|FG004|Overall Study|Withdrawal by Subject|1|||
48892780|NCT01327495|157443627|FG005|Overall Study|Withdrawal by Subject|0|||
48892781|NCT01327495|157443622|FG000|Overall Study|Physician Decision|0|||
48892782|NCT01327495|157443623|FG001|Overall Study|Physician Decision|0|||
48892783|NCT01327495|157443624|FG002|Overall Study|Physician Decision|0|||
48892784|NCT01327495|157443625|FG003|Overall Study|Physician Decision|0|||
48892785|NCT01327495|157443626|FG004|Overall Study|Physician Decision|2|||
48892786|NCT01327495|157443627|FG005|Overall Study|Physician Decision|0|||
48892787|NCT00307684|157443631|FG000|Open Label Phase|Lack of Efficacy|0|||
48892788|NCT00307684|157443632|FG001|Open Label Phase|Lack of Efficacy|0|||
48892789|NCT00307684|157443633|FG002|Open Label Phase|Lack of Efficacy|3|||
48892790|NCT00307684|157443631|FG000|Open Label Phase|Adverse Event|0|||
48892791|NCT00307684|157443632|FG001|Open Label Phase|Adverse Event|0|||
48892792|NCT00307684|157443633|FG002|Open Label Phase|Adverse Event|16|||
48892793|NCT00307684|157443631|FG000|Open Label Phase|Withdrawal by Subject|0|||
48892794|NCT00307684|157443632|FG001|Open Label Phase|Withdrawal by Subject|0|||
48892795|NCT00307684|157443633|FG002|Open Label Phase|Withdrawal by Subject|15|||
48892796|NCT00307684|157443631|FG000|Open Label Phase|Lost to Follow-up|0|||
48892797|NCT00307684|157443632|FG001|Open Label Phase|Lost to Follow-up|0|||
48892798|NCT00307684|157443633|FG002|Open Label Phase|Lost to Follow-up|11|||
48892799|NCT00307684|157443631|FG000|Open Label Phase|non compliance|0|||
48892800|NCT00307684|157443632|FG001|Open Label Phase|non compliance|0|||
48892801|NCT00307684|157443633|FG002|Open Label Phase|non compliance|5|||
48892802|NCT00307684|157443631|FG000|Open Label Phase|other|0|||
48892803|NCT00307684|157443632|FG001|Open Label Phase|other|0|||
48892804|NCT00307684|157443633|FG002|Open Label Phase|other|6|||
48892805|NCT00307684|157443631|FG000|Double Blind Phase|Lack of Efficacy|2|||
48892806|NCT00307684|157443632|FG001|Double Blind Phase|Lack of Efficacy|5|||
48892807|NCT00307684|157443633|FG002|Double Blind Phase|Lack of Efficacy|0|||
48892808|NCT01699503|157443634|FG000|Overall Study|Death|31|||
48892809|NCT01699503|157443635|FG001|Overall Study|Death|40|||
48892810|NCT01699503|157443634|FG000|Overall Study|Withdrawal by Subject|65|||
48892811|NCT01699503|157443635|FG001|Overall Study|Withdrawal by Subject|57|||
48892812|NCT01699503|157443634|FG000|Overall Study|Lost to Follow-up|121|||
48892813|NCT01699503|157443635|FG001|Overall Study|Lost to Follow-up|117|||
48892814|NCT01699503|157443634|FG000|Overall Study|Excluded due to quality|783|||
48892815|NCT01699503|157443635|FG001|Overall Study|Excluded due to quality|791|||
48892816|NCT02580305|157443636|FG000|Overall Study|Adverse Event|15|||
48892817|NCT02580305|157443637|FG001|Overall Study|Adverse Event|19|||
48892818|NCT02580305|157443638|FG002|Overall Study|Adverse Event|10|||
48892819|NCT02580305|157443636|FG000|Overall Study|Lack of Efficacy|5|||
48892820|NCT02580305|157443637|FG001|Overall Study|Lack of Efficacy|0|||
48892821|NCT02580305|157443638|FG002|Overall Study|Lack of Efficacy|2|||
48892822|NCT02580305|157443636|FG000|Overall Study|Protocol Violation|4|||
48892823|NCT02580305|157443637|FG001|Overall Study|Protocol Violation|9|||
48892824|NCT02580305|157443638|FG002|Overall Study|Protocol Violation|6|||
48892825|NCT02580305|157443636|FG000|Overall Study|Lost to Follow-up|4|||
48892826|NCT02580305|157443637|FG001|Overall Study|Lost to Follow-up|4|||
48892827|NCT02580305|157443638|FG002|Overall Study|Lost to Follow-up|2|||
48892828|NCT02580305|157443636|FG000|Overall Study|Withdrawal by Subject|11|||
48892829|NCT02580305|157443637|FG001|Overall Study|Withdrawal by Subject|9|||
48892830|NCT02580305|157443638|FG002|Overall Study|Withdrawal by Subject|7|||
48892831|NCT02580305|157443636|FG000|Overall Study|Randomized in error and never treated|4|||
48892832|NCT02580305|157443637|FG001|Overall Study|Randomized in error and never treated|8|||
48984129|NCT01693562|157774142|FG021|Escalation Phase|Lost to Follow-up|0|||
48984130|NCT01693562|157774143|FG022|Escalation Phase|Lost to Follow-up|0|||
48984131|NCT01693562|157774121|FG000|Escalation Phase|Other|0|||
48892833|NCT02580305|157443638|FG002|Overall Study|Randomized in error and never treated|5|||
48892834|NCT00006011|157443641|FG000|Overall Study|Disease progression|13|||
48892835|NCT00006011|157443642|FG001|Overall Study|Disease progression|6|||
48892836|NCT00006011|157443643|FG002|Overall Study|Disease progression|26|||
48892837|NCT00006011|157443641|FG000|Overall Study|Refused further treatment|15|||
48892838|NCT00006011|157443642|FG001|Overall Study|Refused further treatment|13|||
48892839|NCT00006011|157443643|FG002|Overall Study|Refused further treatment|26|||
48892840|NCT00006011|157443641|FG000|Overall Study|Adverse Event|15|||
48892841|NCT00006011|157443642|FG001|Overall Study|Adverse Event|39|||
48892842|NCT00006011|157443643|FG002|Overall Study|Adverse Event|5|||
48892843|NCT00006011|157443641|FG000|Overall Study|Death|0|||
48892844|NCT00006011|157443642|FG001|Overall Study|Death|1|||
48892845|NCT00006011|157443643|FG002|Overall Study|Death|2|||
48892846|NCT00006011|157443641|FG000|Overall Study|Other|4|||
48892847|NCT00006011|157443642|FG001|Overall Study|Other|2|||
48892848|NCT00006011|157443643|FG002|Overall Study|Other|5|||
48892849|NCT00006011|157443641|FG000|Overall Study|Ineligible|18|||
48892850|NCT00006011|157443642|FG001|Overall Study|Ineligible|16|||
48892851|NCT00006011|157443643|FG002|Overall Study|Ineligible|9|||
48892852|NCT01888900|157443646|FG000|Overall Study|failed treatment|0|||
48892853|NCT01888900|157443647|FG001|Overall Study|failed treatment|2|||
48892854|NCT01639560|157443648|FG000|Overall Study|Withdrawal by Subject|9|||
48892855|NCT01639560|157443649|FG001|Overall Study|Withdrawal by Subject|14|||
48892856|NCT01639560|157443648|FG000|Overall Study|Lack of Efficacy|1|||
48892857|NCT01639560|157443649|FG001|Overall Study|Lack of Efficacy|2|||
48892858|NCT01639560|157443648|FG000|Overall Study|Lost to Follow-up|9|||
48892859|NCT01639560|157443649|FG001|Overall Study|Lost to Follow-up|11|||
48892860|NCT01639560|157443648|FG000|Overall Study|Adverse Event|0|||
48892861|NCT01639560|157443649|FG001|Overall Study|Adverse Event|2|||
48892862|NCT03932812|157443653|FG000|Overall Study|Lost to Follow-up|12|||
48892863|NCT03932812|157443654|FG001|Overall Study|Lost to Follow-up|14|||
48892864|NCT03932812|157443653|FG000|Overall Study|Death of care partner (person living with dementia)|5|||
48892865|NCT03932812|157443654|FG001|Overall Study|Death of care partner (person living with dementia)|1|||
48892866|NCT03292432|157443658|FG000|Overall Study|Lost to Follow-up|11|||
48892867|NCT03292432|157443659|FG001|Overall Study|Lost to Follow-up|8|||
48892868|NCT03292432|157443658|FG000|Overall Study|Death|2|||
48892869|NCT03292432|157443659|FG001|Overall Study|Death|1|||
48892870|NCT03292432|157443658|FG000|Overall Study|Withdrawal by Subject|1|||
48892871|NCT03292432|157443659|FG001|Overall Study|Withdrawal by Subject|2|||
48892872|NCT03292432|157443658|FG000|Overall Study|Site closed before any data collected|1|||
48892873|NCT03292432|157443659|FG001|Overall Study|Site closed before any data collected|0|||
48892874|NCT01844687|157443660|FG000|Visit 1|Protocol Violation|3|||
48892875|NCT01844687|157443660|FG000|Visit 1|Lost to Follow-up|5|||
48892876|NCT01844687|157443660|FG000|Visit 2|Withdrawal by Subject|1|||
48892877|NCT01844687|157443660|FG000|Visit 2|Protocol Violation|1|||
48892878|NCT01844687|157443660|FG000|Visit 3|Lost to Follow-up|1|||
48892879|NCT01844687|157443660|FG000|Visit 3|Withdrawal by Subject|3|||
48892880|NCT01844687|157443660|FG000|Visit 3|child care problems|1|||
48892881|NCT01844687|157443660|FG000|Visit 4|Pregnancy|1|||
48892882|NCT01844687|157443660|FG000|Visit 4|Lost to Follow-up|1|||
48892883|NCT01844687|157443660|FG000|Visit 4|Withdrawal by Subject|2|||
48892884|NCT01859988|157443661|FG000|Overall Study|Withdrawal by Subject|6|||
48892885|NCT01859988|157443662|FG001|Overall Study|Withdrawal by Subject|3|||
48892886|NCT01859988|157443663|FG002|Overall Study|Withdrawal by Subject|4|||
48892887|NCT01859988|157443664|FG003|Overall Study|Withdrawal by Subject|3|||
48892888|NCT01859988|157443665|FG004|Overall Study|Withdrawal by Subject|2|||
48892889|NCT01859988|157443666|FG005|Overall Study|Withdrawal by Subject|2|||
48892890|NCT01859988|157443661|FG000|Overall Study|Lack of Efficacy|1|||
48892891|NCT01859988|157443662|FG001|Overall Study|Lack of Efficacy|1|||
48892892|NCT01859988|157443663|FG002|Overall Study|Lack of Efficacy|5|||
48892893|NCT01859988|157443664|FG003|Overall Study|Lack of Efficacy|0|||
49037951|NCT00045162|157973233|FG001|Overall Study|Withdrawal by Subject|3|||
49037952|NCT00045162|157973232|FG000|Overall Study|Other|21|||
48892894|NCT01859988|157443665|FG004|Overall Study|Lack of Efficacy|7|||
48892895|NCT01859988|157443666|FG005|Overall Study|Lack of Efficacy|9|||
48892896|NCT01859988|157443661|FG000|Overall Study|Physician Decision|1|||
48892897|NCT01859988|157443662|FG001|Overall Study|Physician Decision|3|||
48892898|NCT01859988|157443663|FG002|Overall Study|Physician Decision|1|||
48892899|NCT01859988|157443664|FG003|Overall Study|Physician Decision|3|||
48892900|NCT01859988|157443665|FG004|Overall Study|Physician Decision|4|||
48892901|NCT01859988|157443666|FG005|Overall Study|Physician Decision|1|||
48892902|NCT01859988|157443661|FG000|Overall Study|Adverse Event|2|||
48892903|NCT01859988|157443662|FG001|Overall Study|Adverse Event|1|||
48892904|NCT01859988|157443663|FG002|Overall Study|Adverse Event|3|||
49037953|NCT00045162|157973233|FG001|Overall Study|Other|16|||
48892905|NCT01859988|157443664|FG003|Overall Study|Adverse Event|1|||
48892906|NCT01859988|157443665|FG004|Overall Study|Adverse Event|2|||
48892907|NCT01859988|157443666|FG005|Overall Study|Adverse Event|2|||
48892908|NCT01859988|157443661|FG000|Overall Study|Lost to Follow-up|1|||
48892909|NCT01859988|157443662|FG001|Overall Study|Lost to Follow-up|2|||
48892910|NCT01859988|157443663|FG002|Overall Study|Lost to Follow-up|3|||
49037954|NCT00421304|157973240|FG000|Overall Study|Lost to Follow-up|5|||
49037955|NCT00421304|157973241|FG001|Overall Study|Lost to Follow-up|2|||
49037956|NCT00421304|157973242|FG002|Overall Study|Lost to Follow-up|5|||
49037957|NCT00421304|157973240|FG000|Overall Study|Withdrawal by Subject|2|||
49037958|NCT00421304|157973241|FG001|Overall Study|Withdrawal by Subject|2|||
49037959|NCT00421304|157973242|FG002|Overall Study|Withdrawal by Subject|2|||
49037960|NCT00421304|157973240|FG000|Overall Study|Mistakenly randomized, chose not to participate in study|1|||
49037961|NCT00421304|157973241|FG001|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
49037962|NCT00421304|157973242|FG002|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
49037963|NCT00421304|157973240|FG000|Overall Study|Did not attend Day 360 visit|0|||
49037964|NCT00421304|157973241|FG001|Overall Study|Did not attend Day 360 visit|0|||
49037965|NCT00421304|157973242|FG002|Overall Study|Did not attend Day 360 visit|1|||
49037966|NCT01539239|157973247|FG000|Overall Study|Death|5|||
49037967|NCT01539239|157973248|FG001|Overall Study|Death|5|||
49037968|NCT01539239|157973247|FG000|Overall Study|Lost to Follow-up|7|||
49037969|NCT01539239|157973248|FG001|Overall Study|Lost to Follow-up|12|||
49037970|NCT00070291|157974535|FG000|Step 1|Withdrawal by Subject|1|||
49037971|NCT00070291|157974535|FG000|Step 1|Adverse Event|1|||
49037972|NCT00070291|157974535|FG000|Step 2|Adverse Event|1|||
49037973|NCT00798603|157974536|FG000|Overall Study|Still on treatment as of 11/6/2012|1|||
49037974|NCT00798603|157974536|FG000|Overall Study|Withdrawal by Subject|10|||
49037975|NCT00798603|157974536|FG000|Overall Study|Adverse Event|22|||
49037976|NCT00798603|157974536|FG000|Overall Study|Physician Decision|1|||
49037977|NCT00798603|157974536|FG000|Overall Study|Lack of insurance coverage|1|||
48892911|NCT01859988|157443664|FG003|Overall Study|Lost to Follow-up|0|||
48892912|NCT01859988|157443665|FG004|Overall Study|Lost to Follow-up|3|||
48892913|NCT01859988|157443666|FG005|Overall Study|Lost to Follow-up|2|||
48892914|NCT01859988|157443661|FG000|Overall Study|Protocol Violation|0|||
48892915|NCT01859988|157443662|FG001|Overall Study|Protocol Violation|0|||
48892916|NCT01859988|157443663|FG002|Overall Study|Protocol Violation|1|||
48892917|NCT01859988|157443664|FG003|Overall Study|Protocol Violation|0|||
48892918|NCT01859988|157443665|FG004|Overall Study|Protocol Violation|0|||
48892919|NCT01859988|157443666|FG005|Overall Study|Protocol Violation|0|||
48892920|NCT01859988|157443661|FG000|Overall Study|Other than specified above|0|||
48892921|NCT01859988|157443662|FG001|Overall Study|Other than specified above|2|||
48892922|NCT01859988|157443663|FG002|Overall Study|Other than specified above|11|||
48892923|NCT01859988|157443664|FG003|Overall Study|Other than specified above|3|||
48892924|NCT01859988|157443665|FG004|Overall Study|Other than specified above|5|||
48892925|NCT01859988|157443666|FG005|Overall Study|Other than specified above|3|||
48892926|NCT01871805|157443670|FG000|Phase I|Death|7|||
48892927|NCT01871805|157443671|FG001|Phase I|Death|4|||
48892928|NCT01871805|157443672|FG002|Phase I|Death|6|||
48892929|NCT01871805|157443673|FG003|Phase I|Death|2|||
48892930|NCT01871805|157443674|FG004|Phase I|Death|9|||
48892931|NCT01871805|157443675|FG005|Phase I|Death|0|||
48892932|NCT01871805|157443670|FG000|Phase I|Alive in Survival Follow-up|0|||
48892933|NCT01871805|157443671|FG001|Phase I|Alive in Survival Follow-up|2|||
48892934|NCT01871805|157443672|FG002|Phase I|Alive in Survival Follow-up|4|||
48892935|NCT01871805|157443673|FG003|Phase I|Alive in Survival Follow-up|5|||
48892936|NCT01871805|157443674|FG004|Phase I|Alive in Survival Follow-up|4|||
48892937|NCT01871805|157443675|FG005|Phase I|Alive in Survival Follow-up|0|||
48892938|NCT01871805|157443670|FG000|Phase I|Lost to Follow-up|0|||
48892939|NCT01871805|157443671|FG001|Phase I|Lost to Follow-up|1|||
48892940|NCT01871805|157443672|FG002|Phase I|Lost to Follow-up|3|||
48892941|NCT01871805|157443673|FG003|Phase I|Lost to Follow-up|0|||
48892942|NCT01871805|157443674|FG004|Phase I|Lost to Follow-up|0|||
48892943|NCT01871805|157443675|FG005|Phase I|Lost to Follow-up|0|||
48892944|NCT01871805|157443670|FG000|Phase II|Death|0|||
48892945|NCT01871805|157443671|FG001|Phase II|Death|0|||
48892946|NCT01871805|157443672|FG002|Phase II|Death|0|||
48892947|NCT01871805|157443673|FG003|Phase II|Death|0|||
48892948|NCT01871805|157443674|FG004|Phase II|Death|0|||
48892949|NCT01871805|157443675|FG005|Phase II|Death|45|||
48892950|NCT01871805|157443670|FG000|Phase II|Alive in Survival Follow-up|0|||
48892951|NCT01871805|157443671|FG001|Phase II|Alive in Survival Follow-up|0|||
48892952|NCT01871805|157443672|FG002|Phase II|Alive in Survival Follow-up|0|||
48892953|NCT01871805|157443673|FG003|Phase II|Alive in Survival Follow-up|0|||
48892954|NCT01871805|157443674|FG004|Phase II|Alive in Survival Follow-up|0|||
48892955|NCT01871805|157443675|FG005|Phase II|Alive in Survival Follow-up|29|||
48892956|NCT01871805|157443670|FG000|Phase II|Lost to Follow-up|0|||
48892957|NCT01871805|157443671|FG001|Phase II|Lost to Follow-up|0|||
48892958|NCT01871805|157443672|FG002|Phase II|Lost to Follow-up|0|||
48892959|NCT01871805|157443673|FG003|Phase II|Lost to Follow-up|0|||
48892960|NCT01871805|157443674|FG004|Phase II|Lost to Follow-up|0|||
48892961|NCT01871805|157443675|FG005|Phase II|Lost to Follow-up|13|||
48892962|NCT00564889|157443676|FG000|Overall Study|Death|7|||
48892963|NCT00564889|157443676|FG000|Overall Study|Adverse Event|12|||
48892964|NCT00564889|157443676|FG000|Overall Study|Alternative treatment|3|||
48892965|NCT00564889|157443676|FG000|Overall Study|Disease progression|3|||
48892966|NCT00564889|157443676|FG000|Overall Study|Other, not specified|4|||
48892967|NCT04510090|157443677|FG000|FE-HS|Withdrawal by Subject|0|||
48892968|NCT04510090|157443678|FG001|FE-HS|Withdrawal by Subject|0|||
48892969|NCT04510090|157443679|FG002|FE-HS|Withdrawal by Subject|0|||
48892970|NCT04510090|157443680|FG003|FE-HS|Withdrawal by Subject|0|||
48892971|NCT04510090|157443681|FG004|FE-HS|Withdrawal by Subject|1|||
48892972|NCT04510090|157443682|FG005|FE-HS|Withdrawal by Subject|0|||
48892973|NCT04510090|157443683|FG006|FE-HS|Withdrawal by Subject|0|||
48892974|NCT04510090|157443684|FG007|FE-HS|Withdrawal by Subject|0|||
48892975|NCT03412747|157443685|FG000|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
49037978|NCT00835705|157974537|FG000|First Intervention|Difficulty with vein|1|||
49037979|NCT00835705|157974538|FG001|First Intervention|Difficulty with vein|0|||
49037980|NCT00835705|157974537|FG000|Second Intervention|Difficulty with vein|1|||
49037981|NCT00835705|157974538|FG001|Second Intervention|Difficulty with vein|0|||
49037982|NCT04299087|157974539|FG000|Overall Study|Lost to Follow-up|2|||
49037983|NCT04299087|157974540|FG001|Overall Study|Lost to Follow-up|1|||
49037984|NCT00594035|157974541|FG000|Overall Study|Lost to Follow-up|1|||
49037985|NCT00594035|157974542|FG001|Overall Study|Lost to Follow-up|1|||
49037986|NCT00594035|157974541|FG000|Overall Study|Withdrawal by Subject|1|||
49037987|NCT00594035|157974542|FG001|Overall Study|Withdrawal by Subject|0|||
48892976|NCT03412747|157443686|FG001|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
48892977|NCT03412747|157443687|FG002|Initial Treatment Period: Wk0-Wk16|Adverse Event|3|||
48892978|NCT03412747|157443685|FG000|Initial Treatment Period: Wk0-Wk16|Death|0|||
48892979|NCT03412747|157443686|FG001|Initial Treatment Period: Wk0-Wk16|Death|0|||
48892980|NCT03412747|157443687|FG002|Initial Treatment Period: Wk0-Wk16|Death|1|||
48892981|NCT03412747|157443685|FG000|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
48892982|NCT03412747|157443686|FG001|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
48892983|NCT03412747|157443687|FG002|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|1|||
48892984|NCT03412747|157443685|FG000|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
48892985|NCT03412747|157443686|FG001|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
48892986|NCT03412747|157443687|FG002|Initial Treatment Period: Wk0-Wk16|Protocol Violation|2|||
48892987|NCT03412747|157443685|FG000|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|0|||
48892988|NCT03412747|157443686|FG001|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|2|||
48892989|NCT03412747|157443687|FG002|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|1|||
48892990|NCT03412747|157443685|FG000|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|4|||
48892991|NCT03412747|157443686|FG001|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
48892992|NCT03412747|157443687|FG002|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
48892993|NCT03412747|157443685|FG000|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|1|||
48892994|NCT03412747|157443686|FG001|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
48892995|NCT03412747|157443687|FG002|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
48892996|NCT03412747|157443685|FG000|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|3|||
48892997|NCT03412747|157443686|FG001|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|1|||
48892998|NCT03412747|157443687|FG002|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|0|||
48892999|NCT03412747|157443685|FG000|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|1|||
48893000|NCT03412747|157443686|FG001|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
48893001|NCT03412747|157443687|FG002|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
48893002|NCT03412747|157443685|FG000|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
48893003|NCT03412747|157443686|FG001|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
48893004|NCT03412747|157443687|FG002|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|1|||
48893005|NCT03412747|157443685|FG000|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|1|||
48893006|NCT03412747|157443686|FG001|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
48893007|NCT03412747|157443687|FG002|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
48893008|NCT03412747|157443685|FG000|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|3|||
48893009|NCT03412747|157443686|FG001|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|4|||
48893010|NCT03412747|157443687|FG002|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|6|||
48893011|NCT03412747|157443685|FG000|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|0|||
48893012|NCT03412747|157443686|FG001|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
48893013|NCT03412747|157443687|FG002|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
48893014|NCT03412747|157443685|FG000|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|0|||
48893015|NCT03412747|157443686|FG001|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|2|||
48893016|NCT03412747|157443687|FG002|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|5|||
48893017|NCT03412747|157443685|FG000|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|3|||
48893018|NCT03412747|157443686|FG001|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|1|||
48893019|NCT03412747|157443687|FG002|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|4|||
49037988|NCT00594035|157974541|FG000|Overall Study|Subject transferred to nursing home|0|||
49037989|NCT00594035|157974542|FG001|Overall Study|Subject transferred to nursing home|1|||
49037990|NCT00594035|157974541|FG000|Overall Study|Subject couldn't return due to job|0|||
48893020|NCT03412747|157443685|FG000|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
48893021|NCT03412747|157443686|FG001|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|1|||
48893022|NCT03412747|157443687|FG002|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
49037991|NCT00594035|157974542|FG001|Overall Study|Subject couldn't return due to job|1|||
49037992|NCT01116739|157974549|FG000|Overall Study|Child had 2 years of HS|110|||
49037993|NCT01116739|157974550|FG001|Overall Study|Child had 2 years of HS|128|||
49037994|NCT01116739|157974549|FG000|Overall Study|Withdrawal by Subject|6|||
49037995|NCT01116739|157974550|FG001|Overall Study|Withdrawal by Subject|0|||
49037996|NCT01116739|157974549|FG000|Overall Study|child too young|2|||
49037997|NCT01116739|157974550|FG001|Overall Study|child too young|6|||
49037998|NCT01116739|157974549|FG000|Overall Study|child not enrolled in head start|10|||
49037999|NCT01116739|157974550|FG001|Overall Study|child not enrolled in head start|2|||
49038000|NCT01116739|157974549|FG000|Overall Study|enrolled caregiver not legal guardian|2|||
49038001|NCT01116739|157974550|FG001|Overall Study|enrolled caregiver not legal guardian|0|||
49038002|NCT00470704|157974555|FG000|Overall Study|Withdrawal by Subject|4|||
49038003|NCT00470704|157974556|FG001|Overall Study|Withdrawal by Subject|3|||
49038004|NCT00470704|157974555|FG000|Overall Study|Relapse/Progression|37|||
49038005|NCT00470704|157974556|FG001|Overall Study|Relapse/Progression|42|||
49038006|NCT00470704|157974555|FG000|Overall Study|toxicity|0|||
49038007|NCT00470704|157974556|FG001|Overall Study|toxicity|1|||
49038008|NCT03502811|157974559|FG000|Overall Study|Death|157|||
49038009|NCT03502811|157974559|FG000|Overall Study|Withdrawal by Subject|105|||
49038010|NCT03502811|157974559|FG000|Overall Study|Lost to Follow-up|26|||
49038011|NCT03502811|157974559|FG000|Overall Study|No Visits (Missed)|31|||
49038012|NCT01735994|157974560|FG000|Overall Study|Withdrawal by Subject|6|||
49038013|NCT01735994|157974561|FG001|Overall Study|Withdrawal by Subject|4|||
49038014|NCT01735994|157974560|FG000|Overall Study|Injury|2|||
49038015|NCT01735994|157974561|FG001|Overall Study|Injury|0|||
49038016|NCT01735994|157974560|FG000|Overall Study|Kicked off team|5|||
49038017|NCT01735994|157974561|FG001|Overall Study|Kicked off team|0|||
49038018|NCT01735994|157974560|FG000|Overall Study|Lost to Follow-up|50|||
49038019|NCT01735994|157974561|FG001|Overall Study|Lost to Follow-up|62|||
49038020|NCT03123094|157974562|FG000|Overall Study|Withdrawal by Subject|0|||
49038021|NCT03123094|157974563|FG001|Overall Study|Withdrawal by Subject|2|||
49038022|NCT03123094|157974564|FG002|Overall Study|Withdrawal by Subject|1|||
49038023|NCT03123094|157974565|FG003|Overall Study|Withdrawal by Subject|0|||
49038024|NCT03123094|157974566|FG004|Overall Study|Withdrawal by Subject|1|||
49038025|NCT05239195|157974569|FG000|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|2|||
49038026|NCT05239195|157974570|FG001|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|1|||
49038027|NCT04994535|157974571|FG000|Overall Study|Lost to Follow-up|7|||
49038028|NCT04994535|157974572|FG001|Overall Study|Lost to Follow-up|7|||
49038029|NCT04994535|157974571|FG000|Overall Study|Withdrawal by Subject|10|||
49038030|NCT04994535|157974572|FG001|Overall Study|Withdrawal by Subject|7|||
49038031|NCT04994535|157974571|FG000|Overall Study|Other|1|||
49038032|NCT04994535|157974572|FG001|Overall Study|Other|1|||
49038033|NCT01158118|157974573|FG000|Overall Study|Screen failure|1|||
48893023|NCT02075073|157443688|FG000|Overall Study|Withdrawal by Subject|0|||
48893024|NCT02075073|157443689|FG001|Overall Study|Withdrawal by Subject|1|||
48893025|NCT02075073|157443690|FG002|Overall Study|Withdrawal by Subject|0|||
48893026|NCT00958841|157443691|FG000|Overall Study|Abnormal laboratory value(s)|1|||
48893027|NCT00958841|157443691|FG000|Overall Study|Abnormal test procedure result(s)|3|||
48893028|NCT00958841|157443691|FG000|Overall Study|Administrative problems|1|||
48893029|NCT00958841|157443691|FG000|Overall Study|Adverse Event|8|||
48893030|NCT00958841|157443691|FG000|Overall Study|New cancer therapy|5|||
48893031|NCT00958841|157443691|FG000|Overall Study|Withdrawal by Subject|1|||
48893032|NCT00958841|157443691|FG000|Overall Study|Unsatisfactory therapeutic effect|22|||
48893033|NCT00958841|157443691|FG000|Overall Study|Completed M6/did not enter extension|27|||
48893034|NCT00958841|157443691|FG000|Overall Study|Discontinued prior to M*|28|||
48893035|NCT01125514|157443695|FG000|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1|||
48893036|NCT01125514|157443695|FG000|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1|||
48893037|NCT01125514|157443695|FG000|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3|||
48893038|NCT01125514|157443695|FG000|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2|||
48893039|NCT01125514|157443695|FG000|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1|||
48893040|NCT01125514|157443695|FG000|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1|||
48893041|NCT00858364|157443696|FG000|Overall Study|Administrative Decision|3|||
48893042|NCT00858364|157443697|FG001|Overall Study|Administrative Decision|2|||
48893043|NCT00858364|157443696|FG000|Overall Study|Adverse Event|5|||
49038034|NCT01158118|157974574|FG001|Overall Study|Screen failure|0|||
49038035|NCT01158118|157974573|FG000|Overall Study|Donor match was a screen failure|0|||
49038036|NCT01158118|157974574|FG001|Overall Study|Donor match was a screen failure|1|||
49038037|NCT01158118|157974573|FG000|Overall Study|Suffered stroke prior to transplant|0|||
49038038|NCT01158118|157974574|FG001|Overall Study|Suffered stroke prior to transplant|1|||
49038039|NCT01158118|157974573|FG000|Overall Study|Death|0|||
48893044|NCT00858364|157443697|FG001|Overall Study|Adverse Event|2|||
48893045|NCT00858364|157443696|FG000|Overall Study|Withdrawal by Subject|44|||
48893046|NCT00858364|157443697|FG001|Overall Study|Withdrawal by Subject|118|||
48893047|NCT00858364|157443696|FG000|Overall Study|Ineligibility Determined|1|||
48893048|NCT00858364|157443697|FG001|Overall Study|Ineligibility Determined|10|||
48893049|NCT00858364|157443696|FG000|Overall Study|Lost to Follow-up|24|||
48893050|NCT00858364|157443697|FG001|Overall Study|Lost to Follow-up|54|||
48893051|NCT00858364|157443696|FG000|Overall Study|Noncompliance|3|||
48893052|NCT00858364|157443697|FG001|Overall Study|Noncompliance|4|||
48893053|NCT00858364|157443696|FG000|Overall Study|Protocol Deviation|0|||
48893054|NCT00858364|157443697|FG001|Overall Study|Protocol Deviation|2|||
48893055|NCT00858364|157443696|FG000|Overall Study|Other|9|||
48893056|NCT00858364|157443697|FG001|Overall Study|Other|17|||
48893057|NCT00858364|157443696|FG000|Overall Study|Missing|1|||
48893058|NCT00858364|157443697|FG001|Overall Study|Missing|1|||
48893059|NCT00858364|157443696|FG000|Overall Study|Still on-study|114|||
48893060|NCT00858364|157443697|FG001|Overall Study|Still on-study|247|||
48893061|NCT03980808|157443698|FG000|Overall Study|Lost to Follow-up|2|||
48893062|NCT03980808|157443699|FG001|Overall Study|Lost to Follow-up|2|||
48893063|NCT01806623|157443701|FG000|Overall Study|Withdrawal by Subject|1|||
48893064|NCT01806623|157443701|FG000|Overall Study|Adverse Event|1|||
48893065|NCT01806623|157443701|FG000|Overall Study|Did not meet the inclusion criteria|56|||
48893066|NCT01451827|157443703|FG000|Overall Study|Adverse Event|2|||
48893067|NCT01451827|157443704|FG001|Overall Study|Adverse Event|0|||
48893068|NCT01451827|157443705|FG002|Overall Study|Adverse Event|1|||
48893069|NCT01451827|157443706|FG003|Overall Study|Adverse Event|1|||
48893070|NCT01451827|157443703|FG000|Overall Study|Protocol deviation|1|||
48893071|NCT01451827|157443704|FG001|Overall Study|Protocol deviation|0|||
48893072|NCT01451827|157443705|FG002|Overall Study|Protocol deviation|0|||
48893073|NCT01451827|157443706|FG003|Overall Study|Protocol deviation|0|||
48893074|NCT01451827|157443703|FG000|Overall Study|Lost to Follow-up|0|||
48893075|NCT01451827|157443704|FG001|Overall Study|Lost to Follow-up|3|||
48893076|NCT01451827|157443705|FG002|Overall Study|Lost to Follow-up|0|||
48893077|NCT01451827|157443706|FG003|Overall Study|Lost to Follow-up|2|||
48893078|NCT01451827|157443703|FG000|Overall Study|Participant met withdrawal criteria|0|||
48893079|NCT01451827|157443704|FG001|Overall Study|Participant met withdrawal criteria|2|||
48893080|NCT01451827|157443705|FG002|Overall Study|Participant met withdrawal criteria|0|||
48893081|NCT01451827|157443706|FG003|Overall Study|Participant met withdrawal criteria|0|||
48893082|NCT01451827|157443703|FG000|Overall Study|Withdrawal by Subject|0|||
48893083|NCT01451827|157443704|FG001|Overall Study|Withdrawal by Subject|0|||
48893084|NCT01451827|157443705|FG002|Overall Study|Withdrawal by Subject|1|||
48893085|NCT01451827|157443706|FG003|Overall Study|Withdrawal by Subject|1|||
48893086|NCT01964924|157443707|FG000|Trametinib Monotherapy|Progression|19|||
48893087|NCT01964924|157443708|FG001|Trametinib Monotherapy|Progression|0|||
48893088|NCT02601300|157443710|FG000|Induction Phase|Lack of Efficacy|2|||
48893089|NCT02601300|157443710|FG000|Induction Phase|Protocol Violation|1|||
48893090|NCT02601300|157443710|FG000|Extension Phase|Withdrawal by Subject|3|||
48893091|NCT02601300|157443710|FG000|Extension Phase|Adverse Event|4|||
48893092|NCT02601300|157443710|FG000|Extension Phase|Lack of Efficacy|10|||
48893093|NCT02232243|157443712|FG000|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
48893094|NCT02232243|157443713|FG001|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1|||
48893095|NCT02232243|157443714|FG002|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
48893096|NCT01679405|157443720|FG000|Overall Study|Death|2|||
48893097|NCT01679405|157443721|FG001|Overall Study|Death|5|||
48893098|NCT00658788|157443722|FG000|Overall Study|Adverse Event|11|||
48893099|NCT00658788|157443722|FG000|Overall Study|Withdrawal by Subject|13|||
48893100|NCT00658788|157443722|FG000|Overall Study|Lost to Follow-up|18|||
48893101|NCT00658788|157443722|FG000|Overall Study|Treatment Discontinuation|32|||
48893102|NCT00653523|157443723|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
48893103|NCT00653523|157443723|FG000|Overall Study|Elevated creatine phosphokinase (2)|1|||
48893104|NCT00653523|157443723|FG000|Overall Study|Adverse Event|7|||
48893105|NCT00653523|157443723|FG000|Overall Study|Withdrawal by Subject|6|||
48893106|NCT00653523|157443723|FG000|Overall Study|Elevated alanine aminotransferase (3)|2|||
48893107|NCT00653523|157443723|FG000|Overall Study|Adverse reaction did not improve (4)|1|||
48893108|NCT00529958|157443724|FG000|2-Year Follow-up|Lost to Follow-up|1|||
48893109|NCT00529958|157443725|FG001|2-Year Follow-up|Lost to Follow-up|2|||
48893110|NCT00529958|157443726|FG002|2-Year Follow-up|Lost to Follow-up|2|||
48893111|NCT00529958|157443724|FG000|2-Year Follow-up|Withdrawal by Subject|3|||
48893112|NCT00529958|157443725|FG001|2-Year Follow-up|Withdrawal by Subject|0|||
48893113|NCT00529958|157443726|FG002|2-Year Follow-up|Withdrawal by Subject|0|||
48893114|NCT00529958|157443724|FG000|5-Year Follow-up|Lost to Follow-up|2|||
48893115|NCT00529958|157443725|FG001|5-Year Follow-up|Lost to Follow-up|3|||
48893116|NCT00529958|157443726|FG002|5-Year Follow-up|Lost to Follow-up|1|||
48893117|NCT00529958|157443724|FG000|5-Year Follow-up|Withdrawal by Subject|1|||
48893118|NCT00529958|157443725|FG001|5-Year Follow-up|Withdrawal by Subject|0|||
48893119|NCT00529958|157443726|FG002|5-Year Follow-up|Withdrawal by Subject|0|||
48893120|NCT04227704|157443727|FG000|Overall Study|due to anesthesia being changed to general anesthesia|0|||
48893121|NCT04227704|157443728|FG001|Overall Study|due to anesthesia being changed to general anesthesia|1|||
48893122|NCT04227704|157443729|FG002|Overall Study|due to anesthesia being changed to general anesthesia|0|||
48893123|NCT04227704|157443727|FG000|Overall Study|due to C/S being cancelled|1|||
48893124|NCT04227704|157443728|FG001|Overall Study|due to C/S being cancelled|0|||
49038040|NCT01158118|157974574|FG001|Overall Study|Death|1|||
49038041|NCT03552484|157974577|FG000|Overall Study|Death|6|||
49038042|NCT03552484|157974578|FG001|Overall Study|Death|4|||
49038043|NCT03552484|157974577|FG000|Overall Study|Lost to Follow-up|0|||
49038044|NCT03552484|157974578|FG001|Overall Study|Lost to Follow-up|16|||
49038045|NCT00604162|157974579|FG000|Overall Study|Physician Decision|3|||
49038046|NCT00604162|157974579|FG000|Overall Study|Withdrawal by Subject|1|||
48893125|NCT04227704|157443729|FG002|Overall Study|due to C/S being cancelled|0|||
48893126|NCT03319849|157443736|FG000|Overall Study|Adverse Event|1|||
48893127|NCT03319849|157443737|FG001|Overall Study|Adverse Event|0|||
49038047|NCT03406156|157974588|FG000|Overall Study|Death|9|||
49038048|NCT03406156|157974589|FG001|Overall Study|Death|3|||
49038049|NCT03406156|157974588|FG000|Overall Study|Withdrawal by Subject|1|||
49038050|NCT03406156|157974589|FG001|Overall Study|Withdrawal by Subject|2|||
49038051|NCT03406156|157974588|FG000|Overall Study|COVID-19 infection|1|||
49038052|NCT03406156|157974589|FG001|Overall Study|COVID-19 infection|0|||
49038053|NCT03406156|157974588|FG000|Overall Study|Non-compliance with study procedures|1|||
49038054|NCT03406156|157974589|FG001|Overall Study|Non-compliance with study procedures|1|||
49038055|NCT03406156|157974588|FG000|Overall Study|Lost to Follow-up|0|||
48893128|NCT03319849|157443736|FG000|Overall Study|Physician Decision|0|||
48893129|NCT03319849|157443737|FG001|Overall Study|Physician Decision|1|||
48893130|NCT03319849|157443736|FG000|Overall Study|Withdrawal by Subject|0|||
48893131|NCT03319849|157443737|FG001|Overall Study|Withdrawal by Subject|1|||
48893132|NCT03319849|157443736|FG000|Overall Study|COVID-19|0|||
48893133|NCT03319849|157443737|FG001|Overall Study|COVID-19|1|||
48893134|NCT03319849|157443736|FG000|Overall Study|Other|1|||
48893135|NCT03319849|157443737|FG001|Overall Study|Other|2|||
48893136|NCT03319849|157443736|FG000|Overall Study|Eligible and did not enroll in amendment|1|||
48893137|NCT03319849|157443737|FG001|Overall Study|Eligible and did not enroll in amendment|3|||
48893138|NCT03319849|157443736|FG000|Overall Study|Lost to Follow-up|0|||
48893139|NCT03319849|157443737|FG001|Overall Study|Lost to Follow-up|2|||
48893140|NCT05559476|157443740|FG000|Overall Study|Adverse Event|2|||
48893141|NCT05559476|157443741|FG001|Overall Study|Adverse Event|0|||
48893142|NCT05559476|157443740|FG000|Overall Study|Lost to Follow-up|13|||
48893143|NCT05559476|157443741|FG001|Overall Study|Lost to Follow-up|12|||
48893144|NCT05559476|157443740|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|8|||
48893145|NCT05559476|157443741|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|14|||
48893146|NCT05559476|157443740|FG000|Overall Study|Other|0|||
48893147|NCT05559476|157443741|FG001|Overall Study|Other|2|||
48893148|NCT01307579|157443742|FG000|Overall Study|Death|3|||
48893149|NCT01307579|157443743|FG001|Overall Study|Death|6|||
48893150|NCT01307579|157443742|FG000|Overall Study|Physician Decision|26|||
48893151|NCT01307579|157443743|FG001|Overall Study|Physician Decision|29|||
48893152|NCT01307579|157443742|FG000|Overall Study|Withdrawal by Subject|7|||
48893153|NCT01307579|157443743|FG001|Overall Study|Withdrawal by Subject|3|||
48893154|NCT01307579|157443742|FG000|Overall Study|Institutional diagnosis of IFD|21|||
48893155|NCT01307579|157443743|FG001|Overall Study|Institutional diagnosis of IFD|36|||
48893156|NCT01307579|157443742|FG000|Overall Study|Begin conditioning for HSCT|42|||
48893157|NCT01307579|157443743|FG001|Overall Study|Begin conditioning for HSCT|44|||
48893158|NCT01307579|157443742|FG000|Overall Study|Refractory or relapsed AML|38|||
48893159|NCT01307579|157443743|FG001|Overall Study|Refractory or relapsed AML|23|||
48893160|NCT01307579|157443742|FG000|Overall Study|Ineligible|3|||
48893161|NCT01307579|157443743|FG001|Overall Study|Ineligible|4|||
48893162|NCT01238900|157444876|FG000|<12 Months Post Stent Removal|Lost to Follow-up|4|||
48893163|NCT01238900|157444876|FG000|<12 Months Post Stent Removal|persistent stricture after stenting|1|||
48893164|NCT02233543|157444877|FG000|Period 1|Withdrawal by Subject|1|||
48893165|NCT02233543|157444878|FG001|Period 1|Withdrawal by Subject|0|||
48893166|NCT02233543|157444877|FG000|Period 1|Participants required other treatment.|2|||
48893167|NCT02233543|157444878|FG001|Period 1|Participants required other treatment.|3|||
48893168|NCT02233543|157444877|FG000|Period 2|Adverse Event|1|||
48893169|NCT02233543|157444878|FG001|Period 2|Adverse Event|0|||
48893170|NCT02233543|157444877|FG000|Period 2|Participant required other treatment.|0|||
48893171|NCT02233543|157444878|FG001|Period 2|Participant required other treatment.|1|||
48893172|NCT02233543|157444877|FG000|Period 2|COPD exacerbation|1|||
49038056|NCT03406156|157974589|FG001|Overall Study|Lost to Follow-up|2|||
49038057|NCT03406156|157974588|FG000|Overall Study|Other, not specified|72|||
49038058|NCT03406156|157974589|FG001|Overall Study|Other, not specified|28|||
49038059|NCT03325881|157974595|FG000|Overall Study|Protocol Violation|0|||
48893173|NCT02233543|157444878|FG001|Period 2|COPD exacerbation|0|||
48893174|NCT00603304|157444879|FG000|Overall Study|Lost to Follow-up|5|||
48893175|NCT00603304|157444880|FG001|Overall Study|Lost to Follow-up|7|||
48893176|NCT00603304|157444879|FG000|Overall Study|Withdrawal by Subject|8|||
49038060|NCT03325881|157974596|FG001|Overall Study|Protocol Violation|1|||
48893177|NCT00603304|157444880|FG001|Overall Study|Withdrawal by Subject|5|||
48893178|NCT00603304|157444879|FG000|Overall Study|Protocol Violation|1|||
48893179|NCT00603304|157444880|FG001|Overall Study|Protocol Violation|0|||
49038061|NCT03325881|157974595|FG000|Overall Study|Withdrawal by Subject|0|||
49038062|NCT03325881|157974596|FG001|Overall Study|Withdrawal by Subject|2|||
49038063|NCT03325881|157974595|FG000|Overall Study|Lack of Efficacy|2|||
49038064|NCT03325881|157974596|FG001|Overall Study|Lack of Efficacy|0|||
49038065|NCT03325881|157974595|FG000|Overall Study|Not treated|1|||
49038066|NCT03325881|157974596|FG001|Overall Study|Not treated|0|||
49038067|NCT03366792|157974597|FG000|Overall Study|Withdrawal by Subject|7|||
49038068|NCT03366792|157974597|FG000|Overall Study|Lost to Follow-up|2|||
49038069|NCT03366792|157974597|FG000|Overall Study|Ineligible (could not reach perinium)|2|||
49038070|NCT03366792|157974597|FG000|Overall Study|Study Closure (interim analysis showed no significant results)|4|||
49038071|NCT02450539|157974598|FG000|Overall Study|Withdrawal by Subject|12|||
49038072|NCT02450539|157974599|FG001|Overall Study|Withdrawal by Subject|6|||
49038073|NCT02450539|157974598|FG000|Overall Study|Lost to Follow-up|4|||
49038074|NCT02450539|157974599|FG001|Overall Study|Lost to Follow-up|1|||
48893180|NCT00603304|157444879|FG000|Overall Study|Adverse Event|4|||
48893181|NCT00603304|157444880|FG001|Overall Study|Adverse Event|2|||
48893182|NCT00603304|157444879|FG000|Overall Study|Unacceptable Treatment Toxicity|5|||
48893183|NCT00603304|157444880|FG001|Overall Study|Unacceptable Treatment Toxicity|8|||
48893184|NCT00603304|157444879|FG000|Overall Study|Crossed Over to Open Label Therapy|3|||
48893185|NCT00603304|157444880|FG001|Overall Study|Crossed Over to Open Label Therapy|3|||
48893186|NCT00603304|157444879|FG000|Overall Study|Exclusionary Medication|2|||
48893187|NCT00603304|157444880|FG001|Overall Study|Exclusionary Medication|3|||
48893188|NCT00603304|157444879|FG000|Overall Study|Non-Compliant|0|||
48893189|NCT00603304|157444880|FG001|Overall Study|Non-Compliant|1|||
48893190|NCT00603304|157444879|FG000|Overall Study|Moved Away|0|||
48893191|NCT00603304|157444880|FG001|Overall Study|Moved Away|2|||
48893192|NCT00603304|157444879|FG000|Overall Study|Other|2|||
48893193|NCT00603304|157444880|FG001|Overall Study|Other|0|||
48893194|NCT00603304|157444879|FG000|Overall Study|Patient Decision|2|||
48893195|NCT00603304|157444880|FG001|Overall Study|Patient Decision|0|||
48893196|NCT03573583|157444881|FG000|Overall Study|Lost to Follow-up|1|||
48893197|NCT03573583|157444882|FG001|Overall Study|Lost to Follow-up|0|||
48893198|NCT03573583|157444881|FG000|Overall Study|Withdrawal by Subject|1|||
48893199|NCT03573583|157444882|FG001|Overall Study|Withdrawal by Subject|1|||
48893200|NCT00574873|157444884|FG000|Overall Study|Withdrawal by Subject|18|||
48893201|NCT00574873|157444885|FG001|Overall Study|Withdrawal by Subject|19|||
48893202|NCT00574873|157444884|FG000|Overall Study|Investigator request|18|||
48893203|NCT00574873|157444885|FG001|Overall Study|Investigator request|8|||
48893204|NCT00574873|157444884|FG000|Overall Study|Death|15|||
48893205|NCT00574873|157444885|FG001|Overall Study|Death|14|||
48893206|NCT00574873|157444884|FG000|Overall Study|Lost to Follow-up|14|||
48893207|NCT00574873|157444885|FG001|Overall Study|Lost to Follow-up|5|||
48893208|NCT00574873|157444884|FG000|Overall Study|Other|40|||
48893209|NCT00574873|157444885|FG001|Overall Study|Other|4|||
48893210|NCT00574873|157444884|FG000|Overall Study|Discontinuation of study by sponsor|5|||
48893211|NCT00574873|157444885|FG001|Overall Study|Discontinuation of study by sponsor|199|||
48893212|NCT00574873|157444884|FG000|Overall Study|Blank, site closed per local regulations|2|||
48893213|NCT00574873|157444885|FG001|Overall Study|Blank, site closed per local regulations|2|||
48893214|NCT00574873|157444884|FG000|Overall Study|Extension Study|126|||
48893215|NCT00574873|157444885|FG001|Overall Study|Extension Study|0|||
48893216|NCT01850446|157444888|FG000|Overall Study|Lack of Efficacy|1|||
48893217|NCT01850446|157444889|FG001|Overall Study|Lack of Efficacy|0|||
48893218|NCT01850446|157444888|FG000|Overall Study|Withdrawal by Subject|4|||
48893219|NCT01850446|157444889|FG001|Overall Study|Withdrawal by Subject|0|||
48893220|NCT01850446|157444888|FG000|Overall Study|Protocol Violation|0|||
48893221|NCT01850446|157444889|FG001|Overall Study|Protocol Violation|2|||
48893222|NCT00591721|157444890|FG000|Overall Study|Withdrawal by Subject|10|||
48893223|NCT00591721|157444891|FG001|Overall Study|Withdrawal by Subject|10|||
48893224|NCT00591721|157444890|FG000|Overall Study|Lost to Follow-up|1|||
48893225|NCT00591721|157444891|FG001|Overall Study|Lost to Follow-up|4|||
48893226|NCT00591721|157444890|FG000|Overall Study|Intervention not received|10|||
48893227|NCT00591721|157444891|FG001|Overall Study|Intervention not received|8|||
48893228|NCT02704754|157444892|FG000|Overall Study|Lost to Follow-up|1|||
48893229|NCT02704754|157444893|FG001|Overall Study|Lost to Follow-up|1|||
49038075|NCT04583423|157974600|FG000|Overall Study|Lost to Follow-up|0|||
48893230|NCT02704754|157444892|FG000|Overall Study|Lack of Efficacy|1|||
48893231|NCT02704754|157444893|FG001|Overall Study|Lack of Efficacy|0|||
48893232|NCT02704754|157444892|FG000|Overall Study|Withdrawal by Subject|1|||
48893233|NCT02704754|157444893|FG001|Overall Study|Withdrawal by Subject|0|||
48893234|NCT03828747|157444895|FG000|Double-Blind Treatment Period|Adverse Event|6|||
48893235|NCT03828747|157444896|FG001|Double-Blind Treatment Period|Adverse Event|6|||
48893236|NCT03828747|157444895|FG000|Double-Blind Treatment Period|Death|1|||
48893237|NCT03828747|157444896|FG001|Double-Blind Treatment Period|Death|1|||
49038076|NCT04583423|157974601|FG001|Overall Study|Lost to Follow-up|1|||
49038077|NCT04583423|157974602|FG002|Overall Study|Lost to Follow-up|0|||
49038078|NCT04583423|157974603|FG003|Overall Study|Lost to Follow-up|2|||
48893238|NCT03828747|157444895|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
48893239|NCT03828747|157444896|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
48893240|NCT03828747|157444895|FG000|Double-Blind Treatment Period|Withdrawal by Subject|17|||
48893241|NCT03828747|157444896|FG001|Double-Blind Treatment Period|Withdrawal by Subject|19|||
48893242|NCT03828747|157444895|FG000|Double-Blind Treatment Period|Physician Decision|1|||
48893243|NCT03828747|157444896|FG001|Double-Blind Treatment Period|Physician Decision|4|||
48893244|NCT03828747|157444895|FG000|Double-Blind Treatment Period|Various reasons|5|||
48893245|NCT03828747|157444896|FG001|Double-Blind Treatment Period|Various reasons|3|||
48893246|NCT03828747|157444895|FG000|Open-Label Extension|Adverse Event|9|||
48893247|NCT03828747|157444896|FG001|Open-Label Extension|Adverse Event|7|||
48893248|NCT03828747|157444895|FG000|Open-Label Extension|Death|0|||
48893249|NCT03828747|157444896|FG001|Open-Label Extension|Death|2|||
48893250|NCT03828747|157444895|FG000|Open-Label Extension|Lost to Follow-up|4|||
48893251|NCT03828747|157444896|FG001|Open-Label Extension|Lost to Follow-up|0|||
48893252|NCT03828747|157444895|FG000|Open-Label Extension|Withdrawal by Subject|31|||
48893253|NCT03828747|157444896|FG001|Open-Label Extension|Withdrawal by Subject|30|||
48893254|NCT03828747|157444895|FG000|Open-Label Extension|Various reasons|4|||
48893255|NCT03828747|157444896|FG001|Open-Label Extension|Various reasons|4|||
48893256|NCT03828747|157444895|FG000|Open-Label Extension|Physician Decision|6|||
48893257|NCT03828747|157444896|FG001|Open-Label Extension|Physician Decision|2|||
48893258|NCT01346475|157444897|FG000|First Intervention|Lost to Follow-up|4|||
48893259|NCT01346475|157444898|FG001|First Intervention|Lost to Follow-up|3|||
48893260|NCT01171807|157444899|FG000|Overall Study|Treatment failure|2|||
48893261|NCT01171807|157444900|FG001|Overall Study|Treatment failure|4|||
48893262|NCT01171807|157444899|FG000|Overall Study|Non compliance|1|||
48893263|NCT01171807|157444900|FG001|Overall Study|Non compliance|0|||
48893264|NCT01171807|157444899|FG000|Overall Study|Lost to Follow-up|3|||
48893265|NCT01171807|157444900|FG001|Overall Study|Lost to Follow-up|0|||
48893266|NCT00621777|157444901|FG000|Open Phase|Adverse Event|20|||
48893267|NCT00621777|157444902|FG001|Open Phase|Adverse Event|0|||
48893268|NCT00621777|157444901|FG000|Open Phase|Did not abstain during open phase|56|||
48893269|NCT00621777|157444902|FG001|Open Phase|Did not abstain during open phase|0|||
48893270|NCT00621777|157444901|FG000|Open Phase|Withdrawal by Subject|17|||
48893271|NCT00621777|157444902|FG001|Open Phase|Withdrawal by Subject|0|||
48893272|NCT00621777|157444901|FG000|Open Phase|administrative|13|||
48893273|NCT00621777|157444902|FG001|Open Phase|administrative|0|||
49038079|NCT04583423|157974600|FG000|Overall Study|Study Terminated by Sponsor|32|||
49038080|NCT04583423|157974601|FG001|Overall Study|Study Terminated by Sponsor|35|||
49038081|NCT04583423|157974602|FG002|Overall Study|Study Terminated by Sponsor|36|||
48893274|NCT00621777|157444901|FG000|Open Phase|Lost to Follow-up|10|||
48893275|NCT00621777|157444902|FG001|Open Phase|Lost to Follow-up|0|||
48893276|NCT00621777|157444901|FG000|Randomized Phase|Adverse Event|3|||
48893277|NCT00621777|157444902|FG001|Randomized Phase|Adverse Event|3|||
48893278|NCT00621777|157444901|FG000|Randomized Phase|Lost to Follow-up|3|||
48893279|NCT00621777|157444902|FG001|Randomized Phase|Lost to Follow-up|3|||
48893280|NCT00621777|157444901|FG000|Randomized Phase|Withdrawal by Subject|1|||
49038082|NCT04583423|157974603|FG003|Overall Study|Study Terminated by Sponsor|33|||
49038083|NCT04583423|157974600|FG000|Overall Study|Withdrawal by Subject|3|||
49038084|NCT04583423|157974601|FG001|Overall Study|Withdrawal by Subject|1|||
49038085|NCT04583423|157974602|FG002|Overall Study|Withdrawal by Subject|2|||
49038086|NCT04583423|157974603|FG003|Overall Study|Withdrawal by Subject|1|||
49038087|NCT01808651|157974604|FG000|Study Period 1|Lost to Follow-up|1|||
48893281|NCT00621777|157444902|FG001|Randomized Phase|Withdrawal by Subject|9|||
48893282|NCT00621777|157444901|FG000|Randomized Phase|administrative|0|||
48893283|NCT00621777|157444902|FG001|Randomized Phase|administrative|3|||
48893284|NCT00621777|157444901|FG000|Randomized Phase|Death|0|||
48893285|NCT00621777|157444902|FG001|Randomized Phase|Death|1|||
48893286|NCT00446043|157444904|FG000|Overall Study|Adverse Event|9|||
48893287|NCT00446043|157444904|FG000|Overall Study|Withdrawal by Subject|70|||
48893288|NCT00446043|157444904|FG000|Overall Study|Protocol Violation|2|||
48893289|NCT00446043|157444904|FG000|Overall Study|Lost to Follow-up|42|||
48893290|NCT00446043|157444904|FG000|Overall Study|Pregnancy|2|||
49038088|NCT01808651|157974605|FG001|Study Period 1|Lost to Follow-up|3|||
48893291|NCT01239043|157444905|FG000|Overall Study|Protocol Violation|2|||
48893292|NCT01239043|157444906|FG001|Overall Study|Protocol Violation|1|||
48893293|NCT00309959|157444911|FG000|Overall Study|Ineligible - no prior chemotherapy|2|||
48893294|NCT01895101|157444912|FG000|Overall Study|OPCAB procedure|1|||
48893295|NCT01895101|157444913|FG001|Overall Study|OPCAB procedure|1|||
48893296|NCT01895101|157444914|FG002|Overall Study|OPCAB procedure|3|||
48893297|NCT01895101|157444912|FG000|Overall Study|Withdrawal by Subject|0|||
48893298|NCT01895101|157444913|FG001|Overall Study|Withdrawal by Subject|1|||
49038089|NCT01808651|157974606|FG002|Study Period 1|Lost to Follow-up|0|||
48893299|NCT01895101|157444914|FG002|Overall Study|Withdrawal by Subject|2|||
48893300|NCT01895101|157444912|FG000|Overall Study|another study, enrolled in other study|0|||
48893301|NCT01895101|157444913|FG001|Overall Study|another study, enrolled in other study|1|||
48893302|NCT01895101|157444914|FG002|Overall Study|another study, enrolled in other study|0|||
49038090|NCT01808651|157974604|FG000|Study Period 1|Protocol Violation|1|||
49038091|NCT01808651|157974605|FG001|Study Period 1|Protocol Violation|0|||
48893303|NCT01895101|157444912|FG000|Overall Study|Death|0|||
48893304|NCT01895101|157444913|FG001|Overall Study|Death|1|||
48893305|NCT01895101|157444914|FG002|Overall Study|Death|0|||
48893306|NCT01895101|157444912|FG000|Overall Study|coagulation disorder|0|||
48893307|NCT01895101|157444913|FG001|Overall Study|coagulation disorder|1|||
48893308|NCT01895101|157444914|FG002|Overall Study|coagulation disorder|0|||
48893309|NCT02663518|157444915|FG000|Part 1: Phase 1a Escalation|Death|0|||
48893310|NCT02663518|157444916|FG001|Part 1: Phase 1a Escalation|Death|0|||
48893311|NCT02663518|157444917|FG002|Part 1: Phase 1a Escalation|Death|1|||
48893312|NCT02663518|157444918|FG003|Part 1: Phase 1a Escalation|Death|0|||
48893313|NCT02663518|157444919|FG004|Part 1: Phase 1a Escalation|Death|0|||
48893314|NCT02663518|157444920|FG005|Part 1: Phase 1a Escalation|Death|0|||
48893315|NCT02663518|157444921|FG006|Part 1: Phase 1a Escalation|Death|0|||
48893316|NCT02663518|157444922|FG007|Part 1: Phase 1a Escalation|Death|0|||
48893317|NCT02663518|157444923|FG008|Part 1: Phase 1a Escalation|Death|0|||
48893318|NCT02663518|157444924|FG009|Part 1: Phase 1a Escalation|Death|0|||
48893319|NCT02663518|157444925|FG010|Part 1: Phase 1a Escalation|Death|0|||
48893320|NCT02663518|157444926|FG011|Part 1: Phase 1a Escalation|Death|0|||
48893321|NCT02663518|157444927|FG012|Part 1: Phase 1a Escalation|Death|0|||
48893322|NCT02663518|157444928|FG013|Part 1: Phase 1a Escalation|Death|0|||
48893323|NCT02663518|157444915|FG000|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
48893324|NCT02663518|157444916|FG001|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
48893325|NCT02663518|157444917|FG002|Part 1: Phase 1a Escalation|Lost to Follow-up|1|||
48893326|NCT02663518|157444918|FG003|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
48893327|NCT02663518|157444919|FG004|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
48893328|NCT02663518|157444920|FG005|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
48893329|NCT02663518|157444921|FG006|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
48893330|NCT02663518|157444922|FG007|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
48893331|NCT02663518|157444923|FG008|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
48893332|NCT02663518|157444924|FG009|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
48893333|NCT02663518|157444925|FG010|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
48893334|NCT02663518|157444926|FG011|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
48893335|NCT02663518|157444927|FG012|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
48893336|NCT02663518|157444928|FG013|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
48893337|NCT02663518|157444915|FG000|Part 1: Phase 1a Escalation|Progressive Disease|2|||
48893338|NCT02663518|157444916|FG001|Part 1: Phase 1a Escalation|Progressive Disease|3|||
48893339|NCT02663518|157444917|FG002|Part 1: Phase 1a Escalation|Progressive Disease|2|||
48893340|NCT02663518|157444918|FG003|Part 1: Phase 1a Escalation|Progressive Disease|3|||
48893341|NCT02663518|157444919|FG004|Part 1: Phase 1a Escalation|Progressive Disease|0|||
48893342|NCT02663518|157444920|FG005|Part 1: Phase 1a Escalation|Progressive Disease|0|||
48893343|NCT02663518|157444921|FG006|Part 1: Phase 1a Escalation|Progressive Disease|0|||
49038092|NCT01808651|157974606|FG002|Study Period 1|Protocol Violation|1|||
49038093|NCT01808651|157974604|FG000|Study Period 1|Physician Decision|3|||
48893344|NCT02663518|157444922|FG007|Part 1: Phase 1a Escalation|Progressive Disease|0|||
48893345|NCT02663518|157444923|FG008|Part 1: Phase 1a Escalation|Progressive Disease|0|||
48893346|NCT02663518|157444924|FG009|Part 1: Phase 1a Escalation|Progressive Disease|0|||
48893347|NCT02663518|157444925|FG010|Part 1: Phase 1a Escalation|Progressive Disease|0|||
48893348|NCT02663518|157444926|FG011|Part 1: Phase 1a Escalation|Progressive Disease|0|||
48893349|NCT02663518|157444927|FG012|Part 1: Phase 1a Escalation|Progressive Disease|0|||
48893350|NCT02663518|157444928|FG013|Part 1: Phase 1a Escalation|Progressive Disease|0|||
48893351|NCT02663518|157444915|FG000|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
48893352|NCT02663518|157444916|FG001|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
48893353|NCT02663518|157444917|FG002|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
48893354|NCT02663518|157444918|FG003|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
48893355|NCT02663518|157444919|FG004|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
48893356|NCT02663518|157444920|FG005|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
48893357|NCT02663518|157444921|FG006|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
48893358|NCT02663518|157444922|FG007|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
48893359|NCT02663518|157444923|FG008|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
48893360|NCT02663518|157444924|FG009|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
48893361|NCT02663518|157444925|FG010|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
48893362|NCT02663518|157444926|FG011|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
49038094|NCT01808651|157974605|FG001|Study Period 1|Physician Decision|2|||
48893363|NCT02663518|157444927|FG012|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
48893364|NCT02663518|157444928|FG013|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
48893365|NCT02663518|157444915|FG000|Part 1: Phase 1a Escalation|Other|0|||
48893366|NCT02663518|157444916|FG001|Part 1: Phase 1a Escalation|Other|0|||
49038095|NCT01808651|157974606|FG002|Study Period 1|Physician Decision|0|||
48893367|NCT02663518|157444917|FG002|Part 1: Phase 1a Escalation|Other|2|||
48893368|NCT02663518|157444918|FG003|Part 1: Phase 1a Escalation|Other|0|||
48893369|NCT02663518|157444919|FG004|Part 1: Phase 1a Escalation|Other|0|||
48893370|NCT02663518|157444920|FG005|Part 1: Phase 1a Escalation|Other|0|||
48893371|NCT02663518|157444921|FG006|Part 1: Phase 1a Escalation|Other|0|||
48893372|NCT02663518|157444922|FG007|Part 1: Phase 1a Escalation|Other|0|||
48893373|NCT02663518|157444923|FG008|Part 1: Phase 1a Escalation|Other|0|||
48893374|NCT02663518|157444924|FG009|Part 1: Phase 1a Escalation|Other|0|||
48893375|NCT02663518|157444925|FG010|Part 1: Phase 1a Escalation|Other|0|||
48893376|NCT02663518|157444926|FG011|Part 1: Phase 1a Escalation|Other|0|||
48893377|NCT02663518|157444927|FG012|Part 1: Phase 1a Escalation|Other|0|||
48893378|NCT02663518|157444928|FG013|Part 1: Phase 1a Escalation|Other|0|||
48893379|NCT02663518|157444915|FG000|Part 2 and 3: Phase 1b Expansion|Death|0|||
48893380|NCT02663518|157444916|FG001|Part 2 and 3: Phase 1b Expansion|Death|0|||
48893381|NCT02663518|157444917|FG002|Part 2 and 3: Phase 1b Expansion|Death|0|||
48893382|NCT02663518|157444918|FG003|Part 2 and 3: Phase 1b Expansion|Death|0|||
48893383|NCT02663518|157444919|FG004|Part 2 and 3: Phase 1b Expansion|Death|50|||
48893384|NCT02663518|157444920|FG005|Part 2 and 3: Phase 1b Expansion|Death|0|||
48893385|NCT02663518|157444921|FG006|Part 2 and 3: Phase 1b Expansion|Death|25|||
48893386|NCT02663518|157444922|FG007|Part 2 and 3: Phase 1b Expansion|Death|16|||
48893387|NCT02663518|157444923|FG008|Part 2 and 3: Phase 1b Expansion|Death|0|||
48893388|NCT02663518|157444924|FG009|Part 2 and 3: Phase 1b Expansion|Death|0|||
48893389|NCT02663518|157444925|FG010|Part 2 and 3: Phase 1b Expansion|Death|0|||
48893390|NCT02663518|157444926|FG011|Part 2 and 3: Phase 1b Expansion|Death|0|||
48893391|NCT02663518|157444927|FG012|Part 2 and 3: Phase 1b Expansion|Death|0|||
48893392|NCT02663518|157444928|FG013|Part 2 and 3: Phase 1b Expansion|Death|0|||
48893393|NCT02663518|157444915|FG000|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
48893394|NCT02663518|157444916|FG001|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
48893395|NCT02663518|157444917|FG002|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
48893396|NCT02663518|157444918|FG003|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
48893397|NCT02663518|157444919|FG004|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|4|||
48893398|NCT02663518|157444920|FG005|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
48893399|NCT02663518|157444921|FG006|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
48893400|NCT02663518|157444922|FG007|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
48893401|NCT02663518|157444923|FG008|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
48893402|NCT02663518|157444924|FG009|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
48893403|NCT02663518|157444925|FG010|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
48893404|NCT02663518|157444926|FG011|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
48893405|NCT02663518|157444927|FG012|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
48893406|NCT02663518|157444928|FG013|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
48893407|NCT02663518|157444915|FG000|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
48893408|NCT02663518|157444916|FG001|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
48893409|NCT02663518|157444917|FG002|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
48893410|NCT02663518|157444918|FG003|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
48893411|NCT02663518|157444919|FG004|Part 2 and 3: Phase 1b Expansion|Progressive Disease|2|||
48893412|NCT02663518|157444920|FG005|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
48893413|NCT02663518|157444921|FG006|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
48893414|NCT02663518|157444922|FG007|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
48893415|NCT02663518|157444923|FG008|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
48893416|NCT02663518|157444924|FG009|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
48893417|NCT02663518|157444925|FG010|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
48893418|NCT02663518|157444926|FG011|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
48893419|NCT02663518|157444927|FG012|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
48893420|NCT02663518|157444928|FG013|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
48893421|NCT02663518|157444915|FG000|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
48893422|NCT02663518|157444916|FG001|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
48893423|NCT02663518|157444917|FG002|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
48893424|NCT02663518|157444918|FG003|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
48893425|NCT02663518|157444919|FG004|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|16|||
48893426|NCT02663518|157444920|FG005|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|1|||
48893427|NCT02663518|157444921|FG006|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|3|||
48893428|NCT02663518|157444922|FG007|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|8|||
48893429|NCT02663518|157444923|FG008|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
48893430|NCT02663518|157444924|FG009|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
48893431|NCT02663518|157444925|FG010|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
48893432|NCT02663518|157444926|FG011|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
48893433|NCT02663518|157444927|FG012|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
48893434|NCT02663518|157444928|FG013|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
48893435|NCT02663518|157444915|FG000|Part 2 and 3: Phase 1b Expansion|Other|0|||
48893436|NCT02663518|157444916|FG001|Part 2 and 3: Phase 1b Expansion|Other|0|||
48893437|NCT02663518|157444917|FG002|Part 2 and 3: Phase 1b Expansion|Other|0|||
48893438|NCT02663518|157444918|FG003|Part 2 and 3: Phase 1b Expansion|Other|0|||
48893439|NCT02663518|157444919|FG004|Part 2 and 3: Phase 1b Expansion|Other|6|||
48893440|NCT02663518|157444920|FG005|Part 2 and 3: Phase 1b Expansion|Other|0|||
48893441|NCT02663518|157444921|FG006|Part 2 and 3: Phase 1b Expansion|Other|2|||
48893442|NCT02663518|157444922|FG007|Part 2 and 3: Phase 1b Expansion|Other|0|||
48893443|NCT02663518|157444923|FG008|Part 2 and 3: Phase 1b Expansion|Other|0|||
48893444|NCT02663518|157444924|FG009|Part 2 and 3: Phase 1b Expansion|Other|0|||
48893445|NCT02663518|157444925|FG010|Part 2 and 3: Phase 1b Expansion|Other|0|||
48893446|NCT02663518|157444926|FG011|Part 2 and 3: Phase 1b Expansion|Other|0|||
48893447|NCT02663518|157444927|FG012|Part 2 and 3: Phase 1b Expansion|Other|0|||
48893448|NCT02663518|157444928|FG013|Part 2 and 3: Phase 1b Expansion|Other|0|||
48893449|NCT02663518|157444915|FG000|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
48893450|NCT02663518|157444916|FG001|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
48893451|NCT02663518|157444917|FG002|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
48893452|NCT02663518|157444918|FG003|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
48893453|NCT02663518|157444919|FG004|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
48893454|NCT02663518|157444920|FG005|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
48893455|NCT02663518|157444921|FG006|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|1|||
48893456|NCT02663518|157444922|FG007|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
48893457|NCT02663518|157444923|FG008|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
48893458|NCT02663518|157444924|FG009|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
48893459|NCT02663518|157444925|FG010|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
48893460|NCT02663518|157444926|FG011|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
48893461|NCT02663518|157444927|FG012|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
48893462|NCT02663518|157444928|FG013|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
48893463|NCT02663518|157444915|FG000|Part 4: Phase 1b Dose Optimization|Death|0|||
48893464|NCT02663518|157444916|FG001|Part 4: Phase 1b Dose Optimization|Death|0|||
48893465|NCT02663518|157444917|FG002|Part 4: Phase 1b Dose Optimization|Death|0|||
48893466|NCT02663518|157444918|FG003|Part 4: Phase 1b Dose Optimization|Death|0|||
48893467|NCT02663518|157444919|FG004|Part 4: Phase 1b Dose Optimization|Death|0|||
48893468|NCT02663518|157444920|FG005|Part 4: Phase 1b Dose Optimization|Death|0|||
48893469|NCT02663518|157444921|FG006|Part 4: Phase 1b Dose Optimization|Death|0|||
48893470|NCT02663518|157444922|FG007|Part 4: Phase 1b Dose Optimization|Death|0|||
48893471|NCT02663518|157444923|FG008|Part 4: Phase 1b Dose Optimization|Death|0|||
48893472|NCT02663518|157444924|FG009|Part 4: Phase 1b Dose Optimization|Death|0|||
48893473|NCT02663518|157444925|FG010|Part 4: Phase 1b Dose Optimization|Death|2|||
48893474|NCT02663518|157444926|FG011|Part 4: Phase 1b Dose Optimization|Death|0|||
48893475|NCT02663518|157444927|FG012|Part 4: Phase 1b Dose Optimization|Death|5|||
48893476|NCT02663518|157444928|FG013|Part 4: Phase 1b Dose Optimization|Death|1|||
48893477|NCT02663518|157444915|FG000|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
48893478|NCT02663518|157444916|FG001|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
48893479|NCT02663518|157444917|FG002|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
48893480|NCT02663518|157444918|FG003|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
48893481|NCT02663518|157444919|FG004|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
48893482|NCT02663518|157444920|FG005|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
48893483|NCT02663518|157444921|FG006|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
48893484|NCT02663518|157444922|FG007|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
48893485|NCT02663518|157444923|FG008|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
48893486|NCT02663518|157444924|FG009|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
48893487|NCT02663518|157444925|FG010|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
48893488|NCT02663518|157444926|FG011|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
48893489|NCT02663518|157444927|FG012|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|1|||
48893490|NCT02663518|157444928|FG013|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
48893491|NCT02663518|157444915|FG000|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
48893492|NCT02663518|157444916|FG001|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
48893493|NCT02663518|157444917|FG002|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
48893494|NCT02663518|157444918|FG003|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
48893495|NCT02663518|157444919|FG004|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
48893496|NCT02663518|157444920|FG005|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
48893497|NCT02663518|157444921|FG006|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
48893498|NCT02663518|157444922|FG007|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
49038096|NCT01808651|157974604|FG000|Study Period 1|Lack of Efficacy|2|||
49038097|NCT01808651|157974605|FG001|Study Period 1|Lack of Efficacy|1|||
48893499|NCT02663518|157444923|FG008|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
48893500|NCT02663518|157444924|FG009|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
48893501|NCT02663518|157444925|FG010|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
48893502|NCT02663518|157444926|FG011|Part 4: Phase 1b Dose Optimization|Progressive Disease|1|||
48893503|NCT02663518|157444927|FG012|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
49038098|NCT01808651|157974606|FG002|Study Period 1|Lack of Efficacy|0|||
48893504|NCT02663518|157444928|FG013|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
49038099|NCT01808651|157974604|FG000|Study Period 1|Adverse Event|10|||
49038100|NCT01808651|157974605|FG001|Study Period 1|Adverse Event|4|||
49038101|NCT01808651|157974606|FG002|Study Period 1|Adverse Event|1|||
49038102|NCT01808651|157974604|FG000|Study Period 1|Participant Decision|9|||
49038103|NCT01808651|157974605|FG001|Study Period 1|Participant Decision|7|||
49038104|NCT01808651|157974606|FG002|Study Period 1|Participant Decision|3|||
49038105|NCT02964039|157974611|FG000|Overall Study|Medical reason unrelated to study participation|1|||
49038106|NCT02964039|157974612|FG001|Overall Study|Medical reason unrelated to study participation|0|||
49038107|NCT02964039|157974613|FG002|Overall Study|Medical reason unrelated to study participation|3|||
49038108|NCT02964039|157974611|FG000|Overall Study|Research shutdown due to pandemic|2|||
49038109|NCT02964039|157974612|FG001|Overall Study|Research shutdown due to pandemic|0|||
49038110|NCT02964039|157974613|FG002|Overall Study|Research shutdown due to pandemic|1|||
49038111|NCT02964039|157974611|FG000|Overall Study|Withdrawal by Subject|0|||
49038112|NCT02964039|157974612|FG001|Overall Study|Withdrawal by Subject|1|||
49038113|NCT02964039|157974613|FG002|Overall Study|Withdrawal by Subject|0|||
49038114|NCT02964039|157974611|FG000|Overall Study|Lost to Follow-up|1|||
49038115|NCT02964039|157974612|FG001|Overall Study|Lost to Follow-up|0|||
49038116|NCT02964039|157974613|FG002|Overall Study|Lost to Follow-up|1|||
49038117|NCT00841542|157974616|FG000|Period 1|Adverse Event|1|||
49038118|NCT00841542|157974617|FG001|Period 1|Adverse Event|0|||
49038119|NCT03801707|157974620|FG000|Overall Study|Removed from study due to reaching the study target of 30 transplant from hepatitis C viremic donors|6|||
49038120|NCT00425308|157974621|FG000|Overall Study|Adverse Event|2|||
49038121|NCT00425308|157974622|FG001|Overall Study|Adverse Event|1|||
49038122|NCT00425308|157974621|FG000|Overall Study|Withdrawal by Subject|1|||
49038123|NCT00425308|157974622|FG001|Overall Study|Withdrawal by Subject|0|||
49038124|NCT00425308|157974621|FG000|Overall Study|Death|1|||
49038125|NCT00425308|157974622|FG001|Overall Study|Death|0|||
48893505|NCT02663518|157444915|FG000|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
48893506|NCT02663518|157444916|FG001|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
48893507|NCT02663518|157444917|FG002|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
48893508|NCT02663518|157444918|FG003|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
48893509|NCT02663518|157444919|FG004|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
48893510|NCT02663518|157444920|FG005|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
48893511|NCT02663518|157444921|FG006|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
48893512|NCT02663518|157444922|FG007|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
48893513|NCT02663518|157444923|FG008|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
48893514|NCT02663518|157444924|FG009|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|2|||
48893515|NCT02663518|157444925|FG010|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
48893516|NCT02663518|157444926|FG011|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
48893517|NCT02663518|157444927|FG012|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
48893518|NCT02663518|157444928|FG013|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
48893519|NCT02663518|157444915|FG000|Part 4: Phase 1b Dose Optimization|Other|0|||
48893520|NCT02663518|157444916|FG001|Part 4: Phase 1b Dose Optimization|Other|0|||
48893521|NCT02663518|157444917|FG002|Part 4: Phase 1b Dose Optimization|Other|0|||
48893522|NCT02663518|157444918|FG003|Part 4: Phase 1b Dose Optimization|Other|0|||
48893523|NCT02663518|157444919|FG004|Part 4: Phase 1b Dose Optimization|Other|0|||
48893524|NCT02663518|157444920|FG005|Part 4: Phase 1b Dose Optimization|Other|0|||
48893525|NCT02663518|157444921|FG006|Part 4: Phase 1b Dose Optimization|Other|0|||
48893526|NCT02663518|157444922|FG007|Part 4: Phase 1b Dose Optimization|Other|0|||
48893527|NCT02663518|157444923|FG008|Part 4: Phase 1b Dose Optimization|Other|0|||
48893528|NCT02663518|157444924|FG009|Part 4: Phase 1b Dose Optimization|Other|0|||
48893529|NCT02663518|157444925|FG010|Part 4: Phase 1b Dose Optimization|Other|1|||
48893530|NCT02663518|157444926|FG011|Part 4: Phase 1b Dose Optimization|Other|1|||
48893531|NCT02663518|157444927|FG012|Part 4: Phase 1b Dose Optimization|Other|0|||
48893532|NCT02663518|157444928|FG013|Part 4: Phase 1b Dose Optimization|Other|1|||
48893533|NCT02663518|157444915|FG000|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
48893534|NCT02663518|157444916|FG001|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
48893535|NCT02663518|157444917|FG002|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
48893536|NCT02663518|157444918|FG003|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
48893537|NCT02663518|157444919|FG004|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
48893538|NCT02663518|157444920|FG005|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
48893539|NCT02663518|157444921|FG006|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
48893540|NCT02663518|157444922|FG007|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
48893541|NCT02663518|157444923|FG008|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
49038126|NCT01647828|157974623|FG000|Overall Study|Death|3|||
49038127|NCT01647828|157974624|FG001|Overall Study|Death|4|||
49038128|NCT01647828|157974625|FG002|Overall Study|Death|4|||
49038129|NCT01647828|157974626|FG003|Overall Study|Death|5|||
49038130|NCT01647828|157974627|FG004|Overall Study|Death|6|||
49038131|NCT01647828|157974628|FG005|Overall Study|Death|3|||
49038132|NCT01647828|157974629|FG006|Overall Study|Death|10|||
49038133|NCT01647828|157974630|FG007|Overall Study|Death|60|||
49038134|NCT01647828|157974631|FG008|Overall Study|Death|71|||
49038135|NCT01647828|157974623|FG000|Overall Study|Withdrawal by Subject|2|||
49038136|NCT01647828|157974624|FG001|Overall Study|Withdrawal by Subject|0|||
48893542|NCT02663518|157444924|FG009|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
48893543|NCT02663518|157444925|FG010|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
48893544|NCT02663518|157444926|FG011|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
48893545|NCT02663518|157444927|FG012|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|1|||
49038137|NCT01647828|157974625|FG002|Overall Study|Withdrawal by Subject|0|||
49038138|NCT01647828|157974626|FG003|Overall Study|Withdrawal by Subject|1|||
49038139|NCT01647828|157974627|FG004|Overall Study|Withdrawal by Subject|0|||
49038140|NCT01647828|157974628|FG005|Overall Study|Withdrawal by Subject|0|||
49038141|NCT01647828|157974629|FG006|Overall Study|Withdrawal by Subject|1|||
49038142|NCT01647828|157974630|FG007|Overall Study|Withdrawal by Subject|0|||
49038143|NCT01647828|157974631|FG008|Overall Study|Withdrawal by Subject|2|||
49038144|NCT01647828|157974623|FG000|Overall Study|Study terminated by Sponsor|0|||
49038145|NCT01647828|157974624|FG001|Overall Study|Study terminated by Sponsor|0|||
49038146|NCT01647828|157974625|FG002|Overall Study|Study terminated by Sponsor|0|||
49038147|NCT01647828|157974626|FG003|Overall Study|Study terminated by Sponsor|0|||
49038148|NCT01647828|157974627|FG004|Overall Study|Study terminated by Sponsor|0|||
49038149|NCT01647828|157974628|FG005|Overall Study|Study terminated by Sponsor|0|||
49038150|NCT01647828|157974629|FG006|Overall Study|Study terminated by Sponsor|1|||
49038151|NCT01647828|157974630|FG007|Overall Study|Study terminated by Sponsor|26|||
49038152|NCT01647828|157974631|FG008|Overall Study|Study terminated by Sponsor|16|||
48893546|NCT02663518|157444928|FG013|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
48893547|NCT02947087|157444934|FG000|Overall Study|Withdrawal by Subject|3|||
48893548|NCT02947087|157444935|FG001|Overall Study|Withdrawal by Subject|2|||
48893549|NCT01052103|157444936|FG000|Overall Study|Adverse Event|10|||
48893550|NCT01052103|157444937|FG001|Overall Study|Adverse Event|6|||
48893551|NCT01052103|157444936|FG000|Overall Study|Entry Criteria Not Met|3|||
48893552|NCT01052103|157444937|FG001|Overall Study|Entry Criteria Not Met|1|||
48893553|NCT01052103|157444936|FG000|Overall Study|Lost to Follow-up|3|||
48893554|NCT01052103|157444937|FG001|Overall Study|Lost to Follow-up|5|||
48893555|NCT01052103|157444936|FG000|Overall Study|Protocol Violation|10|||
48893556|NCT01052103|157444937|FG001|Overall Study|Protocol Violation|4|||
48893557|NCT01052103|157444936|FG000|Overall Study|Scheduling conflict|2|||
48893558|NCT01052103|157444937|FG001|Overall Study|Scheduling conflict|1|||
48893559|NCT01052103|157444936|FG000|Overall Study|Sponsor Decision|2|||
48893560|NCT01052103|157444937|FG001|Overall Study|Sponsor Decision|0|||
48893561|NCT01052103|157444936|FG000|Overall Study|Withdrawal by Subject|3|||
48893562|NCT01052103|157444937|FG001|Overall Study|Withdrawal by Subject|6|||
48893563|NCT01052103|157444936|FG000|Overall Study|Perceived Lack of Efficacy|1|||
48893564|NCT01052103|157444937|FG001|Overall Study|Perceived Lack of Efficacy|0|||
48893565|NCT00370682|157444938|FG000|Overall Study|Moved from area|0|||
48893566|NCT00370682|157444939|FG001|Overall Study|Moved from area|2|||
48893567|NCT00370682|157444940|FG002|Overall Study|Moved from area|0|||
48893568|NCT00370682|157444938|FG000|Overall Study|Lost to Follow-up|0|||
48893569|NCT00370682|157444939|FG001|Overall Study|Lost to Follow-up|1|||
48893570|NCT00370682|157444940|FG002|Overall Study|Lost to Follow-up|1|||
48893571|NCT01983254|157444941|FG000|Overall Study|Death|6|||
48893572|NCT01983254|157444942|FG001|Overall Study|Death|6|||
48893573|NCT01983254|157444941|FG000|Overall Study|Lost to Follow-up|17|||
48893574|NCT01983254|157444942|FG001|Overall Study|Lost to Follow-up|16|||
48893575|NCT01983254|157444941|FG000|Overall Study|too ill|11|||
48893576|NCT01983254|157444942|FG001|Overall Study|too ill|8|||
48893577|NCT01160289|157444943|FG000|Screening, Washout, and Lead-In Period|Adverse Event|8|||
48893578|NCT01160289|157444944|FG001|Screening, Washout, and Lead-In Period|Adverse Event|0|||
48893579|NCT01160289|157444945|FG002|Screening, Washout, and Lead-In Period|Adverse Event|0|||
48893580|NCT01160289|157444946|FG003|Screening, Washout, and Lead-In Period|Adverse Event|0|||
48893581|NCT01160289|157444947|FG004|Screening, Washout, and Lead-In Period|Adverse Event|0|||
48893582|NCT01160289|157444948|FG005|Screening, Washout, and Lead-In Period|Adverse Event|0|||
48893583|NCT01160289|157444943|FG000|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308|||
48893584|NCT01160289|157444944|FG001|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
48893585|NCT01160289|157444945|FG002|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
48893586|NCT01160289|157444946|FG003|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
48893587|NCT01160289|157444947|FG004|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
48893588|NCT01160289|157444948|FG005|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
48893589|NCT01160289|157444943|FG000|Screening, Washout, and Lead-In Period|Lack of Efficacy|1|||
49038153|NCT01647828|157974623|FG000|Overall Study|Lost to Follow-up|0|||
49038154|NCT01647828|157974624|FG001|Overall Study|Lost to Follow-up|0|||
49038155|NCT01647828|157974625|FG002|Overall Study|Lost to Follow-up|0|||
49038156|NCT01647828|157974626|FG003|Overall Study|Lost to Follow-up|0|||
49038157|NCT01647828|157974627|FG004|Overall Study|Lost to Follow-up|0|||
49038158|NCT01647828|157974628|FG005|Overall Study|Lost to Follow-up|0|||
48893590|NCT01160289|157444944|FG001|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
48893591|NCT01160289|157444945|FG002|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
48893592|NCT01160289|157444946|FG003|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
48893593|NCT01160289|157444947|FG004|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
48893594|NCT01160289|157444948|FG005|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
48893595|NCT01160289|157444943|FG000|Screening, Washout, and Lead-In Period|Lost to Follow-up|9|||
48893596|NCT01160289|157444944|FG001|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
48893597|NCT01160289|157444945|FG002|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
48893598|NCT01160289|157444946|FG003|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
48893599|NCT01160289|157444947|FG004|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
48893600|NCT01160289|157444948|FG005|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
48893601|NCT01160289|157444943|FG000|Screening, Washout, and Lead-In Period|Physician Decision|26|||
48893602|NCT01160289|157444944|FG001|Screening, Washout, and Lead-In Period|Physician Decision|0|||
48893603|NCT01160289|157444945|FG002|Screening, Washout, and Lead-In Period|Physician Decision|0|||
48893604|NCT01160289|157444946|FG003|Screening, Washout, and Lead-In Period|Physician Decision|0|||
48893605|NCT01160289|157444947|FG004|Screening, Washout, and Lead-In Period|Physician Decision|0|||
48893606|NCT01160289|157444948|FG005|Screening, Washout, and Lead-In Period|Physician Decision|0|||
48893607|NCT01160289|157444943|FG000|Screening, Washout, and Lead-In Period|Protocol Violation|1|||
48893608|NCT01160289|157444944|FG001|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
48893609|NCT01160289|157444945|FG002|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
48893610|NCT01160289|157444946|FG003|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
48893611|NCT01160289|157444947|FG004|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
48893612|NCT01160289|157444948|FG005|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
48893613|NCT01160289|157444943|FG000|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67|||
48893614|NCT01160289|157444944|FG001|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
48893615|NCT01160289|157444945|FG002|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
48893616|NCT01160289|157444946|FG003|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
48893617|NCT01160289|157444947|FG004|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
48893618|NCT01160289|157444948|FG005|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
48893619|NCT01160289|157444943|FG000|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64|||
48893620|NCT01160289|157444944|FG001|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
48893621|NCT01160289|157444945|FG002|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
48893622|NCT01160289|157444946|FG003|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
48893623|NCT01160289|157444947|FG004|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
48893624|NCT01160289|157444948|FG005|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
48893625|NCT01160289|157444943|FG000|Post-Randomization Period|Adverse Event|0|||
48893626|NCT01160289|157444944|FG001|Post-Randomization Period|Adverse Event|4|||
48893627|NCT01160289|157444945|FG002|Post-Randomization Period|Adverse Event|4|||
48893628|NCT01160289|157444946|FG003|Post-Randomization Period|Adverse Event|2|||
48893629|NCT01160289|157444947|FG004|Post-Randomization Period|Adverse Event|0|||
48893630|NCT01160289|157444948|FG005|Post-Randomization Period|Adverse Event|0|||
48893631|NCT01160289|157444943|FG000|Post-Randomization Period|Death|0|||
48893632|NCT01160289|157444944|FG001|Post-Randomization Period|Death|0|||
48893633|NCT01160289|157444945|FG002|Post-Randomization Period|Death|0|||
48893634|NCT01160289|157444946|FG003|Post-Randomization Period|Death|1|||
48893635|NCT01160289|157444947|FG004|Post-Randomization Period|Death|0|||
48893636|NCT01160289|157444948|FG005|Post-Randomization Period|Death|0|||
48893637|NCT01160289|157444943|FG000|Post-Randomization Period|Lack of Efficacy|0|||
48893638|NCT01160289|157444944|FG001|Post-Randomization Period|Lack of Efficacy|1|||
48893639|NCT01160289|157444945|FG002|Post-Randomization Period|Lack of Efficacy|0|||
48893640|NCT01160289|157444946|FG003|Post-Randomization Period|Lack of Efficacy|3|||
48893641|NCT01160289|157444947|FG004|Post-Randomization Period|Lack of Efficacy|0|||
48893642|NCT01160289|157444948|FG005|Post-Randomization Period|Lack of Efficacy|0|||
48893643|NCT01160289|157444943|FG000|Post-Randomization Period|Lost to Follow-up|0|||
48893644|NCT01160289|157444944|FG001|Post-Randomization Period|Lost to Follow-up|3|||
48893645|NCT01160289|157444945|FG002|Post-Randomization Period|Lost to Follow-up|2|||
48893646|NCT01160289|157444946|FG003|Post-Randomization Period|Lost to Follow-up|5|||
48893647|NCT01160289|157444947|FG004|Post-Randomization Period|Lost to Follow-up|3|||
48893648|NCT01160289|157444948|FG005|Post-Randomization Period|Lost to Follow-up|4|||
48893649|NCT01160289|157444943|FG000|Post-Randomization Period|Physician Decision|0|||
48893650|NCT01160289|157444944|FG001|Post-Randomization Period|Physician Decision|0|||
48893651|NCT01160289|157444945|FG002|Post-Randomization Period|Physician Decision|1|||
48893652|NCT01160289|157444946|FG003|Post-Randomization Period|Physician Decision|0|||
48893653|NCT01160289|157444947|FG004|Post-Randomization Period|Physician Decision|0|||
48893654|NCT01160289|157444948|FG005|Post-Randomization Period|Physician Decision|0|||
48893655|NCT01160289|157444943|FG000|Post-Randomization Period|Protocol Violation|0|||
48893656|NCT01160289|157444944|FG001|Post-Randomization Period|Protocol Violation|4|||
48893657|NCT01160289|157444945|FG002|Post-Randomization Period|Protocol Violation|2|||
48893658|NCT01160289|157444946|FG003|Post-Randomization Period|Protocol Violation|0|||
48893659|NCT01160289|157444947|FG004|Post-Randomization Period|Protocol Violation|1|||
48893660|NCT01160289|157444948|FG005|Post-Randomization Period|Protocol Violation|3|||
48893661|NCT01160289|157444943|FG000|Post-Randomization Period|Withdrawal by Subject|0|||
48893662|NCT01160289|157444944|FG001|Post-Randomization Period|Withdrawal by Subject|5|||
48893663|NCT01160289|157444945|FG002|Post-Randomization Period|Withdrawal by Subject|13|||
48893664|NCT01160289|157444946|FG003|Post-Randomization Period|Withdrawal by Subject|8|||
48893665|NCT01160289|157444947|FG004|Post-Randomization Period|Withdrawal by Subject|5|||
48893666|NCT01160289|157444948|FG005|Post-Randomization Period|Withdrawal by Subject|7|||
48893667|NCT01160289|157444943|FG000|Post-Randomization Period|Entry Criteria Not Met|0|||
48893668|NCT01160289|157444944|FG001|Post-Randomization Period|Entry Criteria Not Met|2|||
48893669|NCT01160289|157444945|FG002|Post-Randomization Period|Entry Criteria Not Met|2|||
49038159|NCT01647828|157974629|FG006|Overall Study|Lost to Follow-up|0|||
49038160|NCT01647828|157974630|FG007|Overall Study|Lost to Follow-up|2|||
49038161|NCT01647828|157974631|FG008|Overall Study|Lost to Follow-up|0|||
49038162|NCT03629054|157974633|FG000|Period 2 (4 Days)|Not treated|0|||
49038163|NCT03629054|157974634|FG001|Period 2 (4 Days)|Not treated|1|||
49038164|NCT03808376|157974635|FG000|Overall Study|Withdrawal by Subject|10|||
49038165|NCT03677141|157974638|FG000|Overall Study|Death|2|||
49038166|NCT03677141|157974639|FG001|Overall Study|Death|1|||
49038167|NCT03677141|157974640|FG002|Overall Study|Death|6|||
49038168|NCT03677141|157974641|FG003|Overall Study|Death|9|||
49038169|NCT03677141|157974642|FG004|Overall Study|Death|5|||
49038170|NCT03677141|157974643|FG005|Overall Study|Death|3|||
48893670|NCT01160289|157444946|FG003|Post-Randomization Period|Entry Criteria Not Met|2|||
48893671|NCT01160289|157444947|FG004|Post-Randomization Period|Entry Criteria Not Met|0|||
48893672|NCT01160289|157444948|FG005|Post-Randomization Period|Entry Criteria Not Met|0|||
48893673|NCT01160289|157444943|FG000|Post-Randomization Period|Sponsor Decision|0|||
48893674|NCT01160289|157444944|FG001|Post-Randomization Period|Sponsor Decision|1|||
48893675|NCT01160289|157444945|FG002|Post-Randomization Period|Sponsor Decision|0|||
48893676|NCT01160289|157444946|FG003|Post-Randomization Period|Sponsor Decision|0|||
48893677|NCT01160289|157444947|FG004|Post-Randomization Period|Sponsor Decision|0|||
48893678|NCT01160289|157444948|FG005|Post-Randomization Period|Sponsor Decision|0|||
48893679|NCT00381615|157444950|FG000|Overall Study|Withdrawal by Subject|1|||
48893680|NCT00381615|157444951|FG001|Overall Study|Withdrawal by Subject|3|||
48893681|NCT00381615|157444952|FG002|Overall Study|Withdrawal by Subject|0|||
48893682|NCT00381615|157444953|FG003|Overall Study|Withdrawal by Subject|1|||
48893683|NCT00381615|157444950|FG000|Overall Study|Lost to Follow-up|3|||
48893684|NCT00381615|157444951|FG001|Overall Study|Lost to Follow-up|2|||
48893685|NCT00381615|157444952|FG002|Overall Study|Lost to Follow-up|0|||
48893686|NCT00381615|157444953|FG003|Overall Study|Lost to Follow-up|1|||
48893687|NCT00381615|157444950|FG000|Overall Study|Protocol Violation|0|||
48893688|NCT00381615|157444951|FG001|Overall Study|Protocol Violation|0|||
48893689|NCT00381615|157444952|FG002|Overall Study|Protocol Violation|1|||
48893690|NCT00381615|157444953|FG003|Overall Study|Protocol Violation|0|||
48893691|NCT03014011|157444954|FG000|First Intervention|Withdrawal by Subject|1|||
48893692|NCT03014011|157444955|FG001|First Intervention|Withdrawal by Subject|0|||
48893693|NCT03014011|157444954|FG000|Washout|Withdrawal by Subject|1|||
48893694|NCT03014011|157444955|FG001|Washout|Withdrawal by Subject|0|||
48893695|NCT00620282|157444958|FG000|Overall Study|Adverse Event|0|||
48893696|NCT00620282|157444959|FG001|Overall Study|Adverse Event|1|||
48893697|NCT00620282|157444960|FG002|Overall Study|Adverse Event|0|||
48893698|NCT00620282|157444958|FG000|Overall Study|Arterial line unable to be placed|0|||
48893699|NCT00620282|157444959|FG001|Overall Study|Arterial line unable to be placed|0|||
48893700|NCT00620282|157444960|FG002|Overall Study|Arterial line unable to be placed|1|||
48893701|NCT00620282|157444958|FG000|Overall Study|Withdrawal by Subject|0|||
48893702|NCT00620282|157444959|FG001|Overall Study|Withdrawal by Subject|1|||
48893703|NCT00620282|157444960|FG002|Overall Study|Withdrawal by Subject|0|||
48893704|NCT04738292|157444961|FG000|Overall Study|Death|1|||
48893705|NCT01151410|157444962|FG000|Overall Study|Withdrawal by Subject|3|||
48893706|NCT01151410|157444963|FG001|Overall Study|Withdrawal by Subject|5|||
48893707|NCT01151410|157444962|FG000|Overall Study|Lost to Follow-up|3|||
48893708|NCT01151410|157444963|FG001|Overall Study|Lost to Follow-up|4|||
48893709|NCT01151410|157444962|FG000|Overall Study|Adverse Event|1|||
48893710|NCT01151410|157444963|FG001|Overall Study|Adverse Event|2|||
48893711|NCT01151410|157444962|FG000|Overall Study|Protocol deviation|2|||
48893712|NCT01151410|157444963|FG001|Overall Study|Protocol deviation|1|||
48893713|NCT01151410|157444962|FG000|Overall Study|Administrative problems|1|||
48893714|NCT01151410|157444963|FG001|Overall Study|Administrative problems|1|||
48893715|NCT01151410|157444962|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
49038171|NCT03677141|157974638|FG000|Overall Study|Lost to Follow-up|0|||
48893716|NCT01151410|157444963|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
48893717|NCT01151410|157444962|FG000|Overall Study|Abnormal laboratory value(s)|0|||
49038172|NCT03677141|157974639|FG001|Overall Study|Lost to Follow-up|0|||
49038173|NCT03677141|157974640|FG002|Overall Study|Lost to Follow-up|0|||
49038174|NCT03677141|157974641|FG003|Overall Study|Lost to Follow-up|2|||
48893718|NCT01151410|157444963|FG001|Overall Study|Abnormal laboratory value(s)|1|||
48893719|NCT01131182|157444964|FG000|Overall Study|Withdrawal by Subject|1|||
48893720|NCT01131182|157444965|FG001|Overall Study|Withdrawal by Subject|1|||
48893721|NCT01131182|157444964|FG000|Overall Study|Lost to Follow-up|14|||
48893722|NCT01131182|157444965|FG001|Overall Study|Lost to Follow-up|15|||
48893723|NCT01131182|157444964|FG000|Overall Study|Other Reason|1|||
48893724|NCT01131182|157444965|FG001|Overall Study|Other Reason|0|||
48893725|NCT01034163|157444966|FG000|Overall Study|Treatment completed as per protocol|8|||
48893726|NCT01034163|157444967|FG001|Overall Study|Treatment completed as per protocol|7|||
48893727|NCT01034163|157444966|FG000|Overall Study|Withdrawal by Subject|8|||
48893728|NCT01034163|157444967|FG001|Overall Study|Withdrawal by Subject|2|||
48893729|NCT01034163|157444966|FG000|Overall Study|Protocol deviation|1|||
48893730|NCT01034163|157444967|FG001|Overall Study|Protocol deviation|0|||
48893731|NCT01034163|157444966|FG000|Overall Study|Disease progression|3|||
48893732|NCT01034163|157444967|FG001|Overall Study|Disease progression|4|||
48893733|NCT01034163|157444966|FG000|Overall Study|Adverse Event|6|||
49038175|NCT03677141|157974642|FG004|Overall Study|Lost to Follow-up|0|||
49038176|NCT03677141|157974643|FG005|Overall Study|Lost to Follow-up|0|||
49038177|NCT03677141|157974638|FG000|Overall Study|Screen failure or enrolled in error|0|||
49038178|NCT03677141|157974639|FG001|Overall Study|Screen failure or enrolled in error|0|||
49038179|NCT03677141|157974640|FG002|Overall Study|Screen failure or enrolled in error|0|||
49038180|NCT03677141|157974641|FG003|Overall Study|Screen failure or enrolled in error|0|||
49038181|NCT03677141|157974642|FG004|Overall Study|Screen failure or enrolled in error|2|||
49038182|NCT03677141|157974643|FG005|Overall Study|Screen failure or enrolled in error|0|||
49038183|NCT03677141|157974638|FG000|Overall Study|Physician Decision|0|||
49038184|NCT03677141|157974639|FG001|Overall Study|Physician Decision|0|||
49038185|NCT03677141|157974640|FG002|Overall Study|Physician Decision|0|||
48893734|NCT01034163|157444967|FG001|Overall Study|Adverse Event|0|||
48893735|NCT01034163|157444966|FG000|Overall Study|Administrative problems|0|||
48893736|NCT01034163|157444967|FG001|Overall Study|Administrative problems|1|||
48893737|NCT01034163|157444966|FG000|Overall Study|Abnormal laboratory value|1|||
48893738|NCT01034163|157444967|FG001|Overall Study|Abnormal laboratory value|0|||
48893739|NCT00744757|157444968|FG000|Overall Study|Objective disease progression|7|||
48893740|NCT00744757|157444968|FG000|Overall Study|Physician Decision|5|||
48893741|NCT00744757|157444968|FG000|Overall Study|Withdrawal by Subject|1|||
48893742|NCT00744757|157444968|FG000|Overall Study|Death|6|||
48893743|NCT00744757|157444968|FG000|Overall Study|Adverse Event|2|||
48893744|NCT02442336|157444969|FG000|Overall Study|6 patients assisted with the intervention development only.|6|||
48893745|NCT02442336|157444969|FG000|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19|||
48893746|NCT02442336|157444969|FG000|Overall Study|Lost to Follow-up|11|||
48893747|NCT03189745|157444970|FG000|Overall Study|Conflict in work schedule of participant|1|||
48893748|NCT03189745|157444971|FG001|Overall Study|Conflict in work schedule of participant|1|||
48893749|NCT00760474|157444973|FG000|Period 1 (P1)|Discontinued then re-entered|1|||
48893750|NCT00760474|157444974|FG001|Period 1 (P1)|Discontinued then re-entered|1|||
48893751|NCT00760474|157444973|FG000|Placebo Washout Period|Other|0|||
48893752|NCT00760474|157444974|FG001|Placebo Washout Period|Other|1|||
48893753|NCT00760474|157444973|FG000|Period 2 (P2)|Lost to Follow-up|1|||
48893754|NCT00760474|157444974|FG001|Period 2 (P2)|Lost to Follow-up|0|||
48893755|NCT00760474|157444973|FG000|Period 2 (P2)|Adverse Event|0|||
48893756|NCT00760474|157444974|FG001|Period 2 (P2)|Adverse Event|1|||
48893757|NCT04677179|157444975|FG000|Induction Treatment Period|Adverse Event|1|||
48893758|NCT04677179|157444976|FG001|Induction Treatment Period|Adverse Event|0|||
48893759|NCT04677179|157444977|FG002|Induction Treatment Period|Adverse Event|0|||
48893760|NCT04677179|157444978|FG003|Induction Treatment Period|Adverse Event|0|||
48893761|NCT04677179|157444979|FG004|Induction Treatment Period|Adverse Event|0|||
48893762|NCT04677179|157444980|FG005|Induction Treatment Period|Adverse Event|0|||
48893763|NCT04677179|157444981|FG006|Induction Treatment Period|Adverse Event|0|||
48893764|NCT04677179|157444982|FG007|Induction Treatment Period|Adverse Event|0|||
48893765|NCT04677179|157444983|FG008|Induction Treatment Period|Adverse Event|0|||
48893766|NCT04677179|157444984|FG009|Induction Treatment Period|Adverse Event|0|||
48893767|NCT04677179|157444975|FG000|Induction Treatment Period|Physician Decision|1|||
48893768|NCT04677179|157444976|FG001|Induction Treatment Period|Physician Decision|0|||
48893769|NCT04677179|157444977|FG002|Induction Treatment Period|Physician Decision|1|||
48893770|NCT04677179|157444978|FG003|Induction Treatment Period|Physician Decision|0|||
48893771|NCT04677179|157444979|FG004|Induction Treatment Period|Physician Decision|0|||
48893772|NCT04677179|157444980|FG005|Induction Treatment Period|Physician Decision|0|||
48893773|NCT04677179|157444981|FG006|Induction Treatment Period|Physician Decision|0|||
48893774|NCT04677179|157444982|FG007|Induction Treatment Period|Physician Decision|0|||
48893775|NCT04677179|157444983|FG008|Induction Treatment Period|Physician Decision|0|||
48893776|NCT04677179|157444984|FG009|Induction Treatment Period|Physician Decision|0|||
48893777|NCT04677179|157444975|FG000|Induction Treatment Period|Protocol Violation|0|||
48893778|NCT04677179|157444976|FG001|Induction Treatment Period|Protocol Violation|1|||
49038186|NCT03677141|157974641|FG003|Overall Study|Physician Decision|0|||
49038187|NCT03677141|157974642|FG004|Overall Study|Physician Decision|1|||
48893779|NCT04677179|157444977|FG002|Induction Treatment Period|Protocol Violation|0|||
48893780|NCT04677179|157444978|FG003|Induction Treatment Period|Protocol Violation|0|||
48893781|NCT04677179|157444979|FG004|Induction Treatment Period|Protocol Violation|0|||
48893782|NCT04677179|157444980|FG005|Induction Treatment Period|Protocol Violation|0|||
48893783|NCT04677179|157444981|FG006|Induction Treatment Period|Protocol Violation|0|||
48893784|NCT04677179|157444982|FG007|Induction Treatment Period|Protocol Violation|0|||
48893785|NCT04677179|157444983|FG008|Induction Treatment Period|Protocol Violation|0|||
48893786|NCT04677179|157444984|FG009|Induction Treatment Period|Protocol Violation|0|||
48893787|NCT04677179|157444975|FG000|Induction Treatment Period|Withdrawal by Subject|4|||
48893788|NCT04677179|157444976|FG001|Induction Treatment Period|Withdrawal by Subject|1|||
48893789|NCT04677179|157444977|FG002|Induction Treatment Period|Withdrawal by Subject|1|||
48893790|NCT04677179|157444978|FG003|Induction Treatment Period|Withdrawal by Subject|0|||
48893791|NCT04677179|157444979|FG004|Induction Treatment Period|Withdrawal by Subject|0|||
48893792|NCT04677179|157444980|FG005|Induction Treatment Period|Withdrawal by Subject|0|||
48893793|NCT04677179|157444981|FG006|Induction Treatment Period|Withdrawal by Subject|0|||
48893794|NCT04677179|157444982|FG007|Induction Treatment Period|Withdrawal by Subject|0|||
48893795|NCT04677179|157444983|FG008|Induction Treatment Period|Withdrawal by Subject|0|||
48893796|NCT04677179|157444984|FG009|Induction Treatment Period|Withdrawal by Subject|0|||
48893797|NCT04677179|157444975|FG000|Induction Treatment Period|Study terminated by sponsor|7|||
48893798|NCT04677179|157444976|FG001|Induction Treatment Period|Study terminated by sponsor|11|||
48893799|NCT04677179|157444977|FG002|Induction Treatment Period|Study terminated by sponsor|0|||
48893800|NCT04677179|157444978|FG003|Induction Treatment Period|Study terminated by sponsor|0|||
48893801|NCT04677179|157444979|FG004|Induction Treatment Period|Study terminated by sponsor|0|||
48893802|NCT04677179|157444980|FG005|Induction Treatment Period|Study terminated by sponsor|0|||
48893803|NCT04677179|157444981|FG006|Induction Treatment Period|Study terminated by sponsor|0|||
48893804|NCT04677179|157444982|FG007|Induction Treatment Period|Study terminated by sponsor|0|||
48893805|NCT04677179|157444983|FG008|Induction Treatment Period|Study terminated by sponsor|0|||
48893806|NCT04677179|157444984|FG009|Induction Treatment Period|Study terminated by sponsor|0|||
48893807|NCT04677179|157444975|FG000|Maintenance Treatment Period|Lack of Efficacy|0|||
48893808|NCT04677179|157444976|FG001|Maintenance Treatment Period|Lack of Efficacy|0|||
48893809|NCT04677179|157444977|FG002|Maintenance Treatment Period|Lack of Efficacy|0|||
48893810|NCT04677179|157444978|FG003|Maintenance Treatment Period|Lack of Efficacy|0|||
48893811|NCT04677179|157444979|FG004|Maintenance Treatment Period|Lack of Efficacy|1|||
48893812|NCT04677179|157444980|FG005|Maintenance Treatment Period|Lack of Efficacy|0|||
48893813|NCT04677179|157444981|FG006|Maintenance Treatment Period|Lack of Efficacy|0|||
48893814|NCT04677179|157444982|FG007|Maintenance Treatment Period|Lack of Efficacy|0|||
48893815|NCT04677179|157444983|FG008|Maintenance Treatment Period|Lack of Efficacy|0|||
48893816|NCT04677179|157444984|FG009|Maintenance Treatment Period|Lack of Efficacy|0|||
48893817|NCT04677179|157444975|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
48893818|NCT04677179|157444976|FG001|Maintenance Treatment Period|Withdrawal by Subject|0|||
48893819|NCT04677179|157444977|FG002|Maintenance Treatment Period|Withdrawal by Subject|0|||
48893820|NCT04677179|157444978|FG003|Maintenance Treatment Period|Withdrawal by Subject|1|||
48893821|NCT04677179|157444979|FG004|Maintenance Treatment Period|Withdrawal by Subject|0|||
48893822|NCT04677179|157444980|FG005|Maintenance Treatment Period|Withdrawal by Subject|0|||
48893823|NCT04677179|157444981|FG006|Maintenance Treatment Period|Withdrawal by Subject|0|||
48893824|NCT04677179|157444982|FG007|Maintenance Treatment Period|Withdrawal by Subject|0|||
48893825|NCT04677179|157444983|FG008|Maintenance Treatment Period|Withdrawal by Subject|0|||
48893826|NCT04677179|157444984|FG009|Maintenance Treatment Period|Withdrawal by Subject|0|||
48893827|NCT04677179|157444975|FG000|Maintenance Treatment Period|Study terminated by sponsor|0|||
48893828|NCT04677179|157444976|FG001|Maintenance Treatment Period|Study terminated by sponsor|0|||
48893829|NCT04677179|157444977|FG002|Maintenance Treatment Period|Study terminated by sponsor|0|||
48893830|NCT04677179|157444978|FG003|Maintenance Treatment Period|Study terminated by sponsor|7|||
48893831|NCT04677179|157444979|FG004|Maintenance Treatment Period|Study terminated by sponsor|9|||
48893832|NCT04677179|157444980|FG005|Maintenance Treatment Period|Study terminated by sponsor|5|||
48893833|NCT04677179|157444981|FG006|Maintenance Treatment Period|Study terminated by sponsor|0|||
48893834|NCT04677179|157444982|FG007|Maintenance Treatment Period|Study terminated by sponsor|0|||
48893835|NCT04677179|157444983|FG008|Maintenance Treatment Period|Study terminated by sponsor|0|||
48893836|NCT04677179|157444984|FG009|Maintenance Treatment Period|Study terminated by sponsor|0|||
48893837|NCT04677179|157444975|FG000|Extension Treatment Period|Lack of Efficacy|0|||
48893838|NCT04677179|157444976|FG001|Extension Treatment Period|Lack of Efficacy|0|||
48893839|NCT04677179|157444977|FG002|Extension Treatment Period|Lack of Efficacy|0|||
48893840|NCT04677179|157444978|FG003|Extension Treatment Period|Lack of Efficacy|0|||
48893841|NCT04677179|157444979|FG004|Extension Treatment Period|Lack of Efficacy|0|||
48893842|NCT04677179|157444980|FG005|Extension Treatment Period|Lack of Efficacy|0|||
48893843|NCT04677179|157444981|FG006|Extension Treatment Period|Lack of Efficacy|6|||
48893844|NCT04677179|157444982|FG007|Extension Treatment Period|Lack of Efficacy|0|||
48893845|NCT04677179|157444983|FG008|Extension Treatment Period|Lack of Efficacy|0|||
48893846|NCT04677179|157444984|FG009|Extension Treatment Period|Lack of Efficacy|0|||
48893847|NCT04677179|157444975|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
48893848|NCT04677179|157444976|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
48893849|NCT04677179|157444977|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
48893850|NCT04677179|157444978|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
48893851|NCT04677179|157444979|FG004|Extension Treatment Period|Withdrawal by Subject|0|||
48893852|NCT04677179|157444980|FG005|Extension Treatment Period|Withdrawal by Subject|0|||
48893853|NCT04677179|157444981|FG006|Extension Treatment Period|Withdrawal by Subject|2|||
48893854|NCT04677179|157444982|FG007|Extension Treatment Period|Withdrawal by Subject|0|||
48893855|NCT04677179|157444983|FG008|Extension Treatment Period|Withdrawal by Subject|0|||
48893856|NCT04677179|157444984|FG009|Extension Treatment Period|Withdrawal by Subject|0|||
48893857|NCT04677179|157444975|FG000|Extension Treatment Period|Study terminated by sponsor|0|||
48893858|NCT04677179|157444976|FG001|Extension Treatment Period|Study terminated by sponsor|0|||
48893859|NCT04677179|157444977|FG002|Extension Treatment Period|Study terminated by sponsor|0|||
48893860|NCT04677179|157444978|FG003|Extension Treatment Period|Study terminated by sponsor|0|||
48893861|NCT04677179|157444979|FG004|Extension Treatment Period|Study terminated by sponsor|0|||
48893862|NCT04677179|157444980|FG005|Extension Treatment Period|Study terminated by sponsor|0|||
48893863|NCT04677179|157444981|FG006|Extension Treatment Period|Study terminated by sponsor|18|||
48893864|NCT04677179|157444982|FG007|Extension Treatment Period|Study terminated by sponsor|0|||
48893865|NCT04677179|157444983|FG008|Extension Treatment Period|Study terminated by sponsor|0|||
48893866|NCT04677179|157444984|FG009|Extension Treatment Period|Study terminated by sponsor|0|||
48893867|NCT04677179|157444975|FG000|Post-Treatment Follow-up Period|Adverse Event|0|||
48893868|NCT04677179|157444976|FG001|Post-Treatment Follow-up Period|Adverse Event|0|||
48893869|NCT04677179|157444977|FG002|Post-Treatment Follow-up Period|Adverse Event|0|||
48893870|NCT04677179|157444978|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
48893871|NCT04677179|157444979|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
48893872|NCT04677179|157444980|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
48893873|NCT04677179|157444981|FG006|Post-Treatment Follow-up Period|Adverse Event|0|||
48893874|NCT04677179|157444982|FG007|Post-Treatment Follow-up Period|Adverse Event|1|||
48893875|NCT04677179|157444983|FG008|Post-Treatment Follow-up Period|Adverse Event|0|||
48893876|NCT04677179|157444984|FG009|Post-Treatment Follow-up Period|Adverse Event|0|||
48893877|NCT04677179|157444975|FG000|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
48893878|NCT04677179|157444976|FG001|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
48893879|NCT04677179|157444977|FG002|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
48893880|NCT04677179|157444978|FG003|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
48893881|NCT04677179|157444979|FG004|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
48893882|NCT04677179|157444980|FG005|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
48893883|NCT04677179|157444981|FG006|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
48893884|NCT04677179|157444982|FG007|Post-Treatment Follow-up Period|Lack of Efficacy|2|||
48893885|NCT04677179|157444983|FG008|Post-Treatment Follow-up Period|Lack of Efficacy|3|||
48893886|NCT04677179|157444984|FG009|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
48893887|NCT04677179|157444975|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
48893888|NCT04677179|157444976|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
48893889|NCT04677179|157444977|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
48893890|NCT04677179|157444978|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
48893891|NCT04677179|157444979|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
48893892|NCT04677179|157444980|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
48893893|NCT04677179|157444981|FG006|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
48893894|NCT04677179|157444982|FG007|Post-Treatment Follow-up Period|Lost to Follow-up|1|||
48893895|NCT04677179|157444983|FG008|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
48893896|NCT04677179|157444984|FG009|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
48893897|NCT04677179|157444975|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
48893898|NCT04677179|157444976|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
48893899|NCT04677179|157444977|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
48893900|NCT04677179|157444978|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
48893901|NCT04677179|157444979|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
48893902|NCT04677179|157444980|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
48893903|NCT04677179|157444981|FG006|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
48893904|NCT04677179|157444982|FG007|Post-Treatment Follow-up Period|Withdrawal by Subject|3|||
48893905|NCT04677179|157444983|FG008|Post-Treatment Follow-up Period|Withdrawal by Subject|1|||
48893906|NCT04677179|157444984|FG009|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
48893907|NCT04677179|157444975|FG000|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
48893908|NCT04677179|157444976|FG001|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
48893909|NCT04677179|157444977|FG002|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
48893910|NCT04677179|157444978|FG003|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
48893911|NCT04677179|157444979|FG004|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
48893912|NCT04677179|157444980|FG005|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
49038188|NCT03677141|157974643|FG005|Overall Study|Physician Decision|0|||
49038189|NCT03677141|157974638|FG000|Overall Study|Withdrawal by Subject|0|||
49038190|NCT03677141|157974639|FG001|Overall Study|Withdrawal by Subject|0|||
49038191|NCT03677141|157974640|FG002|Overall Study|Withdrawal by Subject|1|||
49038192|NCT03677141|157974641|FG003|Overall Study|Withdrawal by Subject|1|||
49038193|NCT03677141|157974642|FG004|Overall Study|Withdrawal by Subject|1|||
49038194|NCT03677141|157974643|FG005|Overall Study|Withdrawal by Subject|0|||
49038195|NCT00573313|157974646|FG000|Overall Study|Protocol Violation|5|||
49038196|NCT00573313|157974647|FG001|Overall Study|Protocol Violation|0|||
49038197|NCT00573313|157974648|FG002|Overall Study|Protocol Violation|6|||
49038198|NCT00573313|157974649|FG003|Overall Study|Protocol Violation|0|||
49038199|NCT01229150|157974655|FG000|Overall Study|Toxicity|2|||
49038200|NCT01229150|157974656|FG001|Overall Study|Toxicity|2|||
49038201|NCT01229150|157974657|FG002|Overall Study|Toxicity|0|||
49038202|NCT01229150|157974658|FG003|Overall Study|Toxicity|0|||
49038203|NCT03500094|157974664|FG000|Overall Study|Withdrawal by Subject|1|||
49038204|NCT03500094|157974664|FG000|Overall Study|Withdrawal by Parent or Legally-authorized Representative|1|||
49038205|NCT03500094|157974664|FG000|Overall Study|Lost to Follow-up|1|||
49038206|NCT03201003|157974665|FG000|Overall Study|Adverse Event|14|||
49038207|NCT03201003|157974666|FG001|Overall Study|Adverse Event|1|||
49038208|NCT03201003|157974665|FG000|Overall Study|Other reasons|5|||
49038209|NCT03201003|157974666|FG001|Overall Study|Other reasons|1|||
49038210|NCT03201003|157974665|FG000|Overall Study|Withdrawal by Subject|4|||
49038211|NCT03201003|157974666|FG001|Overall Study|Withdrawal by Subject|1|||
49038212|NCT03201003|157974665|FG000|Overall Study|Lost to Follow-up|2|||
49038213|NCT03201003|157974666|FG001|Overall Study|Lost to Follow-up|0|||
49038214|NCT03201003|157974665|FG000|Overall Study|Protocol Violation|1|||
49038215|NCT03201003|157974666|FG001|Overall Study|Protocol Violation|0|||
49038216|NCT05068284|157974667|FG000|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|2|||
49038217|NCT05068284|157974668|FG001|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|3|||
49038218|NCT05068284|157974669|FG002|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
49038219|NCT05068284|157974670|FG003|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
48893913|NCT04677179|157444981|FG006|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
48893914|NCT04677179|157444982|FG007|Post-Treatment Follow-up Period|Study terminated by sponsor|18|||
48893915|NCT04677179|157444983|FG008|Post-Treatment Follow-up Period|Study terminated by sponsor|26|||
48893916|NCT04677179|157444984|FG009|Post-Treatment Follow-up Period|Study terminated by sponsor|11|||
48893917|NCT00467285|157444986|FG000|Overall Study|Lost to Follow-up|4|||
48893918|NCT00467285|157444987|FG001|Overall Study|Lost to Follow-up|4|||
48893919|NCT05020327|157446357|FG000|Overall Study|Physician Decision|3|||
48893920|NCT05020327|157446358|FG001|Overall Study|Physician Decision|0|||
48893921|NCT05020327|157446359|FG002|Overall Study|Physician Decision|0|||
48893922|NCT05020327|157446357|FG000|Overall Study|Withdrawal by Subject|1|||
48893923|NCT05020327|157446358|FG001|Overall Study|Withdrawal by Subject|1|||
48893924|NCT05020327|157446359|FG002|Overall Study|Withdrawal by Subject|0|||
48893925|NCT05020327|157446357|FG000|Overall Study|personal/cultural, ineligible|12|||
48893926|NCT05020327|157446358|FG001|Overall Study|personal/cultural, ineligible|0|||
48893927|NCT05020327|157446359|FG002|Overall Study|personal/cultural, ineligible|0|||
48893928|NCT00833261|157446360|FG000|Overall Study|Withdrawal by Subject|4|||
48893929|NCT00605215|157446361|FG000|Overall Study|Death|0|||
48893930|NCT00605215|157446362|FG001|Overall Study|Death|0|||
48893931|NCT00605215|157446363|FG002|Overall Study|Death|1|||
48893932|NCT00605215|157446361|FG000|Overall Study|Adverse Event|19|||
48893933|NCT00605215|157446362|FG001|Overall Study|Adverse Event|21|||
48893934|NCT00605215|157446363|FG002|Overall Study|Adverse Event|26|||
48893935|NCT00605215|157446361|FG000|Overall Study|Refusal to sign the re-consent form|8|||
48893936|NCT00605215|157446362|FG001|Overall Study|Refusal to sign the re-consent form|3|||
48893937|NCT00605215|157446363|FG002|Overall Study|Refusal to sign the re-consent form|3|||
48893938|NCT00605215|157446361|FG000|Overall Study|Withdrawal by Subject|39|||
48893939|NCT00605215|157446362|FG001|Overall Study|Withdrawal by Subject|37|||
48893940|NCT00605215|157446363|FG002|Overall Study|Withdrawal by Subject|27|||
48893941|NCT00605215|157446361|FG000|Overall Study|Request of Primary Care Physician or Investigator|6|||
48893942|NCT00605215|157446362|FG001|Overall Study|Request of Primary Care Physician or Investigator|4|||
48893943|NCT00605215|157446363|FG002|Overall Study|Request of Primary Care Physician or Investigator|4|||
48893944|NCT00605215|157446361|FG000|Overall Study|Protocol Violation|3|||
48893945|NCT00605215|157446362|FG001|Overall Study|Protocol Violation|4|||
48893946|NCT00605215|157446363|FG002|Overall Study|Protocol Violation|1|||
48893947|NCT00605215|157446361|FG000|Overall Study|Pregnancy|8|||
49038220|NCT05068284|157974671|FG004|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
49038221|NCT05068284|157974672|FG005|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
49038222|NCT05068284|157974673|FG006|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
49038223|NCT05068284|157974674|FG007|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
48893948|NCT00605215|157446362|FG001|Overall Study|Pregnancy|5|||
48893949|NCT00605215|157446363|FG002|Overall Study|Pregnancy|4|||
48893950|NCT00605215|157446361|FG000|Overall Study|Lost to Follow-up|8|||
48893951|NCT00605215|157446362|FG001|Overall Study|Lost to Follow-up|5|||
49038224|NCT05068284|157974667|FG000|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
49038225|NCT05068284|157974668|FG001|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
48893952|NCT00605215|157446363|FG002|Overall Study|Lost to Follow-up|2|||
48893953|NCT00605215|157446361|FG000|Overall Study|Other than specified|0|||
48893954|NCT00605215|157446362|FG001|Overall Study|Other than specified|2|||
48893955|NCT00605215|157446363|FG002|Overall Study|Other than specified|1|||
48893956|NCT01034176|157446365|FG000|Overall Study|Physician Decision|2|||
48893957|NCT01034176|157446366|FG001|Overall Study|Physician Decision|0|||
48893958|NCT01034176|157446365|FG000|Overall Study|Withdrawal by Subject|0|||
48893959|NCT01034176|157446366|FG001|Overall Study|Withdrawal by Subject|1|||
48893960|NCT01034176|157446365|FG000|Overall Study|Lost to Follow-up|0|||
49038226|NCT05068284|157974669|FG002|Double-Blind Induction (12 Weeks)|Adverse Event|3|||
49038227|NCT05068284|157974670|FG003|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
49038228|NCT05068284|157974671|FG004|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
49038229|NCT05068284|157974672|FG005|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
49038230|NCT05068284|157974673|FG006|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
49038231|NCT05068284|157974674|FG007|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
48893961|NCT01034176|157446366|FG001|Overall Study|Lost to Follow-up|1|||
48893962|NCT04343872|157446367|FG000|Overall Study|Lost to Follow-up|6|||
48893963|NCT04343872|157446368|FG001|Overall Study|Lost to Follow-up|3|||
48893964|NCT00423943|157446373|FG000|Overall Study|Withdrawal by Subject|3|||
48893965|NCT00423943|157446374|FG001|Overall Study|Withdrawal by Subject|1|||
48893966|NCT00581555|157446375|FG000|Overall Study|Adverse Event|4|||
48893967|NCT00581555|157446376|FG001|Overall Study|Adverse Event|3|||
48893968|NCT00581555|157446375|FG000|Overall Study|Physician Decision|3|||
48893969|NCT00581555|157446376|FG001|Overall Study|Physician Decision|2|||
48893970|NCT00581555|157446375|FG000|Overall Study|Withdrawal by Subject|18|||
48893971|NCT00581555|157446376|FG001|Overall Study|Withdrawal by Subject|9|||
48893972|NCT00581555|157446375|FG000|Overall Study|Lost to Follow-up|2|||
48893973|NCT00581555|157446376|FG001|Overall Study|Lost to Follow-up|2|||
48893974|NCT00581555|157446375|FG000|Overall Study|Other reasons|16|||
48893975|NCT00581555|157446376|FG001|Overall Study|Other reasons|4|||
48893976|NCT00194987|157446377|FG000|Overall Study|Withdrawal by Subject|0|||
48893977|NCT00194987|157446378|FG001|Overall Study|Withdrawal by Subject|3|||
48893978|NCT01901341|157446384|FG000|Overall Study|Adverse Event|4|||
49038232|NCT05068284|157974667|FG000|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|7|||
49038233|NCT05068284|157974668|FG001|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|2|||
49038234|NCT05068284|157974669|FG002|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|6|||
49038235|NCT05068284|157974670|FG003|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|5|||
49038236|NCT05068284|157974671|FG004|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|10|||
49038237|NCT05068284|157974672|FG005|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
49038238|NCT05068284|157974673|FG006|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
49038239|NCT05068284|157974674|FG007|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
49038240|NCT05068284|157974667|FG000|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
49038241|NCT05068284|157974668|FG001|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
49038242|NCT05068284|157974669|FG002|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
49038243|NCT05068284|157974670|FG003|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
49038244|NCT05068284|157974671|FG004|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
49038245|NCT05068284|157974672|FG005|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
48893979|NCT01901341|157446385|FG001|Overall Study|Adverse Event|2|||
48893980|NCT01901341|157446384|FG000|Overall Study|Lack of Efficacy|0|||
48893981|NCT01901341|157446385|FG001|Overall Study|Lack of Efficacy|2|||
48893982|NCT01901341|157446384|FG000|Overall Study|Lost to Follow-up|0|||
48893983|NCT01901341|157446385|FG001|Overall Study|Lost to Follow-up|1|||
48893984|NCT01901341|157446384|FG000|Overall Study|Protocol Violation|2|||
48893985|NCT01901341|157446385|FG001|Overall Study|Protocol Violation|0|||
48893986|NCT01901341|157446384|FG000|Overall Study|Study Terminated by Sponsor|13|||
48893987|NCT01901341|157446385|FG001|Overall Study|Study Terminated by Sponsor|15|||
48893988|NCT01901341|157446384|FG000|Overall Study|Withdrawal by Subject|1|||
48893989|NCT01901341|157446385|FG001|Overall Study|Withdrawal by Subject|1|||
48893990|NCT02399254|157446386|FG000|Overall Study|Physician Decision|2|||
48893991|NCT01737827|157446387|FG000|Overall Study|Adverse Event|3|||
48893992|NCT01737827|157446388|FG001|Overall Study|Adverse Event|6|||
48893993|NCT01737827|157446389|FG002|Overall Study|Adverse Event|0|||
48893994|NCT01737827|157446387|FG000|Overall Study|Lost to Follow-up|0|||
48893995|NCT01737827|157446388|FG001|Overall Study|Lost to Follow-up|1|||
48893996|NCT01737827|157446389|FG002|Overall Study|Lost to Follow-up|0|||
48893997|NCT01737827|157446387|FG000|Overall Study|Physician Decision|0|||
48893998|NCT01737827|157446388|FG001|Overall Study|Physician Decision|2|||
48893999|NCT01737827|157446389|FG002|Overall Study|Physician Decision|0|||
48894000|NCT01737827|157446387|FG000|Overall Study|Progressive Disease|5|||
48894001|NCT01737827|157446388|FG001|Overall Study|Progressive Disease|16|||
48894002|NCT01737827|157446389|FG002|Overall Study|Progressive Disease|2|||
48894003|NCT01737827|157446387|FG000|Overall Study|Study Terminated by Sponsor|0|||
48894004|NCT01737827|157446388|FG001|Overall Study|Study Terminated by Sponsor|1|||
48894005|NCT01737827|157446389|FG002|Overall Study|Study Terminated by Sponsor|0|||
48894006|NCT01737827|157446387|FG000|Overall Study|Subject/Guardian Decision|0|||
48894007|NCT01737827|157446388|FG001|Overall Study|Subject/Guardian Decision|2|||
48894008|NCT01737827|157446389|FG002|Overall Study|Subject/Guardian Decision|0|||
48894009|NCT00439231|157446390|FG000|Overall Study|Lack of Efficacy|28|||
48894010|NCT03702231|157446391|FG000|Overall Study|Withdrawal by Subject|1|||
48894011|NCT03702231|157446392|FG001|Overall Study|Withdrawal by Subject|0|||
48894012|NCT03702231|157446393|FG002|Overall Study|Withdrawal by Subject|0|||
48894013|NCT03702231|157446391|FG000|Overall Study|Protocol Violation|0|||
48894014|NCT03702231|157446392|FG001|Overall Study|Protocol Violation|0|||
48894015|NCT03702231|157446393|FG002|Overall Study|Protocol Violation|1|||
48894016|NCT03702231|157446391|FG000|Overall Study|Change in CLL Treatment|0|||
48894017|NCT03702231|157446392|FG001|Overall Study|Change in CLL Treatment|0|||
48894018|NCT03702231|157446393|FG002|Overall Study|Change in CLL Treatment|1|||
48894019|NCT03702231|157446391|FG000|Overall Study|COVID Pandemic|1|||
48894020|NCT03702231|157446392|FG001|Overall Study|COVID Pandemic|4|||
48894021|NCT03702231|157446393|FG002|Overall Study|COVID Pandemic|1|||
48894022|NCT03702231|157446391|FG000|Overall Study|Non-compliance|0|||
48894023|NCT03702231|157446392|FG001|Overall Study|Non-compliance|0|||
48894024|NCT03702231|157446393|FG002|Overall Study|Non-compliance|1|||
48894025|NCT02549196|157446397|FG000|Overall Study|Protocol Violation|0|||
48894026|NCT02549196|157446398|FG001|Overall Study|Protocol Violation|0|||
48894027|NCT02549196|157446399|FG002|Overall Study|Protocol Violation|0|||
48894028|NCT02549196|157446400|FG003|Overall Study|Protocol Violation|1|||
48894029|NCT02549196|157446397|FG000|Overall Study|Withdrawal by Subject|1|||
48894030|NCT02549196|157446398|FG001|Overall Study|Withdrawal by Subject|0|||
48894031|NCT02549196|157446399|FG002|Overall Study|Withdrawal by Subject|1|||
48894032|NCT02549196|157446400|FG003|Overall Study|Withdrawal by Subject|0|||
48894033|NCT03426605|157446401|FG000|Overall Study|AML relapse or progression|2|||
48894034|NCT03426605|157446402|FG001|Overall Study|AML relapse or progression|1|||
48894035|NCT03426605|157446403|FG002|Overall Study|AML relapse or progression|2|||
48894036|NCT03426605|157446404|FG003|Overall Study|AML relapse or progression|2|||
48894037|NCT03426605|157446401|FG000|Overall Study|Treatment failure|3|||
48894038|NCT03426605|157446402|FG001|Overall Study|Treatment failure|2|||
48894039|NCT03426605|157446403|FG002|Overall Study|Treatment failure|0|||
48894040|NCT03426605|157446404|FG003|Overall Study|Treatment failure|0|||
48894041|NCT03426605|157446401|FG000|Overall Study|Adverse Event|1|||
48894042|NCT03426605|157446402|FG001|Overall Study|Adverse Event|0|||
48894043|NCT03426605|157446403|FG002|Overall Study|Adverse Event|1|||
48894044|NCT03426605|157446404|FG003|Overall Study|Adverse Event|1|||
49038246|NCT05068284|157974673|FG006|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
49038247|NCT05068284|157974674|FG007|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
49038248|NCT05068284|157974667|FG000|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
49038249|NCT05068284|157974668|FG001|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
49038250|NCT05068284|157974669|FG002|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
49038251|NCT05068284|157974670|FG003|Double-Blind Re-Induction (12 Weeks)|Adverse Event|2|||
49038252|NCT05068284|157974671|FG004|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
49038253|NCT05068284|157974672|FG005|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
49038254|NCT05068284|157974673|FG006|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
49038255|NCT05068284|157974674|FG007|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
49038256|NCT05068284|157974667|FG000|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
48894045|NCT03426605|157446401|FG000|Overall Study|Withdrawal by Subject|0|||
48894046|NCT03426605|157446402|FG001|Overall Study|Withdrawal by Subject|0|||
48894047|NCT03426605|157446403|FG002|Overall Study|Withdrawal by Subject|1|||
48894048|NCT03426605|157446404|FG003|Overall Study|Withdrawal by Subject|1|||
48894049|NCT00185965|157446405|FG000|Overall Study|Adverse Event|0|||
48894050|NCT00185965|157446406|FG001|Overall Study|Adverse Event|1|||
48894051|NCT02047903|157446409|FG000|Overall Study|Adverse Event|14|||
48894052|NCT02047903|157446409|FG000|Overall Study|Serious adverse event|10|||
48894053|NCT02047903|157446409|FG000|Overall Study|Withdrawal by Subject|16|||
48894054|NCT02047903|157446409|FG000|Overall Study|Lost to Follow-up|4|||
48894055|NCT02047903|157446409|FG000|Overall Study|Reason not listed|6|||
48894056|NCT02047903|157446409|FG000|Overall Study|Not Treated|9|||
48894057|NCT00196976|157446410|FG000|Primary Study|Migrated from study area|0|||
48894058|NCT00196976|157446411|FG001|Primary Study|Migrated from study area|0|||
48894059|NCT00196976|157446412|FG002|Primary Study|Migrated from study area|0|||
48894060|NCT00196976|157446413|FG003|Primary Study|Migrated from study area|0|||
48894061|NCT00196976|157446414|FG004|Primary Study|Migrated from study area|0|||
48894062|NCT00196976|157446415|FG005|Primary Study|Migrated from study area|0|||
48894063|NCT00196976|157446416|FG006|Primary Study|Migrated from study area|0|||
48894064|NCT00196976|157446417|FG007|Primary Study|Migrated from study area|1|||
48894065|NCT00196976|157446418|FG008|Primary Study|Migrated from study area|0|||
48894066|NCT00196976|157446419|FG009|Primary Study|Migrated from study area|0|||
48894067|NCT00196976|157446420|FG010|Primary Study|Migrated from study area|0|||
48894068|NCT00196976|157446421|FG011|Primary Study|Migrated from study area|0|||
48894069|NCT00196976|157446422|FG012|Primary Study|Migrated from study area|0|||
48894070|NCT00196976|157446423|FG013|Primary Study|Migrated from study area|0|||
48894071|NCT00196976|157446410|FG000|Primary Study|Protocol Violation|0|||
48894072|NCT00196976|157446411|FG001|Primary Study|Protocol Violation|1|||
48894073|NCT00196976|157446412|FG002|Primary Study|Protocol Violation|1|||
48894074|NCT00196976|157446413|FG003|Primary Study|Protocol Violation|0|||
48894075|NCT00196976|157446414|FG004|Primary Study|Protocol Violation|0|||
48894076|NCT00196976|157446415|FG005|Primary Study|Protocol Violation|0|||
48894077|NCT00196976|157446416|FG006|Primary Study|Protocol Violation|0|||
48894078|NCT00196976|157446417|FG007|Primary Study|Protocol Violation|0|||
48894079|NCT00196976|157446418|FG008|Primary Study|Protocol Violation|0|||
48894080|NCT00196976|157446419|FG009|Primary Study|Protocol Violation|0|||
48894081|NCT00196976|157446420|FG010|Primary Study|Protocol Violation|0|||
48894082|NCT00196976|157446421|FG011|Primary Study|Protocol Violation|0|||
48894083|NCT00196976|157446422|FG012|Primary Study|Protocol Violation|0|||
48894084|NCT00196976|157446423|FG013|Primary Study|Protocol Violation|0|||
48894085|NCT00196976|157446410|FG000|Primary Study|Withdrawal by Subject|1|||
48894086|NCT00196976|157446411|FG001|Primary Study|Withdrawal by Subject|0|||
48894087|NCT00196976|157446412|FG002|Primary Study|Withdrawal by Subject|1|||
48894088|NCT00196976|157446413|FG003|Primary Study|Withdrawal by Subject|1|||
48894089|NCT00196976|157446414|FG004|Primary Study|Withdrawal by Subject|2|||
48894090|NCT00196976|157446415|FG005|Primary Study|Withdrawal by Subject|1|||
48894091|NCT00196976|157446416|FG006|Primary Study|Withdrawal by Subject|0|||
48894092|NCT00196976|157446417|FG007|Primary Study|Withdrawal by Subject|0|||
48894093|NCT00196976|157446418|FG008|Primary Study|Withdrawal by Subject|0|||
48894094|NCT00196976|157446419|FG009|Primary Study|Withdrawal by Subject|1|||
48894095|NCT00196976|157446420|FG010|Primary Study|Withdrawal by Subject|0|||
48894096|NCT00196976|157446421|FG011|Primary Study|Withdrawal by Subject|0|||
48894097|NCT00196976|157446422|FG012|Primary Study|Withdrawal by Subject|0|||
48894098|NCT00196976|157446423|FG013|Primary Study|Withdrawal by Subject|0|||
48894099|NCT00196976|157446410|FG000|Primary Study|Lost to Follow-up|0|||
48894100|NCT00196976|157446411|FG001|Primary Study|Lost to Follow-up|0|||
48894101|NCT00196976|157446412|FG002|Primary Study|Lost to Follow-up|0|||
48894102|NCT00196976|157446413|FG003|Primary Study|Lost to Follow-up|0|||
48894103|NCT00196976|157446414|FG004|Primary Study|Lost to Follow-up|1|||
48894104|NCT00196976|157446415|FG005|Primary Study|Lost to Follow-up|1|||
48894105|NCT00196976|157446416|FG006|Primary Study|Lost to Follow-up|0|||
48894106|NCT00196976|157446417|FG007|Primary Study|Lost to Follow-up|2|||
48894107|NCT00196976|157446418|FG008|Primary Study|Lost to Follow-up|0|||
48894108|NCT00196976|157446419|FG009|Primary Study|Lost to Follow-up|0|||
48894109|NCT00196976|157446420|FG010|Primary Study|Lost to Follow-up|0|||
48894110|NCT00196976|157446421|FG011|Primary Study|Lost to Follow-up|0|||
48894111|NCT00196976|157446422|FG012|Primary Study|Lost to Follow-up|0|||
48894112|NCT00196976|157446423|FG013|Primary Study|Lost to Follow-up|0|||
48894113|NCT00196976|157446410|FG000|Primary Study|Other|0|||
48894114|NCT00196976|157446411|FG001|Primary Study|Other|0|||
48894115|NCT00196976|157446412|FG002|Primary Study|Other|2|||
48894116|NCT00196976|157446413|FG003|Primary Study|Other|0|||
48894117|NCT00196976|157446414|FG004|Primary Study|Other|0|||
48894118|NCT00196976|157446415|FG005|Primary Study|Other|0|||
48894119|NCT00196976|157446416|FG006|Primary Study|Other|0|||
48894120|NCT00196976|157446417|FG007|Primary Study|Other|0|||
48894121|NCT00196976|157446418|FG008|Primary Study|Other|0|||
48894122|NCT00196976|157446419|FG009|Primary Study|Other|0|||
48894123|NCT00196976|157446420|FG010|Primary Study|Other|0|||
48894124|NCT00196976|157446421|FG011|Primary Study|Other|0|||
48894125|NCT00196976|157446422|FG012|Primary Study|Other|0|||
48894126|NCT00196976|157446423|FG013|Primary Study|Other|0|||
48894127|NCT00196976|157446410|FG000|Booster Study|Withdrawal by Subject|0|||
48894128|NCT00196976|157446411|FG001|Booster Study|Withdrawal by Subject|0|||
48894129|NCT00196976|157446412|FG002|Booster Study|Withdrawal by Subject|0|||
48894130|NCT00196976|157446413|FG003|Booster Study|Withdrawal by Subject|0|||
48894131|NCT00196976|157446414|FG004|Booster Study|Withdrawal by Subject|0|||
48894132|NCT00196976|157446415|FG005|Booster Study|Withdrawal by Subject|0|||
48894133|NCT00196976|157446416|FG006|Booster Study|Withdrawal by Subject|0|||
48894134|NCT00196976|157446417|FG007|Booster Study|Withdrawal by Subject|0|||
48894135|NCT00196976|157446418|FG008|Booster Study|Withdrawal by Subject|0|||
48894136|NCT00196976|157446419|FG009|Booster Study|Withdrawal by Subject|0|||
48894137|NCT00196976|157446420|FG010|Booster Study|Withdrawal by Subject|1|||
48894138|NCT00196976|157446421|FG011|Booster Study|Withdrawal by Subject|0|||
48894139|NCT00196976|157446422|FG012|Booster Study|Withdrawal by Subject|0|||
48894140|NCT00196976|157446423|FG013|Booster Study|Withdrawal by Subject|0|||
49038257|NCT05068284|157974668|FG001|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
48894141|NCT00196976|157446410|FG000|Booster Study|Lost to Follow-up|0|||
48894142|NCT00196976|157446411|FG001|Booster Study|Lost to Follow-up|0|||
48894143|NCT00196976|157446412|FG002|Booster Study|Lost to Follow-up|0|||
48894144|NCT00196976|157446413|FG003|Booster Study|Lost to Follow-up|0|||
48894145|NCT00196976|157446414|FG004|Booster Study|Lost to Follow-up|0|||
48894146|NCT00196976|157446415|FG005|Booster Study|Lost to Follow-up|0|||
48894147|NCT00196976|157446416|FG006|Booster Study|Lost to Follow-up|0|||
48894148|NCT00196976|157446417|FG007|Booster Study|Lost to Follow-up|0|||
48894149|NCT00196976|157446418|FG008|Booster Study|Lost to Follow-up|0|||
48894150|NCT00196976|157446419|FG009|Booster Study|Lost to Follow-up|0|||
48894151|NCT00196976|157446420|FG010|Booster Study|Lost to Follow-up|1|||
48894152|NCT00196976|157446421|FG011|Booster Study|Lost to Follow-up|2|||
48894153|NCT00196976|157446422|FG012|Booster Study|Lost to Follow-up|0|||
48894154|NCT00196976|157446423|FG013|Booster Study|Lost to Follow-up|0|||
48894155|NCT01942590|157446424|FG000|Overall Study|Withdrawal by Subject|0|||
48894156|NCT01942590|157446425|FG001|Overall Study|Withdrawal by Subject|1|||
48894157|NCT01942590|157446424|FG000|Overall Study|Adverse Event|1|||
48894158|NCT01942590|157446425|FG001|Overall Study|Adverse Event|0|||
48894159|NCT01139580|157446427|FG000|Overall Study|Adverse Event|5|||
48894160|NCT01139580|157446428|FG001|Overall Study|Adverse Event|4|||
48894161|NCT01139580|157446427|FG000|Overall Study|Lost to Follow-up|9|||
48894162|NCT01139580|157446428|FG001|Overall Study|Lost to Follow-up|1|||
48894163|NCT01139580|157446427|FG000|Overall Study|Lack of Efficacy|0|||
48894164|NCT01139580|157446428|FG001|Overall Study|Lack of Efficacy|2|||
48894165|NCT01139580|157446427|FG000|Overall Study|Withdrawal by Subject|6|||
48894166|NCT01139580|157446428|FG001|Overall Study|Withdrawal by Subject|9|||
48894167|NCT01139580|157446427|FG000|Overall Study|Used Excluded Medicine After Enrollment|1|||
48894168|NCT01139580|157446428|FG001|Overall Study|Used Excluded Medicine After Enrollment|0|||
48894169|NCT01139580|157446427|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
48894170|NCT01139580|157446428|FG001|Overall Study|Did Not Meet Exclusion Criteria|0|||
48894171|NCT01139580|157446427|FG000|Overall Study|Misrandomized|1|||
48894172|NCT01139580|157446428|FG001|Overall Study|Misrandomized|0|||
48894173|NCT01139580|157446427|FG000|Overall Study|Beginning Study Exclusion Treatment|0|||
48894174|NCT01139580|157446428|FG001|Overall Study|Beginning Study Exclusion Treatment|1|||
48894175|NCT01139580|157446427|FG000|Overall Study|Participant Randomization in Error|0|||
48894176|NCT01139580|157446428|FG001|Overall Study|Participant Randomization in Error|1|||
48894177|NCT02679508|157446430|FG000|Healing Phase|Protocol Violation|1|||
48894178|NCT02679508|157446431|FG001|Healing Phase|Protocol Violation|1|||
48894179|NCT02679508|157446430|FG000|Healing Phase|Lost to Follow-up|1|||
48894180|NCT02679508|157446431|FG001|Healing Phase|Lost to Follow-up|0|||
48894181|NCT02679508|157446430|FG000|Maintenance Phase|Adverse Event|12|||
48894182|NCT02679508|157446431|FG001|Maintenance Phase|Adverse Event|2|||
48894183|NCT02679508|157446430|FG000|Maintenance Phase|Lost to Follow-up|0|||
48894184|NCT02679508|157446431|FG001|Maintenance Phase|Lost to Follow-up|1|||
48894185|NCT02679508|157446430|FG000|Maintenance Phase|Withdrawal by Subject|15|||
48894186|NCT02679508|157446431|FG001|Maintenance Phase|Withdrawal by Subject|8|||
48894187|NCT02679508|157446430|FG000|Maintenance Phase|Other|5|||
48894188|NCT02679508|157446431|FG001|Maintenance Phase|Other|4|||
48894189|NCT00572039|157446451|FG000|Overall Study|Withdrawal by Subject|9|||
48894190|NCT00572039|157446452|FG001|Overall Study|Withdrawal by Subject|6|||
48894191|NCT00572039|157446451|FG000|Overall Study|Death|2|||
48894192|NCT00572039|157446452|FG001|Overall Study|Death|3|||
48894193|NCT00572039|157446451|FG000|Overall Study|Ill|5|||
48894194|NCT00572039|157446452|FG001|Overall Study|Ill|1|||
48894195|NCT02112708|157446457|FG000|Baseline|Physician Decision|16|||
48894196|NCT02112708|157446458|FG001|Baseline|Physician Decision|11|||
48894197|NCT02112708|157446457|FG000|Baseline|Lost to Follow-up|12|||
48894198|NCT02112708|157446458|FG001|Baseline|Lost to Follow-up|0|||
48894199|NCT02112708|157446457|FG000|4 Month|Death|0|||
48894200|NCT02112708|157446458|FG001|4 Month|Death|1|||
48894201|NCT02112708|157446457|FG000|4 Month|Withdrawal by Subject|12|||
48894202|NCT02112708|157446458|FG001|4 Month|Withdrawal by Subject|0|||
48894203|NCT04540887|157446460|FG000|Overall Study|Withdrawal by Subject|2|||
48894204|NCT03965351|157446461|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
48894205|NCT03965351|157446462|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
48894206|NCT03965351|157446461|FG000|Second Intervention (4 Weeks)|Adverse Event|0|||
48894207|NCT03965351|157446462|FG001|Second Intervention (4 Weeks)|Adverse Event|1|||
48894208|NCT00953745|157446464|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1|||
48894209|NCT00953745|157446465|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0|||
48894210|NCT00953745|157446464|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2|||
48894211|NCT00953745|157446465|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0|||
48894212|NCT00953745|157446464|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3|||
48894213|NCT00953745|157446465|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0|||
48894214|NCT00953745|157446464|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1|||
48894215|NCT00953745|157446465|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0|||
48894216|NCT00953745|157446464|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6|||
48894217|NCT00953745|157446465|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0|||
48894218|NCT00953745|157446464|FG000|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1|||
48894219|NCT00953745|157446465|FG001|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0|||
48894220|NCT01323972|157446466|FG000|Overall Study|Withdrawal by Subject|1|||
48894221|NCT01323972|157446467|FG001|Overall Study|Withdrawal by Subject|0|||
48894222|NCT01323972|157446468|FG002|Overall Study|Withdrawal by Subject|1|||
48984132|NCT01693562|157774122|FG001|Escalation Phase|Other|0|||
48894223|NCT01323972|157446469|FG003|Overall Study|Withdrawal by Subject|0|||
48894224|NCT01323972|157446466|FG000|Overall Study|Migrated/moved from study area|1|||
48894225|NCT01323972|157446467|FG001|Overall Study|Migrated/moved from study area|2|||
48894226|NCT01323972|157446468|FG002|Overall Study|Migrated/moved from study area|0|||
48894227|NCT01323972|157446469|FG003|Overall Study|Migrated/moved from study area|0|||
48894228|NCT01323972|157446466|FG000|Overall Study|Lost to Follow-up|0|||
48894229|NCT01323972|157446467|FG001|Overall Study|Lost to Follow-up|1|||
48894230|NCT01323972|157446468|FG002|Overall Study|Lost to Follow-up|1|||
48894231|NCT01323972|157446469|FG003|Overall Study|Lost to Follow-up|1|||
48894232|NCT03218397|157446470|FG000|Overall Study|Prior positive blood culture|8|||
48894233|NCT03218397|157446471|FG001|Overall Study|Prior positive blood culture|13|||
48894234|NCT03218397|157446470|FG000|Overall Study|Comfort care|8|||
48894235|NCT03218397|157446471|FG001|Overall Study|Comfort care|5|||
48894236|NCT03218397|157446470|FG000|Overall Study|Comfort care and positive blood culture|1|||
48894237|NCT03218397|157446471|FG001|Overall Study|Comfort care and positive blood culture|0|||
48894238|NCT03218397|157446470|FG000|Overall Study|Comfort care and mixed culture|0|||
48894239|NCT03218397|157446471|FG001|Overall Study|Comfort care and mixed culture|1|||
48894240|NCT03218397|157446470|FG000|Overall Study|Mixed culture|2|||
48894241|NCT03218397|157446471|FG001|Overall Study|Mixed culture|2|||
48894242|NCT03218397|157446470|FG000|Overall Study|Inaccessible hospital records|2|||
48894243|NCT03218397|157446471|FG001|Overall Study|Inaccessible hospital records|5|||
48894244|NCT03218397|157446470|FG000|Overall Study|No gram-negative bacilli (GNB)|0|||
48894245|NCT03218397|157446471|FG001|Overall Study|No gram-negative bacilli (GNB)|2|||
48894246|NCT03218397|157446470|FG000|Overall Study|Randomized during laboratory off hours|2|||
48894247|NCT03218397|157446471|FG001|Overall Study|Randomized during laboratory off hours|1|||
48894248|NCT01796548|157446472|FG000|Overall Study|Lost to Follow-up|1|||
48894249|NCT01796548|157446472|FG000|Overall Study|Other|2|||
48894250|NCT02665338|157446473|FG000|Overall Study|Withdrawal by Subject|0|||
48894251|NCT02665338|157446474|FG001|Overall Study|Withdrawal by Subject|1|||
48894252|NCT02008877|157446475|FG000|Overall Study|Inevaluable|0|||
48894253|NCT02008877|157446476|FG001|Overall Study|Inevaluable|1|||
48894254|NCT02008877|157446477|FG002|Overall Study|Inevaluable|0|||
48894255|NCT00903682|157446481|FG000|Overall Study|Adverse Event|6|||
48894256|NCT00903682|157446482|FG001|Overall Study|Adverse Event|13|||
48894257|NCT00903682|157446481|FG000|Overall Study|Lost to Follow-up|1|||
48894258|NCT00903682|157446482|FG001|Overall Study|Lost to Follow-up|0|||
48894259|NCT00903682|157446481|FG000|Overall Study|Withdrawal by Subject|5|||
48894260|NCT00903682|157446482|FG001|Overall Study|Withdrawal by Subject|0|||
48894261|NCT00903682|157446481|FG000|Overall Study|Pregnancy|0|||
48894262|NCT00903682|157446482|FG001|Overall Study|Pregnancy|1|||
48894263|NCT00903682|157446481|FG000|Overall Study|Subject Reached A Virologic Endpoint|1|||
48894264|NCT00903682|157446482|FG001|Overall Study|Subject Reached A Virologic Endpoint|1|||
48894265|NCT00903682|157446481|FG000|Overall Study|Subject Non-Compliant|1|||
48894266|NCT00903682|157446482|FG001|Overall Study|Subject Non-Compliant|0|||
48894267|NCT00903682|157446481|FG000|Overall Study|Patient Couldn't Come For The Visit Due|1|||
48894268|NCT00903682|157446482|FG001|Overall Study|Patient Couldn't Come For The Visit Due|0|||
48894269|NCT00903682|157446481|FG000|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1|||
48894270|NCT00903682|157446482|FG001|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0|||
48894271|NCT01204398|157446484|FG000|Overall Study|Adverse Event|1|||
48894272|NCT02523599|157446485|FG000|Overall Study|Adverse Event|1|||
48894273|NCT02523599|157446486|FG001|Overall Study|Adverse Event|0|||
48894274|NCT02523599|157446485|FG000|Overall Study|Physician Decision|1|||
48894275|NCT02523599|157446486|FG001|Overall Study|Physician Decision|0|||
48894276|NCT02523599|157446485|FG000|Overall Study|Lost to Follow-up|4|||
48894277|NCT02523599|157446486|FG001|Overall Study|Lost to Follow-up|1|||
48984133|NCT01693562|157774123|FG002|Escalation Phase|Other|2|||
48984134|NCT01693562|157774124|FG003|Escalation Phase|Other|0|||
48984135|NCT01693562|157774125|FG004|Escalation Phase|Other|0|||
48984136|NCT01693562|157774126|FG005|Escalation Phase|Other|1|||
48984137|NCT01693562|157774127|FG006|Escalation Phase|Other|0|||
48984138|NCT01693562|157774128|FG007|Escalation Phase|Other|0|||
48984139|NCT01693562|157774129|FG008|Escalation Phase|Other|0|||
48984140|NCT01693562|157774130|FG009|Escalation Phase|Other|0|||
48984141|NCT01693562|157774131|FG010|Escalation Phase|Other|0|||
48984142|NCT01693562|157774132|FG011|Escalation Phase|Other|0|||
48984143|NCT01693562|157774133|FG012|Escalation Phase|Other|0|||
48984144|NCT01693562|157774134|FG013|Escalation Phase|Other|0|||
48984145|NCT01693562|157774135|FG014|Escalation Phase|Other|0|||
48984146|NCT01693562|157774136|FG015|Escalation Phase|Other|0|||
48984147|NCT01693562|157774137|FG016|Escalation Phase|Other|0|||
48984148|NCT01693562|157774138|FG017|Escalation Phase|Other|0|||
48984149|NCT01693562|157774139|FG018|Escalation Phase|Other|0|||
48984150|NCT01693562|157774140|FG019|Escalation Phase|Other|0|||
48984151|NCT01693562|157774141|FG020|Escalation Phase|Other|0|||
48984152|NCT01693562|157774142|FG021|Escalation Phase|Other|0|||
48984153|NCT01693562|157774143|FG022|Escalation Phase|Other|0|||
48984154|NCT01693562|157774121|FG000|Exploration Phase|Withdrawal by Subject|0|||
48984155|NCT01693562|157774122|FG001|Exploration Phase|Withdrawal by Subject|0|||
48984156|NCT01693562|157774123|FG002|Exploration Phase|Withdrawal by Subject|0|||
48984157|NCT01693562|157774124|FG003|Exploration Phase|Withdrawal by Subject|0|||
48894278|NCT02523599|157446485|FG000|Overall Study|Did not return for Day 30 visit|2|||
48894279|NCT02523599|157446486|FG001|Overall Study|Did not return for Day 30 visit|0|||
48894280|NCT01427751|157446487|FG000|Overall Study|Adverse Event|18|||
48894281|NCT01427751|157446488|FG001|Overall Study|Adverse Event|2|||
48894282|NCT01427751|157446487|FG000|Overall Study|No further treatment benefit expected|5|||
48894283|NCT01427751|157446488|FG001|Overall Study|No further treatment benefit expected|1|||
48894284|NCT01427751|157446487|FG000|Overall Study|Lost to Follow-up|3|||
48894285|NCT01427751|157446488|FG001|Overall Study|Lost to Follow-up|1|||
48894286|NCT01427751|157446487|FG000|Overall Study|Withdrawal of consent|2|||
48894287|NCT01427751|157446488|FG001|Overall Study|Withdrawal of consent|2|||
48894288|NCT01427751|157446487|FG000|Overall Study|Protocol Violation|6|||
48894289|NCT01427751|157446488|FG001|Overall Study|Protocol Violation|4|||
48894290|NCT01427751|157446487|FG000|Overall Study|Death|2|||
48894291|NCT01427751|157446488|FG001|Overall Study|Death|0|||
48894292|NCT01427751|157446487|FG000|Overall Study|Other miscellaneous reasons|6|||
48894293|NCT01427751|157446488|FG001|Overall Study|Other miscellaneous reasons|4|||
48894294|NCT01028027|157446489|FG000|Overall Study|Lost to Follow-up|4|||
48894295|NCT01028027|157446490|FG001|Overall Study|Lost to Follow-up|1|||
48894296|NCT01028027|157446489|FG000|Overall Study|Withdrawal by Subject|5|||
48894297|NCT01028027|157446490|FG001|Overall Study|Withdrawal by Subject|3|||
48894298|NCT01028027|157446489|FG000|Overall Study|Adverse Event|4|||
48894299|NCT01028027|157446490|FG001|Overall Study|Adverse Event|7|||
48894300|NCT01028027|157446489|FG000|Overall Study|Protocol Violation|3|||
48894301|NCT01028027|157446490|FG001|Overall Study|Protocol Violation|1|||
48894302|NCT01028027|157446489|FG000|Overall Study|Lack of Efficacy|0|||
48894303|NCT01028027|157446490|FG001|Overall Study|Lack of Efficacy|1|||
48894304|NCT03965689|157446493|FG000|Overall Study|Too sick to get study intervention|2|||
48894305|NCT01942785|157446494|FG000|Overall Study|Adverse Event|2|||
48894306|NCT01942785|157446494|FG000|Overall Study|Withdrawal by Subject|1|||
49038258|NCT05068284|157974669|FG002|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|1|||
49038259|NCT05068284|157974670|FG003|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|4|||
49038260|NCT05068284|157974671|FG004|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
49038261|NCT05068284|157974672|FG005|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
49038262|NCT05068284|157974673|FG006|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
49038263|NCT05068284|157974674|FG007|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
49038264|NCT05068284|157974667|FG000|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
49038265|NCT05068284|157974668|FG001|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
49038266|NCT05068284|157974669|FG002|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|2|||
49038267|NCT05068284|157974670|FG003|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
49038268|NCT05068284|157974671|FG004|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
49038269|NCT05068284|157974672|FG005|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
49038270|NCT05068284|157974673|FG006|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
49038271|NCT05068284|157974674|FG007|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
49038272|NCT05068284|157974667|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|1|||
49038273|NCT05068284|157974668|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
49038274|NCT05068284|157974669|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
49038275|NCT05068284|157974670|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
49038276|NCT05068284|157974671|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
49038277|NCT05068284|157974672|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
49038278|NCT05068284|157974673|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
49038279|NCT05068284|157974674|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
49038280|NCT05068284|157974667|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|8|||
49038281|NCT05068284|157974668|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
49038282|NCT05068284|157974669|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
48894307|NCT01942785|157446494|FG000|Overall Study|Protocol Violation|1|||
48894308|NCT05330312|157446496|FG000|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
48894309|NCT05330312|157446497|FG001|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
48894310|NCT05330312|157446498|FG002|Pilot Investigation - Part 1|Withdrawal by Subject|1|||
48894311|NCT05330312|157446496|FG000|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
48894312|NCT05330312|157446497|FG001|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
48894313|NCT05330312|157446498|FG002|Pivotal Investigation - Part 2|Lost to Follow-up|0|||
48894314|NCT05330312|157446496|FG000|Pivotal Investigation - Part 2|Withdrawal by Subject|5|||
48894315|NCT05330312|157446497|FG001|Pivotal Investigation - Part 2|Withdrawal by Subject|2|||
48894316|NCT05330312|157446498|FG002|Pivotal Investigation - Part 2|Withdrawal by Subject|0|||
48894317|NCT05330312|157446496|FG000|Pivotal Investigation - Part 2|Death|1|||
48894318|NCT05330312|157446497|FG001|Pivotal Investigation - Part 2|Death|4|||
48894319|NCT05330312|157446498|FG002|Pivotal Investigation - Part 2|Death|0|||
48894320|NCT03534284|157446499|FG000|Overall Study|Death|2|||
48894321|NCT03534284|157446500|FG001|Overall Study|Death|3|||
48894322|NCT03534284|157446501|FG002|Overall Study|Death|3|||
48894323|NCT03534284|157446499|FG000|Overall Study|Withdrawal by Subject|5|||
48894324|NCT03534284|157446500|FG001|Overall Study|Withdrawal by Subject|0|||
48894325|NCT03534284|157446501|FG002|Overall Study|Withdrawal by Subject|0|||
48894326|NCT05326815|157446502|FG000|Overall Study|Withdrawal by Subject|3|||
48894327|NCT05326815|157446502|FG000|Overall Study|Did not complete required labs|6|||
48894328|NCT05326815|157446502|FG000|Overall Study|Screen fail- abnormal labs|5|||
48894329|NCT00925132|157446504|FG000|Overall Study|Withdrawal by Subject|2|||
48894330|NCT00925132|157446505|FG001|Overall Study|Withdrawal by Subject|0|||
48894331|NCT00925132|157446506|FG002|Overall Study|Withdrawal by Subject|0|||
48894332|NCT00925132|157446507|FG003|Overall Study|Withdrawal by Subject|0|||
48894333|NCT00925132|157446508|FG004|Overall Study|Withdrawal by Subject|1|||
48894334|NCT00925132|157446504|FG000|Overall Study|Removed due to disease progression|0|||
48894335|NCT00925132|157446505|FG001|Overall Study|Removed due to disease progression|0|||
48894336|NCT00925132|157446506|FG002|Overall Study|Removed due to disease progression|0|||
48894337|NCT00925132|157446507|FG003|Overall Study|Removed due to disease progression|0|||
48894338|NCT00925132|157446508|FG004|Overall Study|Removed due to disease progression|4|||
48894339|NCT04737187|157446509|FG000|Overall Study|Switched to marketed drug|32|||
48894340|NCT04737187|157446510|FG001|Overall Study|Switched to marketed drug|4|||
48894341|NCT04737187|157446509|FG000|Overall Study|Radiological Progressive Disease|145|||
48894342|NCT04737187|157446510|FG001|Overall Study|Radiological Progressive Disease|146|||
48894343|NCT04737187|157446509|FG000|Overall Study|Clinical Progressive Disease|20|||
48894344|NCT04737187|157446510|FG001|Overall Study|Clinical Progressive Disease|20|||
48894345|NCT04737187|157446509|FG000|Overall Study|Radiological And Clinical Progressive Disease|26|||
48894346|NCT04737187|157446510|FG001|Overall Study|Radiological And Clinical Progressive Disease|52|||
48894347|NCT04737187|157446509|FG000|Overall Study|Adverse Event|16|||
48894348|NCT04737187|157446510|FG001|Overall Study|Adverse Event|16|||
48894349|NCT04737187|157446509|FG000|Overall Study|Physician Decision|2|||
48894350|NCT04737187|157446510|FG001|Overall Study|Physician Decision|0|||
48894351|NCT04737187|157446509|FG000|Overall Study|Withdrawal by Subject|5|||
48894352|NCT04737187|157446510|FG001|Overall Study|Withdrawal by Subject|8|||
48894353|NCT02730598|157446512|FG000|Overall Study|Withdrawal by Subject|3|||
48894354|NCT02730598|157446513|FG001|Overall Study|Withdrawal by Subject|3|||
48894355|NCT02730598|157446512|FG000|Overall Study|Protocol Violation|0|||
48894356|NCT02730598|157446513|FG001|Overall Study|Protocol Violation|1|||
48894357|NCT02730598|157446512|FG000|Overall Study|Unrelated Injury affecting outcomes.|1|||
48894358|NCT02730598|157446513|FG001|Overall Study|Unrelated Injury affecting outcomes.|0|||
48894359|NCT03282240|157446514|FG000|Overall Study|Adverse Event|2|||
48894360|NCT03282240|157446515|FG001|Overall Study|Adverse Event|2|||
48894361|NCT03282240|157446516|FG002|Overall Study|Adverse Event|0|||
48894362|NCT03282240|157446514|FG000|Overall Study|Lost to Follow-up|3|||
48894363|NCT03282240|157446515|FG001|Overall Study|Lost to Follow-up|0|||
48894364|NCT03282240|157446516|FG002|Overall Study|Lost to Follow-up|0|||
48894365|NCT03282240|157446514|FG000|Overall Study|Protocol Deviation|4|||
48894366|NCT03282240|157446515|FG001|Overall Study|Protocol Deviation|1|||
48894367|NCT03282240|157446516|FG002|Overall Study|Protocol Deviation|2|||
48894368|NCT03282240|157446514|FG000|Overall Study|Withdrawal by Subject|1|||
48894369|NCT03282240|157446515|FG001|Overall Study|Withdrawal by Subject|0|||
49038283|NCT05068284|157974670|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
49038284|NCT05068284|157974671|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
49038285|NCT05068284|157974672|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|3|||
49038286|NCT05068284|157974673|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|1|||
48894370|NCT03282240|157446516|FG002|Overall Study|Withdrawal by Subject|1|||
48894371|NCT00923260|157448201|FG000|Overall Study|Lost to Follow-up|1|||
48894372|NCT00923260|157448202|FG001|Overall Study|Lost to Follow-up|1|||
48894373|NCT00910689|157448204|FG000|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2|||
48894374|NCT00910689|157448205|FG001|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1|||
48894375|NCT00910689|157448206|FG002|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5|||
48894376|NCT00910689|157448207|FG003|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10|||
49038287|NCT05068284|157974674|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
49038288|NCT05068284|157974667|FG000|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
48894377|NCT00910689|157448204|FG000|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
48894378|NCT00910689|157448205|FG001|Month 2- 4: Treatment Period|Lost to Follow-up|4|||
48894379|NCT00910689|157448206|FG002|Month 2- 4: Treatment Period|Lost to Follow-up|1|||
48894380|NCT00910689|157448207|FG003|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
48894381|NCT00910689|157448204|FG000|Month 2- 4: Treatment Period|Adverse Event|2|||
48894382|NCT00910689|157448205|FG001|Month 2- 4: Treatment Period|Adverse Event|3|||
48894383|NCT00910689|157448206|FG002|Month 2- 4: Treatment Period|Adverse Event|2|||
48894384|NCT00910689|157448207|FG003|Month 2- 4: Treatment Period|Adverse Event|0|||
48894385|NCT00910689|157448204|FG000|Month 2- 4: Treatment Period|Time Demands|1|||
48894386|NCT00910689|157448205|FG001|Month 2- 4: Treatment Period|Time Demands|0|||
48894387|NCT00910689|157448206|FG002|Month 2- 4: Treatment Period|Time Demands|4|||
48894388|NCT00910689|157448207|FG003|Month 2- 4: Treatment Period|Time Demands|8|||
49038289|NCT05068284|157974668|FG001|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
49038290|NCT05068284|157974669|FG002|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
49038291|NCT05068284|157974670|FG003|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
49038292|NCT05068284|157974671|FG004|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
48894389|NCT00910689|157448204|FG000|Month 2- 4: Treatment Period|Lack of Efficacy|2|||
48894390|NCT00910689|157448205|FG001|Month 2- 4: Treatment Period|Lack of Efficacy|1|||
48894391|NCT00910689|157448206|FG002|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
48894392|NCT00910689|157448207|FG003|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
48894393|NCT00910689|157448204|FG000|Month 2- 4: Treatment Period|Perceived Improvement|0|||
48894394|NCT00910689|157448205|FG001|Month 2- 4: Treatment Period|Perceived Improvement|0|||
48894395|NCT00910689|157448206|FG002|Month 2- 4: Treatment Period|Perceived Improvement|1|||
48894396|NCT00910689|157448207|FG003|Month 2- 4: Treatment Period|Perceived Improvement|0|||
48894397|NCT00910689|157448204|FG000|Month 2- 4: Treatment Period|Pregnancy|0|||
48894398|NCT00910689|157448205|FG001|Month 2- 4: Treatment Period|Pregnancy|2|||
48894399|NCT00910689|157448206|FG002|Month 2- 4: Treatment Period|Pregnancy|0|||
48894400|NCT00910689|157448207|FG003|Month 2- 4: Treatment Period|Pregnancy|0|||
48894401|NCT00910689|157448204|FG000|Month 2- 4: Treatment Period|Protocol Violation|1|||
48894402|NCT00910689|157448205|FG001|Month 2- 4: Treatment Period|Protocol Violation|0|||
48894403|NCT00910689|157448206|FG002|Month 2- 4: Treatment Period|Protocol Violation|0|||
48894404|NCT00910689|157448207|FG003|Month 2- 4: Treatment Period|Protocol Violation|0|||
48894405|NCT00910689|157448204|FG000|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2|||
48894406|NCT00910689|157448205|FG001|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5|||
48894407|NCT00910689|157448206|FG002|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
48894408|NCT00910689|157448207|FG003|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
48894409|NCT00910689|157448204|FG000|Months 5 - 10: Evaluation Period I|Adverse Event|1|||
48894410|NCT00910689|157448205|FG001|Months 5 - 10: Evaluation Period I|Adverse Event|0|||
48894411|NCT00910689|157448206|FG002|Months 5 - 10: Evaluation Period I|Adverse Event|2|||
48894412|NCT00910689|157448207|FG003|Months 5 - 10: Evaluation Period I|Adverse Event|4|||
48894413|NCT00910689|157448204|FG000|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0|||
48894414|NCT00910689|157448205|FG001|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
48894415|NCT00910689|157448206|FG002|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
48894416|NCT00910689|157448207|FG003|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
48894417|NCT00910689|157448204|FG000|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
48894418|NCT00910689|157448205|FG001|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
48894419|NCT00910689|157448206|FG002|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
48894420|NCT00910689|157448207|FG003|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
48894421|NCT00910689|157448204|FG000|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
48894422|NCT00910689|157448205|FG001|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
48894423|NCT00910689|157448206|FG002|Months 5 - 10: Evaluation Period I|Pregnancy|2|||
48894424|NCT00910689|157448207|FG003|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
49038293|NCT05068284|157974672|FG005|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
49038294|NCT05068284|157974673|FG006|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
48894425|NCT00910689|157448204|FG000|Months 5 - 10: Evaluation Period I|Time Demands|0|||
48894426|NCT00910689|157448205|FG001|Months 5 - 10: Evaluation Period I|Time Demands|0|||
48894427|NCT00910689|157448206|FG002|Months 5 - 10: Evaluation Period I|Time Demands|1|||
48894428|NCT00910689|157448207|FG003|Months 5 - 10: Evaluation Period I|Time Demands|1|||
48894429|NCT00910689|157448204|FG000|Months 11- 16: Evaluation Period II|Lost to Follow-up|3|||
48894430|NCT00910689|157448205|FG001|Months 11- 16: Evaluation Period II|Lost to Follow-up|0|||
48894431|NCT00910689|157448206|FG002|Months 11- 16: Evaluation Period II|Lost to Follow-up|1|||
48894432|NCT00910689|157448207|FG003|Months 11- 16: Evaluation Period II|Lost to Follow-up|2|||
48894433|NCT00910689|157448204|FG000|Months 11- 16: Evaluation Period II|Adverse Event|2|||
48894434|NCT00910689|157448205|FG001|Months 11- 16: Evaluation Period II|Adverse Event|4|||
48894435|NCT00910689|157448206|FG002|Months 11- 16: Evaluation Period II|Adverse Event|2|||
48894436|NCT00910689|157448207|FG003|Months 11- 16: Evaluation Period II|Adverse Event|2|||
48894437|NCT00910689|157448204|FG000|Months 11- 16: Evaluation Period II|Pregnancy|1|||
48894438|NCT00910689|157448205|FG001|Months 11- 16: Evaluation Period II|Pregnancy|0|||
48894439|NCT00910689|157448206|FG002|Months 11- 16: Evaluation Period II|Pregnancy|0|||
48894440|NCT00910689|157448207|FG003|Months 11- 16: Evaluation Period II|Pregnancy|0|||
48894441|NCT00910689|157448204|FG000|Months 11- 16: Evaluation Period II|Lack of Efficacy|2|||
48894442|NCT00910689|157448205|FG001|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
48894443|NCT00910689|157448206|FG002|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
48894444|NCT00910689|157448207|FG003|Months 11- 16: Evaluation Period II|Lack of Efficacy|1|||
48894445|NCT00910689|157448204|FG000|Months 11- 16: Evaluation Period II|Time Demands|2|||
48894446|NCT00910689|157448205|FG001|Months 11- 16: Evaluation Period II|Time Demands|1|||
49038295|NCT05068284|157974674|FG007|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
49038296|NCT05068284|157974667|FG000|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|1|||
49038297|NCT05068284|157974668|FG001|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
49038298|NCT05068284|157974669|FG002|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
49038299|NCT05068284|157974670|FG003|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
49038300|NCT05068284|157974671|FG004|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
49038301|NCT05068284|157974672|FG005|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
49038302|NCT05068284|157974673|FG006|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
49038303|NCT05068284|157974674|FG007|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
49038304|NCT05068284|157974667|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|1|||
49038305|NCT05068284|157974668|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
49038306|NCT05068284|157974669|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
49038307|NCT05068284|157974670|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
49038308|NCT05068284|157974671|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
49038309|NCT05068284|157974672|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
49038310|NCT05068284|157974673|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
49038311|NCT05068284|157974674|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
49038312|NCT05068284|157974667|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|6|||
49038313|NCT05068284|157974668|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
48894447|NCT00910689|157448206|FG002|Months 11- 16: Evaluation Period II|Time Demands|0|||
48894448|NCT00910689|157448207|FG003|Months 11- 16: Evaluation Period II|Time Demands|0|||
48894449|NCT00910689|157448204|FG000|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
48894450|NCT00910689|157448205|FG001|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
48894451|NCT00910689|157448206|FG002|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
48894452|NCT00910689|157448207|FG003|Months 11- 16: Evaluation Period II|Perceived Improvement|1|||
48894453|NCT00910689|157448204|FG000|Months 11- 16: Evaluation Period II|Physician Decision|0|||
48894454|NCT00910689|157448205|FG001|Months 11- 16: Evaluation Period II|Physician Decision|2|||
48894455|NCT00910689|157448206|FG002|Months 11- 16: Evaluation Period II|Physician Decision|1|||
48894456|NCT00910689|157448207|FG003|Months 11- 16: Evaluation Period II|Physician Decision|0|||
48894457|NCT01290029|157448208|FG000|Overall Study|Other|2|||
48894458|NCT00189488|157448209|FG000|Overall Study|Ineligibility determined|1|||
48894459|NCT00189488|157448210|FG001|Overall Study|Ineligibility determined|0|||
48894460|NCT00189488|157448209|FG000|Overall Study|Protocol deviation|2|||
48894461|NCT00189488|157448210|FG001|Overall Study|Protocol deviation|1|||
48894462|NCT00189488|157448209|FG000|Overall Study|Adverse Event|2|||
48894463|NCT00189488|157448210|FG001|Overall Study|Adverse Event|1|||
48894464|NCT00189488|157448209|FG000|Overall Study|Withdrawal by Subject|2|||
48894465|NCT00189488|157448210|FG001|Overall Study|Withdrawal by Subject|6|||
48894466|NCT00189488|157448209|FG000|Overall Study|Disease progression|2|||
48894467|NCT00189488|157448210|FG001|Overall Study|Disease progression|4|||
48894468|NCT00189488|157448209|FG000|Overall Study|Administrative Decision|0|||
48894469|NCT00189488|157448210|FG001|Overall Study|Administrative Decision|2|||
48894470|NCT00189488|157448209|FG000|Overall Study|Death|5|||
48894471|NCT00189488|157448210|FG001|Overall Study|Death|8|||
48894472|NCT00189488|157448209|FG000|Overall Study|Other|1|||
48894473|NCT00189488|157448210|FG001|Overall Study|Other|0|||
48894474|NCT02366468|157448215|FG000|Overall Study|Adverse Event|2|||
48894475|NCT02366468|157448216|FG001|Overall Study|Adverse Event|0|||
48894476|NCT02366468|157448215|FG000|Overall Study|Withdrawal by Subject|1|||
48894477|NCT02366468|157448216|FG001|Overall Study|Withdrawal by Subject|5|||
48894478|NCT02366468|157448215|FG000|Overall Study|Lost to Follow-up|2|||
48894479|NCT02366468|157448216|FG001|Overall Study|Lost to Follow-up|0|||
48894480|NCT02366468|157448215|FG000|Overall Study|Death|1|||
48894481|NCT02366468|157448216|FG001|Overall Study|Death|2|||
48894482|NCT02366468|157448215|FG000|Overall Study|Other|0|||
48894483|NCT02366468|157448216|FG001|Overall Study|Other|2|||
48894484|NCT04797650|157448221|FG000|Overall Study|Reason Not Specified|5|||
48894485|NCT04797650|157448222|FG001|Overall Study|Reason Not Specified|12|||
48894486|NCT04797650|157448223|FG002|Overall Study|Reason Not Specified|5|||
48894487|NCT04797650|157448221|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|1|||
48894488|NCT04797650|157448222|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|7|||
48894489|NCT04797650|157448223|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|0|||
48894490|NCT04797650|157448221|FG000|Overall Study|Lack of Efficacy|1|||
48894491|NCT04797650|157448222|FG001|Overall Study|Lack of Efficacy|0|||
48894492|NCT04797650|157448223|FG002|Overall Study|Lack of Efficacy|1|||
48894493|NCT04797650|157448221|FG000|Overall Study|Non-compliance with Study Drug|0|||
48894494|NCT04797650|157448222|FG001|Overall Study|Non-compliance with Study Drug|0|||
48894495|NCT04797650|157448223|FG002|Overall Study|Non-compliance with Study Drug|2|||
48894496|NCT04797650|157448221|FG000|Overall Study|Lost to Follow-up|4|||
48894497|NCT04797650|157448222|FG001|Overall Study|Lost to Follow-up|6|||
48894498|NCT04797650|157448223|FG002|Overall Study|Lost to Follow-up|1|||
48894499|NCT04289051|157448226|FG000|Overall Study|Lost to Follow-up|0|||
48894500|NCT04289051|157448227|FG001|Overall Study|Lost to Follow-up|0|||
48894501|NCT04289051|157448228|FG002|Overall Study|Lost to Follow-up|2|||
48894502|NCT02874924|157448229|FG000|Overall Study|Adverse Event|2|||
48894503|NCT02874924|157448230|FG001|Overall Study|Adverse Event|0|||
48894504|NCT02874924|157448231|FG002|Overall Study|Adverse Event|0|||
48894505|NCT02874924|157448229|FG000|Overall Study|Withdrawal by Subject|1|||
48894506|NCT02874924|157448230|FG001|Overall Study|Withdrawal by Subject|0|||
48894507|NCT02874924|157448231|FG002|Overall Study|Withdrawal by Subject|0|||
48894508|NCT02040584|157448234|FG000|Overall Study|Adverse Event|13|||
48894509|NCT02040584|157448235|FG001|Overall Study|Adverse Event|6|||
48894510|NCT02040584|157448234|FG000|Overall Study|Protocol Violation|9|||
48894511|NCT02040584|157448235|FG001|Overall Study|Protocol Violation|11|||
48894512|NCT02040584|157448234|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
49038314|NCT05068284|157974669|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
49038315|NCT05068284|157974670|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
49038316|NCT05068284|157974671|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
49038317|NCT05068284|157974672|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|10|||
49099003|NCT02419612|158197015|FG000|Short-term Treatment Period|Withdrawal by Subject|9|||
48894513|NCT02040584|157448235|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
48894514|NCT02040584|157448234|FG000|Overall Study|Death|6|||
48894515|NCT02040584|157448235|FG001|Overall Study|Death|3|||
48894516|NCT02040584|157448234|FG000|Overall Study|Transplant rejection/retransplant|0|||
48894517|NCT02040584|157448235|FG001|Overall Study|Transplant rejection/retransplant|1|||
48894518|NCT02040584|157448234|FG000|Overall Study|Immunosuppressant/prohibited med use|7|||
48894519|NCT02040584|157448235|FG001|Overall Study|Immunosuppressant/prohibited med use|10|||
48894520|NCT00657020|157448236|FG000|PERIOD 1|Adverse Event|0|||
48894521|NCT00657020|157448237|FG001|PERIOD 1|Adverse Event|1|||
48894522|NCT01183234|157448240|FG000|First Intervention|Adverse Event|1|||
48894523|NCT01183234|157448241|FG001|First Intervention|Adverse Event|0|||
48894524|NCT01981473|157448247|FG000|Overall Study|Incorrect diagnosis of RA|0|||
48894525|NCT01981473|157448248|FG001|Overall Study|Incorrect diagnosis of RA|0|||
48894526|NCT01981473|157448249|FG002|Overall Study|Incorrect diagnosis of RA|1|||
48894527|NCT01981473|157448247|FG000|Overall Study|Received treatment for < 6 months|0|||
48894528|NCT01981473|157448248|FG001|Overall Study|Received treatment for < 6 months|0|||
48894529|NCT01981473|157448249|FG002|Overall Study|Received treatment for < 6 months|1|||
48894530|NCT01981473|157448247|FG000|Overall Study|Received treatment for >24 months|2|||
48894531|NCT01981473|157448248|FG001|Overall Study|Received treatment for >24 months|0|||
48894532|NCT01981473|157448249|FG002|Overall Study|Received treatment for >24 months|6|||
48894533|NCT00434213|157448252|FG000|Overall Study|Adverse Event|12|||
48894534|NCT00434213|157448252|FG000|Overall Study|Lack of Efficacy|9|||
48894535|NCT00434213|157448252|FG000|Overall Study|Lost to Follow-up|14|||
48894536|NCT00434213|157448252|FG000|Overall Study|Withdrawal by Subject|7|||
48894537|NCT00434213|157448252|FG000|Overall Study|Protocol Violation|3|||
48894538|NCT00434213|157448252|FG000|Overall Study|Unable to comply with study visit window|2|||
48894539|NCT00434213|157448252|FG000|Overall Study|Application site reaction|1|||
48894540|NCT00434213|157448252|FG000|Overall Study|Non-compliant to study schedule|1|||
48894541|NCT05062759|157448253|FG000|Overall Study|Death|0|||
48894542|NCT05062759|157448254|FG001|Overall Study|Death|1|||
48894543|NCT05062759|157448253|FG000|Overall Study|Lost to Follow-up|1|||
48894544|NCT05062759|157448254|FG001|Overall Study|Lost to Follow-up|0|||
48894545|NCT00766363|157448255|FG000|Overall Study|Withdrawal by Subject|1|||
48894546|NCT00766363|157448256|FG001|Overall Study|Withdrawal by Subject|0|||
48894547|NCT00766363|157448257|FG002|Overall Study|Withdrawal by Subject|0|||
48894548|NCT00766363|157448258|FG003|Overall Study|Withdrawal by Subject|0|||
48894549|NCT00766363|157448255|FG000|Overall Study|Adverse Event Prior to Randomization|0|||
48894550|NCT00766363|157448256|FG001|Overall Study|Adverse Event Prior to Randomization|1|||
48894551|NCT00766363|157448257|FG002|Overall Study|Adverse Event Prior to Randomization|0|||
48894552|NCT00766363|157448258|FG003|Overall Study|Adverse Event Prior to Randomization|0|||
48894553|NCT00768079|157448265|FG000|Overall Study|Lost to Follow-up|2|||
48894554|NCT00768079|157448266|FG001|Overall Study|Lost to Follow-up|0|||
48894555|NCT00768079|157448267|FG002|Overall Study|Lost to Follow-up|4|||
48894556|NCT00768079|157448265|FG000|Overall Study|Participant incarcerated|0|||
48894557|NCT00768079|157448266|FG001|Overall Study|Participant incarcerated|1|||
48894558|NCT00768079|157448267|FG002|Overall Study|Participant incarcerated|0|||
48894559|NCT00993668|157448271|FG000|Single-Blind Period|Adverse Event|1|||
48894560|NCT00993668|157448272|FG001|Single-Blind Period|Adverse Event|1|||
48894561|NCT00993668|157448271|FG000|Single-Blind Period|Lack of Efficacy|0|||
48894562|NCT00993668|157448272|FG001|Single-Blind Period|Lack of Efficacy|1|||
48894563|NCT00993668|157448271|FG000|Single-Blind Period|Lost to Follow-up|3|||
48894564|NCT00993668|157448272|FG001|Single-Blind Period|Lost to Follow-up|1|||
48894565|NCT00993668|157448271|FG000|Open-Label Period|Adverse Event|9|||
48894566|NCT00993668|157448272|FG001|Open-Label Period|Adverse Event|8|||
48894567|NCT00993668|157448271|FG000|Open-Label Period|Lack of Efficacy|4|||
48894568|NCT00993668|157448272|FG001|Open-Label Period|Lack of Efficacy|3|||
48894569|NCT00993668|157448271|FG000|Open-Label Period|Withdrawal by Subject|4|||
48894570|NCT00993668|157448272|FG001|Open-Label Period|Withdrawal by Subject|3|||
49038318|NCT05068284|157974673|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|11|||
49038319|NCT05068284|157974674|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|3|||
49038320|NCT05068284|157974667|FG000|Double-Blind Maintenance (40 Weeks)|Other|0|||
49038321|NCT05068284|157974668|FG001|Double-Blind Maintenance (40 Weeks)|Other|0|||
49038322|NCT05068284|157974669|FG002|Double-Blind Maintenance (40 Weeks)|Other|0|||
49038323|NCT05068284|157974670|FG003|Double-Blind Maintenance (40 Weeks)|Other|0|||
49038324|NCT05068284|157974671|FG004|Double-Blind Maintenance (40 Weeks)|Other|0|||
49038325|NCT05068284|157974672|FG005|Double-Blind Maintenance (40 Weeks)|Other|0|||
48894571|NCT00993668|157448271|FG000|Open-Label Period|Lost to Follow-up|6|||
48894572|NCT00993668|157448272|FG001|Open-Label Period|Lost to Follow-up|1|||
48894573|NCT01236534|157448274|FG000|Overall Study|Adverse Event|3|||
48894574|NCT01236534|157448275|FG001|Overall Study|Adverse Event|0|||
48894575|NCT01659853|157448276|FG000|Washout , 3 to 7 Days|Adverse Event|1|||
48894576|NCT01659853|157448277|FG001|Washout , 3 to 7 Days|Adverse Event|0|||
48894577|NCT01659853|157448276|FG000|Washout , 3 to 7 Days|Protocol Violation|1|||
48894578|NCT01659853|157448277|FG001|Washout , 3 to 7 Days|Protocol Violation|0|||
48894579|NCT01079663|157448280|FG000|Overall Study|Adverse Event|0|||
48894580|NCT01079663|157448281|FG001|Overall Study|Adverse Event|2|||
48894581|NCT01079663|157448280|FG000|Overall Study|Protocol Violation|0|||
48894582|NCT01079663|157448281|FG001|Overall Study|Protocol Violation|2|||
49038326|NCT05068284|157974673|FG006|Double-Blind Maintenance (40 Weeks)|Other|0|||
49038327|NCT05068284|157974674|FG007|Double-Blind Maintenance (40 Weeks)|Other|1|||
49038328|NCT03025087|157976676|FG000|Overall Study|Physician Decision|3|||
49038329|NCT03025087|157976677|FG001|Overall Study|Physician Decision|3|||
49038330|NCT03025087|157976678|FG002|Overall Study|Physician Decision|0|||
49038331|NCT03025087|157976679|FG003|Overall Study|Physician Decision|0|||
49038332|NCT03025087|157976680|FG004|Overall Study|Physician Decision|0|||
49038333|NCT03025087|157976676|FG000|Overall Study|Withdrawal by Subject|1|||
49038334|NCT03025087|157976677|FG001|Overall Study|Withdrawal by Subject|1|||
49038335|NCT03025087|157976678|FG002|Overall Study|Withdrawal by Subject|0|||
49038336|NCT03025087|157976679|FG003|Overall Study|Withdrawal by Subject|0|||
49038337|NCT03025087|157976680|FG004|Overall Study|Withdrawal by Subject|0|||
48894583|NCT00424385|157448293|FG000|Cohort 0|Withdrawal by Subject|5|||
48894584|NCT00424385|157448293|FG000|Cohort 0|Physician Decision|1|||
48894585|NCT00424385|157448293|FG000|Cohort 1|Withdrawal by Subject|1|||
48894586|NCT05653427|157448298|FG000|Overall Study|Study Terminated by Sponsor|13|||
48894587|NCT01621568|157448300|FG000|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|1|||
48894588|NCT01621568|157448301|FG001|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|0|||
48894589|NCT01621568|157448300|FG000|Week 5-6 No Treatment|Death|1|||
48894590|NCT01621568|157448301|FG001|Week 5-6 No Treatment|Death|0|||
48894591|NCT02930226|157448302|FG000|Overall Study|Technical Problems: Leak in plasma bag|0|||
48894592|NCT02930226|157448303|FG001|Overall Study|Technical Problems: Leak in plasma bag|0|||
48894593|NCT02930226|157448304|FG002|Overall Study|Technical Problems: Leak in plasma bag|0|||
48894594|NCT02930226|157448305|FG003|Overall Study|Technical Problems: Leak in plasma bag|0|||
48894595|NCT02930226|157448306|FG004|Overall Study|Technical Problems: Leak in plasma bag|1|||
48894596|NCT02930226|157448307|FG005|Overall Study|Technical Problems: Leak in plasma bag|0|||
48894597|NCT01205152|157448310|FG000|Overall Study|Death|1|||
48894598|NCT00141219|157448319|FG000|Overall Study|Protocol violations|5|||
48894599|NCT00141219|157448320|FG001|Overall Study|Protocol violations|4|||
48894600|NCT00141219|157448319|FG000|Overall Study|Adverse Event|8|||
48894601|NCT00141219|157448320|FG001|Overall Study|Adverse Event|6|||
48894602|NCT00141219|157448319|FG000|Overall Study|Lack of Efficacy|5|||
48894603|NCT00141219|157448320|FG001|Overall Study|Lack of Efficacy|4|||
48894604|NCT00141219|157448319|FG000|Overall Study|Withdrawal by Subject|6|||
48894605|NCT00141219|157448320|FG001|Overall Study|Withdrawal by Subject|2|||
49038338|NCT03025087|157976676|FG000|Overall Study|Unable to complete MRI|2|||
48894606|NCT02595073|157448323|FG000|Overall Study|Progressive Disease|0|||
48894607|NCT02595073|157448324|FG001|Overall Study|Progressive Disease|1|||
48894608|NCT02595073|157448323|FG000|Overall Study|Protocol Violation|2|||
49038339|NCT03025087|157976677|FG001|Overall Study|Unable to complete MRI|2|||
49038340|NCT03025087|157976678|FG002|Overall Study|Unable to complete MRI|0|||
49038341|NCT03025087|157976679|FG003|Overall Study|Unable to complete MRI|0|||
48894609|NCT02595073|157448324|FG001|Overall Study|Protocol Violation|0|||
48894610|NCT01655693|157448325|FG000|Overall Study|Progression of Disease|92|||
48894611|NCT01655693|157448326|FG001|Overall Study|Progression of Disease|76|||
48894612|NCT01655693|157448327|FG002|Overall Study|Progression of Disease|58|||
49038342|NCT03025087|157976680|FG004|Overall Study|Unable to complete MRI|0|||
49038343|NCT01750294|157976681|FG000|Overall Study|Withdrawal by Subject|1|||
49038344|NCT01750294|157976681|FG000|Overall Study|Safety Endpoint|1|||
49038345|NCT01958294|157976682|FG000|Overall Study|Clinical Circumstances|2|||
49038346|NCT00665925|157976683|FG000|Overall Study|Lack of Efficacy|10|||
49038347|NCT00665925|157976684|FG001|Overall Study|Lack of Efficacy|8|||
48894613|NCT01655693|157448325|FG000|Overall Study|Death|8|||
48894614|NCT01655693|157448326|FG001|Overall Study|Death|9|||
48894615|NCT01655693|157448327|FG002|Overall Study|Death|12|||
48894616|NCT01655693|157448325|FG000|Overall Study|Serious Adverse Event|3|||
48894617|NCT01655693|157448326|FG001|Overall Study|Serious Adverse Event|15|||
48894618|NCT01655693|157448327|FG002|Overall Study|Serious Adverse Event|11|||
48894619|NCT01655693|157448325|FG000|Overall Study|Withdrawal by Subject|3|||
48894620|NCT01655693|157448326|FG001|Overall Study|Withdrawal by Subject|2|||
48894621|NCT01655693|157448327|FG002|Overall Study|Withdrawal by Subject|20|||
48894622|NCT01655693|157448325|FG000|Overall Study|Adverse Event|3|||
48894623|NCT01655693|157448326|FG001|Overall Study|Adverse Event|11|||
48894624|NCT01655693|157448327|FG002|Overall Study|Adverse Event|3|||
48894625|NCT01655693|157448325|FG000|Overall Study|Aggravation of Liver Dysfunction|5|||
48894626|NCT01655693|157448326|FG001|Overall Study|Aggravation of Liver Dysfunction|4|||
48894627|NCT01655693|157448327|FG002|Overall Study|Aggravation of Liver Dysfunction|0|||
48894628|NCT01655693|157448325|FG000|Overall Study|Non-Compliance|0|||
48894629|NCT01655693|157448326|FG001|Overall Study|Non-Compliance|0|||
48894630|NCT01655693|157448327|FG002|Overall Study|Non-Compliance|7|||
48894631|NCT01655693|157448325|FG000|Overall Study|No Respect of Criteria for Continuing Treatment|1|||
48894632|NCT01655693|157448326|FG001|Overall Study|No Respect of Criteria for Continuing Treatment|3|||
48894633|NCT01655693|157448327|FG002|Overall Study|No Respect of Criteria for Continuing Treatment|0|||
48894634|NCT01655693|157448325|FG000|Overall Study|Protocol Violation|1|||
48894635|NCT01655693|157448326|FG001|Overall Study|Protocol Violation|0|||
48894636|NCT01655693|157448327|FG002|Overall Study|Protocol Violation|3|||
48894637|NCT01655693|157448325|FG000|Overall Study|Lost to Follow-up|1|||
48894638|NCT01655693|157448326|FG001|Overall Study|Lost to Follow-up|0|||
48894639|NCT01655693|157448327|FG002|Overall Study|Lost to Follow-up|1|||
48894640|NCT01655693|157448325|FG000|Overall Study|Screening Failure|1|||
48894641|NCT01655693|157448326|FG001|Overall Study|Screening Failure|0|||
48894642|NCT01655693|157448327|FG002|Overall Study|Screening Failure|0|||
48894643|NCT01655693|157448325|FG000|Overall Study|Other|8|||
48894644|NCT01655693|157448326|FG001|Overall Study|Other|6|||
48894645|NCT01655693|157448327|FG002|Overall Study|Other|15|||
48894646|NCT00577577|157448333|FG000|Overall Study|Adverse Event|3|||
48894647|NCT00577577|157448334|FG001|Overall Study|Adverse Event|2|||
48894648|NCT00577577|157448333|FG000|Overall Study|Lost to Follow-up|1|||
48894649|NCT00577577|157448334|FG001|Overall Study|Lost to Follow-up|0|||
48894650|NCT00577577|157448333|FG000|Overall Study|Protocol Violation|0|||
48894651|NCT00577577|157448334|FG001|Overall Study|Protocol Violation|3|||
48894652|NCT00577577|157448333|FG000|Overall Study|Transportation|1|||
48894653|NCT00577577|157448334|FG001|Overall Study|Transportation|0|||
48894654|NCT00688870|157448335|FG000|Infant Series|Parent or legal guardian request|4|||
48894655|NCT00688870|157448336|FG001|Infant Series|Parent or legal guardian request|0|||
49038348|NCT00665925|157976685|FG002|Overall Study|Lack of Efficacy|9|||
49038349|NCT00665925|157976686|FG003|Overall Study|Lack of Efficacy|8|||
49038350|NCT00665925|157976683|FG000|Overall Study|Lost to Follow-up|1|||
49038351|NCT00665925|157976684|FG001|Overall Study|Lost to Follow-up|2|||
49038352|NCT00665925|157976685|FG002|Overall Study|Lost to Follow-up|2|||
49038353|NCT00665925|157976686|FG003|Overall Study|Lost to Follow-up|2|||
49038354|NCT00665925|157976683|FG000|Overall Study|Withdrawal by Subject|2|||
49038355|NCT00665925|157976684|FG001|Overall Study|Withdrawal by Subject|2|||
49038356|NCT00665925|157976685|FG002|Overall Study|Withdrawal by Subject|3|||
49038357|NCT00665925|157976686|FG003|Overall Study|Withdrawal by Subject|2|||
49038358|NCT00665925|157976683|FG000|Overall Study|Physician Decision|0|||
49038359|NCT00665925|157976684|FG001|Overall Study|Physician Decision|0|||
49038360|NCT00665925|157976685|FG002|Overall Study|Physician Decision|1|||
49038361|NCT00665925|157976686|FG003|Overall Study|Physician Decision|2|||
49038362|NCT00665925|157976683|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
48894656|NCT00371683|157448340|FG000|DB Treatment Period-Randomized Patients|Death|1|||
48894657|NCT00371683|157448341|FG001|DB Treatment Period-Randomized Patients|Death|1|||
48894658|NCT00371683|157448340|FG000|DB Treatment Period-Randomized Patients|Adverse Event|60|||
48894659|NCT00371683|157448341|FG001|DB Treatment Period-Randomized Patients|Adverse Event|58|||
48894660|NCT00371683|157448340|FG000|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18|||
49038363|NCT00665925|157976684|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
49038364|NCT00665925|157976685|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
49038365|NCT00665925|157976686|FG003|Overall Study|Severe Non-Compliance to Protocol|1|||
49038366|NCT00665925|157976683|FG000|Overall Study|Adverse Event|1|||
49038367|NCT00665925|157976684|FG001|Overall Study|Adverse Event|5|||
49038368|NCT00665925|157976685|FG002|Overall Study|Adverse Event|10|||
49038369|NCT00665925|157976686|FG003|Overall Study|Adverse Event|5|||
48894661|NCT00371683|157448341|FG001|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37|||
49038370|NCT00665925|157976683|FG000|Overall Study|Enrolled by mistake|0|||
49038371|NCT00665925|157976684|FG001|Overall Study|Enrolled by mistake|0|||
49038372|NCT00665925|157976685|FG002|Overall Study|Enrolled by mistake|0|||
49038373|NCT00665925|157976686|FG003|Overall Study|Enrolled by mistake|1|||
49038374|NCT00665925|157976683|FG000|Overall Study|Due to exclusion criteria|1|||
49038375|NCT00665925|157976684|FG001|Overall Study|Due to exclusion criteria|0|||
49038376|NCT00665925|157976685|FG002|Overall Study|Due to exclusion criteria|0|||
49038377|NCT00665925|157976686|FG003|Overall Study|Due to exclusion criteria|0|||
49038378|NCT00795821|157976689|FG000|Acute Treatment Phase|Adverse Event|23|||
49038379|NCT00795821|157976690|FG001|Acute Treatment Phase|Adverse Event|4|||
49038380|NCT00795821|157976689|FG000|Acute Treatment Phase|Death|1|||
49038381|NCT00795821|157976690|FG001|Acute Treatment Phase|Death|0|||
49038382|NCT00795821|157976689|FG000|Acute Treatment Phase|Lack of Efficacy|5|||
49038383|NCT00795821|157976690|FG001|Acute Treatment Phase|Lack of Efficacy|2|||
49038384|NCT00795821|157976689|FG000|Acute Treatment Phase|Lost to Follow-up|9|||
49038385|NCT00795821|157976690|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
49038386|NCT00795821|157976689|FG000|Acute Treatment Phase|Physician Decision|1|||
49038387|NCT00795821|157976690|FG001|Acute Treatment Phase|Physician Decision|1|||
49038388|NCT00795821|157976689|FG000|Acute Treatment Phase|Protocol Violation|1|||
49038389|NCT00795821|157976690|FG001|Acute Treatment Phase|Protocol Violation|2|||
49038390|NCT00795821|157976689|FG000|Acute Treatment Phase|Withdrawal by Subject|16|||
49038391|NCT00795821|157976690|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
49038392|NCT00795821|157976689|FG000|Long-term Extension Phase|Adverse Event|25|||
49038393|NCT00795821|157976690|FG001|Long-term Extension Phase|Adverse Event|32|||
49038394|NCT00795821|157976689|FG000|Long-term Extension Phase|Lack of Efficacy|16|||
49038395|NCT00795821|157976690|FG001|Long-term Extension Phase|Lack of Efficacy|12|||
49038396|NCT00795821|157976689|FG000|Long-term Extension Phase|Lost to Follow-up|20|||
49038397|NCT00795821|157976690|FG001|Long-term Extension Phase|Lost to Follow-up|16|||
49038398|NCT00795821|157976689|FG000|Long-term Extension Phase|Physician Decision|1|||
49038399|NCT00795821|157976690|FG001|Long-term Extension Phase|Physician Decision|2|||
49038400|NCT00795821|157976689|FG000|Long-term Extension Phase|Protocol Violation|3|||
49038401|NCT00795821|157976690|FG001|Long-term Extension Phase|Protocol Violation|5|||
49038402|NCT00795821|157976689|FG000|Long-term Extension Phase|Withdrawal by Subject|25|||
49038403|NCT00795821|157976690|FG001|Long-term Extension Phase|Withdrawal by Subject|25|||
49038404|NCT00795821|157976689|FG000|Taper Phase|Adverse Event|2|||
49038405|NCT00795821|157976690|FG001|Taper Phase|Adverse Event|0|||
49038406|NCT00795821|157976689|FG000|Taper Phase|Lost to Follow-up|1|||
49038407|NCT00795821|157976690|FG001|Taper Phase|Lost to Follow-up|0|||
49038408|NCT00795821|157976689|FG000|Taper Phase|Physician Decision|2|||
48894662|NCT00371683|157448340|FG000|DB Treatment Period-Randomized Patients|Lost to Follow-up|0|||
49038409|NCT00795821|157976690|FG001|Taper Phase|Physician Decision|0|||
49038410|NCT00795821|157976689|FG000|Taper Phase|Withdrawal by Subject|4|||
49038411|NCT00795821|157976690|FG001|Taper Phase|Withdrawal by Subject|0|||
49038412|NCT00081653|157976693|FG000|Overall Study|Adverse Event|23|||
49038413|NCT00081653|157976694|FG001|Overall Study|Adverse Event|17|||
49038414|NCT00081653|157976693|FG000|Overall Study|Lost to Follow-up|2|||
49038415|NCT00081653|157976694|FG001|Overall Study|Lost to Follow-up|4|||
49038416|NCT00081653|157976693|FG000|Overall Study|Refused Treatment|18|||
49038417|NCT00081653|157976694|FG001|Overall Study|Refused Treatment|14|||
49038418|NCT00081653|157976693|FG000|Overall Study|Low bone mineral density|1|||
49038419|NCT00081653|157976694|FG001|Overall Study|Low bone mineral density|0|||
49038420|NCT00081653|157976693|FG000|Overall Study|Bone loss|2|||
49038421|NCT00081653|157976694|FG001|Overall Study|Bone loss|0|||
49038422|NCT00081653|157976693|FG000|Overall Study|Participant leaving country|1|||
49038423|NCT00081653|157976694|FG001|Overall Study|Participant leaving country|0|||
49038424|NCT00081653|157976693|FG000|Overall Study|Loss of bone mass|0|||
49038425|NCT00081653|157976694|FG001|Overall Study|Loss of bone mass|2|||
49038426|NCT02241551|157976695|FG000|Overall Study|Adverse Event|1|||
49038427|NCT02241551|157976696|FG001|Overall Study|Adverse Event|0|||
48894663|NCT00371683|157448341|FG001|DB Treatment Period-Randomized Patients|Lost to Follow-up|1|||
48894664|NCT00371683|157448340|FG000|DB Treatment Period-Randomized Patients|No longer meets study criteria|1|||
49038428|NCT03499353|157976697|FG000|Treatment|Adverse Event|3|||
49038429|NCT03499353|157976697|FG000|Treatment|Progressive Disease|10|||
49038430|NCT03499353|157976697|FG000|Treatment|Other|1|||
49038431|NCT03499353|157976697|FG000|Treatment|Withdrawal by Subject|2|||
49038432|NCT03499353|157976697|FG000|Long-Term Follow-up|Death|2|||
49038433|NCT03499353|157976697|FG000|Long-Term Follow-up|Study Terminated By Sponsor|55|||
49038434|NCT03499353|157976697|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
48894665|NCT00371683|157448341|FG001|DB Treatment Period-Randomized Patients|No longer meets study criteria|2|||
48894666|NCT00371683|157448340|FG000|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1|||
48894667|NCT00371683|157448341|FG001|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0|||
49038435|NCT01015287|157976700|FG000|Overall Study|Death|21|||
49038436|NCT01015287|157976701|FG001|Overall Study|Death|16|||
49038437|NCT01015287|157976700|FG000|Overall Study|Adverse Event|1|||
49038438|NCT01015287|157976701|FG001|Overall Study|Adverse Event|0|||
49038439|NCT01015287|157976700|FG000|Overall Study|Sponsor Decision|3|||
49038440|NCT01015287|157976701|FG001|Overall Study|Sponsor Decision|7|||
48894668|NCT00371683|157448340|FG000|DB Treatment Period-Randomized Patients|non-specified|9|||
48894669|NCT00371683|157448341|FG001|DB Treatment Period-Randomized Patients|non-specified|8|||
48894670|NCT00371683|157448340|FG000|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17|||
48894671|NCT00371683|157448341|FG001|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19|||
48894672|NCT00371683|157448340|FG000|Follow-Up Period - Randomized Patients|Death|0|||
48894673|NCT00371683|157448341|FG001|Follow-Up Period - Randomized Patients|Death|2|||
48894674|NCT00371683|157448340|FG000|Follow-Up Period - Randomized Patients|Lost to Follow-up|38|||
48894675|NCT00371683|157448341|FG001|Follow-Up Period - Randomized Patients|Lost to Follow-up|39|||
48894676|NCT00371683|157448340|FG000|Follow-Up Period - Randomized Patients|non-specified|6|||
48894677|NCT00371683|157448341|FG001|Follow-Up Period - Randomized Patients|non-specified|12|||
48894678|NCT00232544|157448342|FG000|Overall Study|Lost to Follow-up|20|||
48894679|NCT00232544|157448343|FG001|Overall Study|Lost to Follow-up|15|||
48894680|NCT01820585|157448344|FG000|Overall Study|Adverse Event|9|||
48894681|NCT01820585|157448345|FG001|Overall Study|Adverse Event|13|||
48894682|NCT01820585|157448346|FG002|Overall Study|Adverse Event|23|||
48894683|NCT01820585|157448347|FG003|Overall Study|Adverse Event|34|||
48894684|NCT01820585|157448344|FG000|Overall Study|Lack of Efficacy|9|||
48894685|NCT01820585|157448345|FG001|Overall Study|Lack of Efficacy|7|||
48894686|NCT01820585|157448346|FG002|Overall Study|Lack of Efficacy|5|||
48894687|NCT01820585|157448347|FG003|Overall Study|Lack of Efficacy|1|||
48894688|NCT01820585|157448344|FG000|Overall Study|Withdrawal by Subject|3|||
48894689|NCT01820585|157448345|FG001|Overall Study|Withdrawal by Subject|7|||
48894690|NCT01820585|157448346|FG002|Overall Study|Withdrawal by Subject|3|||
48894691|NCT01820585|157448347|FG003|Overall Study|Withdrawal by Subject|8|||
48894692|NCT01820585|157448344|FG000|Overall Study|Lost to Follow-up|3|||
48894693|NCT01820585|157448345|FG001|Overall Study|Lost to Follow-up|3|||
48894694|NCT01820585|157448346|FG002|Overall Study|Lost to Follow-up|0|||
48894695|NCT01820585|157448347|FG003|Overall Study|Lost to Follow-up|3|||
49038441|NCT01015287|157976700|FG000|Overall Study|Physician Decision|19|||
49038442|NCT01015287|157976701|FG001|Overall Study|Physician Decision|21|||
48894696|NCT01820585|157448344|FG000|Overall Study|Protocol Violation|3|||
49038443|NCT01015287|157976700|FG000|Overall Study|Withdrawal by Subject|14|||
49038444|NCT01015287|157976701|FG001|Overall Study|Withdrawal by Subject|19|||
48894697|NCT01820585|157448345|FG001|Overall Study|Protocol Violation|1|||
48894698|NCT01820585|157448346|FG002|Overall Study|Protocol Violation|1|||
48894699|NCT01820585|157448347|FG003|Overall Study|Protocol Violation|1|||
48894700|NCT01820585|157448344|FG000|Overall Study|Subject non-compliance|0|||
48894701|NCT01820585|157448345|FG001|Overall Study|Subject non-compliance|0|||
48894702|NCT01820585|157448346|FG002|Overall Study|Subject non-compliance|1|||
48894703|NCT01820585|157448347|FG003|Overall Study|Subject non-compliance|2|||
48894704|NCT01820585|157448344|FG000|Overall Study|at sponsor request|0|||
48894705|NCT01820585|157448345|FG001|Overall Study|at sponsor request|0|||
48894706|NCT01820585|157448346|FG002|Overall Study|at sponsor request|1|||
48894707|NCT01820585|157448347|FG003|Overall Study|at sponsor request|0|||
48894708|NCT01820585|157448344|FG000|Overall Study|Pregnancy|0|||
48894709|NCT01820585|157448345|FG001|Overall Study|Pregnancy|1|||
49038445|NCT01015287|157976700|FG000|Overall Study|Entry Criteria not Met|11|||
49038446|NCT01015287|157976701|FG001|Overall Study|Entry Criteria not Met|14|||
49038447|NCT01015287|157976700|FG000|Overall Study|Lost to Follow-up|2|||
49038448|NCT01015287|157976701|FG001|Overall Study|Lost to Follow-up|1|||
49038449|NCT01015287|157976700|FG000|Overall Study|Protocol Violation|1|||
49038450|NCT01015287|157976701|FG001|Overall Study|Protocol Violation|1|||
49038451|NCT02658487|157976702|FG000|Overall Study|Death|2|||
49038452|NCT02658487|157976702|FG000|Overall Study|Disease progression|10|||
49038453|NCT02658487|157976702|FG000|Overall Study|Alternative therapy|1|||
49038454|NCT02658487|157976702|FG000|Overall Study|Adverse Event|1|||
49038455|NCT02658487|157976702|FG000|Overall Study|Treatment Failure, circulating blasts|1|||
49038456|NCT02658487|157976702|FG000|Overall Study|Refractory AML|1|||
49038457|NCT01592240|157976703|FG000|Overall Study|Adverse Event|1|||
49038458|NCT01592240|157976704|FG001|Overall Study|Adverse Event|0|||
49038459|NCT01592240|157976705|FG002|Overall Study|Adverse Event|0|||
48894710|NCT01820585|157448346|FG002|Overall Study|Pregnancy|0|||
49038460|NCT01592240|157976706|FG003|Overall Study|Adverse Event|1|||
49038461|NCT01592240|157976707|FG004|Overall Study|Adverse Event|1|||
48894711|NCT01820585|157448347|FG003|Overall Study|Pregnancy|0|||
48894712|NCT00998335|157448355|FG000|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0|||
48894713|NCT00998335|157448356|FG001|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2|||
48894714|NCT02641496|157448357|FG000|Overall Study|Lost to Follow-up|13|||
48894715|NCT02641496|157448358|FG001|Overall Study|Lost to Follow-up|12|||
48894716|NCT02641496|157448357|FG000|Overall Study|Withdrawal by Subject|1|||
48894717|NCT02641496|157448358|FG001|Overall Study|Withdrawal by Subject|0|||
48894718|NCT01910181|157448359|FG000|Overall Study|Death|37|||
48894719|NCT01910181|157448359|FG000|Overall Study|Lost to Follow-up|3|||
48894720|NCT01910181|157448359|FG000|Overall Study|Study Terminated by Sponsor|6|||
48894721|NCT05718466|157450026|FG000|Overall Study|Withdrawal by Subject|1|||
49038462|NCT01592240|157976708|FG005|Overall Study|Adverse Event|0|||
49038463|NCT01592240|157976709|FG006|Overall Study|Adverse Event|0|||
48894722|NCT05718466|157450027|FG001|Overall Study|Withdrawal by Subject|2|||
48894723|NCT05718466|157450026|FG000|Overall Study|Death|0|||
48894724|NCT05718466|157450027|FG001|Overall Study|Death|1|||
48894725|NCT03647488|157450031|FG000|Overall Study|Progressive disease|10|||
48894726|NCT03647488|157450032|FG001|Overall Study|Progressive disease|0|||
48894727|NCT03647488|157450033|FG002|Overall Study|Progressive disease|0|||
48894728|NCT03647488|157450031|FG000|Overall Study|Adverse Event|5|||
48894729|NCT03647488|157450032|FG001|Overall Study|Adverse Event|0|||
48894730|NCT03647488|157450033|FG002|Overall Study|Adverse Event|0|||
48894731|NCT03647488|157450031|FG000|Overall Study|Clinical progression|2|||
48894732|NCT03647488|157450032|FG001|Overall Study|Clinical progression|0|||
48894733|NCT03647488|157450033|FG002|Overall Study|Clinical progression|0|||
48894734|NCT03647488|157450031|FG000|Overall Study|Participant refused to take investigational product|1|||
48894735|NCT03647488|157450032|FG001|Overall Study|Participant refused to take investigational product|0|||
48894736|NCT03647488|157450033|FG002|Overall Study|Participant refused to take investigational product|0|||
48894737|NCT00872989|157450036|FG000|Overall Study|Adverse Event|7|||
48894738|NCT00872989|157450037|FG001|Overall Study|Adverse Event|15|||
48894739|NCT00872989|157450036|FG000|Overall Study|Withdrawal by Subject|8|||
48894740|NCT00872989|157450037|FG001|Overall Study|Withdrawal by Subject|5|||
48894741|NCT00872989|157450036|FG000|Overall Study|Progression/relapse|47|||
48894742|NCT00872989|157450037|FG001|Overall Study|Progression/relapse|35|||
48894743|NCT00872989|157450036|FG000|Overall Study|Not protocol specified|3|||
48894744|NCT00872989|157450037|FG001|Overall Study|Not protocol specified|8|||
48894745|NCT05087979|157450046|FG000|Overall Study|Converted to general anesthesia|1|||
48894746|NCT05087979|157450047|FG001|Overall Study|Converted to general anesthesia|0|||
48894747|NCT01198756|157450048|FG000|Overall Study|Adverse Event|0|||
48894748|NCT01198756|157450049|FG001|Overall Study|Adverse Event|0|||
48894749|NCT01198756|157450050|FG002|Overall Study|Adverse Event|0|||
48894750|NCT01198756|157450051|FG003|Overall Study|Adverse Event|1|||
48894751|NCT01198756|157450048|FG000|Overall Study|Protocol Violation|0|||
48894752|NCT01198756|157450049|FG001|Overall Study|Protocol Violation|0|||
48894753|NCT01198756|157450050|FG002|Overall Study|Protocol Violation|0|||
48894754|NCT01198756|157450051|FG003|Overall Study|Protocol Violation|2|||
48894755|NCT01198756|157450048|FG000|Overall Study|Withdrawal by Subject|9|||
48894756|NCT01198756|157450049|FG001|Overall Study|Withdrawal by Subject|4|||
48894757|NCT01198756|157450050|FG002|Overall Study|Withdrawal by Subject|7|||
48894758|NCT01198756|157450051|FG003|Overall Study|Withdrawal by Subject|5|||
48894759|NCT01198756|157450048|FG000|Overall Study|Lost to Follow-up|29|||
48894760|NCT01198756|157450049|FG001|Overall Study|Lost to Follow-up|36|||
48894761|NCT01198756|157450050|FG002|Overall Study|Lost to Follow-up|23|||
48894762|NCT01198756|157450051|FG003|Overall Study|Lost to Follow-up|18|||
48894763|NCT01127893|157450052|FG000|Overall Study|Study Termination by the Sponsor|1|||
48894764|NCT03207009|157450055|FG000|Overall Study|Withdrew consent prior to conditioning|1|||
48894765|NCT01262677|157450056|FG000|Overall Study|Does not meet entrance criteria|0|||
48894766|NCT01262677|157450057|FG001|Overall Study|Does not meet entrance criteria|2|||
48894767|NCT01262677|157450058|FG002|Overall Study|Does not meet entrance criteria|0|||
48894768|NCT01262677|157450056|FG000|Overall Study|Insufficient clinical response|0|||
48894769|NCT01262677|157450057|FG001|Overall Study|Insufficient clinical response|0|||
48894770|NCT01262677|157450058|FG002|Overall Study|Insufficient clinical response|1|||
48894771|NCT01262677|157450056|FG000|Overall Study|Lost to Follow-up|1|||
48894772|NCT01262677|157450057|FG001|Overall Study|Lost to Follow-up|0|||
48894773|NCT01262677|157450058|FG002|Overall Study|Lost to Follow-up|2|||
48894774|NCT01262677|157450056|FG000|Overall Study|No longer willing to participate|3|||
48894775|NCT01262677|157450057|FG001|Overall Study|No longer willing to participate|3|||
48894776|NCT01262677|157450058|FG002|Overall Study|No longer willing to participate|2|||
48894777|NCT01262677|157450056|FG000|Overall Study|Reason not provided|2|||
48894778|NCT01262677|157450057|FG001|Overall Study|Reason not provided|1|||
48894779|NCT01262677|157450058|FG002|Overall Study|Reason not provided|3|||
48894780|NCT01262677|157450056|FG000|Overall Study|Protocol Violation|0|||
48894781|NCT01262677|157450057|FG001|Overall Study|Protocol Violation|1|||
48894782|NCT01262677|157450058|FG002|Overall Study|Protocol Violation|1|||
48894783|NCT01262677|157450056|FG000|Overall Study|Adverse Event (AE) related to study drug|3|||
48894784|NCT01262677|157450057|FG001|Overall Study|Adverse Event (AE) related to study drug|8|||
48894785|NCT01262677|157450058|FG002|Overall Study|Adverse Event (AE) related to study drug|3|||
49038464|NCT01592240|157976703|FG000|Overall Study|Death|0|||
48894786|NCT02924428|157450059|FG000|Overall Study|Adverse Event|1|||
48894787|NCT02924428|157450060|FG001|Overall Study|Adverse Event|0|||
48894788|NCT02924428|157450059|FG000|Overall Study|Physician Decision|1|||
48894789|NCT02924428|157450060|FG001|Overall Study|Physician Decision|0|||
48894790|NCT02924428|157450059|FG000|Overall Study|Lost to Follow-up|2|||
48894791|NCT02924428|157450060|FG001|Overall Study|Lost to Follow-up|4|||
48894792|NCT02924428|157450059|FG000|Overall Study|Pregnancy|0|||
48894793|NCT02924428|157450060|FG001|Overall Study|Pregnancy|1|||
48894794|NCT01877837|157450061|FG000|Overall Study|Lost to Follow-up|1|||
48894795|NCT01877837|157450061|FG000|Overall Study|Ineligible|4|||
48894796|NCT00996476|157450064|FG000|Overall Study|Withdrawal by Subject|1|||
49038465|NCT01592240|157976704|FG001|Overall Study|Death|1|||
49038466|NCT01592240|157976705|FG002|Overall Study|Death|0|||
49038467|NCT01592240|157976706|FG003|Overall Study|Death|0|||
49038468|NCT01592240|157976707|FG004|Overall Study|Death|0|||
49038469|NCT01592240|157976708|FG005|Overall Study|Death|0|||
49038470|NCT01592240|157976709|FG006|Overall Study|Death|0|||
49038471|NCT01592240|157976703|FG000|Overall Study|Lost to Follow-up|1|||
49038472|NCT01592240|157976704|FG001|Overall Study|Lost to Follow-up|3|||
49038473|NCT01592240|157976705|FG002|Overall Study|Lost to Follow-up|1|||
49038474|NCT01592240|157976706|FG003|Overall Study|Lost to Follow-up|0|||
49038475|NCT01592240|157976707|FG004|Overall Study|Lost to Follow-up|3|||
49038476|NCT01592240|157976708|FG005|Overall Study|Lost to Follow-up|2|||
49038477|NCT01592240|157976709|FG006|Overall Study|Lost to Follow-up|0|||
49038478|NCT01592240|157976703|FG000|Overall Study|Protocol Violation|0|||
49038479|NCT01592240|157976704|FG001|Overall Study|Protocol Violation|0|||
49038480|NCT01592240|157976705|FG002|Overall Study|Protocol Violation|0|||
49038481|NCT01592240|157976706|FG003|Overall Study|Protocol Violation|0|||
49038482|NCT01592240|157976707|FG004|Overall Study|Protocol Violation|0|||
49038483|NCT01592240|157976708|FG005|Overall Study|Protocol Violation|1|||
49038484|NCT01592240|157976709|FG006|Overall Study|Protocol Violation|0|||
48894797|NCT00996476|157450065|FG001|Overall Study|Withdrawal by Subject|2|||
48894798|NCT00996476|157450066|FG002|Overall Study|Withdrawal by Subject|1|||
48894799|NCT00996476|157450067|FG003|Overall Study|Withdrawal by Subject|0|||
48894800|NCT00996476|157450068|FG004|Overall Study|Withdrawal by Subject|1|||
48894801|NCT00996476|157450064|FG000|Overall Study|Adverse Event|0|||
48894802|NCT00996476|157450065|FG001|Overall Study|Adverse Event|1|||
48894803|NCT00996476|157450066|FG002|Overall Study|Adverse Event|0|||
48894804|NCT00996476|157450067|FG003|Overall Study|Adverse Event|0|||
48894805|NCT00996476|157450068|FG004|Overall Study|Adverse Event|1|||
48894806|NCT00757588|157450071|FG000|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3|||
48894807|NCT00757588|157450072|FG001|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2|||
48894808|NCT00757588|157450071|FG000|Period 1: Short-term (24-week) Phase|Adverse Event|6|||
48894809|NCT00757588|157450072|FG001|Period 1: Short-term (24-week) Phase|Adverse Event|3|||
48894810|NCT00757588|157450071|FG000|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13|||
48984158|NCT01693562|157774125|FG004|Exploration Phase|Withdrawal by Subject|0|||
48984159|NCT01693562|157774126|FG005|Exploration Phase|Withdrawal by Subject|0|||
48984160|NCT01693562|157774127|FG006|Exploration Phase|Withdrawal by Subject|2|||
48984161|NCT01693562|157774128|FG007|Exploration Phase|Withdrawal by Subject|0|||
48984162|NCT01693562|157774129|FG008|Exploration Phase|Withdrawal by Subject|0|||
48984163|NCT01693562|157774130|FG009|Exploration Phase|Withdrawal by Subject|0|||
48984164|NCT01693562|157774131|FG010|Exploration Phase|Withdrawal by Subject|0|||
48984165|NCT01693562|157774132|FG011|Exploration Phase|Withdrawal by Subject|0|||
48984166|NCT01693562|157774133|FG012|Exploration Phase|Withdrawal by Subject|0|||
48984167|NCT01693562|157774134|FG013|Exploration Phase|Withdrawal by Subject|0|||
48984168|NCT01693562|157774135|FG014|Exploration Phase|Withdrawal by Subject|0|||
48984169|NCT01693562|157774136|FG015|Exploration Phase|Withdrawal by Subject|0|||
48984170|NCT01693562|157774137|FG016|Exploration Phase|Withdrawal by Subject|0|||
48984171|NCT01693562|157774138|FG017|Exploration Phase|Withdrawal by Subject|0|||
48984172|NCT01693562|157774139|FG018|Exploration Phase|Withdrawal by Subject|0|||
48984173|NCT01693562|157774140|FG019|Exploration Phase|Withdrawal by Subject|0|||
48984174|NCT01693562|157774141|FG020|Exploration Phase|Withdrawal by Subject|0|||
48984175|NCT01693562|157774142|FG021|Exploration Phase|Withdrawal by Subject|0|||
48984176|NCT01693562|157774143|FG022|Exploration Phase|Withdrawal by Subject|0|||
48984177|NCT01693562|157774121|FG000|Exploration Phase|Death|0|||
48984178|NCT01693562|157774122|FG001|Exploration Phase|Death|0|||
48984179|NCT01693562|157774123|FG002|Exploration Phase|Death|0|||
48984180|NCT01693562|157774124|FG003|Exploration Phase|Death|0|||
48984181|NCT01693562|157774125|FG004|Exploration Phase|Death|0|||
48984182|NCT01693562|157774126|FG005|Exploration Phase|Death|0|||
48984183|NCT01693562|157774127|FG006|Exploration Phase|Death|17|||
48984184|NCT01693562|157774128|FG007|Exploration Phase|Death|0|||
48984185|NCT01693562|157774129|FG008|Exploration Phase|Death|0|||
48984186|NCT01693562|157774130|FG009|Exploration Phase|Death|0|||
48984187|NCT01693562|157774131|FG010|Exploration Phase|Death|0|||
48984188|NCT01693562|157774132|FG011|Exploration Phase|Death|0|||
48984189|NCT01693562|157774133|FG012|Exploration Phase|Death|0|||
48984190|NCT01693562|157774134|FG013|Exploration Phase|Death|0|||
48984191|NCT01693562|157774135|FG014|Exploration Phase|Death|0|||
48984192|NCT01693562|157774136|FG015|Exploration Phase|Death|0|||
48984193|NCT01693562|157774137|FG016|Exploration Phase|Death|0|||
48984194|NCT01693562|157774138|FG017|Exploration Phase|Death|0|||
48984195|NCT01693562|157774139|FG018|Exploration Phase|Death|0|||
48984196|NCT01693562|157774140|FG019|Exploration Phase|Death|0|||
48984197|NCT01693562|157774141|FG020|Exploration Phase|Death|0|||
48984198|NCT01693562|157774142|FG021|Exploration Phase|Death|0|||
48984199|NCT01693562|157774143|FG022|Exploration Phase|Death|0|||
49038485|NCT01592240|157976703|FG000|Overall Study|Withdrawal by Subject|0|||
49038486|NCT01592240|157976704|FG001|Overall Study|Withdrawal by Subject|4|||
49038487|NCT01592240|157976705|FG002|Overall Study|Withdrawal by Subject|4|||
49038488|NCT01592240|157976706|FG003|Overall Study|Withdrawal by Subject|1|||
49038489|NCT01592240|157976707|FG004|Overall Study|Withdrawal by Subject|3|||
48894811|NCT00757588|157450072|FG001|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5|||
48894812|NCT00757588|157450071|FG000|Period 1: Short-term (24-week) Phase|Death|1|||
48894813|NCT00757588|157450072|FG001|Period 1: Short-term (24-week) Phase|Death|0|||
48894814|NCT00757588|157450071|FG000|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3|||
48894815|NCT00757588|157450072|FG001|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5|||
48894816|NCT00757588|157450071|FG000|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5|||
48894817|NCT00757588|157450072|FG001|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1|||
48894818|NCT00757588|157450071|FG000|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5|||
48894819|NCT00757588|157450072|FG001|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0|||
49038490|NCT01592240|157976708|FG005|Overall Study|Withdrawal by Subject|0|||
49038491|NCT01592240|157976709|FG006|Overall Study|Withdrawal by Subject|2|||
49038492|NCT01592240|157976703|FG000|Overall Study|Other|0|||
49038493|NCT01592240|157976704|FG001|Overall Study|Other|3|||
49038494|NCT01592240|157976705|FG002|Overall Study|Other|1|||
49038495|NCT01592240|157976706|FG003|Overall Study|Other|1|||
49038496|NCT01592240|157976707|FG004|Overall Study|Other|0|||
49038497|NCT01592240|157976708|FG005|Overall Study|Other|0|||
49038498|NCT01592240|157976709|FG006|Overall Study|Other|1|||
48894820|NCT00757588|157450071|FG000|Period 1: Short-term (24-week) Phase|Other|0|||
48894821|NCT00757588|157450072|FG001|Period 1: Short-term (24-week) Phase|Other|1|||
48894822|NCT00757588|157450071|FG000|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1|||
48894823|NCT00757588|157450072|FG001|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0|||
48894824|NCT00757588|157450071|FG000|Period 2: Long-term (52-week) Phase|Adverse Event|4|||
48894825|NCT00757588|157450072|FG001|Period 2: Long-term (52-week) Phase|Adverse Event|0|||
48894826|NCT00757588|157450071|FG000|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4|||
48894827|NCT00757588|157450072|FG001|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2|||
48894828|NCT00757588|157450071|FG000|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
48894829|NCT00757588|157450072|FG001|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
48894830|NCT00757588|157450071|FG000|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5|||
48894831|NCT00757588|157450072|FG001|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2|||
48894832|NCT00757588|157450071|FG000|Period 2: Long-term (52-week) Phase|Pregnancy|1|||
48894833|NCT00757588|157450072|FG001|Period 2: Long-term (52-week) Phase|Pregnancy|0|||
48894834|NCT00757588|157450071|FG000|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5|||
48894835|NCT00757588|157450072|FG001|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4|||
48894836|NCT00757588|157450071|FG000|Period 2: Long-term (52-week) Phase|Other|1|||
48894837|NCT00757588|157450072|FG001|Period 2: Long-term (52-week) Phase|Other|0|||
48894838|NCT03212989|157450075|FG000|Overall Study|Physician Decision|8|||
48894839|NCT02224690|157450076|FG000|Overall Study|Adverse Event|8|||
48894840|NCT02224690|157450077|FG001|Overall Study|Adverse Event|1|||
48894841|NCT02224690|157450076|FG000|Overall Study|Met Withdrawal Criteria|4|||
48894842|NCT02224690|157450077|FG001|Overall Study|Met Withdrawal Criteria|0|||
48894843|NCT02224690|157450076|FG000|Overall Study|Use of G-tube|1|||
48894844|NCT02224690|157450077|FG001|Overall Study|Use of G-tube|0|||
48894845|NCT02224690|157450076|FG000|Overall Study|Did not meet eligibility criteria|1|||
48894846|NCT02224690|157450077|FG001|Overall Study|Did not meet eligibility criteria|0|||
48894847|NCT01744392|157450078|FG000|Overall Study|Physician Decision|1|||
48894848|NCT04971681|157450079|FG000|Followup|Lost to Follow-up|1|||
48894849|NCT04971681|157450080|FG001|Followup|Lost to Follow-up|0|||
48894850|NCT00948766|157450081|FG000|Core Study|Adverse Event|73|||
48894851|NCT00948766|157450082|FG001|Core Study|Adverse Event|51|||
48894852|NCT00948766|157450081|FG000|Core Study|Unsatisfactory Therapeutic Effect|13|||
48894853|NCT00948766|157450082|FG001|Core Study|Unsatisfactory Therapeutic Effect|14|||
48894854|NCT00948766|157450081|FG000|Core Study|Patient Withdrew Consent|27|||
48894855|NCT00948766|157450082|FG001|Core Study|Patient Withdrew Consent|46|||
48894856|NCT00948766|157450081|FG000|Core Study|Lost to Follow-up|3|||
48894857|NCT00948766|157450082|FG001|Core Study|Lost to Follow-up|2|||
48894858|NCT00948766|157450081|FG000|Core Study|Administrative Problems|2|||
48894859|NCT00948766|157450082|FG001|Core Study|Administrative Problems|2|||
49038499|NCT01592240|157976703|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
49038500|NCT01592240|157976704|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
48894860|NCT00948766|157450081|FG000|Core Study|Death|1|||
48894861|NCT00948766|157450082|FG001|Core Study|Death|1|||
48894862|NCT00948766|157450081|FG000|Core Study|Protocol Deviation|8|||
49038501|NCT01592240|157976705|FG002|Overall Study|Did Not Meet Entrance Criteria|1|||
48894863|NCT00948766|157450082|FG001|Core Study|Protocol Deviation|10|||
48894864|NCT00948766|157450081|FG000|Extension Study|Adverse Event|43|||
48894865|NCT00948766|157450082|FG001|Extension Study|Adverse Event|0|||
48894866|NCT00948766|157450081|FG000|Extension Study|Unsatisfactory Therapeutic Effect|2|||
48894867|NCT00948766|157450082|FG001|Extension Study|Unsatisfactory Therapeutic Effect|0|||
48894868|NCT00948766|157450081|FG000|Extension Study|Study Drug No Longer Required|1|||
49038502|NCT01592240|157976706|FG003|Overall Study|Did Not Meet Entrance Criteria|0|||
49038503|NCT01592240|157976707|FG004|Overall Study|Did Not Meet Entrance Criteria|0|||
49038504|NCT01592240|157976708|FG005|Overall Study|Did Not Meet Entrance Criteria|0|||
48894869|NCT00948766|157450082|FG001|Extension Study|Study Drug No Longer Required|0|||
48894870|NCT00948766|157450081|FG000|Extension Study|Patient Withdrew Consent|32|||
48894871|NCT00948766|157450082|FG001|Extension Study|Patient Withdrew Consent|0|||
48894872|NCT00948766|157450081|FG000|Extension Study|Lost to Follow-up|8|||
48894873|NCT00948766|157450082|FG001|Extension Study|Lost to Follow-up|0|||
48894874|NCT00948766|157450081|FG000|Extension Study|Administrative Problems|1|||
48894875|NCT00948766|157450082|FG001|Extension Study|Administrative Problems|0|||
48894876|NCT00948766|157450081|FG000|Extension Study|Death|4|||
48894877|NCT00948766|157450082|FG001|Extension Study|Death|0|||
48894878|NCT00345293|157450086|FG000|Overall Study|Unable to access line for sample|1|||
48894879|NCT00345293|157450087|FG001|Overall Study|Unable to access line for sample|0|||
48894880|NCT00345293|157450086|FG000|Overall Study|Withdrawal by Subject|1|||
48894881|NCT00345293|157450087|FG001|Overall Study|Withdrawal by Subject|0|||
48894882|NCT02150343|157450088|FG000|Overall Study|Adverse Event|2|||
48894883|NCT02150343|157450089|FG001|Overall Study|Adverse Event|0|||
48894884|NCT02150343|157450090|FG002|Overall Study|Adverse Event|1|||
48894885|NCT02150343|157450091|FG003|Overall Study|Adverse Event|1|||
48894886|NCT02150343|157450088|FG000|Overall Study|Withdrawal by Subject|13|||
48894887|NCT02150343|157450089|FG001|Overall Study|Withdrawal by Subject|10|||
48894888|NCT02150343|157450090|FG002|Overall Study|Withdrawal by Subject|9|||
48894889|NCT02150343|157450091|FG003|Overall Study|Withdrawal by Subject|4|||
48894890|NCT02150343|157450088|FG000|Overall Study|Lost to Follow-up|4|||
48894891|NCT02150343|157450089|FG001|Overall Study|Lost to Follow-up|4|||
48894892|NCT02150343|157450090|FG002|Overall Study|Lost to Follow-up|2|||
48894893|NCT02150343|157450091|FG003|Overall Study|Lost to Follow-up|3|||
48894894|NCT02150343|157450088|FG000|Overall Study|Other|2|||
48894895|NCT02150343|157450089|FG001|Overall Study|Other|6|||
48894896|NCT02150343|157450090|FG002|Overall Study|Other|0|||
48894897|NCT02150343|157450091|FG003|Overall Study|Other|2|||
48894898|NCT03459443|157450092|FG000|Overall Study|Lack of Efficacy|3|||
48894899|NCT03459443|157450092|FG000|Overall Study|Adverse Event|1|||
48894900|NCT03459443|157450092|FG000|Overall Study|Sponsor's decision to close the study|18|||
48894901|NCT01200589|157450093|FG000|Overall Study|Withdrawal by Subject|13|||
49038505|NCT01592240|157976709|FG006|Overall Study|Did Not Meet Entrance Criteria|0|||
49038506|NCT00608322|157976713|FG000|Overall Study|Death|2|||
49038507|NCT00608322|157976714|FG001|Overall Study|Death|1|||
48894902|NCT01200589|157450094|FG001|Overall Study|Withdrawal by Subject|11|||
48894903|NCT01200589|157450093|FG000|Overall Study|Physician Decision|2|||
48894904|NCT01200589|157450094|FG001|Overall Study|Physician Decision|2|||
48894905|NCT01200589|157450093|FG000|Overall Study|Lost to Follow-up|5|||
48894906|NCT01200589|157450094|FG001|Overall Study|Lost to Follow-up|4|||
48894907|NCT01200589|157450093|FG000|Overall Study|Study terminated|170|||
48894908|NCT01200589|157450094|FG001|Overall Study|Study terminated|172|||
48894909|NCT00598273|157450098|FG000|Overall Study|Adverse Event|4|||
48894910|NCT00598273|157450099|FG001|Overall Study|Adverse Event|5|||
48894911|NCT00598273|157450100|FG002|Overall Study|Adverse Event|2|||
48894912|NCT00598273|157450098|FG000|Overall Study|Death|6|||
48894913|NCT00598273|157450099|FG001|Overall Study|Death|12|||
48894914|NCT00598273|157450100|FG002|Overall Study|Death|8|||
48894915|NCT00598273|157450098|FG000|Overall Study|Lost to Follow-up|8|||
48894916|NCT00598273|157450099|FG001|Overall Study|Lost to Follow-up|3|||
48894917|NCT00598273|157450100|FG002|Overall Study|Lost to Follow-up|5|||
48894918|NCT00598273|157450098|FG000|Overall Study|Physician Decision|0|||
48894919|NCT00598273|157450099|FG001|Overall Study|Physician Decision|0|||
48894920|NCT00598273|157450100|FG002|Overall Study|Physician Decision|1|||
48894921|NCT00598273|157450098|FG000|Overall Study|Withdrawal by Subject|12|||
48894922|NCT00598273|157450099|FG001|Overall Study|Withdrawal by Subject|10|||
48894923|NCT00598273|157450100|FG002|Overall Study|Withdrawal by Subject|10|||
48894924|NCT00598273|157450098|FG000|Overall Study|Noncompliance|3|||
48894925|NCT00598273|157450099|FG001|Overall Study|Noncompliance|2|||
48894926|NCT00598273|157450100|FG002|Overall Study|Noncompliance|3|||
48894927|NCT00598273|157450098|FG000|Overall Study|Relocation|0|||
48894928|NCT00598273|157450099|FG001|Overall Study|Relocation|2|||
48894929|NCT00598273|157450100|FG002|Overall Study|Relocation|4|||
49038508|NCT02258074|157976715|FG000|Overall Study|Withdrawal by Subject|1|||
48894930|NCT00598273|157450098|FG000|Overall Study|Renal transplant|1|||
48894931|NCT00598273|157450099|FG001|Overall Study|Renal transplant|0|||
48894932|NCT00598273|157450100|FG002|Overall Study|Renal transplant|1|||
48894933|NCT00598273|157450098|FG000|Overall Study|Site elected to close|1|||
48894934|NCT00598273|157450099|FG001|Overall Study|Site elected to close|0|||
48894935|NCT00598273|157450100|FG002|Overall Study|Site elected to close|0|||
48894936|NCT00598273|157450098|FG000|Overall Study|Started dialysis|6|||
48894937|NCT00598273|157450099|FG001|Overall Study|Started dialysis|4|||
48894938|NCT00598273|157450100|FG002|Overall Study|Started dialysis|5|||
48894939|NCT01146782|157450101|FG000|Screening Cohort|Screen Failure|187|||
48894940|NCT01146782|157450101|FG000|Screening Cohort|Lost to Follow-up|4|||
48894941|NCT01146782|157450101|FG000|Screening Cohort|Physician Decision|1|||
48894942|NCT01146782|157450101|FG000|Screening Cohort|Withdrawal by Subject|29|||
48894943|NCT01146782|157450101|FG000|Safety Cohort|Screen Failure|61|||
49038509|NCT02258074|157976716|FG001|Overall Study|Withdrawal by Subject|0|||
48894944|NCT01146782|157450101|FG000|Safety Cohort|Withdrawal by Subject|4|||
48894945|NCT01146782|157450101|FG000|Safety Cohort|Control AHI <5|4|||
49038510|NCT02258074|157976717|FG002|Overall Study|Withdrawal by Subject|0|||
49038511|NCT02258074|157976718|FG003|Overall Study|Withdrawal by Subject|0|||
49038512|NCT05479058|157976719|FG000|Overall Study|Withdrawal by Subject|1|||
49038513|NCT05479058|157976720|FG001|Overall Study|Withdrawal by Subject|1|||
49038514|NCT05479058|157976719|FG000|Overall Study|Study terminated by sponsor|10|||
49038515|NCT05479058|157976720|FG001|Overall Study|Study terminated by sponsor|10|||
49038516|NCT02593773|157976721|FG000|Overall Study|Voluntary Withdrawal|3|||
49038517|NCT02593773|157976721|FG000|Overall Study|Study Terminated by Sponsor|31|||
49038518|NCT02593773|157976721|FG000|Overall Study|Death|1|||
49038519|NCT00834444|157976722|FG000|First Intervention|Adverse Event|1|||
49038520|NCT00834444|157976723|FG001|First Intervention|Adverse Event|0|||
48894946|NCT01146782|157450101|FG000|Safety Cohort|TST <4 hrs|14|||
48894947|NCT01146782|157450101|FG000|Primary Endpoint Cohort|Withdrawal by Subject|5|||
48894948|NCT01146782|157450101|FG000|Primary Endpoint Cohort|Physician Decision|1|||
48894949|NCT01771107|157450103|FG000|Overall Study|Adverse Event|1|||
48894950|NCT01771107|157450104|FG001|Overall Study|Adverse Event|3|||
48894951|NCT01771107|157450103|FG000|Overall Study|Withdrawal by Subject|0|||
48894952|NCT01771107|157450104|FG001|Overall Study|Withdrawal by Subject|2|||
48894953|NCT01771107|157450103|FG000|Overall Study|Lost to Follow-up|0|||
48894954|NCT01771107|157450104|FG001|Overall Study|Lost to Follow-up|1|||
48894955|NCT01771107|157450103|FG000|Overall Study|participant moved|0|||
48894956|NCT01771107|157450104|FG001|Overall Study|participant moved|1|||
48894957|NCT01771107|157450103|FG000|Overall Study|Other|0|||
48894958|NCT01771107|157450104|FG001|Overall Study|Other|1|||
48894959|NCT02390245|157450105|FG000|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|0|||
48894960|NCT02390245|157450106|FG001|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|103|||
48894961|NCT02390245|157450107|FG002|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|104|||
48894962|NCT02390245|157450105|FG000|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|0|||
48894963|NCT02390245|157450106|FG001|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|95|||
48894964|NCT02390245|157450107|FG002|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|106|||
48894965|NCT02891408|157450108|FG000|Overall Study|Lost to Follow-up|0|||
48894966|NCT02891408|157450109|FG001|Overall Study|Lost to Follow-up|0|||
48894967|NCT02891408|157450110|FG002|Overall Study|Lost to Follow-up|1|||
48894968|NCT02891408|157450111|FG003|Overall Study|Lost to Follow-up|0|||
48894969|NCT02891408|157450112|FG004|Overall Study|Lost to Follow-up|0|||
48894970|NCT02891408|157450113|FG005|Overall Study|Lost to Follow-up|0|||
48894971|NCT02891408|157450114|FG006|Overall Study|Lost to Follow-up|0|||
48894972|NCT00540046|157450115|FG000|Overall Study|Lost to Follow-up|33|||
48894973|NCT00540046|157450116|FG001|Overall Study|Lost to Follow-up|23|||
48894974|NCT02891837|157450117|FG000|Overall Study|Lost to Follow-up|2|||
48894975|NCT02891837|157450118|FG001|Overall Study|Lost to Follow-up|0|||
48894976|NCT02891837|157450117|FG000|Overall Study|Withdrawal by Subject|1|||
48894977|NCT02891837|157450118|FG001|Overall Study|Withdrawal by Subject|0|||
48894978|NCT00709852|157450119|FG000|Period 1|Adverse Event|2|||
48894979|NCT00709852|157450120|FG001|Period 1|Adverse Event|0|||
48894980|NCT00709852|157450119|FG000|Period 1|Withdrawal by Subject|4|||
48894981|NCT00709852|157450120|FG001|Period 1|Withdrawal by Subject|2|||
48894982|NCT00709852|157450119|FG000|Period 1|Protocol Violation|1|||
48894983|NCT00709852|157450120|FG001|Period 1|Protocol Violation|0|||
48894984|NCT00709852|157450119|FG000|Period 1|Defective scanner|0|||
48894985|NCT00709852|157450120|FG001|Period 1|Defective scanner|1|||
48894986|NCT00709852|157450119|FG000|Period 1|Lost to Follow-up|1|||
48894987|NCT00709852|157450120|FG001|Period 1|Lost to Follow-up|0|||
48894988|NCT00709852|157450119|FG000|Period 2|Protocol Violation|4|||
48894989|NCT00709852|157450120|FG001|Period 2|Protocol Violation|1|||
48894990|NCT00709852|157450119|FG000|Period 2|Adverse Event|1|||
48894991|NCT00709852|157450120|FG001|Period 2|Adverse Event|1|||
48894992|NCT00709852|157450119|FG000|Period 2|Lost to Follow-up|1|||
48894993|NCT00709852|157450120|FG001|Period 2|Lost to Follow-up|0|||
48894994|NCT00709852|157450119|FG000|Period 2|No 72-hour follow-up|3|||
48894995|NCT00709852|157450120|FG001|Period 2|No 72-hour follow-up|0|||
48894996|NCT00112047|157450121|FG000|Randomized Phase|Lost to Follow-up|26|||
48894997|NCT00112047|157450122|FG001|Randomized Phase|Lost to Follow-up|33|||
48894998|NCT00112047|157450121|FG000|Randomized Phase|Adverse Event|10|||
48894999|NCT00112047|157450122|FG001|Randomized Phase|Adverse Event|10|||
48895000|NCT00112047|157450121|FG000|Randomized Phase|Withrawal of consent|10|||
48895001|NCT00112047|157450122|FG001|Randomized Phase|Withrawal of consent|18|||
48895002|NCT00112047|157450121|FG000|Randomized Phase|Sub-optimal virological response|3|||
48895003|NCT00112047|157450122|FG001|Randomized Phase|Sub-optimal virological response|13|||
48895004|NCT00112047|157450121|FG000|Randomized Phase|Noncompliance|8|||
48895005|NCT00112047|157450122|FG001|Randomized Phase|Noncompliance|4|||
48895006|NCT00112047|157450121|FG000|Randomized Phase|Protocol Violation|2|||
48895007|NCT00112047|157450122|FG001|Randomized Phase|Protocol Violation|0|||
49038521|NCT00834444|157976722|FG000|First Intervention|Intolerance to Venopuncture|0|||
49038522|NCT00834444|157976723|FG001|First Intervention|Intolerance to Venopuncture|1|||
49038523|NCT00834444|157976722|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
49038524|NCT00834444|157976723|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
49038525|NCT00834444|157976722|FG000|Second Intervention|Adverse Event|1|||
49038526|NCT00834444|157976723|FG001|Second Intervention|Adverse Event|0|||
49038527|NCT01484912|157976730|FG000|Overall Study|Withdrawal by Subject|1|||
49038528|NCT01484912|157976731|FG001|Overall Study|Withdrawal by Subject|0|||
49038529|NCT01484912|157976730|FG000|Overall Study|Physician Decision|0|||
49038530|NCT01484912|157976731|FG001|Overall Study|Physician Decision|1|||
49038531|NCT00829712|157976732|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
49038532|NCT00829712|157976733|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
49038533|NCT00606281|157976734|FG000|Overall Study|Adverse Event|11|||
49038534|NCT00606281|157976735|FG001|Overall Study|Adverse Event|12|||
49038535|NCT00606281|157976734|FG000|Overall Study|Death|1|||
49038536|NCT00606281|157976735|FG001|Overall Study|Death|0|||
49038537|NCT00606281|157976734|FG000|Overall Study|Lack of Efficacy|28|||
49038538|NCT00606281|157976735|FG001|Overall Study|Lack of Efficacy|35|||
49038539|NCT00606281|157976734|FG000|Overall Study|Physician Decision|0|||
48895008|NCT00112047|157450121|FG000|Randomized Phase|Pregnancy|3|||
48895009|NCT00112047|157450122|FG001|Randomized Phase|Pregnancy|1|||
48895010|NCT00112047|157450121|FG000|Randomized Phase|Death|1|||
48895011|NCT00112047|157450122|FG001|Randomized Phase|Death|3|||
48895012|NCT00112047|157450121|FG000|Randomized Phase|Hepatitis C treatment contraindicated|0|||
48895013|NCT00112047|157450122|FG001|Randomized Phase|Hepatitis C treatment contraindicated|1|||
48895014|NCT00112047|157450121|FG000|Randomized Phase|Inability to swallow pills|0|||
48895015|NCT00112047|157450122|FG001|Randomized Phase|Inability to swallow pills|1|||
48895016|NCT00112047|157450121|FG000|Randomized Phase|Incarceration|3|||
48895017|NCT00112047|157450122|FG001|Randomized Phase|Incarceration|2|||
48895018|NCT00112047|157450121|FG000|Randomized Phase|Moved out of State|0|||
48895019|NCT00112047|157450122|FG001|Randomized Phase|Moved out of State|1|||
48895020|NCT00112047|157450121|FG000|Randomized Phase|Baseline NNRTI resistance mutations|4|||
48895021|NCT00112047|157450122|FG001|Randomized Phase|Baseline NNRTI resistance mutations|0|||
48895022|NCT00112047|157450121|FG000|Randomized Phase|High Hepatitis B DNA|0|||
48895023|NCT00112047|157450122|FG001|Randomized Phase|High Hepatitis B DNA|1|||
48895024|NCT00112047|157450121|FG000|Atripla Phase|Adverse Event|2|||
48895025|NCT00112047|157450122|FG001|Atripla Phase|Adverse Event|1|||
48895026|NCT00112047|157450121|FG000|Atripla Phase|Lost to Follow-up|5|||
48895027|NCT00112047|157450122|FG001|Atripla Phase|Lost to Follow-up|7|||
48895028|NCT00112047|157450121|FG000|Atripla Phase|Pregnancy|0|||
48895029|NCT00112047|157450122|FG001|Atripla Phase|Pregnancy|1|||
48895030|NCT00112047|157450121|FG000|Atripla Phase|Death|0|||
48895031|NCT00112047|157450122|FG001|Atripla Phase|Death|2|||
48895032|NCT00112047|157450121|FG000|Atripla Phase|Withdrew consent|7|||
48895033|NCT00112047|157450122|FG001|Atripla Phase|Withdrew consent|7|||
48895034|NCT00112047|157450121|FG000|Atripla Phase|Sub-optimal virological response|0|||
48895035|NCT00112047|157450122|FG001|Atripla Phase|Sub-optimal virological response|1|||
48895036|NCT00112047|157450121|FG000|Atripla Phase|Non-compliance|1|||
48895037|NCT00112047|157450122|FG001|Atripla Phase|Non-compliance|0|||
48895038|NCT00112047|157450121|FG000|Atripla Phase|Other|3|||
48895039|NCT00112047|157450122|FG001|Atripla Phase|Other|1|||
48895040|NCT01021215|157450123|FG000|Overall Study|Lost to Follow-up|3|||
48895041|NCT01021215|157450124|FG001|Overall Study|Lost to Follow-up|0|||
48895042|NCT02533531|157450125|FG000|Overall Study|Device did not turn on|1|||
48895043|NCT03169101|157450126|FG000|Lab Session 1 (Week 1)|Protocol Violation|0|||
48895044|NCT03169101|157450127|FG001|Lab Session 1 (Week 1)|Protocol Violation|0|||
48895045|NCT03169101|157450128|FG002|Lab Session 1 (Week 1)|Protocol Violation|0|||
48895046|NCT03169101|157450129|FG003|Lab Session 1 (Week 1)|Protocol Violation|4|||
48895047|NCT00979134|157450142|FG000|Overall Study|Disease progression|18|||
48895048|NCT00979134|157450143|FG001|Overall Study|Disease progression|2|||
48895049|NCT00979134|157450144|FG002|Overall Study|Disease progression|5|||
48895050|NCT00979134|157450142|FG000|Overall Study|Adverse Event|0|||
48895051|NCT00979134|157450143|FG001|Overall Study|Adverse Event|0|||
48895052|NCT00979134|157450144|FG002|Overall Study|Adverse Event|2|||
48895053|NCT00979134|157450142|FG000|Overall Study|Withdrawal by Subject|1|||
48895054|NCT00979134|157450143|FG001|Overall Study|Withdrawal by Subject|1|||
48895055|NCT00979134|157450144|FG002|Overall Study|Withdrawal by Subject|2|||
48895056|NCT00979134|157450142|FG000|Overall Study|Lost to Follow-up|2|||
48895057|NCT00979134|157450143|FG001|Overall Study|Lost to Follow-up|2|||
48895058|NCT00979134|157450144|FG002|Overall Study|Lost to Follow-up|0|||
48895059|NCT00979134|157450142|FG000|Overall Study|Death|4|||
48895060|NCT00979134|157450143|FG001|Overall Study|Death|0|||
48895061|NCT00979134|157450144|FG002|Overall Study|Death|26|||
48895062|NCT00979134|157450142|FG000|Overall Study|Other|8|||
48895063|NCT00979134|157450143|FG001|Overall Study|Other|1|||
48895064|NCT00979134|157450144|FG002|Overall Study|Other|5|||
48895065|NCT00924027|157450151|FG000|Overall Study|Lost to Further Follow-Up|4|||
48895066|NCT00924027|157450152|FG001|Overall Study|Lost to Further Follow-Up|0|||
49038540|NCT00606281|157976735|FG001|Overall Study|Physician Decision|1|||
49038541|NCT00606281|157976734|FG000|Overall Study|Protocol Violation|3|||
49038542|NCT00606281|157976735|FG001|Overall Study|Protocol Violation|3|||
49038543|NCT00606281|157976734|FG000|Overall Study|Withdrawal by Subject|11|||
48895067|NCT00924027|157450153|FG002|Overall Study|Lost to Further Follow-Up|0|||
48895068|NCT00924027|157450154|FG003|Overall Study|Lost to Further Follow-Up|0|||
48895069|NCT00924027|157450151|FG000|Overall Study|Physician Decision|1|||
48895070|NCT00924027|157450152|FG001|Overall Study|Physician Decision|0|||
48895071|NCT00924027|157450153|FG002|Overall Study|Physician Decision|0|||
48895072|NCT00924027|157450154|FG003|Overall Study|Physician Decision|1|||
48895073|NCT00924027|157450151|FG000|Overall Study|Withdrawal: Refused further treatment|1|||
48895074|NCT00924027|157450152|FG001|Overall Study|Withdrawal: Refused further treatment|0|||
48895075|NCT00924027|157450153|FG002|Overall Study|Withdrawal: Refused further treatment|0|||
48895076|NCT00924027|157450154|FG003|Overall Study|Withdrawal: Refused further treatment|0|||
48895077|NCT00924027|157450151|FG000|Overall Study|Withdrawal: Refused to start treatment|1|||
48895078|NCT00924027|157450152|FG001|Overall Study|Withdrawal: Refused to start treatment|0|||
48895079|NCT00924027|157450153|FG002|Overall Study|Withdrawal: Refused to start treatment|0|||
48895080|NCT00924027|157450154|FG003|Overall Study|Withdrawal: Refused to start treatment|1|||
48895081|NCT00924027|157450151|FG000|Overall Study|Withdrawal: Refused further follow-up|1|||
48895082|NCT00924027|157450152|FG001|Overall Study|Withdrawal: Refused further follow-up|0|||
48895083|NCT00924027|157450153|FG002|Overall Study|Withdrawal: Refused further follow-up|0|||
48895084|NCT00924027|157450154|FG003|Overall Study|Withdrawal: Refused further follow-up|0|||
48895085|NCT00095498|157453077|FG000|Overall Study|Physician Decision|9|||
48895086|NCT00095498|157453078|FG001|Overall Study|Physician Decision|10|||
48895087|NCT00095498|157453079|FG002|Overall Study|Physician Decision|8|||
48895088|NCT00095498|157453077|FG000|Overall Study|Adverse Event|1|||
48895089|NCT00095498|157453078|FG001|Overall Study|Adverse Event|0|||
48895090|NCT00095498|157453079|FG002|Overall Study|Adverse Event|1|||
48895091|NCT00095498|157453077|FG000|Overall Study|Withdrawal by Subject|15|||
48895092|NCT00095498|157453078|FG001|Overall Study|Withdrawal by Subject|16|||
48895093|NCT00095498|157453079|FG002|Overall Study|Withdrawal by Subject|15|||
48895094|NCT00095498|157453077|FG000|Overall Study|Disease progression|0|||
48895095|NCT00095498|157453078|FG001|Overall Study|Disease progression|1|||
48895096|NCT00095498|157453079|FG002|Overall Study|Disease progression|1|||
48895097|NCT00095498|157453077|FG000|Overall Study|Ineligibility determined|3|||
48895098|NCT00095498|157453078|FG001|Overall Study|Ineligibility determined|0|||
48895099|NCT00095498|157453079|FG002|Overall Study|Ineligibility determined|2|||
48895100|NCT00095498|157453077|FG000|Overall Study|Lost to Follow-up|1|||
48895101|NCT00095498|157453078|FG001|Overall Study|Lost to Follow-up|1|||
48895102|NCT00095498|157453079|FG002|Overall Study|Lost to Follow-up|2|||
48895103|NCT00095498|157453077|FG000|Overall Study|Noncompliance|1|||
48895104|NCT00095498|157453078|FG001|Overall Study|Noncompliance|0|||
48895105|NCT00095498|157453079|FG002|Overall Study|Noncompliance|1|||
48895106|NCT00095498|157453077|FG000|Overall Study|Other|6|||
48895107|NCT00095498|157453078|FG001|Overall Study|Other|7|||
48895108|NCT00095498|157453079|FG002|Overall Study|Other|6|||
48895109|NCT00095498|157453077|FG000|Overall Study|Protocol Violation|0|||
48895110|NCT00095498|157453078|FG001|Overall Study|Protocol Violation|0|||
48895111|NCT00095498|157453079|FG002|Overall Study|Protocol Violation|1|||
48895112|NCT00095498|157453077|FG000|Overall Study|Requirement for alternative therapy|1|||
48895113|NCT00095498|157453078|FG001|Overall Study|Requirement for alternative therapy|0|||
48895114|NCT00095498|157453079|FG002|Overall Study|Requirement for alternative therapy|2|||
48895115|NCT03695237|157453080|FG000|Overall Study|Withdrawal by Subject|1|||
48895116|NCT03695237|157453081|FG001|Overall Study|Withdrawal by Subject|3|||
48895117|NCT03695237|157453080|FG000|Overall Study|Lost to Follow-up|1|||
48895118|NCT03695237|157453081|FG001|Overall Study|Lost to Follow-up|2|||
48895119|NCT03695237|157453080|FG000|Overall Study|Other, Not Specified|8|||
48895120|NCT03695237|157453081|FG001|Overall Study|Other, Not Specified|2|||
48895121|NCT04375761|157453082|FG000|Overall Study|Death|1|||
48895122|NCT04375761|157453083|FG001|Overall Study|Death|2|||
48895123|NCT04375761|157453082|FG000|Overall Study|Lost to Follow-up|203|||
48895124|NCT04375761|157453083|FG001|Overall Study|Lost to Follow-up|380|||
48895125|NCT04375761|157453082|FG000|Overall Study|Withdrawal by Subject|47|||
48895126|NCT04375761|157453083|FG001|Overall Study|Withdrawal by Subject|98|||
48895127|NCT04375761|157453082|FG000|Overall Study|Noncompliance with study procedure|121|||
48895128|NCT04375761|157453083|FG001|Overall Study|Noncompliance with study procedure|251|||
48895129|NCT04375761|157453082|FG000|Overall Study|Reimbursement not enough|1|||
48895130|NCT04375761|157453083|FG001|Overall Study|Reimbursement not enough|2|||
48895131|NCT04375761|157453082|FG000|Overall Study|Unforeseen family circumstances|1|||
48895132|NCT04375761|157453083|FG001|Overall Study|Unforeseen family circumstances|3|||
48895133|NCT04375761|157453082|FG000|Overall Study|Test too painful|1|||
48895134|NCT04375761|157453083|FG001|Overall Study|Test too painful|1|||
48895135|NCT04375761|157453082|FG000|Overall Study|Moved|0|||
48895136|NCT04375761|157453083|FG001|Overall Study|Moved|2|||
48895137|NCT04375761|157453082|FG000|Overall Study|Nonresponsive|0|||
48895138|NCT04375761|157453083|FG001|Overall Study|Nonresponsive|5|||
48895139|NCT03725085|157453084|FG000|Overall Study|Lost to Follow-up|2|||
48895140|NCT00705679|157453085|FG000|Overall Study|Adverse Event|1|||
48895141|NCT00705679|157453086|FG001|Overall Study|Adverse Event|1|||
48895142|NCT00705679|157453087|FG002|Overall Study|Adverse Event|0|||
48895143|NCT00705679|157453088|FG003|Overall Study|Adverse Event|0|||
48895144|NCT00705679|157453089|FG004|Overall Study|Adverse Event|0|||
48895145|NCT00705679|157453085|FG000|Overall Study|Death|0|||
48895146|NCT00705679|157453086|FG001|Overall Study|Death|0|||
48895147|NCT00705679|157453087|FG002|Overall Study|Death|3|||
48895148|NCT00705679|157453088|FG003|Overall Study|Death|2|||
48895149|NCT00705679|157453089|FG004|Overall Study|Death|1|||
48895150|NCT00705679|157453085|FG000|Overall Study|Lost to Follow-up|32|||
48895151|NCT00705679|157453086|FG001|Overall Study|Lost to Follow-up|60|||
48895152|NCT00705679|157453087|FG002|Overall Study|Lost to Follow-up|44|||
48895153|NCT00705679|157453088|FG003|Overall Study|Lost to Follow-up|30|||
48895154|NCT00705679|157453089|FG004|Overall Study|Lost to Follow-up|35|||
48895155|NCT00705679|157453085|FG000|Overall Study|Physician Decision|0|||
48895156|NCT00705679|157453086|FG001|Overall Study|Physician Decision|1|||
48895157|NCT00705679|157453087|FG002|Overall Study|Physician Decision|0|||
48895158|NCT00705679|157453088|FG003|Overall Study|Physician Decision|1|||
48895159|NCT00705679|157453089|FG004|Overall Study|Physician Decision|0|||
48895160|NCT00705679|157453085|FG000|Overall Study|Withdrawal by Subject|32|||
48895161|NCT00705679|157453086|FG001|Overall Study|Withdrawal by Subject|77|||
48895162|NCT00705679|157453087|FG002|Overall Study|Withdrawal by Subject|68|||
48895163|NCT00705679|157453088|FG003|Overall Study|Withdrawal by Subject|47|||
48895164|NCT00705679|157453089|FG004|Overall Study|Withdrawal by Subject|33|||
48895165|NCT03730480|157453090|FG000|Overall Study|Meter displayed a HI result which is non evaluable.|1|||
48895166|NCT00959647|157453093|FG000|Overall Study|Adverse Event|2|||
48895167|NCT00959647|157453093|FG000|Overall Study|Progressive disease|6|||
48895168|NCT00959647|157453093|FG000|Overall Study|Study terminated by sponsor|4|||
48895169|NCT00959647|157453093|FG000|Overall Study|Withdrawal by Subject|7|||
48895170|NCT01119105|157453097|FG000|Overall Study|Withdrawal by Subject|1|||
48895171|NCT01119105|157453098|FG001|Overall Study|Withdrawal by Subject|1|||
48895172|NCT01119105|157453099|FG002|Overall Study|Withdrawal by Subject|1|||
48895173|NCT01119105|157453097|FG000|Overall Study|Lost to Follow-up|0|||
48895174|NCT01119105|157453098|FG001|Overall Study|Lost to Follow-up|2|||
48895175|NCT01119105|157453099|FG002|Overall Study|Lost to Follow-up|5|||
48895176|NCT01119105|157453097|FG000|Overall Study|Adverse Event|1|||
48895177|NCT01119105|157453098|FG001|Overall Study|Adverse Event|0|||
48895178|NCT01119105|157453099|FG002|Overall Study|Adverse Event|1|||
48895179|NCT01119105|157453097|FG000|Overall Study|study drug missed on 2 consecutive days|1|||
48895180|NCT01119105|157453098|FG001|Overall Study|study drug missed on 2 consecutive days|2|||
48895181|NCT01119105|157453099|FG002|Overall Study|study drug missed on 2 consecutive days|1|||
48895182|NCT01119105|157453097|FG000|Overall Study|Other|1|||
48895183|NCT01119105|157453098|FG001|Overall Study|Other|1|||
48895184|NCT01119105|157453099|FG002|Overall Study|Other|0|||
48895185|NCT02383056|157453100|FG000|Overall Study|Adverse Event|1|||
48895186|NCT02383056|157453101|FG001|Overall Study|Adverse Event|0|||
48895187|NCT02383056|157453100|FG000|Overall Study|Lost to Follow-up|0|||
48895188|NCT02383056|157453101|FG001|Overall Study|Lost to Follow-up|2|||
48895189|NCT01813929|157453102|FG000|Overall Study|Withdrawal by Subject|0|||
48895190|NCT01813929|157453103|FG001|Overall Study|Withdrawal by Subject|1|||
48895191|NCT00007345|157453104|FG000|Overall Study|Refused further treatment|0|||
48895192|NCT00007345|157453105|FG001|Overall Study|Refused further treatment|7|||
48895193|NCT00007345|157453104|FG000|Overall Study|Switched to alternative treatment|0|||
48895194|NCT00007345|157453105|FG001|Overall Study|Switched to alternative treatment|3|||
48895195|NCT00007345|157453104|FG000|Overall Study|Intercurrent illness|1|||
48895196|NCT00007345|157453105|FG001|Overall Study|Intercurrent illness|0|||
48895197|NCT00007345|157453104|FG000|Overall Study|Death on study|1|||
48895198|NCT00007345|157453105|FG001|Overall Study|Death on study|1|||
48895199|NCT02245737|157453110|FG000|Overall Study|Adverse Event|23|||
48895200|NCT02245737|157453111|FG001|Overall Study|Adverse Event|26|||
48895201|NCT02245737|157453112|FG002|Overall Study|Adverse Event|33|||
48895202|NCT02245737|157453110|FG000|Overall Study|Condition Worsened|9|||
48895203|NCT02245737|157453111|FG001|Overall Study|Condition Worsened|10|||
48895204|NCT02245737|157453112|FG002|Overall Study|Condition Worsened|9|||
48895205|NCT02245737|157453110|FG000|Overall Study|Death|2|||
48895206|NCT02245737|157453111|FG001|Overall Study|Death|4|||
48895207|NCT02245737|157453112|FG002|Overall Study|Death|4|||
48895208|NCT02245737|157453110|FG000|Overall Study|Eligibility Criteria No Longer Met|2|||
48895209|NCT02245737|157453111|FG001|Overall Study|Eligibility Criteria No Longer Met|4|||
48895210|NCT02245737|157453112|FG002|Overall Study|Eligibility Criteria No Longer Met|4|||
48895211|NCT02245737|157453110|FG000|Overall Study|Initiation of Symptomatic AD medication|2|||
48895212|NCT02245737|157453111|FG001|Overall Study|Initiation of Symptomatic AD medication|0|||
48895213|NCT02245737|157453112|FG002|Overall Study|Initiation of Symptomatic AD medication|0|||
48895214|NCT02245737|157453110|FG000|Overall Study|Lost to Follow-up|2|||
48895215|NCT02245737|157453111|FG001|Overall Study|Lost to Follow-up|5|||
48895216|NCT02245737|157453112|FG002|Overall Study|Lost to Follow-up|4|||
48895217|NCT02245737|157453110|FG000|Overall Study|Other-determined by Investigator|9|||
48895218|NCT02245737|157453111|FG001|Overall Study|Other-determined by Investigator|10|||
48895219|NCT02245737|157453112|FG002|Overall Study|Other-determined by Investigator|10|||
48895220|NCT02245737|157453110|FG000|Overall Study|Physician Decision|6|||
48895221|NCT02245737|157453111|FG001|Overall Study|Physician Decision|3|||
48895222|NCT02245737|157453112|FG002|Overall Study|Physician Decision|6|||
48895223|NCT02245737|157453110|FG000|Overall Study|Protocol Violation|3|||
48895224|NCT02245737|157453111|FG001|Overall Study|Protocol Violation|2|||
48895225|NCT02245737|157453112|FG002|Overall Study|Protocol Violation|3|||
48895226|NCT02245737|157453110|FG000|Overall Study|Withdrawal by Subject|40|||
48895227|NCT02245737|157453111|FG001|Overall Study|Withdrawal by Subject|41|||
48895228|NCT02245737|157453112|FG002|Overall Study|Withdrawal by Subject|44|||
48895229|NCT02245737|157453110|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|10|||
48895230|NCT02245737|157453111|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|20|||
48895231|NCT02245737|157453112|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|22|||
48895232|NCT02245737|157453110|FG000|Overall Study|Sponsor Decision|445|||
48895233|NCT02245737|157453111|FG001|Overall Study|Sponsor Decision|430|||
48895234|NCT02245737|157453112|FG002|Overall Study|Sponsor Decision|432|||
48895235|NCT01970345|157453113|FG000|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
48895236|NCT01970345|157453114|FG001|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
48895237|NCT01970345|157453113|FG000|Second Treatment Phase 12 Weeks|Withdrawal by Subject|0|||
48895238|NCT01970345|157453114|FG001|Second Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
48895239|NCT04279392|157453115|FG000|Overall Study|Physician Decision|1|||
48895240|NCT04279392|157453116|FG001|Overall Study|Physician Decision|0|||
48895241|NCT01879722|157453117|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
48895242|NCT01879722|157453118|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
48895243|NCT01879722|157453119|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
48895244|NCT01879722|157453120|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
48895245|NCT01879722|157453121|FG004|Overall Study|Pretreatment Event/Adverse Event|1|||
48895246|NCT01879722|157453122|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
48895247|NCT01879722|157453123|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
48895248|NCT01879722|157453124|FG007|Overall Study|Pretreatment Event/Adverse Event|1|||
48895249|NCT01879722|157453125|FG008|Overall Study|Pretreatment Event/Adverse Event|1|||
48895250|NCT01879722|157453126|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
48895251|NCT01879722|157453117|FG000|Overall Study|Voluntary Withdrawal|0|||
48895252|NCT01879722|157453118|FG001|Overall Study|Voluntary Withdrawal|0|||
48895253|NCT01879722|157453119|FG002|Overall Study|Voluntary Withdrawal|0|||
48895254|NCT01879722|157453120|FG003|Overall Study|Voluntary Withdrawal|0|||
48895255|NCT01879722|157453121|FG004|Overall Study|Voluntary Withdrawal|0|||
48895256|NCT01879722|157453122|FG005|Overall Study|Voluntary Withdrawal|0|||
48895257|NCT01879722|157453123|FG006|Overall Study|Voluntary Withdrawal|0|||
48895258|NCT01879722|157453124|FG007|Overall Study|Voluntary Withdrawal|0|||
48895259|NCT01879722|157453125|FG008|Overall Study|Voluntary Withdrawal|1|||
48895260|NCT01879722|157453126|FG009|Overall Study|Voluntary Withdrawal|0|||
48895261|NCT05398237|157453128|FG000|Overall Study|Withdrawal by Subject|1|||
48895262|NCT04988867|157453129|FG000|Overall Study|Study terminated by Sponsor|12|||
48895263|NCT04988867|157453129|FG000|Overall Study|Adverse Event|2|||
48895264|NCT04988867|157453129|FG000|Overall Study|Study drug noncompliance|1|||
48895265|NCT00903006|157453130|FG000|Overall Study|Withdrawal by Subject|2|||
48895266|NCT00903006|157453131|FG001|Overall Study|Withdrawal by Subject|0|||
48895267|NCT00903006|157453132|FG002|Overall Study|Withdrawal by Subject|0|||
48895268|NCT00903006|157453133|FG003|Overall Study|Withdrawal by Subject|0|||
48895269|NCT00903006|157453130|FG000|Overall Study|Progressive Disease|0|||
48895270|NCT00903006|157453131|FG001|Overall Study|Progressive Disease|3|||
48895271|NCT00903006|157453132|FG002|Overall Study|Progressive Disease|1|||
48895272|NCT00903006|157453133|FG003|Overall Study|Progressive Disease|0|||
48895273|NCT01156792|157453134|FG000|Overall Study|Adverse Event|1|||
48895274|NCT01156792|157453134|FG000|Overall Study|Lack of Efficacy|36|||
48895275|NCT01156792|157453134|FG000|Overall Study|Protocol Violation|6|||
48895276|NCT01156792|157453134|FG000|Overall Study|Lost to Follow-up|3|||
48895277|NCT01156792|157453134|FG000|Overall Study|Physician Decision|3|||
48895278|NCT01156792|157453134|FG000|Overall Study|Withdrawal by Subject|9|||
48895279|NCT01156792|157453134|FG000|Overall Study|other Sponsor Decision (Protocol Amendme|11|||
48895280|NCT01474434|157453138|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
48895281|NCT01474434|157453139|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
48895282|NCT01474434|157453140|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
48895283|NCT01474434|157453141|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
48895284|NCT01474434|157453138|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
48895285|NCT01474434|157453139|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
48895286|NCT01474434|157453140|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
48984200|NCT01693562|157774121|FG000|Exploration Phase|Other|0|||
48984201|NCT01693562|157774122|FG001|Exploration Phase|Other|0|||
48984202|NCT01693562|157774123|FG002|Exploration Phase|Other|0|||
48984203|NCT01693562|157774124|FG003|Exploration Phase|Other|0|||
48984204|NCT01693562|157774125|FG004|Exploration Phase|Other|0|||
48984205|NCT01693562|157774126|FG005|Exploration Phase|Other|0|||
48984206|NCT01693562|157774127|FG006|Exploration Phase|Other|2|||
49038544|NCT00606281|157976735|FG001|Overall Study|Withdrawal by Subject|13|||
49038545|NCT00606281|157976734|FG000|Overall Study|Progression to depressive phase|1|||
49038546|NCT00606281|157976735|FG001|Overall Study|Progression to depressive phase|1|||
49038547|NCT00606281|157976734|FG000|Overall Study|Change of residence or other commitments|1|||
49038548|NCT00606281|157976735|FG001|Overall Study|Change of residence or other commitments|1|||
49038549|NCT02294981|157976736|FG000|Overall Study|Lost to Follow-up|1|||
49038550|NCT03131895|157976738|FG000|Washout Period (at Least 5 Days)|Adverse Event|1|||
49038551|NCT03131895|157976739|FG001|Washout Period (at Least 5 Days)|Adverse Event|0|||
49038552|NCT03131895|157976740|FG002|Washout Period (at Least 5 Days)|Adverse Event|0|||
49038553|NCT03131895|157976741|FG003|Washout Period (at Least 5 Days)|Adverse Event|1|||
49038554|NCT03131895|157976738|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
49038555|NCT03131895|157976739|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
49038556|NCT03131895|157976740|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|2|||
49038557|NCT03131895|157976741|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
49038558|NCT03131895|157976738|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
49038559|NCT03131895|157976739|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|2|||
48895287|NCT01474434|157453141|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1|||
48895288|NCT01474434|157453138|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1|||
48895289|NCT01474434|157453139|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
48895290|NCT01474434|157453140|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
48895291|NCT01474434|157453141|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
48895292|NCT00560066|157453148|FG000|Overall Study|Death|2|||
48895293|NCT00560066|157453149|FG001|Overall Study|Death|1|||
48895294|NCT00560066|157453148|FG000|Overall Study|Withdrawal by Subject|0|||
48895295|NCT00560066|157453149|FG001|Overall Study|Withdrawal by Subject|3|||
48895296|NCT00560066|157453148|FG000|Overall Study|Lost to Follow-up|4|||
48895297|NCT00560066|157453149|FG001|Overall Study|Lost to Follow-up|10|||
48895298|NCT00560066|157453148|FG000|Overall Study|Protocol Violation|0|||
48895299|NCT00560066|157453149|FG001|Overall Study|Protocol Violation|1|||
48895300|NCT00560066|157453148|FG000|Overall Study|Administrative reason|0|||
48895301|NCT00560066|157453149|FG001|Overall Study|Administrative reason|5|||
48895302|NCT00560066|157453148|FG000|Overall Study|Missing primary reason|0|||
48895303|NCT00560066|157453149|FG001|Overall Study|Missing primary reason|2|||
48895304|NCT01153958|157453150|FG000|Overall Study|Study Terminated|36|||
48895305|NCT01153958|157453151|FG001|Overall Study|Study Terminated|32|||
48895306|NCT02004353|157453153|FG000|Overall Study|Voluntary participation|1334|||
48895307|NCT01691768|157453154|FG000|Overall Study|Death|0|||
48895308|NCT01691768|157453155|FG001|Overall Study|Death|2|||
48895309|NCT01691768|157453154|FG000|Overall Study|Lost to Follow-up|4|||
48895310|NCT01691768|157453155|FG001|Overall Study|Lost to Follow-up|3|||
48895311|NCT01691768|157453154|FG000|Overall Study|Withdrawal by Subject|10|||
48895312|NCT01691768|157453155|FG001|Overall Study|Withdrawal by Subject|9|||
48895313|NCT01691768|157453154|FG000|Overall Study|Relocated|0|||
48895314|NCT01691768|157453155|FG001|Overall Study|Relocated|1|||
48895315|NCT01691768|157453154|FG000|Overall Study|Investigator decision|1|||
48895316|NCT01691768|157453155|FG001|Overall Study|Investigator decision|1|||
48895317|NCT02424734|157453156|FG000|Overall Study|Treatment stopped to be discharged home|2|||
48895318|NCT02424734|157453157|FG001|Overall Study|Treatment stopped to be discharged home|2|||
48895319|NCT02424734|157453158|FG002|Overall Study|Treatment stopped to be discharged home|0|||
48895320|NCT00116753|157453159|FG000|Overall Study|Adverse Event|16|||
48895321|NCT00116753|157453160|FG001|Overall Study|Adverse Event|10|||
48895322|NCT00116753|157453161|FG002|Overall Study|Adverse Event|7|||
48895323|NCT00116753|157453159|FG000|Overall Study|Withdrawal by Subject|11|||
48895324|NCT00116753|157453160|FG001|Overall Study|Withdrawal by Subject|12|||
49038560|NCT03131895|157976740|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
49038561|NCT03131895|157976741|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
49038562|NCT03131895|157976738|FG000|Washout Period (at Least 5 Days)|Other|0|||
48895325|NCT00116753|157453161|FG002|Overall Study|Withdrawal by Subject|8|||
48895326|NCT00116753|157453159|FG000|Overall Study|Lost to Follow-up|0|||
48895327|NCT00116753|157453160|FG001|Overall Study|Lost to Follow-up|2|||
48895328|NCT00116753|157453161|FG002|Overall Study|Lost to Follow-up|1|||
49038563|NCT03131895|157976739|FG001|Washout Period (at Least 5 Days)|Other|0|||
49038564|NCT03131895|157976740|FG002|Washout Period (at Least 5 Days)|Other|2|||
49038565|NCT03131895|157976741|FG003|Washout Period (at Least 5 Days)|Other|0|||
49038566|NCT03131895|157976738|FG000|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
48895329|NCT00116753|157453159|FG000|Overall Study|Protocol Violation|0|||
48895330|NCT00116753|157453160|FG001|Overall Study|Protocol Violation|0|||
48895331|NCT00116753|157453161|FG002|Overall Study|Protocol Violation|1|||
48895332|NCT00116753|157453159|FG000|Overall Study|Did not Fulfil Eligibility Criteria|1|||
48895333|NCT00116753|157453160|FG001|Overall Study|Did not Fulfil Eligibility Criteria|1|||
48895334|NCT00116753|157453161|FG002|Overall Study|Did not Fulfil Eligibility Criteria|3|||
48895335|NCT00116753|157453159|FG000|Overall Study|Disease Progression|3|||
48895336|NCT00116753|157453160|FG001|Overall Study|Disease Progression|4|||
48895337|NCT00116753|157453161|FG002|Overall Study|Disease Progression|3|||
48895338|NCT00116753|157453159|FG000|Overall Study|Abnormal Echocardiogram|0|||
48895339|NCT00116753|157453160|FG001|Overall Study|Abnormal Echocardiogram|0|||
48895340|NCT00116753|157453161|FG002|Overall Study|Abnormal Echocardiogram|1|||
48895341|NCT00116753|157453159|FG000|Overall Study|Progressive Parkinson's Disease|1|||
48895342|NCT00116753|157453160|FG001|Overall Study|Progressive Parkinson's Disease|0|||
48895343|NCT00116753|157453161|FG002|Overall Study|Progressive Parkinson's Disease|0|||
48895344|NCT00116753|157453159|FG000|Overall Study|Dosing Error|0|||
48895345|NCT00116753|157453160|FG001|Overall Study|Dosing Error|1|||
48895346|NCT00116753|157453161|FG002|Overall Study|Dosing Error|0|||
48895347|NCT00528645|157453162|FG000|Overall Study|Adverse Event|3|||
48895348|NCT01489891|157453164|FG000|Overall Study|Endoscopy failure|1|||
48895349|NCT01489891|157453165|FG001|Overall Study|Endoscopy failure|0|||
48895350|NCT01445301|157453166|FG000|Overall Study|Adverse Event|15|||
48895351|NCT01445301|157453167|FG001|Overall Study|Adverse Event|25|||
48895352|NCT01445301|157453168|FG002|Overall Study|Adverse Event|4|||
48895353|NCT01445301|157453166|FG000|Overall Study|Lack of Efficacy|0|||
48895354|NCT01445301|157453167|FG001|Overall Study|Lack of Efficacy|1|||
48895355|NCT01445301|157453168|FG002|Overall Study|Lack of Efficacy|0|||
48895356|NCT01445301|157453166|FG000|Overall Study|Protocol Violation|1|||
48895357|NCT01445301|157453167|FG001|Overall Study|Protocol Violation|0|||
48895358|NCT01445301|157453168|FG002|Overall Study|Protocol Violation|0|||
48895359|NCT01445301|157453166|FG000|Overall Study|Protocol-Defined Stopping Criteria|0|||
48895360|NCT01445301|157453167|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
48895361|NCT01445301|157453168|FG002|Overall Study|Protocol-Defined Stopping Criteria|1|||
48895362|NCT01445301|157453166|FG000|Overall Study|Physician Decision|0|||
48895363|NCT01445301|157453167|FG001|Overall Study|Physician Decision|2|||
48895364|NCT01445301|157453168|FG002|Overall Study|Physician Decision|0|||
48895365|NCT01445301|157453166|FG000|Overall Study|Withdrawal by Subject|5|||
48895366|NCT01445301|157453167|FG001|Overall Study|Withdrawal by Subject|6|||
48895367|NCT01445301|157453168|FG002|Overall Study|Withdrawal by Subject|4|||
48895368|NCT00752557|157453169|FG000|Overall Study|Withdrawal by Subject|4|||
48895369|NCT00752557|157453170|FG001|Overall Study|Withdrawal by Subject|3|||
48895370|NCT00752557|157453171|FG002|Overall Study|Withdrawal by Subject|3|||
48895371|NCT00752557|157453169|FG000|Overall Study|Unspecified resaons|0|||
48895372|NCT00752557|157453170|FG001|Overall Study|Unspecified resaons|2|||
48895373|NCT00752557|157453171|FG002|Overall Study|Unspecified resaons|2|||
48895374|NCT00752557|157453169|FG000|Overall Study|Lost to Follow-up|1|||
48895375|NCT00752557|157453170|FG001|Overall Study|Lost to Follow-up|0|||
49038567|NCT03131895|157976739|FG001|Intervention Period 2 (2 Days)|Lost to Follow-up|1|||
49038568|NCT03131895|157976740|FG002|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
49038569|NCT03131895|157976741|FG003|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
49038570|NCT03131895|157976738|FG000|Intervention Period 2 (2 Days)|Withdrawal by Subject|1|||
49038571|NCT03131895|157976739|FG001|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
49038572|NCT03131895|157976740|FG002|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
49038573|NCT03131895|157976741|FG003|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
48895376|NCT00752557|157453171|FG002|Overall Study|Lost to Follow-up|1|||
48895377|NCT01014533|157453174|FG000|Overall Study|Protocol Violation|3|||
48895378|NCT01014533|157453175|FG001|Overall Study|Protocol Violation|2|||
48895379|NCT01014533|157453174|FG000|Overall Study|Withdrawal by Subject|2|||
48895380|NCT01014533|157453175|FG001|Overall Study|Withdrawal by Subject|0|||
48895381|NCT01014533|157453174|FG000|Overall Study|unable to come to appointment|0|||
48895382|NCT01014533|157453175|FG001|Overall Study|unable to come to appointment|3|||
48895383|NCT01535560|157453178|FG000|Overall Study|Adverse Event|12|||
48895384|NCT01535560|157453179|FG001|Overall Study|Adverse Event|7|||
48895385|NCT01535560|157453178|FG000|Overall Study|Lost to Follow-up|1|||
48895386|NCT01535560|157453179|FG001|Overall Study|Lost to Follow-up|3|||
48895387|NCT01535560|157453178|FG000|Overall Study|Subj Decision Unrel to an Adverse Event|3|||
48895388|NCT01535560|157453179|FG001|Overall Study|Subj Decision Unrel to an Adverse Event|1|||
49038574|NCT00540423|157976742|FG000|Double-Blind Treatment Period|Adverse Event|0|||
49038575|NCT00540423|157976743|FG001|Double-Blind Treatment Period|Adverse Event|1|||
49038576|NCT00540423|157976744|FG002|Double-Blind Treatment Period|Adverse Event|0|||
49038577|NCT00540423|157976742|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
49038578|NCT00540423|157976743|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
48895389|NCT01535560|157453178|FG000|Overall Study|Treatment Failure|21|||
48895390|NCT01535560|157453179|FG001|Overall Study|Treatment Failure|83|||
48895391|NCT01535560|157453178|FG000|Overall Study|Other|0|||
48895392|NCT01535560|157453179|FG001|Overall Study|Other|1|||
48895393|NCT01535560|157453178|FG000|Overall Study|Randomized in Error|0|||
48895394|NCT01535560|157453179|FG001|Overall Study|Randomized in Error|1|||
48895395|NCT02689518|157453180|FG000|Overall Study|Withdrawal by Subject|3|||
48895396|NCT02009761|157453181|FG000|Overall Study|Adverse Event|4|||
48895397|NCT02842827|157453186|FG000|Overall Study|Adverse Event|0|||
48895398|NCT02842827|157453187|FG001|Overall Study|Adverse Event|1|||
48895399|NCT02842827|157453188|FG002|Overall Study|Adverse Event|0|||
48895400|NCT02842827|157453189|FG003|Overall Study|Adverse Event|1|||
48895401|NCT02842827|157453190|FG004|Overall Study|Adverse Event|0|||
48895402|NCT02842827|157453191|FG005|Overall Study|Adverse Event|1|||
48895403|NCT02842827|157453192|FG006|Overall Study|Adverse Event|0|||
48895404|NCT02842827|157453193|FG007|Overall Study|Adverse Event|0|||
48895405|NCT02842827|157453186|FG000|Overall Study|Death|1|||
48895406|NCT02842827|157453187|FG001|Overall Study|Death|0|||
48895407|NCT02842827|157453188|FG002|Overall Study|Death|2|||
48895408|NCT02842827|157453189|FG003|Overall Study|Death|3|||
48895409|NCT02842827|157453190|FG004|Overall Study|Death|2|||
48895410|NCT02842827|157453191|FG005|Overall Study|Death|1|||
48895411|NCT02842827|157453192|FG006|Overall Study|Death|0|||
48895412|NCT02842827|157453193|FG007|Overall Study|Death|4|||
48895413|NCT02842827|157453186|FG000|Overall Study|Physician Decision|1|||
48895414|NCT02842827|157453187|FG001|Overall Study|Physician Decision|3|||
48895415|NCT02842827|157453188|FG002|Overall Study|Physician Decision|0|||
48895416|NCT02842827|157453189|FG003|Overall Study|Physician Decision|0|||
48895417|NCT02842827|157453190|FG004|Overall Study|Physician Decision|1|||
48895418|NCT02842827|157453191|FG005|Overall Study|Physician Decision|4|||
48895419|NCT02842827|157453192|FG006|Overall Study|Physician Decision|2|||
48895420|NCT02842827|157453193|FG007|Overall Study|Physician Decision|1|||
48895421|NCT02842827|157453186|FG000|Overall Study|Protocol Defined Disease Progression|0|||
48895422|NCT02842827|157453187|FG001|Overall Study|Protocol Defined Disease Progression|0|||
48895423|NCT02842827|157453188|FG002|Overall Study|Protocol Defined Disease Progression|0|||
48895424|NCT02842827|157453189|FG003|Overall Study|Protocol Defined Disease Progression|0|||
48895425|NCT02842827|157453190|FG004|Overall Study|Protocol Defined Disease Progression|0|||
48895426|NCT02842827|157453191|FG005|Overall Study|Protocol Defined Disease Progression|1|||
48895427|NCT02842827|157453192|FG006|Overall Study|Protocol Defined Disease Progression|0|||
48895428|NCT02842827|157453193|FG007|Overall Study|Protocol Defined Disease Progression|0|||
48895429|NCT02842827|157453186|FG000|Overall Study|Participant Withdrawal of Consent|1|||
48895430|NCT02842827|157453187|FG001|Overall Study|Participant Withdrawal of Consent|2|||
48895431|NCT02842827|157453188|FG002|Overall Study|Participant Withdrawal of Consent|2|||
48895432|NCT02842827|157453189|FG003|Overall Study|Participant Withdrawal of Consent|2|||
48895433|NCT02842827|157453190|FG004|Overall Study|Participant Withdrawal of Consent|2|||
48895434|NCT02842827|157453191|FG005|Overall Study|Participant Withdrawal of Consent|1|||
48895435|NCT02842827|157453192|FG006|Overall Study|Participant Withdrawal of Consent|2|||
48895436|NCT02842827|157453193|FG007|Overall Study|Participant Withdrawal of Consent|1|||
48895437|NCT00825825|157453194|FG000|First Medication Period (14 Days)|Adverse Event|1|||
48895438|NCT00825825|157453195|FG001|First Medication Period (14 Days)|Adverse Event|0|||
48895439|NCT00825825|157453196|FG002|First Medication Period (14 Days)|Adverse Event|0|||
48895440|NCT00825825|157453197|FG003|First Medication Period (14 Days)|Adverse Event|0|||
48895441|NCT00825825|157453198|FG004|First Medication Period (14 Days)|Adverse Event|0|||
48895442|NCT00825825|157453199|FG005|First Medication Period (14 Days)|Adverse Event|1|||
48895443|NCT00825825|157453194|FG000|First Medication Period (14 Days)|Physician Decision|2|||
48895444|NCT00825825|157453195|FG001|First Medication Period (14 Days)|Physician Decision|0|||
48895445|NCT00825825|157453196|FG002|First Medication Period (14 Days)|Physician Decision|1|||
48895446|NCT00825825|157453197|FG003|First Medication Period (14 Days)|Physician Decision|0|||
48895447|NCT00825825|157453198|FG004|First Medication Period (14 Days)|Physician Decision|0|||
48895448|NCT00825825|157453199|FG005|First Medication Period (14 Days)|Physician Decision|1|||
48895449|NCT00825825|157453194|FG000|Second Medication Period (14 Days)|Physician Decision|1|||
48895450|NCT00825825|157453195|FG001|Second Medication Period (14 Days)|Physician Decision|0|||
48895451|NCT00825825|157453196|FG002|Second Medication Period (14 Days)|Physician Decision|0|||
48895452|NCT00825825|157453197|FG003|Second Medication Period (14 Days)|Physician Decision|2|||
48895453|NCT00825825|157453198|FG004|Second Medication Period (14 Days)|Physician Decision|0|||
48895454|NCT00825825|157453199|FG005|Second Medication Period (14 Days)|Physician Decision|0|||
48895455|NCT00825825|157453194|FG000|Second Medication Period (14 Days)|Protocol Violation|1|||
48895456|NCT00825825|157453195|FG001|Second Medication Period (14 Days)|Protocol Violation|0|||
48895457|NCT00825825|157453196|FG002|Second Medication Period (14 Days)|Protocol Violation|0|||
48895458|NCT00825825|157453197|FG003|Second Medication Period (14 Days)|Protocol Violation|0|||
48895459|NCT00825825|157453198|FG004|Second Medication Period (14 Days)|Protocol Violation|1|||
48895460|NCT00825825|157453199|FG005|Second Medication Period (14 Days)|Protocol Violation|0|||
48895461|NCT00825825|157453194|FG000|Third Medication Period (14 Days)|Adverse Event|0|||
48895462|NCT00825825|157453195|FG001|Third Medication Period (14 Days)|Adverse Event|1|||
48895463|NCT00825825|157453196|FG002|Third Medication Period (14 Days)|Adverse Event|0|||
48895464|NCT00825825|157453197|FG003|Third Medication Period (14 Days)|Adverse Event|0|||
48895465|NCT00825825|157453198|FG004|Third Medication Period (14 Days)|Adverse Event|0|||
48895466|NCT00825825|157453199|FG005|Third Medication Period (14 Days)|Adverse Event|0|||
48895467|NCT00825825|157453194|FG000|Third Medication Period (14 Days)|Protocol Violation|0|||
48895468|NCT00825825|157453195|FG001|Third Medication Period (14 Days)|Protocol Violation|0|||
48895469|NCT00825825|157453196|FG002|Third Medication Period (14 Days)|Protocol Violation|0|||
48895470|NCT00825825|157453197|FG003|Third Medication Period (14 Days)|Protocol Violation|0|||
48895471|NCT00825825|157453198|FG004|Third Medication Period (14 Days)|Protocol Violation|0|||
48895472|NCT00825825|157453199|FG005|Third Medication Period (14 Days)|Protocol Violation|2|||
48895473|NCT00825825|157453194|FG000|Third Medication Period (14 Days)|poor data quality|0|||
48895474|NCT00825825|157453195|FG001|Third Medication Period (14 Days)|poor data quality|1|||
48895475|NCT00825825|157453196|FG002|Third Medication Period (14 Days)|poor data quality|0|||
48895476|NCT00825825|157453197|FG003|Third Medication Period (14 Days)|poor data quality|0|||
48895477|NCT00825825|157453198|FG004|Third Medication Period (14 Days)|poor data quality|0|||
48895478|NCT00825825|157453199|FG005|Third Medication Period (14 Days)|poor data quality|0|||
48895479|NCT02433340|157453204|FG000|Overall Study|Adverse Event|0|||
48895480|NCT02433340|157453205|FG001|Overall Study|Adverse Event|0|||
48895481|NCT02433340|157453206|FG002|Overall Study|Adverse Event|1|||
48895482|NCT02433340|157453207|FG003|Overall Study|Adverse Event|0|||
48895483|NCT02433340|157453204|FG000|Overall Study|Withdrawal by Subject|1|||
48895484|NCT02433340|157453205|FG001|Overall Study|Withdrawal by Subject|0|||
48895485|NCT02433340|157453206|FG002|Overall Study|Withdrawal by Subject|1|||
48895486|NCT02433340|157453207|FG003|Overall Study|Withdrawal by Subject|2|||
48895487|NCT02433340|157453204|FG000|Overall Study|Lost to Follow-up|0|||
48895488|NCT02433340|157453205|FG001|Overall Study|Lost to Follow-up|1|||
48895489|NCT02433340|157453206|FG002|Overall Study|Lost to Follow-up|0|||
48895490|NCT02433340|157453207|FG003|Overall Study|Lost to Follow-up|0|||
48895491|NCT02433340|157453204|FG000|Overall Study|Required Alternative/Prohibited Therapy|1|||
48895492|NCT02433340|157453205|FG001|Overall Study|Required Alternative/Prohibited Therapy|0|||
48895493|NCT02433340|157453206|FG002|Overall Study|Required Alternative/Prohibited Therapy|0|||
48895494|NCT02433340|157453207|FG003|Overall Study|Required Alternative/Prohibited Therapy|0|||
48895495|NCT02433340|157453204|FG000|Overall Study|Other|0|||
48895496|NCT02433340|157453205|FG001|Overall Study|Other|1|||
48895497|NCT02433340|157453206|FG002|Overall Study|Other|0|||
48895498|NCT02433340|157453207|FG003|Overall Study|Other|0|||
48895499|NCT00943111|157453208|FG000|52-Weeks Primary Analysis Period|Adverse Event|2|||
48895500|NCT00943111|157453209|FG001|52-Weeks Primary Analysis Period|Adverse Event|1|||
48895501|NCT00943111|157453210|FG002|52-Weeks Primary Analysis Period|Adverse Event|0|||
48895502|NCT00943111|157453208|FG000|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
48895503|NCT00943111|157453209|FG001|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1|||
48895504|NCT00943111|157453210|FG002|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
48895505|NCT00943111|157453208|FG000|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
48895506|NCT00943111|157453209|FG001|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
48895507|NCT00943111|157453210|FG002|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51|||
48895508|NCT00943111|157453208|FG000|5 Years Long-term Treatment Period|Adverse Event|0|||
48895509|NCT00943111|157453209|FG001|5 Years Long-term Treatment Period|Adverse Event|0|||
48895510|NCT00943111|157453210|FG002|5 Years Long-term Treatment Period|Adverse Event|9|||
48895511|NCT00943111|157453208|FG000|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
48895512|NCT00943111|157453209|FG001|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
49038579|NCT00540423|157976744|FG002|Open-Label Treatment Period|Lack of Efficacy|2|||
49038580|NCT02854800|157976745|FG000|Overall Study|Protocol Violation|16|||
49038581|NCT02854800|157976746|FG001|Overall Study|Protocol Violation|11|||
49038582|NCT02854800|157976747|FG002|Overall Study|Protocol Violation|3|||
49038583|NCT02854800|157976745|FG000|Overall Study|Withdrawal by Subject|4|||
49038584|NCT02854800|157976746|FG001|Overall Study|Withdrawal by Subject|2|||
48895513|NCT00943111|157453210|FG002|5 Years Long-term Treatment Period|Withdrawal by Subject|8|||
48895514|NCT00943111|157453208|FG000|5 Years Long-term Treatment Period|Pregnancy|0|||
48895515|NCT00943111|157453209|FG001|5 Years Long-term Treatment Period|Pregnancy|0|||
48895516|NCT00943111|157453210|FG002|5 Years Long-term Treatment Period|Pregnancy|4|||
48895517|NCT00943111|157453208|FG000|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
48895518|NCT00943111|157453209|FG001|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
48895519|NCT00943111|157453210|FG002|5 Years Long-term Treatment Period|Lost to Follow-up|1|||
48895520|NCT00943111|157453208|FG000|5 Years Long-term Treatment Period|Other than specified above|0|||
48895521|NCT00943111|157453209|FG001|5 Years Long-term Treatment Period|Other than specified above|0|||
48895522|NCT00943111|157453210|FG002|5 Years Long-term Treatment Period|Other than specified above|2|||
48895523|NCT01575028|157453215|FG000|Overall Study|Physician Decision|0|||
48895524|NCT01575028|157453216|FG001|Overall Study|Physician Decision|1|||
48895525|NCT01182194|157453217|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
48895526|NCT01182194|157453218|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
48895527|NCT00790751|157453219|FG000|Overall Study|Protocol non-compliance|16|||
48895528|NCT00790751|157453220|FG001|Overall Study|Protocol non-compliance|16|||
48895529|NCT00790751|157453221|FG002|Overall Study|Protocol non-compliance|10|||
48895530|NCT00790751|157453222|FG003|Overall Study|Protocol non-compliance|11|||
48895531|NCT00790751|157453219|FG000|Overall Study|Lost to Follow-up|4|||
48895532|NCT00790751|157453220|FG001|Overall Study|Lost to Follow-up|9|||
48895533|NCT00790751|157453221|FG002|Overall Study|Lost to Follow-up|4|||
48895534|NCT00790751|157453222|FG003|Overall Study|Lost to Follow-up|5|||
48895535|NCT00790751|157453219|FG000|Overall Study|Adverse Event|5|||
48895536|NCT00790751|157453220|FG001|Overall Study|Adverse Event|3|||
48895537|NCT00790751|157453221|FG002|Overall Study|Adverse Event|5|||
48895538|NCT00790751|157453222|FG003|Overall Study|Adverse Event|4|||
48895539|NCT00790751|157453219|FG000|Overall Study|Requirement for restricted medication|0|||
48895540|NCT00790751|157453220|FG001|Overall Study|Requirement for restricted medication|2|||
48895541|NCT00790751|157453221|FG002|Overall Study|Requirement for restricted medication|0|||
48895542|NCT00790751|157453222|FG003|Overall Study|Requirement for restricted medication|0|||
48895543|NCT00790751|157453219|FG000|Overall Study|Death|0|||
48895544|NCT00790751|157453220|FG001|Overall Study|Death|0|||
48895545|NCT00790751|157453221|FG002|Overall Study|Death|1|||
48895546|NCT00790751|157453222|FG003|Overall Study|Death|0|||
48895547|NCT00790751|157453219|FG000|Overall Study|Physician Decision|0|||
48895548|NCT00790751|157453220|FG001|Overall Study|Physician Decision|0|||
48895549|NCT00790751|157453221|FG002|Overall Study|Physician Decision|0|||
48895550|NCT00790751|157453222|FG003|Overall Study|Physician Decision|1|||
48895551|NCT01078454|157453223|FG000|Overall Study|Adverse Event|1|||
48895552|NCT01078454|157453224|FG001|Overall Study|Adverse Event|1|||
48895553|NCT01078454|157453223|FG000|Overall Study|Death|0|||
48895554|NCT01078454|157453224|FG001|Overall Study|Death|1|||
48895555|NCT02545933|157453225|FG000|Overall Study|Adverse Event|3|||
48895556|NCT02545933|157453226|FG001|Overall Study|Adverse Event|0|||
48895557|NCT02545933|157453227|FG002|Overall Study|Adverse Event|0|||
48895558|NCT02545933|157453225|FG000|Overall Study|Withdrawal by Subject|2|||
48895559|NCT02545933|157453226|FG001|Overall Study|Withdrawal by Subject|3|||
48895560|NCT02545933|157453227|FG002|Overall Study|Withdrawal by Subject|3|||
48895561|NCT02545933|157453225|FG000|Overall Study|Protocol Violation|1|||
48895562|NCT02545933|157453226|FG001|Overall Study|Protocol Violation|0|||
48895563|NCT02545933|157453227|FG002|Overall Study|Protocol Violation|1|||
48895564|NCT00423930|157453228|FG000|Overall Study|Withdrawal by Subject|2|||
48895565|NCT01050790|157453233|FG000|Overall Study|Adverse Event|1|||
48895566|NCT03705832|157453234|FG000|Overall Study|Physician Decision|0|||
48895567|NCT03705832|157453235|FG001|Overall Study|Physician Decision|1|||
48895568|NCT03705832|157453234|FG000|Overall Study|Withdrawal by Subject|1|||
48895569|NCT03705832|157453235|FG001|Overall Study|Withdrawal by Subject|0|||
48895570|NCT01880528|157453236|FG000|Overall Study|Other|1|||
48895571|NCT01880528|157453237|FG001|Overall Study|Other|1|||
48895572|NCT00432666|157455437|FG000|Main Period|Adverse Event|1|||
48895573|NCT00432666|157455438|FG001|Main Period|Adverse Event|1|||
48895574|NCT00432666|157455437|FG000|Main Period|Consent Withdrawn|1|||
48895575|NCT00432666|157455438|FG001|Main Period|Consent Withdrawn|0|||
48895576|NCT00432666|157455437|FG000|Open-Label Extension Period|Withdrawal Criteria Occurred|1|||
48895577|NCT00432666|157455438|FG001|Open-Label Extension Period|Withdrawal Criteria Occurred|0|||
48895578|NCT00432666|157455437|FG000|Open-Label Extension Period|Lack of Efficacy|6|||
48895579|NCT00432666|157455438|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
48895580|NCT00432666|157455437|FG000|Open-Label Extension Period|Adverse Event|5|||
48895581|NCT00432666|157455438|FG001|Open-Label Extension Period|Adverse Event|0|||
48895582|NCT00432666|157455437|FG000|Open-Label Extension Period|Consent withdrawn|10|||
48895583|NCT00432666|157455438|FG001|Open-Label Extension Period|Consent withdrawn|0|||
48895584|NCT00432666|157455437|FG000|Open-Label Extension Period|Physician Decision|3|||
48895585|NCT00432666|157455438|FG001|Open-Label Extension Period|Physician Decision|0|||
48895586|NCT00978627|157455439|FG000|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4|||
48895587|NCT00978627|157455440|FG001|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3|||
48895588|NCT00978627|157455439|FG000|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2|||
48895589|NCT00978627|157455440|FG001|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0|||
48895590|NCT00978627|157455439|FG000|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8|||
48895591|NCT00978627|157455440|FG001|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6|||
48895592|NCT00978627|157455439|FG000|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7|||
48895593|NCT00978627|157455440|FG001|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5|||
48895594|NCT00978627|157455439|FG000|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25|||
48895595|NCT00978627|157455440|FG001|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12|||
48895596|NCT00978627|157455439|FG000|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3|||
49038585|NCT02854800|157976747|FG002|Overall Study|Withdrawal by Subject|3|||
48895597|NCT00978627|157455440|FG001|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0|||
48895598|NCT00978627|157455439|FG000|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4|||
48895599|NCT00978627|157455440|FG001|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1|||
48895600|NCT00978627|157455439|FG000|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2|||
48895601|NCT00978627|157455440|FG001|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1|||
48895602|NCT00978627|157455439|FG000|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12|||
48895603|NCT00978627|157455440|FG001|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7|||
49038586|NCT00669162|157976757|FG000|Overall Study|Withdrawal by Subject|1|||
48895604|NCT00812331|157455441|FG000|Overall Study|Adverse Event|1|||
48895605|NCT00812331|157455442|FG001|Overall Study|Adverse Event|0|||
48895606|NCT00812331|157455443|FG002|Overall Study|Adverse Event|0|||
48895607|NCT00812331|157455444|FG003|Overall Study|Adverse Event|0|||
48895608|NCT00812331|157455445|FG004|Overall Study|Adverse Event|0|||
48895609|NCT01077271|157455446|FG000|Overall Study|Parental desire|8|||
48895610|NCT01077271|157455446|FG000|Overall Study|Screen failure, did not take palivizumab|4|||
48895611|NCT01077271|157455446|FG000|Overall Study|Noncompliance|2|||
48895612|NCT01077271|157455446|FG000|Overall Study|Quota used up (insurance reimb issue)|2|||
48895613|NCT01077271|157455446|FG000|Overall Study|Changed doctors|2|||
48895614|NCT01077271|157455446|FG000|Overall Study|Parents thought too many injections|2|||
48895615|NCT01077271|157455446|FG000|Overall Study|End of RSV season nearly reached|1|||
48895616|NCT01077271|157455446|FG000|Overall Study|Mother unconvinced of the necessity|1|||
48895617|NCT03694275|157455447|FG000|Overall Study|Adverse Event|0|||
48895618|NCT03694275|157455448|FG001|Overall Study|Adverse Event|1|||
48895619|NCT03694275|157455447|FG000|Overall Study|Reason not Specified|0|||
48895620|NCT03694275|157455448|FG001|Overall Study|Reason not Specified|1|||
48895621|NCT00591370|157455451|FG000|Overall Study|Not Treated|2|||
48895622|NCT03607422|157455452|FG000|Overall Study|Adverse Event|7|||
48895623|NCT03607422|157455453|FG001|Overall Study|Adverse Event|3|||
48895624|NCT03607422|157455454|FG002|Overall Study|Adverse Event|2|||
48895625|NCT03607422|157455455|FG003|Overall Study|Adverse Event|0|||
48895626|NCT03607422|157455456|FG004|Overall Study|Adverse Event|2|||
48895627|NCT03607422|157455457|FG005|Overall Study|Adverse Event|0|||
48895628|NCT03607422|157455452|FG000|Overall Study|Withdrawal by Subject|11|||
48895629|NCT03607422|157455453|FG001|Overall Study|Withdrawal by Subject|3|||
48895630|NCT03607422|157455454|FG002|Overall Study|Withdrawal by Subject|6|||
48895631|NCT03607422|157455455|FG003|Overall Study|Withdrawal by Subject|2|||
48895632|NCT03607422|157455456|FG004|Overall Study|Withdrawal by Subject|0|||
48895633|NCT03607422|157455457|FG005|Overall Study|Withdrawal by Subject|0|||
48895634|NCT03607422|157455452|FG000|Overall Study|Lost to Follow-up|0|||
48895635|NCT03607422|157455453|FG001|Overall Study|Lost to Follow-up|0|||
48895636|NCT03607422|157455454|FG002|Overall Study|Lost to Follow-up|1|||
48895637|NCT03607422|157455455|FG003|Overall Study|Lost to Follow-up|0|||
48895638|NCT03607422|157455456|FG004|Overall Study|Lost to Follow-up|0|||
48895639|NCT03607422|157455457|FG005|Overall Study|Lost to Follow-up|0|||
48895640|NCT03607422|157455452|FG000|Overall Study|Other|12|||
48895641|NCT03607422|157455453|FG001|Overall Study|Other|4|||
48895642|NCT03607422|157455454|FG002|Overall Study|Other|1|||
48895643|NCT03607422|157455455|FG003|Overall Study|Other|2|||
48895644|NCT03607422|157455456|FG004|Overall Study|Other|0|||
48895645|NCT03607422|157455457|FG005|Overall Study|Other|2|||
48895646|NCT03607422|157455452|FG000|Overall Study|Ongoing at Time of Analysis|8|||
48895647|NCT03607422|157455453|FG001|Overall Study|Ongoing at Time of Analysis|0|||
48895648|NCT03607422|157455454|FG002|Overall Study|Ongoing at Time of Analysis|2|||
48895649|NCT03607422|157455455|FG003|Overall Study|Ongoing at Time of Analysis|1|||
48895650|NCT03607422|157455456|FG004|Overall Study|Ongoing at Time of Analysis|1|||
48895651|NCT03607422|157455457|FG005|Overall Study|Ongoing at Time of Analysis|1|||
48895652|NCT03037931|157455458|FG000|Overall Study|Death|354|||
48895653|NCT03037931|157455459|FG001|Overall Study|Death|367|||
48895654|NCT03037931|157455458|FG000|Overall Study|Lost to Follow-up|7|||
48895655|NCT03037931|157455459|FG001|Overall Study|Lost to Follow-up|4|||
48895656|NCT03037931|157455458|FG000|Overall Study|Withdrawal by Subject|48|||
48895657|NCT03037931|157455459|FG001|Overall Study|Withdrawal by Subject|41|||
48895658|NCT01183260|157455460|FG000|Overall Study|Intraop screen failure|2|||
48895659|NCT01183260|157455461|FG001|Overall Study|Intraop screen failure|0|||
48895660|NCT01183260|157455460|FG000|Overall Study|Withdrawal by Subject|1|||
48895661|NCT01183260|157455461|FG001|Overall Study|Withdrawal by Subject|1|||
49038587|NCT00985439|157976760|FG000|Overall Study|Adverse Event|0|||
49038588|NCT00985439|157976761|FG001|Overall Study|Adverse Event|0|||
49038589|NCT00985439|157976762|FG002|Overall Study|Adverse Event|1|||
49038590|NCT00985439|157976763|FG003|Overall Study|Adverse Event|0|||
49038591|NCT03676634|157976766|FG000|Overall Study|Red blood cell loss|1|||
49038592|NCT03676634|157976766|FG000|Overall Study|Out-of-limit pulse|2|||
49038593|NCT01174186|157976767|FG000|Overall Study|Lost to Follow-up|0|||
49038594|NCT01174186|157976768|FG001|Overall Study|Lost to Follow-up|1|||
49038595|NCT01174186|157976767|FG000|Overall Study|Withdrawal by Subject|0|||
49038596|NCT01174186|157976768|FG001|Overall Study|Withdrawal by Subject|2|||
49038597|NCT02441686|157976769|FG000|Induction|Adverse Event|4|||
48895662|NCT01183260|157455460|FG000|Overall Study|Revised within 30 days|0|||
48895663|NCT01183260|157455461|FG001|Overall Study|Revised within 30 days|1|||
48895664|NCT01183260|157455460|FG000|Overall Study|Death|1|||
48895665|NCT01183260|157455461|FG001|Overall Study|Death|0|||
48895666|NCT00306670|157455464|FG000|Overall Study|patients recruited; Genentech, the st|0|||
48895667|NCT00306670|157455465|FG001|Overall Study|patients recruited; Genentech, the st|2|||
48895668|NCT00091169|157455469|FG000|Overall Study|Disease progression|3|||
48895669|NCT00091169|157455470|FG001|Overall Study|Disease progression|1|||
48895670|NCT00091169|157455469|FG000|Overall Study|Adverse Event|11|||
48895671|NCT00091169|157455470|FG001|Overall Study|Adverse Event|17|||
48895672|NCT00091169|157455469|FG000|Overall Study|Death|4|||
48895673|NCT00091169|157455470|FG001|Overall Study|Death|1|||
48895674|NCT00091169|157455469|FG000|Overall Study|Withdrawal by Subject|10|||
49038598|NCT02441686|157976769|FG000|Induction|Complicating disease|1|||
48895675|NCT00091169|157455470|FG001|Overall Study|Withdrawal by Subject|13|||
49038599|NCT02441686|157976769|FG000|Induction|Physician Decision|1|||
49038600|NCT02441686|157976769|FG000|Induction|Withdrawal by Subject|1|||
49038601|NCT02441686|157976769|FG000|Induction|Did not receive treatment|1|||
48895676|NCT00091169|157455469|FG000|Overall Study|Other|3|||
48895677|NCT00091169|157455470|FG001|Overall Study|Other|4|||
48895678|NCT00091169|157455469|FG000|Overall Study|Not start protocol therapy|26|||
48895679|NCT00091169|157455470|FG001|Overall Study|Not start protocol therapy|17|||
48895680|NCT00833833|157455471|FG000|Phase 1 (as of 01 April 2011)|Still active in study|0|||
49038602|NCT02441686|157976769|FG000|Maintenance|Remaining on Treatment|23|||
49038603|NCT02441686|157976769|FG000|Maintenance|Physician Decision|1|||
49038604|NCT02441686|157976769|FG000|Maintenance|Adverse Event|3|||
49038605|NCT02441686|157976769|FG000|Maintenance|Progressive Disease|10|||
49038606|NCT02441686|157976769|FG000|Maintenance|Withdrawal by Subject|1|||
49038607|NCT01634139|157976770|FG000|Overall Study|Non compliant with protocol|1|||
49038608|NCT01634139|157976771|FG001|Overall Study|Non compliant with protocol|0|||
49038609|NCT01634139|157976772|FG002|Overall Study|Non compliant with protocol|0|||
49038610|NCT01634139|157976770|FG000|Overall Study|Consent withdrawn not due to AE|4|||
49038611|NCT01634139|157976771|FG001|Overall Study|Consent withdrawn not due to AE|3|||
49038612|NCT01634139|157976772|FG002|Overall Study|Consent withdrawn not due to AE|2|||
49038613|NCT01634139|157976770|FG000|Overall Study|Other|4|||
49038614|NCT01634139|157976771|FG001|Overall Study|Other|0|||
49038615|NCT01634139|157976772|FG002|Overall Study|Other|3|||
49038616|NCT01634139|157976770|FG000|Overall Study|Lost to Follow-up|0|||
48895681|NCT00833833|157455472|FG001|Phase 1 (as of 01 April 2011)|Still active in study|0|||
48895682|NCT00833833|157455473|FG002|Phase 1 (as of 01 April 2011)|Still active in study|2|||
49038617|NCT01634139|157976771|FG001|Overall Study|Lost to Follow-up|2|||
49038618|NCT01634139|157976772|FG002|Overall Study|Lost to Follow-up|0|||
49038619|NCT01634139|157976770|FG000|Overall Study|Not treated|1|||
49038620|NCT01634139|157976771|FG001|Overall Study|Not treated|1|||
49038621|NCT01634139|157976772|FG002|Overall Study|Not treated|0|||
49038622|NCT00909038|157976773|FG000|Overall Study|Protocol Violation|187|||
49038623|NCT00909038|157976773|FG000|Overall Study|Non-evaluable Subjects|230|||
49038624|NCT05315713|157976774|FG000|Overall Study|Death|5|||
49038625|NCT05315713|157976774|FG000|Overall Study|Progressive disease|1|||
49038626|NCT05315713|157976774|FG000|Overall Study|Withdrawal by Subject|1|||
49038627|NCT05315713|157976774|FG000|Overall Study|Study terminated by sponsor|1|||
49038628|NCT00484679|157976775|FG000|Overall Study|Withdrawal by Subject|3|||
49038629|NCT00402103|157976776|FG000|Overall Study|Adverse Event|60|||
49038630|NCT00402103|157976777|FG001|Overall Study|Adverse Event|7|||
49038631|NCT00402103|157976776|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
49038632|NCT00402103|157976777|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
49038633|NCT00402103|157976776|FG000|Overall Study|Condition no longer requires study drug|2|||
49038634|NCT00402103|157976777|FG001|Overall Study|Condition no longer requires study drug|0|||
49038635|NCT00402103|157976776|FG000|Overall Study|Protocol Deviation|8|||
49038636|NCT00402103|157976777|FG001|Overall Study|Protocol Deviation|0|||
49038637|NCT00402103|157976776|FG000|Overall Study|Patient withdrew consent|12|||
49038638|NCT00402103|157976777|FG001|Overall Study|Patient withdrew consent|1|||
49038639|NCT00402103|157976776|FG000|Overall Study|Lost to Follow-up|6|||
49038640|NCT00402103|157976777|FG001|Overall Study|Lost to Follow-up|3|||
49038641|NCT00402103|157976776|FG000|Overall Study|Administrative problems|2|||
49038642|NCT00402103|157976777|FG001|Overall Study|Administrative problems|0|||
48895683|NCT00833833|157455474|FG003|Phase 1 (as of 01 April 2011)|Still active in study|2|||
48895684|NCT00833833|157455475|FG004|Phase 1 (as of 01 April 2011)|Still active in study|0|||
48895685|NCT00833833|157455476|FG005|Phase 1 (as of 01 April 2011)|Still active in study|0|||
48895686|NCT00833833|157455471|FG000|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
48895687|NCT00833833|157455472|FG001|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
48895688|NCT00833833|157455473|FG002|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
48895689|NCT00833833|157455474|FG003|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
48895690|NCT00833833|157455475|FG004|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
48895691|NCT00833833|157455476|FG005|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
48895692|NCT00833833|157455471|FG000|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
48895693|NCT00833833|157455472|FG001|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
48895694|NCT00833833|157455473|FG002|Phase 1 (as of 01 April 2011)|Adverse Event|2|||
48895695|NCT00833833|157455474|FG003|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
48895696|NCT00833833|157455475|FG004|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
49038643|NCT01906372|157976791|FG000|Overall Study|Withdrawal by Subject|2|||
49038644|NCT02462837|157976794|FG000|Overall Study|pt developed hives|1|||
49038645|NCT02462837|157976795|FG001|Overall Study|pt developed hives|0|||
48895697|NCT00833833|157455476|FG005|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
49038646|NCT02462837|157976794|FG000|Overall Study|Withdrawal by Subject|1|||
49038647|NCT02462837|157976795|FG001|Overall Study|Withdrawal by Subject|0|||
49038648|NCT02121184|157976800|FG000|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|1|||
49038649|NCT02121184|157976801|FG001|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|0|||
49038650|NCT02121184|157976800|FG000|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|0|||
49038651|NCT02121184|157976801|FG001|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|1|||
49038652|NCT02121184|157976800|FG000|Overall Study|Emergency cesarean section required|0|||
48895698|NCT00833833|157455471|FG000|Phase 1 (as of 01 April 2011)|Death|0|||
48895699|NCT00833833|157455472|FG001|Phase 1 (as of 01 April 2011)|Death|1|||
48895700|NCT00833833|157455473|FG002|Phase 1 (as of 01 April 2011)|Death|2|||
48895701|NCT00833833|157455474|FG003|Phase 1 (as of 01 April 2011)|Death|0|||
48895702|NCT00833833|157455475|FG004|Phase 1 (as of 01 April 2011)|Death|0|||
48895703|NCT00833833|157455476|FG005|Phase 1 (as of 01 April 2011)|Death|0|||
48895704|NCT00833833|157455471|FG000|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
48895705|NCT00833833|157455472|FG001|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
48895706|NCT00833833|157455473|FG002|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
48895707|NCT00833833|157455474|FG003|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
48895708|NCT00833833|157455475|FG004|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
48895709|NCT00833833|157455476|FG005|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
48895710|NCT00833833|157455471|FG000|Phase 1 (as of 01 April 2011)|Other|1|||
48895711|NCT00833833|157455472|FG001|Phase 1 (as of 01 April 2011)|Other|3|||
48895712|NCT00833833|157455473|FG002|Phase 1 (as of 01 April 2011)|Other|0|||
48895713|NCT00833833|157455474|FG003|Phase 1 (as of 01 April 2011)|Other|1|||
48895714|NCT00833833|157455475|FG004|Phase 1 (as of 01 April 2011)|Other|0|||
48895715|NCT00833833|157455476|FG005|Phase 1 (as of 01 April 2011)|Other|0|||
48895716|NCT00833833|157455471|FG000|Phase 2 (as of 01 April 2011)|Still active in study|0|||
48895717|NCT00833833|157455472|FG001|Phase 2 (as of 01 April 2011)|Still active in study|0|||
48895718|NCT00833833|157455473|FG002|Phase 2 (as of 01 April 2011)|Still active in study|0|||
48895719|NCT00833833|157455474|FG003|Phase 2 (as of 01 April 2011)|Still active in study|0|||
48895720|NCT00833833|157455475|FG004|Phase 2 (as of 01 April 2011)|Still active in study|23|||
48895721|NCT00833833|157455476|FG005|Phase 2 (as of 01 April 2011)|Still active in study|22|||
48895722|NCT00833833|157455471|FG000|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
48895723|NCT00833833|157455472|FG001|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
48895724|NCT00833833|157455473|FG002|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
48895725|NCT00833833|157455474|FG003|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
48895726|NCT00833833|157455475|FG004|Phase 2 (as of 01 April 2011)|Adverse Event|8|||
48895727|NCT00833833|157455476|FG005|Phase 2 (as of 01 April 2011)|Adverse Event|13|||
48895728|NCT00833833|157455471|FG000|Phase 2 (as of 01 April 2011)|Death|0|||
48895729|NCT00833833|157455472|FG001|Phase 2 (as of 01 April 2011)|Death|0|||
48895730|NCT00833833|157455473|FG002|Phase 2 (as of 01 April 2011)|Death|0|||
48895731|NCT00833833|157455474|FG003|Phase 2 (as of 01 April 2011)|Death|0|||
48895732|NCT00833833|157455475|FG004|Phase 2 (as of 01 April 2011)|Death|8|||
48895733|NCT00833833|157455476|FG005|Phase 2 (as of 01 April 2011)|Death|9|||
48895734|NCT00833833|157455471|FG000|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
48895735|NCT00833833|157455472|FG001|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
48895736|NCT00833833|157455473|FG002|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
48895737|NCT00833833|157455474|FG003|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
48692503|NCT00453154|156724505|FG002|Double BIind Maintenance|Death|2|||
49038653|NCT02121184|157976801|FG001|Overall Study|Emergency cesarean section required|2|||
49038654|NCT02121184|157976800|FG000|Overall Study|Combined spinal epidural completed without notifying study team|1|||
49038655|NCT02121184|157976801|FG001|Overall Study|Combined spinal epidural completed without notifying study team|0|||
49038656|NCT00840203|157976802|FG000|First Intervention|Protocol Violation|1|||
49038657|NCT00840203|157976803|FG001|First Intervention|Protocol Violation|1|||
49038658|NCT00840203|157976802|FG000|Washout|Protocol Violation|1|||
49038659|NCT00840203|157976803|FG001|Washout|Protocol Violation|0|||
49038660|NCT03694197|157976810|FG000|Overall Study|Adverse Event|9|||
49038661|NCT03694197|157976810|FG000|Overall Study|Protocol became inconvenient to participate|1|||
49038662|NCT03694197|157976810|FG000|Overall Study|Physician Decision|4|||
49038663|NCT03694197|157976810|FG000|Overall Study|Study terminated by sponsor|1350|||
48895738|NCT00833833|157455475|FG004|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7|||
48895739|NCT00833833|157455476|FG005|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6|||
49038664|NCT03694197|157976810|FG000|Overall Study|Participant moved|5|||
49038665|NCT03694197|157976810|FG000|Overall Study|Participant withdrew consent|10|||
49038666|NCT03694197|157976810|FG000|Overall Study|Related to IMP administration|1|||
49038667|NCT03694197|157976810|FG000|Overall Study|Not disclosed|5|||
49038668|NCT00387153|157976811|FG000|Overall Study|Adverse Event|1|||
49038669|NCT00387153|157976811|FG000|Overall Study|Disease Progression|3|||
49038670|NCT00387153|157976811|FG000|Overall Study|Lack of Response|4|||
49038671|NCT03073798|157976812|FG000|Overall Study|Adverse Event|1|||
48895740|NCT00833833|157455471|FG000|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
48895741|NCT00833833|157455472|FG001|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
49038672|NCT03073798|157976812|FG000|Overall Study|Withdrawal by Subject|1|||
49038673|NCT00819169|157976815|FG000|Overall Study|Withdrawal by Subject|2|||
49038674|NCT00819169|157976816|FG001|Overall Study|Withdrawal by Subject|0|||
49038675|NCT00819169|157976817|FG002|Overall Study|Withdrawal by Subject|0|||
49038676|NCT00819169|157976818|FG003|Overall Study|Withdrawal by Subject|1|||
48895742|NCT00833833|157455473|FG002|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
48895743|NCT00833833|157455474|FG003|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
48895744|NCT00833833|157455475|FG004|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5|||
48895745|NCT00833833|157455476|FG005|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7|||
48895746|NCT00833833|157455471|FG000|Phase 2 (as of 01 April 2011)|Other|0|||
48895747|NCT00833833|157455472|FG001|Phase 2 (as of 01 April 2011)|Other|0|||
48895748|NCT00833833|157455473|FG002|Phase 2 (as of 01 April 2011)|Other|0|||
48895749|NCT00833833|157455474|FG003|Phase 2 (as of 01 April 2011)|Other|0|||
48895750|NCT00833833|157455475|FG004|Phase 2 (as of 01 April 2011)|Other|4|||
48895751|NCT00833833|157455476|FG005|Phase 2 (as of 01 April 2011)|Other|3|||
48895752|NCT00833833|157455471|FG000|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
48895753|NCT00833833|157455472|FG001|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
48895754|NCT00833833|157455473|FG002|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
48895755|NCT00833833|157455474|FG003|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
48895756|NCT00833833|157455475|FG004|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
48895757|NCT00833833|157455476|FG005|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1|||
48895758|NCT02407990|157455477|FG000|Overall Study|Death|2|||
48895759|NCT02407990|157455478|FG001|Overall Study|Death|22|||
48895760|NCT02407990|157455479|FG002|Overall Study|Death|23|||
48895761|NCT02407990|157455480|FG003|Overall Study|Death|7|||
48895762|NCT02407990|157455481|FG004|Overall Study|Death|17|||
48895763|NCT02407990|157455482|FG005|Overall Study|Death|16|||
48895764|NCT02407990|157455483|FG006|Overall Study|Death|10|||
48895765|NCT02407990|157455484|FG007|Overall Study|Death|248|||
48895766|NCT02407990|157455477|FG000|Overall Study|Lost to Follow-up|0|||
48895767|NCT02407990|157455478|FG001|Overall Study|Lost to Follow-up|1|||
48895768|NCT02407990|157455479|FG002|Overall Study|Lost to Follow-up|0|||
48895769|NCT02407990|157455480|FG003|Overall Study|Lost to Follow-up|0|||
48895770|NCT02407990|157455481|FG004|Overall Study|Lost to Follow-up|0|||
48895771|NCT02407990|157455482|FG005|Overall Study|Lost to Follow-up|0|||
48895772|NCT02407990|157455483|FG006|Overall Study|Lost to Follow-up|0|||
48895773|NCT02407990|157455484|FG007|Overall Study|Lost to Follow-up|17|||
48895774|NCT02407990|157455477|FG000|Overall Study|Progressive Disease|0|||
49038677|NCT00819169|157976819|FG004|Overall Study|Withdrawal by Subject|1|||
49038678|NCT00819169|157976820|FG005|Overall Study|Withdrawal by Subject|1|||
49038679|NCT00819169|157976821|FG006|Overall Study|Withdrawal by Subject|5|||
49038680|NCT00819169|157976822|FG007|Overall Study|Withdrawal by Subject|1|||
49038681|NCT00819169|157976823|FG008|Overall Study|Withdrawal by Subject|4|||
49038682|NCT00819169|157976815|FG000|Overall Study|Lost to Follow-up|0|||
49038683|NCT00819169|157976816|FG001|Overall Study|Lost to Follow-up|2|||
49038684|NCT00819169|157976817|FG002|Overall Study|Lost to Follow-up|0|||
49038685|NCT00819169|157976818|FG003|Overall Study|Lost to Follow-up|1|||
49038686|NCT00819169|157976819|FG004|Overall Study|Lost to Follow-up|0|||
49038687|NCT00819169|157976820|FG005|Overall Study|Lost to Follow-up|6|||
49038688|NCT00819169|157976821|FG006|Overall Study|Lost to Follow-up|2|||
49038689|NCT00819169|157976822|FG007|Overall Study|Lost to Follow-up|2|||
49038690|NCT00819169|157976823|FG008|Overall Study|Lost to Follow-up|1|||
49038691|NCT00819169|157976815|FG000|Overall Study|Death|1|||
49038692|NCT00819169|157976816|FG001|Overall Study|Death|1|||
49038693|NCT00819169|157976817|FG002|Overall Study|Death|3|||
49038694|NCT00819169|157976818|FG003|Overall Study|Death|8|||
49038695|NCT00819169|157976819|FG004|Overall Study|Death|5|||
49038696|NCT00819169|157976820|FG005|Overall Study|Death|7|||
49038697|NCT00819169|157976821|FG006|Overall Study|Death|9|||
49038698|NCT00819169|157976822|FG007|Overall Study|Death|4|||
49038699|NCT00819169|157976823|FG008|Overall Study|Death|7|||
49038700|NCT00819169|157976815|FG000|Overall Study|Ineligibility determined|0|||
49038701|NCT00819169|157976816|FG001|Overall Study|Ineligibility determined|0|||
49038702|NCT00819169|157976817|FG002|Overall Study|Ineligibility determined|0|||
49038703|NCT00819169|157976818|FG003|Overall Study|Ineligibility determined|2|||
49038704|NCT00819169|157976819|FG004|Overall Study|Ineligibility determined|0|||
49038705|NCT00819169|157976820|FG005|Overall Study|Ineligibility determined|0|||
49038706|NCT00819169|157976821|FG006|Overall Study|Ineligibility determined|0|||
49038707|NCT00819169|157976822|FG007|Overall Study|Ineligibility determined|0|||
48895775|NCT02407990|157455478|FG001|Overall Study|Progressive Disease|0|||
48895776|NCT02407990|157455479|FG002|Overall Study|Progressive Disease|0|||
48895777|NCT02407990|157455480|FG003|Overall Study|Progressive Disease|0|||
48895778|NCT02407990|157455481|FG004|Overall Study|Progressive Disease|0|||
48895779|NCT02407990|157455482|FG005|Overall Study|Progressive Disease|0|||
48895780|NCT02407990|157455483|FG006|Overall Study|Progressive Disease|0|||
49038708|NCT00819169|157976823|FG008|Overall Study|Ineligibility determined|1|||
49038709|NCT00819169|157976815|FG000|Overall Study|Adverse Event|0|||
49038710|NCT00819169|157976816|FG001|Overall Study|Adverse Event|0|||
49038711|NCT00819169|157976817|FG002|Overall Study|Adverse Event|0|||
49038712|NCT00819169|157976818|FG003|Overall Study|Adverse Event|0|||
48895781|NCT02407990|157455484|FG007|Overall Study|Progressive Disease|1|||
49038713|NCT00819169|157976819|FG004|Overall Study|Adverse Event|1|||
49038714|NCT00819169|157976820|FG005|Overall Study|Adverse Event|0|||
48895782|NCT02407990|157455477|FG000|Overall Study|Withdrawal by Subject|0|||
49038715|NCT00819169|157976821|FG006|Overall Study|Adverse Event|0|||
49038716|NCT00819169|157976822|FG007|Overall Study|Adverse Event|0|||
49038717|NCT00819169|157976823|FG008|Overall Study|Adverse Event|0|||
49038718|NCT00819169|157976815|FG000|Overall Study|Administrative Decision|0|||
49038719|NCT00819169|157976816|FG001|Overall Study|Administrative Decision|0|||
49038720|NCT00819169|157976817|FG002|Overall Study|Administrative Decision|0|||
49038721|NCT00819169|157976818|FG003|Overall Study|Administrative Decision|0|||
49038722|NCT00819169|157976819|FG004|Overall Study|Administrative Decision|1|||
49038723|NCT00819169|157976820|FG005|Overall Study|Administrative Decision|2|||
49038724|NCT00819169|157976821|FG006|Overall Study|Administrative Decision|0|||
49038725|NCT00819169|157976822|FG007|Overall Study|Administrative Decision|2|||
49038726|NCT00819169|157976823|FG008|Overall Study|Administrative Decision|0|||
49038727|NCT02637141|157976824|FG000|Overall Study|Adverse Event|1|||
49038728|NCT02637141|157976825|FG001|Overall Study|Adverse Event|1|||
49038729|NCT02637141|157976826|FG002|Overall Study|Adverse Event|0|||
49038730|NCT02637141|157976824|FG000|Overall Study|Withdrawal by Subject|1|||
49038731|NCT02637141|157976825|FG001|Overall Study|Withdrawal by Subject|1|||
49038732|NCT02637141|157976826|FG002|Overall Study|Withdrawal by Subject|1|||
49038733|NCT00533507|157976827|FG000|Overall Study|Withdrawal by Subject|1|||
49038734|NCT03196284|157976828|FG000|Main Part|Withdrawal by Subject|0|||
49038735|NCT03196284|157976829|FG001|Main Part|Withdrawal by Subject|1|||
49038736|NCT03196284|157976830|FG002|Main Part|Withdrawal by Subject|0|||
49038737|NCT03196284|157976828|FG000|Extension Part|Lack of Efficacy|0|||
49038738|NCT03196284|157976829|FG001|Extension Part|Lack of Efficacy|0|||
49038739|NCT03196284|157976830|FG002|Extension Part|Lack of Efficacy|1|||
49038740|NCT03196284|157976828|FG000|Extension Part|Withdrawal by Subject|0|||
49038741|NCT03196284|157976829|FG001|Extension Part|Withdrawal by Subject|0|||
49038742|NCT03196284|157976830|FG002|Extension Part|Withdrawal by Subject|1|||
49038743|NCT03196284|157976828|FG000|Extension Part|Physician Decision|0|||
49038744|NCT03196284|157976829|FG001|Extension Part|Physician Decision|0|||
49038745|NCT03196284|157976830|FG002|Extension Part|Physician Decision|1|||
49038746|NCT01562613|157976836|FG000|Overall Study|Lost to Follow-up|2|||
49038747|NCT01562613|157976836|FG000|Overall Study|Withdrawal by Subject|2|||
49038748|NCT00712959|157978762|FG000|Overall Study|Protocol Violation|3|||
49038749|NCT00712959|157978763|FG001|Overall Study|Protocol Violation|1|||
49038750|NCT00712959|157978762|FG000|Overall Study|Lost to Follow-up|13|||
49038751|NCT00712959|157978763|FG001|Overall Study|Lost to Follow-up|2|||
49038752|NCT00712959|157978762|FG000|Overall Study|Withdrawal by Subject|3|||
49038753|NCT00712959|157978763|FG001|Overall Study|Withdrawal by Subject|0|||
49038754|NCT02316223|157978764|FG000|Overall Study|Lack of Efficacy|0|||
49038755|NCT02316223|157978765|FG001|Overall Study|Lack of Efficacy|1|||
49038756|NCT02316223|157978766|FG002|Overall Study|Lack of Efficacy|1|||
49038757|NCT02316223|157978764|FG000|Overall Study|Lost to Follow-up|27|||
49038758|NCT02316223|157978765|FG001|Overall Study|Lost to Follow-up|34|||
49038759|NCT02316223|157978766|FG002|Overall Study|Lost to Follow-up|36|||
49038760|NCT02316223|157978764|FG000|Overall Study|COPD Diagnosis|3|||
49038761|NCT02316223|157978765|FG001|Overall Study|COPD Diagnosis|2|||
49038762|NCT02316223|157978766|FG002|Overall Study|COPD Diagnosis|3|||
49038763|NCT02316223|157978764|FG000|Overall Study|Reside outside study area|1|||
49038764|NCT02316223|157978765|FG001|Overall Study|Reside outside study area|1|||
49038765|NCT02316223|157978766|FG002|Overall Study|Reside outside study area|1|||
49038766|NCT02316223|157978764|FG000|Overall Study|No asthma|2|||
49038767|NCT02316223|157978765|FG001|Overall Study|No asthma|0|||
49038768|NCT02316223|157978766|FG002|Overall Study|No asthma|0|||
49038769|NCT02316223|157978764|FG000|Overall Study|Discontinued by PI|11|||
49038770|NCT02316223|157978765|FG001|Overall Study|Discontinued by PI|19|||
49038771|NCT02316223|157978766|FG002|Overall Study|Discontinued by PI|3|||
49038772|NCT00508651|157978767|FG000|Overall Study|Lost to Follow-up|3|||
49038773|NCT00508651|157978768|FG001|Overall Study|Lost to Follow-up|1|||
49038774|NCT00508651|157978767|FG000|Overall Study|Withdrawal by Subject|1|||
49038775|NCT00508651|157978768|FG001|Overall Study|Withdrawal by Subject|1|||
49038776|NCT03158727|157978781|FG000|Overall Study|Withdrawal by Subject|2|||
49038777|NCT03158727|157978782|FG001|Overall Study|Withdrawal by Subject|6|||
48895783|NCT02407990|157455478|FG001|Overall Study|Withdrawal by Subject|0|||
49038778|NCT03158727|157978781|FG000|Overall Study|Death|11|||
49038779|NCT03158727|157978782|FG001|Overall Study|Death|12|||
49038780|NCT03158727|157978781|FG000|Overall Study|Lost to Follow-up|1|||
49038781|NCT03158727|157978782|FG001|Overall Study|Lost to Follow-up|0|||
49038782|NCT03158727|157978781|FG000|Overall Study|Participant doesn't want to come back to the hospital for the visit|2|||
49038783|NCT03158727|157978782|FG001|Overall Study|Participant doesn't want to come back to the hospital for the visit|0|||
49038784|NCT03158727|157978781|FG000|Overall Study|Visit 11 not done by mistake|0|||
49038785|NCT03158727|157978782|FG001|Overall Study|Visit 11 not done by mistake|1|||
49038786|NCT03158727|157978781|FG000|Overall Study|Enrolled, not treated|1|||
49038787|NCT03158727|157978782|FG001|Overall Study|Enrolled, not treated|0|||
49038788|NCT00807495|157978783|FG000|Overall Study|Adverse Event|6|||
49038789|NCT00807495|157978784|FG001|Overall Study|Adverse Event|3|||
49038790|NCT00807495|157978785|FG002|Overall Study|Adverse Event|1|||
49038791|NCT00807495|157978786|FG003|Overall Study|Adverse Event|1|||
49038792|NCT00807495|157978787|FG004|Overall Study|Adverse Event|2|||
48895784|NCT02407990|157455479|FG002|Overall Study|Withdrawal by Subject|0|||
48895785|NCT02407990|157455480|FG003|Overall Study|Withdrawal by Subject|0|||
48895786|NCT02407990|157455481|FG004|Overall Study|Withdrawal by Subject|1|||
48895787|NCT02407990|157455482|FG005|Overall Study|Withdrawal by Subject|0|||
48895788|NCT02407990|157455483|FG006|Overall Study|Withdrawal by Subject|0|||
48895789|NCT02407990|157455484|FG007|Overall Study|Withdrawal by Subject|30|||
48895790|NCT02407990|157455477|FG000|Overall Study|Study Terminated by Sponsor|1|||
48895791|NCT02407990|157455478|FG001|Overall Study|Study Terminated by Sponsor|3|||
48895792|NCT02407990|157455479|FG002|Overall Study|Study Terminated by Sponsor|3|||
48895793|NCT02407990|157455480|FG003|Overall Study|Study Terminated by Sponsor|0|||
48895794|NCT02407990|157455481|FG004|Overall Study|Study Terminated by Sponsor|3|||
49038793|NCT00807495|157978783|FG000|Overall Study|Withdrawal by Patient|2|||
49038794|NCT00807495|157978784|FG001|Overall Study|Withdrawal by Patient|0|||
49038795|NCT00807495|157978785|FG002|Overall Study|Withdrawal by Patient|1|||
49038796|NCT00807495|157978786|FG003|Overall Study|Withdrawal by Patient|0|||
49038797|NCT00807495|157978787|FG004|Overall Study|Withdrawal by Patient|0|||
49038798|NCT00807495|157978783|FG000|Overall Study|Reason Not Specified|0|||
49038799|NCT00807495|157978784|FG001|Overall Study|Reason Not Specified|3|||
49038800|NCT00807495|157978785|FG002|Overall Study|Reason Not Specified|2|||
49038801|NCT00807495|157978786|FG003|Overall Study|Reason Not Specified|0|||
49038802|NCT00807495|157978787|FG004|Overall Study|Reason Not Specified|3|||
49038803|NCT02704091|157978788|FG000|Overall Study|Adverse Event|4|||
49038804|NCT02704091|157978789|FG001|Overall Study|Adverse Event|3|||
49038805|NCT02704091|157978788|FG000|Overall Study|Protocol Violation|5|||
49038806|NCT02704091|157978789|FG001|Overall Study|Protocol Violation|3|||
49038807|NCT02704091|157978788|FG000|Overall Study|Consent withdrawn|4|||
49038808|NCT02704091|157978789|FG001|Overall Study|Consent withdrawn|4|||
49038809|NCT02704091|157978788|FG000|Overall Study|Lost to Follow-up|13|||
49038810|NCT02704091|157978789|FG001|Overall Study|Lost to Follow-up|5|||
49038811|NCT02704091|157978788|FG000|Overall Study|Other|2|||
49038812|NCT02704091|157978789|FG001|Overall Study|Other|8|||
49038813|NCT05274763|157978790|FG000|Overall Study|Lost to Follow-up|1|||
49038814|NCT00918684|157978792|FG000|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16|||
49038815|NCT00918684|157978792|FG000|Treatment Phase|Lack of Efficacy|6|||
49038816|NCT00918684|157978792|FG000|Treatment Phase|Lost to Follow-up|2|||
49038817|NCT00918684|157978792|FG000|Treatment Phase|Physician Decision|8|||
49038818|NCT00918684|157978792|FG000|Treatment Phase|Protocol Violation|1|||
49038819|NCT00918684|157978792|FG000|Treatment Phase|Withdrawal by Subject|8|||
49038820|NCT01051349|157978794|FG000|Overall Study|Adverse Event|88|||
49038821|NCT01051349|157978794|FG000|Overall Study|Consent Withdrawn|54|||
49038822|NCT01051349|157978794|FG000|Overall Study|Investigator Decision|6|||
49038823|NCT01051349|157978794|FG000|Overall Study|Lost to Follow-up|6|||
49038824|NCT01051349|157978794|FG000|Overall Study|Subject non-compliance|7|||
49038825|NCT01051349|157978794|FG000|Overall Study|Reason not Specified|12|||
49038826|NCT03214588|157978795|FG000|Overall Study|Adverse Event|1|||
48895795|NCT02407990|157455482|FG005|Overall Study|Study Terminated by Sponsor|4|||
49038827|NCT03214588|157978796|FG001|Overall Study|Adverse Event|0|||
49038828|NCT03214588|157978797|FG002|Overall Study|Adverse Event|2|||
49038829|NCT03214588|157978795|FG000|Overall Study|Reason Not Specified|0|||
49038830|NCT03214588|157978796|FG001|Overall Study|Reason Not Specified|1|||
49038831|NCT03214588|157978797|FG002|Overall Study|Reason Not Specified|0|||
49038832|NCT00205777|157978798|FG000|Core Study (Up to 3 Years)|Adverse Event|260|||
49038833|NCT00205777|157978799|FG001|Core Study (Up to 3 Years)|Adverse Event|267|||
49038834|NCT00205777|157978800|FG002|Core Study (Up to 3 Years)|Adverse Event|252|||
49038835|NCT00205777|157978801|FG003|Core Study (Up to 3 Years)|Adverse Event|232|||
49038836|NCT00205777|157978802|FG004|Core Study (Up to 3 Years)|Adverse Event|0|||
49038837|NCT00205777|157978803|FG005|Core Study (Up to 3 Years)|Adverse Event|0|||
49038838|NCT00205777|157978798|FG000|Core Study (Up to 3 Years)|Death|9|||
49038839|NCT00205777|157978799|FG001|Core Study (Up to 3 Years)|Death|7|||
49038840|NCT00205777|157978800|FG002|Core Study (Up to 3 Years)|Death|14|||
48895796|NCT02407990|157455483|FG006|Overall Study|Study Terminated by Sponsor|3|||
48895797|NCT02407990|157455484|FG007|Overall Study|Study Terminated by Sponsor|37|||
48895798|NCT02407990|157455477|FG000|Overall Study|Logistics|0|||
48895799|NCT02407990|157455478|FG001|Overall Study|Logistics|0|||
48895800|NCT02407990|157455479|FG002|Overall Study|Logistics|0|||
48895801|NCT02407990|157455480|FG003|Overall Study|Logistics|0|||
48895802|NCT02407990|157455481|FG004|Overall Study|Logistics|0|||
49038841|NCT00205777|157978801|FG003|Core Study (Up to 3 Years)|Death|7|||
49038842|NCT00205777|157978802|FG004|Core Study (Up to 3 Years)|Death|0|||
48895803|NCT02407990|157455482|FG005|Overall Study|Logistics|0|||
49038843|NCT00205777|157978803|FG005|Core Study (Up to 3 Years)|Death|0|||
49038844|NCT00205777|157978798|FG000|Core Study (Up to 3 Years)|Failed to return|40|||
49038845|NCT00205777|157978799|FG001|Core Study (Up to 3 Years)|Failed to return|25|||
49038846|NCT00205777|157978800|FG002|Core Study (Up to 3 Years)|Failed to return|27|||
49038847|NCT00205777|157978801|FG003|Core Study (Up to 3 Years)|Failed to return|27|||
48895804|NCT02407990|157455483|FG006|Overall Study|Logistics|0|||
49038848|NCT00205777|157978802|FG004|Core Study (Up to 3 Years)|Failed to return|0|||
49038849|NCT00205777|157978803|FG005|Core Study (Up to 3 Years)|Failed to return|0|||
49038850|NCT00205777|157978798|FG000|Core Study (Up to 3 Years)|Other Event|49|||
49038851|NCT00205777|157978799|FG001|Core Study (Up to 3 Years)|Other Event|52|||
49038852|NCT00205777|157978800|FG002|Core Study (Up to 3 Years)|Other Event|41|||
48895805|NCT02407990|157455484|FG007|Overall Study|Logistics|1|||
48895806|NCT02407990|157455477|FG000|Overall Study|Rolled into long-term extension study|0|||
48895807|NCT02407990|157455478|FG001|Overall Study|Rolled into long-term extension study|0|||
48895808|NCT02407990|157455479|FG002|Overall Study|Rolled into long-term extension study|0|||
48895809|NCT02407990|157455480|FG003|Overall Study|Rolled into long-term extension study|0|||
48895810|NCT02407990|157455481|FG004|Overall Study|Rolled into long-term extension study|0|||
48895811|NCT02407990|157455482|FG005|Overall Study|Rolled into long-term extension study|0|||
48895812|NCT02407990|157455483|FG006|Overall Study|Rolled into long-term extension study|0|||
48895813|NCT02407990|157455484|FG007|Overall Study|Rolled into long-term extension study|1|||
48895814|NCT00522873|157455488|FG000|Overall Study|Adverse Event|41|||
48895815|NCT00522873|157455489|FG001|Overall Study|Adverse Event|26|||
48895816|NCT00522873|157455488|FG000|Overall Study|Withdrawal by Subject|20|||
48895817|NCT00522873|157455489|FG001|Overall Study|Withdrawal by Subject|9|||
48895818|NCT00522873|157455488|FG000|Overall Study|Protocol Violation|14|||
48895819|NCT00522873|157455489|FG001|Overall Study|Protocol Violation|4|||
48895820|NCT00522873|157455488|FG000|Overall Study|Lost to Follow-up|11|||
48895821|NCT00522873|157455489|FG001|Overall Study|Lost to Follow-up|3|||
48895822|NCT00522873|157455488|FG000|Overall Study|Personal Reasons|8|||
48895823|NCT00522873|157455489|FG001|Overall Study|Personal Reasons|1|||
48895824|NCT00522873|157455488|FG000|Overall Study|Medication Errors|1|||
48895825|NCT00522873|157455489|FG001|Overall Study|Medication Errors|1|||
49038853|NCT00205777|157978801|FG003|Core Study (Up to 3 Years)|Other Event|58|||
49038854|NCT00205777|157978802|FG004|Core Study (Up to 3 Years)|Other Event|0|||
49038855|NCT00205777|157978803|FG005|Core Study (Up to 3 Years)|Other Event|0|||
48895826|NCT00522873|157455488|FG000|Overall Study|Never Received Medication|1|||
48895827|NCT00522873|157455489|FG001|Overall Study|Never Received Medication|0|||
48895828|NCT00700258|157455494|FG000|Overall Study|Premature discontinuation of documentation|136|||
48895829|NCT00700258|157455494|FG000|Overall Study|Type of study end not documented|1|||
48895830|NCT00700258|157455494|FG000|Overall Study|Lost to Follow-up|81|||
48895831|NCT00700258|157455494|FG000|Overall Study|Premature discontinuation of therapy|1013|||
48895832|NCT00370331|157455495|FG000|Overall Study|Adverse Event|4|||
48895833|NCT00370331|157455496|FG001|Overall Study|Adverse Event|13|||
48895834|NCT00370331|157455495|FG000|Overall Study|Withdrawal by Subject|2|||
48895835|NCT00370331|157455496|FG001|Overall Study|Withdrawal by Subject|4|||
49038856|NCT00205777|157978798|FG000|Core Study (Up to 3 Years)|Withdrawal by Subject|144|||
49038857|NCT00205777|157978799|FG001|Core Study (Up to 3 Years)|Withdrawal by Subject|169|||
49038858|NCT00205777|157978800|FG002|Core Study (Up to 3 Years)|Withdrawal by Subject|149|||
49038859|NCT00205777|157978801|FG003|Core Study (Up to 3 Years)|Withdrawal by Subject|162|||
49038860|NCT00205777|157978802|FG004|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
49038861|NCT00205777|157978803|FG005|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
49038862|NCT00205777|157978798|FG000|Core Study (Up to 3 Years)|Protocol Violation|53|||
49038863|NCT00205777|157978799|FG001|Core Study (Up to 3 Years)|Protocol Violation|55|||
49038864|NCT00205777|157978800|FG002|Core Study (Up to 3 Years)|Protocol Violation|50|||
49038865|NCT00205777|157978801|FG003|Core Study (Up to 3 Years)|Protocol Violation|42|||
49038866|NCT00205777|157978802|FG004|Core Study (Up to 3 Years)|Protocol Violation|0|||
49038867|NCT00205777|157978803|FG005|Core Study (Up to 3 Years)|Protocol Violation|0|||
49038868|NCT00205777|157978798|FG000|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
49038869|NCT00205777|157978799|FG001|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
49038870|NCT00205777|157978800|FG002|Core Study (Up to 3 Years)|Lack of Efficacy|39|||
49038871|NCT00205777|157978801|FG003|Core Study (Up to 3 Years)|Lack of Efficacy|75|||
49038872|NCT00205777|157978802|FG004|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
49038873|NCT00205777|157978803|FG005|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
49038874|NCT00205777|157978798|FG000|Core Study (Up to 3 Years)|Randomized but not treated|21|||
49038875|NCT00205777|157978799|FG001|Core Study (Up to 3 Years)|Randomized but not treated|32|||
49038876|NCT00205777|157978800|FG002|Core Study (Up to 3 Years)|Randomized but not treated|35|||
49038877|NCT00205777|157978801|FG003|Core Study (Up to 3 Years)|Randomized but not treated|29|||
49038878|NCT00205777|157978802|FG004|Core Study (Up to 3 Years)|Randomized but not treated|0|||
49038879|NCT00205777|157978803|FG005|Core Study (Up to 3 Years)|Randomized but not treated|0|||
49038880|NCT00205777|157978798|FG000|Completed Core Study, Entered SE I|Withdrawal by Subject|180|||
49038881|NCT00205777|157978799|FG001|Completed Core Study, Entered SE I|Withdrawal by Subject|158|||
49038882|NCT00205777|157978800|FG002|Completed Core Study, Entered SE I|Withdrawal by Subject|160|||
49038883|NCT00205777|157978801|FG003|Completed Core Study, Entered SE I|Withdrawal by Subject|174|||
49038884|NCT00205777|157978802|FG004|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
49038885|NCT00205777|157978803|FG005|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
48895836|NCT00370331|157455495|FG000|Overall Study|Lost to Follow-up|0|||
48895837|NCT00370331|157455496|FG001|Overall Study|Lost to Follow-up|3|||
49038886|NCT00205777|157978798|FG000|Completed Core Study, Entered SE I|Other Event|52|||
49038887|NCT00205777|157978799|FG001|Completed Core Study, Entered SE I|Other Event|46|||
48895838|NCT00370331|157455495|FG000|Overall Study|Lack of Efficacy|0|||
48895839|NCT00370331|157455496|FG001|Overall Study|Lack of Efficacy|1|||
48895840|NCT00370331|157455495|FG000|Overall Study|Non-compliance|0|||
48895841|NCT00370331|157455496|FG001|Overall Study|Non-compliance|1|||
48895842|NCT00370331|157455495|FG000|Overall Study|Protocol Violation|1|||
48895843|NCT00370331|157455496|FG001|Overall Study|Protocol Violation|1|||
48895844|NCT01802567|157455497|FG000|Overall Study|Withdrawal by Subject|2|||
48895845|NCT01802567|157455497|FG000|Overall Study|Physician Decision|1|||
48895846|NCT01802567|157455497|FG000|Overall Study|Lack of Efficacy|7|||
48895847|NCT01802567|157455497|FG000|Overall Study|Consented but did not start therapy|7|||
48895848|NCT01802567|157455497|FG000|Overall Study|Protocol Violation|1|||
48895849|NCT02585232|157455500|FG000|Overall Study|Lost to Follow-up|8|||
48895850|NCT02585232|157455501|FG001|Overall Study|Lost to Follow-up|8|||
48895851|NCT02585232|157455500|FG000|Overall Study|Withdrawal by Subject|4|||
48895852|NCT02585232|157455501|FG001|Overall Study|Withdrawal by Subject|8|||
48895853|NCT00297232|157455502|FG000|Overall Study|Lack of Efficacy|7|||
48895854|NCT00297232|157455502|FG000|Overall Study|Lost to Follow-up|10|||
48895855|NCT00297232|157455502|FG000|Overall Study|Adverse Event|63|||
48895856|NCT00297232|157455502|FG000|Overall Study|Voluntary Withdrawal|120|||
48895857|NCT00297232|157455502|FG000|Overall Study|Subject was Noncompliant|9|||
48895858|NCT00297232|157455502|FG000|Overall Study|Death|9|||
48895859|NCT00297232|157455502|FG000|Overall Study|Anti-natalizumab Positive|8|||
48895860|NCT00297232|157455502|FG000|Overall Study|Switched to Commercial Tysabri|22|||
48895861|NCT00297232|157455502|FG000|Overall Study|Disease Progression|8|||
48895862|NCT00297232|157455502|FG000|Overall Study|Fear of PML|10|||
48895863|NCT00297232|157455502|FG000|Overall Study|Anti-JCV Antibody Positive|13|||
48895864|NCT00297232|157455502|FG000|Overall Study|Miscellaneous|5|||
48895865|NCT00297232|157455502|FG000|Overall Study|Sponsor Decision|34|||
48895866|NCT00297232|157455502|FG000|Overall Study|Subject Relocated|7|||
48895867|NCT00297232|157455502|FG000|Overall Study|Subject Withdrew Consent|37|||
48895868|NCT00297232|157455502|FG000|Overall Study|Persistently Positive Antibodies|11|||
48895869|NCT00297232|157455502|FG000|Overall Study|Investigator Withdrew From Program|19|||
48895870|NCT00297232|157455502|FG000|Overall Study|Did Not Enroll to Week 264|34|||
48895871|NCT00297232|157455502|FG000|Overall Study|Did Not Enroll to Week 480|17|||
48895872|NCT00297232|157455502|FG000|Overall Study|No data available after Week 264|161|||
48895873|NCT00297232|157455502|FG000|Overall Study|Other|1|||
48895874|NCT03235284|157455503|FG000|Overall Study|Adverse Event|1|||
48895875|NCT03235284|157455504|FG001|Overall Study|Adverse Event|2|||
48895876|NCT03235284|157455505|FG002|Overall Study|Adverse Event|1|||
48895877|NCT00440999|157455506|FG000|Overall Study|Adverse Event|0|||
48895878|NCT00440999|157455507|FG001|Overall Study|Adverse Event|2|||
48895879|NCT00440999|157455506|FG000|Overall Study|Lack of Efficacy|6|||
48895880|NCT00440999|157455507|FG001|Overall Study|Lack of Efficacy|7|||
48895881|NCT00440999|157455506|FG000|Overall Study|Lost to Follow-up|19|||
48895882|NCT00440999|157455507|FG001|Overall Study|Lost to Follow-up|12|||
48895883|NCT00440999|157455506|FG000|Overall Study|Protocol Violation|1|||
48895884|NCT00440999|157455507|FG001|Overall Study|Protocol Violation|0|||
48895885|NCT00440999|157455506|FG000|Overall Study|Withdrawal by Subject|2|||
48895886|NCT00440999|157455507|FG001|Overall Study|Withdrawal by Subject|5|||
48895887|NCT00440999|157455506|FG000|Overall Study|Subjets missed the visit|1|||
48895888|NCT00440999|157455507|FG001|Overall Study|Subjets missed the visit|0|||
48895889|NCT00440999|157455506|FG000|Overall Study|Mixed infection at entry|1|||
48895890|NCT00440999|157455507|FG001|Overall Study|Mixed infection at entry|0|||
48895891|NCT00440999|157455506|FG000|Overall Study|P. falciparum malaria|5|||
48895892|NCT00440999|157455507|FG001|Overall Study|P. falciparum malaria|14|||
48895893|NCT00440999|157455506|FG000|Overall Study|Subj left hosp without inform staff|0|||
48895894|NCT00440999|157455507|FG001|Overall Study|Subj left hosp without inform staff|1|||
48895895|NCT01656733|157455508|FG000|Overall Study|No permission to collect birth outcomes|0|||
48895896|NCT01656733|157455509|FG001|Overall Study|No permission to collect birth outcomes|1|||
48895897|NCT01656733|157455508|FG000|Overall Study|Delivery at another hospital|0|||
48895898|NCT01656733|157455509|FG001|Overall Study|Delivery at another hospital|2|||
48895899|NCT01656733|157455508|FG000|Overall Study|Spontaneous abortion|0|||
48895900|NCT01656733|157455509|FG001|Overall Study|Spontaneous abortion|1|||
48895901|NCT03484273|157455510|FG000|Overall Study|Equipment Malfunction|1|||
48895902|NCT03484273|157455510|FG000|Overall Study|Data excluded from analysis|1|||
48895903|NCT00249002|157455511|FG000|Overall Study|Adverse Event|2|||
48895904|NCT00249002|157455511|FG000|Overall Study|Study cancellation|3|||
48895905|NCT00249002|157455511|FG000|Overall Study|Other|2|||
48895906|NCT00195091|157455512|FG000|Overall Study|Study terminated and PI has left MSKCC|16|||
48895907|NCT01157676|157455516|FG000|Randomization|Death|1|||
48895908|NCT01157676|157455517|FG001|Randomization|Death|1|||
48895909|NCT01157676|157455516|FG000|Randomization|unresectable|2|||
48895910|NCT01157676|157455517|FG001|Randomization|unresectable|3|||
48895911|NCT01157676|157455516|FG000|Randomization|Withdrawal by Subject|17|||
48895912|NCT01157676|157455517|FG001|Randomization|Withdrawal by Subject|13|||
48895913|NCT01157676|157455516|FG000|Randomization|Physician Decision|1|||
48895914|NCT01157676|157455517|FG001|Randomization|Physician Decision|0|||
48895915|NCT01157676|157455516|FG000|Surgery|underwent open cystectomy|0|||
48895916|NCT01157676|157455517|FG001|Surgery|underwent open cystectomy|4|||
48895917|NCT01157676|157455516|FG000|Surgery|converted to open procedure|0|||
48895918|NCT01157676|157455517|FG001|Surgery|converted to open procedure|5|||
48895919|NCT01157676|157455516|FG000|Surgery|underwent robotic cystectomy|1|||
48895920|NCT01157676|157455517|FG001|Surgery|underwent robotic cystectomy|0|||
48895921|NCT02476279|157455518|FG000|Overall Study|Lost to Follow-up|1|||
48895922|NCT02476279|157455519|FG001|Overall Study|Lost to Follow-up|1|||
48895923|NCT03545503|157455520|FG000|Overall Study|Protocol Violation|14|||
48895924|NCT03545503|157455521|FG001|Overall Study|Protocol Violation|16|||
48895925|NCT00986973|157455525|FG000|Overall Study|Withdrawn by study team|1|||
48895926|NCT01605916|157455526|FG000|Overall Study|Adverse Event|1|||
48895927|NCT01605916|157455527|FG001|Overall Study|Adverse Event|0|||
48895928|NCT01605916|157455528|FG002|Overall Study|Adverse Event|0|||
48895929|NCT01605916|157455529|FG003|Overall Study|Adverse Event|1|||
48895930|NCT01605916|157455530|FG004|Overall Study|Adverse Event|0|||
48895931|NCT01605916|157455526|FG000|Overall Study|Lack of Efficacy|2|||
48895932|NCT01605916|157455527|FG001|Overall Study|Lack of Efficacy|3|||
48895933|NCT01605916|157455528|FG002|Overall Study|Lack of Efficacy|3|||
48895934|NCT01605916|157455529|FG003|Overall Study|Lack of Efficacy|5|||
48895935|NCT01605916|157455530|FG004|Overall Study|Lack of Efficacy|4|||
48895936|NCT01605916|157455526|FG000|Overall Study|Withdrawal by Subject|1|||
48895937|NCT01605916|157455527|FG001|Overall Study|Withdrawal by Subject|1|||
48895938|NCT01605916|157455528|FG002|Overall Study|Withdrawal by Subject|0|||
48895939|NCT01605916|157455529|FG003|Overall Study|Withdrawal by Subject|0|||
48895940|NCT01605916|157455530|FG004|Overall Study|Withdrawal by Subject|2|||
48895941|NCT01590082|157455531|FG000|Overall Study|Withdrawal by Subject|1|||
48895942|NCT01590082|157455532|FG001|Overall Study|Withdrawal by Subject|0|||
48895943|NCT01590082|157455531|FG000|Overall Study|Ineligible|1|||
48895944|NCT01590082|157455532|FG001|Overall Study|Ineligible|0|||
48895945|NCT00470366|157455533|FG000|Overall Study|Adverse Event|3|||
48895946|NCT00470366|157455533|FG000|Overall Study|Poor compliance|1|||
48895947|NCT01853644|157455535|FG000|Registration and Treatment Start|Did not start treatment|1|||
48895948|NCT01853644|157455535|FG000|Reached First Response/Complete 2 Cycles|Adverse Event|2|||
48895949|NCT01853644|157455535|FG000|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1|||
48895950|NCT01853644|157455535|FG000|Reached First Response/Complete 2 Cycles|Other|1|||
48895951|NCT01853644|157455535|FG000|Reached First Response/Complete 2 Cycles|Progressive Disease|2|||
48895952|NCT01853644|157455535|FG000|Continued Treatment After First Response|Adverse Event|2|||
48895953|NCT01853644|157455535|FG000|Continued Treatment After First Response|Progressive Diseaes|10|||
48895954|NCT01920854|157455536|FG000|Overall Study|Withdrawal by Subject|1|||
48895955|NCT01920854|157455537|FG001|Overall Study|Withdrawal by Subject|0|||
48895956|NCT01920854|157455538|FG002|Overall Study|Withdrawal by Subject|0|||
48895957|NCT01920854|157455539|FG003|Overall Study|Withdrawal by Subject|0|||
48895958|NCT01920854|157455540|FG004|Overall Study|Withdrawal by Subject|1|||
48895959|NCT01920854|157455541|FG005|Overall Study|Withdrawal by Subject|0|||
48895960|NCT01920854|157455542|FG006|Overall Study|Withdrawal by Subject|1|||
48895961|NCT01178385|157455544|FG000|Overall Study|Withdrawal by Subject|2|||
48895962|NCT01178385|157455545|FG001|Overall Study|Withdrawal by Subject|0|||
48895963|NCT01226095|157455546|FG000|Overall Study|Poor compliance|1|||
48895964|NCT02372136|157455548|FG000|Overall Study|Death|3|||
48895965|NCT02372136|157455549|FG001|Overall Study|Death|1|||
48895966|NCT01688830|157455550|FG000|Overall Study|Lost to Follow-up|0|||
48895967|NCT01688830|157455551|FG001|Overall Study|Lost to Follow-up|0|||
48895968|NCT01688830|157455552|FG002|Overall Study|Lost to Follow-up|0|||
48895969|NCT01688830|157455553|FG003|Overall Study|Lost to Follow-up|0|||
48895970|NCT01688830|157455554|FG004|Overall Study|Lost to Follow-up|0|||
48895971|NCT01688830|157455555|FG005|Overall Study|Lost to Follow-up|0|||
48895972|NCT01688830|157455556|FG006|Overall Study|Lost to Follow-up|0|||
48895973|NCT01688830|157455557|FG007|Overall Study|Lost to Follow-up|0|||
48895974|NCT01688830|157455558|FG008|Overall Study|Lost to Follow-up|0|||
48895975|NCT01688830|157455559|FG009|Overall Study|Lost to Follow-up|0|||
48895976|NCT01688830|157455560|FG010|Overall Study|Lost to Follow-up|1|||
48895977|NCT01688830|157455561|FG011|Overall Study|Lost to Follow-up|0|||
48895978|NCT01688830|157455562|FG012|Overall Study|Lost to Follow-up|0|||
48895979|NCT01688830|157455563|FG013|Overall Study|Lost to Follow-up|0|||
48895980|NCT01688830|157455564|FG014|Overall Study|Lost to Follow-up|0|||
48895981|NCT01688830|157455565|FG015|Overall Study|Lost to Follow-up|0|||
48895982|NCT01688830|157455566|FG016|Overall Study|Lost to Follow-up|0|||
48895983|NCT01688830|157455567|FG017|Overall Study|Lost to Follow-up|0|||
48895984|NCT01688830|157455568|FG018|Overall Study|Lost to Follow-up|0|||
48895985|NCT01688830|157455569|FG019|Overall Study|Lost to Follow-up|0|||
48895986|NCT01688830|157455570|FG020|Overall Study|Lost to Follow-up|0|||
48895987|NCT03616977|157455575|FG000|Period 1|Physician Decision|0|||
48895988|NCT03616977|157455576|FG001|Period 1|Physician Decision|1|||
48895989|NCT03616977|157455575|FG000|Period 3|Adverse Event|1|||
48895990|NCT03616977|157455576|FG001|Period 3|Adverse Event|1|||
48895991|NCT01049217|157455578|FG000|Overall Study|Adverse Event|2|||
48895992|NCT01049217|157455579|FG001|Overall Study|Adverse Event|1|||
48895993|NCT01049217|157455578|FG000|Overall Study|Lack of Efficacy|1|||
48895994|NCT01049217|157455579|FG001|Overall Study|Lack of Efficacy|1|||
48895995|NCT01049217|157455578|FG000|Overall Study|Lost to Follow-up|3|||
48895996|NCT01049217|157455579|FG001|Overall Study|Lost to Follow-up|8|||
48895997|NCT01049217|157455578|FG000|Overall Study|Withdrawal by Subject|4|||
48895998|NCT01049217|157455579|FG001|Overall Study|Withdrawal by Subject|3|||
48895999|NCT01049217|157455578|FG000|Overall Study|Protocol Violation|1|||
48896000|NCT01049217|157455579|FG001|Overall Study|Protocol Violation|3|||
48896001|NCT01049217|157455578|FG000|Overall Study|Pregnancy|1|||
48896002|NCT01049217|157455579|FG001|Overall Study|Pregnancy|0|||
49038888|NCT00205777|157978800|FG002|Completed Core Study, Entered SE I|Other Event|47|||
49038889|NCT00205777|157978801|FG003|Completed Core Study, Entered SE I|Other Event|50|||
49038890|NCT00205777|157978802|FG004|Completed Core Study, Entered SE I|Other Event|0|||
48896003|NCT01049217|157455578|FG000|Overall Study|Study Terminated by Sponsor|43|||
49038891|NCT00205777|157978803|FG005|Completed Core Study, Entered SE I|Other Event|0|||
49038892|NCT00205777|157978798|FG000|Study Extension I|Adverse Event|57|||
49038893|NCT00205777|157978799|FG001|Study Extension I|Adverse Event|0|||
49038894|NCT00205777|157978800|FG002|Study Extension I|Adverse Event|0|||
49038895|NCT00205777|157978801|FG003|Study Extension I|Adverse Event|61|||
49038896|NCT00205777|157978802|FG004|Study Extension I|Adverse Event|58|||
49038897|NCT00205777|157978803|FG005|Study Extension I|Adverse Event|0|||
49038898|NCT00205777|157978798|FG000|Study Extension I|Death|5|||
49038899|NCT00205777|157978799|FG001|Study Extension I|Death|0|||
49038900|NCT00205777|157978800|FG002|Study Extension I|Death|0|||
49038901|NCT00205777|157978801|FG003|Study Extension I|Death|1|||
49038902|NCT00205777|157978802|FG004|Study Extension I|Death|2|||
49038903|NCT00205777|157978803|FG005|Study Extension I|Death|0|||
49038904|NCT00205777|157978798|FG000|Study Extension I|Withdrawal by Subject|99|||
49038905|NCT00205777|157978799|FG001|Study Extension I|Withdrawal by Subject|0|||
49038906|NCT00205777|157978800|FG002|Study Extension I|Withdrawal by Subject|0|||
49038907|NCT00205777|157978801|FG003|Study Extension I|Withdrawal by Subject|106|||
49038908|NCT00205777|157978802|FG004|Study Extension I|Withdrawal by Subject|89|||
49038909|NCT00205777|157978803|FG005|Study Extension I|Withdrawal by Subject|0|||
49038910|NCT00205777|157978798|FG000|Study Extension I|Protocol Violation|4|||
49038911|NCT00205777|157978799|FG001|Study Extension I|Protocol Violation|0|||
49038912|NCT00205777|157978800|FG002|Study Extension I|Protocol Violation|0|||
49038913|NCT00205777|157978801|FG003|Study Extension I|Protocol Violation|8|||
49038914|NCT00205777|157978802|FG004|Study Extension I|Protocol Violation|8|||
49038915|NCT00205777|157978803|FG005|Study Extension I|Protocol Violation|0|||
48896004|NCT01049217|157455579|FG001|Overall Study|Study Terminated by Sponsor|43|||
48896005|NCT01049217|157455578|FG000|Overall Study|Other|1|||
48896006|NCT01049217|157455579|FG001|Overall Study|Other|2|||
48896007|NCT01049217|157455578|FG000|Overall Study|Randomized but not Treated|0|||
48896008|NCT01049217|157455579|FG001|Overall Study|Randomized but not Treated|2|||
48896009|NCT01946438|157455580|FG000|Overall Study|Adverse Event|0|||
48896010|NCT01946438|157455581|FG001|Overall Study|Adverse Event|0|||
48896011|NCT01946438|157455582|FG002|Overall Study|Adverse Event|0|||
48896012|NCT01946438|157455583|FG003|Overall Study|Adverse Event|1|||
48896013|NCT01946438|157455580|FG000|Overall Study|Serious Adverse event|1|||
48896014|NCT01946438|157455581|FG001|Overall Study|Serious Adverse event|0|||
48896015|NCT01946438|157455582|FG002|Overall Study|Serious Adverse event|0|||
48896016|NCT01946438|157455583|FG003|Overall Study|Serious Adverse event|0|||
48896017|NCT01946438|157455580|FG000|Overall Study|Protocol Violation|0|||
48896018|NCT01946438|157455581|FG001|Overall Study|Protocol Violation|0|||
48896019|NCT01946438|157455582|FG002|Overall Study|Protocol Violation|1|||
48896020|NCT01946438|157455583|FG003|Overall Study|Protocol Violation|0|||
48896021|NCT01946438|157455580|FG000|Overall Study|Withdrawal by Subject|1|||
48896022|NCT01946438|157455581|FG001|Overall Study|Withdrawal by Subject|0|||
48896023|NCT01946438|157455582|FG002|Overall Study|Withdrawal by Subject|0|||
48896024|NCT01946438|157455583|FG003|Overall Study|Withdrawal by Subject|0|||
48896025|NCT02457559|157455584|FG000|Overall Study|Progressive Disease|1|||
48896026|NCT02457559|157455585|FG001|Overall Study|Progressive Disease|2|||
48896027|NCT02457559|157455586|FG002|Overall Study|Progressive Disease|3|||
48896028|NCT02457559|157455587|FG003|Overall Study|Progressive Disease|0|||
48896029|NCT02457559|157455588|FG004|Overall Study|Progressive Disease|0|||
48896030|NCT02457559|157455589|FG005|Overall Study|Progressive Disease|2|||
48896031|NCT02457559|157455590|FG006|Overall Study|Progressive Disease|1|||
48896032|NCT02457559|157455591|FG007|Overall Study|Progressive Disease|0|||
48896033|NCT02457559|157455592|FG008|Overall Study|Progressive Disease|1|||
48896034|NCT02457559|157455593|FG009|Overall Study|Progressive Disease|1|||
48896035|NCT02457559|157455594|FG010|Overall Study|Progressive Disease|1|||
48896036|NCT02457559|157455584|FG000|Overall Study|Investigator's Discretion|0|||
48896037|NCT02457559|157455585|FG001|Overall Study|Investigator's Discretion|0|||
48896038|NCT02457559|157455586|FG002|Overall Study|Investigator's Discretion|2|||
48896039|NCT02457559|157455587|FG003|Overall Study|Investigator's Discretion|0|||
48896040|NCT02457559|157455588|FG004|Overall Study|Investigator's Discretion|1|||
49038916|NCT00205777|157978798|FG000|Study Extension I|Lack of Efficacy|0|||
49038917|NCT00205777|157978799|FG001|Study Extension I|Lack of Efficacy|0|||
49038918|NCT00205777|157978800|FG002|Study Extension I|Lack of Efficacy|0|||
49038919|NCT00205777|157978801|FG003|Study Extension I|Lack of Efficacy|1|||
49038920|NCT00205777|157978802|FG004|Study Extension I|Lack of Efficacy|2|||
49038921|NCT00205777|157978803|FG005|Study Extension I|Lack of Efficacy|0|||
49038922|NCT00205777|157978798|FG000|Study Extension I|Failed to return|15|||
49038923|NCT00205777|157978799|FG001|Study Extension I|Failed to return|0|||
49038924|NCT00205777|157978800|FG002|Study Extension I|Failed to return|0|||
49038925|NCT00205777|157978801|FG003|Study Extension I|Failed to return|17|||
49038926|NCT00205777|157978802|FG004|Study Extension I|Failed to return|13|||
49038927|NCT00205777|157978803|FG005|Study Extension I|Failed to return|0|||
49038928|NCT00205777|157978798|FG000|Study Extension I|Other Event|34|||
49038929|NCT00205777|157978799|FG001|Study Extension I|Other Event|0|||
49038930|NCT00205777|157978800|FG002|Study Extension I|Other Event|0|||
49038931|NCT00205777|157978801|FG003|Study Extension I|Other Event|34|||
49038932|NCT00205777|157978802|FG004|Study Extension I|Other Event|29|||
49038933|NCT00205777|157978803|FG005|Study Extension I|Other Event|0|||
49038934|NCT00205777|157978798|FG000|Study Extension I|Withdrawn as per protocol|0|||
49038935|NCT00205777|157978799|FG001|Study Extension I|Withdrawn as per protocol|0|||
49038936|NCT00205777|157978800|FG002|Study Extension I|Withdrawn as per protocol|1070|||
49038937|NCT00205777|157978801|FG003|Study Extension I|Withdrawn as per protocol|0|||
49038938|NCT00205777|157978802|FG004|Study Extension I|Withdrawn as per protocol|0|||
49038939|NCT00205777|157978803|FG005|Study Extension I|Withdrawn as per protocol|0|||
49038940|NCT00205777|157978798|FG000|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273|||
49038941|NCT00205777|157978799|FG001|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
49038942|NCT00205777|157978800|FG002|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
49038943|NCT00205777|157978801|FG003|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240|||
49038944|NCT00205777|157978802|FG004|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258|||
49038945|NCT00205777|157978803|FG005|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
49038946|NCT00205777|157978798|FG000|Study Extension II|Adverse Event|0|||
49038947|NCT00205777|157978799|FG001|Study Extension II|Adverse Event|0|||
49038948|NCT00205777|157978800|FG002|Study Extension II|Adverse Event|0|||
49038949|NCT00205777|157978801|FG003|Study Extension II|Adverse Event|14|||
49038950|NCT00205777|157978802|FG004|Study Extension II|Adverse Event|0|||
49038951|NCT00205777|157978803|FG005|Study Extension II|Adverse Event|30|||
49038952|NCT00205777|157978798|FG000|Study Extension II|Death|0|||
49038953|NCT00205777|157978799|FG001|Study Extension II|Death|0|||
48896041|NCT02457559|157455589|FG005|Overall Study|Investigator's Discretion|0|||
48896042|NCT02457559|157455590|FG006|Overall Study|Investigator's Discretion|1|||
48896043|NCT02457559|157455591|FG007|Overall Study|Investigator's Discretion|0|||
48896044|NCT02457559|157455592|FG008|Overall Study|Investigator's Discretion|1|||
48896045|NCT02457559|157455593|FG009|Overall Study|Investigator's Discretion|0|||
48896046|NCT02457559|157455594|FG010|Overall Study|Investigator's Discretion|1|||
48896047|NCT02457559|157455584|FG000|Overall Study|Adverse Event|0|||
48896048|NCT02457559|157455585|FG001|Overall Study|Adverse Event|1|||
48896049|NCT02457559|157455586|FG002|Overall Study|Adverse Event|2|||
48896050|NCT02457559|157455587|FG003|Overall Study|Adverse Event|0|||
48896051|NCT02457559|157455588|FG004|Overall Study|Adverse Event|0|||
48896052|NCT02457559|157455589|FG005|Overall Study|Adverse Event|0|||
48896053|NCT02457559|157455590|FG006|Overall Study|Adverse Event|0|||
48896054|NCT02457559|157455591|FG007|Overall Study|Adverse Event|0|||
48896055|NCT02457559|157455592|FG008|Overall Study|Adverse Event|0|||
48896056|NCT02457559|157455593|FG009|Overall Study|Adverse Event|0|||
48896057|NCT02457559|157455594|FG010|Overall Study|Adverse Event|0|||
48896058|NCT02457559|157455584|FG000|Overall Study|Reason not Specified|1|||
48896059|NCT02457559|157455585|FG001|Overall Study|Reason not Specified|0|||
48896060|NCT02457559|157455586|FG002|Overall Study|Reason not Specified|0|||
48896061|NCT02457559|157455587|FG003|Overall Study|Reason not Specified|0|||
48896062|NCT02457559|157455588|FG004|Overall Study|Reason not Specified|0|||
48896063|NCT02457559|157455589|FG005|Overall Study|Reason not Specified|0|||
48896064|NCT02457559|157455590|FG006|Overall Study|Reason not Specified|0|||
48896065|NCT02457559|157455591|FG007|Overall Study|Reason not Specified|0|||
48896066|NCT02457559|157455592|FG008|Overall Study|Reason not Specified|0|||
48896067|NCT02457559|157455593|FG009|Overall Study|Reason not Specified|2|||
48896068|NCT02457559|157455594|FG010|Overall Study|Reason not Specified|0|||
48896069|NCT02457559|157455584|FG000|Overall Study|Death|0|||
48896070|NCT02457559|157455585|FG001|Overall Study|Death|0|||
48896071|NCT02457559|157455586|FG002|Overall Study|Death|0|||
48896072|NCT02457559|157455587|FG003|Overall Study|Death|0|||
49038954|NCT00205777|157978800|FG002|Study Extension II|Death|0|||
48896073|NCT02457559|157455588|FG004|Overall Study|Death|0|||
49038955|NCT00205777|157978801|FG003|Study Extension II|Death|2|||
49038956|NCT00205777|157978802|FG004|Study Extension II|Death|0|||
49038957|NCT00205777|157978803|FG005|Study Extension II|Death|5|||
48896074|NCT02457559|157455589|FG005|Overall Study|Death|0|||
48896075|NCT02457559|157455590|FG006|Overall Study|Death|0|||
48896076|NCT02457559|157455591|FG007|Overall Study|Death|0|||
48896077|NCT02457559|157455592|FG008|Overall Study|Death|1|||
48896078|NCT02457559|157455593|FG009|Overall Study|Death|1|||
49038958|NCT00205777|157978798|FG000|Study Extension II|Withdrawal by Subject|0|||
49038959|NCT00205777|157978799|FG001|Study Extension II|Withdrawal by Subject|0|||
48896079|NCT02457559|157455594|FG010|Overall Study|Death|0|||
48896080|NCT03581825|157455597|FG000|Period 1|Lens Discomfort|1|||
48896081|NCT03581825|157455598|FG001|Period 1|Lens Discomfort|0|||
48896082|NCT03581825|157455597|FG000|Period 2|Unsatisfactory Vision to Test|0|||
48896083|NCT03581825|157455598|FG001|Period 2|Unsatisfactory Vision to Test|1|||
48896084|NCT00178126|157455599|FG000|Overall Study|Lost to Follow-up|21|||
48896085|NCT00178126|157455600|FG001|Overall Study|Lost to Follow-up|21|||
48896086|NCT00178126|157455599|FG000|Overall Study|did not receive intervention|4|||
48896087|NCT00178126|157455600|FG001|Overall Study|did not receive intervention|6|||
48896088|NCT04002401|157455601|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|13|||
48896089|NCT04002401|157455601|FG000|Overall Study|Death|10|||
48896090|NCT04002401|157455601|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|2|||
48896091|NCT04002401|157455601|FG000|Overall Study|Enrolled but Never Treated|1|||
48896092|NCT04002401|157455601|FG000|Overall Study|Lost to Follow-up|1|||
48896093|NCT01675479|157455602|FG000|Overall Study|Lost to Follow-up|11|||
48896094|NCT03035201|157455603|FG000|Overall Study|Death|9|||
48896095|NCT03035201|157455604|FG001|Overall Study|Death|12|||
48896096|NCT03035201|157455605|FG002|Overall Study|Death|9|||
48896097|NCT03035201|157455606|FG003|Overall Study|Death|10|||
48896098|NCT03035201|157455603|FG000|Overall Study|Withdrawal by Subject|51|||
48896099|NCT03035201|157455604|FG001|Overall Study|Withdrawal by Subject|49|||
48896100|NCT03035201|157455605|FG002|Overall Study|Withdrawal by Subject|37|||
48896101|NCT03035201|157455606|FG003|Overall Study|Withdrawal by Subject|46|||
48896102|NCT03035201|157455603|FG000|Overall Study|Lost to Follow-up|67|||
48896103|NCT03035201|157455604|FG001|Overall Study|Lost to Follow-up|51|||
48896104|NCT03035201|157455605|FG002|Overall Study|Lost to Follow-up|64|||
48896105|NCT03035201|157455606|FG003|Overall Study|Lost to Follow-up|69|||
48896106|NCT00734097|157457016|FG000|Screening|Protocol Violation|12|||
48896107|NCT00734097|157457016|FG000|Screening|Withdrawal by Subject|5|||
48896108|NCT00734097|157457016|FG000|Screening|Lost to Follow-up|2|||
48896109|NCT00734097|157457016|FG000|Screening|Unconfirmed pregnancy|1|||
48896110|NCT00734097|157457016|FG000|Open Label|Lost to Follow-up|7|||
48896111|NCT00734097|157457016|FG000|Open Label|Withdrawal by Subject|5|||
48896112|NCT00734097|157457016|FG000|Open Label|Protocol Violation|4|||
48896113|NCT00484289|157457019|FG000|Long Term Phase|Adverse Event|1|||
48896114|NCT00484289|157457020|FG001|Long Term Phase|Adverse Event|17|||
48896115|NCT00484289|157457021|FG002|Long Term Phase|Adverse Event|5|||
48896116|NCT00484289|157457019|FG000|Long Term Phase|Withdrawal by Subject|0|||
48896117|NCT00484289|157457020|FG001|Long Term Phase|Withdrawal by Subject|7|||
48896118|NCT00484289|157457021|FG002|Long Term Phase|Withdrawal by Subject|6|||
48896119|NCT00484289|157457019|FG000|Long Term Phase|Inadequate response|2|||
48896120|NCT00484289|157457020|FG001|Long Term Phase|Inadequate response|7|||
48896121|NCT00484289|157457021|FG002|Long Term Phase|Inadequate response|4|||
48896122|NCT00484289|157457019|FG000|Long Term Phase|Other Reason|0|||
48896123|NCT00484289|157457020|FG001|Long Term Phase|Other Reason|5|||
48896124|NCT00484289|157457021|FG002|Long Term Phase|Other Reason|1|||
48896125|NCT00484289|157457019|FG000|Post Marketing Phase|Adverse Event|0|||
48896126|NCT00484289|157457020|FG001|Post Marketing Phase|Adverse Event|1|||
48896127|NCT00484289|157457021|FG002|Post Marketing Phase|Adverse Event|0|||
48896128|NCT02831387|157457024|FG000|Overall Study|Withdrawal by Subject|1|||
48896129|NCT02831387|157457025|FG001|Overall Study|Withdrawal by Subject|1|||
48896130|NCT02831387|157457024|FG000|Overall Study|Discontinued due to stock recovery|0|||
48896131|NCT02831387|157457025|FG001|Overall Study|Discontinued due to stock recovery|1|||
48896132|NCT00192647|157457026|FG000|Overall Study|Death|1|||
48896133|NCT00192647|157457027|FG001|Overall Study|Death|1|||
48896134|NCT00192647|157457026|FG000|Overall Study|Adverse Event|35|||
48896135|NCT00192647|157457027|FG001|Overall Study|Adverse Event|29|||
48896136|NCT00192647|157457026|FG000|Overall Study|Laboratory Test Abnormality|4|||
48896137|NCT00192647|157457027|FG001|Overall Study|Laboratory Test Abnormality|2|||
48896138|NCT00192647|157457026|FG000|Overall Study|Insufficient Therapeutic Response|53|||
48896139|NCT00192647|157457027|FG001|Overall Study|Insufficient Therapeutic Response|83|||
48896140|NCT00192647|157457026|FG000|Overall Study|Entry Criteria Violation|6|||
48896141|NCT00192647|157457027|FG001|Overall Study|Entry Criteria Violation|6|||
48896142|NCT00192647|157457026|FG000|Overall Study|Protocol Violation|3|||
48896143|NCT00192647|157457027|FG001|Overall Study|Protocol Violation|1|||
48896144|NCT00192647|157457026|FG000|Overall Study|Refused Treatment/Did not Cooperate|10|||
48896145|NCT00192647|157457027|FG001|Overall Study|Refused Treatment/Did not Cooperate|8|||
48896146|NCT00192647|157457026|FG000|Overall Study|Failure to Return|11|||
49038960|NCT00205777|157978800|FG002|Study Extension II|Withdrawal by Subject|0|||
48896147|NCT00192647|157457027|FG001|Overall Study|Failure to Return|13|||
49038961|NCT00205777|157978801|FG003|Study Extension II|Withdrawal by Subject|35|||
48896148|NCT00192647|157457026|FG000|Overall Study|Other/Administrative|5|||
48896149|NCT00192647|157457027|FG001|Overall Study|Other/Administrative|3|||
48896150|NCT01290315|157457028|FG000|Overall Study|Adverse Event|0|||
48896151|NCT01290315|157457029|FG001|Overall Study|Adverse Event|0|||
48896152|NCT01290315|157457030|FG002|Overall Study|Adverse Event|0|||
48896153|NCT01290315|157457031|FG003|Overall Study|Adverse Event|3|||
48896154|NCT01290315|157457028|FG000|Overall Study|Selection criteria/compliance|2|||
48896155|NCT01290315|157457029|FG001|Overall Study|Selection criteria/compliance|1|||
48896156|NCT01290315|157457030|FG002|Overall Study|Selection criteria/compliance|0|||
48896157|NCT01290315|157457031|FG003|Overall Study|Selection criteria/compliance|2|||
48896158|NCT01290315|157457028|FG000|Overall Study|Lost to Follow-up|0|||
48896159|NCT01290315|157457029|FG001|Overall Study|Lost to Follow-up|1|||
48896160|NCT01290315|157457030|FG002|Overall Study|Lost to Follow-up|0|||
48896161|NCT01290315|157457031|FG003|Overall Study|Lost to Follow-up|0|||
48896162|NCT01290315|157457028|FG000|Overall Study|Withdrawal by Subject|1|||
48896163|NCT01290315|157457029|FG001|Overall Study|Withdrawal by Subject|1|||
48896164|NCT01290315|157457030|FG002|Overall Study|Withdrawal by Subject|0|||
48896165|NCT01290315|157457031|FG003|Overall Study|Withdrawal by Subject|0|||
48896166|NCT01248780|157457032|FG000|Overall Study|Lack of Efficacy|2|||
48896167|NCT01248780|157457033|FG001|Overall Study|Lack of Efficacy|0|||
48896168|NCT01248780|157457032|FG000|Overall Study|Lost to Follow-up|0|||
48896169|NCT01248780|157457033|FG001|Overall Study|Lost to Follow-up|1|||
48896170|NCT01248780|157457032|FG000|Overall Study|Death|0|||
48896171|NCT01248780|157457033|FG001|Overall Study|Death|1|||
48896172|NCT01248780|157457032|FG000|Overall Study|Adverse Event|2|||
48896173|NCT01248780|157457033|FG001|Overall Study|Adverse Event|7|||
48896174|NCT01248780|157457032|FG000|Overall Study|Protocol Violation|1|||
48896175|NCT01248780|157457033|FG001|Overall Study|Protocol Violation|1|||
48896176|NCT01248780|157457032|FG000|Overall Study|Withdrawal by Subject|4|||
48896177|NCT01248780|157457033|FG001|Overall Study|Withdrawal by Subject|4|||
48896178|NCT01248780|157457032|FG000|Overall Study|Not treated|0|||
48896179|NCT01248780|157457033|FG001|Overall Study|Not treated|1|||
48896180|NCT03241225|157457034|FG000|Overall Study|Lost to Follow-up|2|||
48896181|NCT03241225|157457035|FG001|Overall Study|Lost to Follow-up|1|||
48896182|NCT03241225|157457034|FG000|Overall Study|Protocol Violation|4|||
48896183|NCT03241225|157457035|FG001|Overall Study|Protocol Violation|1|||
48896184|NCT03241225|157457034|FG000|Overall Study|Withdrawal by Subject|1|||
48896185|NCT03241225|157457035|FG001|Overall Study|Withdrawal by Subject|0|||
48896186|NCT01776541|157457039|FG000|Overall Study|Administrative Reason|6|||
48896187|NCT01776541|157457040|FG001|Overall Study|Administrative Reason|2|||
48896188|NCT01776541|157457039|FG000|Overall Study|Death|4|||
48896189|NCT01776541|157457040|FG001|Overall Study|Death|0|||
48896190|NCT01776541|157457039|FG000|Overall Study|Lost to Follow-up|27|||
48896191|NCT01776541|157457040|FG001|Overall Study|Lost to Follow-up|48|||
48896192|NCT01776541|157457039|FG000|Overall Study|Unclassified|5|||
48896193|NCT01776541|157457040|FG001|Overall Study|Unclassified|4|||
48896194|NCT01776541|157457039|FG000|Overall Study|Protocol Violation|2|||
48896195|NCT01776541|157457040|FG001|Overall Study|Protocol Violation|1|||
48896196|NCT01776541|157457039|FG000|Overall Study|Withdrawal by Subject|12|||
48896197|NCT01776541|157457040|FG001|Overall Study|Withdrawal by Subject|20|||
48896198|NCT00618618|157457041|FG000|Overall Study|Patient Request|0|||
48896199|NCT00618618|157457042|FG001|Overall Study|Patient Request|0|||
48896200|NCT00618618|157457043|FG002|Overall Study|Patient Request|2|||
48896201|NCT00618618|157457044|FG003|Overall Study|Patient Request|0|||
48896202|NCT00618618|157457041|FG000|Overall Study|Inability to Complete Study Procedures|0|||
48896203|NCT00618618|157457042|FG001|Overall Study|Inability to Complete Study Procedures|1|||
48896204|NCT00618618|157457043|FG002|Overall Study|Inability to Complete Study Procedures|0|||
48896205|NCT00618618|157457044|FG003|Overall Study|Inability to Complete Study Procedures|0|||
48896206|NCT00618618|157457041|FG000|Overall Study|Lost to Follow-up|3|||
48896207|NCT00618618|157457042|FG001|Overall Study|Lost to Follow-up|0|||
48896208|NCT00618618|157457043|FG002|Overall Study|Lost to Follow-up|0|||
48896209|NCT00618618|157457044|FG003|Overall Study|Lost to Follow-up|1|||
48896210|NCT00618618|157457041|FG000|Overall Study|Non-compliance|1|||
48896211|NCT00618618|157457042|FG001|Overall Study|Non-compliance|1|||
48896212|NCT00618618|157457043|FG002|Overall Study|Non-compliance|0|||
48896213|NCT00618618|157457044|FG003|Overall Study|Non-compliance|0|||
48896214|NCT00618618|157457041|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
48896215|NCT00618618|157457042|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
48896216|NCT00618618|157457043|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
48896217|NCT00618618|157457044|FG003|Overall Study|Did Not Meet Entry Criteria|0|||
48896218|NCT00618618|157457041|FG000|Overall Study|Death|0|||
48896219|NCT00618618|157457042|FG001|Overall Study|Death|1|||
48896220|NCT00618618|157457043|FG002|Overall Study|Death|0|||
48896221|NCT00618618|157457044|FG003|Overall Study|Death|0|||
48896222|NCT01236365|157457045|FG000|Overall Study|Lost to Follow-up|0|||
48896223|NCT01236365|157457046|FG001|Overall Study|Lost to Follow-up|2|||
48896224|NCT01236365|157457045|FG000|Overall Study|Moved Out of State|1|||
48896225|NCT01236365|157457046|FG001|Overall Study|Moved Out of State|0|||
48896226|NCT01236365|157457045|FG000|Overall Study|Dropped at Randomization due to high LFT|1|||
48896227|NCT01236365|157457046|FG001|Overall Study|Dropped at Randomization due to high LFT|0|||
48896228|NCT04410523|157457047|FG000|Overall Study|Study terminated by sponsor|1|||
48896229|NCT04410523|157457048|FG001|Overall Study|Study terminated by sponsor|3|||
48896230|NCT04410523|157457049|FG002|Overall Study|Study terminated by sponsor|2|||
48896231|NCT04410523|157457050|FG003|Overall Study|Study terminated by sponsor|6|||
49038962|NCT00205777|157978802|FG004|Study Extension II|Withdrawal by Subject|0|||
49038963|NCT00205777|157978803|FG005|Study Extension II|Withdrawal by Subject|59|||
49038964|NCT00205777|157978798|FG000|Study Extension II|Protocol Violation|0|||
49038965|NCT00205777|157978799|FG001|Study Extension II|Protocol Violation|0|||
49038966|NCT00205777|157978800|FG002|Study Extension II|Protocol Violation|0|||
49038967|NCT00205777|157978801|FG003|Study Extension II|Protocol Violation|1|||
49038968|NCT00205777|157978802|FG004|Study Extension II|Protocol Violation|0|||
49038969|NCT00205777|157978803|FG005|Study Extension II|Protocol Violation|10|||
48896232|NCT04410523|157457051|FG004|Overall Study|Study terminated by sponsor|3|||
48896233|NCT04410523|157457052|FG005|Overall Study|Study terminated by sponsor|4|||
48896234|NCT04410523|157457047|FG000|Overall Study|Adverse Event|1|||
48896235|NCT04410523|157457048|FG001|Overall Study|Adverse Event|0|||
48896236|NCT04410523|157457049|FG002|Overall Study|Adverse Event|0|||
48896237|NCT04410523|157457050|FG003|Overall Study|Adverse Event|0|||
48896238|NCT04410523|157457051|FG004|Overall Study|Adverse Event|0|||
48896239|NCT04410523|157457052|FG005|Overall Study|Adverse Event|2|||
48896240|NCT04410523|157457047|FG000|Overall Study|Lost to Follow-up|0|||
48896241|NCT04410523|157457048|FG001|Overall Study|Lost to Follow-up|1|||
48896242|NCT04410523|157457049|FG002|Overall Study|Lost to Follow-up|0|||
48896243|NCT04410523|157457050|FG003|Overall Study|Lost to Follow-up|0|||
48896244|NCT04410523|157457051|FG004|Overall Study|Lost to Follow-up|0|||
48896245|NCT04410523|157457052|FG005|Overall Study|Lost to Follow-up|0|||
48896246|NCT04410523|157457047|FG000|Overall Study|Physician Decision|0|||
48896247|NCT04410523|157457048|FG001|Overall Study|Physician Decision|1|||
48896248|NCT04410523|157457049|FG002|Overall Study|Physician Decision|0|||
48896249|NCT04410523|157457050|FG003|Overall Study|Physician Decision|0|||
48896250|NCT04410523|157457051|FG004|Overall Study|Physician Decision|0|||
48896251|NCT04410523|157457052|FG005|Overall Study|Physician Decision|0|||
48896252|NCT04410523|157457047|FG000|Overall Study|Pregnancy|0|||
48896253|NCT04410523|157457048|FG001|Overall Study|Pregnancy|0|||
48896254|NCT04410523|157457049|FG002|Overall Study|Pregnancy|0|||
48896255|NCT04410523|157457050|FG003|Overall Study|Pregnancy|0|||
48896256|NCT04410523|157457051|FG004|Overall Study|Pregnancy|0|||
48896257|NCT04410523|157457052|FG005|Overall Study|Pregnancy|1|||
48896258|NCT04410523|157457047|FG000|Overall Study|Protocol deviation|0|||
48896259|NCT04410523|157457048|FG001|Overall Study|Protocol deviation|0|||
48896260|NCT04410523|157457049|FG002|Overall Study|Protocol deviation|0|||
48896261|NCT04410523|157457050|FG003|Overall Study|Protocol deviation|0|||
48896262|NCT04410523|157457051|FG004|Overall Study|Protocol deviation|0|||
48896263|NCT04410523|157457052|FG005|Overall Study|Protocol deviation|2|||
48896264|NCT04410523|157457047|FG000|Overall Study|Subject decision|2|||
48896265|NCT04410523|157457048|FG001|Overall Study|Subject decision|0|||
48896266|NCT04410523|157457049|FG002|Overall Study|Subject decision|0|||
48896267|NCT04410523|157457050|FG003|Overall Study|Subject decision|1|||
48896268|NCT04410523|157457051|FG004|Overall Study|Subject decision|0|||
48896269|NCT04410523|157457052|FG005|Overall Study|Subject decision|1|||
48896270|NCT03606668|157457061|FG000|Overall Study|Screen Failure|1|||
48896271|NCT03606668|157457061|FG000|Overall Study|Lost to Follow-up|1|||
48896272|NCT00461032|157457062|FG000|Overall Study|Adverse Event|5|||
48896273|NCT00461032|157457063|FG001|Overall Study|Adverse Event|6|||
48896274|NCT00461032|157457062|FG000|Overall Study|Lack of Efficacy|5|||
48896275|NCT00461032|157457063|FG001|Overall Study|Lack of Efficacy|1|||
48896276|NCT00461032|157457062|FG000|Overall Study|Lost to Follow-up|7|||
48896277|NCT00461032|157457063|FG001|Overall Study|Lost to Follow-up|12|||
48896278|NCT00461032|157457062|FG000|Overall Study|Protocol Violation|4|||
48896279|NCT00461032|157457063|FG001|Overall Study|Protocol Violation|4|||
48896280|NCT00461032|157457062|FG000|Overall Study|Withdrawal by Subject|7|||
48896281|NCT00461032|157457063|FG001|Overall Study|Withdrawal by Subject|15|||
48896282|NCT00461032|157457062|FG000|Overall Study|Patient Moved or Relocated|2|||
48896283|NCT00461032|157457063|FG001|Overall Study|Patient Moved or Relocated|1|||
48896284|NCT00461032|157457062|FG000|Overall Study|Other|7|||
48896285|NCT00461032|157457063|FG001|Overall Study|Other|5|||
48896286|NCT04371198|157457064|FG000|Overall Study|inadequate sample|4|||
48896287|NCT00158860|157457069|FG000|Overall Study|Adverse Event|3|||
48896288|NCT00158860|157457070|FG001|Overall Study|Adverse Event|6|||
48896289|NCT00158860|157457069|FG000|Overall Study|Lost to Follow-up|11|||
48896290|NCT00158860|157457070|FG001|Overall Study|Lost to Follow-up|17|||
48896291|NCT00158860|157457069|FG000|Overall Study|Protocol Violation|8|||
48896292|NCT00158860|157457070|FG001|Overall Study|Protocol Violation|23|||
48896293|NCT00158860|157457069|FG000|Overall Study|Withdrawal by Subject|7|||
48896294|NCT00158860|157457070|FG001|Overall Study|Withdrawal by Subject|17|||
48896295|NCT00158860|157457069|FG000|Overall Study|MOVING OUT OF STATE|1|||
48896296|NCT00158860|157457070|FG001|Overall Study|MOVING OUT OF STATE|0|||
48896297|NCT00158860|157457069|FG000|Overall Study|Pregnancy|3|||
48896298|NCT00158860|157457070|FG001|Overall Study|Pregnancy|3|||
48896299|NCT00158860|157457069|FG000|Overall Study|SPONSOR STOPPED STUDY|2|||
48896300|NCT00158860|157457070|FG001|Overall Study|SPONSOR STOPPED STUDY|2|||
49038970|NCT00205777|157978798|FG000|Study Extension II|Lack of Efficacy|0|||
48896301|NCT00158860|157457069|FG000|Overall Study|SPONSOR REQUEST|0|||
48896302|NCT00158860|157457070|FG001|Overall Study|SPONSOR REQUEST|1|||
48896303|NCT00158860|157457069|FG000|Overall Study|Lost to Follow up but returned per GSK|0|||
48896304|NCT00158860|157457070|FG001|Overall Study|Lost to Follow up but returned per GSK|1|||
48896305|NCT00158860|157457069|FG000|Overall Study|Closed per sponsor|0|||
48896306|NCT00158860|157457070|FG001|Overall Study|Closed per sponsor|1|||
48896307|NCT03500159|157457073|FG000|Overall Study|Study Terminated|2|||
48896308|NCT03500159|157457074|FG001|Overall Study|Study Terminated|1|||
48896309|NCT03256851|157457079|FG000|Overall Study|Withdrawal by Subject|1|||
48896310|NCT03256851|157457080|FG001|Overall Study|Withdrawal by Subject|0|||
48896311|NCT00324675|157457081|FG000|Overall Study|Adverse Event|1|||
48896312|NCT00324675|157457082|FG001|Overall Study|Adverse Event|0|||
48896313|NCT01945060|157457088|FG000|Overall Study|Lost to follow up|1|||
48896314|NCT01945060|157457089|FG001|Overall Study|Lost to follow up|0|||
48896315|NCT01945060|157457088|FG000|Overall Study|Distress related to IV access|0|||
48896316|NCT01945060|157457089|FG001|Overall Study|Distress related to IV access|1|||
48896317|NCT00819390|157457093|FG000|Overall Study|Lost to Follow-up|1|||
48896318|NCT00819390|157457094|FG001|Overall Study|Lost to Follow-up|1|||
48896319|NCT00819390|157457095|FG002|Overall Study|Lost to Follow-up|0|||
48896320|NCT00819390|157457096|FG003|Overall Study|Lost to Follow-up|0|||
48896321|NCT00819390|157457093|FG000|Overall Study|Withdrawal by Subject|2|||
48896322|NCT00819390|157457094|FG001|Overall Study|Withdrawal by Subject|0|||
48896323|NCT00819390|157457095|FG002|Overall Study|Withdrawal by Subject|0|||
48896324|NCT00819390|157457096|FG003|Overall Study|Withdrawal by Subject|0|||
48896325|NCT00819390|157457093|FG000|Overall Study|Adverse Event|0|||
48896326|NCT00819390|157457094|FG001|Overall Study|Adverse Event|0|||
48896327|NCT00819390|157457095|FG002|Overall Study|Adverse Event|1|||
48896328|NCT00819390|157457096|FG003|Overall Study|Adverse Event|0|||
48896329|NCT02729753|157457097|FG000|Overall Study|Device Malfunction. No units in stock.|0|||
48896330|NCT02729753|157457098|FG001|Overall Study|Device Malfunction. No units in stock.|1|||
48896331|NCT01191268|157457099|FG000|Overall Study|Withdrawal by Subject|19|||
48896332|NCT01191268|157457100|FG001|Overall Study|Withdrawal by Subject|25|||
48896333|NCT01191268|157457101|FG002|Overall Study|Withdrawal by Subject|21|||
48896334|NCT01191268|157457099|FG000|Overall Study|Adverse Event|21|||
48896335|NCT01191268|157457100|FG001|Overall Study|Adverse Event|13|||
48896336|NCT01191268|157457101|FG002|Overall Study|Adverse Event|8|||
48896337|NCT01191268|157457099|FG000|Overall Study|Physician Decision|6|||
48896338|NCT01191268|157457100|FG001|Overall Study|Physician Decision|8|||
48896339|NCT01191268|157457101|FG002|Overall Study|Physician Decision|9|||
48896340|NCT01191268|157457099|FG000|Overall Study|Lost to Follow-up|8|||
48896341|NCT01191268|157457100|FG001|Overall Study|Lost to Follow-up|5|||
48896342|NCT01191268|157457101|FG002|Overall Study|Lost to Follow-up|9|||
48896343|NCT01191268|157457099|FG000|Overall Study|Entry Criteria Not Met|3|||
48896344|NCT01191268|157457100|FG001|Overall Study|Entry Criteria Not Met|1|||
48896345|NCT01191268|157457101|FG002|Overall Study|Entry Criteria Not Met|1|||
48896346|NCT01191268|157457099|FG000|Overall Study|Death|0|||
48896347|NCT01191268|157457100|FG001|Overall Study|Death|1|||
48896348|NCT01191268|157457101|FG002|Overall Study|Death|3|||
48896349|NCT01191268|157457099|FG000|Overall Study|Protocol Violation|1|||
48896350|NCT01191268|157457100|FG001|Overall Study|Protocol Violation|0|||
48896351|NCT01191268|157457101|FG002|Overall Study|Protocol Violation|1|||
48896352|NCT01191268|157457099|FG000|Overall Study|Sponsor Decision|0|||
48896353|NCT01191268|157457100|FG001|Overall Study|Sponsor Decision|2|||
48896354|NCT01191268|157457101|FG002|Overall Study|Sponsor Decision|0|||
48896355|NCT02414932|157457102|FG000|Overall Study|Withdrawal by Subject|2|||
48896356|NCT02414932|157457103|FG001|Overall Study|Withdrawal by Subject|3|||
48896357|NCT02414932|157457102|FG000|Overall Study|Adverse Event|1|||
48896358|NCT02414932|157457103|FG001|Overall Study|Adverse Event|0|||
48896359|NCT04493502|157457104|FG000|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|1|||
48896360|NCT04493502|157457105|FG001|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|0|||
48896361|NCT04493502|157457104|FG000|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|3|||
48896362|NCT04493502|157457105|FG001|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|4|||
48984207|NCT01693562|157774128|FG007|Exploration Phase|Other|0|||
48984208|NCT01693562|157774129|FG008|Exploration Phase|Other|0|||
48984209|NCT01693562|157774130|FG009|Exploration Phase|Other|0|||
48984210|NCT01693562|157774131|FG010|Exploration Phase|Other|0|||
48984211|NCT01693562|157774132|FG011|Exploration Phase|Other|0|||
48984212|NCT01693562|157774133|FG012|Exploration Phase|Other|0|||
48984213|NCT01693562|157774134|FG013|Exploration Phase|Other|0|||
48984214|NCT01693562|157774135|FG014|Exploration Phase|Other|0|||
48984215|NCT01693562|157774136|FG015|Exploration Phase|Other|0|||
48984216|NCT01693562|157774137|FG016|Exploration Phase|Other|0|||
48984217|NCT01693562|157774138|FG017|Exploration Phase|Other|0|||
48984218|NCT01693562|157774139|FG018|Exploration Phase|Other|0|||
48984219|NCT01693562|157774140|FG019|Exploration Phase|Other|0|||
48984220|NCT01693562|157774141|FG020|Exploration Phase|Other|0|||
48984221|NCT01693562|157774142|FG021|Exploration Phase|Other|0|||
48984222|NCT01693562|157774143|FG022|Exploration Phase|Other|0|||
48984223|NCT01693562|157774121|FG000|Expansion Phase|Withdrawal by Subject|0|||
48984224|NCT01693562|157774122|FG001|Expansion Phase|Withdrawal by Subject|0|||
48896363|NCT04493502|157457104|FG000|Double Blind Treatment (Week 0 - 16)|Other, Relocation|0|||
48896364|NCT04493502|157457105|FG001|Double Blind Treatment (Week 0 - 16)|Other, Relocation|1|||
48896365|NCT04493502|157457104|FG000|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|0|||
48896366|NCT04493502|157457105|FG001|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|1|||
48896367|NCT04493502|157457104|FG000|Double Blind Treatment (Week 0 - 16)|Physician Decision|1|||
48896368|NCT04493502|157457105|FG001|Double Blind Treatment (Week 0 - 16)|Physician Decision|0|||
48896369|NCT04493502|157457104|FG000|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|3|||
48896370|NCT04493502|157457105|FG001|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|1|||
48896371|NCT04493502|157457104|FG000|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|2|||
48896372|NCT04493502|157457105|FG001|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|3|||
48896373|NCT04493502|157457104|FG000|Open-label Extension (Week 16 - 36)|Lost to Follow-up|1|||
48896374|NCT04493502|157457105|FG001|Open-label Extension (Week 16 - 36)|Lost to Follow-up|0|||
48896375|NCT04493502|157457104|FG000|Open-label Extension (Week 16 - 36)|Physician Decision|0|||
48896376|NCT04493502|157457105|FG001|Open-label Extension (Week 16 - 36)|Physician Decision|1|||
48896377|NCT04493502|157457104|FG000|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|3|||
48896378|NCT04493502|157457105|FG001|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|8|||
48896379|NCT04493502|157457104|FG000|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|0|||
48896380|NCT04493502|157457105|FG001|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|1|||
48896381|NCT04493502|157457104|FG000|Post-treatment Follow-up (10 Weeks)|Physician Decision|0|||
48896382|NCT04493502|157457105|FG001|Post-treatment Follow-up (10 Weeks)|Physician Decision|1|||
48896383|NCT04493502|157457104|FG000|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|2|||
48896384|NCT04493502|157457105|FG001|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|3|||
48896385|NCT01768637|157457106|FG000|Overall Study|Lost to Follow-up|2|||
48896386|NCT01768637|157457107|FG001|Overall Study|Lost to Follow-up|7|||
48896387|NCT01768637|157457106|FG000|Overall Study|Difficult blood draw|1|||
48896388|NCT01768637|157457107|FG001|Overall Study|Difficult blood draw|0|||
48896389|NCT00412061|157457108|FG000|Double Blind Phase|Disease Progression|101|||
48896390|NCT00412061|157457109|FG001|Double Blind Phase|Disease Progression|154|||
48896391|NCT00412061|157457108|FG000|Double Blind Phase|Adverse Event|61|||
48896392|NCT00412061|157457109|FG001|Double Blind Phase|Adverse Event|16|||
48896393|NCT00412061|157457108|FG000|Double Blind Phase|Final Primary Analysis|26|||
48896394|NCT00412061|157457109|FG001|Double Blind Phase|Final Primary Analysis|14|||
48896395|NCT00412061|157457108|FG000|Double Blind Phase|Withdrawal by Subject|18|||
48896396|NCT00412061|157457109|FG001|Double Blind Phase|Withdrawal by Subject|20|||
48896397|NCT00412061|157457108|FG000|Double Blind Phase|Death|6|||
48896398|NCT00412061|157457109|FG001|Double Blind Phase|Death|3|||
48896399|NCT00412061|157457108|FG000|Double Blind Phase|Protocol Violation|3|||
48896400|NCT00412061|157457109|FG001|Double Blind Phase|Protocol Violation|4|||
48896401|NCT00412061|157457108|FG000|Double Blind Phase|New Cander Therapy|1|||
48896402|NCT00412061|157457109|FG001|Double Blind Phase|New Cander Therapy|1|||
48896403|NCT00412061|157457108|FG000|Double Blind Phase|Lost to Follow-up|0|||
48896404|NCT00412061|157457109|FG001|Double Blind Phase|Lost to Follow-up|1|||
48896405|NCT00412061|157457108|FG000|Open Label Phase|Disease Progression|0|||
48896406|NCT00412061|157457109|FG001|Open Label Phase|Disease Progression|86|||
48896407|NCT00412061|157457108|FG000|Open Label Phase|Adverse Event|0|||
48896408|NCT00412061|157457109|FG001|Open Label Phase|Adverse Event|46|||
48896409|NCT00412061|157457108|FG000|Open Label Phase|Withdrawal by Subject|0|||
48896410|NCT00412061|157457109|FG001|Open Label Phase|Withdrawal by Subject|15|||
48896411|NCT00412061|157457108|FG000|Open Label Phase|Administrative Problems|0|||
48896412|NCT00412061|157457109|FG001|Open Label Phase|Administrative Problems|13|||
48896413|NCT00412061|157457108|FG000|Open Label Phase|Death|0|||
48896414|NCT00412061|157457109|FG001|Open Label Phase|Death|7|||
48896415|NCT00412061|157457108|FG000|Open Label Phase|Lost to Follow-up|0|||
48896416|NCT00412061|157457109|FG001|Open Label Phase|Lost to Follow-up|2|||
48896417|NCT00412061|157457108|FG000|Open Label Phase|New Cancer Therapy|0|||
48896418|NCT00412061|157457109|FG001|Open Label Phase|New Cancer Therapy|1|||
48896419|NCT03143166|157457113|FG000|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1|||
48896420|NCT02673515|157457116|FG000|Overall Study|Lack of motivation|2|||
48896421|NCT02673515|157457117|FG001|Overall Study|Lack of motivation|1|||
48896422|NCT00994682|157457118|FG000|Double Bilnd|Withdrawal by Subject|5|||
48896423|NCT00994682|157457119|FG001|Double Bilnd|Withdrawal by Subject|6|||
48896424|NCT00994682|157457118|FG000|Double Bilnd|Lost to Follow-up|3|||
48896425|NCT00994682|157457119|FG001|Double Bilnd|Lost to Follow-up|3|||
48896426|NCT00994682|157457118|FG000|Double Bilnd|Adverse Event|1|||
48896427|NCT00994682|157457119|FG001|Double Bilnd|Adverse Event|0|||
48896428|NCT00994682|157457118|FG000|Pioglitazone Open Label|Withdrawal by Subject|4|||
48896429|NCT00994682|157457119|FG001|Pioglitazone Open Label|Withdrawal by Subject|4|||
48896430|NCT00994682|157457118|FG000|Pioglitazone Open Label|Lost to Follow-up|3|||
48896431|NCT00994682|157457119|FG001|Pioglitazone Open Label|Lost to Follow-up|2|||
48896432|NCT00994682|157457118|FG000|Pioglitazone Open Label|Physician Decision|6|||
48896433|NCT00994682|157457119|FG001|Pioglitazone Open Label|Physician Decision|1|||
48896434|NCT00928018|157457120|FG000|Overall Study|Withdrawal by Subject|1|||
48896435|NCT00928018|157457121|FG001|Overall Study|Withdrawal by Subject|0|||
48896436|NCT02859324|157457123|FG000|Overall Study|Death|4|||
48896437|NCT02859324|157457124|FG001|Overall Study|Death|6|||
48896438|NCT02859324|157457125|FG002|Overall Study|Death|5|||
48896439|NCT02859324|157457123|FG000|Overall Study|Other reasons|3|||
48896440|NCT02859324|157457124|FG001|Overall Study|Other reasons|3|||
48896441|NCT02859324|157457125|FG002|Overall Study|Other reasons|0|||
48896442|NCT00710021|157457126|FG000|Overall Study|Lost to Follow-up|1|||
48896443|NCT00710021|157457127|FG001|Overall Study|Lost to Follow-up|0|||
48896444|NCT00710021|157457128|FG002|Overall Study|Lost to Follow-up|0|||
48896445|NCT00710021|157457126|FG000|Overall Study|Subject's Decision|0|||
48896446|NCT00710021|157457127|FG001|Overall Study|Subject's Decision|1|||
48896447|NCT00710021|157457128|FG002|Overall Study|Subject's Decision|0|||
48896448|NCT00710021|157457126|FG000|Overall Study|Subject misrandomized|0|||
48896449|NCT00710021|157457127|FG001|Overall Study|Subject misrandomized|1|||
48896450|NCT00710021|157457128|FG002|Overall Study|Subject misrandomized|1|||
48896451|NCT00710021|157457126|FG000|Overall Study|Physician Decision|0|||
48896452|NCT00710021|157457127|FG001|Overall Study|Physician Decision|1|||
48896453|NCT00710021|157457128|FG002|Overall Study|Physician Decision|0|||
48896454|NCT02374671|157457131|FG000|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
48896455|NCT02374671|157457132|FG001|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
48896456|NCT02374671|157457133|FG002|Observation (Deferred Implantation)|Withdrawal by Subject|4|||
48896457|NCT02374671|157457131|FG000|Observation (Deferred Implantation)|Adverse Event|0|||
48896458|NCT02374671|157457132|FG001|Observation (Deferred Implantation)|Adverse Event|0|||
48896459|NCT02374671|157457133|FG002|Observation (Deferred Implantation)|Adverse Event|1|||
48896460|NCT02374671|157457131|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17|||
48896461|NCT02374671|157457132|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
48896462|NCT02374671|157457133|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2|||
48896463|NCT02374671|157457131|FG000|Implantation- Nonrandomized & Randomized|Adverse Event|7|||
48896464|NCT02374671|157457132|FG001|Implantation- Nonrandomized & Randomized|Adverse Event|0|||
48896465|NCT02374671|157457133|FG002|Implantation- Nonrandomized & Randomized|Adverse Event|1|||
48896466|NCT02374671|157457131|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
48896467|NCT02374671|157457132|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
48896468|NCT02374671|157457133|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
48896469|NCT03866473|157457134|FG000|Phase 1|Death|1|||
48896470|NCT03866473|157457135|FG001|Phase 1|Death|0|||
48896471|NCT03866473|157457134|FG000|Phase 2|Death|0|||
48896472|NCT03866473|157457135|FG001|Phase 2|Death|2|||
48896473|NCT03866473|157457134|FG000|Phase 2|Dropped|1|||
48896474|NCT03866473|157457135|FG001|Phase 2|Dropped|1|||
48896475|NCT03866473|157457134|FG000|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|1|||
48896476|NCT03866473|157457135|FG001|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|0|||
48896477|NCT03261700|157457136|FG000|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|1|||
48896478|NCT03261700|157457137|FG001|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|0|||
48896479|NCT00600886|157457138|FG000|Core Phase - Full Analysis Set (FAS)|Adverse Event|14|||
48896480|NCT00600886|157457139|FG001|Core Phase - Full Analysis Set (FAS)|Adverse Event|6|||
48896481|NCT00600886|157457138|FG000|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7|||
48896482|NCT00600886|157457139|FG001|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8|||
48896483|NCT00600886|157457138|FG000|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5|||
48896484|NCT00600886|157457139|FG001|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8|||
48896485|NCT00600886|157457138|FG000|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5|||
48896486|NCT00600886|157457139|FG001|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3|||
48896487|NCT00600886|157457138|FG000|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2|||
48896488|NCT00600886|157457139|FG001|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0|||
48896489|NCT00600886|157457138|FG000|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1|||
48896490|NCT00600886|157457139|FG001|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0|||
48896491|NCT00600886|157457138|FG000|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1|||
48896492|NCT00600886|157457139|FG001|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0|||
48896493|NCT00600886|157457138|FG000|Core Phase - Full Analysis Set (FAS)|Death|0|||
48896494|NCT00600886|157457139|FG001|Core Phase - Full Analysis Set (FAS)|Death|1|||
48896495|NCT00600886|157457138|FG000|Extension - Same Treatment (FAS)|Withdrawal by Subject|16|||
49038971|NCT00205777|157978799|FG001|Study Extension II|Lack of Efficacy|0|||
49038972|NCT00205777|157978800|FG002|Study Extension II|Lack of Efficacy|0|||
48896496|NCT00600886|157457139|FG001|Extension - Same Treatment (FAS)|Withdrawal by Subject|2|||
48896497|NCT00600886|157457138|FG000|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
48896498|NCT00600886|157457139|FG001|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
49038973|NCT00205777|157978801|FG003|Study Extension II|Lack of Efficacy|0|||
49038974|NCT00205777|157978802|FG004|Study Extension II|Lack of Efficacy|0|||
48896499|NCT00600886|157457138|FG000|Extension - Same Treatment (FAS)|Administrative Problems|9|||
48896500|NCT00600886|157457139|FG001|Extension - Same Treatment (FAS)|Administrative Problems|3|||
49038975|NCT00205777|157978803|FG005|Study Extension II|Lack of Efficacy|1|||
49038976|NCT00205777|157978798|FG000|Study Extension II|Failed to return|0|||
49038977|NCT00205777|157978799|FG001|Study Extension II|Failed to return|0|||
49038978|NCT00205777|157978800|FG002|Study Extension II|Failed to return|0|||
49038979|NCT00205777|157978801|FG003|Study Extension II|Failed to return|14|||
49038980|NCT00205777|157978802|FG004|Study Extension II|Failed to return|0|||
49038981|NCT00205777|157978803|FG005|Study Extension II|Failed to return|26|||
49038982|NCT00205777|157978798|FG000|Study Extension II|Other Event|0|||
48896501|NCT00600886|157457138|FG000|Extension - Same Treatment (FAS)|Lost to Follow-up|3|||
48896502|NCT00600886|157457139|FG001|Extension - Same Treatment (FAS)|Lost to Follow-up|1|||
48896503|NCT00600886|157457138|FG000|Extension - Same Treatment (FAS)|Adverse Event|4|||
48896504|NCT00600886|157457139|FG001|Extension - Same Treatment (FAS)|Adverse Event|1|||
48896505|NCT00600886|157457138|FG000|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4|||
48896506|NCT00600886|157457139|FG001|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0|||
48896507|NCT00600886|157457138|FG000|Extension - Same Treatment (FAS)|Death|1|||
48896508|NCT00600886|157457139|FG001|Extension - Same Treatment (FAS)|Death|1|||
48896509|NCT00600886|157457138|FG000|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6|||
48896510|NCT00600886|157457139|FG001|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0|||
48896511|NCT00600886|157457138|FG000|Extension - After Crossover (CAS)|Adverse Event|19|||
48896512|NCT00600886|157457139|FG001|Extension - After Crossover (CAS)|Adverse Event|1|||
48896513|NCT00600886|157457138|FG000|Extension - After Crossover (CAS)|Withdrawal by Subject|19|||
48896514|NCT00600886|157457139|FG001|Extension - After Crossover (CAS)|Withdrawal by Subject|4|||
48896515|NCT00600886|157457138|FG000|Extension - After Crossover (CAS)|Lack of Efficacy|13|||
48896516|NCT00600886|157457139|FG001|Extension - After Crossover (CAS)|Lack of Efficacy|4|||
48896517|NCT00600886|157457138|FG000|Extension - After Crossover (CAS)|Administrative Problems|4|||
48896518|NCT00600886|157457139|FG001|Extension - After Crossover (CAS)|Administrative Problems|4|||
48896519|NCT00600886|157457138|FG000|Extension - After Crossover (CAS)|Subject no longer requires study drug|3|||
48896520|NCT00600886|157457139|FG001|Extension - After Crossover (CAS)|Subject no longer requires study drug|0|||
48896521|NCT00600886|157457138|FG000|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3|||
48896522|NCT00600886|157457139|FG001|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0|||
48896523|NCT00600886|157457138|FG000|Extension - After Crossover (CAS)|Death|1|||
48896524|NCT00600886|157457139|FG001|Extension - After Crossover (CAS)|Death|0|||
48896525|NCT01227577|157458825|FG000|Overall Study|Protocol deviation|3|||
48896526|NCT01227577|157458825|FG000|Overall Study|Death|3|||
48896527|NCT01227577|157458825|FG000|Overall Study|Administrative problems|2|||
48896528|NCT01227577|157458825|FG000|Overall Study|Lost to Follow-up|1|||
48896529|NCT01227577|157458825|FG000|Overall Study|Withdrawal by Subject|4|||
48896530|NCT01227577|157458825|FG000|Overall Study|Lack of Efficacy|5|||
48896531|NCT01227577|157458825|FG000|Overall Study|Adverse Event|17|||
48896532|NCT00618982|157458826|FG000|Overall Study|Adverse Event|23|||
48896533|NCT00618982|157458826|FG000|Overall Study|Withdrawal by Subject|1|||
48896534|NCT00618982|157458826|FG000|Overall Study|Protocol Violation|1|||
48896535|NCT00618982|157458826|FG000|Overall Study|ongoing, still treated with study med.|25|||
49038983|NCT00205777|157978799|FG001|Study Extension II|Other Event|0|||
49038984|NCT00205777|157978800|FG002|Study Extension II|Other Event|0|||
49038985|NCT00205777|157978801|FG003|Study Extension II|Other Event|12|||
49038986|NCT00205777|157978802|FG004|Study Extension II|Other Event|0|||
49038987|NCT00205777|157978803|FG005|Study Extension II|Other Event|20|||
49038988|NCT00205777|157978798|FG000|Study Extension II|Enrolled but not treated|0|||
49038989|NCT00205777|157978799|FG001|Study Extension II|Enrolled but not treated|0|||
49038990|NCT00205777|157978800|FG002|Study Extension II|Enrolled but not treated|0|||
49038991|NCT00205777|157978801|FG003|Study Extension II|Enrolled but not treated|71|||
49038992|NCT00205777|157978802|FG004|Study Extension II|Enrolled but not treated|0|||
49038993|NCT00205777|157978803|FG005|Study Extension II|Enrolled but not treated|131|||
49038994|NCT02679729|157978807|FG000|Overall Study|Lost to Follow-up|0|||
49038995|NCT02679729|157978808|FG001|Overall Study|Lost to Follow-up|1|||
49038996|NCT02679729|157978809|FG002|Overall Study|Lost to Follow-up|0|||
49038997|NCT02679729|157978810|FG003|Overall Study|Lost to Follow-up|0|||
49038998|NCT02679729|157978811|FG004|Overall Study|Lost to Follow-up|1|||
49038999|NCT02679729|157978812|FG005|Overall Study|Lost to Follow-up|0|||
49039000|NCT02679729|157978813|FG006|Overall Study|Lost to Follow-up|0|||
49039001|NCT02679729|157978814|FG007|Overall Study|Lost to Follow-up|0|||
49039002|NCT02679729|157978815|FG008|Overall Study|Lost to Follow-up|0|||
49039003|NCT02679729|157978807|FG000|Overall Study|Participant decision|0|||
49039004|NCT02679729|157978808|FG001|Overall Study|Participant decision|1|||
49039005|NCT02679729|157978809|FG002|Overall Study|Participant decision|0|||
49039006|NCT02679729|157978810|FG003|Overall Study|Participant decision|0|||
49039007|NCT02679729|157978811|FG004|Overall Study|Participant decision|0|||
49039008|NCT02679729|157978812|FG005|Overall Study|Participant decision|0|||
48896536|NCT02630693|157458830|FG000|Overall Study|No receive treatment|0|||
49039009|NCT02679729|157978813|FG006|Overall Study|Participant decision|1|||
49039010|NCT02679729|157978814|FG007|Overall Study|Participant decision|0|||
49039011|NCT02679729|157978815|FG008|Overall Study|Participant decision|0|||
48896537|NCT02630693|157458831|FG001|Overall Study|No receive treatment|1|||
48896538|NCT01248065|157458835|FG000|Overall Study|Lost to Follow-up|3|||
48896539|NCT01248065|157458836|FG001|Overall Study|Lost to Follow-up|5|||
48896540|NCT01248065|157458835|FG000|Overall Study|Withdrawal by Subject|14|||
48896541|NCT01248065|157458836|FG001|Overall Study|Withdrawal by Subject|11|||
48896542|NCT01248065|157458835|FG000|Overall Study|Adverse Event|3|||
48896543|NCT01248065|157458836|FG001|Overall Study|Adverse Event|0|||
48896544|NCT01248065|157458835|FG000|Overall Study|Third treatment failure event|3|||
48896545|NCT01248065|157458836|FG001|Overall Study|Third treatment failure event|1|||
48896546|NCT01248065|157458835|FG000|Overall Study|Other|3|||
48896547|NCT01248065|157458836|FG001|Overall Study|Other|5|||
48896548|NCT02781844|157458839|FG000|Treatment Period 1|Adverse Event|0|||
48896549|NCT02781844|157458840|FG001|Treatment Period 1|Adverse Event|0|||
48896550|NCT02781844|157458841|FG002|Treatment Period 1|Adverse Event|0|||
48896551|NCT02781844|157458842|FG003|Treatment Period 1|Adverse Event|0|||
48896552|NCT02781844|157458843|FG004|Treatment Period 1|Adverse Event|0|||
48896553|NCT02781844|157458844|FG005|Treatment Period 1|Adverse Event|1|||
48896554|NCT02781844|157458845|FG006|Treatment Period 1|Adverse Event|0|||
48896555|NCT02781844|157458846|FG007|Treatment Period 1|Adverse Event|0|||
48896556|NCT03010176|157458847|FG000|Overall Study|Death|21|||
48896557|NCT03010176|157458848|FG001|Overall Study|Death|35|||
48896558|NCT03010176|157458849|FG002|Overall Study|Death|19|||
48896559|NCT03010176|157458850|FG003|Overall Study|Death|19|||
48896560|NCT03010176|157458851|FG004|Overall Study|Death|14|||
48896561|NCT03010176|157458852|FG005|Overall Study|Death|0|||
48896562|NCT03010176|157458847|FG000|Overall Study|Lost to Follow-up|0|||
48896563|NCT03010176|157458848|FG001|Overall Study|Lost to Follow-up|0|||
48896564|NCT03010176|157458849|FG002|Overall Study|Lost to Follow-up|0|||
48896565|NCT03010176|157458850|FG003|Overall Study|Lost to Follow-up|0|||
48896566|NCT03010176|157458851|FG004|Overall Study|Lost to Follow-up|1|||
48896567|NCT03010176|157458852|FG005|Overall Study|Lost to Follow-up|0|||
48896568|NCT03010176|157458847|FG000|Overall Study|Physician Decision|0|||
48896569|NCT03010176|157458848|FG001|Overall Study|Physician Decision|4|||
48896570|NCT03010176|157458849|FG002|Overall Study|Physician Decision|0|||
48896571|NCT03010176|157458850|FG003|Overall Study|Physician Decision|1|||
48896572|NCT03010176|157458851|FG004|Overall Study|Physician Decision|0|||
48896573|NCT03010176|157458852|FG005|Overall Study|Physician Decision|0|||
48896574|NCT03010176|157458847|FG000|Overall Study|Sponsor Decision|0|||
48896575|NCT03010176|157458848|FG001|Overall Study|Sponsor Decision|4|||
48896576|NCT03010176|157458849|FG002|Overall Study|Sponsor Decision|4|||
48896577|NCT03010176|157458850|FG003|Overall Study|Sponsor Decision|1|||
48896578|NCT03010176|157458851|FG004|Overall Study|Sponsor Decision|6|||
48896579|NCT03010176|157458852|FG005|Overall Study|Sponsor Decision|0|||
48896580|NCT03010176|157458847|FG000|Overall Study|Withdrawal by Subject|11|||
48896581|NCT03010176|157458848|FG001|Overall Study|Withdrawal by Subject|9|||
48896582|NCT03010176|157458849|FG002|Overall Study|Withdrawal by Subject|3|||
48896583|NCT03010176|157458850|FG003|Overall Study|Withdrawal by Subject|0|||
48896584|NCT03010176|157458851|FG004|Overall Study|Withdrawal by Subject|4|||
48896585|NCT03010176|157458852|FG005|Overall Study|Withdrawal by Subject|0|||
48896586|NCT04275089|157458853|FG000|Overall Study|Unable to be fit with Reia pessary|1|||
48896587|NCT01878214|157458860|FG000|Overall Study|Withdrawal by Subject|18|||
48896588|NCT01878214|157458861|FG001|Overall Study|Withdrawal by Subject|7|||
48896589|NCT01878214|157458860|FG000|Overall Study|Death|0|||
48896590|NCT01878214|157458861|FG001|Overall Study|Death|1|||
48896591|NCT01878214|157458860|FG000|Overall Study|Lost to Follow-up|35|||
48896592|NCT01878214|157458861|FG001|Overall Study|Lost to Follow-up|36|||
48896593|NCT03038438|157458864|FG000|Overall Study|Death|3|||
48896594|NCT03038438|157458864|FG000|Overall Study|Lost to Follow-up|8|||
48896595|NCT03038438|157458864|FG000|Overall Study|Subject Incarcerated, Moved, or Refused|4|||
48896596|NCT03038438|157458864|FG000|Overall Study|Withdrawal by Subject|5|||
48896597|NCT03038438|157458864|FG000|Overall Study|No 36-Month Follow-Up|18|||
48896598|NCT02313233|157458865|FG000|Overall Study|Withdrawal by Subject|1|||
48896599|NCT02313233|157458866|FG001|Overall Study|Withdrawal by Subject|2|||
48896600|NCT02313233|157458865|FG000|Overall Study|Administrative reason|1|||
48896601|NCT02313233|157458866|FG001|Overall Study|Administrative reason|1|||
48896602|NCT00069108|157458867|FG000|Overall Study|Withdrawal by Subject|5|||
48896603|NCT00069108|157458868|FG001|Overall Study|Withdrawal by Subject|9|||
48896604|NCT00069108|157458867|FG000|Overall Study|Adverse Event|64|||
48896605|NCT00069108|157458868|FG001|Overall Study|Adverse Event|42|||
48896606|NCT00069108|157458867|FG000|Overall Study|Death|6|||
48896607|NCT00069108|157458868|FG001|Overall Study|Death|6|||
48896608|NCT00069108|157458867|FG000|Overall Study|Administration|15|||
48896609|NCT00069108|157458868|FG001|Overall Study|Administration|4|||
48896610|NCT00069108|157458867|FG000|Overall Study|Insufficient therapy|117|||
48896611|NCT00069108|157458868|FG001|Overall Study|Insufficient therapy|144|||
48896612|NCT00069108|157458867|FG000|Overall Study|Violation criteria|1|||
48896613|NCT00069108|157458868|FG001|Overall Study|Violation criteria|4|||
48896614|NCT00069108|157458867|FG000|Overall Study|Refused treatment|5|||
48896615|NCT00069108|157458868|FG001|Overall Study|Refused treatment|10|||
48896616|NCT01065844|157458869|FG000|Overall Study|Adverse Event|5|||
48896617|NCT00468104|157458870|FG000|First Intervention|Protocol Violation|2|||
48896618|NCT00468104|157458871|FG001|First Intervention|Protocol Violation|1|||
48896619|NCT00468104|157458870|FG000|First Intervention|bleeding at chest tube site--first dose|1|||
48896620|NCT00468104|157458871|FG001|First Intervention|bleeding at chest tube site--first dose|0|||
48896621|NCT00468104|157458870|FG000|First Intervention|died within 3 weeks|1|||
49039012|NCT00958724|157978817|FG000|Overall Study|Disease Progression|6|||
49039013|NCT05604014|157978818|FG000|Overall Study|Lost to Follow-up|13|||
49039014|NCT04567329|157978836|FG000|Overall Study|Withdrawal by Subject|5|||
49039015|NCT04567329|157978837|FG001|Overall Study|Withdrawal by Subject|6|||
48896622|NCT00468104|157458871|FG001|First Intervention|died within 3 weeks|0|||
48896623|NCT00468104|157458870|FG000|First Intervention|malposition/blocked chest tube tube|2|||
48896624|NCT00468104|157458871|FG001|First Intervention|malposition/blocked chest tube tube|0|||
48896625|NCT00468104|157458870|FG000|First Intervention|large lung mass with minimal effusion|1|||
48896626|NCT00468104|157458871|FG001|First Intervention|large lung mass with minimal effusion|0|||
48896627|NCT00468104|157458870|FG000|First Intervention|associated prolonged pneumothorax|1|||
48896628|NCT00468104|157458871|FG001|First Intervention|associated prolonged pneumothorax|0|||
48896629|NCT00468104|157458870|FG000|First Intervention|trapped lung|1|||
48896630|NCT00468104|157458871|FG001|First Intervention|trapped lung|0|||
48896631|NCT00468104|157458870|FG000|Second Intervention|Withdrawal by Subject|5|||
48896632|NCT00468104|157458871|FG001|Second Intervention|Withdrawal by Subject|2|||
48896633|NCT00468104|157458870|FG000|Second Intervention|discarded for malposition of chest tube|0|||
48896634|NCT00468104|157458871|FG001|Second Intervention|discarded for malposition of chest tube|2|||
48896635|NCT01263665|157458872|FG000|Overall Study|Withdrew Consent|1|||
48896636|NCT01263665|157458872|FG000|Overall Study|Lost to Follow-up|3|||
49039016|NCT04567329|157978836|FG000|Overall Study|Protocol Violation|2|||
49039017|NCT04567329|157978837|FG001|Overall Study|Protocol Violation|3|||
49039018|NCT04567329|157978836|FG000|Overall Study|Discontinued|2|||
49039019|NCT04567329|157978837|FG001|Overall Study|Discontinued|2|||
49039020|NCT04567329|157978836|FG000|Overall Study|Lost to Follow-up|0|||
49039021|NCT04567329|157978837|FG001|Overall Study|Lost to Follow-up|1|||
49039022|NCT04567329|157978836|FG000|Overall Study|Lack of Efficacy|0|||
49039023|NCT04567329|157978837|FG001|Overall Study|Lack of Efficacy|1|||
49039024|NCT04281472|157978838|FG000|Stage A|Lack of Efficacy|8|||
49039025|NCT04281472|157978839|FG001|Stage A|Lack of Efficacy|0|||
49039026|NCT04281472|157978840|FG002|Stage A|Lack of Efficacy|0|||
49039027|NCT04281472|157978838|FG000|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|22|||
49039028|NCT04281472|157978839|FG001|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
49039029|NCT04281472|157978840|FG002|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
49039030|NCT04281472|157978838|FG000|Stage A|Adverse Event|20|||
49039031|NCT04281472|157978839|FG001|Stage A|Adverse Event|0|||
49039032|NCT04281472|157978840|FG002|Stage A|Adverse Event|0|||
49039033|NCT04281472|157978838|FG000|Stage A|Death|1|||
49039034|NCT04281472|157978839|FG001|Stage A|Death|0|||
49039035|NCT04281472|157978840|FG002|Stage A|Death|0|||
49039036|NCT04281472|157978838|FG000|Stage A|Lack of efficacy before end of Stage A|28|||
49039037|NCT04281472|157978839|FG001|Stage A|Lack of efficacy before end of Stage A|0|||
49039038|NCT04281472|157978840|FG002|Stage A|Lack of efficacy before end of Stage A|0|||
49039039|NCT04281472|157978838|FG000|Stage A|Lost to Follow-up|2|||
49039040|NCT04281472|157978839|FG001|Stage A|Lost to Follow-up|0|||
49039041|NCT04281472|157978840|FG002|Stage A|Lost to Follow-up|0|||
49039042|NCT04281472|157978838|FG000|Stage A|Non-compliance with study drug|1|||
49039043|NCT04281472|157978839|FG001|Stage A|Non-compliance with study drug|0|||
49039044|NCT04281472|157978840|FG002|Stage A|Non-compliance with study drug|0|||
49039045|NCT04281472|157978838|FG000|Stage A|Physician Decision|1|||
49039046|NCT04281472|157978839|FG001|Stage A|Physician Decision|0|||
49039047|NCT04281472|157978840|FG002|Stage A|Physician Decision|0|||
49039048|NCT04281472|157978838|FG000|Stage A|Prohibited medications|2|||
49039049|NCT04281472|157978839|FG001|Stage A|Prohibited medications|0|||
49039050|NCT04281472|157978840|FG002|Stage A|Prohibited medications|0|||
49039051|NCT04281472|157978838|FG000|Stage A|Withdrawal by Subject|11|||
49039052|NCT04281472|157978839|FG001|Stage A|Withdrawal by Subject|0|||
49039053|NCT04281472|157978840|FG002|Stage A|Withdrawal by Subject|0|||
48896637|NCT01263665|157458872|FG000|Overall Study|Death|2|||
48896638|NCT01263665|157458872|FG000|Overall Study|Amputation above the ankle|1|||
48896639|NCT01263665|157458872|FG000|Overall Study|Surgical Bypass|2|||
49039054|NCT04281472|157978838|FG000|Stage A|Other|5|||
49039055|NCT04281472|157978839|FG001|Stage A|Other|0|||
49039056|NCT04281472|157978840|FG002|Stage A|Other|0|||
49039057|NCT04281472|157978838|FG000|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
49039058|NCT04281472|157978839|FG001|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|35|||
49039059|NCT04281472|157978840|FG002|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|26|||
49039060|NCT04281472|157978838|FG000|Stage B|Adverse Event|0|||
49039061|NCT04281472|157978839|FG001|Stage B|Adverse Event|3|||
48896640|NCT01415531|157458873|FG000|Overall Study|Adverse Event|7|||
48896641|NCT01415531|157458874|FG001|Overall Study|Adverse Event|10|||
49039062|NCT04281472|157978840|FG002|Stage B|Adverse Event|0|||
48896642|NCT01415531|157458873|FG000|Overall Study|Lack of Efficacy|3|||
48896643|NCT01415531|157458874|FG001|Overall Study|Lack of Efficacy|2|||
48896644|NCT01415531|157458873|FG000|Overall Study|Protocol Violation|0|||
48896645|NCT01415531|157458874|FG001|Overall Study|Protocol Violation|1|||
48896646|NCT01415531|157458873|FG000|Overall Study|Withdrawal by Subject|5|||
48896647|NCT01415531|157458874|FG001|Overall Study|Withdrawal by Subject|4|||
48896648|NCT01415531|157458873|FG000|Overall Study|Lost to Follow-up|6|||
48896649|NCT01415531|157458874|FG001|Overall Study|Lost to Follow-up|14|||
48896650|NCT01415531|157458873|FG000|Overall Study|Lack of Compliance|1|||
48896651|NCT01415531|157458874|FG001|Overall Study|Lack of Compliance|4|||
48896652|NCT01415531|157458873|FG000|Overall Study|Other Reasons|3|||
48896653|NCT01415531|157458874|FG001|Overall Study|Other Reasons|2|||
48896654|NCT02128542|157458875|FG000|Overall Study|Lost to Follow-up|3|||
48896655|NCT02128542|157458876|FG001|Overall Study|Lost to Follow-up|0|||
48896656|NCT02128542|157458875|FG000|Overall Study|Withdrew Consent|1|||
48896657|NCT02128542|157458876|FG001|Overall Study|Withdrew Consent|0|||
49039063|NCT04281472|157978838|FG000|Stage B|Death|0|||
49039064|NCT04281472|157978839|FG001|Stage B|Death|0|||
49039065|NCT04281472|157978840|FG002|Stage B|Death|1|||
49039066|NCT04281472|157978838|FG000|Stage B|Lack of Efficacy|0|||
49039067|NCT04281472|157978839|FG001|Stage B|Lack of Efficacy|0|||
49039068|NCT04281472|157978840|FG002|Stage B|Lack of Efficacy|1|||
49039069|NCT04281472|157978838|FG000|Stage B|Lost to Follow-up|0|||
49039070|NCT04281472|157978839|FG001|Stage B|Lost to Follow-up|0|||
49039071|NCT04281472|157978840|FG002|Stage B|Lost to Follow-up|2|||
49039072|NCT04281472|157978838|FG000|Stage B|Prohibited medications|0|||
49039073|NCT04281472|157978839|FG001|Stage B|Prohibited medications|2|||
49039074|NCT04281472|157978840|FG002|Stage B|Prohibited medications|1|||
49039075|NCT04281472|157978838|FG000|Stage B|Protocol Violation|0|||
49039076|NCT04281472|157978839|FG001|Stage B|Protocol Violation|1|||
49039077|NCT04281472|157978840|FG002|Stage B|Protocol Violation|1|||
49039078|NCT04281472|157978838|FG000|Stage B|Sponsor decision|0|||
49039079|NCT04281472|157978839|FG001|Stage B|Sponsor decision|0|||
49039080|NCT04281472|157978840|FG002|Stage B|Sponsor decision|1|||
49039081|NCT04281472|157978838|FG000|Stage B|Withdrawal by Subject|0|||
49039082|NCT04281472|157978839|FG001|Stage B|Withdrawal by Subject|3|||
49039083|NCT04281472|157978840|FG002|Stage B|Withdrawal by Subject|3|||
49039084|NCT04281472|157978838|FG000|Stage B|Other|0|||
49039085|NCT04281472|157978839|FG001|Stage B|Other|3|||
49039086|NCT04281472|157978840|FG002|Stage B|Other|0|||
49039087|NCT02957331|157978843|FG000|Overall Study|Protocol Violation|1|||
49039088|NCT02957331|157978844|FG001|Overall Study|Protocol Violation|0|||
49039089|NCT02426918|157978845|FG000|Overall Study|Adverse Event|2|||
49039090|NCT02426918|157978846|FG001|Overall Study|Adverse Event|2|||
48896668|NCT01941719|157458880|FG000|Overall Study|Lost to Follow-up|20|||
48896669|NCT01941719|157458881|FG001|Overall Study|Lost to Follow-up|19|||
48896670|NCT01506609|157458882|FG000|Overall Study|Adverse Event Related to Progression|0|||
48896671|NCT01506609|157458883|FG001|Overall Study|Adverse Event Related to Progression|0|||
48896672|NCT01506609|157458884|FG002|Overall Study|Adverse Event Related to Progression|0|||
48896673|NCT01506609|157458885|FG003|Overall Study|Adverse Event Related to Progression|3|||
48896674|NCT01506609|157458886|FG004|Overall Study|Adverse Event Related to Progression|7|||
48896675|NCT01506609|157458887|FG005|Overall Study|Adverse Event Related to Progression|3|||
48896676|NCT01506609|157458882|FG000|Overall Study|Adverse Event Not Related to Progression|0|||
48896677|NCT01506609|157458883|FG001|Overall Study|Adverse Event Not Related to Progression|1|||
49039091|NCT02426918|157978847|FG002|Overall Study|Adverse Event|0|||
49039092|NCT02426918|157978845|FG000|Overall Study|Physician Decision|1|||
49039093|NCT02426918|157978846|FG001|Overall Study|Physician Decision|1|||
48896678|NCT01506609|157458884|FG002|Overall Study|Adverse Event Not Related to Progression|0|||
49039094|NCT02426918|157978847|FG002|Overall Study|Physician Decision|1|||
48896679|NCT01506609|157458885|FG003|Overall Study|Adverse Event Not Related to Progression|6|||
48896680|NCT01506609|157458886|FG004|Overall Study|Adverse Event Not Related to Progression|10|||
49039095|NCT02426918|157978845|FG000|Overall Study|Withdrawal by Subject|5|||
49039096|NCT02426918|157978846|FG001|Overall Study|Withdrawal by Subject|5|||
49039097|NCT02426918|157978847|FG002|Overall Study|Withdrawal by Subject|4|||
49039098|NCT02426918|157978845|FG000|Overall Study|Other|9|||
49039099|NCT02426918|157978846|FG001|Overall Study|Other|11|||
49039100|NCT02426918|157978847|FG002|Overall Study|Other|9|||
49039101|NCT01496118|157978848|FG000|Overall Study|Disease progression|3|||
49039102|NCT01496118|157978849|FG001|Overall Study|Disease progression|2|||
49039103|NCT01496118|157978850|FG002|Overall Study|Disease progression|3|||
49039104|NCT01496118|157978851|FG003|Overall Study|Disease progression|1|||
49039105|NCT01496118|157978852|FG004|Overall Study|Disease progression|2|||
49039106|NCT01496118|157978853|FG005|Overall Study|Disease progression|2|||
49039107|NCT01496118|157978854|FG006|Overall Study|Disease progression|14|||
49039108|NCT01496118|157978855|FG007|Overall Study|Disease progression|10|||
49039109|NCT01496118|157978848|FG000|Overall Study|Physician Decision|0|||
48896681|NCT01506609|157458887|FG005|Overall Study|Adverse Event Not Related to Progression|5|||
48896682|NCT01506609|157458882|FG000|Overall Study|Withdrawal by Subject|0|||
48896683|NCT01506609|157458883|FG001|Overall Study|Withdrawal by Subject|0|||
48896684|NCT01506609|157458884|FG002|Overall Study|Withdrawal by Subject|0|||
48896685|NCT01506609|157458885|FG003|Overall Study|Withdrawal by Subject|9|||
48896686|NCT01506609|157458886|FG004|Overall Study|Withdrawal by Subject|7|||
48896687|NCT01506609|157458887|FG005|Overall Study|Withdrawal by Subject|7|||
48896688|NCT01506609|157458882|FG000|Overall Study|Lost to Follow-up|0|||
48896689|NCT01506609|157458883|FG001|Overall Study|Lost to Follow-up|0|||
48896690|NCT01506609|157458884|FG002|Overall Study|Lost to Follow-up|0|||
48896691|NCT01506609|157458885|FG003|Overall Study|Lost to Follow-up|1|||
48896692|NCT01506609|157458886|FG004|Overall Study|Lost to Follow-up|2|||
48896693|NCT01506609|157458887|FG005|Overall Study|Lost to Follow-up|0|||
48896694|NCT01506609|157458882|FG000|Overall Study|Sponsor Discontinued Study|0|||
48896695|NCT01506609|157458883|FG001|Overall Study|Sponsor Discontinued Study|0|||
48896696|NCT01506609|157458884|FG002|Overall Study|Sponsor Discontinued Study|0|||
48896697|NCT01506609|157458885|FG003|Overall Study|Sponsor Discontinued Study|2|||
48896698|NCT01506609|157458886|FG004|Overall Study|Sponsor Discontinued Study|2|||
48896699|NCT01506609|157458887|FG005|Overall Study|Sponsor Discontinued Study|0|||
48896700|NCT01506609|157458882|FG000|Overall Study|Progressive Disease per Protocol|1|||
48896701|NCT01506609|157458883|FG001|Overall Study|Progressive Disease per Protocol|0|||
48896702|NCT01506609|157458884|FG002|Overall Study|Progressive Disease per Protocol|0|||
48896703|NCT01506609|157458885|FG003|Overall Study|Progressive Disease per Protocol|64|||
48896704|NCT01506609|157458886|FG004|Overall Study|Progressive Disease per Protocol|57|||
49039110|NCT01496118|157978849|FG001|Overall Study|Physician Decision|0|||
49039111|NCT01496118|157978850|FG002|Overall Study|Physician Decision|0|||
49039112|NCT01496118|157978851|FG003|Overall Study|Physician Decision|0|||
49039113|NCT01496118|157978852|FG004|Overall Study|Physician Decision|1|||
49039114|NCT01496118|157978853|FG005|Overall Study|Physician Decision|0|||
49039115|NCT01496118|157978854|FG006|Overall Study|Physician Decision|3|||
49039116|NCT01496118|157978855|FG007|Overall Study|Physician Decision|6|||
49039117|NCT01496118|157978848|FG000|Overall Study|Adverse Event|1|||
49039118|NCT01496118|157978849|FG001|Overall Study|Adverse Event|1|||
49039119|NCT01496118|157978850|FG002|Overall Study|Adverse Event|0|||
49039120|NCT01496118|157978851|FG003|Overall Study|Adverse Event|0|||
49039121|NCT01496118|157978852|FG004|Overall Study|Adverse Event|0|||
49039122|NCT01496118|157978853|FG005|Overall Study|Adverse Event|0|||
49039123|NCT01496118|157978854|FG006|Overall Study|Adverse Event|6|||
49039124|NCT01496118|157978855|FG007|Overall Study|Adverse Event|10|||
49039125|NCT01496118|157978848|FG000|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
49039126|NCT01496118|157978849|FG001|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
49039127|NCT01496118|157978850|FG002|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
49039128|NCT01496118|157978851|FG003|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
49039129|NCT01496118|157978852|FG004|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
49039130|NCT01496118|157978853|FG005|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
49039131|NCT01496118|157978854|FG006|Overall Study|Conditions requiring other treatment not permitted by protocol|1|||
49039132|NCT01496118|157978855|FG007|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
49039133|NCT01496118|157978848|FG000|Overall Study|Death|0|||
49039134|NCT01496118|157978849|FG001|Overall Study|Death|0|||
49039135|NCT01496118|157978850|FG002|Overall Study|Death|0|||
49039136|NCT01496118|157978851|FG003|Overall Study|Death|0|||
49039137|NCT01496118|157978852|FG004|Overall Study|Death|0|||
49039138|NCT01496118|157978853|FG005|Overall Study|Death|0|||
49039139|NCT01496118|157978854|FG006|Overall Study|Death|1|||
49039140|NCT01496118|157978855|FG007|Overall Study|Death|1|||
48896705|NCT01506609|157458887|FG005|Overall Study|Progressive Disease per Protocol|74|||
48896706|NCT01506609|157458882|FG000|Overall Study|Other, Not Specified|0|||
48896707|NCT01506609|157458883|FG001|Overall Study|Other, Not Specified|0|||
48896708|NCT01506609|157458884|FG002|Overall Study|Other, Not Specified|0|||
49039141|NCT01496118|157978848|FG000|Overall Study|Withdrawal by Subject|0|||
49039142|NCT01496118|157978849|FG001|Overall Study|Withdrawal by Subject|0|||
49039143|NCT01496118|157978850|FG002|Overall Study|Withdrawal by Subject|0|||
49039144|NCT01496118|157978851|FG003|Overall Study|Withdrawal by Subject|2|||
49039145|NCT01496118|157978852|FG004|Overall Study|Withdrawal by Subject|0|||
49039146|NCT01496118|157978853|FG005|Overall Study|Withdrawal by Subject|1|||
48896709|NCT01506609|157458885|FG003|Overall Study|Other, Not Specified|10|||
48896710|NCT01506609|157458886|FG004|Overall Study|Other, Not Specified|7|||
48896711|NCT01506609|157458887|FG005|Overall Study|Other, Not Specified|3|||
48896712|NCT01506609|157458882|FG000|Overall Study|Missing / Unknown Reason|1|||
49039147|NCT01496118|157978854|FG006|Overall Study|Withdrawal by Subject|6|||
48896713|NCT01506609|157458883|FG001|Overall Study|Missing / Unknown Reason|0|||
48896714|NCT01506609|157458884|FG002|Overall Study|Missing / Unknown Reason|1|||
48896715|NCT01506609|157458885|FG003|Overall Study|Missing / Unknown Reason|4|||
48896716|NCT01506609|157458886|FG004|Overall Study|Missing / Unknown Reason|4|||
48896717|NCT01506609|157458887|FG005|Overall Study|Missing / Unknown Reason|2|||
48896718|NCT00252577|157458888|FG000|Overall Study|Lost to Follow-up|20|||
48896719|NCT00577473|157458889|FG000|Overall Study|Protocol Violation|1|||
48896720|NCT00577473|157458890|FG001|Overall Study|Protocol Violation|4|||
48896721|NCT00577473|157458889|FG000|Overall Study|Adverse Event|8|||
48896722|NCT00577473|157458890|FG001|Overall Study|Adverse Event|5|||
48896723|NCT00577473|157458889|FG000|Overall Study|Withdrawal by Subject|2|||
48896724|NCT00577473|157458890|FG001|Overall Study|Withdrawal by Subject|6|||
48896725|NCT00577473|157458889|FG000|Overall Study|Physician Decision|2|||
48896726|NCT00577473|157458890|FG001|Overall Study|Physician Decision|2|||
48896727|NCT00577473|157458889|FG000|Overall Study|Lack of Efficacy|8|||
48896728|NCT00577473|157458890|FG001|Overall Study|Lack of Efficacy|7|||
48896729|NCT02962960|157458895|FG000|Overall Study|Withdrawal by Subject|1|||
48896730|NCT02962960|157458896|FG001|Overall Study|Withdrawal by Subject|1|||
48896731|NCT02962960|157458897|FG002|Overall Study|Withdrawal by Subject|0|||
48896732|NCT02962960|157458895|FG000|Overall Study|Adverse Event|1|||
48896733|NCT02962960|157458896|FG001|Overall Study|Adverse Event|1|||
48896734|NCT02962960|157458897|FG002|Overall Study|Adverse Event|0|||
48896735|NCT02962960|157458895|FG000|Overall Study|Protocol Violation|1|||
48896736|NCT02962960|157458896|FG001|Overall Study|Protocol Violation|0|||
48896737|NCT02962960|157458897|FG002|Overall Study|Protocol Violation|0|||
48896738|NCT00842985|157458898|FG000|Screening|Did not meet entrance requirements|27|||
48896739|NCT00842985|157458898|FG000|First Intervention|Withdrawal by Subject|3|||
48896740|NCT00842985|157458898|FG000|First Intervention|Protocol Violation|3|||
48896741|NCT00842985|157458898|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
48896742|NCT00842985|157458898|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
48896743|NCT02413333|157458899|FG000|Period 1|Adverse Event|1|||
48896744|NCT02413333|157458900|FG001|Period 1|Adverse Event|0|||
48896745|NCT02413333|157458899|FG000|Period 1|Reason Not Specified|0|||
48896746|NCT02413333|157458900|FG001|Period 1|Reason Not Specified|1|||
48896747|NCT02413333|157458899|FG000|Period 2|Protocol Deviation|1|||
48896748|NCT02413333|157458900|FG001|Period 2|Protocol Deviation|0|||
48896749|NCT01815138|157458901|FG000|Overall Study|Withdrawal by Subject|0|||
48896750|NCT01815138|157458902|FG001|Overall Study|Withdrawal by Subject|1|||
48896751|NCT01815138|157458901|FG000|Overall Study|Physician Decision|8|||
48896752|NCT01815138|157458902|FG001|Overall Study|Physician Decision|5|||
48896753|NCT01011387|157458904|FG000|Overall Study|Withdrawal by Subject|3|||
48896754|NCT01011387|157458904|FG000|Overall Study|Adverse Event|2|||
48896755|NCT01011387|157458904|FG000|Overall Study|Protocol Violation|1|||
48896756|NCT00757783|157458905|FG000|Overall Study|Adverse Event|0|||
48896757|NCT00757783|157458906|FG001|Overall Study|Adverse Event|2|||
48896758|NCT00757783|157458905|FG000|Overall Study|Lost to Follow-up|1|||
48896759|NCT00757783|157458906|FG001|Overall Study|Lost to Follow-up|1|||
48896760|NCT00757783|157458905|FG000|Overall Study|Protocol Violation|1|||
48896761|NCT00757783|157458906|FG001|Overall Study|Protocol Violation|0|||
48896762|NCT00757783|157458905|FG000|Overall Study|Withdrawal by Subject|2|||
48896763|NCT00757783|157458906|FG001|Overall Study|Withdrawal by Subject|1|||
48896764|NCT00757783|157458905|FG000|Overall Study|Other|1|||
48896765|NCT00757783|157458906|FG001|Overall Study|Other|2|||
48896766|NCT02054520|157458907|FG000|Overall Study|Adverse Event|1|||
48896767|NCT02054520|157458908|FG001|Overall Study|Adverse Event|4|||
49039148|NCT01496118|157978855|FG007|Overall Study|Withdrawal by Subject|3|||
49039149|NCT02845336|157978856|FG000|Overall Study|Lost to Follow-up|3|||
49039150|NCT02845336|157978857|FG001|Overall Study|Lost to Follow-up|1|||
49039151|NCT02845336|157978856|FG000|Overall Study|Inability to get medication|2|||
49039152|NCT02845336|157978857|FG001|Overall Study|Inability to get medication|0|||
49039153|NCT03488108|157978859|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
48896768|NCT02054520|157458909|FG002|Overall Study|Adverse Event|2|||
48896769|NCT02054520|157458910|FG003|Overall Study|Adverse Event|1|||
48896770|NCT02054520|157458911|FG004|Overall Study|Adverse Event|1|||
48896771|NCT02054520|157458912|FG005|Overall Study|Adverse Event|0|||
49039154|NCT03488108|157978860|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
49039155|NCT03488108|157978859|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
48896772|NCT02054520|157458907|FG000|Overall Study|Lack of Efficacy|7|||
48896773|NCT02054520|157458908|FG001|Overall Study|Lack of Efficacy|0|||
48896774|NCT02054520|157458909|FG002|Overall Study|Lack of Efficacy|2|||
48896775|NCT02054520|157458910|FG003|Overall Study|Lack of Efficacy|1|||
48896776|NCT02054520|157458911|FG004|Overall Study|Lack of Efficacy|3|||
48896777|NCT02054520|157458912|FG005|Overall Study|Lack of Efficacy|2|||
49039156|NCT03488108|157978860|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
48896778|NCT02054520|157458907|FG000|Overall Study|Withdrawal by Subject|1|||
48896779|NCT02054520|157458908|FG001|Overall Study|Withdrawal by Subject|0|||
48896780|NCT02054520|157458909|FG002|Overall Study|Withdrawal by Subject|0|||
48896781|NCT02054520|157458910|FG003|Overall Study|Withdrawal by Subject|2|||
48896782|NCT02054520|157458911|FG004|Overall Study|Withdrawal by Subject|1|||
48896783|NCT02054520|157458912|FG005|Overall Study|Withdrawal by Subject|0|||
48896784|NCT02054520|157458907|FG000|Overall Study|Physician Decision|0|||
48896785|NCT02054520|157458908|FG001|Overall Study|Physician Decision|1|||
48896786|NCT02054520|157458909|FG002|Overall Study|Physician Decision|0|||
48896787|NCT02054520|157458910|FG003|Overall Study|Physician Decision|1|||
48896788|NCT02054520|157458911|FG004|Overall Study|Physician Decision|0|||
48896789|NCT02054520|157458912|FG005|Overall Study|Physician Decision|1|||
48896790|NCT02054520|157458907|FG000|Overall Study|Study terminated by Sponsor|0|||
49039157|NCT02420353|157978867|FG000|Overall Study|Withdrawal by Subject|0|||
49039158|NCT02420353|157978868|FG001|Overall Study|Withdrawal by Subject|1|||
49039159|NCT01943435|157978882|FG000|Baseline Eligibility and Randomization|Withdrawal by Subject|4|||
49039160|NCT01943435|157978883|FG001|Baseline Eligibility and Randomization|Withdrawal by Subject|12|||
49039161|NCT01943435|157978884|FG002|Baseline Eligibility and Randomization|Withdrawal by Subject|3|||
49039162|NCT01943435|157978882|FG000|Intervention Period|Withdrawal by Subject|3|||
49039163|NCT01943435|157978883|FG001|Intervention Period|Withdrawal by Subject|3|||
49039164|NCT01943435|157978884|FG002|Intervention Period|Withdrawal by Subject|4|||
49039165|NCT01943435|157978882|FG000|2 Month Follow up|Lost to Follow-up|2|||
49039166|NCT01943435|157978883|FG001|2 Month Follow up|Lost to Follow-up|3|||
48896791|NCT02054520|157458908|FG001|Overall Study|Study terminated by Sponsor|0|||
48896792|NCT02054520|157458909|FG002|Overall Study|Study terminated by Sponsor|2|||
48896793|NCT02054520|157458910|FG003|Overall Study|Study terminated by Sponsor|1|||
48896794|NCT02054520|157458911|FG004|Overall Study|Study terminated by Sponsor|0|||
48896795|NCT02054520|157458912|FG005|Overall Study|Study terminated by Sponsor|0|||
48896796|NCT00985946|157458917|FG000|Overall Study|Lost to Follow-up|6|||
48896797|NCT00985946|157458917|FG000|Overall Study|Withdrawal by Subject|1|||
48896798|NCT03801915|157458918|FG000|Overall Study|Screen failure|0|||
48896799|NCT03801915|157458919|FG001|Overall Study|Screen failure|0|||
48896800|NCT03801915|157458920|FG002|Overall Study|Screen failure|1|||
48896801|NCT03801915|157458918|FG000|Overall Study|Ineligible|1|||
48896802|NCT03801915|157458919|FG001|Overall Study|Ineligible|0|||
48896803|NCT03801915|157458920|FG002|Overall Study|Ineligible|0|||
48896804|NCT03801915|157458918|FG000|Overall Study|Physician Decision|2|||
48896805|NCT03801915|157458919|FG001|Overall Study|Physician Decision|1|||
48896806|NCT03801915|157458920|FG002|Overall Study|Physician Decision|0|||
48896807|NCT00446992|157458923|FG000|Overall Study|Adverse Event|11|||
48896808|NCT00446992|157458923|FG000|Overall Study|Lost to Follow-up|5|||
48896809|NCT00505284|157458928|FG000|Overall Study|Adverse Event|3|||
48896810|NCT00505284|157458929|FG001|Overall Study|Adverse Event|7|||
48896811|NCT00505284|157458930|FG002|Overall Study|Adverse Event|9|||
48896812|NCT00505284|157458931|FG003|Overall Study|Adverse Event|14|||
48896813|NCT00505284|157458932|FG004|Overall Study|Adverse Event|22|||
48896814|NCT00505284|157458928|FG000|Overall Study|Protocol Violation|0|||
48896815|NCT00505284|157458929|FG001|Overall Study|Protocol Violation|1|||
48896816|NCT00505284|157458930|FG002|Overall Study|Protocol Violation|1|||
48896817|NCT00505284|157458931|FG003|Overall Study|Protocol Violation|0|||
48896818|NCT00505284|157458932|FG004|Overall Study|Protocol Violation|0|||
48896819|NCT00505284|157458928|FG000|Overall Study|Withdrawal by Subject|2|||
48896820|NCT00505284|157458929|FG001|Overall Study|Withdrawal by Subject|6|||
48896821|NCT00505284|157458930|FG002|Overall Study|Withdrawal by Subject|1|||
48896822|NCT00505284|157458931|FG003|Overall Study|Withdrawal by Subject|0|||
48896823|NCT00505284|157458932|FG004|Overall Study|Withdrawal by Subject|6|||
48896824|NCT00505284|157458928|FG000|Overall Study|Lack of Efficacy|0|||
48896825|NCT00505284|157458929|FG001|Overall Study|Lack of Efficacy|1|||
48896826|NCT00505284|157458930|FG002|Overall Study|Lack of Efficacy|1|||
48896827|NCT00505284|157458931|FG003|Overall Study|Lack of Efficacy|1|||
48896828|NCT00505284|157458932|FG004|Overall Study|Lack of Efficacy|1|||
48896829|NCT00505284|157458928|FG000|Overall Study|Physician Decision|0|||
48896830|NCT00505284|157458929|FG001|Overall Study|Physician Decision|1|||
48896831|NCT00505284|157458930|FG002|Overall Study|Physician Decision|0|||
48896832|NCT00505284|157458931|FG003|Overall Study|Physician Decision|0|||
49039167|NCT01943435|157978884|FG002|2 Month Follow up|Lost to Follow-up|0|||
49039168|NCT01943435|157978882|FG000|6 Month Follow up|Lost to Follow-up|12|||
48896833|NCT00505284|157458932|FG004|Overall Study|Physician Decision|0|||
48896834|NCT00505284|157458928|FG000|Overall Study|Other|5|||
48896835|NCT00505284|157458929|FG001|Overall Study|Other|0|||
48896836|NCT00505284|157458930|FG002|Overall Study|Other|0|||
48896837|NCT00505284|157458931|FG003|Overall Study|Other|4|||
48896838|NCT00505284|157458932|FG004|Overall Study|Other|4|||
48896839|NCT02075541|157458933|FG000|Overall Study|Serious Adverse Event|1|||
48896840|NCT02075541|157458934|FG001|Overall Study|Serious Adverse Event|4|||
48896841|NCT02075541|157458933|FG000|Overall Study|Protocol Violation|1|||
48896842|NCT02075541|157458934|FG001|Overall Study|Protocol Violation|0|||
48896843|NCT02075541|157458933|FG000|Overall Study|Withdrawal by Subject|1|||
48896844|NCT02075541|157458934|FG001|Overall Study|Withdrawal by Subject|3|||
49039169|NCT01943435|157978883|FG001|6 Month Follow up|Lost to Follow-up|7|||
48896845|NCT02075541|157458933|FG000|Overall Study|Sponsor study termination|0|||
48896846|NCT02075541|157458934|FG001|Overall Study|Sponsor study termination|1|||
48896847|NCT02075541|157458933|FG000|Overall Study|Other- unable to perform study procedure|1|||
48896848|NCT02075541|157458934|FG001|Overall Study|Other- unable to perform study procedure|0|||
48896849|NCT01257425|157458936|FG000|Overall Study|Lack of Efficacy|3|||
48896850|NCT01257425|157458937|FG001|Overall Study|Lack of Efficacy|3|||
48896851|NCT01257425|157458936|FG000|Overall Study|Adverse Event|1|||
48896852|NCT01257425|157458937|FG001|Overall Study|Adverse Event|1|||
48896853|NCT01257425|157458936|FG000|Overall Study|Protocol Violation|1|||
48896854|NCT01257425|157458937|FG001|Overall Study|Protocol Violation|1|||
48896855|NCT01257425|157458936|FG000|Overall Study|Withdrawal by Subject|0|||
48896856|NCT01257425|157458937|FG001|Overall Study|Withdrawal by Subject|1|||
48896857|NCT01257425|157458936|FG000|Overall Study|Death|1|||
48896858|NCT01257425|157458937|FG001|Overall Study|Death|0|||
48896859|NCT00971243|157458944|FG000|Double Blind Period|Adverse Event|2|||
48896860|NCT00971243|157458945|FG001|Double Blind Period|Adverse Event|3|||
48896861|NCT00971243|157458946|FG002|Double Blind Period|Adverse Event|2|||
48896862|NCT00971243|157458947|FG003|Double Blind Period|Adverse Event|2|||
48896863|NCT00971243|157458948|FG004|Double Blind Period|Adverse Event|3|||
48896864|NCT00971243|157458944|FG000|Double Blind Period|Lost to Follow-up|0|||
48896865|NCT00971243|157458945|FG001|Double Blind Period|Lost to Follow-up|1|||
48896866|NCT00971243|157458946|FG002|Double Blind Period|Lost to Follow-up|1|||
48896867|NCT00971243|157458947|FG003|Double Blind Period|Lost to Follow-up|0|||
48896868|NCT00971243|157458948|FG004|Double Blind Period|Lost to Follow-up|1|||
48896869|NCT00971243|157458944|FG000|Double Blind Period|Physician Decision|10|||
48896870|NCT00971243|157458945|FG001|Double Blind Period|Physician Decision|6|||
49039170|NCT01943435|157978884|FG002|6 Month Follow up|Lost to Follow-up|15|||
49039171|NCT01049581|157978887|FG000|Overall Study|Lost to Follow-up|2|||
49039172|NCT01049581|157978888|FG001|Overall Study|Lost to Follow-up|1|||
49039173|NCT03541252|157978889|FG000|Overall Study|Withdrawal by Subject|1|||
49039174|NCT03867760|157978893|FG000|Overall Study|Lost to Follow-up|2|||
48896871|NCT00971243|157458946|FG002|Double Blind Period|Physician Decision|7|||
48896872|NCT00971243|157458947|FG003|Double Blind Period|Physician Decision|6|||
48896873|NCT00971243|157458948|FG004|Double Blind Period|Physician Decision|7|||
48896874|NCT00971243|157458944|FG000|Double Blind Period|Protocol Violation|2|||
48896875|NCT00971243|157458945|FG001|Double Blind Period|Protocol Violation|0|||
48896876|NCT00971243|157458946|FG002|Double Blind Period|Protocol Violation|3|||
49039175|NCT03867760|157978894|FG001|Overall Study|Lost to Follow-up|3|||
49039176|NCT03867760|157978893|FG000|Overall Study|Withdrawal by Subject|1|||
49039177|NCT03867760|157978894|FG001|Overall Study|Withdrawal by Subject|2|||
49039178|NCT03867760|157978893|FG000|Overall Study|subject could not meet study logistics|3|||
49039179|NCT03867760|157978894|FG001|Overall Study|subject could not meet study logistics|3|||
49039180|NCT01401062|157978897|FG000|Overall Study|Death|9|||
49039181|NCT01401062|157978898|FG001|Overall Study|Death|7|||
49039182|NCT01401062|157978897|FG000|Overall Study|Physician Decision|1|||
49039183|NCT01401062|157978898|FG001|Overall Study|Physician Decision|0|||
49039184|NCT01401062|157978897|FG000|Overall Study|Withdrawal by Subject|1|||
49039185|NCT01401062|157978898|FG001|Overall Study|Withdrawal by Subject|1|||
49039186|NCT01131260|157978899|FG000|Overall Study|Randomization error|5|||
49039187|NCT01131260|157978900|FG001|Overall Study|Randomization error|1|||
49039188|NCT01131260|157978899|FG000|Overall Study|Declined to continue participation|8|||
49039189|NCT01131260|157978900|FG001|Overall Study|Declined to continue participation|13|||
49039190|NCT01131260|157978899|FG000|Overall Study|Physician Decision|22|||
49039191|NCT01131260|157978900|FG001|Overall Study|Physician Decision|24|||
49039192|NCT01131260|157978899|FG000|Overall Study|Technical problems|7|||
49039193|NCT01131260|157978900|FG001|Overall Study|Technical problems|6|||
49039194|NCT01131260|157978899|FG000|Overall Study|Staff error|2|||
49039195|NCT01131260|157978900|FG001|Overall Study|Staff error|1|||
49039196|NCT01131260|157978899|FG000|Overall Study|Ineligible|0|||
49039197|NCT01131260|157978900|FG001|Overall Study|Ineligible|2|||
49039198|NCT03555695|157978901|FG000|Overall Study|Withdrawal by Subject|1|||
49039199|NCT03555695|157978901|FG000|Overall Study|Lost to Follow-up|1|||
49039200|NCT03555695|157978901|FG000|Overall Study|appendicitis (unrelated)|1|||
49039201|NCT03555695|157978901|FG000|Overall Study|pre-existing sciatica|1|||
49039202|NCT01426854|157978902|FG000|Overall Study|Adverse Event|1|||
49039203|NCT01426854|157978903|FG001|Overall Study|Adverse Event|5|||
49039204|NCT01426854|157978902|FG000|Overall Study|Subject Decision Unrelated to AE|5|||
49039205|NCT01426854|157978903|FG001|Overall Study|Subject Decision Unrelated to AE|6|||
49039206|NCT01426854|157978902|FG000|Overall Study|Lost to Follow-up|3|||
49039207|NCT01426854|157978903|FG001|Overall Study|Lost to Follow-up|0|||
49039208|NCT01426854|157978902|FG000|Overall Study|Noncompliance|0|||
49039209|NCT01426854|157978903|FG001|Overall Study|Noncompliance|1|||
48896877|NCT00971243|157458947|FG003|Double Blind Period|Protocol Violation|2|||
48896878|NCT00971243|157458948|FG004|Double Blind Period|Protocol Violation|2|||
49039210|NCT01426854|157978902|FG000|Overall Study|Treatment Failure|0|||
49039211|NCT01426854|157978903|FG001|Overall Study|Treatment Failure|16|||
49039212|NCT01426854|157978902|FG000|Overall Study|Protocol Deviation|0|||
48896879|NCT00971243|157458944|FG000|Double Blind Period|Withdrawal by Subject|4|||
49039213|NCT01426854|157978903|FG001|Overall Study|Protocol Deviation|1|||
49039214|NCT01426854|157978902|FG000|Overall Study|Other|3|||
49039215|NCT01426854|157978903|FG001|Overall Study|Other|2|||
49039216|NCT02286466|157978907|FG000|Overall Study|Death|1|||
49039217|NCT02286466|157978908|FG001|Overall Study|Death|3|||
48896880|NCT00971243|157458945|FG001|Double Blind Period|Withdrawal by Subject|1|||
48896881|NCT00971243|157458946|FG002|Double Blind Period|Withdrawal by Subject|4|||
48896882|NCT00971243|157458947|FG003|Double Blind Period|Withdrawal by Subject|4|||
48896883|NCT00971243|157458948|FG004|Double Blind Period|Withdrawal by Subject|4|||
48896884|NCT00971243|157458944|FG000|Double Blind Period|Other reasons|1|||
48896885|NCT00971243|157458945|FG001|Double Blind Period|Other reasons|0|||
48896886|NCT00971243|157458946|FG002|Double Blind Period|Other reasons|2|||
48896887|NCT00971243|157458947|FG003|Double Blind Period|Other reasons|0|||
48896888|NCT00971243|157458948|FG004|Double Blind Period|Other reasons|1|||
48896889|NCT00971243|157458944|FG000|Open-label Period|Adverse Event|1|||
48896890|NCT00971243|157458945|FG001|Open-label Period|Adverse Event|0|||
48896891|NCT00971243|157458946|FG002|Open-label Period|Adverse Event|1|||
48896892|NCT00971243|157458947|FG003|Open-label Period|Adverse Event|1|||
48896893|NCT00971243|157458948|FG004|Open-label Period|Adverse Event|0|||
48896894|NCT00971243|157458944|FG000|Open-label Period|Physician Decision|5|||
48896895|NCT00971243|157458945|FG001|Open-label Period|Physician Decision|9|||
48896896|NCT00971243|157458946|FG002|Open-label Period|Physician Decision|3|||
48896897|NCT00971243|157458947|FG003|Open-label Period|Physician Decision|7|||
48896898|NCT00971243|157458948|FG004|Open-label Period|Physician Decision|2|||
48896899|NCT00971243|157458944|FG000|Open-label Period|Protocol Violation|1|||
48896900|NCT00971243|157458945|FG001|Open-label Period|Protocol Violation|1|||
48896901|NCT00971243|157458946|FG002|Open-label Period|Protocol Violation|1|||
48896902|NCT00971243|157458947|FG003|Open-label Period|Protocol Violation|0|||
48896903|NCT00971243|157458948|FG004|Open-label Period|Protocol Violation|1|||
48896904|NCT00971243|157458944|FG000|Open-label Period|Withdrawal by Subject|1|||
48896905|NCT00971243|157458945|FG001|Open-label Period|Withdrawal by Subject|0|||
48896906|NCT00971243|157458946|FG002|Open-label Period|Withdrawal by Subject|0|||
48896907|NCT00971243|157458947|FG003|Open-label Period|Withdrawal by Subject|2|||
48896908|NCT00971243|157458948|FG004|Open-label Period|Withdrawal by Subject|1|||
48896909|NCT00971243|157458944|FG000|Open-label Period|Other reason|0|||
48896910|NCT00971243|157458945|FG001|Open-label Period|Other reason|0|||
48896911|NCT00971243|157458946|FG002|Open-label Period|Other reason|0|||
48896912|NCT00971243|157458947|FG003|Open-label Period|Other reason|0|||
48896913|NCT00971243|157458948|FG004|Open-label Period|Other reason|2|||
48896914|NCT00585195|157458949|FG000|Overall Study|Adverse Event|0|||
48896915|NCT00585195|157458950|FG001|Overall Study|Adverse Event|0|||
48896916|NCT00585195|157458951|FG002|Overall Study|Adverse Event|0|||
48896917|NCT00585195|157458952|FG003|Overall Study|Adverse Event|0|||
48896918|NCT00585195|157458953|FG004|Overall Study|Adverse Event|2|||
48896919|NCT00585195|157458954|FG005|Overall Study|Adverse Event|1|||
48896920|NCT00585195|157458955|FG006|Overall Study|Adverse Event|0|||
48896921|NCT00585195|157458956|FG007|Overall Study|Adverse Event|1|||
48896922|NCT00585195|157458957|FG008|Overall Study|Adverse Event|0|||
48896923|NCT00585195|157458958|FG009|Overall Study|Adverse Event|0|||
48896924|NCT00585195|157458959|FG010|Overall Study|Adverse Event|3|||
48896925|NCT00585195|157458960|FG011|Overall Study|Adverse Event|0|||
48896926|NCT00585195|157458961|FG012|Overall Study|Adverse Event|8|||
48896927|NCT00585195|157458962|FG013|Overall Study|Adverse Event|6|||
48896928|NCT00585195|157458963|FG014|Overall Study|Adverse Event|4|||
48896929|NCT00585195|157458964|FG015|Overall Study|Adverse Event|1|||
48896930|NCT00585195|157458965|FG016|Overall Study|Adverse Event|14|||
48896931|NCT00585195|157458966|FG017|Overall Study|Adverse Event|9|||
48896932|NCT00585195|157458967|FG018|Overall Study|Adverse Event|2|||
49039218|NCT02286466|157978907|FG000|Overall Study|Withdrawal by Subject|5|||
49039219|NCT02286466|157978908|FG001|Overall Study|Withdrawal by Subject|2|||
48896933|NCT00585195|157458968|FG019|Overall Study|Adverse Event|3|||
48896934|NCT00585195|157458969|FG020|Overall Study|Adverse Event|1|||
48896935|NCT00585195|157458949|FG000|Overall Study|Progressive Disease|2|||
48896936|NCT00585195|157458950|FG001|Overall Study|Progressive Disease|2|||
48896937|NCT00585195|157458951|FG002|Overall Study|Progressive Disease|5|||
48896938|NCT00585195|157458952|FG003|Overall Study|Progressive Disease|4|||
48896939|NCT00585195|157458953|FG004|Overall Study|Progressive Disease|6|||
49039220|NCT02286466|157978907|FG000|Overall Study|Lost to Follow-up|1|||
49039221|NCT02286466|157978908|FG001|Overall Study|Lost to Follow-up|4|||
49039222|NCT02286466|157978907|FG000|Overall Study|Declined Clinician Assessment|0|||
48896940|NCT00585195|157458954|FG005|Overall Study|Progressive Disease|4|||
48896941|NCT00585195|157458955|FG006|Overall Study|Progressive Disease|6|||
48896942|NCT00585195|157458956|FG007|Overall Study|Progressive Disease|3|||
48896943|NCT00585195|157458957|FG008|Overall Study|Progressive Disease|0|||
48896944|NCT00585195|157458958|FG009|Overall Study|Progressive Disease|5|||
48896945|NCT00585195|157458959|FG010|Overall Study|Progressive Disease|2|||
48896946|NCT00585195|157458960|FG011|Overall Study|Progressive Disease|25|||
49039223|NCT02286466|157978908|FG001|Overall Study|Declined Clinician Assessment|1|||
49039224|NCT01139762|157978909|FG000|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258|||
49039225|NCT01139762|157978910|FG001|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
49039226|NCT01139762|157978911|FG002|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
49039227|NCT01139762|157978909|FG000|Washout and Placebo Lead-In Period|Adverse Event|1|||
49039228|NCT01139762|157978910|FG001|Washout and Placebo Lead-In Period|Adverse Event|0|||
49039229|NCT01139762|157978911|FG002|Washout and Placebo Lead-In Period|Adverse Event|0|||
49039230|NCT01139762|157978909|FG000|Washout and Placebo Lead-In Period|Withdrawal by Subject|83|||
49039231|NCT01139762|157978910|FG001|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
49039232|NCT01139762|157978911|FG002|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
49039233|NCT01139762|157978909|FG000|Washout and Placebo Lead-In Period|Physician Decision|12|||
49039234|NCT01139762|157978910|FG001|Washout and Placebo Lead-In Period|Physician Decision|0|||
49039235|NCT01139762|157978911|FG002|Washout and Placebo Lead-In Period|Physician Decision|0|||
49039236|NCT01139762|157978909|FG000|Washout and Placebo Lead-In Period|Sponsor Decision|10|||
49039237|NCT01139762|157978910|FG001|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
49039238|NCT01139762|157978911|FG002|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
49039239|NCT01139762|157978909|FG000|Washout and Placebo Lead-In Period|Lost to Follow-up|10|||
49039240|NCT01139762|157978910|FG001|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
49039241|NCT01139762|157978911|FG002|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
49039242|NCT01139762|157978909|FG000|Double-Blind Randomized Active Treatment|Adverse Event|0|||
49039243|NCT01139762|157978910|FG001|Double-Blind Randomized Active Treatment|Adverse Event|4|||
49039244|NCT01139762|157978911|FG002|Double-Blind Randomized Active Treatment|Adverse Event|10|||
49039245|NCT01139762|157978909|FG000|Double-Blind Randomized Active Treatment|Death|0|||
49039246|NCT01139762|157978910|FG001|Double-Blind Randomized Active Treatment|Death|1|||
49039247|NCT01139762|157978911|FG002|Double-Blind Randomized Active Treatment|Death|1|||
49039248|NCT01139762|157978909|FG000|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0|||
49039249|NCT01139762|157978910|FG001|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14|||
49039250|NCT01139762|157978911|FG002|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17|||
49039251|NCT01139762|157978909|FG000|Double-Blind Randomized Active Treatment|Protocol Violation|0|||
49039252|NCT01139762|157978910|FG001|Double-Blind Randomized Active Treatment|Protocol Violation|2|||
49039253|NCT01139762|157978911|FG002|Double-Blind Randomized Active Treatment|Protocol Violation|8|||
49039254|NCT01139762|157978909|FG000|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0|||
49039255|NCT01139762|157978910|FG001|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6|||
49039256|NCT01139762|157978911|FG002|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13|||
48896947|NCT00585195|157458961|FG012|Overall Study|Progressive Disease|29|||
48896948|NCT00585195|157458962|FG013|Overall Study|Progressive Disease|26|||
48896949|NCT00585195|157458963|FG014|Overall Study|Progressive Disease|21|||
48896950|NCT00585195|157458964|FG015|Overall Study|Progressive Disease|12|||
48896951|NCT00585195|157458965|FG016|Overall Study|Progressive Disease|94|||
48896952|NCT00585195|157458966|FG017|Overall Study|Progressive Disease|42|||
48896953|NCT00585195|157458967|FG018|Overall Study|Progressive Disease|4|||
48896954|NCT00585195|157458968|FG019|Overall Study|Progressive Disease|9|||
48896955|NCT00585195|157458969|FG020|Overall Study|Progressive Disease|8|||
48896956|NCT00585195|157458949|FG000|Overall Study|Withdrawal by Subject|1|||
48896957|NCT00585195|157458950|FG001|Overall Study|Withdrawal by Subject|1|||
48896958|NCT00585195|157458951|FG002|Overall Study|Withdrawal by Subject|2|||
48896959|NCT00585195|157458952|FG003|Overall Study|Withdrawal by Subject|2|||
48896960|NCT00585195|157458953|FG004|Overall Study|Withdrawal by Subject|0|||
48896961|NCT00585195|157458954|FG005|Overall Study|Withdrawal by Subject|0|||
48896962|NCT00585195|157458955|FG006|Overall Study|Withdrawal by Subject|0|||
48896963|NCT00585195|157458956|FG007|Overall Study|Withdrawal by Subject|1|||
48896964|NCT00585195|157458957|FG008|Overall Study|Withdrawal by Subject|0|||
48896965|NCT00585195|157458958|FG009|Overall Study|Withdrawal by Subject|0|||
48896966|NCT00585195|157458959|FG010|Overall Study|Withdrawal by Subject|3|||
48896967|NCT00585195|157458960|FG011|Overall Study|Withdrawal by Subject|8|||
48896968|NCT00585195|157458961|FG012|Overall Study|Withdrawal by Subject|15|||
48896969|NCT00585195|157458962|FG013|Overall Study|Withdrawal by Subject|0|||
48896970|NCT00585195|157458963|FG014|Overall Study|Withdrawal by Subject|3|||
48896971|NCT00585195|157458964|FG015|Overall Study|Withdrawal by Subject|0|||
48896972|NCT00585195|157458965|FG016|Overall Study|Withdrawal by Subject|7|||
48896973|NCT00585195|157458966|FG017|Overall Study|Withdrawal by Subject|1|||
48896974|NCT00585195|157458967|FG018|Overall Study|Withdrawal by Subject|2|||
48896975|NCT00585195|157458968|FG019|Overall Study|Withdrawal by Subject|2|||
48896976|NCT00585195|157458969|FG020|Overall Study|Withdrawal by Subject|0|||
49039257|NCT01139762|157978909|FG000|Double-Blind Randomized Active Treatment|Physician Decision|0|||
48896977|NCT00585195|157458949|FG000|Overall Study|Other|0|||
48896978|NCT00585195|157458950|FG001|Overall Study|Other|1|||
48896979|NCT00585195|157458951|FG002|Overall Study|Other|1|||
48896980|NCT00585195|157458952|FG003|Overall Study|Other|1|||
48896981|NCT00585195|157458953|FG004|Overall Study|Other|0|||
48896982|NCT00585195|157458954|FG005|Overall Study|Other|1|||
48896983|NCT00585195|157458955|FG006|Overall Study|Other|0|||
48896984|NCT00585195|157458956|FG007|Overall Study|Other|0|||
48896985|NCT00585195|157458957|FG008|Overall Study|Other|2|||
48896986|NCT00585195|157458958|FG009|Overall Study|Other|1|||
48896987|NCT00585195|157458959|FG010|Overall Study|Other|0|||
48896988|NCT00585195|157458960|FG011|Overall Study|Other|19|||
48896989|NCT00585195|157458961|FG012|Overall Study|Other|24|||
48896990|NCT00585195|157458962|FG013|Overall Study|Other|7|||
48896991|NCT00585195|157458963|FG014|Overall Study|Other|11|||
48896992|NCT00585195|157458964|FG015|Overall Study|Other|3|||
48896993|NCT00585195|157458965|FG016|Overall Study|Other|28|||
48896994|NCT00585195|157458966|FG017|Overall Study|Other|12|||
48896995|NCT00585195|157458967|FG018|Overall Study|Other|10|||
48896996|NCT00585195|157458968|FG019|Overall Study|Other|4|||
48896997|NCT00585195|157458969|FG020|Overall Study|Other|2|||
48896998|NCT00585195|157458949|FG000|Overall Study|Randomized not treated|0|||
48896999|NCT00585195|157458950|FG001|Overall Study|Randomized not treated|0|||
48897000|NCT00585195|157458951|FG002|Overall Study|Randomized not treated|1|||
48897001|NCT00585195|157458952|FG003|Overall Study|Randomized not treated|0|||
48897002|NCT00585195|157458953|FG004|Overall Study|Randomized not treated|1|||
48897003|NCT00585195|157458954|FG005|Overall Study|Randomized not treated|0|||
48897004|NCT00585195|157458955|FG006|Overall Study|Randomized not treated|1|||
48897005|NCT00585195|157458956|FG007|Overall Study|Randomized not treated|0|||
48897006|NCT00585195|157458957|FG008|Overall Study|Randomized not treated|0|||
48897007|NCT00585195|157458958|FG009|Overall Study|Randomized not treated|0|||
48897008|NCT00585195|157458959|FG010|Overall Study|Randomized not treated|2|||
48897009|NCT00585195|157458960|FG011|Overall Study|Randomized not treated|0|||
48897010|NCT00585195|157458961|FG012|Overall Study|Randomized not treated|0|||
48897011|NCT00585195|157458962|FG013|Overall Study|Randomized not treated|0|||
48897012|NCT00585195|157458963|FG014|Overall Study|Randomized not treated|0|||
48897013|NCT00585195|157458964|FG015|Overall Study|Randomized not treated|1|||
48897014|NCT00585195|157458965|FG016|Overall Study|Randomized not treated|0|||
48897015|NCT00585195|157458966|FG017|Overall Study|Randomized not treated|1|||
48897016|NCT00585195|157458967|FG018|Overall Study|Randomized not treated|3|||
48897017|NCT00585195|157458968|FG019|Overall Study|Randomized not treated|0|||
48897018|NCT00585195|157458969|FG020|Overall Study|Randomized not treated|2|||
48897019|NCT00585195|157458949|FG000|Overall Study|Death|0|||
48897020|NCT00585195|157458950|FG001|Overall Study|Death|0|||
48897021|NCT00585195|157458951|FG002|Overall Study|Death|0|||
48897022|NCT00585195|157458952|FG003|Overall Study|Death|0|||
48897023|NCT00585195|157458953|FG004|Overall Study|Death|0|||
48897024|NCT00585195|157458954|FG005|Overall Study|Death|0|||
48897025|NCT00585195|157458955|FG006|Overall Study|Death|0|||
48897026|NCT00585195|157458956|FG007|Overall Study|Death|0|||
48897027|NCT00585195|157458957|FG008|Overall Study|Death|1|||
48897028|NCT00585195|157458958|FG009|Overall Study|Death|0|||
48897029|NCT00585195|157458959|FG010|Overall Study|Death|1|||
48897030|NCT00585195|157458960|FG011|Overall Study|Death|1|||
48897031|NCT00585195|157458961|FG012|Overall Study|Death|7|||
48897032|NCT00585195|157458962|FG013|Overall Study|Death|2|||
48897033|NCT00585195|157458963|FG014|Overall Study|Death|8|||
48897034|NCT00585195|157458964|FG015|Overall Study|Death|2|||
48897035|NCT00585195|157458965|FG016|Overall Study|Death|11|||
48897036|NCT00585195|157458966|FG017|Overall Study|Death|0|||
48897037|NCT00585195|157458967|FG018|Overall Study|Death|0|||
48897038|NCT00585195|157458968|FG019|Overall Study|Death|0|||
48897039|NCT00585195|157458969|FG020|Overall Study|Death|1|||
48897040|NCT00585195|157458949|FG000|Overall Study|Lost to Follow-up|0|||
48897041|NCT00585195|157458950|FG001|Overall Study|Lost to Follow-up|0|||
48897042|NCT00585195|157458951|FG002|Overall Study|Lost to Follow-up|0|||
48897043|NCT00585195|157458952|FG003|Overall Study|Lost to Follow-up|0|||
48897044|NCT00585195|157458953|FG004|Overall Study|Lost to Follow-up|0|||
48897045|NCT00585195|157458954|FG005|Overall Study|Lost to Follow-up|0|||
48897046|NCT00585195|157458955|FG006|Overall Study|Lost to Follow-up|0|||
48897047|NCT00585195|157458956|FG007|Overall Study|Lost to Follow-up|0|||
48897048|NCT00585195|157458957|FG008|Overall Study|Lost to Follow-up|0|||
48897049|NCT00585195|157458958|FG009|Overall Study|Lost to Follow-up|0|||
48897050|NCT00585195|157458959|FG010|Overall Study|Lost to Follow-up|0|||
48897051|NCT00585195|157458960|FG011|Overall Study|Lost to Follow-up|0|||
48897052|NCT00585195|157458961|FG012|Overall Study|Lost to Follow-up|1|||
48897053|NCT00585195|157458962|FG013|Overall Study|Lost to Follow-up|0|||
48984225|NCT01693562|157774123|FG002|Expansion Phase|Withdrawal by Subject|0|||
48984226|NCT01693562|157774124|FG003|Expansion Phase|Withdrawal by Subject|0|||
48897054|NCT00585195|157458963|FG014|Overall Study|Lost to Follow-up|0|||
48897055|NCT00585195|157458964|FG015|Overall Study|Lost to Follow-up|0|||
48897056|NCT00585195|157458965|FG016|Overall Study|Lost to Follow-up|0|||
48897057|NCT00585195|157458966|FG017|Overall Study|Lost to Follow-up|2|||
48897058|NCT00585195|157458967|FG018|Overall Study|Lost to Follow-up|0|||
48897059|NCT00585195|157458968|FG019|Overall Study|Lost to Follow-up|0|||
48897060|NCT00585195|157458969|FG020|Overall Study|Lost to Follow-up|0|||
48897061|NCT00585195|157458949|FG000|Overall Study|Site Terminated by Sponsor|0|||
48897062|NCT00585195|157458950|FG001|Overall Study|Site Terminated by Sponsor|0|||
48897063|NCT00585195|157458951|FG002|Overall Study|Site Terminated by Sponsor|0|||
48897064|NCT00585195|157458952|FG003|Overall Study|Site Terminated by Sponsor|0|||
48897065|NCT00585195|157458953|FG004|Overall Study|Site Terminated by Sponsor|0|||
48897066|NCT00585195|157458954|FG005|Overall Study|Site Terminated by Sponsor|0|||
48897067|NCT00585195|157458955|FG006|Overall Study|Site Terminated by Sponsor|0|||
48897068|NCT00585195|157458956|FG007|Overall Study|Site Terminated by Sponsor|0|||
48897069|NCT00585195|157458957|FG008|Overall Study|Site Terminated by Sponsor|0|||
48897070|NCT00585195|157458958|FG009|Overall Study|Site Terminated by Sponsor|0|||
48897071|NCT00585195|157458959|FG010|Overall Study|Site Terminated by Sponsor|0|||
48897072|NCT00585195|157458960|FG011|Overall Study|Site Terminated by Sponsor|0|||
48897073|NCT00585195|157458961|FG012|Overall Study|Site Terminated by Sponsor|1|||
48897074|NCT00585195|157458962|FG013|Overall Study|Site Terminated by Sponsor|0|||
48897075|NCT00585195|157458963|FG014|Overall Study|Site Terminated by Sponsor|0|||
48897076|NCT00585195|157458964|FG015|Overall Study|Site Terminated by Sponsor|0|||
48897077|NCT00585195|157458965|FG016|Overall Study|Site Terminated by Sponsor|0|||
48897078|NCT00585195|157458966|FG017|Overall Study|Site Terminated by Sponsor|0|||
48897079|NCT00585195|157458967|FG018|Overall Study|Site Terminated by Sponsor|0|||
48897080|NCT00585195|157458968|FG019|Overall Study|Site Terminated by Sponsor|0|||
48897081|NCT00585195|157458969|FG020|Overall Study|Site Terminated by Sponsor|0|||
48897082|NCT00585195|157458949|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
48897083|NCT00585195|157458950|FG001|Overall Study|Withdrawn Due to Pregnancy|0|||
48897084|NCT00585195|157458951|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
48897085|NCT00585195|157458952|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
48897086|NCT00585195|157458953|FG004|Overall Study|Withdrawn Due to Pregnancy|0|||
48897087|NCT00585195|157458954|FG005|Overall Study|Withdrawn Due to Pregnancy|0|||
48897088|NCT00585195|157458955|FG006|Overall Study|Withdrawn Due to Pregnancy|0|||
48897089|NCT00585195|157458956|FG007|Overall Study|Withdrawn Due to Pregnancy|0|||
48897090|NCT00585195|157458957|FG008|Overall Study|Withdrawn Due to Pregnancy|0|||
48897091|NCT00585195|157458958|FG009|Overall Study|Withdrawn Due to Pregnancy|0|||
48897092|NCT00585195|157458959|FG010|Overall Study|Withdrawn Due to Pregnancy|0|||
48897093|NCT00585195|157458960|FG011|Overall Study|Withdrawn Due to Pregnancy|0|||
48897094|NCT00585195|157458961|FG012|Overall Study|Withdrawn Due to Pregnancy|0|||
48897095|NCT00585195|157458962|FG013|Overall Study|Withdrawn Due to Pregnancy|0|||
48897096|NCT00585195|157458963|FG014|Overall Study|Withdrawn Due to Pregnancy|1|||
48897097|NCT00585195|157458964|FG015|Overall Study|Withdrawn Due to Pregnancy|0|||
48897098|NCT00585195|157458965|FG016|Overall Study|Withdrawn Due to Pregnancy|0|||
48897099|NCT00585195|157458966|FG017|Overall Study|Withdrawn Due to Pregnancy|0|||
48897100|NCT00585195|157458967|FG018|Overall Study|Withdrawn Due to Pregnancy|0|||
48897101|NCT00585195|157458968|FG019|Overall Study|Withdrawn Due to Pregnancy|0|||
48897102|NCT00585195|157458969|FG020|Overall Study|Withdrawn Due to Pregnancy|0|||
48897103|NCT02533570|157458970|FG000|Overall Study|Adverse Event|0|||
48897104|NCT02533570|157458971|FG001|Overall Study|Adverse Event|1|||
48897105|NCT02533570|157458972|FG002|Overall Study|Adverse Event|1|||
48897106|NCT03756129|157458974|FG000|Overall Study|Adverse Event|1|||
48897107|NCT03756129|157458975|FG001|Overall Study|Adverse Event|1|||
48897108|NCT03756129|157458976|FG002|Overall Study|Adverse Event|0|||
48897109|NCT03756129|157458977|FG003|Overall Study|Adverse Event|2|||
48897110|NCT03756129|157458978|FG004|Overall Study|Adverse Event|0|||
48897111|NCT03756129|157458979|FG005|Overall Study|Adverse Event|0|||
48897112|NCT03756129|157458974|FG000|Overall Study|Withdrawal by Subject|2|||
48897113|NCT03756129|157458975|FG001|Overall Study|Withdrawal by Subject|1|||
48897114|NCT03756129|157458976|FG002|Overall Study|Withdrawal by Subject|3|||
48897115|NCT03756129|157458977|FG003|Overall Study|Withdrawal by Subject|1|||
48897116|NCT03756129|157458978|FG004|Overall Study|Withdrawal by Subject|1|||
48897117|NCT03756129|157458979|FG005|Overall Study|Withdrawal by Subject|3|||
48897118|NCT03756129|157458974|FG000|Overall Study|Lost to Follow-up|0|||
48897119|NCT03756129|157458975|FG001|Overall Study|Lost to Follow-up|0|||
48897120|NCT03756129|157458976|FG002|Overall Study|Lost to Follow-up|0|||
48897121|NCT03756129|157458977|FG003|Overall Study|Lost to Follow-up|0|||
48897122|NCT03756129|157458978|FG004|Overall Study|Lost to Follow-up|0|||
48897123|NCT03756129|157458979|FG005|Overall Study|Lost to Follow-up|1|||
48897124|NCT03756129|157458974|FG000|Overall Study|Physician Decision|0|||
48897125|NCT03756129|157458975|FG001|Overall Study|Physician Decision|0|||
48897126|NCT03756129|157458976|FG002|Overall Study|Physician Decision|0|||
48897127|NCT03756129|157458977|FG003|Overall Study|Physician Decision|0|||
48897128|NCT03756129|157458978|FG004|Overall Study|Physician Decision|0|||
48897129|NCT03756129|157458979|FG005|Overall Study|Physician Decision|1|||
48897130|NCT03254485|157458980|FG000|Overall Study|Adverse Event|3|||
48897131|NCT03254485|157458981|FG001|Overall Study|Adverse Event|0|||
48897132|NCT03254485|157458982|FG002|Overall Study|Adverse Event|0|||
48897133|NCT03254485|157458983|FG003|Overall Study|Adverse Event|6|||
48897134|NCT03254485|157458980|FG000|Overall Study|Protocol Violation|6|||
48897135|NCT03254485|157458981|FG001|Overall Study|Protocol Violation|0|||
48897136|NCT03254485|157458982|FG002|Overall Study|Protocol Violation|0|||
48897137|NCT03254485|157458983|FG003|Overall Study|Protocol Violation|2|||
48897138|NCT03254485|157458980|FG000|Overall Study|Withdrawal by Subject|1|||
49039258|NCT01139762|157978910|FG001|Double-Blind Randomized Active Treatment|Physician Decision|2|||
48897139|NCT03254485|157458981|FG001|Overall Study|Withdrawal by Subject|0|||
48897140|NCT03254485|157458982|FG002|Overall Study|Withdrawal by Subject|0|||
48897141|NCT03254485|157458983|FG003|Overall Study|Withdrawal by Subject|4|||
48897142|NCT03254485|157458980|FG000|Overall Study|Death|0|||
48897143|NCT03254485|157458981|FG001|Overall Study|Death|0|||
48897144|NCT03254485|157458982|FG002|Overall Study|Death|0|||
48897145|NCT03254485|157458983|FG003|Overall Study|Death|1|||
48897146|NCT03254485|157458980|FG000|Overall Study|Lost to Follow-up|1|||
48897147|NCT03254485|157458981|FG001|Overall Study|Lost to Follow-up|0|||
48897148|NCT03254485|157458982|FG002|Overall Study|Lost to Follow-up|0|||
48897149|NCT03254485|157458983|FG003|Overall Study|Lost to Follow-up|0|||
48897150|NCT03254485|157458980|FG000|Overall Study|Other|1|||
48897151|NCT03254485|157458981|FG001|Overall Study|Other|0|||
48897152|NCT03254485|157458982|FG002|Overall Study|Other|0|||
48897153|NCT03254485|157458983|FG003|Overall Study|Other|2|||
48897154|NCT03567434|157458987|FG000|Overall Study|Lost to Follow-up|1|||
48897155|NCT03567434|157458988|FG001|Overall Study|Lost to Follow-up|3|||
48897156|NCT00640133|157460836|FG000|Open Label Phase (Month 4-12)|Lack of Efficacy|1|||
48897157|NCT00640133|157460837|FG001|Open Label Phase (Month 4-12)|Lack of Efficacy|0|||
48897158|NCT00640133|157460836|FG000|Open Label Phase (Month 4-12)|Withdrawal by Subject|1|||
48897159|NCT00640133|157460837|FG001|Open Label Phase (Month 4-12)|Withdrawal by Subject|0|||
48897160|NCT00640133|157460836|FG000|Open Label Phase (Month 4-12)|Adverse Event|1|||
48897161|NCT00640133|157460837|FG001|Open Label Phase (Month 4-12)|Adverse Event|0|||
48897162|NCT03541174|157460840|FG000|Part 1 Double-Blind|Adverse Event|6|||
48897163|NCT03541174|157460841|FG001|Part 1 Double-Blind|Adverse Event|5|||
48897164|NCT03541174|157460842|FG002|Part 1 Double-Blind|Adverse Event|2|||
48897165|NCT03541174|157460843|FG003|Part 1 Double-Blind|Adverse Event|0|||
48897166|NCT03541174|157460844|FG004|Part 1 Double-Blind|Adverse Event|0|||
48897167|NCT03541174|157460845|FG005|Part 1 Double-Blind|Adverse Event|0|||
48897168|NCT03541174|157460840|FG000|Part 1 Double-Blind|Withdrawal by Subject|2|||
48897169|NCT03541174|157460841|FG001|Part 1 Double-Blind|Withdrawal by Subject|2|||
48897170|NCT03541174|157460842|FG002|Part 1 Double-Blind|Withdrawal by Subject|1|||
48897171|NCT03541174|157460843|FG003|Part 1 Double-Blind|Withdrawal by Subject|0|||
48897172|NCT03541174|157460844|FG004|Part 1 Double-Blind|Withdrawal by Subject|0|||
48897173|NCT03541174|157460845|FG005|Part 1 Double-Blind|Withdrawal by Subject|0|||
48897174|NCT03541174|157460840|FG000|Part 1 Double-Blind|Other reasons|3|||
48897175|NCT03541174|157460841|FG001|Part 1 Double-Blind|Other reasons|2|||
48897176|NCT03541174|157460842|FG002|Part 1 Double-Blind|Other reasons|3|||
48897177|NCT03541174|157460843|FG003|Part 1 Double-Blind|Other reasons|0|||
49039259|NCT01139762|157978911|FG002|Double-Blind Randomized Active Treatment|Physician Decision|0|||
49039260|NCT01139762|157978909|FG000|Double-Blind Randomized Active Treatment|Sponsor Decision|0|||
49039261|NCT01139762|157978910|FG001|Double-Blind Randomized Active Treatment|Sponsor Decision|5|||
48897178|NCT03541174|157460844|FG004|Part 1 Double-Blind|Other reasons|0|||
48897179|NCT03541174|157460845|FG005|Part 1 Double-Blind|Other reasons|0|||
49039262|NCT01139762|157978911|FG002|Double-Blind Randomized Active Treatment|Sponsor Decision|6|||
49039263|NCT01139762|157978909|FG000|Double-Blind Randomized Active Treatment|Lack of Efficacy|0|||
49039264|NCT01139762|157978910|FG001|Double-Blind Randomized Active Treatment|Lack of Efficacy|3|||
49039265|NCT01139762|157978911|FG002|Double-Blind Randomized Active Treatment|Lack of Efficacy|5|||
49039266|NCT01139762|157978909|FG000|Double-Blind Randomized Active Treatment|Lost to Follow-up|0|||
49039267|NCT01139762|157978910|FG001|Double-Blind Randomized Active Treatment|Lost to Follow-up|3|||
49039268|NCT01139762|157978911|FG002|Double-Blind Randomized Active Treatment|Lost to Follow-up|4|||
49039269|NCT01675596|157978912|FG000|Overall Study|Death|6|||
49039270|NCT01675596|157978912|FG000|Overall Study|Exit with other reason|1|||
49039271|NCT01675596|157978912|FG000|Overall Study|Missed Visit|1|||
49039272|NCT04750239|157978913|FG000|Overall Study|Withdrawal by Subject|2|||
49039273|NCT04750239|157978913|FG000|Overall Study|Trial terminated by sponsor|1|||
49039274|NCT01912807|157978914|FG000|Overall Study|Did not meet elegibility criteria|6|||
49039275|NCT01912807|157978915|FG001|Overall Study|Did not meet elegibility criteria|4|||
49039276|NCT01912807|157978914|FG000|Overall Study|Lost to Follow-up|36|||
49039277|NCT01912807|157978915|FG001|Overall Study|Lost to Follow-up|37|||
49039278|NCT00903877|157978916|FG000|Overall Study|Did not meet study criteria|33|||
49039279|NCT00903877|157978916|FG000|Overall Study|Withdrawal by Subject|3|||
49039280|NCT00903877|157978916|FG000|Overall Study|Adverse Event|2|||
49039281|NCT00903877|157978916|FG000|Overall Study|Lost to Follow-up|1|||
49039282|NCT00903877|157978916|FG000|Overall Study|Participation put on hold|4|||
49039283|NCT00087529|157978918|FG000|Overall Study|Death|1|||
49039284|NCT00087529|157978919|FG001|Overall Study|Death|0|||
48897180|NCT03541174|157460840|FG000|Part 2 Single-Blind|Adverse Event|0|||
48897181|NCT03541174|157460841|FG001|Part 2 Single-Blind|Adverse Event|0|||
48897182|NCT03541174|157460842|FG002|Part 2 Single-Blind|Adverse Event|0|||
48897183|NCT03541174|157460843|FG003|Part 2 Single-Blind|Adverse Event|25|||
48897184|NCT03541174|157460844|FG004|Part 2 Single-Blind|Adverse Event|0|||
48897185|NCT03541174|157460845|FG005|Part 2 Single-Blind|Adverse Event|0|||
48897186|NCT03541174|157460840|FG000|Part 2 Single-Blind|Lack of Efficacy|0|||
48897187|NCT03541174|157460841|FG001|Part 2 Single-Blind|Lack of Efficacy|0|||
48897188|NCT03541174|157460842|FG002|Part 2 Single-Blind|Lack of Efficacy|0|||
49039285|NCT00087529|157978918|FG000|Overall Study|Adverse Event|0|||
49039286|NCT00087529|157978919|FG001|Overall Study|Adverse Event|8|||
49039287|NCT00087529|157978918|FG000|Overall Study|Pregnancy|0|||
48897189|NCT03541174|157460843|FG003|Part 2 Single-Blind|Lack of Efficacy|1|||
48897190|NCT03541174|157460844|FG004|Part 2 Single-Blind|Lack of Efficacy|0|||
48897191|NCT03541174|157460845|FG005|Part 2 Single-Blind|Lack of Efficacy|0|||
48897192|NCT03541174|157460840|FG000|Part 2 Single-Blind|Withdrawal by Subject|0|||
48897193|NCT03541174|157460841|FG001|Part 2 Single-Blind|Withdrawal by Subject|0|||
48897194|NCT03541174|157460842|FG002|Part 2 Single-Blind|Withdrawal by Subject|0|||
48897195|NCT03541174|157460843|FG003|Part 2 Single-Blind|Withdrawal by Subject|19|||
48897196|NCT03541174|157460844|FG004|Part 2 Single-Blind|Withdrawal by Subject|0|||
48897197|NCT03541174|157460845|FG005|Part 2 Single-Blind|Withdrawal by Subject|0|||
48897198|NCT03541174|157460840|FG000|Part 2 Single-Blind|Lost to Follow-up|0|||
48897199|NCT03541174|157460841|FG001|Part 2 Single-Blind|Lost to Follow-up|0|||
48897200|NCT03541174|157460842|FG002|Part 2 Single-Blind|Lost to Follow-up|0|||
48897201|NCT03541174|157460843|FG003|Part 2 Single-Blind|Lost to Follow-up|8|||
48897202|NCT03541174|157460844|FG004|Part 2 Single-Blind|Lost to Follow-up|0|||
48897203|NCT03541174|157460845|FG005|Part 2 Single-Blind|Lost to Follow-up|0|||
48897204|NCT03541174|157460840|FG000|Part 2 Single-Blind|Death|0|||
48897205|NCT03541174|157460841|FG001|Part 2 Single-Blind|Death|0|||
48897206|NCT03541174|157460842|FG002|Part 2 Single-Blind|Death|0|||
48897207|NCT03541174|157460843|FG003|Part 2 Single-Blind|Death|5|||
48897208|NCT03541174|157460844|FG004|Part 2 Single-Blind|Death|0|||
48897209|NCT03541174|157460845|FG005|Part 2 Single-Blind|Death|0|||
48897210|NCT03541174|157460840|FG000|Part 2 Single-Blind|Pregnancy|0|||
48897211|NCT03541174|157460841|FG001|Part 2 Single-Blind|Pregnancy|0|||
48897212|NCT03541174|157460842|FG002|Part 2 Single-Blind|Pregnancy|0|||
48897213|NCT03541174|157460843|FG003|Part 2 Single-Blind|Pregnancy|1|||
48897214|NCT03541174|157460844|FG004|Part 2 Single-Blind|Pregnancy|0|||
48897215|NCT03541174|157460845|FG005|Part 2 Single-Blind|Pregnancy|0|||
48897216|NCT03541174|157460840|FG000|Part 2 Single-Blind|Other reasons|0|||
48897217|NCT03541174|157460841|FG001|Part 2 Single-Blind|Other reasons|0|||
48897218|NCT03541174|157460842|FG002|Part 2 Single-Blind|Other reasons|0|||
48897219|NCT03541174|157460843|FG003|Part 2 Single-Blind|Other reasons|32|||
48897220|NCT03541174|157460844|FG004|Part 2 Single-Blind|Other reasons|0|||
48897221|NCT03541174|157460845|FG005|Part 2 Single-Blind|Other reasons|0|||
48897222|NCT03541174|157460840|FG000|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
48897223|NCT03541174|157460841|FG001|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
48897224|NCT03541174|157460842|FG002|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
48897225|NCT03541174|157460843|FG003|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
48897226|NCT03541174|157460844|FG004|Part 3 Double-Blind Withdrawal|Adverse Event|8|||
48897227|NCT03541174|157460845|FG005|Part 3 Double-Blind Withdrawal|Adverse Event|7|||
48897228|NCT03541174|157460840|FG000|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
48897229|NCT03541174|157460841|FG001|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
48897230|NCT03541174|157460842|FG002|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
48897231|NCT03541174|157460843|FG003|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
48897232|NCT03541174|157460844|FG004|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|1|||
48897233|NCT03541174|157460845|FG005|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|4|||
48897234|NCT03541174|157460840|FG000|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
48897235|NCT03541174|157460841|FG001|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
48897236|NCT03541174|157460842|FG002|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
48897237|NCT03541174|157460843|FG003|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
48897238|NCT03541174|157460844|FG004|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
48897239|NCT03541174|157460845|FG005|Part 3 Double-Blind Withdrawal|Lost to Follow-up|1|||
48897240|NCT03541174|157460840|FG000|Part 3 Double-Blind Withdrawal|Other reasons|0|||
48897241|NCT03541174|157460841|FG001|Part 3 Double-Blind Withdrawal|Other reasons|0|||
48897242|NCT03541174|157460842|FG002|Part 3 Double-Blind Withdrawal|Other reasons|0|||
48897243|NCT03541174|157460843|FG003|Part 3 Double-Blind Withdrawal|Other reasons|0|||
48897244|NCT03541174|157460844|FG004|Part 3 Double-Blind Withdrawal|Other reasons|9|||
48897245|NCT03541174|157460845|FG005|Part 3 Double-Blind Withdrawal|Other reasons|6|||
48897246|NCT03541174|157460840|FG000|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
48897247|NCT03541174|157460841|FG001|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
48897248|NCT03541174|157460842|FG002|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
48897249|NCT03541174|157460843|FG003|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
48897250|NCT03541174|157460844|FG004|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|1|||
48897251|NCT03541174|157460845|FG005|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
49039288|NCT00087529|157978919|FG001|Overall Study|Pregnancy|1|||
48897252|NCT01664598|157460850|FG000|Overall Study|Sponsor Decision|1|||
48897253|NCT01664598|157460850|FG000|Overall Study|Withdrawal of Informed Consent|4|||
48897254|NCT01664598|157460850|FG000|Overall Study|Adverse Event|1|||
48897255|NCT00558259|157460851|FG000|Overall Study|Adverse Event|50|||
48897256|NCT00558259|157460852|FG001|Overall Study|Adverse Event|81|||
48897257|NCT00558259|157460851|FG000|Overall Study|Protocol Violation|9|||
48897258|NCT00558259|157460852|FG001|Overall Study|Protocol Violation|5|||
48897259|NCT00558259|157460851|FG000|Overall Study|Withdrawal by Subject|12|||
48897260|NCT00558259|157460852|FG001|Overall Study|Withdrawal by Subject|13|||
48897261|NCT02121301|157460858|FG000|Overall Study|Protocol Violation|1|||
49039289|NCT00087529|157978918|FG000|Overall Study|Lost to Follow-up|2|||
49039290|NCT00087529|157978919|FG001|Overall Study|Lost to Follow-up|3|||
49039291|NCT00087529|157978918|FG000|Overall Study|Participant Decision|14|||
48897262|NCT02121301|157460859|FG001|Overall Study|Protocol Violation|4|||
48897263|NCT02121301|157460860|FG002|Overall Study|Protocol Violation|1|||
48897264|NCT01874431|157460861|FG000|Overall Study|Physician Decision|0|||
48897265|NCT01874431|157460862|FG001|Overall Study|Physician Decision|0|||
48897266|NCT01874431|157460863|FG002|Overall Study|Physician Decision|1|||
48897267|NCT01874431|157460864|FG003|Overall Study|Physician Decision|0|||
48897268|NCT01874431|157460865|FG004|Overall Study|Physician Decision|0|||
48897269|NCT01874431|157460866|FG005|Overall Study|Physician Decision|0|||
48897270|NCT01874431|157460867|FG006|Overall Study|Physician Decision|0|||
48897271|NCT01874431|157460868|FG007|Overall Study|Physician Decision|0|||
48897272|NCT01874431|157460861|FG000|Overall Study|Adverse Event|5|||
48897273|NCT01874431|157460862|FG001|Overall Study|Adverse Event|4|||
48897274|NCT01874431|157460863|FG002|Overall Study|Adverse Event|6|||
48897275|NCT01874431|157460864|FG003|Overall Study|Adverse Event|5|||
48897276|NCT01874431|157460865|FG004|Overall Study|Adverse Event|2|||
48897277|NCT01874431|157460866|FG005|Overall Study|Adverse Event|8|||
48897278|NCT01874431|157460867|FG006|Overall Study|Adverse Event|2|||
48897279|NCT01874431|157460868|FG007|Overall Study|Adverse Event|3|||
48897280|NCT01874431|157460861|FG000|Overall Study|Protocol Violation|1|||
48897281|NCT01874431|157460862|FG001|Overall Study|Protocol Violation|1|||
49039292|NCT00087529|157978919|FG001|Overall Study|Participant Decision|37|||
49039293|NCT00087529|157978918|FG000|Overall Study|Physician Decision|4|||
49039294|NCT00087529|157978919|FG001|Overall Study|Physician Decision|8|||
49039295|NCT00087529|157978918|FG000|Overall Study|Initiation of Excluded Therapy|0|||
49039296|NCT00087529|157978919|FG001|Overall Study|Initiation of Excluded Therapy|1|||
49039297|NCT00087529|157978918|FG000|Overall Study|Participant Noncompliance|0|||
49039298|NCT00087529|157978919|FG001|Overall Study|Participant Noncompliance|1|||
49039299|NCT00087529|157978918|FG000|Overall Study|Disease Progression|5|||
49039300|NCT00087529|157978919|FG001|Overall Study|Disease Progression|4|||
49039301|NCT00087529|157978918|FG000|Overall Study|Did Not Continue to Safety Follow-Up|5|||
49039302|NCT00087529|157978919|FG001|Overall Study|Did Not Continue to Safety Follow-Up|5|||
49039303|NCT04773600|157978924|FG000|Overall Study|Withdrawal by Subject|15|||
49039304|NCT04773600|157978925|FG001|Overall Study|Withdrawal by Subject|9|||
49039305|NCT04773600|157978924|FG000|Overall Study|Lost to Follow-up|10|||
49039306|NCT04773600|157978925|FG001|Overall Study|Lost to Follow-up|6|||
49039307|NCT04773600|157978924|FG000|Overall Study|Adverse Event|8|||
49039308|NCT04773600|157978925|FG001|Overall Study|Adverse Event|2|||
49039309|NCT04773600|157978924|FG000|Overall Study|Lack of Efficacy|2|||
49039310|NCT04773600|157978925|FG001|Overall Study|Lack of Efficacy|3|||
49039311|NCT04773600|157978924|FG000|Overall Study|Noncompliance|2|||
49039312|NCT04773600|157978925|FG001|Overall Study|Noncompliance|0|||
49039313|NCT04773600|157978924|FG000|Overall Study|Protocol Violation|2|||
48897282|NCT01874431|157460863|FG002|Overall Study|Protocol Violation|1|||
48897283|NCT01874431|157460864|FG003|Overall Study|Protocol Violation|0|||
48897284|NCT01874431|157460865|FG004|Overall Study|Protocol Violation|3|||
48897285|NCT01874431|157460866|FG005|Overall Study|Protocol Violation|2|||
48897286|NCT01874431|157460867|FG006|Overall Study|Protocol Violation|1|||
48897287|NCT01874431|157460868|FG007|Overall Study|Protocol Violation|1|||
48897288|NCT01874431|157460861|FG000|Overall Study|Non-compliance|0|||
48897289|NCT01874431|157460862|FG001|Overall Study|Non-compliance|0|||
48897290|NCT01874431|157460863|FG002|Overall Study|Non-compliance|0|||
48897291|NCT01874431|157460864|FG003|Overall Study|Non-compliance|0|||
48897292|NCT01874431|157460865|FG004|Overall Study|Non-compliance|1|||
48897293|NCT01874431|157460866|FG005|Overall Study|Non-compliance|0|||
48897294|NCT01874431|157460867|FG006|Overall Study|Non-compliance|1|||
48897295|NCT01874431|157460868|FG007|Overall Study|Non-compliance|0|||
48897296|NCT01874431|157460861|FG000|Overall Study|Logistical difficulties|0|||
48897297|NCT01874431|157460862|FG001|Overall Study|Logistical difficulties|0|||
48897298|NCT01874431|157460863|FG002|Overall Study|Logistical difficulties|0|||
48897299|NCT01874431|157460864|FG003|Overall Study|Logistical difficulties|0|||
48897300|NCT01874431|157460865|FG004|Overall Study|Logistical difficulties|0|||
49039314|NCT04773600|157978925|FG001|Overall Study|Protocol Violation|0|||
48897301|NCT01874431|157460866|FG005|Overall Study|Logistical difficulties|0|||
48897302|NCT01874431|157460867|FG006|Overall Study|Logistical difficulties|1|||
48897303|NCT01874431|157460868|FG007|Overall Study|Logistical difficulties|0|||
48897304|NCT01874431|157460861|FG000|Overall Study|Withdrawal by Subject|0|||
48897305|NCT01874431|157460862|FG001|Overall Study|Withdrawal by Subject|0|||
48897306|NCT01874431|157460863|FG002|Overall Study|Withdrawal by Subject|1|||
48897307|NCT01874431|157460864|FG003|Overall Study|Withdrawal by Subject|2|||
48897308|NCT01874431|157460865|FG004|Overall Study|Withdrawal by Subject|1|||
49039315|NCT04773600|157978924|FG000|Overall Study|Physician Decision|0|||
49039316|NCT04773600|157978925|FG001|Overall Study|Physician Decision|1|||
49039317|NCT04773600|157978924|FG000|Overall Study|Caregiver Elected Other Therapy|1|||
49039318|NCT04773600|157978925|FG001|Overall Study|Caregiver Elected Other Therapy|0|||
49039319|NCT04773600|157978924|FG000|Overall Study|Emergency Travel Out of Country|1|||
49039320|NCT04773600|157978925|FG001|Overall Study|Emergency Travel Out of Country|0|||
49039321|NCT00452348|157980675|FG000|Overall Study|Adverse Event|6|||
49039322|NCT00452348|157980676|FG001|Overall Study|Adverse Event|9|||
49039323|NCT00452348|157980675|FG000|Overall Study|Lack of Efficacy|10|||
48897309|NCT01874431|157460866|FG005|Overall Study|Withdrawal by Subject|1|||
49039324|NCT00452348|157980676|FG001|Overall Study|Lack of Efficacy|9|||
49039325|NCT00452348|157980675|FG000|Overall Study|Lost to Follow-up|14|||
49039326|NCT00452348|157980676|FG001|Overall Study|Lost to Follow-up|8|||
49039327|NCT00452348|157980675|FG000|Overall Study|Protocol Violation|22|||
49039328|NCT00452348|157980676|FG001|Overall Study|Protocol Violation|28|||
49039329|NCT00452348|157980675|FG000|Overall Study|Withdrawal by Subject|18|||
49039330|NCT00452348|157980676|FG001|Overall Study|Withdrawal by Subject|21|||
48897310|NCT01874431|157460867|FG006|Overall Study|Withdrawal by Subject|3|||
48897311|NCT01874431|157460868|FG007|Overall Study|Withdrawal by Subject|0|||
48897312|NCT01874431|157460861|FG000|Overall Study|Sponsor decision|0|||
48897313|NCT01874431|157460862|FG001|Overall Study|Sponsor decision|0|||
48897314|NCT01874431|157460863|FG002|Overall Study|Sponsor decision|0|||
48897315|NCT01874431|157460864|FG003|Overall Study|Sponsor decision|0|||
48897316|NCT01874431|157460865|FG004|Overall Study|Sponsor decision|1|||
48897317|NCT01874431|157460866|FG005|Overall Study|Sponsor decision|0|||
48897318|NCT01874431|157460867|FG006|Overall Study|Sponsor decision|0|||
48897319|NCT01874431|157460868|FG007|Overall Study|Sponsor decision|0|||
48897320|NCT01874431|157460861|FG000|Overall Study|Lost to Follow-up|0|||
48897321|NCT01874431|157460862|FG001|Overall Study|Lost to Follow-up|0|||
48897322|NCT01874431|157460863|FG002|Overall Study|Lost to Follow-up|1|||
49039331|NCT00452348|157980675|FG000|Overall Study|Other|9|||
49039332|NCT00452348|157980676|FG001|Overall Study|Other|9|||
49039333|NCT02255149|157980677|FG000|Overall Study|Lost to Follow-up|2|||
49039334|NCT02255149|157980677|FG000|Overall Study|Withdrawal by Subject|1|||
48897323|NCT01874431|157460864|FG003|Overall Study|Lost to Follow-up|0|||
48897324|NCT01874431|157460865|FG004|Overall Study|Lost to Follow-up|0|||
48897325|NCT01874431|157460866|FG005|Overall Study|Lost to Follow-up|0|||
48897326|NCT01874431|157460867|FG006|Overall Study|Lost to Follow-up|0|||
48897327|NCT01874431|157460868|FG007|Overall Study|Lost to Follow-up|0|||
48897328|NCT00545051|157460874|FG000|Overall Study|Adverse Event|7|||
48897329|NCT00545051|157460875|FG001|Overall Study|Adverse Event|3|||
48897330|NCT00545051|157460874|FG000|Overall Study|Death|1|||
48897331|NCT00545051|157460875|FG001|Overall Study|Death|0|||
48897332|NCT00545051|157460874|FG000|Overall Study|Violation of inclusion/exclusion|0|||
48897333|NCT00545051|157460875|FG001|Overall Study|Violation of inclusion/exclusion|2|||
48897334|NCT00545051|157460874|FG000|Overall Study|Protocol Violation|1|||
48897335|NCT00545051|157460875|FG001|Overall Study|Protocol Violation|0|||
48897336|NCT00545051|157460874|FG000|Overall Study|Withdrawal by Subject|0|||
48897337|NCT00545051|157460875|FG001|Overall Study|Withdrawal by Subject|1|||
48897338|NCT00545051|157460874|FG000|Overall Study|Administrative reasons|0|||
48897339|NCT00545051|157460875|FG001|Overall Study|Administrative reasons|1|||
48897340|NCT00799513|157460876|FG000|Overall Study|Physician Decision|1|||
48897341|NCT00799513|157460876|FG000|Overall Study|Adverse Event|1|||
48897342|NCT01383499|157460879|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
48897343|NCT01383499|157460880|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
48897344|NCT01383499|157460881|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
48897345|NCT01383499|157460882|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
48897346|NCT00946101|157460883|FG000|Overall Study|Lost to Follow-up|2|||
48897347|NCT00946101|157460884|FG001|Overall Study|Lost to Follow-up|1|||
48897348|NCT00946101|157460883|FG000|Overall Study|Withdrawal of consent|2|||
48897349|NCT00946101|157460884|FG001|Overall Study|Withdrawal of consent|0|||
48897350|NCT00946101|157460883|FG000|Overall Study|Physician Decision|0|||
48897351|NCT00946101|157460884|FG001|Overall Study|Physician Decision|1|||
48897352|NCT00262951|157460888|FG000|Overall Study|Progressive disease/relapse|3|||
48897353|NCT00262951|157460888|FG000|Overall Study|Adverse Event|7|||
48897354|NCT00262951|157460888|FG000|Overall Study|Death|1|||
48897355|NCT00262951|157460888|FG000|Overall Study|Withdrawal by Subject|1|||
48897356|NCT00262951|157460888|FG000|Overall Study|Alternative treatment|3|||
48897357|NCT00262951|157460888|FG000|Overall Study|Off treatment for other disease|1|||
48897358|NCT02706899|157460889|FG000|Overall Study|Withdrawal by Subject|1|||
48897359|NCT02706899|157460890|FG001|Overall Study|Withdrawal by Subject|0|||
48897360|NCT02706899|157460889|FG000|Overall Study|Death|8|||
48897361|NCT02706899|157460890|FG001|Overall Study|Death|0|||
48897362|NCT02706899|157460889|FG000|Overall Study|Study Termination by Sponsor|4|||
48897363|NCT02706899|157460890|FG001|Overall Study|Study Termination by Sponsor|6|||
48897364|NCT03536754|157460891|FG000|Double Blind Period 1|Withdrawal by Subject|0|||
48897365|NCT03536754|157460892|FG001|Double Blind Period 1|Withdrawal by Subject|0|||
48897366|NCT03536754|157460893|FG002|Double Blind Period 1|Withdrawal by Subject|1|||
48897367|NCT03536754|157460894|FG003|Double Blind Period 1|Withdrawal by Subject|0|||
48897368|NCT03536754|157460895|FG004|Double Blind Period 1|Withdrawal by Subject|0|||
48897369|NCT03536754|157460891|FG000|Open Label Extension|Other|0|||
48897370|NCT03536754|157460892|FG001|Open Label Extension|Other|0|||
49039335|NCT02255149|157980677|FG000|Overall Study|Withdrawal by PI|1|||
49039336|NCT02255149|157980677|FG000|Overall Study|Implant Failure|1|||
49039337|NCT00521586|157980678|FG000|Initial Vaccination (Year 0)|Subject request|8|||
49039338|NCT00521586|157980679|FG001|Initial Vaccination (Year 0)|Subject request|11|||
49039339|NCT00521586|157980678|FG000|Initial Vaccination (Year 0)|Lost to Follow-up|5|||
49039340|NCT00521586|157980679|FG001|Initial Vaccination (Year 0)|Lost to Follow-up|10|||
49039341|NCT00521586|157980678|FG000|Initial Vaccination (Year 0)|Protocol Violation|2|||
49039342|NCT00521586|157980679|FG001|Initial Vaccination (Year 0)|Protocol Violation|5|||
49039343|NCT00521586|157980678|FG000|Initial Vaccination (Year 0)|Other, unspecified|3|||
49039344|NCT00521586|157980679|FG001|Initial Vaccination (Year 0)|Other, unspecified|1|||
49039345|NCT00521586|157980678|FG000|Initial Vaccination (Year 0)|Investigator request|2|||
49039346|NCT00521586|157980679|FG001|Initial Vaccination (Year 0)|Investigator request|0|||
49039347|NCT00521586|157980678|FG000|Initial Vaccination (Year 0)|Adverse Event|0|||
49039348|NCT00521586|157980679|FG001|Initial Vaccination (Year 0)|Adverse Event|1|||
49039349|NCT00521586|157980678|FG000|Initial Vaccination (Year 0)|Death|1|||
49039350|NCT00521586|157980679|FG001|Initial Vaccination (Year 0)|Death|0|||
49039351|NCT00521586|157980678|FG000|Initial Vaccination (Year 0)|Failed to return|0|||
49039352|NCT00521586|157980679|FG001|Initial Vaccination (Year 0)|Failed to return|1|||
49039353|NCT00521586|157980678|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5|||
49039354|NCT00521586|157980679|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1|||
49039355|NCT00521586|157980678|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Death|5|||
49039356|NCT00521586|157980679|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Death|2|||
49039357|NCT00521586|157980678|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7|||
49039358|NCT00521586|157980679|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3|||
49039359|NCT00521586|157980678|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
49039360|NCT00521586|157980679|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
49039361|NCT00521586|157980678|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55|||
49039362|NCT00521586|157980679|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56|||
49039363|NCT00521586|157980678|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Other|22|||
49039364|NCT00521586|157980679|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Other|26|||
49039365|NCT00521586|157980678|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18|||
49039366|NCT00521586|157980679|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22|||
49039367|NCT00521586|157980678|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54|||
49039368|NCT00521586|157980679|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57|||
49039369|NCT00521586|157980678|FG000|Revaccination With 13vPnC (Year 5)|Subject request|0|||
49039370|NCT00521586|157980679|FG001|Revaccination With 13vPnC (Year 5)|Subject request|1|||
49039371|NCT00521586|157980678|FG000|Revaccination With 13vPnC (Year 5)|Failed to return|1|||
49039372|NCT00521586|157980679|FG001|Revaccination With 13vPnC (Year 5)|Failed to return|4|||
49039373|NCT00521586|157980678|FG000|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2|||
49039374|NCT00521586|157980679|FG001|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7|||
49039375|NCT00828321|157980680|FG000|Washout of 42 Days|Withdrawal by Subject|2|||
48897371|NCT03536754|157460893|FG002|Open Label Extension|Other|0|||
48897372|NCT03536754|157460894|FG003|Open Label Extension|Other|0|||
48897373|NCT03536754|157460895|FG004|Open Label Extension|Other|1|||
48897374|NCT00122460|157460896|FG000|Overall Study|investigational study phase ongoing|7|||
48897375|NCT00122460|157460897|FG001|Overall Study|investigational study phase ongoing|1|||
48897376|NCT01853137|157460898|FG000|Overall Study|Lost to Follow-up|4|||
48897377|NCT01853137|157460899|FG001|Overall Study|Lost to Follow-up|1|||
48897378|NCT00848926|157460904|FG000|Treatment Period|Progressive disease|45|||
48897379|NCT00848926|157460904|FG000|Treatment Period|Adverse Event|20|||
48897380|NCT00848926|157460904|FG000|Treatment Period|Physician Decision|12|||
48897381|NCT00848926|157460904|FG000|Treatment Period|Withdrawal by Subject|7|||
48897382|NCT00848926|157460904|FG000|Follow-up Period|Lost to Follow-up|7|||
48897383|NCT00848926|157460904|FG000|Follow-up Period|Withdrawal by Subject|3|||
48897384|NCT00848926|157460904|FG000|Follow-up Period|Other|2|||
48897385|NCT02325557|157460906|FG000|Overall Study|Progressive disease|1|||
48897386|NCT02325557|157460907|FG001|Overall Study|Progressive disease|0|||
48897387|NCT02325557|157460908|FG002|Overall Study|Progressive disease|0|||
48897388|NCT02325557|157460909|FG003|Overall Study|Progressive disease|0|||
48897389|NCT02325557|157460906|FG000|Overall Study|Withdrawal by Subject|4|||
48897390|NCT02325557|157460907|FG001|Overall Study|Withdrawal by Subject|0|||
48897391|NCT02325557|157460908|FG002|Overall Study|Withdrawal by Subject|0|||
48897392|NCT02325557|157460909|FG003|Overall Study|Withdrawal by Subject|15|||
48897393|NCT02325557|157460906|FG000|Overall Study|Death|5|||
48897394|NCT02325557|157460907|FG001|Overall Study|Death|1|||
48897395|NCT02325557|157460908|FG002|Overall Study|Death|1|||
48897396|NCT02325557|157460909|FG003|Overall Study|Death|16|||
48897397|NCT02325557|157460906|FG000|Overall Study|Lost to Follow-up|0|||
48897398|NCT02325557|157460907|FG001|Overall Study|Lost to Follow-up|0|||
48897399|NCT02325557|157460908|FG002|Overall Study|Lost to Follow-up|1|||
48897400|NCT02325557|157460909|FG003|Overall Study|Lost to Follow-up|1|||
48897401|NCT02325557|157460906|FG000|Overall Study|Other|0|||
48897402|NCT02325557|157460907|FG001|Overall Study|Other|0|||
48897403|NCT02325557|157460908|FG002|Overall Study|Other|0|||
48897404|NCT02325557|157460909|FG003|Overall Study|Other|5|||
48897405|NCT01435616|157460910|FG000|Overall Study|Adverse Event|39|||
48897406|NCT01435616|157460911|FG001|Overall Study|Adverse Event|21|||
48897407|NCT01435616|157460910|FG000|Overall Study|Death|7|||
48897408|NCT01435616|157460911|FG001|Overall Study|Death|2|||
48897409|NCT01435616|157460910|FG000|Overall Study|Lost to Follow-up|22|||
48897410|NCT01435616|157460911|FG001|Overall Study|Lost to Follow-up|13|||
48897411|NCT01435616|157460910|FG000|Overall Study|Protocol Violation|16|||
48897412|NCT01435616|157460911|FG001|Overall Study|Protocol Violation|13|||
48897413|NCT01435616|157460910|FG000|Overall Study|Withdrawal by Subject|66|||
48897414|NCT01435616|157460911|FG001|Overall Study|Withdrawal by Subject|24|||
48897415|NCT01435616|157460910|FG000|Overall Study|Physician Decision|20|||
48897416|NCT01435616|157460911|FG001|Overall Study|Physician Decision|7|||
48897417|NCT01435616|157460910|FG000|Overall Study|Sponsor Decision|1|||
48897418|NCT01435616|157460911|FG001|Overall Study|Sponsor Decision|0|||
48897419|NCT01293487|157460912|FG000|Overall Study|Lost to Follow-up|0|||
48897420|NCT01293487|157460913|FG001|Overall Study|Lost to Follow-up|0|||
48897421|NCT01293487|157460914|FG002|Overall Study|Lost to Follow-up|0|||
48897422|NCT01293487|157460915|FG003|Overall Study|Lost to Follow-up|1|||
48897423|NCT01293487|157460916|FG004|Overall Study|Lost to Follow-up|0|||
48897424|NCT01293487|157460917|FG005|Overall Study|Lost to Follow-up|0|||
48897425|NCT01293487|157460918|FG006|Overall Study|Lost to Follow-up|0|||
48897426|NCT01293487|157460919|FG007|Overall Study|Lost to Follow-up|0|||
48897427|NCT01293487|157460912|FG000|Overall Study|Withdrawal by Subject|0|||
48897428|NCT01293487|157460913|FG001|Overall Study|Withdrawal by Subject|0|||
48897429|NCT01293487|157460914|FG002|Overall Study|Withdrawal by Subject|0|||
48897430|NCT01293487|157460915|FG003|Overall Study|Withdrawal by Subject|0|||
48897431|NCT01293487|157460916|FG004|Overall Study|Withdrawal by Subject|0|||
48897432|NCT01293487|157460917|FG005|Overall Study|Withdrawal by Subject|0|||
48897433|NCT01293487|157460918|FG006|Overall Study|Withdrawal by Subject|0|||
48897434|NCT01293487|157460919|FG007|Overall Study|Withdrawal by Subject|2|||
48897435|NCT01642251|157460922|FG000|Overall Study|Progressive disease|0|||
48897436|NCT01642251|157460923|FG001|Overall Study|Progressive disease|0|||
48897437|NCT01642251|157460924|FG002|Overall Study|Progressive disease|3|||
48897438|NCT01642251|157460925|FG003|Overall Study|Progressive disease|3|||
48897439|NCT01642251|157460922|FG000|Overall Study|Adverse Event|0|||
48897440|NCT01642251|157460923|FG001|Overall Study|Adverse Event|0|||
48897441|NCT01642251|157460924|FG002|Overall Study|Adverse Event|5|||
48897442|NCT01642251|157460925|FG003|Overall Study|Adverse Event|4|||
48897443|NCT01642251|157460922|FG000|Overall Study|Death|0|||
48897444|NCT01642251|157460923|FG001|Overall Study|Death|0|||
48897445|NCT01642251|157460924|FG002|Overall Study|Death|1|||
48897446|NCT01642251|157460925|FG003|Overall Study|Death|3|||
48897447|NCT01642251|157460922|FG000|Overall Study|Withdrawal by Subject|0|||
48897448|NCT01642251|157460923|FG001|Overall Study|Withdrawal by Subject|0|||
48897449|NCT01642251|157460924|FG002|Overall Study|Withdrawal by Subject|1|||
48897450|NCT01642251|157460925|FG003|Overall Study|Withdrawal by Subject|3|||
48897451|NCT01642251|157460922|FG000|Overall Study|Alternative therapy|0|||
48897452|NCT01642251|157460923|FG001|Overall Study|Alternative therapy|0|||
48897453|NCT01642251|157460924|FG002|Overall Study|Alternative therapy|0|||
48897454|NCT01642251|157460925|FG003|Overall Study|Alternative therapy|2|||
48897455|NCT01642251|157460922|FG000|Overall Study|Other complicating disease|0|||
48897456|NCT01642251|157460923|FG001|Overall Study|Other complicating disease|0|||
48897457|NCT01642251|157460924|FG002|Overall Study|Other complicating disease|1|||
48897458|NCT01642251|157460925|FG003|Overall Study|Other complicating disease|0|||
48897459|NCT01642251|157460922|FG000|Overall Study|Ineligible/never start protocol therapy|0|||
48897460|NCT01642251|157460923|FG001|Overall Study|Ineligible/never start protocol therapy|0|||
48897461|NCT01642251|157460924|FG002|Overall Study|Ineligible/never start protocol therapy|11|||
48897462|NCT01642251|157460925|FG003|Overall Study|Ineligible/never start protocol therapy|8|||
48897463|NCT04602221|157460926|FG000|Overall Study|Discontinuation of trial treatment|0|||
48897464|NCT04602221|157460927|FG001|Overall Study|Discontinuation of trial treatment|0|||
48897465|NCT04602221|157460928|FG002|Overall Study|Discontinuation of trial treatment|1|||
48897466|NCT04602221|157460929|FG003|Overall Study|Discontinuation of trial treatment|0|||
48897467|NCT04602221|157460930|FG004|Overall Study|Discontinuation of trial treatment|0|||
48897468|NCT04602221|157460931|FG005|Overall Study|Discontinuation of trial treatment|0|||
48897469|NCT04602221|157460932|FG006|Overall Study|Discontinuation of trial treatment|0|||
48897470|NCT04602221|157460933|FG007|Overall Study|Discontinuation of trial treatment|0|||
48897471|NCT04602221|157460934|FG008|Overall Study|Discontinuation of trial treatment|0|||
48897472|NCT04602221|157460935|FG009|Overall Study|Discontinuation of trial treatment|0|||
48897473|NCT04602221|157460936|FG010|Overall Study|Discontinuation of trial treatment|0|||
48897474|NCT04602221|157460937|FG011|Overall Study|Discontinuation of trial treatment|0|||
48897475|NCT04602221|157460938|FG012|Overall Study|Discontinuation of trial treatment|0|||
48897476|NCT04602221|157460939|FG013|Overall Study|Discontinuation of trial treatment|0|||
48897477|NCT04602221|157460940|FG014|Overall Study|Discontinuation of trial treatment|0|||
48897478|NCT04602221|157460941|FG015|Overall Study|Discontinuation of trial treatment|0|||
48897479|NCT04602221|157460942|FG016|Overall Study|Discontinuation of trial treatment|0|||
48897480|NCT04602221|157460943|FG017|Overall Study|Discontinuation of trial treatment|0|||
48796826|NCT01951625|157093802|FG004|Follow Up Period|Death|1|||
48796827|NCT01951625|157093798|FG000|Follow Up Period|Logistical difficulties|1|||
48796828|NCT01951625|157093799|FG001|Follow Up Period|Logistical difficulties|2|||
48796829|NCT01951625|157093800|FG002|Follow Up Period|Logistical difficulties|0|||
48796830|NCT01951625|157093801|FG003|Follow Up Period|Logistical difficulties|0|||
48796831|NCT01951625|157093802|FG004|Follow Up Period|Logistical difficulties|0|||
48796832|NCT01951625|157093798|FG000|Follow Up Period|Adverse Event|0|||
48796833|NCT01951625|157093799|FG001|Follow Up Period|Adverse Event|3|||
48796834|NCT01951625|157093800|FG002|Follow Up Period|Adverse Event|2|||
48796835|NCT01951625|157093801|FG003|Follow Up Period|Adverse Event|3|||
48796836|NCT01951625|157093802|FG004|Follow Up Period|Adverse Event|5|||
48796837|NCT01951625|157093798|FG000|Follow Up Period|Withdrawal by Subject|4|||
48796838|NCT01951625|157093799|FG001|Follow Up Period|Withdrawal by Subject|1|||
48796839|NCT01951625|157093800|FG002|Follow Up Period|Withdrawal by Subject|0|||
48796840|NCT01951625|157093801|FG003|Follow Up Period|Withdrawal by Subject|5|||
48796841|NCT01951625|157093802|FG004|Follow Up Period|Withdrawal by Subject|3|||
48796842|NCT01951625|157093798|FG000|Follow Up Period|Lost to Follow-up|1|||
48796843|NCT01951625|157093799|FG001|Follow Up Period|Lost to Follow-up|0|||
48796844|NCT01951625|157093800|FG002|Follow Up Period|Lost to Follow-up|0|||
48796845|NCT01951625|157093801|FG003|Follow Up Period|Lost to Follow-up|1|||
48796846|NCT01951625|157093802|FG004|Follow Up Period|Lost to Follow-up|1|||
49039376|NCT00828321|157980681|FG001|Washout of 42 Days|Withdrawal by Subject|0|||
49039377|NCT00828321|157980680|FG000|Second Intervention|Protocol Violation|0|||
48796847|NCT03750006|157093803|FG000|Overall Study|Withdrawal by Subject|8|||
48796848|NCT03750006|157093803|FG000|Overall Study|COVID PANDEMIC|11|||
48796849|NCT01592370|157093804|FG000|Overall Study|Disease Progression|62|||
48796850|NCT01592370|157093805|FG001|Overall Study|Disease Progression|16|||
49039378|NCT00828321|157980681|FG001|Second Intervention|Protocol Violation|1|||
49039379|NCT00660660|157980684|FG000|Overall Study|Adverse Event|1|||
49039380|NCT00660660|157980685|FG001|Overall Study|Adverse Event|0|||
49039381|NCT00660660|157980684|FG000|Overall Study|Lost to Follow-up|0|||
49039382|NCT00660660|157980685|FG001|Overall Study|Lost to Follow-up|6|||
49039383|NCT00660660|157980684|FG000|Overall Study|Lack of Efficacy|0|||
49039384|NCT00660660|157980685|FG001|Overall Study|Lack of Efficacy|2|||
49039385|NCT00660660|157980684|FG000|Overall Study|Withdrawal by Subject|3|||
49039386|NCT00660660|157980685|FG001|Overall Study|Withdrawal by Subject|0|||
49039387|NCT00660660|157980684|FG000|Overall Study|Incorrect enrollment and other|0|||
49039388|NCT00660660|157980685|FG001|Overall Study|Incorrect enrollment and other|1|||
49039389|NCT00660660|157980684|FG000|Overall Study|New medication after randomization|1|||
49039390|NCT00660660|157980685|FG001|Overall Study|New medication after randomization|0|||
49039391|NCT01993186|157980690|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|1|||
49039392|NCT01993186|157980691|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
49039393|NCT01993186|157980690|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1|||
49039394|NCT01993186|157980691|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
49039395|NCT01993186|157980690|FG000|Open-Label Extension Period|Other, Not Specified|0|||
49039396|NCT01993186|157980691|FG001|Open-Label Extension Period|Other, Not Specified|1|||
49039397|NCT01993186|157980690|FG000|Open-Label Extension Period|Adverse Event|1|||
49039398|NCT01993186|157980691|FG001|Open-Label Extension Period|Adverse Event|0|||
49039399|NCT01993186|157980690|FG000|Open-Label Extension Period|Principal Investigator Decision|1|||
49039400|NCT01993186|157980691|FG001|Open-Label Extension Period|Principal Investigator Decision|0|||
49039401|NCT01993186|157980690|FG000|Open-Label Extension Period|Withdrawal by Subject|4|||
49039402|NCT01993186|157980691|FG001|Open-Label Extension Period|Withdrawal by Subject|5|||
49039403|NCT01993186|157980690|FG000|Open-Label Extension Period|Subject Non-Compliance|1|||
49039404|NCT01993186|157980691|FG001|Open-Label Extension Period|Subject Non-Compliance|0|||
49039405|NCT00396162|157980692|FG000|Overall Study|Withdrawal by Subject|2|||
49039406|NCT00396162|157980693|FG001|Overall Study|Withdrawal by Subject|3|||
49039407|NCT01117623|157980697|FG000|Overall Study|Adverse Event|0|||
49039408|NCT01117623|157980698|FG001|Overall Study|Adverse Event|2|||
49039409|NCT01117623|157980699|FG002|Overall Study|Adverse Event|4|||
49039410|NCT01117623|157980700|FG003|Overall Study|Adverse Event|0|||
49039411|NCT01117623|157980701|FG004|Overall Study|Adverse Event|2|||
49039412|NCT01117623|157980702|FG005|Overall Study|Adverse Event|0|||
49039413|NCT01117623|157980703|FG006|Overall Study|Adverse Event|0|||
49039414|NCT01117623|157980704|FG007|Overall Study|Adverse Event|2|||
49039415|NCT01117623|157980697|FG000|Overall Study|Disease progression, recurrence, relapse|3|||
49039416|NCT01117623|157980698|FG001|Overall Study|Disease progression, recurrence, relapse|6|||
49039417|NCT01117623|157980699|FG002|Overall Study|Disease progression, recurrence, relapse|5|||
48796851|NCT01592370|157093806|FG002|Overall Study|Disease Progression|52|||
48796852|NCT01592370|157093807|FG003|Overall Study|Disease Progression|3|||
48796853|NCT01592370|157093808|FG004|Overall Study|Disease Progression|3|||
48796854|NCT01592370|157093809|FG005|Overall Study|Disease Progression|31|||
48796855|NCT01592370|157093810|FG006|Overall Study|Disease Progression|14|||
48796856|NCT01592370|157093804|FG000|Overall Study|Study Drug Toxicity|14|||
48796857|NCT01592370|157093805|FG001|Overall Study|Study Drug Toxicity|3|||
48796858|NCT01592370|157093806|FG002|Overall Study|Study Drug Toxicity|0|||
48796859|NCT01592370|157093807|FG003|Overall Study|Study Drug Toxicity|0|||
48796860|NCT01592370|157093808|FG004|Overall Study|Study Drug Toxicity|0|||
48796861|NCT01592370|157093809|FG005|Overall Study|Study Drug Toxicity|0|||
48796862|NCT01592370|157093810|FG006|Overall Study|Study Drug Toxicity|1|||
48796863|NCT01592370|157093804|FG000|Overall Study|AE unrelated to study drug|4|||
48796864|NCT01592370|157093805|FG001|Overall Study|AE unrelated to study drug|3|||
48796865|NCT01592370|157093806|FG002|Overall Study|AE unrelated to study drug|0|||
48796866|NCT01592370|157093807|FG003|Overall Study|AE unrelated to study drug|0|||
48796867|NCT01592370|157093808|FG004|Overall Study|AE unrelated to study drug|0|||
48796868|NCT01592370|157093809|FG005|Overall Study|AE unrelated to study drug|0|||
48796869|NCT01592370|157093810|FG006|Overall Study|AE unrelated to study drug|1|||
48796870|NCT01592370|157093804|FG000|Overall Study|Request to discontinue study treatment|5|||
48796871|NCT01592370|157093805|FG001|Overall Study|Request to discontinue study treatment|0|||
48796872|NCT01592370|157093806|FG002|Overall Study|Request to discontinue study treatment|2|||
48796873|NCT01592370|157093807|FG003|Overall Study|Request to discontinue study treatment|0|||
48796874|NCT01592370|157093808|FG004|Overall Study|Request to discontinue study treatment|1|||
48796875|NCT01592370|157093809|FG005|Overall Study|Request to discontinue study treatment|2|||
48796876|NCT01592370|157093810|FG006|Overall Study|Request to discontinue study treatment|0|||
48796877|NCT01592370|157093804|FG000|Overall Study|Withdrew consent|1|||
49039418|NCT01117623|157980700|FG003|Overall Study|Disease progression, recurrence, relapse|6|||
49039419|NCT01117623|157980701|FG004|Overall Study|Disease progression, recurrence, relapse|8|||
49039420|NCT01117623|157980702|FG005|Overall Study|Disease progression, recurrence, relapse|14|||
49039421|NCT01117623|157980703|FG006|Overall Study|Disease progression, recurrence, relapse|5|||
49039422|NCT01117623|157980704|FG007|Overall Study|Disease progression, recurrence, relapse|22|||
49039423|NCT01117623|157980697|FG000|Overall Study|Withdrawal by Subject|0|||
49039424|NCT01117623|157980698|FG001|Overall Study|Withdrawal by Subject|0|||
49039425|NCT01117623|157980699|FG002|Overall Study|Withdrawal by Subject|2|||
49039426|NCT01117623|157980700|FG003|Overall Study|Withdrawal by Subject|0|||
49039427|NCT01117623|157980701|FG004|Overall Study|Withdrawal by Subject|0|||
49039428|NCT01117623|157980702|FG005|Overall Study|Withdrawal by Subject|1|||
49039429|NCT01117623|157980703|FG006|Overall Study|Withdrawal by Subject|1|||
49039430|NCT01117623|157980704|FG007|Overall Study|Withdrawal by Subject|1|||
49039431|NCT01117623|157980697|FG000|Overall Study|Non-compliance with study medication|0|||
49039432|NCT01117623|157980698|FG001|Overall Study|Non-compliance with study medication|0|||
49039433|NCT01117623|157980699|FG002|Overall Study|Non-compliance with study medication|0|||
49039434|NCT01117623|157980700|FG003|Overall Study|Non-compliance with study medication|0|||
48796878|NCT01592370|157093805|FG001|Overall Study|Withdrew consent|2|||
48796879|NCT01592370|157093806|FG002|Overall Study|Withdrew consent|1|||
48796880|NCT01592370|157093807|FG003|Overall Study|Withdrew consent|1|||
48796881|NCT01592370|157093808|FG004|Overall Study|Withdrew consent|0|||
48796882|NCT01592370|157093809|FG005|Overall Study|Withdrew consent|0|||
48796883|NCT01592370|157093810|FG006|Overall Study|Withdrew consent|0|||
48796884|NCT01592370|157093804|FG000|Overall Study|Maximum clinical benefit|11|||
48796885|NCT01592370|157093805|FG001|Overall Study|Maximum clinical benefit|1|||
48796886|NCT01592370|157093806|FG002|Overall Study|Maximum clinical benefit|7|||
48796887|NCT01592370|157093807|FG003|Overall Study|Maximum clinical benefit|1|||
48796888|NCT01592370|157093808|FG004|Overall Study|Maximum clinical benefit|0|||
48796889|NCT01592370|157093809|FG005|Overall Study|Maximum clinical benefit|0|||
48796890|NCT01592370|157093810|FG006|Overall Study|Maximum clinical benefit|0|||
48796891|NCT01592370|157093804|FG000|Overall Study|No longer meets study criteria|1|||
48796892|NCT01592370|157093805|FG001|Overall Study|No longer meets study criteria|0|||
48796893|NCT01592370|157093806|FG002|Overall Study|No longer meets study criteria|0|||
48796894|NCT01592370|157093807|FG003|Overall Study|No longer meets study criteria|0|||
48796895|NCT01592370|157093808|FG004|Overall Study|No longer meets study criteria|0|||
48796896|NCT01592370|157093809|FG005|Overall Study|No longer meets study criteria|0|||
48796897|NCT01592370|157093810|FG006|Overall Study|No longer meets study criteria|0|||
48796898|NCT01592370|157093804|FG000|Overall Study|Other Reasons|6|||
48796899|NCT01592370|157093805|FG001|Overall Study|Other Reasons|0|||
48796900|NCT01592370|157093806|FG002|Overall Study|Other Reasons|10|||
48796901|NCT01592370|157093807|FG003|Overall Study|Other Reasons|0|||
48796902|NCT01592370|157093808|FG004|Overall Study|Other Reasons|0|||
49039435|NCT01117623|157980701|FG004|Overall Study|Non-compliance with study medication|0|||
48796903|NCT01592370|157093809|FG005|Overall Study|Other Reasons|1|||
48796904|NCT01592370|157093810|FG006|Overall Study|Other Reasons|0|||
48796905|NCT03535337|157093811|FG000|Stage 2 Randomization|Lost to Follow-up|0|||
48796906|NCT03535337|157093812|FG001|Stage 2 Randomization|Lost to Follow-up|0|||
48796907|NCT03535337|157093813|FG002|Stage 2 Randomization|Lost to Follow-up|2|||
48796908|NCT03535337|157093814|FG003|Stage 2 Randomization|Lost to Follow-up|1|||
48796909|NCT03535337|157093815|FG004|Stage 2 Randomization|Lost to Follow-up|5|||
48796910|NCT03535337|157093816|FG005|Stage 2 Randomization|Lost to Follow-up|4|||
48796911|NCT03535337|157093817|FG006|Stage 2 Randomization|Lost to Follow-up|3|||
48796912|NCT03535337|157093818|FG007|Stage 2 Randomization|Lost to Follow-up|6|||
48796913|NCT03535337|157093819|FG008|Stage 2 Randomization|Lost to Follow-up|0|||
48796914|NCT03535337|157093820|FG009|Stage 2 Randomization|Lost to Follow-up|2|||
48796915|NCT04918784|157095211|FG000|Overall Study|Amputation - no longer eligible|1|||
48796916|NCT04918784|157095212|FG001|Overall Study|Amputation - no longer eligible|2|||
48796917|NCT04918784|157095211|FG000|Overall Study|Death|1|||
48796918|NCT04918784|157095212|FG001|Overall Study|Death|0|||
48796919|NCT04918784|157095211|FG000|Overall Study|patient non-compliance|3|||
48796920|NCT04918784|157095212|FG001|Overall Study|patient non-compliance|1|||
48796921|NCT04918784|157095211|FG000|Overall Study|Adverse Event|1|||
48796922|NCT04918784|157095212|FG001|Overall Study|Adverse Event|0|||
48796923|NCT01877408|157095213|FG000|Overall Study|Lost to Follow-up|0|||
48796924|NCT01877408|157095214|FG001|Overall Study|Lost to Follow-up|2|||
48796925|NCT04120233|157095217|FG000|Overall Study|Adverse Event|0|||
48796926|NCT04120233|157095218|FG001|Overall Study|Adverse Event|0|||
48796927|NCT04120233|157095219|FG002|Overall Study|Adverse Event|0|||
48796928|NCT04120233|157095220|FG003|Overall Study|Adverse Event|0|||
48796929|NCT04120233|157095221|FG004|Overall Study|Adverse Event|1|||
48796930|NCT04120233|157095222|FG005|Overall Study|Adverse Event|0|||
48796931|NCT00175825|157095223|FG000|Overall Study|Adverse Event|3|||
48796932|NCT00175825|157095224|FG001|Overall Study|Adverse Event|2|||
48796933|NCT00175825|157095225|FG002|Overall Study|Adverse Event|1|||
48796934|NCT00175825|157095226|FG003|Overall Study|Adverse Event|1|||
48796935|NCT00175825|157095223|FG000|Overall Study|Lost to Follow-up|1|||
48796936|NCT00175825|157095224|FG001|Overall Study|Lost to Follow-up|2|||
48796937|NCT00175825|157095225|FG002|Overall Study|Lost to Follow-up|0|||
48796938|NCT00175825|157095226|FG003|Overall Study|Lost to Follow-up|0|||
48796939|NCT00175825|157095223|FG000|Overall Study|Withdrawal by Subject|1|||
48796940|NCT00175825|157095224|FG001|Overall Study|Withdrawal by Subject|0|||
48796941|NCT00175825|157095225|FG002|Overall Study|Withdrawal by Subject|0|||
48796942|NCT00175825|157095226|FG003|Overall Study|Withdrawal by Subject|0|||
48796943|NCT00857207|157095227|FG000|Overall Study|Withdrawal by Subject|13|||
48796944|NCT00857207|157095228|FG001|Overall Study|Withdrawal by Subject|0|||
48796945|NCT00857207|157095227|FG000|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18|||
48796946|NCT00857207|157095228|FG001|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0|||
48796947|NCT00857207|157095227|FG000|Overall Study|Subject chose not to participate after signing consent|3|||
48796948|NCT00857207|157095228|FG001|Overall Study|Subject chose not to participate after signing consent|0|||
48796949|NCT04205630|157095232|FG000|Overall Study|Disease progression per RECIST 1.1|37|||
48796950|NCT04205630|157095232|FG000|Overall Study|Disease clinical progression|7|||
48796951|NCT04205630|157095232|FG000|Overall Study|Withdrawal by Subject|2|||
48796952|NCT04205630|157095232|FG000|Overall Study|Adverse Event|17|||
48796953|NCT04205630|157095232|FG000|Overall Study|Other|1|||
48796954|NCT04791761|157095235|FG000|Overall Study|Lost to Follow-up|8|||
48796955|NCT04791761|157095236|FG001|Overall Study|Lost to Follow-up|6|||
48796956|NCT04791761|157095237|FG002|Overall Study|Lost to Follow-up|10|||
48796957|NCT04791761|157095235|FG000|Overall Study|Withdrawal by Subject|0|||
48796958|NCT04791761|157095236|FG001|Overall Study|Withdrawal by Subject|1|||
48796959|NCT04791761|157095237|FG002|Overall Study|Withdrawal by Subject|1|||
48796960|NCT04791761|157095235|FG000|Overall Study|Protocol Violation|0|||
48796961|NCT04791761|157095236|FG001|Overall Study|Protocol Violation|1|||
48796962|NCT04791761|157095237|FG002|Overall Study|Protocol Violation|1|||
48796963|NCT03224182|157095238|FG000|Overall Study|Study Drug Not Instilled|6|||
48796964|NCT03224182|157095239|FG001|Overall Study|Study Drug Not Instilled|1|||
48796965|NCT03224182|157095238|FG000|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22|||
48796966|NCT03224182|157095239|FG001|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11|||
48796967|NCT03224182|157095238|FG000|Overall Study|Withdrew of Consent|4|||
48796968|NCT03224182|157095239|FG001|Overall Study|Withdrew of Consent|2|||
48796969|NCT03224182|157095238|FG000|Overall Study|Investigator Decision|3|||
48796970|NCT03224182|157095239|FG001|Overall Study|Investigator Decision|1|||
48796971|NCT03224182|157095238|FG000|Overall Study|Sponsor Decision|26|||
48796972|NCT03224182|157095239|FG001|Overall Study|Sponsor Decision|12|||
48796973|NCT03224182|157095238|FG000|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4|||
48796974|NCT03224182|157095239|FG001|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0|||
48796975|NCT03224182|157095238|FG000|Overall Study|Lost to Follow-up|1|||
48796976|NCT03224182|157095239|FG001|Overall Study|Lost to Follow-up|0|||
48796977|NCT03224182|157095238|FG000|Overall Study|Participant Had Recurrence|11|||
48796978|NCT03224182|157095239|FG001|Overall Study|Participant Had Recurrence|5|||
48796979|NCT03224182|157095238|FG000|Overall Study|Death|0|||
48796980|NCT03224182|157095239|FG001|Overall Study|Death|1|||
48796981|NCT03224182|157095238|FG000|Overall Study|Reason not Specified|3|||
48796982|NCT03224182|157095239|FG001|Overall Study|Reason not Specified|3|||
48796983|NCT03224182|157095238|FG000|Overall Study|Other|1|||
48796984|NCT03224182|157095239|FG001|Overall Study|Other|0|||
48796985|NCT02481310|157095240|FG000|Follow up|Still in follow up|0|||
48796986|NCT02481310|157095241|FG001|Follow up|Still in follow up|3|||
48796987|NCT02481310|157095242|FG002|Follow up|Still in follow up|0|||
48796988|NCT00833560|157095243|FG000|Overall Study|Toxicity|13|||
48796989|NCT00833560|157095243|FG000|Overall Study|Adverse Event|11|||
48796990|NCT00833560|157095243|FG000|Overall Study|Protocol Violation|6|||
48796991|NCT00833560|157095243|FG000|Overall Study|Lack of Efficacy|4|||
48796992|NCT00833560|157095243|FG000|Overall Study|Death|2|||
48796993|NCT00833560|157095243|FG000|Overall Study|Pregression of other disease|1|||
48796994|NCT00833560|157095243|FG000|Overall Study|Other|5|||
48796995|NCT02008890|157095244|FG000|Period 1|Withdrawal by Subject|7|||
48796996|NCT02008890|157095245|FG001|Period 1|Withdrawal by Subject|7|||
48796997|NCT02008890|157095246|FG002|Period 1|Withdrawal by Subject|5|||
48796998|NCT02008890|157095247|FG003|Period 1|Withdrawal by Subject|0|||
48796999|NCT02008890|157095248|FG004|Period 1|Withdrawal by Subject|0|||
48797000|NCT02008890|157095244|FG000|Period 1|Pregnancy|1|||
48797001|NCT02008890|157095245|FG001|Period 1|Pregnancy|0|||
48797002|NCT02008890|157095246|FG002|Period 1|Pregnancy|0|||
48797003|NCT02008890|157095247|FG003|Period 1|Pregnancy|0|||
48797004|NCT02008890|157095248|FG004|Period 1|Pregnancy|0|||
48797005|NCT02008890|157095244|FG000|Period 1|Physician Decision|1|||
48797006|NCT02008890|157095245|FG001|Period 1|Physician Decision|0|||
48797007|NCT02008890|157095246|FG002|Period 1|Physician Decision|1|||
48797008|NCT02008890|157095247|FG003|Period 1|Physician Decision|0|||
48797009|NCT02008890|157095248|FG004|Period 1|Physician Decision|0|||
48797010|NCT02008890|157095244|FG000|Period 1|Adverse Event|6|||
48797011|NCT02008890|157095245|FG001|Period 1|Adverse Event|8|||
48797012|NCT02008890|157095246|FG002|Period 1|Adverse Event|6|||
48797013|NCT02008890|157095247|FG003|Period 1|Adverse Event|0|||
48797014|NCT02008890|157095248|FG004|Period 1|Adverse Event|0|||
48797015|NCT02008890|157095244|FG000|Period 2|Adverse Event|12|||
48797016|NCT02008890|157095245|FG001|Period 2|Adverse Event|7|||
48797017|NCT02008890|157095246|FG002|Period 2|Adverse Event|0|||
48797018|NCT02008890|157095247|FG003|Period 2|Adverse Event|5|||
48797019|NCT02008890|157095248|FG004|Period 2|Adverse Event|5|||
48797020|NCT02008890|157095244|FG000|Period 2|Withdrawal by Subject|11|||
48797021|NCT02008890|157095245|FG001|Period 2|Withdrawal by Subject|8|||
48797022|NCT02008890|157095246|FG002|Period 2|Withdrawal by Subject|0|||
48797023|NCT02008890|157095247|FG003|Period 2|Withdrawal by Subject|7|||
48797024|NCT02008890|157095248|FG004|Period 2|Withdrawal by Subject|2|||
48797025|NCT02008890|157095244|FG000|Period 2|Physician Decision|4|||
48797026|NCT02008890|157095245|FG001|Period 2|Physician Decision|0|||
48797027|NCT02008890|157095246|FG002|Period 2|Physician Decision|0|||
48797028|NCT02008890|157095247|FG003|Period 2|Physician Decision|2|||
48797029|NCT02008890|157095248|FG004|Period 2|Physician Decision|1|||
48797030|NCT02008890|157095244|FG000|Period 2|Lost to Follow-up|0|||
48797031|NCT02008890|157095245|FG001|Period 2|Lost to Follow-up|0|||
48797032|NCT02008890|157095246|FG002|Period 2|Lost to Follow-up|1|||
48797033|NCT02008890|157095247|FG003|Period 2|Lost to Follow-up|0|||
48797034|NCT02008890|157095248|FG004|Period 2|Lost to Follow-up|0|||
48797035|NCT02008890|157095244|FG000|Extension Period|Withdrawal by Subject|3|||
48797036|NCT02008890|157095245|FG001|Extension Period|Withdrawal by Subject|2|||
48797037|NCT02008890|157095246|FG002|Extension Period|Withdrawal by Subject|0|||
48797038|NCT02008890|157095247|FG003|Extension Period|Withdrawal by Subject|4|||
48797039|NCT02008890|157095248|FG004|Extension Period|Withdrawal by Subject|2|||
48797040|NCT02008890|157095244|FG000|Extension Period|Lost to Follow-up|1|||
48797041|NCT02008890|157095245|FG001|Extension Period|Lost to Follow-up|0|||
48797042|NCT02008890|157095246|FG002|Extension Period|Lost to Follow-up|0|||
48797043|NCT02008890|157095247|FG003|Extension Period|Lost to Follow-up|0|||
48797044|NCT02008890|157095248|FG004|Extension Period|Lost to Follow-up|0|||
48797045|NCT02008890|157095244|FG000|Extension Period|Adverse Event|1|||
48797046|NCT02008890|157095245|FG001|Extension Period|Adverse Event|3|||
48797047|NCT02008890|157095246|FG002|Extension Period|Adverse Event|0|||
48797048|NCT02008890|157095247|FG003|Extension Period|Adverse Event|0|||
48797049|NCT02008890|157095248|FG004|Extension Period|Adverse Event|2|||
48797050|NCT00643916|157095249|FG000|Overall Study|Protocol Violation|0|||
48797051|NCT00643916|157095250|FG001|Overall Study|Protocol Violation|1|||
48797052|NCT00643916|157095251|FG002|Overall Study|Protocol Violation|1|||
48797053|NCT00643916|157095252|FG003|Overall Study|Protocol Violation|1|||
48797054|NCT00643916|157095253|FG004|Overall Study|Protocol Violation|0|||
48797055|NCT00643916|157095254|FG005|Overall Study|Protocol Violation|0|||
48797056|NCT00643916|157095249|FG000|Overall Study|Lost to Follow-up|0|||
48797057|NCT00643916|157095250|FG001|Overall Study|Lost to Follow-up|1|||
48797058|NCT00643916|157095251|FG002|Overall Study|Lost to Follow-up|0|||
48797059|NCT00643916|157095252|FG003|Overall Study|Lost to Follow-up|0|||
48797060|NCT00643916|157095253|FG004|Overall Study|Lost to Follow-up|0|||
48797061|NCT00643916|157095254|FG005|Overall Study|Lost to Follow-up|0|||
48797062|NCT00643916|157095249|FG000|Overall Study|Withdrawal by Subject|2|||
48797063|NCT00643916|157095250|FG001|Overall Study|Withdrawal by Subject|2|||
48797064|NCT00643916|157095251|FG002|Overall Study|Withdrawal by Subject|2|||
48797065|NCT00643916|157095252|FG003|Overall Study|Withdrawal by Subject|1|||
48797066|NCT00643916|157095253|FG004|Overall Study|Withdrawal by Subject|0|||
48797067|NCT00643916|157095254|FG005|Overall Study|Withdrawal by Subject|1|||
48797068|NCT00643916|157095249|FG000|Overall Study|Not Vaccinated|2|||
48797069|NCT00643916|157095250|FG001|Overall Study|Not Vaccinated|2|||
48797070|NCT00643916|157095251|FG002|Overall Study|Not Vaccinated|3|||
48797071|NCT00643916|157095252|FG003|Overall Study|Not Vaccinated|0|||
48797072|NCT00643916|157095253|FG004|Overall Study|Not Vaccinated|2|||
48797073|NCT00643916|157095254|FG005|Overall Study|Not Vaccinated|0|||
48797074|NCT00499031|157095256|FG000|Overall Study|Improper pre-protocol treatment|1|||
48797075|NCT00499031|157095256|FG000|Overall Study|Required test not done|1|||
48797076|NCT00499031|157095256|FG000|Overall Study|Never treated|1|||
48797077|NCT02565914|157095260|FG000|Part A (Up to 96 Weeks)|Adverse Event|17|||
48797078|NCT02565914|157095260|FG000|Part A (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|25|||
48797079|NCT02565914|157095260|FG000|Part A (Up to 96 Weeks)|Lost to Follow-up|12|||
48797080|NCT02565914|157095260|FG000|Part A (Up to 96 Weeks)|Death (not treatment emergent)|1|||
48797081|NCT02565914|157095260|FG000|Part A (Up to 96 Weeks)|Other noncompliance|6|||
48797082|NCT02565914|157095260|FG000|Part A (Up to 96 Weeks)|Physician Decision|6|||
48797083|NCT02565914|157095260|FG000|Part A (Up to 96 Weeks)|Parent study termination by sponsor|1|||
48797084|NCT02565914|157095260|FG000|Part A (Up to 96 Weeks)|Commercial drug available|5|||
48797085|NCT02565914|157095260|FG000|Part A (Up to 96 Weeks)|Other|18|||
48797086|NCT02565914|157095260|FG000|Part A (Up to 96 Weeks)|Enrolled, but did not receive study drug|2|||
48797087|NCT02565914|157095260|FG000|Part B (Up to 96 Weeks)|Physician Decision|1|||
48797088|NCT02565914|157095260|FG000|Part B (Up to 96 Weeks)|Other|1|||
48797089|NCT02565914|157095260|FG000|Part B (Up to 96 Weeks)|Enrolled, but did not receive study drug|1|||
48797090|NCT02565914|157095260|FG000|Part B (Up to 96 Weeks)|Adverse Event|4|||
48797091|NCT02565914|157095260|FG000|Part B (Up to 96 Weeks)|Sponsor Decision|2|||
48797092|NCT02565914|157095260|FG000|Part B (Up to 96 Weeks)|Rolled over into another study|25|||
48797093|NCT02565914|157095260|FG000|Part B (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|6|||
48797094|NCT02565914|157095260|FG000|Part B (Up to 96 Weeks)|Commercial drug is available for participant|196|||
48797095|NCT02565914|157095260|FG000|Part C (Up to 192 Weeks)|Physician Decision|5|||
48797096|NCT02565914|157095260|FG000|Part C (Up to 192 Weeks)|Adverse Event|1|||
48797097|NCT02565914|157095260|FG000|Part C (Up to 192 Weeks)|Other non-compliance|2|||
48797098|NCT02565914|157095260|FG000|Part C (Up to 192 Weeks)|Rolled over into another study|11|||
48797099|NCT02565914|157095260|FG000|Part C (Up to 192 Weeks)|Withdrawal of consent (not due to AE)|4|||
48797100|NCT02565914|157095260|FG000|Part C (Up to 192 Weeks)|Commercial drug is available for participant|174|||
48797101|NCT02450331|157095261|FG000|Overall Study|Death|162|||
48797102|NCT02450331|157095262|FG001|Overall Study|Death|171|||
48797103|NCT02450331|157095261|FG000|Overall Study|Lost to Follow-up|14|||
48797104|NCT02450331|157095262|FG001|Overall Study|Lost to Follow-up|12|||
48797105|NCT02450331|157095261|FG000|Overall Study|Withdrawal by Subject|55|||
48797106|NCT02450331|157095262|FG001|Overall Study|Withdrawal by Subject|44|||
48797107|NCT02450331|157095261|FG000|Overall Study|Non-specified other|1|||
48797108|NCT02450331|157095262|FG001|Overall Study|Non-specified other|1|||
48797109|NCT03581981|157095263|FG000|Overall Study|Withdrawal by Subject|12|||
48797110|NCT03581981|157095264|FG001|Overall Study|Withdrawal by Subject|13|||
48797111|NCT03581981|157095263|FG000|Overall Study|Physician Decision|1|||
48797112|NCT03581981|157095264|FG001|Overall Study|Physician Decision|2|||
48797113|NCT03581981|157095263|FG000|Overall Study|Lost to Follow-up|0|||
48797114|NCT03581981|157095264|FG001|Overall Study|Lost to Follow-up|4|||
48797115|NCT02047045|157095267|FG000|Baseline|Withdrawal by Subject|3|||
48797116|NCT02047045|157095268|FG001|Baseline|Withdrawal by Subject|2|||
48797117|NCT02047045|157095267|FG000|Treatment Period (8 Weeks )|Adverse Event|3|||
49039436|NCT01117623|157980702|FG005|Overall Study|Non-compliance with study medication|0|||
49039437|NCT01117623|157980703|FG006|Overall Study|Non-compliance with study medication|0|||
49039438|NCT01117623|157980704|FG007|Overall Study|Non-compliance with study medication|1|||
49039439|NCT01117623|157980697|FG000|Overall Study|Invest. text: completed all planned txs|0|||
49039440|NCT01117623|157980698|FG001|Overall Study|Invest. text: completed all planned txs|0|||
49039441|NCT01117623|157980699|FG002|Overall Study|Invest. text: completed all planned txs|0|||
49039442|NCT01117623|157980700|FG003|Overall Study|Invest. text: completed all planned txs|0|||
49039443|NCT01117623|157980701|FG004|Overall Study|Invest. text: completed all planned txs|0|||
49039444|NCT01117623|157980702|FG005|Overall Study|Invest. text: completed all planned txs|1|||
49039445|NCT01117623|157980703|FG006|Overall Study|Invest. text: completed all planned txs|0|||
49039446|NCT01117623|157980704|FG007|Overall Study|Invest. text: completed all planned txs|0|||
49039447|NCT01253564|157980705|FG000|Overall Study|Disease Progression|22|||
49039448|NCT01253564|157980705|FG000|Overall Study|Withdrawal by Subject|1|||
48797118|NCT02047045|157095268|FG001|Treatment Period (8 Weeks )|Adverse Event|1|||
48797119|NCT02047045|157095267|FG000|Treatment Period (8 Weeks )|Lost to Follow-up|1|||
48797120|NCT02047045|157095268|FG001|Treatment Period (8 Weeks )|Lost to Follow-up|3|||
48797121|NCT02047045|157095267|FG000|Treatment Period (8 Weeks )|Withdrawal by Subject|3|||
48797122|NCT02047045|157095268|FG001|Treatment Period (8 Weeks )|Withdrawal by Subject|5|||
48797123|NCT02047045|157095267|FG000|Treatment Period (8 Weeks )|moved far away out of work|3|||
48797124|NCT02047045|157095268|FG001|Treatment Period (8 Weeks )|moved far away out of work|0|||
48797125|NCT02047045|157095267|FG000|Treatment Period (8 Weeks )|no reason was given|1|||
48797126|NCT02047045|157095268|FG001|Treatment Period (8 Weeks )|no reason was given|0|||
48797127|NCT02047045|157095267|FG000|Treatment Period (8 Weeks )|refused to take drugs|0|||
48797128|NCT02047045|157095268|FG001|Treatment Period (8 Weeks )|refused to take drugs|5|||
48797129|NCT02047045|157095267|FG000|Treatment Period (8 Weeks )|for safety considerations|0|||
48797130|NCT02047045|157095268|FG001|Treatment Period (8 Weeks )|for safety considerations|1|||
48797131|NCT02047045|157095267|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
48797132|NCT02047045|157095268|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
48797133|NCT00082173|157095269|FG000|Overall Study|Withdrawal by Subject|3|||
48797134|NCT00082173|157095270|FG001|Overall Study|Withdrawal by Subject|5|||
48797135|NCT00082173|157095269|FG000|Overall Study|Lost to Follow-up|1|||
48797136|NCT00082173|157095270|FG001|Overall Study|Lost to Follow-up|0|||
48797137|NCT00082173|157095269|FG000|Overall Study|Adverse Event|1|||
48797138|NCT00082173|157095270|FG001|Overall Study|Adverse Event|0|||
48797139|NCT00082173|157095269|FG000|Overall Study|Culture negative or resistant at baselin|5|||
48797140|NCT00082173|157095270|FG001|Overall Study|Culture negative or resistant at baselin|6|||
48797141|NCT04465357|157095271|FG000|Overall Study|Adverse Event|2|||
48797142|NCT04465357|157095271|FG000|Overall Study|Lack of Efficacy|1|||
48797143|NCT04465357|157095271|FG000|Overall Study|Lost to Follow-up|2|||
48797144|NCT04465357|157095271|FG000|Overall Study|Withdrawal by Subject|6|||
48797145|NCT04465357|157095271|FG000|Overall Study|Protocol specified withdrawal criterion met|2|||
48797146|NCT03214367|157095272|FG000|Lead-in Period|Withdrawal by Subject|50|||
48797147|NCT03214367|157095273|FG001|Lead-in Period|Withdrawal by Subject|0|||
48797148|NCT03214367|157095274|FG002|Lead-in Period|Withdrawal by Subject|0|||
48797149|NCT03214367|157095275|FG003|Lead-in Period|Withdrawal by Subject|0|||
48797150|NCT03214367|157095276|FG004|Lead-in Period|Withdrawal by Subject|2|||
48797151|NCT03214367|157095277|FG005|Lead-in Period|Withdrawal by Subject|0|||
48797152|NCT03214367|157095278|FG006|Lead-in Period|Withdrawal by Subject|0|||
48797153|NCT03214367|157095279|FG007|Lead-in Period|Withdrawal by Subject|0|||
48797154|NCT03214367|157095272|FG000|Lead-in Period|Adverse Event|3|||
48797155|NCT03214367|157095273|FG001|Lead-in Period|Adverse Event|0|||
48797156|NCT03214367|157095274|FG002|Lead-in Period|Adverse Event|0|||
48797157|NCT03214367|157095275|FG003|Lead-in Period|Adverse Event|0|||
48797158|NCT03214367|157095276|FG004|Lead-in Period|Adverse Event|0|||
48797159|NCT03214367|157095277|FG005|Lead-in Period|Adverse Event|0|||
48797160|NCT03214367|157095278|FG006|Lead-in Period|Adverse Event|0|||
48797161|NCT03214367|157095279|FG007|Lead-in Period|Adverse Event|0|||
48797162|NCT03214367|157095272|FG000|Lead-in Period|Lost to Follow-up|12|||
48797163|NCT03214367|157095273|FG001|Lead-in Period|Lost to Follow-up|0|||
48797164|NCT03214367|157095274|FG002|Lead-in Period|Lost to Follow-up|0|||
48797165|NCT03214367|157095275|FG003|Lead-in Period|Lost to Follow-up|0|||
48797166|NCT03214367|157095276|FG004|Lead-in Period|Lost to Follow-up|0|||
48797167|NCT03214367|157095277|FG005|Lead-in Period|Lost to Follow-up|0|||
48797168|NCT03214367|157095278|FG006|Lead-in Period|Lost to Follow-up|0|||
48797169|NCT03214367|157095279|FG007|Lead-in Period|Lost to Follow-up|0|||
48797170|NCT03214367|157095272|FG000|Lead-in Period|Sponsor Decision|11|||
48797171|NCT03214367|157095273|FG001|Lead-in Period|Sponsor Decision|0|||
48797172|NCT03214367|157095274|FG002|Lead-in Period|Sponsor Decision|0|||
48797173|NCT03214367|157095275|FG003|Lead-in Period|Sponsor Decision|0|||
48797174|NCT03214367|157095276|FG004|Lead-in Period|Sponsor Decision|0|||
48797175|NCT03214367|157095277|FG005|Lead-in Period|Sponsor Decision|0|||
48797176|NCT03214367|157095278|FG006|Lead-in Period|Sponsor Decision|0|||
48797177|NCT03214367|157095279|FG007|Lead-in Period|Sponsor Decision|0|||
49039449|NCT01253564|157980705|FG000|Overall Study|Serious Adverse Event|1|||
49039450|NCT02694536|157980711|FG000|Overall Study|Progressive Disease|40|||
49039451|NCT02694536|157980711|FG000|Overall Study|Lost to Follow-up|1|||
49039452|NCT02694536|157980711|FG000|Overall Study|Study Drug-Related Adverse Event|1|||
49039453|NCT02694536|157980711|FG000|Overall Study|Withdrawal by Subject|8|||
49039454|NCT02694536|157980711|FG000|Overall Study|Death|8|||
49039455|NCT02694536|157980711|FG000|Overall Study|Other|22|||
49039456|NCT00059332|157980712|FG000|Overall Study|Withdrawal by Subject|2|||
49039457|NCT00059332|157980713|FG001|Overall Study|Withdrawal by Subject|1|||
49039458|NCT00059332|157980712|FG000|Overall Study|Lost to Follow-up|1|||
49039459|NCT00059332|157980713|FG001|Overall Study|Lost to Follow-up|1|||
49039460|NCT02627963|157980718|FG000|Overall Study|Randomized but not treated|2|||
48797178|NCT03214367|157095272|FG000|Lead-in Period|Physician Decision|12|||
48797179|NCT03214367|157095273|FG001|Lead-in Period|Physician Decision|0|||
48797180|NCT03214367|157095274|FG002|Lead-in Period|Physician Decision|0|||
48797181|NCT03214367|157095275|FG003|Lead-in Period|Physician Decision|0|||
48797182|NCT03214367|157095276|FG004|Lead-in Period|Physician Decision|0|||
48797183|NCT03214367|157095277|FG005|Lead-in Period|Physician Decision|0|||
48797184|NCT03214367|157095278|FG006|Lead-in Period|Physician Decision|0|||
48797185|NCT03214367|157095279|FG007|Lead-in Period|Physician Decision|0|||
48797186|NCT03214367|157095272|FG000|Lead-in Period|Protocol Violation|5|||
48797187|NCT03214367|157095273|FG001|Lead-in Period|Protocol Violation|0|||
48797188|NCT03214367|157095274|FG002|Lead-in Period|Protocol Violation|0|||
49039461|NCT02627963|157980719|FG001|Overall Study|Randomized but not treated|6|||
49039462|NCT00663234|157980720|FG000|Overall Study|Not willing to adhere to requirements|1|||
48797189|NCT03214367|157095275|FG003|Lead-in Period|Protocol Violation|0|||
48797190|NCT03214367|157095276|FG004|Lead-in Period|Protocol Violation|0|||
48797191|NCT03214367|157095277|FG005|Lead-in Period|Protocol Violation|0|||
48797192|NCT03214367|157095278|FG006|Lead-in Period|Protocol Violation|0|||
48797193|NCT03214367|157095279|FG007|Lead-in Period|Protocol Violation|0|||
48797194|NCT03214367|157095272|FG000|Lead-in Period|Treatment Interruption|1|||
48797195|NCT03214367|157095273|FG001|Lead-in Period|Treatment Interruption|0|||
48797196|NCT03214367|157095274|FG002|Lead-in Period|Treatment Interruption|0|||
48797197|NCT03214367|157095275|FG003|Lead-in Period|Treatment Interruption|0|||
48797198|NCT03214367|157095276|FG004|Lead-in Period|Treatment Interruption|0|||
48797199|NCT03214367|157095277|FG005|Lead-in Period|Treatment Interruption|0|||
48797200|NCT03214367|157095278|FG006|Lead-in Period|Treatment Interruption|0|||
48797201|NCT03214367|157095279|FG007|Lead-in Period|Treatment Interruption|0|||
48797202|NCT03214367|157095272|FG000|Treatment Period|Adverse Event|0|||
48797203|NCT03214367|157095273|FG001|Treatment Period|Adverse Event|1|||
48797204|NCT03214367|157095274|FG002|Treatment Period|Adverse Event|4|||
48797205|NCT03214367|157095275|FG003|Treatment Period|Adverse Event|2|||
48797206|NCT03214367|157095276|FG004|Treatment Period|Adverse Event|0|||
48797207|NCT03214367|157095277|FG005|Treatment Period|Adverse Event|0|||
48797208|NCT03214367|157095278|FG006|Treatment Period|Adverse Event|0|||
48797209|NCT03214367|157095279|FG007|Treatment Period|Adverse Event|0|||
48797210|NCT03214367|157095272|FG000|Treatment Period|Death|0|||
48797211|NCT03214367|157095273|FG001|Treatment Period|Death|1|||
48797212|NCT03214367|157095274|FG002|Treatment Period|Death|1|||
48797213|NCT03214367|157095275|FG003|Treatment Period|Death|1|||
48797214|NCT03214367|157095276|FG004|Treatment Period|Death|0|||
49039463|NCT01266902|157980721|FG000|Period 1 (Main Study)|Investigator's decision/Participant's decision|2|||
49039464|NCT01266902|157980722|FG001|Period 1 (Main Study)|Investigator's decision/Participant's decision|3|||
49039465|NCT01266902|157980723|FG002|Period 1 (Main Study)|Investigator's decision/Participant's decision|0|||
49039466|NCT01266902|157980721|FG000|Period 1 (Main Study)|Lost to Follow-up|5|||
48797215|NCT03214367|157095277|FG005|Treatment Period|Death|0|||
49039467|NCT01266902|157980722|FG001|Period 1 (Main Study)|Lost to Follow-up|12|||
49039468|NCT01266902|157980723|FG002|Period 1 (Main Study)|Lost to Follow-up|0|||
49039469|NCT01266902|157980721|FG000|Period 1 (Main Study)|Lack of Efficacy|4|||
49039470|NCT01266902|157980722|FG001|Period 1 (Main Study)|Lack of Efficacy|2|||
49039471|NCT01266902|157980723|FG002|Period 1 (Main Study)|Lack of Efficacy|0|||
48797216|NCT03214367|157095278|FG006|Treatment Period|Death|0|||
48797217|NCT03214367|157095279|FG007|Treatment Period|Death|0|||
48797218|NCT03214367|157095272|FG000|Treatment Period|Lost to Follow-up|0|||
48797219|NCT03214367|157095273|FG001|Treatment Period|Lost to Follow-up|5|||
48797220|NCT03214367|157095274|FG002|Treatment Period|Lost to Follow-up|3|||
48797221|NCT03214367|157095275|FG003|Treatment Period|Lost to Follow-up|2|||
48797222|NCT03214367|157095276|FG004|Treatment Period|Lost to Follow-up|0|||
48797223|NCT03214367|157095277|FG005|Treatment Period|Lost to Follow-up|2|||
48797224|NCT03214367|157095278|FG006|Treatment Period|Lost to Follow-up|1|||
48797225|NCT03214367|157095279|FG007|Treatment Period|Lost to Follow-up|0|||
48797226|NCT03214367|157095272|FG000|Treatment Period|Sponsor Decision|0|||
48797227|NCT03214367|157095273|FG001|Treatment Period|Sponsor Decision|3|||
48797228|NCT03214367|157095274|FG002|Treatment Period|Sponsor Decision|0|||
48797229|NCT03214367|157095275|FG003|Treatment Period|Sponsor Decision|0|||
48797230|NCT03214367|157095276|FG004|Treatment Period|Sponsor Decision|0|||
48797231|NCT03214367|157095277|FG005|Treatment Period|Sponsor Decision|0|||
48797232|NCT03214367|157095278|FG006|Treatment Period|Sponsor Decision|0|||
48797233|NCT03214367|157095279|FG007|Treatment Period|Sponsor Decision|0|||
48797234|NCT03214367|157095272|FG000|Treatment Period|Physician Decision|0|||
48797235|NCT03214367|157095273|FG001|Treatment Period|Physician Decision|1|||
48797236|NCT03214367|157095274|FG002|Treatment Period|Physician Decision|2|||
49039472|NCT01266902|157980721|FG000|Period 1 (Main Study)|Adverse Event|3|||
49039473|NCT01266902|157980722|FG001|Period 1 (Main Study)|Adverse Event|11|||
49039474|NCT01266902|157980723|FG002|Period 1 (Main Study)|Adverse Event|0|||
49039475|NCT01266902|157980721|FG000|Period 1 (Main Study)|Withdrawal by Subject|2|||
48797237|NCT03214367|157095275|FG003|Treatment Period|Physician Decision|0|||
48797238|NCT03214367|157095276|FG004|Treatment Period|Physician Decision|0|||
48797239|NCT03214367|157095277|FG005|Treatment Period|Physician Decision|0|||
48797240|NCT03214367|157095278|FG006|Treatment Period|Physician Decision|0|||
48797241|NCT03214367|157095279|FG007|Treatment Period|Physician Decision|0|||
48797242|NCT03214367|157095272|FG000|Treatment Period|Protocol Violation|0|||
48797243|NCT03214367|157095273|FG001|Treatment Period|Protocol Violation|3|||
48797244|NCT03214367|157095274|FG002|Treatment Period|Protocol Violation|0|||
48797245|NCT03214367|157095275|FG003|Treatment Period|Protocol Violation|0|||
48797246|NCT03214367|157095276|FG004|Treatment Period|Protocol Violation|0|||
48797247|NCT03214367|157095277|FG005|Treatment Period|Protocol Violation|0|||
48797248|NCT03214367|157095278|FG006|Treatment Period|Protocol Violation|0|||
48797249|NCT03214367|157095279|FG007|Treatment Period|Protocol Violation|0|||
48797250|NCT03214367|157095272|FG000|Treatment Period|Withdrawal by Subject|0|||
48797251|NCT03214367|157095273|FG001|Treatment Period|Withdrawal by Subject|20|||
49039476|NCT01266902|157980722|FG001|Period 1 (Main Study)|Withdrawal by Subject|12|||
49039477|NCT01266902|157980723|FG002|Period 1 (Main Study)|Withdrawal by Subject|0|||
49039478|NCT01266902|157980721|FG000|Period 1 (Main Study)|Subject non-compliant|3|||
49039479|NCT01266902|157980722|FG001|Period 1 (Main Study)|Subject non-compliant|7|||
49039480|NCT01266902|157980723|FG002|Period 1 (Main Study)|Subject non-compliant|0|||
49039481|NCT01266902|157980721|FG000|Period 1 (Main Study)|Continued RPV treatment|11|||
49039482|NCT01266902|157980722|FG001|Period 1 (Main Study)|Continued RPV treatment|34|||
49039483|NCT01266902|157980723|FG002|Period 1 (Main Study)|Continued RPV treatment|0|||
49039484|NCT01266902|157980721|FG000|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
49039485|NCT01266902|157980722|FG001|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
49039486|NCT01266902|157980723|FG002|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1|||
49039487|NCT01266902|157980721|FG000|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
49039488|NCT01266902|157980722|FG001|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
49039489|NCT01266902|157980723|FG002|Period 2 (After Protocol Amendment 3)|Adverse Event|1|||
49039490|NCT01266902|157980721|FG000|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
49039491|NCT01266902|157980722|FG001|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
49039492|NCT01266902|157980723|FG002|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6|||
49039493|NCT01186458|157980731|FG000|Overall Study|Adverse Event|1|||
49039494|NCT05034874|157980732|FG000|Overall Study|Withdrawal by Subject|6|||
49039495|NCT05034874|157980733|FG001|Overall Study|Withdrawal by Subject|6|||
49039496|NCT05034874|157980732|FG000|Overall Study|Lost to Follow-up|18|||
49039497|NCT05034874|157980733|FG001|Overall Study|Lost to Follow-up|8|||
49039498|NCT05034874|157980732|FG000|Overall Study|Physician Decision|0|||
49039499|NCT05034874|157980733|FG001|Overall Study|Physician Decision|1|||
49039500|NCT05034874|157980732|FG000|Overall Study|Skipped final visits, checked into rehab|2|||
49039501|NCT05034874|157980733|FG001|Overall Study|Skipped final visits, checked into rehab|1|||
49039502|NCT00748566|157980735|FG000|Overall Study|Adverse Event|49|||
49039503|NCT00748566|157980735|FG000|Overall Study|Death|1|||
49039504|NCT00748566|157980735|FG000|Overall Study|Lack of Efficacy|12|||
49039505|NCT00748566|157980735|FG000|Overall Study|Lost to Follow-up|1|||
49039506|NCT00748566|157980735|FG000|Overall Study|Protocol Violation|13|||
49039507|NCT00748566|157980735|FG000|Overall Study|Withdrawal by Subject|22|||
49039508|NCT00748566|157980735|FG000|Overall Study|Study terminated by sponsor|5|||
49039509|NCT00748566|157980735|FG000|Overall Study|Other|9|||
49039510|NCT00989950|157980739|FG000|Randomized Phase|Protocol Violation|1|||
49039511|NCT00989950|157980740|FG001|Randomized Phase|Protocol Violation|0|||
49039512|NCT00989950|157980741|FG002|Randomized Phase|Protocol Violation|0|||
49039513|NCT00989950|157980742|FG003|Randomized Phase|Protocol Violation|0|||
49039514|NCT00989950|157980739|FG000|Randomized Phase|Adverse Event|0|||
48797252|NCT03214367|157095274|FG002|Treatment Period|Withdrawal by Subject|23|||
48797253|NCT03214367|157095275|FG003|Treatment Period|Withdrawal by Subject|14|||
48797254|NCT03214367|157095276|FG004|Treatment Period|Withdrawal by Subject|0|||
48797255|NCT03214367|157095277|FG005|Treatment Period|Withdrawal by Subject|1|||
48797256|NCT03214367|157095278|FG006|Treatment Period|Withdrawal by Subject|1|||
48797257|NCT03214367|157095279|FG007|Treatment Period|Withdrawal by Subject|1|||
48797258|NCT04402866|157095280|FG000|Overall Study|Discontinued Prior to Treatment|0|||
48797259|NCT04402866|157095281|FG001|Overall Study|Discontinued Prior to Treatment|0|||
48797260|NCT04402866|157095282|FG002|Overall Study|Discontinued Prior to Treatment|0|||
48797261|NCT04402866|157095283|FG003|Overall Study|Discontinued Prior to Treatment|0|||
48797262|NCT04402866|157095284|FG004|Overall Study|Discontinued Prior to Treatment|2|||
48797263|NCT04402866|157095285|FG005|Overall Study|Discontinued Prior to Treatment|3|||
48797264|NCT04402866|157095280|FG000|Overall Study|Adverse Event|2|||
48797265|NCT04402866|157095281|FG001|Overall Study|Adverse Event|1|||
48797266|NCT04402866|157095282|FG002|Overall Study|Adverse Event|0|||
48797267|NCT04402866|157095283|FG003|Overall Study|Adverse Event|0|||
48797268|NCT04402866|157095284|FG004|Overall Study|Adverse Event|13|||
48797269|NCT04402866|157095285|FG005|Overall Study|Adverse Event|8|||
48797270|NCT04402866|157095280|FG000|Overall Study|Miscellaneous|0|||
49039515|NCT00989950|157980740|FG001|Randomized Phase|Adverse Event|1|||
48797271|NCT04402866|157095281|FG001|Overall Study|Miscellaneous|0|||
48797272|NCT04402866|157095282|FG002|Overall Study|Miscellaneous|1|||
48797273|NCT04402866|157095283|FG003|Overall Study|Miscellaneous|0|||
48797274|NCT04402866|157095284|FG004|Overall Study|Miscellaneous|0|||
48797275|NCT04402866|157095285|FG005|Overall Study|Miscellaneous|0|||
48797276|NCT04402866|157095280|FG000|Overall Study|Lost to Follow-up|0|||
48797277|NCT04402866|157095281|FG001|Overall Study|Lost to Follow-up|0|||
48797278|NCT04402866|157095282|FG002|Overall Study|Lost to Follow-up|0|||
48797279|NCT04402866|157095283|FG003|Overall Study|Lost to Follow-up|0|||
48797280|NCT04402866|157095284|FG004|Overall Study|Lost to Follow-up|0|||
49039516|NCT00989950|157980741|FG002|Randomized Phase|Adverse Event|0|||
49039517|NCT00989950|157980742|FG003|Randomized Phase|Adverse Event|0|||
49039518|NCT00101439|157980743|FG000|Period 2|Withdrawal by Subject|0|||
49039519|NCT00101439|157980744|FG001|Period 2|Withdrawal by Subject|2|||
49039520|NCT05278858|157980753|FG000|Overall Study|Withdrawal by Subject|1|||
49039521|NCT01867658|157980754|FG000|Overall Study|Withdrawal by Subject|6|||
49039522|NCT01867658|157980754|FG000|Overall Study|Death|2|||
49039523|NCT01867658|157980754|FG000|Overall Study|Subject could not be contacted|1|||
49039524|NCT00840658|157980755|FG000|Overall Study|Death|2|||
49039525|NCT00840658|157980756|FG001|Overall Study|Death|2|||
49039526|NCT00840658|157980757|FG002|Overall Study|Death|3|||
49039527|NCT00840658|157980758|FG003|Overall Study|Death|3|||
49039528|NCT00840658|157980755|FG000|Overall Study|Lost to Follow-up|3|||
49039529|NCT00840658|157980756|FG001|Overall Study|Lost to Follow-up|1|||
48797281|NCT04402866|157095285|FG005|Overall Study|Lost to Follow-up|1|||
48797282|NCT04402866|157095280|FG000|Overall Study|Withdrawal by Subject|0|||
48797283|NCT04402866|157095281|FG001|Overall Study|Withdrawal by Subject|0|||
48797284|NCT04402866|157095282|FG002|Overall Study|Withdrawal by Subject|0|||
48797285|NCT04402866|157095283|FG003|Overall Study|Withdrawal by Subject|0|||
48797286|NCT04402866|157095284|FG004|Overall Study|Withdrawal by Subject|0|||
48797287|NCT04402866|157095285|FG005|Overall Study|Withdrawal by Subject|2|||
48797288|NCT04020341|157095286|FG000|Overall Study|Adverse Event|8|||
48797289|NCT04020341|157095287|FG001|Overall Study|Adverse Event|6|||
48797290|NCT04020341|157095286|FG000|Overall Study|Lost to Follow-up|8|||
48797291|NCT04020341|157095287|FG001|Overall Study|Lost to Follow-up|2|||
48797292|NCT04020341|157095286|FG000|Overall Study|Withdrawal by Subject|16|||
48797293|NCT04020341|157095287|FG001|Overall Study|Withdrawal by Subject|16|||
48797294|NCT04020341|157095286|FG000|Overall Study|Participant not able to swallow the tablet|1|||
48797295|NCT04020341|157095287|FG001|Overall Study|Participant not able to swallow the tablet|0|||
48797296|NCT04020341|157095286|FG000|Overall Study|Physician Decision|0|||
48797297|NCT04020341|157095287|FG001|Overall Study|Physician Decision|2|||
48797298|NCT04020341|157095286|FG000|Overall Study|Protocol Deviation|0|||
48797299|NCT04020341|157095287|FG001|Overall Study|Protocol Deviation|2|||
48797300|NCT05763628|157095288|FG000|Period 1: First Intervention, 2 Weeks|Protocol Violation|0|||
48797301|NCT05763628|157095289|FG001|Period 1: First Intervention, 2 Weeks|Protocol Violation|1|||
49039530|NCT00840658|157980757|FG002|Overall Study|Lost to Follow-up|2|||
49039531|NCT00840658|157980758|FG003|Overall Study|Lost to Follow-up|1|||
49039532|NCT00474058|157980759|FG000|Overall Study|Adverse Event|11|||
49039533|NCT00474058|157980760|FG001|Overall Study|Adverse Event|6|||
49039534|NCT00474058|157980759|FG000|Overall Study|Lack of Efficacy|0|||
49039535|NCT00474058|157980760|FG001|Overall Study|Lack of Efficacy|4|||
49039536|NCT00474058|157980759|FG000|Overall Study|Withdrawal by Subject|11|||
49039537|NCT00474058|157980760|FG001|Overall Study|Withdrawal by Subject|7|||
49039538|NCT00474058|157980759|FG000|Overall Study|Other|2|||
49039539|NCT00474058|157980760|FG001|Overall Study|Other|0|||
49039540|NCT03101358|157980763|FG000|Overall Study|Non-compliance with study schedule|1|||
49039541|NCT03101358|157980764|FG001|Overall Study|Non-compliance with study schedule|0|||
49039542|NCT03101358|157980765|FG002|Overall Study|Non-compliance with study schedule|0|||
49039543|NCT03101358|157980766|FG003|Overall Study|Non-compliance with study schedule|1|||
49039544|NCT03101358|157980763|FG000|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
49039545|NCT03101358|157980764|FG001|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
49039546|NCT03101358|157980765|FG002|Overall Study|Decision to start another clinical trial. Not related to AE.|1|||
49039547|NCT03101358|157980766|FG003|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
49039548|NCT03101358|157980763|FG000|Overall Study|Physician Decision|1|||
49039549|NCT03101358|157980764|FG001|Overall Study|Physician Decision|0|||
49039550|NCT03101358|157980765|FG002|Overall Study|Physician Decision|0|||
49039551|NCT03101358|157980766|FG003|Overall Study|Physician Decision|3|||
49039552|NCT03101358|157980763|FG000|Overall Study|Adverse Event|0|||
49039553|NCT03101358|157980764|FG001|Overall Study|Adverse Event|0|||
49039554|NCT03101358|157980765|FG002|Overall Study|Adverse Event|1|||
49039555|NCT03101358|157980766|FG003|Overall Study|Adverse Event|0|||
49039556|NCT03101358|157980763|FG000|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
49039557|NCT03101358|157980764|FG001|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
49039558|NCT03101358|157980765|FG002|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
49039559|NCT03101358|157980766|FG003|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|1|||
49039560|NCT03101358|157980763|FG000|Overall Study|Lost to Follow-up|1|||
49039561|NCT03101358|157980764|FG001|Overall Study|Lost to Follow-up|0|||
49039562|NCT03101358|157980765|FG002|Overall Study|Lost to Follow-up|0|||
48797302|NCT05763628|157095288|FG000|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|0|||
48797303|NCT05763628|157095289|FG001|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|1|||
48797304|NCT05763628|157095288|FG000|Period 2: Second Intervention, 2 Weeks|Protocol Violation|1|||
48797305|NCT05763628|157095289|FG001|Period 2: Second Intervention, 2 Weeks|Protocol Violation|0|||
48797306|NCT02123108|157095295|FG000|Overall Study|Death|2|||
48797307|NCT02123108|157095296|FG001|Overall Study|Death|3|||
48797308|NCT02013622|157095298|FG000|Overall Study|Lost to Follow-up|10|||
48797309|NCT02013622|157095298|FG000|Overall Study|Adverse Event|3|||
49039563|NCT03101358|157980766|FG003|Overall Study|Lost to Follow-up|1|||
49039564|NCT02640235|157980771|FG000|Overall Study|Withdrawal by Subject|7|||
49039565|NCT02640235|157980772|FG001|Overall Study|Withdrawal by Subject|6|||
49039566|NCT02640235|157980771|FG000|Overall Study|Lost to Follow-up|4|||
49039567|NCT02640235|157980772|FG001|Overall Study|Lost to Follow-up|3|||
49039568|NCT02640235|157980771|FG000|Overall Study|Death|2|||
49039569|NCT02640235|157980772|FG001|Overall Study|Death|3|||
48797310|NCT02013622|157095298|FG000|Overall Study|Met Withdrawal Criteria|3|||
48797311|NCT02013622|157095298|FG000|Overall Study|Withdrawal by Subject|6|||
48797312|NCT02013622|157095298|FG000|Overall Study|Protocol Deviation|1|||
48797313|NCT02013622|157095298|FG000|Overall Study|Lack of Efficacy|1|||
48797314|NCT00645164|157095305|FG000|Overall Study|Lost to Follow-up|2|||
48797315|NCT00645164|157095305|FG000|Overall Study|Withdrawal by Subject|4|||
48797316|NCT00645164|157095305|FG000|Overall Study|Protocol Violation|1|||
48797317|NCT00162370|157095306|FG000|Efficacy Population|Lost to Follow-up|51|||
48797318|NCT00569582|157095307|FG000|Overall Study|Withdrawal by Subject|5|||
48797319|NCT00569582|157095307|FG000|Overall Study|Death|2|||
48797320|NCT00569582|157095307|FG000|Overall Study|Adverse Event|7|||
48797321|NCT00569582|157095307|FG000|Overall Study|Subject was too ill to travel.|1|||
48797322|NCT00569582|157095307|FG000|Overall Study|Subject was non-compliant.|1|||
48797323|NCT01533493|157095308|FG000|Overall Study|Adverse Event|2|||
48797324|NCT01533493|157095309|FG001|Overall Study|Adverse Event|1|||
48797325|NCT01533493|157095308|FG000|Overall Study|Withdrawal by Subject|1|||
48797326|NCT01533493|157095309|FG001|Overall Study|Withdrawal by Subject|2|||
48797327|NCT01533493|157095308|FG000|Overall Study|Lost to Follow-up|2|||
48797328|NCT01533493|157095309|FG001|Overall Study|Lost to Follow-up|0|||
48797329|NCT01967732|157095313|FG000|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
48797330|NCT01967732|157095314|FG001|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1|||
48797331|NCT01967732|157095315|FG002|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
48797332|NCT01967732|157095316|FG003|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
48797333|NCT01967732|157095313|FG000|First Intervention (Day 1)|Poor venous access|0|||
48797334|NCT01967732|157095314|FG001|First Intervention (Day 1)|Poor venous access|1|||
48797335|NCT01967732|157095315|FG002|First Intervention (Day 1)|Poor venous access|0|||
48797336|NCT01967732|157095316|FG003|First Intervention (Day 1)|Poor venous access|0|||
48797337|NCT00701038|157095317|FG000|Overall Study|study amended pilot group of patients|4|||
48797338|NCT00701038|157095318|FG001|Overall Study|study amended pilot group of patients|4|||
48797339|NCT03371940|157095319|FG000|Overall Study|Withdrawal by Subject|8|||
48797340|NCT03371940|157095320|FG001|Overall Study|Withdrawal by Subject|1|||
48797341|NCT03371940|157095321|FG002|Overall Study|Withdrawal by Subject|3|||
48797342|NCT03371940|157095322|FG003|Overall Study|Withdrawal by Subject|4|||
48797343|NCT05099926|157095323|FG000|Overall Study|Lost to Follow-up|1|||
48797344|NCT03923933|157095324|FG000|Overall Study|Lost to Follow-up|1|||
48797345|NCT03923933|157095325|FG001|Overall Study|Lost to Follow-up|0|||
49039570|NCT02640235|157980771|FG000|Overall Study|Other|1|||
49039571|NCT02640235|157980772|FG001|Overall Study|Other|2|||
49039572|NCT00624286|157980773|FG000|Overall Study|Protocol Deviation|7|||
49039573|NCT00624286|157980774|FG001|Overall Study|Protocol Deviation|9|||
49039574|NCT00624286|157980773|FG000|Overall Study|Adverse Event|6|||
49039575|NCT00624286|157980774|FG001|Overall Study|Adverse Event|3|||
49039576|NCT00624286|157980773|FG000|Overall Study|Withdrawal by Subject|5|||
49039577|NCT00624286|157980774|FG001|Overall Study|Withdrawal by Subject|4|||
49039578|NCT00624286|157980773|FG000|Overall Study|Lost to Follow-up|3|||
49039579|NCT00624286|157980774|FG001|Overall Study|Lost to Follow-up|2|||
49039580|NCT00624286|157980773|FG000|Overall Study|Administrative problems|3|||
49039581|NCT00624286|157980774|FG001|Overall Study|Administrative problems|0|||
49039582|NCT00624286|157980773|FG000|Overall Study|Lack of Efficacy|1|||
49039583|NCT00624286|157980774|FG001|Overall Study|Lack of Efficacy|6|||
49039584|NCT00624286|157980773|FG000|Overall Study|Not stated|0|||
49039585|NCT00624286|157980774|FG001|Overall Study|Not stated|1|||
49039586|NCT00624286|157980773|FG000|Overall Study|Abnormal test procedure result(s)|0|||
49039587|NCT00624286|157980774|FG001|Overall Study|Abnormal test procedure result(s)|1|||
49039588|NCT00624286|157980773|FG000|Overall Study|Death|0|||
49039589|NCT00624286|157980774|FG001|Overall Study|Death|1|||
49039590|NCT00841659|157980782|FG000|Washout: 2 Weeks|Protocol Violation|1|||
49039591|NCT00841659|157980783|FG001|Washout: 2 Weeks|Protocol Violation|0|||
49039592|NCT04277507|157980786|FG000|Overall Study|Lost to Follow-up|17|||
49039593|NCT04277507|157980786|FG000|Overall Study|Completed through 24M but not interested in extension to 36M|3|||
49039594|NCT04277507|157980786|FG000|Overall Study|Received Treatment Outside of Study that could affect study results|2|||
49039595|NCT04277507|157980786|FG000|Overall Study|Withdrawal by Subject|3|||
48797346|NCT03923933|157095324|FG000|Overall Study|Withdrawal by Subject|0|||
48797347|NCT03923933|157095325|FG001|Overall Study|Withdrawal by Subject|1|||
48797348|NCT01813474|157095326|FG000|Overall Study|Withdrawal by Subject|0|||
48797349|NCT01813474|157095327|FG001|Overall Study|Withdrawal by Subject|0|||
48797350|NCT01813474|157095328|FG002|Overall Study|Withdrawal by Subject|1|||
49039596|NCT04277507|157980786|FG000|Overall Study|Death due to COVID-19|1|||
49039597|NCT04277507|157980786|FG000|Overall Study|Data missing for full evaluation|5|||
49039598|NCT00863330|157980789|FG000|Overall Study|study terminated early due to administra|6|||
49039599|NCT01297504|157980792|FG000|Overall Study|Invalid Consent|1|||
49039600|NCT01297504|157980792|FG000|Overall Study|Received Palivizumab in Previous Season|1|||
49039601|NCT01297504|157980792|FG000|Overall Study|No Study Visits|4|||
49039602|NCT01297504|157980792|FG000|Overall Study|Death|3|||
48797351|NCT01813474|157095326|FG000|Overall Study|Adverse Event|1|||
48797352|NCT01813474|157095327|FG001|Overall Study|Adverse Event|1|||
48797353|NCT01813474|157095328|FG002|Overall Study|Adverse Event|0|||
48797354|NCT01813474|157095326|FG000|Overall Study|Lack of Efficacy|2|||
48797355|NCT01813474|157095327|FG001|Overall Study|Lack of Efficacy|6|||
48797356|NCT01813474|157095328|FG002|Overall Study|Lack of Efficacy|9|||
48797357|NCT01813474|157095326|FG000|Overall Study|Death|0|||
48797358|NCT01813474|157095327|FG001|Overall Study|Death|0|||
48797359|NCT01813474|157095328|FG002|Overall Study|Death|1|||
48797360|NCT00316082|157095329|FG000|Overall Study|Lack of Efficacy|2|||
49039603|NCT01297504|157980792|FG000|Overall Study|Lost to Follow-up|43|||
49039604|NCT01297504|157980792|FG000|Overall Study|Withdrawal by Subject|9|||
49039605|NCT01297504|157980792|FG000|Overall Study|Site Closure|3|||
49039606|NCT01297504|157980792|FG000|Overall Study|Protocol Violation|3|||
49039607|NCT00323258|157980793|FG000|Primary Outcome (Phone Call at 6 Months)|Death|1|||
49039608|NCT00323258|157980794|FG001|Primary Outcome (Phone Call at 6 Months)|Death|2|||
49039609|NCT00323258|157980793|FG000|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12|||
49039610|NCT00323258|157980794|FG001|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11|||
49039611|NCT00323258|157980793|FG000|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1|||
49039612|NCT00323258|157980794|FG001|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5|||
49039613|NCT00323258|157980793|FG000|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2|||
49039614|NCT00323258|157980794|FG001|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1|||
49039615|NCT00323258|157980793|FG000|Secondary Outcome (6 Mon Refill Records)|Death|1|||
49039616|NCT00323258|157980794|FG001|Secondary Outcome (6 Mon Refill Records)|Death|2|||
49039617|NCT00323258|157980793|FG000|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12|||
49039618|NCT00323258|157980794|FG001|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10|||
49039619|NCT00323258|157980793|FG000|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1|||
49039620|NCT00323258|157980794|FG001|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2|||
49039621|NCT01075516|157980802|FG000|Overall Study|Death|5|||
49039622|NCT01075516|157980803|FG001|Overall Study|Death|9|||
49039623|NCT01075516|157980802|FG000|Overall Study|Lost to Follow-up|10|||
49039624|NCT01075516|157980803|FG001|Overall Study|Lost to Follow-up|2|||
49039625|NCT01075516|157980802|FG000|Overall Study|Withdrawal by Subject|3|||
49039626|NCT01075516|157980803|FG001|Overall Study|Withdrawal by Subject|5|||
49039627|NCT00654186|157980804|FG000|Overall Study|Withdrawal by Subject|5|||
48797361|NCT00316082|157095330|FG001|Overall Study|Lack of Efficacy|3|||
48797362|NCT00316082|157095331|FG002|Overall Study|Lack of Efficacy|3|||
48797363|NCT00316082|157095332|FG003|Overall Study|Lack of Efficacy|4|||
48797364|NCT00316082|157095333|FG004|Overall Study|Lack of Efficacy|6|||
48797365|NCT00316082|157095329|FG000|Overall Study|Withdrawal of Consent by Subject|10|||
48797366|NCT00316082|157095330|FG001|Overall Study|Withdrawal of Consent by Subject|8|||
48797367|NCT00316082|157095331|FG002|Overall Study|Withdrawal of Consent by Subject|2|||
48797368|NCT00316082|157095332|FG003|Overall Study|Withdrawal of Consent by Subject|9|||
48797369|NCT00316082|157095333|FG004|Overall Study|Withdrawal of Consent by Subject|5|||
48797370|NCT00316082|157095329|FG000|Overall Study|Lost to Follow-up|7|||
48797371|NCT00316082|157095330|FG001|Overall Study|Lost to Follow-up|6|||
48797372|NCT00316082|157095331|FG002|Overall Study|Lost to Follow-up|7|||
48797373|NCT00316082|157095332|FG003|Overall Study|Lost to Follow-up|8|||
48797374|NCT00316082|157095333|FG004|Overall Study|Lost to Follow-up|6|||
48797375|NCT00316082|157095329|FG000|Overall Study|Poor/noncompliance|6|||
48797376|NCT00316082|157095330|FG001|Overall Study|Poor/noncompliance|1|||
48797377|NCT00316082|157095331|FG002|Overall Study|Poor/noncompliance|4|||
48797378|NCT00316082|157095332|FG003|Overall Study|Poor/noncompliance|1|||
48797379|NCT00316082|157095333|FG004|Overall Study|Poor/noncompliance|4|||
48797380|NCT00316082|157095329|FG000|Overall Study|Adverse Event|4|||
48797381|NCT00316082|157095330|FG001|Overall Study|Adverse Event|2|||
48797382|NCT00316082|157095331|FG002|Overall Study|Adverse Event|5|||
48797383|NCT00316082|157095332|FG003|Overall Study|Adverse Event|1|||
48797384|NCT00316082|157095333|FG004|Overall Study|Adverse Event|3|||
48797385|NCT00316082|157095329|FG000|Overall Study|Subject no longer meets study criteria|3|||
48797386|NCT00316082|157095330|FG001|Overall Study|Subject no longer meets study criteria|1|||
48797387|NCT00316082|157095331|FG002|Overall Study|Subject no longer meets study criteria|2|||
48797388|NCT00316082|157095332|FG003|Overall Study|Subject no longer meets study criteria|2|||
48797389|NCT00316082|157095333|FG004|Overall Study|Subject no longer meets study criteria|1|||
48797390|NCT00316082|157095329|FG000|Overall Study|Physician Decision|1|||
49039628|NCT00874276|157980805|FG000|Overall Study|Withdrawal by Subject|1|||
48797391|NCT00316082|157095330|FG001|Overall Study|Physician Decision|1|||
48797392|NCT00316082|157095331|FG002|Overall Study|Physician Decision|2|||
48797393|NCT00316082|157095332|FG003|Overall Study|Physician Decision|1|||
48797394|NCT00316082|157095333|FG004|Overall Study|Physician Decision|1|||
48797395|NCT00316082|157095329|FG000|Overall Study|Death|0|||
48797396|NCT00316082|157095330|FG001|Overall Study|Death|0|||
48797397|NCT00316082|157095331|FG002|Overall Study|Death|1|||
48797398|NCT00316082|157095332|FG003|Overall Study|Death|0|||
49039629|NCT00874276|157980806|FG001|Overall Study|Withdrawal by Subject|1|||
48797399|NCT00316082|157095333|FG004|Overall Study|Death|0|||
48797400|NCT00316082|157095329|FG000|Overall Study|Administrative reason by sponsor|0|||
48797401|NCT00316082|157095330|FG001|Overall Study|Administrative reason by sponsor|0|||
48797402|NCT00316082|157095331|FG002|Overall Study|Administrative reason by sponsor|1|||
48797403|NCT00316082|157095332|FG003|Overall Study|Administrative reason by sponsor|0|||
48797404|NCT00316082|157095333|FG004|Overall Study|Administrative reason by sponsor|0|||
49039630|NCT00295490|157980813|FG000|Overall Study|Protocol Violation|0|||
49039631|NCT00295490|157980814|FG001|Overall Study|Protocol Violation|0|||
49039632|NCT00295490|157980815|FG002|Overall Study|Protocol Violation|3|||
49039633|NCT00295490|157980816|FG003|Overall Study|Protocol Violation|3|||
49039634|NCT00295490|157980813|FG000|Overall Study|Withdrawal by Subject|0|||
49039635|NCT00295490|157980814|FG001|Overall Study|Withdrawal by Subject|2|||
49039636|NCT00295490|157980815|FG002|Overall Study|Withdrawal by Subject|0|||
49039637|NCT00295490|157980816|FG003|Overall Study|Withdrawal by Subject|1|||
49039638|NCT00295490|157980813|FG000|Overall Study|Lost to Follow-up|0|||
49039639|NCT00295490|157980814|FG001|Overall Study|Lost to Follow-up|0|||
49039640|NCT00295490|157980815|FG002|Overall Study|Lost to Follow-up|1|||
49039641|NCT00295490|157980816|FG003|Overall Study|Lost to Follow-up|0|||
49039642|NCT00295490|157980813|FG000|Overall Study|Adverse Event|1|||
49039643|NCT00295490|157980814|FG001|Overall Study|Adverse Event|0|||
49039644|NCT00295490|157980815|FG002|Overall Study|Adverse Event|0|||
49039645|NCT00295490|157980816|FG003|Overall Study|Adverse Event|0|||
49039646|NCT00295490|157980813|FG000|Overall Study|Other|0|||
49039647|NCT00295490|157980814|FG001|Overall Study|Other|2|||
49039648|NCT00295490|157980815|FG002|Overall Study|Other|0|||
49039649|NCT00295490|157980816|FG003|Overall Study|Other|1|||
49039650|NCT05098743|157980817|FG000|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|1|||
49039651|NCT05098743|157980818|FG001|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|0|||
49039652|NCT05098743|157980817|FG000|Overall Study|Lost to Follow-up|1|||
49039653|NCT05098743|157980818|FG001|Overall Study|Lost to Follow-up|2|||
49039654|NCT04060251|157980819|FG000|Overall Study|Study terminated due to low enrollment.|7|||
49039655|NCT04060251|157980820|FG001|Overall Study|Study terminated due to low enrollment.|5|||
49039656|NCT04060251|157980821|FG002|Overall Study|Study terminated due to low enrollment.|7|||
49039657|NCT04060251|157980819|FG000|Overall Study|Adverse Event|1|||
49039658|NCT04060251|157980820|FG001|Overall Study|Adverse Event|1|||
49039659|NCT04060251|157980821|FG002|Overall Study|Adverse Event|0|||
49039660|NCT00487435|157980822|FG000|Overall Study|Adverse Event|146|||
49039661|NCT00487435|157980822|FG000|Overall Study|Death|2|||
49039662|NCT00487435|157980822|FG000|Overall Study|Lack of Efficacy|33|||
49039663|NCT00487435|157980822|FG000|Overall Study|Lost to Follow-up|54|||
49039664|NCT00487435|157980822|FG000|Overall Study|Pregnancy|2|||
49039665|NCT00487435|157980822|FG000|Overall Study|Withdrawal by Subject|132|||
49039666|NCT00487435|157980822|FG000|Overall Study|Resolution Of Pain|1|||
49039667|NCT00487435|157980822|FG000|Overall Study|Study Medication Non-Compliant|32|||
49039668|NCT00487435|157980822|FG000|Overall Study|Other|83|||
49039669|NCT01874535|157980825|FG000|Overall Study|Lost to Follow-up|10|||
49039670|NCT01874535|157980826|FG001|Overall Study|Lost to Follow-up|9|||
49039671|NCT01874535|157980825|FG000|Overall Study|incomplete symptom resolution|45|||
49039672|NCT01874535|157980826|FG001|Overall Study|incomplete symptom resolution|35|||
49039673|NCT03573544|157980828|FG000|Overall Study|Adverse Event|0|||
49039674|NCT03573544|157980829|FG001|Overall Study|Adverse Event|0|||
49039675|NCT03573544|157980830|FG002|Overall Study|Adverse Event|0|||
49039676|NCT03573544|157980831|FG003|Overall Study|Adverse Event|3|||
49039677|NCT03573544|157980832|FG004|Overall Study|Adverse Event|1|||
49039678|NCT03573544|157980833|FG005|Overall Study|Adverse Event|0|||
49039679|NCT03573544|157980834|FG006|Overall Study|Adverse Event|2|||
49039680|NCT03573544|157980835|FG007|Overall Study|Adverse Event|0|||
49039681|NCT03573544|157980828|FG000|Overall Study|Physician Decision|0|||
49039682|NCT03573544|157980829|FG001|Overall Study|Physician Decision|0|||
49039683|NCT03573544|157980830|FG002|Overall Study|Physician Decision|0|||
49039684|NCT03573544|157980831|FG003|Overall Study|Physician Decision|0|||
49039685|NCT03573544|157980832|FG004|Overall Study|Physician Decision|0|||
48797405|NCT00540124|157095335|FG000|Overall Study|Adverse Event|0|||
48797406|NCT00540124|157095336|FG001|Overall Study|Adverse Event|2|||
48897481|NCT04602221|157460926|FG000|Overall Study|Other than listed|0|||
49039686|NCT03573544|157980833|FG005|Overall Study|Physician Decision|0|||
49039687|NCT03573544|157980834|FG006|Overall Study|Physician Decision|1|||
49039688|NCT03573544|157980835|FG007|Overall Study|Physician Decision|0|||
49039689|NCT03573544|157980828|FG000|Overall Study|Withdrawal by Subject|2|||
49039690|NCT03573544|157980829|FG001|Overall Study|Withdrawal by Subject|0|||
49039691|NCT03573544|157980830|FG002|Overall Study|Withdrawal by Subject|0|||
49039692|NCT03573544|157980831|FG003|Overall Study|Withdrawal by Subject|1|||
49039693|NCT03573544|157980832|FG004|Overall Study|Withdrawal by Subject|1|||
49039694|NCT03573544|157980833|FG005|Overall Study|Withdrawal by Subject|1|||
49039695|NCT03573544|157980834|FG006|Overall Study|Withdrawal by Subject|0|||
49039696|NCT03573544|157980835|FG007|Overall Study|Withdrawal by Subject|1|||
49039697|NCT03573544|157980828|FG000|Overall Study|Disease progression|3|||
48797407|NCT00540124|157095337|FG002|Overall Study|Adverse Event|1|||
48797408|NCT00540124|157095335|FG000|Overall Study|Entry Criteria Not Met|2|||
48797409|NCT00540124|157095336|FG001|Overall Study|Entry Criteria Not Met|0|||
48797410|NCT00540124|157095337|FG002|Overall Study|Entry Criteria Not Met|0|||
48797411|NCT00540124|157095335|FG000|Overall Study|Lack of Efficacy|1|||
48797412|NCT00540124|157095336|FG001|Overall Study|Lack of Efficacy|0|||
48797413|NCT00540124|157095337|FG002|Overall Study|Lack of Efficacy|0|||
48797414|NCT00540124|157095335|FG000|Overall Study|Withdrawal by Subject|1|||
48797415|NCT00540124|157095336|FG001|Overall Study|Withdrawal by Subject|1|||
48797416|NCT00540124|157095337|FG002|Overall Study|Withdrawal by Subject|0|||
48797417|NCT01569438|157095338|FG000|Overall Study|Lack of Efficacy|1|||
48797418|NCT01569438|157095339|FG001|Overall Study|Lack of Efficacy|2|||
48797419|NCT01569438|157095338|FG000|Overall Study|Withdrawal by Subject|0|||
49039698|NCT03573544|157980829|FG001|Overall Study|Disease progression|3|||
48797420|NCT01569438|157095339|FG001|Overall Study|Withdrawal by Subject|3|||
48797421|NCT01569438|157095338|FG000|Overall Study|Adverse Event|2|||
49039699|NCT03573544|157980830|FG002|Overall Study|Disease progression|6|||
49039700|NCT03573544|157980831|FG003|Overall Study|Disease progression|4|||
49039701|NCT03573544|157980832|FG004|Overall Study|Disease progression|5|||
49039702|NCT03573544|157980833|FG005|Overall Study|Disease progression|7|||
49039703|NCT03573544|157980834|FG006|Overall Study|Disease progression|6|||
49039704|NCT03573544|157980835|FG007|Overall Study|Disease progression|7|||
49039705|NCT03828539|157980838|FG000|Overall Study|Adverse Event|3|||
49039706|NCT03828539|157980839|FG001|Overall Study|Adverse Event|12|||
49039707|NCT03828539|157980838|FG000|Overall Study|Patient's/guardian's decision|3|||
49039708|NCT03828539|157980839|FG001|Overall Study|Patient's/guardian's decision|5|||
49039709|NCT03828539|157980838|FG000|Overall Study|Lost to Follow-up|4|||
49039710|NCT03828539|157980839|FG001|Overall Study|Lost to Follow-up|2|||
49039711|NCT03828539|157980838|FG000|Overall Study|Protocol Violation|3|||
49039712|NCT03828539|157980839|FG001|Overall Study|Protocol Violation|2|||
49039713|NCT03828539|157980838|FG000|Overall Study|Withdrawal of informed consent|2|||
49039714|NCT03828539|157980839|FG001|Overall Study|Withdrawal of informed consent|1|||
49039715|NCT03828539|157980838|FG000|Overall Study|New therapy for study indication|1|||
49039716|NCT03828539|157980839|FG001|Overall Study|New therapy for study indication|0|||
49039717|NCT00227370|157980841|FG000|Overall Study|Withdrawal by Subject|1|||
49039718|NCT00227370|157980842|FG001|Overall Study|Withdrawal by Subject|2|||
49039719|NCT00227370|157980841|FG000|Overall Study|Death|3|||
49039720|NCT00227370|157980842|FG001|Overall Study|Death|4|||
49039721|NCT00227370|157980841|FG000|Overall Study|Adverse Event|6|||
49039722|NCT00227370|157980842|FG001|Overall Study|Adverse Event|11|||
49039723|NCT00227370|157980841|FG000|Overall Study|Physician Decision|9|||
49039724|NCT00227370|157980842|FG001|Overall Study|Physician Decision|6|||
49039725|NCT00227370|157980841|FG000|Overall Study|Other reasons|2|||
49039726|NCT00227370|157980842|FG001|Overall Study|Other reasons|1|||
49039727|NCT01942135|157980845|FG000|Overall Study|Adverse Event|21|||
49039728|NCT01942135|157980846|FG001|Overall Study|Adverse Event|7|||
49039729|NCT01942135|157980845|FG000|Overall Study|Global Deterioration of Health Status|9|||
49039730|NCT01942135|157980846|FG001|Overall Study|Global Deterioration of Health Status|6|||
49039731|NCT01942135|157980845|FG000|Overall Study|Randomized Not Treated|2|||
49039732|NCT01942135|157980846|FG001|Overall Study|Randomized Not Treated|2|||
49039733|NCT01942135|157980845|FG000|Overall Study|Death|2|||
49039734|NCT01942135|157980846|FG001|Overall Study|Death|1|||
49039735|NCT01942135|157980845|FG000|Overall Study|Objective Progression or Relapse + Progressive Disease|279|||
49039736|NCT01942135|157980846|FG001|Overall Study|Objective Progression or Relapse + Progressive Disease|148|||
49039737|NCT01942135|157980845|FG000|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|10|||
49039738|NCT01942135|157980846|FG001|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|3|||
49039739|NCT01942135|157980845|FG000|Overall Study|Withdrawal by Subject|4|||
49039740|NCT01942135|157980846|FG001|Overall Study|Withdrawal by Subject|3|||
49039741|NCT01942135|157980845|FG000|Overall Study|Protocol Violation|1|||
49039742|NCT01942135|157980846|FG001|Overall Study|Protocol Violation|0|||
49039743|NCT01942135|157980845|FG000|Overall Study|Other|19|||
49039744|NCT01942135|157980846|FG001|Overall Study|Other|4|||
49039745|NCT01566435|157980847|FG000|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1|||
48797422|NCT01569438|157095339|FG001|Overall Study|Adverse Event|15|||
48797423|NCT01569438|157095338|FG000|Overall Study|Protocol Violation|2|||
48797424|NCT01569438|157095339|FG001|Overall Study|Protocol Violation|0|||
48797425|NCT01569438|157095338|FG000|Overall Study|Decrease of GFR greater than 30 ml/min|1|||
48797426|NCT01569438|157095339|FG001|Overall Study|Decrease of GFR greater than 30 ml/min|0|||
49039746|NCT00529763|157982278|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
49039747|NCT00529763|157982279|FG001|Overall Study|Adverse Event Unrelated to Study Drug|5|||
49039748|NCT00529763|157982280|FG002|Overall Study|Adverse Event Unrelated to Study Drug|3|||
49039749|NCT00529763|157982278|FG000|Overall Study|Death|1|||
49039750|NCT00529763|157982279|FG001|Overall Study|Death|1|||
49039751|NCT00529763|157982280|FG002|Overall Study|Death|1|||
49039752|NCT00529763|157982278|FG000|Overall Study|Disease Progression|10|||
49039753|NCT00529763|157982279|FG001|Overall Study|Disease Progression|16|||
49039754|NCT00529763|157982280|FG002|Overall Study|Disease Progression|11|||
49039755|NCT00529763|157982278|FG000|Overall Study|Lost to Follow-up|1|||
49039756|NCT00529763|157982279|FG001|Overall Study|Lost to Follow-up|2|||
49039757|NCT00529763|157982280|FG002|Overall Study|Lost to Follow-up|3|||
49039758|NCT00529763|157982278|FG000|Overall Study|Stem Cell Transplant|0|||
49039759|NCT00529763|157982279|FG001|Overall Study|Stem Cell Transplant|3|||
49039760|NCT00529763|157982280|FG002|Overall Study|Stem Cell Transplant|1|||
49039761|NCT00529763|157982278|FG000|Overall Study|Study Drug Toxicity|3|||
49039762|NCT00529763|157982279|FG001|Overall Study|Study Drug Toxicity|6|||
49039763|NCT00529763|157982280|FG002|Overall Study|Study Drug Toxicity|4|||
49039764|NCT00529763|157982278|FG000|Overall Study|Participant Withdrew Consent|2|||
49039765|NCT00529763|157982279|FG001|Overall Study|Participant Withdrew Consent|3|||
49039766|NCT00529763|157982280|FG002|Overall Study|Participant Withdrew Consent|4|||
49039767|NCT00529763|157982278|FG000|Overall Study|Other reasons|2|||
49039768|NCT00529763|157982279|FG001|Overall Study|Other reasons|0|||
49039769|NCT00529763|157982280|FG002|Overall Study|Other reasons|2|||
49039770|NCT00529763|157982278|FG000|Overall Study|Participant request to discontinue treatment|1|||
49039771|NCT00529763|157982279|FG001|Overall Study|Participant request to discontinue treatment|1|||
49039772|NCT00529763|157982280|FG002|Overall Study|Participant request to discontinue treatment|3|||
49039773|NCT03669250|157982281|FG000|Overall Study|Adverse Event|0|||
49039774|NCT03669250|157982282|FG001|Overall Study|Adverse Event|0|||
49039775|NCT03669250|157982283|FG002|Overall Study|Adverse Event|0|||
49039776|NCT03669250|157982284|FG003|Overall Study|Adverse Event|0|||
48797427|NCT01569438|157095338|FG000|Overall Study|Sponsor/Physician decision|1|||
48797428|NCT01569438|157095339|FG001|Overall Study|Sponsor/Physician decision|1|||
48797429|NCT01569438|157095338|FG000|Overall Study|Unable to adhere to study schedule|0|||
48797430|NCT01569438|157095339|FG001|Overall Study|Unable to adhere to study schedule|1|||
48797431|NCT03599349|157095340|FG000|Overall Study|Lost to Follow-up|1|||
48797432|NCT00504426|157095341|FG000|Overall Study|Adverse Event|0|||
48797433|NCT00504426|157095342|FG001|Overall Study|Adverse Event|0|||
48797434|NCT00504426|157095343|FG002|Overall Study|Adverse Event|2|||
48797435|NCT00504426|157095344|FG003|Overall Study|Adverse Event|0|||
48797436|NCT00504426|157095341|FG000|Overall Study|Protocol Violation|1|||
48797437|NCT00504426|157095342|FG001|Overall Study|Protocol Violation|1|||
48797438|NCT00504426|157095343|FG002|Overall Study|Protocol Violation|2|||
48797439|NCT00504426|157095344|FG003|Overall Study|Protocol Violation|0|||
48797440|NCT00504426|157095341|FG000|Overall Study|Withdrawal by Subject|2|||
48797441|NCT00504426|157095342|FG001|Overall Study|Withdrawal by Subject|0|||
48797442|NCT00504426|157095343|FG002|Overall Study|Withdrawal by Subject|0|||
48797443|NCT00504426|157095344|FG003|Overall Study|Withdrawal by Subject|0|||
48797444|NCT00450411|157095351|FG000|Overall Study|Protocol Violation|6|||
48797445|NCT00450411|157095351|FG000|Overall Study|No protocol treatment|2|||
48797446|NCT02778100|157095355|FG000|Period 1 (Common Cold)|Withdrawal by Subject|1|||
48797447|NCT02778100|157095356|FG001|Period 1 (Common Cold)|Withdrawal by Subject|0|||
48797448|NCT00686881|157095361|FG000|Overall Study|Withdrawal by Subject|11|||
48797449|NCT00686881|157095362|FG001|Overall Study|Withdrawal by Subject|18|||
48797450|NCT00686881|157095361|FG000|Overall Study|Lost to Follow-up|0|||
48797451|NCT00686881|157095362|FG001|Overall Study|Lost to Follow-up|1|||
48797452|NCT00686881|157095361|FG000|Overall Study|Treatment-related adverse event|10|||
48797453|NCT00686881|157095362|FG001|Overall Study|Treatment-related adverse event|9|||
48797454|NCT00686881|157095361|FG000|Overall Study|Met discontinuation criteria|5|||
48797455|NCT00686881|157095362|FG001|Overall Study|Met discontinuation criteria|0|||
48797456|NCT00686881|157095361|FG000|Overall Study|Onset of malignant tumor|11|||
48797457|NCT00686881|157095362|FG001|Overall Study|Onset of malignant tumor|11|||
48797458|NCT00686881|157095361|FG000|Overall Study|Lack of Efficacy|4|||
49039777|NCT03669250|157982285|FG004|Overall Study|Adverse Event|1|||
49039778|NCT03669250|157982286|FG005|Overall Study|Adverse Event|0|||
49039779|NCT03669250|157982281|FG000|Overall Study|Withdrawal by Subject|0|||
49039780|NCT03669250|157982282|FG001|Overall Study|Withdrawal by Subject|1|||
49039781|NCT03669250|157982283|FG002|Overall Study|Withdrawal by Subject|0|||
48797459|NCT00686881|157095362|FG001|Overall Study|Lack of Efficacy|3|||
48797460|NCT00686881|157095361|FG000|Overall Study|Physician Decision|1|||
49039782|NCT03669250|157982284|FG003|Overall Study|Withdrawal by Subject|1|||
48797461|NCT00686881|157095362|FG001|Overall Study|Physician Decision|0|||
49039783|NCT03669250|157982285|FG004|Overall Study|Withdrawal by Subject|0|||
48797462|NCT00686881|157095361|FG000|Overall Study|Circumstances of site|1|||
48797463|NCT00686881|157095362|FG001|Overall Study|Circumstances of site|1|||
48797464|NCT00686881|157095361|FG000|Overall Study|Did not meet protocol eligibility|1|||
48797465|NCT00686881|157095362|FG001|Overall Study|Did not meet protocol eligibility|0|||
48797466|NCT00686881|157095361|FG000|Overall Study|Irregular visits|1|||
49039784|NCT03669250|157982286|FG005|Overall Study|Withdrawal by Subject|0|||
49039785|NCT01513239|157982287|FG000|Period 1: Main Phase|Adverse Event|1|||
49039786|NCT01513239|157982288|FG001|Period 1: Main Phase|Adverse Event|1|||
49039787|NCT01513239|157982289|FG002|Period 1: Main Phase|Adverse Event|2|||
49039788|NCT01513239|157982290|FG003|Period 1: Main Phase|Adverse Event|0|||
49039789|NCT01513239|157982291|FG004|Period 1: Main Phase|Adverse Event|0|||
48797467|NCT00686881|157095362|FG001|Overall Study|Irregular visits|0|||
48797468|NCT00686881|157095361|FG000|Overall Study|Study discontinuation|35|||
48797469|NCT00686881|157095362|FG001|Overall Study|Study discontinuation|32|||
48797470|NCT00686881|157095361|FG000|Overall Study|Never received study drug|2|||
48797471|NCT00686881|157095362|FG001|Overall Study|Never received study drug|6|||
48797472|NCT00671931|157095363|FG000|Overall Study|Physician Decision|1|||
48797473|NCT00671931|157095364|FG001|Overall Study|Physician Decision|0|||
48797474|NCT00671931|157095365|FG002|Overall Study|Physician Decision|0|||
48797475|NCT00671931|157095366|FG003|Overall Study|Physician Decision|2|||
48797476|NCT00671931|157095367|FG004|Overall Study|Physician Decision|1|||
48797477|NCT02925676|157095368|FG000|Overall Study|Withdrawal by Subject|1|||
48797478|NCT00541450|157095372|FG000|Phase A|Adverse Event|3|||
48797479|NCT00541450|157095373|FG001|Phase A|Adverse Event|0|||
48797480|NCT00541450|157095372|FG000|Phase A|Creatinine/CrCl -Increase in creatinine|0|||
48797481|NCT00541450|157095373|FG001|Phase A|Creatinine/CrCl -Increase in creatinine|2|||
48797482|NCT00541450|157095372|FG000|Phase A|Hyperglycemia|0|||
48797483|NCT00541450|157095373|FG001|Phase A|Hyperglycemia|1|||
48797484|NCT00541450|157095372|FG000|Phase A|Lost to Follow-up|6|||
48797485|NCT00541450|157095373|FG001|Phase A|Lost to Follow-up|4|||
48797486|NCT00541450|157095372|FG000|Phase A|Physician Decision|2|||
48797487|NCT00541450|157095373|FG001|Phase A|Physician Decision|0|||
48797488|NCT00541450|157095372|FG000|Phase A|Protocol Violation|2|||
48797489|NCT00541450|157095373|FG001|Phase A|Protocol Violation|3|||
49039790|NCT01513239|157982292|FG005|Period 1: Main Phase|Adverse Event|0|||
49039791|NCT01513239|157982287|FG000|Period 1: Main Phase|Death|29|||
49039792|NCT01513239|157982288|FG001|Period 1: Main Phase|Death|22|||
49039793|NCT01513239|157982289|FG002|Period 1: Main Phase|Death|32|||
49039794|NCT01513239|157982290|FG003|Period 1: Main Phase|Death|0|||
49039795|NCT01513239|157982291|FG004|Period 1: Main Phase|Death|0|||
49039796|NCT01513239|157982292|FG005|Period 1: Main Phase|Death|0|||
49039797|NCT01513239|157982287|FG000|Period 1: Main Phase|Lost to Follow-up|11|||
49039798|NCT01513239|157982288|FG001|Period 1: Main Phase|Lost to Follow-up|10|||
49039799|NCT01513239|157982289|FG002|Period 1: Main Phase|Lost to Follow-up|6|||
49039800|NCT01513239|157982290|FG003|Period 1: Main Phase|Lost to Follow-up|0|||
49039801|NCT01513239|157982291|FG004|Period 1: Main Phase|Lost to Follow-up|0|||
49039802|NCT01513239|157982292|FG005|Period 1: Main Phase|Lost to Follow-up|0|||
49039803|NCT01513239|157982287|FG000|Period 1: Main Phase|Physician Decision|4|||
49039804|NCT01513239|157982288|FG001|Period 1: Main Phase|Physician Decision|4|||
49039805|NCT01513239|157982289|FG002|Period 1: Main Phase|Physician Decision|4|||
49039806|NCT01513239|157982290|FG003|Period 1: Main Phase|Physician Decision|0|||
49039807|NCT01513239|157982291|FG004|Period 1: Main Phase|Physician Decision|0|||
49039808|NCT01513239|157982292|FG005|Period 1: Main Phase|Physician Decision|0|||
49039809|NCT01513239|157982287|FG000|Period 1: Main Phase|Protocol Violation|2|||
49039810|NCT01513239|157982288|FG001|Period 1: Main Phase|Protocol Violation|2|||
49039811|NCT01513239|157982289|FG002|Period 1: Main Phase|Protocol Violation|2|||
49039812|NCT01513239|157982290|FG003|Period 1: Main Phase|Protocol Violation|0|||
49039813|NCT01513239|157982291|FG004|Period 1: Main Phase|Protocol Violation|0|||
49039814|NCT01513239|157982292|FG005|Period 1: Main Phase|Protocol Violation|0|||
49039815|NCT01513239|157982287|FG000|Period 1: Main Phase|Technical Problems|1|||
49039816|NCT01513239|157982288|FG001|Period 1: Main Phase|Technical Problems|2|||
49039817|NCT01513239|157982289|FG002|Period 1: Main Phase|Technical Problems|0|||
49039818|NCT01513239|157982290|FG003|Period 1: Main Phase|Technical Problems|0|||
49039819|NCT01513239|157982291|FG004|Period 1: Main Phase|Technical Problems|0|||
49039820|NCT01513239|157982292|FG005|Period 1: Main Phase|Technical Problems|0|||
49039821|NCT01513239|157982287|FG000|Period 1: Main Phase|Withdrawal by Subject|27|||
49039822|NCT01513239|157982288|FG001|Period 1: Main Phase|Withdrawal by Subject|29|||
49039823|NCT01513239|157982289|FG002|Period 1: Main Phase|Withdrawal by Subject|42|||
49039824|NCT01513239|157982290|FG003|Period 1: Main Phase|Withdrawal by Subject|0|||
49039825|NCT01513239|157982291|FG004|Period 1: Main Phase|Withdrawal by Subject|0|||
49039826|NCT01513239|157982292|FG005|Period 1: Main Phase|Withdrawal by Subject|0|||
49039827|NCT01513239|157982287|FG000|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
49039828|NCT01513239|157982288|FG001|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
49039829|NCT01513239|157982289|FG002|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
49039830|NCT01513239|157982290|FG003|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5|||
49039831|NCT01513239|157982291|FG004|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3|||
49039832|NCT01513239|157982292|FG005|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2|||
49039833|NCT01513239|157982287|FG000|Period 2: 9 Month Extension Phase|Death|0|||
48797490|NCT00541450|157095372|FG000|Phase A|Withdrawal by Subject|7|||
48797491|NCT00541450|157095373|FG001|Phase A|Withdrawal by Subject|7|||
48797492|NCT00541450|157095372|FG000|Phase B|Adverse Event|6|||
48797493|NCT00541450|157095373|FG001|Phase B|Adverse Event|6|||
48797494|NCT00541450|157095372|FG000|Phase B|Hyperglycemia|10|||
49039834|NCT01513239|157982288|FG001|Period 2: 9 Month Extension Phase|Death|0|||
49039835|NCT01513239|157982289|FG002|Period 2: 9 Month Extension Phase|Death|0|||
49039836|NCT01513239|157982290|FG003|Period 2: 9 Month Extension Phase|Death|2|||
49039837|NCT01513239|157982291|FG004|Period 2: 9 Month Extension Phase|Death|5|||
48797495|NCT00541450|157095373|FG001|Phase B|Hyperglycemia|9|||
48797496|NCT00541450|157095372|FG000|Phase B|Lost to Follow-up|6|||
48797497|NCT00541450|157095373|FG001|Phase B|Lost to Follow-up|4|||
48797498|NCT00541450|157095372|FG000|Phase B|Physician Decision|4|||
48797499|NCT00541450|157095373|FG001|Phase B|Physician Decision|2|||
48797500|NCT00541450|157095372|FG000|Phase B|Pregnancy|0|||
48797501|NCT00541450|157095373|FG001|Phase B|Pregnancy|1|||
48797502|NCT00541450|157095372|FG000|Phase B|Protocol Violation|3|||
48797503|NCT00541450|157095373|FG001|Phase B|Protocol Violation|3|||
48797504|NCT00541450|157095372|FG000|Phase B|Withdrawal by Subject|8|||
48797505|NCT00541450|157095373|FG001|Phase B|Withdrawal by Subject|6|||
48797506|NCT01951638|157095379|FG000|Treatment Period|Protocol Violation|0|||
48797507|NCT01951638|157095380|FG001|Treatment Period|Protocol Violation|0|||
48797508|NCT01951638|157095381|FG002|Treatment Period|Protocol Violation|0|||
48797509|NCT01951638|157095382|FG003|Treatment Period|Protocol Violation|2|||
48797510|NCT01951638|157095383|FG004|Treatment Period|Protocol Violation|0|||
48797511|NCT01951638|157095379|FG000|Treatment Period|Protocol-driven decision point|1|||
48797512|NCT01951638|157095380|FG001|Treatment Period|Protocol-driven decision point|3|||
48797513|NCT01951638|157095381|FG002|Treatment Period|Protocol-driven decision point|0|||
48797514|NCT01951638|157095382|FG003|Treatment Period|Protocol-driven decision point|0|||
48797515|NCT01951638|157095383|FG004|Treatment Period|Protocol-driven decision point|0|||
48797516|NCT01951638|157095379|FG000|Treatment Period|Logistical difficulties|0|||
48797517|NCT01951638|157095380|FG001|Treatment Period|Logistical difficulties|1|||
48797518|NCT01951638|157095381|FG002|Treatment Period|Logistical difficulties|1|||
48797519|NCT01951638|157095382|FG003|Treatment Period|Logistical difficulties|0|||
48797520|NCT01951638|157095383|FG004|Treatment Period|Logistical difficulties|0|||
48797521|NCT01951638|157095379|FG000|Treatment Period|Withdrawal by Subject|9|||
48797522|NCT01951638|157095380|FG001|Treatment Period|Withdrawal by Subject|6|||
48797523|NCT01951638|157095381|FG002|Treatment Period|Withdrawal by Subject|4|||
48797524|NCT01951638|157095382|FG003|Treatment Period|Withdrawal by Subject|5|||
48797525|NCT01951638|157095383|FG004|Treatment Period|Withdrawal by Subject|4|||
48797526|NCT01951638|157095379|FG000|Treatment Period|Death|0|||
48797527|NCT01951638|157095380|FG001|Treatment Period|Death|0|||
48797528|NCT01951638|157095381|FG002|Treatment Period|Death|0|||
48797529|NCT01951638|157095382|FG003|Treatment Period|Death|3|||
48797530|NCT01951638|157095383|FG004|Treatment Period|Death|1|||
48797531|NCT01951638|157095379|FG000|Treatment Period|Adverse Event|3|||
48797532|NCT01951638|157095380|FG001|Treatment Period|Adverse Event|4|||
48797533|NCT01951638|157095381|FG002|Treatment Period|Adverse Event|8|||
48797534|NCT01951638|157095382|FG003|Treatment Period|Adverse Event|6|||
48797535|NCT01951638|157095383|FG004|Treatment Period|Adverse Event|5|||
48797536|NCT01951638|157095379|FG000|Follow-up Period|Protocol Violation|0|||
48984227|NCT01693562|157774125|FG004|Expansion Phase|Withdrawal by Subject|0|||
48984228|NCT01693562|157774126|FG005|Expansion Phase|Withdrawal by Subject|0|||
48984229|NCT01693562|157774127|FG006|Expansion Phase|Withdrawal by Subject|0|||
48984230|NCT01693562|157774128|FG007|Expansion Phase|Withdrawal by Subject|16|||
48984231|NCT01693562|157774129|FG008|Expansion Phase|Withdrawal by Subject|2|||
48984232|NCT01693562|157774130|FG009|Expansion Phase|Withdrawal by Subject|54|||
48984233|NCT01693562|157774131|FG010|Expansion Phase|Withdrawal by Subject|2|||
48984234|NCT01693562|157774132|FG011|Expansion Phase|Withdrawal by Subject|2|||
48984235|NCT01693562|157774133|FG012|Expansion Phase|Withdrawal by Subject|3|||
48984236|NCT01693562|157774134|FG013|Expansion Phase|Withdrawal by Subject|5|||
48984237|NCT01693562|157774135|FG014|Expansion Phase|Withdrawal by Subject|16|||
48984238|NCT01693562|157774136|FG015|Expansion Phase|Withdrawal by Subject|7|||
48984239|NCT01693562|157774137|FG016|Expansion Phase|Withdrawal by Subject|40|||
48984240|NCT01693562|157774138|FG017|Expansion Phase|Withdrawal by Subject|4|||
48984241|NCT01693562|157774139|FG018|Expansion Phase|Withdrawal by Subject|8|||
48984242|NCT01693562|157774140|FG019|Expansion Phase|Withdrawal by Subject|3|||
48984243|NCT01693562|157774141|FG020|Expansion Phase|Withdrawal by Subject|1|||
48984244|NCT01693562|157774142|FG021|Expansion Phase|Withdrawal by Subject|8|||
48984245|NCT01693562|157774143|FG022|Expansion Phase|Withdrawal by Subject|1|||
48984246|NCT01693562|157774121|FG000|Expansion Phase|Death|0|||
48984247|NCT01693562|157774122|FG001|Expansion Phase|Death|0|||
48984248|NCT01693562|157774123|FG002|Expansion Phase|Death|0|||
48797537|NCT01951638|157095380|FG001|Follow-up Period|Protocol Violation|0|||
48797538|NCT01951638|157095381|FG002|Follow-up Period|Protocol Violation|0|||
48797539|NCT01951638|157095382|FG003|Follow-up Period|Protocol Violation|1|||
48797540|NCT01951638|157095383|FG004|Follow-up Period|Protocol Violation|0|||
48797541|NCT01951638|157095379|FG000|Follow-up Period|Logistical difficulties|0|||
48797542|NCT01951638|157095380|FG001|Follow-up Period|Logistical difficulties|2|||
48797543|NCT01951638|157095381|FG002|Follow-up Period|Logistical difficulties|0|||
48797544|NCT01951638|157095382|FG003|Follow-up Period|Logistical difficulties|0|||
48797545|NCT01951638|157095383|FG004|Follow-up Period|Logistical difficulties|1|||
48797546|NCT01951638|157095379|FG000|Follow-up Period|Withdrawal by Subject|1|||
48797547|NCT01951638|157095380|FG001|Follow-up Period|Withdrawal by Subject|5|||
48984249|NCT01693562|157774124|FG003|Expansion Phase|Death|0|||
48984250|NCT01693562|157774125|FG004|Expansion Phase|Death|0|||
48984251|NCT01693562|157774126|FG005|Expansion Phase|Death|0|||
48797548|NCT01951638|157095381|FG002|Follow-up Period|Withdrawal by Subject|2|||
48797549|NCT01951638|157095382|FG003|Follow-up Period|Withdrawal by Subject|1|||
48797550|NCT01951638|157095383|FG004|Follow-up Period|Withdrawal by Subject|2|||
48797551|NCT01951638|157095379|FG000|Follow-up Period|Lost to Follow-up|0|||
48797552|NCT01951638|157095380|FG001|Follow-up Period|Lost to Follow-up|1|||
48797553|NCT01951638|157095381|FG002|Follow-up Period|Lost to Follow-up|0|||
48797554|NCT01951638|157095382|FG003|Follow-up Period|Lost to Follow-up|1|||
48797555|NCT01951638|157095383|FG004|Follow-up Period|Lost to Follow-up|0|||
48797556|NCT01951638|157095379|FG000|Follow-up Period|Death|1|||
48797557|NCT01951638|157095380|FG001|Follow-up Period|Death|0|||
48797558|NCT01951638|157095381|FG002|Follow-up Period|Death|1|||
48797559|NCT01951638|157095382|FG003|Follow-up Period|Death|4|||
48797560|NCT01951638|157095383|FG004|Follow-up Period|Death|1|||
48797561|NCT01951638|157095379|FG000|Follow-up Period|Adverse Event|0|||
48797562|NCT01951638|157095380|FG001|Follow-up Period|Adverse Event|1|||
48797563|NCT01951638|157095381|FG002|Follow-up Period|Adverse Event|2|||
48797564|NCT01951638|157095382|FG003|Follow-up Period|Adverse Event|1|||
48797565|NCT01951638|157095383|FG004|Follow-up Period|Adverse Event|1|||
48797566|NCT03360942|157095386|FG000|Overall Study|Device explanted|2|||
48797567|NCT03360942|157095386|FG000|Overall Study|Study closure|1|||
48797568|NCT03360942|157095386|FG000|Overall Study|Withdrawal by Subject|2|||
48797569|NCT03703466|157095387|FG000|Overall Study|Death|2|||
48797570|NCT03703466|157095388|FG001|Overall Study|Death|1|||
48797571|NCT03703466|157095389|FG002|Overall Study|Death|0|||
48797572|NCT03703466|157095387|FG000|Overall Study|Withdrawal by Subject|0|||
48797573|NCT03703466|157095388|FG001|Overall Study|Withdrawal by Subject|3|||
48797574|NCT03703466|157095389|FG002|Overall Study|Withdrawal by Subject|0|||
48797575|NCT03703466|157095387|FG000|Overall Study|Completed < 3 Cycles|2|||
48797576|NCT03703466|157095388|FG001|Overall Study|Completed < 3 Cycles|2|||
48797577|NCT03703466|157095389|FG002|Overall Study|Completed < 3 Cycles|2|||
48797578|NCT02120027|157096998|FG000|Overall Study|Adverse Event|4|||
48797579|NCT02120027|157096999|FG001|Overall Study|Adverse Event|5|||
48797580|NCT02120027|157096998|FG000|Overall Study|Lack of Efficacy|3|||
48797581|NCT02120027|157096999|FG001|Overall Study|Lack of Efficacy|5|||
48797582|NCT02120027|157096998|FG000|Overall Study|Lost to Follow-up|5|||
48797583|NCT02120027|157096999|FG001|Overall Study|Lost to Follow-up|13|||
48797584|NCT02120027|157096998|FG000|Overall Study|Other|4|||
48797585|NCT02120027|157096999|FG001|Overall Study|Other|0|||
48797586|NCT02120027|157096998|FG000|Overall Study|Physician Decision|4|||
48797587|NCT02120027|157096999|FG001|Overall Study|Physician Decision|3|||
48797588|NCT02120027|157096998|FG000|Overall Study|Protocol Violation|18|||
48797589|NCT02120027|157096999|FG001|Overall Study|Protocol Violation|21|||
48797590|NCT02120027|157096998|FG000|Overall Study|Study terminated by Sponsor|45|||
48797591|NCT02120027|157096999|FG001|Overall Study|Study terminated by Sponsor|47|||
48797592|NCT02120027|157096998|FG000|Overall Study|Withdrawal by Subject|33|||
48797593|NCT02120027|157096999|FG001|Overall Study|Withdrawal by Subject|25|||
48797594|NCT02701985|157097000|FG000|Overall Study|Withdrawal by Subject|1|||
48797595|NCT02701985|157097001|FG001|Overall Study|Withdrawal by Subject|1|||
48797596|NCT02701985|157097000|FG000|Overall Study|Lost to Follow-up|1|||
48797597|NCT02701985|157097001|FG001|Overall Study|Lost to Follow-up|0|||
48897482|NCT04602221|157460927|FG001|Overall Study|Other than listed|0|||
48897483|NCT04602221|157460928|FG002|Overall Study|Other than listed|0|||
48897484|NCT04602221|157460929|FG003|Overall Study|Other than listed|0|||
48897485|NCT04602221|157460930|FG004|Overall Study|Other than listed|0|||
48897486|NCT04602221|157460931|FG005|Overall Study|Other than listed|0|||
48897487|NCT04602221|157460932|FG006|Overall Study|Other than listed|0|||
48897488|NCT04602221|157460933|FG007|Overall Study|Other than listed|0|||
48897489|NCT04602221|157460934|FG008|Overall Study|Other than listed|0|||
48897490|NCT04602221|157460935|FG009|Overall Study|Other than listed|0|||
48897491|NCT04602221|157460936|FG010|Overall Study|Other than listed|0|||
48897492|NCT04602221|157460937|FG011|Overall Study|Other than listed|0|||
48897493|NCT04602221|157460938|FG012|Overall Study|Other than listed|0|||
48897494|NCT04602221|157460939|FG013|Overall Study|Other than listed|0|||
48897495|NCT04602221|157460940|FG014|Overall Study|Other than listed|0|||
48897496|NCT04602221|157460941|FG015|Overall Study|Other than listed|1|||
48897497|NCT04602221|157460942|FG016|Overall Study|Other than listed|0|||
48897498|NCT04602221|157460943|FG017|Overall Study|Other than listed|1|||
48897499|NCT04602221|157460926|FG000|Overall Study|Withdrawal by Subject|0|||
48897500|NCT04602221|157460927|FG001|Overall Study|Withdrawal by Subject|0|||
48897501|NCT04602221|157460928|FG002|Overall Study|Withdrawal by Subject|0|||
48897502|NCT04602221|157460929|FG003|Overall Study|Withdrawal by Subject|0|||
48897503|NCT04602221|157460930|FG004|Overall Study|Withdrawal by Subject|0|||
48897504|NCT04602221|157460931|FG005|Overall Study|Withdrawal by Subject|0|||
48897505|NCT04602221|157460932|FG006|Overall Study|Withdrawal by Subject|0|||
48897506|NCT04602221|157460933|FG007|Overall Study|Withdrawal by Subject|0|||
48897507|NCT04602221|157460934|FG008|Overall Study|Withdrawal by Subject|0|||
48897508|NCT04602221|157460935|FG009|Overall Study|Withdrawal by Subject|0|||
48897509|NCT04602221|157460936|FG010|Overall Study|Withdrawal by Subject|0|||
48897510|NCT04602221|157460937|FG011|Overall Study|Withdrawal by Subject|0|||
49039838|NCT01513239|157982292|FG005|Period 2: 9 Month Extension Phase|Death|2|||
49039839|NCT01513239|157982287|FG000|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
49039840|NCT01513239|157982288|FG001|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
49039841|NCT01513239|157982289|FG002|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
49039842|NCT01513239|157982290|FG003|Period 2: 9 Month Extension Phase|Lost to Follow-up|2|||
49039843|NCT01513239|157982291|FG004|Period 2: 9 Month Extension Phase|Lost to Follow-up|1|||
49039844|NCT01513239|157982292|FG005|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
49039845|NCT01513239|157982287|FG000|Period 2: 9 Month Extension Phase|Physician Decision|0|||
49039846|NCT01513239|157982288|FG001|Period 2: 9 Month Extension Phase|Physician Decision|0|||
49039847|NCT01513239|157982289|FG002|Period 2: 9 Month Extension Phase|Physician Decision|0|||
49039848|NCT01513239|157982290|FG003|Period 2: 9 Month Extension Phase|Physician Decision|1|||
49039849|NCT01513239|157982291|FG004|Period 2: 9 Month Extension Phase|Physician Decision|0|||
49039850|NCT01513239|157982292|FG005|Period 2: 9 Month Extension Phase|Physician Decision|0|||
49039851|NCT01513239|157982287|FG000|Period 2: 9 Month Extension Phase|Technical Problems|0|||
49039852|NCT01513239|157982288|FG001|Period 2: 9 Month Extension Phase|Technical Problems|0|||
49039853|NCT01513239|157982289|FG002|Period 2: 9 Month Extension Phase|Technical Problems|0|||
49039854|NCT01513239|157982290|FG003|Period 2: 9 Month Extension Phase|Technical Problems|0|||
49039855|NCT01513239|157982291|FG004|Period 2: 9 Month Extension Phase|Technical Problems|1|||
49039856|NCT01513239|157982292|FG005|Period 2: 9 Month Extension Phase|Technical Problems|1|||
49039857|NCT03167606|157982293|FG000|Overall Study|Lost to Follow-up|73|||
49039858|NCT03167606|157982294|FG001|Overall Study|Lost to Follow-up|64|||
49039859|NCT03167606|157982293|FG000|Overall Study|Withdrawal by Subject|6|||
49039860|NCT03167606|157982294|FG001|Overall Study|Withdrawal by Subject|5|||
49039861|NCT03167606|157982293|FG000|Overall Study|Withdrawal by Investigator|0|||
49039862|NCT03167606|157982294|FG001|Overall Study|Withdrawal by Investigator|2|||
48797598|NCT02701985|157097000|FG000|Overall Study|Death|1|||
48797599|NCT02701985|157097001|FG001|Overall Study|Death|0|||
48797600|NCT02701985|157097000|FG000|Overall Study|Adverse Event|0|||
48797601|NCT02701985|157097001|FG001|Overall Study|Adverse Event|5|||
48797602|NCT00999466|157097006|FG000|Main Part|Withdrawal by Subject|0|||
48797603|NCT00999466|157097007|FG001|Main Part|Withdrawal by Subject|0|||
48797604|NCT00999466|157097008|FG002|Main Part|Withdrawal by Subject|2|||
48797605|NCT00999466|157097006|FG000|Main Part|Adverse Event|0|||
48797606|NCT00999466|157097007|FG001|Main Part|Adverse Event|4|||
48797607|NCT00999466|157097008|FG002|Main Part|Adverse Event|2|||
48797608|NCT03409666|157097013|FG000|Overall Study|Physician Decision|0|||
48797609|NCT03409666|157097014|FG001|Overall Study|Physician Decision|1|||
48797610|NCT03409666|157097013|FG000|Overall Study|Protocol Violation|0|||
48797611|NCT03409666|157097014|FG001|Overall Study|Protocol Violation|3|||
48797612|NCT02184611|157097018|FG000|Overall Study|Lack of Efficacy|11|||
48797613|NCT02184611|157097019|FG001|Overall Study|Lack of Efficacy|15|||
48797614|NCT02184611|157097018|FG000|Overall Study|Withdrawal by Subject|5|||
48797615|NCT02184611|157097019|FG001|Overall Study|Withdrawal by Subject|6|||
48797616|NCT02184611|157097018|FG000|Overall Study|Adverse Event|4|||
48797617|NCT02184611|157097019|FG001|Overall Study|Adverse Event|5|||
48797618|NCT02184611|157097018|FG000|Overall Study|Protocol Violation|1|||
48797619|NCT02184611|157097019|FG001|Overall Study|Protocol Violation|1|||
48797620|NCT02184611|157097018|FG000|Overall Study|Protocol defined stopping criteria|0|||
48797621|NCT02184611|157097019|FG001|Overall Study|Protocol defined stopping criteria|1|||
48797622|NCT02366910|157097023|FG000|Overall Study|Withdrawal by Subject|2|||
48797623|NCT02366910|157097023|FG000|Overall Study|Screen Failure|3|||
48797624|NCT00549757|157097028|FG000|Active Treatment Phase: Max. 50 Months|Adverse Event|590|||
48797625|NCT00549757|157097029|FG001|Active Treatment Phase: Max. 50 Months|Adverse Event|462|||
48797626|NCT00549757|157097028|FG000|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98|||
48797627|NCT00549757|157097029|FG001|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58|||
48797628|NCT00549757|157097028|FG000|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
48797629|NCT00549757|157097029|FG001|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
48797630|NCT00549757|157097028|FG000|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47|||
48797631|NCT00549757|157097029|FG001|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53|||
48797632|NCT00549757|157097028|FG000|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
48797633|NCT00549757|157097029|FG001|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
48797634|NCT00549757|157097028|FG000|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41|||
48797635|NCT00549757|157097029|FG001|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29|||
48797636|NCT00549757|157097028|FG000|Active Treatment Phase: Max. 50 Months|Administrative problems|2857|||
48797637|NCT00549757|157097029|FG001|Active Treatment Phase: Max. 50 Months|Administrative problems|3019|||
48797638|NCT00549757|157097028|FG000|Active Treatment Phase: Max. 50 Months|Death|188|||
48797639|NCT00549757|157097029|FG001|Active Treatment Phase: Max. 50 Months|Death|200|||
48797640|NCT00549757|157097028|FG000|Active Treatment Phase: Max. 50 Months|Patient's request|353|||
48797641|NCT00549757|157097029|FG001|Active Treatment Phase: Max. 50 Months|Patient's request|380|||
48797642|NCT00549757|157097028|FG000|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69|||
48797643|NCT00549757|157097029|FG001|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55|||
48797644|NCT00549757|157097028|FG000|Active Treatment Phase: Max. 50 Months|Missing data|8|||
48797645|NCT00549757|157097029|FG001|Active Treatment Phase: Max. 50 Months|Missing data|9|||
48797646|NCT00549757|157097028|FG000|Extension Period (in Average 9 Months)|Death|143|||
48797647|NCT00549757|157097029|FG001|Extension Period (in Average 9 Months)|Death|136|||
48797648|NCT00549757|157097028|FG000|Extension Period (in Average 9 Months)|Lost to Follow-up|52|||
48797649|NCT00549757|157097029|FG001|Extension Period (in Average 9 Months)|Lost to Follow-up|47|||
48797650|NCT00549757|157097028|FG000|Extension Period (in Average 9 Months)|Withdrawal by Subject|9|||
48797651|NCT00549757|157097029|FG001|Extension Period (in Average 9 Months)|Withdrawal by Subject|16|||
48797652|NCT00549757|157097028|FG000|Extension Period (in Average 9 Months)|Patient's request|421|||
48797653|NCT00549757|157097029|FG001|Extension Period (in Average 9 Months)|Patient's request|436|||
48797654|NCT03813238|157097033|FG000|Overall Study|Adverse Event|0|||
48797655|NCT03813238|157097034|FG001|Overall Study|Adverse Event|6|||
48797656|NCT03813238|157097033|FG000|Overall Study|Withdrawal by parent/guardian|0|||
48797657|NCT03813238|157097034|FG001|Overall Study|Withdrawal by parent/guardian|2|||
48797658|NCT03813238|157097033|FG000|Overall Study|Lost to Follow-up|0|||
48797659|NCT03813238|157097034|FG001|Overall Study|Lost to Follow-up|1|||
48797660|NCT03813238|157097033|FG000|Overall Study|Other than specified|1|||
48797661|NCT03813238|157097034|FG001|Overall Study|Other than specified|2|||
48797662|NCT03489304|157097035|FG000|Overall Study|Lost to Follow-up|4|||
48797663|NCT05159622|157097036|FG000|Overall Study|Lost to Follow-up|4|||
48797664|NCT05159622|157097037|FG001|Overall Study|Lost to Follow-up|5|||
48797665|NCT02080871|157097038|FG000|Overall Study|Death|1|||
48797666|NCT02080871|157097038|FG000|Overall Study|Lost to Follow-up|1|||
48797667|NCT01410474|157097039|FG000|Overall Study|Withdrawal by Subject|0|||
48897511|NCT04602221|157460938|FG012|Overall Study|Withdrawal by Subject|1|||
48897512|NCT04602221|157460939|FG013|Overall Study|Withdrawal by Subject|0|||
48897513|NCT04602221|157460940|FG014|Overall Study|Withdrawal by Subject|0|||
48897514|NCT04602221|157460941|FG015|Overall Study|Withdrawal by Subject|0|||
48897515|NCT04602221|157460942|FG016|Overall Study|Withdrawal by Subject|0|||
48897516|NCT04602221|157460943|FG017|Overall Study|Withdrawal by Subject|0|||
48897517|NCT04602221|157460926|FG000|Overall Study|Lost to Follow-up|0|||
48897518|NCT04602221|157460927|FG001|Overall Study|Lost to Follow-up|0|||
48897519|NCT04602221|157460928|FG002|Overall Study|Lost to Follow-up|0|||
48897520|NCT04602221|157460929|FG003|Overall Study|Lost to Follow-up|0|||
48897521|NCT04602221|157460930|FG004|Overall Study|Lost to Follow-up|0|||
48897522|NCT04602221|157460931|FG005|Overall Study|Lost to Follow-up|1|||
48897523|NCT04602221|157460932|FG006|Overall Study|Lost to Follow-up|0|||
48897524|NCT04602221|157460933|FG007|Overall Study|Lost to Follow-up|0|||
48897525|NCT04602221|157460934|FG008|Overall Study|Lost to Follow-up|0|||
48897526|NCT04602221|157460935|FG009|Overall Study|Lost to Follow-up|0|||
48897527|NCT04602221|157460936|FG010|Overall Study|Lost to Follow-up|0|||
48897528|NCT04602221|157460937|FG011|Overall Study|Lost to Follow-up|0|||
48897529|NCT04602221|157460938|FG012|Overall Study|Lost to Follow-up|0|||
48897530|NCT04602221|157460939|FG013|Overall Study|Lost to Follow-up|0|||
48897531|NCT04602221|157460940|FG014|Overall Study|Lost to Follow-up|0|||
48897532|NCT04602221|157460941|FG015|Overall Study|Lost to Follow-up|0|||
48897533|NCT04602221|157460942|FG016|Overall Study|Lost to Follow-up|0|||
48897534|NCT04602221|157460943|FG017|Overall Study|Lost to Follow-up|0|||
48897535|NCT02270515|157460944|FG000|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1|||
48897536|NCT02270515|157460944|FG000|Intervention Period 1: 0-6 Months|No longer patient at study site|5|||
48897537|NCT02270515|157460944|FG000|Intervention Period 1: 0-6 Months|Received transplant|3|||
48897538|NCT02270515|157460944|FG000|Intervention Period 1: 0-6 Months|Death|7|||
48897539|NCT02270515|157460944|FG000|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2|||
48897540|NCT02270515|157460944|FG000|Intervention Period 2: 6-12 Months|No longer patient at study site|7|||
48897541|NCT02270515|157460944|FG000|Intervention Period 2: 6-12 Months|Received transplant|1|||
48897542|NCT02270515|157460944|FG000|Intervention Period 2: 6-12 Months|Death|5|||
48897543|NCT02270515|157460944|FG000|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17|||
48897544|NCT02270515|157460944|FG000|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1|||
48897545|NCT02270515|157460944|FG000|Intervention Period 3: 12-18 Months|No longer patient at study site|2|||
48897546|NCT02270515|157460944|FG000|Intervention Period 3: 12-18 Months|Received transplant|2|||
48897547|NCT02270515|157460944|FG000|Intervention Period 3: 12-18 Months|Death|3|||
48897548|NCT02270515|157460944|FG000|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16|||
48897549|NCT02729831|157460945|FG000|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38|||
48897550|NCT02729831|157460946|FG001|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23|||
48897551|NCT02729831|157460947|FG002|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18|||
48897552|NCT02729831|157460948|FG003|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17|||
48897553|NCT02729831|157460945|FG000|1 Week Post-visit|Lost to Follow-up|43|||
48897554|NCT02729831|157460946|FG001|1 Week Post-visit|Lost to Follow-up|40|||
48897555|NCT02729831|157460947|FG002|1 Week Post-visit|Lost to Follow-up|38|||
48897556|NCT02729831|157460948|FG003|1 Week Post-visit|Lost to Follow-up|36|||
48897557|NCT02729831|157460945|FG000|6 Month Follow-up|Lost to Follow-up|54|||
48897558|NCT02729831|157460946|FG001|6 Month Follow-up|Lost to Follow-up|51|||
48897559|NCT02729831|157460947|FG002|6 Month Follow-up|Lost to Follow-up|48|||
48897560|NCT02729831|157460948|FG003|6 Month Follow-up|Lost to Follow-up|42|||
48897561|NCT02729831|157460945|FG000|6 Month Follow-up|Death|1|||
48897562|NCT02729831|157460946|FG001|6 Month Follow-up|Death|3|||
48897563|NCT02729831|157460947|FG002|6 Month Follow-up|Death|0|||
48897564|NCT02729831|157460948|FG003|6 Month Follow-up|Death|1|||
48897565|NCT02481947|157460949|FG000|Overall Study|Withdrawal by Subject|24|||
48897566|NCT02481947|157460950|FG001|Overall Study|Withdrawal by Subject|10|||
48897567|NCT02481947|157460949|FG000|Overall Study|Lost to Follow-up|11|||
48897568|NCT02481947|157460950|FG001|Overall Study|Lost to Follow-up|5|||
48897569|NCT02481947|157460949|FG000|Overall Study|Adverse Event|6|||
48897570|NCT02481947|157460950|FG001|Overall Study|Adverse Event|11|||
48897571|NCT02481947|157460949|FG000|Overall Study|Physician Decision|4|||
48897572|NCT02481947|157460950|FG001|Overall Study|Physician Decision|5|||
48897573|NCT02481947|157460949|FG000|Overall Study|Protocol Violation|1|||
48897574|NCT02481947|157460950|FG001|Overall Study|Protocol Violation|5|||
48897575|NCT01054170|157460951|FG000|Overall Study|Protocol Violation|1|||
48897576|NCT01054170|157460952|FG001|Overall Study|Protocol Violation|0|||
48897577|NCT01054170|157460951|FG000|Overall Study|Withdrawal by Subject|3|||
48897578|NCT01054170|157460952|FG001|Overall Study|Withdrawal by Subject|2|||
48897579|NCT01054170|157460951|FG000|Overall Study|Adverse Event|0|||
48897580|NCT01054170|157460952|FG001|Overall Study|Adverse Event|4|||
48897581|NCT02951767|157460953|FG000|Overall Study|Study Terminated By Sponsor|9|||
48897582|NCT02951767|157460953|FG000|Overall Study|Withdrawal by Subject|11|||
48897583|NCT02951767|157460953|FG000|Overall Study|Death|96|||
48897584|NCT02951767|157460953|FG000|Overall Study|Lost to Follow-up|2|||
48897585|NCT02951767|157460953|FG000|Overall Study|Physician Decision|1|||
48897586|NCT01237587|157460954|FG000|Double Blind Treatment (Acute Phase)|Adverse Event|5|||
48897587|NCT01237587|157460955|FG001|Double Blind Treatment (Acute Phase)|Adverse Event|1|||
48897588|NCT01237587|157460954|FG000|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1|||
48897589|NCT01237587|157460955|FG001|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3|||
48897590|NCT01237587|157460954|FG000|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2|||
48897591|NCT01237587|157460955|FG001|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3|||
49039919|NCT00385736|157982302|FG000|Efficacy Analysis Set - Induction|Adverse Event|5|||
49039920|NCT00385736|157982303|FG001|Efficacy Analysis Set - Induction|Adverse Event|6|||
49039921|NCT00385736|157982304|FG002|Efficacy Analysis Set - Induction|Adverse Event|4|||
49039922|NCT00385736|157982302|FG000|Efficacy Analysis Set - Induction|Withdrawal by Subject|0|||
49039923|NCT00385736|157982303|FG001|Efficacy Analysis Set - Induction|Withdrawal by Subject|2|||
49039924|NCT00385736|157982304|FG002|Efficacy Analysis Set - Induction|Withdrawal by Subject|1|||
49039925|NCT00385736|157982302|FG000|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
49039926|NCT00385736|157982303|FG001|Efficacy Analysis Set - Induction|Lost to Follow-up|2|||
49039927|NCT00385736|157982304|FG002|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
49039928|NCT00385736|157982302|FG000|Efficacy Analysis Set - Induction|Lack of Efficacy|4|||
49039929|NCT00385736|157982303|FG001|Efficacy Analysis Set - Induction|Lack of Efficacy|2|||
49039930|NCT00385736|157982304|FG002|Efficacy Analysis Set - Induction|Lack of Efficacy|1|||
49039931|NCT00385736|157982302|FG000|Efficacy Analysis Set - Induction|Protocol Violation|0|||
49039932|NCT00385736|157982303|FG001|Efficacy Analysis Set - Induction|Protocol Violation|0|||
49039933|NCT00385736|157982304|FG002|Efficacy Analysis Set - Induction|Protocol Violation|2|||
49039934|NCT00385736|157982302|FG000|Efficacy Analysis Set - Induction|Other|0|||
49039935|NCT00385736|157982303|FG001|Efficacy Analysis Set - Induction|Other|0|||
49039936|NCT00385736|157982304|FG002|Efficacy Analysis Set - Induction|Other|1|||
49039937|NCT00385736|157982302|FG000|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
49039938|NCT00385736|157982303|FG001|Efficacy Analysis Set - Maintenance|Adverse Event|15|||
49039939|NCT00385736|157982304|FG002|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
49039940|NCT00385736|157982302|FG000|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
48692504|NCT00453154|156724506|FG003|Double BIind Maintenance|Death|1|||
48692505|NCT00453154|156724503|FG000|Double BIind Maintenance|Withdrawal by Subject|0|||
48692506|NCT00453154|156724504|FG001|Double BIind Maintenance|Withdrawal by Subject|0|||
48692507|NCT00453154|156724505|FG002|Double BIind Maintenance|Withdrawal by Subject|4|||
48692508|NCT00453154|156724506|FG003|Double BIind Maintenance|Withdrawal by Subject|4|||
48692509|NCT00453154|156724503|FG000|Double BIind Maintenance|Progression|0|||
48692510|NCT00453154|156724504|FG001|Double BIind Maintenance|Progression|0|||
48692511|NCT00453154|156724505|FG002|Double BIind Maintenance|Progression|29|||
48692512|NCT00453154|156724506|FG003|Double BIind Maintenance|Progression|26|||
49039941|NCT00385736|157982303|FG001|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
49039942|NCT00385736|157982304|FG002|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14|||
49039943|NCT00385736|157982302|FG000|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0|||
49039944|NCT00385736|157982303|FG001|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
49039945|NCT00385736|157982304|FG002|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
49039946|NCT00385736|157982302|FG000|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38|||
49039947|NCT00385736|157982303|FG001|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16|||
49039948|NCT00385736|157982304|FG002|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31|||
49039949|NCT00385736|157982302|FG000|Efficacy Analysis Set - Maintenance|Protocol Violation|2|||
49039950|NCT00385736|157982303|FG001|Efficacy Analysis Set - Maintenance|Protocol Violation|1|||
49039951|NCT00385736|157982304|FG002|Efficacy Analysis Set - Maintenance|Protocol Violation|6|||
49039952|NCT00385736|157982302|FG000|Efficacy Analysis Set - Maintenance|Other|0|||
49039953|NCT00385736|157982303|FG001|Efficacy Analysis Set - Maintenance|Other|4|||
49039954|NCT00385736|157982304|FG002|Efficacy Analysis Set - Maintenance|Other|4|||
49039955|NCT00385736|157982302|FG000|Safety Analysis Set|Adverse Event|23|||
49039956|NCT00385736|157982303|FG001|Safety Analysis Set|Adverse Event|15|||
49039957|NCT00385736|157982304|FG002|Safety Analysis Set|Adverse Event|23|||
49039958|NCT00385736|157982302|FG000|Safety Analysis Set|Withdrawal by Subject|6|||
49039959|NCT00385736|157982303|FG001|Safety Analysis Set|Withdrawal by Subject|6|||
48897592|NCT01237587|157460954|FG000|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2|||
48897593|NCT01237587|157460955|FG001|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4|||
48897594|NCT01237587|157460954|FG000|Double Blind Treatment (Acute Phase)|Protocol Violation|4|||
48897595|NCT01237587|157460955|FG001|Double Blind Treatment (Acute Phase)|Protocol Violation|3|||
48897596|NCT01237587|157460954|FG000|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3|||
48897597|NCT01237587|157460955|FG001|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4|||
48897598|NCT01237587|157460954|FG000|Open Label Treatment (Extension Phase)|Lost to Follow-up|4|||
48897599|NCT01237587|157460955|FG001|Open Label Treatment (Extension Phase)|Lost to Follow-up|3|||
48897600|NCT01237587|157460954|FG000|Open Label Treatment (Extension Phase)|Adverse Event|5|||
48897601|NCT01237587|157460955|FG001|Open Label Treatment (Extension Phase)|Adverse Event|5|||
48897602|NCT01237587|157460954|FG000|Open Label Treatment (Extension Phase)|Lack of Efficacy|2|||
48897603|NCT01237587|157460955|FG001|Open Label Treatment (Extension Phase)|Lack of Efficacy|4|||
48897604|NCT01237587|157460954|FG000|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2|||
48897605|NCT01237587|157460955|FG001|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4|||
48897606|NCT01237587|157460954|FG000|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0|||
48897607|NCT01237587|157460955|FG001|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5|||
48897608|NCT01237587|157460954|FG000|Open Label Treatment (Extension Phase)|Sponsor Decision|1|||
48897609|NCT01237587|157460955|FG001|Open Label Treatment (Extension Phase)|Sponsor Decision|0|||
48897610|NCT01237587|157460954|FG000|Open Label Treatment (Extension Phase)|Physician Decision|4|||
48897611|NCT01237587|157460955|FG001|Open Label Treatment (Extension Phase)|Physician Decision|4|||
48897612|NCT01237587|157460954|FG000|Taper Phase|Adverse Event|0|||
48897613|NCT01237587|157460955|FG001|Taper Phase|Adverse Event|2|||
48897614|NCT01237587|157460954|FG000|Taper Phase|Protocol Violation|2|||
48897615|NCT01237587|157460955|FG001|Taper Phase|Protocol Violation|0|||
48897616|NCT01237587|157460954|FG000|Taper Phase|Lack of Efficacy|2|||
48897617|NCT01237587|157460955|FG001|Taper Phase|Lack of Efficacy|5|||
48897618|NCT01237587|157460954|FG000|Taper Phase|Parent/Guardian Decision|0|||
48897619|NCT01237587|157460955|FG001|Taper Phase|Parent/Guardian Decision|2|||
48897620|NCT01237587|157460954|FG000|Taper Phase|Sponsor Decision|1|||
48897621|NCT01237587|157460955|FG001|Taper Phase|Sponsor Decision|0|||
48897622|NCT01237587|157460954|FG000|Taper Phase|Withdrawal by Subject|0|||
48897623|NCT01237587|157460955|FG001|Taper Phase|Withdrawal by Subject|1|||
48897624|NCT03265938|157460956|FG000|Overall Study|Withdrawal by Subject|1|||
48897625|NCT03265938|157460956|FG000|Overall Study|Physician Decision|1|||
48897626|NCT03265938|157460956|FG000|Overall Study|friable mass|6|||
48897627|NCT01211288|157460957|FG000|Overall Study|Lost to Follow-up|1|||
48897628|NCT01211288|157460958|FG001|Overall Study|Lost to Follow-up|1|||
48897629|NCT02447172|157460966|FG000|Overall Study|Adverse Event|11|||
48897630|NCT02447172|157460967|FG001|Overall Study|Adverse Event|8|||
48897631|NCT02447172|157460968|FG002|Overall Study|Adverse Event|7|||
48897632|NCT02447172|157460966|FG000|Overall Study|Death|3|||
48897633|NCT02447172|157460967|FG001|Overall Study|Death|1|||
48897634|NCT02447172|157460968|FG002|Overall Study|Death|0|||
48897635|NCT02447172|157460966|FG000|Overall Study|Protocol Violation|2|||
48897636|NCT02447172|157460967|FG001|Overall Study|Protocol Violation|1|||
48897637|NCT02447172|157460968|FG002|Overall Study|Protocol Violation|2|||
48897638|NCT02447172|157460966|FG000|Overall Study|Lost to Follow-up|7|||
48897639|NCT02447172|157460967|FG001|Overall Study|Lost to Follow-up|4|||
48897640|NCT02447172|157460968|FG002|Overall Study|Lost to Follow-up|4|||
48897641|NCT02447172|157460966|FG000|Overall Study|Withdrawal by Subject|5|||
48897642|NCT02447172|157460967|FG001|Overall Study|Withdrawal by Subject|1|||
48897643|NCT02447172|157460968|FG002|Overall Study|Withdrawal by Subject|3|||
48897644|NCT02447172|157460966|FG000|Overall Study|protocol specific treatment unrelated|3|||
48897645|NCT02447172|157460967|FG001|Overall Study|protocol specific treatment unrelated|0|||
48897646|NCT02447172|157460968|FG002|Overall Study|protocol specific treatment unrelated|2|||
48897647|NCT01281969|157460969|FG000|Overall Study|not randomized didn't meet criteria|0|||
48897648|NCT01281969|157460970|FG001|Overall Study|not randomized didn't meet criteria|0|||
48897649|NCT01281969|157460971|FG002|Overall Study|not randomized didn't meet criteria|7|||
48897650|NCT01281969|157460969|FG000|Overall Study|AE during LP prior to IVIG admin|1|||
48897651|NCT01281969|157460970|FG001|Overall Study|AE during LP prior to IVIG admin|0|||
48897652|NCT01281969|157460971|FG002|Overall Study|AE during LP prior to IVIG admin|3|||
48897653|NCT01281969|157460969|FG000|Overall Study|not randomized, child consent not given|0|||
48897654|NCT01281969|157460970|FG001|Overall Study|not randomized, child consent not given|0|||
48897655|NCT01281969|157460971|FG002|Overall Study|not randomized, child consent not given|2|||
48897656|NCT01723254|157460972|FG000|Overall Study|Conflict with work schedule|0|||
48897657|NCT01723254|157460973|FG001|Overall Study|Conflict with work schedule|0|||
48897658|NCT01723254|157460974|FG002|Overall Study|Conflict with work schedule|0|||
48984252|NCT01693562|157774127|FG006|Expansion Phase|Death|0|||
48984253|NCT01693562|157774128|FG007|Expansion Phase|Death|42|||
48984254|NCT01693562|157774129|FG008|Expansion Phase|Death|17|||
48984255|NCT01693562|157774130|FG009|Expansion Phase|Death|208|||
48984256|NCT01693562|157774131|FG010|Expansion Phase|Death|30|||
48984257|NCT01693562|157774132|FG011|Expansion Phase|Death|8|||
48984258|NCT01693562|157774133|FG012|Expansion Phase|Death|19|||
48897659|NCT01723254|157460975|FG003|Overall Study|Conflict with work schedule|0|||
48897660|NCT01723254|157460976|FG004|Overall Study|Conflict with work schedule|0|||
49039960|NCT00385736|157982304|FG002|Safety Analysis Set|Withdrawal by Subject|14|||
49039961|NCT00385736|157982302|FG000|Safety Analysis Set|Lost to Follow-up|0|||
49039962|NCT00385736|157982303|FG001|Safety Analysis Set|Lost to Follow-up|2|||
49039963|NCT00385736|157982304|FG002|Safety Analysis Set|Lost to Follow-up|2|||
49039964|NCT00385736|157982302|FG000|Safety Analysis Set|Lack of Efficacy|38|||
49039965|NCT00385736|157982303|FG001|Safety Analysis Set|Lack of Efficacy|16|||
49039966|NCT00385736|157982304|FG002|Safety Analysis Set|Lack of Efficacy|31|||
49039967|NCT00385736|157982302|FG000|Safety Analysis Set|Protocol Violation|2|||
49039968|NCT00385736|157982303|FG001|Safety Analysis Set|Protocol Violation|1|||
49039969|NCT00385736|157982304|FG002|Safety Analysis Set|Protocol Violation|6|||
49039970|NCT00385736|157982302|FG000|Safety Analysis Set|Other|1|||
49039971|NCT00385736|157982303|FG001|Safety Analysis Set|Other|4|||
49039972|NCT00385736|157982304|FG002|Safety Analysis Set|Other|4|||
49039973|NCT00469898|157982308|FG000|Overall Study|Adverse Event|7|||
49039974|NCT00469898|157982308|FG000|Overall Study|Withdrawal by Subject|4|||
49039975|NCT00469898|157982308|FG000|Overall Study|Death|4|||
49039976|NCT00469898|157982308|FG000|Overall Study|Disease progression|9|||
49039977|NCT00469898|157982308|FG000|Overall Study|Decreased performance status|1|||
49039978|NCT01741545|157982309|FG000|Treatment Period|Lack of Efficacy|0|||
49039979|NCT01741545|157982310|FG001|Treatment Period|Lack of Efficacy|1|||
49039980|NCT01741545|157982309|FG000|Treatment Period|Adverse event, non-fatal|1|||
49039981|NCT01741545|157982310|FG001|Treatment Period|Adverse event, non-fatal|3|||
49039982|NCT01741545|157982309|FG000|Follow-up Period (24 Weeks)|Other than specified|0|||
49039983|NCT01741545|157982310|FG001|Follow-up Period (24 Weeks)|Other than specified|1|||
49039984|NCT01741545|157982309|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
49039985|NCT01741545|157982310|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
49039986|NCT02483416|157982311|FG000|Overall Study|Other reason|0|||
49039987|NCT02483416|157982312|FG001|Overall Study|Other reason|1|||
49039988|NCT02483416|157982311|FG000|Overall Study|Treatment stop|3|||
49039989|NCT02483416|157982312|FG001|Overall Study|Treatment stop|0|||
49039990|NCT03428750|157982313|FG000|Overall Study|Withdrawal by Subject|11|||
49039991|NCT03428750|157982314|FG001|Overall Study|Withdrawal by Subject|10|||
49039992|NCT03428750|157982313|FG000|Overall Study|Lost to Follow-up|3|||
49039993|NCT03428750|157982314|FG001|Overall Study|Lost to Follow-up|9|||
49039994|NCT03428750|157982313|FG000|Overall Study|Adverse Event|9|||
49039995|NCT03428750|157982314|FG001|Overall Study|Adverse Event|1|||
49039996|NCT03428750|157982313|FG000|Overall Study|Protocol Violation|1|||
49039997|NCT03428750|157982314|FG001|Overall Study|Protocol Violation|0|||
49039998|NCT03428750|157982313|FG000|Overall Study|Administrative|0|||
49039999|NCT03428750|157982314|FG001|Overall Study|Administrative|1|||
49040000|NCT00924638|157982315|FG000|Overall Study|Death|3|||
49040001|NCT00924638|157982316|FG001|Overall Study|Death|2|||
49040002|NCT00924638|157982315|FG000|Overall Study|Lost to Follow-up|1|||
49040003|NCT00924638|157982316|FG001|Overall Study|Lost to Follow-up|1|||
49040004|NCT00924638|157982315|FG000|Overall Study|Withdrawal by Subject|5|||
48897661|NCT01723254|157460977|FG005|Overall Study|Conflict with work schedule|0|||
48897662|NCT01723254|157460978|FG006|Overall Study|Conflict with work schedule|0|||
48897663|NCT01723254|157460979|FG007|Overall Study|Conflict with work schedule|1|||
48897664|NCT01723254|157460972|FG000|Overall Study|Personal issues|0|||
48897665|NCT01723254|157460973|FG001|Overall Study|Personal issues|0|||
48897666|NCT01723254|157460974|FG002|Overall Study|Personal issues|0|||
48897667|NCT01723254|157460975|FG003|Overall Study|Personal issues|0|||
48897668|NCT01723254|157460976|FG004|Overall Study|Personal issues|0|||
48897669|NCT01723254|157460977|FG005|Overall Study|Personal issues|1|||
48897670|NCT01723254|157460978|FG006|Overall Study|Personal issues|0|||
48897671|NCT01723254|157460979|FG007|Overall Study|Personal issues|0|||
48897672|NCT01723254|157460972|FG000|Overall Study|No longer have time to participate|0|||
48897673|NCT01723254|157460973|FG001|Overall Study|No longer have time to participate|0|||
48897674|NCT01723254|157460974|FG002|Overall Study|No longer have time to participate|0|||
48897675|NCT01723254|157460975|FG003|Overall Study|No longer have time to participate|1|||
48897676|NCT01723254|157460976|FG004|Overall Study|No longer have time to participate|0|||
48897677|NCT01723254|157460977|FG005|Overall Study|No longer have time to participate|0|||
48897678|NCT01723254|157460978|FG006|Overall Study|No longer have time to participate|0|||
48897679|NCT01723254|157460979|FG007|Overall Study|No longer have time to participate|0|||
48897680|NCT01723254|157460972|FG000|Overall Study|Move/Left to another country/city|0|||
48897681|NCT01723254|157460973|FG001|Overall Study|Move/Left to another country/city|0|||
48897682|NCT01723254|157460974|FG002|Overall Study|Move/Left to another country/city|2|||
49040005|NCT00924638|157982316|FG001|Overall Study|Withdrawal by Subject|7|||
49040006|NCT00924638|157982315|FG000|Overall Study|Physician Decision|3|||
49040007|NCT00924638|157982316|FG001|Overall Study|Physician Decision|3|||
49040008|NCT03961204|157982329|FG000|Overall Study|Withdrawal by Subject|2|||
49040009|NCT03961204|157982329|FG000|Overall Study|Lost to Follow-up|3|||
49040010|NCT03961204|157982329|FG000|Overall Study|Other|1|||
49040011|NCT03961204|157982329|FG000|Overall Study|Missing|1|||
49040012|NCT04442503|157982330|FG000|Overall Study|Adverse Event|1|||
48897683|NCT01723254|157460975|FG003|Overall Study|Move/Left to another country/city|1|||
48897684|NCT01723254|157460976|FG004|Overall Study|Move/Left to another country/city|1|||
48897685|NCT01723254|157460977|FG005|Overall Study|Move/Left to another country/city|0|||
48897686|NCT01723254|157460978|FG006|Overall Study|Move/Left to another country/city|0|||
48897687|NCT01723254|157460979|FG007|Overall Study|Move/Left to another country/city|0|||
48897688|NCT01723254|157460972|FG000|Overall Study|Protocol Violation|0|||
48897689|NCT01723254|157460973|FG001|Overall Study|Protocol Violation|1|||
48897690|NCT01723254|157460974|FG002|Overall Study|Protocol Violation|0|||
48897691|NCT01723254|157460975|FG003|Overall Study|Protocol Violation|0|||
48897692|NCT01723254|157460976|FG004|Overall Study|Protocol Violation|0|||
48897693|NCT01723254|157460977|FG005|Overall Study|Protocol Violation|0|||
48897694|NCT01723254|157460978|FG006|Overall Study|Protocol Violation|0|||
48897695|NCT01723254|157460979|FG007|Overall Study|Protocol Violation|0|||
48897696|NCT01723254|157460972|FG000|Overall Study|Withdrawal by Subject|1|||
48897697|NCT01723254|157460973|FG001|Overall Study|Withdrawal by Subject|2|||
48897698|NCT01723254|157460974|FG002|Overall Study|Withdrawal by Subject|1|||
48897699|NCT01723254|157460975|FG003|Overall Study|Withdrawal by Subject|0|||
48897700|NCT01723254|157460976|FG004|Overall Study|Withdrawal by Subject|1|||
48897701|NCT01723254|157460977|FG005|Overall Study|Withdrawal by Subject|1|||
48897702|NCT01723254|157460978|FG006|Overall Study|Withdrawal by Subject|1|||
48897703|NCT01723254|157460979|FG007|Overall Study|Withdrawal by Subject|2|||
48897704|NCT02678247|157460988|FG000|First Intervention (7 Weeks)|Withdrawal by Subject|0|||
48897705|NCT02678247|157460989|FG001|First Intervention (7 Weeks)|Withdrawal by Subject|2|||
48897706|NCT02678247|157460988|FG000|First Intervention (7 Weeks)|Adverse Event|1|||
48897707|NCT02678247|157460989|FG001|First Intervention (7 Weeks)|Adverse Event|2|||
48897708|NCT02678247|157460988|FG000|First Intervention (7 Weeks)|Physician Decision|1|||
48897709|NCT02678247|157460989|FG001|First Intervention (7 Weeks)|Physician Decision|0|||
48897710|NCT02678247|157460988|FG000|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
48897711|NCT02678247|157460989|FG001|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
48897712|NCT02678247|157460988|FG000|Second Intervention (7 Weeks)|Adverse Event|2|||
48897713|NCT02678247|157460989|FG001|Second Intervention (7 Weeks)|Adverse Event|1|||
48897714|NCT02678247|157460988|FG000|Second Intervention (7 Weeks)|Physician Decision|1|||
48897715|NCT02678247|157460989|FG001|Second Intervention (7 Weeks)|Physician Decision|0|||
48897716|NCT02337751|157460995|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
48897717|NCT02337751|157460996|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
48897718|NCT02337751|157460995|FG000|Overall Study|Voluntary Withdrawal|6|||
48897719|NCT02337751|157460996|FG001|Overall Study|Voluntary Withdrawal|8|||
48897720|NCT02337751|157460995|FG000|Overall Study|Lack of Efficacy|2|||
48897721|NCT02337751|157460996|FG001|Overall Study|Lack of Efficacy|5|||
48897722|NCT02337751|157460995|FG000|Overall Study|Investigator's Judgement|1|||
49040013|NCT04442503|157982331|FG001|Overall Study|Adverse Event|1|||
49040014|NCT04442503|157982330|FG000|Overall Study|Lost to Follow-up|8|||
48897723|NCT02337751|157460996|FG001|Overall Study|Investigator's Judgement|0|||
48897724|NCT01315353|157460997|FG000|Overall Study|Death|2|||
48897725|NCT01315353|157460998|FG001|Overall Study|Death|1|||
48897726|NCT01315353|157460999|FG002|Overall Study|Death|0|||
48897727|NCT01315353|157460997|FG000|Overall Study|Withdrawal by Subject|2|||
48897728|NCT01315353|157460998|FG001|Overall Study|Withdrawal by Subject|6|||
48897729|NCT01315353|157460999|FG002|Overall Study|Withdrawal by Subject|1|||
48897730|NCT01315353|157460997|FG000|Overall Study|Lost to Follow-up|13|||
48897731|NCT01315353|157460998|FG001|Overall Study|Lost to Follow-up|6|||
48984259|NCT01693562|157774134|FG013|Expansion Phase|Death|42|||
48984260|NCT01693562|157774135|FG014|Expansion Phase|Death|23|||
48984261|NCT01693562|157774136|FG015|Expansion Phase|Death|23|||
48984262|NCT01693562|157774137|FG016|Expansion Phase|Death|128|||
48984263|NCT01693562|157774138|FG017|Expansion Phase|Death|16|||
48984264|NCT01693562|157774139|FG018|Expansion Phase|Death|36|||
48984265|NCT01693562|157774140|FG019|Expansion Phase|Death|16|||
48984266|NCT01693562|157774141|FG020|Expansion Phase|Death|17|||
48984267|NCT01693562|157774142|FG021|Expansion Phase|Death|35|||
48984268|NCT01693562|157774143|FG022|Expansion Phase|Death|7|||
48984269|NCT01693562|157774121|FG000|Expansion Phase|Lost to Follow-up|0|||
48984270|NCT01693562|157774122|FG001|Expansion Phase|Lost to Follow-up|0|||
48984271|NCT01693562|157774123|FG002|Expansion Phase|Lost to Follow-up|0|||
48984272|NCT01693562|157774124|FG003|Expansion Phase|Lost to Follow-up|0|||
48897732|NCT01315353|157460999|FG002|Overall Study|Lost to Follow-up|6|||
48897733|NCT01315353|157460997|FG000|Overall Study|Unwilling to adhere to requirements|5|||
48897734|NCT01315353|157460998|FG001|Overall Study|Unwilling to adhere to requirements|5|||
48897735|NCT01315353|157460999|FG002|Overall Study|Unwilling to adhere to requirements|4|||
48897736|NCT01315353|157460997|FG000|Overall Study|Site closing|7|||
48897737|NCT01315353|157460998|FG001|Overall Study|Site closing|4|||
48984273|NCT01693562|157774125|FG004|Expansion Phase|Lost to Follow-up|0|||
48897738|NCT01315353|157460999|FG002|Overall Study|Site closing|0|||
48984274|NCT01693562|157774126|FG005|Expansion Phase|Lost to Follow-up|0|||
48984275|NCT01693562|157774127|FG006|Expansion Phase|Lost to Follow-up|0|||
48984276|NCT01693562|157774128|FG007|Expansion Phase|Lost to Follow-up|1|||
48984277|NCT01693562|157774129|FG008|Expansion Phase|Lost to Follow-up|2|||
48897739|NCT01315353|157460997|FG000|Overall Study|Taken off study by site in error|0|||
48897740|NCT01315353|157460998|FG001|Overall Study|Taken off study by site in error|1|||
48897741|NCT01315353|157460999|FG002|Overall Study|Taken off study by site in error|0|||
48897742|NCT01315353|157460997|FG000|Overall Study|Inadvertent randomization/assignment|0|||
48897743|NCT01315353|157460998|FG001|Overall Study|Inadvertent randomization/assignment|0|||
48897744|NCT01315353|157460999|FG002|Overall Study|Inadvertent randomization/assignment|2|||
48897745|NCT00153062|157462696|FG000|Overall Study|Death|360|||
48897746|NCT00153062|157462697|FG001|Overall Study|Death|352|||
48897747|NCT00153062|157462698|FG002|Overall Study|Death|369|||
48897748|NCT00153062|157462699|FG003|Overall Study|Death|365|||
48897749|NCT00153062|157462696|FG000|Overall Study|Withdrawal by Subject|14|||
48897750|NCT00153062|157462697|FG001|Overall Study|Withdrawal by Subject|30|||
48897751|NCT00153062|157462698|FG002|Overall Study|Withdrawal by Subject|27|||
48897752|NCT00153062|157462699|FG003|Overall Study|Withdrawal by Subject|28|||
48897753|NCT00153062|157462696|FG000|Overall Study|Lost to Follow-up|12|||
48897754|NCT00153062|157462697|FG001|Overall Study|Lost to Follow-up|20|||
48897755|NCT00153062|157462698|FG002|Overall Study|Lost to Follow-up|15|||
48897756|NCT00153062|157462699|FG003|Overall Study|Lost to Follow-up|16|||
48897757|NCT00153062|157462696|FG000|Overall Study|Adverse Event|0|||
48897758|NCT00153062|157462697|FG001|Overall Study|Adverse Event|1|||
48897759|NCT00153062|157462698|FG002|Overall Study|Adverse Event|1|||
48897760|NCT00153062|157462699|FG003|Overall Study|Adverse Event|0|||
48897761|NCT00153062|157462696|FG000|Overall Study|Protocol Violation|0|||
48897762|NCT00153062|157462697|FG001|Overall Study|Protocol Violation|2|||
48897763|NCT00153062|157462698|FG002|Overall Study|Protocol Violation|1|||
48897764|NCT00153062|157462699|FG003|Overall Study|Protocol Violation|1|||
48897765|NCT00153062|157462696|FG000|Overall Study|No disposition data available|1|||
48897766|NCT00153062|157462697|FG001|Overall Study|No disposition data available|1|||
48897767|NCT00153062|157462698|FG002|Overall Study|No disposition data available|1|||
48897768|NCT00153062|157462699|FG003|Overall Study|No disposition data available|1|||
48897769|NCT00153062|157462696|FG000|Overall Study|Other|0|||
48897770|NCT00153062|157462697|FG001|Overall Study|Other|0|||
48897771|NCT00153062|157462698|FG002|Overall Study|Other|1|||
48897772|NCT00153062|157462699|FG003|Overall Study|Other|0|||
48897773|NCT03439254|157462700|FG000|Double-blind Phase (18 Months)|Adverse Event|11|||
48897774|NCT03439254|157462701|FG001|Double-blind Phase (18 Months)|Adverse Event|12|||
48897775|NCT03439254|157462702|FG002|Double-blind Phase (18 Months)|Adverse Event|15|||
48897776|NCT03439254|157462703|FG003|Double-blind Phase (18 Months)|Adverse Event|0|||
48897777|NCT03439254|157462704|FG004|Double-blind Phase (18 Months)|Adverse Event|0|||
48897778|NCT03439254|157462705|FG005|Double-blind Phase (18 Months)|Adverse Event|0|||
48897779|NCT03439254|157462700|FG000|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|1|||
48897780|NCT03439254|157462701|FG001|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
48897781|NCT03439254|157462702|FG002|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
48897782|NCT03439254|157462703|FG003|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
48897783|NCT03439254|157462704|FG004|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
48897784|NCT03439254|157462705|FG005|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
48897785|NCT03439254|157462700|FG000|Double-blind Phase (18 Months)|Death|1|||
48897786|NCT03439254|157462701|FG001|Double-blind Phase (18 Months)|Death|2|||
48897787|NCT03439254|157462702|FG002|Double-blind Phase (18 Months)|Death|2|||
48897788|NCT03439254|157462703|FG003|Double-blind Phase (18 Months)|Death|0|||
48897789|NCT03439254|157462704|FG004|Double-blind Phase (18 Months)|Death|0|||
48897790|NCT03439254|157462705|FG005|Double-blind Phase (18 Months)|Death|0|||
48897791|NCT03439254|157462700|FG000|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
48897792|NCT03439254|157462701|FG001|Double-blind Phase (18 Months)|Lost to Follow-up|1|||
48897793|NCT03439254|157462702|FG002|Double-blind Phase (18 Months)|Lost to Follow-up|5|||
48897794|NCT03439254|157462703|FG003|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
48897795|NCT03439254|157462704|FG004|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
48897796|NCT03439254|157462705|FG005|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
48897797|NCT03439254|157462700|FG000|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|1|||
48897798|NCT03439254|157462701|FG001|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
48897799|NCT03439254|157462702|FG002|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
48897800|NCT03439254|157462703|FG003|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
48897801|NCT03439254|157462704|FG004|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
48897802|NCT03439254|157462705|FG005|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
49040015|NCT04442503|157982331|FG001|Overall Study|Lost to Follow-up|6|||
48897803|NCT03439254|157462700|FG000|Double-blind Phase (18 Months)|Participant moved to Kansas|1|||
49040016|NCT04442503|157982330|FG000|Overall Study|Physician Decision|0|||
48897804|NCT03439254|157462701|FG001|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
48897805|NCT03439254|157462702|FG002|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
48897806|NCT03439254|157462703|FG003|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
48897807|NCT03439254|157462704|FG004|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
48897808|NCT03439254|157462705|FG005|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
48897809|NCT03439254|157462700|FG000|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|1|||
48897810|NCT03439254|157462701|FG001|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
48897811|NCT03439254|157462702|FG002|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
48897812|NCT03439254|157462703|FG003|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
48897813|NCT03439254|157462704|FG004|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
48897814|NCT03439254|157462705|FG005|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
48897815|NCT03439254|157462700|FG000|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
48897816|NCT03439254|157462701|FG001|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|1|||
48897817|NCT03439254|157462702|FG002|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
48897818|NCT03439254|157462703|FG003|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
48897819|NCT03439254|157462704|FG004|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
49040017|NCT04442503|157982331|FG001|Overall Study|Physician Decision|2|||
49040018|NCT04442503|157982330|FG000|Overall Study|Withdrawal by Subject|3|||
48897820|NCT03439254|157462705|FG005|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
48897821|NCT03439254|157462700|FG000|Double-blind Phase (18 Months)|Drug Holiday|0|||
48897822|NCT03439254|157462701|FG001|Double-blind Phase (18 Months)|Drug Holiday|0|||
48897823|NCT03439254|157462702|FG002|Double-blind Phase (18 Months)|Drug Holiday|1|||
48897824|NCT03439254|157462703|FG003|Double-blind Phase (18 Months)|Drug Holiday|0|||
48897825|NCT03439254|157462704|FG004|Double-blind Phase (18 Months)|Drug Holiday|0|||
48897826|NCT03439254|157462705|FG005|Double-blind Phase (18 Months)|Drug Holiday|0|||
48897827|NCT03439254|157462700|FG000|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
48897828|NCT03439254|157462701|FG001|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
48897829|NCT03439254|157462702|FG002|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|1|||
48897830|NCT03439254|157462703|FG003|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
48897831|NCT03439254|157462704|FG004|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
48897832|NCT03439254|157462705|FG005|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
48897833|NCT03439254|157462700|FG000|Double-blind Phase (18 Months)|Site closure|0|||
48897834|NCT03439254|157462701|FG001|Double-blind Phase (18 Months)|Site closure|0|||
48897835|NCT03439254|157462702|FG002|Double-blind Phase (18 Months)|Site closure|1|||
48897836|NCT03439254|157462703|FG003|Double-blind Phase (18 Months)|Site closure|0|||
48897837|NCT03439254|157462704|FG004|Double-blind Phase (18 Months)|Site closure|0|||
48897838|NCT03439254|157462705|FG005|Double-blind Phase (18 Months)|Site closure|0|||
48897839|NCT03439254|157462700|FG000|Double-blind Phase (18 Months)|Physician Decision|0|||
48897840|NCT03439254|157462701|FG001|Double-blind Phase (18 Months)|Physician Decision|0|||
48897841|NCT03439254|157462702|FG002|Double-blind Phase (18 Months)|Physician Decision|1|||
48897842|NCT03439254|157462703|FG003|Double-blind Phase (18 Months)|Physician Decision|0|||
48897843|NCT03439254|157462704|FG004|Double-blind Phase (18 Months)|Physician Decision|0|||
48897844|NCT03439254|157462705|FG005|Double-blind Phase (18 Months)|Physician Decision|0|||
48897845|NCT03439254|157462700|FG000|Double-blind Phase (18 Months)|Progressive Disease|1|||
48897846|NCT03439254|157462701|FG001|Double-blind Phase (18 Months)|Progressive Disease|0|||
48897847|NCT03439254|157462702|FG002|Double-blind Phase (18 Months)|Progressive Disease|0|||
48897848|NCT03439254|157462703|FG003|Double-blind Phase (18 Months)|Progressive Disease|0|||
48897849|NCT03439254|157462704|FG004|Double-blind Phase (18 Months)|Progressive Disease|0|||
48897850|NCT03439254|157462705|FG005|Double-blind Phase (18 Months)|Progressive Disease|0|||
48897851|NCT03439254|157462700|FG000|Double-blind Phase (18 Months)|Withdrawal by Subject|12|||
48897852|NCT03439254|157462701|FG001|Double-blind Phase (18 Months)|Withdrawal by Subject|6|||
48984278|NCT01693562|157774130|FG009|Expansion Phase|Lost to Follow-up|10|||
48984279|NCT01693562|157774131|FG010|Expansion Phase|Lost to Follow-up|4|||
48984280|NCT01693562|157774132|FG011|Expansion Phase|Lost to Follow-up|4|||
48984281|NCT01693562|157774133|FG012|Expansion Phase|Lost to Follow-up|1|||
48984282|NCT01693562|157774134|FG013|Expansion Phase|Lost to Follow-up|3|||
48984283|NCT01693562|157774135|FG014|Expansion Phase|Lost to Follow-up|0|||
48984284|NCT01693562|157774136|FG015|Expansion Phase|Lost to Follow-up|1|||
48984285|NCT01693562|157774137|FG016|Expansion Phase|Lost to Follow-up|1|||
48984286|NCT01693562|157774138|FG017|Expansion Phase|Lost to Follow-up|0|||
48984287|NCT01693562|157774139|FG018|Expansion Phase|Lost to Follow-up|2|||
49040019|NCT04442503|157982331|FG001|Overall Study|Withdrawal by Subject|4|||
49040020|NCT04442503|157982330|FG000|Overall Study|Reason not Specified|0|||
48897853|NCT03439254|157462702|FG002|Double-blind Phase (18 Months)|Withdrawal by Subject|9|||
48897854|NCT03439254|157462703|FG003|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
48897855|NCT03439254|157462704|FG004|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
48897856|NCT03439254|157462705|FG005|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
48897857|NCT03439254|157462700|FG000|Open Label Extension Phase (12 Months)|Adverse Event|0|||
48897858|NCT03439254|157462701|FG001|Open Label Extension Phase (12 Months)|Adverse Event|0|||
48897859|NCT03439254|157462702|FG002|Open Label Extension Phase (12 Months)|Adverse Event|0|||
48897860|NCT03439254|157462703|FG003|Open Label Extension Phase (12 Months)|Adverse Event|8|||
48897861|NCT03439254|157462704|FG004|Open Label Extension Phase (12 Months)|Adverse Event|5|||
48897862|NCT03439254|157462705|FG005|Open Label Extension Phase (12 Months)|Adverse Event|7|||
49040021|NCT04442503|157982331|FG001|Overall Study|Reason not Specified|1|||
49040022|NCT04442503|157982330|FG000|Overall Study|Randomized but not Treated|3|||
49040023|NCT04442503|157982331|FG001|Overall Study|Randomized but not Treated|1|||
49040024|NCT00177164|157982332|FG000|Overall Study|Protocol Violation|0|||
49040025|NCT00177164|157982333|FG001|Overall Study|Protocol Violation|7|||
49040026|NCT00177164|157982332|FG000|Overall Study|Lost to Follow-up|4|||
49040027|NCT00177164|157982333|FG001|Overall Study|Lost to Follow-up|5|||
49040028|NCT00177164|157982332|FG000|Overall Study|increase in alcohol and drug use|1|||
49040029|NCT00177164|157982333|FG001|Overall Study|increase in alcohol and drug use|2|||
49040030|NCT00177164|157982332|FG000|Overall Study|Adverse Event|1|||
49040031|NCT00177164|157982333|FG001|Overall Study|Adverse Event|0|||
49040032|NCT00177164|157982332|FG000|Overall Study|discharge from hospital|1|||
49040033|NCT00177164|157982333|FG001|Overall Study|discharge from hospital|0|||
49040034|NCT00177164|157982332|FG000|Overall Study|Lack of Efficacy|2|||
49040035|NCT00177164|157982333|FG001|Overall Study|Lack of Efficacy|1|||
49040036|NCT00177164|157982332|FG000|Overall Study|Pregnancy|0|||
49040037|NCT00177164|157982333|FG001|Overall Study|Pregnancy|1|||
49040038|NCT01751087|157982334|FG000|Overall Study|Withdrawal by Subject|1|||
49040039|NCT01751087|157982335|FG001|Overall Study|Withdrawal by Subject|0|||
49040040|NCT01751087|157982336|FG002|Overall Study|Withdrawal by Subject|0|||
49040041|NCT01751087|157982334|FG000|Overall Study|Physician Decision|0|||
49040042|NCT01751087|157982335|FG001|Overall Study|Physician Decision|0|||
49040043|NCT01751087|157982336|FG002|Overall Study|Physician Decision|1|||
49040044|NCT05562011|157982339|FG000|Overall Study|Withdrawal by Subject|3|||
49040045|NCT05562011|157982339|FG000|Overall Study|Lost to Follow-up|1|||
49040046|NCT05562011|157982339|FG000|Overall Study|Could not co-enroll with other research study--device could not be placed postop|1|||
48897863|NCT03439254|157462700|FG000|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
48897864|NCT03439254|157462701|FG001|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
48897865|NCT03439254|157462702|FG002|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
48897866|NCT03439254|157462703|FG003|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
48897867|NCT03439254|157462704|FG004|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
48897868|NCT03439254|157462705|FG005|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
48897869|NCT03439254|157462700|FG000|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
48897870|NCT03439254|157462701|FG001|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
48897871|NCT03439254|157462702|FG002|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
48897872|NCT03439254|157462703|FG003|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
48897873|NCT03439254|157462704|FG004|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
48897874|NCT03439254|157462705|FG005|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|1|||
48897875|NCT03439254|157462700|FG000|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
48897876|NCT03439254|157462701|FG001|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
48897877|NCT03439254|157462702|FG002|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
48897878|NCT03439254|157462703|FG003|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
48897879|NCT03439254|157462704|FG004|Open Label Extension Phase (12 Months)|Lost to Follow-up|2|||
48897880|NCT03439254|157462705|FG005|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
48897881|NCT03439254|157462700|FG000|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
48897882|NCT03439254|157462701|FG001|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
48897883|NCT03439254|157462702|FG002|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
48897884|NCT03439254|157462703|FG003|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
48897885|NCT03439254|157462704|FG004|Open Label Extension Phase (12 Months)|Increase CR from Baseline|1|||
48897886|NCT03439254|157462705|FG005|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
48897887|NCT03439254|157462700|FG000|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
48897888|NCT03439254|157462701|FG001|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
49040047|NCT05562011|157982339|FG000|Overall Study|Device not placed postop due to patient being discharged home after surgery (not staying overnight)|4|||
49040048|NCT05562011|157982339|FG000|Overall Study|Device malfunction|13|||
49040049|NCT02933060|157982344|FG000|Overall Study|Withdrawal by Subject|0|||
49040050|NCT02933060|157982345|FG001|Overall Study|Withdrawal by Subject|1|||
49040051|NCT01945580|157982346|FG000|Overall Study|Withdrawal by Subject|13|||
49040052|NCT01945580|157982347|FG001|Overall Study|Withdrawal by Subject|35|||
48897889|NCT03439254|157462702|FG002|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
48897890|NCT03439254|157462703|FG003|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
48897891|NCT03439254|157462704|FG004|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
48897892|NCT03439254|157462705|FG005|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|1|||
48897893|NCT03439254|157462700|FG000|Open Label Extension Phase (12 Months)|Physician Decision|0|||
48897894|NCT03439254|157462701|FG001|Open Label Extension Phase (12 Months)|Physician Decision|0|||
48897895|NCT03439254|157462702|FG002|Open Label Extension Phase (12 Months)|Physician Decision|0|||
48897896|NCT03439254|157462703|FG003|Open Label Extension Phase (12 Months)|Physician Decision|1|||
48897897|NCT03439254|157462704|FG004|Open Label Extension Phase (12 Months)|Physician Decision|0|||
48897898|NCT03439254|157462705|FG005|Open Label Extension Phase (12 Months)|Physician Decision|0|||
48897899|NCT03439254|157462700|FG000|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
48897900|NCT03439254|157462701|FG001|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
48897901|NCT03439254|157462702|FG002|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
48897902|NCT03439254|157462703|FG003|Open Label Extension Phase (12 Months)|Progressive Disease|1|||
48897903|NCT03439254|157462704|FG004|Open Label Extension Phase (12 Months)|Progressive Disease|2|||
48897904|NCT03439254|157462705|FG005|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
48897905|NCT03439254|157462700|FG000|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
48897906|NCT03439254|157462701|FG001|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
48897907|NCT03439254|157462702|FG002|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
48897908|NCT03439254|157462703|FG003|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
48897909|NCT03439254|157462704|FG004|Open Label Extension Phase (12 Months)|Withdrawal by Subject|3|||
48897910|NCT03439254|157462705|FG005|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
48897911|NCT02217332|157462708|FG000|Overall Study|Adverse Event|3|||
48897912|NCT02217332|157462708|FG000|Overall Study|Dose interruption >1 month|1|||
48897913|NCT02217332|157462708|FG000|Overall Study|Protocol Violation (eligibility)|1|||
48897914|NCT02217332|157462708|FG000|Overall Study|Withdrawal by Subject|1|||
48897915|NCT02217332|157462708|FG000|Overall Study|Lost to Follow-up|1|||
48897916|NCT01022268|157462719|FG000|Overall Study|Withdrawal by Subject|1|||
48897917|NCT01022268|157462720|FG001|Overall Study|Withdrawal by Subject|0|||
48897918|NCT01022268|157462719|FG000|Overall Study|Withdrawal by Subject|1|||
48897919|NCT01022268|157462720|FG001|Overall Study|Withdrawal by Subject|0|||
48897920|NCT03938545|157462721|FG000|Overall Study|Lost to Follow-up|0|||
48897921|NCT03938545|157462722|FG001|Overall Study|Lost to Follow-up|0|||
48897922|NCT03938545|157462723|FG002|Overall Study|Lost to Follow-up|0|||
48897923|NCT03938545|157462724|FG003|Overall Study|Lost to Follow-up|1|||
48897924|NCT03938545|157462721|FG000|Overall Study|Non-compliance with study drug|0|||
48897925|NCT03938545|157462722|FG001|Overall Study|Non-compliance with study drug|0|||
48897926|NCT03938545|157462723|FG002|Overall Study|Non-compliance with study drug|1|||
48897927|NCT03938545|157462724|FG003|Overall Study|Non-compliance with study drug|0|||
48897928|NCT03938545|157462721|FG000|Overall Study|Pregnancy|1|||
48897929|NCT03938545|157462722|FG001|Overall Study|Pregnancy|0|||
48897930|NCT03938545|157462723|FG002|Overall Study|Pregnancy|0|||
48897931|NCT03938545|157462724|FG003|Overall Study|Pregnancy|0|||
48897932|NCT03938545|157462721|FG000|Overall Study|Study terminated by sponsor|6|||
48897933|NCT03938545|157462722|FG001|Overall Study|Study terminated by sponsor|4|||
48897934|NCT03938545|157462723|FG002|Overall Study|Study terminated by sponsor|2|||
48897935|NCT03938545|157462724|FG003|Overall Study|Study terminated by sponsor|4|||
49040053|NCT01945580|157982346|FG000|Overall Study|Physician Decision|3|||
49040054|NCT01945580|157982347|FG001|Overall Study|Physician Decision|2|||
48897936|NCT03938545|157462721|FG000|Overall Study|Withdrawal by Subject|0|||
48897937|NCT03938545|157462722|FG001|Overall Study|Withdrawal by Subject|1|||
48897938|NCT03938545|157462723|FG002|Overall Study|Withdrawal by Subject|0|||
48897939|NCT03938545|157462724|FG003|Overall Study|Withdrawal by Subject|0|||
49040055|NCT01945580|157982346|FG000|Overall Study|Lost to Follow-up|26|||
49040056|NCT01945580|157982347|FG001|Overall Study|Lost to Follow-up|39|||
49040057|NCT01945580|157982346|FG000|Overall Study|Death|7|||
49040058|NCT01945580|157982347|FG001|Overall Study|Death|2|||
49040059|NCT01945580|157982346|FG000|Overall Study|Patient moved out of state|0|||
49040060|NCT01945580|157982347|FG001|Overall Study|Patient moved out of state|1|||
49040061|NCT01945580|157982346|FG000|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1|||
49040062|NCT01945580|157982347|FG001|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0|||
49040063|NCT01945580|157982346|FG000|Overall Study|Family illness - unable to return|0|||
49040064|NCT01945580|157982347|FG001|Overall Study|Family illness - unable to return|1|||
49040065|NCT01945580|157982346|FG000|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0|||
49040066|NCT01945580|157982347|FG001|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1|||
49040067|NCT01945580|157982346|FG000|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0|||
49040068|NCT01945580|157982347|FG001|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1|||
49040069|NCT01945580|157982346|FG000|Overall Study|Noncompliance with 36 month visit|1|||
48897940|NCT03938545|157462721|FG000|Overall Study|Adverse Event|1|||
48897941|NCT03938545|157462722|FG001|Overall Study|Adverse Event|0|||
48897942|NCT03938545|157462723|FG002|Overall Study|Adverse Event|0|||
48897943|NCT03938545|157462724|FG003|Overall Study|Adverse Event|0|||
48897944|NCT00816400|157462725|FG000|Overall Study|Death|2|||
48897945|NCT00816400|157462726|FG001|Overall Study|Death|3|||
48897946|NCT00816400|157462727|FG002|Overall Study|Death|3|||
48897947|NCT00816400|157462728|FG003|Overall Study|Death|3|||
48897948|NCT00816400|157462729|FG004|Overall Study|Death|2|||
48897949|NCT00816400|157462730|FG005|Overall Study|Death|3|||
48897950|NCT00816400|157462731|FG006|Overall Study|Death|2|||
48897951|NCT00816400|157462732|FG007|Overall Study|Death|5|||
48897952|NCT00816400|157462733|FG008|Overall Study|Death|6|||
49040070|NCT01945580|157982347|FG001|Overall Study|Noncompliance with 36 month visit|0|||
48897953|NCT00816400|157462725|FG000|Overall Study|In hospice care at the end of the study|0|||
48897954|NCT00816400|157462726|FG001|Overall Study|In hospice care at the end of the study|0|||
48897955|NCT00816400|157462727|FG002|Overall Study|In hospice care at the end of the study|2|||
48897956|NCT00816400|157462728|FG003|Overall Study|In hospice care at the end of the study|0|||
48897957|NCT00816400|157462729|FG004|Overall Study|In hospice care at the end of the study|0|||
48897958|NCT00816400|157462730|FG005|Overall Study|In hospice care at the end of the study|0|||
48897959|NCT00816400|157462731|FG006|Overall Study|In hospice care at the end of the study|0|||
48897960|NCT00816400|157462732|FG007|Overall Study|In hospice care at the end of the study|0|||
48897961|NCT00816400|157462733|FG008|Overall Study|In hospice care at the end of the study|0|||
48897962|NCT00596427|157462734|FG000|Overall Study|Withdrawal by Subject|2|||
48897963|NCT00596427|157462735|FG001|Overall Study|Withdrawal by Subject|2|||
48897964|NCT00596427|157462734|FG000|Overall Study|Increased Fasting Triacylglycerol level|1|||
48897965|NCT00596427|157462735|FG001|Overall Study|Increased Fasting Triacylglycerol level|0|||
48897966|NCT00596427|157462734|FG000|Overall Study|Protocol Violation|1|||
48897967|NCT00596427|157462735|FG001|Overall Study|Protocol Violation|0|||
48897968|NCT02401867|157462736|FG000|Specimen Collection|Didn't receive 1 or more tests|10|||
48897969|NCT02401867|157462736|FG000|Analysis|Cervical assay could not be conducted|9|||
48897970|NCT04097301|157462737|FG000|Overall Study|Death|1|||
48897971|NCT04097301|157462737|FG000|Overall Study|Withdrawal by Subject|1|||
48897972|NCT04097301|157462737|FG000|Overall Study|Screening Failure|5|||
48897973|NCT01635920|157462738|FG000|Overall Study|Adverse Event|1|||
48897974|NCT01635920|157462739|FG001|Overall Study|Adverse Event|0|||
49040071|NCT01945580|157982346|FG000|Overall Study|The patient moved.|1|||
49040072|NCT01945580|157982347|FG001|Overall Study|The patient moved.|0|||
49040073|NCT01945580|157982346|FG000|Overall Study|No data available|0|||
48897975|NCT01635920|157462738|FG000|Overall Study|Lost to Follow-up|0|||
48897976|NCT01635920|157462739|FG001|Overall Study|Lost to Follow-up|1|||
48897977|NCT01635920|157462738|FG000|Overall Study|Subject decision|2|||
48897978|NCT01635920|157462739|FG001|Overall Study|Subject decision|0|||
48897979|NCT01614197|157462740|FG000|Overall Study|Withdrawal by Subject|0|||
48897980|NCT01614197|157462741|FG001|Overall Study|Withdrawal by Subject|1|||
48897981|NCT01614197|157462742|FG002|Overall Study|Withdrawal by Subject|0|||
48897982|NCT01614197|157462743|FG003|Overall Study|Withdrawal by Subject|0|||
48897983|NCT00971932|157462744|FG000|Overall Study|Withdrawal by Subject|1|||
48897984|NCT00971932|157462744|FG000|Overall Study|Investigator's decision|2|||
48897985|NCT00971932|157462744|FG000|Overall Study|Ongoing|4|||
48897986|NCT02257567|157462745|FG000|Overall Study|Adverse Event|0|||
48897987|NCT02257567|157462746|FG001|Overall Study|Adverse Event|0|||
48897988|NCT02257567|157462747|FG002|Overall Study|Adverse Event|0|||
48897989|NCT02257567|157462748|FG003|Overall Study|Adverse Event|1|||
49040074|NCT01945580|157982347|FG001|Overall Study|No data available|2|||
49040075|NCT04411680|157982350|FG000|Treatment Period|Adverse Event|3|||
49040076|NCT04411680|157982351|FG001|Treatment Period|Adverse Event|0|||
48897990|NCT02257567|157462749|FG004|Overall Study|Adverse Event|1|||
48897991|NCT02257567|157462750|FG005|Overall Study|Adverse Event|0|||
48897992|NCT02257567|157462751|FG006|Overall Study|Adverse Event|0|||
48897993|NCT02257567|157462752|FG007|Overall Study|Adverse Event|0|||
48897994|NCT02257567|157462753|FG008|Overall Study|Adverse Event|1|||
48897995|NCT02257567|157462754|FG009|Overall Study|Adverse Event|0|||
48897996|NCT02257567|157462755|FG010|Overall Study|Adverse Event|0|||
49040077|NCT04411680|157982350|FG000|Treatment Period|Discharged from hospital|18|||
48897997|NCT02257567|157462745|FG000|Overall Study|Death|2|||
48897998|NCT02257567|157462746|FG001|Overall Study|Death|2|||
48897999|NCT02257567|157462747|FG002|Overall Study|Death|2|||
48898000|NCT02257567|157462748|FG003|Overall Study|Death|4|||
48898001|NCT02257567|157462749|FG004|Overall Study|Death|15|||
48898002|NCT02257567|157462750|FG005|Overall Study|Death|11|||
48898003|NCT02257567|157462751|FG006|Overall Study|Death|26|||
48898004|NCT02257567|157462752|FG007|Overall Study|Death|30|||
48898005|NCT02257567|157462753|FG008|Overall Study|Death|2|||
48898006|NCT02257567|157462754|FG009|Overall Study|Death|18|||
48898007|NCT02257567|157462755|FG010|Overall Study|Death|65|||
48898008|NCT02257567|157462745|FG000|Overall Study|Lost to Follow-up|0|||
48898009|NCT02257567|157462746|FG001|Overall Study|Lost to Follow-up|0|||
49040078|NCT04411680|157982351|FG001|Treatment Period|Discharged from hospital|7|||
49040079|NCT04411680|157982350|FG000|Treatment Period|Missed 1 or more doses|8|||
49040080|NCT04411680|157982351|FG001|Treatment Period|Missed 1 or more doses|0|||
49040081|NCT04411680|157982350|FG000|Treatment Period|Transferred to another hospital|0|||
49040082|NCT04411680|157982351|FG001|Treatment Period|Transferred to another hospital|1|||
49040083|NCT04411680|157982350|FG000|Follow up Period|Withdrawal by Subject|2|||
49040084|NCT04411680|157982351|FG001|Follow up Period|Withdrawal by Subject|0|||
49040085|NCT04411680|157982350|FG000|Follow up Period|Lost to Follow-up|5|||
49040086|NCT04411680|157982351|FG001|Follow up Period|Lost to Follow-up|6|||
49040087|NCT04411680|157982350|FG000|Follow up Period|Death|11|||
49040088|NCT04411680|157982351|FG001|Follow up Period|Death|8|||
49040089|NCT02054715|157982356|FG000|Baseline/Follow-up 1|Refused|1|||
49040090|NCT02054715|157982357|FG001|Baseline/Follow-up 1|Refused|3|||
49040091|NCT02054715|157982356|FG000|Baseline/Follow-up 1|Medical|0|||
49040092|NCT02054715|157982357|FG001|Baseline/Follow-up 1|Medical|1|||
49040093|NCT02054715|157982356|FG000|Baseline/Follow-up 1|Changed MD/Facility|0|||
49040094|NCT02054715|157982357|FG001|Baseline/Follow-up 1|Changed MD/Facility|1|||
49040095|NCT02054715|157982356|FG000|Baseline/Follow-up 1|Disliked Procedure|0|||
49040096|NCT02054715|157982357|FG001|Baseline/Follow-up 1|Disliked Procedure|1|||
49040097|NCT02054715|157982356|FG000|Baseline/Follow-up 1|No Reason|0|||
49040098|NCT02054715|157982357|FG001|Baseline/Follow-up 1|No Reason|1|||
49040099|NCT02054715|157982356|FG000|Baseline/Follow-up 1|Overwhelmed|2|||
49040100|NCT02054715|157982357|FG001|Baseline/Follow-up 1|Overwhelmed|0|||
49040101|NCT02054715|157982356|FG000|Baseline/Follow-up 1|Ineligible|3|||
49040102|NCT02054715|157982357|FG001|Baseline/Follow-up 1|Ineligible|0|||
49040103|NCT02054715|157982356|FG000|Baseline/Follow-up 1|Hospitalization|1|||
49040104|NCT02054715|157982357|FG001|Baseline/Follow-up 1|Hospitalization|0|||
49040105|NCT02054715|157982356|FG000|Baseline/Follow-up 1|Changed Mind|1|||
49040106|NCT02054715|157982357|FG001|Baseline/Follow-up 1|Changed Mind|0|||
49040107|NCT02054715|157982356|FG000|Follow-up 2|Lost to Followup|3|||
49040108|NCT02054715|157982357|FG001|Follow-up 2|Lost to Followup|1|||
49040109|NCT02054715|157982356|FG000|Follow-up 2|Refused|3|||
49040110|NCT02054715|157982357|FG001|Follow-up 2|Refused|2|||
49040111|NCT02054715|157982356|FG000|Follow-up 2|Followup Not Completed|3|||
49040112|NCT02054715|157982357|FG001|Follow-up 2|Followup Not Completed|4|||
49040113|NCT02054715|157982356|FG000|Follow-up 2|Ineligible|4|||
49040114|NCT02054715|157982357|FG001|Follow-up 2|Ineligible|5|||
49040115|NCT02054715|157982356|FG000|Follow-up 2|Death|3|||
49040116|NCT02054715|157982357|FG001|Follow-up 2|Death|3|||
49040117|NCT02054715|157982356|FG000|Follow-up 2|Hospitalization|0|||
49040118|NCT02054715|157982357|FG001|Follow-up 2|Hospitalization|2|||
49040119|NCT02054715|157982356|FG000|Follow-up 2|Changed MD/Facility|0|||
49040120|NCT02054715|157982357|FG001|Follow-up 2|Changed MD/Facility|1|||
49040121|NCT02054715|157982356|FG000|Follow-up 2|Changed Mind|0|||
49040122|NCT02054715|157982357|FG001|Follow-up 2|Changed Mind|1|||
49040123|NCT02054715|157982356|FG000|Follow-up 2|No Reason|2|||
49040124|NCT02054715|157982357|FG001|Follow-up 2|No Reason|0|||
49040125|NCT02054715|157982356|FG000|Follow-up 2|Treatment Change or Delay|1|||
49040126|NCT02054715|157982357|FG001|Follow-up 2|Treatment Change or Delay|0|||
49040127|NCT04697173|157982360|FG000|Overall Study|Withdrawal by Subject|34|||
49040128|NCT04697173|157982361|FG001|Overall Study|Withdrawal by Subject|38|||
49040129|NCT03499873|157982362|FG000|Overall Study|Withdrawal by Subject|4|||
49040130|NCT03499873|157982363|FG001|Overall Study|Withdrawal by Subject|6|||
49040131|NCT03499873|157982364|FG002|Overall Study|Withdrawal by Subject|1|||
49040132|NCT03499873|157982362|FG000|Overall Study|Subjects condition worsened|0|||
49040133|NCT03499873|157982363|FG001|Overall Study|Subjects condition worsened|3|||
49040134|NCT03499873|157982364|FG002|Overall Study|Subjects condition worsened|11|||
49040135|NCT03499873|157982362|FG000|Overall Study|Adverse Event|8|||
49040136|NCT03499873|157982363|FG001|Overall Study|Adverse Event|3|||
49040137|NCT03499873|157982364|FG002|Overall Study|Adverse Event|6|||
49040138|NCT03499873|157982362|FG000|Overall Study|Physician Decision|1|||
49040139|NCT03499873|157982363|FG001|Overall Study|Physician Decision|0|||
49040140|NCT03499873|157982364|FG002|Overall Study|Physician Decision|0|||
49040141|NCT03499873|157982362|FG000|Overall Study|Administrative reasons|0|||
49040142|NCT03499873|157982363|FG001|Overall Study|Administrative reasons|1|||
49040143|NCT03499873|157982364|FG002|Overall Study|Administrative reasons|0|||
49040144|NCT03499873|157982362|FG000|Overall Study|Concomitant therapy|5|||
49040145|NCT03499873|157982363|FG001|Overall Study|Concomitant therapy|4|||
49040146|NCT03499873|157982364|FG002|Overall Study|Concomitant therapy|7|||
49040147|NCT03499873|157982362|FG000|Overall Study|Miscellaneous|1|||
49040148|NCT03499873|157982363|FG001|Overall Study|Miscellaneous|2|||
49040149|NCT03499873|157982364|FG002|Overall Study|Miscellaneous|2|||
49040150|NCT03499873|157982362|FG000|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
49040151|NCT03499873|157982363|FG001|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
49040152|NCT03499873|157982364|FG002|Overall Study|Investigational Product (IP) Missed dose compliance|0|||
49040153|NCT04608448|157982365|FG000|Overall Study|Withdrawal by Subject|1|||
49040154|NCT04608448|157982365|FG000|Overall Study|Adverse Event|1|||
49040155|NCT01149057|157982366|FG000|Overall Study|Lack of Efficacy|16|||
49040156|NCT01149057|157982366|FG000|Overall Study|Adverse Event|13|||
49040157|NCT01149057|157982366|FG000|Overall Study|Withdrawal by Subject|9|||
49040158|NCT01149057|157982366|FG000|Overall Study|Positive Hepatitis B Core Antibody|5|||
49040159|NCT01149057|157982366|FG000|Overall Study|B Cell Depletion|4|||
49040160|NCT01149057|157982366|FG000|Overall Study|Participant Non-Compliance|2|||
49040161|NCT01149057|157982366|FG000|Overall Study|Lost to Follow-up|1|||
49040162|NCT01149057|157982366|FG000|Overall Study|High Parathyroid Hormone Value|1|||
49040163|NCT01149057|157982366|FG000|Overall Study|Other|6|||
49040164|NCT01964950|157982367|FG000|Overall Study|Protocol Violation|25|||
49040165|NCT03602339|157982368|FG000|Overall Study|Withdrawal by Subject|9|||
49040166|NCT03602339|157982368|FG000|Overall Study|Physician Decision|2|||
49040167|NCT03602339|157982368|FG000|Overall Study|Other reason|4|||
49040168|NCT04404725|157982369|FG000|First Intervention|Withdrawal by Subject|0|||
49040169|NCT04404725|157982370|FG001|First Intervention|Withdrawal by Subject|2|||
48898010|NCT02257567|157462747|FG002|Overall Study|Lost to Follow-up|0|||
48898011|NCT02257567|157462748|FG003|Overall Study|Lost to Follow-up|0|||
49040170|NCT04404725|157982369|FG000|Second Intervention|Adverse Event|1|||
49040171|NCT04404725|157982370|FG001|Second Intervention|Adverse Event|1|||
49040172|NCT04404725|157982369|FG000|Second Intervention|Withdrawal by Subject|0|||
49040173|NCT04404725|157982370|FG001|Second Intervention|Withdrawal by Subject|1|||
49040174|NCT02252016|157982371|FG000|Overall Study|Lost to Follow-up|2|||
49040175|NCT02252016|157982372|FG001|Overall Study|Lost to Follow-up|1|||
49040176|NCT02252016|157982371|FG000|Overall Study|Physician Decision|1|||
49040177|NCT02252016|157982372|FG001|Overall Study|Physician Decision|0|||
49040178|NCT02252016|157982371|FG000|Overall Study|Withdrawal by Subject|0|||
49040179|NCT02252016|157982372|FG001|Overall Study|Withdrawal by Subject|2|||
49040180|NCT02372006|157982374|FG000|Overall Study|Progressive disease|8|||
49040181|NCT02372006|157982375|FG001|Overall Study|Progressive disease|7|||
49040182|NCT02372006|157982376|FG002|Overall Study|Progressive disease|34|||
49040183|NCT02372006|157982374|FG000|Overall Study|Dose limiting toxicity|0|||
49040184|NCT02372006|157982375|FG001|Overall Study|Dose limiting toxicity|1|||
49040185|NCT02372006|157982376|FG002|Overall Study|Dose limiting toxicity|0|||
49040186|NCT02372006|157982374|FG000|Overall Study|Adverse Event|0|||
49040187|NCT02372006|157982375|FG001|Overall Study|Adverse Event|0|||
49040188|NCT02372006|157982376|FG002|Overall Study|Adverse Event|3|||
49040189|NCT02372006|157982374|FG000|Overall Study|Withdrawal by Subject|0|||
49040190|NCT02372006|157982375|FG001|Overall Study|Withdrawal by Subject|1|||
48898012|NCT02257567|157462749|FG004|Overall Study|Lost to Follow-up|2|||
48898013|NCT02257567|157462750|FG005|Overall Study|Lost to Follow-up|2|||
48898014|NCT02257567|157462751|FG006|Overall Study|Lost to Follow-up|0|||
48898015|NCT02257567|157462752|FG007|Overall Study|Lost to Follow-up|0|||
48898016|NCT02257567|157462753|FG008|Overall Study|Lost to Follow-up|0|||
48898017|NCT02257567|157462754|FG009|Overall Study|Lost to Follow-up|1|||
48898018|NCT02257567|157462755|FG010|Overall Study|Lost to Follow-up|1|||
48898019|NCT02257567|157462745|FG000|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
48898020|NCT02257567|157462746|FG001|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
48898021|NCT02257567|157462747|FG002|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
48898022|NCT02257567|157462748|FG003|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
48898023|NCT02257567|157462749|FG004|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|1|||
48898024|NCT02257567|157462750|FG005|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
48898025|NCT02257567|157462751|FG006|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|2|||
48898026|NCT02257567|157462752|FG007|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
48898027|NCT02257567|157462753|FG008|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
48898028|NCT02257567|157462754|FG009|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
48898029|NCT02257567|157462755|FG010|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
48898030|NCT02257567|157462745|FG000|Overall Study|Physician Decision|0|||
48898031|NCT02257567|157462746|FG001|Overall Study|Physician Decision|0|||
48898032|NCT02257567|157462747|FG002|Overall Study|Physician Decision|0|||
48898033|NCT02257567|157462748|FG003|Overall Study|Physician Decision|0|||
49040191|NCT02372006|157982376|FG002|Overall Study|Withdrawal by Subject|1|||
49040192|NCT02372006|157982374|FG000|Overall Study|Other reason for not completing|0|||
49040193|NCT02372006|157982375|FG001|Overall Study|Other reason for not completing|0|||
49040194|NCT02372006|157982376|FG002|Overall Study|Other reason for not completing|1|||
49040195|NCT01370863|157982381|FG000|Overall Study|Adverse Event|1|||
49040196|NCT01370863|157982382|FG001|Overall Study|Adverse Event|1|||
49040197|NCT01370863|157982381|FG000|Overall Study|Did not want second pH/MII monitoring|1|||
49040198|NCT01370863|157982382|FG001|Overall Study|Did not want second pH/MII monitoring|1|||
49040199|NCT01370863|157982381|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
49040200|NCT01370863|157982382|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
49040201|NCT01698554|157982384|FG000|Overall Study|Adverse Event|2|||
49040202|NCT01698554|157982385|FG001|Overall Study|Adverse Event|5|||
48898034|NCT02257567|157462749|FG004|Overall Study|Physician Decision|0|||
48898035|NCT02257567|157462750|FG005|Overall Study|Physician Decision|0|||
48898036|NCT02257567|157462751|FG006|Overall Study|Physician Decision|0|||
48898037|NCT02257567|157462752|FG007|Overall Study|Physician Decision|2|||
48898038|NCT02257567|157462753|FG008|Overall Study|Physician Decision|0|||
48898039|NCT02257567|157462754|FG009|Overall Study|Physician Decision|1|||
48898040|NCT02257567|157462755|FG010|Overall Study|Physician Decision|0|||
48898041|NCT02257567|157462745|FG000|Overall Study|Withdrawal by Subject|0|||
48898042|NCT02257567|157462746|FG001|Overall Study|Withdrawal by Subject|0|||
48898043|NCT02257567|157462747|FG002|Overall Study|Withdrawal by Subject|2|||
48898044|NCT02257567|157462748|FG003|Overall Study|Withdrawal by Subject|0|||
48898045|NCT02257567|157462749|FG004|Overall Study|Withdrawal by Subject|0|||
48898046|NCT02257567|157462750|FG005|Overall Study|Withdrawal by Subject|6|||
48898047|NCT02257567|157462751|FG006|Overall Study|Withdrawal by Subject|6|||
48898048|NCT02257567|157462752|FG007|Overall Study|Withdrawal by Subject|6|||
48898049|NCT02257567|157462753|FG008|Overall Study|Withdrawal by Subject|1|||
48898050|NCT02257567|157462754|FG009|Overall Study|Withdrawal by Subject|1|||
48898051|NCT02257567|157462755|FG010|Overall Study|Withdrawal by Subject|10|||
48898052|NCT02683876|157462756|FG000|Overall Study|samples damaged during shipping|2|||
48898053|NCT02683876|157462757|FG001|Overall Study|samples damaged during shipping|0|||
48984288|NCT01693562|157774140|FG019|Expansion Phase|Lost to Follow-up|1|||
48984289|NCT01693562|157774141|FG020|Expansion Phase|Lost to Follow-up|2|||
48984290|NCT01693562|157774142|FG021|Expansion Phase|Lost to Follow-up|2|||
48984291|NCT01693562|157774143|FG022|Expansion Phase|Lost to Follow-up|1|||
48984292|NCT01693562|157774121|FG000|Expansion Phase|Other|0|||
48984293|NCT01693562|157774122|FG001|Expansion Phase|Other|0|||
48984294|NCT01693562|157774123|FG002|Expansion Phase|Other|0|||
48984295|NCT01693562|157774124|FG003|Expansion Phase|Other|0|||
48984296|NCT01693562|157774125|FG004|Expansion Phase|Other|0|||
48984297|NCT01693562|157774126|FG005|Expansion Phase|Other|0|||
48984298|NCT01693562|157774127|FG006|Expansion Phase|Other|0|||
48984299|NCT01693562|157774128|FG007|Expansion Phase|Other|3|||
48984300|NCT01693562|157774129|FG008|Expansion Phase|Other|1|||
48984301|NCT01693562|157774130|FG009|Expansion Phase|Other|28|||
48984302|NCT01693562|157774131|FG010|Expansion Phase|Other|4|||
48984303|NCT01693562|157774132|FG011|Expansion Phase|Other|7|||
48984304|NCT01693562|157774133|FG012|Expansion Phase|Other|0|||
48984305|NCT01693562|157774134|FG013|Expansion Phase|Other|1|||
48984306|NCT01693562|157774135|FG014|Expansion Phase|Other|1|||
48984307|NCT01693562|157774136|FG015|Expansion Phase|Other|0|||
48984308|NCT01693562|157774137|FG016|Expansion Phase|Other|28|||
48984309|NCT01693562|157774138|FG017|Expansion Phase|Other|0|||
48984310|NCT01693562|157774139|FG018|Expansion Phase|Other|1|||
48984311|NCT01693562|157774140|FG019|Expansion Phase|Other|0|||
48984312|NCT01693562|157774141|FG020|Expansion Phase|Other|1|||
48984313|NCT01693562|157774142|FG021|Expansion Phase|Other|17|||
48984314|NCT01693562|157774143|FG022|Expansion Phase|Other|1|||
48984315|NCT05466240|157774144|FG000|Overall Study|Adverse Event|1|||
48984316|NCT05466240|157774145|FG001|Overall Study|Adverse Event|0|||
48984317|NCT05466240|157774144|FG000|Overall Study|Withdrawal by Subject|1|||
48984318|NCT05466240|157774145|FG001|Overall Study|Withdrawal by Subject|0|||
48984319|NCT03818399|157774147|FG000|Overall Study|Lost to Follow-up|11|||
48984320|NCT03818399|157774147|FG000|Overall Study|Withdrawal by Subject|1|||
48984321|NCT03818399|157774147|FG000|Overall Study|Protocol Violation|2|||
48984322|NCT00934791|157774148|FG000|Overall Study|Withdrawal by Subject|1|||
48984323|NCT00934791|157774149|FG001|Overall Study|Withdrawal by Subject|0|||
48984324|NCT02425891|157774150|FG000|Overall Study|Death|333|||
48984325|NCT02425891|157774151|FG001|Overall Study|Death|314|||
48984326|NCT02425891|157774150|FG000|Overall Study|Lost to Follow-up|4|||
48984327|NCT02425891|157774151|FG001|Overall Study|Lost to Follow-up|6|||
48984328|NCT02425891|157774150|FG000|Overall Study|Non-Compliance|1|||
48984329|NCT02425891|157774151|FG001|Overall Study|Non-Compliance|1|||
48984330|NCT02425891|157774150|FG000|Overall Study|Accidentally randomized screen failure participant|0|||
48984331|NCT02425891|157774151|FG001|Overall Study|Accidentally randomized screen failure participant|1|||
48984332|NCT02425891|157774150|FG000|Overall Study|Physician Decision|0|||
48984333|NCT02425891|157774151|FG001|Overall Study|Physician Decision|1|||
48984334|NCT02425891|157774150|FG000|Overall Study|Protocol Violation|1|||
48984335|NCT02425891|157774151|FG001|Overall Study|Protocol Violation|1|||
48984336|NCT02425891|157774150|FG000|Overall Study|Study Terminated By Sponsor|85|||
48984337|NCT02425891|157774151|FG001|Overall Study|Study Terminated By Sponsor|95|||
48984338|NCT02425891|157774150|FG000|Overall Study|Withdrawal by Subject|27|||
48984339|NCT02425891|157774151|FG001|Overall Study|Withdrawal by Subject|32|||
48984340|NCT04124952|157774152|FG000|Overall Study|Lost to Follow-up|1|||
48898054|NCT03536143|157462758|FG000|Overall Study|Early termination, Sponsor decision|1|||
48898055|NCT01347762|157462759|FG000|Overall Study|Lost to Follow-up|0|||
48898056|NCT01347762|157462760|FG001|Overall Study|Lost to Follow-up|1|||
48898057|NCT01347762|157462761|FG002|Overall Study|Lost to Follow-up|6|||
48984341|NCT00672139|157774163|FG000|Overall Study|Death|14|||
48984342|NCT00672139|157774164|FG001|Overall Study|Death|23|||
48984343|NCT00672139|157774163|FG000|Overall Study|Withdrawal by Subject|2|||
49040203|NCT01698554|157982386|FG002|Overall Study|Adverse Event|0|||
48898058|NCT01347762|157462762|FG003|Overall Study|Lost to Follow-up|5|||
48898059|NCT01347762|157462759|FG000|Overall Study|Withdrawal by Subject|4|||
48898060|NCT01347762|157462760|FG001|Overall Study|Withdrawal by Subject|1|||
48898061|NCT01347762|157462761|FG002|Overall Study|Withdrawal by Subject|3|||
48898062|NCT01347762|157462762|FG003|Overall Study|Withdrawal by Subject|3|||
49040204|NCT01698554|157982387|FG003|Overall Study|Adverse Event|1|||
49040205|NCT01698554|157982384|FG000|Overall Study|Lost to Follow-up|1|||
49040206|NCT01698554|157982385|FG001|Overall Study|Lost to Follow-up|0|||
49040207|NCT01698554|157982386|FG002|Overall Study|Lost to Follow-up|0|||
49040208|NCT01698554|157982387|FG003|Overall Study|Lost to Follow-up|0|||
49040209|NCT01698554|157982384|FG000|Overall Study|Personal Reasons|0|||
49040210|NCT01698554|157982385|FG001|Overall Study|Personal Reasons|5|||
49040211|NCT01698554|157982386|FG002|Overall Study|Personal Reasons|1|||
49040212|NCT01698554|157982387|FG003|Overall Study|Personal Reasons|1|||
49040213|NCT01698554|157982384|FG000|Overall Study|Protocol Violation|2|||
49040214|NCT01698554|157982385|FG001|Overall Study|Protocol Violation|0|||
49040215|NCT01698554|157982386|FG002|Overall Study|Protocol Violation|1|||
48898063|NCT02057523|157462763|FG000|Overall Study|Withdrawal by Subject|1|||
48898064|NCT02057523|157462763|FG000|Overall Study|Lack of Efficacy|1|||
48898065|NCT02527343|157462764|FG000|RT Period: Weeks 1 to 52|Investigator Judgement|1|||
48898066|NCT02527343|157462765|FG001|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
48898067|NCT02527343|157462766|FG002|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
48898068|NCT02527343|157462767|FG003|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
48898069|NCT02527343|157462768|FG004|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
48898070|NCT02527343|157462769|FG005|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
48898071|NCT02527343|157462764|FG000|RT Period: Weeks 1 to 52|Voluntary withdrawal|1|||
48898072|NCT02527343|157462765|FG001|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
48898073|NCT02527343|157462766|FG002|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
48898074|NCT02527343|157462767|FG003|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
48898075|NCT02527343|157462768|FG004|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
48898076|NCT02527343|157462769|FG005|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
48898077|NCT02527343|157462764|FG000|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
48898078|NCT02527343|157462765|FG001|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4|||
48898079|NCT02527343|157462766|FG002|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
48984344|NCT00672139|157774164|FG001|Overall Study|Withdrawal by Subject|11|||
48984345|NCT00672139|157774163|FG000|Overall Study|Adverse Event|4|||
48984346|NCT00672139|157774164|FG001|Overall Study|Adverse Event|7|||
48984347|NCT00672139|157774163|FG000|Overall Study|Physician Decision|2|||
48984348|NCT00672139|157774164|FG001|Overall Study|Physician Decision|0|||
48984349|NCT00672139|157774163|FG000|Overall Study|Lack of Efficacy|4|||
48984350|NCT00672139|157774164|FG001|Overall Study|Lack of Efficacy|1|||
48984351|NCT00672139|157774163|FG000|Overall Study|Protocol Violation|1|||
48984352|NCT00672139|157774164|FG001|Overall Study|Protocol Violation|1|||
48984353|NCT00672139|157774163|FG000|Overall Study|hospice discharge, caregiver requests|3|||
48984354|NCT00672139|157774164|FG001|Overall Study|hospice discharge, caregiver requests|2|||
48984355|NCT00772889|157774166|FG000|Overall Study|Adverse Event|7|||
48984356|NCT00772889|157774167|FG001|Overall Study|Adverse Event|4|||
48984357|NCT00772889|157774168|FG002|Overall Study|Adverse Event|0|||
48984358|NCT00772889|157774166|FG000|Overall Study|Withdrawal by Subject|9|||
48984359|NCT00772889|157774167|FG001|Overall Study|Withdrawal by Subject|8|||
48984360|NCT00772889|157774168|FG002|Overall Study|Withdrawal by Subject|9|||
48984361|NCT00772889|157774166|FG000|Overall Study|Lost to Follow-up|6|||
48984362|NCT00772889|157774167|FG001|Overall Study|Lost to Follow-up|6|||
49040216|NCT01698554|157982387|FG003|Overall Study|Protocol Violation|0|||
49040217|NCT01698554|157982384|FG000|Overall Study|Other Miscellaneous Reasons|1|||
49040218|NCT01698554|157982385|FG001|Overall Study|Other Miscellaneous Reasons|0|||
49040219|NCT01698554|157982386|FG002|Overall Study|Other Miscellaneous Reasons|0|||
49040220|NCT01698554|157982387|FG003|Overall Study|Other Miscellaneous Reasons|0|||
49040221|NCT03885934|157982388|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
49040222|NCT03885934|157982389|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
49040223|NCT03885934|157982390|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
49040224|NCT03885934|157982391|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
49040225|NCT03885934|157982392|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
48984363|NCT00772889|157774168|FG002|Overall Study|Lost to Follow-up|7|||
48984364|NCT02177942|157774169|FG000|Overall Study|Adverse Event|1|||
48984365|NCT02177942|157774170|FG001|Overall Study|Adverse Event|0|||
48898080|NCT02527343|157462767|FG003|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
48984366|NCT02177942|157774169|FG000|Overall Study|Lost to Follow-up|1|||
48984367|NCT02177942|157774170|FG001|Overall Study|Lost to Follow-up|1|||
48984368|NCT02177942|157774169|FG000|Overall Study|Protocol Violation|4|||
49040226|NCT03885934|157982393|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
49040227|NCT00406393|157982394|FG000|Overall Study|Did not undergo transplantation|2|||
49040228|NCT00406393|157982395|FG001|Overall Study|Did not undergo transplantation|1|||
49040229|NCT01617096|157982400|FG000|Overall Study|Withdrawal by Subject|96|||
48898081|NCT02527343|157462768|FG004|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
48898082|NCT02527343|157462769|FG005|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
48898083|NCT02527343|157462764|FG000|RT Period: Weeks 1 to 52|Other|4|||
48898084|NCT02527343|157462765|FG001|RT Period: Weeks 1 to 52|Other|3|||
48898085|NCT02527343|157462766|FG002|RT Period: Weeks 1 to 52|Other|0|||
48898086|NCT02527343|157462767|FG003|RT Period: Weeks 1 to 52|Other|0|||
48898087|NCT02527343|157462768|FG004|RT Period: Weeks 1 to 52|Other|0|||
48898088|NCT02527343|157462769|FG005|RT Period: Weeks 1 to 52|Other|0|||
48898089|NCT02527343|157462764|FG000|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
48898090|NCT02527343|157462765|FG001|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
48898091|NCT02527343|157462766|FG002|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1|||
48898092|NCT02527343|157462767|FG003|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
48898093|NCT02527343|157462768|FG004|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
48898094|NCT02527343|157462769|FG005|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
48898095|NCT02527343|157462764|FG000|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
48898096|NCT02527343|157462765|FG001|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
48898097|NCT02527343|157462766|FG002|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
48984369|NCT02177942|157774170|FG001|Overall Study|Protocol Violation|6|||
48984370|NCT02177942|157774169|FG000|Overall Study|Withdrawal by Subject|71|||
48984371|NCT02177942|157774170|FG001|Overall Study|Withdrawal by Subject|81|||
48984372|NCT02142712|157774176|FG000|Overall Study|Lost to Follow-up|1|||
48984373|NCT02142712|157774177|FG001|Overall Study|Lost to Follow-up|1|||
48984374|NCT02142712|157774178|FG002|Overall Study|Lost to Follow-up|1|||
48984375|NCT02142712|157774179|FG003|Overall Study|Lost to Follow-up|0|||
48984376|NCT00518336|157774180|FG000|Year 7|Lost to Follow-up|2|||
48984377|NCT00518336|157774181|FG001|Year 7|Lost to Follow-up|0|||
48984378|NCT00518336|157774180|FG000|Year 7|Could not attend in time|0|||
48984379|NCT00518336|157774181|FG001|Year 7|Could not attend in time|3|||
48984380|NCT00518336|157774180|FG000|Year 8|Lost to Follow-up|1|||
48984381|NCT00518336|157774181|FG001|Year 8|Lost to Follow-up|1|||
48984382|NCT00518336|157774180|FG000|Year 8|Could not attend in time|0|||
48984383|NCT00518336|157774181|FG001|Year 8|Could not attend in time|1|||
48984384|NCT00518336|157774180|FG000|Year 9|Migrated/moved from study area|1|||
48984385|NCT00518336|157774181|FG001|Year 9|Migrated/moved from study area|1|||
48984386|NCT00518336|157774180|FG000|Year 9|Lost to Follow-up|3|||
48984387|NCT00518336|157774181|FG001|Year 9|Lost to Follow-up|0|||
48984388|NCT00518336|157774180|FG000|Year 9|Personal reasons|1|||
48984389|NCT00518336|157774181|FG001|Year 9|Personal reasons|0|||
48984390|NCT00631969|157774183|FG000|Overall Study|Adverse Event|3|||
48984391|NCT00631969|157774184|FG001|Overall Study|Adverse Event|1|||
48984392|NCT00631969|157774183|FG000|Overall Study|Lack of Efficacy|2|||
48984393|NCT00631969|157774184|FG001|Overall Study|Lack of Efficacy|8|||
48984394|NCT00631969|157774183|FG000|Overall Study|Lost to Follow-up|2|||
48984395|NCT00631969|157774184|FG001|Overall Study|Lost to Follow-up|1|||
48984396|NCT00631969|157774183|FG000|Overall Study|Protocol Violation|1|||
48984397|NCT00631969|157774184|FG001|Overall Study|Protocol Violation|1|||
48984398|NCT00631969|157774183|FG000|Overall Study|Consent Withdrawn|5|||
48984399|NCT00631969|157774184|FG001|Overall Study|Consent Withdrawn|7|||
48984400|NCT00631969|157774183|FG000|Overall Study|Noncompliant With Study Medication|0|||
48984401|NCT00631969|157774184|FG001|Overall Study|Noncompliant With Study Medication|1|||
48984402|NCT00631969|157774183|FG000|Overall Study|No Drug Exposure|2|||
48984403|NCT00631969|157774184|FG001|Overall Study|No Drug Exposure|2|||
48984404|NCT01981096|157774188|FG000|Overall Study|Parent illness|1|||
48984405|NCT01981096|157774189|FG001|Overall Study|Parent illness|0|||
48984406|NCT01981096|157774188|FG000|Overall Study|Withdrawal by Subject|0|||
48984407|NCT01981096|157774189|FG001|Overall Study|Withdrawal by Subject|1|||
48984408|NCT01981096|157774188|FG000|Overall Study|Lost to Follow-up|2|||
48984409|NCT01981096|157774189|FG001|Overall Study|Lost to Follow-up|0|||
48984410|NCT00703781|157774190|FG000|Overall Study|Withdrawal by Subject|1|||
48984411|NCT00703781|157774191|FG001|Overall Study|Withdrawal by Subject|2|||
48984412|NCT00703781|157774190|FG000|Overall Study|Cancelled surgery|1|||
48984413|NCT00703781|157774191|FG001|Overall Study|Cancelled surgery|0|||
48984414|NCT02168816|157774192|FG000|Overall Study|Lost to Follow-up|2|||
48984415|NCT02168816|157774193|FG001|Overall Study|Lost to Follow-up|2|||
48984416|NCT01241318|157774200|FG000|Overall Study|Woman: false pregnancies|27|||
48984417|NCT01241318|157774201|FG001|Overall Study|Woman: false pregnancies|15|||
48984418|NCT01241318|157774200|FG000|Overall Study|Woman: miscarriage/abortion|46|||
48984419|NCT01241318|157774201|FG001|Overall Study|Woman: miscarriage/abortion|38|||
48984420|NCT01241318|157774200|FG000|Overall Study|Withdrawal by Subject|175|||
48984421|NCT01241318|157774201|FG001|Overall Study|Withdrawal by Subject|46|||
48984422|NCT01241318|157774200|FG000|Overall Study|Lost to Follow-up|740|||
48984423|NCT01241318|157774201|FG001|Overall Study|Lost to Follow-up|455|||
48984424|NCT01241318|157774200|FG000|Overall Study|Death|2|||
48984425|NCT01241318|157774201|FG001|Overall Study|Death|4|||
48984426|NCT01241318|157774200|FG000|Overall Study|Withdrew/Lost to Follow after delivery|60|||
48984427|NCT01241318|157774201|FG001|Overall Study|Withdrew/Lost to Follow after delivery|38|||
48984428|NCT01241318|157774200|FG000|Overall Study|Woman: Stillborn infant|129|||
48898098|NCT02527343|157462767|FG003|RT Post Treatment Follow-up: Weeks 54-65|Other|2|||
48898099|NCT02527343|157462768|FG004|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
48898100|NCT02527343|157462769|FG005|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
48898101|NCT02527343|157462764|FG000|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
48898102|NCT02527343|157462765|FG001|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
48898103|NCT02527343|157462766|FG002|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
48898104|NCT02527343|157462767|FG003|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
48898105|NCT02527343|157462768|FG004|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1|||
48898106|NCT02527343|157462769|FG005|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
48898107|NCT02527343|157462764|FG000|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
48898108|NCT02527343|157462765|FG001|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
48898109|NCT02527343|157462766|FG002|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
48898110|NCT02527343|157462767|FG003|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
48898111|NCT02527343|157462768|FG004|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3|||
48898112|NCT02527343|157462769|FG005|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1|||
48898113|NCT02527343|157462764|FG000|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
48898114|NCT02527343|157462765|FG001|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
48898115|NCT02527343|157462766|FG002|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
48898116|NCT02527343|157462767|FG003|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
48898117|NCT02527343|157462768|FG004|OLE Period-Year 1: Week 53 to 104|AE or SAE|2|||
48898118|NCT02527343|157462769|FG005|OLE Period-Year 1: Week 53 to 104|AE or SAE|1|||
48898119|NCT02527343|157462764|FG000|OLE Period-Year 1: Week 53 to 104|Other|0|||
48898120|NCT02527343|157462765|FG001|OLE Period-Year 1: Week 53 to 104|Other|0|||
48898121|NCT02527343|157462766|FG002|OLE Period-Year 1: Week 53 to 104|Other|0|||
49040230|NCT01617096|157982401|FG001|Overall Study|Withdrawal by Subject|81|||
49040231|NCT01617096|157982400|FG000|Overall Study|Lost to Follow-up|37|||
49040232|NCT01617096|157982401|FG001|Overall Study|Lost to Follow-up|32|||
49040233|NCT01617096|157982400|FG000|Overall Study|Physician Decision|10|||
49040234|NCT01617096|157982401|FG001|Overall Study|Physician Decision|18|||
49040235|NCT01617096|157982400|FG000|Overall Study|Death|4|||
49040236|NCT01617096|157982401|FG001|Overall Study|Death|3|||
49040237|NCT01617096|157982400|FG000|Overall Study|Other|1|||
49040238|NCT01617096|157982401|FG001|Overall Study|Other|3|||
49040239|NCT02616380|157982402|FG000|Overall Study|Lost to Follow-up|1|||
49040240|NCT02616380|157982402|FG000|Overall Study|Other|2|||
49040241|NCT03193021|157982403|FG000|Overall Study|Lost to Follow-up|1|||
49040242|NCT03193021|157982404|FG001|Overall Study|Lost to Follow-up|1|||
49040243|NCT00919711|157982405|FG000|Overall Study|Withdrawal by Subject|15|||
49040244|NCT00919711|157982406|FG001|Overall Study|Withdrawal by Subject|7|||
49040245|NCT00919711|157982405|FG000|Overall Study|Adverse Event|13|||
49040246|NCT00919711|157982406|FG001|Overall Study|Adverse Event|3|||
49040247|NCT00919711|157982405|FG000|Overall Study|Other|1|||
49040248|NCT00919711|157982406|FG001|Overall Study|Other|2|||
49040249|NCT00919711|157982405|FG000|Overall Study|Administrative Decision|0|||
49040250|NCT00919711|157982406|FG001|Overall Study|Administrative Decision|1|||
49040251|NCT00919711|157982405|FG000|Overall Study|Lost to Follow-up|2|||
49040252|NCT00919711|157982406|FG001|Overall Study|Lost to Follow-up|0|||
49040253|NCT00919711|157982405|FG000|Overall Study|Death|1|||
49040254|NCT00919711|157982406|FG001|Overall Study|Death|0|||
49040255|NCT00919711|157982405|FG000|Overall Study|Noncompliance|1|||
49040256|NCT00919711|157982406|FG001|Overall Study|Noncompliance|0|||
49040257|NCT00642811|157982407|FG000|Overall Study|Adverse Event|2|||
49040258|NCT00642811|157982408|FG001|Overall Study|Adverse Event|3|||
49040259|NCT00642811|157982409|FG002|Overall Study|Adverse Event|0|||
49040260|NCT00642811|157982410|FG003|Overall Study|Adverse Event|0|||
49040261|NCT00642811|157982411|FG004|Overall Study|Adverse Event|0|||
49040262|NCT00642811|157982412|FG005|Overall Study|Adverse Event|1|||
49040263|NCT00642811|157982407|FG000|Overall Study|Developement of discontinuation criteria|0|||
49040264|NCT00642811|157982408|FG001|Overall Study|Developement of discontinuation criteria|0|||
49040265|NCT00642811|157982409|FG002|Overall Study|Developement of discontinuation criteria|0|||
49040266|NCT00642811|157982410|FG003|Overall Study|Developement of discontinuation criteria|0|||
49040267|NCT00642811|157982411|FG004|Overall Study|Developement of discontinuation criteria|1|||
49040268|NCT00642811|157982412|FG005|Overall Study|Developement of discontinuation criteria|0|||
49040269|NCT00642811|157982407|FG000|Overall Study|Severe Non-compliance to protocol|1|||
49040270|NCT00642811|157982408|FG001|Overall Study|Severe Non-compliance to protocol|0|||
49040271|NCT00642811|157982409|FG002|Overall Study|Severe Non-compliance to protocol|0|||
49040272|NCT00642811|157982410|FG003|Overall Study|Severe Non-compliance to protocol|0|||
49040273|NCT00642811|157982411|FG004|Overall Study|Severe Non-compliance to protocol|0|||
49040274|NCT00642811|157982412|FG005|Overall Study|Severe Non-compliance to protocol|0|||
49040275|NCT00642811|157982407|FG000|Overall Study|Other|0|||
49040276|NCT00642811|157982408|FG001|Overall Study|Other|1|||
49040277|NCT00642811|157982409|FG002|Overall Study|Other|0|||
49040278|NCT00642811|157982410|FG003|Overall Study|Other|1|||
49040279|NCT00642811|157982411|FG004|Overall Study|Other|0|||
49040280|NCT00642811|157982412|FG005|Overall Study|Other|0|||
48898122|NCT02527343|157462767|FG003|OLE Period-Year 1: Week 53 to 104|Other|0|||
48898123|NCT02527343|157462768|FG004|OLE Period-Year 1: Week 53 to 104|Other|5|||
48898124|NCT02527343|157462769|FG005|OLE Period-Year 1: Week 53 to 104|Other|7|||
48898125|NCT02527343|157462764|FG000|OLE Period-Year 2: Week 105 to 156|Other|0|||
48898126|NCT02527343|157462765|FG001|OLE Period-Year 2: Week 105 to 156|Other|0|||
48898127|NCT02527343|157462766|FG002|OLE Period-Year 2: Week 105 to 156|Other|0|||
48898128|NCT02527343|157462767|FG003|OLE Period-Year 2: Week 105 to 156|Other|0|||
48898129|NCT02527343|157462768|FG004|OLE Period-Year 2: Week 105 to 156|Other|1|||
48898130|NCT02527343|157462769|FG005|OLE Period-Year 2: Week 105 to 156|Other|2|||
48898131|NCT02527343|157462764|FG000|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
48898132|NCT02527343|157462765|FG001|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
48898133|NCT02527343|157462766|FG002|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
48898134|NCT02527343|157462767|FG003|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
48898135|NCT02527343|157462768|FG004|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1|||
48898136|NCT02527343|157462769|FG005|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
48898137|NCT02527343|157462764|FG000|PT Follow-up: Weeks 104 to 169|Other|0|||
48898138|NCT02527343|157462765|FG001|PT Follow-up: Weeks 104 to 169|Other|0|||
48898139|NCT02527343|157462766|FG002|PT Follow-up: Weeks 104 to 169|Other|0|||
48898140|NCT02527343|157462767|FG003|PT Follow-up: Weeks 104 to 169|Other|0|||
48898141|NCT02527343|157462768|FG004|PT Follow-up: Weeks 104 to 169|Other|0|||
48898142|NCT02527343|157462769|FG005|PT Follow-up: Weeks 104 to 169|Other|1|||
48898143|NCT02783768|157462773|FG000|Overall Study|Lost to Follow-up|1|||
48898144|NCT02783768|157462774|FG001|Overall Study|Lost to Follow-up|0|||
48898145|NCT00712673|157462776|FG000|Overall Study|Adverse Event|3|||
49040281|NCT00633022|157982413|FG000|Overall Study|Adverse Event|1|||
49040282|NCT00633022|157982414|FG001|Overall Study|Adverse Event|0|||
49040283|NCT00633022|157982415|FG002|Overall Study|Adverse Event|5|||
49040284|NCT00633022|157982413|FG000|Overall Study|Physician Decision|0|||
49040285|NCT00633022|157982414|FG001|Overall Study|Physician Decision|1|||
49040286|NCT00633022|157982415|FG002|Overall Study|Physician Decision|0|||
49040287|NCT03067987|157982416|FG000|Overall Study|Lost to Follow-up|7|||
49040288|NCT03067987|157982417|FG001|Overall Study|Lost to Follow-up|10|||
49040289|NCT03067987|157982416|FG000|Overall Study|Protocol Violation|1|||
49040290|NCT03067987|157982417|FG001|Overall Study|Protocol Violation|2|||
49040291|NCT03067987|157982416|FG000|Overall Study|Withdrawal by Subject|2|||
49040292|NCT03067987|157982417|FG001|Overall Study|Withdrawal by Subject|1|||
49040293|NCT02614898|157982418|FG000|Overall Study|Participated until study termination|10|||
49040294|NCT02614898|157982419|FG001|Overall Study|Participated until study termination|26|||
49040295|NCT02614898|157982418|FG000|Overall Study|Lost to Follow-up|0|||
49040296|NCT02614898|157982419|FG001|Overall Study|Lost to Follow-up|2|||
49040297|NCT02614898|157982418|FG000|Overall Study|Physician Decision|1|||
49040298|NCT02614898|157982419|FG001|Overall Study|Physician Decision|8|||
49040299|NCT02614898|157982418|FG000|Overall Study|Study Terminated by Sponsor|3|||
49040300|NCT02614898|157982419|FG001|Overall Study|Study Terminated by Sponsor|0|||
49040301|NCT02614898|157982418|FG000|Overall Study|Withdrawal by Subject|0|||
49040302|NCT02614898|157982419|FG001|Overall Study|Withdrawal by Subject|2|||
49040303|NCT02614898|157982418|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
49040304|NCT02614898|157982419|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
49040305|NCT02614898|157982418|FG000|Overall Study|Other-Additional Information Unavailable|0|||
49040306|NCT02614898|157982419|FG001|Overall Study|Other-Additional Information Unavailable|11|||
49040307|NCT02614898|157982418|FG000|Overall Study|Missing|0|||
49040308|NCT02614898|157982419|FG001|Overall Study|Missing|1|||
49040309|NCT02997176|157983914|FG000|Overall Study|Adverse Event|0|||
48898146|NCT00712673|157462777|FG001|Overall Study|Adverse Event|3|||
48898147|NCT00712673|157462778|FG002|Overall Study|Adverse Event|21|||
48898148|NCT00712673|157462779|FG003|Overall Study|Adverse Event|26|||
48898149|NCT00712673|157462776|FG000|Overall Study|Lack of Efficacy|2|||
48898150|NCT00712673|157462777|FG001|Overall Study|Lack of Efficacy|8|||
48898151|NCT00712673|157462778|FG002|Overall Study|Lack of Efficacy|8|||
48898152|NCT00712673|157462779|FG003|Overall Study|Lack of Efficacy|6|||
48898153|NCT00712673|157462776|FG000|Overall Study|Poor Compliance to Protocol|3|||
48898154|NCT00712673|157462777|FG001|Overall Study|Poor Compliance to Protocol|3|||
48898155|NCT00712673|157462778|FG002|Overall Study|Poor Compliance to Protocol|4|||
48898156|NCT00712673|157462779|FG003|Overall Study|Poor Compliance to Protocol|16|||
48898157|NCT00712673|157462776|FG000|Overall Study|Lost to Follow-up|1|||
48898158|NCT00712673|157462777|FG001|Overall Study|Lost to Follow-up|0|||
48898159|NCT00712673|157462778|FG002|Overall Study|Lost to Follow-up|2|||
48898160|NCT00712673|157462779|FG003|Overall Study|Lost to Follow-up|0|||
48898161|NCT00712673|157462776|FG000|Overall Study|Withdrawal by Subject|6|||
49040310|NCT02997176|157983915|FG001|Overall Study|Adverse Event|0|||
49040311|NCT02997176|157983916|FG002|Overall Study|Adverse Event|0|||
49040312|NCT02997176|157983917|FG003|Overall Study|Adverse Event|8|||
49040313|NCT02997176|157983914|FG000|Overall Study|Progressive Disease|1|||
49040314|NCT02997176|157983915|FG001|Overall Study|Progressive Disease|0|||
49040315|NCT02997176|157983916|FG002|Overall Study|Progressive Disease|1|||
49040316|NCT02997176|157983917|FG003|Overall Study|Progressive Disease|1|||
49040317|NCT02997176|157983914|FG000|Overall Study|Death|0|||
49040318|NCT02997176|157983915|FG001|Overall Study|Death|0|||
49040319|NCT02997176|157983916|FG002|Overall Study|Death|1|||
49040320|NCT02997176|157983917|FG003|Overall Study|Death|1|||
49040321|NCT02997176|157983914|FG000|Overall Study|Withdrawal by Subject|0|||
49040322|NCT02997176|157983915|FG001|Overall Study|Withdrawal by Subject|2|||
49040323|NCT02997176|157983916|FG002|Overall Study|Withdrawal by Subject|0|||
49040324|NCT02997176|157983917|FG003|Overall Study|Withdrawal by Subject|1|||
49040325|NCT05511935|157983920|FG000|Overall Study|Lost to Follow-up|9|||
49040326|NCT05511935|157983921|FG001|Overall Study|Lost to Follow-up|27|||
49040327|NCT01911429|157983926|FG000|Overall Study|Adverse Event|5|||
49040328|NCT01911429|157983927|FG001|Overall Study|Adverse Event|3|||
49040329|NCT01911429|157983928|FG002|Overall Study|Adverse Event|9|||
48898162|NCT00712673|157462777|FG001|Overall Study|Withdrawal by Subject|7|||
48898163|NCT00712673|157462778|FG002|Overall Study|Withdrawal by Subject|15|||
48898164|NCT00712673|157462779|FG003|Overall Study|Withdrawal by Subject|20|||
48898165|NCT00712673|157462776|FG000|Overall Study|Familial and Personal Reasons|5|||
48898166|NCT00712673|157462777|FG001|Overall Study|Familial and Personal Reasons|0|||
48898167|NCT00712673|157462778|FG002|Overall Study|Familial and Personal Reasons|5|||
48898168|NCT00712673|157462779|FG003|Overall Study|Familial and Personal Reasons|2|||
48898169|NCT00712673|157462776|FG000|Overall Study|Investigator's Decision|1|||
48898170|NCT00712673|157462777|FG001|Overall Study|Investigator's Decision|0|||
48898171|NCT00712673|157462778|FG002|Overall Study|Investigator's Decision|0|||
48898172|NCT00712673|157462779|FG003|Overall Study|Investigator's Decision|0|||
48898173|NCT00712673|157462776|FG000|Overall Study|Protocol Violation|0|||
48898174|NCT00712673|157462777|FG001|Overall Study|Protocol Violation|0|||
48898175|NCT00712673|157462778|FG002|Overall Study|Protocol Violation|2|||
48898176|NCT00712673|157462779|FG003|Overall Study|Protocol Violation|0|||
48898177|NCT00682890|157462780|FG000|Overall Study|Lost to Follow-up|1|||
48898178|NCT00682890|157462781|FG001|Overall Study|Lost to Follow-up|1|||
48898179|NCT00682890|157462780|FG000|Overall Study|subject moved away|0|||
48898180|NCT00682890|157462781|FG001|Overall Study|subject moved away|1|||
48898181|NCT00682890|157462780|FG000|Overall Study|heavy menstrual bleeding|1|||
48898182|NCT00682890|157462781|FG001|Overall Study|heavy menstrual bleeding|0|||
48898183|NCT01323647|157462782|FG000|Overall Study|Migrated/moved from study area|2|||
48898184|NCT01323647|157462783|FG001|Overall Study|Migrated/moved from study area|0|||
48898185|NCT01323647|157462782|FG000|Overall Study|Withdrawal by Subject|5|||
48898186|NCT01323647|157462783|FG001|Overall Study|Withdrawal by Subject|0|||
48898187|NCT01323647|157462782|FG000|Overall Study|Lost to Follow-up|2|||
48898188|NCT01323647|157462783|FG001|Overall Study|Lost to Follow-up|0|||
48898189|NCT01103362|157462789|FG000|Overall Study|study terminated|596|||
48898190|NCT00513604|157462790|FG000|Overall Study|Not treated|2|||
48898191|NCT00513604|157462791|FG001|Overall Study|Not treated|0|||
48898192|NCT00513604|157462792|FG002|Overall Study|Not treated|1|||
48898193|NCT00513604|157462793|FG003|Overall Study|Not treated|0|||
48898194|NCT00513604|157462794|FG004|Overall Study|Not treated|0|||
48898195|NCT00513604|157462790|FG000|Overall Study|Death during treatment|0|||
48898196|NCT00513604|157462791|FG001|Overall Study|Death during treatment|3|||
48898197|NCT00513604|157462792|FG002|Overall Study|Death during treatment|2|||
48898198|NCT00513604|157462793|FG003|Overall Study|Death during treatment|0|||
48898199|NCT00513604|157462794|FG004|Overall Study|Death during treatment|0|||
48898200|NCT01270971|157462803|FG000|Overall Study|Withdrawal by Subject|24|||
48898201|NCT01270971|157462804|FG001|Overall Study|Withdrawal by Subject|11|||
48898202|NCT01270971|157462803|FG000|Overall Study|Lost to Follow-up|18|||
48898203|NCT01270971|157462804|FG001|Overall Study|Lost to Follow-up|5|||
48898204|NCT01270971|157462803|FG000|Overall Study|Adverse Event|1|||
48898205|NCT01270971|157462804|FG001|Overall Study|Adverse Event|2|||
48898206|NCT01270971|157462803|FG000|Overall Study|Non compliance|2|||
48898207|NCT01270971|157462804|FG001|Overall Study|Non compliance|2|||
48898208|NCT01270971|157462803|FG000|Overall Study|Non-specific|7|||
48898209|NCT01270971|157462804|FG001|Overall Study|Non-specific|3|||
49040330|NCT01911429|157983926|FG000|Overall Study|Lack of Efficacy|1|||
49040331|NCT01911429|157983927|FG001|Overall Study|Lack of Efficacy|2|||
49040332|NCT01911429|157983928|FG002|Overall Study|Lack of Efficacy|4|||
49040333|NCT01911429|157983926|FG000|Overall Study|Lost to Follow-up|0|||
48898210|NCT00413972|157462805|FG000|Overall Study|Adverse Event|2|||
48898211|NCT00413972|157462806|FG001|Overall Study|Adverse Event|1|||
48898212|NCT00413972|157462807|FG002|Overall Study|Adverse Event|0|||
48898213|NCT00413972|157462808|FG003|Overall Study|Adverse Event|0|||
48898214|NCT00413972|157462805|FG000|Overall Study|Lost to Follow-up|1|||
48898215|NCT00413972|157462806|FG001|Overall Study|Lost to Follow-up|2|||
48898216|NCT00413972|157462807|FG002|Overall Study|Lost to Follow-up|1|||
49040334|NCT01911429|157983927|FG001|Overall Study|Lost to Follow-up|0|||
48898217|NCT00413972|157462808|FG003|Overall Study|Lost to Follow-up|0|||
48898218|NCT00413972|157462805|FG000|Overall Study|Withdrawal by Subject|4|||
48898219|NCT00413972|157462806|FG001|Overall Study|Withdrawal by Subject|5|||
49040335|NCT01911429|157983928|FG002|Overall Study|Lost to Follow-up|1|||
49040336|NCT01911429|157983926|FG000|Overall Study|Protocol Violation|0|||
49040337|NCT01911429|157983927|FG001|Overall Study|Protocol Violation|0|||
49040338|NCT01911429|157983928|FG002|Overall Study|Protocol Violation|1|||
49040339|NCT01911429|157983926|FG000|Overall Study|Withdrawal by Subject|5|||
49040340|NCT01911429|157983927|FG001|Overall Study|Withdrawal by Subject|5|||
49040341|NCT01911429|157983928|FG002|Overall Study|Withdrawal by Subject|4|||
49040342|NCT01911429|157983926|FG000|Overall Study|Accidental randomization|0|||
49040343|NCT01911429|157983927|FG001|Overall Study|Accidental randomization|0|||
49040344|NCT01911429|157983928|FG002|Overall Study|Accidental randomization|1|||
49040345|NCT01911429|157983926|FG000|Overall Study|subject left study|1|||
49040346|NCT01911429|157983927|FG001|Overall Study|subject left study|0|||
49040347|NCT01911429|157983928|FG002|Overall Study|subject left study|0|||
49040348|NCT01205035|157983929|FG000|Overall Study|Withdrawal by Subject|1|||
49040349|NCT01205035|157983930|FG001|Overall Study|Withdrawal by Subject|0|||
49040350|NCT01205035|157983929|FG000|Overall Study|Physician Decision|1|||
49040351|NCT01205035|157983930|FG001|Overall Study|Physician Decision|0|||
49040352|NCT02663349|157983933|FG000|Overall Study|Withdrawal by Subject|6|||
49040353|NCT01499043|157983934|FG000|Overall Study|Progressive disease (radiographic)|2|||
49040354|NCT01499043|157983934|FG000|Overall Study|Progressive disease (clinical)|1|||
49040355|NCT01499043|157983934|FG000|Overall Study|Withdrawal by Subject|2|||
49040356|NCT01499043|157983934|FG000|Overall Study|Adverse Event|1|||
49040357|NCT01442376|157983938|FG000|Overall Study|Adverse Event|0|||
49040358|NCT01442376|157983939|FG001|Overall Study|Adverse Event|3|||
49040359|NCT01442376|157983940|FG002|Overall Study|Adverse Event|2|||
49040360|NCT01442376|157983938|FG000|Overall Study|Death|0|||
49040361|NCT01442376|157983939|FG001|Overall Study|Death|1|||
49040362|NCT01442376|157983940|FG002|Overall Study|Death|1|||
49040363|NCT01442376|157983938|FG000|Overall Study|Withdrawal of consent|0|||
49040364|NCT01442376|157983939|FG001|Overall Study|Withdrawal of consent|0|||
49040365|NCT01442376|157983940|FG002|Overall Study|Withdrawal of consent|1|||
49040366|NCT01442376|157983938|FG000|Overall Study|Patients not treated|2|||
49040367|NCT01442376|157983939|FG001|Overall Study|Patients not treated|3|||
49040368|NCT01442376|157983940|FG002|Overall Study|Patients not treated|1|||
49040369|NCT01442376|157983938|FG000|Overall Study|Not eligible for subsequent cycles|1|||
49040370|NCT01442376|157983939|FG001|Overall Study|Not eligible for subsequent cycles|2|||
49040371|NCT01442376|157983940|FG002|Overall Study|Not eligible for subsequent cycles|0|||
49040372|NCT01024855|157983945|FG000|Overall Study|Inclusion/exclusion criteria|1|||
49040373|NCT00577655|157983947|FG000|Overall Study|Patient Request|0|||
49040374|NCT00577655|157983948|FG001|Overall Study|Patient Request|2|||
49040375|NCT00577655|157983947|FG000|Overall Study|Protocol Violation|0|||
49040376|NCT00577655|157983948|FG001|Overall Study|Protocol Violation|1|||
49040377|NCT00577655|157983947|FG000|Overall Study|Lost to Follow-up|1|||
49040378|NCT00577655|157983948|FG001|Overall Study|Lost to Follow-up|1|||
49040379|NCT00674128|157983951|FG000|Overall Study|Withdrawal by Subject|25|||
49040380|NCT00674128|157983952|FG001|Overall Study|Withdrawal by Subject|23|||
49040381|NCT03306277|157983953|FG000|Overall Study|Death|1|||
49040382|NCT03306277|157983953|FG000|Overall Study|Adverse Event|1|||
48898220|NCT00413972|157462807|FG002|Overall Study|Withdrawal by Subject|7|||
48898221|NCT00413972|157462808|FG003|Overall Study|Withdrawal by Subject|2|||
48898222|NCT00413972|157462805|FG000|Overall Study|Protocol Violation|0|||
48898223|NCT00413972|157462806|FG001|Overall Study|Protocol Violation|0|||
48898224|NCT00413972|157462807|FG002|Overall Study|Protocol Violation|2|||
48898225|NCT00413972|157462808|FG003|Overall Study|Protocol Violation|0|||
48898226|NCT00413972|157462805|FG000|Overall Study|Other|0|||
48898227|NCT00413972|157462806|FG001|Overall Study|Other|0|||
48898228|NCT00413972|157462807|FG002|Overall Study|Other|0|||
48898229|NCT00413972|157462808|FG003|Overall Study|Other|1|||
48898230|NCT03170154|157462811|FG000|Overall Study|Lost to Follow-up|4|||
48898231|NCT03170154|157462811|FG000|Overall Study|Death|2|||
48898232|NCT03170154|157462811|FG000|Overall Study|Withdrawal by Subject|2|||
48898233|NCT05543187|157462812|FG000|Overall Study|Ongoing|3|||
48898234|NCT05543187|157462813|FG001|Overall Study|Ongoing|2|||
48898235|NCT03316300|157462814|FG000|Overall Study|Withdrawal by Subject|3|||
48898236|NCT03316300|157462815|FG001|Overall Study|Withdrawal by Subject|2|||
48898237|NCT03316300|157462814|FG000|Overall Study|Eligible and did not enroll in amendment|4|||
48898238|NCT03316300|157462815|FG001|Overall Study|Eligible and did not enroll in amendment|4|||
48898239|NCT03316300|157462814|FG000|Overall Study|Adverse Event|1|||
48898240|NCT03316300|157462815|FG001|Overall Study|Adverse Event|0|||
48898241|NCT03316300|157462814|FG000|Overall Study|COVID-19|0|||
48898242|NCT03316300|157462815|FG001|Overall Study|COVID-19|1|||
48898243|NCT01411839|157462816|FG000|Overall Study|Lost to Follow-up|4|||
49040383|NCT03306277|157983953|FG000|Overall Study|Withdrawal by Subject|1|||
49040384|NCT05004649|157983964|FG000|Overall Study|Eligibility Criteria - Threshold|4|||
49040385|NCT05004649|157983964|FG000|Overall Study|Lost to Follow-up|1|||
49040386|NCT05004649|157983964|FG000|Overall Study|Withdrawal by Subject|2|||
49040387|NCT05004649|157983964|FG000|Overall Study|COVID-19|1|||
49040388|NCT00301964|157983965|FG000|Overall Study|Second primary|2|||
49040389|NCT00301964|157983965|FG000|Overall Study|Wrong primary|1|||
49040390|NCT00301964|157983965|FG000|Overall Study|Inadequate pathology|1|||
49040391|NCT02385708|157983966|FG000|Overall Study|Withdrawal by Subject|0|||
49040392|NCT02385708|157983967|FG001|Overall Study|Withdrawal by Subject|2|||
48898244|NCT01411839|157462817|FG001|Overall Study|Lost to Follow-up|3|||
48898245|NCT02146326|157462820|FG000|Overall Study|Lost to Follow-up|3|||
48898246|NCT02146326|157462821|FG001|Overall Study|Lost to Follow-up|3|||
48898247|NCT02146326|157462822|FG002|Overall Study|Lost to Follow-up|11|||
48898248|NCT02146326|157462823|FG003|Overall Study|Lost to Follow-up|19|||
48898249|NCT02146326|157462820|FG000|Overall Study|Withdrawal by Subject|2|||
48898250|NCT02146326|157462821|FG001|Overall Study|Withdrawal by Subject|1|||
48898251|NCT02146326|157462822|FG002|Overall Study|Withdrawal by Subject|15|||
48898252|NCT02146326|157462823|FG003|Overall Study|Withdrawal by Subject|11|||
48898253|NCT02146326|157462820|FG000|Overall Study|Separated from mental health center|23|||
48898254|NCT02146326|157462821|FG001|Overall Study|Separated from mental health center|33|||
48898255|NCT02146326|157462822|FG002|Overall Study|Separated from mental health center|0|||
48898256|NCT02146326|157462823|FG003|Overall Study|Separated from mental health center|0|||
48898257|NCT02146326|157462820|FG000|Overall Study|Incarcerated|0|||
48898258|NCT02146326|157462821|FG001|Overall Study|Incarcerated|0|||
48898259|NCT02146326|157462822|FG002|Overall Study|Incarcerated|3|||
48898260|NCT02146326|157462823|FG003|Overall Study|Incarcerated|8|||
48898261|NCT02146326|157462820|FG000|Overall Study|Death|0|||
48898262|NCT02146326|157462821|FG001|Overall Study|Death|0|||
48898263|NCT02146326|157462822|FG002|Overall Study|Death|4|||
48898264|NCT02146326|157462823|FG003|Overall Study|Death|4|||
48898265|NCT02146326|157462820|FG000|Overall Study|Unable to complete interview|0|||
48898266|NCT02146326|157462821|FG001|Overall Study|Unable to complete interview|0|||
48692513|NCT00453154|156724503|FG000|Double BIind Maintenance|Medical Issues|0|||
48692514|NCT00453154|156724504|FG001|Double BIind Maintenance|Medical Issues|0|||
48692515|NCT00453154|156724505|FG002|Double BIind Maintenance|Medical Issues|3|||
48692516|NCT00453154|156724506|FG003|Double BIind Maintenance|Medical Issues|1|||
48692517|NCT00453154|156724503|FG000|Double BIind Maintenance|Randomized, did not receive therapy|0|||
48692518|NCT00453154|156724504|FG001|Double BIind Maintenance|Randomized, did not receive therapy|0|||
48692519|NCT00453154|156724505|FG002|Double BIind Maintenance|Randomized, did not receive therapy|5|||
48692520|NCT00453154|156724506|FG003|Double BIind Maintenance|Randomized, did not receive therapy|5|||
48692521|NCT01451723|156724507|FG000|Overall Study|study halted|6|||
48692522|NCT01451723|156724508|FG001|Overall Study|study halted|5|||
48692523|NCT04540913|156724511|FG000|Overall Study|Withdrawal by Subject|14|||
48692524|NCT04540913|156724512|FG001|Overall Study|Withdrawal by Subject|3|||
48692525|NCT01755234|156724519|FG000|Overall Study|Lost to Follow-up|11|||
48692526|NCT01755234|156724520|FG001|Overall Study|Lost to Follow-up|6|||
48692527|NCT01755234|156724519|FG000|Overall Study|Change in surgical case|2|||
48898267|NCT02146326|157462822|FG002|Overall Study|Unable to complete interview|10|||
48898268|NCT02146326|157462823|FG003|Overall Study|Unable to complete interview|6|||
48898269|NCT00081497|157462826|FG000|Overall Study|Adverse Event|2|||
48898270|NCT00081497|157462827|FG001|Overall Study|Adverse Event|0|||
48898271|NCT00081497|157462826|FG000|Overall Study|Death|0|||
48898272|NCT00081497|157462827|FG001|Overall Study|Death|1|||
48898273|NCT00081497|157462826|FG000|Overall Study|Withdrawal by Subject|1|||
48898274|NCT00081497|157462827|FG001|Overall Study|Withdrawal by Subject|0|||
48898275|NCT00081497|157462826|FG000|Overall Study|Non-compliance|0|||
48898276|NCT00081497|157462827|FG001|Overall Study|Non-compliance|1|||
48898277|NCT01439360|157462828|FG000|Overall Study|Adverse Event|4|||
48898278|NCT01439360|157462829|FG001|Overall Study|Adverse Event|16|||
48898279|NCT01439360|157462828|FG000|Overall Study|Lost to Follow-up|43|||
48898280|NCT01439360|157462829|FG001|Overall Study|Lost to Follow-up|58|||
48898281|NCT01439360|157462828|FG000|Overall Study|Others|10|||
48898282|NCT01439360|157462829|FG001|Overall Study|Others|5|||
48898283|NCT01439360|157462828|FG000|Overall Study|Protocol Violation|1|||
48898284|NCT01439360|157462829|FG001|Overall Study|Protocol Violation|0|||
48898285|NCT01439360|157462828|FG000|Overall Study|Withdrawal by Subject|140|||
48898286|NCT01439360|157462829|FG001|Overall Study|Withdrawal by Subject|129|||
48898287|NCT01598311|157462830|FG000|Overall Study|Physician Decision|4|||
48898288|NCT01598311|157462831|FG001|Overall Study|Physician Decision|5|||
48898289|NCT01598311|157462830|FG000|Overall Study|Adverse Event|9|||
48898290|NCT01598311|157462831|FG001|Overall Study|Adverse Event|13|||
48898291|NCT01598311|157462830|FG000|Overall Study|Lost to Follow-up|7|||
48898292|NCT01598311|157462831|FG001|Overall Study|Lost to Follow-up|12|||
48898293|NCT01598311|157462830|FG000|Overall Study|Withdrawal by Subject|9|||
48898294|NCT01598311|157462831|FG001|Overall Study|Withdrawal by Subject|13|||
48898295|NCT01598311|157462830|FG000|Overall Study|No reason provided.|0|||
48898296|NCT01598311|157462831|FG001|Overall Study|No reason provided.|5|||
48898297|NCT01598311|157462830|FG000|Overall Study|Randomized but never treated|8|||
48898298|NCT01598311|157462831|FG001|Overall Study|Randomized but never treated|5|||
48898299|NCT01598311|157462830|FG000|Overall Study|Treated but no confirmed CDAD|9|||
48898300|NCT01598311|157462831|FG001|Overall Study|Treated but no confirmed CDAD|8|||
48898301|NCT01598311|157462830|FG000|Overall Study|Assigned to CB but received vancomycin|1|||
48898302|NCT01598311|157462831|FG001|Overall Study|Assigned to CB but received vancomycin|0|||
48898303|NCT00658684|157462833|FG000|Overall Study|Adverse Event|10|||
48898304|NCT00658684|157462834|FG001|Overall Study|Adverse Event|8|||
48898305|NCT00658684|157462835|FG002|Overall Study|Adverse Event|2|||
48898306|NCT00658684|157462836|FG003|Overall Study|Adverse Event|0|||
48898307|NCT00658684|157462833|FG000|Overall Study|Withdrawal by Subject|6|||
48898308|NCT00658684|157462834|FG001|Overall Study|Withdrawal by Subject|4|||
49040393|NCT02385708|157983966|FG000|Overall Study|Withdrawn - surgery canceled|2|||
49040394|NCT02385708|157983967|FG001|Overall Study|Withdrawn - surgery canceled|5|||
49040395|NCT02385708|157983966|FG000|Overall Study|Investigator decision|5|||
49040396|NCT02385708|157983967|FG001|Overall Study|Investigator decision|7|||
49040397|NCT02385708|157983966|FG000|Overall Study|Protocol Violation|1|||
49040398|NCT02385708|157983967|FG001|Overall Study|Protocol Violation|1|||
49040399|NCT03504085|157983969|FG000|End of Intervention - 12 Weeks|Lost to Follow-up|3|||
49040400|NCT03504085|157983970|FG001|End of Intervention - 12 Weeks|Lost to Follow-up|4|||
49040401|NCT03504085|157983969|FG000|Final Assessment - 6 Months|Lost to Follow-up|5|||
49040402|NCT03504085|157983970|FG001|Final Assessment - 6 Months|Lost to Follow-up|5|||
49040403|NCT02761915|157983971|FG000|Overall Study|Death|3|||
49040404|NCT02761915|157983972|FG001|Overall Study|Death|1|||
49040405|NCT02761915|157983973|FG002|Overall Study|Death|1|||
49040406|NCT02761915|157983974|FG003|Overall Study|Death|1|||
49040407|NCT02761915|157983975|FG004|Overall Study|Death|0|||
49040408|NCT02761915|157983976|FG005|Overall Study|Death|1|||
49040409|NCT02761915|157983971|FG000|Overall Study|Withdrawal by Subject|1|||
49040410|NCT02761915|157983972|FG001|Overall Study|Withdrawal by Subject|0|||
49040411|NCT02761915|157983973|FG002|Overall Study|Withdrawal by Subject|0|||
49040412|NCT02761915|157983974|FG003|Overall Study|Withdrawal by Subject|0|||
49040413|NCT02761915|157983975|FG004|Overall Study|Withdrawal by Subject|1|||
49040414|NCT02761915|157983976|FG005|Overall Study|Withdrawal by Subject|2|||
49040415|NCT02761915|157983971|FG000|Overall Study|Disease Progression|0|||
49040416|NCT02761915|157983972|FG001|Overall Study|Disease Progression|0|||
49040417|NCT02761915|157983973|FG002|Overall Study|Disease Progression|0|||
48898309|NCT00658684|157462835|FG002|Overall Study|Withdrawal by Subject|1|||
48898310|NCT00658684|157462836|FG003|Overall Study|Withdrawal by Subject|1|||
48898311|NCT00658684|157462833|FG000|Overall Study|Lack of Efficacy|1|||
48898312|NCT00658684|157462834|FG001|Overall Study|Lack of Efficacy|1|||
48898313|NCT00658684|157462835|FG002|Overall Study|Lack of Efficacy|0|||
48898314|NCT00658684|157462836|FG003|Overall Study|Lack of Efficacy|0|||
48898315|NCT00658684|157462833|FG000|Overall Study|Protocol Violation|1|||
48898316|NCT00658684|157462834|FG001|Overall Study|Protocol Violation|1|||
48898317|NCT00658684|157462835|FG002|Overall Study|Protocol Violation|0|||
48898318|NCT00658684|157462836|FG003|Overall Study|Protocol Violation|0|||
48898319|NCT00658684|157462833|FG000|Overall Study|Pregnancy|1|||
48898320|NCT00658684|157462834|FG001|Overall Study|Pregnancy|1|||
48898321|NCT00658684|157462835|FG002|Overall Study|Pregnancy|0|||
48898322|NCT00658684|157462836|FG003|Overall Study|Pregnancy|0|||
48898323|NCT00688103|157462837|FG000|Overall Study|Adverse Event|4|||
48898324|NCT00688103|157462838|FG001|Overall Study|Adverse Event|1|||
48898325|NCT00688103|157462837|FG000|Overall Study|Lack of Efficacy|11|||
48898326|NCT00688103|157462838|FG001|Overall Study|Lack of Efficacy|1|||
48898327|NCT00688103|157462837|FG000|Overall Study|Withdrawal by Subject|4|||
48898328|NCT00688103|157462838|FG001|Overall Study|Withdrawal by Subject|2|||
48898329|NCT00688103|157462837|FG000|Overall Study|complex reasons|11|||
48898330|NCT00688103|157462838|FG001|Overall Study|complex reasons|9|||
48898331|NCT03727438|157462842|FG000|Intervention Period|Did not complete at least 3 calls but remained in study|7|||
48898332|NCT03727438|157462843|FG001|Intervention Period|Did not complete at least 3 calls but remained in study|1|||
48898333|NCT03727438|157462842|FG000|Intervention Period|Excluded (health)|1|||
48898334|NCT03727438|157462843|FG001|Intervention Period|Excluded (health)|0|||
48898335|NCT03727438|157462842|FG000|Intervention Period|Withdrawal by Subject|3|||
48898336|NCT03727438|157462843|FG001|Intervention Period|Withdrawal by Subject|1|||
48898337|NCT03727438|157462842|FG000|8 Week Assessment|Did not complete assessment but remained in study|6|||
48898338|NCT03727438|157462843|FG001|8 Week Assessment|Did not complete assessment but remained in study|5|||
48898339|NCT03727438|157462842|FG000|8 Week Assessment|Did not complete due to study error, remained in study|2|||
48898340|NCT03727438|157462843|FG001|8 Week Assessment|Did not complete due to study error, remained in study|0|||
48898341|NCT03727438|157462842|FG000|8 Week Assessment|Withdrawal by Subject|6|||
48898342|NCT03727438|157462843|FG001|8 Week Assessment|Withdrawal by Subject|1|||
48898343|NCT03727438|157462842|FG000|6 mo Assessment|did not complete assessment|10|||
48898344|NCT03727438|157462843|FG001|6 mo Assessment|did not complete assessment|11|||
48898345|NCT01386788|157464949|FG000|Overall Study|Lost to Follow-up|2|||
48898346|NCT00156819|157464950|FG000|Overall Study|Lost to Follow-up|1|||
48898347|NCT00156819|157464951|FG001|Overall Study|Lost to Follow-up|1|||
48898348|NCT00156819|157464952|FG002|Overall Study|Lost to Follow-up|3|||
49040418|NCT02761915|157983974|FG003|Overall Study|Disease Progression|2|||
49040419|NCT02761915|157983975|FG004|Overall Study|Disease Progression|2|||
49040420|NCT02761915|157983976|FG005|Overall Study|Disease Progression|2|||
49040421|NCT01143337|157983982|FG000|Overall Study|Adverse Event|3|||
49040422|NCT01143337|157983983|FG001|Overall Study|Adverse Event|9|||
48898349|NCT01689337|157464953|FG000|Overall Study|Study Discontinuation|1|||
48898350|NCT00642772|157464954|FG000|Overall Study|Lost to Follow-up|3|||
48898351|NCT00642772|157464954|FG000|Overall Study|Withdrawal by Subject|7|||
48898352|NCT00321373|157464956|FG000|Overall Study|Adverse Event|0|||
48898353|NCT00321373|157464957|FG001|Overall Study|Adverse Event|0|||
48898354|NCT00321373|157464958|FG002|Overall Study|Adverse Event|1|||
48898355|NCT00321373|157464956|FG000|Overall Study|Lost to Follow-up|1|||
48898356|NCT00321373|157464957|FG001|Overall Study|Lost to Follow-up|0|||
48898357|NCT00321373|157464958|FG002|Overall Study|Lost to Follow-up|1|||
48898358|NCT00321373|157464956|FG000|Overall Study|Withdrawal by Subject|1|||
48898359|NCT00321373|157464957|FG001|Overall Study|Withdrawal by Subject|0|||
48898360|NCT00321373|157464958|FG002|Overall Study|Withdrawal by Subject|0|||
48898361|NCT00321373|157464956|FG000|Overall Study|Other|0|||
48898362|NCT00321373|157464957|FG001|Overall Study|Other|0|||
48898363|NCT00321373|157464958|FG002|Overall Study|Other|1|||
48898364|NCT00918580|157464959|FG000|Up to 6-month Follow-up(FU)|Adverse Event|1|||
48898365|NCT00918580|157464959|FG000|Up to 6-month Follow-up(FU)|Lost to Follow-up|5|||
48898366|NCT00918580|157464959|FG000|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2|||
48898367|NCT00918580|157464959|FG000|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2|||
49040423|NCT01143337|157983984|FG002|Overall Study|Adverse Event|5|||
49040424|NCT01143337|157983982|FG000|Overall Study|Lack of Efficacy|6|||
49040425|NCT01143337|157983983|FG001|Overall Study|Lack of Efficacy|2|||
49040426|NCT01143337|157983984|FG002|Overall Study|Lack of Efficacy|1|||
49040427|NCT01143337|157983982|FG000|Overall Study|Protocol Violation|1|||
49040428|NCT01143337|157983983|FG001|Overall Study|Protocol Violation|0|||
49040429|NCT01143337|157983984|FG002|Overall Study|Protocol Violation|0|||
49040430|NCT01143337|157983982|FG000|Overall Study|Withdrawal by Subject|0|||
49040431|NCT01143337|157983983|FG001|Overall Study|Withdrawal by Subject|0|||
49040432|NCT01143337|157983984|FG002|Overall Study|Withdrawal by Subject|1|||
49040433|NCT01143337|157983982|FG000|Overall Study|Other reason|0|||
48898368|NCT00918580|157464959|FG000|Up to 6-month Follow-up(FU)|Failed to Return|1|||
48898369|NCT00918580|157464959|FG000|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58|||
48898370|NCT00918580|157464959|FG000|After 6-month FU to 1-year FU|Failed to Return|2|||
48898371|NCT04447846|157464960|FG000|Overall Study|Withdrew due to moderate side effects (fatigue)|1|||
48898372|NCT02292927|157464963|FG000|Overall Study|Protocol Violation|13|||
48898373|NCT02292927|157464964|FG001|Overall Study|Protocol Violation|7|||
48898374|NCT00211185|157464965|FG000|Overall Study|Death|2|||
48898375|NCT00211185|157464965|FG000|Overall Study|Disease progression|7|||
48898376|NCT00211185|157464965|FG000|Overall Study|Withdrawal by Subject|6|||
48898377|NCT00211185|157464965|FG000|Overall Study|Physician Decision|5|||
48898378|NCT03625895|157464966|FG000|Overall Study|Protocol Violation|585|||
48898379|NCT00552240|157464967|FG000|Overall Study|Adverse Event|9|||
48898380|NCT00552240|157464968|FG001|Overall Study|Adverse Event|9|||
48898381|NCT00552240|157464967|FG000|Overall Study|Protocol Violation|1|||
48898382|NCT00552240|157464968|FG001|Overall Study|Protocol Violation|1|||
48898383|NCT00552240|157464967|FG000|Overall Study|Lost to Follow-up|5|||
48898384|NCT00552240|157464968|FG001|Overall Study|Lost to Follow-up|6|||
48898385|NCT00552240|157464967|FG000|Overall Study|Withdrawal by Subject|2|||
48898386|NCT00552240|157464968|FG001|Overall Study|Withdrawal by Subject|2|||
48898387|NCT00552240|157464967|FG000|Overall Study|Lack of Efficacy|6|||
48898388|NCT00552240|157464968|FG001|Overall Study|Lack of Efficacy|0|||
48898389|NCT00552240|157464967|FG000|Overall Study|Other|1|||
48898390|NCT00552240|157464968|FG001|Overall Study|Other|0|||
48898391|NCT02679573|157464972|FG000|Overall Study|Adverse Event|13|||
48898392|NCT02679573|157464973|FG001|Overall Study|Adverse Event|6|||
48898393|NCT02679573|157464972|FG000|Overall Study|Lack of Efficacy|12|||
48898394|NCT02679573|157464973|FG001|Overall Study|Lack of Efficacy|15|||
48898395|NCT02679573|157464972|FG000|Overall Study|Could not complete required study visits|6|||
48898396|NCT02679573|157464973|FG001|Overall Study|Could not complete required study visits|2|||
48898397|NCT02679573|157464972|FG000|Overall Study|Withdrawal by Subject|2|||
48898398|NCT02679573|157464973|FG001|Overall Study|Withdrawal by Subject|9|||
48898399|NCT02679573|157464972|FG000|Overall Study|Death|2|||
48898400|NCT02679573|157464973|FG001|Overall Study|Death|0|||
48898401|NCT02679573|157464972|FG000|Overall Study|Physician Decision|2|||
48898402|NCT02679573|157464973|FG001|Overall Study|Physician Decision|4|||
48898403|NCT02679573|157464972|FG000|Overall Study|Lost to Follow-up|0|||
48898404|NCT02679573|157464973|FG001|Overall Study|Lost to Follow-up|3|||
48898405|NCT00986674|157464974|FG000|Overall Study|Lack of Efficacy|28|||
48898406|NCT00986674|157464975|FG001|Overall Study|Lack of Efficacy|25|||
48898407|NCT00986674|157464976|FG002|Overall Study|Lack of Efficacy|23|||
48898408|NCT00986674|157464974|FG000|Overall Study|Adverse Event|4|||
49040434|NCT01143337|157983983|FG001|Overall Study|Other reason|0|||
49040435|NCT01143337|157983984|FG002|Overall Study|Other reason|5|||
49040436|NCT04133311|157983985|FG000|Period 1 Double Masked Treatment Period|Death|1|||
49040437|NCT04133311|157983986|FG001|Period 1 Double Masked Treatment Period|Death|0|||
48898409|NCT00986674|157464975|FG001|Overall Study|Adverse Event|8|||
48898410|NCT00986674|157464976|FG002|Overall Study|Adverse Event|9|||
48898411|NCT00986674|157464974|FG000|Overall Study|Death|5|||
48898412|NCT00986674|157464975|FG001|Overall Study|Death|0|||
48898413|NCT00986674|157464976|FG002|Overall Study|Death|4|||
48898414|NCT00986674|157464974|FG000|Overall Study|Withdrawal by Subject|6|||
49040438|NCT04133311|157983987|FG002|Period 1 Double Masked Treatment Period|Death|0|||
49040439|NCT04133311|157983988|FG003|Period 1 Double Masked Treatment Period|Death|0|||
49040440|NCT04133311|157983985|FG000|Period 1 Double Masked Treatment Period|Adverse Event|1|||
49040441|NCT04133311|157983986|FG001|Period 1 Double Masked Treatment Period|Adverse Event|1|||
49040442|NCT04133311|157983987|FG002|Period 1 Double Masked Treatment Period|Adverse Event|0|||
49040443|NCT04133311|157983988|FG003|Period 1 Double Masked Treatment Period|Adverse Event|0|||
49040444|NCT04133311|157983985|FG000|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
49040445|NCT04133311|157983986|FG001|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
49040446|NCT04133311|157983987|FG002|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
49040447|NCT04133311|157983988|FG003|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
49040448|NCT04133311|157983985|FG000|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
49040449|NCT04133311|157983986|FG001|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|1|||
49040450|NCT04133311|157983987|FG002|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
49040451|NCT04133311|157983988|FG003|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
49040452|NCT04133311|157983985|FG000|Period 2 Open Label Treatment Period|Adverse Event|0|||
49040453|NCT04133311|157983986|FG001|Period 2 Open Label Treatment Period|Adverse Event|0|||
49040454|NCT04133311|157983987|FG002|Period 2 Open Label Treatment Period|Adverse Event|0|||
49040455|NCT04133311|157983988|FG003|Period 2 Open Label Treatment Period|Adverse Event|2|||
48898415|NCT00986674|157464975|FG001|Overall Study|Withdrawal by Subject|2|||
48898416|NCT00986674|157464976|FG002|Overall Study|Withdrawal by Subject|1|||
48898417|NCT00986674|157464974|FG000|Overall Study|alternative therapy|0|||
48898418|NCT00986674|157464975|FG001|Overall Study|alternative therapy|0|||
48898419|NCT00986674|157464976|FG002|Overall Study|alternative therapy|1|||
48898420|NCT00986674|157464974|FG000|Overall Study|not start protocol therapy|4|||
48898421|NCT00986674|157464975|FG001|Overall Study|not start protocol therapy|3|||
48898422|NCT00986674|157464976|FG002|Overall Study|not start protocol therapy|1|||
48898423|NCT00986674|157464974|FG000|Overall Study|unknown/not specify|0|||
48898424|NCT00986674|157464975|FG001|Overall Study|unknown/not specify|7|||
48898425|NCT00986674|157464976|FG002|Overall Study|unknown/not specify|9|||
48898426|NCT00394082|157464977|FG000|Overall Study|Unacceptable toxicity|15|||
48898427|NCT00394082|157464977|FG000|Overall Study|Adverse Event|4|||
48898428|NCT00394082|157464977|FG000|Overall Study|Physician Decision|4|||
48898429|NCT00394082|157464977|FG000|Overall Study|Withdrawal by Subject|2|||
48898430|NCT00394082|157464977|FG000|Overall Study|Other|1|||
48898431|NCT01801735|157464978|FG000|Overall Study|Adverse Event|79|||
48898432|NCT01801735|157464978|FG000|Overall Study|Lack of Efficacy|28|||
48898433|NCT01801735|157464978|FG000|Overall Study|Withdrawal by Subject|27|||
48898434|NCT01801735|157464978|FG000|Overall Study|Protocol Violation|25|||
48898435|NCT01801735|157464978|FG000|Overall Study|Lost to Follow-up|15|||
48898436|NCT01801735|157464978|FG000|Overall Study|Non-compliance with Trial Drug|13|||
48898437|NCT01801735|157464978|FG000|Overall Study|Physician Decision|3|||
48898438|NCT01801735|157464978|FG000|Overall Study|Death|1|||
48898439|NCT01801735|157464978|FG000|Overall Study|Other, including site closure|19|||
48898440|NCT02344004|157464979|FG000|Overall Study|Adverse Event|11|||
48898441|NCT02344004|157464980|FG001|Overall Study|Adverse Event|1|||
48898442|NCT02344004|157464979|FG000|Overall Study|Death|9|||
48898443|NCT02344004|157464980|FG001|Overall Study|Death|7|||
48898444|NCT02344004|157464979|FG000|Overall Study|Physician Decision|4|||
48898445|NCT02344004|157464980|FG001|Overall Study|Physician Decision|1|||
48898446|NCT02344004|157464979|FG000|Overall Study|Withdrawal by Subject|22|||
48898447|NCT02344004|157464980|FG001|Overall Study|Withdrawal by Subject|5|||
48898448|NCT02344004|157464979|FG000|Overall Study|Rescue Medication|2|||
48898449|NCT02344004|157464980|FG001|Overall Study|Rescue Medication|0|||
48898450|NCT02344004|157464979|FG000|Overall Study|Other Not Specified|12|||
48898451|NCT02344004|157464980|FG001|Overall Study|Other Not Specified|0|||
48898452|NCT02344004|157464979|FG000|Overall Study|Protocol Violation|1|||
48898453|NCT02344004|157464980|FG001|Overall Study|Protocol Violation|0|||
48898454|NCT01768117|157464981|FG000|Overall Study|Lost to Follow-up|1|||
48898455|NCT01768117|157464981|FG000|Overall Study|Withdrawal by Subject|2|||
48898456|NCT01768117|157464981|FG000|Overall Study|Protocol Violation|3|||
48898457|NCT02070588|157464982|FG000|Overall Study|Withdrawal by Subject|29|||
48898458|NCT02070588|157464983|FG001|Overall Study|Withdrawal by Subject|1|||
48898459|NCT02070588|157464984|FG002|Overall Study|Withdrawal by Subject|0|||
48898460|NCT02070588|157464982|FG000|Overall Study|Writhdrawal due to early termination|9|||
48898461|NCT02070588|157464983|FG001|Overall Study|Writhdrawal due to early termination|0|||
48898462|NCT02070588|157464984|FG002|Overall Study|Writhdrawal due to early termination|0|||
48898463|NCT02070588|157464982|FG000|Overall Study|Adverse Event|1|||
48898464|NCT02070588|157464983|FG001|Overall Study|Adverse Event|0|||
48898465|NCT02070588|157464984|FG002|Overall Study|Adverse Event|0|||
49040456|NCT04133311|157983985|FG000|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
48898466|NCT00836095|157464985|FG000|Overall Study|Physician Decision|0|||
48898467|NCT00836095|157464986|FG001|Overall Study|Physician Decision|3|||
48898468|NCT01602562|157464987|FG000|Overall Study|Adverse Event|3|||
48898469|NCT01602562|157464988|FG001|Overall Study|Adverse Event|1|||
48898470|NCT01602562|157464987|FG000|Overall Study|Physician Decision|1|||
48898471|NCT01602562|157464988|FG001|Overall Study|Physician Decision|1|||
48898472|NCT01602562|157464987|FG000|Overall Study|Withdrawal by Subject|1|||
48898473|NCT01602562|157464988|FG001|Overall Study|Withdrawal by Subject|1|||
48898474|NCT01718353|157464989|FG000|Overall Study|Lost to Follow-up|0|||
48898475|NCT01718353|157464990|FG001|Overall Study|Lost to Follow-up|1|||
48898476|NCT01718353|157464989|FG000|Overall Study|Principal Investigator's Decision|10|||
48898477|NCT01718353|157464990|FG001|Overall Study|Principal Investigator's Decision|4|||
48898478|NCT01718353|157464989|FG000|Overall Study|Randomized but not treated|2|||
48898479|NCT01718353|157464990|FG001|Overall Study|Randomized but not treated|0|||
48898480|NCT00190749|157464999|FG000|Overall Study|Lost to Follow-up|8|||
48898481|NCT00190749|157465000|FG001|Overall Study|Lost to Follow-up|11|||
48898482|NCT00190749|157464999|FG000|Overall Study|Withdrawal by Subject|10|||
48898483|NCT00190749|157465000|FG001|Overall Study|Withdrawal by Subject|6|||
48898484|NCT00190749|157464999|FG000|Overall Study|Protocol Violation|5|||
48898485|NCT00190749|157465000|FG001|Overall Study|Protocol Violation|4|||
48898486|NCT00190749|157464999|FG000|Overall Study|Adverse Event|0|||
48898487|NCT00190749|157465000|FG001|Overall Study|Adverse Event|5|||
48898488|NCT00190749|157464999|FG000|Overall Study|Lack of Efficacy|2|||
48898489|NCT00190749|157465000|FG001|Overall Study|Lack of Efficacy|3|||
48898490|NCT00190749|157464999|FG000|Overall Study|Reason Not Specified|0|||
48898491|NCT00190749|157465000|FG001|Overall Study|Reason Not Specified|2|||
48898492|NCT00190749|157464999|FG000|Overall Study|Sponsor Decision|1|||
48898493|NCT00190749|157465000|FG001|Overall Study|Sponsor Decision|0|||
48898494|NCT01090427|157465001|FG000|After Controlled Period|Death|0|||
48898495|NCT01090427|157465002|FG001|After Controlled Period|Death|0|||
48898496|NCT01090427|157465003|FG002|After Controlled Period|Death|0|||
48898497|NCT01090427|157465004|FG003|After Controlled Period|Death|0|||
48898498|NCT01090427|157465005|FG004|After Controlled Period|Death|0|||
48898499|NCT01090427|157465006|FG005|After Controlled Period|Death|1|||
48898500|NCT01090427|157465007|FG006|After Controlled Period|Death|0|||
48898501|NCT01090427|157465001|FG000|After Controlled Period|Lack of Efficacy|0|||
48898502|NCT01090427|157465002|FG001|After Controlled Period|Lack of Efficacy|0|||
48898503|NCT01090427|157465003|FG002|After Controlled Period|Lack of Efficacy|0|||
48898504|NCT01090427|157465004|FG003|After Controlled Period|Lack of Efficacy|0|||
48898505|NCT01090427|157465005|FG004|After Controlled Period|Lack of Efficacy|0|||
48898506|NCT01090427|157465006|FG005|After Controlled Period|Lack of Efficacy|3|||
48898507|NCT01090427|157465007|FG006|After Controlled Period|Lack of Efficacy|2|||
49040457|NCT04133311|157983986|FG001|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
49040458|NCT04133311|157983987|FG002|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
49040459|NCT04133311|157983988|FG003|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
49040460|NCT04133311|157983985|FG000|Period 2 Open Label Treatment Period|Pregnancy|0|||
49040461|NCT04133311|157983986|FG001|Period 2 Open Label Treatment Period|Pregnancy|0|||
49040462|NCT04133311|157983987|FG002|Period 2 Open Label Treatment Period|Pregnancy|1|||
49040463|NCT04133311|157983988|FG003|Period 2 Open Label Treatment Period|Pregnancy|0|||
49040464|NCT04133311|157983985|FG000|Period 2 Open Label Treatment Period|Early Termination|0|||
49040465|NCT04133311|157983986|FG001|Period 2 Open Label Treatment Period|Early Termination|0|||
49040466|NCT04133311|157983987|FG002|Period 2 Open Label Treatment Period|Early Termination|1|||
49040467|NCT04133311|157983988|FG003|Period 2 Open Label Treatment Period|Early Termination|0|||
49040468|NCT02471807|157983991|FG000|Overall Study|Death|14|||
49040469|NCT02471807|157983991|FG000|Overall Study|Withdrawal by Subject|2|||
49040470|NCT02471807|157983991|FG000|Overall Study|Explant|5|||
49040471|NCT02471807|157983991|FG000|Overall Study|Lost to Follow-up|1|||
49040472|NCT01120028|157983994|FG000|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
49040473|NCT01120028|157983995|FG001|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5|||
49040474|NCT01120028|157983996|FG002|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
49040475|NCT01120028|157983997|FG003|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
49040476|NCT01120028|157983994|FG000|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14|||
49040477|NCT01120028|157983995|FG001|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18|||
49040478|NCT01120028|157983996|FG002|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
49040479|NCT01120028|157983997|FG003|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
49040480|NCT00728754|157983998|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
48898508|NCT01090427|157465001|FG000|After Controlled Period|Adverse Event|0|||
48898509|NCT01090427|157465002|FG001|After Controlled Period|Adverse Event|0|||
48898510|NCT01090427|157465003|FG002|After Controlled Period|Adverse Event|0|||
48898511|NCT01090427|157465004|FG003|After Controlled Period|Adverse Event|2|||
48898512|NCT01090427|157465005|FG004|After Controlled Period|Adverse Event|0|||
48898513|NCT01090427|157465006|FG005|After Controlled Period|Adverse Event|1|||
48898514|NCT01090427|157465007|FG006|After Controlled Period|Adverse Event|0|||
48898515|NCT01154010|157465008|FG000|Overall Study|Lost to Follow-up|0|||
48898516|NCT01154010|157465009|FG001|Overall Study|Lost to Follow-up|1|||
48898517|NCT01959334|157465012|FG000|Second Dose|Adverse Event|1|||
48898518|NCT01959334|157465013|FG001|Second Dose|Adverse Event|0|||
48898519|NCT01959334|157465012|FG000|Third Dose|Adverse Event|0|||
48898520|NCT01959334|157465013|FG001|Third Dose|Adverse Event|1|||
48898521|NCT01465347|157465016|FG000|Overall Study|Withdrawal by Subject|1|||
48898522|NCT01465347|157465017|FG001|Overall Study|Withdrawal by Subject|1|||
48898523|NCT01465347|157465016|FG000|Overall Study|Physician Decision|0|||
48898524|NCT01465347|157465017|FG001|Overall Study|Physician Decision|1|||
48898525|NCT01465347|157465016|FG000|Overall Study|Admitted to hospice|0|||
48898526|NCT01465347|157465017|FG001|Overall Study|Admitted to hospice|1|||
48898527|NCT01048671|157465018|FG000|Overall Study|Protocol Violation|0|||
48898528|NCT01048671|157465019|FG001|Overall Study|Protocol Violation|1|||
48898529|NCT01048671|157465020|FG002|Overall Study|Protocol Violation|1|||
48898530|NCT05249829|157465021|FG000|Overall Study|Participant Relocation|0|||
48898531|NCT05249829|157465022|FG001|Overall Study|Participant Relocation|1|||
48898532|NCT05249829|157465023|FG002|Overall Study|Participant Relocation|2|||
48898533|NCT05249829|157465024|FG003|Overall Study|Participant Relocation|2|||
48898534|NCT05249829|157465021|FG000|Overall Study|Withdrawal by Subject|9|||
48898535|NCT05249829|157465022|FG001|Overall Study|Withdrawal by Subject|17|||
48898536|NCT05249829|157465023|FG002|Overall Study|Withdrawal by Subject|40|||
48898537|NCT05249829|157465024|FG003|Overall Study|Withdrawal by Subject|35|||
48898538|NCT05249829|157465021|FG000|Overall Study|Physician Decision|1|||
48898539|NCT05249829|157465022|FG001|Overall Study|Physician Decision|0|||
48898540|NCT05249829|157465023|FG002|Overall Study|Physician Decision|0|||
48898541|NCT05249829|157465024|FG003|Overall Study|Physician Decision|0|||
48898542|NCT05249829|157465021|FG000|Overall Study|Lost to Follow-up|16|||
48898543|NCT05249829|157465022|FG001|Overall Study|Lost to Follow-up|16|||
48898544|NCT05249829|157465023|FG002|Overall Study|Lost to Follow-up|57|||
48898545|NCT05249829|157465024|FG003|Overall Study|Lost to Follow-up|60|||
48898546|NCT05249829|157465021|FG000|Overall Study|Adverse Event|2|||
48898547|NCT05249829|157465022|FG001|Overall Study|Adverse Event|2|||
48898548|NCT05249829|157465023|FG002|Overall Study|Adverse Event|2|||
48898549|NCT05249829|157465024|FG003|Overall Study|Adverse Event|2|||
48898550|NCT05249829|157465021|FG000|Overall Study|COVID-19 Non-Infection Related|0|||
48898551|NCT05249829|157465022|FG001|Overall Study|COVID-19 Non-Infection Related|0|||
48898552|NCT05249829|157465023|FG002|Overall Study|COVID-19 Non-Infection Related|0|||
48898553|NCT05249829|157465024|FG003|Overall Study|COVID-19 Non-Infection Related|1|||
48898554|NCT05249829|157465021|FG000|Overall Study|Protocol Violation|2|||
48898555|NCT05249829|157465022|FG001|Overall Study|Protocol Violation|0|||
48898556|NCT05249829|157465023|FG002|Overall Study|Protocol Violation|5|||
48898557|NCT05249829|157465024|FG003|Overall Study|Protocol Violation|3|||
48898558|NCT05249829|157465021|FG000|Overall Study|Death|0|||
48898559|NCT05249829|157465022|FG001|Overall Study|Death|1|||
48898560|NCT05249829|157465023|FG002|Overall Study|Death|2|||
48898561|NCT05249829|157465024|FG003|Overall Study|Death|4|||
48898562|NCT02649946|157465025|FG000|Overall Study|Withdrawal by Subject|1|||
48898563|NCT02649946|157465026|FG001|Overall Study|Withdrawal by Subject|1|||
48898564|NCT02649946|157465025|FG000|Overall Study|Death|7|||
48898565|NCT02649946|157465026|FG001|Overall Study|Death|9|||
48898566|NCT02649946|157465025|FG000|Overall Study|Physician Decision|1|||
48898567|NCT02649946|157465026|FG001|Overall Study|Physician Decision|0|||
48898568|NCT02649946|157465025|FG000|Overall Study|Lost to Follow-up|2|||
48898569|NCT02649946|157465026|FG001|Overall Study|Lost to Follow-up|1|||
48898570|NCT02649946|157465025|FG000|Overall Study|Erroneously enrolled|1|||
48898571|NCT02649946|157465026|FG001|Overall Study|Erroneously enrolled|0|||
48898572|NCT02649946|157465025|FG000|Overall Study|Missed 6-month follow-up visit|0|||
48898573|NCT02649946|157465026|FG001|Overall Study|Missed 6-month follow-up visit|4|||
48898574|NCT01209780|157465027|FG000|Overall Study|Adverse Event|0|||
48898575|NCT01209780|157465028|FG001|Overall Study|Adverse Event|1|||
48898576|NCT01209780|157465029|FG002|Overall Study|Adverse Event|0|||
48898577|NCT01209780|157465030|FG003|Overall Study|Adverse Event|0|||
48898578|NCT01209780|157465031|FG004|Overall Study|Adverse Event|0|||
48898579|NCT01209780|157465027|FG000|Overall Study|Withdrawal by Subject|9|||
48898580|NCT01209780|157465028|FG001|Overall Study|Withdrawal by Subject|2|||
48898581|NCT01209780|157465029|FG002|Overall Study|Withdrawal by Subject|1|||
48898582|NCT01209780|157465030|FG003|Overall Study|Withdrawal by Subject|1|||
48898583|NCT01209780|157465031|FG004|Overall Study|Withdrawal by Subject|0|||
48898584|NCT01209780|157465027|FG000|Overall Study|Lost to Follow-up|17|||
48898585|NCT01209780|157465028|FG001|Overall Study|Lost to Follow-up|12|||
48898586|NCT01209780|157465029|FG002|Overall Study|Lost to Follow-up|3|||
48898587|NCT01209780|157465030|FG003|Overall Study|Lost to Follow-up|9|||
48898588|NCT01209780|157465031|FG004|Overall Study|Lost to Follow-up|4|||
48898589|NCT01209780|157465027|FG000|Overall Study|Protocol Violation|0|||
48898590|NCT01209780|157465028|FG001|Overall Study|Protocol Violation|1|||
48898591|NCT01209780|157465029|FG002|Overall Study|Protocol Violation|0|||
48898592|NCT01209780|157465030|FG003|Overall Study|Protocol Violation|0|||
48898593|NCT01209780|157465031|FG004|Overall Study|Protocol Violation|0|||
48898594|NCT01209780|157465027|FG000|Overall Study|Inappropriate enrollment|0|||
48898595|NCT01209780|157465028|FG001|Overall Study|Inappropriate enrollment|2|||
48898596|NCT01209780|157465029|FG002|Overall Study|Inappropriate enrollment|0|||
48898597|NCT01209780|157465030|FG003|Overall Study|Inappropriate enrollment|0|||
48898598|NCT01209780|157465031|FG004|Overall Study|Inappropriate enrollment|1|||
48898599|NCT00679627|157465032|FG000|Overall Study|Death|41|||
48898600|NCT00679627|157465033|FG001|Overall Study|Death|29|||
48898601|NCT00679627|157465032|FG000|Overall Study|Adverse Event|43|||
48898602|NCT00679627|157465033|FG001|Overall Study|Adverse Event|53|||
48898603|NCT00679627|157465032|FG000|Overall Study|Withdrawal by Subject|168|||
48898604|NCT00679627|157465033|FG001|Overall Study|Withdrawal by Subject|172|||
48898605|NCT00679627|157465032|FG000|Overall Study|Lost to Follow-up|22|||
48898606|NCT00679627|157465033|FG001|Overall Study|Lost to Follow-up|26|||
48898607|NCT00679627|157465032|FG000|Overall Study|Early Study Closure|425|||
48898608|NCT00679627|157465033|FG001|Overall Study|Early Study Closure|405|||
48898609|NCT01886378|157465036|FG000|Overall Study|Adverse Event|1|||
48898610|NCT01886378|157465036|FG000|Overall Study|Withdrawal by Subject|4|||
48898611|NCT01285609|157465037|FG000|Randomized|Progressive Disease|41|||
48898612|NCT01285609|157465038|FG001|Randomized|Progressive Disease|61|||
48898613|NCT01285609|157465037|FG000|Randomized|Adverse Event Unrelated to Study Drug|18|||
48898614|NCT01285609|157465038|FG001|Randomized|Adverse Event Unrelated to Study Drug|18|||
48898615|NCT01285609|157465037|FG000|Randomized|Study Drug Toxicity|13|||
48898616|NCT01285609|157465038|FG001|Randomized|Study Drug Toxicity|14|||
48898617|NCT01285609|157465037|FG000|Randomized|Death|5|||
48898618|NCT01285609|157465038|FG001|Randomized|Death|7|||
48898619|NCT01285609|157465037|FG000|Randomized|Withdrawal by Subject|8|||
48898620|NCT01285609|157465038|FG001|Randomized|Withdrawal by Subject|11|||
48898621|NCT01285609|157465037|FG000|Randomized|Subject No Longer Met Study Criteria|1|||
48898622|NCT01285609|157465038|FG001|Randomized|Subject No Longer Met Study Criteria|1|||
48898623|NCT01285609|157465037|FG000|Randomized|Undisclosed Reasons|1|||
48898624|NCT01285609|157465038|FG001|Randomized|Undisclosed Reasons|0|||
48898625|NCT01285609|157465037|FG000|Randomized|Randomized but not Treated|4|||
48898626|NCT01285609|157465038|FG001|Randomized|Randomized but not Treated|4|||
48898627|NCT01285609|157465037|FG000|Treated With Blinded Therapy|Progressive Disease|223|||
48898628|NCT01285609|157465038|FG001|Treated With Blinded Therapy|Progressive Disease|305|||
48898629|NCT01285609|157465037|FG000|Treated With Blinded Therapy|Study Drug Toxicity|87|||
48898630|NCT01285609|157465038|FG001|Treated With Blinded Therapy|Study Drug Toxicity|14|||
49040481|NCT00728754|157983999|FG001|Permanent Prosthesis Placement|Adverse Event|1|||
49040482|NCT00728754|157983998|FG000|Permanent Prosthesis Placement|Lost to Follow-up|3|||
49040483|NCT00728754|157983999|FG001|Permanent Prosthesis Placement|Lost to Follow-up|3|||
49040484|NCT00728754|157983998|FG000|One Year Post Placement Follow-up|Adverse Event|1|||
49040485|NCT00728754|157983999|FG001|One Year Post Placement Follow-up|Adverse Event|0|||
49040486|NCT01859598|157984000|FG000|Visit 2 at 3 Months|Lost to Follow-up|1742|||
49040487|NCT02654145|157984005|FG000|Overall Study|Lack of Efficacy|1|||
49040488|NCT02654145|157984005|FG000|Overall Study|Protocol Violation|1|||
49040489|NCT02654145|157984005|FG000|Overall Study|Withdrawal by Subject|5|||
49040490|NCT00009945|157984006|FG000|Overall Study|no follow up data|7|||
49040491|NCT00009945|157984007|FG001|Overall Study|no follow up data|5|||
49040492|NCT02611362|157984013|FG000|Overall Study|Withdrawal by Subject|7|||
49040493|NCT02611362|157984014|FG001|Overall Study|Withdrawal by Subject|2|||
49040494|NCT02611362|157984013|FG000|Overall Study|Lost to Follow-up|2|||
49040495|NCT02611362|157984014|FG001|Overall Study|Lost to Follow-up|4|||
49040496|NCT00354159|157984017|FG000|Randomized Study Period|Withdrawal by Subject|5|||
49040497|NCT00354159|157984018|FG001|Randomized Study Period|Withdrawal by Subject|3|||
49040498|NCT00354159|157984017|FG000|Randomized Study Period|Physician Decision|6|||
49040499|NCT00354159|157984018|FG001|Randomized Study Period|Physician Decision|10|||
49040500|NCT00354159|157984017|FG000|Randomized Study Period|Lost to Follow-up|4|||
49040501|NCT00354159|157984018|FG001|Randomized Study Period|Lost to Follow-up|0|||
49040502|NCT00354159|157984017|FG000|Randomized Study Period|Death|7|||
49040503|NCT00354159|157984018|FG001|Randomized Study Period|Death|9|||
49040504|NCT00354159|157984017|FG000|Long-term Follow-up|Withdrawal by Subject|9|||
49040505|NCT00354159|157984018|FG001|Long-term Follow-up|Withdrawal by Subject|9|||
49040506|NCT00354159|157984017|FG000|Long-term Follow-up|Physician Decision|127|||
49040507|NCT00354159|157984018|FG001|Long-term Follow-up|Physician Decision|122|||
49040508|NCT00354159|157984017|FG000|Long-term Follow-up|Lost to Follow-up|1|||
49040509|NCT00354159|157984018|FG001|Long-term Follow-up|Lost to Follow-up|0|||
49040510|NCT00354159|157984017|FG000|Long-term Follow-up|Death|14|||
49040511|NCT00354159|157984018|FG001|Long-term Follow-up|Death|11|||
49040512|NCT00354159|157984017|FG000|Long-term Follow-up|Study Closed|29|||
48898631|NCT01285609|157465037|FG000|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36|||
48898632|NCT01285609|157465038|FG001|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14|||
48898633|NCT01285609|157465037|FG000|Treated With Blinded Therapy|Withdrawal by Subject|20|||
48898634|NCT01285609|157465038|FG001|Treated With Blinded Therapy|Withdrawal by Subject|7|||
48898635|NCT01285609|157465037|FG000|Treated With Blinded Therapy|Death|11|||
49040513|NCT00354159|157984018|FG001|Long-term Follow-up|Study Closed|34|||
49040514|NCT02046122|157984019|FG000|Overall Study|Physician Decision|8|||
49040515|NCT02046122|157984019|FG000|Overall Study|Withdrawal by Subject|1|||
49040516|NCT01559116|157984024|FG000|Overall Study|Adverse Event|10|||
49040517|NCT01559116|157984024|FG000|Overall Study|Lack of Efficacy|1|||
49040518|NCT01559116|157984024|FG000|Overall Study|Lost to Follow-up|1|||
48898636|NCT01285609|157465038|FG001|Treated With Blinded Therapy|Death|3|||
48898637|NCT01285609|157465037|FG000|Treated With Blinded Therapy|Maximum Clinical Benefit|2|||
48898638|NCT01285609|157465038|FG001|Treated With Blinded Therapy|Maximum Clinical Benefit|4|||
48898639|NCT01285609|157465037|FG000|Treated With Blinded Therapy|Not Reported|0|||
48898640|NCT01285609|157465038|FG001|Treated With Blinded Therapy|Not Reported|2|||
48898641|NCT01285609|157465037|FG000|Treated With Blinded Therapy|Poor/Non-Compliance|1|||
48898642|NCT01285609|157465038|FG001|Treated With Blinded Therapy|Poor/Non-Compliance|2|||
48898643|NCT01285609|157465037|FG000|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1|||
48898644|NCT01285609|157465038|FG001|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0|||
48898645|NCT01285609|157465037|FG000|Treated With Blinded Therapy|Administrative Reason by Sponsor|1|||
48898646|NCT01285609|157465038|FG001|Treated With Blinded Therapy|Administrative Reason by Sponsor|3|||
48898647|NCT01285609|157465037|FG000|Treated With Blinded Therapy|Physician and Patient decision|1|||
48898648|NCT01285609|157465038|FG001|Treated With Blinded Therapy|Physician and Patient decision|3|||
48898649|NCT01285609|157465037|FG000|Treated With Blinded Therapy|Participant refused participation|1|||
48898650|NCT01285609|157465038|FG001|Treated With Blinded Therapy|Participant refused participation|0|||
48898651|NCT01285609|157465037|FG000|Treated With Blinded Therapy|Participant started radiotherapy|1|||
48898652|NCT01285609|157465038|FG001|Treated With Blinded Therapy|Participant started radiotherapy|0|||
48898653|NCT01285609|157465037|FG000|Treated With Blinded Therapy|Participant hospitalized|1|||
48898654|NCT01285609|157465038|FG001|Treated With Blinded Therapy|Participant hospitalized|0|||
48898655|NCT01285609|157465037|FG000|Treated With Blinded Therapy|Investigator's assessment|1|||
48898656|NCT01285609|157465038|FG001|Treated With Blinded Therapy|Investigator's assessment|0|||
48898657|NCT01285609|157465037|FG000|Treated With Blinded Therapy|PI decision to discontinue|0|||
48898658|NCT01285609|157465038|FG001|Treated With Blinded Therapy|PI decision to discontinue|1|||
48984429|NCT01241318|157774201|FG001|Overall Study|Woman: Stillborn infant|146|||
49040519|NCT01559116|157984024|FG000|Overall Study|Protocol Violation|1|||
49040520|NCT01559116|157984024|FG000|Overall Study|Withdrawal by Subject|4|||
49040521|NCT01559116|157984024|FG000|Overall Study|other than stated above|9|||
49040522|NCT02227238|157984025|FG000|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
49040523|NCT02227238|157984026|FG001|Randomized Phase (Up to Week 52)|Reached stopping criteria|1|||
49040524|NCT02227238|157984027|FG002|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
49040525|NCT02227238|157984025|FG000|Randomized Phase (Up to Week 52)|Adverse Event|8|||
49040526|NCT02227238|157984026|FG001|Randomized Phase (Up to Week 52)|Adverse Event|18|||
49040527|NCT02227238|157984027|FG002|Randomized Phase (Up to Week 52)|Adverse Event|0|||
49040528|NCT02227238|157984025|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|10|||
49040529|NCT02227238|157984026|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|22|||
49040530|NCT02227238|157984027|FG002|Randomized Phase (Up to Week 52)|Lack of Efficacy|0|||
49040531|NCT02227238|157984025|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|7|||
49040532|NCT02227238|157984026|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|8|||
49040533|NCT02227238|157984027|FG002|Randomized Phase (Up to Week 52)|Protocol Violation|0|||
49040534|NCT02227238|157984025|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|5|||
49040535|NCT02227238|157984026|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|4|||
49040536|NCT02227238|157984027|FG002|Randomized Phase (Up to Week 52)|Withdrawal by Subject|0|||
49040537|NCT02227238|157984025|FG000|Randomized Phase (Up to Week 52)|Physician Decision|0|||
49040538|NCT02227238|157984026|FG001|Randomized Phase (Up to Week 52)|Physician Decision|9|||
49040539|NCT02227238|157984027|FG002|Randomized Phase (Up to Week 52)|Physician Decision|0|||
49040540|NCT02227238|157984025|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|7|||
49040541|NCT02227238|157984026|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|5|||
48984430|NCT01852591|157774203|FG000|Overall Study|Withdrawal by Subject|2|||
48984431|NCT01852591|157774203|FG000|Overall Study|Not Evaluable at Time of Analysis|1|||
48984432|NCT02994927|157774204|FG000|Overall Study|Withdrawal by parent/guardian|0|||
48984433|NCT02994927|157774205|FG001|Overall Study|Withdrawal by parent/guardian|1|||
48984434|NCT02994927|157774204|FG000|Overall Study|Did not meet eligibility criteria|0|||
48984435|NCT02994927|157774205|FG001|Overall Study|Did not meet eligibility criteria|1|||
48984436|NCT02994927|157774204|FG000|Overall Study|Physician Decision|4|||
48984437|NCT02994927|157774205|FG001|Overall Study|Physician Decision|3|||
48984438|NCT02994927|157774204|FG000|Overall Study|Death|4|||
48984439|NCT02994927|157774205|FG001|Overall Study|Death|2|||
48984440|NCT02994927|157774204|FG000|Overall Study|Adverse Event|2|||
48984441|NCT02994927|157774205|FG001|Overall Study|Adverse Event|1|||
48984442|NCT02994927|157774204|FG000|Overall Study|Withdrawal by Subject|3|||
48984443|NCT02994927|157774205|FG001|Overall Study|Withdrawal by Subject|6|||
48984444|NCT02994927|157774204|FG000|Overall Study|Lost to Follow-up|2|||
48984445|NCT02994927|157774205|FG001|Overall Study|Lost to Follow-up|1|||
48984446|NCT02993783|157774226|FG000|Overall Study|Reason not Specified|6|||
48984447|NCT02993783|157774227|FG001|Overall Study|Reason not Specified|9|||
48984448|NCT03395704|157774228|FG000|Overall Study|Adverse Event|2|||
48984449|NCT03395704|157774229|FG001|Overall Study|Adverse Event|1|||
48984450|NCT03395704|157774228|FG000|Overall Study|Withdrawal by Subject|2|||
48984451|NCT03395704|157774229|FG001|Overall Study|Withdrawal by Subject|1|||
49040542|NCT02227238|157984027|FG002|Randomized Phase (Up to Week 52)|Lost to Follow-up|0|||
49040543|NCT02227238|157984025|FG000|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
49040544|NCT02227238|157984026|FG001|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|3|||
49040545|NCT02227238|157984027|FG002|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
49040546|NCT02227238|157984025|FG000|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
49040547|NCT02227238|157984026|FG001|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
49040548|NCT02227238|157984027|FG002|Continuation Phase(From Weeks 52 to 295)|Adverse Event|8|||
49040549|NCT02227238|157984025|FG000|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
49040550|NCT02227238|157984026|FG001|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
49040551|NCT02227238|157984027|FG002|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|16|||
49040552|NCT02227238|157984025|FG000|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
49040553|NCT02227238|157984026|FG001|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
49040554|NCT02227238|157984027|FG002|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|8|||
49040555|NCT02227238|157984025|FG000|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
49040556|NCT02227238|157984026|FG001|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
49040557|NCT02227238|157984027|FG002|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|6|||
49040558|NCT02227238|157984025|FG000|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
48898659|NCT01285609|157465037|FG000|Treated With Blinded Therapy|Worsening of general condition|0|||
48898660|NCT01285609|157465038|FG001|Treated With Blinded Therapy|Worsening of general condition|1|||
48898661|NCT04822597|157465039|FG000|Overall Study|Withdrawal by Subject|0|||
48898662|NCT04822597|157465040|FG001|Overall Study|Withdrawal by Subject|1|||
48898663|NCT04822597|157465041|FG002|Overall Study|Withdrawal by Subject|1|||
48898664|NCT04822597|157465042|FG003|Overall Study|Withdrawal by Subject|0|||
48898665|NCT04822597|157465039|FG000|Overall Study|Physician Decision|0|||
48898666|NCT04822597|157465040|FG001|Overall Study|Physician Decision|0|||
48898667|NCT04822597|157465041|FG002|Overall Study|Physician Decision|1|||
48898668|NCT04822597|157465042|FG003|Overall Study|Physician Decision|1|||
48898669|NCT04822597|157465039|FG000|Overall Study|Subject withdrawn after enrollment|0|||
48898670|NCT04822597|157465040|FG001|Overall Study|Subject withdrawn after enrollment|1|||
48898671|NCT04822597|157465041|FG002|Overall Study|Subject withdrawn after enrollment|0|||
48898672|NCT04822597|157465042|FG003|Overall Study|Subject withdrawn after enrollment|1|||
48898673|NCT04822597|157465039|FG000|Overall Study|Surgery Re-scheduled, missed by study team|1|||
48898674|NCT04822597|157465040|FG001|Overall Study|Surgery Re-scheduled, missed by study team|0|||
49040559|NCT02227238|157984026|FG001|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
49040560|NCT02227238|157984027|FG002|Continuation Phase(From Weeks 52 to 295)|Physician Decision|4|||
49040561|NCT02227238|157984025|FG000|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
49040562|NCT02227238|157984026|FG001|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
49040563|NCT02227238|157984027|FG002|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|7|||
49040564|NCT03277248|157984028|FG000|Overall Study|Adverse Event|3|||
49040565|NCT03277248|157984029|FG001|Overall Study|Adverse Event|1|||
49040566|NCT03277248|157984028|FG000|Overall Study|Subject Withdrawal of Consent|6|||
49040567|NCT03277248|157984029|FG001|Overall Study|Subject Withdrawal of Consent|23|||
48898675|NCT04822597|157465041|FG002|Overall Study|Surgery Re-scheduled, missed by study team|0|||
48898676|NCT04822597|157465042|FG003|Overall Study|Surgery Re-scheduled, missed by study team|0|||
48898677|NCT03945825|157465051|FG000|Overall Study|Enrolled but treatment not administered|0|||
48898678|NCT03945825|157465052|FG001|Overall Study|Enrolled but treatment not administered|0|||
48898679|NCT03945825|157465053|FG002|Overall Study|Enrolled but treatment not administered|0|||
48898680|NCT03945825|157465054|FG003|Overall Study|Enrolled but treatment not administered|0|||
48898681|NCT03945825|157465055|FG004|Overall Study|Enrolled but treatment not administered|1|||
48898682|NCT03945825|157465056|FG005|Overall Study|Enrolled but treatment not administered|0|||
48898683|NCT03945825|157465051|FG000|Overall Study|Lost to Follow-up|1|||
48898684|NCT03945825|157465052|FG001|Overall Study|Lost to Follow-up|5|||
48898685|NCT03945825|157465053|FG002|Overall Study|Lost to Follow-up|0|||
48898686|NCT03945825|157465054|FG003|Overall Study|Lost to Follow-up|1|||
48898687|NCT03945825|157465055|FG004|Overall Study|Lost to Follow-up|2|||
48898688|NCT03945825|157465056|FG005|Overall Study|Lost to Follow-up|2|||
48898689|NCT03945825|157465051|FG000|Overall Study|Withdrawal by Subject|1|||
48898690|NCT03945825|157465052|FG001|Overall Study|Withdrawal by Subject|0|||
48898691|NCT03945825|157465053|FG002|Overall Study|Withdrawal by Subject|1|||
48898692|NCT03945825|157465054|FG003|Overall Study|Withdrawal by Subject|1|||
48898693|NCT03945825|157465055|FG004|Overall Study|Withdrawal by Subject|0|||
48898694|NCT03945825|157465056|FG005|Overall Study|Withdrawal by Subject|1|||
48898695|NCT02571049|157465059|FG000|Screening|Did not meet entry criteria|2|||
48898696|NCT02571049|157465060|FG001|Screening|Did not meet entry criteria|2|||
48898697|NCT02571049|157465059|FG000|Randomization|No migraine attack|0|||
48898698|NCT02571049|157465060|FG001|Randomization|No migraine attack|1|||
48898699|NCT02571049|157465059|FG000|Randomization|Adverse Event|0|||
48898700|NCT02571049|157465060|FG001|Randomization|Adverse Event|1|||
48898701|NCT04161495|157465061|FG000|Overall Study|Withdrawal by Subject|3|||
49040568|NCT03277248|157984028|FG000|Overall Study|Investigator/Sponsor Decision|2|||
49040569|NCT03277248|157984029|FG001|Overall Study|Investigator/Sponsor Decision|2|||
49040570|NCT03277248|157984028|FG000|Overall Study|Pregnancy|4|||
49040571|NCT03277248|157984029|FG001|Overall Study|Pregnancy|1|||
49040572|NCT03277248|157984028|FG000|Overall Study|Lost to Follow-up|0|||
49040573|NCT03277248|157984029|FG001|Overall Study|Lost to Follow-up|2|||
49040574|NCT03277248|157984028|FG000|Overall Study|Lack of Efficacy|0|||
49040575|NCT03277248|157984029|FG001|Overall Study|Lack of Efficacy|2|||
49040576|NCT03277248|157984028|FG000|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
49040577|NCT03277248|157984029|FG001|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
49040578|NCT00950300|157984030|FG000|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6|||
49040579|NCT00950300|157984031|FG001|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15|||
49040580|NCT00950300|157984030|FG000|Neoadjuvant/Adjuvant Treatment Periods|Death|1|||
49040581|NCT00950300|157984031|FG001|Neoadjuvant/Adjuvant Treatment Periods|Death|3|||
49040582|NCT00950300|157984030|FG000|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3|||
49040583|NCT00950300|157984031|FG001|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0|||
49040584|NCT00950300|157984030|FG000|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2|||
49040585|NCT00950300|157984031|FG001|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1|||
49040586|NCT00950300|157984030|FG000|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1|||
49040587|NCT00950300|157984031|FG001|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0|||
49040588|NCT00950300|157984030|FG000|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4|||
49040589|NCT00950300|157984031|FG001|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5|||
49040590|NCT00950300|157984030|FG000|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2|||
49040591|NCT00950300|157984031|FG001|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1|||
49040592|NCT00950300|157984030|FG000|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12|||
49040593|NCT00950300|157984031|FG001|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11|||
49040594|NCT00950300|157984030|FG000|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10|||
49040595|NCT00950300|157984031|FG001|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5|||
49040596|NCT00950300|157984030|FG000|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
49040597|NCT00950300|157984031|FG001|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
49040598|NCT00950300|157984030|FG000|TFFU Period|Adverse Event or Intercurrent Illness|3|||
49040599|NCT00950300|157984031|FG001|TFFU Period|Adverse Event or Intercurrent Illness|4|||
49040600|NCT00950300|157984030|FG000|TFFU Period|Death|4|||
49040601|NCT00950300|157984031|FG001|TFFU Period|Death|1|||
49040602|NCT00950300|157984030|FG000|TFFU Period|Refused Treatment|10|||
49040603|NCT00950300|157984031|FG001|TFFU Period|Refused Treatment|11|||
49040604|NCT00950300|157984030|FG000|TFFU Period|Failure to Return|16|||
49040605|NCT00950300|157984031|FG001|TFFU Period|Failure to Return|16|||
49040606|NCT00950300|157984030|FG000|TFFU Period|Recurrence of Disease|63|||
49040607|NCT00950300|157984031|FG001|TFFU Period|Recurrence of Disease|72|||
49040608|NCT00950300|157984030|FG000|TFFU Period|Other|4|||
49040609|NCT00950300|157984031|FG001|TFFU Period|Other|3|||
49040610|NCT00950300|157984030|FG000|SFU Period|Death|44|||
49040611|NCT00950300|157984031|FG001|SFU Period|Death|42|||
49040612|NCT00950300|157984030|FG000|SFU Period|Lost to Follow-up|30|||
49040613|NCT00950300|157984031|FG001|SFU Period|Lost to Follow-up|28|||
49040614|NCT00950300|157984030|FG000|SFU Period|Withdrawal by Subject|4|||
49040615|NCT00950300|157984031|FG001|SFU Period|Withdrawal by Subject|8|||
49040616|NCT02011945|157984032|FG000|Overall Study|Participant requested to Discontinue|0|||
49040617|NCT02011945|157984033|FG001|Overall Study|Participant requested to Discontinue|1|||
49040618|NCT02011945|157984034|FG002|Overall Study|Participant requested to Discontinue|1|||
48984452|NCT03395704|157774228|FG000|Overall Study|Physician Decision|0|||
48984453|NCT03395704|157774229|FG001|Overall Study|Physician Decision|1|||
48984454|NCT00266695|157774230|FG000|Overall Study|Adverse Event|1|||
48984455|NCT00266695|157774230|FG000|Overall Study|Death|9|||
48984456|NCT00266695|157774230|FG000|Overall Study|Physician Decision|1|||
48984457|NCT00266695|157774230|FG000|Overall Study|Lost to Follow-up|3|||
48984458|NCT00266695|157774230|FG000|Overall Study|Withdrawal by Subject|15|||
48984459|NCT00606021|157774231|FG000|Induction Phase|Death|73|||
48984460|NCT00606021|157774232|FG001|Induction Phase|Death|0|||
48984461|NCT00606021|157774233|FG002|Induction Phase|Death|0|||
48984462|NCT00606021|157774231|FG000|Induction Phase|Physician Decision|2|||
48984463|NCT00606021|157774232|FG001|Induction Phase|Physician Decision|0|||
48984464|NCT00606021|157774233|FG002|Induction Phase|Physician Decision|0|||
48984465|NCT00606021|157774231|FG000|Induction Phase|Withdrawal by Subject|2|||
48984466|NCT00606021|157774232|FG001|Induction Phase|Withdrawal by Subject|0|||
48984467|NCT00606021|157774233|FG002|Induction Phase|Withdrawal by Subject|0|||
48984468|NCT00606021|157774231|FG000|Induction Phase|Lost to Follow-up|10|||
48984469|NCT00606021|157774232|FG001|Induction Phase|Lost to Follow-up|0|||
48984470|NCT00606021|157774233|FG002|Induction Phase|Lost to Follow-up|0|||
48984471|NCT00606021|157774231|FG000|Maintenance Phase|Death|0|||
48984472|NCT00606021|157774232|FG001|Maintenance Phase|Death|17|||
48984473|NCT00606021|157774233|FG002|Maintenance Phase|Death|15|||
48898702|NCT04161495|157465062|FG001|Overall Study|Withdrawal by Subject|0|||
48898703|NCT04161495|157465061|FG000|Overall Study|Protocol Violation|1|||
48898704|NCT04161495|157465062|FG001|Overall Study|Protocol Violation|0|||
48898705|NCT04161495|157465061|FG000|Overall Study|Prohibited concomitant medication|3|||
48898706|NCT04161495|157465062|FG001|Overall Study|Prohibited concomitant medication|0|||
48898707|NCT04161495|157465061|FG000|Overall Study|Adverse Event|1|||
48898708|NCT04161495|157465062|FG001|Overall Study|Adverse Event|0|||
48898709|NCT04161495|157465061|FG000|Overall Study|Other - Unspecified|1|||
48898710|NCT04161495|157465062|FG001|Overall Study|Other - Unspecified|0|||
48898711|NCT04161495|157465061|FG000|Overall Study|Death|0|||
48898712|NCT04161495|157465062|FG001|Overall Study|Death|1|||
48898713|NCT01536015|157465063|FG000|Overall Study|Adverse Event|1|||
48898714|NCT01536015|157465064|FG001|Overall Study|Adverse Event|4|||
48898715|NCT01536015|157465063|FG000|Overall Study|Lost to Follow-up|0|||
48898716|NCT01536015|157465064|FG001|Overall Study|Lost to Follow-up|1|||
48898717|NCT01536015|157465063|FG000|Overall Study|Inclusion Criterion not met|2|||
48898718|NCT01536015|157465064|FG001|Overall Study|Inclusion Criterion not met|0|||
48898719|NCT01536015|157465063|FG000|Overall Study|Study closure|5|||
48898720|NCT01536015|157465064|FG001|Overall Study|Study closure|5|||
48898721|NCT03110185|157465067|FG000|Overall Study|Death|0|||
48898722|NCT03110185|157465068|FG001|Overall Study|Death|1|||
48898723|NCT03110185|157465067|FG000|Overall Study|Withdrawal by Subject|2|||
48898724|NCT03110185|157465068|FG001|Overall Study|Withdrawal by Subject|7|||
48898725|NCT03110185|157465067|FG000|Overall Study|Time Constraints|0|||
48898726|NCT03110185|157465068|FG001|Overall Study|Time Constraints|6|||
48898727|NCT03110185|157465067|FG000|Overall Study|Conflict with care|5|||
48898728|NCT03110185|157465068|FG001|Overall Study|Conflict with care|12|||
48898729|NCT03110185|157465067|FG000|Overall Study|Protocol Violation|1|||
48898730|NCT03110185|157465068|FG001|Overall Study|Protocol Violation|4|||
48898731|NCT03110185|157465067|FG000|Overall Study|MRI Incompatible|2|||
48898732|NCT03110185|157465068|FG001|Overall Study|MRI Incompatible|0|||
48898733|NCT03110185|157465067|FG000|Overall Study|Patient Refusal|0|||
48898734|NCT03110185|157465068|FG001|Overall Study|Patient Refusal|1|||
48898735|NCT02988622|157465069|FG000|Overall Study|Lost to Follow-up|17|||
48898736|NCT03562247|157465070|FG000|Overall Study|Lost to Follow-up|3|||
48898737|NCT03562247|157465071|FG001|Overall Study|Lost to Follow-up|1|||
48898738|NCT03562247|157465072|FG002|Overall Study|Lost to Follow-up|1|||
48898739|NCT00983931|157465073|FG000|14 Day Washout Period|Physician Decision|1|||
48898740|NCT03075410|157465074|FG000|Part A-Period 2 (14 Days)|Personal reasons|1|||
48898741|NCT03075410|157465075|FG001|Part A-Period 2 (14 Days)|Personal reasons|0|||
48898742|NCT03075410|157465076|FG002|Part A-Period 2 (14 Days)|Personal reasons|1|||
48898743|NCT03075410|157465077|FG003|Part A-Period 2 (14 Days)|Personal reasons|0|||
48898744|NCT03075410|157465078|FG004|Part A-Period 2 (14 Days)|Personal reasons|0|||
48898745|NCT03075410|157465079|FG005|Part A-Period 2 (14 Days)|Personal reasons|0|||
48898746|NCT03075410|157465080|FG006|Part A-Period 2 (14 Days)|Personal reasons|0|||
48898747|NCT03075410|157465081|FG007|Part A-Period 2 (14 Days)|Personal reasons|0|||
48898748|NCT03075410|157465082|FG008|Part A-Period 2 (14 Days)|Personal reasons|0|||
48898749|NCT03075410|157465074|FG000|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1|||
48898750|NCT03075410|157465075|FG001|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
48898751|NCT03075410|157465076|FG002|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
48898752|NCT03075410|157465077|FG003|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
48898753|NCT03075410|157465078|FG004|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
48898754|NCT03075410|157465079|FG005|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
48898755|NCT03075410|157465080|FG006|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
48898756|NCT03075410|157465081|FG007|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
48898757|NCT03075410|157465082|FG008|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
48898758|NCT01759407|157465085|FG000|Overall Study|Protocol Violation|0|||
48898759|NCT01759407|157465086|FG001|Overall Study|Protocol Violation|2|||
48898760|NCT03737474|157465087|FG000|Overall Study|Adverse Event|18|||
48898761|NCT03737474|157465088|FG001|Overall Study|Adverse Event|48|||
48898762|NCT03737474|157465087|FG000|Overall Study|Lack of Efficacy|1|||
48898763|NCT03737474|157465088|FG001|Overall Study|Lack of Efficacy|3|||
48898764|NCT03737474|157465087|FG000|Overall Study|Protocol Violation|0|||
48898765|NCT03737474|157465088|FG001|Overall Study|Protocol Violation|8|||
48898766|NCT03737474|157465087|FG000|Overall Study|Withdrawal by Subject|5|||
48898767|NCT03737474|157465088|FG001|Overall Study|Withdrawal by Subject|20|||
48898768|NCT03737474|157465087|FG000|Overall Study|Non-compliance With Study Drug|0|||
49040619|NCT02011945|157984032|FG000|Overall Study|Adverse Event unrelated to Drug|0|||
48898769|NCT03737474|157465088|FG001|Overall Study|Non-compliance With Study Drug|1|||
48898770|NCT03737474|157465087|FG000|Overall Study|Physician Decision|1|||
48898771|NCT03737474|157465088|FG001|Overall Study|Physician Decision|4|||
48898772|NCT00427895|157465089|FG000|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
48898773|NCT00427895|157465090|FG001|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
48898774|NCT00427895|157465091|FG002|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
48898775|NCT00427895|157465092|FG003|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352|||
48898776|NCT00427895|157465093|FG004|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
48898777|NCT00427895|157465094|FG005|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
48898778|NCT00427895|157465095|FG006|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
48898779|NCT00427895|157465096|FG007|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
48898780|NCT00427895|157465089|FG000|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
48898781|NCT00427895|157465090|FG001|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
48898782|NCT00427895|157465091|FG002|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
48898783|NCT00427895|157465092|FG003|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
48898784|NCT00427895|157465093|FG004|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
48898785|NCT00427895|157465094|FG005|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
48898786|NCT00427895|157465095|FG006|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
48898787|NCT00427895|157465096|FG007|Vax 2/Year 3 to 4|Lost to Follow-up|1|||
48898788|NCT00427895|157465089|FG000|Vax 2/Year 3 to 4|Protocol Violation|0|||
48898789|NCT00427895|157465090|FG001|Vax 2/Year 3 to 4|Protocol Violation|0|||
48898790|NCT00427895|157465091|FG002|Vax 2/Year 3 to 4|Protocol Violation|0|||
49040620|NCT02011945|157984033|FG001|Overall Study|Adverse Event unrelated to Drug|2|||
49040621|NCT02011945|157984034|FG002|Overall Study|Adverse Event unrelated to Drug|1|||
49040622|NCT02011945|157984032|FG000|Overall Study|Study Drug Toxicity|0|||
49040623|NCT02011945|157984033|FG001|Overall Study|Study Drug Toxicity|0|||
49040624|NCT02011945|157984034|FG002|Overall Study|Study Drug Toxicity|1|||
49040625|NCT02011945|157984032|FG000|Overall Study|Treatment Failure|0|||
49040626|NCT02011945|157984033|FG001|Overall Study|Treatment Failure|7|||
49040627|NCT02011945|157984034|FG002|Overall Study|Treatment Failure|6|||
49040628|NCT02011945|157984032|FG000|Overall Study|No Longer Meets Study Criteria|1|||
49040629|NCT02011945|157984033|FG001|Overall Study|No Longer Meets Study Criteria|0|||
49040630|NCT02011945|157984034|FG002|Overall Study|No Longer Meets Study Criteria|0|||
49040631|NCT02011945|157984032|FG000|Overall Study|Proceeded to stem cell transplant|0|||
49040632|NCT02011945|157984033|FG001|Overall Study|Proceeded to stem cell transplant|0|||
49040633|NCT02011945|157984034|FG002|Overall Study|Proceeded to stem cell transplant|1|||
49040634|NCT02011945|157984032|FG000|Overall Study|Sub-Optimal Response to dasatinib|1|||
49040635|NCT02011945|157984033|FG001|Overall Study|Sub-Optimal Response to dasatinib|0|||
49040636|NCT02011945|157984034|FG002|Overall Study|Sub-Optimal Response to dasatinib|0|||
49040637|NCT00902538|157984035|FG000|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49|||
49040638|NCT00902538|157984036|FG001|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
49040639|NCT00902538|157984037|FG002|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
49040640|NCT00902538|157984038|FG003|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
49040641|NCT00902538|157984039|FG004|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
49040642|NCT00902538|157984040|FG005|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
49040643|NCT00902538|157984035|FG000|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30|||
49040644|NCT00902538|157984036|FG001|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
49040645|NCT00902538|157984037|FG002|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
49040646|NCT00902538|157984038|FG003|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
49040647|NCT00902538|157984039|FG004|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
49040648|NCT00902538|157984040|FG005|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
49040649|NCT00902538|157984035|FG000|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22|||
49040650|NCT00902538|157984036|FG001|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
49040651|NCT00902538|157984037|FG002|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
49040652|NCT00902538|157984038|FG003|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
49040653|NCT00902538|157984039|FG004|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
49040654|NCT00902538|157984040|FG005|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
48898791|NCT00427895|157465092|FG003|Vax 2/Year 3 to 4|Protocol Violation|0|||
48898792|NCT00427895|157465093|FG004|Vax 2/Year 3 to 4|Protocol Violation|0|||
48898793|NCT00427895|157465094|FG005|Vax 2/Year 3 to 4|Protocol Violation|0|||
48898794|NCT00427895|157465095|FG006|Vax 2/Year 3 to 4|Protocol Violation|0|||
48898795|NCT00427895|157465096|FG007|Vax 2/Year 3 to 4|Protocol Violation|1|||
48898796|NCT00427895|157465089|FG000|Vax 2/Year 3 to 4|Failed to Return|0|||
48898797|NCT00427895|157465090|FG001|Vax 2/Year 3 to 4|Failed to Return|0|||
48898798|NCT00427895|157465091|FG002|Vax 2/Year 3 to 4|Failed to Return|0|||
48898799|NCT00427895|157465092|FG003|Vax 2/Year 3 to 4|Failed to Return|0|||
48898800|NCT00427895|157465093|FG004|Vax 2/Year 3 to 4|Failed to Return|1|||
48898801|NCT00427895|157465094|FG005|Vax 2/Year 3 to 4|Failed to Return|0|||
48898802|NCT00427895|157465095|FG006|Vax 2/Year 3 to 4|Failed to Return|0|||
48898803|NCT00427895|157465096|FG007|Vax 2/Year 3 to 4|Failed to Return|0|||
49040655|NCT00902538|157984035|FG000|1-Single-blind, Run-in, Single-Treatment|Other Reason|13|||
49040656|NCT00902538|157984036|FG001|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
48898804|NCT00427895|157465089|FG000|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
48898805|NCT00427895|157465090|FG001|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1|||
48898806|NCT00427895|157465091|FG002|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4|||
48898807|NCT00427895|157465092|FG003|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32|||
48898808|NCT00427895|157465093|FG004|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
48898809|NCT00427895|157465094|FG005|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
48898810|NCT00427895|157465095|FG006|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
48898811|NCT00427895|157465096|FG007|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
48898812|NCT00427895|157465089|FG000|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4|||
48898813|NCT00427895|157465090|FG001|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
49040657|NCT00902538|157984037|FG002|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
49040658|NCT00902538|157984038|FG003|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
49040659|NCT00902538|157984039|FG004|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
49040660|NCT00902538|157984040|FG005|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
49040661|NCT00902538|157984035|FG000|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4|||
48898814|NCT00427895|157465091|FG002|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3|||
48898815|NCT00427895|157465092|FG003|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2|||
48898816|NCT00427895|157465093|FG004|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
48898817|NCT00427895|157465094|FG005|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
48898818|NCT00427895|157465095|FG006|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
48898819|NCT00427895|157465096|FG007|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
48898820|NCT00427895|157465089|FG000|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
48898821|NCT00427895|157465090|FG001|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
48898822|NCT00427895|157465091|FG002|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
48898823|NCT00427895|157465092|FG003|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
48898824|NCT00427895|157465093|FG004|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
48898825|NCT00427895|157465094|FG005|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
48898826|NCT00427895|157465095|FG006|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
48898827|NCT00427895|157465096|FG007|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
48898828|NCT00427895|157465089|FG000|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
48898829|NCT00427895|157465090|FG001|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
48898830|NCT00427895|157465091|FG002|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4|||
48898831|NCT00427895|157465092|FG003|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7|||
48898832|NCT00427895|157465093|FG004|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
48898833|NCT00427895|157465094|FG005|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
48898834|NCT00427895|157465095|FG006|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
48898835|NCT00427895|157465096|FG007|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
48898836|NCT00427895|157465089|FG000|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
49040662|NCT00902538|157984036|FG001|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
49040663|NCT00902538|157984037|FG002|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
49040664|NCT00902538|157984038|FG003|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
49040665|NCT00902538|157984039|FG004|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
49040666|NCT00902538|157984040|FG005|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
49040667|NCT00902538|157984035|FG000|2-Randomized Double-blind 3 Treatments|Adverse Event|4|||
49040668|NCT00902538|157984036|FG001|2-Randomized Double-blind 3 Treatments|Adverse Event|2|||
49040669|NCT00902538|157984037|FG002|2-Randomized Double-blind 3 Treatments|Adverse Event|3|||
49040670|NCT00902538|157984038|FG003|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
49040671|NCT00902538|157984039|FG004|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
49040672|NCT00902538|157984040|FG005|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
49040673|NCT00902538|157984035|FG000|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
48898837|NCT00427895|157465090|FG001|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
48898838|NCT00427895|157465091|FG002|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
48898839|NCT00427895|157465092|FG003|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2|||
48898840|NCT00427895|157465093|FG004|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
48898841|NCT00427895|157465094|FG005|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
48898842|NCT00427895|157465095|FG006|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
48898843|NCT00427895|157465096|FG007|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
48898844|NCT00427895|157465089|FG000|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
48898845|NCT00427895|157465090|FG001|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3|||
48898846|NCT00427895|157465091|FG002|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2|||
48898847|NCT00427895|157465092|FG003|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
48898848|NCT00427895|157465093|FG004|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
48898849|NCT00427895|157465094|FG005|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
48898850|NCT00427895|157465095|FG006|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
48898851|NCT00427895|157465096|FG007|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
48898852|NCT00427895|157465089|FG000|Vax 1 Baseline/6-Month Follow-up|Other|0|||
48898853|NCT00427895|157465090|FG001|Vax 1 Baseline/6-Month Follow-up|Other|0|||
48898854|NCT00427895|157465091|FG002|Vax 1 Baseline/6-Month Follow-up|Other|1|||
48898855|NCT00427895|157465092|FG003|Vax 1 Baseline/6-Month Follow-up|Other|2|||
49040674|NCT00902538|157984036|FG001|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2|||
48898856|NCT00427895|157465093|FG004|Vax 1 Baseline/6-Month Follow-up|Other|0|||
48898857|NCT00427895|157465094|FG005|Vax 1 Baseline/6-Month Follow-up|Other|0|||
48898858|NCT00427895|157465095|FG006|Vax 1 Baseline/6-Month Follow-up|Other|0|||
48898859|NCT00427895|157465096|FG007|Vax 1 Baseline/6-Month Follow-up|Other|0|||
48898860|NCT00427895|157465089|FG000|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
48898861|NCT00427895|157465090|FG001|Vax 1/Year 1 Follow-up|Lost to Follow-up|5|||
48898862|NCT00427895|157465091|FG002|Vax 1/Year 1 Follow-up|Lost to Follow-up|2|||
48898863|NCT00427895|157465092|FG003|Vax 1/Year 1 Follow-up|Lost to Follow-up|21|||
48898864|NCT00427895|157465093|FG004|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
48898865|NCT00427895|157465094|FG005|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
48898866|NCT00427895|157465095|FG006|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
48898867|NCT00427895|157465096|FG007|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
48898868|NCT00427895|157465089|FG000|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
48898869|NCT00427895|157465090|FG001|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
48898870|NCT00427895|157465091|FG002|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
48898871|NCT00427895|157465092|FG003|Vax 1/Year 1 Follow-up|Protocol Violation|1|||
48898872|NCT00427895|157465093|FG004|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
48898873|NCT00427895|157465094|FG005|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
48898874|NCT00427895|157465095|FG006|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
48898875|NCT00427895|157465096|FG007|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
48898876|NCT00427895|157465089|FG000|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3|||
48898877|NCT00427895|157465090|FG001|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6|||
48898878|NCT00427895|157465091|FG002|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5|||
48898879|NCT00427895|157465092|FG003|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4|||
48898880|NCT00427895|157465093|FG004|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
48898881|NCT00427895|157465094|FG005|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
48898882|NCT00427895|157465095|FG006|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
48898883|NCT00427895|157465096|FG007|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
48898884|NCT00427895|157465089|FG000|Vax 1/Year 1 Follow-up|Adverse Event|0|||
48898885|NCT00427895|157465090|FG001|Vax 1/Year 1 Follow-up|Adverse Event|1|||
48898886|NCT00427895|157465091|FG002|Vax 1/Year 1 Follow-up|Adverse Event|0|||
48898887|NCT00427895|157465092|FG003|Vax 1/Year 1 Follow-up|Adverse Event|0|||
48898888|NCT00427895|157465093|FG004|Vax 1/Year 1 Follow-up|Adverse Event|0|||
48898889|NCT00427895|157465094|FG005|Vax 1/Year 1 Follow-up|Adverse Event|0|||
48898890|NCT00427895|157465095|FG006|Vax 1/Year 1 Follow-up|Adverse Event|0|||
48898891|NCT00427895|157465096|FG007|Vax 1/Year 1 Follow-up|Adverse Event|0|||
48898892|NCT00427895|157465089|FG000|Vax 1/Year 1 Follow-up|Death|1|||
48898893|NCT00427895|157465090|FG001|Vax 1/Year 1 Follow-up|Death|0|||
48898894|NCT00427895|157465091|FG002|Vax 1/Year 1 Follow-up|Death|0|||
48898895|NCT00427895|157465092|FG003|Vax 1/Year 1 Follow-up|Death|0|||
48898896|NCT00427895|157465093|FG004|Vax 1/Year 1 Follow-up|Death|0|||
48898897|NCT00427895|157465094|FG005|Vax 1/Year 1 Follow-up|Death|0|||
48898898|NCT00427895|157465095|FG006|Vax 1/Year 1 Follow-up|Death|0|||
48898899|NCT00427895|157465096|FG007|Vax 1/Year 1 Follow-up|Death|0|||
48898900|NCT00427895|157465089|FG000|Vax 1/Year 1 Follow-up|Failed to Return|0|||
48898901|NCT00427895|157465090|FG001|Vax 1/Year 1 Follow-up|Failed to Return|0|||
48898902|NCT00427895|157465091|FG002|Vax 1/Year 1 Follow-up|Failed to Return|12|||
48898903|NCT00427895|157465092|FG003|Vax 1/Year 1 Follow-up|Failed to Return|5|||
48898904|NCT00427895|157465093|FG004|Vax 1/Year 1 Follow-up|Failed to Return|0|||
48898905|NCT00427895|157465094|FG005|Vax 1/Year 1 Follow-up|Failed to Return|0|||
49040675|NCT00902538|157984037|FG002|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
49040676|NCT00902538|157984038|FG003|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
49040677|NCT00902538|157984039|FG004|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
49040678|NCT00902538|157984040|FG005|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
49040679|NCT00902538|157984035|FG000|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1|||
49040680|NCT00902538|157984036|FG001|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
49040681|NCT00902538|157984037|FG002|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2|||
49040682|NCT00902538|157984038|FG003|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
48898906|NCT00427895|157465095|FG006|Vax 1/Year 1 Follow-up|Failed to Return|0|||
48898907|NCT00427895|157465096|FG007|Vax 1/Year 1 Follow-up|Failed to Return|0|||
48898908|NCT00427895|157465089|FG000|Vax 1/Year 1 Follow-up|Other|0|||
49040683|NCT00902538|157984039|FG004|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
49040684|NCT00902538|157984040|FG005|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
48898909|NCT00427895|157465090|FG001|Vax 1/Year 1 Follow-up|Other|0|||
48898910|NCT00427895|157465091|FG002|Vax 1/Year 1 Follow-up|Other|0|||
48898911|NCT00427895|157465092|FG003|Vax 1/Year 1 Follow-up|Other|2|||
48898912|NCT00427895|157465093|FG004|Vax 1/Year 1 Follow-up|Other|0|||
48898913|NCT00427895|157465094|FG005|Vax 1/Year 1 Follow-up|Other|0|||
48898914|NCT00427895|157465095|FG006|Vax 1/Year 1 Follow-up|Other|0|||
48898915|NCT00427895|157465096|FG007|Vax 1/Year 1 Follow-up|Other|0|||
48898916|NCT00427895|157465089|FG000|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188|||
48898917|NCT00427895|157465090|FG001|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207|||
48898918|NCT00427895|157465091|FG002|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159|||
48898919|NCT00427895|157465092|FG003|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469|||
48898920|NCT00427895|157465093|FG004|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
48898921|NCT00427895|157465094|FG005|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
48898922|NCT00427895|157465095|FG006|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
48898923|NCT00427895|157465096|FG007|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
48898924|NCT01209143|157465097|FG000|Overall Study|Adverse Event|2|||
48898925|NCT01209143|157465098|FG001|Overall Study|Adverse Event|1|||
48898926|NCT01209143|157465097|FG000|Overall Study|Death|0|||
48898927|NCT01209143|157465098|FG001|Overall Study|Death|1|||
48898928|NCT01209143|157465097|FG000|Overall Study|Physician Decision|3|||
48898929|NCT01209143|157465098|FG001|Overall Study|Physician Decision|1|||
48898930|NCT01209143|157465097|FG000|Overall Study|Lost to Follow-up|1|||
48898931|NCT01209143|157465098|FG001|Overall Study|Lost to Follow-up|0|||
48898932|NCT01209143|157465097|FG000|Overall Study|Withdrawal by Subject|2|||
48898933|NCT01209143|157465098|FG001|Overall Study|Withdrawal by Subject|1|||
48898934|NCT01209143|157465097|FG000|Overall Study|Disease progression|11|||
48898935|NCT01209143|157465098|FG001|Overall Study|Disease progression|16|||
48898936|NCT00723021|157465099|FG000|Intervention Period 4|Adverse Event|0|||
48898937|NCT00723021|157465100|FG001|Intervention Period 4|Adverse Event|0|||
48898938|NCT00723021|157465101|FG002|Intervention Period 4|Adverse Event|0|||
48898939|NCT00723021|157465102|FG003|Intervention Period 4|Adverse Event|0|||
48898940|NCT00723021|157465103|FG004|Intervention Period 4|Adverse Event|1|||
48898941|NCT02796560|157465109|FG000|Overall Study|Adverse Event|2|||
48898942|NCT02796560|157465110|FG001|Overall Study|Adverse Event|0|||
48898943|NCT02796560|157465109|FG000|Overall Study|Withdrawal by Subject|2|||
49040685|NCT00902538|157984035|FG000|2-Randomized Double-blind 3 Treatments|Other|2|||
48898944|NCT02796560|157465110|FG001|Overall Study|Withdrawal by Subject|2|||
48898945|NCT00883051|157465111|FG000|Overall Study|Lost to Follow-up|0|||
48898946|NCT00883051|157465112|FG001|Overall Study|Lost to Follow-up|0|||
49040686|NCT00902538|157984036|FG001|2-Randomized Double-blind 3 Treatments|Other|1|||
49040687|NCT00902538|157984037|FG002|2-Randomized Double-blind 3 Treatments|Other|0|||
49040688|NCT00902538|157984038|FG003|2-Randomized Double-blind 3 Treatments|Other|0|||
49040689|NCT00902538|157984039|FG004|2-Randomized Double-blind 3 Treatments|Other|0|||
49040690|NCT00902538|157984040|FG005|2-Randomized Double-blind 3 Treatments|Other|0|||
49040691|NCT00902538|157984035|FG000|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
49040692|NCT00902538|157984036|FG001|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
49040693|NCT00902538|157984037|FG002|2-Randomized Double-blind 3 Treatments|Protocol Violation|2|||
49040694|NCT00902538|157984038|FG003|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
49040695|NCT00902538|157984039|FG004|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
49040696|NCT00902538|157984040|FG005|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
49040697|NCT00902538|157984035|FG000|3-Single-blind, Single Treatment|Adverse Event|0|||
49040698|NCT00902538|157984036|FG001|3-Single-blind, Single Treatment|Adverse Event|5|||
49040699|NCT00902538|157984037|FG002|3-Single-blind, Single Treatment|Adverse Event|0|||
49040700|NCT00902538|157984038|FG003|3-Single-blind, Single Treatment|Adverse Event|0|||
49040701|NCT00902538|157984039|FG004|3-Single-blind, Single Treatment|Adverse Event|0|||
49040702|NCT00902538|157984040|FG005|3-Single-blind, Single Treatment|Adverse Event|0|||
48898947|NCT00883051|157465113|FG002|Overall Study|Lost to Follow-up|0|||
48898948|NCT00883051|157465114|FG003|Overall Study|Lost to Follow-up|0|||
48898949|NCT00883051|157465115|FG004|Overall Study|Lost to Follow-up|1|||
48898950|NCT00883051|157465111|FG000|Overall Study|Did not use study medication|24|||
48898951|NCT00883051|157465112|FG001|Overall Study|Did not use study medication|22|||
48898952|NCT00883051|157465113|FG002|Overall Study|Did not use study medication|29|||
48898953|NCT00883051|157465114|FG003|Overall Study|Did not use study medication|29|||
48898954|NCT00883051|157465115|FG004|Overall Study|Did not use study medication|17|||
48898955|NCT00810394|157465118|FG000|Overall Study|Withdrawal by Subject|3|||
48984474|NCT00606021|157774231|FG000|Maintenance Phase|Physician Decision|0|||
48984475|NCT00606021|157774232|FG001|Maintenance Phase|Physician Decision|1|||
48984476|NCT00606021|157774233|FG002|Maintenance Phase|Physician Decision|0|||
48984477|NCT00606021|157774231|FG000|Maintenance Phase|Lost to Follow-up|0|||
48984478|NCT00606021|157774232|FG001|Maintenance Phase|Lost to Follow-up|5|||
48984479|NCT00606021|157774233|FG002|Maintenance Phase|Lost to Follow-up|2|||
48984480|NCT00887913|157774234|FG000|Overall Study|Withdrawal by Subject|6|||
48984481|NCT03049852|157774237|FG000|Overall Study|Lost to Follow-up|0|||
48984482|NCT03049852|157774238|FG001|Overall Study|Lost to Follow-up|1|||
48984483|NCT03049852|157774239|FG002|Overall Study|Lost to Follow-up|0|||
48984484|NCT01021293|157774240|FG000|Overall Study|Serious Adverse Event|2|||
48984485|NCT01021293|157774241|FG001|Overall Study|Serious Adverse Event|1|||
48984486|NCT01021293|157774240|FG000|Overall Study|Adverse Event|2|||
49040703|NCT00902538|157984035|FG000|3-Single-blind, Single Treatment|Protocol Violation|0|||
49040704|NCT00902538|157984036|FG001|3-Single-blind, Single Treatment|Protocol Violation|5|||
48898956|NCT02910739|157465119|FG000|Overall Study|Adverse Event|1|||
48898957|NCT02910739|157465120|FG001|Overall Study|Adverse Event|0|||
48898958|NCT02910739|157465121|FG002|Overall Study|Adverse Event|0|||
48898959|NCT02910739|157465122|FG003|Overall Study|Adverse Event|0|||
48898960|NCT05323396|157465123|FG000|Overall Study|Lost to Follow-up|1|||
48898961|NCT05323396|157465124|FG001|Overall Study|Lost to Follow-up|31|||
48898962|NCT05323396|157465123|FG000|Overall Study|Pregnancy|1|||
48898963|NCT05323396|157465124|FG001|Overall Study|Pregnancy|0|||
48898964|NCT02656823|157465125|FG000|Overall Study|Adverse Event|3|||
48898965|NCT02656823|157465125|FG000|Overall Study|Lost to Follow-up|2|||
48898966|NCT01340651|157465127|FG000|Overall Study|Adverse Event|3|||
48898967|NCT01340651|157465127|FG000|Overall Study|Consent Withdrawn|2|||
48898968|NCT01340651|157465127|FG000|Overall Study|Commercial Supply per Sponsor|12|||
48898969|NCT04675151|157465128|FG000|Overall Study|Protocol Violation|1|||
48898970|NCT04675151|157465129|FG001|Overall Study|Protocol Violation|0|||
48898971|NCT04675151|157465130|FG002|Overall Study|Protocol Violation|0|||
48898972|NCT04675151|157465131|FG003|Overall Study|Protocol Violation|1|||
48898973|NCT01009580|157465132|FG000|Overall Study|Adverse Event|4|||
48898974|NCT01009580|157465133|FG001|Overall Study|Adverse Event|4|||
48898975|NCT01009580|157465132|FG000|Overall Study|Lack of Efficacy|0|||
48898976|NCT01009580|157465133|FG001|Overall Study|Lack of Efficacy|1|||
48898977|NCT01009580|157465132|FG000|Overall Study|Protocol Violation|2|||
48898978|NCT01009580|157465133|FG001|Overall Study|Protocol Violation|3|||
48898979|NCT01009580|157465132|FG000|Overall Study|Withdrawal Criteria|4|||
48898980|NCT01009580|157465133|FG001|Overall Study|Withdrawal Criteria|6|||
48898981|NCT01009580|157465132|FG000|Overall Study|Unclassified|17|||
48898982|NCT01009580|157465133|FG001|Overall Study|Unclassified|21|||
48898983|NCT01696942|157465136|FG000|Overall Study|Withdrawal by Subject|1|||
48898984|NCT01696942|157465137|FG001|Overall Study|Withdrawal by Subject|0|||
48898985|NCT01696942|157465136|FG000|Overall Study|Protocol Violation|1|||
48898986|NCT01696942|157465137|FG001|Overall Study|Protocol Violation|2|||
48898987|NCT01696942|157465136|FG000|Overall Study|screen failure|0|||
48898988|NCT01696942|157465137|FG001|Overall Study|screen failure|1|||
48898989|NCT01313117|157465138|FG000|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
48898990|NCT01313117|157465138|FG000|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
48898991|NCT00055601|157466790|FG000|Overall Study|Protocol Violation|1|||
48898992|NCT00055601|157466791|FG001|Overall Study|Protocol Violation|1|||
48898993|NCT00055601|157466790|FG000|Overall Study|No protocol treatment received|1|||
48898994|NCT00055601|157466791|FG001|Overall Study|No protocol treatment received|1|||
48898995|NCT04058366|157466792|FG000|Overall Study|Adverse Event|14|||
48898996|NCT04058366|157466792|FG000|Overall Study|Withdrawal of Consent (not due to AE)|7|||
48898997|NCT04058366|157466792|FG000|Overall Study|Commercial drug is available for participants|6|||
48898998|NCT04058366|157466792|FG000|Overall Study|Death|1|||
48898999|NCT04058366|157466792|FG000|Overall Study|Other non-compliance|2|||
48899000|NCT04058366|157466792|FG000|Overall Study|Other|6|||
48899001|NCT01589237|157466793|FG000|Part A (52 Weeks)|Subject/guardian decision|2|||
48899002|NCT01589237|157466794|FG001|Part A (52 Weeks)|Subject/guardian decision|3|||
48899003|NCT01589237|157466795|FG002|Part A (52 Weeks)|Subject/guardian decision|2|||
48899004|NCT01589237|157466796|FG003|Part A (52 Weeks)|Subject/guardian decision|0|||
48899005|NCT01589237|157466793|FG000|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
48899006|NCT01589237|157466794|FG001|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1|||
48899007|NCT01589237|157466795|FG002|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
48899008|NCT01589237|157466796|FG003|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
48899009|NCT01589237|157466793|FG000|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
48899010|NCT01589237|157466794|FG001|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
48899011|NCT01589237|157466795|FG002|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4|||
48984487|NCT01021293|157774241|FG001|Overall Study|Adverse Event|1|||
48984488|NCT01021293|157774240|FG000|Overall Study|Withdrawal by Subject|1|||
48984489|NCT01021293|157774241|FG001|Overall Study|Withdrawal by Subject|3|||
48984490|NCT01021293|157774240|FG000|Overall Study|Migrated/moved from study area|6|||
48984491|NCT01021293|157774241|FG001|Overall Study|Migrated/moved from study area|18|||
48984492|NCT01021293|157774240|FG000|Overall Study|Lost to Follow-up|1|||
48984493|NCT01021293|157774241|FG001|Overall Study|Lost to Follow-up|1|||
48984494|NCT02067104|157774242|FG000|Overall Study|Study termination due to low accrual|4|||
48984495|NCT02067104|157774243|FG001|Overall Study|Study termination due to low accrual|5|||
48984496|NCT00695318|157774244|FG000|Overall Study|Lost to Follow-up|1|||
48984497|NCT00695318|157774245|FG001|Overall Study|Lost to Follow-up|0|||
48984498|NCT00695318|157774244|FG000|Overall Study|Withdrawal by Subject|2|||
48984499|NCT00695318|157774245|FG001|Overall Study|Withdrawal by Subject|0|||
48984500|NCT00695318|157774244|FG000|Overall Study|Death|1|||
48984501|NCT00695318|157774245|FG001|Overall Study|Death|1|||
48984502|NCT00695318|157774244|FG000|Overall Study|Study Terminated|1|||
48984503|NCT00695318|157774245|FG001|Overall Study|Study Terminated|0|||
48984504|NCT03756285|157774246|FG000|Overall Study|Lost to Follow-up|0|||
48984505|NCT03756285|157774247|FG001|Overall Study|Lost to Follow-up|1|||
49040705|NCT00902538|157984037|FG002|3-Single-blind, Single Treatment|Protocol Violation|0|||
49040706|NCT00902538|157984038|FG003|3-Single-blind, Single Treatment|Protocol Violation|0|||
49040707|NCT00902538|157984039|FG004|3-Single-blind, Single Treatment|Protocol Violation|0|||
49040708|NCT00902538|157984040|FG005|3-Single-blind, Single Treatment|Protocol Violation|0|||
49040709|NCT00902538|157984035|FG000|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
49040710|NCT00902538|157984036|FG001|3-Single-blind, Single Treatment|Withdrawal by Subject|4|||
49040711|NCT00902538|157984037|FG002|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
49040712|NCT00902538|157984038|FG003|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
49040713|NCT00902538|157984039|FG004|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
49040714|NCT00902538|157984040|FG005|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
49040715|NCT00902538|157984035|FG000|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
49040716|NCT00902538|157984036|FG001|3-Single-blind, Single Treatment|Lost to Follow-up|1|||
49040717|NCT00902538|157984037|FG002|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
49040718|NCT00902538|157984038|FG003|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
49040719|NCT00902538|157984039|FG004|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
49040720|NCT00902538|157984040|FG005|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
49040721|NCT00902538|157984035|FG000|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
49040722|NCT00902538|157984036|FG001|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
49040723|NCT00902538|157984037|FG002|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
49040724|NCT00902538|157984038|FG003|4-Randomized Double-blind 2 Treatments|Adverse Event|3|||
49040725|NCT00902538|157984039|FG004|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
49040726|NCT00902538|157984040|FG005|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
49040727|NCT00902538|157984035|FG000|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
49040728|NCT00902538|157984036|FG001|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
49040729|NCT00902538|157984037|FG002|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
49040730|NCT00902538|157984038|FG003|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3|||
49040731|NCT00902538|157984039|FG004|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1|||
49040732|NCT00902538|157984040|FG005|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
49040733|NCT00902538|157984035|FG000|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
49040734|NCT00902538|157984036|FG001|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
49040735|NCT00902538|157984037|FG002|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
49040736|NCT00902538|157984038|FG003|4-Randomized Double-blind 2 Treatments|Protocol Violation|3|||
49040737|NCT00902538|157984039|FG004|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
49040738|NCT00902538|157984040|FG005|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
49040739|NCT02030535|157984041|FG000|Washout Period 1 (21 Days)|Adverse Event|1|||
49040740|NCT01374451|157984044|FG000|Overall Study|Administrative problems|1|||
49040741|NCT01374451|157984045|FG001|Overall Study|Administrative problems|0|||
49040742|NCT04428645|157984046|FG000|Second at Home Period (8 Weeks)|Withdrawal by Subject|1|||
49040743|NCT01490190|157985602|FG000|Overall Study|Withdrawal by Subject|9|||
49040744|NCT01490190|157985602|FG000|Overall Study|Adverse Event|17|||
49040745|NCT01490190|157985602|FG000|Overall Study|Protocol Violation|5|||
49040746|NCT01490190|157985602|FG000|Overall Study|Lost to Follow-up|13|||
49040747|NCT01490190|157985602|FG000|Overall Study|Relocation|1|||
49040748|NCT01490190|157985602|FG000|Overall Study|Inconvenience|1|||
49040749|NCT01490190|157985602|FG000|Overall Study|Ring expulsion|2|||
49040750|NCT03234907|157985607|FG000|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
49040751|NCT03234907|157985608|FG001|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
49040752|NCT03234907|157985609|FG002|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
49040753|NCT03234907|157985610|FG003|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
49040754|NCT03234907|157985611|FG004|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
49040755|NCT03234907|157985612|FG005|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
48899012|NCT01589237|157466796|FG003|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3|||
48899013|NCT01589237|157466793|FG000|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
48899014|NCT01589237|157466794|FG001|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
49040756|NCT03234907|157985607|FG000|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|6|||
49040757|NCT03234907|157985608|FG001|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|4|||
49040758|NCT03234907|157985609|FG002|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
49040759|NCT03234907|157985610|FG003|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
49040760|NCT03234907|157985611|FG004|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
49040761|NCT03234907|157985612|FG005|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
49040762|NCT03234907|157985607|FG000|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|2|||
49040763|NCT03234907|157985608|FG001|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
49040764|NCT03234907|157985609|FG002|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
49040765|NCT03234907|157985610|FG003|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
49040766|NCT03234907|157985611|FG004|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
49040767|NCT03234907|157985612|FG005|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
49040768|NCT03234907|157985607|FG000|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
49040769|NCT03234907|157985608|FG001|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
49040770|NCT03234907|157985609|FG002|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
49040771|NCT03234907|157985610|FG003|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
49040772|NCT03234907|157985611|FG004|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
49040773|NCT03234907|157985612|FG005|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
49040774|NCT03234907|157985607|FG000|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
49040775|NCT03234907|157985608|FG001|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
49040776|NCT03234907|157985609|FG002|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
49040777|NCT03234907|157985610|FG003|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|4|||
49040778|NCT03234907|157985611|FG004|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|3|||
49040779|NCT03234907|157985612|FG005|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|7|||
49040780|NCT03234907|157985607|FG000|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
49040781|NCT03234907|157985608|FG001|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
49040782|NCT03234907|157985609|FG002|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|1|||
49040783|NCT03234907|157985610|FG003|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
49040784|NCT03234907|157985611|FG004|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
49040785|NCT03234907|157985612|FG005|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|4|||
48899015|NCT01589237|157466795|FG002|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
48899016|NCT01589237|157466796|FG003|Part B (Planned for 78 Week-terminated)|Physician Decision|1|||
48899017|NCT01036763|157466797|FG000|Overall Study|Adverse Event|25|||
48899018|NCT01036763|157466797|FG000|Overall Study|Lost to Follow-up|28|||
48899019|NCT01036763|157466797|FG000|Overall Study|Other reason (not specified)|40|||
48899020|NCT01773291|157466812|FG000|Overall Study|Protocol Violation|1|||
48899021|NCT01773291|157466813|FG001|Overall Study|Protocol Violation|0|||
48899022|NCT01773291|157466814|FG002|Overall Study|Protocol Violation|0|||
48899023|NCT01773291|157466812|FG000|Overall Study|Withdrawal by Subject|0|||
48899024|NCT01773291|157466813|FG001|Overall Study|Withdrawal by Subject|0|||
48899025|NCT01773291|157466814|FG002|Overall Study|Withdrawal by Subject|1|||
48899026|NCT00901186|157466815|FG000|Overall Study|Lack of Efficacy|0|||
48899027|NCT00901186|157466816|FG001|Overall Study|Lack of Efficacy|1|||
48899028|NCT00901186|157466815|FG000|Overall Study|Abnormal laboratory values|0|||
48899029|NCT00901186|157466816|FG001|Overall Study|Abnormal laboratory values|1|||
48899030|NCT00901186|157466815|FG000|Overall Study|Lost to Follow-up|2|||
48899031|NCT00901186|157466816|FG001|Overall Study|Lost to Follow-up|0|||
48899032|NCT00901186|157466815|FG000|Overall Study|Adverse Event|2|||
48899033|NCT00901186|157466816|FG001|Overall Study|Adverse Event|4|||
48899034|NCT00901186|157466815|FG000|Overall Study|Administration problems|0|||
48899035|NCT00901186|157466816|FG001|Overall Study|Administration problems|1|||
48899036|NCT00901186|157466815|FG000|Overall Study|Protocol deviations|5|||
48899037|NCT00901186|157466816|FG001|Overall Study|Protocol deviations|4|||
48899038|NCT02502097|157466817|FG000|Period 1|Adverse Event|0|||
48899039|NCT02502097|157466818|FG001|Period 1|Adverse Event|0|||
48899040|NCT02502097|157466819|FG002|Period 1|Adverse Event|1|||
48899041|NCT02502097|157466820|FG003|Period 1|Adverse Event|0|||
48899042|NCT02502097|157466817|FG000|Wash Out Period|Adverse Event|0|||
48899043|NCT02502097|157466818|FG001|Wash Out Period|Adverse Event|1|||
48899044|NCT02502097|157466819|FG002|Wash Out Period|Adverse Event|1|||
48899045|NCT02502097|157466820|FG003|Wash Out Period|Adverse Event|1|||
48899046|NCT02502097|157466817|FG000|Period 2|Adverse Event|0|||
48899047|NCT02502097|157466818|FG001|Period 2|Adverse Event|0|||
48899048|NCT02502097|157466819|FG002|Period 2|Adverse Event|1|||
48899049|NCT02502097|157466820|FG003|Period 2|Adverse Event|0|||
48899050|NCT00203476|157466821|FG000|Overall Study|Lost to Follow-up|1|||
48899051|NCT00203476|157466822|FG001|Overall Study|Lost to Follow-up|0|||
48899052|NCT00203476|157466823|FG002|Overall Study|Lost to Follow-up|0|||
48899053|NCT00203476|157466821|FG000|Overall Study|Withdrawal by Subject|0|||
48899054|NCT00203476|157466822|FG001|Overall Study|Withdrawal by Subject|1|||
48899055|NCT00203476|157466823|FG002|Overall Study|Withdrawal by Subject|0|||
48899056|NCT01190514|157466824|FG000|First Intervention (Period 1)|Adverse Event|1|||
48899057|NCT01190514|157466825|FG001|First Intervention (Period 1)|Adverse Event|0|||
48899058|NCT01190514|157466826|FG002|First Intervention (Period 1)|Adverse Event|0|||
48899059|NCT01190514|157466827|FG003|First Intervention (Period 1)|Adverse Event|0|||
48899060|NCT01190514|157466824|FG000|Third Intervention (Period 3)|Adverse Event|1|||
48899061|NCT01190514|157466825|FG001|Third Intervention (Period 3)|Adverse Event|0|||
48899062|NCT01190514|157466826|FG002|Third Intervention (Period 3)|Adverse Event|0|||
48899063|NCT01190514|157466827|FG003|Third Intervention (Period 3)|Adverse Event|0|||
48899064|NCT01201317|157466828|FG000|Overall Study|Withdrawal by Subject|5|||
48899065|NCT01201317|157466829|FG001|Overall Study|Withdrawal by Subject|0|||
48899066|NCT01201317|157466830|FG002|Overall Study|Withdrawal by Subject|3|||
48899067|NCT01201317|157466828|FG000|Overall Study|Adverse Event|2|||
48899068|NCT01201317|157466829|FG001|Overall Study|Adverse Event|2|||
48899069|NCT01201317|157466830|FG002|Overall Study|Adverse Event|2|||
48899070|NCT01201317|157466828|FG000|Overall Study|Screen failure|1|||
48899071|NCT01201317|157466829|FG001|Overall Study|Screen failure|1|||
48899072|NCT01201317|157466830|FG002|Overall Study|Screen failure|0|||
48899073|NCT01201317|157466828|FG000|Overall Study|Protocol Violation|0|||
48899074|NCT01201317|157466829|FG001|Overall Study|Protocol Violation|1|||
48899075|NCT01201317|157466830|FG002|Overall Study|Protocol Violation|1|||
48899076|NCT01201317|157466828|FG000|Overall Study|Death|0|||
48899077|NCT01201317|157466829|FG001|Overall Study|Death|1|||
48899078|NCT01201317|157466830|FG002|Overall Study|Death|0|||
48899079|NCT01201317|157466828|FG000|Overall Study|Study-specific withdrawal criteria|0|||
48899080|NCT01201317|157466829|FG001|Overall Study|Study-specific withdrawal criteria|0|||
48899081|NCT01201317|157466830|FG002|Overall Study|Study-specific withdrawal criteria|1|||
48899082|NCT01201317|157466828|FG000|Overall Study|Painful Diabetic Neuropathy worsening|0|||
48899083|NCT01201317|157466829|FG001|Overall Study|Painful Diabetic Neuropathy worsening|1|||
48899084|NCT01201317|157466830|FG002|Overall Study|Painful Diabetic Neuropathy worsening|0|||
48899085|NCT01201317|157466828|FG000|Overall Study|Decrease in renal function|0|||
48899086|NCT01201317|157466829|FG001|Overall Study|Decrease in renal function|1|||
48899087|NCT01201317|157466830|FG002|Overall Study|Decrease in renal function|0|||
48899088|NCT01201317|157466828|FG000|Overall Study|Lack of Efficacy|1|||
48899089|NCT01201317|157466829|FG001|Overall Study|Lack of Efficacy|0|||
48899090|NCT01201317|157466830|FG002|Overall Study|Lack of Efficacy|0|||
48899091|NCT01201317|157466828|FG000|Overall Study|Safety, possible history of tuberculosis|0|||
48899092|NCT01201317|157466829|FG001|Overall Study|Safety, possible history of tuberculosis|0|||
48899093|NCT01201317|157466830|FG002|Overall Study|Safety, possible history of tuberculosis|1|||
48899094|NCT00512317|157466831|FG000|Overall Study|Insufficient clinical response|36|||
48899095|NCT00512317|157466831|FG000|Overall Study|Withdrawal by Subject|23|||
48899096|NCT00512317|157466831|FG000|Overall Study|Sponsor closure of study|21|||
48899097|NCT00512317|157466831|FG000|Overall Study|<50% reduction in seizure frequency on or after Visit 7|18|||
48899098|NCT00512317|157466831|FG000|Overall Study|Adverse Event|13|||
48899099|NCT00512317|157466831|FG000|Overall Study|Discretion of the investigator or sponsor|2|||
48899100|NCT00512317|157466831|FG000|Overall Study|Lost to Follow-up|2|||
48899101|NCT00512317|157466831|FG000|Overall Study|Other|2|||
48899102|NCT00852540|157466832|FG000|Overall Study|Adverse Event|10|||
48899103|NCT00852540|157466833|FG001|Overall Study|Adverse Event|3|||
48899104|NCT00852540|157466832|FG000|Overall Study|Lack of Efficacy|15|||
48899105|NCT00852540|157466833|FG001|Overall Study|Lack of Efficacy|3|||
48899106|NCT00852540|157466832|FG000|Overall Study|Protocol Violation|1|||
48899107|NCT00852540|157466833|FG001|Overall Study|Protocol Violation|2|||
48899108|NCT00852540|157466832|FG000|Overall Study|Lost to Follow-up|2|||
48899109|NCT00852540|157466833|FG001|Overall Study|Lost to Follow-up|3|||
48899110|NCT00852540|157466832|FG000|Overall Study|Investigator Discretion|2|||
48899111|NCT00852540|157466833|FG001|Overall Study|Investigator Discretion|3|||
48899112|NCT00852540|157466832|FG000|Overall Study|Withdrawal by Subject|3|||
48899113|NCT00852540|157466833|FG001|Overall Study|Withdrawal by Subject|1|||
48899114|NCT00852540|157466832|FG000|Overall Study|Did Not Receive Study Drug|3|||
48899115|NCT00852540|157466833|FG001|Overall Study|Did Not Receive Study Drug|3|||
48899116|NCT00601419|157466834|FG000|Overall Study|Lost to Follow-up|3|||
48899117|NCT00601419|157466834|FG000|Overall Study|Missed Visits|1|||
48899118|NCT00686725|157466844|FG000|Overall Study|Adverse Event|1|||
48899119|NCT00686725|157466845|FG001|Overall Study|Adverse Event|1|||
48899120|NCT00686725|157466844|FG000|Overall Study|Progressive Disease|17|||
48899121|NCT00686725|157466845|FG001|Overall Study|Progressive Disease|23|||
48899122|NCT00686725|157466844|FG000|Overall Study|Lost to Follow-up|7|||
48899123|NCT00686725|157466845|FG001|Overall Study|Lost to Follow-up|5|||
48899124|NCT00686725|157466844|FG000|Overall Study|Death|6|||
48899125|NCT00686725|157466845|FG001|Overall Study|Death|3|||
48899126|NCT00686725|157466844|FG000|Overall Study|Withdrawal by Subject|13|||
48899127|NCT00686725|157466845|FG001|Overall Study|Withdrawal by Subject|4|||
48899128|NCT00686725|157466844|FG000|Overall Study|Protocol Violation|1|||
48899129|NCT00686725|157466845|FG001|Overall Study|Protocol Violation|3|||
48899130|NCT00686725|157466844|FG000|Overall Study|Other|1|||
48899131|NCT00686725|157466845|FG001|Overall Study|Other|3|||
48899132|NCT04875676|157466846|FG000|Overall Study|Lost to Follow-up|1|||
48899133|NCT04875676|157466847|FG001|Overall Study|Lost to Follow-up|0|||
48899134|NCT04875676|157466848|FG002|Overall Study|Lost to Follow-up|0|||
48899135|NCT04187989|157466851|FG000|Overall Study - 3-Month Follow-Up|Lost to Follow-up|6|||
48899136|NCT04187989|157466852|FG001|Overall Study - 3-Month Follow-Up|Lost to Follow-up|8|||
48899137|NCT04187989|157466851|FG000|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
48899138|NCT04187989|157466852|FG001|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
48899139|NCT00938470|157466853|FG000|Overall Study|Disease Progression|3|||
48899140|NCT00938470|157466854|FG001|Overall Study|Disease Progression|0|||
48899141|NCT00938470|157466853|FG000|Overall Study|Alternate Treatment|1|||
48899142|NCT00938470|157466854|FG001|Overall Study|Alternate Treatment|0|||
48899143|NCT00938470|157466853|FG000|Overall Study|Death|3|||
48899144|NCT00938470|157466854|FG001|Overall Study|Death|2|||
48899145|NCT00938470|157466853|FG000|Overall Study|Other Reason|0|||
48899146|NCT00938470|157466854|FG001|Overall Study|Other Reason|1|||
49040786|NCT03234907|157985607|FG000|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
49040787|NCT03234907|157985608|FG001|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
49040788|NCT03234907|157985609|FG002|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
49040789|NCT03234907|157985610|FG003|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
49040790|NCT03234907|157985611|FG004|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
49040791|NCT03234907|157985612|FG005|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|10|||
49040792|NCT01376037|157985615|FG000|Overall Study|Lost to Follow-up|0|||
49040793|NCT01376037|157985616|FG001|Overall Study|Lost to Follow-up|2|||
49040794|NCT02664415|157985617|FG000|Overall Study|Adverse Event|1|||
49040795|NCT02664415|157985618|FG001|Overall Study|Adverse Event|0|||
49040796|NCT00642993|157985619|FG000|Overall Study|Adverse Event|85|||
49040797|NCT00642993|157985620|FG001|Overall Study|Adverse Event|4|||
48899147|NCT02966301|157466861|FG000|Overall Study|Death|2|||
48899148|NCT02966301|157466861|FG000|Overall Study|Withdrawal by Subject|1|||
48899149|NCT00448279|157466863|FG000|Overall Study|Lost to Follow-up|2|||
48899150|NCT00448279|157466864|FG001|Overall Study|Lost to Follow-up|2|||
48899151|NCT00448279|157466863|FG000|Overall Study|Adverse Event|1|||
48899152|NCT00448279|157466864|FG001|Overall Study|Adverse Event|1|||
48899153|NCT00448279|157466863|FG000|Overall Study|Disease progression|16|||
48899154|NCT00448279|157466864|FG001|Overall Study|Disease progression|18|||
48899155|NCT00448279|157466863|FG000|Overall Study|Withdrawal by Subject|4|||
48899156|NCT00448279|157466864|FG001|Overall Study|Withdrawal by Subject|3|||
48899157|NCT00448279|157466863|FG000|Overall Study|Other|6|||
48899158|NCT00448279|157466864|FG001|Overall Study|Other|4|||
48899159|NCT00448279|157466863|FG000|Overall Study|Protocol Violation|0|||
48899160|NCT00448279|157466864|FG001|Overall Study|Protocol Violation|1|||
48899161|NCT02937454|157466865|FG000|Overall Study|Adverse Event|0|||
48899162|NCT02937454|157466866|FG001|Overall Study|Adverse Event|1|||
48899163|NCT02937454|157466865|FG000|Overall Study|Death|98|||
48899164|NCT02937454|157466866|FG001|Overall Study|Death|95|||
48899165|NCT02937454|157466865|FG000|Overall Study|Lost to Follow-up|1|||
48899166|NCT02937454|157466866|FG001|Overall Study|Lost to Follow-up|1|||
48899167|NCT02937454|157466865|FG000|Overall Study|Physician Decision|0|||
48899168|NCT02937454|157466866|FG001|Overall Study|Physician Decision|1|||
48899169|NCT02937454|157466865|FG000|Overall Study|Protocol Violation|6|||
48899170|NCT02937454|157466866|FG001|Overall Study|Protocol Violation|10|||
48899171|NCT02937454|157466865|FG000|Overall Study|Withdrawal by Subject|27|||
48899172|NCT02937454|157466866|FG001|Overall Study|Withdrawal by Subject|15|||
48899173|NCT02937454|157466865|FG000|Overall Study|Other|8|||
48899174|NCT02937454|157466866|FG001|Overall Study|Other|5|||
48899175|NCT00346632|157466869|FG000|Overall Study|Progressive Disease|2|||
48899176|NCT00346632|157466870|FG001|Overall Study|Progressive Disease|2|||
48899177|NCT00346632|157466871|FG002|Overall Study|Progressive Disease|4|||
48899178|NCT00346632|157466872|FG003|Overall Study|Progressive Disease|3|||
48899179|NCT00346632|157466873|FG004|Overall Study|Progressive Disease|3|||
48899180|NCT00346632|157466874|FG005|Overall Study|Progressive Disease|1|||
48899181|NCT00346632|157466875|FG006|Overall Study|Progressive Disease|2|||
48899182|NCT00346632|157466876|FG007|Overall Study|Progressive Disease|2|||
48899183|NCT00346632|157466877|FG008|Overall Study|Progressive Disease|2|||
48899184|NCT00346632|157466878|FG009|Overall Study|Progressive Disease|2|||
48899185|NCT00346632|157466869|FG000|Overall Study|Adverse Event|0|||
48899186|NCT00346632|157466870|FG001|Overall Study|Adverse Event|0|||
48899187|NCT00346632|157466871|FG002|Overall Study|Adverse Event|0|||
48899188|NCT00346632|157466872|FG003|Overall Study|Adverse Event|0|||
48899189|NCT00346632|157466873|FG004|Overall Study|Adverse Event|1|||
48899190|NCT00346632|157466874|FG005|Overall Study|Adverse Event|1|||
48899191|NCT00346632|157466875|FG006|Overall Study|Adverse Event|1|||
48899192|NCT00346632|157466876|FG007|Overall Study|Adverse Event|0|||
48899193|NCT00346632|157466877|FG008|Overall Study|Adverse Event|0|||
48899194|NCT00346632|157466878|FG009|Overall Study|Adverse Event|0|||
48899195|NCT00346632|157466869|FG000|Overall Study|Death|0|||
48899196|NCT00346632|157466870|FG001|Overall Study|Death|0|||
48899197|NCT00346632|157466871|FG002|Overall Study|Death|1|||
48899198|NCT00346632|157466872|FG003|Overall Study|Death|0|||
49040798|NCT00642993|157985619|FG000|Overall Study|Lost to Follow-up|8|||
49040799|NCT00642993|157985620|FG001|Overall Study|Lost to Follow-up|4|||
49040800|NCT00642993|157985619|FG000|Overall Study|Withdrew - reason unrelated to treatment|11|||
48899199|NCT00346632|157466873|FG004|Overall Study|Death|0|||
48899200|NCT00346632|157466874|FG005|Overall Study|Death|0|||
48899201|NCT00346632|157466875|FG006|Overall Study|Death|0|||
48899202|NCT00346632|157466876|FG007|Overall Study|Death|0|||
48899203|NCT00346632|157466877|FG008|Overall Study|Death|0|||
48899204|NCT00346632|157466878|FG009|Overall Study|Death|0|||
48899205|NCT00346632|157466869|FG000|Overall Study|Protocol Violation|0|||
48899206|NCT00346632|157466870|FG001|Overall Study|Protocol Violation|0|||
48899207|NCT00346632|157466871|FG002|Overall Study|Protocol Violation|0|||
48899208|NCT00346632|157466872|FG003|Overall Study|Protocol Violation|0|||
48899209|NCT00346632|157466873|FG004|Overall Study|Protocol Violation|0|||
48899210|NCT00346632|157466874|FG005|Overall Study|Protocol Violation|0|||
48899211|NCT00346632|157466875|FG006|Overall Study|Protocol Violation|1|||
49040801|NCT00642993|157985620|FG001|Overall Study|Withdrew - reason unrelated to treatment|3|||
49040802|NCT00642993|157985619|FG000|Overall Study|Protocol Violation|1|||
49040803|NCT00642993|157985620|FG001|Overall Study|Protocol Violation|4|||
49040804|NCT00642993|157985619|FG000|Overall Study|Did not meet protocol eligibility|0|||
49040805|NCT00642993|157985620|FG001|Overall Study|Did not meet protocol eligibility|1|||
49040806|NCT00642993|157985619|FG000|Overall Study|Administrative|1|||
49040807|NCT00642993|157985620|FG001|Overall Study|Administrative|0|||
49040808|NCT00373256|157985626|FG000|Overall Study|Adverse Event (AE)|1|||
49040809|NCT00373256|157985627|FG001|Overall Study|Adverse Event (AE)|5|||
49040810|NCT00373256|157985626|FG000|Overall Study|Lost to Follow-up|2|||
49040811|NCT00373256|157985627|FG001|Overall Study|Lost to Follow-up|1|||
49040812|NCT00373256|157985626|FG000|Overall Study|Death|9|||
49040813|NCT00373256|157985627|FG001|Overall Study|Death|8|||
49040814|NCT00373256|157985626|FG000|Overall Study|Objective Progression or Relapse|111|||
49040815|NCT00373256|157985627|FG001|Overall Study|Objective Progression or Relapse|104|||
49040816|NCT00373256|157985626|FG000|Overall Study|Refused Treatment-Reason Other Than AE|4|||
49040817|NCT00373256|157985627|FG001|Overall Study|Refused Treatment-Reason Other Than AE|7|||
49040818|NCT00373256|157985626|FG000|Overall Study|Other|73|||
49040819|NCT00373256|157985627|FG001|Overall Study|Other|107|||
49040820|NCT00373256|157985626|FG000|Overall Study|Protocol Violation|0|||
49040821|NCT00373256|157985627|FG001|Overall Study|Protocol Violation|2|||
49040822|NCT00373256|157985626|FG000|Overall Study|Study Terminated by Sponsor|41|||
49040823|NCT00373256|157985627|FG001|Overall Study|Study Terminated by Sponsor|13|||
49040824|NCT02986139|157985629|FG000|Overall Study|Sponsor Decision|1|||
49040825|NCT02986139|157985630|FG001|Overall Study|Sponsor Decision|2|||
49040826|NCT02986139|157985629|FG000|Overall Study|Withdrawal by Subject|0|||
49040827|NCT02986139|157985630|FG001|Overall Study|Withdrawal by Subject|1|||
49040828|NCT02986139|157985629|FG000|Overall Study|Lost to Follow-up|0|||
49040829|NCT02986139|157985630|FG001|Overall Study|Lost to Follow-up|1|||
49040830|NCT00516295|157985632|FG000|Overall Study|Lack of Efficacy|2|||
49040831|NCT00516295|157985633|FG001|Overall Study|Lack of Efficacy|0|||
49040832|NCT00516295|157985634|FG002|Overall Study|Lack of Efficacy|0|||
49040833|NCT00516295|157985632|FG000|Overall Study|Ineligible|1|||
49040834|NCT00516295|157985633|FG001|Overall Study|Ineligible|0|||
49040835|NCT00516295|157985634|FG002|Overall Study|Ineligible|0|||
49040836|NCT01456962|157985635|FG000|Overall Study|Lost to Follow-up|2|||
49040837|NCT01456962|157985636|FG001|Overall Study|Lost to Follow-up|1|||
49040838|NCT02727192|157985637|FG000|Overall Study|Lost to Follow-up|1|||
49040839|NCT02727192|157985638|FG001|Overall Study|Lost to Follow-up|0|||
49040840|NCT02727192|157985639|FG002|Overall Study|Lost to Follow-up|0|||
49040841|NCT04590027|157985645|FG000|Overall Study|Lost to Follow-up|17|||
49040842|NCT04590027|157985646|FG001|Overall Study|Lost to Follow-up|14|||
49040843|NCT04590027|157985645|FG000|Overall Study|Protocol Violation|0|||
49040844|NCT04590027|157985646|FG001|Overall Study|Protocol Violation|3|||
49040845|NCT00673660|157985647|FG000|Overall Study|Lost to Follow-up|107|||
49040846|NCT02699866|157985648|FG000|Overall Study|Withdrawal by Subject|3|||
49040847|NCT02699866|157985648|FG000|Overall Study|Physician Decision|2|||
49040848|NCT02699866|157985648|FG000|Overall Study|Adverse Event|3|||
49040849|NCT01572662|157985649|FG000|Overall Study|Withdrawal by Subject|1|||
49040850|NCT01572662|157985650|FG001|Overall Study|Withdrawal by Subject|0|||
49040851|NCT01572662|157985649|FG000|Overall Study|Physician Decision|0|||
49040852|NCT01572662|157985650|FG001|Overall Study|Physician Decision|1|||
49040853|NCT04203823|157985651|FG000|Overall Study|Withdrawal by Subject|2|||
49040854|NCT04203823|157985652|FG001|Overall Study|Withdrawal by Subject|2|||
49040855|NCT04203823|157985651|FG000|Overall Study|Adverse Event|1|||
49040856|NCT04203823|157985652|FG001|Overall Study|Adverse Event|1|||
49040857|NCT04203823|157985651|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
49040858|NCT04203823|157985652|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
49040859|NCT01923740|157985653|FG000|Overall Study|Lost to Follow-up|4|||
49040860|NCT01923740|157985654|FG001|Overall Study|Lost to Follow-up|9|||
49040861|NCT01923740|157985653|FG000|Overall Study|Withdrawal by Subject|2|||
49040862|NCT01923740|157985654|FG001|Overall Study|Withdrawal by Subject|0|||
49040863|NCT03497130|157985655|FG000|Overall Study|Lost to Follow-up|1|||
49040864|NCT03497130|157985656|FG001|Overall Study|Lost to Follow-up|1|||
49040865|NCT04002648|157985657|FG000|Overall Study|Lost to Follow-up|2|||
49040866|NCT04002648|157985658|FG001|Overall Study|Lost to Follow-up|0|||
49040867|NCT00731939|157985660|FG000|Overall Study|Adverse Event|6|||
49040868|NCT00731939|157985660|FG000|Overall Study|Lost to Follow-up|15|||
49040869|NCT00731939|157985660|FG000|Overall Study|Not implanted with study device|9|||
49040870|NCT00731939|157985660|FG000|Overall Study|Withdrawal by Subject|2|||
49040871|NCT00731939|157985660|FG000|Overall Study|Did not meet enrollment criteria|2|||
49040872|NCT00874822|157985661|FG000|Overall Study|excluded by criteria|8|||
49040873|NCT01438060|157985662|FG000|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7|||
49040874|NCT01438060|157985663|FG001|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9|||
49040875|NCT01438060|157985662|FG000|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6|||
49040876|NCT01438060|157985663|FG001|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3|||
49040877|NCT01438060|157985662|FG000|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3|||
49040878|NCT01438060|157985663|FG001|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4|||
49040879|NCT01438060|157985662|FG000|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1|||
49040880|NCT01438060|157985663|FG001|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0|||
49040881|NCT01438060|157985662|FG000|Acute Phase: Double-blind, 10 Weeks|Death|0|||
49040882|NCT01438060|157985663|FG001|Acute Phase: Double-blind, 10 Weeks|Death|2|||
49040883|NCT01438060|157985662|FG000|Acute Phase: Double-blind, 10 Weeks|Other Reason|1|||
49040884|NCT01438060|157985663|FG001|Acute Phase: Double-blind, 10 Weeks|Other Reason|0|||
49040885|NCT01438060|157985662|FG000|Extension Phase: Week 10 to Week 130|Adverse Event|15|||
49040886|NCT01438060|157985663|FG001|Extension Phase: Week 10 to Week 130|Adverse Event|16|||
49040887|NCT01438060|157985662|FG000|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
49040888|NCT01438060|157985663|FG001|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
49040889|NCT01438060|157985662|FG000|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3|||
49040890|NCT01438060|157985663|FG001|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5|||
49040891|NCT01438060|157985662|FG000|Extension Phase: Week 10 to Week 130|Participant Unreliability|1|||
49040892|NCT01438060|157985663|FG001|Extension Phase: Week 10 to Week 130|Participant Unreliability|0|||
49040893|NCT01438060|157985662|FG000|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2|||
49040894|NCT01438060|157985663|FG001|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0|||
49040895|NCT01438060|157985662|FG000|Extension Phase: Week 10 to Week 130|Death|22|||
49040896|NCT01438060|157985663|FG001|Extension Phase: Week 10 to Week 130|Death|12|||
49040897|NCT01438060|157985662|FG000|Extension Phase: Week 10 to Week 130|Other Reason|7|||
49040898|NCT01438060|157985663|FG001|Extension Phase: Week 10 to Week 130|Other Reason|15|||
49040899|NCT01438060|157985662|FG000|On Study Beyond Week 140|Adverse Event|0|||
49040900|NCT01438060|157985663|FG001|On Study Beyond Week 140|Adverse Event|2|||
49040901|NCT01438060|157985662|FG000|On Study Beyond Week 140|Lack of Efficacy|0|||
49040902|NCT01438060|157985663|FG001|On Study Beyond Week 140|Lack of Efficacy|1|||
49040903|NCT01438060|157985662|FG000|On Study Beyond Week 140|Withdrawal by Subject|0|||
49040904|NCT01438060|157985663|FG001|On Study Beyond Week 140|Withdrawal by Subject|1|||
49040905|NCT01438060|157985662|FG000|On Study Beyond Week 140|Death|0|||
49040906|NCT01438060|157985663|FG001|On Study Beyond Week 140|Death|1|||
49040907|NCT01438060|157985662|FG000|On Study Beyond Week 140|Other Reason|0|||
49040908|NCT01438060|157985663|FG001|On Study Beyond Week 140|Other Reason|3|||
49040909|NCT00503867|157985667|FG000|Overall Study|Lost to Follow-up|1|||
49040910|NCT00503867|157985667|FG000|Overall Study|Adverse Event|1|||
49040911|NCT00858780|157985669|FG000|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18|||
49040912|NCT00858780|157985670|FG001|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
49040913|NCT00858780|157985671|FG002|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
49040914|NCT00858780|157985672|FG003|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
49040915|NCT00858780|157985673|FG004|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
49040916|NCT00858780|157985669|FG000|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
49040917|NCT00858780|157985670|FG001|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
49040918|NCT00858780|157985671|FG002|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1|||
49040919|NCT00858780|157985672|FG003|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
49040920|NCT00858780|157985673|FG004|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
49040921|NCT00858780|157985669|FG000|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
49040922|NCT00858780|157985670|FG001|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
49040923|NCT00858780|157985671|FG002|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
49040924|NCT00858780|157985672|FG003|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
49040925|NCT00858780|157985673|FG004|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
49040926|NCT00858780|157985669|FG000|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
49040927|NCT00858780|157985670|FG001|Double-Blind (Week 0 to Failure/Week 48)|Other|1|||
49040928|NCT00858780|157985671|FG002|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
49040929|NCT00858780|157985672|FG003|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
49040930|NCT00858780|157985673|FG004|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
49040931|NCT00858780|157985669|FG000|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
49040932|NCT00858780|157985670|FG001|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
49040933|NCT00858780|157985671|FG002|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
49040934|NCT00858780|157985672|FG003|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
49040935|NCT00858780|157985673|FG004|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1|||
49040936|NCT00858780|157985669|FG000|OL Re-Treatment (Failure to Week 48)|Other|0|||
49040937|NCT00858780|157985670|FG001|OL Re-Treatment (Failure to Week 48)|Other|0|||
49040938|NCT00858780|157985671|FG002|OL Re-Treatment (Failure to Week 48)|Other|0|||
48899212|NCT00346632|157466876|FG007|Overall Study|Protocol Violation|0|||
48899213|NCT00346632|157466877|FG008|Overall Study|Protocol Violation|0|||
49040939|NCT00858780|157985672|FG003|OL Re-Treatment (Failure to Week 48)|Other|0|||
48899214|NCT00346632|157466878|FG009|Overall Study|Protocol Violation|0|||
48899215|NCT00346632|157466869|FG000|Overall Study|Withdrawal by Subject|0|||
48899216|NCT00346632|157466870|FG001|Overall Study|Withdrawal by Subject|0|||
49040940|NCT00858780|157985673|FG004|OL Re-Treatment (Failure to Week 48)|Other|1|||
48899217|NCT00346632|157466871|FG002|Overall Study|Withdrawal by Subject|0|||
48899218|NCT00346632|157466872|FG003|Overall Study|Withdrawal by Subject|0|||
48899219|NCT00346632|157466873|FG004|Overall Study|Withdrawal by Subject|0|||
48899220|NCT00346632|157466874|FG005|Overall Study|Withdrawal by Subject|0|||
48899221|NCT00346632|157466875|FG006|Overall Study|Withdrawal by Subject|1|||
48899222|NCT00346632|157466876|FG007|Overall Study|Withdrawal by Subject|0|||
48899223|NCT00346632|157466877|FG008|Overall Study|Withdrawal by Subject|0|||
48899224|NCT00346632|157466878|FG009|Overall Study|Withdrawal by Subject|0|||
48899225|NCT00346632|157466869|FG000|Overall Study|Switched to alternative treatment|0|||
48899226|NCT00346632|157466870|FG001|Overall Study|Switched to alternative treatment|0|||
49040941|NCT00965757|157985674|FG000|Double-blind Phase|Progression of concomitant disease|1|||
49040942|NCT00965757|157985675|FG001|Double-blind Phase|Progression of concomitant disease|2|||
49040943|NCT00965757|157985676|FG002|Double-blind Phase|Progression of concomitant disease|0|||
49040944|NCT00965757|157985677|FG003|Double-blind Phase|Progression of concomitant disease|0|||
49040945|NCT00965757|157985674|FG000|Double-blind Phase|Adverse drug reaction|2|||
49040946|NCT00965757|157985675|FG001|Double-blind Phase|Adverse drug reaction|1|||
49040947|NCT00965757|157985676|FG002|Double-blind Phase|Adverse drug reaction|0|||
49040948|NCT00965757|157985677|FG003|Double-blind Phase|Adverse drug reaction|0|||
49040949|NCT00965757|157985674|FG000|Double-blind Phase|Abnormal Laboratory Value|2|||
49040950|NCT00965757|157985675|FG001|Double-blind Phase|Abnormal Laboratory Value|0|||
49040951|NCT00965757|157985676|FG002|Double-blind Phase|Abnormal Laboratory Value|0|||
49040952|NCT00965757|157985677|FG003|Double-blind Phase|Abnormal Laboratory Value|0|||
49040953|NCT00965757|157985674|FG000|Double-blind Phase|Lack of Efficacy|7|||
49040954|NCT00965757|157985675|FG001|Double-blind Phase|Lack of Efficacy|11|||
49040955|NCT00965757|157985676|FG002|Double-blind Phase|Lack of Efficacy|0|||
49040956|NCT00965757|157985677|FG003|Double-blind Phase|Lack of Efficacy|0|||
49040957|NCT00965757|157985674|FG000|Double-blind Phase|Drug Refusal Due to Adverse Event|2|||
49040958|NCT00965757|157985675|FG001|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
49040959|NCT00965757|157985676|FG002|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
49040960|NCT00965757|157985677|FG003|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
49040961|NCT00965757|157985674|FG000|Double-blind Phase|Lost to Follow-up|0|||
49040962|NCT00965757|157985675|FG001|Double-blind Phase|Lost to Follow-up|1|||
48899227|NCT00346632|157466871|FG002|Overall Study|Switched to alternative treatment|1|||
48899228|NCT00346632|157466872|FG003|Overall Study|Switched to alternative treatment|0|||
48899229|NCT00346632|157466873|FG004|Overall Study|Switched to alternative treatment|0|||
48899230|NCT00346632|157466874|FG005|Overall Study|Switched to alternative treatment|0|||
48899231|NCT00346632|157466875|FG006|Overall Study|Switched to alternative treatment|0|||
48899232|NCT00346632|157466876|FG007|Overall Study|Switched to alternative treatment|0|||
48899233|NCT00346632|157466877|FG008|Overall Study|Switched to alternative treatment|0|||
48899234|NCT00346632|157466878|FG009|Overall Study|Switched to alternative treatment|0|||
48899235|NCT00346632|157466869|FG000|Overall Study|Not Stated|1|||
48899236|NCT00346632|157466870|FG001|Overall Study|Not Stated|1|||
49040963|NCT00965757|157985676|FG002|Double-blind Phase|Lost to Follow-up|0|||
49040964|NCT00965757|157985677|FG003|Double-blind Phase|Lost to Follow-up|0|||
49040965|NCT00965757|157985674|FG000|Double-blind Phase|Ineligible after Taking Study Drug|2|||
49040966|NCT00965757|157985675|FG001|Double-blind Phase|Ineligible after Taking Study Drug|3|||
49040967|NCT00965757|157985676|FG002|Double-blind Phase|Ineligible after Taking Study Drug|0|||
49040968|NCT00965757|157985677|FG003|Double-blind Phase|Ineligible after Taking Study Drug|0|||
49040969|NCT00965757|157985674|FG000|Double-blind Phase|Other|1|||
49040970|NCT00965757|157985675|FG001|Double-blind Phase|Other|0|||
49040971|NCT00965757|157985676|FG002|Double-blind Phase|Other|0|||
48899237|NCT00346632|157466871|FG002|Overall Study|Not Stated|0|||
48899238|NCT00346632|157466872|FG003|Overall Study|Not Stated|0|||
48899239|NCT00346632|157466873|FG004|Overall Study|Not Stated|0|||
48899240|NCT00346632|157466874|FG005|Overall Study|Not Stated|0|||
48899241|NCT00346632|157466875|FG006|Overall Study|Not Stated|0|||
48899242|NCT00346632|157466876|FG007|Overall Study|Not Stated|2|||
48899243|NCT00346632|157466877|FG008|Overall Study|Not Stated|2|||
48899244|NCT00346632|157466878|FG009|Overall Study|Not Stated|1|||
48899245|NCT04882995|157466879|FG000|Overall Study|Withdrawal by Subject|1|||
48899246|NCT04882995|157466880|FG001|Overall Study|Withdrawal by Subject|2|||
48899247|NCT04882995|157466879|FG000|Overall Study|Protocol Violation|4|||
48899248|NCT04882995|157466880|FG001|Overall Study|Protocol Violation|4|||
48899249|NCT04882995|157466879|FG000|Overall Study|Surgery postponed due to COVID|1|||
48899250|NCT04882995|157466880|FG001|Overall Study|Surgery postponed due to COVID|1|||
48899251|NCT00319839|157466883|FG000|Overall Study|Adverse Event|5|||
49040972|NCT00965757|157985677|FG003|Double-blind Phase|Other|0|||
49040973|NCT00965757|157985674|FG000|Extension Phase|Progression of concomitant disease|0|||
49040974|NCT00965757|157985675|FG001|Extension Phase|Progression of concomitant disease|0|||
49040975|NCT00965757|157985676|FG002|Extension Phase|Progression of concomitant disease|4|||
49040976|NCT00965757|157985677|FG003|Extension Phase|Progression of concomitant disease|2|||
49040977|NCT00965757|157985674|FG000|Extension Phase|Adverse drug reaction|0|||
49040978|NCT00965757|157985675|FG001|Extension Phase|Adverse drug reaction|0|||
49040979|NCT00965757|157985676|FG002|Extension Phase|Adverse drug reaction|6|||
48899252|NCT00319839|157466883|FG000|Overall Study|Withdrawal by Subject|1|||
48899253|NCT00825916|157466884|FG000|Overall Study|Lost to Follow-up|4|||
48899254|NCT00825916|157466885|FG001|Overall Study|Lost to Follow-up|2|||
48899255|NCT00825916|157466886|FG002|Overall Study|Lost to Follow-up|1|||
48899256|NCT00903630|157466887|FG000|Phase 2|Adverse Event|0|||
48899257|NCT00903630|157466888|FG001|Phase 2|Adverse Event|0|||
48899258|NCT00903630|157466889|FG002|Phase 2|Adverse Event|1|||
48899259|NCT04025580|157466890|FG000|Overall Study|COVID 19 restrictions at Clinical Center|11|||
48899260|NCT04025580|157466891|FG001|Overall Study|COVID 19 restrictions at Clinical Center|0|||
48899261|NCT04025580|157466892|FG002|Overall Study|COVID 19 restrictions at Clinical Center|0|||
48899262|NCT00966277|157466895|FG000|Overall Study|Withdrawal by Subject|3|||
48899263|NCT00966277|157466896|FG001|Overall Study|Withdrawal by Subject|0|||
48899264|NCT00966277|157466895|FG000|Overall Study|Ineligible|1|||
48899265|NCT00966277|157466896|FG001|Overall Study|Ineligible|3|||
48899266|NCT00966277|157466895|FG000|Overall Study|Treatment Plan Changed|0|||
48899267|NCT00966277|157466896|FG001|Overall Study|Treatment Plan Changed|1|||
48899268|NCT02084056|157466899|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
48899269|NCT02084056|157466900|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
48899270|NCT02084056|157466901|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
48899271|NCT02084056|157466902|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
48899272|NCT02084056|157466899|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
48899273|NCT02084056|157466900|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
48899274|NCT02084056|157466901|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
48899275|NCT02084056|157466902|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
48899276|NCT03305731|157466903|FG000|Overall Study|Protocol Violation|1|||
48899277|NCT01952054|157466904|FG000|Overall Study|Physician Decision|1|||
48899278|NCT01498653|157466906|FG000|Overall Study|Adverse Event|2|||
48899279|NCT01498653|157466907|FG001|Overall Study|Adverse Event|2|||
48899280|NCT01498653|157466906|FG000|Overall Study|Lack of Efficacy|12|||
48899281|NCT01498653|157466907|FG001|Overall Study|Lack of Efficacy|26|||
48899282|NCT01498653|157466906|FG000|Overall Study|Protocol Violation|0|||
48899283|NCT01498653|157466907|FG001|Overall Study|Protocol Violation|4|||
48899284|NCT01498653|157466906|FG000|Overall Study|Lost to Follow-up|1|||
48899285|NCT01498653|157466907|FG001|Overall Study|Lost to Follow-up|0|||
48899286|NCT01498653|157466906|FG000|Overall Study|Physician Decision|2|||
48899287|NCT01498653|157466907|FG001|Overall Study|Physician Decision|0|||
48899288|NCT01498653|157466906|FG000|Overall Study|Withdrawal by Subject|2|||
48899289|NCT01498653|157466907|FG001|Overall Study|Withdrawal by Subject|3|||
48899290|NCT01210664|157466908|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
48899291|NCT01210664|157466909|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
48899292|NCT01210664|157466910|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1|||
48899293|NCT01210664|157466911|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
48899294|NCT01210664|157466908|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
48899295|NCT01210664|157466909|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
48899296|NCT01210664|157466910|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1|||
48899297|NCT01210664|157466911|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
48899298|NCT01210664|157466908|FG000|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
48899299|NCT01210664|157466909|FG001|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
48899300|NCT01210664|157466910|FG002|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
48899301|NCT01210664|157466911|FG003|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1|||
48899302|NCT02318797|157466912|FG000|Overall Study|Death|3|||
48899303|NCT02318797|157466913|FG001|Overall Study|Death|6|||
48899304|NCT02318797|157466912|FG000|Overall Study|Lost to Follow-up|85|||
48899305|NCT02318797|157466913|FG001|Overall Study|Lost to Follow-up|96|||
48899306|NCT02709096|157466914|FG000|Overall Study|non-compliance|1|||
48899307|NCT02709096|157466915|FG001|Overall Study|non-compliance|1|||
48899308|NCT01275131|157466916|FG000|Period 1|Withdrawal by Subject|1|||
48899309|NCT01275131|157466917|FG001|Period 1|Withdrawal by Subject|0|||
48899310|NCT01275131|157466918|FG002|Period 1|Withdrawal by Subject|3|||
48899311|NCT01275131|157466919|FG003|Period 1|Withdrawal by Subject|2|||
48899312|NCT01275131|157466916|FG000|Period 1|Physician Decision|1|||
48899313|NCT01275131|157466917|FG001|Period 1|Physician Decision|0|||
48899314|NCT01275131|157466918|FG002|Period 1|Physician Decision|0|||
48899315|NCT01275131|157466919|FG003|Period 1|Physician Decision|0|||
48899316|NCT01275131|157466916|FG000|Period 2 (Crossover)|Adverse Event|0|||
48899317|NCT01275131|157466917|FG001|Period 2 (Crossover)|Adverse Event|1|||
48899318|NCT01275131|157466918|FG002|Period 2 (Crossover)|Adverse Event|0|||
48899319|NCT01275131|157466919|FG003|Period 2 (Crossover)|Adverse Event|0|||
48899320|NCT01275131|157466916|FG000|Period 2 (Crossover)|Withdrawal by Subject|1|||
48899321|NCT01275131|157466917|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
48899322|NCT01275131|157466918|FG002|Period 2 (Crossover)|Withdrawal by Subject|1|||
48899323|NCT01275131|157466919|FG003|Period 2 (Crossover)|Withdrawal by Subject|2|||
48899324|NCT01142596|157466920|FG000|Overall Study|Withdrawal by Subject|9|||
48899325|NCT01142596|157466921|FG001|Overall Study|Withdrawal by Subject|35|||
48899326|NCT01142596|157466920|FG000|Overall Study|Adverse Event|8|||
49040980|NCT00965757|157985677|FG003|Extension Phase|Adverse drug reaction|3|||
49040981|NCT00965757|157985674|FG000|Extension Phase|Abnormal Laboratory Value|0|||
49040982|NCT00965757|157985675|FG001|Extension Phase|Abnormal Laboratory Value|0|||
49040983|NCT00965757|157985676|FG002|Extension Phase|Abnormal Laboratory Value|6|||
49040984|NCT00965757|157985677|FG003|Extension Phase|Abnormal Laboratory Value|1|||
49040985|NCT00965757|157985674|FG000|Extension Phase|Lack of Efficacy|0|||
49040986|NCT00965757|157985675|FG001|Extension Phase|Lack of Efficacy|0|||
49040987|NCT00965757|157985676|FG002|Extension Phase|Lack of Efficacy|8|||
49040988|NCT00965757|157985677|FG003|Extension Phase|Lack of Efficacy|12|||
49040989|NCT00965757|157985674|FG000|Extension Phase|Drug Refusal Due to Adverse Event|0|||
49040990|NCT00965757|157985675|FG001|Extension Phase|Drug Refusal Due to Adverse Event|0|||
49040991|NCT00965757|157985676|FG002|Extension Phase|Drug Refusal Due to Adverse Event|4|||
49040992|NCT00965757|157985677|FG003|Extension Phase|Drug Refusal Due to Adverse Event|0|||
49040993|NCT00965757|157985674|FG000|Extension Phase|Lost to Follow-up|0|||
49040994|NCT00965757|157985675|FG001|Extension Phase|Lost to Follow-up|0|||
49040995|NCT00965757|157985676|FG002|Extension Phase|Lost to Follow-up|0|||
49040996|NCT00965757|157985677|FG003|Extension Phase|Lost to Follow-up|1|||
49040997|NCT00965757|157985674|FG000|Extension Phase|Ineligible after Taking Study Drug|0|||
49040998|NCT00965757|157985675|FG001|Extension Phase|Ineligible after Taking Study Drug|0|||
49040999|NCT00965757|157985676|FG002|Extension Phase|Ineligible after Taking Study Drug|3|||
49041000|NCT00965757|157985677|FG003|Extension Phase|Ineligible after Taking Study Drug|3|||
49041001|NCT00965757|157985674|FG000|Extension Phase|Protocol Violation|0|||
49041002|NCT00965757|157985675|FG001|Extension Phase|Protocol Violation|0|||
49041003|NCT00965757|157985676|FG002|Extension Phase|Protocol Violation|0|||
49041004|NCT00965757|157985677|FG003|Extension Phase|Protocol Violation|1|||
49041005|NCT00965757|157985674|FG000|Extension Phase|Other|0|||
49041006|NCT00965757|157985675|FG001|Extension Phase|Other|0|||
49041007|NCT00965757|157985676|FG002|Extension Phase|Other|2|||
49041008|NCT00965757|157985677|FG003|Extension Phase|Other|1|||
49041009|NCT03807440|157985678|FG000|Overall Study|No documentation of index date 2|320|||
49041010|NCT03807440|157985678|FG000|Overall Study|No informed consent for index date 2|117|||
49041011|NCT02451358|157985679|FG000|Overall Study|Withdrawal by Subject|1|||
49041012|NCT02451358|157985680|FG001|Overall Study|Withdrawal by Subject|1|||
49041013|NCT02451358|157985681|FG002|Overall Study|Withdrawal by Subject|0|||
49041014|NCT02451358|157985682|FG003|Overall Study|Withdrawal by Subject|0|||
49041015|NCT02451358|157985679|FG000|Overall Study|Protocol Violation|0|||
49041016|NCT02451358|157985680|FG001|Overall Study|Protocol Violation|1|||
49041017|NCT02451358|157985681|FG002|Overall Study|Protocol Violation|1|||
49041018|NCT02451358|157985682|FG003|Overall Study|Protocol Violation|0|||
49041019|NCT00685334|157985683|FG000|Overall Study|Withdrawal by Subject|5|||
49041020|NCT00685334|157985684|FG001|Overall Study|Withdrawal by Subject|6|||
49041021|NCT00685334|157985683|FG000|Overall Study|Lost to Follow-up|4|||
49041022|NCT00685334|157985684|FG001|Overall Study|Lost to Follow-up|0|||
49041023|NCT00685334|157985683|FG000|Overall Study|Chose to enter hospital|1|||
49041024|NCT00685334|157985684|FG001|Overall Study|Chose to enter hospital|1|||
49041025|NCT01055834|157985691|FG000|Treatment Period I|Adverse Event|1|||
49041026|NCT01055834|157985692|FG001|Treatment Period I|Adverse Event|0|||
48899327|NCT01142596|157466921|FG001|Overall Study|Adverse Event|35|||
48899328|NCT01142596|157466920|FG000|Overall Study|Lack of Efficacy|5|||
48899329|NCT01142596|157466921|FG001|Overall Study|Lack of Efficacy|9|||
48899330|NCT01142596|157466920|FG000|Overall Study|Lost to Follow-up|2|||
48899331|NCT01142596|157466921|FG001|Overall Study|Lost to Follow-up|3|||
48899332|NCT01142596|157466920|FG000|Overall Study|Other reason (not specified)|5|||
48899333|NCT01142596|157466921|FG001|Overall Study|Other reason (not specified)|4|||
48899334|NCT01588496|157466922|FG000|Overall Study|Withdrawal by Subject|0|||
48899335|NCT01588496|157466923|FG001|Overall Study|Withdrawal by Subject|1|||
48899336|NCT01588496|157466924|FG002|Overall Study|Withdrawal by Subject|0|||
48899337|NCT01668667|157466925|FG000|Overall Study|Adverse Event|3|||
48899338|NCT01668667|157466926|FG001|Overall Study|Adverse Event|6|||
48899339|NCT01668667|157466927|FG002|Overall Study|Adverse Event|4|||
48899340|NCT01668667|157466928|FG003|Overall Study|Adverse Event|4|||
49041027|NCT01717313|157985693|FG000|Phase A (Weeks 0 to 24)|Death|0|||
49041028|NCT01717313|157985694|FG001|Phase A (Weeks 0 to 24)|Death|1|||
49041029|NCT01717313|157985693|FG000|Phase A (Weeks 0 to 24)|Lost to Follow-up|1|||
49041030|NCT01717313|157985694|FG001|Phase A (Weeks 0 to 24)|Lost to Follow-up|3|||
49041031|NCT01717313|157985693|FG000|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12|||
49041032|NCT01717313|157985694|FG001|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6|||
49041033|NCT01717313|157985693|FG000|Phase A (Weeks 0 to 24)|Adverse Event|4|||
49041034|NCT01717313|157985694|FG001|Phase A (Weeks 0 to 24)|Adverse Event|2|||
49041035|NCT01717313|157985693|FG000|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
49041036|NCT01717313|157985694|FG001|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
49041037|NCT01717313|157985693|FG000|Interphase|Completed Phase A Did Not Enter Phase B|1|||
49041038|NCT01717313|157985694|FG001|Interphase|Completed Phase A Did Not Enter Phase B|0|||
48899341|NCT01668667|157466925|FG000|Overall Study|Lack of Efficacy|3|||
48899342|NCT01668667|157466926|FG001|Overall Study|Lack of Efficacy|2|||
48899343|NCT01668667|157466927|FG002|Overall Study|Lack of Efficacy|2|||
49041039|NCT01717313|157985693|FG000|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
49041040|NCT01717313|157985694|FG001|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
49041041|NCT01717313|157985693|FG000|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7|||
49041042|NCT01717313|157985694|FG001|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9|||
49041043|NCT01717313|157985693|FG000|Phase B (Weeks 24 to 54)|Lost to Follow-up|1|||
49041044|NCT01717313|157985694|FG001|Phase B (Weeks 24 to 54)|Lost to Follow-up|3|||
49041045|NCT03255980|157985699|FG000|Overall Study|Grade =>3 Skin Toxicity|1|||
49041046|NCT03255980|157985700|FG001|Overall Study|Grade =>3 Skin Toxicity|4|||
49041047|NCT03255980|157985701|FG002|Overall Study|Grade =>3 Skin Toxicity|6|||
49041048|NCT03255980|157985702|FG003|Overall Study|Grade =>3 Skin Toxicity|5|||
49041049|NCT03255980|157985699|FG000|Overall Study|Adverse Event|1|||
49041050|NCT03255980|157985700|FG001|Overall Study|Adverse Event|1|||
49041051|NCT03255980|157985701|FG002|Overall Study|Adverse Event|0|||
48899344|NCT01668667|157466928|FG003|Overall Study|Lack of Efficacy|3|||
48899345|NCT01668667|157466925|FG000|Overall Study|Protocol Violation|6|||
48899346|NCT01668667|157466926|FG001|Overall Study|Protocol Violation|10|||
48899347|NCT01668667|157466927|FG002|Overall Study|Protocol Violation|12|||
48899348|NCT01668667|157466928|FG003|Overall Study|Protocol Violation|5|||
48899349|NCT01668667|157466925|FG000|Overall Study|Lost to Follow-up|9|||
48899350|NCT01668667|157466926|FG001|Overall Study|Lost to Follow-up|4|||
48899351|NCT01668667|157466927|FG002|Overall Study|Lost to Follow-up|7|||
48899352|NCT01668667|157466928|FG003|Overall Study|Lost to Follow-up|6|||
48899353|NCT01668667|157466925|FG000|Overall Study|Physician Decision|3|||
48899354|NCT01668667|157466926|FG001|Overall Study|Physician Decision|0|||
48899355|NCT01668667|157466927|FG002|Overall Study|Physician Decision|1|||
48899356|NCT01668667|157466928|FG003|Overall Study|Physician Decision|0|||
48899357|NCT01668667|157466925|FG000|Overall Study|Withdrawal by Subject|7|||
48899358|NCT01668667|157466926|FG001|Overall Study|Withdrawal by Subject|4|||
48899359|NCT01668667|157466927|FG002|Overall Study|Withdrawal by Subject|5|||
48899360|NCT01668667|157466928|FG003|Overall Study|Withdrawal by Subject|5|||
48899361|NCT00511901|157466929|FG000|Overall Study|Withdrawal by Subject|1|||
48899362|NCT00511901|157466930|FG001|Overall Study|Withdrawal by Subject|3|||
48899363|NCT00421707|157466931|FG000|Period 1: Treatment Period 1|Withdrawal by Subject|1|||
48899364|NCT00421707|157466932|FG001|Period 1: Treatment Period 1|Withdrawal by Subject|5|||
48899365|NCT00421707|157466931|FG000|Period 1: Treatment Period 1|Adverse Event|7|||
48899366|NCT00421707|157466932|FG001|Period 1: Treatment Period 1|Adverse Event|2|||
48899367|NCT00421707|157466931|FG000|Period 1: Treatment Period 1|Lost to Follow-up|2|||
48899368|NCT00421707|157466932|FG001|Period 1: Treatment Period 1|Lost to Follow-up|2|||
48899369|NCT00421707|157466931|FG000|Period 1: Treatment Period 1|Protocol Violation|1|||
48899370|NCT00421707|157466932|FG001|Period 1: Treatment Period 1|Protocol Violation|0|||
48899371|NCT00421707|157466931|FG000|Period 2: Washout|Adverse Event|1|||
48899372|NCT00421707|157466932|FG001|Period 2: Washout|Adverse Event|1|||
48899373|NCT00421707|157466931|FG000|Period 2: Washout|Withdrawal by Subject|0|||
48899374|NCT00421707|157466932|FG001|Period 2: Washout|Withdrawal by Subject|1|||
48899375|NCT00421707|157466931|FG000|Period 2: Washout|Lost to Follow-up|0|||
48899376|NCT00421707|157466932|FG001|Period 2: Washout|Lost to Follow-up|1|||
48899377|NCT00421707|157466931|FG000|Period 2: Washout|Other: Pregnancy|0|||
48899378|NCT00421707|157466932|FG001|Period 2: Washout|Other: Pregnancy|1|||
48984506|NCT03756285|157774246|FG000|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0|||
48984507|NCT03756285|157774247|FG001|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1|||
48984508|NCT03756285|157774246|FG000|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
48984509|NCT03756285|157774247|FG001|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
48984510|NCT02192190|157774248|FG000|Overall Study|Adverse Event|1|||
48984511|NCT02192190|157774249|FG001|Overall Study|Adverse Event|1|||
48984512|NCT02192190|157774250|FG002|Overall Study|Adverse Event|0|||
48984513|NCT02192190|157774251|FG003|Overall Study|Adverse Event|0|||
48984514|NCT02192190|157774252|FG004|Overall Study|Adverse Event|0|||
48984515|NCT02192190|157774253|FG005|Overall Study|Adverse Event|0|||
48984516|NCT02192190|157774248|FG000|Overall Study|Lost to Follow-up|3|||
48984517|NCT02192190|157774249|FG001|Overall Study|Lost to Follow-up|3|||
48984518|NCT02192190|157774250|FG002|Overall Study|Lost to Follow-up|2|||
48984519|NCT02192190|157774251|FG003|Overall Study|Lost to Follow-up|1|||
48984520|NCT02192190|157774252|FG004|Overall Study|Lost to Follow-up|4|||
48984521|NCT02192190|157774253|FG005|Overall Study|Lost to Follow-up|3|||
48984522|NCT02192190|157774248|FG000|Overall Study|Physician Decision|2|||
48899379|NCT00421707|157466931|FG000|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
48899380|NCT00421707|157466932|FG001|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
48899381|NCT00421707|157466931|FG000|Period 3:Treatment Period 2|Protocol Violation|1|||
48899382|NCT00421707|157466932|FG001|Period 3:Treatment Period 2|Protocol Violation|0|||
48899383|NCT00421707|157466931|FG000|Period 3:Treatment Period 2|Adverse Event|0|||
48899384|NCT00421707|157466932|FG001|Period 3:Treatment Period 2|Adverse Event|2|||
48899385|NCT01201265|157466933|FG000|Overall Study|Death|14|||
48984523|NCT02192190|157774249|FG001|Overall Study|Physician Decision|0|||
48984524|NCT02192190|157774250|FG002|Overall Study|Physician Decision|0|||
48899386|NCT01201265|157466933|FG000|Overall Study|Insufficient Therapeutic Response|3|||
48899387|NCT01201265|157466933|FG000|Overall Study|Lost to Follow-up|10|||
48899388|NCT01201265|157466933|FG000|Overall Study|Withdrawal by Subject|7|||
48899389|NCT01201265|157466933|FG000|Overall Study|Disease Progression|4|||
48899390|NCT02667587|157466936|FG000|Pre-Treatment|Not reported|1|||
48899391|NCT02667587|157466937|FG001|Pre-Treatment|Not reported|0|||
48899392|NCT02667587|157466936|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
48899393|NCT02667587|157466937|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
48899394|NCT02667587|157466936|FG000|Pre-Treatment|Participant withdrew consent|0|||
48899395|NCT02667587|157466937|FG001|Pre-Treatment|Participant withdrew consent|1|||
48899396|NCT02667587|157466936|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
48899397|NCT02667587|157466937|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
48899398|NCT02667587|157466936|FG000|End of Treatment|Other reasons|11|||
48899399|NCT02667587|157466937|FG001|End of Treatment|Other reasons|8|||
48899400|NCT02667587|157466936|FG000|End of Treatment|Participant no Longer Meets Study Criteria|1|||
48899401|NCT02667587|157466937|FG001|End of Treatment|Participant no Longer Meets Study Criteria|2|||
48899402|NCT02667587|157466936|FG000|End of Treatment|Poor/Non-Compliance|0|||
48899403|NCT02667587|157466937|FG001|End of Treatment|Poor/Non-Compliance|1|||
48899404|NCT02667587|157466936|FG000|End of Treatment|Maximum Clinical Benefit|3|||
49041052|NCT03255980|157985702|FG003|Overall Study|Adverse Event|1|||
49041053|NCT03255980|157985699|FG000|Overall Study|Lack of compliance to study or assessmen|0|||
49041054|NCT03255980|157985700|FG001|Overall Study|Lack of compliance to study or assessmen|1|||
49041055|NCT03255980|157985701|FG002|Overall Study|Lack of compliance to study or assessmen|0|||
49041056|NCT03255980|157985702|FG003|Overall Study|Lack of compliance to study or assessmen|0|||
49041057|NCT03255980|157985699|FG000|Overall Study|Lost to Follow-up|1|||
49041058|NCT03255980|157985700|FG001|Overall Study|Lost to Follow-up|1|||
49041059|NCT03255980|157985701|FG002|Overall Study|Lost to Follow-up|0|||
49041060|NCT03255980|157985702|FG003|Overall Study|Lost to Follow-up|3|||
49041061|NCT03255980|157985699|FG000|Overall Study|Withdrawal by Subject|0|||
49041062|NCT03255980|157985700|FG001|Overall Study|Withdrawal by Subject|1|||
49041063|NCT03255980|157985701|FG002|Overall Study|Withdrawal by Subject|0|||
49041064|NCT03255980|157985702|FG003|Overall Study|Withdrawal by Subject|3|||
49041065|NCT04473326|157985711|FG000|Overall Study|Death|0|||
48899405|NCT02667587|157466937|FG001|End of Treatment|Maximum Clinical Benefit|3|||
48899406|NCT02667587|157466936|FG000|End of Treatment|Participant Withdrew Consent|5|||
48899407|NCT02667587|157466937|FG001|End of Treatment|Participant Withdrew Consent|6|||
48984525|NCT02192190|157774251|FG003|Overall Study|Physician Decision|0|||
48984526|NCT02192190|157774252|FG004|Overall Study|Physician Decision|0|||
48984527|NCT02192190|157774253|FG005|Overall Study|Physician Decision|0|||
48984528|NCT02192190|157774248|FG000|Overall Study|Terminated by Sponsor|43|||
48984529|NCT02192190|157774249|FG001|Overall Study|Terminated by Sponsor|23|||
48984530|NCT02192190|157774250|FG002|Overall Study|Terminated by Sponsor|20|||
48984531|NCT02192190|157774251|FG003|Overall Study|Terminated by Sponsor|23|||
48984532|NCT02192190|157774252|FG004|Overall Study|Terminated by Sponsor|21|||
48984533|NCT02192190|157774253|FG005|Overall Study|Terminated by Sponsor|23|||
48984534|NCT02192190|157774248|FG000|Overall Study|Withdrawal by Subject|4|||
48984535|NCT02192190|157774249|FG001|Overall Study|Withdrawal by Subject|1|||
48984536|NCT02192190|157774250|FG002|Overall Study|Withdrawal by Subject|2|||
48984537|NCT02192190|157774251|FG003|Overall Study|Withdrawal by Subject|1|||
48984538|NCT02192190|157774252|FG004|Overall Study|Withdrawal by Subject|5|||
48984539|NCT02192190|157774253|FG005|Overall Study|Withdrawal by Subject|3|||
48984540|NCT02192190|157774248|FG000|Overall Study|Could not Keep Visit Schedule|1|||
48984541|NCT02192190|157774249|FG001|Overall Study|Could not Keep Visit Schedule|0|||
48984542|NCT02192190|157774250|FG002|Overall Study|Could not Keep Visit Schedule|0|||
48984543|NCT02192190|157774251|FG003|Overall Study|Could not Keep Visit Schedule|0|||
48984544|NCT02192190|157774252|FG004|Overall Study|Could not Keep Visit Schedule|0|||
48984545|NCT02192190|157774253|FG005|Overall Study|Could not Keep Visit Schedule|0|||
48984546|NCT02192190|157774248|FG000|Overall Study|Positive Drug Screen|0|||
48984547|NCT02192190|157774249|FG001|Overall Study|Positive Drug Screen|0|||
48984548|NCT02192190|157774250|FG002|Overall Study|Positive Drug Screen|0|||
48984549|NCT02192190|157774251|FG003|Overall Study|Positive Drug Screen|1|||
48984550|NCT02192190|157774252|FG004|Overall Study|Positive Drug Screen|0|||
48984551|NCT02192190|157774253|FG005|Overall Study|Positive Drug Screen|0|||
48984552|NCT02192190|157774248|FG000|Overall Study|Inadequate Pain Relief|0|||
48984553|NCT02192190|157774249|FG001|Overall Study|Inadequate Pain Relief|1|||
48984554|NCT02192190|157774250|FG002|Overall Study|Inadequate Pain Relief|1|||
48984555|NCT02192190|157774251|FG003|Overall Study|Inadequate Pain Relief|0|||
48984556|NCT02192190|157774252|FG004|Overall Study|Inadequate Pain Relief|0|||
48984557|NCT02192190|157774253|FG005|Overall Study|Inadequate Pain Relief|0|||
48984558|NCT00806494|157774254|FG000|Overall Study|Adverse Event|29|||
48984559|NCT00806494|157774254|FG000|Overall Study|Lack of Efficacy|6|||
48984560|NCT00806494|157774254|FG000|Overall Study|Lost to Follow-up|10|||
48984561|NCT00806494|157774254|FG000|Overall Study|Other|30|||
49041066|NCT04473326|157985712|FG001|Overall Study|Death|1|||
49041067|NCT04473326|157985711|FG000|Overall Study|Withdrawal by Subject|1|||
49041068|NCT04473326|157985712|FG001|Overall Study|Withdrawal by Subject|2|||
49041069|NCT01597791|157985713|FG000|Overall Study|Physician Decision|2|||
49041070|NCT01597791|157985714|FG001|Overall Study|Physician Decision|1|||
49041071|NCT01597791|157985713|FG000|Overall Study|Cesarean Section|6|||
49041072|NCT01597791|157985714|FG001|Overall Study|Cesarean Section|7|||
49041073|NCT01597791|157985713|FG000|Overall Study|Subject withdrawal|0|||
49041074|NCT01597791|157985714|FG001|Overall Study|Subject withdrawal|1|||
49041075|NCT01597791|157985713|FG000|Overall Study|Protocol Violation|0|||
49041076|NCT01597791|157985714|FG001|Overall Study|Protocol Violation|1|||
49041077|NCT01155531|157985715|FG000|Overall Study|Adverse Event|0|||
49041078|NCT01155531|157985716|FG001|Overall Study|Adverse Event|0|||
49041079|NCT01155531|157985717|FG002|Overall Study|Adverse Event|1|||
49041080|NCT01155531|157985718|FG003|Overall Study|Adverse Event|0|||
49041081|NCT01155531|157985715|FG000|Overall Study|Lost to Follow-up|0|||
49041082|NCT01155531|157985716|FG001|Overall Study|Lost to Follow-up|0|||
49041083|NCT01155531|157985717|FG002|Overall Study|Lost to Follow-up|0|||
49041084|NCT01155531|157985718|FG003|Overall Study|Lost to Follow-up|1|||
49041085|NCT01155531|157985715|FG000|Overall Study|Withdrawal by Subject|1|||
49041086|NCT01155531|157985716|FG001|Overall Study|Withdrawal by Subject|0|||
49041087|NCT01155531|157985717|FG002|Overall Study|Withdrawal by Subject|1|||
49041088|NCT01155531|157985718|FG003|Overall Study|Withdrawal by Subject|0|||
49041089|NCT00438633|157985719|FG000|Overall Study|Withdrawal by Subject|1|||
49041090|NCT00438633|157985720|FG001|Overall Study|Withdrawal by Subject|0|||
49041091|NCT00438633|157985719|FG000|Overall Study|Lost to Follow-up|15|||
49041092|NCT00438633|157985720|FG001|Overall Study|Lost to Follow-up|17|||
49041093|NCT00562718|157985724|FG000|Overall Study|Death|1|||
49041094|NCT00562718|157985724|FG000|Overall Study|Withdrawal by Subject|3|||
49041095|NCT00562718|157985724|FG000|Overall Study|Adverse Event|4|||
48899408|NCT02667587|157466936|FG000|End of Treatment|Participants Request to Discontinue Study Treatment|25|||
48899409|NCT02667587|157466937|FG001|End of Treatment|Participants Request to Discontinue Study Treatment|26|||
48899410|NCT02667587|157466936|FG000|End of Treatment|Adverse Event Unrelated to Study Drug|19|||
48899411|NCT02667587|157466937|FG001|End of Treatment|Adverse Event Unrelated to Study Drug|20|||
48899412|NCT02667587|157466936|FG000|End of Treatment|Death|2|||
48899413|NCT02667587|157466937|FG001|End of Treatment|Death|1|||
48899414|NCT02667587|157466936|FG000|End of Treatment|Study Drug Toxicity|74|||
48899415|NCT02667587|157466937|FG001|End of Treatment|Study Drug Toxicity|18|||
48899416|NCT02667587|157466936|FG000|End of Treatment|Disease progression|177|||
48899417|NCT02667587|157466937|FG001|End of Treatment|Disease progression|222|||
48899418|NCT02667587|157466936|FG000|End of Treatment|Lost to Follow-up|1|||
48899419|NCT02667587|157466937|FG001|End of Treatment|Lost to Follow-up|3|||
48899420|NCT01585987|157466938|FG000|Randomized|Withdrawal by Subject|0|||
48899421|NCT01585987|157466939|FG001|Randomized|Withdrawal by Subject|4|||
48899422|NCT01585987|157466938|FG000|Randomized|No longer met criteria|0|||
48899423|NCT01585987|157466939|FG001|Randomized|No longer met criteria|2|||
48899424|NCT01585987|157466938|FG000|Treated|Disease Progression|39|||
48899425|NCT01585987|157466939|FG001|Treated|Disease Progression|36|||
48899426|NCT01585987|157466938|FG000|Treated|Study Drug Toxicity|9|||
48899427|NCT01585987|157466939|FG001|Treated|Study Drug Toxicity|5|||
48899428|NCT01585987|157466938|FG000|Treated|Adverse Event|3|||
48899429|NCT01585987|157466939|FG001|Treated|Adverse Event|0|||
48899430|NCT01585987|157466938|FG000|Treated|Withdrawal by Subject|1|||
48899431|NCT01585987|157466939|FG001|Treated|Withdrawal by Subject|2|||
48899432|NCT01585987|157466938|FG000|Treated|Death|1|||
48899433|NCT01585987|157466939|FG001|Treated|Death|0|||
48899434|NCT01585987|157466938|FG000|Treated|Lost to Follow-up|0|||
48899435|NCT01585987|157466939|FG001|Treated|Lost to Follow-up|1|||
48899436|NCT01585987|157466938|FG000|Treated|Maximum Clinical Benefit|0|||
48899437|NCT01585987|157466939|FG001|Treated|Maximum Clinical Benefit|1|||
48899438|NCT01585987|157466938|FG000|Treated|Non-Specified|1|||
48899439|NCT01585987|157466939|FG001|Treated|Non-Specified|2|||
48899440|NCT01585987|157466938|FG000|Treated|Subject Request|0|||
49041096|NCT00562718|157985724|FG000|Overall Study|Lack of Efficacy|2|||
49041097|NCT00562718|157985724|FG000|Overall Study|not stated|1|||
49041098|NCT01868243|157985725|FG000|Overall Study|Death|0|||
49041099|NCT01868243|157985726|FG001|Overall Study|Death|1|||
49041100|NCT00252564|157985727|FG000|Overall Study|Adverse Event|17|||
48899441|NCT01585987|157466939|FG001|Treated|Subject Request|1|||
48899442|NCT01585987|157466938|FG000|Treated|Poor/Non-Compliance|0|||
48899443|NCT01585987|157466939|FG001|Treated|Poor/Non-Compliance|1|||
48899444|NCT00770341|157466940|FG000|Overall Study|Did not meet eligibility criteria|1|||
48899445|NCT00770341|157466941|FG001|Overall Study|Did not meet eligibility criteria|0|||
48899446|NCT00770341|157466942|FG002|Overall Study|Did not meet eligibility criteria|0|||
49041101|NCT00252564|157985728|FG001|Overall Study|Adverse Event|13|||
49041102|NCT00252564|157985727|FG000|Overall Study|Unrelated Complication|2|||
49041103|NCT00252564|157985728|FG001|Overall Study|Unrelated Complication|1|||
49041104|NCT00252564|157985727|FG000|Overall Study|Disease Progression|14|||
49041105|NCT00252564|157985728|FG001|Overall Study|Disease Progression|20|||
49041106|NCT00252564|157985727|FG000|Overall Study|Death|0|||
48984562|NCT00806494|157774254|FG000|Overall Study|Withdrawal by Subject|5|||
48984563|NCT03607994|157774255|FG000|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
48984564|NCT03607994|157774256|FG001|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
48984565|NCT02417935|157774258|FG000|Treatment Period|Adverse Event|12|||
48984566|NCT02417935|157774259|FG001|Treatment Period|Adverse Event|10|||
48984567|NCT02417935|157774258|FG000|Treatment Period|Lost to Follow-up|1|||
48984568|NCT02417935|157774259|FG001|Treatment Period|Lost to Follow-up|0|||
48984569|NCT02417935|157774258|FG000|Treatment Period|Entry Criteria not met|0|||
48984570|NCT02417935|157774259|FG001|Treatment Period|Entry Criteria not met|1|||
48984571|NCT02417935|157774258|FG000|Treatment Period|Protocol Violation|2|||
48984572|NCT02417935|157774259|FG001|Treatment Period|Protocol Violation|1|||
48984573|NCT02417935|157774258|FG000|Treatment Period|Withdrawal by Subject|3|||
48984574|NCT02417935|157774259|FG001|Treatment Period|Withdrawal by Subject|3|||
48984575|NCT02417935|157774258|FG000|Treatment Period|Physician Decision|3|||
48984576|NCT02417935|157774259|FG001|Treatment Period|Physician Decision|1|||
48984577|NCT01289028|157774264|FG000|Overall Study|Progressive Disease|49|||
48984578|NCT01289028|157774264|FG000|Overall Study|Adverse Event|14|||
48984579|NCT01289028|157774264|FG000|Overall Study|Withdrawal by Subject|6|||
48984580|NCT01289028|157774264|FG000|Overall Study|Death|4|||
48984581|NCT01289028|157774264|FG000|Overall Study|Lack of Efficacy|2|||
48984582|NCT01289028|157774264|FG000|Overall Study|No longer required|2|||
48984583|NCT01289028|157774264|FG000|Overall Study|Lost to Follow-up|2|||
48984584|NCT01289028|157774264|FG000|Overall Study|New Cancer Therapy|2|||
48984585|NCT01289028|157774264|FG000|Overall Study|Abnormal Lab Value|1|||
48984586|NCT01289028|157774264|FG000|Overall Study|Missing reason for discon|1|||
48984587|NCT02141854|157774267|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|25|||
48984588|NCT02141854|157774268|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
48984589|NCT02141854|157774269|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
48984590|NCT02141854|157774270|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
48984591|NCT02141854|157774271|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
48984592|NCT02141854|157774272|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
48984593|NCT02141854|157774267|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|76|||
48984594|NCT02141854|157774268|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
48984595|NCT02141854|157774269|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
48984596|NCT02141854|157774270|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
48984597|NCT02141854|157774271|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
48984598|NCT02141854|157774272|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
48984599|NCT02141854|157774267|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|14|||
48984600|NCT02141854|157774268|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
48984601|NCT02141854|157774269|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
48984602|NCT02141854|157774270|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
48984603|NCT02141854|157774271|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
48984604|NCT02141854|157774272|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
48984605|NCT02141854|157774267|FG000|Run-In Period (Pre-assignment)|Other|14|||
48984606|NCT02141854|157774268|FG001|Run-In Period (Pre-assignment)|Other|0|||
48984607|NCT02141854|157774269|FG002|Run-In Period (Pre-assignment)|Other|0|||
48984608|NCT02141854|157774270|FG003|Run-In Period (Pre-assignment)|Other|0|||
48984609|NCT02141854|157774271|FG004|Run-In Period (Pre-assignment)|Other|0|||
48984610|NCT02141854|157774272|FG005|Run-In Period (Pre-assignment)|Other|0|||
48984611|NCT02141854|157774267|FG000|Run-In Period (Pre-assignment)|Adverse Event|10|||
48984612|NCT02141854|157774268|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
48984613|NCT02141854|157774269|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
48984614|NCT02141854|157774270|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
48984615|NCT02141854|157774271|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
48984616|NCT02141854|157774272|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
48984617|NCT02141854|157774267|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|9|||
48984618|NCT02141854|157774268|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
48984619|NCT02141854|157774269|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
48984620|NCT02141854|157774270|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
48984621|NCT02141854|157774271|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
48984622|NCT02141854|157774272|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
48984623|NCT02141854|157774267|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
48984624|NCT02141854|157774268|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
48984625|NCT02141854|157774269|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
48984626|NCT02141854|157774270|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
48984627|NCT02141854|157774271|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
48984628|NCT02141854|157774272|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
48984629|NCT02141854|157774267|FG000|Treatment Period|Protocol Violation|0|||
48984630|NCT02141854|157774268|FG001|Treatment Period|Protocol Violation|1|||
48984631|NCT02141854|157774269|FG002|Treatment Period|Protocol Violation|0|||
48899447|NCT00770341|157466940|FG000|Overall Study|Withdrawal by Subject|0|||
48899448|NCT00770341|157466941|FG001|Overall Study|Withdrawal by Subject|1|||
48899449|NCT00770341|157466942|FG002|Overall Study|Withdrawal by Subject|0|||
48899450|NCT00770341|157466940|FG000|Overall Study|Clinical Adverse Event|3|||
48899451|NCT00770341|157466941|FG001|Overall Study|Clinical Adverse Event|1|||
48899452|NCT00770341|157466942|FG002|Overall Study|Clinical Adverse Event|2|||
48899453|NCT00770341|157466940|FG000|Overall Study|Laboratory adverse event|3|||
48899454|NCT00770341|157466941|FG001|Overall Study|Laboratory adverse event|3|||
48899455|NCT00770341|157466942|FG002|Overall Study|Laboratory adverse event|0|||
48899456|NCT00770341|157466940|FG000|Overall Study|Lack of Efficacy|3|||
48899457|NCT00770341|157466941|FG001|Overall Study|Lack of Efficacy|0|||
48899458|NCT00770341|157466942|FG002|Overall Study|Lack of Efficacy|1|||
48899459|NCT00770341|157466940|FG000|Overall Study|Other|1|||
48899460|NCT00770341|157466941|FG001|Overall Study|Other|0|||
48899461|NCT00770341|157466942|FG002|Overall Study|Other|0|||
48899462|NCT00770341|157466940|FG000|Overall Study|Not treated|1|||
48899463|NCT00770341|157466941|FG001|Overall Study|Not treated|0|||
48899464|NCT00770341|157466942|FG002|Overall Study|Not treated|0|||
48899465|NCT02739360|157466943|FG000|Overall Study|Adverse Event|1|||
48899466|NCT02739360|157466943|FG000|Overall Study|Study terminated by Sponsor|2|||
48899467|NCT00960531|157466944|FG000|Overall Study|Lack of Efficacy|1|||
48899468|NCT00960531|157466945|FG001|Overall Study|Lack of Efficacy|0|||
48899469|NCT00960531|157466946|FG002|Overall Study|Lack of Efficacy|0|||
49041107|NCT00252564|157985728|FG001|Overall Study|Death|3|||
49041108|NCT00252564|157985727|FG000|Overall Study|Physician Decision|1|||
49041109|NCT00252564|157985728|FG001|Overall Study|Physician Decision|0|||
48899470|NCT00960531|157466947|FG003|Overall Study|Lack of Efficacy|0|||
48899471|NCT00960531|157466948|FG004|Overall Study|Lack of Efficacy|0|||
48899472|NCT00960531|157466949|FG005|Overall Study|Lack of Efficacy|0|||
48899473|NCT00960531|157466950|FG006|Overall Study|Lack of Efficacy|0|||
48899474|NCT00960531|157466951|FG007|Overall Study|Lack of Efficacy|0|||
48899475|NCT00960531|157466952|FG008|Overall Study|Lack of Efficacy|0|||
48899476|NCT00960531|157466953|FG009|Overall Study|Lack of Efficacy|0|||
48899477|NCT00960531|157466944|FG000|Overall Study|Withdrawal by Subject|1|||
48899478|NCT00960531|157466945|FG001|Overall Study|Withdrawal by Subject|0|||
48899479|NCT00960531|157466946|FG002|Overall Study|Withdrawal by Subject|5|||
48899480|NCT00960531|157466947|FG003|Overall Study|Withdrawal by Subject|2|||
48899481|NCT00960531|157466948|FG004|Overall Study|Withdrawal by Subject|0|||
48899482|NCT00960531|157466949|FG005|Overall Study|Withdrawal by Subject|0|||
48899483|NCT00960531|157466950|FG006|Overall Study|Withdrawal by Subject|2|||
48899484|NCT00960531|157466951|FG007|Overall Study|Withdrawal by Subject|0|||
48899485|NCT00960531|157466952|FG008|Overall Study|Withdrawal by Subject|1|||
48899486|NCT00960531|157466953|FG009|Overall Study|Withdrawal by Subject|0|||
48899487|NCT00960531|157466944|FG000|Overall Study|Caregiver Request|2|||
49041110|NCT00252564|157985727|FG000|Overall Study|Lost to Follow-up|1|||
49041111|NCT00252564|157985728|FG001|Overall Study|Lost to Follow-up|0|||
49041112|NCT00252564|157985727|FG000|Overall Study|Patient Request|4|||
49041113|NCT00252564|157985728|FG001|Overall Study|Patient Request|5|||
49041114|NCT00252564|157985727|FG000|Overall Study|Withdrawal by Subject|0|||
49041115|NCT00252564|157985728|FG001|Overall Study|Withdrawal by Subject|2|||
49041116|NCT04025021|157985729|FG000|Overall Study|Study discontinued with onset of COVID-19 pandemic|2|||
49041117|NCT04025021|157985730|FG001|Overall Study|Study discontinued with onset of COVID-19 pandemic|1|||
49041118|NCT02096705|157985731|FG000|Treatment|Adverse Event|6|||
49041119|NCT02096705|157985732|FG001|Treatment|Adverse Event|3|||
49041120|NCT02096705|157985731|FG000|Treatment|Subject request to discontinue treatment|1|||
49041121|NCT02096705|157985732|FG001|Treatment|Subject request to discontinue treatment|1|||
49041122|NCT02096705|157985731|FG000|Treatment|Withdrawal by Subject|1|||
49041123|NCT02096705|157985732|FG001|Treatment|Withdrawal by Subject|0|||
49041124|NCT02096705|157985731|FG000|Treatment|Other|1|||
49041125|NCT02096705|157985732|FG001|Treatment|Other|1|||
49041126|NCT02096705|157985731|FG000|Follow-up|Withdrawal by Subject|1|||
49041127|NCT02096705|157985732|FG001|Follow-up|Withdrawal by Subject|0|||
49041128|NCT02096705|157985731|FG000|Follow-up|Adverse Event|2|||
48899488|NCT00960531|157466945|FG001|Overall Study|Caregiver Request|0|||
48899489|NCT00960531|157466946|FG002|Overall Study|Caregiver Request|6|||
48899490|NCT00960531|157466947|FG003|Overall Study|Caregiver Request|5|||
48899491|NCT00960531|157466948|FG004|Overall Study|Caregiver Request|0|||
48899492|NCT00960531|157466949|FG005|Overall Study|Caregiver Request|2|||
48899493|NCT00960531|157466950|FG006|Overall Study|Caregiver Request|3|||
48899494|NCT00960531|157466951|FG007|Overall Study|Caregiver Request|1|||
48899495|NCT00960531|157466952|FG008|Overall Study|Caregiver Request|3|||
49041129|NCT02096705|157985732|FG001|Follow-up|Adverse Event|2|||
49041130|NCT02096705|157985731|FG000|Follow-up|Subjects not reporting status|1|||
49041131|NCT02096705|157985732|FG001|Follow-up|Subjects not reporting status|2|||
49041132|NCT01507662|157985734|FG000|Overall Study|Death|26|||
49041133|NCT01507662|157985735|FG001|Overall Study|Death|18|||
48899496|NCT00960531|157466953|FG009|Overall Study|Caregiver Request|0|||
48899497|NCT00960531|157466944|FG000|Overall Study|Investigator Request|0|||
49041134|NCT01507662|157985734|FG000|Overall Study|Withdrawal by Subject|290|||
49041135|NCT01507662|157985735|FG001|Overall Study|Withdrawal by Subject|287|||
49041136|NCT01507662|157985734|FG000|Overall Study|Lost to Follow-up|498|||
49041137|NCT01507662|157985735|FG001|Overall Study|Lost to Follow-up|523|||
49041138|NCT01507662|157985734|FG000|Overall Study|Proxy interview done|2|||
49041139|NCT01507662|157985735|FG001|Overall Study|Proxy interview done|3|||
49041140|NCT00414726|157987435|FG000|Overall Study|Withdrawal by Subject|0|||
49041141|NCT00414726|157987436|FG001|Overall Study|Withdrawal by Subject|1|||
49041142|NCT02328040|157987437|FG000|First Intervention (2 Days)|Withdrawal by Subject|1|||
49041143|NCT02328040|157987438|FG001|First Intervention (2 Days)|Withdrawal by Subject|1|||
49041144|NCT02313558|157987439|FG000|Overall Study|Withdrawal by Subject|2|||
49041145|NCT02313558|157987440|FG001|Overall Study|Withdrawal by Subject|0|||
49041146|NCT02313558|157987439|FG000|Overall Study|Lost to Follow-up|4|||
49041147|NCT02313558|157987440|FG001|Overall Study|Lost to Follow-up|4|||
49041148|NCT04968925|157987449|FG000|Phase I- Period 1|COVID-19 related|0|||
49041149|NCT04968925|157987450|FG001|Phase I- Period 1|COVID-19 related|1|||
49041150|NCT04968925|157987451|FG002|Phase I- Period 1|COVID-19 related|0|||
49041151|NCT04968925|157987452|FG003|Phase I- Period 1|COVID-19 related|0|||
49041152|NCT04968925|157987449|FG000|Phase I- Period 1|Subject enrolled in error|1|||
49041153|NCT04968925|157987450|FG001|Phase I- Period 1|Subject enrolled in error|1|||
49041154|NCT04968925|157987451|FG002|Phase I- Period 1|Subject enrolled in error|0|||
49041155|NCT04968925|157987452|FG003|Phase I- Period 1|Subject enrolled in error|0|||
49041156|NCT04968925|157987449|FG000|Phase II- Period 1|COVID-19 Related|0|||
49041157|NCT04968925|157987450|FG001|Phase II- Period 1|COVID-19 Related|0|||
49041158|NCT04968925|157987451|FG002|Phase II- Period 1|COVID-19 Related|6|||
49041159|NCT04968925|157987452|FG003|Phase II- Period 1|COVID-19 Related|6|||
49041160|NCT04968925|157987449|FG000|Phase II- Period 1|Subject enrolled in error|0|||
49041161|NCT04968925|157987450|FG001|Phase II- Period 1|Subject enrolled in error|0|||
49041162|NCT04968925|157987451|FG002|Phase II- Period 1|Subject enrolled in error|1|||
49041163|NCT04968925|157987452|FG003|Phase II- Period 1|Subject enrolled in error|0|||
49041164|NCT04968925|157987449|FG000|Phase II -Period 2|COVID-19 related|0|||
49041165|NCT04968925|157987450|FG001|Phase II -Period 2|COVID-19 related|0|||
49041166|NCT04968925|157987451|FG002|Phase II -Period 2|COVID-19 related|4|||
49041167|NCT04968925|157987452|FG003|Phase II -Period 2|COVID-19 related|3|||
49041168|NCT04968925|157987449|FG000|Phase II -Period 2|Incorrectly dispensed|0|||
49041169|NCT04968925|157987450|FG001|Phase II -Period 2|Incorrectly dispensed|0|||
49041170|NCT04968925|157987451|FG002|Phase II -Period 2|Incorrectly dispensed|0|||
49041171|NCT04968925|157987452|FG003|Phase II -Period 2|Incorrectly dispensed|1|||
49041172|NCT01709903|157987458|FG000|Overall Study|administrative problems|2|||
49041173|NCT01709903|157987459|FG001|Overall Study|administrative problems|6|||
49041174|NCT01709903|157987458|FG000|Overall Study|Abnormal test procedure results|1|||
49041175|NCT01709903|157987459|FG001|Overall Study|Abnormal test procedure results|0|||
49041176|NCT01709903|157987458|FG000|Overall Study|In ability to use device|1|||
49041177|NCT01709903|157987459|FG001|Overall Study|In ability to use device|1|||
49041178|NCT01709903|157987458|FG000|Overall Study|no longer needed study drug|0|||
49041179|NCT01709903|157987459|FG001|Overall Study|no longer needed study drug|1|||
49041180|NCT01709903|157987458|FG000|Overall Study|Lost to Follow-up|0|||
49041181|NCT01709903|157987459|FG001|Overall Study|Lost to Follow-up|2|||
49041182|NCT01709903|157987458|FG000|Overall Study|Death|2|||
49041183|NCT01709903|157987459|FG001|Overall Study|Death|0|||
49041184|NCT01709903|157987458|FG000|Overall Study|Protocol Violation|3|||
49041185|NCT01709903|157987459|FG001|Overall Study|Protocol Violation|2|||
49041186|NCT01709903|157987458|FG000|Overall Study|Lack of Efficacy|3|||
49041187|NCT01709903|157987459|FG001|Overall Study|Lack of Efficacy|3|||
49041188|NCT01709903|157987458|FG000|Overall Study|Withdrawal by Subject|6|||
49041189|NCT01709903|157987459|FG001|Overall Study|Withdrawal by Subject|6|||
49041190|NCT01709903|157987458|FG000|Overall Study|Adverse Event|11|||
49041191|NCT01709903|157987459|FG001|Overall Study|Adverse Event|18|||
49041192|NCT00928057|157987461|FG000|Overall Study|Adverse Event|1|||
49041193|NCT00928057|157987462|FG001|Overall Study|Adverse Event|2|||
49041194|NCT00928057|157987461|FG000|Overall Study|Withdrawal by Subject|1|||
49041195|NCT00928057|157987462|FG001|Overall Study|Withdrawal by Subject|0|||
49041196|NCT00928057|157987461|FG000|Overall Study|Lost to Follow-up|0|||
49041197|NCT00928057|157987462|FG001|Overall Study|Lost to Follow-up|1|||
49041198|NCT00928057|157987461|FG000|Overall Study|Protocol Violation|0|||
49041199|NCT00928057|157987462|FG001|Overall Study|Protocol Violation|1|||
49041200|NCT03387462|157987463|FG000|Overall Study|Lost to Follow-up|1|||
49041201|NCT05497557|157987464|FG000|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
49041202|NCT05497557|157987465|FG001|Period 2: Omeprazole Alone|Withdrawal by Subject|2|||
49041203|NCT05497557|157987466|FG002|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
49041204|NCT01896934|157987469|FG000|Overall Study|Adverse Event|1|||
49041205|NCT01896934|157987469|FG000|Overall Study|Withdrawal by Subject|1|||
49041206|NCT02751424|157987470|FG000|Part 2|Adverse Event|0|||
49041207|NCT02751424|157987471|FG001|Part 2|Adverse Event|0|||
49041208|NCT02751424|157987472|FG002|Part 2|Adverse Event|0|||
49041209|NCT02751424|157987473|FG003|Part 2|Adverse Event|0|||
49041210|NCT02751424|157987474|FG004|Part 2|Adverse Event|0|||
49041211|NCT02751424|157987475|FG005|Part 2|Adverse Event|0|||
49041212|NCT02751424|157987476|FG006|Part 2|Adverse Event|0|||
49041213|NCT02751424|157987477|FG007|Part 2|Adverse Event|5|||
49041214|NCT02751424|157987478|FG008|Part 2|Adverse Event|0|||
49041215|NCT02197416|157987479|FG000|Overall Study|Other reasons|0|||
49041216|NCT02197416|157987480|FG001|Overall Study|Other reasons|2|||
49041217|NCT02197416|157987481|FG002|Overall Study|Other reasons|5|||
48899498|NCT00960531|157466945|FG001|Overall Study|Investigator Request|0|||
48899499|NCT00960531|157466946|FG002|Overall Study|Investigator Request|1|||
49041218|NCT02197416|157987479|FG000|Overall Study|Withdrawal by Subject|0|||
49041219|NCT02197416|157987480|FG001|Overall Study|Withdrawal by Subject|2|||
49041220|NCT02197416|157987481|FG002|Overall Study|Withdrawal by Subject|1|||
49041221|NCT02197416|157987479|FG000|Overall Study|Protocol Violation|1|||
49041222|NCT02197416|157987480|FG001|Overall Study|Protocol Violation|0|||
49041223|NCT02197416|157987481|FG002|Overall Study|Protocol Violation|1|||
49041224|NCT02197416|157987479|FG000|Overall Study|Adverse Event|0|||
49041225|NCT02197416|157987480|FG001|Overall Study|Adverse Event|0|||
49041226|NCT02197416|157987481|FG002|Overall Study|Adverse Event|1|||
49041227|NCT02415127|157987484|FG000|Overall Study|Adverse Event|1|||
49041228|NCT02415127|157987485|FG001|Overall Study|Adverse Event|0|||
49041229|NCT01087502|157987486|FG000|Up to Interim Analysis (Week 12)|Adverse Event|5|||
49041230|NCT01087502|157987487|FG001|Up to Interim Analysis (Week 12)|Adverse Event|4|||
49041231|NCT01087502|157987486|FG000|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
49041232|NCT01087502|157987487|FG001|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
48899500|NCT00960531|157466947|FG003|Overall Study|Investigator Request|0|||
48899501|NCT00960531|157466948|FG004|Overall Study|Investigator Request|0|||
48899502|NCT00960531|157466949|FG005|Overall Study|Investigator Request|0|||
48899503|NCT00960531|157466950|FG006|Overall Study|Investigator Request|0|||
49041233|NCT01087502|157987486|FG000|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
49041234|NCT01087502|157987487|FG001|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
49041235|NCT01087502|157987486|FG000|Up to Interim Analysis (Week 12)|Lack of Efficacy|1|||
49041236|NCT01087502|157987487|FG001|Up to Interim Analysis (Week 12)|Lack of Efficacy|0|||
49041237|NCT01087502|157987486|FG000|Up to Interim Analysis (Week 12)|Other reason not described above|1|||
49041238|NCT01087502|157987487|FG001|Up to Interim Analysis (Week 12)|Other reason not described above|2|||
49041239|NCT01087502|157987486|FG000|Up to Final Analysis (Week 52)|Adverse Event|17|||
49041240|NCT01087502|157987487|FG001|Up to Final Analysis (Week 52)|Adverse Event|10|||
49041241|NCT01087502|157987486|FG000|Up to Final Analysis (Week 52)|Lack of Efficacy|1|||
49041242|NCT01087502|157987487|FG001|Up to Final Analysis (Week 52)|Lack of Efficacy|2|||
49041243|NCT01087502|157987486|FG000|Up to Final Analysis (Week 52)|Protocol Violation|4|||
49041244|NCT01087502|157987487|FG001|Up to Final Analysis (Week 52)|Protocol Violation|0|||
49041245|NCT01087502|157987486|FG000|Up to Final Analysis (Week 52)|Lost to Follow-up|2|||
49041246|NCT01087502|157987487|FG001|Up to Final Analysis (Week 52)|Lost to Follow-up|0|||
49041247|NCT01087502|157987486|FG000|Up to Final Analysis (Week 52)|Withdrawal by Subject|3|||
49041248|NCT01087502|157987487|FG001|Up to Final Analysis (Week 52)|Withdrawal by Subject|2|||
49041249|NCT01087502|157987486|FG000|Up to Final Analysis (Week 52)|Study site excluded from analysis|1|||
49041250|NCT01087502|157987487|FG001|Up to Final Analysis (Week 52)|Study site excluded from analysis|5|||
49041251|NCT01087502|157987486|FG000|Up to Final Analysis (Week 52)|Other reason not described above|5|||
49041252|NCT01087502|157987487|FG001|Up to Final Analysis (Week 52)|Other reason not described above|4|||
49041253|NCT02229084|157987488|FG000|Overall Study|Adverse Event|1|||
49041254|NCT02229084|157987489|FG001|Overall Study|Adverse Event|0|||
49041255|NCT02229084|157987490|FG002|Overall Study|Adverse Event|0|||
49041256|NCT02229084|157987491|FG003|Overall Study|Adverse Event|0|||
49041257|NCT02229084|157987492|FG004|Overall Study|Adverse Event|0|||
49041258|NCT02229084|157987493|FG005|Overall Study|Adverse Event|0|||
49041259|NCT02229084|157987494|FG006|Overall Study|Adverse Event|0|||
49041260|NCT02229084|157987488|FG000|Overall Study|Lost to Follow-up|0|||
49041261|NCT02229084|157987489|FG001|Overall Study|Lost to Follow-up|0|||
49041262|NCT02229084|157987490|FG002|Overall Study|Lost to Follow-up|1|||
49041263|NCT02229084|157987491|FG003|Overall Study|Lost to Follow-up|1|||
48899504|NCT00960531|157466951|FG007|Overall Study|Investigator Request|0|||
48899505|NCT00960531|157466952|FG008|Overall Study|Investigator Request|0|||
49041264|NCT02229084|157987492|FG004|Overall Study|Lost to Follow-up|0|||
49041265|NCT02229084|157987493|FG005|Overall Study|Lost to Follow-up|0|||
48899506|NCT00960531|157466953|FG009|Overall Study|Investigator Request|0|||
48899507|NCT00960531|157466944|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
48899508|NCT00960531|157466945|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
48899509|NCT00960531|157466946|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
49041266|NCT02229084|157987494|FG006|Overall Study|Lost to Follow-up|1|||
49041267|NCT02229084|157987488|FG000|Overall Study|Physician Decision|0|||
49041268|NCT02229084|157987489|FG001|Overall Study|Physician Decision|0|||
49041269|NCT02229084|157987490|FG002|Overall Study|Physician Decision|0|||
49041270|NCT02229084|157987491|FG003|Overall Study|Physician Decision|1|||
49041271|NCT02229084|157987492|FG004|Overall Study|Physician Decision|3|||
49041272|NCT02229084|157987493|FG005|Overall Study|Physician Decision|0|||
48899510|NCT00960531|157466947|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
49041273|NCT02229084|157987494|FG006|Overall Study|Physician Decision|1|||
48899511|NCT00960531|157466948|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
48899512|NCT00960531|157466949|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
48899513|NCT00960531|157466950|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
48899514|NCT00960531|157466951|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
48899515|NCT00960531|157466952|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
48899516|NCT00960531|157466953|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
48899517|NCT00960531|157466944|FG000|Overall Study|Lost to Follow-up|0|||
48899518|NCT00960531|157466945|FG001|Overall Study|Lost to Follow-up|0|||
48899519|NCT00960531|157466946|FG002|Overall Study|Lost to Follow-up|1|||
48899520|NCT00960531|157466947|FG003|Overall Study|Lost to Follow-up|0|||
48899521|NCT00960531|157466948|FG004|Overall Study|Lost to Follow-up|0|||
48899522|NCT00960531|157466949|FG005|Overall Study|Lost to Follow-up|0|||
49041274|NCT02229084|157987488|FG000|Overall Study|Withdrawal by Subject|0|||
49041275|NCT02229084|157987489|FG001|Overall Study|Withdrawal by Subject|0|||
48899523|NCT00960531|157466950|FG006|Overall Study|Lost to Follow-up|1|||
48899524|NCT00960531|157466951|FG007|Overall Study|Lost to Follow-up|0|||
48899525|NCT00960531|157466952|FG008|Overall Study|Lost to Follow-up|0|||
49041276|NCT02229084|157987490|FG002|Overall Study|Withdrawal by Subject|1|||
49041277|NCT02229084|157987491|FG003|Overall Study|Withdrawal by Subject|0|||
49041278|NCT02229084|157987492|FG004|Overall Study|Withdrawal by Subject|1|||
49041279|NCT02229084|157987493|FG005|Overall Study|Withdrawal by Subject|1|||
49041280|NCT02229084|157987494|FG006|Overall Study|Withdrawal by Subject|1|||
49041281|NCT02229084|157987488|FG000|Overall Study|Death|0|||
48899526|NCT00960531|157466953|FG009|Overall Study|Lost to Follow-up|0|||
48899527|NCT00960531|157466944|FG000|Overall Study|Failed to Return|2|||
48899528|NCT00960531|157466945|FG001|Overall Study|Failed to Return|0|||
48899529|NCT00960531|157466946|FG002|Overall Study|Failed to Return|0|||
48899530|NCT00960531|157466947|FG003|Overall Study|Failed to Return|0|||
48899531|NCT00960531|157466948|FG004|Overall Study|Failed to Return|0|||
48899532|NCT00960531|157466949|FG005|Overall Study|Failed to Return|0|||
48899533|NCT00960531|157466950|FG006|Overall Study|Failed to Return|0|||
48899534|NCT00960531|157466951|FG007|Overall Study|Failed to Return|2|||
48899535|NCT00960531|157466952|FG008|Overall Study|Failed to Return|0|||
48899536|NCT00960531|157466953|FG009|Overall Study|Failed to Return|0|||
48899537|NCT00960531|157466944|FG000|Overall Study|Adverse Event (AE)|2|||
48899538|NCT00960531|157466945|FG001|Overall Study|Adverse Event (AE)|0|||
48899539|NCT00960531|157466946|FG002|Overall Study|Adverse Event (AE)|0|||
48899540|NCT00960531|157466947|FG003|Overall Study|Adverse Event (AE)|0|||
48899541|NCT00960531|157466948|FG004|Overall Study|Adverse Event (AE)|0|||
48899542|NCT00960531|157466949|FG005|Overall Study|Adverse Event (AE)|1|||
48899543|NCT00960531|157466950|FG006|Overall Study|Adverse Event (AE)|2|||
48899544|NCT00960531|157466951|FG007|Overall Study|Adverse Event (AE)|0|||
48899545|NCT00960531|157466952|FG008|Overall Study|Adverse Event (AE)|2|||
48899546|NCT00960531|157466953|FG009|Overall Study|Adverse Event (AE)|0|||
48899547|NCT00960531|157466944|FG000|Overall Study|Reason not Specified|2|||
48899548|NCT00960531|157466945|FG001|Overall Study|Reason not Specified|1|||
48899549|NCT00960531|157466946|FG002|Overall Study|Reason not Specified|13|||
48899550|NCT00960531|157466947|FG003|Overall Study|Reason not Specified|1|||
48899551|NCT00960531|157466948|FG004|Overall Study|Reason not Specified|2|||
48899552|NCT00960531|157466949|FG005|Overall Study|Reason not Specified|0|||
48899553|NCT00960531|157466950|FG006|Overall Study|Reason not Specified|16|||
48899554|NCT00960531|157466951|FG007|Overall Study|Reason not Specified|0|||
49041282|NCT02229084|157987489|FG001|Overall Study|Death|0|||
49041283|NCT02229084|157987490|FG002|Overall Study|Death|0|||
49041284|NCT02229084|157987491|FG003|Overall Study|Death|0|||
49041285|NCT02229084|157987492|FG004|Overall Study|Death|0|||
49041286|NCT02229084|157987493|FG005|Overall Study|Death|0|||
49041287|NCT02229084|157987494|FG006|Overall Study|Death|1|||
49041288|NCT01653704|157987497|FG000|Overall Study|Technical failure during recording|1|||
49041289|NCT01653704|157987498|FG001|Overall Study|Technical failure during recording|1|||
49041290|NCT01653704|157987497|FG000|Overall Study|Performance not reflective of training|1|||
49041291|NCT01653704|157987498|FG001|Overall Study|Performance not reflective of training|0|||
49041292|NCT01728116|157987499|FG000|Overall Study|Sponsor Terminated Study|106|||
48899555|NCT00960531|157466952|FG008|Overall Study|Reason not Specified|8|||
48899556|NCT00960531|157466953|FG009|Overall Study|Reason not Specified|1|||
49041293|NCT01728116|157987500|FG001|Overall Study|Sponsor Terminated Study|35|||
48899557|NCT00607022|157466954|FG000|Overall Study|Withdrawal by Subject|1|||
48899558|NCT00607022|157466955|FG001|Overall Study|Withdrawal by Subject|0|||
48899559|NCT00607022|157466956|FG002|Overall Study|Withdrawal by Subject|0|||
48899560|NCT00777946|157466957|FG000|Overall Study|Adverse Event|11|||
48899561|NCT00777946|157466958|FG001|Overall Study|Adverse Event|1|||
48899562|NCT00777946|157466959|FG002|Overall Study|Adverse Event|3|||
48899563|NCT00777946|157466957|FG000|Overall Study|Lack of Efficacy|0|||
48899564|NCT00777946|157466958|FG001|Overall Study|Lack of Efficacy|0|||
48899565|NCT00777946|157466959|FG002|Overall Study|Lack of Efficacy|9|||
48899566|NCT00777946|157466957|FG000|Overall Study|Condition no longer required study drug|1|||
49041294|NCT01728116|157987499|FG000|Overall Study|Withdrawal by Subject|16|||
49041295|NCT01728116|157987500|FG001|Overall Study|Withdrawal by Subject|9|||
48899567|NCT00777946|157466958|FG001|Overall Study|Condition no longer required study drug|0|||
48899568|NCT00777946|157466959|FG002|Overall Study|Condition no longer required study drug|0|||
48899569|NCT00777946|157466957|FG000|Overall Study|Patient withdrew consent|3|||
48899570|NCT00777946|157466958|FG001|Overall Study|Patient withdrew consent|2|||
48899571|NCT00777946|157466959|FG002|Overall Study|Patient withdrew consent|3|||
49041296|NCT01728116|157987499|FG000|Overall Study|Adverse Event|13|||
49041297|NCT01728116|157987500|FG001|Overall Study|Adverse Event|0|||
49041298|NCT01728116|157987499|FG000|Overall Study|Procedure/device failure|7|||
49041299|NCT01728116|157987500|FG001|Overall Study|Procedure/device failure|0|||
49041300|NCT01728116|157987499|FG000|Overall Study|Lost to Follow-up|9|||
49041301|NCT01728116|157987500|FG001|Overall Study|Lost to Follow-up|2|||
48899572|NCT00777946|157466957|FG000|Overall Study|Lost to Follow-up|3|||
48899573|NCT00777946|157466958|FG001|Overall Study|Lost to Follow-up|1|||
48899574|NCT00777946|157466959|FG002|Overall Study|Lost to Follow-up|0|||
48899575|NCT00777946|157466957|FG000|Overall Study|Protocol deviation|2|||
48899576|NCT00777946|157466958|FG001|Overall Study|Protocol deviation|1|||
48899577|NCT00777946|157466959|FG002|Overall Study|Protocol deviation|1|||
48899578|NCT00777946|157466957|FG000|Overall Study|Randomized in error|1|||
48899579|NCT00777946|157466958|FG001|Overall Study|Randomized in error|1|||
48899580|NCT00777946|157466959|FG002|Overall Study|Randomized in error|0|||
48899581|NCT02684357|157466960|FG000|Part A|Adverse Event (Worsening of Disease)|1|||
48899582|NCT02684357|157466961|FG001|Part A|Adverse Event (Worsening of Disease)|0|||
48899583|NCT02684357|157466962|FG002|Part A|Adverse Event (Worsening of Disease)|0|||
48899584|NCT02684357|157466963|FG003|Part A|Adverse Event (Worsening of Disease)|0|||
48899585|NCT02684357|157466964|FG004|Part A|Adverse Event (Worsening of Disease)|0|||
48899586|NCT02684357|157466965|FG005|Part A|Adverse Event (Worsening of Disease)|0|||
48899587|NCT02684357|157466960|FG000|Part A|Lost to Follow-up|0|||
48899588|NCT02684357|157466961|FG001|Part A|Lost to Follow-up|2|||
48899589|NCT02684357|157466962|FG002|Part A|Lost to Follow-up|2|||
48899590|NCT02684357|157466963|FG003|Part A|Lost to Follow-up|0|||
48899591|NCT02684357|157466964|FG004|Part A|Lost to Follow-up|0|||
48899592|NCT02684357|157466965|FG005|Part A|Lost to Follow-up|0|||
48899593|NCT02684357|157466960|FG000|Part A|Withdrawal by Subject|3|||
48899594|NCT02684357|157466961|FG001|Part A|Withdrawal by Subject|0|||
48899595|NCT02684357|157466962|FG002|Part A|Withdrawal by Subject|0|||
48899596|NCT02684357|157466963|FG003|Part A|Withdrawal by Subject|0|||
49041302|NCT01728116|157987499|FG000|Overall Study|Physician Decision|2|||
49041303|NCT01728116|157987500|FG001|Overall Study|Physician Decision|0|||
49041304|NCT01728116|157987499|FG000|Overall Study|Subject Non-Compliance|2|||
49041305|NCT01728116|157987500|FG001|Overall Study|Subject Non-Compliance|0|||
49041306|NCT01728116|157987499|FG000|Overall Study|Inter-current finding at procedure|1|||
48899597|NCT02684357|157466964|FG004|Part A|Withdrawal by Subject|0|||
48899598|NCT02684357|157466965|FG005|Part A|Withdrawal by Subject|0|||
48899599|NCT02684357|157466960|FG000|Part A|Other|0|||
48899600|NCT02684357|157466961|FG001|Part A|Other|1|||
48899601|NCT02684357|157466962|FG002|Part A|Other|0|||
48899602|NCT02684357|157466963|FG003|Part A|Other|0|||
48899603|NCT02684357|157466964|FG004|Part A|Other|0|||
48899604|NCT02684357|157466965|FG005|Part A|Other|0|||
48899605|NCT02684357|157466960|FG000|Part B|Adverse Event (Other)|0|||
48899606|NCT02684357|157466961|FG001|Part B|Adverse Event (Other)|0|||
48899607|NCT02684357|157466962|FG002|Part B|Adverse Event (Other)|0|||
48899608|NCT02684357|157466963|FG003|Part B|Adverse Event (Other)|1|||
48899609|NCT02684357|157466964|FG004|Part B|Adverse Event (Other)|1|||
48899610|NCT02684357|157466965|FG005|Part B|Adverse Event (Other)|1|||
48899611|NCT02684357|157466960|FG000|Part B|Lost to Follow-up|0|||
48899612|NCT02684357|157466961|FG001|Part B|Lost to Follow-up|0|||
48899613|NCT02684357|157466962|FG002|Part B|Lost to Follow-up|0|||
48899614|NCT02684357|157466963|FG003|Part B|Lost to Follow-up|1|||
48899615|NCT02684357|157466964|FG004|Part B|Lost to Follow-up|1|||
48899616|NCT02684357|157466965|FG005|Part B|Lost to Follow-up|7|||
48899617|NCT02684357|157466960|FG000|Part B|Withdrawal by Subject|0|||
48899618|NCT02684357|157466961|FG001|Part B|Withdrawal by Subject|0|||
48899619|NCT02684357|157466962|FG002|Part B|Withdrawal by Subject|0|||
48899620|NCT02684357|157466963|FG003|Part B|Withdrawal by Subject|0|||
48899621|NCT02684357|157466964|FG004|Part B|Withdrawal by Subject|2|||
49041307|NCT01728116|157987500|FG001|Overall Study|Inter-current finding at procedure|0|||
48899622|NCT02684357|157466965|FG005|Part B|Withdrawal by Subject|4|||
48899623|NCT02684357|157466960|FG000|Part B|Other|0|||
48899624|NCT02684357|157466961|FG001|Part B|Other|0|||
48899625|NCT02684357|157466962|FG002|Part B|Other|0|||
49041308|NCT01728116|157987499|FG000|Overall Study|Incorrectly enrolled in Study|0|||
48899626|NCT02684357|157466963|FG003|Part B|Other|1|||
48899627|NCT02684357|157466964|FG004|Part B|Other|0|||
48899628|NCT02684357|157466965|FG005|Part B|Other|1|||
48899629|NCT01658826|157466969|FG000|Period 1: First Intervention (28 Days)|Withdrawal by Subject|1|||
49041309|NCT01728116|157987500|FG001|Overall Study|Incorrectly enrolled in Study|1|||
49041310|NCT01728116|157987499|FG000|Overall Study|various not noted previously|5|||
48899630|NCT01658826|157466970|FG001|Period 1: First Intervention (28 Days)|Withdrawal by Subject|0|||
48899631|NCT01658826|157466969|FG000|Period 1: First Intervention (28 Days)|Adverse Event|1|||
49041311|NCT01728116|157987500|FG001|Overall Study|various not noted previously|0|||
49041312|NCT01598896|157987501|FG000|Overall Study|Withdrawal by Subject|0|||
49041313|NCT01598896|157987502|FG001|Overall Study|Withdrawal by Subject|1|||
49041314|NCT01598896|157987501|FG000|Overall Study|Lack of Efficacy|0|||
49041315|NCT01598896|157987502|FG001|Overall Study|Lack of Efficacy|1|||
49041316|NCT02705716|157987505|FG000|Overall Study|Adverse Event|0|||
49041317|NCT02705716|157987506|FG001|Overall Study|Adverse Event|1|||
49041318|NCT02705716|157987505|FG000|Overall Study|Protocol Violation|3|||
49041319|NCT02705716|157987506|FG001|Overall Study|Protocol Violation|0|||
49041320|NCT02705716|157987505|FG000|Overall Study|Withdrawal of Consent|1|||
49041321|NCT02705716|157987506|FG001|Overall Study|Withdrawal of Consent|1|||
49041322|NCT01344018|157987507|FG000|Overall Study|Death|22|||
49041323|NCT01344018|157987508|FG001|Overall Study|Death|25|||
49041324|NCT01344018|157987507|FG000|Overall Study|Lost to Follow-up|4|||
49041325|NCT01344018|157987508|FG001|Overall Study|Lost to Follow-up|7|||
48899632|NCT01658826|157466970|FG001|Period 1: First Intervention (28 Days)|Adverse Event|2|||
48899633|NCT01658826|157466969|FG000|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|5|||
48899634|NCT01658826|157466970|FG001|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|6|||
48899635|NCT01658826|157466969|FG000|Period 1: First Intervention (28 Days)|Protocol Violation|0|||
48899636|NCT01658826|157466970|FG001|Period 1: First Intervention (28 Days)|Protocol Violation|1|||
49041326|NCT05070754|157987514|FG000|Overall Study|Withdrawal by Subject|0|||
49041327|NCT05070754|157987515|FG001|Overall Study|Withdrawal by Subject|0|||
49041328|NCT05070754|157987516|FG002|Overall Study|Withdrawal by Subject|0|||
49041329|NCT05070754|157987517|FG003|Overall Study|Withdrawal by Subject|1|||
49041330|NCT05070754|157987514|FG000|Overall Study|Protocol Violation|0|||
49041331|NCT05070754|157987515|FG001|Overall Study|Protocol Violation|0|||
49041332|NCT05070754|157987516|FG002|Overall Study|Protocol Violation|0|||
49041333|NCT05070754|157987517|FG003|Overall Study|Protocol Violation|1|||
49041334|NCT01196390|157987520|FG000|Overall Study|Protocol Violation|4|||
49041335|NCT01196390|157987521|FG001|Overall Study|Protocol Violation|5|||
49041336|NCT01532908|157987522|FG000|Overall Study|Not Transplanted|1|||
49041337|NCT01532908|157987523|FG001|Overall Study|Not Transplanted|0|||
49041338|NCT01151618|157987524|FG000|Overall Study|Adverse Event|2|||
49041339|NCT01151618|157987524|FG000|Overall Study|Withdrawal by Subject|7|||
48899637|NCT01658826|157466969|FG000|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|0|||
48899638|NCT01658826|157466970|FG001|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|1|||
48899639|NCT01658826|157466969|FG000|Washout Period: 28 Days|Withdrawal by Subject|1|||
48899640|NCT01658826|157466970|FG001|Washout Period: 28 Days|Withdrawal by Subject|1|||
48899641|NCT01658826|157466969|FG000|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|5|||
48899642|NCT01658826|157466970|FG001|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|3|||
48899643|NCT01658826|157466969|FG000|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|0|||
48899644|NCT01658826|157466970|FG001|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|1|||
48899645|NCT01658826|157466969|FG000|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|3|||
48899646|NCT01658826|157466970|FG001|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|4|||
48899647|NCT00475033|157466971|FG000|Infant Series|Failed to return|3|||
49041340|NCT01632306|157987525|FG000|Overall Study|Protocol Violation|1|||
49041341|NCT01632306|157987526|FG001|Overall Study|Protocol Violation|0|||
49041342|NCT01632306|157987527|FG002|Overall Study|Protocol Violation|0|||
48899648|NCT00475033|157466972|FG001|Infant Series|Failed to return|4|||
48899649|NCT00475033|157466971|FG000|Infant Series|Parent or legal guardian request|1|||
48899650|NCT00475033|157466972|FG001|Infant Series|Parent or legal guardian request|5|||
48899651|NCT00475033|157466971|FG000|Infant Series|Protocol Violation|1|||
48899652|NCT00475033|157466972|FG001|Infant Series|Protocol Violation|2|||
48899653|NCT00475033|157466971|FG000|Infant Series|Lost to Follow-up|2|||
48899654|NCT00475033|157466972|FG001|Infant Series|Lost to Follow-up|0|||
48899655|NCT00475033|157466971|FG000|Infant Series|Adverse Event|0|||
48899656|NCT00475033|157466972|FG001|Infant Series|Adverse Event|2|||
48899657|NCT00475033|157466971|FG000|After the Infant Series|Adverse Event|0|||
48899658|NCT00475033|157466972|FG001|After the Infant Series|Adverse Event|4|||
48899659|NCT00475033|157466971|FG000|After the Infant Series|Parent or legal guardian request|2|||
48899660|NCT00475033|157466972|FG001|After the Infant Series|Parent or legal guardian request|2|||
48899661|NCT00475033|157466971|FG000|After the Infant Series|Failed to return|2|||
48899662|NCT00475033|157466972|FG001|After the Infant Series|Failed to return|1|||
49041343|NCT03248128|157987528|FG000|Overall Study|Lost to Follow-up|1|||
49041344|NCT03248128|157987529|FG001|Overall Study|Lost to Follow-up|0|||
49041345|NCT03248128|157987528|FG000|Overall Study|Withdrawal by Subject|16|||
49041346|NCT03248128|157987529|FG001|Overall Study|Withdrawal by Subject|14|||
49041347|NCT03248128|157987528|FG000|Overall Study|Site Closed|4|||
49041348|NCT03248128|157987529|FG001|Overall Study|Site Closed|3|||
49041349|NCT03248128|157987528|FG000|Overall Study|Randomized, but did not receive treatment|1|||
49041350|NCT03248128|157987529|FG001|Overall Study|Randomized, but did not receive treatment|3|||
49041351|NCT03141151|157987536|FG000|Overall Study|Lost to Follow-up|3|||
48899663|NCT00475033|157466971|FG000|After the Infant Series|Protocol Violation|1|||
48899664|NCT00475033|157466972|FG001|After the Infant Series|Protocol Violation|0|||
48899665|NCT00475033|157466971|FG000|After the Infant Series|Lost to Follow-up|1|||
48899666|NCT00475033|157466972|FG001|After the Infant Series|Lost to Follow-up|0|||
48899667|NCT00475033|157466971|FG000|After the Infant Series|Other|0|||
48899668|NCT00475033|157466972|FG001|After the Infant Series|Other|1|||
48899669|NCT00475033|157466971|FG000|Toddler Dose|Parent or legal guardian request|2|||
48899670|NCT00475033|157466972|FG001|Toddler Dose|Parent or legal guardian request|0|||
48899671|NCT00475033|157466971|FG000|Toddler Dose|Failed to return|1|||
48899672|NCT00475033|157466972|FG001|Toddler Dose|Failed to return|0|||
48899673|NCT00475033|157466971|FG000|Toddler Dose|Lost to Follow-up|1|||
48899674|NCT00475033|157466972|FG001|Toddler Dose|Lost to Follow-up|0|||
48899675|NCT02502799|157468388|FG000|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
48899676|NCT02502799|157468389|FG001|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
48899677|NCT02502799|157468390|FG002|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
48899678|NCT02502799|157468391|FG003|Phase 1: Brief Intervention Sessions|Lost to Follow-up|12|||
48899679|NCT02502799|157468388|FG000|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
49041352|NCT03141151|157987537|FG001|Overall Study|Lost to Follow-up|2|||
49041353|NCT03141151|157987536|FG000|Overall Study|Withdrawal by Subject|3|||
49041354|NCT03141151|157987537|FG001|Overall Study|Withdrawal by Subject|2|||
48899680|NCT02502799|157468389|FG001|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
48899681|NCT02502799|157468390|FG002|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
49041355|NCT01986647|157987538|FG000|Overall Study|Lost to Follow-up|4|||
49041356|NCT01986647|157987539|FG001|Overall Study|Lost to Follow-up|1|||
49041357|NCT01986647|157987540|FG002|Overall Study|Lost to Follow-up|4|||
49041358|NCT01986647|157987541|FG003|Overall Study|Lost to Follow-up|4|||
49041359|NCT01986647|157987538|FG000|Overall Study|Withdrawal by Subject|1|||
49041360|NCT01986647|157987539|FG001|Overall Study|Withdrawal by Subject|3|||
49041361|NCT01986647|157987540|FG002|Overall Study|Withdrawal by Subject|2|||
49041362|NCT01986647|157987541|FG003|Overall Study|Withdrawal by Subject|3|||
49041363|NCT01986647|157987538|FG000|Overall Study|Health|5|||
49041364|NCT01986647|157987539|FG001|Overall Study|Health|3|||
49041365|NCT01986647|157987540|FG002|Overall Study|Health|6|||
49041366|NCT01986647|157987541|FG003|Overall Study|Health|4|||
49041367|NCT03498560|157987542|FG000|Overall Study|Found Ineligible|2|||
49041368|NCT03498560|157987542|FG000|Overall Study|Withdrawal by Subject|14|||
49041369|NCT03498560|157987542|FG000|Overall Study|Lost to Follow-up|4|||
49041370|NCT03498560|157987542|FG000|Overall Study|Death|1|||
49041371|NCT01483820|157987543|FG000|Overall Study|Lack of Efficacy|6|||
49041372|NCT01483820|157987543|FG000|Overall Study|Adverse Event|1|||
49041373|NCT01483820|157987543|FG000|Overall Study|Death|1|||
49041374|NCT00867360|157987550|FG000|Overall Study|Withdrawal by Subject|1|||
49041375|NCT00867360|157987551|FG001|Overall Study|Withdrawal by Subject|0|||
49041376|NCT00867360|157987550|FG000|Overall Study|Physician Decision|0|||
49041377|NCT00867360|157987551|FG001|Overall Study|Physician Decision|1|||
49041378|NCT00640926|157987554|FG000|Overall Study|Adverse Event|2|||
49041379|NCT00640926|157987555|FG001|Overall Study|Adverse Event|3|||
49041380|NCT00640926|157987556|FG002|Overall Study|Adverse Event|2|||
49041381|NCT00640926|157987554|FG000|Overall Study|Lack of Efficacy|0|||
49041382|NCT00640926|157987555|FG001|Overall Study|Lack of Efficacy|2|||
49041383|NCT00640926|157987556|FG002|Overall Study|Lack of Efficacy|1|||
49041384|NCT00640926|157987554|FG000|Overall Study|Protocol Violation|2|||
49041385|NCT00640926|157987555|FG001|Overall Study|Protocol Violation|0|||
49041386|NCT00640926|157987556|FG002|Overall Study|Protocol Violation|2|||
49041387|NCT00640926|157987554|FG000|Overall Study|Lost to Follow-up|3|||
49041388|NCT00640926|157987555|FG001|Overall Study|Lost to Follow-up|1|||
49041389|NCT00640926|157987556|FG002|Overall Study|Lost to Follow-up|2|||
49041390|NCT00640926|157987554|FG000|Overall Study|Withdrawal by Subject|1|||
49041391|NCT00640926|157987555|FG001|Overall Study|Withdrawal by Subject|0|||
49041392|NCT00640926|157987556|FG002|Overall Study|Withdrawal by Subject|1|||
49041393|NCT03922750|157987563|FG000|Overall Study|Unclassified|0|||
49041394|NCT03922750|157987564|FG001|Overall Study|Unclassified|0|||
49041395|NCT03922750|157987565|FG002|Overall Study|Unclassified|1|||
49041396|NCT03922750|157987563|FG000|Overall Study|Adverse Event|0|||
49041397|NCT03922750|157987564|FG001|Overall Study|Adverse Event|1|||
49041398|NCT03922750|157987565|FG002|Overall Study|Adverse Event|0|||
49041399|NCT01993940|157987566|FG000|Overall Study|Adverse Event|16|||
49041400|NCT01993940|157987567|FG001|Overall Study|Adverse Event|11|||
49041401|NCT01993940|157987566|FG000|Overall Study|Withdrawal by Subject|15|||
49041402|NCT01993940|157987567|FG001|Overall Study|Withdrawal by Subject|19|||
49041403|NCT01993940|157987566|FG000|Overall Study|Lost to Follow-up|2|||
49041404|NCT01993940|157987567|FG001|Overall Study|Lost to Follow-up|5|||
49041405|NCT01993940|157987566|FG000|Overall Study|Protocol Violation|5|||
48899682|NCT02502799|157468391|FG003|Phase 1: Brief Intervention Sessions|Early termination of study|5|||
49041406|NCT01993940|157987567|FG001|Overall Study|Protocol Violation|8|||
49041407|NCT01993940|157987566|FG000|Overall Study|Death|1|||
49041408|NCT01993940|157987567|FG001|Overall Study|Death|0|||
49041409|NCT01993940|157987566|FG000|Overall Study|Other - Miscellaneous|1|||
48899683|NCT02502799|157468388|FG000|Phase 2: Intervention Phase|Lost to Follow-up|3|||
48899684|NCT02502799|157468389|FG001|Phase 2: Intervention Phase|Lost to Follow-up|4|||
48899685|NCT02502799|157468390|FG002|Phase 2: Intervention Phase|Lost to Follow-up|1|||
48899686|NCT02502799|157468391|FG003|Phase 2: Intervention Phase|Lost to Follow-up|0|||
48899687|NCT02502799|157468388|FG000|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
48899688|NCT02502799|157468389|FG001|Phase 2: Intervention Phase|Withdrawal by Subject|2|||
48899689|NCT02502799|157468390|FG002|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
48899690|NCT02502799|157468391|FG003|Phase 2: Intervention Phase|Withdrawal by Subject|0|||
48899691|NCT02502799|157468388|FG000|Phase 2: Intervention Phase|Study terminated prior to completion|4|||
48899692|NCT02502799|157468389|FG001|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
48899693|NCT02502799|157468390|FG002|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
48899694|NCT02502799|157468391|FG003|Phase 2: Intervention Phase|Study terminated prior to completion|0|||
48899695|NCT01672723|157468394|FG000|First Intervention|Adverse Event|3|||
48899696|NCT01672723|157468395|FG001|First Intervention|Adverse Event|0|||
48899697|NCT01076192|157468402|FG000|Overall Study|Other|197|||
48899698|NCT02915302|157468403|FG000|Overall Study|Adverse Event|3|||
48899699|NCT02915302|157468404|FG001|Overall Study|Adverse Event|0|||
48899700|NCT02915302|157468403|FG000|Overall Study|Protocol Violation|20|||
48899701|NCT02915302|157468404|FG001|Overall Study|Protocol Violation|27|||
48899702|NCT02915302|157468403|FG000|Overall Study|Lost to Follow-up|19|||
48899703|NCT02915302|157468404|FG001|Overall Study|Lost to Follow-up|22|||
48899704|NCT02915302|157468403|FG000|Overall Study|Withdrawal by Subject|22|||
48899705|NCT02915302|157468404|FG001|Overall Study|Withdrawal by Subject|29|||
48899706|NCT02915302|157468403|FG000|Overall Study|Other|1|||
48899707|NCT02915302|157468404|FG001|Overall Study|Other|0|||
48899708|NCT03527173|157468405|FG000|Overall Study|Lost to Follow-up|4|||
48899709|NCT03527173|157468406|FG001|Overall Study|Lost to Follow-up|2|||
48899710|NCT03527173|157468405|FG000|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1|||
48899711|NCT03527173|157468406|FG001|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0|||
48899712|NCT03527173|157468405|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
48899713|NCT03527173|157468406|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
48899714|NCT03527173|157468405|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
48899715|NCT03527173|157468406|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
48899716|NCT00932113|157468407|FG000|Overall Study|Lost to Follow-up|1|||
48899717|NCT00932113|157468408|FG001|Overall Study|Lost to Follow-up|0|||
48899718|NCT03809429|157468414|FG000|Overall Study|Withdrawal by Subject|7|||
48899719|NCT03809429|157468415|FG001|Overall Study|Withdrawal by Subject|3|||
48899720|NCT03809429|157468414|FG000|Overall Study|Adverse Event|6|||
48899721|NCT03809429|157468415|FG001|Overall Study|Adverse Event|9|||
48899722|NCT03809429|157468414|FG000|Overall Study|COVID-19|3|||
48899723|NCT03809429|157468415|FG001|Overall Study|COVID-19|1|||
48899724|NCT03809429|157468414|FG000|Overall Study|Participant was discontinued by investigator|12|||
48899725|NCT03809429|157468415|FG001|Overall Study|Participant was discontinued by investigator|7|||
48899726|NCT04433585|157468417|FG000|Overall Study|Withdrawal by Subject|15|||
48899727|NCT04433585|157468418|FG001|Overall Study|Withdrawal by Subject|3|||
48899728|NCT04433585|157468419|FG002|Overall Study|Withdrawal by Subject|15|||
48899729|NCT04433585|157468420|FG003|Overall Study|Withdrawal by Subject|6|||
48899730|NCT04433585|157468417|FG000|Overall Study|Adverse Event|10|||
48899731|NCT04433585|157468418|FG001|Overall Study|Adverse Event|4|||
48899732|NCT04433585|157468419|FG002|Overall Study|Adverse Event|1|||
48899733|NCT04433585|157468420|FG003|Overall Study|Adverse Event|0|||
48899734|NCT04433585|157468417|FG000|Overall Study|Due to the conflict in Ukraine|2|||
48899735|NCT04433585|157468418|FG001|Overall Study|Due to the conflict in Ukraine|1|||
48899736|NCT04433585|157468419|FG002|Overall Study|Due to the conflict in Ukraine|1|||
48899737|NCT04433585|157468420|FG003|Overall Study|Due to the conflict in Ukraine|2|||
48899738|NCT04433585|157468417|FG000|Overall Study|Physician Decision|1|||
48899739|NCT04433585|157468418|FG001|Overall Study|Physician Decision|2|||
48899740|NCT04433585|157468419|FG002|Overall Study|Physician Decision|0|||
48899741|NCT04433585|157468420|FG003|Overall Study|Physician Decision|0|||
48899742|NCT04433585|157468417|FG000|Overall Study|Lost to Follow-up|1|||
48899743|NCT04433585|157468418|FG001|Overall Study|Lost to Follow-up|1|||
48899744|NCT04433585|157468419|FG002|Overall Study|Lost to Follow-up|1|||
48899745|NCT04433585|157468420|FG003|Overall Study|Lost to Follow-up|0|||
48899746|NCT04433585|157468417|FG000|Overall Study|Lack of Efficacy|0|||
48899747|NCT04433585|157468418|FG001|Overall Study|Lack of Efficacy|1|||
48899748|NCT04433585|157468419|FG002|Overall Study|Lack of Efficacy|1|||
48899749|NCT04433585|157468420|FG003|Overall Study|Lack of Efficacy|1|||
48899750|NCT04433585|157468417|FG000|Overall Study|Death|0|||
48899751|NCT04433585|157468418|FG001|Overall Study|Death|1|||
48899752|NCT04433585|157468419|FG002|Overall Study|Death|0|||
48899753|NCT04433585|157468420|FG003|Overall Study|Death|0|||
48899754|NCT03064035|157468423|FG000|Overall Study|Did not receive allocated intervention|4|||
48899755|NCT03064035|157468424|FG001|Overall Study|Did not receive allocated intervention|2|||
48899756|NCT03064035|157468423|FG000|Overall Study|Lost to Follow-up|1|||
48899757|NCT03064035|157468424|FG001|Overall Study|Lost to Follow-up|1|||
48899758|NCT02029846|157468425|FG000|Overall Study|n=1 each arm|1|||
48899759|NCT02029846|157468426|FG001|Overall Study|n=1 each arm|1|||
48899760|NCT00762970|157468427|FG000|Overall Study|Withdrawal by Subject|7|||
48899761|NCT00762970|157468428|FG001|Overall Study|Withdrawal by Subject|4|||
48899762|NCT00762970|157468429|FG002|Overall Study|Withdrawal by Subject|0|||
48899763|NCT00762970|157468427|FG000|Overall Study|Protocol Violation|3|||
48899764|NCT00762970|157468428|FG001|Overall Study|Protocol Violation|1|||
48899765|NCT00762970|157468429|FG002|Overall Study|Protocol Violation|1|||
48899766|NCT00762970|157468427|FG000|Overall Study|Lost to Follow-up|1|||
48899767|NCT00762970|157468428|FG001|Overall Study|Lost to Follow-up|2|||
48899768|NCT00762970|157468429|FG002|Overall Study|Lost to Follow-up|0|||
48899769|NCT00762970|157468427|FG000|Overall Study|Difficulty of handling lens|1|||
48899770|NCT00762970|157468428|FG001|Overall Study|Difficulty of handling lens|2|||
48899771|NCT00762970|157468429|FG002|Overall Study|Difficulty of handling lens|0|||
48899772|NCT03718533|157468430|FG000|Overall Study|Myelodysplastic syndrome and study indication|1|||
48899773|NCT03718533|157468430|FG000|Overall Study|Protocol deviation|1|||
48899774|NCT03718533|157468430|FG000|Overall Study|Disease progression|1|||
48899775|NCT03718533|157468430|FG000|Overall Study|Relapse|1|||
48899776|NCT03718533|157468430|FG000|Overall Study|Physician Decision|2|||
48899777|NCT03718533|157468430|FG000|Overall Study|Physician Decision and Adverse Event|1|||
48899778|NCT04256629|157468431|FG000|Overall Study|Adverse Event|0|||
48899779|NCT04256629|157468432|FG001|Overall Study|Adverse Event|0|||
48899780|NCT04256629|157468433|FG002|Overall Study|Adverse Event|0|||
48899781|NCT04256629|157468434|FG003|Overall Study|Adverse Event|0|||
48899782|NCT04256629|157468435|FG004|Overall Study|Adverse Event|0|||
48899783|NCT04256629|157468436|FG005|Overall Study|Adverse Event|1|||
48899784|NCT04256629|157468431|FG000|Overall Study|Protocol Violation|0|||
48899785|NCT04256629|157468432|FG001|Overall Study|Protocol Violation|1|||
48899786|NCT04256629|157468433|FG002|Overall Study|Protocol Violation|0|||
48899787|NCT04256629|157468434|FG003|Overall Study|Protocol Violation|0|||
48899788|NCT04256629|157468435|FG004|Overall Study|Protocol Violation|0|||
48899789|NCT04256629|157468436|FG005|Overall Study|Protocol Violation|0|||
48899790|NCT01774487|157468437|FG000|Overall Study|Did not tolerate taste|4|||
48899791|NCT01774487|157468438|FG001|Overall Study|Did not tolerate taste|4|||
48899792|NCT00495586|157468446|FG000|Overall Study|Withdrawal by Subject|4|||
48899793|NCT00495586|157468447|FG001|Overall Study|Withdrawal by Subject|4|||
48899794|NCT01590017|157468448|FG000|Overall Study|Adverse Event|1|||
48899795|NCT01590017|157468448|FG000|Overall Study|Withdrawal by Subject|1|||
48899796|NCT01590017|157468448|FG000|Overall Study|Lack of Efficacy|1|||
48899797|NCT01590017|157468448|FG000|Overall Study|Physician Decision|1|||
48899798|NCT02038543|157468449|FG000|Overall Study|Screen Failure|0|||
48899799|NCT02038543|157468450|FG001|Overall Study|Screen Failure|0|||
48899800|NCT02038543|157468451|FG002|Overall Study|Screen Failure|0|||
48899801|NCT02038543|157468452|FG003|Overall Study|Screen Failure|1|||
48899802|NCT02038543|157468449|FG000|Overall Study|Withdrawal by Subject|0|||
48899803|NCT02038543|157468450|FG001|Overall Study|Withdrawal by Subject|0|||
48899804|NCT02038543|157468451|FG002|Overall Study|Withdrawal by Subject|0|||
48899805|NCT02038543|157468452|FG003|Overall Study|Withdrawal by Subject|1|||
48899806|NCT03214094|157468453|FG000|Overall Study|Case Report Forms Uncollected|14|||
48899807|NCT03214094|157468453|FG000|Overall Study|Protocol Deviation|46|||
48899808|NCT01029652|157468454|FG000|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0|||
48899809|NCT01029652|157468455|FG001|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4|||
48899810|NCT01029652|157468454|FG000|Core Study (0-12 Weeks)|Patient Withdrew Consent|1|||
48899811|NCT01029652|157468455|FG001|Core Study (0-12 Weeks)|Patient Withdrew Consent|3|||
48899812|NCT01029652|157468454|FG000|Core Study (0-12 Weeks)|Lost to Follow-up|3|||
49041410|NCT01993940|157987567|FG001|Overall Study|Other - Miscellaneous|1|||
49041411|NCT01395017|157987568|FG000|Overall Study|Lost to Follow-up|1|||
49041412|NCT01395017|157987569|FG001|Overall Study|Lost to Follow-up|0|||
49041413|NCT01395017|157987568|FG000|Overall Study|Adverse Event|26|||
49041414|NCT01395017|157987569|FG001|Overall Study|Adverse Event|12|||
49041415|NCT01395017|157987568|FG000|Overall Study|Physician Decision|11|||
49041416|NCT01395017|157987569|FG001|Overall Study|Physician Decision|15|||
48899813|NCT01029652|157468455|FG001|Core Study (0-12 Weeks)|Lost to Follow-up|1|||
49041417|NCT01395017|157987568|FG000|Overall Study|Withdrawal by Subject|14|||
49041418|NCT01395017|157987569|FG001|Overall Study|Withdrawal by Subject|8|||
48899814|NCT01029652|157468454|FG000|Core Study (0-12 Weeks)|Administrative problems|2|||
48899815|NCT01029652|157468455|FG001|Core Study (0-12 Weeks)|Administrative problems|1|||
48899816|NCT01029652|157468454|FG000|Core Study (0-12 Weeks)|Death|0|||
48899817|NCT01029652|157468455|FG001|Core Study (0-12 Weeks)|Death|1|||
48899818|NCT01029652|157468454|FG000|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0|||
48899819|NCT01029652|157468455|FG001|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1|||
48899820|NCT01029652|157468454|FG000|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2|||
48899821|NCT01029652|157468455|FG001|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3|||
48899822|NCT01029652|157468454|FG000|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1|||
48899823|NCT01029652|157468455|FG001|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0|||
48899824|NCT01029652|157468454|FG000|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0|||
49041419|NCT01395017|157987568|FG000|Overall Study|Protocol deviation|1|||
49041420|NCT01395017|157987569|FG001|Overall Study|Protocol deviation|2|||
49041421|NCT01395017|157987568|FG000|Overall Study|Death|4|||
49041422|NCT01395017|157987569|FG001|Overall Study|Death|3|||
49041423|NCT01395017|157987568|FG000|Overall Study|Disease progression|42|||
49041424|NCT01395017|157987569|FG001|Overall Study|Disease progression|58|||
49041425|NCT01395017|157987568|FG000|Overall Study|Sponsor discontinued study|1|||
49041426|NCT01395017|157987569|FG001|Overall Study|Sponsor discontinued study|4|||
49041427|NCT01663896|157987570|FG000|Overall Study|Various reasons|43|||
49041428|NCT00668395|157987571|FG000|Overall Study|Withdrawal by Subject|4|||
49041429|NCT00668395|157987572|FG001|Overall Study|Withdrawal by Subject|4|||
49041430|NCT00668395|157987573|FG002|Overall Study|Withdrawal by Subject|1|||
48899825|NCT01029652|157468455|FG001|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1|||
48899826|NCT01029652|157468454|FG000|Extension Study 2 (25-72 Weeks)|Death|1|||
48899827|NCT01029652|157468455|FG001|Extension Study 2 (25-72 Weeks)|Death|1|||
48899828|NCT01029652|157468454|FG000|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0|||
48899829|NCT01029652|157468455|FG001|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1|||
48899830|NCT01029652|157468454|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0|||
48899831|NCT01029652|157468455|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1|||
48899832|NCT01577745|157468456|FG000|Overall Study|Withdrawal by Subject|0|||
48899833|NCT01577745|157468457|FG001|Overall Study|Withdrawal by Subject|1|||
48899834|NCT01577745|157468458|FG002|Overall Study|Withdrawal by Subject|0|||
48899835|NCT01577745|157468459|FG003|Overall Study|Withdrawal by Subject|3|||
48899836|NCT01577745|157468460|FG004|Overall Study|Withdrawal by Subject|2|||
48899837|NCT01577745|157468461|FG005|Overall Study|Withdrawal by Subject|0|||
48899838|NCT01577745|157468456|FG000|Overall Study|Death|3|||
48899839|NCT01577745|157468457|FG001|Overall Study|Death|2|||
48899840|NCT01577745|157468458|FG002|Overall Study|Death|2|||
48899841|NCT01577745|157468459|FG003|Overall Study|Death|1|||
48899842|NCT01577745|157468460|FG004|Overall Study|Death|1|||
48899843|NCT01577745|157468461|FG005|Overall Study|Death|3|||
48899844|NCT01577745|157468456|FG000|Overall Study|Physician Decision|0|||
48899845|NCT01577745|157468457|FG001|Overall Study|Physician Decision|0|||
48899846|NCT01577745|157468458|FG002|Overall Study|Physician Decision|0|||
48899847|NCT01577745|157468459|FG003|Overall Study|Physician Decision|1|||
48899848|NCT01577745|157468460|FG004|Overall Study|Physician Decision|1|||
48899849|NCT01577745|157468461|FG005|Overall Study|Physician Decision|0|||
49041431|NCT00668395|157987571|FG000|Overall Study|Adverse Event|1|||
49041432|NCT00668395|157987572|FG001|Overall Study|Adverse Event|1|||
49041433|NCT00668395|157987573|FG002|Overall Study|Adverse Event|0|||
49041434|NCT00668395|157987571|FG000|Overall Study|Physician Decision|1|||
49041435|NCT00668395|157987572|FG001|Overall Study|Physician Decision|1|||
49041436|NCT00668395|157987573|FG002|Overall Study|Physician Decision|0|||
49041437|NCT03250117|157987574|FG000|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|1|||
49041438|NCT03250117|157987575|FG001|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
49041439|NCT03250117|157987576|FG002|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
49041440|NCT03250117|157987577|FG003|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
49041441|NCT03203642|157987578|FG000|Overall Study|Adverse Event|3|||
49041442|NCT03203642|157987579|FG001|Overall Study|Adverse Event|1|||
49041443|NCT03203642|157987578|FG000|Overall Study|Withdrawal by Subject|6|||
49041444|NCT03203642|157987579|FG001|Overall Study|Withdrawal by Subject|6|||
49041445|NCT03203642|157987578|FG000|Overall Study|Lost to Follow-up|2|||
49041446|NCT03203642|157987579|FG001|Overall Study|Lost to Follow-up|1|||
49041447|NCT03203642|157987578|FG000|Overall Study|Termination of the study by sponsor|1|||
49041448|NCT03203642|157987579|FG001|Overall Study|Termination of the study by sponsor|1|||
49041449|NCT03203642|157987578|FG000|Overall Study|Participant moved|0|||
49041450|NCT03203642|157987579|FG001|Overall Study|Participant moved|1|||
49041451|NCT03203642|157987578|FG000|Overall Study|Investigator's decision|3|||
49041452|NCT03203642|157987579|FG001|Overall Study|Investigator's decision|0|||
49041453|NCT03203642|157987578|FG000|Overall Study|Other than above specified|0|||
49041454|NCT03203642|157987579|FG001|Overall Study|Other than above specified|1|||
49041455|NCT01670097|157987580|FG000|Overall Study|Started Phase 1 cancer treatment|1|||
49041456|NCT01670097|157987581|FG001|Overall Study|Started Phase 1 cancer treatment|0|||
48899850|NCT01577745|157468456|FG000|Overall Study|Lost to Follow-up|0|||
48899851|NCT01577745|157468457|FG001|Overall Study|Lost to Follow-up|0|||
48899852|NCT01577745|157468458|FG002|Overall Study|Lost to Follow-up|0|||
48899853|NCT01577745|157468459|FG003|Overall Study|Lost to Follow-up|0|||
48899854|NCT01577745|157468460|FG004|Overall Study|Lost to Follow-up|0|||
48899855|NCT01577745|157468461|FG005|Overall Study|Lost to Follow-up|1|||
49041457|NCT01670097|157987580|FG000|Overall Study|Study burden|1|||
49041458|NCT01670097|157987581|FG001|Overall Study|Study burden|0|||
49041459|NCT01670097|157987580|FG000|Overall Study|COPD exacerbation|0|||
49041460|NCT01670097|157987581|FG001|Overall Study|COPD exacerbation|1|||
49041461|NCT01670097|157987580|FG000|Overall Study|Neutropenia|0|||
49041462|NCT01670097|157987581|FG001|Overall Study|Neutropenia|1|||
48899856|NCT01577745|157468456|FG000|Overall Study|Alternative Therapy|0|||
48899857|NCT01577745|157468457|FG001|Overall Study|Alternative Therapy|0|||
49041463|NCT01670097|157987580|FG000|Overall Study|Clinical deterioration|0|||
49041464|NCT01670097|157987581|FG001|Overall Study|Clinical deterioration|1|||
49041465|NCT01670097|157987580|FG000|Overall Study|Disease progression|0|||
49041466|NCT01670097|157987581|FG001|Overall Study|Disease progression|1|||
48899858|NCT01577745|157468458|FG002|Overall Study|Alternative Therapy|0|||
48899859|NCT01577745|157468459|FG003|Overall Study|Alternative Therapy|1|||
48899860|NCT01577745|157468460|FG004|Overall Study|Alternative Therapy|1|||
48899861|NCT01577745|157468461|FG005|Overall Study|Alternative Therapy|0|||
48899862|NCT02483585|157468464|FG000|Double-blind Treatment Phase|Decision by Sponsor|1|||
48899863|NCT02483585|157468465|FG001|Double-blind Treatment Phase|Decision by Sponsor|1|||
48899864|NCT02483585|157468464|FG000|Double-blind Treatment Phase|Withdrawal by Subject|12|||
48899865|NCT02483585|157468465|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
48899866|NCT02483585|157468464|FG000|Double-blind Treatment Phase|Lost to Follow-up|3|||
48899867|NCT02483585|157468465|FG001|Double-blind Treatment Phase|Lost to Follow-up|2|||
48899868|NCT02483585|157468464|FG000|Open-label Treatment Phase|Protocol-specified Criteria|6|||
48899869|NCT02483585|157468465|FG001|Open-label Treatment Phase|Protocol-specified Criteria|5|||
48899870|NCT02483585|157468464|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
48899871|NCT02483585|157468465|FG001|Open-label Treatment Phase|Decision by Sponsor|1|||
48899872|NCT02483585|157468464|FG000|Open-label Treatment Phase|Withdrawal by Subject|18|||
48899873|NCT02483585|157468465|FG001|Open-label Treatment Phase|Withdrawal by Subject|14|||
48899874|NCT02483585|157468464|FG000|Open-label Treatment Phase|Lost to Follow-up|3|||
48899875|NCT02483585|157468465|FG001|Open-label Treatment Phase|Lost to Follow-up|5|||
48899876|NCT01990560|157468467|FG000|Overall Study|Withdrawal by Subject|1|||
48899877|NCT01236339|157468468|FG000|Overall Study|Termination of study by sponsor|11|||
48899878|NCT01236339|157468469|FG001|Overall Study|Termination of study by sponsor|13|||
48899879|NCT01411215|157468470|FG000|Overall Study|Adverse Event|1|||
49041467|NCT03259165|157987585|FG000|Overall Study|COVID 19 pandemic|1|||
49041468|NCT03259165|157987586|FG001|Overall Study|COVID 19 pandemic|1|||
49041469|NCT00474188|157987587|FG000|Overall Study|Withdrawal by Subject|1|||
49041470|NCT00474188|157987587|FG000|Overall Study|Study discontinued by sponsor|5|||
49041471|NCT00112437|157987588|FG000|Year 1 (12-Month Base Study)|Adverse Event|9|||
49041472|NCT00112437|157987589|FG001|Year 1 (12-Month Base Study)|Adverse Event|10|||
49041473|NCT00112437|157987590|FG002|Year 1 (12-Month Base Study)|Adverse Event|6|||
49041474|NCT00112437|157987591|FG003|Year 1 (12-Month Base Study)|Adverse Event|4|||
49041475|NCT00112437|157987592|FG004|Year 1 (12-Month Base Study)|Adverse Event|3|||
49041476|NCT00112437|157987593|FG005|Year 1 (12-Month Base Study)|Adverse Event|0|||
49041477|NCT00112437|157987594|FG006|Year 1 (12-Month Base Study)|Adverse Event|0|||
49041478|NCT00112437|157987595|FG007|Year 1 (12-Month Base Study)|Adverse Event|0|||
49041479|NCT00112437|157987596|FG008|Year 1 (12-Month Base Study)|Adverse Event|0|||
49041480|NCT00112437|157987597|FG009|Year 1 (12-Month Base Study)|Adverse Event|0|||
49041481|NCT00112437|157987598|FG010|Year 1 (12-Month Base Study)|Adverse Event|0|||
49041482|NCT00112437|157987599|FG011|Year 1 (12-Month Base Study)|Adverse Event|0|||
49041483|NCT00112437|157987600|FG012|Year 1 (12-Month Base Study)|Adverse Event|0|||
49041484|NCT00112437|157987601|FG013|Year 1 (12-Month Base Study)|Adverse Event|0|||
49041485|NCT00112437|157987602|FG014|Year 1 (12-Month Base Study)|Adverse Event|0|||
49041486|NCT00112437|157987603|FG015|Year 1 (12-Month Base Study)|Adverse Event|0|||
49041487|NCT00112437|157987604|FG016|Year 1 (12-Month Base Study)|Adverse Event|0|||
49041488|NCT00112437|157987605|FG017|Year 1 (12-Month Base Study)|Adverse Event|0|||
49041489|NCT00112437|157987606|FG018|Year 1 (12-Month Base Study)|Adverse Event|0|||
49041490|NCT00112437|157987607|FG019|Year 1 (12-Month Base Study)|Adverse Event|0|||
49041491|NCT00112437|157987608|FG020|Year 1 (12-Month Base Study)|Adverse Event|0|||
49041492|NCT00112437|157987609|FG021|Year 1 (12-Month Base Study)|Adverse Event|0|||
49041493|NCT00112437|157987610|FG022|Year 1 (12-Month Base Study)|Adverse Event|0|||
49041494|NCT00112437|157987611|FG023|Year 1 (12-Month Base Study)|Adverse Event|0|||
49041495|NCT00112437|157987612|FG024|Year 1 (12-Month Base Study)|Adverse Event|0|||
49041496|NCT00112437|157987613|FG025|Year 1 (12-Month Base Study)|Adverse Event|0|||
49041497|NCT00112437|157987588|FG000|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
49041498|NCT00112437|157987589|FG001|Year 1 (12-Month Base Study)|Lack of Efficacy|1|||
49041499|NCT00112437|157987590|FG002|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
49041500|NCT00112437|157987591|FG003|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
49041501|NCT00112437|157987592|FG004|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
49041502|NCT00112437|157987593|FG005|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
49041503|NCT00112437|157987594|FG006|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
49041504|NCT00112437|157987595|FG007|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
49041505|NCT00112437|157987596|FG008|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
49041506|NCT00112437|157987597|FG009|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
49041507|NCT00112437|157987598|FG010|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
49041508|NCT00112437|157987599|FG011|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
49041509|NCT00112437|157987600|FG012|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
48899880|NCT01411215|157468471|FG001|Overall Study|Adverse Event|2|||
49041510|NCT00112437|157987601|FG013|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
48899881|NCT01411215|157468470|FG000|Overall Study|Lack of Efficacy|2|||
48899882|NCT01411215|157468471|FG001|Overall Study|Lack of Efficacy|4|||
48899883|NCT01411215|157468470|FG000|Overall Study|Lost to Follow-up|12|||
48899884|NCT01411215|157468471|FG001|Overall Study|Lost to Follow-up|18|||
48899885|NCT01411215|157468470|FG000|Overall Study|Did not meet entrance criteria|0|||
48899886|NCT01411215|157468471|FG001|Overall Study|Did not meet entrance criteria|1|||
48899887|NCT01411215|157468470|FG000|Overall Study|Study terminated by sponsor|2|||
48899888|NCT01411215|157468471|FG001|Overall Study|Study terminated by sponsor|15|||
48899889|NCT01411215|157468470|FG000|Overall Study|Protocol Violation|3|||
48899890|NCT01411215|157468471|FG001|Overall Study|Protocol Violation|5|||
48899891|NCT01411215|157468470|FG000|Overall Study|Withdrawal by Subject|34|||
48899892|NCT01411215|157468471|FG001|Overall Study|Withdrawal by Subject|21|||
48899893|NCT01411215|157468470|FG000|Overall Study|Other|12|||
48899894|NCT01411215|157468471|FG001|Overall Study|Other|17|||
48899895|NCT01411215|157468470|FG000|Overall Study|Screen failure|0|||
48899896|NCT01411215|157468471|FG001|Overall Study|Screen failure|1|||
48899897|NCT02924064|157468472|FG000|Overall Study|Adverse Event|2|||
48899898|NCT02924064|157468473|FG001|Overall Study|Adverse Event|2|||
48899899|NCT02924064|157468472|FG000|Overall Study|Lost to Follow-up|0|||
48899900|NCT02924064|157468473|FG001|Overall Study|Lost to Follow-up|2|||
48899901|NCT02924064|157468472|FG000|Overall Study|Physician Decision|0|||
48899902|NCT02924064|157468473|FG001|Overall Study|Physician Decision|2|||
48899903|NCT02924064|157468472|FG000|Overall Study|Protocol Violation|1|||
48899904|NCT02924064|157468473|FG001|Overall Study|Protocol Violation|3|||
48899905|NCT02924064|157468472|FG000|Overall Study|Withdrawal by Subject|4|||
48899906|NCT02924064|157468473|FG001|Overall Study|Withdrawal by Subject|5|||
48899907|NCT02924064|157468472|FG000|Overall Study|Other|17|||
48899908|NCT02924064|157468473|FG001|Overall Study|Other|29|||
48899909|NCT02875977|157468474|FG000|Overall Study|Lost to Follow-up|42|||
48899910|NCT02875977|157468475|FG001|Overall Study|Lost to Follow-up|29|||
48899911|NCT01127139|157468476|FG000|Overall Study|Adverse Event|40|||
48899912|NCT01127139|157468476|FG000|Overall Study|Incompliance|12|||
48899913|NCT01127139|157468476|FG000|Overall Study|Lack of Efficacy|4|||
48899914|NCT01127139|157468476|FG000|Overall Study|Reason not specified|1|||
48899915|NCT01831856|157468479|FG000|Overall Study|Adverse Event|5|||
48899916|NCT01831856|157468480|FG001|Overall Study|Adverse Event|8|||
48899917|NCT01831856|157468479|FG000|Overall Study|Lack of Efficacy|13|||
48899918|NCT01831856|157468480|FG001|Overall Study|Lack of Efficacy|11|||
48899919|NCT01831856|157468479|FG000|Overall Study|Unsuccessful Electrical Cardioversion|16|||
48899920|NCT01831856|157468480|FG001|Overall Study|Unsuccessful Electrical Cardioversion|18|||
48899921|NCT00336895|157468483|FG000|Overall Study|diarrhea|1|||
48899922|NCT00336895|157468483|FG000|Overall Study|nausea and upset stomach|1|||
48899923|NCT00336895|157468483|FG000|Overall Study|Physician Decision|1|||
48899924|NCT00336895|157468483|FG000|Overall Study|screen failed|1|||
48899925|NCT00906945|157468484|FG000|Overall Study|Found to be not eligible|0|||
48899926|NCT00906945|157468485|FG001|Overall Study|Found to be not eligible|0|||
48899927|NCT00906945|157468486|FG002|Overall Study|Found to be not eligible|0|||
48899928|NCT00906945|157468487|FG003|Overall Study|Found to be not eligible|1|||
48899929|NCT00906945|157468488|FG004|Overall Study|Found to be not eligible|1|||
48899930|NCT00906945|157468489|FG005|Overall Study|Found to be not eligible|1|||
48899931|NCT00906945|157468484|FG000|Overall Study|Physician Decision|0|||
48899932|NCT00906945|157468485|FG001|Overall Study|Physician Decision|0|||
48899933|NCT00906945|157468486|FG002|Overall Study|Physician Decision|0|||
48899934|NCT00906945|157468487|FG003|Overall Study|Physician Decision|0|||
48899935|NCT00906945|157468488|FG004|Overall Study|Physician Decision|0|||
48899936|NCT00906945|157468489|FG005|Overall Study|Physician Decision|1|||
48899937|NCT01007448|157468490|FG000|Overall Study|Continuing Prohibited Systemic Drugs|1|||
48899938|NCT01007448|157468491|FG001|Overall Study|Continuing Prohibited Systemic Drugs|0|||
48899939|NCT01007448|157468490|FG000|Overall Study|Staph Skin Infection Flare|1|||
48899940|NCT01007448|157468491|FG001|Overall Study|Staph Skin Infection Flare|0|||
48899941|NCT01007448|157468490|FG000|Overall Study|Participant Leaving the Country|1|||
48899942|NCT01007448|157468491|FG001|Overall Study|Participant Leaving the Country|0|||
48899943|NCT01007448|157468490|FG000|Overall Study|Participant Given Prohibited Medication|1|||
48899944|NCT01007448|157468491|FG001|Overall Study|Participant Given Prohibited Medication|0|||
48899945|NCT01007448|157468490|FG000|Overall Study|Progressive Disease|1|||
48899946|NCT01007448|157468491|FG001|Overall Study|Progressive Disease|2|||
48899947|NCT01007448|157468490|FG000|Overall Study|Lack of Efficacy|2|||
48899948|NCT01007448|157468491|FG001|Overall Study|Lack of Efficacy|0|||
48899949|NCT01007448|157468490|FG000|Overall Study|Withdrawal by Subject|2|||
48899950|NCT01007448|157468491|FG001|Overall Study|Withdrawal by Subject|3|||
48899951|NCT01007448|157468490|FG000|Overall Study|Adverse Event|1|||
48899952|NCT01007448|157468491|FG001|Overall Study|Adverse Event|4|||
48899953|NCT02121834|157468492|FG000|Overall Study|Protocol Violation|0|||
48899954|NCT02121834|157468493|FG001|Overall Study|Protocol Violation|1|||
48984632|NCT02141854|157774270|FG003|Treatment Period|Protocol Violation|2|||
48984633|NCT02141854|157774271|FG004|Treatment Period|Protocol Violation|2|||
48984634|NCT02141854|157774272|FG005|Treatment Period|Protocol Violation|1|||
48899955|NCT02121834|157468494|FG002|Overall Study|Protocol Violation|0|||
48899956|NCT02121834|157468495|FG003|Overall Study|Protocol Violation|0|||
48899957|NCT02121834|157468496|FG004|Overall Study|Protocol Violation|0|||
48899958|NCT02121834|157468497|FG005|Overall Study|Protocol Violation|0|||
48899959|NCT02121834|157468498|FG006|Overall Study|Protocol Violation|0|||
48899960|NCT02121834|157468492|FG000|Overall Study|Withdrawal by Subject|0|||
48899961|NCT02121834|157468493|FG001|Overall Study|Withdrawal by Subject|1|||
48899962|NCT02121834|157468494|FG002|Overall Study|Withdrawal by Subject|1|||
48899963|NCT02121834|157468495|FG003|Overall Study|Withdrawal by Subject|0|||
48899964|NCT02121834|157468496|FG004|Overall Study|Withdrawal by Subject|0|||
48899965|NCT02121834|157468497|FG005|Overall Study|Withdrawal by Subject|0|||
48899966|NCT02121834|157468498|FG006|Overall Study|Withdrawal by Subject|0|||
48899967|NCT02121834|157468492|FG000|Overall Study|Lost to Follow-up|0|||
48899968|NCT02121834|157468493|FG001|Overall Study|Lost to Follow-up|0|||
48899969|NCT02121834|157468494|FG002|Overall Study|Lost to Follow-up|1|||
48899970|NCT02121834|157468495|FG003|Overall Study|Lost to Follow-up|0|||
48899971|NCT02121834|157468496|FG004|Overall Study|Lost to Follow-up|0|||
48899972|NCT02121834|157468497|FG005|Overall Study|Lost to Follow-up|0|||
48899973|NCT02121834|157468498|FG006|Overall Study|Lost to Follow-up|0|||
48899974|NCT03814187|157468499|FG000|Overall Study|Sponsor's Administrative Decision|0|||
48899975|NCT03814187|157468500|FG001|Overall Study|Sponsor's Administrative Decision|0|||
48899976|NCT03814187|157468501|FG002|Overall Study|Sponsor's Administrative Decision|272|||
48899977|NCT03814187|157468499|FG000|Overall Study|Death|80|||
48899978|NCT03814187|157468500|FG001|Overall Study|Death|81|||
48899979|NCT03814187|157468501|FG002|Overall Study|Death|4|||
48899980|NCT03814187|157468499|FG000|Overall Study|Withdrew Consent|77|||
48899981|NCT03814187|157468500|FG001|Overall Study|Withdrew Consent|78|||
48899982|NCT03814187|157468501|FG002|Overall Study|Withdrew Consent|2|||
48899983|NCT03814187|157468499|FG000|Overall Study|Lost to Follow-up|47|||
48899984|NCT03814187|157468500|FG001|Overall Study|Lost to Follow-up|52|||
48899985|NCT03814187|157468501|FG002|Overall Study|Lost to Follow-up|1|||
48899986|NCT03814187|157468499|FG000|Overall Study|Adverse Event|22|||
48899987|NCT03814187|157468500|FG001|Overall Study|Adverse Event|23|||
48899988|NCT03814187|157468501|FG002|Overall Study|Adverse Event|0|||
48899989|NCT03814187|157468499|FG000|Overall Study|Physician Decision|7|||
48899990|NCT03814187|157468500|FG001|Overall Study|Physician Decision|4|||
48899991|NCT03814187|157468501|FG002|Overall Study|Physician Decision|2|||
48899992|NCT03814187|157468499|FG000|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
48899993|NCT03814187|157468500|FG001|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
48984635|NCT02141854|157774267|FG000|Treatment Period|Noncompliance|0|||
48984636|NCT02141854|157774268|FG001|Treatment Period|Noncompliance|0|||
48899994|NCT03814187|157468501|FG002|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|1|||
48899995|NCT03814187|157468499|FG000|Overall Study|Other reasons|34|||
48899996|NCT03814187|157468500|FG001|Overall Study|Other reasons|40|||
48899997|NCT03814187|157468501|FG002|Overall Study|Other reasons|2|||
48899998|NCT00950950|157468502|FG000|Overall Study|Adverse Event|1|||
48984637|NCT02141854|157774269|FG002|Treatment Period|Noncompliance|0|||
48984638|NCT02141854|157774270|FG003|Treatment Period|Noncompliance|1|||
48984639|NCT02141854|157774271|FG004|Treatment Period|Noncompliance|0|||
48984640|NCT02141854|157774272|FG005|Treatment Period|Noncompliance|0|||
48984641|NCT02141854|157774267|FG000|Treatment Period|Lack of Efficacy|0|||
48984642|NCT02141854|157774268|FG001|Treatment Period|Lack of Efficacy|0|||
48984643|NCT02141854|157774269|FG002|Treatment Period|Lack of Efficacy|0|||
48984644|NCT02141854|157774270|FG003|Treatment Period|Lack of Efficacy|1|||
48984645|NCT02141854|157774271|FG004|Treatment Period|Lack of Efficacy|1|||
48984646|NCT02141854|157774272|FG005|Treatment Period|Lack of Efficacy|7|||
48984647|NCT02141854|157774267|FG000|Treatment Period|Pregnancy|0|||
48984648|NCT02141854|157774268|FG001|Treatment Period|Pregnancy|1|||
48984649|NCT02141854|157774269|FG002|Treatment Period|Pregnancy|0|||
48984650|NCT02141854|157774270|FG003|Treatment Period|Pregnancy|0|||
48984651|NCT02141854|157774271|FG004|Treatment Period|Pregnancy|0|||
48984652|NCT02141854|157774272|FG005|Treatment Period|Pregnancy|0|||
48984653|NCT02141854|157774267|FG000|Treatment Period|Other|0|||
48984654|NCT02141854|157774268|FG001|Treatment Period|Other|1|||
48984655|NCT02141854|157774269|FG002|Treatment Period|Other|2|||
48984656|NCT02141854|157774270|FG003|Treatment Period|Other|0|||
48899999|NCT00950950|157468503|FG001|Overall Study|Adverse Event|0|||
48900000|NCT00950950|157468502|FG000|Overall Study|Withdrawal by Subject|0|||
48900001|NCT00950950|157468503|FG001|Overall Study|Withdrawal by Subject|1|||
48900002|NCT01047293|157468504|FG000|Overall Study|DLT criteria not fulfilled|1|||
48900003|NCT01047293|157468505|FG001|Overall Study|DLT criteria not fulfilled|1|||
48900004|NCT01047293|157468506|FG002|Overall Study|DLT criteria not fulfilled|0|||
48900005|NCT01047293|157468507|FG003|Overall Study|DLT criteria not fulfilled|0|||
48900006|NCT00940108|157468508|FG000|Overall Study|Adverse Event|2|||
48900007|NCT00940108|157468509|FG001|Overall Study|Adverse Event|4|||
48900008|NCT00940108|157468510|FG002|Overall Study|Adverse Event|0|||
48900009|NCT00940108|157468511|FG003|Overall Study|Adverse Event|2|||
49041511|NCT00112437|157987602|FG014|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
48984657|NCT02141854|157774271|FG004|Treatment Period|Other|1|||
48984658|NCT02141854|157774272|FG005|Treatment Period|Other|2|||
48900010|NCT00940108|157468508|FG000|Overall Study|Withdrew Consent|2|||
48900011|NCT00940108|157468509|FG001|Overall Study|Withdrew Consent|1|||
48900012|NCT00940108|157468510|FG002|Overall Study|Withdrew Consent|0|||
48900013|NCT00940108|157468511|FG003|Overall Study|Withdrew Consent|1|||
48900014|NCT00940108|157468508|FG000|Overall Study|Dose 2 contraindicated|1|||
48900015|NCT00940108|157468509|FG001|Overall Study|Dose 2 contraindicated|1|||
48900016|NCT00940108|157468510|FG002|Overall Study|Dose 2 contraindicated|0|||
48900017|NCT00940108|157468511|FG003|Overall Study|Dose 2 contraindicated|1|||
48900018|NCT00940108|157468508|FG000|Overall Study|Declined further vaccination|0|||
48900019|NCT00940108|157468509|FG001|Overall Study|Declined further vaccination|1|||
48900020|NCT00940108|157468510|FG002|Overall Study|Declined further vaccination|3|||
48900021|NCT00940108|157468511|FG003|Overall Study|Declined further vaccination|0|||
48900022|NCT00940108|157468508|FG000|Overall Study|Refused - pyrexia after Dose 1|0|||
48900023|NCT00940108|157468509|FG001|Overall Study|Refused - pyrexia after Dose 1|1|||
48900024|NCT00940108|157468510|FG002|Overall Study|Refused - pyrexia after Dose 1|0|||
48900025|NCT00940108|157468511|FG003|Overall Study|Refused - pyrexia after Dose 1|0|||
48900026|NCT00940108|157468508|FG000|Overall Study|Viral illness after Dose 1|0|||
48900027|NCT00940108|157468509|FG001|Overall Study|Viral illness after Dose 1|1|||
48900028|NCT00940108|157468510|FG002|Overall Study|Viral illness after Dose 1|0|||
48900029|NCT00940108|157468511|FG003|Overall Study|Viral illness after Dose 1|0|||
48900030|NCT00940108|157468508|FG000|Overall Study|Diagnosed with H1N1|0|||
48900031|NCT00940108|157468509|FG001|Overall Study|Diagnosed with H1N1|0|||
48900032|NCT00940108|157468510|FG002|Overall Study|Diagnosed with H1N1|0|||
48900033|NCT00940108|157468511|FG003|Overall Study|Diagnosed with H1N1|1|||
48900034|NCT02076178|157468512|FG000|Oral Phase|Adverse Event|0|||
48900035|NCT02076178|157468513|FG001|Oral Phase|Adverse Event|7|||
48900036|NCT02076178|157468512|FG000|Oral Phase|Withdrawal by Subject|0|||
48900037|NCT02076178|157468513|FG001|Oral Phase|Withdrawal by Subject|4|||
48900038|NCT02076178|157468512|FG000|Oral Phase|Physician Decision|0|||
48900039|NCT02076178|157468513|FG001|Oral Phase|Physician Decision|1|||
48900040|NCT02076178|157468512|FG000|Injection Phase|Protocol defined stopping criteria|1|||
48900041|NCT02076178|157468513|FG001|Injection Phase|Protocol defined stopping criteria|0|||
48900042|NCT02076178|157468512|FG000|Injection Phase|Withdrawal by Subject|0|||
48900043|NCT02076178|157468513|FG001|Injection Phase|Withdrawal by Subject|3|||
48900044|NCT02076178|157468512|FG000|Injection Phase|Physician Decision|0|||
48900045|NCT02076178|157468513|FG001|Injection Phase|Physician Decision|3|||
48900046|NCT02076178|157468512|FG000|Injection Phase|Lost to Follow-up|0|||
48900047|NCT02076178|157468513|FG001|Injection Phase|Lost to Follow-up|1|||
48900048|NCT00731120|157468514|FG000|Overall Study|Adverse Event|7|||
48900049|NCT00731120|157468515|FG001|Overall Study|Adverse Event|6|||
48900050|NCT00731120|157468516|FG002|Overall Study|Adverse Event|8|||
48900051|NCT00731120|157468514|FG000|Overall Study|Lack of Efficacy|4|||
48900052|NCT00731120|157468515|FG001|Overall Study|Lack of Efficacy|5|||
48900053|NCT00731120|157468516|FG002|Overall Study|Lack of Efficacy|4|||
48900054|NCT00731120|157468514|FG000|Overall Study|Noncompliance with Study Drug|3|||
48900055|NCT00731120|157468515|FG001|Overall Study|Noncompliance with Study Drug|3|||
48900056|NCT00731120|157468516|FG002|Overall Study|Noncompliance with Study Drug|1|||
48900057|NCT00731120|157468514|FG000|Overall Study|Protocol Deviations|1|||
48900058|NCT00731120|157468515|FG001|Overall Study|Protocol Deviations|6|||
48900059|NCT00731120|157468516|FG002|Overall Study|Protocol Deviations|1|||
48900060|NCT00731120|157468514|FG000|Overall Study|Withdrawal of Consent|13|||
48900061|NCT00731120|157468515|FG001|Overall Study|Withdrawal of Consent|8|||
48900062|NCT00731120|157468516|FG002|Overall Study|Withdrawal of Consent|4|||
48900063|NCT00731120|157468514|FG000|Overall Study|Lost to Follow-up|10|||
48900064|NCT00731120|157468515|FG001|Overall Study|Lost to Follow-up|15|||
48900065|NCT00731120|157468516|FG002|Overall Study|Lost to Follow-up|17|||
48900066|NCT00731120|157468514|FG000|Overall Study|Other|4|||
48900067|NCT00731120|157468515|FG001|Overall Study|Other|0|||
48900068|NCT00731120|157468516|FG002|Overall Study|Other|1|||
48900069|NCT00928447|157468517|FG000|Overall Study|Withdrawal by Subject|1|||
48900070|NCT00928447|157468517|FG000|Overall Study|Investigator's decision|1|||
48900071|NCT01012713|157468518|FG000|Overall Study|Lack of Efficacy|3|||
48900072|NCT05056987|157468520|FG000|First Wear Period, Day 14 or Day 28|Adverse Event|1|||
48900073|NCT05056987|157468521|FG001|First Wear Period, Day 14 or Day 28|Adverse Event|0|||
48900074|NCT05056987|157468520|FG000|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|0|||
48900075|NCT05056987|157468521|FG001|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|2|||
48900076|NCT01296347|157468522|FG000|Allocation|Withdrawal by Subject|1|||
48900077|NCT01296347|157468523|FG001|Allocation|Withdrawal by Subject|2|||
48900078|NCT01296347|157468522|FG000|Allocation|Lack of Efficacy|1|||
48900079|NCT01296347|157468523|FG001|Allocation|Lack of Efficacy|2|||
48900080|NCT01296347|157468522|FG000|Allocation|not received infusion|1|||
48900081|NCT01296347|157468523|FG001|Allocation|not received infusion|0|||
48900082|NCT01296347|157468522|FG000|6 Week Follow up|Death|0|||
48900083|NCT01296347|157468523|FG001|6 Week Follow up|Death|1|||
48900084|NCT01296347|157468522|FG000|3 Month Follow up|Death|1|||
48900085|NCT01296347|157468523|FG001|3 Month Follow up|Death|0|||
48900086|NCT01296347|157468522|FG000|3 Month Follow up|Lost to Follow-up|0|||
48900087|NCT01296347|157468523|FG001|3 Month Follow up|Lost to Follow-up|1|||
48900088|NCT01296347|157468522|FG000|6 Month Follow up|Death|2|||
48900089|NCT01296347|157468523|FG001|6 Month Follow up|Death|1|||
48900090|NCT01296347|157468522|FG000|6 Month Follow up|Lost to Follow-up|0|||
48900091|NCT01296347|157468523|FG001|6 Month Follow up|Lost to Follow-up|1|||
48900092|NCT01296347|157468522|FG000|12 Month Follow up|Lost to Follow-up|3|||
48900093|NCT01296347|157468523|FG001|12 Month Follow up|Lost to Follow-up|1|||
48900094|NCT01296347|157468522|FG000|12 Month Follow up|Death|1|||
48900095|NCT01296347|157468523|FG001|12 Month Follow up|Death|1|||
48900096|NCT01296347|157468522|FG000|12 Month Follow up|Withdrawal by Subject|0|||
48900097|NCT01296347|157468523|FG001|12 Month Follow up|Withdrawal by Subject|1|||
48900098|NCT01853982|157468526|FG000|Overall Study|Withdrawal by Subject|1|||
48900099|NCT01853982|157468527|FG001|Overall Study|Withdrawal by Subject|0|||
48900100|NCT01853982|157468526|FG000|Overall Study|Death|1|||
48900101|NCT01853982|157468527|FG001|Overall Study|Death|0|||
48900102|NCT01853982|157468526|FG000|Overall Study|Lost to Follow-up|0|||
48900103|NCT01853982|157468527|FG001|Overall Study|Lost to Follow-up|1|||
48900104|NCT00346268|157470183|FG000|Overall Study|Adverse Event|1|||
48900105|NCT00346268|157470184|FG001|Overall Study|Adverse Event|0|||
48900106|NCT00346268|157470183|FG000|Overall Study|Protocol Violation|1|||
48900107|NCT00346268|157470184|FG001|Overall Study|Protocol Violation|0|||
48900108|NCT00346268|157470183|FG000|Overall Study|Participant refused|0|||
48900109|NCT00346268|157470184|FG001|Overall Study|Participant refused|3|||
48900110|NCT00275262|157470185|FG000|Overall Study|Adverse Event|2|||
48900111|NCT00275262|157470186|FG001|Overall Study|Adverse Event|0|||
48900112|NCT00275262|157470185|FG000|Overall Study|Disease progression|2|||
48900113|NCT00275262|157470186|FG001|Overall Study|Disease progression|5|||
48900114|NCT00275262|157470185|FG000|Overall Study|Lost to Follow-up|0|||
48900115|NCT00275262|157470186|FG001|Overall Study|Lost to Follow-up|2|||
48900116|NCT00275262|157470185|FG000|Overall Study|Protocol Violation|0|||
48900117|NCT00275262|157470186|FG001|Overall Study|Protocol Violation|2|||
48900118|NCT00275262|157470185|FG000|Overall Study|Death|1|||
48900119|NCT00275262|157470186|FG001|Overall Study|Death|0|||
48900120|NCT00275262|157470185|FG000|Overall Study|Started Chemotherapy|1|||
48900121|NCT00275262|157470186|FG001|Overall Study|Started Chemotherapy|0|||
48900122|NCT00759915|157470193|FG000|Overall Study|Withdrawal by Subject|1|||
48900123|NCT00759915|157470194|FG001|Overall Study|Withdrawal by Subject|0|||
48900124|NCT00759915|157470193|FG000|Overall Study|Adverse Event|0|||
48900125|NCT00759915|157470194|FG001|Overall Study|Adverse Event|1|||
48900126|NCT00320541|157470196|FG000|Overall Study|Adverse Event|21|||
48900127|NCT00320541|157470197|FG001|Overall Study|Adverse Event|19|||
48900128|NCT00320541|157470196|FG000|Overall Study|Protocol Violation|0|||
48900129|NCT00320541|157470197|FG001|Overall Study|Protocol Violation|1|||
48900130|NCT00320541|157470196|FG000|Overall Study|Withdrawal by Subject|12|||
48900131|NCT00320541|157470197|FG001|Overall Study|Withdrawal by Subject|16|||
48900132|NCT00320541|157470196|FG000|Overall Study|Physician Decision|9|||
48900133|NCT00320541|157470197|FG001|Overall Study|Physician Decision|13|||
48900134|NCT00320541|157470196|FG000|Overall Study|Other|3|||
48900135|NCT00320541|157470197|FG001|Overall Study|Other|4|||
48900136|NCT00320541|157470196|FG000|Overall Study|Sponsor Decision|2|||
48900137|NCT00320541|157470197|FG001|Overall Study|Sponsor Decision|1|||
48900138|NCT00320541|157470196|FG000|Overall Study|Death due to Study Disease|1|||
48900139|NCT00320541|157470197|FG001|Overall Study|Death due to Study Disease|3|||
48900140|NCT00320541|157470196|FG000|Overall Study|Death due to Adverse Event(s)|1|||
48900141|NCT00320541|157470197|FG001|Overall Study|Death due to Adverse Event(s)|0|||
48900142|NCT00320541|157470196|FG000|Overall Study|Protocol Entry Criterion Not Met|1|||
48900143|NCT00320541|157470197|FG001|Overall Study|Protocol Entry Criterion Not Met|0|||
48900144|NCT02134977|157470200|FG000|Overall Study|Protocol Deviation|102|||
48900145|NCT02480153|157470201|FG000|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
48984659|NCT02141854|157774267|FG000|Treatment Period|Adverse Event|0|||
48984660|NCT02141854|157774268|FG001|Treatment Period|Adverse Event|2|||
48984661|NCT02141854|157774269|FG002|Treatment Period|Adverse Event|2|||
48984662|NCT02141854|157774270|FG003|Treatment Period|Adverse Event|0|||
48984663|NCT02141854|157774271|FG004|Treatment Period|Adverse Event|2|||
48984664|NCT02141854|157774272|FG005|Treatment Period|Adverse Event|2|||
48984665|NCT02141854|157774267|FG000|Treatment Period|Withdrawal by Subject|0|||
48984666|NCT02141854|157774268|FG001|Treatment Period|Withdrawal by Subject|2|||
48984667|NCT02141854|157774269|FG002|Treatment Period|Withdrawal by Subject|3|||
48984668|NCT02141854|157774270|FG003|Treatment Period|Withdrawal by Subject|3|||
48984669|NCT02141854|157774271|FG004|Treatment Period|Withdrawal by Subject|4|||
48984670|NCT02141854|157774272|FG005|Treatment Period|Withdrawal by Subject|7|||
48984671|NCT02141854|157774267|FG000|Treatment Period|Disease progression|0|||
48984672|NCT02141854|157774268|FG001|Treatment Period|Disease progression|2|||
48984673|NCT02141854|157774269|FG002|Treatment Period|Disease progression|1|||
48984674|NCT02141854|157774270|FG003|Treatment Period|Disease progression|3|||
48984675|NCT02141854|157774271|FG004|Treatment Period|Disease progression|0|||
48984676|NCT02141854|157774272|FG005|Treatment Period|Disease progression|18|||
48984677|NCT02141854|157774267|FG000|Treatment Period|Lost to Follow-up|0|||
48900146|NCT02480153|157470202|FG001|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1|||
48900147|NCT02480153|157470203|FG002|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
48900148|NCT02480153|157470201|FG000|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
48900149|NCT02480153|157470202|FG001|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1|||
48900150|NCT02480153|157470203|FG002|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
48900151|NCT02480153|157470201|FG000|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1|||
48900152|NCT02480153|157470202|FG001|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2|||
48900153|NCT02480153|157470203|FG002|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0|||
48900154|NCT02480153|157470201|FG000|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3|||
48900155|NCT02480153|157470202|FG001|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8|||
48900156|NCT02480153|157470203|FG002|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0|||
48900157|NCT02480153|157470201|FG000|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
48900158|NCT02480153|157470202|FG001|Period 1: First Dose to Week 26 Pre-dose|Other|1|||
48900159|NCT02480153|157470203|FG002|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
48900160|NCT02480153|157470201|FG000|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
48900161|NCT02480153|157470202|FG001|Period 1: First Dose to Week 26 Pre-dose|Death|1|||
48900162|NCT02480153|157470203|FG002|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
48900163|NCT02480153|157470201|FG000|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
48900164|NCT02480153|157470202|FG001|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2|||
48900165|NCT02480153|157470203|FG002|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
48900166|NCT02480153|157470201|FG000|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4|||
48900167|NCT02480153|157470202|FG001|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1|||
48900168|NCT02480153|157470203|FG002|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3|||
48900169|NCT02480153|157470201|FG000|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
48900170|NCT02480153|157470202|FG001|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1|||
48900171|NCT02480153|157470203|FG002|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
48900172|NCT02480153|157470201|FG000|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8|||
48900173|NCT02480153|157470202|FG001|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3|||
48900174|NCT02480153|157470203|FG002|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1|||
48900175|NCT02480153|157470201|FG000|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6|||
48900176|NCT02480153|157470202|FG001|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7|||
48900177|NCT02480153|157470203|FG002|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3|||
48900178|NCT02480153|157470201|FG000|Period 2: Week 26 to Week 52 Pre-dose|Other|2|||
48900179|NCT02480153|157470202|FG001|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
48900180|NCT02480153|157470203|FG002|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
48900181|NCT02480153|157470201|FG000|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
48900182|NCT02480153|157470202|FG001|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1|||
48900183|NCT02480153|157470203|FG002|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
48984678|NCT02141854|157774268|FG001|Treatment Period|Lost to Follow-up|1|||
48984679|NCT02141854|157774269|FG002|Treatment Period|Lost to Follow-up|1|||
48984680|NCT02141854|157774270|FG003|Treatment Period|Lost to Follow-up|1|||
48984681|NCT02141854|157774271|FG004|Treatment Period|Lost to Follow-up|0|||
48984682|NCT02141854|157774272|FG005|Treatment Period|Lost to Follow-up|1|||
48984683|NCT05643170|157775571|FG000|Overall Study|Withdrew from study treatment due to study termination|3|||
48984684|NCT05643170|157775571|FG000|Overall Study|Adverse event (AE) that lead to treatment discontinuation|1|||
48984685|NCT01432756|157775574|FG000|Overall Study|Lost to Follow-up|1|||
48984686|NCT01432756|157775575|FG001|Overall Study|Lost to Follow-up|0|||
48984687|NCT01432756|157775576|FG002|Overall Study|Lost to Follow-up|2|||
48984688|NCT01432756|157775577|FG003|Overall Study|Lost to Follow-up|1|||
48984689|NCT02358863|157775578|FG000|Overall Study|Physician Decision|3|||
48984690|NCT01696396|157775586|FG000|Overall Study|Withdrawal by Subject|19|||
48984691|NCT01696396|157775587|FG001|Overall Study|Withdrawal by Subject|5|||
48984692|NCT01696396|157775588|FG002|Overall Study|Withdrawal by Subject|19|||
48984693|NCT01696396|157775589|FG003|Overall Study|Withdrawal by Subject|11|||
48984694|NCT01696396|157775586|FG000|Overall Study|Decision by Sponsor|3|||
48984695|NCT01696396|157775587|FG001|Overall Study|Decision by Sponsor|1|||
48984696|NCT01696396|157775588|FG002|Overall Study|Decision by Sponsor|2|||
48984697|NCT01696396|157775589|FG003|Overall Study|Decision by Sponsor|2|||
48984698|NCT01696396|157775586|FG000|Overall Study|Lost to Follow-up|9|||
48984699|NCT01696396|157775587|FG001|Overall Study|Lost to Follow-up|1|||
48984700|NCT01696396|157775588|FG002|Overall Study|Lost to Follow-up|4|||
48984701|NCT01696396|157775589|FG003|Overall Study|Lost to Follow-up|1|||
48984702|NCT01696396|157775586|FG000|Overall Study|Death|0|||
48984703|NCT01696396|157775587|FG001|Overall Study|Death|0|||
48984704|NCT01696396|157775588|FG002|Overall Study|Death|1|||
48984705|NCT01696396|157775589|FG003|Overall Study|Death|0|||
48984706|NCT00621764|157775592|FG000|Overall Study|Protocol Violation|0|||
48984707|NCT00621764|157775593|FG001|Overall Study|Protocol Violation|0|||
48984708|NCT00621764|157775594|FG002|Overall Study|Protocol Violation|0|||
49041512|NCT00112437|157987603|FG015|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
49041513|NCT00112437|157987604|FG016|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
49041514|NCT00112437|157987605|FG017|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
49041515|NCT00112437|157987606|FG018|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
49041516|NCT00112437|157987607|FG019|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
49041517|NCT00112437|157987608|FG020|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
49041518|NCT00112437|157987609|FG021|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
49041519|NCT00112437|157987610|FG022|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
49041520|NCT00112437|157987611|FG023|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
49041521|NCT00112437|157987612|FG024|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
49041522|NCT00112437|157987613|FG025|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
49041523|NCT00112437|157987588|FG000|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
49041524|NCT00112437|157987589|FG001|Year 1 (12-Month Base Study)|Lost to Follow-up|1|||
49041525|NCT00112437|157987590|FG002|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
49041526|NCT00112437|157987591|FG003|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
49041527|NCT00112437|157987592|FG004|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
49041528|NCT00112437|157987593|FG005|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
49041529|NCT00112437|157987594|FG006|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
49041530|NCT00112437|157987595|FG007|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
49041531|NCT00112437|157987596|FG008|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
49041532|NCT00112437|157987597|FG009|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
48900184|NCT02480153|157470201|FG000|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3|||
48900185|NCT02480153|157470202|FG001|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2|||
48900186|NCT02480153|157470203|FG002|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1|||
48900187|NCT02480153|157470201|FG000|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4|||
49041533|NCT00112437|157987598|FG010|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
49041534|NCT00112437|157987599|FG011|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
49041535|NCT00112437|157987600|FG012|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
49041536|NCT00112437|157987601|FG013|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
49041537|NCT00112437|157987602|FG014|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
48900188|NCT02480153|157470202|FG001|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0|||
48900189|NCT02480153|157470203|FG002|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1|||
48900190|NCT02480153|157470201|FG000|Period 3: Week 52 Dosing to Week 78|Other|0|||
49041538|NCT00112437|157987603|FG015|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
49041539|NCT00112437|157987604|FG016|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
49041540|NCT00112437|157987605|FG017|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
49041541|NCT00112437|157987606|FG018|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
48900191|NCT02480153|157470202|FG001|Period 3: Week 52 Dosing to Week 78|Other|0|||
48900192|NCT02480153|157470203|FG002|Period 3: Week 52 Dosing to Week 78|Other|1|||
48900193|NCT02480153|157470201|FG000|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
48900194|NCT02480153|157470202|FG001|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
48900195|NCT02480153|157470203|FG002|Period 3: Week 52 Dosing to Week 78|Adverse Event|1|||
48900196|NCT02480153|157470201|FG000|Period 3: Week 52 Dosing to Week 78|Death|0|||
48900197|NCT02480153|157470202|FG001|Period 3: Week 52 Dosing to Week 78|Death|1|||
48900198|NCT02480153|157470203|FG002|Period 3: Week 52 Dosing to Week 78|Death|0|||
48900199|NCT00953407|157470204|FG000|Overall Study|Failed inclusion criteria|1|||
48900200|NCT00953407|157470205|FG001|Overall Study|Failed inclusion criteria|1|||
48900201|NCT00953407|157470206|FG002|Overall Study|Failed inclusion criteria|1|||
48900202|NCT00953407|157470207|FG003|Overall Study|Failed inclusion criteria|1|||
48900203|NCT00953407|157470208|FG004|Overall Study|Failed inclusion criteria|1|||
48900204|NCT00953407|157470204|FG000|Overall Study|Lost to Follow-up|0|||
48900205|NCT00953407|157470205|FG001|Overall Study|Lost to Follow-up|0|||
48900206|NCT00953407|157470206|FG002|Overall Study|Lost to Follow-up|0|||
48900207|NCT00953407|157470207|FG003|Overall Study|Lost to Follow-up|1|||
48900208|NCT00953407|157470208|FG004|Overall Study|Lost to Follow-up|0|||
48900209|NCT01639495|157470212|FG000|Overall Study|Lost to Follow-up|6|||
48900210|NCT01639495|157470212|FG000|Overall Study|Consented but didn't have study catheter|4|||
48900211|NCT01639495|157470212|FG000|Overall Study|Not meeting inclusion/exclusion criteria|4|||
48900212|NCT01639495|157470212|FG000|Overall Study|No radiofrequency energy applied|2|||
48900213|NCT04214600|157470215|FG000|Overall Study|Lost to Follow-up|9|||
48900214|NCT04214600|157470216|FG001|Overall Study|Lost to Follow-up|14|||
48900215|NCT00896051|157470217|FG000|Overall Study|Adverse Event|2|||
48900216|NCT00896051|157470218|FG001|Overall Study|Adverse Event|1|||
48900217|NCT00896051|157470217|FG000|Overall Study|Lost to Follow-up|3|||
49041542|NCT00112437|157987607|FG019|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
48900218|NCT00896051|157470218|FG001|Overall Study|Lost to Follow-up|2|||
48900219|NCT00896051|157470217|FG000|Overall Study|Withdrawal by Subject|3|||
48900220|NCT00896051|157470218|FG001|Overall Study|Withdrawal by Subject|2|||
49041543|NCT00112437|157987608|FG020|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
49041544|NCT00112437|157987609|FG021|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
49041545|NCT00112437|157987610|FG022|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
49041546|NCT00112437|157987611|FG023|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
48900221|NCT00896051|157470217|FG000|Overall Study|Subject noncompliant|1|||
48900222|NCT00896051|157470218|FG001|Overall Study|Subject noncompliant|3|||
48900223|NCT00896051|157470217|FG000|Overall Study|Other|1|||
48900224|NCT00896051|157470218|FG001|Overall Study|Other|1|||
48900225|NCT02935452|157470219|FG000|Overall Study|work and life commintment|3|||
48900226|NCT02935452|157470220|FG001|Overall Study|work and life commintment|1|||
48900227|NCT02074553|157470227|FG000|Intervention Period 1|Family Emergency|0|||
48900228|NCT02074553|157470228|FG001|Intervention Period 1|Family Emergency|0|||
48900229|NCT02074553|157470229|FG002|Intervention Period 1|Family Emergency|0|||
48900230|NCT02074553|157470230|FG003|Intervention Period 1|Family Emergency|1|||
48900231|NCT02074553|157470231|FG004|Intervention Period 1|Family Emergency|0|||
48900232|NCT02074553|157470232|FG005|Intervention Period 1|Family Emergency|0|||
48900233|NCT02074553|157470233|FG006|Intervention Period 1|Family Emergency|0|||
48900234|NCT02074553|157470234|FG007|Intervention Period 1|Family Emergency|0|||
48900235|NCT02074553|157470227|FG000|Washout Period 1|Adverse Event|1|||
48900236|NCT02074553|157470228|FG001|Washout Period 1|Adverse Event|0|||
48900237|NCT02074553|157470229|FG002|Washout Period 1|Adverse Event|0|||
48900238|NCT02074553|157470230|FG003|Washout Period 1|Adverse Event|0|||
48900239|NCT02074553|157470231|FG004|Washout Period 1|Adverse Event|0|||
49041547|NCT00112437|157987612|FG024|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
48900240|NCT02074553|157470232|FG005|Washout Period 1|Adverse Event|0|||
48900241|NCT02074553|157470233|FG006|Washout Period 1|Adverse Event|0|||
48900242|NCT02074553|157470234|FG007|Washout Period 1|Adverse Event|0|||
48900243|NCT02074553|157470227|FG000|Washout Period 1|Physician Decision|0|||
48900244|NCT02074553|157470228|FG001|Washout Period 1|Physician Decision|0|||
48900245|NCT02074553|157470229|FG002|Washout Period 1|Physician Decision|0|||
48900246|NCT02074553|157470230|FG003|Washout Period 1|Physician Decision|1|||
48900247|NCT02074553|157470231|FG004|Washout Period 1|Physician Decision|0|||
48900248|NCT02074553|157470232|FG005|Washout Period 1|Physician Decision|0|||
48900249|NCT02074553|157470233|FG006|Washout Period 1|Physician Decision|0|||
48900250|NCT02074553|157470234|FG007|Washout Period 1|Physician Decision|0|||
48900251|NCT02074553|157470227|FG000|Washout Period 1|Other|0|||
48900252|NCT02074553|157470228|FG001|Washout Period 1|Other|0|||
48900253|NCT02074553|157470229|FG002|Washout Period 1|Other|0|||
48900254|NCT02074553|157470230|FG003|Washout Period 1|Other|0|||
48900255|NCT02074553|157470231|FG004|Washout Period 1|Other|0|||
48900256|NCT02074553|157470232|FG005|Washout Period 1|Other|1|||
48900257|NCT02074553|157470233|FG006|Washout Period 1|Other|0|||
48900258|NCT02074553|157470234|FG007|Washout Period 1|Other|0|||
48900259|NCT02074553|157470227|FG000|Washout Period 2|Adverse Event|0|||
48900260|NCT02074553|157470228|FG001|Washout Period 2|Adverse Event|0|||
48900261|NCT02074553|157470229|FG002|Washout Period 2|Adverse Event|0|||
48900262|NCT02074553|157470230|FG003|Washout Period 2|Adverse Event|0|||
48900263|NCT02074553|157470231|FG004|Washout Period 2|Adverse Event|0|||
48900264|NCT02074553|157470232|FG005|Washout Period 2|Adverse Event|0|||
48900265|NCT02074553|157470233|FG006|Washout Period 2|Adverse Event|1|||
48900266|NCT02074553|157470234|FG007|Washout Period 2|Adverse Event|0|||
48900267|NCT02074553|157470227|FG000|Washout Period 2|Physician Decision|0|||
48900268|NCT02074553|157470228|FG001|Washout Period 2|Physician Decision|0|||
48900269|NCT02074553|157470229|FG002|Washout Period 2|Physician Decision|0|||
48900270|NCT02074553|157470230|FG003|Washout Period 2|Physician Decision|0|||
48900271|NCT02074553|157470231|FG004|Washout Period 2|Physician Decision|0|||
48900272|NCT02074553|157470232|FG005|Washout Period 2|Physician Decision|1|||
48900273|NCT02074553|157470233|FG006|Washout Period 2|Physician Decision|0|||
48900274|NCT02074553|157470234|FG007|Washout Period 2|Physician Decision|0|||
48900275|NCT02074553|157470227|FG000|Washout Period 2|Lost to Follow-up|0|||
48900276|NCT02074553|157470228|FG001|Washout Period 2|Lost to Follow-up|0|||
48900277|NCT02074553|157470229|FG002|Washout Period 2|Lost to Follow-up|1|||
48900278|NCT02074553|157470230|FG003|Washout Period 2|Lost to Follow-up|0|||
48900279|NCT02074553|157470231|FG004|Washout Period 2|Lost to Follow-up|0|||
48900280|NCT02074553|157470232|FG005|Washout Period 2|Lost to Follow-up|0|||
48900281|NCT02074553|157470233|FG006|Washout Period 2|Lost to Follow-up|0|||
48900282|NCT02074553|157470234|FG007|Washout Period 2|Lost to Follow-up|0|||
48900283|NCT02074553|157470227|FG000|Washout Period 3|Physician Decision|0|||
48900284|NCT02074553|157470228|FG001|Washout Period 3|Physician Decision|0|||
48900285|NCT02074553|157470229|FG002|Washout Period 3|Physician Decision|0|||
48900286|NCT02074553|157470230|FG003|Washout Period 3|Physician Decision|0|||
48900287|NCT02074553|157470231|FG004|Washout Period 3|Physician Decision|0|||
48900288|NCT02074553|157470232|FG005|Washout Period 3|Physician Decision|0|||
48900289|NCT02074553|157470233|FG006|Washout Period 3|Physician Decision|0|||
48900290|NCT02074553|157470234|FG007|Washout Period 3|Physician Decision|1|||
48900291|NCT01640054|157470235|FG000|Overall Study|Study-specific disc criteria|1|||
48900292|NCT01640054|157470235|FG000|Overall Study|Lack of Efficacy|3|||
48900293|NCT01640054|157470235|FG000|Overall Study|Adverse Event|2|||
48900294|NCT05220254|157470236|FG000|Overall Study|Withdrawal by Subject|4|||
48900295|NCT05220254|157470236|FG000|Overall Study|Removed due to ineligibility|1|||
48900296|NCT05220254|157470236|FG000|Overall Study|Lost to Follow-up|7|||
48900297|NCT02080221|157470239|FG000|Overall Study|Withdrawal by Subject|1|||
48900298|NCT02080221|157470239|FG000|Overall Study|Clinical Progression of Disease|1|||
48900299|NCT02090959|157470240|FG000|Overall Study|Withdrawal by Subject|10|||
48900300|NCT02090959|157470240|FG000|Overall Study|Adverse Event|1|||
48900301|NCT02090959|157470240|FG000|Overall Study|Investigator decision|2|||
48900302|NCT02090959|157470240|FG000|Overall Study|Study termination|6|||
48900303|NCT02090959|157470240|FG000|Overall Study|Enrolled but not treated|1|||
48900304|NCT02090959|157470240|FG000|Overall Study|Transfer for compassionate use medicine|4|||
48900305|NCT02090959|157470240|FG000|Overall Study|Move to medical need program|3|||
48900306|NCT02090959|157470240|FG000|Overall Study|Entered in to other study|34|||
48900307|NCT02090959|157470240|FG000|Overall Study|Switched to commercial supply|88|||
48900308|NCT02090959|157470240|FG000|Overall Study|Other than specified|2|||
48900309|NCT00738582|157470241|FG000|Combination Therapy|Completed Combination Therapy|1|||
48900310|NCT00738582|157470242|FG001|Combination Therapy|Completed Combination Therapy|0|||
48900311|NCT00738582|157470241|FG000|Combination Therapy|Physician Decision|1|||
48900312|NCT00738582|157470242|FG001|Combination Therapy|Physician Decision|0|||
48900313|NCT00738582|157470241|FG000|Combination Therapy|Toxicity to Chemotherapy|1|||
48900314|NCT00738582|157470242|FG001|Combination Therapy|Toxicity to Chemotherapy|0|||
48900315|NCT00738582|157470241|FG000|Combination Therapy|Other|5|||
48900316|NCT00738582|157470242|FG001|Combination Therapy|Other|0|||
48900317|NCT00738582|157470241|FG000|Combination Therapy|Adverse Event|16|||
48900318|NCT00738582|157470242|FG001|Combination Therapy|Adverse Event|0|||
48900319|NCT00738582|157470241|FG000|Combination Therapy|Progressive Disease|9|||
48900320|NCT00738582|157470242|FG001|Combination Therapy|Progressive Disease|0|||
48900321|NCT00738582|157470241|FG000|Maintenance Therapy|Other|0|||
48900322|NCT00738582|157470242|FG001|Maintenance Therapy|Other|2|||
48900323|NCT00738582|157470241|FG000|Maintenance Therapy|Adverse Event|0|||
48900324|NCT00738582|157470242|FG001|Maintenance Therapy|Adverse Event|6|||
48900325|NCT00738582|157470241|FG000|Maintenance Therapy|Progressive Disease|0|||
48900326|NCT00738582|157470242|FG001|Maintenance Therapy|Progressive Disease|47|||
48900327|NCT00738582|157470241|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
48900328|NCT00738582|157470242|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
48900329|NCT00666679|157470245|FG000|First Intervention|Lost to Follow-up|1|||
48900330|NCT00666679|157470246|FG001|First Intervention|Lost to Follow-up|0|||
48900331|NCT00666679|157470245|FG000|First Intervention|Protocol Violation|1|||
48900332|NCT00666679|157470246|FG001|First Intervention|Protocol Violation|0|||
48900333|NCT00666679|157470245|FG000|First Intervention|Withdrawal by Subject|1|||
48900334|NCT00666679|157470246|FG001|First Intervention|Withdrawal by Subject|0|||
48900335|NCT00666679|157470245|FG000|First Intervention|Randomized did not start treatment|1|||
48900336|NCT00666679|157470246|FG001|First Intervention|Randomized did not start treatment|1|||
48900337|NCT00666679|157470245|FG000|Washout Period of 1 Week|Lost to Follow-up|0|||
48900338|NCT00666679|157470246|FG001|Washout Period of 1 Week|Lost to Follow-up|1|||
48900339|NCT00666679|157470245|FG000|Washout Period of 1 Week|Protocol Violation|0|||
48900340|NCT00666679|157470246|FG001|Washout Period of 1 Week|Protocol Violation|1|||
48900341|NCT00666679|157470245|FG000|Second Intervention|Adverse Event|1|||
48900342|NCT00666679|157470246|FG001|Second Intervention|Adverse Event|0|||
48900343|NCT00666679|157470245|FG000|Second Intervention|Death|0|||
48900344|NCT00666679|157470246|FG001|Second Intervention|Death|1|||
48900345|NCT02354508|157470247|FG000|Period 1: Core Phase|Adverse Event|1|||
48900346|NCT02354508|157470248|FG001|Period 1: Core Phase|Adverse Event|1|||
48900347|NCT02354508|157470249|FG002|Period 1: Core Phase|Adverse Event|2|||
48900348|NCT02354508|157470247|FG000|Period 1: Core Phase|Unsatisfactory therapeutic effect|1|||
48900349|NCT02354508|157470248|FG001|Period 1: Core Phase|Unsatisfactory therapeutic effect|0|||
48900350|NCT02354508|157470249|FG002|Period 1: Core Phase|Unsatisfactory therapeutic effect|2|||
48900351|NCT02354508|157470247|FG000|Period 1: Core Phase|Withdrawal by Subject|0|||
48900352|NCT02354508|157470248|FG001|Period 1: Core Phase|Withdrawal by Subject|1|||
48900353|NCT02354508|157470249|FG002|Period 1: Core Phase|Withdrawal by Subject|2|||
48900354|NCT02354508|157470247|FG000|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1|||
48900355|NCT02354508|157470248|FG001|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3|||
48900356|NCT02354508|157470249|FG002|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2|||
48900357|NCT02354508|157470247|FG000|Period 2: Extension Phase|Withdrawal by Subject|0|||
48900358|NCT02354508|157470248|FG001|Period 2: Extension Phase|Withdrawal by Subject|1|||
48900359|NCT02354508|157470249|FG002|Period 2: Extension Phase|Withdrawal by Subject|0|||
48900360|NCT02354508|157470247|FG000|Period 2: Extension Phase|Physician Decision|5|||
48900361|NCT02354508|157470248|FG001|Period 2: Extension Phase|Physician Decision|0|||
48900362|NCT02354508|157470249|FG002|Period 2: Extension Phase|Physician Decision|1|||
48900363|NCT02354508|157470247|FG000|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1|||
48900364|NCT02354508|157470248|FG001|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
48900365|NCT02354508|157470249|FG002|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
48900366|NCT02354508|157470247|FG000|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
48900367|NCT02354508|157470248|FG001|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1|||
48900368|NCT02354508|157470249|FG002|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
48984709|NCT00621764|157775595|FG003|Overall Study|Protocol Violation|1|||
49041548|NCT00112437|157987613|FG025|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
49041549|NCT00112437|157987588|FG000|Year 1 (12-Month Base Study)|Protocol Violation|1|||
49041550|NCT00112437|157987589|FG001|Year 1 (12-Month Base Study)|Protocol Violation|0|||
49041551|NCT00112437|157987590|FG002|Year 1 (12-Month Base Study)|Protocol Violation|3|||
49041552|NCT00112437|157987591|FG003|Year 1 (12-Month Base Study)|Protocol Violation|1|||
49041553|NCT00112437|157987592|FG004|Year 1 (12-Month Base Study)|Protocol Violation|1|||
49041554|NCT00112437|157987593|FG005|Year 1 (12-Month Base Study)|Protocol Violation|0|||
49041555|NCT00112437|157987594|FG006|Year 1 (12-Month Base Study)|Protocol Violation|0|||
49041556|NCT00112437|157987595|FG007|Year 1 (12-Month Base Study)|Protocol Violation|0|||
49041557|NCT00112437|157987596|FG008|Year 1 (12-Month Base Study)|Protocol Violation|0|||
49041558|NCT00112437|157987597|FG009|Year 1 (12-Month Base Study)|Protocol Violation|0|||
49041559|NCT00112437|157987598|FG010|Year 1 (12-Month Base Study)|Protocol Violation|0|||
49041560|NCT00112437|157987599|FG011|Year 1 (12-Month Base Study)|Protocol Violation|0|||
49041561|NCT00112437|157987600|FG012|Year 1 (12-Month Base Study)|Protocol Violation|0|||
49041562|NCT00112437|157987601|FG013|Year 1 (12-Month Base Study)|Protocol Violation|0|||
49041563|NCT00112437|157987602|FG014|Year 1 (12-Month Base Study)|Protocol Violation|0|||
49041564|NCT00112437|157987603|FG015|Year 1 (12-Month Base Study)|Protocol Violation|0|||
49041565|NCT00112437|157987604|FG016|Year 1 (12-Month Base Study)|Protocol Violation|0|||
49041566|NCT00112437|157987605|FG017|Year 1 (12-Month Base Study)|Protocol Violation|0|||
49041567|NCT00112437|157987606|FG018|Year 1 (12-Month Base Study)|Protocol Violation|0|||
49041568|NCT00112437|157987607|FG019|Year 1 (12-Month Base Study)|Protocol Violation|0|||
49041569|NCT00112437|157987608|FG020|Year 1 (12-Month Base Study)|Protocol Violation|0|||
49041570|NCT00112437|157987609|FG021|Year 1 (12-Month Base Study)|Protocol Violation|0|||
49041571|NCT00112437|157987610|FG022|Year 1 (12-Month Base Study)|Protocol Violation|0|||
48900369|NCT02354508|157470247|FG000|Period 3: Post-treatment Follow up Phase|Physician Decision|3|||
48900370|NCT02354508|157470248|FG001|Period 3: Post-treatment Follow up Phase|Physician Decision|0|||
48900371|NCT02354508|157470249|FG002|Period 3: Post-treatment Follow up Phase|Physician Decision|1|||
48900372|NCT00372229|157470254|FG000|Study Phase|Graft loss|0|||
48900373|NCT00372229|157470255|FG001|Study Phase|Graft loss|3|||
48900374|NCT00372229|157470254|FG000|Study Phase|Protocol Violation|3|||
48900375|NCT00372229|157470255|FG001|Study Phase|Protocol Violation|4|||
48900376|NCT00372229|157470254|FG000|Study Phase|Consent withdrawn|16|||
48900377|NCT00372229|157470255|FG001|Study Phase|Consent withdrawn|14|||
48900378|NCT00372229|157470254|FG000|Study Phase|Refused treatment/did not cooperate|3|||
48900379|NCT00372229|157470255|FG001|Study Phase|Refused treatment/did not cooperate|1|||
48900380|NCT00372229|157470254|FG000|Study Phase|Death|3|||
48900381|NCT00372229|157470255|FG001|Study Phase|Death|2|||
48900382|NCT00372229|157470254|FG000|Study Phase|Reason not specified|3|||
48900383|NCT00372229|157470255|FG001|Study Phase|Reason not specified|2|||
48900384|NCT00372229|157470254|FG000|Study Phase|Lost to Follow-up|3|||
48900385|NCT00372229|157470255|FG001|Study Phase|Lost to Follow-up|3|||
48900386|NCT00372229|157470254|FG000|Follow-Up Phase|Graft loss|8|||
48900387|NCT00372229|157470255|FG001|Follow-Up Phase|Graft loss|7|||
48900388|NCT00372229|157470254|FG000|Follow-Up Phase|Consent withdrawn|13|||
48900389|NCT00372229|157470255|FG001|Follow-Up Phase|Consent withdrawn|19|||
48900390|NCT00372229|157470254|FG000|Follow-Up Phase|Refused treatment/did not cooperate|0|||
48900391|NCT00372229|157470255|FG001|Follow-Up Phase|Refused treatment/did not cooperate|1|||
48900392|NCT00372229|157470254|FG000|Follow-Up Phase|Adverse event/intercurrent illness|1|||
48900393|NCT00372229|157470255|FG001|Follow-Up Phase|Adverse event/intercurrent illness|0|||
48900394|NCT00372229|157470254|FG000|Follow-Up Phase|Death|9|||
48900395|NCT00372229|157470255|FG001|Follow-Up Phase|Death|12|||
48900396|NCT00372229|157470254|FG000|Follow-Up Phase|Administrative|1|||
48900397|NCT00372229|157470255|FG001|Follow-Up Phase|Administrative|0|||
48900398|NCT00372229|157470254|FG000|Follow-Up Phase|Reason not specified|2|||
48900399|NCT00372229|157470255|FG001|Follow-Up Phase|Reason not specified|3|||
48900400|NCT00372229|157470254|FG000|Follow-Up Phase|Lost to Follow-up|12|||
48900401|NCT00372229|157470255|FG001|Follow-Up Phase|Lost to Follow-up|10|||
48900402|NCT02095951|157470256|FG000|Overall Study|NO POSITIVE BLOOD CULTURE|9|||
48900403|NCT02095951|157470257|FG001|Overall Study|NO POSITIVE BLOOD CULTURE|6|||
48900404|NCT03618823|157470258|FG000|Overall Study|Lost to Follow-up|63|||
48900405|NCT03618823|157470259|FG001|Overall Study|Lost to Follow-up|61|||
49041572|NCT00112437|157987611|FG023|Year 1 (12-Month Base Study)|Protocol Violation|0|||
49041573|NCT00112437|157987612|FG024|Year 1 (12-Month Base Study)|Protocol Violation|0|||
49041574|NCT00112437|157987613|FG025|Year 1 (12-Month Base Study)|Protocol Violation|0|||
49041575|NCT00112437|157987588|FG000|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
48900406|NCT02208999|157470260|FG000|Overall Study|Lost to Follow-up|1|||
48900407|NCT01778023|157470261|FG000|Overall Study|Withdrawal by Subject|0|||
48900408|NCT01778023|157470262|FG001|Overall Study|Withdrawal by Subject|3|||
48900409|NCT01098097|157470263|FG000|Overall Study|Adverse Event|17|||
48900410|NCT01098097|157470263|FG000|Overall Study|Lost to Follow-up|18|||
48900411|NCT01098097|157470263|FG000|Overall Study|Status unknown|16|||
48900412|NCT01098097|157470263|FG000|Overall Study|No reason reported|31|||
48900413|NCT02216357|157470267|FG000|Overall Study|Inclusion or exclusion criteria not met|2|||
48900414|NCT02216357|157470268|FG001|Overall Study|Inclusion or exclusion criteria not met|1|||
48900415|NCT00818649|157470276|FG000|Overall Study|Declining performance status|2|||
48900416|NCT00818649|157470276|FG000|Overall Study|Unrelated hip fracture-unable to proceed|1|||
48900417|NCT00818649|157470276|FG000|Overall Study|Adverse Event|1|||
48900418|NCT03513588|157470277|FG000|Overall Study|Lost to Follow-up|0|||
48900419|NCT03513588|157470278|FG001|Overall Study|Lost to Follow-up|1|||
48900420|NCT03513588|157470279|FG002|Overall Study|Lost to Follow-up|1|||
48900421|NCT03513588|157470277|FG000|Overall Study|Study dosing paused by sponsor|1|||
48900422|NCT03513588|157470278|FG001|Overall Study|Study dosing paused by sponsor|1|||
48900423|NCT03513588|157470279|FG002|Overall Study|Study dosing paused by sponsor|0|||
48900424|NCT03513588|157470277|FG000|Overall Study|Death|0|||
48900425|NCT03513588|157470278|FG001|Overall Study|Death|0|||
48900426|NCT03513588|157470279|FG002|Overall Study|Death|1|||
48900427|NCT02434939|157470285|FG000|Overall Study|Lack of Efficacy|34|||
48900428|NCT02434939|157470286|FG001|Overall Study|Lack of Efficacy|48|||
48900429|NCT02434939|157470285|FG000|Overall Study|Withdrawal by Subject|3|||
48900430|NCT02434939|157470286|FG001|Overall Study|Withdrawal by Subject|0|||
48900431|NCT02434939|157470285|FG000|Overall Study|Adverse Event|0|||
48900432|NCT02434939|157470286|FG001|Overall Study|Adverse Event|1|||
48900433|NCT02471833|157470293|FG000|Overall Study|Lost to Follow-up|1|||
48900434|NCT02471833|157470294|FG001|Overall Study|Lost to Follow-up|0|||
48900435|NCT02471833|157470295|FG002|Overall Study|Lost to Follow-up|0|||
48900436|NCT02471833|157470293|FG000|Overall Study|Withdrawal by Subject|2|||
48900437|NCT02471833|157470294|FG001|Overall Study|Withdrawal by Subject|1|||
48900438|NCT02471833|157470295|FG002|Overall Study|Withdrawal by Subject|5|||
48900439|NCT04079803|157470296|FG000|Overall Study|Withdrawal by Subject|0|||
48900440|NCT04079803|157470297|FG001|Overall Study|Withdrawal by Subject|0|||
48900441|NCT04079803|157470298|FG002|Overall Study|Withdrawal by Subject|1|||
48900442|NCT02640157|157470299|FG000|Overall Study|Adverse Event|2|||
48900443|NCT02640157|157470300|FG001|Overall Study|Adverse Event|2|||
48900444|NCT02640157|157470301|FG002|Overall Study|Adverse Event|1|||
48900445|NCT02640157|157470299|FG000|Overall Study|Withdrew consent|2|||
48900446|NCT02640157|157470300|FG001|Overall Study|Withdrew consent|0|||
48900447|NCT02640157|157470301|FG002|Overall Study|Withdrew consent|2|||
48900448|NCT02640157|157470299|FG000|Overall Study|Lost to Follow-up|9|||
48900449|NCT02640157|157470300|FG001|Overall Study|Lost to Follow-up|2|||
48900450|NCT02640157|157470301|FG002|Overall Study|Lost to Follow-up|7|||
48900451|NCT02640157|157470299|FG000|Overall Study|Randomized in error; did not receive Tx|0|||
48900452|NCT02640157|157470300|FG001|Overall Study|Randomized in error; did not receive Tx|1|||
48900453|NCT02640157|157470301|FG002|Overall Study|Randomized in error; did not receive Tx|0|||
48900454|NCT01596621|157470302|FG000|Overall Study|Death|4|||
48900455|NCT01596621|157470302|FG000|Overall Study|Withdrawal by Subject|9|||
48900456|NCT01596621|157470302|FG000|Overall Study|Disease Progression|49|||
48900457|NCT01596621|157470302|FG000|Overall Study|Lost to Follow-up|3|||
48900458|NCT01596621|157470302|FG000|Overall Study|Other than specified|13|||
48900459|NCT01074216|157470303|FG000|Overall Study|Physician Decision|1|||
48900460|NCT01074216|157470303|FG000|Overall Study|Not Treated|12|||
48900461|NCT01948908|157470305|FG000|Overall Study|Protocol Violation|1|||
48900462|NCT01948908|157470306|FG001|Overall Study|Protocol Violation|0|||
48900463|NCT01948908|157470307|FG002|Overall Study|Protocol Violation|2|||
48900464|NCT03343301|157470308|FG000|Overall Study|Withdrawal by Subject|1|||
48900465|NCT03343301|157470309|FG001|Overall Study|Withdrawal by Subject|1|||
48900466|NCT03343301|157470308|FG000|Overall Study|Death|0|||
48900467|NCT03343301|157470309|FG001|Overall Study|Death|2|||
48900468|NCT03343301|157470308|FG000|Overall Study|Other|0|||
48900469|NCT03343301|157470309|FG001|Overall Study|Other|6|||
48900470|NCT03343301|157470308|FG000|Overall Study|Missing|2|||
48900471|NCT03343301|157470309|FG001|Overall Study|Missing|0|||
48900472|NCT03291587|157470310|FG000|Overall Study|Lost to Follow-up|62|||
48900473|NCT03291587|157470311|FG001|Overall Study|Lost to Follow-up|43|||
48900474|NCT03291587|157470310|FG000|Overall Study|Refused to Answer|5|||
48900475|NCT03291587|157470311|FG001|Overall Study|Refused to Answer|2|||
48900476|NCT03291587|157470310|FG000|Overall Study|Death|2|||
48900477|NCT03291587|157470311|FG001|Overall Study|Death|4|||
48900478|NCT03291587|157470310|FG000|Overall Study|Not interested in participating|8|||
48900479|NCT03291587|157470311|FG001|Overall Study|Not interested in participating|6|||
48900480|NCT03291587|157470310|FG000|Overall Study|Too busy to participate|4|||
48900481|NCT03291587|157470311|FG001|Overall Study|Too busy to participate|2|||
48900482|NCT02041520|157470313|FG000|Overall Study|Adverse Event|2|||
48900483|NCT02041520|157470314|FG001|Overall Study|Adverse Event|1|||
48900484|NCT02041520|157470313|FG000|Overall Study|Withdrawal by Subject|3|||
48900485|NCT02041520|157470314|FG001|Overall Study|Withdrawal by Subject|4|||
48900486|NCT02041520|157470313|FG000|Overall Study|Protocol Violation|1|||
48900487|NCT02041520|157470314|FG001|Overall Study|Protocol Violation|0|||
48900488|NCT02041520|157470313|FG000|Overall Study|Lost to Follow-up|0|||
48900489|NCT02041520|157470314|FG001|Overall Study|Lost to Follow-up|1|||
48900490|NCT02041520|157470313|FG000|Overall Study|Hypothiroidism identified during follow-|0|||
48900491|NCT02041520|157470314|FG001|Overall Study|Hypothiroidism identified during follow-|1|||
48900492|NCT00494481|157470317|FG000|Overall Study|Condition under investigation worsened|11|||
48900493|NCT00494481|157470318|FG001|Overall Study|Condition under investigation worsened|13|||
48900494|NCT00494481|157470317|FG000|Overall Study|Adverse Event|15|||
48900495|NCT00494481|157470318|FG001|Overall Study|Adverse Event|11|||
48900496|NCT00494481|157470317|FG000|Overall Study|Other|1|||
48900497|NCT00494481|157470318|FG001|Overall Study|Other|0|||
48900498|NCT00494481|157470317|FG000|Overall Study|Never received IP|2|||
48900499|NCT00494481|157470318|FG001|Overall Study|Never received IP|0|||
48900500|NCT01030198|157470319|FG000|Overall Study|Could not measure efficacy accurately|0|||
48900501|NCT01030198|157470320|FG001|Overall Study|Could not measure efficacy accurately|7|||
48900502|NCT01163916|157470321|FG000|Overall Study|Withdrawal by Subject|2|||
48900503|NCT01163916|157470322|FG001|Overall Study|Withdrawal by Subject|0|||
48900504|NCT01163916|157470323|FG002|Overall Study|Withdrawal by Subject|2|||
48900505|NCT01163916|157470321|FG000|Overall Study|Adverse Event|2|||
48900506|NCT01163916|157470322|FG001|Overall Study|Adverse Event|0|||
48900507|NCT01163916|157470323|FG002|Overall Study|Adverse Event|1|||
48900508|NCT01163916|157470321|FG000|Overall Study|Lack of Efficacy|2|||
48900509|NCT01163916|157470322|FG001|Overall Study|Lack of Efficacy|0|||
48900510|NCT01163916|157470323|FG002|Overall Study|Lack of Efficacy|1|||
49041576|NCT00112437|157987589|FG001|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
49041577|NCT00112437|157987590|FG002|Year 1 (12-Month Base Study)|Withdrawal by Subject|2|||
49041578|NCT00112437|157987591|FG003|Year 1 (12-Month Base Study)|Withdrawal by Subject|1|||
49041579|NCT00112437|157987592|FG004|Year 1 (12-Month Base Study)|Withdrawal by Subject|7|||
49041580|NCT00112437|157987593|FG005|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
49041581|NCT00112437|157987594|FG006|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
49041582|NCT00112437|157987595|FG007|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
49041583|NCT00112437|157987596|FG008|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
49041584|NCT00112437|157987597|FG009|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
49041585|NCT00112437|157987598|FG010|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
49041586|NCT00112437|157987599|FG011|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
49041587|NCT00112437|157987600|FG012|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
49041588|NCT00112437|157987601|FG013|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
49041589|NCT00112437|157987602|FG014|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
49041590|NCT00112437|157987603|FG015|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
49041591|NCT00112437|157987604|FG016|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
49041592|NCT00112437|157987605|FG017|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
49041593|NCT00112437|157987606|FG018|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
49041594|NCT00112437|157987607|FG019|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
49041595|NCT00112437|157987608|FG020|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
49041596|NCT00112437|157987609|FG021|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
49041597|NCT00112437|157987610|FG022|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
49041598|NCT00112437|157987611|FG023|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
49041599|NCT00112437|157987612|FG024|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
49041600|NCT00112437|157987613|FG025|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
49041601|NCT00112437|157987588|FG000|Year 1 (12-Month Base Study)|moved|0|||
49041602|NCT00112437|157987589|FG001|Year 1 (12-Month Base Study)|moved|1|||
49041603|NCT00112437|157987590|FG002|Year 1 (12-Month Base Study)|moved|1|||
49041604|NCT00112437|157987591|FG003|Year 1 (12-Month Base Study)|moved|0|||
49041605|NCT00112437|157987592|FG004|Year 1 (12-Month Base Study)|moved|0|||
49041606|NCT00112437|157987593|FG005|Year 1 (12-Month Base Study)|moved|0|||
49041607|NCT00112437|157987594|FG006|Year 1 (12-Month Base Study)|moved|0|||
49041608|NCT00112437|157987595|FG007|Year 1 (12-Month Base Study)|moved|0|||
49041609|NCT00112437|157987596|FG008|Year 1 (12-Month Base Study)|moved|0|||
49041610|NCT00112437|157987597|FG009|Year 1 (12-Month Base Study)|moved|0|||
49041611|NCT00112437|157987598|FG010|Year 1 (12-Month Base Study)|moved|0|||
49041612|NCT00112437|157987599|FG011|Year 1 (12-Month Base Study)|moved|0|||
49041613|NCT00112437|157987600|FG012|Year 1 (12-Month Base Study)|moved|0|||
49041614|NCT00112437|157987601|FG013|Year 1 (12-Month Base Study)|moved|0|||
49041615|NCT00112437|157987602|FG014|Year 1 (12-Month Base Study)|moved|0|||
49041616|NCT00112437|157987603|FG015|Year 1 (12-Month Base Study)|moved|0|||
49041617|NCT00112437|157987604|FG016|Year 1 (12-Month Base Study)|moved|0|||
49041618|NCT00112437|157987605|FG017|Year 1 (12-Month Base Study)|moved|0|||
49041619|NCT00112437|157987606|FG018|Year 1 (12-Month Base Study)|moved|0|||
49041620|NCT00112437|157987607|FG019|Year 1 (12-Month Base Study)|moved|0|||
49041621|NCT00112437|157987608|FG020|Year 1 (12-Month Base Study)|moved|0|||
49041622|NCT00112437|157987609|FG021|Year 1 (12-Month Base Study)|moved|0|||
49041623|NCT00112437|157987610|FG022|Year 1 (12-Month Base Study)|moved|0|||
49041624|NCT00112437|157987611|FG023|Year 1 (12-Month Base Study)|moved|0|||
49041625|NCT00112437|157987612|FG024|Year 1 (12-Month Base Study)|moved|0|||
48900511|NCT01163916|157470321|FG000|Overall Study|Other|24|||
48900512|NCT01163916|157470322|FG001|Overall Study|Other|4|||
48900513|NCT01163916|157470323|FG002|Overall Study|Other|16|||
48900514|NCT01506453|157472259|FG000|Overall Study|Withdrawal prior to treatment|0|||
48900515|NCT01506453|157472260|FG001|Overall Study|Withdrawal prior to treatment|2|||
48900516|NCT00775463|157472261|FG000|Overall Study|Withdrawal by Subject|0|||
48900517|NCT00775463|157472262|FG001|Overall Study|Withdrawal by Subject|1|||
48900518|NCT00775463|157472261|FG000|Overall Study|Adverse Event|7|||
48900519|NCT00775463|157472262|FG001|Overall Study|Adverse Event|9|||
48900520|NCT00775463|157472261|FG000|Overall Study|Protocol Violation|2|||
48900521|NCT00775463|157472262|FG001|Overall Study|Protocol Violation|2|||
48900522|NCT00775463|157472261|FG000|Overall Study|Lost to Follow-up|1|||
48900523|NCT00775463|157472262|FG001|Overall Study|Lost to Follow-up|0|||
48900524|NCT00775463|157472261|FG000|Overall Study|Lack of Efficacy|1|||
48900525|NCT00775463|157472262|FG001|Overall Study|Lack of Efficacy|1|||
48900526|NCT01650246|157472263|FG000|Overall Study|Adverse Event|23|||
48900527|NCT01650246|157472263|FG000|Overall Study|Protocol Violation|5|||
48900528|NCT01650246|157472263|FG000|Overall Study|Sponsor terminated study|53|||
48900529|NCT01650246|157472263|FG000|Overall Study|Lost to Follow-up|5|||
48900530|NCT01650246|157472263|FG000|Overall Study|Withdrawal by Subject|26|||
48900531|NCT01650246|157472263|FG000|Overall Study|Death|1|||
48900532|NCT01650246|157472263|FG000|Overall Study|Lack of Efficacy|30|||
48900533|NCT03628898|157472277|FG000|Overall Study|Device deficiency|1|||
48900534|NCT01217957|157472280|FG000|Phase 1|Withdrawal by Patient|1|||
48900535|NCT01217957|157472281|FG001|Phase 1|Withdrawal by Patient|0|||
48900536|NCT01217957|157472282|FG002|Phase 1|Withdrawal by Patient|1|||
48900537|NCT01217957|157472283|FG003|Phase 1|Withdrawal by Patient|1|||
48900538|NCT01217957|157472284|FG004|Phase 1|Withdrawal by Patient|0|||
48900539|NCT01217957|157472280|FG000|Phase 2|Withdrawal by Patient|0|||
48900540|NCT01217957|157472281|FG001|Phase 2|Withdrawal by Patient|0|||
48900541|NCT01217957|157472282|FG002|Phase 2|Withdrawal by Patient|0|||
48900542|NCT01217957|157472283|FG003|Phase 2|Withdrawal by Patient|0|||
48900543|NCT01217957|157472284|FG004|Phase 2|Withdrawal by Patient|1|||
48900544|NCT01111474|157472285|FG000|Overall Study|Lost to Follow-up|12|||
48900545|NCT01143038|157472286|FG000|Overall Study|Withdrawal by Subject|4|||
48900546|NCT01143038|157472286|FG000|Overall Study|Requirement for alternative therapy|5|||
48900547|NCT01143038|157472286|FG000|Overall Study|Adverse Event|3|||
48900548|NCT01143038|157472286|FG000|Overall Study|Lost to Follow-up|2|||
48900549|NCT01143038|157472286|FG000|Overall Study|Protocol Deviation|1|||
48900550|NCT01143038|157472286|FG000|Overall Study|Death|1|||
48900551|NCT00706433|157472287|FG000|Overall Study|Lost to Follow-up|3|||
48900552|NCT00706433|157472288|FG001|Overall Study|Lost to Follow-up|1|||
48900553|NCT00706433|157472289|FG002|Overall Study|Lost to Follow-up|6|||
48900554|NCT00706433|157472290|FG003|Overall Study|Lost to Follow-up|0|||
48900555|NCT00706433|157472287|FG000|Overall Study|Withdrawal by Subject|1|||
48900556|NCT00706433|157472288|FG001|Overall Study|Withdrawal by Subject|2|||
48900557|NCT00706433|157472289|FG002|Overall Study|Withdrawal by Subject|3|||
48900558|NCT00706433|157472290|FG003|Overall Study|Withdrawal by Subject|1|||
48900559|NCT00706433|157472287|FG000|Overall Study|Adverse Event|0|||
48900560|NCT00706433|157472288|FG001|Overall Study|Adverse Event|0|||
48900561|NCT00706433|157472289|FG002|Overall Study|Adverse Event|1|||
48900562|NCT00706433|157472290|FG003|Overall Study|Adverse Event|0|||
48900563|NCT00706433|157472287|FG000|Overall Study|Protocol Violation|1|||
48900564|NCT00706433|157472288|FG001|Overall Study|Protocol Violation|0|||
48900565|NCT00706433|157472289|FG002|Overall Study|Protocol Violation|0|||
48900566|NCT00706433|157472290|FG003|Overall Study|Protocol Violation|0|||
48900567|NCT00706433|157472287|FG000|Overall Study|new job|0|||
48900568|NCT00706433|157472288|FG001|Overall Study|new job|0|||
48900569|NCT00706433|157472289|FG002|Overall Study|new job|0|||
48900570|NCT00706433|157472290|FG003|Overall Study|new job|1|||
48900571|NCT00717067|157472291|FG000|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
48900572|NCT00717067|157472292|FG001|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
48900573|NCT00717067|157472293|FG002|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1|||
48900574|NCT00717067|157472294|FG003|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
48900575|NCT00717067|157472295|FG004|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
48900576|NCT00822172|157472296|FG000|Overall Study|Adverse Event|10|||
48900577|NCT00822172|157472297|FG001|Overall Study|Adverse Event|12|||
48900578|NCT00822172|157472296|FG000|Overall Study|Death|1|||
48900579|NCT00822172|157472297|FG001|Overall Study|Death|0|||
48900580|NCT00822172|157472296|FG000|Overall Study|Lost to Follow-up|3|||
48900581|NCT00822172|157472297|FG001|Overall Study|Lost to Follow-up|1|||
48900582|NCT00822172|157472296|FG000|Overall Study|Withdrawal by Subject|1|||
48900583|NCT00822172|157472297|FG001|Overall Study|Withdrawal by Subject|4|||
48900584|NCT00822172|157472296|FG000|Overall Study|site closed|0|||
48900585|NCT00822172|157472297|FG001|Overall Study|site closed|1|||
48900586|NCT00822172|157472296|FG000|Overall Study|Other|0|||
48900587|NCT00822172|157472297|FG001|Overall Study|Other|1|||
48900588|NCT01295034|157472298|FG000|Overall Study|Lost to Follow-up|5|||
48900589|NCT01295034|157472299|FG001|Overall Study|Lost to Follow-up|5|||
48900590|NCT03271021|157472303|FG000|Overall Study|Adverse Event|3|||
48900591|NCT03271021|157472304|FG001|Overall Study|Adverse Event|2|||
48900592|NCT03271021|157472303|FG000|Overall Study|Withdrawal by Subject|36|||
48900593|NCT03271021|157472304|FG001|Overall Study|Withdrawal by Subject|53|||
48900594|NCT03271021|157472303|FG000|Overall Study|Lost to Follow-up|34|||
48900595|NCT03271021|157472304|FG001|Overall Study|Lost to Follow-up|39|||
48900596|NCT03271021|157472303|FG000|Overall Study|Protocol Violation|6|||
48900597|NCT03271021|157472304|FG001|Overall Study|Protocol Violation|4|||
48900598|NCT03271021|157472303|FG000|Overall Study|Abnormal Lab Results|1|||
48900599|NCT03271021|157472304|FG001|Overall Study|Abnormal Lab Results|0|||
48900600|NCT03271021|157472303|FG000|Overall Study|Miscellaneous|9|||
49041626|NCT00112437|157987613|FG025|Year 1 (12-Month Base Study)|moved|0|||
49041627|NCT00112437|157987588|FG000|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
49041628|NCT00112437|157987589|FG001|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
49041629|NCT00112437|157987590|FG002|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
49041630|NCT00112437|157987591|FG003|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2|||
49041631|NCT00112437|157987592|FG004|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
49041632|NCT00112437|157987593|FG005|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
49041633|NCT00112437|157987594|FG006|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
49041634|NCT00112437|157987595|FG007|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
49041635|NCT00112437|157987596|FG008|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
49041636|NCT00112437|157987597|FG009|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
49041637|NCT00112437|157987598|FG010|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
49041638|NCT00112437|157987599|FG011|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
49041639|NCT00112437|157987600|FG012|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
49041640|NCT00112437|157987601|FG013|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
49041641|NCT00112437|157987602|FG014|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
49041642|NCT00112437|157987603|FG015|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
49041643|NCT00112437|157987604|FG016|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
49041644|NCT00112437|157987605|FG017|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
49041645|NCT00112437|157987606|FG018|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
49041646|NCT00112437|157987607|FG019|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
49041647|NCT00112437|157987608|FG020|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
49041648|NCT00112437|157987609|FG021|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
49041649|NCT00112437|157987610|FG022|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
49041650|NCT00112437|157987611|FG023|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
49041651|NCT00112437|157987612|FG024|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
49041652|NCT00112437|157987613|FG025|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
49041653|NCT00112437|157987588|FG000|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
49041654|NCT00112437|157987589|FG001|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
49041655|NCT00112437|157987590|FG002|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
49041656|NCT00112437|157987591|FG003|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
49041657|NCT00112437|157987592|FG004|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1|||
49041658|NCT00112437|157987593|FG005|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
49041659|NCT00112437|157987594|FG006|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
49041660|NCT00112437|157987595|FG007|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
49041661|NCT00112437|157987596|FG008|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
49041662|NCT00112437|157987597|FG009|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
49041663|NCT00112437|157987598|FG010|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
49041664|NCT00112437|157987599|FG011|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
49041665|NCT00112437|157987600|FG012|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
48900601|NCT03271021|157472304|FG001|Overall Study|Miscellaneous|8|||
48900602|NCT02518490|157472305|FG000|Overall Study|Withdrawal by Subject|1|||
48900603|NCT02518490|157472306|FG001|Overall Study|Withdrawal by Subject|1|||
48900604|NCT01498679|157472309|FG000|Overall Study|Adverse Event|1|||
48900605|NCT01498679|157472310|FG001|Overall Study|Adverse Event|4|||
48900606|NCT01498679|157472309|FG000|Overall Study|Lack of Efficacy|72|||
48900607|NCT01498679|157472310|FG001|Overall Study|Lack of Efficacy|12|||
48900608|NCT01498679|157472309|FG000|Overall Study|Protocol Violation|4|||
48900609|NCT01498679|157472310|FG001|Overall Study|Protocol Violation|0|||
48900610|NCT01498679|157472309|FG000|Overall Study|Physician Decision|0|||
48900611|NCT01498679|157472310|FG001|Overall Study|Physician Decision|2|||
48900612|NCT01498679|157472309|FG000|Overall Study|Withdrawal by Subject|12|||
48900613|NCT01498679|157472310|FG001|Overall Study|Withdrawal by Subject|4|||
48900614|NCT00477334|157472311|FG000|Overall Study|Discontinued prior to taking study drug|106|||
48900615|NCT00477334|157472312|FG001|Overall Study|Discontinued prior to taking study drug|53|||
48900616|NCT00477334|157472311|FG000|Overall Study|Adverse Event|1|||
48900617|NCT00477334|157472312|FG001|Overall Study|Adverse Event|2|||
48900618|NCT00477334|157472311|FG000|Overall Study|Withdrawal by Subject|2|||
48900619|NCT00477334|157472312|FG001|Overall Study|Withdrawal by Subject|1|||
48900620|NCT00477334|157472311|FG000|Overall Study|Lost to Follow-up|15|||
48900621|NCT00477334|157472312|FG001|Overall Study|Lost to Follow-up|4|||
48900622|NCT00477334|157472311|FG000|Overall Study|Administrative Problems|39|||
48900623|NCT00477334|157472312|FG001|Overall Study|Administrative Problems|15|||
48900624|NCT00477334|157472311|FG000|Overall Study|Protocol Violation|7|||
49041666|NCT00112437|157987601|FG013|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
49041667|NCT00112437|157987602|FG014|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
48900625|NCT00477334|157472312|FG001|Overall Study|Protocol Violation|1|||
48900626|NCT02572882|157472313|FG000|Overall Study|Withdrawal by Subject|1|||
48900627|NCT02572882|157472313|FG000|Overall Study|Participant received kidney transplant|1|||
48900628|NCT03215810|157472314|FG000|Overall Study|Still responding to nivolumab|1|||
48900629|NCT03215810|157472314|FG000|Overall Study|Insufficient TIL growth|1|||
48900630|NCT03215810|157472314|FG000|Overall Study|Decline in performance status|1|||
48900631|NCT03215810|157472314|FG000|Overall Study|Withdrawal by Subject|1|||
48900632|NCT00871780|157472315|FG000|Overall Study|Enrolled But Not Treated|6|||
48900633|NCT00871780|157472315|FG000|Overall Study|Withdrawal by Subject|9|||
48900634|NCT00871780|157472315|FG000|Overall Study|Adverse Event|6|||
49041668|NCT00112437|157987603|FG015|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
48900635|NCT00871780|157472315|FG000|Overall Study|Voluntary Discontinuation|4|||
48900636|NCT00871780|157472315|FG000|Overall Study|Death|1|||
48900637|NCT00871780|157472315|FG000|Overall Study|Physician Decision|1|||
48900638|NCT01607554|157472319|FG000|Overall Study|Disease progression|2|||
48900639|NCT02054741|157472323|FG000|Overall Study|Protocol Violation|13|||
48900640|NCT02054741|157472324|FG001|Overall Study|Protocol Violation|2|||
49041669|NCT00112437|157987604|FG016|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
48900641|NCT02054741|157472323|FG000|Overall Study|Withdrawal by Subject|10|||
48900642|NCT02054741|157472324|FG001|Overall Study|Withdrawal by Subject|5|||
48900643|NCT02054741|157472323|FG000|Overall Study|Death|94|||
48900644|NCT02054741|157472324|FG001|Overall Study|Death|90|||
48900645|NCT02054741|157472323|FG000|Overall Study|Subject passively continued participation only with data obtained from their medical records|35|||
48900646|NCT02054741|157472324|FG001|Overall Study|Subject passively continued participation only with data obtained from their medical records|32|||
48900647|NCT00784693|157472327|FG000|Overall Study|Lost to Follow-up|0|||
48900648|NCT00784693|157472328|FG001|Overall Study|Lost to Follow-up|1|||
48900649|NCT00784693|157472327|FG000|Overall Study|Lack of Efficacy|1|||
48900650|NCT00784693|157472328|FG001|Overall Study|Lack of Efficacy|1|||
48900651|NCT00784693|157472327|FG000|Overall Study|Withdrawal by Subject|0|||
48900652|NCT00784693|157472328|FG001|Overall Study|Withdrawal by Subject|4|||
48900653|NCT00784693|157472327|FG000|Overall Study|Randomized but not Treated|1|||
48900654|NCT00784693|157472328|FG001|Overall Study|Randomized but not Treated|0|||
48900655|NCT00784693|157472327|FG000|Overall Study|Other|1|||
48900656|NCT00784693|157472328|FG001|Overall Study|Other|0|||
48900657|NCT04507126|157472329|FG000|Overall Study|Withdrawal by Subject|1|||
48900658|NCT04507126|157472329|FG000|Overall Study|Protocol Violation|2|||
48900659|NCT04507126|157472329|FG000|Overall Study|Physician Decision|1|||
48900660|NCT01502631|157472330|FG000|Overall Study|Adverse Event|5|||
48900661|NCT01502631|157472331|FG001|Overall Study|Adverse Event|8|||
49041670|NCT00112437|157987605|FG017|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
49041671|NCT00112437|157987606|FG018|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
49041672|NCT00112437|157987607|FG019|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
49041673|NCT00112437|157987608|FG020|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
49041674|NCT00112437|157987609|FG021|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
49041675|NCT00112437|157987610|FG022|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
49041676|NCT00112437|157987611|FG023|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
49041677|NCT00112437|157987612|FG024|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
49041678|NCT00112437|157987613|FG025|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
49041679|NCT00112437|157987588|FG000|Year 2 (12-Month Extension)|Adverse Event|0|||
48900662|NCT01502631|157472330|FG000|Overall Study|Lost to Follow-up|2|||
48900663|NCT01502631|157472331|FG001|Overall Study|Lost to Follow-up|2|||
48900664|NCT01502631|157472330|FG000|Overall Study|Participant withdrew consent|2|||
48900665|NCT01502631|157472331|FG001|Overall Study|Participant withdrew consent|4|||
48900666|NCT01502631|157472330|FG000|Overall Study|Participant non-compliant|1|||
49041680|NCT00112437|157987589|FG001|Year 2 (12-Month Extension)|Adverse Event|0|||
49041681|NCT00112437|157987590|FG002|Year 2 (12-Month Extension)|Adverse Event|0|||
48900667|NCT01502631|157472331|FG001|Overall Study|Participant non-compliant|0|||
48900668|NCT01502631|157472330|FG000|Overall Study|Investigator's decision|0|||
48900669|NCT01502631|157472331|FG001|Overall Study|Investigator's decision|1|||
48900670|NCT01502631|157472330|FG000|Overall Study|Other|10|||
48900671|NCT01502631|157472331|FG001|Overall Study|Other|5|||
48900672|NCT00138671|157472335|FG000|Overall Study|Death|0|||
48900673|NCT00138671|157472336|FG001|Overall Study|Death|3|||
48900674|NCT00138671|157472335|FG000|Overall Study|Adverse Event|6|||
48900675|NCT00138671|157472336|FG001|Overall Study|Adverse Event|3|||
48900676|NCT00138671|157472335|FG000|Overall Study|Lost to Follow-up|1|||
49041682|NCT00112437|157987591|FG003|Year 2 (12-Month Extension)|Adverse Event|0|||
49041683|NCT00112437|157987592|FG004|Year 2 (12-Month Extension)|Adverse Event|0|||
49041684|NCT00112437|157987593|FG005|Year 2 (12-Month Extension)|Adverse Event|1|||
49041685|NCT00112437|157987594|FG006|Year 2 (12-Month Extension)|Adverse Event|2|||
49041686|NCT00112437|157987595|FG007|Year 2 (12-Month Extension)|Adverse Event|6|||
49041687|NCT00112437|157987596|FG008|Year 2 (12-Month Extension)|Adverse Event|1|||
49041688|NCT00112437|157987597|FG009|Year 2 (12-Month Extension)|Adverse Event|7|||
49041689|NCT00112437|157987598|FG010|Year 2 (12-Month Extension)|Adverse Event|0|||
49041690|NCT00112437|157987599|FG011|Year 2 (12-Month Extension)|Adverse Event|0|||
49041691|NCT00112437|157987600|FG012|Year 2 (12-Month Extension)|Adverse Event|0|||
49041692|NCT00112437|157987601|FG013|Year 2 (12-Month Extension)|Adverse Event|0|||
49041693|NCT00112437|157987602|FG014|Year 2 (12-Month Extension)|Adverse Event|0|||
49041694|NCT00112437|157987603|FG015|Year 2 (12-Month Extension)|Adverse Event|0|||
49041695|NCT00112437|157987604|FG016|Year 2 (12-Month Extension)|Adverse Event|0|||
49041696|NCT00112437|157987605|FG017|Year 2 (12-Month Extension)|Adverse Event|0|||
49041697|NCT00112437|157987606|FG018|Year 2 (12-Month Extension)|Adverse Event|0|||
49041698|NCT00112437|157987607|FG019|Year 2 (12-Month Extension)|Adverse Event|0|||
49041699|NCT00112437|157987608|FG020|Year 2 (12-Month Extension)|Adverse Event|0|||
49041700|NCT00112437|157987609|FG021|Year 2 (12-Month Extension)|Adverse Event|0|||
49041701|NCT00112437|157987610|FG022|Year 2 (12-Month Extension)|Adverse Event|0|||
48900677|NCT00138671|157472336|FG001|Overall Study|Lost to Follow-up|2|||
48900678|NCT00138671|157472335|FG000|Overall Study|Withdrawal by Subject|3|||
48900679|NCT00138671|157472336|FG001|Overall Study|Withdrawal by Subject|5|||
48900680|NCT00138671|157472335|FG000|Overall Study|Other|3|||
48900681|NCT00138671|157472336|FG001|Overall Study|Other|3|||
48900682|NCT00402597|157472339|FG000|Overall Study|Death|15|||
48900683|NCT00402597|157472340|FG001|Overall Study|Death|7|||
48900684|NCT00402597|157472341|FG002|Overall Study|Death|6|||
48900685|NCT00402597|157472342|FG003|Overall Study|Death|4|||
48900686|NCT00402597|157472343|FG004|Overall Study|Death|6|||
48900687|NCT00402597|157472339|FG000|Overall Study|Adverse Event|81|||
48900688|NCT00402597|157472340|FG001|Overall Study|Adverse Event|18|||
49041702|NCT00112437|157987611|FG023|Year 2 (12-Month Extension)|Adverse Event|0|||
49041703|NCT00112437|157987612|FG024|Year 2 (12-Month Extension)|Adverse Event|0|||
48900689|NCT00402597|157472341|FG002|Overall Study|Adverse Event|106|||
48900690|NCT00402597|157472342|FG003|Overall Study|Adverse Event|39|||
48900691|NCT00402597|157472343|FG004|Overall Study|Adverse Event|71|||
48900692|NCT00402597|157472339|FG000|Overall Study|Lost to Follow-up|8|||
48900693|NCT00402597|157472340|FG001|Overall Study|Lost to Follow-up|1|||
48900694|NCT00402597|157472341|FG002|Overall Study|Lost to Follow-up|8|||
48900695|NCT00402597|157472342|FG003|Overall Study|Lost to Follow-up|2|||
48900696|NCT00402597|157472343|FG004|Overall Study|Lost to Follow-up|3|||
48900697|NCT00402597|157472339|FG000|Overall Study|Withdrawal by Subject|57|||
48900698|NCT00402597|157472340|FG001|Overall Study|Withdrawal by Subject|16|||
48900699|NCT00402597|157472341|FG002|Overall Study|Withdrawal by Subject|65|||
48900700|NCT00402597|157472342|FG003|Overall Study|Withdrawal by Subject|15|||
48900701|NCT00402597|157472343|FG004|Overall Study|Withdrawal by Subject|24|||
48900702|NCT00402597|157472339|FG000|Overall Study|reason not specified|30|||
48900703|NCT00402597|157472340|FG001|Overall Study|reason not specified|4|||
48900704|NCT00402597|157472341|FG002|Overall Study|reason not specified|27|||
48900705|NCT00402597|157472342|FG003|Overall Study|reason not specified|14|||
48900706|NCT00402597|157472343|FG004|Overall Study|reason not specified|20|||
48900707|NCT05208866|157472344|FG000|Maintenance Treatment Period|Sponsor Termination of Study|1|||
48900708|NCT00938860|157472346|FG000|Overall Study|Adverse Event|2|||
48900709|NCT00938860|157472347|FG001|Overall Study|Adverse Event|1|||
48900710|NCT00938860|157472346|FG000|Overall Study|Abnormal laboratory values|2|||
48900711|NCT00938860|157472347|FG001|Overall Study|Abnormal laboratory values|2|||
48900712|NCT00938860|157472346|FG000|Overall Study|Withdrawal by Subject|11|||
48900713|NCT00938860|157472347|FG001|Overall Study|Withdrawal by Subject|8|||
48900714|NCT00938860|157472346|FG000|Overall Study|Lost to Follow-up|4|||
48900715|NCT00938860|157472347|FG001|Overall Study|Lost to Follow-up|4|||
49041704|NCT00112437|157987613|FG025|Year 2 (12-Month Extension)|Adverse Event|0|||
49041705|NCT00112437|157987588|FG000|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
49041706|NCT00112437|157987589|FG001|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
49041707|NCT00112437|157987590|FG002|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
49041708|NCT00112437|157987591|FG003|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
48900716|NCT00938860|157472346|FG000|Overall Study|Administration problems|2|||
48900717|NCT00938860|157472347|FG001|Overall Study|Administration problems|0|||
48900718|NCT00938860|157472346|FG000|Overall Study|Death|1|||
48900719|NCT00938860|157472347|FG001|Overall Study|Death|1|||
48900720|NCT00938860|157472346|FG000|Overall Study|Protocol Violation|3|||
48900721|NCT00938860|157472347|FG001|Overall Study|Protocol Violation|1|||
48900722|NCT00899548|157472348|FG000|Overall Study|Physician Decision|3|||
48900723|NCT01636960|157472360|FG000|Induction Phase|Adverse Event|2|||
48900724|NCT01636960|157472360|FG000|Maintenance Phase|Continued drug after regulatory approval|3|||
48900725|NCT01636960|157472360|FG000|Maintenance Phase|Adverse Event|3|||
48900726|NCT01636960|157472360|FG000|Maintenance Phase|Progressive disease|1|||
48900727|NCT01745848|157472361|FG000|Overall Study|Adverse Event|6|||
48900728|NCT03226275|157472362|FG000|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
48900729|NCT03226275|157472363|FG001|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
48900730|NCT03226275|157472364|FG002|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1|||
48900731|NCT03226275|157472365|FG003|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
48900732|NCT03226275|157472362|FG000|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
48900733|NCT03226275|157472363|FG001|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
48900734|NCT03226275|157472364|FG002|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
48900735|NCT03226275|157472365|FG003|Treatment Period 1 (8 Days)|Protocol non-compliance|1|||
48900736|NCT00511472|157472368|FG000|Overall Study|Clinical Adverse Event|1|||
48900737|NCT00511472|157472369|FG001|Overall Study|Clinical Adverse Event|2|||
48900738|NCT00511472|157472368|FG000|Overall Study|Laboratory Adverse Event|0|||
48900739|NCT00511472|157472369|FG001|Overall Study|Laboratory Adverse Event|2|||
48900740|NCT00511472|157472368|FG000|Overall Study|Not reported|2|||
48900741|NCT00511472|157472369|FG001|Overall Study|Not reported|2|||
48900742|NCT01079741|157472370|FG000|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
48900743|NCT01079741|157472371|FG001|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1|||
48900744|NCT01079741|157472372|FG002|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
48900745|NCT01079741|157472373|FG003|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
48900746|NCT01079741|157472374|FG004|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
48900747|NCT01079741|157472370|FG000|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
48900748|NCT01079741|157472371|FG001|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
48900749|NCT01079741|157472372|FG002|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
48900750|NCT01079741|157472373|FG003|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
48900751|NCT01079741|157472374|FG004|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3|||
48900752|NCT00069238|157472376|FG000|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9|||
48900753|NCT00069238|157472377|FG001|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
48900754|NCT00069238|157472378|FG002|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
48900755|NCT00069238|157472376|FG000|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
48900756|NCT00069238|157472377|FG001|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2|||
48900757|NCT00069238|157472378|FG002|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
48900758|NCT00069238|157472376|FG000|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
48900759|NCT00069238|157472377|FG001|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
48900760|NCT00069238|157472378|FG002|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2|||
48900761|NCT03333837|157472379|FG000|Overall Study|Adverse Event|2|||
48900762|NCT03333837|157472380|FG001|Overall Study|Adverse Event|1|||
48900763|NCT03333837|157472381|FG002|Overall Study|Adverse Event|1|||
48900764|NCT03333837|157472382|FG003|Overall Study|Adverse Event|1|||
48900765|NCT03333837|157472383|FG004|Overall Study|Adverse Event|0|||
48900766|NCT03333837|157472379|FG000|Overall Study|Caregiver withdrew|0|||
48900767|NCT03333837|157472380|FG001|Overall Study|Caregiver withdrew|2|||
48900768|NCT03333837|157472381|FG002|Overall Study|Caregiver withdrew|1|||
48900769|NCT03333837|157472382|FG003|Overall Study|Caregiver withdrew|0|||
48900770|NCT03333837|157472383|FG004|Overall Study|Caregiver withdrew|0|||
48900771|NCT03333837|157472379|FG000|Overall Study|Withdrawal by Subject|0|||
48900772|NCT03333837|157472380|FG001|Overall Study|Withdrawal by Subject|0|||
48900773|NCT03333837|157472381|FG002|Overall Study|Withdrawal by Subject|1|||
48900774|NCT03333837|157472382|FG003|Overall Study|Withdrawal by Subject|1|||
48900775|NCT03333837|157472383|FG004|Overall Study|Withdrawal by Subject|3|||
48900776|NCT03333837|157472379|FG000|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
48900777|NCT03333837|157472380|FG001|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
49041709|NCT00112437|157987592|FG004|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
49041710|NCT00112437|157987593|FG005|Year 2 (12-Month Extension)|Lack of Efficacy|1|||
49041711|NCT00112437|157987594|FG006|Year 2 (12-Month Extension)|Lack of Efficacy|6|||
49041712|NCT00112437|157987595|FG007|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
49041713|NCT00112437|157987596|FG008|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
49041714|NCT00112437|157987597|FG009|Year 2 (12-Month Extension)|Lack of Efficacy|2|||
49041715|NCT00112437|157987598|FG010|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
49041716|NCT00112437|157987599|FG011|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
49041717|NCT00112437|157987600|FG012|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
49041718|NCT00112437|157987601|FG013|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
48900778|NCT03333837|157472381|FG002|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|2|||
49041719|NCT00112437|157987602|FG014|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
49041720|NCT00112437|157987603|FG015|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
49041721|NCT00112437|157987604|FG016|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
48900779|NCT03333837|157472382|FG003|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
48900780|NCT03333837|157472383|FG004|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
48900781|NCT01551212|157472384|FG000|Overall Study|Graft loss/Retransplantation|0|||
48900782|NCT01551212|157472385|FG001|Overall Study|Graft loss/Retransplantation|1|||
49041722|NCT00112437|157987605|FG017|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
48900783|NCT01551212|157472384|FG000|Overall Study|Administrative problems|1|||
48900784|NCT01551212|157472385|FG001|Overall Study|Administrative problems|2|||
48900785|NCT01551212|157472384|FG000|Overall Study|Lost to Follow-up|0|||
48900786|NCT01551212|157472385|FG001|Overall Study|Lost to Follow-up|1|||
48900787|NCT01551212|157472384|FG000|Overall Study|Protocol Violation|0|||
48900788|NCT01551212|157472385|FG001|Overall Study|Protocol Violation|1|||
48900789|NCT01551212|157472384|FG000|Overall Study|Withdrawal by Subject|0|||
48900790|NCT01551212|157472385|FG001|Overall Study|Withdrawal by Subject|7|||
48900791|NCT01551212|157472384|FG000|Overall Study|Death|2|||
48900792|NCT01551212|157472385|FG001|Overall Study|Death|4|||
48900793|NCT01551212|157472384|FG000|Overall Study|Never Received Study Treatment|2|||
48900794|NCT01551212|157472385|FG001|Overall Study|Never Received Study Treatment|4|||
48900795|NCT01001832|157472386|FG000|Short-term Period|Adverse Event|2|||
48900796|NCT01001832|157472387|FG001|Short-term Period|Adverse Event|3|||
48900797|NCT01001832|157472386|FG000|Long-term Period|Adverse Event|2|||
48900798|NCT01001832|157472387|FG001|Long-term Period|Adverse Event|1|||
48900799|NCT01001832|157472386|FG000|Long-term Period|Withdrawal by Subject|1|||
48900800|NCT01001832|157472387|FG001|Long-term Period|Withdrawal by Subject|0|||
48900801|NCT01001832|157472386|FG000|Long-term Period|Lack of Efficacy|0|||
48900802|NCT01001832|157472387|FG001|Long-term Period|Lack of Efficacy|2|||
48900803|NCT01001832|157472386|FG000|Long-term Period|Other|1|||
48900804|NCT01001832|157472387|FG001|Long-term Period|Other|2|||
48900805|NCT01001832|157472386|FG000|Follow-up Period|Withdrawal by Subject|1|||
48900806|NCT01001832|157472387|FG001|Follow-up Period|Withdrawal by Subject|0|||
48900807|NCT01001832|157472386|FG000|Follow-up Period|Follow-up no longer required /protocol|15|||
48900808|NCT01001832|157472387|FG001|Follow-up Period|Follow-up no longer required /protocol|20|||
48900809|NCT01001832|157472386|FG000|Follow-up Period|Other|2|||
48900810|NCT01001832|157472387|FG001|Follow-up Period|Other|1|||
48900811|NCT03353350|157472393|FG000|30-week Core Treatment Period|Protocol Violation|1|||
48900812|NCT03353350|157472394|FG001|30-week Core Treatment Period|Protocol Violation|1|||
48900813|NCT03353350|157472395|FG002|30-week Core Treatment Period|Protocol Violation|1|||
48900814|NCT03353350|157472396|FG003|30-week Core Treatment Period|Protocol Violation|0|||
48900815|NCT03353350|157472393|FG000|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
48900816|NCT03353350|157472394|FG001|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
48900817|NCT03353350|157472395|FG002|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
48900818|NCT03353350|157472396|FG003|30-week Core Treatment Period|Other: Not related to COVID-19|0|||
48900819|NCT03353350|157472393|FG000|30-week Core Treatment Period|Adverse Event|0|||
48900820|NCT03353350|157472394|FG001|30-week Core Treatment Period|Adverse Event|4|||
48900821|NCT03353350|157472395|FG002|30-week Core Treatment Period|Adverse Event|2|||
48900822|NCT03353350|157472396|FG003|30-week Core Treatment Period|Adverse Event|3|||
48900823|NCT03353350|157472393|FG000|30-week Core Treatment Period|Withdrawal by Subject|19|||
48900824|NCT03353350|157472394|FG001|30-week Core Treatment Period|Withdrawal by Subject|12|||
48900825|NCT03353350|157472395|FG002|30-week Core Treatment Period|Withdrawal by Subject|19|||
48900826|NCT03353350|157472396|FG003|30-week Core Treatment Period|Withdrawal by Subject|19|||
48900827|NCT03353350|157472393|FG000|26-week Treatment Extension Period|Protocol Violation|2|||
48900828|NCT03353350|157472394|FG001|26-week Treatment Extension Period|Protocol Violation|0|||
48900829|NCT03353350|157472395|FG002|26-week Treatment Extension Period|Protocol Violation|0|||
48900830|NCT03353350|157472396|FG003|26-week Treatment Extension Period|Protocol Violation|0|||
48900831|NCT03353350|157472393|FG000|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
48900832|NCT03353350|157472394|FG001|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
48900833|NCT03353350|157472395|FG002|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
48900834|NCT03353350|157472396|FG003|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
48900835|NCT03353350|157472393|FG000|26-week Treatment Extension Period|Adverse Event|1|||
48900836|NCT03353350|157472394|FG001|26-week Treatment Extension Period|Adverse Event|0|||
48900837|NCT03353350|157472395|FG002|26-week Treatment Extension Period|Adverse Event|0|||
48900838|NCT03353350|157472396|FG003|26-week Treatment Extension Period|Adverse Event|1|||
48900839|NCT03353350|157472393|FG000|26-week Treatment Extension Period|Withdrawal by Subject|2|||
48900840|NCT03353350|157472394|FG001|26-week Treatment Extension Period|Withdrawal by Subject|3|||
48900841|NCT03353350|157472395|FG002|26-week Treatment Extension Period|Withdrawal by Subject|3|||
48900842|NCT03353350|157472396|FG003|26-week Treatment Extension Period|Withdrawal by Subject|12|||
48900843|NCT02003573|157472398|FG000|Overall Study|Progressive disease|2|||
48900844|NCT02003573|157472399|FG001|Overall Study|Progressive disease|0|||
48900845|NCT02003573|157472400|FG002|Overall Study|Progressive disease|1|||
48900846|NCT02003573|157472398|FG000|Overall Study|Other Adverse event|0|||
48900847|NCT02003573|157472399|FG001|Overall Study|Other Adverse event|1|||
48900848|NCT02003573|157472400|FG002|Overall Study|Other Adverse event|1|||
48900849|NCT02003573|157472398|FG000|Overall Study|Refuse to take trial medication|0|||
48900850|NCT02003573|157472399|FG001|Overall Study|Refuse to take trial medication|1|||
48900851|NCT02003573|157472400|FG002|Overall Study|Refuse to take trial medication|1|||
48900852|NCT02003573|157472398|FG000|Overall Study|Other than specified|1|||
48900853|NCT02003573|157472399|FG001|Overall Study|Other than specified|2|||
48900854|NCT02003573|157472400|FG002|Overall Study|Other than specified|3|||
48900855|NCT00985153|157472401|FG000|Overall Study|Lost to Follow-up|16|||
48900856|NCT00985153|157472402|FG001|Overall Study|Lost to Follow-up|19|||
48900857|NCT00985153|157472403|FG002|Overall Study|Lost to Follow-up|17|||
48900858|NCT00985153|157472404|FG003|Overall Study|Lost to Follow-up|20|||
48900859|NCT00985153|157472401|FG000|Overall Study|Protocol Violation|3|||
48900860|NCT00985153|157472402|FG001|Overall Study|Protocol Violation|2|||
48900861|NCT00985153|157472403|FG002|Overall Study|Protocol Violation|4|||
48900862|NCT00985153|157472404|FG003|Overall Study|Protocol Violation|3|||
48900863|NCT00985153|157472401|FG000|Overall Study|Withdrawal by Subject|6|||
48900864|NCT00985153|157472402|FG001|Overall Study|Withdrawal by Subject|11|||
48900865|NCT00985153|157472403|FG002|Overall Study|Withdrawal by Subject|11|||
48900866|NCT00985153|157472404|FG003|Overall Study|Withdrawal by Subject|10|||
48900867|NCT00985153|157472401|FG000|Overall Study|Missed One or More Bleeds|7|||
48900868|NCT00985153|157472402|FG001|Overall Study|Missed One or More Bleeds|7|||
48900869|NCT00985153|157472403|FG002|Overall Study|Missed One or More Bleeds|8|||
48900870|NCT00985153|157472404|FG003|Overall Study|Missed One or More Bleeds|10|||
48900871|NCT00985153|157472401|FG000|Overall Study|Incomplete Safety Follow-up|3|||
48900872|NCT00985153|157472402|FG001|Overall Study|Incomplete Safety Follow-up|5|||
48900873|NCT00985153|157472403|FG002|Overall Study|Incomplete Safety Follow-up|4|||
48900874|NCT00985153|157472404|FG003|Overall Study|Incomplete Safety Follow-up|4|||
48900875|NCT01323634|157472405|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125|||
48900876|NCT01323634|157472406|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
48900877|NCT01323634|157472407|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
48900878|NCT01323634|157472405|FG000|2-week Run-in Period|Continuation Criteria not Met|73|||
48900879|NCT01323634|157472406|FG001|2-week Run-in Period|Continuation Criteria not Met|0|||
48900880|NCT01323634|157472407|FG002|2-week Run-in Period|Continuation Criteria not Met|0|||
48900881|NCT01323634|157472405|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
48900882|NCT01323634|157472406|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
48900883|NCT01323634|157472407|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
48900884|NCT01323634|157472405|FG000|2-week Run-in Period|Physician Decision|5|||
48900885|NCT01323634|157472406|FG001|2-week Run-in Period|Physician Decision|0|||
48900886|NCT01323634|157472407|FG002|2-week Run-in Period|Physician Decision|0|||
48900887|NCT01323634|157472405|FG000|2-week Run-in Period|Protocol Violation|1|||
48900888|NCT01323634|157472406|FG001|2-week Run-in Period|Protocol Violation|0|||
48900889|NCT01323634|157472407|FG002|2-week Run-in Period|Protocol Violation|0|||
48900890|NCT01323634|157472405|FG000|2-week Run-in Period|Adverse Event|1|||
48900891|NCT01323634|157472406|FG001|2-week Run-in Period|Adverse Event|0|||
48900892|NCT01323634|157472407|FG002|2-week Run-in Period|Adverse Event|0|||
48900893|NCT01323634|157472405|FG000|Double-Blind (DB) Treatment Period|Adverse Event|0|||
48900894|NCT01323634|157472406|FG001|Double-Blind (DB) Treatment Period|Adverse Event|8|||
48900895|NCT01323634|157472407|FG002|Double-Blind (DB) Treatment Period|Adverse Event|4|||
48900896|NCT01323634|157472405|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
48900897|NCT01323634|157472406|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
48900898|NCT01323634|157472407|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
48900899|NCT01323634|157472405|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
48900900|NCT01323634|157472406|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|6|||
48900901|NCT01323634|157472407|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|7|||
48900902|NCT01323634|157472405|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
48900903|NCT01323634|157472406|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
48900904|NCT01323634|157472407|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
48900905|NCT01323634|157472405|FG000|Double-Blind (DB) Treatment Period|Physician Decision|0|||
48900906|NCT01323634|157472406|FG001|Double-Blind (DB) Treatment Period|Physician Decision|2|||
48900907|NCT01323634|157472407|FG002|Double-Blind (DB) Treatment Period|Physician Decision|3|||
48900908|NCT01323634|157472405|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
48900909|NCT01323634|157472406|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7|||
48900910|NCT01323634|157472407|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4|||
48900911|NCT01323634|157472405|FG000|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0|||
48900912|NCT01323634|157472406|FG001|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
48900913|NCT01323634|157472407|FG002|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
48900914|NCT02409368|157472408|FG000|ECOG Reclassification|Adverse event unrelated to study drug|17|||
48900915|NCT02409368|157472409|FG001|ECOG Reclassification|Adverse event unrelated to study drug|49|||
48900916|NCT02409368|157472410|FG002|ECOG Reclassification|Adverse event unrelated to study drug|12|||
48900917|NCT02409368|157472411|FG003|ECOG Reclassification|Adverse event unrelated to study drug|0|||
48900918|NCT02409368|157472408|FG000|ECOG Reclassification|Death|1|||
48900919|NCT02409368|157472409|FG001|ECOG Reclassification|Death|5|||
48900920|NCT02409368|157472410|FG002|ECOG Reclassification|Death|0|||
48900921|NCT02409368|157472411|FG003|ECOG Reclassification|Death|0|||
48900922|NCT02409368|157472408|FG000|ECOG Reclassification|Disease Progression|113|||
48900923|NCT02409368|157472409|FG001|ECOG Reclassification|Disease Progression|382|||
48900924|NCT02409368|157472410|FG002|ECOG Reclassification|Disease Progression|70|||
48900925|NCT02409368|157472411|FG003|ECOG Reclassification|Disease Progression|1|||
48900926|NCT02409368|157472408|FG000|ECOG Reclassification|Lost to Follow-up|1|||
48900927|NCT02409368|157472409|FG001|ECOG Reclassification|Lost to Follow-up|5|||
48900928|NCT02409368|157472410|FG002|ECOG Reclassification|Lost to Follow-up|0|||
48900929|NCT02409368|157472411|FG003|ECOG Reclassification|Lost to Follow-up|0|||
48900930|NCT02409368|157472408|FG000|ECOG Reclassification|Maximum clinical benefit|6|||
48900931|NCT02409368|157472409|FG001|ECOG Reclassification|Maximum clinical benefit|5|||
48900932|NCT02409368|157472410|FG002|ECOG Reclassification|Maximum clinical benefit|0|||
48900933|NCT02409368|157472411|FG003|ECOG Reclassification|Maximum clinical benefit|0|||
48900934|NCT02409368|157472408|FG000|ECOG Reclassification|Poor/non-compliance|0|||
48900935|NCT02409368|157472409|FG001|ECOG Reclassification|Poor/non-compliance|3|||
48900936|NCT02409368|157472410|FG002|ECOG Reclassification|Poor/non-compliance|2|||
48900937|NCT02409368|157472411|FG003|ECOG Reclassification|Poor/non-compliance|0|||
48900938|NCT02409368|157472408|FG000|ECOG Reclassification|Study drug toxicity|17|||
48900939|NCT02409368|157472409|FG001|ECOG Reclassification|Study drug toxicity|42|||
48900940|NCT02409368|157472410|FG002|ECOG Reclassification|Study drug toxicity|7|||
48900941|NCT02409368|157472411|FG003|ECOG Reclassification|Study drug toxicity|0|||
48900942|NCT02409368|157472408|FG000|ECOG Reclassification|Participant no longer meets study criteria|3|||
48900943|NCT02409368|157472409|FG001|ECOG Reclassification|Participant no longer meets study criteria|8|||
48900944|NCT02409368|157472410|FG002|ECOG Reclassification|Participant no longer meets study criteria|3|||
48900945|NCT02409368|157472411|FG003|ECOG Reclassification|Participant no longer meets study criteria|0|||
48900946|NCT02409368|157472408|FG000|ECOG Reclassification|Participant request to discontinue study treatment|6|||
48900947|NCT02409368|157472409|FG001|ECOG Reclassification|Participant request to discontinue study treatment|6|||
48900948|NCT02409368|157472410|FG002|ECOG Reclassification|Participant request to discontinue study treatment|2|||
48900949|NCT02409368|157472411|FG003|ECOG Reclassification|Participant request to discontinue study treatment|0|||
48900950|NCT02409368|157472408|FG000|ECOG Reclassification|Participant withdrew consent|2|||
48900951|NCT02409368|157472409|FG001|ECOG Reclassification|Participant withdrew consent|3|||
48900952|NCT02409368|157472410|FG002|ECOG Reclassification|Participant withdrew consent|4|||
48900953|NCT02409368|157472411|FG003|ECOG Reclassification|Participant withdrew consent|0|||
48900954|NCT02409368|157472408|FG000|ECOG Reclassification|Other Reasons|5|||
48900955|NCT02409368|157472409|FG001|ECOG Reclassification|Other Reasons|26|||
48900956|NCT02409368|157472410|FG002|ECOG Reclassification|Other Reasons|2|||
48900957|NCT02409368|157472411|FG003|ECOG Reclassification|Other Reasons|0|||
49041723|NCT00112437|157987606|FG018|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
49041724|NCT00112437|157987607|FG019|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
49041725|NCT00112437|157987608|FG020|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
49041726|NCT00112437|157987609|FG021|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
49041727|NCT00112437|157987610|FG022|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
49041728|NCT00112437|157987611|FG023|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
49041729|NCT00112437|157987612|FG024|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
49041730|NCT00112437|157987613|FG025|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
49041731|NCT00112437|157987588|FG000|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
49041732|NCT00112437|157987589|FG001|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
49041733|NCT00112437|157987590|FG002|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
49041734|NCT00112437|157987591|FG003|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
49041735|NCT00112437|157987592|FG004|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
49041736|NCT00112437|157987593|FG005|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
49041737|NCT00112437|157987594|FG006|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
49041738|NCT00112437|157987595|FG007|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
49041739|NCT00112437|157987596|FG008|Year 2 (12-Month Extension)|Lost to Follow-up|1|||
49041740|NCT00112437|157987597|FG009|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
49041741|NCT00112437|157987598|FG010|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
49041742|NCT00112437|157987599|FG011|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
49041743|NCT00112437|157987600|FG012|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
49041744|NCT00112437|157987601|FG013|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
49041745|NCT00112437|157987602|FG014|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
49041746|NCT00112437|157987603|FG015|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
49041747|NCT00112437|157987604|FG016|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
49041748|NCT00112437|157987605|FG017|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
49041749|NCT00112437|157987606|FG018|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
49041750|NCT00112437|157987607|FG019|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
49041751|NCT00112437|157987608|FG020|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
49041752|NCT00112437|157987609|FG021|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
49041753|NCT00112437|157987610|FG022|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
49041754|NCT00112437|157987611|FG023|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
49041755|NCT00112437|157987612|FG024|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
48900958|NCT02409368|157472408|FG000|ECOG Reclassification|Administrative reason by sponsor|1|||
48900959|NCT02409368|157472409|FG001|ECOG Reclassification|Administrative reason by sponsor|3|||
49041756|NCT00112437|157987613|FG025|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
49041757|NCT00112437|157987588|FG000|Year 2 (12-Month Extension)|Protocol Violation|0|||
48984710|NCT02499172|157775596|FG000|Overall Study|Financial reason|0|||
48984711|NCT02499172|157775597|FG001|Overall Study|Financial reason|0|||
48984712|NCT02499172|157775598|FG002|Overall Study|Financial reason|523|||
48984713|NCT02499172|157775599|FG003|Overall Study|Financial reason|436|||
48984714|NCT02499172|157775596|FG000|Overall Study|Lost to Follow-up|65|||
48984715|NCT02499172|157775597|FG001|Overall Study|Lost to Follow-up|64|||
48984716|NCT02499172|157775598|FG002|Overall Study|Lost to Follow-up|0|||
48984717|NCT02499172|157775599|FG003|Overall Study|Lost to Follow-up|0|||
48984718|NCT02583399|157775600|FG000|Overall Study|Able to be discharged|3|||
48984719|NCT02583399|157775600|FG000|Overall Study|Wanted to use a restricted medication|3|||
48984720|NCT00098865|157775601|FG000|Overall Study|Progressive Disease|6|||
48984721|NCT00098865|157775601|FG000|Overall Study|Adverse Event|2|||
48984722|NCT00098865|157775601|FG000|Overall Study|Alternative Therapy|1|||
48984723|NCT03557801|157775608|FG000|Overall Study|Protocol Violation|1|||
48984724|NCT03557801|157775609|FG001|Overall Study|Protocol Violation|0|||
48984725|NCT03557801|157775610|FG002|Overall Study|Protocol Violation|0|||
48984726|NCT03557801|157775608|FG000|Overall Study|Withdrawal by Subject|1|||
48984727|NCT03557801|157775609|FG001|Overall Study|Withdrawal by Subject|0|||
48984728|NCT03557801|157775610|FG002|Overall Study|Withdrawal by Subject|3|||
48984729|NCT03557801|157775608|FG000|Overall Study|Lost to Follow-up|0|||
48984730|NCT03557801|157775609|FG001|Overall Study|Lost to Follow-up|1|||
48984731|NCT03557801|157775610|FG002|Overall Study|Lost to Follow-up|0|||
48984732|NCT04905563|157775612|FG000|Overall Study|Withdrawal by Subject|1|||
48984733|NCT04905563|157775613|FG001|Overall Study|Withdrawal by Subject|0|||
48984734|NCT04905563|157775612|FG000|Overall Study|Standard of care orders entered by resident|1|||
48984735|NCT04905563|157775613|FG001|Overall Study|Standard of care orders entered by resident|0|||
48984736|NCT04905563|157775612|FG000|Overall Study|Patient discharged from PACU. No study meds adinistered|0|||
48984737|NCT04905563|157775613|FG001|Overall Study|Patient discharged from PACU. No study meds adinistered|1|||
48984738|NCT04905563|157775612|FG000|Overall Study|Withdrawal by Subject|0|||
48984739|NCT04905563|157775613|FG001|Overall Study|Withdrawal by Subject|1|||
48984740|NCT02881151|157775614|FG000|Post-surgical Washout (65 to 93 Days)|Device explantation|1|||
48984741|NCT01904760|157775617|FG000|Overall Study|Protocol Violation|1|||
48984742|NCT01904760|157775618|FG001|Overall Study|Protocol Violation|0|||
48984743|NCT00697255|157775619|FG000|Stage 1a|Insufficient ovarian response|1|||
48984744|NCT00697255|157775620|FG001|Stage 1a|Insufficient ovarian response|0|||
48984745|NCT00697255|157775619|FG000|Stage 1a|Multifollicular growth|1|||
48984746|NCT00697255|157775620|FG001|Stage 1a|Multifollicular growth|0|||
48984747|NCT00697255|157775619|FG000|Stage 1a|Not growing of dominant follicle|1|||
48984748|NCT00697255|157775620|FG001|Stage 1a|Not growing of dominant follicle|0|||
48984749|NCT00697255|157775619|FG000|Stage 1b|Not growing of dominant follicle|0|||
48984750|NCT00697255|157775620|FG001|Stage 1b|Not growing of dominant follicle|1|||
48984751|NCT00697255|157775619|FG000|Stage 1b|Insufficient ovarian response|0|||
48984752|NCT00697255|157775620|FG001|Stage 1b|Insufficient ovarian response|1|||
48984753|NCT03137433|157775621|FG000|Overall Study|Withdrawal by Subject|11|||
48984754|NCT03137433|157775622|FG001|Overall Study|Withdrawal by Subject|11|||
48984755|NCT03137433|157775621|FG000|Overall Study|Lost to Follow-up|5|||
48984756|NCT03137433|157775622|FG001|Overall Study|Lost to Follow-up|6|||
48984757|NCT03137433|157775621|FG000|Overall Study|Physician Decision|2|||
48984758|NCT03137433|157775622|FG001|Overall Study|Physician Decision|0|||
48984759|NCT03137433|157775621|FG000|Overall Study|Moved out of study area|1|||
48984760|NCT03137433|157775622|FG001|Overall Study|Moved out of study area|0|||
48984761|NCT03137433|157775621|FG000|Overall Study|Too far out of window due to COVID|0|||
48984762|NCT03137433|157775622|FG001|Overall Study|Too far out of window due to COVID|1|||
48984763|NCT00638989|157775623|FG000|Overall Study|Lost to Follow-up|0|||
48984764|NCT00638989|157775624|FG001|Overall Study|Lost to Follow-up|0|||
48984765|NCT00638989|157775625|FG002|Overall Study|Lost to Follow-up|1|||
48984766|NCT04554394|157775631|FG000|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
48984767|NCT04554394|157775632|FG001|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
48984768|NCT04554394|157775631|FG000|Overall Study|Withdrawal by Subject|2|||
48984769|NCT04554394|157775632|FG001|Overall Study|Withdrawal by Subject|2|||
48984770|NCT04554394|157775631|FG000|Overall Study|Lost to Follow-up|2|||
48984771|NCT04554394|157775632|FG001|Overall Study|Lost to Follow-up|2|||
48984772|NCT04554394|157775631|FG000|Overall Study|Physician Decision|1|||
48984773|NCT04554394|157775632|FG001|Overall Study|Physician Decision|1|||
48984774|NCT00082628|157775633|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
48984775|NCT00082628|157775634|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1|||
48984776|NCT00082628|157775635|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
48984777|NCT00082628|157775636|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
48984778|NCT00082628|157775637|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
48984779|NCT00082628|157775633|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2|||
48984780|NCT00082628|157775634|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1|||
48984781|NCT00082628|157775635|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
49041758|NCT00112437|157987589|FG001|Year 2 (12-Month Extension)|Protocol Violation|0|||
48900960|NCT02409368|157472410|FG002|ECOG Reclassification|Administrative reason by sponsor|0|||
49041759|NCT00112437|157987590|FG002|Year 2 (12-Month Extension)|Protocol Violation|0|||
49041760|NCT00112437|157987591|FG003|Year 2 (12-Month Extension)|Protocol Violation|0|||
49041761|NCT00112437|157987592|FG004|Year 2 (12-Month Extension)|Protocol Violation|0|||
49041762|NCT00112437|157987593|FG005|Year 2 (12-Month Extension)|Protocol Violation|0|||
49041763|NCT00112437|157987594|FG006|Year 2 (12-Month Extension)|Protocol Violation|0|||
49041764|NCT00112437|157987595|FG007|Year 2 (12-Month Extension)|Protocol Violation|0|||
49041765|NCT00112437|157987596|FG008|Year 2 (12-Month Extension)|Protocol Violation|1|||
49041766|NCT00112437|157987597|FG009|Year 2 (12-Month Extension)|Protocol Violation|0|||
49041767|NCT00112437|157987598|FG010|Year 2 (12-Month Extension)|Protocol Violation|0|||
49041768|NCT00112437|157987599|FG011|Year 2 (12-Month Extension)|Protocol Violation|0|||
49041769|NCT00112437|157987600|FG012|Year 2 (12-Month Extension)|Protocol Violation|0|||
49041770|NCT00112437|157987601|FG013|Year 2 (12-Month Extension)|Protocol Violation|0|||
49041771|NCT00112437|157987602|FG014|Year 2 (12-Month Extension)|Protocol Violation|0|||
49041772|NCT00112437|157987603|FG015|Year 2 (12-Month Extension)|Protocol Violation|0|||
49041773|NCT00112437|157987604|FG016|Year 2 (12-Month Extension)|Protocol Violation|0|||
49041774|NCT00112437|157987605|FG017|Year 2 (12-Month Extension)|Protocol Violation|0|||
49041775|NCT00112437|157987606|FG018|Year 2 (12-Month Extension)|Protocol Violation|0|||
49041776|NCT00112437|157987607|FG019|Year 2 (12-Month Extension)|Protocol Violation|0|||
49041777|NCT00112437|157987608|FG020|Year 2 (12-Month Extension)|Protocol Violation|0|||
48900961|NCT02409368|157472411|FG003|ECOG Reclassification|Administrative reason by sponsor|0|||
48900962|NCT00753272|157472415|FG000|Overall Study|Adverse Event|878|||
48900963|NCT00753272|157472416|FG001|Overall Study|Adverse Event|869|||
48900964|NCT00753272|157472415|FG000|Overall Study|Protocol Violation|28|||
48900965|NCT00753272|157472416|FG001|Overall Study|Protocol Violation|46|||
48900966|NCT00753272|157472415|FG000|Overall Study|Withdrawal by Subject|2481|||
48900967|NCT00753272|157472416|FG001|Overall Study|Withdrawal by Subject|2407|||
48900968|NCT00753272|157472415|FG000|Overall Study|Lost to Follow-up|491|||
48900969|NCT00753272|157472416|FG001|Overall Study|Lost to Follow-up|497|||
48900970|NCT00753272|157472415|FG000|Overall Study|Other|1104|||
48900971|NCT00753272|157472416|FG001|Overall Study|Other|1088|||
48900972|NCT01328717|157474089|FG000|Overall Study|Adverse Event|1|||
48900973|NCT00031551|157474093|FG000|Overall Study|Withdrew due to chemotherapy effects|2|||
48900974|NCT00031551|157474094|FG001|Overall Study|Withdrew due to chemotherapy effects|0|||
48900975|NCT02359877|157474095|FG000|Overall Study|Withdrawal by Subject|1|||
48900976|NCT02359877|157474096|FG001|Overall Study|Withdrawal by Subject|0|||
48900977|NCT02359877|157474097|FG002|Overall Study|Withdrawal by Subject|0|||
48900978|NCT02359877|157474098|FG003|Overall Study|Withdrawal by Subject|2|||
48900979|NCT02359877|157474095|FG000|Overall Study|Adverse Event|0|||
48900980|NCT02359877|157474096|FG001|Overall Study|Adverse Event|0|||
48900981|NCT02359877|157474097|FG002|Overall Study|Adverse Event|0|||
48900982|NCT02359877|157474098|FG003|Overall Study|Adverse Event|1|||
48900983|NCT01919814|157474105|FG000|Overall Study|Adverse Event|1|||
48900984|NCT01919814|157474106|FG001|Overall Study|Adverse Event|0|||
48900985|NCT01919814|157474105|FG000|Overall Study|Protocol Violation|1|||
48900986|NCT01919814|157474106|FG001|Overall Study|Protocol Violation|0|||
48900987|NCT01919814|157474105|FG000|Overall Study|Withdrawal by Subject|1|||
48900988|NCT01919814|157474106|FG001|Overall Study|Withdrawal by Subject|0|||
48900989|NCT00690443|157474118|FG000|Overall Study|Adverse Event|1|||
48900990|NCT00690443|157474119|FG001|Overall Study|Adverse Event|2|||
48900991|NCT02680002|157474120|FG000|Overall Study|Lost to Follow-up|5|||
48900992|NCT02680002|157474121|FG001|Overall Study|Lost to Follow-up|1|||
48900993|NCT02680002|157474122|FG002|Overall Study|Lost to Follow-up|4|||
48900994|NCT02680002|157474123|FG003|Overall Study|Lost to Follow-up|2|||
48900995|NCT02680002|157474124|FG004|Overall Study|Lost to Follow-up|0|||
48900996|NCT02680002|157474125|FG005|Overall Study|Lost to Follow-up|2|||
48900997|NCT02680002|157474120|FG000|Overall Study|Physician Decision|5|||
48900998|NCT02680002|157474121|FG001|Overall Study|Physician Decision|1|||
48900999|NCT02680002|157474122|FG002|Overall Study|Physician Decision|1|||
48901000|NCT02680002|157474123|FG003|Overall Study|Physician Decision|1|||
48901001|NCT02680002|157474124|FG004|Overall Study|Physician Decision|1|||
49041778|NCT00112437|157987609|FG021|Year 2 (12-Month Extension)|Protocol Violation|0|||
49041779|NCT00112437|157987610|FG022|Year 2 (12-Month Extension)|Protocol Violation|0|||
49041780|NCT00112437|157987611|FG023|Year 2 (12-Month Extension)|Protocol Violation|0|||
48901002|NCT02680002|157474125|FG005|Overall Study|Physician Decision|1|||
48901003|NCT02680002|157474120|FG000|Overall Study|Protocol Violation|1|||
48901004|NCT02680002|157474121|FG001|Overall Study|Protocol Violation|0|||
48901005|NCT02680002|157474122|FG002|Overall Study|Protocol Violation|1|||
48901006|NCT02680002|157474123|FG003|Overall Study|Protocol Violation|0|||
48901007|NCT02680002|157474124|FG004|Overall Study|Protocol Violation|1|||
48901008|NCT02680002|157474125|FG005|Overall Study|Protocol Violation|2|||
48901009|NCT02680002|157474120|FG000|Overall Study|Withdrawal by Subject|0|||
48901010|NCT02680002|157474121|FG001|Overall Study|Withdrawal by Subject|0|||
49041781|NCT00112437|157987612|FG024|Year 2 (12-Month Extension)|Protocol Violation|0|||
49041782|NCT00112437|157987613|FG025|Year 2 (12-Month Extension)|Protocol Violation|0|||
49041783|NCT00112437|157987588|FG000|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
48901011|NCT02680002|157474122|FG002|Overall Study|Withdrawal by Subject|1|||
48901012|NCT02680002|157474123|FG003|Overall Study|Withdrawal by Subject|0|||
48901013|NCT02680002|157474124|FG004|Overall Study|Withdrawal by Subject|2|||
48901014|NCT02680002|157474125|FG005|Overall Study|Withdrawal by Subject|2|||
48901015|NCT02680002|157474120|FG000|Overall Study|Missed Visit 8 (Day 201)|2|||
48901016|NCT02680002|157474121|FG001|Overall Study|Missed Visit 8 (Day 201)|1|||
48901017|NCT02680002|157474122|FG002|Overall Study|Missed Visit 8 (Day 201)|3|||
48901018|NCT02680002|157474123|FG003|Overall Study|Missed Visit 8 (Day 201)|1|||
48901019|NCT02680002|157474124|FG004|Overall Study|Missed Visit 8 (Day 201)|5|||
48901020|NCT02680002|157474125|FG005|Overall Study|Missed Visit 8 (Day 201)|0|||
48901021|NCT02680002|157474120|FG000|Overall Study|Other|0|||
48901022|NCT02680002|157474121|FG001|Overall Study|Other|1|||
48901023|NCT02680002|157474122|FG002|Overall Study|Other|0|||
48901024|NCT02680002|157474123|FG003|Overall Study|Other|0|||
48901025|NCT02680002|157474124|FG004|Overall Study|Other|1|||
48901026|NCT02680002|157474125|FG005|Overall Study|Other|0|||
48901027|NCT02680002|157474120|FG000|Overall Study|Adverse Event|0|||
48901028|NCT02680002|157474121|FG001|Overall Study|Adverse Event|0|||
48901029|NCT02680002|157474122|FG002|Overall Study|Adverse Event|0|||
48901030|NCT02680002|157474123|FG003|Overall Study|Adverse Event|0|||
48901031|NCT02680002|157474124|FG004|Overall Study|Adverse Event|1|||
48901032|NCT02680002|157474125|FG005|Overall Study|Adverse Event|2|||
48901033|NCT00645801|157474126|FG000|Overall Study|unclear if patient took all the medication.|1|||
48901034|NCT00645801|157474127|FG001|Overall Study|unclear if patient took all the medication.|0|||
48901035|NCT00645801|157474126|FG000|Overall Study|Lost to Follow-up|19|||
48901036|NCT00645801|157474127|FG001|Overall Study|Lost to Follow-up|15|||
48901037|NCT01403610|157474128|FG000|Overall Study|Withdrawal by Subject|2|||
48901038|NCT01403610|157474129|FG001|Overall Study|Withdrawal by Subject|0|||
48901039|NCT01403610|157474130|FG002|Overall Study|Withdrawal by Subject|0|||
48901040|NCT01403610|157474131|FG003|Overall Study|Withdrawal by Subject|0|||
48901041|NCT01403610|157474128|FG000|Overall Study|Didn't recover from surgery sufficiently|0|||
48901042|NCT01403610|157474129|FG001|Overall Study|Didn't recover from surgery sufficiently|3|||
48901043|NCT01403610|157474130|FG002|Overall Study|Didn't recover from surgery sufficiently|0|||
48901044|NCT01403610|157474131|FG003|Overall Study|Didn't recover from surgery sufficiently|0|||
48901045|NCT02342743|157474139|FG000|Baseline Period|Withdrawal by Subject|3|||
48901046|NCT02342743|157474139|FG000|Baseline Period|Lost to Follow-up|2|||
48901047|NCT02342743|157474139|FG000|Baseline Period|Change in prophylactic medication|3|||
48901048|NCT02342743|157474139|FG000|Baseline Period|Screening failure regarding baseline|7|||
48901049|NCT02342743|157474139|FG000|Treatment Period|Withdrawal by Subject|2|||
48901050|NCT02342743|157474139|FG000|Treatment Period|Lost to Follow-up|8|||
48901051|NCT02342743|157474139|FG000|Treatment Period|Change in prophylactic medication|1|||
48901052|NCT00092495|157474140|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
49041784|NCT00112437|157987589|FG001|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
49041785|NCT00112437|157987590|FG002|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
49041786|NCT00112437|157987591|FG003|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
49041787|NCT00112437|157987592|FG004|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
49041788|NCT00112437|157987593|FG005|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
49041789|NCT00112437|157987594|FG006|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
49041790|NCT00112437|157987595|FG007|Year 2 (12-Month Extension)|Withdrawal by Subject|2|||
49041791|NCT00112437|157987596|FG008|Year 2 (12-Month Extension)|Withdrawal by Subject|4|||
49041792|NCT00112437|157987597|FG009|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
49041793|NCT00112437|157987598|FG010|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
49041794|NCT00112437|157987599|FG011|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
49041795|NCT00112437|157987600|FG012|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
49041796|NCT00112437|157987601|FG013|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
49041797|NCT00112437|157987602|FG014|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
49041798|NCT00112437|157987603|FG015|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
49041799|NCT00112437|157987604|FG016|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
49041800|NCT00112437|157987605|FG017|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
49041801|NCT00112437|157987606|FG018|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
49041802|NCT00112437|157987607|FG019|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
49041803|NCT00112437|157987608|FG020|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
49041804|NCT00112437|157987609|FG021|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
49041805|NCT00112437|157987610|FG022|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
49041806|NCT00112437|157987611|FG023|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
49041807|NCT00112437|157987612|FG024|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
48901053|NCT00092495|157474141|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
48901054|NCT00092495|157474142|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
48901055|NCT00092495|157474143|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|4|||
48901056|NCT00092495|157474144|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
48901057|NCT00092495|157474140|FG000|Base Study Vaccination Period|Extended|0|||
48901058|NCT00092495|157474141|FG001|Base Study Vaccination Period|Extended|0|||
49041808|NCT00112437|157987613|FG025|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
48901059|NCT00092495|157474142|FG002|Base Study Vaccination Period|Extended|0|||
49041809|NCT00112437|157987588|FG000|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
48901060|NCT00092495|157474143|FG003|Base Study Vaccination Period|Extended|1|||
48901061|NCT00092495|157474144|FG004|Base Study Vaccination Period|Extended|0|||
48901062|NCT00092495|157474140|FG000|Base Study Vaccination Period|*Clinical AE|1|||
48901063|NCT00092495|157474141|FG001|Base Study Vaccination Period|*Clinical AE|0|||
48901064|NCT00092495|157474142|FG002|Base Study Vaccination Period|*Clinical AE|1|||
48901065|NCT00092495|157474143|FG003|Base Study Vaccination Period|*Clinical AE|2|||
48901066|NCT00092495|157474144|FG004|Base Study Vaccination Period|*Clinical AE|0|||
48901067|NCT00092495|157474140|FG000|Base Study Vaccination Period|*Other reasons|1|||
48901068|NCT00092495|157474141|FG001|Base Study Vaccination Period|*Other reasons|0|||
48901069|NCT00092495|157474142|FG002|Base Study Vaccination Period|*Other reasons|0|||
48901070|NCT00092495|157474143|FG003|Base Study Vaccination Period|*Other reasons|1|||
48901071|NCT00092495|157474144|FG004|Base Study Vaccination Period|*Other reasons|0|||
48901072|NCT00092495|157474140|FG000|Base Study Vaccination Period|*Pregnancy|0|||
48901073|NCT00092495|157474141|FG001|Base Study Vaccination Period|*Pregnancy|2|||
48901074|NCT00092495|157474142|FG002|Base Study Vaccination Period|*Pregnancy|5|||
48901075|NCT00092495|157474143|FG003|Base Study Vaccination Period|*Pregnancy|7|||
48901076|NCT00092495|157474144|FG004|Base Study Vaccination Period|*Pregnancy|0|||
48901077|NCT00092495|157474140|FG000|Base Study Vaccination Period|Adverse Event|1|||
48901078|NCT00092495|157474141|FG001|Base Study Vaccination Period|Adverse Event|0|||
48901079|NCT00092495|157474142|FG002|Base Study Vaccination Period|Adverse Event|0|||
48901080|NCT00092495|157474143|FG003|Base Study Vaccination Period|Adverse Event|3|||
48901081|NCT00092495|157474144|FG004|Base Study Vaccination Period|Adverse Event|0|||
48901082|NCT00092495|157474140|FG000|Base Study Vaccination Period|Lost to Follow-up|16|||
48901083|NCT00092495|157474141|FG001|Base Study Vaccination Period|Lost to Follow-up|6|||
48901084|NCT00092495|157474142|FG002|Base Study Vaccination Period|Lost to Follow-up|11|||
48901085|NCT00092495|157474143|FG003|Base Study Vaccination Period|Lost to Follow-up|36|||
48901086|NCT00092495|157474144|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
48901087|NCT00092495|157474140|FG000|Base Study Vaccination Period|Moved|3|||
48901088|NCT00092495|157474141|FG001|Base Study Vaccination Period|Moved|1|||
48901089|NCT00092495|157474142|FG002|Base Study Vaccination Period|Moved|2|||
48901090|NCT00092495|157474143|FG003|Base Study Vaccination Period|Moved|2|||
48901091|NCT00092495|157474144|FG004|Base Study Vaccination Period|Moved|0|||
48901092|NCT00092495|157474140|FG000|Base Study Vaccination Period|Other|1|||
48901093|NCT00092495|157474141|FG001|Base Study Vaccination Period|Other|1|||
48901094|NCT00092495|157474142|FG002|Base Study Vaccination Period|Other|0|||
48901095|NCT00092495|157474143|FG003|Base Study Vaccination Period|Other|2|||
48901096|NCT00092495|157474144|FG004|Base Study Vaccination Period|Other|0|||
48901097|NCT00092495|157474140|FG000|Base Study Vaccination Period|Pregnancy|2|||
48901098|NCT00092495|157474141|FG001|Base Study Vaccination Period|Pregnancy|0|||
48901099|NCT00092495|157474142|FG002|Base Study Vaccination Period|Pregnancy|0|||
48901100|NCT00092495|157474143|FG003|Base Study Vaccination Period|Pregnancy|0|||
48901101|NCT00092495|157474144|FG004|Base Study Vaccination Period|Pregnancy|0|||
48901102|NCT00092495|157474140|FG000|Base Study Vaccination Period|Parent Withdrew Consent|1|||
48901103|NCT00092495|157474141|FG001|Base Study Vaccination Period|Parent Withdrew Consent|1|||
49041810|NCT00112437|157987589|FG001|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
49041811|NCT00112437|157987590|FG002|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
49041812|NCT00112437|157987591|FG003|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
49041813|NCT00112437|157987592|FG004|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
49041814|NCT00112437|157987593|FG005|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
49041815|NCT00112437|157987594|FG006|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
49041816|NCT00112437|157987595|FG007|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
49041817|NCT00112437|157987596|FG008|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
49041818|NCT00112437|157987597|FG009|Year 2 (12-Month Extension)|Patient stopped taking medication|1|||
49041819|NCT00112437|157987598|FG010|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
49041820|NCT00112437|157987599|FG011|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
49041821|NCT00112437|157987600|FG012|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
49041822|NCT00112437|157987601|FG013|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
49041823|NCT00112437|157987602|FG014|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
49041824|NCT00112437|157987603|FG015|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
49041825|NCT00112437|157987604|FG016|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
48901104|NCT00092495|157474142|FG002|Base Study Vaccination Period|Parent Withdrew Consent|1|||
48901105|NCT00092495|157474143|FG003|Base Study Vaccination Period|Parent Withdrew Consent|5|||
48901106|NCT00092495|157474144|FG004|Base Study Vaccination Period|Parent Withdrew Consent|0|||
48901107|NCT00092495|157474140|FG000|Base Study Vaccination Period|Protocol Violation|1|||
48901108|NCT00092495|157474141|FG001|Base Study Vaccination Period|Protocol Violation|0|||
48901109|NCT00092495|157474142|FG002|Base Study Vaccination Period|Protocol Violation|0|||
48901110|NCT00092495|157474143|FG003|Base Study Vaccination Period|Protocol Violation|0|||
49041826|NCT00112437|157987605|FG017|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
49041827|NCT00112437|157987606|FG018|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
49041828|NCT00112437|157987607|FG019|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
49041829|NCT00112437|157987608|FG020|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
49041830|NCT00112437|157987609|FG021|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
49041831|NCT00112437|157987610|FG022|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
49041832|NCT00112437|157987611|FG023|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
49041833|NCT00112437|157987612|FG024|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
49041834|NCT00112437|157987613|FG025|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
49041835|NCT00112437|157987588|FG000|Year 2 (12-Month Extension)|patient was out of windows|0|||
49041836|NCT00112437|157987589|FG001|Year 2 (12-Month Extension)|patient was out of windows|0|||
49041837|NCT00112437|157987590|FG002|Year 2 (12-Month Extension)|patient was out of windows|0|||
49041838|NCT00112437|157987591|FG003|Year 2 (12-Month Extension)|patient was out of windows|0|||
49041839|NCT00112437|157987592|FG004|Year 2 (12-Month Extension)|patient was out of windows|0|||
49041840|NCT00112437|157987593|FG005|Year 2 (12-Month Extension)|patient was out of windows|0|||
49041841|NCT00112437|157987594|FG006|Year 2 (12-Month Extension)|patient was out of windows|0|||
49041842|NCT00112437|157987595|FG007|Year 2 (12-Month Extension)|patient was out of windows|0|||
49041843|NCT00112437|157987596|FG008|Year 2 (12-Month Extension)|patient was out of windows|0|||
49041844|NCT00112437|157987597|FG009|Year 2 (12-Month Extension)|patient was out of windows|1|||
49041845|NCT00112437|157987598|FG010|Year 2 (12-Month Extension)|patient was out of windows|0|||
49041846|NCT00112437|157987599|FG011|Year 2 (12-Month Extension)|patient was out of windows|0|||
49041847|NCT00112437|157987600|FG012|Year 2 (12-Month Extension)|patient was out of windows|0|||
49041848|NCT00112437|157987601|FG013|Year 2 (12-Month Extension)|patient was out of windows|0|||
49041849|NCT00112437|157987602|FG014|Year 2 (12-Month Extension)|patient was out of windows|0|||
49041850|NCT00112437|157987603|FG015|Year 2 (12-Month Extension)|patient was out of windows|0|||
49041851|NCT00112437|157987604|FG016|Year 2 (12-Month Extension)|patient was out of windows|0|||
49041852|NCT00112437|157987605|FG017|Year 2 (12-Month Extension)|patient was out of windows|0|||
49041853|NCT00112437|157987606|FG018|Year 2 (12-Month Extension)|patient was out of windows|0|||
49041854|NCT00112437|157987607|FG019|Year 2 (12-Month Extension)|patient was out of windows|0|||
49041855|NCT00112437|157987608|FG020|Year 2 (12-Month Extension)|patient was out of windows|0|||
49041856|NCT00112437|157987609|FG021|Year 2 (12-Month Extension)|patient was out of windows|0|||
49041857|NCT00112437|157987610|FG022|Year 2 (12-Month Extension)|patient was out of windows|0|||
49041858|NCT00112437|157987611|FG023|Year 2 (12-Month Extension)|patient was out of windows|0|||
49041859|NCT00112437|157987612|FG024|Year 2 (12-Month Extension)|patient was out of windows|0|||
49041860|NCT00112437|157987613|FG025|Year 2 (12-Month Extension)|patient was out of windows|0|||
49041861|NCT00112437|157987588|FG000|Year 2 (12-Month Extension)|Moved|0|||
49041862|NCT00112437|157987589|FG001|Year 2 (12-Month Extension)|Moved|0|||
49041863|NCT00112437|157987590|FG002|Year 2 (12-Month Extension)|Moved|0|||
49041864|NCT00112437|157987591|FG003|Year 2 (12-Month Extension)|Moved|0|||
49041865|NCT00112437|157987592|FG004|Year 2 (12-Month Extension)|Moved|0|||
49041866|NCT00112437|157987593|FG005|Year 2 (12-Month Extension)|Moved|0|||
49041867|NCT00112437|157987594|FG006|Year 2 (12-Month Extension)|Moved|0|||
49041868|NCT00112437|157987595|FG007|Year 2 (12-Month Extension)|Moved|0|||
49041869|NCT00112437|157987596|FG008|Year 2 (12-Month Extension)|Moved|0|||
49041870|NCT00112437|157987597|FG009|Year 2 (12-Month Extension)|Moved|1|||
49041871|NCT00112437|157987598|FG010|Year 2 (12-Month Extension)|Moved|0|||
49041872|NCT00112437|157987599|FG011|Year 2 (12-Month Extension)|Moved|0|||
49041873|NCT00112437|157987600|FG012|Year 2 (12-Month Extension)|Moved|0|||
49041874|NCT00112437|157987601|FG013|Year 2 (12-Month Extension)|Moved|0|||
49041875|NCT00112437|157987602|FG014|Year 2 (12-Month Extension)|Moved|0|||
49041876|NCT00112437|157987603|FG015|Year 2 (12-Month Extension)|Moved|0|||
48901111|NCT00092495|157474144|FG004|Base Study Vaccination Period|Protocol Violation|0|||
48901112|NCT00092495|157474140|FG000|Base Study Vaccination Period|Withdrawal by Subject|9|||
48901113|NCT00092495|157474141|FG001|Base Study Vaccination Period|Withdrawal by Subject|10|||
48901114|NCT00092495|157474142|FG002|Base Study Vaccination Period|Withdrawal by Subject|14|||
48901115|NCT00092495|157474143|FG003|Base Study Vaccination Period|Withdrawal by Subject|25|||
48901116|NCT00092495|157474144|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
48901117|NCT00092495|157474140|FG000|Base Study Follow-up Period|Extended|0|||
48901118|NCT00092495|157474141|FG001|Base Study Follow-up Period|Extended|0|||
48901119|NCT00092495|157474142|FG002|Base Study Follow-up Period|Extended|1|||
48901120|NCT00092495|157474143|FG003|Base Study Follow-up Period|Extended|2|||
48901121|NCT00092495|157474144|FG004|Base Study Follow-up Period|Extended|0|||
48901122|NCT00092495|157474140|FG000|Base Study Follow-up Period|Lost to Follow-up|1|||
48901123|NCT00092495|157474141|FG001|Base Study Follow-up Period|Lost to Follow-up|3|||
48901124|NCT00092495|157474142|FG002|Base Study Follow-up Period|Lost to Follow-up|3|||
48901125|NCT00092495|157474143|FG003|Base Study Follow-up Period|Lost to Follow-up|12|||
48901126|NCT00092495|157474144|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
48901127|NCT00092495|157474140|FG000|Base Study Follow-up Period|Withdrawal by Subject|2|||
48901128|NCT00092495|157474141|FG001|Base Study Follow-up Period|Withdrawal by Subject|0|||
49041877|NCT00112437|157987604|FG016|Year 2 (12-Month Extension)|Moved|0|||
49041878|NCT00112437|157987605|FG017|Year 2 (12-Month Extension)|Moved|0|||
49041879|NCT00112437|157987606|FG018|Year 2 (12-Month Extension)|Moved|0|||
49041880|NCT00112437|157987607|FG019|Year 2 (12-Month Extension)|Moved|0|||
49041881|NCT00112437|157987608|FG020|Year 2 (12-Month Extension)|Moved|0|||
49041882|NCT00112437|157987609|FG021|Year 2 (12-Month Extension)|Moved|0|||
49041883|NCT00112437|157987610|FG022|Year 2 (12-Month Extension)|Moved|0|||
49041884|NCT00112437|157987611|FG023|Year 2 (12-Month Extension)|Moved|0|||
49041885|NCT00112437|157987612|FG024|Year 2 (12-Month Extension)|Moved|0|||
49041886|NCT00112437|157987613|FG025|Year 2 (12-Month Extension)|Moved|0|||
49041887|NCT00112437|157987588|FG000|Year 3 (12-Month Extension)|Adverse Event|0|||
49041888|NCT00112437|157987589|FG001|Year 3 (12-Month Extension)|Adverse Event|0|||
49041889|NCT00112437|157987590|FG002|Year 3 (12-Month Extension)|Adverse Event|0|||
49041890|NCT00112437|157987591|FG003|Year 3 (12-Month Extension)|Adverse Event|0|||
49041891|NCT00112437|157987592|FG004|Year 3 (12-Month Extension)|Adverse Event|0|||
49041892|NCT00112437|157987593|FG005|Year 3 (12-Month Extension)|Adverse Event|0|||
49041893|NCT00112437|157987594|FG006|Year 3 (12-Month Extension)|Adverse Event|0|||
49041894|NCT00112437|157987595|FG007|Year 3 (12-Month Extension)|Adverse Event|0|||
49041895|NCT00112437|157987596|FG008|Year 3 (12-Month Extension)|Adverse Event|0|||
49041896|NCT00112437|157987597|FG009|Year 3 (12-Month Extension)|Adverse Event|0|||
49041897|NCT00112437|157987598|FG010|Year 3 (12-Month Extension)|Adverse Event|1|||
49041898|NCT00112437|157987599|FG011|Year 3 (12-Month Extension)|Adverse Event|0|||
49041899|NCT00112437|157987600|FG012|Year 3 (12-Month Extension)|Adverse Event|0|||
49041900|NCT00112437|157987601|FG013|Year 3 (12-Month Extension)|Adverse Event|0|||
49041901|NCT00112437|157987602|FG014|Year 3 (12-Month Extension)|Adverse Event|0|||
49041902|NCT00112437|157987603|FG015|Year 3 (12-Month Extension)|Adverse Event|1|||
49041903|NCT00112437|157987604|FG016|Year 3 (12-Month Extension)|Adverse Event|3|||
49041904|NCT00112437|157987605|FG017|Year 3 (12-Month Extension)|Adverse Event|1|||
49041905|NCT00112437|157987606|FG018|Year 3 (12-Month Extension)|Adverse Event|0|||
49041906|NCT00112437|157987607|FG019|Year 3 (12-Month Extension)|Adverse Event|1|||
49041907|NCT00112437|157987608|FG020|Year 3 (12-Month Extension)|Adverse Event|0|||
49041908|NCT00112437|157987609|FG021|Year 3 (12-Month Extension)|Adverse Event|0|||
49041909|NCT00112437|157987610|FG022|Year 3 (12-Month Extension)|Adverse Event|0|||
49041910|NCT00112437|157987611|FG023|Year 3 (12-Month Extension)|Adverse Event|0|||
49041911|NCT00112437|157987612|FG024|Year 3 (12-Month Extension)|Adverse Event|0|||
49041912|NCT00112437|157987613|FG025|Year 3 (12-Month Extension)|Adverse Event|0|||
49041913|NCT00112437|157987588|FG000|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
49041914|NCT00112437|157987589|FG001|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
49041915|NCT00112437|157987590|FG002|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
49041916|NCT00112437|157987591|FG003|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
49041917|NCT00112437|157987592|FG004|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
49041918|NCT00112437|157987593|FG005|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
49041919|NCT00112437|157987594|FG006|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
49041920|NCT00112437|157987595|FG007|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
49041921|NCT00112437|157987596|FG008|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
49041922|NCT00112437|157987597|FG009|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
49041923|NCT00112437|157987598|FG010|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
49041924|NCT00112437|157987599|FG011|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
49041925|NCT00112437|157987600|FG012|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
49041926|NCT00112437|157987601|FG013|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
49041927|NCT00112437|157987602|FG014|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
49041928|NCT00112437|157987603|FG015|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
49041929|NCT00112437|157987604|FG016|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
49041930|NCT00112437|157987605|FG017|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
49041931|NCT00112437|157987606|FG018|Year 3 (12-Month Extension)|Lack of Efficacy|2|||
49041932|NCT00112437|157987607|FG019|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
49041933|NCT00112437|157987608|FG020|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
49041934|NCT00112437|157987609|FG021|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
49041935|NCT00112437|157987610|FG022|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
49041936|NCT00112437|157987611|FG023|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
49041937|NCT00112437|157987612|FG024|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
49041938|NCT00112437|157987613|FG025|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
49041939|NCT00112437|157987588|FG000|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
48901129|NCT00092495|157474142|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
48901130|NCT00092495|157474143|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
49041940|NCT00112437|157987589|FG001|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
49041941|NCT00112437|157987590|FG002|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
49041942|NCT00112437|157987591|FG003|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
49041943|NCT00112437|157987592|FG004|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
49041944|NCT00112437|157987593|FG005|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
49041945|NCT00112437|157987594|FG006|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
48901131|NCT00092495|157474144|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
48901132|NCT03103763|157474151|FG000|Overall Study|Death|15|||
49041946|NCT00112437|157987595|FG007|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
49041947|NCT00112437|157987596|FG008|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
49041948|NCT00112437|157987597|FG009|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
49041949|NCT00112437|157987598|FG010|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
49041950|NCT00112437|157987599|FG011|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
49041951|NCT00112437|157987600|FG012|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
49041952|NCT00112437|157987601|FG013|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
49041953|NCT00112437|157987602|FG014|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
49041954|NCT00112437|157987603|FG015|Year 3 (12-Month Extension)|Lost to Follow-up|1|||
49041955|NCT00112437|157987604|FG016|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
49041956|NCT00112437|157987605|FG017|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
49041957|NCT00112437|157987606|FG018|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
49041958|NCT00112437|157987607|FG019|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
49041959|NCT00112437|157987608|FG020|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
49041960|NCT00112437|157987609|FG021|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
49041961|NCT00112437|157987610|FG022|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
49041962|NCT00112437|157987611|FG023|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
49041963|NCT00112437|157987612|FG024|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
49041964|NCT00112437|157987613|FG025|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
49041965|NCT00112437|157987588|FG000|Year 3 (12-Month Extension)|Protocol Violation|0|||
49041966|NCT00112437|157987589|FG001|Year 3 (12-Month Extension)|Protocol Violation|0|||
49041967|NCT00112437|157987590|FG002|Year 3 (12-Month Extension)|Protocol Violation|0|||
49041968|NCT00112437|157987591|FG003|Year 3 (12-Month Extension)|Protocol Violation|0|||
49041969|NCT00112437|157987592|FG004|Year 3 (12-Month Extension)|Protocol Violation|0|||
49041970|NCT00112437|157987593|FG005|Year 3 (12-Month Extension)|Protocol Violation|0|||
49041971|NCT00112437|157987594|FG006|Year 3 (12-Month Extension)|Protocol Violation|0|||
49041972|NCT00112437|157987595|FG007|Year 3 (12-Month Extension)|Protocol Violation|0|||
49041973|NCT00112437|157987596|FG008|Year 3 (12-Month Extension)|Protocol Violation|0|||
49041974|NCT00112437|157987597|FG009|Year 3 (12-Month Extension)|Protocol Violation|0|||
49041975|NCT00112437|157987598|FG010|Year 3 (12-Month Extension)|Protocol Violation|0|||
49041976|NCT00112437|157987599|FG011|Year 3 (12-Month Extension)|Protocol Violation|0|||
49041977|NCT00112437|157987600|FG012|Year 3 (12-Month Extension)|Protocol Violation|0|||
49041978|NCT00112437|157987601|FG013|Year 3 (12-Month Extension)|Protocol Violation|0|||
49041979|NCT00112437|157987602|FG014|Year 3 (12-Month Extension)|Protocol Violation|0|||
49041980|NCT00112437|157987603|FG015|Year 3 (12-Month Extension)|Protocol Violation|1|||
49041981|NCT00112437|157987604|FG016|Year 3 (12-Month Extension)|Protocol Violation|0|||
49041982|NCT00112437|157987605|FG017|Year 3 (12-Month Extension)|Protocol Violation|0|||
49041983|NCT00112437|157987606|FG018|Year 3 (12-Month Extension)|Protocol Violation|0|||
49041984|NCT00112437|157987607|FG019|Year 3 (12-Month Extension)|Protocol Violation|0|||
49041985|NCT00112437|157987608|FG020|Year 3 (12-Month Extension)|Protocol Violation|0|||
49041986|NCT00112437|157987609|FG021|Year 3 (12-Month Extension)|Protocol Violation|0|||
49041987|NCT00112437|157987610|FG022|Year 3 (12-Month Extension)|Protocol Violation|0|||
49041988|NCT00112437|157987611|FG023|Year 3 (12-Month Extension)|Protocol Violation|0|||
49041989|NCT00112437|157987612|FG024|Year 3 (12-Month Extension)|Protocol Violation|0|||
49041990|NCT00112437|157987613|FG025|Year 3 (12-Month Extension)|Protocol Violation|0|||
49041991|NCT00112437|157987588|FG000|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
49041992|NCT00112437|157987589|FG001|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
49041993|NCT00112437|157987590|FG002|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
49041994|NCT00112437|157987591|FG003|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
49041995|NCT00112437|157987592|FG004|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
49041996|NCT00112437|157987593|FG005|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
49041997|NCT00112437|157987594|FG006|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
49041998|NCT00112437|157987595|FG007|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
49041999|NCT00112437|157987596|FG008|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
49042000|NCT00112437|157987597|FG009|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
49042001|NCT00112437|157987598|FG010|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
49042002|NCT00112437|157987599|FG011|Year 3 (12-Month Extension)|Withdrawal by Subject|3|||
49042003|NCT00112437|157987600|FG012|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
48901133|NCT03103763|157474152|FG001|Overall Study|Death|5|||
48901134|NCT03103763|157474153|FG002|Overall Study|Death|5|||
48901135|NCT03103763|157474151|FG000|Overall Study|Withdrawal by Subject|0|||
48901136|NCT03103763|157474152|FG001|Overall Study|Withdrawal by Subject|3|||
48901137|NCT03103763|157474153|FG002|Overall Study|Withdrawal by Subject|2|||
48901138|NCT01280812|157474154|FG000|Overall Study|Withdrawal by Subject|2|||
48901139|NCT01280812|157474155|FG001|Overall Study|Withdrawal by Subject|1|||
48901140|NCT01280812|157474156|FG002|Overall Study|Withdrawal by Subject|0|||
48901141|NCT01280812|157474154|FG000|Overall Study|Lost to Follow-up|1|||
49042004|NCT00112437|157987601|FG013|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
49042005|NCT00112437|157987602|FG014|Year 3 (12-Month Extension)|Withdrawal by Subject|1|||
48901142|NCT01280812|157474155|FG001|Overall Study|Lost to Follow-up|1|||
48901143|NCT01280812|157474156|FG002|Overall Study|Lost to Follow-up|1|||
49042006|NCT00112437|157987603|FG015|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
49042007|NCT00112437|157987604|FG016|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
49042008|NCT00112437|157987605|FG017|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
49042009|NCT00112437|157987606|FG018|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
49042010|NCT00112437|157987607|FG019|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
49042011|NCT00112437|157987608|FG020|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
49042012|NCT00112437|157987609|FG021|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
49042013|NCT00112437|157987610|FG022|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
49042014|NCT00112437|157987611|FG023|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
49042015|NCT00112437|157987612|FG024|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
49042016|NCT00112437|157987613|FG025|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
49042017|NCT00112437|157987588|FG000|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
49042018|NCT00112437|157987589|FG001|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
49042019|NCT00112437|157987590|FG002|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
49042020|NCT00112437|157987591|FG003|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
49042021|NCT00112437|157987592|FG004|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
49042022|NCT00112437|157987593|FG005|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
49042023|NCT00112437|157987594|FG006|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
49042024|NCT00112437|157987595|FG007|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
49042025|NCT00112437|157987596|FG008|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
49042026|NCT00112437|157987597|FG009|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
49042027|NCT00112437|157987598|FG010|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
49042028|NCT00112437|157987599|FG011|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
49042029|NCT00112437|157987600|FG012|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
49042030|NCT00112437|157987601|FG013|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
48901144|NCT00250679|157474157|FG000|Overall Study|Adverse Event|12|||
48901145|NCT00250679|157474158|FG001|Overall Study|Adverse Event|15|||
48901146|NCT00250679|157474159|FG002|Overall Study|Adverse Event|16|||
48901147|NCT00250679|157474157|FG000|Overall Study|Protocol Violation|2|||
48901148|NCT00250679|157474158|FG001|Overall Study|Protocol Violation|4|||
48901149|NCT00250679|157474159|FG002|Overall Study|Protocol Violation|3|||
48901150|NCT00250679|157474157|FG000|Overall Study|Withdrawal by Subject|15|||
48901151|NCT00250679|157474158|FG001|Overall Study|Withdrawal by Subject|18|||
48901152|NCT00250679|157474159|FG002|Overall Study|Withdrawal by Subject|15|||
48901153|NCT00250679|157474157|FG000|Overall Study|Lost to Follow-up|3|||
49042031|NCT00112437|157987602|FG014|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
49042032|NCT00112437|157987603|FG015|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
49042033|NCT00112437|157987604|FG016|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
49042034|NCT00112437|157987605|FG017|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
49042035|NCT00112437|157987606|FG018|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
49042036|NCT00112437|157987607|FG019|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
49042037|NCT00112437|157987608|FG020|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
49042038|NCT00112437|157987609|FG021|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
48901154|NCT00250679|157474158|FG001|Overall Study|Lost to Follow-up|4|||
48901155|NCT00250679|157474159|FG002|Overall Study|Lost to Follow-up|2|||
48901156|NCT00250679|157474157|FG000|Overall Study|Does Not Meet Entry Criteria|1|||
48901157|NCT00250679|157474158|FG001|Overall Study|Does Not Meet Entry Criteria|4|||
48901158|NCT00250679|157474159|FG002|Overall Study|Does Not Meet Entry Criteria|2|||
48901159|NCT00250679|157474157|FG000|Overall Study|Lack of Efficacy|0|||
48901160|NCT00250679|157474158|FG001|Overall Study|Lack of Efficacy|1|||
48901161|NCT00250679|157474159|FG002|Overall Study|Lack of Efficacy|3|||
48901162|NCT00250679|157474157|FG000|Overall Study|Technical Holter issues|1|||
48901163|NCT00250679|157474158|FG001|Overall Study|Technical Holter issues|0|||
48901164|NCT00250679|157474159|FG002|Overall Study|Technical Holter issues|2|||
48901165|NCT00250679|157474157|FG000|Overall Study|Moved|1|||
48901166|NCT00250679|157474158|FG001|Overall Study|Moved|1|||
48901167|NCT00250679|157474159|FG002|Overall Study|Moved|0|||
48901168|NCT00250679|157474157|FG000|Overall Study|Non-compliance|1|||
48901169|NCT00250679|157474158|FG001|Overall Study|Non-compliance|1|||
48901170|NCT00250679|157474159|FG002|Overall Study|Non-compliance|0|||
48901171|NCT00250679|157474157|FG000|Overall Study|various single events: hip surgery,diary|3|||
48901172|NCT00250679|157474158|FG001|Overall Study|various single events: hip surgery,diary|1|||
48901173|NCT00250679|157474159|FG002|Overall Study|various single events: hip surgery,diary|1|||
48901174|NCT00824161|157474160|FG000|Overall Study|Withdrawal by Subject|1|||
48901175|NCT00824161|157474160|FG000|Overall Study|Screen Failure|1|||
48901176|NCT01676909|157474161|FG000|Overall Study|Withdrawal by Subject|3|||
48901177|NCT01676909|157474162|FG001|Overall Study|Withdrawal by Subject|5|||
48901178|NCT01676909|157474161|FG000|Overall Study|Lost to Follow-up|15|||
48901179|NCT01676909|157474162|FG001|Overall Study|Lost to Follow-up|9|||
48901180|NCT02175004|157474165|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
49042039|NCT00112437|157987610|FG022|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
49042040|NCT00112437|157987611|FG023|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
49042041|NCT00112437|157987612|FG024|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
49042042|NCT00112437|157987613|FG025|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
49042043|NCT00112437|157987588|FG000|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
49042044|NCT00112437|157987589|FG001|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
49042045|NCT00112437|157987590|FG002|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
49042046|NCT00112437|157987591|FG003|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
49042047|NCT00112437|157987592|FG004|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
49042048|NCT00112437|157987593|FG005|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
48901181|NCT02175004|157474166|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|14|||
48901182|NCT02175004|157474165|FG000|Overall Study|Investigator Judgment|1|||
48901183|NCT02175004|157474166|FG001|Overall Study|Investigator Judgment|4|||
48901184|NCT02175004|157474165|FG000|Overall Study|Voluntary Withdrawal|6|||
48901185|NCT02175004|157474166|FG001|Overall Study|Voluntary Withdrawal|19|||
48901186|NCT02175004|157474165|FG000|Overall Study|Liver Transplant|1|||
48901187|NCT02175004|157474166|FG001|Overall Study|Liver Transplant|0|||
48901188|NCT02175004|157474165|FG000|Overall Study|Disease Progression|1|||
48901189|NCT02175004|157474166|FG001|Overall Study|Disease Progression|0|||
48901190|NCT02175004|157474165|FG000|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|27|||
48901191|NCT02175004|157474166|FG001|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|39|||
48901192|NCT03401229|157474168|FG000|Overall Study|Lost to Follow-up|2|||
48901193|NCT03401229|157474169|FG001|Overall Study|Lost to Follow-up|1|||
48901194|NCT03401229|157474168|FG000|Overall Study|Other|1|||
49042049|NCT00112437|157987594|FG006|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
49042050|NCT00112437|157987595|FG007|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
49042051|NCT00112437|157987596|FG008|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
48901195|NCT03401229|157474169|FG001|Overall Study|Other|3|||
48901196|NCT03401229|157474168|FG000|Overall Study|Adverse Event|8|||
48901197|NCT03401229|157474169|FG001|Overall Study|Adverse Event|6|||
48901198|NCT03401229|157474168|FG000|Overall Study|Withdrawal by Subject|29|||
48901199|NCT03401229|157474169|FG001|Overall Study|Withdrawal by Subject|26|||
48901200|NCT03401229|157474168|FG000|Overall Study|COVID-19|0|||
48901201|NCT03401229|157474169|FG001|Overall Study|COVID-19|1|||
48901202|NCT02963610|157474170|FG000|Overall Study|Study terminated prematurely due to funding/support being withdrawn by grantor. No analyses occurred|3|||
48901203|NCT01324440|157474175|FG000|Overall Study|Subject moved|0|||
48901204|NCT01324440|157474176|FG001|Overall Study|Subject moved|1|||
48901205|NCT00063154|157474182|FG000|Overall Study|Disease progression|27|||
48901206|NCT00063154|157474182|FG000|Overall Study|Adverse Event|2|||
48901207|NCT00063154|157474182|FG000|Overall Study|Physician Decision|10|||
48901208|NCT00063154|157474182|FG000|Overall Study|Death|3|||
48901209|NCT00063154|157474182|FG000|Overall Study|Reason unspecified|1|||
48901210|NCT00063154|157474182|FG000|Overall Study|Did not receive treatment|8|||
48901211|NCT01122862|157474183|FG000|Period 1|Protocol Violation|0|||
48901212|NCT01122862|157474184|FG001|Period 1|Protocol Violation|1|||
48901213|NCT01122862|157474185|FG002|Period 1|Protocol Violation|0|||
48901214|NCT01122862|157474183|FG000|Period 2|Adverse Event|0|||
48901215|NCT01122862|157474184|FG001|Period 2|Adverse Event|0|||
48901216|NCT01122862|157474185|FG002|Period 2|Adverse Event|1|||
48901217|NCT02752074|157474186|FG000|Overall Study|Lost to Follow-up|1|||
48901218|NCT02752074|157474187|FG001|Overall Study|Lost to Follow-up|4|||
48901219|NCT02752074|157474186|FG000|Overall Study|Death|146|||
48901220|NCT02752074|157474187|FG001|Overall Study|Death|129|||
48901221|NCT02752074|157474186|FG000|Overall Study|Withdrawal by Subject|9|||
48901222|NCT02752074|157474187|FG001|Overall Study|Withdrawal by Subject|10|||
48901223|NCT02699983|157474188|FG000|Overall Study|Withdrawal by Subject|1|||
48901224|NCT02699983|157474189|FG001|Overall Study|Withdrawal by Subject|0|||
48901225|NCT01249274|157474190|FG000|Overall Study|Lost to Follow-up|3|||
48901226|NCT01249274|157474191|FG001|Overall Study|Lost to Follow-up|4|||
48901227|NCT01249274|157474190|FG000|Overall Study|Received inpatient substance treatment|1|||
48901228|NCT01249274|157474191|FG001|Overall Study|Received inpatient substance treatment|2|||
48901229|NCT03451162|157474192|FG000|Overall Study|Lost to Follow-up|1|||
48901230|NCT03451162|157474193|FG001|Overall Study|Lost to Follow-up|0|||
49042052|NCT00112437|157987597|FG009|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
48901231|NCT03451162|157474194|FG002|Overall Study|Lost to Follow-up|0|||
48901232|NCT03451162|157474195|FG003|Overall Study|Lost to Follow-up|0|||
48901233|NCT03451162|157474196|FG004|Overall Study|Lost to Follow-up|0|||
49042053|NCT00112437|157987598|FG010|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
49042054|NCT00112437|157987599|FG011|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
48901234|NCT03451162|157474192|FG000|Overall Study|Physician Decision|0|||
49042055|NCT00112437|157987600|FG012|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
48901235|NCT03451162|157474193|FG001|Overall Study|Physician Decision|1|||
48901236|NCT03451162|157474194|FG002|Overall Study|Physician Decision|0|||
48901237|NCT03451162|157474195|FG003|Overall Study|Physician Decision|0|||
48901238|NCT03451162|157474196|FG004|Overall Study|Physician Decision|0|||
49042056|NCT00112437|157987601|FG013|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
49042057|NCT00112437|157987602|FG014|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
49042058|NCT00112437|157987603|FG015|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
49042059|NCT00112437|157987604|FG016|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
49042060|NCT00112437|157987605|FG017|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
49042061|NCT00112437|157987606|FG018|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
49042062|NCT00112437|157987607|FG019|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
49042063|NCT00112437|157987608|FG020|Years 4-5 (24-Month Extension)|Lack of Efficacy|2|||
49042064|NCT00112437|157987609|FG021|Years 4-5 (24-Month Extension)|Lack of Efficacy|1|||
49042065|NCT00112437|157987610|FG022|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
48901239|NCT03451162|157474192|FG000|Overall Study|Withdrawal by Subject|1|||
49042066|NCT00112437|157987611|FG023|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
49042067|NCT00112437|157987612|FG024|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
49042068|NCT00112437|157987613|FG025|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
48901240|NCT03451162|157474193|FG001|Overall Study|Withdrawal by Subject|1|||
48901241|NCT03451162|157474194|FG002|Overall Study|Withdrawal by Subject|0|||
48901242|NCT03451162|157474195|FG003|Overall Study|Withdrawal by Subject|0|||
48901243|NCT03451162|157474196|FG004|Overall Study|Withdrawal by Subject|0|||
48901244|NCT01488487|157474197|FG000|Overall Study|Adverse Event|6|||
48901245|NCT01488487|157474197|FG000|Overall Study|Death|1|||
48901246|NCT01488487|157474197|FG000|Overall Study|Withdrawal by Subject|2|||
48901247|NCT04634825|157474198|FG000|Overall Study|Death|10|||
48901248|NCT04634825|157474199|FG001|Overall Study|Death|3|||
48901249|NCT04634825|157474198|FG000|Overall Study|Lost to Follow-up|1|||
48901250|NCT04634825|157474199|FG001|Overall Study|Lost to Follow-up|0|||
48901251|NCT04634825|157474198|FG000|Overall Study|Study terminated by sponsor|35|||
48901252|NCT04634825|157474199|FG001|Overall Study|Study terminated by sponsor|11|||
48901253|NCT04634825|157474198|FG000|Overall Study|Withdrawal by Subject|2|||
48901254|NCT04634825|157474199|FG001|Overall Study|Withdrawal by Subject|0|||
48901255|NCT01959516|157474200|FG000|Epoch 1|Adverse Event|4|||
48901256|NCT01959516|157474201|FG001|Epoch 1|Adverse Event|1|||
48901257|NCT01959516|157474200|FG000|Epoch 1|unsatisfactory therapeutic effect|1|||
48901258|NCT01959516|157474201|FG001|Epoch 1|unsatisfactory therapeutic effect|0|||
48901259|NCT01959516|157474200|FG000|Epoch 1|Subject withdrew consent|3|||
48901260|NCT01959516|157474201|FG001|Epoch 1|Subject withdrew consent|2|||
48901261|NCT01959516|157474200|FG000|Epoch 1|Administrative problems|1|||
48901262|NCT01959516|157474201|FG001|Epoch 1|Administrative problems|0|||
48901263|NCT01959516|157474200|FG000|Epoch 1|Use of prohibited treatment|1|||
48901264|NCT01959516|157474201|FG001|Epoch 1|Use of prohibited treatment|0|||
48901265|NCT01959516|157474200|FG000|Epoch 1|Moderate or severe COPD exacerbation|0|||
48901266|NCT01959516|157474201|FG001|Epoch 1|Moderate or severe COPD exacerbation|1|||
48901267|NCT01959516|157474200|FG000|Epoch 1|Protocol deviation|0|||
48901268|NCT01959516|157474201|FG001|Epoch 1|Protocol deviation|1|||
48901269|NCT01959516|157474200|FG000|Epoch 2|unsatisfactory therapeutic effect|1|||
48901270|NCT01959516|157474201|FG001|Epoch 2|unsatisfactory therapeutic effect|0|||
48901271|NCT01959516|157474200|FG000|Epoch 2|Subject withdrew consent|1|||
48901272|NCT01959516|157474201|FG001|Epoch 2|Subject withdrew consent|0|||
48901273|NCT01959516|157474200|FG000|Epoch 2|Moderate or severe COPD exacerbation|0|||
48901274|NCT01959516|157474201|FG001|Epoch 2|Moderate or severe COPD exacerbation|1|||
48901275|NCT01477333|157474202|FG000|Overall Study|Adverse Event|1|||
48901276|NCT01477333|157474202|FG000|Overall Study|Withdrawal by Subject|1|||
48901277|NCT01477333|157474202|FG000|Overall Study|Clinical Deterioration|1|||
48901278|NCT03426267|157474205|FG000|Overall Study|Physician Decision|1|||
48901279|NCT03426267|157474206|FG001|Overall Study|Physician Decision|4|||
48901280|NCT03426267|157474205|FG000|Overall Study|Lost to Follow-up|1|||
48901281|NCT03426267|157474206|FG001|Overall Study|Lost to Follow-up|0|||
48901282|NCT03426267|157474205|FG000|Overall Study|Withdrawal by Subject|4|||
48901283|NCT03426267|157474206|FG001|Overall Study|Withdrawal by Subject|10|||
48901284|NCT03426267|157474205|FG000|Overall Study|Protocol Violation|1|||
48901285|NCT03426267|157474206|FG001|Overall Study|Protocol Violation|3|||
48901286|NCT03426267|157474205|FG000|Overall Study|Adverse Event|9|||
48901287|NCT03426267|157474206|FG001|Overall Study|Adverse Event|27|||
48901288|NCT03426267|157474205|FG000|Overall Study|Prohibited Treatment Intake|2|||
48901289|NCT03426267|157474206|FG001|Overall Study|Prohibited Treatment Intake|3|||
48901290|NCT03426267|157474205|FG000|Overall Study|Lack of Efficacy|0|||
48901291|NCT03426267|157474206|FG001|Overall Study|Lack of Efficacy|25|||
48901292|NCT03426267|157474205|FG000|Overall Study|other|3|||
48901293|NCT03426267|157474206|FG001|Overall Study|other|0|||
48901294|NCT01580969|157474207|FG000|Overall Study|Physician Decision|3|||
48901295|NCT01580969|157474208|FG001|Overall Study|Physician Decision|0|||
48901296|NCT01580969|157474209|FG002|Overall Study|Physician Decision|0|||
48901297|NCT02578862|157474210|FG000|Overall Study|Withdrawal by Subject|0|||
48901298|NCT02578862|157474211|FG001|Overall Study|Withdrawal by Subject|1|||
48901299|NCT02578862|157474210|FG000|Overall Study|Unplanned unilateral procedure|0|||
49042069|NCT00112437|157987588|FG000|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
48901300|NCT02578862|157474211|FG001|Overall Study|Unplanned unilateral procedure|1|||
48901301|NCT00448123|157474212|FG000|Overall Study|Lost to Follow-up|9|||
48901302|NCT00448123|157474213|FG001|Overall Study|Lost to Follow-up|6|||
48901303|NCT00448123|157474212|FG000|Overall Study|Physician Decision|6|||
48901304|NCT00448123|157474213|FG001|Overall Study|Physician Decision|6|||
48901305|NCT02027623|157474214|FG000|Overall Study|Lost to Follow-up|3|||
48901306|NCT02027623|157474215|FG001|Overall Study|Lost to Follow-up|3|||
48901307|NCT02027623|157474214|FG000|Overall Study|Withdrawal by Subject|6|||
48901308|NCT02027623|157474215|FG001|Overall Study|Withdrawal by Subject|9|||
48901309|NCT02349360|157474219|FG000|Overall Study|Withdrawal by Subject|0|||
48901310|NCT02349360|157474220|FG001|Overall Study|Withdrawal by Subject|1|||
48901311|NCT04744285|157474229|FG000|Overall Study|Withdrawal by Subject|1|||
48901312|NCT04744285|157474230|FG001|Overall Study|Withdrawal by Subject|1|||
48901313|NCT04744285|157474231|FG002|Overall Study|Withdrawal by Subject|2|||
48901314|NCT04744285|157474232|FG003|Overall Study|Withdrawal by Subject|1|||
48901315|NCT01116882|157474233|FG000|30-day|Lost to Follow-up|50|||
48901316|NCT01116882|157474234|FG001|30-day|Lost to Follow-up|21|||
48901317|NCT01116882|157474233|FG000|30-day|Withdrawal by Subject|2|||
48901318|NCT01116882|157474234|FG001|30-day|Withdrawal by Subject|4|||
48901319|NCT01116882|157474233|FG000|30-day|Other Reasons|16|||
48901320|NCT01116882|157474234|FG001|30-day|Other Reasons|6|||
48901321|NCT01116882|157474233|FG000|12-month|Lost to Follow-up|111|||
48901322|NCT01116882|157474234|FG001|12-month|Lost to Follow-up|42|||
48901323|NCT01116882|157474233|FG000|12-month|Other Reasons|151|||
48901324|NCT01116882|157474234|FG001|12-month|Other Reasons|49|||
48901325|NCT01116882|157474233|FG000|12-month|Withdrawal by Subject|5|||
48901326|NCT01116882|157474234|FG001|12-month|Withdrawal by Subject|8|||
48901327|NCT01966471|157474235|FG000|Overall Study|Death|44|||
48901328|NCT01966471|157474236|FG001|Overall Study|Death|56|||
48901329|NCT01966471|157474235|FG000|Overall Study|Lost to Follow-up|46|||
48901330|NCT01966471|157474236|FG001|Overall Study|Lost to Follow-up|39|||
48901331|NCT01966471|157474235|FG000|Overall Study|Various reasons|4|||
48901332|NCT01966471|157474236|FG001|Overall Study|Various reasons|4|||
48901333|NCT01966471|157474235|FG000|Overall Study|Physician Decision|7|||
48901334|NCT01966471|157474236|FG001|Overall Study|Physician Decision|5|||
48901335|NCT01966471|157474235|FG000|Overall Study|Study Terminated By Sponsor|758|||
48901336|NCT01966471|157474236|FG001|Overall Study|Study Terminated By Sponsor|773|||
48901337|NCT01966471|157474235|FG000|Overall Study|Withdrawal by Subject|59|||
48901338|NCT01966471|157474236|FG001|Overall Study|Withdrawal by Subject|51|||
48901339|NCT00593957|157474237|FG000|Overall Study|Physician Decision|0|||
48901340|NCT00593957|157474238|FG001|Overall Study|Physician Decision|1|||
48901341|NCT00593957|157474239|FG002|Overall Study|Physician Decision|2|||
48901342|NCT01193920|157474240|FG000|Overall Study|Withdrawal by Subject|1|||
48901343|NCT01193920|157474241|FG001|Overall Study|Withdrawal by Subject|0|||
48901344|NCT01193920|157474242|FG002|Overall Study|Withdrawal by Subject|5|||
48901345|NCT01193920|157474243|FG003|Overall Study|Withdrawal by Subject|1|||
48901346|NCT01193920|157474244|FG004|Overall Study|Withdrawal by Subject|3|||
48901347|NCT01193920|157474245|FG005|Overall Study|Withdrawal by Subject|1|||
48901348|NCT01193920|157474246|FG006|Overall Study|Withdrawal by Subject|3|||
48901349|NCT01193920|157474247|FG007|Overall Study|Withdrawal by Subject|0|||
48901350|NCT01193920|157474248|FG008|Overall Study|Withdrawal by Subject|1|||
48901351|NCT01193920|157474249|FG009|Overall Study|Withdrawal by Subject|0|||
48901352|NCT01193920|157474240|FG000|Overall Study|Lost to Follow-up|1|||
48901353|NCT01193920|157474241|FG001|Overall Study|Lost to Follow-up|0|||
48901354|NCT01193920|157474242|FG002|Overall Study|Lost to Follow-up|1|||
48901355|NCT01193920|157474243|FG003|Overall Study|Lost to Follow-up|1|||
48901356|NCT01193920|157474244|FG004|Overall Study|Lost to Follow-up|3|||
48901357|NCT01193920|157474245|FG005|Overall Study|Lost to Follow-up|3|||
48901358|NCT01193920|157474246|FG006|Overall Study|Lost to Follow-up|1|||
48901359|NCT01193920|157474247|FG007|Overall Study|Lost to Follow-up|0|||
48901360|NCT01193920|157474248|FG008|Overall Study|Lost to Follow-up|2|||
48901361|NCT01193920|157474249|FG009|Overall Study|Lost to Follow-up|3|||
48901362|NCT01193920|157474240|FG000|Overall Study|Protocol Violation|1|||
48901363|NCT01193920|157474241|FG001|Overall Study|Protocol Violation|0|||
49042070|NCT00112437|157987589|FG001|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
48901364|NCT01193920|157474242|FG002|Overall Study|Protocol Violation|0|||
48901365|NCT01193920|157474243|FG003|Overall Study|Protocol Violation|0|||
48901366|NCT01193920|157474244|FG004|Overall Study|Protocol Violation|0|||
48901367|NCT01193920|157474245|FG005|Overall Study|Protocol Violation|0|||
48901368|NCT01193920|157474246|FG006|Overall Study|Protocol Violation|0|||
48901369|NCT01193920|157474247|FG007|Overall Study|Protocol Violation|0|||
48901370|NCT01193920|157474248|FG008|Overall Study|Protocol Violation|0|||
48901371|NCT01193920|157474249|FG009|Overall Study|Protocol Violation|0|||
48901372|NCT01193920|157474240|FG000|Overall Study|Death|0|||
48901373|NCT01193920|157474241|FG001|Overall Study|Death|0|||
48901374|NCT01193920|157474242|FG002|Overall Study|Death|0|||
48901375|NCT01193920|157474243|FG003|Overall Study|Death|1|||
48901376|NCT01193920|157474244|FG004|Overall Study|Death|0|||
48901377|NCT01193920|157474245|FG005|Overall Study|Death|0|||
48901378|NCT01193920|157474246|FG006|Overall Study|Death|2|||
48901379|NCT01193920|157474247|FG007|Overall Study|Death|3|||
48901380|NCT01193920|157474248|FG008|Overall Study|Death|2|||
48901381|NCT01193920|157474249|FG009|Overall Study|Death|4|||
48901382|NCT01193920|157474240|FG000|Overall Study|Unable to classify|0|||
48901383|NCT01193920|157474241|FG001|Overall Study|Unable to classify|0|||
48901384|NCT01193920|157474242|FG002|Overall Study|Unable to classify|0|||
48901385|NCT01193920|157474243|FG003|Overall Study|Unable to classify|1|||
48901386|NCT01193920|157474244|FG004|Overall Study|Unable to classify|0|||
48901387|NCT01193920|157474245|FG005|Overall Study|Unable to classify|0|||
48901388|NCT01193920|157474246|FG006|Overall Study|Unable to classify|0|||
48901389|NCT01193920|157474247|FG007|Overall Study|Unable to classify|1|||
48901390|NCT01193920|157474248|FG008|Overall Study|Unable to classify|0|||
48901391|NCT01193920|157474249|FG009|Overall Study|Unable to classify|0|||
48901392|NCT01012739|157474250|FG000|Treatment Period 1|Adverse Event|0|||
48901393|NCT01012739|157474251|FG001|Treatment Period 1|Adverse Event|0|||
48901394|NCT01012739|157474252|FG002|Treatment Period 1|Adverse Event|0|||
48901395|NCT01012739|157474253|FG003|Treatment Period 1|Adverse Event|1|||
48901396|NCT01012739|157474250|FG000|Treatment Period 2|Abnormal test procedure results|0|||
48901397|NCT01012739|157474251|FG001|Treatment Period 2|Abnormal test procedure results|0|||
48901398|NCT01012739|157474252|FG002|Treatment Period 2|Abnormal test procedure results|0|||
48901399|NCT01012739|157474253|FG003|Treatment Period 2|Abnormal test procedure results|1|||
48901400|NCT00252733|157475757|FG000|Overall Study|Withdrawal by Subject|73|||
48901401|NCT00252733|157475758|FG001|Overall Study|Withdrawal by Subject|67|||
48901402|NCT00252733|157475757|FG000|Overall Study|Death|7|||
48901403|NCT00252733|157475758|FG001|Overall Study|Death|5|||
48901404|NCT00252733|157475757|FG000|Overall Study|Lost to Follow-up|12|||
48901405|NCT00252733|157475758|FG001|Overall Study|Lost to Follow-up|6|||
48901406|NCT00252733|157475757|FG000|Overall Study|Multiple Reasons|14|||
48901407|NCT00252733|157475758|FG001|Overall Study|Multiple Reasons|14|||
48901408|NCT00081770|157475759|FG000|Overall Study|Adverse Event|130|||
48901409|NCT00081770|157475760|FG001|Overall Study|Adverse Event|98|||
48901410|NCT00081770|157475761|FG002|Overall Study|Adverse Event|136|||
48901411|NCT00081770|157475759|FG000|Overall Study|Lack of Efficacy|262|||
48901412|NCT00081770|157475760|FG001|Overall Study|Lack of Efficacy|357|||
48692528|NCT01755234|156724520|FG001|Overall Study|Change in surgical case|1|||
48692529|NCT01755234|156724519|FG000|Overall Study|case cancelled|1|||
48692530|NCT01755234|156724520|FG001|Overall Study|case cancelled|0|||
48692531|NCT01755234|156724519|FG000|Overall Study|Withdrawal by Subject|0|||
48692532|NCT01755234|156724520|FG001|Overall Study|Withdrawal by Subject|1|||
48692533|NCT01755234|156724519|FG000|Overall Study|unblinded|1|||
48901413|NCT00081770|157475761|FG002|Overall Study|Lack of Efficacy|211|||
48901414|NCT00081770|157475759|FG000|Overall Study|Lost to Follow-up|45|||
48901415|NCT00081770|157475760|FG001|Overall Study|Lost to Follow-up|34|||
48984782|NCT00082628|157775636|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
48901416|NCT00081770|157475761|FG002|Overall Study|Lost to Follow-up|45|||
48901417|NCT00081770|157475759|FG000|Overall Study|Protocol Violation|15|||
48901418|NCT00081770|157475760|FG001|Overall Study|Protocol Violation|10|||
48901419|NCT00081770|157475761|FG002|Overall Study|Protocol Violation|10|||
48901420|NCT00081770|157475759|FG000|Overall Study|Withdrawal by Subject|45|||
48901421|NCT00081770|157475760|FG001|Overall Study|Withdrawal by Subject|40|||
48901422|NCT00081770|157475761|FG002|Overall Study|Withdrawal by Subject|42|||
48901423|NCT00081770|157475759|FG000|Overall Study|Did not meet protocol eligibility|2|||
48901424|NCT00081770|157475760|FG001|Overall Study|Did not meet protocol eligibility|0|||
48901425|NCT00081770|157475761|FG002|Overall Study|Did not meet protocol eligibility|3|||
48901426|NCT00081770|157475759|FG000|Overall Study|Administrative|1|||
48901427|NCT00081770|157475760|FG001|Overall Study|Administrative|0|||
48901428|NCT00081770|157475761|FG002|Overall Study|Administrative|1|||
48901429|NCT00081770|157475759|FG000|Overall Study|Other|2|||
48901430|NCT00081770|157475760|FG001|Overall Study|Other|7|||
48901431|NCT00081770|157475761|FG002|Overall Study|Other|8|||
48901432|NCT01350336|157475762|FG000|Overall Study|Lost to Follow-up|31|||
48901433|NCT01350336|157475762|FG000|Overall Study|Withdrawal by Subject|14|||
48901434|NCT01350336|157475762|FG000|Overall Study|Physician Decision|8|||
48901435|NCT01350336|157475762|FG000|Overall Study|Death|4|||
48901436|NCT01491672|157475765|FG000|Overall Study|Lost to Follow-up|0|||
48901437|NCT01491672|157475766|FG001|Overall Study|Lost to Follow-up|4|||
48901438|NCT01491672|157475767|FG002|Overall Study|Lost to Follow-up|1|||
48901439|NCT01491672|157475765|FG000|Overall Study|Withdrawal by Subject|6|||
48901440|NCT01491672|157475766|FG001|Overall Study|Withdrawal by Subject|7|||
48901441|NCT01491672|157475767|FG002|Overall Study|Withdrawal by Subject|0|||
48901442|NCT01491672|157475765|FG000|Overall Study|Adverse Event|8|||
48692534|NCT01755234|156724520|FG001|Overall Study|unblinded|0|||
48692535|NCT02322281|156724523|FG000|Overall Study|Progressive Disease|42|||
48901443|NCT01491672|157475766|FG001|Overall Study|Adverse Event|10|||
48901444|NCT01491672|157475767|FG002|Overall Study|Adverse Event|4|||
48901445|NCT01491672|157475765|FG000|Overall Study|Disease progression|42|||
48901446|NCT01491672|157475766|FG001|Overall Study|Disease progression|34|||
48901447|NCT01491672|157475767|FG002|Overall Study|Disease progression|6|||
48901448|NCT01491672|157475765|FG000|Overall Study|Protocol deviation|0|||
48901449|NCT01491672|157475766|FG001|Overall Study|Protocol deviation|1|||
48901450|NCT01491672|157475767|FG002|Overall Study|Protocol deviation|0|||
48901451|NCT01491672|157475765|FG000|Overall Study|Death|0|||
48901452|NCT01491672|157475766|FG001|Overall Study|Death|4|||
48901453|NCT01491672|157475767|FG002|Overall Study|Death|0|||
48901454|NCT03435497|157475768|FG000|Overall Study|Lost to Follow-up|1|||
48901455|NCT03435497|157475769|FG001|Overall Study|Lost to Follow-up|0|||
48901456|NCT03435497|157475768|FG000|Overall Study|Death|1|||
48901457|NCT03435497|157475769|FG001|Overall Study|Death|0|||
48901458|NCT03435497|157475768|FG000|Overall Study|Withdrawal by Subject|0|||
48901459|NCT03435497|157475769|FG001|Overall Study|Withdrawal by Subject|4|||
48901460|NCT03435497|157475768|FG000|Overall Study|Wrong survey administered|0|||
48901461|NCT03435497|157475769|FG001|Overall Study|Wrong survey administered|2|||
48901462|NCT02795429|157475770|FG000|Overall Study|Adverse Event|1|||
48901463|NCT02795429|157475771|FG001|Overall Study|Adverse Event|2|||
48901464|NCT02795429|157475772|FG002|Overall Study|Adverse Event|1|||
48901465|NCT02795429|157475773|FG003|Overall Study|Adverse Event|2|||
48901466|NCT02795429|157475774|FG004|Overall Study|Adverse Event|1|||
48901467|NCT02795429|157475770|FG000|Overall Study|Death|1|||
48901468|NCT02795429|157475771|FG001|Overall Study|Death|0|||
48901469|NCT02795429|157475772|FG002|Overall Study|Death|1|||
48901470|NCT02795429|157475773|FG003|Overall Study|Death|2|||
48901471|NCT02795429|157475774|FG004|Overall Study|Death|1|||
48901472|NCT02795429|157475770|FG000|Overall Study|Physician Decision|0|||
48901473|NCT02795429|157475771|FG001|Overall Study|Physician Decision|0|||
48901474|NCT02795429|157475772|FG002|Overall Study|Physician Decision|2|||
48901475|NCT02795429|157475773|FG003|Overall Study|Physician Decision|1|||
48901476|NCT02795429|157475774|FG004|Overall Study|Physician Decision|5|||
48901477|NCT02795429|157475770|FG000|Overall Study|Progressive disease|3|||
48901478|NCT02795429|157475771|FG001|Overall Study|Progressive disease|7|||
48901479|NCT02795429|157475772|FG002|Overall Study|Progressive disease|6|||
48901480|NCT02795429|157475773|FG003|Overall Study|Progressive disease|26|||
48901481|NCT02795429|157475774|FG004|Overall Study|Progressive disease|20|||
48901482|NCT02795429|157475770|FG000|Overall Study|Subject/guardian decision|1|||
48901483|NCT02795429|157475771|FG001|Overall Study|Subject/guardian decision|1|||
48901484|NCT02795429|157475772|FG002|Overall Study|Subject/guardian decision|1|||
48901485|NCT02795429|157475773|FG003|Overall Study|Subject/guardian decision|1|||
48901486|NCT02795429|157475774|FG004|Overall Study|Subject/guardian decision|3|||
48901487|NCT04281004|157475775|FG000|Overall Study|Physician Decision|1|||
48901488|NCT04281004|157475776|FG001|Overall Study|Physician Decision|0|||
48901489|NCT02079610|157475777|FG000|Overall Study|Withdrawal by Subject|1|||
48901490|NCT02079610|157475778|FG001|Overall Study|Withdrawal by Subject|1|||
48901491|NCT01658150|157475779|FG000|Overall Study|Withdrawal by Subject|1|||
48901492|NCT06023082|157475780|FG000|Overall Study|Withdrawal by Subject|2|||
48984783|NCT00082628|157775637|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
48984784|NCT00082628|157775633|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5|||
48984785|NCT00082628|157775634|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43|||
48984786|NCT00082628|157775635|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
48984787|NCT00082628|157775636|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
48984788|NCT00082628|157775637|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
48984789|NCT00082628|157775633|FG000|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1|||
48984790|NCT00082628|157775634|FG001|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15|||
48984791|NCT00082628|157775635|FG002|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
48984792|NCT00082628|157775636|FG003|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
48984793|NCT00082628|157775637|FG004|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
48984794|NCT00082628|157775633|FG000|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
48984795|NCT00082628|157775634|FG001|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
48984796|NCT00082628|157775635|FG002|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
48984797|NCT00082628|157775636|FG003|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
48984798|NCT00082628|157775637|FG004|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1|||
48984799|NCT00082628|157775633|FG000|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
48984800|NCT00082628|157775634|FG001|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
48984801|NCT00082628|157775635|FG002|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
48984802|NCT00082628|157775636|FG003|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1|||
48984803|NCT00082628|157775637|FG004|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
48984804|NCT00082628|157775633|FG000|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
48901493|NCT06023082|157475780|FG000|Overall Study|Lost to Follow-up|15|||
48901494|NCT06023082|157475780|FG000|Overall Study|Side effects|5|||
48901495|NCT01016977|157475781|FG000|Overall Study|Lost to Follow-up|1|||
48901496|NCT01016977|157475782|FG001|Overall Study|Lost to Follow-up|0|||
48901497|NCT01016977|157475781|FG000|Overall Study|Withdrawal by Subject|2|||
48901498|NCT01016977|157475782|FG001|Overall Study|Withdrawal by Subject|2|||
48901499|NCT03019185|157475787|FG000|Overall Study|Lost to Follow-up|3|||
48901500|NCT03019185|157475788|FG001|Overall Study|Lost to Follow-up|0|||
48984805|NCT00082628|157775634|FG001|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
48984806|NCT00082628|157775635|FG002|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
48984807|NCT00082628|157775636|FG003|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
48984808|NCT00082628|157775637|FG004|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17|||
48984809|NCT01021553|157775638|FG000|Overall Study|Adverse Event|1|||
48984810|NCT01021553|157775639|FG001|Overall Study|Adverse Event|0|||
48984811|NCT01021553|157775640|FG002|Overall Study|Adverse Event|0|||
48984812|NCT01021553|157775638|FG000|Overall Study|Lack of Efficacy|2|||
48984813|NCT01021553|157775639|FG001|Overall Study|Lack of Efficacy|2|||
48984814|NCT01021553|157775640|FG002|Overall Study|Lack of Efficacy|0|||
48984815|NCT01021553|157775638|FG000|Overall Study|Protocol Violation|0|||
48984816|NCT01021553|157775639|FG001|Overall Study|Protocol Violation|2|||
48984817|NCT01021553|157775640|FG002|Overall Study|Protocol Violation|2|||
48984818|NCT01021553|157775638|FG000|Overall Study|Lost to Follow-up|0|||
48984819|NCT01021553|157775639|FG001|Overall Study|Lost to Follow-up|0|||
48984820|NCT01021553|157775640|FG002|Overall Study|Lost to Follow-up|1|||
48984821|NCT01021553|157775638|FG000|Overall Study|Withdrawal by Subject|1|||
48984822|NCT01021553|157775639|FG001|Overall Study|Withdrawal by Subject|1|||
48984823|NCT01021553|157775640|FG002|Overall Study|Withdrawal by Subject|0|||
48984824|NCT00696774|157775641|FG000|Period II|Adverse Event|0|||
48984825|NCT00696774|157775642|FG001|Period II|Adverse Event|0|||
48984826|NCT00696774|157775643|FG002|Period II|Adverse Event|15|||
48984827|NCT00696774|157775641|FG000|Period II|Lost to Follow-up|0|||
48984828|NCT00696774|157775642|FG001|Period II|Lost to Follow-up|0|||
48984829|NCT00696774|157775643|FG002|Period II|Lost to Follow-up|4|||
48984830|NCT00696774|157775641|FG000|Period II|Protocol Violation|0|||
48984831|NCT00696774|157775642|FG001|Period II|Protocol Violation|0|||
48984832|NCT00696774|157775643|FG002|Period II|Protocol Violation|11|||
48984833|NCT00696774|157775641|FG000|Period II|Withdrawal by Subject|0|||
48984834|NCT00696774|157775642|FG001|Period II|Withdrawal by Subject|0|||
48984835|NCT00696774|157775643|FG002|Period II|Withdrawal by Subject|4|||
48984836|NCT00696774|157775641|FG000|Period II|Sponsor Decision|0|||
48984837|NCT00696774|157775642|FG001|Period II|Sponsor Decision|0|||
48984838|NCT00696774|157775643|FG002|Period II|Sponsor Decision|0|||
48984839|NCT00696774|157775641|FG000|Period II|Lack of Efficacy|0|||
48984840|NCT00696774|157775642|FG001|Period II|Lack of Efficacy|0|||
48984841|NCT00696774|157775643|FG002|Period II|Lack of Efficacy|2|||
48984842|NCT00696774|157775641|FG000|Period III|Adverse Event|1|||
48984843|NCT00696774|157775642|FG001|Period III|Adverse Event|1|||
48984844|NCT00696774|157775643|FG002|Period III|Adverse Event|0|||
48984845|NCT00696774|157775641|FG000|Period III|Lost to Follow-up|2|||
48984846|NCT00696774|157775642|FG001|Period III|Lost to Follow-up|1|||
48984847|NCT00696774|157775643|FG002|Period III|Lost to Follow-up|0|||
48984848|NCT00696774|157775641|FG000|Period III|Protocol Violation|1|||
48984849|NCT00696774|157775642|FG001|Period III|Protocol Violation|1|||
49042071|NCT00112437|157987590|FG002|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
49042072|NCT00112437|157987591|FG003|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
49042073|NCT00112437|157987592|FG004|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
49042074|NCT00112437|157987593|FG005|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
49042075|NCT00112437|157987594|FG006|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
49042076|NCT00112437|157987595|FG007|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
49042077|NCT00112437|157987596|FG008|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
49042078|NCT00112437|157987597|FG009|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
49042079|NCT00112437|157987598|FG010|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
49042080|NCT00112437|157987599|FG011|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
49042081|NCT00112437|157987600|FG012|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
49042082|NCT00112437|157987601|FG013|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
49042083|NCT00112437|157987602|FG014|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
49042084|NCT00112437|157987603|FG015|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
49042085|NCT00112437|157987604|FG016|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
48984850|NCT00696774|157775643|FG002|Period III|Protocol Violation|0|||
48984851|NCT00696774|157775641|FG000|Period III|Withdrawal by Subject|1|||
48984852|NCT00696774|157775642|FG001|Period III|Withdrawal by Subject|2|||
48984853|NCT00696774|157775643|FG002|Period III|Withdrawal by Subject|0|||
48984854|NCT00696774|157775641|FG000|Period III|Sponsor Decision|2|||
48984855|NCT00696774|157775642|FG001|Period III|Sponsor Decision|0|||
48984856|NCT00696774|157775643|FG002|Period III|Sponsor Decision|0|||
48984857|NCT00696774|157775641|FG000|Period III|Lack of Efficacy|0|||
48984858|NCT00696774|157775642|FG001|Period III|Lack of Efficacy|2|||
48984859|NCT00696774|157775643|FG002|Period III|Lack of Efficacy|0|||
48984860|NCT03481634|157775644|FG000|Overall Study|Withdrawal by Subject|16|||
48984861|NCT03481634|157775645|FG001|Overall Study|Withdrawal by Subject|19|||
48984862|NCT03481634|157775646|FG002|Overall Study|Withdrawal by Subject|14|||
48984863|NCT03481634|157775644|FG000|Overall Study|Protocol Violation|1|||
49042086|NCT00112437|157987605|FG017|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
49042087|NCT00112437|157987606|FG018|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
49042088|NCT00112437|157987607|FG019|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
49042089|NCT00112437|157987608|FG020|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1|||
49042090|NCT00112437|157987609|FG021|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
49042091|NCT00112437|157987610|FG022|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
49042092|NCT00112437|157987611|FG023|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
49042093|NCT00112437|157987612|FG024|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
49042094|NCT00112437|157987613|FG025|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
49042095|NCT00112437|157987588|FG000|Years 4-5 (24-Month Extension)|Adverse Event|0|||
49042096|NCT00112437|157987589|FG001|Years 4-5 (24-Month Extension)|Adverse Event|0|||
49042097|NCT00112437|157987590|FG002|Years 4-5 (24-Month Extension)|Adverse Event|0|||
49042098|NCT00112437|157987591|FG003|Years 4-5 (24-Month Extension)|Adverse Event|0|||
49042099|NCT00112437|157987592|FG004|Years 4-5 (24-Month Extension)|Adverse Event|0|||
49042100|NCT00112437|157987593|FG005|Years 4-5 (24-Month Extension)|Adverse Event|0|||
49042101|NCT00112437|157987594|FG006|Years 4-5 (24-Month Extension)|Adverse Event|0|||
49042102|NCT00112437|157987595|FG007|Years 4-5 (24-Month Extension)|Adverse Event|0|||
49042103|NCT00112437|157987596|FG008|Years 4-5 (24-Month Extension)|Adverse Event|0|||
49042104|NCT00112437|157987597|FG009|Years 4-5 (24-Month Extension)|Adverse Event|0|||
49042105|NCT00112437|157987598|FG010|Years 4-5 (24-Month Extension)|Adverse Event|0|||
49042106|NCT00112437|157987599|FG011|Years 4-5 (24-Month Extension)|Adverse Event|0|||
49042107|NCT00112437|157987600|FG012|Years 4-5 (24-Month Extension)|Adverse Event|0|||
49042108|NCT00112437|157987601|FG013|Years 4-5 (24-Month Extension)|Adverse Event|0|||
49042109|NCT00112437|157987602|FG014|Years 4-5 (24-Month Extension)|Adverse Event|0|||
49042110|NCT00112437|157987603|FG015|Years 4-5 (24-Month Extension)|Adverse Event|0|||
49042111|NCT00112437|157987604|FG016|Years 4-5 (24-Month Extension)|Adverse Event|0|||
49042112|NCT00112437|157987605|FG017|Years 4-5 (24-Month Extension)|Adverse Event|0|||
49042113|NCT00112437|157987606|FG018|Years 4-5 (24-Month Extension)|Adverse Event|0|||
49042114|NCT00112437|157987607|FG019|Years 4-5 (24-Month Extension)|Adverse Event|0|||
49042115|NCT00112437|157987608|FG020|Years 4-5 (24-Month Extension)|Adverse Event|0|||
49042116|NCT00112437|157987609|FG021|Years 4-5 (24-Month Extension)|Adverse Event|4|||
49042117|NCT00112437|157987610|FG022|Years 4-5 (24-Month Extension)|Adverse Event|0|||
49042118|NCT00112437|157987611|FG023|Years 4-5 (24-Month Extension)|Adverse Event|0|||
49042119|NCT00112437|157987612|FG024|Years 4-5 (24-Month Extension)|Adverse Event|0|||
49042120|NCT00112437|157987613|FG025|Years 4-5 (24-Month Extension)|Adverse Event|0|||
49042121|NCT00112437|157987588|FG000|Years 4-5 (24-Month Extension)|Participant moved|0|||
49042122|NCT00112437|157987589|FG001|Years 4-5 (24-Month Extension)|Participant moved|0|||
49042123|NCT00112437|157987590|FG002|Years 4-5 (24-Month Extension)|Participant moved|0|||
49042124|NCT00112437|157987591|FG003|Years 4-5 (24-Month Extension)|Participant moved|0|||
49042125|NCT00112437|157987592|FG004|Years 4-5 (24-Month Extension)|Participant moved|0|||
49042126|NCT00112437|157987593|FG005|Years 4-5 (24-Month Extension)|Participant moved|0|||
49042127|NCT00112437|157987594|FG006|Years 4-5 (24-Month Extension)|Participant moved|0|||
49042128|NCT00112437|157987595|FG007|Years 4-5 (24-Month Extension)|Participant moved|0|||
48984864|NCT03481634|157775645|FG001|Overall Study|Protocol Violation|0|||
48984865|NCT03481634|157775646|FG002|Overall Study|Protocol Violation|1|||
48984866|NCT03481634|157775644|FG000|Overall Study|Progressive disease|0|||
48984867|NCT03481634|157775645|FG001|Overall Study|Progressive disease|1|||
48984868|NCT03481634|157775646|FG002|Overall Study|Progressive disease|0|||
48984869|NCT03481634|157775644|FG000|Overall Study|Physician Decision|3|||
48984870|NCT03481634|157775645|FG001|Overall Study|Physician Decision|0|||
48984871|NCT03481634|157775646|FG002|Overall Study|Physician Decision|1|||
48984872|NCT03481634|157775644|FG000|Overall Study|Lost to Follow-up|3|||
48984873|NCT03481634|157775645|FG001|Overall Study|Lost to Follow-up|4|||
48984874|NCT03481634|157775646|FG002|Overall Study|Lost to Follow-up|4|||
48984875|NCT03481634|157775644|FG000|Overall Study|Death|4|||
48984876|NCT03481634|157775645|FG001|Overall Study|Death|8|||
48984877|NCT03481634|157775646|FG002|Overall Study|Death|7|||
48984878|NCT03481634|157775644|FG000|Overall Study|Adverse Event|6|||
48984879|NCT03481634|157775645|FG001|Overall Study|Adverse Event|3|||
48984880|NCT03481634|157775646|FG002|Overall Study|Adverse Event|7|||
48984881|NCT00890201|157775647|FG000|Overall Study|Protocol Violation|5|||
49042129|NCT00112437|157987596|FG008|Years 4-5 (24-Month Extension)|Participant moved|0|||
49042130|NCT00112437|157987597|FG009|Years 4-5 (24-Month Extension)|Participant moved|0|||
49042131|NCT00112437|157987598|FG010|Years 4-5 (24-Month Extension)|Participant moved|0|||
49042132|NCT00112437|157987599|FG011|Years 4-5 (24-Month Extension)|Participant moved|0|||
49042133|NCT00112437|157987600|FG012|Years 4-5 (24-Month Extension)|Participant moved|0|||
49042134|NCT00112437|157987601|FG013|Years 4-5 (24-Month Extension)|Participant moved|0|||
49042135|NCT00112437|157987602|FG014|Years 4-5 (24-Month Extension)|Participant moved|0|||
48984882|NCT00890201|157775648|FG001|Overall Study|Protocol Violation|56|||
48984883|NCT00942422|157775649|FG000|Overall Study|Withdrawal by Subject|1|||
48984884|NCT00942422|157775649|FG000|Overall Study|Death|1|||
48984885|NCT00942422|157775649|FG000|Overall Study|Progressive diease|1|||
48984886|NCT02975206|157775652|FG000|Overall Study|Withdrawal by Subject|14|||
48984887|NCT02975206|157775653|FG001|Overall Study|Withdrawal by Subject|11|||
48984888|NCT02975206|157775654|FG002|Overall Study|Withdrawal by Subject|11|||
48984889|NCT02975206|157775652|FG000|Overall Study|Other (e.g., lost to follow up)|13|||
48984890|NCT02975206|157775653|FG001|Overall Study|Other (e.g., lost to follow up)|6|||
48984891|NCT02975206|157775654|FG002|Overall Study|Other (e.g., lost to follow up)|6|||
48984892|NCT00866606|157775655|FG000|Overall Study|Lost to Follow-up|3|||
48984893|NCT00866606|157775655|FG000|Overall Study|Adverse Event|1|||
48984894|NCT01058356|157775660|FG000|Overall Study|Adverse Event|5|||
48984895|NCT01058356|157775660|FG000|Overall Study|Administration of contraindicated drugs|12|||
48984896|NCT01058356|157775660|FG000|Overall Study|Withdrawal by Subject|21|||
48984897|NCT01058356|157775660|FG000|Overall Study|Lost to Follow-up|4|||
48984898|NCT01682759|157775661|FG000|Overall Study|Death|2|||
48984899|NCT01682759|157775662|FG001|Overall Study|Death|1|||
48984900|NCT01682759|157775661|FG000|Overall Study|Lost to Follow-up|10|||
48984901|NCT01682759|157775662|FG001|Overall Study|Lost to Follow-up|13|||
48984902|NCT01682759|157775661|FG000|Overall Study|Physician Decision|1|||
48984903|NCT01682759|157775662|FG001|Overall Study|Physician Decision|1|||
48984904|NCT01682759|157775661|FG000|Overall Study|Withdrawal by Subject|56|||
48984905|NCT01682759|157775662|FG001|Overall Study|Withdrawal by Subject|55|||
48984906|NCT00397891|157775663|FG000|Overall Study|Withdrawal by Subject|1|||
48984907|NCT00397891|157775664|FG001|Overall Study|Withdrawal by Subject|0|||
48984908|NCT00397891|157775665|FG002|Overall Study|Withdrawal by Subject|0|||
48984909|NCT00397891|157775666|FG003|Overall Study|Withdrawal by Subject|0|||
48984910|NCT00397891|157775667|FG004|Overall Study|Withdrawal by Subject|1|||
48984911|NCT00392210|157775670|FG000|First Voiding Trial|Physician Decision|2|||
48984912|NCT00392210|157775671|FG001|First Voiding Trial|Physician Decision|2|||
48984913|NCT01362049|157775674|FG000|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
48984914|NCT01362049|157775675|FG001|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
48984915|NCT01362049|157775676|FG002|Follow-Up at 7 Weeks|Lost to Follow-up|2|||
48984916|NCT01362049|157775677|FG003|Follow-Up at 7 Weeks|Lost to Follow-up|1|||
48984917|NCT01362049|157775674|FG000|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5|||
48984918|NCT01362049|157775675|FG001|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
48984919|NCT01362049|157775676|FG002|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2|||
48984920|NCT01362049|157775677|FG003|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
48984921|NCT02098733|157775679|FG000|Overall Study|Data Not Available|5|||
48984922|NCT02098733|157775679|FG000|Overall Study|Lost to Follow-up|5|||
48984923|NCT02442765|157775685|FG000|Stage 2- (Days 43 to 85)|Adverse Event|0|||
48984924|NCT02442765|157775686|FG001|Stage 2- (Days 43 to 85)|Adverse Event|0|||
48984925|NCT02442765|157775687|FG002|Stage 2- (Days 43 to 85)|Adverse Event|0|||
48984926|NCT02442765|157775688|FG003|Stage 2- (Days 43 to 85)|Adverse Event|2|||
48984927|NCT02442765|157775689|FG004|Stage 2- (Days 43 to 85)|Adverse Event|6|||
48984928|NCT02442765|157775690|FG005|Stage 2- (Days 43 to 85)|Adverse Event|1|||
48984929|NCT02442765|157775691|FG006|Stage 2- (Days 43 to 85)|Adverse Event|1|||
48984930|NCT02442765|157775692|FG007|Stage 2- (Days 43 to 85)|Adverse Event|5|||
48984931|NCT02442765|157775685|FG000|Stage 2- (Days 43 to 85)|Death|0|||
48984932|NCT02442765|157775686|FG001|Stage 2- (Days 43 to 85)|Death|0|||
48984933|NCT02442765|157775687|FG002|Stage 2- (Days 43 to 85)|Death|0|||
48984934|NCT02442765|157775688|FG003|Stage 2- (Days 43 to 85)|Death|1|||
48984935|NCT02442765|157775689|FG004|Stage 2- (Days 43 to 85)|Death|1|||
48984936|NCT02442765|157775690|FG005|Stage 2- (Days 43 to 85)|Death|0|||
48984937|NCT02442765|157775691|FG006|Stage 2- (Days 43 to 85)|Death|2|||
48984938|NCT02442765|157775692|FG007|Stage 2- (Days 43 to 85)|Death|0|||
48984939|NCT02442765|157775685|FG000|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
48984940|NCT02442765|157775686|FG001|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
48984941|NCT02442765|157775687|FG002|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
48984942|NCT02442765|157775688|FG003|Stage 2- (Days 43 to 85)|Lack of Efficacy|1|||
48984943|NCT02442765|157775689|FG004|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
48984944|NCT02442765|157775690|FG005|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
48984945|NCT02442765|157775691|FG006|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
48984946|NCT02442765|157775692|FG007|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
48984947|NCT02442765|157775685|FG000|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
48984948|NCT02442765|157775686|FG001|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
48984949|NCT02442765|157775687|FG002|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
48984950|NCT02442765|157775688|FG003|Stage 2- (Days 43 to 85)|Protocol Deviation|1|||
48984951|NCT02442765|157775689|FG004|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
48984952|NCT02442765|157775690|FG005|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
48984953|NCT02442765|157775691|FG006|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
48984954|NCT02442765|157775692|FG007|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
48984955|NCT02442765|157775685|FG000|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
48984956|NCT02442765|157775686|FG001|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
48984957|NCT02442765|157775687|FG002|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
48984958|NCT02442765|157775688|FG003|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
49042136|NCT00112437|157987603|FG015|Years 4-5 (24-Month Extension)|Participant moved|0|||
49042137|NCT00112437|157987604|FG016|Years 4-5 (24-Month Extension)|Participant moved|0|||
49042138|NCT00112437|157987605|FG017|Years 4-5 (24-Month Extension)|Participant moved|0|||
49042139|NCT00112437|157987606|FG018|Years 4-5 (24-Month Extension)|Participant moved|0|||
49042140|NCT00112437|157987607|FG019|Years 4-5 (24-Month Extension)|Participant moved|0|||
49042141|NCT00112437|157987608|FG020|Years 4-5 (24-Month Extension)|Participant moved|0|||
49042142|NCT00112437|157987609|FG021|Years 4-5 (24-Month Extension)|Participant moved|1|||
49042143|NCT00112437|157987610|FG022|Years 4-5 (24-Month Extension)|Participant moved|0|||
49042144|NCT00112437|157987611|FG023|Years 4-5 (24-Month Extension)|Participant moved|0|||
49042145|NCT00112437|157987612|FG024|Years 4-5 (24-Month Extension)|Participant moved|0|||
48901501|NCT03019185|157475789|FG002|Overall Study|Lost to Follow-up|2|||
48901502|NCT03019185|157475787|FG000|Overall Study|Withdrawal by Subject|1|||
48901503|NCT03019185|157475788|FG001|Overall Study|Withdrawal by Subject|1|||
48901504|NCT03019185|157475789|FG002|Overall Study|Withdrawal by Subject|0|||
48901505|NCT03019185|157475787|FG000|Overall Study|Inability to continue due to increased serum creatinine|1|||
48901506|NCT03019185|157475788|FG001|Overall Study|Inability to continue due to increased serum creatinine|0|||
48901507|NCT03019185|157475789|FG002|Overall Study|Inability to continue due to increased serum creatinine|0|||
48901508|NCT03019185|157475787|FG000|Overall Study|ESKD Resulting in Kidney Transplant|1|||
48901509|NCT03019185|157475788|FG001|Overall Study|ESKD Resulting in Kidney Transplant|0|||
48901510|NCT03019185|157475789|FG002|Overall Study|ESKD Resulting in Kidney Transplant|0|||
48901511|NCT03907410|157475790|FG000|Overall Study|Lost to Follow-up|4|||
48901512|NCT03907410|157475791|FG001|Overall Study|Lost to Follow-up|1|||
48901513|NCT03907410|157475792|FG002|Overall Study|Lost to Follow-up|1|||
48901514|NCT03907410|157475790|FG000|Overall Study|Lost to follow-up and research burden|0|||
48901515|NCT03907410|157475791|FG001|Overall Study|Lost to follow-up and research burden|0|||
48901516|NCT03907410|157475792|FG002|Overall Study|Lost to follow-up and research burden|1|||
48901517|NCT04335812|157475793|FG000|Overall Study|Withdrawal by Subject|1|||
48901518|NCT04335812|157475794|FG001|Overall Study|Withdrawal by Subject|3|||
48901519|NCT04335812|157475793|FG000|Overall Study|Lost to Follow-up|12|||
48901520|NCT04335812|157475794|FG001|Overall Study|Lost to Follow-up|12|||
48901521|NCT04335812|157475793|FG000|Overall Study|Did not engage in the intervention|22|||
48901522|NCT04335812|157475794|FG001|Overall Study|Did not engage in the intervention|18|||
48901523|NCT02768870|157475795|FG000|Overall Study|Death|1|||
48901524|NCT02768870|157475795|FG000|Overall Study|Reoperation|6|||
48901525|NCT02768870|157475795|FG000|Overall Study|Lost to Follow-up|1|||
48901526|NCT02768870|157475795|FG000|Overall Study|Exit|4|||
48901527|NCT00343252|157475796|FG000|6 Months (All Treated Participants)|Adverse Event|17|||
48901528|NCT00343252|157475797|FG001|6 Months (All Treated Participants)|Adverse Event|11|||
48901529|NCT00343252|157475796|FG000|6 Months (All Treated Participants)|Death|0|||
48901530|NCT00343252|157475797|FG001|6 Months (All Treated Participants)|Death|2|||
48901531|NCT00343252|157475796|FG000|6 Months (All Treated Participants)|Entry Criteria Not Met|10|||
48901532|NCT00343252|157475797|FG001|6 Months (All Treated Participants)|Entry Criteria Not Met|8|||
48901533|NCT00343252|157475796|FG000|6 Months (All Treated Participants)|Lack of Efficacy|0|||
48901534|NCT00343252|157475797|FG001|6 Months (All Treated Participants)|Lack of Efficacy|1|||
48901535|NCT00343252|157475796|FG000|6 Months (All Treated Participants)|Lost to Follow-up|0|||
48901536|NCT00343252|157475797|FG001|6 Months (All Treated Participants)|Lost to Follow-up|4|||
48901537|NCT00343252|157475796|FG000|6 Months (All Treated Participants)|Physician Decision|1|||
48901538|NCT00343252|157475797|FG001|6 Months (All Treated Participants)|Physician Decision|3|||
48901539|NCT00343252|157475796|FG000|6 Months (All Treated Participants)|Protocol Violation|2|||
48901540|NCT00343252|157475797|FG001|6 Months (All Treated Participants)|Protocol Violation|2|||
48901541|NCT00343252|157475796|FG000|6 Months (All Treated Participants)|Sponsor Decision|7|||
48901542|NCT00343252|157475797|FG001|6 Months (All Treated Participants)|Sponsor Decision|4|||
48901543|NCT00343252|157475796|FG000|6 Months (All Treated Participants)|Withdrawal by Subject|19|||
48901544|NCT00343252|157475797|FG001|6 Months (All Treated Participants)|Withdrawal by Subject|9|||
48901545|NCT00343252|157475796|FG000|12 Months (All Treated Participants)|Adverse Event|22|||
48901546|NCT00343252|157475797|FG001|12 Months (All Treated Participants)|Adverse Event|20|||
48901547|NCT00343252|157475796|FG000|12 Months (All Treated Participants)|Death|3|||
48901548|NCT00343252|157475797|FG001|12 Months (All Treated Participants)|Death|3|||
48901549|NCT00343252|157475796|FG000|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
48901550|NCT00343252|157475797|FG001|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
48901551|NCT00343252|157475796|FG000|12 Months (All Treated Participants)|Lack of Efficacy|1|||
48901552|NCT00343252|157475797|FG001|12 Months (All Treated Participants)|Lack of Efficacy|1|||
48901553|NCT00343252|157475796|FG000|12 Months (All Treated Participants)|Lost to Follow-up|1|||
48901554|NCT00343252|157475797|FG001|12 Months (All Treated Participants)|Lost to Follow-up|5|||
48901555|NCT00343252|157475796|FG000|12 Months (All Treated Participants)|Physician Decision|4|||
48901556|NCT00343252|157475797|FG001|12 Months (All Treated Participants)|Physician Decision|5|||
48901557|NCT00343252|157475796|FG000|12 Months (All Treated Participants)|Protocol Violation|3|||
48901558|NCT00343252|157475797|FG001|12 Months (All Treated Participants)|Protocol Violation|2|||
48901559|NCT00343252|157475796|FG000|12 Months (All Treated Participants)|Sponsor Decision|9|||
48901560|NCT00343252|157475797|FG001|12 Months (All Treated Participants)|Sponsor Decision|6|||
48901561|NCT00343252|157475796|FG000|12 Months (All Treated Participants)|Withdrawal by Subject|33|||
48901562|NCT00343252|157475797|FG001|12 Months (All Treated Participants)|Withdrawal by Subject|17|||
48901563|NCT00343252|157475796|FG000|18 Months (All Treated Participants)|Adverse Event|31|||
48901564|NCT00343252|157475797|FG001|18 Months (All Treated Participants)|Adverse Event|23|||
48901565|NCT00343252|157475796|FG000|18 Months (All Treated Participants)|Death|4|||
48901566|NCT00343252|157475797|FG001|18 Months (All Treated Participants)|Death|5|||
48901567|NCT00343252|157475796|FG000|18 Months (All Treated Participants)|Entry Criteria Not Met|11|||
48901568|NCT00343252|157475797|FG001|18 Months (All Treated Participants)|Entry Criteria Not Met|10|||
48901569|NCT00343252|157475796|FG000|18 Months (All Treated Participants)|Lack of Efficacy|1|||
48901570|NCT00343252|157475797|FG001|18 Months (All Treated Participants)|Lack of Efficacy|1|||
48901571|NCT00343252|157475796|FG000|18 Months (All Treated Participants)|Lost to Follow-up|3|||
48901572|NCT00343252|157475797|FG001|18 Months (All Treated Participants)|Lost to Follow-up|7|||
48901573|NCT00343252|157475796|FG000|18 Months (All Treated Participants)|Physician Decision|4|||
48901574|NCT00343252|157475797|FG001|18 Months (All Treated Participants)|Physician Decision|7|||
48901575|NCT00343252|157475796|FG000|18 Months (All Treated Participants)|Protocol Violation|3|||
48901576|NCT00343252|157475797|FG001|18 Months (All Treated Participants)|Protocol Violation|3|||
48901577|NCT00343252|157475796|FG000|18 Months (All Treated Participants)|Sponsor Decision|8|||
49042146|NCT00112437|157987613|FG025|Years 4-5 (24-Month Extension)|Participant moved|0|||
49042147|NCT00112437|157987588|FG000|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
49042148|NCT00112437|157987589|FG001|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
49042149|NCT00112437|157987590|FG002|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
49042150|NCT00112437|157987591|FG003|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
49042151|NCT00112437|157987592|FG004|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
49042152|NCT00112437|157987593|FG005|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
49042153|NCT00112437|157987594|FG006|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
49042154|NCT00112437|157987595|FG007|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
49042155|NCT00112437|157987596|FG008|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
49042156|NCT00112437|157987597|FG009|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
49042157|NCT00112437|157987598|FG010|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
48901578|NCT00343252|157475797|FG001|18 Months (All Treated Participants)|Sponsor Decision|5|||
49042158|NCT00112437|157987599|FG011|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
49042159|NCT00112437|157987600|FG012|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
49042160|NCT00112437|157987601|FG013|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
49042161|NCT00112437|157987602|FG014|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
49042162|NCT00112437|157987603|FG015|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
49042163|NCT00112437|157987604|FG016|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
49042164|NCT00112437|157987605|FG017|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
49042165|NCT00112437|157987606|FG018|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
49042166|NCT00112437|157987607|FG019|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
49042167|NCT00112437|157987608|FG020|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1|||
49042168|NCT00112437|157987609|FG021|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2|||
49042169|NCT00112437|157987610|FG022|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
49042170|NCT00112437|157987611|FG023|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
49042171|NCT00112437|157987612|FG024|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
49042172|NCT00112437|157987613|FG025|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
49042173|NCT00112437|157987588|FG000|Years 6-10 (60-Month Extension)|Adverse Event|0|||
49042174|NCT00112437|157987589|FG001|Years 6-10 (60-Month Extension)|Adverse Event|0|||
49042175|NCT00112437|157987590|FG002|Years 6-10 (60-Month Extension)|Adverse Event|0|||
49042176|NCT00112437|157987591|FG003|Years 6-10 (60-Month Extension)|Adverse Event|0|||
49042177|NCT00112437|157987592|FG004|Years 6-10 (60-Month Extension)|Adverse Event|0|||
49042178|NCT00112437|157987593|FG005|Years 6-10 (60-Month Extension)|Adverse Event|0|||
49042179|NCT00112437|157987594|FG006|Years 6-10 (60-Month Extension)|Adverse Event|0|||
49042180|NCT00112437|157987595|FG007|Years 6-10 (60-Month Extension)|Adverse Event|0|||
49042181|NCT00112437|157987596|FG008|Years 6-10 (60-Month Extension)|Adverse Event|0|||
49042182|NCT00112437|157987597|FG009|Years 6-10 (60-Month Extension)|Adverse Event|0|||
49042183|NCT00112437|157987598|FG010|Years 6-10 (60-Month Extension)|Adverse Event|0|||
49042184|NCT00112437|157987599|FG011|Years 6-10 (60-Month Extension)|Adverse Event|0|||
49042185|NCT00112437|157987600|FG012|Years 6-10 (60-Month Extension)|Adverse Event|0|||
49042186|NCT00112437|157987601|FG013|Years 6-10 (60-Month Extension)|Adverse Event|0|||
49042187|NCT00112437|157987602|FG014|Years 6-10 (60-Month Extension)|Adverse Event|0|||
49042188|NCT00112437|157987603|FG015|Years 6-10 (60-Month Extension)|Adverse Event|0|||
48901579|NCT00343252|157475796|FG000|18 Months (All Treated Participants)|Withdrawal by Subject|36|||
48901580|NCT00343252|157475797|FG001|18 Months (All Treated Participants)|Withdrawal by Subject|20|||
48901581|NCT01003990|157475800|FG000|Overall Study|Adverse Event|8|||
48901582|NCT01003990|157475801|FG001|Overall Study|Adverse Event|5|||
49042189|NCT00112437|157987604|FG016|Years 6-10 (60-Month Extension)|Adverse Event|0|||
49042190|NCT00112437|157987605|FG017|Years 6-10 (60-Month Extension)|Adverse Event|0|||
49042191|NCT00112437|157987606|FG018|Years 6-10 (60-Month Extension)|Adverse Event|0|||
49042192|NCT00112437|157987607|FG019|Years 6-10 (60-Month Extension)|Adverse Event|0|||
49042193|NCT00112437|157987608|FG020|Years 6-10 (60-Month Extension)|Adverse Event|0|||
49042194|NCT00112437|157987609|FG021|Years 6-10 (60-Month Extension)|Adverse Event|0|||
49042195|NCT00112437|157987610|FG022|Years 6-10 (60-Month Extension)|Adverse Event|1|||
49042196|NCT00112437|157987611|FG023|Years 6-10 (60-Month Extension)|Adverse Event|2|||
49042197|NCT00112437|157987612|FG024|Years 6-10 (60-Month Extension)|Adverse Event|0|||
49042198|NCT00112437|157987613|FG025|Years 6-10 (60-Month Extension)|Adverse Event|1|||
49042199|NCT00112437|157987588|FG000|Years 6-10 (60-Month Extension)|Death|0|||
49042200|NCT00112437|157987589|FG001|Years 6-10 (60-Month Extension)|Death|0|||
49042201|NCT00112437|157987590|FG002|Years 6-10 (60-Month Extension)|Death|0|||
49042202|NCT00112437|157987591|FG003|Years 6-10 (60-Month Extension)|Death|0|||
49042203|NCT00112437|157987592|FG004|Years 6-10 (60-Month Extension)|Death|0|||
49042204|NCT00112437|157987593|FG005|Years 6-10 (60-Month Extension)|Death|0|||
49042205|NCT00112437|157987594|FG006|Years 6-10 (60-Month Extension)|Death|0|||
49042206|NCT00112437|157987595|FG007|Years 6-10 (60-Month Extension)|Death|0|||
49042207|NCT00112437|157987596|FG008|Years 6-10 (60-Month Extension)|Death|0|||
49042208|NCT00112437|157987597|FG009|Years 6-10 (60-Month Extension)|Death|0|||
49042209|NCT00112437|157987598|FG010|Years 6-10 (60-Month Extension)|Death|0|||
49042210|NCT00112437|157987599|FG011|Years 6-10 (60-Month Extension)|Death|0|||
49042211|NCT00112437|157987600|FG012|Years 6-10 (60-Month Extension)|Death|0|||
49042212|NCT00112437|157987601|FG013|Years 6-10 (60-Month Extension)|Death|0|||
49042213|NCT00112437|157987602|FG014|Years 6-10 (60-Month Extension)|Death|0|||
49042214|NCT00112437|157987603|FG015|Years 6-10 (60-Month Extension)|Death|0|||
49042215|NCT00112437|157987604|FG016|Years 6-10 (60-Month Extension)|Death|0|||
49042216|NCT00112437|157987605|FG017|Years 6-10 (60-Month Extension)|Death|0|||
49042217|NCT00112437|157987606|FG018|Years 6-10 (60-Month Extension)|Death|0|||
49042218|NCT00112437|157987607|FG019|Years 6-10 (60-Month Extension)|Death|0|||
49042219|NCT00112437|157987608|FG020|Years 6-10 (60-Month Extension)|Death|0|||
49042220|NCT00112437|157987609|FG021|Years 6-10 (60-Month Extension)|Death|0|||
49042221|NCT00112437|157987610|FG022|Years 6-10 (60-Month Extension)|Death|0|||
49042222|NCT00112437|157987611|FG023|Years 6-10 (60-Month Extension)|Death|2|||
49042223|NCT00112437|157987612|FG024|Years 6-10 (60-Month Extension)|Death|0|||
49042224|NCT00112437|157987613|FG025|Years 6-10 (60-Month Extension)|Death|0|||
49042225|NCT00112437|157987588|FG000|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
49042226|NCT00112437|157987589|FG001|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
49042227|NCT00112437|157987590|FG002|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
49042228|NCT00112437|157987591|FG003|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
49042229|NCT00112437|157987592|FG004|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
49042230|NCT00112437|157987593|FG005|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
49042231|NCT00112437|157987594|FG006|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
49042232|NCT00112437|157987595|FG007|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
49042233|NCT00112437|157987596|FG008|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
49042234|NCT00112437|157987597|FG009|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
49042235|NCT00112437|157987598|FG010|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
49042236|NCT00112437|157987599|FG011|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
49042237|NCT00112437|157987600|FG012|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
49042238|NCT00112437|157987601|FG013|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
49042239|NCT00112437|157987602|FG014|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
49042240|NCT00112437|157987603|FG015|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
49042241|NCT00112437|157987604|FG016|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
49042242|NCT00112437|157987605|FG017|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
49042243|NCT00112437|157987606|FG018|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
49042244|NCT00112437|157987607|FG019|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
49042245|NCT00112437|157987608|FG020|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
49042246|NCT00112437|157987609|FG021|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
49042247|NCT00112437|157987610|FG022|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
49042248|NCT00112437|157987611|FG023|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
49042249|NCT00112437|157987612|FG024|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
49042250|NCT00112437|157987613|FG025|Years 6-10 (60-Month Extension)|Lost to Follow-up|1|||
49042251|NCT00112437|157987588|FG000|Years 6-10 (60-Month Extension)|Other|0|||
49042252|NCT00112437|157987589|FG001|Years 6-10 (60-Month Extension)|Other|0|||
49042253|NCT00112437|157987590|FG002|Years 6-10 (60-Month Extension)|Other|0|||
49042254|NCT00112437|157987591|FG003|Years 6-10 (60-Month Extension)|Other|0|||
49042255|NCT00112437|157987592|FG004|Years 6-10 (60-Month Extension)|Other|0|||
49042256|NCT00112437|157987593|FG005|Years 6-10 (60-Month Extension)|Other|0|||
49042257|NCT00112437|157987594|FG006|Years 6-10 (60-Month Extension)|Other|0|||
49042258|NCT00112437|157987595|FG007|Years 6-10 (60-Month Extension)|Other|0|||
49042259|NCT00112437|157987596|FG008|Years 6-10 (60-Month Extension)|Other|0|||
49042260|NCT00112437|157987597|FG009|Years 6-10 (60-Month Extension)|Other|0|||
49042261|NCT00112437|157987598|FG010|Years 6-10 (60-Month Extension)|Other|0|||
49042262|NCT00112437|157987599|FG011|Years 6-10 (60-Month Extension)|Other|0|||
49042263|NCT00112437|157987600|FG012|Years 6-10 (60-Month Extension)|Other|0|||
48901583|NCT01003990|157475802|FG002|Overall Study|Adverse Event|11|||
48901584|NCT01003990|157475800|FG000|Overall Study|Death|0|||
48901585|NCT01003990|157475801|FG001|Overall Study|Death|8|||
48901586|NCT01003990|157475802|FG002|Overall Study|Death|1|||
48901587|NCT01003990|157475800|FG000|Overall Study|Lack of Efficacy|10|||
48901588|NCT01003990|157475801|FG001|Overall Study|Lack of Efficacy|2|||
48901589|NCT01003990|157475802|FG002|Overall Study|Lack of Efficacy|3|||
48901590|NCT01003990|157475800|FG000|Overall Study|Lost to Follow-up|30|||
48901591|NCT01003990|157475801|FG001|Overall Study|Lost to Follow-up|12|||
48901592|NCT01003990|157475802|FG002|Overall Study|Lost to Follow-up|7|||
48901593|NCT01003990|157475800|FG000|Overall Study|Reasons Not Identified|14|||
48901594|NCT01003990|157475801|FG001|Overall Study|Reasons Not Identified|13|||
48901595|NCT01003990|157475802|FG002|Overall Study|Reasons Not Identified|8|||
48901596|NCT01003990|157475800|FG000|Overall Study|Poor/Non-compliance|4|||
48901597|NCT01003990|157475801|FG001|Overall Study|Poor/Non-compliance|3|||
48984959|NCT02442765|157775689|FG004|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
48984960|NCT02442765|157775690|FG005|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
48984961|NCT02442765|157775691|FG006|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
48984962|NCT02442765|157775692|FG007|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|4|||
48984963|NCT02442765|157775685|FG000|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
48984964|NCT02442765|157775686|FG001|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
48984965|NCT02442765|157775687|FG002|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
48984966|NCT02442765|157775688|FG003|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
48984967|NCT02442765|157775689|FG004|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
48984968|NCT02442765|157775690|FG005|Stage 2- (Days 43 to 85)|Lost to Follow-up|3|||
48984969|NCT02442765|157775691|FG006|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
48984970|NCT02442765|157775692|FG007|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
48984971|NCT02442765|157775685|FG000|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
48984972|NCT02442765|157775686|FG001|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
48984973|NCT02442765|157775687|FG002|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
48984974|NCT02442765|157775688|FG003|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
48984975|NCT02442765|157775689|FG004|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
48984976|NCT02442765|157775690|FG005|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
48984977|NCT02442765|157775691|FG006|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
48984978|NCT02442765|157775692|FG007|Stage 2- (Days 43 to 85)|Withdrawal by Subject|1|||
48984979|NCT02442765|157775685|FG000|Stage 2- (Days 43 to 85)|Reason not specified|0|||
48984980|NCT02442765|157775686|FG001|Stage 2- (Days 43 to 85)|Reason not specified|0|||
48984981|NCT02442765|157775687|FG002|Stage 2- (Days 43 to 85)|Reason not specified|0|||
48984982|NCT02442765|157775688|FG003|Stage 2- (Days 43 to 85)|Reason not specified|0|||
48984983|NCT02442765|157775689|FG004|Stage 2- (Days 43 to 85)|Reason not specified|1|||
48984984|NCT02442765|157775690|FG005|Stage 2- (Days 43 to 85)|Reason not specified|0|||
48984985|NCT02442765|157775691|FG006|Stage 2- (Days 43 to 85)|Reason not specified|0|||
48984986|NCT02442765|157775692|FG007|Stage 2- (Days 43 to 85)|Reason not specified|1|||
48984987|NCT01279954|157775695|FG000|Overall Study|Lack of Efficacy|3|||
48984988|NCT01279954|157775696|FG001|Overall Study|Lack of Efficacy|4|||
48984989|NCT02140762|157775697|FG000|Overall Study|Adverse Event|1|||
48984990|NCT02140762|157775698|FG001|Overall Study|Adverse Event|1|||
48984991|NCT02140762|157775697|FG000|Overall Study|Lost to Follow-up|9|||
48984992|NCT02140762|157775698|FG001|Overall Study|Lost to Follow-up|5|||
48984993|NCT02140762|157775697|FG000|Overall Study|Protocol Violation|1|||
48984994|NCT02140762|157775698|FG001|Overall Study|Protocol Violation|1|||
48984995|NCT02140762|157775697|FG000|Overall Study|Withdrawal by Subject|6|||
48984996|NCT02140762|157775698|FG001|Overall Study|Withdrawal by Subject|4|||
48984997|NCT02140762|157775697|FG000|Overall Study|Other|0|||
48984998|NCT02140762|157775698|FG001|Overall Study|Other|1|||
48984999|NCT01078974|157775699|FG000|Overall Study|Adverse Event|3|||
48985000|NCT01454531|157775702|FG000|Overall Study|Adverse Event|14|||
48985001|NCT01454531|157775702|FG000|Overall Study|Withdrawal by Subject|5|||
48985002|NCT01454531|157775702|FG000|Overall Study|Lost to Follow-up|1|||
48985003|NCT01454531|157775702|FG000|Overall Study|Physician Decision|1|||
48985004|NCT01454531|157775702|FG000|Overall Study|Delay in IMP administration|1|||
48985005|NCT01454531|157775702|FG000|Overall Study|Other|1|||
48985006|NCT00537810|157775704|FG000|Overall Study|Withdrawal by Subject|4|||
48985007|NCT00537810|157775705|FG001|Overall Study|Withdrawal by Subject|11|||
48985008|NCT00537810|157775706|FG002|Overall Study|Withdrawal by Subject|4|||
48985009|NCT00537810|157775707|FG003|Overall Study|Withdrawal by Subject|3|||
48985010|NCT00537810|157775704|FG000|Overall Study|Medically withdrawn|2|||
48985011|NCT00537810|157775705|FG001|Overall Study|Medically withdrawn|2|||
48985012|NCT00537810|157775706|FG002|Overall Study|Medically withdrawn|0|||
48985013|NCT00537810|157775707|FG003|Overall Study|Medically withdrawn|1|||
48985014|NCT03452397|157775709|FG000|Overall Study|Adverse Event|1|||
48985015|NCT03452397|157775710|FG001|Overall Study|Adverse Event|0|||
48985016|NCT03452397|157775711|FG002|Overall Study|Adverse Event|0|||
48985017|NCT03452397|157775712|FG003|Overall Study|Adverse Event|0|||
48985018|NCT03452397|157775709|FG000|Overall Study|Administrative reason|0|||
48901598|NCT01003990|157475802|FG002|Overall Study|Poor/Non-compliance|2|||
48901599|NCT01003990|157475800|FG000|Overall Study|Pregnancy|10|||
48901600|NCT01003990|157475801|FG001|Overall Study|Pregnancy|2|||
48901601|NCT01003990|157475802|FG002|Overall Study|Pregnancy|4|||
48901602|NCT01003990|157475800|FG000|Overall Study|No Longer Met Study Criteria|4|||
48901603|NCT01003990|157475801|FG001|Overall Study|No Longer Met Study Criteria|1|||
48901604|NCT01003990|157475802|FG002|Overall Study|No Longer Met Study Criteria|0|||
48901605|NCT01003990|157475800|FG000|Overall Study|Subject Withdrew Consent|12|||
48901606|NCT01003990|157475801|FG001|Overall Study|Subject Withdrew Consent|5|||
48901607|NCT01003990|157475802|FG002|Overall Study|Subject Withdrew Consent|7|||
49042264|NCT00112437|157987601|FG013|Years 6-10 (60-Month Extension)|Other|0|||
49042265|NCT00112437|157987602|FG014|Years 6-10 (60-Month Extension)|Other|0|||
49042266|NCT00112437|157987603|FG015|Years 6-10 (60-Month Extension)|Other|0|||
49042267|NCT00112437|157987604|FG016|Years 6-10 (60-Month Extension)|Other|0|||
49042268|NCT00112437|157987605|FG017|Years 6-10 (60-Month Extension)|Other|0|||
49042269|NCT00112437|157987606|FG018|Years 6-10 (60-Month Extension)|Other|0|||
49042270|NCT00112437|157987607|FG019|Years 6-10 (60-Month Extension)|Other|0|||
49042271|NCT00112437|157987608|FG020|Years 6-10 (60-Month Extension)|Other|0|||
49042272|NCT00112437|157987609|FG021|Years 6-10 (60-Month Extension)|Other|0|||
49042273|NCT00112437|157987610|FG022|Years 6-10 (60-Month Extension)|Other|0|||
49042274|NCT00112437|157987611|FG023|Years 6-10 (60-Month Extension)|Other|0|||
49042275|NCT00112437|157987612|FG024|Years 6-10 (60-Month Extension)|Other|1|||
49042276|NCT00112437|157987613|FG025|Years 6-10 (60-Month Extension)|Other|0|||
49042277|NCT00112437|157987588|FG000|Years 6-10 (60-Month Extension)|Physician Decision|0|||
49042278|NCT00112437|157987589|FG001|Years 6-10 (60-Month Extension)|Physician Decision|0|||
49042279|NCT00112437|157987590|FG002|Years 6-10 (60-Month Extension)|Physician Decision|0|||
49042280|NCT00112437|157987591|FG003|Years 6-10 (60-Month Extension)|Physician Decision|0|||
49042281|NCT00112437|157987592|FG004|Years 6-10 (60-Month Extension)|Physician Decision|0|||
49042282|NCT00112437|157987593|FG005|Years 6-10 (60-Month Extension)|Physician Decision|0|||
49042283|NCT00112437|157987594|FG006|Years 6-10 (60-Month Extension)|Physician Decision|0|||
49042284|NCT00112437|157987595|FG007|Years 6-10 (60-Month Extension)|Physician Decision|0|||
49042285|NCT00112437|157987596|FG008|Years 6-10 (60-Month Extension)|Physician Decision|0|||
49042286|NCT00112437|157987597|FG009|Years 6-10 (60-Month Extension)|Physician Decision|0|||
49042287|NCT00112437|157987598|FG010|Years 6-10 (60-Month Extension)|Physician Decision|0|||
49042288|NCT00112437|157987599|FG011|Years 6-10 (60-Month Extension)|Physician Decision|0|||
49042289|NCT00112437|157987600|FG012|Years 6-10 (60-Month Extension)|Physician Decision|0|||
49042290|NCT00112437|157987601|FG013|Years 6-10 (60-Month Extension)|Physician Decision|0|||
49042291|NCT00112437|157987602|FG014|Years 6-10 (60-Month Extension)|Physician Decision|0|||
49042292|NCT00112437|157987603|FG015|Years 6-10 (60-Month Extension)|Physician Decision|0|||
49042293|NCT00112437|157987604|FG016|Years 6-10 (60-Month Extension)|Physician Decision|0|||
49042294|NCT00112437|157987605|FG017|Years 6-10 (60-Month Extension)|Physician Decision|0|||
49042295|NCT00112437|157987606|FG018|Years 6-10 (60-Month Extension)|Physician Decision|0|||
49042296|NCT00112437|157987607|FG019|Years 6-10 (60-Month Extension)|Physician Decision|0|||
49042297|NCT00112437|157987608|FG020|Years 6-10 (60-Month Extension)|Physician Decision|0|||
49042298|NCT00112437|157987609|FG021|Years 6-10 (60-Month Extension)|Physician Decision|0|||
49042299|NCT00112437|157987610|FG022|Years 6-10 (60-Month Extension)|Physician Decision|0|||
49042300|NCT00112437|157987611|FG023|Years 6-10 (60-Month Extension)|Physician Decision|2|||
49042301|NCT00112437|157987612|FG024|Years 6-10 (60-Month Extension)|Physician Decision|0|||
49042302|NCT00112437|157987613|FG025|Years 6-10 (60-Month Extension)|Physician Decision|0|||
49042303|NCT00112437|157987588|FG000|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
48901608|NCT02019927|157475803|FG000|Overall Study|Lost to Follow-up|2|||
48901609|NCT02019927|157475804|FG001|Overall Study|Lost to Follow-up|4|||
48901610|NCT02019927|157475805|FG002|Overall Study|Lost to Follow-up|1|||
48901611|NCT02019927|157475806|FG003|Overall Study|Lost to Follow-up|2|||
49042304|NCT00112437|157987589|FG001|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
49042305|NCT00112437|157987590|FG002|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
49042306|NCT00112437|157987591|FG003|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
49042307|NCT00112437|157987592|FG004|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
48901612|NCT02019927|157475807|FG004|Overall Study|Lost to Follow-up|3|||
48901613|NCT02019927|157475808|FG005|Overall Study|Lost to Follow-up|1|||
48901614|NCT01054846|157475809|FG000|Overall Study|Lost to Follow-up|76|||
49042308|NCT00112437|157987593|FG005|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
49042309|NCT00112437|157987594|FG006|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
49042310|NCT00112437|157987595|FG007|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
49042311|NCT00112437|157987596|FG008|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
49042312|NCT00112437|157987597|FG009|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
49042313|NCT00112437|157987598|FG010|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
48901615|NCT01054846|157475810|FG001|Overall Study|Lost to Follow-up|17|||
48901616|NCT00394953|157475811|FG000|First Treatment Period|Adverse Event|1|||
48901617|NCT00394953|157475812|FG001|First Treatment Period|Adverse Event|2|||
49042314|NCT00112437|157987599|FG011|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
49042315|NCT00112437|157987600|FG012|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
49042316|NCT00112437|157987601|FG013|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
49042317|NCT00112437|157987602|FG014|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
49042318|NCT00112437|157987603|FG015|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
49042319|NCT00112437|157987604|FG016|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
49042320|NCT00112437|157987605|FG017|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
49042321|NCT00112437|157987606|FG018|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
49042322|NCT00112437|157987607|FG019|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
49042323|NCT00112437|157987608|FG020|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
49042324|NCT00112437|157987609|FG021|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
49042325|NCT00112437|157987610|FG022|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4|||
49042326|NCT00112437|157987611|FG023|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6|||
49042327|NCT00112437|157987612|FG024|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
49042328|NCT00112437|157987613|FG025|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3|||
49042329|NCT00379353|157987616|FG000|Overall Study|Hospitalization|3|||
49042330|NCT00379353|157987617|FG001|Overall Study|Hospitalization|3|||
49042331|NCT00379353|157987616|FG000|Overall Study|Withdrawal by Subject|5|||
49042332|NCT00379353|157987617|FG001|Overall Study|Withdrawal by Subject|2|||
49042333|NCT00379353|157987616|FG000|Overall Study|Death|1|||
49042334|NCT00379353|157987617|FG001|Overall Study|Death|0|||
49042335|NCT00379353|157987616|FG000|Overall Study|Cardiac Tamponade|1|||
49042336|NCT00379353|157987617|FG001|Overall Study|Cardiac Tamponade|0|||
49042337|NCT00379353|157987616|FG000|Overall Study|Non-compliance|1|||
49042338|NCT00379353|157987617|FG001|Overall Study|Non-compliance|0|||
49042339|NCT00379353|157987616|FG000|Overall Study|Conflicting drug treatment|0|||
49042340|NCT00379353|157987617|FG001|Overall Study|Conflicting drug treatment|1|||
49042341|NCT04892147|157987618|FG000|Overall Study|Withdrawal by Subject|2|||
49042342|NCT04892147|157987619|FG001|Overall Study|Withdrawal by Subject|0|||
49042343|NCT01215721|157987620|FG000|Overall Study|Adverse Event|2|||
49042344|NCT02760433|157987621|FG000|Overall Study|Lost to Follow-up|1|||
49042345|NCT02760433|157987622|FG001|Overall Study|Lost to Follow-up|0|||
49042346|NCT02760433|157987623|FG002|Overall Study|Lost to Follow-up|1|||
49042347|NCT02760433|157987624|FG003|Overall Study|Lost to Follow-up|0|||
49042348|NCT02760433|157987625|FG004|Overall Study|Lost to Follow-up|0|||
49042349|NCT02760433|157987621|FG000|Overall Study|Withdrawal by Subject|23|||
49042350|NCT02760433|157987622|FG001|Overall Study|Withdrawal by Subject|9|||
49042351|NCT02760433|157987623|FG002|Overall Study|Withdrawal by Subject|0|||
49042352|NCT02760433|157987624|FG003|Overall Study|Withdrawal by Subject|2|||
49042353|NCT02760433|157987625|FG004|Overall Study|Withdrawal by Subject|9|||
49042354|NCT02760433|157987621|FG000|Overall Study|Lack of Response At Week 14|0|||
49042355|NCT02760433|157987622|FG001|Overall Study|Lack of Response At Week 14|0|||
49042356|NCT02760433|157987623|FG002|Overall Study|Lack of Response At Week 14|0|||
49042357|NCT02760433|157987624|FG003|Overall Study|Lack of Response At Week 14|0|||
49042358|NCT02760433|157987625|FG004|Overall Study|Lack of Response At Week 14|1|||
48901618|NCT00394953|157475811|FG000|First Treatment Period|Death|6|||
48901619|NCT00394953|157475812|FG001|First Treatment Period|Death|7|||
49042359|NCT02760433|157987621|FG000|Overall Study|Subject refused to continue the study|1|||
49042360|NCT02760433|157987622|FG001|Overall Study|Subject refused to continue the study|0|||
49042361|NCT02760433|157987623|FG002|Overall Study|Subject refused to continue the study|0|||
49042362|NCT02760433|157987624|FG003|Overall Study|Subject refused to continue the study|0|||
49042363|NCT02760433|157987625|FG004|Overall Study|Subject refused to continue the study|0|||
49042364|NCT02760433|157987621|FG000|Overall Study|Subject was taking prohibited medications and refused to stop.|2|||
49042365|NCT02760433|157987622|FG001|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
49042366|NCT02760433|157987623|FG002|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
49042367|NCT02760433|157987624|FG003|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
49042368|NCT02760433|157987625|FG004|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
49042369|NCT02760433|157987621|FG000|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
49042370|NCT02760433|157987622|FG001|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1|||
49042371|NCT02760433|157987623|FG002|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
48901620|NCT00394953|157475811|FG000|First Treatment Period|Lack of Efficacy|1|||
49042372|NCT02760433|157987624|FG003|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
49042373|NCT02760433|157987625|FG004|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
49042374|NCT00826241|157987626|FG000|Overall Study|Withdrawal from Follow-up|1|||
48901621|NCT00394953|157475812|FG001|First Treatment Period|Lack of Efficacy|1|||
48901622|NCT00394953|157475811|FG000|First Treatment Period|Withdrawal by Subject|6|||
48901623|NCT00394953|157475812|FG001|First Treatment Period|Withdrawal by Subject|3|||
48901624|NCT00394953|157475811|FG000|First Treatment Period|Lost to Follow-up|0|||
49042375|NCT00826241|157987626|FG000|Overall Study|Withdrew consent|2|||
49042376|NCT00826241|157987626|FG000|Overall Study|Death|4|||
49042377|NCT00826241|157987626|FG000|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1|||
49042378|NCT00826241|157987626|FG000|Overall Study|Non-compliance|1|||
49042379|NCT00826241|157987626|FG000|Overall Study|Progression of disease|1|||
49042380|NCT00826241|157987626|FG000|Overall Study|Patient refused follow-up|3|||
49042381|NCT00826241|157987626|FG000|Overall Study|Lost to Follow-up|9|||
49042382|NCT00826241|157987626|FG000|Overall Study|Could not obtain records|1|||
49042383|NCT00826241|157987626|FG000|Overall Study|Screen failure|2|||
49042384|NCT00826241|157987626|FG000|Overall Study|Pt unable to proceed to registration|1|||
49042385|NCT00826241|157987626|FG000|Overall Study|Pt opt not to proceed w/trmt|1|||
49042386|NCT02416934|157987627|FG000|Overall Study|given steroids|1|||
49042387|NCT02416934|157987628|FG001|Overall Study|given steroids|2|||
49042388|NCT02416934|157987627|FG000|Overall Study|Lost to Follow-up|0|||
49042389|NCT02416934|157987628|FG001|Overall Study|Lost to Follow-up|2|||
49042390|NCT02416934|157987627|FG000|Overall Study|Withdrawal by Subject|1|||
49042391|NCT02416934|157987628|FG001|Overall Study|Withdrawal by Subject|0|||
49042392|NCT02416934|157987627|FG000|Overall Study|recruited during continuing renewal proc|0|||
49042393|NCT02416934|157987628|FG001|Overall Study|recruited during continuing renewal proc|1|||
49042394|NCT02416934|157987627|FG000|Overall Study|Protocol Violation|0|||
49042395|NCT02416934|157987628|FG001|Overall Study|Protocol Violation|1|||
49042396|NCT02416934|157987627|FG000|Overall Study|surgery started late|0|||
49042397|NCT02416934|157987628|FG001|Overall Study|surgery started late|1|||
49042398|NCT02416934|157987627|FG000|Overall Study|re-operation|1|||
49042399|NCT02416934|157987628|FG001|Overall Study|re-operation|0|||
49042400|NCT03370510|157987635|FG000|Overall Study|COVID-19|2|||
49042401|NCT03370510|157987636|FG001|Overall Study|COVID-19|0|||
49042402|NCT04148287|157987637|FG000|Overall Study|Death|2|||
49042403|NCT01624233|157989718|FG000|Period 2 - Induction|Adverse Event|1|||
49042404|NCT01624233|157989718|FG000|Period 3 - Maintenance|Adverse Event|2|||
49042405|NCT01624233|157989718|FG000|Period 3 - Maintenance|Lack of Efficacy|1|||
49042406|NCT01624233|157989718|FG000|Period 3 - Maintenance|Physician Decision|2|||
49042407|NCT01624233|157989718|FG000|Period 3 - Maintenance|Withdrawal by Subject|2|||
49042408|NCT01624233|157989718|FG000|Period 4 - Drug Free Period|Relapsed|61|||
49042409|NCT01624233|157989718|FG000|Period 5 - Retreatment Period|Adverse Event|5|||
49042410|NCT01624233|157989718|FG000|Period 5 - Retreatment Period|Lack of Efficacy|1|||
49042411|NCT01624233|157989718|FG000|Period 5 - Retreatment Period|Physician Decision|1|||
49042412|NCT01624233|157989718|FG000|Period 5 - Retreatment Period|Withdrawal by Subject|3|||
49042413|NCT01624233|157989718|FG000|Period 6: Follow-up|Adverse Event|3|||
49042414|NCT01624233|157989718|FG000|Period 6: Follow-up|Lack of Efficacy|2|||
49042415|NCT01624233|157989718|FG000|Period 6: Follow-up|Physician Decision|1|||
49042416|NCT01624233|157989718|FG000|Period 6: Follow-up|Withdrawal by Subject|3|||
49042417|NCT02583048|157989722|FG000|Overall Study|Withdrawal by Subject|0|||
49042418|NCT02583048|157989723|FG001|Overall Study|Withdrawal by Subject|1|||
49042419|NCT02583048|157989724|FG002|Overall Study|Withdrawal by Subject|0|||
49042420|NCT02583048|157989722|FG000|Overall Study|Failed to meet eligibility criterion|0|||
49042421|NCT02583048|157989723|FG001|Overall Study|Failed to meet eligibility criterion|0|||
49042422|NCT02583048|157989724|FG002|Overall Study|Failed to meet eligibility criterion|1|||
49042423|NCT02107196|157989725|FG000|12-week Treatment Period|Adverse Event|6|||
49042424|NCT02107196|157989726|FG001|12-week Treatment Period|Adverse Event|3|||
48901625|NCT00394953|157475812|FG001|First Treatment Period|Lost to Follow-up|1|||
48901626|NCT00394953|157475811|FG000|First Treatment Period|Renal transplant|11|||
48901627|NCT00394953|157475812|FG001|First Treatment Period|Renal transplant|7|||
48901628|NCT00394953|157475811|FG000|First Treatment Period|Not defined|4|||
48901629|NCT00394953|157475812|FG001|First Treatment Period|Not defined|1|||
48901630|NCT00394953|157475811|FG000|Second Treatment Period|Adverse Event|2|||
48901631|NCT00394953|157475812|FG001|Second Treatment Period|Adverse Event|5|||
48901632|NCT00394953|157475811|FG000|Second Treatment Period|Death|8|||
48901633|NCT00394953|157475812|FG001|Second Treatment Period|Death|4|||
48901634|NCT00394953|157475811|FG000|Second Treatment Period|Lack of Efficacy|9|||
48901635|NCT00394953|157475812|FG001|Second Treatment Period|Lack of Efficacy|47|||
48901636|NCT00394953|157475811|FG000|Second Treatment Period|Withdrawal by Subject|3|||
48901637|NCT00394953|157475812|FG001|Second Treatment Period|Withdrawal by Subject|3|||
48901638|NCT00394953|157475811|FG000|Second Treatment Period|Lost to Follow-up|0|||
48901639|NCT00394953|157475812|FG001|Second Treatment Period|Lost to Follow-up|1|||
48901640|NCT00394953|157475811|FG000|Second Treatment Period|Renal transplant|4|||
48901641|NCT00394953|157475812|FG001|Second Treatment Period|Renal transplant|6|||
48901642|NCT00394953|157475811|FG000|Second Treatment Period|Not defined|3|||
48901643|NCT00394953|157475812|FG001|Second Treatment Period|Not defined|8|||
48901644|NCT01259284|157475815|FG000|Overall Study|Study Termination|2|||
48901645|NCT01259284|157475816|FG001|Overall Study|Study Termination|0|||
48901646|NCT01259284|157475817|FG002|Overall Study|Study Termination|0|||
48901647|NCT03021954|157475818|FG000|Overall Study|Lost to Follow-up|10|||
48901648|NCT03021954|157475819|FG001|Overall Study|Lost to Follow-up|43|||
48901649|NCT03021954|157475818|FG000|Overall Study|Subjects had avulsion trauma|4|||
48901650|NCT03021954|157475819|FG001|Overall Study|Subjects had avulsion trauma|1|||
48901651|NCT01498289|157475821|FG000|Overall Study|Adverse Event|16|||
48901652|NCT01498289|157475822|FG001|Overall Study|Adverse Event|18|||
48901653|NCT01498289|157475821|FG000|Overall Study|Death|6|||
48901654|NCT01498289|157475822|FG001|Overall Study|Death|8|||
48901655|NCT01498289|157475821|FG000|Overall Study|Withdrawal unrelated to AE|16|||
48901656|NCT01498289|157475822|FG001|Overall Study|Withdrawal unrelated to AE|16|||
48901657|NCT01498289|157475821|FG000|Overall Study|Progression/relapse|53|||
48901658|NCT01498289|157475822|FG001|Overall Study|Progression/relapse|59|||
48901659|NCT01498289|157475821|FG000|Overall Study|Not protocol specified|7|||
48901660|NCT01498289|157475822|FG001|Overall Study|Not protocol specified|2|||
48901661|NCT01498289|157475821|FG000|Overall Study|Reason under review|0|||
48901662|NCT01498289|157475822|FG001|Overall Study|Reason under review|1|||
48901663|NCT00051363|157475823|FG000|Overall Study|Dropped Post-Rand for Any Reason|102|||
48985019|NCT03452397|157775710|FG001|Overall Study|Administrative reason|0|||
48985020|NCT03452397|157775711|FG002|Overall Study|Administrative reason|1|||
48901664|NCT00051363|157475824|FG001|Overall Study|Dropped Post-Rand for Any Reason|126|||
48901665|NCT00051363|157475823|FG000|Overall Study|Disqualified Post-Rand for Any Reason|9|||
48901666|NCT00051363|157475824|FG001|Overall Study|Disqualified Post-Rand for Any Reason|11|||
48901667|NCT00051363|157475823|FG000|Overall Study|Death|2|||
48901668|NCT00051363|157475824|FG001|Overall Study|Death|2|||
48901669|NCT00051363|157475823|FG000|Overall Study|Excluded Pre-Randomization|2|||
48901670|NCT00051363|157475824|FG001|Overall Study|Excluded Pre-Randomization|5|||
48901671|NCT00807235|157475825|FG000|Overall Study|Adverse Event|1|||
48901672|NCT00807235|157475826|FG001|Overall Study|Adverse Event|0|||
48901673|NCT00926211|157475827|FG000|Overall Study|Lost to Follow-up|1|||
48901674|NCT00412971|157475828|FG000|Overall Study|Lost to Follow-up|17|||
48901675|NCT00412971|157475829|FG001|Overall Study|Lost to Follow-up|9|||
48901676|NCT00412971|157475828|FG000|Overall Study|Protocol Violation|13|||
48901677|NCT00412971|157475829|FG001|Overall Study|Protocol Violation|1|||
48901678|NCT02513745|157475831|FG000|Overall Study|Criteria at time of surgery not met.|3|||
48901679|NCT02513745|157475832|FG001|Overall Study|Criteria at time of surgery not met.|3|||
48901680|NCT01145755|157475833|FG000|Overall Study|Adverse Event|2|||
48901681|NCT01145755|157475834|FG001|Overall Study|Adverse Event|4|||
48901682|NCT01145755|157475835|FG002|Overall Study|Adverse Event|2|||
48901683|NCT01145755|157475833|FG000|Overall Study|Withdrawal by Subject|2|||
48901684|NCT01145755|157475834|FG001|Overall Study|Withdrawal by Subject|2|||
48901685|NCT01145755|157475835|FG002|Overall Study|Withdrawal by Subject|2|||
48901686|NCT01145755|157475833|FG000|Overall Study|Lost to Follow-up|2|||
48901687|NCT01145755|157475834|FG001|Overall Study|Lost to Follow-up|3|||
48901688|NCT01145755|157475835|FG002|Overall Study|Lost to Follow-up|1|||
48901689|NCT01145755|157475833|FG000|Overall Study|Protocol Violation|0|||
48901690|NCT01145755|157475834|FG001|Overall Study|Protocol Violation|3|||
48901691|NCT01145755|157475835|FG002|Overall Study|Protocol Violation|1|||
48901692|NCT01145755|157475833|FG000|Overall Study|Study Closure|14|||
48901693|NCT01145755|157475834|FG001|Overall Study|Study Closure|14|||
48901694|NCT01145755|157475835|FG002|Overall Study|Study Closure|17|||
48901695|NCT01145755|157475833|FG000|Overall Study|Lack of Efficacy|0|||
48901696|NCT01145755|157475834|FG001|Overall Study|Lack of Efficacy|1|||
48901697|NCT01145755|157475835|FG002|Overall Study|Lack of Efficacy|0|||
48901698|NCT01145755|157475833|FG000|Overall Study|Patient could not swollow medication|0|||
48901699|NCT01145755|157475834|FG001|Overall Study|Patient could not swollow medication|0|||
48901700|NCT01145755|157475835|FG002|Overall Study|Patient could not swollow medication|1|||
48901701|NCT01145755|157475833|FG000|Overall Study|Withdrawal by Subject|0|||
48901702|NCT01145755|157475834|FG001|Overall Study|Withdrawal by Subject|0|||
48901703|NCT01145755|157475835|FG002|Overall Study|Withdrawal by Subject|1|||
48901704|NCT01145755|157475833|FG000|Overall Study|Positive urine ethanol|0|||
48901705|NCT01145755|157475834|FG001|Overall Study|Positive urine ethanol|1|||
48901706|NCT01145755|157475835|FG002|Overall Study|Positive urine ethanol|0|||
48901707|NCT00547365|157475836|FG000|Overall Study|Physician Decision|1|||
48901708|NCT00547365|157475836|FG000|Overall Study|Lost to Follow-up|1|||
48901709|NCT00547365|157475836|FG000|Overall Study|Protocol Violation|2|||
48901710|NCT00547365|157475836|FG000|Overall Study|death (not related to study)|4|||
48901711|NCT01139658|157475837|FG000|Overall Study|Adverse Event|10|||
48901712|NCT01139658|157475838|FG001|Overall Study|Adverse Event|27|||
48985021|NCT03452397|157775712|FG003|Overall Study|Administrative reason|1|||
48985022|NCT03452397|157775709|FG000|Overall Study|Withdrawal by Subject|0|||
48985023|NCT03452397|157775710|FG001|Overall Study|Withdrawal by Subject|0|||
48985024|NCT03452397|157775711|FG002|Overall Study|Withdrawal by Subject|1|||
48985025|NCT03452397|157775712|FG003|Overall Study|Withdrawal by Subject|0|||
48985026|NCT00362297|157775713|FG000|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0|||
48985027|NCT00362297|157775714|FG001|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4|||
48985028|NCT00121485|157777532|FG000|Overall Study|Not implanted|1|||
48985029|NCT00121485|157777533|FG001|Overall Study|Not implanted|5|||
48985030|NCT00121485|157777532|FG000|Overall Study|Crossover|0|||
48985031|NCT00121485|157777533|FG001|Overall Study|Crossover|2|||
48985032|NCT01183104|157777537|FG000|Overall Study|Adverse Event|8|||
49042425|NCT02107196|157989725|FG000|12-week Treatment Period|Lack of Efficacy|2|||
49042426|NCT02107196|157989726|FG001|12-week Treatment Period|Lack of Efficacy|1|||
49042427|NCT02107196|157989725|FG000|12-week Treatment Period|Lost to Follow-up|3|||
49042428|NCT02107196|157989726|FG001|12-week Treatment Period|Lost to Follow-up|6|||
49042429|NCT02107196|157989725|FG000|12-week Treatment Period|Physician Decision|0|||
49042430|NCT02107196|157989726|FG001|12-week Treatment Period|Physician Decision|1|||
49042431|NCT02107196|157989725|FG000|12-week Treatment Period|Withdrawal by Subject|15|||
49042432|NCT02107196|157989726|FG001|12-week Treatment Period|Withdrawal by Subject|12|||
49042433|NCT02107196|157989725|FG000|12-week Treatment Period|Protocol Violation|7|||
49042434|NCT02107196|157989726|FG001|12-week Treatment Period|Protocol Violation|8|||
49042435|NCT02107196|157989725|FG000|12-week Treatment Period|Reason Missing|11|||
49042436|NCT02107196|157989726|FG001|12-week Treatment Period|Reason Missing|8|||
49042437|NCT02107196|157989725|FG000|4-week Randomized Withdrawal (RW) Period|Adverse Event|2|||
49042438|NCT02107196|157989726|FG001|4-week Randomized Withdrawal (RW) Period|Adverse Event|0|||
49042439|NCT02107196|157989725|FG000|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
49042440|NCT02107196|157989726|FG001|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
49042441|NCT02107196|157989725|FG000|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2|||
49042442|NCT02107196|157989726|FG001|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0|||
49042443|NCT02107196|157989725|FG000|4-week Randomized Withdrawal (RW) Period|Reason Missing|18|||
49042444|NCT02107196|157989726|FG001|4-week Randomized Withdrawal (RW) Period|Reason Missing|5|||
49042445|NCT02034513|157989729|FG000|Overall Study|Adverse Event|11|||
49042446|NCT02034513|157989730|FG001|Overall Study|Adverse Event|10|||
49042447|NCT02034513|157989729|FG000|Overall Study|Lack of Efficacy|0|||
49042448|NCT02034513|157989730|FG001|Overall Study|Lack of Efficacy|1|||
49042449|NCT02034513|157989729|FG000|Overall Study|Lost to Follow-up|6|||
49042450|NCT02034513|157989730|FG001|Overall Study|Lost to Follow-up|7|||
49042451|NCT02034513|157989729|FG000|Overall Study|Pregnancy|0|||
49042452|NCT02034513|157989730|FG001|Overall Study|Pregnancy|3|||
49042453|NCT02034513|157989729|FG000|Overall Study|Protocol Violation|7|||
48901713|NCT01139658|157475837|FG000|Overall Study|Lack of Efficacy|15|||
48901714|NCT01139658|157475838|FG001|Overall Study|Lack of Efficacy|7|||
48901715|NCT01139658|157475837|FG000|Overall Study|Withdrawal by Subject|2|||
48901716|NCT01139658|157475838|FG001|Overall Study|Withdrawal by Subject|4|||
48901717|NCT01139658|157475837|FG000|Overall Study|No documentation of treatment|1|||
48901718|NCT01139658|157475838|FG001|Overall Study|No documentation of treatment|0|||
48901719|NCT01139658|157475837|FG000|Overall Study|Other|28|||
48901720|NCT01139658|157475838|FG001|Overall Study|Other|75|||
48901721|NCT01777269|157475839|FG000|Overall Study|Adverse Event|24|||
48901722|NCT01777269|157475840|FG001|Overall Study|Adverse Event|33|||
48901723|NCT01777269|157475839|FG000|Overall Study|Lack of Efficacy|8|||
48901724|NCT01777269|157475840|FG001|Overall Study|Lack of Efficacy|10|||
48985033|NCT01183104|157777538|FG001|Overall Study|Adverse Event|6|||
48985034|NCT01183104|157777537|FG000|Overall Study|Death|0|||
48985035|NCT01183104|157777538|FG001|Overall Study|Death|1|||
48985036|NCT01183104|157777537|FG000|Overall Study|Lost to Follow-up|14|||
48985037|NCT01183104|157777538|FG001|Overall Study|Lost to Follow-up|7|||
48901725|NCT01777269|157475839|FG000|Overall Study|Protocol Violation|4|||
48901726|NCT01777269|157475840|FG001|Overall Study|Protocol Violation|4|||
48901727|NCT01777269|157475839|FG000|Overall Study|Participants reached stopping criteria|1|||
48985038|NCT01183104|157777537|FG000|Overall Study|Physician Decision|5|||
48985039|NCT01183104|157777538|FG001|Overall Study|Physician Decision|8|||
48985040|NCT01183104|157777537|FG000|Overall Study|Withdrawal by Subject|6|||
48985041|NCT01183104|157777538|FG001|Overall Study|Withdrawal by Subject|11|||
48985042|NCT01183104|157777537|FG000|Overall Study|Nonparticipation in Extension Study|39|||
48985043|NCT01183104|157777538|FG001|Overall Study|Nonparticipation in Extension Study|50|||
48985044|NCT01183104|157777537|FG000|Overall Study|Did not receive study drug|5|||
48985045|NCT01183104|157777538|FG001|Overall Study|Did not receive study drug|9|||
48985046|NCT03267511|157777539|FG000|Overall Study|Lost to Follow-up|0|||
48985047|NCT03267511|157777540|FG001|Overall Study|Lost to Follow-up|0|||
48985048|NCT03267511|157777541|FG002|Overall Study|Lost to Follow-up|0|||
48985049|NCT03267511|157777542|FG003|Overall Study|Lost to Follow-up|1|||
48985050|NCT00439309|157777543|FG000|Follow-Up|Death|1|||
48985051|NCT00439309|157777544|FG001|Follow-Up|Death|0|||
48985052|NCT00439309|157777543|FG000|Follow-Up|Lost to Follow-up|2|||
48985053|NCT00439309|157777544|FG001|Follow-Up|Lost to Follow-up|0|||
48985054|NCT00439309|157777543|FG000|Follow-Up|Withdrawal by Subject|0|||
48985055|NCT00439309|157777544|FG001|Follow-Up|Withdrawal by Subject|1|||
48985056|NCT00439309|157777543|FG000|Follow-Up|Late response by subject|0|||
48985057|NCT00439309|157777544|FG001|Follow-Up|Late response by subject|1|||
48985058|NCT01977040|157777545|FG000|Overall Study|Vasa previa not confirmed|2|||
48985059|NCT01572844|157777546|FG000|Overall Study|Physician Decision|1|||
48985060|NCT01572844|157777547|FG001|Overall Study|Physician Decision|1|||
49042454|NCT02034513|157989730|FG001|Overall Study|Protocol Violation|10|||
49042455|NCT02034513|157989729|FG000|Overall Study|Withdrawal by Subject|25|||
49042456|NCT02034513|157989730|FG001|Overall Study|Withdrawal by Subject|25|||
48901728|NCT01777269|157475840|FG001|Overall Study|Participants reached stopping criteria|1|||
49042457|NCT02034513|157989729|FG000|Overall Study|Unclassified|0|||
49042458|NCT02034513|157989730|FG001|Overall Study|Unclassified|1|||
49042459|NCT01243151|157989733|FG000|Overall Study|Adverse Event|0|||
49042460|NCT01243151|157989734|FG001|Overall Study|Adverse Event|1|||
49042461|NCT01243151|157989735|FG002|Overall Study|Adverse Event|0|||
49042462|NCT01243151|157989736|FG003|Overall Study|Adverse Event|0|||
49042463|NCT01243151|157989737|FG004|Overall Study|Adverse Event|0|||
48901729|NCT01777269|157475839|FG000|Overall Study|Lost to Follow-up|4|||
48901730|NCT01777269|157475840|FG001|Overall Study|Lost to Follow-up|0|||
48901731|NCT01777269|157475839|FG000|Overall Study|Physician Decision|5|||
48901732|NCT01777269|157475840|FG001|Overall Study|Physician Decision|2|||
48901733|NCT01777269|157475839|FG000|Overall Study|Withdrawal by Subject|9|||
48901734|NCT01777269|157475840|FG001|Overall Study|Withdrawal by Subject|9|||
48901735|NCT00504881|157475841|FG000|Overall Study|Lack of Efficacy|1|||
48901736|NCT00504881|157475842|FG001|Overall Study|Lack of Efficacy|5|||
48901737|NCT00504881|157475841|FG000|Overall Study|Lost to Follow-up|0|||
48901738|NCT00504881|157475842|FG001|Overall Study|Lost to Follow-up|2|||
48901739|NCT00504881|157475841|FG000|Overall Study|Withdrawal by Subject|1|||
48901740|NCT00504881|157475842|FG001|Overall Study|Withdrawal by Subject|4|||
48901741|NCT00504881|157475841|FG000|Overall Study|Non-Compliance|1|||
48901742|NCT00504881|157475842|FG001|Overall Study|Non-Compliance|0|||
48901743|NCT00504881|157475841|FG000|Overall Study|No Birth Control|0|||
48901744|NCT00504881|157475842|FG001|Overall Study|No Birth Control|1|||
48901745|NCT00504881|157475841|FG000|Overall Study|Safety Visit not performed|0|||
48901746|NCT00504881|157475842|FG001|Overall Study|Safety Visit not performed|1|||
48901747|NCT00504881|157475841|FG000|Overall Study|AE, serious fatal|0|||
48901748|NCT00504881|157475842|FG001|Overall Study|AE, serious fatal|1|||
48901749|NCT00504881|157475841|FG000|Overall Study|SAE, non-fatal|2|||
48901750|NCT00504881|157475842|FG001|Overall Study|SAE, non-fatal|6|||
48901751|NCT00504881|157475841|FG000|Overall Study|AE, non-serious non-fatal|4|||
48901752|NCT00504881|157475842|FG001|Overall Study|AE, non-serious non-fatal|14|||
48901753|NCT00504881|157475841|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
48901754|NCT00504881|157475842|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2|||
48901755|NCT00504881|157475841|FG000|Overall Study|AE of unknown type|1|||
48901756|NCT00504881|157475842|FG001|Overall Study|AE of unknown type|0|||
48901757|NCT00688181|157475849|FG000|Overall Study|Lost to Follow-up|17|||
48901758|NCT00688181|157475849|FG000|Overall Study|Unknown Reason|4|||
48901759|NCT00688181|157475849|FG000|Overall Study|Non-clinical Reason|2|||
48901760|NCT03604523|157475850|FG000|Overall Study|Physician Decision|1|||
48901761|NCT03604523|157475851|FG001|Overall Study|Physician Decision|0|||
48901762|NCT02958267|157475854|FG000|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1|||
49042464|NCT01243151|157989733|FG000|Overall Study|Protocol Violation|0|||
49042465|NCT01243151|157989734|FG001|Overall Study|Protocol Violation|0|||
49042466|NCT01243151|157989735|FG002|Overall Study|Protocol Violation|1|||
49042467|NCT01243151|157989736|FG003|Overall Study|Protocol Violation|0|||
49042468|NCT01243151|157989737|FG004|Overall Study|Protocol Violation|0|||
49042469|NCT01243151|157989733|FG000|Overall Study|Other|0|||
49042470|NCT01243151|157989734|FG001|Overall Study|Other|0|||
49042471|NCT01243151|157989735|FG002|Overall Study|Other|0|||
49042472|NCT01243151|157989736|FG003|Overall Study|Other|1|||
49042473|NCT01243151|157989737|FG004|Overall Study|Other|0|||
49042474|NCT01243151|157989733|FG000|Overall Study|Randomized but not treated|0|||
49042475|NCT01243151|157989734|FG001|Overall Study|Randomized but not treated|0|||
49042476|NCT01243151|157989735|FG002|Overall Study|Randomized but not treated|0|||
49042477|NCT01243151|157989736|FG003|Overall Study|Randomized but not treated|1|||
48901763|NCT02958267|157475855|FG001|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0|||
48901764|NCT02958267|157475854|FG000|Enrollment to Actual Treatment Complete|Physician Decision|1|||
48901765|NCT02958267|157475855|FG001|Enrollment to Actual Treatment Complete|Physician Decision|0|||
48901766|NCT02958267|157475854|FG000|Follow-up Visits|Additional treatment pursued|2|||
48901767|NCT02958267|157475855|FG001|Follow-up Visits|Additional treatment pursued|1|||
48901768|NCT01079130|157475856|FG000|Overall Study|Adverse Event|1|||
48901769|NCT01079130|157475857|FG001|Overall Study|Adverse Event|1|||
48901770|NCT01079130|157475858|FG002|Overall Study|Adverse Event|0|||
48901771|NCT01079130|157475859|FG003|Overall Study|Adverse Event|1|||
49042478|NCT01243151|157989737|FG004|Overall Study|Randomized but not treated|0|||
49042479|NCT03119662|157989738|FG000|Overall Study|Withdrawal by Subject|0|||
49042480|NCT03119662|157989739|FG001|Overall Study|Withdrawal by Subject|1|||
48901772|NCT01079130|157475860|FG004|Overall Study|Adverse Event|5|||
48901773|NCT01079130|157475861|FG005|Overall Study|Adverse Event|1|||
49042481|NCT00874549|157989741|FG000|Overall Study|Adverse Event|0|||
49042482|NCT00874549|157989742|FG001|Overall Study|Adverse Event|0|||
49042483|NCT00874549|157989743|FG002|Overall Study|Adverse Event|1|||
49042484|NCT00874549|157989744|FG003|Overall Study|Adverse Event|0|||
49042485|NCT00874549|157989741|FG000|Overall Study|Protocol Violation|1|||
49042486|NCT00874549|157989742|FG001|Overall Study|Protocol Violation|0|||
48901774|NCT01079130|157475856|FG000|Overall Study|Administrative problems|1|||
48901775|NCT01079130|157475857|FG001|Overall Study|Administrative problems|3|||
48901776|NCT01079130|157475858|FG002|Overall Study|Administrative problems|0|||
49042487|NCT00874549|157989743|FG002|Overall Study|Protocol Violation|2|||
49042488|NCT00874549|157989744|FG003|Overall Study|Protocol Violation|1|||
49042489|NCT00874549|157989741|FG000|Overall Study|Lost to Follow-up|0|||
49042490|NCT00874549|157989742|FG001|Overall Study|Lost to Follow-up|0|||
49042491|NCT00874549|157989743|FG002|Overall Study|Lost to Follow-up|1|||
49042492|NCT00874549|157989744|FG003|Overall Study|Lost to Follow-up|0|||
49042493|NCT00874549|157989741|FG000|Overall Study|Withdrawal by Subject|0|||
49042494|NCT00874549|157989742|FG001|Overall Study|Withdrawal by Subject|1|||
49042495|NCT00874549|157989743|FG002|Overall Study|Withdrawal by Subject|0|||
49042496|NCT00874549|157989744|FG003|Overall Study|Withdrawal by Subject|1|||
49042497|NCT03246503|157989749|FG000|Overall Study|Lost to Follow-up|23|||
49042498|NCT03246503|157989749|FG000|Overall Study|Withdrawal by Subject|20|||
49042499|NCT03246503|157989749|FG000|Overall Study|Physician Decision|5|||
49042500|NCT03246503|157989749|FG000|Overall Study|Received phtototherapy prior to study visit=4, blood specimen not obtained =1|5|||
49042501|NCT00835796|157989751|FG000|First Intervention|Withdrawal by Subject|0|||
49042502|NCT00835796|157989752|FG001|First Intervention|Withdrawal by Subject|1|||
49042503|NCT03206749|157989753|FG000|Overall Study|Withdrawal of consent|5|||
49042504|NCT03206749|157989754|FG001|Overall Study|Withdrawal of consent|3|||
49042505|NCT03206749|157989755|FG002|Overall Study|Withdrawal of consent|6|||
49042506|NCT03206749|157989753|FG000|Overall Study|Lost to Follow-up|0|||
49042507|NCT03206749|157989754|FG001|Overall Study|Lost to Follow-up|0|||
49042508|NCT03206749|157989755|FG002|Overall Study|Lost to Follow-up|1|||
49042509|NCT00397254|157989756|FG000|Overall Study|Lost to Follow-up|2|||
49042510|NCT00397254|157989757|FG001|Overall Study|Lost to Follow-up|2|||
49042511|NCT00467597|157989760|FG000|Overall Study|Withdrawal by Subject|2|||
49042512|NCT00467597|157989761|FG001|Overall Study|Withdrawal by Subject|0|||
49042513|NCT00985751|157989762|FG000|Overall Study|Adverse Event|0|||
49042514|NCT00985751|157989763|FG001|Overall Study|Adverse Event|0|||
48901777|NCT01079130|157475859|FG003|Overall Study|Administrative problems|0|||
48901778|NCT01079130|157475860|FG004|Overall Study|Administrative problems|0|||
49042515|NCT00985751|157989764|FG002|Overall Study|Adverse Event|0|||
49042516|NCT00985751|157989765|FG003|Overall Study|Adverse Event|0|||
49042517|NCT00985751|157989766|FG004|Overall Study|Adverse Event|1|||
49042518|NCT01451541|157989767|FG000|Overall Study|Adverse Event|4|||
49042519|NCT01451541|157989768|FG001|Overall Study|Adverse Event|3|||
49042520|NCT01451541|157989769|FG002|Overall Study|Adverse Event|6|||
49042521|NCT01451541|157989767|FG000|Overall Study|Lack of Efficacy|2|||
49042522|NCT01451541|157989768|FG001|Overall Study|Lack of Efficacy|0|||
49042523|NCT01451541|157989769|FG002|Overall Study|Lack of Efficacy|0|||
49042524|NCT01451541|157989767|FG000|Overall Study|Lost to Follow-up|4|||
49042525|NCT01451541|157989768|FG001|Overall Study|Lost to Follow-up|4|||
49042526|NCT01451541|157989769|FG002|Overall Study|Lost to Follow-up|7|||
49042527|NCT01451541|157989767|FG000|Overall Study|Withdrawal by Subject|15|||
49042528|NCT01451541|157989768|FG001|Overall Study|Withdrawal by Subject|8|||
49042529|NCT01451541|157989769|FG002|Overall Study|Withdrawal by Subject|6|||
49042530|NCT01451541|157989767|FG000|Overall Study|randomization error, noncompliance|11|||
49042531|NCT01451541|157989768|FG001|Overall Study|randomization error, noncompliance|10|||
49042532|NCT01451541|157989769|FG002|Overall Study|randomization error, noncompliance|8|||
49042533|NCT02858037|157989779|FG000|Overall Study|Death|1|||
48901779|NCT01079130|157475861|FG005|Overall Study|Administrative problems|1|||
48901780|NCT01079130|157475856|FG000|Overall Study|Withdrawal by Subject|0|||
48901781|NCT01079130|157475857|FG001|Overall Study|Withdrawal by Subject|1|||
48901782|NCT01079130|157475858|FG002|Overall Study|Withdrawal by Subject|0|||
48901783|NCT01079130|157475859|FG003|Overall Study|Withdrawal by Subject|0|||
48901784|NCT01079130|157475860|FG004|Overall Study|Withdrawal by Subject|1|||
48901785|NCT01079130|157475861|FG005|Overall Study|Withdrawal by Subject|3|||
48901786|NCT01079130|157475856|FG000|Overall Study|Protocol deviation|0|||
48901787|NCT01079130|157475857|FG001|Overall Study|Protocol deviation|2|||
48901788|NCT01079130|157475858|FG002|Overall Study|Protocol deviation|1|||
48901789|NCT01079130|157475859|FG003|Overall Study|Protocol deviation|2|||
48901790|NCT01079130|157475860|FG004|Overall Study|Protocol deviation|0|||
48901791|NCT01079130|157475861|FG005|Overall Study|Protocol deviation|0|||
48901792|NCT01079130|157475856|FG000|Overall Study|Abnormal test procedure result(s)|0|||
48901793|NCT01079130|157475857|FG001|Overall Study|Abnormal test procedure result(s)|0|||
48901794|NCT01079130|157475858|FG002|Overall Study|Abnormal test procedure result(s)|0|||
48901795|NCT01079130|157475859|FG003|Overall Study|Abnormal test procedure result(s)|0|||
48901796|NCT01079130|157475860|FG004|Overall Study|Abnormal test procedure result(s)|1|||
48901797|NCT01079130|157475861|FG005|Overall Study|Abnormal test procedure result(s)|0|||
48901798|NCT01079130|157475856|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
48901799|NCT01079130|157475857|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
48901800|NCT01079130|157475858|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
48901801|NCT01079130|157475859|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
48901802|NCT01079130|157475860|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
48901803|NCT01079130|157475861|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
48901804|NCT01079130|157475856|FG000|Overall Study|Lost to Follow-up|0|||
48901805|NCT01079130|157475857|FG001|Overall Study|Lost to Follow-up|0|||
49042534|NCT02858037|157989779|FG000|Overall Study|Withdrawal by Subject|18|||
49042535|NCT02858037|157989779|FG000|Overall Study|Participant Relocated, no follow-up planned|26|||
49042536|NCT02858037|157989779|FG000|Overall Study|Lost to Follow-up|3|||
49042537|NCT02858037|157989779|FG000|Overall Study|Other|4|||
49042538|NCT03366428|157989780|FG000|Overall Study|Progressive disease per RECIST v1.1|33|||
49042539|NCT03366428|157989780|FG000|Overall Study|Adverse Event|12|||
49042540|NCT03366428|157989780|FG000|Overall Study|Clinical progression|2|||
49042541|NCT03366428|157989780|FG000|Overall Study|Withdrawal by Subject|4|||
49042542|NCT00210639|157989784|FG000|Overall Study|Lost to Follow-up|37|||
49042543|NCT00210639|157989785|FG001|Overall Study|Lost to Follow-up|29|||
49042544|NCT00210639|157989784|FG000|Overall Study|Withdrawal by Subject|8|||
49042545|NCT00210639|157989785|FG001|Overall Study|Withdrawal by Subject|1|||
49042546|NCT00210639|157989784|FG000|Overall Study|Other|18|||
49042547|NCT00210639|157989785|FG001|Overall Study|Other|12|||
49042548|NCT00724958|157989796|FG000|Overall Study|Adverse Event|28|||
49042549|NCT00724958|157989796|FG000|Overall Study|Loss of Response|40|||
49042550|NCT00724958|157989796|FG000|Overall Study|No Response|18|||
49042551|NCT00724958|157989796|FG000|Overall Study|Remission|7|||
49042552|NCT00724958|157989796|FG000|Overall Study|Other Reason|76|||
49042553|NCT00724958|157989796|FG000|Overall Study|No documentation for end of therapy|13|||
49042554|NCT01046084|157989804|FG000|Third Washout of 7 Days|Withdrawal by Subject|2|||
49042555|NCT01046084|157989805|FG001|Third Washout of 7 Days|Withdrawal by Subject|0|||
49042556|NCT02166606|157989806|FG000|Overall Study|Adverse Event|3|||
49042557|NCT02166606|157989806|FG000|Overall Study|Death|31|||
49042558|NCT02166606|157989806|FG000|Overall Study|Protocol Violation|7|||
49042559|NCT02166606|157989806|FG000|Overall Study|Lost to Follow-up|30|||
49042560|NCT02166606|157989806|FG000|Overall Study|Withdrawal by Subject|1|||
49042561|NCT02166606|157989806|FG000|Overall Study|Physician Decision|1|||
49042562|NCT02166606|157989806|FG000|Overall Study|Device upgrade|1|||
49042563|NCT02166606|157989806|FG000|Overall Study|Enrolled after End of Enrollment|4|||
49042564|NCT00999687|157989807|FG000|First Intervention|Withdrawal by Subject|1|||
49042565|NCT00999687|157989807|FG000|Second Intervention|Withdrawal by Subject|2|||
49042566|NCT00999687|157989807|FG000|Second Intervention|Lack of Efficacy|1|||
49042567|NCT01949532|157989810|FG000|Overall Study|On-study at the Data Cut-off Date|3|||
49042568|NCT01949532|157989811|FG001|Overall Study|On-study at the Data Cut-off Date|3|||
49042569|NCT03614728|157989819|FG000|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|1|||
49042570|NCT03614728|157989820|FG001|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
49042571|NCT03614728|157989821|FG002|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
49042572|NCT03614728|157989822|FG003|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
49042573|NCT03614728|157989819|FG000|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
49042574|NCT03614728|157989820|FG001|Part 1 (Up to 30.8 Months)|Physician Decision|1|||
49042575|NCT03614728|157989821|FG002|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
49042576|NCT03614728|157989822|FG003|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
49042577|NCT03732833|157989823|FG000|Overall Study|Adverse Event|0|||
49042578|NCT03732833|157989824|FG001|Overall Study|Adverse Event|3|||
49042579|NCT03732833|157989825|FG002|Overall Study|Adverse Event|1|||
49042580|NCT03732833|157989823|FG000|Overall Study|Withdrawal by Subject|11|||
49042581|NCT03732833|157989824|FG001|Overall Study|Withdrawal by Subject|13|||
49042582|NCT03732833|157989825|FG002|Overall Study|Withdrawal by Subject|8|||
49042583|NCT03732833|157989823|FG000|Overall Study|Lost to Follow-up|3|||
49042584|NCT03732833|157989824|FG001|Overall Study|Lost to Follow-up|5|||
49042585|NCT03732833|157989825|FG002|Overall Study|Lost to Follow-up|4|||
49042586|NCT03732833|157989823|FG000|Overall Study|Pregnancy|0|||
49042587|NCT03732833|157989824|FG001|Overall Study|Pregnancy|2|||
48901806|NCT01079130|157475858|FG002|Overall Study|Lost to Follow-up|0|||
48901807|NCT01079130|157475859|FG003|Overall Study|Lost to Follow-up|0|||
48901808|NCT01079130|157475860|FG004|Overall Study|Lost to Follow-up|1|||
48901809|NCT01079130|157475861|FG005|Overall Study|Lost to Follow-up|0|||
48901810|NCT00390910|157475862|FG000|Overall Study|Adverse Event|1|||
48901811|NCT00390910|157475863|FG001|Overall Study|Adverse Event|0|||
48901812|NCT00390910|157475864|FG002|Overall Study|Adverse Event|0|||
48985061|NCT01603615|157777552|FG000|Overall Study|Did not Receive Treatment|7|||
48985062|NCT01603615|157777552|FG000|Overall Study|Lost to Follow-up|9|||
48985063|NCT01603615|157777552|FG000|Overall Study|Personal Reasons|17|||
48985064|NCT01603615|157777552|FG000|Overall Study|Other Miscellaneous|1|||
48985065|NCT02759939|157777553|FG000|Overall Study|Missing data on first outcome assessed|11|||
48985066|NCT02759939|157777554|FG001|Overall Study|Missing data on first outcome assessed|2|||
48985067|NCT02759939|157777555|FG002|Overall Study|Missing data on first outcome assessed|5|||
48985068|NCT02759939|157777556|FG003|Overall Study|Missing data on first outcome assessed|2|||
48985069|NCT02759939|157777553|FG000|Overall Study|Ineligible for T2 and T3|310|||
49042588|NCT03732833|157989825|FG002|Overall Study|Pregnancy|0|||
48901813|NCT00390910|157475862|FG000|Overall Study|Lost to Follow-up|0|||
48985070|NCT02759939|157777554|FG001|Overall Study|Ineligible for T2 and T3|179|||
49042589|NCT03732833|157989823|FG000|Overall Study|Physician Decision|2|||
49042590|NCT03732833|157989824|FG001|Overall Study|Physician Decision|3|||
49042591|NCT03732833|157989825|FG002|Overall Study|Physician Decision|1|||
48901814|NCT00390910|157475863|FG001|Overall Study|Lost to Follow-up|1|||
48901815|NCT00390910|157475864|FG002|Overall Study|Lost to Follow-up|5|||
48901816|NCT00390910|157475862|FG000|Overall Study|Withdrawal by Subject|1|||
48901817|NCT00390910|157475863|FG001|Overall Study|Withdrawal by Subject|3|||
48901818|NCT00390910|157475864|FG002|Overall Study|Withdrawal by Subject|2|||
48901819|NCT00390910|157475862|FG000|Overall Study|Migrated/moved from study area|0|||
48901820|NCT00390910|157475863|FG001|Overall Study|Migrated/moved from study area|0|||
48901821|NCT00390910|157475864|FG002|Overall Study|Migrated/moved from study area|3|||
48901822|NCT01839487|157475865|FG000|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1|||
48901823|NCT01839487|157475866|FG001|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
48901824|NCT01839487|157475867|FG002|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
48901825|NCT01839487|157475868|FG003|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
48901826|NCT01839487|157475869|FG004|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
48901827|NCT01839487|157475870|FG005|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
48901828|NCT01839487|157475865|FG000|Run-in Phase (Maximum Exposure:295 Days)|Death|14|||
48901829|NCT01839487|157475866|FG001|Run-in Phase (Maximum Exposure:295 Days)|Death|6|||
48901830|NCT01839487|157475867|FG002|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
48901831|NCT01839487|157475868|FG003|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
48901832|NCT01839487|157475869|FG004|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
48901833|NCT01839487|157475870|FG005|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
48901834|NCT01839487|157475865|FG000|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
48901835|NCT01839487|157475866|FG001|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1|||
48901836|NCT01839487|157475867|FG002|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
48901837|NCT01839487|157475868|FG003|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
48901838|NCT01839487|157475869|FG004|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
48901839|NCT01839487|157475870|FG005|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
48901840|NCT01839487|157475865|FG000|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1|||
48901841|NCT01839487|157475866|FG001|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
48901842|NCT01839487|157475867|FG002|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
48901843|NCT01839487|157475868|FG003|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
48901844|NCT01839487|157475869|FG004|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
48901845|NCT01839487|157475870|FG005|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
48901846|NCT01839487|157475865|FG000|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
48901847|NCT01839487|157475866|FG001|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
48901848|NCT01839487|157475867|FG002|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12|||
48901849|NCT01839487|157475868|FG003|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9|||
48901850|NCT01839487|157475869|FG004|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4|||
48901851|NCT01839487|157475870|FG005|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8|||
48901852|NCT01839487|157475865|FG000|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
48901853|NCT01839487|157475866|FG001|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
48901854|NCT01839487|157475867|FG002|Phase 2 (Maximum Exposure:935 Days)|Death|46|||
48901855|NCT01839487|157475868|FG003|Phase 2 (Maximum Exposure:935 Days)|Death|49|||
48901856|NCT01839487|157475869|FG004|Phase 2 (Maximum Exposure:935 Days)|Death|71|||
48901857|NCT01839487|157475870|FG005|Phase 2 (Maximum Exposure:935 Days)|Death|32|||
48901858|NCT01839487|157475865|FG000|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
48901859|NCT01839487|157475866|FG001|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
48901860|NCT01839487|157475867|FG002|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2|||
48901861|NCT01839487|157475868|FG003|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
48901862|NCT01839487|157475869|FG004|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1|||
48901863|NCT01839487|157475870|FG005|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
48901864|NCT01839487|157475865|FG000|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
48901865|NCT01839487|157475866|FG001|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
48901866|NCT01839487|157475867|FG002|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
48901867|NCT01839487|157475868|FG003|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1|||
48901868|NCT01839487|157475869|FG004|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10|||
48901869|NCT01839487|157475870|FG005|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3|||
48901870|NCT01839487|157475865|FG000|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
48985071|NCT02759939|157777555|FG002|Overall Study|Ineligible for T2 and T3|366|||
48985072|NCT02759939|157777556|FG003|Overall Study|Ineligible for T2 and T3|391|||
48985073|NCT02759939|157777553|FG000|Overall Study|Lost to Follow-up|735|||
48985074|NCT02759939|157777554|FG001|Overall Study|Lost to Follow-up|791|||
48985075|NCT02759939|157777555|FG002|Overall Study|Lost to Follow-up|783|||
48985076|NCT02759939|157777556|FG003|Overall Study|Lost to Follow-up|650|||
48985077|NCT03419741|157777557|FG000|Overall Study|Adverse Event|1|||
48985078|NCT03419741|157777558|FG001|Overall Study|Adverse Event|0|||
48985079|NCT03419741|157777557|FG000|Overall Study|Withdrawal by Subject|1|||
48985080|NCT03419741|157777558|FG001|Overall Study|Withdrawal by Subject|2|||
48985081|NCT00303329|157777560|FG000|Overall Study|Adverse Event|7|||
48901871|NCT01839487|157475866|FG001|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
48901872|NCT01839487|157475867|FG002|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
48901873|NCT01839487|157475868|FG003|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3|||
48901874|NCT01839487|157475869|FG004|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2|||
48901875|NCT01839487|157475870|FG005|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
48901876|NCT02499770|157475885|FG000|Overall Study|Death|17|||
48901877|NCT02499770|157475886|FG001|Overall Study|Death|56|||
48901878|NCT02499770|157475885|FG000|Overall Study|Study completion|1|||
48901879|NCT02499770|157475886|FG001|Overall Study|Study completion|10|||
48901880|NCT02499770|157475885|FG000|Overall Study|Withdrawal by Subject|0|||
48901881|NCT02499770|157475886|FG001|Overall Study|Withdrawal by Subject|7|||
48901882|NCT02499770|157475885|FG000|Overall Study|Lost to Follow-up|0|||
48901883|NCT02499770|157475886|FG001|Overall Study|Lost to Follow-up|2|||
48901884|NCT02499770|157475885|FG000|Overall Study|Subject declined further treatment|1|||
48901885|NCT02499770|157475886|FG001|Overall Study|Subject declined further treatment|0|||
48901886|NCT02499770|157475885|FG000|Overall Study|Withdrawn by PI for compassionate reason|0|||
48901887|NCT02499770|157475886|FG001|Overall Study|Withdrawn by PI for compassionate reason|1|||
48901888|NCT02499770|157475885|FG000|Overall Study|Randomized but not enrolled|0|||
48901889|NCT02499770|157475886|FG001|Overall Study|Randomized but not enrolled|1|||
48901890|NCT02881957|157475892|FG000|Overall Study|Comfort care|0|||
48901891|NCT02881957|157475893|FG001|Overall Study|Comfort care|1|||
48901892|NCT02881957|157475892|FG000|Overall Study|Concurrent trial enrollment|0|||
48901893|NCT02881957|157475893|FG001|Overall Study|Concurrent trial enrollment|1|||
48901894|NCT02881957|157475892|FG000|Overall Study|Discharged within 48 hours|0|||
48901895|NCT02881957|157475893|FG001|Overall Study|Discharged within 48 hours|1|||
48901896|NCT02881957|157475892|FG000|Overall Study|Withdrawal by Subject|2|||
48901897|NCT02881957|157475893|FG001|Overall Study|Withdrawal by Subject|1|||
48901898|NCT02881957|157475892|FG000|Overall Study|Protocol Violation|1|||
48901899|NCT02881957|157475893|FG001|Overall Study|Protocol Violation|0|||
48901900|NCT01201343|157477537|FG000|Overall Study|Adverse Event|6|||
48901901|NCT01201343|157477537|FG000|Overall Study|Withdrawal by Subject|5|||
48901902|NCT01201343|157477537|FG000|Overall Study|Lost to Follow-up|2|||
48901903|NCT01201343|157477537|FG000|Overall Study|Lack of Efficacy|2|||
48901904|NCT01201343|157477537|FG000|Overall Study|Participant wrongly included in trial|1|||
48901905|NCT01201343|157477537|FG000|Overall Study|Randomized, not treated|3|||
48901906|NCT02164383|157477538|FG000|Overall Study|Lost to Follow-up|1|||
48901907|NCT02164383|157477539|FG001|Overall Study|Lost to Follow-up|0|||
48901908|NCT01440374|157477543|FG000|Part 1: Open-label Phase|Adverse Event|5|||
48901909|NCT01440374|157477544|FG001|Part 1: Open-label Phase|Adverse Event|0|||
48901910|NCT01440374|157477545|FG002|Part 1: Open-label Phase|Adverse Event|0|||
48901911|NCT01440374|157477546|FG003|Part 1: Open-label Phase|Adverse Event|0|||
48901912|NCT01440374|157477543|FG000|Part 1: Open-label Phase|Physician Decision|1|||
48901913|NCT01440374|157477544|FG001|Part 1: Open-label Phase|Physician Decision|0|||
48901914|NCT01440374|157477545|FG002|Part 1: Open-label Phase|Physician Decision|0|||
49042592|NCT03732833|157989823|FG000|Overall Study|Covid-19 related and other reasons|2|||
49042593|NCT03732833|157989824|FG001|Overall Study|Covid-19 related and other reasons|7|||
49042594|NCT03732833|157989825|FG002|Overall Study|Covid-19 related and other reasons|3|||
49042595|NCT01519947|157989826|FG000|Overall Study|Death|0|||
49042596|NCT01519947|157989827|FG001|Overall Study|Death|0|||
49042597|NCT01519947|157989828|FG002|Overall Study|Death|0|||
49042598|NCT01519947|157989829|FG003|Overall Study|Death|1|||
49042599|NCT01519947|157989826|FG000|Overall Study|Protocol Violation|0|||
49042600|NCT01519947|157989827|FG001|Overall Study|Protocol Violation|0|||
49042601|NCT01519947|157989828|FG002|Overall Study|Protocol Violation|2|||
49042602|NCT01519947|157989829|FG003|Overall Study|Protocol Violation|1|||
49042603|NCT01519947|157989826|FG000|Overall Study|Peritoneal Dialysis Needed|0|||
49042604|NCT01519947|157989827|FG001|Overall Study|Peritoneal Dialysis Needed|1|||
49042605|NCT01519947|157989828|FG002|Overall Study|Peritoneal Dialysis Needed|0|||
49042606|NCT01519947|157989829|FG003|Overall Study|Peritoneal Dialysis Needed|0|||
49042607|NCT01519947|157989826|FG000|Overall Study|Development of Anemia|0|||
49042608|NCT01519947|157989827|FG001|Overall Study|Development of Anemia|1|||
49042609|NCT01519947|157989828|FG002|Overall Study|Development of Anemia|0|||
49042610|NCT01519947|157989829|FG003|Overall Study|Development of Anemia|1|||
49042611|NCT01519947|157989826|FG000|Overall Study|Blood Transfusion|0|||
49042612|NCT01519947|157989827|FG001|Overall Study|Blood Transfusion|1|||
49042613|NCT01519947|157989828|FG002|Overall Study|Blood Transfusion|1|||
48901915|NCT01440374|157477546|FG003|Part 1: Open-label Phase|Physician Decision|0|||
48901916|NCT01440374|157477543|FG000|Part 2; Double-blind Phase|Physician Decision|0|||
49042614|NCT01519947|157989829|FG003|Overall Study|Blood Transfusion|0|||
48901917|NCT01440374|157477544|FG001|Part 2; Double-blind Phase|Physician Decision|8|||
48901918|NCT01440374|157477545|FG002|Part 2; Double-blind Phase|Physician Decision|17|||
48901919|NCT01440374|157477546|FG003|Part 2; Double-blind Phase|Physician Decision|0|||
48901920|NCT01440374|157477543|FG000|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
48901921|NCT01440374|157477544|FG001|Part 2; Double-blind Phase|Withdrawal by Subject|4|||
48901922|NCT01440374|157477545|FG002|Part 2; Double-blind Phase|Withdrawal by Subject|5|||
48901923|NCT01440374|157477546|FG003|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
48901924|NCT01440374|157477543|FG000|Part 2; Double-blind Phase|Protocol Violation|0|||
48901925|NCT01440374|157477544|FG001|Part 2; Double-blind Phase|Protocol Violation|0|||
48901926|NCT01440374|157477545|FG002|Part 2; Double-blind Phase|Protocol Violation|1|||
48901927|NCT01440374|157477546|FG003|Part 2; Double-blind Phase|Protocol Violation|0|||
48901928|NCT01440374|157477543|FG000|Part 2; Double-blind Phase|Lack of Efficacy|0|||
48901929|NCT01440374|157477544|FG001|Part 2; Double-blind Phase|Lack of Efficacy|1|||
48901930|NCT01440374|157477545|FG002|Part 2; Double-blind Phase|Lack of Efficacy|0|||
48901931|NCT01440374|157477546|FG003|Part 2; Double-blind Phase|Lack of Efficacy|0|||
48901932|NCT01440374|157477543|FG000|Part 2; Double-blind Phase|Adverse Event|0|||
48901933|NCT01440374|157477544|FG001|Part 2; Double-blind Phase|Adverse Event|7|||
48901934|NCT01440374|157477545|FG002|Part 2; Double-blind Phase|Adverse Event|31|||
48901935|NCT01440374|157477546|FG003|Part 2; Double-blind Phase|Adverse Event|0|||
48901936|NCT01440374|157477543|FG000|Part 2; Double-blind Phase|Not treated|0|||
48901937|NCT01440374|157477544|FG001|Part 2; Double-blind Phase|Not treated|0|||
48901938|NCT01440374|157477545|FG002|Part 2; Double-blind Phase|Not treated|1|||
48901939|NCT01440374|157477546|FG003|Part 2; Double-blind Phase|Not treated|0|||
48901940|NCT01440374|157477543|FG000|Part 3: Extension|Withdrawal by Subject|0|||
48901941|NCT01440374|157477544|FG001|Part 3: Extension|Withdrawal by Subject|0|||
48901942|NCT01440374|157477545|FG002|Part 3: Extension|Withdrawal by Subject|0|||
48901943|NCT01440374|157477546|FG003|Part 3: Extension|Withdrawal by Subject|5|||
48901944|NCT01440374|157477543|FG000|Part 3: Extension|Adverse Event|0|||
48901945|NCT01440374|157477544|FG001|Part 3: Extension|Adverse Event|0|||
48901946|NCT01440374|157477545|FG002|Part 3: Extension|Adverse Event|0|||
48901947|NCT01440374|157477546|FG003|Part 3: Extension|Adverse Event|13|||
48901948|NCT01440374|157477543|FG000|Part 3: Extension|Physician Decision|0|||
48901949|NCT01440374|157477544|FG001|Part 3: Extension|Physician Decision|0|||
48901950|NCT01440374|157477545|FG002|Part 3: Extension|Physician Decision|0|||
48901951|NCT01440374|157477546|FG003|Part 3: Extension|Physician Decision|14|||
48901952|NCT00743275|157477547|FG000|Overall Study|Protocol Violation|0|||
48901953|NCT00743275|157477548|FG001|Overall Study|Protocol Violation|1|||
48901954|NCT02186223|157477552|FG000|Overall Study|Not eligible for device placement|6|||
48901955|NCT02186223|157477552|FG000|Overall Study|Unable to obtain femoral access|3|||
48901956|NCT02186223|157477552|FG000|Overall Study|Death|3|||
48901957|NCT02186223|157477552|FG000|Overall Study|Device in place less than 48 hours|9|||
48901958|NCT00876928|157477553|FG000|Overall Study|Lost to Follow-up|2|||
48901959|NCT00876928|157477554|FG001|Overall Study|Lost to Follow-up|5|||
48901960|NCT00876928|157477553|FG000|Overall Study|Hypokalemia-affects insulin secretion|1|||
48901961|NCT00876928|157477554|FG001|Overall Study|Hypokalemia-affects insulin secretion|0|||
48901962|NCT00701779|157477555|FG000|Overall Study|Adverse Event|6|||
48901963|NCT00701779|157477555|FG000|Overall Study|Lost to Follow-up|1|||
48901964|NCT00701779|157477555|FG000|Overall Study|Withdrawal by Subject|2|||
48901965|NCT01716117|157477559|FG000|Overall Study|Death|5|||
48901966|NCT01716117|157477560|FG001|Overall Study|Death|2|||
48901967|NCT01716117|157477559|FG000|Overall Study|Withdrawal by Subject|2|||
48901968|NCT01716117|157477560|FG001|Overall Study|Withdrawal by Subject|0|||
48901969|NCT02336178|157477561|FG000|Overall Study|Lost to Follow-up|1|||
48901970|NCT02336178|157477561|FG000|Overall Study|Protocol Violation|1|||
48901971|NCT02336178|157477561|FG000|Overall Study|Withdrawal by Subject|1|||
48901972|NCT02336178|157477561|FG000|Overall Study|Other|1|||
48901973|NCT01146054|157477562|FG000|Overall Study|Did not meet dose constraints for SBRT|5|||
48901974|NCT01146054|157477562|FG000|Overall Study|Rapid tumor progression|2|||
48901975|NCT01146054|157477562|FG000|Overall Study|Other illness precluded treatment|2|||
48901976|NCT01146054|157477562|FG000|Overall Study|Lost to Follow-up|1|||
48901977|NCT00655863|157477568|FG000|Overall Study|Lost to Follow-up|0|||
48901978|NCT00655863|157477569|FG001|Overall Study|Lost to Follow-up|0|||
49042615|NCT01519947|157989826|FG000|Overall Study|Withdrawal by Subject|0|||
49042616|NCT01519947|157989827|FG001|Overall Study|Withdrawal by Subject|1|||
48901979|NCT00655863|157477570|FG002|Overall Study|Lost to Follow-up|1|||
48901980|NCT04975438|157477571|FG000|Overall Study|Lost to Follow-up|1|||
48901981|NCT04975438|157477572|FG001|Overall Study|Lost to Follow-up|0|||
48901982|NCT04975438|157477573|FG002|Overall Study|Lost to Follow-up|1|||
49042617|NCT01519947|157989828|FG002|Overall Study|Withdrawal by Subject|0|||
48901983|NCT04975438|157477574|FG003|Overall Study|Lost to Follow-up|0|||
48901984|NCT04975438|157477571|FG000|Overall Study|Withdrawal by Subject|1|||
48901985|NCT04975438|157477572|FG001|Overall Study|Withdrawal by Subject|0|||
48901986|NCT04975438|157477573|FG002|Overall Study|Withdrawal by Subject|0|||
48901987|NCT04975438|157477574|FG003|Overall Study|Withdrawal by Subject|0|||
48901988|NCT03588728|157477576|FG000|Overall Study|Did not meet eligibility ctriteria|0|||
48901989|NCT03588728|157477577|FG001|Overall Study|Did not meet eligibility ctriteria|0|||
48901990|NCT03588728|157477578|FG002|Overall Study|Did not meet eligibility ctriteria|3|||
48901991|NCT03588728|157477579|FG003|Overall Study|Did not meet eligibility ctriteria|2|||
48901992|NCT03588728|157477576|FG000|Overall Study|Lab shut down due to COVID-19|0|||
48901993|NCT03588728|157477577|FG001|Overall Study|Lab shut down due to COVID-19|0|||
48901994|NCT03588728|157477578|FG002|Overall Study|Lab shut down due to COVID-19|0|||
48901995|NCT03588728|157477579|FG003|Overall Study|Lab shut down due to COVID-19|1|||
48901996|NCT03588728|157477576|FG000|Overall Study|multiple technical issues|1|||
48901997|NCT03588728|157477577|FG001|Overall Study|multiple technical issues|0|||
48901998|NCT03588728|157477578|FG002|Overall Study|multiple technical issues|0|||
48901999|NCT03588728|157477579|FG003|Overall Study|multiple technical issues|0|||
48902000|NCT03588728|157477576|FG000|Overall Study|Hospitalized for COVID|1|||
48985082|NCT00303329|157777561|FG001|Overall Study|Adverse Event|14|||
48985083|NCT00303329|157777560|FG000|Overall Study|Abnormal Laboratory Values|0|||
48985084|NCT00303329|157777561|FG001|Overall Study|Abnormal Laboratory Values|1|||
48985085|NCT00303329|157777560|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
48985086|NCT00303329|157777561|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
48985087|NCT00303329|157777560|FG000|Overall Study|Condition no longer requires study drug|0|||
48985088|NCT00303329|157777561|FG001|Overall Study|Condition no longer requires study drug|8|||
48985089|NCT00303329|157777560|FG000|Overall Study|Protocol Violation|3|||
48985090|NCT00303329|157777561|FG001|Overall Study|Protocol Violation|0|||
48985091|NCT00303329|157777560|FG000|Overall Study|Withdrawal by Subject|9|||
48985092|NCT00303329|157777561|FG001|Overall Study|Withdrawal by Subject|15|||
48985093|NCT00303329|157777560|FG000|Overall Study|Lost to Follow-up|0|||
48985094|NCT00303329|157777561|FG001|Overall Study|Lost to Follow-up|1|||
48985095|NCT00303329|157777560|FG000|Overall Study|Administrative problems|1|||
48985096|NCT00303329|157777561|FG001|Overall Study|Administrative problems|0|||
48985097|NCT00303329|157777560|FG000|Overall Study|Death|2|||
48985098|NCT00303329|157777561|FG001|Overall Study|Death|12|||
48985099|NCT00303329|157777560|FG000|Overall Study|Stopped at end of core|3|||
48985100|NCT00303329|157777561|FG001|Overall Study|Stopped at end of core|9|||
48985101|NCT00303329|157777560|FG000|Overall Study|Stopped at end of extension 1|1|||
48985102|NCT00303329|157777561|FG001|Overall Study|Stopped at end of extension 1|0|||
48985103|NCT04354870|157777578|FG000|Overall Study|Lost to Follow-up|32|||
48985104|NCT04354870|157777579|FG001|Overall Study|Lost to Follow-up|12|||
48985105|NCT04354870|157777578|FG000|Overall Study|Withdrawal by Subject|10|||
48985106|NCT04354870|157777579|FG001|Overall Study|Withdrawal by Subject|16|||
48985107|NCT04354870|157777578|FG000|Overall Study|Did not complete all study visits|6|||
48985108|NCT04354870|157777579|FG001|Overall Study|Did not complete all study visits|5|||
48985109|NCT04735432|157777580|FG000|Overall Study|Other - due to personal reason|1|||
48985110|NCT04735432|157777581|FG001|Overall Study|Other - due to personal reason|0|||
48985111|NCT04735432|157777580|FG000|Overall Study|Adverse Event|2|||
48985112|NCT04735432|157777581|FG001|Overall Study|Adverse Event|0|||
48985113|NCT02646891|157777586|FG000|Overall Study|Adverse Event|0|||
48985114|NCT02646891|157777587|FG001|Overall Study|Adverse Event|1|||
48985115|NCT02646891|157777588|FG002|Overall Study|Adverse Event|0|||
48985116|NCT02646891|157777589|FG003|Overall Study|Adverse Event|0|||
48985117|NCT02646891|157777590|FG004|Overall Study|Adverse Event|0|||
48985118|NCT02646891|157777591|FG005|Overall Study|Adverse Event|0|||
48985119|NCT02646891|157777592|FG006|Overall Study|Adverse Event|0|||
48985120|NCT02646891|157777593|FG007|Overall Study|Adverse Event|0|||
48985121|NCT02646891|157777594|FG008|Overall Study|Adverse Event|0|||
48985122|NCT02646891|157777595|FG009|Overall Study|Adverse Event|0|||
48985123|NCT02646891|157777586|FG000|Overall Study|Lost to Follow-up|0|||
48985124|NCT02646891|157777587|FG001|Overall Study|Lost to Follow-up|0|||
48985125|NCT02646891|157777588|FG002|Overall Study|Lost to Follow-up|0|||
48985126|NCT02646891|157777589|FG003|Overall Study|Lost to Follow-up|0|||
48985127|NCT02646891|157777590|FG004|Overall Study|Lost to Follow-up|0|||
48985128|NCT02646891|157777591|FG005|Overall Study|Lost to Follow-up|0|||
48985129|NCT02646891|157777592|FG006|Overall Study|Lost to Follow-up|2|||
48985130|NCT02646891|157777593|FG007|Overall Study|Lost to Follow-up|2|||
48985131|NCT02646891|157777594|FG008|Overall Study|Lost to Follow-up|2|||
48985132|NCT02646891|157777595|FG009|Overall Study|Lost to Follow-up|2|||
48985133|NCT02646891|157777586|FG000|Overall Study|Protocol Violation|0|||
48985134|NCT02646891|157777587|FG001|Overall Study|Protocol Violation|0|||
48985135|NCT02646891|157777588|FG002|Overall Study|Protocol Violation|0|||
48985136|NCT02646891|157777589|FG003|Overall Study|Protocol Violation|0|||
48985137|NCT02646891|157777590|FG004|Overall Study|Protocol Violation|0|||
48985138|NCT02646891|157777591|FG005|Overall Study|Protocol Violation|0|||
48985139|NCT02646891|157777592|FG006|Overall Study|Protocol Violation|1|||
48985140|NCT02646891|157777593|FG007|Overall Study|Protocol Violation|1|||
48985141|NCT02646891|157777594|FG008|Overall Study|Protocol Violation|0|||
48985142|NCT02646891|157777595|FG009|Overall Study|Protocol Violation|0|||
48985143|NCT02646891|157777586|FG000|Overall Study|Withdrawal by Subject|2|||
48985144|NCT02646891|157777587|FG001|Overall Study|Withdrawal by Subject|0|||
48985145|NCT02646891|157777588|FG002|Overall Study|Withdrawal by Subject|1|||
48985146|NCT02646891|157777589|FG003|Overall Study|Withdrawal by Subject|0|||
48985147|NCT02646891|157777590|FG004|Overall Study|Withdrawal by Subject|0|||
48985148|NCT02646891|157777591|FG005|Overall Study|Withdrawal by Subject|0|||
48985149|NCT02646891|157777592|FG006|Overall Study|Withdrawal by Subject|5|||
48985150|NCT02646891|157777593|FG007|Overall Study|Withdrawal by Subject|9|||
48902001|NCT03588728|157477577|FG001|Overall Study|Hospitalized for COVID|0|||
48902002|NCT03588728|157477578|FG002|Overall Study|Hospitalized for COVID|0|||
48902003|NCT03588728|157477579|FG003|Overall Study|Hospitalized for COVID|0|||
48902004|NCT03588728|157477576|FG000|Overall Study|Schedule change unable to attend sessions|1|||
48902005|NCT03588728|157477577|FG001|Overall Study|Schedule change unable to attend sessions|0|||
48902006|NCT03588728|157477578|FG002|Overall Study|Schedule change unable to attend sessions|0|||
48902007|NCT03588728|157477579|FG003|Overall Study|Schedule change unable to attend sessions|0|||
48902008|NCT00395460|157477581|FG000|Overall Study|Withdrawal by Subject|1|||
48902009|NCT00395460|157477582|FG001|Overall Study|Withdrawal by Subject|0|||
48902010|NCT01136772|157477583|FG000|Overall Study|Adverse Event|15|||
48902011|NCT01136772|157477584|FG001|Overall Study|Adverse Event|14|||
48902012|NCT01136772|157477583|FG000|Overall Study|Lack of Efficacy|42|||
48902013|NCT01136772|157477584|FG001|Overall Study|Lack of Efficacy|39|||
48902014|NCT01136772|157477583|FG000|Overall Study|Administrative|14|||
48902015|NCT01136772|157477584|FG001|Overall Study|Administrative|12|||
48902016|NCT01136772|157477583|FG000|Overall Study|Withdrawal by Subject|33|||
48902017|NCT01136772|157477584|FG001|Overall Study|Withdrawal by Subject|36|||
48902018|NCT01136772|157477583|FG000|Overall Study|Did not receive injection|10|||
48902019|NCT01136772|157477584|FG001|Overall Study|Did not receive injection|7|||
48902020|NCT01136772|157477583|FG000|Overall Study|Did not follow up after first injection|2|||
48902021|NCT01136772|157477584|FG001|Overall Study|Did not follow up after first injection|2|||
48902022|NCT01100034|157477585|FG000|Overall Study|Lost to Follow-up|11|||
48902023|NCT01100034|157477585|FG000|Overall Study|Withdrawal of parent/guardian consent|1|||
48902024|NCT01100034|157477585|FG000|Overall Study|Withdrawal by Subject|4|||
48902025|NCT01100034|157477585|FG000|Overall Study|Sponsor decision|21|||
48902026|NCT01100034|157477585|FG000|Overall Study|Participated in another clinical trial|1|||
48902027|NCT01100034|157477585|FG000|Overall Study|Participants moved to another hospital|4|||
48902028|NCT01100034|157477585|FG000|Overall Study|Site closed due to non-responsiveness|1|||
48902029|NCT01259726|157477586|FG000|Overall Study|Death|1|||
48902030|NCT01259726|157477587|FG001|Overall Study|Death|0|||
48902031|NCT01259726|157477588|FG002|Overall Study|Death|0|||
48902032|NCT01259726|157477589|FG003|Overall Study|Death|0|||
48902033|NCT01259726|157477586|FG000|Overall Study|Physician Decision|2|||
48902034|NCT01259726|157477587|FG001|Overall Study|Physician Decision|0|||
48902035|NCT01259726|157477588|FG002|Overall Study|Physician Decision|1|||
48902036|NCT01259726|157477589|FG003|Overall Study|Physician Decision|1|||
48902037|NCT01259726|157477586|FG000|Overall Study|Withdrawal by Subject|1|||
48902038|NCT01259726|157477587|FG001|Overall Study|Withdrawal by Subject|3|||
48902039|NCT01259726|157477588|FG002|Overall Study|Withdrawal by Subject|2|||
48902040|NCT01259726|157477589|FG003|Overall Study|Withdrawal by Subject|1|||
48902041|NCT01259726|157477586|FG000|Overall Study|Lost to Follow-up|1|||
48902042|NCT01259726|157477587|FG001|Overall Study|Lost to Follow-up|1|||
48902043|NCT01259726|157477588|FG002|Overall Study|Lost to Follow-up|1|||
48902044|NCT01259726|157477589|FG003|Overall Study|Lost to Follow-up|3|||
48902045|NCT02319525|157477593|FG000|Overall Study|Withdrawal by Subject|2|||
48902046|NCT02319525|157477594|FG001|Overall Study|Withdrawal by Subject|1|||
48902047|NCT04964414|157477595|FG000|Overall Study|Lost to Follow-up|10|||
48902048|NCT04964414|157477596|FG001|Overall Study|Lost to Follow-up|8|||
48902049|NCT04964414|157477595|FG000|Overall Study|Withdrawal by Subject|1|||
48902050|NCT04964414|157477596|FG001|Overall Study|Withdrawal by Subject|1|||
48902051|NCT03881553|157477597|FG000|Overall Study|Discharged prior to participation|1|||
48902052|NCT03881553|157477598|FG001|Overall Study|Discharged prior to participation|1|||
48902053|NCT03881553|157477599|FG002|Overall Study|Discharged prior to participation|0|||
48902054|NCT03881553|157477597|FG000|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
48902055|NCT03881553|157477598|FG001|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
48902056|NCT03881553|157477599|FG002|Overall Study|Developed infection prior to participation--excluded per protocol criteria|1|||
48902057|NCT01128894|157477600|FG000|Overall Study|Adverse Event|31|||
48902058|NCT01128894|157477601|FG001|Overall Study|Adverse Event|41|||
48902059|NCT01128894|157477600|FG000|Overall Study|Protocol Violation|2|||
48902060|NCT01128894|157477601|FG001|Overall Study|Protocol Violation|1|||
48902061|NCT01128894|157477600|FG000|Overall Study|Noncompliance|4|||
48902062|NCT01128894|157477601|FG001|Overall Study|Noncompliance|5|||
48902063|NCT01128894|157477600|FG000|Overall Study|Lost to Follow-up|8|||
48902064|NCT01128894|157477601|FG001|Overall Study|Lost to Follow-up|8|||
48902065|NCT01128894|157477600|FG000|Overall Study|Withdrawal by Subject|10|||
48902066|NCT01128894|157477601|FG001|Overall Study|Withdrawal by Subject|12|||
48902067|NCT01128894|157477600|FG000|Overall Study|Physician Decision|2|||
48902068|NCT01128894|157477601|FG001|Overall Study|Physician Decision|1|||
48902069|NCT01128894|157477600|FG000|Overall Study|Conflicting HbA1c Results at Screening|1|||
48902070|NCT01128894|157477601|FG001|Overall Study|Conflicting HbA1c Results at Screening|0|||
48902071|NCT03437278|157477603|FG000|Overall Study|Adverse Event|0|||
48902072|NCT03437278|157477604|FG001|Overall Study|Adverse Event|0|||
48902073|NCT03437278|157477605|FG002|Overall Study|Adverse Event|1|||
48902074|NCT03437278|157477603|FG000|Overall Study|Progressive disease|1|||
48902075|NCT03437278|157477604|FG001|Overall Study|Progressive disease|0|||
48902076|NCT03437278|157477605|FG002|Overall Study|Progressive disease|0|||
48902077|NCT03437278|157477603|FG000|Overall Study|Physician Decision|1|||
48902078|NCT03437278|157477604|FG001|Overall Study|Physician Decision|0|||
48902079|NCT03437278|157477605|FG002|Overall Study|Physician Decision|1|||
48902080|NCT03153137|157477606|FG000|Overall Study|Lost to Follow-up|1|||
48902081|NCT03153137|157477607|FG001|Overall Study|Lost to Follow-up|0|||
48902082|NCT03153137|157477606|FG000|Overall Study|Withdrawal by Subject|2|||
48902083|NCT03153137|157477607|FG001|Overall Study|Withdrawal by Subject|1|||
48902084|NCT03153137|157477606|FG000|Overall Study|Physician Decision|0|||
48902085|NCT03153137|157477607|FG001|Overall Study|Physician Decision|3|||
48902086|NCT00195507|157477608|FG000|Overall Study|Adverse Event|24|||
48902087|NCT00195507|157477609|FG001|Overall Study|Adverse Event|13|||
48902088|NCT00195507|157477608|FG000|Overall Study|Death|0|||
48902089|NCT00195507|157477609|FG001|Overall Study|Death|1|||
48902090|NCT00195507|157477608|FG000|Overall Study|Failed to Return|4|||
48902091|NCT00195507|157477609|FG001|Overall Study|Failed to Return|3|||
48902092|NCT00195507|157477608|FG000|Overall Study|Physician Decision|1|||
48902093|NCT00195507|157477609|FG001|Overall Study|Physician Decision|2|||
48902094|NCT00195507|157477608|FG000|Overall Study|Lost to Follow-up|3|||
48902095|NCT00195507|157477609|FG001|Overall Study|Lost to Follow-up|2|||
48902096|NCT00195507|157477608|FG000|Overall Study|Protocol Violation|5|||
48902097|NCT00195507|157477609|FG001|Overall Study|Protocol Violation|4|||
48902098|NCT00195507|157477608|FG000|Overall Study|Lack of Efficacy|40|||
48902099|NCT00195507|157477609|FG001|Overall Study|Lack of Efficacy|67|||
48902100|NCT00195507|157477608|FG000|Overall Study|Withdrawal by Subject|16|||
48902101|NCT00195507|157477609|FG001|Overall Study|Withdrawal by Subject|23|||
48902102|NCT00195507|157477608|FG000|Overall Study|Protocol Deviation|6|||
48902103|NCT00195507|157477609|FG001|Overall Study|Protocol Deviation|3|||
48902104|NCT02260882|157477615|FG000|Overall Study|Protocol Violation|0|||
48902105|NCT02260882|157477616|FG001|Overall Study|Protocol Violation|1|||
48902106|NCT02683941|157477618|FG000|Double-blind Phase|Adverse Event|0|||
48902107|NCT02683941|157477619|FG001|Double-blind Phase|Adverse Event|1|||
48902108|NCT02683941|157477618|FG000|Double-blind Phase|Withdrawal by Subject|4|||
48902109|NCT02683941|157477619|FG001|Double-blind Phase|Withdrawal by Subject|2|||
48902110|NCT02683941|157477618|FG000|Double-blind Phase|Lost to Follow-up|1|||
48902111|NCT02683941|157477619|FG001|Double-blind Phase|Lost to Follow-up|0|||
48902112|NCT02683941|157477618|FG000|Double-blind Phase|Disease Progression|5|||
48902113|NCT02683941|157477619|FG001|Double-blind Phase|Disease Progression|2|||
48902114|NCT02683941|157477618|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
48902115|NCT02683941|157477619|FG001|Open-label Treatment Phase|Withdrawal by Subject|2|||
48902116|NCT02683941|157477618|FG000|Open-label Treatment Phase|Disease Progression|1|||
48902117|NCT02683941|157477619|FG001|Open-label Treatment Phase|Disease Progression|2|||
48902118|NCT02683941|157477618|FG000|Open-label Treatment Phase|Study Termination by the Sponsor|18|||
48902119|NCT02683941|157477619|FG001|Open-label Treatment Phase|Study Termination by the Sponsor|9|||
48902120|NCT02683941|157477618|FG000|Open-label Treatment Phase|Other|1|||
48902121|NCT02683941|157477619|FG001|Open-label Treatment Phase|Other|0|||
48985151|NCT02646891|157777594|FG008|Overall Study|Withdrawal by Subject|7|||
48985152|NCT02646891|157777595|FG009|Overall Study|Withdrawal by Subject|3|||
48985153|NCT02646891|157777586|FG000|Overall Study|Death|0|||
48985154|NCT02646891|157777587|FG001|Overall Study|Death|0|||
48985155|NCT02646891|157777588|FG002|Overall Study|Death|0|||
48902122|NCT02683941|157477618|FG000|Open-label Follow-up Phase|Withdrawal by Subject|3|||
48902123|NCT02683941|157477619|FG001|Open-label Follow-up Phase|Withdrawal by Subject|3|||
48902124|NCT02683941|157477618|FG000|Open-label Follow-up Phase|Lost to Follow-up|1|||
48902125|NCT02683941|157477619|FG001|Open-label Follow-up Phase|Lost to Follow-up|0|||
48902126|NCT02683941|157477618|FG000|Open-label Follow-up Phase|Study Termination by the Sponsor|6|||
48902127|NCT02683941|157477619|FG001|Open-label Follow-up Phase|Study Termination by the Sponsor|4|||
48902128|NCT02683941|157477618|FG000|Open-label Follow-up Phase|Other|8|||
48902129|NCT02683941|157477619|FG001|Open-label Follow-up Phase|Other|1|||
48902130|NCT02168842|157477623|FG000|Overall Study|Withdrawal by Subject|5|||
48902131|NCT02168842|157477624|FG001|Overall Study|Withdrawal by Subject|3|||
48902132|NCT02168842|157477623|FG000|Overall Study|Lost to Follow-up|0|||
48902133|NCT02168842|157477624|FG001|Overall Study|Lost to Follow-up|2|||
48902134|NCT02168842|157477623|FG000|Overall Study|Death|2|||
48902135|NCT02168842|157477624|FG001|Overall Study|Death|1|||
48902136|NCT02168842|157477623|FG000|Overall Study|Physician Decision|1|||
48902137|NCT02168842|157477624|FG001|Overall Study|Physician Decision|2|||
48902138|NCT02147353|157477625|FG000|Overall Study|Lost to Follow-up|2|||
48902139|NCT02147353|157477626|FG001|Overall Study|Lost to Follow-up|0|||
48902140|NCT02147353|157477625|FG000|Overall Study|unable to make visits|4|||
48902141|NCT02147353|157477626|FG001|Overall Study|unable to make visits|0|||
48902142|NCT02147353|157477625|FG000|Overall Study|medication noncompliance|3|||
48902143|NCT02147353|157477626|FG001|Overall Study|medication noncompliance|0|||
48902144|NCT02745392|157477627|FG000|Overall Study|Lost to Follow-up|0|||
48902145|NCT02745392|157477628|FG001|Overall Study|Lost to Follow-up|1|||
48902146|NCT02745392|157477629|FG002|Overall Study|Lost to Follow-up|0|||
48902147|NCT02745392|157477630|FG003|Overall Study|Lost to Follow-up|0|||
48985156|NCT02646891|157777589|FG003|Overall Study|Death|0|||
49042618|NCT01519947|157989829|FG003|Overall Study|Withdrawal by Subject|1|||
49042619|NCT01519947|157989826|FG000|Overall Study|Lost to Follow-up|0|||
49042620|NCT01519947|157989827|FG001|Overall Study|Lost to Follow-up|0|||
49042621|NCT01519947|157989828|FG002|Overall Study|Lost to Follow-up|3|||
49042622|NCT01519947|157989829|FG003|Overall Study|Lost to Follow-up|2|||
49042623|NCT01519947|157989826|FG000|Overall Study|Poor Response|1|||
49042624|NCT01519947|157989827|FG001|Overall Study|Poor Response|0|||
49042625|NCT01519947|157989828|FG002|Overall Study|Poor Response|0|||
49042626|NCT01519947|157989829|FG003|Overall Study|Poor Response|1|||
49042627|NCT01519947|157989826|FG000|Overall Study|Adverse Event|1|||
49042628|NCT01519947|157989827|FG001|Overall Study|Adverse Event|0|||
49042629|NCT01519947|157989828|FG002|Overall Study|Adverse Event|1|||
49042630|NCT01519947|157989829|FG003|Overall Study|Adverse Event|1|||
49042631|NCT00550147|157989830|FG000|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4|||
49042632|NCT00550147|157989830|FG000|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2|||
49042633|NCT00550147|157989830|FG000|Quetiapine Addition Treatment Period|Adverse Event|3|||
49042634|NCT00550147|157989830|FG000|Quetiapine Addition Treatment Period|Noncompliance|2|||
48902148|NCT02547233|157477631|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
49042635|NCT00550147|157989830|FG000|Quetiapine Addition Treatment Period|Moved out of state|1|||
49042636|NCT01958476|157989831|FG000|Overall Study|Parent requested exclusion from analysis|1|||
49042637|NCT01958476|157989832|FG001|Overall Study|Parent requested exclusion from analysis|0|||
49042638|NCT00046839|157989833|FG000|Overall Study|Ineligible / No protocol treatment|0|||
49042639|NCT00046839|157989834|FG001|Overall Study|Ineligible / No protocol treatment|2|||
49042640|NCT00046839|157989833|FG000|Overall Study|Withdrawal of consent|1|||
49042641|NCT00046839|157989834|FG001|Overall Study|Withdrawal of consent|0|||
49042642|NCT00556673|157989838|FG000|Overall Study|Protocol deviation|3|||
49042643|NCT00556673|157989839|FG001|Overall Study|Protocol deviation|2|||
49042644|NCT01528735|157989840|FG000|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
49042645|NCT01528735|157989841|FG001|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
49042646|NCT01528735|157989840|FG000|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1|||
49042647|NCT01528735|157989841|FG001|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0|||
49042648|NCT00757172|157989842|FG000|Overall Study|Withdrawal by Subject|4|||
49042649|NCT00757172|157989842|FG000|Overall Study|Physician Decision|3|||
49042650|NCT00757172|157989842|FG000|Overall Study|Progression|4|||
49042651|NCT01971554|157989843|FG000|Overall Study|Lost to Follow-up|1|||
49042652|NCT01971554|157989844|FG001|Overall Study|Lost to Follow-up|0|||
49042653|NCT01971554|157989845|FG002|Overall Study|Lost to Follow-up|0|||
49042654|NCT01971554|157989846|FG003|Overall Study|Lost to Follow-up|0|||
49042655|NCT03531827|157989847|FG000|Overall Study|Adverse Event|2|||
48902149|NCT02547233|157477632|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
48902150|NCT02547233|157477631|FG000|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1|||
48902151|NCT02547233|157477632|FG001|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0|||
48902152|NCT02547233|157477631|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0|||
48902153|NCT02547233|157477632|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9|||
48902154|NCT02547233|157477631|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
48902155|NCT02547233|157477632|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
48902156|NCT02547233|157477631|FG000|12-month Follow-up|Withdrawal by Subject|10|||
48902157|NCT02547233|157477632|FG001|12-month Follow-up|Withdrawal by Subject|10|||
48902158|NCT02547233|157477631|FG000|12-month Follow-up|Lost to Follow-up|3|||
48902159|NCT02547233|157477632|FG001|12-month Follow-up|Lost to Follow-up|3|||
48902160|NCT02547233|157477631|FG000|12-month Follow-up|Lack of Efficacy|1|||
48902161|NCT02547233|157477632|FG001|12-month Follow-up|Lack of Efficacy|2|||
48902162|NCT02547233|157477631|FG000|12-month Follow-up|Protocol Violation|0|||
48902163|NCT02547233|157477632|FG001|12-month Follow-up|Protocol Violation|1|||
48902164|NCT02547233|157477631|FG000|12-month Follow-up|Other|0|||
48902165|NCT02547233|157477632|FG001|12-month Follow-up|Other|1|||
48902166|NCT01759368|157477633|FG000|Overall Study|Lost to Follow-up|1|||
48902167|NCT01759368|157477634|FG001|Overall Study|Lost to Follow-up|0|||
48902168|NCT01313689|157477635|FG000|24-Week Randomization 1|Adverse Event|10|||
48902169|NCT01313689|157477636|FG001|24-Week Randomization 1|Adverse Event|5|||
48902170|NCT01313689|157477637|FG002|24-Week Randomization 1|Adverse Event|0|||
48902171|NCT01313689|157477638|FG003|24-Week Randomization 1|Adverse Event|0|||
48902172|NCT01313689|157477639|FG004|24-Week Randomization 1|Adverse Event|0|||
48902173|NCT01313689|157477635|FG000|24-Week Randomization 1|Physician Decision|4|||
48902174|NCT01313689|157477636|FG001|24-Week Randomization 1|Physician Decision|5|||
48902175|NCT01313689|157477637|FG002|24-Week Randomization 1|Physician Decision|0|||
49042656|NCT03531827|157989848|FG001|Overall Study|Adverse Event|0|||
49042657|NCT03531827|157989847|FG000|Overall Study|Progressive disease|1|||
49042658|NCT03531827|157989848|FG001|Overall Study|Progressive disease|0|||
49042659|NCT02387762|157989849|FG000|Overall Study|Withdrawal by Subject|1|||
49042660|NCT02387762|157989850|FG001|Overall Study|Withdrawal by Subject|0|||
49042661|NCT01717040|157989851|FG000|Overall Study|Lost to Follow-up|2|||
49042662|NCT01717040|157989852|FG001|Overall Study|Lost to Follow-up|3|||
49042663|NCT01717040|157989851|FG000|Overall Study|Lack of Efficacy|1|||
48902176|NCT01313689|157477638|FG003|24-Week Randomization 1|Physician Decision|0|||
48902177|NCT01313689|157477639|FG004|24-Week Randomization 1|Physician Decision|0|||
48902178|NCT01313689|157477635|FG000|24-Week Randomization 1|Withdrawal by Subject|5|||
48902179|NCT01313689|157477636|FG001|24-Week Randomization 1|Withdrawal by Subject|0|||
48902180|NCT01313689|157477637|FG002|24-Week Randomization 1|Withdrawal by Subject|0|||
48902181|NCT01313689|157477638|FG003|24-Week Randomization 1|Withdrawal by Subject|0|||
49042664|NCT01717040|157989852|FG001|Overall Study|Lack of Efficacy|1|||
49042665|NCT01717040|157989851|FG000|Overall Study|Adverse Event|1|||
49042666|NCT01717040|157989852|FG001|Overall Study|Adverse Event|0|||
49042667|NCT01717040|157989851|FG000|Overall Study|Required Medication Change|0|||
49042668|NCT01717040|157989852|FG001|Overall Study|Required Medication Change|1|||
49042669|NCT01717040|157989851|FG000|Overall Study|New Substance Use Disorder|1|||
49042670|NCT01717040|157989852|FG001|Overall Study|New Substance Use Disorder|0|||
49042671|NCT00494013|157989856|FG000|Overall Study|Adverse Event|0|||
49042672|NCT00494013|157989857|FG001|Overall Study|Adverse Event|1|||
49042673|NCT00494013|157989856|FG000|Overall Study|Entry Criteria Not Met|1|||
49042674|NCT00494013|157989857|FG001|Overall Study|Entry Criteria Not Met|4|||
49042675|NCT00494013|157989856|FG000|Overall Study|Lost to Follow-up|5|||
49042676|NCT00494013|157989857|FG001|Overall Study|Lost to Follow-up|6|||
49042677|NCT00494013|157989856|FG000|Overall Study|Physician Decision|3|||
49042678|NCT00494013|157989857|FG001|Overall Study|Physician Decision|5|||
49042679|NCT00494013|157989856|FG000|Overall Study|Protocol Violation|8|||
49042680|NCT00494013|157989857|FG001|Overall Study|Protocol Violation|5|||
49042681|NCT00494013|157989856|FG000|Overall Study|Withdrawal by Subject|13|||
49042682|NCT00494013|157989857|FG001|Overall Study|Withdrawal by Subject|14|||
49042683|NCT00494013|157989856|FG000|Overall Study|Sponsor Decision|0|||
49042684|NCT00494013|157989857|FG001|Overall Study|Sponsor Decision|1|||
49042685|NCT02614196|157989858|FG000|Double Blind Treatment Phase|Adverse Event|8|||
49042686|NCT02614196|157989859|FG001|Double Blind Treatment Phase|Adverse Event|5|||
49042687|NCT02614196|157989860|FG002|Double Blind Treatment Phase|Adverse Event|9|||
48902182|NCT01313689|157477639|FG004|24-Week Randomization 1|Withdrawal by Subject|0|||
48985157|NCT02646891|157777590|FG004|Overall Study|Death|0|||
48985158|NCT02646891|157777591|FG005|Overall Study|Death|0|||
48985159|NCT02646891|157777592|FG006|Overall Study|Death|1|||
48985160|NCT02646891|157777593|FG007|Overall Study|Death|1|||
48985161|NCT02646891|157777594|FG008|Overall Study|Death|1|||
48985162|NCT02646891|157777595|FG009|Overall Study|Death|0|||
48985163|NCT03225833|157777596|FG000|Overall Study|Adverse Event|0|||
48985164|NCT03225833|157777597|FG001|Overall Study|Adverse Event|1|||
48985165|NCT03225833|157777598|FG002|Overall Study|Adverse Event|2|||
48985166|NCT03225833|157777599|FG003|Overall Study|Adverse Event|0|||
48985167|NCT03225833|157777600|FG004|Overall Study|Adverse Event|0|||
48985168|NCT03225833|157777601|FG005|Overall Study|Adverse Event|2|||
48902183|NCT01313689|157477635|FG000|24-Week Randomization 2|Adverse Event|0|||
48902184|NCT01313689|157477636|FG001|24-Week Randomization 2|Adverse Event|0|||
48902185|NCT01313689|157477637|FG002|24-Week Randomization 2|Adverse Event|2|||
48902186|NCT01313689|157477638|FG003|24-Week Randomization 2|Adverse Event|0|||
48902187|NCT01313689|157477639|FG004|24-Week Randomization 2|Adverse Event|8|||
48902188|NCT01313689|157477635|FG000|24-Week Randomization 2|Withdrawal by Subject|0|||
48902189|NCT01313689|157477636|FG001|24-Week Randomization 2|Withdrawal by Subject|0|||
48902190|NCT01313689|157477637|FG002|24-Week Randomization 2|Withdrawal by Subject|1|||
48902191|NCT01313689|157477638|FG003|24-Week Randomization 2|Withdrawal by Subject|1|||
48902192|NCT01313689|157477639|FG004|24-Week Randomization 2|Withdrawal by Subject|3|||
48902193|NCT01313689|157477635|FG000|24-Week Randomization 2|Physician Decision|0|||
48902194|NCT01313689|157477636|FG001|24-Week Randomization 2|Physician Decision|0|||
48902195|NCT01313689|157477637|FG002|24-Week Randomization 2|Physician Decision|0|||
48902196|NCT01313689|157477638|FG003|24-Week Randomization 2|Physician Decision|0|||
48902197|NCT01313689|157477639|FG004|24-Week Randomization 2|Physician Decision|4|||
48902198|NCT02294227|157477640|FG000|Overall Study|Death|0|||
48902199|NCT02294227|157477641|FG001|Overall Study|Death|0|||
48902200|NCT02294227|157477642|FG002|Overall Study|Death|1|||
48902201|NCT02294227|157477640|FG000|Overall Study|Subject/Guardian Decision|6|||
48902202|NCT02294227|157477641|FG001|Overall Study|Subject/Guardian Decision|3|||
48902203|NCT02294227|157477642|FG002|Overall Study|Subject/Guardian Decision|7|||
48902204|NCT02294227|157477640|FG000|Overall Study|Physician Decision|1|||
48902205|NCT02294227|157477641|FG001|Overall Study|Physician Decision|2|||
48902206|NCT02294227|157477642|FG002|Overall Study|Physician Decision|1|||
48902207|NCT02294227|157477640|FG000|Overall Study|Lost to Follow-up|1|||
48902208|NCT02294227|157477641|FG001|Overall Study|Lost to Follow-up|0|||
48902209|NCT02294227|157477642|FG002|Overall Study|Lost to Follow-up|0|||
48902210|NCT02294227|157477640|FG000|Overall Study|Lack of Efficacy|11|||
48902211|NCT02294227|157477641|FG001|Overall Study|Lack of Efficacy|12|||
48902212|NCT02294227|157477642|FG002|Overall Study|Lack of Efficacy|8|||
48902213|NCT02294227|157477640|FG000|Overall Study|Adverse Event|6|||
48902214|NCT02294227|157477641|FG001|Overall Study|Adverse Event|8|||
48902215|NCT02294227|157477642|FG002|Overall Study|Adverse Event|2|||
48985169|NCT03225833|157777596|FG000|Overall Study|Withdrawal by Subject|1|||
48985170|NCT03225833|157777597|FG001|Overall Study|Withdrawal by Subject|0|||
48985171|NCT03225833|157777598|FG002|Overall Study|Withdrawal by Subject|0|||
48985172|NCT03225833|157777599|FG003|Overall Study|Withdrawal by Subject|0|||
48985173|NCT03225833|157777600|FG004|Overall Study|Withdrawal by Subject|1|||
48985174|NCT03225833|157777601|FG005|Overall Study|Withdrawal by Subject|0|||
48985175|NCT03225833|157777596|FG000|Overall Study|Termination of Study by Sponsor|4|||
48985176|NCT03225833|157777597|FG001|Overall Study|Termination of Study by Sponsor|0|||
48985177|NCT03225833|157777598|FG002|Overall Study|Termination of Study by Sponsor|0|||
48985178|NCT03225833|157777599|FG003|Overall Study|Termination of Study by Sponsor|0|||
48985179|NCT03225833|157777600|FG004|Overall Study|Termination of Study by Sponsor|0|||
48985180|NCT03225833|157777601|FG005|Overall Study|Termination of Study by Sponsor|7|||
48985181|NCT03225833|157777596|FG000|Overall Study|Sponsor Decision|0|||
48985182|NCT03225833|157777597|FG001|Overall Study|Sponsor Decision|0|||
48985183|NCT03225833|157777598|FG002|Overall Study|Sponsor Decision|0|||
48985184|NCT03225833|157777599|FG003|Overall Study|Sponsor Decision|0|||
48985185|NCT03225833|157777600|FG004|Overall Study|Sponsor Decision|0|||
48985186|NCT03225833|157777601|FG005|Overall Study|Sponsor Decision|1|||
48985187|NCT00808028|157777602|FG000|Stage 1 (6 Months)|Withdrawal by Subject|3|||
48985188|NCT00808028|157777603|FG001|Stage 1 (6 Months)|Withdrawal by Subject|0|||
48985189|NCT00808028|157777604|FG002|Stage 1 (6 Months)|Withdrawal by Subject|2|||
48985190|NCT00808028|157777605|FG003|Stage 1 (6 Months)|Withdrawal by Subject|5|||
48985191|NCT00808028|157777602|FG000|Stage 1 (6 Months)|Other|1|||
48985192|NCT00808028|157777603|FG001|Stage 1 (6 Months)|Other|0|||
48985193|NCT00808028|157777604|FG002|Stage 1 (6 Months)|Other|2|||
48985194|NCT00808028|157777605|FG003|Stage 1 (6 Months)|Other|4|||
48985195|NCT00808028|157777602|FG000|Stage 1 (6 Months)|Parent/legal guardian request|0|||
48985196|NCT00808028|157777603|FG001|Stage 1 (6 Months)|Parent/legal guardian request|1|||
48985197|NCT00808028|157777604|FG002|Stage 1 (6 Months)|Parent/legal guardian request|1|||
48985198|NCT00808028|157777605|FG003|Stage 1 (6 Months)|Parent/legal guardian request|3|||
48985199|NCT00808028|157777602|FG000|Stage 1 (6 Months)|Adverse Event|0|||
48985200|NCT00808028|157777603|FG001|Stage 1 (6 Months)|Adverse Event|0|||
48985201|NCT00808028|157777604|FG002|Stage 1 (6 Months)|Adverse Event|1|||
48985202|NCT00808028|157777605|FG003|Stage 1 (6 Months)|Adverse Event|2|||
48985203|NCT00808028|157777602|FG000|Stage 1 (6 Months)|Lost to Follow-up|1|||
48985204|NCT00808028|157777603|FG001|Stage 1 (6 Months)|Lost to Follow-up|0|||
48985205|NCT00808028|157777604|FG002|Stage 1 (6 Months)|Lost to Follow-up|1|||
48985206|NCT00808028|157777605|FG003|Stage 1 (6 Months)|Lost to Follow-up|0|||
48985207|NCT00808028|157777602|FG000|Stage 1 (6 Months)|Protocol Violation|0|||
48985208|NCT00808028|157777603|FG001|Stage 1 (6 Months)|Protocol Violation|0|||
48985209|NCT00808028|157777604|FG002|Stage 1 (6 Months)|Protocol Violation|0|||
48985210|NCT00808028|157777605|FG003|Stage 1 (6 Months)|Protocol Violation|1|||
48985211|NCT00808028|157777602|FG000|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6|||
48985212|NCT00808028|157777603|FG001|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0|||
48985213|NCT00808028|157777604|FG002|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9|||
48985214|NCT00808028|157777605|FG003|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11|||
48985215|NCT00808028|157777602|FG000|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
48985216|NCT00808028|157777603|FG001|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
48985217|NCT00808028|157777604|FG002|Stage 2 (Followed up to 48 Months )|Protocol Violation|1|||
48985218|NCT00808028|157777605|FG003|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
48985219|NCT00808028|157777602|FG000|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2|||
48985220|NCT00808028|157777603|FG001|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0|||
48985221|NCT00808028|157777604|FG002|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8|||
48985222|NCT00808028|157777605|FG003|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7|||
48985223|NCT00808028|157777602|FG000|Stage 2 (Followed up to 48 Months )|Failed to return|2|||
48985224|NCT00808028|157777603|FG001|Stage 2 (Followed up to 48 Months )|Failed to return|0|||
48985225|NCT00808028|157777604|FG002|Stage 2 (Followed up to 48 Months )|Failed to return|5|||
48985226|NCT00808028|157777605|FG003|Stage 2 (Followed up to 48 Months )|Failed to return|4|||
48985227|NCT00808028|157777602|FG000|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
48985228|NCT00808028|157777603|FG001|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
48985229|NCT00808028|157777604|FG002|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
48985230|NCT00808028|157777605|FG003|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
48985231|NCT00808028|157777602|FG000|Stage 2 (Followed up to 48 Months )|Other|0|||
48985232|NCT00808028|157777603|FG001|Stage 2 (Followed up to 48 Months )|Other|0|||
48985233|NCT00808028|157777604|FG002|Stage 2 (Followed up to 48 Months )|Other|1|||
48985234|NCT00808028|157777605|FG003|Stage 2 (Followed up to 48 Months )|Other|1|||
48985235|NCT00808028|157777602|FG000|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
48985236|NCT00808028|157777603|FG001|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
48985237|NCT00808028|157777604|FG002|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2|||
48985238|NCT00808028|157777605|FG003|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
48985239|NCT00808028|157777602|FG000|Stage 2 (Followed up to 48 Months )|Death|0|||
48985240|NCT00808028|157777603|FG001|Stage 2 (Followed up to 48 Months )|Death|0|||
48985241|NCT00808028|157777604|FG002|Stage 2 (Followed up to 48 Months )|Death|1|||
49042688|NCT02614196|157989861|FG003|Double Blind Treatment Phase|Adverse Event|0|||
49042689|NCT02614196|157989862|FG004|Double Blind Treatment Phase|Adverse Event|0|||
49042690|NCT02614196|157989863|FG005|Double Blind Treatment Phase|Adverse Event|0|||
49042691|NCT02614196|157989858|FG000|Double Blind Treatment Phase|Lack of Efficacy|6|||
49042692|NCT02614196|157989859|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
49042693|NCT02614196|157989860|FG002|Double Blind Treatment Phase|Lack of Efficacy|1|||
49042694|NCT02614196|157989861|FG003|Double Blind Treatment Phase|Lack of Efficacy|0|||
49042695|NCT02614196|157989862|FG004|Double Blind Treatment Phase|Lack of Efficacy|0|||
49042696|NCT02614196|157989863|FG005|Double Blind Treatment Phase|Lack of Efficacy|0|||
49042697|NCT02614196|157989858|FG000|Double Blind Treatment Phase|Lost to Follow-up|10|||
49042698|NCT02614196|157989859|FG001|Double Blind Treatment Phase|Lost to Follow-up|7|||
49042699|NCT02614196|157989860|FG002|Double Blind Treatment Phase|Lost to Follow-up|1|||
49042700|NCT02614196|157989861|FG003|Double Blind Treatment Phase|Lost to Follow-up|0|||
49042701|NCT02614196|157989862|FG004|Double Blind Treatment Phase|Lost to Follow-up|0|||
49042702|NCT02614196|157989863|FG005|Double Blind Treatment Phase|Lost to Follow-up|0|||
49042703|NCT02614196|157989858|FG000|Double Blind Treatment Phase|Physician Decision|4|||
49042704|NCT02614196|157989859|FG001|Double Blind Treatment Phase|Physician Decision|0|||
49042705|NCT02614196|157989860|FG002|Double Blind Treatment Phase|Physician Decision|2|||
49042706|NCT02614196|157989861|FG003|Double Blind Treatment Phase|Physician Decision|0|||
49042707|NCT02614196|157989862|FG004|Double Blind Treatment Phase|Physician Decision|0|||
49042708|NCT02614196|157989863|FG005|Double Blind Treatment Phase|Physician Decision|0|||
49042709|NCT02614196|157989858|FG000|Double Blind Treatment Phase|Pregnancy|1|||
49042710|NCT02614196|157989859|FG001|Double Blind Treatment Phase|Pregnancy|2|||
49042711|NCT02614196|157989860|FG002|Double Blind Treatment Phase|Pregnancy|0|||
49042712|NCT02614196|157989861|FG003|Double Blind Treatment Phase|Pregnancy|0|||
49042713|NCT02614196|157989862|FG004|Double Blind Treatment Phase|Pregnancy|0|||
49042714|NCT02614196|157989863|FG005|Double Blind Treatment Phase|Pregnancy|0|||
49042715|NCT02614196|157989858|FG000|Double Blind Treatment Phase|Protocol Violation|5|||
49042716|NCT02614196|157989859|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
49042717|NCT02614196|157989860|FG002|Double Blind Treatment Phase|Protocol Violation|1|||
49042718|NCT02614196|157989861|FG003|Double Blind Treatment Phase|Protocol Violation|0|||
49042719|NCT02614196|157989862|FG004|Double Blind Treatment Phase|Protocol Violation|1|||
49042720|NCT02614196|157989863|FG005|Double Blind Treatment Phase|Protocol Violation|0|||
49042721|NCT02614196|157989858|FG000|Double Blind Treatment Phase|Terminated by sponsor|1|||
49042722|NCT02614196|157989859|FG001|Double Blind Treatment Phase|Terminated by sponsor|0|||
49042723|NCT02614196|157989860|FG002|Double Blind Treatment Phase|Terminated by sponsor|0|||
49042724|NCT02614196|157989861|FG003|Double Blind Treatment Phase|Terminated by sponsor|0|||
49042725|NCT02614196|157989862|FG004|Double Blind Treatment Phase|Terminated by sponsor|0|||
49042726|NCT02614196|157989863|FG005|Double Blind Treatment Phase|Terminated by sponsor|0|||
49042727|NCT02614196|157989858|FG000|Double Blind Treatment Phase|Withdrawal by Subject|39|||
49042728|NCT02614196|157989859|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
49042729|NCT02614196|157989860|FG002|Double Blind Treatment Phase|Withdrawal by Subject|14|||
49042730|NCT02614196|157989861|FG003|Double Blind Treatment Phase|Withdrawal by Subject|4|||
49042731|NCT02614196|157989862|FG004|Double Blind Treatment Phase|Withdrawal by Subject|0|||
49042732|NCT02614196|157989863|FG005|Double Blind Treatment Phase|Withdrawal by Subject|0|||
49042733|NCT02614196|157989858|FG000|Double Blind Treatment Phase|Did not receive study drug|2|||
48985242|NCT00808028|157777605|FG003|Stage 2 (Followed up to 48 Months )|Death|0|||
48985243|NCT00808028|157777602|FG000|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
48985244|NCT00808028|157777603|FG001|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
48985245|NCT00808028|157777604|FG002|Stage 2 (Followed up to 48 Months )|Non-compliance|1|||
48985246|NCT00808028|157777605|FG003|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
48985247|NCT01058395|157777608|FG000|Overall Study|Death|2|||
48985248|NCT01058395|157777609|FG001|Overall Study|Death|1|||
48985249|NCT01058395|157777608|FG000|Overall Study|Lost to Follow-up|1|||
48985250|NCT01058395|157777609|FG001|Overall Study|Lost to Follow-up|0|||
48985251|NCT00963820|157777613|FG000|Dose Escalation Phase|Progressive Disease|3|||
48985252|NCT00963820|157777614|FG001|Dose Escalation Phase|Progressive Disease|3|||
48985253|NCT00963820|157777615|FG002|Dose Escalation Phase|Progressive Disease|3|||
48985254|NCT00963820|157777616|FG003|Dose Escalation Phase|Progressive Disease|3|||
48985255|NCT00963820|157777617|FG004|Dose Escalation Phase|Progressive Disease|4|||
48985256|NCT00963820|157777618|FG005|Dose Escalation Phase|Progressive Disease|3|||
48985257|NCT00963820|157777619|FG006|Dose Escalation Phase|Progressive Disease|3|||
48985258|NCT00963820|157777620|FG007|Dose Escalation Phase|Progressive Disease|2|||
48985259|NCT00963820|157777621|FG008|Dose Escalation Phase|Progressive Disease|0|||
49042734|NCT02614196|157989859|FG001|Double Blind Treatment Phase|Did not receive study drug|2|||
49042735|NCT02614196|157989860|FG002|Double Blind Treatment Phase|Did not receive study drug|3|||
48985260|NCT00963820|157777622|FG009|Dose Escalation Phase|Progressive Disease|0|||
48985261|NCT00963820|157777623|FG010|Dose Escalation Phase|Progressive Disease|0|||
48985262|NCT00963820|157777624|FG011|Dose Escalation Phase|Progressive Disease|0|||
48985263|NCT00963820|157777613|FG000|Dose Escalation Phase|Adverse Event|0|||
48985264|NCT00963820|157777614|FG001|Dose Escalation Phase|Adverse Event|0|||
48985265|NCT00963820|157777615|FG002|Dose Escalation Phase|Adverse Event|0|||
48985266|NCT00963820|157777616|FG003|Dose Escalation Phase|Adverse Event|0|||
48985267|NCT00963820|157777617|FG004|Dose Escalation Phase|Adverse Event|0|||
48985268|NCT00963820|157777618|FG005|Dose Escalation Phase|Adverse Event|0|||
48985269|NCT00963820|157777619|FG006|Dose Escalation Phase|Adverse Event|3|||
48985270|NCT00963820|157777620|FG007|Dose Escalation Phase|Adverse Event|1|||
48985271|NCT00963820|157777621|FG008|Dose Escalation Phase|Adverse Event|0|||
48985272|NCT00963820|157777622|FG009|Dose Escalation Phase|Adverse Event|0|||
48985273|NCT00963820|157777623|FG010|Dose Escalation Phase|Adverse Event|0|||
48985274|NCT00963820|157777624|FG011|Dose Escalation Phase|Adverse Event|0|||
48985275|NCT00963820|157777613|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
48985276|NCT00963820|157777614|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
48985277|NCT00963820|157777615|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
48985278|NCT00963820|157777616|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
48985279|NCT00963820|157777617|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
48985280|NCT00963820|157777618|FG005|Dose Escalation Phase|Withdrawal by Subject|0|||
48985281|NCT00963820|157777619|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
48985282|NCT00963820|157777620|FG007|Dose Escalation Phase|Withdrawal by Subject|2|||
48985283|NCT00963820|157777621|FG008|Dose Escalation Phase|Withdrawal by Subject|0|||
48985284|NCT00963820|157777622|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
48985285|NCT00963820|157777623|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
48985286|NCT00963820|157777624|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
49042736|NCT02614196|157989861|FG003|Double Blind Treatment Phase|Did not receive study drug|0|||
49042737|NCT02614196|157989862|FG004|Double Blind Treatment Phase|Did not receive study drug|0|||
48985287|NCT00963820|157777613|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
48985288|NCT00963820|157777614|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
48985289|NCT00963820|157777615|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
48985290|NCT00963820|157777616|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
48985291|NCT00963820|157777617|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
48985292|NCT00963820|157777618|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
48985293|NCT00963820|157777619|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
48985294|NCT00963820|157777620|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
49042738|NCT02614196|157989863|FG005|Double Blind Treatment Phase|Did not receive study drug|0|||
49042739|NCT02614196|157989858|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|8|||
49042740|NCT02614196|157989859|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
49042741|NCT02614196|157989860|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
49042742|NCT02614196|157989861|FG003|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
49042743|NCT02614196|157989862|FG004|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
49042744|NCT02614196|157989863|FG005|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
49042745|NCT02614196|157989858|FG000|Post Treatment Follow-up Phase|Pregnancy|2|||
49042746|NCT02614196|157989859|FG001|Post Treatment Follow-up Phase|Pregnancy|0|||
48985295|NCT00963820|157777621|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
48985296|NCT00963820|157777622|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
48985297|NCT00963820|157777623|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
48985298|NCT00963820|157777624|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
48985299|NCT00963820|157777613|FG000|Expansion Phase|Progressive Disease|0|||
48985300|NCT00963820|157777614|FG001|Expansion Phase|Progressive Disease|0|||
48985301|NCT00963820|157777615|FG002|Expansion Phase|Progressive Disease|0|||
48985302|NCT00963820|157777616|FG003|Expansion Phase|Progressive Disease|0|||
48985303|NCT00963820|157777617|FG004|Expansion Phase|Progressive Disease|0|||
48985304|NCT00963820|157777618|FG005|Expansion Phase|Progressive Disease|0|||
48985305|NCT00963820|157777619|FG006|Expansion Phase|Progressive Disease|0|||
48985306|NCT00963820|157777620|FG007|Expansion Phase|Progressive Disease|0|||
48985307|NCT00963820|157777621|FG008|Expansion Phase|Progressive Disease|8|||
48985308|NCT00963820|157777622|FG009|Expansion Phase|Progressive Disease|6|||
48985309|NCT00963820|157777623|FG010|Expansion Phase|Progressive Disease|4|||
48985310|NCT00963820|157777624|FG011|Expansion Phase|Progressive Disease|2|||
48985311|NCT00963820|157777613|FG000|Expansion Phase|Adverse Event|0|||
48985312|NCT00963820|157777614|FG001|Expansion Phase|Adverse Event|0|||
48985313|NCT00963820|157777615|FG002|Expansion Phase|Adverse Event|0|||
48985314|NCT00963820|157777616|FG003|Expansion Phase|Adverse Event|0|||
48985315|NCT00963820|157777617|FG004|Expansion Phase|Adverse Event|0|||
48985316|NCT00963820|157777618|FG005|Expansion Phase|Adverse Event|0|||
48985317|NCT00963820|157777619|FG006|Expansion Phase|Adverse Event|0|||
48985318|NCT00963820|157777620|FG007|Expansion Phase|Adverse Event|0|||
48985319|NCT00963820|157777621|FG008|Expansion Phase|Adverse Event|1|||
48985320|NCT00963820|157777622|FG009|Expansion Phase|Adverse Event|3|||
49042747|NCT02614196|157989860|FG002|Post Treatment Follow-up Phase|Pregnancy|0|||
48985321|NCT00963820|157777623|FG010|Expansion Phase|Adverse Event|0|||
48985322|NCT00963820|157777624|FG011|Expansion Phase|Adverse Event|0|||
48985323|NCT00963820|157777613|FG000|Expansion Phase|Withdrawal by Subject|0|||
48985324|NCT00963820|157777614|FG001|Expansion Phase|Withdrawal by Subject|0|||
48985325|NCT00963820|157777615|FG002|Expansion Phase|Withdrawal by Subject|0|||
48985326|NCT00963820|157777616|FG003|Expansion Phase|Withdrawal by Subject|0|||
48985327|NCT00963820|157777617|FG004|Expansion Phase|Withdrawal by Subject|0|||
48985328|NCT00963820|157777618|FG005|Expansion Phase|Withdrawal by Subject|0|||
48985329|NCT00963820|157777619|FG006|Expansion Phase|Withdrawal by Subject|0|||
48985330|NCT00963820|157777620|FG007|Expansion Phase|Withdrawal by Subject|0|||
48985331|NCT00963820|157777621|FG008|Expansion Phase|Withdrawal by Subject|1|||
48985332|NCT00963820|157777622|FG009|Expansion Phase|Withdrawal by Subject|0|||
48985333|NCT00963820|157777623|FG010|Expansion Phase|Withdrawal by Subject|1|||
48985334|NCT00963820|157777624|FG011|Expansion Phase|Withdrawal by Subject|1|||
48985335|NCT00963820|157777613|FG000|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
48985336|NCT00963820|157777614|FG001|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
48985337|NCT00963820|157777615|FG002|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
48985338|NCT00963820|157777616|FG003|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
48985339|NCT00963820|157777617|FG004|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
48985340|NCT00963820|157777618|FG005|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
48985341|NCT00963820|157777619|FG006|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
48985342|NCT00963820|157777620|FG007|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
48985343|NCT00963820|157777621|FG008|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
48985344|NCT00963820|157777622|FG009|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
48985345|NCT00963820|157777623|FG010|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
48985346|NCT00963820|157777624|FG011|Expansion Phase|Unsatisfactory Therapeutic Response|1|||
48985347|NCT03018340|157777629|FG000|Overall Study|Adverse Event|1|||
48985348|NCT03018340|157777630|FG001|Overall Study|Adverse Event|2|||
48985349|NCT03018340|157777629|FG000|Overall Study|Withdrawal by Subject|0|||
48985350|NCT03018340|157777630|FG001|Overall Study|Withdrawal by Subject|8|||
48985351|NCT03018340|157777629|FG000|Overall Study|Lack of Efficacy|0|||
48985352|NCT03018340|157777630|FG001|Overall Study|Lack of Efficacy|1|||
48985353|NCT03018340|157777629|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
48985354|NCT03018340|157777630|FG001|Overall Study|Non-compliance with study drug/procedure|4|||
48985355|NCT03018340|157777629|FG000|Overall Study|Lost to Follow-up|1|||
48985356|NCT03018340|157777630|FG001|Overall Study|Lost to Follow-up|7|||
48985357|NCT03018340|157777629|FG000|Overall Study|Protocol Violation|3|||
48985358|NCT03018340|157777630|FG001|Overall Study|Protocol Violation|7|||
48985359|NCT03018340|157777629|FG000|Overall Study|Not further specified|0|||
48985360|NCT03018340|157777630|FG001|Overall Study|Not further specified|1|||
48985361|NCT01836549|157777631|FG000|Overall Study|Did not receive study drug|0|||
48985362|NCT01836549|157777632|FG001|Overall Study|Did not receive study drug|0|||
48985363|NCT01836549|157777633|FG002|Overall Study|Did not receive study drug|1|||
48985364|NCT01836549|157777634|FG003|Overall Study|Did not receive study drug|0|||
48985365|NCT01836549|157777635|FG004|Overall Study|Did not receive study drug|0|||
48985366|NCT01836549|157777636|FG005|Overall Study|Did not receive study drug|0|||
48985367|NCT01836549|157777637|FG006|Overall Study|Did not receive study drug|0|||
48985368|NCT01836549|157777631|FG000|Overall Study|Patient declared ineligible|0|||
48985369|NCT01836549|157777632|FG001|Overall Study|Patient declared ineligible|0|||
48985370|NCT01836549|157777633|FG002|Overall Study|Patient declared ineligible|0|||
48985371|NCT01836549|157777634|FG003|Overall Study|Patient declared ineligible|1|||
48985372|NCT01836549|157777635|FG004|Overall Study|Patient declared ineligible|0|||
48985373|NCT01836549|157777636|FG005|Overall Study|Patient declared ineligible|0|||
48985374|NCT01836549|157777637|FG006|Overall Study|Patient declared ineligible|0|||
48985375|NCT01836549|157777631|FG000|Overall Study|Patient inevaluable to start therapy|0|||
48985376|NCT01836549|157777632|FG001|Overall Study|Patient inevaluable to start therapy|0|||
48985377|NCT01836549|157777633|FG002|Overall Study|Patient inevaluable to start therapy|0|||
48985378|NCT01836549|157777634|FG003|Overall Study|Patient inevaluable to start therapy|0|||
48985379|NCT01836549|157777635|FG004|Overall Study|Patient inevaluable to start therapy|0|||
48985380|NCT01836549|157777636|FG005|Overall Study|Patient inevaluable to start therapy|0|||
48985381|NCT01836549|157777637|FG006|Overall Study|Patient inevaluable to start therapy|1|||
48985382|NCT02324049|157777640|FG000|Part C|Study terminated|11|||
48985383|NCT04062240|157777642|FG000|Overall Study|equipment malfunction|1|||
48985384|NCT01195636|157777644|FG000|First Intervention (3 Weeks)|Adverse Event|2|||
48985385|NCT01195636|157777645|FG001|First Intervention (3 Weeks)|Adverse Event|3|||
48985386|NCT01195636|157777644|FG000|First Intervention (3 Weeks)|Protocol Violation|1|||
48985387|NCT01195636|157777645|FG001|First Intervention (3 Weeks)|Protocol Violation|0|||
48985388|NCT01195636|157777644|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
48985389|NCT01195636|157777645|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
48985390|NCT01195636|157777644|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
48985391|NCT01195636|157777645|FG001|First Intervention (3 Weeks)|Lost to Follow-up|0|||
48985392|NCT01195636|157777644|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
48985393|NCT01195636|157777645|FG001|Washout Period (2 Weeks)|Adverse Event|1|||
48985394|NCT01195636|157777644|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
48985395|NCT01195636|157777645|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
48985396|NCT01195636|157777644|FG000|Second Intervention (3 Weeks)|Adverse Event|1|||
48985397|NCT01195636|157777645|FG001|Second Intervention (3 Weeks)|Adverse Event|1|||
48985398|NCT01195636|157777644|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
48985399|NCT01195636|157777645|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
48985400|NCT03961529|157777646|FG000|Overall Study|Adverse Event|13|||
48985401|NCT03961529|157777647|FG001|Overall Study|Adverse Event|5|||
48985402|NCT03961529|157777648|FG002|Overall Study|Adverse Event|2|||
48985403|NCT03961529|157777646|FG000|Overall Study|Withdrawal by Subject|17|||
48985404|NCT03961529|157777647|FG001|Overall Study|Withdrawal by Subject|2|||
48985405|NCT03961529|157777648|FG002|Overall Study|Withdrawal by Subject|1|||
48985406|NCT03961529|157777646|FG000|Overall Study|Withdrawal by parent/guardian|0|||
48985407|NCT03961529|157777647|FG001|Overall Study|Withdrawal by parent/guardian|7|||
48985408|NCT03961529|157777648|FG002|Overall Study|Withdrawal by parent/guardian|0|||
48985409|NCT03961529|157777646|FG000|Overall Study|Physician Decision|2|||
48985410|NCT03961529|157777647|FG001|Overall Study|Physician Decision|1|||
48985411|NCT03961529|157777648|FG002|Overall Study|Physician Decision|1|||
48985412|NCT03961529|157777646|FG000|Overall Study|Lost to Follow-up|2|||
48985413|NCT03961529|157777647|FG001|Overall Study|Lost to Follow-up|1|||
48985414|NCT03961529|157777648|FG002|Overall Study|Lost to Follow-up|0|||
48985415|NCT03961529|157777646|FG000|Overall Study|Lack of Efficacy|2|||
48985416|NCT03961529|157777647|FG001|Overall Study|Lack of Efficacy|0|||
48985417|NCT03961529|157777648|FG002|Overall Study|Lack of Efficacy|1|||
48985418|NCT03961529|157777646|FG000|Overall Study|Other|6|||
48985419|NCT03961529|157777647|FG001|Overall Study|Other|1|||
48985420|NCT03961529|157777648|FG002|Overall Study|Other|0|||
48985421|NCT03644173|157777650|FG000|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21|||
48985422|NCT03644173|157777650|FG000|Participants at the 1-month Follow up|Lost to Follow-up|2|||
48985423|NCT03644173|157777650|FG000|Participants at the 1-month Follow up|Death|2|||
48985424|NCT03644173|157777650|FG000|Participants at the 3-month Follow up|Lost to Follow-up|2|||
48985425|NCT00381706|157777651|FG000|Overall Study|Never treated|7|||
48985426|NCT00381706|157777652|FG001|Overall Study|Never treated|2|||
48985427|NCT00381706|157777653|FG002|Overall Study|Never treated|1|||
48985428|NCT03480841|157777657|FG000|Overall Study|Lost to Follow-up|2|||
48985429|NCT02380703|157777658|FG000|Overall Study|Withdrawal by Subject|12|||
48985430|NCT02380703|157777659|FG001|Overall Study|Withdrawal by Subject|9|||
48985431|NCT02380703|157777658|FG000|Overall Study|Lost to Follow-up|12|||
48985432|NCT02380703|157777659|FG001|Overall Study|Lost to Follow-up|12|||
48985433|NCT02380703|157777658|FG000|Overall Study|Caregiver death|1|||
48985434|NCT02380703|157777659|FG001|Overall Study|Caregiver death|0|||
48985435|NCT02380703|157777658|FG000|Overall Study|Person with dementia (PWD) death|7|||
48985436|NCT02380703|157777659|FG001|Overall Study|Person with dementia (PWD) death|8|||
48985437|NCT02380703|157777658|FG000|Overall Study|Entered Long-term Care|4|||
48985438|NCT02380703|157777659|FG001|Overall Study|Entered Long-term Care|7|||
48985439|NCT01987609|157777660|FG000|Overall Study|Adverse Event|1|||
48985440|NCT02610231|157777661|FG000|Overall Study|Withdrawal by Subject|27|||
48985441|NCT02610231|157777661|FG000|Overall Study|Adverse Event|20|||
48985442|NCT02610231|157777661|FG000|Overall Study|Death|5|||
48985443|NCT02610231|157777661|FG000|Overall Study|Surgery|2|||
48985444|NCT02610231|157777661|FG000|Overall Study|Physician Decision|1|||
48985445|NCT02610231|157777661|FG000|Overall Study|Non Compliance|2|||
48985446|NCT02610231|157777661|FG000|Overall Study|Other|3|||
48985447|NCT00434876|157777662|FG000|Overall Study|Lost to Follow-up|1|||
48985448|NCT00434876|157777663|FG001|Overall Study|Lost to Follow-up|1|||
48985449|NCT04815291|157777664|FG000|Overall Study|Lost to Follow-up|1|||
48985450|NCT04815291|157777664|FG000|Overall Study|Physician Decision|4|||
48985451|NCT04815291|157777664|FG000|Overall Study|Surgery not planned and subject not operated.|3|||
48985452|NCT02709889|157777665|FG000|Overall Study|Withdrawal by Subject|11|||
48985453|NCT02709889|157777666|FG001|Overall Study|Withdrawal by Subject|10|||
48985454|NCT02709889|157777667|FG002|Overall Study|Withdrawal by Subject|2|||
48985455|NCT02709889|157777668|FG003|Overall Study|Withdrawal by Subject|12|||
48985456|NCT02709889|157777665|FG000|Overall Study|Death|25|||
48985457|NCT02709889|157777666|FG001|Overall Study|Death|38|||
48985458|NCT02709889|157777667|FG002|Overall Study|Death|4|||
48985459|NCT02709889|157777668|FG003|Overall Study|Death|44|||
49042748|NCT02614196|157989861|FG003|Post Treatment Follow-up Phase|Pregnancy|0|||
49042749|NCT02614196|157989862|FG004|Post Treatment Follow-up Phase|Pregnancy|0|||
49042750|NCT02614196|157989863|FG005|Post Treatment Follow-up Phase|Pregnancy|0|||
49042751|NCT02614196|157989858|FG000|Post Treatment Follow-up Phase|Protocol Violation|0|||
48985460|NCT02709889|157777665|FG000|Overall Study|Physician Decision|1|||
48985461|NCT02709889|157777666|FG001|Overall Study|Physician Decision|2|||
48985462|NCT02709889|157777667|FG002|Overall Study|Physician Decision|3|||
48985463|NCT02709889|157777668|FG003|Overall Study|Physician Decision|5|||
48985464|NCT02709889|157777665|FG000|Overall Study|Lost to Follow-up|2|||
48985465|NCT02709889|157777666|FG001|Overall Study|Lost to Follow-up|0|||
48985466|NCT02709889|157777667|FG002|Overall Study|Lost to Follow-up|0|||
48985467|NCT02709889|157777668|FG003|Overall Study|Lost to Follow-up|4|||
48985468|NCT02709889|157777665|FG000|Overall Study|Study Terminated by Sponsor|4|||
48985469|NCT02709889|157777666|FG001|Overall Study|Study Terminated by Sponsor|6|||
48985470|NCT02709889|157777667|FG002|Overall Study|Study Terminated by Sponsor|2|||
48985471|NCT02709889|157777668|FG003|Overall Study|Study Terminated by Sponsor|17|||
48985472|NCT02709889|157777665|FG000|Overall Study|Other, Not Specified|0|||
48985473|NCT02709889|157777666|FG001|Overall Study|Other, Not Specified|1|||
48985474|NCT02709889|157777667|FG002|Overall Study|Other, Not Specified|1|||
48985475|NCT02709889|157777668|FG003|Overall Study|Other, Not Specified|6|||
48985476|NCT00989664|157777670|FG000|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1|||
48985477|NCT00989664|157777670|FG000|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2|||
48985478|NCT00989664|157777670|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|49|||
48985479|NCT00989664|157777670|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
48985480|NCT00989664|157777670|FG000|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7|||
48985481|NCT00989664|157777670|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1|||
48985482|NCT00989664|157777670|FG000|Long-Term Follow-Up|Death|3|||
48985483|NCT00962780|157777674|FG000|Overall Study|Death|0|||
48985484|NCT00962780|157777675|FG001|Overall Study|Death|1|||
48985485|NCT00962780|157777674|FG000|Overall Study|Protocol Violation|9|||
48985486|NCT00962780|157777675|FG001|Overall Study|Protocol Violation|4|||
48985487|NCT00962780|157777674|FG000|Overall Study|Withdrawal by Subject|1|||
48985488|NCT00962780|157777675|FG001|Overall Study|Withdrawal by Subject|8|||
48985489|NCT00962780|157777674|FG000|Overall Study|Other|0|||
48985490|NCT00962780|157777675|FG001|Overall Study|Other|1|||
48985491|NCT02309372|157777677|FG000|Overall Study|Lost to Follow-up|3|||
48985492|NCT02309372|157777678|FG001|Overall Study|Lost to Follow-up|2|||
48985493|NCT01066546|157777679|FG000|Overall Study|Study terminated by sponsor|5|||
48985494|NCT00242658|157777680|FG000|Overall Study|Lost to Follow-up|22|||
48985495|NCT00242658|157777681|FG001|Overall Study|Lost to Follow-up|19|||
48985496|NCT02853318|157777683|FG000|Overall Study|Withdrawal by Subject|1|||
48985497|NCT00252499|157777686|FG000|Overall Study|Lost to Follow-up|1|||
48985498|NCT00252499|157777687|FG001|Overall Study|Lost to Follow-up|0|||
48985499|NCT00252499|157777688|FG002|Overall Study|Lost to Follow-up|0|||
48985500|NCT02646332|157777689|FG000|Overall Study|Lost to Follow-up|0|||
48985501|NCT02646332|157777690|FG001|Overall Study|Lost to Follow-up|3|||
48985502|NCT01882439|157777692|FG000|Overall Study|Adverse event related to study drug|3|||
48985503|NCT01882439|157777693|FG001|Overall Study|Adverse event related to study drug|8|||
48985504|NCT01882439|157777694|FG002|Overall Study|Adverse event related to study drug|1|||
48985505|NCT01882439|157777695|FG003|Overall Study|Adverse event related to study drug|2|||
48985506|NCT01882439|157777692|FG000|Overall Study|Pregnancy|0|||
48985507|NCT01882439|157777693|FG001|Overall Study|Pregnancy|1|||
48985508|NCT01882439|157777694|FG002|Overall Study|Pregnancy|0|||
48985509|NCT01882439|157777695|FG003|Overall Study|Pregnancy|0|||
48985510|NCT01882439|157777692|FG000|Overall Study|Protocol Violation|2|||
48985511|NCT01882439|157777693|FG001|Overall Study|Protocol Violation|2|||
48985512|NCT01882439|157777694|FG002|Overall Study|Protocol Violation|0|||
48985513|NCT01882439|157777695|FG003|Overall Study|Protocol Violation|1|||
48985514|NCT01882439|157777692|FG000|Overall Study|No longer willing to participate|1|||
48985515|NCT01882439|157777693|FG001|Overall Study|No longer willing to participate|4|||
48985516|NCT01882439|157777694|FG002|Overall Study|No longer willing to participate|2|||
48985517|NCT01882439|157777695|FG003|Overall Study|No longer willing to participate|3|||
48985518|NCT01882439|157777692|FG000|Overall Study|Medication error with no associated AE|0|||
48985519|NCT01882439|157777693|FG001|Overall Study|Medication error with no associated AE|0|||
48985520|NCT01882439|157777694|FG002|Overall Study|Medication error with no associated AE|2|||
48985521|NCT01882439|157777695|FG003|Overall Study|Medication error with no associated AE|0|||
48985522|NCT01882439|157777692|FG000|Overall Study|Insufficient clinical response|1|||
48985523|NCT01882439|157777693|FG001|Overall Study|Insufficient clinical response|4|||
48985524|NCT01882439|157777694|FG002|Overall Study|Insufficient clinical response|4|||
48985525|NCT01882439|157777695|FG003|Overall Study|Insufficient clinical response|2|||
48985526|NCT01882439|157777692|FG000|Overall Study|Adverse event unrelated to study drug|2|||
48985527|NCT01882439|157777693|FG001|Overall Study|Adverse event unrelated to study drug|2|||
48985528|NCT01882439|157777694|FG002|Overall Study|Adverse event unrelated to study drug|1|||
48985529|NCT01882439|157777695|FG003|Overall Study|Adverse event unrelated to study drug|1|||
48985530|NCT02363322|157777696|FG000|Overall Study|Lost to Follow-up|1|||
48985531|NCT02363322|157777697|FG001|Overall Study|Lost to Follow-up|0|||
48985532|NCT01775995|157777704|FG000|Overall Study|Lost to Follow-up|1|||
48985533|NCT01775995|157777705|FG001|Overall Study|Lost to Follow-up|1|||
48985534|NCT01469637|157777710|FG000|First Intervention|Unacceptable behavior|0|||
48985535|NCT01469637|157777711|FG001|First Intervention|Unacceptable behavior|1|||
48985536|NCT01469637|157777710|FG000|Second Intervention|Incarcerated|1|||
48985537|NCT01469637|157777711|FG001|Second Intervention|Incarcerated|0|||
48985538|NCT01843933|157777712|FG000|Overall Study|Data lost|6|||
48985539|NCT01843933|157777713|FG001|Overall Study|Data lost|4|||
48985540|NCT00424463|157777716|FG000|Overall Study|Adverse Event|2|||
48985541|NCT00424463|157777717|FG001|Overall Study|Adverse Event|3|||
48985542|NCT00424463|157777718|FG002|Overall Study|Adverse Event|2|||
48985543|NCT00424463|157777716|FG000|Overall Study|Physician Decision|0|||
48985544|NCT00424463|157777717|FG001|Overall Study|Physician Decision|2|||
48985545|NCT00424463|157777718|FG002|Overall Study|Physician Decision|2|||
48985546|NCT00424463|157777716|FG000|Overall Study|Withdrawal by Subject|4|||
49042752|NCT02614196|157989859|FG001|Post Treatment Follow-up Phase|Protocol Violation|1|||
49042753|NCT02614196|157989860|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
49042754|NCT02614196|157989861|FG003|Post Treatment Follow-up Phase|Protocol Violation|0|||
49042755|NCT02614196|157989862|FG004|Post Treatment Follow-up Phase|Protocol Violation|1|||
49042756|NCT02614196|157989863|FG005|Post Treatment Follow-up Phase|Protocol Violation|0|||
49042757|NCT02614196|157989858|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|10|||
49042758|NCT02614196|157989859|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
49042759|NCT02614196|157989860|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
49042760|NCT02614196|157989861|FG003|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
49042761|NCT02614196|157989862|FG004|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
49042762|NCT02614196|157989863|FG005|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
49042763|NCT04553406|157989865|FG000|Overall Study|Study Discontinuation|0|||
49042764|NCT04553406|157989866|FG001|Overall Study|Study Discontinuation|1|||
49042765|NCT03185741|157989867|FG000|Baseline|Withdrawal by Subject|1|||
49042766|NCT03185741|157989868|FG001|Baseline|Withdrawal by Subject|3|||
49042767|NCT03185741|157989869|FG002|Baseline|Withdrawal by Subject|2|||
49042768|NCT03185741|157989867|FG000|Baseline|Lost to Follow-up|1|||
49042769|NCT03185741|157989868|FG001|Baseline|Lost to Follow-up|2|||
49042770|NCT03185741|157989869|FG002|Baseline|Lost to Follow-up|3|||
49042771|NCT03185741|157989867|FG000|3Month|Death|1|||
49042772|NCT03185741|157989868|FG001|3Month|Death|1|||
49042773|NCT03185741|157989869|FG002|3Month|Death|2|||
49042774|NCT03185741|157989867|FG000|3Month|Withdrawal by Subject|1|||
49042775|NCT03185741|157989868|FG001|3Month|Withdrawal by Subject|5|||
49042776|NCT03185741|157989869|FG002|3Month|Withdrawal by Subject|1|||
49042777|NCT03185741|157989867|FG000|3Month|Lost to Follow-up|7|||
49042778|NCT03185741|157989868|FG001|3Month|Lost to Follow-up|9|||
49042779|NCT03185741|157989869|FG002|3Month|Lost to Follow-up|8|||
49042780|NCT03185741|157989867|FG000|3Month|Unavailable for 3Month|11|||
49042781|NCT03185741|157989868|FG001|3Month|Unavailable for 3Month|10|||
49042782|NCT03185741|157989869|FG002|3Month|Unavailable for 3Month|11|||
49042783|NCT03185741|157989867|FG000|3Month|Protocol Violation|0|||
49042784|NCT03185741|157989868|FG001|3Month|Protocol Violation|0|||
49042785|NCT03185741|157989869|FG002|3Month|Protocol Violation|3|||
48985547|NCT00424463|157777717|FG001|Overall Study|Withdrawal by Subject|2|||
48985548|NCT00424463|157777718|FG002|Overall Study|Withdrawal by Subject|5|||
48985549|NCT00424463|157777716|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
48985550|NCT00424463|157777717|FG001|Overall Study|Tracheotomy due to worsening of ALS|7|||
48985551|NCT00424463|157777718|FG002|Overall Study|Tracheotomy due to worsening of ALS|6|||
48985552|NCT00424463|157777716|FG000|Overall Study|Patient's convenience|0|||
48985553|NCT00424463|157777717|FG001|Overall Study|Patient's convenience|0|||
48985554|NCT00424463|157777718|FG002|Overall Study|Patient's convenience|1|||
48985555|NCT02504424|157777719|FG000|Overall Study|Withdrawal by Subject|2|||
48985556|NCT00440232|157777724|FG000|Overall Study|Lost to Follow-up|1|||
48985557|NCT00440232|157777725|FG001|Overall Study|Lost to Follow-up|1|||
48985558|NCT00440232|157777724|FG000|Overall Study|Unable to treat within allowed time|0|||
48985559|NCT00440232|157777725|FG001|Overall Study|Unable to treat within allowed time|1|||
48985560|NCT00440232|157777724|FG000|Overall Study|Onset of headache within 4 hours of fast|2|||
48985561|NCT00440232|157777725|FG001|Overall Study|Onset of headache within 4 hours of fast|2|||
48985562|NCT01673373|157780019|FG000|Overall Study|Death|2|||
48985563|NCT00003389|157780020|FG000|Overall Study|Disease progression|6|||
48985564|NCT00003389|157780021|FG001|Overall Study|Disease progression|1|||
48985565|NCT00003389|157780020|FG000|Overall Study|Adverse Event|13|||
48985566|NCT00003389|157780021|FG001|Overall Study|Adverse Event|2|||
48985567|NCT00003389|157780020|FG000|Overall Study|Death|0|||
48985568|NCT00003389|157780021|FG001|Overall Study|Death|3|||
48985569|NCT00003389|157780020|FG000|Overall Study|Withdrawal by Subject|12|||
48985570|NCT00003389|157780021|FG001|Overall Study|Withdrawal by Subject|5|||
48985571|NCT00003389|157780020|FG000|Overall Study|Alternative therapy|2|||
48985572|NCT00003389|157780021|FG001|Overall Study|Alternative therapy|1|||
48985573|NCT00003389|157780020|FG000|Overall Study|Complicating disease|1|||
48985574|NCT00003389|157780021|FG001|Overall Study|Complicating disease|0|||
48985575|NCT00003389|157780020|FG000|Overall Study|Off-treatment reason missing|31|||
48985576|NCT00003389|157780021|FG001|Overall Study|Off-treatment reason missing|21|||
48985577|NCT00003389|157780020|FG000|Overall Study|Ineligible|33|||
48985578|NCT00003389|157780021|FG001|Overall Study|Ineligible|27|||
48985579|NCT03793010|157780024|FG000|Overall Study|Withdrawal by Subject|5|||
48985580|NCT03793010|157780025|FG001|Overall Study|Withdrawal by Subject|7|||
48985581|NCT03793010|157780024|FG000|Overall Study|Withdrawn by Investigator or Sponsor|19|||
48985582|NCT03793010|157780025|FG001|Overall Study|Withdrawn by Investigator or Sponsor|18|||
48985583|NCT03793010|157780024|FG000|Overall Study|Lost to Follow-up|1|||
48985584|NCT03793010|157780025|FG001|Overall Study|Lost to Follow-up|2|||
48985585|NCT03793010|157780024|FG000|Overall Study|Patient couldn't sit still for injection|1|||
49042786|NCT03185741|157989867|FG000|6Month|Death|1|||
49042787|NCT03185741|157989868|FG001|6Month|Death|1|||
48985586|NCT03793010|157780025|FG001|Overall Study|Patient couldn't sit still for injection|0|||
48985587|NCT03793010|157780024|FG000|Overall Study|Withdrew to pursue other treatment|1|||
48985588|NCT03793010|157780025|FG001|Overall Study|Withdrew to pursue other treatment|0|||
48985589|NCT03793010|157780024|FG000|Overall Study|Did not meet eligibility criteria|1|||
48985590|NCT03793010|157780025|FG001|Overall Study|Did not meet eligibility criteria|0|||
48985591|NCT00366444|157780028|FG000|Overall Study|Withdrawal by Subject|1|||
48985592|NCT00366444|157780029|FG001|Overall Study|Withdrawal by Subject|1|||
48985593|NCT00366444|157780028|FG000|Overall Study|Lack of Efficacy|0|||
48985594|NCT00366444|157780029|FG001|Overall Study|Lack of Efficacy|1|||
48985595|NCT00305773|157780030|FG000|Overall Study|Death|3|||
48985596|NCT00305773|157780031|FG001|Overall Study|Death|2|||
48985597|NCT00305773|157780030|FG000|Overall Study|Adverse Event|1|||
48985598|NCT00305773|157780031|FG001|Overall Study|Adverse Event|2|||
48985599|NCT00305773|157780030|FG000|Overall Study|Alternative Treatment|4|||
48985600|NCT00305773|157780031|FG001|Overall Study|Alternative Treatment|4|||
48985601|NCT00305773|157780030|FG000|Overall Study|Physician Decision|1|||
48985602|NCT00305773|157780031|FG001|Overall Study|Physician Decision|1|||
48985603|NCT00305773|157780030|FG000|Overall Study|Withdrawal by Subject|1|||
48985604|NCT00305773|157780031|FG001|Overall Study|Withdrawal by Subject|4|||
48985605|NCT00305773|157780030|FG000|Overall Study|Disease Progression|1|||
48985606|NCT00305773|157780031|FG001|Overall Study|Disease Progression|3|||
48985607|NCT00305773|157780030|FG000|Overall Study|All other reasons|3|||
48985608|NCT00305773|157780031|FG001|Overall Study|All other reasons|2|||
48985609|NCT01077193|157780033|FG000|Overall Study|Lost to Follow-up|1|||
48985610|NCT01077193|157780033|FG000|Overall Study|Withdrawal by Subject|2|||
48985611|NCT01077193|157780033|FG000|Overall Study|Lack of Efficacy|1|||
48985612|NCT01077193|157780033|FG000|Overall Study|Study Terminated by Sponsor|40|||
48985613|NCT02807376|157780034|FG000|Overall Study|Intra-operative exclusion criteria|3|||
48985614|NCT02807376|157780035|FG001|Overall Study|Intra-operative exclusion criteria|0|||
48985615|NCT02807376|157780034|FG000|Overall Study|Lost to Follow-up|0|||
48985616|NCT02807376|157780035|FG001|Overall Study|Lost to Follow-up|1|||
48985617|NCT01453439|157780036|FG000|Treatment Phase|Withdrawal by Subject|13|||
48985618|NCT01453439|157780037|FG001|Treatment Phase|Withdrawal by Subject|10|||
48985619|NCT01453439|157780036|FG000|Treatment Phase|Suicidal Ideation|2|||
48985620|NCT01453439|157780037|FG001|Treatment Phase|Suicidal Ideation|0|||
48985621|NCT01453439|157780036|FG000|Treatment Phase|Need for higher level of care|1|||
48985622|NCT01453439|157780037|FG001|Treatment Phase|Need for higher level of care|1|||
48985623|NCT01453439|157780036|FG000|Treatment Phase|Therapist conflict of interest|1|||
48985624|NCT01453439|157780037|FG001|Treatment Phase|Therapist conflict of interest|0|||
48985625|NCT01453439|157780036|FG000|Follow-up|Withdrawal by Subject|0|||
48985626|NCT01453439|157780037|FG001|Follow-up|Withdrawal by Subject|1|||
48985627|NCT01453439|157780036|FG000|Follow-up|Lost to Follow-up|5|||
48985628|NCT01453439|157780037|FG001|Follow-up|Lost to Follow-up|10|||
48985629|NCT01051856|157780041|FG000|Overall Study|Withdrawal by Subject|1|||
48985630|NCT01051856|157780042|FG001|Overall Study|Withdrawal by Subject|0|||
48985631|NCT02243306|157780043|FG000|Overall Study|Adverse Event|0|||
48985632|NCT02243306|157780044|FG001|Overall Study|Adverse Event|1|||
48985633|NCT02243306|157780043|FG000|Overall Study|Other: Reached stopping criteria|0|||
48985634|NCT02243306|157780044|FG001|Overall Study|Other: Reached stopping criteria|1|||
48985635|NCT02243306|157780043|FG000|Overall Study|Physician Decision|0|||
48985636|NCT02243306|157780044|FG001|Overall Study|Physician Decision|1|||
48985637|NCT02176226|157780045|FG000|Overall Study|Lost to Follow-up|3|||
48985638|NCT02176226|157780045|FG000|Overall Study|Withdrew prior to treatment|6|||
48985639|NCT01072500|157780048|FG000|Overall Study|Death|2|||
48985640|NCT01072500|157780049|FG001|Overall Study|Death|2|||
48985641|NCT01072500|157780048|FG000|Overall Study|Lost to Follow-up|5|||
48985642|NCT01072500|157780049|FG001|Overall Study|Lost to Follow-up|2|||
48985643|NCT01072500|157780048|FG000|Overall Study|Withdrawal by Subject|17|||
48985644|NCT01072500|157780049|FG001|Overall Study|Withdrawal by Subject|10|||
48985645|NCT02908841|157780050|FG000|Overall Study|Physician Decision|4|||
48985646|NCT02908841|157780051|FG001|Overall Study|Physician Decision|0|||
48985647|NCT00103207|157780052|FG000|Overall Study|Adverse Event|3|||
48985648|NCT00103207|157780052|FG000|Overall Study|Death|1|||
48985649|NCT00103207|157780052|FG000|Overall Study|Withdrawal by Subject|2|||
48985650|NCT00103207|157780052|FG000|Overall Study|Other complicating disease|1|||
48985651|NCT00103207|157780052|FG000|Overall Study|Ineligible|4|||
48985652|NCT00103207|157780052|FG000|Overall Study|Diagnosis of BAC not confirmed|27|||
48985653|NCT01266876|157780053|FG000|Overall Study|Adverse Event|0|||
48985654|NCT01266876|157780054|FG001|Overall Study|Adverse Event|0|||
48985655|NCT01266876|157780055|FG002|Overall Study|Adverse Event|0|||
48985656|NCT01266876|157780056|FG003|Overall Study|Adverse Event|1|||
48985657|NCT01266876|157780057|FG004|Overall Study|Adverse Event|0|||
48985658|NCT00750867|157780058|FG000|Overall Study|Adverse Event|2|||
48985659|NCT01117428|157780067|FG000|Overall Study|Lack of Efficacy|1|||
48985660|NCT01117428|157780068|FG001|Overall Study|Lack of Efficacy|0|||
48985661|NCT01117428|157780069|FG002|Overall Study|Lack of Efficacy|0|||
48985662|NCT01117428|157780070|FG003|Overall Study|Lack of Efficacy|0|||
48985663|NCT01117428|157780071|FG004|Overall Study|Lack of Efficacy|0|||
48985664|NCT01117428|157780072|FG005|Overall Study|Lack of Efficacy|0|||
48985665|NCT01117428|157780067|FG000|Overall Study|Adverse Event|4|||
48985666|NCT01117428|157780068|FG001|Overall Study|Adverse Event|0|||
48985667|NCT01117428|157780069|FG002|Overall Study|Adverse Event|0|||
48985668|NCT01117428|157780070|FG003|Overall Study|Adverse Event|0|||
48985669|NCT01117428|157780071|FG004|Overall Study|Adverse Event|1|||
48985670|NCT01117428|157780072|FG005|Overall Study|Adverse Event|2|||
48985671|NCT01117428|157780067|FG000|Overall Study|Death|0|||
48985672|NCT01117428|157780068|FG001|Overall Study|Death|1|||
48985673|NCT01117428|157780069|FG002|Overall Study|Death|2|||
48985674|NCT01117428|157780070|FG003|Overall Study|Death|0|||
48985675|NCT01117428|157780071|FG004|Overall Study|Death|0|||
48985676|NCT01117428|157780072|FG005|Overall Study|Death|1|||
48985677|NCT01117428|157780067|FG000|Overall Study|Physician Decision|0|||
48985678|NCT01117428|157780068|FG001|Overall Study|Physician Decision|1|||
48985679|NCT01117428|157780069|FG002|Overall Study|Physician Decision|0|||
48985680|NCT01117428|157780070|FG003|Overall Study|Physician Decision|0|||
48985681|NCT01117428|157780071|FG004|Overall Study|Physician Decision|0|||
48985682|NCT01117428|157780072|FG005|Overall Study|Physician Decision|0|||
48985683|NCT01117428|157780067|FG000|Overall Study|Withdrawal by Subject|0|||
48985684|NCT01117428|157780068|FG001|Overall Study|Withdrawal by Subject|0|||
48985685|NCT01117428|157780069|FG002|Overall Study|Withdrawal by Subject|1|||
48985686|NCT01117428|157780070|FG003|Overall Study|Withdrawal by Subject|0|||
48985687|NCT01117428|157780071|FG004|Overall Study|Withdrawal by Subject|0|||
48985688|NCT01117428|157780072|FG005|Overall Study|Withdrawal by Subject|0|||
48985689|NCT01117428|157780067|FG000|Overall Study|Progressive disease|15|||
48985690|NCT01117428|157780068|FG001|Overall Study|Progressive disease|27|||
48985691|NCT01117428|157780069|FG002|Overall Study|Progressive disease|10|||
48985692|NCT01117428|157780070|FG003|Overall Study|Progressive disease|12|||
48985693|NCT01117428|157780071|FG004|Overall Study|Progressive disease|16|||
48985694|NCT01117428|157780072|FG005|Overall Study|Progressive disease|17|||
48985695|NCT03018028|157780073|FG000|Overall Study|Withdrawal by Subject|3|||
48985696|NCT03018028|157780074|FG001|Overall Study|Withdrawal by Subject|0|||
48985697|NCT03018028|157780075|FG002|Overall Study|Withdrawal by Subject|1|||
48985698|NCT03018028|157780076|FG003|Overall Study|Withdrawal by Subject|2|||
48985699|NCT03018028|157780077|FG004|Overall Study|Withdrawal by Subject|0|||
48985700|NCT02561273|157780089|FG000|Overall Study|Protocol Violation|1|||
48985701|NCT02561273|157780090|FG001|Overall Study|Protocol Violation|0|||
48985702|NCT00545740|157780093|FG000|Overall Study|Lack of Efficacy|34|||
48985703|NCT00545740|157780094|FG001|Overall Study|Lack of Efficacy|35|||
48985704|NCT00545740|157780095|FG002|Overall Study|Lack of Efficacy|47|||
48985705|NCT00545740|157780096|FG003|Overall Study|Lack of Efficacy|36|||
48985706|NCT00545740|157780093|FG000|Overall Study|Withdrawal by Subject|17|||
48985707|NCT00545740|157780094|FG001|Overall Study|Withdrawal by Subject|15|||
48985708|NCT00545740|157780095|FG002|Overall Study|Withdrawal by Subject|16|||
48985709|NCT00545740|157780096|FG003|Overall Study|Withdrawal by Subject|18|||
48985710|NCT00545740|157780093|FG000|Overall Study|Adverse Event|10|||
48985711|NCT00545740|157780094|FG001|Overall Study|Adverse Event|18|||
48985712|NCT00545740|157780095|FG002|Overall Study|Adverse Event|19|||
48985713|NCT00545740|157780096|FG003|Overall Study|Adverse Event|9|||
48985714|NCT00545740|157780093|FG000|Overall Study|Lost to Follow-up|7|||
48985715|NCT00545740|157780094|FG001|Overall Study|Lost to Follow-up|5|||
48985716|NCT00545740|157780095|FG002|Overall Study|Lost to Follow-up|5|||
48985717|NCT00545740|157780096|FG003|Overall Study|Lost to Follow-up|6|||
48985718|NCT00545740|157780093|FG000|Overall Study|Protocol Violation|1|||
48985719|NCT00545740|157780094|FG001|Overall Study|Protocol Violation|3|||
48985720|NCT00545740|157780095|FG002|Overall Study|Protocol Violation|1|||
48985721|NCT00545740|157780096|FG003|Overall Study|Protocol Violation|0|||
48985722|NCT00545740|157780093|FG000|Overall Study|Non-compliance|0|||
48985723|NCT00545740|157780094|FG001|Overall Study|Non-compliance|2|||
48985724|NCT00545740|157780095|FG002|Overall Study|Non-compliance|1|||
48985725|NCT00545740|157780096|FG003|Overall Study|Non-compliance|0|||
48985726|NCT00545740|157780093|FG000|Overall Study|Moved|2|||
48985727|NCT00545740|157780094|FG001|Overall Study|Moved|0|||
48985728|NCT00545740|157780095|FG002|Overall Study|Moved|1|||
48985729|NCT00545740|157780096|FG003|Overall Study|Moved|0|||
48985730|NCT00545740|157780093|FG000|Overall Study|Diverticulitis attack|0|||
48985731|NCT00545740|157780094|FG001|Overall Study|Diverticulitis attack|0|||
48985732|NCT00545740|157780095|FG002|Overall Study|Diverticulitis attack|1|||
48985733|NCT00545740|157780096|FG003|Overall Study|Diverticulitis attack|1|||
48985734|NCT00545740|157780093|FG000|Overall Study|Suspected Diverticulitis Recurrence|1|||
48985735|NCT00545740|157780094|FG001|Overall Study|Suspected Diverticulitis Recurrence|1|||
48985736|NCT00545740|157780095|FG002|Overall Study|Suspected Diverticulitis Recurrence|1|||
48985737|NCT00545740|157780096|FG003|Overall Study|Suspected Diverticulitis Recurrence|1|||
48985738|NCT00545740|157780093|FG000|Overall Study|Site closure|1|||
48985739|NCT00545740|157780094|FG001|Overall Study|Site closure|0|||
48985740|NCT00545740|157780095|FG002|Overall Study|Site closure|0|||
48985741|NCT00545740|157780096|FG003|Overall Study|Site closure|0|||
48985742|NCT00545740|157780093|FG000|Overall Study|Missed visit|1|||
48985743|NCT00545740|157780094|FG001|Overall Study|Missed visit|0|||
49042788|NCT03185741|157989869|FG002|6Month|Death|2|||
49042789|NCT03185741|157989867|FG000|6Month|Withdrawal by Subject|2|||
49042790|NCT03185741|157989868|FG001|6Month|Withdrawal by Subject|3|||
49042791|NCT03185741|157989869|FG002|6Month|Withdrawal by Subject|1|||
49042792|NCT03185741|157989867|FG000|6Month|Lost to Follow-up|16|||
49042793|NCT03185741|157989868|FG001|6Month|Lost to Follow-up|15|||
49042794|NCT03185741|157989869|FG002|6Month|Lost to Follow-up|16|||
49042795|NCT00772148|157989870|FG000|Pharmacokinetic Phase (14 Days)|Adverse Event|3|||
49042796|NCT00772148|157989871|FG001|Pharmacokinetic Phase (14 Days)|Adverse Event|1|||
49042797|NCT00772148|157989870|FG000|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3|||
48985744|NCT00545740|157780095|FG002|Overall Study|Missed visit|0|||
48985745|NCT00545740|157780096|FG003|Overall Study|Missed visit|0|||
48985746|NCT00545740|157780093|FG000|Overall Study|Physician Decision|0|||
48985747|NCT00545740|157780094|FG001|Overall Study|Physician Decision|0|||
48985748|NCT00545740|157780095|FG002|Overall Study|Physician Decision|3|||
48985749|NCT00545740|157780096|FG003|Overall Study|Physician Decision|0|||
48985750|NCT00545740|157780093|FG000|Overall Study|Accepted only monthly telephone calls|1|||
48985751|NCT00545740|157780094|FG001|Overall Study|Accepted only monthly telephone calls|0|||
48985752|NCT00545740|157780095|FG002|Overall Study|Accepted only monthly telephone calls|0|||
48985753|NCT00545740|157780096|FG003|Overall Study|Accepted only monthly telephone calls|0|||
48985754|NCT00545740|157780093|FG000|Overall Study|Sponsor decision|0|||
48985755|NCT00545740|157780094|FG001|Overall Study|Sponsor decision|1|||
48985756|NCT00545740|157780095|FG002|Overall Study|Sponsor decision|0|||
48985757|NCT00545740|157780096|FG003|Overall Study|Sponsor decision|0|||
48985758|NCT00545740|157780093|FG000|Overall Study|Lack of time|0|||
48985759|NCT00545740|157780094|FG001|Overall Study|Lack of time|1|||
48985760|NCT00545740|157780095|FG002|Overall Study|Lack of time|0|||
48985761|NCT00545740|157780096|FG003|Overall Study|Lack of time|0|||
48985762|NCT00545740|157780093|FG000|Overall Study|Non-adherence to visits|0|||
48985763|NCT00545740|157780094|FG001|Overall Study|Non-adherence to visits|1|||
48985764|NCT00545740|157780095|FG002|Overall Study|Non-adherence to visits|0|||
48985765|NCT00545740|157780096|FG003|Overall Study|Non-adherence to visits|0|||
48985766|NCT00545740|157780093|FG000|Overall Study|Patient difficulties|0|||
48985767|NCT00545740|157780094|FG001|Overall Study|Patient difficulties|1|||
48985768|NCT00545740|157780095|FG002|Overall Study|Patient difficulties|0|||
48985769|NCT00545740|157780096|FG003|Overall Study|Patient difficulties|0|||
48985770|NCT00545740|157780093|FG000|Overall Study|Husband against study|0|||
48985771|NCT00545740|157780094|FG001|Overall Study|Husband against study|0|||
48985772|NCT00545740|157780095|FG002|Overall Study|Husband against study|1|||
48985773|NCT00545740|157780096|FG003|Overall Study|Husband against study|0|||
48985774|NCT01060150|157780097|FG000|Overall Study|Adverse Event|6|||
48985775|NCT01060150|157780097|FG000|Overall Study|Lost to Follow-up|1|||
48985776|NCT01060150|157780097|FG000|Overall Study|Protocol Violation|6|||
48985777|NCT01060150|157780097|FG000|Overall Study|Withdrawal by Subject|8|||
48985778|NCT01060150|157780097|FG000|Overall Study|Enrolled, but not treated|2|||
48985779|NCT01969565|157780098|FG000|Overall Study|Withdrawal by Subject|1|||
48985780|NCT01738594|157780099|FG000|Registration and Treatment Start|Adverse Event|0|||
48985781|NCT01738594|157780100|FG001|Registration and Treatment Start|Adverse Event|1|||
48985782|NCT01738594|157780101|FG002|Registration and Treatment Start|Adverse Event|0|||
48985783|NCT01738594|157780102|FG003|Registration and Treatment Start|Adverse Event|0|||
48985784|NCT01738594|157780103|FG004|Registration and Treatment Start|Adverse Event|0|||
48985785|NCT01738594|157780104|FG005|Registration and Treatment Start|Adverse Event|0|||
48985786|NCT01738594|157780105|FG006|Registration and Treatment Start|Adverse Event|0|||
48985787|NCT01738594|157780106|FG007|Registration and Treatment Start|Adverse Event|0|||
48985788|NCT01738594|157780099|FG000|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
48985789|NCT01738594|157780100|FG001|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
48985790|NCT01738594|157780101|FG002|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
48985791|NCT01738594|157780102|FG003|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
48985792|NCT01738594|157780103|FG004|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
48985793|NCT01738594|157780104|FG005|Completed 2 Cycles/Reached 1st Response|Physician Decision|1|||
48985794|NCT01738594|157780105|FG006|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
48985795|NCT01738594|157780106|FG007|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
48985796|NCT01738594|157780099|FG000|Completed 4 Cycles of Treatment|Progressive disease|0|||
49042798|NCT00772148|157989871|FG001|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5|||
49042799|NCT00772148|157989870|FG000|Pharmacokinetic Phase (14 Days)|Administrative/other|2|||
48985797|NCT01738594|157780100|FG001|Completed 4 Cycles of Treatment|Progressive disease|2|||
48985798|NCT01738594|157780101|FG002|Completed 4 Cycles of Treatment|Progressive disease|0|||
48985799|NCT01738594|157780102|FG003|Completed 4 Cycles of Treatment|Progressive disease|0|||
48985800|NCT01738594|157780103|FG004|Completed 4 Cycles of Treatment|Progressive disease|0|||
48985801|NCT01738594|157780104|FG005|Completed 4 Cycles of Treatment|Progressive disease|0|||
48985802|NCT01738594|157780105|FG006|Completed 4 Cycles of Treatment|Progressive disease|0|||
48985803|NCT01738594|157780106|FG007|Completed 4 Cycles of Treatment|Progressive disease|0|||
49042800|NCT00772148|157989871|FG001|Pharmacokinetic Phase (14 Days)|Administrative/other|0|||
49042801|NCT00772148|157989870|FG000|Maintenance Phase (Week 52)|Death|2|||
49042802|NCT00772148|157989871|FG001|Maintenance Phase (Week 52)|Death|2|||
49042803|NCT00772148|157989870|FG000|Maintenance Phase (Week 52)|Adverse Event|1|||
49042804|NCT00772148|157989871|FG001|Maintenance Phase (Week 52)|Adverse Event|0|||
49042805|NCT00772148|157989870|FG000|Maintenance Phase (Week 52)|Withdrawal by Subject|0|||
49042806|NCT00772148|157989871|FG001|Maintenance Phase (Week 52)|Withdrawal by Subject|1|||
49042807|NCT00772148|157989870|FG000|Maintenance Phase (Week 52)|Administrative/other|1|||
49042808|NCT00772148|157989871|FG001|Maintenance Phase (Week 52)|Administrative/other|2|||
48985804|NCT01738594|157780099|FG000|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
48985805|NCT01738594|157780100|FG001|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
48985806|NCT01738594|157780101|FG002|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
48985807|NCT01738594|157780102|FG003|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
48985808|NCT01738594|157780103|FG004|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
48985809|NCT01738594|157780104|FG005|Completed 4 Cycles of Treatment|No response/patient benefit|1|||
48985810|NCT01738594|157780105|FG006|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
48985811|NCT01738594|157780106|FG007|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
48985812|NCT01738594|157780099|FG000|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
48985813|NCT01738594|157780100|FG001|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
48985814|NCT01738594|157780101|FG002|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
48985815|NCT01738594|157780102|FG003|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
48985816|NCT01738594|157780103|FG004|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
48985817|NCT01738594|157780104|FG005|Went on to Continue Treatment Cycle 5|Progressive Disease|1|||
48985818|NCT01738594|157780105|FG006|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
48985819|NCT01738594|157780106|FG007|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
48985820|NCT01738594|157780099|FG000|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
48985821|NCT01738594|157780100|FG001|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
48985822|NCT01738594|157780101|FG002|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
48985823|NCT01738594|157780102|FG003|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
48985824|NCT01738594|157780103|FG004|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1|||
48985825|NCT01738594|157780104|FG005|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
48985826|NCT01738594|157780105|FG006|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
48985827|NCT01738594|157780106|FG007|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
48985828|NCT01738594|157780099|FG000|Follow up for 1 Year|Death|0|||
48985829|NCT01738594|157780100|FG001|Follow up for 1 Year|Death|0|||
48985830|NCT01738594|157780101|FG002|Follow up for 1 Year|Death|0|||
48985831|NCT01738594|157780102|FG003|Follow up for 1 Year|Death|0|||
48985832|NCT01738594|157780103|FG004|Follow up for 1 Year|Death|0|||
48985833|NCT01738594|157780104|FG005|Follow up for 1 Year|Death|1|||
48985834|NCT01738594|157780105|FG006|Follow up for 1 Year|Death|0|||
48985835|NCT01738594|157780106|FG007|Follow up for 1 Year|Death|0|||
48985836|NCT01738594|157780099|FG000|Follow up for 1 Year|Other|0|||
48985837|NCT01738594|157780100|FG001|Follow up for 1 Year|Other|0|||
48985838|NCT01738594|157780101|FG002|Follow up for 1 Year|Other|0|||
48985839|NCT01738594|157780102|FG003|Follow up for 1 Year|Other|0|||
48985840|NCT01738594|157780103|FG004|Follow up for 1 Year|Other|0|||
48985841|NCT01738594|157780104|FG005|Follow up for 1 Year|Other|2|||
48985842|NCT01738594|157780105|FG006|Follow up for 1 Year|Other|0|||
48985843|NCT01738594|157780106|FG007|Follow up for 1 Year|Other|0|||
48985844|NCT01957111|157780107|FG000|Overall Study|Withdrawal by Subject|1|||
48985845|NCT01957111|157780108|FG001|Overall Study|Withdrawal by Subject|1|||
48985846|NCT00579527|157780109|FG000|Overall Study|Death|4|||
48985847|NCT00403390|157780110|FG000|Overall Study|Withdrawal by Subject|1|||
48985848|NCT00403390|157780111|FG001|Overall Study|Withdrawal by Subject|0|||
48985849|NCT00403390|157780110|FG000|Overall Study|samples lost|1|||
48985850|NCT00403390|157780111|FG001|Overall Study|samples lost|0|||
48985851|NCT00403390|157780110|FG000|Overall Study|non-compliant|1|||
48985852|NCT00403390|157780111|FG001|Overall Study|non-compliant|0|||
48985853|NCT01497899|157780112|FG000|Double-Blind Phase|Randomized but not Treated|1|||
48985854|NCT01497899|157780113|FG001|Double-Blind Phase|Randomized but not Treated|0|||
48985855|NCT01497899|157780114|FG002|Double-Blind Phase|Randomized but not Treated|0|||
48985856|NCT01497899|157780115|FG003|Double-Blind Phase|Randomized but not Treated|0|||
49042809|NCT03573336|157989872|FG000|Overall Study|Study terminated|2|||
49042810|NCT03573336|157989873|FG001|Overall Study|Study terminated|4|||
48985857|NCT01497899|157780112|FG000|Double-Blind Phase|Adverse Event|1|||
48985858|NCT01497899|157780113|FG001|Double-Blind Phase|Adverse Event|0|||
48985859|NCT01497899|157780114|FG002|Double-Blind Phase|Adverse Event|0|||
48985860|NCT01497899|157780115|FG003|Double-Blind Phase|Adverse Event|0|||
48985861|NCT01497899|157780112|FG000|Double-Blind Phase|Lack of Efficacy|0|||
48985862|NCT01497899|157780113|FG001|Double-Blind Phase|Lack of Efficacy|1|||
48985863|NCT01497899|157780114|FG002|Double-Blind Phase|Lack of Efficacy|0|||
48985864|NCT01497899|157780115|FG003|Double-Blind Phase|Lack of Efficacy|0|||
49042811|NCT03573336|157989874|FG002|Overall Study|Study terminated|2|||
49042812|NCT01525628|157989875|FG000|Overall Study|Adverse Event|1|||
49042813|NCT01525628|157989876|FG001|Overall Study|Adverse Event|1|||
49042814|NCT01525628|157989877|FG002|Overall Study|Adverse Event|2|||
49042815|NCT01525628|157989878|FG003|Overall Study|Adverse Event|0|||
49042816|NCT01525628|157989879|FG004|Overall Study|Adverse Event|1|||
49042817|NCT01525628|157989875|FG000|Overall Study|Lack of Efficacy|0|||
49042818|NCT01525628|157989876|FG001|Overall Study|Lack of Efficacy|2|||
49042819|NCT01525628|157989877|FG002|Overall Study|Lack of Efficacy|2|||
49042820|NCT01525628|157989878|FG003|Overall Study|Lack of Efficacy|1|||
49042821|NCT01525628|157989879|FG004|Overall Study|Lack of Efficacy|2|||
49042822|NCT01525628|157989875|FG000|Overall Study|Protocol Violation|0|||
49042823|NCT01525628|157989876|FG001|Overall Study|Protocol Violation|0|||
49042824|NCT01525628|157989877|FG002|Overall Study|Protocol Violation|1|||
49042825|NCT01525628|157989878|FG003|Overall Study|Protocol Violation|0|||
49042826|NCT01525628|157989879|FG004|Overall Study|Protocol Violation|0|||
49042827|NCT01525628|157989875|FG000|Overall Study|Lost to Follow-up|1|||
49042828|NCT01525628|157989876|FG001|Overall Study|Lost to Follow-up|1|||
48985865|NCT01497899|157780112|FG000|Double-Blind Phase|Investigator's Discretion|1|||
48985866|NCT01497899|157780113|FG001|Double-Blind Phase|Investigator's Discretion|0|||
48985867|NCT01497899|157780114|FG002|Double-Blind Phase|Investigator's Discretion|0|||
48985868|NCT01497899|157780115|FG003|Double-Blind Phase|Investigator's Discretion|0|||
48985869|NCT01497899|157780112|FG000|Double-Blind Phase|Withdrew Consent|0|||
48985870|NCT01497899|157780113|FG001|Double-Blind Phase|Withdrew Consent|1|||
49042829|NCT01525628|157989877|FG002|Overall Study|Lost to Follow-up|0|||
49042830|NCT01525628|157989878|FG003|Overall Study|Lost to Follow-up|0|||
49042831|NCT01525628|157989879|FG004|Overall Study|Lost to Follow-up|0|||
49042832|NCT01525628|157989875|FG000|Overall Study|Withdrawal by Subject|0|||
49042833|NCT01525628|157989876|FG001|Overall Study|Withdrawal by Subject|1|||
49042834|NCT01525628|157989877|FG002|Overall Study|Withdrawal by Subject|0|||
49042835|NCT01525628|157989878|FG003|Overall Study|Withdrawal by Subject|0|||
49042836|NCT01525628|157989879|FG004|Overall Study|Withdrawal by Subject|0|||
49042837|NCT01525628|157989875|FG000|Overall Study|Other reason not defined above|0|||
49042838|NCT01525628|157989876|FG001|Overall Study|Other reason not defined above|0|||
49042839|NCT01525628|157989877|FG002|Overall Study|Other reason not defined above|0|||
49042840|NCT01525628|157989878|FG003|Overall Study|Other reason not defined above|3|||
49042841|NCT01525628|157989879|FG004|Overall Study|Other reason not defined above|0|||
48692536|NCT02322281|156724524|FG001|Overall Study|Progressive Disease|14|||
48692537|NCT02322281|156724525|FG002|Overall Study|Progressive Disease|49|||
48692538|NCT02322281|156724523|FG000|Overall Study|Adverse Event|3|||
48692539|NCT02322281|156724524|FG001|Overall Study|Adverse Event|4|||
48692540|NCT02322281|156724525|FG002|Overall Study|Adverse Event|6|||
48692541|NCT02322281|156724523|FG000|Overall Study|Death|3|||
48692542|NCT02322281|156724524|FG001|Overall Study|Death|3|||
48692543|NCT02322281|156724525|FG002|Overall Study|Death|3|||
48692544|NCT02322281|156724523|FG000|Overall Study|Withdrawal by Subject|1|||
48692545|NCT02322281|156724524|FG001|Overall Study|Withdrawal by Subject|1|||
48692546|NCT02322281|156724525|FG002|Overall Study|Withdrawal by Subject|6|||
48692547|NCT02322281|156724523|FG000|Overall Study|Physician Decision|2|||
48692548|NCT02322281|156724524|FG001|Overall Study|Physician Decision|0|||
48692549|NCT02322281|156724525|FG002|Overall Study|Physician Decision|5|||
48692550|NCT02322281|156724523|FG000|Overall Study|Study Terminated by Sponsor|2|||
49042842|NCT04388787|157989880|FG000|Blinded Period|Patient could not follow instructions|1|||
48985871|NCT01497899|157780114|FG002|Double-Blind Phase|Withdrew Consent|0|||
48985872|NCT01497899|157780115|FG003|Double-Blind Phase|Withdrew Consent|0|||
48985873|NCT01497899|157780112|FG000|Double-Blind Phase|Lost to Follow-up|3|||
48985874|NCT01497899|157780113|FG001|Double-Blind Phase|Lost to Follow-up|2|||
48985875|NCT01497899|157780114|FG002|Double-Blind Phase|Lost to Follow-up|0|||
48985876|NCT01497899|157780115|FG003|Double-Blind Phase|Lost to Follow-up|0|||
48985877|NCT01497899|157780112|FG000|Double-Blind Phase|Subject Non-Compliance|0|||
48985878|NCT01497899|157780113|FG001|Double-Blind Phase|Subject Non-Compliance|1|||
48985879|NCT01497899|157780114|FG002|Double-Blind Phase|Subject Non-Compliance|0|||
48985880|NCT01497899|157780115|FG003|Double-Blind Phase|Subject Non-Compliance|0|||
48985881|NCT01497899|157780112|FG000|Open-Label Extension Phase|Adverse Event|1|||
48985882|NCT01497899|157780113|FG001|Open-Label Extension Phase|Adverse Event|0|||
48985883|NCT01497899|157780114|FG002|Open-Label Extension Phase|Adverse Event|0|||
49042843|NCT04388787|157989880|FG000|Unblinded Period|Patients became fatiged after a single round of testing with sham vs subthreshold|9|||
49042844|NCT03382041|157989881|FG000|Overall Study|Consent Form Lost|2|||
49042845|NCT03382041|157989882|FG001|Overall Study|Consent Form Lost|1|||
48985884|NCT01497899|157780115|FG003|Open-Label Extension Phase|Adverse Event|0|||
48985885|NCT01497899|157780112|FG000|Open-Label Extension Phase|Death|1|||
48692551|NCT02322281|156724524|FG001|Overall Study|Study Terminated by Sponsor|0|||
49042846|NCT03382041|157989881|FG000|Overall Study|Withdrawal by Subject|1|||
49042847|NCT03382041|157989882|FG001|Overall Study|Withdrawal by Subject|4|||
48692552|NCT02322281|156724525|FG002|Overall Study|Study Terminated by Sponsor|0|||
48692553|NCT02322281|156724523|FG000|Overall Study|Missing|0|||
48692554|NCT02322281|156724524|FG001|Overall Study|Missing|0|||
49042848|NCT03382041|157989881|FG000|Overall Study|Lost to Follow-up|1|||
49042849|NCT03382041|157989882|FG001|Overall Study|Lost to Follow-up|4|||
49042850|NCT01891357|157989885|FG000|Overall Study|Protocol Violation|3|||
49042851|NCT02308241|157991048|FG000|Overall Study|Withdrawal by Subject|3|||
49042852|NCT02651987|157991049|FG000|Overall Study|Adverse Event|2|||
49042853|NCT02651987|157991050|FG001|Overall Study|Adverse Event|2|||
49042854|NCT02651987|157991049|FG000|Overall Study|Consent Withdrawn|2|||
49042855|NCT02651987|157991050|FG001|Overall Study|Consent Withdrawn|0|||
49042856|NCT02651987|157991049|FG000|Overall Study|Local PD|0|||
49042857|NCT02651987|157991050|FG001|Overall Study|Local PD|2|||
49042858|NCT02651987|157991049|FG000|Overall Study|Investigator Decision|1|||
49042859|NCT02651987|157991050|FG001|Overall Study|Investigator Decision|1|||
49042860|NCT01630616|157991051|FG000|Overall Study|Adverse Event|0|||
49042861|NCT01630616|157991052|FG001|Overall Study|Adverse Event|0|||
49042862|NCT01630616|157991053|FG002|Overall Study|Adverse Event|0|||
49042863|NCT01630616|157991054|FG003|Overall Study|Adverse Event|1|||
49042864|NCT01630616|157991055|FG004|Overall Study|Adverse Event|0|||
49042865|NCT01630616|157991056|FG005|Overall Study|Adverse Event|0|||
49042866|NCT01630616|157991051|FG000|Overall Study|Withdrawal by Subject|0|||
48985886|NCT01497899|157780113|FG001|Open-Label Extension Phase|Death|0|||
48985887|NCT01497899|157780114|FG002|Open-Label Extension Phase|Death|0|||
48985888|NCT01497899|157780115|FG003|Open-Label Extension Phase|Death|0|||
48985889|NCT01497899|157780112|FG000|Open-Label Extension Phase|Withdrew Consent|8|||
48985890|NCT01497899|157780113|FG001|Open-Label Extension Phase|Withdrew Consent|3|||
49042867|NCT01630616|157991052|FG001|Overall Study|Withdrawal by Subject|0|||
48985891|NCT01497899|157780114|FG002|Open-Label Extension Phase|Withdrew Consent|2|||
48985892|NCT01497899|157780115|FG003|Open-Label Extension Phase|Withdrew Consent|0|||
48985893|NCT01497899|157780112|FG000|Open-Label Extension Phase|Pregnancy|0|||
48985894|NCT01497899|157780113|FG001|Open-Label Extension Phase|Pregnancy|1|||
48985895|NCT01497899|157780114|FG002|Open-Label Extension Phase|Pregnancy|1|||
48985896|NCT01497899|157780115|FG003|Open-Label Extension Phase|Pregnancy|0|||
48985897|NCT01497899|157780112|FG000|Open-Label Extension Phase|Protocol Violation|0|||
48985898|NCT01497899|157780113|FG001|Open-Label Extension Phase|Protocol Violation|0|||
48985899|NCT01497899|157780114|FG002|Open-Label Extension Phase|Protocol Violation|1|||
48985900|NCT01497899|157780115|FG003|Open-Label Extension Phase|Protocol Violation|0|||
48985901|NCT01497899|157780112|FG000|Open-Label Extension Phase|Lost to Follow-up|9|||
48985902|NCT01497899|157780113|FG001|Open-Label Extension Phase|Lost to Follow-up|3|||
48985903|NCT01497899|157780114|FG002|Open-Label Extension Phase|Lost to Follow-up|5|||
48985904|NCT01497899|157780115|FG003|Open-Label Extension Phase|Lost to Follow-up|5|||
48985905|NCT03500419|157780116|FG000|Overall Study|Withdrawal by Subject|2|||
48985906|NCT03500419|157780117|FG001|Overall Study|Withdrawal by Subject|25|||
48985907|NCT01796106|157780118|FG000|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|5|||
48985908|NCT01796106|157780119|FG001|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|7|||
48985909|NCT02364999|157780122|FG000|Overall Study|Death|136|||
48985910|NCT02364999|157780123|FG001|Overall Study|Death|138|||
48985911|NCT02364999|157780122|FG000|Overall Study|Lost to Follow-up|10|||
48985912|NCT02364999|157780123|FG001|Overall Study|Lost to Follow-up|15|||
48985913|NCT02364999|157780122|FG000|Overall Study|Protocol Violation|3|||
48985914|NCT02364999|157780123|FG001|Overall Study|Protocol Violation|2|||
48985915|NCT02364999|157780122|FG000|Overall Study|Withdrawal by Subject|14|||
48985916|NCT02364999|157780123|FG001|Overall Study|Withdrawal by Subject|14|||
48985917|NCT02364999|157780122|FG000|Overall Study|Other|0|||
48985918|NCT02364999|157780123|FG001|Overall Study|Other|1|||
48985919|NCT02364999|157780122|FG000|Overall Study|Randomized but did not receive treatment|2|||
48985920|NCT02364999|157780123|FG001|Overall Study|Randomized but did not receive treatment|3|||
48985921|NCT01234337|157780126|FG000|Overall Study|Adverse Event|58|||
48985922|NCT01234337|157780127|FG001|Overall Study|Adverse Event|21|||
48985923|NCT01234337|157780126|FG000|Overall Study|Disease progression/recurrence/relapse|181|||
48985924|NCT01234337|157780127|FG001|Overall Study|Disease progression/recurrence/relapse|223|||
48985925|NCT01234337|157780126|FG000|Overall Study|Investi. decision not protocol driven|5|||
48985926|NCT01234337|157780127|FG001|Overall Study|Investi. decision not protocol driven|6|||
48985927|NCT01234337|157780126|FG000|Overall Study|Non-compliant with study medication|3|||
48985928|NCT01234337|157780127|FG001|Overall Study|Non-compliant with study medication|2|||
48985929|NCT01234337|157780126|FG000|Overall Study|Randomized but not treated|6|||
48985930|NCT01234337|157780127|FG001|Overall Study|Randomized but not treated|4|||
48985931|NCT01234337|157780126|FG000|Overall Study|Lost to Follow-up|0|||
49042868|NCT01630616|157991053|FG002|Overall Study|Withdrawal by Subject|0|||
49042869|NCT01630616|157991054|FG003|Overall Study|Withdrawal by Subject|2|||
48985932|NCT01234337|157780127|FG001|Overall Study|Lost to Follow-up|1|||
48985933|NCT01234337|157780126|FG000|Overall Study|Protocol Violation|2|||
48985934|NCT01234337|157780127|FG001|Overall Study|Protocol Violation|3|||
49042870|NCT01630616|157991055|FG004|Overall Study|Withdrawal by Subject|0|||
49042871|NCT01630616|157991056|FG005|Overall Study|Withdrawal by Subject|0|||
48985935|NCT01234337|157780126|FG000|Overall Study|Withdrawal by Subject|11|||
49042872|NCT04408924|157991057|FG000|Overall Study|Off Treatment on Post-Treatment-Discontinuation Follow-up|3|||
48985936|NCT01234337|157780127|FG001|Overall Study|Withdrawal by Subject|9|||
48985937|NCT01234337|157780126|FG000|Overall Study|Death|0|||
48985938|NCT01234337|157780127|FG001|Overall Study|Death|1|||
48985939|NCT01234337|157780126|FG000|Overall Study|Switch to commercial drug|0|||
48985940|NCT01234337|157780127|FG001|Overall Study|Switch to commercial drug|1|||
48985941|NCT00994890|157780131|FG000|Overall Study|Adverse Event|13|||
48985942|NCT00994890|157780132|FG001|Overall Study|Adverse Event|9|||
48985943|NCT00994890|157780133|FG002|Overall Study|Adverse Event|11|||
48985944|NCT00994890|157780131|FG000|Overall Study|Lack of Efficacy|0|||
48985945|NCT00994890|157780132|FG001|Overall Study|Lack of Efficacy|0|||
48985946|NCT00994890|157780133|FG002|Overall Study|Lack of Efficacy|1|||
48985947|NCT00994890|157780131|FG000|Overall Study|Lost to Follow-up|6|||
48985948|NCT00994890|157780132|FG001|Overall Study|Lost to Follow-up|1|||
48985949|NCT00994890|157780133|FG002|Overall Study|Lost to Follow-up|3|||
48985950|NCT00994890|157780131|FG000|Overall Study|No longer willing to participate|8|||
48985951|NCT00994890|157780132|FG001|Overall Study|No longer willing to participate|5|||
48985952|NCT00994890|157780133|FG002|Overall Study|No longer willing to participate|13|||
48985953|NCT00994890|157780131|FG000|Overall Study|Protocol Violation|2|||
48985954|NCT00994890|157780132|FG001|Overall Study|Protocol Violation|4|||
48985955|NCT00994890|157780133|FG002|Overall Study|Protocol Violation|0|||
48985956|NCT00994890|157780131|FG000|Overall Study|Study terminated by sponsor|199|||
48985957|NCT00994890|157780132|FG001|Overall Study|Study terminated by sponsor|201|||
48985958|NCT00994890|157780133|FG002|Overall Study|Study terminated by sponsor|197|||
48985959|NCT00994890|157780131|FG000|Overall Study|Randomized, but not treated|1|||
48985960|NCT00994890|157780132|FG001|Overall Study|Randomized, but not treated|0|||
48985961|NCT00994890|157780133|FG002|Overall Study|Randomized, but not treated|0|||
48985962|NCT00994890|157780131|FG000|Overall Study|Other|2|||
48985963|NCT00994890|157780132|FG001|Overall Study|Other|2|||
48985964|NCT00994890|157780133|FG002|Overall Study|Other|1|||
48985965|NCT02555722|157780144|FG000|Week 2|Adverse Event|0|||
48985966|NCT02555722|157780145|FG001|Week 2|Adverse Event|1|||
48985967|NCT02555722|157780144|FG000|Week 2|Withdrawal by Subject|1|||
48985968|NCT02555722|157780145|FG001|Week 2|Withdrawal by Subject|0|||
48985969|NCT02555722|157780144|FG000|Month 1|Lens Discomfort|1|||
48985970|NCT02555722|157780145|FG001|Month 1|Lens Discomfort|0|||
48985971|NCT02555722|157780144|FG000|Month 2|Withdrawal by Subject|3|||
48985972|NCT02555722|157780145|FG001|Month 2|Withdrawal by Subject|0|||
48985973|NCT02555722|157780144|FG000|Month 2|Lost to Follow-up|1|||
48985974|NCT02555722|157780145|FG001|Month 2|Lost to Follow-up|0|||
48985975|NCT04212221|157780147|FG000|Overall Study|Remained on Treatment|0|||
48985976|NCT04212221|157780148|FG001|Overall Study|Remained on Treatment|0|||
48985977|NCT04212221|157780149|FG002|Overall Study|Remained on Treatment|0|||
48985978|NCT04212221|157780150|FG003|Overall Study|Remained on Treatment|1|||
48985979|NCT04212221|157780151|FG004|Overall Study|Remained on Treatment|0|||
48985980|NCT04212221|157780152|FG005|Overall Study|Remained on Treatment|0|||
48985981|NCT04212221|157780153|FG006|Overall Study|Remained on Treatment|3|||
48985982|NCT04212221|157780154|FG007|Overall Study|Remained on Treatment|9|||
48985983|NCT04212221|157780147|FG000|Overall Study|Adverse Event|0|||
48985984|NCT04212221|157780148|FG001|Overall Study|Adverse Event|0|||
48985985|NCT04212221|157780149|FG002|Overall Study|Adverse Event|0|||
48985986|NCT04212221|157780150|FG003|Overall Study|Adverse Event|0|||
48985987|NCT04212221|157780151|FG004|Overall Study|Adverse Event|0|||
48985988|NCT04212221|157780152|FG005|Overall Study|Adverse Event|0|||
48985989|NCT04212221|157780153|FG006|Overall Study|Adverse Event|2|||
48985990|NCT04212221|157780154|FG007|Overall Study|Adverse Event|3|||
48985991|NCT04212221|157780147|FG000|Overall Study|Death|0|||
48985992|NCT04212221|157780148|FG001|Overall Study|Death|0|||
48985993|NCT04212221|157780149|FG002|Overall Study|Death|0|||
48985994|NCT04212221|157780150|FG003|Overall Study|Death|0|||
48985995|NCT04212221|157780151|FG004|Overall Study|Death|0|||
48985996|NCT04212221|157780152|FG005|Overall Study|Death|0|||
48985997|NCT04212221|157780153|FG006|Overall Study|Death|0|||
48985998|NCT04212221|157780154|FG007|Overall Study|Death|2|||
48985999|NCT04212221|157780147|FG000|Overall Study|Disease progression according to irRECIST|1|||
48986000|NCT04212221|157780148|FG001|Overall Study|Disease progression according to irRECIST|2|||
48986001|NCT04212221|157780149|FG002|Overall Study|Disease progression according to irRECIST|3|||
48986002|NCT04212221|157780150|FG003|Overall Study|Disease progression according to irRECIST|3|||
48986003|NCT04212221|157780151|FG004|Overall Study|Disease progression according to irRECIST|2|||
48986004|NCT04212221|157780152|FG005|Overall Study|Disease progression according to irRECIST|2|||
48986005|NCT04212221|157780153|FG006|Overall Study|Disease progression according to irRECIST|21|||
48986006|NCT04212221|157780154|FG007|Overall Study|Disease progression according to irRECIST|17|||
48986007|NCT04212221|157780147|FG000|Overall Study|Global Deterioration of Health Status|0|||
48986008|NCT04212221|157780148|FG001|Overall Study|Global Deterioration of Health Status|0|||
48986009|NCT04212221|157780149|FG002|Overall Study|Global Deterioration of Health Status|0|||
48986010|NCT04212221|157780150|FG003|Overall Study|Global Deterioration of Health Status|0|||
48986011|NCT04212221|157780151|FG004|Overall Study|Global Deterioration of Health Status|0|||
48986012|NCT04212221|157780152|FG005|Overall Study|Global Deterioration of Health Status|0|||
49042873|NCT04408924|157991057|FG000|Overall Study|Lost to Follow-up|3|||
48986013|NCT04212221|157780153|FG006|Overall Study|Global Deterioration of Health Status|0|||
48986014|NCT04212221|157780154|FG007|Overall Study|Global Deterioration of Health Status|2|||
48986015|NCT04212221|157780147|FG000|Overall Study|Investigator's Decision|0|||
48986016|NCT04212221|157780148|FG001|Overall Study|Investigator's Decision|0|||
48986017|NCT04212221|157780149|FG002|Overall Study|Investigator's Decision|0|||
48986018|NCT04212221|157780150|FG003|Overall Study|Investigator's Decision|1|||
48986019|NCT04212221|157780151|FG004|Overall Study|Investigator's Decision|0|||
48986020|NCT04212221|157780152|FG005|Overall Study|Investigator's Decision|0|||
48986021|NCT04212221|157780153|FG006|Overall Study|Investigator's Decision|3|||
48986022|NCT04212221|157780154|FG007|Overall Study|Investigator's Decision|0|||
48986023|NCT04212221|157780147|FG000|Overall Study|Participant refused to continue treatment|0|||
48986024|NCT04212221|157780148|FG001|Overall Study|Participant refused to continue treatment|1|||
48986025|NCT04212221|157780149|FG002|Overall Study|Participant refused to continue treatment|0|||
48986026|NCT04212221|157780150|FG003|Overall Study|Participant refused to continue treatment|1|||
48986027|NCT04212221|157780151|FG004|Overall Study|Participant refused to continue treatment|1|||
48986028|NCT04212221|157780152|FG005|Overall Study|Participant refused to continue treatment|2|||
48986029|NCT04212221|157780153|FG006|Overall Study|Participant refused to continue treatment|4|||
48986030|NCT04212221|157780154|FG007|Overall Study|Participant refused to continue treatment|2|||
48986031|NCT04212221|157780147|FG000|Overall Study|Protocol Violation|0|||
48986032|NCT04212221|157780148|FG001|Overall Study|Protocol Violation|0|||
48986033|NCT04212221|157780149|FG002|Overall Study|Protocol Violation|0|||
48986034|NCT04212221|157780150|FG003|Overall Study|Protocol Violation|0|||
48986035|NCT04212221|157780151|FG004|Overall Study|Protocol Violation|0|||
48986036|NCT04212221|157780152|FG005|Overall Study|Protocol Violation|0|||
48986037|NCT04212221|157780153|FG006|Overall Study|Protocol Violation|0|||
48986038|NCT04212221|157780154|FG007|Overall Study|Protocol Violation|1|||
48986039|NCT02850276|157780155|FG000|Overall Study|screen failure|43|||
48986040|NCT02850276|157780155|FG000|Overall Study|Withdrawal by Subject|14|||
48986041|NCT02850276|157780155|FG000|Overall Study|Physician Decision|2|||
48986042|NCT02850276|157780155|FG000|Overall Study|Lost to Follow-up|2|||
48986043|NCT01899729|157780156|FG000|Overall Study|Adverse Event|1|||
48986044|NCT01899729|157780157|FG001|Overall Study|Adverse Event|0|||
48986045|NCT01899729|157780158|FG002|Overall Study|Adverse Event|0|||
48986046|NCT01899729|157780159|FG003|Overall Study|Adverse Event|0|||
48986047|NCT01899729|157780160|FG004|Overall Study|Adverse Event|1|||
48986048|NCT01899729|157780156|FG000|Overall Study|Withdrawal by Subject|1|||
48986049|NCT01899729|157780157|FG001|Overall Study|Withdrawal by Subject|2|||
48986050|NCT01899729|157780158|FG002|Overall Study|Withdrawal by Subject|0|||
48986051|NCT01899729|157780159|FG003|Overall Study|Withdrawal by Subject|0|||
48986052|NCT01899729|157780160|FG004|Overall Study|Withdrawal by Subject|0|||
48986053|NCT01899729|157780156|FG000|Overall Study|Lack of Efficacy|0|||
48986054|NCT01899729|157780157|FG001|Overall Study|Lack of Efficacy|0|||
48986055|NCT01899729|157780158|FG002|Overall Study|Lack of Efficacy|2|||
48986056|NCT01899729|157780159|FG003|Overall Study|Lack of Efficacy|0|||
48986057|NCT01899729|157780160|FG004|Overall Study|Lack of Efficacy|1|||
48986058|NCT00095836|157780161|FG000|Overall Study|Lost to Follow-up|1|||
48986059|NCT00095836|157780161|FG000|Overall Study|Adverse Event|1|||
48986060|NCT00095836|157780161|FG000|Overall Study|Death|2|||
48986061|NCT04490499|157780171|FG000|Overall Study|Withdrawal by Subject|2|||
48986062|NCT01997333|157780172|FG000|Randomization and Treatment|Disease Progression|70|||
48986063|NCT01997333|157780173|FG001|Randomization and Treatment|Disease Progression|159|||
48986064|NCT01997333|157780172|FG000|Randomization and Treatment|Adverse Event|10|||
48986065|NCT01997333|157780173|FG001|Randomization and Treatment|Adverse Event|32|||
48986066|NCT01997333|157780172|FG000|Randomization and Treatment|Physician Decision|0|||
48986067|NCT01997333|157780173|FG001|Randomization and Treatment|Physician Decision|4|||
48986068|NCT01997333|157780172|FG000|Randomization and Treatment|Withdrawal by Subject|6|||
48986069|NCT01997333|157780173|FG001|Randomization and Treatment|Withdrawal by Subject|3|||
48986070|NCT01997333|157780172|FG000|Randomization and Treatment|Did not receive treatment|17|||
48986071|NCT01997333|157780173|FG001|Randomization and Treatment|Did not receive treatment|5|||
48986072|NCT01997333|157780172|FG000|Survival Follow up|Withdrawal by Subject|15|||
48986073|NCT01997333|157780173|FG001|Survival Follow up|Withdrawal by Subject|6|||
48986074|NCT01997333|157780172|FG000|Survival Follow up|Lost to Follow-up|0|||
48986075|NCT01997333|157780173|FG001|Survival Follow up|Lost to Follow-up|6|||
48986076|NCT01997333|157780172|FG000|Survival Follow up|Various|1|||
48986077|NCT01997333|157780173|FG001|Survival Follow up|Various|2|||
48986078|NCT02269709|157780174|FG000|Time of Enrollment|Withdrawal by Subject|3|||
48986079|NCT02269709|157780174|FG000|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1|||
48986080|NCT02269709|157780174|FG000|Six Month Follow-up|Lost to Follow-up|12|||
48986081|NCT02909504|157780175|FG000|Overall Study|Adverse Event|2|||
48986082|NCT02909504|157780175|FG000|Overall Study|Lack of Efficacy|3|||
48986083|NCT02909504|157780175|FG000|Overall Study|Withdrawal by Subject|4|||
48986084|NCT02909504|157780175|FG000|Overall Study|Pregnancy|1|||
48986085|NCT02909504|157780175|FG000|Overall Study|Subject moved|1|||
48986086|NCT02909504|157780175|FG000|Overall Study|Lost to Follow-up|1|||
48986087|NCT02055976|157780176|FG000|Overall Study|Other|0|||
48986088|NCT02055976|157780177|FG001|Overall Study|Other|0|||
48986089|NCT02055976|157780178|FG002|Overall Study|Other|1|||
48986090|NCT02055976|157780179|FG003|Overall Study|Other|0|||
48986091|NCT02055976|157780180|FG004|Overall Study|Other|0|||
48986092|NCT02055976|157780181|FG005|Overall Study|Other|0|||
48986093|NCT02055976|157780182|FG006|Overall Study|Other|0|||
48986094|NCT02055976|157780183|FG007|Overall Study|Other|0|||
48986095|NCT02055976|157780184|FG008|Overall Study|Other|0|||
48986096|NCT02055976|157780176|FG000|Overall Study|Adverse Event|0|||
48986097|NCT02055976|157780177|FG001|Overall Study|Adverse Event|0|||
48986098|NCT02055976|157780178|FG002|Overall Study|Adverse Event|0|||
48986099|NCT02055976|157780179|FG003|Overall Study|Adverse Event|0|||
48986100|NCT02055976|157780180|FG004|Overall Study|Adverse Event|0|||
48986101|NCT02055976|157780181|FG005|Overall Study|Adverse Event|1|||
48986102|NCT02055976|157780182|FG006|Overall Study|Adverse Event|1|||
48986103|NCT02055976|157780183|FG007|Overall Study|Adverse Event|0|||
48986104|NCT02055976|157780184|FG008|Overall Study|Adverse Event|0|||
48986105|NCT02055976|157780176|FG000|Overall Study|Does not meet entrance criteria|0|||
48986106|NCT02055976|157780177|FG001|Overall Study|Does not meet entrance criteria|0|||
48986107|NCT02055976|157780178|FG002|Overall Study|Does not meet entrance criteria|0|||
48986108|NCT02055976|157780179|FG003|Overall Study|Does not meet entrance criteria|0|||
48986109|NCT02055976|157780180|FG004|Overall Study|Does not meet entrance criteria|0|||
48986110|NCT02055976|157780181|FG005|Overall Study|Does not meet entrance criteria|0|||
48986111|NCT02055976|157780182|FG006|Overall Study|Does not meet entrance criteria|1|||
48986112|NCT02055976|157780183|FG007|Overall Study|Does not meet entrance criteria|0|||
48986113|NCT02055976|157780184|FG008|Overall Study|Does not meet entrance criteria|0|||
48986114|NCT02055976|157780176|FG000|Overall Study|Lost to Follow-up|0|||
48986115|NCT02055976|157780177|FG001|Overall Study|Lost to Follow-up|0|||
48986116|NCT02055976|157780178|FG002|Overall Study|Lost to Follow-up|0|||
48986117|NCT02055976|157780179|FG003|Overall Study|Lost to Follow-up|1|||
48986118|NCT02055976|157780180|FG004|Overall Study|Lost to Follow-up|0|||
48986119|NCT02055976|157780181|FG005|Overall Study|Lost to Follow-up|0|||
48986120|NCT02055976|157780182|FG006|Overall Study|Lost to Follow-up|0|||
48986121|NCT02055976|157780183|FG007|Overall Study|Lost to Follow-up|0|||
48986122|NCT02055976|157780184|FG008|Overall Study|Lost to Follow-up|0|||
48986123|NCT03137173|157780185|FG000|Overall Study|Withdrawal by Subject|8|||
48986124|NCT03137173|157780186|FG001|Overall Study|Withdrawal by Subject|13|||
48986125|NCT03137173|157780185|FG000|Overall Study|Death|1|||
48986126|NCT03137173|157780186|FG001|Overall Study|Death|3|||
48986127|NCT03137173|157780185|FG000|Overall Study|Physician Decision|1|||
48986128|NCT03137173|157780186|FG001|Overall Study|Physician Decision|0|||
48986129|NCT03137173|157780185|FG000|Overall Study|Lost to Follow-up|13|||
48986130|NCT03137173|157780186|FG001|Overall Study|Lost to Follow-up|18|||
48986131|NCT03137173|157780185|FG000|Overall Study|Other reasons|3|||
48986132|NCT03137173|157780186|FG001|Overall Study|Other reasons|2|||
48986133|NCT04411472|157780187|FG000|Overall Study|Adverse Event|5|||
48986134|NCT04411472|157780188|FG001|Overall Study|Adverse Event|10|||
48986135|NCT04411472|157780189|FG002|Overall Study|Adverse Event|1|||
48986136|NCT04411472|157780190|FG003|Overall Study|Adverse Event|0|||
48986137|NCT04411472|157780191|FG004|Overall Study|Adverse Event|0|||
48986138|NCT04411472|157780192|FG005|Overall Study|Adverse Event|0|||
48986139|NCT04411472|157780187|FG000|Overall Study|Protocol Violation|1|||
48986140|NCT04411472|157780188|FG001|Overall Study|Protocol Violation|0|||
48986141|NCT04411472|157780189|FG002|Overall Study|Protocol Violation|0|||
48986142|NCT04411472|157780190|FG003|Overall Study|Protocol Violation|0|||
48986143|NCT04411472|157780191|FG004|Overall Study|Protocol Violation|0|||
48986144|NCT04411472|157780192|FG005|Overall Study|Protocol Violation|0|||
48986145|NCT04411472|157780187|FG000|Overall Study|Withdrawal by Subject|0|||
48986146|NCT04411472|157780188|FG001|Overall Study|Withdrawal by Subject|1|||
48986147|NCT04411472|157780189|FG002|Overall Study|Withdrawal by Subject|0|||
48986148|NCT04411472|157780190|FG003|Overall Study|Withdrawal by Subject|1|||
48986149|NCT04411472|157780191|FG004|Overall Study|Withdrawal by Subject|0|||
48986150|NCT04411472|157780192|FG005|Overall Study|Withdrawal by Subject|0|||
48986151|NCT04411472|157780187|FG000|Overall Study|Physician Decision|1|||
48986152|NCT04411472|157780188|FG001|Overall Study|Physician Decision|0|||
48986153|NCT04411472|157780189|FG002|Overall Study|Physician Decision|0|||
48986154|NCT04411472|157780190|FG003|Overall Study|Physician Decision|0|||
48986155|NCT04411472|157780191|FG004|Overall Study|Physician Decision|0|||
48986156|NCT04411472|157780192|FG005|Overall Study|Physician Decision|0|||
48986157|NCT04411472|157780187|FG000|Overall Study|Study terminated by sponsor|17|||
48986158|NCT04411472|157780188|FG001|Overall Study|Study terminated by sponsor|20|||
48986159|NCT04411472|157780189|FG002|Overall Study|Study terminated by sponsor|3|||
48986160|NCT04411472|157780190|FG003|Overall Study|Study terminated by sponsor|0|||
48986161|NCT04411472|157780191|FG004|Overall Study|Study terminated by sponsor|0|||
48986162|NCT04411472|157780192|FG005|Overall Study|Study terminated by sponsor|0|||
48986163|NCT01535638|157780194|FG000|Treatment 1 (Single Dose)|Protocol Violation|0|||
48986164|NCT01535638|157780195|FG001|Treatment 1 (Single Dose)|Protocol Violation|0|||
48986165|NCT01535638|157780196|FG002|Treatment 1 (Single Dose)|Protocol Violation|0|||
48986166|NCT01535638|157780197|FG003|Treatment 1 (Single Dose)|Protocol Violation|0|||
48986167|NCT01535638|157780198|FG004|Treatment 1 (Single Dose)|Protocol Violation|0|||
48986168|NCT01535638|157780199|FG005|Treatment 1 (Single Dose)|Protocol Violation|1|||
48986169|NCT01535638|157780194|FG000|Treatment 3 (Single Dose)|Protocol Violation|0|||
48986170|NCT01535638|157780195|FG001|Treatment 3 (Single Dose)|Protocol Violation|0|||
48986171|NCT01535638|157780196|FG002|Treatment 3 (Single Dose)|Protocol Violation|0|||
48986172|NCT01535638|157780197|FG003|Treatment 3 (Single Dose)|Protocol Violation|1|||
48986173|NCT01535638|157780198|FG004|Treatment 3 (Single Dose)|Protocol Violation|0|||
48986174|NCT01535638|157780199|FG005|Treatment 3 (Single Dose)|Protocol Violation|0|||
48986175|NCT05060003|157780200|FG000|Overall Study|ctDNA negative|7|||
48986176|NCT00643851|157780201|FG000|Overall Study|Death|0|||
48986177|NCT00643851|157780202|FG001|Overall Study|Death|1|||
48986178|NCT00643851|157780203|FG002|Overall Study|Death|0|||
48986179|NCT00643851|157780201|FG000|Overall Study|Lack of Efficacy|0|||
48986180|NCT00643851|157780202|FG001|Overall Study|Lack of Efficacy|1|||
48986181|NCT00643851|157780203|FG002|Overall Study|Lack of Efficacy|0|||
48986182|NCT00643851|157780201|FG000|Overall Study|Adverse Event|2|||
48986183|NCT00643851|157780202|FG001|Overall Study|Adverse Event|6|||
48986184|NCT00643851|157780203|FG002|Overall Study|Adverse Event|6|||
48986185|NCT00643851|157780201|FG000|Overall Study|Lost to Follow-up|4|||
48986186|NCT00643851|157780202|FG001|Overall Study|Lost to Follow-up|6|||
48986187|NCT00643851|157780203|FG002|Overall Study|Lost to Follow-up|9|||
48986188|NCT00643851|157780201|FG000|Overall Study|Withdrawal by Subject|8|||
48986189|NCT00643851|157780202|FG001|Overall Study|Withdrawal by Subject|15|||
48986190|NCT00643851|157780203|FG002|Overall Study|Withdrawal by Subject|9|||
48986191|NCT00643851|157780201|FG000|Overall Study|Non-compl., not met criteria, etc.|3|||
48986192|NCT00643851|157780202|FG001|Overall Study|Non-compl., not met criteria, etc.|4|||
48986193|NCT00643851|157780203|FG002|Overall Study|Non-compl., not met criteria, etc.|6|||
48986194|NCT00827112|157780204|FG000|Overall Study|Adverse Event|2|||
48986195|NCT00827112|157780205|FG001|Overall Study|Adverse Event|0|||
48986196|NCT00827112|157780204|FG000|Overall Study|Lack of Efficacy|2|||
48986197|NCT00827112|157780205|FG001|Overall Study|Lack of Efficacy|0|||
48986198|NCT00827112|157780204|FG000|Overall Study|Lost to Follow-up|3|||
48986199|NCT00827112|157780205|FG001|Overall Study|Lost to Follow-up|2|||
48986200|NCT00827112|157780204|FG000|Overall Study|Pregnancy|0|||
48986201|NCT00827112|157780205|FG001|Overall Study|Pregnancy|1|||
48986202|NCT00827112|157780204|FG000|Overall Study|Protocol Violation|0|||
48986203|NCT00827112|157780205|FG001|Overall Study|Protocol Violation|2|||
48986204|NCT00827112|157780204|FG000|Overall Study|Withdrawal by Subject|2|||
48986205|NCT00827112|157780205|FG001|Overall Study|Withdrawal by Subject|1|||
48986206|NCT00827112|157780204|FG000|Overall Study|Randomized but not treated|5|||
48986207|NCT00827112|157780205|FG001|Overall Study|Randomized but not treated|3|||
48986208|NCT00827112|157780204|FG000|Overall Study|Other|1|||
48986209|NCT00827112|157780205|FG001|Overall Study|Other|3|||
48986210|NCT01004159|157781622|FG000|Overall Study|Adverse Event|2|||
48986211|NCT01004159|157781622|FG000|Overall Study|Disease Progression|18|||
48986212|NCT04610827|157781623|FG000|Overall Study|Withdrawal by Subject|1|||
48986213|NCT04610827|157781624|FG001|Overall Study|Withdrawal by Subject|1|||
48986214|NCT04610827|157781625|FG002|Overall Study|Withdrawal by Subject|0|||
48986215|NCT01888965|157781626|FG000|Overall Study|Adverse Event|5|||
48986216|NCT01888965|157781626|FG000|Overall Study|Lack of Efficacy|4|||
48986217|NCT01594749|157781627|FG000|Overall Study|Adverse Event|2|||
48986218|NCT01594749|157781628|FG001|Overall Study|Adverse Event|1|||
48986219|NCT01594749|157781627|FG000|Overall Study|Withdrawal by Subject|2|||
48986220|NCT01594749|157781628|FG001|Overall Study|Withdrawal by Subject|2|||
48986221|NCT01594749|157781627|FG000|Overall Study|Protocol Violation|2|||
48986222|NCT01594749|157781628|FG001|Overall Study|Protocol Violation|0|||
48986223|NCT01594749|157781627|FG000|Overall Study|Physician Decision|1|||
48986224|NCT01594749|157781628|FG001|Overall Study|Physician Decision|1|||
48986225|NCT01594749|157781627|FG000|Overall Study|Non-compliance with Protocol|0|||
48986226|NCT01594749|157781628|FG001|Overall Study|Non-compliance with Protocol|1|||
48986227|NCT01594749|157781627|FG000|Overall Study|Lost to Follow-up|1|||
48986228|NCT01594749|157781628|FG001|Overall Study|Lost to Follow-up|0|||
48986229|NCT01594749|157781627|FG000|Overall Study|Death|9|||
48986230|NCT01594749|157781628|FG001|Overall Study|Death|3|||
48986231|NCT01594749|157781627|FG000|Overall Study|Not Treated|4|||
48986232|NCT01594749|157781628|FG001|Overall Study|Not Treated|10|||
48986233|NCT01594749|157781627|FG000|Overall Study|Lost Source Documentation|1|||
48986234|NCT01594749|157781628|FG001|Overall Study|Lost Source Documentation|0|||
48986235|NCT03347279|157781633|FG000|Overall Study|Withdrawal by Subject|8|||
48986236|NCT03347279|157781634|FG001|Overall Study|Withdrawal by Subject|15|||
48986237|NCT03347279|157781633|FG000|Overall Study|Death|0|||
48986238|NCT03347279|157781634|FG001|Overall Study|Death|2|||
48986239|NCT03347279|157781633|FG000|Overall Study|Lost to Follow-up|5|||
48986240|NCT03347279|157781634|FG001|Overall Study|Lost to Follow-up|2|||
48986241|NCT03347279|157781633|FG000|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
48986242|NCT03347279|157781634|FG001|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
48986243|NCT03763942|157781635|FG000|Overall Study|Lost to Follow-up|114|||
48986244|NCT03763942|157781636|FG001|Overall Study|Lost to Follow-up|54|||
48986245|NCT03763942|157781635|FG000|Overall Study|Protocol Violation|1|||
48986246|NCT03763942|157781636|FG001|Overall Study|Protocol Violation|0|||
48986247|NCT03763942|157781635|FG000|Overall Study|Withdrawal by Subject|2|||
48986248|NCT03763942|157781636|FG001|Overall Study|Withdrawal by Subject|0|||
48986249|NCT03763942|157781635|FG000|Overall Study|Other|2|||
48986250|NCT03763942|157781636|FG001|Overall Study|Other|3|||
48986251|NCT01542632|157781641|FG000|Overall Study|Withdrawal of Consent|0|||
48986252|NCT01542632|157781642|FG001|Overall Study|Withdrawal of Consent|0|||
48986253|NCT01542632|157781643|FG002|Overall Study|Withdrawal of Consent|0|||
48986254|NCT01542632|157781644|FG003|Overall Study|Withdrawal of Consent|2|||
48986255|NCT01542632|157781645|FG004|Overall Study|Withdrawal of Consent|3|||
48986256|NCT01542632|157781646|FG005|Overall Study|Withdrawal of Consent|0|||
48986257|NCT01542632|157781641|FG000|Overall Study|Adverse Event|0|||
48986258|NCT01542632|157781642|FG001|Overall Study|Adverse Event|0|||
48986259|NCT01542632|157781643|FG002|Overall Study|Adverse Event|1|||
48986260|NCT01542632|157781644|FG003|Overall Study|Adverse Event|0|||
48986261|NCT01542632|157781645|FG004|Overall Study|Adverse Event|0|||
48986262|NCT01542632|157781646|FG005|Overall Study|Adverse Event|0|||
48986263|NCT01542632|157781641|FG000|Overall Study|Lost to Follow-up|0|||
48986264|NCT01542632|157781642|FG001|Overall Study|Lost to Follow-up|1|||
48986265|NCT01542632|157781643|FG002|Overall Study|Lost to Follow-up|0|||
48986266|NCT01542632|157781644|FG003|Overall Study|Lost to Follow-up|0|||
48986267|NCT01542632|157781645|FG004|Overall Study|Lost to Follow-up|0|||
48986268|NCT01542632|157781646|FG005|Overall Study|Lost to Follow-up|0|||
48986269|NCT01542632|157781641|FG000|Overall Study|Sponsor/Investigator Decision|0|||
48986270|NCT01542632|157781642|FG001|Overall Study|Sponsor/Investigator Decision|0|||
48986271|NCT01542632|157781643|FG002|Overall Study|Sponsor/Investigator Decision|0|||
48986272|NCT01542632|157781644|FG003|Overall Study|Sponsor/Investigator Decision|0|||
48986273|NCT01542632|157781645|FG004|Overall Study|Sponsor/Investigator Decision|1|||
48986274|NCT01542632|157781646|FG005|Overall Study|Sponsor/Investigator Decision|0|||
48986275|NCT01222767|157781649|FG000|Overall Study|Progressive disease|13|||
48986276|NCT01222767|157781649|FG000|Overall Study|Adverse Event|2|||
48986277|NCT01222767|157781649|FG000|Overall Study|Surgical resection|1|||
48986278|NCT01222767|157781649|FG000|Overall Study|Never treated|1|||
48986279|NCT00089505|157781650|FG000|Overall Study|Death|4|||
48986280|NCT00089505|157781651|FG001|Overall Study|Death|1|||
48986281|NCT00089505|157781652|FG002|Overall Study|Death|5|||
48986282|NCT00089505|157781653|FG003|Overall Study|Death|8|||
48986283|NCT00089505|157781650|FG000|Overall Study|Withdrawal by Subject|3|||
48986284|NCT00089505|157781651|FG001|Overall Study|Withdrawal by Subject|0|||
48986285|NCT00089505|157781652|FG002|Overall Study|Withdrawal by Subject|6|||
48986286|NCT00089505|157781653|FG003|Overall Study|Withdrawal by Subject|6|||
48986287|NCT00089505|157781650|FG000|Overall Study|Lost to Follow-up|1|||
48986288|NCT00089505|157781651|FG001|Overall Study|Lost to Follow-up|1|||
48986289|NCT00089505|157781652|FG002|Overall Study|Lost to Follow-up|9|||
48986290|NCT00089505|157781653|FG003|Overall Study|Lost to Follow-up|7|||
48986291|NCT00089505|157781650|FG000|Overall Study|Physician Decision|1|||
48986292|NCT00089505|157781651|FG001|Overall Study|Physician Decision|0|||
48986293|NCT00089505|157781652|FG002|Overall Study|Physician Decision|0|||
48986294|NCT00089505|157781653|FG003|Overall Study|Physician Decision|0|||
48986295|NCT00089505|157781650|FG000|Overall Study|Protocol Violation|0|||
48986296|NCT00089505|157781651|FG001|Overall Study|Protocol Violation|0|||
48986297|NCT00089505|157781652|FG002|Overall Study|Protocol Violation|1|||
48986298|NCT00089505|157781653|FG003|Overall Study|Protocol Violation|0|||
48986299|NCT01590810|157781658|FG000|Overall Study|Physician Decision|0|||
48986300|NCT01590810|157781659|FG001|Overall Study|Physician Decision|1|||
48986301|NCT01590810|157781660|FG002|Overall Study|Physician Decision|1|||
48986302|NCT01590810|157781661|FG003|Overall Study|Physician Decision|0|||
48986303|NCT01590810|157781662|FG004|Overall Study|Physician Decision|0|||
48986304|NCT00426842|157781663|FG000|Overall Study|Lost to Follow-up|1|||
48986305|NCT00819052|157781664|FG000|Overall Study|Adverse Event|0|||
48986306|NCT00819052|157781665|FG001|Overall Study|Adverse Event|5|||
48986307|NCT00819052|157781664|FG000|Overall Study|Protocol Violation|1|||
48986308|NCT00819052|157781665|FG001|Overall Study|Protocol Violation|2|||
48986309|NCT00819052|157781664|FG000|Overall Study|Lost to Follow-up|1|||
48986310|NCT00819052|157781665|FG001|Overall Study|Lost to Follow-up|2|||
48986311|NCT00819052|157781664|FG000|Overall Study|Withdrawal by Subject|1|||
48986312|NCT00819052|157781665|FG001|Overall Study|Withdrawal by Subject|2|||
48986313|NCT00819052|157781664|FG000|Overall Study|Lack of Efficacy|1|||
48986314|NCT00819052|157781665|FG001|Overall Study|Lack of Efficacy|1|||
48986315|NCT00819052|157781664|FG000|Overall Study|Pregnancy|1|||
48986316|NCT00819052|157781665|FG001|Overall Study|Pregnancy|2|||
48986317|NCT00819052|157781664|FG000|Overall Study|Death or events leading to death|1|||
48986318|NCT00819052|157781665|FG001|Overall Study|Death or events leading to death|0|||
48986319|NCT00125268|157781666|FG000|Overall Study|Withdrawal by Subject|1|||
48986320|NCT00125268|157781667|FG001|Overall Study|Withdrawal by Subject|1|||
48986321|NCT03258762|157781668|FG000|Overall Study|Lost to Follow-up|0|||
48986322|NCT03258762|157781669|FG001|Overall Study|Lost to Follow-up|1|||
48986323|NCT01277666|157781674|FG000|Overall Study|Adverse Event|26|||
48986324|NCT01277666|157781675|FG001|Overall Study|Adverse Event|25|||
48986325|NCT01277666|157781676|FG002|Overall Study|Adverse Event|20|||
48986326|NCT01277666|157781674|FG000|Overall Study|Lack of Efficacy|8|||
48986327|NCT01277666|157781675|FG001|Overall Study|Lack of Efficacy|20|||
48986328|NCT01277666|157781676|FG002|Overall Study|Lack of Efficacy|12|||
48986329|NCT01277666|157781674|FG000|Overall Study|Protocol Violation|2|||
48986330|NCT01277666|157781675|FG001|Overall Study|Protocol Violation|3|||
48986331|NCT01277666|157781676|FG002|Overall Study|Protocol Violation|2|||
48986332|NCT01277666|157781674|FG000|Overall Study|Protocol Defined Stopping criteria|1|||
48986333|NCT01277666|157781675|FG001|Overall Study|Protocol Defined Stopping criteria|2|||
48986334|NCT01277666|157781676|FG002|Overall Study|Protocol Defined Stopping criteria|6|||
48986335|NCT01277666|157781674|FG000|Overall Study|Lost to Follow-up|1|||
48986336|NCT01277666|157781675|FG001|Overall Study|Lost to Follow-up|1|||
48986337|NCT01277666|157781676|FG002|Overall Study|Lost to Follow-up|2|||
48986338|NCT01277666|157781674|FG000|Overall Study|Withdrawal by Subject|7|||
48986339|NCT01277666|157781675|FG001|Overall Study|Withdrawal by Subject|8|||
48986340|NCT01277666|157781676|FG002|Overall Study|Withdrawal by Subject|6|||
48986341|NCT01277666|157781674|FG000|Overall Study|Death|0|||
48986342|NCT01277666|157781675|FG001|Overall Study|Death|0|||
48986343|NCT01277666|157781676|FG002|Overall Study|Death|1|||
48986344|NCT00967343|157781677|FG000|Overall Study|Study termination by sponsor|12|||
48986345|NCT00967343|157781677|FG000|Overall Study|Death|24|||
48986346|NCT00967343|157781677|FG000|Overall Study|Relapse|1|||
48986347|NCT00967343|157781677|FG000|Overall Study|Lost to Follow-up|1|||
48986348|NCT01365468|157781678|FG000|Overall Study|Physician Decision|1|||
48986349|NCT01365468|157781679|FG001|Overall Study|Physician Decision|0|||
48986350|NCT01365468|157781678|FG000|Overall Study|Disease progression|1|||
48986351|NCT01365468|157781679|FG001|Overall Study|Disease progression|0|||
48986352|NCT01365468|157781678|FG000|Overall Study|Lost to Follow-up|2|||
48986353|NCT01365468|157781679|FG001|Overall Study|Lost to Follow-up|0|||
48986354|NCT01747655|157781680|FG000|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5|||
48986355|NCT01747655|157781681|FG001|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0|||
48986356|NCT01747655|157781680|FG000|PEG-J Period (Duodopa Treatment)|Patient Decision|8|||
48986357|NCT01747655|157781681|FG001|PEG-J Period (Duodopa Treatment)|Patient Decision|0|||
48986358|NCT01747655|157781680|FG000|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1|||
48986359|NCT01747655|157781681|FG001|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0|||
48986360|NCT01711359|157781682|FG000|Treatment Period|Withdrawal by Subject|18|||
48986361|NCT01711359|157781683|FG001|Treatment Period|Withdrawal by Subject|7|||
48986362|NCT01711359|157781684|FG002|Treatment Period|Withdrawal by Subject|13|||
48986363|NCT01711359|157781682|FG000|Treatment Period|Lack of Efficacy|13|||
48986364|NCT01711359|157781683|FG001|Treatment Period|Lack of Efficacy|2|||
48986365|NCT01711359|157781684|FG002|Treatment Period|Lack of Efficacy|2|||
48986366|NCT01711359|157781682|FG000|Treatment Period|Adverse Event|8|||
48986367|NCT01711359|157781683|FG001|Treatment Period|Adverse Event|10|||
48986368|NCT01711359|157781684|FG002|Treatment Period|Adverse Event|24|||
48986369|NCT01711359|157781682|FG000|Treatment Period|Physician Decision|4|||
48986370|NCT01711359|157781683|FG001|Treatment Period|Physician Decision|3|||
48986371|NCT01711359|157781684|FG002|Treatment Period|Physician Decision|2|||
48986372|NCT01711359|157781682|FG000|Treatment Period|Death|3|||
48986373|NCT01711359|157781683|FG001|Treatment Period|Death|0|||
48986374|NCT01711359|157781684|FG002|Treatment Period|Death|0|||
48986375|NCT01711359|157781682|FG000|Treatment Period|Entry Criteria Not Met|1|||
48986376|NCT01711359|157781683|FG001|Treatment Period|Entry Criteria Not Met|0|||
48986377|NCT01711359|157781684|FG002|Treatment Period|Entry Criteria Not Met|0|||
48986378|NCT01711359|157781682|FG000|Treatment Period|Sponsor Decision|1|||
48986379|NCT01711359|157781683|FG001|Treatment Period|Sponsor Decision|0|||
48986380|NCT01711359|157781684|FG002|Treatment Period|Sponsor Decision|0|||
48986381|NCT01711359|157781682|FG000|Treatment Period|Lost to Follow-up|1|||
48986382|NCT01711359|157781683|FG001|Treatment Period|Lost to Follow-up|1|||
48986383|NCT01711359|157781684|FG002|Treatment Period|Lost to Follow-up|1|||
48986384|NCT01711359|157781682|FG000|Treatment Period|Randomized, Not Treated|3|||
48986385|NCT01711359|157781683|FG001|Treatment Period|Randomized, Not Treated|1|||
48986386|NCT01711359|157781684|FG002|Treatment Period|Randomized, Not Treated|0|||
48986387|NCT03524664|157781687|FG000|Overall Study|Withdrawal by Subject|1|||
48986388|NCT03524664|157781688|FG001|Overall Study|Withdrawal by Subject|2|||
48986389|NCT03524664|157781687|FG000|Overall Study|Lost to Follow-up|4|||
48986390|NCT03524664|157781688|FG001|Overall Study|Lost to Follow-up|13|||
48986391|NCT00982111|157781689|FG000|Overall Study|Adverse Event|1|||
48986392|NCT00982111|157781690|FG001|Overall Study|Adverse Event|1|||
48986393|NCT00982111|157781689|FG000|Overall Study|Progressive Disease|46|||
48986394|NCT00982111|157781690|FG001|Overall Study|Progressive Disease|39|||
48986395|NCT00982111|157781689|FG000|Overall Study|Lost to Follow-up|9|||
48986396|NCT00982111|157781690|FG001|Overall Study|Lost to Follow-up|6|||
48986397|NCT00982111|157781689|FG000|Overall Study|New Anti-Cancer Therapy|5|||
48986398|NCT00982111|157781690|FG001|Overall Study|New Anti-Cancer Therapy|5|||
48986399|NCT00982111|157781689|FG000|Overall Study|Medical Decision|1|||
48986400|NCT00982111|157781690|FG001|Overall Study|Medical Decision|0|||
48986401|NCT00982111|157781689|FG000|Overall Study|Withdrawal by Subject|17|||
48986402|NCT00982111|157781690|FG001|Overall Study|Withdrawal by Subject|19|||
48986403|NCT00982111|157781689|FG000|Overall Study|Global Study End|0|||
48986404|NCT00982111|157781690|FG001|Overall Study|Global Study End|1|||
48986405|NCT00982111|157781689|FG000|Overall Study|Sponsor's Decision|0|||
48986406|NCT00982111|157781690|FG001|Overall Study|Sponsor's Decision|1|||
48986407|NCT04604015|157781693|FG000|Overall Study|Incomplete Data Collection|33|||
48986408|NCT03769753|157781696|FG000|Overall Study|Not Treated|6|||
48986409|NCT03769753|157781696|FG000|Overall Study|Inevaluable - No Evidence of Disease|1|||
48986410|NCT00523744|157781697|FG000|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2|||
48986411|NCT00523744|157781697|FG000|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1|||
48986412|NCT00523744|157781697|FG000|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2|||
48986413|NCT00523744|157781697|FG000|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1|||
48986414|NCT00523744|157781697|FG000|Phase 2 - Amlodipine+Valsartan|Adverse Event|2|||
48986415|NCT00523744|157781697|FG000|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1|||
48986416|NCT01482598|157781699|FG000|Overall Study|Death|7|||
48986417|NCT01482598|157781700|FG001|Overall Study|Death|10|||
48986418|NCT01482598|157781699|FG000|Overall Study|Physician Decision|0|||
48986419|NCT01482598|157781700|FG001|Overall Study|Physician Decision|3|||
48986420|NCT01482598|157781699|FG000|Overall Study|Withdrawal by Subject|4|||
48986421|NCT01482598|157781700|FG001|Overall Study|Withdrawal by Subject|5|||
48986422|NCT01482598|157781699|FG000|Overall Study|Lost to Follow-up|5|||
48986423|NCT01482598|157781700|FG001|Overall Study|Lost to Follow-up|4|||
48986424|NCT01373294|157781701|FG000|Overall Study|Adverse Event|1|||
48986425|NCT01373294|157781702|FG001|Overall Study|Adverse Event|0|||
48986426|NCT02694562|157781703|FG000|Overall Study|Death|8|||
48986427|NCT02694562|157781703|FG000|Overall Study|Protocol Violation|4|||
48986428|NCT02694562|157781703|FG000|Overall Study|Lost to Follow-up|3|||
48986429|NCT02694562|157781703|FG000|Overall Study|Screen Failure|2|||
48986430|NCT02694562|157781703|FG000|Overall Study|Physician Decision|1|||
48986431|NCT01038635|157781704|FG000|Overall Study|Disease Progression|2|||
48986432|NCT01038635|157781705|FG001|Overall Study|Disease Progression|0|||
48986433|NCT01038635|157781706|FG002|Overall Study|Disease Progression|0|||
48986434|NCT01038635|157781707|FG003|Overall Study|Disease Progression|0|||
48986435|NCT01038635|157781708|FG004|Overall Study|Disease Progression|0|||
48986436|NCT01038635|157781709|FG005|Overall Study|Disease Progression|0|||
48986437|NCT01038635|157781710|FG006|Overall Study|Disease Progression|1|||
48986438|NCT01038635|157781711|FG007|Overall Study|Disease Progression|4|||
48986439|NCT01038635|157781712|FG008|Overall Study|Disease Progression|0|||
48986440|NCT01038635|157781704|FG000|Overall Study|Death|0|||
48986441|NCT01038635|157781705|FG001|Overall Study|Death|0|||
48986442|NCT01038635|157781706|FG002|Overall Study|Death|0|||
48986443|NCT01038635|157781707|FG003|Overall Study|Death|0|||
48986444|NCT01038635|157781708|FG004|Overall Study|Death|1|||
48986445|NCT01038635|157781709|FG005|Overall Study|Death|0|||
48986446|NCT01038635|157781710|FG006|Overall Study|Death|1|||
48986447|NCT01038635|157781711|FG007|Overall Study|Death|1|||
48986448|NCT01038635|157781712|FG008|Overall Study|Death|2|||
48986449|NCT00423267|157781713|FG000|Period A|Withdrawal by Subject|0|||
48986450|NCT00423267|157781714|FG001|Period A|Withdrawal by Subject|1|||
48986451|NCT00423267|157781713|FG000|Period A|Non-compliance with protocol|1|||
48986452|NCT00423267|157781714|FG001|Period A|Non-compliance with protocol|0|||
48986453|NCT00423267|157781713|FG000|Period A|Administrative|1|||
48986454|NCT00423267|157781714|FG001|Period A|Administrative|0|||
48986455|NCT03702166|157781715|FG000|Overall Study|Lost to Follow-up|1|||
48986456|NCT03702166|157781715|FG000|Overall Study|Withdrawal by Subject|1|||
48986457|NCT01070381|157781716|FG000|Period 2, 1 Week of Wear|Handling|0|||
48986458|NCT01070381|157781717|FG001|Period 2, 1 Week of Wear|Handling|1|||
48986459|NCT01070381|157781716|FG000|Period 2, 1 Week of Wear|Unacceptable Vision|1|||
48986460|NCT01070381|157781717|FG001|Period 2, 1 Week of Wear|Unacceptable Vision|0|||
48986461|NCT00106626|157781718|FG000|Overall Study|Adverse Event|5|||
48986462|NCT00106626|157781719|FG001|Overall Study|Adverse Event|4|||
48986463|NCT00106626|157781720|FG002|Overall Study|Adverse Event|3|||
48986464|NCT00106626|157781721|FG003|Overall Study|Adverse Event|3|||
48986465|NCT00106626|157781718|FG000|Overall Study|Progressive Disease|4|||
48986466|NCT00106626|157781719|FG001|Overall Study|Progressive Disease|1|||
48986467|NCT00106626|157781720|FG002|Overall Study|Progressive Disease|9|||
48986468|NCT00106626|157781721|FG003|Overall Study|Progressive Disease|10|||
48986469|NCT00106626|157781718|FG000|Overall Study|Received radiation on new therapy|1|||
48986470|NCT00106626|157781719|FG001|Overall Study|Received radiation on new therapy|0|||
48986471|NCT00106626|157781720|FG002|Overall Study|Received radiation on new therapy|0|||
48986472|NCT00106626|157781721|FG003|Overall Study|Received radiation on new therapy|0|||
48986473|NCT00106626|157781718|FG000|Overall Study|> 14 day delay in therapy start|0|||
48986474|NCT00106626|157781719|FG001|Overall Study|> 14 day delay in therapy start|1|||
48986475|NCT00106626|157781720|FG002|Overall Study|> 14 day delay in therapy start|0|||
48986476|NCT00106626|157781721|FG003|Overall Study|> 14 day delay in therapy start|0|||
48986477|NCT00684073|157781722|FG000|Selection|Selection/non-selection criteria|3|||
48986478|NCT00684073|157781722|FG000|Selection|Death|1|||
48986479|NCT00684073|157781722|FG000|Selection|noncompliance|1|||
48986480|NCT00684073|157781722|FG000|Selection|Lost to Follow-up|1|||
48986481|NCT00684073|157781722|FG000|Selection|request of the sponsor|1|||
48986482|NCT00684073|157781722|FG000|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1|||
48986483|NCT01657903|157781724|FG000|Overall Study|Lost to Follow-up|1|||
48986484|NCT01657903|157781724|FG000|Overall Study|Withdrawal by Subject|1|||
48986485|NCT03512028|157781727|FG000|Overall Study|Withdrawal by Subject|2|||
48986486|NCT03512028|157781728|FG001|Overall Study|Withdrawal by Subject|0|||
48986487|NCT03512028|157781727|FG000|Overall Study|Protocol Violation|2|||
48986488|NCT03512028|157781728|FG001|Overall Study|Protocol Violation|0|||
48986489|NCT01475214|157781729|FG000|Overall Study|Lost to Follow-up|1|||
48986490|NCT01475214|157781730|FG001|Overall Study|Lost to Follow-up|0|||
48986491|NCT01475214|157781731|FG002|Overall Study|Lost to Follow-up|1|||
48986492|NCT01475214|157781729|FG000|Overall Study|Physician Decision|2|||
48986493|NCT01475214|157781730|FG001|Overall Study|Physician Decision|0|||
48986494|NCT01475214|157781731|FG002|Overall Study|Physician Decision|0|||
48986495|NCT01475214|157781729|FG000|Overall Study|Withdrawal by Subject|2|||
48986496|NCT01475214|157781730|FG001|Overall Study|Withdrawal by Subject|4|||
48986497|NCT01475214|157781731|FG002|Overall Study|Withdrawal by Subject|1|||
48986498|NCT01385098|157781732|FG000|Overall Study|Adverse Event|10|||
48986499|NCT01385098|157781732|FG000|Overall Study|Lost to Follow-up|4|||
48986500|NCT02743494|157781733|FG000|Pre-treatment Period|Participant request to discontinue treatment|0|||
48986501|NCT02743494|157781734|FG001|Pre-treatment Period|Participant request to discontinue treatment|1|||
48986502|NCT02743494|157781733|FG000|Pre-treatment Period|Participant no longer meeting study criteria|0|||
48986503|NCT02743494|157781734|FG001|Pre-treatment Period|Participant no longer meeting study criteria|1|||
48986504|NCT02743494|157781733|FG000|Treatment Period|Completed treatment|229|||
48986505|NCT02743494|157781734|FG001|Treatment Period|Completed treatment|99|||
48986506|NCT02743494|157781733|FG000|Treatment Period|Disease recurrence|149|||
48986507|NCT02743494|157781734|FG001|Treatment Period|Disease recurrence|113|||
48986508|NCT02743494|157781733|FG000|Treatment Period|Study drug toxicity|57|||
48986509|NCT02743494|157781734|FG001|Treatment Period|Study drug toxicity|8|||
48986510|NCT02743494|157781733|FG000|Treatment Period|Death|1|||
48986511|NCT02743494|157781734|FG001|Treatment Period|Death|0|||
48986512|NCT02743494|157781733|FG000|Treatment Period|Adverse event unrelated to study drug|15|||
48986513|NCT02743494|157781734|FG001|Treatment Period|Adverse event unrelated to study drug|9|||
48986514|NCT02743494|157781733|FG000|Treatment Period|Participant request to discontinue treatment|30|||
48986515|NCT02743494|157781734|FG001|Treatment Period|Participant request to discontinue treatment|5|||
48986516|NCT02743494|157781733|FG000|Treatment Period|Participant withdrew consent|12|||
48986517|NCT02743494|157781734|FG001|Treatment Period|Participant withdrew consent|4|||
48986518|NCT02743494|157781733|FG000|Treatment Period|Lost to Follow-up|0|||
48986519|NCT02743494|157781734|FG001|Treatment Period|Lost to Follow-up|1|||
48986520|NCT02743494|157781733|FG000|Treatment Period|Poor/Non-compliance|1|||
48986521|NCT02743494|157781734|FG001|Treatment Period|Poor/Non-compliance|0|||
48986522|NCT02743494|157781733|FG000|Treatment Period|Other reasons|7|||
48986523|NCT02743494|157781734|FG001|Treatment Period|Other reasons|2|||
48986524|NCT00554840|157781735|FG000|Overall Study|Physician Decision|0|||
48986525|NCT00554840|157781736|FG001|Overall Study|Physician Decision|1|||
48986526|NCT03529162|157781739|FG000|Overall Study|Lost to Follow-up|2|||
48986527|NCT03529162|157781740|FG001|Overall Study|Lost to Follow-up|2|||
48986528|NCT03044730|157781741|FG000|3 Cycles of Pembro + Capecitab|Progressive Disease|1|||
48986529|NCT03044730|157781741|FG000|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1|||
48986530|NCT03044730|157781741|FG000|3 Cycles of Pembro + Capecitab|Death|1|||
48986531|NCT03044730|157781741|FG000|3 Cycles of Pembro + Capecitab|Adverse Event|1|||
48986532|NCT03044730|157781741|FG000|Cycles 4 and Beyond|Progressive Disease|9|||
48986533|NCT03044730|157781741|FG000|Cycles 4 and Beyond|Adverse Event|1|||
48986534|NCT03044730|157781741|FG000|On Follow-up for 2 Years|Still in follow-up|7|||
48986535|NCT03044730|157781741|FG000|On Follow-up for 2 Years|Lost to Follow-up|1|||
49042874|NCT04408924|157991057|FG000|Overall Study|Withdrawal by Subject|5|||
49042875|NCT04408924|157991057|FG000|Overall Study|Sponsor Decision|2|||
49042876|NCT00736190|157991058|FG000|Overall Study|Pregnancy|1|||
48986536|NCT03044730|157781741|FG000|On Follow-up for 2 Years|Death|17|||
48986537|NCT02475564|157781742|FG000|Overall Study|Withdrawal by Subject|1|||
48986538|NCT02475564|157781743|FG001|Overall Study|Withdrawal by Subject|0|||
48986539|NCT02475564|157781742|FG000|Overall Study|Lost to Follow-up|2|||
48986540|NCT02475564|157781743|FG001|Overall Study|Lost to Follow-up|1|||
48986541|NCT02475564|157781742|FG000|Overall Study|Intense Menstrual bleeding|1|||
48986542|NCT02475564|157781743|FG001|Overall Study|Intense Menstrual bleeding|0|||
48986543|NCT01906489|157781752|FG000|Overall Study|Adverse Event|10|||
48986544|NCT01906489|157781753|FG001|Overall Study|Adverse Event|3|||
48986545|NCT01906489|157781752|FG000|Overall Study|Worsening of CKD|6|||
48986546|NCT01906489|157781753|FG001|Overall Study|Worsening of CKD|4|||
48986547|NCT01906489|157781752|FG000|Overall Study|Withdrawal by Subject|5|||
48986548|NCT01906489|157781753|FG001|Overall Study|Withdrawal by Subject|0|||
48986549|NCT01906489|157781752|FG000|Overall Study|Worsening of Anemia|1|||
48986550|NCT01906489|157781753|FG001|Overall Study|Worsening of Anemia|0|||
48986551|NCT01906489|157781752|FG000|Overall Study|Protocol Violation|0|||
48986552|NCT01906489|157781753|FG001|Overall Study|Protocol Violation|1|||
48986553|NCT01906489|157781752|FG000|Overall Study|Non- Compliance|1|||
48986554|NCT01906489|157781753|FG001|Overall Study|Non- Compliance|0|||
48986555|NCT01906489|157781752|FG000|Overall Study|Sponsor Decision|1|||
48986556|NCT01906489|157781753|FG001|Overall Study|Sponsor Decision|0|||
48986557|NCT01906489|157781752|FG000|Overall Study|Lost to Follow-up|1|||
48986558|NCT01906489|157781753|FG001|Overall Study|Lost to Follow-up|1|||
48986559|NCT01906489|157781752|FG000|Overall Study|Other|1|||
48986560|NCT01906489|157781753|FG001|Overall Study|Other|0|||
48986561|NCT01592773|157784218|FG000|Overall Study|Study Terminated by Sponsor|582|||
48986562|NCT01592773|157784218|FG000|Overall Study|Withdrawal by Subject|35|||
48986563|NCT01592773|157784218|FG000|Overall Study|Lost to Follow-up|19|||
48986564|NCT01592773|157784218|FG000|Overall Study|Adverse Event|17|||
48986565|NCT01592773|157784218|FG000|Overall Study|Lack of Efficacy|9|||
48986566|NCT01592773|157784218|FG000|Overall Study|Protocol Violation|2|||
48986567|NCT01592773|157784218|FG000|Overall Study|Inclusion/exclusion not meet|1|||
48986568|NCT01592773|157784218|FG000|Overall Study|Other Reason|1|||
48986569|NCT01293123|157784221|FG000|Overall Study|Lost to Follow-up|0|||
48986570|NCT01293123|157784222|FG001|Overall Study|Lost to Follow-up|1|||
48986571|NCT00669240|157784226|FG000|Overall Study|Lack of Efficacy|33|||
48986572|NCT00669240|157784226|FG000|Overall Study|Withdrawal by Subject|42|||
48986573|NCT00669240|157784226|FG000|Overall Study|Lost to Follow-up|34|||
48986574|NCT00669240|157784226|FG000|Overall Study|Adverse Event|21|||
48986575|NCT00669240|157784226|FG000|Overall Study|Other|19|||
48986576|NCT00669240|157784226|FG000|Overall Study|Enrolled but not treated|15|||
48986577|NCT00669240|157784226|FG000|Overall Study|Enrolled but no dosing record|1|||
48986578|NCT04097925|157784228|FG000|Overall Study|Withdrawal by Subject|1|||
48986579|NCT02679222|157784229|FG000|Overall Study|No time for project|1|||
48986580|NCT02059174|157784238|FG000|Period 1|Withdrawal by Subject|0|||
48986581|NCT02059174|157784239|FG001|Period 1|Withdrawal by Subject|2|||
48986582|NCT02059174|157784238|FG000|Period 2|Withdrawal by Subject|0|||
48986583|NCT02059174|157784239|FG001|Period 2|Withdrawal by Subject|2|||
48986584|NCT02059174|157784238|FG000|Period 2|Protocol Violation|1|||
48986585|NCT02059174|157784239|FG001|Period 2|Protocol Violation|0|||
48986586|NCT02059174|157784238|FG000|Period 3|Physician Decision|1|||
48986587|NCT02059174|157784239|FG001|Period 3|Physician Decision|0|||
48986588|NCT04397757|157784240|FG000|Overall Study|Death|3|||
48986589|NCT04397757|157784241|FG001|Overall Study|Death|11|||
48986590|NCT04397757|157784240|FG000|Overall Study|Withdrawal by Subject|2|||
48986591|NCT04397757|157784241|FG001|Overall Study|Withdrawal by Subject|0|||
48986592|NCT04397757|157784240|FG000|Overall Study|Lost to Follow-up|4|||
48986593|NCT04397757|157784241|FG001|Overall Study|Lost to Follow-up|3|||
48986594|NCT02306148|157784242|FG000|Overall Study|Adverse Event|12|||
48986595|NCT02306148|157784243|FG001|Overall Study|Adverse Event|6|||
48986596|NCT02306148|157784242|FG000|Overall Study|Lost to Follow-up|1|||
48986597|NCT02306148|157784243|FG001|Overall Study|Lost to Follow-up|4|||
48986598|NCT03384316|157784244|FG000|Overall Study|Screen failure|0|||
48986599|NCT03384316|157784245|FG001|Overall Study|Screen failure|1|||
48986600|NCT02608099|157784246|FG000|Overall Study|Ablation procedure not initiated|3|||
48986601|NCT02608099|157784247|FG001|Overall Study|Ablation procedure not initiated|2|||
48986602|NCT00963469|157784255|FG000|Overall Study|Adverse Event|15|||
48986603|NCT00963469|157784256|FG001|Overall Study|Adverse Event|11|||
48986604|NCT00963469|157784257|FG002|Overall Study|Adverse Event|1|||
48986605|NCT00963469|157784255|FG000|Overall Study|Lack of Efficacy|10|||
48986606|NCT00963469|157784256|FG001|Overall Study|Lack of Efficacy|7|||
48986607|NCT00963469|157784257|FG002|Overall Study|Lack of Efficacy|2|||
48986608|NCT00963469|157784255|FG000|Overall Study|Lost to Follow-up|1|||
48986609|NCT00963469|157784256|FG001|Overall Study|Lost to Follow-up|1|||
48986610|NCT00963469|157784257|FG002|Overall Study|Lost to Follow-up|0|||
48986611|NCT00963469|157784255|FG000|Overall Study|Protocol Violation|5|||
48986612|NCT00963469|157784256|FG001|Overall Study|Protocol Violation|5|||
48986613|NCT00963469|157784257|FG002|Overall Study|Protocol Violation|3|||
48986614|NCT00963469|157784255|FG000|Overall Study|Withdrawal by Subject|4|||
48986615|NCT00963469|157784256|FG001|Overall Study|Withdrawal by Subject|1|||
48986616|NCT00963469|157784257|FG002|Overall Study|Withdrawal by Subject|1|||
48986617|NCT00963469|157784255|FG000|Overall Study|Pre-randomization Adverse Event|1|||
48986618|NCT00963469|157784256|FG001|Overall Study|Pre-randomization Adverse Event|2|||
49042877|NCT00736190|157991058|FG000|Overall Study|Withdrawal by Subject|1|||
48986619|NCT00963469|157784257|FG002|Overall Study|Pre-randomization Adverse Event|0|||
48986620|NCT00963469|157784255|FG000|Overall Study|Moved|1|||
48986621|NCT00963469|157784256|FG001|Overall Study|Moved|0|||
48986622|NCT00963469|157784257|FG002|Overall Study|Moved|0|||
48986623|NCT00963469|157784255|FG000|Overall Study|Site closed (local pollen Season ended)|4|||
48986624|NCT00963469|157784256|FG001|Overall Study|Site closed (local pollen Season ended)|1|||
48986625|NCT00963469|157784257|FG002|Overall Study|Site closed (local pollen Season ended)|3|||
48986626|NCT04880642|157784258|FG000|Randomization|Withdrawal by Subject|2|||
48986627|NCT04880642|157784259|FG001|Randomization|Withdrawal by Subject|3|||
48986628|NCT04880642|157784258|FG000|Treatment Period|Adverse Event|0|||
48986629|NCT04880642|157784259|FG001|Treatment Period|Adverse Event|1|||
48986630|NCT04880642|157784258|FG000|Treatment Period|Death|6|||
48986631|NCT04880642|157784259|FG001|Treatment Period|Death|6|||
48986632|NCT04880642|157784258|FG000|Treatment Period|Lost to Follow-up|1|||
48986633|NCT04880642|157784259|FG001|Treatment Period|Lost to Follow-up|0|||
48986634|NCT04880642|157784258|FG000|Treatment Period|Protocol Violation|0|||
48986635|NCT04880642|157784259|FG001|Treatment Period|Protocol Violation|1|||
48986636|NCT04880642|157784258|FG000|Treatment Period|Withdrawal by Subject|5|||
48986637|NCT04880642|157784259|FG001|Treatment Period|Withdrawal by Subject|3|||
48986638|NCT04880642|157784258|FG000|Treatment Period|Discontinuation criteria of eGFR|0|||
48986639|NCT04880642|157784259|FG001|Treatment Period|Discontinuation criteria of eGFR|1|||
48986640|NCT04880642|157784258|FG000|Follow-up|Death|4|||
48986641|NCT04880642|157784259|FG001|Follow-up|Death|3|||
48986642|NCT04880642|157784258|FG000|Follow-up|Withdrawal by Subject|1|||
48986643|NCT04880642|157784259|FG001|Follow-up|Withdrawal by Subject|0|||
48986644|NCT00141297|157784260|FG000|Overall Study|Adverse Event|0|||
48986645|NCT00141297|157784261|FG001|Overall Study|Adverse Event|0|||
48986646|NCT00141297|157784262|FG002|Overall Study|Adverse Event|1|||
48986647|NCT00141297|157784263|FG003|Overall Study|Adverse Event|0|||
48986648|NCT00141297|157784264|FG004|Overall Study|Adverse Event|1|||
48986649|NCT00141297|157784265|FG005|Overall Study|Adverse Event|1|||
48986650|NCT00141297|157784266|FG006|Overall Study|Adverse Event|0|||
48986651|NCT00141297|157784267|FG007|Overall Study|Adverse Event|1|||
48986652|NCT00141297|157784268|FG008|Overall Study|Adverse Event|1|||
48986653|NCT00141297|157784269|FG009|Overall Study|Adverse Event|0|||
48986654|NCT00141297|157784260|FG000|Overall Study|Death|1|||
48986655|NCT00141297|157784261|FG001|Overall Study|Death|0|||
48986656|NCT00141297|157784262|FG002|Overall Study|Death|0|||
48986657|NCT00141297|157784263|FG003|Overall Study|Death|0|||
48986658|NCT00141297|157784264|FG004|Overall Study|Death|0|||
48986659|NCT00141297|157784265|FG005|Overall Study|Death|0|||
48986660|NCT00141297|157784266|FG006|Overall Study|Death|0|||
48986661|NCT00141297|157784267|FG007|Overall Study|Death|0|||
48986662|NCT00141297|157784268|FG008|Overall Study|Death|1|||
48986663|NCT00141297|157784269|FG009|Overall Study|Death|0|||
48986664|NCT00141297|157784260|FG000|Overall Study|Withdrawal by Subject|0|||
48986665|NCT00141297|157784261|FG001|Overall Study|Withdrawal by Subject|0|||
48986666|NCT00141297|157784262|FG002|Overall Study|Withdrawal by Subject|0|||
48986667|NCT00141297|157784263|FG003|Overall Study|Withdrawal by Subject|0|||
48986668|NCT00141297|157784264|FG004|Overall Study|Withdrawal by Subject|0|||
48986669|NCT00141297|157784265|FG005|Overall Study|Withdrawal by Subject|0|||
48986670|NCT00141297|157784266|FG006|Overall Study|Withdrawal by Subject|0|||
48986671|NCT00141297|157784267|FG007|Overall Study|Withdrawal by Subject|0|||
48986672|NCT00141297|157784268|FG008|Overall Study|Withdrawal by Subject|1|||
48986673|NCT00141297|157784269|FG009|Overall Study|Withdrawal by Subject|0|||
48986674|NCT00141297|157784260|FG000|Overall Study|Other|0|||
48986675|NCT00141297|157784261|FG001|Overall Study|Other|0|||
48986676|NCT00141297|157784262|FG002|Overall Study|Other|0|||
48986677|NCT00141297|157784263|FG003|Overall Study|Other|1|||
48986678|NCT00141297|157784264|FG004|Overall Study|Other|5|||
48986679|NCT00141297|157784265|FG005|Overall Study|Other|0|||
48986680|NCT00141297|157784266|FG006|Overall Study|Other|0|||
48986681|NCT00141297|157784267|FG007|Overall Study|Other|0|||
48986682|NCT00141297|157784268|FG008|Overall Study|Other|2|||
48986683|NCT00141297|157784269|FG009|Overall Study|Other|0|||
48986684|NCT00141297|157784260|FG000|Overall Study|Progressive Disease|2|||
48986685|NCT00141297|157784261|FG001|Overall Study|Progressive Disease|3|||
48986686|NCT00141297|157784262|FG002|Overall Study|Progressive Disease|6|||
48986687|NCT00141297|157784263|FG003|Overall Study|Progressive Disease|2|||
48986688|NCT00141297|157784264|FG004|Overall Study|Progressive Disease|15|||
48986689|NCT00141297|157784265|FG005|Overall Study|Progressive Disease|2|||
48986690|NCT00141297|157784266|FG006|Overall Study|Progressive Disease|3|||
48986691|NCT00141297|157784267|FG007|Overall Study|Progressive Disease|3|||
48986692|NCT00141297|157784268|FG008|Overall Study|Progressive Disease|15|||
48986693|NCT00141297|157784269|FG009|Overall Study|Progressive Disease|6|||
48986694|NCT00141297|157784260|FG000|Overall Study|Transitioned|0|||
48986695|NCT00141297|157784261|FG001|Overall Study|Transitioned|0|||
48986696|NCT00141297|157784262|FG002|Overall Study|Transitioned|0|||
48986697|NCT00141297|157784263|FG003|Overall Study|Transitioned|0|||
48986698|NCT00141297|157784264|FG004|Overall Study|Transitioned|1|||
48986699|NCT00141297|157784265|FG005|Overall Study|Transitioned|0|||
48986700|NCT00141297|157784266|FG006|Overall Study|Transitioned|0|||
48986701|NCT00141297|157784267|FG007|Overall Study|Transitioned|0|||
48986702|NCT00141297|157784268|FG008|Overall Study|Transitioned|0|||
48986703|NCT00141297|157784269|FG009|Overall Study|Transitioned|0|||
48986704|NCT02987205|157784270|FG000|Overall Study|Adverse Event|1|||
48986705|NCT02987205|157784270|FG000|Overall Study|Withdrawal by Subject|3|||
48986706|NCT02145429|157784271|FG000|Overall Study|Death|4|||
48986707|NCT02145429|157784272|FG001|Overall Study|Death|5|||
48986708|NCT02145429|157784271|FG000|Overall Study|Lost to Follow-up|4|||
48986709|NCT02145429|157784272|FG001|Overall Study|Lost to Follow-up|3|||
48986710|NCT02145429|157784271|FG000|Overall Study|Withdrawal by Subject|8|||
48986711|NCT02145429|157784272|FG001|Overall Study|Withdrawal by Subject|3|||
48986712|NCT02275052|157784273|FG000|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
48986713|NCT02275052|157784274|FG001|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
48986714|NCT02275052|157784275|FG002|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
48986715|NCT02275052|157784276|FG003|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
48986716|NCT02275052|157784273|FG000|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
48986717|NCT02275052|157784274|FG001|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1|||
48986718|NCT02275052|157784275|FG002|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
48986719|NCT02275052|157784276|FG003|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
48986720|NCT02275052|157784273|FG000|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6|||
48986721|NCT02275052|157784274|FG001|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4|||
48986722|NCT02275052|157784275|FG002|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
49042878|NCT00736190|157991058|FG000|Overall Study|Adverse Event|1|||
49042879|NCT00716625|157991067|FG000|Overall Study|Safety was not Assessable|1|||
49042880|NCT01492439|157991068|FG000|Overall Study|Withdrew from RTE|4|||
49042881|NCT01492439|157991069|FG001|Overall Study|Withdrew from RTE|9|||
49042882|NCT04535986|157991070|FG000|Overall Study|Death|4|||
49042883|NCT04535986|157991071|FG001|Overall Study|Death|5|||
49042884|NCT04535986|157991070|FG000|Overall Study|COPD exacerbation withdrawal criteria|7|||
49042885|NCT04535986|157991071|FG001|Overall Study|COPD exacerbation withdrawal criteria|5|||
49042886|NCT04535986|157991070|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|8|||
49042887|NCT04535986|157991071|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|6|||
49042888|NCT04535986|157991070|FG000|Overall Study|Adverse Event|10|||
49042889|NCT04535986|157991071|FG001|Overall Study|Adverse Event|1|||
49042890|NCT04535986|157991070|FG000|Overall Study|Lack of Efficacy|3|||
49042891|NCT04535986|157991071|FG001|Overall Study|Lack of Efficacy|2|||
49042892|NCT04535986|157991070|FG000|Overall Study|Investigator discretion|3|||
49042893|NCT04535986|157991071|FG001|Overall Study|Investigator discretion|0|||
49042894|NCT04535986|157991070|FG000|Overall Study|Withdrawal by Subject|32|||
49042895|NCT04535986|157991071|FG001|Overall Study|Withdrawal by Subject|14|||
49042896|NCT04535986|157991070|FG000|Overall Study|Lost to Follow-up|5|||
49042897|NCT04535986|157991071|FG001|Overall Study|Lost to Follow-up|3|||
49042898|NCT04535986|157991070|FG000|Overall Study|Other|7|||
49042899|NCT04535986|157991071|FG001|Overall Study|Other|3|||
49042900|NCT00868998|157991081|FG000|Overall Study|Screen Failure|1|||
49042901|NCT00868998|157991081|FG000|Overall Study|Withdrawal by Subject|1|||
49042902|NCT00868998|157991081|FG000|Overall Study|Progression of disease|2|||
49042903|NCT00868998|157991081|FG000|Overall Study|Death|1|||
49042904|NCT04010227|157991082|FG000|Overall Study|Death|1|||
49042905|NCT04010227|157991083|FG001|Overall Study|Death|2|||
49042906|NCT04010227|157991082|FG000|Overall Study|Medical Reasons|4|||
49042907|NCT04010227|157991083|FG001|Overall Study|Medical Reasons|3|||
49042908|NCT04010227|157991082|FG000|Overall Study|Withdrawal by Subject|2|||
49042909|NCT04010227|157991083|FG001|Overall Study|Withdrawal by Subject|0|||
49042910|NCT04010227|157991082|FG000|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
49042911|NCT04010227|157991083|FG001|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
49042912|NCT00881569|157991084|FG000|Overall Study|Disease progression|1|||
49042913|NCT00881569|157991085|FG001|Overall Study|Disease progression|1|||
49042914|NCT00697827|157991086|FG000|Overall Study|enrolled but not treated|2|||
49042915|NCT00697827|157991087|FG001|Overall Study|enrolled but not treated|1|||
49042916|NCT00283842|157991088|FG000|Overall Study|Adverse Event|8|||
49042917|NCT00283842|157991089|FG001|Overall Study|Adverse Event|7|||
49042918|NCT00283842|157991090|FG002|Overall Study|Adverse Event|21|||
49042919|NCT00283842|157991091|FG003|Overall Study|Adverse Event|21|||
49042920|NCT00283842|157991092|FG004|Overall Study|Adverse Event|5|||
49042921|NCT00283842|157991088|FG000|Overall Study|Protocol Violation|1|||
49042922|NCT00283842|157991089|FG001|Overall Study|Protocol Violation|5|||
49042923|NCT00283842|157991090|FG002|Overall Study|Protocol Violation|4|||
49042924|NCT00283842|157991091|FG003|Overall Study|Protocol Violation|0|||
49042925|NCT00283842|157991092|FG004|Overall Study|Protocol Violation|0|||
49042926|NCT00283842|157991088|FG000|Overall Study|Protocol deviation|0|||
49042927|NCT00283842|157991089|FG001|Overall Study|Protocol deviation|0|||
49042928|NCT00283842|157991090|FG002|Overall Study|Protocol deviation|0|||
49042929|NCT00283842|157991091|FG003|Overall Study|Protocol deviation|0|||
49042930|NCT00283842|157991092|FG004|Overall Study|Protocol deviation|2|||
49042931|NCT00283842|157991088|FG000|Overall Study|Withdrawal by Subject|2|||
49042932|NCT00283842|157991089|FG001|Overall Study|Withdrawal by Subject|1|||
49042933|NCT00283842|157991090|FG002|Overall Study|Withdrawal by Subject|1|||
49042934|NCT00283842|157991091|FG003|Overall Study|Withdrawal by Subject|5|||
48986723|NCT02275052|157784276|FG003|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
48986724|NCT02275052|157784273|FG000|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1|||
48986725|NCT02275052|157784274|FG001|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
48986726|NCT02275052|157784275|FG002|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
48986727|NCT02275052|157784276|FG003|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
48986728|NCT02275052|157784273|FG000|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2|||
48986729|NCT02275052|157784274|FG001|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
48986730|NCT02275052|157784275|FG002|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
48986731|NCT02275052|157784276|FG003|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
48986732|NCT02275052|157784273|FG000|Washout Period (12-17 Days)|Withdrawal by Subject|3|||
48986733|NCT02275052|157784274|FG001|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
48986734|NCT02275052|157784275|FG002|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
48986735|NCT02275052|157784276|FG003|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
48986736|NCT02275052|157784273|FG000|Washout Period (12-17 Days)|Lack of Efficacy|1|||
48986737|NCT02275052|157784274|FG001|Washout Period (12-17 Days)|Lack of Efficacy|0|||
48986738|NCT02275052|157784275|FG002|Washout Period (12-17 Days)|Lack of Efficacy|0|||
48986739|NCT02275052|157784276|FG003|Washout Period (12-17 Days)|Lack of Efficacy|0|||
48986740|NCT02275052|157784273|FG000|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
48986741|NCT02275052|157784274|FG001|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
48986742|NCT02275052|157784275|FG002|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3|||
48986743|NCT02275052|157784276|FG003|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2|||
48986744|NCT02275052|157784273|FG000|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
48986745|NCT02275052|157784274|FG001|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
48986746|NCT02275052|157784275|FG002|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
48986747|NCT02275052|157784276|FG003|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4|||
48986748|NCT02275052|157784273|FG000|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
48986749|NCT02275052|157784274|FG001|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
48986750|NCT02275052|157784275|FG002|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
48986751|NCT02275052|157784276|FG003|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6|||
48986752|NCT02275052|157784273|FG000|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
48986753|NCT02275052|157784274|FG001|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
48986754|NCT02275052|157784275|FG002|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
48986755|NCT02275052|157784276|FG003|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2|||
48986756|NCT03055806|157784279|FG000|Overall Study|Adverse Event|0|||
48986757|NCT03055806|157784280|FG001|Overall Study|Adverse Event|0|||
48986758|NCT03055806|157784281|FG002|Overall Study|Adverse Event|1|||
48986759|NCT03055806|157784282|FG003|Overall Study|Adverse Event|1|||
48986760|NCT03055806|157784279|FG000|Overall Study|Lost to Follow-up|0|||
48986761|NCT03055806|157784280|FG001|Overall Study|Lost to Follow-up|3|||
48986762|NCT03055806|157784281|FG002|Overall Study|Lost to Follow-up|6|||
48986763|NCT03055806|157784282|FG003|Overall Study|Lost to Follow-up|7|||
48986764|NCT03055806|157784279|FG000|Overall Study|Physician Decision|1|||
48986765|NCT03055806|157784280|FG001|Overall Study|Physician Decision|0|||
48986766|NCT03055806|157784281|FG002|Overall Study|Physician Decision|0|||
48986767|NCT03055806|157784282|FG003|Overall Study|Physician Decision|1|||
48986768|NCT03055806|157784279|FG000|Overall Study|Protocol Violation|1|||
48986769|NCT03055806|157784280|FG001|Overall Study|Protocol Violation|0|||
48986770|NCT03055806|157784281|FG002|Overall Study|Protocol Violation|0|||
48986771|NCT03055806|157784282|FG003|Overall Study|Protocol Violation|0|||
48986772|NCT03055806|157784279|FG000|Overall Study|Withdrawal of consent to continue drug|1|||
48986773|NCT03055806|157784280|FG001|Overall Study|Withdrawal of consent to continue drug|1|||
48986774|NCT03055806|157784281|FG002|Overall Study|Withdrawal of consent to continue drug|2|||
48986775|NCT03055806|157784282|FG003|Overall Study|Withdrawal of consent to continue drug|0|||
48986776|NCT03055806|157784279|FG000|Overall Study|Withdrawal of consent to continue study|2|||
48986777|NCT03055806|157784280|FG001|Overall Study|Withdrawal of consent to continue study|3|||
48986778|NCT03055806|157784281|FG002|Overall Study|Withdrawal of consent to continue study|4|||
48986779|NCT03055806|157784282|FG003|Overall Study|Withdrawal of consent to continue study|6|||
48986780|NCT03055806|157784279|FG000|Overall Study|Partner not willing to try intercourse|1|||
48986781|NCT03055806|157784280|FG001|Overall Study|Partner not willing to try intercourse|0|||
48986782|NCT03055806|157784281|FG002|Overall Study|Partner not willing to try intercourse|0|||
48986783|NCT03055806|157784282|FG003|Overall Study|Partner not willing to try intercourse|0|||
48986784|NCT00125138|157784283|FG000|Overall Study|Adverse Event|1|||
48986785|NCT00125138|157784284|FG001|Overall Study|Adverse Event|0|||
48986786|NCT00125138|157784285|FG002|Overall Study|Adverse Event|3|||
48986787|NCT00125138|157784286|FG003|Overall Study|Adverse Event|2|||
48986788|NCT00125138|157784283|FG000|Overall Study|Withdrawal by Subject|2|||
48986789|NCT00125138|157784284|FG001|Overall Study|Withdrawal by Subject|3|||
48986790|NCT00125138|157784285|FG002|Overall Study|Withdrawal by Subject|1|||
48986791|NCT00125138|157784286|FG003|Overall Study|Withdrawal by Subject|1|||
48986792|NCT00125138|157784283|FG000|Overall Study|Lack of Efficacy|0|||
48986793|NCT00125138|157784284|FG001|Overall Study|Lack of Efficacy|0|||
48986794|NCT00125138|157784285|FG002|Overall Study|Lack of Efficacy|0|||
48986795|NCT00125138|157784286|FG003|Overall Study|Lack of Efficacy|1|||
48986796|NCT00125138|157784283|FG000|Overall Study|Sponsor decision-pt moved to assist care|0|||
48986797|NCT00125138|157784284|FG001|Overall Study|Sponsor decision-pt moved to assist care|0|||
48986798|NCT00125138|157784285|FG002|Overall Study|Sponsor decision-pt moved to assist care|0|||
48986799|NCT00125138|157784286|FG003|Overall Study|Sponsor decision-pt moved to assist care|1|||
48986800|NCT02630459|157784287|FG000|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
48986801|NCT02630459|157784288|FG001|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1|||
48986802|NCT02630459|157784289|FG002|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
48986803|NCT02630459|157784290|FG003|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2|||
48986804|NCT02630459|157784291|FG004|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
48986805|NCT02630459|157784292|FG005|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
48986806|NCT02630459|157784293|FG006|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
48986807|NCT02630459|157784294|FG007|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
48986808|NCT02630459|157784287|FG000|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
48986809|NCT02630459|157784288|FG001|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
48986810|NCT02630459|157784289|FG002|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1|||
48986811|NCT02630459|157784290|FG003|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
48986812|NCT02630459|157784291|FG004|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
48986813|NCT02630459|157784292|FG005|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
48986814|NCT02630459|157784293|FG006|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
48986815|NCT02630459|157784294|FG007|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
48986816|NCT02630459|157784287|FG000|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2|||
48986817|NCT02630459|157784288|FG001|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
48986818|NCT02630459|157784289|FG002|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4|||
48986819|NCT02630459|157784290|FG003|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
48986820|NCT02630459|157784291|FG004|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
48986821|NCT02630459|157784292|FG005|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
48986822|NCT02630459|157784293|FG006|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
48986823|NCT02630459|157784294|FG007|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
48986824|NCT02630459|157784287|FG000|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1|||
48986825|NCT02630459|157784288|FG001|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
48986826|NCT02630459|157784289|FG002|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
48986827|NCT02630459|157784290|FG003|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
48986828|NCT02630459|157784291|FG004|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
48986829|NCT02630459|157784292|FG005|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
48986830|NCT02630459|157784293|FG006|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
48986831|NCT02630459|157784294|FG007|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
48986832|NCT02630459|157784287|FG000|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
48986833|NCT02630459|157784288|FG001|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
48986834|NCT02630459|157784289|FG002|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
48986835|NCT02630459|157784290|FG003|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
48986836|NCT02630459|157784291|FG004|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4|||
48986837|NCT02630459|157784292|FG005|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1|||
48986838|NCT02630459|157784293|FG006|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
48986839|NCT02630459|157784294|FG007|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
48986840|NCT02630459|157784287|FG000|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
48986841|NCT02630459|157784288|FG001|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
48986842|NCT02630459|157784289|FG002|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
48986843|NCT02630459|157784290|FG003|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
48986844|NCT02630459|157784291|FG004|Open-Label Treatment Phase (OLTP)|Subject Request|24|||
48986845|NCT02630459|157784292|FG005|Open-Label Treatment Phase (OLTP)|Subject Request|3|||
48986846|NCT02630459|157784293|FG006|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
48986847|NCT02630459|157784294|FG007|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
48986848|NCT02630459|157784287|FG000|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
48986849|NCT02630459|157784288|FG001|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
48986850|NCT02630459|157784289|FG002|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
48986851|NCT02630459|157784290|FG003|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
48986852|NCT02630459|157784291|FG004|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1|||
48986853|NCT02630459|157784292|FG005|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
48986854|NCT02630459|157784293|FG006|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
48986855|NCT02630459|157784294|FG007|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
48986856|NCT01797302|157784297|FG000|Overall Study|Lost to Follow-up|16|||
48986857|NCT01797302|157784298|FG001|Overall Study|Lost to Follow-up|23|||
48986858|NCT01797302|157784299|FG002|Overall Study|Lost to Follow-up|22|||
48986859|NCT01797302|157784297|FG000|Overall Study|Withdrawal by Subject|1|||
48986860|NCT01797302|157784298|FG001|Overall Study|Withdrawal by Subject|3|||
48986861|NCT01797302|157784299|FG002|Overall Study|Withdrawal by Subject|4|||
48986862|NCT03228836|157784300|FG000|Overall Study|Adverse Event|3|||
48986863|NCT03228836|157784300|FG000|Overall Study|Withdrawal by Subject|1|||
48986864|NCT03228836|157784300|FG000|Overall Study|Death|1|||
48986865|NCT03228836|157784300|FG000|Overall Study|Physician Decision|1|||
48986866|NCT03228836|157784300|FG000|Overall Study|Disease Progression|7|||
48986867|NCT03228836|157784300|FG000|Overall Study|Other|4|||
48986868|NCT02773849|157784303|FG000|Overall Study|Lost to Follow-up|11|||
48986869|NCT02773849|157784303|FG000|Overall Study|Death|26|||
48986870|NCT02773849|157784303|FG000|Overall Study|Withdrawal by Subject|5|||
48986871|NCT02773849|157784303|FG000|Overall Study|Withdrawal of Consent|9|||
48986872|NCT02773849|157784303|FG000|Overall Study|Other: not due to lack of tolerability|11|||
48986873|NCT00732199|157784304|FG000|Overall Study|Withdrawal by Subject|25|||
48986874|NCT00732199|157784305|FG001|Overall Study|Withdrawal by Subject|18|||
48986875|NCT00732199|157784304|FG000|Overall Study|sleep apnea, inadequate signals/sleep|9|||
48986876|NCT00732199|157784305|FG001|Overall Study|sleep apnea, inadequate signals/sleep|8|||
49042935|NCT00283842|157991092|FG004|Overall Study|Withdrawal by Subject|4|||
49042936|NCT00283842|157991088|FG000|Overall Study|Lack of Efficacy|1|||
49042937|NCT00283842|157991089|FG001|Overall Study|Lack of Efficacy|3|||
49042938|NCT00283842|157991090|FG002|Overall Study|Lack of Efficacy|1|||
49042939|NCT00283842|157991091|FG003|Overall Study|Lack of Efficacy|0|||
49042940|NCT00283842|157991092|FG004|Overall Study|Lack of Efficacy|3|||
49042941|NCT00283842|157991088|FG000|Overall Study|Lost to Follow-up|0|||
49042942|NCT00283842|157991089|FG001|Overall Study|Lost to Follow-up|2|||
49042943|NCT00283842|157991090|FG002|Overall Study|Lost to Follow-up|4|||
49042944|NCT00283842|157991091|FG003|Overall Study|Lost to Follow-up|1|||
49042945|NCT00283842|157991092|FG004|Overall Study|Lost to Follow-up|1|||
49042946|NCT05665387|157991093|FG000|Overall Study|Withdrawal by Subject|1|||
49042947|NCT05665387|157991094|FG001|Overall Study|Withdrawal by Subject|0|||
49042948|NCT05665387|157991095|FG002|Overall Study|Withdrawal by Subject|1|||
49042949|NCT02004691|157991099|FG000|PAP: Up to 52 Weeks|Poor compliance|1|||
49042950|NCT02004691|157991100|FG001|PAP: Up to 52 Weeks|Poor compliance|0|||
49042951|NCT02004691|157991099|FG000|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|1|||
49042952|NCT02004691|157991100|FG001|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|0|||
49042953|NCT02004691|157991099|FG000|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
49042954|NCT02004691|157991100|FG001|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
49042955|NCT02004691|157991099|FG000|ETP: From Week 52 up to 5 Years|Pregnancy|1|||
49042956|NCT02004691|157991100|FG001|ETP: From Week 52 up to 5 Years|Pregnancy|0|||
49042957|NCT02004691|157991099|FG000|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|1|||
49042958|NCT02004691|157991100|FG001|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|0|||
49042959|NCT02004691|157991099|FG000|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|0|||
49042960|NCT02004691|157991100|FG001|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|1|||
49042961|NCT02676973|157991101|FG000|Overall Study|Withdrawal by Subject|9|||
49042962|NCT02676973|157991102|FG001|Overall Study|Withdrawal by Subject|8|||
49042963|NCT02676973|157991103|FG002|Overall Study|Withdrawal by Subject|11|||
49042964|NCT02676973|157991101|FG000|Overall Study|Lost to Follow-up|8|||
49042965|NCT02676973|157991102|FG001|Overall Study|Lost to Follow-up|12|||
49042966|NCT02676973|157991103|FG002|Overall Study|Lost to Follow-up|8|||
49042967|NCT02676973|157991101|FG000|Overall Study|Death|2|||
49042968|NCT02676973|157991102|FG001|Overall Study|Death|1|||
49042969|NCT02676973|157991103|FG002|Overall Study|Death|5|||
49042970|NCT02472639|157991104|FG000|Overall Study|Physician Decision|4|||
49042971|NCT02472639|157991105|FG001|Overall Study|Physician Decision|3|||
49042972|NCT00420095|157991107|FG000|Overall Study|Adverse Event|1|||
49042973|NCT00420095|157991108|FG001|Overall Study|Adverse Event|0|||
49042974|NCT00420095|157991107|FG000|Overall Study|Protocol Violation|1|||
49042975|NCT00420095|157991108|FG001|Overall Study|Protocol Violation|1|||
49042976|NCT00420095|157991107|FG000|Overall Study|Lost to Follow-up|1|||
49042977|NCT00420095|157991108|FG001|Overall Study|Lost to Follow-up|0|||
49042978|NCT03493919|157991111|FG000|Overall Study|Other|2|||
49042979|NCT03493919|157991112|FG001|Overall Study|Other|0|||
49042980|NCT03493919|157991113|FG002|Overall Study|Other|1|||
48986877|NCT04005885|157784306|FG000|First Intervention|Withdrawal by Subject|1|||
49042981|NCT03493919|157991114|FG003|Overall Study|Other|0|||
49042982|NCT03493919|157991111|FG000|Overall Study|Withdrawal by Subject|9|||
49042983|NCT03493919|157991112|FG001|Overall Study|Withdrawal by Subject|3|||
49042984|NCT03493919|157991113|FG002|Overall Study|Withdrawal by Subject|1|||
49042985|NCT03493919|157991114|FG003|Overall Study|Withdrawal by Subject|1|||
49042986|NCT03493919|157991111|FG000|Overall Study|Lost to Follow-up|5|||
48986878|NCT04005885|157784307|FG001|First Intervention|Withdrawal by Subject|1|||
48986879|NCT04005885|157784306|FG000|Second Intervention|Withdrawal by Subject|0|||
48986880|NCT04005885|157784307|FG001|Second Intervention|Withdrawal by Subject|2|||
48986881|NCT01474993|157784309|FG000|Overall Study|Lost to Follow-up|1|||
48986882|NCT01474993|157784310|FG001|Overall Study|Lost to Follow-up|2|||
48986883|NCT01474993|157784309|FG000|Overall Study|Adverse Event|0|||
48986884|NCT01474993|157784310|FG001|Overall Study|Adverse Event|1|||
48986885|NCT01412333|157784311|FG000|Overall Study|Adverse Event|40|||
48986886|NCT01412333|157784312|FG001|Overall Study|Adverse Event|42|||
48986887|NCT01412333|157784311|FG000|Overall Study|Death|5|||
48986888|NCT01412333|157784312|FG001|Overall Study|Death|6|||
48986889|NCT01412333|157784311|FG000|Overall Study|Lack of Efficacy|22|||
48986890|NCT01412333|157784312|FG001|Overall Study|Lack of Efficacy|10|||
48986891|NCT01412333|157784311|FG000|Overall Study|Lost to Follow-up|15|||
48986892|NCT01412333|157784312|FG001|Overall Study|Lost to Follow-up|12|||
48986893|NCT01412333|157784311|FG000|Overall Study|Non-Compliance|3|||
48986894|NCT01412333|157784312|FG001|Overall Study|Non-Compliance|7|||
48986895|NCT01412333|157784311|FG000|Overall Study|Non-Compliance With Study Drug|1|||
48986896|NCT01412333|157784312|FG001|Overall Study|Non-Compliance With Study Drug|1|||
48986897|NCT01412333|157784311|FG000|Overall Study|Other|30|||
48986898|NCT01412333|157784312|FG001|Overall Study|Other|33|||
48986899|NCT01412333|157784311|FG000|Overall Study|Physician Decision|11|||
48986900|NCT01412333|157784312|FG001|Overall Study|Physician Decision|16|||
48986901|NCT01412333|157784311|FG000|Overall Study|Pregnancy|6|||
48986902|NCT01412333|157784312|FG001|Overall Study|Pregnancy|4|||
48986903|NCT01412333|157784311|FG000|Overall Study|Protocol Violation|1|||
48986904|NCT01412333|157784312|FG001|Overall Study|Protocol Violation|2|||
48986905|NCT01412333|157784311|FG000|Overall Study|Study Terminated By Sponsor|3|||
48986906|NCT01412333|157784312|FG001|Overall Study|Study Terminated By Sponsor|2|||
48986907|NCT01412333|157784311|FG000|Overall Study|Withdrawal by Subject|51|||
48986908|NCT01412333|157784312|FG001|Overall Study|Withdrawal by Subject|54|||
48986909|NCT01412333|157784311|FG000|Overall Study|Missing|1|||
48986910|NCT01412333|157784312|FG001|Overall Study|Missing|3|||
48986911|NCT01218477|157784313|FG000|Overall Study|Disease progression|2|||
48986912|NCT01218477|157784314|FG001|Overall Study|Disease progression|3|||
48986913|NCT01218477|157784315|FG002|Overall Study|Disease progression|6|||
48986914|NCT01218477|157784316|FG003|Overall Study|Disease progression|2|||
48986915|NCT01218477|157784313|FG000|Overall Study|Study drug toxicity|0|||
48986916|NCT01218477|157784314|FG001|Overall Study|Study drug toxicity|2|||
48986917|NCT01218477|157784315|FG002|Overall Study|Study drug toxicity|5|||
48986918|NCT01218477|157784316|FG003|Overall Study|Study drug toxicity|0|||
48986919|NCT01218477|157784313|FG000|Overall Study|No longer meets study criteria|1|||
48986920|NCT01218477|157784314|FG001|Overall Study|No longer meets study criteria|0|||
48986921|NCT01218477|157784315|FG002|Overall Study|No longer meets study criteria|0|||
48986922|NCT01218477|157784316|FG003|Overall Study|No longer meets study criteria|0|||
48986923|NCT01218477|157784313|FG000|Overall Study|Withdrawal by Subject|0|||
48986924|NCT01218477|157784314|FG001|Overall Study|Withdrawal by Subject|0|||
48986925|NCT01218477|157784315|FG002|Overall Study|Withdrawal by Subject|1|||
48986926|NCT01218477|157784316|FG003|Overall Study|Withdrawal by Subject|0|||
48986927|NCT01218477|157784313|FG000|Overall Study|Prepared for cell transplantation|0|||
48986928|NCT01218477|157784314|FG001|Overall Study|Prepared for cell transplantation|1|||
48986929|NCT01218477|157784315|FG002|Overall Study|Prepared for cell transplantation|1|||
48986930|NCT01218477|157784316|FG003|Overall Study|Prepared for cell transplantation|0|||
48986931|NCT01218477|157784313|FG000|Overall Study|Administrative reason by sponsor|0|||
48986932|NCT01218477|157784314|FG001|Overall Study|Administrative reason by sponsor|0|||
48986933|NCT01218477|157784315|FG002|Overall Study|Administrative reason by sponsor|1|||
48986934|NCT01218477|157784316|FG003|Overall Study|Administrative reason by sponsor|0|||
48986935|NCT01218477|157784313|FG000|Overall Study|Maximum clinical benefit|0|||
48986936|NCT01218477|157784314|FG001|Overall Study|Maximum clinical benefit|2|||
48986937|NCT01218477|157784315|FG002|Overall Study|Maximum clinical benefit|0|||
48986938|NCT01218477|157784316|FG003|Overall Study|Maximum clinical benefit|0|||
48986939|NCT02135848|157784317|FG000|Overall Study|Adverse Event|2|||
48986940|NCT02135848|157784318|FG001|Overall Study|Adverse Event|0|||
48986941|NCT02135848|157784317|FG000|Overall Study|Withdrawal by Subject|1|||
48986942|NCT02135848|157784318|FG001|Overall Study|Withdrawal by Subject|1|||
48986943|NCT00787527|157784322|FG000|Overall Study|Toxicity|3|||
48986944|NCT02381795|157784323|FG000|Overall Study|Withdrawal by Subject|1|||
48986945|NCT02381795|157784323|FG000|Overall Study|Study Terminated|2|||
48986946|NCT00083616|157784324|FG000|Overall Study|Disease Progression|16|||
48986947|NCT00083616|157784324|FG000|Overall Study|Lost to Follow-up|1|||
48986948|NCT00083616|157784324|FG000|Overall Study|Physician Decision|2|||
48986949|NCT00083616|157784324|FG000|Overall Study|Withdrawal by Subject|3|||
48986950|NCT00083616|157784324|FG000|Overall Study|Ineligibility determined|2|||
48986951|NCT00083616|157784324|FG000|Overall Study|Non-compliance|1|||
48986952|NCT00083616|157784324|FG000|Overall Study|Other|6|||
48986953|NCT01488994|157784325|FG000|Overall Study|Withdrawal by Subject|0|||
48986954|NCT01488994|157784326|FG001|Overall Study|Withdrawal by Subject|1|||
48986955|NCT00829010|157784327|FG000|Overall Study|Adverse Event|1|||
48986956|NCT00829010|157784328|FG001|Overall Study|Adverse Event|0|||
48986957|NCT00829010|157784329|FG002|Overall Study|Adverse Event|0|||
48986958|NCT00829010|157784330|FG003|Overall Study|Adverse Event|0|||
48986959|NCT00829010|157784331|FG004|Overall Study|Adverse Event|0|||
48986960|NCT00829010|157784327|FG000|Overall Study|Withdrawal by Subject|0|||
48986961|NCT00829010|157784328|FG001|Overall Study|Withdrawal by Subject|1|||
48986962|NCT00829010|157784329|FG002|Overall Study|Withdrawal by Subject|1|||
48986963|NCT00829010|157784330|FG003|Overall Study|Withdrawal by Subject|0|||
48986964|NCT00829010|157784331|FG004|Overall Study|Withdrawal by Subject|2|||
48986965|NCT00829010|157784327|FG000|Overall Study|Lost to Follow-up|1|||
48986966|NCT00829010|157784328|FG001|Overall Study|Lost to Follow-up|0|||
48986967|NCT00829010|157784329|FG002|Overall Study|Lost to Follow-up|2|||
48986968|NCT00829010|157784330|FG003|Overall Study|Lost to Follow-up|0|||
48986969|NCT00829010|157784331|FG004|Overall Study|Lost to Follow-up|0|||
48986970|NCT00829010|157784327|FG000|Overall Study|Fatality|5|||
48986971|NCT00829010|157784328|FG001|Overall Study|Fatality|4|||
48986972|NCT00829010|157784329|FG002|Overall Study|Fatality|0|||
48986973|NCT00829010|157784330|FG003|Overall Study|Fatality|3|||
48986974|NCT00829010|157784331|FG004|Overall Study|Fatality|0|||
48986975|NCT00829010|157784327|FG000|Overall Study|Migrated/Moved from study area|3|||
48986976|NCT00829010|157784328|FG001|Overall Study|Migrated/Moved from study area|4|||
48986977|NCT00829010|157784329|FG002|Overall Study|Migrated/Moved from study area|0|||
48986978|NCT00829010|157784330|FG003|Overall Study|Migrated/Moved from study area|5|||
48986979|NCT00829010|157784331|FG004|Overall Study|Migrated/Moved from study area|0|||
48986980|NCT01611558|157784332|FG000|Induction Phase|Study drug toxicity|15|||
48986981|NCT01611558|157784332|FG000|Induction Phase|Disease progression|18|||
48986982|NCT01611558|157784332|FG000|Induction Phase|Heart arrest,urosepsis,respiratory fail|1|||
48986983|NCT01611558|157784332|FG000|Induction Phase|Adverse event unrelated to study drug|3|||
48986984|NCT01611558|157784332|FG000|Induction Phase|Death|1|||
48986985|NCT01611558|157784332|FG000|Maintenance Phase|Withdrawal by Subject|1|||
48986986|NCT01611558|157784332|FG000|Maintenance Phase|Elevated Uric acid|1|||
48986987|NCT03798366|157784342|FG000|Overall Study|Lost to Follow-up|0|||
48986988|NCT03798366|157784343|FG001|Overall Study|Lost to Follow-up|1|||
48986989|NCT01326481|157784344|FG000|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1|||
48986990|NCT00307736|157784345|FG000|Overall Study|Adverse Event|0|||
48986991|NCT00307736|157784346|FG001|Overall Study|Adverse Event|0|||
48986992|NCT00307736|157784347|FG002|Overall Study|Adverse Event|1|||
48986993|NCT00307736|157784348|FG003|Overall Study|Adverse Event|3|||
48986994|NCT00307736|157784345|FG000|Overall Study|Withdrawal by Subject|0|||
48986995|NCT00307736|157784346|FG001|Overall Study|Withdrawal by Subject|0|||
48986996|NCT00307736|157784347|FG002|Overall Study|Withdrawal by Subject|2|||
48986997|NCT00307736|157784348|FG003|Overall Study|Withdrawal by Subject|0|||
48986998|NCT00606931|157784359|FG000|Overall Study|Withdrawal by Subject|3|||
48986999|NCT00808132|157784360|FG000|Overall Study|Adverse Event|34|||
49042987|NCT03493919|157991112|FG001|Overall Study|Lost to Follow-up|0|||
49042988|NCT03493919|157991113|FG002|Overall Study|Lost to Follow-up|0|||
49042989|NCT03493919|157991114|FG003|Overall Study|Lost to Follow-up|3|||
49042990|NCT03493919|157991111|FG000|Overall Study|Adverse Event|0|||
49042991|NCT03493919|157991112|FG001|Overall Study|Adverse Event|1|||
49042992|NCT03493919|157991113|FG002|Overall Study|Adverse Event|0|||
49042993|NCT03493919|157991114|FG003|Overall Study|Adverse Event|0|||
49042994|NCT00884390|157991115|FG000|Overall Study|Adverse Event|0|||
49042995|NCT00884390|157991116|FG001|Overall Study|Adverse Event|1|||
49042996|NCT00884390|157991115|FG000|Overall Study|Lost to Follow-up|0|||
49042997|NCT00884390|157991116|FG001|Overall Study|Lost to Follow-up|1|||
49042998|NCT00884390|157991115|FG000|Overall Study|Physician Decision|2|||
49042999|NCT00884390|157991116|FG001|Overall Study|Physician Decision|1|||
49043000|NCT00884390|157991115|FG000|Overall Study|Protocol Violation|4|||
49043001|NCT00884390|157991116|FG001|Overall Study|Protocol Violation|1|||
49043002|NCT00884390|157991115|FG000|Overall Study|Withdrawal by Subject|4|||
49043003|NCT00884390|157991116|FG001|Overall Study|Withdrawal by Subject|1|||
49043004|NCT00884390|157991115|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
49043005|NCT00884390|157991116|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
49043006|NCT00884390|157991115|FG000|Overall Study|Other|11|||
48987000|NCT00808132|157784361|FG001|Overall Study|Adverse Event|33|||
48987001|NCT00808132|157784362|FG002|Overall Study|Adverse Event|16|||
49043007|NCT00884390|157991116|FG001|Overall Study|Other|1|||
49043008|NCT02448563|157991117|FG000|Overall Study|Lost to Follow-up|16|||
49043009|NCT02448563|157991118|FG001|Overall Study|Lost to Follow-up|10|||
49043010|NCT02448563|157991117|FG000|Overall Study|Withdrawal by Subject|0|||
49043011|NCT02448563|157991118|FG001|Overall Study|Withdrawal by Subject|1|||
49043012|NCT00751023|157991119|FG000|Overall Study|Lost to Follow-up|11|||
49043013|NCT00751023|157991120|FG001|Overall Study|Lost to Follow-up|7|||
48987002|NCT00808132|157784363|FG003|Overall Study|Adverse Event|31|||
48987003|NCT00808132|157784364|FG004|Overall Study|Adverse Event|33|||
48987004|NCT00808132|157784360|FG000|Overall Study|Death|0|||
48987005|NCT00808132|157784361|FG001|Overall Study|Death|0|||
48987006|NCT00808132|157784362|FG002|Overall Study|Death|0|||
48987007|NCT00808132|157784363|FG003|Overall Study|Death|0|||
48987008|NCT00808132|157784364|FG004|Overall Study|Death|1|||
48987009|NCT00808132|157784360|FG000|Overall Study|Physician Decision|0|||
48987010|NCT00808132|157784361|FG001|Overall Study|Physician Decision|1|||
48987011|NCT00808132|157784362|FG002|Overall Study|Physician Decision|0|||
48987012|NCT00808132|157784363|FG003|Overall Study|Physician Decision|0|||
48987013|NCT00808132|157784364|FG004|Overall Study|Physician Decision|0|||
48987014|NCT00808132|157784360|FG000|Overall Study|Lost to Follow-up|8|||
48987015|NCT00808132|157784361|FG001|Overall Study|Lost to Follow-up|10|||
48987016|NCT00808132|157784362|FG002|Overall Study|Lost to Follow-up|11|||
48987017|NCT00808132|157784363|FG003|Overall Study|Lost to Follow-up|8|||
48987018|NCT00808132|157784364|FG004|Overall Study|Lost to Follow-up|9|||
48987019|NCT00808132|157784360|FG000|Overall Study|Protocol Violation|8|||
48987020|NCT00808132|157784361|FG001|Overall Study|Protocol Violation|9|||
48987021|NCT00808132|157784362|FG002|Overall Study|Protocol Violation|4|||
48987022|NCT00808132|157784363|FG003|Overall Study|Protocol Violation|9|||
48987023|NCT00808132|157784364|FG004|Overall Study|Protocol Violation|5|||
48987024|NCT00808132|157784360|FG000|Overall Study|Withdrawal by Subject|27|||
48987025|NCT00808132|157784361|FG001|Overall Study|Withdrawal by Subject|18|||
48987026|NCT00808132|157784362|FG002|Overall Study|Withdrawal by Subject|2|||
48987027|NCT00808132|157784363|FG003|Overall Study|Withdrawal by Subject|7|||
48987028|NCT00808132|157784364|FG004|Overall Study|Withdrawal by Subject|16|||
48987029|NCT00808132|157784360|FG000|Overall Study|Other|6|||
48987030|NCT00808132|157784361|FG001|Overall Study|Other|4|||
48987031|NCT00808132|157784362|FG002|Overall Study|Other|6|||
48987032|NCT00808132|157784363|FG003|Overall Study|Other|2|||
48987033|NCT00808132|157784364|FG004|Overall Study|Other|15|||
48987034|NCT00808132|157784360|FG000|Overall Study|Randomized, but not treated|10|||
48987035|NCT00808132|157784361|FG001|Overall Study|Randomized, but not treated|7|||
48987036|NCT00808132|157784362|FG002|Overall Study|Randomized, but not treated|9|||
48987037|NCT00808132|157784363|FG003|Overall Study|Randomized, but not treated|8|||
48987038|NCT00808132|157784364|FG004|Overall Study|Randomized, but not treated|9|||
48987039|NCT00808132|157784360|FG000|Overall Study|Unsatisfactory response|5|||
48987040|NCT00808132|157784361|FG001|Overall Study|Unsatisfactory response|6|||
48987041|NCT00808132|157784362|FG002|Overall Study|Unsatisfactory response|6|||
48987042|NCT00808132|157784363|FG003|Overall Study|Unsatisfactory response|4|||
48987043|NCT00808132|157784364|FG004|Overall Study|Unsatisfactory response|12|||
48987044|NCT01351415|157784365|FG000|Overall Study|Withdrawal by Subject|15|||
48987045|NCT01351415|157784366|FG001|Overall Study|Withdrawal by Subject|17|||
48987046|NCT01351415|157784365|FG000|Overall Study|Trial termination by the Sponsor|28|||
48987047|NCT01351415|157784366|FG001|Overall Study|Trial termination by the Sponsor|19|||
48987048|NCT01351415|157784365|FG000|Overall Study|Lost to Follow-up|5|||
48987049|NCT01351415|157784366|FG001|Overall Study|Lost to Follow-up|7|||
48987050|NCT01351415|157784365|FG000|Overall Study|Death|190|||
48987051|NCT01351415|157784366|FG001|Overall Study|Death|187|||
48987052|NCT01351415|157784365|FG000|Overall Study|Physician Decision|2|||
48987053|NCT01351415|157784366|FG001|Overall Study|Physician Decision|3|||
48987054|NCT01351415|157784365|FG000|Overall Study|Reason unknown|0|||
48987055|NCT01351415|157784366|FG001|Overall Study|Reason unknown|2|||
48987056|NCT01351415|157784365|FG000|Overall Study|Never Started|5|||
48987057|NCT01351415|157784366|FG001|Overall Study|Never Started|5|||
48987058|NCT01849289|157784367|FG000|Overall Study|Adverse Event|3|||
48987059|NCT01849289|157784368|FG001|Overall Study|Adverse Event|3|||
48987060|NCT01849289|157784367|FG000|Overall Study|Protocol Violation|3|||
48987061|NCT01849289|157784368|FG001|Overall Study|Protocol Violation|3|||
48987062|NCT01849289|157784367|FG000|Overall Study|Withdrawal criteria|1|||
48987063|NCT01849289|157784368|FG001|Overall Study|Withdrawal criteria|0|||
48987064|NCT01849289|157784367|FG000|Overall Study|Unclassified|25|||
48987065|NCT01849289|157784368|FG001|Overall Study|Unclassified|18|||
48987066|NCT03125902|157784370|FG000|Overall Study|Adverse Event|0|||
48987067|NCT03125902|157784371|FG001|Overall Study|Adverse Event|1|||
48987068|NCT03125902|157784370|FG000|Overall Study|Death|119|||
48987069|NCT03125902|157784371|FG001|Overall Study|Death|229|||
48987070|NCT03125902|157784370|FG000|Overall Study|Lost to Follow-up|4|||
48987071|NCT03125902|157784371|FG001|Overall Study|Lost to Follow-up|13|||
48987072|NCT03125902|157784370|FG000|Overall Study|Other|0|||
48987073|NCT03125902|157784371|FG001|Overall Study|Other|4|||
48987074|NCT03125902|157784370|FG000|Overall Study|Physician Decision|2|||
48987075|NCT03125902|157784371|FG001|Overall Study|Physician Decision|1|||
48987076|NCT03125902|157784370|FG000|Overall Study|Progressive Disease|0|||
48987077|NCT03125902|157784371|FG001|Overall Study|Progressive Disease|3|||
48987078|NCT03125902|157784370|FG000|Overall Study|Study Terminated By Sponsor|74|||
48987079|NCT03125902|157784371|FG001|Overall Study|Study Terminated By Sponsor|143|||
48987080|NCT03125902|157784370|FG000|Overall Study|Withdrawal by Subject|21|||
48987081|NCT03125902|157784371|FG001|Overall Study|Withdrawal by Subject|37|||
48987082|NCT01815099|157784372|FG000|Overall Study|Lack of Efficacy|1|||
48987083|NCT01815099|157784372|FG000|Overall Study|unable to attend study visits|1|||
48987084|NCT01333865|157784373|FG000|Overall Study|Adverse Event|2|||
48987085|NCT01259388|157784376|FG000|Overall Study|Adverse Event|3|||
48987086|NCT01259388|157784377|FG001|Overall Study|Adverse Event|0|||
48987087|NCT01259388|157784376|FG000|Overall Study|Withdrawal by Subject|1|||
48987088|NCT01259388|157784377|FG001|Overall Study|Withdrawal by Subject|1|||
48987089|NCT01259388|157784376|FG000|Overall Study|Physician Decision|1|||
48987090|NCT01259388|157784377|FG001|Overall Study|Physician Decision|0|||
48987091|NCT00983827|157784378|FG000|Overall Study|Withdrawal by Subject|1|||
48987092|NCT02728804|157784382|FG000|Overall Study|Ineligible|3|||
48987093|NCT02728804|157784382|FG000|Overall Study|Did not complete baseline questionnaire|9|||
48987094|NCT02728804|157784382|FG000|Overall Study|Death|99|||
48987095|NCT03590613|157784383|FG000|Period 2, 4 Days|Physician Decision|0|||
48987096|NCT03590613|157784384|FG001|Period 2, 4 Days|Physician Decision|0|||
48987097|NCT03590613|157784385|FG002|Period 2, 4 Days|Physician Decision|0|||
48987098|NCT03590613|157784386|FG003|Period 2, 4 Days|Physician Decision|1|||
48987099|NCT01854918|157784387|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|20|||
48987100|NCT01854918|157784388|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|49|||
48987101|NCT01854918|157784387|FG000|SOC-controlled Period (Year 1)|Decision by Sponsor|2|||
48987102|NCT01854918|157784388|FG001|SOC-controlled Period (Year 1)|Decision by Sponsor|1|||
48987103|NCT01854918|157784387|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|3|||
48987104|NCT01854918|157784388|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|8|||
48987105|NCT01854918|157784387|FG000|SOC-controlled Period (Year 1)|Death|5|||
48987106|NCT01854918|157784388|FG001|SOC-controlled Period (Year 1)|Death|5|||
48987107|NCT01854918|157784387|FG000|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78|||
48987108|NCT01854918|157784388|FG001|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117|||
48987109|NCT01854918|157784387|FG000|All-IP Period (Years 2 and 3)|Decision by Sponsor|8|||
48987110|NCT01854918|157784388|FG001|All-IP Period (Years 2 and 3)|Decision by Sponsor|11|||
48987111|NCT01854918|157784387|FG000|All-IP Period (Years 2 and 3)|Lost to Follow-up|27|||
48987112|NCT01854918|157784388|FG001|All-IP Period (Years 2 and 3)|Lost to Follow-up|51|||
48987113|NCT01854918|157784387|FG000|All-IP Period (Years 2 and 3)|Death|5|||
48987114|NCT01854918|157784388|FG001|All-IP Period (Years 2 and 3)|Death|16|||
48987115|NCT00784836|157784389|FG000|Overall Study|Early Study Termination|3|||
48987116|NCT01920061|157784391|FG000|Overall Study|Death|1|||
48987117|NCT01920061|157784392|FG001|Overall Study|Death|1|||
48987118|NCT01920061|157784393|FG002|Overall Study|Death|0|||
48987119|NCT01920061|157784394|FG003|Overall Study|Death|1|||
48987120|NCT01920061|157784395|FG004|Overall Study|Death|1|||
48987121|NCT01920061|157784396|FG005|Overall Study|Death|0|||
48987122|NCT01920061|157784397|FG006|Overall Study|Death|0|||
48987123|NCT01920061|157784398|FG007|Overall Study|Death|1|||
48987124|NCT01920061|157784399|FG008|Overall Study|Death|0|||
48987125|NCT01920061|157784400|FG009|Overall Study|Death|1|||
48987126|NCT01920061|157784401|FG010|Overall Study|Death|0|||
48987127|NCT01920061|157784402|FG011|Overall Study|Death|1|||
48987128|NCT01920061|157784403|FG012|Overall Study|Death|0|||
48987129|NCT01920061|157784404|FG013|Overall Study|Death|2|||
48987130|NCT01920061|157784405|FG014|Overall Study|Death|0|||
48987131|NCT01920061|157784406|FG015|Overall Study|Death|0|||
48987132|NCT01920061|157784407|FG016|Overall Study|Death|0|||
48987133|NCT01920061|157784408|FG017|Overall Study|Death|0|||
48987134|NCT01920061|157784409|FG018|Overall Study|Death|1|||
48987135|NCT01920061|157784410|FG019|Overall Study|Death|0|||
48987136|NCT01920061|157784391|FG000|Overall Study|Lost to Follow-up|0|||
48987137|NCT01920061|157784392|FG001|Overall Study|Lost to Follow-up|2|||
48987138|NCT01920061|157784393|FG002|Overall Study|Lost to Follow-up|0|||
48987139|NCT01920061|157784394|FG003|Overall Study|Lost to Follow-up|0|||
48987140|NCT01920061|157784395|FG004|Overall Study|Lost to Follow-up|0|||
48987141|NCT01920061|157784396|FG005|Overall Study|Lost to Follow-up|0|||
48987142|NCT01920061|157784397|FG006|Overall Study|Lost to Follow-up|1|||
48987143|NCT01920061|157784398|FG007|Overall Study|Lost to Follow-up|0|||
48987144|NCT01920061|157784399|FG008|Overall Study|Lost to Follow-up|0|||
48987145|NCT01920061|157784400|FG009|Overall Study|Lost to Follow-up|0|||
48987146|NCT01920061|157784401|FG010|Overall Study|Lost to Follow-up|3|||
48987147|NCT01920061|157784402|FG011|Overall Study|Lost to Follow-up|0|||
48987148|NCT01920061|157784403|FG012|Overall Study|Lost to Follow-up|0|||
48987149|NCT01920061|157784404|FG013|Overall Study|Lost to Follow-up|0|||
48987150|NCT01920061|157784405|FG014|Overall Study|Lost to Follow-up|0|||
48987151|NCT01920061|157784406|FG015|Overall Study|Lost to Follow-up|0|||
48987152|NCT01920061|157784407|FG016|Overall Study|Lost to Follow-up|0|||
48987153|NCT01920061|157784408|FG017|Overall Study|Lost to Follow-up|1|||
48987154|NCT01920061|157784409|FG018|Overall Study|Lost to Follow-up|4|||
48987155|NCT01920061|157784410|FG019|Overall Study|Lost to Follow-up|3|||
48987156|NCT01920061|157784391|FG000|Overall Study|Other|1|||
48987157|NCT01920061|157784392|FG001|Overall Study|Other|1|||
48987158|NCT01920061|157784393|FG002|Overall Study|Other|2|||
48987159|NCT01920061|157784394|FG003|Overall Study|Other|1|||
48987160|NCT01920061|157784395|FG004|Overall Study|Other|0|||
48987161|NCT01920061|157784396|FG005|Overall Study|Other|1|||
48987162|NCT01920061|157784397|FG006|Overall Study|Other|0|||
48987163|NCT01920061|157784398|FG007|Overall Study|Other|0|||
48987164|NCT01920061|157784399|FG008|Overall Study|Other|0|||
48987165|NCT01920061|157784400|FG009|Overall Study|Other|1|||
48987166|NCT01920061|157784401|FG010|Overall Study|Other|1|||
48987167|NCT01920061|157784402|FG011|Overall Study|Other|2|||
48987168|NCT01920061|157784403|FG012|Overall Study|Other|1|||
48987169|NCT01920061|157784404|FG013|Overall Study|Other|4|||
48987170|NCT01920061|157784405|FG014|Overall Study|Other|0|||
48987171|NCT01920061|157784406|FG015|Overall Study|Other|1|||
48987172|NCT01920061|157784407|FG016|Overall Study|Other|1|||
48987173|NCT01920061|157784408|FG017|Overall Study|Other|0|||
48987174|NCT01920061|157784409|FG018|Overall Study|Other|1|||
48987175|NCT01920061|157784410|FG019|Overall Study|Other|1|||
48987176|NCT01920061|157784391|FG000|Overall Study|Participant refused further follow-up|0|||
48987177|NCT01920061|157784392|FG001|Overall Study|Participant refused further follow-up|0|||
48987178|NCT01920061|157784393|FG002|Overall Study|Participant refused further follow-up|0|||
48987179|NCT01920061|157784394|FG003|Overall Study|Participant refused further follow-up|0|||
48987180|NCT01920061|157784395|FG004|Overall Study|Participant refused further follow-up|1|||
48987181|NCT01920061|157784396|FG005|Overall Study|Participant refused further follow-up|1|||
48987182|NCT01920061|157784397|FG006|Overall Study|Participant refused further follow-up|0|||
48987183|NCT01920061|157784398|FG007|Overall Study|Participant refused further follow-up|0|||
48987184|NCT01920061|157784399|FG008|Overall Study|Participant refused further follow-up|1|||
48987185|NCT01920061|157784400|FG009|Overall Study|Participant refused further follow-up|0|||
48987186|NCT01920061|157784401|FG010|Overall Study|Participant refused further follow-up|1|||
48987187|NCT01920061|157784402|FG011|Overall Study|Participant refused further follow-up|0|||
48987188|NCT01920061|157784403|FG012|Overall Study|Participant refused further follow-up|1|||
48987189|NCT01920061|157784404|FG013|Overall Study|Participant refused further follow-up|0|||
48987190|NCT01920061|157784405|FG014|Overall Study|Participant refused further follow-up|1|||
48987191|NCT01920061|157784406|FG015|Overall Study|Participant refused further follow-up|2|||
48987192|NCT01920061|157784407|FG016|Overall Study|Participant refused further follow-up|1|||
48987193|NCT01920061|157784408|FG017|Overall Study|Participant refused further follow-up|1|||
48987194|NCT01920061|157784409|FG018|Overall Study|Participant refused further follow-up|0|||
48987195|NCT01920061|157784410|FG019|Overall Study|Participant refused further follow-up|0|||
48987196|NCT00364351|157786418|FG000|Overall Study|Adverse Event|90|||
48987197|NCT00364351|157786419|FG001|Overall Study|Adverse Event|44|||
48987198|NCT00364351|157786418|FG000|Overall Study|Condition under investigation worsened|469|||
48987199|NCT00364351|157786419|FG001|Overall Study|Condition under investigation worsened|497|||
48987200|NCT00364351|157786418|FG000|Overall Study|Prohibited concomitant medication|0|||
48987201|NCT00364351|157786419|FG001|Overall Study|Prohibited concomitant medication|2|||
48987202|NCT00364351|157786418|FG000|Overall Study|Lost to Follow-up|1|||
48987203|NCT00364351|157786419|FG001|Overall Study|Lost to Follow-up|1|||
48987204|NCT00364351|157786418|FG000|Overall Study|Withdrawal by Subject|30|||
48987205|NCT00364351|157786419|FG001|Overall Study|Withdrawal by Subject|29|||
48987206|NCT00364351|157786418|FG000|Overall Study|Incorrect enrollment|1|||
48987207|NCT00364351|157786419|FG001|Overall Study|Incorrect enrollment|1|||
48987208|NCT00364351|157786418|FG000|Overall Study|Sponsor decision|1|||
48987209|NCT00364351|157786419|FG001|Overall Study|Sponsor decision|0|||
48987210|NCT00364351|157786418|FG000|Overall Study|Poor treatment compliance|0|||
48987211|NCT00364351|157786419|FG001|Overall Study|Poor treatment compliance|3|||
48987212|NCT00364351|157786418|FG000|Overall Study|Investigator error|0|||
48987213|NCT00364351|157786419|FG001|Overall Study|Investigator error|2|||
48987214|NCT00364351|157786418|FG000|Overall Study|Patient could not travel to site|0|||
48987215|NCT00364351|157786419|FG001|Overall Study|Patient could not travel to site|1|||
48987216|NCT00364351|157786418|FG000|Overall Study|Randomised treatment not started|0|||
48987217|NCT00364351|157786419|FG001|Overall Study|Randomised treatment not started|3|||
48987218|NCT04657003|157786427|FG000|Overall Study|Adverse Event|5|||
48987219|NCT04657003|157786428|FG001|Overall Study|Adverse Event|1|||
48987220|NCT04657003|157786429|FG002|Overall Study|Adverse Event|5|||
48987221|NCT04657003|157786427|FG000|Overall Study|Death|0|||
48987222|NCT04657003|157786428|FG001|Overall Study|Death|2|||
48987223|NCT04657003|157786429|FG002|Overall Study|Death|0|||
48987224|NCT04657003|157786427|FG000|Overall Study|Lost to Follow-up|8|||
48987225|NCT04657003|157786428|FG001|Overall Study|Lost to Follow-up|4|||
48987226|NCT04657003|157786429|FG002|Overall Study|Lost to Follow-up|10|||
48987227|NCT04657003|157786427|FG000|Overall Study|Other - As Reported by Investigator|3|||
48987228|NCT04657003|157786428|FG001|Overall Study|Other - As Reported by Investigator|2|||
48987229|NCT04657003|157786429|FG002|Overall Study|Other - As Reported by Investigator|2|||
48987230|NCT04657003|157786427|FG000|Overall Study|Pregnancy|2|||
48987231|NCT04657003|157786428|FG001|Overall Study|Pregnancy|0|||
48987232|NCT04657003|157786429|FG002|Overall Study|Pregnancy|2|||
48987233|NCT04657003|157786427|FG000|Overall Study|Withdrawal by Subject|16|||
48987234|NCT04657003|157786428|FG001|Overall Study|Withdrawal by Subject|7|||
49043014|NCT01726803|157991123|FG000|Overall Study|Lost to Follow-up|6|||
48987235|NCT04657003|157786429|FG002|Overall Study|Withdrawal by Subject|10|||
48987236|NCT03824704|157786430|FG000|Overall Study|Study Terminated by Sponsor|1|||
48987237|NCT01736176|157786436|FG000|Overall Study|Adverse Event|3|||
48987238|NCT01736176|157786436|FG000|Overall Study|Withdrawal by Subject|4|||
48987239|NCT01736176|157786436|FG000|Overall Study|Lack of Efficacy|3|||
48987240|NCT01736176|157786436|FG000|Overall Study|Unable to Complete PEG Placement|1|||
48987241|NCT00626327|157786437|FG000|Overall Study|Withdrawal by Subject|21|||
48987242|NCT00626327|157786438|FG001|Overall Study|Withdrawal by Subject|29|||
48987243|NCT00626327|157786439|FG002|Overall Study|Withdrawal by Subject|30|||
48987244|NCT00626327|157786437|FG000|Overall Study|Adverse Event|1|||
49043015|NCT01726803|157991124|FG001|Overall Study|Lost to Follow-up|1|||
49043016|NCT01726803|157991123|FG000|Overall Study|Withdrawal by Subject|1|||
49043017|NCT01726803|157991124|FG001|Overall Study|Withdrawal by Subject|0|||
49043018|NCT00702507|157991125|FG000|Initial Treatment Phase|Adverse Event|2|||
49043019|NCT00702507|157991125|FG000|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3|||
49043020|NCT00702507|157991125|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
49043021|NCT00702507|157991125|FG000|Initial Treatment Phase|Negative Candida Culture|34|||
49043022|NCT00702507|157991125|FG000|Follow-up Phase|Participant's Caretaker Withdrew Consent|1|||
49043023|NCT00702507|157991125|FG000|Follow-up Phase|Protocol Violation|2|||
49043024|NCT00702507|157991125|FG000|Follow-up Phase|Lost to Follow-up|23|||
49043025|NCT00702507|157991125|FG000|Follow-up Phase|Late Enrollment|1|||
49043026|NCT03358147|157991126|FG000|Overall Study|Withdrawal by Subject|13|||
49043027|NCT03358147|157991127|FG001|Overall Study|Withdrawal by Subject|19|||
49043028|NCT03358147|157991128|FG002|Overall Study|Withdrawal by Subject|16|||
49043029|NCT03358147|157991129|FG003|Overall Study|Withdrawal by Subject|10|||
49043030|NCT03358147|157991130|FG004|Overall Study|Withdrawal by Subject|5|||
49043031|NCT03358147|157991126|FG000|Overall Study|Adverse Event|3|||
49043032|NCT03358147|157991127|FG001|Overall Study|Adverse Event|9|||
49043033|NCT03358147|157991128|FG002|Overall Study|Adverse Event|7|||
49043034|NCT03358147|157991129|FG003|Overall Study|Adverse Event|5|||
49043035|NCT03358147|157991130|FG004|Overall Study|Adverse Event|2|||
49043036|NCT03358147|157991126|FG000|Overall Study|Lost to Follow-up|4|||
49043037|NCT03358147|157991127|FG001|Overall Study|Lost to Follow-up|3|||
49043038|NCT03358147|157991128|FG002|Overall Study|Lost to Follow-up|7|||
49043039|NCT03358147|157991129|FG003|Overall Study|Lost to Follow-up|6|||
49043040|NCT03358147|157991130|FG004|Overall Study|Lost to Follow-up|4|||
49043041|NCT03358147|157991126|FG000|Overall Study|Major Protocol Deviation|11|||
49043042|NCT03358147|157991127|FG001|Overall Study|Major Protocol Deviation|3|||
49043043|NCT03358147|157991128|FG002|Overall Study|Major Protocol Deviation|2|||
49043044|NCT03358147|157991129|FG003|Overall Study|Major Protocol Deviation|3|||
49043045|NCT03358147|157991130|FG004|Overall Study|Major Protocol Deviation|1|||
49043046|NCT03358147|157991126|FG000|Overall Study|Protocol specified criteria|2|||
49043047|NCT03358147|157991127|FG001|Overall Study|Protocol specified criteria|3|||
49043048|NCT03358147|157991128|FG002|Overall Study|Protocol specified criteria|0|||
49043049|NCT03358147|157991129|FG003|Overall Study|Protocol specified criteria|3|||
49043050|NCT03358147|157991130|FG004|Overall Study|Protocol specified criteria|1|||
49043051|NCT03358147|157991126|FG000|Overall Study|Physician Decision|1|||
49043052|NCT03358147|157991127|FG001|Overall Study|Physician Decision|0|||
49043053|NCT03358147|157991128|FG002|Overall Study|Physician Decision|1|||
49043054|NCT03358147|157991129|FG003|Overall Study|Physician Decision|6|||
49043055|NCT03358147|157991130|FG004|Overall Study|Physician Decision|1|||
49043056|NCT03358147|157991126|FG000|Overall Study|Administrative reasons|0|||
49043057|NCT03358147|157991127|FG001|Overall Study|Administrative reasons|1|||
49043058|NCT03358147|157991128|FG002|Overall Study|Administrative reasons|0|||
49043059|NCT03358147|157991129|FG003|Overall Study|Administrative reasons|3|||
49043060|NCT03358147|157991130|FG004|Overall Study|Administrative reasons|0|||
49043061|NCT03358147|157991126|FG000|Overall Study|Lack of Efficacy|0|||
49043062|NCT03358147|157991127|FG001|Overall Study|Lack of Efficacy|1|||
49043063|NCT03358147|157991128|FG002|Overall Study|Lack of Efficacy|1|||
49043064|NCT03358147|157991129|FG003|Overall Study|Lack of Efficacy|0|||
49043065|NCT03358147|157991130|FG004|Overall Study|Lack of Efficacy|0|||
49043066|NCT02786953|157991133|FG000|Overall Study|Withdrawal by Subject|3|||
49043067|NCT02786953|157991134|FG001|Overall Study|Withdrawal by Subject|0|||
49043068|NCT02786953|157991133|FG000|Overall Study|Physician Decision|0|||
49043069|NCT02786953|157991134|FG001|Overall Study|Physician Decision|1|||
49043070|NCT00393705|157991135|FG000|Overall Study|Adverse Event|0|||
49043071|NCT00393705|157991136|FG001|Overall Study|Adverse Event|2|||
49043072|NCT00393705|157991135|FG000|Overall Study|Death|0|||
49043073|NCT00393705|157991136|FG001|Overall Study|Death|1|||
49043074|NCT00393705|157991135|FG000|Overall Study|Lost to Follow-up|2|||
49043075|NCT00393705|157991136|FG001|Overall Study|Lost to Follow-up|2|||
49043076|NCT00393705|157991135|FG000|Overall Study|Entry Criteria Not Met|10|||
49043077|NCT00393705|157991136|FG001|Overall Study|Entry Criteria Not Met|10|||
49043078|NCT00393705|157991135|FG000|Overall Study|Protocol Violation|4|||
49043079|NCT00393705|157991136|FG001|Overall Study|Protocol Violation|3|||
49043080|NCT00393705|157991135|FG000|Overall Study|Withdrawal by Subject|5|||
49043081|NCT00393705|157991136|FG001|Overall Study|Withdrawal by Subject|3|||
49043082|NCT00393705|157991135|FG000|Overall Study|Physician Decision|2|||
49043083|NCT00393705|157991136|FG001|Overall Study|Physician Decision|2|||
49043084|NCT02308696|157991137|FG000|Overall Study|Lost to Follow-up|28|||
49043085|NCT02308696|157991138|FG001|Overall Study|Lost to Follow-up|21|||
49043086|NCT02308696|157991137|FG000|Overall Study|Death|8|||
49043087|NCT02308696|157991138|FG001|Overall Study|Death|4|||
49043088|NCT02308696|157991137|FG000|Overall Study|Moved to a Higher Level of Care|17|||
49043089|NCT02308696|157991138|FG001|Overall Study|Moved to a Higher Level of Care|6|||
49043090|NCT04974580|157991140|FG000|Overall Study|Lost to Follow-up|33|||
49043091|NCT04974580|157991141|FG001|Overall Study|Lost to Follow-up|39|||
49043092|NCT04974580|157991142|FG002|Overall Study|Lost to Follow-up|30|||
49043093|NCT04974580|157991143|FG003|Overall Study|Lost to Follow-up|29|||
49043094|NCT01962298|157991144|FG000|Overall Study|Protocol Violation|1|||
49043095|NCT01962298|157991145|FG001|Overall Study|Protocol Violation|0|||
49043096|NCT01962298|157991146|FG002|Overall Study|Protocol Violation|1|||
49043097|NCT01962298|157991147|FG003|Overall Study|Protocol Violation|1|||
49043098|NCT01962298|157991148|FG004|Overall Study|Protocol Violation|0|||
49043099|NCT01962298|157991144|FG000|Overall Study|Data quality insufficient|2|||
49043100|NCT01962298|157991145|FG001|Overall Study|Data quality insufficient|0|||
49043101|NCT01962298|157991146|FG002|Overall Study|Data quality insufficient|3|||
49043102|NCT01962298|157991147|FG003|Overall Study|Data quality insufficient|1|||
49043103|NCT01962298|157991148|FG004|Overall Study|Data quality insufficient|4|||
49043104|NCT01962298|157991144|FG000|Overall Study|Insufficient data|0|||
49043105|NCT01962298|157991145|FG001|Overall Study|Insufficient data|2|||
49043106|NCT01962298|157991146|FG002|Overall Study|Insufficient data|1|||
49043107|NCT01962298|157991147|FG003|Overall Study|Insufficient data|0|||
49043108|NCT01962298|157991148|FG004|Overall Study|Insufficient data|1|||
49043109|NCT01962298|157991144|FG000|Overall Study|Incorrect data recorded|0|||
49043110|NCT01962298|157991145|FG001|Overall Study|Incorrect data recorded|1|||
49043111|NCT01962298|157991146|FG002|Overall Study|Incorrect data recorded|0|||
49043112|NCT01962298|157991147|FG003|Overall Study|Incorrect data recorded|0|||
49043113|NCT01962298|157991148|FG004|Overall Study|Incorrect data recorded|0|||
49043114|NCT01962298|157991144|FG000|Overall Study|Physician Decision|0|||
49043115|NCT01962298|157991145|FG001|Overall Study|Physician Decision|1|||
49043116|NCT01962298|157991146|FG002|Overall Study|Physician Decision|0|||
49043117|NCT01962298|157991147|FG003|Overall Study|Physician Decision|0|||
49043118|NCT01962298|157991148|FG004|Overall Study|Physician Decision|1|||
49043119|NCT01971645|157991149|FG000|Overall Study|Adverse Event|1|||
49043120|NCT01971645|157991150|FG001|Overall Study|Adverse Event|0|||
49043121|NCT01971645|157991151|FG002|Overall Study|Adverse Event|0|||
49043122|NCT01971645|157991149|FG000|Overall Study|Lost to Follow-up|1|||
49043123|NCT01971645|157991150|FG001|Overall Study|Lost to Follow-up|0|||
49043124|NCT01971645|157991151|FG002|Overall Study|Lost to Follow-up|1|||
49043125|NCT01971645|157991149|FG000|Overall Study|Protocol Violation|0|||
49043126|NCT01971645|157991150|FG001|Overall Study|Protocol Violation|0|||
49043127|NCT01971645|157991151|FG002|Overall Study|Protocol Violation|1|||
49043128|NCT01073631|157991160|FG000|Overall Study|Death|82|||
49043129|NCT01073631|157991160|FG000|Overall Study|Adverse Event|24|||
49043130|NCT01073631|157991160|FG000|Overall Study|Other|63|||
49043131|NCT04203667|157991161|FG000|Overall Study|Withdrawal by Subject|1|||
49043132|NCT04203667|157991161|FG000|Overall Study|Lost to Follow-up|1|||
49043133|NCT04203667|157991161|FG000|Overall Study|Death|1|||
49043134|NCT04203667|157991161|FG000|Overall Study|PI left center and never scheduled 90 day follow-up visit.|1|||
49043135|NCT02167594|157991163|FG000|Overall Study|Withdrawal by Subject|2|||
49043136|NCT02167594|157991164|FG001|Overall Study|Withdrawal by Subject|0|||
49043137|NCT02167594|157991165|FG002|Overall Study|Withdrawal by Subject|0|||
49043138|NCT02167594|157991163|FG000|Overall Study|Death|0|||
49043139|NCT02167594|157991164|FG001|Overall Study|Death|1|||
49043140|NCT02167594|157991165|FG002|Overall Study|Death|0|||
49043141|NCT00613730|157991166|FG000|Overall Study|Disease progression|2|||
49043142|NCT00613730|157991166|FG000|Overall Study|Administrative decision|1|||
49043143|NCT01835548|157991172|FG000|Dose Optimization Period|Adverse Event|0|||
49043144|NCT01835548|157991173|FG001|Dose Optimization Period|Adverse Event|0|||
49043145|NCT01835548|157991174|FG002|Dose Optimization Period|Adverse Event|1|||
49043146|NCT01835548|157991172|FG000|Dose Optimization Period|Withdrawal by Subject|0|||
49043147|NCT01835548|157991173|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
49043148|NCT01835548|157991174|FG002|Dose Optimization Period|Withdrawal by Subject|1|||
49043149|NCT01835548|157991172|FG000|Double-Blind Treatment Period|Adverse Event|0|||
49043150|NCT01835548|157991173|FG001|Double-Blind Treatment Period|Adverse Event|1|||
49043151|NCT01835548|157991174|FG002|Double-Blind Treatment Period|Adverse Event|0|||
49043152|NCT01835548|157991172|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
49043153|NCT01835548|157991173|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
49043154|NCT01835548|157991174|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
49043155|NCT01151280|157992830|FG000|Overall Study|Adverse Event|1|||
49043156|NCT01151280|157992830|FG000|Overall Study|Lack of Efficacy|3|||
49043157|NCT02435433|157992831|FG000|Overall Study|Withdrawal by Subject|2|||
49043158|NCT02435433|157992832|FG001|Overall Study|Withdrawal by Subject|3|||
49043159|NCT02435433|157992833|FG002|Overall Study|Withdrawal by Subject|1|||
49043160|NCT02435433|157992834|FG003|Overall Study|Withdrawal by Subject|0|||
49043161|NCT02435433|157992835|FG004|Overall Study|Withdrawal by Subject|0|||
49043162|NCT02435433|157992831|FG000|Overall Study|Lost to Follow-up|2|||
49043163|NCT02435433|157992832|FG001|Overall Study|Lost to Follow-up|2|||
49043164|NCT02435433|157992833|FG002|Overall Study|Lost to Follow-up|4|||
49043165|NCT02435433|157992834|FG003|Overall Study|Lost to Follow-up|1|||
49043166|NCT02435433|157992835|FG004|Overall Study|Lost to Follow-up|0|||
49043167|NCT00960154|157992836|FG000|Overall Study|Study termination|25|||
49043168|NCT00960154|157992837|FG001|Overall Study|Study termination|25|||
49043169|NCT00757705|157992838|FG000|Overall Study|Adverse Event|19|||
49043170|NCT00757705|157992838|FG000|Overall Study|Lost to Follow-up|16|||
49043171|NCT00757705|157992838|FG000|Overall Study|Withdrawal by Subject|25|||
49043172|NCT00757705|157992838|FG000|Overall Study|Insufficient Response|26|||
49043173|NCT00757705|157992838|FG000|Overall Study|Ineligible to continue|8|||
49043174|NCT00757705|157992838|FG000|Overall Study|Non-compliant|9|||
49043175|NCT00757705|157992838|FG000|Overall Study|Other|18|||
49043176|NCT02817828|157992839|FG000|Overall Study|Lost to Follow-up|41|||
49043177|NCT02817828|157992839|FG000|Overall Study|Adverse event not related to bleeding|104|||
49043178|NCT02817828|157992839|FG000|Overall Study|Adverse event related to bleeding|53|||
49043179|NCT02817828|157992839|FG000|Overall Study|Protocol Violation|11|||
49043180|NCT02817828|157992839|FG000|Overall Study|Pregnancy|7|||
49043181|NCT02817828|157992839|FG000|Overall Study|Pregnancy wish|15|||
49043182|NCT02817828|157992839|FG000|Overall Study|Withdrawal by Subject|78|||
49043183|NCT02817828|157992839|FG000|Overall Study|Other|26|||
49043184|NCT00659815|157992842|FG000|Overall Study|Study related symptoms and complaints|2|||
49043185|NCT00659815|157992843|FG001|Overall Study|Study related symptoms and complaints|1|||
49043186|NCT00659815|157992842|FG000|Overall Study|Inability to maintain wearing schedule|1|||
49043187|NCT00659815|157992843|FG001|Overall Study|Inability to maintain wearing schedule|2|||
49043188|NCT00659815|157992842|FG000|Overall Study|Withdrawal by Subject|1|||
49043189|NCT00659815|157992843|FG001|Overall Study|Withdrawal by Subject|1|||
49043190|NCT00377156|157992846|FG000|Overall Study|Death|23|||
49043191|NCT00377156|157992847|FG001|Overall Study|Death|19|||
48987245|NCT00626327|157786438|FG001|Overall Study|Adverse Event|0|||
48987246|NCT00626327|157786439|FG002|Overall Study|Adverse Event|0|||
48987247|NCT00626327|157786437|FG000|Overall Study|Lost to Follow-up|24|||
48987248|NCT00626327|157786438|FG001|Overall Study|Lost to Follow-up|21|||
48987249|NCT00626327|157786439|FG002|Overall Study|Lost to Follow-up|23|||
48987250|NCT00626327|157786437|FG000|Overall Study|Inappropriate enrollment|4|||
48987251|NCT00626327|157786438|FG001|Overall Study|Inappropriate enrollment|5|||
48987252|NCT00626327|157786439|FG002|Overall Study|Inappropriate enrollment|3|||
48987253|NCT00626327|157786437|FG000|Overall Study|Administrative Reason|2|||
48987254|NCT00626327|157786438|FG001|Overall Study|Administrative Reason|0|||
48987255|NCT00626327|157786439|FG002|Overall Study|Administrative Reason|6|||
48987256|NCT00626327|157786437|FG000|Overall Study|Protocol Violation|26|||
48987257|NCT00626327|157786438|FG001|Overall Study|Protocol Violation|4|||
48987258|NCT00626327|157786439|FG002|Overall Study|Protocol Violation|26|||
48987259|NCT00535236|157786441|FG000|Overall Study|Adverse Event|1|||
48987260|NCT00535236|157786442|FG001|Overall Study|Adverse Event|0|||
48987261|NCT00535236|157786443|FG002|Overall Study|Adverse Event|9|||
49043192|NCT00377156|157992846|FG000|Overall Study|Withdrawal by Subject|16|||
49043193|NCT00377156|157992847|FG001|Overall Study|Withdrawal by Subject|24|||
49043194|NCT00377156|157992846|FG000|Overall Study|Had follow-up <90 d|3|||
49043195|NCT00377156|157992847|FG001|Overall Study|Had follow-up <90 d|6|||
49043196|NCT00377156|157992846|FG000|Overall Study|Cancellation|1|||
49043197|NCT00377156|157992847|FG001|Overall Study|Cancellation|0|||
49043198|NCT00377156|157992846|FG000|Overall Study|Refused testing|0|||
49043199|NCT00377156|157992847|FG001|Overall Study|Refused testing|1|||
49043200|NCT00377156|157992846|FG000|Overall Study|Ineligible|0|||
49043201|NCT00377156|157992847|FG001|Overall Study|Ineligible|1|||
49043202|NCT00377156|157992846|FG000|Overall Study|Disability or language problem|0|||
49043203|NCT00377156|157992847|FG001|Overall Study|Disability or language problem|1|||
49043204|NCT00377156|157992846|FG000|Overall Study|Other|5|||
49043205|NCT00377156|157992847|FG001|Overall Study|Other|2|||
49043206|NCT00486434|157992848|FG000|Overall Study|Withdrawal by Subject|34|||
49043207|NCT00486434|157992849|FG001|Overall Study|Withdrawal by Subject|39|||
49043208|NCT00486434|157992848|FG000|Overall Study|Adverse Event|118|||
49043209|NCT00486434|157992849|FG001|Overall Study|Adverse Event|44|||
48987262|NCT00535236|157786444|FG003|Overall Study|Adverse Event|3|||
48987263|NCT00535236|157786445|FG004|Overall Study|Adverse Event|3|||
48987264|NCT00535236|157786446|FG005|Overall Study|Adverse Event|0|||
48987265|NCT00535236|157786447|FG006|Overall Study|Adverse Event|5|||
48987266|NCT00535236|157786448|FG007|Overall Study|Adverse Event|1|||
49043210|NCT00486434|157992848|FG000|Overall Study|Protocol Violation|22|||
49043211|NCT00486434|157992849|FG001|Overall Study|Protocol Violation|21|||
49043212|NCT00486434|157992848|FG000|Overall Study|Lack of Efficacy|12|||
49043213|NCT00486434|157992849|FG001|Overall Study|Lack of Efficacy|19|||
49043214|NCT00486434|157992848|FG000|Overall Study|Lost to Follow-up|2|||
49043215|NCT00486434|157992849|FG001|Overall Study|Lost to Follow-up|3|||
49043216|NCT00486434|157992848|FG000|Overall Study|Death|1|||
48987267|NCT00535236|157786449|FG008|Overall Study|Adverse Event|2|||
48987268|NCT00535236|157786450|FG009|Overall Study|Adverse Event|1|||
48987269|NCT00535236|157786441|FG000|Overall Study|Lost to Follow-up|1|||
48987270|NCT00535236|157786442|FG001|Overall Study|Lost to Follow-up|2|||
48987271|NCT00535236|157786443|FG002|Overall Study|Lost to Follow-up|0|||
48987272|NCT00535236|157786444|FG003|Overall Study|Lost to Follow-up|0|||
48987273|NCT00535236|157786445|FG004|Overall Study|Lost to Follow-up|2|||
48987274|NCT00535236|157786446|FG005|Overall Study|Lost to Follow-up|0|||
49043217|NCT00486434|157992849|FG001|Overall Study|Death|2|||
49043218|NCT00486434|157992848|FG000|Overall Study|Personal reasons|5|||
49043219|NCT00486434|157992849|FG001|Overall Study|Personal reasons|6|||
48987275|NCT00535236|157786447|FG006|Overall Study|Lost to Follow-up|0|||
48987276|NCT00535236|157786448|FG007|Overall Study|Lost to Follow-up|0|||
48987277|NCT00535236|157786449|FG008|Overall Study|Lost to Follow-up|6|||
48987278|NCT00535236|157786450|FG009|Overall Study|Lost to Follow-up|1|||
48987279|NCT00535236|157786441|FG000|Overall Study|Physician Decision|0|||
49043220|NCT00522041|157992850|FG000|Overall Study|Adverse Event|9|||
49043221|NCT00522041|157992851|FG001|Overall Study|Adverse Event|3|||
49043222|NCT00522041|157992850|FG000|Overall Study|Protocol Violation|2|||
48987280|NCT00535236|157786442|FG001|Overall Study|Physician Decision|0|||
48987281|NCT00535236|157786443|FG002|Overall Study|Physician Decision|0|||
48987282|NCT00535236|157786444|FG003|Overall Study|Physician Decision|0|||
48987283|NCT00535236|157786445|FG004|Overall Study|Physician Decision|1|||
48987284|NCT00535236|157786446|FG005|Overall Study|Physician Decision|0|||
48987285|NCT00535236|157786447|FG006|Overall Study|Physician Decision|1|||
48987286|NCT00535236|157786448|FG007|Overall Study|Physician Decision|0|||
48692555|NCT02322281|156724525|FG002|Overall Study|Missing|1|||
48692556|NCT02322281|156724523|FG000|Overall Study|Miscellaneous|0|||
48692557|NCT02322281|156724524|FG001|Overall Study|Miscellaneous|0|||
48987287|NCT00535236|157786449|FG008|Overall Study|Physician Decision|0|||
48987288|NCT00535236|157786450|FG009|Overall Study|Physician Decision|0|||
48987289|NCT00535236|157786441|FG000|Overall Study|Protocol Violation|2|||
48987290|NCT00535236|157786442|FG001|Overall Study|Protocol Violation|0|||
48987291|NCT00535236|157786443|FG002|Overall Study|Protocol Violation|1|||
48987292|NCT00535236|157786444|FG003|Overall Study|Protocol Violation|0|||
48987293|NCT00535236|157786445|FG004|Overall Study|Protocol Violation|0|||
48987294|NCT00535236|157786446|FG005|Overall Study|Protocol Violation|0|||
48987295|NCT00535236|157786447|FG006|Overall Study|Protocol Violation|0|||
48987296|NCT00535236|157786448|FG007|Overall Study|Protocol Violation|0|||
48987297|NCT00535236|157786449|FG008|Overall Study|Protocol Violation|1|||
48987298|NCT00535236|157786450|FG009|Overall Study|Protocol Violation|0|||
48987299|NCT00535236|157786441|FG000|Overall Study|Withdrawal by Subject|3|||
48987300|NCT00535236|157786442|FG001|Overall Study|Withdrawal by Subject|0|||
48987301|NCT00535236|157786443|FG002|Overall Study|Withdrawal by Subject|2|||
48987302|NCT00535236|157786444|FG003|Overall Study|Withdrawal by Subject|1|||
48987303|NCT00535236|157786445|FG004|Overall Study|Withdrawal by Subject|6|||
48987304|NCT00535236|157786446|FG005|Overall Study|Withdrawal by Subject|1|||
48987305|NCT00535236|157786447|FG006|Overall Study|Withdrawal by Subject|5|||
48987306|NCT00535236|157786448|FG007|Overall Study|Withdrawal by Subject|0|||
48987307|NCT00535236|157786449|FG008|Overall Study|Withdrawal by Subject|4|||
48987308|NCT00535236|157786450|FG009|Overall Study|Withdrawal by Subject|2|||
48987309|NCT01654224|157786454|FG000|Overall Study|Lost to Follow-up|2|||
48987310|NCT01654224|157786455|FG001|Overall Study|Lost to Follow-up|2|||
48987311|NCT01654224|157786454|FG000|Overall Study|Did not receive allocation|1|||
48987312|NCT01654224|157786455|FG001|Overall Study|Did not receive allocation|8|||
48987313|NCT01654224|157786454|FG000|Overall Study|Insufficient blood sample|3|||
48987314|NCT01654224|157786455|FG001|Overall Study|Insufficient blood sample|2|||
48987315|NCT00104299|157786456|FG000|Overall Study|Adverse Event|3|||
48987316|NCT00104299|157786457|FG001|Overall Study|Adverse Event|1|||
48987317|NCT00104299|157786456|FG000|Overall Study|Death|2|||
48987318|NCT00104299|157786457|FG001|Overall Study|Death|2|||
48987319|NCT00104299|157786456|FG000|Overall Study|Withdrawal by Subject|2|||
48987320|NCT00104299|157786457|FG001|Overall Study|Withdrawal by Subject|6|||
48987321|NCT00104299|157786456|FG000|Overall Study|Physician Decision|1|||
48987322|NCT00104299|157786457|FG001|Overall Study|Physician Decision|1|||
48987323|NCT00104299|157786456|FG000|Overall Study|To have renal transplant|1|||
48987324|NCT00104299|157786457|FG001|Overall Study|To have renal transplant|0|||
48987325|NCT02906644|157786458|FG000|First 2 Weeks|Withdrawal by Subject|0|||
48987326|NCT02906644|157786459|FG001|First 2 Weeks|Withdrawal by Subject|2|||
48987327|NCT02906644|157786458|FG000|First 2 Weeks|Physician Decision|1|||
48987328|NCT02906644|157786459|FG001|First 2 Weeks|Physician Decision|1|||
48987329|NCT02906644|157786458|FG000|Weeks 3 to 14|Withdrawal by Subject|13|||
48987330|NCT02906644|157786459|FG001|Weeks 3 to 14|Withdrawal by Subject|7|||
49043223|NCT00522041|157992851|FG001|Overall Study|Protocol Violation|0|||
48987331|NCT02906644|157786458|FG000|Weeks 3 to 14|Lost to Follow-up|3|||
48987332|NCT02906644|157786459|FG001|Weeks 3 to 14|Lost to Follow-up|4|||
48987333|NCT01716585|157786462|FG000|Double-blind Treatment|Did Not Receive Study Drug|4|||
48987334|NCT01716585|157786463|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
48987335|NCT01716585|157786462|FG000|Double-blind Treatment|Adverse Event|2|||
48987336|NCT01716585|157786463|FG001|Double-blind Treatment|Adverse Event|1|||
48987337|NCT01716585|157786462|FG000|Double-blind Treatment|Withdrawal by Subject|3|||
48987338|NCT01716585|157786463|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
48987339|NCT01716585|157786462|FG000|Double-blind Treatment|Lost to Follow-up|2|||
48987340|NCT01716585|157786463|FG001|Double-blind Treatment|Lost to Follow-up|0|||
48987341|NCT01716585|157786462|FG000|Double-blind Treatment|Subject Noncompliant|1|||
48987342|NCT01716585|157786463|FG001|Double-blind Treatment|Subject Noncompliant|0|||
48987343|NCT01716585|157786462|FG000|Double-blind Treatment|Other|1|||
48987344|NCT01716585|157786463|FG001|Double-blind Treatment|Other|0|||
48987345|NCT01716585|157786462|FG000|Open-label Treatment|Adverse Event|0|||
48987346|NCT01716585|157786463|FG001|Open-label Treatment|Adverse Event|2|||
48987347|NCT01716585|157786462|FG000|Open-label Treatment|Virologic Failure|0|||
48987348|NCT01716585|157786463|FG001|Open-label Treatment|Virologic Failure|2|||
48987349|NCT01716585|157786462|FG000|Open-label Treatment|Withdrawal by Subject|0|||
48987350|NCT01716585|157786463|FG001|Open-label Treatment|Withdrawal by Subject|3|||
48987351|NCT03558503|157786464|FG000|Overall Study|Adverse Event|1|||
48987352|NCT03558503|157786464|FG000|Overall Study|Death|1|||
48987353|NCT03558503|157786464|FG000|Overall Study|Refused to come in for the final 12-month assessment due to COVID-19|1|||
48987354|NCT02200510|157786465|FG000|Overall Study|Death|1|||
48987355|NCT02200510|157786466|FG001|Overall Study|Death|1|||
48987356|NCT02200510|157786465|FG000|Overall Study|Protocol Violation|0|||
48987357|NCT02200510|157786466|FG001|Overall Study|Protocol Violation|1|||
48987358|NCT02200510|157786465|FG000|Overall Study|Lost to Follow-up|7|||
48987359|NCT02200510|157786466|FG001|Overall Study|Lost to Follow-up|1|||
48987360|NCT02200510|157786465|FG000|Overall Study|potential COI - joined study team|1|||
48987361|NCT02200510|157786466|FG001|Overall Study|potential COI - joined study team|0|||
48987362|NCT03288987|157786467|FG000|Overall Study|Protocol Violation|10|||
48987363|NCT03288987|157786468|FG001|Overall Study|Protocol Violation|4|||
48987364|NCT00033514|157786470|FG000|Overall Study|Lost to Follow-up|1|||
48987365|NCT00033514|157786471|FG001|Overall Study|Lost to Follow-up|1|||
48987366|NCT00033514|157786470|FG000|Overall Study|Withdrawal by Subject|0|||
48987367|NCT00033514|157786471|FG001|Overall Study|Withdrawal by Subject|3|||
48987368|NCT00723489|157786475|FG000|Overall Study|Physician Decision|0|||
48987369|NCT00723489|157786476|FG001|Overall Study|Physician Decision|1|||
48987370|NCT00723489|157786477|FG002|Overall Study|Physician Decision|0|||
48987371|NCT00723489|157786478|FG003|Overall Study|Physician Decision|0|||
48987372|NCT00723489|157786475|FG000|Overall Study|Pregnancy|0|||
48692558|NCT02322281|156724525|FG002|Overall Study|Miscellaneous|4|||
48987373|NCT00723489|157786476|FG001|Overall Study|Pregnancy|0|||
48987374|NCT00723489|157786477|FG002|Overall Study|Pregnancy|0|||
48987375|NCT00723489|157786478|FG003|Overall Study|Pregnancy|1|||
48987376|NCT00723489|157786475|FG000|Overall Study|Withdrawal by Subject|0|||
48987377|NCT00723489|157786476|FG001|Overall Study|Withdrawal by Subject|0|||
48987378|NCT00723489|157786477|FG002|Overall Study|Withdrawal by Subject|0|||
48987379|NCT00723489|157786478|FG003|Overall Study|Withdrawal by Subject|1|||
48987380|NCT00723489|157786475|FG000|Overall Study|Seropositive at baseline|1|||
48987381|NCT00723489|157786476|FG001|Overall Study|Seropositive at baseline|0|||
48987382|NCT00723489|157786477|FG002|Overall Study|Seropositive at baseline|0|||
48987383|NCT00723489|157786478|FG003|Overall Study|Seropositive at baseline|0|||
48987384|NCT00723489|157786475|FG000|Overall Study|Prohibited Medication|0|||
48987385|NCT00723489|157786476|FG001|Overall Study|Prohibited Medication|0|||
48987386|NCT00723489|157786477|FG002|Overall Study|Prohibited Medication|0|||
48987387|NCT00723489|157786478|FG003|Overall Study|Prohibited Medication|1|||
48987388|NCT00723489|157786475|FG000|Overall Study|Samples Collected Out of Window|0|||
48987389|NCT00723489|157786476|FG001|Overall Study|Samples Collected Out of Window|3|||
48987390|NCT00723489|157786477|FG002|Overall Study|Samples Collected Out of Window|0|||
48987391|NCT00723489|157786478|FG003|Overall Study|Samples Collected Out of Window|0|||
48987392|NCT00948389|157786480|FG000|Overall Study|Disease Progression/Relapse/Death|3|||
48987393|NCT00948389|157786481|FG001|Overall Study|Disease Progression/Relapse/Death|3|||
48987394|NCT00948389|157786482|FG002|Overall Study|Disease Progression/Relapse/Death|7|||
48987395|NCT00948389|157786483|FG003|Overall Study|Disease Progression/Relapse/Death|8|||
48987396|NCT00948389|157786484|FG004|Overall Study|Disease Progression/Relapse/Death|1|||
48987397|NCT00948389|157786480|FG000|Overall Study|Thrombocytopenia, Grade 4|2|||
48987398|NCT00948389|157786481|FG001|Overall Study|Thrombocytopenia, Grade 4|0|||
48987399|NCT00948389|157786482|FG002|Overall Study|Thrombocytopenia, Grade 4|0|||
48987400|NCT00948389|157786483|FG003|Overall Study|Thrombocytopenia, Grade 4|1|||
48987401|NCT00948389|157786484|FG004|Overall Study|Thrombocytopenia, Grade 4|0|||
48987402|NCT00948389|157786480|FG000|Overall Study|Both Progression and Toxicity|1|||
48987403|NCT00948389|157786481|FG001|Overall Study|Both Progression and Toxicity|0|||
48987404|NCT00948389|157786482|FG002|Overall Study|Both Progression and Toxicity|0|||
48987405|NCT00948389|157786483|FG003|Overall Study|Both Progression and Toxicity|0|||
48987406|NCT00948389|157786484|FG004|Overall Study|Both Progression and Toxicity|0|||
48987407|NCT00917553|157786486|FG000|Overall Study|Lost to Follow-up|2|||
48987408|NCT00917553|157786487|FG001|Overall Study|Lost to Follow-up|1|||
48987409|NCT02519777|157786495|FG000|Overall Study|Death|1|||
48987410|NCT02519777|157786496|FG001|Overall Study|Death|0|||
48987411|NCT02519777|157786497|FG002|Overall Study|Death|0|||
48987412|NCT02519777|157786495|FG000|Overall Study|Lost to Follow-up|0|||
48987413|NCT02519777|157786496|FG001|Overall Study|Lost to Follow-up|4|||
48987414|NCT02519777|157786497|FG002|Overall Study|Lost to Follow-up|2|||
48987415|NCT02519777|157786495|FG000|Overall Study|Withdrawal by Subject|3|||
48987416|NCT02519777|157786496|FG001|Overall Study|Withdrawal by Subject|1|||
48987417|NCT02519777|157786497|FG002|Overall Study|Withdrawal by Subject|0|||
48987418|NCT02519777|157786495|FG000|Overall Study|Severe Debilitation|1|||
48987419|NCT02519777|157786496|FG001|Overall Study|Severe Debilitation|1|||
48987420|NCT02519777|157786497|FG002|Overall Study|Severe Debilitation|1|||
48987421|NCT02519777|157786495|FG000|Overall Study|Not able to get to clinic|1|||
48987422|NCT02519777|157786496|FG001|Overall Study|Not able to get to clinic|2|||
48987423|NCT02519777|157786497|FG002|Overall Study|Not able to get to clinic|1|||
48987424|NCT02041533|157786500|FG000|Pre-Treatment Period|Disease Progression|1|||
48987425|NCT02041533|157786501|FG001|Pre-Treatment Period|Disease Progression|1|||
48987426|NCT02041533|157786500|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
48987427|NCT02041533|157786501|FG001|Pre-Treatment Period|Participant Withdrew Consent|5|||
48987428|NCT02041533|157786500|FG000|Pre-Treatment Period|Participant no Longer Meets Study Criteria|3|||
48987429|NCT02041533|157786501|FG001|Pre-Treatment Period|Participant no Longer Meets Study Criteria|1|||
48987430|NCT02041533|157786500|FG000|Treatment Period|Disease progression|189|||
48987431|NCT02041533|157786501|FG001|Treatment Period|Disease progression|146|||
48987432|NCT02041533|157786500|FG000|Treatment Period|Study drug toxicity|30|||
48987433|NCT02041533|157786501|FG001|Treatment Period|Study drug toxicity|34|||
48987434|NCT02041533|157786500|FG000|Treatment Period|Death|1|||
48987435|NCT02041533|157786501|FG001|Treatment Period|Death|0|||
48987436|NCT02041533|157786500|FG000|Treatment Period|Adverse event unrelated to study drug|22|||
48987437|NCT02041533|157786501|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
48987438|NCT02041533|157786500|FG000|Treatment Period|Participant request to discontinue study treatment|12|||
48987439|NCT02041533|157786501|FG001|Treatment Period|Participant request to discontinue study treatment|9|||
48987440|NCT02041533|157786500|FG000|Treatment Period|Participant withdrew consent|2|||
48987441|NCT02041533|157786501|FG001|Treatment Period|Participant withdrew consent|2|||
48987442|NCT02041533|157786500|FG000|Treatment Period|Maximum clinical benefit|0|||
48987443|NCT02041533|157786501|FG001|Treatment Period|Maximum clinical benefit|18|||
48987444|NCT02041533|157786500|FG000|Treatment Period|Poor/Non-compliance|1|||
48987445|NCT02041533|157786501|FG001|Treatment Period|Poor/Non-compliance|0|||
48987446|NCT02041533|157786500|FG000|Treatment Period|Administrative reason by sponsor|1|||
48987447|NCT02041533|157786501|FG001|Treatment Period|Administrative reason by sponsor|0|||
48987448|NCT02041533|157786500|FG000|Treatment Period|Other reasons|9|||
48987449|NCT02041533|157786501|FG001|Treatment Period|Other reasons|2|||
48987450|NCT02041533|157786500|FG000|Treatment Period|Not Reported|0|||
48987451|NCT02041533|157786501|FG001|Treatment Period|Not Reported|1|||
48987452|NCT01562327|157786504|FG000|Overall Study|Adverse Event|2|||
48987453|NCT01562327|157786504|FG000|Overall Study|Lack of Efficacy|1|||
48987454|NCT01562327|157786504|FG000|Overall Study|Participant drop-out|1|||
48987455|NCT01562327|157786504|FG000|Overall Study|Infusion not received at 6 month window|4|||
48987456|NCT02117024|157786505|FG000|Overall Study|Progressive Disease|26|||
48987457|NCT02117024|157786506|FG001|Overall Study|Progressive Disease|9|||
48987458|NCT02117024|157786505|FG000|Overall Study|Significant Clinical Progression|7|||
48987459|NCT02117024|157786506|FG001|Overall Study|Significant Clinical Progression|4|||
48987460|NCT02117024|157786505|FG000|Overall Study|Death|5|||
48987461|NCT02117024|157786506|FG001|Overall Study|Death|0|||
48987462|NCT02117024|157786505|FG000|Overall Study|Withdrawal by Subject|3|||
48987463|NCT02117024|157786506|FG001|Overall Study|Withdrawal by Subject|1|||
48987464|NCT02117024|157786505|FG000|Overall Study|Protocol Violation|1|||
48987465|NCT02117024|157786506|FG001|Overall Study|Protocol Violation|0|||
48987466|NCT02117024|157786505|FG000|Overall Study|Adverse Event|1|||
48987467|NCT02117024|157786506|FG001|Overall Study|Adverse Event|2|||
48987468|NCT02117024|157786505|FG000|Overall Study|Randomized in Error|1|||
48987469|NCT02117024|157786506|FG001|Overall Study|Randomized in Error|0|||
48987470|NCT02117024|157786505|FG000|Overall Study|Patient returned to primary oncologist|0|||
48987471|NCT02117024|157786506|FG001|Overall Study|Patient returned to primary oncologist|1|||
48987472|NCT02117024|157786505|FG000|Overall Study|Patient took treatment break|0|||
48987473|NCT02117024|157786506|FG001|Overall Study|Patient took treatment break|1|||
48987474|NCT02117024|157786505|FG000|Overall Study|Physician Decision|0|||
48987475|NCT02117024|157786506|FG001|Overall Study|Physician Decision|2|||
48987476|NCT02813681|157786518|FG000|Overall Study|Physician Decision|5|||
48987477|NCT02813681|157786519|FG001|Overall Study|Physician Decision|5|||
48987478|NCT02813681|157786520|FG002|Overall Study|Physician Decision|0|||
48987479|NCT02813681|157786518|FG000|Overall Study|Lost to Follow-up|0|||
48987480|NCT02813681|157786519|FG001|Overall Study|Lost to Follow-up|1|||
48987481|NCT02813681|157786520|FG002|Overall Study|Lost to Follow-up|0|||
48987482|NCT02500706|157786521|FG000|Overall Study|Adverse Event|0|||
48987483|NCT02500706|157786522|FG001|Overall Study|Adverse Event|0|||
48987484|NCT02500706|157786523|FG002|Overall Study|Adverse Event|1|||
48987485|NCT02500706|157786521|FG000|Overall Study|Lost to Follow-up|0|||
48987486|NCT02500706|157786522|FG001|Overall Study|Lost to Follow-up|1|||
48987487|NCT02500706|157786523|FG002|Overall Study|Lost to Follow-up|1|||
48987488|NCT02500706|157786521|FG000|Overall Study|Withdrawal by Subject|4|||
48987489|NCT02500706|157786522|FG001|Overall Study|Withdrawal by Subject|6|||
48987490|NCT02500706|157786523|FG002|Overall Study|Withdrawal by Subject|4|||
48987491|NCT02500706|157786521|FG000|Overall Study|Unclassified|0|||
48987492|NCT02500706|157786522|FG001|Overall Study|Unclassified|0|||
49043224|NCT00522041|157992850|FG000|Overall Study|Lost to Follow-up|1|||
49043225|NCT00522041|157992851|FG001|Overall Study|Lost to Follow-up|4|||
49043226|NCT00522041|157992850|FG000|Overall Study|Voluntary withdrawal|5|||
49043227|NCT00522041|157992851|FG001|Overall Study|Voluntary withdrawal|4|||
49043228|NCT00522041|157992850|FG000|Overall Study|Did not receive treatment|0|||
49043229|NCT00522041|157992851|FG001|Overall Study|Did not receive treatment|1|||
49043230|NCT02218541|157992852|FG000|Overall Study|Lost to Follow-up|2|||
49043231|NCT02218541|157992853|FG001|Overall Study|Lost to Follow-up|1|||
49043232|NCT02218541|157992852|FG000|Overall Study|Implant Failure|4|||
49043233|NCT02218541|157992853|FG001|Overall Study|Implant Failure|1|||
49043234|NCT04878211|157992854|FG000|Overall Study|Lost to Follow-up|0|||
49043235|NCT04878211|157992855|FG001|Overall Study|Lost to Follow-up|0|||
49043236|NCT04878211|157992856|FG002|Overall Study|Lost to Follow-up|0|||
49043237|NCT04878211|157992857|FG003|Overall Study|Lost to Follow-up|1|||
49043238|NCT04878211|157992858|FG004|Overall Study|Lost to Follow-up|0|||
49043239|NCT04878211|157992859|FG005|Overall Study|Lost to Follow-up|1|||
49043240|NCT04878211|157992854|FG000|Overall Study|Protocol deviation|1|||
49043241|NCT04878211|157992855|FG001|Overall Study|Protocol deviation|0|||
49043242|NCT04878211|157992856|FG002|Overall Study|Protocol deviation|0|||
49043243|NCT04878211|157992857|FG003|Overall Study|Protocol deviation|0|||
49043244|NCT04878211|157992858|FG004|Overall Study|Protocol deviation|0|||
49043245|NCT04878211|157992859|FG005|Overall Study|Protocol deviation|0|||
49043246|NCT04878211|157992854|FG000|Overall Study|Study terminated by sponsor|0|||
49043247|NCT04878211|157992855|FG001|Overall Study|Study terminated by sponsor|0|||
49043248|NCT04878211|157992856|FG002|Overall Study|Study terminated by sponsor|0|||
49043249|NCT04878211|157992857|FG003|Overall Study|Study terminated by sponsor|0|||
48987493|NCT02500706|157786523|FG002|Overall Study|Unclassified|1|||
48987494|NCT01683058|157786534|FG000|Overall Study|Lost to Follow-up|9|||
48987495|NCT01683058|157786534|FG000|Overall Study|Adverse Event|6|||
48987496|NCT01683058|157786534|FG000|Overall Study|Subject Met Withdrawal Criteria|5|||
48987497|NCT01683058|157786534|FG000|Overall Study|Withdrawal by Subject|7|||
48987498|NCT01683058|157786534|FG000|Overall Study|Lack of Efficacy|2|||
48987499|NCT02260791|157786535|FG000|Overall Study|Lost to Follow-up|4|||
48987500|NCT02260791|157786536|FG001|Overall Study|Lost to Follow-up|4|||
48987501|NCT02260791|157786535|FG000|Overall Study|Lack of Efficacy|2|||
48987502|NCT02260791|157786536|FG001|Overall Study|Lack of Efficacy|1|||
48987503|NCT02260791|157786535|FG000|Overall Study|Adverse Event|13|||
48987504|NCT02260791|157786536|FG001|Overall Study|Adverse Event|9|||
48987505|NCT02260791|157786535|FG000|Overall Study|Death|1|||
48987506|NCT02260791|157786536|FG001|Overall Study|Death|0|||
48987507|NCT02260791|157786535|FG000|Overall Study|Withdrawal by Subject|11|||
49043250|NCT04878211|157992858|FG004|Overall Study|Study terminated by sponsor|9|||
49043251|NCT04878211|157992859|FG005|Overall Study|Study terminated by sponsor|4|||
49043252|NCT04878211|157992854|FG000|Overall Study|Subject decision|0|||
49043253|NCT04878211|157992855|FG001|Overall Study|Subject decision|0|||
49043254|NCT04878211|157992856|FG002|Overall Study|Subject decision|0|||
49043255|NCT04878211|157992857|FG003|Overall Study|Subject decision|0|||
49043256|NCT04878211|157992858|FG004|Overall Study|Subject decision|1|||
49043257|NCT04878211|157992859|FG005|Overall Study|Subject decision|0|||
49043258|NCT04661202|157992860|FG000|Overall Study|Withdrawal by Subject|1|||
49043259|NCT04661202|157992861|FG001|Overall Study|Withdrawal by Subject|1|||
49043260|NCT04661202|157992860|FG000|Overall Study|Lack of Efficacy|2|||
49043261|NCT04661202|157992861|FG001|Overall Study|Lack of Efficacy|0|||
49043262|NCT02578641|157992862|FG000|Overall Study|Adverse Event|5|||
49043263|NCT02578641|157992863|FG001|Overall Study|Adverse Event|15|||
49043264|NCT02578641|157992862|FG000|Overall Study|Death|16|||
49043265|NCT02578641|157992863|FG001|Overall Study|Death|8|||
49043266|NCT02578641|157992862|FG000|Overall Study|Lost to Follow-up|0|||
49043267|NCT02578641|157992863|FG001|Overall Study|Lost to Follow-up|1|||
49043268|NCT02578641|157992862|FG000|Overall Study|Withdrawal by Subject|14|||
49043269|NCT02578641|157992863|FG001|Overall Study|Withdrawal by Subject|7|||
49043270|NCT02578641|157992862|FG000|Overall Study|Progressive Disease|69|||
49043271|NCT02578641|157992863|FG001|Overall Study|Progressive Disease|21|||
48987508|NCT02260791|157786536|FG001|Overall Study|Withdrawal by Subject|16|||
48987509|NCT02260791|157786535|FG000|Overall Study|Screen failure|0|||
49043272|NCT02578641|157992862|FG000|Overall Study|No Study Drug|2|||
49043273|NCT02578641|157992863|FG001|Overall Study|No Study Drug|0|||
49043274|NCT02578641|157992862|FG000|Overall Study|Randomized by Mistake with Study Treatment|0|||
49043275|NCT02578641|157992863|FG001|Overall Study|Randomized by Mistake with Study Treatment|1|||
49043276|NCT02578641|157992862|FG000|Overall Study|Non-compliance with Study Schedule|1|||
49043277|NCT02578641|157992863|FG001|Overall Study|Non-compliance with Study Schedule|0|||
49043278|NCT02578641|157992862|FG000|Overall Study|Other|1|||
48987510|NCT02260791|157786536|FG001|Overall Study|Screen failure|1|||
49043279|NCT02578641|157992863|FG001|Overall Study|Other|10|||
48987511|NCT02260791|157786535|FG000|Overall Study|Protocol deviation|2|||
48987512|NCT02260791|157786536|FG001|Overall Study|Protocol deviation|3|||
48987513|NCT02405091|157786539|FG000|Overall Study|Adverse Event|16|||
48987514|NCT02405091|157786540|FG001|Overall Study|Adverse Event|10|||
48987515|NCT02405091|157786541|FG002|Overall Study|Adverse Event|0|||
49043280|NCT02578641|157992862|FG000|Overall Study|Not treated|1|||
49043281|NCT02578641|157992863|FG001|Overall Study|Not treated|4|||
49043282|NCT00413049|157992865|FG000|Overall Study|Adverse Event|10|||
49043283|NCT00413049|157992866|FG001|Overall Study|Adverse Event|8|||
49043284|NCT00413049|157992865|FG000|Overall Study|Withdrawal by Subject|7|||
49043285|NCT00413049|157992866|FG001|Overall Study|Withdrawal by Subject|5|||
49043286|NCT00413049|157992865|FG000|Overall Study|Lost to Follow-up|2|||
49043287|NCT00413049|157992866|FG001|Overall Study|Lost to Follow-up|3|||
49043288|NCT00413049|157992865|FG000|Overall Study|Protocol Violation|3|||
49043289|NCT00413049|157992866|FG001|Overall Study|Protocol Violation|1|||
49043290|NCT00413049|157992865|FG000|Overall Study|Subject no longer requires study drug|0|||
49043291|NCT00413049|157992866|FG001|Overall Study|Subject no longer requires study drug|1|||
49043292|NCT00413049|157992865|FG000|Overall Study|Abnormal laboratory value(s)|1|||
48987516|NCT02405091|157786539|FG000|Overall Study|Protocol Violation|1|||
48987517|NCT02405091|157786540|FG001|Overall Study|Protocol Violation|0|||
48987518|NCT02405091|157786541|FG002|Overall Study|Protocol Violation|0|||
48987519|NCT02405091|157786539|FG000|Overall Study|Noncompliance|1|||
48987520|NCT02405091|157786540|FG001|Overall Study|Noncompliance|6|||
48987521|NCT02405091|157786541|FG002|Overall Study|Noncompliance|2|||
48987522|NCT02405091|157786539|FG000|Overall Study|Withdrawal by Subject|4|||
48987523|NCT02405091|157786540|FG001|Overall Study|Withdrawal by Subject|8|||
48987524|NCT02405091|157786541|FG002|Overall Study|Withdrawal by Subject|0|||
48987525|NCT02405091|157786539|FG000|Overall Study|Death|0|||
48987526|NCT02405091|157786540|FG001|Overall Study|Death|1|||
48987527|NCT02405091|157786541|FG002|Overall Study|Death|0|||
48987528|NCT02405091|157786539|FG000|Overall Study|Lost to Follow-up|5|||
48987529|NCT02405091|157786540|FG001|Overall Study|Lost to Follow-up|6|||
48987530|NCT02405091|157786541|FG002|Overall Study|Lost to Follow-up|0|||
48987531|NCT02405091|157786539|FG000|Overall Study|Physician Decision|2|||
48987532|NCT02405091|157786540|FG001|Overall Study|Physician Decision|2|||
48987533|NCT02405091|157786541|FG002|Overall Study|Physician Decision|0|||
48987534|NCT03490734|157786544|FG000|Pre-intervention Scan Visit|fMRI contraindications|2|||
48987535|NCT03490734|157786545|FG001|Pre-intervention Scan Visit|fMRI contraindications|1|||
48987536|NCT03490734|157786546|FG002|Pre-intervention Scan Visit|fMRI contraindications|0|||
48987537|NCT03490734|157786547|FG003|Pre-intervention Scan Visit|fMRI contraindications|2|||
48987538|NCT03490734|157786544|FG000|Pre-intervention Scan Visit|Lost to Follow-up|0|||
48987539|NCT03490734|157786545|FG001|Pre-intervention Scan Visit|Lost to Follow-up|0|||
48987540|NCT03490734|157786546|FG002|Pre-intervention Scan Visit|Lost to Follow-up|0|||
48987541|NCT03490734|157786547|FG003|Pre-intervention Scan Visit|Lost to Follow-up|1|||
49043293|NCT00413049|157992866|FG001|Overall Study|Abnormal laboratory value(s)|0|||
49043294|NCT00413049|157992865|FG000|Overall Study|Lack of Efficacy|1|||
49043295|NCT00413049|157992866|FG001|Overall Study|Lack of Efficacy|0|||
49043296|NCT02587143|157992867|FG000|Overall Study|Adverse Event|1|||
49043297|NCT02587143|157992868|FG001|Overall Study|Adverse Event|0|||
48987542|NCT03490734|157786544|FG000|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
48987543|NCT03490734|157786545|FG001|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
48987544|NCT03490734|157786546|FG002|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
48987545|NCT03490734|157786547|FG003|Pre-intervention Scan Visit|Withdrawal by Subject|1|||
48987546|NCT03490734|157786544|FG000|Post-intervention Scan Visit|Adverse Event|2|||
48987547|NCT03490734|157786545|FG001|Post-intervention Scan Visit|Adverse Event|0|||
48987548|NCT03490734|157786546|FG002|Post-intervention Scan Visit|Adverse Event|0|||
49043298|NCT01460628|157992869|FG000|Overall Study|Adverse Event|3|||
49043299|NCT01460628|157992869|FG000|Overall Study|Withdrawal by Subject|2|||
49043300|NCT03540160|157992870|FG000|Overall Study|Protocol Violation|1|||
49043301|NCT03540160|157992870|FG000|Overall Study|Physician Decision|8|||
49043302|NCT03540160|157992870|FG000|Overall Study|Lack of Efficacy|60|||
49043303|NCT03540160|157992870|FG000|Overall Study|Pregnancy|1|||
49043304|NCT03540160|157992870|FG000|Overall Study|Adverse Event|20|||
48987549|NCT03490734|157786547|FG003|Post-intervention Scan Visit|Adverse Event|0|||
49043305|NCT03540160|157992870|FG000|Overall Study|Withdrawal by Subject|68|||
49043306|NCT03540160|157992870|FG000|Overall Study|COVID-19|2|||
49043307|NCT03540160|157992870|FG000|Overall Study|Study Closure|10|||
49043308|NCT03540160|157992870|FG000|Overall Study|Lost to Follow-up|18|||
49043309|NCT03540160|157992870|FG000|Overall Study|Sponsor decision|191|||
49043310|NCT03224624|157992872|FG000|Overall Study|Lost to Follow-up|9|||
48987550|NCT03490734|157786544|FG000|Post-intervention Scan Visit|Lost to Follow-up|0|||
48987551|NCT03490734|157786545|FG001|Post-intervention Scan Visit|Lost to Follow-up|1|||
49043311|NCT03224624|157992873|FG001|Overall Study|Lost to Follow-up|4|||
48987552|NCT03490734|157786546|FG002|Post-intervention Scan Visit|Lost to Follow-up|0|||
48987553|NCT03490734|157786547|FG003|Post-intervention Scan Visit|Lost to Follow-up|0|||
48987554|NCT03490734|157786544|FG000|Post-intervention Scan Visit|Withdrawal by Subject|0|||
49043312|NCT03224624|157992872|FG000|Overall Study|Death|1|||
49043313|NCT03224624|157992873|FG001|Overall Study|Death|0|||
49043314|NCT01664039|157992874|FG000|Overall Study|Adverse Event|3|||
48987555|NCT03490734|157786545|FG001|Post-intervention Scan Visit|Withdrawal by Subject|2|||
48987556|NCT03490734|157786546|FG002|Post-intervention Scan Visit|Withdrawal by Subject|0|||
48987557|NCT03490734|157786547|FG003|Post-intervention Scan Visit|Withdrawal by Subject|3|||
48987558|NCT00374452|157786555|FG000|Overall Study|Left clinic before intervention started|4|||
48987559|NCT00374452|157786556|FG001|Overall Study|Left clinic before intervention started|1|||
48987560|NCT00374452|157786555|FG000|Overall Study|Change in job role before intervention|0|||
48987561|NCT00374452|157786556|FG001|Overall Study|Change in job role before intervention|1|||
48987562|NCT00374452|157786555|FG000|Overall Study|Left clinic after intervention started|1|||
48987563|NCT00374452|157786556|FG001|Overall Study|Left clinic after intervention started|1|||
48987564|NCT00374452|157786555|FG000|Overall Study|Withdrawal by Subject|0|||
48987565|NCT00374452|157786556|FG001|Overall Study|Withdrawal by Subject|2|||
48987566|NCT00283062|157786557|FG000|Overall Study|Did not receive any study medication|5|||
48987567|NCT00283062|157786558|FG001|Overall Study|Did not receive any study medication|4|||
48987568|NCT00283062|157786559|FG002|Overall Study|Did not receive any study medication|36|||
48987569|NCT00283062|157786560|FG003|Overall Study|Did not receive any study medication|45|||
48987570|NCT00283062|157786557|FG000|Overall Study|Adverse Event|2|||
48987571|NCT00283062|157786558|FG001|Overall Study|Adverse Event|0|||
48987572|NCT00283062|157786559|FG002|Overall Study|Adverse Event|1|||
48987573|NCT00283062|157786560|FG003|Overall Study|Adverse Event|0|||
48987574|NCT00283062|157786557|FG000|Overall Study|Lost to Follow-up|1|||
48987575|NCT00283062|157786558|FG001|Overall Study|Lost to Follow-up|0|||
48987576|NCT00283062|157786559|FG002|Overall Study|Lost to Follow-up|1|||
48987577|NCT00283062|157786560|FG003|Overall Study|Lost to Follow-up|0|||
48987578|NCT00283062|157786557|FG000|Overall Study|Progressive disease|0|||
48987579|NCT00283062|157786558|FG001|Overall Study|Progressive disease|0|||
48987580|NCT00283062|157786559|FG002|Overall Study|Progressive disease|1|||
48987581|NCT00283062|157786560|FG003|Overall Study|Progressive disease|0|||
48987582|NCT00283062|157786557|FG000|Overall Study|Participant did not wish to continue|3|||
48987583|NCT00283062|157786558|FG001|Overall Study|Participant did not wish to continue|2|||
48987584|NCT00283062|157786559|FG002|Overall Study|Participant did not wish to continue|1|||
48987585|NCT00283062|157786560|FG003|Overall Study|Participant did not wish to continue|0|||
48987586|NCT00283062|157786557|FG000|Overall Study|Undefined|0|||
48987587|NCT00283062|157786558|FG001|Overall Study|Undefined|1|||
48987588|NCT00283062|157786559|FG002|Overall Study|Undefined|1|||
48987589|NCT00283062|157786560|FG003|Overall Study|Undefined|4|||
48987590|NCT00283062|157786557|FG000|Overall Study|chemotherapy not completed (cycle 6)|1|||
48987591|NCT00283062|157786558|FG001|Overall Study|chemotherapy not completed (cycle 6)|0|||
48987592|NCT00283062|157786559|FG002|Overall Study|chemotherapy not completed (cycle 6)|0|||
48987593|NCT00283062|157786560|FG003|Overall Study|chemotherapy not completed (cycle 6)|0|||
49043315|NCT01664039|157992875|FG001|Overall Study|Adverse Event|4|||
49043316|NCT01664039|157992874|FG000|Overall Study|Lost to Follow-up|1|||
49043317|NCT01664039|157992875|FG001|Overall Study|Lost to Follow-up|1|||
49043318|NCT01664039|157992874|FG000|Overall Study|Withdrawal by Subject|1|||
49043319|NCT01664039|157992875|FG001|Overall Study|Withdrawal by Subject|3|||
49043320|NCT01664039|157992874|FG000|Overall Study|Noncompliance|1|||
49043321|NCT01664039|157992875|FG001|Overall Study|Noncompliance|1|||
49043322|NCT02451696|157992876|FG000|Overall Study|Surgery postponed|1|||
48987594|NCT00087685|157786566|FG000|Overall Study|Adverse Event|5|||
48987595|NCT00087685|157786566|FG000|Overall Study|Non-Compliance|1|||
48987596|NCT00087685|157786566|FG000|Overall Study|Progressive Disease|5|||
48987597|NCT00087685|157786566|FG000|Overall Study|Withdrawal by Subject|3|||
48987598|NCT00620815|157786567|FG000|Overall Study|Adverse Event|1|||
48987599|NCT00620815|157786568|FG001|Overall Study|Adverse Event|1|||
48987600|NCT00620815|157786569|FG002|Overall Study|Adverse Event|2|||
48987601|NCT00620815|157786567|FG000|Overall Study|Withdrawal by Subject|1|||
48987602|NCT00620815|157786568|FG001|Overall Study|Withdrawal by Subject|2|||
48987603|NCT00620815|157786569|FG002|Overall Study|Withdrawal by Subject|0|||
48987604|NCT00620815|157786567|FG000|Overall Study|Lost to Follow-up|1|||
48987605|NCT00620815|157786568|FG001|Overall Study|Lost to Follow-up|6|||
48987606|NCT00620815|157786569|FG002|Overall Study|Lost to Follow-up|3|||
48987607|NCT00620815|157786567|FG000|Overall Study|Inappropriate enrolment|0|||
48987608|NCT00620815|157786568|FG001|Overall Study|Inappropriate enrolment|0|||
48987609|NCT00620815|157786569|FG002|Overall Study|Inappropriate enrolment|1|||
48987610|NCT00620815|157786567|FG000|Overall Study|Protocol Violation|1|||
48987611|NCT00620815|157786568|FG001|Overall Study|Protocol Violation|2|||
48987612|NCT00620815|157786569|FG002|Overall Study|Protocol Violation|1|||
48987613|NCT01230827|157786573|FG000|Overall Study|Lost to Follow-up|0|||
48987614|NCT01230827|157786574|FG001|Overall Study|Lost to Follow-up|0|||
49043323|NCT02451696|157992877|FG001|Overall Study|Surgery postponed|0|||
49043324|NCT01944722|157992880|FG000|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171|||
48987615|NCT01230827|157786575|FG002|Overall Study|Lost to Follow-up|1|||
49043325|NCT01944722|157992880|FG000|Overall Study|Specimen Shipping Issues|34|||
48987616|NCT01230827|157786576|FG003|Overall Study|Lost to Follow-up|3|||
48987617|NCT01230827|157786573|FG000|Overall Study|Withdrawal by Subject|1|||
48987618|NCT01230827|157786574|FG001|Overall Study|Withdrawal by Subject|0|||
48987619|NCT01230827|157786575|FG002|Overall Study|Withdrawal by Subject|3|||
48987620|NCT01230827|157786576|FG003|Overall Study|Withdrawal by Subject|2|||
49043326|NCT01944722|157992880|FG000|Overall Study|Improper Storage/Transport|5|||
49043327|NCT01944722|157992880|FG000|Overall Study|Insufficient Volume for Test|1|||
49043328|NCT01944722|157992880|FG000|Overall Study|Missing Specimens|3|||
49043329|NCT01944722|157992880|FG000|Overall Study|Specimens Mislabeled|2|||
49043330|NCT01944722|157992880|FG000|Overall Study|Withdrawal by Subject|8|||
49043331|NCT01944722|157992880|FG000|Overall Study|NILM Subjects <30 years old|8106|||
49043332|NCT01944722|157992880|FG000|Overall Study|Unsatisfactory Cytology Result|63|||
49043333|NCT01944722|157992880|FG000|Overall Study|>ASCUS Cytology|1122|||
49043334|NCT01853176|157992881|FG000|Overall Study|Study terminated|4|||
49043335|NCT01853176|157992882|FG001|Overall Study|Study terminated|0|||
49043336|NCT01721772|157992883|FG000|Pre-Treatment|Participant no longer meets study criteria|3|||
49043337|NCT01721772|157992884|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
49043338|NCT01721772|157992883|FG000|Pre-Treatment|Poor/non-compliance|0|||
49043339|NCT01721772|157992884|FG001|Pre-Treatment|Poor/non-compliance|1|||
49043340|NCT01721772|157992883|FG000|Pre-Treatment|Participant withdrew consent|0|||
49043341|NCT01721772|157992884|FG001|Pre-Treatment|Participant withdrew consent|1|||
49043342|NCT01721772|157992883|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
48987621|NCT01230827|157786573|FG000|Overall Study|Lack of Efficacy|14|||
48987622|NCT01230827|157786574|FG001|Overall Study|Lack of Efficacy|1|||
48987623|NCT01230827|157786575|FG002|Overall Study|Lack of Efficacy|2|||
48987624|NCT01230827|157786576|FG003|Overall Study|Lack of Efficacy|3|||
48987625|NCT01230827|157786573|FG000|Overall Study|Adverse Event|4|||
48987626|NCT01230827|157786574|FG001|Overall Study|Adverse Event|2|||
48987627|NCT01230827|157786575|FG002|Overall Study|Adverse Event|3|||
48987628|NCT01230827|157786576|FG003|Overall Study|Adverse Event|7|||
48987629|NCT01230827|157786573|FG000|Overall Study|Recovery|0|||
48987630|NCT01230827|157786574|FG001|Overall Study|Recovery|6|||
48987631|NCT01230827|157786575|FG002|Overall Study|Recovery|0|||
48987632|NCT01230827|157786576|FG003|Overall Study|Recovery|0|||
48987633|NCT01230827|157786573|FG000|Overall Study|Study terminated by Sponsor|0|||
48987634|NCT01230827|157786574|FG001|Overall Study|Study terminated by Sponsor|2|||
48987635|NCT01230827|157786575|FG002|Overall Study|Study terminated by Sponsor|56|||
48987636|NCT01230827|157786576|FG003|Overall Study|Study terminated by Sponsor|63|||
48987637|NCT02698176|157786579|FG000|Overall Study|Progressive disease|4|||
48987638|NCT02698176|157786580|FG001|Overall Study|Progressive disease|3|||
48987639|NCT02698176|157786581|FG002|Overall Study|Progressive disease|1|||
48987640|NCT02698176|157786582|FG003|Overall Study|Progressive disease|0|||
48987641|NCT02698176|157786579|FG000|Overall Study|Adverse Event|2|||
48987642|NCT02698176|157786580|FG001|Overall Study|Adverse Event|0|||
48987643|NCT02698176|157786581|FG002|Overall Study|Adverse Event|0|||
48987644|NCT02698176|157786582|FG003|Overall Study|Adverse Event|0|||
48987645|NCT02698176|157786579|FG000|Overall Study|Clinical progression|3|||
49043343|NCT01721772|157992884|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
49043344|NCT01721772|157992883|FG000|Treatment|Disease progression|119|||
49043345|NCT01721772|157992884|FG001|Treatment|Disease progression|168|||
49043346|NCT01721772|157992883|FG000|Treatment|Study drug toxicity|19|||
49043347|NCT01721772|157992884|FG001|Treatment|Study drug toxicity|10|||
48987646|NCT02698176|157786580|FG001|Overall Study|Clinical progression|0|||
48987647|NCT02698176|157786581|FG002|Overall Study|Clinical progression|0|||
48987648|NCT02698176|157786582|FG003|Overall Study|Clinical progression|0|||
48987649|NCT03289676|157786583|FG000|Overall Study|Withdrawal by Subject|2|||
48987650|NCT03289676|157786584|FG001|Overall Study|Withdrawal by Subject|0|||
48987651|NCT03289676|157786583|FG000|Overall Study|Protocol Violation|2|||
48987652|NCT03289676|157786584|FG001|Overall Study|Protocol Violation|0|||
48987653|NCT03289676|157786583|FG000|Overall Study|Lost to Follow-up|0|||
48987654|NCT03289676|157786584|FG001|Overall Study|Lost to Follow-up|1|||
48987655|NCT00760994|157786585|FG000|Overall Study|Lost to Follow-up|4|||
48987656|NCT00760994|157786586|FG001|Overall Study|Lost to Follow-up|4|||
48987657|NCT00760994|157786587|FG002|Overall Study|Lost to Follow-up|3|||
48987658|NCT01029691|157786588|FG000|Continued APAP to Delivery|Death|0|||
48987659|NCT01029691|157786589|FG001|Continued APAP to Delivery|Death|0|||
48987660|NCT01029691|157786590|FG002|Continued APAP to Delivery|Death|1|||
48987661|NCT01521494|157786592|FG000|Overall Study|Adverse Event|1|||
48987662|NCT01521494|157786593|FG001|Overall Study|Adverse Event|2|||
49043348|NCT01721772|157992883|FG000|Treatment|Adverse event unrelated to study drug|7|||
48987663|NCT01521494|157786594|FG002|Overall Study|Adverse Event|9|||
48987664|NCT01521494|157786595|FG003|Overall Study|Adverse Event|6|||
48987665|NCT01521494|157786596|FG004|Overall Study|Adverse Event|2|||
48987666|NCT01521494|157786592|FG000|Overall Study|Lack of Efficacy|0|||
48987667|NCT01521494|157786593|FG001|Overall Study|Lack of Efficacy|0|||
48987668|NCT01521494|157786594|FG002|Overall Study|Lack of Efficacy|0|||
49043349|NCT01721772|157992884|FG001|Treatment|Adverse event unrelated to study drug|7|||
49043350|NCT01721772|157992883|FG000|Treatment|Maximum clinical benefit|16|||
48987669|NCT01521494|157786595|FG003|Overall Study|Lack of Efficacy|0|||
48987670|NCT01521494|157786596|FG004|Overall Study|Lack of Efficacy|2|||
48987671|NCT01521494|157786592|FG000|Overall Study|Withdrawal by Subject|1|||
48987672|NCT01521494|157786593|FG001|Overall Study|Withdrawal by Subject|1|||
48987673|NCT01521494|157786594|FG002|Overall Study|Withdrawal by Subject|0|||
49043351|NCT01721772|157992884|FG001|Treatment|Maximum clinical benefit|4|||
49043352|NCT01721772|157992883|FG000|Treatment|Other|19|||
49043353|NCT01721772|157992884|FG001|Treatment|Other|2|||
49043354|NCT01721772|157992883|FG000|Treatment|Participant withdrew consent|2|||
49043355|NCT01721772|157992884|FG001|Treatment|Participant withdrew consent|5|||
49043356|NCT01721772|157992883|FG000|Treatment|Participant request to discontinue study treatment|21|||
49043357|NCT01721772|157992884|FG001|Treatment|Participant request to discontinue study treatment|8|||
49043358|NCT01721772|157992883|FG000|Treatment|Death|1|||
49043359|NCT01721772|157992884|FG001|Treatment|Death|0|||
49043360|NCT01721772|157992883|FG000|Treatment|Not reported|1|||
48987674|NCT01521494|157786595|FG003|Overall Study|Withdrawal by Subject|2|||
48987675|NCT01521494|157786596|FG004|Overall Study|Withdrawal by Subject|0|||
48987676|NCT01521494|157786592|FG000|Overall Study|Decrease in serum phosphate|0|||
48987677|NCT01521494|157786593|FG001|Overall Study|Decrease in serum phosphate|2|||
48987678|NCT01521494|157786594|FG002|Overall Study|Decrease in serum phosphate|3|||
48987679|NCT01521494|157786595|FG003|Overall Study|Decrease in serum phosphate|12|||
48987680|NCT01521494|157786596|FG004|Overall Study|Decrease in serum phosphate|0|||
48987681|NCT01521494|157786592|FG000|Overall Study|Decrease in serum calcium|0|||
48987682|NCT01521494|157786593|FG001|Overall Study|Decrease in serum calcium|0|||
48987683|NCT01521494|157786594|FG002|Overall Study|Decrease in serum calcium|0|||
48987684|NCT01521494|157786595|FG003|Overall Study|Decrease in serum calcium|1|||
48987685|NCT01521494|157786596|FG004|Overall Study|Decrease in serum calcium|1|||
48987686|NCT01521494|157786592|FG000|Overall Study|Physician Decision|0|||
49043361|NCT01721772|157992884|FG001|Treatment|Not reported|0|||
49043362|NCT01721772|157992883|FG000|Treatment|Poor/non-compliance|1|||
49043363|NCT01721772|157992884|FG001|Treatment|Poor/non-compliance|0|||
49043364|NCT01721772|157992883|FG000|Treatment|Lost to Follow-up|0|||
49043365|NCT01721772|157992884|FG001|Treatment|Lost to Follow-up|1|||
49043366|NCT02327325|157992885|FG000|Overall Study|Withdrawal by Subject|1|||
49043367|NCT02327325|157992886|FG001|Overall Study|Withdrawal by Subject|4|||
49043368|NCT02327325|157992887|FG002|Overall Study|Withdrawal by Subject|4|||
49043369|NCT02327325|157992885|FG000|Overall Study|Excluded by Study Team|0|||
49043370|NCT02327325|157992886|FG001|Overall Study|Excluded by Study Team|0|||
49043371|NCT02327325|157992887|FG002|Overall Study|Excluded by Study Team|1|||
49043372|NCT01408888|157992888|FG000|First Intervention|Adverse Event|0|||
49043373|NCT01408888|157992889|FG001|First Intervention|Adverse Event|1|||
49043374|NCT01408888|157992888|FG000|First Intervention|Withdrawal by Subject|0|||
49043375|NCT01408888|157992889|FG001|First Intervention|Withdrawal by Subject|2|||
49043376|NCT01408888|157992888|FG000|Second Intervention|Withdrawal by Subject|1|||
49043377|NCT01408888|157992889|FG001|Second Intervention|Withdrawal by Subject|0|||
49043378|NCT01408888|157992888|FG000|Second Intervention|Adverse Event|1|||
49043379|NCT01408888|157992889|FG001|Second Intervention|Adverse Event|0|||
49043380|NCT03966911|157992890|FG000|Overall Study|Adverse Event|1|||
49043381|NCT03966911|157992891|FG001|Overall Study|Adverse Event|1|||
48987687|NCT01521494|157786593|FG001|Overall Study|Physician Decision|0|||
48987688|NCT01521494|157786594|FG002|Overall Study|Physician Decision|0|||
48987689|NCT01521494|157786595|FG003|Overall Study|Physician Decision|0|||
48987690|NCT01521494|157786596|FG004|Overall Study|Physician Decision|2|||
48987691|NCT00925522|157786603|FG000|Overall Study|study closed -- business decision|20|||
48987692|NCT01888367|157786606|FG000|Overall Study|Physician Decision|3|||
48987693|NCT01888367|157786607|FG001|Overall Study|Physician Decision|4|||
48987694|NCT01888367|157786608|FG002|Overall Study|Physician Decision|2|||
48987695|NCT01888367|157786606|FG000|Overall Study|Death|2|||
48987696|NCT01888367|157786607|FG001|Overall Study|Death|0|||
48987697|NCT01888367|157786608|FG002|Overall Study|Death|1|||
48987698|NCT01888367|157786606|FG000|Overall Study|Withdrawal by Subject|1|||
48987699|NCT01888367|157786607|FG001|Overall Study|Withdrawal by Subject|0|||
49043382|NCT03966911|157992890|FG000|Overall Study|Withdrawal by Subject|8|||
49043383|NCT03966911|157992891|FG001|Overall Study|Withdrawal by Subject|2|||
49043384|NCT03966911|157992890|FG000|Overall Study|Unable to complete study visits due to COVID-19|0|||
49043385|NCT03966911|157992891|FG001|Overall Study|Unable to complete study visits due to COVID-19|13|||
49043386|NCT01398787|157992892|FG000|Overall Study|Adverse Event|1|||
48987700|NCT01888367|157786608|FG002|Overall Study|Withdrawal by Subject|1|||
48987701|NCT01888367|157786606|FG000|Overall Study|Lost to Follow-up|1|||
48987702|NCT01888367|157786607|FG001|Overall Study|Lost to Follow-up|1|||
48987703|NCT01888367|157786608|FG002|Overall Study|Lost to Follow-up|0|||
48987704|NCT01888367|157786606|FG000|Overall Study|Protocol Violation|0|||
48987705|NCT01888367|157786607|FG001|Overall Study|Protocol Violation|0|||
48987706|NCT01888367|157786608|FG002|Overall Study|Protocol Violation|1|||
48987707|NCT01888367|157786606|FG000|Overall Study|30-Day Visit Too Early (< 28 Days)|1|||
48987708|NCT01888367|157786607|FG001|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
48987709|NCT01888367|157786608|FG002|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
48987710|NCT00591786|157786609|FG000|Overall Study|Withdrawal of Informed Consent|0|||
48987711|NCT00591786|157786610|FG001|Overall Study|Withdrawal of Informed Consent|0|||
49043387|NCT01583530|157992893|FG000|Overall Study|Adverse Event|0|||
49043388|NCT01583530|157992894|FG001|Overall Study|Adverse Event|0|||
48987712|NCT00591786|157786611|FG002|Overall Study|Withdrawal of Informed Consent|1|||
48987713|NCT00591786|157786612|FG003|Overall Study|Withdrawal of Informed Consent|0|||
48987714|NCT00591786|157786613|FG004|Overall Study|Withdrawal of Informed Consent|0|||
48987715|NCT00591786|157786614|FG005|Overall Study|Withdrawal of Informed Consent|0|||
48987716|NCT00591786|157786615|FG006|Overall Study|Withdrawal of Informed Consent|0|||
48987717|NCT00591786|157786616|FG007|Overall Study|Withdrawal of Informed Consent|0|||
48987718|NCT00591786|157786617|FG008|Overall Study|Withdrawal of Informed Consent|0|||
48987719|NCT00591786|157786618|FG009|Overall Study|Withdrawal of Informed Consent|0|||
48987720|NCT00950755|157786619|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
48987721|NCT00950755|157786619|FG000|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1|||
48987722|NCT00950755|157786619|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|27|||
48987723|NCT00950755|157786619|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
48987724|NCT00950755|157786619|FG000|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1|||
48987725|NCT00950755|157786619|FG000|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1|||
48987726|NCT00950755|157786619|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6|||
48987727|NCT00950755|157786619|FG000|Dosimetric and Therapeutic Treatment|Investigator Discretion|1|||
48987728|NCT00950755|157786619|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
48987729|NCT00950755|157786619|FG000|Long-Term Follow-Up|Death|8|||
48987730|NCT00554229|157786630|FG000|Overall Study|Lost to Follow-up|3|||
48987731|NCT00554229|157786631|FG001|Overall Study|Lost to Follow-up|6|||
48987732|NCT00554229|157786630|FG000|Overall Study|Withdrawal by Subject|29|||
48987733|NCT00554229|157786631|FG001|Overall Study|Withdrawal by Subject|37|||
48987734|NCT00554229|157786630|FG000|Overall Study|Adverse Event|71|||
48987735|NCT00554229|157786631|FG001|Overall Study|Adverse Event|39|||
48987736|NCT00554229|157786630|FG000|Overall Study|Protocol Violation|3|||
48987737|NCT00554229|157786631|FG001|Overall Study|Protocol Violation|3|||
48987738|NCT00554229|157786630|FG000|Overall Study|Reason not otherwise captured, eg; death|119|||
48987739|NCT00554229|157786631|FG001|Overall Study|Reason not otherwise captured, eg; death|140|||
48987740|NCT00554229|157786630|FG000|Overall Study|Randomised but no treatment received|1|||
48987741|NCT00554229|157786631|FG001|Overall Study|Randomised but no treatment received|0|||
48987742|NCT03958149|157788921|FG000|Overall Study|Withdrawal by Subject|0|||
48987743|NCT03958149|157788922|FG001|Overall Study|Withdrawal by Subject|1|||
48987744|NCT03037489|157788923|FG000|Overall Study|Adverse Event|4|||
48987745|NCT03037489|157788924|FG001|Overall Study|Adverse Event|0|||
48987746|NCT03037489|157788923|FG000|Overall Study|Withdrawal by Subject|3|||
48987747|NCT03037489|157788924|FG001|Overall Study|Withdrawal by Subject|0|||
48987748|NCT04586920|157788927|FG000|Overall Study|Lost to Follow-up|0|||
48987749|NCT04586920|157788928|FG001|Overall Study|Lost to Follow-up|0|||
48987750|NCT04586920|157788929|FG002|Overall Study|Lost to Follow-up|0|||
48987751|NCT04586920|157788930|FG003|Overall Study|Lost to Follow-up|0|||
48987752|NCT04586920|157788931|FG004|Overall Study|Lost to Follow-up|0|||
48987753|NCT04586920|157788932|FG005|Overall Study|Lost to Follow-up|0|||
48987754|NCT04586920|157788933|FG006|Overall Study|Lost to Follow-up|1|||
48987755|NCT04586920|157788934|FG007|Overall Study|Lost to Follow-up|1|||
48987756|NCT04586920|157788935|FG008|Overall Study|Lost to Follow-up|0|||
48987757|NCT04586920|157788936|FG009|Overall Study|Lost to Follow-up|1|||
48987758|NCT04586920|157788937|FG010|Overall Study|Lost to Follow-up|0|||
48987759|NCT04586920|157788938|FG011|Overall Study|Lost to Follow-up|0|||
48987760|NCT04586920|157788939|FG012|Overall Study|Lost to Follow-up|0|||
48987761|NCT04586920|157788940|FG013|Overall Study|Lost to Follow-up|1|||
48987762|NCT04586920|157788941|FG014|Overall Study|Lost to Follow-up|0|||
48987763|NCT04586920|157788942|FG015|Overall Study|Lost to Follow-up|0|||
48987764|NCT04586920|157788943|FG016|Overall Study|Lost to Follow-up|0|||
48987765|NCT04586920|157788944|FG017|Overall Study|Lost to Follow-up|0|||
48987766|NCT04586920|157788927|FG000|Overall Study|Withdrawal by Subject|0|||
48987767|NCT04586920|157788928|FG001|Overall Study|Withdrawal by Subject|0|||
48987768|NCT04586920|157788929|FG002|Overall Study|Withdrawal by Subject|0|||
48987769|NCT04586920|157788930|FG003|Overall Study|Withdrawal by Subject|0|||
48987770|NCT04586920|157788931|FG004|Overall Study|Withdrawal by Subject|0|||
48987771|NCT04586920|157788932|FG005|Overall Study|Withdrawal by Subject|0|||
48987772|NCT04586920|157788933|FG006|Overall Study|Withdrawal by Subject|0|||
48987773|NCT04586920|157788934|FG007|Overall Study|Withdrawal by Subject|1|||
48987774|NCT04586920|157788935|FG008|Overall Study|Withdrawal by Subject|0|||
48987775|NCT04586920|157788936|FG009|Overall Study|Withdrawal by Subject|1|||
48987776|NCT04586920|157788937|FG010|Overall Study|Withdrawal by Subject|0|||
48987777|NCT04586920|157788938|FG011|Overall Study|Withdrawal by Subject|1|||
48987778|NCT04586920|157788939|FG012|Overall Study|Withdrawal by Subject|0|||
48987779|NCT04586920|157788940|FG013|Overall Study|Withdrawal by Subject|0|||
48987780|NCT04586920|157788941|FG014|Overall Study|Withdrawal by Subject|0|||
48987781|NCT04586920|157788942|FG015|Overall Study|Withdrawal by Subject|0|||
48987782|NCT04586920|157788943|FG016|Overall Study|Withdrawal by Subject|0|||
48987783|NCT04586920|157788944|FG017|Overall Study|Withdrawal by Subject|0|||
48987784|NCT01004861|157788948|FG000|Overall Study|Disease progression|3|||
48987785|NCT01004861|157788949|FG001|Overall Study|Disease progression|4|||
48987786|NCT01004861|157788950|FG002|Overall Study|Disease progression|5|||
48987787|NCT01004861|157788951|FG003|Overall Study|Disease progression|4|||
48987788|NCT01004861|157788952|FG004|Overall Study|Disease progression|4|||
48987789|NCT01004861|157788953|FG005|Overall Study|Disease progression|4|||
48987790|NCT01004861|157788954|FG006|Overall Study|Disease progression|5|||
48987791|NCT01004861|157788955|FG007|Overall Study|Disease progression|1|||
48987792|NCT01004861|157788956|FG008|Overall Study|Disease progression|4|||
48987793|NCT01004861|157788957|FG009|Overall Study|Disease progression|7|||
48987794|NCT01004861|157788958|FG010|Overall Study|Disease progression|6|||
48987795|NCT01004861|157788959|FG011|Overall Study|Disease progression|3|||
48987796|NCT01004861|157788960|FG012|Overall Study|Disease progression|8|||
48987797|NCT01004861|157788948|FG000|Overall Study|Physician Decision|0|||
48987798|NCT01004861|157788949|FG001|Overall Study|Physician Decision|2|||
48987799|NCT01004861|157788950|FG002|Overall Study|Physician Decision|1|||
48987800|NCT01004861|157788951|FG003|Overall Study|Physician Decision|1|||
48987801|NCT01004861|157788952|FG004|Overall Study|Physician Decision|1|||
48987802|NCT01004861|157788953|FG005|Overall Study|Physician Decision|0|||
48987803|NCT01004861|157788954|FG006|Overall Study|Physician Decision|0|||
48987804|NCT01004861|157788955|FG007|Overall Study|Physician Decision|1|||
48987805|NCT01004861|157788956|FG008|Overall Study|Physician Decision|0|||
48987806|NCT01004861|157788957|FG009|Overall Study|Physician Decision|0|||
48987807|NCT01004861|157788958|FG010|Overall Study|Physician Decision|0|||
48987808|NCT01004861|157788959|FG011|Overall Study|Physician Decision|0|||
48987809|NCT01004861|157788960|FG012|Overall Study|Physician Decision|3|||
48987810|NCT01004861|157788948|FG000|Overall Study|Adverse Event|0|||
48987811|NCT01004861|157788949|FG001|Overall Study|Adverse Event|0|||
48987812|NCT01004861|157788950|FG002|Overall Study|Adverse Event|0|||
48987813|NCT01004861|157788951|FG003|Overall Study|Adverse Event|1|||
48987814|NCT01004861|157788952|FG004|Overall Study|Adverse Event|0|||
48987815|NCT01004861|157788953|FG005|Overall Study|Adverse Event|2|||
48987816|NCT01004861|157788954|FG006|Overall Study|Adverse Event|1|||
48987817|NCT01004861|157788955|FG007|Overall Study|Adverse Event|1|||
49043389|NCT01583530|157992895|FG002|Overall Study|Adverse Event|0|||
49043390|NCT01583530|157992896|FG003|Overall Study|Adverse Event|0|||
49043391|NCT01583530|157992897|FG004|Overall Study|Adverse Event|0|||
49043392|NCT01583530|157992898|FG005|Overall Study|Adverse Event|1|||
49043393|NCT01583530|157992893|FG000|Overall Study|Withdrawal by Subject|0|||
49043394|NCT01583530|157992894|FG001|Overall Study|Withdrawal by Subject|3|||
49043395|NCT01583530|157992895|FG002|Overall Study|Withdrawal by Subject|0|||
49043396|NCT01583530|157992896|FG003|Overall Study|Withdrawal by Subject|1|||
49043397|NCT01583530|157992897|FG004|Overall Study|Withdrawal by Subject|1|||
49043398|NCT01583530|157992898|FG005|Overall Study|Withdrawal by Subject|2|||
49043399|NCT01583530|157992893|FG000|Overall Study|Lost to Follow-up|0|||
49043400|NCT01583530|157992894|FG001|Overall Study|Lost to Follow-up|0|||
49043401|NCT01583530|157992895|FG002|Overall Study|Lost to Follow-up|0|||
49043402|NCT01583530|157992896|FG003|Overall Study|Lost to Follow-up|0|||
49043403|NCT01583530|157992897|FG004|Overall Study|Lost to Follow-up|3|||
49043404|NCT01583530|157992898|FG005|Overall Study|Lost to Follow-up|0|||
49043405|NCT01583530|157992893|FG000|Overall Study|Lack of compliance|0|||
49043406|NCT01583530|157992894|FG001|Overall Study|Lack of compliance|0|||
49043407|NCT01583530|157992895|FG002|Overall Study|Lack of compliance|0|||
49043408|NCT01583530|157992896|FG003|Overall Study|Lack of compliance|0|||
49043409|NCT01583530|157992897|FG004|Overall Study|Lack of compliance|1|||
49043410|NCT01583530|157992898|FG005|Overall Study|Lack of compliance|0|||
49043411|NCT01824498|157992899|FG000|Washout (8 Weeks)|Withdrawal by Subject|2|||
49043412|NCT01824498|157992900|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
49043413|NCT01824498|157992901|FG002|Washout (8 Weeks)|Withdrawal by Subject|2|||
49043414|NCT01824498|157992902|FG003|Washout (8 Weeks)|Withdrawal by Subject|1|||
49043415|NCT01824498|157992903|FG004|Washout (8 Weeks)|Withdrawal by Subject|1|||
49043416|NCT01824498|157992904|FG005|Washout (8 Weeks)|Withdrawal by Subject|0|||
49043417|NCT04320745|157992905|FG000|Overall Study|Adverse Event|26|||
49043418|NCT04320745|157992905|FG000|Overall Study|Withdrawal by Subject|4|||
49043419|NCT04320745|157992905|FG000|Overall Study|Lost to Follow-up|12|||
49043420|NCT04320745|157992905|FG000|Overall Study|Protocol Deviation|2|||
49043421|NCT04320745|157992905|FG000|Overall Study|Non-compliance With Study Drug|2|||
49043422|NCT04320745|157992905|FG000|Overall Study|Reason Not Specified|1|||
48987818|NCT01004861|157788956|FG008|Overall Study|Adverse Event|13|||
48987819|NCT01004861|157788957|FG009|Overall Study|Adverse Event|1|||
48987820|NCT01004861|157788958|FG010|Overall Study|Adverse Event|1|||
49043423|NCT01567527|157992906|FG000|Conversion Phase.|Protocol deviation|3|||
49043424|NCT01567527|157992907|FG001|Conversion Phase.|Protocol deviation|0|||
49043425|NCT01567527|157992908|FG002|Conversion Phase.|Protocol deviation|0|||
48987821|NCT01004861|157788959|FG011|Overall Study|Adverse Event|0|||
48987822|NCT01004861|157788960|FG012|Overall Study|Adverse Event|2|||
49043426|NCT01567527|157992909|FG003|Conversion Phase.|Protocol deviation|0|||
49043427|NCT01567527|157992910|FG004|Conversion Phase.|Protocol deviation|0|||
49043428|NCT01567527|157992906|FG000|Conversion Phase.|Met withdrawal criteria|10|||
49043429|NCT01567527|157992907|FG001|Conversion Phase.|Met withdrawal criteria|0|||
49043430|NCT01567527|157992908|FG002|Conversion Phase.|Met withdrawal criteria|0|||
49043431|NCT01567527|157992909|FG003|Conversion Phase.|Met withdrawal criteria|0|||
49043432|NCT01567527|157992910|FG004|Conversion Phase.|Met withdrawal criteria|0|||
49043433|NCT01567527|157992906|FG000|Conversion Phase.|Withdrawal by Subject|32|||
49043434|NCT01567527|157992907|FG001|Conversion Phase.|Withdrawal by Subject|0|||
49043435|NCT01567527|157992908|FG002|Conversion Phase.|Withdrawal by Subject|0|||
49043436|NCT01567527|157992909|FG003|Conversion Phase.|Withdrawal by Subject|0|||
49043437|NCT01567527|157992910|FG004|Conversion Phase.|Withdrawal by Subject|0|||
49043438|NCT01567527|157992906|FG000|Conversion Phase.|Lost to Follow-up|16|||
49043439|NCT01567527|157992907|FG001|Conversion Phase.|Lost to Follow-up|0|||
49043440|NCT01567527|157992908|FG002|Conversion Phase.|Lost to Follow-up|0|||
49043441|NCT01567527|157992909|FG003|Conversion Phase.|Lost to Follow-up|0|||
49043442|NCT01567527|157992910|FG004|Conversion Phase.|Lost to Follow-up|0|||
49043443|NCT01567527|157992906|FG000|Conversion Phase.|Lack of Efficacy|2|||
49043444|NCT01567527|157992907|FG001|Conversion Phase.|Lack of Efficacy|0|||
49043445|NCT01567527|157992908|FG002|Conversion Phase.|Lack of Efficacy|0|||
49043446|NCT01567527|157992909|FG003|Conversion Phase.|Lack of Efficacy|0|||
48987823|NCT01004861|157788948|FG000|Overall Study|Protocol Violation|0|||
49043447|NCT01567527|157992910|FG004|Conversion Phase.|Lack of Efficacy|0|||
48987824|NCT01004861|157788949|FG001|Overall Study|Protocol Violation|0|||
48987825|NCT01004861|157788950|FG002|Overall Study|Protocol Violation|0|||
49043448|NCT01567527|157992906|FG000|Conversion Phase.|Adverse Event|33|||
49043449|NCT01567527|157992907|FG001|Conversion Phase.|Adverse Event|0|||
49043450|NCT01567527|157992908|FG002|Conversion Phase.|Adverse Event|0|||
49043451|NCT01567527|157992909|FG003|Conversion Phase.|Adverse Event|0|||
49043452|NCT01567527|157992910|FG004|Conversion Phase.|Adverse Event|0|||
49043453|NCT01567527|157992906|FG000|Conversion Phase.|Withdrawn by the investigator|3|||
49043454|NCT01567527|157992907|FG001|Conversion Phase.|Withdrawn by the investigator|0|||
49043455|NCT01567527|157992908|FG002|Conversion Phase.|Withdrawn by the investigator|0|||
49043456|NCT01567527|157992909|FG003|Conversion Phase.|Withdrawn by the investigator|0|||
49043457|NCT01567527|157992910|FG004|Conversion Phase.|Withdrawn by the investigator|0|||
49043458|NCT01567527|157992906|FG000|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
49043459|NCT01567527|157992907|FG001|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41|||
49043460|NCT01567527|157992908|FG002|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
49043461|NCT01567527|157992909|FG003|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
49043462|NCT01567527|157992910|FG004|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
49043463|NCT01567527|157992906|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
49043464|NCT01567527|157992907|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45|||
49043465|NCT01567527|157992908|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
49043466|NCT01567527|157992909|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
49043467|NCT01567527|157992910|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
49043468|NCT01567527|157992906|FG000|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
49043469|NCT01567527|157992907|FG001|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44|||
49043470|NCT01567527|157992908|FG002|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
48987826|NCT01004861|157788951|FG003|Overall Study|Protocol Violation|0|||
48987827|NCT01004861|157788952|FG004|Overall Study|Protocol Violation|1|||
48987828|NCT01004861|157788953|FG005|Overall Study|Protocol Violation|0|||
48987829|NCT01004861|157788954|FG006|Overall Study|Protocol Violation|0|||
48987830|NCT01004861|157788955|FG007|Overall Study|Protocol Violation|0|||
48987831|NCT01004861|157788956|FG008|Overall Study|Protocol Violation|0|||
48987832|NCT01004861|157788957|FG009|Overall Study|Protocol Violation|0|||
48987833|NCT01004861|157788958|FG010|Overall Study|Protocol Violation|0|||
48987834|NCT01004861|157788959|FG011|Overall Study|Protocol Violation|0|||
48987835|NCT01004861|157788960|FG012|Overall Study|Protocol Violation|0|||
48987836|NCT01004861|157788948|FG000|Overall Study|Lost to Follow-up|0|||
48987837|NCT01004861|157788949|FG001|Overall Study|Lost to Follow-up|0|||
48987838|NCT01004861|157788950|FG002|Overall Study|Lost to Follow-up|0|||
48987839|NCT01004861|157788951|FG003|Overall Study|Lost to Follow-up|0|||
48987840|NCT01004861|157788952|FG004|Overall Study|Lost to Follow-up|0|||
49043471|NCT01567527|157992909|FG003|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
49043472|NCT01567527|157992910|FG004|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
49043473|NCT01567527|157992906|FG000|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
48987841|NCT01004861|157788953|FG005|Overall Study|Lost to Follow-up|0|||
48987842|NCT01004861|157788954|FG006|Overall Study|Lost to Follow-up|0|||
48987843|NCT01004861|157788955|FG007|Overall Study|Lost to Follow-up|1|||
48987844|NCT01004861|157788956|FG008|Overall Study|Lost to Follow-up|3|||
48987845|NCT01004861|157788957|FG009|Overall Study|Lost to Follow-up|0|||
48987846|NCT01004861|157788958|FG010|Overall Study|Lost to Follow-up|0|||
48987847|NCT01004861|157788959|FG011|Overall Study|Lost to Follow-up|1|||
48987848|NCT01004861|157788960|FG012|Overall Study|Lost to Follow-up|0|||
48987849|NCT01004861|157788948|FG000|Overall Study|Non-compliance|0|||
48987850|NCT01004861|157788949|FG001|Overall Study|Non-compliance|0|||
48987851|NCT01004861|157788950|FG002|Overall Study|Non-compliance|0|||
48987852|NCT01004861|157788951|FG003|Overall Study|Non-compliance|0|||
48987853|NCT01004861|157788952|FG004|Overall Study|Non-compliance|0|||
48987854|NCT01004861|157788953|FG005|Overall Study|Non-compliance|0|||
48987855|NCT01004861|157788954|FG006|Overall Study|Non-compliance|0|||
48987856|NCT01004861|157788955|FG007|Overall Study|Non-compliance|0|||
48987857|NCT01004861|157788956|FG008|Overall Study|Non-compliance|5|||
48987858|NCT01004861|157788957|FG009|Overall Study|Non-compliance|0|||
48987859|NCT01004861|157788958|FG010|Overall Study|Non-compliance|0|||
48987860|NCT01004861|157788959|FG011|Overall Study|Non-compliance|0|||
48987861|NCT01004861|157788960|FG012|Overall Study|Non-compliance|1|||
48987862|NCT01004861|157788948|FG000|Overall Study|Other|0|||
48987863|NCT01004861|157788949|FG001|Overall Study|Other|0|||
48987864|NCT01004861|157788950|FG002|Overall Study|Other|0|||
48987865|NCT01004861|157788951|FG003|Overall Study|Other|0|||
48987866|NCT01004861|157788952|FG004|Overall Study|Other|0|||
48987867|NCT01004861|157788953|FG005|Overall Study|Other|0|||
48987868|NCT01004861|157788954|FG006|Overall Study|Other|0|||
48987869|NCT01004861|157788955|FG007|Overall Study|Other|0|||
48987870|NCT01004861|157788956|FG008|Overall Study|Other|0|||
48987871|NCT01004861|157788957|FG009|Overall Study|Other|2|||
48987872|NCT01004861|157788958|FG010|Overall Study|Other|1|||
48987873|NCT01004861|157788959|FG011|Overall Study|Other|2|||
48987874|NCT01004861|157788960|FG012|Overall Study|Other|3|||
48987875|NCT01004861|157788948|FG000|Overall Study|Patient decision|0|||
48987876|NCT01004861|157788949|FG001|Overall Study|Patient decision|0|||
48987877|NCT01004861|157788950|FG002|Overall Study|Patient decision|0|||
48987878|NCT01004861|157788951|FG003|Overall Study|Patient decision|0|||
48987879|NCT01004861|157788952|FG004|Overall Study|Patient decision|1|||
48987880|NCT01004861|157788953|FG005|Overall Study|Patient decision|0|||
48987881|NCT01004861|157788954|FG006|Overall Study|Patient decision|1|||
48987882|NCT01004861|157788955|FG007|Overall Study|Patient decision|0|||
48987883|NCT01004861|157788956|FG008|Overall Study|Patient decision|7|||
48987884|NCT01004861|157788957|FG009|Overall Study|Patient decision|1|||
48987885|NCT01004861|157788958|FG010|Overall Study|Patient decision|1|||
48987886|NCT01004861|157788959|FG011|Overall Study|Patient decision|2|||
48987887|NCT01004861|157788960|FG012|Overall Study|Patient decision|3|||
48987888|NCT01004861|157788948|FG000|Overall Study|Transitioned to Phase 4 study|0|||
48987889|NCT01004861|157788949|FG001|Overall Study|Transitioned to Phase 4 study|0|||
48987890|NCT01004861|157788950|FG002|Overall Study|Transitioned to Phase 4 study|0|||
48987891|NCT01004861|157788951|FG003|Overall Study|Transitioned to Phase 4 study|0|||
48987892|NCT01004861|157788952|FG004|Overall Study|Transitioned to Phase 4 study|0|||
48987893|NCT01004861|157788953|FG005|Overall Study|Transitioned to Phase 4 study|0|||
48987894|NCT01004861|157788954|FG006|Overall Study|Transitioned to Phase 4 study|0|||
48987895|NCT01004861|157788955|FG007|Overall Study|Transitioned to Phase 4 study|0|||
48987896|NCT01004861|157788956|FG008|Overall Study|Transitioned to Phase 4 study|2|||
48987897|NCT01004861|157788957|FG009|Overall Study|Transitioned to Phase 4 study|0|||
48987898|NCT01004861|157788958|FG010|Overall Study|Transitioned to Phase 4 study|0|||
48987899|NCT01004861|157788959|FG011|Overall Study|Transitioned to Phase 4 study|0|||
48987900|NCT01004861|157788960|FG012|Overall Study|Transitioned to Phase 4 study|0|||
48987901|NCT01004861|157788948|FG000|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
48987902|NCT01004861|157788949|FG001|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
48987903|NCT01004861|157788950|FG002|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
48987904|NCT01004861|157788951|FG003|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
48987905|NCT01004861|157788952|FG004|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
48987906|NCT01004861|157788953|FG005|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
48987907|NCT01004861|157788954|FG006|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
48987908|NCT01004861|157788955|FG007|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
48987909|NCT01004861|157788956|FG008|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|1|||
48987910|NCT01004861|157788957|FG009|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
48987911|NCT01004861|157788958|FG010|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
48987912|NCT01004861|157788959|FG011|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
48987913|NCT01004861|157788960|FG012|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
48987914|NCT01004861|157788948|FG000|Overall Study|Patient withdrew|0|||
48987915|NCT01004861|157788949|FG001|Overall Study|Patient withdrew|0|||
48987916|NCT01004861|157788950|FG002|Overall Study|Patient withdrew|0|||
48987917|NCT01004861|157788951|FG003|Overall Study|Patient withdrew|0|||
48987918|NCT01004861|157788952|FG004|Overall Study|Patient withdrew|0|||
48987919|NCT01004861|157788953|FG005|Overall Study|Patient withdrew|0|||
48987920|NCT01004861|157788954|FG006|Overall Study|Patient withdrew|0|||
48987921|NCT01004861|157788955|FG007|Overall Study|Patient withdrew|0|||
48987922|NCT01004861|157788956|FG008|Overall Study|Patient withdrew|1|||
48987923|NCT01004861|157788957|FG009|Overall Study|Patient withdrew|0|||
48987924|NCT01004861|157788958|FG010|Overall Study|Patient withdrew|0|||
48987925|NCT01004861|157788959|FG011|Overall Study|Patient withdrew|0|||
48987926|NCT01004861|157788960|FG012|Overall Study|Patient withdrew|0|||
48987927|NCT01004861|157788948|FG000|Overall Study|Surgical resection|0|||
49043474|NCT01567527|157992907|FG001|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12|||
49043475|NCT01567527|157992908|FG002|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
49043476|NCT01567527|157992909|FG003|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
48987928|NCT01004861|157788949|FG001|Overall Study|Surgical resection|0|||
48987929|NCT01004861|157788950|FG002|Overall Study|Surgical resection|0|||
49043477|NCT01567527|157992910|FG004|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
49043478|NCT01567527|157992906|FG000|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
49043479|NCT01567527|157992907|FG001|Oral Aripiprazole Stabilization Phase.|Adverse Event|63|||
49043480|NCT01567527|157992908|FG002|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
49043481|NCT01567527|157992909|FG003|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
49043482|NCT01567527|157992910|FG004|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
49043483|NCT01567527|157992906|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
49043484|NCT01567527|157992907|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2|||
49043485|NCT01567527|157992908|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
49043486|NCT01567527|157992909|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
49043487|NCT01567527|157992910|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
49043488|NCT01567527|157992906|FG000|IM Depot Stabilization.|Protocol deviation|0|||
49043489|NCT01567527|157992907|FG001|IM Depot Stabilization.|Protocol deviation|0|||
49043490|NCT01567527|157992908|FG002|IM Depot Stabilization.|Protocol deviation|5|||
49043491|NCT01567527|157992909|FG003|IM Depot Stabilization.|Protocol deviation|0|||
49043492|NCT01567527|157992910|FG004|IM Depot Stabilization.|Protocol deviation|0|||
49043493|NCT01567527|157992906|FG000|IM Depot Stabilization.|Met withdrawal criteria|0|||
49043494|NCT01567527|157992907|FG001|IM Depot Stabilization.|Met withdrawal criteria|0|||
49043495|NCT01567527|157992908|FG002|IM Depot Stabilization.|Met withdrawal criteria|26|||
49043496|NCT01567527|157992909|FG003|IM Depot Stabilization.|Met withdrawal criteria|0|||
49043497|NCT01567527|157992910|FG004|IM Depot Stabilization.|Met withdrawal criteria|0|||
49043498|NCT01567527|157992906|FG000|IM Depot Stabilization.|Withdrawal by Subject|0|||
49043499|NCT01567527|157992907|FG001|IM Depot Stabilization.|Withdrawal by Subject|0|||
49043500|NCT01567527|157992908|FG002|IM Depot Stabilization.|Withdrawal by Subject|56|||
49043501|NCT01567527|157992909|FG003|IM Depot Stabilization.|Withdrawal by Subject|0|||
49043502|NCT01567527|157992910|FG004|IM Depot Stabilization.|Withdrawal by Subject|0|||
49043503|NCT01567527|157992906|FG000|IM Depot Stabilization.|Sponsor discontinued study|0|||
49043504|NCT01567527|157992907|FG001|IM Depot Stabilization.|Sponsor discontinued study|0|||
48987930|NCT01004861|157788951|FG003|Overall Study|Surgical resection|0|||
48987931|NCT01004861|157788952|FG004|Overall Study|Surgical resection|0|||
49043505|NCT01567527|157992908|FG002|IM Depot Stabilization.|Sponsor discontinued study|1|||
49043506|NCT01567527|157992909|FG003|IM Depot Stabilization.|Sponsor discontinued study|0|||
49043507|NCT01567527|157992910|FG004|IM Depot Stabilization.|Sponsor discontinued study|0|||
49043508|NCT01567527|157992906|FG000|IM Depot Stabilization.|Lost to Follow-up|0|||
49043509|NCT01567527|157992907|FG001|IM Depot Stabilization.|Lost to Follow-up|0|||
48987932|NCT01004861|157788953|FG005|Overall Study|Surgical resection|0|||
48987933|NCT01004861|157788954|FG006|Overall Study|Surgical resection|0|||
48987934|NCT01004861|157788955|FG007|Overall Study|Surgical resection|0|||
48987935|NCT01004861|157788956|FG008|Overall Study|Surgical resection|1|||
48987936|NCT01004861|157788957|FG009|Overall Study|Surgical resection|0|||
48987937|NCT01004861|157788958|FG010|Overall Study|Surgical resection|0|||
48987938|NCT01004861|157788959|FG011|Overall Study|Surgical resection|0|||
48987939|NCT01004861|157788960|FG012|Overall Study|Surgical resection|0|||
48987940|NCT01004861|157788948|FG000|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
48987941|NCT01004861|157788949|FG001|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
48987942|NCT01004861|157788950|FG002|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
48987943|NCT01004861|157788951|FG003|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
48987944|NCT01004861|157788952|FG004|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
48987945|NCT01004861|157788953|FG005|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
48987946|NCT01004861|157788954|FG006|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
48987947|NCT01004861|157788955|FG007|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
48987948|NCT01004861|157788956|FG008|Overall Study|Patient maintained complete response status throughout drug holiday|1|||
48987949|NCT01004861|157788957|FG009|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
48987950|NCT01004861|157788958|FG010|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
48987951|NCT01004861|157788959|FG011|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
48987952|NCT01004861|157788960|FG012|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
48987953|NCT01004861|157788948|FG000|Overall Study|Study termination by Sponsor|0|||
49043510|NCT01567527|157992908|FG002|IM Depot Stabilization.|Lost to Follow-up|21|||
49043511|NCT01567527|157992909|FG003|IM Depot Stabilization.|Lost to Follow-up|0|||
49043512|NCT01567527|157992910|FG004|IM Depot Stabilization.|Lost to Follow-up|0|||
49043513|NCT01567527|157992906|FG000|IM Depot Stabilization.|Lack of Efficacy|0|||
49043514|NCT01567527|157992907|FG001|IM Depot Stabilization.|Lack of Efficacy|0|||
49043515|NCT01567527|157992908|FG002|IM Depot Stabilization.|Lack of Efficacy|7|||
49043516|NCT01567527|157992909|FG003|IM Depot Stabilization.|Lack of Efficacy|0|||
49043517|NCT01567527|157992910|FG004|IM Depot Stabilization.|Lack of Efficacy|0|||
49043518|NCT01567527|157992906|FG000|IM Depot Stabilization.|Adverse Event|0|||
49043519|NCT01567527|157992907|FG001|IM Depot Stabilization.|Adverse Event|0|||
49043520|NCT01567527|157992908|FG002|IM Depot Stabilization.|Adverse Event|37|||
49043521|NCT01567527|157992909|FG003|IM Depot Stabilization.|Adverse Event|0|||
49043522|NCT01567527|157992910|FG004|IM Depot Stabilization.|Adverse Event|0|||
49043523|NCT01567527|157992906|FG000|IM Depot Stabilization.|Withdrawn by the investigator|0|||
49043524|NCT01567527|157992907|FG001|IM Depot Stabilization.|Withdrawn by the investigator|0|||
49043525|NCT01567527|157992908|FG002|IM Depot Stabilization.|Withdrawn by the investigator|6|||
49043526|NCT01567527|157992909|FG003|IM Depot Stabilization.|Withdrawn by the investigator|0|||
49043527|NCT01567527|157992910|FG004|IM Depot Stabilization.|Withdrawn by the investigator|0|||
49043528|NCT01567527|157992906|FG000|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
49043529|NCT01567527|157992907|FG001|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
49043530|NCT01567527|157992908|FG002|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
49043531|NCT01567527|157992909|FG003|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
49043532|NCT01567527|157992910|FG004|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
49043533|NCT01567527|157992906|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
49043534|NCT01567527|157992907|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
48987954|NCT01004861|157788949|FG001|Overall Study|Study termination by Sponsor|0|||
48987955|NCT01004861|157788950|FG002|Overall Study|Study termination by Sponsor|0|||
48987956|NCT01004861|157788951|FG003|Overall Study|Study termination by Sponsor|0|||
49043535|NCT01567527|157992908|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
49043536|NCT01567527|157992909|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16|||
49043537|NCT01567527|157992910|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33|||
49043538|NCT01567527|157992906|FG000|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
49043539|NCT01567527|157992907|FG001|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
49043540|NCT01567527|157992908|FG002|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
49043541|NCT01567527|157992909|FG003|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4|||
49043542|NCT01567527|157992910|FG004|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7|||
49043543|NCT01567527|157992906|FG000|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
49043544|NCT01567527|157992907|FG001|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
49043545|NCT01567527|157992908|FG002|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
49043546|NCT01567527|157992909|FG003|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7|||
49043547|NCT01567527|157992910|FG004|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1|||
49043548|NCT01567527|157992906|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
49043549|NCT01567527|157992907|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
49043550|NCT01567527|157992908|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
49043551|NCT01567527|157992909|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13|||
49043552|NCT01567527|157992910|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10|||
49043553|NCT01567527|157992906|FG000|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
49043554|NCT01567527|157992907|FG001|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
49043555|NCT01567527|157992908|FG002|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
49043556|NCT01567527|157992909|FG003|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1|||
49043557|NCT01567527|157992910|FG004|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3|||
49043558|NCT01567527|157992906|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
49043559|NCT01567527|157992907|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
49043560|NCT01567527|157992908|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
49043561|NCT01567527|157992909|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19|||
49043562|NCT01567527|157992910|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35|||
49043563|NCT01567527|157992906|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
49043564|NCT01567527|157992907|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
49043565|NCT01567527|157992908|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
49043566|NCT01567527|157992909|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8|||
49043567|NCT01567527|157992910|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5|||
48987957|NCT01004861|157788952|FG004|Overall Study|Study termination by Sponsor|0|||
48987958|NCT01004861|157788953|FG005|Overall Study|Study termination by Sponsor|0|||
48987959|NCT01004861|157788954|FG006|Overall Study|Study termination by Sponsor|0|||
48987960|NCT01004861|157788955|FG007|Overall Study|Study termination by Sponsor|0|||
48987961|NCT01004861|157788956|FG008|Overall Study|Study termination by Sponsor|1|||
48987962|NCT01004861|157788957|FG009|Overall Study|Study termination by Sponsor|0|||
49043568|NCT01824576|157992916|FG000|Overall Study|Device deficiency|2|||
49043569|NCT02311894|157992917|FG000|Overall Study|Discontinued in error|1|||
49043570|NCT02311894|157992917|FG000|Overall Study|Lost to Follow-up|1|||
49043571|NCT02311894|157992917|FG000|Overall Study|Adverse Event|1|||
49043572|NCT02311894|157992917|FG000|Overall Study|Withdrawal by Subject|1|||
49043573|NCT02623218|157992918|FG000|Overall Study|Lost to Follow-up|0|||
49043574|NCT02623218|157992919|FG001|Overall Study|Lost to Follow-up|1|||
49043575|NCT02623218|157992920|FG002|Overall Study|Lost to Follow-up|0|||
49043576|NCT02623218|157992921|FG003|Overall Study|Lost to Follow-up|0|||
49043577|NCT02623218|157992922|FG004|Overall Study|Lost to Follow-up|0|||
49043578|NCT03008005|157992923|FG000|Overall Study|Physician Decision|1|||
49043579|NCT03008005|157992924|FG001|Overall Study|Physician Decision|0|||
49043580|NCT03008005|157992925|FG002|Overall Study|Physician Decision|0|||
49043581|NCT03008005|157992923|FG000|Overall Study|Withdrawal by Subject|1|||
49043582|NCT03008005|157992924|FG001|Overall Study|Withdrawal by Subject|0|||
49043583|NCT03008005|157992925|FG002|Overall Study|Withdrawal by Subject|0|||
49043584|NCT03008005|157992923|FG000|Overall Study|Ineligible|0|||
49043585|NCT03008005|157992924|FG001|Overall Study|Ineligible|1|||
49043586|NCT03008005|157992925|FG002|Overall Study|Ineligible|0|||
49043587|NCT00842309|157992933|FG000|Overall Study|Withdrawal by Subject|3|||
49043588|NCT00842309|157992934|FG001|Overall Study|Withdrawal by Subject|1|||
49043589|NCT02597049|157992940|FG000|Overall Study|Lost to Follow-up|0|||
49043590|NCT02597049|157992941|FG001|Overall Study|Lost to Follow-up|3|||
49043591|NCT02597049|157992942|FG002|Overall Study|Lost to Follow-up|2|||
49043592|NCT02597049|157992940|FG000|Overall Study|Withdrawal by Subject|2|||
49043593|NCT02597049|157992941|FG001|Overall Study|Withdrawal by Subject|2|||
49043594|NCT02597049|157992942|FG002|Overall Study|Withdrawal by Subject|1|||
49043595|NCT02597049|157992940|FG000|Overall Study|Adverse Event|2|||
49043596|NCT02597049|157992941|FG001|Overall Study|Adverse Event|0|||
49043597|NCT02597049|157992942|FG002|Overall Study|Adverse Event|0|||
49043598|NCT02597049|157992940|FG000|Overall Study|Death|2|||
49043599|NCT02597049|157992941|FG001|Overall Study|Death|0|||
49043600|NCT02597049|157992942|FG002|Overall Study|Death|0|||
49043601|NCT02597049|157992940|FG000|Overall Study|Noncompliant with Study Visits|1|||
49043602|NCT02597049|157992941|FG001|Overall Study|Noncompliant with Study Visits|0|||
49043603|NCT02597049|157992942|FG002|Overall Study|Noncompliant with Study Visits|0|||
49043604|NCT01044433|157992943|FG000|Overall Study|Lost to Follow-up|3|||
49043605|NCT01044433|157992943|FG000|Overall Study|Withdrawal by Subject|3|||
49043606|NCT01547728|157992949|FG000|Overall Study|Change in procedure and equipment|1|||
49043607|NCT01547728|157992949|FG000|Overall Study|Drug not ready for subject|1|||
48987963|NCT01004861|157788958|FG010|Overall Study|Study termination by Sponsor|0|||
48987964|NCT01004861|157788959|FG011|Overall Study|Study termination by Sponsor|0|||
48987965|NCT01004861|157788960|FG012|Overall Study|Study termination by Sponsor|0|||
48987966|NCT02630823|157788961|FG000|Overall Study|Withdrawal by Subject|1|||
48987967|NCT02630823|157788961|FG000|Overall Study|Did not undergo cytoreductive surgery due to pre-operative disease progression|1|||
48987968|NCT02554721|157788962|FG000|Overall Study|Adverse Event|1|||
48987969|NCT02554721|157788963|FG001|Overall Study|Adverse Event|0|||
48987970|NCT02554721|157788964|FG002|Overall Study|Adverse Event|0|||
48987971|NCT02554721|157788965|FG003|Overall Study|Adverse Event|0|||
48987972|NCT02554721|157788966|FG004|Overall Study|Adverse Event|1|||
48987973|NCT02554721|157788962|FG000|Overall Study|Noncompliance|0|||
48987974|NCT02554721|157788963|FG001|Overall Study|Noncompliance|0|||
48987975|NCT02554721|157788964|FG002|Overall Study|Noncompliance|0|||
48987976|NCT02554721|157788965|FG003|Overall Study|Noncompliance|0|||
48987977|NCT02554721|157788966|FG004|Overall Study|Noncompliance|1|||
48987978|NCT05009251|157788980|FG000|Overall Study|Protocol Violation|100|||
48987979|NCT05009251|157788981|FG001|Overall Study|Protocol Violation|105|||
48987980|NCT05009251|157788982|FG002|Overall Study|Protocol Violation|119|||
48987981|NCT05009251|157788983|FG003|Overall Study|Protocol Violation|120|||
48987982|NCT05009251|157788984|FG004|Overall Study|Protocol Violation|119|||
48987983|NCT05009251|157788980|FG000|Overall Study|Death|25|||
48987984|NCT05009251|157788981|FG001|Overall Study|Death|22|||
48987985|NCT05009251|157788982|FG002|Overall Study|Death|24|||
48987986|NCT05009251|157788983|FG003|Overall Study|Death|19|||
48987987|NCT05009251|157788984|FG004|Overall Study|Death|15|||
49043608|NCT01547728|157992949|FG000|Overall Study|Screen failure|39|||
49043609|NCT05263505|157992951|FG000|Overall Study|Adverse Event|0|||
49043610|NCT05263505|157992952|FG001|Overall Study|Adverse Event|1|||
49043611|NCT03105297|157992953|FG000|Baseline Phase (Day 1)|Other|21|||
48987988|NCT01640353|157788985|FG000|Overall Study|Withdrew prior to treatment|10|||
48987989|NCT01640353|157788985|FG000|Overall Study|Withdrawn from analysis at term site|12|||
48987990|NCT01640353|157788985|FG000|Overall Study|Withdrawal by Subject|5|||
49043612|NCT03105297|157992953|FG000|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1|||
49043613|NCT03105297|157992953|FG000|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7|||
49043614|NCT01341405|157992954|FG000|Overall Study|Adverse Event|0|||
49043615|NCT01341405|157992955|FG001|Overall Study|Adverse Event|1|||
49043616|NCT01341405|157992956|FG002|Overall Study|Adverse Event|1|||
49043617|NCT01341405|157992954|FG000|Overall Study|Withdrawal by Subject|3|||
48987991|NCT01640353|157788985|FG000|Overall Study|Death|2|||
48987992|NCT01640353|157788985|FG000|Overall Study|Early site termination|3|||
48987993|NCT01640353|157788985|FG000|Overall Study|Lost to Follow-up|12|||
48987994|NCT01640353|157788985|FG000|Overall Study|Physician Decision|1|||
48987995|NCT01524900|157788986|FG000|Overall Study|Lost to Follow-up|3|||
48987996|NCT01524900|157788987|FG001|Overall Study|Lost to Follow-up|12|||
48987997|NCT01524900|157788988|FG002|Overall Study|Lost to Follow-up|1|||
48987998|NCT01524900|157788989|FG003|Overall Study|Lost to Follow-up|0|||
48987999|NCT01524900|157788990|FG004|Overall Study|Lost to Follow-up|0|||
48988000|NCT01524900|157788986|FG000|Overall Study|Other reason than stated above|1|||
48988001|NCT01524900|157788987|FG001|Overall Study|Other reason than stated above|1|||
48988002|NCT01524900|157788988|FG002|Overall Study|Other reason than stated above|0|||
48988003|NCT01524900|157788989|FG003|Overall Study|Other reason than stated above|0|||
48988004|NCT01524900|157788990|FG004|Overall Study|Other reason than stated above|0|||
48988005|NCT01524900|157788986|FG000|Overall Study|No reason documented|2|||
48988006|NCT01524900|157788987|FG001|Overall Study|No reason documented|1|||
48988007|NCT01524900|157788988|FG002|Overall Study|No reason documented|0|||
48988008|NCT01524900|157788989|FG003|Overall Study|No reason documented|1|||
48988009|NCT01524900|157788990|FG004|Overall Study|No reason documented|0|||
48988010|NCT00959192|157788991|FG000|Overall Study|Adverse Event|1|||
48988011|NCT00959192|157788992|FG001|Overall Study|Adverse Event|1|||
48988012|NCT00959192|157788993|FG002|Overall Study|Adverse Event|1|||
48988013|NCT00959192|157788994|FG003|Overall Study|Adverse Event|0|||
48988014|NCT00959192|157788991|FG000|Overall Study|Investigator Request|1|||
48988015|NCT00959192|157788992|FG001|Overall Study|Investigator Request|0|||
48988016|NCT00959192|157788993|FG002|Overall Study|Investigator Request|0|||
48988017|NCT00959192|157788994|FG003|Overall Study|Investigator Request|0|||
48988018|NCT00959192|157788991|FG000|Overall Study|Caregiver Request|0|||
48988019|NCT00959192|157788992|FG001|Overall Study|Caregiver Request|0|||
48988020|NCT00959192|157788993|FG002|Overall Study|Caregiver Request|2|||
48988021|NCT00959192|157788994|FG003|Overall Study|Caregiver Request|1|||
48988022|NCT00413231|157788995|FG000|0 to 30-day Post Treatment|Death|5|||
48988023|NCT00413231|157788995|FG000|0 to 30-day Post Treatment|Intend to treat, but not implanted|3|||
48988024|NCT00413231|157788995|FG000|30-day to 365-day Post Treatment|Death|13|||
48988025|NCT00413231|157788995|FG000|365-day to 60-month Post Treatment|Death|36|||
48988026|NCT00413231|157788995|FG000|365-day to 60-month Post Treatment|Withdrawal by Subject|5|||
48988027|NCT00413231|157788995|FG000|365-day to 60-month Post Treatment|Lost to Follow-up|4|||
48988028|NCT00413231|157788995|FG000|365-day to 60-month Post Treatment|Exited after surgical conversion|1|||
48988029|NCT00087594|157788996|FG000|Overall Study|Adverse Event|2|||
48988030|NCT00087594|157788997|FG001|Overall Study|Adverse Event|3|||
48988031|NCT00087594|157788996|FG000|Overall Study|Lost to Follow-up|0|||
48988032|NCT00087594|157788997|FG001|Overall Study|Lost to Follow-up|2|||
48988033|NCT00087594|157788996|FG000|Overall Study|Withdrawal by Subject|4|||
48988034|NCT00087594|157788997|FG001|Overall Study|Withdrawal by Subject|2|||
48988035|NCT00087594|157788996|FG000|Overall Study|Lack of Efficacy|2|||
48988036|NCT00087594|157788997|FG001|Overall Study|Lack of Efficacy|5|||
48988037|NCT01952041|157789004|FG000|Overall Study|Lost to Follow-up|9|||
48988038|NCT01952041|157789005|FG001|Overall Study|Lost to Follow-up|16|||
48988039|NCT01952041|157789004|FG000|Overall Study|Withdrawal by Subject|7|||
48988040|NCT01952041|157789005|FG001|Overall Study|Withdrawal by Subject|5|||
48988041|NCT01952041|157789004|FG000|Overall Study|Death|1|||
48988042|NCT01952041|157789005|FG001|Overall Study|Death|0|||
48988043|NCT00945945|157789009|FG000|Overall Study|Adverse Event|15|||
48988044|NCT00945945|157789010|FG001|Overall Study|Adverse Event|35|||
48988045|NCT00945945|157789009|FG000|Overall Study|Withdrawal by Subject|7|||
48988046|NCT00945945|157789010|FG001|Overall Study|Withdrawal by Subject|10|||
48988047|NCT00945945|157789009|FG000|Overall Study|Lost to Follow-up|4|||
48988048|NCT00945945|157789010|FG001|Overall Study|Lost to Follow-up|5|||
48988049|NCT00945945|157789009|FG000|Overall Study|Lack of Efficacy|6|||
48988050|NCT00945945|157789010|FG001|Overall Study|Lack of Efficacy|2|||
48988051|NCT00945945|157789009|FG000|Overall Study|Protocol Violation|4|||
48988052|NCT00945945|157789010|FG001|Overall Study|Protocol Violation|2|||
48988053|NCT00945945|157789009|FG000|Overall Study|Entry Criteria Not Met|0|||
48988054|NCT00945945|157789010|FG001|Overall Study|Entry Criteria Not Met|1|||
48988055|NCT04450394|157789011|FG000|Overall Study|Adverse Event|2|||
48988056|NCT04450394|157789012|FG001|Overall Study|Adverse Event|0|||
48988057|NCT04450394|157789013|FG002|Overall Study|Adverse Event|0|||
48988058|NCT04450394|157789011|FG000|Overall Study|Death|0|||
48988059|NCT04450394|157789012|FG001|Overall Study|Death|1|||
48988060|NCT04450394|157789013|FG002|Overall Study|Death|0|||
48988061|NCT04450394|157789011|FG000|Overall Study|Lost to Follow-up|0|||
48988062|NCT04450394|157789012|FG001|Overall Study|Lost to Follow-up|3|||
48988063|NCT04450394|157789013|FG002|Overall Study|Lost to Follow-up|0|||
48988064|NCT04450394|157789011|FG000|Overall Study|Physician Decision|0|||
48988065|NCT04450394|157789012|FG001|Overall Study|Physician Decision|1|||
48988066|NCT04450394|157789013|FG002|Overall Study|Physician Decision|0|||
48988067|NCT04450394|157789011|FG000|Overall Study|Protocol Violation|2|||
48988068|NCT04450394|157789012|FG001|Overall Study|Protocol Violation|0|||
48988069|NCT04450394|157789013|FG002|Overall Study|Protocol Violation|0|||
48988070|NCT04450394|157789011|FG000|Overall Study|Withdrawal by Subject|6|||
48988071|NCT04450394|157789012|FG001|Overall Study|Withdrawal by Subject|9|||
48988072|NCT04450394|157789013|FG002|Overall Study|Withdrawal by Subject|0|||
48988073|NCT01823991|157789014|FG000|Overall Study|Withdrawal by Subject|8|||
48988074|NCT01823991|157789015|FG001|Overall Study|Withdrawal by Subject|5|||
48988075|NCT05158244|157789016|FG000|Overall Study|Withdrawal by principal investigator due to protocol deviation|1|||
48988076|NCT05158244|157789017|FG001|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
48988077|NCT05158244|157789018|FG002|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
48988078|NCT05158244|157789019|FG003|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
48988079|NCT05158244|157789020|FG004|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
48988080|NCT05158244|157789016|FG000|Overall Study|Withdrawal by Subject|0|||
48988081|NCT05158244|157789017|FG001|Overall Study|Withdrawal by Subject|0|||
48988082|NCT05158244|157789018|FG002|Overall Study|Withdrawal by Subject|1|||
48988083|NCT05158244|157789019|FG003|Overall Study|Withdrawal by Subject|0|||
48988084|NCT05158244|157789020|FG004|Overall Study|Withdrawal by Subject|0|||
48988085|NCT02194699|157789024|FG000|Randomised|Did not receive treatment|1|||
48988086|NCT02194699|157789025|FG001|Randomised|Did not receive treatment|5|||
48988087|NCT02194699|157789024|FG000|Randomised|Without potential for 52 weeks of IP|5|||
48988088|NCT02194699|157789025|FG001|Randomised|Without potential for 52 weeks of IP|5|||
48988089|NCT02194699|157789024|FG000|Randomised|Duplicate patient|2|||
48988090|NCT02194699|157789025|FG001|Randomised|Duplicate patient|1|||
48988091|NCT02194699|157789024|FG000|With Potential to Receive 52 Weeks of IP|Adverse Event|4|||
48988092|NCT02194699|157789025|FG001|With Potential to Receive 52 Weeks of IP|Adverse Event|3|||
48988093|NCT02194699|157789024|FG000|With Potential to Receive 52 Weeks of IP|Death|1|||
48988094|NCT02194699|157789025|FG001|With Potential to Receive 52 Weeks of IP|Death|3|||
48988095|NCT02194699|157789024|FG000|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5|||
48988096|NCT02194699|157789025|FG001|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8|||
48988097|NCT02194699|157789024|FG000|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
48988098|NCT02194699|157789025|FG001|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
48988099|NCT02194699|157789024|FG000|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14|||
48988100|NCT02194699|157789025|FG001|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20|||
48988101|NCT02194699|157789024|FG000|With Potential to Receive 52 Weeks of IP|Other|24|||
48988102|NCT02194699|157789025|FG001|With Potential to Receive 52 Weeks of IP|Other|16|||
48988103|NCT02452034|157789031|FG000|Overall Study|Adverse Event|0|||
48988104|NCT02452034|157789032|FG001|Overall Study|Adverse Event|0|||
48988105|NCT02452034|157789033|FG002|Overall Study|Adverse Event|0|||
48988106|NCT02452034|157789034|FG003|Overall Study|Adverse Event|0|||
48988107|NCT02452034|157789035|FG004|Overall Study|Adverse Event|0|||
48988108|NCT02452034|157789036|FG005|Overall Study|Adverse Event|1|||
48988109|NCT02452034|157789031|FG000|Overall Study|Death|0|||
48988110|NCT02452034|157789032|FG001|Overall Study|Death|0|||
48988111|NCT02452034|157789033|FG002|Overall Study|Death|0|||
48988112|NCT02452034|157789034|FG003|Overall Study|Death|0|||
48988113|NCT02452034|157789035|FG004|Overall Study|Death|1|||
49043618|NCT01341405|157992955|FG001|Overall Study|Withdrawal by Subject|2|||
49043619|NCT01341405|157992956|FG002|Overall Study|Withdrawal by Subject|1|||
49043620|NCT05692154|157992957|FG000|Overall Study|Adverse Event|0|||
49043621|NCT05692154|157992958|FG001|Overall Study|Adverse Event|1|||
49043622|NCT02218216|157992959|FG000|Overall Study|Study terminated before completed|6|||
49043623|NCT02218216|157992960|FG001|Overall Study|Study terminated before completed|0|||
48988114|NCT02452034|157789036|FG005|Overall Study|Death|1|||
49043624|NCT02218216|157992961|FG002|Overall Study|Study terminated before completed|0|||
49043625|NCT02151149|157992962|FG000|Treatment Period|Death|2|||
49043626|NCT02151149|157992963|FG001|Treatment Period|Death|3|||
49043627|NCT02151149|157992962|FG000|Treatment Period|Adverse Event|17|||
49043628|NCT02151149|157992963|FG001|Treatment Period|Adverse Event|14|||
49043629|NCT02151149|157992962|FG000|Treatment Period|Progressive Disease|25|||
49043630|NCT02151149|157992963|FG001|Treatment Period|Progressive Disease|24|||
49043631|NCT02151149|157992962|FG000|Treatment Period|Symptomatic Deterioration|2|||
48988115|NCT02452034|157789031|FG000|Overall Study|Physician Decision|0|||
48988116|NCT02452034|157789032|FG001|Overall Study|Physician Decision|1|||
48988117|NCT02452034|157789033|FG002|Overall Study|Physician Decision|1|||
49043632|NCT02151149|157992963|FG001|Treatment Period|Symptomatic Deterioration|10|||
48988118|NCT02452034|157789034|FG003|Overall Study|Physician Decision|0|||
48988119|NCT02452034|157789035|FG004|Overall Study|Physician Decision|0|||
48988120|NCT02452034|157789036|FG005|Overall Study|Physician Decision|0|||
48988121|NCT02452034|157789031|FG000|Overall Study|Protocol Violation|0|||
48988122|NCT02452034|157789032|FG001|Overall Study|Protocol Violation|0|||
48988123|NCT02452034|157789033|FG002|Overall Study|Protocol Violation|0|||
48988124|NCT02452034|157789034|FG003|Overall Study|Protocol Violation|0|||
49043633|NCT02151149|157992962|FG000|Treatment Period|Withdrawal by Subject|13|||
49043634|NCT02151149|157992963|FG001|Treatment Period|Withdrawal by Subject|11|||
49043635|NCT02151149|157992962|FG000|Treatment Period|Miscellaneous|8|||
48988125|NCT02452034|157789035|FG004|Overall Study|Protocol Violation|0|||
48988126|NCT02452034|157789036|FG005|Overall Study|Protocol Violation|1|||
48988127|NCT02452034|157789031|FG000|Overall Study|Screen Failure|1|||
48988128|NCT02452034|157789032|FG001|Overall Study|Screen Failure|0|||
48988129|NCT02452034|157789033|FG002|Overall Study|Screen Failure|0|||
48988130|NCT02452034|157789034|FG003|Overall Study|Screen Failure|1|||
48988131|NCT02452034|157789035|FG004|Overall Study|Screen Failure|0|||
48988132|NCT02452034|157789036|FG005|Overall Study|Screen Failure|0|||
48988133|NCT02452034|157789031|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
48988134|NCT02452034|157789032|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
48988135|NCT02452034|157789033|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
48988136|NCT02452034|157789034|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
48988137|NCT02452034|157789035|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
48988138|NCT02452034|157789036|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
48988139|NCT00166504|157789037|FG000|Overall Study|Adverse Event|3|||
48988140|NCT00166504|157789038|FG001|Overall Study|Adverse Event|3|||
48988141|NCT00166504|157789037|FG000|Overall Study|Lost to Follow-up|1|||
48988142|NCT00166504|157789038|FG001|Overall Study|Lost to Follow-up|1|||
48988143|NCT00166504|157789037|FG000|Overall Study|Withdrawal by Subject|1|||
48988144|NCT00166504|157789038|FG001|Overall Study|Withdrawal by Subject|0|||
48988145|NCT01853397|157789046|FG000|Overall Study|Withdrawal by Subject|0|||
48988146|NCT01853397|157789047|FG001|Overall Study|Withdrawal by Subject|0|||
48988147|NCT01853397|157789048|FG002|Overall Study|Withdrawal by Subject|0|||
48988148|NCT01853397|157789049|FG003|Overall Study|Withdrawal by Subject|1|||
48988149|NCT01853397|157789046|FG000|Overall Study|Subject Noncompliance|0|||
48988150|NCT01853397|157789047|FG001|Overall Study|Subject Noncompliance|0|||
48988151|NCT01853397|157789048|FG002|Overall Study|Subject Noncompliance|0|||
48988152|NCT01853397|157789049|FG003|Overall Study|Subject Noncompliance|1|||
48988153|NCT01724021|157789053|FG000|Overall Study|Adverse Event|11|||
48988154|NCT01724021|157789054|FG001|Overall Study|Adverse Event|6|||
48988155|NCT01724021|157789053|FG000|Overall Study|Death|46|||
48988156|NCT01724021|157789054|FG001|Overall Study|Death|58|||
48988157|NCT01724021|157789053|FG000|Overall Study|Participant request/ Withdrew consent|18|||
48988158|NCT01724021|157789054|FG001|Overall Study|Participant request/ Withdrew consent|14|||
48988159|NCT01724021|157789053|FG000|Overall Study|Lost to Follow-up|15|||
48988160|NCT01724021|157789054|FG001|Overall Study|Lost to Follow-up|15|||
48988161|NCT01724021|157789053|FG000|Overall Study|Reason Not Specified|36|||
48988162|NCT01724021|157789054|FG001|Overall Study|Reason Not Specified|39|||
48988163|NCT01724021|157789053|FG000|Overall Study|Missing|1|||
48988164|NCT01724021|157789054|FG001|Overall Study|Missing|1|||
48988165|NCT02795182|157789069|FG000|Overall Study|Death|5|||
48988166|NCT02795182|157789070|FG001|Overall Study|Death|4|||
48988167|NCT02795182|157789071|FG002|Overall Study|Death|4|||
48988168|NCT02795182|157789072|FG003|Overall Study|Death|18|||
48988169|NCT02795182|157789069|FG000|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
48988170|NCT02795182|157789070|FG001|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
48988171|NCT02795182|157789071|FG002|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
48988172|NCT02795182|157789072|FG003|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|1|||
48988173|NCT02795182|157789069|FG000|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
48988174|NCT02795182|157789070|FG001|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
48988175|NCT02795182|157789071|FG002|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
48988176|NCT02795182|157789072|FG003|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|2|||
48988177|NCT02795182|157789069|FG000|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|3|||
48988178|NCT02795182|157789070|FG001|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|2|||
48988179|NCT02795182|157789071|FG002|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|0|||
48988180|NCT02795182|157789072|FG003|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|8|||
48988181|NCT02795182|157789069|FG000|Overall Study|Withdrawal by Subject|4|||
48988182|NCT02795182|157789070|FG001|Overall Study|Withdrawal by Subject|0|||
48988183|NCT02795182|157789071|FG002|Overall Study|Withdrawal by Subject|0|||
48988184|NCT02795182|157789072|FG003|Overall Study|Withdrawal by Subject|3|||
48988185|NCT02795182|157789069|FG000|Overall Study|Lost to Follow-up|0|||
48988186|NCT02795182|157789070|FG001|Overall Study|Lost to Follow-up|0|||
48988187|NCT02795182|157789071|FG002|Overall Study|Lost to Follow-up|1|||
48988188|NCT02795182|157789072|FG003|Overall Study|Lost to Follow-up|1|||
48988189|NCT02795182|157789069|FG000|Overall Study|Roll Over to Long Term Extension|3|||
48988190|NCT02795182|157789070|FG001|Overall Study|Roll Over to Long Term Extension|3|||
48988191|NCT02795182|157789071|FG002|Overall Study|Roll Over to Long Term Extension|2|||
48988192|NCT02795182|157789072|FG003|Overall Study|Roll Over to Long Term Extension|5|||
48988193|NCT02795182|157789069|FG000|Overall Study|Progressive Disease|0|||
48988194|NCT02795182|157789070|FG001|Overall Study|Progressive Disease|1|||
48988195|NCT02795182|157789071|FG002|Overall Study|Progressive Disease|0|||
48988196|NCT02795182|157789072|FG003|Overall Study|Progressive Disease|4|||
48988197|NCT02795182|157789069|FG000|Overall Study|Physician Decision|0|||
48988198|NCT02795182|157789070|FG001|Overall Study|Physician Decision|0|||
48988199|NCT02795182|157789071|FG002|Overall Study|Physician Decision|0|||
48988200|NCT02795182|157789072|FG003|Overall Study|Physician Decision|1|||
48988201|NCT00247962|157789076|FG000|Overall Study|Adverse Event|15|||
48988202|NCT00247962|157789077|FG001|Overall Study|Adverse Event|12|||
48988203|NCT00247962|157789076|FG000|Overall Study|Lost to Follow-up|3|||
48988204|NCT00247962|157789077|FG001|Overall Study|Lost to Follow-up|1|||
48988205|NCT00247962|157789076|FG000|Overall Study|Physician Decision|0|||
48988206|NCT00247962|157789077|FG001|Overall Study|Physician Decision|1|||
49043636|NCT02151149|157992963|FG001|Treatment Period|Miscellaneous|7|||
49043637|NCT02151149|157992962|FG000|Treatment Period|Participants randomized but not treated|3|||
49043638|NCT02151149|157992963|FG001|Treatment Period|Participants randomized but not treated|2|||
49043639|NCT02151149|157992962|FG000|Follow-Up Period|Lost to Follow-up|2|||
49043640|NCT02151149|157992963|FG001|Follow-Up Period|Lost to Follow-up|3|||
49043641|NCT02151149|157992962|FG000|Follow-Up Period|Death|37|||
49043642|NCT02151149|157992963|FG001|Follow-Up Period|Death|34|||
49043643|NCT00766493|157992964|FG000|30 Days Post-Procedure|Discontinued|7|||
49043644|NCT00766493|157992964|FG000|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4|||
49043645|NCT00766493|157992964|FG000|30 Days Post-Procedure|Missed Visit - No Phone Contact|1|||
49043646|NCT00714051|157992965|FG000|Overall Study|Withdrawal by Subject|1|||
49043647|NCT00714051|157992966|FG001|Overall Study|Withdrawal by Subject|0|||
48988207|NCT00247962|157789076|FG000|Overall Study|Protocol Violation|1|||
48988208|NCT00247962|157789077|FG001|Overall Study|Protocol Violation|1|||
48988209|NCT00247962|157789076|FG000|Overall Study|Withdrawal by Subject|3|||
48988210|NCT00247962|157789077|FG001|Overall Study|Withdrawal by Subject|2|||
48988211|NCT00247962|157789076|FG000|Overall Study|Lack of Efficacy|4|||
48988212|NCT00247962|157789077|FG001|Overall Study|Lack of Efficacy|2|||
48988213|NCT03480360|157789080|FG000|Overall Study|Death|2|||
48988214|NCT02129192|157789081|FG000|Period 1 Including Washout Period|Withdrawal by Subject|0|||
48988215|NCT02129192|157789082|FG001|Period 1 Including Washout Period|Withdrawal by Subject|1|||
48988216|NCT01231620|157789083|FG000|Overall Study|Physician Decision|3|||
48988217|NCT01231620|157789084|FG001|Overall Study|Physician Decision|5|||
48988218|NCT01231620|157789085|FG002|Overall Study|Physician Decision|10|||
48988219|NCT01231620|157789083|FG000|Overall Study|Death|12|||
48988220|NCT01231620|157789084|FG001|Overall Study|Death|14|||
48988221|NCT01231620|157789085|FG002|Overall Study|Death|11|||
49043648|NCT00714051|157992965|FG000|Overall Study|Death|0|||
48988222|NCT01231620|157789083|FG000|Overall Study|Adverse Event|2|||
48988223|NCT01231620|157789084|FG001|Overall Study|Adverse Event|2|||
48988224|NCT01231620|157789085|FG002|Overall Study|Adverse Event|1|||
48988225|NCT01231620|157789083|FG000|Overall Study|Withdrawal by Subject|6|||
48988226|NCT01231620|157789084|FG001|Overall Study|Withdrawal by Subject|6|||
48988227|NCT01231620|157789085|FG002|Overall Study|Withdrawal by Subject|8|||
48988228|NCT01231620|157789083|FG000|Overall Study|Lost to Follow-up|3|||
48988229|NCT01231620|157789084|FG001|Overall Study|Lost to Follow-up|4|||
48988230|NCT01231620|157789085|FG002|Overall Study|Lost to Follow-up|9|||
48988231|NCT02400281|157789086|FG000|Overall Study|Adverse Event|0|||
48988232|NCT02400281|157789087|FG001|Overall Study|Adverse Event|0|||
48988233|NCT02400281|157789088|FG002|Overall Study|Adverse Event|1|||
48988234|NCT02400281|157789089|FG003|Overall Study|Adverse Event|0|||
48988235|NCT02400281|157789090|FG004|Overall Study|Adverse Event|1|||
48988236|NCT02400281|157789091|FG005|Overall Study|Adverse Event|0|||
48988237|NCT02400281|157789086|FG000|Overall Study|Physician Decision|0|||
48988238|NCT02400281|157789087|FG001|Overall Study|Physician Decision|0|||
49043649|NCT00714051|157992966|FG001|Overall Study|Death|1|||
49043650|NCT00860262|157992969|FG000|Overall Study|Adverse Event|9|||
49043651|NCT00860262|157992970|FG001|Overall Study|Adverse Event|6|||
49043652|NCT00860262|157992971|FG002|Overall Study|Adverse Event|7|||
49043653|NCT00860262|157992969|FG000|Overall Study|Protocol Violation|0|||
49043654|NCT00860262|157992970|FG001|Overall Study|Protocol Violation|1|||
49043655|NCT00860262|157992971|FG002|Overall Study|Protocol Violation|0|||
48988239|NCT02400281|157789088|FG002|Overall Study|Physician Decision|1|||
48988240|NCT02400281|157789089|FG003|Overall Study|Physician Decision|0|||
48988241|NCT02400281|157789090|FG004|Overall Study|Physician Decision|0|||
49043656|NCT00860262|157992969|FG000|Overall Study|Lost to Follow-up|2|||
48988242|NCT02400281|157789091|FG005|Overall Study|Physician Decision|0|||
48988243|NCT00412360|157789094|FG000|Overall Study|Lost to Follow-up|0|||
48988244|NCT00412360|157789095|FG001|Overall Study|Lost to Follow-up|1|||
49043657|NCT00860262|157992970|FG001|Overall Study|Lost to Follow-up|0|||
49043658|NCT00860262|157992971|FG002|Overall Study|Lost to Follow-up|1|||
48988245|NCT00412360|157789094|FG000|Overall Study|Not Transplanted|1|||
48988246|NCT00412360|157789095|FG001|Overall Study|Not Transplanted|2|||
48988247|NCT03370133|157789105|FG000|Initial Treatment Period (WK 16)|Adverse Event|5|||
48988248|NCT03370133|157789106|FG001|Initial Treatment Period (WK 16)|Adverse Event|5|||
48988249|NCT03370133|157789107|FG002|Initial Treatment Period (WK 16)|Adverse Event|2|||
48988250|NCT03370133|157789108|FG003|Initial Treatment Period (WK 16)|Adverse Event|0|||
48988251|NCT03370133|157789109|FG004|Initial Treatment Period (WK 16)|Adverse Event|0|||
49043659|NCT00860262|157992969|FG000|Overall Study|Withdrawal by Subject|4|||
49043660|NCT00860262|157992970|FG001|Overall Study|Withdrawal by Subject|8|||
49043661|NCT00860262|157992971|FG002|Overall Study|Withdrawal by Subject|6|||
49043662|NCT00860262|157992969|FG000|Overall Study|Lack of Efficacy|0|||
49043663|NCT00860262|157992970|FG001|Overall Study|Lack of Efficacy|4|||
49043664|NCT00860262|157992971|FG002|Overall Study|Lack of Efficacy|3|||
49043665|NCT00860262|157992969|FG000|Overall Study|Other|5|||
49043666|NCT00860262|157992970|FG001|Overall Study|Other|3|||
49043667|NCT00860262|157992971|FG002|Overall Study|Other|1|||
49043668|NCT01596127|157992976|FG000|Overall Study|Patient Ineligible|1|||
49043669|NCT04194151|157992978|FG000|Overall Study|Physician Decision|1|||
49043670|NCT04194151|157992979|FG001|Overall Study|Physician Decision|1|||
49043671|NCT04194151|157992980|FG002|Overall Study|Physician Decision|1|||
49043672|NCT04194151|157992981|FG003|Overall Study|Physician Decision|1|||
49043673|NCT04194151|157992982|FG004|Overall Study|Physician Decision|0|||
49043674|NCT04194151|157992983|FG005|Overall Study|Physician Decision|1|||
49043675|NCT04194151|157992978|FG000|Overall Study|Monitorization problem|0|||
49043676|NCT04194151|157992979|FG001|Overall Study|Monitorization problem|1|||
49043677|NCT04194151|157992980|FG002|Overall Study|Monitorization problem|0|||
49043678|NCT04194151|157992981|FG003|Overall Study|Monitorization problem|0|||
49043679|NCT04194151|157992982|FG004|Overall Study|Monitorization problem|0|||
49043680|NCT04194151|157992983|FG005|Overall Study|Monitorization problem|0|||
49043681|NCT01378962|157992984|FG000|Overall Study|Death|14|||
49043682|NCT01378962|157992984|FG000|Overall Study|Lost to Follow-up|1|||
49043683|NCT01378962|157992984|FG000|Overall Study|Other|2|||
49043684|NCT02369458|157992985|FG000|Overall Study|Determined to be not eligible|1|||
49043685|NCT02369458|157992986|FG001|Overall Study|Determined to be not eligible|0|||
49043686|NCT00239005|157992987|FG000|Overall Study|Adverse Event|6|||
49043687|NCT00239005|157992988|FG001|Overall Study|Adverse Event|6|||
49043688|NCT00239005|157992987|FG000|Overall Study|Withdrawal by Subject|3|||
48988252|NCT03370133|157789110|FG005|Initial Treatment Period (WK 16)|Adverse Event|0|||
48988253|NCT03370133|157789105|FG000|Initial Treatment Period (WK 16)|Death|1|||
48988254|NCT03370133|157789106|FG001|Initial Treatment Period (WK 16)|Death|1|||
48988255|NCT03370133|157789107|FG002|Initial Treatment Period (WK 16)|Death|1|||
48988256|NCT03370133|157789108|FG003|Initial Treatment Period (WK 16)|Death|0|||
48988257|NCT03370133|157789109|FG004|Initial Treatment Period (WK 16)|Death|0|||
48988258|NCT03370133|157789110|FG005|Initial Treatment Period (WK 16)|Death|0|||
48988259|NCT03370133|157789105|FG000|Initial Treatment Period (WK 16)|Lack of Efficacy|2|||
49043689|NCT00239005|157992988|FG001|Overall Study|Withdrawal by Subject|4|||
49043690|NCT00239005|157992987|FG000|Overall Study|Unsatisfactory Therapeutic effect|2|||
49043691|NCT00239005|157992988|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
49043692|NCT00239005|157992987|FG000|Overall Study|Protocol Violation|1|||
49043693|NCT00239005|157992988|FG001|Overall Study|Protocol Violation|0|||
49043694|NCT00239005|157992987|FG000|Overall Study|Subj. cond. no longer needs study drug|0|||
49043695|NCT00239005|157992988|FG001|Overall Study|Subj. cond. no longer needs study drug|1|||
49043696|NCT00239005|157992987|FG000|Overall Study|Lost to Follow-up|0|||
49043697|NCT00239005|157992988|FG001|Overall Study|Lost to Follow-up|1|||
49043698|NCT00688844|157992989|FG000|Overall Study|Lost to Follow-up|10|||
49043699|NCT01968031|157992994|FG000|Overall Study|Adverse Event|13|||
49043700|NCT01968031|157992995|FG001|Overall Study|Adverse Event|10|||
49043701|NCT01968031|157992996|FG002|Overall Study|Adverse Event|22|||
49043702|NCT01968031|157992994|FG000|Overall Study|Withdrawal by Subject|3|||
48988260|NCT03370133|157789106|FG001|Initial Treatment Period (WK 16)|Lack of Efficacy|1|||
48988261|NCT03370133|157789107|FG002|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
48988262|NCT03370133|157789108|FG003|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
48988263|NCT03370133|157789109|FG004|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
48988264|NCT03370133|157789110|FG005|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
48988265|NCT03370133|157789105|FG000|Initial Treatment Period (WK 16)|Protocol Violation|0|||
48988266|NCT03370133|157789106|FG001|Initial Treatment Period (WK 16)|Protocol Violation|0|||
48988267|NCT03370133|157789107|FG002|Initial Treatment Period (WK 16)|Protocol Violation|2|||
48988268|NCT03370133|157789108|FG003|Initial Treatment Period (WK 16)|Protocol Violation|0|||
48988269|NCT03370133|157789109|FG004|Initial Treatment Period (WK 16)|Protocol Violation|0|||
48988270|NCT03370133|157789110|FG005|Initial Treatment Period (WK 16)|Protocol Violation|0|||
48988271|NCT03370133|157789105|FG000|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
48988272|NCT03370133|157789106|FG001|Initial Treatment Period (WK 16)|Lost to Follow-up|3|||
48988273|NCT03370133|157789107|FG002|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
49043703|NCT01968031|157992995|FG001|Overall Study|Withdrawal by Subject|7|||
49043704|NCT01968031|157992996|FG002|Overall Study|Withdrawal by Subject|3|||
49043705|NCT01968031|157992994|FG000|Overall Study|Did not meet entry criteria|1|||
49043706|NCT01968031|157992995|FG001|Overall Study|Did not meet entry criteria|1|||
49043707|NCT01968031|157992996|FG002|Overall Study|Did not meet entry criteria|1|||
49043708|NCT01968031|157992994|FG000|Overall Study|Noncompliance|0|||
49043709|NCT01968031|157992995|FG001|Overall Study|Noncompliance|0|||
49043710|NCT01968031|157992996|FG002|Overall Study|Noncompliance|2|||
49043711|NCT01968031|157992994|FG000|Overall Study|Failed inclusion criteria|0|||
49043712|NCT01968031|157992995|FG001|Overall Study|Failed inclusion criteria|2|||
48988274|NCT03370133|157789108|FG003|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
48988275|NCT03370133|157789109|FG004|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
48988276|NCT03370133|157789110|FG005|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
48988277|NCT03370133|157789105|FG000|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
48988278|NCT03370133|157789106|FG001|Initial Treatment Period (WK 16)|Withdrawal by Subject|2|||
48988279|NCT03370133|157789107|FG002|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
48988280|NCT03370133|157789108|FG003|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
48988281|NCT03370133|157789109|FG004|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
48988282|NCT03370133|157789110|FG005|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
48988283|NCT03370133|157789105|FG000|Initial Treatment Period (WK 16)|Non-compliance|0|||
48988284|NCT03370133|157789106|FG001|Initial Treatment Period (WK 16)|Non-compliance|1|||
48988285|NCT03370133|157789107|FG002|Initial Treatment Period (WK 16)|Non-compliance|0|||
48988286|NCT03370133|157789108|FG003|Initial Treatment Period (WK 16)|Non-compliance|0|||
48988287|NCT03370133|157789109|FG004|Initial Treatment Period (WK 16)|Non-compliance|0|||
48988288|NCT03370133|157789110|FG005|Initial Treatment Period (WK 16)|Non-compliance|0|||
48988289|NCT03370133|157789105|FG000|Initial Treatment Period (WK 16)|Site closed|0|||
48988290|NCT03370133|157789106|FG001|Initial Treatment Period (WK 16)|Site closed|2|||
48988291|NCT03370133|157789107|FG002|Initial Treatment Period (WK 16)|Site closed|0|||
48988292|NCT03370133|157789108|FG003|Initial Treatment Period (WK 16)|Site closed|0|||
48988293|NCT03370133|157789109|FG004|Initial Treatment Period (WK 16)|Site closed|0|||
48988294|NCT03370133|157789110|FG005|Initial Treatment Period (WK 16)|Site closed|0|||
48988295|NCT03370133|157789105|FG000|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
48988296|NCT03370133|157789106|FG001|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
48988297|NCT03370133|157789107|FG002|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
48988298|NCT03370133|157789108|FG003|Maintenance Treatment Period (WK 52)|Adverse Event|3|||
48988299|NCT03370133|157789109|FG004|Maintenance Treatment Period (WK 52)|Adverse Event|12|||
48988300|NCT03370133|157789110|FG005|Maintenance Treatment Period (WK 52)|Adverse Event|4|||
48988301|NCT03370133|157789105|FG000|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
48988302|NCT03370133|157789106|FG001|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
48988303|NCT03370133|157789107|FG002|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
48988304|NCT03370133|157789108|FG003|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
48988305|NCT03370133|157789109|FG004|Maintenance Treatment Period (WK 52)|Lack of Efficacy|1|||
48988306|NCT03370133|157789110|FG005|Maintenance Treatment Period (WK 52)|Lack of Efficacy|4|||
48988307|NCT03370133|157789105|FG000|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
48988308|NCT03370133|157789106|FG001|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
48988309|NCT03370133|157789107|FG002|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
48988310|NCT03370133|157789108|FG003|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
48988311|NCT03370133|157789109|FG004|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
48988312|NCT03370133|157789110|FG005|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
48988313|NCT03370133|157789105|FG000|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
48988314|NCT03370133|157789106|FG001|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
48988315|NCT03370133|157789107|FG002|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
48988316|NCT03370133|157789108|FG003|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
48988317|NCT03370133|157789109|FG004|Maintenance Treatment Period (WK 52)|Lost to Follow-up|4|||
48988318|NCT03370133|157789110|FG005|Maintenance Treatment Period (WK 52)|Lost to Follow-up|3|||
48988319|NCT03370133|157789105|FG000|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
48988320|NCT03370133|157789106|FG001|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
48988321|NCT03370133|157789107|FG002|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
48988322|NCT03370133|157789108|FG003|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|1|||
48988323|NCT03370133|157789109|FG004|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
48988324|NCT03370133|157789110|FG005|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
48988325|NCT03370133|157789105|FG000|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
48988326|NCT03370133|157789106|FG001|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
48988327|NCT03370133|157789107|FG002|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
48988328|NCT03370133|157789108|FG003|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
48988329|NCT03370133|157789109|FG004|Maintenance Treatment Period (WK 52)|Non-compliance|1|||
48988330|NCT03370133|157789110|FG005|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
48988331|NCT03370133|157789105|FG000|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
48988332|NCT03370133|157789106|FG001|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
48988333|NCT03370133|157789107|FG002|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
48988334|NCT03370133|157789108|FG003|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
48988335|NCT03370133|157789109|FG004|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
48988336|NCT03370133|157789110|FG005|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|1|||
48988337|NCT00689728|157789111|FG000|Double-Blind Treatment|Adverse Event|1|||
48988338|NCT00689728|157789112|FG001|Double-Blind Treatment|Adverse Event|0|||
48988339|NCT00689728|157789113|FG002|Double-Blind Treatment|Adverse Event|0|||
48988340|NCT00689728|157789111|FG000|Double-Blind Treatment|Protocol Violation|0|||
48988341|NCT00689728|157789112|FG001|Double-Blind Treatment|Protocol Violation|0|||
48988342|NCT00689728|157789113|FG002|Double-Blind Treatment|Protocol Violation|1|||
48988343|NCT00689728|157789111|FG000|Double-Blind Treatment|Withdrawal by Subject|3|||
48988344|NCT00689728|157789112|FG001|Double-Blind Treatment|Withdrawal by Subject|3|||
48988345|NCT00689728|157789113|FG002|Double-Blind Treatment|Withdrawal by Subject|2|||
48988346|NCT00689728|157789111|FG000|Double-Blind Treatment|Lack of Efficacy|0|||
48988347|NCT00689728|157789112|FG001|Double-Blind Treatment|Lack of Efficacy|1|||
48988348|NCT00689728|157789113|FG002|Double-Blind Treatment|Lack of Efficacy|2|||
48988349|NCT00689728|157789111|FG000|Rescue|Adverse Event|0|||
48988350|NCT00689728|157789112|FG001|Rescue|Adverse Event|1|||
48988351|NCT00689728|157789113|FG002|Rescue|Adverse Event|0|||
48988352|NCT00689728|157789111|FG000|Rescue|Withdrawal by Subject|1|||
48988353|NCT00689728|157789112|FG001|Rescue|Withdrawal by Subject|1|||
49043713|NCT01968031|157992996|FG002|Overall Study|Failed inclusion criteria|0|||
49043714|NCT01968031|157992994|FG000|Overall Study|Death|0|||
49043715|NCT01968031|157992995|FG001|Overall Study|Death|0|||
49043716|NCT01968031|157992996|FG002|Overall Study|Death|1|||
49043717|NCT01968031|157992994|FG000|Overall Study|Prohibited concomitant medication|1|||
49043718|NCT01968031|157992995|FG001|Overall Study|Prohibited concomitant medication|0|||
49043719|NCT01968031|157992996|FG002|Overall Study|Prohibited concomitant medication|0|||
49043720|NCT02490800|157992998|FG000|Overall Study|Adverse Event|0|||
49043721|NCT02490800|157992999|FG001|Overall Study|Adverse Event|0|||
49043722|NCT02490800|157993000|FG002|Overall Study|Adverse Event|0|||
49043723|NCT02490800|157993001|FG003|Overall Study|Adverse Event|2|||
49043724|NCT02490800|157993002|FG004|Overall Study|Adverse Event|3|||
48988354|NCT00689728|157789113|FG002|Rescue|Withdrawal by Subject|1|||
48988355|NCT00689728|157789111|FG000|Optional Follow-Up|Adverse Event|1|||
48988356|NCT00689728|157789112|FG001|Optional Follow-Up|Adverse Event|0|||
48988357|NCT00689728|157789113|FG002|Optional Follow-Up|Adverse Event|0|||
48988358|NCT00689728|157789111|FG000|Optional Follow-Up|Lack of Efficacy|0|||
48988359|NCT00689728|157789112|FG001|Optional Follow-Up|Lack of Efficacy|1|||
48988360|NCT00689728|157789113|FG002|Optional Follow-Up|Lack of Efficacy|1|||
48988361|NCT00689728|157789111|FG000|Optional Follow-Up|Lost to Follow-up|0|||
48988362|NCT00689728|157789112|FG001|Optional Follow-Up|Lost to Follow-up|1|||
48988363|NCT00689728|157789113|FG002|Optional Follow-Up|Lost to Follow-up|1|||
48988364|NCT00689728|157789111|FG000|Optional Follow-Up|Protocol Violation|0|||
48988365|NCT00689728|157789112|FG001|Optional Follow-Up|Protocol Violation|0|||
48988366|NCT00689728|157789113|FG002|Optional Follow-Up|Protocol Violation|1|||
48988367|NCT00689728|157789111|FG000|Optional Follow-Up|Withdrawal by Subject|2|||
48988368|NCT00689728|157789112|FG001|Optional Follow-Up|Withdrawal by Subject|4|||
48988369|NCT00689728|157789113|FG002|Optional Follow-Up|Withdrawal by Subject|3|||
49043725|NCT02490800|157993003|FG005|Overall Study|Adverse Event|2|||
49043726|NCT02490800|157993004|FG006|Overall Study|Adverse Event|0|||
49043727|NCT02490800|157993005|FG007|Overall Study|Adverse Event|0|||
49043728|NCT02490800|157993006|FG008|Overall Study|Adverse Event|0|||
49043729|NCT02490800|157993007|FG009|Overall Study|Adverse Event|0|||
49043730|NCT02490800|157993008|FG010|Overall Study|Adverse Event|0|||
49043731|NCT02490800|157993009|FG011|Overall Study|Adverse Event|2|||
49043732|NCT02490800|157993010|FG012|Overall Study|Adverse Event|2|||
49043733|NCT02490800|157992998|FG000|Overall Study|Withdrawal by Subject|0|||
49043734|NCT02490800|157992999|FG001|Overall Study|Withdrawal by Subject|0|||
48988370|NCT03655951|157789114|FG000|Overall Study|Lost to Follow-up|39|||
48988371|NCT03655951|157789115|FG001|Overall Study|Lost to Follow-up|20|||
48988372|NCT03655951|157789114|FG000|Overall Study|Withdrawal by Subject|0|||
48988373|NCT03655951|157789115|FG001|Overall Study|Withdrawal by Subject|1|||
48988374|NCT04806334|157789116|FG000|Overall Study|Withdrawal by Subject|1|||
48988375|NCT00598585|157789123|FG000|Overall Study|Lost to Follow-up|1|||
48988376|NCT00598585|157789124|FG001|Overall Study|Lost to Follow-up|0|||
48988377|NCT00842829|157789129|FG000|Dose Titration Period|Adverse Event|11|||
48988378|NCT00842829|157789130|FG001|Dose Titration Period|Adverse Event|10|||
49043735|NCT02490800|157993000|FG002|Overall Study|Withdrawal by Subject|0|||
49043736|NCT02490800|157993001|FG003|Overall Study|Withdrawal by Subject|1|||
49043737|NCT02490800|157993002|FG004|Overall Study|Withdrawal by Subject|0|||
49043738|NCT02490800|157993003|FG005|Overall Study|Withdrawal by Subject|0|||
49043739|NCT02490800|157993004|FG006|Overall Study|Withdrawal by Subject|0|||
49043740|NCT02490800|157993005|FG007|Overall Study|Withdrawal by Subject|0|||
48988379|NCT00842829|157789131|FG002|Dose Titration Period|Adverse Event|0|||
48988380|NCT00842829|157789129|FG000|Dose Titration Period|Lack of Efficacy|4|||
48988381|NCT00842829|157789130|FG001|Dose Titration Period|Lack of Efficacy|1|||
48988382|NCT00842829|157789131|FG002|Dose Titration Period|Lack of Efficacy|0|||
48988383|NCT00842829|157789129|FG000|Dose Titration Period|Unstable persistent cancer pain|1|||
48988384|NCT00842829|157789130|FG001|Dose Titration Period|Unstable persistent cancer pain|0|||
49043741|NCT02490800|157993006|FG008|Overall Study|Withdrawal by Subject|1|||
49043742|NCT02490800|157993007|FG009|Overall Study|Withdrawal by Subject|0|||
49043743|NCT02490800|157993008|FG010|Overall Study|Withdrawal by Subject|0|||
48988385|NCT00842829|157789131|FG002|Dose Titration Period|Unstable persistent cancer pain|0|||
48988386|NCT00842829|157789129|FG000|Dose Titration Period|Withdrawal by Subject|2|||
48988387|NCT00842829|157789130|FG001|Dose Titration Period|Withdrawal by Subject|6|||
48988388|NCT00842829|157789131|FG002|Dose Titration Period|Withdrawal by Subject|0|||
48988389|NCT00842829|157789129|FG000|Dose Titration Period|Other|5|||
48988390|NCT00842829|157789130|FG001|Dose Titration Period|Other|4|||
48988391|NCT00842829|157789131|FG002|Dose Titration Period|Other|0|||
48988392|NCT00842829|157789129|FG000|Dose Titration Period|Non-compliance to study procedures|1|||
48988393|NCT00842829|157789130|FG001|Dose Titration Period|Non-compliance to study procedures|1|||
48988394|NCT00842829|157789131|FG002|Dose Titration Period|Non-compliance to study procedures|0|||
48988395|NCT00842829|157789129|FG000|Dose Titration Period|Non-compliance to study drug|2|||
49043744|NCT02490800|157993009|FG011|Overall Study|Withdrawal by Subject|0|||
49043745|NCT02490800|157993010|FG012|Overall Study|Withdrawal by Subject|0|||
49043746|NCT02490800|157992998|FG000|Overall Study|Progressive disease|3|||
49043747|NCT02490800|157992999|FG001|Overall Study|Progressive disease|3|||
48988396|NCT00842829|157789130|FG001|Dose Titration Period|Non-compliance to study drug|1|||
48988397|NCT00842829|157789131|FG002|Dose Titration Period|Non-compliance to study drug|0|||
48988398|NCT00842829|157789129|FG000|Treatment Period|Adverse Event|0|||
48988399|NCT00842829|157789130|FG001|Treatment Period|Adverse Event|0|||
49043748|NCT02490800|157993000|FG002|Overall Study|Progressive disease|3|||
49043749|NCT02490800|157993001|FG003|Overall Study|Progressive disease|4|||
49043750|NCT02490800|157993002|FG004|Overall Study|Progressive disease|4|||
49043751|NCT02490800|157993003|FG005|Overall Study|Progressive disease|1|||
49043752|NCT02490800|157993004|FG006|Overall Study|Progressive disease|4|||
49043753|NCT02490800|157993005|FG007|Overall Study|Progressive disease|3|||
49043754|NCT02490800|157993006|FG008|Overall Study|Progressive disease|6|||
49043755|NCT02490800|157993007|FG009|Overall Study|Progressive disease|2|||
49043756|NCT02490800|157993008|FG010|Overall Study|Progressive disease|7|||
49043757|NCT02490800|157993009|FG011|Overall Study|Progressive disease|1|||
49043758|NCT02490800|157993010|FG012|Overall Study|Progressive disease|10|||
49043759|NCT02490800|157992998|FG000|Overall Study|Patient enrolled in post-trial access|0|||
49043760|NCT02490800|157992999|FG001|Overall Study|Patient enrolled in post-trial access|0|||
49043761|NCT02490800|157993000|FG002|Overall Study|Patient enrolled in post-trial access|0|||
49043762|NCT02490800|157993001|FG003|Overall Study|Patient enrolled in post-trial access|0|||
49043763|NCT02490800|157993002|FG004|Overall Study|Patient enrolled in post-trial access|0|||
49043764|NCT02490800|157993003|FG005|Overall Study|Patient enrolled in post-trial access|0|||
49043765|NCT02490800|157993004|FG006|Overall Study|Patient enrolled in post-trial access|0|||
48988400|NCT00842829|157789131|FG002|Treatment Period|Adverse Event|15|||
48988401|NCT00842829|157789129|FG000|Treatment Period|Lack of Efficacy|0|||
48988402|NCT00842829|157789130|FG001|Treatment Period|Lack of Efficacy|0|||
48988403|NCT00842829|157789131|FG002|Treatment Period|Lack of Efficacy|6|||
48988404|NCT00842829|157789129|FG000|Treatment Period|Unstable persistent cancer pain|0|||
48988405|NCT00842829|157789130|FG001|Treatment Period|Unstable persistent cancer pain|0|||
48988406|NCT00842829|157789131|FG002|Treatment Period|Unstable persistent cancer pain|5|||
48988407|NCT00842829|157789129|FG000|Treatment Period|Withdrawal by Subject|0|||
48988408|NCT00842829|157789130|FG001|Treatment Period|Withdrawal by Subject|0|||
48988409|NCT00842829|157789131|FG002|Treatment Period|Withdrawal by Subject|11|||
48988410|NCT00842829|157789129|FG000|Treatment Period|Consistently >4 BTP episodes daily|0|||
48988411|NCT00842829|157789130|FG001|Treatment Period|Consistently >4 BTP episodes daily|0|||
48988412|NCT00842829|157789131|FG002|Treatment Period|Consistently >4 BTP episodes daily|1|||
48988413|NCT00842829|157789129|FG000|Treatment Period|Protocol Violation|0|||
48988414|NCT00842829|157789130|FG001|Treatment Period|Protocol Violation|0|||
48988415|NCT00842829|157789131|FG002|Treatment Period|Protocol Violation|2|||
48988416|NCT00842829|157789129|FG000|Treatment Period|Other|0|||
48988417|NCT00842829|157789130|FG001|Treatment Period|Other|0|||
48988418|NCT00842829|157789131|FG002|Treatment Period|Other|18|||
48988419|NCT00842829|157789129|FG000|Treatment Period|Non-compliance to study procedures|0|||
48988420|NCT00842829|157789130|FG001|Treatment Period|Non-compliance to study procedures|0|||
48988421|NCT00842829|157789131|FG002|Treatment Period|Non-compliance to study procedures|4|||
48988422|NCT00842829|157789129|FG000|Treatment Period|Unclear completion status|0|||
48988423|NCT00842829|157789130|FG001|Treatment Period|Unclear completion status|0|||
48988424|NCT00842829|157789131|FG002|Treatment Period|Unclear completion status|1|||
48988425|NCT00842829|157789129|FG000|Continuation Period|Adverse Event|0|||
48988426|NCT00842829|157789130|FG001|Continuation Period|Adverse Event|0|||
48988427|NCT00842829|157789131|FG002|Continuation Period|Adverse Event|32|||
49043766|NCT02490800|157993005|FG007|Overall Study|Patient enrolled in post-trial access|0|||
49043767|NCT02490800|157993006|FG008|Overall Study|Patient enrolled in post-trial access|0|||
49043768|NCT02490800|157993007|FG009|Overall Study|Patient enrolled in post-trial access|1|||
48988428|NCT00842829|157789129|FG000|Continuation Period|Lack of Efficacy|0|||
48988429|NCT00842829|157789130|FG001|Continuation Period|Lack of Efficacy|0|||
49043769|NCT02490800|157993008|FG010|Overall Study|Patient enrolled in post-trial access|1|||
49043770|NCT02490800|157993009|FG011|Overall Study|Patient enrolled in post-trial access|0|||
49043771|NCT02490800|157993010|FG012|Overall Study|Patient enrolled in post-trial access|6|||
48988430|NCT00842829|157789131|FG002|Continuation Period|Lack of Efficacy|6|||
48988431|NCT00842829|157789129|FG000|Continuation Period|Unstable persistent cancer pain|0|||
48988432|NCT00842829|157789130|FG001|Continuation Period|Unstable persistent cancer pain|0|||
48988433|NCT00842829|157789131|FG002|Continuation Period|Unstable persistent cancer pain|3|||
48988434|NCT00842829|157789129|FG000|Continuation Period|Withdrawal by Subject|0|||
48988435|NCT00842829|157789130|FG001|Continuation Period|Withdrawal by Subject|0|||
48988436|NCT00842829|157789131|FG002|Continuation Period|Withdrawal by Subject|10|||
48988437|NCT00842829|157789129|FG000|Continuation Period|Other|0|||
48988438|NCT00842829|157789130|FG001|Continuation Period|Other|0|||
48988439|NCT00842829|157789131|FG002|Continuation Period|Other|7|||
49043772|NCT01169038|157993011|FG000|Overall Study|Death|1|||
49043773|NCT01169038|157993011|FG000|Overall Study|Adverse Event|5|||
49043774|NCT01169038|157993011|FG000|Overall Study|Required antibiotic administration|1|||
49043775|NCT01488448|157993012|FG000|Overall Study|Withdrawal by Subject|3|||
49043776|NCT01488448|157993013|FG001|Overall Study|Withdrawal by Subject|1|||
49043777|NCT01488448|157993012|FG000|Overall Study|Adverse Event|9|||
49043778|NCT01488448|157993013|FG001|Overall Study|Adverse Event|4|||
49043779|NCT01488448|157993012|FG000|Overall Study|Physician Decision|4|||
49043780|NCT01488448|157993013|FG001|Overall Study|Physician Decision|9|||
49043781|NCT01488448|157993012|FG000|Overall Study|Protocol Violation|4|||
49043782|NCT01488448|157993013|FG001|Overall Study|Protocol Violation|3|||
49043783|NCT01992094|157993014|FG000|Overall Study|ADMINISTRATIVE REASON|6|||
49043784|NCT01992094|157993015|FG001|Overall Study|ADMINISTRATIVE REASON|7|||
49043785|NCT01992094|157993016|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
49043786|NCT01992094|157993014|FG000|Overall Study|Adverse Event|1|||
49043787|NCT01992094|157993015|FG001|Overall Study|Adverse Event|0|||
49043788|NCT01992094|157993016|FG002|Overall Study|Adverse Event|0|||
49043789|NCT01992094|157993014|FG000|Overall Study|Death|5|||
49043790|NCT01992094|157993015|FG001|Overall Study|Death|5|||
49043791|NCT01992094|157993016|FG002|Overall Study|Death|2|||
49043792|NCT01992094|157993014|FG000|Overall Study|Lost to Follow-up|26|||
49043793|NCT01992094|157993015|FG001|Overall Study|Lost to Follow-up|9|||
49043794|NCT01992094|157993016|FG002|Overall Study|Lost to Follow-up|13|||
49043795|NCT01992094|157993014|FG000|Overall Study|OTHER|4|||
49043796|NCT01992094|157993015|FG001|Overall Study|OTHER|0|||
49043797|NCT01992094|157993016|FG002|Overall Study|OTHER|0|||
49043798|NCT01992094|157993014|FG000|Overall Study|Protocol Violation|1|||
49043799|NCT01992094|157993015|FG001|Overall Study|Protocol Violation|0|||
49043800|NCT01992094|157993016|FG002|Overall Study|Protocol Violation|1|||
49043801|NCT01992094|157993014|FG000|Overall Study|Withdrawal by Subject|7|||
49043802|NCT01992094|157993015|FG001|Overall Study|Withdrawal by Subject|3|||
49043803|NCT01992094|157993016|FG002|Overall Study|Withdrawal by Subject|4|||
49043804|NCT04640194|157993017|FG000|Overall Study|Adverse Event|3|||
49043805|NCT04640194|157993018|FG001|Overall Study|Adverse Event|7|||
49043806|NCT04640194|157993019|FG002|Overall Study|Adverse Event|0|||
49043807|NCT04640194|157993020|FG003|Overall Study|Adverse Event|5|||
49043808|NCT04640194|157993021|FG004|Overall Study|Adverse Event|0|||
49043809|NCT04640194|157993022|FG005|Overall Study|Adverse Event|4|||
49043810|NCT04640194|157993023|FG006|Overall Study|Adverse Event|0|||
49043811|NCT04640194|157993017|FG000|Overall Study|pO2/FIO2 ratio too high|0|||
49043812|NCT04640194|157993018|FG001|Overall Study|pO2/FIO2 ratio too high|0|||
49043813|NCT04640194|157993019|FG002|Overall Study|pO2/FIO2 ratio too high|0|||
49043814|NCT04640194|157993020|FG003|Overall Study|pO2/FIO2 ratio too high|1|||
49043815|NCT04640194|157993021|FG004|Overall Study|pO2/FIO2 ratio too high|0|||
49043816|NCT04640194|157993022|FG005|Overall Study|pO2/FIO2 ratio too high|0|||
49043817|NCT04640194|157993023|FG006|Overall Study|pO2/FIO2 ratio too high|0|||
49043818|NCT04640194|157993017|FG000|Overall Study|fibrinogen level too low|0|||
49043819|NCT04640194|157993018|FG001|Overall Study|fibrinogen level too low|0|||
49043820|NCT04640194|157993019|FG002|Overall Study|fibrinogen level too low|0|||
49043821|NCT04640194|157993020|FG003|Overall Study|fibrinogen level too low|1|||
49043822|NCT04640194|157993021|FG004|Overall Study|fibrinogen level too low|0|||
49043823|NCT04640194|157993022|FG005|Overall Study|fibrinogen level too low|0|||
49043824|NCT04640194|157993023|FG006|Overall Study|fibrinogen level too low|0|||
49043825|NCT04640194|157993017|FG000|Overall Study|mild bleeding|0|||
49043826|NCT04640194|157993018|FG001|Overall Study|mild bleeding|0|||
49043827|NCT04640194|157993019|FG002|Overall Study|mild bleeding|0|||
49043828|NCT04640194|157993020|FG003|Overall Study|mild bleeding|1|||
49043829|NCT04640194|157993021|FG004|Overall Study|mild bleeding|0|||
49043830|NCT04640194|157993022|FG005|Overall Study|mild bleeding|0|||
49043831|NCT04640194|157993023|FG006|Overall Study|mild bleeding|0|||
49043832|NCT04640194|157993017|FG000|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
49043833|NCT04640194|157993018|FG001|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|1|||
49043834|NCT04640194|157993019|FG002|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
49043835|NCT04640194|157993020|FG003|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
48988440|NCT00842829|157789129|FG000|Continuation Period|Non-compliance to study procedures|0|||
49043836|NCT04640194|157993021|FG004|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
48988441|NCT00842829|157789130|FG001|Continuation Period|Non-compliance to study procedures|0|||
48988442|NCT00842829|157789131|FG002|Continuation Period|Non-compliance to study procedures|2|||
48988443|NCT00842829|157789129|FG000|Continuation Period|Non-compliance to study drug|0|||
48988444|NCT00842829|157789130|FG001|Continuation Period|Non-compliance to study drug|0|||
48988445|NCT00842829|157789131|FG002|Continuation Period|Non-compliance to study drug|1|||
48988446|NCT02972658|157790850|FG000|Overall Study|Adverse Event|0|||
48988447|NCT02972658|157790851|FG001|Overall Study|Adverse Event|3|||
48988448|NCT02972658|157790852|FG002|Overall Study|Adverse Event|0|||
48988449|NCT02972658|157790853|FG003|Overall Study|Adverse Event|2|||
48988450|NCT02972658|157790850|FG000|Overall Study|Other-determined by Investigator|1|||
48988451|NCT02972658|157790851|FG001|Overall Study|Other-determined by Investigator|1|||
48988452|NCT02972658|157790852|FG002|Overall Study|Other-determined by Investigator|0|||
48988453|NCT02972658|157790853|FG003|Overall Study|Other-determined by Investigator|0|||
48988454|NCT02972658|157790850|FG000|Overall Study|Death|0|||
48988455|NCT02972658|157790851|FG001|Overall Study|Death|0|||
48988456|NCT02972658|157790852|FG002|Overall Study|Death|0|||
48988457|NCT02972658|157790853|FG003|Overall Study|Death|1|||
48988458|NCT02972658|157790850|FG000|Overall Study|Lost to Follow-up|0|||
48988459|NCT02972658|157790851|FG001|Overall Study|Lost to Follow-up|1|||
48988460|NCT02972658|157790852|FG002|Overall Study|Lost to Follow-up|1|||
48988461|NCT02972658|157790853|FG003|Overall Study|Lost to Follow-up|2|||
48988462|NCT02972658|157790850|FG000|Overall Study|Progressive Disease|0|||
48988463|NCT02972658|157790851|FG001|Overall Study|Progressive Disease|1|||
48988464|NCT02972658|157790852|FG002|Overall Study|Progressive Disease|0|||
48988465|NCT02972658|157790853|FG003|Overall Study|Progressive Disease|1|||
48988466|NCT02972658|157790850|FG000|Overall Study|Withdrawal by Subject|4|||
48988467|NCT02972658|157790851|FG001|Overall Study|Withdrawal by Subject|4|||
48988468|NCT02972658|157790852|FG002|Overall Study|Withdrawal by Subject|1|||
48988469|NCT02972658|157790853|FG003|Overall Study|Withdrawal by Subject|6|||
48988470|NCT02972658|157790850|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
48988471|NCT02972658|157790851|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
48988472|NCT02972658|157790852|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
48988473|NCT02972658|157790853|FG003|Overall Study|Withdrawal due to Caregiver Circumstance|0|||
48988474|NCT02972658|157790850|FG000|Overall Study|Sponsor Decision|70|||
48988475|NCT02972658|157790851|FG001|Overall Study|Sponsor Decision|127|||
48988476|NCT02972658|157790852|FG002|Overall Study|Sponsor Decision|72|||
48988477|NCT02972658|157790853|FG003|Overall Study|Sponsor Decision|119|||
48988478|NCT02146274|157790854|FG000|Overall Study|Protocol Violation|73|||
48988479|NCT02039687|157790857|FG000|Overall Study|Adverse Event|0|||
48988480|NCT02039687|157790858|FG001|Overall Study|Adverse Event|0|||
48988481|NCT02039687|157790859|FG002|Overall Study|Adverse Event|1|||
48988482|NCT02039687|157790860|FG003|Overall Study|Adverse Event|0|||
48988483|NCT02039687|157790857|FG000|Overall Study|Withdrawal by Subject|0|||
48988484|NCT02039687|157790858|FG001|Overall Study|Withdrawal by Subject|1|||
48988485|NCT02039687|157790859|FG002|Overall Study|Withdrawal by Subject|0|||
48988486|NCT02039687|157790860|FG003|Overall Study|Withdrawal by Subject|0|||
48988487|NCT02039687|157790857|FG000|Overall Study|treatment assignment could not be confir|0|||
48988488|NCT02039687|157790858|FG001|Overall Study|treatment assignment could not be confir|0|||
48988489|NCT02039687|157790859|FG002|Overall Study|treatment assignment could not be confir|2|||
48988490|NCT02039687|157790860|FG003|Overall Study|treatment assignment could not be confir|0|||
48988491|NCT00768040|157790863|FG000|Overall Study|Adverse Event|3|||
48988492|NCT00768040|157790864|FG001|Overall Study|Adverse Event|2|||
48988493|NCT00768040|157790863|FG000|Overall Study|Abnormal laboratory value|1|||
48988494|NCT00768040|157790864|FG001|Overall Study|Abnormal laboratory value|1|||
48988495|NCT01066819|157790865|FG000|Overall Study|Adverse Event|18|||
48988496|NCT01066819|157790866|FG001|Overall Study|Adverse Event|1|||
48988497|NCT01066819|157790867|FG002|Overall Study|Adverse Event|6|||
48988498|NCT01066819|157790868|FG003|Overall Study|Adverse Event|0|||
48988499|NCT01066819|157790869|FG004|Overall Study|Adverse Event|0|||
48988500|NCT01066819|157790870|FG005|Overall Study|Adverse Event|0|||
48988501|NCT01066819|157790865|FG000|Overall Study|Death|5|||
48988502|NCT01066819|157790866|FG001|Overall Study|Death|0|||
48988503|NCT01066819|157790867|FG002|Overall Study|Death|1|||
48988504|NCT01066819|157790868|FG003|Overall Study|Death|0|||
48988505|NCT01066819|157790869|FG004|Overall Study|Death|0|||
48988506|NCT01066819|157790870|FG005|Overall Study|Death|0|||
48988507|NCT01066819|157790865|FG000|Overall Study|Lack of Efficacy|22|||
48988508|NCT01066819|157790866|FG001|Overall Study|Lack of Efficacy|1|||
48988509|NCT01066819|157790867|FG002|Overall Study|Lack of Efficacy|2|||
48988510|NCT01066819|157790868|FG003|Overall Study|Lack of Efficacy|1|||
48988511|NCT01066819|157790869|FG004|Overall Study|Lack of Efficacy|0|||
48988512|NCT01066819|157790870|FG005|Overall Study|Lack of Efficacy|0|||
48988513|NCT01066819|157790865|FG000|Overall Study|Physician Decision|6|||
48988514|NCT01066819|157790866|FG001|Overall Study|Physician Decision|2|||
48988515|NCT01066819|157790867|FG002|Overall Study|Physician Decision|3|||
48988516|NCT01066819|157790868|FG003|Overall Study|Physician Decision|0|||
48988517|NCT01066819|157790869|FG004|Overall Study|Physician Decision|0|||
48988518|NCT01066819|157790870|FG005|Overall Study|Physician Decision|0|||
48988519|NCT01066819|157790865|FG000|Overall Study|Protocol Violation|12|||
48988520|NCT01066819|157790866|FG001|Overall Study|Protocol Violation|6|||
48988521|NCT01066819|157790867|FG002|Overall Study|Protocol Violation|0|||
48988522|NCT01066819|157790868|FG003|Overall Study|Protocol Violation|0|||
48988523|NCT01066819|157790869|FG004|Overall Study|Protocol Violation|0|||
48988524|NCT01066819|157790870|FG005|Overall Study|Protocol Violation|0|||
48988525|NCT01066819|157790865|FG000|Overall Study|Withdrawal by Subject|29|||
48988526|NCT01066819|157790866|FG001|Overall Study|Withdrawal by Subject|11|||
48988527|NCT01066819|157790867|FG002|Overall Study|Withdrawal by Subject|6|||
48988528|NCT01066819|157790868|FG003|Overall Study|Withdrawal by Subject|0|||
48988529|NCT01066819|157790869|FG004|Overall Study|Withdrawal by Subject|0|||
48988530|NCT01066819|157790870|FG005|Overall Study|Withdrawal by Subject|0|||
48988531|NCT01066819|157790865|FG000|Overall Study|Administrative|6|||
48988532|NCT01066819|157790866|FG001|Overall Study|Administrative|4|||
48988533|NCT01066819|157790867|FG002|Overall Study|Administrative|2|||
48988534|NCT01066819|157790868|FG003|Overall Study|Administrative|0|||
48988535|NCT01066819|157790869|FG004|Overall Study|Administrative|0|||
48988536|NCT01066819|157790870|FG005|Overall Study|Administrative|0|||
48988537|NCT01066819|157790865|FG000|Overall Study|Not met inclusion/exclusion criteria|1|||
48988538|NCT01066819|157790866|FG001|Overall Study|Not met inclusion/exclusion criteria|0|||
48988539|NCT01066819|157790867|FG002|Overall Study|Not met inclusion/exclusion criteria|0|||
48988540|NCT01066819|157790868|FG003|Overall Study|Not met inclusion/exclusion criteria|0|||
48988541|NCT01066819|157790869|FG004|Overall Study|Not met inclusion/exclusion criteria|0|||
48988542|NCT01066819|157790870|FG005|Overall Study|Not met inclusion/exclusion criteria|0|||
48988543|NCT01066819|157790865|FG000|Overall Study|Early termination|2|||
48988544|NCT01066819|157790866|FG001|Overall Study|Early termination|0|||
48988545|NCT01066819|157790867|FG002|Overall Study|Early termination|0|||
48988546|NCT01066819|157790868|FG003|Overall Study|Early termination|0|||
48988547|NCT01066819|157790869|FG004|Overall Study|Early termination|0|||
48988548|NCT01066819|157790870|FG005|Overall Study|Early termination|0|||
48988549|NCT01066819|157790865|FG000|Overall Study|Failed to return|298|||
48988550|NCT01066819|157790866|FG001|Overall Study|Failed to return|107|||
48988551|NCT01066819|157790867|FG002|Overall Study|Failed to return|68|||
48988552|NCT01066819|157790868|FG003|Overall Study|Failed to return|7|||
48988553|NCT01066819|157790869|FG004|Overall Study|Failed to return|2|||
48988554|NCT01066819|157790870|FG005|Overall Study|Failed to return|3|||
49043837|NCT04640194|157993022|FG005|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
49043838|NCT04640194|157993023|FG006|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
49043839|NCT01214239|157993024|FG000|Overall Study|Adverse Event|3|||
49043840|NCT01214239|157993025|FG001|Overall Study|Adverse Event|4|||
48988555|NCT01066819|157790865|FG000|Overall Study|Lab test not done|9|||
48988556|NCT01066819|157790866|FG001|Overall Study|Lab test not done|0|||
48988557|NCT01066819|157790867|FG002|Overall Study|Lab test not done|2|||
48988558|NCT01066819|157790868|FG003|Overall Study|Lab test not done|1|||
48988559|NCT01066819|157790869|FG004|Overall Study|Lab test not done|0|||
48988560|NCT01066819|157790870|FG005|Overall Study|Lab test not done|0|||
49043841|NCT01214239|157993024|FG000|Overall Study|Protocol Violation|2|||
49043842|NCT01214239|157993025|FG001|Overall Study|Protocol Violation|1|||
49043843|NCT01214239|157993024|FG000|Overall Study|Lost to Follow-up|1|||
49043844|NCT01214239|157993025|FG001|Overall Study|Lost to Follow-up|1|||
48988561|NCT01066819|157790865|FG000|Overall Study|Miscellaneous|28|||
48988562|NCT01066819|157790866|FG001|Overall Study|Miscellaneous|10|||
48988563|NCT01066819|157790867|FG002|Overall Study|Miscellaneous|18|||
49043845|NCT01214239|157993024|FG000|Overall Study|Withdrawal by Subject|4|||
48988564|NCT01066819|157790868|FG003|Overall Study|Miscellaneous|1|||
48988565|NCT01066819|157790869|FG004|Overall Study|Miscellaneous|0|||
48988566|NCT01066819|157790870|FG005|Overall Study|Miscellaneous|0|||
48988567|NCT01066819|157790865|FG000|Overall Study|Non responders|123|||
48988568|NCT01066819|157790866|FG001|Overall Study|Non responders|2|||
48988569|NCT01066819|157790867|FG002|Overall Study|Non responders|7|||
48988570|NCT01066819|157790868|FG003|Overall Study|Non responders|2|||
48988571|NCT01066819|157790869|FG004|Overall Study|Non responders|0|||
48988572|NCT01066819|157790870|FG005|Overall Study|Non responders|1|||
48988573|NCT01066819|157790865|FG000|Overall Study|Not categorised|9|||
48988574|NCT01066819|157790866|FG001|Overall Study|Not categorised|2|||
48988575|NCT01066819|157790867|FG002|Overall Study|Not categorised|6|||
48988576|NCT01066819|157790868|FG003|Overall Study|Not categorised|1|||
49043846|NCT01214239|157993025|FG001|Overall Study|Withdrawal by Subject|9|||
49043847|NCT01214239|157993024|FG000|Overall Study|Lack of Efficacy|1|||
48988577|NCT01066819|157790869|FG004|Overall Study|Not categorised|0|||
48988578|NCT01066819|157790870|FG005|Overall Study|Not categorised|0|||
48988579|NCT01066819|157790865|FG000|Overall Study|Relapse|16|||
48988580|NCT01066819|157790866|FG001|Overall Study|Relapse|4|||
48988581|NCT01066819|157790867|FG002|Overall Study|Relapse|3|||
48988582|NCT01066819|157790868|FG003|Overall Study|Relapse|0|||
48988583|NCT01066819|157790869|FG004|Overall Study|Relapse|0|||
48988584|NCT01066819|157790870|FG005|Overall Study|Relapse|0|||
48988585|NCT01066819|157790865|FG000|Overall Study|Results not available|1|||
49043848|NCT01214239|157993025|FG001|Overall Study|Lack of Efficacy|2|||
49043849|NCT01214239|157993024|FG000|Overall Study|patient's private reason|1|||
49043850|NCT01214239|157993025|FG001|Overall Study|patient's private reason|1|||
49043851|NCT00834613|157993026|FG000|First Intervention|Protocol Violation|1|||
49043852|NCT00834613|157993027|FG001|First Intervention|Protocol Violation|0|||
49043853|NCT03088813|157994578|FG000|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
49043854|NCT03088813|157994579|FG001|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|1|||
49043855|NCT03088813|157994580|FG002|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
49043856|NCT03088813|157994581|FG003|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
49043857|NCT03088813|157994578|FG000|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
49043858|NCT03088813|157994579|FG001|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
49043859|NCT03088813|157994580|FG002|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|1|||
49043860|NCT03088813|157994581|FG003|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
49043861|NCT03088813|157994578|FG000|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
49043862|NCT03088813|157994579|FG001|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
49043863|NCT03088813|157994580|FG002|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
49043864|NCT03088813|157994581|FG003|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
49043865|NCT03088813|157994578|FG000|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
49043866|NCT03088813|157994579|FG001|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
49043867|NCT03088813|157994580|FG002|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|3|||
49043868|NCT03088813|157994581|FG003|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|4|||
49043869|NCT03088813|157994578|FG000|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
49043870|NCT03088813|157994579|FG001|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
49043871|NCT03088813|157994580|FG002|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|18|||
49043872|NCT03088813|157994581|FG003|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|14|||
49043873|NCT03088813|157994578|FG000|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
49043874|NCT03088813|157994579|FG001|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
49043875|NCT03088813|157994580|FG002|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
49043876|NCT03088813|157994581|FG003|Part 2: Randomized Study (Upto Week 197)|Screen failure|1|||
49043877|NCT03088813|157994578|FG000|Part 2: Randomized Study (Upto Week 197)|Other|0|||
49043878|NCT03088813|157994579|FG001|Part 2: Randomized Study (Upto Week 197)|Other|0|||
49043879|NCT03088813|157994580|FG002|Part 2: Randomized Study (Upto Week 197)|Other|3|||
49043880|NCT03088813|157994581|FG003|Part 2: Randomized Study (Upto Week 197)|Other|0|||
49043881|NCT00288704|157994582|FG000|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
49043882|NCT00288704|157994583|FG001|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1|||
49043883|NCT00288704|157994584|FG002|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
49043884|NCT00288704|157994582|FG000|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
49043885|NCT00288704|157994583|FG001|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1|||
49043886|NCT00288704|157994584|FG002|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
49043887|NCT00288704|157994582|FG000|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
49043888|NCT00288704|157994583|FG001|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
49043889|NCT00288704|157994584|FG002|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1|||
49043890|NCT00288704|157994582|FG000|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
49043891|NCT00288704|157994583|FG001|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
49043892|NCT00288704|157994584|FG002|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1|||
49043893|NCT00288704|157994582|FG000|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
49043894|NCT00288704|157994583|FG001|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
49043895|NCT00288704|157994584|FG002|Open-Label Extension (OLE) Weeks 24-117|Death|2|||
49043896|NCT00288704|157994582|FG000|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
49043897|NCT00288704|157994583|FG001|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
49043898|NCT00288704|157994584|FG002|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15|||
49043899|NCT00288704|157994582|FG000|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
49043900|NCT00288704|157994583|FG001|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
49043901|NCT00288704|157994584|FG002|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1|||
49043902|NCT00691704|157994586|FG000|Induction Therapy|Disease Progression|1|||
49043903|NCT00691704|157994586|FG000|Induction Therapy|Active Hepatitis|1|||
49043904|NCT00691704|157994586|FG000|Two Years of Maintenance Therapy|Disease Progression|8|||
49043905|NCT00691704|157994586|FG000|Two Years of Maintenance Therapy|Physician Decision|4|||
49043906|NCT00691704|157994586|FG000|Two Years of Maintenance Therapy|Withdrawal by Subject|1|||
49043907|NCT01579006|157994587|FG000|Overall Study|Lack of Efficacy|10|||
49043908|NCT01579006|157994587|FG000|Overall Study|Adverse Event|13|||
49043909|NCT01579006|157994587|FG000|Overall Study|Withdrawal by Subject|5|||
49043910|NCT01579006|157994587|FG000|Overall Study|Non-compliance|3|||
49043911|NCT01579006|157994587|FG000|Overall Study|Due to participant's health fund|1|||
49043912|NCT01579006|157994587|FG000|Overall Study|Scheduled surgery|1|||
49043913|NCT00544167|157994588|FG000|Overall Study|Adverse Event|21|||
49043914|NCT00544167|157994588|FG000|Overall Study|Physician Decision|8|||
48988586|NCT01066819|157790866|FG001|Overall Study|Results not available|0|||
48988587|NCT01066819|157790867|FG002|Overall Study|Results not available|0|||
48988588|NCT01066819|157790868|FG003|Overall Study|Results not available|0|||
48988589|NCT01066819|157790869|FG004|Overall Study|Results not available|0|||
48988590|NCT01066819|157790870|FG005|Overall Study|Results not available|0|||
48988591|NCT01066819|157790865|FG000|Overall Study|Screen failure|1|||
48988592|NCT01066819|157790866|FG001|Overall Study|Screen failure|0|||
48988593|NCT01066819|157790867|FG002|Overall Study|Screen failure|0|||
48988594|NCT01066819|157790868|FG003|Overall Study|Screen failure|0|||
48988595|NCT01066819|157790869|FG004|Overall Study|Screen failure|0|||
48988596|NCT01066819|157790870|FG005|Overall Study|Screen failure|0|||
48988597|NCT01066819|157790865|FG000|Overall Study|Spontaneous cure|1|||
48988598|NCT01066819|157790866|FG001|Overall Study|Spontaneous cure|0|||
48988599|NCT01066819|157790867|FG002|Overall Study|Spontaneous cure|0|||
48988600|NCT01066819|157790868|FG003|Overall Study|Spontaneous cure|0|||
48988601|NCT01066819|157790869|FG004|Overall Study|Spontaneous cure|0|||
48988602|NCT01066819|157790870|FG005|Overall Study|Spontaneous cure|0|||
48988603|NCT01066819|157790865|FG000|Overall Study|Treatment never started|85|||
48988604|NCT01066819|157790866|FG001|Overall Study|Treatment never started|19|||
48988605|NCT01066819|157790867|FG002|Overall Study|Treatment never started|19|||
48988606|NCT01066819|157790868|FG003|Overall Study|Treatment never started|3|||
48988607|NCT01066819|157790869|FG004|Overall Study|Treatment never started|2|||
48988608|NCT01066819|157790870|FG005|Overall Study|Treatment never started|2|||
48988609|NCT01066819|157790865|FG000|Overall Study|Treatment stopped|12|||
49043915|NCT00198133|157994591|FG000|Overall Study|Disease progression|2|||
49043916|NCT00198133|157994592|FG001|Overall Study|Disease progression|5|||
49043917|NCT00198133|157994591|FG000|Overall Study|Adverse Event|1|||
49043918|NCT00198133|157994592|FG001|Overall Study|Adverse Event|3|||
49043919|NCT00198133|157994591|FG000|Overall Study|Withdrawal by Subject|1|||
49043920|NCT00198133|157994592|FG001|Overall Study|Withdrawal by Subject|0|||
49043921|NCT00198133|157994591|FG000|Overall Study|Physician Decision|1|||
49043922|NCT00198133|157994592|FG001|Overall Study|Physician Decision|0|||
49043923|NCT03314857|157994593|FG000|Overall Study|Death|4|||
49043924|NCT03314857|157994593|FG000|Overall Study|Physician Decision|1|||
49043925|NCT00396630|157994594|FG000|Overall Study|Lost to Follow-up|1|||
49043926|NCT00396630|157994595|FG001|Overall Study|Lost to Follow-up|1|||
49043927|NCT00396630|157994594|FG000|Overall Study|Withdrawal by Subject|1|||
49043928|NCT00396630|157994595|FG001|Overall Study|Withdrawal by Subject|1|||
49043929|NCT00396630|157994594|FG000|Overall Study|Not vaccinated at Visit 3|3|||
49043930|NCT00396630|157994595|FG001|Overall Study|Not vaccinated at Visit 3|3|||
49043931|NCT01119625|157994598|FG000|Overall Study|Lost to Follow-up|1|||
49043932|NCT01119625|157994599|FG001|Overall Study|Lost to Follow-up|2|||
49043933|NCT01119625|157994598|FG000|Overall Study|Withdrawal by Subject|2|||
49043934|NCT01119625|157994599|FG001|Overall Study|Withdrawal by Subject|1|||
49043935|NCT01119625|157994598|FG000|Overall Study|Other|0|||
49043936|NCT01119625|157994599|FG001|Overall Study|Other|1|||
48988610|NCT01066819|157790866|FG001|Overall Study|Treatment stopped|1|||
48988611|NCT01066819|157790867|FG002|Overall Study|Treatment stopped|2|||
48988612|NCT01066819|157790868|FG003|Overall Study|Treatment stopped|1|||
48988613|NCT01066819|157790869|FG004|Overall Study|Treatment stopped|0|||
48988614|NCT01066819|157790870|FG005|Overall Study|Treatment stopped|0|||
48988615|NCT01066819|157790865|FG000|Overall Study|Other|5|||
48988616|NCT01066819|157790866|FG001|Overall Study|Other|1|||
48988617|NCT01066819|157790867|FG002|Overall Study|Other|1|||
48988618|NCT01066819|157790868|FG003|Overall Study|Other|0|||
49043937|NCT03888235|157994600|FG000|Overall Study|Lost to Follow-up|1|||
49043938|NCT03888235|157994601|FG001|Overall Study|Lost to Follow-up|1|||
49043939|NCT03888235|157994602|FG002|Overall Study|Lost to Follow-up|0|||
49043940|NCT02906917|157994603|FG000|Initiation Period (Week 0-26)|Unclassified|1|||
49043941|NCT02906917|157994604|FG001|Initiation Period (Week 0-26)|Unclassified|3|||
49043942|NCT02906917|157994603|FG000|Initiation Period (Week 0-26)|Adverse Event|1|||
49043943|NCT02906917|157994604|FG001|Initiation Period (Week 0-26)|Adverse Event|0|||
49043944|NCT02906917|157994603|FG000|Initiation Period (Week 0-26)|Lost to Follow-up|1|||
49043945|NCT02906917|157994604|FG001|Initiation Period (Week 0-26)|Lost to Follow-up|4|||
49043946|NCT02906917|157994603|FG000|Initiation Period (Week 0-26)|Withdrawal by Subject|3|||
49043947|NCT02906917|157994604|FG001|Initiation Period (Week 0-26)|Withdrawal by Subject|4|||
49043948|NCT02906917|157994603|FG000|Intensification Period (Week 26-38)|Unclassified|3|||
49043949|NCT02906917|157994604|FG001|Intensification Period (Week 26-38)|Unclassified|2|||
48988619|NCT01066819|157790869|FG004|Overall Study|Other|0|||
48988620|NCT01066819|157790870|FG005|Overall Study|Other|0|||
48988621|NCT03322540|157790871|FG000|Overall Study|Death|21|||
48988622|NCT03322540|157790872|FG001|Overall Study|Death|28|||
48988623|NCT03322540|157790871|FG000|Overall Study|Lost to Follow-up|0|||
48988624|NCT03322540|157790872|FG001|Overall Study|Lost to Follow-up|1|||
48988625|NCT03322540|157790871|FG000|Overall Study|Physician Decision|7|||
48988626|NCT03322540|157790872|FG001|Overall Study|Physician Decision|6|||
48988627|NCT03322540|157790871|FG000|Overall Study|Withdrawal by Subject|3|||
48988628|NCT03322540|157790872|FG001|Overall Study|Withdrawal by Subject|1|||
48988629|NCT03322540|157790871|FG000|Overall Study|Study terminated by sponsor|0|||
48988630|NCT03322540|157790872|FG001|Overall Study|Study terminated by sponsor|1|||
48988631|NCT01038609|157790874|FG000|Overall Study|Adverse Event|0|||
48988632|NCT01038609|157790875|FG001|Overall Study|Adverse Event|0|||
48988633|NCT01038609|157790876|FG002|Overall Study|Adverse Event|1|||
48988634|NCT01038609|157790877|FG003|Overall Study|Adverse Event|0|||
48988635|NCT01038609|157790878|FG004|Overall Study|Adverse Event|0|||
48988636|NCT01038609|157790874|FG000|Overall Study|Dosing Error|0|||
48988637|NCT01038609|157790875|FG001|Overall Study|Dosing Error|0|||
48988638|NCT01038609|157790876|FG002|Overall Study|Dosing Error|0|||
48988639|NCT01038609|157790877|FG003|Overall Study|Dosing Error|1|||
48988640|NCT01038609|157790878|FG004|Overall Study|Dosing Error|1|||
48988641|NCT01038609|157790874|FG000|Overall Study|Death in the Family|1|||
48988642|NCT01038609|157790875|FG001|Overall Study|Death in the Family|0|||
48988643|NCT01038609|157790876|FG002|Overall Study|Death in the Family|0|||
48988644|NCT01038609|157790877|FG003|Overall Study|Death in the Family|0|||
48988645|NCT01038609|157790878|FG004|Overall Study|Death in the Family|0|||
48988646|NCT01038609|157790874|FG000|Overall Study|Refusal of Blood Draws|0|||
48988647|NCT01038609|157790875|FG001|Overall Study|Refusal of Blood Draws|1|||
48988648|NCT01038609|157790876|FG002|Overall Study|Refusal of Blood Draws|0|||
48988649|NCT01038609|157790877|FG003|Overall Study|Refusal of Blood Draws|0|||
48988650|NCT01038609|157790878|FG004|Overall Study|Refusal of Blood Draws|0|||
48988651|NCT04047472|157790879|FG000|Overall Study|Adverse Event|3|||
48988652|NCT04047472|157790880|FG001|Overall Study|Adverse Event|3|||
48988653|NCT04047472|157790879|FG000|Overall Study|Death|0|||
48988654|NCT04047472|157790880|FG001|Overall Study|Death|1|||
48988655|NCT04047472|157790879|FG000|Overall Study|Lost to Follow-up|1|||
48988656|NCT04047472|157790880|FG001|Overall Study|Lost to Follow-up|0|||
48988657|NCT04047472|157790879|FG000|Overall Study|Physician Decision|1|||
48988658|NCT04047472|157790880|FG001|Overall Study|Physician Decision|2|||
48988659|NCT04047472|157790879|FG000|Overall Study|Protocol Violation|1|||
48988660|NCT04047472|157790880|FG001|Overall Study|Protocol Violation|0|||
48988661|NCT04047472|157790879|FG000|Overall Study|Withdrawal by Subject|10|||
48988662|NCT04047472|157790880|FG001|Overall Study|Withdrawal by Subject|10|||
48988663|NCT05405985|157790883|FG000|Overall Study|Withdrawal by Subject|1|||
48988664|NCT05405985|157790884|FG001|Overall Study|Withdrawal by Subject|0|||
48988665|NCT00565721|157790885|FG000|Overall Study|Screen Failure|2|||
48988666|NCT00565721|157790885|FG000|Overall Study|Lost to Follow-up|6|||
48988667|NCT00565721|157790885|FG000|Overall Study|Technical Problems|1|||
48988668|NCT00565721|157790885|FG000|Overall Study|Physician Decision|2|||
48988669|NCT00565721|157790885|FG000|Overall Study|Other reasons|6|||
48988670|NCT01005875|157790891|FG000|Overall Study|Death|3|||
48988671|NCT00203294|157790894|FG000|Overall Study|Withdrawal by Subject|8|||
48988672|NCT00203294|157790895|FG001|Overall Study|Withdrawal by Subject|13|||
48988673|NCT05047601|157790898|FG000|Overall Study|Lost to Follow-up|9|||
48988674|NCT05047601|157790899|FG001|Overall Study|Lost to Follow-up|11|||
48988675|NCT05047601|157790900|FG002|Overall Study|Lost to Follow-up|7|||
48988676|NCT05047601|157790898|FG000|Overall Study|Withdrawal by Subject|25|||
48988677|NCT05047601|157790899|FG001|Overall Study|Withdrawal by Subject|36|||
48988678|NCT05047601|157790900|FG002|Overall Study|Withdrawal by Subject|23|||
48988679|NCT05047601|157790898|FG000|Overall Study|Other|10|||
48988680|NCT05047601|157790899|FG001|Overall Study|Other|6|||
48988681|NCT05047601|157790900|FG002|Overall Study|Other|5|||
48988682|NCT00545584|157790905|FG000|Overall Study|Only one reason for discontinuation|62|||
48988683|NCT00545584|157790906|FG001|Overall Study|Only one reason for discontinuation|61|||
48988684|NCT00545584|157790907|FG002|Overall Study|Only one reason for discontinuation|48|||
48988685|NCT00545584|157790905|FG000|Overall Study|Two or more reasons for discontinuation|17|||
48988686|NCT00545584|157790906|FG001|Overall Study|Two or more reasons for discontinuation|19|||
48988687|NCT00545584|157790907|FG002|Overall Study|Two or more reasons for discontinuation|8|||
48988688|NCT03525613|157790908|FG000|Overall Study|Adverse Event|11|||
48988689|NCT03525613|157790909|FG001|Overall Study|Adverse Event|8|||
48988690|NCT03525613|157790910|FG002|Overall Study|Adverse Event|3|||
48988691|NCT03525613|157790911|FG003|Overall Study|Adverse Event|3|||
48988692|NCT03525613|157790908|FG000|Overall Study|Lost to Follow-up|4|||
48988693|NCT03525613|157790909|FG001|Overall Study|Lost to Follow-up|5|||
48988694|NCT03525613|157790910|FG002|Overall Study|Lost to Follow-up|3|||
48988695|NCT03525613|157790911|FG003|Overall Study|Lost to Follow-up|2|||
48988696|NCT03525613|157790908|FG000|Overall Study|Physician Decision|0|||
48988697|NCT03525613|157790909|FG001|Overall Study|Physician Decision|1|||
48988698|NCT03525613|157790910|FG002|Overall Study|Physician Decision|0|||
48988699|NCT03525613|157790911|FG003|Overall Study|Physician Decision|1|||
48988700|NCT03525613|157790908|FG000|Overall Study|Consent Withdrawal|25|||
48988701|NCT03525613|157790909|FG001|Overall Study|Consent Withdrawal|16|||
48988702|NCT03525613|157790910|FG002|Overall Study|Consent Withdrawal|12|||
48988703|NCT03525613|157790911|FG003|Overall Study|Consent Withdrawal|9|||
48988704|NCT03525613|157790908|FG000|Overall Study|Death|20|||
48988705|NCT03525613|157790909|FG001|Overall Study|Death|9|||
48988706|NCT03525613|157790910|FG002|Overall Study|Death|7|||
48988707|NCT03525613|157790911|FG003|Overall Study|Death|1|||
48988708|NCT03525613|157790908|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|9|||
48988709|NCT03525613|157790909|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
48988710|NCT03525613|157790910|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|5|||
48988711|NCT03525613|157790911|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|8|||
48988712|NCT00135694|157790915|FG000|Overall Study|Adverse Event|17|||
48988713|NCT00135694|157790916|FG001|Overall Study|Adverse Event|4|||
48988714|NCT00135694|157790917|FG002|Overall Study|Adverse Event|0|||
48988715|NCT00135694|157790915|FG000|Overall Study|Death|14|||
48988716|NCT00135694|157790916|FG001|Overall Study|Death|1|||
48988717|NCT00135694|157790917|FG002|Overall Study|Death|2|||
48988718|NCT00135694|157790915|FG000|Overall Study|Lost to Follow-up|8|||
48988719|NCT00135694|157790916|FG001|Overall Study|Lost to Follow-up|7|||
48988720|NCT00135694|157790917|FG002|Overall Study|Lost to Follow-up|1|||
48988721|NCT00135694|157790915|FG000|Overall Study|Withdrawal by Subject|41|||
48988722|NCT00135694|157790916|FG001|Overall Study|Withdrawal by Subject|7|||
48988723|NCT00135694|157790917|FG002|Overall Study|Withdrawal by Subject|4|||
48988724|NCT00135694|157790915|FG000|Overall Study|Protocol Violation|19|||
48988725|NCT00135694|157790916|FG001|Overall Study|Protocol Violation|1|||
48988726|NCT00135694|157790917|FG002|Overall Study|Protocol Violation|0|||
48988727|NCT00135694|157790915|FG000|Overall Study|Hepatitis C related reasons|39|||
48988728|NCT00135694|157790916|FG001|Overall Study|Hepatitis C related reasons|1|||
48988729|NCT00135694|157790917|FG002|Overall Study|Hepatitis C related reasons|0|||
48988730|NCT00135694|157790915|FG000|Overall Study|Ineligible for Random assignment|42|||
48988731|NCT00135694|157790916|FG001|Overall Study|Ineligible for Random assignment|0|||
48988732|NCT00135694|157790917|FG002|Overall Study|Ineligible for Random assignment|0|||
48988733|NCT02584660|157790918|FG000|Overall Study|Adverse Event|4|||
48988734|NCT02584660|157790919|FG001|Overall Study|Adverse Event|0|||
48988735|NCT02584660|157790918|FG000|Overall Study|Lost to Follow-up|3|||
48988736|NCT02584660|157790919|FG001|Overall Study|Lost to Follow-up|4|||
48988737|NCT02584660|157790918|FG000|Overall Study|Protocol Violation|0|||
48988738|NCT02584660|157790919|FG001|Overall Study|Protocol Violation|1|||
48988739|NCT02584660|157790918|FG000|Overall Study|Withdrawal by Subject|0|||
48988740|NCT02584660|157790919|FG001|Overall Study|Withdrawal by Subject|2|||
48988741|NCT02584660|157790918|FG000|Overall Study|Other|0|||
48988742|NCT02584660|157790919|FG001|Overall Study|Other|1|||
48988743|NCT00461552|157790920|FG000|Overall Study|Drug Dispensing error|0|||
48988744|NCT00461552|157790921|FG001|Overall Study|Drug Dispensing error|2|||
48988745|NCT00660816|157790924|FG000|Overall Study|Adverse Event|1|||
48988746|NCT00660816|157790925|FG001|Overall Study|Adverse Event|2|||
48988747|NCT00660816|157790924|FG000|Overall Study|Withdrawal by Subject|1|||
48988748|NCT00660816|157790925|FG001|Overall Study|Withdrawal by Subject|0|||
48988749|NCT00660816|157790924|FG000|Overall Study|Death|0|||
48988750|NCT00660816|157790925|FG001|Overall Study|Death|2|||
48988751|NCT00660816|157790924|FG000|Overall Study|Lack of Efficacy|1|||
48988752|NCT00660816|157790925|FG001|Overall Study|Lack of Efficacy|0|||
48988753|NCT00660816|157790924|FG000|Overall Study|Physician Decision|0|||
48988754|NCT00660816|157790925|FG001|Overall Study|Physician Decision|2|||
48988755|NCT00660816|157790924|FG000|Overall Study|Protocol Violation|1|||
48988756|NCT00660816|157790925|FG001|Overall Study|Protocol Violation|0|||
48988757|NCT00660816|157790924|FG000|Overall Study|Disease Progression|16|||
48988758|NCT00660816|157790925|FG001|Overall Study|Disease Progression|12|||
48988759|NCT00660816|157790924|FG000|Overall Study|Complicating Disease|0|||
48988760|NCT00660816|157790925|FG001|Overall Study|Complicating Disease|1|||
48988761|NCT05890105|157790926|FG000|Overall Study|Adverse Event|1|||
48988762|NCT05890105|157790927|FG001|Overall Study|Adverse Event|0|||
48988763|NCT05890105|157790928|FG002|Overall Study|Adverse Event|0|||
48988764|NCT05890105|157790926|FG000|Overall Study|Other|1|||
48988765|NCT05890105|157790927|FG001|Overall Study|Other|2|||
48988766|NCT05890105|157790928|FG002|Overall Study|Other|0|||
48988767|NCT01314261|157790929|FG000|Overall Study|Adverse Event|1|||
48988768|NCT01314261|157790930|FG001|Overall Study|Adverse Event|0|||
48988769|NCT01314261|157790931|FG002|Overall Study|Adverse Event|0|||
48988770|NCT01314261|157790932|FG003|Overall Study|Adverse Event|0|||
48988771|NCT01314261|157790929|FG000|Overall Study|Withdrawal by Subject|0|||
48988772|NCT01314261|157790930|FG001|Overall Study|Withdrawal by Subject|3|||
48988773|NCT01314261|157790931|FG002|Overall Study|Withdrawal by Subject|1|||
48988774|NCT01314261|157790932|FG003|Overall Study|Withdrawal by Subject|0|||
48988775|NCT01314261|157790929|FG000|Overall Study|Lost to Follow-up|1|||
48988776|NCT01314261|157790930|FG001|Overall Study|Lost to Follow-up|0|||
48988777|NCT01314261|157790931|FG002|Overall Study|Lost to Follow-up|2|||
48988778|NCT01314261|157790932|FG003|Overall Study|Lost to Follow-up|2|||
48988779|NCT01314261|157790929|FG000|Overall Study|Virologic Failure|0|||
48988780|NCT01314261|157790930|FG001|Overall Study|Virologic Failure|1|||
48988781|NCT01314261|157790931|FG002|Overall Study|Virologic Failure|0|||
48988782|NCT01314261|157790932|FG003|Overall Study|Virologic Failure|1|||
48988783|NCT00877929|157790933|FG000|Overall Study|Adverse Event|11|||
48988784|NCT00877929|157790934|FG001|Overall Study|Adverse Event|20|||
48988785|NCT00877929|157790933|FG000|Overall Study|Protocol Violation|3|||
48988786|NCT00877929|157790934|FG001|Overall Study|Protocol Violation|3|||
48988787|NCT00877929|157790933|FG000|Overall Study|Lost to Follow-up|0|||
48988788|NCT00877929|157790934|FG001|Overall Study|Lost to Follow-up|1|||
48988789|NCT00877929|157790933|FG000|Overall Study|Withdrawal by Subject|4|||
48988790|NCT00877929|157790934|FG001|Overall Study|Withdrawal by Subject|4|||
48988791|NCT00877929|157790933|FG000|Overall Study|Lack of Efficacy|0|||
48988792|NCT00877929|157790934|FG001|Overall Study|Lack of Efficacy|1|||
48988793|NCT00877929|157790933|FG000|Overall Study|Other reason (not specified)|2|||
48988794|NCT00877929|157790934|FG001|Overall Study|Other reason (not specified)|6|||
48988795|NCT01140646|157790935|FG000|Overall Study|Adverse Event|4|||
48988796|NCT01140646|157790935|FG000|Overall Study|Refused Further Treatment|5|||
48988797|NCT04524507|157790936|FG000|Overall Study|Lost to Follow-up|2|||
48988798|NCT04524507|157790937|FG001|Overall Study|Lost to Follow-up|4|||
48988799|NCT04524507|157790936|FG000|Overall Study|Withdrawal by Subject|2|||
48988800|NCT04524507|157790937|FG001|Overall Study|Withdrawal by Subject|9|||
48988801|NCT04524507|157790936|FG000|Overall Study|Death|2|||
48988802|NCT04524507|157790937|FG001|Overall Study|Death|10|||
48988803|NCT02711306|157790938|FG000|Overall Study|Withdrawal by Subject|2|||
48988804|NCT02711306|157790939|FG001|Overall Study|Withdrawal by Subject|2|||
48988805|NCT02576652|157790940|FG000|Overall Study|Withdrawal by Subject|2|||
48988806|NCT02354599|157790942|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
48988807|NCT02354599|157790943|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
48988808|NCT02354599|157790944|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
48988809|NCT02354599|157790945|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
48988810|NCT02354599|157790946|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
48988811|NCT02354599|157790947|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
48988812|NCT02354599|157790942|FG000|Overall Study|Withdrawal by Subject|1|||
48988813|NCT02354599|157790943|FG001|Overall Study|Withdrawal by Subject|1|||
48988814|NCT02354599|157790944|FG002|Overall Study|Withdrawal by Subject|0|||
48988815|NCT02354599|157790945|FG003|Overall Study|Withdrawal by Subject|0|||
48988816|NCT02354599|157790946|FG004|Overall Study|Withdrawal by Subject|0|||
48988817|NCT02354599|157790947|FG005|Overall Study|Withdrawal by Subject|0|||
48988818|NCT02146352|157790948|FG000|Overall Study|Death|1|||
48988819|NCT02146352|157790948|FG000|Overall Study|Patient entered hospice care|1|||
48988820|NCT02811640|157790950|FG000|Overall Study|Technology malfunction|2|||
49043950|NCT02906917|157994603|FG000|Intensification Period (Week 26-38)|Adverse Event|0|||
49043951|NCT02906917|157994604|FG001|Intensification Period (Week 26-38)|Adverse Event|2|||
49043952|NCT02906917|157994603|FG000|Intensification Period (Week 26-38)|Lost to Follow-up|3|||
49043953|NCT02906917|157994604|FG001|Intensification Period (Week 26-38)|Lost to Follow-up|1|||
49043954|NCT02906917|157994603|FG000|Intensification Period (Week 26-38)|Withdrawal by Subject|3|||
49043955|NCT02906917|157994604|FG001|Intensification Period (Week 26-38)|Withdrawal by Subject|2|||
49043956|NCT01557751|157994618|FG000|Overall Study|Physician Decision|3|||
49043957|NCT02161549|157994619|FG000|Overall Study|Physician Decision|6|||
49043958|NCT02161549|157994620|FG001|Overall Study|Physician Decision|2|||
49043959|NCT04561115|157994621|FG000|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|1|||
49043960|NCT04561115|157994622|FG001|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|0|||
49043961|NCT04561115|157994621|FG000|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
49043962|NCT04561115|157994622|FG001|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
49043963|NCT04561115|157994621|FG000|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
49043964|NCT04561115|157994622|FG001|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
49043965|NCT00380588|157994623|FG000|Overall Study|Unequivocal Disease Progression|25|||
49043966|NCT00380588|157994624|FG001|Overall Study|Unequivocal Disease Progression|34|||
49043967|NCT00380588|157994623|FG000|Overall Study|Next Cycle Not Started|4|||
49043968|NCT00380588|157994624|FG001|Overall Study|Next Cycle Not Started|0|||
49043969|NCT00380588|157994623|FG000|Overall Study|Adverse Event|7|||
49043970|NCT00380588|157994624|FG001|Overall Study|Adverse Event|3|||
49043971|NCT00380588|157994623|FG000|Overall Study|Withdrawal by Subject|1|||
49043972|NCT00380588|157994624|FG001|Overall Study|Withdrawal by Subject|3|||
49043973|NCT00380588|157994623|FG000|Overall Study|Physician Decision|2|||
49043974|NCT00380588|157994624|FG001|Overall Study|Physician Decision|0|||
49043975|NCT00743145|157994625|FG000|Overall Study|Withdrawal by Subject|1|||
49043976|NCT00743145|157994625|FG000|Overall Study|Adverse Event|2|||
49043977|NCT00743145|157994625|FG000|Overall Study|Pregnancy|1|||
49043978|NCT01691612|157994627|FG000|Overall Study|deemed ineligible after 1st visit|6|||
49043979|NCT01691612|157994627|FG000|Overall Study|Adverse Event|1|||
49043980|NCT02050321|157994629|FG000|Overall Study|Withdrawal by Subject|1|||
49043981|NCT02050321|157994629|FG000|Overall Study|Adverse Event|1|||
49043982|NCT01211262|157994631|FG000|Overall Study|Progressive Disease|18|||
49043983|NCT01211262|157994632|FG001|Overall Study|Progressive Disease|9|||
49043984|NCT01211262|157994631|FG000|Overall Study|Adverse Event|4|||
49043985|NCT01211262|157994632|FG001|Overall Study|Adverse Event|0|||
48988821|NCT03077646|157790951|FG000|Overall Study|Lost to Follow-up|29|||
48988822|NCT03077646|157790952|FG001|Overall Study|Lost to Follow-up|30|||
48988823|NCT03077646|157790953|FG002|Overall Study|Lost to Follow-up|31|||
48988824|NCT00660829|157790960|FG000|Overall Study|Adverse Event|3|||
48988825|NCT00660829|157790961|FG001|Overall Study|Adverse Event|4|||
48988826|NCT00660829|157790960|FG000|Overall Study|Lack of Efficacy|2|||
48988827|NCT00660829|157790961|FG001|Overall Study|Lack of Efficacy|3|||
48988828|NCT00660829|157790960|FG000|Overall Study|Non-Compliance|0|||
48988829|NCT00660829|157790961|FG001|Overall Study|Non-Compliance|4|||
48988830|NCT00660829|157790960|FG000|Overall Study|Withdrawal by Subject|1|||
48988831|NCT00660829|157790961|FG001|Overall Study|Withdrawal by Subject|2|||
48988832|NCT00660829|157790960|FG000|Overall Study|Lost to Follow-up|3|||
48988833|NCT00660829|157790961|FG001|Overall Study|Lost to Follow-up|2|||
48988834|NCT00660829|157790960|FG000|Overall Study|Other|9|||
48988835|NCT00660829|157790961|FG001|Overall Study|Other|4|||
48988836|NCT01875731|157790962|FG000|Overall Study|Fail to obtain lab sample|1|||
48988837|NCT01875731|157790963|FG001|Overall Study|Fail to obtain lab sample|0|||
48988838|NCT04557189|157790964|FG000|Overall Study|Adverse Event|0|||
48988839|NCT04557189|157790965|FG001|Overall Study|Adverse Event|1|||
48988840|NCT04557189|157790964|FG000|Overall Study|Lost to Follow-up|1|||
48988841|NCT04557189|157790965|FG001|Overall Study|Lost to Follow-up|1|||
48988842|NCT04557189|157790964|FG000|Overall Study|Withdrawal by Subject|2|||
48988843|NCT04557189|157790965|FG001|Overall Study|Withdrawal by Subject|1|||
48988844|NCT04557189|157790964|FG000|Overall Study|Reason not Specified|3|||
48988845|NCT04557189|157790965|FG001|Overall Study|Reason not Specified|6|||
48988846|NCT02561572|157790966|FG000|Overall Study|Inadequate time before surgery|2|||
48988847|NCT02561572|157790967|FG001|Overall Study|Inadequate time before surgery|1|||
48988848|NCT02561572|157790966|FG000|Overall Study|Protocol Violation|0|||
48988849|NCT02561572|157790967|FG001|Overall Study|Protocol Violation|1|||
48988850|NCT00795717|157790968|FG000|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1|||
48988851|NCT00795717|157790969|FG001|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0|||
48988852|NCT00795717|157790968|FG000|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
48988853|NCT00795717|157790969|FG001|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
48988854|NCT00795717|157790968|FG000|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0|||
48988855|NCT00795717|157790969|FG001|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1|||
48988856|NCT00795717|157790968|FG000|Phase II|too busy|0|||
48988857|NCT00795717|157790969|FG001|Phase II|too busy|1|||
48988858|NCT02918006|157790970|FG000|Allocation and Follow-Up|Lost to Follow-up|1|||
48988859|NCT02918006|157790971|FG001|Allocation and Follow-Up|Lost to Follow-up|2|||
48988860|NCT02918006|157790972|FG002|Allocation and Follow-Up|Lost to Follow-up|1|||
48988861|NCT02918006|157790970|FG000|Allocation and Follow-Up|Withdrawal by Subject|1|||
48988862|NCT02918006|157790971|FG001|Allocation and Follow-Up|Withdrawal by Subject|0|||
48988863|NCT02918006|157790972|FG002|Allocation and Follow-Up|Withdrawal by Subject|0|||
48988864|NCT02918006|157790970|FG000|Vaccination Phase Analysis|Withdrawal by Subject|3|||
48988865|NCT02918006|157790971|FG001|Vaccination Phase Analysis|Withdrawal by Subject|7|||
48988866|NCT02918006|157790972|FG002|Vaccination Phase Analysis|Withdrawal by Subject|2|||
48988867|NCT02918006|157790970|FG000|Vaccination Phase Analysis|Biofire Positive|5|||
48988868|NCT02918006|157790971|FG001|Vaccination Phase Analysis|Biofire Positive|5|||
48988869|NCT02918006|157790972|FG002|Vaccination Phase Analysis|Biofire Positive|0|||
48988870|NCT02918006|157790970|FG000|Vaccination Phase Analysis|Symptoms of Sinusitis|1|||
48988871|NCT02918006|157790971|FG001|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
48988872|NCT02918006|157790972|FG002|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
48988873|NCT02918006|157790970|FG000|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
48988874|NCT02918006|157790971|FG001|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|3|||
48988875|NCT02918006|157790972|FG002|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
48988876|NCT02918006|157790970|FG000|Vaccination Phase Analysis|Seasonal allergies|0|||
48988877|NCT02918006|157790971|FG001|Vaccination Phase Analysis|Seasonal allergies|1|||
48988878|NCT02918006|157790972|FG002|Vaccination Phase Analysis|Seasonal allergies|0|||
48988879|NCT02918006|157790970|FG000|Challenge Phase Analysis|Withdrawal by Subject|0|||
48988880|NCT02918006|157790971|FG001|Challenge Phase Analysis|Withdrawal by Subject|0|||
48988881|NCT02918006|157790972|FG002|Challenge Phase Analysis|Withdrawal by Subject|1|||
48988882|NCT02918006|157790970|FG000|Challenge Phase Analysis|Lost to Follow-up|0|||
48988883|NCT02918006|157790971|FG001|Challenge Phase Analysis|Lost to Follow-up|0|||
48988884|NCT02918006|157790972|FG002|Challenge Phase Analysis|Lost to Follow-up|1|||
48988885|NCT02408016|157792766|FG000|Overall Study|Death|6|||
48988886|NCT02408016|157792767|FG001|Overall Study|Death|1|||
48988887|NCT02408016|157792768|FG002|Overall Study|Death|0|||
48988888|NCT02408016|157792766|FG000|Overall Study|Physician Decision|0|||
48988889|NCT02408016|157792767|FG001|Overall Study|Physician Decision|2|||
48988890|NCT02408016|157792768|FG002|Overall Study|Physician Decision|0|||
48988891|NCT00805194|157792776|FG000|Overall Study|Progressive disease (modified RECIST)|404|||
48988892|NCT00805194|157792777|FG001|Overall Study|Progressive disease (modified RECIST)|435|||
48988893|NCT00805194|157792776|FG000|Overall Study|Worsening or AE of underlying disease|64|||
48988894|NCT00805194|157792777|FG001|Overall Study|Worsening or AE of underlying disease|70|||
48988895|NCT00805194|157792776|FG000|Overall Study|Other AE|84|||
48988896|NCT00805194|157792777|FG001|Overall Study|Other AE|73|||
48988897|NCT00805194|157792776|FG000|Overall Study|Protocol Violation|9|||
48988898|NCT00805194|157792777|FG001|Overall Study|Protocol Violation|9|||
48988899|NCT00805194|157792776|FG000|Overall Study|Lost to Follow-up|5|||
48988900|NCT00805194|157792777|FG001|Overall Study|Lost to Follow-up|5|||
48988901|NCT00805194|157792776|FG000|Overall Study|Withdrawal by Subject|60|||
48988902|NCT00805194|157792777|FG001|Overall Study|Withdrawal by Subject|42|||
48988903|NCT00805194|157792776|FG000|Overall Study|Not treated|3|||
48988904|NCT00805194|157792777|FG001|Overall Study|Not treated|4|||
48988905|NCT00805194|157792776|FG000|Overall Study|Reasons other than stated above|20|||
48988906|NCT00805194|157792777|FG001|Overall Study|Reasons other than stated above|16|||
48988907|NCT00417248|157792780|FG000|Overall Study|Study Terminated|6|||
48988908|NCT00417248|157792780|FG000|Overall Study|Death|1|||
48988909|NCT00417248|157792780|FG000|Overall Study|Lack of Efficacy|1|||
48988910|NCT00775138|157792781|FG000|Overall Study|Withdrawal by Subject|0|||
48988911|NCT00775138|157792782|FG001|Overall Study|Withdrawal by Subject|0|||
48988912|NCT00775138|157792783|FG002|Overall Study|Withdrawal by Subject|2|||
48988913|NCT00775138|157792784|FG003|Overall Study|Withdrawal by Subject|2|||
48988914|NCT00775138|157792781|FG000|Overall Study|Adverse Event|0|||
48988915|NCT00775138|157792782|FG001|Overall Study|Adverse Event|0|||
48988916|NCT00775138|157792783|FG002|Overall Study|Adverse Event|1|||
48988917|NCT00775138|157792784|FG003|Overall Study|Adverse Event|0|||
48988918|NCT04601194|157792786|FG000|Overall Study|Lost to Follow-up|7|||
48988919|NCT01616173|157792787|FG000|Overall Study|Lost to Follow-up|0|||
48988920|NCT01616173|157792788|FG001|Overall Study|Lost to Follow-up|2|||
48988921|NCT01616173|157792789|FG002|Overall Study|Lost to Follow-up|0|||
48988922|NCT02545504|157792792|FG000|Overall Study|Death|174|||
48988923|NCT02545504|157792793|FG001|Overall Study|Death|168|||
48988924|NCT02545504|157792792|FG000|Overall Study|Unknown reason|30|||
48988925|NCT02545504|157792793|FG001|Overall Study|Unknown reason|32|||
48988926|NCT02545504|157792792|FG000|Overall Study|Withdrew consent|9|||
48988927|NCT02545504|157792793|FG001|Overall Study|Withdrew consent|11|||
48988928|NCT02545504|157792792|FG000|Overall Study|Investigator's discretion|3|||
48988929|NCT02545504|157792793|FG001|Overall Study|Investigator's discretion|1|||
48988930|NCT02545504|157792792|FG000|Overall Study|Lost to Follow-up|2|||
48988931|NCT02545504|157792793|FG001|Overall Study|Lost to Follow-up|2|||
48988932|NCT00348686|157792802|FG000|Overall Study|Withdrawal by Subject|45|||
48988933|NCT00348686|157792802|FG000|Overall Study|Adverse Event|5|||
48988934|NCT00348686|157792802|FG000|Overall Study|Protocol Violation|6|||
48988935|NCT00348686|157792802|FG000|Overall Study|Lost to Follow-up|2|||
48988936|NCT00348686|157792802|FG000|Overall Study|Multiple Reasons|8|||
48988937|NCT02242305|157792803|FG000|Overall Study|Without spasm-like pain during 3 weeks|1|||
48988938|NCT02242305|157792804|FG001|Overall Study|Without spasm-like pain during 3 weeks|4|||
48988939|NCT02242305|157792803|FG000|Overall Study|Adverse Event|1|||
48988940|NCT02242305|157792804|FG001|Overall Study|Adverse Event|0|||
48988941|NCT02242305|157792803|FG000|Overall Study|Non-compliance dosing regimen or visit|2|||
48988942|NCT02242305|157792804|FG001|Overall Study|Non-compliance dosing regimen or visit|2|||
48988943|NCT02242305|157792803|FG000|Overall Study|Subject withdraws inform consent|0|||
48988944|NCT02242305|157792804|FG001|Overall Study|Subject withdraws inform consent|4|||
48988945|NCT02242305|157792803|FG000|Overall Study|Lost to Follow-up|2|||
48988946|NCT02242305|157792804|FG001|Overall Study|Lost to Follow-up|0|||
48988947|NCT01632345|157792805|FG000|Treatment: Part I|Adverse Event|1|||
48988948|NCT01632345|157792806|FG001|Treatment: Part I|Adverse Event|4|||
48988949|NCT01632345|157792807|FG002|Treatment: Part I|Adverse Event|2|||
48988950|NCT01632345|157792808|FG003|Treatment: Part I|Adverse Event|1|||
48988951|NCT01632345|157792809|FG004|Treatment: Part I|Adverse Event|3|||
48988952|NCT01632345|157792810|FG005|Treatment: Part I|Adverse Event|0|||
48988953|NCT01632345|157792811|FG006|Treatment: Part I|Adverse Event|0|||
48988954|NCT01632345|157792805|FG000|Treatment: Part I|Lack of Efficacy|0|||
48988955|NCT01632345|157792806|FG001|Treatment: Part I|Lack of Efficacy|1|||
48988956|NCT01632345|157792807|FG002|Treatment: Part I|Lack of Efficacy|0|||
48988957|NCT01632345|157792808|FG003|Treatment: Part I|Lack of Efficacy|1|||
48988958|NCT01632345|157792809|FG004|Treatment: Part I|Lack of Efficacy|1|||
48988959|NCT01632345|157792810|FG005|Treatment: Part I|Lack of Efficacy|0|||
48988960|NCT01632345|157792811|FG006|Treatment: Part I|Lack of Efficacy|0|||
48988961|NCT01632345|157792805|FG000|Treatment: Part I|Lost to Follow-up|3|||
48988962|NCT01632345|157792806|FG001|Treatment: Part I|Lost to Follow-up|2|||
48988963|NCT01632345|157792807|FG002|Treatment: Part I|Lost to Follow-up|1|||
48988964|NCT01632345|157792808|FG003|Treatment: Part I|Lost to Follow-up|3|||
48988965|NCT01632345|157792809|FG004|Treatment: Part I|Lost to Follow-up|4|||
48988966|NCT01632345|157792810|FG005|Treatment: Part I|Lost to Follow-up|0|||
48988967|NCT01632345|157792811|FG006|Treatment: Part I|Lost to Follow-up|0|||
48988968|NCT01632345|157792805|FG000|Treatment: Part I|Non-Compliance with Study Drug|3|||
48988969|NCT01632345|157792806|FG001|Treatment: Part I|Non-Compliance with Study Drug|2|||
48988970|NCT01632345|157792807|FG002|Treatment: Part I|Non-Compliance with Study Drug|2|||
48988971|NCT01632345|157792808|FG003|Treatment: Part I|Non-Compliance with Study Drug|1|||
48988972|NCT01632345|157792809|FG004|Treatment: Part I|Non-Compliance with Study Drug|0|||
48988973|NCT01632345|157792810|FG005|Treatment: Part I|Non-Compliance with Study Drug|0|||
48988974|NCT01632345|157792811|FG006|Treatment: Part I|Non-Compliance with Study Drug|0|||
48988975|NCT01632345|157792805|FG000|Treatment: Part I|Physician Decision|2|||
48988976|NCT01632345|157792806|FG001|Treatment: Part I|Physician Decision|1|||
48988977|NCT01632345|157792807|FG002|Treatment: Part I|Physician Decision|0|||
48988978|NCT01632345|157792808|FG003|Treatment: Part I|Physician Decision|0|||
48988979|NCT01632345|157792809|FG004|Treatment: Part I|Physician Decision|1|||
48988980|NCT01632345|157792810|FG005|Treatment: Part I|Physician Decision|0|||
48988981|NCT01632345|157792811|FG006|Treatment: Part I|Physician Decision|0|||
48988982|NCT01632345|157792805|FG000|Treatment: Part I|Pregnancy|0|||
48988983|NCT01632345|157792806|FG001|Treatment: Part I|Pregnancy|1|||
48988984|NCT01632345|157792807|FG002|Treatment: Part I|Pregnancy|0|||
48988985|NCT01632345|157792808|FG003|Treatment: Part I|Pregnancy|0|||
48988986|NCT01632345|157792809|FG004|Treatment: Part I|Pregnancy|0|||
48988987|NCT01632345|157792810|FG005|Treatment: Part I|Pregnancy|0|||
48988988|NCT01632345|157792811|FG006|Treatment: Part I|Pregnancy|0|||
48988989|NCT01632345|157792805|FG000|Treatment: Part I|Protocol Deviation|0|||
48988990|NCT01632345|157792806|FG001|Treatment: Part I|Protocol Deviation|0|||
48988991|NCT01632345|157792807|FG002|Treatment: Part I|Protocol Deviation|1|||
48988992|NCT01632345|157792808|FG003|Treatment: Part I|Protocol Deviation|1|||
48988993|NCT01632345|157792809|FG004|Treatment: Part I|Protocol Deviation|0|||
48988994|NCT01632345|157792810|FG005|Treatment: Part I|Protocol Deviation|0|||
48988995|NCT01632345|157792811|FG006|Treatment: Part I|Protocol Deviation|0|||
48988996|NCT01632345|157792805|FG000|Treatment: Part I|Withdrawal by Subject|3|||
48988997|NCT01632345|157792806|FG001|Treatment: Part I|Withdrawal by Subject|4|||
48988998|NCT01632345|157792807|FG002|Treatment: Part I|Withdrawal by Subject|4|||
48988999|NCT01632345|157792808|FG003|Treatment: Part I|Withdrawal by Subject|1|||
48989000|NCT01632345|157792809|FG004|Treatment: Part I|Withdrawal by Subject|4|||
48989001|NCT01632345|157792810|FG005|Treatment: Part I|Withdrawal by Subject|0|||
49043986|NCT01211262|157994631|FG000|Overall Study|Withdrawal of Consent|1|||
49043987|NCT01211262|157994632|FG001|Overall Study|Withdrawal of Consent|0|||
49043988|NCT01211262|157994631|FG000|Overall Study|Other|0|||
49043989|NCT01211262|157994632|FG001|Overall Study|Other|1|||
49043990|NCT01277510|157994633|FG000|Double-blind Phase|Non-compliance|0|||
49043991|NCT01277510|157994634|FG001|Double-blind Phase|Non-compliance|1|||
49043992|NCT01277510|157994633|FG000|Double-blind Phase|Adverse Event|1|||
49043993|NCT01277510|157994634|FG001|Double-blind Phase|Adverse Event|0|||
49043994|NCT01277510|157994633|FG000|Double-blind Phase|Withdrawal by Subject|2|||
49043995|NCT01277510|157994634|FG001|Double-blind Phase|Withdrawal by Subject|0|||
49043996|NCT01277510|157994633|FG000|Double-blind Phase|Administrative decision|7|||
49043997|NCT01277510|157994634|FG001|Double-blind Phase|Administrative decision|9|||
49043998|NCT01277510|157994633|FG000|Double-blind Phase|Death|0|||
49043999|NCT01277510|157994634|FG001|Double-blind Phase|Death|1|||
49044000|NCT01277510|157994633|FG000|Double-blind Phase|Protocol-specified criteria|2|||
49044001|NCT01277510|157994634|FG001|Double-blind Phase|Protocol-specified criteria|6|||
49044002|NCT01277510|157994633|FG000|Double-blind Phase|Other|1|||
49044003|NCT01277510|157994634|FG001|Double-blind Phase|Other|1|||
49044004|NCT01277510|157994633|FG000|Open-label Phase|Administrative decision|4|||
49044005|NCT01277510|157994634|FG001|Open-label Phase|Administrative decision|3|||
49044006|NCT01277510|157994633|FG000|Open-label Phase|Protocol-specified criteria|1|||
49044007|NCT01277510|157994634|FG001|Open-label Phase|Protocol-specified criteria|0|||
49044008|NCT01277510|157994633|FG000|Open-label Phase|Never received investigational product|2|||
49044009|NCT01277510|157994634|FG001|Open-label Phase|Never received investigational product|0|||
49044010|NCT04768114|157994635|FG000|Overall Study|Lost to Follow-up|5|||
49044011|NCT04768114|157994636|FG001|Overall Study|Lost to Follow-up|10|||
49044012|NCT04768114|157994635|FG000|Overall Study|Withdrawal by Subject|0|||
49044013|NCT04768114|157994636|FG001|Overall Study|Withdrawal by Subject|1|||
49044014|NCT05412121|157994640|FG000|Overall Study|Withdrawal by Subject|4|||
49044015|NCT05412121|157994640|FG000|Overall Study|Physician Decision|1|||
49044016|NCT05412121|157994640|FG000|Overall Study|Lost to Follow-up|5|||
49044017|NCT00113919|157994641|FG000|Overall Study|Physician Decision|8|||
49044018|NCT00113919|157994641|FG000|Overall Study|Death|6|||
49044019|NCT04439123|157994642|FG000|Overall Study|Adverse Event|11|||
49044020|NCT04439123|157994642|FG000|Overall Study|Death|1|||
49044021|NCT04439123|157994642|FG000|Overall Study|Disease progression|19|||
48989002|NCT01632345|157792811|FG006|Treatment: Part I|Withdrawal by Subject|0|||
48989003|NCT01632345|157792805|FG000|Treatment: Part II|Adverse Event|0|||
48989004|NCT01632345|157792806|FG001|Treatment: Part II|Adverse Event|0|||
48989005|NCT01632345|157792807|FG002|Treatment: Part II|Adverse Event|0|||
48989006|NCT01632345|157792808|FG003|Treatment: Part II|Adverse Event|0|||
48989007|NCT01632345|157792809|FG004|Treatment: Part II|Adverse Event|0|||
48989008|NCT01632345|157792810|FG005|Treatment: Part II|Adverse Event|3|||
49044022|NCT04439123|157994642|FG000|Overall Study|Withdrawal by Subject|2|||
49044023|NCT04439123|157994642|FG000|Overall Study|Still on treatment|2|||
48989009|NCT01632345|157792811|FG006|Treatment: Part II|Adverse Event|8|||
49044024|NCT01685008|157994643|FG000|Main Study Treatment (Cycles 1 - 2)|Adverse Event|2|||
49044025|NCT01685008|157994644|FG001|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
49044026|NCT01685008|157994645|FG002|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
49044027|NCT01685008|157994646|FG003|Main Study Treatment (Cycles 1 - 2)|Adverse Event|1|||
49044028|NCT01685008|157994643|FG000|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
49044029|NCT01685008|157994644|FG001|Main Study Treatment (Cycles 1 - 2)|Physician Decision|2|||
49044030|NCT01685008|157994645|FG002|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
49044031|NCT01685008|157994646|FG003|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
49044032|NCT01685008|157994643|FG000|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
49044033|NCT01685008|157994644|FG001|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|1|||
49044034|NCT01685008|157994645|FG002|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
49044035|NCT01685008|157994646|FG003|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
49044036|NCT01685008|157994643|FG000|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|2|||
49044037|NCT01685008|157994644|FG001|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|4|||
49044038|NCT01685008|157994645|FG002|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|1|||
48989010|NCT01632345|157792805|FG000|Treatment: Part II|Lost to Follow-up|0|||
48989011|NCT01632345|157792806|FG001|Treatment: Part II|Lost to Follow-up|0|||
48989012|NCT01632345|157792807|FG002|Treatment: Part II|Lost to Follow-up|0|||
48989013|NCT01632345|157792808|FG003|Treatment: Part II|Lost to Follow-up|0|||
48989014|NCT01632345|157792809|FG004|Treatment: Part II|Lost to Follow-up|0|||
48989015|NCT01632345|157792810|FG005|Treatment: Part II|Lost to Follow-up|3|||
49044039|NCT01685008|157994646|FG003|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|0|||
49044040|NCT01685008|157994643|FG000|Main Study Treatment (Cycles 1 - 2)|Death|0|||
49044041|NCT01685008|157994644|FG001|Main Study Treatment (Cycles 1 - 2)|Death|3|||
49044042|NCT01685008|157994645|FG002|Main Study Treatment (Cycles 1 - 2)|Death|1|||
49044043|NCT01685008|157994646|FG003|Main Study Treatment (Cycles 1 - 2)|Death|0|||
49044044|NCT02670551|157994649|FG000|Overall Study|Adverse Event|4|||
49044045|NCT02670551|157994650|FG001|Overall Study|Adverse Event|7|||
49044046|NCT02670551|157994651|FG002|Overall Study|Adverse Event|9|||
49044047|NCT02670551|157994649|FG000|Overall Study|Lack of Efficacy|2|||
49044048|NCT02670551|157994650|FG001|Overall Study|Lack of Efficacy|0|||
49044049|NCT02670551|157994651|FG002|Overall Study|Lack of Efficacy|3|||
49044050|NCT02670551|157994649|FG000|Overall Study|Withdrawal of Consent|6|||
49044051|NCT02670551|157994650|FG001|Overall Study|Withdrawal of Consent|3|||
48989016|NCT01632345|157792811|FG006|Treatment: Part II|Lost to Follow-up|1|||
48989017|NCT01632345|157792805|FG000|Treatment: Part II|Non-Compliance with Study Drug|0|||
48989018|NCT01632345|157792806|FG001|Treatment: Part II|Non-Compliance with Study Drug|0|||
48989019|NCT01632345|157792807|FG002|Treatment: Part II|Non-Compliance with Study Drug|0|||
48989020|NCT01632345|157792808|FG003|Treatment: Part II|Non-Compliance with Study Drug|0|||
48989021|NCT01632345|157792809|FG004|Treatment: Part II|Non-Compliance with Study Drug|0|||
48989022|NCT01632345|157792810|FG005|Treatment: Part II|Non-Compliance with Study Drug|3|||
48989023|NCT01632345|157792811|FG006|Treatment: Part II|Non-Compliance with Study Drug|0|||
48989024|NCT01632345|157792805|FG000|Treatment: Part II|Withdrawal by Subject|0|||
48989025|NCT01632345|157792806|FG001|Treatment: Part II|Withdrawal by Subject|0|||
48989026|NCT01632345|157792807|FG002|Treatment: Part II|Withdrawal by Subject|0|||
48989027|NCT01632345|157792808|FG003|Treatment: Part II|Withdrawal by Subject|0|||
48989028|NCT01632345|157792809|FG004|Treatment: Part II|Withdrawal by Subject|0|||
48989029|NCT01632345|157792810|FG005|Treatment: Part II|Withdrawal by Subject|2|||
48989030|NCT01632345|157792811|FG006|Treatment: Part II|Withdrawal by Subject|2|||
48989031|NCT02132312|157792812|FG000|Overall Study|Adverse Event|2|||
48989032|NCT02132312|157792813|FG001|Overall Study|Adverse Event|0|||
48989033|NCT02132312|157792812|FG000|Overall Study|Physician Decision|1|||
48989034|NCT02132312|157792813|FG001|Overall Study|Physician Decision|1|||
48989035|NCT02132312|157792812|FG000|Overall Study|Protocol Violation|0|||
48989036|NCT02132312|157792813|FG001|Overall Study|Protocol Violation|1|||
48989037|NCT02132312|157792812|FG000|Overall Study|Withdrawal by Subject|1|||
48989038|NCT02132312|157792813|FG001|Overall Study|Withdrawal by Subject|0|||
48989039|NCT02132312|157792812|FG000|Overall Study|Lost to Follow-up|2|||
48989040|NCT02132312|157792813|FG001|Overall Study|Lost to Follow-up|1|||
48989041|NCT00955682|157792816|FG000|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
48989042|NCT00955682|157792817|FG001|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
48989043|NCT04034225|157792819|FG000|Overall Study|Death|3|||
48989044|NCT04034225|157792819|FG000|Overall Study|Withdrawal by Subject|2|||
48989045|NCT04034225|157792819|FG000|Overall Study|Study termination by Sponsor|18|||
48989046|NCT04034225|157792819|FG000|Overall Study|Physician Decision|1|||
48989047|NCT04034225|157792819|FG000|Overall Study|Lack of Efficacy|1|||
48989048|NCT03328325|157792821|FG000|Overall Study|Lost to Follow-up|4|||
49044052|NCT02670551|157994651|FG002|Overall Study|Withdrawal of Consent|8|||
48989049|NCT03328325|157792821|FG000|Overall Study|Physician Decision|1|||
48989050|NCT03328325|157792821|FG000|Overall Study|Withdrawal by Subject|3|||
48989051|NCT03328325|157792821|FG000|Overall Study|Early Study Termination due to COVID-19 pandemic|3|||
49044053|NCT02670551|157994649|FG000|Overall Study|Lost to Follow-up|5|||
49044054|NCT02670551|157994650|FG001|Overall Study|Lost to Follow-up|7|||
49044055|NCT02670551|157994651|FG002|Overall Study|Lost to Follow-up|6|||
49044056|NCT02670551|157994649|FG000|Overall Study|Protocol Violation|1|||
49044057|NCT02670551|157994650|FG001|Overall Study|Protocol Violation|0|||
48989052|NCT00286234|157792822|FG000|Overall Study|Protocol Violation|1|||
48989053|NCT00286234|157792823|FG001|Overall Study|Protocol Violation|2|||
48989054|NCT00286234|157792824|FG002|Overall Study|Protocol Violation|0|||
48989055|NCT00286234|157792825|FG003|Overall Study|Protocol Violation|1|||
49044058|NCT02670551|157994651|FG002|Overall Study|Protocol Violation|0|||
49044059|NCT02670551|157994649|FG000|Overall Study|Noncompliance with study drug|3|||
49044060|NCT02670551|157994650|FG001|Overall Study|Noncompliance with study drug|3|||
49044061|NCT02670551|157994651|FG002|Overall Study|Noncompliance with study drug|2|||
49044062|NCT02670551|157994649|FG000|Overall Study|Other Miscellaneous Reasons|2|||
49044063|NCT02670551|157994650|FG001|Overall Study|Other Miscellaneous Reasons|3|||
49044064|NCT02670551|157994651|FG002|Overall Study|Other Miscellaneous Reasons|3|||
49044065|NCT02670551|157994649|FG000|Overall Study|Did Not Receive Treatment|5|||
49044066|NCT02670551|157994650|FG001|Overall Study|Did Not Receive Treatment|3|||
49044067|NCT02670551|157994651|FG002|Overall Study|Did Not Receive Treatment|0|||
49044068|NCT04049097|157994652|FG000|Overall Study|Adverse Event|18|||
49044069|NCT04049097|157994652|FG000|Overall Study|Death|2|||
49044070|NCT04049097|157994652|FG000|Overall Study|Lost to Follow-up|1|||
49044071|NCT04049097|157994652|FG000|Overall Study|Physician Decision|2|||
49044072|NCT04049097|157994652|FG000|Overall Study|Withdrawal by Subject|9|||
49044073|NCT04049097|157994652|FG000|Overall Study|Protocol Violation|2|||
49044074|NCT04049097|157994652|FG000|Overall Study|Other|1|||
49044075|NCT04049097|157994652|FG000|Overall Study|The trial was terminated early by the sponsor|86|||
49044076|NCT04476277|157994655|FG000|Overall Study|Withdrawal by Subject|0|||
49044077|NCT04476277|157994656|FG001|Overall Study|Withdrawal by Subject|0|||
49044078|NCT04476277|157994657|FG002|Overall Study|Withdrawal by Subject|1|||
49044079|NCT04476277|157994658|FG003|Overall Study|Withdrawal by Subject|0|||
49044080|NCT00715676|157994659|FG000|Overall Study|Adverse Event|3|||
49044081|NCT00715676|157994660|FG001|Overall Study|Adverse Event|5|||
49044082|NCT00715676|157994661|FG002|Overall Study|Adverse Event|21|||
49044083|NCT00715676|157994659|FG000|Overall Study|Withdrawal by Subject|1|||
49044084|NCT00715676|157994660|FG001|Overall Study|Withdrawal by Subject|3|||
49044085|NCT00715676|157994661|FG002|Overall Study|Withdrawal by Subject|8|||
49044086|NCT00715676|157994659|FG000|Overall Study|Lost to Follow-up|1|||
49044087|NCT00715676|157994660|FG001|Overall Study|Lost to Follow-up|2|||
49044088|NCT00715676|157994661|FG002|Overall Study|Lost to Follow-up|1|||
49044089|NCT00715676|157994659|FG000|Overall Study|Terminated by Sponsor|1|||
49044090|NCT00715676|157994660|FG001|Overall Study|Terminated by Sponsor|0|||
49044091|NCT00715676|157994661|FG002|Overall Study|Terminated by Sponsor|0|||
49044092|NCT00715676|157994659|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
49044093|NCT00715676|157994660|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
49044094|NCT00715676|157994661|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
49044095|NCT00715676|157994659|FG000|Overall Study|Use of Exclusionary Medication|0|||
49044096|NCT00715676|157994660|FG001|Overall Study|Use of Exclusionary Medication|0|||
49044097|NCT00715676|157994661|FG002|Overall Study|Use of Exclusionary Medication|1|||
48989056|NCT00286234|157792822|FG000|Overall Study|Physician Decision|1|||
48989057|NCT00286234|157792823|FG001|Overall Study|Physician Decision|0|||
48989058|NCT00286234|157792824|FG002|Overall Study|Physician Decision|0|||
48989059|NCT00286234|157792825|FG003|Overall Study|Physician Decision|1|||
48989060|NCT00286234|157792822|FG000|Overall Study|Adverse Event|0|||
48989061|NCT00286234|157792823|FG001|Overall Study|Adverse Event|0|||
48989062|NCT00286234|157792824|FG002|Overall Study|Adverse Event|0|||
48989063|NCT00286234|157792825|FG003|Overall Study|Adverse Event|1|||
48989064|NCT00286234|157792822|FG000|Overall Study|Adverse Event|0|||
48989065|NCT00286234|157792823|FG001|Overall Study|Adverse Event|0|||
48989066|NCT00286234|157792824|FG002|Overall Study|Adverse Event|0|||
48989067|NCT00286234|157792825|FG003|Overall Study|Adverse Event|1|||
48989068|NCT02924129|157792826|FG000|Overall Study|Adverse Event Unrelated to Device or Stimulation|2|||
48989069|NCT02924129|157792827|FG001|Overall Study|Adverse Event Unrelated to Device or Stimulation|1|||
48989070|NCT02924129|157792826|FG000|Overall Study|Withdrawal by Subject|2|||
48989071|NCT02924129|157792827|FG001|Overall Study|Withdrawal by Subject|2|||
48989072|NCT02924129|157792826|FG000|Overall Study|Physician Decision|1|||
48989073|NCT02924129|157792827|FG001|Overall Study|Physician Decision|0|||
48989074|NCT02924129|157792826|FG000|Overall Study|Missed Visit|0|||
48989075|NCT02924129|157792827|FG001|Overall Study|Missed Visit|1|||
49044098|NCT00715676|157994659|FG000|Overall Study|Elevated Blood Glucose|0|||
48989076|NCT00699582|157792835|FG000|Overall Study|Adverse Event|4|||
48989077|NCT00699582|157792836|FG001|Overall Study|Adverse Event|11|||
48989078|NCT00699582|157792837|FG002|Overall Study|Adverse Event|23|||
48989079|NCT00699582|157792835|FG000|Overall Study|Withdrawal by Subject|6|||
48989080|NCT00699582|157792836|FG001|Overall Study|Withdrawal by Subject|7|||
49044099|NCT00715676|157994660|FG001|Overall Study|Elevated Blood Glucose|1|||
49044100|NCT00715676|157994661|FG002|Overall Study|Elevated Blood Glucose|0|||
49044101|NCT01963260|157994662|FG000|Overall Study|Withdrawal by Subject|2|||
49044102|NCT01963260|157994663|FG001|Overall Study|Withdrawal by Subject|0|||
49044103|NCT01963260|157994664|FG002|Overall Study|Withdrawal by Subject|0|||
49044104|NCT01963260|157994665|FG003|Overall Study|Withdrawal by Subject|1|||
49044105|NCT01963260|157994666|FG004|Overall Study|Withdrawal by Subject|2|||
48989081|NCT00699582|157792837|FG002|Overall Study|Withdrawal by Subject|4|||
48989082|NCT00699582|157792835|FG000|Overall Study|Lack of Efficacy|1|||
48989083|NCT00699582|157792836|FG001|Overall Study|Lack of Efficacy|0|||
48989084|NCT00699582|157792837|FG002|Overall Study|Lack of Efficacy|1|||
48989085|NCT00699582|157792835|FG000|Overall Study|Progressive Disease|1|||
48989086|NCT00699582|157792836|FG001|Overall Study|Progressive Disease|0|||
48989087|NCT00699582|157792837|FG002|Overall Study|Progressive Disease|0|||
48989088|NCT00699582|157792835|FG000|Overall Study|Administrative/Other|4|||
48989089|NCT00699582|157792836|FG001|Overall Study|Administrative/Other|3|||
48989090|NCT00699582|157792837|FG002|Overall Study|Administrative/Other|0|||
48989091|NCT00699582|157792835|FG000|Overall Study|Randomized, Not Treated|2|||
48989092|NCT00699582|157792836|FG001|Overall Study|Randomized, Not Treated|1|||
48989093|NCT00699582|157792837|FG002|Overall Study|Randomized, Not Treated|0|||
48989094|NCT00352027|157792838|FG000|Overall Study|Progressive disease|3|||
48989095|NCT00702949|157792843|FG000|Overall Study|Refusal|3|||
48989096|NCT00702949|157792844|FG001|Overall Study|Refusal|2|||
48989097|NCT00702949|157792845|FG002|Overall Study|Refusal|2|||
48989098|NCT00702949|157792843|FG000|Overall Study|Adverse Event|1|||
48989099|NCT00702949|157792844|FG001|Overall Study|Adverse Event|6|||
48989100|NCT00702949|157792845|FG002|Overall Study|Adverse Event|3|||
48989101|NCT00702949|157792843|FG000|Overall Study|Other Medical Reason/unknown|1|||
48989102|NCT00702949|157792844|FG001|Overall Study|Other Medical Reason/unknown|1|||
48989103|NCT00702949|157792845|FG002|Overall Study|Other Medical Reason/unknown|3|||
48989104|NCT03759340|157792846|FG000|Overall Study|Adverse Event|2|||
48989105|NCT03759340|157792846|FG000|Overall Study|Lost to Follow-up|1|||
48989106|NCT03759340|157792846|FG000|Overall Study|Withdrawal by Subject|15|||
48989107|NCT03759340|157792846|FG000|Overall Study|Study Terminated by Sponsor|38|||
48989108|NCT01200758|157792848|FG000|Stage I|Death|0|||
48989109|NCT01200758|157792849|FG001|Stage I|Death|1|||
48989110|NCT01200758|157792850|FG002|Stage I|Death|0|||
48989111|NCT01200758|157792851|FG003|Stage I|Death|0|||
48989112|NCT01200758|157792848|FG000|Stage I|Physician Decision|1|||
48989113|NCT01200758|157792849|FG001|Stage I|Physician Decision|1|||
48989114|NCT01200758|157792850|FG002|Stage I|Physician Decision|0|||
48989115|NCT01200758|157792851|FG003|Stage I|Physician Decision|0|||
48989116|NCT01200758|157792848|FG000|Stage I|Lack of Efficacy|2|||
48989117|NCT01200758|157792849|FG001|Stage I|Lack of Efficacy|1|||
48989118|NCT01200758|157792850|FG002|Stage I|Lack of Efficacy|0|||
48989119|NCT01200758|157792851|FG003|Stage I|Lack of Efficacy|0|||
48989120|NCT01200758|157792848|FG000|Stage I|Adverse Event|5|||
48989121|NCT01200758|157792849|FG001|Stage I|Adverse Event|5|||
48989122|NCT01200758|157792850|FG002|Stage I|Adverse Event|0|||
48989123|NCT01200758|157792851|FG003|Stage I|Adverse Event|0|||
48989124|NCT01200758|157792848|FG000|Stage I|Withdrawal by Subject|1|||
48989125|NCT01200758|157792849|FG001|Stage I|Withdrawal by Subject|2|||
48989126|NCT01200758|157792850|FG002|Stage I|Withdrawal by Subject|0|||
48989127|NCT01200758|157792851|FG003|Stage I|Withdrawal by Subject|0|||
48989128|NCT01200758|157792848|FG000|Stage I|Disease Progression|9|||
48989129|NCT01200758|157792849|FG001|Stage I|Disease Progression|7|||
48989130|NCT01200758|157792850|FG002|Stage I|Disease Progression|0|||
48989131|NCT01200758|157792851|FG003|Stage I|Disease Progression|0|||
48989132|NCT01200758|157792848|FG000|Stage 2|Disease Progression|0|||
48989133|NCT01200758|157792849|FG001|Stage 2|Disease Progression|0|||
48989134|NCT01200758|157792850|FG002|Stage 2|Disease Progression|16|||
48989135|NCT01200758|157792851|FG003|Stage 2|Disease Progression|21|||
48989136|NCT01200758|157792848|FG000|Stage 2|Lack of Efficacy|0|||
48989137|NCT01200758|157792849|FG001|Stage 2|Lack of Efficacy|0|||
48989138|NCT01200758|157792850|FG002|Stage 2|Lack of Efficacy|4|||
48989139|NCT01200758|157792851|FG003|Stage 2|Lack of Efficacy|2|||
48989140|NCT01200758|157792848|FG000|Stage 2|Physician Decision|0|||
48989141|NCT01200758|157792849|FG001|Stage 2|Physician Decision|0|||
48989142|NCT01200758|157792850|FG002|Stage 2|Physician Decision|5|||
48989143|NCT01200758|157792851|FG003|Stage 2|Physician Decision|7|||
48989144|NCT01200758|157792848|FG000|Stage 2|Adverse Event|0|||
48989145|NCT01200758|157792849|FG001|Stage 2|Adverse Event|0|||
48989146|NCT01200758|157792850|FG002|Stage 2|Adverse Event|5|||
48989147|NCT01200758|157792851|FG003|Stage 2|Adverse Event|9|||
48989148|NCT01200758|157792848|FG000|Stage 2|Withdrawal by Subject|0|||
48989149|NCT01200758|157792849|FG001|Stage 2|Withdrawal by Subject|0|||
48989150|NCT01200758|157792850|FG002|Stage 2|Withdrawal by Subject|4|||
48989151|NCT01200758|157792851|FG003|Stage 2|Withdrawal by Subject|1|||
48989152|NCT01200758|157792848|FG000|Stage 2|Lost to Follow-up|0|||
48989153|NCT01200758|157792849|FG001|Stage 2|Lost to Follow-up|0|||
48989154|NCT01200758|157792850|FG002|Stage 2|Lost to Follow-up|3|||
48989155|NCT01200758|157792851|FG003|Stage 2|Lost to Follow-up|1|||
48989156|NCT01200758|157792848|FG000|Stage 2|Protocol Violation|0|||
48989157|NCT01200758|157792849|FG001|Stage 2|Protocol Violation|0|||
48989158|NCT01200758|157792850|FG002|Stage 2|Protocol Violation|1|||
48989159|NCT01200758|157792851|FG003|Stage 2|Protocol Violation|4|||
48989160|NCT01200758|157792848|FG000|Stage 2|Death|0|||
48989161|NCT01200758|157792849|FG001|Stage 2|Death|0|||
48989162|NCT01200758|157792850|FG002|Stage 2|Death|3|||
48989163|NCT01200758|157792851|FG003|Stage 2|Death|5|||
48989164|NCT01371721|157792852|FG000|Overall Study|Adverse Event|5|||
48989165|NCT01371721|157792853|FG001|Overall Study|Adverse Event|4|||
48989166|NCT01371721|157792854|FG002|Overall Study|Adverse Event|5|||
48989167|NCT01371721|157792852|FG000|Overall Study|Protocol Violation|6|||
48989168|NCT01371721|157792853|FG001|Overall Study|Protocol Violation|4|||
48989169|NCT01371721|157792854|FG002|Overall Study|Protocol Violation|5|||
48989170|NCT01371721|157792852|FG000|Overall Study|Lost to Follow-up|8|||
48989171|NCT01371721|157792853|FG001|Overall Study|Lost to Follow-up|2|||
48989172|NCT01371721|157792854|FG002|Overall Study|Lost to Follow-up|6|||
48989173|NCT01371721|157792852|FG000|Overall Study|Withdrawal by Subject|5|||
48989174|NCT01371721|157792853|FG001|Overall Study|Withdrawal by Subject|7|||
48989175|NCT01371721|157792854|FG002|Overall Study|Withdrawal by Subject|11|||
48989176|NCT01371721|157792852|FG000|Overall Study|Other|2|||
48989177|NCT01371721|157792853|FG001|Overall Study|Other|3|||
48989178|NCT01371721|157792854|FG002|Overall Study|Other|0|||
48989179|NCT01371721|157792852|FG000|Overall Study|Lack of Efficacy|2|||
48989180|NCT01371721|157792853|FG001|Overall Study|Lack of Efficacy|4|||
48989181|NCT01371721|157792854|FG002|Overall Study|Lack of Efficacy|3|||
48989182|NCT01371721|157792852|FG000|Overall Study|Randomized but not treated|1|||
48989183|NCT01371721|157792853|FG001|Overall Study|Randomized but not treated|0|||
48989184|NCT01371721|157792854|FG002|Overall Study|Randomized but not treated|0|||
48989185|NCT03969589|157792859|FG000|Overall Study|Lost to Follow-up|3|||
48989186|NCT03969589|157792860|FG001|Overall Study|Lost to Follow-up|2|||
48989187|NCT03969589|157792859|FG000|Overall Study|Declined Follow-Up|0|||
48989188|NCT03969589|157792860|FG001|Overall Study|Declined Follow-Up|1|||
48989189|NCT01731600|157792863|FG000|Overall Study|Adverse Event|2|||
48989190|NCT01731600|157792864|FG001|Overall Study|Adverse Event|0|||
48989191|NCT01731600|157792863|FG000|Overall Study|Withdrawal criteria|1|||
48989192|NCT01731600|157792864|FG001|Overall Study|Withdrawal criteria|0|||
48989193|NCT01731600|157792863|FG000|Overall Study|Other reasons|3|||
48989194|NCT01731600|157792864|FG001|Overall Study|Other reasons|0|||
48989195|NCT03091920|157792866|FG000|Overall Study|Adverse Event|0|||
48989196|NCT03091920|157792867|FG001|Overall Study|Adverse Event|1|||
48989197|NCT03091920|157792868|FG002|Overall Study|Adverse Event|0|||
48989198|NCT00765726|157792869|FG000|Overall Study|Withdrawal by Subject|1|||
48989199|NCT00765726|157792869|FG000|Overall Study|Discontinuation of study by sponsor|8|||
48989200|NCT02993731|157792870|FG000|Overall Study|Study Termination|101|||
48989201|NCT02993731|157792871|FG001|Overall Study|Study Termination|105|||
48989202|NCT02058966|157792872|FG000|Open-Label Methamphetamine|Adverse Event|1|||
48989203|NCT02058966|157792872|FG000|First Intervention|Withdrawal by Subject|1|||
48989204|NCT03143855|157792873|FG000|Overall Study|Withdrawal by Subject|4|||
48989205|NCT03143855|157792874|FG001|Overall Study|Withdrawal by Subject|3|||
48989206|NCT03143855|157792873|FG000|Overall Study|Protocol Violation|1|||
48989207|NCT03143855|157792874|FG001|Overall Study|Protocol Violation|0|||
48989208|NCT03143855|157792873|FG000|Overall Study|Participant experienced withdrawal|0|||
48989209|NCT03143855|157792874|FG001|Overall Study|Participant experienced withdrawal|1|||
48989210|NCT00453349|157792876|FG000|Randomized|Adverse Event|12|||
48989211|NCT00453349|157792877|FG001|Randomized|Adverse Event|11|||
48989212|NCT00453349|157792876|FG000|Randomized|Lack of Efficacy|2|||
48989213|NCT00453349|157792877|FG001|Randomized|Lack of Efficacy|1|||
48989214|NCT00453349|157792876|FG000|Randomized|Lost to Follow-up|7|||
48989215|NCT00453349|157792877|FG001|Randomized|Lost to Follow-up|5|||
48989216|NCT00453349|157792876|FG000|Randomized|Protocol Violation|1|||
48989217|NCT00453349|157792877|FG001|Randomized|Protocol Violation|1|||
48989218|NCT00453349|157792876|FG000|Randomized|Withdrawal by Subject|3|||
48989219|NCT00453349|157792877|FG001|Randomized|Withdrawal by Subject|5|||
48989220|NCT00453349|157792876|FG000|Reaching of Primary Endpoint (TOC)|Missing information|10|||
48989221|NCT00453349|157792877|FG001|Reaching of Primary Endpoint (TOC)|Missing information|11|||
48989222|NCT00453349|157792876|FG000|Completed Study|Adverse Event|12|||
48989223|NCT00453349|157792877|FG001|Completed Study|Adverse Event|11|||
48989224|NCT00453349|157792876|FG000|Completed Study|Lack of Efficacy|2|||
48989225|NCT00453349|157792877|FG001|Completed Study|Lack of Efficacy|1|||
48989226|NCT00453349|157792876|FG000|Completed Study|Lost to Follow-up|7|||
48989227|NCT00453349|157792877|FG001|Completed Study|Lost to Follow-up|5|||
48989228|NCT00453349|157792876|FG000|Completed Study|Protocol Violation|1|||
48989229|NCT00453349|157792877|FG001|Completed Study|Protocol Violation|1|||
48989230|NCT00453349|157792876|FG000|Completed Study|Withdrawal by Subject|3|||
48989231|NCT00453349|157792877|FG001|Completed Study|Withdrawal by Subject|5|||
48989232|NCT00453349|157792876|FG000|Completed Study|Lost to follow up after study treatment|2|||
48989233|NCT00453349|157792877|FG001|Completed Study|Lost to follow up after study treatment|11|||
48989234|NCT03575975|157792878|FG000|Overall Study|Lost to Follow-up|1|||
48989235|NCT03575975|157792879|FG001|Overall Study|Lost to Follow-up|0|||
48989236|NCT03575975|157792880|FG002|Overall Study|Lost to Follow-up|0|||
48989237|NCT04369742|157792881|FG000|Overall Study|Lost to Follow-Up (Day 14)|7|||
48989238|NCT04369742|157792882|FG001|Overall Study|Lost to Follow-Up (Day 14)|4|||
48989239|NCT04369742|157792881|FG000|Overall Study|Lost to Follow-Up (Day 30)|7|||
48989240|NCT04369742|157792882|FG001|Overall Study|Lost to Follow-Up (Day 30)|7|||
48989241|NCT00805142|157792883|FG000|Titration Period|Adverse Event|3|||
49044106|NCT01963260|157994667|FG005|Overall Study|Withdrawal by Subject|0|||
49044107|NCT01963260|157994668|FG006|Overall Study|Withdrawal by Subject|0|||
49044108|NCT01963260|157994669|FG007|Overall Study|Withdrawal by Subject|0|||
48989242|NCT00805142|157792884|FG001|Titration Period|Adverse Event|3|||
48989243|NCT00805142|157792883|FG000|Titration Period|Lack of Efficacy|1|||
48989244|NCT00805142|157792884|FG001|Titration Period|Lack of Efficacy|1|||
48989245|NCT00805142|157792883|FG000|Titration Period|Lost to Follow-up|0|||
48989246|NCT00805142|157792884|FG001|Titration Period|Lost to Follow-up|1|||
48989247|NCT00805142|157792883|FG000|Titration Period|Disease Progression|2|||
48989248|NCT00805142|157792884|FG001|Titration Period|Disease Progression|1|||
48989249|NCT00805142|157792883|FG000|Titration Period|Withdrawal of consent|0|||
49044109|NCT01963260|157994670|FG008|Overall Study|Withdrawal by Subject|0|||
49044110|NCT01963260|157994671|FG009|Overall Study|Withdrawal by Subject|0|||
49044111|NCT02340962|157994672|FG000|Overall Study|Lost to Follow-up|1|||
48989250|NCT00805142|157792884|FG001|Titration Period|Withdrawal of consent|1|||
48989251|NCT00805142|157792883|FG000|Titration Period|Other|0|||
48989252|NCT00805142|157792884|FG001|Titration Period|Other|3|||
48989253|NCT00805142|157792883|FG000|Maintenance Period|Adverse Event|0|||
49044112|NCT02340962|157994673|FG001|Overall Study|Lost to Follow-up|0|||
49044113|NCT02003391|157994674|FG000|Overall Study|Withdrawal by Subject|2|||
49044114|NCT02003391|157994675|FG001|Overall Study|Withdrawal by Subject|1|||
49044115|NCT02003391|157994674|FG000|Overall Study|Protocol Violation|0|||
49044116|NCT02003391|157994675|FG001|Overall Study|Protocol Violation|1|||
49044117|NCT02003391|157994674|FG000|Overall Study|Adverse Event|1|||
49044118|NCT02003391|157994675|FG001|Overall Study|Adverse Event|0|||
49044119|NCT01970592|157994676|FG000|Overall Study|Withdrawal by Subject|4|||
49044120|NCT01970592|157994676|FG000|Overall Study|Physician Decision|1|||
49044121|NCT01970592|157994676|FG000|Overall Study|Adverse Event|1|||
49044122|NCT03727139|157994677|FG000|Overall Study|Protocol Violation|60|||
49044123|NCT00566722|157994678|FG000|Overall Study|Adverse Event|0|||
49044124|NCT00566722|157994679|FG001|Overall Study|Adverse Event|1|||
49044125|NCT00566722|157994680|FG002|Overall Study|Adverse Event|0|||
49044126|NCT00566722|157994678|FG000|Overall Study|Withdrawal by Subject|0|||
49044127|NCT00566722|157994679|FG001|Overall Study|Withdrawal by Subject|0|||
49044128|NCT00566722|157994680|FG002|Overall Study|Withdrawal by Subject|1|||
49044129|NCT00566722|157994678|FG000|Overall Study|Lost to Follow-up|1|||
49044130|NCT00566722|157994679|FG001|Overall Study|Lost to Follow-up|1|||
49044131|NCT00566722|157994680|FG002|Overall Study|Lost to Follow-up|1|||
49044132|NCT00566722|157994678|FG000|Overall Study|Lack of Efficacy|1|||
49044133|NCT00566722|157994679|FG001|Overall Study|Lack of Efficacy|2|||
49044134|NCT00566722|157994680|FG002|Overall Study|Lack of Efficacy|4|||
49044135|NCT00566722|157994678|FG000|Overall Study|Did not meet exclusion criteria|0|||
49044136|NCT00566722|157994679|FG001|Overall Study|Did not meet exclusion criteria|0|||
49044137|NCT00566722|157994680|FG002|Overall Study|Did not meet exclusion criteria|2|||
49044138|NCT00566722|157994678|FG000|Overall Study|Serious adverse event|0|||
49044139|NCT00566722|157994679|FG001|Overall Study|Serious adverse event|1|||
49044140|NCT00566722|157994680|FG002|Overall Study|Serious adverse event|0|||
49044141|NCT00566722|157994678|FG000|Overall Study|Noncompliant with drug administration|0|||
49044142|NCT00566722|157994679|FG001|Overall Study|Noncompliant with drug administration|0|||
49044143|NCT00566722|157994680|FG002|Overall Study|Noncompliant with drug administration|1|||
49044144|NCT01320722|157994681|FG000|Overall Study|Did not Receive Intervention|3|||
49044145|NCT01320722|157994682|FG001|Overall Study|Did not Receive Intervention|2|||
49044146|NCT01320722|157994683|FG002|Overall Study|Did not Receive Intervention|1|||
49044147|NCT01320722|157994684|FG003|Overall Study|Did not Receive Intervention|1|||
49044148|NCT01320722|157994685|FG004|Overall Study|Did not Receive Intervention|2|||
49044149|NCT01320722|157994681|FG000|Overall Study|Lost to Follow-up|0|||
49044150|NCT01320722|157994682|FG001|Overall Study|Lost to Follow-up|1|||
49044151|NCT01320722|157994683|FG002|Overall Study|Lost to Follow-up|0|||
49044152|NCT01320722|157994684|FG003|Overall Study|Lost to Follow-up|1|||
49044153|NCT01320722|157994685|FG004|Overall Study|Lost to Follow-up|3|||
49044154|NCT01320722|157994681|FG000|Overall Study|Not Available for the 8 Week Visit|0|||
49044155|NCT01320722|157994682|FG001|Overall Study|Not Available for the 8 Week Visit|3|||
49044156|NCT01320722|157994683|FG002|Overall Study|Not Available for the 8 Week Visit|0|||
49044157|NCT01320722|157994684|FG003|Overall Study|Not Available for the 8 Week Visit|0|||
49044158|NCT01320722|157994685|FG004|Overall Study|Not Available for the 8 Week Visit|0|||
49044159|NCT01320722|157994681|FG000|Overall Study|Participant Developed a Rash|0|||
49044160|NCT01320722|157994682|FG001|Overall Study|Participant Developed a Rash|0|||
48989254|NCT00805142|157792884|FG001|Maintenance Period|Adverse Event|1|||
49044161|NCT01320722|157994683|FG002|Overall Study|Participant Developed a Rash|2|||
49044162|NCT01320722|157994684|FG003|Overall Study|Participant Developed a Rash|1|||
49044163|NCT01320722|157994685|FG004|Overall Study|Participant Developed a Rash|1|||
49044164|NCT01320722|157994681|FG000|Overall Study|Non-compliant with Medication|0|||
49044165|NCT01320722|157994682|FG001|Overall Study|Non-compliant with Medication|0|||
49044166|NCT01320722|157994683|FG002|Overall Study|Non-compliant with Medication|1|||
48989255|NCT00805142|157792883|FG000|Maintenance Period|Other|0|||
48989256|NCT00805142|157792884|FG001|Maintenance Period|Other|1|||
48989257|NCT00280059|157792885|FG000|Efficacy Assessment Phase|Death|2|||
48989258|NCT00280059|157792886|FG001|Efficacy Assessment Phase|Death|0|||
48989259|NCT00280059|157792885|FG000|Efficacy Assessment Phase|Adverse Event|33|||
48989260|NCT00280059|157792886|FG001|Efficacy Assessment Phase|Adverse Event|31|||
48989261|NCT00280059|157792885|FG000|Efficacy Assessment Phase|Laboratory abnormaility|1|||
48989262|NCT00280059|157792886|FG001|Efficacy Assessment Phase|Laboratory abnormaility|0|||
48989263|NCT00280059|157792885|FG000|Efficacy Assessment Phase|Lack of Efficacy|19|||
48989264|NCT00280059|157792886|FG001|Efficacy Assessment Phase|Lack of Efficacy|3|||
48989265|NCT00280059|157792885|FG000|Efficacy Assessment Phase|Lost to Follow-up|6|||
48989266|NCT00280059|157792886|FG001|Efficacy Assessment Phase|Lost to Follow-up|13|||
48989267|NCT00280059|157792885|FG000|Efficacy Assessment Phase|Other|7|||
48989268|NCT00280059|157792886|FG001|Efficacy Assessment Phase|Other|8|||
48989269|NCT00280059|157792885|FG000|Efficacy Assessment Phase|Withdrawal by Subject|26|||
48989270|NCT00280059|157792886|FG001|Efficacy Assessment Phase|Withdrawal by Subject|25|||
48989271|NCT02576951|157792889|FG000|Overall Study|Lost to Follow-up|0|||
48989272|NCT02576951|157792890|FG001|Overall Study|Lost to Follow-up|0|||
48989273|NCT02576951|157792891|FG002|Overall Study|Lost to Follow-up|2|||
48989274|NCT02576951|157792892|FG003|Overall Study|Lost to Follow-up|2|||
48989275|NCT02576951|157792889|FG000|Overall Study|Withdrawal by Subject|1|||
48989276|NCT02576951|157792890|FG001|Overall Study|Withdrawal by Subject|0|||
48989277|NCT02576951|157792891|FG002|Overall Study|Withdrawal by Subject|0|||
48989278|NCT02576951|157792892|FG003|Overall Study|Withdrawal by Subject|2|||
48989279|NCT02576951|157792889|FG000|Overall Study|Protocol Violation|0|||
48989280|NCT02576951|157792890|FG001|Overall Study|Protocol Violation|0|||
48989281|NCT02576951|157792891|FG002|Overall Study|Protocol Violation|0|||
48989282|NCT02576951|157792892|FG003|Overall Study|Protocol Violation|1|||
48989283|NCT00465894|157792893|FG000|Treatment For 12 Weeks|Lost to Follow-up|4|||
48989284|NCT00465894|157792894|FG001|Treatment For 12 Weeks|Lost to Follow-up|1|||
48989285|NCT00465894|157792893|FG000|Treatment For 12 Weeks|Family Issues|1|||
48989286|NCT00465894|157792894|FG001|Treatment For 12 Weeks|Family Issues|1|||
48989287|NCT00465894|157792893|FG000|Treatment For 12 Weeks|Withdrawal by Subject|0|||
48989288|NCT00465894|157792894|FG001|Treatment For 12 Weeks|Withdrawal by Subject|1|||
48989289|NCT01362062|157792895|FG000|Overall Study|Adverse Event|1|||
48989290|NCT01362062|157792896|FG001|Overall Study|Adverse Event|0|||
48989291|NCT01362062|157792895|FG000|Overall Study|Lost to Follow-up|11|||
48989292|NCT01362062|157792896|FG001|Overall Study|Lost to Follow-up|0|||
48989293|NCT01362062|157792895|FG000|Overall Study|Withdrawal by Subject|2|||
48989294|NCT01362062|157792896|FG001|Overall Study|Withdrawal by Subject|0|||
48989295|NCT01362062|157792895|FG000|Overall Study|Non-compliant participant|2|||
48989296|NCT01362062|157792896|FG001|Overall Study|Non-compliant participant|0|||
48989297|NCT01362062|157792895|FG000|Overall Study|Detected with Spondylo-arthritis|1|||
48989298|NCT01362062|157792896|FG001|Overall Study|Detected with Spondylo-arthritis|0|||
48989299|NCT01362062|157792895|FG000|Overall Study|Had significant improvement|9|||
48989300|NCT01362062|157792896|FG001|Overall Study|Had significant improvement|0|||
48989301|NCT02612194|157792899|FG000|Overall Study|Death|5|||
48989302|NCT02612194|157792900|FG001|Overall Study|Death|0|||
48989303|NCT02612194|157792901|FG002|Overall Study|Death|2|||
48989304|NCT02612194|157792899|FG000|Overall Study|Early Study Termination|1|||
48989305|NCT02612194|157792900|FG001|Overall Study|Early Study Termination|0|||
48989306|NCT02612194|157792901|FG002|Overall Study|Early Study Termination|0|||
48989307|NCT00540228|157792902|FG000|Overall Study|Adverse Event|2|||
48989308|NCT00540228|157792903|FG001|Overall Study|Adverse Event|0|||
48989309|NCT00540228|157792904|FG002|Overall Study|Adverse Event|0|||
48989310|NCT00540228|157792905|FG003|Overall Study|Adverse Event|0|||
48989311|NCT00540228|157792906|FG004|Overall Study|Adverse Event|0|||
48989312|NCT00540228|157792902|FG000|Overall Study|Lost to Follow-up|1|||
48989313|NCT00540228|157792903|FG001|Overall Study|Lost to Follow-up|1|||
48989314|NCT00540228|157792904|FG002|Overall Study|Lost to Follow-up|0|||
48989315|NCT00540228|157792905|FG003|Overall Study|Lost to Follow-up|0|||
48989316|NCT00540228|157792906|FG004|Overall Study|Lost to Follow-up|0|||
48989317|NCT02312934|157792907|FG000|Overall Study|Lost to Follow-up|1|||
48989318|NCT02312934|157792908|FG001|Overall Study|Lost to Follow-up|0|||
48989319|NCT02312934|157792907|FG000|Overall Study|Physician Decision|1|||
48989320|NCT02312934|157792908|FG001|Overall Study|Physician Decision|0|||
48989321|NCT02173158|157792909|FG000|Efficacy Phase|Adverse Event|1|||
48989322|NCT02719028|157794591|FG000|Overall Study|Adverse Event|2|||
48989323|NCT02719028|157794592|FG001|Overall Study|Adverse Event|1|||
48989324|NCT02719028|157794593|FG002|Overall Study|Adverse Event|4|||
48989325|NCT02719028|157794594|FG003|Overall Study|Adverse Event|8|||
48989326|NCT02719028|157794591|FG000|Overall Study|Physician Decision|0|||
48989327|NCT02719028|157794592|FG001|Overall Study|Physician Decision|1|||
48989328|NCT02719028|157794593|FG002|Overall Study|Physician Decision|1|||
48989329|NCT02719028|157794594|FG003|Overall Study|Physician Decision|1|||
48989330|NCT02719028|157794591|FG000|Overall Study|Use of prohibited medication|0|||
48989331|NCT02719028|157794592|FG001|Overall Study|Use of prohibited medication|0|||
48989332|NCT02719028|157794593|FG002|Overall Study|Use of prohibited medication|1|||
49044167|NCT01320722|157994684|FG003|Overall Study|Non-compliant with Medication|0|||
49044168|NCT01320722|157994685|FG004|Overall Study|Non-compliant with Medication|0|||
49044169|NCT01320722|157994681|FG000|Overall Study|Adverse Event|0|||
48989333|NCT02719028|157794594|FG003|Overall Study|Use of prohibited medication|0|||
48989334|NCT02719028|157794591|FG000|Overall Study|Protocol Violation|0|||
48989335|NCT02719028|157794592|FG001|Overall Study|Protocol Violation|0|||
48989336|NCT02719028|157794593|FG002|Overall Study|Protocol Violation|0|||
48989337|NCT02719028|157794594|FG003|Overall Study|Protocol Violation|1|||
48989338|NCT04237298|157794595|FG000|Overall Study|Lost to Follow-up|4|||
49044170|NCT01320722|157994682|FG001|Overall Study|Adverse Event|0|||
49044171|NCT01320722|157994683|FG002|Overall Study|Adverse Event|3|||
49044172|NCT01320722|157994684|FG003|Overall Study|Adverse Event|6|||
49044173|NCT01320722|157994685|FG004|Overall Study|Adverse Event|0|||
49044174|NCT01320722|157994681|FG000|Overall Study|Not Compliant with Study Procedures|0|||
49044175|NCT01320722|157994682|FG001|Overall Study|Not Compliant with Study Procedures|0|||
49044176|NCT01320722|157994683|FG002|Overall Study|Not Compliant with Study Procedures|0|||
49044177|NCT01320722|157994684|FG003|Overall Study|Not Compliant with Study Procedures|4|||
49044178|NCT01320722|157994685|FG004|Overall Study|Not Compliant with Study Procedures|0|||
49044179|NCT01320722|157994681|FG000|Overall Study|Pregnancy|0|||
49044180|NCT01320722|157994682|FG001|Overall Study|Pregnancy|0|||
49044181|NCT01320722|157994683|FG002|Overall Study|Pregnancy|0|||
49044182|NCT01320722|157994684|FG003|Overall Study|Pregnancy|1|||
49044183|NCT01320722|157994685|FG004|Overall Study|Pregnancy|0|||
49044184|NCT01320722|157994681|FG000|Overall Study|Started an Exclusionary Medication|0|||
49044185|NCT01320722|157994682|FG001|Overall Study|Started an Exclusionary Medication|0|||
49044186|NCT01320722|157994683|FG002|Overall Study|Started an Exclusionary Medication|0|||
49044187|NCT01320722|157994684|FG003|Overall Study|Started an Exclusionary Medication|0|||
49044188|NCT01320722|157994685|FG004|Overall Study|Started an Exclusionary Medication|1|||
49044189|NCT01320722|157994681|FG000|Overall Study|Withdrew due to Health Condition|0|||
49044190|NCT01320722|157994682|FG001|Overall Study|Withdrew due to Health Condition|0|||
49044191|NCT01320722|157994683|FG002|Overall Study|Withdrew due to Health Condition|0|||
49044192|NCT01320722|157994684|FG003|Overall Study|Withdrew due to Health Condition|0|||
49044193|NCT01320722|157994685|FG004|Overall Study|Withdrew due to Health Condition|1|||
49044194|NCT04994431|157994686|FG000|Overall Study|Adverse Event|1|||
49044195|NCT04994431|157994687|FG001|Overall Study|Adverse Event|0|||
48989339|NCT04237298|157794596|FG001|Overall Study|Lost to Follow-up|5|||
48989340|NCT00186121|157794598|FG000|Overall Study|Subject withdrawal (no treatment)|1|||
48989341|NCT00186121|157794598|FG000|Overall Study|Underwent oophorectomy (no treatment)|1|||
48989342|NCT00186121|157794598|FG000|Overall Study|Not eligible (no treatment)|1|||
48989343|NCT03650387|157794599|FG000|Overall Study|Withdrawal by Subject|13|||
48989344|NCT03650387|157794599|FG000|Overall Study|Lost to Follow-up|12|||
48989345|NCT03650387|157794599|FG000|Overall Study|Adverse Event (Not related)|1|||
48989346|NCT03650387|157794599|FG000|Overall Study|Due to COVID-19 Pandemic|8|||
48989347|NCT01539720|157794600|FG000|Overall Study|Screen Fail|15|||
48989348|NCT01539720|157794601|FG001|Overall Study|Screen Fail|3|||
48989349|NCT01539720|157794600|FG000|Overall Study|Lost to Follow-up|14|||
48989350|NCT01539720|157794601|FG001|Overall Study|Lost to Follow-up|7|||
48989351|NCT00298766|157794602|FG000|Overall Study|Adverse Event|18|||
48989352|NCT00298766|157794602|FG000|Overall Study|Death|2|||
48989353|NCT00298766|157794602|FG000|Overall Study|Withdrawal by Subject|9|||
48989354|NCT00298766|157794602|FG000|Overall Study|Treatment ongoing|4|||
48989355|NCT00298766|157794602|FG000|Overall Study|Progression of amyloid markers|4|||
48989356|NCT00298766|157794602|FG000|Overall Study|Deterioration in KPS and organ function|1|||
48989357|NCT00298766|157794602|FG000|Overall Study|Subjects overall condition deterioration|4|||
48989358|NCT00298766|157794602|FG000|Overall Study|Other|4|||
48989359|NCT03287960|157794609|FG000|Open-Label Period (10 Weeks)|Adverse Event|1|||
48989360|NCT03287960|157794609|FG000|Open-Label Period (32 Weeks)|Serious Adverse Event|1|||
48989361|NCT02505945|157794610|FG000|Overall Study|Withdrawal by Subject|13|||
48989362|NCT02505945|157794611|FG001|Overall Study|Withdrawal by Subject|2|||
48989363|NCT02505945|157794610|FG000|Overall Study|Adverse Event|1|||
48989364|NCT02505945|157794611|FG001|Overall Study|Adverse Event|0|||
49044196|NCT02896296|157994688|FG000|Overall Study|Adverse Event|1|||
49044197|NCT02896296|157994688|FG000|Overall Study|Lost to Follow-up|19|||
49044198|NCT02896296|157994688|FG000|Overall Study|Pregnancy|1|||
49044199|NCT02896296|157994688|FG000|Overall Study|Physician Decision|2|||
49044200|NCT02896296|157994688|FG000|Overall Study|Withdrawal by Subject|10|||
49044201|NCT02896296|157994688|FG000|Overall Study|Site closing|7|||
49044202|NCT02896296|157994688|FG000|Overall Study|Incarceration|1|||
48989365|NCT02505945|157794610|FG000|Overall Study|Physician Decision|2|||
48989366|NCT02505945|157794611|FG001|Overall Study|Physician Decision|1|||
48989367|NCT02505945|157794610|FG000|Overall Study|Lost to Follow-up|6|||
48989368|NCT02505945|157794611|FG001|Overall Study|Lost to Follow-up|1|||
48989369|NCT00661362|157794612|FG000|Overall Study|Adverse Event|5|||
48989370|NCT00661362|157794613|FG001|Overall Study|Adverse Event|4|||
48989371|NCT00661362|157794612|FG000|Overall Study|Incorrect enrollment|2|||
48989372|NCT00661362|157794613|FG001|Overall Study|Incorrect enrollment|0|||
49044203|NCT02896296|157994688|FG000|Overall Study|Relocation|1|||
49044204|NCT00160524|157994689|FG000|Overall Study|Adverse Event|119|||
49044205|NCT00160524|157994689|FG000|Overall Study|Adverse Event and Other|94|||
49044206|NCT00160524|157994689|FG000|Overall Study|Protocol Violation|16|||
49044207|NCT00160524|157994689|FG000|Overall Study|Protocol Violation and Other|2|||
49044208|NCT00160524|157994689|FG000|Overall Study|Withdrawal by Subject|141|||
49044209|NCT00160524|157994689|FG000|Overall Study|Withdrawal by Subject and Other|17|||
49044210|NCT00160524|157994689|FG000|Overall Study|Physician Decision|27|||
49044211|NCT00160524|157994689|FG000|Overall Study|Physician Decision and Other|6|||
49044212|NCT00160524|157994689|FG000|Overall Study|Lost to Follow-up|13|||
48989373|NCT00661362|157794612|FG000|Overall Study|Study specific discontinuation criteria|4|||
48989374|NCT00661362|157794613|FG001|Overall Study|Study specific discontinuation criteria|11|||
48989375|NCT00661362|157794612|FG000|Overall Study|Withdrawal by Subject|13|||
49044213|NCT00160524|157994689|FG000|Overall Study|Lost to Follow-up and Other|1|||
49044214|NCT00160524|157994689|FG000|Overall Study|Lack of Efficacy|21|||
49044215|NCT00160524|157994689|FG000|Overall Study|Lack of Efficacy and Other|1|||
49044216|NCT00160524|157994689|FG000|Overall Study|Other|20|||
49044217|NCT00697619|157994690|FG000|Overall Study|Lack of Efficacy|2|||
49044218|NCT00697619|157994691|FG001|Overall Study|Lack of Efficacy|2|||
49044219|NCT00697619|157994690|FG000|Overall Study|Adverse Event|4|||
49044220|NCT00697619|157994691|FG001|Overall Study|Adverse Event|6|||
49044221|NCT02611323|157994692|FG000|Overall Study|Death|3|||
49044222|NCT02611323|157994693|FG001|Overall Study|Death|1|||
49044223|NCT02611323|157994694|FG002|Overall Study|Death|0|||
49044224|NCT02611323|157994695|FG003|Overall Study|Death|0|||
49044225|NCT02611323|157994696|FG004|Overall Study|Death|1|||
48989376|NCT00661362|157794613|FG001|Overall Study|Withdrawal by Subject|23|||
48989377|NCT00661362|157794612|FG000|Overall Study|Lost to Follow-up|3|||
48989378|NCT00661362|157794613|FG001|Overall Study|Lost to Follow-up|1|||
48989379|NCT00661362|157794612|FG000|Overall Study|Severe non-compliance to protocol|0|||
48989380|NCT00661362|157794613|FG001|Overall Study|Severe non-compliance to protocol|1|||
48989381|NCT00661362|157794612|FG000|Overall Study|Safety reasons|1|||
49044226|NCT02611323|157994697|FG005|Overall Study|Death|1|||
49044227|NCT02611323|157994698|FG006|Overall Study|Death|8|||
49044228|NCT02611323|157994699|FG007|Overall Study|Death|0|||
49044229|NCT02611323|157994700|FG008|Overall Study|Death|4|||
49044230|NCT02611323|157994701|FG009|Overall Study|Death|6|||
49044231|NCT02611323|157994702|FG010|Overall Study|Death|26|||
49044232|NCT02611323|157994692|FG000|Overall Study|Lost to Follow-up|1|||
49044233|NCT02611323|157994693|FG001|Overall Study|Lost to Follow-up|0|||
49044234|NCT02611323|157994694|FG002|Overall Study|Lost to Follow-up|0|||
49044235|NCT02611323|157994695|FG003|Overall Study|Lost to Follow-up|0|||
49044236|NCT02611323|157994696|FG004|Overall Study|Lost to Follow-up|0|||
49044237|NCT02611323|157994697|FG005|Overall Study|Lost to Follow-up|0|||
49044238|NCT02611323|157994698|FG006|Overall Study|Lost to Follow-up|3|||
49044239|NCT02611323|157994699|FG007|Overall Study|Lost to Follow-up|0|||
48989382|NCT00661362|157794613|FG001|Overall Study|Safety reasons|0|||
48989383|NCT00661362|157794612|FG000|Overall Study|Metformin dose haven't decreasd to 2.5 g|1|||
48989384|NCT00661362|157794613|FG001|Overall Study|Metformin dose haven't decreasd to 2.5 g|0|||
48989385|NCT00679354|157794614|FG000|Overall Study|Death|3|||
48989386|NCT00679354|157794614|FG000|Overall Study|Lack of Efficacy|22|||
48989387|NCT00679354|157794614|FG000|Overall Study|Physician Decision|4|||
48989388|NCT00679354|157794614|FG000|Overall Study|Ineligible|1|||
48989389|NCT00718887|157794615|FG000|Overall Study|Withdrawal by Subject|3|||
48989390|NCT00718887|157794616|FG001|Overall Study|Withdrawal by Subject|2|||
48989391|NCT00718887|157794615|FG000|Overall Study|Not identified|2|||
48989392|NCT00718887|157794616|FG001|Overall Study|Not identified|7|||
48989393|NCT02074059|157794617|FG000|Overall Study|Death|0|||
48989394|NCT02074059|157794618|FG001|Overall Study|Death|0|||
48989395|NCT02074059|157794619|FG002|Overall Study|Death|0|||
48989396|NCT02074059|157794620|FG003|Overall Study|Death|0|||
49044240|NCT02611323|157994700|FG008|Overall Study|Lost to Follow-up|0|||
49044241|NCT02611323|157994701|FG009|Overall Study|Lost to Follow-up|0|||
49044242|NCT02611323|157994702|FG010|Overall Study|Lost to Follow-up|2|||
49044243|NCT02611323|157994692|FG000|Overall Study|Found Another Malignancy After Starting Trial|0|||
49044244|NCT02611323|157994693|FG001|Overall Study|Found Another Malignancy After Starting Trial|0|||
49044245|NCT02611323|157994694|FG002|Overall Study|Found Another Malignancy After Starting Trial|0|||
49044246|NCT02611323|157994695|FG003|Overall Study|Found Another Malignancy After Starting Trial|0|||
49044247|NCT02611323|157994696|FG004|Overall Study|Found Another Malignancy After Starting Trial|0|||
49044248|NCT02611323|157994697|FG005|Overall Study|Found Another Malignancy After Starting Trial|0|||
48989397|NCT02074059|157794621|FG004|Overall Study|Death|1|||
48989398|NCT02074059|157794622|FG005|Overall Study|Death|1|||
48989399|NCT04856163|157794624|FG000|Overall Study|Lost to Follow-up|97|||
48989400|NCT04856163|157794625|FG001|Overall Study|Lost to Follow-up|100|||
48989401|NCT01258738|157794628|FG000|Double-blind Period|Did not meet inclusion criteria|3|||
48989402|NCT01258738|157794629|FG001|Double-blind Period|Did not meet inclusion criteria|3|||
48989403|NCT01258738|157794628|FG000|Double-blind Period|Withdrawal by Subject|2|||
48989404|NCT01258738|157794629|FG001|Double-blind Period|Withdrawal by Subject|2|||
48989405|NCT01258738|157794628|FG000|Double-blind Period|Protocol Violation|1|||
48989406|NCT01258738|157794629|FG001|Double-blind Period|Protocol Violation|1|||
48989407|NCT01258738|157794628|FG000|Double-blind Period|Adverse Event|3|||
48989408|NCT01258738|157794629|FG001|Double-blind Period|Adverse Event|1|||
48989409|NCT01258738|157794628|FG000|Open-label Period|Did not meet inclusion criteria|0|||
48989410|NCT01258738|157794629|FG001|Open-label Period|Did not meet inclusion criteria|1|||
48989411|NCT01258738|157794628|FG000|Open-label Period|Insufficient clinical response|5|||
48989412|NCT01258738|157794629|FG001|Open-label Period|Insufficient clinical response|3|||
48989413|NCT01258738|157794628|FG000|Open-label Period|Lost to Follow-up|0|||
48989414|NCT01258738|157794629|FG001|Open-label Period|Lost to Follow-up|2|||
48989415|NCT01258738|157794628|FG000|Open-label Period|Withdrawal by Subject|5|||
48989416|NCT01258738|157794629|FG001|Open-label Period|Withdrawal by Subject|6|||
48989417|NCT01258738|157794628|FG000|Open-label Period|Protocol Violation|2|||
48989418|NCT01258738|157794629|FG001|Open-label Period|Protocol Violation|2|||
48989419|NCT01258738|157794628|FG000|Open-label Period|Adverse Event|4|||
48989420|NCT01258738|157794629|FG001|Open-label Period|Adverse Event|5|||
48989421|NCT01258738|157794628|FG000|Open-label Period|Other Reasons|0|||
48989422|NCT01258738|157794629|FG001|Open-label Period|Other Reasons|1|||
48989423|NCT01258738|157794628|FG000|Open-label Period|Withdrawn due to pregnancy|1|||
48989424|NCT01258738|157794629|FG001|Open-label Period|Withdrawn due to pregnancy|1|||
48989425|NCT03432819|157794630|FG000|Overall Study|Lost to Follow-up|2|||
48989426|NCT03432819|157794631|FG001|Overall Study|Lost to Follow-up|2|||
48989427|NCT03432819|157794630|FG000|Overall Study|Withdrawal by Subject|5|||
49044249|NCT02611323|157994698|FG006|Overall Study|Found Another Malignancy After Starting Trial|0|||
49044250|NCT02611323|157994699|FG007|Overall Study|Found Another Malignancy After Starting Trial|0|||
49044251|NCT02611323|157994700|FG008|Overall Study|Found Another Malignancy After Starting Trial|0|||
49044252|NCT02611323|157994701|FG009|Overall Study|Found Another Malignancy After Starting Trial|1|||
49044253|NCT02611323|157994702|FG010|Overall Study|Found Another Malignancy After Starting Trial|0|||
49044254|NCT02611323|157994692|FG000|Overall Study|Progressive Disease|0|||
49044255|NCT02611323|157994693|FG001|Overall Study|Progressive Disease|0|||
49044256|NCT02611323|157994694|FG002|Overall Study|Progressive Disease|0|||
49044257|NCT02611323|157994695|FG003|Overall Study|Progressive Disease|0|||
49044258|NCT02611323|157994696|FG004|Overall Study|Progressive Disease|0|||
49044259|NCT02611323|157994697|FG005|Overall Study|Progressive Disease|0|||
49044260|NCT02611323|157994698|FG006|Overall Study|Progressive Disease|0|||
49044261|NCT02611323|157994699|FG007|Overall Study|Progressive Disease|0|||
49044262|NCT02611323|157994700|FG008|Overall Study|Progressive Disease|0|||
49044263|NCT02611323|157994701|FG009|Overall Study|Progressive Disease|0|||
49044264|NCT02611323|157994702|FG010|Overall Study|Progressive Disease|1|||
49044265|NCT02611323|157994692|FG000|Overall Study|Withdrawal by Subject|1|||
49044266|NCT02611323|157994693|FG001|Overall Study|Withdrawal by Subject|0|||
49044267|NCT02611323|157994694|FG002|Overall Study|Withdrawal by Subject|0|||
49044268|NCT02611323|157994695|FG003|Overall Study|Withdrawal by Subject|0|||
49044269|NCT02611323|157994696|FG004|Overall Study|Withdrawal by Subject|0|||
49044270|NCT02611323|157994697|FG005|Overall Study|Withdrawal by Subject|0|||
49044271|NCT02611323|157994698|FG006|Overall Study|Withdrawal by Subject|0|||
49044272|NCT02611323|157994699|FG007|Overall Study|Withdrawal by Subject|1|||
49044273|NCT02611323|157994700|FG008|Overall Study|Withdrawal by Subject|0|||
49044274|NCT02611323|157994701|FG009|Overall Study|Withdrawal by Subject|1|||
49044275|NCT02611323|157994702|FG010|Overall Study|Withdrawal by Subject|0|||
49044276|NCT01067521|157994703|FG000|Double-Blind Placebo-Controlled Period|Death|0|||
49044277|NCT01067521|157994704|FG001|Double-Blind Placebo-Controlled Period|Death|1|||
49044278|NCT01067521|157994703|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|29|||
49044279|NCT01067521|157994704|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|6|||
49044280|NCT01067521|157994703|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34|||
49044281|NCT01067521|157994704|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17|||
49044282|NCT01067521|157994703|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
49044283|NCT01067521|157994704|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
49044284|NCT01067521|157994703|FG000|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4|||
49044285|NCT01067521|157994704|FG001|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1|||
49044286|NCT01067521|157994703|FG000|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2|||
48989428|NCT03432819|157794631|FG001|Overall Study|Withdrawal by Subject|3|||
48989429|NCT02418000|157794633|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2|||
49044287|NCT01067521|157994704|FG001|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0|||
49044288|NCT01067521|157994703|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|2|||
49044289|NCT01067521|157994704|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
49044290|NCT01067521|157994703|FG000|Double-Blind Placebo-Controlled Period|Pregnancy|7|||
49044291|NCT01067521|157994704|FG001|Double-Blind Placebo-Controlled Period|Pregnancy|4|||
49044292|NCT01067521|157994703|FG000|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5|||
49044293|NCT01067521|157994704|FG001|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1|||
48989430|NCT02418000|157794634|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
48989431|NCT02418000|157794635|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
48989432|NCT02418000|157794636|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
48989433|NCT02418000|157794637|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
48989434|NCT02418000|157794633|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4|||
48989435|NCT02418000|157794634|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
48989436|NCT02418000|157794635|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
48989437|NCT02418000|157794636|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
48989438|NCT02418000|157794637|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
48989439|NCT02418000|157794633|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1|||
48989440|NCT02418000|157794634|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
48989441|NCT02418000|157794635|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
48989442|NCT02418000|157794636|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
48989443|NCT02418000|157794637|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
48989444|NCT02418000|157794633|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
48989445|NCT02418000|157794634|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1|||
48989446|NCT02418000|157794635|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
48989447|NCT02418000|157794636|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
48989448|NCT02418000|157794637|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
48989449|NCT02418000|157794633|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
48989450|NCT02418000|157794634|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9|||
48989451|NCT02418000|157794635|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
48989452|NCT02418000|157794636|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
48989453|NCT02418000|157794637|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
48989454|NCT02418000|157794633|FG000|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
48989455|NCT02418000|157794634|FG001|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
48989456|NCT02418000|157794635|FG002|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
48989457|NCT02418000|157794636|FG003|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
48989458|NCT02418000|157794637|FG004|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
48989459|NCT02418000|157794633|FG000|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
48989460|NCT02418000|157794634|FG001|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
48989461|NCT02418000|157794635|FG002|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
48989462|NCT02418000|157794636|FG003|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
48989463|NCT02418000|157794637|FG004|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
49044294|NCT01067521|157994703|FG000|Open-Label Period|Death|3|||
49044295|NCT01067521|157994704|FG001|Open-Label Period|Death|1|||
49044296|NCT01067521|157994703|FG000|Open-Label Period|Adverse Event|30|||
49044297|NCT01067521|157994704|FG001|Open-Label Period|Adverse Event|28|||
49044298|NCT01067521|157994703|FG000|Open-Label Period|Withdrawal by Subject|160|||
49044299|NCT01067521|157994704|FG001|Open-Label Period|Withdrawal by Subject|88|||
49044300|NCT01067521|157994703|FG000|Open-Label Period|Physician Decision|13|||
49044301|NCT01067521|157994704|FG001|Open-Label Period|Physician Decision|11|||
49044302|NCT01067521|157994703|FG000|Open-Label Period|Non-compliance with study drug|5|||
49044303|NCT01067521|157994704|FG001|Open-Label Period|Non-compliance with study drug|0|||
49044304|NCT01067521|157994703|FG000|Open-Label Period|Protocol Violation|3|||
49044305|NCT01067521|157994704|FG001|Open-Label Period|Protocol Violation|0|||
49044306|NCT01067521|157994703|FG000|Open-Label Period|Pregnancy|14|||
49044307|NCT01067521|157994704|FG001|Open-Label Period|Pregnancy|8|||
49044308|NCT01067521|157994703|FG000|Open-Label Period|Teva requested subject to be withdrawn|5|||
49044309|NCT01067521|157994704|FG001|Open-Label Period|Teva requested subject to be withdrawn|2|||
49044310|NCT01067521|157994703|FG000|Open-Label Period|Lost to Follow-up|21|||
49044311|NCT01067521|157994704|FG001|Open-Label Period|Lost to Follow-up|20|||
49044312|NCT00024258|157994707|FG000|Overall Study|Withdrawal by Subject|1|||
49044313|NCT00024258|157994707|FG000|Overall Study|Disease Progression|8|||
49044314|NCT01863433|157994712|FG000|Overall Study|Protocol Violation|1|||
49044315|NCT02279095|157995738|FG000|Overall Study|Non-Compliance|1|||
49044316|NCT02279095|157995738|FG000|Overall Study|Withdrawal by Subject|8|||
49044317|NCT02279095|157995738|FG000|Overall Study|Adverse Event|2|||
48989464|NCT02418000|157794633|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
48989465|NCT02418000|157794634|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
48989466|NCT02418000|157794635|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
48989467|NCT02418000|157794636|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
48989468|NCT02418000|157794637|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1|||
48989469|NCT02418000|157794633|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
48989470|NCT02418000|157794634|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
48989471|NCT02418000|157794635|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
48989472|NCT02418000|157794636|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
48989473|NCT02418000|157794637|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
49044318|NCT02279095|157995738|FG000|Overall Study|Other|7|||
49044319|NCT02279095|157995738|FG000|Overall Study|Lost to Follow-up|1|||
49044320|NCT03945773|157995739|FG000|Overall Study|Consent Withdrawn|1|||
49044321|NCT03945773|157995740|FG001|Overall Study|Consent Withdrawn|1|||
48989474|NCT00689611|157794638|FG000|Overall Study|Death|6|||
48989475|NCT00689611|157794639|FG001|Overall Study|Death|9|||
48989476|NCT00689611|157794638|FG000|Overall Study|Withdrawal by Subject|8|||
48989477|NCT00689611|157794639|FG001|Overall Study|Withdrawal by Subject|9|||
48989478|NCT00689611|157794638|FG000|Overall Study|Lost to Follow-up|27|||
48989479|NCT00689611|157794639|FG001|Overall Study|Lost to Follow-up|28|||
48989480|NCT04382066|157794640|FG000|Overall Study|Adverse Event|1|||
48989481|NCT04382066|157794641|FG001|Overall Study|Adverse Event|0|||
48989482|NCT04382066|157794642|FG002|Overall Study|Adverse Event|0|||
48989483|NCT04382066|157794640|FG000|Overall Study|Death|1|||
48989484|NCT04382066|157794641|FG001|Overall Study|Death|0|||
48989485|NCT04382066|157794642|FG002|Overall Study|Death|1|||
48989486|NCT00508001|157794644|FG000|Overall Study|Adverse Event|2|||
48989487|NCT00508001|157794645|FG001|Overall Study|Adverse Event|0|||
48989488|NCT00508001|157794646|FG002|Overall Study|Adverse Event|4|||
48989489|NCT00508001|157794644|FG000|Overall Study|condition under investigation worsened|13|||
48989490|NCT00508001|157794645|FG001|Overall Study|condition under investigation worsened|7|||
48989491|NCT00508001|157794646|FG002|Overall Study|condition under investigation worsened|1|||
48989492|NCT00508001|157794644|FG000|Overall Study|Death|0|||
48989493|NCT00508001|157794645|FG001|Overall Study|Death|1|||
48989494|NCT00508001|157794646|FG002|Overall Study|Death|1|||
48989495|NCT00508001|157794644|FG000|Overall Study|Withdrawal by Subject|4|||
48989496|NCT00508001|157794645|FG001|Overall Study|Withdrawal by Subject|4|||
48989497|NCT00508001|157794646|FG002|Overall Study|Withdrawal by Subject|1|||
48989498|NCT04419558|157794647|FG000|DB Period (48 Weeks)|Adverse Event|6|||
49044322|NCT03945773|157995739|FG000|Overall Study|Lost to Follow-up|1|||
49044323|NCT03945773|157995740|FG001|Overall Study|Lost to Follow-up|0|||
49044324|NCT03945773|157995739|FG000|Overall Study|Death|46|||
49044325|NCT03945773|157995740|FG001|Overall Study|Death|22|||
49044326|NCT03945773|157995739|FG000|Overall Study|Physician Decision|1|||
49044327|NCT03945773|157995740|FG001|Overall Study|Physician Decision|0|||
49044328|NCT03945773|157995739|FG000|Overall Study|Other|1|||
49044329|NCT03945773|157995740|FG001|Overall Study|Other|0|||
49044330|NCT03945773|157995739|FG000|Overall Study|Ongoing at the time of DCO|4|||
49044331|NCT03945773|157995740|FG001|Overall Study|Ongoing at the time of DCO|3|||
49044332|NCT02605837|157995741|FG000|Overall Study|Adverse Event|3|||
49044333|NCT02605837|157995742|FG001|Overall Study|Adverse Event|1|||
49044334|NCT02605837|157995741|FG000|Overall Study|Non-Compliance with Study Drug|0|||
49044335|NCT02605837|157995742|FG001|Overall Study|Non-Compliance with Study Drug|1|||
49044336|NCT02605837|157995741|FG000|Overall Study|Withdrawal by Subject|8|||
49044337|NCT02605837|157995742|FG001|Overall Study|Withdrawal by Subject|8|||
49044338|NCT02605837|157995741|FG000|Overall Study|Physician Decision|0|||
49044339|NCT02605837|157995742|FG001|Overall Study|Physician Decision|1|||
49044340|NCT00609791|157995743|FG000|Overall Study|Subject was deemed ineligible after starting study procedures|1|||
49044341|NCT02396199|157995747|FG000|Overall Study|Lost to Follow-up|1|||
49044342|NCT02396199|157995747|FG000|Overall Study|Death|4|||
49044343|NCT02597946|157995755|FG000|Overall Study|Withdrawal by Subject|1|||
49044344|NCT02597946|157995755|FG000|Overall Study|Progressive disease|16|||
49044345|NCT02597946|157995755|FG000|Overall Study|Other than above|1|||
49044346|NCT05062265|157995756|FG000|Overall Study|Withdrawal by Subject|1|||
49044347|NCT05062265|157995757|FG001|Overall Study|Withdrawal by Subject|0|||
49044348|NCT03113500|157995760|FG000|Overall Study|Withdrawal by Subject|1|||
49044349|NCT00856349|157995763|FG000|Overall Study|Death|418|||
49044350|NCT00856349|157995763|FG000|Overall Study|Withdrawal by Subject|116|||
49044351|NCT00856349|157995763|FG000|Overall Study|Lost to Follow-up|91|||
49044352|NCT00856349|157995763|FG000|Overall Study|Protocol Violation|38|||
49044353|NCT00856349|157995763|FG000|Overall Study|Physician Decision|13|||
49044354|NCT00856349|157995763|FG000|Overall Study|Subject relocation|104|||
49044355|NCT00856349|157995763|FG000|Overall Study|Device explant|33|||
49044356|NCT00856349|157995763|FG000|Overall Study|Site closure|78|||
49044357|NCT00856349|157995763|FG000|Overall Study|Subject changed Dr, insurance issue, etc|130|||
49044358|NCT02725515|157995764|FG000|Overall Study|Refused infusion (no study treatment)|1|||
49044359|NCT02725515|157995765|FG001|Overall Study|Refused infusion (no study treatment)|0|||
49044360|NCT02725515|157995764|FG000|Overall Study|Loss of Improvement per Protocol|14|||
49044361|NCT02725515|157995765|FG001|Overall Study|Loss of Improvement per Protocol|25|||
48989499|NCT04419558|157794648|FG001|DB Period (48 Weeks)|Adverse Event|6|||
48989500|NCT04419558|157794647|FG000|DB Period (48 Weeks)|Death|14|||
48989501|NCT04419558|157794648|FG001|DB Period (48 Weeks)|Death|11|||
48989502|NCT04419558|157794647|FG000|DB Period (48 Weeks)|Lost to Follow-up|1|||
48989503|NCT04419558|157794648|FG001|DB Period (48 Weeks)|Lost to Follow-up|3|||
48989504|NCT04419558|157794647|FG000|DB Period (48 Weeks)|Investigator Decision|0|||
48989505|NCT04419558|157794648|FG001|DB Period (48 Weeks)|Investigator Decision|1|||
48989506|NCT04419558|157794647|FG000|DB Period (48 Weeks)|Study terminated by sponsor|99|||
49044362|NCT02725515|157995764|FG000|Overall Study|Withdrawal by Subject|2|||
49044363|NCT02725515|157995765|FG001|Overall Study|Withdrawal by Subject|1|||
49044364|NCT02725515|157995764|FG000|Overall Study|Non-Compliance With Study Drug|0|||
49044365|NCT02725515|157995765|FG001|Overall Study|Non-Compliance With Study Drug|3|||
49044366|NCT02725515|157995764|FG000|Overall Study|Lost to Follow-up|1|||
49044367|NCT02725515|157995765|FG001|Overall Study|Lost to Follow-up|1|||
49044368|NCT02725515|157995764|FG000|Overall Study|Adverse Event|7|||
49044369|NCT02725515|157995765|FG001|Overall Study|Adverse Event|2|||
49044370|NCT02725515|157995764|FG000|Overall Study|No Documented Disease Improvement|0|||
49044371|NCT02725515|157995765|FG001|Overall Study|No Documented Disease Improvement|1|||
49044372|NCT02725515|157995764|FG000|Overall Study|Completed Study Under Original Protocol|0|||
49044373|NCT02725515|157995765|FG001|Overall Study|Completed Study Under Original Protocol|1|||
49044374|NCT02725515|157995764|FG000|Overall Study|Lack of Response|0|||
49044375|NCT02725515|157995765|FG001|Overall Study|Lack of Response|1|||
49044376|NCT02736409|157995766|FG000|Overall Study|Withdrawal by Subject|4|||
49044377|NCT02736409|157995767|FG001|Overall Study|Withdrawal by Subject|2|||
49044378|NCT02736409|157995768|FG002|Overall Study|Withdrawal by Subject|17|||
49044379|NCT02736409|157995769|FG003|Overall Study|Withdrawal by Subject|3|||
49044380|NCT02736409|157995766|FG000|Overall Study|Non-Compliance with Study Drug|0|||
49044381|NCT02736409|157995767|FG001|Overall Study|Non-Compliance with Study Drug|0|||
48989507|NCT04419558|157794648|FG001|DB Period (48 Weeks)|Study terminated by sponsor|101|||
48989508|NCT04419558|157794647|FG000|DB Period (48 Weeks)|Disease Progression|1|||
48989509|NCT04419558|157794648|FG001|DB Period (48 Weeks)|Disease Progression|0|||
49044382|NCT02736409|157995768|FG002|Overall Study|Non-Compliance with Study Drug|0|||
49044383|NCT02736409|157995769|FG003|Overall Study|Non-Compliance with Study Drug|1|||
49044384|NCT02736409|157995766|FG000|Overall Study|Adverse Event|0|||
48989510|NCT04419558|157794647|FG000|DB Period (48 Weeks)|Withdrawal by Subject|11|||
48989511|NCT04419558|157794648|FG001|DB Period (48 Weeks)|Withdrawal by Subject|7|||
48989512|NCT04419558|157794647|FG000|DB Period (48 Weeks)|Lung Transplant|1|||
48989513|NCT04419558|157794648|FG001|DB Period (48 Weeks)|Lung Transplant|0|||
48989514|NCT04419558|157794647|FG000|DB Period (48 Weeks)|Participant Decision|4|||
48989515|NCT04419558|157794648|FG001|DB Period (48 Weeks)|Participant Decision|3|||
48989516|NCT04419558|157794647|FG000|OLE Period (48 Weeks)|Adverse Event|3|||
48989517|NCT04419558|157794648|FG001|OLE Period (48 Weeks)|Adverse Event|1|||
48989518|NCT04419558|157794647|FG000|OLE Period (48 Weeks)|Death|4|||
48989519|NCT04419558|157794648|FG001|OLE Period (48 Weeks)|Death|6|||
48989520|NCT04419558|157794647|FG000|OLE Period (48 Weeks)|Study terminated by sponsor|34|||
48989521|NCT04419558|157794648|FG001|OLE Period (48 Weeks)|Study terminated by sponsor|37|||
48989522|NCT04419558|157794647|FG000|OLE Period (48 Weeks)|Withdrawal by Subject|0|||
48989523|NCT04419558|157794648|FG001|OLE Period (48 Weeks)|Withdrawal by Subject|1|||
48989524|NCT00665002|157794651|FG000|Overall Study|Progression/relapse during treatment|11|||
48989525|NCT00665002|157794651|FG000|Overall Study|Cytogenetic resistance|1|||
48989526|NCT00851721|157794652|FG000|Overall Study|planned surgery|1|||
48989527|NCT00851721|157794653|FG001|Overall Study|planned surgery|0|||
48989528|NCT00851721|157794652|FG000|Overall Study|Death|1|||
48989529|NCT00851721|157794653|FG001|Overall Study|Death|0|||
48989530|NCT00851721|157794652|FG000|Overall Study|Adverse Event|0|||
48989531|NCT00851721|157794653|FG001|Overall Study|Adverse Event|1|||
48989532|NCT01990339|157794669|FG000|Overall Study|Data Not Available|49|||
48989533|NCT01990339|157794669|FG000|Overall Study|Voluntary Withdrawal|1402|||
48989534|NCT01990339|157794669|FG000|Overall Study|Lost to Follow-up|861|||
48989535|NCT00529152|157794670|FG000|Overall Study|Adverse Event|2|||
48989536|NCT00529152|157794670|FG000|Overall Study|Withdrawal by Subject|2|||
48989537|NCT00529152|157794670|FG000|Overall Study|Lost to Follow-up|1|||
48989538|NCT04118127|157794676|FG000|Overall Study|Trial terminated by sponsor|0|||
48989539|NCT04118127|157794677|FG001|Overall Study|Trial terminated by sponsor|12|||
48989540|NCT04118127|157794676|FG000|Overall Study|Adverse Event|1|||
48989541|NCT04118127|157794677|FG001|Overall Study|Adverse Event|2|||
48989542|NCT04118127|157794676|FG000|Overall Study|Physician Decision|0|||
48989543|NCT04118127|157794677|FG001|Overall Study|Physician Decision|1|||
48989544|NCT04118127|157794676|FG000|Overall Study|Withdrawal by Subject|2|||
48989545|NCT04118127|157794677|FG001|Overall Study|Withdrawal by Subject|1|||
48989546|NCT01638546|157794679|FG000|Overall Study|Adverse Event|1|||
48989547|NCT01638546|157794680|FG001|Overall Study|Adverse Event|3|||
48989548|NCT04491591|157794681|FG000|Overall Study|Accidently randomized|3|||
48989549|NCT04491591|157794682|FG001|Overall Study|Accidently randomized|1|||
48989550|NCT04491591|157794683|FG002|Overall Study|Accidently randomized|0|||
48989551|NCT04491591|157794681|FG000|Overall Study|Did not complete survey|28|||
48989552|NCT04491591|157794682|FG001|Overall Study|Did not complete survey|20|||
48989553|NCT04491591|157794683|FG002|Overall Study|Did not complete survey|3|||
48989554|NCT01365182|157794684|FG000|Overall Study|Withdrawal by Subject|10|||
48989555|NCT01365182|157794685|FG001|Overall Study|Withdrawal by Subject|13|||
48989556|NCT01365182|157794686|FG002|Overall Study|Withdrawal by Subject|12|||
48989557|NCT01003691|157794687|FG000|Overall Study|Adverse Event|0|||
48989558|NCT01003691|157794688|FG001|Overall Study|Adverse Event|0|||
49044385|NCT02736409|157995767|FG001|Overall Study|Adverse Event|1|||
48989559|NCT01003691|157794689|FG002|Overall Study|Adverse Event|0|||
48989560|NCT01003691|157794690|FG003|Overall Study|Adverse Event|1|||
48989561|NCT00553319|157794706|FG000|Overall Study|Lost to Follow-up|10|||
48989562|NCT00553319|157794707|FG001|Overall Study|Lost to Follow-up|9|||
49044386|NCT02736409|157995768|FG002|Overall Study|Adverse Event|5|||
49044387|NCT02736409|157995769|FG003|Overall Study|Adverse Event|4|||
49044388|NCT02736409|157995766|FG000|Overall Study|Other|0|||
49044389|NCT02736409|157995767|FG001|Overall Study|Other|0|||
49044390|NCT02736409|157995768|FG002|Overall Study|Other|1|||
49044391|NCT02736409|157995769|FG003|Overall Study|Other|1|||
49044392|NCT02736409|157995766|FG000|Overall Study|Pregnancy|0|||
49044393|NCT02736409|157995767|FG001|Overall Study|Pregnancy|0|||
49044394|NCT02736409|157995768|FG002|Overall Study|Pregnancy|1|||
49044395|NCT02736409|157995769|FG003|Overall Study|Pregnancy|0|||
49044396|NCT02736409|157995766|FG000|Overall Study|Lost to Follow-up|0|||
49044397|NCT02736409|157995767|FG001|Overall Study|Lost to Follow-up|0|||
49044398|NCT02736409|157995768|FG002|Overall Study|Lost to Follow-up|2|||
49044399|NCT02736409|157995769|FG003|Overall Study|Lost to Follow-up|1|||
49044400|NCT02736409|157995766|FG000|Overall Study|Physician Decision|0|||
49044401|NCT02736409|157995767|FG001|Overall Study|Physician Decision|0|||
49044402|NCT02736409|157995768|FG002|Overall Study|Physician Decision|0|||
49044403|NCT02736409|157995769|FG003|Overall Study|Physician Decision|2|||
49044404|NCT04221490|157995777|FG000|At 30 Days Follow-up|Death|7|||
49044405|NCT04221490|157995777|FG000|At 30 Days Follow-up|Missed Visit|4|||
49044406|NCT04221490|157995777|FG000|At 30 Days Follow-up|Exited for Other Reasons|1|||
49044407|NCT04221490|157995777|FG000|At 6 Months Follow-up|Death|9|||
49044408|NCT04221490|157995777|FG000|At 6 Months Follow-up|Physician Decision|1|||
49044409|NCT04221490|157995777|FG000|At 6 Months Follow-up|Missed Visit|8|||
49044410|NCT04221490|157995777|FG000|At 6 Months Follow-up|Exited for Other Reasons|8|||
49044411|NCT03557697|157995782|FG000|Overall Study|Withdrawal by Subject|2|||
49044412|NCT03557697|157995783|FG001|Overall Study|Withdrawal by Subject|4|||
49044413|NCT03980522|157995784|FG000|Treatment Period|Adverse Event|1|||
49044414|NCT03980522|157995785|FG001|Treatment Period|Adverse Event|0|||
49044415|NCT03980522|157995786|FG002|Treatment Period|Adverse Event|0|||
49044416|NCT03980522|157995787|FG003|Treatment Period|Adverse Event|0|||
49044417|NCT03980522|157995788|FG004|Treatment Period|Adverse Event|0|||
49044418|NCT04364763|157995789|FG000|Overall Study|Death|1|||
49044419|NCT04364763|157995790|FG001|Overall Study|Death|2|||
49044420|NCT04364763|157995789|FG000|Overall Study|Lost to Follow-up|1|||
49044421|NCT04364763|157995790|FG001|Overall Study|Lost to Follow-up|0|||
49044422|NCT00021541|157995791|FG000|Period 1-First Treatment|Withdrawal by Subject|3|||
49044423|NCT00021541|157995792|FG001|Period 1-First Treatment|Withdrawal by Subject|3|||
49044424|NCT00021541|157995791|FG000|Period 1-First Treatment|Adverse Event|2|||
49044425|NCT00021541|157995792|FG001|Period 1-First Treatment|Adverse Event|1|||
49044426|NCT00021541|157995791|FG000|Period 1-First Treatment|non-adherence|3|||
49044427|NCT00021541|157995792|FG001|Period 1-First Treatment|non-adherence|0|||
49044428|NCT00021541|157995791|FG000|Period 1-First Treatment|Death|1|||
49044429|NCT00021541|157995792|FG001|Period 1-First Treatment|Death|0|||
49044430|NCT00021541|157995791|FG000|Period 1-First Treatment|Pts that did not progress|2|||
49044431|NCT00021541|157995792|FG001|Period 1-First Treatment|Pts that did not progress|2|||
49044432|NCT00021541|157995791|FG000|Period 1-First Treatment|Ineligible|0|||
49044433|NCT00021541|157995792|FG001|Period 1-First Treatment|Ineligible|2|||
49044434|NCT00021541|157995791|FG000|Period 2-crossover|refused phase B|2|||
49044435|NCT00021541|157995792|FG001|Period 2-crossover|refused phase B|2|||
49044436|NCT00021541|157995791|FG000|Period 2-crossover|Withdrawal by Subject|3|||
49044437|NCT00021541|157995792|FG001|Period 2-crossover|Withdrawal by Subject|4|||
49044438|NCT00021541|157995791|FG000|Period 2-crossover|Adverse Event|2|||
49044439|NCT00021541|157995792|FG001|Period 2-crossover|Adverse Event|2|||
49044440|NCT00021541|157995791|FG000|Period 2-crossover|non-adherence|1|||
49044441|NCT00021541|157995792|FG001|Period 2-crossover|non-adherence|0|||
49044442|NCT00021541|157995791|FG000|Period 2-crossover|Pts that did not progress|2|||
49044443|NCT00021541|157995792|FG001|Period 2-crossover|Pts that did not progress|3|||
49044444|NCT00858403|157995794|FG000|Overall Study|Withdrawal by Subject|1|||
49044445|NCT00858403|157995794|FG000|Overall Study|Death|3|||
49044446|NCT00858403|157995794|FG000|Overall Study|Disease Progression|1|||
49044447|NCT03439085|157995795|FG000|Overall Study|Death|2|||
49044448|NCT03439085|157995795|FG000|Overall Study|Screen Failure|20|||
49044449|NCT01292837|157995797|FG000|Overall Study|Adverse Event|1|||
49044450|NCT01292837|157995797|FG000|Overall Study|Further treatment determined|1|||
49044451|NCT03942211|157995798|FG000|Overall Study|Death|1|||
49044452|NCT03942211|157995799|FG001|Overall Study|Death|0|||
49044453|NCT03942211|157995798|FG000|Overall Study|Study terminated by sponsor|5|||
49044454|NCT03942211|157995799|FG001|Overall Study|Study terminated by sponsor|3|||
49044455|NCT03942211|157995798|FG000|Overall Study|Adverse Event|0|||
49044456|NCT03942211|157995799|FG001|Overall Study|Adverse Event|1|||
49044457|NCT00593827|157995800|FG000|Overall Study|On Active Treatment/Pending|0|||
49044458|NCT00593827|157995801|FG001|Overall Study|On Active Treatment/Pending|2|||
49044459|NCT01435928|157995802|FG000|Open Label Phase - up to 24 Weeks|Adverse Event|83|||
49044460|NCT01435928|157995803|FG001|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
49044461|NCT01435928|157995804|FG002|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
49044462|NCT01435928|157995802|FG000|Open Label Phase - up to 24 Weeks|Death|1|||
49044463|NCT01435928|157995803|FG001|Open Label Phase - up to 24 Weeks|Death|0|||
48989563|NCT00553319|157794708|FG002|Overall Study|Lost to Follow-up|5|||
48989564|NCT00553319|157794706|FG000|Overall Study|wanted treatment elsewhere|2|||
48989565|NCT00553319|157794707|FG001|Overall Study|wanted treatment elsewhere|1|||
48989566|NCT00553319|157794708|FG002|Overall Study|wanted treatment elsewhere|1|||
48989567|NCT00553319|157794706|FG000|Overall Study|non-compliance|0|||
48989568|NCT00553319|157794707|FG001|Overall Study|non-compliance|0|||
48989569|NCT00553319|157794708|FG002|Overall Study|non-compliance|2|||
48989570|NCT00553319|157794706|FG000|Overall Study|incarceration|1|||
48989571|NCT00553319|157794707|FG001|Overall Study|incarceration|0|||
48989572|NCT00553319|157794708|FG002|Overall Study|incarceration|0|||
48989573|NCT00553319|157794706|FG000|Overall Study|moved|1|||
48989574|NCT00553319|157794707|FG001|Overall Study|moved|0|||
48989575|NCT00553319|157794708|FG002|Overall Study|moved|1|||
48989576|NCT04678557|157794718|FG000|Overall Study|Withdrawal by Subject|1|||
48989577|NCT04678557|157794719|FG001|Overall Study|Withdrawal by Subject|0|||
48989578|NCT04678557|157794718|FG000|Overall Study|Lack of Efficacy|0|||
48989579|NCT04678557|157794719|FG001|Overall Study|Lack of Efficacy|13|||
48989580|NCT04678557|157794718|FG000|Overall Study|Safety Evaluation|0|||
48989581|NCT04678557|157794719|FG001|Overall Study|Safety Evaluation|1|||
48989582|NCT00495794|157794720|FG000|Overall Study|Pharmacist did not activate patient|522|||
48989583|NCT00495794|157794721|FG001|Overall Study|Pharmacist did not activate patient|0|||
48989584|NCT01265511|157794724|FG000|Overall Study|Lack of Efficacy|2|||
48989585|NCT01265511|157794725|FG001|Overall Study|Lack of Efficacy|1|||
48989586|NCT01265511|157794724|FG000|Overall Study|Met stopping rules|0|||
48989587|NCT01265511|157794725|FG001|Overall Study|Met stopping rules|2|||
48989588|NCT00526227|157794726|FG000|Overall Study|Device not implanted|1|||
48989589|NCT00526227|157794726|FG000|Overall Study|Death|1|||
48989590|NCT00740116|157796690|FG000|Overall Study|Withdrawal by Subject|1|||
48989591|NCT00740116|157796691|FG001|Overall Study|Withdrawal by Subject|1|||
48989592|NCT00740116|157796690|FG000|Overall Study|Protocol Violation|1|||
48989593|NCT00740116|157796691|FG001|Overall Study|Protocol Violation|4|||
48989594|NCT00960323|157796692|FG000|Atorvastatin Alone|Withdrawal by Subject|1|||
48989595|NCT02785588|157796693|FG000|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1|||
48989596|NCT02785588|157796693|FG000|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1|||
48989597|NCT03424811|157796694|FG000|Overall Study|Lost to Follow-up|9|||
48989598|NCT03424811|157796695|FG001|Overall Study|Lost to Follow-up|0|||
48989599|NCT03031327|157796696|FG000|Overall Study|Withdrawal by Subject|0|||
48989600|NCT03031327|157796697|FG001|Overall Study|Withdrawal by Subject|1|||
48989601|NCT03031327|157796698|FG002|Overall Study|Withdrawal by Subject|1|||
48989602|NCT00211536|157796699|FG000|Overall Study|Withdrawal by Subject|2|||
49044464|NCT01435928|157995804|FG002|Open Label Phase - up to 24 Weeks|Death|0|||
49044465|NCT01435928|157995802|FG000|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46|||
49044466|NCT01435928|157995803|FG001|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
49044467|NCT01435928|157995804|FG002|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
48989603|NCT00211536|157796700|FG001|Overall Study|Withdrawal by Subject|2|||
48989604|NCT00211536|157796699|FG000|Overall Study|Physician Decision|0|||
48989605|NCT00211536|157796700|FG001|Overall Study|Physician Decision|5|||
48989606|NCT00211536|157796699|FG000|Overall Study|Adverse Event|2|||
48989607|NCT00211536|157796700|FG001|Overall Study|Adverse Event|0|||
48989608|NCT02155660|157796702|FG000|Overall Study|Other Reason|8|||
48989609|NCT02155660|157796703|FG001|Overall Study|Other Reason|6|||
48989610|NCT02155660|157796704|FG002|Overall Study|Other Reason|10|||
48989611|NCT02155660|157796705|FG003|Overall Study|Other Reason|10|||
48989612|NCT02155660|157796702|FG000|Overall Study|Study-specific withdrawal criteria|0|||
48989613|NCT02155660|157796703|FG001|Overall Study|Study-specific withdrawal criteria|1|||
48989614|NCT02155660|157796704|FG002|Overall Study|Study-specific withdrawal criteria|1|||
48989615|NCT02155660|157796705|FG003|Overall Study|Study-specific withdrawal criteria|1|||
48989616|NCT02155660|157796702|FG000|Overall Study|Severe non-compliance|0|||
48989617|NCT02155660|157796703|FG001|Overall Study|Severe non-compliance|4|||
48989618|NCT02155660|157796704|FG002|Overall Study|Severe non-compliance|0|||
48989619|NCT02155660|157796705|FG003|Overall Study|Severe non-compliance|1|||
48989620|NCT02155660|157796702|FG000|Overall Study|Adverse Event|2|||
48989621|NCT02155660|157796703|FG001|Overall Study|Adverse Event|6|||
48989622|NCT02155660|157796704|FG002|Overall Study|Adverse Event|3|||
48989623|NCT02155660|157796705|FG003|Overall Study|Adverse Event|1|||
48989624|NCT02155660|157796702|FG000|Overall Study|Lost to Follow-up|3|||
48989625|NCT02155660|157796703|FG001|Overall Study|Lost to Follow-up|6|||
48989626|NCT02155660|157796704|FG002|Overall Study|Lost to Follow-up|5|||
48989627|NCT02155660|157796705|FG003|Overall Study|Lost to Follow-up|8|||
48989628|NCT02155660|157796702|FG000|Overall Study|Death|17|||
48989629|NCT02155660|157796703|FG001|Overall Study|Death|19|||
48989630|NCT02155660|157796704|FG002|Overall Study|Death|17|||
48989631|NCT02155660|157796705|FG003|Overall Study|Death|19|||
48989632|NCT02155660|157796702|FG000|Overall Study|Withdrawal by Subject|28|||
48989633|NCT02155660|157796703|FG001|Overall Study|Withdrawal by Subject|31|||
48989634|NCT02155660|157796704|FG002|Overall Study|Withdrawal by Subject|24|||
48989635|NCT02155660|157796705|FG003|Overall Study|Withdrawal by Subject|21|||
48989636|NCT01087944|157796706|FG000|Period 1 (Week 1-3)|Adverse Event|1|||
48989637|NCT01087944|157796707|FG001|Period 1 (Week 1-3)|Adverse Event|0|||
48989638|NCT01087944|157796706|FG000|Period 2 (Week 4-6)|Adverse Event|0|||
48989639|NCT01087944|157796707|FG001|Period 2 (Week 4-6)|Adverse Event|2|||
48989640|NCT01569568|157796710|FG000|Overall Study|Physician Decision|0|||
48989641|NCT01569568|157796711|FG001|Overall Study|Physician Decision|2|||
48989642|NCT03812224|157796713|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
48989643|NCT03812224|157796714|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
48989644|NCT03812224|157796713|FG000|Double-blind Treatment Period|Decision by Sponsor|0|||
48989645|NCT03812224|157796714|FG001|Double-blind Treatment Period|Decision by Sponsor|1|||
48989646|NCT03812224|157796713|FG000|Open-label Treatment Period|Withdrawal by Subject|2|||
48989647|NCT03812224|157796714|FG001|Open-label Treatment Period|Withdrawal by Subject|2|||
48989648|NCT03812224|157796713|FG000|Open-label Treatment Period|Decision by Sponsor|0|||
48989649|NCT03812224|157796714|FG001|Open-label Treatment Period|Decision by Sponsor|1|||
48989650|NCT00303719|157796720|FG000|Overall Study|Not evaluable, prior therapies|0|||
48989651|NCT00303719|157796721|FG001|Overall Study|Not evaluable, prior therapies|30|||
48989652|NCT00303719|157796720|FG000|Overall Study|Lost to Follow-up|0|||
48989653|NCT00303719|157796721|FG001|Overall Study|Lost to Follow-up|7|||
48989654|NCT03730987|157796722|FG000|Overall Study|Lost to Follow-up|2|||
48989655|NCT03730987|157796723|FG001|Overall Study|Lost to Follow-up|0|||
48989656|NCT03730987|157796724|FG002|Overall Study|Lost to Follow-up|2|||
48989657|NCT03730987|157796725|FG003|Overall Study|Lost to Follow-up|0|||
48989658|NCT00656136|157796729|FG000|Overall Study|Progressive disease|177|||
48989659|NCT00656136|157796730|FG001|Overall Study|Progressive disease|322|||
48989660|NCT00656136|157796729|FG000|Overall Study|Other Adverse Event|5|||
48989661|NCT00656136|157796730|FG001|Overall Study|Other Adverse Event|51|||
48989662|NCT00656136|157796729|FG000|Overall Study|Protocol Violation|2|||
48989663|NCT00656136|157796730|FG001|Overall Study|Protocol Violation|3|||
49044468|NCT01435928|157995802|FG000|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60|||
48989664|NCT00656136|157796729|FG000|Overall Study|Patient refused to take study medication|7|||
48989665|NCT00656136|157796730|FG001|Overall Study|Patient refused to take study medication|10|||
48989666|NCT00656136|157796729|FG000|Overall Study|Unknown and others|4|||
49044469|NCT01435928|157995803|FG001|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
49044470|NCT01435928|157995804|FG002|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
49044471|NCT01435928|157995802|FG000|Open Label Phase - up to 24 Weeks|Protocol Violation|39|||
49044472|NCT01435928|157995803|FG001|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
49044473|NCT01435928|157995804|FG002|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
49044474|NCT01435928|157995802|FG000|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96|||
49044475|NCT01435928|157995803|FG001|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
49044476|NCT01435928|157995804|FG002|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
49044477|NCT01435928|157995802|FG000|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44|||
49044478|NCT01435928|157995803|FG001|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
48989667|NCT00656136|157796730|FG001|Overall Study|Unknown and others|4|||
48989668|NCT02087085|157796731|FG000|Overall Study|Adverse Event|10|||
48989669|NCT02087085|157796732|FG001|Overall Study|Adverse Event|14|||
48989670|NCT02087085|157796731|FG000|Overall Study|Lack of Efficacy|4|||
49044479|NCT01435928|157995804|FG002|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
49044480|NCT01435928|157995802|FG000|Open Label Phase - up to 24 Weeks|Terminated at study completion|6|||
49044481|NCT01435928|157995803|FG001|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
49044482|NCT01435928|157995804|FG002|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
49044483|NCT01435928|157995802|FG000|Open Label Phase - up to 24 Weeks|Administrative|14|||
49044484|NCT01435928|157995803|FG001|Open Label Phase - up to 24 Weeks|Administrative|0|||
49044485|NCT01435928|157995804|FG002|Open Label Phase - up to 24 Weeks|Administrative|0|||
49044486|NCT01435928|157995802|FG000|Double Blind Phase - 28 Weeks|Adverse Event|0|||
49044487|NCT01435928|157995803|FG001|Double Blind Phase - 28 Weeks|Adverse Event|3|||
48989671|NCT02087085|157796732|FG001|Overall Study|Lack of Efficacy|3|||
48989672|NCT02087085|157796731|FG000|Overall Study|Lost to Follow-up|6|||
48989673|NCT02087085|157796732|FG001|Overall Study|Lost to Follow-up|4|||
48989674|NCT02087085|157796731|FG000|Overall Study|Withdrawal by Subject|9|||
48989675|NCT02087085|157796732|FG001|Overall Study|Withdrawal by Subject|11|||
48989676|NCT02087085|157796731|FG000|Overall Study|Protocol Violation|1|||
48989677|NCT02087085|157796732|FG001|Overall Study|Protocol Violation|0|||
49044488|NCT01435928|157995804|FG002|Double Blind Phase - 28 Weeks|Adverse Event|1|||
49044489|NCT01435928|157995802|FG000|Double Blind Phase - 28 Weeks|Lost to Follow-up|0|||
49044490|NCT01435928|157995803|FG001|Double Blind Phase - 28 Weeks|Lost to Follow-up|2|||
49044491|NCT01435928|157995804|FG002|Double Blind Phase - 28 Weeks|Lost to Follow-up|5|||
48989678|NCT02087085|157796731|FG000|Overall Study|Study Terminated by Sponsor|87|||
48989679|NCT02087085|157796732|FG001|Overall Study|Study Terminated by Sponsor|80|||
48989680|NCT02087085|157796731|FG000|Overall Study|Other Miscellaneous Reasons|3|||
48989681|NCT02087085|157796732|FG001|Overall Study|Other Miscellaneous Reasons|4|||
48989682|NCT01191190|157796734|FG000|Overall Study|Withdrawal by Subject|1|||
48989683|NCT01425268|157796735|FG000|Overall Study|Withdrawal by Subject|2|||
49044492|NCT01435928|157995802|FG000|Double Blind Phase - 28 Weeks|Protocol Violation|0|||
49044493|NCT01435928|157995803|FG001|Double Blind Phase - 28 Weeks|Protocol Violation|11|||
49044494|NCT01435928|157995804|FG002|Double Blind Phase - 28 Weeks|Protocol Violation|4|||
49044495|NCT01435928|157995802|FG000|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0|||
49044496|NCT01435928|157995803|FG001|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5|||
49044497|NCT01435928|157995804|FG002|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12|||
49044498|NCT01435928|157995802|FG000|Double Blind Phase - 28 Weeks|Terminated at study completion|0|||
48989684|NCT01425268|157796736|FG001|Overall Study|Withdrawal by Subject|0|||
48989685|NCT01425268|157796735|FG000|Overall Study|Sponsor Decision|5|||
49044499|NCT01435928|157995803|FG001|Double Blind Phase - 28 Weeks|Terminated at study completion|47|||
49044500|NCT01435928|157995804|FG002|Double Blind Phase - 28 Weeks|Terminated at study completion|39|||
49044501|NCT01435928|157995802|FG000|Double Blind Phase - 28 Weeks|Relapse criteria met|0|||
48989686|NCT01425268|157796736|FG001|Overall Study|Sponsor Decision|0|||
48989687|NCT01425268|157796735|FG000|Overall Study|Physician Decision|1|||
48989688|NCT01425268|157796736|FG001|Overall Study|Physician Decision|0|||
48989689|NCT03172026|157796743|FG000|Overall Study|Withdrawal by Subject|1|||
48989690|NCT03172026|157796744|FG001|Overall Study|Withdrawal by Subject|0|||
48989691|NCT03172026|157796743|FG000|Overall Study|COVID restrictions|1|||
48989692|NCT03172026|157796744|FG001|Overall Study|COVID restrictions|0|||
48989693|NCT03907072|157796748|FG000|Overall Study|Study Terminated by Sponsor|2|||
48989694|NCT03907072|157796749|FG001|Overall Study|Study Terminated by Sponsor|2|||
48989695|NCT03907072|157796750|FG002|Overall Study|Study Terminated by Sponsor|2|||
48989696|NCT00568399|157796755|FG000|Overall Study|Death|2|||
48989697|NCT00568399|157796755|FG000|Overall Study|Adverse Event|5|||
48989698|NCT00568399|157796755|FG000|Overall Study|Withdrawal by Subject|8|||
48989699|NCT01177943|157796757|FG000|First Intervention|Withdrawal by Subject|2|||
48989700|NCT01177943|157796758|FG001|First Intervention|Withdrawal by Subject|0|||
48989701|NCT02195531|157796769|FG000|Overall Study|Withdrawal by Subject|1|||
48989702|NCT02195531|157796770|FG001|Overall Study|Withdrawal by Subject|1|||
48989703|NCT02195531|157796771|FG002|Overall Study|Withdrawal by Subject|1|||
48989704|NCT01284127|157796774|FG000|Overall Study|Adverse Event|2|||
48989705|NCT01284127|157796774|FG000|Overall Study|Withdrawal by Subject|4|||
48989706|NCT01284127|157796774|FG000|Overall Study|Physician Decision|1|||
48989707|NCT03604159|157796777|FG000|Overall Study|Lost to Follow-up|6|||
48989708|NCT03604159|157796778|FG001|Overall Study|Lost to Follow-up|7|||
48989709|NCT00405756|157796779|FG000|Double-blind Treatment|Ongoing in Double-blind Treatment|45|||
48989710|NCT00405756|157796780|FG001|Double-blind Treatment|Ongoing in Double-blind Treatment|24|||
48989711|NCT00405756|157796781|FG002|Double-blind Treatment|Ongoing in Double-blind Treatment|18|||
48989712|NCT00405756|157796779|FG000|Double-blind Treatment|Adverse Event|31|||
48989713|NCT00405756|157796780|FG001|Double-blind Treatment|Adverse Event|27|||
48989714|NCT00405756|157796781|FG002|Double-blind Treatment|Adverse Event|12|||
48989715|NCT00405756|157796779|FG000|Double-blind Treatment|Disease Progression|47|||
48989716|NCT00405756|157796780|FG001|Double-blind Treatment|Disease Progression|81|||
48989717|NCT00405756|157796781|FG002|Double-blind Treatment|Disease Progression|102|||
48989718|NCT00405756|157796779|FG000|Double-blind Treatment|Lack of Efficacy|1|||
48989719|NCT00405756|157796780|FG001|Double-blind Treatment|Lack of Efficacy|4|||
48989720|NCT00405756|157796781|FG002|Double-blind Treatment|Lack of Efficacy|2|||
48989721|NCT00405756|157796779|FG000|Double-blind Treatment|Withdrawal by Subject|15|||
48989722|NCT00405756|157796780|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
48989723|NCT00405756|157796781|FG002|Double-blind Treatment|Withdrawal by Subject|10|||
48989724|NCT00405756|157796779|FG000|Double-blind Treatment|Lost to Follow-up|1|||
48989725|NCT00405756|157796780|FG001|Double-blind Treatment|Lost to Follow-up|0|||
48989726|NCT00405756|157796781|FG002|Double-blind Treatment|Lost to Follow-up|0|||
48989727|NCT00405756|157796779|FG000|Double-blind Treatment|Death|4|||
48989728|NCT00405756|157796780|FG001|Double-blind Treatment|Death|4|||
48989729|NCT00405756|157796781|FG002|Double-blind Treatment|Death|4|||
48989730|NCT00405756|157796779|FG000|Double-blind Treatment|Protocol Violation|1|||
48989731|NCT00405756|157796780|FG001|Double-blind Treatment|Protocol Violation|0|||
48989732|NCT00405756|157796781|FG002|Double-blind Treatment|Protocol Violation|2|||
48989733|NCT00405756|157796779|FG000|Double-blind Treatment|Other|7|||
48989734|NCT00405756|157796780|FG001|Double-blind Treatment|Other|4|||
48989735|NCT00405756|157796781|FG002|Double-blind Treatment|Other|4|||
48989736|NCT00405756|157796779|FG000|Open-label Extension|Ongoing in Open Label Period|7|||
48989737|NCT00405756|157796780|FG001|Open-label Extension|Ongoing in Open Label Period|15|||
48989738|NCT00405756|157796781|FG002|Open-label Extension|Ongoing in Open Label Period|25|||
48989739|NCT00405756|157796779|FG000|Open-label Extension|Adverse Event|1|||
48989740|NCT00405756|157796780|FG001|Open-label Extension|Adverse Event|3|||
48989741|NCT00405756|157796781|FG002|Open-label Extension|Adverse Event|7|||
48989742|NCT00405756|157796779|FG000|Open-label Extension|Disease Progression|8|||
48989743|NCT00405756|157796780|FG001|Open-label Extension|Disease Progression|23|||
48989744|NCT00405756|157796781|FG002|Open-label Extension|Disease Progression|26|||
48989745|NCT00405756|157796779|FG000|Open-label Extension|Withdrawal by Subject|2|||
48989746|NCT00405756|157796780|FG001|Open-label Extension|Withdrawal by Subject|3|||
48989747|NCT00405756|157796781|FG002|Open-label Extension|Withdrawal by Subject|3|||
48989748|NCT00405756|157796779|FG000|Open-label Extension|Death|1|||
48989749|NCT00405756|157796780|FG001|Open-label Extension|Death|2|||
48989750|NCT00405756|157796781|FG002|Open-label Extension|Death|4|||
48989751|NCT00405756|157796779|FG000|Open-label Extension|Other|0|||
48989752|NCT00405756|157796780|FG001|Open-label Extension|Other|1|||
48989753|NCT00405756|157796781|FG002|Open-label Extension|Other|7|||
48989754|NCT00405756|157796779|FG000|Follow-up|Ongoing in Follow-up Period|52|||
48989755|NCT00405756|157796780|FG001|Follow-up|Ongoing in Follow-up Period|51|||
48989756|NCT00405756|157796781|FG002|Follow-up|Ongoing in Follow-up Period|60|||
48989757|NCT00405756|157796779|FG000|Follow-up|Death|21|||
48989758|NCT00405756|157796780|FG001|Follow-up|Death|31|||
48989759|NCT00405756|157796781|FG002|Follow-up|Death|24|||
48989760|NCT00405756|157796779|FG000|Follow-up|Lost to Follow-up|2|||
48989761|NCT00405756|157796780|FG001|Follow-up|Lost to Follow-up|8|||
48989762|NCT00405756|157796781|FG002|Follow-up|Lost to Follow-up|4|||
48989763|NCT02127931|157796783|FG000|Overall Study|Glitch in Game|1|||
48989764|NCT01636076|157796784|FG000|Overall Study|Terminated by sponsor|1|||
48989765|NCT01636076|157796785|FG001|Overall Study|Terminated by sponsor|1|||
48989766|NCT01636076|157796784|FG000|Overall Study|Lack of Efficacy|0|||
48989767|NCT01636076|157796785|FG001|Overall Study|Lack of Efficacy|1|||
48989768|NCT01636076|157796784|FG000|Overall Study|Lost to Follow-up|1|||
48989769|NCT01636076|157796785|FG001|Overall Study|Lost to Follow-up|0|||
48989770|NCT01636076|157796784|FG000|Overall Study|Physician Decision|1|||
48989771|NCT01636076|157796785|FG001|Overall Study|Physician Decision|1|||
48989772|NCT01636076|157796784|FG000|Overall Study|Non-compliance with study treatment|1|||
48989773|NCT01636076|157796785|FG001|Overall Study|Non-compliance with study treatment|1|||
48989774|NCT01636076|157796784|FG000|Overall Study|Adverse Event|6|||
48989775|NCT01636076|157796785|FG001|Overall Study|Adverse Event|11|||
48989776|NCT01636076|157796784|FG000|Overall Study|Withdrawal by Subject|7|||
48989777|NCT01636076|157796785|FG001|Overall Study|Withdrawal by Subject|10|||
48989778|NCT01130831|157796786|FG000|Overall Study|Withdrawal by Subject|7|||
48989779|NCT01130831|157796786|FG000|Overall Study|Death|4|||
48989780|NCT01130831|157796786|FG000|Overall Study|Information was missing|3|||
48989781|NCT01159665|157796787|FG000|Overall Study|Withdrawal by Subject|0|||
48989782|NCT01159665|157796788|FG001|Overall Study|Withdrawal by Subject|1|||
48989783|NCT01159665|157796789|FG002|Overall Study|Withdrawal by Subject|0|||
48989784|NCT01159665|157796790|FG003|Overall Study|Withdrawal by Subject|0|||
48989785|NCT01159665|157796791|FG004|Overall Study|Withdrawal by Subject|0|||
48989786|NCT01159665|157796792|FG005|Overall Study|Withdrawal by Subject|0|||
48989787|NCT00951912|157796795|FG000|Overall Study|Lack of Efficacy|1|||
48989788|NCT00951912|157796796|FG001|Overall Study|Lack of Efficacy|0|||
48989789|NCT00951912|157796797|FG002|Overall Study|Lack of Efficacy|0|||
48989790|NCT00951912|157796795|FG000|Overall Study|Adverse Event|0|||
48989791|NCT00951912|157796796|FG001|Overall Study|Adverse Event|1|||
48989792|NCT00951912|157796797|FG002|Overall Study|Adverse Event|1|||
48989793|NCT00951912|157796795|FG000|Overall Study|Lost to Follow-up|2|||
48989794|NCT00951912|157796796|FG001|Overall Study|Lost to Follow-up|2|||
48989795|NCT00951912|157796797|FG002|Overall Study|Lost to Follow-up|0|||
48989796|NCT00951912|157796795|FG000|Overall Study|Physician Decision|1|||
48989797|NCT00951912|157796796|FG001|Overall Study|Physician Decision|0|||
48989798|NCT00951912|157796797|FG002|Overall Study|Physician Decision|1|||
48989799|NCT00951912|157796795|FG000|Overall Study|Withdrawal by Subject|1|||
48989800|NCT00951912|157796796|FG001|Overall Study|Withdrawal by Subject|1|||
48989801|NCT00951912|157796797|FG002|Overall Study|Withdrawal by Subject|0|||
48989802|NCT00951912|157796795|FG000|Overall Study|Other:Depression|1|||
48989803|NCT00951912|157796796|FG001|Overall Study|Other:Depression|0|||
48989804|NCT00951912|157796797|FG002|Overall Study|Other:Depression|0|||
48989805|NCT00951912|157796795|FG000|Overall Study|Other: Colon cancer|1|||
48989806|NCT00951912|157796796|FG001|Overall Study|Other: Colon cancer|0|||
48989807|NCT00951912|157796797|FG002|Overall Study|Other: Colon cancer|0|||
48989808|NCT00951912|157796795|FG000|Overall Study|Other: Stroke|0|||
48989809|NCT00951912|157796796|FG001|Overall Study|Other: Stroke|1|||
48989810|NCT00951912|157796797|FG002|Overall Study|Other: Stroke|0|||
48989811|NCT02441517|157796799|FG000|Overall Study|Lost to Follow-up|1|||
48989812|NCT02441517|157796799|FG000|Overall Study|Withdrawal by Subject|2|||
48989813|NCT02441517|157796799|FG000|Overall Study|Study Terminated by Sponsor|1|||
48989814|NCT03417999|157796800|FG000|Overall Study|Withdrawal by Subject|1|||
48989815|NCT03417999|157796801|FG001|Overall Study|Withdrawal by Subject|0|||
48989816|NCT03417999|157796802|FG002|Overall Study|Withdrawal by Subject|0|||
48989817|NCT03417999|157796800|FG000|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
48989818|NCT03417999|157796801|FG001|Overall Study|Procedure cancelled; subject did not receive study drug|0|||
48989819|NCT03417999|157796802|FG002|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
48989820|NCT03417999|157796800|FG000|Overall Study|Met exclusion criteria after obtaining consent|0|||
48989821|NCT03417999|157796801|FG001|Overall Study|Met exclusion criteria after obtaining consent|0|||
48989822|NCT03417999|157796802|FG002|Overall Study|Met exclusion criteria after obtaining consent|1|||
48989823|NCT03417999|157796800|FG000|Overall Study|Inadequate study staff available to process samples|0|||
48989824|NCT03417999|157796801|FG001|Overall Study|Inadequate study staff available to process samples|0|||
48989825|NCT03417999|157796802|FG002|Overall Study|Inadequate study staff available to process samples|1|||
48989826|NCT01513460|157796803|FG000|Overall Study|Death|0|||
48989827|NCT01513460|157796804|FG001|Overall Study|Death|0|||
48989828|NCT01513460|157796805|FG002|Overall Study|Death|1|||
48989829|NCT01513460|157796803|FG000|Overall Study|Lost to Follow-up|0|||
48989830|NCT01513460|157796804|FG001|Overall Study|Lost to Follow-up|0|||
48989831|NCT01513460|157796805|FG002|Overall Study|Lost to Follow-up|2|||
48989832|NCT01513460|157796803|FG000|Overall Study|Abnormal laboratory value|1|||
48989833|NCT01513460|157796804|FG001|Overall Study|Abnormal laboratory value|0|||
48989834|NCT01513460|157796805|FG002|Overall Study|Abnormal laboratory value|1|||
48989835|NCT01513460|157796803|FG000|Overall Study|Lack of Efficacy|1|||
48989836|NCT01513460|157796804|FG001|Overall Study|Lack of Efficacy|2|||
48989837|NCT01513460|157796805|FG002|Overall Study|Lack of Efficacy|5|||
48989838|NCT01513460|157796803|FG000|Overall Study|Protocol deviations|3|||
48989839|NCT01513460|157796804|FG001|Overall Study|Protocol deviations|4|||
48989840|NCT01513460|157796805|FG002|Overall Study|Protocol deviations|3|||
48989841|NCT01513460|157796803|FG000|Overall Study|Withdrawal by Subject|7|||
48989842|NCT01513460|157796804|FG001|Overall Study|Withdrawal by Subject|8|||
48989843|NCT01513460|157796805|FG002|Overall Study|Withdrawal by Subject|21|||
48989844|NCT01513460|157796803|FG000|Overall Study|Adverse Event|16|||
48989845|NCT01513460|157796804|FG001|Overall Study|Adverse Event|18|||
48989846|NCT01513460|157796805|FG002|Overall Study|Adverse Event|23|||
48989847|NCT01513460|157796803|FG000|Overall Study|Abnormal test procedure|1|||
48989848|NCT01513460|157796804|FG001|Overall Study|Abnormal test procedure|0|||
48989849|NCT01513460|157796805|FG002|Overall Study|Abnormal test procedure|0|||
48989850|NCT01393444|157796807|FG000|Overall Study|Withdrawal by Subject|1|||
48989851|NCT01393444|157796807|FG000|Overall Study|Determined ineligible during screening.|2|||
48989852|NCT00489216|157796813|FG000|Overall Study|Adverse Event|1|||
48989853|NCT02207413|157796814|FG000|Overall Study|Withdrawal by Subject|1|||
48989854|NCT02207413|157796815|FG001|Overall Study|Withdrawal by Subject|0|||
48989855|NCT02207413|157796816|FG002|Overall Study|Withdrawal by Subject|0|||
48989856|NCT02207413|157796817|FG003|Overall Study|Withdrawal by Subject|0|||
48989857|NCT02207413|157796818|FG004|Overall Study|Withdrawal by Subject|3|||
48989858|NCT02207413|157796819|FG005|Overall Study|Withdrawal by Subject|7|||
48989859|NCT02207413|157796814|FG000|Overall Study|Lost to Follow-up|0|||
48989860|NCT02207413|157796815|FG001|Overall Study|Lost to Follow-up|0|||
48989861|NCT02207413|157796816|FG002|Overall Study|Lost to Follow-up|0|||
48989862|NCT02207413|157796817|FG003|Overall Study|Lost to Follow-up|1|||
48989863|NCT02207413|157796818|FG004|Overall Study|Lost to Follow-up|1|||
48989864|NCT02207413|157796819|FG005|Overall Study|Lost to Follow-up|5|||
48989865|NCT02207413|157796814|FG000|Overall Study|Adverse Event|0|||
48989866|NCT02207413|157796815|FG001|Overall Study|Adverse Event|0|||
48989867|NCT02207413|157796816|FG002|Overall Study|Adverse Event|0|||
48989868|NCT02207413|157796817|FG003|Overall Study|Adverse Event|0|||
48989869|NCT02207413|157796818|FG004|Overall Study|Adverse Event|2|||
48989870|NCT02207413|157796819|FG005|Overall Study|Adverse Event|1|||
48989871|NCT02207413|157796814|FG000|Overall Study|Migrated/moved from study area|0|||
48989872|NCT02207413|157796815|FG001|Overall Study|Migrated/moved from study area|0|||
48989873|NCT02207413|157796816|FG002|Overall Study|Migrated/moved from study area|0|||
48989874|NCT02207413|157796817|FG003|Overall Study|Migrated/moved from study area|0|||
48989875|NCT02207413|157796818|FG004|Overall Study|Migrated/moved from study area|1|||
48989876|NCT02207413|157796819|FG005|Overall Study|Migrated/moved from study area|0|||
48989877|NCT01021423|157796820|FG000|Overall Study|Study terminated|4|||
48989878|NCT01021423|157796821|FG001|Overall Study|Study terminated|5|||
48989879|NCT03417102|157796826|FG000|Overall Study|Adverse Event|0|||
48989880|NCT03417102|157796827|FG001|Overall Study|Adverse Event|1|||
48989881|NCT03417102|157796826|FG000|Overall Study|Related to Coronavirus Pandemic (Covid-19)|0|||
48989882|NCT03417102|157796827|FG001|Overall Study|Related to Coronavirus Pandemic (Covid-19)|3|||
48989883|NCT03417102|157796826|FG000|Overall Study|Other|0|||
48989884|NCT03417102|157796827|FG001|Overall Study|Other|1|||
48989885|NCT03039699|157796831|FG000|Overall Study|Incorrect inclusion|5|||
48989886|NCT03039699|157796832|FG001|Overall Study|Incorrect inclusion|4|||
48989887|NCT03039699|157796831|FG000|Overall Study|Lack of data to assess study endpoint|5|||
48989888|NCT03039699|157796832|FG001|Overall Study|Lack of data to assess study endpoint|3|||
48989889|NCT03039699|157796831|FG000|Overall Study|Bacterial infection|12|||
48989890|NCT03039699|157796832|FG001|Overall Study|Bacterial infection|28|||
48989891|NCT02260804|157796833|FG000|Induction Study Period|Protocol Violation|2|||
48989892|NCT02260804|157796834|FG001|Induction Study Period|Protocol Violation|0|||
48989893|NCT02260804|157796833|FG000|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6|||
48989894|NCT02260804|157796834|FG001|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9|||
48989895|NCT02260804|157796833|FG000|1st Year of the Maintenance Period (MP1)|Adverse Event|3|||
48989896|NCT02260804|157796834|FG001|1st Year of the Maintenance Period (MP1)|Adverse Event|1|||
48989897|NCT02260804|157796833|FG000|1st Year of the Maintenance Period (MP1)|Physician Decision|1|||
48989898|NCT02260804|157796834|FG001|1st Year of the Maintenance Period (MP1)|Physician Decision|3|||
48989899|NCT02260804|157796833|FG000|1st Year of the Maintenance Period (MP1)|Protocol Violation|1|||
49044502|NCT01435928|157995803|FG001|Double Blind Phase - 28 Weeks|Relapse criteria met|43|||
49044503|NCT01435928|157995804|FG002|Double Blind Phase - 28 Weeks|Relapse criteria met|58|||
49044504|NCT01435928|157995802|FG000|Double Blind Phase - 28 Weeks|Administrative|0|||
49044505|NCT01435928|157995803|FG001|Double Blind Phase - 28 Weeks|Administrative|5|||
49044506|NCT01435928|157995804|FG002|Double Blind Phase - 28 Weeks|Administrative|2|||
49044507|NCT00292227|157995805|FG000|Patch Period|Adverse Event|1|||
49044508|NCT00292227|157995806|FG001|Patch Period|Adverse Event|0|||
49044509|NCT00292227|157995807|FG002|Patch Period|Adverse Event|2|||
49044510|NCT00292227|157995805|FG000|Patch Period|Withdrawal by Subject|0|||
49044511|NCT00292227|157995806|FG001|Patch Period|Withdrawal by Subject|0|||
49044512|NCT00292227|157995807|FG002|Patch Period|Withdrawal by Subject|1|||
49044513|NCT01223027|157995808|FG000|Overall Study|Adverse Event|20|||
49044514|NCT01223027|157995809|FG001|Overall Study|Adverse Event|10|||
49044515|NCT01223027|157995808|FG000|Overall Study|Death|42|||
49044516|NCT01223027|157995809|FG001|Overall Study|Death|42|||
49044517|NCT01223027|157995808|FG000|Overall Study|Lost to Follow-up|2|||
48989900|NCT02260804|157796834|FG001|1st Year of the Maintenance Period (MP1)|Protocol Violation|0|||
48989901|NCT02260804|157796833|FG000|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1|||
48989902|NCT02260804|157796834|FG001|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0|||
48989903|NCT02260804|157796833|FG000|1st Year of the Maintenance Period (MP1)|Death|0|||
48989904|NCT02260804|157796834|FG001|1st Year of the Maintenance Period (MP1)|Death|1|||
49044518|NCT01223027|157995809|FG001|Overall Study|Lost to Follow-up|1|||
49044519|NCT01223027|157995808|FG000|Overall Study|Physician Decision|4|||
49044520|NCT01223027|157995809|FG001|Overall Study|Physician Decision|8|||
49044521|NCT01223027|157995808|FG000|Overall Study|Progressive Disease|167|||
49044522|NCT01223027|157995809|FG001|Overall Study|Progressive Disease|183|||
48989905|NCT02260804|157796833|FG000|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0|||
48989906|NCT02260804|157796834|FG001|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1|||
48989907|NCT02260804|157796833|FG000|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6|||
48989908|NCT02260804|157796834|FG001|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5|||
48989909|NCT02260804|157796833|FG000|2nd Year of the Maintenance Period (MP2)|Adverse Event|3|||
48989910|NCT02260804|157796834|FG001|2nd Year of the Maintenance Period (MP2)|Adverse Event|0|||
48989911|NCT02260804|157796833|FG000|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0|||
48989912|NCT02260804|157796834|FG001|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1|||
48989913|NCT00758394|157796835|FG000|2nd Intervention Order|Lost to Follow-up|0|||
48989914|NCT00758394|157796836|FG001|2nd Intervention Order|Lost to Follow-up|1|||
48989915|NCT00758394|157796837|FG002|2nd Intervention Order|Lost to Follow-up|0|||
48989916|NCT00758394|157796838|FG003|2nd Intervention Order|Lost to Follow-up|0|||
48989917|NCT00758394|157796835|FG000|3rd Intervention|Lost to Follow-up|1|||
48989918|NCT00758394|157796836|FG001|3rd Intervention|Lost to Follow-up|0|||
48989919|NCT00758394|157796837|FG002|3rd Intervention|Lost to Follow-up|0|||
48989920|NCT00758394|157796838|FG003|3rd Intervention|Lost to Follow-up|1|||
48989921|NCT02539160|157796839|FG000|Phase 1 Pre-crossover|Adverse Event|3|||
48989922|NCT02539160|157796840|FG001|Phase 1 Pre-crossover|Adverse Event|3|||
48989923|NCT02539160|157796841|FG002|Phase 1 Pre-crossover|Adverse Event|2|||
48989924|NCT02539160|157796842|FG003|Phase 1 Pre-crossover|Adverse Event|1|||
48989925|NCT02539160|157796839|FG000|Phase 1 Pre-crossover|Withdrawal by Subject|2|||
48989926|NCT02539160|157796840|FG001|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
48989927|NCT02539160|157796841|FG002|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
48989928|NCT02539160|157796842|FG003|Phase 1 Pre-crossover|Withdrawal by Subject|0|||
48989929|NCT02539160|157796839|FG000|Phase 1 Pre-crossover|Protocol Violation|0|||
48989930|NCT02539160|157796840|FG001|Phase 1 Pre-crossover|Protocol Violation|0|||
48989931|NCT02539160|157796841|FG002|Phase 1 Pre-crossover|Protocol Violation|0|||
48989932|NCT02539160|157796842|FG003|Phase 1 Pre-crossover|Protocol Violation|2|||
48989933|NCT01681004|157796845|FG000|Primary Endpoint: 6 Months|Withdrawal by Subject|1|||
48989934|NCT01681004|157796846|FG001|Primary Endpoint: 6 Months|Withdrawal by Subject|2|||
48989935|NCT01681004|157796845|FG000|Study Completion|Lost to Follow-up|8|||
48989936|NCT01681004|157796846|FG001|Study Completion|Lost to Follow-up|3|||
48989937|NCT01681004|157796845|FG000|Study Completion|Physician Decision|1|||
49044523|NCT01223027|157995808|FG000|Overall Study|Protocol Violation|2|||
49044524|NCT01223027|157995809|FG001|Overall Study|Protocol Violation|1|||
49044525|NCT01223027|157995808|FG000|Overall Study|Subject/guardian decicion|18|||
49044526|NCT01223027|157995809|FG001|Overall Study|Subject/guardian decicion|16|||
49044527|NCT01223027|157995808|FG000|Overall Study|New therapy for study indication|17|||
49044528|NCT01223027|157995809|FG001|Overall Study|New therapy for study indication|8|||
48989938|NCT01681004|157796846|FG001|Study Completion|Physician Decision|3|||
48989939|NCT01681004|157796845|FG000|Study Completion|Site Termination|2|||
48989940|NCT01681004|157796846|FG001|Study Completion|Site Termination|1|||
48989941|NCT01681004|157796845|FG000|Study Completion|Death|1|||
48989942|NCT01681004|157796846|FG001|Study Completion|Death|1|||
49044529|NCT01223027|157995808|FG000|Overall Study|Study terminated by sponsor|2|||
49044530|NCT01223027|157995809|FG001|Overall Study|Study terminated by sponsor|8|||
49044531|NCT04232540|157995810|FG000|Overall Study|Lost to Follow-up|1|||
49044532|NCT04232540|157995811|FG001|Overall Study|Lost to Follow-up|0|||
49044533|NCT03257254|157995812|FG000|Overall Study|Withdrawal by Subject|7|||
49044534|NCT03257254|157995812|FG000|Overall Study|Lost to Follow-up|9|||
49044535|NCT03257254|157995812|FG000|Overall Study|Study discontinued by sponsor|5|||
49044536|NCT04419168|157996869|FG000|Overall Study|Protocol Violation|1|||
49044537|NCT04419168|157996870|FG001|Overall Study|Protocol Violation|1|||
49044538|NCT04419168|157996869|FG000|Overall Study|Lost to Follow-up|7|||
48989943|NCT00129220|157796847|FG000|Study Period II|Adverse Event|9|||
48989944|NCT00129220|157796848|FG001|Study Period II|Adverse Event|5|||
48989945|NCT00129220|157796849|FG002|Study Period II|Adverse Event|7|||
48989946|NCT00129220|157796847|FG000|Study Period II|Lack of Efficacy|15|||
48989947|NCT00129220|157796848|FG001|Study Period II|Lack of Efficacy|1|||
48989948|NCT00129220|157796849|FG002|Study Period II|Lack of Efficacy|28|||
48989949|NCT00129220|157796847|FG000|Study Period II|Entry Criteria Not Met|2|||
48989950|NCT00129220|157796848|FG001|Study Period II|Entry Criteria Not Met|0|||
48989951|NCT00129220|157796849|FG002|Study Period II|Entry Criteria Not Met|2|||
48989952|NCT00129220|157796847|FG000|Study Period II|Protocol Violation|4|||
48989953|NCT00129220|157796848|FG001|Study Period II|Protocol Violation|2|||
48989954|NCT00129220|157796849|FG002|Study Period II|Protocol Violation|1|||
48989955|NCT00129220|157796847|FG000|Study Period II|Physician Decision|0|||
48989956|NCT00129220|157796848|FG001|Study Period II|Physician Decision|1|||
48989957|NCT00129220|157796849|FG002|Study Period II|Physician Decision|0|||
48989958|NCT00129220|157796847|FG000|Study Period II|Withdrawal by Subject|1|||
48989959|NCT00129220|157796848|FG001|Study Period II|Withdrawal by Subject|3|||
48989960|NCT00129220|157796849|FG002|Study Period II|Withdrawal by Subject|4|||
48989961|NCT00129220|157796847|FG000|Study Period II|Reason Not Specified|2|||
48989962|NCT00129220|157796848|FG001|Study Period II|Reason Not Specified|0|||
48989963|NCT00129220|157796849|FG002|Study Period II|Reason Not Specified|5|||
48989964|NCT00129220|157796847|FG000|Study Period III|Adverse Event|1|||
48989965|NCT00129220|157796848|FG001|Study Period III|Adverse Event|0|||
48989966|NCT00129220|157796849|FG002|Study Period III|Adverse Event|3|||
48989967|NCT00129220|157796847|FG000|Study Period III|Protocol Violation|1|||
48989968|NCT00129220|157796848|FG001|Study Period III|Protocol Violation|1|||
48989969|NCT00129220|157796849|FG002|Study Period III|Protocol Violation|2|||
48989970|NCT00129220|157796847|FG000|Study Period III|Withdrawal by Subject|1|||
48989971|NCT00129220|157796848|FG001|Study Period III|Withdrawal by Subject|0|||
48989972|NCT00129220|157796849|FG002|Study Period III|Withdrawal by Subject|3|||
48989973|NCT00129220|157796847|FG000|Study Period III|Sponsor Decision|1|||
48989974|NCT00129220|157796848|FG001|Study Period III|Sponsor Decision|0|||
48989975|NCT00129220|157796849|FG002|Study Period III|Sponsor Decision|0|||
48989976|NCT00129220|157796847|FG000|Study Period III|Reason Not Specified|9|||
48989977|NCT00129220|157796848|FG001|Study Period III|Reason Not Specified|0|||
48989978|NCT00129220|157796849|FG002|Study Period III|Reason Not Specified|2|||
48989979|NCT01790633|157796851|FG000|Overall Study|Protocol Violation|1|||
48989980|NCT01790633|157796852|FG001|Overall Study|Protocol Violation|2|||
48989981|NCT01790633|157796851|FG000|Overall Study|Did not have serology performed|47|||
48989982|NCT01790633|157796852|FG001|Overall Study|Did not have serology performed|0|||
48989983|NCT01790633|157796851|FG000|Overall Study|RT failure and no follow-up ELISA|0|||
48989984|NCT01790633|157796852|FG001|Overall Study|RT failure and no follow-up ELISA|3|||
48989985|NCT00701064|157796866|FG000|Overall Study|Protocol Violation|1|||
48989986|NCT00701064|157796867|FG001|Overall Study|Protocol Violation|1|||
48989987|NCT00701064|157796866|FG000|Overall Study|Withdrawal by Subject|1|||
48989988|NCT00701064|157796867|FG001|Overall Study|Withdrawal by Subject|1|||
48989989|NCT00701064|157796866|FG000|Overall Study|initiated other PTSD treatment|2|||
48989990|NCT00701064|157796867|FG001|Overall Study|initiated other PTSD treatment|2|||
48989991|NCT00689299|157796868|FG000|Overall Study|Adverse Event|2|||
48989992|NCT00689299|157796869|FG001|Overall Study|Adverse Event|1|||
48989993|NCT00689299|157796870|FG002|Overall Study|Adverse Event|1|||
48989994|NCT00689299|157796868|FG000|Overall Study|Lost to Follow-up|0|||
49044539|NCT04419168|157996870|FG001|Overall Study|Lost to Follow-up|7|||
49044540|NCT04419168|157996869|FG000|Overall Study|Missed 6-month Visit|48|||
49044541|NCT04419168|157996870|FG001|Overall Study|Missed 6-month Visit|45|||
49044542|NCT04523480|157996875|FG000|Overall Study|Lost to Follow-up|30|||
49044543|NCT04523480|157996876|FG001|Overall Study|Lost to Follow-up|35|||
49044544|NCT04523480|157996877|FG002|Overall Study|Lost to Follow-up|0|||
49044545|NCT00735696|157996878|FG000|Overall Study|Withdrawal by Subject|1|||
48989995|NCT00689299|157796869|FG001|Overall Study|Lost to Follow-up|1|||
48989996|NCT00689299|157796870|FG002|Overall Study|Lost to Follow-up|1|||
48989997|NCT00689299|157796868|FG000|Overall Study|Withdrawal by Subject|4|||
48989998|NCT00689299|157796869|FG001|Overall Study|Withdrawal by Subject|1|||
48989999|NCT00689299|157796870|FG002|Overall Study|Withdrawal by Subject|3|||
48990000|NCT00689299|157796868|FG000|Overall Study|Protocol Violation|1|||
48990001|NCT00689299|157796869|FG001|Overall Study|Protocol Violation|0|||
48990002|NCT00689299|157796870|FG002|Overall Study|Protocol Violation|0|||
48990003|NCT01190839|157796873|FG000|Overall Study|Adverse Event|32|||
48990004|NCT01190839|157796874|FG001|Overall Study|Adverse Event|41|||
48990005|NCT01190839|157796873|FG000|Overall Study|Protocol Violation|2|||
49044546|NCT00735696|157996878|FG000|Overall Study|Enrolled but never Treated|1|||
48990006|NCT01190839|157796874|FG001|Overall Study|Protocol Violation|2|||
48990007|NCT01190839|157796873|FG000|Overall Study|Lost to Follow-up|7|||
48990008|NCT01190839|157796874|FG001|Overall Study|Lost to Follow-up|1|||
48990009|NCT01190839|157796873|FG000|Overall Study|Death|1|||
48990010|NCT01190839|157796874|FG001|Overall Study|Death|0|||
48990011|NCT01190839|157796873|FG000|Overall Study|Trial stopped by Sponsor|71|||
48990012|NCT01190839|157796874|FG001|Overall Study|Trial stopped by Sponsor|68|||
48990013|NCT01190839|157796873|FG000|Overall Study|Undefined|35|||
48990014|NCT01190839|157796874|FG001|Overall Study|Undefined|31|||
48990015|NCT01190839|157796873|FG000|Overall Study|Randomized but not treated|2|||
48990016|NCT01190839|157796874|FG001|Overall Study|Randomized but not treated|4|||
48990017|NCT02613910|157796875|FG000|Overall Study|Termination of study|1|||
48990018|NCT01641952|157798346|FG000|Overall Study|Lost to Follow-up|28|||
48990019|NCT01641952|157798346|FG000|Overall Study|Adverse Event|6|||
48990020|NCT02500901|157798349|FG000|Overall Study|Disease ProgressionDD|2|||
48990021|NCT00386152|157798350|FG000|Overall Study|Adverse Event|6|||
48990022|NCT00386152|157798351|FG001|Overall Study|Adverse Event|5|||
48990023|NCT00386152|157798352|FG002|Overall Study|Adverse Event|4|||
48990024|NCT00386152|157798350|FG000|Overall Study|Chang from original chemo stratification|4|||
48990025|NCT00386152|157798351|FG001|Overall Study|Chang from original chemo stratification|5|||
48990026|NCT00386152|157798352|FG002|Overall Study|Chang from original chemo stratification|6|||
48990027|NCT00386152|157798350|FG000|Overall Study|Death|3|||
48990028|NCT00386152|157798351|FG001|Overall Study|Death|0|||
48990029|NCT00386152|157798352|FG002|Overall Study|Death|1|||
48990030|NCT00386152|157798350|FG000|Overall Study|Disease progression|7|||
48990031|NCT00386152|157798351|FG001|Overall Study|Disease progression|4|||
48990032|NCT00386152|157798352|FG002|Overall Study|Disease progression|5|||
48990033|NCT00386152|157798350|FG000|Overall Study|Physician Decision|13|||
48990034|NCT00386152|157798351|FG001|Overall Study|Physician Decision|10|||
48990035|NCT00386152|157798352|FG002|Overall Study|Physician Decision|4|||
48990036|NCT00386152|157798350|FG000|Overall Study|Lost to Follow-up|1|||
48990037|NCT00386152|157798351|FG001|Overall Study|Lost to Follow-up|0|||
48990038|NCT00386152|157798352|FG002|Overall Study|Lost to Follow-up|0|||
48990039|NCT00386152|157798350|FG000|Overall Study|Completed chemotherapy|4|||
48990040|NCT00386152|157798351|FG001|Overall Study|Completed chemotherapy|5|||
48990041|NCT00386152|157798352|FG002|Overall Study|Completed chemotherapy|1|||
48990042|NCT00386152|157798350|FG000|Overall Study|Protocol Violation|3|||
48990043|NCT00386152|157798351|FG001|Overall Study|Protocol Violation|5|||
48990044|NCT00386152|157798352|FG002|Overall Study|Protocol Violation|2|||
48990045|NCT00386152|157798350|FG000|Overall Study|Withdrawal by Subject|3|||
48990046|NCT00386152|157798351|FG001|Overall Study|Withdrawal by Subject|6|||
48990047|NCT00386152|157798352|FG002|Overall Study|Withdrawal by Subject|10|||
48990048|NCT01370499|157798353|FG000|Overall Study|Adverse Event|38|||
49044547|NCT02473393|157996879|FG000|Overall Study|Adverse Event|0|||
49044548|NCT02473393|157996880|FG001|Overall Study|Adverse Event|0|||
48990049|NCT01370499|157798354|FG001|Overall Study|Adverse Event|12|||
48990050|NCT01370499|157798353|FG000|Overall Study|Lack of Efficacy|4|||
48990051|NCT01370499|157798354|FG001|Overall Study|Lack of Efficacy|2|||
49044549|NCT02473393|157996881|FG002|Overall Study|Adverse Event|1|||
49044550|NCT02473393|157996882|FG003|Overall Study|Adverse Event|0|||
49044551|NCT02473393|157996879|FG000|Overall Study|Withdrawal by Subject|0|||
49044552|NCT02473393|157996880|FG001|Overall Study|Withdrawal by Subject|0|||
49044553|NCT02473393|157996881|FG002|Overall Study|Withdrawal by Subject|1|||
49044554|NCT02473393|157996882|FG003|Overall Study|Withdrawal by Subject|1|||
49044555|NCT00640393|157996883|FG000|Part 1|Lost to Follow-up|2|||
49044556|NCT00640393|157996884|FG001|Part 1|Lost to Follow-up|0|||
49044557|NCT00640393|157996885|FG002|Part 1|Lost to Follow-up|0|||
49044558|NCT00640393|157996883|FG000|Part 1|Withdrawal by Subject|3|||
49044559|NCT00640393|157996884|FG001|Part 1|Withdrawal by Subject|0|||
49044560|NCT00640393|157996885|FG002|Part 1|Withdrawal by Subject|0|||
49044561|NCT00640393|157996883|FG000|Randomization|Withdrawn per protocol|17|||
49044562|NCT00640393|157996884|FG001|Randomization|Withdrawn per protocol|0|||
49044563|NCT00640393|157996885|FG002|Randomization|Withdrawn per protocol|0|||
49044564|NCT00640393|157996883|FG000|Randomization|Never randomized by site|2|||
49044565|NCT00640393|157996884|FG001|Randomization|Never randomized by site|0|||
49044566|NCT00640393|157996885|FG002|Randomization|Never randomized by site|0|||
49044567|NCT00640393|157996883|FG000|Part 2|Lost to Follow-up|0|||
49044568|NCT00640393|157996884|FG001|Part 2|Lost to Follow-up|2|||
48990052|NCT01370499|157798353|FG000|Overall Study|Lost to Follow-up|2|||
48990053|NCT01370499|157798354|FG001|Overall Study|Lost to Follow-up|1|||
48990054|NCT01370499|157798353|FG000|Overall Study|Physician Decision|3|||
48990055|NCT01370499|157798354|FG001|Overall Study|Physician Decision|3|||
48990056|NCT01370499|157798353|FG000|Overall Study|Protocol Violation|5|||
49044569|NCT00640393|157996885|FG002|Part 2|Lost to Follow-up|2|||
49044570|NCT00640393|157996883|FG000|Part 2|Withdrawal by Subject|0|||
49044571|NCT00640393|157996884|FG001|Part 2|Withdrawal by Subject|6|||
48990057|NCT01370499|157798354|FG001|Overall Study|Protocol Violation|4|||
48990058|NCT01370499|157798353|FG000|Overall Study|Withdrawal by Subject|18|||
48990059|NCT01370499|157798354|FG001|Overall Study|Withdrawal by Subject|7|||
49044572|NCT00640393|157996885|FG002|Part 2|Withdrawal by Subject|1|||
48990060|NCT01370499|157798353|FG000|Overall Study|Sponsor Decision|41|||
48990061|NCT01370499|157798354|FG001|Overall Study|Sponsor Decision|15|||
48990062|NCT04511533|157798355|FG000|Treatment|Other|2|||
48990063|NCT04511533|157798355|FG000|Treatment|Withdrawal by Subject|11|||
48990064|NCT04511533|157798355|FG000|Treatment|Death|5|||
48990065|NCT04511533|157798355|FG000|Treatment|Physician Decision|1|||
48990066|NCT04511533|157798355|FG000|Treatment|Progressive Disease|61|||
48990067|NCT04511533|157798355|FG000|Follow-Up|Other|7|||
48990068|NCT04511533|157798355|FG000|Follow-Up|Withdrawal by Subject|5|||
48990069|NCT04511533|157798355|FG000|Follow-Up|Lost to Follow-up|2|||
48990070|NCT04511533|157798355|FG000|Follow-Up|Death|4|||
48990071|NCT01982942|157798356|FG000|Overall Study|Adverse Event|10|||
48990072|NCT01982942|157798357|FG001|Overall Study|Adverse Event|5|||
48990073|NCT01982942|157798356|FG000|Overall Study|Lost to Follow-up|4|||
48990074|NCT01982942|157798357|FG001|Overall Study|Lost to Follow-up|3|||
48990075|NCT01982942|157798356|FG000|Overall Study|Multiple sclerosis progression|3|||
48990076|NCT01982942|157798357|FG001|Overall Study|Multiple sclerosis progression|2|||
48990077|NCT01982942|157798356|FG000|Overall Study|Wanted to try therapy not permitted|1|||
48990078|NCT01982942|157798357|FG001|Overall Study|Wanted to try therapy not permitted|0|||
48990079|NCT01982942|157798356|FG000|Overall Study|Subject declined future visits|0|||
48990080|NCT01982942|157798357|FG001|Overall Study|Subject declined future visits|1|||
48990081|NCT01982942|157798356|FG000|Overall Study|Left geographical area|2|||
48990082|NCT01982942|157798357|FG001|Overall Study|Left geographical area|0|||
48990083|NCT01982942|157798356|FG000|Overall Study|Too many pills|1|||
48990084|NCT01982942|157798357|FG001|Overall Study|Too many pills|0|||
48990085|NCT01982942|157798356|FG000|Overall Study|MS Relapse|0|||
48990086|NCT01982942|157798357|FG001|Overall Study|MS Relapse|1|||
48990087|NCT01982942|157798356|FG000|Overall Study|Chose to join a stem cell trial|0|||
48990088|NCT01982942|157798357|FG001|Overall Study|Chose to join a stem cell trial|1|||
48990089|NCT01982942|157798356|FG000|Overall Study|Subject bedridden, rapidly declining|0|||
49044573|NCT00640393|157996883|FG000|Part 2|Non-adherence|0|||
48990090|NCT01982942|157798357|FG001|Overall Study|Subject bedridden, rapidly declining|1|||
48990091|NCT01224171|157798358|FG000|Overall Study|Adverse Event|8|||
48990092|NCT01224171|157798359|FG001|Overall Study|Adverse Event|4|||
49044574|NCT00640393|157996884|FG001|Part 2|Non-adherence|1|||
49044575|NCT00640393|157996885|FG002|Part 2|Non-adherence|0|||
49044576|NCT00640393|157996883|FG000|Part 2|Adverse Event|0|||
49044577|NCT00640393|157996884|FG001|Part 2|Adverse Event|1|||
49044578|NCT00640393|157996885|FG002|Part 2|Adverse Event|0|||
49044579|NCT02907099|157996891|FG000|Overall Study|Adverse Event|1|||
49044580|NCT02907099|157996891|FG000|Overall Study|Withdrawal by Subject|2|||
49044581|NCT02907099|157996891|FG000|Overall Study|Screen Fail|2|||
48990093|NCT01224171|157798358|FG000|Overall Study|Protocol Violation|0|||
49044582|NCT00876265|157996893|FG000|Overall Study|Miscellaneous reasons|4|||
49044583|NCT00876265|157996893|FG000|Overall Study|Lost to Follow-up|6|||
49044584|NCT00876265|157996893|FG000|Overall Study|Withdrawal by Subject|2|||
49044585|NCT02754492|157996894|FG000|Overall Study|Protocol Violation|2|||
49044586|NCT02754492|157996895|FG001|Overall Study|Protocol Violation|2|||
49044587|NCT02754492|157996896|FG002|Overall Study|Protocol Violation|0|||
48990094|NCT01224171|157798359|FG001|Overall Study|Protocol Violation|1|||
48990095|NCT01224171|157798358|FG000|Overall Study|Lack of Efficacy|5|||
48990096|NCT01224171|157798359|FG001|Overall Study|Lack of Efficacy|1|||
48990097|NCT01224171|157798358|FG000|Overall Study|Withdrawal of Consent|2|||
48990098|NCT01224171|157798359|FG001|Overall Study|Withdrawal of Consent|4|||
48990099|NCT01224171|157798358|FG000|Overall Study|Lost to Follow-up|0|||
48990100|NCT01224171|157798359|FG001|Overall Study|Lost to Follow-up|3|||
48990101|NCT02185040|157798360|FG000|Part 1 Treatment Phase|Miscellaneous|0|||
48990102|NCT02185040|157798361|FG001|Part 1 Treatment Phase|Miscellaneous|0|||
49044588|NCT02754492|157996897|FG003|Overall Study|Protocol Violation|1|||
49044589|NCT02754492|157996894|FG000|Overall Study|Withdrawal by Subject|2|||
49044590|NCT02754492|157996895|FG001|Overall Study|Withdrawal by Subject|0|||
49044591|NCT02754492|157996896|FG002|Overall Study|Withdrawal by Subject|0|||
49044592|NCT02754492|157996897|FG003|Overall Study|Withdrawal by Subject|0|||
49044593|NCT02754492|157996894|FG000|Overall Study|Equipment malfuntion|0|||
49044594|NCT02754492|157996895|FG001|Overall Study|Equipment malfuntion|0|||
48990103|NCT02185040|157798362|FG002|Part 1 Treatment Phase|Miscellaneous|1|||
48990104|NCT02185040|157798363|FG003|Part 1 Treatment Phase|Miscellaneous|0|||
48990105|NCT02185040|157798364|FG004|Part 1 Treatment Phase|Miscellaneous|0|||
48990106|NCT02185040|157798365|FG005|Part 1 Treatment Phase|Miscellaneous|0|||
48990107|NCT02185040|157798366|FG006|Part 1 Treatment Phase|Miscellaneous|0|||
48990108|NCT02185040|157798360|FG000|Part 1 Treatment Phase|Adverse Event|1|||
48990109|NCT02185040|157798361|FG001|Part 1 Treatment Phase|Adverse Event|0|||
48990110|NCT02185040|157798362|FG002|Part 1 Treatment Phase|Adverse Event|0|||
49044595|NCT02754492|157996896|FG002|Overall Study|Equipment malfuntion|2|||
49044596|NCT02754492|157996897|FG003|Overall Study|Equipment malfuntion|5|||
49044597|NCT02754492|157996894|FG000|Overall Study|Adverse Event|0|||
49044598|NCT02754492|157996895|FG001|Overall Study|Adverse Event|0|||
49044599|NCT02754492|157996896|FG002|Overall Study|Adverse Event|0|||
49044600|NCT02754492|157996897|FG003|Overall Study|Adverse Event|13|||
49044601|NCT02754492|157996894|FG000|Overall Study|Venous access issues not resulting in AE|0|||
49044602|NCT02754492|157996895|FG001|Overall Study|Venous access issues not resulting in AE|0|||
49044603|NCT02754492|157996896|FG002|Overall Study|Venous access issues not resulting in AE|0|||
49044604|NCT02754492|157996897|FG003|Overall Study|Venous access issues not resulting in AE|4|||
49044605|NCT05087992|157996898|FG000|Overall Study|Adverse Event|0|||
49044606|NCT05087992|157996899|FG001|Overall Study|Adverse Event|1|||
49044607|NCT05087992|157996900|FG002|Overall Study|Adverse Event|0|||
49044608|NCT05087992|157996898|FG000|Overall Study|Withdrawal by Subject|2|||
49044609|NCT05087992|157996899|FG001|Overall Study|Withdrawal by Subject|0|||
49044610|NCT05087992|157996900|FG002|Overall Study|Withdrawal by Subject|0|||
49044611|NCT05087992|157996898|FG000|Overall Study|clinical disease progression|3|||
49044612|NCT05087992|157996899|FG001|Overall Study|clinical disease progression|1|||
49044613|NCT05087992|157996900|FG002|Overall Study|clinical disease progression|0|||
49044614|NCT05087992|157996898|FG000|Overall Study|objective disease progression|4|||
49044615|NCT05087992|157996899|FG001|Overall Study|objective disease progression|1|||
49044616|NCT05087992|157996900|FG002|Overall Study|objective disease progression|0|||
49044617|NCT03097549|157996903|FG000|Overall Study|Withdrawal by Subject|1|||
49044618|NCT03097549|157996904|FG001|Overall Study|Withdrawal by Subject|0|||
49044619|NCT03097549|157996903|FG000|Overall Study|Lost to Follow-up|1|||
49044620|NCT03097549|157996904|FG001|Overall Study|Lost to Follow-up|0|||
48990111|NCT02185040|157798363|FG003|Part 1 Treatment Phase|Adverse Event|2|||
48990112|NCT02185040|157798364|FG004|Part 1 Treatment Phase|Adverse Event|3|||
48990113|NCT02185040|157798365|FG005|Part 1 Treatment Phase|Adverse Event|0|||
48990114|NCT02185040|157798366|FG006|Part 1 Treatment Phase|Adverse Event|0|||
48990115|NCT02185040|157798360|FG000|Part 1 Treatment Phase|Withdrawal by Subject|0|||
48990116|NCT02185040|157798361|FG001|Part 1 Treatment Phase|Withdrawal by Subject|1|||
48990117|NCT02185040|157798362|FG002|Part 1 Treatment Phase|Withdrawal by Subject|0|||
48990118|NCT02185040|157798363|FG003|Part 1 Treatment Phase|Withdrawal by Subject|0|||
48990119|NCT02185040|157798364|FG004|Part 1 Treatment Phase|Withdrawal by Subject|0|||
48990120|NCT02185040|157798365|FG005|Part 1 Treatment Phase|Withdrawal by Subject|0|||
48990121|NCT02185040|157798366|FG006|Part 1 Treatment Phase|Withdrawal by Subject|0|||
48990122|NCT02185040|157798360|FG000|Part 1 Treatment Phase|Lost to Follow-up|0|||
48990123|NCT02185040|157798361|FG001|Part 1 Treatment Phase|Lost to Follow-up|1|||
48990124|NCT02185040|157798362|FG002|Part 1 Treatment Phase|Lost to Follow-up|0|||
48990125|NCT02185040|157798363|FG003|Part 1 Treatment Phase|Lost to Follow-up|0|||
48990126|NCT02185040|157798364|FG004|Part 1 Treatment Phase|Lost to Follow-up|0|||
48990127|NCT02185040|157798365|FG005|Part 1 Treatment Phase|Lost to Follow-up|0|||
48990128|NCT02185040|157798366|FG006|Part 1 Treatment Phase|Lost to Follow-up|0|||
48990129|NCT02185040|157798360|FG000|Active Treatment Extension Phase|Miscellaneous|0|||
48990130|NCT02185040|157798361|FG001|Active Treatment Extension Phase|Miscellaneous|0|||
48990131|NCT02185040|157798362|FG002|Active Treatment Extension Phase|Miscellaneous|0|||
48990132|NCT02185040|157798363|FG003|Active Treatment Extension Phase|Miscellaneous|0|||
48990133|NCT02185040|157798364|FG004|Active Treatment Extension Phase|Miscellaneous|0|||
48990134|NCT02185040|157798365|FG005|Active Treatment Extension Phase|Miscellaneous|1|||
48990135|NCT02185040|157798366|FG006|Active Treatment Extension Phase|Miscellaneous|0|||
48990136|NCT02185040|157798360|FG000|Active Treatment Extension Phase|Adverse Event|0|||
48990137|NCT02185040|157798361|FG001|Active Treatment Extension Phase|Adverse Event|0|||
48990138|NCT02185040|157798362|FG002|Active Treatment Extension Phase|Adverse Event|0|||
48990139|NCT02185040|157798363|FG003|Active Treatment Extension Phase|Adverse Event|0|||
48990140|NCT02185040|157798364|FG004|Active Treatment Extension Phase|Adverse Event|0|||
48990141|NCT02185040|157798365|FG005|Active Treatment Extension Phase|Adverse Event|1|||
48990142|NCT02185040|157798366|FG006|Active Treatment Extension Phase|Adverse Event|4|||
48990143|NCT02185040|157798360|FG000|Active Treatment Extension Phase|Withdrawal by Subject|0|||
48990144|NCT02185040|157798361|FG001|Active Treatment Extension Phase|Withdrawal by Subject|0|||
49044621|NCT03596866|157996905|FG000|Overall Study|Ongoing at Data Cut-off|91|||
49044622|NCT03596866|157996906|FG001|Overall Study|Ongoing at Data Cut-off|101|||
49044623|NCT03596866|157996905|FG000|Overall Study|Randomized but Never Received Drug|0|||
49044624|NCT03596866|157996906|FG001|Overall Study|Randomized but Never Received Drug|1|||
49044625|NCT03596866|157996905|FG000|Overall Study|Death|27|||
49044626|NCT03596866|157996906|FG001|Overall Study|Death|14|||
49044627|NCT03596866|157996905|FG000|Overall Study|Withdrawal by Subject|6|||
49044628|NCT03596866|157996906|FG001|Overall Study|Withdrawal by Subject|5|||
49044629|NCT03596866|157996905|FG000|Overall Study|Lost to Follow-up|1|||
49044630|NCT03596866|157996906|FG001|Overall Study|Lost to Follow-up|1|||
48990145|NCT02185040|157798362|FG002|Active Treatment Extension Phase|Withdrawal by Subject|0|||
48990146|NCT02185040|157798363|FG003|Active Treatment Extension Phase|Withdrawal by Subject|0|||
48990147|NCT02185040|157798364|FG004|Active Treatment Extension Phase|Withdrawal by Subject|0|||
49044631|NCT03596866|157996905|FG000|Overall Study|Reason Not Specified|0|||
49044632|NCT03596866|157996906|FG001|Overall Study|Reason Not Specified|1|||
49044633|NCT03092518|157996907|FG000|Overall Study|Ineligible|2|||
49044634|NCT03113487|157996908|FG000|Overall Study|After cycle 1 sepsis was deemed present at baseline, so the patient was ineligible|1|||
49044635|NCT04537715|157996909|FG000|Overall Study|Death|3|||
48990148|NCT02185040|157798365|FG005|Active Treatment Extension Phase|Withdrawal by Subject|1|||
48990149|NCT02185040|157798366|FG006|Active Treatment Extension Phase|Withdrawal by Subject|1|||
48990150|NCT02185040|157798360|FG000|Active Treatment Extension Phase|Lost to Follow-up|0|||
48990151|NCT02185040|157798361|FG001|Active Treatment Extension Phase|Lost to Follow-up|0|||
48990152|NCT02185040|157798362|FG002|Active Treatment Extension Phase|Lost to Follow-up|0|||
48990153|NCT02185040|157798363|FG003|Active Treatment Extension Phase|Lost to Follow-up|0|||
48990154|NCT02185040|157798364|FG004|Active Treatment Extension Phase|Lost to Follow-up|0|||
48990155|NCT02185040|157798365|FG005|Active Treatment Extension Phase|Lost to Follow-up|0|||
48990156|NCT02185040|157798366|FG006|Active Treatment Extension Phase|Lost to Follow-up|2|||
48990157|NCT00635804|157798368|FG000|Overall Study|Adverse Event|0|||
48990158|NCT00635804|157798369|FG001|Overall Study|Adverse Event|0|||
48990159|NCT00635804|157798370|FG002|Overall Study|Adverse Event|0|||
48990160|NCT00635804|157798371|FG003|Overall Study|Adverse Event|0|||
48990161|NCT00635804|157798372|FG004|Overall Study|Adverse Event|0|||
48990162|NCT00635804|157798373|FG005|Overall Study|Adverse Event|1|||
48990163|NCT00635804|157798374|FG006|Overall Study|Adverse Event|0|||
48990164|NCT00635804|157798375|FG007|Overall Study|Adverse Event|0|||
48990165|NCT00635804|157798368|FG000|Overall Study|Withdrawal by Subject|1|||
48990166|NCT00635804|157798369|FG001|Overall Study|Withdrawal by Subject|0|||
48990167|NCT00635804|157798370|FG002|Overall Study|Withdrawal by Subject|0|||
48990168|NCT00635804|157798371|FG003|Overall Study|Withdrawal by Subject|0|||
48990169|NCT00635804|157798372|FG004|Overall Study|Withdrawal by Subject|0|||
48990170|NCT00635804|157798373|FG005|Overall Study|Withdrawal by Subject|0|||
48990171|NCT00635804|157798374|FG006|Overall Study|Withdrawal by Subject|0|||
48990172|NCT00635804|157798375|FG007|Overall Study|Withdrawal by Subject|0|||
48990173|NCT01667731|157798386|FG000|Overall Study|Enrolled but not treated|0|||
48990174|NCT01667731|157798387|FG001|Overall Study|Enrolled but not treated|0|||
48990175|NCT01667731|157798388|FG002|Overall Study|Enrolled but not treated|0|||
48990176|NCT01667731|157798389|FG003|Overall Study|Enrolled but not treated|0|||
48990177|NCT01667731|157798390|FG004|Overall Study|Enrolled but not treated|1|||
48990178|NCT01667731|157798386|FG000|Overall Study|Efficacy Failure|1|||
48990179|NCT01667731|157798387|FG001|Overall Study|Efficacy Failure|12|||
48990180|NCT01667731|157798388|FG002|Overall Study|Efficacy Failure|0|||
48990181|NCT01667731|157798389|FG003|Overall Study|Efficacy Failure|1|||
48990182|NCT01667731|157798390|FG004|Overall Study|Efficacy Failure|24|||
48990183|NCT01667731|157798386|FG000|Overall Study|Lost to Follow-up|2|||
48990184|NCT01667731|157798387|FG001|Overall Study|Lost to Follow-up|3|||
48990185|NCT01667731|157798388|FG002|Overall Study|Lost to Follow-up|1|||
48990186|NCT01667731|157798389|FG003|Overall Study|Lost to Follow-up|1|||
48990187|NCT01667731|157798390|FG004|Overall Study|Lost to Follow-up|2|||
48990188|NCT01667731|157798386|FG000|Overall Study|Subject Withdrew Consent|2|||
48990189|NCT01667731|157798387|FG001|Overall Study|Subject Withdrew Consent|0|||
48990190|NCT01667731|157798388|FG002|Overall Study|Subject Withdrew Consent|1|||
48990191|NCT01667731|157798389|FG003|Overall Study|Subject Withdrew Consent|0|||
48990192|NCT01667731|157798390|FG004|Overall Study|Subject Withdrew Consent|1|||
48990193|NCT01667731|157798386|FG000|Overall Study|Death|0|||
48990194|NCT01667731|157798387|FG001|Overall Study|Death|1|||
48990195|NCT01667731|157798388|FG002|Overall Study|Death|0|||
48990196|NCT01667731|157798389|FG003|Overall Study|Death|0|||
48990197|NCT01667731|157798390|FG004|Overall Study|Death|0|||
48990198|NCT02718131|157798391|FG000|Overall Study|Withdrawal by Subject|1|||
48990199|NCT02718131|157798392|FG001|Overall Study|Withdrawal by Subject|0|||
48990200|NCT02718131|157798391|FG000|Overall Study|Adverse Event|1|||
48990201|NCT02718131|157798392|FG001|Overall Study|Adverse Event|0|||
48990202|NCT02718131|157798391|FG000|Overall Study|Data was incomplete. Patient was inevaluable|1|||
48990203|NCT02718131|157798392|FG001|Overall Study|Data was incomplete. Patient was inevaluable|0|||
48990204|NCT01097057|157798396|FG000|Overall Study|Physician Decision|3|||
48990205|NCT00887822|157798401|FG000|Overall Study|Insufficient therapeutic response|53|||
48990206|NCT00887822|157798402|FG001|Overall Study|Insufficient therapeutic response|55|||
48990207|NCT00887822|157798401|FG000|Overall Study|Adverse Event|14|||
48990208|NCT00887822|157798402|FG001|Overall Study|Adverse Event|17|||
48990209|NCT00887822|157798401|FG000|Overall Study|Failure to return|11|||
48990210|NCT00887822|157798402|FG001|Overall Study|Failure to return|11|||
48990211|NCT00887822|157798401|FG000|Overall Study|Refused treatment/Did not cooperate|12|||
48990212|NCT00887822|157798402|FG001|Overall Study|Refused treatment/Did not cooperate|10|||
48990213|NCT00887822|157798401|FG000|Overall Study|Administrative/Other than specified|5|||
48990214|NCT00887822|157798402|FG001|Overall Study|Administrative/Other than specified|4|||
48990215|NCT00887822|157798401|FG000|Overall Study|Death|2|||
48990216|NCT00887822|157798402|FG001|Overall Study|Death|3|||
48990217|NCT00887822|157798401|FG000|Overall Study|Protocol Violation|0|||
48990218|NCT00887822|157798402|FG001|Overall Study|Protocol Violation|1|||
48990219|NCT00887822|157798401|FG000|Overall Study|Randomized but not treated|0|||
48990220|NCT00887822|157798402|FG001|Overall Study|Randomized but not treated|1|||
48990221|NCT01101321|157798403|FG000|Period 1|Withdrawal by Subject|1|||
48990222|NCT01101321|157798404|FG001|Period 1|Withdrawal by Subject|1|||
48990223|NCT01101321|157798403|FG000|Period 1|Adverse Event|3|||
48990224|NCT01101321|157798404|FG001|Period 1|Adverse Event|3|||
48990225|NCT00719706|157798405|FG000|Overall Study|Adverse Event|5|||
48990226|NCT00719706|157798406|FG001|Overall Study|Adverse Event|4|||
48990227|NCT00719706|157798405|FG000|Overall Study|Withdrawal by Subject|1|||
48990228|NCT00719706|157798406|FG001|Overall Study|Withdrawal by Subject|2|||
48990229|NCT00719706|157798405|FG000|Overall Study|Protocol Violation|3|||
48990230|NCT00719706|157798406|FG001|Overall Study|Protocol Violation|0|||
48990231|NCT00361504|157798410|FG000|Overall Study|Withdrawal by Subject|94|||
48990232|NCT00361504|157798411|FG001|Overall Study|Withdrawal by Subject|31|||
48990233|NCT00361504|157798410|FG000|Overall Study|Lost to Follow-up|40|||
48990234|NCT00361504|157798411|FG001|Overall Study|Lost to Follow-up|7|||
48990235|NCT00361504|157798410|FG000|Overall Study|Adverse Event|203|||
48990236|NCT00361504|157798411|FG001|Overall Study|Adverse Event|82|||
48990237|NCT00361504|157798410|FG000|Overall Study|Lack of Efficacy|72|||
48990238|NCT00361504|157798411|FG001|Overall Study|Lack of Efficacy|7|||
48990239|NCT00361504|157798410|FG000|Overall Study|Resolution of Pain|2|||
48990240|NCT00361504|157798411|FG001|Overall Study|Resolution of Pain|0|||
48990241|NCT00361504|157798410|FG000|Overall Study|Study medication non compliant|42|||
48990242|NCT00361504|157798411|FG001|Overall Study|Study medication non compliant|15|||
48990243|NCT00361504|157798410|FG000|Overall Study|All other|28|||
48990244|NCT00361504|157798411|FG001|Overall Study|All other|3|||
48990245|NCT00408408|157798412|FG000|Overall Study|No follow up data|2|||
48990246|NCT00408408|157798413|FG001|Overall Study|No follow up data|3|||
48990247|NCT00408408|157798414|FG002|Overall Study|No follow up data|0|||
48990248|NCT00408408|157798415|FG003|Overall Study|No follow up data|7|||
48990249|NCT00408408|157798416|FG004|Overall Study|No follow up data|5|||
48990250|NCT00408408|157798417|FG005|Overall Study|No follow up data|3|||
48990251|NCT00401726|157798418|FG000|Overall Study|Adverse Event|34|||
48990252|NCT00401726|157798419|FG001|Overall Study|Adverse Event|45|||
49044636|NCT04537715|157996910|FG001|Overall Study|Death|1|||
49044637|NCT04537715|157996909|FG000|Overall Study|Withdrawal by Subject|3|||
49044638|NCT04537715|157996910|FG001|Overall Study|Withdrawal by Subject|1|||
49044639|NCT04537715|157996909|FG000|Overall Study|Other|4|||
49044640|NCT04537715|157996910|FG001|Overall Study|Other|3|||
49044641|NCT04537715|157996909|FG000|Overall Study|Progressive disease|1|||
49044642|NCT04537715|157996910|FG001|Overall Study|Progressive disease|0|||
49044643|NCT02043678|157996911|FG000|Overall Study|Never treated|11|||
49044644|NCT02043678|157996912|FG001|Overall Study|Never treated|9|||
49044645|NCT02043678|157996911|FG000|Overall Study|AE with clinical progressive disease(PD)|20|||
49044646|NCT02043678|157996912|FG001|Overall Study|AE with clinical progressive disease(PD)|19|||
49044647|NCT02043678|157996911|FG000|Overall Study|AE without clinical PD|54|||
49044648|NCT02043678|157996912|FG001|Overall Study|AE without clinical PD|36|||
49044649|NCT02043678|157996911|FG000|Overall Study|Lost to Follow-up|1|||
48990253|NCT00401726|157798418|FG000|Overall Study|Death|0|||
48990254|NCT00401726|157798419|FG001|Overall Study|Death|3|||
48990255|NCT00401726|157798418|FG000|Overall Study|Sponsor Request|0|||
48990256|NCT00401726|157798419|FG001|Overall Study|Sponsor Request|1|||
48990257|NCT00401726|157798418|FG000|Overall Study|Physician Decision|3|||
48990258|NCT00401726|157798419|FG001|Overall Study|Physician Decision|6|||
48990259|NCT00401726|157798418|FG000|Overall Study|Lost to Follow-up|23|||
48990260|NCT00401726|157798419|FG001|Overall Study|Lost to Follow-up|20|||
48990261|NCT00401726|157798418|FG000|Overall Study|Protocol Violation|6|||
48990262|NCT00401726|157798419|FG001|Overall Study|Protocol Violation|3|||
48990263|NCT00401726|157798418|FG000|Overall Study|Withdrawal by Subject|18|||
48990264|NCT00401726|157798419|FG001|Overall Study|Withdrawal by Subject|24|||
48990265|NCT00401726|157798418|FG000|Overall Study|Lack of Efficacy|4|||
48990266|NCT00401726|157798419|FG001|Overall Study|Lack of Efficacy|6|||
48990267|NCT00401726|157798418|FG000|Overall Study|Protocol Deviation|9|||
48990268|NCT00401726|157798419|FG001|Overall Study|Protocol Deviation|4|||
48990269|NCT03672006|157798420|FG000|Overall Study|exclusion criteria met|0|||
48990270|NCT03672006|157798421|FG001|Overall Study|exclusion criteria met|1|||
48990271|NCT04235959|157798422|FG000|Overall Study|Protocol Violation|0|||
48990272|NCT04235959|157798423|FG001|Overall Study|Protocol Violation|1|||
48990273|NCT04235959|157798424|FG002|Overall Study|Protocol Violation|0|||
48990274|NCT04235959|157798422|FG000|Overall Study|Adverse Event|1|||
48990275|NCT04235959|157798423|FG001|Overall Study|Adverse Event|0|||
48990276|NCT04235959|157798424|FG002|Overall Study|Adverse Event|0|||
48990277|NCT00612456|157798430|FG000|Overall Study|Adverse Event|1|||
48990278|NCT00612456|157798431|FG001|Overall Study|Adverse Event|0|||
48990279|NCT00612456|157798432|FG002|Overall Study|Adverse Event|0|||
48990280|NCT00612456|157798430|FG000|Overall Study|Lack of Efficacy|1|||
48990281|NCT00612456|157798431|FG001|Overall Study|Lack of Efficacy|1|||
48990282|NCT00612456|157798432|FG002|Overall Study|Lack of Efficacy|0|||
48990283|NCT00612456|157798430|FG000|Overall Study|Withdrawal by Subject|0|||
48990284|NCT00612456|157798431|FG001|Overall Study|Withdrawal by Subject|1|||
48990285|NCT00612456|157798432|FG002|Overall Study|Withdrawal by Subject|0|||
49044650|NCT02043678|157996912|FG001|Overall Study|Lost to Follow-up|1|||
49044651|NCT02043678|157996911|FG000|Overall Study|Other|10|||
49044652|NCT02043678|157996912|FG001|Overall Study|Other|14|||
49044653|NCT02043678|157996911|FG000|Overall Study|Clinical PD|114|||
48990286|NCT01219959|157798435|FG000|Overall Study|Adverse Event|6|||
48990287|NCT01219959|157798436|FG001|Overall Study|Adverse Event|14|||
48990288|NCT01219959|157798435|FG000|Overall Study|Physician Decision|0|||
48990289|NCT01219959|157798436|FG001|Overall Study|Physician Decision|4|||
48990290|NCT01219959|157798435|FG000|Overall Study|Withdrawal by Subject|0|||
48990291|NCT01219959|157798436|FG001|Overall Study|Withdrawal by Subject|2|||
48990292|NCT01219959|157798435|FG000|Overall Study|Renal Transplantation|0|||
48990293|NCT01219959|157798436|FG001|Overall Study|Renal Transplantation|3|||
48990294|NCT01219959|157798435|FG000|Overall Study|Other|1|||
48990295|NCT01219959|157798436|FG001|Overall Study|Other|0|||
48990296|NCT01430559|157798437|FG000|Overall Study|Adverse Event|7|||
48990297|NCT01430559|157798438|FG001|Overall Study|Adverse Event|3|||
48990298|NCT01430559|157798437|FG000|Overall Study|Entry criteria not met|1|||
48990299|NCT01430559|157798438|FG001|Overall Study|Entry criteria not met|1|||
48990300|NCT01430559|157798437|FG000|Overall Study|Lost to Follow-up|1|||
48990301|NCT01430559|157798438|FG001|Overall Study|Lost to Follow-up|0|||
48990302|NCT01430559|157798437|FG000|Overall Study|Medication error|1|||
48990303|NCT01430559|157798438|FG001|Overall Study|Medication error|0|||
48990304|NCT01430559|157798437|FG000|Overall Study|Withdrawal by Subject|3|||
48990305|NCT01430559|157798438|FG001|Overall Study|Withdrawal by Subject|2|||
48990306|NCT01430559|157798437|FG000|Overall Study|Protocol Violation|1|||
48990307|NCT01430559|157798438|FG001|Overall Study|Protocol Violation|0|||
48990308|NCT01430559|157798437|FG000|Overall Study|Other|3|||
48990309|NCT01430559|157798438|FG001|Overall Study|Other|3|||
48990310|NCT01430559|157798437|FG000|Overall Study|Randomized, Not Treated|3|||
48990311|NCT01430559|157798438|FG001|Overall Study|Randomized, Not Treated|3|||
48990312|NCT00265109|157798439|FG000|Overall Study|Withdrawal by Subject|5|||
48990313|NCT00265109|157798439|FG000|Overall Study|Adverse Event|1|||
48990314|NCT02463097|157798440|FG000|Overall Study|Withdrawal by Subject|1|||
48990315|NCT01552408|157798443|FG000|Overall Study|Lost to Follow-up|2|||
48990316|NCT01552408|157798444|FG001|Overall Study|Lost to Follow-up|0|||
48990317|NCT01552408|157798443|FG000|Overall Study|Relocation|0|||
48990318|NCT01552408|157798444|FG001|Overall Study|Relocation|1|||
48990319|NCT01552408|157798443|FG000|Overall Study|Withdrawal by Subject|2|||
48990320|NCT01552408|157798444|FG001|Overall Study|Withdrawal by Subject|1|||
48990321|NCT03205605|157798452|FG000|Overall Study|Withdrawal by Subject|1|||
48990322|NCT01955005|157798455|FG000|Overall Study|Withdrawal by Subject|3|||
48990323|NCT01955005|157798456|FG001|Overall Study|Withdrawal by Subject|5|||
48990324|NCT00422942|157798461|FG000|Overall Study|Study terminated by Sponsor|3|||
48990325|NCT02911285|157798463|FG000|Overall Study|Lost to Follow-up|8|||
48990326|NCT02911285|157798464|FG001|Overall Study|Lost to Follow-up|5|||
48990327|NCT02911285|157798463|FG000|Overall Study|Participant got a job and no longer had time to participate.|1|||
48990328|NCT02911285|157798464|FG001|Overall Study|Participant got a job and no longer had time to participate.|0|||
48990329|NCT01397409|157798465|FG000|Stage 2|Adverse Event|0|||
48990330|NCT01397409|157798466|FG001|Stage 2|Adverse Event|0|||
48990331|NCT01397409|157798467|FG002|Stage 2|Adverse Event|0|||
48990332|NCT01397409|157798468|FG003|Stage 2|Adverse Event|0|||
48990333|NCT01397409|157798469|FG004|Stage 2|Adverse Event|6|||
48990334|NCT01397409|157798470|FG005|Stage 2|Adverse Event|3|||
48990335|NCT01397409|157798471|FG006|Stage 2|Adverse Event|0|||
48990336|NCT01397409|157798472|FG007|Stage 2|Adverse Event|0|||
48990337|NCT01397409|157798473|FG008|Stage 2|Adverse Event|0|||
48990338|NCT01397409|157798474|FG009|Stage 2|Adverse Event|0|||
48990339|NCT01397409|157798465|FG000|Stage 2|Personal Reasons|0|||
48990340|NCT01397409|157798466|FG001|Stage 2|Personal Reasons|0|||
48990341|NCT01397409|157798467|FG002|Stage 2|Personal Reasons|0|||
48990342|NCT01397409|157798468|FG003|Stage 2|Personal Reasons|0|||
48990343|NCT01397409|157798469|FG004|Stage 2|Personal Reasons|1|||
48990344|NCT01397409|157798470|FG005|Stage 2|Personal Reasons|0|||
48990345|NCT01397409|157798471|FG006|Stage 2|Personal Reasons|0|||
48990346|NCT01397409|157798472|FG007|Stage 2|Personal Reasons|0|||
48990347|NCT01397409|157798473|FG008|Stage 2|Personal Reasons|0|||
48990348|NCT01397409|157798474|FG009|Stage 2|Personal Reasons|0|||
48990349|NCT01397409|157798465|FG000|Stage 2|Other Miscellaneous Reasons|0|||
48990350|NCT01397409|157798466|FG001|Stage 2|Other Miscellaneous Reasons|0|||
48990351|NCT01397409|157798467|FG002|Stage 2|Other Miscellaneous Reasons|0|||
48990352|NCT01397409|157798468|FG003|Stage 2|Other Miscellaneous Reasons|0|||
48990353|NCT01397409|157798469|FG004|Stage 2|Other Miscellaneous Reasons|1|||
48990354|NCT01397409|157798470|FG005|Stage 2|Other Miscellaneous Reasons|1|||
48990355|NCT01397409|157798471|FG006|Stage 2|Other Miscellaneous Reasons|0|||
48990356|NCT01397409|157798472|FG007|Stage 2|Other Miscellaneous Reasons|0|||
48990357|NCT01397409|157798473|FG008|Stage 2|Other Miscellaneous Reasons|0|||
48990358|NCT01397409|157798474|FG009|Stage 2|Other Miscellaneous Reasons|0|||
48990359|NCT01397409|157798465|FG000|Stage 3|Adverse Event|0|||
48990360|NCT01397409|157798466|FG001|Stage 3|Adverse Event|0|||
48990361|NCT01397409|157798467|FG002|Stage 3|Adverse Event|0|||
48990362|NCT01397409|157798468|FG003|Stage 3|Adverse Event|0|||
48990363|NCT01397409|157798469|FG004|Stage 3|Adverse Event|0|||
48990364|NCT01397409|157798470|FG005|Stage 3|Adverse Event|0|||
48990365|NCT01397409|157798471|FG006|Stage 3|Adverse Event|0|||
48990366|NCT01397409|157798472|FG007|Stage 3|Adverse Event|1|||
48990367|NCT01397409|157798473|FG008|Stage 3|Adverse Event|0|||
48990368|NCT01397409|157798474|FG009|Stage 3|Adverse Event|0|||
48990369|NCT01397409|157798465|FG000|Stage 3|Other Miscellaneous Reasons|0|||
48990370|NCT01397409|157798466|FG001|Stage 3|Other Miscellaneous Reasons|0|||
48990371|NCT01397409|157798467|FG002|Stage 3|Other Miscellaneous Reasons|0|||
48990372|NCT01397409|157798468|FG003|Stage 3|Other Miscellaneous Reasons|0|||
48990373|NCT01397409|157798469|FG004|Stage 3|Other Miscellaneous Reasons|0|||
48990374|NCT01397409|157798470|FG005|Stage 3|Other Miscellaneous Reasons|0|||
48990375|NCT01397409|157798471|FG006|Stage 3|Other Miscellaneous Reasons|0|||
48990376|NCT01397409|157798472|FG007|Stage 3|Other Miscellaneous Reasons|1|||
48990377|NCT01397409|157798473|FG008|Stage 3|Other Miscellaneous Reasons|0|||
48990378|NCT01397409|157798474|FG009|Stage 3|Other Miscellaneous Reasons|0|||
48990379|NCT01728454|157798475|FG000|Stage 1 and 2|Pregnancy|1|||
48990380|NCT01728454|157798476|FG001|Stage 1 and 2|Pregnancy|0|||
48990381|NCT01728454|157798477|FG002|Stage 1 and 2|Pregnancy|0|||
48990382|NCT01728454|157798475|FG000|Stage 1 and 2|Non-compliance with Protocol|0|||
48990383|NCT01728454|157798476|FG001|Stage 1 and 2|Non-compliance with Protocol|0|||
48990384|NCT01728454|157798477|FG002|Stage 1 and 2|Non-compliance with Protocol|1|||
48990385|NCT01728454|157798475|FG000|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1|||
48990386|NCT01728454|157798476|FG001|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
48990387|NCT01728454|157798477|FG002|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
48990388|NCT01728454|157798475|FG000|Stage 1 and 2|Lost to Follow-up|1|||
48990389|NCT01728454|157798476|FG001|Stage 1 and 2|Lost to Follow-up|1|||
48990390|NCT01728454|157798477|FG002|Stage 1 and 2|Lost to Follow-up|0|||
48990391|NCT01728454|157798475|FG000|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2|||
48990392|NCT01728454|157798476|FG001|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
48990393|NCT01728454|157798477|FG002|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
48990394|NCT01728454|157798475|FG000|Stage 3|Reason Missing|0|||
48990395|NCT01728454|157798476|FG001|Stage 3|Reason Missing|0|||
48990396|NCT01728454|157798477|FG002|Stage 3|Reason Missing|1|||
48990397|NCT01728454|157798475|FG000|Stage 3|Subject Required Other Treatment|0|||
48990398|NCT01728454|157798476|FG001|Stage 3|Subject Required Other Treatment|1|||
48990399|NCT01728454|157798477|FG002|Stage 3|Subject Required Other Treatment|0|||
48990400|NCT01728454|157798475|FG000|Stage 3|Pregnancy|1|||
48990401|NCT01728454|157798476|FG001|Stage 3|Pregnancy|0|||
48990402|NCT01728454|157798477|FG002|Stage 3|Pregnancy|0|||
48990403|NCT01728454|157798475|FG000|Stage 3|Withdrew Consent|1|||
48990404|NCT01728454|157798476|FG001|Stage 3|Withdrew Consent|0|||
48990405|NCT01728454|157798477|FG002|Stage 3|Withdrew Consent|1|||
48990406|NCT01728454|157798475|FG000|Stage 3|Non-compliance with Protocol|0|||
48990407|NCT01728454|157798476|FG001|Stage 3|Non-compliance with Protocol|0|||
48990408|NCT01728454|157798477|FG002|Stage 3|Non-compliance with Protocol|1|||
48990409|NCT01728454|157798475|FG000|Stage 3|Lost to Follow-up|0|||
48990410|NCT01728454|157798476|FG001|Stage 3|Lost to Follow-up|3|||
48990411|NCT01728454|157798477|FG002|Stage 3|Lost to Follow-up|1|||
48990412|NCT01728454|157798475|FG000|Stage 3|Withdrew due to Adverse Events/Toxicity|1|||
48990413|NCT01728454|157798476|FG001|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
48990414|NCT01728454|157798477|FG002|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
48990415|NCT01298661|157798481|FG000|Overall Study|Withdrawal by Subject|2|||
48990416|NCT01298661|157798482|FG001|Overall Study|Withdrawal by Subject|0|||
48990417|NCT01298661|157798483|FG002|Overall Study|Withdrawal by Subject|2|||
48990418|NCT00027846|157799678|FG000|Overall Study|Lost to Follow-up|0|||
48990419|NCT00027846|157799679|FG001|Overall Study|Lost to Follow-up|41|||
48990420|NCT00027846|157799680|FG002|Overall Study|Lost to Follow-up|9|||
48990421|NCT00027846|157799678|FG000|Overall Study|Withdrawal by Subject|0|||
48990422|NCT00027846|157799679|FG001|Overall Study|Withdrawal by Subject|14|||
48990423|NCT00027846|157799680|FG002|Overall Study|Withdrawal by Subject|7|||
48990424|NCT00027846|157799678|FG000|Overall Study|Ineligible for study|2|||
48990425|NCT00027846|157799679|FG001|Overall Study|Ineligible for study|6|||
48990426|NCT00027846|157799680|FG002|Overall Study|Ineligible for study|14|||
48990427|NCT00027846|157799678|FG000|Overall Study|Entry into another COG therapeutic study|0|||
48990428|NCT00027846|157799679|FG001|Overall Study|Entry into another COG therapeutic study|5|||
48990429|NCT00027846|157799680|FG002|Overall Study|Entry into another COG therapeutic study|2|||
48990430|NCT00027846|157799678|FG000|Overall Study|Neuraxis dissemination during/after ther|0|||
48990431|NCT00027846|157799679|FG001|Overall Study|Neuraxis dissemination during/after ther|2|||
48990432|NCT00027846|157799680|FG002|Overall Study|Neuraxis dissemination during/after ther|5|||
48990433|NCT01078389|157799681|FG000|Overall Study|Adverse Event|10|||
48990434|NCT01078389|157799682|FG001|Overall Study|Adverse Event|6|||
48990435|NCT01078389|157799681|FG000|Overall Study|Major Protocol Deviation|2|||
48990436|NCT01078389|157799682|FG001|Overall Study|Major Protocol Deviation|0|||
48990437|NCT01078389|157799681|FG000|Overall Study|Lost to Follow-up|23|||
48990438|NCT01078389|157799682|FG001|Overall Study|Lost to Follow-up|23|||
48990439|NCT01078389|157799681|FG000|Overall Study|Voluntary Withdrawal|20|||
48990440|NCT01078389|157799682|FG001|Overall Study|Voluntary Withdrawal|36|||
48990441|NCT01078389|157799681|FG000|Overall Study|Other|9|||
48990442|NCT01078389|157799682|FG001|Overall Study|Other|2|||
48990443|NCT00027027|157799683|FG000|Overall Study|Adverse Event|0|||
48990444|NCT00027027|157799684|FG001|Overall Study|Adverse Event|0|||
48990445|NCT00027027|157799685|FG002|Overall Study|Adverse Event|1|||
48990446|NCT00027027|157799686|FG003|Overall Study|Adverse Event|0|||
48990447|NCT00027027|157799687|FG004|Overall Study|Adverse Event|1|||
48990448|NCT00027027|157799683|FG000|Overall Study|Admitted for Signs of PD|0|||
48990449|NCT00027027|157799684|FG001|Overall Study|Admitted for Signs of PD|0|||
48990450|NCT00027027|157799685|FG002|Overall Study|Admitted for Signs of PD|0|||
48990451|NCT00027027|157799686|FG003|Overall Study|Admitted for Signs of PD|0|||
48990452|NCT00027027|157799687|FG004|Overall Study|Admitted for Signs of PD|1|||
48990453|NCT00027027|157799683|FG000|Overall Study|Clinical Symptoms Progression not PD|1|||
48990454|NCT00027027|157799684|FG001|Overall Study|Clinical Symptoms Progression not PD|0|||
48990455|NCT00027027|157799685|FG002|Overall Study|Clinical Symptoms Progression not PD|0|||
48990456|NCT00027027|157799686|FG003|Overall Study|Clinical Symptoms Progression not PD|0|||
48990457|NCT00027027|157799687|FG004|Overall Study|Clinical Symptoms Progression not PD|0|||
48990458|NCT00027027|157799683|FG000|Overall Study|PD Requiring Surgery|0|||
48990459|NCT00027027|157799684|FG001|Overall Study|PD Requiring Surgery|0|||
48990460|NCT00027027|157799685|FG002|Overall Study|PD Requiring Surgery|1|||
48990461|NCT00027027|157799686|FG003|Overall Study|PD Requiring Surgery|0|||
48990462|NCT00027027|157799687|FG004|Overall Study|PD Requiring Surgery|0|||
48990463|NCT00027027|157799683|FG000|Overall Study|Physician Decision Due To PD|2|||
48990464|NCT00027027|157799684|FG001|Overall Study|Physician Decision Due To PD|3|||
48990465|NCT00027027|157799685|FG002|Overall Study|Physician Decision Due To PD|2|||
48990466|NCT00027027|157799686|FG003|Overall Study|Physician Decision Due To PD|3|||
48990467|NCT00027027|157799687|FG004|Overall Study|Physician Decision Due To PD|5|||
48990468|NCT00027027|157799683|FG000|Overall Study|Withdrawal by Subject|0|||
48990469|NCT00027027|157799684|FG001|Overall Study|Withdrawal by Subject|0|||
48990470|NCT00027027|157799685|FG002|Overall Study|Withdrawal by Subject|0|||
48990471|NCT00027027|157799686|FG003|Overall Study|Withdrawal by Subject|0|||
48990472|NCT00027027|157799687|FG004|Overall Study|Withdrawal by Subject|1|||
48990473|NCT00134563|157799696|FG000|Overall Study|Not treated due to protocol violation|0|||
48990474|NCT00134563|157799697|FG001|Overall Study|Not treated due to protocol violation|1|||
48990475|NCT00134563|157799698|FG002|Overall Study|Not treated due to protocol violation|1|||
48990476|NCT00134563|157799696|FG000|Overall Study|Adverse Event|29|||
48990477|NCT00134563|157799697|FG001|Overall Study|Adverse Event|37|||
48990478|NCT00134563|157799698|FG002|Overall Study|Adverse Event|38|||
48990479|NCT00134563|157799696|FG000|Overall Study|Lack of Efficacy|24|||
48990480|NCT00134563|157799697|FG001|Overall Study|Lack of Efficacy|14|||
48990481|NCT00134563|157799698|FG002|Overall Study|Lack of Efficacy|17|||
48990482|NCT00134563|157799696|FG000|Overall Study|Protocol Violation|3|||
48990483|NCT00134563|157799697|FG001|Overall Study|Protocol Violation|2|||
48990484|NCT00134563|157799698|FG002|Overall Study|Protocol Violation|5|||
48990485|NCT00134563|157799696|FG000|Overall Study|Lost to Follow-up|4|||
48990486|NCT00134563|157799697|FG001|Overall Study|Lost to Follow-up|0|||
48990487|NCT00134563|157799698|FG002|Overall Study|Lost to Follow-up|2|||
48990488|NCT00134563|157799696|FG000|Overall Study|progressive disease|11|||
48990489|NCT00134563|157799697|FG001|Overall Study|progressive disease|4|||
48990490|NCT00134563|157799698|FG002|Overall Study|progressive disease|2|||
48990491|NCT00134563|157799696|FG000|Overall Study|did not wish to continue|33|||
48990492|NCT00134563|157799697|FG001|Overall Study|did not wish to continue|32|||
48990493|NCT00134563|157799698|FG002|Overall Study|did not wish to continue|26|||
48990494|NCT00134563|157799696|FG000|Overall Study|Reason other than above|0|||
48990495|NCT00134563|157799697|FG001|Overall Study|Reason other than above|2|||
48990496|NCT00134563|157799698|FG002|Overall Study|Reason other than above|5|||
48990497|NCT00577382|157799702|FG000|Overall Study|Adverse Event|0|||
48990498|NCT00577382|157799703|FG001|Overall Study|Adverse Event|6|||
48990499|NCT00577382|157799702|FG000|Overall Study|Withdrawal by Subject|0|||
48990500|NCT00577382|157799703|FG001|Overall Study|Withdrawal by Subject|1|||
48990501|NCT00577382|157799702|FG000|Overall Study|Progressive Disease|17|||
48990502|NCT00577382|157799703|FG001|Overall Study|Progressive Disease|19|||
48990503|NCT00577382|157799702|FG000|Overall Study|Intercurrent Illness|1|||
48990504|NCT00577382|157799703|FG001|Overall Study|Intercurrent Illness|2|||
48990505|NCT00577382|157799702|FG000|Overall Study|Death|1|||
48990506|NCT00577382|157799703|FG001|Overall Study|Death|1|||
48990507|NCT00577382|157799702|FG000|Overall Study|Lost to Follow-up|2|||
48990508|NCT00577382|157799703|FG001|Overall Study|Lost to Follow-up|2|||
48990509|NCT00505765|157799706|FG000|Overall Study|Withdrawal by Subject|1|||
48990510|NCT00505765|157799707|FG001|Overall Study|Withdrawal by Subject|0|||
48990511|NCT00505765|157799708|FG002|Overall Study|Withdrawal by Subject|0|||
48990512|NCT00505765|157799706|FG000|Overall Study|Adverse Event|1|||
48990513|NCT00505765|157799707|FG001|Overall Study|Adverse Event|2|||
48990514|NCT00505765|157799708|FG002|Overall Study|Adverse Event|0|||
48990515|NCT00505765|157799706|FG000|Overall Study|Noncompliance|0|||
48990516|NCT00505765|157799707|FG001|Overall Study|Noncompliance|1|||
48990517|NCT00505765|157799708|FG002|Overall Study|Noncompliance|3|||
48990518|NCT00561795|157799712|FG000|Overall Study|Adverse Event|3|||
48990519|NCT00561795|157799713|FG001|Overall Study|Adverse Event|3|||
48990520|NCT00561795|157799714|FG002|Overall Study|Adverse Event|0|||
48990521|NCT00561795|157799715|FG003|Overall Study|Adverse Event|0|||
48990522|NCT00561795|157799712|FG000|Overall Study|Study Closed/Terminated|0|||
48990523|NCT00561795|157799713|FG001|Overall Study|Study Closed/Terminated|3|||
48990524|NCT00561795|157799714|FG002|Overall Study|Study Closed/Terminated|0|||
48990525|NCT00561795|157799715|FG003|Overall Study|Study Closed/Terminated|0|||
48990526|NCT00561795|157799712|FG000|Overall Study|Physician Decision|1|||
48990527|NCT00561795|157799713|FG001|Overall Study|Physician Decision|0|||
48990528|NCT00561795|157799714|FG002|Overall Study|Physician Decision|0|||
48990529|NCT00561795|157799715|FG003|Overall Study|Physician Decision|0|||
48990530|NCT02898662|157799717|FG000|Overall Study|Adverse Event|1|||
48990531|NCT02898662|157799718|FG001|Overall Study|Adverse Event|0|||
48990532|NCT02898662|157799717|FG000|Overall Study|Loss of asthma control|23|||
48990533|NCT02898662|157799718|FG001|Overall Study|Loss of asthma control|24|||
48990534|NCT02898662|157799717|FG000|Overall Study|Withdrawal by Subject|4|||
48990535|NCT02898662|157799718|FG001|Overall Study|Withdrawal by Subject|1|||
48990536|NCT02898662|157799717|FG000|Overall Study|Technical issue|0|||
48990537|NCT02898662|157799718|FG001|Overall Study|Technical issue|1|||
48990538|NCT02898662|157799717|FG000|Overall Study|Randomized in error|0|||
48990539|NCT02898662|157799718|FG001|Overall Study|Randomized in error|1|||
48990540|NCT02898662|157799717|FG000|Overall Study|Subject decision|1|||
48990541|NCT02898662|157799718|FG001|Overall Study|Subject decision|0|||
48990542|NCT02898662|157799717|FG000|Overall Study|Other|0|||
48990543|NCT02898662|157799718|FG001|Overall Study|Other|1|||
48990544|NCT03802331|157799719|FG000|Treatment Period 1 (P1) + Washout|Adverse Event|1|||
48990545|NCT03802331|157799720|FG001|Treatment Period 1 (P1) + Washout|Adverse Event|0|||
48990546|NCT01014442|157799721|FG000|Overall Study|Adverse Event|0|||
48990547|NCT01014442|157799722|FG001|Overall Study|Adverse Event|8|||
48990548|NCT01014442|157799721|FG000|Overall Study|Withdrawal by Subject|4|||
48990549|NCT01014442|157799722|FG001|Overall Study|Withdrawal by Subject|4|||
48990550|NCT01014442|157799721|FG000|Overall Study|Protocol Violation|2|||
48990551|NCT01014442|157799722|FG001|Overall Study|Protocol Violation|5|||
48990552|NCT01014442|157799721|FG000|Overall Study|Lack of Compliance|0|||
48990553|NCT01014442|157799722|FG001|Overall Study|Lack of Compliance|1|||
48990554|NCT01014442|157799721|FG000|Overall Study|Unspecified Reason|1|||
48990555|NCT01014442|157799722|FG001|Overall Study|Unspecified Reason|1|||
48990556|NCT00504595|157799724|FG000|Overall Study|Lack of Efficacy|1|||
48990557|NCT00504595|157799725|FG001|Overall Study|Lack of Efficacy|0|||
48990558|NCT00504595|157799726|FG002|Overall Study|Lack of Efficacy|0|||
48990559|NCT00504595|157799727|FG003|Overall Study|Lack of Efficacy|0|||
48990560|NCT00504595|157799724|FG000|Overall Study|Other|0|||
48990561|NCT00504595|157799725|FG001|Overall Study|Other|0|||
49044654|NCT02043678|157996912|FG001|Overall Study|Clinical PD|148|||
49044655|NCT02043678|157996911|FG000|Overall Study|Radiological PD|100|||
49044656|NCT02043678|157996912|FG001|Overall Study|Radiological PD|90|||
49044657|NCT02043678|157996911|FG000|Overall Study|Protocol-driven decision point|59|||
49044658|NCT02043678|157996912|FG001|Overall Study|Protocol-driven decision point|58|||
49044659|NCT02043678|157996911|FG000|Overall Study|Withdrawal by Subject|16|||
49044660|NCT02043678|157996912|FG001|Overall Study|Withdrawal by Subject|20|||
49044661|NCT02043678|157996911|FG000|Overall Study|Protocol Violation|1|||
49044662|NCT02043678|157996912|FG001|Overall Study|Protocol Violation|0|||
49044663|NCT02043678|157996911|FG000|Overall Study|Deterioration of general conditions|1|||
49044664|NCT02043678|157996912|FG001|Overall Study|Deterioration of general conditions|1|||
49044665|NCT02043678|157996911|FG000|Overall Study|Logistical difficulties|2|||
49044666|NCT02043678|157996912|FG001|Overall Study|Logistical difficulties|0|||
49044667|NCT02043678|157996911|FG000|Overall Study|Non-compliance with study drug|3|||
49044668|NCT02043678|157996912|FG001|Overall Study|Non-compliance with study drug|1|||
49044669|NCT02043678|157996911|FG000|Overall Study|Physician Decision|4|||
49044670|NCT02043678|157996912|FG001|Overall Study|Physician Decision|3|||
49044671|NCT02043678|157996911|FG000|Overall Study|Subject decision|0|||
49044672|NCT02043678|157996912|FG001|Overall Study|Subject decision|1|||
49044673|NCT02043678|157996911|FG000|Overall Study|Switching to other therapy|3|||
49044674|NCT02043678|157996912|FG001|Overall Study|Switching to other therapy|2|||
49044675|NCT02043678|157996911|FG000|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
49044676|NCT02043678|157996912|FG001|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
49044677|NCT02043678|157996911|FG000|Overall Study|Missing|1|||
48990562|NCT00504595|157799726|FG002|Overall Study|Other|2|||
48990563|NCT00504595|157799727|FG003|Overall Study|Other|0|||
48990564|NCT00764465|157799734|FG000|Overall Study|Adverse Event|2|||
48990565|NCT00764465|157799735|FG001|Overall Study|Adverse Event|0|||
48990566|NCT00764465|157799736|FG002|Overall Study|Adverse Event|0|||
48990567|NCT00764465|157799737|FG003|Overall Study|Adverse Event|1|||
48990568|NCT00764465|157799738|FG004|Overall Study|Adverse Event|1|||
48990569|NCT00764465|157799739|FG005|Overall Study|Adverse Event|1|||
49044678|NCT02043678|157996912|FG001|Overall Study|Missing|0|||
49044679|NCT02043678|157996911|FG000|Overall Study|Adverse Event|0|||
49044680|NCT02043678|157996912|FG001|Overall Study|Adverse Event|1|||
49044681|NCT03652389|157996913|FG000|Overall Study|Lost to Follow-up|1|||
48990570|NCT00764465|157799734|FG000|Overall Study|Withdrawal by Subject|0|||
48990571|NCT00764465|157799735|FG001|Overall Study|Withdrawal by Subject|1|||
48990572|NCT00764465|157799736|FG002|Overall Study|Withdrawal by Subject|1|||
48990573|NCT00764465|157799737|FG003|Overall Study|Withdrawal by Subject|0|||
48990574|NCT00764465|157799738|FG004|Overall Study|Withdrawal by Subject|0|||
48990575|NCT00764465|157799739|FG005|Overall Study|Withdrawal by Subject|0|||
48990576|NCT00496782|157799743|FG000|Overall Study|Protocol Violation|1|||
48990577|NCT00496782|157799744|FG001|Overall Study|Protocol Violation|2|||
48990578|NCT00323479|157799752|FG000|Overall Study|Adverse Event|2|||
48990579|NCT00323479|157799752|FG000|Overall Study|Withdrawal by Subject|2|||
48990580|NCT00323479|157799752|FG000|Overall Study|Protocol Violation|3|||
48990581|NCT00323479|157799752|FG000|Overall Study|house moving|1|||
48990582|NCT02828982|157799753|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
48990583|NCT02828982|157799754|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
48990584|NCT00372905|157799756|FG000|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2|||
48990585|NCT00372905|157799757|FG001|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
48990586|NCT00372905|157799758|FG002|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
48990587|NCT00372905|157799759|FG003|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
48990588|NCT00372905|157799756|FG000|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
48990589|NCT00372905|157799757|FG001|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
48990590|NCT00372905|157799758|FG002|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2|||
48990591|NCT00372905|157799759|FG003|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
48990592|NCT00372905|157799756|FG000|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
48990593|NCT00372905|157799757|FG001|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
48990594|NCT00372905|157799758|FG002|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1|||
48990595|NCT00372905|157799759|FG003|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
48990596|NCT00372905|157799756|FG000|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
48990597|NCT00372905|157799757|FG001|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
48990598|NCT00372905|157799758|FG002|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
48990599|NCT00372905|157799759|FG003|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2|||
48990600|NCT00372905|157799756|FG000|Follow up Until Relapse or Progression|Study closed|0|||
48990601|NCT00372905|157799757|FG001|Follow up Until Relapse or Progression|Study closed|0|||
48990602|NCT00372905|157799758|FG002|Follow up Until Relapse or Progression|Study closed|0|||
48990603|NCT00372905|157799759|FG003|Follow up Until Relapse or Progression|Study closed|3|||
48990604|NCT00372905|157799756|FG000|Follow up Until Relapse or Progression|Other|0|||
48990605|NCT00372905|157799757|FG001|Follow up Until Relapse or Progression|Other|1|||
48990606|NCT00372905|157799758|FG002|Follow up Until Relapse or Progression|Other|0|||
48990607|NCT00372905|157799759|FG003|Follow up Until Relapse or Progression|Other|0|||
48990608|NCT01883362|157799760|FG000|Treatment|Adverse Event|1|||
48990609|NCT01883362|157799761|FG001|Treatment|Adverse Event|8|||
48990610|NCT01883362|157799760|FG000|Treatment|Withdrawal by Subject|6|||
48990611|NCT01883362|157799761|FG001|Treatment|Withdrawal by Subject|2|||
48990612|NCT01883362|157799760|FG000|Treatment|Administrative problems|4|||
48990613|NCT01883362|157799761|FG001|Treatment|Administrative problems|1|||
48990614|NCT01883362|157799760|FG000|Treatment|Relapse|4|||
48990615|NCT01883362|157799761|FG001|Treatment|Relapse|2|||
48990616|NCT01883362|157799760|FG000|Treatment|Randomized, not treated|1|||
48990617|NCT01883362|157799761|FG001|Treatment|Randomized, not treated|1|||
48990618|NCT01883362|157799760|FG000|Post Treatment Follow-up|Protocol Violation|0|||
48990619|NCT01883362|157799761|FG001|Post Treatment Follow-up|Protocol Violation|1|||
48990620|NCT01883362|157799760|FG000|Post Treatment Follow-up|Withdrawal by Subject|4|||
48990621|NCT01883362|157799761|FG001|Post Treatment Follow-up|Withdrawal by Subject|3|||
48990622|NCT01883362|157799760|FG000|Post Treatment Follow-up|Lost to Follow-up|1|||
48990623|NCT01883362|157799761|FG001|Post Treatment Follow-up|Lost to Follow-up|4|||
48990624|NCT01883362|157799760|FG000|Post Treatment Follow-up|Administrative problems|2|||
48990625|NCT01883362|157799761|FG001|Post Treatment Follow-up|Administrative problems|0|||
48990626|NCT01883362|157799760|FG000|Post Treatment Follow-up|Death|8|||
48990627|NCT01883362|157799761|FG001|Post Treatment Follow-up|Death|4|||
48990628|NCT01883362|157799760|FG000|Post Treatment Follow-up|Relapse|1|||
48990629|NCT01883362|157799761|FG001|Post Treatment Follow-up|Relapse|2|||
48990630|NCT01349816|157799764|FG000|Overall Study|Withdrawal by Subject|4|||
48990631|NCT01349816|157799764|FG000|Overall Study|Physician Decision|1|||
48990632|NCT01349816|157799764|FG000|Overall Study|Adverse Event|14|||
48990633|NCT01349816|157799764|FG000|Overall Study|Lost to Follow-up|2|||
48990634|NCT01349816|157799764|FG000|Overall Study|Protocol Violation|1|||
48990635|NCT01349816|157799764|FG000|Overall Study|Protocol-specified criteria|8|||
48990636|NCT02569996|157799765|FG000|Overall Study|Adverse Event|6|||
48990637|NCT02569996|157799765|FG000|Overall Study|Physician Decision|3|||
48990638|NCT02569996|157799765|FG000|Overall Study|Progression of the disease|18|||
48990639|NCT02569996|157799765|FG000|Overall Study|New anti-lymphoma treatment|1|||
48990640|NCT02569996|157799765|FG000|Overall Study|Non-compliance|9|||
48990641|NCT02569996|157799765|FG000|Overall Study|Withdrawal by Subject|5|||
48990642|NCT02569996|157799765|FG000|Overall Study|Lost to Follow-up|5|||
48990643|NCT02569996|157799765|FG000|Overall Study|Complete remission|7|||
48990644|NCT02569996|157799765|FG000|Overall Study|Unknown reason|1|||
48990645|NCT01383317|157799766|FG000|Overall Study|Lost to Follow-up|2|||
48990646|NCT01383317|157799767|FG001|Overall Study|Lost to Follow-up|1|||
48990647|NCT01383317|157799766|FG000|Overall Study|Death|1|||
49044682|NCT03652389|157996914|FG001|Overall Study|Lost to Follow-up|5|||
49044683|NCT03652389|157996913|FG000|Overall Study|Withdrawal by Subject|5|||
49044684|NCT03652389|157996914|FG001|Overall Study|Withdrawal by Subject|1|||
49044685|NCT03652389|157996913|FG000|Overall Study|New diagnosis|2|||
49044686|NCT03652389|157996914|FG001|Overall Study|New diagnosis|0|||
49044687|NCT03625167|157996917|FG000|Overall Study|Protocol Violation|5|||
48990648|NCT01383317|157799767|FG001|Overall Study|Death|0|||
48990649|NCT01383317|157799766|FG000|Overall Study|Adverse Event|0|||
48990650|NCT01383317|157799767|FG001|Overall Study|Adverse Event|1|||
48990651|NCT01377194|157799770|FG000|Overall Study|Adverse Event|3|||
48990652|NCT01377194|157799771|FG001|Overall Study|Adverse Event|12|||
48990653|NCT01377194|157799772|FG002|Overall Study|Adverse Event|19|||
48990654|NCT01377194|157799770|FG000|Overall Study|Lack of Efficacy|3|||
48990655|NCT01377194|157799771|FG001|Overall Study|Lack of Efficacy|3|||
48990656|NCT01377194|157799772|FG002|Overall Study|Lack of Efficacy|3|||
48990657|NCT01377194|157799770|FG000|Overall Study|Protocol Violation|4|||
48990658|NCT01377194|157799771|FG001|Overall Study|Protocol Violation|10|||
48990659|NCT01377194|157799772|FG002|Overall Study|Protocol Violation|6|||
48990660|NCT01377194|157799770|FG000|Overall Study|Withdrawal by Subject|8|||
48990661|NCT01377194|157799771|FG001|Overall Study|Withdrawal by Subject|10|||
48990662|NCT01377194|157799772|FG002|Overall Study|Withdrawal by Subject|7|||
48990663|NCT01377194|157799770|FG000|Overall Study|Lost to Follow-up|14|||
48990664|NCT01377194|157799771|FG001|Overall Study|Lost to Follow-up|8|||
48990665|NCT01377194|157799772|FG002|Overall Study|Lost to Follow-up|11|||
48990666|NCT00422227|157799773|FG000|Overall Study|Adverse Event|3|||
48990667|NCT00422227|157799774|FG001|Overall Study|Adverse Event|8|||
48990668|NCT00422227|157799773|FG000|Overall Study|Lost to Follow-up|1|||
48990669|NCT00422227|157799774|FG001|Overall Study|Lost to Follow-up|3|||
48990670|NCT00422227|157799773|FG000|Overall Study|Withdrawal by Subject|0|||
48990671|NCT00422227|157799774|FG001|Overall Study|Withdrawal by Subject|4|||
48990672|NCT01207427|157799775|FG000|Double-blind Treatment Period|Adverse Event|0|||
48990673|NCT01207427|157799776|FG001|Double-blind Treatment Period|Adverse Event|1|||
48990674|NCT01207427|157799777|FG002|Double-blind Treatment Period|Adverse Event|0|||
48990675|NCT01207427|157799775|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
48990676|NCT01207427|157799776|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
48990677|NCT01207427|157799777|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
48990678|NCT01207427|157799775|FG000|Double-blind Treatment Period|Protocol Violation|2|||
48990679|NCT01207427|157799776|FG001|Double-blind Treatment Period|Protocol Violation|1|||
48990680|NCT01207427|157799777|FG002|Double-blind Treatment Period|Protocol Violation|1|||
48990681|NCT01207427|157799775|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
48990682|NCT01207427|157799776|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
48990683|NCT01207427|157799777|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
48990684|NCT03418727|157799778|FG000|Overall Study|Adverse Event|1|||
48990685|NCT03418727|157799779|FG001|Overall Study|Adverse Event|2|||
48990686|NCT03418727|157799780|FG002|Overall Study|Adverse Event|0|||
48990687|NCT03418727|157799778|FG000|Overall Study|Withdrawal by Subject|0|||
48990688|NCT03418727|157799779|FG001|Overall Study|Withdrawal by Subject|0|||
48990689|NCT03418727|157799780|FG002|Overall Study|Withdrawal by Subject|2|||
48990690|NCT01756846|157799784|FG000|Overall Study|Lost to Follow-up|5|||
48990691|NCT01756846|157799785|FG001|Overall Study|Lost to Follow-up|10|||
48990692|NCT01756846|157799784|FG000|Overall Study|Withdrawal by Subject|1|||
48990693|NCT01756846|157799785|FG001|Overall Study|Withdrawal by Subject|2|||
48990694|NCT01230489|157799786|FG000|Overall Study|Death|2|||
48990695|NCT01230489|157799786|FG000|Overall Study|Adverse Event|2|||
48990696|NCT01230489|157799786|FG000|Overall Study|Treatment modality changed|1|||
48990697|NCT00686894|157799787|FG000|Overall Study|Relapse|2|||
48990698|NCT00686894|157799787|FG000|Overall Study|Protocol Violation|4|||
49044688|NCT04314713|157996918|FG000|Overall Study|Lost to Follow-up|0|||
49044689|NCT04314713|157996919|FG001|Overall Study|Lost to Follow-up|0|||
49044690|NCT04314713|157996920|FG002|Overall Study|Lost to Follow-up|0|||
49044691|NCT04314713|157996921|FG003|Overall Study|Lost to Follow-up|1|||
49044692|NCT04314713|157996922|FG004|Overall Study|Lost to Follow-up|0|||
48990699|NCT01791543|157799788|FG000|Overall Study|Lost to Follow-up|1|||
48990700|NCT01791543|157799788|FG000|Overall Study|Adverse Event|1|||
48990701|NCT03145207|157799789|FG000|Overall Study|volunteer started taking allergy shots|1|||
48990702|NCT03145207|157799789|FG000|Overall Study|baseline blood pressure high|1|||
48990703|NCT00486720|157799790|FG000|Overall Study|Adverse Event|1|||
48990704|NCT00486720|157799791|FG001|Overall Study|Adverse Event|2|||
48990705|NCT00486720|157799790|FG000|Overall Study|Lack of Efficacy|4|||
48990706|NCT00486720|157799791|FG001|Overall Study|Lack of Efficacy|6|||
48990707|NCT00486720|157799790|FG000|Overall Study|Physician Decision|1|||
48990708|NCT00486720|157799791|FG001|Overall Study|Physician Decision|2|||
48990709|NCT00486720|157799790|FG000|Overall Study|Protocol Violation|1|||
49044693|NCT04314713|157996923|FG005|Overall Study|Lost to Follow-up|0|||
48990710|NCT00486720|157799791|FG001|Overall Study|Protocol Violation|0|||
48990711|NCT00486720|157799790|FG000|Overall Study|Withdrawal by Subject|3|||
48990712|NCT00486720|157799791|FG001|Overall Study|Withdrawal by Subject|1|||
48990713|NCT00486720|157799790|FG000|Overall Study|Progressive Disease|0|||
48990714|NCT00486720|157799791|FG001|Overall Study|Progressive Disease|1|||
48990715|NCT01728194|157799796|FG000|Overall Study|Lost to Follow-up|4|||
48990716|NCT01728194|157799797|FG001|Overall Study|Lost to Follow-up|3|||
48990717|NCT01728194|157799796|FG000|Overall Study|Physician Decision|4|||
48990718|NCT01728194|157799797|FG001|Overall Study|Physician Decision|0|||
48990719|NCT01728194|157799796|FG000|Overall Study|Withdrawal by Subject|7|||
48990720|NCT01728194|157799797|FG001|Overall Study|Withdrawal by Subject|3|||
48990721|NCT01728194|157799796|FG000|Overall Study|Perceived Medication Side Effects|4|||
48990722|NCT01728194|157799797|FG001|Overall Study|Perceived Medication Side Effects|0|||
48990723|NCT01728194|157799796|FG000|Overall Study|Family Member Request|1|||
48990724|NCT01728194|157799797|FG001|Overall Study|Family Member Request|0|||
48990725|NCT03188991|157799798|FG000|Overall Study|Withdrawal by Subject|0|||
48990726|NCT03188991|157799799|FG001|Overall Study|Withdrawal by Subject|0|||
48990727|NCT03188991|157799800|FG002|Overall Study|Withdrawal by Subject|0|||
48990728|NCT03188991|157799801|FG003|Overall Study|Withdrawal by Subject|1|||
48990729|NCT01977573|157799810|FG000|Overall Study|Adverse Event|7|||
48990730|NCT01977573|157799811|FG001|Overall Study|Adverse Event|0|||
48990731|NCT01977573|157799812|FG002|Overall Study|Adverse Event|2|||
48990732|NCT01977573|157799813|FG003|Overall Study|Adverse Event|1|||
48990733|NCT01977573|157799810|FG000|Overall Study|Lost to Follow-up|1|||
48990734|NCT01977573|157799811|FG001|Overall Study|Lost to Follow-up|0|||
48990735|NCT01977573|157799812|FG002|Overall Study|Lost to Follow-up|0|||
48990736|NCT01977573|157799813|FG003|Overall Study|Lost to Follow-up|1|||
48990737|NCT01977573|157799810|FG000|Overall Study|Physician Decision|1|||
49044694|NCT05029622|157996924|FG000|Overall Study|Lost to Follow-up|1|||
49044695|NCT04909801|157996925|FG000|Overall Study|Lack of Efficacy|2|||
49044696|NCT04909801|157996926|FG001|Overall Study|Lack of Efficacy|1|||
49044697|NCT04909801|157996925|FG000|Overall Study|Adverse Event|1|||
49044698|NCT04909801|157996926|FG001|Overall Study|Adverse Event|2|||
49044699|NCT04909801|157996925|FG000|Overall Study|Participant request to discontinue study treatment|1|||
49044700|NCT04909801|157996926|FG001|Overall Study|Participant request to discontinue study treatment|2|||
49044701|NCT04909801|157996925|FG000|Overall Study|Withdrawal by Subject|2|||
49044702|NCT04909801|157996926|FG001|Overall Study|Withdrawal by Subject|1|||
49044703|NCT04909801|157996925|FG000|Overall Study|other reasons|1|||
49044704|NCT04909801|157996926|FG001|Overall Study|other reasons|1|||
49044705|NCT04158141|157996927|FG000|Step 1: Registration|Does not meet requirements for Step 2|1|||
49044706|NCT04158141|157996928|FG001|Step 1: Registration|Does not meet requirements for Step 2|0|||
49044707|NCT04158141|157996929|FG002|Step 1: Registration|Does not meet requirements for Step 2|0|||
48990738|NCT01977573|157799811|FG001|Overall Study|Physician Decision|0|||
48990739|NCT01977573|157799812|FG002|Overall Study|Physician Decision|0|||
48990740|NCT01977573|157799813|FG003|Overall Study|Physician Decision|0|||
48990741|NCT01977573|157799810|FG000|Overall Study|Protocol Violation|3|||
48990742|NCT01977573|157799811|FG001|Overall Study|Protocol Violation|1|||
48990743|NCT01977573|157799812|FG002|Overall Study|Protocol Violation|0|||
48990744|NCT01977573|157799813|FG003|Overall Study|Protocol Violation|0|||
48990745|NCT01977573|157799810|FG000|Overall Study|Reached Defined Stopping Criteria|2|||
48990746|NCT01977573|157799811|FG001|Overall Study|Reached Defined Stopping Criteria|1|||
48990747|NCT01977573|157799812|FG002|Overall Study|Reached Defined Stopping Criteria|1|||
48990748|NCT01977573|157799813|FG003|Overall Study|Reached Defined Stopping Criteria|0|||
48990749|NCT01977573|157799810|FG000|Overall Study|Withdrawal by Subject|6|||
48990750|NCT01977573|157799811|FG001|Overall Study|Withdrawal by Subject|1|||
48990751|NCT01977573|157799812|FG002|Overall Study|Withdrawal by Subject|1|||
48990752|NCT01977573|157799813|FG003|Overall Study|Withdrawal by Subject|1|||
48990753|NCT02390167|157801533|FG000|Overall Study|Lost to Follow-up|1|||
48990754|NCT01084096|157801534|FG000|Overall Study|Lost to Follow-up|1501|||
48990755|NCT01084096|157801535|FG001|Overall Study|Lost to Follow-up|1833|||
48990756|NCT01084096|157801534|FG000|Overall Study|Withdrawal by Subject|3|||
48990757|NCT01084096|157801535|FG001|Overall Study|Withdrawal by Subject|0|||
49044708|NCT04158141|157996927|FG000|Step 1: Registration|Adverse Event|1|||
49044709|NCT04158141|157996928|FG001|Step 1: Registration|Adverse Event|0|||
49044710|NCT04158141|157996929|FG002|Step 1: Registration|Adverse Event|0|||
49044711|NCT04158141|157996927|FG000|Step 1: Registration|Withdrawal by Subject|1|||
49044712|NCT04158141|157996928|FG001|Step 1: Registration|Withdrawal by Subject|0|||
48990758|NCT01084096|157801534|FG000|Overall Study|Woman had a miscarriage|21|||
48990759|NCT01084096|157801535|FG001|Overall Study|Woman had a miscarriage|17|||
48990760|NCT02033369|157801537|FG000|Overall Study|Physician Decision|1|||
48990761|NCT02033369|157801538|FG001|Overall Study|Physician Decision|2|||
48990762|NCT02033369|157801537|FG000|Overall Study|Not a good demographic match|0|||
48990763|NCT02033369|157801538|FG001|Overall Study|Not a good demographic match|2|||
48990764|NCT02033369|157801537|FG000|Overall Study|Withdrawal by Subject|1|||
49044713|NCT04158141|157996929|FG002|Step 1: Registration|Withdrawal by Subject|0|||
49044714|NCT04158141|157996927|FG000|Step 1: Registration|Study terminated immediately after patient enrolled|2|||
49044715|NCT04158141|157996928|FG001|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
49044716|NCT04158141|157996929|FG002|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
49044717|NCT04295759|157996930|FG000|Overall Study|Lack of Efficacy|9|||
49044718|NCT04295759|157996930|FG000|Overall Study|Death|1|||
49044719|NCT04295759|157996930|FG000|Overall Study|Withdrawal by Subject|2|||
49044720|NCT04295759|157996930|FG000|Overall Study|Deemed ineligible|1|||
49044721|NCT03386578|157996931|FG000|PK Component|Lost to Follow-up|0|||
49044722|NCT03386578|157996932|FG001|PK Component|Lost to Follow-up|1|||
48990765|NCT02033369|157801538|FG001|Overall Study|Withdrawal by Subject|1|||
48990766|NCT02033369|157801537|FG000|Overall Study|Lost to Follow-up|1|||
48990767|NCT02033369|157801538|FG001|Overall Study|Lost to Follow-up|0|||
48990768|NCT02033369|157801537|FG000|Overall Study|Protocol Violation|2|||
48990769|NCT02033369|157801538|FG001|Overall Study|Protocol Violation|0|||
48990770|NCT01503229|157801541|FG000|Overall Study|Withdrew consent|1|||
48990771|NCT01002573|157801542|FG000|Overall Study|Subject did not receive at least 1 dose|11|||
49044723|NCT03386578|157996933|FG002|PK Component|Lost to Follow-up|0|||
49044724|NCT03386578|157996934|FG003|PK Component|Lost to Follow-up|0|||
49044725|NCT03386578|157996935|FG004|PK Component|Lost to Follow-up|0|||
49044726|NCT03386578|157996936|FG005|PK Component|Lost to Follow-up|0|||
49044727|NCT03386578|157996937|FG006|PK Component|Lost to Follow-up|1|||
49044728|NCT03386578|157996938|FG007|PK Component|Lost to Follow-up|0|||
49044729|NCT03386578|157996939|FG008|PK Component|Lost to Follow-up|0|||
49044730|NCT03386578|157996940|FG009|PK Component|Lost to Follow-up|0|||
49044731|NCT03386578|157996931|FG000|PK Component|Stillbirth/Abortion|0|||
49044732|NCT03386578|157996932|FG001|PK Component|Stillbirth/Abortion|0|||
49044733|NCT03386578|157996933|FG002|PK Component|Stillbirth/Abortion|0|||
49044734|NCT03386578|157996934|FG003|PK Component|Stillbirth/Abortion|0|||
49044735|NCT03386578|157996935|FG004|PK Component|Stillbirth/Abortion|0|||
49044736|NCT03386578|157996936|FG005|PK Component|Stillbirth/Abortion|2|||
49044737|NCT03386578|157996937|FG006|PK Component|Stillbirth/Abortion|0|||
49044738|NCT03386578|157996938|FG007|PK Component|Stillbirth/Abortion|0|||
49044739|NCT03386578|157996939|FG008|PK Component|Stillbirth/Abortion|0|||
49044740|NCT03386578|157996940|FG009|PK Component|Stillbirth/Abortion|0|||
49044741|NCT03386578|157996931|FG000|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
49044742|NCT03386578|157996932|FG001|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
49044743|NCT03386578|157996933|FG002|PrEP Comparison Component Step 1|Lost to Follow-up|17|||
49044744|NCT03386578|157996934|FG003|PrEP Comparison Component Step 1|Lost to Follow-up|9|||
49044745|NCT03386578|157996935|FG004|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
49044746|NCT03386578|157996936|FG005|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
49044747|NCT03386578|157996937|FG006|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
49044748|NCT03386578|157996938|FG007|PrEP Comparison Component Step 1|Lost to Follow-up|7|||
49044749|NCT03386578|157996939|FG008|PrEP Comparison Component Step 1|Lost to Follow-up|5|||
49044750|NCT03386578|157996940|FG009|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
49044751|NCT03386578|157996931|FG000|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
49044752|NCT03386578|157996932|FG001|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
49044753|NCT03386578|157996933|FG002|PrEP Comparison Component Step 1|Withdrawal by Subject|9|||
49044754|NCT03386578|157996934|FG003|PrEP Comparison Component Step 1|Withdrawal by Subject|4|||
49044755|NCT03386578|157996935|FG004|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
49044756|NCT03386578|157996936|FG005|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
49044757|NCT03386578|157996937|FG006|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
49044758|NCT03386578|157996938|FG007|PrEP Comparison Component Step 1|Withdrawal by Subject|5|||
49044759|NCT03386578|157996939|FG008|PrEP Comparison Component Step 1|Withdrawal by Subject|1|||
49044760|NCT03386578|157996940|FG009|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
49044761|NCT03386578|157996931|FG000|PrEP Comparison Component Step 1|Death|0|||
49044762|NCT03386578|157996932|FG001|PrEP Comparison Component Step 1|Death|0|||
49044763|NCT03386578|157996933|FG002|PrEP Comparison Component Step 1|Death|1|||
49044764|NCT03386578|157996934|FG003|PrEP Comparison Component Step 1|Death|0|||
49044765|NCT03386578|157996935|FG004|PrEP Comparison Component Step 1|Death|0|||
49044766|NCT03386578|157996936|FG005|PrEP Comparison Component Step 1|Death|0|||
49044767|NCT03386578|157996937|FG006|PrEP Comparison Component Step 1|Death|0|||
49044768|NCT03386578|157996938|FG007|PrEP Comparison Component Step 1|Death|9|||
48990772|NCT01002573|157801543|FG001|Overall Study|Subject did not receive at least 1 dose|7|||
48990773|NCT01354964|157801545|FG000|Overall Study|Lost to Follow-up|2|||
48990774|NCT01354964|157801546|FG001|Overall Study|Lost to Follow-up|0|||
48990775|NCT01354964|157801545|FG000|Overall Study|IV access issues|1|||
48990776|NCT01354964|157801546|FG001|Overall Study|IV access issues|1|||
49044769|NCT03386578|157996939|FG008|PrEP Comparison Component Step 1|Death|5|||
48990777|NCT01354964|157801545|FG000|Overall Study|Physician Decision|1|||
49044770|NCT03386578|157996940|FG009|PrEP Comparison Component Step 1|Death|0|||
49044771|NCT03386578|157996931|FG000|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
49044772|NCT03386578|157996932|FG001|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
49044773|NCT03386578|157996933|FG002|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
49044774|NCT03386578|157996934|FG003|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
49044775|NCT03386578|157996935|FG004|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
49044776|NCT03386578|157996936|FG005|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
49044777|NCT03386578|157996937|FG006|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
49044778|NCT03386578|157996938|FG007|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
49044779|NCT03386578|157996939|FG008|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
49044780|NCT03386578|157996940|FG009|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
49044781|NCT03386578|157996931|FG000|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
49044782|NCT03386578|157996932|FG001|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
49044783|NCT03386578|157996933|FG002|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
49044784|NCT03386578|157996934|FG003|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
49044785|NCT03386578|157996935|FG004|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
49044786|NCT03386578|157996936|FG005|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
49044787|NCT03386578|157996937|FG006|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
49044788|NCT03386578|157996938|FG007|PrEP Comparison Component Step 1|Stillbirth/Abortion|2|||
49044789|NCT03386578|157996939|FG008|PrEP Comparison Component Step 1|Stillbirth/Abortion|4|||
49044790|NCT03386578|157996940|FG009|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
49044791|NCT03386578|157996931|FG000|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
49044792|NCT03386578|157996932|FG001|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
49044793|NCT03386578|157996933|FG002|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
48990778|NCT01354964|157801546|FG001|Overall Study|Physician Decision|0|||
48990779|NCT03726320|157801547|FG000|Overall Study|Lost to Follow-up|2|||
48990780|NCT03726320|157801548|FG001|Overall Study|Lost to Follow-up|4|||
48990781|NCT03726320|157801549|FG002|Overall Study|Lost to Follow-up|0|||
48990782|NCT03726320|157801547|FG000|Overall Study|Time Constraints|4|||
48990783|NCT03726320|157801548|FG001|Overall Study|Time Constraints|1|||
48990784|NCT03726320|157801549|FG002|Overall Study|Time Constraints|0|||
48990785|NCT03726320|157801547|FG000|Overall Study|Ineligible after enrollment|3|||
48990786|NCT03726320|157801548|FG001|Overall Study|Ineligible after enrollment|3|||
48990787|NCT03726320|157801549|FG002|Overall Study|Ineligible after enrollment|0|||
48990788|NCT03726320|157801547|FG000|Overall Study|Clinic / insurance issue|2|||
48990789|NCT03726320|157801548|FG001|Overall Study|Clinic / insurance issue|0|||
48990790|NCT03726320|157801549|FG002|Overall Study|Clinic / insurance issue|0|||
48990791|NCT03726320|157801547|FG000|Overall Study|Language barrier|1|||
48990792|NCT03726320|157801548|FG001|Overall Study|Language barrier|0|||
48990793|NCT03726320|157801549|FG002|Overall Study|Language barrier|0|||
48990794|NCT03726320|157801547|FG000|Overall Study|Provider left the clinic|0|||
48990795|NCT03726320|157801548|FG001|Overall Study|Provider left the clinic|0|||
48990796|NCT03726320|157801549|FG002|Overall Study|Provider left the clinic|1|||
48990797|NCT00690612|157801550|FG000|Overall Study|Adverse Event|1|||
48990798|NCT00690612|157801550|FG000|Overall Study|Withdrawal by Subject|2|||
48990799|NCT01855919|157801551|FG000|Overall Study|Adverse Event|16|||
48990800|NCT01855919|157801552|FG001|Overall Study|Adverse Event|8|||
48990801|NCT01855919|157801551|FG000|Overall Study|Lack of Efficacy|1|||
48990802|NCT01855919|157801552|FG001|Overall Study|Lack of Efficacy|3|||
48990803|NCT01855919|157801551|FG000|Overall Study|Withdrawal by Subject|4|||
48990804|NCT01855919|157801552|FG001|Overall Study|Withdrawal by Subject|10|||
48990805|NCT01855919|157801551|FG000|Overall Study|Entry Criteria Not Met|1|||
48990806|NCT01855919|157801552|FG001|Overall Study|Entry Criteria Not Met|1|||
48990807|NCT01855919|157801551|FG000|Overall Study|Protocol Violation|1|||
48990808|NCT01855919|157801552|FG001|Overall Study|Protocol Violation|4|||
48990809|NCT05604781|157801553|FG000|Overall Study|Lost to Follow-up|3|||
48990810|NCT05604781|157801553|FG000|Overall Study|Adverse Event|1|||
48990811|NCT00724243|157801561|FG000|Overall Study|Lack of Efficacy|10|||
48990812|NCT00724243|157801561|FG000|Overall Study|Adverse Event|5|||
48990813|NCT00532441|157801564|FG000|Overall Study|Death|1|||
48990814|NCT00532441|157801565|FG001|Overall Study|Death|0|||
48990815|NCT01967134|157801566|FG000|Overall Study|Lost to Follow-up|0|||
48990816|NCT01967134|157801567|FG001|Overall Study|Lost to Follow-up|1|||
48990817|NCT01967134|157801568|FG002|Overall Study|Lost to Follow-up|0|||
48990818|NCT01928758|157801569|FG000|Overall Study|Lost to Follow-up|14|||
48990819|NCT01928758|157801570|FG001|Overall Study|Lost to Follow-up|9|||
48990820|NCT01928758|157801569|FG000|Overall Study|Withdrawal by Subject|5|||
48990821|NCT01928758|157801570|FG001|Overall Study|Withdrawal by Subject|2|||
48990822|NCT01928758|157801569|FG000|Overall Study|Adverse Event|3|||
48990823|NCT01928758|157801570|FG001|Overall Study|Adverse Event|5|||
48990824|NCT01928758|157801569|FG000|Overall Study|Protocol Violation|3|||
48990825|NCT01928758|157801570|FG001|Overall Study|Protocol Violation|4|||
48990826|NCT03633461|157801573|FG000|Overall Study|Lost to Follow-up|0|||
48990827|NCT03633461|157801574|FG001|Overall Study|Lost to Follow-up|1|||
48990828|NCT02681094|157801578|FG000|1 -Modified Enrolled Participants Set|Participant decision|7|||
48990829|NCT02681094|157801579|FG001|1 -Modified Enrolled Participants Set|Participant decision|10|||
48990830|NCT02681094|157801580|FG002|1 -Modified Enrolled Participants Set|Participant decision|9|||
49044794|NCT03386578|157996934|FG003|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
48990831|NCT02681094|157801578|FG000|1 -Modified Enrolled Participants Set|Adverse Event|10|||
48990832|NCT02681094|157801579|FG001|1 -Modified Enrolled Participants Set|Adverse Event|4|||
48990833|NCT02681094|157801580|FG002|1 -Modified Enrolled Participants Set|Adverse Event|1|||
48990834|NCT02681094|157801578|FG000|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2|||
48990835|NCT02681094|157801579|FG001|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0|||
48990836|NCT02681094|157801580|FG002|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1|||
48990837|NCT02681094|157801578|FG000|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1|||
48990838|NCT02681094|157801579|FG001|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5|||
48990839|NCT02681094|157801580|FG002|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14|||
48990840|NCT02681094|157801578|FG000|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11|||
48990841|NCT02681094|157801579|FG001|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13|||
48990842|NCT02681094|157801580|FG002|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20|||
48990843|NCT02681094|157801578|FG000|1 -Modified Enrolled Participants Set|Other|6|||
48990844|NCT02681094|157801579|FG001|1 -Modified Enrolled Participants Set|Other|6|||
48990845|NCT02681094|157801580|FG002|1 -Modified Enrolled Participants Set|Other|7|||
48990846|NCT02681094|157801578|FG000|1 -Modified Enrolled Participants Set|No treatment given|0|||
48990847|NCT02681094|157801579|FG001|1 -Modified Enrolled Participants Set|No treatment given|1|||
48990848|NCT02681094|157801580|FG002|1 -Modified Enrolled Participants Set|No treatment given|1|||
48990849|NCT02681094|157801578|FG000|2 - Enrolled Participants Set|Participant decision|7|||
48990850|NCT02681094|157801579|FG001|2 - Enrolled Participants Set|Participant decision|10|||
48990851|NCT02681094|157801580|FG002|2 - Enrolled Participants Set|Participant decision|9|||
48990852|NCT02681094|157801578|FG000|2 - Enrolled Participants Set|Adverse Event|10|||
48990853|NCT02681094|157801579|FG001|2 - Enrolled Participants Set|Adverse Event|4|||
48990854|NCT02681094|157801580|FG002|2 - Enrolled Participants Set|Adverse Event|1|||
48990855|NCT02681094|157801578|FG000|2 - Enrolled Participants Set|Severe non-compliance to protocol|2|||
48990856|NCT02681094|157801579|FG001|2 - Enrolled Participants Set|Severe non-compliance to protocol|0|||
48990857|NCT02681094|157801580|FG002|2 - Enrolled Participants Set|Severe non-compliance to protocol|1|||
48990858|NCT02681094|157801578|FG000|2 - Enrolled Participants Set|Lack of therapeutic response|1|||
48990859|NCT02681094|157801579|FG001|2 - Enrolled Participants Set|Lack of therapeutic response|5|||
48990860|NCT02681094|157801580|FG002|2 - Enrolled Participants Set|Lack of therapeutic response|14|||
48990861|NCT02681094|157801578|FG000|2 - Enrolled Participants Set|Study specific discontinuation criteria|14|||
48990862|NCT02681094|157801579|FG001|2 - Enrolled Participants Set|Study specific discontinuation criteria|15|||
48990863|NCT02681094|157801580|FG002|2 - Enrolled Participants Set|Study specific discontinuation criteria|21|||
48990864|NCT02681094|157801578|FG000|2 - Enrolled Participants Set|Other|6|||
48990865|NCT02681094|157801579|FG001|2 - Enrolled Participants Set|Other|6|||
48990866|NCT02681094|157801580|FG002|2 - Enrolled Participants Set|Other|7|||
48990867|NCT02681094|157801578|FG000|2 - Enrolled Participants Set|No treatment given|0|||
48990868|NCT02681094|157801579|FG001|2 - Enrolled Participants Set|No treatment given|1|||
48990869|NCT02681094|157801580|FG002|2 - Enrolled Participants Set|No treatment given|1|||
48990870|NCT00561912|157801581|FG000|Overall Study|ineligible|1|||
48990871|NCT01270139|157801584|FG000|Overall Study|Adverse Event|8|||
48990872|NCT01270139|157801585|FG001|Overall Study|Adverse Event|17|||
48990873|NCT01270139|157801586|FG002|Overall Study|Adverse Event|18|||
48990874|NCT01270139|157801584|FG000|Overall Study|Lost to Follow-up|10|||
48990875|NCT01270139|157801585|FG001|Overall Study|Lost to Follow-up|9|||
48990876|NCT01270139|157801586|FG002|Overall Study|Lost to Follow-up|2|||
48990877|NCT04576702|157801587|FG000|Overall Study|Death|1|||
48990878|NCT04576702|157801588|FG001|Overall Study|Death|0|||
48990879|NCT04576702|157801589|FG002|Overall Study|Death|0|||
48990880|NCT04576702|157801590|FG003|Overall Study|Death|0|||
48990881|NCT04576702|157801587|FG000|Overall Study|Withdrawal by Subject|0|||
48990882|NCT04576702|157801588|FG001|Overall Study|Withdrawal by Subject|2|||
48990883|NCT04576702|157801589|FG002|Overall Study|Withdrawal by Subject|1|||
48990884|NCT04576702|157801590|FG003|Overall Study|Withdrawal by Subject|0|||
48990885|NCT04576702|157801587|FG000|Overall Study|Lost to Follow-up|3|||
48990886|NCT04576702|157801588|FG001|Overall Study|Lost to Follow-up|3|||
48990887|NCT04576702|157801589|FG002|Overall Study|Lost to Follow-up|3|||
48990888|NCT04576702|157801590|FG003|Overall Study|Lost to Follow-up|4|||
48990889|NCT03198559|157801596|FG000|Overall Study|Adverse Event|2|||
48990890|NCT01072175|157801597|FG000|Part A (Drug-Drug Interaction)|Death|1|||
48990891|NCT01072175|157801598|FG001|Part A (Drug-Drug Interaction)|Death|0|||
48990892|NCT01072175|157801599|FG002|Part A (Drug-Drug Interaction)|Death|0|||
48990893|NCT01072175|157801600|FG003|Part A (Drug-Drug Interaction)|Death|0|||
48990894|NCT01072175|157801601|FG004|Part A (Drug-Drug Interaction)|Death|0|||
48990895|NCT01072175|157801602|FG005|Part A (Drug-Drug Interaction)|Death|0|||
48990896|NCT01072175|157801603|FG006|Part A (Drug-Drug Interaction)|Death|0|||
48990897|NCT01072175|157801604|FG007|Part A (Drug-Drug Interaction)|Death|0|||
48990898|NCT01072175|157801605|FG008|Part A (Drug-Drug Interaction)|Death|0|||
48990899|NCT01072175|157801606|FG009|Part A (Drug-Drug Interaction)|Death|0|||
48990900|NCT01072175|157801607|FG010|Part A (Drug-Drug Interaction)|Death|0|||
48990901|NCT01072175|157801608|FG011|Part A (Drug-Drug Interaction)|Death|0|||
48990902|NCT01072175|157801609|FG012|Part A (Drug-Drug Interaction)|Death|0|||
48990903|NCT01072175|157801597|FG000|Part A (Drug-Drug Interaction)|Physician Decision|6|||
48990904|NCT01072175|157801598|FG001|Part A (Drug-Drug Interaction)|Physician Decision|0|||
48990905|NCT01072175|157801599|FG002|Part A (Drug-Drug Interaction)|Physician Decision|0|||
48990906|NCT01072175|157801600|FG003|Part A (Drug-Drug Interaction)|Physician Decision|0|||
48990907|NCT01072175|157801601|FG004|Part A (Drug-Drug Interaction)|Physician Decision|0|||
48990908|NCT01072175|157801602|FG005|Part A (Drug-Drug Interaction)|Physician Decision|0|||
48990909|NCT01072175|157801603|FG006|Part A (Drug-Drug Interaction)|Physician Decision|0|||
48990910|NCT01072175|157801604|FG007|Part A (Drug-Drug Interaction)|Physician Decision|0|||
48990911|NCT01072175|157801605|FG008|Part A (Drug-Drug Interaction)|Physician Decision|0|||
48990912|NCT01072175|157801606|FG009|Part A (Drug-Drug Interaction)|Physician Decision|0|||
48990913|NCT01072175|157801607|FG010|Part A (Drug-Drug Interaction)|Physician Decision|0|||
48990914|NCT01072175|157801608|FG011|Part A (Drug-Drug Interaction)|Physician Decision|0|||
48990915|NCT01072175|157801609|FG012|Part A (Drug-Drug Interaction)|Physician Decision|0|||
48990916|NCT01072175|157801597|FG000|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1|||
48990917|NCT01072175|157801598|FG001|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
48990918|NCT01072175|157801599|FG002|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
48990919|NCT01072175|157801600|FG003|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
48990920|NCT01072175|157801601|FG004|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
48990921|NCT01072175|157801602|FG005|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
48990922|NCT01072175|157801603|FG006|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
48990923|NCT01072175|157801604|FG007|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
48990924|NCT01072175|157801605|FG008|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
48990925|NCT01072175|157801606|FG009|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
48990926|NCT01072175|157801607|FG010|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
48990927|NCT01072175|157801608|FG011|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
48990928|NCT01072175|157801609|FG012|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
48990929|NCT01072175|157801597|FG000|Part B (Dose Escalation and Expansion)|Death|0|||
48990930|NCT01072175|157801598|FG001|Part B (Dose Escalation and Expansion)|Death|4|||
48990931|NCT01072175|157801599|FG002|Part B (Dose Escalation and Expansion)|Death|18|||
48990932|NCT01072175|157801600|FG003|Part B (Dose Escalation and Expansion)|Death|21|||
48990933|NCT01072175|157801601|FG004|Part B (Dose Escalation and Expansion)|Death|68|||
48990934|NCT01072175|157801602|FG005|Part B (Dose Escalation and Expansion)|Death|0|||
48990935|NCT01072175|157801603|FG006|Part B (Dose Escalation and Expansion)|Death|0|||
48990936|NCT01072175|157801604|FG007|Part B (Dose Escalation and Expansion)|Death|0|||
48990937|NCT01072175|157801605|FG008|Part B (Dose Escalation and Expansion)|Death|0|||
48990938|NCT01072175|157801606|FG009|Part B (Dose Escalation and Expansion)|Death|0|||
48990939|NCT01072175|157801607|FG010|Part B (Dose Escalation and Expansion)|Death|0|||
48990940|NCT01072175|157801608|FG011|Part B (Dose Escalation and Expansion)|Death|0|||
48990941|NCT01072175|157801609|FG012|Part B (Dose Escalation and Expansion)|Death|0|||
48990942|NCT01072175|157801597|FG000|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
48990943|NCT01072175|157801598|FG001|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
48990944|NCT01072175|157801599|FG002|Part B (Dose Escalation and Expansion)|Physician Decision|2|||
48990945|NCT01072175|157801600|FG003|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
48990946|NCT01072175|157801601|FG004|Part B (Dose Escalation and Expansion)|Physician Decision|4|||
48990947|NCT01072175|157801602|FG005|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
48990948|NCT01072175|157801603|FG006|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
48990949|NCT01072175|157801604|FG007|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
48990950|NCT01072175|157801605|FG008|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
48990951|NCT01072175|157801606|FG009|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
48990952|NCT01072175|157801607|FG010|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
48990953|NCT01072175|157801608|FG011|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
48990954|NCT01072175|157801609|FG012|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
48990955|NCT01072175|157801597|FG000|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
48990956|NCT01072175|157801598|FG001|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
48990957|NCT01072175|157801599|FG002|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
48990958|NCT01072175|157801600|FG003|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
48990959|NCT01072175|157801601|FG004|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6|||
48990960|NCT01072175|157801602|FG005|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
48990961|NCT01072175|157801603|FG006|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
48990962|NCT01072175|157801604|FG007|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
48990963|NCT01072175|157801605|FG008|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
48990964|NCT01072175|157801606|FG009|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
48990965|NCT01072175|157801607|FG010|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
48990966|NCT01072175|157801608|FG011|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
48990967|NCT01072175|157801609|FG012|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
49044795|NCT03386578|157996935|FG004|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
49044796|NCT03386578|157996936|FG005|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
49044797|NCT03386578|157996937|FG006|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
49044798|NCT03386578|157996938|FG007|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|10|||
49044799|NCT03386578|157996939|FG008|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|5|||
49044800|NCT03386578|157996940|FG009|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
49044801|NCT01005745|157996941|FG000|Overall Study|No TIL growth|1|||
49044802|NCT01005745|157996941|FG000|Overall Study|Disease progressed during TIL growth|3|||
49044803|NCT01005745|157996941|FG000|Overall Study|Death prior to treatment|1|||
49044804|NCT01005745|157996941|FG000|Overall Study|Inappropriate antidiuretic hormone|1|||
49044805|NCT03513302|157996942|FG000|First Intervention (14 Days)|Screen failure|15|||
49044806|NCT03513302|157996943|FG001|First Intervention (14 Days)|Screen failure|16|||
49044807|NCT02970318|157996944|FG000|Overall for Arm A & Main for Arm B|Lost to Follow-up|2|||
49044808|NCT02970318|157996945|FG001|Overall for Arm A & Main for Arm B|Lost to Follow-up|1|||
49044809|NCT02970318|157996946|FG002|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
49044810|NCT02970318|157996947|FG003|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
48692559|NCT04630262|156724526|FG000|Overall Study|Intraoperative Screen Failure|5|||
48692560|NCT04630262|156724526|FG000|Overall Study|Study terminated prematurely|71|||
48990968|NCT01072175|157801597|FG000|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
48990969|NCT01072175|157801598|FG001|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
48990970|NCT01072175|157801599|FG002|Part B (Dose Escalation and Expansion)|Study closed/terminated|3|||
48990971|NCT01072175|157801600|FG003|Part B (Dose Escalation and Expansion)|Study closed/terminated|2|||
48990972|NCT01072175|157801601|FG004|Part B (Dose Escalation and Expansion)|Study closed/terminated|10|||
48990973|NCT01072175|157801602|FG005|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
48692561|NCT04630262|156724526|FG000|Overall Study|Withdrawal by Subject|2|||
48692562|NCT04630262|156724526|FG000|Overall Study|Physician Decision|2|||
48692563|NCT05101486|156724527|FG000|Overall Study|Death|1|||
48990974|NCT01072175|157801603|FG006|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
48990975|NCT01072175|157801604|FG007|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
48990976|NCT01072175|157801605|FG008|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
48990977|NCT01072175|157801606|FG009|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
48990978|NCT01072175|157801607|FG010|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
48990979|NCT01072175|157801608|FG011|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
48990980|NCT01072175|157801609|FG012|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
48990981|NCT01072175|157801597|FG000|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
48990982|NCT01072175|157801598|FG001|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1|||
48990983|NCT01072175|157801599|FG002|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
48990984|NCT01072175|157801600|FG003|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3|||
48990985|NCT01072175|157801601|FG004|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6|||
48990986|NCT01072175|157801602|FG005|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
48990987|NCT01072175|157801603|FG006|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
48990988|NCT01072175|157801604|FG007|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
48990989|NCT01072175|157801605|FG008|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
48990990|NCT01072175|157801606|FG009|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
48990991|NCT01072175|157801607|FG010|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
48990992|NCT01072175|157801608|FG011|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
48990993|NCT01072175|157801609|FG012|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
48990994|NCT01072175|157801597|FG000|Part C (Phase II: Randomized Phase)|Death|0|||
48990995|NCT01072175|157801598|FG001|Part C (Phase II: Randomized Phase)|Death|0|||
48990996|NCT01072175|157801599|FG002|Part C (Phase II: Randomized Phase)|Death|0|||
48990997|NCT01072175|157801600|FG003|Part C (Phase II: Randomized Phase)|Death|0|||
48990998|NCT01072175|157801601|FG004|Part C (Phase II: Randomized Phase)|Death|0|||
48990999|NCT01072175|157801602|FG005|Part C (Phase II: Randomized Phase)|Death|44|||
48991000|NCT01072175|157801603|FG006|Part C (Phase II: Randomized Phase)|Death|34|||
48991001|NCT01072175|157801604|FG007|Part C (Phase II: Randomized Phase)|Death|39|||
48991002|NCT01072175|157801605|FG008|Part C (Phase II: Randomized Phase)|Death|0|||
48991003|NCT01072175|157801606|FG009|Part C (Phase II: Randomized Phase)|Death|0|||
48991004|NCT01072175|157801607|FG010|Part C (Phase II: Randomized Phase)|Death|0|||
48991005|NCT01072175|157801608|FG011|Part C (Phase II: Randomized Phase)|Death|0|||
48991006|NCT01072175|157801609|FG012|Part C (Phase II: Randomized Phase)|Death|0|||
48991007|NCT01072175|157801597|FG000|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
48991008|NCT01072175|157801598|FG001|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
48991009|NCT01072175|157801599|FG002|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
48991010|NCT01072175|157801600|FG003|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
48692564|NCT05101486|156724528|FG001|Overall Study|Death|0|||
48692565|NCT05101486|156724529|FG002|Overall Study|Death|1|||
48692566|NCT05101486|156724527|FG000|Overall Study|Lost to Follow-up|12|||
48692567|NCT05101486|156724528|FG001|Overall Study|Lost to Follow-up|8|||
48692568|NCT05101486|156724529|FG002|Overall Study|Lost to Follow-up|17|||
48692569|NCT05101486|156724527|FG000|Overall Study|Physician Decision|1|||
48692570|NCT05101486|156724528|FG001|Overall Study|Physician Decision|0|||
48692571|NCT05101486|156724529|FG002|Overall Study|Physician Decision|0|||
48692572|NCT05101486|156724527|FG000|Overall Study|Protocol Violation|0|||
48692573|NCT05101486|156724528|FG001|Overall Study|Protocol Violation|0|||
48692574|NCT05101486|156724529|FG002|Overall Study|Protocol Violation|1|||
48692575|NCT05101486|156724527|FG000|Overall Study|Withdrawal by Subject|5|||
48692576|NCT05101486|156724528|FG001|Overall Study|Withdrawal by Subject|2|||
48692577|NCT05101486|156724529|FG002|Overall Study|Withdrawal by Subject|4|||
48692578|NCT05101486|156724527|FG000|Overall Study|Randomized but not vaccinated|1|||
48692579|NCT05101486|156724528|FG001|Overall Study|Randomized but not vaccinated|1|||
48692580|NCT05101486|156724529|FG002|Overall Study|Randomized but not vaccinated|1|||
48692581|NCT04349891|156724531|FG000|First Intervention - 4 Weeks|Withdrawal by Subject|3|||
48692582|NCT04349891|156724532|FG001|First Intervention - 4 Weeks|Withdrawal by Subject|4|||
48692583|NCT04349891|156724531|FG000|First Intervention - 4 Weeks|Adverse Event|1|||
48692584|NCT04349891|156724532|FG001|First Intervention - 4 Weeks|Adverse Event|1|||
48692585|NCT04349891|156724531|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
48692586|NCT04349891|156724532|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
48692587|NCT04349891|156724531|FG000|Second Intervention - 4 Weeks|Withdrawal by Subject|2|||
48692588|NCT04349891|156724532|FG001|Second Intervention - 4 Weeks|Withdrawal by Subject|0|||
48692589|NCT02727699|156724533|FG000|Overall Study|Adverse Event|2|||
48692590|NCT02727699|156724534|FG001|Overall Study|Adverse Event|0|||
48692591|NCT02727699|156724533|FG000|Overall Study|Withdrawal by Subject|5|||
48692592|NCT02727699|156724534|FG001|Overall Study|Withdrawal by Subject|3|||
48991011|NCT01072175|157801601|FG004|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
48991012|NCT01072175|157801602|FG005|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
48991013|NCT01072175|157801603|FG006|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
48991014|NCT01072175|157801604|FG007|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
48991015|NCT01072175|157801605|FG008|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
49044811|NCT02970318|157996944|FG000|Overall for Arm A & Main for Arm B|Withdrawal by Subject|13|||
49044812|NCT02970318|157996945|FG001|Overall for Arm A & Main for Arm B|Withdrawal by Subject|14|||
49044813|NCT02970318|157996946|FG002|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
49044814|NCT02970318|157996947|FG003|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
49044815|NCT02970318|157996944|FG000|Overall for Arm A & Main for Arm B|Death|41|||
49044816|NCT02970318|157996945|FG001|Overall for Arm A & Main for Arm B|Death|33|||
49044817|NCT02970318|157996946|FG002|Overall for Arm A & Main for Arm B|Death|0|||
49044818|NCT02970318|157996947|FG003|Overall for Arm A & Main for Arm B|Death|0|||
49044819|NCT02970318|157996944|FG000|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
49044820|NCT02970318|157996945|FG001|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|80|||
49044821|NCT02970318|157996946|FG002|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
48991016|NCT01072175|157801606|FG009|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
48991017|NCT01072175|157801607|FG010|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
48991018|NCT01072175|157801608|FG011|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
48991019|NCT01072175|157801609|FG012|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
48991020|NCT01072175|157801597|FG000|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
48991021|NCT01072175|157801598|FG001|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
48991022|NCT01072175|157801599|FG002|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
48991023|NCT01072175|157801600|FG003|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
48991024|NCT01072175|157801601|FG004|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
48991025|NCT01072175|157801602|FG005|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
48991026|NCT01072175|157801603|FG006|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
48991027|NCT01072175|157801604|FG007|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
48991028|NCT01072175|157801605|FG008|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
48991029|NCT01072175|157801606|FG009|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
49044822|NCT02970318|157996947|FG003|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
49044823|NCT02970318|157996944|FG000|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
49044824|NCT02970318|157996945|FG001|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
49044825|NCT02970318|157996946|FG002|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|2|||
49044826|NCT02970318|157996947|FG003|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
49044827|NCT02970318|157996944|FG000|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
49044828|NCT02970318|157996945|FG001|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
49044829|NCT02970318|157996946|FG002|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
48692593|NCT02727699|156724533|FG000|Overall Study|Protocol Violation|0|||
48692594|NCT02727699|156724534|FG001|Overall Study|Protocol Violation|1|||
48692595|NCT02727699|156724533|FG000|Overall Study|Physician Decision|0|||
49044830|NCT02970318|157996947|FG003|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
49044831|NCT02970318|157996944|FG000|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
49044832|NCT02970318|157996945|FG001|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
49044833|NCT02970318|157996946|FG002|ArmB: Inv.Choice Crossed Over to Acala|Death|18|||
49044834|NCT02970318|157996947|FG003|ArmB: Inv.Choice Crossed Over to Acala|Death|2|||
49044835|NCT00530348|157996949|FG000|Overall Study|Adverse Event|5|||
49044836|NCT00530348|157996950|FG001|Overall Study|Adverse Event|1|||
49044837|NCT00530348|157996949|FG000|Overall Study|Death|0|||
49044838|NCT00530348|157996950|FG001|Overall Study|Death|1|||
49044839|NCT00530348|157996949|FG000|Overall Study|Lack of Efficacy|2|||
49044840|NCT00530348|157996950|FG001|Overall Study|Lack of Efficacy|0|||
49044841|NCT00530348|157996949|FG000|Overall Study|Lost to Follow-up|0|||
49044842|NCT00530348|157996950|FG001|Overall Study|Lost to Follow-up|2|||
49044843|NCT00530348|157996949|FG000|Overall Study|Physician Decision|1|||
49044844|NCT00530348|157996950|FG001|Overall Study|Physician Decision|2|||
49044845|NCT00530348|157996949|FG000|Overall Study|Pregnancy|1|||
49044846|NCT00530348|157996950|FG001|Overall Study|Pregnancy|0|||
49044847|NCT00530348|157996949|FG000|Overall Study|Withdrawal by Subject|12|||
49044848|NCT00530348|157996950|FG001|Overall Study|Withdrawal by Subject|12|||
49044849|NCT00530348|157996949|FG000|Overall Study|Randomised in error|1|||
49044850|NCT00530348|157996950|FG001|Overall Study|Randomised in error|0|||
49044851|NCT00530348|157996949|FG000|Overall Study|Noncompliance with inclusion criterion 3|0|||
49044852|NCT00530348|157996950|FG001|Overall Study|Noncompliance with inclusion criterion 3|1|||
49044853|NCT01091363|157996951|FG000|Overall Study|Withdrawal by Subject|11|||
49044854|NCT01091363|157996952|FG001|Overall Study|Withdrawal by Subject|15|||
49044855|NCT01091363|157996951|FG000|Overall Study|Lost to Follow-up|2|||
49044856|NCT01091363|157996952|FG001|Overall Study|Lost to Follow-up|2|||
49044857|NCT02000115|157996953|FG000|Overall Study|Death|56|||
49044858|NCT02000115|157996954|FG001|Overall Study|Death|45|||
49044859|NCT02000115|157996955|FG002|Overall Study|Death|0|||
49044860|NCT02000115|157996956|FG003|Overall Study|Death|0|||
49044861|NCT02000115|157996953|FG000|Overall Study|Missed Visit|6|||
49044862|NCT02000115|157996954|FG001|Overall Study|Missed Visit|8|||
49044863|NCT02000115|157996955|FG002|Overall Study|Missed Visit|1|||
49044864|NCT02000115|157996956|FG003|Overall Study|Missed Visit|0|||
49044865|NCT02000115|157996953|FG000|Overall Study|Protocol Violation|2|||
49044866|NCT02000115|157996954|FG001|Overall Study|Protocol Violation|1|||
49044867|NCT02000115|157996955|FG002|Overall Study|Protocol Violation|0|||
49044868|NCT02000115|157996956|FG003|Overall Study|Protocol Violation|0|||
49044869|NCT02000115|157996953|FG000|Overall Study|Physician Decision|2|||
49044870|NCT02000115|157996954|FG001|Overall Study|Physician Decision|0|||
49044871|NCT02000115|157996955|FG002|Overall Study|Physician Decision|0|||
49044872|NCT02000115|157996956|FG003|Overall Study|Physician Decision|0|||
49044873|NCT02000115|157996953|FG000|Overall Study|Withdrawal by Subject|11|||
49044874|NCT02000115|157996954|FG001|Overall Study|Withdrawal by Subject|11|||
49044875|NCT02000115|157996955|FG002|Overall Study|Withdrawal by Subject|0|||
49044876|NCT02000115|157996956|FG003|Overall Study|Withdrawal by Subject|0|||
49044877|NCT02000115|157996953|FG000|Overall Study|Lost to Follow-up|0|||
49044878|NCT02000115|157996954|FG001|Overall Study|Lost to Follow-up|1|||
49044879|NCT02000115|157996955|FG002|Overall Study|Lost to Follow-up|0|||
49044880|NCT02000115|157996956|FG003|Overall Study|Lost to Follow-up|0|||
49044881|NCT02000115|157996953|FG000|Overall Study|Non-compliance|2|||
49044882|NCT02000115|157996954|FG001|Overall Study|Non-compliance|1|||
49044883|NCT02000115|157996955|FG002|Overall Study|Non-compliance|0|||
49044884|NCT02000115|157996956|FG003|Overall Study|Non-compliance|0|||
49044885|NCT02000115|157996953|FG000|Overall Study|Withdrawn on day of randomization|0|||
49044886|NCT02000115|157996954|FG001|Overall Study|Withdrawn on day of randomization|1|||
49044887|NCT02000115|157996955|FG002|Overall Study|Withdrawn on day of randomization|0|||
49044888|NCT02000115|157996956|FG003|Overall Study|Withdrawn on day of randomization|0|||
49044889|NCT02000115|157996953|FG000|Overall Study|Still on Study|0|||
49044890|NCT02000115|157996954|FG001|Overall Study|Still on Study|0|||
49044891|NCT02000115|157996955|FG002|Overall Study|Still on Study|0|||
49044892|NCT02000115|157996956|FG003|Overall Study|Still on Study|53|||
49044893|NCT03222856|157996958|FG000|Overall Study|Adverse Event|6|||
49044894|NCT03222856|157996958|FG000|Overall Study|Death|1|||
48692596|NCT02727699|156724534|FG001|Overall Study|Physician Decision|1|||
48692597|NCT02727699|156724533|FG000|Overall Study|Lost to Follow-up|1|||
48692598|NCT02727699|156724534|FG001|Overall Study|Lost to Follow-up|0|||
48692599|NCT02727699|156724533|FG000|Overall Study|Sponsor Decision|1|||
48692600|NCT02727699|156724534|FG001|Overall Study|Sponsor Decision|0|||
48692601|NCT04034251|156724535|FG000|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|1|||
48692602|NCT04034251|156724536|FG001|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
48692603|NCT04034251|156724537|FG002|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
49044895|NCT02208362|157996959|FG000|Overall Study|Participant did not complete treatment|0|||
49044896|NCT02208362|157996960|FG001|Overall Study|Participant did not complete treatment|1|||
49044897|NCT02208362|157996961|FG002|Overall Study|Participant did not complete treatment|0|||
48991030|NCT01072175|157801607|FG010|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
48991031|NCT01072175|157801608|FG011|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
48991032|NCT01072175|157801609|FG012|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
48991033|NCT01072175|157801597|FG000|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
48991034|NCT01072175|157801598|FG001|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
48991035|NCT01072175|157801599|FG002|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
48991036|NCT01072175|157801600|FG003|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
48991037|NCT01072175|157801601|FG004|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
48991038|NCT01072175|157801602|FG005|Part C (Phase II: Randomized Phase)|Study closed/terminated|6|||
48991039|NCT01072175|157801603|FG006|Part C (Phase II: Randomized Phase)|Study closed/terminated|9|||
48991040|NCT01072175|157801604|FG007|Part C (Phase II: Randomized Phase)|Study closed/terminated|11|||
48991041|NCT01072175|157801605|FG008|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
48991042|NCT01072175|157801606|FG009|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
48991043|NCT01072175|157801607|FG010|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
48991044|NCT01072175|157801608|FG011|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
48991045|NCT01072175|157801609|FG012|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
48991046|NCT01072175|157801597|FG000|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
48991047|NCT01072175|157801598|FG001|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
48991048|NCT01072175|157801599|FG002|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
48991049|NCT01072175|157801600|FG003|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
48991050|NCT01072175|157801601|FG004|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
48991051|NCT01072175|157801602|FG005|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3|||
48991052|NCT01072175|157801603|FG006|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7|||
48991053|NCT01072175|157801604|FG007|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
48991054|NCT01072175|157801605|FG008|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
48991055|NCT01072175|157801606|FG009|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
48991056|NCT01072175|157801607|FG010|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
48991057|NCT01072175|157801608|FG011|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
48991058|NCT01072175|157801609|FG012|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
48991059|NCT01072175|157801597|FG000|Part C (Phase II: Crossover Phase [CP])|Death|0|||
48991060|NCT01072175|157801598|FG001|Part C (Phase II: Crossover Phase [CP])|Death|0|||
48991061|NCT01072175|157801599|FG002|Part C (Phase II: Crossover Phase [CP])|Death|0|||
48991062|NCT01072175|157801600|FG003|Part C (Phase II: Crossover Phase [CP])|Death|0|||
48991063|NCT01072175|157801601|FG004|Part C (Phase II: Crossover Phase [CP])|Death|0|||
48991064|NCT01072175|157801602|FG005|Part C (Phase II: Crossover Phase [CP])|Death|0|||
48991065|NCT01072175|157801603|FG006|Part C (Phase II: Crossover Phase [CP])|Death|0|||
48991066|NCT01072175|157801604|FG007|Part C (Phase II: Crossover Phase [CP])|Death|0|||
48991067|NCT01072175|157801605|FG008|Part C (Phase II: Crossover Phase [CP])|Death|37|||
48991068|NCT01072175|157801606|FG009|Part C (Phase II: Crossover Phase [CP])|Death|0|||
48991069|NCT01072175|157801607|FG010|Part C (Phase II: Crossover Phase [CP])|Death|0|||
48991070|NCT01072175|157801608|FG011|Part C (Phase II: Crossover Phase [CP])|Death|0|||
48991071|NCT01072175|157801609|FG012|Part C (Phase II: Crossover Phase [CP])|Death|0|||
48991072|NCT01072175|157801597|FG000|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
48991073|NCT01072175|157801598|FG001|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
48991074|NCT01072175|157801599|FG002|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
48991075|NCT01072175|157801600|FG003|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
48991076|NCT01072175|157801601|FG004|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
48991077|NCT01072175|157801602|FG005|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
48991078|NCT01072175|157801603|FG006|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
48991079|NCT01072175|157801604|FG007|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
48991080|NCT01072175|157801605|FG008|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1|||
48991081|NCT01072175|157801606|FG009|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
48991082|NCT01072175|157801607|FG010|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
48991083|NCT01072175|157801608|FG011|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
48991084|NCT01072175|157801609|FG012|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
48991085|NCT01072175|157801597|FG000|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
48991086|NCT01072175|157801598|FG001|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
48991087|NCT01072175|157801599|FG002|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
48991088|NCT01072175|157801600|FG003|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
48991089|NCT01072175|157801601|FG004|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
48991090|NCT01072175|157801602|FG005|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
48991091|NCT01072175|157801603|FG006|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
48991092|NCT01072175|157801604|FG007|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
48991093|NCT01072175|157801605|FG008|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4|||
48991094|NCT01072175|157801606|FG009|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
48991095|NCT01072175|157801607|FG010|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
48991096|NCT01072175|157801608|FG011|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
48991097|NCT01072175|157801609|FG012|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
48991098|NCT01072175|157801597|FG000|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
48991099|NCT01072175|157801598|FG001|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
48991100|NCT01072175|157801599|FG002|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
48991101|NCT01072175|157801600|FG003|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
48991102|NCT01072175|157801601|FG004|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
48991103|NCT01072175|157801602|FG005|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
48991104|NCT01072175|157801603|FG006|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
48991105|NCT01072175|157801604|FG007|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
48991106|NCT01072175|157801605|FG008|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3|||
48991107|NCT01072175|157801606|FG009|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
48991108|NCT01072175|157801607|FG010|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
48991109|NCT01072175|157801608|FG011|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
48991110|NCT01072175|157801609|FG012|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
48991111|NCT01072175|157801597|FG000|Part D (HPMC Capsules)|Death|0|||
48991112|NCT01072175|157801598|FG001|Part D (HPMC Capsules)|Death|0|||
48991113|NCT01072175|157801599|FG002|Part D (HPMC Capsules)|Death|0|||
48991114|NCT01072175|157801600|FG003|Part D (HPMC Capsules)|Death|0|||
48991115|NCT01072175|157801601|FG004|Part D (HPMC Capsules)|Death|0|||
48991116|NCT01072175|157801602|FG005|Part D (HPMC Capsules)|Death|0|||
48991117|NCT01072175|157801603|FG006|Part D (HPMC Capsules)|Death|0|||
48991118|NCT01072175|157801604|FG007|Part D (HPMC Capsules)|Death|0|||
48991119|NCT01072175|157801605|FG008|Part D (HPMC Capsules)|Death|0|||
48991120|NCT01072175|157801606|FG009|Part D (HPMC Capsules)|Death|10|||
48991121|NCT01072175|157801607|FG010|Part D (HPMC Capsules)|Death|12|||
48991122|NCT01072175|157801608|FG011|Part D (HPMC Capsules)|Death|28|||
48991123|NCT01072175|157801609|FG012|Part D (HPMC Capsules)|Death|26|||
48991124|NCT01072175|157801597|FG000|Part D (HPMC Capsules)|Physician Decision|0|||
48991125|NCT01072175|157801598|FG001|Part D (HPMC Capsules)|Physician Decision|0|||
48991126|NCT01072175|157801599|FG002|Part D (HPMC Capsules)|Physician Decision|0|||
48991127|NCT01072175|157801600|FG003|Part D (HPMC Capsules)|Physician Decision|0|||
48991128|NCT01072175|157801601|FG004|Part D (HPMC Capsules)|Physician Decision|0|||
48991129|NCT01072175|157801602|FG005|Part D (HPMC Capsules)|Physician Decision|0|||
48991130|NCT01072175|157801603|FG006|Part D (HPMC Capsules)|Physician Decision|0|||
48991131|NCT01072175|157801604|FG007|Part D (HPMC Capsules)|Physician Decision|0|||
48991132|NCT01072175|157801605|FG008|Part D (HPMC Capsules)|Physician Decision|0|||
48991133|NCT01072175|157801606|FG009|Part D (HPMC Capsules)|Physician Decision|0|||
48692604|NCT04663321|156724538|FG000|Overall Study|Study terminated by Sponsor|2|||
48692605|NCT04663321|156724539|FG001|Overall Study|Study terminated by Sponsor|1|||
48692606|NCT04663321|156724540|FG002|Overall Study|Study terminated by Sponsor|2|||
48692607|NCT04663321|156724538|FG000|Overall Study|Withdrawal by Subject|10|||
48692608|NCT04663321|156724539|FG001|Overall Study|Withdrawal by Subject|3|||
48692609|NCT04663321|156724540|FG002|Overall Study|Withdrawal by Subject|2|||
48692610|NCT04663321|156724538|FG000|Overall Study|Not provided|0|||
48692611|NCT04663321|156724539|FG001|Overall Study|Not provided|0|||
48692612|NCT04663321|156724540|FG002|Overall Study|Not provided|1|||
48692613|NCT03001557|156724541|FG000|Core Phase|Randomized but not treated|0|||
48692614|NCT03001557|156724542|FG001|Core Phase|Randomized but not treated|0|||
48692615|NCT03001557|156724543|FG002|Core Phase|Randomized but not treated|1|||
48692616|NCT03001557|156724544|FG003|Core Phase|Randomized but not treated|0|||
49044898|NCT02208362|157996962|FG003|Overall Study|Participant did not complete treatment|0|||
49044899|NCT02208362|157996963|FG004|Overall Study|Participant did not complete treatment|0|||
49044900|NCT02208362|157996964|FG005|Overall Study|Participant did not complete treatment|0|||
49044901|NCT02208362|157996965|FG006|Overall Study|Participant did not complete treatment|1|||
49044902|NCT02208362|157996966|FG007|Overall Study|Participant did not complete treatment|1|||
48991134|NCT01072175|157801607|FG010|Part D (HPMC Capsules)|Physician Decision|1|||
48991135|NCT01072175|157801608|FG011|Part D (HPMC Capsules)|Physician Decision|1|||
48991136|NCT01072175|157801609|FG012|Part D (HPMC Capsules)|Physician Decision|1|||
49044903|NCT02208362|157996967|FG008|Overall Study|Participant did not complete treatment|2|||
49044904|NCT02208362|157996968|FG009|Overall Study|Participant did not complete treatment|0|||
49044905|NCT02208362|157996969|FG010|Overall Study|Participant did not complete treatment|1|||
49044906|NCT02208362|157996970|FG011|Overall Study|Participant did not complete treatment|0|||
49044907|NCT02208362|157996959|FG000|Overall Study|Participant received disallowed treatment|0|||
48991137|NCT01072175|157801597|FG000|Part D (HPMC Capsules)|Lost to Follow-up|0|||
48991138|NCT01072175|157801598|FG001|Part D (HPMC Capsules)|Lost to Follow-up|0|||
48991139|NCT01072175|157801599|FG002|Part D (HPMC Capsules)|Lost to Follow-up|0|||
49044908|NCT02208362|157996960|FG001|Overall Study|Participant received disallowed treatment|0|||
49044909|NCT02208362|157996961|FG002|Overall Study|Participant received disallowed treatment|0|||
48991140|NCT01072175|157801600|FG003|Part D (HPMC Capsules)|Lost to Follow-up|0|||
48991141|NCT01072175|157801601|FG004|Part D (HPMC Capsules)|Lost to Follow-up|0|||
48991142|NCT01072175|157801602|FG005|Part D (HPMC Capsules)|Lost to Follow-up|0|||
48991143|NCT01072175|157801603|FG006|Part D (HPMC Capsules)|Lost to Follow-up|0|||
48991144|NCT01072175|157801604|FG007|Part D (HPMC Capsules)|Lost to Follow-up|0|||
48991145|NCT01072175|157801605|FG008|Part D (HPMC Capsules)|Lost to Follow-up|0|||
48991146|NCT01072175|157801606|FG009|Part D (HPMC Capsules)|Lost to Follow-up|0|||
48991147|NCT01072175|157801607|FG010|Part D (HPMC Capsules)|Lost to Follow-up|1|||
48991148|NCT01072175|157801608|FG011|Part D (HPMC Capsules)|Lost to Follow-up|1|||
48991149|NCT01072175|157801609|FG012|Part D (HPMC Capsules)|Lost to Follow-up|3|||
48991150|NCT01072175|157801597|FG000|Part D (HPMC Capsules)|Study closed/terminated|0|||
48991151|NCT01072175|157801598|FG001|Part D (HPMC Capsules)|Study closed/terminated|0|||
48991152|NCT01072175|157801599|FG002|Part D (HPMC Capsules)|Study closed/terminated|0|||
48991153|NCT01072175|157801600|FG003|Part D (HPMC Capsules)|Study closed/terminated|0|||
48991154|NCT01072175|157801601|FG004|Part D (HPMC Capsules)|Study closed/terminated|0|||
48991155|NCT01072175|157801602|FG005|Part D (HPMC Capsules)|Study closed/terminated|0|||
48991156|NCT01072175|157801603|FG006|Part D (HPMC Capsules)|Study closed/terminated|0|||
48991157|NCT01072175|157801604|FG007|Part D (HPMC Capsules)|Study closed/terminated|0|||
48991158|NCT01072175|157801605|FG008|Part D (HPMC Capsules)|Study closed/terminated|0|||
48991159|NCT01072175|157801606|FG009|Part D (HPMC Capsules)|Study closed/terminated|2|||
48991160|NCT01072175|157801607|FG010|Part D (HPMC Capsules)|Study closed/terminated|1|||
48991161|NCT01072175|157801608|FG011|Part D (HPMC Capsules)|Study closed/terminated|10|||
48991162|NCT01072175|157801609|FG012|Part D (HPMC Capsules)|Study closed/terminated|9|||
48991163|NCT01072175|157801597|FG000|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
48991164|NCT01072175|157801598|FG001|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
48991165|NCT01072175|157801599|FG002|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
48991166|NCT01072175|157801600|FG003|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
48991167|NCT01072175|157801601|FG004|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
48991168|NCT01072175|157801602|FG005|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
48991169|NCT01072175|157801603|FG006|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
48991170|NCT01072175|157801604|FG007|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
48991171|NCT01072175|157801605|FG008|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
48991172|NCT01072175|157801606|FG009|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
48991173|NCT01072175|157801607|FG010|Part D (HPMC Capsules)|Withdrawal by Subject|1|||
48991174|NCT01072175|157801608|FG011|Part D (HPMC Capsules)|Withdrawal by Subject|3|||
48991175|NCT01072175|157801609|FG012|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
48991176|NCT02577107|157801610|FG000|Overall Study|Protocol deviation|0|||
48991177|NCT02577107|157801611|FG001|Overall Study|Protocol deviation|1|||
48991178|NCT02516605|157801612|FG000|Overall Study|Protocol Violation|0|||
48991179|NCT02516605|157801613|FG001|Overall Study|Protocol Violation|0|||
48991180|NCT02516605|157801614|FG002|Overall Study|Protocol Violation|0|||
48991181|NCT02516605|157801615|FG003|Overall Study|Protocol Violation|0|||
48991182|NCT02516605|157801616|FG004|Overall Study|Protocol Violation|1|||
48991183|NCT02516605|157801612|FG000|Overall Study|Withdrawal by Subject|0|||
48991184|NCT02516605|157801613|FG001|Overall Study|Withdrawal by Subject|0|||
48991185|NCT02516605|157801614|FG002|Overall Study|Withdrawal by Subject|0|||
48991186|NCT02516605|157801615|FG003|Overall Study|Withdrawal by Subject|1|||
48991187|NCT02516605|157801616|FG004|Overall Study|Withdrawal by Subject|0|||
48991188|NCT02643420|157801617|FG000|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|6|||
48991189|NCT02643420|157801618|FG001|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|12|||
48991190|NCT02643420|157801617|FG000|Overall Study|Withdrawal by Subject|25|||
48991191|NCT02643420|157801618|FG001|Overall Study|Withdrawal by Subject|19|||
48991192|NCT02643420|157801617|FG000|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|6|||
48991193|NCT02643420|157801618|FG001|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|10|||
48991194|NCT02643420|157801617|FG000|Overall Study|Lost to Follow-up|6|||
48991195|NCT02643420|157801618|FG001|Overall Study|Lost to Follow-up|10|||
48991196|NCT02643420|157801617|FG000|Overall Study|Investigator Decision|2|||
48991197|NCT02643420|157801618|FG001|Overall Study|Investigator Decision|4|||
48991198|NCT02643420|157801617|FG000|Overall Study|Sponsor decision|1|||
48991199|NCT02643420|157801618|FG001|Overall Study|Sponsor decision|1|||
48991200|NCT02643420|157801617|FG000|Overall Study|Death|0|||
48991201|NCT02643420|157801618|FG001|Overall Study|Death|2|||
48991202|NCT02643420|157801617|FG000|Overall Study|Reason not Specified|8|||
48991203|NCT02643420|157801618|FG001|Overall Study|Reason not Specified|7|||
48991204|NCT02127970|157801619|FG000|Overall Study|Adverse Event|2|||
48991205|NCT02127970|157801620|FG001|Overall Study|Adverse Event|1|||
48991206|NCT02127970|157801619|FG000|Overall Study|Death|1|||
48991207|NCT02127970|157801620|FG001|Overall Study|Death|1|||
48991208|NCT02127970|157801619|FG000|Overall Study|Lost to Follow-up|14|||
48991209|NCT02127970|157801620|FG001|Overall Study|Lost to Follow-up|14|||
48991210|NCT02127970|157801619|FG000|Overall Study|Reason not Specified|4|||
48991211|NCT02127970|157801620|FG001|Overall Study|Reason not Specified|7|||
48991212|NCT02127970|157801619|FG000|Overall Study|Pregnancy|0|||
49044910|NCT02208362|157996962|FG003|Overall Study|Participant received disallowed treatment|0|||
49044911|NCT02208362|157996963|FG004|Overall Study|Participant received disallowed treatment|0|||
49044912|NCT02208362|157996964|FG005|Overall Study|Participant received disallowed treatment|0|||
49044913|NCT02208362|157996965|FG006|Overall Study|Participant received disallowed treatment|0|||
49044914|NCT02208362|157996966|FG007|Overall Study|Participant received disallowed treatment|0|||
49044915|NCT02208362|157996967|FG008|Overall Study|Participant received disallowed treatment|1|||
49044916|NCT02208362|157996968|FG009|Overall Study|Participant received disallowed treatment|0|||
49044917|NCT02208362|157996969|FG010|Overall Study|Participant received disallowed treatment|0|||
49044918|NCT02208362|157996970|FG011|Overall Study|Participant received disallowed treatment|0|||
49044919|NCT04153890|157996971|FG000|Overall Study|Lost to Follow-up|9|||
49044920|NCT04153890|157996972|FG001|Overall Study|Lost to Follow-up|0|||
49044921|NCT04153890|157996973|FG002|Overall Study|Lost to Follow-up|9|||
49044922|NCT04153890|157996974|FG003|Overall Study|Lost to Follow-up|0|||
49044923|NCT04153890|157996971|FG000|Overall Study|Death|0|||
49044924|NCT04153890|157996972|FG001|Overall Study|Death|2|||
49044925|NCT04153890|157996973|FG002|Overall Study|Death|0|||
49044926|NCT04153890|157996974|FG003|Overall Study|Death|0|||
49044927|NCT04153890|157996971|FG000|Overall Study|Withdrawal by Subject|0|||
49044928|NCT04153890|157996972|FG001|Overall Study|Withdrawal by Subject|0|||
49044929|NCT04153890|157996973|FG002|Overall Study|Withdrawal by Subject|0|||
49044930|NCT04153890|157996974|FG003|Overall Study|Withdrawal by Subject|2|||
49044931|NCT02969356|157996977|FG000|Overall Study|Adverse Event|7|||
49044932|NCT02969356|157996977|FG000|Overall Study|Consent withdrawn|2|||
49044933|NCT02969356|157996977|FG000|Overall Study|Lost to Follow-up|3|||
49044934|NCT02969356|157996977|FG000|Overall Study|Did not need to be reinjected|6|||
49044935|NCT02969356|157996977|FG000|Overall Study|Personal reasons|5|||
49044936|NCT00084864|157998078|FG000|Overall Study|Adverse Event|1|||
49044937|NCT00084864|157998079|FG001|Overall Study|Adverse Event|0|||
49044938|NCT00084864|157998080|FG002|Overall Study|Adverse Event|0|||
49044939|NCT00084864|157998081|FG003|Overall Study|Adverse Event|0|||
49044940|NCT01841060|157998082|FG000|Overall Study|Protocol Violation|10|||
48991213|NCT02127970|157801620|FG001|Overall Study|Pregnancy|1|||
48991214|NCT02127970|157801619|FG000|Overall Study|Subject Withdrew Consent|5|||
48991215|NCT02127970|157801620|FG001|Overall Study|Subject Withdrew Consent|3|||
48991216|NCT00643006|157801621|FG000|Overall Study|Lost to Follow-up|5|||
48991217|NCT00643006|157801622|FG001|Overall Study|Lost to Follow-up|4|||
48991218|NCT01710709|157801623|FG000|Overall Study|Lost to Follow-up|29|||
48991219|NCT01710709|157801623|FG000|Overall Study|Adverse Event|48|||
48991220|NCT01710709|157801623|FG000|Overall Study|Participant met withdrawal criteria|33|||
48991221|NCT01710709|157801623|FG000|Overall Study|Participant withdrawn by investigator|2|||
48991222|NCT01710709|157801623|FG000|Overall Study|Withdrawal by Subject|53|||
48991223|NCT01710709|157801623|FG000|Overall Study|Protocol Violation|5|||
48991224|NCT01710709|157801623|FG000|Overall Study|Lack of Efficacy|3|||
48991225|NCT02477215|157801625|FG000|Dose Escalation Phase|Physician Decision|1|||
48991226|NCT02477215|157801626|FG001|Dose Escalation Phase|Physician Decision|2|||
48991227|NCT02477215|157801627|FG002|Dose Escalation Phase|Physician Decision|0|||
48991228|NCT02477215|157801625|FG000|Fixed Dose Phase|Physician Decision|0|||
48991229|NCT02477215|157801626|FG001|Fixed Dose Phase|Physician Decision|7|||
48991230|NCT02477215|157801627|FG002|Fixed Dose Phase|Physician Decision|0|||
48991231|NCT04052425|157801628|FG000|24-Week Double-blind Period|Adverse Event|0|||
48991232|NCT04052425|157801629|FG001|24-Week Double-blind Period|Adverse Event|1|||
49044941|NCT04406194|157998083|FG000|Period 1|Withdrawal by Subject|0|||
49044942|NCT04406194|157998084|FG001|Period 1|Withdrawal by Subject|1|||
49044943|NCT00651183|157998087|FG000|Overall Study|Lack of Efficacy|1|||
49044944|NCT00651183|157998088|FG001|Overall Study|Lack of Efficacy|0|||
49044945|NCT00651183|157998087|FG000|Overall Study|Efficacy insufficient + patients wish|0|||
49044946|NCT00651183|157998088|FG001|Overall Study|Efficacy insufficient + patients wish|1|||
49044947|NCT00651183|157998087|FG000|Overall Study|Tolerability insufficient|5|||
48991233|NCT04052425|157801630|FG002|24-Week Double-blind Period|Adverse Event|0|||
48991234|NCT04052425|157801631|FG003|24-Week Double-blind Period|Adverse Event|0|||
48991235|NCT04052425|157801628|FG000|24-Week Double-blind Period|Lack of Efficacy|0|||
48991236|NCT04052425|157801629|FG001|24-Week Double-blind Period|Lack of Efficacy|1|||
48991237|NCT04052425|157801630|FG002|24-Week Double-blind Period|Lack of Efficacy|0|||
48991238|NCT04052425|157801631|FG003|24-Week Double-blind Period|Lack of Efficacy|0|||
48991239|NCT04052425|157801628|FG000|24-Week Double-blind Period|Lost to Follow-up|14|||
48991240|NCT04052425|157801629|FG001|24-Week Double-blind Period|Lost to Follow-up|7|||
48991241|NCT04052425|157801630|FG002|24-Week Double-blind Period|Lost to Follow-up|0|||
48991242|NCT04052425|157801631|FG003|24-Week Double-blind Period|Lost to Follow-up|0|||
48991243|NCT04052425|157801628|FG000|24-Week Double-blind Period|Physician Decision|1|||
48991244|NCT04052425|157801629|FG001|24-Week Double-blind Period|Physician Decision|0|||
48991245|NCT04052425|157801630|FG002|24-Week Double-blind Period|Physician Decision|0|||
48991246|NCT04052425|157801631|FG003|24-Week Double-blind Period|Physician Decision|0|||
48991247|NCT04052425|157801628|FG000|24-Week Double-blind Period|Protocol Violation|1|||
48991248|NCT04052425|157801629|FG001|24-Week Double-blind Period|Protocol Violation|0|||
48991249|NCT04052425|157801630|FG002|24-Week Double-blind Period|Protocol Violation|0|||
49044948|NCT00651183|157998088|FG001|Overall Study|Tolerability insufficient|2|||
49044949|NCT00651183|157998087|FG000|Overall Study|Tolerability insufficient +Patients wish|0|||
49044950|NCT00651183|157998088|FG001|Overall Study|Tolerability insufficient +Patients wish|1|||
49044951|NCT00651183|157998087|FG000|Overall Study|Withdrawal by Subject|6|||
49044952|NCT00651183|157998088|FG001|Overall Study|Withdrawal by Subject|3|||
49044953|NCT00651183|157998087|FG000|Overall Study|Lost to Follow-up|3|||
49044954|NCT00651183|157998088|FG001|Overall Study|Lost to Follow-up|1|||
49044955|NCT00651183|157998087|FG000|Overall Study|Other reasons|4|||
49044956|NCT00651183|157998088|FG001|Overall Study|Other reasons|2|||
49044957|NCT00651183|157998087|FG000|Overall Study|missing|1|||
49044958|NCT00651183|157998088|FG001|Overall Study|missing|0|||
49044959|NCT00487695|157998089|FG000|First Procedure|invasive cancer on EGD (excl criteria)|1|||
49044960|NCT00487695|157998090|FG001|First Procedure|invasive cancer on EGD (excl criteria)|0|||
49044961|NCT00487695|157998089|FG000|First Procedure|active wheezing (did not have procedure)|1|||
49044962|NCT00487695|157998090|FG001|First Procedure|active wheezing (did not have procedure)|0|||
49044963|NCT00487695|157998089|FG000|First Procedure|esophageal stricture found (excl crit)|1|||
49044964|NCT00487695|157998090|FG001|First Procedure|esophageal stricture found (excl crit)|0|||
49044965|NCT00487695|157998089|FG000|Second Procedure|active wheezing|0|||
49044966|NCT00487695|157998090|FG001|Second Procedure|active wheezing|1|||
49044967|NCT00487695|157998089|FG000|Second Procedure|Withdrawal by Subject|1|||
49044968|NCT00487695|157998090|FG001|Second Procedure|Withdrawal by Subject|2|||
48991250|NCT04052425|157801631|FG003|24-Week Double-blind Period|Protocol Violation|0|||
49044969|NCT00695110|157998091|FG000|Treatment Period 1|Adverse Event|1|||
48991251|NCT04052425|157801628|FG000|24-Week Double-blind Period|Withdrawal by Subject|9|||
48991252|NCT04052425|157801629|FG001|24-Week Double-blind Period|Withdrawal by Subject|10|||
48991253|NCT04052425|157801630|FG002|24-Week Double-blind Period|Withdrawal by Subject|0|||
48991254|NCT04052425|157801631|FG003|24-Week Double-blind Period|Withdrawal by Subject|0|||
48991255|NCT04052425|157801628|FG000|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|3|||
48991256|NCT04052425|157801629|FG001|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
48991257|NCT04052425|157801630|FG002|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
48991258|NCT04052425|157801631|FG003|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
48991259|NCT04052425|157801628|FG000|28-Week Treatment-Extension Period|Adverse Event|0|||
48991260|NCT04052425|157801629|FG001|28-Week Treatment-Extension Period|Adverse Event|0|||
48991261|NCT04052425|157801630|FG002|28-Week Treatment-Extension Period|Adverse Event|1|||
48991262|NCT04052425|157801631|FG003|28-Week Treatment-Extension Period|Adverse Event|0|||
48991263|NCT04052425|157801628|FG000|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
48991264|NCT04052425|157801629|FG001|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
48991265|NCT04052425|157801630|FG002|28-Week Treatment-Extension Period|Lack of Efficacy|1|||
48991266|NCT04052425|157801631|FG003|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
48991267|NCT04052425|157801628|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
48991268|NCT04052425|157801629|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
48991269|NCT04052425|157801630|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
48991270|NCT04052425|157801631|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|1|||
48991271|NCT04052425|157801628|FG000|28-Week Treatment-Extension Period|Physician Decision|0|||
48991272|NCT04052425|157801629|FG001|28-Week Treatment-Extension Period|Physician Decision|0|||
48991273|NCT04052425|157801630|FG002|28-Week Treatment-Extension Period|Physician Decision|0|||
48991274|NCT04052425|157801631|FG003|28-Week Treatment-Extension Period|Physician Decision|1|||
48991275|NCT04052425|157801628|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
48991276|NCT04052425|157801629|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
48991277|NCT04052425|157801630|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|10|||
48991278|NCT04052425|157801631|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|7|||
48991279|NCT04052425|157801628|FG000|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
48991280|NCT04052425|157801629|FG001|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
48991281|NCT04052425|157801630|FG002|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|1|||
48991282|NCT04052425|157801631|FG003|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
48991283|NCT04052425|157801628|FG000|28-Week Treatment-Extension Period|Participant Moved|0|||
48991284|NCT04052425|157801629|FG001|28-Week Treatment-Extension Period|Participant Moved|0|||
48991285|NCT04052425|157801630|FG002|28-Week Treatment-Extension Period|Participant Moved|1|||
48991286|NCT04052425|157801631|FG003|28-Week Treatment-Extension Period|Participant Moved|1|||
48991287|NCT02985996|157801632|FG000|Overall Study|Withdrawal by Subject|0|||
48991288|NCT02985996|157801633|FG001|Overall Study|Withdrawal by Subject|0|||
48991289|NCT02985996|157801634|FG002|Overall Study|Withdrawal by Subject|1|||
48991290|NCT02985996|157801635|FG003|Overall Study|Withdrawal by Subject|0|||
49044970|NCT00695110|157998091|FG000|Treatment Period 1|Withdrawal by Subject|2|||
48991291|NCT02985996|157801636|FG004|Overall Study|Withdrawal by Subject|0|||
49044971|NCT00695110|157998091|FG000|Treatment Period 3|Withdrawal by Subject|1|||
49044972|NCT00695110|157998091|FG000|Treatment Period 4|Adverse Event|1|||
49044973|NCT02340780|157998096|FG000|Overall Study|Ineligible|1|||
49044974|NCT01745094|157998097|FG000|Overall Study|Not Meeting the Eligibility Criteria|1|||
48991292|NCT02985996|157801632|FG000|Overall Study|Protocol Violation|0|||
48991293|NCT02985996|157801633|FG001|Overall Study|Protocol Violation|1|||
48991294|NCT02985996|157801634|FG002|Overall Study|Protocol Violation|0|||
48991295|NCT02985996|157801635|FG003|Overall Study|Protocol Violation|0|||
48991296|NCT02985996|157801636|FG004|Overall Study|Protocol Violation|0|||
48991297|NCT05102734|157801639|FG000|Overall Study|Did not require vasopressors|1|||
48991298|NCT05102734|157801640|FG001|Overall Study|Did not require vasopressors|0|||
48991299|NCT05102734|157801639|FG000|Overall Study|Did not have functioning PA catheter|1|||
48991300|NCT05102734|157801640|FG001|Overall Study|Did not have functioning PA catheter|0|||
48991301|NCT05102734|157801639|FG000|Overall Study|Inadequate video quality|2|||
48991302|NCT05102734|157801640|FG001|Overall Study|Inadequate video quality|0|||
48991303|NCT00608426|157801641|FG000|Overall Study|Death|32|||
48991304|NCT00608426|157801642|FG001|Overall Study|Death|36|||
48991305|NCT00608426|157801641|FG000|Overall Study|Lost to Follow-up|485|||
48991306|NCT00608426|157801642|FG001|Overall Study|Lost to Follow-up|521|||
48991307|NCT00608426|157801641|FG000|Overall Study|refused, health issues, wrong address|319|||
48991308|NCT00608426|157801642|FG001|Overall Study|refused, health issues, wrong address|348|||
48991309|NCT04837807|157801643|FG000|First Sequence (Week 1)|Withdrawal by Subject|0|||
48991310|NCT04837807|157801644|FG001|First Sequence (Week 1)|Withdrawal by Subject|1|||
48991311|NCT00761891|157801645|FG000|Overall Study|Withdrawal by Subject|10|||
48991312|NCT02369874|157801652|FG000|Overall Study|Lost to Follow-up|2|||
48991313|NCT02369874|157801653|FG001|Overall Study|Lost to Follow-up|2|||
48991314|NCT02369874|157801654|FG002|Overall Study|Lost to Follow-up|2|||
48991315|NCT02369874|157801652|FG000|Overall Study|Withdrawal by Subject|7|||
48991316|NCT02369874|157801653|FG001|Overall Study|Withdrawal by Subject|9|||
48991317|NCT02369874|157801654|FG002|Overall Study|Withdrawal by Subject|27|||
48991318|NCT02369874|157801652|FG000|Overall Study|Miscellaneous|1|||
48991319|NCT02369874|157801653|FG001|Overall Study|Miscellaneous|1|||
48991320|NCT02369874|157801654|FG002|Overall Study|Miscellaneous|0|||
48991321|NCT02369874|157801652|FG000|Overall Study|On Treatment/Off Study|34|||
48991322|NCT02369874|157801653|FG001|Overall Study|On Treatment/Off Study|45|||
48991323|NCT02369874|157801654|FG002|Overall Study|On Treatment/Off Study|32|||
48991324|NCT01396434|157801655|FG000|Overall Study|Lost to Follow-up|1|||
48991325|NCT01396434|157801656|FG001|Overall Study|Lost to Follow-up|0|||
48991326|NCT01396434|157801657|FG002|Overall Study|Lost to Follow-up|0|||
48991327|NCT01396434|157801655|FG000|Overall Study|Other|10|||
48991328|NCT01396434|157801656|FG001|Overall Study|Other|0|||
48991329|NCT01396434|157801657|FG002|Overall Study|Other|0|||
48991330|NCT00808665|157801658|FG000|Overall Study|Withdrawal by Subject|1|||
48991331|NCT00808665|157801659|FG001|Overall Study|Withdrawal by Subject|0|||
48991332|NCT00808665|157801658|FG000|Overall Study|only required minimally invasive surgery|1|||
48991333|NCT00808665|157801659|FG001|Overall Study|only required minimally invasive surgery|0|||
48991334|NCT00808665|157801658|FG000|Overall Study|surgery cancelled|1|||
48991335|NCT00808665|157801659|FG001|Overall Study|surgery cancelled|0|||
48991336|NCT00808665|157801658|FG000|Overall Study|required an additional procedure|0|||
48991337|NCT00808665|157801659|FG001|Overall Study|required an additional procedure|1|||
48991338|NCT00808665|157801658|FG000|Overall Study|Physician Decision|3|||
48991339|NCT00808665|157801659|FG001|Overall Study|Physician Decision|1|||
48991340|NCT00808665|157801658|FG000|Overall Study|Medication stopped by resident|0|||
48991341|NCT00808665|157801659|FG001|Overall Study|Medication stopped by resident|1|||
48991342|NCT03326323|157801661|FG000|Overall Study|Unable to receive ANH protocol|3|||
48991343|NCT01757821|157801664|FG000|Overall Study|Adverse Event|1|||
48991344|NCT00634933|157801665|FG000|Part A: Baseline to Week 24|Adverse Event|4|||
48991345|NCT00634933|157801666|FG001|Part A: Baseline to Week 24|Adverse Event|4|||
48991346|NCT00634933|157801667|FG002|Part A: Baseline to Week 24|Adverse Event|8|||
48991347|NCT00634933|157801668|FG003|Part A: Baseline to Week 24|Adverse Event|0|||
48991348|NCT00634933|157801669|FG004|Part A: Baseline to Week 24|Adverse Event|0|||
48991349|NCT00634933|157801665|FG000|Part A: Baseline to Week 24|Death|1|||
48991350|NCT00634933|157801666|FG001|Part A: Baseline to Week 24|Death|0|||
48991351|NCT00634933|157801667|FG002|Part A: Baseline to Week 24|Death|0|||
48991352|NCT00634933|157801668|FG003|Part A: Baseline to Week 24|Death|0|||
48991353|NCT00634933|157801669|FG004|Part A: Baseline to Week 24|Death|0|||
48991354|NCT00634933|157801665|FG000|Part A: Baseline to Week 24|Failed to Return|1|||
48991355|NCT00634933|157801666|FG001|Part A: Baseline to Week 24|Failed to Return|0|||
48991356|NCT00634933|157801667|FG002|Part A: Baseline to Week 24|Failed to Return|0|||
48991357|NCT00634933|157801668|FG003|Part A: Baseline to Week 24|Failed to Return|0|||
48991358|NCT00634933|157801669|FG004|Part A: Baseline to Week 24|Failed to Return|0|||
48991359|NCT00634933|157801665|FG000|Part A: Baseline to Week 24|Investigator Request|1|||
48991360|NCT00634933|157801666|FG001|Part A: Baseline to Week 24|Investigator Request|1|||
48991361|NCT00634933|157801667|FG002|Part A: Baseline to Week 24|Investigator Request|1|||
48991362|NCT00634933|157801668|FG003|Part A: Baseline to Week 24|Investigator Request|0|||
48991363|NCT00634933|157801669|FG004|Part A: Baseline to Week 24|Investigator Request|0|||
48991364|NCT00634933|157801665|FG000|Part A: Baseline to Week 24|Lost to Follow-up|0|||
48991365|NCT00634933|157801666|FG001|Part A: Baseline to Week 24|Lost to Follow-up|1|||
48991366|NCT00634933|157801667|FG002|Part A: Baseline to Week 24|Lost to Follow-up|1|||
49044975|NCT01745094|157998098|FG001|Overall Study|Not Meeting the Eligibility Criteria|0|||
49044976|NCT01745094|157998099|FG002|Overall Study|Not Meeting the Eligibility Criteria|3|||
49044977|NCT01745094|157998100|FG003|Overall Study|Not Meeting the Eligibility Criteria|0|||
49044978|NCT01745094|157998097|FG000|Overall Study|Adverse Event|0|||
48991367|NCT00634933|157801668|FG003|Part A: Baseline to Week 24|Lost to Follow-up|0|||
48991368|NCT00634933|157801669|FG004|Part A: Baseline to Week 24|Lost to Follow-up|0|||
48991369|NCT00634933|157801665|FG000|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
48991370|NCT00634933|157801666|FG001|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
48991371|NCT00634933|157801667|FG002|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
48991372|NCT00634933|157801668|FG003|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
48991373|NCT00634933|157801669|FG004|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
48991374|NCT00634933|157801665|FG000|Part A: Baseline to Week 24|Lack of Efficacy|3|||
48991375|NCT00634933|157801666|FG001|Part A: Baseline to Week 24|Lack of Efficacy|1|||
48991376|NCT00634933|157801667|FG002|Part A: Baseline to Week 24|Lack of Efficacy|0|||
48991377|NCT00634933|157801668|FG003|Part A: Baseline to Week 24|Lack of Efficacy|0|||
48991378|NCT00634933|157801669|FG004|Part A: Baseline to Week 24|Lack of Efficacy|0|||
48991379|NCT00634933|157801665|FG000|Part A: Baseline to Week 24|Other|1|||
48991380|NCT00634933|157801666|FG001|Part A: Baseline to Week 24|Other|8|||
48991381|NCT00634933|157801667|FG002|Part A: Baseline to Week 24|Other|5|||
48991382|NCT00634933|157801668|FG003|Part A: Baseline to Week 24|Other|0|||
48991383|NCT00634933|157801669|FG004|Part A: Baseline to Week 24|Other|0|||
48991384|NCT00634933|157801665|FG000|Between Part A and Part B|Physician Decision|0|||
48991385|NCT00634933|157801666|FG001|Between Part A and Part B|Physician Decision|1|||
48991386|NCT00634933|157801667|FG002|Between Part A and Part B|Physician Decision|0|||
48991387|NCT00634933|157801668|FG003|Between Part A and Part B|Physician Decision|0|||
49044979|NCT01745094|157998098|FG001|Overall Study|Adverse Event|0|||
49044980|NCT01745094|157998099|FG002|Overall Study|Adverse Event|3|||
49044981|NCT01745094|157998100|FG003|Overall Study|Adverse Event|0|||
49044982|NCT01745094|157998097|FG000|Overall Study|Withdrawal by Subject|2|||
49044983|NCT01745094|157998098|FG001|Overall Study|Withdrawal by Subject|0|||
49044984|NCT01745094|157998099|FG002|Overall Study|Withdrawal by Subject|1|||
49044985|NCT01745094|157998100|FG003|Overall Study|Withdrawal by Subject|2|||
49044986|NCT01745094|157998097|FG000|Overall Study|Protocol Violation|1|||
49044987|NCT01745094|157998098|FG001|Overall Study|Protocol Violation|0|||
49044988|NCT01745094|157998099|FG002|Overall Study|Protocol Violation|3|||
49044989|NCT01745094|157998100|FG003|Overall Study|Protocol Violation|1|||
49044990|NCT01745094|157998097|FG000|Overall Study|Need Further Examinations Due to Biopsy|0|||
49044991|NCT01745094|157998098|FG001|Overall Study|Need Further Examinations Due to Biopsy|0|||
49044992|NCT01745094|157998099|FG002|Overall Study|Need Further Examinations Due to Biopsy|1|||
49044993|NCT01745094|157998100|FG003|Overall Study|Need Further Examinations Due to Biopsy|0|||
48991388|NCT00634933|157801669|FG004|Between Part A and Part B|Physician Decision|0|||
48991389|NCT00634933|157801665|FG000|Part B: Week 24 to Week 52|Adverse Event|0|||
48991390|NCT00634933|157801666|FG001|Part B: Week 24 to Week 52|Adverse Event|1|||
48991391|NCT00634933|157801667|FG002|Part B: Week 24 to Week 52|Adverse Event|1|||
48991392|NCT00634933|157801668|FG003|Part B: Week 24 to Week 52|Adverse Event|1|||
48991393|NCT00634933|157801669|FG004|Part B: Week 24 to Week 52|Adverse Event|0|||
48991394|NCT00634933|157801665|FG000|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0|||
48991395|NCT00634933|157801666|FG001|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11|||
48991396|NCT00634933|157801667|FG002|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14|||
48991397|NCT00634933|157801668|FG003|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3|||
48991398|NCT00634933|157801669|FG004|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7|||
48991399|NCT00634933|157801665|FG000|Part B: Week 24 to Week 52|Physician Decision|0|||
48991400|NCT00634933|157801666|FG001|Part B: Week 24 to Week 52|Physician Decision|1|||
48991401|NCT00634933|157801667|FG002|Part B: Week 24 to Week 52|Physician Decision|1|||
48991402|NCT00634933|157801668|FG003|Part B: Week 24 to Week 52|Physician Decision|0|||
48991403|NCT00634933|157801669|FG004|Part B: Week 24 to Week 52|Physician Decision|0|||
48991404|NCT00634933|157801665|FG000|Part B: Week 24 to Week 52|Protocol Violation|0|||
48991405|NCT00634933|157801666|FG001|Part B: Week 24 to Week 52|Protocol Violation|0|||
48991406|NCT00634933|157801667|FG002|Part B: Week 24 to Week 52|Protocol Violation|0|||
48991407|NCT00634933|157801668|FG003|Part B: Week 24 to Week 52|Protocol Violation|0|||
48991408|NCT00634933|157801669|FG004|Part B: Week 24 to Week 52|Protocol Violation|1|||
49044994|NCT01745094|157998097|FG000|Overall Study|Show no Stable Solifenacin Intake|0|||
49044995|NCT01745094|157998098|FG001|Overall Study|Show no Stable Solifenacin Intake|0|||
48991409|NCT00634933|157801665|FG000|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
48991410|NCT00634933|157801666|FG001|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
48991411|NCT00634933|157801667|FG002|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
49044996|NCT01745094|157998099|FG002|Overall Study|Show no Stable Solifenacin Intake|1|||
48991412|NCT00634933|157801668|FG003|Part B: Week 24 to Week 52|Withdrawal by Subject|2|||
49044997|NCT01745094|157998100|FG003|Overall Study|Show no Stable Solifenacin Intake|0|||
49044998|NCT01745094|157998097|FG000|Overall Study|Untenable Due to Recurrent Cystitis|1|||
49044999|NCT01745094|157998098|FG001|Overall Study|Untenable Due to Recurrent Cystitis|0|||
48991413|NCT00634933|157801669|FG004|Part B: Week 24 to Week 52|Withdrawal by Subject|1|||
48991414|NCT00634933|157801665|FG000|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
48991415|NCT00634933|157801666|FG001|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
48991416|NCT00634933|157801667|FG002|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
48991417|NCT00634933|157801668|FG003|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
48991418|NCT00634933|157801669|FG004|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
48991419|NCT00634933|157801665|FG000|Part B: Week 24 to Week 52|Other|0|||
48991420|NCT00634933|157801666|FG001|Part B: Week 24 to Week 52|Other|0|||
48991421|NCT00634933|157801667|FG002|Part B: Week 24 to Week 52|Other|5|||
48991422|NCT00634933|157801668|FG003|Part B: Week 24 to Week 52|Other|0|||
48991423|NCT00634933|157801669|FG004|Part B: Week 24 to Week 52|Other|1|||
49045000|NCT01745094|157998099|FG002|Overall Study|Untenable Due to Recurrent Cystitis|0|||
49045001|NCT01745094|157998100|FG003|Overall Study|Untenable Due to Recurrent Cystitis|0|||
49045002|NCT04610580|157998101|FG000|Two-way Crossover Period|Adverse Event|1|||
49045003|NCT04610580|157998102|FG001|Two-way Crossover Period|Adverse Event|0|||
49045004|NCT04610580|157998103|FG002|Two-way Crossover Period|Adverse Event|0|||
49045005|NCT04610580|157998104|FG003|Two-way Crossover Period|Adverse Event|0|||
49045006|NCT04610580|157998105|FG004|Two-way Crossover Period|Adverse Event|0|||
49045007|NCT04610580|157998106|FG005|Two-way Crossover Period|Adverse Event|0|||
49045008|NCT04610580|157998101|FG000|Two-way Crossover Period|Physician Decision|1|||
49045009|NCT04610580|157998102|FG001|Two-way Crossover Period|Physician Decision|0|||
49045010|NCT04610580|157998103|FG002|Two-way Crossover Period|Physician Decision|0|||
49045011|NCT04610580|157998104|FG003|Two-way Crossover Period|Physician Decision|0|||
49045012|NCT04610580|157998105|FG004|Two-way Crossover Period|Physician Decision|0|||
49045013|NCT04610580|157998106|FG005|Two-way Crossover Period|Physician Decision|0|||
49045014|NCT04610580|157998101|FG000|Two-way Crossover Period|Withdrawal by Subject|0|||
49045015|NCT04610580|157998102|FG001|Two-way Crossover Period|Withdrawal by Subject|1|||
49045016|NCT04610580|157998103|FG002|Two-way Crossover Period|Withdrawal by Subject|0|||
49045017|NCT04610580|157998104|FG003|Two-way Crossover Period|Withdrawal by Subject|0|||
49045018|NCT04610580|157998105|FG004|Two-way Crossover Period|Withdrawal by Subject|0|||
49045019|NCT04610580|157998106|FG005|Two-way Crossover Period|Withdrawal by Subject|0|||
49045020|NCT04610580|157998101|FG000|Two-way Crossover Period|Other than specified|0|||
48991424|NCT01220024|157801670|FG000|Overall Study|Lost to Follow-up|1|||
48991425|NCT01220024|157801671|FG001|Overall Study|Lost to Follow-up|1|||
48991426|NCT03982069|157801678|FG000|Overall Study|Lost to Follow-up|5|||
48991427|NCT03982069|157801679|FG001|Overall Study|Lost to Follow-up|5|||
48991428|NCT03982069|157801680|FG002|Overall Study|Lost to Follow-up|3|||
48991429|NCT03982069|157801681|FG003|Overall Study|Lost to Follow-up|5|||
48991430|NCT03982069|157801678|FG000|Overall Study|Physician Decision|0|||
49045021|NCT04610580|157998102|FG001|Two-way Crossover Period|Other than specified|1|||
49045022|NCT04610580|157998103|FG002|Two-way Crossover Period|Other than specified|0|||
49045023|NCT04610580|157998104|FG003|Two-way Crossover Period|Other than specified|0|||
49045024|NCT04610580|157998105|FG004|Two-way Crossover Period|Other than specified|0|||
49045025|NCT04610580|157998106|FG005|Two-way Crossover Period|Other than specified|0|||
49045026|NCT04610580|157998101|FG000|Washout Before Extension Period|Other than specified|0|||
49045027|NCT04610580|157998102|FG001|Washout Before Extension Period|Other than specified|1|||
49045028|NCT04610580|157998103|FG002|Washout Before Extension Period|Other than specified|0|||
48991431|NCT03982069|157801679|FG001|Overall Study|Physician Decision|1|||
48991432|NCT03982069|157801680|FG002|Overall Study|Physician Decision|0|||
48991433|NCT03982069|157801681|FG003|Overall Study|Physician Decision|0|||
48991434|NCT03982069|157801678|FG000|Overall Study|Withdrawal by Subject|2|||
48991435|NCT03982069|157801679|FG001|Overall Study|Withdrawal by Subject|1|||
48991436|NCT03982069|157801680|FG002|Overall Study|Withdrawal by Subject|5|||
48991437|NCT03982069|157801681|FG003|Overall Study|Withdrawal by Subject|2|||
48991438|NCT03982069|157801678|FG000|Overall Study|Specimen loss|3|||
48991439|NCT03982069|157801679|FG001|Overall Study|Specimen loss|3|||
48991440|NCT03982069|157801680|FG002|Overall Study|Specimen loss|1|||
48991441|NCT03982069|157801681|FG003|Overall Study|Specimen loss|1|||
48991442|NCT02030067|157801683|FG000|Overall Study|Disease Progression|1|||
48991443|NCT02030067|157801684|FG001|Overall Study|Disease Progression|1|||
48991444|NCT02030067|157801685|FG002|Overall Study|Disease Progression|2|||
48991445|NCT02030067|157801686|FG003|Overall Study|Disease Progression|2|||
48991446|NCT02030067|157801687|FG004|Overall Study|Disease Progression|3|||
49045029|NCT04610580|157998104|FG003|Washout Before Extension Period|Other than specified|0|||
49045030|NCT04610580|157998105|FG004|Washout Before Extension Period|Other than specified|0|||
49045031|NCT04610580|157998106|FG005|Washout Before Extension Period|Other than specified|0|||
48991447|NCT02030067|157801688|FG005|Overall Study|Disease Progression|2|||
48991448|NCT02030067|157801689|FG006|Overall Study|Disease Progression|3|||
48991449|NCT02030067|157801690|FG007|Overall Study|Disease Progression|3|||
48991450|NCT02030067|157801691|FG008|Overall Study|Disease Progression|4|||
48991451|NCT02030067|157801692|FG009|Overall Study|Disease Progression|3|||
48991452|NCT02030067|157801693|FG010|Overall Study|Disease Progression|7|||
48991453|NCT02030067|157801694|FG011|Overall Study|Disease Progression|2|||
48991454|NCT02030067|157801695|FG012|Overall Study|Disease Progression|59|||
49045032|NCT04610580|157998101|FG000|Washout Before Extension Period|Withdrawal by Subject|0|||
49045033|NCT04610580|157998102|FG001|Washout Before Extension Period|Withdrawal by Subject|2|||
49045034|NCT04610580|157998103|FG002|Washout Before Extension Period|Withdrawal by Subject|0|||
49045035|NCT04610580|157998104|FG003|Washout Before Extension Period|Withdrawal by Subject|0|||
49045036|NCT04610580|157998105|FG004|Washout Before Extension Period|Withdrawal by Subject|0|||
49045037|NCT04610580|157998106|FG005|Washout Before Extension Period|Withdrawal by Subject|0|||
49045038|NCT04610580|157998101|FG000|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
49045039|NCT04610580|157998102|FG001|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
49045040|NCT04610580|157998103|FG002|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
49045041|NCT04610580|157998104|FG003|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
48991455|NCT02030067|157801683|FG000|Overall Study|Withdrawal by Subject|0|||
48991456|NCT02030067|157801684|FG001|Overall Study|Withdrawal by Subject|0|||
48991457|NCT02030067|157801685|FG002|Overall Study|Withdrawal by Subject|0|||
48991458|NCT02030067|157801686|FG003|Overall Study|Withdrawal by Subject|1|||
48991459|NCT02030067|157801687|FG004|Overall Study|Withdrawal by Subject|0|||
48991460|NCT02030067|157801688|FG005|Overall Study|Withdrawal by Subject|0|||
48991461|NCT02030067|157801689|FG006|Overall Study|Withdrawal by Subject|0|||
48991462|NCT02030067|157801690|FG007|Overall Study|Withdrawal by Subject|1|||
48991463|NCT02030067|157801691|FG008|Overall Study|Withdrawal by Subject|0|||
48991464|NCT02030067|157801692|FG009|Overall Study|Withdrawal by Subject|0|||
48991465|NCT02030067|157801693|FG010|Overall Study|Withdrawal by Subject|3|||
48991466|NCT02030067|157801694|FG011|Overall Study|Withdrawal by Subject|0|||
48991467|NCT02030067|157801695|FG012|Overall Study|Withdrawal by Subject|6|||
48991468|NCT02030067|157801683|FG000|Overall Study|Physician Decision|0|||
48991469|NCT02030067|157801684|FG001|Overall Study|Physician Decision|0|||
48991470|NCT02030067|157801685|FG002|Overall Study|Physician Decision|0|||
48991471|NCT02030067|157801686|FG003|Overall Study|Physician Decision|0|||
48991472|NCT02030067|157801687|FG004|Overall Study|Physician Decision|0|||
48991473|NCT02030067|157801688|FG005|Overall Study|Physician Decision|0|||
48991474|NCT02030067|157801689|FG006|Overall Study|Physician Decision|0|||
48991475|NCT02030067|157801690|FG007|Overall Study|Physician Decision|0|||
48991476|NCT02030067|157801691|FG008|Overall Study|Physician Decision|0|||
48991477|NCT02030067|157801692|FG009|Overall Study|Physician Decision|0|||
48991478|NCT02030067|157801693|FG010|Overall Study|Physician Decision|1|||
48991479|NCT02030067|157801694|FG011|Overall Study|Physician Decision|0|||
48991480|NCT02030067|157801695|FG012|Overall Study|Physician Decision|3|||
48991481|NCT02030067|157801683|FG000|Overall Study|other reasons|0|||
48991482|NCT02030067|157801684|FG001|Overall Study|other reasons|0|||
48991483|NCT02030067|157801685|FG002|Overall Study|other reasons|0|||
48991484|NCT02030067|157801686|FG003|Overall Study|other reasons|0|||
48991485|NCT02030067|157801687|FG004|Overall Study|other reasons|0|||
48991486|NCT02030067|157801688|FG005|Overall Study|other reasons|1|||
48991487|NCT02030067|157801689|FG006|Overall Study|other reasons|0|||
48991488|NCT02030067|157801690|FG007|Overall Study|other reasons|0|||
48991489|NCT02030067|157801691|FG008|Overall Study|other reasons|2|||
48991490|NCT02030067|157801692|FG009|Overall Study|other reasons|0|||
48991491|NCT02030067|157801693|FG010|Overall Study|other reasons|0|||
48991492|NCT02030067|157801694|FG011|Overall Study|other reasons|0|||
48991493|NCT02030067|157801695|FG012|Overall Study|other reasons|4|||
48991494|NCT02030067|157801683|FG000|Overall Study|Adverse Event|0|||
48991495|NCT02030067|157801684|FG001|Overall Study|Adverse Event|0|||
48991496|NCT02030067|157801685|FG002|Overall Study|Adverse Event|0|||
48991497|NCT02030067|157801686|FG003|Overall Study|Adverse Event|0|||
48991498|NCT02030067|157801687|FG004|Overall Study|Adverse Event|0|||
48991499|NCT02030067|157801688|FG005|Overall Study|Adverse Event|0|||
48991500|NCT02030067|157801689|FG006|Overall Study|Adverse Event|0|||
48991501|NCT02030067|157801690|FG007|Overall Study|Adverse Event|0|||
48991502|NCT02030067|157801691|FG008|Overall Study|Adverse Event|0|||
48991503|NCT02030067|157801692|FG009|Overall Study|Adverse Event|0|||
48991504|NCT02030067|157801693|FG010|Overall Study|Adverse Event|0|||
48991505|NCT02030067|157801694|FG011|Overall Study|Adverse Event|1|||
48991506|NCT02030067|157801695|FG012|Overall Study|Adverse Event|8|||
48991507|NCT02221882|157801696|FG000|Overall Study|Withdrawal by Subject|0|||
48991508|NCT02221882|157801697|FG001|Overall Study|Withdrawal by Subject|0|||
48991509|NCT02221882|157801698|FG002|Overall Study|Withdrawal by Subject|4|||
48991510|NCT02221882|157801699|FG003|Overall Study|Withdrawal by Subject|2|||
48991511|NCT02221882|157801700|FG004|Overall Study|Withdrawal by Subject|2|||
48991512|NCT02221882|157801701|FG005|Overall Study|Withdrawal by Subject|2|||
49045042|NCT04610580|157998105|FG004|Dose-Proportionality Extension Period|Lost to Follow-up|1|||
49045043|NCT04610580|157998106|FG005|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
48991513|NCT02221882|157801696|FG000|Overall Study|Death|0|||
48991514|NCT02221882|157801697|FG001|Overall Study|Death|1|||
48991515|NCT02221882|157801698|FG002|Overall Study|Death|0|||
48991516|NCT02221882|157801699|FG003|Overall Study|Death|0|||
48991517|NCT02221882|157801700|FG004|Overall Study|Death|0|||
48991518|NCT02221882|157801701|FG005|Overall Study|Death|0|||
48991519|NCT01288911|157801702|FG000|Double-blind Period|Death|11|||
48991520|NCT01288911|157801703|FG001|Double-blind Period|Death|7|||
48991521|NCT01288911|157801702|FG000|Double-blind Period|Lost to Follow-up|0|||
48991522|NCT01288911|157801703|FG001|Double-blind Period|Lost to Follow-up|2|||
48991523|NCT01288911|157801702|FG000|Double-blind Period|Progressive Disease|75|||
48991524|NCT01288911|157801703|FG001|Double-blind Period|Progressive Disease|103|||
48991525|NCT01288911|157801702|FG000|Double-blind Period|Protocol Violation|1|||
48991526|NCT01288911|157801703|FG001|Double-blind Period|Protocol Violation|0|||
48991527|NCT01288911|157801702|FG000|Double-blind Period|Withdrawal by Subject|25|||
48991528|NCT01288911|157801703|FG001|Double-blind Period|Withdrawal by Subject|26|||
48991529|NCT01288911|157801702|FG000|Double-blind Period|Miscellaneous Reason|29|||
48991530|NCT01288911|157801703|FG001|Double-blind Period|Miscellaneous Reason|42|||
48991531|NCT01288911|157801702|FG000|Double-blind Period|Randomized but never received study drug|1|||
48991532|NCT01288911|157801703|FG001|Double-blind Period|Randomized but never received study drug|2|||
48991533|NCT01288911|157801702|FG000|Open-label Period (All Enzalutamide)|Death|0|||
48991534|NCT01288911|157801703|FG001|Open-label Period (All Enzalutamide)|Death|1|||
48991535|NCT01288911|157801702|FG000|Open-label Period (All Enzalutamide)|Lost to Follow-up|1|||
48991536|NCT01288911|157801703|FG001|Open-label Period (All Enzalutamide)|Lost to Follow-up|0|||
48991537|NCT01288911|157801702|FG000|Open-label Period (All Enzalutamide)|Progressive disease|18|||
48991538|NCT01288911|157801703|FG001|Open-label Period (All Enzalutamide)|Progressive disease|3|||
48991539|NCT01288911|157801702|FG000|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1|||
48991540|NCT01288911|157801703|FG001|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0|||
48991541|NCT01288911|157801702|FG000|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5|||
48991542|NCT01288911|157801703|FG001|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0|||
48991543|NCT01288911|157801702|FG000|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17|||
48991544|NCT01288911|157801703|FG001|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5|||
48991545|NCT03258710|157801704|FG000|Overall Study|Adverse Event|1|||
48991546|NCT03258710|157801704|FG000|Overall Study|Protocol-defined stopping criteria|1|||
48991547|NCT03258710|157801704|FG000|Overall Study|Physician Decision|1|||
48991548|NCT02079077|157802870|FG000|Overall Study|Lost to Follow-up|5|||
48991549|NCT02079077|157802871|FG001|Overall Study|Lost to Follow-up|7|||
48991550|NCT02079077|157802870|FG000|Overall Study|Became STIs Positive|1|||
48991551|NCT02079077|157802871|FG001|Overall Study|Became STIs Positive|2|||
48991552|NCT03938857|157802872|FG000|Overall Study|Physician Decision|1|||
48991553|NCT03938857|157802873|FG001|Overall Study|Physician Decision|0|||
48991554|NCT03938857|157802874|FG002|Overall Study|Physician Decision|0|||
48991555|NCT03938857|157802875|FG003|Overall Study|Physician Decision|0|||
48991556|NCT02452320|157802876|FG000|Overall Study|Adverse Event|0|||
48991557|NCT02452320|157802877|FG001|Overall Study|Adverse Event|1|||
48991558|NCT02624713|157802879|FG000|Overall Study|Lost to Follow-up|14|||
48991559|NCT02624713|157802880|FG001|Overall Study|Lost to Follow-up|0|||
48991560|NCT01398176|157802891|FG000|Overall Study|Lost to Follow-up|1|||
48991561|NCT01398176|157802892|FG001|Overall Study|Lost to Follow-up|3|||
48991562|NCT01398176|157802891|FG000|Overall Study|Physician Decision|2|||
48991563|NCT01398176|157802892|FG001|Overall Study|Physician Decision|3|||
48991564|NCT00542321|157802893|FG000|Overall Study|Death|0|||
48991565|NCT00542321|157802894|FG001|Overall Study|Death|1|||
48991566|NCT01871870|157802900|FG000|Overall Study|Hardware issues|7|||
48991567|NCT01871870|157802900|FG000|Overall Study|hyperglycemia|2|||
48991568|NCT00174460|157802904|FG000|Overall Study|Withdrawal by Subject|0|||
48991569|NCT00174460|157802905|FG001|Overall Study|Withdrawal by Subject|1|||
48991570|NCT04225026|157802906|FG000|Overall Study|Withdrawal by Subject|4|||
48991571|NCT04225026|157802906|FG000|Overall Study|Adverse Event|1|||
48991572|NCT04225026|157802906|FG000|Overall Study|Other|1|||
48991573|NCT04225026|157802906|FG000|Overall Study|Death|11|||
48991574|NCT04225026|157802906|FG000|Overall Study|Study Terminated Early By Sponsor|7|||
48991575|NCT05116787|157802909|FG000|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|0|||
48991576|NCT05116787|157802910|FG001|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|1|||
48991577|NCT05116787|157802909|FG000|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|1|||
48991578|NCT05116787|157802910|FG001|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|0|||
48991579|NCT05116787|157802909|FG000|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|1|||
48991580|NCT05116787|157802910|FG001|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|0|||
48991581|NCT05116787|157802909|FG000|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|4|||
48991582|NCT05116787|157802910|FG001|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|0|||
48991583|NCT00490815|157802911|FG000|Overall Study|Adverse Event|2|||
48991584|NCT00490815|157802912|FG001|Overall Study|Adverse Event|3|||
48991585|NCT00490815|157802911|FG000|Overall Study|Withdrawal by Subject|4|||
48991586|NCT00490815|157802912|FG001|Overall Study|Withdrawal by Subject|0|||
48991587|NCT00490815|157802911|FG000|Overall Study|Lost to Follow-up|1|||
49045044|NCT02416180|157998107|FG000|Overall Study|Withdrawal by Subject|1|||
48991588|NCT00490815|157802912|FG001|Overall Study|Lost to Follow-up|3|||
48991589|NCT00490815|157802911|FG000|Overall Study|Death|1|||
48991590|NCT00490815|157802912|FG001|Overall Study|Death|3|||
48991591|NCT02058849|157802913|FG000|Overall Study|Hospitalization|1|||
48991592|NCT02058849|157802914|FG001|Overall Study|Hospitalization|1|||
48991593|NCT02058849|157802913|FG000|Overall Study|Death|1|||
48991594|NCT02058849|157802914|FG001|Overall Study|Death|0|||
48991595|NCT02058849|157802913|FG000|Overall Study|Lost to Follow-up|1|||
48991596|NCT02058849|157802914|FG001|Overall Study|Lost to Follow-up|0|||
48991597|NCT02058849|157802913|FG000|Overall Study|Withdrawal by Subject|4|||
48991598|NCT02058849|157802914|FG001|Overall Study|Withdrawal by Subject|0|||
48991599|NCT00157157|157802916|FG000|Overall Study|Withdrawal by Subject|6|||
48991600|NCT00157157|157802916|FG000|Overall Study|Physician Decision|1|||
48991601|NCT00157157|157802916|FG000|Overall Study|Lost to Follow-up|1|||
48991602|NCT00157157|157802916|FG000|Overall Study|Enrolled in another study|1|||
48991603|NCT00157157|157802916|FG000|Overall Study|Met exclusion criteria|1|||
48991604|NCT00157157|157802916|FG000|Overall Study|Inclusion not met- baseline FVIII value|1|||
48991605|NCT01539512|157802918|FG000|Overall Study|Adverse Event|9|||
48991606|NCT01539512|157802919|FG001|Overall Study|Adverse Event|7|||
48991607|NCT01539512|157802918|FG000|Overall Study|Physician Decision|1|||
48991608|NCT01539512|157802919|FG001|Overall Study|Physician Decision|1|||
48991609|NCT01539512|157802918|FG000|Overall Study|Withdrawal by Subject|12|||
48991610|NCT01539512|157802919|FG001|Overall Study|Withdrawal by Subject|5|||
48991611|NCT01539512|157802918|FG000|Overall Study|Richter's Transformation|1|||
48991612|NCT01539512|157802919|FG001|Overall Study|Richter's Transformation|0|||
48991613|NCT03640312|157802920|FG000|Overall Study|Lost to Follow-up|3|||
48991614|NCT03640312|157802921|FG001|Overall Study|Lost to Follow-up|6|||
48991615|NCT04738123|157802922|FG000|Overall Study|Changes in condition making participant ineligible for further treatment|1|||
49045045|NCT01097694|157998108|FG000|Overall Study|Adverse Event|5|||
49045046|NCT01097694|157998109|FG001|Overall Study|Adverse Event|0|||
49045047|NCT01097694|157998108|FG000|Overall Study|Lost to Follow-up|0|||
49045048|NCT01097694|157998109|FG001|Overall Study|Lost to Follow-up|3|||
49045049|NCT01097694|157998108|FG000|Overall Study|Withdrawal by Subject|3|||
49045050|NCT01097694|157998109|FG001|Overall Study|Withdrawal by Subject|1|||
49045051|NCT02179190|157998110|FG000|Enrollment|Exit Prior to Device Attempt|11|||
49045052|NCT02179190|157998110|FG000|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7|||
49045053|NCT02179190|157998110|FG000|Follow-Up Post Barrel VRD Implanted|Death|3|||
49045054|NCT02179190|157998110|FG000|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3|||
49045055|NCT02179190|157998110|FG000|Follow-Up Post Barrel VRD Implanted|Physician Decision|2|||
49045056|NCT02179190|157998110|FG000|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1|||
49045057|NCT02005276|157998111|FG000|Overall Study|No longer interested|5|||
49045058|NCT02005276|157998112|FG001|Overall Study|No longer interested|2|||
49045059|NCT02005276|157998113|FG002|Overall Study|No longer interested|3|||
48991616|NCT04738123|157802923|FG001|Overall Study|Changes in condition making participant ineligible for further treatment|0|||
48991617|NCT04738123|157802922|FG000|Overall Study|Progressive Disease|0|||
48991618|NCT04738123|157802923|FG001|Overall Study|Progressive Disease|4|||
48991619|NCT04738123|157802922|FG000|Overall Study|Adverse Event|8|||
48991620|NCT04738123|157802923|FG001|Overall Study|Adverse Event|7|||
48991621|NCT04738123|157802922|FG000|Overall Study|Other Reasons|0|||
48991622|NCT04738123|157802923|FG001|Overall Study|Other Reasons|1|||
48991623|NCT04738123|157802922|FG000|Overall Study|Suicidal or assaultive behavior|0|||
48991624|NCT04738123|157802923|FG001|Overall Study|Suicidal or assaultive behavior|2|||
48991625|NCT04738123|157802922|FG000|Overall Study|Protocol Violation|2|||
48991626|NCT04738123|157802923|FG001|Overall Study|Protocol Violation|2|||
48991627|NCT04738123|157802922|FG000|Overall Study|Consent Withdrawn|35|||
48991628|NCT04738123|157802923|FG001|Overall Study|Consent Withdrawn|22|||
48991629|NCT04298229|157802924|FG000|Overall Study|Physician Decision|1|||
48991630|NCT04298229|157802925|FG001|Overall Study|Physician Decision|1|||
48991631|NCT04298229|157802924|FG000|Overall Study|Withdrawal by Subject|1|||
48991632|NCT04298229|157802925|FG001|Overall Study|Withdrawal by Subject|1|||
48991633|NCT04298229|157802924|FG000|Overall Study|Did not receive IV loop diuretics|2|||
48991634|NCT04298229|157802925|FG001|Overall Study|Did not receive IV loop diuretics|0|||
48991635|NCT00779506|157802929|FG000|Overall Study|Screening Failed|2|||
48991636|NCT00779506|157802929|FG000|Overall Study|Adverse Event|4|||
48991637|NCT00779506|157802929|FG000|Overall Study|Lack of Efficacy|11|||
48991638|NCT00779506|157802929|FG000|Overall Study|Protocol Violation|5|||
48991639|NCT00779506|157802929|FG000|Overall Study|Withdrawal by Subject|6|||
48991640|NCT00779506|157802929|FG000|Overall Study|Lost to Follow-up|1|||
48991641|NCT02283411|157802930|FG000|Overall Study|Withdrawal by Subject|3|||
48991642|NCT02283411|157802930|FG000|Overall Study|Screen Failed|28|||
48991643|NCT00265382|157802931|FG000|Overall Study|Adverse Event|21|||
48991644|NCT00265382|157802931|FG000|Overall Study|Laboratory Abnormality|1|||
48991645|NCT00265382|157802931|FG000|Overall Study|Lost to Follow-up|3|||
48991646|NCT00265382|157802931|FG000|Overall Study|Lack of Efficacy|6|||
48991647|NCT00265382|157802931|FG000|Overall Study|Miscellaneous|6|||
48991648|NCT00265382|157802931|FG000|Overall Study|Withdrawal by Subject|13|||
48991649|NCT00265382|157802931|FG000|Overall Study|Study terminated by sponsor|94|||
48991650|NCT00265382|157802931|FG000|Overall Study|Death|1|||
48991651|NCT01083121|157802943|FG000|Overall Study|Use of Humira outside the approved label|81|||
48991652|NCT04409262|157802944|FG000|Overall Study|Adverse Event|0|||
48991653|NCT04409262|157802945|FG001|Overall Study|Adverse Event|2|||
48991654|NCT04409262|157802944|FG000|Overall Study|Death|55|||
48991655|NCT04409262|157802945|FG001|Overall Study|Death|97|||
48991656|NCT04409262|157802944|FG000|Overall Study|Lost to Follow-up|12|||
48991657|NCT04409262|157802945|FG001|Overall Study|Lost to Follow-up|23|||
48991658|NCT04409262|157802944|FG000|Overall Study|Lack of Staff|0|||
48991659|NCT04409262|157802945|FG001|Overall Study|Lack of Staff|1|||
48991660|NCT04409262|157802944|FG000|Overall Study|Protocol Violation|3|||
48991661|NCT04409262|157802945|FG001|Overall Study|Protocol Violation|1|||
48991662|NCT04409262|157802944|FG000|Overall Study|Withdrawal by Subject|5|||
48991663|NCT04409262|157802945|FG001|Overall Study|Withdrawal by Subject|10|||
48991664|NCT00972309|157802950|FG000|Overall Study|Switched to alternative treatment|0|||
48991665|NCT00972309|157802951|FG001|Overall Study|Switched to alternative treatment|2|||
48991666|NCT00972309|157802950|FG000|Overall Study|Refused further treatment|0|||
48991667|NCT00972309|157802951|FG001|Overall Study|Refused further treatment|1|||
48991668|NCT00972309|157802950|FG000|Overall Study|Late determination of ineligibility|0|||
48991669|NCT00972309|157802951|FG001|Overall Study|Late determination of ineligibility|1|||
48991670|NCT00972309|157802950|FG000|Overall Study|Second malignancy|1|||
48991671|NCT00972309|157802951|FG001|Overall Study|Second malignancy|1|||
48991672|NCT00972309|157802950|FG000|Overall Study|Visa issues|0|||
48991673|NCT00972309|157802951|FG001|Overall Study|Visa issues|1|||
48991674|NCT00972309|157802950|FG000|Overall Study|Secondary cancer (SCC)|0|||
48991675|NCT00972309|157802951|FG001|Overall Study|Secondary cancer (SCC)|1|||
48991676|NCT00972309|157802950|FG000|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|0|||
48991677|NCT00972309|157802951|FG001|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|1|||
48991678|NCT00972309|157802950|FG000|Overall Study|Lost to Follow-up|1|||
48991679|NCT00972309|157802951|FG001|Overall Study|Lost to Follow-up|1|||
48991680|NCT00972309|157802950|FG000|Overall Study|Disease progression on study|10|||
48991681|NCT00972309|157802951|FG001|Overall Study|Disease progression on study|4|||
48991682|NCT04794491|157802952|FG000|Overall Study|Adverse Event|1|||
48991683|NCT04794491|157802952|FG000|Overall Study|Alcohol or Urine Drug Screen Result Is Positive|4|||
48991684|NCT04794491|157802952|FG000|Overall Study|Noncompliance With Study Intervention|1|||
48991685|NCT04794491|157802952|FG000|Overall Study|Withdrawal by Subject|2|||
48991686|NCT00931515|157802953|FG000|Overall Study|Lost to Follow-up|2|||
48991687|NCT00931515|157802954|FG001|Overall Study|Lost to Follow-up|5|||
48991688|NCT04246996|157802963|FG000|Overall Study|Physician Decision|1|||
48991689|NCT04246996|157802964|FG001|Overall Study|Physician Decision|1|||
48991690|NCT04246996|157802963|FG000|Overall Study|Did not meet eligibility criteria|1|||
48991691|NCT04246996|157802964|FG001|Overall Study|Did not meet eligibility criteria|4|||
48991692|NCT00302731|157802965|FG000|Overall Study|Lost to Follow-up|1|||
48991693|NCT00302731|157802966|FG001|Overall Study|Lost to Follow-up|2|||
48991694|NCT00302731|157802967|FG002|Overall Study|Lost to Follow-up|0|||
48991695|NCT00302731|157802968|FG003|Overall Study|Lost to Follow-up|0|||
48991696|NCT00302731|157802965|FG000|Overall Study|Adverse Event|0|||
48991697|NCT00302731|157802966|FG001|Overall Study|Adverse Event|2|||
48991698|NCT00302731|157802967|FG002|Overall Study|Adverse Event|2|||
48991699|NCT00302731|157802968|FG003|Overall Study|Adverse Event|0|||
48991700|NCT00302731|157802965|FG000|Overall Study|Withdrawal by Subject|1|||
48991701|NCT00302731|157802966|FG001|Overall Study|Withdrawal by Subject|1|||
48991702|NCT00302731|157802967|FG002|Overall Study|Withdrawal by Subject|0|||
48991703|NCT00302731|157802968|FG003|Overall Study|Withdrawal by Subject|0|||
48991704|NCT00302731|157802965|FG000|Overall Study|Protocol Violation|1|||
48991705|NCT00302731|157802966|FG001|Overall Study|Protocol Violation|0|||
48991706|NCT00302731|157802967|FG002|Overall Study|Protocol Violation|0|||
48991707|NCT00302731|157802968|FG003|Overall Study|Protocol Violation|0|||
48991708|NCT00302731|157802965|FG000|Overall Study|cancer unrelated to study discovered|1|||
48991709|NCT00302731|157802966|FG001|Overall Study|cancer unrelated to study discovered|0|||
48991710|NCT00302731|157802967|FG002|Overall Study|cancer unrelated to study discovered|1|||
48991711|NCT00302731|157802968|FG003|Overall Study|cancer unrelated to study discovered|0|||
48991712|NCT00736840|157802969|FG000|Overall Study|Lost to Follow-up|13|||
48991713|NCT02815670|157802970|FG000|Overall Study|Prematurely discontinued of the trial|1|||
48991714|NCT01874288|157802973|FG000|Overall Study|Withdrawal by Subject|1|||
48991715|NCT01874288|157802974|FG001|Overall Study|Withdrawal by Subject|0|||
48991716|NCT01874288|157802975|FG002|Overall Study|Withdrawal by Subject|2|||
48991717|NCT01874288|157802976|FG003|Overall Study|Withdrawal by Subject|1|||
48991718|NCT01874288|157802977|FG004|Overall Study|Withdrawal by Subject|1|||
48991719|NCT01874288|157802973|FG000|Overall Study|Physician Decision|0|||
48991720|NCT01874288|157802974|FG001|Overall Study|Physician Decision|0|||
48991721|NCT01874288|157802975|FG002|Overall Study|Physician Decision|0|||
48991722|NCT01874288|157802976|FG003|Overall Study|Physician Decision|1|||
48991723|NCT01874288|157802977|FG004|Overall Study|Physician Decision|0|||
49045060|NCT02005276|157998114|FG003|Overall Study|No longer interested|3|||
48991724|NCT01874288|157802973|FG000|Overall Study|Progressive disease|2|||
48991725|NCT01874288|157802974|FG001|Overall Study|Progressive disease|0|||
48991726|NCT01874288|157802975|FG002|Overall Study|Progressive disease|3|||
48991727|NCT01874288|157802976|FG003|Overall Study|Progressive disease|5|||
48991728|NCT01874288|157802977|FG004|Overall Study|Progressive disease|1|||
49045061|NCT00372996|157998117|FG000|Overall Study|Death|11|||
49045062|NCT00372996|157998118|FG001|Overall Study|Death|4|||
49045063|NCT00372996|157998119|FG002|Overall Study|Death|8|||
49045064|NCT00372996|157998120|FG003|Overall Study|Death|7|||
49045065|NCT00372996|157998117|FG000|Overall Study|Lost to Follow-up|0|||
49045066|NCT00372996|157998118|FG001|Overall Study|Lost to Follow-up|2|||
49045067|NCT00372996|157998119|FG002|Overall Study|Lost to Follow-up|0|||
49045068|NCT00372996|157998120|FG003|Overall Study|Lost to Follow-up|1|||
49045069|NCT00372996|157998117|FG000|Overall Study|Withdrawal by Subject|12|||
49045070|NCT00372996|157998118|FG001|Overall Study|Withdrawal by Subject|6|||
49045071|NCT00372996|157998119|FG002|Overall Study|Withdrawal by Subject|9|||
48991729|NCT02062385|157802979|FG000|Overall Study|Adverse Event|19|||
48991730|NCT02062385|157802980|FG001|Overall Study|Adverse Event|13|||
48991731|NCT02062385|157802981|FG002|Overall Study|Adverse Event|1|||
48991732|NCT02062385|157802982|FG003|Overall Study|Adverse Event|0|||
48991733|NCT02062385|157802979|FG000|Overall Study|Protocol Violation|1|||
48991734|NCT02062385|157802980|FG001|Overall Study|Protocol Violation|0|||
48991735|NCT02062385|157802981|FG002|Overall Study|Protocol Violation|0|||
48991736|NCT02062385|157802982|FG003|Overall Study|Protocol Violation|0|||
48991737|NCT02062385|157802979|FG000|Overall Study|Incomplete EPI by database lock|2|||
48991738|NCT02062385|157802980|FG001|Overall Study|Incomplete EPI by database lock|0|||
48991739|NCT02062385|157802981|FG002|Overall Study|Incomplete EPI by database lock|0|||
48991740|NCT02062385|157802982|FG003|Overall Study|Incomplete EPI by database lock|0|||
48991741|NCT02062385|157802979|FG000|Overall Study|Moved|10|||
48991742|NCT02062385|157802980|FG001|Overall Study|Moved|11|||
48991743|NCT02062385|157802981|FG002|Overall Study|Moved|1|||
48991744|NCT02062385|157802982|FG003|Overall Study|Moved|0|||
48991745|NCT02062385|157802979|FG000|Overall Study|Withdrawn by parent/guardian|46|||
48991746|NCT02062385|157802980|FG001|Overall Study|Withdrawn by parent/guardian|41|||
48991747|NCT02062385|157802981|FG002|Overall Study|Withdrawn by parent/guardian|9|||
48991748|NCT02062385|157802982|FG003|Overall Study|Withdrawn by parent/guardian|8|||
48991749|NCT02062385|157802979|FG000|Overall Study|Death|0|||
48991750|NCT02062385|157802980|FG001|Overall Study|Death|0|||
48991751|NCT02062385|157802981|FG002|Overall Study|Death|0|||
48991752|NCT02062385|157802982|FG003|Overall Study|Death|1|||
48991753|NCT02062385|157802979|FG000|Overall Study|Lost to Follow-up|0|||
48991754|NCT02062385|157802980|FG001|Overall Study|Lost to Follow-up|0|||
48991755|NCT02062385|157802981|FG002|Overall Study|Lost to Follow-up|1|||
48991756|NCT02062385|157802982|FG003|Overall Study|Lost to Follow-up|0|||
48991757|NCT02452892|157802986|FG000|Week 1 Initial Randommization|Adverse Event|1|||
48991758|NCT02452892|157802987|FG001|Week 1 Initial Randommization|Adverse Event|0|||
48991759|NCT02452892|157802988|FG002|Week 1 Initial Randommization|Adverse Event|0|||
48991760|NCT02452892|157802989|FG003|Week 1 Initial Randommization|Adverse Event|0|||
48991761|NCT02452892|157802986|FG000|Week 1 Initial Randommization|Lost to Follow-up|0|||
48991762|NCT02452892|157802987|FG001|Week 1 Initial Randommization|Lost to Follow-up|0|||
49045072|NCT00372996|157998120|FG003|Overall Study|Withdrawal by Subject|5|||
49045073|NCT00372996|157998117|FG000|Overall Study|Study Terminated by Sponsor|4|||
49045074|NCT00372996|157998118|FG001|Overall Study|Study Terminated by Sponsor|0|||
49045075|NCT00372996|157998119|FG002|Overall Study|Study Terminated by Sponsor|4|||
48991763|NCT02452892|157802988|FG002|Week 1 Initial Randommization|Lost to Follow-up|1|||
48991764|NCT02452892|157802989|FG003|Week 1 Initial Randommization|Lost to Follow-up|0|||
48991765|NCT02452892|157802986|FG000|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
48991766|NCT02452892|157802987|FG001|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
48991767|NCT02452892|157802988|FG002|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
48991768|NCT02452892|157802989|FG003|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2|||
48991769|NCT02452892|157802986|FG000|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2|||
48991770|NCT02452892|157802987|FG001|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
48991771|NCT02452892|157802988|FG002|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
48991772|NCT02452892|157802989|FG003|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
48991773|NCT02452892|157802986|FG000|Follow-up|Withdrawal by Subject|0|||
48991774|NCT02452892|157802987|FG001|Follow-up|Withdrawal by Subject|0|||
48991775|NCT02452892|157802988|FG002|Follow-up|Withdrawal by Subject|0|||
48991776|NCT02452892|157802989|FG003|Follow-up|Withdrawal by Subject|1|||
48991777|NCT02452892|157802986|FG000|Follow-up|Subject left town on Day 42|1|||
48991778|NCT02452892|157802987|FG001|Follow-up|Subject left town on Day 42|0|||
48991779|NCT02452892|157802988|FG002|Follow-up|Subject left town on Day 42|0|||
48991780|NCT02452892|157802989|FG003|Follow-up|Subject left town on Day 42|0|||
48991781|NCT02451137|157802990|FG000|Overall Study|Randomized but not treated|19|||
48991782|NCT02451137|157802991|FG001|Overall Study|Randomized but not treated|27|||
48991783|NCT02451137|157802990|FG000|Overall Study|Adverse Event|43|||
48991784|NCT02451137|157802991|FG001|Overall Study|Adverse Event|42|||
48991785|NCT02451137|157802990|FG000|Overall Study|Lack of Efficacy|4|||
48991786|NCT02451137|157802991|FG001|Overall Study|Lack of Efficacy|9|||
48991787|NCT02451137|157802990|FG000|Overall Study|Participant decision:discontinue insulin|41|||
49045076|NCT00372996|157998120|FG003|Overall Study|Study Terminated by Sponsor|0|||
49045077|NCT00372996|157998117|FG000|Overall Study|Other|10|||
49045078|NCT00372996|157998118|FG001|Overall Study|Other|2|||
49045079|NCT00372996|157998119|FG002|Overall Study|Other|7|||
49045080|NCT00372996|157998120|FG003|Overall Study|Other|7|||
49045081|NCT01186016|157998121|FG000|Overall Study|Withdrawal by Subject|46|||
49045082|NCT01186016|157998122|FG001|Overall Study|Withdrawal by Subject|29|||
49045083|NCT03750695|157998126|FG000|Overall Study|Lost to Follow-up|0|||
49045084|NCT03750695|157998127|FG001|Overall Study|Lost to Follow-up|1|||
49045085|NCT01899053|157998131|FG000|Overall Study|Progressive Disease|4|||
49045086|NCT01899053|157998132|FG001|Overall Study|Progressive Disease|0|||
49045087|NCT01899053|157998133|FG002|Overall Study|Progressive Disease|3|||
49045088|NCT01899053|157998134|FG003|Overall Study|Progressive Disease|0|||
49045089|NCT01899053|157998135|FG004|Overall Study|Progressive Disease|3|||
49045090|NCT01899053|157998136|FG005|Overall Study|Progressive Disease|1|||
49045091|NCT01899053|157998137|FG006|Overall Study|Progressive Disease|1|||
49045092|NCT01899053|157998138|FG007|Overall Study|Progressive Disease|1|||
49045093|NCT01899053|157998139|FG008|Overall Study|Progressive Disease|4|||
49045094|NCT01899053|157998140|FG009|Overall Study|Progressive Disease|3|||
49045095|NCT01899053|157998141|FG010|Overall Study|Progressive Disease|12|||
49045096|NCT01899053|157998142|FG011|Overall Study|Progressive Disease|5|||
49045097|NCT01899053|157998143|FG012|Overall Study|Progressive Disease|8|||
49045098|NCT01899053|157998144|FG013|Overall Study|Progressive Disease|17|||
48991788|NCT02451137|157802991|FG001|Overall Study|Participant decision:discontinue insulin|43|||
48991789|NCT02451137|157802990|FG000|Overall Study|Hypoglycemia|2|||
49045099|NCT01899053|157998131|FG000|Overall Study|Adverse Event|1|||
49045100|NCT01899053|157998132|FG001|Overall Study|Adverse Event|1|||
48991790|NCT02451137|157802991|FG001|Overall Study|Hypoglycemia|1|||
48991791|NCT02451137|157802990|FG000|Overall Study|Investigator's decision|23|||
48991792|NCT02451137|157802991|FG001|Overall Study|Investigator's decision|19|||
48991793|NCT02451137|157802990|FG000|Overall Study|Lost to Follow-up|53|||
48991794|NCT02451137|157802991|FG001|Overall Study|Lost to Follow-up|61|||
48991795|NCT02451137|157802990|FG000|Overall Study|Physician Decision|6|||
48991796|NCT02451137|157802991|FG001|Overall Study|Physician Decision|5|||
48991797|NCT02451137|157802990|FG000|Overall Study|Sponsor decision|13|||
48991798|NCT02451137|157802991|FG001|Overall Study|Sponsor decision|25|||
48991799|NCT02451137|157802990|FG000|Overall Study|Withdrawal by Subject|40|||
48991800|NCT02451137|157802991|FG001|Overall Study|Withdrawal by Subject|63|||
48991801|NCT02451137|157802990|FG000|Overall Study|Other than specified above|2|||
48991802|NCT02451137|157802991|FG001|Overall Study|Other than specified above|3|||
48991803|NCT03664804|157802992|FG000|Overall Study|Withdrawal by Subject|7|||
48991804|NCT03053180|157804480|FG000|Overall Study|Failure to Return|1|||
48991805|NCT04823494|157804481|FG000|Overall Study|Programming software malfunction.|1|||
48991806|NCT04823494|157804482|FG001|Overall Study|Programming software malfunction.|0|||
48991807|NCT04823494|157804481|FG000|Overall Study|Withdrawal by Subject|1|||
48991808|NCT04823494|157804482|FG001|Overall Study|Withdrawal by Subject|0|||
49045101|NCT01899053|157998133|FG002|Overall Study|Adverse Event|1|||
49045102|NCT01899053|157998134|FG003|Overall Study|Adverse Event|3|||
49045103|NCT01899053|157998135|FG004|Overall Study|Adverse Event|1|||
49045104|NCT01899053|157998136|FG005|Overall Study|Adverse Event|1|||
49045105|NCT01899053|157998137|FG006|Overall Study|Adverse Event|1|||
49045106|NCT01899053|157998138|FG007|Overall Study|Adverse Event|0|||
49045107|NCT01899053|157998139|FG008|Overall Study|Adverse Event|2|||
49045108|NCT01899053|157998140|FG009|Overall Study|Adverse Event|0|||
49045109|NCT01899053|157998141|FG010|Overall Study|Adverse Event|3|||
49045110|NCT01899053|157998142|FG011|Overall Study|Adverse Event|1|||
48991809|NCT04823494|157804481|FG000|Overall Study|Devices lost|0|||
48991810|NCT04823494|157804482|FG001|Overall Study|Devices lost|1|||
48991811|NCT02028182|157804493|FG000|Overall Study|Protocol Violation|2|||
48991812|NCT01684930|157804496|FG000|Overall Study|Withdrawal by Subject|3|||
48991813|NCT01684930|157804497|FG001|Overall Study|Withdrawal by Subject|1|||
48991814|NCT02198040|157804499|FG000|Overall Study|Work reasons|0|||
48991815|NCT02198040|157804500|FG001|Overall Study|Work reasons|1|||
48991816|NCT02198040|157804501|FG002|Overall Study|Work reasons|0|||
48991817|NCT02198040|157804499|FG000|Overall Study|Withdrawal by Subject|0|||
48991818|NCT02198040|157804500|FG001|Overall Study|Withdrawal by Subject|0|||
48991819|NCT02198040|157804501|FG002|Overall Study|Withdrawal by Subject|1|||
48991820|NCT04524663|157804502|FG000|Overall Study|Withdrawal by Subject|0|||
48991821|NCT04524663|157804503|FG001|Overall Study|Withdrawal by Subject|2|||
48991822|NCT01265719|157804504|FG000|Overall Study|Does not meet entrance criteria|0|||
48991823|NCT01265719|157804505|FG001|Overall Study|Does not meet entrance criteria|3|||
48991824|NCT01265719|157804504|FG000|Overall Study|Other reasons|2|||
48991825|NCT01265719|157804505|FG001|Overall Study|Other reasons|0|||
49045111|NCT01899053|157998143|FG012|Overall Study|Adverse Event|2|||
49045112|NCT01899053|157998144|FG013|Overall Study|Adverse Event|2|||
49045113|NCT01899053|157998131|FG000|Overall Study|Reason Not Specified|0|||
49045114|NCT01899053|157998132|FG001|Overall Study|Reason Not Specified|0|||
49045115|NCT01899053|157998133|FG002|Overall Study|Reason Not Specified|0|||
49045116|NCT01899053|157998134|FG003|Overall Study|Reason Not Specified|0|||
49045117|NCT01899053|157998135|FG004|Overall Study|Reason Not Specified|0|||
49045118|NCT01899053|157998136|FG005|Overall Study|Reason Not Specified|0|||
49045119|NCT01899053|157998137|FG006|Overall Study|Reason Not Specified|1|||
49045120|NCT01899053|157998138|FG007|Overall Study|Reason Not Specified|0|||
49045121|NCT01899053|157998139|FG008|Overall Study|Reason Not Specified|0|||
49045122|NCT01899053|157998140|FG009|Overall Study|Reason Not Specified|0|||
48991826|NCT01265719|157804504|FG000|Overall Study|Withdrawal by Subject|8|||
48991827|NCT01265719|157804505|FG001|Overall Study|Withdrawal by Subject|3|||
48991828|NCT01265719|157804504|FG000|Overall Study|Lost to Follow-up|2|||
48991829|NCT01265719|157804505|FG001|Overall Study|Lost to Follow-up|7|||
48991830|NCT01265719|157804504|FG000|Overall Study|Adverse Event|2|||
48991831|NCT01265719|157804505|FG001|Overall Study|Adverse Event|0|||
48991832|NCT00337935|157804506|FG000|Overall Study|Adverse Event|2|||
48991833|NCT00337935|157804507|FG001|Overall Study|Adverse Event|5|||
48991834|NCT00337935|157804506|FG000|Overall Study|Death|2|||
48991835|NCT00337935|157804507|FG001|Overall Study|Death|8|||
48991836|NCT00337935|157804506|FG000|Overall Study|Physician Decision|1|||
48991837|NCT00337935|157804507|FG001|Overall Study|Physician Decision|1|||
48991838|NCT00337935|157804506|FG000|Overall Study|Lost to Follow-up|0|||
48991839|NCT00337935|157804507|FG001|Overall Study|Lost to Follow-up|1|||
48991840|NCT00337935|157804506|FG000|Overall Study|Protocol Violation|4|||
48991841|NCT00337935|157804507|FG001|Overall Study|Protocol Violation|3|||
48991842|NCT00337935|157804506|FG000|Overall Study|Withdrawal by Subject|1|||
48991843|NCT00337935|157804507|FG001|Overall Study|Withdrawal by Subject|7|||
48991844|NCT00337935|157804506|FG000|Overall Study|Other|0|||
48991845|NCT00337935|157804507|FG001|Overall Study|Other|1|||
48991846|NCT00337935|157804506|FG000|Overall Study|Lack of Efficacy|0|||
48991847|NCT00337935|157804507|FG001|Overall Study|Lack of Efficacy|1|||
48991848|NCT01884675|157804508|FG000|Overall Study|Study closed/terminated|3|||
48991849|NCT01884675|157804509|FG001|Overall Study|Study closed/terminated|2|||
48991850|NCT02534324|157804513|FG000|Overall Study|Protocol Violation|4|||
48991851|NCT02534324|157804514|FG001|Overall Study|Protocol Violation|1|||
48991852|NCT02534324|157804513|FG000|Overall Study|Lost to Follow-up|20|||
48991853|NCT02534324|157804514|FG001|Overall Study|Lost to Follow-up|7|||
48991854|NCT02534324|157804513|FG000|Overall Study|Adverse Event|1|||
48991855|NCT02534324|157804514|FG001|Overall Study|Adverse Event|0|||
48991856|NCT00303602|157804515|FG000|Overall Study|Adverse Event|2|||
48991857|NCT00303602|157804516|FG001|Overall Study|Adverse Event|2|||
48991858|NCT00303602|157804515|FG000|Overall Study|Withdrawal by Subject|5|||
48991859|NCT00303602|157804516|FG001|Overall Study|Withdrawal by Subject|6|||
48991860|NCT00303602|157804515|FG000|Overall Study|Lost to Follow-up|5|||
48991861|NCT00303602|157804516|FG001|Overall Study|Lost to Follow-up|2|||
48991862|NCT00303602|157804515|FG000|Overall Study|Protocol entry criteria not met|2|||
48991863|NCT00303602|157804516|FG001|Overall Study|Protocol entry criteria not met|2|||
48991864|NCT00303602|157804515|FG000|Overall Study|Physician Decision|2|||
48991865|NCT00303602|157804516|FG001|Overall Study|Physician Decision|1|||
48991866|NCT00303602|157804515|FG000|Overall Study|Noncompliance|2|||
48991867|NCT00303602|157804516|FG001|Overall Study|Noncompliance|2|||
48991868|NCT00303602|157804515|FG000|Overall Study|Protocol Violation|1|||
48991869|NCT00303602|157804516|FG001|Overall Study|Protocol Violation|0|||
48991870|NCT02551874|157804521|FG000|Overall Study|Lost to Follow-up|0|||
48991871|NCT02551874|157804522|FG001|Overall Study|Lost to Follow-up|2|||
48991872|NCT02551874|157804521|FG000|Overall Study|Pregnancy|0|||
48991873|NCT02551874|157804522|FG001|Overall Study|Pregnancy|1|||
48991874|NCT02551874|157804521|FG000|Overall Study|Reason not reported|10|||
48991875|NCT02551874|157804522|FG001|Overall Study|Reason not reported|4|||
48991876|NCT02551874|157804521|FG000|Overall Study|Did not receive randomized treatment|0|||
48991877|NCT02551874|157804522|FG001|Overall Study|Did not receive randomized treatment|7|||
48991878|NCT02551874|157804521|FG000|Overall Study|Did not enter long-term study|18|||
48991879|NCT02551874|157804522|FG001|Overall Study|Did not enter long-term study|25|||
48991880|NCT00313716|157804523|FG000|Overall Study|Death|3|||
48991881|NCT00313716|157804524|FG001|Overall Study|Death|2|||
48991882|NCT00313716|157804525|FG002|Overall Study|Death|9|||
48991883|NCT00313716|157804526|FG003|Overall Study|Death|3|||
48991884|NCT00313716|157804527|FG004|Overall Study|Death|5|||
48991885|NCT00313716|157804528|FG005|Overall Study|Death|9|||
48991886|NCT00313716|157804523|FG000|Overall Study|Lost to Follow-up|2|||
48991887|NCT00313716|157804524|FG001|Overall Study|Lost to Follow-up|5|||
48991888|NCT00313716|157804525|FG002|Overall Study|Lost to Follow-up|2|||
48991889|NCT00313716|157804526|FG003|Overall Study|Lost to Follow-up|1|||
48991890|NCT00313716|157804527|FG004|Overall Study|Lost to Follow-up|0|||
48991891|NCT00313716|157804528|FG005|Overall Study|Lost to Follow-up|4|||
48991892|NCT00313716|157804523|FG000|Overall Study|Withdrawal by Subject|0|||
48991893|NCT00313716|157804524|FG001|Overall Study|Withdrawal by Subject|1|||
48991894|NCT00313716|157804525|FG002|Overall Study|Withdrawal by Subject|1|||
48991895|NCT00313716|157804526|FG003|Overall Study|Withdrawal by Subject|0|||
48991896|NCT00313716|157804527|FG004|Overall Study|Withdrawal by Subject|1|||
48991897|NCT00313716|157804528|FG005|Overall Study|Withdrawal by Subject|0|||
48991898|NCT02491463|157804529|FG000|Overall Study|Withdrawal by Subject|1|||
48991899|NCT02491463|157804530|FG001|Overall Study|Withdrawal by Subject|2|||
48991900|NCT02491463|157804531|FG002|Overall Study|Withdrawal by Subject|0|||
48991901|NCT02491463|157804532|FG003|Overall Study|Withdrawal by Subject|0|||
48991902|NCT02491463|157804529|FG000|Overall Study|Migrated/moved from study area|1|||
48991903|NCT02491463|157804530|FG001|Overall Study|Migrated/moved from study area|5|||
48991904|NCT02491463|157804531|FG002|Overall Study|Migrated/moved from study area|1|||
48991905|NCT02491463|157804532|FG003|Overall Study|Migrated/moved from study area|1|||
48991906|NCT02491463|157804529|FG000|Overall Study|Lost to Follow-up|0|||
48991907|NCT02491463|157804530|FG001|Overall Study|Lost to Follow-up|3|||
48991908|NCT02491463|157804531|FG002|Overall Study|Lost to Follow-up|3|||
48991909|NCT02491463|157804532|FG003|Overall Study|Lost to Follow-up|0|||
48991910|NCT01491802|157804533|FG000|Overall Study|Adverse Event|1|||
48991911|NCT01491802|157804534|FG001|Overall Study|Adverse Event|1|||
48991912|NCT01491802|157804533|FG000|Overall Study|Withdrawal by Subject|0|||
48991913|NCT01491802|157804534|FG001|Overall Study|Withdrawal by Subject|1|||
48991914|NCT01864746|157804537|FG000|Overall Study|Disease recurrence|25|||
48991915|NCT01864746|157804538|FG001|Overall Study|Disease recurrence|40|||
48991916|NCT01864746|157804537|FG000|Overall Study|Second primary invasive nonbreast|2|||
48991917|NCT01864746|157804538|FG001|Overall Study|Second primary invasive nonbreast|3|||
48991918|NCT01864746|157804537|FG000|Overall Study|Death|2|||
48991919|NCT01864746|157804538|FG001|Overall Study|Death|1|||
48991920|NCT01864746|157804537|FG000|Overall Study|Adverse Event|33|||
48991921|NCT01864746|157804538|FG001|Overall Study|Adverse Event|5|||
48991922|NCT01864746|157804537|FG000|Overall Study|Withdrawal by Subject|56|||
48991923|NCT01864746|157804538|FG001|Overall Study|Withdrawal by Subject|41|||
48991924|NCT01864746|157804537|FG000|Overall Study|Physician Decision|5|||
48991925|NCT01864746|157804538|FG001|Overall Study|Physician Decision|6|||
48991926|NCT01005966|157804539|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
48991927|NCT01005966|157804540|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
48991928|NCT01005966|157804541|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
48991929|NCT01005966|157804542|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
48991930|NCT01005966|157804543|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
48991931|NCT01005966|157804539|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
48991932|NCT01005966|157804540|FG001|Treatment Period 1 (14 Days)|Protocol Violation|0|||
48991933|NCT01005966|157804541|FG002|Treatment Period 1 (14 Days)|Protocol Violation|1|||
48991934|NCT01005966|157804542|FG003|Treatment Period 1 (14 Days)|Protocol Violation|0|||
48991935|NCT01005966|157804543|FG004|Treatment Period 1 (14 Days)|Protocol Violation|0|||
48991936|NCT01005966|157804539|FG000|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
48991937|NCT01005966|157804540|FG001|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
48991938|NCT01005966|157804541|FG002|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
48991939|NCT01005966|157804542|FG003|Washout Period 1 (4 Days)|Withdrawal by Subject|1|||
48991940|NCT01005966|157804543|FG004|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
48991941|NCT01005966|157804539|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
48991942|NCT01005966|157804540|FG001|Treatment Period 2 (14 Days)|Adverse Event|1|||
48991943|NCT01005966|157804541|FG002|Treatment Period 2 (14 Days)|Adverse Event|1|||
48991944|NCT01005966|157804542|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
48991945|NCT01005966|157804543|FG004|Treatment Period 2 (14 Days)|Adverse Event|0|||
48991946|NCT01005966|157804539|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
48991947|NCT01005966|157804540|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
48991948|NCT01005966|157804541|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
48991949|NCT01005966|157804542|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
48991950|NCT01005966|157804543|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
48991951|NCT01005966|157804539|FG000|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
48991952|NCT01005966|157804540|FG001|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
48991953|NCT01005966|157804541|FG002|Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
48991954|NCT01005966|157804542|FG003|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
48991955|NCT01005966|157804543|FG004|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
48991956|NCT01005966|157804539|FG000|Treatment Period 3 (14 Days)|Protocol Violation|0|||
48991957|NCT01005966|157804540|FG001|Treatment Period 3 (14 Days)|Protocol Violation|1|||
48991958|NCT01005966|157804541|FG002|Treatment Period 3 (14 Days)|Protocol Violation|0|||
48991959|NCT01005966|157804542|FG003|Treatment Period 3 (14 Days)|Protocol Violation|0|||
48991960|NCT01005966|157804543|FG004|Treatment Period 3 (14 Days)|Protocol Violation|1|||
48991961|NCT01005966|157804539|FG000|Treatment Period 4 (14 Days)|Protocol Violation|0|||
48991962|NCT01005966|157804540|FG001|Treatment Period 4 (14 Days)|Protocol Violation|1|||
48991963|NCT01005966|157804541|FG002|Treatment Period 4 (14 Days)|Protocol Violation|0|||
48991964|NCT01005966|157804542|FG003|Treatment Period 4 (14 Days)|Protocol Violation|0|||
48991965|NCT01005966|157804543|FG004|Treatment Period 4 (14 Days)|Protocol Violation|0|||
48991966|NCT01005966|157804539|FG000|Treatment Period 4 (14 Days)|Other Reason|0|||
48991967|NCT01005966|157804540|FG001|Treatment Period 4 (14 Days)|Other Reason|0|||
48991968|NCT01005966|157804541|FG002|Treatment Period 4 (14 Days)|Other Reason|0|||
48991969|NCT01005966|157804542|FG003|Treatment Period 4 (14 Days)|Other Reason|0|||
48991970|NCT01005966|157804543|FG004|Treatment Period 4 (14 Days)|Other Reason|1|||
48991971|NCT01451203|157804545|FG000|Double-blind Treatment Period|Did not receive treatment|1|||
48991972|NCT01451203|157804546|FG001|Double-blind Treatment Period|Did not receive treatment|2|||
48991973|NCT01451203|157804545|FG000|Double-blind Treatment Period|Consent Withdrawn|3|||
48991974|NCT01451203|157804546|FG001|Double-blind Treatment Period|Consent Withdrawn|2|||
48991975|NCT01451203|157804545|FG000|Double-blind Treatment Period|Lack of Efficacy|71|||
48991976|NCT01451203|157804546|FG001|Double-blind Treatment Period|Lack of Efficacy|36|||
48991977|NCT01451203|157804545|FG000|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0|||
48991978|NCT01451203|157804546|FG001|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1|||
48991979|NCT01451203|157804545|FG000|Double-blind Treatment Period|Adverse Event|6|||
48991980|NCT01451203|157804546|FG001|Double-blind Treatment Period|Adverse Event|9|||
48991981|NCT01451203|157804545|FG000|Double-blind Treatment Period|Missing study medication ≥6 times|1|||
48991982|NCT01451203|157804546|FG001|Double-blind Treatment Period|Missing study medication ≥6 times|0|||
48991983|NCT01451203|157804545|FG000|Double-blind Treatment Period|Violation of eligibility criteria|1|||
48991984|NCT01451203|157804546|FG001|Double-blind Treatment Period|Violation of eligibility criteria|0|||
48991985|NCT01451203|157804545|FG000|Double-blind Treatment Period|Investigator decision|2|||
48991986|NCT01451203|157804546|FG001|Double-blind Treatment Period|Investigator decision|0|||
48991987|NCT01451203|157804545|FG000|Post-treatment Period|Consent withdrawn|2|||
48991988|NCT01451203|157804546|FG001|Post-treatment Period|Consent withdrawn|4|||
48991989|NCT01451203|157804545|FG000|Post-treatment Period|Lack of Efficacy|12|||
48991990|NCT01451203|157804546|FG001|Post-treatment Period|Lack of Efficacy|28|||
48991991|NCT01451203|157804545|FG000|Post-treatment Period|Adverse Event|0|||
48991992|NCT01451203|157804546|FG001|Post-treatment Period|Adverse Event|1|||
48991993|NCT01451203|157804545|FG000|Post-treatment Period|Investigator decision|0|||
48991994|NCT01451203|157804546|FG001|Post-treatment Period|Investigator decision|1|||
48991995|NCT00039377|157804547|FG000|Initial Registration|Adverse Event|2|||
48991996|NCT00039377|157804548|FG001|Initial Registration|Adverse Event|0|||
48991997|NCT00039377|157804549|FG002|Initial Registration|Adverse Event|0|||
48991998|NCT00039377|157804550|FG003|Initial Registration|Adverse Event|0|||
48991999|NCT00039377|157804547|FG000|Initial Registration|Relapsed|6|||
48992000|NCT00039377|157804548|FG001|Initial Registration|Relapsed|0|||
48992001|NCT00039377|157804549|FG002|Initial Registration|Relapsed|0|||
48992002|NCT00039377|157804550|FG003|Initial Registration|Relapsed|0|||
48992003|NCT00039377|157804547|FG000|Initial Registration|Received non-protocol therapy|11|||
48992004|NCT00039377|157804548|FG001|Initial Registration|Received non-protocol therapy|0|||
48992005|NCT00039377|157804549|FG002|Initial Registration|Received non-protocol therapy|0|||
48992006|NCT00039377|157804550|FG003|Initial Registration|Received non-protocol therapy|0|||
48992007|NCT00039377|157804547|FG000|Initial Registration|Withdrawal by Subject|3|||
48992008|NCT00039377|157804548|FG001|Initial Registration|Withdrawal by Subject|0|||
48992009|NCT00039377|157804549|FG002|Initial Registration|Withdrawal by Subject|0|||
48992010|NCT00039377|157804550|FG003|Initial Registration|Withdrawal by Subject|0|||
48992011|NCT02927990|157804551|FG000|Overall Study|Protocol Violation|4|||
48992012|NCT02927990|157804551|FG000|Overall Study|Physician Decision|9|||
48992013|NCT02927990|157804551|FG000|Overall Study|Room switched and therefore no study device available|15|||
48992014|NCT02927990|157804551|FG000|Overall Study|No procedure performed, only diagnostic catheterization|28|||
48992015|NCT03704194|157804557|FG000|Overall Study|Withdrawal by Subject|0|||
48992016|NCT03704194|157804558|FG001|Overall Study|Withdrawal by Subject|1|||
48992017|NCT03382639|157804559|FG000|Overall Study|Adverse Event|2|||
48992018|NCT03382639|157804560|FG001|Overall Study|Adverse Event|0|||
48992019|NCT03382639|157804561|FG002|Overall Study|Adverse Event|1|||
48992020|NCT03382639|157804562|FG003|Overall Study|Adverse Event|1|||
48992021|NCT03382639|157804559|FG000|Overall Study|Lost to Follow-up|1|||
48992022|NCT03382639|157804560|FG001|Overall Study|Lost to Follow-up|0|||
48992023|NCT03382639|157804561|FG002|Overall Study|Lost to Follow-up|0|||
48992024|NCT03382639|157804562|FG003|Overall Study|Lost to Follow-up|0|||
49045123|NCT01899053|157998141|FG010|Overall Study|Reason Not Specified|0|||
49045124|NCT01899053|157998142|FG011|Overall Study|Reason Not Specified|0|||
49045125|NCT01899053|157998143|FG012|Overall Study|Reason Not Specified|1|||
49045126|NCT01899053|157998144|FG013|Overall Study|Reason Not Specified|0|||
49045127|NCT01899053|157998131|FG000|Overall Study|Withdrawal by Subject|1|||
49045128|NCT01899053|157998132|FG001|Overall Study|Withdrawal by Subject|1|||
49045129|NCT01899053|157998133|FG002|Overall Study|Withdrawal by Subject|2|||
48992025|NCT03382639|157804559|FG000|Overall Study|Withdrawal by Subject|4|||
48992026|NCT03382639|157804560|FG001|Overall Study|Withdrawal by Subject|3|||
49045130|NCT01899053|157998134|FG003|Overall Study|Withdrawal by Subject|0|||
49045131|NCT01899053|157998135|FG004|Overall Study|Withdrawal by Subject|2|||
48992027|NCT03382639|157804561|FG002|Overall Study|Withdrawal by Subject|2|||
48992028|NCT03382639|157804562|FG003|Overall Study|Withdrawal by Subject|3|||
48992029|NCT03382639|157804559|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
49045132|NCT01899053|157998136|FG005|Overall Study|Withdrawal by Subject|0|||
49045133|NCT01899053|157998137|FG006|Overall Study|Withdrawal by Subject|0|||
48992030|NCT03382639|157804560|FG001|Overall Study|Unsatisfactory therapeutic response|0|||
48992031|NCT03382639|157804561|FG002|Overall Study|Unsatisfactory therapeutic response|0|||
49045134|NCT01899053|157998138|FG007|Overall Study|Withdrawal by Subject|1|||
49045135|NCT01899053|157998139|FG008|Overall Study|Withdrawal by Subject|0|||
48992032|NCT03382639|157804562|FG003|Overall Study|Unsatisfactory therapeutic response|0|||
48992033|NCT03382639|157804559|FG000|Overall Study|Noncompliance with study drug during the DBTP|1|||
48992034|NCT03382639|157804560|FG001|Overall Study|Noncompliance with study drug during the DBTP|2|||
48992035|NCT03382639|157804561|FG002|Overall Study|Noncompliance with study drug during the DBTP|1|||
48992036|NCT03382639|157804562|FG003|Overall Study|Noncompliance with study drug during the DBTP|1|||
48992037|NCT03382639|157804559|FG000|Overall Study|Other|2|||
48992038|NCT03382639|157804560|FG001|Overall Study|Other|0|||
48992039|NCT03382639|157804561|FG002|Overall Study|Other|0|||
48992040|NCT03382639|157804562|FG003|Overall Study|Other|3|||
48992041|NCT02406586|157804563|FG000|Overall Study|Lost to Follow-up|0|||
48992042|NCT02406586|157804564|FG001|Overall Study|Lost to Follow-up|4|||
48992043|NCT02406586|157804565|FG002|Overall Study|Lost to Follow-up|2|||
48992044|NCT02406586|157804563|FG000|Overall Study|Withdrawal by Subject|1|||
48992045|NCT02406586|157804564|FG001|Overall Study|Withdrawal by Subject|0|||
48992046|NCT02406586|157804565|FG002|Overall Study|Withdrawal by Subject|0|||
48992047|NCT02839330|157804566|FG000|Overall Study|Adverse Event|0|||
48992048|NCT02839330|157804567|FG001|Overall Study|Adverse Event|1|||
48992049|NCT02839330|157804568|FG002|Overall Study|Adverse Event|2|||
48992050|NCT02839330|157804569|FG003|Overall Study|Adverse Event|2|||
48992051|NCT02839330|157804566|FG000|Overall Study|Death|4|||
48992052|NCT02839330|157804567|FG001|Overall Study|Death|6|||
48992053|NCT02839330|157804568|FG002|Overall Study|Death|1|||
48992054|NCT02839330|157804569|FG003|Overall Study|Death|1|||
48992055|NCT02839330|157804566|FG000|Overall Study|Withdrawal by Subject|27|||
48992056|NCT02839330|157804567|FG001|Overall Study|Withdrawal by Subject|19|||
48992057|NCT02839330|157804568|FG002|Overall Study|Withdrawal by Subject|11|||
48992058|NCT02839330|157804569|FG003|Overall Study|Withdrawal by Subject|13|||
48992059|NCT02839330|157804566|FG000|Overall Study|Lost to Follow-up|22|||
48992060|NCT02839330|157804567|FG001|Overall Study|Lost to Follow-up|27|||
49045136|NCT01899053|157998140|FG009|Overall Study|Withdrawal by Subject|0|||
48992061|NCT02839330|157804568|FG002|Overall Study|Lost to Follow-up|29|||
48992062|NCT02839330|157804569|FG003|Overall Study|Lost to Follow-up|25|||
48992063|NCT02839330|157804566|FG000|Overall Study|Administrative Reason|0|||
48992064|NCT02839330|157804567|FG001|Overall Study|Administrative Reason|0|||
48992065|NCT02839330|157804568|FG002|Overall Study|Administrative Reason|0|||
48992066|NCT02839330|157804569|FG003|Overall Study|Administrative Reason|1|||
49045137|NCT01899053|157998141|FG010|Overall Study|Withdrawal by Subject|0|||
49045138|NCT01899053|157998142|FG011|Overall Study|Withdrawal by Subject|0|||
49045139|NCT01899053|157998143|FG012|Overall Study|Withdrawal by Subject|1|||
49045140|NCT01899053|157998144|FG013|Overall Study|Withdrawal by Subject|1|||
49045141|NCT01899053|157998131|FG000|Overall Study|Protocol Violation|0|||
49045142|NCT01899053|157998132|FG001|Overall Study|Protocol Violation|0|||
49045143|NCT01899053|157998133|FG002|Overall Study|Protocol Violation|1|||
49045144|NCT01899053|157998134|FG003|Overall Study|Protocol Violation|0|||
49045145|NCT01899053|157998135|FG004|Overall Study|Protocol Violation|0|||
48992067|NCT02839330|157804566|FG000|Overall Study|Protocol Violation|1|||
48992068|NCT02839330|157804567|FG001|Overall Study|Protocol Violation|2|||
48992069|NCT02839330|157804568|FG002|Overall Study|Protocol Violation|2|||
48992070|NCT02839330|157804569|FG003|Overall Study|Protocol Violation|3|||
48992071|NCT02839330|157804566|FG000|Overall Study|Other reason, not specified|4|||
48992072|NCT02839330|157804567|FG001|Overall Study|Other reason, not specified|3|||
48992073|NCT02839330|157804568|FG002|Overall Study|Other reason, not specified|3|||
48992074|NCT02839330|157804569|FG003|Overall Study|Other reason, not specified|6|||
48992075|NCT00682539|157804570|FG000|Bevacizumab vs Triamcinolone|Lost to Follow-up|3|||
48992076|NCT00682539|157804571|FG001|Bevacizumab vs Triamcinolone|Lost to Follow-up|1|||
48992077|NCT00682539|157804572|FG002|Bevacizumab vs Triamcinolone|Lost to Follow-up|0|||
48992078|NCT00682539|157804570|FG000|Ranibizumab vs Triamcinolone|Lost to Follow-up|0|||
48992079|NCT00682539|157804571|FG001|Ranibizumab vs Triamcinolone|Lost to Follow-up|3|||
48992080|NCT00682539|157804572|FG002|Ranibizumab vs Triamcinolone|Lost to Follow-up|8|||
48992081|NCT03737812|157804573|FG000|Overall Study|Withdrawal by Subject|1|||
48992082|NCT03737812|157804574|FG001|Overall Study|Withdrawal by Subject|2|||
48992083|NCT03737812|157804575|FG002|Overall Study|Withdrawal by Subject|1|||
48992084|NCT03737812|157804573|FG000|Overall Study|Sponsor Discontinued the Study|4|||
49045146|NCT01899053|157998136|FG005|Overall Study|Protocol Violation|0|||
49045147|NCT01899053|157998137|FG006|Overall Study|Protocol Violation|0|||
49045148|NCT01899053|157998138|FG007|Overall Study|Protocol Violation|0|||
49045149|NCT01899053|157998139|FG008|Overall Study|Protocol Violation|0|||
49045150|NCT01899053|157998140|FG009|Overall Study|Protocol Violation|0|||
48992085|NCT03737812|157804574|FG001|Overall Study|Sponsor Discontinued the Study|3|||
48992086|NCT03737812|157804575|FG002|Overall Study|Sponsor Discontinued the Study|2|||
48992087|NCT03737812|157804573|FG000|Overall Study|Adverse Event|0|||
48992088|NCT03737812|157804574|FG001|Overall Study|Adverse Event|1|||
48992089|NCT03737812|157804575|FG002|Overall Study|Adverse Event|0|||
48992090|NCT03737812|157804573|FG000|Overall Study|COVID -19 Logistical Restrictions|0|||
48992091|NCT03737812|157804574|FG001|Overall Study|COVID -19 Logistical Restrictions|0|||
49045151|NCT01899053|157998141|FG010|Overall Study|Protocol Violation|0|||
49045152|NCT01899053|157998142|FG011|Overall Study|Protocol Violation|0|||
48992092|NCT03737812|157804575|FG002|Overall Study|COVID -19 Logistical Restrictions|1|||
48992093|NCT01345162|157804578|FG000|Overall Study|Protocol Violation|2|||
48992094|NCT01345162|157804579|FG001|Overall Study|Protocol Violation|4|||
48992095|NCT00285857|157804580|FG000|Overall Study|Withdrawal by Subject|2|||
48992096|NCT00285857|157804580|FG000|Overall Study|Inadequate initial breast cytology|1|||
48992097|NCT00285857|157804580|FG000|Overall Study|Adverse Event|1|||
48992098|NCT02506101|157804581|FG000|Overall Study|Transportation issues|1|||
48992099|NCT02506101|157804582|FG001|Overall Study|Transportation issues|0|||
48992100|NCT02506101|157804581|FG000|Overall Study|No enrollment and staff unavailability|1|||
48992101|NCT02506101|157804582|FG001|Overall Study|No enrollment and staff unavailability|0|||
48992102|NCT00508872|157804583|FG000|Overall Study|Lost to Follow-up|1|||
48992103|NCT00508872|157804583|FG000|Overall Study|Physician Decision|1|||
48992104|NCT01161173|157804585|FG000|Overall Study|Protocol Violation|13|||
48992105|NCT01161173|157804585|FG000|Overall Study|Lost to Follow-up|7|||
48992106|NCT01161173|157804585|FG000|Overall Study|Progressive Disease|82|||
48992107|NCT01161173|157804585|FG000|Overall Study|Withdrawal of Consent|5|||
48992108|NCT01161173|157804585|FG000|Overall Study|Unacceptable Toxicity|21|||
48992109|NCT01161173|157804585|FG000|Overall Study|Death|194|||
48992110|NCT01161173|157804585|FG000|Overall Study|End of Study|2|||
48992111|NCT01161173|157804585|FG000|Overall Study|Reasons Not Specified|23|||
48992112|NCT01911546|157804588|FG000|Overall Study|Lost to Follow-up|1|||
48992113|NCT01911546|157804588|FG000|Overall Study|Everolimus was discontinued|5|||
48992114|NCT03007472|157804590|FG000|Overall Study|Did not have aidable contralateral thresholds at the time|2|||
48992115|NCT03007472|157804590|FG000|Overall Study|Death|2|||
48992116|NCT03007472|157804590|FG000|Overall Study|Loss to Follow Up|1|||
48992117|NCT02210559|157804599|FG000|Overall Study|Progressive Disease|3|||
48992118|NCT02210559|157804600|FG001|Overall Study|Progressive Disease|2|||
48992119|NCT02210559|157804599|FG000|Overall Study|Adverse Event|2|||
48992120|NCT02210559|157804600|FG001|Overall Study|Adverse Event|2|||
48992121|NCT02210559|157804599|FG000|Overall Study|Physician Decision|1|||
48992122|NCT02210559|157804600|FG001|Overall Study|Physician Decision|0|||
48992123|NCT02210559|157804599|FG000|Overall Study|Withdrawal by Subject|0|||
48992124|NCT02210559|157804600|FG001|Overall Study|Withdrawal by Subject|1|||
48992125|NCT02210559|157804599|FG000|Overall Study|Other than specified|0|||
48992126|NCT02210559|157804600|FG001|Overall Study|Other than specified|1|||
48992127|NCT01151085|157804604|FG000|Overall Study|Lost to Follow-up|31|||
48992128|NCT01151085|157804604|FG000|Overall Study|Protocol Violation|25|||
48992129|NCT00267202|157804612|FG000|Overall Study|Unsatisfactory therapeutic effect|21|||
48992130|NCT00267202|157804613|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
48992131|NCT00267202|157804612|FG000|Overall Study|Withdrawal by Subject|12|||
48992132|NCT00267202|157804613|FG001|Overall Study|Withdrawal by Subject|15|||
48992133|NCT00267202|157804612|FG000|Overall Study|Adverse Event|13|||
48992134|NCT00267202|157804613|FG001|Overall Study|Adverse Event|7|||
48992135|NCT00267202|157804612|FG000|Overall Study|Protocol Violation|2|||
48992136|NCT00267202|157804613|FG001|Overall Study|Protocol Violation|3|||
48992137|NCT00267202|157804612|FG000|Overall Study|Administrative problems|2|||
48992138|NCT00267202|157804613|FG001|Overall Study|Administrative problems|1|||
48992139|NCT00267202|157804612|FG000|Overall Study|Lost to Follow-up|3|||
48992140|NCT00267202|157804613|FG001|Overall Study|Lost to Follow-up|0|||
48992141|NCT01049360|157804618|FG000|Period 1|Adverse Event|0|||
48992142|NCT01049360|157804619|FG001|Period 1|Adverse Event|1|||
48992143|NCT01049360|157804620|FG002|Period 1|Adverse Event|0|||
48992144|NCT01049360|157804621|FG003|Period 1|Adverse Event|1|||
48992145|NCT01049360|157804622|FG004|Period 1|Adverse Event|0|||
48992146|NCT01049360|157804623|FG005|Period 1|Adverse Event|0|||
48992147|NCT01049360|157804624|FG006|Period 1|Adverse Event|0|||
48992148|NCT01049360|157804625|FG007|Period 1|Adverse Event|1|||
48992149|NCT01049360|157804626|FG008|Period 1|Adverse Event|0|||
48992150|NCT01049360|157804627|FG009|Period 1|Adverse Event|0|||
48992151|NCT01049360|157804628|FG010|Period 1|Adverse Event|0|||
48992152|NCT01049360|157804629|FG011|Period 1|Adverse Event|0|||
48992153|NCT01049360|157804630|FG012|Period 1|Adverse Event|1|||
48992154|NCT01049360|157804631|FG013|Period 1|Adverse Event|1|||
48992155|NCT01049360|157804632|FG014|Period 1|Adverse Event|0|||
48992156|NCT01049360|157804633|FG015|Period 1|Adverse Event|0|||
48992157|NCT01049360|157804634|FG016|Period 1|Adverse Event|1|||
48992158|NCT01049360|157804635|FG017|Period 1|Adverse Event|0|||
48992159|NCT01049360|157804636|FG018|Period 1|Adverse Event|1|||
48992160|NCT01049360|157804637|FG019|Period 1|Adverse Event|0|||
48992161|NCT01049360|157804618|FG000|Period 1|Did not meet inc/exc criteria|0|||
48992162|NCT01049360|157804619|FG001|Period 1|Did not meet inc/exc criteria|0|||
48992163|NCT01049360|157804620|FG002|Period 1|Did not meet inc/exc criteria|0|||
48992164|NCT01049360|157804621|FG003|Period 1|Did not meet inc/exc criteria|0|||
48992165|NCT01049360|157804622|FG004|Period 1|Did not meet inc/exc criteria|0|||
48992166|NCT01049360|157804623|FG005|Period 1|Did not meet inc/exc criteria|0|||
48992167|NCT01049360|157804624|FG006|Period 1|Did not meet inc/exc criteria|0|||
48992168|NCT01049360|157804625|FG007|Period 1|Did not meet inc/exc criteria|1|||
48992169|NCT01049360|157804626|FG008|Period 1|Did not meet inc/exc criteria|1|||
48992170|NCT01049360|157804627|FG009|Period 1|Did not meet inc/exc criteria|0|||
48992171|NCT01049360|157804628|FG010|Period 1|Did not meet inc/exc criteria|0|||
48992172|NCT01049360|157804629|FG011|Period 1|Did not meet inc/exc criteria|0|||
48992173|NCT01049360|157804630|FG012|Period 1|Did not meet inc/exc criteria|0|||
48992174|NCT01049360|157804631|FG013|Period 1|Did not meet inc/exc criteria|0|||
48992175|NCT01049360|157804632|FG014|Period 1|Did not meet inc/exc criteria|0|||
48992176|NCT01049360|157804633|FG015|Period 1|Did not meet inc/exc criteria|0|||
48992177|NCT01049360|157804634|FG016|Period 1|Did not meet inc/exc criteria|0|||
48992178|NCT01049360|157804635|FG017|Period 1|Did not meet inc/exc criteria|0|||
48992179|NCT01049360|157804636|FG018|Period 1|Did not meet inc/exc criteria|0|||
48992180|NCT01049360|157804637|FG019|Period 1|Did not meet inc/exc criteria|0|||
48992181|NCT01049360|157804618|FG000|Period 1|Withdrawal by Subject|0|||
48992182|NCT01049360|157804619|FG001|Period 1|Withdrawal by Subject|0|||
48992183|NCT01049360|157804620|FG002|Period 1|Withdrawal by Subject|0|||
48992184|NCT01049360|157804621|FG003|Period 1|Withdrawal by Subject|0|||
48992185|NCT01049360|157804622|FG004|Period 1|Withdrawal by Subject|0|||
48992186|NCT01049360|157804623|FG005|Period 1|Withdrawal by Subject|0|||
48992187|NCT01049360|157804624|FG006|Period 1|Withdrawal by Subject|0|||
48992188|NCT01049360|157804625|FG007|Period 1|Withdrawal by Subject|0|||
48992189|NCT01049360|157804626|FG008|Period 1|Withdrawal by Subject|1|||
48992190|NCT01049360|157804627|FG009|Period 1|Withdrawal by Subject|0|||
48992191|NCT01049360|157804628|FG010|Period 1|Withdrawal by Subject|1|||
48992192|NCT01049360|157804629|FG011|Period 1|Withdrawal by Subject|0|||
48992193|NCT01049360|157804630|FG012|Period 1|Withdrawal by Subject|1|||
48992194|NCT01049360|157804631|FG013|Period 1|Withdrawal by Subject|0|||
48992195|NCT01049360|157804632|FG014|Period 1|Withdrawal by Subject|0|||
48992196|NCT01049360|157804633|FG015|Period 1|Withdrawal by Subject|0|||
48992197|NCT01049360|157804634|FG016|Period 1|Withdrawal by Subject|0|||
48992198|NCT01049360|157804635|FG017|Period 1|Withdrawal by Subject|0|||
48992199|NCT01049360|157804636|FG018|Period 1|Withdrawal by Subject|0|||
48992200|NCT01049360|157804637|FG019|Period 1|Withdrawal by Subject|0|||
48992201|NCT01049360|157804618|FG000|Period 2|Protocol Violation|0|||
48992202|NCT01049360|157804619|FG001|Period 2|Protocol Violation|0|||
48992203|NCT01049360|157804620|FG002|Period 2|Protocol Violation|0|||
48992204|NCT01049360|157804621|FG003|Period 2|Protocol Violation|1|||
48992205|NCT01049360|157804622|FG004|Period 2|Protocol Violation|0|||
48992206|NCT01049360|157804623|FG005|Period 2|Protocol Violation|0|||
48992207|NCT01049360|157804624|FG006|Period 2|Protocol Violation|0|||
48992208|NCT01049360|157804625|FG007|Period 2|Protocol Violation|0|||
48992209|NCT01049360|157804626|FG008|Period 2|Protocol Violation|0|||
48992210|NCT01049360|157804627|FG009|Period 2|Protocol Violation|0|||
48992211|NCT01049360|157804628|FG010|Period 2|Protocol Violation|0|||
48992212|NCT01049360|157804629|FG011|Period 2|Protocol Violation|0|||
48992213|NCT01049360|157804630|FG012|Period 2|Protocol Violation|0|||
48992214|NCT01049360|157804631|FG013|Period 2|Protocol Violation|0|||
48992215|NCT01049360|157804632|FG014|Period 2|Protocol Violation|1|||
48992216|NCT01049360|157804633|FG015|Period 2|Protocol Violation|1|||
48992217|NCT01049360|157804634|FG016|Period 2|Protocol Violation|0|||
48992218|NCT01049360|157804635|FG017|Period 2|Protocol Violation|0|||
48992219|NCT01049360|157804636|FG018|Period 2|Protocol Violation|0|||
48992220|NCT01049360|157804637|FG019|Period 2|Protocol Violation|0|||
48992221|NCT01049360|157804618|FG000|Period 2|Adverse Event|0|||
48992222|NCT01049360|157804619|FG001|Period 2|Adverse Event|1|||
48992223|NCT01049360|157804620|FG002|Period 2|Adverse Event|0|||
48992224|NCT01049360|157804621|FG003|Period 2|Adverse Event|0|||
48992225|NCT01049360|157804622|FG004|Period 2|Adverse Event|0|||
48992226|NCT01049360|157804623|FG005|Period 2|Adverse Event|0|||
48992227|NCT01049360|157804624|FG006|Period 2|Adverse Event|0|||
48992228|NCT01049360|157804625|FG007|Period 2|Adverse Event|0|||
48992229|NCT01049360|157804626|FG008|Period 2|Adverse Event|1|||
48992230|NCT01049360|157804627|FG009|Period 2|Adverse Event|0|||
48992231|NCT01049360|157804628|FG010|Period 2|Adverse Event|0|||
48992232|NCT01049360|157804629|FG011|Period 2|Adverse Event|0|||
48992233|NCT01049360|157804630|FG012|Period 2|Adverse Event|0|||
48992234|NCT01049360|157804631|FG013|Period 2|Adverse Event|0|||
48992235|NCT01049360|157804632|FG014|Period 2|Adverse Event|0|||
48992236|NCT01049360|157804633|FG015|Period 2|Adverse Event|0|||
48992237|NCT01049360|157804634|FG016|Period 2|Adverse Event|0|||
48992238|NCT01049360|157804635|FG017|Period 2|Adverse Event|0|||
48992239|NCT01049360|157804636|FG018|Period 2|Adverse Event|0|||
48992240|NCT01049360|157804637|FG019|Period 2|Adverse Event|1|||
48992241|NCT01049360|157804618|FG000|Period 2|Withdrawal by Subject|0|||
48992242|NCT01049360|157804619|FG001|Period 2|Withdrawal by Subject|0|||
48992243|NCT01049360|157804620|FG002|Period 2|Withdrawal by Subject|0|||
48992244|NCT01049360|157804621|FG003|Period 2|Withdrawal by Subject|1|||
48992245|NCT01049360|157804622|FG004|Period 2|Withdrawal by Subject|0|||
48992246|NCT01049360|157804623|FG005|Period 2|Withdrawal by Subject|0|||
48992247|NCT01049360|157804624|FG006|Period 2|Withdrawal by Subject|0|||
48992248|NCT01049360|157804625|FG007|Period 2|Withdrawal by Subject|0|||
48992249|NCT01049360|157804626|FG008|Period 2|Withdrawal by Subject|0|||
48992250|NCT01049360|157804627|FG009|Period 2|Withdrawal by Subject|0|||
48992251|NCT01049360|157804628|FG010|Period 2|Withdrawal by Subject|0|||
48992252|NCT01049360|157804629|FG011|Period 2|Withdrawal by Subject|0|||
49045153|NCT01899053|157998143|FG012|Overall Study|Protocol Violation|0|||
48992253|NCT01049360|157804630|FG012|Period 2|Withdrawal by Subject|0|||
49045154|NCT01899053|157998144|FG013|Overall Study|Protocol Violation|0|||
49045155|NCT01899053|157998131|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
49045156|NCT01899053|157998132|FG001|Overall Study|Unsatisfactory Therapeutic Response|1|||
49045157|NCT01899053|157998133|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
49045158|NCT01899053|157998134|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
49045159|NCT01899053|157998135|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
49045160|NCT01899053|157998136|FG005|Overall Study|Unsatisfactory Therapeutic Response|0|||
49045161|NCT01899053|157998137|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
49045162|NCT01899053|157998138|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
49045163|NCT01899053|157998139|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
49045164|NCT01899053|157998140|FG009|Overall Study|Unsatisfactory Therapeutic Response|0|||
49045165|NCT01899053|157998141|FG010|Overall Study|Unsatisfactory Therapeutic Response|1|||
49045166|NCT01899053|157998142|FG011|Overall Study|Unsatisfactory Therapeutic Response|0|||
49045167|NCT01899053|157998143|FG012|Overall Study|Unsatisfactory Therapeutic Response|0|||
49045168|NCT01899053|157998144|FG013|Overall Study|Unsatisfactory Therapeutic Response|0|||
49045169|NCT01899053|157998131|FG000|Overall Study|Symptomatic Deterioration|0|||
49045170|NCT01899053|157998132|FG001|Overall Study|Symptomatic Deterioration|0|||
49045171|NCT01899053|157998133|FG002|Overall Study|Symptomatic Deterioration|0|||
48992254|NCT01049360|157804631|FG013|Period 2|Withdrawal by Subject|0|||
48992255|NCT01049360|157804632|FG014|Period 2|Withdrawal by Subject|1|||
48992256|NCT01049360|157804633|FG015|Period 2|Withdrawal by Subject|0|||
48992257|NCT01049360|157804634|FG016|Period 2|Withdrawal by Subject|0|||
48992258|NCT01049360|157804635|FG017|Period 2|Withdrawal by Subject|0|||
48992259|NCT01049360|157804636|FG018|Period 2|Withdrawal by Subject|0|||
48992260|NCT01049360|157804637|FG019|Period 2|Withdrawal by Subject|1|||
48992261|NCT01049360|157804618|FG000|Period 2|Lack of Efficacy|0|||
48992262|NCT01049360|157804619|FG001|Period 2|Lack of Efficacy|0|||
48992263|NCT01049360|157804620|FG002|Period 2|Lack of Efficacy|0|||
48992264|NCT01049360|157804621|FG003|Period 2|Lack of Efficacy|0|||
48992265|NCT01049360|157804622|FG004|Period 2|Lack of Efficacy|0|||
48992266|NCT01049360|157804623|FG005|Period 2|Lack of Efficacy|1|||
48992267|NCT01049360|157804624|FG006|Period 2|Lack of Efficacy|0|||
48992268|NCT01049360|157804625|FG007|Period 2|Lack of Efficacy|0|||
48992269|NCT01049360|157804626|FG008|Period 2|Lack of Efficacy|0|||
48992270|NCT01049360|157804627|FG009|Period 2|Lack of Efficacy|0|||
48992271|NCT01049360|157804628|FG010|Period 2|Lack of Efficacy|0|||
48992272|NCT01049360|157804629|FG011|Period 2|Lack of Efficacy|0|||
48992273|NCT01049360|157804630|FG012|Period 2|Lack of Efficacy|0|||
48992274|NCT01049360|157804631|FG013|Period 2|Lack of Efficacy|0|||
48992275|NCT01049360|157804632|FG014|Period 2|Lack of Efficacy|0|||
48992276|NCT01049360|157804633|FG015|Period 2|Lack of Efficacy|0|||
48992277|NCT01049360|157804634|FG016|Period 2|Lack of Efficacy|0|||
48992278|NCT01049360|157804635|FG017|Period 2|Lack of Efficacy|0|||
48992279|NCT01049360|157804636|FG018|Period 2|Lack of Efficacy|0|||
48992280|NCT01049360|157804637|FG019|Period 2|Lack of Efficacy|0|||
48992281|NCT01049360|157804618|FG000|Period 4|Protocol Violation|0|||
48992282|NCT01049360|157804619|FG001|Period 4|Protocol Violation|0|||
48992283|NCT01049360|157804620|FG002|Period 4|Protocol Violation|0|||
48992284|NCT01049360|157804621|FG003|Period 4|Protocol Violation|0|||
48992285|NCT01049360|157804622|FG004|Period 4|Protocol Violation|0|||
48992286|NCT01049360|157804623|FG005|Period 4|Protocol Violation|0|||
48992287|NCT01049360|157804624|FG006|Period 4|Protocol Violation|0|||
48992288|NCT01049360|157804625|FG007|Period 4|Protocol Violation|0|||
48992289|NCT01049360|157804626|FG008|Period 4|Protocol Violation|0|||
48992290|NCT01049360|157804627|FG009|Period 4|Protocol Violation|0|||
48992291|NCT01049360|157804628|FG010|Period 4|Protocol Violation|0|||
48992292|NCT01049360|157804629|FG011|Period 4|Protocol Violation|0|||
48992293|NCT01049360|157804630|FG012|Period 4|Protocol Violation|0|||
48992294|NCT01049360|157804631|FG013|Period 4|Protocol Violation|0|||
48992295|NCT01049360|157804632|FG014|Period 4|Protocol Violation|0|||
48992296|NCT01049360|157804633|FG015|Period 4|Protocol Violation|0|||
48992297|NCT01049360|157804634|FG016|Period 4|Protocol Violation|0|||
48992298|NCT01049360|157804635|FG017|Period 4|Protocol Violation|1|||
48992299|NCT01049360|157804636|FG018|Period 4|Protocol Violation|0|||
49045172|NCT01899053|157998134|FG003|Overall Study|Symptomatic Deterioration|0|||
49045173|NCT01899053|157998135|FG004|Overall Study|Symptomatic Deterioration|0|||
49045174|NCT01899053|157998136|FG005|Overall Study|Symptomatic Deterioration|1|||
49045175|NCT01899053|157998137|FG006|Overall Study|Symptomatic Deterioration|0|||
48992300|NCT01049360|157804637|FG019|Period 4|Protocol Violation|0|||
48992301|NCT01049360|157804618|FG000|Period 4|Withdrawal by Subject|0|||
48992302|NCT01049360|157804619|FG001|Period 4|Withdrawal by Subject|0|||
48992303|NCT01049360|157804620|FG002|Period 4|Withdrawal by Subject|0|||
48992304|NCT01049360|157804621|FG003|Period 4|Withdrawal by Subject|1|||
48992305|NCT01049360|157804622|FG004|Period 4|Withdrawal by Subject|0|||
48992306|NCT01049360|157804623|FG005|Period 4|Withdrawal by Subject|0|||
48992307|NCT01049360|157804624|FG006|Period 4|Withdrawal by Subject|0|||
48992308|NCT01049360|157804625|FG007|Period 4|Withdrawal by Subject|0|||
48992309|NCT01049360|157804626|FG008|Period 4|Withdrawal by Subject|0|||
48992310|NCT01049360|157804627|FG009|Period 4|Withdrawal by Subject|0|||
48992311|NCT01049360|157804628|FG010|Period 4|Withdrawal by Subject|0|||
48992312|NCT01049360|157804629|FG011|Period 4|Withdrawal by Subject|0|||
48992313|NCT01049360|157804630|FG012|Period 4|Withdrawal by Subject|0|||
48992314|NCT01049360|157804631|FG013|Period 4|Withdrawal by Subject|0|||
48992315|NCT01049360|157804632|FG014|Period 4|Withdrawal by Subject|0|||
48992316|NCT01049360|157804633|FG015|Period 4|Withdrawal by Subject|0|||
48992317|NCT01049360|157804634|FG016|Period 4|Withdrawal by Subject|0|||
48992318|NCT01049360|157804635|FG017|Period 4|Withdrawal by Subject|0|||
48992319|NCT01049360|157804636|FG018|Period 4|Withdrawal by Subject|0|||
48992320|NCT01049360|157804637|FG019|Period 4|Withdrawal by Subject|0|||
48992321|NCT00579059|157804638|FG000|Overall Study|Study Canceled at 1 Year|21|||
48992322|NCT00579059|157804639|FG001|Overall Study|Study Canceled at 1 Year|10|||
48992323|NCT00383292|157804640|FG000|Overall Study|Adverse Event|4|||
48992324|NCT00383292|157804641|FG001|Overall Study|Adverse Event|1|||
48992325|NCT00383292|157804642|FG002|Overall Study|Adverse Event|2|||
48992326|NCT00383292|157804640|FG000|Overall Study|Death|3|||
48992327|NCT00383292|157804641|FG001|Overall Study|Death|3|||
48992328|NCT00383292|157804642|FG002|Overall Study|Death|3|||
48992329|NCT00383292|157804640|FG000|Overall Study|Physician Decision|4|||
48992330|NCT00383292|157804641|FG001|Overall Study|Physician Decision|0|||
48992331|NCT00383292|157804642|FG002|Overall Study|Physician Decision|1|||
48992332|NCT00383292|157804640|FG000|Overall Study|Withdrawal by Subject|3|||
48992333|NCT00383292|157804641|FG001|Overall Study|Withdrawal by Subject|2|||
48992334|NCT00383292|157804642|FG002|Overall Study|Withdrawal by Subject|2|||
48992335|NCT00383292|157804640|FG000|Overall Study|Other|1|||
48992336|NCT00383292|157804641|FG001|Overall Study|Other|0|||
48992337|NCT00383292|157804642|FG002|Overall Study|Other|0|||
48992338|NCT04533204|157804643|FG000|Overall Study|Unable to understand training instructions|1|||
48992339|NCT04533204|157804644|FG001|Overall Study|Unable to understand training instructions|1|||
48992340|NCT01000311|157804654|FG000|Overall Study|Adverse Event|2|||
48992341|NCT01000311|157804655|FG001|Overall Study|Adverse Event|5|||
48992342|NCT01000311|157804654|FG000|Overall Study|Withdrawal by Subject|16|||
48992343|NCT01000311|157804655|FG001|Overall Study|Withdrawal by Subject|24|||
48992344|NCT01000311|157804654|FG000|Overall Study|Lost to Follow-up|15|||
48992345|NCT01000311|157804655|FG001|Overall Study|Lost to Follow-up|24|||
48992346|NCT01000311|157804654|FG000|Overall Study|Protocol Violation|1|||
48992347|NCT01000311|157804655|FG001|Overall Study|Protocol Violation|2|||
48992348|NCT01000311|157804654|FG000|Overall Study|Inappropriate enrollment|2|||
48992349|NCT01000311|157804655|FG001|Overall Study|Inappropriate enrollment|0|||
48992350|NCT01000311|157804654|FG000|Overall Study|Administrative reason|9|||
48992351|NCT01000311|157804655|FG001|Overall Study|Administrative reason|15|||
48992352|NCT01054443|157804656|FG000|Overall Study|Withdrawal by Subject|0|||
48992353|NCT01054443|157804657|FG001|Overall Study|Withdrawal by Subject|0|||
48992354|NCT01054443|157804658|FG002|Overall Study|Withdrawal by Subject|0|||
48992355|NCT01054443|157804659|FG003|Overall Study|Withdrawal by Subject|1|||
48992356|NCT01411917|157804660|FG000|Overall Study|Patient did not undergo scheduled surger|0|||
48992357|NCT01411917|157804661|FG001|Overall Study|Patient did not undergo scheduled surger|1|||
48992358|NCT00945815|157804662|FG000|Overall Study|Death|3|||
48992359|NCT00945815|157804662|FG000|Overall Study|Not protocol specified|1|||
48992360|NCT00945815|157804662|FG000|Overall Study|Ineligible|3|||
48992361|NCT00945815|157804662|FG000|Overall Study|Did not begin protocol therapy|1|||
48992362|NCT03691831|157806707|FG000|Overall Study|Lost to Follow-up|16|||
48992363|NCT03691831|157806708|FG001|Overall Study|Lost to Follow-up|12|||
48992364|NCT03691831|157806707|FG000|Overall Study|Withdrawal by Subject|9|||
48992365|NCT03691831|157806708|FG001|Overall Study|Withdrawal by Subject|17|||
48992366|NCT03691831|157806707|FG000|Overall Study|Investigator Decision|2|||
48992367|NCT03691831|157806708|FG001|Overall Study|Investigator Decision|2|||
48992368|NCT02926833|157806709|FG000|Overall Study|Death|1|||
48992369|NCT02926833|157806710|FG001|Overall Study|Death|1|||
48992370|NCT02926833|157806711|FG002|Overall Study|Death|2|||
48992371|NCT02926833|157806712|FG003|Overall Study|Death|13|||
48992372|NCT02926833|157806709|FG000|Overall Study|Lost to Follow-up|1|||
48992373|NCT02926833|157806710|FG001|Overall Study|Lost to Follow-up|2|||
48992374|NCT02926833|157806711|FG002|Overall Study|Lost to Follow-up|0|||
48992375|NCT02926833|157806712|FG003|Overall Study|Lost to Follow-up|3|||
48992376|NCT02926833|157806709|FG000|Overall Study|Full Consent Withdrawal|0|||
48992377|NCT02926833|157806710|FG001|Overall Study|Full Consent Withdrawal|0|||
48992378|NCT02926833|157806711|FG002|Overall Study|Full Consent Withdrawal|0|||
48992379|NCT02926833|157806712|FG003|Overall Study|Full Consent Withdrawal|2|||
48992380|NCT02926833|157806709|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
48992381|NCT02926833|157806710|FG001|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
48992382|NCT02926833|157806711|FG002|Overall Study|Rolled Over to Long-term Follow-up Study|3|||
48992383|NCT02926833|157806712|FG003|Overall Study|Rolled Over to Long-term Follow-up Study|4|||
48992384|NCT02926833|157806709|FG000|Overall Study|Investigator Decision|0|||
48992385|NCT02926833|157806710|FG001|Overall Study|Investigator Decision|1|||
48992386|NCT02926833|157806711|FG002|Overall Study|Investigator Decision|0|||
48992387|NCT02926833|157806712|FG003|Overall Study|Investigator Decision|0|||
48992388|NCT02926833|157806709|FG000|Overall Study|Adverse Event|0|||
48992389|NCT02926833|157806710|FG001|Overall Study|Adverse Event|0|||
48992390|NCT02926833|157806711|FG002|Overall Study|Adverse Event|1|||
48992391|NCT02926833|157806712|FG003|Overall Study|Adverse Event|0|||
48992392|NCT02926833|157806709|FG000|Overall Study|Partial Withdrawal of Consent|0|||
48992393|NCT02926833|157806710|FG001|Overall Study|Partial Withdrawal of Consent|0|||
48992394|NCT02926833|157806711|FG002|Overall Study|Partial Withdrawal of Consent|0|||
48992395|NCT02926833|157806712|FG003|Overall Study|Partial Withdrawal of Consent|1|||
48992396|NCT02361307|157806713|FG000|Overall Study|Unstable medical condition.|0|||
48992397|NCT02361307|157806714|FG001|Overall Study|Unstable medical condition.|1|||
48992398|NCT00711009|157806715|FG000|Overall Study|Adverse Event/HIV-Related Event|4|||
48992399|NCT00711009|157806716|FG001|Overall Study|Adverse Event/HIV-Related Event|5|||
48992400|NCT00711009|157806715|FG000|Overall Study|Withdrawal by Subject|4|||
48992401|NCT00711009|157806716|FG001|Overall Study|Withdrawal by Subject|2|||
48992402|NCT00711009|157806715|FG000|Overall Study|Lost to Follow-up|3|||
48992403|NCT00711009|157806716|FG001|Overall Study|Lost to Follow-up|9|||
48992404|NCT00711009|157806715|FG000|Overall Study|Participant Noncompliant|0|||
48992405|NCT00711009|157806716|FG001|Overall Study|Participant Noncompliant|1|||
48992406|NCT00711009|157806715|FG000|Overall Study|Virologic Failure|2|||
48992407|NCT00711009|157806716|FG001|Overall Study|Virologic Failure|1|||
48992408|NCT00711009|157806715|FG000|Overall Study|Pregnancy|1|||
48992409|NCT00711009|157806716|FG001|Overall Study|Pregnancy|0|||
48992410|NCT00711009|157806715|FG000|Overall Study|Site closing|0|||
48992411|NCT00711009|157806716|FG001|Overall Study|Site closing|1|||
48992412|NCT00711009|157806715|FG000|Overall Study|Dose adjustment|1|||
48992413|NCT00711009|157806716|FG001|Overall Study|Dose adjustment|0|||
48992414|NCT03359811|157806717|FG000|Overall Study|Protocol Violation|2|||
48992415|NCT03359811|157806718|FG001|Overall Study|Protocol Violation|0|||
48992416|NCT04335929|157806721|FG000|Overall Study|Lost to Follow-up|10|||
48992417|NCT01189201|157806726|FG000|Overall Study|Adverse Event|1|||
48992418|NCT01682876|157806733|FG000|Overall Study|Administrative reason|4|||
48992419|NCT01682876|157806734|FG001|Overall Study|Administrative reason|4|||
48992420|NCT01682876|157806735|FG002|Overall Study|Administrative reason|0|||
48992421|NCT01682876|157806736|FG003|Overall Study|Administrative reason|3|||
48992422|NCT01682876|157806733|FG000|Overall Study|Adverse Event|0|||
48992423|NCT01682876|157806734|FG001|Overall Study|Adverse Event|0|||
48992424|NCT01682876|157806735|FG002|Overall Study|Adverse Event|0|||
48992425|NCT01682876|157806736|FG003|Overall Study|Adverse Event|1|||
48992426|NCT01682876|157806733|FG000|Overall Study|Lost to Follow-up|11|||
48992427|NCT01682876|157806734|FG001|Overall Study|Lost to Follow-up|15|||
48992428|NCT01682876|157806735|FG002|Overall Study|Lost to Follow-up|9|||
48992429|NCT01682876|157806736|FG003|Overall Study|Lost to Follow-up|11|||
48992430|NCT01682876|157806733|FG000|Overall Study|Protocol Violation|1|||
48992431|NCT01682876|157806734|FG001|Overall Study|Protocol Violation|1|||
48992432|NCT01682876|157806735|FG002|Overall Study|Protocol Violation|1|||
48992433|NCT01682876|157806736|FG003|Overall Study|Protocol Violation|1|||
48992434|NCT01682876|157806733|FG000|Overall Study|Withdrawal by Subject|4|||
48992435|NCT01682876|157806734|FG001|Overall Study|Withdrawal by Subject|0|||
48992436|NCT01682876|157806735|FG002|Overall Study|Withdrawal by Subject|0|||
48992437|NCT01682876|157806736|FG003|Overall Study|Withdrawal by Subject|2|||
48992438|NCT01682876|157806733|FG000|Overall Study|Other|1|||
48992439|NCT01682876|157806734|FG001|Overall Study|Other|0|||
48992440|NCT01682876|157806735|FG002|Overall Study|Other|1|||
48992441|NCT01682876|157806736|FG003|Overall Study|Other|1|||
48992442|NCT01277757|157806737|FG000|Overall Study|Disease Progression|1|||
48992443|NCT01277757|157806737|FG000|Overall Study|Withdrawal by Subject|1|||
48992444|NCT01459016|157806741|FG000|Overall Study|Withdrawal by Subject|11|||
48992445|NCT01459016|157806741|FG000|Overall Study|Amendment Discontinuation Criteria|4|||
48992446|NCT04623008|157806742|FG000|Baseline to T2|Withdrawal by Subject|4|||
48992447|NCT04623008|157806743|FG001|Baseline to T2|Withdrawal by Subject|2|||
48992448|NCT04623008|157806742|FG000|Baseline to T3|Withdrawal by Subject|4|||
48992449|NCT04623008|157806743|FG001|Baseline to T3|Withdrawal by Subject|2|||
48992450|NCT03922945|157806757|FG000|Overall Study|Adverse Event|1|||
48992451|NCT03922945|157806758|FG001|Overall Study|Adverse Event|1|||
48992452|NCT03922945|157806759|FG002|Overall Study|Adverse Event|2|||
48992453|NCT03922945|157806757|FG000|Overall Study|Lost to Follow-up|13|||
48992454|NCT03922945|157806758|FG001|Overall Study|Lost to Follow-up|9|||
48992455|NCT03922945|157806759|FG002|Overall Study|Lost to Follow-up|20|||
48992456|NCT03922945|157806757|FG000|Overall Study|Lack of Efficacy|2|||
48992457|NCT03922945|157806758|FG001|Overall Study|Lack of Efficacy|0|||
48992458|NCT03922945|157806759|FG002|Overall Study|Lack of Efficacy|1|||
48992459|NCT03922945|157806757|FG000|Overall Study|Protocol Non-Compliance|0|||
48992460|NCT03922945|157806758|FG001|Overall Study|Protocol Non-Compliance|0|||
48992461|NCT03922945|157806759|FG002|Overall Study|Protocol Non-Compliance|1|||
48992462|NCT03922945|157806757|FG000|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|10|||
48992463|NCT03922945|157806758|FG001|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|6|||
48992464|NCT03922945|157806759|FG002|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|14|||
48992465|NCT03922945|157806757|FG000|Overall Study|All Other Personal Reasons|1|||
48992466|NCT03922945|157806758|FG001|Overall Study|All Other Personal Reasons|1|||
48992467|NCT03922945|157806759|FG002|Overall Study|All Other Personal Reasons|2|||
48992468|NCT00911508|157806760|FG000|Overall Study|Lost to Follow-up|27|||
48992469|NCT00911508|157806761|FG001|Overall Study|Lost to Follow-up|18|||
48992470|NCT00911508|157806760|FG000|Overall Study|Withdrawal by Subject|79|||
48992471|NCT00911508|157806761|FG001|Overall Study|Withdrawal by Subject|112|||
48992472|NCT00663208|157806764|FG000|Treatment Period|Lost to Follow-up|0|||
48992473|NCT00663208|157806765|FG001|Treatment Period|Lost to Follow-up|1|||
48992474|NCT00663208|157806766|FG002|Treatment Period|Lost to Follow-up|0|||
48992475|NCT00663208|157806767|FG003|Treatment Period|Lost to Follow-up|0|||
48992476|NCT00663208|157806768|FG004|Treatment Period|Lost to Follow-up|0|||
48992477|NCT00663208|157806769|FG005|Treatment Period|Lost to Follow-up|0|||
48992478|NCT00663208|157806770|FG006|Treatment Period|Lost to Follow-up|0|||
48992479|NCT00663208|157806764|FG000|Follow-up Period|Lost to Follow-up|2|||
48992480|NCT00663208|157806765|FG001|Follow-up Period|Lost to Follow-up|0|||
48992481|NCT00663208|157806766|FG002|Follow-up Period|Lost to Follow-up|3|||
48992482|NCT00663208|157806767|FG003|Follow-up Period|Lost to Follow-up|2|||
48992483|NCT00663208|157806768|FG004|Follow-up Period|Lost to Follow-up|0|||
48992484|NCT00663208|157806769|FG005|Follow-up Period|Lost to Follow-up|0|||
48992485|NCT00663208|157806770|FG006|Follow-up Period|Lost to Follow-up|0|||
48992486|NCT00663208|157806764|FG000|Follow-up Period|Other reason|1|||
48992487|NCT00663208|157806765|FG001|Follow-up Period|Other reason|0|||
48992488|NCT00663208|157806766|FG002|Follow-up Period|Other reason|0|||
48992489|NCT00663208|157806767|FG003|Follow-up Period|Other reason|0|||
48992490|NCT00663208|157806768|FG004|Follow-up Period|Other reason|0|||
48992491|NCT00663208|157806769|FG005|Follow-up Period|Other reason|0|||
48992492|NCT00663208|157806770|FG006|Follow-up Period|Other reason|1|||
48992493|NCT00525499|157806774|FG000|Overall Study|Lost to Follow-up|2|||
48992494|NCT00525499|157806775|FG001|Overall Study|Lost to Follow-up|4|||
48992495|NCT00525499|157806776|FG002|Overall Study|Lost to Follow-up|1|||
48992496|NCT00525499|157806777|FG003|Overall Study|Lost to Follow-up|4|||
48992497|NCT00525499|157806774|FG000|Overall Study|Adverse Event|0|||
48992498|NCT00525499|157806775|FG001|Overall Study|Adverse Event|1|||
48992499|NCT00525499|157806776|FG002|Overall Study|Adverse Event|0|||
48992500|NCT00525499|157806777|FG003|Overall Study|Adverse Event|1|||
48992501|NCT00525499|157806774|FG000|Overall Study|Withdrawal by Subject|5|||
48992502|NCT00525499|157806775|FG001|Overall Study|Withdrawal by Subject|1|||
48992503|NCT00525499|157806776|FG002|Overall Study|Withdrawal by Subject|5|||
48992504|NCT00525499|157806777|FG003|Overall Study|Withdrawal by Subject|2|||
48992505|NCT00525499|157806774|FG000|Overall Study|Protocol Violation|0|||
48992506|NCT00525499|157806775|FG001|Overall Study|Protocol Violation|1|||
48992507|NCT00525499|157806776|FG002|Overall Study|Protocol Violation|1|||
48992508|NCT00525499|157806777|FG003|Overall Study|Protocol Violation|0|||
48992509|NCT00438815|157806778|FG000|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30|||
48992510|NCT00438815|157806778|FG000|Overall Study|3-month follow-up no longer required|12|||
48992511|NCT00438815|157806778|FG000|Overall Study|Noncompliance with protocol requirements|9|||
48992512|NCT00438815|157806778|FG000|Overall Study|Transitioned to commercial C1INH-nf|6|||
48992513|NCT00438815|157806778|FG000|Overall Study|Lost to Follow-up|6|||
48992514|NCT00438815|157806778|FG000|Overall Study|Withdrawal by Subject|6|||
48992515|NCT00438815|157806778|FG000|Overall Study|Death|1|||
48992516|NCT00253747|157806779|FG000|Overall Study|Lost to Follow-up|13|||
48992517|NCT00253747|157806780|FG001|Overall Study|Lost to Follow-up|14|||
48992518|NCT00253747|157806779|FG000|Overall Study|Withdrawal by Subject|10|||
48992519|NCT00253747|157806780|FG001|Overall Study|Withdrawal by Subject|11|||
48992520|NCT00253747|157806779|FG000|Overall Study|Administrative Discharge (1), Other (2)|1|||
48992521|NCT00253747|157806780|FG001|Overall Study|Administrative Discharge (1), Other (2)|2|||
48992522|NCT01977651|157806783|FG000|4 Month Treatment Period|Adverse Event|34|||
48992523|NCT01977651|157806783|FG000|4 Month Treatment Period|Death|3|||
48992524|NCT01977651|157806783|FG000|4 Month Treatment Period|Progressive Disease|43|||
48992525|NCT01977651|157806783|FG000|4 Month Treatment Period|Withdrawal by Subject|17|||
48992526|NCT01977651|157806783|FG000|4 Month Treatment Period|Physician Decision|4|||
48992527|NCT01977651|157806783|FG000|1 Year Extension Period|Adverse Event|14|||
48992528|NCT01977651|157806783|FG000|1 Year Extension Period|Death|10|||
48992529|NCT01977651|157806783|FG000|1 Year Extension Period|Lost to Follow-up|2|||
48992530|NCT01977651|157806783|FG000|1 Year Extension Period|Progressive Disease|86|||
48992531|NCT01977651|157806783|FG000|1 Year Extension Period|Withdrawal by Subject|11|||
48992532|NCT01977651|157806783|FG000|1 Year Extension Period|Physician Decision|6|||
48992533|NCT01977651|157806783|FG000|1 Year Extension Period|Miscellaneous|1|||
48992534|NCT01977651|157806783|FG000|Post 1 Year Extension Period|Adverse Event|5|||
48992535|NCT01977651|157806783|FG000|Post 1 Year Extension Period|Death|13|||
48992536|NCT01977651|157806783|FG000|Post 1 Year Extension Period|Progressive Disease|60|||
48992537|NCT01977651|157806783|FG000|Post 1 Year Extension Period|Withdrawal by Subject|13|||
48992538|NCT01977651|157806783|FG000|Post 1 Year Extension Period|Physician Decision|4|||
48992539|NCT01977651|157806783|FG000|Post 1 Year Extension Period|Miscellaneous|49|||
48992540|NCT01856920|157806784|FG000|Overall Study|Disease Progression On Study|3|||
48992541|NCT01856920|157806785|FG001|Overall Study|Disease Progression On Study|4|||
48992542|NCT01856920|157806784|FG000|Overall Study|Disease Progression before Treatment|1|||
48992543|NCT01856920|157806785|FG001|Overall Study|Disease Progression before Treatment|0|||
48992544|NCT01856920|157806784|FG000|Overall Study|Ineligible|0|||
48992545|NCT01856920|157806785|FG001|Overall Study|Ineligible|1|||
48992546|NCT01856920|157806784|FG000|Overall Study|Patient Declined to Participate (before treatment started.)|1|||
48992547|NCT01856920|157806785|FG001|Overall Study|Patient Declined to Participate (before treatment started.)|0|||
48992548|NCT01856920|157806784|FG000|Overall Study|Refused further Treatment|5|||
48992549|NCT01856920|157806785|FG001|Overall Study|Refused further Treatment|1|||
48992550|NCT01856920|157806784|FG000|Overall Study|Other Reasons|0|||
48992551|NCT01856920|157806785|FG001|Overall Study|Other Reasons|1|||
48992552|NCT01856920|157806784|FG000|Overall Study|Completed treatment phase but refused the Protocol-Specified|0|||
48992553|NCT01856920|157806785|FG001|Overall Study|Completed treatment phase but refused the Protocol-Specified|2|||
48992554|NCT03764813|157806791|FG000|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
48992555|NCT03764813|157806792|FG001|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
48992556|NCT03764813|157806793|FG002|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
48992557|NCT03764813|157806794|FG003|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
48992558|NCT03219372|157806804|FG000|Overall Study|Withdrawal by Subject|1|||
48992559|NCT03219372|157806805|FG001|Overall Study|Withdrawal by Subject|0|||
48992560|NCT00450814|157806806|FG000|Overall Study|Failed to complete the initial therapy|0|||
48992561|NCT00450814|157806807|FG001|Overall Study|Failed to complete the initial therapy|0|||
48992562|NCT00450814|157806808|FG002|Overall Study|Failed to complete the initial therapy|0|||
48992563|NCT00450814|157806809|FG003|Overall Study|Failed to complete the initial therapy|1|||
48992564|NCT00450814|157806810|FG004|Overall Study|Failed to complete the initial therapy|1|||
48992565|NCT00450814|157806811|FG005|Overall Study|Failed to complete the initial therapy|1|||
48992566|NCT00450814|157806812|FG006|Overall Study|Failed to complete the initial therapy|0|||
48992567|NCT00450814|157806813|FG007|Overall Study|Failed to complete the initial therapy|0|||
48992568|NCT00450814|157806814|FG008|Overall Study|Failed to complete the initial therapy|0|||
48992569|NCT00450814|157806815|FG009|Overall Study|Failed to complete the initial therapy|0|||
48992570|NCT00450814|157806816|FG010|Overall Study|Failed to complete the initial therapy|0|||
48992571|NCT00450814|157806806|FG000|Overall Study|Patient withdrawal prior to treatment|0|||
48992572|NCT00450814|157806807|FG001|Overall Study|Patient withdrawal prior to treatment|0|||
48992573|NCT00450814|157806808|FG002|Overall Study|Patient withdrawal prior to treatment|0|||
48992574|NCT00450814|157806809|FG003|Overall Study|Patient withdrawal prior to treatment|0|||
48992575|NCT00450814|157806810|FG004|Overall Study|Patient withdrawal prior to treatment|0|||
48992576|NCT00450814|157806811|FG005|Overall Study|Patient withdrawal prior to treatment|0|||
48992577|NCT00450814|157806812|FG006|Overall Study|Patient withdrawal prior to treatment|0|||
48992578|NCT00450814|157806813|FG007|Overall Study|Patient withdrawal prior to treatment|0|||
48992579|NCT00450814|157806814|FG008|Overall Study|Patient withdrawal prior to treatment|0|||
48992580|NCT00450814|157806815|FG009|Overall Study|Patient withdrawal prior to treatment|1|||
48992581|NCT00450814|157806816|FG010|Overall Study|Patient withdrawal prior to treatment|0|||
48992582|NCT01654666|157806817|FG000|Overall Study|Protocol Violation|7|||
48992583|NCT01654666|157806818|FG001|Overall Study|Protocol Violation|4|||
48992584|NCT01654666|157806819|FG002|Overall Study|Protocol Violation|8|||
48992585|NCT01654666|157806817|FG000|Overall Study|Lost to Follow-up|4|||
48992586|NCT01654666|157806818|FG001|Overall Study|Lost to Follow-up|5|||
48992587|NCT01654666|157806819|FG002|Overall Study|Lost to Follow-up|5|||
48992588|NCT01654666|157806817|FG000|Overall Study|Withdrawal by Subject|4|||
48992589|NCT01654666|157806818|FG001|Overall Study|Withdrawal by Subject|4|||
48992590|NCT01654666|157806819|FG002|Overall Study|Withdrawal by Subject|1|||
48992591|NCT00429026|157806821|FG000|Overall Study|Inevaluable for response.|40|||
48992592|NCT03831282|157806822|FG000|Overall Study|Could not place sensor|1|||
48992593|NCT00334893|157806825|FG000|Overall Study|Not Treated|1|||
48992594|NCT00334893|157806826|FG001|Overall Study|Not Treated|0|||
48992595|NCT01694849|157806827|FG000|Treatment Period (Visit 2 to Visit 8)|Adverse Event|6|||
48992596|NCT01694849|157806828|FG001|Treatment Period (Visit 2 to Visit 8)|Adverse Event|7|||
48992597|NCT01694849|157806829|FG002|Treatment Period (Visit 2 to Visit 8)|Adverse Event|4|||
48992598|NCT01694849|157806827|FG000|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|1|||
48992599|NCT01694849|157806828|FG001|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|3|||
48992600|NCT01694849|157806829|FG002|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|7|||
48992601|NCT01694849|157806827|FG000|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
48992602|NCT01694849|157806828|FG001|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
48992603|NCT01694849|157806829|FG002|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|1|||
48992604|NCT01694849|157806827|FG000|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
48992605|NCT01694849|157806828|FG001|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|0|||
48992606|NCT01694849|157806829|FG002|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
48992607|NCT01694849|157806827|FG000|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
48992608|NCT01694849|157806828|FG001|Treatment Period (Visit 2 to Visit 8)|Non-compliance|0|||
48992609|NCT01694849|157806829|FG002|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
48992610|NCT01694849|157806827|FG000|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
48992611|NCT01694849|157806828|FG001|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|1|||
48992612|NCT01694849|157806829|FG002|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
48992613|NCT01694849|157806827|FG000|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
48992614|NCT01694849|157806828|FG001|Follow-up Period (to Visit 9)|Withdrawal by Subject|1|||
48992615|NCT01694849|157806829|FG002|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
48992616|NCT01694849|157806827|FG000|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
48992617|NCT01694849|157806828|FG001|Follow-up Period (to Visit 9)|Lost to Follow-up|2|||
48992618|NCT01694849|157806829|FG002|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
48992619|NCT02764229|157806830|FG000|Overall Study|Withdrawal by Subject|15|||
48992620|NCT02764229|157806830|FG000|Overall Study|Adverse Event|9|||
48992621|NCT02764229|157806830|FG000|Overall Study|Physician Decision|5|||
48992622|NCT02764229|157806830|FG000|Overall Study|Lost to Follow-up|3|||
48992623|NCT02764229|157806830|FG000|Overall Study|Lack of Efficacy|1|||
48992624|NCT02764229|157806830|FG000|Overall Study|Study Stopped by Sponsor|69|||
48992625|NCT01258803|157806831|FG000|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
48992626|NCT01258803|157806832|FG001|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
48992627|NCT01258803|157806833|FG002|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
48992628|NCT01258803|157806834|FG003|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
48992629|NCT01258803|157806835|FG004|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
48992630|NCT01258803|157806836|FG005|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
48992631|NCT01258803|157806831|FG000|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
48992632|NCT01258803|157806832|FG001|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1|||
48992633|NCT01258803|157806833|FG002|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
48992634|NCT01258803|157806834|FG003|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
48992635|NCT01258803|157806835|FG004|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
48992636|NCT01258803|157806836|FG005|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
48992637|NCT01258803|157806831|FG000|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
48992638|NCT01258803|157806832|FG001|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
48992639|NCT01258803|157806833|FG002|Treatment Period 3 (1 Dose)|Protocol Violation|1|||
48992640|NCT01258803|157806834|FG003|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
48992641|NCT01258803|157806835|FG004|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
48992642|NCT01258803|157806836|FG005|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
48992643|NCT00920582|157806837|FG000|Overall Study|Lost to Follow-up|5|||
48992644|NCT00920582|157806838|FG001|Overall Study|Lost to Follow-up|1|||
48992645|NCT00920582|157806839|FG002|Overall Study|Lost to Follow-up|2|||
48992646|NCT00920582|157806840|FG003|Overall Study|Lost to Follow-up|0|||
48992647|NCT00920582|157806837|FG000|Overall Study|Withdrawal by Subject|5|||
48992648|NCT00920582|157806838|FG001|Overall Study|Withdrawal by Subject|4|||
48992649|NCT00920582|157806839|FG002|Overall Study|Withdrawal by Subject|6|||
48992650|NCT00920582|157806840|FG003|Overall Study|Withdrawal by Subject|3|||
48992651|NCT00920582|157806837|FG000|Overall Study|Protocol Violation|1|||
48992652|NCT00920582|157806838|FG001|Overall Study|Protocol Violation|0|||
48992653|NCT00920582|157806839|FG002|Overall Study|Protocol Violation|0|||
48992654|NCT00920582|157806840|FG003|Overall Study|Protocol Violation|0|||
48992655|NCT00920582|157806837|FG000|Overall Study|Other|2|||
48992656|NCT00920582|157806838|FG001|Overall Study|Other|1|||
48992657|NCT00920582|157806839|FG002|Overall Study|Other|3|||
48992658|NCT00920582|157806840|FG003|Overall Study|Other|2|||
48992659|NCT03319160|157806841|FG000|Overall Study|Data not available.|7|||
48992660|NCT05807464|157806842|FG000|Overall Study|Adverse Event|1|||
48992661|NCT04668157|157806843|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|1|||
48992662|NCT04668157|157806844|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
48992663|NCT04668157|157806843|FG000|Treatment Period (52 Weeks)|Other|0|||
48992664|NCT04668157|157806844|FG001|Treatment Period (52 Weeks)|Other|2|||
48992665|NCT00223990|157806845|FG000|Overall Study|Moved from area|2|||
48992666|NCT00223990|157806846|FG001|Overall Study|Moved from area|1|||
48992667|NCT00223990|157806845|FG000|Overall Study|Withdrawal by Subject|4|||
48992668|NCT00223990|157806846|FG001|Overall Study|Withdrawal by Subject|8|||
48992669|NCT00223990|157806845|FG000|Overall Study|Lost to Follow-up|1|||
48992670|NCT00223990|157806846|FG001|Overall Study|Lost to Follow-up|0|||
48992671|NCT03451630|157806847|FG000|Overall Study|Death|15|||
48992672|NCT03451630|157806848|FG001|Overall Study|Death|16|||
48992673|NCT03451630|157806849|FG002|Overall Study|Death|11|||
48992674|NCT03451630|157806847|FG000|Overall Study|Lost to Follow-up|9|||
48992675|NCT03451630|157806848|FG001|Overall Study|Lost to Follow-up|0|||
48992676|NCT03451630|157806849|FG002|Overall Study|Lost to Follow-up|4|||
48992677|NCT03451630|157806847|FG000|Overall Study|Withdrawal by Subject|0|||
48992678|NCT03451630|157806848|FG001|Overall Study|Withdrawal by Subject|3|||
48992679|NCT03451630|157806849|FG002|Overall Study|Withdrawal by Subject|0|||
48992680|NCT03451630|157806847|FG000|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
48992681|NCT03451630|157806848|FG001|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|4|||
48992682|NCT03451630|157806849|FG002|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
48992683|NCT05403502|157806852|FG000|Humalog Lead-In Period|Withdrawal by Subject|1|||
48992684|NCT05403502|157806852|FG000|Humalog Lead-In Period|Physician Decision|2|||
48992685|NCT05403502|157806852|FG000|Humalog Lead-In Period|Protocol Violation|1|||
48992686|NCT05403502|157806852|FG000|Lyumjev Treatment Period|Withdrawal by Subject|4|||
48992687|NCT05403502|157806852|FG000|Lyumjev Treatment Period|Physician Decision|2|||
48992688|NCT02950831|157806854|FG000|Overall Study|Lost to Follow-up|1|||
48992689|NCT02950831|157806854|FG000|Overall Study|Withdrawal by Subject|3|||
48992690|NCT02950831|157806854|FG000|Overall Study|stimulation trail failure|5|||
48992691|NCT01610752|157806855|FG000|Overall Study|Miscarriage/Pregnancy loss|0|||
48992692|NCT01610752|157806856|FG001|Overall Study|Miscarriage/Pregnancy loss|0|||
48992693|NCT01610752|157806857|FG002|Overall Study|Miscarriage/Pregnancy loss|4|||
48992694|NCT02146365|157806862|FG000|Overall Study|Lost to Follow-up|2|||
48992695|NCT02146365|157806863|FG001|Overall Study|Lost to Follow-up|1|||
48992696|NCT02146365|157806864|FG002|Overall Study|Lost to Follow-up|3|||
48992697|NCT02146365|157806865|FG003|Overall Study|Lost to Follow-up|3|||
48992698|NCT02146365|157806866|FG004|Overall Study|Lost to Follow-up|1|||
48992699|NCT02146365|157806867|FG005|Overall Study|Lost to Follow-up|1|||
48992700|NCT02146365|157806868|FG006|Overall Study|Lost to Follow-up|0|||
48992701|NCT02146365|157806869|FG007|Overall Study|Lost to Follow-up|1|||
48992702|NCT02146365|157806862|FG000|Overall Study|Withdrawal by Subject|1|||
48992703|NCT02146365|157806863|FG001|Overall Study|Withdrawal by Subject|2|||
48992704|NCT02146365|157806864|FG002|Overall Study|Withdrawal by Subject|1|||
48992705|NCT02146365|157806865|FG003|Overall Study|Withdrawal by Subject|5|||
48992706|NCT02146365|157806866|FG004|Overall Study|Withdrawal by Subject|1|||
48992707|NCT02146365|157806867|FG005|Overall Study|Withdrawal by Subject|0|||
48992708|NCT02146365|157806868|FG006|Overall Study|Withdrawal by Subject|0|||
48992709|NCT02146365|157806869|FG007|Overall Study|Withdrawal by Subject|0|||
48992710|NCT02146365|157806862|FG000|Overall Study|Unable to Comply with Protocol|0|||
48992711|NCT02146365|157806863|FG001|Overall Study|Unable to Comply with Protocol|1|||
48992712|NCT02146365|157806864|FG002|Overall Study|Unable to Comply with Protocol|1|||
48992713|NCT02146365|157806865|FG003|Overall Study|Unable to Comply with Protocol|0|||
48992714|NCT02146365|157806866|FG004|Overall Study|Unable to Comply with Protocol|0|||
48992715|NCT02146365|157806867|FG005|Overall Study|Unable to Comply with Protocol|0|||
48992716|NCT02146365|157806868|FG006|Overall Study|Unable to Comply with Protocol|0|||
48992717|NCT02146365|157806869|FG007|Overall Study|Unable to Comply with Protocol|0|||
48992718|NCT02146365|157806862|FG000|Overall Study|Other|1|||
48992719|NCT02146365|157806863|FG001|Overall Study|Other|0|||
48992720|NCT02146365|157806864|FG002|Overall Study|Other|2|||
48992721|NCT02146365|157806865|FG003|Overall Study|Other|1|||
48992722|NCT02146365|157806866|FG004|Overall Study|Other|0|||
48992723|NCT02146365|157806867|FG005|Overall Study|Other|0|||
48992724|NCT02146365|157806868|FG006|Overall Study|Other|0|||
48992725|NCT02146365|157806869|FG007|Overall Study|Other|0|||
48992726|NCT02889861|157809133|FG000|Overall Study|Ongoing in Survival Follow-up|2|||
48992727|NCT00240331|157809134|FG000|Overall Study|Withdrawal by Subject|125|||
48992728|NCT00240331|157809135|FG001|Overall Study|Withdrawal by Subject|132|||
48992729|NCT00240331|157809134|FG000|Overall Study|Option selected by investigator|1|||
48992730|NCT00240331|157809135|FG001|Overall Study|Option selected by investigator|2|||
48992731|NCT01409382|157809136|FG000|Overall Study|Lost to Follow-up|1|||
48992732|NCT01409382|157809137|FG001|Overall Study|Lost to Follow-up|1|||
48992733|NCT01409382|157809136|FG000|Overall Study|Protocol Violation|0|||
48992734|NCT01409382|157809137|FG001|Overall Study|Protocol Violation|3|||
48992735|NCT01409382|157809136|FG000|Overall Study|Multiple pregnancy|2|||
48992736|NCT01409382|157809137|FG001|Overall Study|Multiple pregnancy|4|||
48992737|NCT01409382|157809136|FG000|Overall Study|Still pregnant when study ended|13|||
48992738|NCT01409382|157809137|FG001|Overall Study|Still pregnant when study ended|2|||
48992739|NCT01409382|157809136|FG000|Overall Study|Did not manage to get pregnant|64|||
48992740|NCT01409382|157809137|FG001|Overall Study|Did not manage to get pregnant|70|||
48992741|NCT01409382|157809136|FG000|Overall Study|Had a 2nd trimester loss after accident|1|||
48992742|NCT01409382|157809137|FG001|Overall Study|Had a 2nd trimester loss after accident|0|||
48992743|NCT04067310|157809143|FG000|Overall Study|Physician Decision|2|||
48992744|NCT04067310|157809144|FG001|Overall Study|Physician Decision|6|||
48992745|NCT04067310|157809143|FG000|Overall Study|Lost to Follow-up|0|||
48992746|NCT04067310|157809144|FG001|Overall Study|Lost to Follow-up|1|||
48992747|NCT04067310|157809143|FG000|Overall Study|Withdrawal by Subject|3|||
48992748|NCT04067310|157809144|FG001|Overall Study|Withdrawal by Subject|0|||
48992749|NCT01347931|157809147|FG000|Standard Oxygen Therapy|Withdrawal by Subject|1|||
48992750|NCT01249404|157809148|FG000|Overall Study|Study treatment not received|0|||
48992751|NCT01249404|157809149|FG001|Overall Study|Study treatment not received|1|||
48992752|NCT01249404|157809150|FG002|Overall Study|Study treatment not received|2|||
48992753|NCT01249404|157809148|FG000|Overall Study|No MAS Score at baseline and/or Week 4|2|||
48992754|NCT01249404|157809149|FG001|Overall Study|No MAS Score at baseline and/or Week 4|0|||
48992755|NCT01249404|157809150|FG002|Overall Study|No MAS Score at baseline and/or Week 4|2|||
48992756|NCT01249404|157809148|FG000|Overall Study|Adverse Event|2|||
48992757|NCT01249404|157809149|FG001|Overall Study|Adverse Event|2|||
48992758|NCT01249404|157809150|FG002|Overall Study|Adverse Event|2|||
48992759|NCT01249404|157809148|FG000|Overall Study|Withdrawal by Subject|2|||
48992760|NCT01249404|157809149|FG001|Overall Study|Withdrawal by Subject|2|||
48992761|NCT01249404|157809150|FG002|Overall Study|Withdrawal by Subject|0|||
48992762|NCT01249404|157809148|FG000|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
48992763|NCT01249404|157809149|FG001|Overall Study|Botulinum toxin (BTX) in upper limb|2|||
48992764|NCT01249404|157809150|FG002|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
48992765|NCT01249404|157809148|FG000|Overall Study|Non compliance to visit schedule|0|||
48992766|NCT01249404|157809149|FG001|Overall Study|Non compliance to visit schedule|1|||
48992767|NCT01249404|157809150|FG002|Overall Study|Non compliance to visit schedule|0|||
48992768|NCT04308668|157809151|FG000|Overall Study|Lost to Follow-up|32|||
48992769|NCT04308668|157809152|FG001|Overall Study|Lost to Follow-up|38|||
48992770|NCT04308668|157809151|FG000|Overall Study|Withdrawal by Subject|4|||
48992771|NCT04308668|157809152|FG001|Overall Study|Withdrawal by Subject|4|||
48992772|NCT01266967|157809153|FG000|Overall Study|Death|69|||
49045176|NCT01899053|157998138|FG007|Overall Study|Symptomatic Deterioration|1|||
49045177|NCT01899053|157998139|FG008|Overall Study|Symptomatic Deterioration|0|||
48992773|NCT01266967|157809154|FG001|Overall Study|Death|61|||
48992774|NCT01266967|157809153|FG000|Overall Study|Study Closed/Terminated|15|||
48992775|NCT01266967|157809154|FG001|Overall Study|Study Closed/Terminated|17|||
48992776|NCT01266967|157809153|FG000|Overall Study|Lost to Follow-up|2|||
48992777|NCT01266967|157809154|FG001|Overall Study|Lost to Follow-up|1|||
48992778|NCT01266967|157809153|FG000|Overall Study|Physician Decision|0|||
48992779|NCT01266967|157809154|FG001|Overall Study|Physician Decision|1|||
48992780|NCT01266967|157809153|FG000|Overall Study|Withdrawal by Subject|3|||
48992781|NCT01266967|157809154|FG001|Overall Study|Withdrawal by Subject|3|||
48992782|NCT02493712|157809155|FG000|Overall Study|Withdrawal by Subject|1|||
48992783|NCT02493712|157809156|FG001|Overall Study|Withdrawal by Subject|0|||
48992784|NCT02493712|157809157|FG002|Overall Study|Withdrawal by Subject|2|||
48992785|NCT02493712|157809155|FG000|Overall Study|Protocol Violation|0|||
48992786|NCT02493712|157809156|FG001|Overall Study|Protocol Violation|0|||
48992787|NCT02493712|157809157|FG002|Overall Study|Protocol Violation|1|||
48992788|NCT02493712|157809155|FG000|Overall Study|Lost to Follow-up|1|||
48992789|NCT02493712|157809156|FG001|Overall Study|Lost to Follow-up|0|||
48992790|NCT02493712|157809157|FG002|Overall Study|Lost to Follow-up|0|||
48992791|NCT02493712|157809155|FG000|Overall Study|Physician Decision|0|||
48992792|NCT02493712|157809156|FG001|Overall Study|Physician Decision|1|||
48992793|NCT02493712|157809157|FG002|Overall Study|Physician Decision|0|||
48992794|NCT02493712|157809155|FG000|Overall Study|Lack of Efficacy|0|||
48992795|NCT02493712|157809156|FG001|Overall Study|Lack of Efficacy|5|||
48992796|NCT02493712|157809157|FG002|Overall Study|Lack of Efficacy|3|||
48992797|NCT04563845|157809158|FG000|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
48992798|NCT04563845|157809159|FG001|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
49045178|NCT01899053|157998140|FG009|Overall Study|Symptomatic Deterioration|0|||
49045179|NCT01899053|157998141|FG010|Overall Study|Symptomatic Deterioration|0|||
49045180|NCT01899053|157998142|FG011|Overall Study|Symptomatic Deterioration|1|||
49045181|NCT01899053|157998143|FG012|Overall Study|Symptomatic Deterioration|2|||
49045182|NCT01899053|157998144|FG013|Overall Study|Symptomatic Deterioration|0|||
49045183|NCT00057941|157998145|FG000|Overall Study|Death|1|||
49045184|NCT00057941|157998146|FG001|Overall Study|Death|2|||
49045185|NCT00057941|157998145|FG000|Overall Study|Adverse Event|7|||
48992799|NCT04563845|157809160|FG002|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
48992800|NCT04563845|157809161|FG003|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
48992801|NCT04563845|157809162|FG004|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
48992802|NCT04563845|157809163|FG005|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
48992803|NCT04563845|157809164|FG006|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
48992804|NCT04563845|157809165|FG007|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|1|||
48992805|NCT04563845|157809166|FG008|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
48992806|NCT04563845|157809167|FG009|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
48992807|NCT04563845|157809168|FG010|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
48992808|NCT04563845|157809169|FG011|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
49045186|NCT00057941|157998146|FG001|Overall Study|Adverse Event|9|||
49045187|NCT00057941|157998145|FG000|Overall Study|Lack of Efficacy|54|||
49045188|NCT00057941|157998146|FG001|Overall Study|Lack of Efficacy|53|||
48992809|NCT04563845|157809170|FG012|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
48992810|NCT04563845|157809171|FG013|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
48992811|NCT04563845|157809158|FG000|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
49045189|NCT00057941|157998145|FG000|Overall Study|Withdrawal by Subject|6|||
49045190|NCT00057941|157998146|FG001|Overall Study|Withdrawal by Subject|1|||
48992812|NCT04563845|157809159|FG001|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
49045191|NCT00057941|157998145|FG000|Overall Study|still on treatment|3|||
49045192|NCT00057941|157998146|FG001|Overall Study|still on treatment|1|||
48992813|NCT04563845|157809160|FG002|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
49045193|NCT00057941|157998145|FG000|Overall Study|insurance, symptomatic deterioration|1|||
49045194|NCT00057941|157998146|FG001|Overall Study|insurance, symptomatic deterioration|3|||
49045195|NCT00057941|157998145|FG000|Overall Study|Ineligible|2|||
49045196|NCT00057941|157998146|FG001|Overall Study|Ineligible|5|||
49045197|NCT00965731|157998147|FG000|Overall Study|Death|0|||
49045198|NCT00965731|157998148|FG001|Overall Study|Death|4|||
49045199|NCT00965731|157998147|FG000|Overall Study|Withdrawal by Subject|0|||
49045200|NCT00965731|157998148|FG001|Overall Study|Withdrawal by Subject|1|||
49045201|NCT00965731|157998147|FG000|Overall Study|Other|7|||
49045202|NCT00965731|157998148|FG001|Overall Study|Other|15|||
49045203|NCT01849458|157998149|FG000|Overall Study|Lost to Follow-up|4|||
49045204|NCT03950674|157998152|FG000|Overall Study|Death|16|||
49045205|NCT03950674|157998153|FG001|Overall Study|Death|15|||
49045206|NCT03950674|157998152|FG000|Overall Study|Participation in the study terminated by the sponsor|9|||
49045207|NCT03950674|157998153|FG001|Overall Study|Participation in the study terminated by the sponsor|0|||
49045208|NCT02119936|157998158|FG000|Overall Study|Lost to Follow-up|10|||
49045209|NCT00879684|157998160|FG000|Stage 1: Dose Escalation|Adverse Event|1|||
49045210|NCT00879684|157998161|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
49045211|NCT00879684|157998162|FG002|Stage 1: Dose Escalation|Adverse Event|0|||
49045212|NCT00879684|157998163|FG003|Stage 1: Dose Escalation|Adverse Event|0|||
49045213|NCT00879684|157998164|FG004|Stage 1: Dose Escalation|Adverse Event|0|||
49045214|NCT00879684|157998165|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
49045215|NCT00879684|157998166|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
49045216|NCT00879684|157998160|FG000|Stage 1: Dose Escalation|Progressive Disease|2|||
49045217|NCT00879684|157998161|FG001|Stage 1: Dose Escalation|Progressive Disease|3|||
49045218|NCT00879684|157998162|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
49045219|NCT00879684|157998163|FG003|Stage 1: Dose Escalation|Progressive Disease|4|||
48992814|NCT04563845|157809161|FG003|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
48992815|NCT04563845|157809162|FG004|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|1|||
48992816|NCT04563845|157809163|FG005|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
48992817|NCT04563845|157809164|FG006|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
49045220|NCT00879684|157998164|FG004|Stage 1: Dose Escalation|Progressive Disease|3|||
49045221|NCT00879684|157998165|FG005|Stage 1: Dose Escalation|Progressive Disease|3|||
49045222|NCT00879684|157998166|FG006|Stage 1: Dose Escalation|Progressive Disease|0|||
49045223|NCT00879684|157998160|FG000|Stage 1: Dose Escalation|Investigator declined participation|0|||
49045224|NCT00879684|157998161|FG001|Stage 1: Dose Escalation|Investigator declined participation|0|||
49045225|NCT00879684|157998162|FG002|Stage 1: Dose Escalation|Investigator declined participation|2|||
49045226|NCT00879684|157998163|FG003|Stage 1: Dose Escalation|Investigator declined participation|2|||
49045227|NCT00879684|157998164|FG004|Stage 1: Dose Escalation|Investigator declined participation|0|||
49045228|NCT00879684|157998165|FG005|Stage 1: Dose Escalation|Investigator declined participation|0|||
49045229|NCT00879684|157998166|FG006|Stage 1: Dose Escalation|Investigator declined participation|0|||
49045230|NCT00879684|157998160|FG000|Stage 1: Dose Escalation|Death|0|||
49045231|NCT00879684|157998161|FG001|Stage 1: Dose Escalation|Death|0|||
49045232|NCT00879684|157998162|FG002|Stage 1: Dose Escalation|Death|1|||
49045233|NCT00879684|157998163|FG003|Stage 1: Dose Escalation|Death|0|||
48992818|NCT04563845|157809165|FG007|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
48992819|NCT04563845|157809166|FG008|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
48992820|NCT04563845|157809167|FG009|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
48992821|NCT04563845|157809168|FG010|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
48992822|NCT04563845|157809169|FG011|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
48992823|NCT04563845|157809170|FG012|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
48992824|NCT04563845|157809171|FG013|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
48992825|NCT03890731|157809172|FG000|Overall Study|Progressive disease|1|||
48992826|NCT03890731|157809172|FG000|Overall Study|Patient's decision|1|||
49045234|NCT00879684|157998164|FG004|Stage 1: Dose Escalation|Death|0|||
49045235|NCT00879684|157998165|FG005|Stage 1: Dose Escalation|Death|0|||
49045236|NCT00879684|157998166|FG006|Stage 1: Dose Escalation|Death|0|||
49045237|NCT00879684|157998160|FG000|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
49045238|NCT00879684|157998161|FG001|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
49045239|NCT00879684|157998162|FG002|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
49045240|NCT00879684|157998163|FG003|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
49045241|NCT00879684|157998164|FG004|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
49045242|NCT00879684|157998165|FG005|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
48992827|NCT03890731|157809172|FG000|Overall Study|Adverse Event|4|||
48992828|NCT03758612|157809173|FG000|Washout Period|Withdrawal by Subject|0|||
48992829|NCT03758612|157809174|FG001|Washout Period|Withdrawal by Subject|0|||
48992830|NCT03758612|157809175|FG002|Washout Period|Withdrawal by Subject|2|||
49045243|NCT00879684|157998166|FG006|Stage 2: Expanded Cohort|Lost to Follow-up|1|||
49045244|NCT00879684|157998160|FG000|Stage 2: Expanded Cohort|Progressive Disease|0|||
49045245|NCT00879684|157998161|FG001|Stage 2: Expanded Cohort|Progressive Disease|0|||
49045246|NCT00879684|157998162|FG002|Stage 2: Expanded Cohort|Progressive Disease|0|||
48992831|NCT03758612|157809176|FG003|Washout Period|Withdrawal by Subject|0|||
48992832|NCT03758612|157809177|FG004|Washout Period|Withdrawal by Subject|0|||
48992833|NCT03758612|157809178|FG005|Washout Period|Withdrawal by Subject|0|||
48992834|NCT03758612|157809179|FG006|Washout Period|Withdrawal by Subject|0|||
48992835|NCT03758612|157809180|FG007|Washout Period|Withdrawal by Subject|0|||
48992836|NCT03758612|157809181|FG008|Washout Period|Withdrawal by Subject|0|||
48992837|NCT03758612|157809182|FG009|Washout Period|Withdrawal by Subject|0|||
48992838|NCT03758612|157809183|FG010|Washout Period|Withdrawal by Subject|0|||
48992839|NCT03758612|157809184|FG011|Washout Period|Withdrawal by Subject|0|||
48992840|NCT03758612|157809173|FG000|Period 2|Protocol Violation|0|||
48992841|NCT03758612|157809174|FG001|Period 2|Protocol Violation|0|||
48992842|NCT03758612|157809175|FG002|Period 2|Protocol Violation|0|||
49045247|NCT00879684|157998163|FG003|Stage 2: Expanded Cohort|Progressive Disease|0|||
49045248|NCT00879684|157998164|FG004|Stage 2: Expanded Cohort|Progressive Disease|0|||
49045249|NCT00879684|157998165|FG005|Stage 2: Expanded Cohort|Progressive Disease|0|||
49045250|NCT00879684|157998166|FG006|Stage 2: Expanded Cohort|Progressive Disease|11|||
49045251|NCT00879684|157998160|FG000|Stage 2: Expanded Cohort|Investigator declined participation|0|||
49045252|NCT00879684|157998161|FG001|Stage 2: Expanded Cohort|Investigator declined participation|0|||
49045253|NCT00879684|157998162|FG002|Stage 2: Expanded Cohort|Investigator declined participation|0|||
49045254|NCT00879684|157998163|FG003|Stage 2: Expanded Cohort|Investigator declined participation|0|||
49045255|NCT00879684|157998164|FG004|Stage 2: Expanded Cohort|Investigator declined participation|0|||
49045256|NCT00879684|157998165|FG005|Stage 2: Expanded Cohort|Investigator declined participation|0|||
49045257|NCT00879684|157998166|FG006|Stage 2: Expanded Cohort|Investigator declined participation|1|||
49045258|NCT02163694|157998167|FG000|Overall Study|Adverse event- related to progression|4|||
49045259|NCT02163694|157998168|FG001|Overall Study|Adverse event- related to progression|10|||
49045260|NCT02163694|157998167|FG000|Overall Study|Adverse event- not related to progression|7|||
49045261|NCT02163694|157998168|FG001|Overall Study|Adverse event- not related to progression|22|||
49045262|NCT02163694|157998167|FG000|Overall Study|Withdrew consent|13|||
49045263|NCT02163694|157998168|FG001|Overall Study|Withdrew consent|28|||
49045264|NCT02163694|157998167|FG000|Overall Study|Lost to Follow-up|2|||
49045265|NCT02163694|157998168|FG001|Overall Study|Lost to Follow-up|2|||
49045266|NCT02163694|157998167|FG000|Overall Study|Sponsor discontinued study|3|||
49045267|NCT02163694|157998168|FG001|Overall Study|Sponsor discontinued study|29|||
49045268|NCT02163694|157998167|FG000|Overall Study|Progressive disease per protocol|125|||
49045269|NCT02163694|157998168|FG001|Overall Study|Progressive disease per protocol|224|||
49045270|NCT02163694|157998167|FG000|Overall Study|Other, not specified|17|||
49045271|NCT02163694|157998168|FG001|Overall Study|Other, not specified|22|||
49045272|NCT02163694|157998167|FG000|Overall Study|Randomized but Not Treated|1|||
49045273|NCT02163694|157998168|FG001|Overall Study|Randomized but Not Treated|0|||
49045274|NCT02163694|157998167|FG000|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
49045275|NCT02163694|157998168|FG001|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
49045276|NCT03245840|157998169|FG000|Overall Study|Adverse Event|6|||
49045277|NCT03245840|157998170|FG001|Overall Study|Adverse Event|0|||
49045278|NCT03245840|157998169|FG000|Overall Study|Death|2|||
49045279|NCT03245840|157998170|FG001|Overall Study|Death|0|||
49045280|NCT03245840|157998169|FG000|Overall Study|Withdrawal by Subject|31|||
49045281|NCT03245840|157998170|FG001|Overall Study|Withdrawal by Subject|1|||
49045282|NCT03245840|157998169|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
49045283|NCT03245840|157998170|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
49045284|NCT03245840|157998169|FG000|Overall Study|Physician Decision|4|||
49045285|NCT03245840|157998170|FG001|Overall Study|Physician Decision|1|||
49045286|NCT03245840|157998169|FG000|Overall Study|Study Terminated by Sponsor|56|||
49045287|NCT03245840|157998170|FG001|Overall Study|Study Terminated by Sponsor|6|||
49045288|NCT03245840|157998169|FG000|Overall Study|Site Terminated by Sponsor|4|||
49045289|NCT03245840|157998170|FG001|Overall Study|Site Terminated by Sponsor|0|||
48992843|NCT03758612|157809176|FG003|Period 2|Protocol Violation|0|||
48992844|NCT03758612|157809177|FG004|Period 2|Protocol Violation|1|||
48992845|NCT03758612|157809178|FG005|Period 2|Protocol Violation|0|||
48992846|NCT03758612|157809179|FG006|Period 2|Protocol Violation|0|||
49045290|NCT03245840|157998169|FG000|Overall Study|Lost to Follow-up|12|||
48992847|NCT03758612|157809180|FG007|Period 2|Protocol Violation|0|||
48992848|NCT03758612|157809181|FG008|Period 2|Protocol Violation|0|||
48992849|NCT03758612|157809182|FG009|Period 2|Protocol Violation|0|||
48992850|NCT03758612|157809183|FG010|Period 2|Protocol Violation|0|||
48992851|NCT03758612|157809184|FG011|Period 2|Protocol Violation|0|||
48992852|NCT00772031|157809187|FG000|Overall Study|Early termination of trial|12|||
48992853|NCT00772031|157809188|FG001|Overall Study|Early termination of trial|10|||
48992854|NCT00772031|157809187|FG000|Overall Study|Lost to Follow-up|20|||
48992855|NCT00772031|157809188|FG001|Overall Study|Lost to Follow-up|33|||
48992856|NCT00883896|157809189|FG000|Overall Study|Lost to Follow-up|0|||
49045291|NCT03245840|157998170|FG001|Overall Study|Lost to Follow-up|2|||
49045292|NCT03245840|157998169|FG000|Overall Study|Pregnancy|2|||
49045293|NCT03245840|157998170|FG001|Overall Study|Pregnancy|0|||
49045294|NCT03245840|157998169|FG000|Overall Study|Non-Compliance with Study Drug|2|||
49045295|NCT03245840|157998170|FG001|Overall Study|Non-Compliance with Study Drug|0|||
49045296|NCT03245840|157998169|FG000|Overall Study|Not treated|1|||
49045297|NCT03245840|157998170|FG001|Overall Study|Not treated|1|||
49045298|NCT05652010|157998171|FG000|First Intervention|Withdrawal by Subject|0|||
49045299|NCT05652010|157998172|FG001|First Intervention|Withdrawal by Subject|1|||
49045300|NCT05652010|157998171|FG000|Second Intervention|Withdrawal by Subject|1|||
49045301|NCT05652010|157998172|FG001|Second Intervention|Withdrawal by Subject|0|||
49045302|NCT04287868|157998177|FG000|Overall Study|Screening fail|1|||
49045303|NCT04287868|157998178|FG001|Overall Study|Screening fail|0|||
49045304|NCT00640341|158000041|FG000|Overall Study|Adverse Event|0|||
49045305|NCT00640341|158000042|FG001|Overall Study|Adverse Event|0|||
49045306|NCT00640341|158000043|FG002|Overall Study|Adverse Event|1|||
49045307|NCT00640341|158000041|FG000|Overall Study|Positive Slit Lamp Findings|0|||
49045308|NCT00640341|158000042|FG001|Overall Study|Positive Slit Lamp Findings|0|||
49045309|NCT00640341|158000043|FG002|Overall Study|Positive Slit Lamp Findings|1|||
49045310|NCT00640341|158000041|FG000|Overall Study|Study Related Symptoms/Complaints|2|||
49045311|NCT00640341|158000042|FG001|Overall Study|Study Related Symptoms/Complaints|1|||
49045312|NCT00640341|158000043|FG002|Overall Study|Study Related Symptoms/Complaints|2|||
49045313|NCT00640341|158000041|FG000|Overall Study|Inability to Maintain Wearing Schedule|1|||
49045314|NCT00640341|158000042|FG001|Overall Study|Inability to Maintain Wearing Schedule|1|||
49045315|NCT00640341|158000043|FG002|Overall Study|Inability to Maintain Wearing Schedule|0|||
49045316|NCT00640341|158000041|FG000|Overall Study|Failure to Follow Subject Instructions|1|||
49045317|NCT00640341|158000042|FG001|Overall Study|Failure to Follow Subject Instructions|0|||
49045318|NCT00640341|158000043|FG002|Overall Study|Failure to Follow Subject Instructions|0|||
49045319|NCT00640341|158000041|FG000|Overall Study|Lost to Follow-up|2|||
49045320|NCT00640341|158000042|FG001|Overall Study|Lost to Follow-up|0|||
49045321|NCT00640341|158000043|FG002|Overall Study|Lost to Follow-up|0|||
49045322|NCT00640341|158000041|FG000|Overall Study|Withdrawal by Subject|4|||
49045323|NCT00640341|158000042|FG001|Overall Study|Withdrawal by Subject|0|||
49045324|NCT00640341|158000043|FG002|Overall Study|Withdrawal by Subject|1|||
49045325|NCT00640341|158000041|FG000|Overall Study|Unacceptable Lens Movement|1|||
49045326|NCT00640341|158000042|FG001|Overall Study|Unacceptable Lens Movement|0|||
49045327|NCT00640341|158000043|FG002|Overall Study|Unacceptable Lens Movement|0|||
49045328|NCT00640341|158000041|FG000|Overall Study|Poor fit/Uncomfortable|4|||
49045329|NCT00640341|158000042|FG001|Overall Study|Poor fit/Uncomfortable|0|||
49045330|NCT00640341|158000043|FG002|Overall Study|Poor fit/Uncomfortable|0|||
49045331|NCT00640341|158000041|FG000|Overall Study|Ineligable at Baseline|5|||
49045332|NCT00640341|158000042|FG001|Overall Study|Ineligable at Baseline|3|||
49045333|NCT00640341|158000043|FG002|Overall Study|Ineligable at Baseline|2|||
49045334|NCT00640341|158000041|FG000|Overall Study|Adverse event and positive slit lamp|1|||
49045335|NCT00640341|158000042|FG001|Overall Study|Adverse event and positive slit lamp|0|||
49045336|NCT00640341|158000043|FG002|Overall Study|Adverse event and positive slit lamp|0|||
49045337|NCT03247686|158000047|FG000|Overall Study|Withdrawal by Subject|1|||
49045338|NCT03247686|158000048|FG001|Overall Study|Withdrawal by Subject|2|||
49045339|NCT01710358|158000049|FG000|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15|||
49045340|NCT01710358|158000050|FG001|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18|||
49045341|NCT01710358|158000051|FG002|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7|||
49045342|NCT01710358|158000049|FG000|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
49045343|NCT01710358|158000050|FG001|Treatment Period Part A (Weeks 0 to 24)|Death|2|||
49045344|NCT01710358|158000051|FG002|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
49045345|NCT01710358|158000049|FG000|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0|||
49045346|NCT01710358|158000050|FG001|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
49045347|NCT01710358|158000051|FG002|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
49045348|NCT01710358|158000049|FG000|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15|||
49045349|NCT01710358|158000050|FG001|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1|||
49045350|NCT01710358|158000051|FG002|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3|||
49045351|NCT01710358|158000049|FG000|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
49045352|NCT01710358|158000050|FG001|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1|||
49045353|NCT01710358|158000051|FG002|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
49045354|NCT01710358|158000049|FG000|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1|||
49045355|NCT01710358|158000050|FG001|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
49045356|NCT01710358|158000051|FG002|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
49045357|NCT01710358|158000049|FG000|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4|||
49045358|NCT01710358|158000050|FG001|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
49045359|NCT01710358|158000051|FG002|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
49045360|NCT01710358|158000049|FG000|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15|||
49045361|NCT01710358|158000050|FG001|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5|||
49045362|NCT01710358|158000051|FG002|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12|||
49045363|NCT01710358|158000049|FG000|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
49045364|NCT01710358|158000050|FG001|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
49045365|NCT01710358|158000051|FG002|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0|||
49045366|NCT01710358|158000049|FG000|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10|||
49045367|NCT01710358|158000050|FG001|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16|||
49045368|NCT01710358|158000051|FG002|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5|||
49045369|NCT01710358|158000049|FG000|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
49045370|NCT01710358|158000050|FG001|Treatment Period Part B (Weeks 24 to 52)|Death|0|||
49045371|NCT01710358|158000051|FG002|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
49045372|NCT01710358|158000049|FG000|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
49045373|NCT01710358|158000050|FG001|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
49045374|NCT01710358|158000051|FG002|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1|||
49045375|NCT01710358|158000049|FG000|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
49045376|NCT01710358|158000050|FG001|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
49045377|NCT01710358|158000051|FG002|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1|||
49045378|NCT01710358|158000049|FG000|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
49045379|NCT01710358|158000050|FG001|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1|||
48992857|NCT00883896|157809190|FG001|Overall Study|Lost to Follow-up|0|||
48992858|NCT00883896|157809191|FG002|Overall Study|Lost to Follow-up|0|||
48992859|NCT00883896|157809192|FG003|Overall Study|Lost to Follow-up|2|||
48992860|NCT00883896|157809189|FG000|Overall Study|Withdrawal by Subject|5|||
48992861|NCT00883896|157809190|FG001|Overall Study|Withdrawal by Subject|0|||
48992862|NCT00883896|157809191|FG002|Overall Study|Withdrawal by Subject|1|||
48992863|NCT00883896|157809192|FG003|Overall Study|Withdrawal by Subject|3|||
48992864|NCT00883896|157809189|FG000|Overall Study|Lack of Efficacy|0|||
48992865|NCT00883896|157809190|FG001|Overall Study|Lack of Efficacy|0|||
48992866|NCT00883896|157809191|FG002|Overall Study|Lack of Efficacy|0|||
48992867|NCT00883896|157809192|FG003|Overall Study|Lack of Efficacy|2|||
48992868|NCT00883896|157809189|FG000|Overall Study|Other|1|||
48992869|NCT00883896|157809190|FG001|Overall Study|Other|0|||
48992870|NCT00883896|157809191|FG002|Overall Study|Other|0|||
48992871|NCT00883896|157809192|FG003|Overall Study|Other|0|||
49045380|NCT01710358|158000051|FG002|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
49045381|NCT01710358|158000049|FG000|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1|||
49045382|NCT01710358|158000050|FG001|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2|||
49045383|NCT01710358|158000051|FG002|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0|||
49045384|NCT01710358|158000049|FG000|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4|||
48992872|NCT02546193|157809193|FG000|Overall Study|Withdrawal by Subject|2|||
48992873|NCT02546193|157809194|FG001|Overall Study|Withdrawal by Subject|0|||
48992874|NCT02546193|157809195|FG002|Overall Study|Withdrawal by Subject|1|||
48992875|NCT02546193|157809196|FG003|Overall Study|Withdrawal by Subject|0|||
48992876|NCT02546193|157809193|FG000|Overall Study|Not eligible at time of induction|4|||
48992877|NCT02546193|157809194|FG001|Overall Study|Not eligible at time of induction|6|||
48992878|NCT02546193|157809195|FG002|Overall Study|Not eligible at time of induction|1|||
48992879|NCT02546193|157809196|FG003|Overall Study|Not eligible at time of induction|0|||
48992880|NCT01474291|157809199|FG000|Overall Study|Not Evaluable for Efficacy|26|||
48992881|NCT01474291|157809199|FG000|Overall Study|Lack of Treatment Efficacy|88|||
48992882|NCT01474291|157809199|FG000|Overall Study|Adverse Event|53|||
48992883|NCT01474291|157809199|FG000|Overall Study|Lost to Follow-up|29|||
49045385|NCT01710358|158000050|FG001|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3|||
49045386|NCT01710358|158000051|FG002|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7|||
49045387|NCT01710358|158000049|FG000|Rescue Period|Adverse Event|0|||
48992884|NCT01474291|157809199|FG000|Overall Study|Patient No Longer Wanted to Participate|12|||
48992885|NCT01474291|157809199|FG000|Overall Study|No Reason Reported|10|||
48992886|NCT01474291|157809199|FG000|Overall Study|Death|2|||
48992887|NCT00310440|157809200|FG000|Overall Study|Lost to Follow-up|17|||
48992888|NCT00310440|157809201|FG001|Overall Study|Lost to Follow-up|8|||
48992889|NCT00310440|157809200|FG000|Overall Study|Withdrawal by Subject|2|||
48992890|NCT00310440|157809201|FG001|Overall Study|Withdrawal by Subject|1|||
48992891|NCT00310440|157809200|FG000|Overall Study|Missed 12 Month Visit|7|||
48992892|NCT00310440|157809201|FG001|Overall Study|Missed 12 Month Visit|4|||
48992893|NCT00792467|157809202|FG000|Overall Study|progression of disease|17|||
49045388|NCT01710358|158000050|FG001|Rescue Period|Adverse Event|15|||
49045389|NCT01710358|158000051|FG002|Rescue Period|Adverse Event|0|||
49045390|NCT01710358|158000049|FG000|Rescue Period|Death|0|||
49045391|NCT01710358|158000050|FG001|Rescue Period|Death|1|||
48992894|NCT00792467|157809202|FG000|Overall Study|Adverse Event|1|||
49045392|NCT01710358|158000051|FG002|Rescue Period|Death|0|||
49045393|NCT01710358|158000049|FG000|Rescue Period|Lack of Efficacy|0|||
48992895|NCT00792467|157809202|FG000|Overall Study|patient request|1|||
48992896|NCT00792467|157809202|FG000|Overall Study|Lost to Follow-up|1|||
48992897|NCT00792467|157809202|FG000|Overall Study|Patient achieved a PR and allogenic transplant was performed|1|||
48992898|NCT00792467|157809202|FG000|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1|||
48992899|NCT01287403|157809210|FG000|1st Intervention (1 Day)|Adverse Event|1|||
48992900|NCT02988115|157809213|FG000|Overall Study|Adverse Event|6|||
49045394|NCT01710358|158000050|FG001|Rescue Period|Lack of Efficacy|7|||
49045395|NCT01710358|158000051|FG002|Rescue Period|Lack of Efficacy|0|||
49045396|NCT01710358|158000049|FG000|Rescue Period|Withdrawal by Subject|0|||
49045397|NCT01710358|158000050|FG001|Rescue Period|Withdrawal by Subject|8|||
49045398|NCT01710358|158000051|FG002|Rescue Period|Withdrawal by Subject|0|||
49045399|NCT05061992|158000055|FG000|Overall Study|Excess bowel movements|1|||
49045400|NCT05061992|158000056|FG001|Overall Study|Excess bowel movements|0|||
49045401|NCT05061992|158000055|FG000|Overall Study|Complications of Medical Care|1|||
49045402|NCT05061992|158000056|FG001|Overall Study|Complications of Medical Care|0|||
49045403|NCT05061992|158000055|FG000|Overall Study|Diarrhea Prior to Starting Therapy|1|||
49045404|NCT05061992|158000056|FG001|Overall Study|Diarrhea Prior to Starting Therapy|0|||
49045405|NCT05061992|158000055|FG000|Overall Study|Withdrawal by Subject|0|||
49045406|NCT05061992|158000056|FG001|Overall Study|Withdrawal by Subject|1|||
49045407|NCT01872715|158000060|FG000|Overall Study|Adverse Event|1|||
49045408|NCT01872715|158000060|FG000|Overall Study|Protocol Violation|1|||
49045409|NCT01872715|158000060|FG000|Overall Study|Withdrawal by Subject|2|||
49045410|NCT01929681|158000077|FG000|Overall Study|Withdrawal by Subject|1|||
49045411|NCT01929681|158000078|FG001|Overall Study|Withdrawal by Subject|0|||
49045412|NCT01929681|158000077|FG000|Overall Study|Physician Decision|1|||
49045413|NCT01929681|158000078|FG001|Overall Study|Physician Decision|1|||
49045414|NCT02377349|158000080|FG000|Overall Study|Serious Adverse Event|1|||
49045415|NCT02377349|158000081|FG001|Overall Study|Serious Adverse Event|0|||
49045416|NCT02377349|158000080|FG000|Overall Study|Protocol Violation|3|||
49045417|NCT02377349|158000081|FG001|Overall Study|Protocol Violation|2|||
49045418|NCT02377349|158000080|FG000|Overall Study|Withdrawal by Subject|5|||
49045419|NCT02377349|158000081|FG001|Overall Study|Withdrawal by Subject|3|||
49045420|NCT02377349|158000080|FG000|Overall Study|Lost to follow-up (partial vaccination)|1|||
49045421|NCT02377349|158000081|FG001|Overall Study|Lost to follow-up (partial vaccination)|0|||
49045422|NCT02377349|158000080|FG000|Overall Study|Lost to follow-up (complete vaccination)|6|||
49045423|NCT02377349|158000081|FG001|Overall Study|Lost to follow-up (complete vaccination)|5|||
49045424|NCT02377349|158000080|FG000|Overall Study|Other|0|||
49045425|NCT02377349|158000081|FG001|Overall Study|Other|1|||
49045426|NCT03407729|158000086|FG000|Overall Study|Lost to Follow-up|2|||
49045427|NCT03407729|158000087|FG001|Overall Study|Lost to Follow-up|0|||
49045428|NCT03407729|158000086|FG000|Overall Study|Unable to schedule|0|||
49045429|NCT03407729|158000087|FG001|Overall Study|Unable to schedule|3|||
49045430|NCT03419962|158000090|FG000|Overall Study|Change to other medication|1|||
49045431|NCT03419962|158000090|FG000|Overall Study|Refusal of continuing with trial drug|1|||
49045432|NCT03419962|158000090|FG000|Overall Study|Lost to Follow-up|3|||
49045433|NCT03419962|158000090|FG000|Overall Study|Difficulty in inhaling the doses|1|||
49045434|NCT03419962|158000090|FG000|Overall Study|Missing completion data|31|||
49045435|NCT02914457|158000093|FG000|Overall Study|Withdrawal by Subject|1|||
49045436|NCT02914457|158000093|FG000|Overall Study|Physician Decision|1|||
49045437|NCT02914457|158000093|FG000|Overall Study|No veins available for lead placement|1|||
49045438|NCT02914457|158000093|FG000|Overall Study|Electrical instability of patient|1|||
49045439|NCT02914457|158000093|FG000|Overall Study|ECG acquisition error due to sweating|1|||
49045440|NCT02914457|158000093|FG000|Overall Study|Protocol Violation|1|||
49045441|NCT01098539|158000094|FG000|Overall Study|Adverse Event|26|||
49045442|NCT01098539|158000095|FG001|Overall Study|Adverse Event|26|||
49045443|NCT01098539|158000094|FG000|Overall Study|Protocol Violation|1|||
49045444|NCT01098539|158000095|FG001|Overall Study|Protocol Violation|4|||
49045445|NCT01098539|158000094|FG000|Overall Study|Noncompliance|3|||
49045446|NCT01098539|158000095|FG001|Overall Study|Noncompliance|5|||
49045447|NCT01098539|158000094|FG000|Overall Study|Lost to Follow-up|4|||
49045448|NCT01098539|158000095|FG001|Overall Study|Lost to Follow-up|4|||
49045449|NCT01098539|158000094|FG000|Overall Study|Withdrawal by Subject|12|||
49045450|NCT01098539|158000095|FG001|Overall Study|Withdrawal by Subject|26|||
49045451|NCT01098539|158000094|FG000|Overall Study|Physician Decision|5|||
49045452|NCT01098539|158000095|FG001|Overall Study|Physician Decision|3|||
49045453|NCT03843125|158000096|FG000|Overall Study|Adverse Event|17|||
49045454|NCT03843125|158000097|FG001|Overall Study|Adverse Event|13|||
49045455|NCT03843125|158000098|FG002|Overall Study|Adverse Event|5|||
49045456|NCT03843125|158000099|FG003|Overall Study|Adverse Event|9|||
49045457|NCT03843125|158000096|FG000|Overall Study|Death|0|||
49045458|NCT03843125|158000097|FG001|Overall Study|Death|6|||
49045459|NCT03843125|158000098|FG002|Overall Study|Death|2|||
49045460|NCT03843125|158000099|FG003|Overall Study|Death|0|||
49045461|NCT03843125|158000096|FG000|Overall Study|Lack of Efficacy|14|||
49045462|NCT03843125|158000097|FG001|Overall Study|Lack of Efficacy|11|||
49045463|NCT03843125|158000098|FG002|Overall Study|Lack of Efficacy|9|||
49045464|NCT03843125|158000099|FG003|Overall Study|Lack of Efficacy|4|||
49045465|NCT03843125|158000096|FG000|Overall Study|Lost to Follow-up|3|||
49045466|NCT03843125|158000097|FG001|Overall Study|Lost to Follow-up|4|||
49045467|NCT03843125|158000098|FG002|Overall Study|Lost to Follow-up|0|||
49045468|NCT03843125|158000099|FG003|Overall Study|Lost to Follow-up|2|||
49045469|NCT03843125|158000096|FG000|Overall Study|Other|12|||
49045470|NCT03843125|158000097|FG001|Overall Study|Other|14|||
49045471|NCT03843125|158000098|FG002|Overall Study|Other|3|||
48992901|NCT02988115|157809214|FG001|Overall Study|Adverse Event|1|||
48992902|NCT02988115|157809213|FG000|Overall Study|Sponsor Decision|5|||
48992903|NCT02988115|157809214|FG001|Overall Study|Sponsor Decision|2|||
48992904|NCT02988115|157809213|FG000|Overall Study|Withdrawal by Subject|1|||
48992905|NCT02988115|157809214|FG001|Overall Study|Withdrawal by Subject|1|||
48992906|NCT02988115|157809213|FG000|Overall Study|Withdrawn by Mistake|1|||
48992907|NCT02988115|157809214|FG001|Overall Study|Withdrawn by Mistake|0|||
48992908|NCT02988115|157809213|FG000|Overall Study|Lost to Follow-up|1|||
48992909|NCT02988115|157809214|FG001|Overall Study|Lost to Follow-up|0|||
48992910|NCT00148109|157809215|FG000|Overall Study|Lack of Efficacy|10|||
48992911|NCT00148109|157809216|FG001|Overall Study|Lack of Efficacy|18|||
48992912|NCT00148109|157809215|FG000|Overall Study|Adverse Event|0|||
48992913|NCT00148109|157809216|FG001|Overall Study|Adverse Event|2|||
48992914|NCT00148109|157809215|FG000|Overall Study|Withdrawal by Subject|2|||
48992915|NCT00148109|157809216|FG001|Overall Study|Withdrawal by Subject|0|||
48992916|NCT01731951|157809217|FG000|Overall Study|Documented Disease Progression|1|||
48992917|NCT01731951|157809218|FG001|Overall Study|Documented Disease Progression|0|||
48992918|NCT01731951|157809219|FG002|Overall Study|Documented Disease Progression|0|||
48992919|NCT01731951|157809220|FG003|Overall Study|Documented Disease Progression|0|||
48992920|NCT01731951|157809221|FG004|Overall Study|Documented Disease Progression|0|||
48992921|NCT01731951|157809222|FG005|Overall Study|Documented Disease Progression|0|||
48992922|NCT01731951|157809217|FG000|Overall Study|Lost to Follow-up|2|||
48992923|NCT01731951|157809218|FG001|Overall Study|Lost to Follow-up|0|||
48992924|NCT01731951|157809219|FG002|Overall Study|Lost to Follow-up|0|||
48992925|NCT01731951|157809220|FG003|Overall Study|Lost to Follow-up|1|||
48992926|NCT01731951|157809221|FG004|Overall Study|Lost to Follow-up|3|||
48992927|NCT01731951|157809222|FG005|Overall Study|Lost to Follow-up|1|||
48992928|NCT01731951|157809217|FG000|Overall Study|Withdrawal of Consent|1|||
48992929|NCT01731951|157809218|FG001|Overall Study|Withdrawal of Consent|0|||
48992930|NCT01731951|157809219|FG002|Overall Study|Withdrawal of Consent|0|||
48992931|NCT01731951|157809220|FG003|Overall Study|Withdrawal of Consent|0|||
48992932|NCT01731951|157809221|FG004|Overall Study|Withdrawal of Consent|0|||
48992933|NCT01731951|157809222|FG005|Overall Study|Withdrawal of Consent|2|||
48992934|NCT01731951|157809217|FG000|Overall Study|Death|13|||
48992935|NCT01731951|157809218|FG001|Overall Study|Death|15|||
48992936|NCT01731951|157809219|FG002|Overall Study|Death|9|||
48992937|NCT01731951|157809220|FG003|Overall Study|Death|8|||
48992938|NCT01731951|157809221|FG004|Overall Study|Death|9|||
48992939|NCT01731951|157809222|FG005|Overall Study|Death|6|||
48992940|NCT00649220|157809229|FG000|Overall Study|Adverse Event|2|||
48992941|NCT00649220|157809229|FG000|Overall Study|Withdrawal by Subject|1|||
48992942|NCT03814746|157809230|FG000|Overall Study|Participant decision|9|||
48992943|NCT03814746|157809231|FG001|Overall Study|Participant decision|6|||
48992944|NCT03814746|157809232|FG002|Overall Study|Participant decision|15|||
48992945|NCT03814746|157809230|FG000|Overall Study|Physician Decision|2|||
48992946|NCT03814746|157809231|FG001|Overall Study|Physician Decision|2|||
48992947|NCT03814746|157809232|FG002|Overall Study|Physician Decision|4|||
48992948|NCT03814746|157809230|FG000|Overall Study|Death|2|||
48992949|NCT03814746|157809231|FG001|Overall Study|Death|2|||
48992950|NCT03814746|157809232|FG002|Overall Study|Death|2|||
48992951|NCT03814746|157809230|FG000|Overall Study|Adverse Event|2|||
48992952|NCT03814746|157809231|FG001|Overall Study|Adverse Event|2|||
48992953|NCT03814746|157809232|FG002|Overall Study|Adverse Event|1|||
48992954|NCT03814746|157809230|FG000|Overall Study|Lost to Follow-up|2|||
48992955|NCT03814746|157809231|FG001|Overall Study|Lost to Follow-up|1|||
48992956|NCT03814746|157809232|FG002|Overall Study|Lost to Follow-up|2|||
48992957|NCT03814746|157809230|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
48992958|NCT03814746|157809231|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
48992959|NCT03814746|157809232|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
48992960|NCT03814746|157809230|FG000|Overall Study|Pregnancy|0|||
48992961|NCT03814746|157809231|FG001|Overall Study|Pregnancy|1|||
48992962|NCT03814746|157809232|FG002|Overall Study|Pregnancy|1|||
48992963|NCT03814746|157809230|FG000|Overall Study|Protocol Violation|1|||
48992964|NCT03814746|157809231|FG001|Overall Study|Protocol Violation|0|||
48992965|NCT03814746|157809232|FG002|Overall Study|Protocol Violation|0|||
48992966|NCT03339999|157809233|FG000|Overall Study|Adverse Event|1|||
48992967|NCT03339999|157809234|FG001|Overall Study|Adverse Event|2|||
48992968|NCT03339999|157809235|FG002|Overall Study|Adverse Event|2|||
48992969|NCT03339999|157809236|FG003|Overall Study|Adverse Event|1|||
48992970|NCT03339999|157809233|FG000|Overall Study|Lack of Efficacy|0|||
48992971|NCT03339999|157809234|FG001|Overall Study|Lack of Efficacy|1|||
48992972|NCT03339999|157809235|FG002|Overall Study|Lack of Efficacy|0|||
48992973|NCT03339999|157809236|FG003|Overall Study|Lack of Efficacy|0|||
48992974|NCT03339999|157809233|FG000|Overall Study|Lost to Follow-up|0|||
48992975|NCT03339999|157809234|FG001|Overall Study|Lost to Follow-up|0|||
48992976|NCT03339999|157809235|FG002|Overall Study|Lost to Follow-up|0|||
48992977|NCT03339999|157809236|FG003|Overall Study|Lost to Follow-up|1|||
48992978|NCT03339999|157809233|FG000|Overall Study|Study Terminated by Sponsor|6|||
48992979|NCT03339999|157809234|FG001|Overall Study|Study Terminated by Sponsor|3|||
48992980|NCT03339999|157809235|FG002|Overall Study|Study Terminated by Sponsor|4|||
48992981|NCT03339999|157809236|FG003|Overall Study|Study Terminated by Sponsor|3|||
48992982|NCT01399619|157809239|FG000|Overall Study|Adverse Event|10|||
48992983|NCT01399619|157809240|FG001|Overall Study|Adverse Event|0|||
48992984|NCT01399619|157809241|FG002|Overall Study|Adverse Event|4|||
48992985|NCT01399619|157809242|FG003|Overall Study|Adverse Event|10|||
48992986|NCT01399619|157809239|FG000|Overall Study|Lack of Efficacy|9|||
48992987|NCT01399619|157809240|FG001|Overall Study|Lack of Efficacy|0|||
48992988|NCT01399619|157809241|FG002|Overall Study|Lack of Efficacy|5|||
48992989|NCT01399619|157809242|FG003|Overall Study|Lack of Efficacy|0|||
48992990|NCT01399619|157809239|FG000|Overall Study|Withdrawal by Subject|6|||
48992991|NCT01399619|157809240|FG001|Overall Study|Withdrawal by Subject|0|||
48992992|NCT01399619|157809241|FG002|Overall Study|Withdrawal by Subject|3|||
48992993|NCT01399619|157809242|FG003|Overall Study|Withdrawal by Subject|4|||
48992994|NCT01399619|157809239|FG000|Overall Study|Protocol Violation|0|||
48992995|NCT01399619|157809240|FG001|Overall Study|Protocol Violation|0|||
48992996|NCT01399619|157809241|FG002|Overall Study|Protocol Violation|0|||
48992997|NCT01399619|157809242|FG003|Overall Study|Protocol Violation|1|||
48992998|NCT01399619|157809239|FG000|Overall Study|Not treated|0|||
48992999|NCT01399619|157809240|FG001|Overall Study|Not treated|0|||
48993000|NCT01399619|157809241|FG002|Overall Study|Not treated|0|||
48993001|NCT01399619|157809242|FG003|Overall Study|Not treated|2|||
48993002|NCT01733758|157809243|FG000|Overall Study|Adverse Event|5|||
48993003|NCT01733758|157809244|FG001|Overall Study|Adverse Event|7|||
48993004|NCT01733758|157809245|FG002|Overall Study|Adverse Event|8|||
48993005|NCT01733758|157809246|FG003|Overall Study|Adverse Event|1|||
48993006|NCT01733758|157809243|FG000|Overall Study|Withdrawal by Subject|1|||
48993007|NCT01733758|157809244|FG001|Overall Study|Withdrawal by Subject|1|||
48993008|NCT01733758|157809245|FG002|Overall Study|Withdrawal by Subject|5|||
48993009|NCT01733758|157809246|FG003|Overall Study|Withdrawal by Subject|3|||
48993010|NCT01733758|157809243|FG000|Overall Study|Persistent Hyperglycemia|3|||
48993011|NCT01733758|157809244|FG001|Overall Study|Persistent Hyperglycemia|2|||
48993012|NCT01733758|157809245|FG002|Overall Study|Persistent Hyperglycemia|0|||
48993013|NCT01733758|157809246|FG003|Overall Study|Persistent Hyperglycemia|0|||
48993014|NCT01733758|157809243|FG000|Overall Study|Protocol Violation|0|||
48993015|NCT01733758|157809244|FG001|Overall Study|Protocol Violation|1|||
48993016|NCT01733758|157809245|FG002|Overall Study|Protocol Violation|2|||
48993017|NCT01733758|157809246|FG003|Overall Study|Protocol Violation|2|||
48993018|NCT01733758|157809243|FG000|Overall Study|Non-compliance|1|||
48993019|NCT01733758|157809244|FG001|Overall Study|Non-compliance|0|||
48993020|NCT01733758|157809245|FG002|Overall Study|Non-compliance|0|||
48993021|NCT01733758|157809246|FG003|Overall Study|Non-compliance|0|||
48993022|NCT01733758|157809243|FG000|Overall Study|Intro of New Anti-Diabetic Medication|4|||
48993023|NCT01733758|157809244|FG001|Overall Study|Intro of New Anti-Diabetic Medication|0|||
48993024|NCT01733758|157809245|FG002|Overall Study|Intro of New Anti-Diabetic Medication|0|||
48993025|NCT01733758|157809246|FG003|Overall Study|Intro of New Anti-Diabetic Medication|1|||
48993026|NCT01733758|157809243|FG000|Overall Study|Inv Decision, HbA1c not controlled|1|||
49045472|NCT03843125|158000099|FG003|Overall Study|Other|4|||
49045473|NCT03843125|158000096|FG000|Overall Study|Due to Epidemic/Pandemic|1|||
49045474|NCT03843125|158000097|FG001|Overall Study|Due to Epidemic/Pandemic|0|||
49045475|NCT03843125|158000098|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
49045476|NCT03843125|158000099|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
49045477|NCT03843125|158000096|FG000|Overall Study|Study Terminated by Sponsor|318|||
48993027|NCT01733758|157809244|FG001|Overall Study|Inv Decision, HbA1c not controlled|1|||
48993028|NCT01733758|157809245|FG002|Overall Study|Inv Decision, HbA1c not controlled|0|||
48993029|NCT01733758|157809246|FG003|Overall Study|Inv Decision, HbA1c not controlled|1|||
48993030|NCT02557308|157809249|FG000|Overall Study|Withdrawal by Subject|11|||
48993031|NCT02557308|157809250|FG001|Overall Study|Withdrawal by Subject|3|||
48993032|NCT02557308|157809251|FG002|Overall Study|Withdrawal by Subject|2|||
49045478|NCT03843125|158000097|FG001|Overall Study|Study Terminated by Sponsor|318|||
49045479|NCT03843125|158000098|FG002|Overall Study|Study Terminated by Sponsor|163|||
49045480|NCT03843125|158000099|FG003|Overall Study|Study Terminated by Sponsor|163|||
49045481|NCT03843125|158000096|FG000|Overall Study|Withdrawal by Subject|23|||
48993033|NCT02557308|157809252|FG003|Overall Study|Withdrawal by Subject|0|||
48993034|NCT02557308|157809253|FG004|Overall Study|Withdrawal by Subject|1|||
48993035|NCT02557308|157809254|FG005|Overall Study|Withdrawal by Subject|0|||
49045482|NCT03843125|158000097|FG001|Overall Study|Withdrawal by Subject|12|||
49045483|NCT03843125|158000098|FG002|Overall Study|Withdrawal by Subject|6|||
48993036|NCT02557308|157809255|FG006|Overall Study|Withdrawal by Subject|10|||
48993037|NCT02557308|157809256|FG007|Overall Study|Withdrawal by Subject|1|||
49045484|NCT03843125|158000099|FG003|Overall Study|Withdrawal by Subject|9|||
49045485|NCT03843125|158000096|FG000|Overall Study|Missing data|0|||
48993038|NCT02557308|157809249|FG000|Overall Study|Disease Progression|0|||
48993039|NCT02557308|157809250|FG001|Overall Study|Disease Progression|1|||
48993040|NCT02557308|157809251|FG002|Overall Study|Disease Progression|0|||
48993041|NCT02557308|157809252|FG003|Overall Study|Disease Progression|0|||
48993042|NCT02557308|157809253|FG004|Overall Study|Disease Progression|0|||
49045486|NCT03843125|158000097|FG001|Overall Study|Missing data|1|||
49045487|NCT03843125|158000098|FG002|Overall Study|Missing data|1|||
49045488|NCT03843125|158000099|FG003|Overall Study|Missing data|0|||
49045489|NCT01386125|158000100|FG000|Overall Study|Lost to Follow-up|3|||
49045490|NCT01386125|158000101|FG001|Overall Study|Lost to Follow-up|9|||
49045491|NCT01386125|158000100|FG000|Overall Study|Physician Decision|0|||
49045492|NCT01386125|158000101|FG001|Overall Study|Physician Decision|1|||
49045493|NCT01386125|158000100|FG000|Overall Study|Protocol Violation|5|||
49045494|NCT01386125|158000101|FG001|Overall Study|Protocol Violation|7|||
49045495|NCT01386125|158000100|FG000|Overall Study|Disease Progress|1|||
49045496|NCT01386125|158000101|FG001|Overall Study|Disease Progress|2|||
49045497|NCT01386125|158000100|FG000|Overall Study|Withdrawal by Subject|13|||
49045498|NCT01386125|158000101|FG001|Overall Study|Withdrawal by Subject|12|||
49045499|NCT01386125|158000100|FG000|Overall Study|Adverse Event|2|||
49045500|NCT01386125|158000101|FG001|Overall Study|Adverse Event|5|||
49045501|NCT01386125|158000100|FG000|Overall Study|Lack of Efficacy|0|||
49045502|NCT01386125|158000101|FG001|Overall Study|Lack of Efficacy|1|||
49045503|NCT01386125|158000100|FG000|Overall Study|Participant Leaving Country|1|||
49045504|NCT01386125|158000101|FG001|Overall Study|Participant Leaving Country|0|||
49045505|NCT02943096|158000107|FG000|Overall Study|Lack of Efficacy|0|||
48993043|NCT02557308|157809254|FG005|Overall Study|Disease Progression|0|||
48993044|NCT02557308|157809255|FG006|Overall Study|Disease Progression|0|||
48993045|NCT02557308|157809256|FG007|Overall Study|Disease Progression|0|||
48993046|NCT02557308|157809249|FG000|Overall Study|Lack of Efficacy|3|||
48993047|NCT02557308|157809250|FG001|Overall Study|Lack of Efficacy|0|||
49045506|NCT02943096|158000108|FG001|Overall Study|Lack of Efficacy|1|||
49045507|NCT04142658|158000109|FG000|Overall Study|Death|2|||
48993048|NCT02557308|157809251|FG002|Overall Study|Lack of Efficacy|0|||
48993049|NCT02557308|157809252|FG003|Overall Study|Lack of Efficacy|0|||
48993050|NCT02557308|157809253|FG004|Overall Study|Lack of Efficacy|0|||
48993051|NCT02557308|157809254|FG005|Overall Study|Lack of Efficacy|0|||
48993052|NCT02557308|157809255|FG006|Overall Study|Lack of Efficacy|1|||
48993053|NCT02557308|157809256|FG007|Overall Study|Lack of Efficacy|0|||
48993054|NCT02557308|157809249|FG000|Overall Study|Adverse Event|4|||
48993055|NCT02557308|157809250|FG001|Overall Study|Adverse Event|1|||
48993056|NCT02557308|157809251|FG002|Overall Study|Adverse Event|2|||
48993057|NCT02557308|157809252|FG003|Overall Study|Adverse Event|0|||
48993058|NCT02557308|157809253|FG004|Overall Study|Adverse Event|0|||
48993059|NCT02557308|157809254|FG005|Overall Study|Adverse Event|0|||
48993060|NCT02557308|157809255|FG006|Overall Study|Adverse Event|4|||
48993061|NCT02557308|157809256|FG007|Overall Study|Adverse Event|1|||
48993062|NCT02557308|157809249|FG000|Overall Study|Lost to Follow-up|2|||
48993063|NCT02557308|157809250|FG001|Overall Study|Lost to Follow-up|0|||
48993064|NCT02557308|157809251|FG002|Overall Study|Lost to Follow-up|1|||
48993065|NCT02557308|157809252|FG003|Overall Study|Lost to Follow-up|0|||
48993066|NCT02557308|157809253|FG004|Overall Study|Lost to Follow-up|0|||
48993067|NCT02557308|157809254|FG005|Overall Study|Lost to Follow-up|0|||
48993068|NCT02557308|157809255|FG006|Overall Study|Lost to Follow-up|2|||
48993069|NCT02557308|157809256|FG007|Overall Study|Lost to Follow-up|0|||
48993070|NCT02557308|157809249|FG000|Overall Study|Death|1|||
48993071|NCT02557308|157809250|FG001|Overall Study|Death|0|||
48993072|NCT02557308|157809251|FG002|Overall Study|Death|0|||
48993073|NCT02557308|157809252|FG003|Overall Study|Death|0|||
48993074|NCT02557308|157809253|FG004|Overall Study|Death|0|||
48993075|NCT02557308|157809254|FG005|Overall Study|Death|0|||
48993076|NCT02557308|157809255|FG006|Overall Study|Death|0|||
48993077|NCT02557308|157809256|FG007|Overall Study|Death|0|||
48993078|NCT02557308|157809249|FG000|Overall Study|Study Close|98|||
48993079|NCT02557308|157809250|FG001|Overall Study|Study Close|18|||
48993080|NCT02557308|157809251|FG002|Overall Study|Study Close|5|||
48993081|NCT02557308|157809252|FG003|Overall Study|Study Close|3|||
48993082|NCT02557308|157809253|FG004|Overall Study|Study Close|1|||
48993083|NCT02557308|157809254|FG005|Overall Study|Study Close|0|||
48993084|NCT02557308|157809255|FG006|Overall Study|Study Close|123|||
48993085|NCT02557308|157809256|FG007|Overall Study|Study Close|5|||
48993086|NCT02557308|157809249|FG000|Overall Study|Except for study close|5|||
48993087|NCT02557308|157809250|FG001|Overall Study|Except for study close|0|||
48993088|NCT02557308|157809251|FG002|Overall Study|Except for study close|0|||
48993089|NCT02557308|157809252|FG003|Overall Study|Except for study close|0|||
48993090|NCT02557308|157809253|FG004|Overall Study|Except for study close|3|||
48993091|NCT02557308|157809254|FG005|Overall Study|Except for study close|0|||
49045508|NCT04142658|158000110|FG001|Overall Study|Death|1|||
48993092|NCT02557308|157809255|FG006|Overall Study|Except for study close|6|||
48993093|NCT02557308|157809256|FG007|Overall Study|Except for study close|10|||
48993094|NCT03911401|157809259|FG000|Overall Study|Adverse Event|1|||
48993095|NCT03911401|157809260|FG001|Overall Study|Adverse Event|2|||
48993096|NCT03911401|157809261|FG002|Overall Study|Adverse Event|5|||
48993097|NCT03911401|157809259|FG000|Overall Study|Lack of Efficacy|1|||
48993098|NCT03911401|157809260|FG001|Overall Study|Lack of Efficacy|1|||
48993099|NCT03911401|157809261|FG002|Overall Study|Lack of Efficacy|8|||
49045509|NCT04142658|158000109|FG000|Overall Study|Lost to Follow-up|4|||
49045510|NCT04142658|158000110|FG001|Overall Study|Lost to Follow-up|13|||
48993100|NCT03911401|157809259|FG000|Overall Study|Physician Decision|0|||
48993101|NCT03911401|157809260|FG001|Overall Study|Physician Decision|0|||
48993102|NCT03911401|157809261|FG002|Overall Study|Physician Decision|1|||
48993103|NCT03911401|157809259|FG000|Overall Study|Withdrawal by Subject|1|||
48993104|NCT03911401|157809260|FG001|Overall Study|Withdrawal by Subject|2|||
48993105|NCT03911401|157809261|FG002|Overall Study|Withdrawal by Subject|0|||
48993106|NCT03911401|157809259|FG000|Overall Study|Withdrawal by parent/guardian|4|||
48993107|NCT03911401|157809260|FG001|Overall Study|Withdrawal by parent/guardian|4|||
48993108|NCT03911401|157809261|FG002|Overall Study|Withdrawal by parent/guardian|11|||
48993109|NCT05602818|157809265|FG000|Qualification Phase (3 Days)|Adverse Event|1|||
48993110|NCT05602818|157809266|FG001|Qualification Phase (3 Days)|Adverse Event|0|||
48993111|NCT05602818|157809267|FG002|Qualification Phase (3 Days)|Adverse Event|0|||
48993112|NCT05602818|157809268|FG003|Qualification Phase (3 Days)|Adverse Event|0|||
48993113|NCT05602818|157809269|FG004|Qualification Phase (3 Days)|Adverse Event|0|||
48993114|NCT05602818|157809270|FG005|Qualification Phase (3 Days)|Adverse Event|0|||
48993115|NCT05602818|157809271|FG006|Qualification Phase (3 Days)|Adverse Event|0|||
49045511|NCT04142658|158000109|FG000|Overall Study|Withdrawal by Subject|9|||
49045512|NCT04142658|158000110|FG001|Overall Study|Withdrawal by Subject|16|||
49045513|NCT05065619|158000111|FG000|Up to Day 42|Lost to Follow-up|1|||
49045514|NCT05065619|158000112|FG001|Up to Day 42|Lost to Follow-up|0|||
49045515|NCT05065619|158000111|FG000|Up to Day 42|Withdrawal by Subject|1|||
49045516|NCT05065619|158000112|FG001|Up to Day 42|Withdrawal by Subject|0|||
49045517|NCT05065619|158000111|FG000|After Day 43|Lost to Follow-up|1|||
49045518|NCT05065619|158000112|FG001|After Day 43|Lost to Follow-up|0|||
49045519|NCT05065619|158000111|FG000|After Day 43|Physician Decision|3|||
49045520|NCT05065619|158000112|FG001|After Day 43|Physician Decision|0|||
48993116|NCT05602818|157809272|FG007|Qualification Phase (3 Days)|Adverse Event|0|||
48993117|NCT05602818|157809273|FG008|Qualification Phase (3 Days)|Adverse Event|0|||
48993118|NCT05602818|157809274|FG009|Qualification Phase (3 Days)|Adverse Event|0|||
48993119|NCT05602818|157809275|FG010|Qualification Phase (3 Days)|Adverse Event|0|||
48993120|NCT05602818|157809276|FG011|Qualification Phase (3 Days)|Adverse Event|0|||
48993121|NCT05602818|157809265|FG000|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
49045521|NCT05065619|158000111|FG000|After Day 43|Withdrawal by Subject|1|||
49045522|NCT05065619|158000112|FG001|After Day 43|Withdrawal by Subject|2|||
49045523|NCT05065619|158000111|FG000|After Day 43|Public vaccination|6|||
49045524|NCT05065619|158000112|FG001|After Day 43|Public vaccination|8|||
49045525|NCT05065619|158000111|FG000|After Day 43|Difficult to go to the hospital due to moving|1|||
49045526|NCT05065619|158000112|FG001|After Day 43|Difficult to go to the hospital due to moving|0|||
49045527|NCT05065619|158000111|FG000|After Day 43|Study Terminated by Sponsor|88|||
49045528|NCT05065619|158000112|FG001|After Day 43|Study Terminated by Sponsor|16|||
49045529|NCT01781234|158000113|FG000|Overall Study|Adverse Event|2|||
49045530|NCT01781234|158000114|FG001|Overall Study|Adverse Event|0|||
49045531|NCT01781234|158000113|FG000|Overall Study|Protocol Violation|3|||
49045532|NCT01781234|158000114|FG001|Overall Study|Protocol Violation|0|||
48993122|NCT05602818|157809266|FG001|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
48993123|NCT05602818|157809267|FG002|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
48993124|NCT05602818|157809268|FG003|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
48993125|NCT05602818|157809269|FG004|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
48993126|NCT05602818|157809270|FG005|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
48993127|NCT05602818|157809271|FG006|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
48993128|NCT05602818|157809272|FG007|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
48993129|NCT05602818|157809273|FG008|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
48993130|NCT05602818|157809274|FG009|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
48993131|NCT05602818|157809275|FG010|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
48993132|NCT05602818|157809276|FG011|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
48993133|NCT05602818|157809265|FG000|Qualification Phase (3 Days)|Withdrawal by Subject|2|||
48993134|NCT05602818|157809266|FG001|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
48993135|NCT05602818|157809267|FG002|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
48993136|NCT05602818|157809268|FG003|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
48993137|NCT05602818|157809269|FG004|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
48993138|NCT05602818|157809270|FG005|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
48993139|NCT05602818|157809271|FG006|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
49045533|NCT01781234|158000113|FG000|Overall Study|Withdrawal by Subject|4|||
49045534|NCT01781234|158000114|FG001|Overall Study|Withdrawal by Subject|3|||
48993140|NCT05602818|157809272|FG007|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
48993141|NCT05602818|157809273|FG008|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
48993142|NCT05602818|157809274|FG009|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
48993143|NCT05602818|157809275|FG010|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
49045535|NCT02834390|158000115|FG000|Induction Phase|Progressive disease|0|||
49045536|NCT02834390|158000116|FG001|Induction Phase|Progressive disease|1|||
48993144|NCT05602818|157809276|FG011|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
49045537|NCT02834390|158000115|FG000|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2|||
49045538|NCT02834390|158000116|FG001|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0|||
49045539|NCT02834390|158000115|FG000|Induction Phase|Relapse after CR, CRp, or CRi|0|||
49045540|NCT02834390|158000116|FG001|Induction Phase|Relapse after CR, CRp, or CRi|1|||
49045541|NCT02834390|158000115|FG000|Consolidation Phase|Physician Decision|1|||
49045542|NCT02834390|158000116|FG001|Consolidation Phase|Physician Decision|1|||
49045543|NCT00939523|158000119|FG000|Overall Study|Lack of Efficacy|1|||
49045544|NCT00939523|158000119|FG000|Overall Study|Physician Decision|2|||
49045545|NCT01206439|158000124|FG000|Overall Study|subject did not meet inclusion criteria|1|||
49045546|NCT00830167|158000139|FG000|Overall Study|Lack of Efficacy|26|||
49045547|NCT00830167|158000140|FG001|Overall Study|Lack of Efficacy|10|||
49045548|NCT00830167|158000139|FG000|Overall Study|Adverse Event|8|||
49045549|NCT00830167|158000140|FG001|Overall Study|Adverse Event|24|||
49045550|NCT00830167|158000139|FG000|Overall Study|Not meeting entrance criteria|2|||
49045551|NCT00830167|158000140|FG001|Overall Study|Not meeting entrance criteria|5|||
49045552|NCT00830167|158000139|FG000|Overall Study|Withdrawal by Subject|2|||
49045553|NCT00830167|158000140|FG001|Overall Study|Withdrawal by Subject|0|||
49045554|NCT00830167|158000139|FG000|Overall Study|Lost to Follow-up|0|||
49045555|NCT00830167|158000140|FG001|Overall Study|Lost to Follow-up|1|||
49045556|NCT00830167|158000139|FG000|Overall Study|Protocol Violation|0|||
49045557|NCT00830167|158000140|FG001|Overall Study|Protocol Violation|1|||
49045558|NCT00830167|158000139|FG000|Overall Study|Other|2|||
49045559|NCT00830167|158000140|FG001|Overall Study|Other|2|||
49045560|NCT04480307|158000143|FG000|Overall Study|Withdrawal by Subject|0|||
49045561|NCT04480307|158000144|FG001|Overall Study|Withdrawal by Subject|1|||
49045562|NCT04480307|158000145|FG002|Overall Study|Withdrawal by Subject|0|||
49045563|NCT04480307|158000146|FG003|Overall Study|Withdrawal by Subject|0|||
49045564|NCT04480307|158000143|FG000|Overall Study|Adverse Event|0|||
49045565|NCT04480307|158000144|FG001|Overall Study|Adverse Event|0|||
49045566|NCT04480307|158000145|FG002|Overall Study|Adverse Event|0|||
49045567|NCT04480307|158000146|FG003|Overall Study|Adverse Event|1|||
49045568|NCT04254809|158000147|FG000|Overall Study|Lost to Follow-up|5|||
49045569|NCT04254809|158000148|FG001|Overall Study|Lost to Follow-up|10|||
49045570|NCT01928615|158000149|FG000|Overall Study|Study Terminated by Sponsor|2|||
49045571|NCT02972515|158000150|FG000|Overall Study|Lost to Follow-up|78|||
49045572|NCT02224053|158000153|FG000|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11|||
49045573|NCT02224053|158000153|FG000|AZD9291 and Omeprazole Co-administration|Protocol Violation|4|||
49045574|NCT02224053|158000153|FG000|AZD9291 and Omeprazole Co-administration|Adverse Event|3|||
49045575|NCT02224053|158000153|FG000|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1|||
49045576|NCT02224053|158000153|FG000|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2|||
49045577|NCT01898598|158000157|FG000|Overall Study|Adverse Event|1|||
49045578|NCT01898598|158000158|FG001|Overall Study|Adverse Event|0|||
49045579|NCT01898598|158000157|FG000|Overall Study|Withdrawal by Subject|3|||
49045580|NCT01898598|158000158|FG001|Overall Study|Withdrawal by Subject|0|||
49045581|NCT01898598|158000157|FG000|Overall Study|Lost to Follow-up|0|||
48993145|NCT05602818|157809265|FG000|Qualification Phase (3 Days)|Other|1|||
48993146|NCT05602818|157809266|FG001|Qualification Phase (3 Days)|Other|0|||
49045582|NCT01898598|158000158|FG001|Overall Study|Lost to Follow-up|1|||
49045583|NCT01898598|158000157|FG000|Overall Study|Other|0|||
49045584|NCT01898598|158000158|FG001|Overall Study|Other|1|||
49045585|NCT03833427|158000159|FG000|Overall Study|Death|4|||
49045586|NCT03833427|158000160|FG001|Overall Study|Death|2|||
49045587|NCT03833427|158000161|FG002|Overall Study|Death|9|||
49045588|NCT03833427|158000162|FG003|Overall Study|Death|11|||
48993147|NCT05602818|157809267|FG002|Qualification Phase (3 Days)|Other|0|||
48993148|NCT05602818|157809268|FG003|Qualification Phase (3 Days)|Other|0|||
48993149|NCT05602818|157809269|FG004|Qualification Phase (3 Days)|Other|0|||
48993150|NCT05602818|157809270|FG005|Qualification Phase (3 Days)|Other|0|||
48993151|NCT05602818|157809271|FG006|Qualification Phase (3 Days)|Other|0|||
48993152|NCT05602818|157809272|FG007|Qualification Phase (3 Days)|Other|0|||
48993153|NCT05602818|157809273|FG008|Qualification Phase (3 Days)|Other|0|||
48993154|NCT05602818|157809274|FG009|Qualification Phase (3 Days)|Other|0|||
48993155|NCT05602818|157809275|FG010|Qualification Phase (3 Days)|Other|0|||
48993156|NCT05602818|157809276|FG011|Qualification Phase (3 Days)|Other|0|||
48993157|NCT05602818|157809265|FG000|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
48993158|NCT05602818|157809266|FG001|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|1|||
48993159|NCT05602818|157809267|FG002|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
48993160|NCT05602818|157809268|FG003|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
48993161|NCT05602818|157809269|FG004|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
48993162|NCT05602818|157809270|FG005|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
48993163|NCT05602818|157809271|FG006|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
48993164|NCT05602818|157809272|FG007|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
48993165|NCT05602818|157809273|FG008|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
48993166|NCT05602818|157809274|FG009|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
48993167|NCT05602818|157809275|FG010|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
48993168|NCT05602818|157809276|FG011|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
48993169|NCT05602818|157809265|FG000|Treatment Phase (29 Days)|Protocol Violation|0|||
48993170|NCT05602818|157809266|FG001|Treatment Phase (29 Days)|Protocol Violation|0|||
48993171|NCT05602818|157809267|FG002|Treatment Phase (29 Days)|Protocol Violation|2|||
48993172|NCT05602818|157809268|FG003|Treatment Phase (29 Days)|Protocol Violation|1|||
48993173|NCT05602818|157809269|FG004|Treatment Phase (29 Days)|Protocol Violation|1|||
48993174|NCT05602818|157809270|FG005|Treatment Phase (29 Days)|Protocol Violation|1|||
48993175|NCT05602818|157809271|FG006|Treatment Phase (29 Days)|Protocol Violation|2|||
48993176|NCT05602818|157809272|FG007|Treatment Phase (29 Days)|Protocol Violation|2|||
48993177|NCT05602818|157809273|FG008|Treatment Phase (29 Days)|Protocol Violation|1|||
48993178|NCT05602818|157809274|FG009|Treatment Phase (29 Days)|Protocol Violation|1|||
48993179|NCT05602818|157809275|FG010|Treatment Phase (29 Days)|Protocol Violation|2|||
48993180|NCT05602818|157809276|FG011|Treatment Phase (29 Days)|Protocol Violation|1|||
48993181|NCT05602818|157809265|FG000|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
48993182|NCT05602818|157809266|FG001|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
48993183|NCT05602818|157809267|FG002|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
48993184|NCT05602818|157809268|FG003|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
48993185|NCT05602818|157809269|FG004|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
48993186|NCT05602818|157809270|FG005|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
48993187|NCT05602818|157809271|FG006|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
48993188|NCT05602818|157809272|FG007|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
48993189|NCT05602818|157809273|FG008|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
49045589|NCT03833427|158000163|FG004|Overall Study|Death|0|||
49045590|NCT03833427|158000164|FG005|Overall Study|Death|0|||
49045591|NCT03833427|158000165|FG006|Overall Study|Death|0|||
49045592|NCT03833427|158000159|FG000|Overall Study|Withdrawal by Subject|0|||
49045593|NCT03833427|158000160|FG001|Overall Study|Withdrawal by Subject|1|||
49045594|NCT03833427|158000161|FG002|Overall Study|Withdrawal by Subject|1|||
48993190|NCT05602818|157809274|FG009|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
48993191|NCT05602818|157809275|FG010|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
48993192|NCT05602818|157809276|FG011|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
48993193|NCT05602818|157809265|FG000|Treatment Phase (29 Days)|Physician Decision|0|||
48993194|NCT05602818|157809266|FG001|Treatment Phase (29 Days)|Physician Decision|0|||
48993195|NCT05602818|157809267|FG002|Treatment Phase (29 Days)|Physician Decision|1|||
48993196|NCT05602818|157809268|FG003|Treatment Phase (29 Days)|Physician Decision|0|||
48993197|NCT05602818|157809269|FG004|Treatment Phase (29 Days)|Physician Decision|0|||
48993198|NCT05602818|157809270|FG005|Treatment Phase (29 Days)|Physician Decision|0|||
48993199|NCT05602818|157809271|FG006|Treatment Phase (29 Days)|Physician Decision|1|||
48993200|NCT05602818|157809272|FG007|Treatment Phase (29 Days)|Physician Decision|0|||
48993201|NCT05602818|157809273|FG008|Treatment Phase (29 Days)|Physician Decision|0|||
48993202|NCT05602818|157809274|FG009|Treatment Phase (29 Days)|Physician Decision|0|||
48993203|NCT05602818|157809275|FG010|Treatment Phase (29 Days)|Physician Decision|1|||
48993204|NCT05602818|157809276|FG011|Treatment Phase (29 Days)|Physician Decision|0|||
48993205|NCT00535262|157809277|FG000|Overall Study|No funding|3|||
48993206|NCT01707667|157809278|FG000|Period 1|expulsion of colonic sensor catheter|1|||
48993207|NCT01707667|157809279|FG001|Period 1|expulsion of colonic sensor catheter|0|||
48993208|NCT01050998|157809280|FG000|Overall Study|Adverse Event|1|||
48993209|NCT01050998|157809281|FG001|Overall Study|Adverse Event|0|||
48993210|NCT01050998|157809282|FG002|Overall Study|Adverse Event|1|||
48993211|NCT01050998|157809283|FG003|Overall Study|Adverse Event|0|||
48993212|NCT01050998|157809284|FG004|Overall Study|Adverse Event|2|||
48993213|NCT01050998|157809280|FG000|Overall Study|Withdrawal by Subject|0|||
48993214|NCT01050998|157809281|FG001|Overall Study|Withdrawal by Subject|0|||
48993215|NCT01050998|157809282|FG002|Overall Study|Withdrawal by Subject|0|||
48993216|NCT01050998|157809283|FG003|Overall Study|Withdrawal by Subject|1|||
48993217|NCT01050998|157809284|FG004|Overall Study|Withdrawal by Subject|3|||
48993218|NCT01050998|157809280|FG000|Overall Study|Other|3|||
48993219|NCT01050998|157809281|FG001|Overall Study|Other|2|||
48993220|NCT01050998|157809282|FG002|Overall Study|Other|1|||
48993221|NCT01050998|157809283|FG003|Overall Study|Other|1|||
48993222|NCT01050998|157809284|FG004|Overall Study|Other|5|||
48993223|NCT01050998|157809280|FG000|Overall Study|Data integrity issues|0|||
48993224|NCT01050998|157809281|FG001|Overall Study|Data integrity issues|0|||
48993225|NCT01050998|157809282|FG002|Overall Study|Data integrity issues|1|||
48993226|NCT01050998|157809283|FG003|Overall Study|Data integrity issues|1|||
48993227|NCT01050998|157809284|FG004|Overall Study|Data integrity issues|4|||
48993228|NCT01428882|157809285|FG000|Overall Study|Lack of Efficacy|2|||
49045595|NCT03833427|158000162|FG003|Overall Study|Withdrawal by Subject|0|||
49045596|NCT03833427|158000163|FG004|Overall Study|Withdrawal by Subject|0|||
49045597|NCT03833427|158000164|FG005|Overall Study|Withdrawal by Subject|0|||
48993229|NCT01428882|157809286|FG001|Overall Study|Lack of Efficacy|7|||
48993230|NCT01428882|157809285|FG000|Overall Study|Protocol Violation|4|||
48993231|NCT01428882|157809286|FG001|Overall Study|Protocol Violation|3|||
48993232|NCT02331680|157809287|FG000|Overall Study|Adverse Event|3|||
48993233|NCT02331680|157809288|FG001|Overall Study|Adverse Event|0|||
48993234|NCT02331680|157809289|FG002|Overall Study|Adverse Event|2|||
48993235|NCT02331680|157809287|FG000|Overall Study|Physician Decision|1|||
48993236|NCT02331680|157809288|FG001|Overall Study|Physician Decision|1|||
48993237|NCT02331680|157809289|FG002|Overall Study|Physician Decision|2|||
48993238|NCT02331680|157809287|FG000|Overall Study|Withdrawal by Subject|0|||
48993239|NCT02331680|157809288|FG001|Overall Study|Withdrawal by Subject|1|||
48993240|NCT02331680|157809289|FG002|Overall Study|Withdrawal by Subject|2|||
48993241|NCT02331680|157809287|FG000|Overall Study|Met withdrawal criteria|2|||
48993242|NCT02331680|157809288|FG001|Overall Study|Met withdrawal criteria|2|||
48993243|NCT02331680|157809289|FG002|Overall Study|Met withdrawal criteria|5|||
48993244|NCT02331680|157809287|FG000|Overall Study|Non-compliance with study drug|0|||
48993245|NCT02331680|157809288|FG001|Overall Study|Non-compliance with study drug|0|||
48993246|NCT02331680|157809289|FG002|Overall Study|Non-compliance with study drug|1|||
48993247|NCT02331680|157809287|FG000|Overall Study|Protocol Violation|0|||
48993248|NCT02331680|157809288|FG001|Overall Study|Protocol Violation|0|||
48993249|NCT02331680|157809289|FG002|Overall Study|Protocol Violation|3|||
48993250|NCT00779142|157809290|FG000|Overall Study|Screen Failures|3|||
48993251|NCT02500732|157809293|FG000|Overall Study|Physician Decision|0|||
48993252|NCT02500732|157809294|FG001|Overall Study|Physician Decision|1|||
48993253|NCT02431559|157809295|FG000|Overall Study|Adverse Event|0|||
48993254|NCT02431559|157809296|FG001|Overall Study|Adverse Event|1|||
48993255|NCT02431559|157809297|FG002|Overall Study|Adverse Event|0|||
48993256|NCT02431559|157809298|FG003|Overall Study|Adverse Event|4|||
48993257|NCT02431559|157809295|FG000|Overall Study|Progressive disease|2|||
48993258|NCT02431559|157809296|FG001|Overall Study|Progressive disease|1|||
48993259|NCT02431559|157809297|FG002|Overall Study|Progressive disease|4|||
48993260|NCT02431559|157809298|FG003|Overall Study|Progressive disease|22|||
48993261|NCT02431559|157809295|FG000|Overall Study|Withdrawal by Subject|0|||
48993262|NCT02431559|157809296|FG001|Overall Study|Withdrawal by Subject|1|||
48993263|NCT02431559|157809297|FG002|Overall Study|Withdrawal by Subject|0|||
48993264|NCT02431559|157809298|FG003|Overall Study|Withdrawal by Subject|4|||
48993265|NCT02431559|157809295|FG000|Overall Study|Physician Decision|0|||
48993266|NCT02431559|157809296|FG001|Overall Study|Physician Decision|0|||
48993267|NCT02431559|157809297|FG002|Overall Study|Physician Decision|0|||
48993268|NCT02431559|157809298|FG003|Overall Study|Physician Decision|1|||
49045598|NCT03833427|158000165|FG006|Overall Study|Withdrawal by Subject|0|||
49045599|NCT03833427|158000159|FG000|Overall Study|Sponsor Decision|0|||
49045600|NCT03833427|158000160|FG001|Overall Study|Sponsor Decision|0|||
49045601|NCT03833427|158000161|FG002|Overall Study|Sponsor Decision|1|||
49045602|NCT03833427|158000162|FG003|Overall Study|Sponsor Decision|3|||
49045603|NCT03833427|158000163|FG004|Overall Study|Sponsor Decision|0|||
48993269|NCT04236986|157809299|FG000|Overall Study|Withdrawal by Subject|3|||
48993270|NCT04236986|157809300|FG001|Overall Study|Withdrawal by Subject|1|||
48993271|NCT01233284|157809301|FG000|Period 1 (4 Weeks)|Lost to Follow-up|1|||
48993272|NCT01233284|157809302|FG001|Period 1 (4 Weeks)|Lost to Follow-up|0|||
48993273|NCT01233284|157809303|FG002|Period 1 (4 Weeks)|Lost to Follow-up|0|||
48993274|NCT01233284|157809304|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
48993275|NCT01233284|157809305|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
48993276|NCT01233284|157809301|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
48993277|NCT01233284|157809302|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
48993278|NCT01233284|157809303|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
48993279|NCT01233284|157809304|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
48993280|NCT01233284|157809305|FG004|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
48993281|NCT01233284|157809301|FG000|Period 1 (4 Weeks)|Other|0|||
48993282|NCT01233284|157809302|FG001|Period 1 (4 Weeks)|Other|0|||
48993283|NCT01233284|157809303|FG002|Period 1 (4 Weeks)|Other|1|||
48993284|NCT01233284|157809304|FG003|Period 1 (4 Weeks)|Other|0|||
48993285|NCT01233284|157809305|FG004|Period 1 (4 Weeks)|Other|0|||
48993286|NCT01233284|157809301|FG000|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
49045604|NCT03833427|158000164|FG005|Overall Study|Sponsor Decision|0|||
49045605|NCT03833427|158000165|FG006|Overall Study|Sponsor Decision|0|||
49045606|NCT04531527|158000166|FG000|Overall Study|Found to be Ineligible|3|||
49045607|NCT03310619|158000171|FG000|Pre-Treatment Period|Death|1|||
48993287|NCT01233284|157809302|FG001|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
48993288|NCT01233284|157809303|FG002|Period 2 (4 Weeks)|Withdrawal by Subject|1|||
48993289|NCT01233284|157809304|FG003|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
48993290|NCT01233284|157809305|FG004|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
48993291|NCT01233284|157809301|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
48993292|NCT01233284|157809302|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
48993293|NCT01233284|157809303|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
48993294|NCT01233284|157809304|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
48993295|NCT01233284|157809305|FG004|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
48993296|NCT01233284|157809301|FG000|Period 3 (4 Weeks)|Other|0|||
48993297|NCT01233284|157809302|FG001|Period 3 (4 Weeks)|Other|0|||
48993298|NCT01233284|157809303|FG002|Period 3 (4 Weeks)|Other|0|||
48993299|NCT01233284|157809304|FG003|Period 3 (4 Weeks)|Other|1|||
48993300|NCT01233284|157809305|FG004|Period 3 (4 Weeks)|Other|0|||
48993301|NCT01233284|157809301|FG000|Period 4 (4 Weeks)|Adverse Event|0|||
48993302|NCT01233284|157809302|FG001|Period 4 (4 Weeks)|Adverse Event|1|||
48993303|NCT01233284|157809303|FG002|Period 4 (4 Weeks)|Adverse Event|0|||
48993304|NCT01233284|157809304|FG003|Period 4 (4 Weeks)|Adverse Event|0|||
48993305|NCT01233284|157809305|FG004|Period 4 (4 Weeks)|Adverse Event|0|||
48993306|NCT01233284|157809301|FG000|Period 4 (4 Weeks)|Lost to Follow-up|0|||
48993307|NCT01233284|157809302|FG001|Period 4 (4 Weeks)|Lost to Follow-up|0|||
48993308|NCT01233284|157809303|FG002|Period 4 (4 Weeks)|Lost to Follow-up|0|||
49045608|NCT03310619|158000172|FG001|Pre-Treatment Period|Death|0|||
49045609|NCT03310619|158000173|FG002|Pre-Treatment Period|Death|0|||
49045610|NCT03310619|158000174|FG003|Pre-Treatment Period|Death|0|||
49045611|NCT03310619|158000175|FG004|Pre-Treatment Period|Death|1|||
49045612|NCT03310619|158000176|FG005|Pre-Treatment Period|Death|0|||
49045613|NCT03310619|158000177|FG006|Pre-Treatment Period|Death|0|||
49045614|NCT03310619|158000178|FG007|Pre-Treatment Period|Death|0|||
49045615|NCT03310619|158000171|FG000|Pre-Treatment Period|Other reasons|2|||
49045616|NCT03310619|158000172|FG001|Pre-Treatment Period|Other reasons|1|||
49045617|NCT03310619|158000173|FG002|Pre-Treatment Period|Other reasons|2|||
48993309|NCT01233284|157809304|FG003|Period 4 (4 Weeks)|Lost to Follow-up|1|||
48993310|NCT01233284|157809305|FG004|Period 4 (4 Weeks)|Lost to Follow-up|0|||
48993311|NCT01348828|157809306|FG000|Overall Study|Death|20|||
48993312|NCT01348828|157809306|FG000|Overall Study|Withdrawals/Lost to Follow-up|10|||
48993313|NCT01348828|157809306|FG000|Overall Study|Conversion|2|||
48993314|NCT01348828|157809306|FG000|Overall Study|missed visit|1|||
48993315|NCT00985114|157809307|FG000|Overall Study|Adverse Event|1|||
48993316|NCT00985114|157809308|FG001|Overall Study|Adverse Event|0|||
48993317|NCT00985114|157809307|FG000|Overall Study|Withdrawal by Subject|0|||
48993318|NCT00985114|157809308|FG001|Overall Study|Withdrawal by Subject|2|||
48993319|NCT00167414|157809309|FG000|Overall Study|Death|10|||
48993320|NCT01593761|157809310|FG000|Overall Study|Lost to Follow-up|1|||
48993321|NCT01593761|157809310|FG000|Overall Study|culture negative for MRSA at baseline|5|||
48993322|NCT01593761|157809310|FG000|Overall Study|positive for hepatitis C virus|1|||
48993323|NCT01593761|157809310|FG000|Overall Study|secondary cellulitis|1|||
48993324|NCT04502862|157809311|FG000|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|4|||
48993325|NCT04502862|157809312|FG001|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|6|||
48993326|NCT04502862|157809311|FG000|Overall Study|Withdrawal by Subject|1|||
48993327|NCT04502862|157809312|FG001|Overall Study|Withdrawal by Subject|0|||
48993328|NCT04502862|157809311|FG000|Overall Study|Adverse Event|1|||
48993329|NCT04502862|157809312|FG001|Overall Study|Adverse Event|1|||
48993330|NCT01233076|157810514|FG000|Period 2, One Week|Lost to Follow-up|1|||
48993331|NCT01233076|157810515|FG001|Period 2, One Week|Lost to Follow-up|0|||
48993332|NCT01041027|157810516|FG000|Overall Study|Withdrawal by Subject|2|||
48993333|NCT01041027|157810516|FG000|Overall Study|Protocol Violation|1|||
48993334|NCT01041027|157810516|FG000|Overall Study|Delayed Radiation Therapy|1|||
48993335|NCT01041027|157810516|FG000|Overall Study|Adverse Event|4|||
48993336|NCT01674010|157810518|FG000|Open Treatment Phase 1|Adverse Event|10|||
48993337|NCT01674010|157810519|FG001|Open Treatment Phase 1|Adverse Event|0|||
48993338|NCT01674010|157810520|FG002|Open Treatment Phase 1|Adverse Event|0|||
48993339|NCT01674010|157810518|FG000|Open Treatment Phase 1|Death|1|||
48993340|NCT01674010|157810519|FG001|Open Treatment Phase 1|Death|0|||
48993341|NCT01674010|157810520|FG002|Open Treatment Phase 1|Death|0|||
48993342|NCT01674010|157810518|FG000|Open Treatment Phase 1|Lost to Follow-up|19|||
48993343|NCT01674010|157810519|FG001|Open Treatment Phase 1|Lost to Follow-up|0|||
48993344|NCT01674010|157810520|FG002|Open Treatment Phase 1|Lost to Follow-up|0|||
48993345|NCT01674010|157810518|FG000|Open Treatment Phase 1|Physician Decision|9|||
48993346|NCT01674010|157810519|FG001|Open Treatment Phase 1|Physician Decision|0|||
48993347|NCT01674010|157810520|FG002|Open Treatment Phase 1|Physician Decision|0|||
48993348|NCT01674010|157810518|FG000|Open Treatment Phase 1|Protocol Violation|7|||
48993349|NCT01674010|157810519|FG001|Open Treatment Phase 1|Protocol Violation|0|||
48993350|NCT01674010|157810520|FG002|Open Treatment Phase 1|Protocol Violation|0|||
48993351|NCT01674010|157810518|FG000|Open Treatment Phase 1|Sponsor Decision|79|||
48993352|NCT01674010|157810519|FG001|Open Treatment Phase 1|Sponsor Decision|0|||
48993353|NCT01674010|157810520|FG002|Open Treatment Phase 1|Sponsor Decision|0|||
48993354|NCT01674010|157810518|FG000|Open Treatment Phase 1|Did not remain in a stable remission|30|||
48993355|NCT01674010|157810519|FG001|Open Treatment Phase 1|Did not remain in a stable remission|0|||
48993356|NCT01674010|157810520|FG002|Open Treatment Phase 1|Did not remain in a stable remission|0|||
48993357|NCT01674010|157810518|FG000|Open Treatment Phase 1|Withdrawal by Subject|25|||
49045618|NCT03310619|158000174|FG003|Pre-Treatment Period|Other reasons|0|||
48993358|NCT01674010|157810519|FG001|Open Treatment Phase 1|Withdrawal by Subject|0|||
48993359|NCT01674010|157810520|FG002|Open Treatment Phase 1|Withdrawal by Subject|0|||
48993360|NCT01674010|157810518|FG000|Randomization Phase 2|Adverse Event|0|||
48993361|NCT01674010|157810519|FG001|Randomization Phase 2|Adverse Event|1|||
49045619|NCT03310619|158000175|FG004|Pre-Treatment Period|Other reasons|0|||
49045620|NCT03310619|158000176|FG005|Pre-Treatment Period|Other reasons|0|||
49045621|NCT03310619|158000177|FG006|Pre-Treatment Period|Other reasons|2|||
49045622|NCT03310619|158000178|FG007|Pre-Treatment Period|Other reasons|0|||
49045623|NCT03310619|158000171|FG000|Treatment Period|Death|1|||
48993362|NCT01674010|157810520|FG002|Randomization Phase 2|Adverse Event|1|||
48993363|NCT01674010|157810518|FG000|Randomization Phase 2|Lost to Follow-up|0|||
48993364|NCT01674010|157810519|FG001|Randomization Phase 2|Lost to Follow-up|1|||
48993365|NCT01674010|157810520|FG002|Randomization Phase 2|Lost to Follow-up|2|||
48993366|NCT01674010|157810518|FG000|Randomization Phase 2|Mood episode recurrence|0|||
48993367|NCT01674010|157810519|FG001|Randomization Phase 2|Mood episode recurrence|8|||
48993368|NCT01674010|157810520|FG002|Randomization Phase 2|Mood episode recurrence|2|||
48993369|NCT01674010|157810518|FG000|Randomization Phase 2|Physician Decision|0|||
48993370|NCT01674010|157810519|FG001|Randomization Phase 2|Physician Decision|0|||
48993371|NCT01674010|157810520|FG002|Randomization Phase 2|Physician Decision|2|||
48993372|NCT01674010|157810518|FG000|Randomization Phase 2|Pregnancy|0|||
48993373|NCT01674010|157810519|FG001|Randomization Phase 2|Pregnancy|1|||
48993374|NCT01674010|157810520|FG002|Randomization Phase 2|Pregnancy|1|||
48993375|NCT01674010|157810518|FG000|Randomization Phase 2|Protocol Violation|0|||
48993376|NCT01674010|157810519|FG001|Randomization Phase 2|Protocol Violation|1|||
48993377|NCT01674010|157810520|FG002|Randomization Phase 2|Protocol Violation|1|||
48993378|NCT01674010|157810518|FG000|Randomization Phase 2|Sponsor Decision|0|||
48993379|NCT01674010|157810519|FG001|Randomization Phase 2|Sponsor Decision|42|||
48993380|NCT01674010|157810520|FG002|Randomization Phase 2|Sponsor Decision|45|||
48993381|NCT01674010|157810518|FG000|Randomization Phase 2|Withdrawal by Subject|0|||
48993382|NCT01674010|157810519|FG001|Randomization Phase 2|Withdrawal by Subject|8|||
48993383|NCT01674010|157810520|FG002|Randomization Phase 2|Withdrawal by Subject|7|||
48993384|NCT01020812|157810521|FG000|Overall Study|Physician Decision|1|||
48993385|NCT01020812|157810521|FG000|Overall Study|Withdrawal by Subject|1|||
48993386|NCT01020812|157810521|FG000|Overall Study|Protocol Violation|1|||
48993387|NCT03159455|157810524|FG000|Overall Study|Adverse Event|0|||
48993388|NCT03159455|157810525|FG001|Overall Study|Adverse Event|0|||
48993389|NCT03159455|157810526|FG002|Overall Study|Adverse Event|0|||
48993390|NCT03159455|157810527|FG003|Overall Study|Adverse Event|0|||
48993391|NCT03159455|157810528|FG004|Overall Study|Adverse Event|0|||
48993392|NCT03159455|157810529|FG005|Overall Study|Adverse Event|1|||
48993393|NCT01302366|157810538|FG000|Overall Study|patient choice or noncompliance|5|||
48993394|NCT01801475|157810541|FG000|Overall Study|Withdrawal by Subject|0|||
48993395|NCT01801475|157810542|FG001|Overall Study|Withdrawal by Subject|0|||
48993396|NCT01801475|157810543|FG002|Overall Study|Withdrawal by Subject|0|||
48993397|NCT01801475|157810544|FG003|Overall Study|Withdrawal by Subject|0|||
48993398|NCT01801475|157810545|FG004|Overall Study|Withdrawal by Subject|1|||
48993399|NCT01786707|157810548|FG000|Overall Study|Lost to Follow-up|1|||
48993400|NCT01786707|157810549|FG001|Overall Study|Lost to Follow-up|1|||
48993401|NCT02058940|157810555|FG000|Overall Study|Discharged from Critical Care Unit|1|||
48993402|NCT04144140|157810556|FG000|Overall Study|Other|0|||
48993403|NCT04144140|157810557|FG001|Overall Study|Other|0|||
48993404|NCT04144140|157810558|FG002|Overall Study|Other|0|||
48993405|NCT04144140|157810559|FG003|Overall Study|Other|0|||
48993406|NCT04144140|157810560|FG004|Overall Study|Other|0|||
48993407|NCT04144140|157810561|FG005|Overall Study|Other|1|||
48993408|NCT04144140|157810562|FG006|Overall Study|Other|0|||
48993409|NCT01465958|157810563|FG000|Run-in Phase|Protocol Violation|1|||
48993410|NCT01465958|157810564|FG001|Run-in Phase|Protocol Violation|0|||
48993411|NCT01465958|157810563|FG000|Subcutaneous (SC) Phase|Adverse Event|0|||
48993412|NCT01465958|157810564|FG001|Subcutaneous (SC) Phase|Adverse Event|1|||
48993413|NCT02713490|157810565|FG000|Overall Study|Withdrawal by Subject|2|||
48993414|NCT02713490|157810566|FG001|Overall Study|Withdrawal by Subject|1|||
48993415|NCT02713490|157810565|FG000|Overall Study|Did not receive study drug|1|||
48993416|NCT02713490|157810566|FG001|Overall Study|Did not receive study drug|0|||
48993417|NCT02713490|157810565|FG000|Overall Study|Met exclusion criteria|0|||
48993418|NCT02713490|157810566|FG001|Overall Study|Met exclusion criteria|1|||
48993419|NCT01519700|157810567|FG000|Overall Study|Death|1|||
48993420|NCT01519700|157810568|FG001|Overall Study|Death|0|||
48993421|NCT01519700|157810569|FG002|Overall Study|Death|0|||
48993422|NCT01519700|157810570|FG003|Overall Study|Death|0|||
48993423|NCT01519700|157810567|FG000|Overall Study|Lost to Follow-up|0|||
48993424|NCT01519700|157810568|FG001|Overall Study|Lost to Follow-up|0|||
48993425|NCT01519700|157810569|FG002|Overall Study|Lost to Follow-up|1|||
48993426|NCT01519700|157810570|FG003|Overall Study|Lost to Follow-up|1|||
48993427|NCT01519700|157810567|FG000|Overall Study|Physician Decision|1|||
48993428|NCT01519700|157810568|FG001|Overall Study|Physician Decision|1|||
48993429|NCT01519700|157810569|FG002|Overall Study|Physician Decision|3|||
48993430|NCT01519700|157810570|FG003|Overall Study|Physician Decision|0|||
48993431|NCT01519700|157810567|FG000|Overall Study|Withdrawal by Subject|5|||
48993432|NCT01519700|157810568|FG001|Overall Study|Withdrawal by Subject|3|||
48993433|NCT01519700|157810569|FG002|Overall Study|Withdrawal by Subject|3|||
48993434|NCT01519700|157810570|FG003|Overall Study|Withdrawal by Subject|2|||
48993435|NCT01519700|157810567|FG000|Overall Study|Other Reason|2|||
48993436|NCT01519700|157810568|FG001|Overall Study|Other Reason|2|||
48993437|NCT01519700|157810569|FG002|Overall Study|Other Reason|0|||
48993438|NCT01519700|157810570|FG003|Overall Study|Other Reason|4|||
48993439|NCT00346775|157810571|FG000|Period 1: Intervention Period 1|Lost to Follow-up|1|||
48993440|NCT00346775|157810572|FG001|Period 1: Intervention Period 1|Lost to Follow-up|1|||
48993441|NCT00346775|157810571|FG000|Period 1: Intervention Period 1|Protocol Violation|3|||
48993442|NCT00346775|157810572|FG001|Period 1: Intervention Period 1|Protocol Violation|2|||
48993443|NCT00346775|157810571|FG000|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1|||
48993444|NCT00346775|157810572|FG001|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0|||
48993445|NCT02946515|157810573|FG000|Overall Study|Lost to Follow-up|2|||
48993446|NCT02946515|157810574|FG001|Overall Study|Lost to Follow-up|1|||
48993447|NCT03799198|157810575|FG000|Overall Study|Lost to Follow-up|4|||
48993448|NCT03799198|157810576|FG001|Overall Study|Lost to Follow-up|8|||
48993449|NCT03799198|157810575|FG000|Overall Study|Death|0|||
48993450|NCT03799198|157810576|FG001|Overall Study|Death|1|||
48993451|NCT00960869|157810581|FG000|Overall Study|Adverse Event|17|||
48993452|NCT00960869|157810582|FG001|Overall Study|Adverse Event|26|||
48993453|NCT00960869|157810581|FG000|Overall Study|Withdrawal by Subject|16|||
48993454|NCT00960869|157810582|FG001|Overall Study|Withdrawal by Subject|14|||
48993455|NCT00960869|157810581|FG000|Overall Study|Lost to Follow-up|1|||
48993456|NCT00960869|157810582|FG001|Overall Study|Lost to Follow-up|4|||
48993457|NCT00960869|157810581|FG000|Overall Study|Misc|19|||
48993458|NCT00960869|157810582|FG001|Overall Study|Misc|18|||
48993459|NCT01098266|157810585|FG000|Overall Study|Physician Decision|1|||
48993460|NCT01098266|157810586|FG001|Overall Study|Physician Decision|0|||
48993461|NCT01098266|157810585|FG000|Overall Study|Death|3|||
48993462|NCT01098266|157810586|FG001|Overall Study|Death|2|||
48993463|NCT01098266|157810585|FG000|Overall Study|Withdrawal by Subject|3|||
48993464|NCT01098266|157810586|FG001|Overall Study|Withdrawal by Subject|5|||
48993465|NCT02213666|157810587|FG000|Overall Study|Withdrawal by Subject|1|||
48993466|NCT01319422|157810588|FG000|Overall Study|Withdrawal by Subject|1|||
48993467|NCT01319422|157810589|FG001|Overall Study|Withdrawal by Subject|0|||
48993468|NCT01308476|157810590|FG000|Overall Study|Lost to Follow-up|2|||
48993469|NCT01308476|157810591|FG001|Overall Study|Lost to Follow-up|2|||
48993470|NCT01308476|157810590|FG000|Overall Study|Other|1|||
48993471|NCT01308476|157810591|FG001|Overall Study|Other|0|||
48993472|NCT02219477|157810597|FG000|Overall Study|Adverse Event|0|||
48993473|NCT02219477|157810598|FG001|Overall Study|Adverse Event|1|||
48993474|NCT02219477|157810599|FG002|Overall Study|Adverse Event|1|||
48993475|NCT02219477|157810597|FG000|Overall Study|Withdrawal by Subject|0|||
48993476|NCT02219477|157810598|FG001|Overall Study|Withdrawal by Subject|1|||
48993477|NCT02219477|157810599|FG002|Overall Study|Withdrawal by Subject|0|||
48993478|NCT03457701|157810605|FG000|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
48993479|NCT03457701|157810606|FG001|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
48993480|NCT03457701|157810605|FG000|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|0|||
48993481|NCT03457701|157810606|FG001|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
48993482|NCT01016912|157810607|FG000|End of Treatment Period|Lack of Efficacy|0|||
48993483|NCT01016912|157810608|FG001|End of Treatment Period|Lack of Efficacy|1|||
48993484|NCT01016912|157810609|FG002|End of Treatment Period|Lack of Efficacy|0|||
48993485|NCT01016912|157810610|FG003|End of Treatment Period|Lack of Efficacy|4|||
48993486|NCT01016912|157810611|FG004|End of Treatment Period|Lack of Efficacy|4|||
48993487|NCT01016912|157810607|FG000|End of Treatment Period|Adverse Event|0|||
48993488|NCT01016912|157810608|FG001|End of Treatment Period|Adverse Event|1|||
48993489|NCT01016912|157810609|FG002|End of Treatment Period|Adverse Event|1|||
48993490|NCT01016912|157810610|FG003|End of Treatment Period|Adverse Event|0|||
48993491|NCT01016912|157810611|FG004|End of Treatment Period|Adverse Event|0|||
48993492|NCT01016912|157810607|FG000|End of Treatment Period|Completed double-blind period only|0|||
48993493|NCT01016912|157810608|FG001|End of Treatment Period|Completed double-blind period only|1|||
48993494|NCT01016912|157810609|FG002|End of Treatment Period|Completed double-blind period only|0|||
48993495|NCT01016912|157810610|FG003|End of Treatment Period|Completed double-blind period only|0|||
48993496|NCT01016912|157810611|FG004|End of Treatment Period|Completed double-blind period only|0|||
48993497|NCT01016912|157810607|FG000|Follow-up Period|Other reason|0|||
48993498|NCT01016912|157810608|FG001|Follow-up Period|Other reason|0|||
49045624|NCT03310619|158000172|FG001|Treatment Period|Death|2|||
49045625|NCT03310619|158000173|FG002|Treatment Period|Death|0|||
48993499|NCT01016912|157810609|FG002|Follow-up Period|Other reason|1|||
48993500|NCT01016912|157810610|FG003|Follow-up Period|Other reason|1|||
48993501|NCT01016912|157810611|FG004|Follow-up Period|Other reason|0|||
48993502|NCT00914940|157810612|FG000|D0 to D100 Post-transplant|Death|2|||
48993503|NCT00914940|157810612|FG000|D101 to 2 Years Post-transplant|Death|8|||
48993504|NCT00914940|157810612|FG000|2 Years to 5 Years Post-transplant|Death|3|||
48993505|NCT00796367|157810613|FG000|Overall Study|Adverse Event|6|||
48993506|NCT00796367|157810614|FG001|Overall Study|Adverse Event|4|||
49045626|NCT03310619|158000174|FG003|Treatment Period|Death|0|||
48993507|NCT00796367|157810615|FG002|Overall Study|Adverse Event|7|||
48993508|NCT00796367|157810613|FG000|Overall Study|Lost to Follow-up|5|||
48993509|NCT00796367|157810614|FG001|Overall Study|Lost to Follow-up|4|||
48993510|NCT00796367|157810615|FG002|Overall Study|Lost to Follow-up|21|||
48993511|NCT00796367|157810613|FG000|Overall Study|Withdrawal by Subject|9|||
48993512|NCT00796367|157810614|FG001|Overall Study|Withdrawal by Subject|11|||
48993513|NCT00796367|157810615|FG002|Overall Study|Withdrawal by Subject|12|||
48993514|NCT00796367|157810613|FG000|Overall Study|Lack of Efficacy|2|||
48993515|NCT00796367|157810614|FG001|Overall Study|Lack of Efficacy|1|||
48993516|NCT00796367|157810615|FG002|Overall Study|Lack of Efficacy|0|||
48993517|NCT00796367|157810613|FG000|Overall Study|non compliance|3|||
48993518|NCT00796367|157810614|FG001|Overall Study|non compliance|1|||
48993519|NCT00796367|157810615|FG002|Overall Study|non compliance|1|||
48993520|NCT00796367|157810613|FG000|Overall Study|Pregnancy|1|||
48993521|NCT00796367|157810614|FG001|Overall Study|Pregnancy|0|||
48993522|NCT00796367|157810615|FG002|Overall Study|Pregnancy|1|||
48993523|NCT00796367|157810613|FG000|Overall Study|Requirement for restricted medication|2|||
48993524|NCT00796367|157810614|FG001|Overall Study|Requirement for restricted medication|0|||
48993525|NCT00796367|157810615|FG002|Overall Study|Requirement for restricted medication|2|||
48993526|NCT00796367|157810613|FG000|Overall Study|other|2|||
48993527|NCT00796367|157810614|FG001|Overall Study|other|4|||
48993528|NCT00796367|157810615|FG002|Overall Study|other|3|||
48993529|NCT05664672|157810617|FG000|Overall Study|Adverse Event|0|||
48993530|NCT05664672|157810618|FG001|Overall Study|Adverse Event|0|||
48993531|NCT05664672|157810619|FG002|Overall Study|Adverse Event|0|||
48993532|NCT05664672|157810620|FG003|Overall Study|Adverse Event|0|||
48993533|NCT05664672|157810621|FG004|Overall Study|Adverse Event|0|||
48993534|NCT05664672|157810622|FG005|Overall Study|Adverse Event|1|||
48993535|NCT05664672|157810617|FG000|Overall Study|Withdrawal by Subject|0|||
48993536|NCT05664672|157810618|FG001|Overall Study|Withdrawal by Subject|1|||
48993537|NCT05664672|157810619|FG002|Overall Study|Withdrawal by Subject|3|||
48993538|NCT05664672|157810620|FG003|Overall Study|Withdrawal by Subject|0|||
48993539|NCT05664672|157810621|FG004|Overall Study|Withdrawal by Subject|5|||
48993540|NCT05664672|157810622|FG005|Overall Study|Withdrawal by Subject|6|||
48993541|NCT05664672|157810617|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
48993542|NCT05664672|157810618|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
48993543|NCT05664672|157810619|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
48993544|NCT05664672|157810620|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
48993545|NCT05664672|157810621|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
48993546|NCT05664672|157810622|FG005|Overall Study|Failure to Meet Randomization Criteria|0|||
48993547|NCT05664672|157810617|FG000|Overall Study|Met Eligibility Criteria But Not Needed|1|||
48993548|NCT05664672|157810618|FG001|Overall Study|Met Eligibility Criteria But Not Needed|0|||
48993549|NCT05664672|157810619|FG002|Overall Study|Met Eligibility Criteria But Not Needed|0|||
48993550|NCT05664672|157810620|FG003|Overall Study|Met Eligibility Criteria But Not Needed|0|||
48993551|NCT05664672|157810621|FG004|Overall Study|Met Eligibility Criteria But Not Needed|0|||
48993552|NCT05664672|157810622|FG005|Overall Study|Met Eligibility Criteria But Not Needed|0|||
48993553|NCT02442284|157810623|FG000|Overall Study|Adverse Event|1|||
48993554|NCT02442284|157810623|FG000|Overall Study|Withdrew Consent|2|||
48993555|NCT02442284|157810623|FG000|Overall Study|Lost to Follow-up|3|||
48993556|NCT02442284|157810623|FG000|Overall Study|Other|1|||
48993557|NCT00948896|157810624|FG000|Randomization to 24 Months of Age|Death|1|||
48993558|NCT00948896|157810625|FG001|Randomization to 24 Months of Age|Death|0|||
48993559|NCT00948896|157810626|FG002|Randomization to 24 Months of Age|Death|0|||
48993560|NCT00948896|157810627|FG003|Randomization to 24 Months of Age|Death|0|||
48993561|NCT00948896|157810628|FG004|Randomization to 24 Months of Age|Death|2|||
48993562|NCT00948896|157810629|FG005|Randomization to 24 Months of Age|Death|1|||
48993563|NCT00948896|157810630|FG006|Randomization to 24 Months of Age|Death|2|||
48993564|NCT00948896|157810631|FG007|Randomization to 24 Months of Age|Death|1|||
48993565|NCT00948896|157810624|FG000|Randomization to 24 Months of Age|Withdrawal by Subject|3|||
48993566|NCT00948896|157810625|FG001|Randomization to 24 Months of Age|Withdrawal by Subject|5|||
48993567|NCT00948896|157810626|FG002|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
48993568|NCT00948896|157810627|FG003|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
48993569|NCT00948896|157810628|FG004|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
48993570|NCT00948896|157810629|FG005|Randomization to 24 Months of Age|Withdrawal by Subject|1|||
48993571|NCT00948896|157810630|FG006|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
48993572|NCT00948896|157810631|FG007|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
48993573|NCT00948896|157810624|FG000|Randomization to 24 Months of Age|Lost to Follow-up|4|||
48993574|NCT00948896|157810625|FG001|Randomization to 24 Months of Age|Lost to Follow-up|4|||
48993575|NCT00948896|157810626|FG002|Randomization to 24 Months of Age|Lost to Follow-up|2|||
48993576|NCT00948896|157810627|FG003|Randomization to 24 Months of Age|Lost to Follow-up|5|||
48993577|NCT00948896|157810628|FG004|Randomization to 24 Months of Age|Lost to Follow-up|0|||
48993578|NCT00948896|157810629|FG005|Randomization to 24 Months of Age|Lost to Follow-up|0|||
48993579|NCT00948896|157810630|FG006|Randomization to 24 Months of Age|Lost to Follow-up|1|||
48993580|NCT00948896|157810631|FG007|Randomization to 24 Months of Age|Lost to Follow-up|0|||
48993581|NCT00948896|157810624|FG000|Randomization to 24 Months of Age|Protocol Violation|0|||
48993582|NCT00948896|157810625|FG001|Randomization to 24 Months of Age|Protocol Violation|1|||
48993583|NCT00948896|157810626|FG002|Randomization to 24 Months of Age|Protocol Violation|0|||
48993584|NCT00948896|157810627|FG003|Randomization to 24 Months of Age|Protocol Violation|1|||
48993585|NCT00948896|157810628|FG004|Randomization to 24 Months of Age|Protocol Violation|0|||
48993586|NCT00948896|157810629|FG005|Randomization to 24 Months of Age|Protocol Violation|0|||
48993587|NCT00948896|157810630|FG006|Randomization to 24 Months of Age|Protocol Violation|1|||
48993588|NCT00948896|157810631|FG007|Randomization to 24 Months of Age|Protocol Violation|1|||
48993589|NCT00948896|157810624|FG000|Randomization to 24 Months of Age|Moved out of Study Area|0|||
48993590|NCT00948896|157810625|FG001|Randomization to 24 Months of Age|Moved out of Study Area|3|||
48993591|NCT00948896|157810626|FG002|Randomization to 24 Months of Age|Moved out of Study Area|3|||
48993592|NCT00948896|157810627|FG003|Randomization to 24 Months of Age|Moved out of Study Area|1|||
48993593|NCT00948896|157810628|FG004|Randomization to 24 Months of Age|Moved out of Study Area|0|||
48993594|NCT00948896|157810629|FG005|Randomization to 24 Months of Age|Moved out of Study Area|2|||
48993595|NCT00948896|157810630|FG006|Randomization to 24 Months of Age|Moved out of Study Area|0|||
48993596|NCT00948896|157810631|FG007|Randomization to 24 Months of Age|Moved out of Study Area|0|||
48993597|NCT00948896|157810624|FG000|24 Months of Age to 36 Months of Age|Death|0|||
48993598|NCT00948896|157810625|FG001|24 Months of Age to 36 Months of Age|Death|2|||
48993599|NCT00948896|157810626|FG002|24 Months of Age to 36 Months of Age|Death|2|||
48993600|NCT00948896|157810627|FG003|24 Months of Age to 36 Months of Age|Death|0|||
48993601|NCT00948896|157810628|FG004|24 Months of Age to 36 Months of Age|Death|0|||
48993602|NCT00948896|157810629|FG005|24 Months of Age to 36 Months of Age|Death|1|||
48993603|NCT00948896|157810630|FG006|24 Months of Age to 36 Months of Age|Death|0|||
48993604|NCT00948896|157810631|FG007|24 Months of Age to 36 Months of Age|Death|0|||
48993605|NCT00948896|157810624|FG000|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
48993606|NCT00948896|157810625|FG001|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
48993607|NCT00948896|157810626|FG002|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
48993608|NCT00948896|157810627|FG003|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
48993609|NCT00948896|157810628|FG004|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
48993610|NCT00948896|157810629|FG005|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
48993611|NCT00948896|157810630|FG006|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
49045627|NCT03310619|158000175|FG004|Treatment Period|Death|1|||
49045628|NCT03310619|158000176|FG005|Treatment Period|Death|0|||
49045629|NCT03310619|158000177|FG006|Treatment Period|Death|2|||
49045630|NCT03310619|158000178|FG007|Treatment Period|Death|0|||
49045631|NCT03310619|158000171|FG000|Treatment Period|Adverse Event|0|||
49045632|NCT03310619|158000172|FG001|Treatment Period|Adverse Event|1|||
49045633|NCT03310619|158000173|FG002|Treatment Period|Adverse Event|4|||
49045634|NCT03310619|158000174|FG003|Treatment Period|Adverse Event|1|||
49045635|NCT03310619|158000175|FG004|Treatment Period|Adverse Event|0|||
49045636|NCT03310619|158000176|FG005|Treatment Period|Adverse Event|0|||
49045637|NCT03310619|158000177|FG006|Treatment Period|Adverse Event|0|||
49045638|NCT03310619|158000178|FG007|Treatment Period|Adverse Event|0|||
49045639|NCT03310619|158000171|FG000|Treatment Period|Withdrawal by participant|0|||
49045640|NCT03310619|158000172|FG001|Treatment Period|Withdrawal by participant|0|||
49045641|NCT03310619|158000173|FG002|Treatment Period|Withdrawal by participant|1|||
49045642|NCT03310619|158000174|FG003|Treatment Period|Withdrawal by participant|0|||
49045643|NCT03310619|158000175|FG004|Treatment Period|Withdrawal by participant|0|||
49045644|NCT03310619|158000176|FG005|Treatment Period|Withdrawal by participant|0|||
49045645|NCT03310619|158000177|FG006|Treatment Period|Withdrawal by participant|0|||
49045646|NCT03310619|158000178|FG007|Treatment Period|Withdrawal by participant|0|||
48993612|NCT00948896|157810631|FG007|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
48993613|NCT00948896|157810624|FG000|24 Months of Age to 36 Months of Age|Lost to Follow-up|2|||
48993614|NCT00948896|157810625|FG001|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
48993615|NCT00948896|157810626|FG002|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
48993616|NCT00948896|157810627|FG003|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
48993617|NCT00948896|157810628|FG004|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
48993618|NCT00948896|157810629|FG005|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
49045647|NCT03310619|158000171|FG000|Treatment Period|Lost to Follow-up|0|||
49045648|NCT03310619|158000172|FG001|Treatment Period|Lost to Follow-up|0|||
49045649|NCT03310619|158000173|FG002|Treatment Period|Lost to Follow-up|0|||
49045650|NCT03310619|158000174|FG003|Treatment Period|Lost to Follow-up|0|||
49045651|NCT03310619|158000175|FG004|Treatment Period|Lost to Follow-up|0|||
48993619|NCT00948896|157810630|FG006|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
48993620|NCT00948896|157810631|FG007|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
49045652|NCT03310619|158000176|FG005|Treatment Period|Lost to Follow-up|0|||
49045653|NCT03310619|158000177|FG006|Treatment Period|Lost to Follow-up|0|||
49045654|NCT03310619|158000178|FG007|Treatment Period|Lost to Follow-up|1|||
49045655|NCT03310619|158000171|FG000|Treatment Period|Study terminated by sponsor|0|||
48993621|NCT00948896|157810624|FG000|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
48993622|NCT00948896|157810625|FG001|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
48993623|NCT00948896|157810626|FG002|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
48993624|NCT00948896|157810627|FG003|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
48993625|NCT00948896|157810628|FG004|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
48993626|NCT00948896|157810629|FG005|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
48993627|NCT00948896|157810630|FG006|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
48993628|NCT00948896|157810631|FG007|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
48993629|NCT00948896|157810624|FG000|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
48993630|NCT00948896|157810625|FG001|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
48993631|NCT00948896|157810626|FG002|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
48993632|NCT00948896|157810627|FG003|24 Months of Age to 36 Months of Age|Moved out of Study Area|1|||
48993633|NCT00948896|157810628|FG004|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
48993634|NCT00948896|157810629|FG005|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
48993635|NCT00948896|157810630|FG006|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
48993636|NCT00948896|157810631|FG007|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
48993637|NCT03795233|157810632|FG000|Overall Study|Withdrawal by Subject|2|||
48993638|NCT03795233|157810633|FG001|Overall Study|Withdrawal by Subject|1|||
48993639|NCT03795233|157810632|FG000|Overall Study|Lost to Follow-up|1|||
48993640|NCT03795233|157810633|FG001|Overall Study|Lost to Follow-up|0|||
48993641|NCT03795233|157810632|FG000|Overall Study|Death|1|||
48993642|NCT03795233|157810633|FG001|Overall Study|Death|0|||
48993643|NCT02756182|157810634|FG000|Overall Study|StudyTechnical Difficulties|4|||
48993644|NCT01965600|157810635|FG000|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
48993645|NCT01965600|157810636|FG001|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3|||
48993646|NCT01965600|157810637|FG002|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2|||
48993647|NCT01965600|157810638|FG003|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
48993648|NCT01965600|157810635|FG000|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
48993649|NCT01965600|157810636|FG001|Washout Period of Approximately 15 Days|Withdrawal by Subject|1|||
48993650|NCT01965600|157810637|FG002|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
48993651|NCT01965600|157810638|FG003|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
48993652|NCT01965600|157810635|FG000|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1|||
48993653|NCT01965600|157810636|FG001|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
48993654|NCT01965600|157810637|FG002|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
48993655|NCT01965600|157810638|FG003|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
48993656|NCT01965600|157810635|FG000|Washout Period of Approximately 15 Days|Adverse Event|0|||
48993657|NCT01965600|157810636|FG001|Washout Period of Approximately 15 Days|Adverse Event|0|||
48993658|NCT01965600|157810637|FG002|Washout Period of Approximately 15 Days|Adverse Event|0|||
48993659|NCT01965600|157810638|FG003|Washout Period of Approximately 15 Days|Adverse Event|1|||
48993660|NCT01965600|157810635|FG000|Second Intervention|Study terminated by Sponsor|0|||
48993661|NCT01965600|157810636|FG001|Second Intervention|Study terminated by Sponsor|0|||
48993662|NCT01965600|157810637|FG002|Second Intervention|Study terminated by Sponsor|2|||
48993663|NCT01965600|157810638|FG003|Second Intervention|Study terminated by Sponsor|2|||
48993664|NCT01945866|157812004|FG000|Overall Study|Eyes did not complete or were dropped|2|||
48993665|NCT01945866|157812005|FG001|Overall Study|Eyes did not complete or were dropped|0|||
48993666|NCT01336647|157812007|FG000|Overall Study|Lost to Follow-up|4|||
48993667|NCT01336647|157812008|FG001|Overall Study|Lost to Follow-up|1|||
48993668|NCT01336647|157812009|FG002|Overall Study|Lost to Follow-up|3|||
48993669|NCT03808298|157812010|FG000|Overall Study|Adverse Event|3|||
48993670|NCT03808298|157812010|FG000|Overall Study|Physician Decision|1|||
48993671|NCT03808298|157812010|FG000|Overall Study|Withdrawal by Subject|1|||
48993672|NCT03808298|157812010|FG000|Overall Study|Positive Urine Drug Screen at Check-in|3|||
48993673|NCT01018680|157812013|FG000|Overall Study|Adverse Event|23|||
48993674|NCT01018680|157812014|FG001|Overall Study|Adverse Event|40|||
48993675|NCT01018680|157812013|FG000|Overall Study|Withdrawal by Subject|10|||
48993676|NCT01018680|157812014|FG001|Overall Study|Withdrawal by Subject|10|||
48993677|NCT01018680|157812013|FG000|Overall Study|Protocol Violation|5|||
48993678|NCT01018680|157812014|FG001|Overall Study|Protocol Violation|8|||
48993679|NCT01018680|157812013|FG000|Overall Study|Sponsor Decision|6|||
48993680|NCT01018680|157812014|FG001|Overall Study|Sponsor Decision|7|||
48993681|NCT01018680|157812013|FG000|Overall Study|Lack of Efficacy|8|||
48993682|NCT01018680|157812014|FG001|Overall Study|Lack of Efficacy|2|||
48993683|NCT01018680|157812013|FG000|Overall Study|Lost to Follow-up|5|||
48993684|NCT01018680|157812014|FG001|Overall Study|Lost to Follow-up|3|||
48993685|NCT01018680|157812013|FG000|Overall Study|Entry Criteria Not Met|1|||
48993686|NCT01018680|157812014|FG001|Overall Study|Entry Criteria Not Met|4|||
48993687|NCT01018680|157812013|FG000|Overall Study|Physician Decision|3|||
48993688|NCT01018680|157812014|FG001|Overall Study|Physician Decision|1|||
48993689|NCT02930889|157812015|FG000|Overall Study|Lost to Follow-up|2|||
48993690|NCT02930889|157812015|FG000|Overall Study|Withdrawal by Subject|6|||
48993691|NCT02930889|157812015|FG000|Overall Study|Did not meet inclusion/exclusion criteria|8|||
48993692|NCT04398030|157812016|FG000|Treatment Period 1 (1 Week)|Withdrawal by Subject|0|||
48993693|NCT04398030|157812017|FG001|Treatment Period 1 (1 Week)|Withdrawal by Subject|1|||
48993694|NCT04398030|157812016|FG000|Treatment Period 2 (1 Week)|Physician Decision|1|||
48993695|NCT04398030|157812017|FG001|Treatment Period 2 (1 Week)|Physician Decision|0|||
48993696|NCT01004822|157812018|FG000|Overall Study|Objective progression or relapse|3|||
48993697|NCT01004822|157812019|FG001|Overall Study|Objective progression or relapse|3|||
48993698|NCT01004822|157812020|FG002|Overall Study|Objective progression or relapse|0|||
48993699|NCT01004822|157812021|FG003|Overall Study|Objective progression or relapse|1|||
48993700|NCT01004822|157812022|FG004|Overall Study|Objective progression or relapse|2|||
48993701|NCT01004822|157812023|FG005|Overall Study|Objective progression or relapse|2|||
48993702|NCT01004822|157812024|FG006|Overall Study|Objective progression or relapse|1|||
48993703|NCT01004822|157812025|FG007|Overall Study|Objective progression or relapse|4|||
48993704|NCT01004822|157812018|FG000|Overall Study|Global deterioration of health status|0|||
48993705|NCT01004822|157812019|FG001|Overall Study|Global deterioration of health status|0|||
48993706|NCT01004822|157812020|FG002|Overall Study|Global deterioration of health status|0|||
48993707|NCT01004822|157812021|FG003|Overall Study|Global deterioration of health status|1|||
48993708|NCT01004822|157812022|FG004|Overall Study|Global deterioration of health status|0|||
48993709|NCT01004822|157812023|FG005|Overall Study|Global deterioration of health status|0|||
48993710|NCT01004822|157812024|FG006|Overall Study|Global deterioration of health status|1|||
48993711|NCT01004822|157812025|FG007|Overall Study|Global deterioration of health status|0|||
48993712|NCT01004822|157812018|FG000|Overall Study|No longer willing to continue|0|||
48993713|NCT01004822|157812019|FG001|Overall Study|No longer willing to continue|0|||
48993714|NCT01004822|157812020|FG002|Overall Study|No longer willing to continue|0|||
48993715|NCT01004822|157812021|FG003|Overall Study|No longer willing to continue|1|||
48993716|NCT01004822|157812022|FG004|Overall Study|No longer willing to continue|2|||
48993717|NCT01004822|157812023|FG005|Overall Study|No longer willing to continue|1|||
48993718|NCT01004822|157812024|FG006|Overall Study|No longer willing to continue|1|||
48993719|NCT01004822|157812025|FG007|Overall Study|No longer willing to continue|0|||
48993720|NCT01004822|157812018|FG000|Overall Study|Adverse Event|0|||
48993721|NCT01004822|157812019|FG001|Overall Study|Adverse Event|0|||
49045656|NCT03310619|158000172|FG001|Treatment Period|Study terminated by sponsor|0|||
49045657|NCT03310619|158000173|FG002|Treatment Period|Study terminated by sponsor|0|||
49045658|NCT03310619|158000174|FG003|Treatment Period|Study terminated by sponsor|0|||
48993722|NCT01004822|157812020|FG002|Overall Study|Adverse Event|0|||
48993723|NCT01004822|157812021|FG003|Overall Study|Adverse Event|0|||
48993724|NCT01004822|157812022|FG004|Overall Study|Adverse Event|0|||
48993725|NCT01004822|157812023|FG005|Overall Study|Adverse Event|0|||
48993726|NCT01004822|157812024|FG006|Overall Study|Adverse Event|1|||
48993727|NCT01004822|157812025|FG007|Overall Study|Adverse Event|1|||
48993728|NCT01004822|157812018|FG000|Overall Study|Other|0|||
48993729|NCT01004822|157812019|FG001|Overall Study|Other|0|||
48993730|NCT01004822|157812020|FG002|Overall Study|Other|4|||
48993731|NCT01004822|157812021|FG003|Overall Study|Other|1|||
48993732|NCT01004822|157812022|FG004|Overall Study|Other|0|||
48993733|NCT01004822|157812023|FG005|Overall Study|Other|1|||
48993734|NCT01004822|157812024|FG006|Overall Study|Other|0|||
49045659|NCT03310619|158000175|FG004|Treatment Period|Study terminated by sponsor|0|||
49045660|NCT03310619|158000176|FG005|Treatment Period|Study terminated by sponsor|0|||
49045661|NCT03310619|158000177|FG006|Treatment Period|Study terminated by sponsor|0|||
49045662|NCT03310619|158000178|FG007|Treatment Period|Study terminated by sponsor|1|||
49045663|NCT03310619|158000171|FG000|Treatment Period|Physician Decision|0|||
49045664|NCT03310619|158000172|FG001|Treatment Period|Physician Decision|0|||
49045665|NCT03310619|158000173|FG002|Treatment Period|Physician Decision|0|||
49045666|NCT03310619|158000174|FG003|Treatment Period|Physician Decision|0|||
49045667|NCT03310619|158000175|FG004|Treatment Period|Physician Decision|3|||
49045668|NCT03310619|158000176|FG005|Treatment Period|Physician Decision|0|||
49045669|NCT03310619|158000177|FG006|Treatment Period|Physician Decision|0|||
49045670|NCT03310619|158000178|FG007|Treatment Period|Physician Decision|0|||
49045671|NCT03310619|158000171|FG000|Treatment Period|Other reasons|1|||
49045672|NCT03310619|158000172|FG001|Treatment Period|Other reasons|0|||
48993735|NCT01004822|157812025|FG007|Overall Study|Other|0|||
48993736|NCT01858701|157812026|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
48993737|NCT01858701|157812027|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
48993738|NCT01858701|157812026|FG000|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1|||
48993739|NCT01858701|157812027|FG001|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0|||
48993740|NCT01858701|157812026|FG000|Washout Period, 1-13 Days|Withdrawal by Subject|1|||
48993741|NCT01858701|157812027|FG001|Washout Period, 1-13 Days|Withdrawal by Subject|2|||
49045673|NCT03310619|158000173|FG002|Treatment Period|Other reasons|2|||
49045674|NCT03310619|158000174|FG003|Treatment Period|Other reasons|0|||
48993742|NCT01858701|157812026|FG000|Period 2, Second 30 Days of Wear|Comfort|0|||
48993743|NCT01858701|157812027|FG001|Period 2, Second 30 Days of Wear|Comfort|1|||
48993744|NCT00421928|157812028|FG000|Overall Study|Adverse Event|61|||
48993745|NCT00421928|157812029|FG001|Overall Study|Adverse Event|140|||
48993746|NCT00421928|157812030|FG002|Overall Study|Adverse Event|22|||
48993747|NCT00421928|157812028|FG000|Overall Study|Lost to Follow-up|5|||
48993748|NCT00421928|157812029|FG001|Overall Study|Lost to Follow-up|0|||
48993749|NCT00421928|157812030|FG002|Overall Study|Lost to Follow-up|3|||
48993750|NCT00421928|157812028|FG000|Overall Study|Withdrawal by Subject|50|||
49045675|NCT03310619|158000175|FG004|Treatment Period|Other reasons|0|||
49045676|NCT03310619|158000176|FG005|Treatment Period|Other reasons|0|||
49045677|NCT03310619|158000177|FG006|Treatment Period|Other reasons|0|||
49045678|NCT03310619|158000178|FG007|Treatment Period|Other reasons|0|||
49045679|NCT00360490|158000179|FG000|Overall Study|Adverse Event|4|||
49045680|NCT00360490|158000180|FG001|Overall Study|Adverse Event|2|||
49045681|NCT00360490|158000179|FG000|Overall Study|Lost to Follow-up|2|||
49045682|NCT00360490|158000180|FG001|Overall Study|Lost to Follow-up|1|||
49045683|NCT00360490|158000179|FG000|Overall Study|Physician Decision|2|||
49045684|NCT00360490|158000180|FG001|Overall Study|Physician Decision|1|||
49045685|NCT00360490|158000179|FG000|Overall Study|Protocol Violation|0|||
49045686|NCT00360490|158000180|FG001|Overall Study|Protocol Violation|4|||
49045687|NCT00360490|158000179|FG000|Overall Study|Withdrawal by Subject|1|||
49045688|NCT00360490|158000180|FG001|Overall Study|Withdrawal by Subject|3|||
49045689|NCT04449341|158000181|FG000|Overall Study|Protocol Violation|1|||
48993751|NCT00421928|157812029|FG001|Overall Study|Withdrawal by Subject|48|||
48993752|NCT00421928|157812030|FG002|Overall Study|Withdrawal by Subject|43|||
48993753|NCT00421928|157812028|FG000|Overall Study|Lack of Efficacy|15|||
48993754|NCT00421928|157812029|FG001|Overall Study|Lack of Efficacy|7|||
48993755|NCT00421928|157812030|FG002|Overall Study|Lack of Efficacy|35|||
48993756|NCT00421928|157812028|FG000|Overall Study|Study drug non-compliant|6|||
48993757|NCT00421928|157812029|FG001|Overall Study|Study drug non-compliant|7|||
48993758|NCT00421928|157812030|FG002|Overall Study|Study drug non-compliant|4|||
48993759|NCT00421928|157812028|FG000|Overall Study|All other|26|||
48993760|NCT00421928|157812029|FG001|Overall Study|All other|21|||
49045690|NCT04449341|158000182|FG001|Overall Study|Protocol Violation|0|||
49045691|NCT00127166|158000183|FG000|Period I|Protocol Violation|0|||
49045692|NCT00127166|158000184|FG001|Period I|Protocol Violation|2|||
49045693|NCT00127166|158000183|FG000|Period I|Withdrawal by Subject|2|||
49045694|NCT00127166|158000184|FG001|Period I|Withdrawal by Subject|0|||
49045695|NCT00127166|158000183|FG000|Period I|Patient did not meet inclusion criteria|1|||
49045696|NCT00127166|158000184|FG001|Period I|Patient did not meet inclusion criteria|0|||
49045697|NCT00127166|158000183|FG000|Washout Period|Patient did not meet inclusion criteria|0|||
49045698|NCT00127166|158000184|FG001|Washout Period|Patient did not meet inclusion criteria|1|||
49045699|NCT00127166|158000183|FG000|Period II|Withdrawal by Subject|2|||
49045700|NCT00127166|158000184|FG001|Period II|Withdrawal by Subject|0|||
49045701|NCT00127166|158000183|FG000|Period II|Patient did not perform Visit 6 exercise|1|||
49045702|NCT00127166|158000184|FG001|Period II|Patient did not perform Visit 6 exercise|0|||
48993761|NCT00421928|157812030|FG002|Overall Study|All other|27|||
48993762|NCT00421928|157812028|FG000|Overall Study|Death|0|||
48993763|NCT00421928|157812029|FG001|Overall Study|Death|1|||
48993764|NCT00421928|157812030|FG002|Overall Study|Death|0|||
48993765|NCT05056311|157812037|FG000|Overall Study|Lost to Follow-up|14|||
48993766|NCT05056311|157812037|FG000|Overall Study|Withdrawal by Subject|1|||
48993767|NCT05056311|157812037|FG000|Overall Study|Dropped from study due to no Hypospadias|23|||
48993768|NCT02528643|157812038|FG000|DB (Median Duration up to 14.65 Months)|Adverse Event|5|||
48993769|NCT02528643|157812039|FG001|DB (Median Duration up to 14.65 Months)|Adverse Event|8|||
48993770|NCT02528643|157812038|FG000|DB (Median Duration up to 14.65 Months)|Death|1|||
48993771|NCT02528643|157812039|FG001|DB (Median Duration up to 14.65 Months)|Death|6|||
48993772|NCT02528643|157812038|FG000|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|0|||
48993773|NCT02528643|157812039|FG001|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|1|||
48993774|NCT02528643|157812038|FG000|DB (Median Duration up to 14.65 Months)|Progressive Disease|44|||
48993775|NCT02528643|157812039|FG001|DB (Median Duration up to 14.65 Months)|Progressive Disease|82|||
48993776|NCT02528643|157812038|FG000|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|2|||
48993777|NCT02528643|157812039|FG001|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|8|||
48993778|NCT02528643|157812038|FG000|DB (Median Duration up to 14.65 Months)|Miscellaneous|3|||
48993779|NCT02528643|157812039|FG001|DB (Median Duration up to 14.65 Months)|Miscellaneous|5|||
48993780|NCT02528643|157812038|FG000|OL (Median Duration up to 27.56 Months)|Progressive Disease|0|||
48993781|NCT02528643|157812039|FG001|OL (Median Duration up to 27.56 Months)|Progressive Disease|1|||
48993782|NCT00198107|157812040|FG000|Double-Blind Period|Adverse Event|1|||
48993783|NCT00198107|157812041|FG001|Double-Blind Period|Adverse Event|1|||
48993784|NCT00198107|157812042|FG002|Double-Blind Period|Adverse Event|0|||
49045703|NCT00105157|158000185|FG000|Double-Blind (DB)|Never Treated|1|||
49045704|NCT00105157|158000186|FG001|Double-Blind (DB)|Never Treated|0|||
48993785|NCT00198107|157812040|FG000|Double-Blind Period|Lack of Efficacy|2|||
48993786|NCT00198107|157812041|FG001|Double-Blind Period|Lack of Efficacy|0|||
48993787|NCT00198107|157812042|FG002|Double-Blind Period|Lack of Efficacy|0|||
49045705|NCT00105157|158000187|FG002|Double-Blind (DB)|Never Treated|0|||
49045706|NCT00105157|158000188|FG003|Double-Blind (DB)|Never Treated|0|||
48993788|NCT00198107|157812040|FG000|Double-Blind Period|Lost to Follow-up|2|||
48993789|NCT00198107|157812041|FG001|Double-Blind Period|Lost to Follow-up|1|||
48993790|NCT00198107|157812042|FG002|Double-Blind Period|Lost to Follow-up|0|||
48993791|NCT00198107|157812040|FG000|Double-Blind Period|Physician Decision|1|||
48993792|NCT00198107|157812041|FG001|Double-Blind Period|Physician Decision|0|||
48993793|NCT00198107|157812042|FG002|Double-Blind Period|Physician Decision|0|||
48993794|NCT00198107|157812040|FG000|Double-Blind Period|Withdrawal by Subject|0|||
48993795|NCT00198107|157812041|FG001|Double-Blind Period|Withdrawal by Subject|1|||
48993796|NCT00198107|157812042|FG002|Double-Blind Period|Withdrawal by Subject|0|||
48993797|NCT00198107|157812040|FG000|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
48993798|NCT00198107|157812041|FG001|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
48993799|NCT00198107|157812042|FG002|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2|||
48993800|NCT04001790|157812043|FG000|Overall Study|Withdrawal by Subject|1|||
48993801|NCT04001790|157812044|FG001|Overall Study|Withdrawal by Subject|2|||
48993802|NCT02528331|157812045|FG000|Overall Study|Withdrawal by Subject|2|||
48993803|NCT02706327|157812046|FG000|Overall Study|Lost to Follow-up|1|||
48993804|NCT02706327|157812047|FG001|Overall Study|Lost to Follow-up|1|||
48993805|NCT02706327|157812048|FG002|Overall Study|Lost to Follow-up|2|||
48993806|NCT03471507|157812049|FG000|Overall Study|Lost to Follow-up|1|||
48993807|NCT03471507|157812050|FG001|Overall Study|Lost to Follow-up|3|||
48993808|NCT03471507|157812049|FG000|Overall Study|Physician Decision|0|||
48993809|NCT03471507|157812050|FG001|Overall Study|Physician Decision|1|||
48993810|NCT03471507|157812049|FG000|Overall Study|Withdrawal by Subject|2|||
49045707|NCT00105157|158000185|FG000|Double-Blind (DB)|Adverse Event|2|||
49045708|NCT00105157|158000186|FG001|Double-Blind (DB)|Adverse Event|0|||
49045709|NCT00105157|158000187|FG002|Double-Blind (DB)|Adverse Event|1|||
49045710|NCT00105157|158000188|FG003|Double-Blind (DB)|Adverse Event|1|||
49045711|NCT00105157|158000185|FG000|Double-Blind (DB)|Lack of Efficacy|11|||
49045712|NCT00105157|158000186|FG001|Double-Blind (DB)|Lack of Efficacy|14|||
48993811|NCT03471507|157812050|FG001|Overall Study|Withdrawal by Subject|1|||
48993812|NCT00750061|157812052|FG000|Overall Study|Adverse Event|2|||
48993813|NCT00750061|157812053|FG001|Overall Study|Adverse Event|0|||
48993814|NCT00750061|157812052|FG000|Overall Study|Withdrawal by Subject|0|||
48993815|NCT00750061|157812053|FG001|Overall Study|Withdrawal by Subject|1|||
48993816|NCT00750061|157812052|FG000|Overall Study|Physician Decision|0|||
48993817|NCT00750061|157812053|FG001|Overall Study|Physician Decision|1|||
48993818|NCT03814499|157812057|FG000|Overall Study|Lost to Follow-up|3|||
48993819|NCT01589185|157812059|FG000|Overall Study|Death|1|||
48993820|NCT01589185|157812060|FG001|Overall Study|Death|2|||
48993821|NCT01589185|157812061|FG002|Overall Study|Death|2|||
48993822|NCT01589185|157812062|FG003|Overall Study|Death|0|||
48993823|NCT01589185|157812063|FG004|Overall Study|Death|1|||
48993824|NCT01589185|157812059|FG000|Overall Study|Lost to Follow-up|1|||
48993825|NCT01589185|157812060|FG001|Overall Study|Lost to Follow-up|0|||
48993826|NCT01589185|157812061|FG002|Overall Study|Lost to Follow-up|2|||
48993827|NCT01589185|157812062|FG003|Overall Study|Lost to Follow-up|3|||
48993828|NCT01589185|157812063|FG004|Overall Study|Lost to Follow-up|0|||
48993829|NCT02046993|157812064|FG000|Overall Study|Withdrawal by Subject|2|||
48993830|NCT02046993|157812065|FG001|Overall Study|Withdrawal by Subject|10|||
48993831|NCT02046993|157812064|FG000|Overall Study|Lost to Follow-up|1|||
48993832|NCT02046993|157812065|FG001|Overall Study|Lost to Follow-up|1|||
48993833|NCT03417245|157812066|FG000|Overall Study|Adverse Event|1|||
48993834|NCT03417245|157812067|FG001|Overall Study|Adverse Event|0|||
48993835|NCT03417245|157812066|FG000|Overall Study|Protocol Violation|1|||
48993836|NCT03417245|157812067|FG001|Overall Study|Protocol Violation|0|||
48993837|NCT03417245|157812066|FG000|Overall Study|Withdrawal by Subject|1|||
48993838|NCT03417245|157812067|FG001|Overall Study|Withdrawal by Subject|1|||
48993839|NCT02743117|157812075|FG000|Overall Study|Lost to Follow-up|0|||
48993840|NCT02743117|157812076|FG001|Overall Study|Lost to Follow-up|1|||
48993841|NCT02743117|157812075|FG000|Overall Study|Other|1|||
48993842|NCT02743117|157812076|FG001|Overall Study|Other|0|||
48993843|NCT02067728|157812077|FG000|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7|||
48993844|NCT02067728|157812078|FG001|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28|||
48993845|NCT02067728|157812077|FG000|6 Month Follow up Survey|Lost to Follow-up|48|||
48993846|NCT02067728|157812078|FG001|6 Month Follow up Survey|Lost to Follow-up|60|||
48993847|NCT02067728|157812077|FG000|6 Month Measurements|Unable to attend|114|||
48993848|NCT02067728|157812078|FG001|6 Month Measurements|Unable to attend|97|||
48993849|NCT00933543|157812079|FG000|Overall Study|Adverse Event|2|||
48993850|NCT00933543|157812080|FG001|Overall Study|Adverse Event|1|||
48993851|NCT00933543|157812079|FG000|Overall Study|Lost to Follow-up|0|||
48993852|NCT00933543|157812080|FG001|Overall Study|Lost to Follow-up|1|||
48993853|NCT00933543|157812079|FG000|Overall Study|Withdrawal by Subject|0|||
48993854|NCT00933543|157812080|FG001|Overall Study|Withdrawal by Subject|1|||
48993855|NCT00933543|157812079|FG000|Overall Study|Lack of Efficacy|0|||
48993856|NCT00933543|157812080|FG001|Overall Study|Lack of Efficacy|3|||
49045713|NCT00105157|158000187|FG002|Double-Blind (DB)|Lack of Efficacy|11|||
49045714|NCT00105157|158000188|FG003|Double-Blind (DB)|Lack of Efficacy|38|||
48993857|NCT00933543|157812079|FG000|Overall Study|Other|1|||
48993858|NCT00933543|157812080|FG001|Overall Study|Other|1|||
48993859|NCT00368069|157812087|FG000|Overall Study|Adverse Event|5|||
48993860|NCT00368069|157812088|FG001|Overall Study|Adverse Event|2|||
48993861|NCT00368069|157812087|FG000|Overall Study|Lack of Efficacy|0|||
48993862|NCT00368069|157812088|FG001|Overall Study|Lack of Efficacy|1|||
48993863|NCT00368069|157812087|FG000|Overall Study|Lost to Follow-up|1|||
48993864|NCT00368069|157812088|FG001|Overall Study|Lost to Follow-up|0|||
48993865|NCT00368069|157812087|FG000|Overall Study|Protocol Violation|0|||
48993866|NCT00368069|157812088|FG001|Overall Study|Protocol Violation|2|||
48993867|NCT00368069|157812087|FG000|Overall Study|Withdrawal of Consent|2|||
48993868|NCT00368069|157812088|FG001|Overall Study|Withdrawal of Consent|1|||
48993869|NCT00368069|157812087|FG000|Overall Study|no blood sampling possible|0|||
48993870|NCT00368069|157812088|FG001|Overall Study|no blood sampling possible|1|||
48993871|NCT00399542|157812089|FG000|Overall Study|Adverse Event|18|||
48993872|NCT00399542|157812090|FG001|Overall Study|Adverse Event|15|||
48993873|NCT00399542|157812089|FG000|Overall Study|Protocol Violation|13|||
48993874|NCT00399542|157812090|FG001|Overall Study|Protocol Violation|3|||
48993875|NCT00399542|157812089|FG000|Overall Study|Withdrawal by Subject|28|||
48993876|NCT00399542|157812090|FG001|Overall Study|Withdrawal by Subject|10|||
48993877|NCT00399542|157812089|FG000|Overall Study|Lack of Efficacy|18|||
48993878|NCT00399542|157812090|FG001|Overall Study|Lack of Efficacy|8|||
48993879|NCT00399542|157812089|FG000|Overall Study|Lost to Follow-up|6|||
48993880|NCT00399542|157812090|FG001|Overall Study|Lost to Follow-up|6|||
48993881|NCT00399542|157812089|FG000|Overall Study|Other|1|||
48993882|NCT00399542|157812090|FG001|Overall Study|Other|0|||
48993883|NCT00399542|157812089|FG000|Overall Study|Physician Decision|0|||
48993884|NCT00399542|157812090|FG001|Overall Study|Physician Decision|1|||
48993885|NCT01012765|157812095|FG000|Treatment Period 1|Adverse Event|1|||
48993886|NCT01012765|157812096|FG001|Treatment Period 1|Adverse Event|0|||
48993887|NCT01012765|157812097|FG002|Treatment Period 1|Adverse Event|1|||
48993888|NCT01012765|157812098|FG003|Treatment Period 1|Adverse Event|0|||
48993889|NCT01012765|157812099|FG004|Treatment Period 1|Adverse Event|0|||
48993890|NCT01012765|157812100|FG005|Treatment Period 1|Adverse Event|0|||
48993891|NCT01012765|157812095|FG000|Treatment Period 1|Withdrawal by Subject|2|||
48993892|NCT01012765|157812096|FG001|Treatment Period 1|Withdrawal by Subject|0|||
48993893|NCT01012765|157812097|FG002|Treatment Period 1|Withdrawal by Subject|0|||
48993894|NCT01012765|157812098|FG003|Treatment Period 1|Withdrawal by Subject|0|||
48993895|NCT01012765|157812099|FG004|Treatment Period 1|Withdrawal by Subject|0|||
48993896|NCT01012765|157812100|FG005|Treatment Period 1|Withdrawal by Subject|0|||
48993897|NCT01012765|157812095|FG000|Treatment Period 1|Administrative problems|0|||
48993898|NCT01012765|157812096|FG001|Treatment Period 1|Administrative problems|0|||
48993899|NCT01012765|157812097|FG002|Treatment Period 1|Administrative problems|1|||
48993900|NCT01012765|157812098|FG003|Treatment Period 1|Administrative problems|1|||
48993901|NCT01012765|157812099|FG004|Treatment Period 1|Administrative problems|1|||
48993902|NCT01012765|157812100|FG005|Treatment Period 1|Administrative problems|0|||
48993903|NCT01012765|157812095|FG000|Treatment Period 1|Protocol Violation|0|||
48993904|NCT01012765|157812096|FG001|Treatment Period 1|Protocol Violation|0|||
48993905|NCT01012765|157812097|FG002|Treatment Period 1|Protocol Violation|0|||
48993906|NCT01012765|157812098|FG003|Treatment Period 1|Protocol Violation|2|||
48993907|NCT01012765|157812099|FG004|Treatment Period 1|Protocol Violation|1|||
48993908|NCT01012765|157812100|FG005|Treatment Period 1|Protocol Violation|0|||
48993909|NCT01012765|157812095|FG000|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
48993910|NCT01012765|157812096|FG001|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
48993911|NCT01012765|157812097|FG002|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
48993912|NCT01012765|157812098|FG003|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
48993913|NCT01012765|157812099|FG004|Treatment Period 1|Unsatisfactory therapeutic effect|1|||
48993914|NCT01012765|157812100|FG005|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
48993915|NCT01012765|157812095|FG000|Treatment Period 2|Withdrawal by Subject|1|||
48993916|NCT01012765|157812096|FG001|Treatment Period 2|Withdrawal by Subject|0|||
48993917|NCT01012765|157812097|FG002|Treatment Period 2|Withdrawal by Subject|1|||
48993918|NCT01012765|157812098|FG003|Treatment Period 2|Withdrawal by Subject|0|||
48993919|NCT01012765|157812099|FG004|Treatment Period 2|Withdrawal by Subject|1|||
48993920|NCT01012765|157812100|FG005|Treatment Period 2|Withdrawal by Subject|0|||
48993921|NCT01012765|157812095|FG000|Treatment Period 2|Abnormal laboratory value(s)|0|||
48993922|NCT01012765|157812096|FG001|Treatment Period 2|Abnormal laboratory value(s)|0|||
48993923|NCT01012765|157812097|FG002|Treatment Period 2|Abnormal laboratory value(s)|0|||
48993924|NCT01012765|157812098|FG003|Treatment Period 2|Abnormal laboratory value(s)|0|||
48993925|NCT01012765|157812099|FG004|Treatment Period 2|Abnormal laboratory value(s)|0|||
48993926|NCT01012765|157812100|FG005|Treatment Period 2|Abnormal laboratory value(s)|1|||
48993927|NCT01012765|157812095|FG000|Treatment Period 2|Adverse Event|0|||
48993928|NCT01012765|157812096|FG001|Treatment Period 2|Adverse Event|1|||
48993929|NCT01012765|157812097|FG002|Treatment Period 2|Adverse Event|1|||
48993930|NCT01012765|157812098|FG003|Treatment Period 2|Adverse Event|0|||
48993931|NCT01012765|157812099|FG004|Treatment Period 2|Adverse Event|0|||
48993932|NCT01012765|157812100|FG005|Treatment Period 2|Adverse Event|0|||
48993933|NCT01012765|157812095|FG000|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
49045715|NCT00105157|158000185|FG000|Open-Label Continuation of DB|Adverse Event|3|||
49045716|NCT00105157|158000186|FG001|Open-Label Continuation of DB|Adverse Event|1|||
49045717|NCT00105157|158000187|FG002|Open-Label Continuation of DB|Adverse Event|0|||
49045718|NCT00105157|158000188|FG003|Open-Label Continuation of DB|Adverse Event|0|||
49045719|NCT00105157|158000185|FG000|Open-Label Continuation of DB|Lack of Efficacy|1|||
49045720|NCT00105157|158000186|FG001|Open-Label Continuation of DB|Lack of Efficacy|4|||
49045721|NCT00105157|158000187|FG002|Open-Label Continuation of DB|Lack of Efficacy|3|||
49045722|NCT00105157|158000188|FG003|Open-Label Continuation of DB|Lack of Efficacy|1|||
48993934|NCT01012765|157812096|FG001|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
48993935|NCT01012765|157812097|FG002|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
48993936|NCT01012765|157812098|FG003|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
48993937|NCT01012765|157812099|FG004|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
48993938|NCT01012765|157812100|FG005|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
48993939|NCT00672490|157812101|FG000|Overall Study|Withdrawal by Subject|8|||
48993940|NCT00672490|157812102|FG001|Overall Study|Withdrawal by Subject|8|||
48993941|NCT00672490|157812101|FG000|Overall Study|Lack of Compliance|2|||
48993942|NCT00672490|157812102|FG001|Overall Study|Lack of Compliance|7|||
48993943|NCT00672490|157812101|FG000|Overall Study|Mismatch Include/Exclude Criteria|1|||
48993944|NCT00672490|157812102|FG001|Overall Study|Mismatch Include/Exclude Criteria|0|||
48993945|NCT00672490|157812101|FG000|Overall Study|Adverse Event|5|||
48993946|NCT00672490|157812102|FG001|Overall Study|Adverse Event|8|||
48993947|NCT00672490|157812101|FG000|Overall Study|Violation of Concomitant Medicine|1|||
48993948|NCT00672490|157812102|FG001|Overall Study|Violation of Concomitant Medicine|0|||
48993949|NCT00672490|157812101|FG000|Overall Study|Intolerance|0|||
48993950|NCT00672490|157812102|FG001|Overall Study|Intolerance|2|||
48993951|NCT00672490|157812101|FG000|Overall Study|Lost to Follow-up|1|||
48993952|NCT00672490|157812102|FG001|Overall Study|Lost to Follow-up|5|||
48993953|NCT00672490|157812101|FG000|Overall Study|No reason was provided|6|||
48993954|NCT00672490|157812102|FG001|Overall Study|No reason was provided|2|||
48993955|NCT01326312|157812107|FG000|Overall Study|Adverse Event|11|||
48993956|NCT01326312|157812108|FG001|Overall Study|Adverse Event|11|||
48993957|NCT01326312|157812109|FG002|Overall Study|Adverse Event|1|||
48993958|NCT01326312|157812107|FG000|Overall Study|Withdrawal by Subject|1|||
48993959|NCT01326312|157812108|FG001|Overall Study|Withdrawal by Subject|2|||
48993960|NCT01326312|157812109|FG002|Overall Study|Withdrawal by Subject|1|||
48993961|NCT01326312|157812107|FG000|Overall Study|Protocol Violation|0|||
48993962|NCT01326312|157812108|FG001|Overall Study|Protocol Violation|1|||
48993963|NCT01326312|157812109|FG002|Overall Study|Protocol Violation|0|||
48993964|NCT01326312|157812107|FG000|Overall Study|Lack of Efficacy|13|||
48993965|NCT01326312|157812108|FG001|Overall Study|Lack of Efficacy|7|||
48993966|NCT01326312|157812109|FG002|Overall Study|Lack of Efficacy|1|||
48993967|NCT01326312|157812107|FG000|Overall Study|Death|1|||
48993968|NCT01326312|157812108|FG001|Overall Study|Death|0|||
48993969|NCT01326312|157812109|FG002|Overall Study|Death|1|||
48993970|NCT01326312|157812107|FG000|Overall Study|progressive disease|0|||
48993971|NCT01326312|157812108|FG001|Overall Study|progressive disease|1|||
48993972|NCT01326312|157812109|FG002|Overall Study|progressive disease|1|||
48993973|NCT01326312|157812107|FG000|Overall Study|Study terminated by Sponsor|8|||
48993974|NCT01326312|157812108|FG001|Overall Study|Study terminated by Sponsor|32|||
48993975|NCT01326312|157812109|FG002|Overall Study|Study terminated by Sponsor|46|||
48993976|NCT01326312|157812107|FG000|Overall Study|Treatment arm terminated|19|||
48993977|NCT01326312|157812108|FG001|Overall Study|Treatment arm terminated|0|||
48993978|NCT01326312|157812109|FG002|Overall Study|Treatment arm terminated|0|||
48993979|NCT01326312|157812107|FG000|Overall Study|QTc > 500|0|||
48993980|NCT01326312|157812108|FG001|Overall Study|QTc > 500|1|||
48993981|NCT01326312|157812109|FG002|Overall Study|QTc > 500|0|||
48993982|NCT04652245|157812110|FG000|Wash-Out Period|Adverse Event|0|||
48993983|NCT04652245|157812111|FG001|Wash-Out Period|Adverse Event|2|||
48993984|NCT04652245|157812110|FG000|Wash-Out Period|Withdrawal by Subject|0|||
48993985|NCT04652245|157812111|FG001|Wash-Out Period|Withdrawal by Subject|2|||
48993986|NCT02788981|157812120|FG000|Overall Study|Patient chose to pursue alternative treatment|0|||
48993987|NCT02788981|157812121|FG001|Overall Study|Patient chose to pursue alternative treatment|1|||
48993988|NCT01484691|157812127|FG000|Overall Study|Withdrawal by Subject|1|||
48993989|NCT01484691|157812128|FG001|Overall Study|Withdrawal by Subject|1|||
48993990|NCT01484691|157812129|FG002|Overall Study|Withdrawal by Subject|1|||
48993991|NCT01484691|157812127|FG000|Overall Study|Physician Decision|0|||
48993992|NCT01484691|157812128|FG001|Overall Study|Physician Decision|2|||
48993993|NCT01484691|157812129|FG002|Overall Study|Physician Decision|1|||
48993994|NCT05261126|157812130|FG000|Overall Study|Death|0|||
48993995|NCT05261126|157812131|FG001|Overall Study|Death|0|||
48993996|NCT05261126|157812132|FG002|Overall Study|Death|1|||
48993997|NCT05261126|157812133|FG003|Overall Study|Death|0|||
48993998|NCT05261126|157812134|FG004|Overall Study|Death|0|||
49045723|NCT00105157|158000185|FG000|Open-Label Continuation of DB|Lost to Follow-up|1|||
48993999|NCT05261126|157812130|FG000|Overall Study|Lost to Follow-up|0|||
48994000|NCT05261126|157812131|FG001|Overall Study|Lost to Follow-up|0|||
48994001|NCT05261126|157812132|FG002|Overall Study|Lost to Follow-up|0|||
49045724|NCT00105157|158000186|FG001|Open-Label Continuation of DB|Lost to Follow-up|1|||
49045725|NCT00105157|158000187|FG002|Open-Label Continuation of DB|Lost to Follow-up|1|||
49045726|NCT00105157|158000188|FG003|Open-Label Continuation of DB|Lost to Follow-up|0|||
49045727|NCT00105157|158000185|FG000|Open-Label Continuation of DB|Withdrawal by Subject|0|||
49045728|NCT00105157|158000186|FG001|Open-Label Continuation of DB|Withdrawal by Subject|1|||
49045729|NCT00105157|158000187|FG002|Open-Label Continuation of DB|Withdrawal by Subject|3|||
49045730|NCT00105157|158000188|FG003|Open-Label Continuation of DB|Withdrawal by Subject|0|||
49045731|NCT00105157|158000185|FG000|Open-Label Continuation of DB|Patient did not continue in extension|1|||
49045732|NCT00105157|158000186|FG001|Open-Label Continuation of DB|Patient did not continue in extension|0|||
49045733|NCT00105157|158000187|FG002|Open-Label Continuation of DB|Patient did not continue in extension|0|||
49045734|NCT00105157|158000188|FG003|Open-Label Continuation of DB|Patient did not continue in extension|0|||
49045735|NCT00105157|158000185|FG000|Open-Label Continuation of DB|Patient moved/site stopped trial|1|||
49045736|NCT00105157|158000186|FG001|Open-Label Continuation of DB|Patient moved/site stopped trial|3|||
49045737|NCT00105157|158000187|FG002|Open-Label Continuation of DB|Patient moved/site stopped trial|2|||
49045738|NCT00105157|158000188|FG003|Open-Label Continuation of DB|Patient moved/site stopped trial|0|||
49045739|NCT00105157|158000185|FG000|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
49045740|NCT00105157|158000186|FG001|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
49045741|NCT00105157|158000187|FG002|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
49045742|NCT00105157|158000188|FG003|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1|||
49045743|NCT00105157|158000185|FG000|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7|||
49045744|NCT00105157|158000186|FG001|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6|||
49045745|NCT00105157|158000187|FG002|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5|||
49045746|NCT00105157|158000188|FG003|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10|||
49045747|NCT00105157|158000185|FG000|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
49045748|NCT00105157|158000186|FG001|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
49045749|NCT00105157|158000187|FG002|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
49045750|NCT00105157|158000188|FG003|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
49045751|NCT00105157|158000185|FG000|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
49045752|NCT00105157|158000186|FG001|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
49045753|NCT00105157|158000187|FG002|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
49045754|NCT00105157|158000188|FG003|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5|||
49045755|NCT00105157|158000185|FG000|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
49045756|NCT00105157|158000186|FG001|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0|||
49045757|NCT00105157|158000187|FG002|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
49045758|NCT00105157|158000188|FG003|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
49045759|NCT00708682|158000195|FG000|Infant Series|Adverse Event|1|||
49045760|NCT00708682|158000195|FG000|Infant Series|Lost to Follow-up|4|||
49045761|NCT00708682|158000195|FG000|Infant Series|Protocol Violation|1|||
49045762|NCT00708682|158000195|FG000|Infant Series|Parent/legal guardian request|6|||
49045763|NCT00708682|158000195|FG000|Infant Series|Failed to return|2|||
49045764|NCT00708682|158000195|FG000|Infant Series|Other|19|||
49045765|NCT00708682|158000195|FG000|After Infant Series|Parent/Legal Guardian Request|1|||
49045766|NCT00708682|158000195|FG000|Toddler Dose|Parent/Legal Guardian Request|1|||
49045767|NCT00708682|158000195|FG000|Toddler Dose|Lost to Follow-up|3|||
49045768|NCT00708682|158000195|FG000|Toddler Dose|Failed to Return|4|||
49045769|NCT01833169|158000196|FG000|Overall Study|Disease Progression|99|||
49045770|NCT01833169|158000196|FG000|Overall Study|Adverse Event|33|||
49045771|NCT01833169|158000196|FG000|Overall Study|Withdrawal by Subject|9|||
49045772|NCT01833169|158000196|FG000|Overall Study|Death|3|||
49045773|NCT01833169|158000196|FG000|Overall Study|Physician Decision|2|||
49045774|NCT00258856|158001998|FG000|Overall Study|Lost to Follow-up|1|||
49045775|NCT00258856|158001999|FG001|Overall Study|Lost to Follow-up|0|||
49045776|NCT00258856|158002000|FG002|Overall Study|Lost to Follow-up|2|||
49045777|NCT00258856|158002001|FG003|Overall Study|Lost to Follow-up|0|||
49045778|NCT00258856|158001998|FG000|Overall Study|Non-compliance|2|||
48994002|NCT05261126|157812133|FG003|Overall Study|Lost to Follow-up|0|||
48994003|NCT05261126|157812134|FG004|Overall Study|Lost to Follow-up|1|||
48994004|NCT05261126|157812130|FG000|Overall Study|Physician Decision|1|||
48994005|NCT05261126|157812131|FG001|Overall Study|Physician Decision|0|||
48994006|NCT05261126|157812132|FG002|Overall Study|Physician Decision|0|||
48994007|NCT05261126|157812133|FG003|Overall Study|Physician Decision|0|||
48994008|NCT05261126|157812134|FG004|Overall Study|Physician Decision|0|||
48994009|NCT05261126|157812130|FG000|Overall Study|Screen Failure|0|||
48994010|NCT05261126|157812131|FG001|Overall Study|Screen Failure|0|||
48994011|NCT05261126|157812132|FG002|Overall Study|Screen Failure|0|||
48994012|NCT05261126|157812133|FG003|Overall Study|Screen Failure|0|||
48994013|NCT05261126|157812134|FG004|Overall Study|Screen Failure|1|||
48994014|NCT05261126|157812130|FG000|Overall Study|Withdrawal by Subject|1|||
48994015|NCT05261126|157812131|FG001|Overall Study|Withdrawal by Subject|0|||
48994016|NCT05261126|157812132|FG002|Overall Study|Withdrawal by Subject|1|||
49045779|NCT00258856|158001999|FG001|Overall Study|Non-compliance|0|||
49045780|NCT00258856|158002000|FG002|Overall Study|Non-compliance|0|||
49045781|NCT00258856|158002001|FG003|Overall Study|Non-compliance|1|||
49045782|NCT04573309|158002002|FG000|Overall Study|Protocol Violation|1|||
49045783|NCT04573309|158002003|FG001|Overall Study|Protocol Violation|0|||
49045784|NCT03578809|158002004|FG000|Overall Study|Death|0|||
49045785|NCT03578809|158002005|FG001|Overall Study|Death|2|||
49045786|NCT03578809|158002006|FG002|Overall Study|Death|0|||
49045787|NCT03578809|158002007|FG003|Overall Study|Death|1|||
49045788|NCT03578809|158002004|FG000|Overall Study|Lost to Follow-up|0|||
49045789|NCT03578809|158002005|FG001|Overall Study|Lost to Follow-up|1|||
49045790|NCT03578809|158002006|FG002|Overall Study|Lost to Follow-up|0|||
49045791|NCT03578809|158002007|FG003|Overall Study|Lost to Follow-up|0|||
49045792|NCT03578809|158002004|FG000|Overall Study|Withdrawal by Subject|3|||
49045793|NCT03578809|158002005|FG001|Overall Study|Withdrawal by Subject|5|||
49045794|NCT03578809|158002006|FG002|Overall Study|Withdrawal by Subject|2|||
49045795|NCT03578809|158002007|FG003|Overall Study|Withdrawal by Subject|0|||
48994017|NCT05261126|157812133|FG003|Overall Study|Withdrawal by Subject|1|||
48994018|NCT05261126|157812134|FG004|Overall Study|Withdrawal by Subject|0|||
48994019|NCT05261126|157812130|FG000|Overall Study|Not Recorded|0|||
48994020|NCT05261126|157812131|FG001|Overall Study|Not Recorded|0|||
48994021|NCT05261126|157812132|FG002|Overall Study|Not Recorded|0|||
48994022|NCT05261126|157812133|FG003|Overall Study|Not Recorded|1|||
48994023|NCT05261126|157812134|FG004|Overall Study|Not Recorded|0|||
48994024|NCT00938366|157812135|FG000|Overall Study|Withdrawal by Subject|1|||
48994025|NCT00938366|157812136|FG001|Overall Study|Withdrawal by Subject|0|||
48994026|NCT01958619|157812141|FG000|Overall Study|Protocol Violation|2|||
48994027|NCT01958619|157812142|FG001|Overall Study|Protocol Violation|0|||
48994028|NCT01958619|157812143|FG002|Overall Study|Protocol Violation|1|||
48994029|NCT01958619|157812144|FG003|Overall Study|Protocol Violation|0|||
48994030|NCT02501642|157813526|FG000|Overall Study|Lost to Follow-up|7|||
48994031|NCT02501642|157813527|FG001|Overall Study|Lost to Follow-up|11|||
48994032|NCT02513732|157813528|FG000|Overall Study|Lost to Follow-up|11|||
48994033|NCT02513732|157813528|FG000|Overall Study|Death|9|||
48994034|NCT02513732|157813528|FG000|Overall Study|Changing hospital|2|||
48994035|NCT00467051|157813531|FG000|Overall Study|Adverse Event|2|||
48994036|NCT00934661|157813532|FG000|Overall Study|Failure of Combined/Spinal Epidural|1|||
48994037|NCT00934661|157813533|FG001|Overall Study|Failure of Combined/Spinal Epidural|0|||
48994038|NCT01740297|157813535|FG000|Overall Study|Withdrawal by Subject|4|||
48994039|NCT01740297|157813536|FG001|Overall Study|Withdrawal by Subject|16|||
48994040|NCT01740297|157813537|FG002|Overall Study|Withdrawal by Subject|17|||
48994041|NCT01740297|157813535|FG000|Overall Study|Death|8|||
48994042|NCT01740297|157813536|FG001|Overall Study|Death|46|||
48994043|NCT01740297|157813537|FG002|Overall Study|Death|40|||
48994044|NCT01740297|157813535|FG000|Overall Study|Lost to Follow-up|1|||
48994045|NCT01740297|157813536|FG001|Overall Study|Lost to Follow-up|2|||
48994046|NCT01740297|157813537|FG002|Overall Study|Lost to Follow-up|4|||
48994047|NCT00761462|157813540|FG000|Treatment|Subjects never received study medication|23|||
48994048|NCT00761462|157813541|FG001|Treatment|Subjects never received study medication|12|||
48994049|NCT00761462|157813540|FG000|2 or 5 Years Long-term Safety Follow-up|Death|4|||
48994050|NCT00761462|157813541|FG001|2 or 5 Years Long-term Safety Follow-up|Death|0|||
48994051|NCT00761462|157813540|FG000|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75|||
48994052|NCT00761462|157813541|FG001|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30|||
48994053|NCT00761462|157813540|FG000|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75|||
48994054|NCT00761462|157813541|FG001|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21|||
48994055|NCT02545270|157813555|FG000|Overall Study|technical difficulties|0|||
48994056|NCT02545270|157813556|FG001|Overall Study|technical difficulties|1|||
48994057|NCT02545270|157813557|FG002|Overall Study|technical difficulties|0|||
48994058|NCT02545270|157813555|FG000|Overall Study|Videos being too similar to other|0|||
48994059|NCT02545270|157813556|FG001|Overall Study|Videos being too similar to other|0|||
48994060|NCT02545270|157813557|FG002|Overall Study|Videos being too similar to other|2|||
48994061|NCT03287089|157813560|FG000|Overall Study|Lost to Follow-up|0|||
48994062|NCT03287089|157813561|FG001|Overall Study|Lost to Follow-up|2|||
48994063|NCT03287089|157813560|FG000|Overall Study|Physician Decision|0|||
48994064|NCT03287089|157813561|FG001|Overall Study|Physician Decision|2|||
48994065|NCT03287089|157813560|FG000|Overall Study|Withdrawal by Subject|0|||
48994066|NCT03287089|157813561|FG001|Overall Study|Withdrawal by Subject|2|||
49045796|NCT03578809|158002004|FG000|Overall Study|Other|3|||
49045797|NCT03578809|158002005|FG001|Overall Study|Other|6|||
49045798|NCT03578809|158002006|FG002|Overall Study|Other|2|||
49045799|NCT03578809|158002007|FG003|Overall Study|Other|8|||
49045800|NCT01520987|158002009|FG000|Overall Study|Withdrawal by Subject|1|||
48994067|NCT03380091|157813562|FG000|Overall Study|Withdrawal by Subject|2|||
48994068|NCT03380091|157813563|FG001|Overall Study|Withdrawal by Subject|1|||
48994069|NCT03772574|157813564|FG000|Overall Study|Protocol Violation|2|||
48994070|NCT03772574|157813565|FG001|Overall Study|Protocol Violation|0|||
49045801|NCT01520987|158002010|FG001|Overall Study|Withdrawal by Subject|0|||
48994071|NCT03772574|157813566|FG002|Overall Study|Protocol Violation|0|||
49045802|NCT01520987|158002011|FG002|Overall Study|Withdrawal by Subject|0|||
49045803|NCT01520987|158002012|FG003|Overall Study|Withdrawal by Subject|0|||
49045804|NCT01520987|158002013|FG004|Overall Study|Withdrawal by Subject|0|||
49045805|NCT01520987|158002014|FG005|Overall Study|Withdrawal by Subject|1|||
49045806|NCT01520987|158002015|FG006|Overall Study|Withdrawal by Subject|0|||
49045807|NCT01520987|158002016|FG007|Overall Study|Withdrawal by Subject|0|||
49045808|NCT00526162|158002017|FG000|Overall Study|Device not implanted|3|||
49045809|NCT02005562|158002018|FG000|Overall Study|Death|2|||
49045810|NCT02005562|158002019|FG001|Overall Study|Death|2|||
49045811|NCT02005562|158002018|FG000|Overall Study|Graft loss|7|||
49045812|NCT02005562|158002019|FG001|Overall Study|Graft loss|6|||
49045813|NCT02005562|158002018|FG000|Overall Study|Withdrawal by Subject|2|||
49045814|NCT02005562|158002019|FG001|Overall Study|Withdrawal by Subject|2|||
49045815|NCT02005562|158002018|FG000|Overall Study|No transplant|1|||
49045816|NCT02005562|158002019|FG001|Overall Study|No transplant|4|||
49045817|NCT02005562|158002018|FG000|Overall Study|Physician Decision|0|||
49045818|NCT02005562|158002019|FG001|Overall Study|Physician Decision|1|||
48994072|NCT03772574|157813564|FG000|Overall Study|Discomfort|0|||
48994073|NCT03772574|157813565|FG001|Overall Study|Discomfort|5|||
48994074|NCT03772574|157813566|FG002|Overall Study|Discomfort|4|||
48994075|NCT02918968|157813567|FG000|1st Line AAT|Progressive disease|9|||
48994076|NCT02918968|157813568|FG001|1st Line AAT|Progressive disease|4|||
48994077|NCT02918968|157813567|FG000|1st Line AAT|Adverse Event|12|||
48994078|NCT02918968|157813568|FG001|1st Line AAT|Adverse Event|3|||
48994079|NCT02918968|157813567|FG000|1st Line AAT|Physician Decision|4|||
48994080|NCT02918968|157813568|FG001|1st Line AAT|Physician Decision|2|||
48994081|NCT02918968|157813567|FG000|1st Line AAT|Withdrawal by Subject|2|||
48994082|NCT02918968|157813568|FG001|1st Line AAT|Withdrawal by Subject|1|||
48994083|NCT02918968|157813567|FG000|1st Line AAT|Lost to Follow-up|0|||
48994084|NCT02918968|157813568|FG001|1st Line AAT|Lost to Follow-up|1|||
48994085|NCT02918968|157813567|FG000|1st Line AAT|Death|1|||
48994086|NCT02918968|157813568|FG001|1st Line AAT|Death|0|||
48994087|NCT02918968|157813567|FG000|1st Line AAT|Miscellaneous|1|||
48994088|NCT02918968|157813568|FG001|1st Line AAT|Miscellaneous|0|||
48994089|NCT02918968|157813567|FG000|2nd Line AAT|Progressive disease|21|||
48994090|NCT02918968|157813568|FG001|2nd Line AAT|Progressive disease|3|||
48994091|NCT02918968|157813567|FG000|2nd Line AAT|Adverse Event|2|||
48994092|NCT02918968|157813568|FG001|2nd Line AAT|Adverse Event|5|||
48994093|NCT02918968|157813567|FG000|2nd Line AAT|Physician Decision|0|||
48994094|NCT02918968|157813568|FG001|2nd Line AAT|Physician Decision|1|||
48994095|NCT02918968|157813567|FG000|2nd Line AAT|Withdrawal by Subject|2|||
48994096|NCT02918968|157813568|FG001|2nd Line AAT|Withdrawal by Subject|2|||
48994097|NCT02918968|157813567|FG000|2nd Line AAT|Death|0|||
48994098|NCT02918968|157813568|FG001|2nd Line AAT|Death|1|||
48994099|NCT00727246|157813571|FG000|Overall Study|could not complete MRI|0|||
48994100|NCT00727246|157813572|FG001|Overall Study|could not complete MRI|1|||
48994101|NCT00727246|157813573|FG002|Overall Study|could not complete MRI|0|||
48994102|NCT00727246|157813574|FG003|Overall Study|could not complete MRI|1|||
48994103|NCT00727246|157813571|FG000|Overall Study|incidental finding|0|||
48994104|NCT00727246|157813572|FG001|Overall Study|incidental finding|0|||
48994105|NCT00727246|157813573|FG002|Overall Study|incidental finding|0|||
48994106|NCT00727246|157813574|FG003|Overall Study|incidental finding|1|||
48994107|NCT00727246|157813571|FG000|Overall Study|withdrawn|0|||
48994108|NCT00727246|157813572|FG001|Overall Study|withdrawn|0|||
48994109|NCT00727246|157813573|FG002|Overall Study|withdrawn|1|||
48994110|NCT00727246|157813574|FG003|Overall Study|withdrawn|0|||
48994111|NCT04594213|157813581|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
48994112|NCT04594213|157813582|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|6|||
48994113|NCT04594213|157813583|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
48994114|NCT04594213|157813584|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
48994115|NCT04594213|157813585|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
48994116|NCT04594213|157813586|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
48994117|NCT04594213|157813581|FG000|Main Period (Up to 22 Weeks)|Physician Decision|0|||
48994118|NCT04594213|157813582|FG001|Main Period (Up to 22 Weeks)|Physician Decision|1|||
48994119|NCT04594213|157813583|FG002|Main Period (Up to 22 Weeks)|Physician Decision|0|||
48994120|NCT04594213|157813584|FG003|Main Period (Up to 22 Weeks)|Physician Decision|0|||
48994121|NCT04594213|157813585|FG004|Main Period (Up to 22 Weeks)|Physician Decision|0|||
49045819|NCT00199901|158002020|FG000|Overall Study|Protocol Violation|2|||
49045820|NCT00199901|158002021|FG001|Overall Study|Protocol Violation|0|||
48994122|NCT04594213|157813586|FG005|Main Period (Up to 22 Weeks)|Physician Decision|0|||
48994123|NCT04594213|157813581|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
48994124|NCT04594213|157813582|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
48994125|NCT04594213|157813583|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
48994126|NCT04594213|157813584|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
48994127|NCT04594213|157813585|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
48994128|NCT04594213|157813586|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
48994129|NCT04594213|157813581|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
48994130|NCT04594213|157813582|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
48994131|NCT04594213|157813583|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
48994132|NCT04594213|157813584|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
48994133|NCT04594213|157813585|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|2|||
48994134|NCT04594213|157813586|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
48994135|NCT04594213|157813581|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
48994136|NCT04594213|157813582|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
48994137|NCT04594213|157813583|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
48994138|NCT04594213|157813584|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|4|||
48994139|NCT04594213|157813585|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|6|||
48994140|NCT04594213|157813586|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
48994141|NCT04594213|157813581|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
48994142|NCT04594213|157813582|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
48994143|NCT04594213|157813583|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
48994144|NCT04594213|157813584|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
48994145|NCT04594213|157813585|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
48994146|NCT04594213|157813586|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
48994147|NCT04594213|157813581|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
48994148|NCT04594213|157813582|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
48994149|NCT04594213|157813583|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
48994150|NCT04594213|157813584|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
48994151|NCT04594213|157813585|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
48994152|NCT04594213|157813586|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
48994153|NCT04594213|157813581|FG000|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
48994154|NCT04594213|157813582|FG001|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
48994155|NCT04594213|157813583|FG002|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
48994156|NCT04594213|157813584|FG003|OLEX Period (Up to 39 Weeks)|Protocol Violation|1|||
48994157|NCT04594213|157813585|FG004|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
48994158|NCT04594213|157813586|FG005|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
48994159|NCT04594213|157813581|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
48994160|NCT04594213|157813582|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
48994161|NCT04594213|157813583|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
48994162|NCT04594213|157813584|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|6|||
48994163|NCT04594213|157813585|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|11|||
48994164|NCT04594213|157813586|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
48994165|NCT04594213|157813581|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
48994166|NCT04594213|157813582|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
48994167|NCT04594213|157813583|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
48994168|NCT04594213|157813584|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|7|||
48994169|NCT04594213|157813585|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|22|||
48994170|NCT04594213|157813586|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|5|||
48994171|NCT04594213|157813581|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
48994172|NCT04594213|157813582|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
48994173|NCT04594213|157813583|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
48994174|NCT04594213|157813584|FG003|OLEX Period (Up to 39 Weeks)|Other|1|||
48994175|NCT04594213|157813585|FG004|OLEX Period (Up to 39 Weeks)|Other|3|||
48994176|NCT04594213|157813586|FG005|OLEX Period (Up to 39 Weeks)|Other|1|||
48994177|NCT03586427|157813588|FG000|Overall Study|Lost to Follow-up|0|||
48994178|NCT03586427|157813589|FG001|Overall Study|Lost to Follow-up|3|||
48994179|NCT03586427|157813590|FG002|Overall Study|Lost to Follow-up|1|||
48994180|NCT03586427|157813591|FG003|Overall Study|Lost to Follow-up|3|||
48994181|NCT03586427|157813592|FG004|Overall Study|Lost to Follow-up|3|||
48994182|NCT03586427|157813588|FG000|Overall Study|Withdrawal by Subject|0|||
48994183|NCT03586427|157813589|FG001|Overall Study|Withdrawal by Subject|1|||
48994184|NCT03586427|157813590|FG002|Overall Study|Withdrawal by Subject|2|||
48994185|NCT03586427|157813591|FG003|Overall Study|Withdrawal by Subject|1|||
48994186|NCT03586427|157813592|FG004|Overall Study|Withdrawal by Subject|1|||
48994187|NCT03586427|157813588|FG000|Overall Study|Adverse Event|0|||
48994188|NCT03586427|157813589|FG001|Overall Study|Adverse Event|0|||
48994189|NCT03586427|157813590|FG002|Overall Study|Adverse Event|1|||
48994190|NCT03586427|157813591|FG003|Overall Study|Adverse Event|0|||
48994191|NCT03586427|157813592|FG004|Overall Study|Adverse Event|0|||
48994192|NCT03586427|157813588|FG000|Overall Study|Protocol Violation|0|||
48994193|NCT03586427|157813589|FG001|Overall Study|Protocol Violation|0|||
48994194|NCT03586427|157813590|FG002|Overall Study|Protocol Violation|1|||
48994195|NCT03586427|157813591|FG003|Overall Study|Protocol Violation|0|||
48994196|NCT03586427|157813592|FG004|Overall Study|Protocol Violation|1|||
48994197|NCT03586427|157813588|FG000|Overall Study|Noncompliance with study drug|0|||
48994198|NCT03586427|157813589|FG001|Overall Study|Noncompliance with study drug|0|||
48994199|NCT03586427|157813590|FG002|Overall Study|Noncompliance with study drug|1|||
48994200|NCT03586427|157813591|FG003|Overall Study|Noncompliance with study drug|0|||
48994201|NCT03586427|157813592|FG004|Overall Study|Noncompliance with study drug|0|||
48994202|NCT00598442|157813593|FG000|Overall Study|Adverse Event|3|||
48994203|NCT00598442|157813594|FG001|Overall Study|Adverse Event|0|||
48994204|NCT00598442|157813595|FG002|Overall Study|Adverse Event|0|||
48994205|NCT00598442|157813593|FG000|Overall Study|Death|19|||
48994206|NCT00598442|157813594|FG001|Overall Study|Death|11|||
48994207|NCT00598442|157813595|FG002|Overall Study|Death|11|||
48994208|NCT00598442|157813593|FG000|Overall Study|Lost to Follow-up|4|||
48994209|NCT00598442|157813594|FG001|Overall Study|Lost to Follow-up|3|||
48994210|NCT00598442|157813595|FG002|Overall Study|Lost to Follow-up|3|||
48994211|NCT00598442|157813593|FG000|Overall Study|Physician Decision|2|||
48994212|NCT00598442|157813594|FG001|Overall Study|Physician Decision|1|||
48994213|NCT00598442|157813595|FG002|Overall Study|Physician Decision|1|||
48994214|NCT00598442|157813593|FG000|Overall Study|Withdrawal by Subject|8|||
48994215|NCT00598442|157813594|FG001|Overall Study|Withdrawal by Subject|16|||
48994216|NCT00598442|157813595|FG002|Overall Study|Withdrawal by Subject|6|||
48994217|NCT00598442|157813593|FG000|Overall Study|Noncompliance|0|||
48994218|NCT00598442|157813594|FG001|Overall Study|Noncompliance|2|||
48994219|NCT00598442|157813595|FG002|Overall Study|Noncompliance|1|||
48994220|NCT00598442|157813593|FG000|Overall Study|Relocation|1|||
48994221|NCT00598442|157813594|FG001|Overall Study|Relocation|4|||
48994222|NCT00598442|157813595|FG002|Overall Study|Relocation|0|||
48994223|NCT00598442|157813593|FG000|Overall Study|Renal transplant|0|||
48994224|NCT00598442|157813594|FG001|Overall Study|Renal transplant|0|||
48994225|NCT00598442|157813595|FG002|Overall Study|Renal transplant|1|||
48994226|NCT00598442|157813593|FG000|Overall Study|Site closed by sponsor|5|||
48994227|NCT00598442|157813594|FG001|Overall Study|Site closed by sponsor|2|||
48994228|NCT00598442|157813595|FG002|Overall Study|Site closed by sponsor|1|||
48994229|NCT00598442|157813593|FG000|Overall Study|Started dialysis|1|||
48994230|NCT00598442|157813594|FG001|Overall Study|Started dialysis|0|||
48994231|NCT00598442|157813595|FG002|Overall Study|Started dialysis|0|||
48994232|NCT03781167|157813598|FG000|Overall Study|Adverse Event|23|||
48994233|NCT03781167|157813599|FG001|Overall Study|Adverse Event|25|||
48994234|NCT03781167|157813598|FG000|Overall Study|Withdrew consent|16|||
48994235|NCT03781167|157813599|FG001|Overall Study|Withdrew consent|12|||
48994236|NCT03781167|157813598|FG000|Overall Study|Lost to Follow-up|0|||
48994237|NCT03781167|157813599|FG001|Overall Study|Lost to Follow-up|1|||
48994238|NCT03781167|157813598|FG000|Overall Study|Lack of Efficacy|4|||
48994239|NCT03781167|157813599|FG001|Overall Study|Lack of Efficacy|5|||
48994240|NCT03781167|157813598|FG000|Overall Study|Difficulty with drug delivery system|2|||
48994241|NCT03781167|157813599|FG001|Overall Study|Difficulty with drug delivery system|3|||
48994242|NCT03781167|157813598|FG000|Overall Study|Other, not specified|2|||
48994243|NCT03781167|157813599|FG001|Overall Study|Other, not specified|2|||
48994244|NCT02116309|157813600|FG000|Overall Study|Lost to Follow-up|0|||
48994245|NCT02116309|157813601|FG001|Overall Study|Lost to Follow-up|1|||
48994246|NCT05147311|157813602|FG000|Overall Study|Did not complete survey|2|||
48994247|NCT05147311|157813603|FG001|Overall Study|Did not complete survey|1|||
48994248|NCT05147311|157813602|FG000|Overall Study|Patient too sick|1|||
48994249|NCT05147311|157813603|FG001|Overall Study|Patient too sick|2|||
48994250|NCT05147311|157813602|FG000|Overall Study|Death|0|||
48994251|NCT05147311|157813603|FG001|Overall Study|Death|1|||
48994252|NCT05147311|157813602|FG000|Overall Study|Declined survey|1|||
48994253|NCT05147311|157813603|FG001|Overall Study|Declined survey|0|||
48994254|NCT00499694|157813606|FG000|Overall Study|Patient never received treatment.|1|||
48994255|NCT02304484|157813610|FG000|Overall Study|Death|9|||
48994256|NCT02304484|157813610|FG000|Overall Study|Withdrawal by Subject|14|||
48994257|NCT02304484|157813610|FG000|Overall Study|Lost to Follow-up|2|||
48994258|NCT04338685|157813611|FG000|Overall Study|Death|3|||
48994259|NCT04338685|157813612|FG001|Overall Study|Death|4|||
48994260|NCT04338685|157813613|FG002|Overall Study|Death|2|||
48994261|NCT04338685|157813614|FG003|Overall Study|Death|4|||
48994262|NCT04338685|157813615|FG004|Overall Study|Death|4|||
48994263|NCT04338685|157813616|FG005|Overall Study|Death|8|||
48994264|NCT04338685|157813617|FG006|Overall Study|Death|1|||
48994265|NCT04338685|157813618|FG007|Overall Study|Death|0|||
48994266|NCT04338685|157813619|FG008|Overall Study|Death|0|||
48994267|NCT04338685|157813611|FG000|Overall Study|Study terminated by Sponsor|0|||
48994268|NCT04338685|157813612|FG001|Overall Study|Study terminated by Sponsor|0|||
48994269|NCT04338685|157813613|FG002|Overall Study|Study terminated by Sponsor|1|||
48994270|NCT04338685|157813614|FG003|Overall Study|Study terminated by Sponsor|4|||
48994271|NCT04338685|157813615|FG004|Overall Study|Study terminated by Sponsor|0|||
48994272|NCT04338685|157813616|FG005|Overall Study|Study terminated by Sponsor|5|||
48994273|NCT04338685|157813617|FG006|Overall Study|Study terminated by Sponsor|2|||
48994274|NCT04338685|157813618|FG007|Overall Study|Study terminated by Sponsor|4|||
48994275|NCT04338685|157813619|FG008|Overall Study|Study terminated by Sponsor|1|||
48994276|NCT04338685|157813611|FG000|Overall Study|Withdrawal by Subject|1|||
48994277|NCT04338685|157813612|FG001|Overall Study|Withdrawal by Subject|2|||
48994278|NCT04338685|157813613|FG002|Overall Study|Withdrawal by Subject|0|||
48994279|NCT04338685|157813614|FG003|Overall Study|Withdrawal by Subject|2|||
48994280|NCT04338685|157813615|FG004|Overall Study|Withdrawal by Subject|0|||
48994281|NCT04338685|157813616|FG005|Overall Study|Withdrawal by Subject|5|||
48994282|NCT04338685|157813617|FG006|Overall Study|Withdrawal by Subject|1|||
48994283|NCT04338685|157813618|FG007|Overall Study|Withdrawal by Subject|1|||
48994284|NCT04338685|157813619|FG008|Overall Study|Withdrawal by Subject|0|||
48994285|NCT00234533|157813620|FG000|Overall Study|Withdrawal by Subject|6|||
48994286|NCT00234533|157813620|FG000|Overall Study|Adverse Event|2|||
48994287|NCT00234533|157813620|FG000|Overall Study|Enrolled but not treated|3|||
48994288|NCT00596466|157813621|FG000|Overall Study|Lack of Efficacy|5|||
48994289|NCT00596466|157813621|FG000|Overall Study|Adverse Event|4|||
48994290|NCT00596466|157813621|FG000|Overall Study|Withdrawal by Subject|2|||
48994291|NCT00596466|157813621|FG000|Overall Study|Protocol Violation|2|||
48994292|NCT00596466|157813621|FG000|Overall Study|Unpecified|2|||
48994293|NCT00596466|157813621|FG000|Overall Study|Enrolled, not treated|2|||
48994294|NCT02967055|157813622|FG000|Overall Study|Excluded|40|||
48994295|NCT02967055|157813622|FG000|Overall Study|Screen fail|3|||
48994296|NCT02967055|157813622|FG000|Overall Study|Lost to Follow-up|2|||
48994297|NCT02967055|157813622|FG000|Overall Study|Stopped due to side effects|3|||
48994298|NCT02967055|157813622|FG000|Overall Study|Stopped due to drug cost|1|||
48994299|NCT00145795|157813623|FG000|Overall Study|Adverse Event|1|||
48994300|NCT00145795|157813624|FG001|Overall Study|Adverse Event|0|||
48994301|NCT00570492|157813625|FG000|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98|||
48994302|NCT00570492|157813626|FG001|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
48994303|NCT00570492|157813627|FG002|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
48994304|NCT00570492|157813625|FG000|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263|||
48994305|NCT00570492|157813626|FG001|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
48994306|NCT00570492|157813627|FG002|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
48994307|NCT00570492|157813625|FG000|16-week Single-blind Baseline Period|Withdrawal by Subject|56|||
48994308|NCT00570492|157813626|FG001|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
48994309|NCT00570492|157813627|FG002|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
48994310|NCT00570492|157813625|FG000|16-week Single-blind Baseline Period|Protocol Violation|15|||
48994311|NCT00570492|157813626|FG001|16-week Single-blind Baseline Period|Protocol Violation|0|||
48994312|NCT00570492|157813627|FG002|16-week Single-blind Baseline Period|Protocol Violation|0|||
48994313|NCT00570492|157813625|FG000|16-week Single-blind Baseline Period|Lost to Follow-up|2|||
48994314|NCT00570492|157813626|FG001|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
48994315|NCT00570492|157813627|FG002|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
48994316|NCT00570492|157813625|FG000|16-week Single-blind Baseline Period|Adverse Event|1|||
48994317|NCT00570492|157813626|FG001|16-week Single-blind Baseline Period|Adverse Event|0|||
48994318|NCT00570492|157813627|FG002|16-week Single-blind Baseline Period|Adverse Event|0|||
48994319|NCT00570492|157813625|FG000|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1|||
48994320|NCT00570492|157813626|FG001|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
48994321|NCT00570492|157813627|FG002|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
48994322|NCT00570492|157813625|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
48994323|NCT00570492|157813626|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
48994324|NCT00570492|157813627|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
48994325|NCT00570492|157813625|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
48994326|NCT00570492|157813626|FG001|52-week Double-blind Treatment Period|Protocol Violation|12|||
48994327|NCT00570492|157813627|FG002|52-week Double-blind Treatment Period|Protocol Violation|15|||
48994328|NCT00570492|157813625|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
48994329|NCT00570492|157813626|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|5|||
48994330|NCT00570492|157813627|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|7|||
48994331|NCT00570492|157813625|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
48994332|NCT00570492|157813626|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
48994333|NCT00570492|157813627|FG002|52-week Double-blind Treatment Period|Adverse Event|5|||
48994334|NCT00570492|157813625|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
48994335|NCT00570492|157813626|FG001|52-week Double-blind Treatment Period|Physician Decision|2|||
48994336|NCT00570492|157813627|FG002|52-week Double-blind Treatment Period|Physician Decision|4|||
48994337|NCT00570492|157813625|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
48994338|NCT00570492|157813626|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|3|||
48994339|NCT00570492|157813627|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
48994340|NCT00570492|157813625|FG000|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
48994341|NCT00570492|157813626|FG001|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3|||
48994342|NCT00570492|157813627|FG002|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
48994343|NCT00976989|157813628|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
48994344|NCT00976989|157813629|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
48994345|NCT00976989|157813630|FG002|Overall Study|Violation of Selection Criteria at Entry|1|||
49045821|NCT00199901|158002020|FG000|Overall Study|Withdrawal by Subject|1|||
49045822|NCT00199901|158002021|FG001|Overall Study|Withdrawal by Subject|0|||
48994346|NCT00976989|157813628|FG000|Overall Study|Death|5|||
48994347|NCT00976989|157813629|FG001|Overall Study|Death|7|||
48994348|NCT00976989|157813630|FG002|Overall Study|Death|10|||
48994349|NCT00976989|157813628|FG000|Overall Study|Refused Treatment|4|||
48994350|NCT00976989|157813629|FG001|Overall Study|Refused Treatment|3|||
48994351|NCT00976989|157813630|FG002|Overall Study|Refused Treatment|5|||
48994352|NCT00976989|157813628|FG000|Overall Study|Failure to Return|2|||
48994353|NCT00976989|157813629|FG001|Overall Study|Failure to Return|1|||
48994354|NCT00976989|157813630|FG002|Overall Study|Failure to Return|0|||
48994355|NCT00976989|157813628|FG000|Overall Study|Recurrence of Disease|0|||
48994356|NCT00976989|157813629|FG001|Overall Study|Recurrence of Disease|1|||
48994357|NCT00976989|157813630|FG002|Overall Study|Recurrence of Disease|0|||
48994358|NCT00976989|157813628|FG000|Overall Study|Other|1|||
48994359|NCT00976989|157813629|FG001|Overall Study|Other|0|||
48994360|NCT00976989|157813630|FG002|Overall Study|Other|1|||
48994361|NCT05146999|157813632|FG000|Overall Study|Withdrew consent|6|||
48994362|NCT05146999|157813633|FG001|Overall Study|Withdrew consent|1|||
48994363|NCT05146999|157813632|FG000|Overall Study|Lost to Follow-up|3|||
48994364|NCT05146999|157813633|FG001|Overall Study|Lost to Follow-up|2|||
48994365|NCT05146999|157813632|FG000|Overall Study|Other|1|||
48994366|NCT05146999|157813633|FG001|Overall Study|Other|3|||
48994367|NCT05643573|157813634|FG000|Overall Study|Adverse Event|117|||
48994368|NCT05643573|157813635|FG001|Overall Study|Adverse Event|90|||
48994369|NCT05643573|157813634|FG000|Overall Study|Death|53|||
48994370|NCT05643573|157813635|FG001|Overall Study|Death|57|||
48994371|NCT05643573|157813634|FG000|Overall Study|Lost to Follow-up|6|||
48994372|NCT05643573|157813635|FG001|Overall Study|Lost to Follow-up|3|||
48994373|NCT05643573|157813634|FG000|Overall Study|Other|18|||
48994374|NCT05643573|157813635|FG001|Overall Study|Other|15|||
48994375|NCT05643573|157813634|FG000|Overall Study|Outcome event|64|||
48994376|NCT05643573|157813635|FG001|Overall Study|Outcome event|36|||
48994377|NCT05643573|157813634|FG000|Overall Study|Physician Decision|33|||
48994378|NCT05643573|157813635|FG001|Overall Study|Physician Decision|19|||
48994379|NCT05643573|157813634|FG000|Overall Study|Protocol-specified withdrawal criterion met|2|||
48994380|NCT05643573|157813635|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
48994381|NCT05643573|157813634|FG000|Overall Study|Site terminated by sponsor|10|||
48994382|NCT05643573|157813635|FG001|Overall Study|Site terminated by sponsor|10|||
48994383|NCT05643573|157813634|FG000|Overall Study|Study terminated by sponsor|1|||
48994384|NCT05643573|157813635|FG001|Overall Study|Study terminated by sponsor|0|||
48994385|NCT05643573|157813634|FG000|Overall Study|Withdrawal by Subject|178|||
48994386|NCT05643573|157813635|FG001|Overall Study|Withdrawal by Subject|130|||
48994387|NCT02184988|157813638|FG000|Overall Study|Pregnancy|2|||
48994388|NCT02184988|157813638|FG000|Overall Study|Adverse Event|2|||
48994389|NCT02184988|157813638|FG000|Overall Study|moving away/travelling/unable to complet|6|||
48994390|NCT02184988|157813638|FG000|Overall Study|work scheduling issues|4|||
48994391|NCT02184988|157813638|FG000|Overall Study|various other reasons|9|||
48994392|NCT02184988|157813638|FG000|Overall Study|Lost to Follow-up|32|||
48994393|NCT00483717|157813640|FG000|Overall Study|Protocol Violation|5|||
48994394|NCT00483717|157813641|FG001|Overall Study|Protocol Violation|7|||
48994395|NCT00483717|157813640|FG000|Overall Study|Time of dosing missing|1|||
48994396|NCT00483717|157813641|FG001|Overall Study|Time of dosing missing|1|||
48994397|NCT00483717|157813640|FG000|Overall Study|No treatment for migraine|16|||
48994398|NCT00483717|157813641|FG001|Overall Study|No treatment for migraine|13|||
48994399|NCT00483717|157813640|FG000|Overall Study|Lost to Follow-up|1|||
48994400|NCT00483717|157813641|FG001|Overall Study|Lost to Follow-up|0|||
48994401|NCT00483717|157813640|FG000|Overall Study|Withdrawal by Subject|1|||
48994402|NCT00483717|157813641|FG001|Overall Study|Withdrawal by Subject|0|||
48994403|NCT03878108|157813642|FG000|Overall Study|Adverse Event|1|||
48994404|NCT03878108|157813643|FG001|Overall Study|Adverse Event|0|||
48994405|NCT00975000|157813647|FG000|Overall Study|Other|1|||
48994406|NCT00975000|157813648|FG001|Overall Study|Other|0|||
48994407|NCT00975000|157813647|FG000|Overall Study|Adverse Event|1|||
48994408|NCT00975000|157813648|FG001|Overall Study|Adverse Event|1|||
48994409|NCT00975000|157813647|FG000|Overall Study|Withdrawal by Subject|2|||
48994410|NCT00975000|157813648|FG001|Overall Study|Withdrawal by Subject|2|||
48994411|NCT00975000|157813647|FG000|Overall Study|Lost to Follow-up|0|||
48994412|NCT00975000|157813648|FG001|Overall Study|Lost to Follow-up|1|||
48994413|NCT00975000|157813647|FG000|Overall Study|Protocol-specified Criteria|1|||
48994414|NCT00975000|157813648|FG001|Overall Study|Protocol-specified Criteria|0|||
48994415|NCT00975000|157813647|FG000|Overall Study|Non-compliance|0|||
48994416|NCT00975000|157813648|FG001|Overall Study|Non-compliance|1|||
48994417|NCT01869959|157813649|FG000|Randomization Period|Physician Decision|0|||
48994418|NCT01869959|157813650|FG001|Randomization Period|Physician Decision|0|||
48994419|NCT01869959|157813651|FG002|Randomization Period|Physician Decision|0|||
48994420|NCT01869959|157813652|FG003|Randomization Period|Physician Decision|0|||
48994421|NCT01869959|157813653|FG004|Randomization Period|Physician Decision|1|||
48994422|NCT01869959|157813649|FG000|Treatment Period|Adverse Event|1|||
48994423|NCT01869959|157813650|FG001|Treatment Period|Adverse Event|0|||
48994424|NCT01869959|157813651|FG002|Treatment Period|Adverse Event|3|||
48994425|NCT01869959|157813652|FG003|Treatment Period|Adverse Event|1|||
48994426|NCT01869959|157813653|FG004|Treatment Period|Adverse Event|0|||
48994427|NCT01869959|157813649|FG000|Treatment Period|Sponsor decision|0|||
48994428|NCT01869959|157813650|FG001|Treatment Period|Sponsor decision|1|||
48994429|NCT01869959|157813651|FG002|Treatment Period|Sponsor decision|0|||
48994430|NCT01869959|157813652|FG003|Treatment Period|Sponsor decision|1|||
48994431|NCT01869959|157813653|FG004|Treatment Period|Sponsor decision|0|||
48994432|NCT01869959|157813649|FG000|Treatment Period|Withdrawal by Subject|0|||
48994433|NCT01869959|157813650|FG001|Treatment Period|Withdrawal by Subject|1|||
48994434|NCT01869959|157813651|FG002|Treatment Period|Withdrawal by Subject|0|||
48994435|NCT01869959|157813652|FG003|Treatment Period|Withdrawal by Subject|0|||
48994436|NCT01869959|157813653|FG004|Treatment Period|Withdrawal by Subject|0|||
48994437|NCT00828009|157813654|FG000|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10|||
48994438|NCT00828009|157813654|FG000|Step 1 - Chemo RT/Consolidation Chemo|Death|2|||
48994439|NCT00828009|157813654|FG000|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3|||
48994440|NCT00828009|157813654|FG000|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11|||
48994441|NCT00828009|157813654|FG000|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1|||
48994442|NCT00828009|157813654|FG000|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2|||
48994443|NCT00828009|157813654|FG000|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2|||
48994444|NCT00828009|157813654|FG000|Step 2 - Maintenance Therapy|Progressive disease|12|||
48994445|NCT00828009|157813654|FG000|Step 2 - Maintenance Therapy|Adverse Event|13|||
48994446|NCT00828009|157813654|FG000|Step 2 - Maintenance Therapy|Death|1|||
48994447|NCT00828009|157813654|FG000|Step 2 - Maintenance Therapy|Withdrawal by Subject|4|||
48994448|NCT00828009|157813654|FG000|Step 2 - Maintenance Therapy|Complicating disease|2|||
48994449|NCT00828009|157813654|FG000|Step 2 - Maintenance Therapy|Other|1|||
48994450|NCT01714726|157814942|FG000|Double-Blinded Induction Period|Subject not in open label period|3|||
48994451|NCT01714726|157814943|FG001|Double-Blinded Induction Period|Subject not in open label period|1|||
48994452|NCT01714726|157814944|FG002|Double-Blinded Induction Period|Subject not in open label period|0|||
48994453|NCT01714726|157814945|FG003|Double-Blinded Induction Period|Subject not in open label period|0|||
48994454|NCT01714726|157814942|FG000|Double-Blinded Induction Period|Adverse Event|0|||
48994455|NCT01714726|157814943|FG001|Double-Blinded Induction Period|Adverse Event|1|||
48994456|NCT01714726|157814944|FG002|Double-Blinded Induction Period|Adverse Event|0|||
48994457|NCT01714726|157814945|FG003|Double-Blinded Induction Period|Adverse Event|0|||
48994458|NCT01714726|157814942|FG000|Double-Blinded Induction Period|Withdrawal by Subject|5|||
48994459|NCT01714726|157814943|FG001|Double-Blinded Induction Period|Withdrawal by Subject|3|||
48994460|NCT01714726|157814944|FG002|Double-Blinded Induction Period|Withdrawal by Subject|0|||
48994461|NCT01714726|157814945|FG003|Double-Blinded Induction Period|Withdrawal by Subject|0|||
48994462|NCT01714726|157814942|FG000|Double-Blinded Induction Period|Lost to Follow-up|0|||
48994463|NCT01714726|157814943|FG001|Double-Blinded Induction Period|Lost to Follow-up|2|||
48994464|NCT01714726|157814944|FG002|Double-Blinded Induction Period|Lost to Follow-up|0|||
48994465|NCT01714726|157814945|FG003|Double-Blinded Induction Period|Lost to Follow-up|0|||
48994466|NCT01714726|157814942|FG000|Open-Label Period|Other|0|||
48994467|NCT01714726|157814943|FG001|Open-Label Period|Other|0|||
48994468|NCT01714726|157814944|FG002|Open-Label Period|Other|1|||
48994469|NCT01714726|157814945|FG003|Open-Label Period|Other|3|||
48994470|NCT01714726|157814942|FG000|Open-Label Period|Adverse Event|0|||
48994471|NCT01714726|157814943|FG001|Open-Label Period|Adverse Event|0|||
48994472|NCT01714726|157814944|FG002|Open-Label Period|Adverse Event|1|||
48994473|NCT01714726|157814945|FG003|Open-Label Period|Adverse Event|0|||
48994474|NCT01714726|157814942|FG000|Open-Label Period|Withdrawal by Subject|0|||
48994475|NCT01714726|157814943|FG001|Open-Label Period|Withdrawal by Subject|0|||
48994476|NCT01714726|157814944|FG002|Open-Label Period|Withdrawal by Subject|9|||
48994477|NCT01714726|157814945|FG003|Open-Label Period|Withdrawal by Subject|19|||
48994478|NCT01714726|157814942|FG000|Open-Label Period|Developed specific withdrawal criteria|0|||
48994479|NCT01714726|157814943|FG001|Open-Label Period|Developed specific withdrawal criteria|0|||
48994480|NCT01714726|157814944|FG002|Open-Label Period|Developed specific withdrawal criteria|5|||
48994481|NCT01714726|157814945|FG003|Open-Label Period|Developed specific withdrawal criteria|2|||
48994482|NCT01714726|157814942|FG000|Open-Label Period|Lost to Follow-up|0|||
48994483|NCT01714726|157814943|FG001|Open-Label Period|Lost to Follow-up|0|||
48994484|NCT01714726|157814944|FG002|Open-Label Period|Lost to Follow-up|3|||
48994485|NCT01714726|157814945|FG003|Open-Label Period|Lost to Follow-up|4|||
48994486|NCT00548340|157814948|FG000|Overall Study|Protocol Violation|2|||
48994487|NCT00548340|157814949|FG001|Overall Study|Protocol Violation|3|||
48994488|NCT00548340|157814950|FG002|Overall Study|Protocol Violation|3|||
48994489|NCT00548340|157814948|FG000|Overall Study|Adverse Event|2|||
48994490|NCT00548340|157814949|FG001|Overall Study|Adverse Event|2|||
48994491|NCT00548340|157814950|FG002|Overall Study|Adverse Event|2|||
48994492|NCT00548340|157814948|FG000|Overall Study|Lost to Follow-up|1|||
48994493|NCT00548340|157814949|FG001|Overall Study|Lost to Follow-up|1|||
48994494|NCT00548340|157814950|FG002|Overall Study|Lost to Follow-up|0|||
48994495|NCT00548340|157814948|FG000|Overall Study|Withdrawal by Subject|2|||
48994496|NCT00548340|157814949|FG001|Overall Study|Withdrawal by Subject|4|||
48994497|NCT00548340|157814950|FG002|Overall Study|Withdrawal by Subject|3|||
49045823|NCT00199901|158002020|FG000|Overall Study|Progressive Disease|24|||
48994498|NCT00548340|157814948|FG000|Overall Study|Other|1|||
48994499|NCT00548340|157814949|FG001|Overall Study|Other|1|||
48994500|NCT00548340|157814950|FG002|Overall Study|Other|1|||
48994501|NCT02985541|157814951|FG000|Overall Study|Withdrawal by Subject|33|||
48994502|NCT02985541|157814951|FG000|Overall Study|Lost to Follow-up|26|||
48994503|NCT02985541|157814951|FG000|Overall Study|Adverse Event|27|||
48994504|NCT02985541|157814951|FG000|Overall Study|Physician Decision|2|||
48994505|NCT02985541|157814951|FG000|Overall Study|Pregnancy|2|||
48994506|NCT02985541|157814951|FG000|Overall Study|Wish for pregnancy|44|||
48994507|NCT02985541|157814951|FG000|Overall Study|Other reason|5|||
48994508|NCT02985541|157814951|FG000|Overall Study|Not valid for analysis|2|||
48994509|NCT00812968|157814954|FG000|Overall Study|Relapse after erythroid response|6|||
48994510|NCT00812968|157814954|FG000|Overall Study|Disease progression|1|||
48994511|NCT00812968|157814954|FG000|Overall Study|No further treatment required|1|||
48994512|NCT00812968|157814954|FG000|Overall Study|Study closed due to marketing approval|3|||
48994513|NCT02696382|157814955|FG000|Overall Study|Death|7|||
48994514|NCT02696382|157814956|FG001|Overall Study|Death|2|||
48994515|NCT02696382|157814955|FG000|Overall Study|Withdrawal by Subject|5|||
48994516|NCT02696382|157814956|FG001|Overall Study|Withdrawal by Subject|12|||
48994517|NCT02696382|157814955|FG000|Overall Study|Lost to Follow-up|4|||
48994518|NCT02696382|157814956|FG001|Overall Study|Lost to Follow-up|7|||
48994519|NCT01980056|157814958|FG000|Overall Study|Death|1|||
48994520|NCT01980056|157814959|FG001|Overall Study|Death|1|||
48994521|NCT01980056|157814960|FG002|Overall Study|Death|0|||
48994522|NCT00351611|157814961|FG000|Overall Study|Adverse Event|11|||
48994523|NCT00351611|157814962|FG001|Overall Study|Adverse Event|3|||
48994524|NCT00351611|157814961|FG000|Overall Study|Death|1|||
48994525|NCT00351611|157814962|FG001|Overall Study|Death|0|||
48994526|NCT00351611|157814961|FG000|Overall Study|Lost to Follow-up|1|||
48994527|NCT00351611|157814962|FG001|Overall Study|Lost to Follow-up|0|||
48994528|NCT00351611|157814961|FG000|Overall Study|No Longer Willing to Participate in Study|0|||
48994529|NCT00351611|157814962|FG001|Overall Study|No Longer Willing to Participate in Study|5|||
48994530|NCT00351611|157814961|FG000|Overall Study|Other|1|||
48994531|NCT00351611|157814962|FG001|Overall Study|Other|0|||
48994532|NCT00351611|157814961|FG000|Overall Study|Protocol Violation|0|||
48994533|NCT00351611|157814962|FG001|Overall Study|Protocol Violation|2|||
48994534|NCT02708524|157814968|FG000|Overall Study|Adverse Event|0|||
48994535|NCT02708524|157814969|FG001|Overall Study|Adverse Event|1|||
48994536|NCT02708524|157814970|FG002|Overall Study|Adverse Event|0|||
48994537|NCT02708524|157814971|FG003|Overall Study|Adverse Event|0|||
48994538|NCT02708524|157814968|FG000|Overall Study|Lens Discomfort|1|||
48994539|NCT02708524|157814969|FG001|Overall Study|Lens Discomfort|0|||
48994540|NCT02708524|157814970|FG002|Overall Study|Lens Discomfort|1|||
48994541|NCT02708524|157814971|FG003|Overall Study|Lens Discomfort|0|||
48994542|NCT02708524|157814968|FG000|Overall Study|Lost to Follow-up|1|||
48994543|NCT02708524|157814969|FG001|Overall Study|Lost to Follow-up|1|||
48994544|NCT02708524|157814970|FG002|Overall Study|Lost to Follow-up|1|||
48994545|NCT02708524|157814971|FG003|Overall Study|Lost to Follow-up|0|||
48994546|NCT02708524|157814968|FG000|Overall Study|Protocol Violation|0|||
48994547|NCT02708524|157814969|FG001|Overall Study|Protocol Violation|1|||
48994548|NCT02708524|157814970|FG002|Overall Study|Protocol Violation|0|||
48994549|NCT02708524|157814971|FG003|Overall Study|Protocol Violation|0|||
48994550|NCT02708524|157814968|FG000|Overall Study|Withdrawal by Subject|1|||
48994551|NCT02708524|157814969|FG001|Overall Study|Withdrawal by Subject|1|||
48994552|NCT02708524|157814970|FG002|Overall Study|Withdrawal by Subject|0|||
48994553|NCT02708524|157814971|FG003|Overall Study|Withdrawal by Subject|0|||
48994554|NCT02708524|157814968|FG000|Overall Study|Dispensed incorrect study lens|0|||
48994555|NCT02708524|157814969|FG001|Overall Study|Dispensed incorrect study lens|1|||
48994556|NCT02708524|157814970|FG002|Overall Study|Dispensed incorrect study lens|1|||
48994557|NCT02708524|157814971|FG003|Overall Study|Dispensed incorrect study lens|0|||
48994558|NCT02708524|157814968|FG000|Overall Study|Did not wear lens at final visit|0|||
48994559|NCT02708524|157814969|FG001|Overall Study|Did not wear lens at final visit|1|||
48994560|NCT02708524|157814970|FG002|Overall Study|Did not wear lens at final visit|0|||
48994561|NCT02708524|157814971|FG003|Overall Study|Did not wear lens at final visit|0|||
49045824|NCT00199901|158002021|FG001|Overall Study|Progressive Disease|24|||
49045825|NCT01691430|158002022|FG000|Overall Study|Death|17|||
49045826|NCT01691430|158002023|FG001|Overall Study|Death|16|||
48994562|NCT02708524|157814968|FG000|Overall Study|Subject lost study lens|1|||
48994563|NCT02708524|157814969|FG001|Overall Study|Subject lost study lens|0|||
48994564|NCT02708524|157814970|FG002|Overall Study|Subject lost study lens|0|||
48994565|NCT02708524|157814971|FG003|Overall Study|Subject lost study lens|0|||
48994566|NCT00462501|157814977|FG000|Overall Study|Not treated|3|||
48994567|NCT00462501|157814977|FG000|Overall Study|Adverse Event|2|||
48994568|NCT03193996|157814980|FG000|Overall Study|Withdrawal by Subject|4|||
48994569|NCT03193996|157814980|FG000|Overall Study|Lost to Follow-up|4|||
48994570|NCT03193996|157814980|FG000|Overall Study|Physician Decision|2|||
48994571|NCT03193996|157814980|FG000|Overall Study|Pregnancy|1|||
48994572|NCT03193996|157814980|FG000|Overall Study|Subject did not proceed to reconstructive surgery.|1|||
48994573|NCT03193996|157814980|FG000|Overall Study|Complicating disease|1|||
48994574|NCT00494234|157814981|FG000|Overall Study|Withdrawal by Subject|1|||
48994575|NCT00494234|157814982|FG001|Overall Study|Withdrawal by Subject|0|||
48994576|NCT00494234|157814981|FG000|Overall Study|Disease progression|11|||
48994577|NCT00494234|157814982|FG001|Overall Study|Disease progression|8|||
48994578|NCT00494234|157814981|FG000|Overall Study|Death|2|||
48994579|NCT00494234|157814982|FG001|Overall Study|Death|1|||
48994580|NCT01729559|157814983|FG000|Overall Study|Protocol Violation|31|||
48994581|NCT01729559|157814984|FG001|Overall Study|Protocol Violation|28|||
48994582|NCT00423137|157814988|FG000|Overall Study|Lost to Follow-up|0|||
48994583|NCT00423137|157814989|FG001|Overall Study|Lost to Follow-up|0|||
48994584|NCT00423137|157814990|FG002|Overall Study|Lost to Follow-up|1|||
48994585|NCT00423137|157814991|FG003|Overall Study|Lost to Follow-up|0|||
48994586|NCT00423137|157814988|FG000|Overall Study|Protocol Violation|0|||
48994587|NCT00423137|157814989|FG001|Overall Study|Protocol Violation|0|||
48994588|NCT00423137|157814990|FG002|Overall Study|Protocol Violation|0|||
48994589|NCT00423137|157814991|FG003|Overall Study|Protocol Violation|1|||
48994590|NCT00423137|157814988|FG000|Overall Study|Adverse Event Study disease worse|1|||
48994591|NCT00423137|157814989|FG001|Overall Study|Adverse Event Study disease worse|0|||
48994592|NCT00423137|157814990|FG002|Overall Study|Adverse Event Study disease worse|3|||
48994593|NCT00423137|157814991|FG003|Overall Study|Adverse Event Study disease worse|1|||
48994594|NCT00423137|157814988|FG000|Overall Study|Adverse Event Other|0|||
48994595|NCT00423137|157814989|FG001|Overall Study|Adverse Event Other|0|||
48994596|NCT00423137|157814990|FG002|Overall Study|Adverse Event Other|2|||
48994597|NCT00423137|157814991|FG003|Overall Study|Adverse Event Other|0|||
48994598|NCT03246152|157814992|FG000|Overall Study|Lost to Follow-up|2|||
48994599|NCT03246152|157814992|FG000|Overall Study|Protocol Violation|1|||
48994600|NCT03292731|157814994|FG000|Overall Study|Protocol Violation|4|||
48994601|NCT03292731|157814995|FG001|Overall Study|Protocol Violation|11|||
48994602|NCT03292731|157814996|FG002|Overall Study|Protocol Violation|1|||
48994603|NCT01243762|157815006|FG000|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
48994604|NCT01243762|157815007|FG001|Part 1 (Dose Escalation/MTD)|Adverse Event|2|||
48994605|NCT01243762|157815008|FG002|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
48994606|NCT01243762|157815009|FG003|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
48994607|NCT01243762|157815010|FG004|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
48994608|NCT01243762|157815011|FG005|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
48994609|NCT01243762|157815012|FG006|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
48994610|NCT01243762|157815006|FG000|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
48994611|NCT01243762|157815007|FG001|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
48994612|NCT01243762|157815008|FG002|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
48994613|NCT01243762|157815009|FG003|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
48994614|NCT01243762|157815010|FG004|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
48994615|NCT01243762|157815011|FG005|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
48994616|NCT01243762|157815012|FG006|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
48994617|NCT01243762|157815006|FG000|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
48994618|NCT01243762|157815007|FG001|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
48994619|NCT01243762|157815008|FG002|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
48994620|NCT01243762|157815009|FG003|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
48994621|NCT01243762|157815010|FG004|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
48994622|NCT01243762|157815011|FG005|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
48994623|NCT01243762|157815012|FG006|Part 1 (Dose Escalation/MTD)|Progressive Disease|0|||
48994624|NCT01243762|157815006|FG000|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
48994625|NCT01243762|157815007|FG001|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3|||
48994626|NCT01243762|157815008|FG002|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
48994627|NCT01243762|157815009|FG003|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
48994628|NCT01243762|157815010|FG004|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
48994629|NCT01243762|157815011|FG005|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
48994630|NCT01243762|157815012|FG006|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
48994631|NCT01243762|157815006|FG000|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
49045827|NCT01691430|158002022|FG000|Overall Study|Withdrawal by Subject|5|||
48994632|NCT01243762|157815007|FG001|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1|||
48994633|NCT01243762|157815008|FG002|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
48994634|NCT01243762|157815009|FG003|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
48994635|NCT01243762|157815010|FG004|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
48994636|NCT01243762|157815011|FG005|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
48994637|NCT01243762|157815012|FG006|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3|||
48994638|NCT01243762|157815006|FG000|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
48994639|NCT01243762|157815007|FG001|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
48994640|NCT01243762|157815008|FG002|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
48994641|NCT01243762|157815009|FG003|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
48994642|NCT01243762|157815010|FG004|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2|||
48994643|NCT01243762|157815011|FG005|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
48994644|NCT01243762|157815012|FG006|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
49045828|NCT01691430|158002023|FG001|Overall Study|Withdrawal by Subject|1|||
48994645|NCT01243762|157815006|FG000|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
48994646|NCT01243762|157815007|FG001|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
48994647|NCT01243762|157815008|FG002|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
48994648|NCT01243762|157815009|FG003|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
48994649|NCT01243762|157815010|FG004|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
48994650|NCT01243762|157815011|FG005|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
48994651|NCT01243762|157815012|FG006|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
48994652|NCT01243762|157815006|FG000|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
48994653|NCT01243762|157815007|FG001|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
48994654|NCT01243762|157815008|FG002|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
48994655|NCT01243762|157815009|FG003|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
48994656|NCT01243762|157815010|FG004|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
48994657|NCT01243762|157815011|FG005|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
48994658|NCT01243762|157815012|FG006|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
48994659|NCT00475657|157815013|FG000|Overall Study|Death|1|||
48994660|NCT00475657|157815013|FG000|Overall Study|Sponsor's Decision|3|||
48994661|NCT03710824|157815014|FG000|Overall Study|Withdrawal by Subject|1|||
48994662|NCT03710824|157815014|FG000|Overall Study|Lost to Follow-up|3|||
48994663|NCT03710824|157815014|FG000|Overall Study|Adverse Event|25|||
48994664|NCT03710824|157815014|FG000|Overall Study|Treatment discontinuation|2|||
48994665|NCT04359758|157815015|FG000|Overall Study|Protocol Violation|3|||
48994666|NCT04359758|157815016|FG001|Overall Study|Protocol Violation|2|||
48994667|NCT00761735|157815017|FG000|Overall Study|Lost to Follow-up|6|||
48994668|NCT00761735|157815017|FG000|Overall Study|Withdrawal by Subject|6|||
48994669|NCT00761735|157815017|FG000|Overall Study|Non-compliance with protocol|1|||
48994670|NCT00761735|157815017|FG000|Overall Study|Administrative|1|||
48994671|NCT01605370|157815018|FG000|Overall Study|Adverse Event|1|||
48994672|NCT01605370|157815019|FG001|Overall Study|Adverse Event|0|||
48994673|NCT03556202|157815020|FG000|Extension Treatment Period|Adverse Event|18|||
48994674|NCT03556202|157815021|FG001|Extension Treatment Period|Adverse Event|14|||
48994675|NCT03556202|157815022|FG002|Extension Treatment Period|Adverse Event|9|||
48994676|NCT03556202|157815020|FG000|Extension Treatment Period|Death|2|||
48994677|NCT03556202|157815021|FG001|Extension Treatment Period|Death|6|||
48994678|NCT03556202|157815022|FG002|Extension Treatment Period|Death|0|||
48994679|NCT03556202|157815020|FG000|Extension Treatment Period|Lack of Efficacy|5|||
48994680|NCT03556202|157815021|FG001|Extension Treatment Period|Lack of Efficacy|12|||
48994681|NCT03556202|157815022|FG002|Extension Treatment Period|Lack of Efficacy|18|||
48994682|NCT03556202|157815020|FG000|Extension Treatment Period|Lost to Follow-up|9|||
48994683|NCT03556202|157815021|FG001|Extension Treatment Period|Lost to Follow-up|20|||
48994684|NCT03556202|157815022|FG002|Extension Treatment Period|Lost to Follow-up|2|||
48994685|NCT03556202|157815020|FG000|Extension Treatment Period|Pregnancy|2|||
48994686|NCT03556202|157815021|FG001|Extension Treatment Period|Pregnancy|4|||
48994687|NCT03556202|157815022|FG002|Extension Treatment Period|Pregnancy|3|||
48994688|NCT03556202|157815020|FG000|Extension Treatment Period|Study Terminated by Sponsor|469|||
48994689|NCT03556202|157815021|FG001|Extension Treatment Period|Study Terminated by Sponsor|907|||
48994690|NCT03556202|157815022|FG002|Extension Treatment Period|Study Terminated by Sponsor|331|||
48994691|NCT03556202|157815020|FG000|Extension Treatment Period|Withdrawal by Subject|22|||
48994692|NCT03556202|157815021|FG001|Extension Treatment Period|Withdrawal by Subject|47|||
48994693|NCT03556202|157815022|FG002|Extension Treatment Period|Withdrawal by Subject|22|||
48994694|NCT03556202|157815020|FG000|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
48994695|NCT03556202|157815021|FG001|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
48994696|NCT03556202|157815022|FG002|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|1|||
48994697|NCT03556202|157815020|FG000|Extension Treatment Period|Physician Decision|0|||
48994698|NCT03556202|157815021|FG001|Extension Treatment Period|Physician Decision|8|||
48994699|NCT03556202|157815022|FG002|Extension Treatment Period|Physician Decision|2|||
48994700|NCT03556202|157815020|FG000|Extension Treatment Period|Protocol Violation|0|||
48994701|NCT03556202|157815021|FG001|Extension Treatment Period|Protocol Violation|1|||
48994702|NCT03556202|157815022|FG002|Extension Treatment Period|Protocol Violation|1|||
48994703|NCT03556202|157815020|FG000|Extension Treatment Period|Sponsor Decision|0|||
48994704|NCT03556202|157815021|FG001|Extension Treatment Period|Sponsor Decision|1|||
48994705|NCT03556202|157815022|FG002|Extension Treatment Period|Sponsor Decision|0|||
48994706|NCT03556202|157815020|FG000|Follow-Up Period (12 Weeks)|Adverse Event|11|||
48994707|NCT03556202|157815021|FG001|Follow-Up Period (12 Weeks)|Adverse Event|11|||
48994708|NCT03556202|157815022|FG002|Follow-Up Period (12 Weeks)|Adverse Event|8|||
48994709|NCT03556202|157815020|FG000|Follow-Up Period (12 Weeks)|Death|1|||
48994710|NCT03556202|157815021|FG001|Follow-Up Period (12 Weeks)|Death|0|||
48994711|NCT03556202|157815022|FG002|Follow-Up Period (12 Weeks)|Death|0|||
48994712|NCT03556202|157815020|FG000|Follow-Up Period (12 Weeks)|Lack of Efficacy|4|||
48994713|NCT03556202|157815021|FG001|Follow-Up Period (12 Weeks)|Lack of Efficacy|9|||
48994714|NCT03556202|157815022|FG002|Follow-Up Period (12 Weeks)|Lack of Efficacy|13|||
48994715|NCT03556202|157815020|FG000|Follow-Up Period (12 Weeks)|Lost to Follow-up|4|||
48994716|NCT03556202|157815021|FG001|Follow-Up Period (12 Weeks)|Lost to Follow-up|14|||
48994717|NCT03556202|157815022|FG002|Follow-Up Period (12 Weeks)|Lost to Follow-up|3|||
48994718|NCT03556202|157815020|FG000|Follow-Up Period (12 Weeks)|Pregnancy|1|||
48994719|NCT03556202|157815021|FG001|Follow-Up Period (12 Weeks)|Pregnancy|4|||
48994720|NCT03556202|157815022|FG002|Follow-Up Period (12 Weeks)|Pregnancy|1|||
48994721|NCT03556202|157815020|FG000|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|396|||
48994722|NCT03556202|157815021|FG001|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|750|||
48994723|NCT03556202|157815022|FG002|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|273|||
48994724|NCT03556202|157815020|FG000|Follow-Up Period (12 Weeks)|Withdrawal by Subject|36|||
48994725|NCT03556202|157815021|FG001|Follow-Up Period (12 Weeks)|Withdrawal by Subject|65|||
48994726|NCT03556202|157815022|FG002|Follow-Up Period (12 Weeks)|Withdrawal by Subject|31|||
48994727|NCT03556202|157815020|FG000|Follow-Up Period (12 Weeks)|Physician Decision|0|||
48994728|NCT03556202|157815021|FG001|Follow-Up Period (12 Weeks)|Physician Decision|3|||
48994729|NCT03556202|157815022|FG002|Follow-Up Period (12 Weeks)|Physician Decision|1|||
48994730|NCT03556202|157815020|FG000|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
48994731|NCT03556202|157815021|FG001|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|1|||
48994732|NCT03556202|157815022|FG002|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
48994733|NCT03556202|157815020|FG000|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|0|||
48994734|NCT03556202|157815021|FG001|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|2|||
48994735|NCT03556202|157815022|FG002|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|1|||
48994736|NCT03556202|157815020|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
48994737|NCT03556202|157815021|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|1|||
48994738|NCT03556202|157815022|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
48994739|NCT03556202|157815020|FG000|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
48994740|NCT03556202|157815021|FG001|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|1|||
48994741|NCT03556202|157815022|FG002|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
48994742|NCT03556202|157815020|FG000|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
48994743|NCT03556202|157815021|FG001|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
48994744|NCT03556202|157815022|FG002|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|1|||
48994745|NCT03556202|157815020|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
48994746|NCT03556202|157815021|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
48994747|NCT03556202|157815022|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|1|||
48994748|NCT00908375|157815023|FG000|Overall Study|Withdrawal by Subject|2|||
48994749|NCT00908375|157815024|FG001|Overall Study|Withdrawal by Subject|4|||
48994750|NCT00908375|157815023|FG000|Overall Study|Lost to Follow-up|8|||
48994751|NCT00908375|157815024|FG001|Overall Study|Lost to Follow-up|6|||
48994752|NCT02734290|157815025|FG000|Overall Study|Adverse Event|1|||
48994753|NCT02734290|157815026|FG001|Overall Study|Adverse Event|0|||
48994754|NCT02734290|157815025|FG000|Overall Study|Death|1|||
48994755|NCT02734290|157815026|FG001|Overall Study|Death|0|||
48994756|NCT01333501|157815037|FG000|Overall Study|Adverse Event|3|||
48994757|NCT01333501|157815038|FG001|Overall Study|Adverse Event|1|||
48994758|NCT01333501|157815037|FG000|Overall Study|Abnormal laboratory value|2|||
48994759|NCT01333501|157815038|FG001|Overall Study|Abnormal laboratory value|1|||
48994760|NCT01333501|157815037|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
48994761|NCT01333501|157815038|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
48994762|NCT01333501|157815037|FG000|Overall Study|Withdrawn consent|3|||
48994763|NCT01333501|157815038|FG001|Overall Study|Withdrawn consent|12|||
48994764|NCT01303159|157815039|FG000|Overall Study|Death|16|||
48994765|NCT01303159|157815039|FG000|Overall Study|Study Termination|7|||
48994766|NCT03329404|157815040|FG000|Overall Study|The study was suspended.|1|||
48994767|NCT03329404|157815041|FG001|Overall Study|The study was suspended.|4|||
48994768|NCT04768881|157815045|FG000|Overall Study|Completed Study Follow-up|0|||
48994769|NCT04768881|157815046|FG001|Overall Study|Completed Study Follow-up|2|||
48994770|NCT04768881|157815045|FG000|Overall Study|Death|3|||
48994771|NCT04768881|157815046|FG001|Overall Study|Death|2|||
48994772|NCT04768881|157815045|FG000|Overall Study|Study Terminated by Sponsor|2|||
48994773|NCT04768881|157815046|FG001|Overall Study|Study Terminated by Sponsor|2|||
48994774|NCT04768881|157815045|FG000|Overall Study|Withdrawal by Subject|2|||
48994775|NCT04768881|157815046|FG001|Overall Study|Withdrawal by Subject|0|||
48994776|NCT04768881|157815045|FG000|Overall Study|Other|2|||
48994777|NCT04768881|157815046|FG001|Overall Study|Other|0|||
48994778|NCT02370173|157815047|FG000|Overall Study|Protocol Violation|1|||
48994779|NCT02370173|157815048|FG001|Overall Study|Protocol Violation|1|||
48994780|NCT02370173|157815047|FG000|Overall Study|Withdrawal by Subject|2|||
48994781|NCT02370173|157815048|FG001|Overall Study|Withdrawal by Subject|2|||
48994782|NCT02543918|157815049|FG000|Overall Study|Never treated|0|||
48994783|NCT02543918|157815050|FG001|Overall Study|Never treated|1|||
48994784|NCT02543918|157815049|FG000|Overall Study|Lost to Follow-up|1|||
48994785|NCT02543918|157815050|FG001|Overall Study|Lost to Follow-up|1|||
48994786|NCT02543918|157815049|FG000|Overall Study|Withdrawal by Subject|1|||
48994787|NCT02543918|157815050|FG001|Overall Study|Withdrawal by Subject|1|||
48994788|NCT02543918|157815049|FG000|Overall Study|Adverse Event|1|||
48994789|NCT02543918|157815050|FG001|Overall Study|Adverse Event|1|||
48994790|NCT03743571|157815051|FG000|Overall Study|Withdrawal by Subject|1|||
48994791|NCT03743571|157815052|FG001|Overall Study|Withdrawal by Subject|1|||
48994792|NCT03743571|157815051|FG000|Overall Study|Lost to Follow-up|1|||
48994793|NCT03743571|157815052|FG001|Overall Study|Lost to Follow-up|2|||
48994794|NCT00752895|157815057|FG000|Overall Study|Withdrawal by Subject|8|||
48994795|NCT00752895|157815058|FG001|Overall Study|Withdrawal by Subject|3|||
48994796|NCT01119118|157815062|FG000|Overall Study|Adverse Event|1|||
48994797|NCT00690573|157815065|FG000|Overall Study|Lack of Efficacy|8|||
48994798|NCT00690573|157815065|FG000|Overall Study|Withdrawal by Subject|1|||
48994799|NCT00633217|157815066|FG000|Overall Study|Adverse Event|5|||
48994800|NCT00633217|157815067|FG001|Overall Study|Adverse Event|9|||
48994801|NCT00633217|157815066|FG000|Overall Study|Lack of Efficacy|0|||
48994802|NCT00633217|157815067|FG001|Overall Study|Lack of Efficacy|2|||
48994803|NCT00633217|157815066|FG000|Overall Study|Protocol Violation|3|||
48994804|NCT00633217|157815067|FG001|Overall Study|Protocol Violation|7|||
48994805|NCT00633217|157815066|FG000|Overall Study|Lost to Follow-up|2|||
48994806|NCT00633217|157815067|FG001|Overall Study|Lost to Follow-up|2|||
48994807|NCT00633217|157815066|FG000|Overall Study|Investigator Discretion|2|||
48994808|NCT00633217|157815067|FG001|Overall Study|Investigator Discretion|0|||
48994809|NCT00633217|157815066|FG000|Overall Study|Withdrew Consent|3|||
48994810|NCT00633217|157815067|FG001|Overall Study|Withdrew Consent|3|||
48994811|NCT00314262|157815068|FG000|Overall Study|Adverse Event|2|||
48994812|NCT00314262|157815068|FG000|Overall Study|Withdrawal by Subject|2|||
48994813|NCT00314262|157815068|FG000|Overall Study|Physician Decision|1|||
48994814|NCT00083226|157815069|FG000|Overall Study|Lack of Efficacy|19|||
48994815|NCT00083226|157815069|FG000|Overall Study|Adverse Event|9|||
48994816|NCT00083226|157815069|FG000|Overall Study|Death|4|||
48994817|NCT00083226|157815069|FG000|Overall Study|Withdrawal by Subject|4|||
48994818|NCT00083226|157815069|FG000|Overall Study|Other|2|||
48994819|NCT00083226|157815069|FG000|Overall Study|ineligible or not receiving treatment|4|||
48994820|NCT00795886|157815071|FG000|Overall Study|Death|10|||
48994821|NCT00509223|157816956|FG000|Overall Study|Lost to Follow-up|1|||
48994822|NCT00509223|157816957|FG001|Overall Study|Lost to Follow-up|1|||
48994823|NCT00509223|157816956|FG000|Overall Study|Adverse Event|1|||
48994824|NCT00509223|157816957|FG001|Overall Study|Adverse Event|1|||
48994825|NCT00509223|157816956|FG000|Overall Study|Withdrawal by Subject|25|||
48994826|NCT00509223|157816957|FG001|Overall Study|Withdrawal by Subject|6|||
48994827|NCT00509223|157816956|FG000|Overall Study|Including: subject change of address|5|||
48994828|NCT00509223|157816957|FG001|Overall Study|Including: subject change of address|2|||
48994829|NCT00509223|157816956|FG000|Overall Study|Did not meet revised inclusion criteria|56|||
48994830|NCT00509223|157816957|FG001|Overall Study|Did not meet revised inclusion criteria|62|||
48994831|NCT01096017|157816961|FG000|Treatment Period 2|Eligibility criteria not fulfilled|1|||
48994832|NCT01096017|157816962|FG001|Treatment Period 2|Eligibility criteria not fulfilled|1|||
48994833|NCT02383966|157816963|FG000|Overall Study|Ongoing at clinical cut-off date|25|||
48994834|NCT02383966|157816964|FG001|Overall Study|Ongoing at clinical cut-off date|4|||
48994835|NCT02383966|157816963|FG000|Overall Study|Randomized, but not treated|1|||
48994836|NCT02383966|157816964|FG001|Overall Study|Randomized, but not treated|3|||
48994837|NCT02163759|157816965|FG000|Overall Study|Withdrawal by Subject|1|||
48994838|NCT02163759|157816966|FG001|Overall Study|Withdrawal by Subject|5|||
48994839|NCT02163759|157816967|FG002|Overall Study|Withdrawal by Subject|1|||
48994840|NCT02163759|157816965|FG000|Overall Study|Adverse Event|0|||
48994841|NCT02163759|157816966|FG001|Overall Study|Adverse Event|0|||
48994842|NCT02163759|157816967|FG002|Overall Study|Adverse Event|1|||
48994843|NCT02163759|157816965|FG000|Overall Study|Death|0|||
48994844|NCT02163759|157816966|FG001|Overall Study|Death|0|||
48994845|NCT02163759|157816967|FG002|Overall Study|Death|1|||
48994846|NCT01846442|157816968|FG000|Overall Study|Adverse Event|2|||
48994847|NCT01846442|157816969|FG001|Overall Study|Adverse Event|4|||
48994848|NCT01846442|157816970|FG002|Overall Study|Adverse Event|2|||
48994849|NCT01846442|157816971|FG003|Overall Study|Adverse Event|1|||
48994850|NCT01846442|157816968|FG000|Overall Study|Lost to Follow-up|0|||
48994851|NCT01846442|157816969|FG001|Overall Study|Lost to Follow-up|0|||
48994852|NCT01846442|157816970|FG002|Overall Study|Lost to Follow-up|1|||
48994853|NCT01846442|157816971|FG003|Overall Study|Lost to Follow-up|0|||
48994854|NCT01846442|157816968|FG000|Overall Study|Withdrawal by Subject|3|||
48994855|NCT01846442|157816969|FG001|Overall Study|Withdrawal by Subject|2|||
48994856|NCT01846442|157816970|FG002|Overall Study|Withdrawal by Subject|0|||
48994857|NCT01846442|157816971|FG003|Overall Study|Withdrawal by Subject|1|||
48994858|NCT01846442|157816968|FG000|Overall Study|Left the city/Lost medication|1|||
48994859|NCT01846442|157816969|FG001|Overall Study|Left the city/Lost medication|0|||
48994860|NCT01846442|157816970|FG002|Overall Study|Left the city/Lost medication|1|||
48994861|NCT01846442|157816971|FG003|Overall Study|Left the city/Lost medication|1|||
48994862|NCT03996694|157816977|FG000|First Washout (7 Days)|positive urine drug screen|0|||
48994863|NCT03996694|157816978|FG001|First Washout (7 Days)|positive urine drug screen|0|||
48994864|NCT03996694|157816979|FG002|First Washout (7 Days)|positive urine drug screen|1|||
48994865|NCT03996694|157816980|FG003|First Washout (7 Days)|positive urine drug screen|0|||
48994866|NCT03996694|157816981|FG004|First Washout (7 Days)|positive urine drug screen|0|||
48994867|NCT03996694|157816982|FG005|First Washout (7 Days)|positive urine drug screen|0|||
48994868|NCT03996694|157816977|FG000|First Washout (7 Days)|Adverse Event|0|||
48994869|NCT03996694|157816978|FG001|First Washout (7 Days)|Adverse Event|1|||
48994870|NCT03996694|157816979|FG002|First Washout (7 Days)|Adverse Event|0|||
48994871|NCT03996694|157816980|FG003|First Washout (7 Days)|Adverse Event|0|||
48994872|NCT03996694|157816981|FG004|First Washout (7 Days)|Adverse Event|0|||
48994873|NCT03996694|157816982|FG005|First Washout (7 Days)|Adverse Event|0|||
48994874|NCT03996694|157816977|FG000|First Washout (7 Days)|Lost to Follow-up|0|||
48994875|NCT03996694|157816978|FG001|First Washout (7 Days)|Lost to Follow-up|0|||
48994876|NCT03996694|157816979|FG002|First Washout (7 Days)|Lost to Follow-up|1|||
48994877|NCT03996694|157816980|FG003|First Washout (7 Days)|Lost to Follow-up|0|||
48994878|NCT03996694|157816981|FG004|First Washout (7 Days)|Lost to Follow-up|0|||
48994879|NCT03996694|157816982|FG005|First Washout (7 Days)|Lost to Follow-up|0|||
48994880|NCT03996694|157816977|FG000|Third Washout (7 Days)|Withdrawal by Subject|0|||
48994881|NCT03996694|157816978|FG001|Third Washout (7 Days)|Withdrawal by Subject|0|||
48994882|NCT03996694|157816979|FG002|Third Washout (7 Days)|Withdrawal by Subject|0|||
48994883|NCT03996694|157816980|FG003|Third Washout (7 Days)|Withdrawal by Subject|0|||
48994884|NCT03996694|157816981|FG004|Third Washout (7 Days)|Withdrawal by Subject|1|||
48994885|NCT03996694|157816982|FG005|Third Washout (7 Days)|Withdrawal by Subject|0|||
48994886|NCT02600559|157816998|FG000|Overall Study|Withdrawal by Subject|3|||
48994887|NCT02600559|157816998|FG000|Overall Study|Lost to Follow-up|20|||
48994888|NCT01153971|157816999|FG000|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2|||
48994889|NCT01153971|157816999|FG000|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1|||
48994890|NCT01153971|157816999|FG000|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2|||
48994891|NCT01153971|157816999|FG000|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1|||
48994892|NCT01153971|157816999|FG000|Follow-up (Months 17-40 of Study)|Adverse Event|1|||
48994893|NCT01153971|157816999|FG000|Follow-up (Months 17-40 of Study)|Protocol Violation|1|||
48994894|NCT01153971|157816999|FG000|Follow-up (Months 17-40 of Study)|Disease progression|2|||
48994895|NCT04120116|157817000|FG000|Overall Study|Lost to Follow-up|0|||
48994896|NCT04120116|157817001|FG001|Overall Study|Lost to Follow-up|1|||
48994897|NCT04120116|157817002|FG002|Overall Study|Lost to Follow-up|0|||
48994898|NCT04120116|157817003|FG003|Overall Study|Lost to Follow-up|2|||
48994899|NCT04120116|157817000|FG000|Overall Study|Withdrawal by Subject|1|||
48994900|NCT04120116|157817001|FG001|Overall Study|Withdrawal by Subject|0|||
48994901|NCT04120116|157817002|FG002|Overall Study|Withdrawal by Subject|1|||
48994902|NCT04120116|157817003|FG003|Overall Study|Withdrawal by Subject|1|||
48994903|NCT04120116|157817000|FG000|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
48994904|NCT04120116|157817001|FG001|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
48994905|NCT04120116|157817002|FG002|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|1|||
48994906|NCT04120116|157817003|FG003|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
48994907|NCT03410693|157817004|FG000|Overall Study|Disc trt: Withdrawal by participant|6|||
48994908|NCT03410693|157817005|FG001|Overall Study|Disc trt: Withdrawal by participant|4|||
48994909|NCT03410693|157817004|FG000|Overall Study|Disc trt: Lost to follow up|0|||
48994910|NCT03410693|157817005|FG001|Overall Study|Disc trt: Lost to follow up|1|||
48994911|NCT03410693|157817004|FG000|Overall Study|Disc trt: radiological progression|58|||
48994912|NCT03410693|157817005|FG001|Overall Study|Disc trt: radiological progression|50|||
48994913|NCT03410693|157817004|FG000|Overall Study|Disc trt: Other|1|||
48994914|NCT03410693|157817005|FG001|Overall Study|Disc trt: Other|0|||
48994915|NCT03410693|157817004|FG000|Overall Study|Study drug never administered|1|||
48994916|NCT03410693|157817005|FG001|Overall Study|Study drug never administered|6|||
48994917|NCT03410693|157817004|FG000|Overall Study|Discontinued (disc) treatment (trt): Death|6|||
48994918|NCT03410693|157817005|FG001|Overall Study|Discontinued (disc) treatment (trt): Death|4|||
48994919|NCT03410693|157817004|FG000|Overall Study|Disc trt: Adverse Event (AE)|13|||
48994920|NCT03410693|157817005|FG001|Overall Study|Disc trt: Adverse Event (AE)|9|||
48994921|NCT03410693|157817004|FG000|Overall Study|Disc trt: Physician decision|0|||
48994922|NCT03410693|157817005|FG001|Overall Study|Disc trt: Physician decision|5|||
48994923|NCT03410693|157817004|FG000|Overall Study|Disc trt: clinical progression|1|||
48994924|NCT03410693|157817005|FG001|Overall Study|Disc trt: clinical progression|5|||
48994925|NCT03410693|157817004|FG000|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|1|||
48994926|NCT03410693|157817005|FG001|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|4|||
48994927|NCT03628781|157817006|FG000|Overall Study|Lost to Follow-up|16|||
48994928|NCT03628781|157817007|FG001|Overall Study|Lost to Follow-up|8|||
48994929|NCT03628781|157817006|FG000|Overall Study|Withdrawal by Subject|16|||
48994930|NCT03628781|157817007|FG001|Overall Study|Withdrawal by Subject|1|||
48994931|NCT03575806|157817011|FG000|Overall Study|Withdrawal by Subject|0|||
48994932|NCT03575806|157817012|FG001|Overall Study|Withdrawal by Subject|2|||
48994933|NCT03575806|157817011|FG000|Overall Study|Protocol Violation|0|||
48994934|NCT03575806|157817012|FG001|Overall Study|Protocol Violation|2|||
48994935|NCT02059265|157817015|FG000|Overall Study|Ineligible|4|||
48994936|NCT00229931|157817018|FG000|Overall Study|Death|1|||
48994937|NCT00229931|157817019|FG001|Overall Study|Death|0|||
48994938|NCT00229931|157817018|FG000|Overall Study|Lost to Follow-up|3|||
48994939|NCT00229931|157817019|FG001|Overall Study|Lost to Follow-up|2|||
48994940|NCT00348348|157817020|FG000|Overall Study|Adverse event - unrelated to study drug|0|||
48994941|NCT00348348|157817021|FG001|Overall Study|Adverse event - unrelated to study drug|1|||
48994942|NCT00348348|157817020|FG000|Overall Study|Lack of Efficacy|1|||
48994943|NCT00348348|157817021|FG001|Overall Study|Lack of Efficacy|1|||
48994944|NCT00348348|157817020|FG000|Overall Study|Lost to Follow-up|8|||
48994945|NCT00348348|157817021|FG001|Overall Study|Lost to Follow-up|10|||
48994946|NCT00348348|157817020|FG000|Overall Study|Withdrawal by Subject|4|||
48994947|NCT00348348|157817021|FG001|Overall Study|Withdrawal by Subject|1|||
48994948|NCT00348348|157817020|FG000|Overall Study|Other|7|||
48994949|NCT00348348|157817021|FG001|Overall Study|Other|4|||
48994950|NCT00348348|157817020|FG000|Overall Study|Dissallowed Meds - unrelated to study|1|||
48994951|NCT00348348|157817021|FG001|Overall Study|Dissallowed Meds - unrelated to study|3|||
48994952|NCT00348348|157817020|FG000|Overall Study|Dissallowed Meds - unlikley related|1|||
48994953|NCT00348348|157817021|FG001|Overall Study|Dissallowed Meds - unlikley related|1|||
48994954|NCT00348348|157817020|FG000|Overall Study|Dissallowed Meds - possibly releated|1|||
48994955|NCT00348348|157817021|FG001|Overall Study|Dissallowed Meds - possibly releated|1|||
48994956|NCT00348348|157817020|FG000|Overall Study|Worsening of BC - Unrelated to study|0|||
48994957|NCT00348348|157817021|FG001|Overall Study|Worsening of BC - Unrelated to study|3|||
48994958|NCT00348348|157817020|FG000|Overall Study|Worsening of BC - Unlikely related|1|||
48994959|NCT00348348|157817021|FG001|Overall Study|Worsening of BC - Unlikely related|2|||
48994960|NCT00348348|157817020|FG000|Overall Study|Adverse event probably related to study|1|||
48994961|NCT00348348|157817021|FG001|Overall Study|Adverse event probably related to study|0|||
48994962|NCT02992743|157817022|FG000|Overall Study|Withdrawal by Subject|1|||
48994963|NCT02992743|157817023|FG001|Overall Study|Withdrawal by Subject|1|||
48994964|NCT02992743|157817022|FG000|Overall Study|Death-Prior to T-Cell Infusion|1|||
48994965|NCT02992743|157817023|FG001|Overall Study|Death-Prior to T-Cell Infusion|0|||
48994966|NCT02992743|157817022|FG000|Overall Study|Did Not Meet Inclusion/Exclusion|1|||
48994967|NCT02992743|157817023|FG001|Overall Study|Did Not Meet Inclusion/Exclusion|0|||
48994968|NCT02992743|157817022|FG000|Overall Study|No measurable disease|1|||
48994969|NCT02992743|157817023|FG001|Overall Study|No measurable disease|0|||
48994970|NCT02992743|157817022|FG000|Overall Study|Lost to Follow-up|0|||
48994971|NCT02992743|157817023|FG001|Overall Study|Lost to Follow-up|1|||
48994972|NCT01471197|157817024|FG000|Overall Study|Disease Progression|4|||
48994973|NCT01471197|157817025|FG001|Overall Study|Disease Progression|2|||
48994974|NCT01471197|157817024|FG000|Overall Study|Death|1|||
48994975|NCT01471197|157817025|FG001|Overall Study|Death|0|||
48994976|NCT01471197|157817024|FG000|Overall Study|Study Drug Toxicity|1|||
48994977|NCT01471197|157817025|FG001|Overall Study|Study Drug Toxicity|0|||
48994978|NCT03358407|157817029|FG000|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
48994979|NCT03358407|157817030|FG001|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
48994980|NCT03358407|157817031|FG002|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1|||
48994981|NCT03358407|157817032|FG003|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
48994982|NCT03358407|157817033|FG004|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
48994983|NCT03358407|157817034|FG005|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
48994984|NCT03358407|157817035|FG006|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
48994985|NCT03358407|157817036|FG007|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
48994986|NCT03358407|157817037|FG008|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
48994987|NCT03358407|157817038|FG009|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
48994988|NCT03358407|157817029|FG000|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
48994989|NCT03358407|157817030|FG001|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
48994990|NCT03358407|157817031|FG002|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
48994991|NCT03358407|157817032|FG003|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
48994992|NCT03358407|157817033|FG004|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1|||
48994993|NCT03358407|157817034|FG005|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
48994994|NCT03358407|157817035|FG006|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
48994995|NCT03358407|157817036|FG007|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
48994996|NCT03358407|157817037|FG008|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
48994997|NCT03358407|157817038|FG009|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
48994998|NCT03358407|157817029|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
48994999|NCT03358407|157817030|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
48995000|NCT03358407|157817031|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
48995001|NCT03358407|157817032|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
48995002|NCT03358407|157817033|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
49045829|NCT01691430|158002022|FG000|Overall Study|Lost to Follow-up|0|||
49045830|NCT01691430|158002023|FG001|Overall Study|Lost to Follow-up|3|||
48995003|NCT03358407|157817034|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1|||
48995004|NCT03358407|157817035|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
48995005|NCT03358407|157817036|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2|||
48995006|NCT03358407|157817037|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
48995007|NCT03358407|157817038|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
48995008|NCT03358407|157817029|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
48995009|NCT03358407|157817030|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
48995010|NCT03358407|157817031|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
48995011|NCT03358407|157817032|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
48995012|NCT03358407|157817033|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
48995013|NCT03358407|157817034|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
48995014|NCT03358407|157817035|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
48995015|NCT03358407|157817036|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
48995016|NCT03358407|157817037|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
48995017|NCT03358407|157817038|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
48995018|NCT03358407|157817029|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
48995019|NCT03358407|157817030|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
48995020|NCT03358407|157817031|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
48995021|NCT03358407|157817032|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
48995022|NCT03358407|157817033|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
48995023|NCT03358407|157817034|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
48995024|NCT03358407|157817035|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
48995025|NCT03358407|157817036|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
48995026|NCT03358407|157817037|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
48995027|NCT03358407|157817038|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
48995028|NCT03358407|157817029|FG000|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
48995029|NCT03358407|157817030|FG001|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
48995030|NCT03358407|157817031|FG002|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
48995031|NCT03358407|157817032|FG003|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
48995032|NCT03358407|157817033|FG004|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
48995033|NCT03358407|157817034|FG005|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
48995034|NCT03358407|157817035|FG006|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
48995035|NCT03358407|157817036|FG007|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6|||
48995036|NCT03358407|157817037|FG008|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
48995037|NCT03358407|157817038|FG009|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
48995038|NCT03290131|157817039|FG000|Overall Study|Adverse Event|22|||
48995039|NCT03290131|157817040|FG001|Overall Study|Adverse Event|57|||
48995040|NCT03290131|157817041|FG002|Overall Study|Adverse Event|11|||
48995041|NCT03290131|157817039|FG000|Overall Study|Withdrawal by Subject|18|||
48995042|NCT03290131|157817040|FG001|Overall Study|Withdrawal by Subject|13|||
48995043|NCT03290131|157817041|FG002|Overall Study|Withdrawal by Subject|8|||
48995044|NCT03290131|157817039|FG000|Overall Study|MS Relapse|2|||
48995045|NCT03290131|157817040|FG001|Overall Study|MS Relapse|1|||
48995046|NCT03290131|157817041|FG002|Overall Study|MS Relapse|0|||
48995047|NCT03290131|157817039|FG000|Overall Study|Unknown reason|0|||
48995048|NCT03290131|157817040|FG001|Overall Study|Unknown reason|1|||
48995049|NCT03290131|157817041|FG002|Overall Study|Unknown reason|0|||
48995050|NCT00924313|157817046|FG000|Overall Study|not imaged due to failed tracer imaging|1|||
48995051|NCT02329834|157817047|FG000|Overall Study|Physician Decision|1|||
48995052|NCT02329834|157817048|FG001|Overall Study|Physician Decision|0|||
48995053|NCT03605758|157817049|FG000|Overall Study|Lost to Follow-up|2|||
48995054|NCT03605758|157817050|FG001|Overall Study|Lost to Follow-up|1|||
48995055|NCT03605758|157817049|FG000|Overall Study|Illness|0|||
48995056|NCT03605758|157817050|FG001|Overall Study|Illness|1|||
48995057|NCT03605758|157817049|FG000|Overall Study|Did not complete all 3 scheduled visits|20|||
48995058|NCT03605758|157817050|FG001|Overall Study|Did not complete all 3 scheduled visits|22|||
48995059|NCT04753606|157817057|FG000|Overall Study|Adverse Event|1|||
48995060|NCT04753606|157817058|FG001|Overall Study|Adverse Event|0|||
48995061|NCT04753606|157817059|FG002|Overall Study|Adverse Event|0|||
48995062|NCT02319642|157817060|FG000|Overall Study|Adverse Event|2|||
48995063|NCT02319642|157817061|FG001|Overall Study|Adverse Event|4|||
48995064|NCT02319642|157817060|FG000|Overall Study|Lack of Efficacy|1|||
48995065|NCT02319642|157817061|FG001|Overall Study|Lack of Efficacy|1|||
48995066|NCT02319642|157817060|FG000|Overall Study|Withdrawal by Subject|1|||
48995067|NCT02319642|157817061|FG001|Overall Study|Withdrawal by Subject|1|||
48995068|NCT04221373|157817062|FG000|Overall Study|Physician Decision|4|||
48995069|NCT04221373|157817063|FG001|Overall Study|Physician Decision|0|||
48995070|NCT00779857|157817066|FG000|Overall Study|Death|1|||
48995071|NCT00779857|157817066|FG000|Overall Study|Withdrawal by Subject|3|||
48995072|NCT00779857|157817066|FG000|Overall Study|Missed Visit|2|||
48995073|NCT01725217|157817074|FG000|Overall Study|Withdrawal by Subject|1|||
48995074|NCT01725217|157817075|FG001|Overall Study|Withdrawal by Subject|0|||
48995075|NCT01725217|157817076|FG002|Overall Study|Withdrawal by Subject|0|||
48995076|NCT02190604|157817077|FG000|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
48995077|NCT02190604|157817078|FG001|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
48995078|NCT02190604|157817079|FG002|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
48995079|NCT02190604|157817080|FG003|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
48995080|NCT02190604|157817081|FG004|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
48995081|NCT02190604|157817082|FG005|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
48995082|NCT02190604|157817083|FG006|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
48995083|NCT02190604|157817084|FG007|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
48995084|NCT02190604|157817085|FG008|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
48995085|NCT02190604|157817086|FG009|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
48995086|NCT02190604|157817087|FG010|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
48995087|NCT02190604|157817088|FG011|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
48995088|NCT02190604|157817089|FG012|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
48995089|NCT02190604|157817090|FG013|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
48995090|NCT02190604|157817091|FG014|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2|||
48995091|NCT02190604|157817092|FG015|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
48995092|NCT02190604|157817093|FG016|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
48995093|NCT02190604|157817094|FG017|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
48995094|NCT02190604|157817095|FG018|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
48995095|NCT02190604|157817077|FG000|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
48995096|NCT02190604|157817078|FG001|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
48995097|NCT02190604|157817079|FG002|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
48995098|NCT02190604|157817080|FG003|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
48995099|NCT02190604|157817081|FG004|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
48995100|NCT02190604|157817082|FG005|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
48995101|NCT02190604|157817083|FG006|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
48995102|NCT02190604|157817084|FG007|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
48995103|NCT02190604|157817085|FG008|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
48995104|NCT02190604|157817086|FG009|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
48995105|NCT02190604|157817087|FG010|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
48995106|NCT02190604|157817088|FG011|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
48995107|NCT02190604|157817089|FG012|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
48995108|NCT02190604|157817090|FG013|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1|||
48995109|NCT02190604|157817091|FG014|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
48995110|NCT02190604|157817092|FG015|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
48995111|NCT02190604|157817093|FG016|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
48995112|NCT02190604|157817094|FG017|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
48995113|NCT02190604|157817095|FG018|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
48995114|NCT00814502|157817096|FG000|Overall Study|Adverse Event|1|||
48995115|NCT00814502|157817097|FG001|Overall Study|Adverse Event|0|||
48995116|NCT00814502|157817096|FG000|Overall Study|Withdrawal by Subject|0|||
48995117|NCT00814502|157817097|FG001|Overall Study|Withdrawal by Subject|2|||
48995118|NCT04281030|157817098|FG000|Overall Study|Technology issues prevented participant from receiving intervention|2|||
48995119|NCT04281030|157817099|FG001|Overall Study|Technology issues prevented participant from receiving intervention|2|||
48995120|NCT04281030|157817098|FG000|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|8|||
48995121|NCT04281030|157817099|FG001|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|6|||
48995122|NCT02335411|157817100|FG000|Overall Study|Death|223|||
48995123|NCT02335411|157817101|FG001|Overall Study|Death|22|||
48995124|NCT02335411|157817102|FG002|Overall Study|Death|26|||
48995125|NCT02335411|157817100|FG000|Overall Study|Physician Decision|3|||
48995126|NCT02335411|157817101|FG001|Overall Study|Physician Decision|0|||
48995127|NCT02335411|157817102|FG002|Overall Study|Physician Decision|0|||
48995128|NCT02335411|157817100|FG000|Overall Study|Protocol Violation|1|||
48995129|NCT02335411|157817101|FG001|Overall Study|Protocol Violation|0|||
48995130|NCT02335411|157817102|FG002|Overall Study|Protocol Violation|0|||
48995131|NCT02335411|157817100|FG000|Overall Study|Withdrawal by Subject|11|||
48995132|NCT02335411|157817101|FG001|Overall Study|Withdrawal by Subject|0|||
48995133|NCT02335411|157817102|FG002|Overall Study|Withdrawal by Subject|3|||
48995134|NCT02335411|157817100|FG000|Overall Study|Sponsor Decision|12|||
48995135|NCT02335411|157817101|FG001|Overall Study|Sponsor Decision|3|||
48995136|NCT02335411|157817102|FG002|Overall Study|Sponsor Decision|2|||
48995137|NCT02335411|157817100|FG000|Overall Study|Adverse Event|9|||
48995138|NCT02335411|157817101|FG001|Overall Study|Adverse Event|0|||
48995139|NCT02335411|157817102|FG002|Overall Study|Adverse Event|0|||
48995140|NCT00938015|157817103|FG000|Overall Study|Death|2|||
48995141|NCT00938015|157817103|FG000|Overall Study|Lost to Follow-up|32|||
48995142|NCT00938015|157817103|FG000|Overall Study|Adverse Event|32|||
49045831|NCT01894230|158002024|FG000|Overall Study|Lost to Follow-up|2|||
48995143|NCT00938015|157817103|FG000|Overall Study|Non-responder|52|||
48995144|NCT00938015|157817103|FG000|Overall Study|Reason not related to Etanercept|29|||
48995145|NCT01886105|157817104|FG000|Overall Study|Lack of Efficacy|3|||
48995146|NCT02341482|157817105|FG000|Overall Study|Adverse Event|1|||
48995147|NCT01876901|157817106|FG000|Overall Study|Protocol Violation|10|||
48995148|NCT01876901|157817107|FG001|Overall Study|Protocol Violation|2|||
48995149|NCT01876901|157817106|FG000|Overall Study|No or other surgical intervention|7|||
48995150|NCT01876901|157817107|FG001|Overall Study|No or other surgical intervention|5|||
48995151|NCT01418365|157817108|FG000|First Intervention|Withdrawal by Subject|0|||
48995152|NCT01418365|157817109|FG001|First Intervention|Withdrawal by Subject|1|||
48995153|NCT01418365|157817108|FG000|First Intervention|Non-compliance|1|||
48995154|NCT01418365|157817109|FG001|First Intervention|Non-compliance|0|||
48995155|NCT01418365|157817108|FG000|Second Intervention|Withdrawal by Subject|0|||
48995156|NCT01418365|157817109|FG001|Second Intervention|Withdrawal by Subject|1|||
48995157|NCT01283282|157817110|FG000|First Intervention (6 Weeks)|Physician Decision|0|||
48995158|NCT01283282|157817111|FG001|First Intervention (6 Weeks)|Physician Decision|1|||
48995159|NCT01283282|157817110|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|2|||
48995160|NCT01283282|157817111|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|3|||
48995161|NCT01283282|157817110|FG000|First Intervention (6 Weeks)|Lost to Follow-up|1|||
48995162|NCT01283282|157817111|FG001|First Intervention (6 Weeks)|Lost to Follow-up|0|||
48995163|NCT01977482|157817112|FG000|Overall Study|Adverse Event|0|||
48995164|NCT01977482|157817113|FG001|Overall Study|Adverse Event|1|||
48995165|NCT01977482|157817114|FG002|Overall Study|Adverse Event|1|||
48995166|NCT01977482|157817115|FG003|Overall Study|Adverse Event|0|||
48995167|NCT01977482|157817116|FG004|Overall Study|Adverse Event|2|||
48995168|NCT01977482|157817117|FG005|Overall Study|Adverse Event|0|||
48995169|NCT01977482|157817112|FG000|Overall Study|Lost to Follow-up|1|||
48995170|NCT01977482|157817113|FG001|Overall Study|Lost to Follow-up|0|||
48995171|NCT01977482|157817114|FG002|Overall Study|Lost to Follow-up|0|||
48995172|NCT01977482|157817115|FG003|Overall Study|Lost to Follow-up|0|||
48995173|NCT01977482|157817116|FG004|Overall Study|Lost to Follow-up|0|||
48995174|NCT01977482|157817117|FG005|Overall Study|Lost to Follow-up|0|||
48995175|NCT01977482|157817112|FG000|Overall Study|Physician Decision|0|||
48995176|NCT01977482|157817113|FG001|Overall Study|Physician Decision|1|||
48995177|NCT01977482|157817114|FG002|Overall Study|Physician Decision|0|||
48995178|NCT01977482|157817115|FG003|Overall Study|Physician Decision|0|||
48995179|NCT01977482|157817116|FG004|Overall Study|Physician Decision|0|||
48995180|NCT01977482|157817117|FG005|Overall Study|Physician Decision|0|||
48995181|NCT01977482|157817112|FG000|Overall Study|Protocol Violation|0|||
48995182|NCT01977482|157817113|FG001|Overall Study|Protocol Violation|0|||
48995183|NCT01977482|157817114|FG002|Overall Study|Protocol Violation|1|||
48995184|NCT01977482|157817115|FG003|Overall Study|Protocol Violation|0|||
48995185|NCT01977482|157817116|FG004|Overall Study|Protocol Violation|0|||
48995186|NCT01977482|157817117|FG005|Overall Study|Protocol Violation|0|||
48995187|NCT01977482|157817112|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
48995188|NCT01977482|157817113|FG001|Overall Study|Other-Protocol-defined Stopping Criteria|3|||
48995189|NCT01977482|157817114|FG002|Overall Study|Other-Protocol-defined Stopping Criteria|2|||
48995190|NCT01977482|157817115|FG003|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
48995191|NCT01977482|157817116|FG004|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
48995192|NCT01977482|157817117|FG005|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
48995193|NCT01977482|157817112|FG000|Overall Study|Withdrawal by Subject|2|||
48995194|NCT01977482|157817113|FG001|Overall Study|Withdrawal by Subject|4|||
48995195|NCT01977482|157817114|FG002|Overall Study|Withdrawal by Subject|1|||
48995196|NCT01977482|157817115|FG003|Overall Study|Withdrawal by Subject|3|||
48995197|NCT01977482|157817116|FG004|Overall Study|Withdrawal by Subject|1|||
48995198|NCT01977482|157817117|FG005|Overall Study|Withdrawal by Subject|5|||
48995199|NCT05022121|157817118|FG000|Overall Study|Lack of Efficacy|1|||
48995200|NCT05022121|157817119|FG001|Overall Study|Lack of Efficacy|0|||
48995201|NCT05022121|157817118|FG000|Overall Study|Lost to Follow-up|0|||
48995202|NCT05022121|157817119|FG001|Overall Study|Lost to Follow-up|2|||
48995203|NCT01361308|157819257|FG000|Overall Study|Withdrawal by Subject|9|||
48995204|NCT01361308|157819258|FG001|Overall Study|Withdrawal by Subject|13|||
48995205|NCT01361308|157819257|FG000|Overall Study|Physician Decision|3|||
48995206|NCT01361308|157819258|FG001|Overall Study|Physician Decision|3|||
48995207|NCT01361308|157819257|FG000|Overall Study|Lack of Efficacy|2|||
48995208|NCT01361308|157819258|FG001|Overall Study|Lack of Efficacy|0|||
48995209|NCT01361308|157819257|FG000|Overall Study|Protocol Violation|1|||
48995210|NCT01361308|157819258|FG001|Overall Study|Protocol Violation|0|||
48995211|NCT01361308|157819257|FG000|Overall Study|Lost to Follow-up|5|||
48995212|NCT01361308|157819258|FG001|Overall Study|Lost to Follow-up|4|||
48995213|NCT01361308|157819257|FG000|Overall Study|Adverse Event|8|||
48995214|NCT01361308|157819258|FG001|Overall Study|Adverse Event|4|||
48995215|NCT01361308|157819257|FG000|Overall Study|Eligibility Criteria Not Met|2|||
48995216|NCT01361308|157819258|FG001|Overall Study|Eligibility Criteria Not Met|3|||
48995217|NCT01361308|157819257|FG000|Overall Study|Failed C-SSRS|5|||
48995218|NCT01361308|157819258|FG001|Overall Study|Failed C-SSRS|2|||
48995219|NCT01361308|157819257|FG000|Overall Study|Other|0|||
48995220|NCT01361308|157819258|FG001|Overall Study|Other|1|||
48995221|NCT01479777|157819261|FG000|Overall Study|Physician Decision|2|||
48995222|NCT01789476|157819263|FG000|Overall Study|Lack of Efficacy|6|||
48995223|NCT01789476|157819264|FG001|Overall Study|Lack of Efficacy|2|||
48995224|NCT01789476|157819263|FG000|Overall Study|Adverse Event|1|||
48995225|NCT01789476|157819264|FG001|Overall Study|Adverse Event|0|||
48995226|NCT01789476|157819263|FG000|Overall Study|Unable to get IV access|1|||
48995227|NCT01789476|157819264|FG001|Overall Study|Unable to get IV access|0|||
48995228|NCT00953576|157819265|FG000|Overall Study|Adverse Event|0|||
48995229|NCT00953576|157819266|FG001|Overall Study|Adverse Event|1|||
48995230|NCT00953576|157819265|FG000|Overall Study|Ineligible after Consent|2|||
48995231|NCT00953576|157819266|FG001|Overall Study|Ineligible after Consent|0|||
48995232|NCT00501969|157819267|FG000|Overall Study|Major Protocol Violation|4|||
48995233|NCT00501969|157819267|FG000|Overall Study|Lack of Efficacy|29|||
48995234|NCT00501969|157819267|FG000|Overall Study|Adverse Event|76|||
48995235|NCT00501969|157819267|FG000|Overall Study|Unsatisfactory compliance of subject|7|||
48995236|NCT00501969|157819267|FG000|Overall Study|Subject withdrew consent|51|||
48995237|NCT00501969|157819267|FG000|Overall Study|Lost to Follow-up|4|||
48995238|NCT00501969|157819267|FG000|Overall Study|Other: Tired Of Clinical Trial Process|1|||
48995239|NCT00501969|157819267|FG000|Overall Study|Other: Sponsors Request|10|||
48995240|NCT00501969|157819267|FG000|Overall Study|Other: Sponsor Termination at Site|1|||
48995241|NCT00501969|157819267|FG000|Overall Study|Other: Sponsor Stopped Study|12|||
48995242|NCT00501969|157819267|FG000|Overall Study|Other: Severe Dementia Unable Sign PIC|1|||
48995243|NCT00501969|157819267|FG000|Overall Study|Other: Patients + Investigator Agreement|1|||
48995244|NCT00501969|157819267|FG000|Overall Study|Other: Patient is Going to Have DBS|1|||
48995245|NCT00501969|157819267|FG000|Overall Study|Other: Pat Pending Surgery for PD|1|||
48995246|NCT00501969|157819267|FG000|Overall Study|Other: DX Changed - Parkinsons to PSNP|1|||
48995247|NCT00501969|157819267|FG000|Overall Study|Other: As Required by Local EC|2|||
48995248|NCT00501969|157819267|FG000|Overall Study|Other: Admin Request from the Sponsor|3|||
48995249|NCT00501969|157819267|FG000|Overall Study|Other: Sponsor Termination/Commercial RX|1|||
48995250|NCT00451191|157819273|FG000|Overall Study|withdrawal or received alternate tx|15|||
48995251|NCT00451191|157819274|FG001|Overall Study|withdrawal or received alternate tx|11|||
48995252|NCT00665366|157819275|FG000|Overall Study|Lack of Efficacy|11|||
48995253|NCT00665366|157819276|FG001|Overall Study|Lack of Efficacy|10|||
48995254|NCT00665366|157819275|FG000|Overall Study|Adverse Event|25|||
48995255|NCT00665366|157819276|FG001|Overall Study|Adverse Event|23|||
48995256|NCT00665366|157819275|FG000|Overall Study|Withdrawal by Subject|11|||
48995257|NCT00665366|157819276|FG001|Overall Study|Withdrawal by Subject|14|||
48995258|NCT00665366|157819275|FG000|Overall Study|Lost to Follow-up|3|||
48995259|NCT00665366|157819276|FG001|Overall Study|Lost to Follow-up|5|||
48995260|NCT00665366|157819275|FG000|Overall Study|Poor compliance/noncompliance|3|||
48995261|NCT00665366|157819276|FG001|Overall Study|Poor compliance/noncompliance|5|||
48995262|NCT00665366|157819275|FG000|Overall Study|Pregnancy|1|||
48995263|NCT00665366|157819276|FG001|Overall Study|Pregnancy|0|||
48995264|NCT00665366|157819275|FG000|Overall Study|No longer meets study criteria|0|||
48995265|NCT00665366|157819276|FG001|Overall Study|No longer meets study criteria|1|||
48995266|NCT00665366|157819275|FG000|Overall Study|Other reasons|4|||
48995267|NCT00665366|157819276|FG001|Overall Study|Other reasons|1|||
48995268|NCT02087865|157819281|FG000|Overall Study|Withdrawal by Subject|6|||
48995269|NCT02087865|157819282|FG001|Overall Study|Withdrawal by Subject|0|||
48995270|NCT02087865|157819283|FG002|Overall Study|Withdrawal by Subject|1|||
48995271|NCT02087865|157819281|FG000|Overall Study|Lost to Follow-up|0|||
48995272|NCT02087865|157819282|FG001|Overall Study|Lost to Follow-up|0|||
48995273|NCT02087865|157819283|FG002|Overall Study|Lost to Follow-up|1|||
48995274|NCT02087865|157819281|FG000|Overall Study|Drug Non-compliance|0|||
48995275|NCT02087865|157819282|FG001|Overall Study|Drug Non-compliance|2|||
48995276|NCT02087865|157819283|FG002|Overall Study|Drug Non-compliance|0|||
48995277|NCT02087865|157819281|FG000|Overall Study|Not analyzed due to anatomical abnormalities|0|||
48995278|NCT02087865|157819282|FG001|Overall Study|Not analyzed due to anatomical abnormalities|1|||
48995279|NCT02087865|157819283|FG002|Overall Study|Not analyzed due to anatomical abnormalities|1|||
48995280|NCT00965458|157819293|FG000|Overall Study|Adverse Event|1|||
48995281|NCT00965458|157819294|FG001|Overall Study|Adverse Event|0|||
48995282|NCT00965458|157819293|FG000|Overall Study|Lost to Follow-up|1|||
48995283|NCT00965458|157819294|FG001|Overall Study|Lost to Follow-up|3|||
48995284|NCT00965458|157819293|FG000|Overall Study|Withdrawal by Subject|0|||
48995285|NCT00965458|157819294|FG001|Overall Study|Withdrawal by Subject|1|||
48995286|NCT00656669|157819298|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4|||
48995287|NCT00656669|157819298|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2|||
48995288|NCT00656669|157819298|FG000|AC (Cycles 6-9)|Adverse Event|1|||
48995289|NCT00656669|157819298|FG000|AC (Cycles 6-9)|Did not start segment 3|1|||
48995290|NCT00219349|157819303|FG000|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6|||
48995291|NCT00219349|157819303|FG000|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2|||
48995292|NCT00219349|157819303|FG000|Cognitive Behavioral Therapy Phase|Protocol Violation|2|||
48995293|NCT00219349|157819303|FG000|Escitalopram Phase|Withdrawal by Subject|3|||
49045832|NCT01894230|158002025|FG001|Overall Study|Lost to Follow-up|2|||
48995294|NCT03778021|157819306|FG000|Overall Study|Student failed to respond to follow-up survey|28|||
48995295|NCT03778021|157819307|FG001|Overall Study|Student failed to respond to follow-up survey|53|||
48995296|NCT00679042|157819308|FG000|Transplant + 1 Year Follow Up|Withdrawal by Subject|2|||
48995297|NCT00679042|157819308|FG000|5-Year Follow Up|In follow-up (ongoing)|6|||
48995298|NCT00679042|157819308|FG000|5-Year Follow Up|Death|1|||
48995299|NCT00679042|157819308|FG000|5-Year Follow Up|Did not consent to continue into 10-year follow up|7|||
48995300|NCT00679042|157819308|FG000|10-Year Follow Up|In follow-up (ongoing)|5|||
48995301|NCT02687815|157819310|FG000|Overall Study|Lost to Follow-up|2|||
48995302|NCT02687815|157819311|FG001|Overall Study|Lost to Follow-up|4|||
48995303|NCT02687815|157819310|FG000|Overall Study|Withdrawal by Subject|2|||
48995304|NCT02687815|157819311|FG001|Overall Study|Withdrawal by Subject|4|||
48995305|NCT02777554|157819312|FG000|Overall Study|Adverse Event|4|||
48995306|NCT02777554|157819313|FG001|Overall Study|Adverse Event|4|||
48995307|NCT02777554|157819314|FG002|Overall Study|Adverse Event|0|||
48995308|NCT02777554|157819315|FG003|Overall Study|Adverse Event|1|||
48995309|NCT02777554|157819316|FG004|Overall Study|Adverse Event|0|||
48995310|NCT02777554|157819317|FG005|Overall Study|Adverse Event|0|||
48995311|NCT02777554|157819312|FG000|Overall Study|Withdrawal by Subject|3|||
48995312|NCT02777554|157819313|FG001|Overall Study|Withdrawal by Subject|1|||
48995313|NCT02777554|157819314|FG002|Overall Study|Withdrawal by Subject|1|||
48995314|NCT02777554|157819315|FG003|Overall Study|Withdrawal by Subject|0|||
48995315|NCT02777554|157819316|FG004|Overall Study|Withdrawal by Subject|0|||
48995316|NCT02777554|157819317|FG005|Overall Study|Withdrawal by Subject|0|||
48995317|NCT02777554|157819312|FG000|Overall Study|Discharged early due to hurricane|22|||
48995318|NCT02777554|157819313|FG001|Overall Study|Discharged early due to hurricane|20|||
48995319|NCT02777554|157819314|FG002|Overall Study|Discharged early due to hurricane|0|||
48995320|NCT02777554|157819315|FG003|Overall Study|Discharged early due to hurricane|0|||
48995321|NCT02777554|157819316|FG004|Overall Study|Discharged early due to hurricane|0|||
48995322|NCT02777554|157819317|FG005|Overall Study|Discharged early due to hurricane|0|||
48995323|NCT02777554|157819312|FG000|Overall Study|Other - Miscellaneous|1|||
48995324|NCT02777554|157819313|FG001|Overall Study|Other - Miscellaneous|0|||
48995325|NCT02777554|157819314|FG002|Overall Study|Other - Miscellaneous|0|||
48995326|NCT02777554|157819315|FG003|Overall Study|Other - Miscellaneous|0|||
48995327|NCT02777554|157819316|FG004|Overall Study|Other - Miscellaneous|0|||
48995328|NCT02777554|157819317|FG005|Overall Study|Other - Miscellaneous|0|||
48995329|NCT00270205|157819326|FG000|Overall Study|Lost to Follow-up|1|||
48995330|NCT00270205|157819327|FG001|Overall Study|Lost to Follow-up|0|||
48995331|NCT00270205|157819328|FG002|Overall Study|Lost to Follow-up|0|||
48995332|NCT00270205|157819329|FG003|Overall Study|Lost to Follow-up|1|||
48995333|NCT00066573|157819335|FG000|Overall Study|Did not received protocol treatment|28|||
48995334|NCT00066573|157819336|FG001|Overall Study|Did not received protocol treatment|28|||
48995335|NCT00869362|157819337|FG000|Overall Study|Death|0|||
48995336|NCT00869362|157819338|FG001|Overall Study|Death|2|||
48995337|NCT00869362|157819337|FG000|Overall Study|Lost to Follow-up|1|||
48995338|NCT00869362|157819338|FG001|Overall Study|Lost to Follow-up|3|||
48995339|NCT04177862|157819339|FG000|Overall Study|Protocol Violation|2|||
48995340|NCT04177862|157819340|FG001|Overall Study|Protocol Violation|7|||
48995341|NCT03053102|157819341|FG000|Study Part 2: 84-Day Treatment|Adverse Event|1|||
48995342|NCT03053102|157819341|FG000|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1|||
48995343|NCT00003526|157819352|FG000|Overall Study|Not evaluable|6|||
48995344|NCT04196023|157819359|FG000|Overall Study|Withdrawal by Subject|0|||
48995345|NCT04196023|157819360|FG001|Overall Study|Withdrawal by Subject|1|||
48995346|NCT04196023|157819359|FG000|Overall Study|Adverse Event|3|||
48995347|NCT04196023|157819360|FG001|Overall Study|Adverse Event|1|||
48995348|NCT04196023|157819359|FG000|Overall Study|Lost to Follow-up|0|||
48995349|NCT04196023|157819360|FG001|Overall Study|Lost to Follow-up|1|||
48995350|NCT00471237|157819361|FG000|Overall Study|Adverse Event|6|||
48995351|NCT00471237|157819362|FG001|Overall Study|Adverse Event|5|||
48995352|NCT00471237|157819363|FG002|Overall Study|Adverse Event|4|||
48995353|NCT00471237|157819364|FG003|Overall Study|Adverse Event|8|||
48995354|NCT00471237|157819365|FG004|Overall Study|Adverse Event|7|||
48995355|NCT00471237|157819366|FG005|Overall Study|Adverse Event|5|||
48995356|NCT00471237|157819367|FG006|Overall Study|Adverse Event|0|||
48995357|NCT00471237|157819361|FG000|Overall Study|Lost to Follow-up|1|||
48995358|NCT00471237|157819362|FG001|Overall Study|Lost to Follow-up|1|||
48995359|NCT00471237|157819363|FG002|Overall Study|Lost to Follow-up|0|||
48995360|NCT00471237|157819364|FG003|Overall Study|Lost to Follow-up|2|||
48995361|NCT00471237|157819365|FG004|Overall Study|Lost to Follow-up|3|||
48995362|NCT00471237|157819366|FG005|Overall Study|Lost to Follow-up|0|||
48995363|NCT00471237|157819367|FG006|Overall Study|Lost to Follow-up|0|||
48995364|NCT00471237|157819361|FG000|Overall Study|Protocol Violation|3|||
48995365|NCT00471237|157819362|FG001|Overall Study|Protocol Violation|6|||
48995366|NCT00471237|157819363|FG002|Overall Study|Protocol Violation|3|||
48995367|NCT00471237|157819364|FG003|Overall Study|Protocol Violation|2|||
48995368|NCT00471237|157819365|FG004|Overall Study|Protocol Violation|2|||
48995369|NCT00471237|157819366|FG005|Overall Study|Protocol Violation|4|||
48995370|NCT00471237|157819367|FG006|Overall Study|Protocol Violation|1|||
48995371|NCT00471237|157819361|FG000|Overall Study|Withdrawal by Subject|8|||
48995372|NCT00471237|157819362|FG001|Overall Study|Withdrawal by Subject|6|||
48995373|NCT00471237|157819363|FG002|Overall Study|Withdrawal by Subject|5|||
48995374|NCT00471237|157819364|FG003|Overall Study|Withdrawal by Subject|8|||
48995375|NCT00471237|157819365|FG004|Overall Study|Withdrawal by Subject|7|||
48995376|NCT00471237|157819366|FG005|Overall Study|Withdrawal by Subject|4|||
48995377|NCT00471237|157819367|FG006|Overall Study|Withdrawal by Subject|2|||
48995378|NCT00471237|157819361|FG000|Overall Study|Sponsor terminated study|20|||
48995379|NCT00471237|157819362|FG001|Overall Study|Sponsor terminated study|23|||
48995380|NCT00471237|157819363|FG002|Overall Study|Sponsor terminated study|19|||
48995381|NCT00471237|157819364|FG003|Overall Study|Sponsor terminated study|22|||
48995382|NCT00471237|157819365|FG004|Overall Study|Sponsor terminated study|18|||
48995383|NCT00471237|157819366|FG005|Overall Study|Sponsor terminated study|24|||
48995384|NCT00471237|157819367|FG006|Overall Study|Sponsor terminated study|0|||
48995385|NCT00471237|157819361|FG000|Overall Study|Non-compliance|0|||
48995386|NCT00471237|157819362|FG001|Overall Study|Non-compliance|1|||
48995387|NCT00471237|157819363|FG002|Overall Study|Non-compliance|0|||
48995388|NCT00471237|157819364|FG003|Overall Study|Non-compliance|1|||
48995389|NCT00471237|157819365|FG004|Overall Study|Non-compliance|0|||
48995390|NCT00471237|157819366|FG005|Overall Study|Non-compliance|0|||
48995391|NCT00471237|157819367|FG006|Overall Study|Non-compliance|0|||
48995392|NCT00471237|157819361|FG000|Overall Study|Met serum creatinine withdrawal criteria|1|||
48995393|NCT00471237|157819362|FG001|Overall Study|Met serum creatinine withdrawal criteria|0|||
48995394|NCT00471237|157819363|FG002|Overall Study|Met serum creatinine withdrawal criteria|2|||
48995395|NCT00471237|157819364|FG003|Overall Study|Met serum creatinine withdrawal criteria|2|||
48995396|NCT00471237|157819365|FG004|Overall Study|Met serum creatinine withdrawal criteria|0|||
48995397|NCT00471237|157819366|FG005|Overall Study|Met serum creatinine withdrawal criteria|0|||
48995398|NCT00471237|157819367|FG006|Overall Study|Met serum creatinine withdrawal criteria|0|||
48995399|NCT00471237|157819361|FG000|Overall Study|Early stopping due to non-efficacy|1|||
48995400|NCT00471237|157819362|FG001|Overall Study|Early stopping due to non-efficacy|0|||
48995401|NCT00471237|157819363|FG002|Overall Study|Early stopping due to non-efficacy|0|||
48995402|NCT00471237|157819364|FG003|Overall Study|Early stopping due to non-efficacy|0|||
48995403|NCT00471237|157819365|FG004|Overall Study|Early stopping due to non-efficacy|1|||
48995404|NCT00471237|157819366|FG005|Overall Study|Early stopping due to non-efficacy|0|||
48995405|NCT00471237|157819367|FG006|Overall Study|Early stopping due to non-efficacy|0|||
48995406|NCT00471237|157819361|FG000|Overall Study|Participant planned to travel to abraod|1|||
48995407|NCT00471237|157819362|FG001|Overall Study|Participant planned to travel to abraod|0|||
48995408|NCT00471237|157819363|FG002|Overall Study|Participant planned to travel to abraod|0|||
48995409|NCT00471237|157819364|FG003|Overall Study|Participant planned to travel to abraod|0|||
48995410|NCT00471237|157819365|FG004|Overall Study|Participant planned to travel to abraod|0|||
48995411|NCT00471237|157819366|FG005|Overall Study|Participant planned to travel to abraod|1|||
48995412|NCT00471237|157819367|FG006|Overall Study|Participant planned to travel to abraod|0|||
48995413|NCT00471237|157819361|FG000|Overall Study|High parathyroid hormone|0|||
48995414|NCT00471237|157819362|FG001|Overall Study|High parathyroid hormone|0|||
48995415|NCT00471237|157819363|FG002|Overall Study|High parathyroid hormone|1|||
48995416|NCT00471237|157819364|FG003|Overall Study|High parathyroid hormone|0|||
48995417|NCT00471237|157819365|FG004|Overall Study|High parathyroid hormone|0|||
48995418|NCT00471237|157819366|FG005|Overall Study|High parathyroid hormone|0|||
48995419|NCT00471237|157819367|FG006|Overall Study|High parathyroid hormone|0|||
48995420|NCT00471237|157819361|FG000|Overall Study|Participant lost medication|0|||
48995421|NCT00471237|157819362|FG001|Overall Study|Participant lost medication|0|||
48995422|NCT00471237|157819363|FG002|Overall Study|Participant lost medication|0|||
48995423|NCT00471237|157819364|FG003|Overall Study|Participant lost medication|0|||
48995424|NCT00471237|157819365|FG004|Overall Study|Participant lost medication|1|||
48995425|NCT00471237|157819366|FG005|Overall Study|Participant lost medication|0|||
48995426|NCT00471237|157819367|FG006|Overall Study|Participant lost medication|0|||
48995427|NCT00471237|157819361|FG000|Overall Study|Administration of prohibited medicine|0|||
48995428|NCT00471237|157819362|FG001|Overall Study|Administration of prohibited medicine|0|||
48995429|NCT00471237|157819363|FG002|Overall Study|Administration of prohibited medicine|0|||
48995430|NCT00471237|157819364|FG003|Overall Study|Administration of prohibited medicine|0|||
48995431|NCT00471237|157819365|FG004|Overall Study|Administration of prohibited medicine|1|||
48995432|NCT00471237|157819366|FG005|Overall Study|Administration of prohibited medicine|0|||
48995433|NCT00471237|157819367|FG006|Overall Study|Administration of prohibited medicine|0|||
48995434|NCT00471237|157819361|FG000|Overall Study|Participant shifted residence|0|||
48995435|NCT00471237|157819362|FG001|Overall Study|Participant shifted residence|0|||
48995436|NCT00471237|157819363|FG002|Overall Study|Participant shifted residence|0|||
48995437|NCT00471237|157819364|FG003|Overall Study|Participant shifted residence|0|||
48995438|NCT00471237|157819365|FG004|Overall Study|Participant shifted residence|1|||
48995439|NCT00471237|157819366|FG005|Overall Study|Participant shifted residence|0|||
48995440|NCT00471237|157819367|FG006|Overall Study|Participant shifted residence|0|||
48995441|NCT00471237|157819361|FG000|Overall Study|Participant's decision|0|||
48995442|NCT00471237|157819362|FG001|Overall Study|Participant's decision|0|||
48995443|NCT00471237|157819363|FG002|Overall Study|Participant's decision|0|||
48995444|NCT00471237|157819364|FG003|Overall Study|Participant's decision|0|||
48995445|NCT00471237|157819365|FG004|Overall Study|Participant's decision|0|||
48995446|NCT00471237|157819366|FG005|Overall Study|Participant's decision|1|||
48995447|NCT00471237|157819367|FG006|Overall Study|Participant's decision|0|||
48995448|NCT01590628|157819368|FG000|Overall Study|Death|2|||
48995449|NCT01590628|157819369|FG001|Overall Study|Death|0|||
48995450|NCT00593385|157819370|FG000|Overall Study|Death|14|||
48995451|NCT00593385|157819370|FG000|Overall Study|Lost to Follow-up|17|||
48995452|NCT00593385|157819370|FG000|Overall Study|Withdrawal by Subject|9|||
48995453|NCT00848965|157819372|FG000|Overall Study|Adverse Event|1|||
48995454|NCT00848965|157819372|FG000|Overall Study|Withdrawal by Subject|1|||
48995455|NCT04165824|157819377|FG000|Overall Study|Adverse Event|23|||
48995456|NCT04165824|157819377|FG000|Overall Study|Physician Decision|1|||
48995457|NCT04165824|157819377|FG000|Overall Study|Withdrawal by Subject|17|||
48995458|NCT04165824|157819377|FG000|Overall Study|Other|5|||
48995459|NCT00381680|157819378|FG000|Overall Study|Adverse Event|9|||
48995460|NCT00381680|157819379|FG001|Overall Study|Adverse Event|3|||
48995461|NCT00381680|157819378|FG000|Overall Study|Death|10|||
48995462|NCT00381680|157819379|FG001|Overall Study|Death|7|||
48995463|NCT00381680|157819378|FG000|Overall Study|Lost to Follow-up|3|||
48995464|NCT00381680|157819379|FG001|Overall Study|Lost to Follow-up|2|||
48995465|NCT00381680|157819378|FG000|Overall Study|Physician Decision|25|||
48995466|NCT00381680|157819379|FG001|Overall Study|Physician Decision|6|||
48995467|NCT00381680|157819378|FG000|Overall Study|Withdrawal by Subject|3|||
48995468|NCT00381680|157819379|FG001|Overall Study|Withdrawal by Subject|1|||
48995469|NCT00381680|157819378|FG000|Overall Study|Entry onto another COG Trial|1|||
48995470|NCT00381680|157819379|FG001|Overall Study|Entry onto another COG Trial|2|||
48995471|NCT00381680|157819378|FG000|Overall Study|Alternative Therapy|11|||
48995472|NCT00381680|157819379|FG001|Overall Study|Alternative Therapy|5|||
48995473|NCT00381680|157819378|FG000|Overall Study|Secondary Malignancy|3|||
48995474|NCT00381680|157819379|FG001|Overall Study|Secondary Malignancy|0|||
48995475|NCT00381680|157819378|FG000|Overall Study|Delay initiation|1|||
48995476|NCT00381680|157819379|FG001|Overall Study|Delay initiation|0|||
48995477|NCT00381680|157819378|FG000|Overall Study|Stem Cell Transplant|26|||
48995478|NCT00381680|157819379|FG001|Overall Study|Stem Cell Transplant|10|||
48995479|NCT00381680|157819378|FG000|Overall Study|Relapse|18|||
48995480|NCT00381680|157819379|FG001|Overall Study|Relapse|9|||
48995481|NCT00381680|157819378|FG000|Overall Study|Induction Failure|4|||
48995482|NCT00381680|157819379|FG001|Overall Study|Induction Failure|1|||
48995483|NCT00381680|157819378|FG000|Overall Study|Progression|1|||
48995484|NCT00381680|157819379|FG001|Overall Study|Progression|1|||
48995485|NCT00381680|157819378|FG000|Overall Study|Other not otherwise specified|7|||
48995486|NCT00381680|157819379|FG001|Overall Study|Other not otherwise specified|2|||
48995487|NCT00381680|157819378|FG000|Overall Study|Ineligible|3|||
48995488|NCT00381680|157819379|FG001|Overall Study|Ineligible|1|||
48995489|NCT00483574|157819380|FG000|Overall Study|Adverse Event|6|||
48995490|NCT00483574|157819381|FG001|Overall Study|Adverse Event|0|||
48995491|NCT00483574|157819380|FG000|Overall Study|Protocol Violation|28|||
48995492|NCT00483574|157819381|FG001|Overall Study|Protocol Violation|9|||
48995493|NCT00483574|157819380|FG000|Overall Study|Lost to Follow-up|16|||
48995494|NCT00483574|157819381|FG001|Overall Study|Lost to Follow-up|4|||
48995495|NCT00483574|157819380|FG000|Overall Study|Withdrawal by Subject|52|||
48995496|NCT00483574|157819381|FG001|Overall Study|Withdrawal by Subject|0|||
48995497|NCT00465101|157819382|FG000|Overall Study|Aborted Proc./Treatment Not Attempted|3|||
48995498|NCT00465101|157819382|FG000|Overall Study|Change in health precluded follow up|4|||
48995499|NCT00465101|157819382|FG000|Overall Study|Did not meet study criteria|4|||
48995500|NCT00465101|157819382|FG000|Overall Study|Lost to Follow-up|5|||
48995501|NCT00465101|157819382|FG000|Overall Study|Other|6|||
48995502|NCT00465101|157819382|FG000|Overall Study|Pt. Insurance not accepted at center|2|||
48995503|NCT00465101|157819382|FG000|Overall Study|Patient postponed procedure|1|||
48995504|NCT00465101|157819382|FG000|Overall Study|Site closed due to IRB expiration|1|||
48995505|NCT00465101|157819382|FG000|Overall Study|Unable to obtain IRB approval|1|||
48995506|NCT00465101|157819382|FG000|Overall Study|Death|3|||
48995507|NCT00465101|157819382|FG000|Overall Study|Withdrawal by Subject|25|||
48995508|NCT00465101|157819382|FG000|Overall Study|Physician Decision|1|||
48995509|NCT00465101|157819382|FG000|Overall Study|Withdrew consent prior to procedure|3|||
48995510|NCT03099096|157819383|FG000|Overall Study|Adverse Event|1|||
48995511|NCT03099096|157819383|FG000|Overall Study|Physician Decision|1|||
48995512|NCT00131937|157819384|FG000|Overall Study|Adverse Event|3|||
48995513|NCT00131937|157819384|FG000|Overall Study|Withdrawal by Subject|2|||
48995514|NCT00131937|157819384|FG000|Overall Study|Physician Decision|1|||
48995515|NCT00131937|157819384|FG000|Overall Study|Disease Progression|7|||
48995516|NCT00131937|157819384|FG000|Overall Study|Alternative therapy|1|||
48995517|NCT00910000|157819385|FG000|Overall Study|Adverse Event|0|||
48995518|NCT00910000|157819386|FG001|Overall Study|Adverse Event|3|||
48995519|NCT00910000|157819387|FG002|Overall Study|Adverse Event|2|||
48995520|NCT00910000|157819388|FG003|Overall Study|Adverse Event|2|||
48995521|NCT00910000|157819389|FG004|Overall Study|Adverse Event|0|||
48995522|NCT00910000|157819390|FG005|Overall Study|Adverse Event|1|||
48995523|NCT00910000|157819385|FG000|Overall Study|Withdrawal by Subject|0|||
48995524|NCT00910000|157819386|FG001|Overall Study|Withdrawal by Subject|0|||
48995525|NCT00910000|157819387|FG002|Overall Study|Withdrawal by Subject|1|||
48995526|NCT00910000|157819388|FG003|Overall Study|Withdrawal by Subject|0|||
48995527|NCT00910000|157819389|FG004|Overall Study|Withdrawal by Subject|1|||
48995528|NCT00910000|157819390|FG005|Overall Study|Withdrawal by Subject|0|||
48995529|NCT04409509|157819391|FG000|Overall Study|Failure to meet randomization requirement|1|||
48995530|NCT04409509|157819392|FG001|Overall Study|Failure to meet randomization requirement|0|||
48995531|NCT04409509|157819391|FG000|Overall Study|Adverse Event|0|||
48995532|NCT04409509|157819392|FG001|Overall Study|Adverse Event|1|||
48995533|NCT04409509|157819391|FG000|Overall Study|Death|11|||
48995534|NCT04409509|157819392|FG001|Overall Study|Death|10|||
48995535|NCT04409509|157819391|FG000|Overall Study|Non-compliance with study drug|0|||
48995536|NCT04409509|157819392|FG001|Overall Study|Non-compliance with study drug|1|||
48995537|NCT04409509|157819391|FG000|Overall Study|Lost to Follow-up|0|||
48995538|NCT04409509|157819392|FG001|Overall Study|Lost to Follow-up|3|||
48995539|NCT04409509|157819391|FG000|Overall Study|Withdrawal by Subject|0|||
48995540|NCT04409509|157819392|FG001|Overall Study|Withdrawal by Subject|3|||
48995541|NCT04409509|157819391|FG000|Overall Study|Randomized by mistake|0|||
48995542|NCT04409509|157819392|FG001|Overall Study|Randomized by mistake|1|||
48995543|NCT04409509|157819391|FG000|Overall Study|Other|1|||
48995544|NCT04409509|157819392|FG001|Overall Study|Other|1|||
48995545|NCT00903357|157819397|FG000|First Intervention|Withdrawal by Subject|5|||
48995546|NCT00903357|157819398|FG001|First Intervention|Withdrawal by Subject|3|||
48995547|NCT00903357|157819397|FG000|First Intervention|Flu|0|||
48995548|NCT00903357|157819398|FG001|First Intervention|Flu|1|||
48995549|NCT00903357|157819397|FG000|Wash Out Period of 2 Weeks|Flu|0|||
48995550|NCT00903357|157819398|FG001|Wash Out Period of 2 Weeks|Flu|1|||
48995551|NCT00903357|157819397|FG000|Second Intervention|Lost to Follow-up|1|||
48995552|NCT00903357|157819398|FG001|Second Intervention|Lost to Follow-up|0|||
48995553|NCT03426995|157819400|FG000|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
48995554|NCT03426995|157819401|FG001|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
48995555|NCT03426995|157819402|FG002|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1|||
48995556|NCT03426995|157819403|FG003|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
48995557|NCT03426995|157819404|FG004|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
48995558|NCT03426995|157819405|FG005|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
48995559|NCT03426995|157819406|FG006|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
48995560|NCT03426995|157819407|FG007|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
48995561|NCT03426995|157819408|FG008|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
48995562|NCT03426995|157819409|FG009|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
48995563|NCT03426995|157819410|FG010|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
48995564|NCT03426995|157819411|FG011|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
48995565|NCT03426995|157819412|FG012|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
48995566|NCT03426995|157819413|FG013|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
48995567|NCT03426995|157819414|FG014|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
48995568|NCT03426995|157819415|FG015|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
48995569|NCT03426995|157819416|FG016|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
48995570|NCT03426995|157819417|FG017|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
48995571|NCT03426995|157819418|FG018|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
48995572|NCT03426995|157819400|FG000|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
48995573|NCT03426995|157819401|FG001|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
48995574|NCT03426995|157819402|FG002|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
48995575|NCT03426995|157819403|FG003|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
48995576|NCT03426995|157819404|FG004|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
48995577|NCT03426995|157819405|FG005|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1|||
48995578|NCT03426995|157819406|FG006|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
48995579|NCT03426995|157819407|FG007|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
48995580|NCT03426995|157819408|FG008|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
48995581|NCT03426995|157819409|FG009|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
48995582|NCT03426995|157819410|FG010|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
48995583|NCT03426995|157819411|FG011|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
48995584|NCT03426995|157819412|FG012|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
48995585|NCT03426995|157819413|FG013|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
48995586|NCT03426995|157819414|FG014|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
48995587|NCT03426995|157819415|FG015|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
48995588|NCT03426995|157819416|FG016|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
49045833|NCT01894230|158002024|FG000|Overall Study|Withdrawal by Subject|4|||
48995589|NCT03426995|157819417|FG017|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
48995590|NCT03426995|157819418|FG018|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
48995591|NCT03426995|157819400|FG000|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
48995592|NCT03426995|157819401|FG001|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
48995593|NCT03426995|157819402|FG002|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
48995594|NCT03426995|157819403|FG003|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
48995595|NCT03426995|157819404|FG004|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
48995596|NCT03426995|157819405|FG005|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
48995597|NCT03426995|157819406|FG006|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
48995598|NCT03426995|157819407|FG007|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
48995599|NCT03426995|157819408|FG008|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
48995600|NCT03426995|157819409|FG009|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
48995601|NCT03426995|157819410|FG010|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
48995602|NCT03426995|157819411|FG011|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
48995603|NCT03426995|157819412|FG012|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
48995604|NCT03426995|157819413|FG013|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
48995605|NCT03426995|157819414|FG014|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
48995606|NCT03426995|157819415|FG015|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
48995607|NCT03426995|157819416|FG016|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
48995608|NCT03426995|157819417|FG017|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
48995609|NCT03426995|157819418|FG018|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
48995610|NCT03426995|157819400|FG000|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
48995611|NCT03426995|157819401|FG001|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
48995612|NCT03426995|157819402|FG002|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
48995613|NCT03426995|157819403|FG003|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
48995614|NCT03426995|157819404|FG004|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
48995615|NCT03426995|157819405|FG005|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
48995616|NCT03426995|157819406|FG006|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
48995617|NCT03426995|157819407|FG007|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
48995618|NCT03426995|157819408|FG008|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
48995619|NCT03426995|157819409|FG009|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
48995620|NCT03426995|157819410|FG010|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1|||
48995621|NCT03426995|157819411|FG011|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
48995622|NCT03426995|157819412|FG012|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
48995623|NCT03426995|157819413|FG013|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
48995624|NCT03426995|157819414|FG014|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
48995625|NCT03426995|157819415|FG015|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
48995626|NCT03426995|157819416|FG016|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
48995627|NCT03426995|157819417|FG017|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
48995628|NCT03426995|157819418|FG018|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
48995629|NCT03426995|157819400|FG000|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
48995630|NCT03426995|157819401|FG001|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
48995631|NCT03426995|157819402|FG002|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
48995632|NCT03426995|157819403|FG003|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
48995633|NCT03426995|157819404|FG004|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
48995634|NCT03426995|157819405|FG005|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
48995635|NCT03426995|157819406|FG006|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
48995636|NCT03426995|157819407|FG007|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1|||
48995637|NCT03426995|157819408|FG008|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
48995638|NCT03426995|157819409|FG009|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
48995639|NCT03426995|157819410|FG010|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
48995640|NCT03426995|157819411|FG011|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
48995641|NCT03426995|157819412|FG012|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
48995642|NCT03426995|157819413|FG013|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
48995643|NCT03426995|157819414|FG014|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
48995644|NCT03426995|157819415|FG015|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
48995645|NCT03426995|157819416|FG016|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
48995646|NCT03426995|157819417|FG017|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
48995647|NCT03426995|157819418|FG018|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
48995648|NCT03426995|157819400|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
48995649|NCT03426995|157819401|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
48995650|NCT03426995|157819402|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
48995651|NCT03426995|157819403|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
48995652|NCT03426995|157819404|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
48995653|NCT03426995|157819405|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
48995654|NCT03426995|157819406|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
48995655|NCT03426995|157819407|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
48995656|NCT03426995|157819408|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
48995657|NCT03426995|157819409|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
48995658|NCT03426995|157819410|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
48692617|NCT03001557|156724545|FG004|Core Phase|Randomized but not treated|0|||
48692618|NCT03001557|156724546|FG005|Core Phase|Randomized but not treated|0|||
48692619|NCT03001557|156724547|FG006|Core Phase|Randomized but not treated|0|||
48692620|NCT03001557|156724548|FG007|Core Phase|Randomized but not treated|0|||
48692621|NCT03001557|156724541|FG000|Extension Phase|Adverse Event|0|||
48692622|NCT03001557|156724542|FG001|Extension Phase|Adverse Event|0|||
48692623|NCT03001557|156724543|FG002|Extension Phase|Adverse Event|0|||
48692624|NCT03001557|156724544|FG003|Extension Phase|Adverse Event|0|||
48692625|NCT03001557|156724545|FG004|Extension Phase|Adverse Event|0|||
48692626|NCT03001557|156724546|FG005|Extension Phase|Adverse Event|2|||
48692627|NCT03001557|156724547|FG006|Extension Phase|Adverse Event|0|||
48692628|NCT03001557|156724548|FG007|Extension Phase|Adverse Event|0|||
48692629|NCT03001557|156724541|FG000|Extension Phase|Withdrawal by Subject|0|||
48692630|NCT03001557|156724542|FG001|Extension Phase|Withdrawal by Subject|0|||
48692631|NCT03001557|156724543|FG002|Extension Phase|Withdrawal by Subject|0|||
48692632|NCT03001557|156724544|FG003|Extension Phase|Withdrawal by Subject|0|||
48692633|NCT03001557|156724545|FG004|Extension Phase|Withdrawal by Subject|0|||
48692634|NCT03001557|156724546|FG005|Extension Phase|Withdrawal by Subject|1|||
48692635|NCT03001557|156724547|FG006|Extension Phase|Withdrawal by Subject|5|||
48692636|NCT03001557|156724548|FG007|Extension Phase|Withdrawal by Subject|2|||
48692637|NCT03001557|156724541|FG000|Extension Phase|Lost to Follow-up|0|||
48995659|NCT03426995|157819411|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
48995660|NCT03426995|157819412|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
48995661|NCT03426995|157819413|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
48995662|NCT03426995|157819414|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8|||
48995663|NCT03426995|157819415|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9|||
48995664|NCT03426995|157819416|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
48995665|NCT03426995|157819417|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
48995666|NCT03426995|157819418|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
48995667|NCT03426995|157819400|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
48995668|NCT03426995|157819401|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
48995669|NCT03426995|157819402|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
48995670|NCT03426995|157819403|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
48995671|NCT03426995|157819404|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
48995672|NCT03426995|157819405|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
48995673|NCT03426995|157819406|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
48995674|NCT03426995|157819407|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
48995675|NCT03426995|157819408|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
48995676|NCT03426995|157819409|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
48995677|NCT03426995|157819410|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
48995678|NCT03426995|157819411|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
48995679|NCT03426995|157819412|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
48995680|NCT03426995|157819413|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
48995681|NCT03426995|157819414|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1|||
48995682|NCT03426995|157819415|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3|||
48995683|NCT03426995|157819416|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
48995684|NCT03426995|157819417|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
48995685|NCT03426995|157819418|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
48995686|NCT02279888|157819419|FG000|Overall Study|Death|326|||
48995687|NCT02279888|157819419|FG000|Overall Study|Withdrawal by Subject|38|||
48995688|NCT02279888|157819419|FG000|Overall Study|Lost to Follow-up|21|||
48995689|NCT02279888|157819419|FG000|Overall Study|Physician Decision|62|||
48995690|NCT02279888|157819419|FG000|Overall Study|Subject Non-compliance|43|||
48995691|NCT02279888|157819419|FG000|Overall Study|Not implanted|14|||
48995692|NCT02279888|157819419|FG000|Overall Study|Visit not performed|26|||
48995693|NCT04505592|157819421|FG000|Overall Study|Death|2|||
48995694|NCT04505592|157819422|FG001|Overall Study|Death|1|||
48995695|NCT01683565|157819423|FG000|Overall Study|Lost to Follow-up|2|||
48995696|NCT01683565|157819424|FG001|Overall Study|Lost to Follow-up|0|||
48995697|NCT01683565|157819423|FG000|Overall Study|Discontinued Intervention|1|||
48995698|NCT01683565|157819424|FG001|Overall Study|Discontinued Intervention|1|||
48995699|NCT01241591|157821311|FG000|Overall Study|Lack of Efficacy|5|||
48995700|NCT01241591|157821312|FG001|Overall Study|Lack of Efficacy|2|||
48995701|NCT01241591|157821313|FG002|Overall Study|Lack of Efficacy|2|||
48995702|NCT01241591|157821314|FG003|Overall Study|Lack of Efficacy|3|||
48995703|NCT01241591|157821311|FG000|Overall Study|Protocol Violation|5|||
48995704|NCT01241591|157821312|FG001|Overall Study|Protocol Violation|2|||
48692638|NCT03001557|156724542|FG001|Extension Phase|Lost to Follow-up|0|||
48692639|NCT03001557|156724543|FG002|Extension Phase|Lost to Follow-up|0|||
48995705|NCT01241591|157821313|FG002|Overall Study|Protocol Violation|3|||
48995706|NCT01241591|157821314|FG003|Overall Study|Protocol Violation|0|||
48995707|NCT01241591|157821311|FG000|Overall Study|Lost to Follow-up|1|||
48995708|NCT01241591|157821312|FG001|Overall Study|Lost to Follow-up|2|||
48995709|NCT01241591|157821313|FG002|Overall Study|Lost to Follow-up|2|||
48995710|NCT01241591|157821314|FG003|Overall Study|Lost to Follow-up|2|||
48995711|NCT01241591|157821311|FG000|Overall Study|Screen Failure|3|||
48995712|NCT01241591|157821312|FG001|Overall Study|Screen Failure|2|||
48995713|NCT01241591|157821313|FG002|Overall Study|Screen Failure|1|||
48995714|NCT01241591|157821314|FG003|Overall Study|Screen Failure|0|||
48995715|NCT01241591|157821311|FG000|Overall Study|Withdrawal by Subject|6|||
48995716|NCT01241591|157821312|FG001|Overall Study|Withdrawal by Subject|4|||
48995717|NCT01241591|157821313|FG002|Overall Study|Withdrawal by Subject|2|||
48995718|NCT01241591|157821314|FG003|Overall Study|Withdrawal by Subject|2|||
48995719|NCT01241591|157821311|FG000|Overall Study|Other|0|||
48995720|NCT01241591|157821312|FG001|Overall Study|Other|1|||
48995721|NCT01241591|157821313|FG002|Overall Study|Other|0|||
48995722|NCT01241591|157821314|FG003|Overall Study|Other|1|||
48995723|NCT01241591|157821311|FG000|Overall Study|Adverse Event|3|||
48995724|NCT01241591|157821312|FG001|Overall Study|Adverse Event|11|||
48995725|NCT01241591|157821313|FG002|Overall Study|Adverse Event|12|||
48995726|NCT01241591|157821314|FG003|Overall Study|Adverse Event|4|||
48995727|NCT05111548|157821315|FG000|Overall Study|Withdrawal by Subject|2|||
48995728|NCT05111548|157821316|FG001|Overall Study|Withdrawal by Subject|1|||
48995729|NCT05111548|157821315|FG000|Overall Study|Adverse Event|1|||
48995730|NCT05111548|157821316|FG001|Overall Study|Adverse Event|0|||
48995731|NCT01846039|157821317|FG000|Overall Study|Protocol Violation|1|||
48995732|NCT01846039|157821317|FG000|Overall Study|Subject Withdrew Consent|1|||
48995733|NCT00379639|157821318|FG000|Overall Study|Disease Progression|3|||
48995734|NCT00379639|157821319|FG001|Overall Study|Disease Progression|3|||
48995735|NCT00379639|157821320|FG002|Overall Study|Disease Progression|3|||
48995736|NCT00379639|157821321|FG003|Overall Study|Disease Progression|4|||
48995737|NCT00379639|157821322|FG004|Overall Study|Disease Progression|4|||
48995738|NCT00379639|157821318|FG000|Overall Study|Physician Decision|0|||
48995739|NCT00379639|157821319|FG001|Overall Study|Physician Decision|2|||
48995740|NCT00379639|157821320|FG002|Overall Study|Physician Decision|1|||
48995741|NCT00379639|157821321|FG003|Overall Study|Physician Decision|1|||
48995742|NCT00379639|157821322|FG004|Overall Study|Physician Decision|0|||
48995743|NCT00379639|157821318|FG000|Overall Study|Symptomatic Deterioration|0|||
48995744|NCT00379639|157821319|FG001|Overall Study|Symptomatic Deterioration|0|||
48995745|NCT00379639|157821320|FG002|Overall Study|Symptomatic Deterioration|1|||
48995746|NCT00379639|157821321|FG003|Overall Study|Symptomatic Deterioration|0|||
48995747|NCT00379639|157821322|FG004|Overall Study|Symptomatic Deterioration|1|||
48995748|NCT00379639|157821318|FG000|Overall Study|Adverse Event|0|||
48995749|NCT00379639|157821319|FG001|Overall Study|Adverse Event|0|||
48995750|NCT00379639|157821320|FG002|Overall Study|Adverse Event|1|||
48995751|NCT00379639|157821321|FG003|Overall Study|Adverse Event|0|||
48995752|NCT00379639|157821322|FG004|Overall Study|Adverse Event|1|||
48995753|NCT00379639|157821318|FG000|Overall Study|Lost to Follow-up|0|||
48995754|NCT00379639|157821319|FG001|Overall Study|Lost to Follow-up|0|||
48995755|NCT00379639|157821320|FG002|Overall Study|Lost to Follow-up|0|||
48995756|NCT00379639|157821321|FG003|Overall Study|Lost to Follow-up|1|||
48995757|NCT00379639|157821322|FG004|Overall Study|Lost to Follow-up|0|||
48995758|NCT00379639|157821318|FG000|Overall Study|Other|0|||
48995759|NCT00379639|157821319|FG001|Overall Study|Other|0|||
48995760|NCT00379639|157821320|FG002|Overall Study|Other|3|||
48995761|NCT00379639|157821321|FG003|Overall Study|Other|0|||
48995762|NCT00379639|157821322|FG004|Overall Study|Other|0|||
48995763|NCT00594958|157821323|FG000|Overall Study|Withdrawal by Subject|1|||
48995764|NCT00594958|157821324|FG001|Overall Study|Withdrawal by Subject|0|||
48995765|NCT00594958|157821325|FG002|Overall Study|Withdrawal by Subject|1|||
48995766|NCT00594958|157821323|FG000|Overall Study|Adverse Event|4|||
48995767|NCT00594958|157821324|FG001|Overall Study|Adverse Event|1|||
48995768|NCT00594958|157821325|FG002|Overall Study|Adverse Event|2|||
48995769|NCT00594958|157821323|FG000|Overall Study|Pregnancy|0|||
48995770|NCT00594958|157821324|FG001|Overall Study|Pregnancy|2|||
48995771|NCT00594958|157821325|FG002|Overall Study|Pregnancy|0|||
48995772|NCT00594958|157821323|FG000|Overall Study|Protocol Violation|1|||
48995773|NCT00594958|157821324|FG001|Overall Study|Protocol Violation|0|||
48995774|NCT00594958|157821325|FG002|Overall Study|Protocol Violation|2|||
48995775|NCT00594958|157821323|FG000|Overall Study|Lost to Follow-up|5|||
48995776|NCT00594958|157821324|FG001|Overall Study|Lost to Follow-up|0|||
48995777|NCT00594958|157821325|FG002|Overall Study|Lost to Follow-up|3|||
48995778|NCT00594958|157821323|FG000|Overall Study|administrative|3|||
49045834|NCT01894230|158002025|FG001|Overall Study|Withdrawal by Subject|4|||
48995779|NCT00594958|157821324|FG001|Overall Study|administrative|0|||
48995780|NCT00594958|157821325|FG002|Overall Study|administrative|2|||
48995781|NCT01945034|157821326|FG000|Overall Study|Medication Error|0|||
48995782|NCT01945034|157821327|FG001|Overall Study|Medication Error|1|||
48995783|NCT01945034|157821328|FG002|Overall Study|Medication Error|0|||
48995784|NCT01945034|157821326|FG000|Overall Study|Withdrawal by Subject|0|||
48995785|NCT01945034|157821327|FG001|Overall Study|Withdrawal by Subject|3|||
48995786|NCT01945034|157821328|FG002|Overall Study|Withdrawal by Subject|1|||
48995787|NCT01945034|157821326|FG000|Overall Study|Other|0|||
48995788|NCT01945034|157821327|FG001|Overall Study|Other|1|||
48995789|NCT01945034|157821328|FG002|Overall Study|Other|3|||
48995790|NCT01945034|157821326|FG000|Overall Study|Lost to Follow-up|0|||
48995791|NCT01945034|157821327|FG001|Overall Study|Lost to Follow-up|0|||
48995792|NCT01945034|157821328|FG002|Overall Study|Lost to Follow-up|2|||
48995793|NCT01945034|157821326|FG000|Overall Study|Protocol Violation|1|||
48995794|NCT01945034|157821327|FG001|Overall Study|Protocol Violation|0|||
48995795|NCT01945034|157821328|FG002|Overall Study|Protocol Violation|1|||
48995796|NCT01798056|157821335|FG000|Overall Study|Serious Adverse Event|13|||
48995797|NCT01798056|157821336|FG001|Overall Study|Serious Adverse Event|12|||
48995798|NCT01798056|157821335|FG000|Overall Study|Withdrawal by Subject|12|||
48995799|NCT01798056|157821336|FG001|Overall Study|Withdrawal by Subject|9|||
48995800|NCT01798056|157821335|FG000|Overall Study|Migrated/moved from study area|1|||
48995801|NCT01798056|157821336|FG001|Overall Study|Migrated/moved from study area|1|||
48995802|NCT01798056|157821335|FG000|Overall Study|Lost to Follow-up|1|||
48995803|NCT01798056|157821336|FG001|Overall Study|Lost to Follow-up|1|||
48995804|NCT01798056|157821335|FG000|Overall Study|Other|0|||
48995805|NCT01798056|157821336|FG001|Overall Study|Other|2|||
48995806|NCT02147132|157821337|FG000|Overall Study|Lost to Follow-up|1|||
48995807|NCT02147132|157821338|FG001|Overall Study|Lost to Follow-up|0|||
48995808|NCT02147132|157821339|FG002|Overall Study|Lost to Follow-up|0|||
48995809|NCT02147132|157821340|FG003|Overall Study|Lost to Follow-up|0|||
48995810|NCT01013207|157821341|FG000|CPAP Post Nexus (S9)|Lost to Follow-up|6|||
48995811|NCT00489411|157821342|FG000|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6|||
48995812|NCT00489411|157821343|FG001|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5|||
48995813|NCT00489411|157821342|FG000|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21|||
48995814|NCT00489411|157821343|FG001|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12|||
48995815|NCT00489411|157821342|FG000|Initial Treatment Period (Weeks 1-5)|Incomplete data|1|||
48995816|NCT00489411|157821343|FG001|Initial Treatment Period (Weeks 1-5)|Incomplete data|5|||
48995817|NCT00489411|157821342|FG000|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11|||
48995818|NCT00489411|157821343|FG001|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12|||
48995819|NCT00489411|157821342|FG000|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
48995820|NCT00489411|157821343|FG001|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
48995821|NCT01298362|157821346|FG000|Overall Study|Did not provide 12month BMD measurements|38|||
48995822|NCT01298362|157821347|FG001|Overall Study|Did not provide 12month BMD measurements|43|||
48995823|NCT01976104|157821354|FG000|Overall Study|Adverse Event|0|||
48995824|NCT01976104|157821355|FG001|Overall Study|Adverse Event|0|||
48995825|NCT01976104|157821356|FG002|Overall Study|Adverse Event|1|||
48995826|NCT01976104|157821357|FG003|Overall Study|Adverse Event|0|||
48995827|NCT01976104|157821354|FG000|Overall Study|Lost to Follow-up|3|||
48995828|NCT01976104|157821355|FG001|Overall Study|Lost to Follow-up|0|||
48995829|NCT01976104|157821356|FG002|Overall Study|Lost to Follow-up|1|||
48995830|NCT01976104|157821357|FG003|Overall Study|Lost to Follow-up|1|||
48995831|NCT01976104|157821354|FG000|Overall Study|Subject Choice|0|||
48995832|NCT01976104|157821355|FG001|Overall Study|Subject Choice|1|||
48995833|NCT01976104|157821356|FG002|Overall Study|Subject Choice|0|||
48995834|NCT01976104|157821357|FG003|Overall Study|Subject Choice|1|||
48995835|NCT01976104|157821354|FG000|Overall Study|Withdrawal by Subject|3|||
48995836|NCT01976104|157821355|FG001|Overall Study|Withdrawal by Subject|0|||
48995837|NCT01976104|157821356|FG002|Overall Study|Withdrawal by Subject|0|||
48995838|NCT01976104|157821357|FG003|Overall Study|Withdrawal by Subject|1|||
48995839|NCT01976104|157821354|FG000|Overall Study|Other|0|||
48995840|NCT01976104|157821355|FG001|Overall Study|Other|1|||
48995841|NCT01976104|157821356|FG002|Overall Study|Other|0|||
48995842|NCT01976104|157821357|FG003|Overall Study|Other|0|||
48995843|NCT01317199|157821358|FG000|Dose-escalation Phase 1|Physician Decision|5|||
48995844|NCT01317199|157821359|FG001|Dose-escalation Phase 1|Physician Decision|0|||
48995845|NCT01317199|157821360|FG002|Dose-escalation Phase 1|Physician Decision|0|||
48995846|NCT01317199|157821361|FG003|Dose-escalation Phase 1|Physician Decision|0|||
48995847|NCT01317199|157821358|FG000|Dose-escalation Phase 1|Disease progression|1|||
48995848|NCT01317199|157821359|FG001|Dose-escalation Phase 1|Disease progression|0|||
48692640|NCT03001557|156724544|FG003|Extension Phase|Lost to Follow-up|0|||
48995849|NCT01317199|157821360|FG002|Dose-escalation Phase 1|Disease progression|0|||
48995850|NCT01317199|157821361|FG003|Dose-escalation Phase 1|Disease progression|0|||
48995851|NCT01317199|157821358|FG000|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1|||
48995852|NCT01317199|157821359|FG001|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
48995853|NCT01317199|157821360|FG002|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
48995854|NCT01317199|157821361|FG003|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
48995855|NCT01317199|157821358|FG000|Randomized Phase 2|Disease progression|0|||
48995856|NCT01317199|157821359|FG001|Randomized Phase 2|Disease progression|3|||
48995857|NCT01317199|157821360|FG002|Randomized Phase 2|Disease progression|7|||
48995858|NCT01317199|157821361|FG003|Randomized Phase 2|Disease progression|5|||
48995859|NCT01317199|157821358|FG000|Randomized Phase 2|Withdrawal by Subject|0|||
48995860|NCT01317199|157821359|FG001|Randomized Phase 2|Withdrawal by Subject|3|||
48995861|NCT01317199|157821360|FG002|Randomized Phase 2|Withdrawal by Subject|5|||
48995862|NCT01317199|157821361|FG003|Randomized Phase 2|Withdrawal by Subject|4|||
48995863|NCT01317199|157821358|FG000|Randomized Phase 2|Adverse Event|0|||
48995864|NCT01317199|157821359|FG001|Randomized Phase 2|Adverse Event|0|||
48995865|NCT01317199|157821360|FG002|Randomized Phase 2|Adverse Event|0|||
48995866|NCT01317199|157821361|FG003|Randomized Phase 2|Adverse Event|1|||
48995867|NCT01317199|157821358|FG000|Randomized Phase 2|Comorbidities|0|||
48995868|NCT01317199|157821359|FG001|Randomized Phase 2|Comorbidities|2|||
48995869|NCT01317199|157821360|FG002|Randomized Phase 2|Comorbidities|2|||
48995870|NCT01317199|157821361|FG003|Randomized Phase 2|Comorbidities|2|||
48995871|NCT01317199|157821358|FG000|Randomized Phase 2|Rising PSA, not as defined by protocol|0|||
48995872|NCT01317199|157821359|FG001|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
48995873|NCT01317199|157821360|FG002|Randomized Phase 2|Rising PSA, not as defined by protocol|5|||
48995874|NCT01317199|157821361|FG003|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
48995875|NCT01317199|157821358|FG000|Randomized Phase 2|Disenrolled before treatment|0|||
48995876|NCT01317199|157821359|FG001|Randomized Phase 2|Disenrolled before treatment|1|||
48995877|NCT01317199|157821360|FG002|Randomized Phase 2|Disenrolled before treatment|1|||
48995878|NCT01317199|157821361|FG003|Randomized Phase 2|Disenrolled before treatment|2|||
48995879|NCT01317199|157821358|FG000|Randomized Phase 2|Patient stopped taking study drug|0|||
48995880|NCT01317199|157821359|FG001|Randomized Phase 2|Patient stopped taking study drug|0|||
48995881|NCT01317199|157821360|FG002|Randomized Phase 2|Patient stopped taking study drug|0|||
48995882|NCT01317199|157821361|FG003|Randomized Phase 2|Patient stopped taking study drug|1|||
48995883|NCT01317199|157821358|FG000|Randomized Phase 2|Patient transferred to other facility|0|||
48995884|NCT01317199|157821359|FG001|Randomized Phase 2|Patient transferred to other facility|0|||
48995885|NCT01317199|157821360|FG002|Randomized Phase 2|Patient transferred to other facility|1|||
48995886|NCT01317199|157821361|FG003|Randomized Phase 2|Patient transferred to other facility|0|||
48995887|NCT01353209|157821362|FG000|Overall Study|Adverse Event|1|||
48995888|NCT01353209|157821363|FG001|Overall Study|Adverse Event|1|||
48995889|NCT01283009|157821364|FG000|Overall Study|Death|83|||
48995890|NCT01283009|157821365|FG001|Overall Study|Death|78|||
48995891|NCT01283009|157821364|FG000|Overall Study|Study ended early|23|||
48995892|NCT01283009|157821365|FG001|Overall Study|Study ended early|26|||
48995893|NCT01283009|157821364|FG000|Overall Study|Withdrawal by Subject|10|||
48995894|NCT01283009|157821365|FG001|Overall Study|Withdrawal by Subject|8|||
48995895|NCT01283009|157821364|FG000|Overall Study|Physician Decision|1|||
48995896|NCT01283009|157821365|FG001|Overall Study|Physician Decision|1|||
48995897|NCT01283009|157821364|FG000|Overall Study|Lost to Follow-up|1|||
48995898|NCT01283009|157821365|FG001|Overall Study|Lost to Follow-up|0|||
48995899|NCT01283009|157821364|FG000|Overall Study|Patient Withdrawn by LAR/DPOA|0|||
48995900|NCT01283009|157821365|FG001|Overall Study|Patient Withdrawn by LAR/DPOA|4|||
48995901|NCT01374516|157821369|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|43|||
48995902|NCT01374516|157821370|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|14|||
48995903|NCT01374516|157821369|FG000|Vaccination Phase (Up to 25 Months)|Adverse Event|3|||
48995904|NCT01374516|157821370|FG001|Vaccination Phase (Up to 25 Months)|Adverse Event|0|||
48995905|NCT01374516|157821369|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480|||
48995906|NCT01374516|157821370|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240|||
48995907|NCT01374516|157821369|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106|||
48995908|NCT01374516|157821370|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46|||
48995909|NCT01374516|157821369|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|7|||
48995910|NCT01374516|157821370|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|9|||
48995911|NCT01374516|157821369|FG000|Surveillance Expansion Period|Protocol Violation|386|||
48995912|NCT01374516|157821370|FG001|Surveillance Expansion Period|Protocol Violation|217|||
48995913|NCT01374516|157821369|FG000|Surveillance Expansion Period|Withdrawal by Subject|1870|||
48995914|NCT01374516|157821370|FG001|Surveillance Expansion Period|Withdrawal by Subject|986|||
48995915|NCT01374516|157821369|FG000|Surveillance Expansion Period|Lost to Follow-up|73|||
48995916|NCT01374516|157821370|FG001|Surveillance Expansion Period|Lost to Follow-up|45|||
48995917|NCT01374516|157821369|FG000|Surveillance Expansion Period|Serious adverse event|20|||
48995918|NCT01374516|157821370|FG001|Surveillance Expansion Period|Serious adverse event|5|||
48995919|NCT04822701|157821376|FG000|Overall Study|Not treated|2|||
48995920|NCT04822701|157821377|FG001|Overall Study|Not treated|0|||
48995921|NCT04822701|157821376|FG000|Overall Study|Lost to Follow-up|1|||
48995922|NCT04822701|157821377|FG001|Overall Study|Lost to Follow-up|0|||
48995923|NCT04822701|157821376|FG000|Overall Study|Withdrawal by Subject|1|||
48995924|NCT04822701|157821377|FG001|Overall Study|Withdrawal by Subject|0|||
48995925|NCT04640168|157821381|FG000|Overall Study|Withdrawal by Subject|8|||
48995926|NCT04640168|157821382|FG001|Overall Study|Withdrawal by Subject|7|||
48995927|NCT04640168|157821381|FG000|Overall Study|Lost to Follow-up|1|||
48995928|NCT04640168|157821382|FG001|Overall Study|Lost to Follow-up|0|||
48995929|NCT04640168|157821381|FG000|Overall Study|Enrolled but not treated|12|||
48995930|NCT04640168|157821382|FG001|Overall Study|Enrolled but not treated|12|||
48995931|NCT04988035|157821383|FG000|Overall Study|Death|19|||
48995932|NCT04988035|157821384|FG001|Overall Study|Death|13|||
48995933|NCT04988035|157821383|FG000|Overall Study|Lost to Follow-up|12|||
48995934|NCT04988035|157821384|FG001|Overall Study|Lost to Follow-up|6|||
48995935|NCT04988035|157821383|FG000|Overall Study|Protocol Violation|0|||
48995936|NCT04988035|157821384|FG001|Overall Study|Protocol Violation|1|||
48995937|NCT04988035|157821383|FG000|Overall Study|Withdrawal by Subject|2|||
48995938|NCT04988035|157821384|FG001|Overall Study|Withdrawal by Subject|4|||
48995939|NCT04988035|157821383|FG000|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
48995940|NCT04988035|157821384|FG001|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
48995941|NCT03532048|157821386|FG000|Overall Study|Lost to Follow-up|12|||
48995942|NCT03532048|157821387|FG001|Overall Study|Lost to Follow-up|17|||
48995943|NCT03532048|157821386|FG000|Overall Study|Withdrawal by Subject|7|||
48995944|NCT03532048|157821387|FG001|Overall Study|Withdrawal by Subject|0|||
48995945|NCT00483119|157821390|FG000|Overall Study|Adverse Event|0|||
48995946|NCT00483119|157821391|FG001|Overall Study|Adverse Event|1|||
48995947|NCT00483119|157821390|FG000|Overall Study|Physician Decision|1|||
48995948|NCT00483119|157821391|FG001|Overall Study|Physician Decision|0|||
48995949|NCT04668066|157821394|FG000|Part 1: Treatment Phase|Adverse Event|0|||
48995950|NCT04668066|157821395|FG001|Part 1: Treatment Phase|Adverse Event|0|||
48995951|NCT04668066|157821396|FG002|Part 1: Treatment Phase|Adverse Event|0|||
48995952|NCT04668066|157821397|FG003|Part 1: Treatment Phase|Adverse Event|0|||
48995953|NCT04668066|157821398|FG004|Part 1: Treatment Phase|Adverse Event|0|||
48995954|NCT04668066|157821399|FG005|Part 1: Treatment Phase|Adverse Event|0|||
48995955|NCT04668066|157821400|FG006|Part 1: Treatment Phase|Adverse Event|0|||
48995956|NCT04668066|157821401|FG007|Part 1: Treatment Phase|Adverse Event|0|||
48995957|NCT04668066|157821402|FG008|Part 1: Treatment Phase|Adverse Event|0|||
48995958|NCT04668066|157821403|FG009|Part 1: Treatment Phase|Adverse Event|0|||
48995959|NCT04668066|157821404|FG010|Part 1: Treatment Phase|Adverse Event|0|||
48995960|NCT04668066|157821405|FG011|Part 1: Treatment Phase|Adverse Event|1|||
48995961|NCT04668066|157821406|FG012|Part 1: Treatment Phase|Adverse Event|1|||
48995962|NCT04668066|157821407|FG013|Part 1: Treatment Phase|Adverse Event|0|||
48995963|NCT04668066|157821408|FG014|Part 1: Treatment Phase|Adverse Event|0|||
48995964|NCT04668066|157821409|FG015|Part 1: Treatment Phase|Adverse Event|0|||
48995965|NCT04668066|157821410|FG016|Part 1: Treatment Phase|Adverse Event|0|||
48995966|NCT04668066|157821411|FG017|Part 1: Treatment Phase|Adverse Event|0|||
48995967|NCT04668066|157821412|FG018|Part 1: Treatment Phase|Adverse Event|0|||
48995968|NCT04668066|157821394|FG000|Part 1: Treatment Phase|Lost to Follow-up|0|||
48995969|NCT04668066|157821395|FG001|Part 1: Treatment Phase|Lost to Follow-up|0|||
48995970|NCT04668066|157821396|FG002|Part 1: Treatment Phase|Lost to Follow-up|1|||
48995971|NCT04668066|157821397|FG003|Part 1: Treatment Phase|Lost to Follow-up|0|||
48995972|NCT04668066|157821398|FG004|Part 1: Treatment Phase|Lost to Follow-up|0|||
48995973|NCT04668066|157821399|FG005|Part 1: Treatment Phase|Lost to Follow-up|0|||
48995974|NCT04668066|157821400|FG006|Part 1: Treatment Phase|Lost to Follow-up|0|||
48995975|NCT04668066|157821401|FG007|Part 1: Treatment Phase|Lost to Follow-up|0|||
48995976|NCT04668066|157821402|FG008|Part 1: Treatment Phase|Lost to Follow-up|0|||
48995977|NCT04668066|157821403|FG009|Part 1: Treatment Phase|Lost to Follow-up|0|||
48995978|NCT04668066|157821404|FG010|Part 1: Treatment Phase|Lost to Follow-up|0|||
48995979|NCT04668066|157821405|FG011|Part 1: Treatment Phase|Lost to Follow-up|0|||
48995980|NCT04668066|157821406|FG012|Part 1: Treatment Phase|Lost to Follow-up|0|||
48995981|NCT04668066|157821407|FG013|Part 1: Treatment Phase|Lost to Follow-up|0|||
48995982|NCT04668066|157821408|FG014|Part 1: Treatment Phase|Lost to Follow-up|0|||
48995983|NCT04668066|157821409|FG015|Part 1: Treatment Phase|Lost to Follow-up|0|||
48995984|NCT04668066|157821410|FG016|Part 1: Treatment Phase|Lost to Follow-up|0|||
48995985|NCT04668066|157821411|FG017|Part 1: Treatment Phase|Lost to Follow-up|0|||
48995986|NCT04668066|157821412|FG018|Part 1: Treatment Phase|Lost to Follow-up|0|||
48995987|NCT04668066|157821394|FG000|Part 1: Treatment Phase|Other|0|||
48995988|NCT04668066|157821395|FG001|Part 1: Treatment Phase|Other|0|||
48995989|NCT04668066|157821396|FG002|Part 1: Treatment Phase|Other|0|||
48995990|NCT04668066|157821397|FG003|Part 1: Treatment Phase|Other|0|||
48995991|NCT04668066|157821398|FG004|Part 1: Treatment Phase|Other|0|||
48995992|NCT04668066|157821399|FG005|Part 1: Treatment Phase|Other|0|||
48995993|NCT04668066|157821400|FG006|Part 1: Treatment Phase|Other|0|||
48995994|NCT04668066|157821401|FG007|Part 1: Treatment Phase|Other|0|||
48995995|NCT04668066|157821402|FG008|Part 1: Treatment Phase|Other|0|||
48995996|NCT04668066|157821403|FG009|Part 1: Treatment Phase|Other|0|||
48995997|NCT04668066|157821404|FG010|Part 1: Treatment Phase|Other|0|||
48995998|NCT04668066|157821405|FG011|Part 1: Treatment Phase|Other|1|||
48995999|NCT04668066|157821406|FG012|Part 1: Treatment Phase|Other|0|||
48996000|NCT04668066|157821407|FG013|Part 1: Treatment Phase|Other|0|||
48996001|NCT04668066|157821408|FG014|Part 1: Treatment Phase|Other|0|||
48996002|NCT04668066|157821409|FG015|Part 1: Treatment Phase|Other|0|||
48996003|NCT04668066|157821410|FG016|Part 1: Treatment Phase|Other|0|||
48996004|NCT04668066|157821411|FG017|Part 1: Treatment Phase|Other|0|||
48996005|NCT04668066|157821412|FG018|Part 1: Treatment Phase|Other|0|||
48996006|NCT04668066|157821394|FG000|Part 1: Treatment Phase|Withdrawal by Subject|0|||
48996007|NCT04668066|157821395|FG001|Part 1: Treatment Phase|Withdrawal by Subject|0|||
48996008|NCT04668066|157821396|FG002|Part 1: Treatment Phase|Withdrawal by Subject|0|||
48996009|NCT04668066|157821397|FG003|Part 1: Treatment Phase|Withdrawal by Subject|0|||
48996010|NCT04668066|157821398|FG004|Part 1: Treatment Phase|Withdrawal by Subject|0|||
48996011|NCT04668066|157821399|FG005|Part 1: Treatment Phase|Withdrawal by Subject|0|||
48996012|NCT04668066|157821400|FG006|Part 1: Treatment Phase|Withdrawal by Subject|0|||
48996013|NCT04668066|157821401|FG007|Part 1: Treatment Phase|Withdrawal by Subject|0|||
48996014|NCT04668066|157821402|FG008|Part 1: Treatment Phase|Withdrawal by Subject|0|||
48996015|NCT04668066|157821403|FG009|Part 1: Treatment Phase|Withdrawal by Subject|0|||
48996016|NCT04668066|157821404|FG010|Part 1: Treatment Phase|Withdrawal by Subject|0|||
48996017|NCT04668066|157821405|FG011|Part 1: Treatment Phase|Withdrawal by Subject|0|||
48996018|NCT04668066|157821406|FG012|Part 1: Treatment Phase|Withdrawal by Subject|1|||
48996019|NCT04668066|157821407|FG013|Part 1: Treatment Phase|Withdrawal by Subject|0|||
48996020|NCT04668066|157821408|FG014|Part 1: Treatment Phase|Withdrawal by Subject|0|||
48996021|NCT04668066|157821409|FG015|Part 1: Treatment Phase|Withdrawal by Subject|2|||
48996022|NCT04668066|157821410|FG016|Part 1: Treatment Phase|Withdrawal by Subject|0|||
48996023|NCT04668066|157821411|FG017|Part 1: Treatment Phase|Withdrawal by Subject|0|||
48996024|NCT04668066|157821412|FG018|Part 1: Treatment Phase|Withdrawal by Subject|0|||
48996025|NCT04668066|157821394|FG000|Part 1: Follow-Up|Adverse Event|0|||
48996026|NCT04668066|157821395|FG001|Part 1: Follow-Up|Adverse Event|0|||
48996027|NCT04668066|157821396|FG002|Part 1: Follow-Up|Adverse Event|0|||
48996028|NCT04668066|157821397|FG003|Part 1: Follow-Up|Adverse Event|0|||
48996029|NCT04668066|157821398|FG004|Part 1: Follow-Up|Adverse Event|0|||
48996030|NCT04668066|157821399|FG005|Part 1: Follow-Up|Adverse Event|0|||
48996031|NCT04668066|157821400|FG006|Part 1: Follow-Up|Adverse Event|0|||
48996032|NCT04668066|157821401|FG007|Part 1: Follow-Up|Adverse Event|0|||
48996033|NCT04668066|157821402|FG008|Part 1: Follow-Up|Adverse Event|0|||
48996034|NCT04668066|157821403|FG009|Part 1: Follow-Up|Adverse Event|0|||
48996035|NCT04668066|157821404|FG010|Part 1: Follow-Up|Adverse Event|0|||
48996036|NCT04668066|157821405|FG011|Part 1: Follow-Up|Adverse Event|1|||
48996037|NCT04668066|157821406|FG012|Part 1: Follow-Up|Adverse Event|0|||
48996038|NCT04668066|157821407|FG013|Part 1: Follow-Up|Adverse Event|0|||
48996039|NCT04668066|157821408|FG014|Part 1: Follow-Up|Adverse Event|0|||
48996040|NCT04668066|157821409|FG015|Part 1: Follow-Up|Adverse Event|0|||
48996041|NCT04668066|157821410|FG016|Part 1: Follow-Up|Adverse Event|0|||
48996042|NCT04668066|157821411|FG017|Part 1: Follow-Up|Adverse Event|0|||
48996043|NCT04668066|157821412|FG018|Part 1: Follow-Up|Adverse Event|0|||
48996044|NCT04668066|157821394|FG000|Part 1: Follow-Up|Other|0|||
48996045|NCT04668066|157821395|FG001|Part 1: Follow-Up|Other|0|||
48996046|NCT04668066|157821396|FG002|Part 1: Follow-Up|Other|0|||
48996047|NCT04668066|157821397|FG003|Part 1: Follow-Up|Other|0|||
48996048|NCT04668066|157821398|FG004|Part 1: Follow-Up|Other|0|||
48996049|NCT04668066|157821399|FG005|Part 1: Follow-Up|Other|0|||
48996050|NCT04668066|157821400|FG006|Part 1: Follow-Up|Other|0|||
48996051|NCT04668066|157821401|FG007|Part 1: Follow-Up|Other|0|||
48996052|NCT04668066|157821402|FG008|Part 1: Follow-Up|Other|0|||
48996053|NCT04668066|157821403|FG009|Part 1: Follow-Up|Other|0|||
48996054|NCT04668066|157821404|FG010|Part 1: Follow-Up|Other|0|||
48996055|NCT04668066|157821405|FG011|Part 1: Follow-Up|Other|1|||
48996056|NCT04668066|157821406|FG012|Part 1: Follow-Up|Other|1|||
48996057|NCT04668066|157821407|FG013|Part 1: Follow-Up|Other|0|||
48996058|NCT04668066|157821408|FG014|Part 1: Follow-Up|Other|0|||
48996059|NCT04668066|157821409|FG015|Part 1: Follow-Up|Other|0|||
48996060|NCT04668066|157821410|FG016|Part 1: Follow-Up|Other|0|||
48996061|NCT04668066|157821411|FG017|Part 1: Follow-Up|Other|0|||
48996062|NCT04668066|157821412|FG018|Part 1: Follow-Up|Other|0|||
48996063|NCT04668066|157821394|FG000|Part 1: Follow-Up|Withdrawal by Subject|0|||
48996064|NCT04668066|157821395|FG001|Part 1: Follow-Up|Withdrawal by Subject|0|||
48996065|NCT04668066|157821396|FG002|Part 1: Follow-Up|Withdrawal by Subject|0|||
48996066|NCT04668066|157821397|FG003|Part 1: Follow-Up|Withdrawal by Subject|0|||
48996067|NCT04668066|157821398|FG004|Part 1: Follow-Up|Withdrawal by Subject|0|||
48996068|NCT04668066|157821399|FG005|Part 1: Follow-Up|Withdrawal by Subject|0|||
48996069|NCT04668066|157821400|FG006|Part 1: Follow-Up|Withdrawal by Subject|0|||
48996070|NCT04668066|157821401|FG007|Part 1: Follow-Up|Withdrawal by Subject|0|||
48996071|NCT04668066|157821402|FG008|Part 1: Follow-Up|Withdrawal by Subject|0|||
48996072|NCT04668066|157821403|FG009|Part 1: Follow-Up|Withdrawal by Subject|0|||
48996073|NCT04668066|157821404|FG010|Part 1: Follow-Up|Withdrawal by Subject|0|||
48996074|NCT04668066|157821405|FG011|Part 1: Follow-Up|Withdrawal by Subject|0|||
48996075|NCT04668066|157821406|FG012|Part 1: Follow-Up|Withdrawal by Subject|1|||
48996076|NCT04668066|157821407|FG013|Part 1: Follow-Up|Withdrawal by Subject|0|||
48996077|NCT04668066|157821408|FG014|Part 1: Follow-Up|Withdrawal by Subject|0|||
48996078|NCT04668066|157821409|FG015|Part 1: Follow-Up|Withdrawal by Subject|2|||
48996079|NCT04668066|157821410|FG016|Part 1: Follow-Up|Withdrawal by Subject|0|||
48996080|NCT04668066|157821411|FG017|Part 1: Follow-Up|Withdrawal by Subject|0|||
48996081|NCT04668066|157821412|FG018|Part 1: Follow-Up|Withdrawal by Subject|0|||
48996082|NCT04668066|157821394|FG000|Part 2: Treatment Phase|Withdrawal by Subject|0|||
48996083|NCT04668066|157821395|FG001|Part 2: Treatment Phase|Withdrawal by Subject|0|||
48996084|NCT04668066|157821396|FG002|Part 2: Treatment Phase|Withdrawal by Subject|0|||
48996085|NCT04668066|157821397|FG003|Part 2: Treatment Phase|Withdrawal by Subject|0|||
48996086|NCT04668066|157821398|FG004|Part 2: Treatment Phase|Withdrawal by Subject|0|||
48996087|NCT04668066|157821399|FG005|Part 2: Treatment Phase|Withdrawal by Subject|0|||
48996088|NCT04668066|157821400|FG006|Part 2: Treatment Phase|Withdrawal by Subject|0|||
48996089|NCT04668066|157821401|FG007|Part 2: Treatment Phase|Withdrawal by Subject|0|||
48996090|NCT04668066|157821402|FG008|Part 2: Treatment Phase|Withdrawal by Subject|0|||
48996091|NCT04668066|157821403|FG009|Part 2: Treatment Phase|Withdrawal by Subject|0|||
48996092|NCT04668066|157821404|FG010|Part 2: Treatment Phase|Withdrawal by Subject|0|||
48996093|NCT04668066|157821405|FG011|Part 2: Treatment Phase|Withdrawal by Subject|0|||
48996094|NCT04668066|157821406|FG012|Part 2: Treatment Phase|Withdrawal by Subject|0|||
48996095|NCT04668066|157821407|FG013|Part 2: Treatment Phase|Withdrawal by Subject|0|||
48996096|NCT04668066|157821408|FG014|Part 2: Treatment Phase|Withdrawal by Subject|0|||
48996097|NCT04668066|157821409|FG015|Part 2: Treatment Phase|Withdrawal by Subject|0|||
48996098|NCT04668066|157821410|FG016|Part 2: Treatment Phase|Withdrawal by Subject|0|||
48996099|NCT04668066|157821411|FG017|Part 2: Treatment Phase|Withdrawal by Subject|0|||
48996100|NCT04668066|157821412|FG018|Part 2: Treatment Phase|Withdrawal by Subject|1|||
48996101|NCT04668066|157821394|FG000|Part 2: Treatment Phase|Lost to Follow-up|0|||
48996102|NCT04668066|157821395|FG001|Part 2: Treatment Phase|Lost to Follow-up|0|||
48996103|NCT04668066|157821396|FG002|Part 2: Treatment Phase|Lost to Follow-up|0|||
48996104|NCT04668066|157821397|FG003|Part 2: Treatment Phase|Lost to Follow-up|0|||
48996105|NCT04668066|157821398|FG004|Part 2: Treatment Phase|Lost to Follow-up|0|||
48996106|NCT04668066|157821399|FG005|Part 2: Treatment Phase|Lost to Follow-up|0|||
48996107|NCT04668066|157821400|FG006|Part 2: Treatment Phase|Lost to Follow-up|0|||
48996108|NCT04668066|157821401|FG007|Part 2: Treatment Phase|Lost to Follow-up|0|||
48996109|NCT04668066|157821402|FG008|Part 2: Treatment Phase|Lost to Follow-up|0|||
48996110|NCT04668066|157821403|FG009|Part 2: Treatment Phase|Lost to Follow-up|0|||
48996111|NCT04668066|157821404|FG010|Part 2: Treatment Phase|Lost to Follow-up|0|||
48996112|NCT04668066|157821405|FG011|Part 2: Treatment Phase|Lost to Follow-up|0|||
48996113|NCT04668066|157821406|FG012|Part 2: Treatment Phase|Lost to Follow-up|0|||
48996114|NCT04668066|157821407|FG013|Part 2: Treatment Phase|Lost to Follow-up|0|||
48996115|NCT04668066|157821408|FG014|Part 2: Treatment Phase|Lost to Follow-up|0|||
48996116|NCT04668066|157821409|FG015|Part 2: Treatment Phase|Lost to Follow-up|0|||
48996117|NCT04668066|157821410|FG016|Part 2: Treatment Phase|Lost to Follow-up|0|||
48996118|NCT04668066|157821411|FG017|Part 2: Treatment Phase|Lost to Follow-up|0|||
48996119|NCT04668066|157821412|FG018|Part 2: Treatment Phase|Lost to Follow-up|1|||
48996120|NCT04668066|157821394|FG000|Part 2: Treatment Phase|Other|0|||
48996121|NCT04668066|157821395|FG001|Part 2: Treatment Phase|Other|0|||
48996122|NCT04668066|157821396|FG002|Part 2: Treatment Phase|Other|0|||
48996123|NCT04668066|157821397|FG003|Part 2: Treatment Phase|Other|0|||
48996124|NCT04668066|157821398|FG004|Part 2: Treatment Phase|Other|0|||
48996125|NCT04668066|157821399|FG005|Part 2: Treatment Phase|Other|0|||
48996126|NCT04668066|157821400|FG006|Part 2: Treatment Phase|Other|0|||
48996127|NCT04668066|157821401|FG007|Part 2: Treatment Phase|Other|0|||
48996128|NCT04668066|157821402|FG008|Part 2: Treatment Phase|Other|0|||
48996129|NCT04668066|157821403|FG009|Part 2: Treatment Phase|Other|0|||
48996130|NCT04668066|157821404|FG010|Part 2: Treatment Phase|Other|0|||
48996131|NCT04668066|157821405|FG011|Part 2: Treatment Phase|Other|0|||
48996132|NCT04668066|157821406|FG012|Part 2: Treatment Phase|Other|0|||
48996133|NCT04668066|157821407|FG013|Part 2: Treatment Phase|Other|0|||
48996134|NCT04668066|157821408|FG014|Part 2: Treatment Phase|Other|0|||
48996135|NCT04668066|157821409|FG015|Part 2: Treatment Phase|Other|0|||
48996136|NCT04668066|157821410|FG016|Part 2: Treatment Phase|Other|0|||
48996137|NCT04668066|157821411|FG017|Part 2: Treatment Phase|Other|0|||
48996138|NCT04668066|157821412|FG018|Part 2: Treatment Phase|Other|1|||
48996139|NCT04668066|157821394|FG000|Part 2: Follow-Up|Withdrawal by Subject|0|||
48996140|NCT04668066|157821395|FG001|Part 2: Follow-Up|Withdrawal by Subject|0|||
48996141|NCT04668066|157821396|FG002|Part 2: Follow-Up|Withdrawal by Subject|0|||
48996142|NCT04668066|157821397|FG003|Part 2: Follow-Up|Withdrawal by Subject|0|||
48996143|NCT04668066|157821398|FG004|Part 2: Follow-Up|Withdrawal by Subject|0|||
48996144|NCT04668066|157821399|FG005|Part 2: Follow-Up|Withdrawal by Subject|0|||
48996145|NCT04668066|157821400|FG006|Part 2: Follow-Up|Withdrawal by Subject|0|||
48996146|NCT04668066|157821401|FG007|Part 2: Follow-Up|Withdrawal by Subject|0|||
48996147|NCT04668066|157821402|FG008|Part 2: Follow-Up|Withdrawal by Subject|0|||
48996148|NCT04668066|157821403|FG009|Part 2: Follow-Up|Withdrawal by Subject|0|||
48996149|NCT04668066|157821404|FG010|Part 2: Follow-Up|Withdrawal by Subject|0|||
48996150|NCT04668066|157821405|FG011|Part 2: Follow-Up|Withdrawal by Subject|0|||
48996151|NCT04668066|157821406|FG012|Part 2: Follow-Up|Withdrawal by Subject|0|||
48996152|NCT04668066|157821407|FG013|Part 2: Follow-Up|Withdrawal by Subject|0|||
48996153|NCT04668066|157821408|FG014|Part 2: Follow-Up|Withdrawal by Subject|0|||
48996154|NCT04668066|157821409|FG015|Part 2: Follow-Up|Withdrawal by Subject|0|||
48996155|NCT04668066|157821410|FG016|Part 2: Follow-Up|Withdrawal by Subject|0|||
48996156|NCT04668066|157821411|FG017|Part 2: Follow-Up|Withdrawal by Subject|0|||
48996157|NCT04668066|157821412|FG018|Part 2: Follow-Up|Withdrawal by Subject|1|||
48996158|NCT00227591|157821413|FG000|Overall Study|Withdrawal by Subject|1|||
48996159|NCT03186794|157821414|FG000|Overall Study|Physician Decision|2|||
49045835|NCT01894230|158002024|FG000|Overall Study|Non-adherent|0|||
48996160|NCT03186794|157821414|FG000|Overall Study|Withdrawal due to COVID-19 pandemic closure|2|||
48996161|NCT00752206|157821415|FG000|Overall Study|Disease progression|8|||
48996162|NCT00752206|157821416|FG001|Overall Study|Disease progression|11|||
48996163|NCT00752206|157821415|FG000|Overall Study|Pregnancy|1|||
48996164|NCT00752206|157821416|FG001|Overall Study|Pregnancy|0|||
48996165|NCT00678652|157821417|FG000|Overall Study|Protocol Violation|2|||
48996166|NCT00678652|157821418|FG001|Overall Study|Protocol Violation|0|||
48996167|NCT00678652|157821419|FG002|Overall Study|Protocol Violation|0|||
48996168|NCT00678652|157821420|FG003|Overall Study|Protocol Violation|0|||
48996169|NCT00678652|157821417|FG000|Overall Study|Pregnancy|0|||
48996170|NCT00678652|157821418|FG001|Overall Study|Pregnancy|0|||
48996171|NCT00678652|157821419|FG002|Overall Study|Pregnancy|1|||
48996172|NCT00678652|157821420|FG003|Overall Study|Pregnancy|0|||
48996173|NCT00678652|157821417|FG000|Overall Study|Relocation|1|||
48996174|NCT00678652|157821418|FG001|Overall Study|Relocation|0|||
48996175|NCT00678652|157821419|FG002|Overall Study|Relocation|0|||
48996176|NCT00678652|157821420|FG003|Overall Study|Relocation|0|||
48996177|NCT01381068|157821421|FG000|Overall Study|Death|1|||
48996178|NCT01381068|157821422|FG001|Overall Study|Death|0|||
48996179|NCT01891669|157821426|FG000|Overall Study|Death|0|||
48996180|NCT01891669|157821427|FG001|Overall Study|Death|0|||
48996181|NCT01891669|157821428|FG002|Overall Study|Death|0|||
48996182|NCT01891669|157821429|FG003|Overall Study|Death|0|||
48996183|NCT01891669|157821430|FG004|Overall Study|Death|0|||
48996184|NCT01891669|157821431|FG005|Overall Study|Death|0|||
48996185|NCT01891669|157821432|FG006|Overall Study|Death|0|||
48996186|NCT01891669|157821433|FG007|Overall Study|Death|1|||
48996187|NCT01891669|157821434|FG008|Overall Study|Death|0|||
48996188|NCT01891669|157821435|FG009|Overall Study|Death|1|||
48996189|NCT01891669|157821426|FG000|Overall Study|Withdrawal by Subject|1|||
48996190|NCT01891669|157821427|FG001|Overall Study|Withdrawal by Subject|1|||
48996191|NCT01891669|157821428|FG002|Overall Study|Withdrawal by Subject|0|||
48996192|NCT01891669|157821429|FG003|Overall Study|Withdrawal by Subject|0|||
48996193|NCT01891669|157821430|FG004|Overall Study|Withdrawal by Subject|0|||
48996194|NCT01891669|157821431|FG005|Overall Study|Withdrawal by Subject|0|||
48996195|NCT01891669|157821432|FG006|Overall Study|Withdrawal by Subject|1|||
48996196|NCT01891669|157821433|FG007|Overall Study|Withdrawal by Subject|2|||
48996197|NCT01891669|157821434|FG008|Overall Study|Withdrawal by Subject|1|||
48996198|NCT01891669|157821435|FG009|Overall Study|Withdrawal by Subject|1|||
48996199|NCT01891669|157821426|FG000|Overall Study|Other|1|||
48996200|NCT01891669|157821427|FG001|Overall Study|Other|0|||
48996201|NCT01891669|157821428|FG002|Overall Study|Other|0|||
48996202|NCT01891669|157821429|FG003|Overall Study|Other|0|||
48996203|NCT01891669|157821430|FG004|Overall Study|Other|0|||
48996204|NCT01891669|157821431|FG005|Overall Study|Other|0|||
48996205|NCT01891669|157821432|FG006|Overall Study|Other|0|||
48996206|NCT01891669|157821433|FG007|Overall Study|Other|1|||
48996207|NCT01891669|157821434|FG008|Overall Study|Other|0|||
48996208|NCT01891669|157821435|FG009|Overall Study|Other|0|||
48996209|NCT03958045|157821440|FG000|Overall Study|Withdrawal by Subject|1|||
48996210|NCT00965562|157821441|FG000|Overall Study|Lost to Follow-up|1|||
48996211|NCT00965562|157821442|FG001|Overall Study|Lost to Follow-up|2|||
48996212|NCT00965562|157821443|FG002|Overall Study|Lost to Follow-up|3|||
48996213|NCT00965562|157821441|FG000|Overall Study|Withdrawal by Subject|2|||
48996214|NCT00965562|157821442|FG001|Overall Study|Withdrawal by Subject|2|||
48996215|NCT00965562|157821443|FG002|Overall Study|Withdrawal by Subject|0|||
48996216|NCT00859313|157821444|FG000|Overall Study|Lack of Efficacy|2|||
48996217|NCT00859313|157821444|FG000|Overall Study|Adverse Event|1|||
48996218|NCT00859313|157821444|FG000|Overall Study|staff error|1|||
48996219|NCT00071006|157821445|FG000|Overall Study|Lack of Efficacy|7|||
48996220|NCT00071006|157821445|FG000|Overall Study|Adverse Event|1|||
48996221|NCT00071006|157821445|FG000|Overall Study|Withdrawal by Subject|1|||
48996222|NCT00071006|157821445|FG000|Overall Study|Other|3|||
48996223|NCT00905437|157821449|FG000|Overall Study|Adverse Event|3|||
48996224|NCT00905437|157821450|FG001|Overall Study|Adverse Event|2|||
48996225|NCT00905437|157821449|FG000|Overall Study|Lost to Follow-up|0|||
48996226|NCT00905437|157821450|FG001|Overall Study|Lost to Follow-up|1|||
48996227|NCT00905437|157821449|FG000|Overall Study|Withdrawal by Subject|0|||
48996228|NCT00905437|157821450|FG001|Overall Study|Withdrawal by Subject|1|||
48996229|NCT00905437|157821449|FG000|Overall Study|Other|5|||
48996230|NCT00905437|157821450|FG001|Overall Study|Other|6|||
48996231|NCT01329562|157821451|FG000|Overall Study|Protocol Violation|5|||
48996232|NCT01329562|157821452|FG001|Overall Study|Protocol Violation|3|||
48996233|NCT01329562|157821451|FG000|Overall Study|Lost to Follow-up|1|||
48996234|NCT01329562|157821452|FG001|Overall Study|Lost to Follow-up|1|||
48996235|NCT01329562|157821451|FG000|Overall Study|Subject withdrew due to personal issues.|3|||
48996236|NCT01329562|157821452|FG001|Overall Study|Subject withdrew due to personal issues.|2|||
48996237|NCT01329562|157821451|FG000|Overall Study|Physician Decision|0|||
48996238|NCT01329562|157821452|FG001|Overall Study|Physician Decision|1|||
48996239|NCT01463631|157821453|FG000|Overall Study|Withdrawal by Subject|0|||
48996240|NCT01463631|157821454|FG001|Overall Study|Withdrawal by Subject|0|||
48996241|NCT01463631|157821455|FG002|Overall Study|Withdrawal by Subject|0|||
48996242|NCT01463631|157821456|FG003|Overall Study|Withdrawal by Subject|1|||
48996243|NCT01463631|157821453|FG000|Overall Study|Death|0|||
48996244|NCT01463631|157821454|FG001|Overall Study|Death|0|||
48996245|NCT01463631|157821455|FG002|Overall Study|Death|1|||
48996246|NCT01463631|157821456|FG003|Overall Study|Death|0|||
48996247|NCT01463631|157821453|FG000|Overall Study|Progressive Disease|0|||
48996248|NCT01463631|157821454|FG001|Overall Study|Progressive Disease|0|||
48996249|NCT01463631|157821455|FG002|Overall Study|Progressive Disease|0|||
48996250|NCT01463631|157821456|FG003|Overall Study|Progressive Disease|5|||
48996251|NCT04066894|157821457|FG000|Overall Study|Lack of Efficacy|1|||
48996252|NCT04066894|157821457|FG000|Overall Study|Screen Failure|1|||
48996253|NCT02396849|157821460|FG000|Overall Study|Lost to Follow-up|1|||
48996254|NCT02396849|157821461|FG001|Overall Study|Lost to Follow-up|1|||
48996255|NCT02396849|157821460|FG000|Overall Study|Did not tolerate intervention|1|||
48996256|NCT02396849|157821461|FG001|Overall Study|Did not tolerate intervention|1|||
48996257|NCT04115488|157821462|FG000|Overall Study|Adverse Event|8|||
48996258|NCT04115488|157821463|FG001|Overall Study|Adverse Event|4|||
48996259|NCT04115488|157821462|FG000|Overall Study|Withdrawal by Subject|3|||
48996260|NCT04115488|157821463|FG001|Overall Study|Withdrawal by Subject|6|||
48996261|NCT04115488|157821462|FG000|Overall Study|Investigator/ Sponsor Decision|2|||
48996262|NCT04115488|157821463|FG001|Overall Study|Investigator/ Sponsor Decision|0|||
48996263|NCT04115488|157821462|FG000|Overall Study|Patient 's location change|1|||
48996264|NCT04115488|157821463|FG001|Overall Study|Patient 's location change|0|||
48996265|NCT04115488|157821462|FG000|Overall Study|Due to COVID-19 restrictions at site|0|||
48996266|NCT04115488|157821463|FG001|Overall Study|Due to COVID-19 restrictions at site|1|||
48996267|NCT00096031|157821464|FG000|Overall Study|Adverse Event|3|||
48996268|NCT00096031|157821464|FG000|Overall Study|Lack of Efficacy|42|||
48996269|NCT00096031|157821464|FG000|Overall Study|Death|4|||
48996270|NCT00096031|157821464|FG000|Overall Study|Withdrawal by Subject|1|||
48996271|NCT00096031|157821464|FG000|Overall Study|Ineligible|8|||
48996272|NCT00096031|157821464|FG000|Overall Study|Not protocol specified|5|||
48996273|NCT01821391|157821465|FG000|Overall Study|Adverse Event|1|||
48996274|NCT01821391|157821466|FG001|Overall Study|Adverse Event|0|||
48996275|NCT00700115|157823326|FG000|Overall Study|Withdrawal by Subject|1|||
48996276|NCT00700115|157823327|FG001|Overall Study|Withdrawal by Subject|0|||
48996277|NCT00700115|157823326|FG000|Overall Study|Lost to Follow-up|0|||
48996278|NCT00700115|157823327|FG001|Overall Study|Lost to Follow-up|1|||
48996279|NCT05637515|157823328|FG000|Overall Study|Withdrawal by Subject|17|||
48996280|NCT05637515|157823329|FG001|Overall Study|Withdrawal by Subject|17|||
48996281|NCT02503215|157823330|FG000|Overall Study|Unable to wear compression stockings|1|||
48996282|NCT02503215|157823330|FG000|Overall Study|Unable to use positive airway pressure|2|||
48996283|NCT03233009|157823331|FG000|Overall Study|Lost to Follow-up|1|||
48996284|NCT01541644|157823337|FG000|Overall Study|Withdrawal by Subject|3|||
48996285|NCT01458535|157823340|FG000|Overall Study|Other|0|||
48996286|NCT01458535|157823341|FG001|Overall Study|Other|0|||
48996287|NCT01458535|157823342|FG002|Overall Study|Other|0|||
48996288|NCT01458535|157823343|FG003|Overall Study|Other|0|||
48996289|NCT01458535|157823344|FG004|Overall Study|Other|1|||
48996290|NCT01458535|157823345|FG005|Overall Study|Other|1|||
48996291|NCT01458535|157823340|FG000|Overall Study|Withdrawal by Subject|0|||
48996292|NCT01458535|157823341|FG001|Overall Study|Withdrawal by Subject|0|||
48996293|NCT01458535|157823342|FG002|Overall Study|Withdrawal by Subject|2|||
48996294|NCT01458535|157823343|FG003|Overall Study|Withdrawal by Subject|0|||
48996295|NCT01458535|157823344|FG004|Overall Study|Withdrawal by Subject|1|||
48996296|NCT01458535|157823345|FG005|Overall Study|Withdrawal by Subject|1|||
48996297|NCT01458535|157823340|FG000|Overall Study|Lost to Follow-up|0|||
48996298|NCT01458535|157823341|FG001|Overall Study|Lost to Follow-up|2|||
48996299|NCT01458535|157823342|FG002|Overall Study|Lost to Follow-up|0|||
48996300|NCT01458535|157823343|FG003|Overall Study|Lost to Follow-up|3|||
48996301|NCT01458535|157823344|FG004|Overall Study|Lost to Follow-up|2|||
48996302|NCT01458535|157823345|FG005|Overall Study|Lost to Follow-up|2|||
48996303|NCT01458535|157823340|FG000|Overall Study|Adverse Event|0|||
48996304|NCT01458535|157823341|FG001|Overall Study|Adverse Event|0|||
48996305|NCT01458535|157823342|FG002|Overall Study|Adverse Event|0|||
48996306|NCT01458535|157823343|FG003|Overall Study|Adverse Event|1|||
48996307|NCT01458535|157823344|FG004|Overall Study|Adverse Event|0|||
48996308|NCT01458535|157823345|FG005|Overall Study|Adverse Event|0|||
48996309|NCT02842736|157823346|FG000|Overall Study|Lost to Follow-up|13|||
48996310|NCT02842736|157823346|FG000|Overall Study|Intervention for menstrual bleeding|17|||
48996311|NCT02842736|157823346|FG000|Overall Study|Withdrawal by Subject|4|||
48996312|NCT02842736|157823346|FG000|Overall Study|Pregnancy|3|||
48996313|NCT02842736|157823346|FG000|Overall Study|Hysterectomy for fibroids|2|||
48996314|NCT02842736|157823346|FG000|Overall Study|Hysterectomy for uterine prolapse|1|||
48996315|NCT02842736|157823346|FG000|Overall Study|IUD: Mirena|1|||
48996316|NCT00151775|157823348|FG000|Period 2 - Double-Blind Dose Response|Adverse Event|1|||
48996317|NCT00151775|157823349|FG001|Period 2 - Double-Blind Dose Response|Adverse Event|2|||
48996318|NCT00151775|157823350|FG002|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
48996319|NCT00151775|157823351|FG003|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
48996320|NCT00151775|157823352|FG004|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
48996321|NCT00151775|157823353|FG005|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
48996322|NCT00151775|157823354|FG006|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
48996323|NCT00151775|157823355|FG007|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
48996324|NCT00151775|157823356|FG008|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
48996325|NCT00151775|157823357|FG009|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
48996326|NCT00151775|157823358|FG010|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
48996327|NCT00151775|157823359|FG011|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
48996328|NCT00151775|157823348|FG000|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
48996329|NCT00151775|157823349|FG001|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
48996330|NCT00151775|157823350|FG002|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
48996331|NCT00151775|157823351|FG003|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
48996332|NCT00151775|157823352|FG004|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
48996333|NCT00151775|157823353|FG005|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
48996334|NCT00151775|157823354|FG006|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
48996335|NCT00151775|157823355|FG007|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
48996336|NCT00151775|157823356|FG008|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
48996337|NCT00151775|157823357|FG009|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
48996338|NCT00151775|157823358|FG010|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
48996339|NCT00151775|157823359|FG011|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
48996340|NCT00151775|157823348|FG000|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
48996341|NCT00151775|157823349|FG001|Period 2 - Double-Blind Dose Response|Protocol Violation|4|||
48996342|NCT00151775|157823350|FG002|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
48996343|NCT00151775|157823351|FG003|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
48996344|NCT00151775|157823352|FG004|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
48996345|NCT00151775|157823353|FG005|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
48996346|NCT00151775|157823354|FG006|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
48996347|NCT00151775|157823355|FG007|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
48996348|NCT00151775|157823356|FG008|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
48996349|NCT00151775|157823357|FG009|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
48996350|NCT00151775|157823358|FG010|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
48996351|NCT00151775|157823359|FG011|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
48996352|NCT00151775|157823348|FG000|Period 2 - Double-Blind Dose Response|Other|0|||
48996353|NCT00151775|157823349|FG001|Period 2 - Double-Blind Dose Response|Other|0|||
48996354|NCT00151775|157823350|FG002|Period 2 - Double-Blind Dose Response|Other|0|||
48996355|NCT00151775|157823351|FG003|Period 2 - Double-Blind Dose Response|Other|0|||
48996356|NCT00151775|157823352|FG004|Period 2 - Double-Blind Dose Response|Other|0|||
48996357|NCT00151775|157823353|FG005|Period 2 - Double-Blind Dose Response|Other|0|||
48996358|NCT00151775|157823354|FG006|Period 2 - Double-Blind Dose Response|Other|1|||
48996359|NCT00151775|157823355|FG007|Period 2 - Double-Blind Dose Response|Other|0|||
48996360|NCT00151775|157823356|FG008|Period 2 - Double-Blind Dose Response|Other|0|||
48996361|NCT00151775|157823357|FG009|Period 2 - Double-Blind Dose Response|Other|0|||
48996362|NCT00151775|157823358|FG010|Period 2 - Double-Blind Dose Response|Other|0|||
48996363|NCT00151775|157823359|FG011|Period 2 - Double-Blind Dose Response|Other|0|||
48996364|NCT00151775|157823348|FG000|Period 2 - Double-Blind Dose Response|non-compliance|0|||
48996365|NCT00151775|157823349|FG001|Period 2 - Double-Blind Dose Response|non-compliance|0|||
48996366|NCT00151775|157823350|FG002|Period 2 - Double-Blind Dose Response|non-compliance|0|||
48996367|NCT00151775|157823351|FG003|Period 2 - Double-Blind Dose Response|non-compliance|0|||
48996368|NCT00151775|157823352|FG004|Period 2 - Double-Blind Dose Response|non-compliance|0|||
48996369|NCT00151775|157823353|FG005|Period 2 - Double-Blind Dose Response|non-compliance|1|||
48996370|NCT00151775|157823354|FG006|Period 2 - Double-Blind Dose Response|non-compliance|0|||
48996371|NCT00151775|157823355|FG007|Period 2 - Double-Blind Dose Response|non-compliance|0|||
48996372|NCT00151775|157823356|FG008|Period 2 - Double-Blind Dose Response|non-compliance|0|||
48996373|NCT00151775|157823357|FG009|Period 2 - Double-Blind Dose Response|non-compliance|0|||
48996374|NCT00151775|157823358|FG010|Period 2 - Double-Blind Dose Response|non-compliance|0|||
48996375|NCT00151775|157823359|FG011|Period 2 - Double-Blind Dose Response|non-compliance|0|||
48996376|NCT00151775|157823348|FG000|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
48996377|NCT00151775|157823349|FG001|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
48996378|NCT00151775|157823350|FG002|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
48996379|NCT00151775|157823351|FG003|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
48996380|NCT00151775|157823352|FG004|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
48996381|NCT00151775|157823353|FG005|Period 2 - Double-Blind Dose Response|Physician Decision|1|||
48996382|NCT00151775|157823354|FG006|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
48996383|NCT00151775|157823355|FG007|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
48996384|NCT00151775|157823356|FG008|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
48996385|NCT00151775|157823357|FG009|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
48996386|NCT00151775|157823358|FG010|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
48996387|NCT00151775|157823359|FG011|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
48996388|NCT00151775|157823348|FG000|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
48996389|NCT00151775|157823349|FG001|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
48996390|NCT00151775|157823350|FG002|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
48996391|NCT00151775|157823351|FG003|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
48996392|NCT00151775|157823352|FG004|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
48996393|NCT00151775|157823353|FG005|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
48996394|NCT00151775|157823354|FG006|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1|||
48996395|NCT00151775|157823355|FG007|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
48996396|NCT00151775|157823356|FG008|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
48996397|NCT00151775|157823357|FG009|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
48996398|NCT00151775|157823358|FG010|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
48996399|NCT00151775|157823359|FG011|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
48996400|NCT00151775|157823348|FG000|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
48996401|NCT00151775|157823349|FG001|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
48996402|NCT00151775|157823350|FG002|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
48996403|NCT00151775|157823351|FG003|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
48996404|NCT00151775|157823352|FG004|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
48996405|NCT00151775|157823353|FG005|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1|||
48996406|NCT00151775|157823354|FG006|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
48996407|NCT00151775|157823355|FG007|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
48996408|NCT00151775|157823356|FG008|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
48996409|NCT00151775|157823357|FG009|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
48996410|NCT00151775|157823358|FG010|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
48996411|NCT00151775|157823359|FG011|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
48996412|NCT00151775|157823348|FG000|Period 3: Double-blind, Withdrawal|Other|0|||
48996413|NCT00151775|157823349|FG001|Period 3: Double-blind, Withdrawal|Other|0|||
48996414|NCT00151775|157823350|FG002|Period 3: Double-blind, Withdrawal|Other|1|||
48996415|NCT00151775|157823351|FG003|Period 3: Double-blind, Withdrawal|Other|0|||
48996416|NCT00151775|157823352|FG004|Period 3: Double-blind, Withdrawal|Other|0|||
48996417|NCT00151775|157823353|FG005|Period 3: Double-blind, Withdrawal|Other|0|||
48996418|NCT00151775|157823354|FG006|Period 3: Double-blind, Withdrawal|Other|0|||
48996419|NCT00151775|157823355|FG007|Period 3: Double-blind, Withdrawal|Other|1|||
48996420|NCT00151775|157823356|FG008|Period 3: Double-blind, Withdrawal|Other|0|||
48996421|NCT00151775|157823357|FG009|Period 3: Double-blind, Withdrawal|Other|0|||
48996422|NCT00151775|157823358|FG010|Period 3: Double-blind, Withdrawal|Other|0|||
48996423|NCT00151775|157823359|FG011|Period 3: Double-blind, Withdrawal|Other|0|||
48996424|NCT00151775|157823348|FG000|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
48996425|NCT00151775|157823349|FG001|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
48996426|NCT00151775|157823350|FG002|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
48996427|NCT00151775|157823351|FG003|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
48996428|NCT00151775|157823352|FG004|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
48996429|NCT00151775|157823353|FG005|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
48996430|NCT00151775|157823354|FG006|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1|||
48996431|NCT00151775|157823355|FG007|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
48996432|NCT00151775|157823356|FG008|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
48996433|NCT00151775|157823357|FG009|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
48996434|NCT00151775|157823358|FG010|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
48996435|NCT00151775|157823359|FG011|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
48996436|NCT00151775|157823348|FG000|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
48996437|NCT00151775|157823349|FG001|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
48996438|NCT00151775|157823350|FG002|Period 3: Double-blind, Withdrawal|Adverse Event|1|||
48996439|NCT00151775|157823351|FG003|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
48996440|NCT00151775|157823352|FG004|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
48996441|NCT00151775|157823353|FG005|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
48996442|NCT00151775|157823354|FG006|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
48996443|NCT00151775|157823355|FG007|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
48996444|NCT00151775|157823356|FG008|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
48996445|NCT00151775|157823357|FG009|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
48996446|NCT00151775|157823358|FG010|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
48996447|NCT00151775|157823359|FG011|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
48996448|NCT00151775|157823348|FG000|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
48996449|NCT00151775|157823349|FG001|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
48692641|NCT03001557|156724545|FG004|Extension Phase|Lost to Follow-up|0|||
48996450|NCT00151775|157823350|FG002|Period 3: Double-blind, Withdrawal|Protocol Violation|1|||
48996451|NCT00151775|157823351|FG003|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
48996452|NCT00151775|157823352|FG004|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
48996453|NCT00151775|157823353|FG005|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
48996454|NCT00151775|157823354|FG006|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
48996455|NCT00151775|157823355|FG007|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
48996456|NCT00151775|157823356|FG008|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
48996457|NCT00151775|157823357|FG009|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
48996458|NCT00151775|157823358|FG010|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
48996459|NCT00151775|157823359|FG011|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
48996460|NCT00151775|157823348|FG000|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
48996461|NCT00151775|157823349|FG001|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
48996462|NCT00151775|157823350|FG002|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
48996463|NCT00151775|157823351|FG003|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
48996464|NCT00151775|157823352|FG004|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
48996465|NCT00151775|157823353|FG005|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
48996466|NCT00151775|157823354|FG006|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
48996467|NCT00151775|157823355|FG007|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
48996468|NCT00151775|157823356|FG008|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
48996469|NCT00151775|157823357|FG009|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
48996470|NCT00151775|157823358|FG010|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
48996471|NCT00151775|157823359|FG011|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1|||
48996472|NCT00151775|157823348|FG000|Period 4: Open Label|Increased blood pressure|0|||
48996473|NCT00151775|157823349|FG001|Period 4: Open Label|Increased blood pressure|0|||
48996474|NCT00151775|157823350|FG002|Period 4: Open Label|Increased blood pressure|0|||
48996475|NCT00151775|157823351|FG003|Period 4: Open Label|Increased blood pressure|0|||
48996476|NCT00151775|157823352|FG004|Period 4: Open Label|Increased blood pressure|1|||
48996477|NCT00151775|157823353|FG005|Period 4: Open Label|Increased blood pressure|0|||
48996478|NCT00151775|157823354|FG006|Period 4: Open Label|Increased blood pressure|0|||
48996479|NCT00151775|157823355|FG007|Period 4: Open Label|Increased blood pressure|0|||
48996480|NCT00151775|157823356|FG008|Period 4: Open Label|Increased blood pressure|0|||
48996481|NCT00151775|157823357|FG009|Period 4: Open Label|Increased blood pressure|1|||
48996482|NCT00151775|157823358|FG010|Period 4: Open Label|Increased blood pressure|0|||
48996483|NCT00151775|157823359|FG011|Period 4: Open Label|Increased blood pressure|0|||
48996484|NCT00151775|157823348|FG000|Period 4: Open Label|Withdrawal by Subject|0|||
48996485|NCT00151775|157823349|FG001|Period 4: Open Label|Withdrawal by Subject|0|||
48996486|NCT00151775|157823350|FG002|Period 4: Open Label|Withdrawal by Subject|0|||
48996487|NCT00151775|157823351|FG003|Period 4: Open Label|Withdrawal by Subject|0|||
48996488|NCT00151775|157823352|FG004|Period 4: Open Label|Withdrawal by Subject|5|||
48996489|NCT00151775|157823353|FG005|Period 4: Open Label|Withdrawal by Subject|0|||
48996490|NCT00151775|157823354|FG006|Period 4: Open Label|Withdrawal by Subject|0|||
48996491|NCT00151775|157823355|FG007|Period 4: Open Label|Withdrawal by Subject|0|||
48996492|NCT00151775|157823356|FG008|Period 4: Open Label|Withdrawal by Subject|0|||
48996493|NCT00151775|157823357|FG009|Period 4: Open Label|Withdrawal by Subject|2|||
48996494|NCT00151775|157823358|FG010|Period 4: Open Label|Withdrawal by Subject|0|||
48996495|NCT00151775|157823359|FG011|Period 4: Open Label|Withdrawal by Subject|0|||
48996496|NCT00151775|157823348|FG000|Period 4: Open Label|Adverse Event|0|||
48996497|NCT00151775|157823349|FG001|Period 4: Open Label|Adverse Event|0|||
48996498|NCT00151775|157823350|FG002|Period 4: Open Label|Adverse Event|0|||
48996499|NCT00151775|157823351|FG003|Period 4: Open Label|Adverse Event|0|||
48996500|NCT00151775|157823352|FG004|Period 4: Open Label|Adverse Event|1|||
48996501|NCT00151775|157823353|FG005|Period 4: Open Label|Adverse Event|0|||
48996502|NCT00151775|157823354|FG006|Period 4: Open Label|Adverse Event|0|||
48996503|NCT00151775|157823355|FG007|Period 4: Open Label|Adverse Event|0|||
48996504|NCT00151775|157823356|FG008|Period 4: Open Label|Adverse Event|0|||
48996505|NCT00151775|157823357|FG009|Period 4: Open Label|Adverse Event|2|||
48996506|NCT00151775|157823358|FG010|Period 4: Open Label|Adverse Event|0|||
48996507|NCT00151775|157823359|FG011|Period 4: Open Label|Adverse Event|0|||
48996508|NCT00151775|157823348|FG000|Period 4: Open Label|Lost to Follow-up|0|||
48996509|NCT00151775|157823349|FG001|Period 4: Open Label|Lost to Follow-up|0|||
48996510|NCT00151775|157823350|FG002|Period 4: Open Label|Lost to Follow-up|0|||
48996511|NCT00151775|157823351|FG003|Period 4: Open Label|Lost to Follow-up|0|||
48996512|NCT00151775|157823352|FG004|Period 4: Open Label|Lost to Follow-up|17|||
48996513|NCT00151775|157823353|FG005|Period 4: Open Label|Lost to Follow-up|0|||
48996514|NCT00151775|157823354|FG006|Period 4: Open Label|Lost to Follow-up|0|||
48996515|NCT00151775|157823355|FG007|Period 4: Open Label|Lost to Follow-up|0|||
48996516|NCT00151775|157823356|FG008|Period 4: Open Label|Lost to Follow-up|0|||
48996517|NCT00151775|157823357|FG009|Period 4: Open Label|Lost to Follow-up|7|||
48996518|NCT00151775|157823358|FG010|Period 4: Open Label|Lost to Follow-up|0|||
48996519|NCT00151775|157823359|FG011|Period 4: Open Label|Lost to Follow-up|0|||
48996520|NCT00151775|157823348|FG000|Period 4: Open Label|Non-compliance with protocol|0|||
48996521|NCT00151775|157823349|FG001|Period 4: Open Label|Non-compliance with protocol|0|||
48996522|NCT00151775|157823350|FG002|Period 4: Open Label|Non-compliance with protocol|0|||
48996523|NCT00151775|157823351|FG003|Period 4: Open Label|Non-compliance with protocol|0|||
48996524|NCT00151775|157823352|FG004|Period 4: Open Label|Non-compliance with protocol|4|||
48996525|NCT00151775|157823353|FG005|Period 4: Open Label|Non-compliance with protocol|0|||
48996526|NCT00151775|157823354|FG006|Period 4: Open Label|Non-compliance with protocol|0|||
48996527|NCT00151775|157823355|FG007|Period 4: Open Label|Non-compliance with protocol|0|||
48996528|NCT00151775|157823356|FG008|Period 4: Open Label|Non-compliance with protocol|0|||
48996529|NCT00151775|157823357|FG009|Period 4: Open Label|Non-compliance with protocol|4|||
48996530|NCT00151775|157823358|FG010|Period 4: Open Label|Non-compliance with protocol|0|||
48996531|NCT00151775|157823359|FG011|Period 4: Open Label|Non-compliance with protocol|0|||
48996532|NCT00151775|157823348|FG000|Period 4: Open Label|Other|0|||
48996533|NCT00151775|157823349|FG001|Period 4: Open Label|Other|0|||
48996534|NCT00151775|157823350|FG002|Period 4: Open Label|Other|0|||
48996535|NCT00151775|157823351|FG003|Period 4: Open Label|Other|0|||
48996536|NCT00151775|157823352|FG004|Period 4: Open Label|Other|1|||
48996537|NCT00151775|157823353|FG005|Period 4: Open Label|Other|0|||
48996538|NCT00151775|157823354|FG006|Period 4: Open Label|Other|0|||
48996539|NCT00151775|157823355|FG007|Period 4: Open Label|Other|0|||
48996540|NCT00151775|157823356|FG008|Period 4: Open Label|Other|0|||
48996541|NCT00151775|157823357|FG009|Period 4: Open Label|Other|3|||
48996542|NCT00151775|157823358|FG010|Period 4: Open Label|Other|0|||
48996543|NCT00151775|157823359|FG011|Period 4: Open Label|Other|0|||
48996544|NCT00151775|157823348|FG000|Period 4: Open Label|Physician Decision|0|||
48996545|NCT00151775|157823349|FG001|Period 4: Open Label|Physician Decision|0|||
48996546|NCT00151775|157823350|FG002|Period 4: Open Label|Physician Decision|0|||
48996547|NCT00151775|157823351|FG003|Period 4: Open Label|Physician Decision|0|||
48996548|NCT00151775|157823352|FG004|Period 4: Open Label|Physician Decision|0|||
48996549|NCT00151775|157823353|FG005|Period 4: Open Label|Physician Decision|0|||
48996550|NCT00151775|157823354|FG006|Period 4: Open Label|Physician Decision|0|||
48996551|NCT00151775|157823355|FG007|Period 4: Open Label|Physician Decision|0|||
48996552|NCT00151775|157823356|FG008|Period 4: Open Label|Physician Decision|0|||
48996553|NCT00151775|157823357|FG009|Period 4: Open Label|Physician Decision|2|||
48996554|NCT00151775|157823358|FG010|Period 4: Open Label|Physician Decision|0|||
48996555|NCT00151775|157823359|FG011|Period 4: Open Label|Physician Decision|0|||
48996556|NCT00151775|157823348|FG000|Period 4: Open Label|Protocol Violation|0|||
48996557|NCT00151775|157823349|FG001|Period 4: Open Label|Protocol Violation|0|||
48996558|NCT00151775|157823350|FG002|Period 4: Open Label|Protocol Violation|0|||
48996559|NCT00151775|157823351|FG003|Period 4: Open Label|Protocol Violation|0|||
48996560|NCT00151775|157823352|FG004|Period 4: Open Label|Protocol Violation|1|||
48996561|NCT00151775|157823353|FG005|Period 4: Open Label|Protocol Violation|0|||
48996562|NCT00151775|157823354|FG006|Period 4: Open Label|Protocol Violation|0|||
48996563|NCT00151775|157823355|FG007|Period 4: Open Label|Protocol Violation|0|||
48996564|NCT00151775|157823356|FG008|Period 4: Open Label|Protocol Violation|0|||
48996565|NCT00151775|157823357|FG009|Period 4: Open Label|Protocol Violation|0|||
48996566|NCT00151775|157823358|FG010|Period 4: Open Label|Protocol Violation|0|||
48996567|NCT00151775|157823359|FG011|Period 4: Open Label|Protocol Violation|0|||
48996568|NCT01238861|157823360|FG000|Overall Study|Lost to Follow-up|4|||
48996569|NCT01238861|157823361|FG001|Overall Study|Lost to Follow-up|2|||
48996570|NCT01238861|157823362|FG002|Overall Study|Lost to Follow-up|3|||
48996571|NCT01238861|157823363|FG003|Overall Study|Lost to Follow-up|1|||
48996572|NCT01238861|157823364|FG004|Overall Study|Lost to Follow-up|1|||
48996573|NCT01238861|157823365|FG005|Overall Study|Lost to Follow-up|2|||
48996574|NCT01238861|157823360|FG000|Overall Study|Unplanned surgery|1|||
48996575|NCT01238861|157823361|FG001|Overall Study|Unplanned surgery|0|||
48996576|NCT01238861|157823362|FG002|Overall Study|Unplanned surgery|0|||
48996577|NCT01238861|157823363|FG003|Overall Study|Unplanned surgery|0|||
48996578|NCT01238861|157823364|FG004|Overall Study|Unplanned surgery|0|||
48996579|NCT01238861|157823365|FG005|Overall Study|Unplanned surgery|0|||
48996580|NCT01238861|157823360|FG000|Overall Study|Did not meet entry ACQ-6 criteria|0|||
48996581|NCT01238861|157823361|FG001|Overall Study|Did not meet entry ACQ-6 criteria|0|||
48996582|NCT01238861|157823362|FG002|Overall Study|Did not meet entry ACQ-6 criteria|1|||
48996583|NCT01238861|157823363|FG003|Overall Study|Did not meet entry ACQ-6 criteria|0|||
48996584|NCT01238861|157823364|FG004|Overall Study|Did not meet entry ACQ-6 criteria|1|||
48996585|NCT01238861|157823365|FG005|Overall Study|Did not meet entry ACQ-6 criteria|1|||
48996586|NCT01238861|157823360|FG000|Overall Study|Incorrect enrollment/randomization|0|||
48996587|NCT01238861|157823361|FG001|Overall Study|Incorrect enrollment/randomization|0|||
48996588|NCT01238861|157823362|FG002|Overall Study|Incorrect enrollment/randomization|1|||
48996589|NCT01238861|157823363|FG003|Overall Study|Incorrect enrollment/randomization|0|||
48996590|NCT01238861|157823364|FG004|Overall Study|Incorrect enrollment/randomization|1|||
48996591|NCT01238861|157823365|FG005|Overall Study|Incorrect enrollment/randomization|0|||
48996592|NCT01238861|157823360|FG000|Overall Study|Subject traveled to Argentina by 1 year|0|||
48996593|NCT01238861|157823361|FG001|Overall Study|Subject traveled to Argentina by 1 year|0|||
48996594|NCT01238861|157823362|FG002|Overall Study|Subject traveled to Argentina by 1 year|1|||
48996595|NCT01238861|157823363|FG003|Overall Study|Subject traveled to Argentina by 1 year|0|||
48996596|NCT01238861|157823364|FG004|Overall Study|Subject traveled to Argentina by 1 year|0|||
48996597|NCT01238861|157823365|FG005|Overall Study|Subject traveled to Argentina by 1 year|0|||
48996598|NCT01238861|157823360|FG000|Overall Study|Subject moved out of state/area|0|||
48996599|NCT01238861|157823361|FG001|Overall Study|Subject moved out of state/area|0|||
48996600|NCT01238861|157823362|FG002|Overall Study|Subject moved out of state/area|1|||
48996601|NCT01238861|157823363|FG003|Overall Study|Subject moved out of state/area|1|||
48996602|NCT01238861|157823364|FG004|Overall Study|Subject moved out of state/area|0|||
48996603|NCT01238861|157823365|FG005|Overall Study|Subject moved out of state/area|0|||
48996604|NCT01238861|157823360|FG000|Overall Study|Strongyloides stercoralis antibodies +|0|||
48996605|NCT01238861|157823361|FG001|Overall Study|Strongyloides stercoralis antibodies +|0|||
48996606|NCT01238861|157823362|FG002|Overall Study|Strongyloides stercoralis antibodies +|0|||
48996607|NCT01238861|157823363|FG003|Overall Study|Strongyloides stercoralis antibodies +|1|||
48996608|NCT01238861|157823364|FG004|Overall Study|Strongyloides stercoralis antibodies +|0|||
48996609|NCT01238861|157823365|FG005|Overall Study|Strongyloides stercoralis antibodies +|0|||
48996610|NCT01238861|157823360|FG000|Overall Study|Personal problems|0|||
48996611|NCT01238861|157823361|FG001|Overall Study|Personal problems|0|||
48996612|NCT01238861|157823362|FG002|Overall Study|Personal problems|0|||
48996613|NCT01238861|157823363|FG003|Overall Study|Personal problems|1|||
48996614|NCT01238861|157823364|FG004|Overall Study|Personal problems|0|||
48996615|NCT01238861|157823365|FG005|Overall Study|Personal problems|0|||
48996616|NCT01238861|157823360|FG000|Overall Study|Unable to continue visits|0|||
48996617|NCT01238861|157823361|FG001|Overall Study|Unable to continue visits|0|||
48996618|NCT01238861|157823362|FG002|Overall Study|Unable to continue visits|0|||
48996619|NCT01238861|157823363|FG003|Overall Study|Unable to continue visits|1|||
48996620|NCT01238861|157823364|FG004|Overall Study|Unable to continue visits|0|||
48996621|NCT01238861|157823365|FG005|Overall Study|Unable to continue visits|1|||
48996622|NCT01238861|157823360|FG000|Overall Study|Serious adverse event|0|||
48996623|NCT01238861|157823361|FG001|Overall Study|Serious adverse event|0|||
48996624|NCT01238861|157823362|FG002|Overall Study|Serious adverse event|0|||
48996625|NCT01238861|157823363|FG003|Overall Study|Serious adverse event|0|||
48996626|NCT01238861|157823364|FG004|Overall Study|Serious adverse event|0|||
48996627|NCT01238861|157823365|FG005|Overall Study|Serious adverse event|1|||
48996628|NCT01238861|157823360|FG000|Overall Study|Lack of compliance|0|||
48996629|NCT01238861|157823361|FG001|Overall Study|Lack of compliance|0|||
48996630|NCT01238861|157823362|FG002|Overall Study|Lack of compliance|0|||
48996631|NCT01238861|157823363|FG003|Overall Study|Lack of compliance|0|||
48996632|NCT01238861|157823364|FG004|Overall Study|Lack of compliance|0|||
48996633|NCT01238861|157823365|FG005|Overall Study|Lack of compliance|1|||
48996634|NCT01238861|157823360|FG000|Overall Study|Adverse Event|0|||
48996635|NCT01238861|157823361|FG001|Overall Study|Adverse Event|1|||
48996636|NCT01238861|157823362|FG002|Overall Study|Adverse Event|0|||
48996637|NCT01238861|157823363|FG003|Overall Study|Adverse Event|0|||
48996638|NCT01238861|157823364|FG004|Overall Study|Adverse Event|0|||
48996639|NCT01238861|157823365|FG005|Overall Study|Adverse Event|0|||
48996640|NCT01238861|157823360|FG000|Overall Study|Withdrawal by Subject|6|||
48996641|NCT01238861|157823361|FG001|Overall Study|Withdrawal by Subject|5|||
48996642|NCT01238861|157823362|FG002|Overall Study|Withdrawal by Subject|4|||
48996643|NCT01238861|157823363|FG003|Overall Study|Withdrawal by Subject|8|||
48996644|NCT01238861|157823364|FG004|Overall Study|Withdrawal by Subject|10|||
48996645|NCT01238861|157823365|FG005|Overall Study|Withdrawal by Subject|9|||
48996646|NCT02389621|157823366|FG000|Treatment Period|Withdrawal by Subject|1|||
48996647|NCT02389621|157823367|FG001|Treatment Period|Withdrawal by Subject|1|||
48996648|NCT02389621|157823366|FG000|Posttreatment Period|Adverse Event|3|||
48996649|NCT02389621|157823367|FG001|Posttreatment Period|Adverse Event|1|||
48996650|NCT02389621|157823366|FG000|Posttreatment Period|Withdrawal by Subject|3|||
48996651|NCT02389621|157823367|FG001|Posttreatment Period|Withdrawal by Subject|2|||
48996652|NCT02389621|157823366|FG000|Posttreatment Period|Lost to Follow-up|1|||
48996653|NCT02389621|157823367|FG001|Posttreatment Period|Lost to Follow-up|1|||
48996654|NCT02389621|157823366|FG000|Posttreatment Period|Other - Miscellaneous|2|||
48996655|NCT02389621|157823367|FG001|Posttreatment Period|Other - Miscellaneous|0|||
48996656|NCT01711736|157823369|FG000|Overall Study|Lost to Follow-up|4|||
48996657|NCT01711736|157823370|FG001|Overall Study|Lost to Follow-up|1|||
48996658|NCT01711736|157823369|FG000|Overall Study|Withdrawal by Subject|6|||
48996659|NCT01711736|157823370|FG001|Overall Study|Withdrawal by Subject|6|||
48996660|NCT01711736|157823369|FG000|Overall Study|Migrated/moved from study area|2|||
48996661|NCT01711736|157823370|FG001|Overall Study|Migrated/moved from study area|1|||
48996662|NCT03526549|157823372|FG000|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|0|||
48996663|NCT03526549|157823373|FG001|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|238|||
48996664|NCT03526549|157823372|FG000|180 Days Observational Phase|Withdrawal by Subject|40|||
48996665|NCT03526549|157823373|FG001|180 Days Observational Phase|Withdrawal by Subject|2|||
48996666|NCT03526549|157823372|FG000|180 Days Observational Phase|Lost to Follow-up|1|||
48996667|NCT03526549|157823373|FG001|180 Days Observational Phase|Lost to Follow-up|0|||
48996668|NCT03526549|157823372|FG000|Open-label Phase|Adverse Event|4|||
48996669|NCT03526549|157823373|FG001|Open-label Phase|Adverse Event|0|||
48996670|NCT03526549|157823372|FG000|Open-label Phase|Withdrawal by Subject|54|||
48996671|NCT03526549|157823373|FG001|Open-label Phase|Withdrawal by Subject|0|||
48996672|NCT03526549|157823372|FG000|Open-label Phase|Lost to Follow-up|35|||
48996673|NCT03526549|157823373|FG001|Open-label Phase|Lost to Follow-up|0|||
48996674|NCT03526549|157823372|FG000|Open-label Phase|Other than Specified|5|||
48996675|NCT03526549|157823373|FG001|Open-label Phase|Other than Specified|0|||
48996676|NCT00998166|157823378|FG000|Overall Study|Early Study Termination|8|||
48996677|NCT00578448|157823381|FG000|Day 1 up to 3 Years of Planned Study|Death|1|||
48996678|NCT00578448|157823381|FG000|Day 1 up to 3 Years of Planned Study|Adverse Event|1|||
48996679|NCT00578448|157823381|FG000|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1|||
48996680|NCT00578448|157823381|FG000|1 Year Long Term Extension (LTE)|Adverse Event|1|||
48996681|NCT03237325|157823383|FG000|Overall Study|Lost to Follow-up|3|||
48996682|NCT03237325|157823384|FG001|Overall Study|Lost to Follow-up|5|||
48996683|NCT03237325|157823383|FG000|Overall Study|Physician Decision|2|||
48996684|NCT03237325|157823384|FG001|Overall Study|Physician Decision|4|||
48996685|NCT03237325|157823383|FG000|Overall Study|Withdrawal by Subject|9|||
48996686|NCT03237325|157823384|FG001|Overall Study|Withdrawal by Subject|12|||
48996687|NCT03237325|157823383|FG000|Overall Study|Noncompliance with Study Procedures|1|||
48996688|NCT03237325|157823384|FG001|Overall Study|Noncompliance with Study Procedures|1|||
48996689|NCT03237325|157823383|FG000|Overall Study|Termination by Sponsor|0|||
48996690|NCT03237325|157823384|FG001|Overall Study|Termination by Sponsor|1|||
48996691|NCT03237325|157823383|FG000|Overall Study|Reason other than described|0|||
48996692|NCT03237325|157823384|FG001|Overall Study|Reason other than described|2|||
48996693|NCT04021602|157823386|FG000|Overall Study|Lost to Follow-up|3|||
48996694|NCT04021602|157823387|FG001|Overall Study|Lost to Follow-up|3|||
48996695|NCT04021602|157823388|FG002|Overall Study|Lost to Follow-up|1|||
48996696|NCT04021602|157823386|FG000|Overall Study|Adverse Event|1|||
48996697|NCT04021602|157823387|FG001|Overall Study|Adverse Event|0|||
48996698|NCT04021602|157823388|FG002|Overall Study|Adverse Event|1|||
48996699|NCT01207219|157823389|FG000|Overall Study|changed diagnosis during study period|5|||
48996700|NCT01207219|157823390|FG001|Overall Study|changed diagnosis during study period|3|||
48996701|NCT01207219|157823391|FG002|Overall Study|changed diagnosis during study period|1|||
48996702|NCT01207219|157823389|FG000|Overall Study|Lost to Follow-up|6|||
48996703|NCT01207219|157823390|FG001|Overall Study|Lost to Follow-up|8|||
48996704|NCT01207219|157823391|FG002|Overall Study|Lost to Follow-up|6|||
48996705|NCT01453296|157823392|FG000|Treatment Period 1|Adverse Event|0|||
48996706|NCT01453296|157823393|FG001|Treatment Period 1|Adverse Event|1|||
48996707|NCT01453296|157823392|FG000|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1|||
48996708|NCT01453296|157823393|FG001|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0|||
48996709|NCT01453296|157823392|FG000|Treatment Period 2|Adverse Event|1|||
48996710|NCT01453296|157823393|FG001|Treatment Period 2|Adverse Event|0|||
48996711|NCT01453296|157823392|FG000|Treatment Period 2|Withdrawal by Subject|1|||
48996712|NCT01453296|157823393|FG001|Treatment Period 2|Withdrawal by Subject|0|||
48996713|NCT04629534|157823396|FG000|Overall Study|Physician Decision|1|||
48996714|NCT04629534|157823397|FG001|Overall Study|Physician Decision|0|||
48996715|NCT04629534|157823396|FG000|Overall Study|Protocol Violation|0|||
48996716|NCT04629534|157823397|FG001|Overall Study|Protocol Violation|2|||
48996717|NCT01353586|157823398|FG000|Overall Study|Procedure terminated prior to ablation|3|||
48996718|NCT01353586|157823399|FG001|Overall Study|Procedure terminated prior to ablation|0|||
48996719|NCT01353586|157823398|FG000|Overall Study|Never had insertion of study catheter|4|||
48996720|NCT01353586|157823399|FG001|Overall Study|Never had insertion of study catheter|1|||
48996721|NCT01353586|157823398|FG000|Overall Study|Neurological exam not done|0|||
48996722|NCT01353586|157823399|FG001|Overall Study|Neurological exam not done|1|||
48996723|NCT00585468|157823400|FG000|First Intervention|Withdrawal by Subject|1|||
48996724|NCT00585468|157823401|FG001|First Intervention|Withdrawal by Subject|1|||
48996725|NCT01023815|157823406|FG000|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144|||
48996726|NCT01023815|157823407|FG001|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
48996727|NCT01023815|157823408|FG002|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
48996728|NCT01023815|157823409|FG003|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
48996729|NCT01023815|157823406|FG000|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
48996730|NCT01023815|157823407|FG001|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
48996731|NCT01023815|157823408|FG002|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
48996732|NCT01023815|157823409|FG003|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
48996733|NCT01023815|157823406|FG000|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
48996734|NCT01023815|157823407|FG001|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
48996735|NCT01023815|157823408|FG002|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
48996736|NCT01023815|157823409|FG003|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
48996737|NCT01023815|157823406|FG000|Randomized Period (Day 90 to Month 12)|Administrative Problems|0|||
48996738|NCT01023815|157823407|FG001|Randomized Period (Day 90 to Month 12)|Administrative Problems|1|||
49045836|NCT01894230|158002025|FG001|Overall Study|Non-adherent|1|||
48996739|NCT01023815|157823408|FG002|Randomized Period (Day 90 to Month 12)|Administrative Problems|6|||
48996740|NCT01023815|157823409|FG003|Randomized Period (Day 90 to Month 12)|Administrative Problems|2|||
48996741|NCT01023815|157823406|FG000|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
48996742|NCT01023815|157823407|FG001|Randomized Period (Day 90 to Month 12)|Graft Loss|1|||
48996743|NCT01023815|157823408|FG002|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
48996744|NCT01023815|157823409|FG003|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
48996745|NCT00762073|157823410|FG000|Overall Study|Lack of Efficacy|1|||
48996746|NCT00762073|157823411|FG001|Overall Study|Lack of Efficacy|1|||
48996747|NCT00762073|157823412|FG002|Overall Study|Lack of Efficacy|0|||
48996748|NCT00762073|157823413|FG003|Overall Study|Lack of Efficacy|0|||
48996749|NCT00762073|157823410|FG000|Overall Study|Adverse Event|1|||
48996750|NCT00762073|157823411|FG001|Overall Study|Adverse Event|0|||
48996751|NCT00762073|157823412|FG002|Overall Study|Adverse Event|1|||
48996752|NCT00762073|157823413|FG003|Overall Study|Adverse Event|1|||
48996753|NCT00762073|157823410|FG000|Overall Study|Significant Subject Noncompliance|0|||
48996754|NCT00762073|157823411|FG001|Overall Study|Significant Subject Noncompliance|1|||
48996755|NCT00762073|157823412|FG002|Overall Study|Significant Subject Noncompliance|0|||
48996756|NCT00762073|157823413|FG003|Overall Study|Significant Subject Noncompliance|1|||
48996757|NCT00762073|157823410|FG000|Overall Study|Withdrawal by Subject|1|||
48996758|NCT00762073|157823411|FG001|Overall Study|Withdrawal by Subject|2|||
48996759|NCT00762073|157823412|FG002|Overall Study|Withdrawal by Subject|1|||
48996760|NCT00762073|157823413|FG003|Overall Study|Withdrawal by Subject|1|||
48996761|NCT00762073|157823410|FG000|Overall Study|Not on treatment for >/= 77 days|1|||
48996762|NCT00762073|157823411|FG001|Overall Study|Not on treatment for >/= 77 days|0|||
48996763|NCT00762073|157823412|FG002|Overall Study|Not on treatment for >/= 77 days|0|||
48996764|NCT00762073|157823413|FG003|Overall Study|Not on treatment for >/= 77 days|0|||
48996765|NCT03733301|157823414|FG000|Overall Study|Screen Fail|1|||
48996766|NCT03733301|157823415|FG001|Overall Study|Screen Fail|0|||
48996767|NCT03733301|157823416|FG002|Overall Study|Screen Fail|0|||
48996768|NCT03733301|157823414|FG000|Overall Study|Non-compliance|1|||
48996769|NCT03733301|157823415|FG001|Overall Study|Non-compliance|0|||
48996770|NCT03733301|157823416|FG002|Overall Study|Non-compliance|0|||
48996771|NCT03733301|157823414|FG000|Overall Study|Lack of Efficacy|2|||
48996772|NCT03733301|157823415|FG001|Overall Study|Lack of Efficacy|3|||
48996773|NCT03733301|157823416|FG002|Overall Study|Lack of Efficacy|0|||
48996774|NCT03733301|157823414|FG000|Overall Study|Adverse Event|0|||
48996775|NCT03733301|157823415|FG001|Overall Study|Adverse Event|1|||
48996776|NCT03733301|157823416|FG002|Overall Study|Adverse Event|3|||
48996777|NCT03733301|157823414|FG000|Overall Study|Withdrawal by Subject|3|||
48996778|NCT03733301|157823415|FG001|Overall Study|Withdrawal by Subject|5|||
48996779|NCT03733301|157823416|FG002|Overall Study|Withdrawal by Subject|1|||
48996780|NCT02057549|157823418|FG000|Overall Study|Lost to Follow-up|1|||
48996781|NCT02057549|157823419|FG001|Overall Study|Lost to Follow-up|0|||
48996782|NCT02057549|157823418|FG000|Overall Study|Physician Decision|1|||
48996783|NCT02057549|157823419|FG001|Overall Study|Physician Decision|0|||
48996784|NCT02057549|157823418|FG000|Overall Study|Withdrawal by Subject|1|||
48996785|NCT02057549|157823419|FG001|Overall Study|Withdrawal by Subject|0|||
48996786|NCT00664066|157823421|FG000|Overall Study|Study terminated|3|||
48996787|NCT01015118|157823422|FG000|Overall Study|Protocol Violation|5|||
48996788|NCT01015118|157823423|FG001|Overall Study|Protocol Violation|6|||
48996789|NCT01015118|157823422|FG000|Overall Study|Withdrawal by Subject|103|||
48996790|NCT01015118|157823423|FG001|Overall Study|Withdrawal by Subject|27|||
48996791|NCT01015118|157823422|FG000|Overall Study|Other Adverse Event (AE)|141|||
48996792|NCT01015118|157823423|FG001|Overall Study|Other Adverse Event (AE)|33|||
48996793|NCT01015118|157823422|FG000|Overall Study|Worsening or AE of underlying disease|5|||
48996794|NCT01015118|157823423|FG001|Overall Study|Worsening or AE of underlying disease|4|||
48996795|NCT01015118|157823422|FG000|Overall Study|Progressive disease|364|||
48996796|NCT01015118|157823423|FG001|Overall Study|Progressive disease|229|||
48996797|NCT01015118|157823422|FG000|Overall Study|Not treated|9|||
48996798|NCT01015118|157823423|FG001|Overall Study|Not treated|5|||
48996799|NCT01015118|157823422|FG000|Overall Study|Other than stated above|42|||
48996800|NCT01015118|157823423|FG001|Overall Study|Other than stated above|23|||
48996801|NCT04882085|157823428|FG000|Overall Study|Death|6|||
48996802|NCT04882085|157823429|FG001|Overall Study|Death|9|||
48996803|NCT04882085|157823428|FG000|Overall Study|Withdrawal by Subject|0|||
48996804|NCT04882085|157823429|FG001|Overall Study|Withdrawal by Subject|3|||
48996805|NCT04882085|157823428|FG000|Overall Study|Randomized not treated|1|||
48996806|NCT04882085|157823429|FG001|Overall Study|Randomized not treated|0|||
48996807|NCT01215968|157823432|FG000|Overall Study|Adverse Event|0|||
48996808|NCT01215968|157823433|FG001|Overall Study|Adverse Event|2|||
48996809|NCT01215968|157823432|FG000|Overall Study|Protocol Violation|2|||
48996810|NCT01215968|157823433|FG001|Overall Study|Protocol Violation|4|||
48996811|NCT01215968|157823432|FG000|Overall Study|Not received study drug|0|||
48996812|NCT01215968|157823433|FG001|Overall Study|Not received study drug|1|||
48996813|NCT00816166|157823437|FG000|Overall Study|Lost to Follow-up|6|||
48996814|NCT00816166|157823438|FG001|Overall Study|Lost to Follow-up|10|||
48996815|NCT00816166|157823437|FG000|Overall Study|Death|4|||
48996816|NCT00816166|157823438|FG001|Overall Study|Death|2|||
48996817|NCT02268214|157823447|FG000|Overall Study|Subject no longer meets study criteria|0|||
48996818|NCT02268214|157823448|FG001|Overall Study|Subject no longer meets study criteria|2|||
48996819|NCT02268214|157823449|FG002|Overall Study|Subject no longer meets study criteria|0|||
48996820|NCT02268214|157823447|FG000|Overall Study|Pregnancy|2|||
48996821|NCT02268214|157823448|FG001|Overall Study|Pregnancy|2|||
48996822|NCT02268214|157823449|FG002|Overall Study|Pregnancy|1|||
48996823|NCT02268214|157823447|FG000|Overall Study|Lost to Follow-up|3|||
48996824|NCT02268214|157823448|FG001|Overall Study|Lost to Follow-up|3|||
48996825|NCT02268214|157823449|FG002|Overall Study|Lost to Follow-up|4|||
48996826|NCT02268214|157823447|FG000|Overall Study|Lack of Efficacy|1|||
48996827|NCT02268214|157823448|FG001|Overall Study|Lack of Efficacy|0|||
48996828|NCT02268214|157823449|FG002|Overall Study|Lack of Efficacy|2|||
48996829|NCT02268214|157823447|FG000|Overall Study|Adverse Event|11|||
48996830|NCT02268214|157823448|FG001|Overall Study|Adverse Event|14|||
48996831|NCT02268214|157823449|FG002|Overall Study|Adverse Event|9|||
48996832|NCT02268214|157823447|FG000|Overall Study|Withdrawal by Subject|4|||
48996833|NCT02268214|157823448|FG001|Overall Study|Withdrawal by Subject|5|||
48996834|NCT02268214|157823449|FG002|Overall Study|Withdrawal by Subject|10|||
48996835|NCT02268214|157823447|FG000|Overall Study|Subject request to discontinue treatment|10|||
48996836|NCT02268214|157823448|FG001|Overall Study|Subject request to discontinue treatment|8|||
48996837|NCT02268214|157823449|FG002|Overall Study|Subject request to discontinue treatment|6|||
48996838|NCT02268214|157823447|FG000|Overall Study|Poor/non-compliance|2|||
48996839|NCT02268214|157823448|FG001|Overall Study|Poor/non-compliance|1|||
48996840|NCT02268214|157823449|FG002|Overall Study|Poor/non-compliance|2|||
48996841|NCT02268214|157823447|FG000|Overall Study|Other reasons|7|||
48996842|NCT02268214|157823448|FG001|Overall Study|Other reasons|3|||
48996843|NCT02268214|157823449|FG002|Overall Study|Other reasons|3|||
48996844|NCT02268214|157823447|FG000|Overall Study|Not entering long-term period|2|||
48996845|NCT02268214|157823448|FG001|Overall Study|Not entering long-term period|3|||
48996846|NCT02268214|157823449|FG002|Overall Study|Not entering long-term period|5|||
48996847|NCT02873195|157823450|FG000|Overall Study|Ineligible|5|||
48996848|NCT02873195|157823451|FG001|Overall Study|Ineligible|0|||
48996849|NCT04342390|157823454|FG000|Overall Study|Lost to Follow-up|3|||
48996850|NCT04342390|157823455|FG001|Overall Study|Lost to Follow-up|0|||
48996851|NCT01058707|157823457|FG000|Overall Study|Disease Progression|15|||
48996852|NCT01058707|157823458|FG001|Overall Study|Disease Progression|20|||
48996853|NCT01058707|157823459|FG002|Overall Study|Disease Progression|20|||
48996854|NCT01058707|157823460|FG003|Overall Study|Disease Progression|15|||
48996855|NCT01058707|157823461|FG004|Overall Study|Disease Progression|23|||
48996856|NCT01058707|157823462|FG005|Overall Study|Disease Progression|10|||
48996857|NCT01058707|157823463|FG006|Overall Study|Disease Progression|12|||
48996858|NCT01058707|157823457|FG000|Overall Study|Adverse Event|11|||
48996859|NCT01058707|157823458|FG001|Overall Study|Adverse Event|4|||
48996860|NCT01058707|157823459|FG002|Overall Study|Adverse Event|7|||
48996861|NCT01058707|157823460|FG003|Overall Study|Adverse Event|6|||
48996862|NCT01058707|157823461|FG004|Overall Study|Adverse Event|7|||
48996863|NCT01058707|157823462|FG005|Overall Study|Adverse Event|3|||
48996864|NCT01058707|157823463|FG006|Overall Study|Adverse Event|1|||
48996865|NCT01058707|157823457|FG000|Overall Study|Subject Decision|5|||
48996866|NCT01058707|157823458|FG001|Overall Study|Subject Decision|3|||
48996867|NCT01058707|157823459|FG002|Overall Study|Subject Decision|3|||
48996868|NCT01058707|157823460|FG003|Overall Study|Subject Decision|1|||
48996869|NCT01058707|157823461|FG004|Overall Study|Subject Decision|2|||
48996870|NCT01058707|157823462|FG005|Overall Study|Subject Decision|3|||
48996871|NCT01058707|157823463|FG006|Overall Study|Subject Decision|6|||
48996872|NCT01058707|157823457|FG000|Overall Study|Lost to Follow-up|0|||
48996873|NCT01058707|157823458|FG001|Overall Study|Lost to Follow-up|0|||
48996874|NCT01058707|157823459|FG002|Overall Study|Lost to Follow-up|1|||
48996875|NCT01058707|157823460|FG003|Overall Study|Lost to Follow-up|0|||
48996876|NCT01058707|157823461|FG004|Overall Study|Lost to Follow-up|0|||
48996877|NCT01058707|157823462|FG005|Overall Study|Lost to Follow-up|0|||
48996878|NCT01058707|157823463|FG006|Overall Study|Lost to Follow-up|0|||
48996879|NCT01058707|157823457|FG000|Overall Study|Reason Not Specified|0|||
48996880|NCT01058707|157823458|FG001|Overall Study|Reason Not Specified|3|||
48996881|NCT01058707|157823459|FG002|Overall Study|Reason Not Specified|2|||
48996882|NCT01058707|157823460|FG003|Overall Study|Reason Not Specified|0|||
48996883|NCT01058707|157823461|FG004|Overall Study|Reason Not Specified|7|||
48996884|NCT01058707|157823462|FG005|Overall Study|Reason Not Specified|1|||
49045837|NCT01894230|158002024|FG000|Overall Study|Death|1|||
48996885|NCT01058707|157823463|FG006|Overall Study|Reason Not Specified|7|||
48996886|NCT00777920|157823468|FG000|Overall Study|Adverse Event|39|||
48996887|NCT00777920|157823468|FG000|Overall Study|Withdrawal of Consent|4|||
48996888|NCT00777920|157823468|FG000|Overall Study|Lost to Follow-up|1|||
48996889|NCT00777920|157823468|FG000|Overall Study|Investigator's discretion|1|||
48996890|NCT00777920|157823468|FG000|Overall Study|Clinical status did not improve|1|||
48996891|NCT00777920|157823468|FG000|Overall Study|Other, not specified|4|||
48996892|NCT00909857|157823469|FG000|Overall Study|Withdrawal by Subject|6|||
49045838|NCT01894230|158002025|FG001|Overall Study|Death|0|||
48996893|NCT00909857|157823470|FG001|Overall Study|Withdrawal by Subject|10|||
48996894|NCT00909857|157823469|FG000|Overall Study|Adverse Event|5|||
48996895|NCT00909857|157823470|FG001|Overall Study|Adverse Event|5|||
48996896|NCT00909857|157823469|FG000|Overall Study|Lost to Follow-up|2|||
48996897|NCT00909857|157823470|FG001|Overall Study|Lost to Follow-up|5|||
48996898|NCT00909857|157823469|FG000|Overall Study|Protocol Violation|2|||
48996899|NCT00909857|157823470|FG001|Overall Study|Protocol Violation|1|||
48996900|NCT00909857|157823469|FG000|Overall Study|Pregnancy|1|||
48996901|NCT00909857|157823470|FG001|Overall Study|Pregnancy|0|||
48996902|NCT00909857|157823469|FG000|Overall Study|Other|1|||
48996903|NCT00909857|157823470|FG001|Overall Study|Other|0|||
48996904|NCT00909857|157823469|FG000|Overall Study|Did not receive study medication|19|||
48996905|NCT00909857|157823470|FG001|Overall Study|Did not receive study medication|24|||
48996906|NCT00604175|157823471|FG000|Entry Through Week 28|Death|2|||
48996907|NCT00604175|157823472|FG001|Entry Through Week 28|Death|0|||
48996908|NCT00604175|157823473|FG002|Entry Through Week 28|Death|0|||
48996909|NCT00604175|157823471|FG000|Entry Through Week 28|Withdrawal by Subject|1|||
48996910|NCT00604175|157823472|FG001|Entry Through Week 28|Withdrawal by Subject|0|||
48996911|NCT00604175|157823473|FG002|Entry Through Week 28|Withdrawal by Subject|0|||
48996912|NCT00604175|157823471|FG000|Entry Through Week 28|Lost to Follow-up|4|||
48996913|NCT00604175|157823472|FG001|Entry Through Week 28|Lost to Follow-up|3|||
48996914|NCT00604175|157823473|FG002|Entry Through Week 28|Lost to Follow-up|0|||
48996915|NCT00604175|157823471|FG000|Entry Through Week 28|Ineligible|1|||
48996916|NCT00604175|157823472|FG001|Entry Through Week 28|Ineligible|0|||
48996917|NCT00604175|157823473|FG002|Entry Through Week 28|Ineligible|0|||
48996918|NCT00604175|157823471|FG000|Entry Through Week 28|Did not start intervention|2|||
48996919|NCT00604175|157823472|FG001|Entry Through Week 28|Did not start intervention|0|||
48996920|NCT00604175|157823473|FG002|Entry Through Week 28|Did not start intervention|1|||
48996921|NCT00604175|157823471|FG000|Week 29 Through Week 72|Death|0|||
48996922|NCT00604175|157823472|FG001|Week 29 Through Week 72|Death|0|||
48996923|NCT00604175|157823473|FG002|Week 29 Through Week 72|Death|1|||
48996924|NCT00604175|157823471|FG000|Week 29 Through Week 72|Lost to Follow-up|12|||
48996925|NCT00604175|157823472|FG001|Week 29 Through Week 72|Lost to Follow-up|6|||
48996926|NCT00604175|157823473|FG002|Week 29 Through Week 72|Lost to Follow-up|2|||
48996927|NCT00604175|157823471|FG000|Week 29 Through Week 72|Site closure|0|||
48996928|NCT00604175|157823472|FG001|Week 29 Through Week 72|Site closure|1|||
48996929|NCT00604175|157823473|FG002|Week 29 Through Week 72|Site closure|0|||
48996930|NCT00604175|157823471|FG000|Week 29 Through Week 72|Non-adherence to study requirements|0|||
48996931|NCT00604175|157823472|FG001|Week 29 Through Week 72|Non-adherence to study requirements|0|||
48996932|NCT00604175|157823473|FG002|Week 29 Through Week 72|Non-adherence to study requirements|1|||
48996933|NCT01682681|157823477|FG000|Overall Study|Lack of Efficacy|62|||
48996934|NCT01682681|157823477|FG000|Overall Study|Withdrawal by Subject|1|||
48996935|NCT01682681|157823477|FG000|Overall Study|Moved to other hospital|10|||
48996936|NCT01682681|157823477|FG000|Overall Study|Lost to Follow-up|174|||
48996937|NCT01682681|157823477|FG000|Overall Study|Adverse Event|46|||
48996938|NCT01682681|157823477|FG000|Overall Study|tapering of topiramate|5|||
48996939|NCT01682681|157823477|FG000|Overall Study|Other|21|||
48996940|NCT01682681|157823477|FG000|Overall Study|Low compliance|13|||
48996941|NCT02044094|157823478|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3|||
48996942|NCT02044094|157823478|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3|||
48996943|NCT02044094|157823478|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3|||
48996944|NCT02044094|157823478|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4|||
48996945|NCT02044094|157823478|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5|||
48996946|NCT02044094|157823478|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2|||
48996947|NCT02044094|157823478|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1|||
48996948|NCT02044094|157823478|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1|||
48996949|NCT00883129|157823479|FG000|Overall Study|Adverse Event|7|||
48996950|NCT00883129|157823480|FG001|Overall Study|Adverse Event|15|||
48996951|NCT00883129|157823479|FG000|Overall Study|Withdrawal by Subject|8|||
48996952|NCT00883129|157823480|FG001|Overall Study|Withdrawal by Subject|9|||
48996953|NCT00883129|157823479|FG000|Overall Study|Non-compliance|3|||
48996954|NCT00883129|157823480|FG001|Overall Study|Non-compliance|6|||
48996955|NCT00883129|157823479|FG000|Overall Study|Lost to Follow-up|1|||
48996956|NCT00883129|157823480|FG001|Overall Study|Lost to Follow-up|2|||
48996957|NCT00883129|157823479|FG000|Overall Study|Death|1|||
48996958|NCT00883129|157823480|FG001|Overall Study|Death|2|||
48996959|NCT00883129|157823479|FG000|Overall Study|Defined Treatment Failure|0|||
48996960|NCT00883129|157823480|FG001|Overall Study|Defined Treatment Failure|2|||
48996961|NCT01545375|157824670|FG000|Overall Study|Adverse Event|2|||
48996962|NCT01545375|157824671|FG001|Overall Study|Adverse Event|1|||
48996963|NCT01545375|157824670|FG000|Overall Study|Lost to Follow-up|34|||
48996964|NCT01545375|157824671|FG001|Overall Study|Lost to Follow-up|31|||
48996965|NCT01545375|157824670|FG000|Overall Study|Protocol Violation|3|||
48996966|NCT01545375|157824671|FG001|Overall Study|Protocol Violation|3|||
48996967|NCT01545375|157824670|FG000|Overall Study|Withdrawal by Subject|58|||
48996968|NCT01545375|157824671|FG001|Overall Study|Withdrawal by Subject|55|||
48996969|NCT03839693|157824673|FG000|Overall Study|Lost to Follow-up|0|||
48996970|NCT03839693|157824674|FG001|Overall Study|Lost to Follow-up|2|||
48996971|NCT03839693|157824675|FG002|Overall Study|Lost to Follow-up|2|||
48996972|NCT03839693|157824673|FG000|Overall Study|Withdrawal by Subject|1|||
48996973|NCT03839693|157824674|FG001|Overall Study|Withdrawal by Subject|0|||
48996974|NCT03839693|157824675|FG002|Overall Study|Withdrawal by Subject|2|||
48996975|NCT03839693|157824673|FG000|Overall Study|subject moved out of the area|1|||
48996976|NCT03839693|157824674|FG001|Overall Study|subject moved out of the area|0|||
48996977|NCT03839693|157824675|FG002|Overall Study|subject moved out of the area|0|||
48996978|NCT02983305|157824682|FG000|Overall Study|incomplete data|2|||
48996979|NCT02983305|157824683|FG001|Overall Study|incomplete data|0|||
48996980|NCT00706901|157824684|FG000|Overall Study|Lost to Follow-up|2|||
48996981|NCT00706901|157824685|FG001|Overall Study|Lost to Follow-up|3|||
48996982|NCT00706901|157824686|FG002|Overall Study|Lost to Follow-up|2|||
48996983|NCT00706901|157824684|FG000|Overall Study|Withdrawal by Subject|4|||
48996984|NCT00706901|157824685|FG001|Overall Study|Withdrawal by Subject|2|||
48996985|NCT00706901|157824686|FG002|Overall Study|Withdrawal by Subject|5|||
48996986|NCT00706901|157824684|FG000|Overall Study|In Jail|1|||
48996987|NCT00706901|157824685|FG001|Overall Study|In Jail|0|||
48996988|NCT00706901|157824686|FG002|Overall Study|In Jail|1|||
48996989|NCT00706901|157824684|FG000|Overall Study|Death|1|||
48996990|NCT00706901|157824685|FG001|Overall Study|Death|0|||
48996991|NCT00706901|157824686|FG002|Overall Study|Death|0|||
48996992|NCT01319994|157824687|FG000|Overall Study|Protocol Violation|7|||
48996993|NCT01319994|157824688|FG001|Overall Study|Protocol Violation|6|||
48996994|NCT00822237|157824689|FG000|Dose 1 Vaccination|Not vaccinated|3|||
48996995|NCT00822237|157824690|FG001|Dose 1 Vaccination|Not vaccinated|0|||
48996996|NCT00822237|157824689|FG000|Dose 1 Vaccination|Withdrawal by Subject|13|||
48996997|NCT00822237|157824690|FG001|Dose 1 Vaccination|Withdrawal by Subject|14|||
48996998|NCT00822237|157824689|FG000|Dose 1 Vaccination|Lost to Follow-up|9|||
48996999|NCT00822237|157824690|FG001|Dose 1 Vaccination|Lost to Follow-up|12|||
48997000|NCT00822237|157824689|FG000|Dose 2 Vaccination|Withdrawal by Subject|2|||
48997001|NCT00822237|157824690|FG001|Dose 2 Vaccination|Withdrawal by Subject|2|||
48997002|NCT00822237|157824689|FG000|Dose 2 Vaccination|Lost to Follow-up|2|||
48997003|NCT00822237|157824690|FG001|Dose 2 Vaccination|Lost to Follow-up|9|||
48997004|NCT01269346|157824693|FG000|Treatment Phase|Disease progression|3|||
48997005|NCT01269346|157824693|FG000|Treatment Phase|Adverse Event|3|||
48997006|NCT01269346|157824693|FG000|Treatment Phase|Withdrawal by Subject|1|||
48997007|NCT01269346|157824693|FG000|Treatment Phase|Other|2|||
48997008|NCT01269346|157824693|FG000|Extension Phase|Adverse Event|6|||
48997009|NCT01269346|157824693|FG000|Extension Phase|Withdrawal by Subject|4|||
48997010|NCT01269346|157824693|FG000|Extension Phase|Disease progression|22|||
48997011|NCT01269346|157824693|FG000|Extension Phase|Physician decision or participant choice|9|||
48997012|NCT01269346|157824693|FG000|Extension Phase|Clinical progression|1|||
48997013|NCT01269346|157824693|FG000|Extension Phase|Started a prohibited con med|1|||
48997014|NCT00247416|157824696|FG000|Overall Study|3 patients were found to be ineligible|1|||
48997015|NCT00247416|157824697|FG001|Overall Study|3 patients were found to be ineligible|2|||
48997016|NCT02815540|157824698|FG000|Overall Study|Physician left institution and study was discontinued. No other PI was available.|2|||
48997017|NCT02222246|157824699|FG000|Overall Study|No Emergency Department Visits|27|||
48997018|NCT02222246|157824700|FG001|Overall Study|No Emergency Department Visits|26|||
48997019|NCT02222246|157824699|FG000|Overall Study|Physician Decision|0|||
48997020|NCT02222246|157824700|FG001|Overall Study|Physician Decision|1|||
48997021|NCT01646268|157824701|FG000|Overall Study|Adverse Event|6|||
48997022|NCT01646268|157824702|FG001|Overall Study|Adverse Event|7|||
48997023|NCT01646268|157824701|FG000|Overall Study|Lack of Efficacy|1|||
48997024|NCT01646268|157824702|FG001|Overall Study|Lack of Efficacy|3|||
48997025|NCT01646268|157824701|FG000|Overall Study|Protocol Violation|0|||
48997026|NCT01646268|157824702|FG001|Overall Study|Protocol Violation|1|||
48997027|NCT01646268|157824701|FG000|Overall Study|Withdrawal by Subject|2|||
48997028|NCT01646268|157824702|FG001|Overall Study|Withdrawal by Subject|5|||
48997029|NCT01646268|157824701|FG000|Overall Study|Other|2|||
48997030|NCT01646268|157824702|FG001|Overall Study|Other|0|||
48997031|NCT02064231|157824703|FG000|First Test Period (Test A or Test C)|Lack of Efficacy|5|||
48997032|NCT02064231|157824704|FG001|First Test Period (Test A or Test C)|Lack of Efficacy|3|||
48997033|NCT02064231|157824705|FG002|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
48997034|NCT02064231|157824706|FG003|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
48997035|NCT02064231|157824703|FG000|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
48997036|NCT02064231|157824704|FG001|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
48997037|NCT02064231|157824705|FG002|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
48997038|NCT02064231|157824706|FG003|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
48997039|NCT02064231|157824703|FG000|First Test Period (Test A or Test C)|Adverse Event|1|||
48997040|NCT02064231|157824704|FG001|First Test Period (Test A or Test C)|Adverse Event|0|||
48997041|NCT02064231|157824705|FG002|First Test Period (Test A or Test C)|Adverse Event|1|||
48997042|NCT02064231|157824706|FG003|First Test Period (Test A or Test C)|Adverse Event|0|||
48997043|NCT02064231|157824703|FG000|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
48997044|NCT02064231|157824704|FG001|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
48997045|NCT02064231|157824705|FG002|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
48997046|NCT02064231|157824706|FG003|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
48997047|NCT00278473|157824707|FG000|Overall Study|drop out|4|||
48997048|NCT00278473|157824708|FG001|Overall Study|drop out|3|||
48997049|NCT03971422|157824709|FG000|Overall Study|Lost to Follow-up|0|||
48997050|NCT03971422|157824710|FG001|Overall Study|Lost to Follow-up|1|||
48997051|NCT03971422|157824711|FG002|Overall Study|Lost to Follow-up|0|||
48997052|NCT03971422|157824709|FG000|Overall Study|Lack of Efficacy|5|||
48997053|NCT03971422|157824710|FG001|Overall Study|Lack of Efficacy|1|||
48997054|NCT03971422|157824711|FG002|Overall Study|Lack of Efficacy|1|||
48997055|NCT03971422|157824709|FG000|Overall Study|Adverse event, not fatal|2|||
48997056|NCT03971422|157824710|FG001|Overall Study|Adverse event, not fatal|2|||
48997057|NCT03971422|157824711|FG002|Overall Study|Adverse event, not fatal|5|||
48997058|NCT03971422|157824709|FG000|Overall Study|Worsening of MG Symptoms|1|||
48997059|NCT03971422|157824710|FG001|Overall Study|Worsening of MG Symptoms|4|||
48997060|NCT03971422|157824711|FG002|Overall Study|Worsening of MG Symptoms|2|||
48997061|NCT03971422|157824709|FG000|Overall Study|Roll over to MG0007 (NCT04650854)|10|||
48997062|NCT03971422|157824710|FG001|Overall Study|Roll over to MG0007 (NCT04650854)|6|||
48997063|NCT03971422|157824711|FG002|Overall Study|Roll over to MG0007 (NCT04650854)|9|||
48997064|NCT03971422|157824709|FG000|Overall Study|Roll over to MG0004 (NCT04124965)|7|||
48997065|NCT03971422|157824710|FG001|Overall Study|Roll over to MG0004 (NCT04124965)|8|||
48997066|NCT03971422|157824711|FG002|Overall Study|Roll over to MG0004 (NCT04124965)|6|||
48997067|NCT03971422|157824709|FG000|Overall Study|Due to COVID-19 pandemic|0|||
48997068|NCT03971422|157824710|FG001|Overall Study|Due to COVID-19 pandemic|1|||
48997069|NCT03971422|157824711|FG002|Overall Study|Due to COVID-19 pandemic|1|||
48997070|NCT04812548|157824712|FG000|Overall Study|Adverse Event|2|||
48997071|NCT04812548|157824713|FG001|Overall Study|Adverse Event|7|||
48997072|NCT04812548|157824712|FG000|Overall Study|HSCT Planned|2|||
48997073|NCT04812548|157824713|FG001|Overall Study|HSCT Planned|3|||
48997074|NCT04812548|157824712|FG000|Overall Study|Progressive Disease|0|||
48997075|NCT04812548|157824713|FG001|Overall Study|Progressive Disease|2|||
48997076|NCT04812548|157824712|FG000|Overall Study|Death|0|||
48997077|NCT04812548|157824713|FG001|Overall Study|Death|1|||
48997078|NCT04812548|157824712|FG000|Overall Study|Post Study Access to Treatment|0|||
48997079|NCT04812548|157824713|FG001|Overall Study|Post Study Access to Treatment|1|||
48997080|NCT04812548|157824712|FG000|Overall Study|Withdrawal by Subject|0|||
48997081|NCT04812548|157824713|FG001|Overall Study|Withdrawal by Subject|1|||
48997082|NCT04812548|157824712|FG000|Overall Study|Physician Decision|1|||
48997083|NCT04812548|157824713|FG001|Overall Study|Physician Decision|0|||
48997084|NCT05299359|157824714|FG000|Main Part: Day 1 up to Day 366|Participants moved to extension part|129|||
48997085|NCT05299359|157824715|FG001|Main Part: Day 1 up to Day 366|Participants moved to extension part|0|||
48997086|NCT05299359|157824714|FG000|Main Part: Day 1 up to Day 366|Other|2|||
48997087|NCT05299359|157824715|FG001|Main Part: Day 1 up to Day 366|Other|0|||
48997088|NCT05299359|157824714|FG000|Main Part: Day 1 up to Day 366|Withdrawal by Subject|1|||
48997089|NCT05299359|157824715|FG001|Main Part: Day 1 up to Day 366|Withdrawal by Subject|0|||
48997090|NCT05299359|157824714|FG000|Main Part: Day 1 up to Day 366|Lost to Follow-up|1|||
48997091|NCT05299359|157824715|FG001|Main Part: Day 1 up to Day 366|Lost to Follow-up|0|||
48997092|NCT05299359|157824714|FG000|Extension Part: Day 1 to Day 366|Lost to Follow-up|0|||
48997093|NCT05299359|157824715|FG001|Extension Part: Day 1 to Day 366|Lost to Follow-up|2|||
48997094|NCT05299359|157824714|FG000|Extension Part: Day 1 to Day 366|Withdrawal by Subject|0|||
48997095|NCT05299359|157824715|FG001|Extension Part: Day 1 to Day 366|Withdrawal by Subject|5|||
48997096|NCT05299359|157824714|FG000|Extension Part: Day 1 to Day 366|Other|0|||
48997097|NCT05299359|157824715|FG001|Extension Part: Day 1 to Day 366|Other|1|||
48997098|NCT04780776|157824716|FG000|Titration Week 1-5|Lost to Follow-up|2|||
48997099|NCT04780776|157824717|FG001|Titration Week 1-5|Lost to Follow-up|8|||
48997100|NCT04780776|157824716|FG000|Treatment Week 6-21|Lost to Follow-up|4|||
48997101|NCT04780776|157824717|FG001|Treatment Week 6-21|Lost to Follow-up|4|||
48997102|NCT04780776|157824716|FG000|Follow up Week 22-25|Lost to Follow-up|2|||
48997103|NCT04780776|157824717|FG001|Follow up Week 22-25|Lost to Follow-up|2|||
48997104|NCT01748162|157824727|FG000|Overall Study|no additional croup episodes to evaluate|2|||
48997105|NCT01748162|157824728|FG001|Overall Study|no additional croup episodes to evaluate|2|||
48997106|NCT01748162|157824727|FG000|Overall Study|participant consented but did not begin|0|||
48997107|NCT01748162|157824728|FG001|Overall Study|participant consented but did not begin|1|||
48997108|NCT01748162|157824727|FG000|Overall Study|reasons not available|3|||
48997109|NCT01748162|157824728|FG001|Overall Study|reasons not available|2|||
48997110|NCT03841331|157824731|FG000|Overall Study|Withdrawal by Subject|4|||
48997111|NCT03841331|157824732|FG001|Overall Study|Withdrawal by Subject|9|||
48997112|NCT03841331|157824731|FG000|Overall Study|Lost to Follow-up|5|||
48997113|NCT03841331|157824732|FG001|Overall Study|Lost to Follow-up|1|||
48997114|NCT04145531|157824733|FG000|Part A|Adverse Event|2|||
48997115|NCT04145531|157824734|FG001|Part A|Adverse Event|12|||
48997116|NCT04145531|157824735|FG002|Part A|Adverse Event|6|||
48997117|NCT04145531|157824736|FG003|Part A|Adverse Event|0|||
48997118|NCT04145531|157824733|FG000|Part A|Death|1|||
48997119|NCT04145531|157824734|FG001|Part A|Death|2|||
48997120|NCT04145531|157824735|FG002|Part A|Death|0|||
48997121|NCT04145531|157824736|FG003|Part A|Death|0|||
48997122|NCT04145531|157824733|FG000|Part A|Physician Decision|2|||
48997123|NCT04145531|157824734|FG001|Part A|Physician Decision|5|||
48997124|NCT04145531|157824735|FG002|Part A|Physician Decision|2|||
48997125|NCT04145531|157824736|FG003|Part A|Physician Decision|0|||
48997126|NCT04145531|157824733|FG000|Part A|Progressive disease|0|||
48997127|NCT04145531|157824734|FG001|Part A|Progressive disease|2|||
48997128|NCT04145531|157824735|FG002|Part A|Progressive disease|1|||
48997129|NCT04145531|157824736|FG003|Part A|Progressive disease|0|||
48997130|NCT04145531|157824733|FG000|Part A|Protocol deviation|0|||
48997131|NCT04145531|157824734|FG001|Part A|Protocol deviation|0|||
48997132|NCT04145531|157824735|FG002|Part A|Protocol deviation|1|||
48997133|NCT04145531|157824736|FG003|Part A|Protocol deviation|0|||
48997134|NCT04145531|157824733|FG000|Part A|Withdrawal by parent or guardian|1|||
48997135|NCT04145531|157824734|FG001|Part A|Withdrawal by parent or guardian|0|||
48997136|NCT04145531|157824735|FG002|Part A|Withdrawal by parent or guardian|0|||
48997137|NCT04145531|157824736|FG003|Part A|Withdrawal by parent or guardian|0|||
48997138|NCT04145531|157824733|FG000|Part A|Withdrawal by participant|0|||
48997139|NCT04145531|157824734|FG001|Part A|Withdrawal by participant|0|||
48997140|NCT04145531|157824735|FG002|Part A|Withdrawal by participant|1|||
48997141|NCT04145531|157824736|FG003|Part A|Withdrawal by participant|0|||
48997142|NCT04145531|157824733|FG000|Part A|Other|0|||
48997143|NCT04145531|157824734|FG001|Part A|Other|0|||
48997144|NCT04145531|157824735|FG002|Part A|Other|1|||
48997145|NCT04145531|157824736|FG003|Part A|Other|0|||
48997146|NCT04145531|157824733|FG000|Part B|Adverse Event|0|||
48997147|NCT04145531|157824734|FG001|Part B|Adverse Event|0|||
48997148|NCT04145531|157824735|FG002|Part B|Adverse Event|0|||
48997149|NCT04145531|157824736|FG003|Part B|Adverse Event|21|||
48997150|NCT04145531|157824733|FG000|Part B|Physician Decision|0|||
48997151|NCT04145531|157824734|FG001|Part B|Physician Decision|0|||
48997152|NCT04145531|157824735|FG002|Part B|Physician Decision|0|||
48997153|NCT04145531|157824736|FG003|Part B|Physician Decision|7|||
48997154|NCT04145531|157824733|FG000|Part B|Progressive disease|0|||
48997155|NCT04145531|157824734|FG001|Part B|Progressive disease|0|||
48997156|NCT04145531|157824735|FG002|Part B|Progressive disease|0|||
48997157|NCT04145531|157824736|FG003|Part B|Progressive disease|1|||
48997158|NCT04145531|157824733|FG000|Part B|Recurrent disease|0|||
48997159|NCT04145531|157824734|FG001|Part B|Recurrent disease|0|||
48997160|NCT04145531|157824735|FG002|Part B|Recurrent disease|0|||
48997161|NCT04145531|157824736|FG003|Part B|Recurrent disease|1|||
48997162|NCT04145531|157824733|FG000|Part B|Withdrawal by parent or guardian|0|||
48997163|NCT04145531|157824734|FG001|Part B|Withdrawal by parent or guardian|0|||
48997164|NCT04145531|157824735|FG002|Part B|Withdrawal by parent or guardian|0|||
48997165|NCT04145531|157824736|FG003|Part B|Withdrawal by parent or guardian|3|||
48997166|NCT04145531|157824733|FG000|Part B|Withdrawal by participant|0|||
48997167|NCT04145531|157824734|FG001|Part B|Withdrawal by participant|0|||
48997168|NCT04145531|157824735|FG002|Part B|Withdrawal by participant|0|||
48997169|NCT04145531|157824736|FG003|Part B|Withdrawal by participant|1|||
48997170|NCT04145531|157824733|FG000|Part B|Other|0|||
48997171|NCT04145531|157824734|FG001|Part B|Other|0|||
48997172|NCT04145531|157824735|FG002|Part B|Other|0|||
48997173|NCT04145531|157824736|FG003|Part B|Other|1|||
48997174|NCT03446157|157824737|FG000|Overall Study|Death|11|||
48997175|NCT03446157|157824738|FG001|Overall Study|Death|9|||
48997176|NCT03446157|157824737|FG000|Overall Study|Lost to Follow-up|0|||
48997177|NCT03446157|157824738|FG001|Overall Study|Lost to Follow-up|1|||
48997178|NCT03446157|157824737|FG000|Overall Study|Withdrawal by Subject|2|||
48997179|NCT03446157|157824738|FG001|Overall Study|Withdrawal by Subject|1|||
48997180|NCT01301625|157824742|FG000|Overall Study|Death|5|||
48997181|NCT01301625|157824742|FG000|Overall Study|Not Due|21|||
48997182|NCT01301625|157824742|FG000|Overall Study|Expected|8|||
48997183|NCT01301625|157824742|FG000|Overall Study|Lost to Follow-up|1|||
48997184|NCT01012609|157824743|FG000|Overall Study|Withdrawal by Subject|1|||
48997185|NCT01012609|157824744|FG001|Overall Study|Withdrawal by Subject|1|||
48997186|NCT00620776|157824751|FG000|Overall Study|Did not receive treatment|3|||
48997187|NCT00620776|157824752|FG001|Overall Study|Did not receive treatment|5|||
48997188|NCT00620776|157824751|FG000|Overall Study|Adverse Event|2|||
48997189|NCT00620776|157824752|FG001|Overall Study|Adverse Event|3|||
48997190|NCT00620776|157824751|FG000|Overall Study|Lack of Efficacy|2|||
48997191|NCT00620776|157824752|FG001|Overall Study|Lack of Efficacy|1|||
48997192|NCT00620776|157824751|FG000|Overall Study|Lost to Follow-up|2|||
48997193|NCT00620776|157824752|FG001|Overall Study|Lost to Follow-up|5|||
48997194|NCT00620776|157824751|FG000|Overall Study|Withdrawal by Subject|3|||
48997195|NCT00620776|157824752|FG001|Overall Study|Withdrawal by Subject|2|||
48997196|NCT03602976|157824753|FG000|Overall Study|Withdrawal by Subject|1|||
48997197|NCT04366258|157824754|FG000|Baseline Assessments|Screen Failure|21|||
48997198|NCT04366258|157824754|FG000|Baseline Assessments|Early Termination|3|||
48997199|NCT00183170|157824760|FG000|First Intervention|Did not complete study|1|||
48997200|NCT00183170|157824761|FG001|First Intervention|Did not complete study|0|||
48997201|NCT00183170|157824760|FG000|First Intervention|Did not meet targeted BrAC|1|||
48997202|NCT00183170|157824761|FG001|First Intervention|Did not meet targeted BrAC|0|||
48997203|NCT00183170|157824760|FG000|Washout 1 Week|Did not complete study|6|||
48997204|NCT00183170|157824761|FG001|Washout 1 Week|Did not complete study|8|||
48997205|NCT00183170|157824760|FG000|Second Intervention|Did not complete study|1|||
48997206|NCT00183170|157824761|FG001|Second Intervention|Did not complete study|0|||
48997207|NCT00183170|157824760|FG000|Second Intervention|Did not meet targeted BrAC|0|||
48997208|NCT00183170|157824761|FG001|Second Intervention|Did not meet targeted BrAC|2|||
48997209|NCT05102162|157824765|FG000|Overall Study|Withdrawal by Subject|3|||
48997210|NCT05102162|157824766|FG001|Overall Study|Withdrawal by Subject|0|||
48997211|NCT05102162|157824765|FG000|Overall Study|Baseline cultures negative|4|||
48997212|NCT05102162|157824766|FG001|Overall Study|Baseline cultures negative|2|||
48997213|NCT05102162|157824765|FG000|Overall Study|<72 Hours on study beta-lactam|7|||
48997214|NCT05102162|157824766|FG001|Overall Study|<72 Hours on study beta-lactam|0|||
48997215|NCT05102162|157824765|FG000|Overall Study|Baseline cultures resistant to all study beta-lactams|0|||
48997216|NCT05102162|157824766|FG001|Overall Study|Baseline cultures resistant to all study beta-lactams|1|||
48997217|NCT00924820|157824767|FG000|Overall Study|Death|2|||
48997218|NCT00924820|157824767|FG000|Overall Study|Ineligible, Screen Failure|5|||
48997219|NCT04983589|157824768|FG000|Overall Study|Withdrawal by Subject|0|||
48997220|NCT04983589|157824769|FG001|Overall Study|Withdrawal by Subject|3|||
48997221|NCT04983589|157824768|FG000|Overall Study|COVID-19 Infection|1|||
48997222|NCT04983589|157824769|FG001|Overall Study|COVID-19 Infection|0|||
48997223|NCT04983589|157824768|FG000|Overall Study|COVID-19 Logistical Restrictions|2|||
48997224|NCT04983589|157824769|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
48997225|NCT00761969|157824772|FG000|Overall Study|Death|112|||
48997226|NCT00761969|157824773|FG001|Overall Study|Death|47|||
48997227|NCT00761969|157824772|FG000|Overall Study|Lost to Follow-up|88|||
48997228|NCT00761969|157824773|FG001|Overall Study|Lost to Follow-up|93|||
48997229|NCT02797951|157824774|FG000|Overall Study|Adverse Event|4|||
48997230|NCT02797951|157824774|FG000|Overall Study|Death|1|||
48997231|NCT02797951|157824774|FG000|Overall Study|Lack of Efficacy|19|||
48997232|NCT02797951|157824774|FG000|Overall Study|Lost to Follow-up|4|||
48997233|NCT02797951|157824774|FG000|Overall Study|Physician Decision|6|||
48997234|NCT02797951|157824774|FG000|Overall Study|Withdrawal by Subject|15|||
48997235|NCT00320801|157824775|FG000|Open-label Run-in Period|Withdrawal by Subject|2|||
48997236|NCT00320801|157824776|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
48997237|NCT00320801|157824777|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
48997238|NCT00320801|157824778|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
48997239|NCT00320801|157824775|FG000|Open-label Run-in Period|Adverse Event|33|||
48997240|NCT00320801|157824776|FG001|Open-label Run-in Period|Adverse Event|0|||
48997241|NCT00320801|157824777|FG002|Open-label Run-in Period|Adverse Event|0|||
48997242|NCT00320801|157824778|FG003|Open-label Run-in Period|Adverse Event|0|||
48997243|NCT00320801|157824775|FG000|Open-label Run-in Period|Administrative|10|||
48997244|NCT00320801|157824776|FG001|Open-label Run-in Period|Administrative|0|||
48997245|NCT00320801|157824777|FG002|Open-label Run-in Period|Administrative|0|||
48997246|NCT00320801|157824778|FG003|Open-label Run-in Period|Administrative|0|||
48997247|NCT00320801|157824775|FG000|Open-label Run-in Period|Lack of Efficacy|44|||
48997248|NCT00320801|157824776|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
48997249|NCT00320801|157824777|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
48997250|NCT00320801|157824778|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
48997251|NCT00320801|157824775|FG000|Open-label Run-in Period|Lost to Follow-up|2|||
48997252|NCT00320801|157824776|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
48997253|NCT00320801|157824777|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
48997254|NCT00320801|157824778|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
48997255|NCT00320801|157824775|FG000|Open-label Run-in Period|Did not qualify|1|||
48997256|NCT00320801|157824776|FG001|Open-label Run-in Period|Did not qualify|0|||
48997257|NCT00320801|157824777|FG002|Open-label Run-in Period|Did not qualify|0|||
48997258|NCT00320801|157824778|FG003|Open-label Run-in Period|Did not qualify|0|||
48997259|NCT00320801|157824775|FG000|Double-blind Phase|Withdrawal by Subject|0|||
48997260|NCT00320801|157824776|FG001|Double-blind Phase|Withdrawal by Subject|0|||
48997261|NCT00320801|157824777|FG002|Double-blind Phase|Withdrawal by Subject|1|||
48997262|NCT00320801|157824778|FG003|Double-blind Phase|Withdrawal by Subject|0|||
48997263|NCT00320801|157824775|FG000|Double-blind Phase|Adverse Event|0|||
48997264|NCT00320801|157824776|FG001|Double-blind Phase|Adverse Event|2|||
48997265|NCT00320801|157824777|FG002|Double-blind Phase|Adverse Event|8|||
48997266|NCT00320801|157824778|FG003|Double-blind Phase|Adverse Event|0|||
48997267|NCT00320801|157824775|FG000|Double-blind Phase|Administrative|0|||
48997268|NCT00320801|157824776|FG001|Double-blind Phase|Administrative|0|||
48997269|NCT00320801|157824777|FG002|Double-blind Phase|Administrative|4|||
48997270|NCT00320801|157824778|FG003|Double-blind Phase|Administrative|0|||
48997271|NCT00320801|157824775|FG000|Double-blind Phase|Lack of Efficacy|0|||
48997272|NCT00320801|157824776|FG001|Double-blind Phase|Lack of Efficacy|9|||
48997273|NCT00320801|157824777|FG002|Double-blind Phase|Lack of Efficacy|1|||
48997274|NCT00320801|157824778|FG003|Double-blind Phase|Lack of Efficacy|0|||
48997275|NCT00320801|157824775|FG000|Extension Phase|Withdrawal by Subject|0|||
48997276|NCT00320801|157824776|FG001|Extension Phase|Withdrawal by Subject|0|||
48997277|NCT00320801|157824777|FG002|Extension Phase|Withdrawal by Subject|0|||
48997278|NCT00320801|157824778|FG003|Extension Phase|Withdrawal by Subject|6|||
48997279|NCT00320801|157824775|FG000|Extension Phase|Adverse Event|0|||
48997280|NCT00320801|157824776|FG001|Extension Phase|Adverse Event|0|||
48997281|NCT00320801|157824777|FG002|Extension Phase|Adverse Event|0|||
48997282|NCT00320801|157824778|FG003|Extension Phase|Adverse Event|8|||
48997283|NCT00320801|157824775|FG000|Extension Phase|Administrative|0|||
48997284|NCT00320801|157824776|FG001|Extension Phase|Administrative|0|||
48997285|NCT00320801|157824777|FG002|Extension Phase|Administrative|0|||
48997286|NCT00320801|157824778|FG003|Extension Phase|Administrative|29|||
48997287|NCT00320801|157824775|FG000|Extension Phase|Lack of Efficacy|0|||
48997288|NCT00320801|157824776|FG001|Extension Phase|Lack of Efficacy|0|||
48997289|NCT00320801|157824777|FG002|Extension Phase|Lack of Efficacy|0|||
48997290|NCT00320801|157824778|FG003|Extension Phase|Lack of Efficacy|2|||
48997291|NCT00320801|157824775|FG000|Extension Phase|Lost to Follow-up|0|||
48997292|NCT00320801|157824776|FG001|Extension Phase|Lost to Follow-up|0|||
48997293|NCT00320801|157824777|FG002|Extension Phase|Lost to Follow-up|0|||
48997294|NCT00320801|157824778|FG003|Extension Phase|Lost to Follow-up|3|||
48997295|NCT02325739|157824779|FG000|Phase I Part|Adverse Event|1|||
48997296|NCT02325739|157824780|FG001|Phase I Part|Adverse Event|0|||
48997297|NCT02325739|157824781|FG002|Phase I Part|Adverse Event|1|||
48997298|NCT02325739|157824782|FG003|Phase I Part|Adverse Event|2|||
48997299|NCT02325739|157824783|FG004|Phase I Part|Adverse Event|3|||
48997300|NCT02325739|157824784|FG005|Phase I Part|Adverse Event|1|||
48997301|NCT02325739|157824785|FG006|Phase I Part|Adverse Event|0|||
48997302|NCT02325739|157824786|FG007|Phase I Part|Adverse Event|2|||
48997303|NCT02325739|157824787|FG008|Phase I Part|Adverse Event|0|||
48997304|NCT02325739|157824788|FG009|Phase I Part|Adverse Event|0|||
48997305|NCT02325739|157824789|FG010|Phase I Part|Adverse Event|0|||
48997306|NCT02325739|157824779|FG000|Phase I Part|Progressive disease|9|||
48997307|NCT02325739|157824780|FG001|Phase I Part|Progressive disease|6|||
48997308|NCT02325739|157824781|FG002|Phase I Part|Progressive disease|3|||
48997309|NCT02325739|157824782|FG003|Phase I Part|Progressive disease|23|||
48997310|NCT02325739|157824783|FG004|Phase I Part|Progressive disease|14|||
48997311|NCT02325739|157824784|FG005|Phase I Part|Progressive disease|6|||
48997312|NCT02325739|157824785|FG006|Phase I Part|Progressive disease|6|||
48997313|NCT02325739|157824786|FG007|Phase I Part|Progressive disease|3|||
48997314|NCT02325739|157824787|FG008|Phase I Part|Progressive disease|0|||
48997315|NCT02325739|157824788|FG009|Phase I Part|Progressive disease|0|||
48997316|NCT02325739|157824789|FG010|Phase I Part|Progressive disease|0|||
48997317|NCT02325739|157824779|FG000|Phase I Part|Subject/guardian decision|1|||
48997318|NCT02325739|157824780|FG001|Phase I Part|Subject/guardian decision|0|||
48997319|NCT02325739|157824781|FG002|Phase I Part|Subject/guardian decision|1|||
48997320|NCT02325739|157824782|FG003|Phase I Part|Subject/guardian decision|1|||
48997321|NCT02325739|157824783|FG004|Phase I Part|Subject/guardian decision|0|||
48997322|NCT02325739|157824784|FG005|Phase I Part|Subject/guardian decision|0|||
48997323|NCT02325739|157824785|FG006|Phase I Part|Subject/guardian decision|0|||
48997324|NCT02325739|157824786|FG007|Phase I Part|Subject/guardian decision|1|||
48997325|NCT02325739|157824787|FG008|Phase I Part|Subject/guardian decision|0|||
48997326|NCT02325739|157824788|FG009|Phase I Part|Subject/guardian decision|0|||
48997327|NCT02325739|157824789|FG010|Phase I Part|Subject/guardian decision|0|||
48997328|NCT02325739|157824779|FG000|Phase I Part|Death|0|||
48997329|NCT02325739|157824780|FG001|Phase I Part|Death|0|||
48997330|NCT02325739|157824781|FG002|Phase I Part|Death|0|||
48997331|NCT02325739|157824782|FG003|Phase I Part|Death|0|||
48997332|NCT02325739|157824783|FG004|Phase I Part|Death|2|||
48997333|NCT02325739|157824784|FG005|Phase I Part|Death|0|||
48997334|NCT02325739|157824785|FG006|Phase I Part|Death|0|||
48997335|NCT02325739|157824786|FG007|Phase I Part|Death|0|||
48997336|NCT02325739|157824787|FG008|Phase I Part|Death|0|||
48997337|NCT02325739|157824788|FG009|Phase I Part|Death|0|||
48997338|NCT02325739|157824789|FG010|Phase I Part|Death|0|||
48997339|NCT02325739|157824779|FG000|Phase II Part|Adverse Event|0|||
48997340|NCT02325739|157824780|FG001|Phase II Part|Adverse Event|0|||
48997341|NCT02325739|157824781|FG002|Phase II Part|Adverse Event|0|||
48997342|NCT02325739|157824782|FG003|Phase II Part|Adverse Event|0|||
48997343|NCT02325739|157824783|FG004|Phase II Part|Adverse Event|0|||
48997344|NCT02325739|157824784|FG005|Phase II Part|Adverse Event|0|||
48997345|NCT02325739|157824785|FG006|Phase II Part|Adverse Event|0|||
48997346|NCT02325739|157824786|FG007|Phase II Part|Adverse Event|0|||
48997347|NCT02325739|157824787|FG008|Phase II Part|Adverse Event|4|||
48997348|NCT02325739|157824788|FG009|Phase II Part|Adverse Event|5|||
48997349|NCT02325739|157824789|FG010|Phase II Part|Adverse Event|1|||
48997350|NCT02325739|157824779|FG000|Phase II Part|Physician Decision|0|||
48997351|NCT02325739|157824780|FG001|Phase II Part|Physician Decision|0|||
48997352|NCT02325739|157824781|FG002|Phase II Part|Physician Decision|0|||
48997353|NCT02325739|157824782|FG003|Phase II Part|Physician Decision|0|||
48997354|NCT02325739|157824783|FG004|Phase II Part|Physician Decision|0|||
48997355|NCT02325739|157824784|FG005|Phase II Part|Physician Decision|0|||
48997356|NCT02325739|157824785|FG006|Phase II Part|Physician Decision|0|||
48997357|NCT02325739|157824786|FG007|Phase II Part|Physician Decision|0|||
48997358|NCT02325739|157824787|FG008|Phase II Part|Physician Decision|0|||
48997359|NCT02325739|157824788|FG009|Phase II Part|Physician Decision|1|||
48997360|NCT02325739|157824789|FG010|Phase II Part|Physician Decision|0|||
48997361|NCT02325739|157824779|FG000|Phase II Part|Progressive disease|0|||
48997362|NCT02325739|157824780|FG001|Phase II Part|Progressive disease|0|||
48997363|NCT02325739|157824781|FG002|Phase II Part|Progressive disease|0|||
48997364|NCT02325739|157824782|FG003|Phase II Part|Progressive disease|0|||
48997365|NCT02325739|157824783|FG004|Phase II Part|Progressive disease|0|||
48997366|NCT02325739|157824784|FG005|Phase II Part|Progressive disease|0|||
48997367|NCT02325739|157824785|FG006|Phase II Part|Progressive disease|0|||
48997368|NCT02325739|157824786|FG007|Phase II Part|Progressive disease|0|||
48997369|NCT02325739|157824787|FG008|Phase II Part|Progressive disease|22|||
48997370|NCT02325739|157824788|FG009|Phase II Part|Progressive disease|29|||
48997371|NCT02325739|157824789|FG010|Phase II Part|Progressive disease|18|||
48997372|NCT02325739|157824779|FG000|Phase II Part|Subject/guardian decision|0|||
48997373|NCT02325739|157824780|FG001|Phase II Part|Subject/guardian decision|0|||
48997374|NCT02325739|157824781|FG002|Phase II Part|Subject/guardian decision|0|||
48997375|NCT02325739|157824782|FG003|Phase II Part|Subject/guardian decision|0|||
48997376|NCT02325739|157824783|FG004|Phase II Part|Subject/guardian decision|0|||
48997377|NCT02325739|157824784|FG005|Phase II Part|Subject/guardian decision|0|||
48997378|NCT02325739|157824785|FG006|Phase II Part|Subject/guardian decision|0|||
48997379|NCT02325739|157824786|FG007|Phase II Part|Subject/guardian decision|0|||
48997380|NCT02325739|157824787|FG008|Phase II Part|Subject/guardian decision|4|||
48997381|NCT02325739|157824788|FG009|Phase II Part|Subject/guardian decision|1|||
48997382|NCT02325739|157824789|FG010|Phase II Part|Subject/guardian decision|1|||
48997383|NCT03179462|157824795|FG000|Overall Study|screening failure|1|||
48997384|NCT03179462|157824796|FG001|Overall Study|screening failure|2|||
48997385|NCT03179462|157824797|FG002|Overall Study|screening failure|0|||
48997386|NCT01761565|157824798|FG000|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1|||
48997387|NCT01608321|157824799|FG000|Overall Study|Withdrawal by Subject|1|||
48997388|NCT01608321|157824800|FG001|Overall Study|Withdrawal by Subject|0|||
48997389|NCT03433482|157826477|FG000|Overall Study|Lost to Follow-up|1|||
48997390|NCT03433482|157826478|FG001|Overall Study|Lost to Follow-up|0|||
48997391|NCT03433482|157826479|FG002|Overall Study|Lost to Follow-up|1|||
48997392|NCT03433482|157826480|FG003|Overall Study|Lost to Follow-up|1|||
48997393|NCT03433482|157826477|FG000|Overall Study|Withdrawal by Subject|0|||
48997394|NCT03433482|157826478|FG001|Overall Study|Withdrawal by Subject|0|||
48997395|NCT03433482|157826479|FG002|Overall Study|Withdrawal by Subject|1|||
48997396|NCT03433482|157826480|FG003|Overall Study|Withdrawal by Subject|0|||
48997397|NCT03433482|157826477|FG000|Overall Study|Unknown reason|0|||
48997398|NCT03433482|157826478|FG001|Overall Study|Unknown reason|0|||
48997399|NCT03433482|157826479|FG002|Overall Study|Unknown reason|2|||
48997400|NCT03433482|157826480|FG003|Overall Study|Unknown reason|0|||
48997401|NCT00437294|157826483|FG000|Overall Study|Adverse Event|5|||
48997402|NCT00437294|157826484|FG001|Overall Study|Adverse Event|4|||
48997403|NCT00437294|157826483|FG000|Overall Study|Death|5|||
48997404|NCT00437294|157826484|FG001|Overall Study|Death|2|||
48997405|NCT00437294|157826483|FG000|Overall Study|Physician Decision|0|||
48997406|NCT00437294|157826484|FG001|Overall Study|Physician Decision|3|||
48997407|NCT00437294|157826483|FG000|Overall Study|Withdrawal by Subject|5|||
48997408|NCT00437294|157826484|FG001|Overall Study|Withdrawal by Subject|0|||
48997409|NCT00437294|157826483|FG000|Overall Study|Progressive Disease|19|||
48997410|NCT00437294|157826484|FG001|Overall Study|Progressive Disease|23|||
48997411|NCT00437294|157826483|FG000|Overall Study|Sponsor Decision|8|||
48997412|NCT00437294|157826484|FG001|Overall Study|Sponsor Decision|9|||
48997413|NCT00437294|157826483|FG000|Overall Study|Protocol Violation|0|||
48997414|NCT00437294|157826484|FG001|Overall Study|Protocol Violation|1|||
48997415|NCT00437294|157826483|FG000|Overall Study|Entry criteria not met|1|||
48997416|NCT00437294|157826484|FG001|Overall Study|Entry criteria not met|1|||
48997417|NCT03323034|157826486|FG000|Overall Study|Lack of Efficacy|5|||
48997418|NCT03323034|157826487|FG001|Overall Study|Lack of Efficacy|5|||
48997419|NCT03323034|157826488|FG002|Overall Study|Lack of Efficacy|6|||
48997420|NCT03323034|157826489|FG003|Overall Study|Lack of Efficacy|5|||
48997421|NCT03323034|157826490|FG004|Overall Study|Lack of Efficacy|5|||
48997422|NCT03323034|157826486|FG000|Overall Study|Physician Decision|0|||
48997423|NCT03323034|157826487|FG001|Overall Study|Physician Decision|0|||
48997424|NCT03323034|157826488|FG002|Overall Study|Physician Decision|0|||
48997425|NCT03323034|157826489|FG003|Overall Study|Physician Decision|0|||
48997426|NCT03323034|157826490|FG004|Overall Study|Physician Decision|1|||
48997427|NCT03323034|157826486|FG000|Overall Study|Withdrawal by Subject|1|||
48997428|NCT03323034|157826487|FG001|Overall Study|Withdrawal by Subject|1|||
48997429|NCT03323034|157826488|FG002|Overall Study|Withdrawal by Subject|0|||
48997430|NCT03323034|157826489|FG003|Overall Study|Withdrawal by Subject|1|||
48997431|NCT03323034|157826490|FG004|Overall Study|Withdrawal by Subject|0|||
48997432|NCT02646566|157826492|FG000|Overall Study|Lost to Follow-up|5|||
48997433|NCT02646566|157826493|FG001|Overall Study|Lost to Follow-up|4|||
48997434|NCT02646566|157826494|FG002|Overall Study|Lost to Follow-up|5|||
48997435|NCT02646566|157826492|FG000|Overall Study|Treatment failure|1|||
48997436|NCT02646566|157826493|FG001|Overall Study|Treatment failure|0|||
48997437|NCT02646566|157826494|FG002|Overall Study|Treatment failure|0|||
48997438|NCT00474994|157826514|FG000|Overall Study|Patient Not treated|1|||
48997439|NCT00474994|157826514|FG000|Overall Study|Patient evaluable for toxicity only|3|||
48997440|NCT00474994|157826514|FG000|Overall Study|Patient found to be ineligible|1|||
48997441|NCT02660489|157826519|FG000|Overall Study|Lost to Follow-up|1|||
48997442|NCT02660489|157826520|FG001|Overall Study|Lost to Follow-up|1|||
48997443|NCT02660489|157826519|FG000|Overall Study|Adverse Event|1|||
48997444|NCT02660489|157826520|FG001|Overall Study|Adverse Event|3|||
48997445|NCT02660489|157826519|FG000|Overall Study|no rhinovirus infection|4|||
48997446|NCT02660489|157826520|FG001|Overall Study|no rhinovirus infection|4|||
48997447|NCT04516291|157826521|FG000|Treatment Period (24 Weeks)|Other|1|||
48997448|NCT04516291|157826522|FG001|Treatment Period (24 Weeks)|Other|0|||
48997449|NCT04516291|157826523|FG002|Treatment Period (24 Weeks)|Other|0|||
48997450|NCT04516291|157826524|FG003|Treatment Period (24 Weeks)|Other|2|||
48997451|NCT04516291|157826525|FG004|Treatment Period (24 Weeks)|Other|2|||
48997452|NCT04516291|157826526|FG005|Treatment Period (24 Weeks)|Other|4|||
48997453|NCT04516291|157826527|FG006|Treatment Period (24 Weeks)|Other|2|||
48997454|NCT04516291|157826528|FG007|Treatment Period (24 Weeks)|Other|0|||
48997455|NCT04516291|157826521|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
48997456|NCT04516291|157826522|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
48997457|NCT04516291|157826523|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
48997458|NCT04516291|157826524|FG003|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
48997459|NCT04516291|157826525|FG004|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
48997460|NCT04516291|157826526|FG005|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
48997461|NCT04516291|157826527|FG006|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
48997462|NCT04516291|157826528|FG007|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
48997463|NCT04516291|157826521|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
48997464|NCT04516291|157826522|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
48997465|NCT04516291|157826523|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
48997466|NCT04516291|157826524|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
48997467|NCT04516291|157826525|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
48997468|NCT04516291|157826526|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
48997469|NCT04516291|157826527|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
48997470|NCT04516291|157826528|FG007|Treatment Period (24 Weeks)|Protocol Violation|0|||
48997471|NCT04516291|157826521|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
48997472|NCT04516291|157826522|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|1|||
48997473|NCT04516291|157826523|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
48997474|NCT04516291|157826524|FG003|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
48997475|NCT04516291|157826525|FG004|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
48997476|NCT04516291|157826526|FG005|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
48997477|NCT04516291|157826527|FG006|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
48997478|NCT04516291|157826528|FG007|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
48997479|NCT04516291|157826521|FG000|Treatment Period (24 Weeks)|Adverse Event|1|||
48997480|NCT04516291|157826522|FG001|Treatment Period (24 Weeks)|Adverse Event|2|||
48997481|NCT04516291|157826523|FG002|Treatment Period (24 Weeks)|Adverse Event|3|||
48997482|NCT04516291|157826524|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
48997483|NCT04516291|157826525|FG004|Treatment Period (24 Weeks)|Adverse Event|9|||
48997484|NCT04516291|157826526|FG005|Treatment Period (24 Weeks)|Adverse Event|4|||
48997485|NCT04516291|157826527|FG006|Treatment Period (24 Weeks)|Adverse Event|7|||
48997486|NCT04516291|157826528|FG007|Treatment Period (24 Weeks)|Adverse Event|14|||
48997487|NCT04516291|157826521|FG000|Follow-up Period (12 Weeks)|Other|0|||
48997488|NCT04516291|157826522|FG001|Follow-up Period (12 Weeks)|Other|1|||
48997489|NCT04516291|157826523|FG002|Follow-up Period (12 Weeks)|Other|0|||
48997490|NCT04516291|157826524|FG003|Follow-up Period (12 Weeks)|Other|2|||
48997491|NCT04516291|157826525|FG004|Follow-up Period (12 Weeks)|Other|0|||
48997492|NCT04516291|157826526|FG005|Follow-up Period (12 Weeks)|Other|0|||
48997493|NCT04516291|157826527|FG006|Follow-up Period (12 Weeks)|Other|0|||
48997494|NCT04516291|157826528|FG007|Follow-up Period (12 Weeks)|Other|0|||
48997495|NCT04516291|157826521|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
48997496|NCT04516291|157826522|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
48997497|NCT04516291|157826523|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
48997498|NCT04516291|157826524|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
48997499|NCT04516291|157826525|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
48997500|NCT04516291|157826526|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
48997501|NCT04516291|157826527|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
48997502|NCT04516291|157826528|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
48997503|NCT04516291|157826521|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
48997504|NCT04516291|157826522|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
48997505|NCT04516291|157826523|FG002|Follow-up Period (12 Weeks)|Adverse Event|1|||
48997506|NCT04516291|157826524|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
48997507|NCT04516291|157826525|FG004|Follow-up Period (12 Weeks)|Adverse Event|1|||
48997508|NCT04516291|157826526|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
49045839|NCT02300987|158002026|FG000|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1|||
48997509|NCT04516291|157826527|FG006|Follow-up Period (12 Weeks)|Adverse Event|0|||
48997510|NCT04516291|157826528|FG007|Follow-up Period (12 Weeks)|Adverse Event|0|||
48997511|NCT04887922|157826537|FG000|1st Randomization|Decided not to have surgery|0|||
48997512|NCT04887922|157826538|FG001|1st Randomization|Decided not to have surgery|1|||
48997513|NCT04887922|157826539|FG002|1st Randomization|Decided not to have surgery|0|||
48997514|NCT04887922|157826540|FG003|1st Randomization|Decided not to have surgery|0|||
48997515|NCT04887922|157826541|FG004|1st Randomization|Decided not to have surgery|0|||
48997516|NCT03039686|157826542|FG000|Double-blind Period|Administrative Reason by Sponsor|24|||
48997517|NCT03039686|157826543|FG001|Double-blind Period|Administrative Reason by Sponsor|25|||
48997518|NCT03039686|157826544|FG002|Double-blind Period|Administrative Reason by Sponsor|21|||
48997519|NCT03039686|157826542|FG000|Double-blind Period|Subject Request to Discontinue Study Treatment|1|||
48997520|NCT03039686|157826543|FG001|Double-blind Period|Subject Request to Discontinue Study Treatment|2|||
48997521|NCT03039686|157826544|FG002|Double-blind Period|Subject Request to Discontinue Study Treatment|0|||
48997522|NCT03039686|157826542|FG000|Double-blind Period|Withdrawal by Subject|2|||
48997523|NCT03039686|157826543|FG001|Double-blind Period|Withdrawal by Subject|2|||
48997524|NCT03039686|157826544|FG002|Double-blind Period|Withdrawal by Subject|1|||
48997525|NCT03039686|157826542|FG000|Double-blind Period|Death|0|||
48997526|NCT03039686|157826543|FG001|Double-blind Period|Death|0|||
48997527|NCT03039686|157826544|FG002|Double-blind Period|Death|1|||
48997528|NCT03039686|157826542|FG000|Open Label Period|Administrative Reason by Sponsor|0|||
48997529|NCT03039686|157826543|FG001|Open Label Period|Administrative Reason by Sponsor|34|||
48997530|NCT03039686|157826544|FG002|Open Label Period|Administrative Reason by Sponsor|41|||
48997531|NCT03039686|157826542|FG000|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
48997532|NCT03039686|157826543|FG001|Open Label Period|Subject Request to Discontinue Study Treatment|1|||
48997533|NCT03039686|157826544|FG002|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
48997534|NCT03039686|157826542|FG000|Open Label Period|Withdrawal by Subject|0|||
48997535|NCT03039686|157826543|FG001|Open Label Period|Withdrawal by Subject|3|||
48997536|NCT03039686|157826544|FG002|Open Label Period|Withdrawal by Subject|1|||
48997537|NCT02322866|157826545|FG000|Overall Study|Adverse Event|6|||
48997538|NCT02322866|157826546|FG001|Overall Study|Adverse Event|11|||
48997539|NCT02322866|157826545|FG000|Overall Study|Withdrawal of Consent|16|||
48997540|NCT02322866|157826546|FG001|Overall Study|Withdrawal of Consent|25|||
48997541|NCT02322866|157826545|FG000|Overall Study|Lost to Follow-up|36|||
48997542|NCT02322866|157826546|FG001|Overall Study|Lost to Follow-up|39|||
48997543|NCT02322866|157826545|FG000|Overall Study|Protocol Violation|1|||
48997544|NCT02322866|157826546|FG001|Overall Study|Protocol Violation|0|||
48997545|NCT02322866|157826545|FG000|Overall Study|Noncompliance with Treatment|3|||
48997546|NCT02322866|157826546|FG001|Overall Study|Noncompliance with Treatment|4|||
48997547|NCT02322866|157826545|FG000|Overall Study|Lack of Efficacy|3|||
48997548|NCT02322866|157826546|FG001|Overall Study|Lack of Efficacy|1|||
48997549|NCT02322866|157826545|FG000|Overall Study|Other Miscellaneous Reasons|6|||
48997550|NCT02322866|157826546|FG001|Overall Study|Other Miscellaneous Reasons|6|||
48997551|NCT01855607|157826547|FG000|Overall Study|Withdrawal by Subject|1|||
48997552|NCT01855607|157826547|FG000|Overall Study|Study was terminated|11|||
48997553|NCT00718809|157826548|FG000|Overall Study|Disease progression|9|||
48997554|NCT00718809|157826549|FG001|Overall Study|Disease progression|7|||
48997555|NCT00718809|157826548|FG000|Overall Study|Adverse Event|1|||
48997556|NCT00718809|157826549|FG001|Overall Study|Adverse Event|1|||
48997557|NCT00718809|157826548|FG000|Overall Study|Withdrawal by Subject|0|||
48997558|NCT00718809|157826549|FG001|Overall Study|Withdrawal by Subject|1|||
48997559|NCT00718809|157826548|FG000|Overall Study|Lost to Follow-up|1|||
48997560|NCT00718809|157826549|FG001|Overall Study|Lost to Follow-up|0|||
48997561|NCT00718809|157826548|FG000|Overall Study|Noncompliance|1|||
48997562|NCT00718809|157826549|FG001|Overall Study|Noncompliance|0|||
48997563|NCT00463385|157826550|FG000|Overall Study|Other|4|||
48997564|NCT00463385|157826551|FG001|Overall Study|Other|3|||
48997565|NCT00463385|157826552|FG002|Overall Study|Other|6|||
48997566|NCT00463385|157826553|FG003|Overall Study|Other|4|||
48997567|NCT00463385|157826550|FG000|Overall Study|Adverse Event|5|||
48997568|NCT00463385|157826551|FG001|Overall Study|Adverse Event|8|||
48997569|NCT00463385|157826552|FG002|Overall Study|Adverse Event|4|||
48997570|NCT00463385|157826553|FG003|Overall Study|Adverse Event|2|||
48997571|NCT00463385|157826550|FG000|Overall Study|Lack of Efficacy|6|||
48997572|NCT00463385|157826551|FG001|Overall Study|Lack of Efficacy|6|||
48997573|NCT00463385|157826552|FG002|Overall Study|Lack of Efficacy|7|||
48997574|NCT00463385|157826553|FG003|Overall Study|Lack of Efficacy|9|||
48997575|NCT00463385|157826550|FG000|Overall Study|Withdrawal by Subject|3|||
48997576|NCT00463385|157826551|FG001|Overall Study|Withdrawal by Subject|3|||
48997577|NCT00463385|157826552|FG002|Overall Study|Withdrawal by Subject|3|||
48997578|NCT00463385|157826553|FG003|Overall Study|Withdrawal by Subject|4|||
48997579|NCT00463385|157826550|FG000|Overall Study|Lost to Follow-up|0|||
48997580|NCT00463385|157826551|FG001|Overall Study|Lost to Follow-up|0|||
48997581|NCT00463385|157826552|FG002|Overall Study|Lost to Follow-up|0|||
48997582|NCT00463385|157826553|FG003|Overall Study|Lost to Follow-up|1|||
48997583|NCT00463385|157826550|FG000|Overall Study|Death|2|||
48997584|NCT00463385|157826551|FG001|Overall Study|Death|1|||
48997585|NCT00463385|157826552|FG002|Overall Study|Death|2|||
48997586|NCT00463385|157826553|FG003|Overall Study|Death|0|||
48997587|NCT00463385|157826550|FG000|Overall Study|Missing|2|||
48997588|NCT00463385|157826551|FG001|Overall Study|Missing|0|||
48997589|NCT00463385|157826552|FG002|Overall Study|Missing|0|||
48997590|NCT00463385|157826553|FG003|Overall Study|Missing|2|||
48997591|NCT00463385|157826550|FG000|Overall Study|1 participant received commercial drug|0|||
48997592|NCT00463385|157826551|FG001|Overall Study|1 participant received commercial drug|1|||
48997593|NCT00463385|157826552|FG002|Overall Study|1 participant received commercial drug|0|||
48997594|NCT00463385|157826553|FG003|Overall Study|1 participant received commercial drug|0|||
48997595|NCT00798161|157826557|FG000|Overall Study|Adverse Event|3|||
48997596|NCT00798161|157826558|FG001|Overall Study|Adverse Event|4|||
48997597|NCT00798161|157826559|FG002|Overall Study|Adverse Event|6|||
48997598|NCT00798161|157826560|FG003|Overall Study|Adverse Event|6|||
48997599|NCT00798161|157826561|FG004|Overall Study|Adverse Event|5|||
48997600|NCT00798161|157826562|FG005|Overall Study|Adverse Event|2|||
48997601|NCT00798161|157826563|FG006|Overall Study|Adverse Event|4|||
48997602|NCT00798161|157826557|FG000|Overall Study|Protocol Violation|2|||
48997603|NCT00798161|157826558|FG001|Overall Study|Protocol Violation|1|||
48997604|NCT00798161|157826559|FG002|Overall Study|Protocol Violation|3|||
48997605|NCT00798161|157826560|FG003|Overall Study|Protocol Violation|3|||
48997606|NCT00798161|157826561|FG004|Overall Study|Protocol Violation|3|||
48997607|NCT00798161|157826562|FG005|Overall Study|Protocol Violation|2|||
48997608|NCT00798161|157826563|FG006|Overall Study|Protocol Violation|0|||
48997609|NCT00798161|157826557|FG000|Overall Study|Lost to Follow-up|1|||
48997610|NCT00798161|157826558|FG001|Overall Study|Lost to Follow-up|3|||
48997611|NCT00798161|157826559|FG002|Overall Study|Lost to Follow-up|4|||
48997612|NCT00798161|157826560|FG003|Overall Study|Lost to Follow-up|3|||
48997613|NCT00798161|157826561|FG004|Overall Study|Lost to Follow-up|4|||
48997614|NCT00798161|157826562|FG005|Overall Study|Lost to Follow-up|0|||
48997615|NCT00798161|157826563|FG006|Overall Study|Lost to Follow-up|0|||
48997616|NCT00798161|157826557|FG000|Overall Study|Withdrawal by Subject|5|||
48997617|NCT00798161|157826558|FG001|Overall Study|Withdrawal by Subject|4|||
48997618|NCT00798161|157826559|FG002|Overall Study|Withdrawal by Subject|5|||
48997619|NCT00798161|157826560|FG003|Overall Study|Withdrawal by Subject|4|||
48997620|NCT00798161|157826561|FG004|Overall Study|Withdrawal by Subject|2|||
48997621|NCT00798161|157826562|FG005|Overall Study|Withdrawal by Subject|3|||
48997622|NCT00798161|157826563|FG006|Overall Study|Withdrawal by Subject|1|||
48997623|NCT00798161|157826557|FG000|Overall Study|Other reason (incl. lack of efficacy)|7|||
48997624|NCT00798161|157826558|FG001|Overall Study|Other reason (incl. lack of efficacy)|5|||
48997625|NCT00798161|157826559|FG002|Overall Study|Other reason (incl. lack of efficacy)|3|||
48997626|NCT00798161|157826560|FG003|Overall Study|Other reason (incl. lack of efficacy)|5|||
48997627|NCT00798161|157826561|FG004|Overall Study|Other reason (incl. lack of efficacy)|2|||
48997628|NCT00798161|157826562|FG005|Overall Study|Other reason (incl. lack of efficacy)|4|||
48997629|NCT00798161|157826563|FG006|Overall Study|Other reason (incl. lack of efficacy)|5|||
48997630|NCT00449761|157826564|FG000|Overall Study|Disease progression|12|||
48997631|NCT00449761|157826564|FG000|Overall Study|Death|5|||
48997632|NCT00449761|157826564|FG000|Overall Study|New cancer therapy|1|||
48997633|NCT01339273|157826565|FG000|Overall Study|Lost to Follow-up|8|||
48997634|NCT01339273|157826566|FG001|Overall Study|Lost to Follow-up|8|||
48997635|NCT00726882|157826567|FG000|Overall Study|Withdrawal by Subject|5|||
48997636|NCT00726882|157826567|FG000|Overall Study|Lost to Follow-up|7|||
48997637|NCT00726882|157826567|FG000|Overall Study|Other|10|||
48997638|NCT00347776|157826568|FG000|1.5 Month Follow-up|Death|2|||
48997639|NCT00347776|157826569|FG001|1.5 Month Follow-up|Death|0|||
48997640|NCT00347776|157826570|FG002|1.5 Month Follow-up|Death|0|||
48997641|NCT00347776|157826568|FG000|1.5 Month Follow-up|reached the endpoint|12|||
48997642|NCT00347776|157826569|FG001|1.5 Month Follow-up|reached the endpoint|8|||
48997643|NCT00347776|157826570|FG002|1.5 Month Follow-up|reached the endpoint|12|||
48997644|NCT00347776|157826568|FG000|6 Month Follow-up|Death|2|||
48997645|NCT00347776|157826569|FG001|6 Month Follow-up|Death|1|||
48997646|NCT00347776|157826570|FG002|6 Month Follow-up|Death|3|||
48997647|NCT00347776|157826568|FG000|6 Month Follow-up|reached endpont|20|||
48997648|NCT00347776|157826569|FG001|6 Month Follow-up|reached endpont|12|||
48997649|NCT00347776|157826570|FG002|6 Month Follow-up|reached endpont|15|||
48997650|NCT00347776|157826568|FG000|12 Month Follow-up|Lost to Follow-up|7|||
48997651|NCT00347776|157826569|FG001|12 Month Follow-up|Lost to Follow-up|6|||
48997652|NCT00347776|157826570|FG002|12 Month Follow-up|Lost to Follow-up|6|||
48997653|NCT00347776|157826568|FG000|12 Month Follow-up|Death|3|||
48997654|NCT00347776|157826569|FG001|12 Month Follow-up|Death|4|||
48997655|NCT00347776|157826570|FG002|12 Month Follow-up|Death|4|||
48997656|NCT00347776|157826568|FG000|12 Month Follow-up|Reached endpoint|13|||
48997657|NCT00347776|157826569|FG001|12 Month Follow-up|Reached endpoint|6|||
48997658|NCT00347776|157826570|FG002|12 Month Follow-up|Reached endpoint|9|||
48997659|NCT01100073|157826571|FG000|Overall Study|Lack of Efficacy|4|||
48997660|NCT01100073|157826571|FG000|Overall Study|Insufficient Tolerability|21|||
48997661|NCT01100073|157826571|FG000|Overall Study|Withdrawal by Subject|13|||
48997662|NCT01100073|157826571|FG000|Overall Study|Lost to Follow-up|39|||
48997663|NCT01100073|157826571|FG000|Overall Study|Lack of effect + patient's wish|2|||
48997664|NCT01100073|157826571|FG000|Overall Study|Insufficient tolerability +patients wish|8|||
48997665|NCT01100073|157826571|FG000|Overall Study|Other|8|||
48997666|NCT01100073|157826571|FG000|Overall Study|Missing|5|||
48997667|NCT04633434|157826577|FG000|Overall Study|Lost to Follow-up|32|||
48997668|NCT04633434|157826578|FG001|Overall Study|Lost to Follow-up|32|||
48997669|NCT05993299|157826579|FG000|Overall Study|Did not meet treatment eligibility criteria|2|||
48997670|NCT05993299|157826579|FG000|Overall Study|Ongoing|4|||
48997671|NCT01569594|157826580|FG000|Overall Study|Physician Decision|4|||
48997672|NCT01569594|157826580|FG000|Overall Study|Death|13|||
48997673|NCT01569594|157826580|FG000|Overall Study|Lost to Follow-up|22|||
48997674|NCT01569594|157826580|FG000|Overall Study|Adverse Event|2|||
48997675|NCT01569594|157826580|FG000|Overall Study|Withdrawal by Subject|13|||
48997676|NCT01569594|157826580|FG000|Overall Study|Other|4|||
48997677|NCT01569594|157826580|FG000|Overall Study|No ECM used|9|||
48997678|NCT01165424|157826581|FG000|Overall Study|Clinical adverse experiences|1|||
48997679|NCT01165424|157826581|FG000|Overall Study|Laboratory adverse experiences|1|||
48997680|NCT01165424|157826581|FG000|Overall Study|Did not meet entry criteria|1|||
48997681|NCT01165424|157826581|FG000|Overall Study|Participant moved (relocated)|1|||
48997682|NCT00422058|157826582|FG000|Double-Blind, Week 0-20|Adverse Event|3|||
48997683|NCT00422058|157826583|FG001|Double-Blind, Week 0-20|Adverse Event|4|||
48997684|NCT00422058|157826584|FG002|Double-Blind, Week 0-20|Adverse Event|5|||
48997685|NCT00422058|157826585|FG003|Double-Blind, Week 0-20|Adverse Event|9|||
48997686|NCT00422058|157826586|FG004|Double-Blind, Week 0-20|Adverse Event|5|||
48997687|NCT00422058|157826587|FG005|Double-Blind, Week 0-20|Adverse Event|3|||
48997688|NCT00422058|157826582|FG000|Double-Blind, Week 0-20|Protocol Violation|3|||
48997689|NCT00422058|157826583|FG001|Double-Blind, Week 0-20|Protocol Violation|2|||
48997690|NCT00422058|157826584|FG002|Double-Blind, Week 0-20|Protocol Violation|2|||
48997691|NCT00422058|157826585|FG003|Double-Blind, Week 0-20|Protocol Violation|3|||
48997692|NCT00422058|157826586|FG004|Double-Blind, Week 0-20|Protocol Violation|2|||
48997693|NCT00422058|157826587|FG005|Double-Blind, Week 0-20|Protocol Violation|2|||
48997694|NCT00422058|157826582|FG000|Double-Blind, Week 0-20|Lack of Efficacy|2|||
48997695|NCT00422058|157826583|FG001|Double-Blind, Week 0-20|Lack of Efficacy|1|||
48997696|NCT00422058|157826584|FG002|Double-Blind, Week 0-20|Lack of Efficacy|1|||
48997697|NCT00422058|157826585|FG003|Double-Blind, Week 0-20|Lack of Efficacy|0|||
48997698|NCT00422058|157826586|FG004|Double-Blind, Week 0-20|Lack of Efficacy|0|||
48997699|NCT00422058|157826587|FG005|Double-Blind, Week 0-20|Lack of Efficacy|1|||
48997700|NCT00422058|157826582|FG000|Double-Blind, Week 0-20|Other|11|||
48997701|NCT00422058|157826583|FG001|Double-Blind, Week 0-20|Other|3|||
48997702|NCT00422058|157826584|FG002|Double-Blind, Week 0-20|Other|8|||
48997703|NCT00422058|157826585|FG003|Double-Blind, Week 0-20|Other|8|||
48997704|NCT00422058|157826586|FG004|Double-Blind, Week 0-20|Other|4|||
48997705|NCT00422058|157826587|FG005|Double-Blind, Week 0-20|Other|10|||
48997706|NCT00422058|157826582|FG000|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
48997707|NCT00422058|157826583|FG001|Open-Label Extension, Week 20-104|Not giving consent for extension|17|||
48997708|NCT00422058|157826584|FG002|Open-Label Extension, Week 20-104|Not giving consent for extension|15|||
48997709|NCT00422058|157826585|FG003|Open-Label Extension, Week 20-104|Not giving consent for extension|8|||
48997710|NCT00422058|157826586|FG004|Open-Label Extension, Week 20-104|Not giving consent for extension|10|||
48997711|NCT00422058|157826587|FG005|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
48997712|NCT00422058|157826582|FG000|Open-Label Extension, Week 20-104|Adverse Event|3|||
48997713|NCT00422058|157826583|FG001|Open-Label Extension, Week 20-104|Adverse Event|4|||
48997714|NCT00422058|157826584|FG002|Open-Label Extension, Week 20-104|Adverse Event|7|||
48997715|NCT00422058|157826585|FG003|Open-Label Extension, Week 20-104|Adverse Event|4|||
48997716|NCT00422058|157826586|FG004|Open-Label Extension, Week 20-104|Adverse Event|4|||
48997717|NCT00422058|157826587|FG005|Open-Label Extension, Week 20-104|Adverse Event|0|||
48997718|NCT00422058|157826582|FG000|Open-Label Extension, Week 20-104|Protocol Violation|1|||
48997719|NCT00422058|157826583|FG001|Open-Label Extension, Week 20-104|Protocol Violation|2|||
48997720|NCT00422058|157826584|FG002|Open-Label Extension, Week 20-104|Protocol Violation|3|||
48997721|NCT00422058|157826585|FG003|Open-Label Extension, Week 20-104|Protocol Violation|1|||
48997722|NCT00422058|157826586|FG004|Open-Label Extension, Week 20-104|Protocol Violation|5|||
48997723|NCT00422058|157826587|FG005|Open-Label Extension, Week 20-104|Protocol Violation|3|||
48997724|NCT00422058|157826582|FG000|Open-Label Extension, Week 20-104|Lack of Efficacy|3|||
48997725|NCT00422058|157826583|FG001|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
48997726|NCT00422058|157826584|FG002|Open-Label Extension, Week 20-104|Lack of Efficacy|5|||
48997727|NCT00422058|157826585|FG003|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
48997728|NCT00422058|157826586|FG004|Open-Label Extension, Week 20-104|Lack of Efficacy|0|||
48997729|NCT00422058|157826587|FG005|Open-Label Extension, Week 20-104|Lack of Efficacy|1|||
48997730|NCT00422058|157826582|FG000|Open-Label Extension, Week 20-104|Other|13|||
48997731|NCT00422058|157826583|FG001|Open-Label Extension, Week 20-104|Other|14|||
48997732|NCT00422058|157826584|FG002|Open-Label Extension, Week 20-104|Other|6|||
48997733|NCT00422058|157826585|FG003|Open-Label Extension, Week 20-104|Other|13|||
48997734|NCT00422058|157826586|FG004|Open-Label Extension, Week 20-104|Other|16|||
48997735|NCT00422058|157826587|FG005|Open-Label Extension, Week 20-104|Other|18|||
48997736|NCT04139642|157826588|FG000|First Intervention (9 Months)|Permission denied to use the device by clinic manager|0|||
48997737|NCT04139642|157826589|FG001|First Intervention (9 Months)|Permission denied to use the device by clinic manager|1|||
48997738|NCT03732534|157826594|FG000|Overall Study|Study terminated by Sponsor|6|||
48997739|NCT00276458|157826595|FG000|Overall Study|Adverse Event|0|||
48997740|NCT00276458|157826596|FG001|Overall Study|Adverse Event|2|||
48997741|NCT00276458|157826595|FG000|Overall Study|Lost to Follow-up|2|||
48997742|NCT00276458|157826596|FG001|Overall Study|Lost to Follow-up|2|||
48997743|NCT00276458|157826595|FG000|Overall Study|Protocol Violation|4|||
48997744|NCT00276458|157826596|FG001|Overall Study|Protocol Violation|3|||
48997745|NCT03901352|157826597|FG000|Double-blind Phase|Adverse Event|6|||
48997746|NCT03901352|157826598|FG001|Double-blind Phase|Adverse Event|4|||
48997747|NCT03901352|157826597|FG000|Double-blind Phase|Death|1|||
48997748|NCT03901352|157826598|FG001|Double-blind Phase|Death|0|||
48997749|NCT03901352|157826597|FG000|Double-blind Phase|Lack of Efficacy|0|||
48997750|NCT03901352|157826598|FG001|Double-blind Phase|Lack of Efficacy|1|||
48997751|NCT03901352|157826597|FG000|Double-blind Phase|Protocol Violation|0|||
48997752|NCT03901352|157826598|FG001|Double-blind Phase|Protocol Violation|1|||
48997753|NCT03901352|157826597|FG000|Double-blind Phase|Withdrawal by Subject|10|||
48997754|NCT03901352|157826598|FG001|Double-blind Phase|Withdrawal by Subject|8|||
48997755|NCT03901352|157826597|FG000|Open-label Extension Phase|Adverse Event|24|||
48997756|NCT03901352|157826598|FG001|Open-label Extension Phase|Adverse Event|0|||
48997757|NCT03901352|157826597|FG000|Open-label Extension Phase|Lack of Efficacy|1|||
48997758|NCT03901352|157826598|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
48997759|NCT03901352|157826597|FG000|Open-label Extension Phase|Withdrawal by Subject|14|||
48997760|NCT03901352|157826598|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
48997761|NCT03901352|157826597|FG000|Open-label Extension Phase|Other|1|||
48997762|NCT03901352|157826598|FG001|Open-label Extension Phase|Other|0|||
48997763|NCT03843775|157826601|FG000|Overall Study|Adverse Event|1|||
48997764|NCT03843775|157826602|FG001|Overall Study|Adverse Event|1|||
48997765|NCT03843775|157826601|FG000|Overall Study|Lack of Efficacy|2|||
48997766|NCT03843775|157826602|FG001|Overall Study|Lack of Efficacy|6|||
48997767|NCT03843775|157826601|FG000|Overall Study|Withdrawal by Subject|0|||
48997768|NCT03843775|157826602|FG001|Overall Study|Withdrawal by Subject|1|||
48997769|NCT02575807|157826603|FG000|Overall Study|Death|8|||
48997770|NCT02575807|157826604|FG001|Overall Study|Death|3|||
48997771|NCT02575807|157826605|FG002|Overall Study|Death|7|||
48997772|NCT02575807|157826606|FG003|Overall Study|Death|0|||
48997773|NCT02575807|157826607|FG004|Overall Study|Death|1|||
48997774|NCT02575807|157826603|FG000|Overall Study|Study terminated by Sponsor|0|||
48997775|NCT02575807|157826604|FG001|Overall Study|Study terminated by Sponsor|1|||
48997776|NCT02575807|157826605|FG002|Overall Study|Study terminated by Sponsor|7|||
48997777|NCT02575807|157826606|FG003|Overall Study|Study terminated by Sponsor|0|||
48997778|NCT02575807|157826607|FG004|Overall Study|Study terminated by Sponsor|1|||
48997779|NCT02575807|157826603|FG000|Overall Study|Terminated due to FDA clinical hold|1|||
48997780|NCT02575807|157826604|FG001|Overall Study|Terminated due to FDA clinical hold|0|||
48997781|NCT02575807|157826605|FG002|Overall Study|Terminated due to FDA clinical hold|0|||
48997782|NCT02575807|157826606|FG003|Overall Study|Terminated due to FDA clinical hold|0|||
48997783|NCT02575807|157826607|FG004|Overall Study|Terminated due to FDA clinical hold|0|||
48997784|NCT02575807|157826603|FG000|Overall Study|Terminated due to physician decision|0|||
48997785|NCT02575807|157826604|FG001|Overall Study|Terminated due to physician decision|0|||
48997786|NCT02575807|157826605|FG002|Overall Study|Terminated due to physician decision|1|||
48997787|NCT02575807|157826606|FG003|Overall Study|Terminated due to physician decision|0|||
48997788|NCT02575807|157826607|FG004|Overall Study|Terminated due to physician decision|0|||
48997789|NCT02575807|157826603|FG000|Overall Study|Subject ineligible - medical implant|0|||
48997790|NCT02575807|157826604|FG001|Overall Study|Subject ineligible - medical implant|0|||
48997791|NCT02575807|157826605|FG002|Overall Study|Subject ineligible - medical implant|0|||
48997792|NCT02575807|157826606|FG003|Overall Study|Subject ineligible - medical implant|1|||
48997793|NCT02575807|157826607|FG004|Overall Study|Subject ineligible - medical implant|0|||
48997794|NCT02575807|157826603|FG000|Overall Study|Withdrawal by Subject|0|||
48997795|NCT02575807|157826604|FG001|Overall Study|Withdrawal by Subject|0|||
48997796|NCT02575807|157826605|FG002|Overall Study|Withdrawal by Subject|1|||
48997797|NCT02575807|157826606|FG003|Overall Study|Withdrawal by Subject|1|||
48997798|NCT02575807|157826607|FG004|Overall Study|Withdrawal by Subject|2|||
48997799|NCT03319368|157826608|FG000|Overall Study|Discharge swabs not collected from resident|57|||
48997800|NCT03319368|157826609|FG001|Overall Study|Discharge swabs not collected from resident|46|||
48997801|NCT02180659|157826610|FG000|Overall Study|Adverse Event|1|||
48997802|NCT02180659|157826611|FG001|Overall Study|Adverse Event|0|||
48997803|NCT02180659|157826610|FG000|Overall Study|Lost to Follow-up|4|||
48997804|NCT02180659|157826611|FG001|Overall Study|Lost to Follow-up|2|||
48997805|NCT02180659|157826610|FG000|Overall Study|Subject incarcerated during conduct|1|||
48997806|NCT02180659|157826611|FG001|Overall Study|Subject incarcerated during conduct|0|||
48997807|NCT02180659|157826610|FG000|Overall Study|Withdrawal by Subject|0|||
48997808|NCT02180659|157826611|FG001|Overall Study|Withdrawal by Subject|2|||
48997809|NCT02180659|157826610|FG000|Overall Study|AT REQUEST OF THE SPONSOR|0|||
48997810|NCT02180659|157826611|FG001|Overall Study|AT REQUEST OF THE SPONSOR|1|||
48997811|NCT03000075|157826612|FG000|Part A|Adverse Event|4|||
48997812|NCT03000075|157826613|FG001|Part A|Adverse Event|0|||
48997813|NCT03000075|157826614|FG002|Part A|Adverse Event|0|||
48997814|NCT03000075|157826615|FG003|Part A|Adverse Event|0|||
48997815|NCT03000075|157826616|FG004|Part A|Adverse Event|0|||
48997816|NCT03000075|157826617|FG005|Part A|Adverse Event|0|||
48997817|NCT03000075|157826618|FG006|Part A|Adverse Event|0|||
48997818|NCT03000075|157826612|FG000|Part B|Not dosed due to AE|0|||
48997819|NCT03000075|157826613|FG001|Part B|Not dosed due to AE|0|||
48997820|NCT03000075|157826614|FG002|Part B|Not dosed due to AE|0|||
48997821|NCT03000075|157826615|FG003|Part B|Not dosed due to AE|0|||
48997822|NCT03000075|157826616|FG004|Part B|Not dosed due to AE|0|||
48997823|NCT03000075|157826617|FG005|Part B|Not dosed due to AE|2|||
48997824|NCT03000075|157826618|FG006|Part B|Not dosed due to AE|1|||
48997825|NCT03000075|157826612|FG000|Part B|Adverse Event|0|||
48997826|NCT03000075|157826613|FG001|Part B|Adverse Event|0|||
48997827|NCT03000075|157826614|FG002|Part B|Adverse Event|0|||
48997828|NCT03000075|157826615|FG003|Part B|Adverse Event|0|||
48997829|NCT03000075|157826616|FG004|Part B|Adverse Event|1|||
48997830|NCT03000075|157826617|FG005|Part B|Adverse Event|0|||
48997831|NCT03000075|157826618|FG006|Part B|Adverse Event|0|||
48997832|NCT01525407|157826621|FG000|Overall Study|Change in recipient treatment plan|2|||
48997833|NCT01525407|157826622|FG001|Overall Study|Change in recipient treatment plan|2|||
48997834|NCT01525407|157826621|FG000|Overall Study|Withdrawal by Subject|0|||
48997835|NCT01525407|157826622|FG001|Overall Study|Withdrawal by Subject|1|||
48997836|NCT01525407|157826621|FG000|Overall Study|Transplant was delayed|0|||
48997837|NCT01525407|157826622|FG001|Overall Study|Transplant was delayed|1|||
48997838|NCT01525407|157826621|FG000|Overall Study|Delay in Transplant|1|||
48997839|NCT01525407|157826622|FG001|Overall Study|Delay in Transplant|0|||
48997840|NCT00111007|157826623|FG000|Double-blind (DB) Treatment|Adverse Event|12|||
48997841|NCT00111007|157826624|FG001|Double-blind (DB) Treatment|Adverse Event|4|||
48997842|NCT00111007|157826623|FG000|Double-blind (DB) Treatment|Death|5|||
48997843|NCT00111007|157826624|FG001|Double-blind (DB) Treatment|Death|2|||
48997844|NCT00111007|157826623|FG000|Double-blind (DB) Treatment|Protocol Violation|0|||
48997845|NCT00111007|157826624|FG001|Double-blind (DB) Treatment|Protocol Violation|1|||
48997846|NCT00111007|157826623|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|6|||
48997847|NCT00111007|157826624|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|8|||
48997848|NCT00111007|157826623|FG000|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1|||
48997849|NCT00111007|157826624|FG001|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0|||
48997850|NCT00111007|157826623|FG000|Double-blind (DB) Treatment|Relapse|1|||
48997851|NCT00111007|157826624|FG001|Double-blind (DB) Treatment|Relapse|0|||
48997852|NCT00111007|157826623|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|0|||
48997853|NCT00111007|157826624|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
48997854|NCT00111007|157826623|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|83|||
48997855|NCT00111007|157826624|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|93|||
48997856|NCT00111007|157826623|FG000|Double-blind (DB) Treatment|Primary reason with other category|0|||
48997857|NCT00111007|157826624|FG001|Double-blind (DB) Treatment|Primary reason with other category|1|||
48997858|NCT00111007|157826623|FG000|Active Follow-up|Adverse Event|1|||
48997859|NCT00111007|157826624|FG001|Active Follow-up|Adverse Event|0|||
48997860|NCT00111007|157826623|FG000|Active Follow-up|Death|2|||
48997861|NCT00111007|157826624|FG001|Active Follow-up|Death|0|||
48997862|NCT00111007|157826623|FG000|Active Follow-up|Disease progression/recurrence/relapse|3|||
48997863|NCT00111007|157826624|FG001|Active Follow-up|Disease progression/recurrence/relapse|2|||
48997864|NCT00111007|157826623|FG000|Long Term Follow-up|Death|34|||
48997865|NCT00111007|157826624|FG001|Long Term Follow-up|Death|39|||
48997866|NCT00111007|157826623|FG000|Long Term Follow-up|Lost to Follow-up|1|||
48997867|NCT00111007|157826624|FG001|Long Term Follow-up|Lost to Follow-up|1|||
48997868|NCT00111007|157826623|FG000|Long Term Follow-up|Withdrawal by Subject|0|||
48997869|NCT00111007|157826624|FG001|Long Term Follow-up|Withdrawal by Subject|1|||
48997870|NCT00111007|157826623|FG000|Long Term Follow-up|Disease progression/recurrence/relapse|2|||
48997871|NCT00111007|157826624|FG001|Long Term Follow-up|Disease progression/recurrence/relapse|1|||
48997872|NCT00111007|157826623|FG000|Long Term Follow-up|Missing|10|||
48997873|NCT00111007|157826624|FG001|Long Term Follow-up|Missing|3|||
48997874|NCT04150107|157826625|FG000|Period 3 Crossover-Treatment B or A|Adverse Event|2|||
48997875|NCT04150107|157826626|FG001|Period 3 Crossover-Treatment B or A|Adverse Event|0|||
48997876|NCT04150107|157826625|FG000|Period 3 Crossover-Treatment B or A|Patient non-compliance|0|||
48997877|NCT04150107|157826626|FG001|Period 3 Crossover-Treatment B or A|Patient non-compliance|1|||
48997878|NCT00440193|157826627|FG000|Treatment Period|Adverse Event|74|||
48997879|NCT00440193|157826628|FG001|Treatment Period|Adverse Event|67|||
48997880|NCT00440193|157826627|FG000|Treatment Period|Death|19|||
48997881|NCT00440193|157826628|FG001|Treatment Period|Death|22|||
48997882|NCT00440193|157826627|FG000|Treatment Period|Lack of Efficacy|0|||
48997883|NCT00440193|157826628|FG001|Treatment Period|Lack of Efficacy|1|||
48997884|NCT00440193|157826627|FG000|Treatment Period|Lost to Follow-up|12|||
48997885|NCT00440193|157826628|FG001|Treatment Period|Lost to Follow-up|18|||
48997886|NCT00440193|157826627|FG000|Treatment Period|Physician Decision|3|||
48997887|NCT00440193|157826628|FG001|Treatment Period|Physician Decision|6|||
48997888|NCT00440193|157826627|FG000|Treatment Period|Protocol Violation|16|||
48997889|NCT00440193|157826628|FG001|Treatment Period|Protocol Violation|19|||
48997890|NCT00440193|157826627|FG000|Treatment Period|Withdrawal by Subject|36|||
48997891|NCT00440193|157826628|FG001|Treatment Period|Withdrawal by Subject|77|||
48997892|NCT00440193|157826627|FG000|Treatment Period|Clinical endpoint reached|28|||
48997893|NCT00440193|157826628|FG001|Treatment Period|Clinical endpoint reached|25|||
48997894|NCT00440193|157826627|FG000|Treatment Period|Study terminated by sponsor|102|||
48997895|NCT00440193|157826628|FG001|Treatment Period|Study terminated by sponsor|94|||
48997896|NCT00440193|157826627|FG000|Treatment Period|Protocol driven decision point|2|||
48997897|NCT00440193|157826628|FG001|Treatment Period|Protocol driven decision point|2|||
48997898|NCT00440193|157826627|FG000|Treatment Period|Switch to commercial drug|0|||
48997899|NCT00440193|157826628|FG001|Treatment Period|Switch to commercial drug|2|||
48997900|NCT00440193|157826627|FG000|Treatment Period|Technical problems|1|||
48997901|NCT00440193|157826628|FG001|Treatment Period|Technical problems|1|||
48997902|NCT00440193|157826627|FG000|Treatment Period|Participant convenience|5|||
48997903|NCT00440193|157826628|FG001|Treatment Period|Participant convenience|2|||
48997904|NCT00440193|157826627|FG000|Treatment Period|Participant did not receive treatment|7|||
48997905|NCT00440193|157826628|FG001|Treatment Period|Participant did not receive treatment|13|||
48997906|NCT00440193|157826627|FG000|Treatment Period|Site closed by investigator|0|||
48997907|NCT00440193|157826628|FG001|Treatment Period|Site closed by investigator|2|||
48997908|NCT00440193|157826627|FG000|Observational Period|Adverse Event|2|||
48997909|NCT00440193|157826628|FG001|Observational Period|Adverse Event|2|||
48997910|NCT00440193|157826627|FG000|Observational Period|Death|15|||
48997911|NCT00440193|157826628|FG001|Observational Period|Death|20|||
48997912|NCT00440193|157826627|FG000|Observational Period|Lost to Follow-up|12|||
48997913|NCT00440193|157826628|FG001|Observational Period|Lost to Follow-up|8|||
48997914|NCT00440193|157826627|FG000|Observational Period|Protocol Violation|1|||
48997915|NCT00440193|157826628|FG001|Observational Period|Protocol Violation|0|||
48997916|NCT00440193|157826627|FG000|Observational Period|Withdrawal by Subject|11|||
48997917|NCT00440193|157826628|FG001|Observational Period|Withdrawal by Subject|8|||
48997918|NCT00440193|157826627|FG000|Observational Period|Physician Decision|1|||
48997919|NCT00440193|157826628|FG001|Observational Period|Physician Decision|0|||
48997920|NCT00440193|157826627|FG000|Observational Period|Clinical endpoint reached|1|||
48997921|NCT00440193|157826628|FG001|Observational Period|Clinical endpoint reached|0|||
48997922|NCT00440193|157826627|FG000|Observational Period|Participant convenience|2|||
48997923|NCT00440193|157826628|FG001|Observational Period|Participant convenience|0|||
48997924|NCT01495793|157826630|FG000|Overall Study|Lost to Follow-up|1|||
48997925|NCT01495793|157826630|FG000|Overall Study|Violation of inclusion criteria|1|||
48997926|NCT03480243|157826631|FG000|Padsevonil (Period 2)|Consent withdrawal by subject|1|||
48997927|NCT03480243|157826631|FG000|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1|||
48997928|NCT02851069|157826633|FG000|Overall Study|Failure to Return|3|||
48997929|NCT02851069|157826633|FG000|Overall Study|Other|3|||
48997930|NCT05182840|157826634|FG000|Run-in Period|Not treated|0|||
48997931|NCT05182840|157826635|FG001|Run-in Period|Not treated|1|||
48997932|NCT05182840|157826636|FG002|Run-in Period|Not treated|0|||
48997933|NCT05182840|157826637|FG003|Run-in Period|Not treated|0|||
48997934|NCT05182840|157826638|FG004|Run-in Period|Not treated|0|||
48997935|NCT05182840|157826639|FG005|Run-in Period|Not treated|0|||
48997936|NCT05182840|157826640|FG006|Run-in Period|Not treated|0|||
48997937|NCT05182840|157826641|FG007|Run-in Period|Not treated|0|||
48997938|NCT05182840|157826642|FG008|Run-in Period|Not treated|0|||
48997939|NCT05182840|157826643|FG009|Run-in Period|Not treated|0|||
48997940|NCT05182840|157826634|FG000|Run-in Period|Other reason but not sponsor termination|14|||
48997941|NCT05182840|157826635|FG001|Run-in Period|Other reason but not sponsor termination|18|||
48997942|NCT05182840|157826636|FG002|Run-in Period|Other reason but not sponsor termination|0|||
48997943|NCT05182840|157826637|FG003|Run-in Period|Other reason but not sponsor termination|0|||
48997944|NCT05182840|157826638|FG004|Run-in Period|Other reason but not sponsor termination|0|||
48997945|NCT05182840|157826639|FG005|Run-in Period|Other reason but not sponsor termination|0|||
48997946|NCT05182840|157826640|FG006|Run-in Period|Other reason but not sponsor termination|0|||
48997947|NCT05182840|157826641|FG007|Run-in Period|Other reason but not sponsor termination|0|||
48997948|NCT05182840|157826642|FG008|Run-in Period|Other reason but not sponsor termination|0|||
48997949|NCT05182840|157826643|FG009|Run-in Period|Other reason but not sponsor termination|0|||
48997950|NCT05182840|157826634|FG000|Run-in Period|No reason available|2|||
48997951|NCT05182840|157826635|FG001|Run-in Period|No reason available|2|||
48997952|NCT05182840|157826636|FG002|Run-in Period|No reason available|0|||
48997953|NCT05182840|157826637|FG003|Run-in Period|No reason available|0|||
48997954|NCT05182840|157826638|FG004|Run-in Period|No reason available|0|||
48997955|NCT05182840|157826639|FG005|Run-in Period|No reason available|0|||
48997956|NCT05182840|157826640|FG006|Run-in Period|No reason available|0|||
48997957|NCT05182840|157826641|FG007|Run-in Period|No reason available|0|||
48997958|NCT05182840|157826642|FG008|Run-in Period|No reason available|0|||
48997959|NCT05182840|157826643|FG009|Run-in Period|No reason available|0|||
48997960|NCT05182840|157826634|FG000|Run-in Period|Burden of study procedures|2|||
48997961|NCT05182840|157826635|FG001|Run-in Period|Burden of study procedures|2|||
48997962|NCT05182840|157826636|FG002|Run-in Period|Burden of study procedures|0|||
48997963|NCT05182840|157826637|FG003|Run-in Period|Burden of study procedures|0|||
48997964|NCT05182840|157826638|FG004|Run-in Period|Burden of study procedures|0|||
48997965|NCT05182840|157826639|FG005|Run-in Period|Burden of study procedures|0|||
48997966|NCT05182840|157826640|FG006|Run-in Period|Burden of study procedures|0|||
48997967|NCT05182840|157826641|FG007|Run-in Period|Burden of study procedures|0|||
48997968|NCT05182840|157826642|FG008|Run-in Period|Burden of study procedures|0|||
48997969|NCT05182840|157826643|FG009|Run-in Period|Burden of study procedures|0|||
48997970|NCT05182840|157826634|FG000|Run-in Period|Change of residence|1|||
48997971|NCT05182840|157826635|FG001|Run-in Period|Change of residence|0|||
48997972|NCT05182840|157826636|FG002|Run-in Period|Change of residence|0|||
48997973|NCT05182840|157826637|FG003|Run-in Period|Change of residence|0|||
48997974|NCT05182840|157826638|FG004|Run-in Period|Change of residence|0|||
48997975|NCT05182840|157826639|FG005|Run-in Period|Change of residence|0|||
48997976|NCT05182840|157826640|FG006|Run-in Period|Change of residence|0|||
48997977|NCT05182840|157826641|FG007|Run-in Period|Change of residence|0|||
48997978|NCT05182840|157826642|FG008|Run-in Period|Change of residence|0|||
48997979|NCT05182840|157826643|FG009|Run-in Period|Change of residence|0|||
48997980|NCT05182840|157826634|FG000|Run-in Period|Adverse Event|5|||
48997981|NCT05182840|157826635|FG001|Run-in Period|Adverse Event|5|||
48997982|NCT05182840|157826636|FG002|Run-in Period|Adverse Event|0|||
48997983|NCT05182840|157826637|FG003|Run-in Period|Adverse Event|0|||
48997984|NCT05182840|157826638|FG004|Run-in Period|Adverse Event|0|||
48997985|NCT05182840|157826639|FG005|Run-in Period|Adverse Event|0|||
48997986|NCT05182840|157826640|FG006|Run-in Period|Adverse Event|0|||
48997987|NCT05182840|157826641|FG007|Run-in Period|Adverse Event|0|||
48997988|NCT05182840|157826642|FG008|Run-in Period|Adverse Event|0|||
48997989|NCT05182840|157826643|FG009|Run-in Period|Adverse Event|0|||
48997990|NCT05182840|157826634|FG000|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|34|||
48997991|NCT05182840|157826635|FG001|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|44|||
48997992|NCT05182840|157826636|FG002|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
48997993|NCT05182840|157826637|FG003|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
48997994|NCT05182840|157826638|FG004|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
48997995|NCT05182840|157826639|FG005|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
48997996|NCT05182840|157826640|FG006|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
48997997|NCT05182840|157826641|FG007|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
48997998|NCT05182840|157826642|FG008|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
48997999|NCT05182840|157826643|FG009|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
48998000|NCT05182840|157826634|FG000|Treatment Period|Reason missing|0|||
48998001|NCT05182840|157826635|FG001|Treatment Period|Reason missing|0|||
48998002|NCT05182840|157826636|FG002|Treatment Period|Reason missing|1|||
48998003|NCT05182840|157826637|FG003|Treatment Period|Reason missing|0|||
48998004|NCT05182840|157826638|FG004|Treatment Period|Reason missing|0|||
48998005|NCT05182840|157826639|FG005|Treatment Period|Reason missing|0|||
48998006|NCT05182840|157826640|FG006|Treatment Period|Reason missing|0|||
48998007|NCT05182840|157826641|FG007|Treatment Period|Reason missing|0|||
48998008|NCT05182840|157826642|FG008|Treatment Period|Reason missing|0|||
48998009|NCT05182840|157826643|FG009|Treatment Period|Reason missing|0|||
48998010|NCT05182840|157826634|FG000|Treatment Period|Other but not sponsor termination|0|||
48998011|NCT05182840|157826635|FG001|Treatment Period|Other but not sponsor termination|0|||
48998012|NCT05182840|157826636|FG002|Treatment Period|Other but not sponsor termination|8|||
48998013|NCT05182840|157826637|FG003|Treatment Period|Other but not sponsor termination|6|||
48998014|NCT05182840|157826638|FG004|Treatment Period|Other but not sponsor termination|6|||
48998015|NCT05182840|157826639|FG005|Treatment Period|Other but not sponsor termination|7|||
48998016|NCT05182840|157826640|FG006|Treatment Period|Other but not sponsor termination|5|||
48998017|NCT05182840|157826641|FG007|Treatment Period|Other but not sponsor termination|8|||
48998018|NCT05182840|157826642|FG008|Treatment Period|Other but not sponsor termination|7|||
48998019|NCT05182840|157826643|FG009|Treatment Period|Other but not sponsor termination|2|||
48998020|NCT05182840|157826634|FG000|Treatment Period|Protocol deviation|0|||
48998021|NCT05182840|157826635|FG001|Treatment Period|Protocol deviation|0|||
48998022|NCT05182840|157826636|FG002|Treatment Period|Protocol deviation|0|||
48998023|NCT05182840|157826637|FG003|Treatment Period|Protocol deviation|0|||
48998024|NCT05182840|157826638|FG004|Treatment Period|Protocol deviation|0|||
48998025|NCT05182840|157826639|FG005|Treatment Period|Protocol deviation|0|||
48998026|NCT05182840|157826640|FG006|Treatment Period|Protocol deviation|0|||
48998027|NCT05182840|157826641|FG007|Treatment Period|Protocol deviation|0|||
48998028|NCT05182840|157826642|FG008|Treatment Period|Protocol deviation|1|||
48998029|NCT05182840|157826643|FG009|Treatment Period|Protocol deviation|0|||
48998030|NCT05182840|157826634|FG000|Treatment Period|No reason available|0|||
48998031|NCT05182840|157826635|FG001|Treatment Period|No reason available|0|||
48998032|NCT05182840|157826636|FG002|Treatment Period|No reason available|0|||
48998033|NCT05182840|157826637|FG003|Treatment Period|No reason available|1|||
48998034|NCT05182840|157826638|FG004|Treatment Period|No reason available|0|||
48998035|NCT05182840|157826639|FG005|Treatment Period|No reason available|2|||
48998036|NCT05182840|157826640|FG006|Treatment Period|No reason available|0|||
48998037|NCT05182840|157826641|FG007|Treatment Period|No reason available|1|||
48998038|NCT05182840|157826642|FG008|Treatment Period|No reason available|0|||
48998039|NCT05182840|157826643|FG009|Treatment Period|No reason available|0|||
48998040|NCT05182840|157826634|FG000|Treatment Period|Burden of study procedures|0|||
48998041|NCT05182840|157826635|FG001|Treatment Period|Burden of study procedures|0|||
48998042|NCT05182840|157826636|FG002|Treatment Period|Burden of study procedures|0|||
48998043|NCT05182840|157826637|FG003|Treatment Period|Burden of study procedures|0|||
48998044|NCT05182840|157826638|FG004|Treatment Period|Burden of study procedures|1|||
48998045|NCT05182840|157826639|FG005|Treatment Period|Burden of study procedures|0|||
48998046|NCT05182840|157826640|FG006|Treatment Period|Burden of study procedures|0|||
48998047|NCT05182840|157826641|FG007|Treatment Period|Burden of study procedures|0|||
48998048|NCT05182840|157826642|FG008|Treatment Period|Burden of study procedures|0|||
48998049|NCT05182840|157826643|FG009|Treatment Period|Burden of study procedures|0|||
48998050|NCT05182840|157826634|FG000|Treatment Period|Change of residence|0|||
48998051|NCT05182840|157826635|FG001|Treatment Period|Change of residence|0|||
48998052|NCT05182840|157826636|FG002|Treatment Period|Change of residence|0|||
48998053|NCT05182840|157826637|FG003|Treatment Period|Change of residence|0|||
48998054|NCT05182840|157826638|FG004|Treatment Period|Change of residence|0|||
48998055|NCT05182840|157826639|FG005|Treatment Period|Change of residence|1|||
48998056|NCT05182840|157826640|FG006|Treatment Period|Change of residence|0|||
48998057|NCT05182840|157826641|FG007|Treatment Period|Change of residence|0|||
48998058|NCT05182840|157826642|FG008|Treatment Period|Change of residence|0|||
48998059|NCT05182840|157826643|FG009|Treatment Period|Change of residence|0|||
48998060|NCT05182840|157826634|FG000|Treatment Period|Adverse Event|0|||
48998061|NCT05182840|157826635|FG001|Treatment Period|Adverse Event|0|||
48998062|NCT05182840|157826636|FG002|Treatment Period|Adverse Event|4|||
48998063|NCT05182840|157826637|FG003|Treatment Period|Adverse Event|16|||
48998064|NCT05182840|157826638|FG004|Treatment Period|Adverse Event|12|||
48998065|NCT05182840|157826639|FG005|Treatment Period|Adverse Event|6|||
48998066|NCT05182840|157826640|FG006|Treatment Period|Adverse Event|4|||
48998067|NCT05182840|157826641|FG007|Treatment Period|Adverse Event|8|||
48998068|NCT05182840|157826642|FG008|Treatment Period|Adverse Event|16|||
48998069|NCT05182840|157826643|FG009|Treatment Period|Adverse Event|5|||
48998070|NCT05182840|157826634|FG000|Treatment Period|Not treated with study drug|0|||
48998071|NCT05182840|157826635|FG001|Treatment Period|Not treated with study drug|0|||
48998072|NCT05182840|157826636|FG002|Treatment Period|Not treated with study drug|0|||
48998073|NCT05182840|157826637|FG003|Treatment Period|Not treated with study drug|1|||
48998074|NCT05182840|157826638|FG004|Treatment Period|Not treated with study drug|0|||
48998075|NCT05182840|157826639|FG005|Treatment Period|Not treated with study drug|0|||
48998076|NCT05182840|157826640|FG006|Treatment Period|Not treated with study drug|1|||
48998077|NCT05182840|157826641|FG007|Treatment Period|Not treated with study drug|1|||
48998078|NCT05182840|157826642|FG008|Treatment Period|Not treated with study drug|0|||
48998079|NCT05182840|157826643|FG009|Treatment Period|Not treated with study drug|0|||
48998080|NCT05153629|157826645|FG000|Overall Study|Withdrawal by Subject|0|||
48998081|NCT05153629|157826646|FG001|Overall Study|Withdrawal by Subject|2|||
48998082|NCT02061293|157826647|FG000|Overall Study|Elevated Blood Pressure|1|||
48998083|NCT02061293|157826648|FG001|Overall Study|Elevated Blood Pressure|1|||
48998084|NCT02392377|157826649|FG000|Overall Study|Withdrawal by Subject|0|||
48998085|NCT02392377|157826650|FG001|Overall Study|Withdrawal by Subject|1|||
48998086|NCT00209560|157826651|FG000|Overall Study|Lack of Efficacy|1|||
48998087|NCT00209560|157826652|FG001|Overall Study|Lack of Efficacy|0|||
48998088|NCT00953017|157828132|FG000|Overall Study|DId not show up for colonoscopy|4|||
48998089|NCT00953017|157828133|FG001|Overall Study|DId not show up for colonoscopy|4|||
48998090|NCT00953017|157828134|FG002|Overall Study|DId not show up for colonoscopy|5|||
48998091|NCT00953017|157828135|FG003|Overall Study|DId not show up for colonoscopy|4|||
48998092|NCT00953017|157828132|FG000|Overall Study|Incomplete data|1|||
48998093|NCT00953017|157828133|FG001|Overall Study|Incomplete data|1|||
48998094|NCT00953017|157828134|FG002|Overall Study|Incomplete data|0|||
48998095|NCT00953017|157828135|FG003|Overall Study|Incomplete data|0|||
48998096|NCT00953017|157828132|FG000|Overall Study|Procedure incomplete due to pain/looping|0|||
48998097|NCT00953017|157828133|FG001|Overall Study|Procedure incomplete due to pain/looping|1|||
48998098|NCT00953017|157828134|FG002|Overall Study|Procedure incomplete due to pain/looping|0|||
48998099|NCT00953017|157828135|FG003|Overall Study|Procedure incomplete due to pain/looping|1|||
48998100|NCT00953017|157828132|FG000|Overall Study|Brown stool prior to procedure|0|||
48998101|NCT00953017|157828133|FG001|Overall Study|Brown stool prior to procedure|0|||
48998102|NCT00953017|157828134|FG002|Overall Study|Brown stool prior to procedure|1|||
48998103|NCT00953017|157828135|FG003|Overall Study|Brown stool prior to procedure|0|||
48998104|NCT01519635|157828136|FG000|Overall Study|Withdrawal by Subject|0|||
48998105|NCT01519635|157828137|FG001|Overall Study|Withdrawal by Subject|1|||
48998106|NCT01519635|157828136|FG000|Overall Study|No possibility to put a catheter|1|||
48998107|NCT01519635|157828137|FG001|Overall Study|No possibility to put a catheter|2|||
48998108|NCT01300741|157828138|FG000|Overall Study|Lens deposits|1|||
48998109|NCT01300741|157828138|FG000|Overall Study|Lost to Follow-up|1|||
48998110|NCT01300741|157828138|FG000|Overall Study|Discomfort|1|||
48998111|NCT01473602|157828139|FG000|Overall Study|Adverse Event|1|||
48998112|NCT01473602|157828140|FG001|Overall Study|Adverse Event|2|||
48998113|NCT01473602|157828139|FG000|Overall Study|Death|0|||
48998114|NCT01473602|157828140|FG001|Overall Study|Death|1|||
48998115|NCT01473602|157828139|FG000|Overall Study|Lost to Follow-up|1|||
48998116|NCT01473602|157828140|FG001|Overall Study|Lost to Follow-up|1|||
48998117|NCT01473602|157828139|FG000|Overall Study|Withdrawal by Subject|5|||
48998118|NCT01473602|157828140|FG001|Overall Study|Withdrawal by Subject|4|||
48998119|NCT01473602|157828139|FG000|Overall Study|Physician Decision|1|||
48998120|NCT01473602|157828140|FG001|Overall Study|Physician Decision|0|||
48998121|NCT02158949|157828141|FG000|Overall Study|Withdrawal by Subject|1|||
48998122|NCT02158949|157828142|FG001|Overall Study|Withdrawal by Subject|0|||
48998123|NCT02158949|157828141|FG000|Overall Study|Lost to Follow-up|5|||
48998124|NCT02158949|157828142|FG001|Overall Study|Lost to Follow-up|11|||
48998125|NCT04478994|157828145|FG000|Overall Study|Withdrawal by Subject|1|||
48998126|NCT04478994|157828146|FG001|Overall Study|Withdrawal by Subject|1|||
48998127|NCT00299546|157828151|FG000|Overall Study|Death|3|||
48998128|NCT00299546|157828152|FG001|Overall Study|Death|2|||
48998129|NCT00299546|157828153|FG002|Overall Study|Death|0|||
48998130|NCT00299546|157828151|FG000|Overall Study|Lost to Follow-up|2|||
48998131|NCT00299546|157828152|FG001|Overall Study|Lost to Follow-up|2|||
48998132|NCT00299546|157828153|FG002|Overall Study|Lost to Follow-up|5|||
48998133|NCT00299546|157828151|FG000|Overall Study|Adverse Event|37|||
48998134|NCT00299546|157828152|FG001|Overall Study|Adverse Event|22|||
48998135|NCT00299546|157828153|FG002|Overall Study|Adverse Event|27|||
48998136|NCT00299546|157828151|FG000|Overall Study|Unsatisfactory therapeutic effect|34|||
48998137|NCT00299546|157828152|FG001|Overall Study|Unsatisfactory therapeutic effect|39|||
48998138|NCT00299546|157828153|FG002|Overall Study|Unsatisfactory therapeutic effect|34|||
48998139|NCT00299546|157828151|FG000|Overall Study|Other|24|||
48998140|NCT00299546|157828152|FG001|Overall Study|Other|26|||
48998141|NCT00299546|157828153|FG002|Overall Study|Other|19|||
48998142|NCT00299546|157828151|FG000|Overall Study|Not treated|0|||
48998143|NCT00299546|157828152|FG001|Overall Study|Not treated|1|||
48998144|NCT00299546|157828153|FG002|Overall Study|Not treated|1|||
48998145|NCT03099265|157828154|FG000|Overall Study|Adverse Event|1|||
48998146|NCT02526017|157828160|FG000|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
48998147|NCT02526017|157828161|FG001|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
48998148|NCT02526017|157828162|FG002|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
48998149|NCT02526017|157828163|FG003|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
48998150|NCT02526017|157828164|FG004|Overall Study|Withdrew Consent Before Receiving Study Treatment|1|||
48998151|NCT02526017|157828165|FG005|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
48998152|NCT02526017|157828166|FG006|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
48998153|NCT02526017|157828167|FG007|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
48998154|NCT02526017|157828168|FG008|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
48998155|NCT02181634|157828177|FG000|Overall Study|Lack of Efficacy|33|||
48998156|NCT02181634|157828177|FG000|Overall Study|Adverse Event|17|||
48998157|NCT02181634|157828177|FG000|Overall Study|Physician Decision|8|||
48998158|NCT02181634|157828177|FG000|Overall Study|Withdrawal by Subject|5|||
48998159|NCT02181634|157828177|FG000|Overall Study|Death|2|||
48998160|NCT02181634|157828177|FG000|Overall Study|Treatment delayed greater than 4 weeks|3|||
48998161|NCT02181634|157828177|FG000|Overall Study|Ineligible|1|||
48998162|NCT02181634|157828177|FG000|Overall Study|Max number of dose reduction|1|||
48998163|NCT02181634|157828177|FG000|Overall Study|Symptomatic progression|1|||
48998164|NCT02181634|157828177|FG000|Overall Study|Patient opted to proceed to surgery|1|||
48998165|NCT02216214|157828179|FG000|Overall Study|Randomized Never Received Study Drug|1|||
48998166|NCT02216214|157828180|FG001|Overall Study|Randomized Never Received Study Drug|0|||
48998167|NCT02216214|157828179|FG000|Overall Study|Adverse Event|10|||
48998168|NCT02216214|157828180|FG001|Overall Study|Adverse Event|8|||
48998169|NCT02216214|157828179|FG000|Overall Study|Lack of Efficacy|2|||
48998170|NCT02216214|157828180|FG001|Overall Study|Lack of Efficacy|2|||
48998171|NCT02216214|157828179|FG000|Overall Study|Lost to Follow-up|3|||
48998172|NCT02216214|157828180|FG001|Overall Study|Lost to Follow-up|2|||
48998173|NCT02216214|157828179|FG000|Overall Study|Protocol Violation|4|||
48998174|NCT02216214|157828180|FG001|Overall Study|Protocol Violation|2|||
48998175|NCT02216214|157828179|FG000|Overall Study|Withdrawal by Subject|22|||
48998176|NCT02216214|157828180|FG001|Overall Study|Withdrawal by Subject|20|||
48998177|NCT02216214|157828179|FG000|Overall Study|Study Terminated By Sponsor|0|||
48998178|NCT02216214|157828180|FG001|Overall Study|Study Terminated By Sponsor|1|||
48998179|NCT02216214|157828179|FG000|Overall Study|Miscellaneous|1|||
48998180|NCT02216214|157828180|FG001|Overall Study|Miscellaneous|1|||
48998181|NCT04484805|157828182|FG000|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|1|||
48998182|NCT04484805|157828183|FG001|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|0|||
48998183|NCT04484805|157828182|FG000|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|1|||
48998184|NCT04484805|157828183|FG001|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|0|||
48998185|NCT01414062|157828184|FG000|Overall Study|Lost to Follow-up|3|||
48998186|NCT01414062|157828185|FG001|Overall Study|Lost to Follow-up|2|||
48998187|NCT01414062|157828184|FG000|Overall Study|Left Country|1|||
48998188|NCT01414062|157828185|FG001|Overall Study|Left Country|1|||
48998189|NCT01414062|157828184|FG000|Overall Study|Family Disapproval|1|||
48998190|NCT01414062|157828185|FG001|Overall Study|Family Disapproval|0|||
48998191|NCT01414062|157828184|FG000|Overall Study|Withdrawal by Subject|0|||
48998192|NCT01414062|157828185|FG001|Overall Study|Withdrawal by Subject|1|||
48998193|NCT02684370|157828186|FG000|Part A|Adverse Event|2|||
48998194|NCT02684370|157828187|FG001|Part A|Adverse Event|0|||
48998195|NCT02684370|157828188|FG002|Part A|Adverse Event|1|||
48998196|NCT02684370|157828189|FG003|Part A|Adverse Event|0|||
48998197|NCT02684370|157828190|FG004|Part A|Adverse Event|0|||
48998198|NCT02684370|157828191|FG005|Part A|Adverse Event|0|||
48998199|NCT02684370|157828186|FG000|Part A|Lost to Follow-up|1|||
48998200|NCT02684370|157828187|FG001|Part A|Lost to Follow-up|1|||
48998201|NCT02684370|157828188|FG002|Part A|Lost to Follow-up|0|||
48998202|NCT02684370|157828189|FG003|Part A|Lost to Follow-up|0|||
48998203|NCT02684370|157828190|FG004|Part A|Lost to Follow-up|0|||
48998204|NCT02684370|157828191|FG005|Part A|Lost to Follow-up|0|||
48998205|NCT02684370|157828186|FG000|Part A|Subject Withdrawal|1|||
48998206|NCT02684370|157828187|FG001|Part A|Subject Withdrawal|0|||
48998207|NCT02684370|157828188|FG002|Part A|Subject Withdrawal|3|||
48998208|NCT02684370|157828189|FG003|Part A|Subject Withdrawal|0|||
48998209|NCT02684370|157828190|FG004|Part A|Subject Withdrawal|0|||
48998210|NCT02684370|157828191|FG005|Part A|Subject Withdrawal|0|||
48998211|NCT02684370|157828186|FG000|Part A|Other|0|||
48998212|NCT02684370|157828187|FG001|Part A|Other|0|||
48998213|NCT02684370|157828188|FG002|Part A|Other|1|||
48998214|NCT02684370|157828189|FG003|Part A|Other|0|||
48998215|NCT02684370|157828190|FG004|Part A|Other|0|||
48998216|NCT02684370|157828191|FG005|Part A|Other|0|||
48998217|NCT02684370|157828186|FG000|Part B|Adverse Event|0|||
48998218|NCT02684370|157828187|FG001|Part B|Adverse Event|0|||
48998219|NCT02684370|157828188|FG002|Part B|Adverse Event|0|||
48998220|NCT02684370|157828189|FG003|Part B|Adverse Event|0|||
48998221|NCT02684370|157828190|FG004|Part B|Adverse Event|2|||
48998222|NCT02684370|157828191|FG005|Part B|Adverse Event|1|||
48998223|NCT02684370|157828186|FG000|Part B|Lost to Follow-up|0|||
48998224|NCT02684370|157828187|FG001|Part B|Lost to Follow-up|0|||
48998225|NCT02684370|157828188|FG002|Part B|Lost to Follow-up|0|||
48998226|NCT02684370|157828189|FG003|Part B|Lost to Follow-up|1|||
48998227|NCT02684370|157828190|FG004|Part B|Lost to Follow-up|2|||
48998228|NCT02684370|157828191|FG005|Part B|Lost to Follow-up|5|||
48998229|NCT02684370|157828186|FG000|Part B|Subject Withdrawal|0|||
48998230|NCT02684370|157828187|FG001|Part B|Subject Withdrawal|0|||
48998231|NCT02684370|157828188|FG002|Part B|Subject Withdrawal|0|||
48998232|NCT02684370|157828189|FG003|Part B|Subject Withdrawal|1|||
48998233|NCT02684370|157828190|FG004|Part B|Subject Withdrawal|1|||
48998234|NCT02684370|157828191|FG005|Part B|Subject Withdrawal|2|||
48998235|NCT00627094|157828193|FG000|Overall Study|Adverse Event|8|||
48998236|NCT00627094|157828194|FG001|Overall Study|Adverse Event|7|||
48998237|NCT00627094|157828193|FG000|Overall Study|Lost to Follow-up|1|||
48998238|NCT00627094|157828194|FG001|Overall Study|Lost to Follow-up|0|||
48998239|NCT00627094|157828193|FG000|Overall Study|Withdrawal by Subject|1|||
48998240|NCT00627094|157828194|FG001|Overall Study|Withdrawal by Subject|1|||
48998241|NCT00627094|157828193|FG000|Overall Study|ulcer healed|1|||
48998242|NCT00627094|157828194|FG001|Overall Study|ulcer healed|7|||
48998243|NCT00627094|157828193|FG000|Overall Study|Other reason|1|||
48998244|NCT00627094|157828194|FG001|Overall Study|Other reason|0|||
48998245|NCT00442572|157828195|FG000|Overall Study|Relapse|8|||
48998246|NCT00442572|157828196|FG001|Overall Study|Relapse|1|||
48998247|NCT00442572|157828195|FG000|Overall Study|Lost to Follow-up|0|||
48998248|NCT00442572|157828196|FG001|Overall Study|Lost to Follow-up|1|||
48998249|NCT00442572|157828195|FG000|Overall Study|Withdrawal by Subject|0|||
48998250|NCT00442572|157828196|FG001|Overall Study|Withdrawal by Subject|1|||
48998251|NCT03557775|157828197|FG000|Overall Study|Withdrawal by Subject|1|||
48998252|NCT03557775|157828198|FG001|Overall Study|Withdrawal by Subject|2|||
48998253|NCT03557775|157828199|FG002|Overall Study|Withdrawal by Subject|4|||
48998254|NCT03557775|157828197|FG000|Overall Study|Physician Decision|0|||
48998255|NCT03557775|157828198|FG001|Overall Study|Physician Decision|1|||
48998256|NCT03557775|157828199|FG002|Overall Study|Physician Decision|0|||
48998257|NCT00308555|157828200|FG000|Overall Study|Withdrawal by Subject|1|||
48998258|NCT00308555|157828201|FG001|Overall Study|Withdrawal by Subject|0|||
48998259|NCT00308555|157828200|FG000|Overall Study|Physician Decision|2|||
48998260|NCT00308555|157828201|FG001|Overall Study|Physician Decision|0|||
48998261|NCT00978120|157828205|FG000|Overall Study|Death|0|||
48998262|NCT00978120|157828206|FG001|Overall Study|Death|0|||
48998263|NCT00978120|157828207|FG002|Overall Study|Death|0|||
48998264|NCT00978120|157828208|FG003|Overall Study|Death|1|||
48998265|NCT00978120|157828205|FG000|Overall Study|Lost to Follow-up|0|||
48998266|NCT00978120|157828206|FG001|Overall Study|Lost to Follow-up|0|||
48998267|NCT00978120|157828207|FG002|Overall Study|Lost to Follow-up|3|||
48998268|NCT00978120|157828208|FG003|Overall Study|Lost to Follow-up|0|||
48998269|NCT00978120|157828205|FG000|Overall Study|Withdrawal by Subject|2|||
48998270|NCT00978120|157828206|FG001|Overall Study|Withdrawal by Subject|0|||
48998271|NCT00978120|157828207|FG002|Overall Study|Withdrawal by Subject|0|||
48998272|NCT00978120|157828208|FG003|Overall Study|Withdrawal by Subject|0|||
48998273|NCT00978120|157828205|FG000|Overall Study|Moved out of state|0|||
48998274|NCT00978120|157828206|FG001|Overall Study|Moved out of state|0|||
48998275|NCT00978120|157828207|FG002|Overall Study|Moved out of state|0|||
48998276|NCT00978120|157828208|FG003|Overall Study|Moved out of state|1|||
48998277|NCT02940392|157828209|FG000|Overall Study|Lost to Follow-up|3|||
48998278|NCT02940392|157828209|FG000|Overall Study|Retreatment|3|||
48998279|NCT02940392|157828209|FG000|Overall Study|Death|2|||
48998280|NCT02120456|157828212|FG000|Part 2 Double-blind Phase|Lost to Follow-up|0|||
48998281|NCT02120456|157828213|FG001|Part 2 Double-blind Phase|Lost to Follow-up|0|||
48998282|NCT02120456|157828214|FG002|Part 2 Double-blind Phase|Lost to Follow-up|0|||
48998283|NCT02120456|157828215|FG003|Part 2 Double-blind Phase|Lost to Follow-up|0|||
48998284|NCT02120456|157828216|FG004|Part 2 Double-blind Phase|Lost to Follow-up|0|||
48998285|NCT02120456|157828217|FG005|Part 2 Double-blind Phase|Lost to Follow-up|0|||
48998286|NCT02120456|157828218|FG006|Part 2 Double-blind Phase|Lost to Follow-up|1|||
48998287|NCT02120456|157828219|FG007|Part 2 Double-blind Phase|Lost to Follow-up|0|||
48998288|NCT02120456|157828220|FG008|Part 2 Double-blind Phase|Lost to Follow-up|0|||
48998289|NCT02120456|157828212|FG000|Part 2 Double-blind Phase|Withdrawal of consent|0|||
48998290|NCT02120456|157828213|FG001|Part 2 Double-blind Phase|Withdrawal of consent|0|||
48998291|NCT02120456|157828214|FG002|Part 2 Double-blind Phase|Withdrawal of consent|0|||
48998292|NCT02120456|157828215|FG003|Part 2 Double-blind Phase|Withdrawal of consent|0|||
48998293|NCT02120456|157828216|FG004|Part 2 Double-blind Phase|Withdrawal of consent|0|||
48998294|NCT02120456|157828217|FG005|Part 2 Double-blind Phase|Withdrawal of consent|0|||
48998295|NCT02120456|157828218|FG006|Part 2 Double-blind Phase|Withdrawal of consent|1|||
48998296|NCT02120456|157828219|FG007|Part 2 Double-blind Phase|Withdrawal of consent|0|||
48998297|NCT02120456|157828220|FG008|Part 2 Double-blind Phase|Withdrawal of consent|0|||
48998298|NCT02120456|157828212|FG000|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
48998299|NCT02120456|157828213|FG001|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
48998300|NCT02120456|157828214|FG002|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
48998301|NCT02120456|157828215|FG003|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
48998302|NCT02120456|157828216|FG004|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
48998303|NCT02120456|157828217|FG005|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
48998304|NCT02120456|157828218|FG006|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
48998305|NCT02120456|157828219|FG007|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
48998306|NCT02120456|157828220|FG008|Part 2 Double-blind Phase|Unable to attend visit due to work|1|||
48998307|NCT03992456|157828221|FG000|Overall Study|Withdrawal by Subject|1|||
48998308|NCT03992456|157828222|FG001|Overall Study|Withdrawal by Subject|0|||
48998309|NCT03992456|157828221|FG000|Overall Study|Disease progression|4|||
48998310|NCT03992456|157828222|FG001|Overall Study|Disease progression|5|||
48998311|NCT03992456|157828221|FG000|Overall Study|Emergency surgery unrelated to treatment|0|||
48998312|NCT03992456|157828222|FG001|Overall Study|Emergency surgery unrelated to treatment|1|||
48998313|NCT01901393|157828223|FG000|Overall Study|Adverse Event|1|||
48998314|NCT01901393|157828224|FG001|Overall Study|Adverse Event|0|||
48998315|NCT03155269|157828231|FG000|Overall Study|Withdrawal by Subject|4|||
48998316|NCT03155269|157828232|FG001|Overall Study|Withdrawal by Subject|5|||
48998317|NCT03155269|157828231|FG000|Overall Study|Lost to Follow-up|1|||
48998318|NCT03155269|157828232|FG001|Overall Study|Lost to Follow-up|2|||
48998319|NCT02181673|157828233|FG000|Up to Week 24|Adverse Event|2|||
48998320|NCT02181673|157828234|FG001|Up to Week 24|Adverse Event|0|||
48998321|NCT02181673|157828235|FG002|Up to Week 24|Adverse Event|3|||
48998322|NCT02181673|157828233|FG000|Up to Week 24|Death|1|||
48998323|NCT02181673|157828234|FG001|Up to Week 24|Death|0|||
48998324|NCT02181673|157828235|FG002|Up to Week 24|Death|0|||
48998325|NCT02181673|157828233|FG000|Up to Week 24|Lack of Efficacy|1|||
48998326|NCT02181673|157828234|FG001|Up to Week 24|Lack of Efficacy|0|||
48998327|NCT02181673|157828235|FG002|Up to Week 24|Lack of Efficacy|0|||
48998328|NCT02181673|157828233|FG000|Up to Week 24|Lost to Follow-up|1|||
48998329|NCT02181673|157828234|FG001|Up to Week 24|Lost to Follow-up|0|||
48998330|NCT02181673|157828235|FG002|Up to Week 24|Lost to Follow-up|0|||
48998331|NCT02181673|157828233|FG000|Up to Week 24|Physician Decision|0|||
48998332|NCT02181673|157828234|FG001|Up to Week 24|Physician Decision|0|||
48998333|NCT02181673|157828235|FG002|Up to Week 24|Physician Decision|3|||
48998334|NCT02181673|157828233|FG000|Up to Week 24|Withdrawal by Subject|10|||
48998335|NCT02181673|157828234|FG001|Up to Week 24|Withdrawal by Subject|0|||
48998336|NCT02181673|157828235|FG002|Up to Week 24|Withdrawal by Subject|1|||
48998337|NCT02181673|157828233|FG000|Up to Week 24|Other|2|||
48998338|NCT02181673|157828234|FG001|Up to Week 24|Other|0|||
48998339|NCT02181673|157828235|FG002|Up to Week 24|Other|3|||
48998340|NCT02181673|157828233|FG000|Up to Week 24|Randomized not Treated|0|||
48998341|NCT02181673|157828234|FG001|Up to Week 24|Randomized not Treated|0|||
48998342|NCT02181673|157828235|FG002|Up to Week 24|Randomized not Treated|1|||
48998343|NCT02181673|157828233|FG000|Week 24-Week 60|Adverse Event|0|||
48998344|NCT02181673|157828234|FG001|Week 24-Week 60|Adverse Event|4|||
48998345|NCT02181673|157828235|FG002|Week 24-Week 60|Adverse Event|10|||
48998346|NCT02181673|157828233|FG000|Week 24-Week 60|Other|0|||
48998347|NCT02181673|157828234|FG001|Week 24-Week 60|Other|2|||
48998348|NCT02181673|157828235|FG002|Week 24-Week 60|Other|1|||
48998349|NCT02181673|157828233|FG000|Week 24-Week 60|Withdrawal by Subject|0|||
48998350|NCT02181673|157828234|FG001|Week 24-Week 60|Withdrawal by Subject|2|||
48998351|NCT02181673|157828235|FG002|Week 24-Week 60|Withdrawal by Subject|2|||
48998352|NCT02181673|157828233|FG000|Week 24-Week 60|Pregnancy|0|||
48998353|NCT02181673|157828234|FG001|Week 24-Week 60|Pregnancy|0|||
48998354|NCT02181673|157828235|FG002|Week 24-Week 60|Pregnancy|1|||
48998355|NCT02181673|157828233|FG000|Week 24-Week 60|Lack of Efficacy|0|||
48998356|NCT02181673|157828234|FG001|Week 24-Week 60|Lack of Efficacy|0|||
48998357|NCT02181673|157828235|FG002|Week 24-Week 60|Lack of Efficacy|1|||
48998358|NCT02181673|157828233|FG000|Week 24-Week 60|Lost to Follow-up|0|||
48998359|NCT02181673|157828234|FG001|Week 24-Week 60|Lost to Follow-up|0|||
48998360|NCT02181673|157828235|FG002|Week 24-Week 60|Lost to Follow-up|1|||
48998361|NCT02181673|157828233|FG000|Week 24-Week 60|Physician Decision|0|||
48998362|NCT02181673|157828234|FG001|Week 24-Week 60|Physician Decision|0|||
48998363|NCT02181673|157828235|FG002|Week 24-Week 60|Physician Decision|1|||
48998364|NCT00824993|157828244|FG000|Overall Study|Withdrawal by Subject|1|||
48998365|NCT00824993|157828245|FG001|Overall Study|Withdrawal by Subject|1|||
48998366|NCT00824993|157828244|FG000|Overall Study|Malignancy Relapse|9|||
48998367|NCT00824993|157828245|FG001|Overall Study|Malignancy Relapse|10|||
48998368|NCT00824993|157828244|FG000|Overall Study|Rapid Bone Loss|0|||
48998369|NCT00824993|157828245|FG001|Overall Study|Rapid Bone Loss|1|||
48998370|NCT00824993|157828244|FG000|Overall Study|Non-Compliant|2|||
48998371|NCT00824993|157828245|FG001|Overall Study|Non-Compliant|1|||
48998372|NCT00824993|157828244|FG000|Overall Study|Insurance Issue|2|||
48998373|NCT00824993|157828245|FG001|Overall Study|Insurance Issue|1|||
48998374|NCT00824993|157828244|FG000|Overall Study|Death|0|||
48998375|NCT00824993|157828245|FG001|Overall Study|Death|3|||
48998376|NCT03075826|157828246|FG000|Overall Study|Withdrawal by Subject|1|||
48998377|NCT03075826|157828246|FG000|Overall Study|Received less than 3 cycles of study drug|5|||
48998378|NCT00834366|157828247|FG000|Treatment Period 1|Adverse Event|1|||
48998379|NCT00834366|157828248|FG001|Treatment Period 1|Adverse Event|1|||
48998380|NCT03522506|157828252|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
48998381|NCT03522506|157828253|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
48998382|NCT03522506|157828254|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
48998383|NCT03522506|157828255|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
48998384|NCT03522506|157828252|FG000|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
48998385|NCT03522506|157828253|FG001|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
48998386|NCT03522506|157828254|FG002|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
48998387|NCT03522506|157828255|FG003|Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
48998388|NCT00650806|157828256|FG000|Overall Study|Adverse Event|0|||
48998389|NCT00650806|157828257|FG001|Overall Study|Adverse Event|5|||
48998390|NCT00650806|157828258|FG002|Overall Study|Adverse Event|3|||
48998391|NCT00650806|157828259|FG003|Overall Study|Adverse Event|4|||
48998392|NCT00650806|157828256|FG000|Overall Study|Lost to Follow-up|7|||
48998393|NCT00650806|157828257|FG001|Overall Study|Lost to Follow-up|6|||
48998394|NCT00650806|157828258|FG002|Overall Study|Lost to Follow-up|11|||
48998395|NCT00650806|157828259|FG003|Overall Study|Lost to Follow-up|10|||
48998396|NCT00650806|157828256|FG000|Overall Study|Protocol Violation|0|||
48998397|NCT00650806|157828257|FG001|Overall Study|Protocol Violation|0|||
48998398|NCT00650806|157828258|FG002|Overall Study|Protocol Violation|0|||
48998399|NCT00650806|157828259|FG003|Overall Study|Protocol Violation|1|||
48998400|NCT00650806|157828256|FG000|Overall Study|Pregnancy|0|||
48998401|NCT00650806|157828257|FG001|Overall Study|Pregnancy|0|||
48998402|NCT00650806|157828258|FG002|Overall Study|Pregnancy|0|||
48998403|NCT00650806|157828259|FG003|Overall Study|Pregnancy|1|||
48998404|NCT00650806|157828256|FG000|Overall Study|Withdrawal by Subject|7|||
48998405|NCT00650806|157828257|FG001|Overall Study|Withdrawal by Subject|5|||
48998406|NCT00650806|157828258|FG002|Overall Study|Withdrawal by Subject|8|||
48998407|NCT00650806|157828259|FG003|Overall Study|Withdrawal by Subject|6|||
48998408|NCT00650806|157828256|FG000|Overall Study|Noncompliance with study drug regimen|1|||
48998409|NCT00650806|157828257|FG001|Overall Study|Noncompliance with study drug regimen|1|||
48998410|NCT00650806|157828258|FG002|Overall Study|Noncompliance with study drug regimen|0|||
48998411|NCT00650806|157828259|FG003|Overall Study|Noncompliance with study drug regimen|0|||
48998412|NCT00650806|157828256|FG000|Overall Study|Study terminated by sponsor|2|||
48998413|NCT00650806|157828257|FG001|Overall Study|Study terminated by sponsor|3|||
48998414|NCT00650806|157828258|FG002|Overall Study|Study terminated by sponsor|5|||
48998415|NCT00650806|157828259|FG003|Overall Study|Study terminated by sponsor|4|||
48998416|NCT00650806|157828256|FG000|Overall Study|Other|1|||
48998417|NCT00650806|157828257|FG001|Overall Study|Other|1|||
48998418|NCT00650806|157828258|FG002|Overall Study|Other|2|||
48998419|NCT00650806|157828259|FG003|Overall Study|Other|0|||
48998420|NCT03014570|157828260|FG000|Overall Study|COVID-19 Restrictions|38|||
48998421|NCT03014570|157828261|FG001|Overall Study|COVID-19 Restrictions|24|||
48998422|NCT03014570|157828260|FG000|Overall Study|Death|70|||
48998423|NCT03014570|157828261|FG001|Overall Study|Death|79|||
48998424|NCT03014570|157828260|FG000|Overall Study|Transfer from facility|11|||
48998425|NCT03014570|157828261|FG001|Overall Study|Transfer from facility|14|||
48998426|NCT03014570|157828260|FG000|Overall Study|Hospitalized|5|||
48998427|NCT03014570|157828261|FG001|Overall Study|Hospitalized|3|||
48998428|NCT03014570|157828260|FG000|Overall Study|Transfer within facility|1|||
48998429|NCT03014570|157828261|FG001|Overall Study|Transfer within facility|0|||
48998430|NCT03014570|157828260|FG000|Overall Study|Site refusal|0|||
48998431|NCT03014570|157828261|FG001|Overall Study|Site refusal|11|||
48998432|NCT00554788|157828266|FG000|Overall Study|Adverse Event|0|||
48998433|NCT00554788|157828267|FG001|Overall Study|Adverse Event|1|||
48998434|NCT00554788|157828268|FG002|Overall Study|Adverse Event|2|||
48998435|NCT00554788|157828266|FG000|Overall Study|Lost to Follow-up|4|||
48998436|NCT00554788|157828267|FG001|Overall Study|Lost to Follow-up|3|||
48998437|NCT00554788|157828268|FG002|Overall Study|Lost to Follow-up|3|||
48998438|NCT00554788|157828266|FG000|Overall Study|Physician Decision|1|||
48998439|NCT00554788|157828267|FG001|Overall Study|Physician Decision|1|||
48998440|NCT00554788|157828268|FG002|Overall Study|Physician Decision|3|||
48998441|NCT00554788|157828266|FG000|Overall Study|Withdrawal by Subject|0|||
48998442|NCT00554788|157828267|FG001|Overall Study|Withdrawal by Subject|0|||
48998443|NCT00554788|157828268|FG002|Overall Study|Withdrawal by Subject|1|||
48998444|NCT00554788|157828266|FG000|Overall Study|Refusal of further protocol therapy|0|||
48998445|NCT00554788|157828267|FG001|Overall Study|Refusal of further protocol therapy|1|||
48998446|NCT00554788|157828268|FG002|Overall Study|Refusal of further protocol therapy|1|||
48998447|NCT00554788|157828266|FG000|Overall Study|Progressive disease|0|||
48998448|NCT00554788|157828267|FG001|Overall Study|Progressive disease|0|||
48998449|NCT00554788|157828268|FG002|Overall Study|Progressive disease|3|||
48998450|NCT00554788|157828266|FG000|Overall Study|Ineligible|2|||
48998451|NCT00554788|157828267|FG001|Overall Study|Ineligible|0|||
48998452|NCT00554788|157828268|FG002|Overall Study|Ineligible|1|||
48998453|NCT02998645|157828269|FG000|Treatment Period 1|Adverse Event|6|||
48998454|NCT02998645|157828269|FG000|Treatment Period 1|Death|5|||
48998455|NCT02998645|157828269|FG000|Treatment Period 1|Technical Problems|4|||
48998456|NCT02998645|157828269|FG000|Treatment Period 1|Lack of Efficacy|2|||
48998457|NCT02998645|157828269|FG000|Treatment Period 1|Progressive disease|1|||
48998458|NCT02998645|157828269|FG000|Treatment Period 1|Subject/guardian decision|1|||
48998459|NCT02998645|157828269|FG000|Treatment Period 2|Lack of Efficacy|5|||
48998460|NCT02998645|157828269|FG000|Treatment Period 2|Adverse Event|2|||
48998461|NCT02998645|157828269|FG000|Treatment Period 2|Progressive disease|2|||
48998462|NCT02998645|157828269|FG000|Treatment Period 2|Physician Decision|1|||
48998463|NCT03930615|157828271|FG000|Overall Study|Death|9|||
48998464|NCT03930615|157828272|FG001|Overall Study|Death|3|||
48998465|NCT03930615|157828271|FG000|Overall Study|Lost to Follow-up|1|||
48998466|NCT03930615|157828272|FG001|Overall Study|Lost to Follow-up|2|||
48998467|NCT03930615|157828271|FG000|Overall Study|Physician Decision|3|||
48998468|NCT03930615|157828272|FG001|Overall Study|Physician Decision|4|||
48998469|NCT03930615|157828271|FG000|Overall Study|Withdrawal by Subject|13|||
48998470|NCT03930615|157828272|FG001|Overall Study|Withdrawal by Subject|2|||
48998471|NCT03930615|157828271|FG000|Overall Study|Not treated|1|||
48998472|NCT03930615|157828272|FG001|Overall Study|Not treated|1|||
48998473|NCT00674440|157828275|FG000|Overall Study|consented but not scanned (Withdrawn due to genetics)|1|||
48998474|NCT00674440|157828275|FG000|Overall Study|did not have surgery, so unevaluable|7|||
48998475|NCT00674440|157828275|FG000|Overall Study|had atypical histology or had second PET scan after initial surgery - not counted twice|3|||
48998476|NCT01195662|157828276|FG000|Double Blind Treatment Period|Adverse Event|4|||
48998477|NCT01195662|157828277|FG001|Double Blind Treatment Period|Adverse Event|1|||
48998478|NCT01195662|157828278|FG002|Double Blind Treatment Period|Adverse Event|2|||
48998479|NCT01195662|157828276|FG000|Double Blind Treatment Period|Withdrawal by Subject|6|||
48998480|NCT01195662|157828277|FG001|Double Blind Treatment Period|Withdrawal by Subject|4|||
48998481|NCT01195662|157828278|FG002|Double Blind Treatment Period|Withdrawal by Subject|4|||
48998482|NCT01195662|157828276|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
48998483|NCT01195662|157828277|FG001|Double Blind Treatment Period|Lost to Follow-up|2|||
48998484|NCT01195662|157828278|FG002|Double Blind Treatment Period|Lost to Follow-up|3|||
49045840|NCT02300987|158002027|FG001|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0|||
48998485|NCT01195662|157828276|FG000|Double Blind Treatment Period|Administrative reason|2|||
48998486|NCT01195662|157828277|FG001|Double Blind Treatment Period|Administrative reason|1|||
48998487|NCT01195662|157828278|FG002|Double Blind Treatment Period|Administrative reason|1|||
48998488|NCT01195662|157828276|FG000|Double Blind Treatment Period|Requested discontinue treatment|1|||
48998489|NCT01195662|157828277|FG001|Double Blind Treatment Period|Requested discontinue treatment|0|||
48998490|NCT01195662|157828278|FG002|Double Blind Treatment Period|Requested discontinue treatment|1|||
48998491|NCT01195662|157828276|FG000|Double Blind Treatment Period|No Longer Meets Criteria|1|||
48998492|NCT01195662|157828277|FG001|Double Blind Treatment Period|No Longer Meets Criteria|5|||
48998493|NCT01195662|157828278|FG002|Double Blind Treatment Period|No Longer Meets Criteria|2|||
48998494|NCT01195662|157828276|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
48998495|NCT01195662|157828277|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
48998496|NCT01195662|157828278|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
48998497|NCT01195662|157828276|FG000|Double Blind Treatment Period|Non-specified|3|||
48998498|NCT01195662|157828277|FG001|Double Blind Treatment Period|Non-specified|0|||
48998499|NCT01195662|157828278|FG002|Double Blind Treatment Period|Non-specified|0|||
48998500|NCT01195662|157828276|FG000|Double Blind Treatment Period|Missing disposition information|0|||
48998501|NCT01195662|157828277|FG001|Double Blind Treatment Period|Missing disposition information|1|||
48998502|NCT01195662|157828278|FG002|Double Blind Treatment Period|Missing disposition information|1|||
48998503|NCT01195662|157828276|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2|||
48998504|NCT01195662|157828277|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0|||
48998505|NCT01195662|157828278|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1|||
48998506|NCT01195662|157828276|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1|||
48998507|NCT01195662|157828277|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
48998508|NCT01195662|157828278|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
48998509|NCT03128931|157828279|FG000|Overall Study|Physician Decision|1|||
48998510|NCT03128931|157828279|FG000|Overall Study|Equipment Issues|3|||
48998511|NCT01907516|157828283|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|5|||
48998512|NCT01907516|157828284|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|9|||
48998513|NCT01907516|157828283|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
48998514|NCT01907516|157828284|FG001|First Intervention (3 Weeks)|Lost to Follow-up|3|||
48998515|NCT01907516|157828283|FG000|First Intervention (3 Weeks)|Delivered before second arm|3|||
48998516|NCT01907516|157828284|FG001|First Intervention (3 Weeks)|Delivered before second arm|4|||
48998517|NCT01907516|157828283|FG000|First Intervention (3 Weeks)|Developed DKA during study|1|||
48998518|NCT01907516|157828284|FG001|First Intervention (3 Weeks)|Developed DKA during study|0|||
48998519|NCT03205163|157828287|FG000|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1|||
48998520|NCT03205163|157828288|FG001|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0|||
48998521|NCT02325414|157829645|FG000|Overall Study|Withdrawal by Subject|3|||
48998522|NCT02325414|157829646|FG001|Overall Study|Withdrawal by Subject|1|||
48998523|NCT02325414|157829645|FG000|Overall Study|Lost to Follow-up|5|||
48998524|NCT02325414|157829646|FG001|Overall Study|Lost to Follow-up|5|||
48998525|NCT04854421|157829647|FG000|Overall Study|Removed from the final analysis due to poor image quality.|2|||
48998526|NCT04854421|157829648|FG001|Overall Study|Removed from the final analysis due to poor image quality.|2|||
48998527|NCT00560573|157829649|FG000|Overall Study|Death|4|||
48998528|NCT00560573|157829650|FG001|Overall Study|Death|1|||
48998529|NCT00560573|157829651|FG002|Overall Study|Death|4|||
48998530|NCT00560573|157829652|FG003|Overall Study|Death|5|||
48998531|NCT00560573|157829653|FG004|Overall Study|Death|1|||
48998532|NCT00560573|157829654|FG005|Overall Study|Death|10|||
48998533|NCT00560573|157829649|FG000|Overall Study|Lost to Follow-up|0|||
48998534|NCT00560573|157829650|FG001|Overall Study|Lost to Follow-up|0|||
48998535|NCT00560573|157829651|FG002|Overall Study|Lost to Follow-up|0|||
48998536|NCT00560573|157829652|FG003|Overall Study|Lost to Follow-up|1|||
48998537|NCT00560573|157829653|FG004|Overall Study|Lost to Follow-up|1|||
48998538|NCT00560573|157829654|FG005|Overall Study|Lost to Follow-up|0|||
48998539|NCT00560573|157829649|FG000|Overall Study|Withdrawal by Subject|0|||
48998540|NCT00560573|157829650|FG001|Overall Study|Withdrawal by Subject|0|||
48998541|NCT00560573|157829651|FG002|Overall Study|Withdrawal by Subject|0|||
48998542|NCT00560573|157829652|FG003|Overall Study|Withdrawal by Subject|1|||
48998543|NCT00560573|157829653|FG004|Overall Study|Withdrawal by Subject|1|||
48998544|NCT00560573|157829654|FG005|Overall Study|Withdrawal by Subject|0|||
48998545|NCT00560573|157829649|FG000|Overall Study|Other|2|||
48998546|NCT00560573|157829650|FG001|Overall Study|Other|2|||
48998547|NCT00560573|157829651|FG002|Overall Study|Other|2|||
48998548|NCT00560573|157829652|FG003|Overall Study|Other|3|||
48998549|NCT00560573|157829653|FG004|Overall Study|Other|3|||
48998550|NCT00560573|157829654|FG005|Overall Study|Other|3|||
48998551|NCT00560573|157829649|FG000|Overall Study|Enrolled, not treated|0|||
48998552|NCT00560573|157829650|FG001|Overall Study|Enrolled, not treated|0|||
48998553|NCT00560573|157829651|FG002|Overall Study|Enrolled, not treated|0|||
48998554|NCT00560573|157829652|FG003|Overall Study|Enrolled, not treated|0|||
48998555|NCT00560573|157829653|FG004|Overall Study|Enrolled, not treated|1|||
48998556|NCT00560573|157829654|FG005|Overall Study|Enrolled, not treated|0|||
49045841|NCT02300987|158002026|FG000|Primary Phase : Prior to Cross-over|Physician Decision|2|||
48998557|NCT00344968|157829657|FG000|Overall Study|Adverse Event|5|||
48998558|NCT00344968|157829658|FG001|Overall Study|Adverse Event|4|||
48998559|NCT00344968|157829659|FG002|Overall Study|Adverse Event|15|||
48998560|NCT00344968|157829657|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
48998561|NCT00344968|157829658|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
48998562|NCT00344968|157829659|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
48998563|NCT00344968|157829657|FG000|Overall Study|Protocol Violation|2|||
48998564|NCT00344968|157829658|FG001|Overall Study|Protocol Violation|2|||
48998565|NCT00344968|157829659|FG002|Overall Study|Protocol Violation|5|||
48998566|NCT00344968|157829657|FG000|Overall Study|Withdrawal by Subject|14|||
48998567|NCT00344968|157829658|FG001|Overall Study|Withdrawal by Subject|31|||
48998568|NCT00344968|157829659|FG002|Overall Study|Withdrawal by Subject|27|||
48998569|NCT00344968|157829657|FG000|Overall Study|Lost to Follow-up|24|||
48998570|NCT00344968|157829658|FG001|Overall Study|Lost to Follow-up|37|||
48998571|NCT00344968|157829659|FG002|Overall Study|Lost to Follow-up|37|||
48998572|NCT00344968|157829657|FG000|Overall Study|Death|11|||
48998573|NCT00344968|157829658|FG001|Overall Study|Death|27|||
48998574|NCT00344968|157829659|FG002|Overall Study|Death|31|||
48998575|NCT00344968|157829657|FG000|Overall Study|Other|0|||
48998576|NCT00344968|157829658|FG001|Overall Study|Other|1|||
48998577|NCT00344968|157829659|FG002|Overall Study|Other|0|||
48998578|NCT00594568|157829660|FG000|Initial Treatment|Adverse Event|51|||
48998579|NCT00594568|157829661|FG001|Initial Treatment|Adverse Event|121|||
48998580|NCT00594568|157829662|FG002|Initial Treatment|Adverse Event|144|||
48998581|NCT00594568|157829660|FG000|Initial Treatment|Death|6|||
48998582|NCT00594568|157829661|FG001|Initial Treatment|Death|11|||
48998583|NCT00594568|157829662|FG002|Initial Treatment|Death|15|||
48998584|NCT00594568|157829660|FG000|Initial Treatment|Lost to Follow-up|4|||
48998585|NCT00594568|157829661|FG001|Initial Treatment|Lost to Follow-up|1|||
48998586|NCT00594568|157829662|FG002|Initial Treatment|Lost to Follow-up|4|||
48998587|NCT00594568|157829660|FG000|Initial Treatment|Physician Decision|3|||
48998588|NCT00594568|157829661|FG001|Initial Treatment|Physician Decision|2|||
48998589|NCT00594568|157829662|FG002|Initial Treatment|Physician Decision|4|||
48998590|NCT00594568|157829660|FG000|Initial Treatment|Protocol Violation|2|||
48998591|NCT00594568|157829661|FG001|Initial Treatment|Protocol Violation|2|||
48998592|NCT00594568|157829662|FG002|Initial Treatment|Protocol Violation|5|||
48998593|NCT00594568|157829660|FG000|Initial Treatment|Withdrawal by Subject|25|||
48998594|NCT00594568|157829661|FG001|Initial Treatment|Withdrawal by Subject|31|||
48998595|NCT00594568|157829662|FG002|Initial Treatment|Withdrawal by Subject|46|||
48998596|NCT00594568|157829660|FG000|Initial Treatment|Sponsor decision|193|||
48998597|NCT00594568|157829661|FG001|Initial Treatment|Sponsor decision|142|||
48998598|NCT00594568|157829662|FG002|Initial Treatment|Sponsor decision|147|||
48998599|NCT00594568|157829660|FG000|Initial Treatment|Caregiver decision|21|||
48998600|NCT00594568|157829661|FG001|Initial Treatment|Caregiver decision|36|||
48998601|NCT00594568|157829662|FG002|Initial Treatment|Caregiver decision|36|||
48998602|NCT00594568|157829660|FG000|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
48998603|NCT00594568|157829661|FG001|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
48998604|NCT00594568|157829662|FG002|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6|||
48998605|NCT00594568|157829660|FG000|Initial Treatment|Entry criteria exclusion|0|||
48998606|NCT00594568|157829661|FG001|Initial Treatment|Entry criteria exclusion|1|||
48998607|NCT00594568|157829662|FG002|Initial Treatment|Entry criteria exclusion|1|||
48998608|NCT00594568|157829660|FG000|Delayed Start|Death|0|||
48998609|NCT00594568|157829661|FG001|Delayed Start|Death|0|||
48998610|NCT00594568|157829662|FG002|Delayed Start|Death|1|||
48998611|NCT00594568|157829660|FG000|Delayed Start|Adverse Event|12|||
48998612|NCT00594568|157829661|FG001|Delayed Start|Adverse Event|2|||
48998613|NCT00594568|157829662|FG002|Delayed Start|Adverse Event|2|||
48998614|NCT00594568|157829660|FG000|Delayed Start|Withdrawal by Subject|4|||
48998615|NCT00594568|157829661|FG001|Delayed Start|Withdrawal by Subject|3|||
48998616|NCT00594568|157829662|FG002|Delayed Start|Withdrawal by Subject|0|||
48998617|NCT00594568|157829660|FG000|Delayed Start|Physician Decision|0|||
48998618|NCT00594568|157829661|FG001|Delayed Start|Physician Decision|0|||
48998619|NCT00594568|157829662|FG002|Delayed Start|Physician Decision|1|||
48998620|NCT00594568|157829660|FG000|Delayed Start|Lost to Follow-up|0|||
48998621|NCT00594568|157829661|FG001|Delayed Start|Lost to Follow-up|0|||
48998622|NCT00594568|157829662|FG002|Delayed Start|Lost to Follow-up|1|||
48998623|NCT00594568|157829660|FG000|Delayed Start|Caregiver Decision|5|||
48998624|NCT00594568|157829661|FG001|Delayed Start|Caregiver Decision|6|||
48998625|NCT00594568|157829662|FG002|Delayed Start|Caregiver Decision|2|||
48998626|NCT00594568|157829660|FG000|Delayed Start|Sponsor Decision|77|||
48998627|NCT00594568|157829661|FG001|Delayed Start|Sponsor Decision|66|||
48998628|NCT00594568|157829662|FG002|Delayed Start|Sponsor Decision|59|||
48998629|NCT00594568|157829660|FG000|Safety Follow Up (SFU)-Optional|Death|0|||
48998630|NCT00594568|157829661|FG001|Safety Follow Up (SFU)-Optional|Death|1|||
48998631|NCT00594568|157829662|FG002|Safety Follow Up (SFU)-Optional|Death|0|||
48998632|NCT00594568|157829660|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|5|||
48998633|NCT00594568|157829661|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
48998634|NCT00594568|157829662|FG002|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
48998635|NCT00594568|157829660|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12|||
48998636|NCT00594568|157829661|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15|||
48998637|NCT00594568|157829662|FG002|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13|||
48998638|NCT00594568|157829660|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
48998639|NCT00594568|157829661|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
48998640|NCT00594568|157829662|FG002|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
48998641|NCT00594568|157829660|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|17|||
48998642|NCT00594568|157829661|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|16|||
48998643|NCT00594568|157829662|FG002|Safety Follow Up (SFU)-Optional|Caregiver Decision|9|||
48998644|NCT00594568|157829660|FG000|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25|||
48998645|NCT00594568|157829661|FG001|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22|||
48998646|NCT00594568|157829662|FG002|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18|||
48998647|NCT03735680|157829663|FG000|Overall Study|Withdrawal by Subject|0|||
48998648|NCT03735680|157829664|FG001|Overall Study|Withdrawal by Subject|1|||
48998649|NCT03735680|157829665|FG002|Overall Study|Withdrawal by Subject|0|||
48998650|NCT03735680|157829666|FG003|Overall Study|Withdrawal by Subject|0|||
48998651|NCT03735680|157829667|FG004|Overall Study|Withdrawal by Subject|0|||
48998652|NCT03735680|157829668|FG005|Overall Study|Withdrawal by Subject|1|||
48998653|NCT03735680|157829663|FG000|Overall Study|Patient unable or unwilling to continue|0|||
48998654|NCT03735680|157829664|FG001|Overall Study|Patient unable or unwilling to continue|0|||
48998655|NCT03735680|157829665|FG002|Overall Study|Patient unable or unwilling to continue|1|||
48998656|NCT03735680|157829666|FG003|Overall Study|Patient unable or unwilling to continue|0|||
48998657|NCT03735680|157829667|FG004|Overall Study|Patient unable or unwilling to continue|0|||
48998658|NCT03735680|157829668|FG005|Overall Study|Patient unable or unwilling to continue|0|||
48998659|NCT01340794|157829670|FG000|Overall Study|Withdrawal by Subject|0|||
48998660|NCT01340794|157829671|FG001|Overall Study|Withdrawal by Subject|1|||
48998661|NCT01422876|157829672|FG000|Week 24|Lost to Follow-up|1|||
48998662|NCT01422876|157829673|FG001|Week 24|Lost to Follow-up|1|||
48998663|NCT01422876|157829674|FG002|Week 24|Lost to Follow-up|2|||
48998664|NCT01422876|157829675|FG003|Week 24|Lost to Follow-up|4|||
48998665|NCT01422876|157829676|FG004|Week 24|Lost to Follow-up|2|||
48998666|NCT01422876|157829677|FG005|Week 24|Lost to Follow-up|0|||
48998667|NCT01422876|157829678|FG006|Week 24|Lost to Follow-up|1|||
48998668|NCT01422876|157829679|FG007|Week 24|Lost to Follow-up|3|||
48998669|NCT01422876|157829680|FG008|Week 24|Lost to Follow-up|3|||
48998670|NCT01422876|157829681|FG009|Week 24|Lost to Follow-up|4|||
48998671|NCT01422876|157829672|FG000|Week 24|Consent withdrawn|5|||
48998672|NCT01422876|157829673|FG001|Week 24|Consent withdrawn|1|||
48998673|NCT01422876|157829674|FG002|Week 24|Consent withdrawn|3|||
48998674|NCT01422876|157829675|FG003|Week 24|Consent withdrawn|4|||
48998675|NCT01422876|157829676|FG004|Week 24|Consent withdrawn|5|||
48998676|NCT01422876|157829677|FG005|Week 24|Consent withdrawn|6|||
48998677|NCT01422876|157829678|FG006|Week 24|Consent withdrawn|5|||
48998678|NCT01422876|157829679|FG007|Week 24|Consent withdrawn|4|||
48998679|NCT01422876|157829680|FG008|Week 24|Consent withdrawn|3|||
48998680|NCT01422876|157829681|FG009|Week 24|Consent withdrawn|6|||
48998681|NCT01422876|157829672|FG000|Week 24|Death|0|||
48998682|NCT01422876|157829673|FG001|Week 24|Death|1|||
48998683|NCT01422876|157829674|FG002|Week 24|Death|0|||
48998684|NCT01422876|157829675|FG003|Week 24|Death|0|||
48998685|NCT01422876|157829676|FG004|Week 24|Death|0|||
48998686|NCT01422876|157829677|FG005|Week 24|Death|0|||
48998687|NCT01422876|157829678|FG006|Week 24|Death|0|||
48998688|NCT01422876|157829679|FG007|Week 24|Death|0|||
48998689|NCT01422876|157829680|FG008|Week 24|Death|0|||
48998690|NCT01422876|157829681|FG009|Week 24|Death|0|||
48998691|NCT01422876|157829672|FG000|Week 52|Lost to Follow-up|3|||
48998692|NCT01422876|157829673|FG001|Week 52|Lost to Follow-up|5|||
48998693|NCT01422876|157829674|FG002|Week 52|Lost to Follow-up|7|||
48998694|NCT01422876|157829675|FG003|Week 52|Lost to Follow-up|5|||
48998695|NCT01422876|157829676|FG004|Week 52|Lost to Follow-up|8|||
48998696|NCT01422876|157829677|FG005|Week 52|Lost to Follow-up|5|||
48998697|NCT01422876|157829678|FG006|Week 52|Lost to Follow-up|5|||
48998698|NCT01422876|157829679|FG007|Week 52|Lost to Follow-up|8|||
48998699|NCT01422876|157829680|FG008|Week 52|Lost to Follow-up|7|||
48998700|NCT01422876|157829681|FG009|Week 52|Lost to Follow-up|8|||
48998701|NCT01422876|157829672|FG000|Week 52|Consent withdrawn|9|||
48998702|NCT01422876|157829673|FG001|Week 52|Consent withdrawn|4|||
48998703|NCT01422876|157829674|FG002|Week 52|Consent withdrawn|6|||
48998704|NCT01422876|157829675|FG003|Week 52|Consent withdrawn|12|||
48998705|NCT01422876|157829676|FG004|Week 52|Consent withdrawn|7|||
48998706|NCT01422876|157829677|FG005|Week 52|Consent withdrawn|12|||
48998707|NCT01422876|157829678|FG006|Week 52|Consent withdrawn|10|||
48998708|NCT01422876|157829679|FG007|Week 52|Consent withdrawn|12|||
48998709|NCT01422876|157829680|FG008|Week 52|Consent withdrawn|13|||
48998710|NCT01422876|157829681|FG009|Week 52|Consent withdrawn|9|||
48998711|NCT01422876|157829672|FG000|Week 52|Death|0|||
48998712|NCT01422876|157829673|FG001|Week 52|Death|1|||
48998713|NCT01422876|157829674|FG002|Week 52|Death|0|||
48998714|NCT01422876|157829675|FG003|Week 52|Death|1|||
48998715|NCT01422876|157829676|FG004|Week 52|Death|0|||
48998716|NCT01422876|157829677|FG005|Week 52|Death|0|||
48998717|NCT01422876|157829678|FG006|Week 52|Death|1|||
48998718|NCT01422876|157829679|FG007|Week 52|Death|3|||
48998719|NCT01422876|157829680|FG008|Week 52|Death|1|||
48998720|NCT01422876|157829681|FG009|Week 52|Death|0|||
48998721|NCT00761761|157829685|FG000|Overall Study|Lost to Follow-up|3|||
48998722|NCT00761761|157829686|FG001|Overall Study|Lost to Follow-up|1|||
48998723|NCT00761761|157829685|FG000|Overall Study|Withdrawal by Subject|3|||
48998724|NCT00761761|157829686|FG001|Overall Study|Withdrawal by Subject|0|||
48998725|NCT00536991|157829688|FG000|Overall Study|Withdrawal by Subject|10|||
48998726|NCT00536991|157829688|FG000|Overall Study|Physician Decision|1|||
48998727|NCT00536991|157829688|FG000|Overall Study|patient ineligible|2|||
48998728|NCT00968539|157829692|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
48998729|NCT00968539|157829693|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
48998730|NCT00396318|157829694|FG000|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5|||
48998731|NCT00326118|157829695|FG000|Active Phase|Withdrawal by Subject|4|||
48998732|NCT00326118|157829696|FG001|Active Phase|Withdrawal by Subject|1|||
48998733|NCT04888377|157829699|FG000|Overall Study|Incomplete Follow-up or No Study Data|1|||
48998734|NCT04888377|157829700|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
48998735|NCT04888377|157829699|FG000|Overall Study|Physician Decision|6|||
48998736|NCT04888377|157829700|FG001|Overall Study|Physician Decision|6|||
48998737|NCT04888377|157829699|FG000|Overall Study|Withdrawal by Subject|7|||
48998738|NCT04888377|157829700|FG001|Overall Study|Withdrawal by Subject|3|||
48998739|NCT05279807|157829701|FG000|Overall Study|Withdrawal by Subject|1|||
48998740|NCT05279807|157829702|FG001|Overall Study|Withdrawal by Subject|0|||
48998741|NCT05279807|157829701|FG000|Overall Study|Adverse Event|0|||
48998742|NCT05279807|157829702|FG001|Overall Study|Adverse Event|1|||
48998743|NCT05279807|157829701|FG000|Overall Study|Laboratory Abnormal Results|1|||
48998744|NCT05279807|157829702|FG001|Overall Study|Laboratory Abnormal Results|0|||
48998745|NCT01826201|157829705|FG000|Overall Study|Non compliance with protocol|4|||
48998746|NCT01615822|157829708|FG000|Period 1|Withdrawal by Subject|0|||
48998747|NCT01615822|157829709|FG001|Period 1|Withdrawal by Subject|1|||
48998748|NCT01615822|157829710|FG002|Period 1|Withdrawal by Subject|0|||
48998749|NCT01615822|157829708|FG000|Period 1|Adverse Event|1|||
48998750|NCT01615822|157829709|FG001|Period 1|Adverse Event|1|||
48998751|NCT01615822|157829710|FG002|Period 1|Adverse Event|0|||
48998752|NCT01615822|157829708|FG000|Period 2|Lost to Follow-up|0|||
48998753|NCT01615822|157829709|FG001|Period 2|Lost to Follow-up|1|||
48998754|NCT01615822|157829710|FG002|Period 2|Lost to Follow-up|2|||
48998755|NCT00539006|157829711|FG000|Pre-treatment|Other|0|||
48998756|NCT00539006|157829712|FG001|Pre-treatment|Other|1|||
48998757|NCT00539006|157829713|FG002|Pre-treatment|Other|0|||
48998758|NCT00539006|157829714|FG003|Pre-treatment|Other|0|||
48998759|NCT00539006|157829711|FG000|Treatment Period 1|Lost to Follow-up|0|||
48998760|NCT00539006|157829712|FG001|Treatment Period 1|Lost to Follow-up|0|||
48998761|NCT00539006|157829713|FG002|Treatment Period 1|Lost to Follow-up|1|||
48998762|NCT00539006|157829714|FG003|Treatment Period 1|Lost to Follow-up|0|||
48998763|NCT00539006|157829711|FG000|Treatment Period 1|Protocol Violation|0|||
48998764|NCT00539006|157829712|FG001|Treatment Period 1|Protocol Violation|0|||
48998765|NCT00539006|157829713|FG002|Treatment Period 1|Protocol Violation|1|||
48998766|NCT00539006|157829714|FG003|Treatment Period 1|Protocol Violation|0|||
48998767|NCT00539006|157829711|FG000|Treatment Period 1|Lack of Efficacy|0|||
48998768|NCT00539006|157829712|FG001|Treatment Period 1|Lack of Efficacy|0|||
48998769|NCT00539006|157829713|FG002|Treatment Period 1|Lack of Efficacy|0|||
48998770|NCT00539006|157829714|FG003|Treatment Period 1|Lack of Efficacy|1|||
48998771|NCT00539006|157829711|FG000|Washout|Adverse Event|2|||
48998772|NCT00539006|157829712|FG001|Washout|Adverse Event|1|||
48998773|NCT00539006|157829713|FG002|Washout|Adverse Event|0|||
48998774|NCT00539006|157829714|FG003|Washout|Adverse Event|0|||
48998775|NCT00539006|157829711|FG000|Washout|Protocol Violation|1|||
48998776|NCT00539006|157829712|FG001|Washout|Protocol Violation|1|||
48998777|NCT00539006|157829713|FG002|Washout|Protocol Violation|0|||
48998778|NCT00539006|157829714|FG003|Washout|Protocol Violation|0|||
48998779|NCT00539006|157829711|FG000|Washout|Withdrawal by Subject|0|||
48998780|NCT00539006|157829712|FG001|Washout|Withdrawal by Subject|2|||
48998781|NCT00539006|157829713|FG002|Washout|Withdrawal by Subject|0|||
48998782|NCT00539006|157829714|FG003|Washout|Withdrawal by Subject|0|||
48998783|NCT00539006|157829711|FG000|Washout|Failed to meet continuation criteria|16|||
48998784|NCT00539006|157829712|FG001|Washout|Failed to meet continuation criteria|5|||
48998785|NCT00539006|157829713|FG002|Washout|Failed to meet continuation criteria|14|||
48998786|NCT00539006|157829714|FG003|Washout|Failed to meet continuation criteria|6|||
48998787|NCT00539006|157829711|FG000|Washout|Other|1|||
48998788|NCT00539006|157829712|FG001|Washout|Other|1|||
48998789|NCT00539006|157829713|FG002|Washout|Other|2|||
48998790|NCT00539006|157829714|FG003|Washout|Other|3|||
48998791|NCT00539006|157829711|FG000|Treatment Period 2|Protocol Violation|1|||
48998792|NCT00539006|157829712|FG001|Treatment Period 2|Protocol Violation|0|||
48998793|NCT00539006|157829713|FG002|Treatment Period 2|Protocol Violation|0|||
48998794|NCT00539006|157829714|FG003|Treatment Period 2|Protocol Violation|0|||
48998795|NCT00539006|157829711|FG000|Treatment Period 2|Other|0|||
48998796|NCT00539006|157829712|FG001|Treatment Period 2|Other|1|||
48998797|NCT00539006|157829713|FG002|Treatment Period 2|Other|0|||
48998798|NCT00539006|157829714|FG003|Treatment Period 2|Other|0|||
48998799|NCT02769832|157829719|FG000|Overall Study|Death|30|||
48998800|NCT00902265|157829722|FG000|Overall Study|Lost to Follow-up Prior to First Visit|1|||
48998801|NCT00902265|157829722|FG000|Overall Study|Adverse Event|2|||
48998802|NCT00902265|157829722|FG000|Overall Study|Lack of Efficacy|2|||
48998803|NCT00902265|157829722|FG000|Overall Study|Protocol Violation|1|||
48998804|NCT04764669|157829727|FG000|Overall Study|Adverse Event|1|||
48998805|NCT04764669|157829728|FG001|Overall Study|Adverse Event|0|||
48998806|NCT04764669|157829729|FG002|Overall Study|Adverse Event|1|||
48998807|NCT04764669|157829730|FG003|Overall Study|Adverse Event|0|||
48998808|NCT04764669|157829727|FG000|Overall Study|Subject Choice|0|||
48998809|NCT04764669|157829728|FG001|Overall Study|Subject Choice|0|||
48998810|NCT04764669|157829729|FG002|Overall Study|Subject Choice|1|||
48998811|NCT04764669|157829730|FG003|Overall Study|Subject Choice|0|||
48998812|NCT04764669|157829727|FG000|Overall Study|Withdrawal by Subject|2|||
48998813|NCT04764669|157829728|FG001|Overall Study|Withdrawal by Subject|0|||
48998814|NCT04764669|157829729|FG002|Overall Study|Withdrawal by Subject|0|||
48998815|NCT04764669|157829730|FG003|Overall Study|Withdrawal by Subject|0|||
48998816|NCT00807040|157829731|FG000|Overall Study|Death|24|||
48998817|NCT00807040|157829732|FG001|Overall Study|Death|29|||
48998818|NCT00807040|157829731|FG000|Overall Study|Withdrawal by Subject|8|||
48998819|NCT00807040|157829732|FG001|Overall Study|Withdrawal by Subject|6|||
48998820|NCT00807040|157829731|FG000|Overall Study|Lost to Follow-up|4|||
48998821|NCT00807040|157829732|FG001|Overall Study|Lost to Follow-up|6|||
48998822|NCT02353572|157829737|FG000|Overall Study|Withdrawal by Subject|1|||
48998823|NCT02353572|157829737|FG000|Overall Study|Study terminated|2|||
48998824|NCT00077766|157829741|FG000|Overall Study|Adverse Event|1|||
48998825|NCT00077766|157829742|FG001|Overall Study|Adverse Event|1|||
48998826|NCT00077766|157829741|FG000|Overall Study|Withdrawal by Subject|4|||
48998827|NCT00077766|157829742|FG001|Overall Study|Withdrawal by Subject|3|||
48998828|NCT00077766|157829741|FG000|Overall Study|Death|12|||
48998829|NCT00077766|157829742|FG001|Overall Study|Death|10|||
48998830|NCT00077766|157829741|FG000|Overall Study|Lost to Follow-up|2|||
48998831|NCT00077766|157829742|FG001|Overall Study|Lost to Follow-up|0|||
48998832|NCT00077766|157829741|FG000|Overall Study|Protocol Violation|1|||
48998833|NCT00077766|157829742|FG001|Overall Study|Protocol Violation|0|||
48998834|NCT00077766|157829741|FG000|Overall Study|Kidney Transplantation|9|||
48998835|NCT00077766|157829742|FG001|Overall Study|Kidney Transplantation|5|||
48998836|NCT00077766|157829741|FG000|Overall Study|Transplantation|5|||
48998837|NCT00077766|157829742|FG001|Overall Study|Transplantation|1|||
48998838|NCT00077766|157829741|FG000|Overall Study|Investigators Discretion|1|||
48998839|NCT00077766|157829742|FG001|Overall Study|Investigators Discretion|0|||
48998840|NCT00077766|157829741|FG000|Overall Study|Participant's decision|1|||
48998841|NCT00077766|157829742|FG001|Overall Study|Participant's decision|0|||
48998842|NCT00077766|157829741|FG000|Overall Study|Dialysis Discontinued|1|||
48998843|NCT00077766|157829742|FG001|Overall Study|Dialysis Discontinued|0|||
48998844|NCT00077766|157829741|FG000|Overall Study|Dialysis|0|||
48998845|NCT00077766|157829742|FG001|Overall Study|Dialysis|1|||
48998846|NCT00077766|157829741|FG000|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0|||
48998847|NCT00077766|157829742|FG001|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1|||
48998848|NCT00077766|157829741|FG000|Overall Study|Started Nocturnal Dialysis|0|||
48998849|NCT00077766|157829742|FG001|Overall Study|Started Nocturnal Dialysis|1|||
48998850|NCT00077766|157829741|FG000|Overall Study|Stop Dialysis|0|||
48998851|NCT00077766|157829742|FG001|Overall Study|Stop Dialysis|1|||
48998852|NCT00077766|157829741|FG000|Overall Study|Participants Vacation|2|||
48998853|NCT00077766|157829742|FG001|Overall Study|Participants Vacation|1|||
48998854|NCT00530621|157829745|FG000|Overall Study|Adverse Event|11|||
48998855|NCT00530621|157829746|FG001|Overall Study|Adverse Event|8|||
48998856|NCT00530621|157829745|FG000|Overall Study|Physician Decision|2|||
48998857|NCT00530621|157829746|FG001|Overall Study|Physician Decision|4|||
48998858|NCT00530621|157829745|FG000|Overall Study|Progressive Disease (PD)|47|||
48998859|NCT00530621|157829746|FG001|Overall Study|Progressive Disease (PD)|40|||
48998860|NCT00530621|157829745|FG000|Overall Study|Sponsor Decision|12|||
48998861|NCT00530621|157829746|FG001|Overall Study|Sponsor Decision|15|||
48998862|NCT00530621|157829745|FG000|Overall Study|Subject Decision|4|||
48998863|NCT00530621|157829746|FG001|Overall Study|Subject Decision|7|||
48998864|NCT00530621|157829745|FG000|Overall Study|Death|3|||
48998865|NCT00530621|157829746|FG001|Overall Study|Death|6|||
48998866|NCT00530621|157829745|FG000|Overall Study|Not Treated Due to PD Prior to Dosing|1|||
48998867|NCT00530621|157829746|FG001|Overall Study|Not Treated Due to PD Prior to Dosing|0|||
48998868|NCT02596009|157829747|FG000|Overall Study|Administrative problems|0|||
48998869|NCT02596009|157829748|FG001|Overall Study|Administrative problems|1|||
48998870|NCT02596009|157829749|FG002|Overall Study|Administrative problems|0|||
48998871|NCT02596009|157829750|FG003|Overall Study|Administrative problems|0|||
48998872|NCT02596009|157829751|FG004|Overall Study|Administrative problems|0|||
48998873|NCT02596009|157829752|FG005|Overall Study|Administrative problems|0|||
48998874|NCT00518011|157829753|FG000|Overall Study|Death|1|||
48998875|NCT00518011|157829754|FG001|Overall Study|Death|1|||
48998876|NCT00518011|157829753|FG000|Overall Study|Adverse Event|2|||
48998877|NCT00518011|157829754|FG001|Overall Study|Adverse Event|3|||
48998878|NCT00518011|157829753|FG000|Overall Study|Disease Progression|2|||
48998879|NCT00518011|157829754|FG001|Overall Study|Disease Progression|2|||
48998880|NCT00518011|157829753|FG000|Overall Study|Other Reasons|3|||
48998881|NCT00518011|157829754|FG001|Overall Study|Other Reasons|2|||
48998882|NCT00518011|157829753|FG000|Overall Study|Withdrawal by Subject|1|||
48998883|NCT00518011|157829754|FG001|Overall Study|Withdrawal by Subject|0|||
48998884|NCT03409328|157829755|FG000|Overall Study|Lost to Follow-up|6|||
48998885|NCT03409328|157829756|FG001|Overall Study|Lost to Follow-up|3|||
48998886|NCT00090259|157829757|FG000|Overall Study|Lost to Follow-up|30|||
48998887|NCT00090259|157829758|FG001|Overall Study|Lost to Follow-up|26|||
48998888|NCT00090259|157829757|FG000|Overall Study|Withdrawal by Subject|21|||
48998889|NCT00090259|157829758|FG001|Overall Study|Withdrawal by Subject|15|||
48998890|NCT00090259|157829757|FG000|Overall Study|Investigator site closed|11|||
48998891|NCT00090259|157829758|FG001|Overall Study|Investigator site closed|7|||
48998892|NCT04611152|157829771|FG000|Overall Study|Adverse Event|9|||
48998893|NCT04611152|157829772|FG001|Overall Study|Adverse Event|8|||
48998894|NCT04611152|157829771|FG000|Overall Study|Non-compliance with study schedule|1|||
48998895|NCT04611152|157829772|FG001|Overall Study|Non-compliance with study schedule|3|||
48998896|NCT04611152|157829771|FG000|Overall Study|Withdrawal by Subject|5|||
48998897|NCT04611152|157829772|FG001|Overall Study|Withdrawal by Subject|6|||
48998898|NCT04611152|157829771|FG000|Overall Study|Lost to Follow-up|11|||
48998899|NCT04611152|157829772|FG001|Overall Study|Lost to Follow-up|2|||
48998900|NCT04456998|157829773|FG000|Overall Study|Adverse Event|0|||
48998901|NCT04456998|157829774|FG001|Overall Study|Adverse Event|4|||
48998902|NCT04456998|157829773|FG000|Overall Study|Protocol Deviation|0|||
48998903|NCT04456998|157829774|FG001|Overall Study|Protocol Deviation|1|||
48998904|NCT04456998|157829773|FG000|Overall Study|Withdrawal by Subject|0|||
48998905|NCT04456998|157829774|FG001|Overall Study|Withdrawal by Subject|1|||
48998906|NCT03940742|157829775|FG000|Overall Study|Lost to Follow-up|0|||
48998907|NCT03940742|157829776|FG001|Overall Study|Lost to Follow-up|0|||
48998908|NCT03940742|157829777|FG002|Overall Study|Lost to Follow-up|0|||
48998909|NCT03940742|157829778|FG003|Overall Study|Lost to Follow-up|1|||
48998910|NCT03075215|157829783|FG000|12-Month Primary Endpoint|Death|152|||
48998911|NCT03075215|157829783|FG000|12-Month Primary Endpoint|Withdrawal by Subject|267|||
48998912|NCT03075215|157829783|FG000|Post Market Clinical Follow-Up ONLY|Death|15|||
48998913|NCT03075215|157829783|FG000|Post Market Clinical Follow-Up ONLY|Withdrawal by Subject|25|||
48998914|NCT03353415|157829784|FG000|Masked CGM Wear|Lost to Follow-up|2|||
48998915|NCT03353415|157829784|FG000|Unmasked CGM Wear|Excluded due to missing data.|1|||
48998916|NCT02395536|157829793|FG000|Overall Study|Lost to Follow-up|4|||
48998917|NCT02395536|157829794|FG001|Overall Study|Lost to Follow-up|4|||
48998918|NCT02395536|157829793|FG000|Overall Study|Death|2|||
48998919|NCT02395536|157829794|FG001|Overall Study|Death|0|||
48998920|NCT02395536|157829793|FG000|Overall Study|Physician Decision|4|||
48998921|NCT02395536|157829794|FG001|Overall Study|Physician Decision|6|||
48998922|NCT02395536|157829793|FG000|Overall Study|Withdrawal by Subject|9|||
48998923|NCT02395536|157829794|FG001|Overall Study|Withdrawal by Subject|17|||
48998924|NCT02395536|157829793|FG000|Overall Study|Inclusion/Excusion Criteria Violation|1|||
48998925|NCT02395536|157829794|FG001|Overall Study|Inclusion/Excusion Criteria Violation|2|||
48998926|NCT02395536|157829793|FG000|Overall Study|Insurance issue|0|||
48998927|NCT02395536|157829794|FG001|Overall Study|Insurance issue|1|||
48998928|NCT01600755|157831592|FG000|Overall Study|Withdrawal by Subject|6|||
48998929|NCT00457249|157831599|FG000|Overall Study|Lost to Follow-up|3|||
48998930|NCT00457249|157831600|FG001|Overall Study|Lost to Follow-up|0|||
48998931|NCT00457249|157831599|FG000|Overall Study|Protocol Violation|4|||
48998932|NCT00457249|157831600|FG001|Overall Study|Protocol Violation|1|||
48998933|NCT00457249|157831599|FG000|Overall Study|Withdrawal by Subject|3|||
48998934|NCT00457249|157831600|FG001|Overall Study|Withdrawal by Subject|1|||
48998935|NCT00457249|157831599|FG000|Overall Study|Serious Adverse Events|2|||
48998936|NCT00457249|157831600|FG001|Overall Study|Serious Adverse Events|0|||
48998937|NCT01808508|157831601|FG000|Overall Study|Lost to Follow-up|1|||
48998938|NCT01808508|157831602|FG001|Overall Study|Lost to Follow-up|0|||
48998939|NCT01808508|157831603|FG002|Overall Study|Lost to Follow-up|0|||
48998940|NCT01118949|157831604|FG000|Overall Study|Adverse Event|5|||
48998941|NCT01118949|157831604|FG000|Overall Study|Withdrawal by Subject|4|||
48998942|NCT04621227|157831605|FG000|Period 3 (29 Days)|Physician decision due to inappropriate behavior and noncompliance|1|||
48998943|NCT04621227|157831605|FG000|Period 3 (29 Days)|Adverse Event|1|||
48998944|NCT04621227|157831605|FG000|Period 8 (2 Days)|Adverse Event|1|||
48998945|NCT01548573|157831606|FG000|Overall Study|Death|3|||
48998946|NCT01548573|157831606|FG000|Overall Study|Withdrawal by Subject|2|||
48998947|NCT02916056|157831617|FG000|Overall Study|Adverse Event|6|||
48998948|NCT02916056|157831617|FG000|Overall Study|Lost to Follow-up|1|||
48998949|NCT02916056|157831617|FG000|Overall Study|Other|12|||
48998950|NCT02916056|157831617|FG000|Overall Study|Protocol Violation|1|||
48998951|NCT02916056|157831617|FG000|Overall Study|Withdrawal by Subject|8|||
48998952|NCT02916056|157831617|FG000|Overall Study|Study Terminated by Sponsor|269|||
48998953|NCT00290511|157831618|FG000|Overall Study|Adverse Event|1|||
48998954|NCT00290511|157831618|FG000|Overall Study|Death|1|||
48998955|NCT00290511|157831618|FG000|Overall Study|Physician Decision|1|||
48998956|NCT00290511|157831618|FG000|Overall Study|Withdrawal by Subject|1|||
48998957|NCT00124709|157831619|FG000|Overall Study|Randomized but did not take medication|3|||
48998958|NCT00124709|157831620|FG001|Overall Study|Randomized but did not take medication|1|||
48998959|NCT00124709|157831619|FG000|Overall Study|Adverse Event|3|||
48998960|NCT00124709|157831620|FG001|Overall Study|Adverse Event|0|||
48998961|NCT00124709|157831619|FG000|Overall Study|Lack of Efficacy|5|||
48998962|NCT00124709|157831620|FG001|Overall Study|Lack of Efficacy|10|||
48998963|NCT00124709|157831619|FG000|Overall Study|Protocol Violation|3|||
48998964|NCT00124709|157831620|FG001|Overall Study|Protocol Violation|5|||
48998965|NCT00124709|157831619|FG000|Overall Study|Withdrawal by Subject|127|||
48998966|NCT00124709|157831620|FG001|Overall Study|Withdrawal by Subject|136|||
48998967|NCT00124709|157831619|FG000|Overall Study|Lost to Follow-up|114|||
48998968|NCT00124709|157831620|FG001|Overall Study|Lost to Follow-up|120|||
48998969|NCT00122954|157831621|FG000|Overall Study|Withdrawal by Subject|2|||
48998970|NCT00122954|157831622|FG001|Overall Study|Withdrawal by Subject|2|||
48998971|NCT00122954|157831621|FG000|Overall Study|Protocol Violation|0|||
48998972|NCT00122954|157831622|FG001|Overall Study|Protocol Violation|1|||
48998973|NCT03255226|157831623|FG000|Overall Study|Adverse Event|2|||
48998974|NCT03255226|157831623|FG000|Overall Study|Physician Decision|3|||
48998975|NCT03255226|157831623|FG000|Overall Study|Withdrawal by Subject|1|||
48998976|NCT03255226|157831623|FG000|Overall Study|Serum or blood sodium increased|4|||
48998977|NCT03255226|157831623|FG000|Overall Study|Serum or blood potassium increased|4|||
48998978|NCT01017731|157831624|FG000|Overall Study|Lost to Follow-up|2|||
48998979|NCT01017731|157831624|FG000|Overall Study|Withdrawal by Subject|3|||
48998980|NCT01017731|157831624|FG000|Overall Study|Physician Decision|2|||
48998981|NCT01017731|157831624|FG000|Overall Study|Adverse Event|1|||
48998982|NCT01035229|157831625|FG000|Overall Study|Adverse Event|61|||
48998983|NCT01035229|157831626|FG001|Overall Study|Adverse Event|14|||
48998984|NCT01035229|157831625|FG000|Overall Study|Withdrawal by Subject|20|||
48998985|NCT01035229|157831626|FG001|Overall Study|Withdrawal by Subject|7|||
48998986|NCT01035229|157831625|FG000|Overall Study|Lost to Follow-up|1|||
48998987|NCT01035229|157831626|FG001|Overall Study|Lost to Follow-up|0|||
48998988|NCT01035229|157831625|FG000|Overall Study|Administrative problems|1|||
48998989|NCT01035229|157831626|FG001|Overall Study|Administrative problems|1|||
48998990|NCT01035229|157831625|FG000|Overall Study|Death|13|||
48998991|NCT01035229|157831626|FG001|Overall Study|Death|5|||
48998992|NCT01035229|157831625|FG000|Overall Study|New cancer therapy|2|||
48998993|NCT01035229|157831626|FG001|Overall Study|New cancer therapy|0|||
48998994|NCT01035229|157831625|FG000|Overall Study|Protocol Violation|0|||
48998995|NCT01035229|157831626|FG001|Overall Study|Protocol Violation|2|||
48998996|NCT01035229|157831625|FG000|Overall Study|Sponsor's decision to end study|3|||
48998997|NCT01035229|157831626|FG001|Overall Study|Sponsor's decision to end study|3|||
48998998|NCT01035229|157831625|FG000|Overall Study|Disease Progression|261|||
48998999|NCT01035229|157831626|FG001|Overall Study|Disease Progression|152|||
48999000|NCT00558831|157831629|FG000|Overall Study|Lost to Follow-up|1|||
48999001|NCT01741259|157831636|FG000|Overall Study|Protocol Violation|6|||
48999002|NCT01741259|157831637|FG001|Overall Study|Protocol Violation|4|||
48999003|NCT01741259|157831636|FG000|Overall Study|Withdrawal by Subject|0|||
48999004|NCT01741259|157831637|FG001|Overall Study|Withdrawal by Subject|2|||
48999005|NCT04285983|157831648|FG000|Overall Study|Protocol Violation|6|||
48999006|NCT04936334|157831649|FG000|Overall Study|Metastatic disease found on PSMA-PET, surgery cancelled|1|||
48999007|NCT03205046|157831650|FG000|Overall Study|Death|10|||
48999008|NCT03205046|157831651|FG001|Overall Study|Death|6|||
48999009|NCT03205046|157831650|FG000|Overall Study|Withdrawal by Subject|1|||
48999010|NCT03205046|157831651|FG001|Overall Study|Withdrawal by Subject|2|||
48999011|NCT03205046|157831650|FG000|Overall Study|Lost to Follow-up|0|||
48999012|NCT03205046|157831651|FG001|Overall Study|Lost to Follow-up|1|||
48999013|NCT03205046|157831650|FG000|Overall Study|Study terminated by sponsor|2|||
48999014|NCT03205046|157831651|FG001|Overall Study|Study terminated by sponsor|1|||
48999015|NCT03253809|157831654|FG000|Overall Study|Unable to obtain study related data|14|||
48999016|NCT01068418|157831655|FG000|Overall Study|Physician Decision|12|||
48999017|NCT00433771|157831658|FG000|Overall Study|screen fail|14|||
48999018|NCT00433771|157831658|FG000|Overall Study|Treated and later found to be ineligible|2|||
48999019|NCT00433771|157831658|FG000|Overall Study|Death|2|||
48999020|NCT00433771|157831658|FG000|Overall Study|Failure to deploy stent|1|||
48999021|NCT02871921|157831659|FG000|Overall Study|Withdrawal by Subject|34|||
48999022|NCT02871921|157831660|FG001|Overall Study|Withdrawal by Subject|27|||
48999023|NCT02871921|157831661|FG002|Overall Study|Withdrawal by Subject|27|||
48999024|NCT02871921|157831662|FG003|Overall Study|Withdrawal by Subject|30|||
48999025|NCT04637815|157831666|FG000|Overall Study|Death|1|||
48999026|NCT04637815|157831667|FG001|Overall Study|Death|0|||
48999027|NCT04637815|157831666|FG000|Overall Study|Lost to Follow-up|5|||
48999028|NCT04637815|157831667|FG001|Overall Study|Lost to Follow-up|2|||
48999029|NCT00337727|157831668|FG000|Overall Study|Adverse Event|5|||
48999030|NCT00337727|157831669|FG001|Overall Study|Adverse Event|3|||
48999031|NCT00337727|157831668|FG000|Overall Study|Lost to Follow-up|5|||
48999032|NCT00337727|157831669|FG001|Overall Study|Lost to Follow-up|4|||
48999033|NCT00337727|157831668|FG000|Overall Study|Physician Decision|1|||
48999034|NCT00337727|157831669|FG001|Overall Study|Physician Decision|0|||
48999035|NCT00337727|157831668|FG000|Overall Study|Protocol Violation|4|||
48999036|NCT00337727|157831669|FG001|Overall Study|Protocol Violation|0|||
48999037|NCT00337727|157831668|FG000|Overall Study|Withdrawal by Subject|3|||
48999038|NCT00337727|157831669|FG001|Overall Study|Withdrawal by Subject|5|||
48999039|NCT01965431|157831670|FG000|Overall Study|Adverse Event|0|||
48999040|NCT01965431|157831671|FG001|Overall Study|Adverse Event|1|||
48999041|NCT01965431|157831672|FG002|Overall Study|Adverse Event|0|||
48999042|NCT01965431|157831673|FG003|Overall Study|Adverse Event|0|||
48999043|NCT01965431|157831674|FG004|Overall Study|Adverse Event|0|||
48999044|NCT01965431|157831675|FG005|Overall Study|Adverse Event|0|||
48999045|NCT01965431|157831670|FG000|Overall Study|Other than stated above|6|||
48999046|NCT01965431|157831671|FG001|Overall Study|Other than stated above|5|||
48999047|NCT01965431|157831672|FG002|Overall Study|Other than stated above|6|||
48999048|NCT01965431|157831673|FG003|Overall Study|Other than stated above|6|||
48999049|NCT01965431|157831674|FG004|Overall Study|Other than stated above|6|||
48999050|NCT01965431|157831675|FG005|Overall Study|Other than stated above|6|||
48999051|NCT00577031|157831677|FG000|Overall Study|Adverse Event|52|||
48999052|NCT00577031|157831677|FG000|Overall Study|Progression of disease|93|||
48999053|NCT00577031|157831677|FG000|Overall Study|Protocol Violation|5|||
48999054|NCT00577031|157831677|FG000|Overall Study|Participant withdrew consent|13|||
48999055|NCT00577031|157831677|FG000|Overall Study|Participant non-compliance|5|||
48999056|NCT00577031|157831677|FG000|Overall Study|Need for surgery|17|||
48999057|NCT00577031|157831677|FG000|Overall Study|Medical decision|14|||
48999058|NCT00577031|157831677|FG000|Overall Study|Death|6|||
48999059|NCT03707145|157831684|FG000|Overall Study|Lost to Follow-up|0|||
48999060|NCT03707145|157831685|FG001|Overall Study|Lost to Follow-up|1|||
48999061|NCT03707145|157831686|FG002|Overall Study|Lost to Follow-up|1|||
48999062|NCT03707145|157831687|FG003|Overall Study|Lost to Follow-up|0|||
48999063|NCT03917654|157831688|FG000|Year 1|Withdrawal by Subject|1|||
48999064|NCT03917654|157831689|FG001|Year 1|Withdrawal by Subject|0|||
48999065|NCT03917654|157831690|FG002|Year 1|Withdrawal by Subject|0|||
48999066|NCT03917654|157831691|FG003|Year 1|Withdrawal by Subject|0|||
48999067|NCT03917654|157831692|FG004|Year 1|Withdrawal by Subject|0|||
48999068|NCT03917654|157831693|FG005|Year 1|Withdrawal by Subject|1|||
48999069|NCT03917654|157831694|FG006|Year 1|Withdrawal by Subject|6|||
48999070|NCT03917654|157831695|FG007|Year 1|Withdrawal by Subject|2|||
48999071|NCT03917654|157831696|FG008|Year 1|Withdrawal by Subject|5|||
48999072|NCT03917654|157831697|FG009|Year 1|Withdrawal by Subject|3|||
48999073|NCT03917654|157831698|FG010|Year 1|Withdrawal by Subject|1|||
48999074|NCT03917654|157831699|FG011|Year 1|Withdrawal by Subject|0|||
48999075|NCT03917654|157831688|FG000|Year 1|Travel|0|||
48999076|NCT03917654|157831689|FG001|Year 1|Travel|1|||
48999077|NCT03917654|157831690|FG002|Year 1|Travel|1|||
48999078|NCT03917654|157831691|FG003|Year 1|Travel|0|||
48999079|NCT03917654|157831692|FG004|Year 1|Travel|4|||
48999080|NCT03917654|157831693|FG005|Year 1|Travel|4|||
48999081|NCT03917654|157831694|FG006|Year 1|Travel|10|||
48999082|NCT03917654|157831695|FG007|Year 1|Travel|8|||
48999083|NCT03917654|157831696|FG008|Year 1|Travel|2|||
48999084|NCT03917654|157831697|FG009|Year 1|Travel|5|||
48999085|NCT03917654|157831698|FG010|Year 1|Travel|3|||
48999086|NCT03917654|157831699|FG011|Year 1|Travel|3|||
48999087|NCT03917654|157831688|FG000|Year 1|Subject moved away from site|0|||
48999088|NCT03917654|157831689|FG001|Year 1|Subject moved away from site|1|||
48999089|NCT03917654|157831690|FG002|Year 1|Subject moved away from site|0|||
48999090|NCT03917654|157831691|FG003|Year 1|Subject moved away from site|0|||
48999091|NCT03917654|157831692|FG004|Year 1|Subject moved away from site|0|||
48999092|NCT03917654|157831693|FG005|Year 1|Subject moved away from site|0|||
48999093|NCT03917654|157831694|FG006|Year 1|Subject moved away from site|1|||
48999094|NCT03917654|157831695|FG007|Year 1|Subject moved away from site|2|||
48999095|NCT03917654|157831696|FG008|Year 1|Subject moved away from site|1|||
48999096|NCT03917654|157831697|FG009|Year 1|Subject moved away from site|0|||
48999097|NCT03917654|157831698|FG010|Year 1|Subject moved away from site|0|||
48999098|NCT03917654|157831699|FG011|Year 1|Subject moved away from site|3|||
48999099|NCT03917654|157831688|FG000|Year 1|Spouse/Family member request|0|||
48999100|NCT03917654|157831689|FG001|Year 1|Spouse/Family member request|0|||
48999101|NCT03917654|157831690|FG002|Year 1|Spouse/Family member request|1|||
48999102|NCT03917654|157831691|FG003|Year 1|Spouse/Family member request|0|||
48999103|NCT03917654|157831692|FG004|Year 1|Spouse/Family member request|1|||
48999104|NCT03917654|157831693|FG005|Year 1|Spouse/Family member request|0|||
48999105|NCT03917654|157831694|FG006|Year 1|Spouse/Family member request|0|||
48999106|NCT03917654|157831695|FG007|Year 1|Spouse/Family member request|2|||
48999107|NCT03917654|157831696|FG008|Year 1|Spouse/Family member request|0|||
48999108|NCT03917654|157831697|FG009|Year 1|Spouse/Family member request|0|||
48999109|NCT03917654|157831698|FG010|Year 1|Spouse/Family member request|0|||
48999110|NCT03917654|157831699|FG011|Year 1|Spouse/Family member request|1|||
48999111|NCT03917654|157831688|FG000|Year 1|Death|0|||
48999112|NCT03917654|157831689|FG001|Year 1|Death|0|||
48999113|NCT03917654|157831690|FG002|Year 1|Death|0|||
48999114|NCT03917654|157831691|FG003|Year 1|Death|0|||
48999115|NCT03917654|157831692|FG004|Year 1|Death|0|||
48999116|NCT03917654|157831693|FG005|Year 1|Death|0|||
48999117|NCT03917654|157831694|FG006|Year 1|Death|0|||
48999118|NCT03917654|157831695|FG007|Year 1|Death|0|||
48999119|NCT03917654|157831696|FG008|Year 1|Death|1|||
48999120|NCT03917654|157831697|FG009|Year 1|Death|1|||
48999121|NCT03917654|157831698|FG010|Year 1|Death|0|||
48999122|NCT03917654|157831699|FG011|Year 1|Death|0|||
48999123|NCT03917654|157831688|FG000|Year 1|Lost to Follow-up|0|||
48999124|NCT03917654|157831689|FG001|Year 1|Lost to Follow-up|0|||
48999125|NCT03917654|157831690|FG002|Year 1|Lost to Follow-up|0|||
48999126|NCT03917654|157831691|FG003|Year 1|Lost to Follow-up|0|||
48999127|NCT03917654|157831692|FG004|Year 1|Lost to Follow-up|0|||
48999128|NCT03917654|157831693|FG005|Year 1|Lost to Follow-up|0|||
48999129|NCT03917654|157831694|FG006|Year 1|Lost to Follow-up|2|||
48999130|NCT03917654|157831695|FG007|Year 1|Lost to Follow-up|0|||
48999131|NCT03917654|157831696|FG008|Year 1|Lost to Follow-up|0|||
48999132|NCT03917654|157831697|FG009|Year 1|Lost to Follow-up|0|||
48999133|NCT03917654|157831698|FG010|Year 1|Lost to Follow-up|0|||
48999134|NCT03917654|157831699|FG011|Year 1|Lost to Follow-up|0|||
48999135|NCT03917654|157831688|FG000|Year 1|Missed visits|0|||
48999136|NCT03917654|157831689|FG001|Year 1|Missed visits|0|||
48999137|NCT03917654|157831690|FG002|Year 1|Missed visits|0|||
48999138|NCT03917654|157831691|FG003|Year 1|Missed visits|0|||
48999139|NCT03917654|157831692|FG004|Year 1|Missed visits|0|||
48999140|NCT03917654|157831693|FG005|Year 1|Missed visits|0|||
48999141|NCT03917654|157831694|FG006|Year 1|Missed visits|0|||
48999142|NCT03917654|157831695|FG007|Year 1|Missed visits|0|||
48999143|NCT03917654|157831696|FG008|Year 1|Missed visits|0|||
48999144|NCT03917654|157831697|FG009|Year 1|Missed visits|0|||
48999145|NCT03917654|157831698|FG010|Year 1|Missed visits|1|||
48999146|NCT03917654|157831699|FG011|Year 1|Missed visits|1|||
48999147|NCT03917654|157831688|FG000|Year 1|Pregnancy|0|||
48999148|NCT03917654|157831689|FG001|Year 1|Pregnancy|0|||
48999149|NCT03917654|157831690|FG002|Year 1|Pregnancy|0|||
48999150|NCT03917654|157831691|FG003|Year 1|Pregnancy|0|||
48999151|NCT03917654|157831692|FG004|Year 1|Pregnancy|0|||
48999152|NCT03917654|157831693|FG005|Year 1|Pregnancy|0|||
48999153|NCT03917654|157831694|FG006|Year 1|Pregnancy|0|||
48999154|NCT03917654|157831695|FG007|Year 1|Pregnancy|1|||
48999155|NCT03917654|157831696|FG008|Year 1|Pregnancy|0|||
48999156|NCT03917654|157831697|FG009|Year 1|Pregnancy|1|||
48999157|NCT03917654|157831698|FG010|Year 1|Pregnancy|0|||
48999158|NCT03917654|157831699|FG011|Year 1|Pregnancy|0|||
48999159|NCT03917654|157831688|FG000|Year 2|Travel|1|||
48999160|NCT03917654|157831689|FG001|Year 2|Travel|0|||
48999161|NCT03917654|157831690|FG002|Year 2|Travel|0|||
48999162|NCT03917654|157831691|FG003|Year 2|Travel|0|||
48999163|NCT03917654|157831692|FG004|Year 2|Travel|1|||
48999164|NCT03917654|157831693|FG005|Year 2|Travel|1|||
48999165|NCT03917654|157831694|FG006|Year 2|Travel|2|||
48999166|NCT03917654|157831695|FG007|Year 2|Travel|1|||
48999167|NCT03917654|157831696|FG008|Year 2|Travel|0|||
48999168|NCT03917654|157831697|FG009|Year 2|Travel|1|||
48999169|NCT03917654|157831698|FG010|Year 2|Travel|0|||
48999170|NCT03917654|157831699|FG011|Year 2|Travel|1|||
48999171|NCT03917654|157831688|FG000|Year 2|Married|1|||
48999172|NCT03917654|157831689|FG001|Year 2|Married|0|||
48999173|NCT03917654|157831690|FG002|Year 2|Married|0|||
48999174|NCT03917654|157831691|FG003|Year 2|Married|0|||
48999175|NCT03917654|157831692|FG004|Year 2|Married|0|||
48999176|NCT03917654|157831693|FG005|Year 2|Married|0|||
48999177|NCT03917654|157831694|FG006|Year 2|Married|1|||
48999178|NCT03917654|157831695|FG007|Year 2|Married|1|||
48999179|NCT03917654|157831696|FG008|Year 2|Married|0|||
48999180|NCT03917654|157831697|FG009|Year 2|Married|0|||
48999181|NCT03917654|157831698|FG010|Year 2|Married|0|||
48999182|NCT03917654|157831699|FG011|Year 2|Married|0|||
48999183|NCT03917654|157831688|FG000|Year 2|Subject moved away from site|1|||
48999184|NCT03917654|157831689|FG001|Year 2|Subject moved away from site|0|||
48999185|NCT03917654|157831690|FG002|Year 2|Subject moved away from site|0|||
48999186|NCT03917654|157831691|FG003|Year 2|Subject moved away from site|0|||
48999187|NCT03917654|157831692|FG004|Year 2|Subject moved away from site|1|||
48999188|NCT03917654|157831693|FG005|Year 2|Subject moved away from site|0|||
48999189|NCT03917654|157831694|FG006|Year 2|Subject moved away from site|2|||
48999190|NCT03917654|157831695|FG007|Year 2|Subject moved away from site|3|||
48999191|NCT03917654|157831696|FG008|Year 2|Subject moved away from site|0|||
48999192|NCT03917654|157831697|FG009|Year 2|Subject moved away from site|2|||
48999193|NCT03917654|157831698|FG010|Year 2|Subject moved away from site|0|||
48999194|NCT03917654|157831699|FG011|Year 2|Subject moved away from site|1|||
48999195|NCT03917654|157831688|FG000|Year 2|Year 2 Screening failure|0|||
48999196|NCT03917654|157831689|FG001|Year 2|Year 2 Screening failure|1|||
48999197|NCT03917654|157831690|FG002|Year 2|Year 2 Screening failure|0|||
48999198|NCT03917654|157831691|FG003|Year 2|Year 2 Screening failure|0|||
48999199|NCT03917654|157831692|FG004|Year 2|Year 2 Screening failure|2|||
48999200|NCT03917654|157831693|FG005|Year 2|Year 2 Screening failure|0|||
48999201|NCT03917654|157831694|FG006|Year 2|Year 2 Screening failure|4|||
48999202|NCT03917654|157831695|FG007|Year 2|Year 2 Screening failure|3|||
48999203|NCT03917654|157831696|FG008|Year 2|Year 2 Screening failure|10|||
48999204|NCT03917654|157831697|FG009|Year 2|Year 2 Screening failure|2|||
48999205|NCT03917654|157831698|FG010|Year 2|Year 2 Screening failure|1|||
48999206|NCT03917654|157831699|FG011|Year 2|Year 2 Screening failure|1|||
48999207|NCT03917654|157831688|FG000|Year 2|Death|0|||
48999208|NCT03917654|157831689|FG001|Year 2|Death|0|||
48999209|NCT03917654|157831690|FG002|Year 2|Death|0|||
48999210|NCT03917654|157831691|FG003|Year 2|Death|0|||
48999211|NCT03917654|157831692|FG004|Year 2|Death|0|||
48999212|NCT03917654|157831693|FG005|Year 2|Death|1|||
48999213|NCT03917654|157831694|FG006|Year 2|Death|0|||
48999214|NCT03917654|157831695|FG007|Year 2|Death|0|||
48999215|NCT03917654|157831696|FG008|Year 2|Death|1|||
48999216|NCT03917654|157831697|FG009|Year 2|Death|1|||
48999217|NCT03917654|157831698|FG010|Year 2|Death|0|||
48999218|NCT03917654|157831699|FG011|Year 2|Death|0|||
48999219|NCT03917654|157831688|FG000|Year 2|Withdrawal by Subject|0|||
48999220|NCT03917654|157831689|FG001|Year 2|Withdrawal by Subject|0|||
48999221|NCT03917654|157831690|FG002|Year 2|Withdrawal by Subject|0|||
48999222|NCT03917654|157831691|FG003|Year 2|Withdrawal by Subject|0|||
48999223|NCT03917654|157831692|FG004|Year 2|Withdrawal by Subject|0|||
48999224|NCT03917654|157831693|FG005|Year 2|Withdrawal by Subject|0|||
48999225|NCT03917654|157831694|FG006|Year 2|Withdrawal by Subject|3|||
48999226|NCT03917654|157831695|FG007|Year 2|Withdrawal by Subject|0|||
48999227|NCT03917654|157831696|FG008|Year 2|Withdrawal by Subject|2|||
48999228|NCT03917654|157831697|FG009|Year 2|Withdrawal by Subject|5|||
48999229|NCT03917654|157831698|FG010|Year 2|Withdrawal by Subject|0|||
48999230|NCT03917654|157831699|FG011|Year 2|Withdrawal by Subject|0|||
48999231|NCT03917654|157831688|FG000|Year 2|Spouse/family member request|0|||
48999232|NCT03917654|157831689|FG001|Year 2|Spouse/family member request|0|||
48999233|NCT03917654|157831690|FG002|Year 2|Spouse/family member request|0|||
48999234|NCT03917654|157831691|FG003|Year 2|Spouse/family member request|0|||
48999235|NCT03917654|157831692|FG004|Year 2|Spouse/family member request|0|||
48999236|NCT03917654|157831693|FG005|Year 2|Spouse/family member request|0|||
48999237|NCT03917654|157831694|FG006|Year 2|Spouse/family member request|1|||
48999238|NCT03917654|157831695|FG007|Year 2|Spouse/family member request|0|||
48999239|NCT03917654|157831696|FG008|Year 2|Spouse/family member request|0|||
48999240|NCT03917654|157831697|FG009|Year 2|Spouse/family member request|0|||
48999241|NCT03917654|157831698|FG010|Year 2|Spouse/family member request|0|||
48999242|NCT03917654|157831699|FG011|Year 2|Spouse/family member request|0|||
48999243|NCT03917654|157831688|FG000|Year 2|Lost to Follow-up|0|||
48999244|NCT03917654|157831689|FG001|Year 2|Lost to Follow-up|0|||
48999245|NCT03917654|157831690|FG002|Year 2|Lost to Follow-up|0|||
48999246|NCT03917654|157831691|FG003|Year 2|Lost to Follow-up|0|||
48999247|NCT03917654|157831692|FG004|Year 2|Lost to Follow-up|0|||
48999248|NCT03917654|157831693|FG005|Year 2|Lost to Follow-up|0|||
48999249|NCT03917654|157831694|FG006|Year 2|Lost to Follow-up|1|||
48999250|NCT03917654|157831695|FG007|Year 2|Lost to Follow-up|0|||
48999251|NCT03917654|157831696|FG008|Year 2|Lost to Follow-up|1|||
48999252|NCT03917654|157831697|FG009|Year 2|Lost to Follow-up|0|||
48999253|NCT03917654|157831698|FG010|Year 2|Lost to Follow-up|0|||
48999254|NCT03917654|157831699|FG011|Year 2|Lost to Follow-up|1|||
48999255|NCT03917654|157831688|FG000|Year 2|Adverse Event|0|||
48999256|NCT03917654|157831689|FG001|Year 2|Adverse Event|0|||
48999257|NCT03917654|157831690|FG002|Year 2|Adverse Event|0|||
48999258|NCT03917654|157831691|FG003|Year 2|Adverse Event|0|||
48999259|NCT03917654|157831692|FG004|Year 2|Adverse Event|0|||
48999260|NCT03917654|157831693|FG005|Year 2|Adverse Event|0|||
48999261|NCT03917654|157831694|FG006|Year 2|Adverse Event|0|||
48999262|NCT03917654|157831695|FG007|Year 2|Adverse Event|0|||
48999263|NCT03917654|157831696|FG008|Year 2|Adverse Event|0|||
48999264|NCT03917654|157831697|FG009|Year 2|Adverse Event|1|||
48999265|NCT03917654|157831698|FG010|Year 2|Adverse Event|0|||
48999266|NCT03917654|157831699|FG011|Year 2|Adverse Event|0|||
48999267|NCT04513665|157831701|FG000|Overall Study|Adverse Event|2|||
48999268|NCT04513665|157831702|FG001|Overall Study|Adverse Event|0|||
49045842|NCT02300987|158002027|FG001|Primary Phase : Prior to Cross-over|Physician Decision|0|||
48999269|NCT04513665|157831701|FG000|Overall Study|Lack of Efficacy|14|||
48999270|NCT04513665|157831702|FG001|Overall Study|Lack of Efficacy|0|||
48999271|NCT00621309|157831703|FG000|Overall Study|Withdrawal by Subject|2|||
48999272|NCT00621309|157831704|FG001|Overall Study|Withdrawal by Subject|0|||
48999273|NCT00621309|157831705|FG002|Overall Study|Withdrawal by Subject|1|||
48999274|NCT00621309|157831706|FG003|Overall Study|Withdrawal by Subject|1|||
48999275|NCT00621309|157831707|FG004|Overall Study|Withdrawal by Subject|1|||
48999276|NCT00621309|157831708|FG005|Overall Study|Withdrawal by Subject|1|||
48999277|NCT03252015|157831709|FG000|Overall Study|Withdrawal by Subject|0|||
48999278|NCT03252015|157831710|FG001|Overall Study|Withdrawal by Subject|1|||
48999279|NCT03252015|157831711|FG002|Overall Study|Withdrawal by Subject|1|||
48999280|NCT03252015|157831712|FG003|Overall Study|Withdrawal by Subject|0|||
48999281|NCT03252015|157831709|FG000|Overall Study|Adverse Event|1|||
48999282|NCT03252015|157831710|FG001|Overall Study|Adverse Event|0|||
48999283|NCT03252015|157831711|FG002|Overall Study|Adverse Event|0|||
48999284|NCT03252015|157831712|FG003|Overall Study|Adverse Event|1|||
48999285|NCT04993339|157831713|FG000|Overall Study|Lost to Follow-up|0|||
48999286|NCT04993339|157831714|FG001|Overall Study|Lost to Follow-up|1|||
48999287|NCT04993339|157831713|FG000|Overall Study|no MRI scan|3|||
48999288|NCT04993339|157831714|FG001|Overall Study|no MRI scan|1|||
48999289|NCT00285012|157831715|FG000|Assigned to Study Treatment (Tx)|Other|2|||
48999290|NCT00285012|157831716|FG001|Assigned to Study Treatment (Tx)|Other|3|||
48999291|NCT00285012|157831715|FG000|Received Study Tx|Death|2|||
48999292|NCT00285012|157831716|FG001|Received Study Tx|Death|1|||
48999293|NCT00285012|157831715|FG000|Received Study Tx|Adverse Event|5|||
48999294|NCT00285012|157831716|FG001|Received Study Tx|Adverse Event|11|||
48999295|NCT00285012|157831715|FG000|Received Study Tx|Lack of Efficacy|0|||
48999296|NCT00285012|157831716|FG001|Received Study Tx|Lack of Efficacy|3|||
48999297|NCT00285012|157831715|FG000|Received Study Tx|Lost to Follow-up|29|||
48999298|NCT00285012|157831716|FG001|Received Study Tx|Lost to Follow-up|31|||
48999299|NCT00285012|157831715|FG000|Received Study Tx|Withdrawal by Subject|31|||
48999300|NCT00285012|157831716|FG001|Received Study Tx|Withdrawal by Subject|43|||
48999301|NCT00285012|157831715|FG000|Received Study Tx|Other|5|||
48999302|NCT00285012|157831716|FG001|Received Study Tx|Other|5|||
48999303|NCT01250418|157831717|FG000|Overall Study|monitor data failure|1|||
48999304|NCT01250418|157831718|FG001|Overall Study|monitor data failure|1|||
48999305|NCT01071278|157831719|FG000|Overall Study|Premature Discontinuation|254|||
48999306|NCT01071278|157831719|FG000|Overall Study|Completion Status Unknown|459|||
48999307|NCT00352664|157831720|FG000|Overall Study|Withdrawal by Subject|7|||
48999308|NCT00352664|157831721|FG001|Overall Study|Withdrawal by Subject|0|||
48999309|NCT03252756|157831722|FG000|Overall Study|Protocol Violation|2|||
48999310|NCT03252756|157831723|FG001|Overall Study|Protocol Violation|4|||
48999311|NCT03252756|157831722|FG000|Overall Study|COVID-19 Pandemic|1|||
48999312|NCT03252756|157831723|FG001|Overall Study|COVID-19 Pandemic|1|||
48999313|NCT03252756|157831722|FG000|Overall Study|Study Drug Expiration|0|||
48999314|NCT03252756|157831723|FG001|Overall Study|Study Drug Expiration|1|||
48999315|NCT03868059|157831724|FG000|Overall Study|Adverse Event|3|||
48999316|NCT03868059|157831724|FG000|Overall Study|Lost to Follow-up|3|||
48999317|NCT03868059|157831724|FG000|Overall Study|Withdrawal by Subject|6|||
48999318|NCT04278872|157831726|FG000|Overall Study|Adverse Event|1|||
48999319|NCT04278872|157831727|FG001|Overall Study|Adverse Event|0|||
48999320|NCT04278872|157831726|FG000|Overall Study|Protocol Violation|0|||
48999321|NCT04278872|157831727|FG001|Overall Study|Protocol Violation|1|||
48999322|NCT04278872|157831726|FG000|Overall Study|Study Termination|2|||
48999323|NCT04278872|157831727|FG001|Overall Study|Study Termination|0|||
48999324|NCT04355767|157831734|FG000|Overall Study|Withdrawal by Subject|2|||
48999325|NCT04355767|157831735|FG001|Overall Study|Withdrawal by Subject|2|||
48999326|NCT04355767|157831734|FG000|Overall Study|Death|5|||
48999327|NCT04355767|157831735|FG001|Overall Study|Death|1|||
48999328|NCT00902486|157831736|FG000|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
48999329|NCT00902486|157831737|FG001|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
48999330|NCT00902486|157831738|FG002|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
48999331|NCT00902486|157831739|FG003|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
48999332|NCT00902486|157831740|FG004|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
48999333|NCT00902486|157831741|FG005|Treatment Period (Weeks 0 Through 12)|Adverse Event|2|||
48999334|NCT00902486|157831736|FG000|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1|||
48999335|NCT00902486|157831737|FG001|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
48999336|NCT00902486|157831738|FG002|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
48999337|NCT00902486|157831739|FG003|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
48999338|NCT00902486|157831740|FG004|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
48999339|NCT00902486|157831741|FG005|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2|||
48999340|NCT00902486|157831736|FG000|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
48999341|NCT00902486|157831737|FG001|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
48999342|NCT00902486|157831738|FG002|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
48999343|NCT00902486|157831739|FG003|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
48999344|NCT00902486|157831740|FG004|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
48999345|NCT00902486|157831741|FG005|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
48999346|NCT00902486|157831736|FG000|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
48999347|NCT00902486|157831737|FG001|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
48999348|NCT00902486|157831738|FG002|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
48999349|NCT00902486|157831739|FG003|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1|||
48999350|NCT00902486|157831740|FG004|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
48999351|NCT00902486|157831741|FG005|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
48999352|NCT00902486|157831736|FG000|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
48999353|NCT00902486|157831737|FG001|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
48999354|NCT00902486|157831738|FG002|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
48999355|NCT00902486|157831739|FG003|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1|||
48999356|NCT00902486|157831740|FG004|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
48999357|NCT00902486|157831741|FG005|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
48999358|NCT00902486|157831736|FG000|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
48999359|NCT00902486|157831737|FG001|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
48999360|NCT00902486|157831738|FG002|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
48999361|NCT00902486|157831739|FG003|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
48999362|NCT00902486|157831740|FG004|Extension Period (Weeks 12 Through 24)|Adverse Event|1|||
48999363|NCT00902486|157831741|FG005|Extension Period (Weeks 12 Through 24)|Adverse Event|2|||
48999364|NCT00902486|157831736|FG000|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
48999365|NCT00902486|157831737|FG001|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
48999366|NCT00902486|157831738|FG002|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
48999367|NCT00902486|157831739|FG003|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
48999368|NCT00902486|157831740|FG004|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
48999369|NCT00902486|157831741|FG005|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
48999370|NCT00902486|157831736|FG000|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
48999371|NCT00902486|157831737|FG001|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
48999372|NCT00902486|157831738|FG002|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
48999373|NCT00902486|157831739|FG003|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
48999374|NCT00902486|157831740|FG004|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
48999375|NCT00902486|157831741|FG005|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1|||
48999376|NCT00902486|157831736|FG000|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
48999377|NCT00902486|157831737|FG001|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
48999378|NCT00902486|157831738|FG002|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
48999379|NCT00902486|157831739|FG003|Extension Period (Weeks 12 Through 24)|Disease Progression|1|||
48999380|NCT00902486|157831740|FG004|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
48999381|NCT00902486|157831741|FG005|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
48999382|NCT00902486|157831736|FG000|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
48999383|NCT00902486|157831737|FG001|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
48999384|NCT00902486|157831738|FG002|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1|||
48999385|NCT00902486|157831739|FG003|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
48999386|NCT00902486|157831740|FG004|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
48999387|NCT00902486|157831741|FG005|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
48999388|NCT00902486|157831736|FG000|Follow-up (After Week 24)|Lost to Follow-up|0|||
48999389|NCT00902486|157831737|FG001|Follow-up (After Week 24)|Lost to Follow-up|0|||
48999390|NCT00902486|157831738|FG002|Follow-up (After Week 24)|Lost to Follow-up|0|||
48999391|NCT00902486|157831739|FG003|Follow-up (After Week 24)|Lost to Follow-up|1|||
48999392|NCT00902486|157831740|FG004|Follow-up (After Week 24)|Lost to Follow-up|0|||
48999393|NCT00902486|157831741|FG005|Follow-up (After Week 24)|Lost to Follow-up|0|||
48999394|NCT01898884|157831742|FG000|Multiple Dose Period|Adverse Event|0|||
48999395|NCT01898884|157831743|FG001|Multiple Dose Period|Adverse Event|0|||
48999396|NCT01898884|157831744|FG002|Multiple Dose Period|Adverse Event|0|||
48999397|NCT01898884|157831745|FG003|Multiple Dose Period|Adverse Event|0|||
48999398|NCT01898884|157831746|FG004|Multiple Dose Period|Adverse Event|0|||
48999399|NCT01898884|157831747|FG005|Multiple Dose Period|Adverse Event|0|||
48999400|NCT01898884|157831748|FG006|Multiple Dose Period|Adverse Event|1|||
48999401|NCT01898884|157831749|FG007|Multiple Dose Period|Adverse Event|0|||
48999402|NCT01898884|157831750|FG008|Multiple Dose Period|Adverse Event|0|||
48999403|NCT01898884|157831742|FG000|Multiple Dose Period|Randomized Not Treated|0|||
48999404|NCT01898884|157831743|FG001|Multiple Dose Period|Randomized Not Treated|0|||
48999405|NCT01898884|157831744|FG002|Multiple Dose Period|Randomized Not Treated|0|||
48999406|NCT01898884|157831745|FG003|Multiple Dose Period|Randomized Not Treated|0|||
48999407|NCT01898884|157831746|FG004|Multiple Dose Period|Randomized Not Treated|0|||
48999408|NCT01898884|157831747|FG005|Multiple Dose Period|Randomized Not Treated|0|||
48999409|NCT01898884|157831748|FG006|Multiple Dose Period|Randomized Not Treated|0|||
48999410|NCT01898884|157831749|FG007|Multiple Dose Period|Randomized Not Treated|0|||
48999411|NCT01898884|157831750|FG008|Multiple Dose Period|Randomized Not Treated|1|||
48999412|NCT02787746|157831754|FG000|Overall Study|Adverse Event|42|||
48999413|NCT02787746|157831754|FG000|Overall Study|Withdrawal by Subject|65|||
48999414|NCT02787746|157831754|FG000|Overall Study|Failure to up-titrate to 10mg/day: 12 patients; Other reasons: 30 patients|41|||
48999415|NCT05257109|157831763|FG000|Overall Study|Withdrawal by Subject|1|||
48999416|NCT05257109|157831764|FG001|Overall Study|Withdrawal by Subject|0|||
48999417|NCT05257109|157831765|FG002|Overall Study|Withdrawal by Subject|0|||
48999418|NCT05257109|157831766|FG003|Overall Study|Withdrawal by Subject|0|||
48999419|NCT01876082|157832821|FG000|Overall Study|Withdrawal by Subject|0|||
48999420|NCT01876082|157832822|FG001|Overall Study|Withdrawal by Subject|2|||
48999421|NCT01876082|157832821|FG000|Overall Study|Protocol Violation|1|||
48999422|NCT01876082|157832822|FG001|Overall Study|Protocol Violation|0|||
48999423|NCT01876082|157832821|FG000|Overall Study|Adverse Event|1|||
48999424|NCT01876082|157832822|FG001|Overall Study|Adverse Event|1|||
48999425|NCT01876082|157832821|FG000|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0|||
48999426|NCT01876082|157832822|FG001|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1|||
48999427|NCT01392469|157832823|FG000|Overall Study|Adverse Event|2|||
48999428|NCT01392469|157832823|FG000|Overall Study|Withdrawal by Subject|1|||
48999429|NCT01392469|157832823|FG000|Overall Study|Protocol Violation|1|||
48999430|NCT00518531|157832825|FG000|Treatment Period 1|Adverse Event|5|||
48999431|NCT00518531|157832826|FG001|Treatment Period 1|Adverse Event|0|||
48999432|NCT00518531|157832825|FG000|Treatment Period 1|Lost to Follow-up|5|||
48999433|NCT00518531|157832826|FG001|Treatment Period 1|Lost to Follow-up|3|||
48999434|NCT00518531|157832825|FG000|Treatment Period 1|Physician Decision|1|||
48999435|NCT00518531|157832826|FG001|Treatment Period 1|Physician Decision|0|||
48999436|NCT00518531|157832825|FG000|Treatment Period 1|Protocol Violation|2|||
48999437|NCT00518531|157832826|FG001|Treatment Period 1|Protocol Violation|0|||
48999438|NCT00518531|157832825|FG000|Treatment Period 1|Withdrawal by Subject|4|||
48999439|NCT00518531|157832826|FG001|Treatment Period 1|Withdrawal by Subject|6|||
48999440|NCT00518531|157832825|FG000|Treatment Period 1|Early crossover|1|||
48999441|NCT00518531|157832826|FG001|Treatment Period 1|Early crossover|3|||
48999442|NCT00518531|157832825|FG000|Treatment Period 2|Withdrawal by Subject|0|||
48999443|NCT00518531|157832826|FG001|Treatment Period 2|Withdrawal by Subject|8|||
48999444|NCT00518531|157832825|FG000|Treatment Period 2|Complete out of scheduled visit window|1|||
48999445|NCT00518531|157832826|FG001|Treatment Period 2|Complete out of scheduled visit window|2|||
48999446|NCT00518531|157832825|FG000|Treatment Period 2|Adverse Event|1|||
48999447|NCT00518531|157832826|FG001|Treatment Period 2|Adverse Event|7|||
48999448|NCT00518531|157832825|FG000|Treatment Period 2|Protocol-specified criteria|0|||
48999449|NCT00518531|157832826|FG001|Treatment Period 2|Protocol-specified criteria|1|||
48999450|NCT00518531|157832825|FG000|Treatment Period 2|Non-compliance|1|||
48999451|NCT00518531|157832826|FG001|Treatment Period 2|Non-compliance|2|||
48999452|NCT01656850|157832827|FG000|First Intervention (3 Months)|Withdrawal by Subject|3|||
48999453|NCT01656850|157832828|FG001|First Intervention (3 Months)|Withdrawal by Subject|4|||
48999454|NCT00054639|157832829|FG000|Overall Study|Lack of Efficacy|1|||
48999455|NCT00054639|157832829|FG000|Overall Study|Physician Decision|1|||
48999456|NCT02674568|157832830|FG000|Overall Study|Withdrawal by Subject|5|||
48999457|NCT02674568|157832830|FG000|Overall Study|Death|303|||
48999458|NCT02674568|157832830|FG000|Overall Study|Physician Decision|2|||
48999459|NCT02674568|157832830|FG000|Overall Study|Lost to Follow-up|9|||
48999460|NCT02674568|157832830|FG000|Overall Study|Other, Not Specified|20|||
48999461|NCT00938392|157832831|FG000|Overall Study|Adverse Event|0|||
48999462|NCT00938392|157832832|FG001|Overall Study|Adverse Event|1|||
48999463|NCT00938392|157832831|FG000|Overall Study|Withdrawal by Subject|0|||
48999464|NCT00938392|157832832|FG001|Overall Study|Withdrawal by Subject|1|||
48999465|NCT00938392|157832831|FG000|Overall Study|Lost to Follow-up|2|||
48999466|NCT00938392|157832832|FG001|Overall Study|Lost to Follow-up|2|||
48999467|NCT01366846|157832836|FG000|Overall Study|Withdrawal by Subject|2|||
48999468|NCT01366846|157832837|FG001|Overall Study|Withdrawal by Subject|0|||
48999469|NCT01366846|157832838|FG002|Overall Study|Withdrawal by Subject|0|||
48999470|NCT01366846|157832839|FG003|Overall Study|Withdrawal by Subject|0|||
48999471|NCT01366846|157832836|FG000|Overall Study|Communication Difficulties|1|||
48999472|NCT01366846|157832837|FG001|Overall Study|Communication Difficulties|4|||
48999473|NCT01366846|157832838|FG002|Overall Study|Communication Difficulties|0|||
48999474|NCT01366846|157832839|FG003|Overall Study|Communication Difficulties|1|||
48999475|NCT01366846|157832836|FG000|Overall Study|Scheduling Conflicts|0|||
48999476|NCT01366846|157832837|FG001|Overall Study|Scheduling Conflicts|0|||
48999477|NCT01366846|157832838|FG002|Overall Study|Scheduling Conflicts|1|||
48999478|NCT01366846|157832839|FG003|Overall Study|Scheduling Conflicts|0|||
48999479|NCT00602927|157832840|FG000|Period 1: 13 Days|Protocol Violation|2|||
48999480|NCT00602927|157832841|FG001|Period 1: 13 Days|Protocol Violation|4|||
48999481|NCT00602927|157832840|FG000|Period 1: 13 Days|MRI scanner technical issue|1|||
48999482|NCT00602927|157832841|FG001|Period 1: 13 Days|MRI scanner technical issue|0|||
48999483|NCT00602927|157832840|FG000|Period 1: 13 Days|Time|1|||
48999484|NCT00602927|157832841|FG001|Period 1: 13 Days|Time|0|||
48999485|NCT00602927|157832840|FG000|Period 1: 13 Days|Claustrophobia|0|||
48999486|NCT00602927|157832841|FG001|Period 1: 13 Days|Claustrophobia|1|||
48999487|NCT00602927|157832840|FG000|Period 2: 14 Days|Protocol Violation|0|||
48999488|NCT00602927|157832841|FG001|Period 2: 14 Days|Protocol Violation|2|||
48999489|NCT00602927|157832840|FG000|Period 3: 13 Days|Protocol Violation|0|||
48999490|NCT00602927|157832841|FG001|Period 3: 13 Days|Protocol Violation|1|||
48999491|NCT00602927|157832840|FG000|Period 3: 13 Days|MRI data quality|2|||
48999492|NCT00602927|157832841|FG001|Period 3: 13 Days|MRI data quality|2|||
48999493|NCT05378269|157832842|FG000|Overall Study|Protocol Violation|1|||
48999494|NCT05378269|157832843|FG001|Overall Study|Protocol Violation|0|||
48999495|NCT05378269|157832844|FG002|Overall Study|Protocol Violation|2|||
48999496|NCT05378269|157832845|FG003|Overall Study|Protocol Violation|0|||
48999497|NCT05378269|157832846|FG004|Overall Study|Protocol Violation|0|||
48999498|NCT01728376|157832847|FG000|Overall Study|Adverse Event|1|||
48999499|NCT01728376|157832848|FG001|Overall Study|Adverse Event|1|||
48999500|NCT01728376|157832849|FG002|Overall Study|Adverse Event|1|||
48999501|NCT01728376|157832850|FG003|Overall Study|Adverse Event|1|||
48999502|NCT01728376|157832851|FG004|Overall Study|Adverse Event|1|||
48999503|NCT01728376|157832852|FG005|Overall Study|Adverse Event|0|||
48999504|NCT01728376|157832847|FG000|Overall Study|Persistent Positive Blood Cultures|1|||
48999505|NCT01728376|157832848|FG001|Overall Study|Persistent Positive Blood Cultures|0|||
48999506|NCT01728376|157832849|FG002|Overall Study|Persistent Positive Blood Cultures|1|||
48999507|NCT01728376|157832850|FG003|Overall Study|Persistent Positive Blood Cultures|0|||
48999508|NCT01728376|157832851|FG004|Overall Study|Persistent Positive Blood Cultures|0|||
48999509|NCT01728376|157832852|FG005|Overall Study|Persistent Positive Blood Cultures|0|||
48999510|NCT01728376|157832847|FG000|Overall Study|No relevant bacteria|2|||
48999511|NCT01728376|157832848|FG001|Overall Study|No relevant bacteria|0|||
48999512|NCT01728376|157832849|FG002|Overall Study|No relevant bacteria|0|||
48999513|NCT01728376|157832850|FG003|Overall Study|No relevant bacteria|0|||
48999514|NCT01728376|157832851|FG004|Overall Study|No relevant bacteria|1|||
48999515|NCT01728376|157832852|FG005|Overall Study|No relevant bacteria|1|||
48999516|NCT01728376|157832847|FG000|Overall Study|Did not receive treatment|0|||
48999517|NCT01728376|157832848|FG001|Overall Study|Did not receive treatment|1|||
48999518|NCT01728376|157832849|FG002|Overall Study|Did not receive treatment|0|||
48999519|NCT01728376|157832850|FG003|Overall Study|Did not receive treatment|0|||
48999520|NCT01728376|157832851|FG004|Overall Study|Did not receive treatment|0|||
48999521|NCT01728376|157832852|FG005|Overall Study|Did not receive treatment|0|||
48999522|NCT01728376|157832847|FG000|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
48999523|NCT01728376|157832848|FG001|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
48999524|NCT01728376|157832849|FG002|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
48999525|NCT01728376|157832850|FG003|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
48999526|NCT01728376|157832851|FG004|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
48999527|NCT01728376|157832852|FG005|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
48999528|NCT00359073|157832855|FG000|Overall Study|Withdrawal by Subject|1|||
48999529|NCT00359073|157832856|FG001|Overall Study|Withdrawal by Subject|1|||
48999530|NCT00359073|157832855|FG000|Overall Study|Eligibility criteria no longer met|3|||
48999531|NCT00359073|157832856|FG001|Overall Study|Eligibility criteria no longer met|0|||
48999532|NCT00359073|157832855|FG000|Overall Study|developed RV16 antibody|0|||
48999533|NCT00359073|157832856|FG001|Overall Study|developed RV16 antibody|1|||
48999534|NCT00648739|157832858|FG000|Overall Study|Adverse Event|1|||
48999535|NCT00648739|157832859|FG001|Overall Study|Adverse Event|0|||
48999536|NCT00648739|157832860|FG002|Overall Study|Adverse Event|1|||
48999537|NCT00648739|157832861|FG003|Overall Study|Adverse Event|2|||
48999538|NCT00648739|157832862|FG004|Overall Study|Adverse Event|1|||
48999539|NCT00648739|157832863|FG005|Overall Study|Adverse Event|0|||
48999540|NCT00648739|157832864|FG006|Overall Study|Adverse Event|0|||
48999541|NCT00648739|157832858|FG000|Overall Study|Withdrawal by Subject|1|||
48999542|NCT00648739|157832859|FG001|Overall Study|Withdrawal by Subject|0|||
48999543|NCT00648739|157832860|FG002|Overall Study|Withdrawal by Subject|1|||
48999544|NCT00648739|157832861|FG003|Overall Study|Withdrawal by Subject|0|||
48999545|NCT00648739|157832862|FG004|Overall Study|Withdrawal by Subject|0|||
48999546|NCT00648739|157832863|FG005|Overall Study|Withdrawal by Subject|2|||
48999547|NCT00648739|157832864|FG006|Overall Study|Withdrawal by Subject|0|||
48999548|NCT00648739|157832858|FG000|Overall Study|Lack of Efficacy|0|||
48999549|NCT00648739|157832859|FG001|Overall Study|Lack of Efficacy|0|||
48999550|NCT00648739|157832860|FG002|Overall Study|Lack of Efficacy|0|||
48999551|NCT00648739|157832861|FG003|Overall Study|Lack of Efficacy|0|||
48999552|NCT00648739|157832862|FG004|Overall Study|Lack of Efficacy|1|||
48999553|NCT00648739|157832863|FG005|Overall Study|Lack of Efficacy|2|||
48999554|NCT00648739|157832864|FG006|Overall Study|Lack of Efficacy|0|||
48999555|NCT00648739|157832858|FG000|Overall Study|Investigator Considered it Advisable|0|||
48999556|NCT00648739|157832859|FG001|Overall Study|Investigator Considered it Advisable|0|||
48999557|NCT00648739|157832860|FG002|Overall Study|Investigator Considered it Advisable|0|||
48999558|NCT00648739|157832861|FG003|Overall Study|Investigator Considered it Advisable|0|||
48999559|NCT00648739|157832862|FG004|Overall Study|Investigator Considered it Advisable|0|||
48999560|NCT00648739|157832863|FG005|Overall Study|Investigator Considered it Advisable|1|||
48999561|NCT00648739|157832864|FG006|Overall Study|Investigator Considered it Advisable|1|||
48999562|NCT00648739|157832858|FG000|Overall Study|Death|0|||
48999563|NCT00648739|157832859|FG001|Overall Study|Death|1|||
48999564|NCT00648739|157832860|FG002|Overall Study|Death|0|||
48999565|NCT00648739|157832861|FG003|Overall Study|Death|0|||
48999566|NCT00648739|157832862|FG004|Overall Study|Death|0|||
48999567|NCT00648739|157832863|FG005|Overall Study|Death|0|||
48999568|NCT00648739|157832864|FG006|Overall Study|Death|0|||
48999569|NCT00648739|157832858|FG000|Overall Study|Positive Human Anti-human Antibody|0|||
48999570|NCT00648739|157832859|FG001|Overall Study|Positive Human Anti-human Antibody|0|||
48999571|NCT00648739|157832860|FG002|Overall Study|Positive Human Anti-human Antibody|1|||
48999572|NCT00648739|157832861|FG003|Overall Study|Positive Human Anti-human Antibody|0|||
48999573|NCT00648739|157832862|FG004|Overall Study|Positive Human Anti-human Antibody|0|||
48999574|NCT00648739|157832863|FG005|Overall Study|Positive Human Anti-human Antibody|0|||
48999575|NCT00648739|157832864|FG006|Overall Study|Positive Human Anti-human Antibody|0|||
48999576|NCT00648739|157832858|FG000|Overall Study|Follow-up Visits Not Completed|0|||
48999577|NCT00648739|157832859|FG001|Overall Study|Follow-up Visits Not Completed|1|||
48999578|NCT00648739|157832860|FG002|Overall Study|Follow-up Visits Not Completed|0|||
48999579|NCT00648739|157832861|FG003|Overall Study|Follow-up Visits Not Completed|0|||
48999580|NCT00648739|157832862|FG004|Overall Study|Follow-up Visits Not Completed|0|||
48999581|NCT00648739|157832863|FG005|Overall Study|Follow-up Visits Not Completed|0|||
48999582|NCT00648739|157832864|FG006|Overall Study|Follow-up Visits Not Completed|0|||
48999583|NCT00685763|157832865|FG000|Overall Study|Intercurrent death-incomplete treatment|1|||
48999584|NCT00685763|157832865|FG000|Overall Study|Protocol Violation|1|||
48999585|NCT00698009|157832870|FG000|Overall Study|Withdrawal by Subject|1|||
48999586|NCT04341727|157832876|FG000|Overall Study|Withdrawal by Subject|0|||
48999587|NCT04341727|157832877|FG001|Overall Study|Withdrawal by Subject|0|||
48999588|NCT04341727|157832878|FG002|Overall Study|Withdrawal by Subject|1|||
48999589|NCT04341727|157832879|FG003|Overall Study|Withdrawal by Subject|0|||
48999590|NCT04341727|157832876|FG000|Overall Study|Lost to Follow-up|0|||
48999591|NCT04341727|157832877|FG001|Overall Study|Lost to Follow-up|0|||
48999592|NCT04341727|157832878|FG002|Overall Study|Lost to Follow-up|0|||
48999593|NCT04341727|157832879|FG003|Overall Study|Lost to Follow-up|1|||
48999594|NCT00054275|157832880|FG000|Overall Study|Withdrawal by Subject|4|||
48999595|NCT00054275|157832880|FG000|Overall Study|Adverse Event|5|||
48999596|NCT00054275|157832880|FG000|Overall Study|Progressive disease in cycle 1|1|||
48999597|NCT00054275|157832880|FG000|Overall Study|Physician Decision|1|||
48999598|NCT01157065|157832883|FG000|Overall Study|Death|0|||
48999599|NCT01157065|157832884|FG001|Overall Study|Death|1|||
48999600|NCT00943826|157832885|FG000|Concurrent Phase|Adverse Event|50|||
48999601|NCT00943826|157832886|FG001|Concurrent Phase|Adverse Event|27|||
48999602|NCT00943826|157832885|FG000|Concurrent Phase|Withdrew consent|3|||
48999603|NCT00943826|157832886|FG001|Concurrent Phase|Withdrew consent|7|||
48999604|NCT00943826|157832885|FG000|Concurrent Phase|Refused treatment/Did not cooperate|5|||
48999605|NCT00943826|157832886|FG001|Concurrent Phase|Refused treatment/Did not cooperate|7|||
48999606|NCT00943826|157832885|FG000|Concurrent Phase|Administrative reasons|2|||
48999607|NCT00943826|157832886|FG001|Concurrent Phase|Administrative reasons|1|||
48999608|NCT00943826|157832885|FG000|Concurrent Phase|Protocol Violation|1|||
48999609|NCT00943826|157832886|FG001|Concurrent Phase|Protocol Violation|0|||
48999610|NCT00943826|157832885|FG000|Maintenance Phase|Adverse Event|31|||
48999611|NCT00943826|157832886|FG001|Maintenance Phase|Adverse Event|30|||
48999612|NCT00943826|157832885|FG000|Maintenance Phase|Withdrew consent|2|||
48999613|NCT00943826|157832886|FG001|Maintenance Phase|Withdrew consent|4|||
48999614|NCT00943826|157832885|FG000|Maintenance Phase|Refused treatment/Did not cooperate|6|||
48999615|NCT00943826|157832886|FG001|Maintenance Phase|Refused treatment/Did not cooperate|3|||
48999616|NCT00943826|157832885|FG000|Maintenance Phase|Administrative reasons|4|||
48999617|NCT00943826|157832886|FG001|Maintenance Phase|Administrative reasons|1|||
48999618|NCT00943826|157832885|FG000|Maintenance Phase|Failure to return|0|||
48999619|NCT00943826|157832886|FG001|Maintenance Phase|Failure to return|1|||
48999620|NCT00943826|157832885|FG000|Monotherapy Phase|Adverse Event|42|||
48999621|NCT00943826|157832886|FG001|Monotherapy Phase|Adverse Event|5|||
48999622|NCT00943826|157832885|FG000|Monotherapy Phase|Administrative reasons|11|||
48999623|NCT00943826|157832886|FG001|Monotherapy Phase|Administrative reasons|5|||
48999624|NCT00943826|157832885|FG000|Monotherapy Phase|Refused treatment/ Did not cooperate|8|||
48999625|NCT00943826|157832886|FG001|Monotherapy Phase|Refused treatment/ Did not cooperate|2|||
48999626|NCT00943826|157832885|FG000|Monotherapy Phase|Withdrew Consent|2|||
48999627|NCT00943826|157832886|FG001|Monotherapy Phase|Withdrew Consent|3|||
48999628|NCT00943826|157832885|FG000|Monotherapy Phase|Failure to return|2|||
48999629|NCT00943826|157832886|FG001|Monotherapy Phase|Failure to return|1|||
48999630|NCT00943826|157832885|FG000|After Primary Overall Survival Analysis|Adverse Event|11|||
48999631|NCT00943826|157832886|FG001|After Primary Overall Survival Analysis|Adverse Event|0|||
48999632|NCT00943826|157832885|FG000|After Primary Overall Survival Analysis|Administrative reasons|10|||
48999633|NCT00943826|157832886|FG001|After Primary Overall Survival Analysis|Administrative reasons|16|||
48999634|NCT00943826|157832885|FG000|After Primary Overall Survival Analysis|Progression of Disease|2|||
48999635|NCT00943826|157832886|FG001|After Primary Overall Survival Analysis|Progression of Disease|4|||
48999636|NCT00943826|157832885|FG000|After Primary Overall Survival Analysis|Withdrew Consent|4|||
48999637|NCT00943826|157832886|FG001|After Primary Overall Survival Analysis|Withdrew Consent|0|||
48999638|NCT02050373|157832887|FG000|Overall Study|Adverse Event|4|||
48999639|NCT02050373|157832888|FG001|Overall Study|Adverse Event|7|||
48999640|NCT02050373|157832887|FG000|Overall Study|Death|3|||
48999641|NCT02050373|157832888|FG001|Overall Study|Death|3|||
48999642|NCT00326625|157832889|FG000|Overall Study|Adverse Event|20|||
48999643|NCT00326625|157832890|FG001|Overall Study|Adverse Event|9|||
48999644|NCT00326625|157832889|FG000|Overall Study|Withdrawal by Subject|15|||
48999645|NCT00326625|157832890|FG001|Overall Study|Withdrawal by Subject|12|||
48999646|NCT00326625|157832889|FG000|Overall Study|Death|18|||
48999647|NCT00326625|157832890|FG001|Overall Study|Death|16|||
48999648|NCT00326625|157832889|FG000|Overall Study|Lost to Follow-up|1|||
48999649|NCT00326625|157832890|FG001|Overall Study|Lost to Follow-up|0|||
48999650|NCT00326625|157832889|FG000|Overall Study|prescheduled medical intervention|0|||
48999651|NCT00326625|157832890|FG001|Overall Study|prescheduled medical intervention|1|||
48999652|NCT01977625|157832891|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
48999653|NCT01977625|157832892|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
48999654|NCT01977625|157832891|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
48999655|NCT01977625|157832892|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
48999656|NCT04113746|157832893|FG000|Overall Study|Lost to Follow-up|4|||
48999657|NCT04113746|157832894|FG001|Overall Study|Lost to Follow-up|4|||
48999658|NCT03901339|157832895|FG000|Overall Study|Death|220|||
48999659|NCT03901339|157832896|FG001|Overall Study|Death|192|||
48999660|NCT03901339|157832895|FG000|Overall Study|Informed consent withdrawn|13|||
48999661|NCT03901339|157832896|FG001|Overall Study|Informed consent withdrawn|40|||
48999662|NCT03901339|157832895|FG000|Overall Study|Sponsor request|30|||
48999663|NCT03901339|157832896|FG001|Overall Study|Sponsor request|23|||
48999664|NCT03901339|157832895|FG000|Overall Study|Reason not specified|5|||
48999665|NCT03901339|157832896|FG001|Overall Study|Reason not specified|7|||
48999666|NCT03901339|157832895|FG000|Overall Study|Lost to Follow-up|4|||
48999667|NCT03901339|157832896|FG001|Overall Study|Lost to Follow-up|7|||
48999668|NCT03901339|157832895|FG000|Overall Study|Covid19|0|||
48999669|NCT03901339|157832896|FG001|Overall Study|Covid19|2|||
48999670|NCT00491322|157832897|FG000|Overall Study|Protocol Violation|1|||
48999671|NCT00491322|157832898|FG001|Overall Study|Protocol Violation|0|||
48999672|NCT00491322|157832897|FG000|Overall Study|Pregnancy|0|||
48999673|NCT00491322|157832898|FG001|Overall Study|Pregnancy|1|||
48999674|NCT02861534|157832899|FG000|Overall Study|Death|541|||
48999675|NCT02861534|157832900|FG001|Overall Study|Death|552|||
48999676|NCT02861534|157832899|FG000|Overall Study|Lost to Follow-up|14|||
48999677|NCT02861534|157832900|FG001|Overall Study|Lost to Follow-up|14|||
48999678|NCT02861534|157832899|FG000|Overall Study|Site Terminated by Sponsor|4|||
48999679|NCT02861534|157832900|FG001|Overall Study|Site Terminated by Sponsor|3|||
48999680|NCT02861534|157832899|FG000|Overall Study|Withdrawal by Subject|15|||
48999681|NCT02861534|157832900|FG001|Overall Study|Withdrawal by Subject|18|||
48999682|NCT06067191|157832903|FG000|Overall Study|Withdrawal by Subject|0|||
48999683|NCT06067191|157832904|FG001|Overall Study|Withdrawal by Subject|1|||
48999684|NCT02886494|157832905|FG000|Overall Study|Adverse Event|1|||
48999685|NCT02886494|157832906|FG001|Overall Study|Adverse Event|0|||
48999686|NCT02886494|157832905|FG000|Overall Study|Withdrawal by Subject|12|||
48999687|NCT02886494|157832906|FG001|Overall Study|Withdrawal by Subject|3|||
48999688|NCT02886494|157832905|FG000|Overall Study|Protocol Violation|4|||
48999689|NCT02886494|157832906|FG001|Overall Study|Protocol Violation|1|||
48999690|NCT03919669|157832910|FG000|Overall Study|Withdrawal by Subject|1|||
48999691|NCT03919669|157832911|FG001|Overall Study|Withdrawal by Subject|0|||
48999692|NCT03919669|157832912|FG002|Overall Study|Withdrawal by Subject|0|||
48999693|NCT00625846|157832913|FG000|Overall Study|Withdrawal by Subject|2|||
48999694|NCT00625846|157832914|FG001|Overall Study|Withdrawal by Subject|0|||
48999695|NCT00625846|157832915|FG002|Overall Study|Withdrawal by Subject|1|||
48999696|NCT00625846|157832916|FG003|Overall Study|Withdrawal by Subject|2|||
48999697|NCT01067339|157832919|FG000|Overall Study|Withdrawal by Subject|6|||
48999698|NCT01067339|157832920|FG001|Overall Study|Withdrawal by Subject|5|||
48999699|NCT02780115|157832921|FG000|Overall Study|Withdrawal by Subject|0|||
48999700|NCT02780115|157832922|FG001|Overall Study|Withdrawal by Subject|1|||
48999701|NCT02780115|157832923|FG002|Overall Study|Withdrawal by Subject|1|||
48999702|NCT02780115|157832924|FG003|Overall Study|Withdrawal by Subject|0|||
48999703|NCT02780115|157832925|FG004|Overall Study|Withdrawal by Subject|0|||
48999704|NCT02780115|157832921|FG000|Overall Study|Adverse Event|0|||
48999705|NCT02780115|157832922|FG001|Overall Study|Adverse Event|0|||
48999706|NCT02780115|157832923|FG002|Overall Study|Adverse Event|0|||
48999707|NCT02780115|157832924|FG003|Overall Study|Adverse Event|1|||
48999708|NCT02780115|157832925|FG004|Overall Study|Adverse Event|1|||
48999709|NCT00890409|157832926|FG000|Overall Study|Lost to Follow-up|20|||
48999710|NCT00890409|157832927|FG001|Overall Study|Lost to Follow-up|21|||
48999711|NCT04054011|157832936|FG000|Overall Study|COVID|3|||
48999712|NCT03099161|157832939|FG000|Overall Study|Adverse Event|0|||
48999713|NCT03099161|157832940|FG001|Overall Study|Adverse Event|0|||
48999714|NCT03099161|157832941|FG002|Overall Study|Adverse Event|2|||
48999715|NCT03099161|157832939|FG000|Overall Study|Physician Decision|2|||
48999716|NCT03099161|157832940|FG001|Overall Study|Physician Decision|0|||
48999717|NCT03099161|157832941|FG002|Overall Study|Physician Decision|0|||
48999718|NCT03099161|157832939|FG000|Overall Study|Progressive Disease|1|||
48999719|NCT03099161|157832940|FG001|Overall Study|Progressive Disease|4|||
48999720|NCT03099161|157832941|FG002|Overall Study|Progressive Disease|1|||
48999721|NCT00447265|157834395|FG000|Overall Study|Physician Decision|1|||
48999722|NCT00447265|157834396|FG001|Overall Study|Physician Decision|0|||
48999723|NCT03387423|157834402|FG000|Overall Study|Lost to Follow-up|16|||
48999724|NCT03387423|157834403|FG001|Overall Study|Lost to Follow-up|12|||
48999725|NCT03387423|157834404|FG002|Overall Study|Lost to Follow-up|1|||
48999726|NCT03387423|157834405|FG003|Overall Study|Lost to Follow-up|0|||
48999727|NCT03387423|157834402|FG000|Overall Study|Other|0|||
48999728|NCT03387423|157834403|FG001|Overall Study|Other|3|||
48999729|NCT03387423|157834404|FG002|Overall Study|Other|0|||
48999730|NCT03387423|157834405|FG003|Overall Study|Other|0|||
48999731|NCT03387423|157834402|FG000|Overall Study|Administrative Reason|166|||
48999732|NCT03387423|157834403|FG001|Overall Study|Administrative Reason|89|||
48999733|NCT03387423|157834404|FG002|Overall Study|Administrative Reason|17|||
48999734|NCT03387423|157834405|FG003|Overall Study|Administrative Reason|19|||
48999735|NCT03387423|157834402|FG000|Overall Study|Revocation Consent|76|||
48999736|NCT03387423|157834403|FG001|Overall Study|Revocation Consent|32|||
48999737|NCT03387423|157834404|FG002|Overall Study|Revocation Consent|3|||
48999738|NCT03387423|157834405|FG003|Overall Study|Revocation Consent|5|||
48999739|NCT01371006|157834406|FG000|Overall Study|Adverse Event|1|||
48999740|NCT01371006|157834407|FG001|Overall Study|Adverse Event|0|||
48999741|NCT02204449|157834410|FG000|Overall Study|Lost to Follow-up|7|||
48999742|NCT02204449|157834411|FG001|Overall Study|Lost to Follow-up|9|||
48999743|NCT02204449|157834410|FG000|Overall Study|Death|0|||
48999744|NCT02204449|157834411|FG001|Overall Study|Death|1|||
48999745|NCT02204449|157834410|FG000|Overall Study|Withdrawal by Subject|0|||
48999746|NCT02204449|157834411|FG001|Overall Study|Withdrawal by Subject|1|||
48999747|NCT00503035|157834412|FG000|Overall Study|Lost to Follow-up|2|||
48999748|NCT00503035|157834412|FG000|Overall Study|Physician Decision|3|||
48999749|NCT00503035|157834412|FG000|Overall Study|Ineligible|15|||
48999750|NCT05604521|157834417|FG000|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|23|||
48999751|NCT05604521|157834418|FG001|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|7|||
48999752|NCT05604521|157834417|FG000|Overall Study|Adverse Event|1|||
48999753|NCT05604521|157834418|FG001|Overall Study|Adverse Event|0|||
48999754|NCT05354206|157834426|FG000|Overall Study|Withdrawal by Subject|1|||
48999755|NCT05354206|157834427|FG001|Overall Study|Withdrawal by Subject|0|||
48999756|NCT02594384|157834432|FG000|Overall Study|Disease Progression|3|||
48999757|NCT02594384|157834433|FG001|Overall Study|Disease Progression|7|||
48999758|NCT02594384|157834434|FG002|Overall Study|Disease Progression|0|||
48999759|NCT02594384|157834435|FG003|Overall Study|Disease Progression|2|||
48999760|NCT02594384|157834436|FG004|Overall Study|Disease Progression|2|||
48999761|NCT02594384|157834437|FG005|Overall Study|Disease Progression|12|||
48999762|NCT02594384|157834438|FG006|Overall Study|Disease Progression|5|||
48999763|NCT02594384|157834439|FG007|Overall Study|Disease Progression|5|||
48999764|NCT02594384|157834432|FG000|Overall Study|Adverse Event|0|||
48999765|NCT02594384|157834433|FG001|Overall Study|Adverse Event|1|||
48999766|NCT02594384|157834434|FG002|Overall Study|Adverse Event|4|||
48999767|NCT02594384|157834435|FG003|Overall Study|Adverse Event|1|||
48999768|NCT02594384|157834436|FG004|Overall Study|Adverse Event|0|||
48999769|NCT02594384|157834437|FG005|Overall Study|Adverse Event|6|||
48999770|NCT02594384|157834438|FG006|Overall Study|Adverse Event|1|||
48999771|NCT02594384|157834439|FG007|Overall Study|Adverse Event|1|||
48999772|NCT02594384|157834432|FG000|Overall Study|Withdrawal by Subject|0|||
48999773|NCT02594384|157834433|FG001|Overall Study|Withdrawal by Subject|0|||
48999774|NCT02594384|157834434|FG002|Overall Study|Withdrawal by Subject|0|||
48999775|NCT02594384|157834435|FG003|Overall Study|Withdrawal by Subject|1|||
48999776|NCT02594384|157834436|FG004|Overall Study|Withdrawal by Subject|0|||
48999777|NCT02594384|157834437|FG005|Overall Study|Withdrawal by Subject|0|||
48999778|NCT02594384|157834438|FG006|Overall Study|Withdrawal by Subject|0|||
48999779|NCT02594384|157834439|FG007|Overall Study|Withdrawal by Subject|1|||
48999780|NCT02594384|157834432|FG000|Overall Study|Physician Decision|0|||
48999781|NCT02594384|157834433|FG001|Overall Study|Physician Decision|0|||
48999782|NCT02594384|157834434|FG002|Overall Study|Physician Decision|0|||
48999783|NCT02594384|157834435|FG003|Overall Study|Physician Decision|0|||
48999784|NCT02594384|157834436|FG004|Overall Study|Physician Decision|0|||
48999785|NCT02594384|157834437|FG005|Overall Study|Physician Decision|1|||
48999786|NCT02594384|157834438|FG006|Overall Study|Physician Decision|2|||
48999787|NCT02594384|157834439|FG007|Overall Study|Physician Decision|0|||
48999788|NCT02594384|157834432|FG000|Overall Study|Progressive Leukocytosis|0|||
48999789|NCT02594384|157834433|FG001|Overall Study|Progressive Leukocytosis|0|||
48999790|NCT02594384|157834434|FG002|Overall Study|Progressive Leukocytosis|1|||
48999791|NCT02594384|157834435|FG003|Overall Study|Progressive Leukocytosis|0|||
48999792|NCT02594384|157834436|FG004|Overall Study|Progressive Leukocytosis|0|||
48999793|NCT02594384|157834437|FG005|Overall Study|Progressive Leukocytosis|0|||
48999794|NCT02594384|157834438|FG006|Overall Study|Progressive Leukocytosis|0|||
48999795|NCT02594384|157834439|FG007|Overall Study|Progressive Leukocytosis|0|||
48999796|NCT02594384|157834432|FG000|Overall Study|Lack of Efficacy|0|||
48999797|NCT02594384|157834433|FG001|Overall Study|Lack of Efficacy|0|||
49045843|NCT02300987|158002026|FG000|Primary Phase : Prior to Cross-over|progressive disease|3|||
49045844|NCT02300987|158002027|FG001|Primary Phase : Prior to Cross-over|progressive disease|2|||
48999798|NCT02594384|157834434|FG002|Overall Study|Lack of Efficacy|0|||
48999799|NCT02594384|157834435|FG003|Overall Study|Lack of Efficacy|0|||
48999800|NCT02594384|157834436|FG004|Overall Study|Lack of Efficacy|1|||
48999801|NCT02594384|157834437|FG005|Overall Study|Lack of Efficacy|0|||
48999802|NCT02594384|157834438|FG006|Overall Study|Lack of Efficacy|0|||
48999803|NCT02594384|157834439|FG007|Overall Study|Lack of Efficacy|0|||
48999804|NCT02594384|157834432|FG000|Overall Study|Substantial noncompliance|0|||
48999805|NCT02594384|157834433|FG001|Overall Study|Substantial noncompliance|0|||
48999806|NCT02594384|157834434|FG002|Overall Study|Substantial noncompliance|0|||
48999807|NCT02594384|157834435|FG003|Overall Study|Substantial noncompliance|0|||
48999808|NCT02594384|157834436|FG004|Overall Study|Substantial noncompliance|0|||
48999809|NCT02594384|157834437|FG005|Overall Study|Substantial noncompliance|0|||
48999810|NCT02594384|157834438|FG006|Overall Study|Substantial noncompliance|1|||
48999811|NCT02594384|157834439|FG007|Overall Study|Substantial noncompliance|0|||
48999812|NCT00572910|157834442|FG000|Overall Study|Adverse Event|1|||
48999813|NCT00572910|157834443|FG001|Overall Study|Adverse Event|2|||
48999814|NCT00572910|157834444|FG002|Overall Study|Adverse Event|0|||
48999815|NCT00572910|157834445|FG003|Overall Study|Adverse Event|2|||
48999816|NCT00572910|157834446|FG004|Overall Study|Adverse Event|0|||
48999817|NCT00572910|157834447|FG005|Overall Study|Adverse Event|0|||
48999818|NCT00572910|157834448|FG006|Overall Study|Adverse Event|4|||
48999819|NCT00572910|157834449|FG007|Overall Study|Adverse Event|2|||
48999820|NCT00572910|157834450|FG008|Overall Study|Adverse Event|1|||
48999821|NCT00572910|157834451|FG009|Overall Study|Adverse Event|3|||
48999822|NCT00572910|157834452|FG010|Overall Study|Adverse Event|2|||
48999823|NCT00572910|157834442|FG000|Overall Study|Lost to Follow-up|0|||
48999824|NCT00572910|157834443|FG001|Overall Study|Lost to Follow-up|1|||
48999825|NCT00572910|157834444|FG002|Overall Study|Lost to Follow-up|1|||
48999826|NCT00572910|157834445|FG003|Overall Study|Lost to Follow-up|2|||
48999827|NCT00572910|157834446|FG004|Overall Study|Lost to Follow-up|1|||
48999828|NCT00572910|157834447|FG005|Overall Study|Lost to Follow-up|0|||
48999829|NCT00572910|157834448|FG006|Overall Study|Lost to Follow-up|0|||
48999830|NCT00572910|157834449|FG007|Overall Study|Lost to Follow-up|0|||
48999831|NCT00572910|157834450|FG008|Overall Study|Lost to Follow-up|0|||
48999832|NCT00572910|157834451|FG009|Overall Study|Lost to Follow-up|1|||
48999833|NCT00572910|157834452|FG010|Overall Study|Lost to Follow-up|0|||
48999834|NCT00572910|157834442|FG000|Overall Study|Withdrawal by Subject|3|||
48999835|NCT00572910|157834443|FG001|Overall Study|Withdrawal by Subject|0|||
48999836|NCT00572910|157834444|FG002|Overall Study|Withdrawal by Subject|1|||
48999837|NCT00572910|157834445|FG003|Overall Study|Withdrawal by Subject|0|||
48999838|NCT00572910|157834446|FG004|Overall Study|Withdrawal by Subject|1|||
48999839|NCT00572910|157834447|FG005|Overall Study|Withdrawal by Subject|3|||
48999840|NCT00572910|157834448|FG006|Overall Study|Withdrawal by Subject|0|||
48999841|NCT00572910|157834449|FG007|Overall Study|Withdrawal by Subject|2|||
48999842|NCT00572910|157834450|FG008|Overall Study|Withdrawal by Subject|2|||
48999843|NCT00572910|157834451|FG009|Overall Study|Withdrawal by Subject|2|||
48999844|NCT00572910|157834452|FG010|Overall Study|Withdrawal by Subject|1|||
48999845|NCT00916617|157834454|FG000|Overall Study|Adverse Event|3|||
48999846|NCT00916617|157834455|FG001|Overall Study|Adverse Event|2|||
48999847|NCT00916617|157834456|FG002|Overall Study|Adverse Event|6|||
48999848|NCT00916617|157834457|FG003|Overall Study|Adverse Event|3|||
48999849|NCT00916617|157834454|FG000|Overall Study|Withdrawal by Subject|3|||
48999850|NCT00916617|157834455|FG001|Overall Study|Withdrawal by Subject|2|||
48999851|NCT00916617|157834456|FG002|Overall Study|Withdrawal by Subject|0|||
48999852|NCT00916617|157834457|FG003|Overall Study|Withdrawal by Subject|1|||
48999853|NCT00916617|157834454|FG000|Overall Study|Caregiver Request|3|||
48999854|NCT00916617|157834455|FG001|Overall Study|Caregiver Request|2|||
48999855|NCT00916617|157834456|FG002|Overall Study|Caregiver Request|1|||
48999856|NCT00916617|157834457|FG003|Overall Study|Caregiver Request|0|||
48999857|NCT00916617|157834454|FG000|Overall Study|Physician Decision|1|||
48999858|NCT00916617|157834455|FG001|Overall Study|Physician Decision|1|||
48999859|NCT00916617|157834456|FG002|Overall Study|Physician Decision|0|||
48999860|NCT00916617|157834457|FG003|Overall Study|Physician Decision|0|||
48999861|NCT00916617|157834454|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
48999862|NCT00916617|157834455|FG001|Overall Study|Discontinuation of Study by Sponsor|13|||
48999863|NCT00916617|157834456|FG002|Overall Study|Discontinuation of Study by Sponsor|3|||
48999864|NCT00916617|157834457|FG003|Overall Study|Discontinuation of Study by Sponsor|1|||
48999865|NCT00916617|157834454|FG000|Overall Study|Lost to Follow-up|2|||
48999866|NCT00916617|157834455|FG001|Overall Study|Lost to Follow-up|1|||
48999867|NCT00916617|157834456|FG002|Overall Study|Lost to Follow-up|0|||
48999868|NCT00916617|157834457|FG003|Overall Study|Lost to Follow-up|0|||
48999869|NCT00916617|157834454|FG000|Overall Study|Lack of Efficacy|1|||
48999870|NCT00916617|157834455|FG001|Overall Study|Lack of Efficacy|0|||
48999871|NCT00916617|157834456|FG002|Overall Study|Lack of Efficacy|0|||
48999872|NCT00916617|157834457|FG003|Overall Study|Lack of Efficacy|0|||
48999873|NCT00916617|157834454|FG000|Overall Study|Other|2|||
48999874|NCT00916617|157834455|FG001|Overall Study|Other|0|||
48999875|NCT00916617|157834456|FG002|Overall Study|Other|0|||
48999876|NCT00916617|157834457|FG003|Overall Study|Other|2|||
48999877|NCT03668613|157834462|FG000|Overall Study|Adverse Event|1|||
48999878|NCT03668613|157834463|FG001|Overall Study|Adverse Event|2|||
48999879|NCT03668613|157834462|FG000|Overall Study|Lack of Efficacy|5|||
48999880|NCT03668613|157834463|FG001|Overall Study|Lack of Efficacy|1|||
48999881|NCT03668613|157834462|FG000|Overall Study|Pregnancy|0|||
48999882|NCT03668613|157834463|FG001|Overall Study|Pregnancy|2|||
48999883|NCT03668613|157834462|FG000|Overall Study|Protocol Violation|1|||
48999884|NCT03668613|157834463|FG001|Overall Study|Protocol Violation|0|||
48999885|NCT03668613|157834462|FG000|Overall Study|Physician Decision|1|||
48999886|NCT03668613|157834463|FG001|Overall Study|Physician Decision|0|||
48999887|NCT03668613|157834462|FG000|Overall Study|Withdrawal by Subject|2|||
48999888|NCT03668613|157834463|FG001|Overall Study|Withdrawal by Subject|1|||
48999889|NCT03668613|157834462|FG000|Overall Study|Guardian decision|1|||
48999890|NCT03668613|157834463|FG001|Overall Study|Guardian decision|0|||
48999891|NCT02304302|157834464|FG000|Overall Study|Adverse Event|2|||
48999892|NCT02304302|157834465|FG001|Overall Study|Adverse Event|3|||
48999893|NCT02304302|157834464|FG000|Overall Study|Lost to Follow-up|1|||
48999894|NCT02304302|157834465|FG001|Overall Study|Lost to Follow-up|4|||
48999895|NCT02304302|157834464|FG000|Overall Study|Removed from analysis due to low medication compliance|0|||
48999896|NCT02304302|157834465|FG001|Overall Study|Removed from analysis due to low medication compliance|1|||
48999897|NCT00769132|157834466|FG000|Period 1|Adverse Event|1|||
48999898|NCT00769132|157834467|FG001|Period 1|Adverse Event|0|||
48999899|NCT00769132|157834468|FG002|Period 1|Adverse Event|0|||
48999900|NCT00769132|157834469|FG003|Period 1|Adverse Event|1|||
48999901|NCT00769132|157834466|FG000|Period 2|Withdrawal by Subject|0|||
48999902|NCT00769132|157834467|FG001|Period 2|Withdrawal by Subject|0|||
48999903|NCT00769132|157834468|FG002|Period 2|Withdrawal by Subject|0|||
48999904|NCT00769132|157834469|FG003|Period 2|Withdrawal by Subject|1|||
48999905|NCT00769132|157834466|FG000|Period 3|Withdrawal by Subject|1|||
48999906|NCT00769132|157834467|FG001|Period 3|Withdrawal by Subject|0|||
48999907|NCT00769132|157834468|FG002|Period 3|Withdrawal by Subject|0|||
48999908|NCT00769132|157834469|FG003|Period 3|Withdrawal by Subject|0|||
48999909|NCT00769132|157834466|FG000|Period 4|Withdrawal by Subject|0|||
48999910|NCT00769132|157834467|FG001|Period 4|Withdrawal by Subject|1|||
48999911|NCT00769132|157834468|FG002|Period 4|Withdrawal by Subject|0|||
48999912|NCT00769132|157834469|FG003|Period 4|Withdrawal by Subject|0|||
48999913|NCT00499252|157834472|FG000|Overall Study|Adverse Event|3|||
48999914|NCT00499252|157834472|FG000|Overall Study|Refused further treatment|2|||
48999915|NCT00499252|157834472|FG000|Overall Study|Ineligible|4|||
48999916|NCT00499252|157834472|FG000|Overall Study|<no further label>|3|||
48999917|NCT01988337|157834473|FG000|Overall Study|Study was terminated due to insufficient recruitment before 36 month follow up could be completed|56|||
48999918|NCT02230332|157834474|FG000|Overall Study|Adverse Event|2|||
48999919|NCT02230332|157834475|FG001|Overall Study|Adverse Event|1|||
48999920|NCT02230332|157834474|FG000|Overall Study|Lost to Follow-up|1|||
48999921|NCT02230332|157834475|FG001|Overall Study|Lost to Follow-up|0|||
48999922|NCT02230332|157834474|FG000|Overall Study|Protocol Violation|1|||
48999923|NCT02230332|157834475|FG001|Overall Study|Protocol Violation|0|||
48999924|NCT01260194|157834477|FG000|Overall Study|Withdrawal of Consent|1|||
48999925|NCT00877799|157834479|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2|||
48999926|NCT00877799|157834480|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
48999927|NCT00877799|157834481|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
48999928|NCT00877799|157834482|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
48999929|NCT00877799|157834483|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
48999930|NCT00877799|157834479|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
48999931|NCT00877799|157834480|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
48999932|NCT00877799|157834481|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2|||
48999933|NCT00877799|157834482|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
48999934|NCT00877799|157834483|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
48999935|NCT00877799|157834479|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
48999936|NCT00877799|157834480|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3|||
48999937|NCT00877799|157834481|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
48999938|NCT00877799|157834482|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
48999939|NCT00877799|157834483|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
48999940|NCT00877799|157834479|FG000|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
48999941|NCT00877799|157834480|FG001|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
48999942|NCT00877799|157834481|FG002|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
48999943|NCT00877799|157834482|FG003|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1|||
48999944|NCT00877799|157834483|FG004|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
48999945|NCT00877799|157834479|FG000|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
48999946|NCT00877799|157834480|FG001|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
48999947|NCT00877799|157834481|FG002|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
48999948|NCT00877799|157834482|FG003|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
48999949|NCT00877799|157834483|FG004|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
48999950|NCT00592007|157834484|FG000|Overall Study|Withdrawal by Subject|1|||
48999951|NCT00592007|157834484|FG000|Overall Study|patient ineligible (out of lab range)|1|||
48999952|NCT00595127|157834485|FG000|Overall Study|Death|6|||
48999953|NCT00595127|157834485|FG000|Overall Study|Relapsed|3|||
48999954|NCT00595127|157834485|FG000|Overall Study|joined another trial|1|||
48999955|NCT01785472|157834486|FG000|Overall Study|Adverse Event|5|||
48999956|NCT01785472|157834487|FG001|Overall Study|Adverse Event|4|||
48999957|NCT01785472|157834488|FG002|Overall Study|Adverse Event|6|||
48999958|NCT01785472|157834486|FG000|Overall Study|Lack of Efficacy|2|||
48999959|NCT01785472|157834487|FG001|Overall Study|Lack of Efficacy|0|||
48999960|NCT01785472|157834488|FG002|Overall Study|Lack of Efficacy|1|||
48999961|NCT01785472|157834486|FG000|Overall Study|Lost to Follow-up|1|||
48999962|NCT01785472|157834487|FG001|Overall Study|Lost to Follow-up|2|||
48999963|NCT01785472|157834488|FG002|Overall Study|Lost to Follow-up|0|||
48999964|NCT01785472|157834486|FG000|Overall Study|Physician Decision|1|||
48999965|NCT01785472|157834487|FG001|Overall Study|Physician Decision|1|||
48999966|NCT01785472|157834488|FG002|Overall Study|Physician Decision|1|||
48999967|NCT01785472|157834486|FG000|Overall Study|Protocol deviation|0|||
48999968|NCT01785472|157834487|FG001|Overall Study|Protocol deviation|2|||
48999969|NCT01785472|157834488|FG002|Overall Study|Protocol deviation|2|||
48999970|NCT01785472|157834486|FG000|Overall Study|Subject/guardian decision|15|||
48999971|NCT01785472|157834487|FG001|Overall Study|Subject/guardian decision|10|||
48999972|NCT01785472|157834488|FG002|Overall Study|Subject/guardian decision|11|||
48999973|NCT01785472|157834486|FG000|Overall Study|Technical problems|0|||
48999974|NCT01785472|157834487|FG001|Overall Study|Technical problems|0|||
48999975|NCT01785472|157834488|FG002|Overall Study|Technical problems|1|||
48999976|NCT00557830|157834494|FG000|Screening Treatment Phase|Withdrawal by Subject|1|||
48999977|NCT00557830|157834495|FG001|Screening Treatment Phase|Withdrawal by Subject|0|||
48999978|NCT00557830|157834496|FG002|Screening Treatment Phase|Withdrawal by Subject|0|||
48999979|NCT00557830|157834494|FG000|Screening Treatment Phase|Adverse Event|2|||
48999980|NCT00557830|157834495|FG001|Screening Treatment Phase|Adverse Event|0|||
48999981|NCT00557830|157834496|FG002|Screening Treatment Phase|Adverse Event|0|||
48999982|NCT00557830|157834494|FG000|Screening Treatment Phase|Unable to tolerate standard dose|3|||
48999983|NCT00557830|157834495|FG001|Screening Treatment Phase|Unable to tolerate standard dose|0|||
48999984|NCT00557830|157834496|FG002|Screening Treatment Phase|Unable to tolerate standard dose|0|||
48999985|NCT02086968|157834499|FG000|Overall Study|Adverse Event|1|||
48999986|NCT02086968|157834500|FG001|Overall Study|Adverse Event|5|||
48999987|NCT02086968|157834499|FG000|Overall Study|Lost to Follow-up|2|||
48999988|NCT02086968|157834500|FG001|Overall Study|Lost to Follow-up|3|||
48999989|NCT02086968|157834499|FG000|Overall Study|Study drug received outside protocol|0|||
48999990|NCT02086968|157834500|FG001|Overall Study|Study drug received outside protocol|1|||
48999991|NCT02086968|157834499|FG000|Overall Study|Physician Decision|4|||
48999992|NCT02086968|157834500|FG001|Overall Study|Physician Decision|0|||
48999993|NCT02086968|157834499|FG000|Overall Study|Withdrawal by Subject|1|||
48999994|NCT02086968|157834500|FG001|Overall Study|Withdrawal by Subject|4|||
48999995|NCT00538473|157834502|FG000|Overall Study|Adverse Event|1|||
48999996|NCT00538473|157834503|FG001|Overall Study|Adverse Event|0|||
48999997|NCT04964960|157834504|FG000|Overall Study|Withdrawal by Subject|1|||
48999998|NCT02007512|157834505|FG000|Double Blind Treatment Period|Adverse Event|4|||
48999999|NCT02007512|157834506|FG001|Double Blind Treatment Period|Adverse Event|2|||
49000000|NCT02007512|157834507|FG002|Double Blind Treatment Period|Adverse Event|6|||
49000001|NCT02007512|157834508|FG003|Double Blind Treatment Period|Adverse Event|2|||
49000002|NCT02007512|157834505|FG000|Double Blind Treatment Period|Death|1|||
49000003|NCT02007512|157834506|FG001|Double Blind Treatment Period|Death|0|||
49000004|NCT02007512|157834507|FG002|Double Blind Treatment Period|Death|0|||
49000005|NCT02007512|157834508|FG003|Double Blind Treatment Period|Death|0|||
49000006|NCT02007512|157834505|FG000|Double Blind Treatment Period|Disease progression|44|||
49000007|NCT02007512|157834506|FG001|Double Blind Treatment Period|Disease progression|49|||
49000008|NCT02007512|157834507|FG002|Double Blind Treatment Period|Disease progression|45|||
49000009|NCT02007512|157834508|FG003|Double Blind Treatment Period|Disease progression|51|||
49000010|NCT02007512|157834505|FG000|Double Blind Treatment Period|Withdrawal by Subject|4|||
49000011|NCT02007512|157834506|FG001|Double Blind Treatment Period|Withdrawal by Subject|2|||
49000012|NCT02007512|157834507|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
49000013|NCT02007512|157834508|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
49000014|NCT02007512|157834505|FG000|Double Blind Treatment Period|Protocol Violation|0|||
49000015|NCT02007512|157834506|FG001|Double Blind Treatment Period|Protocol Violation|0|||
49000016|NCT02007512|157834507|FG002|Double Blind Treatment Period|Protocol Violation|0|||
49000017|NCT02007512|157834508|FG003|Double Blind Treatment Period|Protocol Violation|1|||
49000018|NCT02007512|157834505|FG000|Double Blind Treatment Period|Other|0|||
49000019|NCT02007512|157834506|FG001|Double Blind Treatment Period|Other|0|||
49000020|NCT02007512|157834507|FG002|Double Blind Treatment Period|Other|1|||
49000021|NCT02007512|157834508|FG003|Double Blind Treatment Period|Other|2|||
49000022|NCT02007512|157834505|FG000|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|10|||
49000023|NCT02007512|157834506|FG001|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|11|||
49000024|NCT02007512|157834507|FG002|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|5|||
49000025|NCT02007512|157834508|FG003|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|1|||
49000026|NCT02007512|157834505|FG000|Open Label Treatment Period|Adverse Event|0|||
49045845|NCT02300987|158002026|FG000|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1|||
49045846|NCT02300987|158002027|FG001|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0|||
49000027|NCT02007512|157834506|FG001|Open Label Treatment Period|Adverse Event|1|||
49000028|NCT02007512|157834507|FG002|Open Label Treatment Period|Adverse Event|0|||
49000029|NCT02007512|157834508|FG003|Open Label Treatment Period|Adverse Event|0|||
49000030|NCT02007512|157834505|FG000|Open Label Treatment Period|Other|0|||
49000031|NCT02007512|157834506|FG001|Open Label Treatment Period|Other|0|||
49000032|NCT02007512|157834507|FG002|Open Label Treatment Period|Other|0|||
49000033|NCT02007512|157834508|FG003|Open Label Treatment Period|Other|1|||
49000034|NCT02007512|157834505|FG000|Open Label Treatment Period|Disease progression|0|||
49000035|NCT02007512|157834506|FG001|Open Label Treatment Period|Disease progression|17|||
49000036|NCT02007512|157834507|FG002|Open Label Treatment Period|Disease progression|0|||
49000037|NCT02007512|157834508|FG003|Open Label Treatment Period|Disease progression|11|||
49000038|NCT02007512|157834505|FG000|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
49000039|NCT02007512|157834506|FG001|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|3|||
49000040|NCT02007512|157834507|FG002|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
49000041|NCT02007512|157834508|FG003|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
49000042|NCT03701516|157834514|FG000|Period 1|Lost to Follow-up|0|||
49000043|NCT03701516|157834515|FG001|Period 1|Lost to Follow-up|1|||
49000044|NCT03701516|157834514|FG000|Period 1|Adverse Event|0|||
49000045|NCT03701516|157834515|FG001|Period 1|Adverse Event|2|||
49000046|NCT03701516|157834514|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|2|||
49000047|NCT03701516|157834515|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
49000048|NCT03701516|157834514|FG000|Period 1|Non Compliance to Protocol|2|||
49000049|NCT03701516|157834515|FG001|Period 1|Non Compliance to Protocol|1|||
49000050|NCT03701516|157834514|FG000|Period 1|Withdrawal by Subject|0|||
49000051|NCT03701516|157834515|FG001|Period 1|Withdrawal by Subject|1|||
49000052|NCT03701516|157834514|FG000|Period 2|failed to meet all eligibility creiteria|1|||
49000053|NCT03701516|157834515|FG001|Period 2|failed to meet all eligibility creiteria|0|||
49000054|NCT03701516|157834514|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
49000055|NCT03701516|157834515|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
49000056|NCT03644927|157834516|FG000|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|1|||
49000057|NCT03644927|157834517|FG001|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|0|||
49000058|NCT00956813|157834520|FG000|Flaxseed and Placebo|Withdrawal by Subject|5|||
49000059|NCT00956813|157834521|FG001|Flaxseed and Placebo|Withdrawal by Subject|4|||
49000060|NCT00956813|157834520|FG000|Flaxseed and Placebo|Ineligible|3|||
49000061|NCT00956813|157834521|FG001|Flaxseed and Placebo|Ineligible|1|||
49000062|NCT04797637|157834522|FG000|Overall Study|Lost to Follow-up|23|||
49000063|NCT04797637|157834523|FG001|Overall Study|Lost to Follow-up|32|||
49000064|NCT04797637|157834522|FG000|Overall Study|Withdrawal by Subject|0|||
49000065|NCT04797637|157834523|FG001|Overall Study|Withdrawal by Subject|1|||
49000066|NCT03151707|157834524|FG000|Overall Study|Lost to Follow-up|6|||
49000067|NCT03332212|157834526|FG000|Overall Study|Not treated|0|||
49000068|NCT03332212|157834527|FG001|Overall Study|Not treated|1|||
49000069|NCT03332212|157834528|FG002|Overall Study|Not treated|0|||
49000070|NCT03332212|157834529|FG003|Overall Study|Not treated|0|||
49000071|NCT03332212|157834526|FG000|Overall Study|Adverse Event|0|||
49000072|NCT03332212|157834527|FG001|Overall Study|Adverse Event|0|||
49000073|NCT03332212|157834528|FG002|Overall Study|Adverse Event|0|||
49000074|NCT03332212|157834529|FG003|Overall Study|Adverse Event|1|||
49000075|NCT03332212|157834526|FG000|Overall Study|worsening of disease under study|1|||
49000076|NCT03332212|157834527|FG001|Overall Study|worsening of disease under study|1|||
49000077|NCT03332212|157834528|FG002|Overall Study|worsening of disease under study|0|||
49000078|NCT03332212|157834529|FG003|Overall Study|worsening of disease under study|0|||
49000079|NCT02666768|157834539|FG000|Overall Study|Withdrawal by Subject|4|||
49000080|NCT03728257|157834540|FG000|Overall Study|Death|3|||
49045847|NCT02300987|158002026|FG000|Secondary Phase : Cross-over to LEE011|Adverse Event|0|||
49000081|NCT03728257|157834541|FG001|Overall Study|Death|0|||
49000082|NCT00061568|157834543|FG000|Overall Study|Lost to Follow-up|12|||
49000083|NCT00061568|157834544|FG001|Overall Study|Lost to Follow-up|0|||
49000084|NCT00061568|157834543|FG000|Overall Study|Death|6|||
49000085|NCT00061568|157834544|FG001|Overall Study|Death|0|||
49000086|NCT00061568|157834543|FG000|Overall Study|Withdrawal by Subject|1|||
49000087|NCT00061568|157834544|FG001|Overall Study|Withdrawal by Subject|0|||
49000088|NCT04798027|157834549|FG000|Overall Study|Protocol Violation|0|||
49000089|NCT04798027|157834550|FG001|Overall Study|Protocol Violation|0|||
49000090|NCT04798027|157834551|FG002|Overall Study|Protocol Violation|0|||
49000091|NCT04798027|157834552|FG003|Overall Study|Protocol Violation|0|||
49000092|NCT04798027|157834553|FG004|Overall Study|Protocol Violation|1|||
49000093|NCT04798027|157834554|FG005|Overall Study|Protocol Violation|0|||
49000094|NCT04798027|157834555|FG006|Overall Study|Protocol Violation|0|||
49000095|NCT04798027|157834556|FG007|Overall Study|Protocol Violation|1|||
49000096|NCT04798027|157834557|FG008|Overall Study|Protocol Violation|0|||
49000097|NCT04798027|157834549|FG000|Overall Study|Withdrawal by Subject|1|||
49000098|NCT04798027|157834550|FG001|Overall Study|Withdrawal by Subject|0|||
49000099|NCT04798027|157834551|FG002|Overall Study|Withdrawal by Subject|1|||
49000100|NCT04798027|157834552|FG003|Overall Study|Withdrawal by Subject|1|||
49000101|NCT04798027|157834553|FG004|Overall Study|Withdrawal by Subject|1|||
49000102|NCT04798027|157834554|FG005|Overall Study|Withdrawal by Subject|1|||
49000103|NCT04798027|157834555|FG006|Overall Study|Withdrawal by Subject|3|||
49000104|NCT04798027|157834556|FG007|Overall Study|Withdrawal by Subject|2|||
49000105|NCT04798027|157834557|FG008|Overall Study|Withdrawal by Subject|2|||
49000106|NCT04798027|157834549|FG000|Overall Study|Lost to Follow-up|1|||
49000107|NCT04798027|157834550|FG001|Overall Study|Lost to Follow-up|3|||
49000108|NCT04798027|157834551|FG002|Overall Study|Lost to Follow-up|0|||
49000109|NCT04798027|157834552|FG003|Overall Study|Lost to Follow-up|0|||
49000110|NCT04798027|157834553|FG004|Overall Study|Lost to Follow-up|0|||
49000111|NCT04798027|157834554|FG005|Overall Study|Lost to Follow-up|1|||
49000112|NCT04798027|157834555|FG006|Overall Study|Lost to Follow-up|0|||
49000113|NCT04798027|157834556|FG007|Overall Study|Lost to Follow-up|0|||
49000114|NCT04798027|157834557|FG008|Overall Study|Lost to Follow-up|1|||
49000115|NCT04798027|157834549|FG000|Overall Study|Withdrawal by Sponsor|8|||
49000116|NCT04798027|157834550|FG001|Overall Study|Withdrawal by Sponsor|22|||
49000117|NCT04798027|157834551|FG002|Overall Study|Withdrawal by Sponsor|9|||
49000118|NCT04798027|157834552|FG003|Overall Study|Withdrawal by Sponsor|26|||
49000119|NCT04798027|157834553|FG004|Overall Study|Withdrawal by Sponsor|24|||
49000120|NCT04798027|157834554|FG005|Overall Study|Withdrawal by Sponsor|11|||
49000121|NCT04798027|157834555|FG006|Overall Study|Withdrawal by Sponsor|25|||
49000122|NCT04798027|157834556|FG007|Overall Study|Withdrawal by Sponsor|26|||
49000123|NCT04798027|157834557|FG008|Overall Study|Withdrawal by Sponsor|11|||
49000124|NCT00903409|157834558|FG000|Overall Study|Adverse Event|11|||
49000125|NCT00903409|157834559|FG001|Overall Study|Adverse Event|9|||
49000126|NCT00903409|157834558|FG000|Overall Study|Non-compliance with Protocol|1|||
49000127|NCT00903409|157834559|FG001|Overall Study|Non-compliance with Protocol|1|||
49000128|NCT00903409|157834558|FG000|Overall Study|Laboratory Abnormality|2|||
49000129|NCT00903409|157834559|FG001|Overall Study|Laboratory Abnormality|0|||
49000130|NCT00903409|157834558|FG000|Overall Study|Withdrawal by Subject|8|||
49000131|NCT00903409|157834559|FG001|Overall Study|Withdrawal by Subject|8|||
49000132|NCT00903409|157834558|FG000|Overall Study|Other|2|||
49000133|NCT00903409|157834559|FG001|Overall Study|Other|3|||
49000134|NCT00903409|157834558|FG000|Overall Study|Lost to Follow-up|2|||
49000135|NCT00903409|157834559|FG001|Overall Study|Lost to Follow-up|6|||
49000136|NCT03862807|157836120|FG000|Overall Study|Not Treated Due to Eligibility Criteria Failure|1|||
49000137|NCT04362761|157836121|FG000|Part A (48 Weeks)|Adverse Event|2|||
49000138|NCT04362761|157836121|FG000|Part A (48 Weeks)|Withdrawal of consent (not due to AE)|4|||
49000139|NCT04362761|157836121|FG000|Part A (48 Weeks)|Commercial drug is available for participant|2|||
49000140|NCT04362761|157836121|FG000|Part A (48 Weeks)|Other|5|||
49000141|NCT04362761|157836121|FG000|Part B (86 Weeks)|Commercial drug is available for participant|46|||
49000142|NCT04362761|157836121|FG000|Part B (86 Weeks)|Other|4|||
49000143|NCT00684645|157836122|FG000|Overall Study|Death|2|||
49000144|NCT00684645|157836122|FG000|Overall Study|Progressive disease|67|||
49000145|NCT00684645|157836122|FG000|Overall Study|Adverse Event|27|||
49000146|NCT00684645|157836122|FG000|Overall Study|Lost to Follow-up|3|||
49000147|NCT00684645|157836122|FG000|Overall Study|Other|15|||
49000148|NCT02856282|157836129|FG000|Overall Study|Withdrawal by Subject|1|||
49000149|NCT00057330|157836130|FG000|Overall Study|Adverse Event|9|||
49000150|NCT00057330|157836131|FG001|Overall Study|Adverse Event|12|||
49000151|NCT00057330|157836130|FG000|Overall Study|Death|1|||
49000152|NCT00057330|157836131|FG001|Overall Study|Death|0|||
49000153|NCT00057330|157836130|FG000|Overall Study|Protocol Violation|1|||
49000154|NCT00057330|157836131|FG001|Overall Study|Protocol Violation|1|||
49000155|NCT00057330|157836130|FG000|Overall Study|Withdrawal by Subject|115|||
49000156|NCT00057330|157836131|FG001|Overall Study|Withdrawal by Subject|84|||
49000157|NCT00057330|157836130|FG000|Overall Study|Lost to Follow-up|745|||
49000158|NCT00057330|157836131|FG001|Overall Study|Lost to Follow-up|617|||
49000159|NCT00057330|157836130|FG000|Overall Study|Physician Decision|1|||
49000160|NCT00057330|157836131|FG001|Overall Study|Physician Decision|0|||
49000161|NCT00057330|157836130|FG000|Overall Study|Other|260|||
49000162|NCT00057330|157836131|FG001|Overall Study|Other|206|||
49000163|NCT02074982|157836132|FG000|Overall Study|Adverse Event|15|||
49000164|NCT02074982|157836133|FG001|Overall Study|Adverse Event|7|||
49000165|NCT02074982|157836132|FG000|Overall Study|Lack of Efficacy|6|||
49000166|NCT02074982|157836133|FG001|Overall Study|Lack of Efficacy|1|||
49000167|NCT02074982|157836132|FG000|Overall Study|Lost to Follow-up|9|||
49000168|NCT02074982|157836133|FG001|Overall Study|Lost to Follow-up|10|||
49000169|NCT02074982|157836132|FG000|Overall Study|Non-compliance with study treatment|0|||
49000170|NCT02074982|157836133|FG001|Overall Study|Non-compliance with study treatment|2|||
49000171|NCT02074982|157836132|FG000|Overall Study|Physician Decision|1|||
49000172|NCT02074982|157836133|FG001|Overall Study|Physician Decision|1|||
49000173|NCT02074982|157836132|FG000|Overall Study|Pregnancy|1|||
49000174|NCT02074982|157836133|FG001|Overall Study|Pregnancy|2|||
49000175|NCT02074982|157836132|FG000|Overall Study|Protocol deviation|4|||
49000176|NCT02074982|157836133|FG001|Overall Study|Protocol deviation|3|||
49000177|NCT02074982|157836132|FG000|Overall Study|Technical problems|0|||
49000178|NCT02074982|157836133|FG001|Overall Study|Technical problems|2|||
49000179|NCT02074982|157836132|FG000|Overall Study|Subject/guardian decision|15|||
49000180|NCT02074982|157836133|FG001|Overall Study|Subject/guardian decision|24|||
49000181|NCT02074982|157836132|FG000|Overall Study|Death|0|||
49000182|NCT02074982|157836133|FG001|Overall Study|Death|2|||
49000183|NCT00798707|157836139|FG000|Overall Study|Adverse Event|6|||
49000184|NCT00798707|157836140|FG001|Overall Study|Adverse Event|8|||
49000185|NCT00798707|157836141|FG002|Overall Study|Adverse Event|8|||
49000186|NCT00798707|157836139|FG000|Overall Study|Failed to return|2|||
49000187|NCT00798707|157836140|FG001|Overall Study|Failed to return|2|||
49000188|NCT00798707|157836141|FG002|Overall Study|Failed to return|0|||
49000189|NCT00798707|157836139|FG000|Overall Study|Investigator|0|||
49000190|NCT00798707|157836140|FG001|Overall Study|Investigator|1|||
49000191|NCT00798707|157836141|FG002|Overall Study|Investigator|2|||
49000192|NCT00798707|157836139|FG000|Overall Study|Lack of Efficacy|2|||
49000193|NCT00798707|157836140|FG001|Overall Study|Lack of Efficacy|2|||
49000194|NCT00798707|157836141|FG002|Overall Study|Lack of Efficacy|1|||
49000195|NCT00798707|157836139|FG000|Overall Study|Lost to Follow-up|5|||
49000196|NCT00798707|157836140|FG001|Overall Study|Lost to Follow-up|6|||
49000197|NCT00798707|157836141|FG002|Overall Study|Lost to Follow-up|6|||
49000198|NCT00798707|157836139|FG000|Overall Study|Other|0|||
49000199|NCT00798707|157836140|FG001|Overall Study|Other|1|||
49000200|NCT00798707|157836141|FG002|Overall Study|Other|0|||
49000201|NCT00798707|157836139|FG000|Overall Study|Protocol Violation|4|||
49000202|NCT00798707|157836140|FG001|Overall Study|Protocol Violation|0|||
49000203|NCT00798707|157836141|FG002|Overall Study|Protocol Violation|2|||
49000204|NCT00798707|157836139|FG000|Overall Study|Withdrawal by Subject|3|||
49000205|NCT00798707|157836140|FG001|Overall Study|Withdrawal by Subject|8|||
49000206|NCT00798707|157836141|FG002|Overall Study|Withdrawal by Subject|2|||
49000207|NCT00798707|157836139|FG000|Overall Study|Randomized not treated|4|||
49000208|NCT00798707|157836140|FG001|Overall Study|Randomized not treated|5|||
49000209|NCT00798707|157836141|FG002|Overall Study|Randomized not treated|1|||
49000210|NCT04635631|157836145|FG000|Overall Study|Adverse Event|1|||
49000211|NCT04635631|157836145|FG000|Overall Study|Progressive disease|13|||
49000212|NCT04635631|157836145|FG000|Overall Study|Withdrawal by Subject|1|||
49000213|NCT04512976|157836151|FG000|Overall Study|Unable to complete the exercise protocols in the study.|0|||
49000214|NCT04512976|157836152|FG001|Overall Study|Unable to complete the exercise protocols in the study.|0|||
49000215|NCT04512976|157836153|FG002|Overall Study|Unable to complete the exercise protocols in the study.|0|||
49000216|NCT04512976|157836154|FG003|Overall Study|Unable to complete the exercise protocols in the study.|0|||
49000217|NCT04512976|157836155|FG004|Overall Study|Unable to complete the exercise protocols in the study.|0|||
49000218|NCT04512976|157836156|FG005|Overall Study|Unable to complete the exercise protocols in the study.|3|||
49000219|NCT01569074|157836157|FG000|Overall Study|Study stopped|6|||
49000220|NCT01569074|157836158|FG001|Overall Study|Study stopped|6|||
49000221|NCT01569074|157836159|FG002|Overall Study|Study stopped|8|||
49000222|NCT01569074|157836160|FG003|Overall Study|Study stopped|7|||
49000223|NCT01569074|157836161|FG004|Overall Study|Study stopped|7|||
49000224|NCT01569074|157836157|FG000|Overall Study|Study-specific discontinuation criteria|0|||
49000225|NCT01569074|157836158|FG001|Overall Study|Study-specific discontinuation criteria|1|||
49000226|NCT01569074|157836159|FG002|Overall Study|Study-specific discontinuation criteria|0|||
49000227|NCT01569074|157836160|FG003|Overall Study|Study-specific discontinuation criteria|0|||
49000228|NCT01569074|157836161|FG004|Overall Study|Study-specific discontinuation criteria|0|||
49000229|NCT01569074|157836157|FG000|Overall Study|Severe non-compliance to protocol|0|||
49000230|NCT01569074|157836158|FG001|Overall Study|Severe non-compliance to protocol|0|||
49000231|NCT01569074|157836159|FG002|Overall Study|Severe non-compliance to protocol|1|||
49000232|NCT01569074|157836160|FG003|Overall Study|Severe non-compliance to protocol|0|||
49000233|NCT01569074|157836161|FG004|Overall Study|Severe non-compliance to protocol|0|||
49000234|NCT01569074|157836157|FG000|Overall Study|eg change in circumstances|0|||
49000235|NCT01569074|157836158|FG001|Overall Study|eg change in circumstances|2|||
49000236|NCT01569074|157836159|FG002|Overall Study|eg change in circumstances|0|||
49000237|NCT01569074|157836160|FG003|Overall Study|eg change in circumstances|1|||
49000238|NCT01569074|157836161|FG004|Overall Study|eg change in circumstances|1|||
49000239|NCT01569074|157836157|FG000|Overall Study|Adverse Event|1|||
49000240|NCT01569074|157836158|FG001|Overall Study|Adverse Event|0|||
49000241|NCT01569074|157836159|FG002|Overall Study|Adverse Event|3|||
49000242|NCT01569074|157836160|FG003|Overall Study|Adverse Event|0|||
49000243|NCT01569074|157836161|FG004|Overall Study|Adverse Event|0|||
49000244|NCT03387735|157836162|FG000|Overall Study|Lost to Follow-up|4|||
49000245|NCT03387735|157836163|FG001|Overall Study|Lost to Follow-up|8|||
49000246|NCT03387735|157836162|FG000|Overall Study|Death|4|||
49000247|NCT03387735|157836163|FG001|Overall Study|Death|8|||
49000248|NCT01803464|157836164|FG000|Overall Study|Incomplete data|0|||
49000249|NCT01803464|157836165|FG001|Overall Study|Incomplete data|0|||
49000250|NCT01803464|157836166|FG002|Overall Study|Incomplete data|4|||
49000251|NCT01803464|157836167|FG003|Overall Study|Incomplete data|0|||
49000252|NCT01803464|157836164|FG000|Overall Study|Withdrawal by Subject|1|||
49000253|NCT01803464|157836165|FG001|Overall Study|Withdrawal by Subject|0|||
49000254|NCT01803464|157836166|FG002|Overall Study|Withdrawal by Subject|0|||
49000255|NCT01803464|157836167|FG003|Overall Study|Withdrawal by Subject|0|||
49000256|NCT02297438|157836168|FG000|Overall Study|Death|79|||
49000257|NCT02297438|157836169|FG001|Overall Study|Death|86|||
49000258|NCT02297438|157836168|FG000|Overall Study|Lost to Follow-up|9|||
49000259|NCT02297438|157836169|FG001|Overall Study|Lost to Follow-up|7|||
49000260|NCT02297438|157836168|FG000|Overall Study|Withdrawal by Subject|7|||
49000261|NCT02297438|157836169|FG001|Overall Study|Withdrawal by Subject|0|||
49000262|NCT02297438|157836168|FG000|Overall Study|Other|9|||
49000263|NCT02297438|157836169|FG001|Overall Study|Other|5|||
49000264|NCT02297438|157836168|FG000|Overall Study|Ongoing|65|||
49000265|NCT02297438|157836169|FG001|Overall Study|Ongoing|73|||
49000266|NCT01833897|157836170|FG000|Overall Study|Lack of Efficacy|1|||
49000267|NCT04856917|157836175|FG000|Overall Study|Withdrawal by Subject|4|||
49000268|NCT04856917|157836176|FG001|Overall Study|Withdrawal by Subject|3|||
49000269|NCT04856917|157836177|FG002|Overall Study|Withdrawal by Subject|1|||
49000270|NCT04856917|157836175|FG000|Overall Study|Lost to Follow-up|3|||
49000271|NCT04856917|157836176|FG001|Overall Study|Lost to Follow-up|1|||
49000272|NCT04856917|157836177|FG002|Overall Study|Lost to Follow-up|1|||
49000273|NCT04856917|157836175|FG000|Overall Study|Used of Prohibited Medication or Treatment|0|||
49000274|NCT04856917|157836176|FG001|Overall Study|Used of Prohibited Medication or Treatment|1|||
49000275|NCT04856917|157836177|FG002|Overall Study|Used of Prohibited Medication or Treatment|2|||
49000276|NCT04856917|157836175|FG000|Overall Study|Other|1|||
49000277|NCT04856917|157836176|FG001|Overall Study|Other|1|||
49000278|NCT04856917|157836177|FG002|Overall Study|Other|0|||
49000279|NCT01360021|157836178|FG000|Overall Study|Eligibility criteria + other|2|||
49000280|NCT01360021|157836179|FG001|Overall Study|Eligibility criteria + other|1|||
49000281|NCT01360021|157836180|FG002|Overall Study|Eligibility criteria + other|1|||
49000282|NCT01360021|157836178|FG000|Overall Study|Protocol Violation|0|||
49000283|NCT01360021|157836179|FG001|Overall Study|Protocol Violation|0|||
49000284|NCT01360021|157836180|FG002|Overall Study|Protocol Violation|1|||
49000285|NCT01360021|157836178|FG000|Overall Study|Withdrawal by Subject|4|||
49000286|NCT01360021|157836179|FG001|Overall Study|Withdrawal by Subject|0|||
49000287|NCT01360021|157836180|FG002|Overall Study|Withdrawal by Subject|2|||
49000288|NCT01360021|157836178|FG000|Overall Study|Adverse Event|2|||
49000289|NCT01360021|157836179|FG001|Overall Study|Adverse Event|3|||
49000290|NCT01360021|157836180|FG002|Overall Study|Adverse Event|3|||
49000291|NCT00110084|157836181|FG000|Overall Study|Adverse Event|9|||
49000292|NCT00110084|157836181|FG000|Overall Study|Death|1|||
49000293|NCT00110084|157836181|FG000|Overall Study|Patient Refusal|10|||
49000294|NCT00110084|157836181|FG000|Overall Study|Alternate Therapy|5|||
49000295|NCT00110084|157836181|FG000|Overall Study|Intercurrent Illness|1|||
49000296|NCT00110084|157836181|FG000|Overall Study|Other|2|||
49000297|NCT00537056|157836183|FG000|Interim PET/CT|scheduling conflicts and/or exposure|5|||
49000298|NCT04854707|157836184|FG000|Overall Study|Lack of Efficacy|78|||
49000299|NCT04854707|157836185|FG001|Overall Study|Lack of Efficacy|59|||
49000300|NCT04854707|157836186|FG002|Overall Study|Lack of Efficacy|30|||
49000301|NCT01257737|157836188|FG000|Overall Study|Lost to Follow-up|1|||
49000302|NCT01257737|157836189|FG001|Overall Study|Lost to Follow-up|2|||
49000303|NCT01257737|157836188|FG000|Overall Study|Liver transplant|1|||
49000304|NCT01257737|157836189|FG001|Overall Study|Liver transplant|0|||
49000305|NCT01257737|157836188|FG000|Overall Study|Relocation out of the country|0|||
49000306|NCT01257737|157836189|FG001|Overall Study|Relocation out of the country|1|||
49000307|NCT01257737|157836188|FG000|Overall Study|Withdrew from study|0|||
49000308|NCT01257737|157836189|FG001|Overall Study|Withdrew from study|1|||
49000309|NCT03170271|157836197|FG000|Overall Study|Adverse Event|7|||
49000310|NCT03170271|157836198|FG001|Overall Study|Adverse Event|2|||
49000311|NCT03170271|157836197|FG000|Overall Study|Lost to Follow-up|0|||
49000312|NCT03170271|157836198|FG001|Overall Study|Lost to Follow-up|1|||
49000313|NCT03170271|157836197|FG000|Overall Study|Physician Decision|1|||
49000314|NCT03170271|157836198|FG001|Overall Study|Physician Decision|0|||
49000315|NCT03170271|157836197|FG000|Overall Study|Protocol-specified withdrawal criterion|2|||
49000316|NCT03170271|157836198|FG001|Overall Study|Protocol-specified withdrawal criterion|1|||
49045848|NCT02300987|158002027|FG001|Secondary Phase : Cross-over to LEE011|Adverse Event|1|||
49000317|NCT03170271|157836197|FG000|Overall Study|Withdrawal by Subject|17|||
49000318|NCT03170271|157836198|FG001|Overall Study|Withdrawal by Subject|5|||
49000319|NCT03170271|157836197|FG000|Overall Study|Other|2|||
49000320|NCT03170271|157836198|FG001|Overall Study|Other|2|||
49000321|NCT03170271|157836197|FG000|Overall Study|Randomized in error|4|||
49000322|NCT03170271|157836198|FG001|Overall Study|Randomized in error|0|||
49000323|NCT02380248|157836199|FG000|Overall Study|Lost to Follow-up|11|||
49000324|NCT02380248|157836199|FG000|Overall Study|Withdrawal by Subject|3|||
49000325|NCT03985293|157836200|FG000|DOUBLE-BLIND TREATMENT|Adverse Event|5|||
49000326|NCT03985293|157836201|FG001|DOUBLE-BLIND TREATMENT|Adverse Event|2|||
49000327|NCT03985293|157836202|FG002|DOUBLE-BLIND TREATMENT|Adverse Event|3|||
49000328|NCT03985293|157836203|FG003|DOUBLE-BLIND TREATMENT|Adverse Event|8|||
49000329|NCT03985293|157836204|FG004|DOUBLE-BLIND TREATMENT|Adverse Event|15|||
49000330|NCT03985293|157836205|FG005|DOUBLE-BLIND TREATMENT|Adverse Event|24|||
49000331|NCT03985293|157836200|FG000|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
49000332|NCT03985293|157836201|FG001|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
49000333|NCT03985293|157836202|FG002|DOUBLE-BLIND TREATMENT|Lost to Follow-up|0|||
49000334|NCT03985293|157836203|FG003|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
49000335|NCT03985293|157836204|FG004|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
49000336|NCT03985293|157836205|FG005|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
49000337|NCT03985293|157836200|FG000|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
49000338|NCT03985293|157836201|FG001|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
49000339|NCT03985293|157836202|FG002|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
49000340|NCT03985293|157836203|FG003|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
49000341|NCT03985293|157836204|FG004|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
49000342|NCT03985293|157836205|FG005|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
49000343|NCT03985293|157836200|FG000|DOUBLE-BLIND TREATMENT|Other|1|||
49000344|NCT03985293|157836201|FG001|DOUBLE-BLIND TREATMENT|Other|2|||
49000345|NCT03985293|157836202|FG002|DOUBLE-BLIND TREATMENT|Other|0|||
49000346|NCT03985293|157836203|FG003|DOUBLE-BLIND TREATMENT|Other|2|||
49000347|NCT03985293|157836204|FG004|DOUBLE-BLIND TREATMENT|Other|1|||
49000348|NCT03985293|157836205|FG005|DOUBLE-BLIND TREATMENT|Other|0|||
49000349|NCT03985293|157836200|FG000|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
49000350|NCT03985293|157836201|FG001|DOUBLE-BLIND TREATMENT|Protocol Violation|2|||
49000351|NCT03985293|157836202|FG002|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
49000352|NCT03985293|157836203|FG003|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
49000353|NCT03985293|157836204|FG004|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
49000354|NCT03985293|157836205|FG005|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
49000355|NCT03985293|157836200|FG000|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
49000356|NCT03985293|157836201|FG001|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|4|||
49000357|NCT03985293|157836202|FG002|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|2|||
49000358|NCT03985293|157836203|FG003|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
49000359|NCT03985293|157836204|FG004|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|1|||
49000360|NCT03985293|157836205|FG005|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|7|||
49000361|NCT03985293|157836200|FG000|FOLLOW-UP|Lost to Follow-up|0|||
49000362|NCT03985293|157836201|FG001|FOLLOW-UP|Lost to Follow-up|0|||
49000363|NCT03985293|157836202|FG002|FOLLOW-UP|Lost to Follow-up|1|||
49000364|NCT03985293|157836203|FG003|FOLLOW-UP|Lost to Follow-up|0|||
49000365|NCT03985293|157836204|FG004|FOLLOW-UP|Lost to Follow-up|0|||
49000366|NCT03985293|157836205|FG005|FOLLOW-UP|Lost to Follow-up|0|||
49000367|NCT01311505|157836206|FG000|First Intervention Period|Protocol Violation|0|||
49000368|NCT01311505|157836207|FG001|First Intervention Period|Protocol Violation|1|||
49000369|NCT03239340|157836208|FG000|Overall Study|Other|26|||
49000370|NCT03239340|157836208|FG000|Overall Study|Patients who are ongoing in the study at DCO|10|||
49000371|NCT03239340|157836208|FG000|Overall Study|Death|40|||
49000372|NCT03239340|157836208|FG000|Overall Study|Lost to Follow-up|2|||
49000373|NCT03239340|157836208|FG000|Overall Study|Physician Decision|16|||
49000374|NCT03239340|157836208|FG000|Overall Study|Withdrawal by Subject|27|||
49000375|NCT03022799|157836212|FG000|Overall Study|Adverse Event|0|||
49000376|NCT03022799|157836213|FG001|Overall Study|Adverse Event|0|||
49000377|NCT03022799|157836214|FG002|Overall Study|Adverse Event|0|||
49000378|NCT03022799|157836215|FG003|Overall Study|Adverse Event|0|||
49000379|NCT03022799|157836216|FG004|Overall Study|Adverse Event|0|||
49000380|NCT03022799|157836217|FG005|Overall Study|Adverse Event|0|||
49000381|NCT03022799|157836218|FG006|Overall Study|Adverse Event|0|||
49000382|NCT03022799|157836219|FG007|Overall Study|Adverse Event|0|||
49000383|NCT03022799|157836220|FG008|Overall Study|Adverse Event|0|||
49000384|NCT03022799|157836221|FG009|Overall Study|Adverse Event|1|||
49000385|NCT03022799|157836222|FG010|Overall Study|Adverse Event|1|||
49000386|NCT03022799|157836223|FG011|Overall Study|Adverse Event|0|||
49000387|NCT03022799|157836224|FG012|Overall Study|Adverse Event|0|||
49000388|NCT01843660|157836240|FG000|Overall Study|Other|30|||
49000389|NCT00563706|157838182|FG000|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4|||
49000390|NCT00563706|157838183|FG001|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
49000391|NCT00563706|157838184|FG002|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
49000392|NCT00563706|157838185|FG003|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
49000393|NCT00563706|157838186|FG004|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
49000394|NCT00563706|157838187|FG005|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
49000395|NCT00563706|157838188|FG006|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
49000396|NCT00563706|157838189|FG007|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
49000397|NCT00563706|157838190|FG008|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5|||
49000398|NCT00563706|157838182|FG000|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
49000399|NCT00563706|157838183|FG001|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
49000400|NCT00563706|157838184|FG002|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
49000401|NCT00563706|157838185|FG003|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4|||
49000402|NCT00563706|157838186|FG004|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
49000403|NCT00563706|157838187|FG005|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
49000404|NCT00563706|157838188|FG006|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
49000405|NCT00563706|157838189|FG007|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5|||
49000406|NCT00563706|157838190|FG008|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
49000407|NCT00563706|157838182|FG000|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9|||
49000408|NCT00563706|157838183|FG001|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
49000409|NCT00563706|157838184|FG002|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2|||
49000410|NCT00563706|157838185|FG003|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5|||
49000411|NCT00563706|157838186|FG004|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4|||
49000412|NCT00563706|157838187|FG005|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
49000413|NCT00563706|157838188|FG006|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1|||
49000414|NCT00563706|157838189|FG007|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6|||
49000415|NCT00563706|157838190|FG008|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
49000416|NCT00563706|157838182|FG000|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2|||
49000417|NCT00563706|157838183|FG001|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
49000418|NCT00563706|157838184|FG002|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
49000419|NCT00563706|157838185|FG003|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
49000420|NCT00563706|157838186|FG004|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
49000421|NCT00563706|157838187|FG005|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
49000422|NCT00563706|157838188|FG006|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
49000423|NCT00563706|157838189|FG007|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1|||
49000424|NCT00563706|157838190|FG008|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
49000425|NCT00563706|157838182|FG000|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
49000426|NCT00563706|157838183|FG001|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
49000427|NCT00563706|157838184|FG002|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
49000428|NCT00563706|157838185|FG003|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
49000429|NCT00563706|157838186|FG004|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
49000430|NCT00563706|157838187|FG005|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
49000431|NCT00563706|157838188|FG006|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
49000432|NCT00563706|157838189|FG007|DB Treatment Period (Day 1 up to Day 28)|Other|1|||
49000433|NCT00563706|157838190|FG008|DB Treatment Period (Day 1 up to Day 28)|Other|2|||
49000434|NCT00564486|157838195|FG000|Overall Study|Adverse Event|0|||
49000435|NCT00564486|157838196|FG001|Overall Study|Adverse Event|1|||
49000436|NCT00564486|157838197|FG002|Overall Study|Adverse Event|0|||
49000437|NCT00564486|157838198|FG003|Overall Study|Adverse Event|0|||
49000438|NCT00564486|157838195|FG000|Overall Study|Withdrawal by Subject|4|||
49000439|NCT00564486|157838196|FG001|Overall Study|Withdrawal by Subject|0|||
49000440|NCT00564486|157838197|FG002|Overall Study|Withdrawal by Subject|0|||
49000441|NCT00564486|157838198|FG003|Overall Study|Withdrawal by Subject|5|||
49000442|NCT00564486|157838195|FG000|Overall Study|Subject refused to have blood drawn|0|||
49000443|NCT00564486|157838196|FG001|Overall Study|Subject refused to have blood drawn|0|||
49000444|NCT00564486|157838197|FG002|Overall Study|Subject refused to have blood drawn|1|||
49000445|NCT00564486|157838198|FG003|Overall Study|Subject refused to have blood drawn|0|||
49000446|NCT00564486|157838195|FG000|Overall Study|Lost to Follow-up|3|||
49000447|NCT00564486|157838196|FG001|Overall Study|Lost to Follow-up|0|||
49000448|NCT00564486|157838197|FG002|Overall Study|Lost to Follow-up|2|||
49000449|NCT00564486|157838198|FG003|Overall Study|Lost to Follow-up|2|||
49000450|NCT00138658|157838203|FG000|Overall Study|Adverse Event|23|||
49000451|NCT00138658|157838203|FG000|Overall Study|Death|1|||
49000452|NCT00138658|157838203|FG000|Overall Study|Disease Progression|21|||
49000453|NCT00138658|157838203|FG000|Overall Study|Physician Decision|11|||
49000454|NCT00138658|157838203|FG000|Overall Study|Withdrawal by Subject|5|||
49000455|NCT02723786|157838207|FG000|Overall Study|Lost to Follow-up|1|||
49000456|NCT00669110|157838208|FG000|Overall Study|Adverse Event|4|||
49000457|NCT00669110|157838209|FG001|Overall Study|Adverse Event|3|||
49000458|NCT00669110|157838208|FG000|Overall Study|Caregiver request|3|||
49000459|NCT00669110|157838209|FG001|Overall Study|Caregiver request|2|||
49000460|NCT00669110|157838208|FG000|Overall Study|Physician Decision|0|||
49000461|NCT00669110|157838209|FG001|Overall Study|Physician Decision|1|||
49000462|NCT00669110|157838208|FG000|Overall Study|Lost to Follow-up|1|||
49000463|NCT00669110|157838209|FG001|Overall Study|Lost to Follow-up|0|||
49000464|NCT00669110|157838208|FG000|Overall Study|Protocol Violation|0|||
49000465|NCT00669110|157838209|FG001|Overall Study|Protocol Violation|5|||
49000466|NCT00669110|157838208|FG000|Overall Study|Withdrawal by Subject|0|||
49000467|NCT00669110|157838209|FG001|Overall Study|Withdrawal by Subject|2|||
49000468|NCT03683719|157838212|FG000|Overall Study|Lack of Efficacy|1|||
49000469|NCT03683719|157838213|FG001|Overall Study|Lack of Efficacy|3|||
49000470|NCT03683719|157838214|FG002|Overall Study|Lack of Efficacy|4|||
49000471|NCT03683719|157838215|FG003|Overall Study|Lack of Efficacy|0|||
49000472|NCT03683719|157838216|FG004|Overall Study|Lack of Efficacy|4|||
49000473|NCT03683719|157838212|FG000|Overall Study|Adverse Event|6|||
49000474|NCT03683719|157838213|FG001|Overall Study|Adverse Event|6|||
49000475|NCT03683719|157838214|FG002|Overall Study|Adverse Event|0|||
49000476|NCT03683719|157838215|FG003|Overall Study|Adverse Event|1|||
49000477|NCT03683719|157838216|FG004|Overall Study|Adverse Event|3|||
49000478|NCT03683719|157838212|FG000|Overall Study|Withdrawal by Subject|4|||
49000479|NCT03683719|157838213|FG001|Overall Study|Withdrawal by Subject|4|||
49000480|NCT03683719|157838214|FG002|Overall Study|Withdrawal by Subject|3|||
49000481|NCT03683719|157838215|FG003|Overall Study|Withdrawal by Subject|5|||
49000482|NCT03683719|157838216|FG004|Overall Study|Withdrawal by Subject|5|||
49000483|NCT03683719|157838212|FG000|Overall Study|Lost to Follow-up|1|||
49000484|NCT03683719|157838213|FG001|Overall Study|Lost to Follow-up|0|||
49000485|NCT03683719|157838214|FG002|Overall Study|Lost to Follow-up|0|||
49000486|NCT03683719|157838215|FG003|Overall Study|Lost to Follow-up|1|||
49000487|NCT03683719|157838216|FG004|Overall Study|Lost to Follow-up|1|||
49000488|NCT03683719|157838212|FG000|Overall Study|Other personal reasons|0|||
49000489|NCT03683719|157838213|FG001|Overall Study|Other personal reasons|0|||
49000490|NCT03683719|157838214|FG002|Overall Study|Other personal reasons|1|||
49000491|NCT03683719|157838215|FG003|Overall Study|Other personal reasons|0|||
49000492|NCT03683719|157838216|FG004|Overall Study|Other personal reasons|1|||
49000493|NCT01870921|157838217|FG000|Overall Study|Subject decision|80|||
49000494|NCT01870921|157838217|FG000|Overall Study|Severe non-compliance to protocol|7|||
49000495|NCT01870921|157838217|FG000|Overall Study|Subject Lost to Follow up|2|||
49000496|NCT01870921|157838217|FG000|Overall Study|Other|1|||
49000497|NCT03123120|157838222|FG000|Overall Study|Lost to Follow-up|0|||
49000498|NCT03123120|157838223|FG001|Overall Study|Lost to Follow-up|1|||
49000499|NCT03123120|157838222|FG000|Overall Study|Withdrawal by Subject|0|||
49000500|NCT03123120|157838223|FG001|Overall Study|Withdrawal by Subject|1|||
49000501|NCT00203892|157838224|FG000|Overall Study|Physician Decision|1|||
49000502|NCT00203892|157838225|FG001|Overall Study|Physician Decision|2|||
49000503|NCT00203892|157838226|FG002|Overall Study|Physician Decision|0|||
49000504|NCT00203892|157838224|FG000|Overall Study|Death|1|||
49000505|NCT00203892|157838225|FG001|Overall Study|Death|0|||
49000506|NCT00203892|157838226|FG002|Overall Study|Death|0|||
49000507|NCT00806416|157838227|FG000|Period 1 - Part I|Adverse Event|0|||
49000508|NCT00806416|157838228|FG001|Period 1 - Part I|Adverse Event|1|||
49000509|NCT00806416|157838229|FG002|Period 1 - Part I|Adverse Event|0|||
49000510|NCT00806416|157838230|FG003|Period 1 - Part I|Adverse Event|0|||
49000511|NCT00806416|157838227|FG000|Period 1 - Part I|Lost to Follow-up|0|||
49000512|NCT00806416|157838228|FG001|Period 1 - Part I|Lost to Follow-up|2|||
49000513|NCT00806416|157838229|FG002|Period 1 - Part I|Lost to Follow-up|0|||
49000514|NCT00806416|157838230|FG003|Period 1 - Part I|Lost to Follow-up|0|||
49000515|NCT00806416|157838227|FG000|Period 1 - Part I|Withdrawal by Subject|3|||
49000516|NCT00806416|157838228|FG001|Period 1 - Part I|Withdrawal by Subject|1|||
49000517|NCT00806416|157838229|FG002|Period 1 - Part I|Withdrawal by Subject|0|||
49000518|NCT00806416|157838230|FG003|Period 1 - Part I|Withdrawal by Subject|0|||
49000519|NCT00806416|157838227|FG000|Period 1 - Part II|Withdrawal by Subject|0|||
49000520|NCT00806416|157838228|FG001|Period 1 - Part II|Withdrawal by Subject|0|||
49000521|NCT00806416|157838229|FG002|Period 1 - Part II|Withdrawal by Subject|0|||
49000522|NCT00806416|157838230|FG003|Period 1 - Part II|Withdrawal by Subject|2|||
49000523|NCT01610284|157838236|FG000|Randomization Phase|Adverse Event|1|||
49000524|NCT01610284|157838237|FG001|Randomization Phase|Adverse Event|0|||
49000525|NCT01610284|157838236|FG000|Randomization Phase|Physician Decision|1|||
49000526|NCT01610284|157838237|FG001|Randomization Phase|Physician Decision|1|||
49000527|NCT01610284|157838236|FG000|Randomization Phase|Death|0|||
49000528|NCT01610284|157838237|FG001|Randomization Phase|Death|1|||
49000529|NCT01610284|157838236|FG000|Treatment Phase|Adverse Event|80|||
49000530|NCT01610284|157838237|FG001|Treatment Phase|Adverse Event|12|||
49000531|NCT01610284|157838236|FG000|Treatment Phase|Lost to Follow-up|1|||
49000532|NCT01610284|157838237|FG001|Treatment Phase|Lost to Follow-up|0|||
49000533|NCT01610284|157838236|FG000|Treatment Phase|Non-compliance with Study Treatment|8|||
49000534|NCT01610284|157838237|FG001|Treatment Phase|Non-compliance with Study Treatment|1|||
49000535|NCT01610284|157838236|FG000|Treatment Phase|Physician Decision|27|||
49000536|NCT01610284|157838237|FG001|Treatment Phase|Physician Decision|24|||
49000537|NCT01610284|157838236|FG000|Treatment Phase|Progressive Disease|377|||
49000538|NCT01610284|157838237|FG001|Treatment Phase|Progressive Disease|486|||
49000539|NCT01610284|157838236|FG000|Treatment Phase|Protocol Deviation|2|||
49000540|NCT01610284|157838237|FG001|Treatment Phase|Protocol Deviation|3|||
49000541|NCT01610284|157838236|FG000|Treatment Phase|Study terminated by Sponsor|18|||
49000542|NCT01610284|157838237|FG001|Treatment Phase|Study terminated by Sponsor|15|||
49000543|NCT01610284|157838236|FG000|Treatment Phase|Subject/Guardian Decision|55|||
49000544|NCT01610284|157838237|FG001|Treatment Phase|Subject/Guardian Decision|23|||
49000545|NCT01610284|157838236|FG000|Treatment Phase|Death|6|||
49000546|NCT01610284|157838237|FG001|Treatment Phase|Death|5|||
49000547|NCT01610284|157838236|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
49000548|NCT01610284|157838237|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
49000549|NCT01610284|157838236|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10|||
49000550|NCT01610284|157838237|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3|||
49000551|NCT01610284|157838236|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24|||
49045849|NCT00660387|158002030|FG000|Overall Study|Adverse Event|1|||
49000552|NCT01610284|157838237|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8|||
49000553|NCT01610284|157838236|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11|||
49000554|NCT01610284|157838237|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
49000555|NCT01610284|157838236|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
49000556|NCT01610284|157838237|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
49000557|NCT01610284|157838236|FG000|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38|||
49000558|NCT01610284|157838237|FG001|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13|||
49000559|NCT03083639|157838238|FG000|Washout Period (at Least 6 Days)|Pregnancy|0|||
49000560|NCT03083639|157838239|FG001|Washout Period (at Least 6 Days)|Pregnancy|1|||
49000561|NCT03083639|157838238|FG000|Washout Period (at Least 6 Days)|Lost to Follow-up|1|||
49000562|NCT03083639|157838239|FG001|Washout Period (at Least 6 Days)|Lost to Follow-up|0|||
49000563|NCT01591499|157838242|FG000|Baseline Visit|Withdrawal by Subject|0|||
49000564|NCT01591499|157838243|FG001|Baseline Visit|Withdrawal by Subject|2|||
49000565|NCT01591499|157838244|FG002|Baseline Visit|Withdrawal by Subject|0|||
49000566|NCT01591499|157838245|FG003|Baseline Visit|Withdrawal by Subject|2|||
49000567|NCT01591499|157838242|FG000|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
49000568|NCT01591499|157838243|FG001|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
49000569|NCT01591499|157838244|FG002|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
49000570|NCT01591499|157838245|FG003|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
49000571|NCT01591499|157838242|FG000|Second Intervention (up to 24 Days)|Lost to Follow-up|4|||
49000572|NCT01591499|157838243|FG001|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
49000573|NCT01591499|157838244|FG002|Second Intervention (up to 24 Days)|Lost to Follow-up|1|||
49000574|NCT01591499|157838245|FG003|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
49000575|NCT01275170|157838246|FG000|Part 1: Period 1|Equipment malfunction before study drug|1|||
49000576|NCT01275170|157838247|FG001|Part 1: Period 1|Equipment malfunction before study drug|0|||
49000577|NCT01275170|157838248|FG002|Part 1: Period 1|Equipment malfunction before study drug|0|||
49000578|NCT01275170|157838249|FG003|Part 1: Period 1|Equipment malfunction before study drug|0|||
49000579|NCT01275170|157838250|FG004|Part 1: Period 1|Equipment malfunction before study drug|0|||
49000580|NCT01275170|157838251|FG005|Part 1: Period 1|Equipment malfunction before study drug|0|||
49000581|NCT01275170|157838252|FG006|Part 1: Period 1|Equipment malfunction before study drug|0|||
49000582|NCT01275170|157838253|FG007|Part 1: Period 1|Equipment malfunction before study drug|0|||
49000583|NCT01308762|157838254|FG000|Overall Study|Protocol Violation|0|||
49000584|NCT01308762|157838255|FG001|Overall Study|Protocol Violation|1|||
49000585|NCT01308762|157838256|FG002|Overall Study|Protocol Violation|0|||
49000586|NCT00605839|157838257|FG000|Overall Study|Protocol Violation|1|||
49000587|NCT00605839|157838258|FG001|Overall Study|Protocol Violation|0|||
49000588|NCT00605839|157838259|FG002|Overall Study|Protocol Violation|0|||
49000589|NCT05166512|157838268|FG000|Randomized|Lost to Follow-up|2|||
49000590|NCT05166512|157838269|FG001|Randomized|Lost to Follow-up|0|||
49000591|NCT05166512|157838268|FG000|Randomized|Withdrawal by Subject|1|||
49000592|NCT05166512|157838269|FG001|Randomized|Withdrawal by Subject|0|||
49000593|NCT05166512|157838268|FG000|Baseline Data Collection|Lost to Follow-up|0|||
49000594|NCT05166512|157838269|FG001|Baseline Data Collection|Lost to Follow-up|3|||
49000595|NCT05166512|157838268|FG000|Baseline Data Collection|Withdrawal by Subject|1|||
49000596|NCT05166512|157838269|FG001|Baseline Data Collection|Withdrawal by Subject|0|||
49000597|NCT05166512|157838268|FG000|Baseline Data Collection|Protocol Violation|2|||
49000598|NCT05166512|157838269|FG001|Baseline Data Collection|Protocol Violation|0|||
49000599|NCT05166512|157838268|FG000|4 Month Data Collection|Lost to Follow-up|1|||
49000600|NCT05166512|157838269|FG001|4 Month Data Collection|Lost to Follow-up|0|||
49000601|NCT05166512|157838268|FG000|4 Month Data Collection|Withdrawal by Subject|1|||
49000602|NCT05166512|157838269|FG001|4 Month Data Collection|Withdrawal by Subject|5|||
49000603|NCT05166512|157838268|FG000|12 Month Data Collection|Lost to Follow-up|3|||
49000604|NCT05166512|157838269|FG001|12 Month Data Collection|Lost to Follow-up|1|||
49000605|NCT05166512|157838268|FG000|12 Month Data Collection|Withdrawal by Subject|1|||
49000606|NCT05166512|157838269|FG001|12 Month Data Collection|Withdrawal by Subject|0|||
49000607|NCT00390572|157838270|FG000|Overall Study|Lost to Follow-up|8|||
49000608|NCT00390572|157838271|FG001|Overall Study|Lost to Follow-up|4|||
49000609|NCT00390572|157838270|FG000|Overall Study|health condition|0|||
49000610|NCT00390572|157838271|FG001|Overall Study|health condition|1|||
49000611|NCT03185949|157838274|FG000|ITT Analysis|Withdrawal by Subject|4|||
49000612|NCT03185949|157838275|FG001|ITT Analysis|Withdrawal by Subject|3|||
49000613|NCT03185949|157838274|FG000|PP Analysis|Protocol Violation|2|||
49000614|NCT03185949|157838275|FG001|PP Analysis|Protocol Violation|2|||
49000615|NCT03185949|157838274|FG000|PP Analysis|Failed/Incomplete LGA embolization|0|||
49000616|NCT03185949|157838275|FG001|PP Analysis|Failed/Incomplete LGA embolization|2|||
49000617|NCT03107715|157838276|FG000|Overall Study|did not deliver at the home hospital|4|||
49000618|NCT03107715|157838277|FG001|Overall Study|did not deliver at the home hospital|6|||
49000619|NCT03107715|157838276|FG000|Overall Study|infant stillborn|0|||
49000620|NCT03107715|157838277|FG001|Overall Study|infant stillborn|1|||
49000621|NCT03594175|157838279|FG000|Overall Study|Not treated|8|||
49000622|NCT03594175|157838280|FG001|Overall Study|Not treated|1|||
49000623|NCT03594175|157838281|FG002|Overall Study|Not treated|5|||
49000624|NCT03594175|157838279|FG000|Overall Study|Adverse Event|3|||
49000625|NCT03594175|157838280|FG001|Overall Study|Adverse Event|0|||
49000626|NCT03594175|157838281|FG002|Overall Study|Adverse Event|0|||
49000627|NCT03594175|157838279|FG000|Overall Study|Withdrawal by Subject|3|||
49000628|NCT03594175|157838280|FG001|Overall Study|Withdrawal by Subject|0|||
49000629|NCT03594175|157838281|FG002|Overall Study|Withdrawal by Subject|0|||
49000630|NCT03594175|157838279|FG000|Overall Study|Protocol Violation|2|||
49000631|NCT03594175|157838280|FG001|Overall Study|Protocol Violation|2|||
49000632|NCT03594175|157838281|FG002|Overall Study|Protocol Violation|2|||
49000633|NCT01915498|157838282|FG000|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
49000634|NCT01915498|157838283|FG001|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
49000635|NCT01915498|157838284|FG002|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
49000636|NCT01915498|157838285|FG003|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
49000637|NCT01915498|157838286|FG004|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
49000638|NCT01915498|157838287|FG005|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
49000639|NCT01915498|157838288|FG006|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
49000640|NCT01915498|157838289|FG007|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
49000641|NCT01915498|157838290|FG008|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
49000642|NCT01915498|157838291|FG009|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
49000643|NCT01915498|157838292|FG010|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
49000644|NCT01915498|157838293|FG011|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
49000645|NCT01915498|157838294|FG012|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
49000646|NCT01915498|157838295|FG013|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
49000647|NCT01915498|157838296|FG014|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
49000648|NCT01915498|157838297|FG015|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
49000649|NCT01915498|157838298|FG016|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
49000650|NCT01915498|157838299|FG017|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
49000651|NCT01915498|157838300|FG018|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
49000652|NCT01915498|157838282|FG000|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
49000653|NCT01915498|157838283|FG001|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
49000654|NCT01915498|157838284|FG002|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
49000655|NCT01915498|157838285|FG003|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
49000656|NCT01915498|157838286|FG004|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
49000657|NCT01915498|157838287|FG005|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
49000658|NCT01915498|157838288|FG006|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
49000659|NCT01915498|157838289|FG007|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
49000660|NCT01915498|157838290|FG008|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
49000661|NCT01915498|157838291|FG009|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
49000662|NCT01915498|157838292|FG010|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
49000663|NCT01915498|157838293|FG011|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
49000664|NCT01915498|157838294|FG012|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
49000665|NCT01915498|157838295|FG013|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
49000666|NCT01915498|157838296|FG014|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
49000667|NCT01915498|157838297|FG015|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
49000668|NCT01915498|157838298|FG016|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
49000669|NCT01915498|157838299|FG017|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
49000670|NCT01915498|157838300|FG018|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
49000671|NCT01915498|157838282|FG000|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
49000672|NCT01915498|157838283|FG001|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
49000673|NCT01915498|157838284|FG002|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
49000674|NCT01915498|157838285|FG003|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
49000675|NCT01915498|157838286|FG004|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
49000676|NCT01915498|157838287|FG005|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
49000677|NCT01915498|157838288|FG006|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
49000678|NCT01915498|157838289|FG007|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
49000679|NCT01915498|157838290|FG008|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
49000680|NCT01915498|157838291|FG009|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
49000681|NCT01915498|157838292|FG010|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
49000682|NCT01915498|157838293|FG011|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
49000683|NCT01915498|157838294|FG012|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
49000684|NCT01915498|157838295|FG013|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
49000685|NCT01915498|157838296|FG014|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
49000686|NCT01915498|157838297|FG015|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
49000687|NCT01915498|157838298|FG016|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
49000688|NCT01915498|157838299|FG017|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|2|||
49000689|NCT01915498|157838300|FG018|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
49000690|NCT01915498|157838282|FG000|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
49000691|NCT01915498|157838283|FG001|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
49000692|NCT01915498|157838284|FG002|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
49000693|NCT01915498|157838285|FG003|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
49000694|NCT01915498|157838286|FG004|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
49000695|NCT01915498|157838287|FG005|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
49000696|NCT01915498|157838288|FG006|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
49000697|NCT01915498|157838289|FG007|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
49000698|NCT01915498|157838290|FG008|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
49000699|NCT01915498|157838291|FG009|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
49000700|NCT01915498|157838292|FG010|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
49000701|NCT01915498|157838293|FG011|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
49000702|NCT01915498|157838294|FG012|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
49000703|NCT01915498|157838295|FG013|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
49000704|NCT01915498|157838296|FG014|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
49000705|NCT01915498|157838297|FG015|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
49000706|NCT01915498|157838298|FG016|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
49000707|NCT01915498|157838299|FG017|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
49000708|NCT01915498|157838300|FG018|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
49000709|NCT01915498|157838282|FG000|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
49000710|NCT01915498|157838283|FG001|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
49000711|NCT01915498|157838284|FG002|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
49000712|NCT01915498|157838285|FG003|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
49000713|NCT01915498|157838286|FG004|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
49000714|NCT01915498|157838287|FG005|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
49000715|NCT01915498|157838288|FG006|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
49000716|NCT01915498|157838289|FG007|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
49000717|NCT01915498|157838290|FG008|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
49000718|NCT01915498|157838291|FG009|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
49000719|NCT01915498|157838292|FG010|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
49000720|NCT01915498|157838293|FG011|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
49000721|NCT01915498|157838294|FG012|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
49000722|NCT01915498|157838295|FG013|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6|||
49000723|NCT01915498|157838296|FG014|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5|||
49000724|NCT01915498|157838297|FG015|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
49000725|NCT01915498|157838298|FG016|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
49000726|NCT01915498|157838299|FG017|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9|||
49000727|NCT01915498|157838300|FG018|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
49000728|NCT01915498|157838282|FG000|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
49000729|NCT01915498|157838283|FG001|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
49000730|NCT01915498|157838284|FG002|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2|||
49000731|NCT01915498|157838285|FG003|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
49000732|NCT01915498|157838286|FG004|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
49000733|NCT01915498|157838287|FG005|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
49000734|NCT01915498|157838288|FG006|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
49000735|NCT01915498|157838289|FG007|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
49000736|NCT01915498|157838290|FG008|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
49000737|NCT01915498|157838291|FG009|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
49000738|NCT01915498|157838292|FG010|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
49000739|NCT01915498|157838293|FG011|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
49000740|NCT01915498|157838294|FG012|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
49000741|NCT01915498|157838295|FG013|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
49000742|NCT01915498|157838296|FG014|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
49000743|NCT01915498|157838297|FG015|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
49000744|NCT01915498|157838298|FG016|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4|||
49000745|NCT01915498|157838299|FG017|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8|||
49000746|NCT01915498|157838300|FG018|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
49000747|NCT01915498|157838282|FG000|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
49000748|NCT01915498|157838283|FG001|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
49000749|NCT01915498|157838284|FG002|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
49000750|NCT01915498|157838285|FG003|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
49000751|NCT01915498|157838286|FG004|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
49000752|NCT01915498|157838287|FG005|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
49000753|NCT01915498|157838288|FG006|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
49000754|NCT01915498|157838289|FG007|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
49000755|NCT01915498|157838290|FG008|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
49000756|NCT01915498|157838291|FG009|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
49000757|NCT01915498|157838292|FG010|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
49000758|NCT01915498|157838293|FG011|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
49000759|NCT01915498|157838294|FG012|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
49000760|NCT01915498|157838295|FG013|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
49000761|NCT01915498|157838296|FG014|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
49000762|NCT01915498|157838297|FG015|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
49000763|NCT01915498|157838298|FG016|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
49000764|NCT01915498|157838299|FG017|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
49000765|NCT01915498|157838300|FG018|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
49000766|NCT01915498|157838282|FG000|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
49000767|NCT01915498|157838283|FG001|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
49000768|NCT01915498|157838284|FG002|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
49000769|NCT01915498|157838285|FG003|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
49000770|NCT01915498|157838286|FG004|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
49000771|NCT01915498|157838287|FG005|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
49000772|NCT01915498|157838288|FG006|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
49000773|NCT01915498|157838289|FG007|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
49000774|NCT01915498|157838290|FG008|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
49000775|NCT01915498|157838291|FG009|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
49000776|NCT01915498|157838292|FG010|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
49000777|NCT01915498|157838293|FG011|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
49000778|NCT01915498|157838294|FG012|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
49000779|NCT01915498|157838295|FG013|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
49000780|NCT01915498|157838296|FG014|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
49000781|NCT01915498|157838297|FG015|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
49000782|NCT01915498|157838298|FG016|Main Analysis (Sept 2013 - Sept 2017)|Death|3|||
49000783|NCT01915498|157838299|FG017|Main Analysis (Sept 2013 - Sept 2017)|Death|16|||
49000784|NCT01915498|157838300|FG018|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
49000785|NCT01915498|157838282|FG000|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
49000786|NCT01915498|157838283|FG001|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
49000787|NCT01915498|157838284|FG002|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
49000788|NCT01915498|157838285|FG003|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
49000789|NCT01915498|157838286|FG004|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
49000790|NCT01915498|157838287|FG005|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
49000791|NCT01915498|157838288|FG006|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
49000792|NCT01915498|157838289|FG007|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
49000793|NCT01915498|157838290|FG008|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
49000794|NCT01915498|157838291|FG009|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
49000795|NCT01915498|157838292|FG010|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1|||
49000796|NCT01915498|157838293|FG011|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
49000797|NCT01915498|157838294|FG012|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
49000798|NCT01915498|157838295|FG013|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
49000799|NCT01915498|157838296|FG014|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
49000800|NCT01915498|157838297|FG015|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
49000801|NCT01915498|157838298|FG016|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
49000802|NCT01915498|157838299|FG017|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
49000803|NCT01915498|157838300|FG018|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
49000804|NCT01915498|157838282|FG000|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
49000805|NCT01915498|157838283|FG001|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
49000806|NCT01915498|157838284|FG002|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
49000807|NCT01915498|157838285|FG003|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
49000808|NCT01915498|157838286|FG004|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
49000809|NCT01915498|157838287|FG005|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
49000810|NCT01915498|157838288|FG006|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
49000811|NCT01915498|157838289|FG007|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
49000812|NCT01915498|157838290|FG008|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
49000813|NCT01915498|157838291|FG009|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
49000814|NCT01915498|157838292|FG010|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
49000815|NCT01915498|157838293|FG011|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
49000816|NCT01915498|157838294|FG012|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
49000817|NCT01915498|157838295|FG013|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
49000818|NCT01915498|157838296|FG014|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
49000819|NCT01915498|157838297|FG015|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
49000820|NCT01915498|157838298|FG016|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
49000821|NCT01915498|157838299|FG017|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16|||
49000822|NCT01915498|157838300|FG018|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
49000823|NCT01915498|157838282|FG000|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1|||
49000824|NCT01915498|157838283|FG001|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
49000825|NCT01915498|157838284|FG002|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
49000826|NCT01915498|157838285|FG003|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
49000827|NCT01915498|157838286|FG004|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
49000828|NCT01915498|157838287|FG005|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
49000829|NCT01915498|157838288|FG006|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
49000830|NCT01915498|157838289|FG007|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15|||
49000831|NCT01915498|157838290|FG008|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
49000832|NCT01915498|157838291|FG009|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7|||
49000833|NCT01915498|157838292|FG010|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
49000834|NCT01915498|157838293|FG011|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
49000835|NCT01915498|157838294|FG012|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
49000836|NCT01915498|157838295|FG013|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24|||
49000837|NCT01915498|157838296|FG014|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14|||
49000838|NCT01915498|157838297|FG015|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9|||
49000839|NCT01915498|157838298|FG016|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8|||
49000840|NCT01915498|157838299|FG017|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41|||
49000841|NCT01915498|157838300|FG018|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0|||
49000842|NCT01915498|157838282|FG000|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
49000843|NCT01915498|157838283|FG001|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
49000844|NCT01915498|157838284|FG002|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
49000845|NCT01915498|157838285|FG003|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
49000846|NCT01915498|157838286|FG004|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
49000847|NCT01915498|157838287|FG005|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
49000848|NCT01915498|157838288|FG006|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
49000849|NCT01915498|157838289|FG007|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
49000850|NCT01915498|157838290|FG008|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
49000851|NCT01915498|157838291|FG009|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
49000852|NCT01915498|157838292|FG010|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
49000853|NCT01915498|157838293|FG011|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
49000854|NCT01915498|157838294|FG012|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
49000855|NCT01915498|157838295|FG013|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
49000856|NCT01915498|157838296|FG014|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
49000857|NCT01915498|157838297|FG015|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
49000858|NCT01915498|157838298|FG016|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
49000859|NCT01915498|157838299|FG017|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
49000860|NCT01915498|157838300|FG018|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|2|||
49000861|NCT01915498|157838282|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
49000862|NCT01915498|157838283|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
49000863|NCT01915498|157838284|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
49000864|NCT01915498|157838285|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
49000865|NCT01915498|157838286|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
49000866|NCT01915498|157838287|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
49000867|NCT01915498|157838288|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
49000868|NCT01915498|157838289|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
49000869|NCT01915498|157838290|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
49000870|NCT01915498|157838291|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
49000871|NCT01915498|157838292|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
49000872|NCT01915498|157838293|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
49000873|NCT01915498|157838294|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
49000874|NCT01915498|157838295|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
49000875|NCT01915498|157838296|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
49000876|NCT01915498|157838297|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
49000877|NCT01915498|157838298|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
49000878|NCT01915498|157838299|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
49000879|NCT01915498|157838300|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|1|||
49000880|NCT01915498|157838282|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
49000881|NCT01915498|157838283|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
49000882|NCT01915498|157838284|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
49000883|NCT01915498|157838285|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
49000884|NCT01915498|157838286|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
49000885|NCT01915498|157838287|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
49000886|NCT01915498|157838288|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
49000887|NCT01915498|157838289|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
49000888|NCT01915498|157838290|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
49000889|NCT01915498|157838291|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
49000890|NCT01915498|157838292|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
49000891|NCT01915498|157838293|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
49000892|NCT01915498|157838294|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
49000893|NCT01915498|157838295|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
49000894|NCT01915498|157838296|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
49000895|NCT01915498|157838297|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
49000896|NCT01915498|157838298|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
49000897|NCT01915498|157838299|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
49000898|NCT01915498|157838300|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|1|||
49000899|NCT05004181|157838301|FG000|Overall Study|Withdrawal of consent|0|||
49000900|NCT05004181|157838302|FG001|Overall Study|Withdrawal of consent|0|||
49000901|NCT05004181|157838303|FG002|Overall Study|Withdrawal of consent|1|||
49000902|NCT05004181|157838304|FG003|Overall Study|Withdrawal of consent|3|||
49000903|NCT05004181|157838305|FG004|Overall Study|Withdrawal of consent|3|||
49000904|NCT05004181|157838306|FG005|Overall Study|Withdrawal of consent|0|||
49000905|NCT05004181|157838307|FG006|Overall Study|Withdrawal of consent|30|||
49000906|NCT05004181|157838308|FG007|Overall Study|Withdrawal of consent|9|||
49000907|NCT05004181|157838309|FG008|Overall Study|Withdrawal of consent|3|||
49000908|NCT05004181|157838310|FG009|Overall Study|Withdrawal of consent|2|||
49000909|NCT05004181|157838311|FG010|Overall Study|Withdrawal of consent|5|||
49000910|NCT05004181|157838312|FG011|Overall Study|Withdrawal of consent|1|||
49000911|NCT05004181|157838301|FG000|Overall Study|Lost to Follow-up|2|||
49000912|NCT05004181|157838302|FG001|Overall Study|Lost to Follow-up|4|||
49000913|NCT05004181|157838303|FG002|Overall Study|Lost to Follow-up|2|||
49000914|NCT05004181|157838304|FG003|Overall Study|Lost to Follow-up|3|||
49000915|NCT05004181|157838305|FG004|Overall Study|Lost to Follow-up|5|||
49000916|NCT05004181|157838306|FG005|Overall Study|Lost to Follow-up|2|||
49000917|NCT05004181|157838307|FG006|Overall Study|Lost to Follow-up|15|||
49000918|NCT05004181|157838308|FG007|Overall Study|Lost to Follow-up|12|||
49000919|NCT05004181|157838309|FG008|Overall Study|Lost to Follow-up|38|||
49000920|NCT05004181|157838310|FG009|Overall Study|Lost to Follow-up|6|||
49000921|NCT05004181|157838311|FG010|Overall Study|Lost to Follow-up|6|||
49000922|NCT05004181|157838312|FG011|Overall Study|Lost to Follow-up|0|||
49000923|NCT05004181|157838301|FG000|Overall Study|Death|0|||
49000924|NCT05004181|157838302|FG001|Overall Study|Death|0|||
49000925|NCT05004181|157838303|FG002|Overall Study|Death|0|||
49000926|NCT05004181|157838304|FG003|Overall Study|Death|0|||
49000927|NCT05004181|157838305|FG004|Overall Study|Death|0|||
49000928|NCT05004181|157838306|FG005|Overall Study|Death|0|||
49000929|NCT05004181|157838307|FG006|Overall Study|Death|1|||
49000930|NCT05004181|157838308|FG007|Overall Study|Death|0|||
49000931|NCT05004181|157838309|FG008|Overall Study|Death|2|||
49000932|NCT05004181|157838310|FG009|Overall Study|Death|0|||
49000933|NCT05004181|157838311|FG010|Overall Study|Death|0|||
49000934|NCT05004181|157838312|FG011|Overall Study|Death|0|||
49000935|NCT05004181|157838301|FG000|Overall Study|Physician Decision|0|||
49000936|NCT05004181|157838302|FG001|Overall Study|Physician Decision|0|||
49000937|NCT05004181|157838303|FG002|Overall Study|Physician Decision|0|||
49000938|NCT05004181|157838304|FG003|Overall Study|Physician Decision|0|||
49000939|NCT05004181|157838305|FG004|Overall Study|Physician Decision|0|||
49000940|NCT05004181|157838306|FG005|Overall Study|Physician Decision|0|||
49000941|NCT05004181|157838307|FG006|Overall Study|Physician Decision|2|||
49000942|NCT05004181|157838308|FG007|Overall Study|Physician Decision|0|||
49000943|NCT05004181|157838309|FG008|Overall Study|Physician Decision|7|||
49000944|NCT05004181|157838310|FG009|Overall Study|Physician Decision|0|||
49000945|NCT05004181|157838311|FG010|Overall Study|Physician Decision|0|||
49000946|NCT05004181|157838312|FG011|Overall Study|Physician Decision|0|||
49000947|NCT05004181|157838301|FG000|Overall Study|Withdrawal by Subject|2|||
49000948|NCT05004181|157838302|FG001|Overall Study|Withdrawal by Subject|3|||
49000949|NCT05004181|157838303|FG002|Overall Study|Withdrawal by Subject|2|||
49000950|NCT05004181|157838304|FG003|Overall Study|Withdrawal by Subject|2|||
49000951|NCT05004181|157838305|FG004|Overall Study|Withdrawal by Subject|4|||
49000952|NCT05004181|157838306|FG005|Overall Study|Withdrawal by Subject|2|||
49000953|NCT05004181|157838307|FG006|Overall Study|Withdrawal by Subject|4|||
49000954|NCT05004181|157838308|FG007|Overall Study|Withdrawal by Subject|22|||
49000955|NCT05004181|157838309|FG008|Overall Study|Withdrawal by Subject|8|||
49000956|NCT05004181|157838310|FG009|Overall Study|Withdrawal by Subject|1|||
49000957|NCT05004181|157838311|FG010|Overall Study|Withdrawal by Subject|3|||
49000958|NCT05004181|157838312|FG011|Overall Study|Withdrawal by Subject|2|||
49000959|NCT05004181|157838301|FG000|Overall Study|Protocol Violation|2|||
49000960|NCT05004181|157838302|FG001|Overall Study|Protocol Violation|3|||
49000961|NCT05004181|157838303|FG002|Overall Study|Protocol Violation|0|||
49000962|NCT05004181|157838304|FG003|Overall Study|Protocol Violation|0|||
49000963|NCT05004181|157838305|FG004|Overall Study|Protocol Violation|1|||
49000964|NCT05004181|157838306|FG005|Overall Study|Protocol Violation|0|||
49000965|NCT05004181|157838307|FG006|Overall Study|Protocol Violation|16|||
49000966|NCT05004181|157838308|FG007|Overall Study|Protocol Violation|18|||
49000967|NCT05004181|157838309|FG008|Overall Study|Protocol Violation|2|||
49000968|NCT05004181|157838310|FG009|Overall Study|Protocol Violation|2|||
49000969|NCT05004181|157838311|FG010|Overall Study|Protocol Violation|2|||
49000970|NCT05004181|157838312|FG011|Overall Study|Protocol Violation|1|||
49000971|NCT05004181|157838301|FG000|Overall Study|Not further specified|1|||
49000972|NCT05004181|157838302|FG001|Overall Study|Not further specified|0|||
49000973|NCT05004181|157838303|FG002|Overall Study|Not further specified|0|||
49000974|NCT05004181|157838304|FG003|Overall Study|Not further specified|0|||
49000975|NCT05004181|157838305|FG004|Overall Study|Not further specified|0|||
49000976|NCT05004181|157838306|FG005|Overall Study|Not further specified|0|||
49000977|NCT05004181|157838307|FG006|Overall Study|Not further specified|1|||
49000978|NCT05004181|157838308|FG007|Overall Study|Not further specified|0|||
49000979|NCT05004181|157838309|FG008|Overall Study|Not further specified|2|||
49000980|NCT05004181|157838310|FG009|Overall Study|Not further specified|1|||
49000981|NCT05004181|157838311|FG010|Overall Study|Not further specified|0|||
49000982|NCT05004181|157838312|FG011|Overall Study|Not further specified|1|||
49000983|NCT02949219|157838313|FG000|Overall Study|Withdrawal by Subject|1|||
49000984|NCT03914469|157838314|FG000|Overall Study|Lost to Follow-up|1|||
49000985|NCT03914469|157838315|FG001|Overall Study|Lost to Follow-up|4|||
49000986|NCT03273257|157838327|FG000|Overall Study|Death|0|||
49000987|NCT03273257|157838328|FG001|Overall Study|Death|1|||
49000988|NCT03273257|157838327|FG000|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
49000989|NCT03273257|157838328|FG001|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
49000990|NCT03273257|157838327|FG000|Overall Study|Study terminated|3|||
49000991|NCT03273257|157838328|FG001|Overall Study|Study terminated|2|||
49000992|NCT01126359|157838329|FG000|First Intervention (20-minutes)|Physician Decision|0|||
49000993|NCT01126359|157838330|FG001|First Intervention (20-minutes)|Physician Decision|1|||
49000994|NCT01966107|157838331|FG000|Overall Study|excluded from FAS|21|||
49000995|NCT01966107|157838332|FG001|Overall Study|excluded from FAS|20|||
49000996|NCT01966107|157838331|FG000|Overall Study|discontinued treatment|345|||
49000997|NCT01966107|157838332|FG001|Overall Study|discontinued treatment|372|||
49000998|NCT01966107|157838331|FG000|Overall Study|due to study closure|164|||
49000999|NCT01966107|157838332|FG001|Overall Study|due to study closure|186|||
49001000|NCT01966107|157838331|FG000|Overall Study|withdrew from the study|272|||
49001001|NCT01966107|157838332|FG001|Overall Study|withdrew from the study|303|||
49001002|NCT00532779|157838335|FG000|Overall Study|Adverse Event|122|||
49001003|NCT00532779|157838336|FG001|Overall Study|Adverse Event|112|||
49001004|NCT00532779|157838337|FG002|Overall Study|Adverse Event|56|||
49001005|NCT00532779|157838335|FG000|Overall Study|Lost to Follow-up|76|||
49001006|NCT00532779|157838336|FG001|Overall Study|Lost to Follow-up|65|||
49001007|NCT00532779|157838337|FG002|Overall Study|Lost to Follow-up|66|||
49001008|NCT00532779|157838335|FG000|Overall Study|Withdrawal by Subject|63|||
49001009|NCT00532779|157838336|FG001|Overall Study|Withdrawal by Subject|60|||
49001010|NCT00532779|157838337|FG002|Overall Study|Withdrawal by Subject|90|||
49001011|NCT00532779|157838335|FG000|Overall Study|Lack of Efficacy|12|||
49001012|NCT00532779|157838336|FG001|Overall Study|Lack of Efficacy|12|||
49001013|NCT00532779|157838337|FG002|Overall Study|Lack of Efficacy|40|||
49001014|NCT00532779|157838335|FG000|Overall Study|Protocol Violation|5|||
49001015|NCT00532779|157838336|FG001|Overall Study|Protocol Violation|9|||
49001016|NCT00532779|157838337|FG002|Overall Study|Protocol Violation|7|||
49001017|NCT00532779|157838335|FG000|Overall Study|Pregnancy|2|||
49001018|NCT00532779|157838336|FG001|Overall Study|Pregnancy|5|||
49001019|NCT00532779|157838337|FG002|Overall Study|Pregnancy|3|||
49001020|NCT00532779|157838335|FG000|Overall Study|Death|0|||
49001021|NCT00532779|157838336|FG001|Overall Study|Death|1|||
49001022|NCT00532779|157838337|FG002|Overall Study|Death|0|||
49001023|NCT00532779|157838335|FG000|Overall Study|Drug noncompliance, moved, other|14|||
49001024|NCT00532779|157838336|FG001|Overall Study|Drug noncompliance, moved, other|23|||
49001025|NCT00532779|157838337|FG002|Overall Study|Drug noncompliance, moved, other|29|||
49001026|NCT02332655|157838339|FG000|Overall Study|Lack of Efficacy|1|||
49001027|NCT02662556|157838340|FG000|Overall Study|Adverse Event|4|||
49001028|NCT02662556|157838340|FG000|Overall Study|Lack of Efficacy|4|||
49001029|NCT01556165|157838341|FG000|Overall Study|Adverse Event|5|||
49001030|NCT01556165|157838342|FG001|Overall Study|Adverse Event|3|||
49001031|NCT01556165|157838341|FG000|Overall Study|Protocol Violation|0|||
49001032|NCT01556165|157838342|FG001|Overall Study|Protocol Violation|3|||
49001033|NCT01556165|157838341|FG000|Overall Study|Withdrawal of Consent|7|||
49001034|NCT01556165|157838342|FG001|Overall Study|Withdrawal of Consent|1|||
49001035|NCT01238172|157838343|FG000|Overall Study|Ineligible: based on Eligibility Review|2|||
49001036|NCT01238172|157838344|FG001|Overall Study|Ineligible: based on Eligibility Review|5|||
49001037|NCT01238172|157838343|FG000|Overall Study|Ineligible: based on Central Path Review|9|||
49001038|NCT01238172|157838344|FG001|Overall Study|Ineligible: based on Central Path Review|19|||
49001039|NCT03505606|157840263|FG000|Overall Study|Unable to complete testing / poor co-operation|0|||
49001040|NCT03505606|157840264|FG001|Overall Study|Unable to complete testing / poor co-operation|1|||
49001041|NCT03505606|157840265|FG002|Overall Study|Unable to complete testing / poor co-operation|0|||
49001042|NCT03505606|157840263|FG000|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|1|||
49001043|NCT03505606|157840264|FG001|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
49001044|NCT03505606|157840265|FG002|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
49001045|NCT03505606|157840263|FG000|Overall Study|Stimulus deprivation / previous haemangioma|0|||
49001046|NCT03505606|157840264|FG001|Overall Study|Stimulus deprivation / previous haemangioma|1|||
49001047|NCT03505606|157840265|FG002|Overall Study|Stimulus deprivation / previous haemangioma|0|||
49001048|NCT03505606|157840263|FG000|Overall Study|Poor compliance with refractive correction|0|||
49001049|NCT03505606|157840264|FG001|Overall Study|Poor compliance with refractive correction|0|||
49001050|NCT03505606|157840265|FG002|Overall Study|Poor compliance with refractive correction|1|||
49001051|NCT03505606|157840263|FG000|Overall Study|Insufficient anisometropia|0|||
49001052|NCT03505606|157840264|FG001|Overall Study|Insufficient anisometropia|0|||
49001053|NCT03505606|157840265|FG002|Overall Study|Insufficient anisometropia|2|||
49001054|NCT03505606|157840263|FG000|Overall Study|Ectopia Lentis|0|||
49001055|NCT03505606|157840264|FG001|Overall Study|Ectopia Lentis|0|||
49001056|NCT03505606|157840265|FG002|Overall Study|Ectopia Lentis|1|||
49001057|NCT03505606|157840263|FG000|Overall Study|alternation of amblyopic eye|0|||
49001058|NCT03505606|157840264|FG001|Overall Study|alternation of amblyopic eye|1|||
49001059|NCT03505606|157840265|FG002|Overall Study|alternation of amblyopic eye|0|||
49001060|NCT03280628|157840270|FG000|Overall Study|Lost to Follow-up|8|||
49001061|NCT03280628|157840271|FG001|Overall Study|Lost to Follow-up|6|||
49001062|NCT03280628|157840272|FG002|Overall Study|Lost to Follow-up|11|||
49001063|NCT02525627|157840279|FG000|Overall Study|Revision|1|||
49001064|NCT02525627|157840280|FG001|Overall Study|Revision|1|||
49001065|NCT02525627|157840279|FG000|Overall Study|Withdrawal by Subject|1|||
49001066|NCT02525627|157840280|FG001|Overall Study|Withdrawal by Subject|2|||
49001067|NCT02525627|157840279|FG000|Overall Study|Death|1|||
49001068|NCT02525627|157840280|FG001|Overall Study|Death|0|||
49001069|NCT02525627|157840279|FG000|Overall Study|Site terminated|11|||
49001070|NCT02525627|157840280|FG001|Overall Study|Site terminated|10|||
49001071|NCT03746080|157840281|FG000|Overall Study|In follow up|2|||
49001072|NCT03746080|157840281|FG000|Overall Study|Death|15|||
49001073|NCT02094573|157840282|FG000|Overall Study|Adverse Event|4|||
49001074|NCT02094573|157840283|FG001|Overall Study|Adverse Event|14|||
49001075|NCT02094573|157840282|FG000|Overall Study|Clinical Progressive Disease|9|||
49001076|NCT02094573|157840283|FG001|Overall Study|Clinical Progressive Disease|13|||
49001077|NCT02094573|157840282|FG000|Overall Study|Death|11|||
49001078|NCT02094573|157840283|FG001|Overall Study|Death|3|||
49001079|NCT02094573|157840282|FG000|Overall Study|Documented Progressive Disease (RECIST 1.1)|63|||
49001080|NCT02094573|157840283|FG001|Overall Study|Documented Progressive Disease (RECIST 1.1)|50|||
49001081|NCT02094573|157840282|FG000|Overall Study|Non-compliance with Study Drug|1|||
49001082|NCT02094573|157840283|FG001|Overall Study|Non-compliance with Study Drug|1|||
49001083|NCT02094573|157840282|FG000|Overall Study|Subject Received a New Systemic Anticancer Therapy|1|||
49001084|NCT02094573|157840283|FG001|Overall Study|Subject Received a New Systemic Anticancer Therapy|0|||
49001085|NCT02094573|157840282|FG000|Overall Study|Physician Decision|4|||
49001086|NCT02094573|157840283|FG001|Overall Study|Physician Decision|4|||
49001087|NCT02094573|157840282|FG000|Overall Study|Site Terminated by Sponsor|10|||
49001088|NCT02094573|157840283|FG001|Overall Study|Site Terminated by Sponsor|17|||
49001089|NCT02094573|157840282|FG000|Overall Study|Withdrawal by Subject|6|||
49001090|NCT02094573|157840283|FG001|Overall Study|Withdrawal by Subject|8|||
49001091|NCT02094573|157840282|FG000|Overall Study|Randomized but not Treated|3|||
49001092|NCT02094573|157840283|FG001|Overall Study|Randomized but not Treated|0|||
49001093|NCT01473589|157840284|FG000|Overall Study|Adverse Event|1|||
49001094|NCT01473589|157840285|FG001|Overall Study|Adverse Event|1|||
49001095|NCT01473589|157840284|FG000|Overall Study|Death|2|||
49001096|NCT01473589|157840285|FG001|Overall Study|Death|0|||
49001097|NCT01473589|157840284|FG000|Overall Study|Lost to Follow-up|2|||
49001098|NCT01473589|157840285|FG001|Overall Study|Lost to Follow-up|2|||
49001099|NCT01473589|157840284|FG000|Overall Study|Protocol Violation|1|||
49001100|NCT01473589|157840285|FG001|Overall Study|Protocol Violation|0|||
49001101|NCT01473589|157840284|FG000|Overall Study|Withdrawal by Subject|5|||
49001102|NCT01473589|157840285|FG001|Overall Study|Withdrawal by Subject|11|||
49001103|NCT01473589|157840284|FG000|Overall Study|Physician Decision|0|||
49001104|NCT01473589|157840285|FG001|Overall Study|Physician Decision|1|||
49001105|NCT01473589|157840284|FG000|Overall Study|Entry criteria not met|0|||
49001106|NCT01473589|157840285|FG001|Overall Study|Entry criteria not met|1|||
49001107|NCT01819467|157840286|FG000|Overall Study|Physician Decision|20|||
49001108|NCT01819467|157840287|FG001|Overall Study|Physician Decision|9|||
49001109|NCT01160770|157840289|FG000|Overall Study|Adverse Event|10|||
49001110|NCT01160770|157840289|FG000|Overall Study|Protocol Violation|2|||
49001111|NCT01160770|157840289|FG000|Overall Study|Subject/parent/caregiver request|33|||
49001112|NCT01160770|157840289|FG000|Overall Study|Physician Decision|1|||
49001113|NCT01160770|157840289|FG000|Overall Study|Lost to Follow-up|7|||
49001114|NCT01160770|157840289|FG000|Overall Study|Study termination or sponsor request|1|||
49001115|NCT01160770|157840289|FG000|Overall Study|Death|9|||
49001116|NCT01160770|157840289|FG000|Overall Study|Lack of Efficacy|15|||
49001117|NCT01160770|157840289|FG000|Overall Study|Other Reasons|1|||
49001118|NCT04469465|157840298|FG000|Treatment Period 1 (TP1)|Adverse Event|2|||
49001119|NCT04469465|157840299|FG001|Treatment Period 1 (TP1)|Adverse Event|1|||
49001120|NCT04469465|157840298|FG000|Treatment Period 1 (TP1)|Withdrawal by Subject|0|||
49001121|NCT04469465|157840299|FG001|Treatment Period 1 (TP1)|Withdrawal by Subject|1|||
49001122|NCT04469465|157840298|FG000|Treatment Period 2 (TP2)|Adverse Event|1|||
49001123|NCT04469465|157840299|FG001|Treatment Period 2 (TP2)|Adverse Event|1|||
49001124|NCT04469465|157840298|FG000|Long-Term Extension (LTE)|Withdrawal by Subject|3|||
49001125|NCT04469465|157840299|FG001|Long-Term Extension (LTE)|Withdrawal by Subject|0|||
49001126|NCT04469465|157840298|FG000|Long-Term Extension (LTE)|Physician Decision|3|||
49001127|NCT04469465|157840299|FG001|Long-Term Extension (LTE)|Physician Decision|0|||
49001128|NCT04469465|157840298|FG000|Long-Term Extension (LTE)|Noncompliance with study intervention|1|||
49001129|NCT04469465|157840299|FG001|Long-Term Extension (LTE)|Noncompliance with study intervention|0|||
49001130|NCT04469465|157840298|FG000|Long-Term Extension (LTE)|Death|0|||
49001131|NCT04469465|157840299|FG001|Long-Term Extension (LTE)|Death|1|||
49001132|NCT04469465|157840298|FG000|Long-Term Extension (LTE)|Adverse Event|1|||
49001133|NCT04469465|157840299|FG001|Long-Term Extension (LTE)|Adverse Event|1|||
49001134|NCT03069365|157840300|FG000|Overall Study|Adverse Event|1|||
49001135|NCT01060007|157840311|FG000|Overall Study|Withdrawal by Subject|1|||
49001136|NCT01060007|157840311|FG000|Overall Study|Inevaluable for response at surgery|3|||
49001137|NCT01036594|157840314|FG000|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1|||
49001138|NCT01036594|157840315|FG001|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0|||
49001139|NCT01036594|157840314|FG000|First Treatment Regimen|Withdrawal by Subject|1|||
49001140|NCT01036594|157840315|FG001|First Treatment Regimen|Withdrawal by Subject|0|||
49001141|NCT01036594|157840314|FG000|Week 12 Evaluation|Adverse Event|5|||
49001142|NCT01036594|157840315|FG001|Week 12 Evaluation|Adverse Event|0|||
49001143|NCT01036594|157840314|FG000|Week 12 Evaluation|Physician Decision|1|||
49001144|NCT01036594|157840315|FG001|Week 12 Evaluation|Physician Decision|0|||
49001145|NCT01036594|157840314|FG000|Treatment Regiments Post Week 12|Physician Decision|1|||
49001146|NCT01036594|157840315|FG001|Treatment Regiments Post Week 12|Physician Decision|1|||
49001147|NCT01036594|157840314|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|1|||
49001148|NCT01036594|157840315|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
49001149|NCT01036594|157840314|FG000|Treatment Regiments Post Week 12|Adverse Event|0|||
49001150|NCT01036594|157840315|FG001|Treatment Regiments Post Week 12|Adverse Event|1|||
49001151|NCT01036594|157840314|FG000|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0|||
49001152|NCT01036594|157840315|FG001|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1|||
49001153|NCT01036594|157840314|FG000|Treatment Regiments Post Week 12|Lack of Efficacy|0|||
49001154|NCT01036594|157840315|FG001|Treatment Regiments Post Week 12|Lack of Efficacy|1|||
49001155|NCT01244516|157840320|FG000|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4|||
49001156|NCT01244516|157840321|FG001|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5|||
49001157|NCT01244516|157840322|FG002|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2|||
49001158|NCT01244516|157840320|FG000|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
49001159|NCT01244516|157840321|FG001|Period 1 (Baseline to 1-week Visit)|Poor Vision|1|||
49001160|NCT01244516|157840322|FG002|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
49001161|NCT01244516|157840320|FG000|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
49001162|NCT01244516|157840321|FG001|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
49001163|NCT01244516|157840322|FG002|Period 1 (Baseline to 1-week Visit)|Poor comfort|1|||
49001164|NCT01244516|157840320|FG000|Period 2 (1-week to 2-week Visit)|Adverse Event|2|||
49001165|NCT01244516|157840321|FG001|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
49001166|NCT01244516|157840322|FG002|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
49001167|NCT01244516|157840320|FG000|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
49001168|NCT01244516|157840321|FG001|Period 2 (1-week to 2-week Visit)|Protocol Violation|0|||
49001169|NCT01244516|157840322|FG002|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
49001170|NCT01244516|157840320|FG000|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
49001171|NCT01244516|157840321|FG001|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1|||
49045850|NCT00660387|158002031|FG001|Overall Study|Adverse Event|2|||
49045851|NCT00660387|158002030|FG000|Overall Study|Lack of Efficacy|0|||
49001172|NCT01244516|157840322|FG002|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
49001173|NCT01244516|157840320|FG000|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
49001174|NCT01244516|157840321|FG001|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
49001175|NCT01244516|157840322|FG002|Period 2 (1-week to 2-week Visit)|Poor Comfort|1|||
49001176|NCT02866695|157840323|FG000|Overall Study|Adverse Event|1|||
49001177|NCT02866695|157840323|FG000|Overall Study|Lost to Follow-up|1|||
49001178|NCT03224234|157840324|FG000|Main Study|Lost to Follow-up|5|||
49001179|NCT03224234|157840325|FG001|Main Study|Lost to Follow-up|5|||
49001180|NCT03466060|157840326|FG000|Period 1|Test Lens Damage|0|||
49001181|NCT03466060|157840327|FG001|Period 1|Test Lens Damage|2|||
49001182|NCT03466060|157840328|FG002|Period 1|Test Lens Damage|0|||
49001183|NCT03466060|157840329|FG003|Period 1|Test Lens Damage|0|||
49001184|NCT03466060|157840330|FG004|Period 1|Test Lens Damage|0|||
49001185|NCT03466060|157840331|FG005|Period 1|Test Lens Damage|0|||
49001186|NCT03466060|157840326|FG000|Period 1|Withdrawal by Subject|0|||
49001187|NCT03466060|157840327|FG001|Period 1|Withdrawal by Subject|0|||
49001188|NCT03466060|157840328|FG002|Period 1|Withdrawal by Subject|2|||
49001189|NCT03466060|157840329|FG003|Period 1|Withdrawal by Subject|0|||
49001190|NCT03466060|157840330|FG004|Period 1|Withdrawal by Subject|0|||
49001191|NCT03466060|157840331|FG005|Period 1|Withdrawal by Subject|0|||
49001192|NCT03466060|157840326|FG000|Period 1|Lost to Follow-up|0|||
49001193|NCT03466060|157840327|FG001|Period 1|Lost to Follow-up|0|||
49001194|NCT03466060|157840328|FG002|Period 1|Lost to Follow-up|0|||
49001195|NCT03466060|157840329|FG003|Period 1|Lost to Follow-up|1|||
49001196|NCT03466060|157840330|FG004|Period 1|Lost to Follow-up|0|||
49001197|NCT03466060|157840331|FG005|Period 1|Lost to Follow-up|0|||
49001198|NCT03466060|157840326|FG000|Period 1|Grade 2 Conjunctivitis|0|||
49001199|NCT03466060|157840327|FG001|Period 1|Grade 2 Conjunctivitis|0|||
49001200|NCT03466060|157840328|FG002|Period 1|Grade 2 Conjunctivitis|1|||
49001201|NCT03466060|157840329|FG003|Period 1|Grade 2 Conjunctivitis|0|||
49001202|NCT03466060|157840330|FG004|Period 1|Grade 2 Conjunctivitis|0|||
49001203|NCT03466060|157840331|FG005|Period 1|Grade 2 Conjunctivitis|0|||
49001204|NCT03466060|157840326|FG000|Period 2|Lens Handling Difficulties|0|||
49001205|NCT03466060|157840327|FG001|Period 2|Lens Handling Difficulties|0|||
49001206|NCT03466060|157840328|FG002|Period 2|Lens Handling Difficulties|1|||
49001207|NCT03466060|157840329|FG003|Period 2|Lens Handling Difficulties|0|||
49001208|NCT03466060|157840330|FG004|Period 2|Lens Handling Difficulties|0|||
49001209|NCT03466060|157840331|FG005|Period 2|Lens Handling Difficulties|0|||
49001210|NCT03359473|157840334|FG000|Overall Study|Adverse Event|0|||
49001211|NCT03359473|157840335|FG001|Overall Study|Adverse Event|2|||
49001212|NCT03359473|157840336|FG002|Overall Study|Adverse Event|5|||
49001213|NCT03359473|157840337|FG003|Overall Study|Adverse Event|3|||
49001214|NCT03359473|157840334|FG000|Overall Study|Lost to Follow-up|0|||
49001215|NCT03359473|157840335|FG001|Overall Study|Lost to Follow-up|1|||
49001216|NCT03359473|157840336|FG002|Overall Study|Lost to Follow-up|0|||
49001217|NCT03359473|157840337|FG003|Overall Study|Lost to Follow-up|0|||
49001218|NCT03359473|157840334|FG000|Overall Study|Physician Decision|0|||
49001219|NCT03359473|157840335|FG001|Overall Study|Physician Decision|1|||
49001220|NCT03359473|157840336|FG002|Overall Study|Physician Decision|0|||
49001221|NCT03359473|157840337|FG003|Overall Study|Physician Decision|1|||
49001222|NCT03359473|157840334|FG000|Overall Study|Withdrawal by Subject|1|||
49001223|NCT03359473|157840335|FG001|Overall Study|Withdrawal by Subject|2|||
49001224|NCT03359473|157840336|FG002|Overall Study|Withdrawal by Subject|1|||
49001225|NCT03359473|157840337|FG003|Overall Study|Withdrawal by Subject|0|||
49001226|NCT03359473|157840334|FG000|Overall Study|Protocol-defined stopping criteria|1|||
49001227|NCT03359473|157840335|FG001|Overall Study|Protocol-defined stopping criteria|0|||
49001228|NCT03359473|157840336|FG002|Overall Study|Protocol-defined stopping criteria|0|||
49001229|NCT03359473|157840337|FG003|Overall Study|Protocol-defined stopping criteria|1|||
49001230|NCT05302414|157840338|FG000|Pretest to Posttest|Lost to Follow-up|12|||
49001231|NCT05302414|157840339|FG001|Pretest to Posttest|Lost to Follow-up|8|||
49001232|NCT05302414|157840340|FG002|Pretest to Posttest|Lost to Follow-up|8|||
49001233|NCT05302414|157840338|FG000|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
49001234|NCT05302414|157840339|FG001|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
49001235|NCT05302414|157840340|FG002|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
49001236|NCT01500434|157840341|FG000|Overall Study|Death|1|||
49001237|NCT01500434|157840341|FG000|Overall Study|Withdrawal by Subject|1|||
49001238|NCT01500434|157840341|FG000|Overall Study|Missed 12-month follow-up|5|||
49001239|NCT01154673|157840342|FG000|Overall Study|Lost to Follow-up|1|||
49001240|NCT01154673|157840343|FG001|Overall Study|Lost to Follow-up|0|||
49001241|NCT01154673|157840342|FG000|Overall Study|moved out of province|1|||
49001242|NCT01154673|157840343|FG001|Overall Study|moved out of province|0|||
49001243|NCT02125734|157840349|FG000|Period 2|Adverse Event|0|||
49001244|NCT02125734|157840350|FG001|Period 2|Adverse Event|1|||
49001245|NCT00646282|157840351|FG000|Overall Study|Protocol terminated|4|||
49001246|NCT00646282|157840352|FG001|Overall Study|Protocol terminated|4|||
49001247|NCT02032823|157840364|FG000|Overall Study|Death|75|||
49001248|NCT02032823|157840365|FG001|Overall Study|Death|109|||
49001249|NCT02032823|157840364|FG000|Overall Study|Lost to Follow-up|18|||
49001250|NCT02032823|157840365|FG001|Overall Study|Lost to Follow-up|17|||
49001251|NCT02032823|157840364|FG000|Overall Study|Withdrawal by Subject|70|||
49001252|NCT02032823|157840365|FG001|Overall Study|Withdrawal by Subject|53|||
49001253|NCT02032823|157840364|FG000|Overall Study|Ongoing study at data cut-off|755|||
49001254|NCT02032823|157840365|FG001|Overall Study|Ongoing study at data cut-off|731|||
49001255|NCT02032823|157840364|FG000|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|3|||
49001256|NCT02032823|157840365|FG001|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|5|||
49001257|NCT03889197|157840366|FG000|Overall Study|Withdrawal by Subject|1|||
49001258|NCT03889197|157840367|FG001|Overall Study|Withdrawal by Subject|0|||
49001259|NCT03889197|157840366|FG000|Overall Study|Physician Decision|0|||
49001260|NCT03889197|157840367|FG001|Overall Study|Physician Decision|1|||
49001261|NCT03889197|157840366|FG000|Overall Study|met exclusion criteria|0|||
49001262|NCT03889197|157840367|FG001|Overall Study|met exclusion criteria|1|||
49001263|NCT03889197|157840366|FG000|Overall Study|Protocol Violation|1|||
49001264|NCT03889197|157840367|FG001|Overall Study|Protocol Violation|0|||
49001265|NCT05899218|157840368|FG000|Overall Study|Lost to Follow-up|2|||
49001266|NCT05899218|157840369|FG001|Overall Study|Lost to Follow-up|2|||
49001267|NCT05899218|157840368|FG000|Overall Study|deemed ineligible out of country|1|||
49001268|NCT05899218|157840369|FG001|Overall Study|deemed ineligible out of country|0|||
49001269|NCT01220128|157840370|FG000|Overall Study|Progressive disease|0|||
49001270|NCT01220128|157840371|FG001|Overall Study|Progressive disease|0|||
49001271|NCT01220128|157840372|FG002|Overall Study|Progressive disease|2|||
49001272|NCT01220128|157840373|FG003|Overall Study|Progressive disease|0|||
49001273|NCT01220128|157840374|FG004|Overall Study|Progressive disease|0|||
49001274|NCT01220128|157840375|FG005|Overall Study|Progressive disease|0|||
49001275|NCT01220128|157840376|FG006|Overall Study|Progressive disease|0|||
49001276|NCT01220128|157840370|FG000|Overall Study|Sponsor study termination|0|||
49001277|NCT01220128|157840371|FG001|Overall Study|Sponsor study termination|1|||
49001278|NCT01220128|157840372|FG002|Overall Study|Sponsor study termination|0|||
49001279|NCT01220128|157840373|FG003|Overall Study|Sponsor study termination|0|||
49001280|NCT01220128|157840374|FG004|Overall Study|Sponsor study termination|0|||
49001281|NCT01220128|157840375|FG005|Overall Study|Sponsor study termination|0|||
49001282|NCT01220128|157840376|FG006|Overall Study|Sponsor study termination|1|||
49001283|NCT01220128|157840370|FG000|Overall Study|Adverse event, serious fatal|2|||
49001284|NCT01220128|157840371|FG001|Overall Study|Adverse event, serious fatal|0|||
49001285|NCT01220128|157840372|FG002|Overall Study|Adverse event, serious fatal|0|||
49001286|NCT01220128|157840373|FG003|Overall Study|Adverse event, serious fatal|0|||
49001287|NCT01220128|157840374|FG004|Overall Study|Adverse event, serious fatal|0|||
49001288|NCT01220128|157840375|FG005|Overall Study|Adverse event, serious fatal|0|||
49001289|NCT01220128|157840376|FG006|Overall Study|Adverse event, serious fatal|1|||
49001290|NCT01220128|157840370|FG000|Overall Study|Adverse event, non-fatal|1|||
49001291|NCT01220128|157840371|FG001|Overall Study|Adverse event, non-fatal|0|||
49001292|NCT01220128|157840372|FG002|Overall Study|Adverse event, non-fatal|0|||
49001293|NCT01220128|157840373|FG003|Overall Study|Adverse event, non-fatal|0|||
49001294|NCT01220128|157840374|FG004|Overall Study|Adverse event, non-fatal|0|||
49001295|NCT01220128|157840375|FG005|Overall Study|Adverse event, non-fatal|0|||
49001296|NCT01220128|157840376|FG006|Overall Study|Adverse event, non-fatal|3|||
49001297|NCT01220128|157840370|FG000|Overall Study|Other|0|||
49001298|NCT01220128|157840371|FG001|Overall Study|Other|0|||
49001299|NCT01220128|157840372|FG002|Overall Study|Other|1|||
49001300|NCT01220128|157840373|FG003|Overall Study|Other|0|||
49001301|NCT01220128|157840374|FG004|Overall Study|Other|0|||
49001302|NCT01220128|157840375|FG005|Overall Study|Other|0|||
49001303|NCT01220128|157840376|FG006|Overall Study|Other|0|||
49001304|NCT01220128|157840370|FG000|Overall Study|Consent withdrawn by subject|1|||
49001305|NCT01220128|157840371|FG001|Overall Study|Consent withdrawn by subject|0|||
49001306|NCT01220128|157840372|FG002|Overall Study|Consent withdrawn by subject|0|||
49001307|NCT01220128|157840373|FG003|Overall Study|Consent withdrawn by subject|0|||
49001308|NCT01220128|157840374|FG004|Overall Study|Consent withdrawn by subject|0|||
49001309|NCT01220128|157840375|FG005|Overall Study|Consent withdrawn by subject|0|||
49001310|NCT01220128|157840376|FG006|Overall Study|Consent withdrawn by subject|0|||
49001311|NCT02392559|157840377|FG000|Overall Study|Withdrawal by Subject|0|||
49001312|NCT02392559|157840378|FG001|Overall Study|Withdrawal by Subject|1|||
49001313|NCT01345058|157840379|FG000|Overall Study|Withdrawal by Subject|1|||
49001314|NCT01345058|157840380|FG001|Overall Study|Withdrawal by Subject|0|||
49001315|NCT01345058|157840379|FG000|Overall Study|Participant Reported Increase in Events|1|||
49001316|NCT01345058|157840380|FG001|Overall Study|Participant Reported Increase in Events|0|||
49001317|NCT01345058|157840379|FG000|Overall Study|Side Effects of Hair Loss and Itchiness|1|||
49001318|NCT01345058|157840380|FG001|Overall Study|Side Effects of Hair Loss and Itchiness|0|||
49001319|NCT01345058|157840379|FG000|Overall Study|Participant Stopped Taking Study Drug|1|||
49001320|NCT01345058|157840380|FG001|Overall Study|Participant Stopped Taking Study Drug|0|||
49001321|NCT01345058|157840379|FG000|Overall Study|Participant No-Show at Multiple Visits|1|||
49001322|NCT01345058|157840380|FG001|Overall Study|Participant No-Show at Multiple Visits|0|||
49001323|NCT02508649|157840383|FG000|Overall Study|Withdrawal by Subject|4|||
49001324|NCT02508649|157840384|FG001|Overall Study|Withdrawal by Subject|6|||
49001325|NCT02508649|157840385|FG002|Overall Study|Withdrawal by Subject|5|||
49001326|NCT02508649|157840386|FG003|Overall Study|Withdrawal by Subject|6|||
49001327|NCT02508649|157840383|FG000|Overall Study|Investigator withdrew the subject|1|||
49001328|NCT02508649|157840384|FG001|Overall Study|Investigator withdrew the subject|2|||
49001329|NCT02508649|157840385|FG002|Overall Study|Investigator withdrew the subject|1|||
49001330|NCT02508649|157840386|FG003|Overall Study|Investigator withdrew the subject|0|||
49001331|NCT02508649|157840383|FG000|Overall Study|Post randomization screening failure|12|||
49001332|NCT02508649|157840384|FG001|Overall Study|Post randomization screening failure|4|||
49001333|NCT02508649|157840385|FG002|Overall Study|Post randomization screening failure|9|||
49001334|NCT02508649|157840386|FG003|Overall Study|Post randomization screening failure|3|||
49001335|NCT02508649|157840383|FG000|Overall Study|Lost to Follow-up|1|||
49001336|NCT02508649|157840384|FG001|Overall Study|Lost to Follow-up|1|||
49001337|NCT02508649|157840385|FG002|Overall Study|Lost to Follow-up|0|||
49001338|NCT02508649|157840386|FG003|Overall Study|Lost to Follow-up|1|||
49001339|NCT00446134|157840387|FG000|Overall Study|Adverse Event|7|||
49001340|NCT00446134|157840388|FG001|Overall Study|Adverse Event|17|||
49001341|NCT00446134|157840389|FG002|Overall Study|Adverse Event|13|||
49001342|NCT00446134|157840390|FG003|Overall Study|Adverse Event|18|||
49001343|NCT00446134|157840387|FG000|Overall Study|Lack of Efficacy|19|||
49001344|NCT00446134|157840388|FG001|Overall Study|Lack of Efficacy|19|||
49001345|NCT00446134|157840389|FG002|Overall Study|Lack of Efficacy|24|||
49001346|NCT00446134|157840390|FG003|Overall Study|Lack of Efficacy|19|||
49001347|NCT00446134|157840387|FG000|Overall Study|Protocol Violation|0|||
49001348|NCT00446134|157840388|FG001|Overall Study|Protocol Violation|2|||
49001349|NCT00446134|157840389|FG002|Overall Study|Protocol Violation|1|||
49001350|NCT00446134|157840390|FG003|Overall Study|Protocol Violation|0|||
49001351|NCT00446134|157840387|FG000|Overall Study|Lost to Follow-up|1|||
49001352|NCT00446134|157840388|FG001|Overall Study|Lost to Follow-up|3|||
49001353|NCT00446134|157840389|FG002|Overall Study|Lost to Follow-up|1|||
49001354|NCT00446134|157840390|FG003|Overall Study|Lost to Follow-up|1|||
49001355|NCT00446134|157840387|FG000|Overall Study|Withdrawal by Subject|3|||
49001356|NCT00446134|157840388|FG001|Overall Study|Withdrawal by Subject|3|||
49001357|NCT00446134|157840389|FG002|Overall Study|Withdrawal by Subject|1|||
49001358|NCT00446134|157840390|FG003|Overall Study|Withdrawal by Subject|3|||
49001359|NCT00446134|157840387|FG000|Overall Study|Physician Decision|0|||
49001360|NCT00446134|157840388|FG001|Overall Study|Physician Decision|0|||
49001361|NCT00446134|157840389|FG002|Overall Study|Physician Decision|0|||
49001362|NCT00446134|157840390|FG003|Overall Study|Physician Decision|2|||
49001363|NCT00446134|157840387|FG000|Overall Study|Adverse Event-Diarrhea|1|||
49001364|NCT00446134|157840388|FG001|Overall Study|Adverse Event-Diarrhea|1|||
49001365|NCT00446134|157840389|FG002|Overall Study|Adverse Event-Diarrhea|2|||
49001366|NCT00446134|157840390|FG003|Overall Study|Adverse Event-Diarrhea|0|||
49001367|NCT00446134|157840387|FG000|Overall Study|Reason Not Completed|3|||
49001368|NCT00446134|157840388|FG001|Overall Study|Reason Not Completed|0|||
49001369|NCT00446134|157840389|FG002|Overall Study|Reason Not Completed|1|||
49001370|NCT00446134|157840390|FG003|Overall Study|Reason Not Completed|2|||
49001371|NCT04881448|157840395|FG000|Overall Study|Study cancelled by sponsor|220|||
49001372|NCT04881448|157840395|FG000|Overall Study|Withdrawal by Subject|2|||
49001373|NCT04881448|157840395|FG000|Overall Study|Exhausted all attempts to contact subject|1|||
49001374|NCT01861717|157840398|FG000|Overall Study|Lost to Follow-up|1|||
49001375|NCT01861717|157840398|FG000|Overall Study|Withdrawal by Subject|1|||
49001376|NCT03033069|157840401|FG000|Overall Study|Adverse Event|6|||
49001377|NCT03033069|157840402|FG001|Overall Study|Adverse Event|7|||
49001378|NCT03033069|157840403|FG002|Overall Study|Adverse Event|4|||
49001379|NCT03033069|157840404|FG003|Overall Study|Adverse Event|6|||
49001380|NCT03033069|157840401|FG000|Overall Study|Lack of Efficacy|0|||
49001381|NCT03033069|157840402|FG001|Overall Study|Lack of Efficacy|0|||
49001382|NCT03033069|157840403|FG002|Overall Study|Lack of Efficacy|1|||
49001383|NCT03033069|157840404|FG003|Overall Study|Lack of Efficacy|0|||
49001384|NCT03033069|157840401|FG000|Overall Study|Lost to Follow-up|6|||
49001385|NCT03033069|157840402|FG001|Overall Study|Lost to Follow-up|5|||
49001386|NCT03033069|157840403|FG002|Overall Study|Lost to Follow-up|5|||
49001387|NCT03033069|157840404|FG003|Overall Study|Lost to Follow-up|6|||
49001388|NCT03033069|157840401|FG000|Overall Study|Non-Compliance With Study Drug|1|||
49001389|NCT03033069|157840402|FG001|Overall Study|Non-Compliance With Study Drug|1|||
49001390|NCT03033069|157840403|FG002|Overall Study|Non-Compliance With Study Drug|1|||
49001391|NCT03033069|157840404|FG003|Overall Study|Non-Compliance With Study Drug|0|||
49001392|NCT03033069|157840401|FG000|Overall Study|Protocol Deviation|0|||
49001393|NCT03033069|157840402|FG001|Overall Study|Protocol Deviation|1|||
49001394|NCT03033069|157840403|FG002|Overall Study|Protocol Deviation|0|||
49001395|NCT03033069|157840404|FG003|Overall Study|Protocol Deviation|0|||
49001396|NCT03033069|157840401|FG000|Overall Study|Withdrawal by Subject|10|||
49001397|NCT03033069|157840402|FG001|Overall Study|Withdrawal by Subject|10|||
49045852|NCT00660387|158002031|FG001|Overall Study|Lack of Efficacy|1|||
49001398|NCT03033069|157840403|FG002|Overall Study|Withdrawal by Subject|11|||
49001399|NCT03033069|157840404|FG003|Overall Study|Withdrawal by Subject|6|||
49001400|NCT03033069|157840401|FG000|Overall Study|Withdrawal By Caregiver|1|||
49001401|NCT03033069|157840402|FG001|Overall Study|Withdrawal By Caregiver|0|||
49001402|NCT03033069|157840403|FG002|Overall Study|Withdrawal By Caregiver|0|||
49001403|NCT03033069|157840404|FG003|Overall Study|Withdrawal By Caregiver|0|||
49001404|NCT03033069|157840401|FG000|Overall Study|Reason not Specified|0|||
49001405|NCT03033069|157840402|FG001|Overall Study|Reason not Specified|1|||
49001406|NCT03033069|157840403|FG002|Overall Study|Reason not Specified|0|||
49001407|NCT03033069|157840404|FG003|Overall Study|Reason not Specified|1|||
49001408|NCT03690206|157840405|FG000|Overall Study|Withdrawal by Subject|2|||
49001409|NCT03690206|157840406|FG001|Overall Study|Withdrawal by Subject|0|||
49001410|NCT03690206|157840407|FG002|Overall Study|Withdrawal by Subject|0|||
49001411|NCT03690206|157840405|FG000|Overall Study|ICF withdrawal|2|||
49001412|NCT03690206|157840406|FG001|Overall Study|ICF withdrawal|0|||
49001413|NCT03690206|157840407|FG002|Overall Study|ICF withdrawal|0|||
49001414|NCT05458895|157840408|FG000|Overall Study|Withdrawal by Subject|8|||
49001415|NCT05458895|157840408|FG000|Overall Study|Lost to Follow-up|17|||
49001416|NCT05458895|157840408|FG000|Overall Study|Pregnancy|2|||
49001417|NCT05458895|157840408|FG000|Overall Study|Withdrawal by Study Team|1|||
49001418|NCT02875340|157842558|FG000|Overall Study|Death|2|||
49001419|NCT02875340|157842558|FG000|Overall Study|Withdrawal by Subject|2|||
49001420|NCT02875340|157842558|FG000|Overall Study|Physician Decision|3|||
49001421|NCT02875340|157842558|FG000|Overall Study|Adverse Event|1|||
49001422|NCT01607398|157842567|FG000|Overall Study|Adverse Event|0|||
49001423|NCT01607398|157842568|FG001|Overall Study|Adverse Event|2|||
49001424|NCT01607398|157842567|FG000|Overall Study|Severe COPD|2|||
49001425|NCT01607398|157842568|FG001|Overall Study|Severe COPD|0|||
49001426|NCT03457727|157842569|FG000|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
49001427|NCT03457727|157842570|FG001|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
49001428|NCT03457727|157842571|FG002|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
49001429|NCT03457727|157842572|FG003|Part 2, Washout Period 1 (5 Days)|Adverse Event|1|||
49001430|NCT00929201|157842573|FG000|Period 1|Withdrawal by Subject|0|||
49001431|NCT00929201|157842574|FG001|Period 1|Withdrawal by Subject|1|||
49001432|NCT03606109|157842578|FG000|Overall Study|Lost to Follow-up|2|||
49001433|NCT03606109|157842579|FG001|Overall Study|Lost to Follow-up|1|||
49001434|NCT01976663|157842580|FG000|Overall Study|Completed 18 mos but no repeat treatment|24|||
49001435|NCT01976663|157842580|FG000|Overall Study|Personal Reasons|6|||
49001436|NCT01976663|157842580|FG000|Overall Study|Withdrawal by Subject|4|||
49001437|NCT01976663|157842580|FG000|Overall Study|Screen Failure|3|||
49001438|NCT01976663|157842580|FG000|Overall Study|Adverse Event|2|||
49001439|NCT01976663|157842580|FG000|Overall Study|Lost to Follow-up|3|||
49001440|NCT02118896|157842582|FG000|Overall Study|Death|4|||
49001441|NCT02118896|157842583|FG001|Overall Study|Death|0|||
49001442|NCT02118896|157842584|FG002|Overall Study|Death|4|||
49001443|NCT02118896|157842585|FG003|Overall Study|Death|6|||
49001444|NCT02118896|157842586|FG004|Overall Study|Death|3|||
49001445|NCT02118896|157842587|FG005|Overall Study|Death|1|||
49001446|NCT02118896|157842588|FG006|Overall Study|Death|0|||
49001447|NCT02118896|157842589|FG007|Overall Study|Death|0|||
49001448|NCT02118896|157842590|FG008|Overall Study|Death|0|||
49001449|NCT02118896|157842591|FG009|Overall Study|Death|0|||
49001450|NCT02118896|157842582|FG000|Overall Study|Adverse Event|5|||
49001451|NCT02118896|157842583|FG001|Overall Study|Adverse Event|4|||
49001452|NCT02118896|157842584|FG002|Overall Study|Adverse Event|4|||
49001453|NCT02118896|157842585|FG003|Overall Study|Adverse Event|5|||
49001454|NCT02118896|157842586|FG004|Overall Study|Adverse Event|5|||
49001455|NCT02118896|157842587|FG005|Overall Study|Adverse Event|9|||
49001456|NCT02118896|157842588|FG006|Overall Study|Adverse Event|1|||
49001457|NCT02118896|157842589|FG007|Overall Study|Adverse Event|1|||
49001458|NCT02118896|157842590|FG008|Overall Study|Adverse Event|4|||
49001459|NCT02118896|157842591|FG009|Overall Study|Adverse Event|0|||
49001460|NCT02118896|157842582|FG000|Overall Study|Consent withdrawn|2|||
49001461|NCT02118896|157842583|FG001|Overall Study|Consent withdrawn|0|||
49001462|NCT02118896|157842584|FG002|Overall Study|Consent withdrawn|3|||
49001463|NCT02118896|157842585|FG003|Overall Study|Consent withdrawn|4|||
49001464|NCT02118896|157842586|FG004|Overall Study|Consent withdrawn|1|||
49001465|NCT02118896|157842587|FG005|Overall Study|Consent withdrawn|4|||
49001466|NCT02118896|157842588|FG006|Overall Study|Consent withdrawn|0|||
49001467|NCT02118896|157842589|FG007|Overall Study|Consent withdrawn|0|||
49001468|NCT02118896|157842590|FG008|Overall Study|Consent withdrawn|0|||
49001469|NCT02118896|157842591|FG009|Overall Study|Consent withdrawn|0|||
49001470|NCT02118896|157842582|FG000|Overall Study|Non-compliance|2|||
49001471|NCT02118896|157842583|FG001|Overall Study|Non-compliance|1|||
49001472|NCT02118896|157842584|FG002|Overall Study|Non-compliance|1|||
49001473|NCT02118896|157842585|FG003|Overall Study|Non-compliance|5|||
49001474|NCT02118896|157842586|FG004|Overall Study|Non-compliance|0|||
49001475|NCT02118896|157842587|FG005|Overall Study|Non-compliance|1|||
49001476|NCT02118896|157842588|FG006|Overall Study|Non-compliance|0|||
49001477|NCT02118896|157842589|FG007|Overall Study|Non-compliance|1|||
49001478|NCT02118896|157842590|FG008|Overall Study|Non-compliance|0|||
49001479|NCT02118896|157842591|FG009|Overall Study|Non-compliance|0|||
49001480|NCT02118896|157842582|FG000|Overall Study|Pregnancy|1|||
49001481|NCT02118896|157842583|FG001|Overall Study|Pregnancy|1|||
49001482|NCT02118896|157842584|FG002|Overall Study|Pregnancy|0|||
49001483|NCT02118896|157842585|FG003|Overall Study|Pregnancy|0|||
49001484|NCT02118896|157842586|FG004|Overall Study|Pregnancy|1|||
49001485|NCT02118896|157842587|FG005|Overall Study|Pregnancy|3|||
49001486|NCT02118896|157842588|FG006|Overall Study|Pregnancy|1|||
49001487|NCT02118896|157842589|FG007|Overall Study|Pregnancy|0|||
49001488|NCT02118896|157842590|FG008|Overall Study|Pregnancy|0|||
49001489|NCT02118896|157842591|FG009|Overall Study|Pregnancy|0|||
49001490|NCT02118896|157842582|FG000|Overall Study|Lost to Follow-up|1|||
49001491|NCT02118896|157842583|FG001|Overall Study|Lost to Follow-up|2|||
49001492|NCT02118896|157842584|FG002|Overall Study|Lost to Follow-up|1|||
49001493|NCT02118896|157842585|FG003|Overall Study|Lost to Follow-up|0|||
49001494|NCT02118896|157842586|FG004|Overall Study|Lost to Follow-up|2|||
49001495|NCT02118896|157842587|FG005|Overall Study|Lost to Follow-up|1|||
49001496|NCT02118896|157842588|FG006|Overall Study|Lost to Follow-up|0|||
49001497|NCT02118896|157842589|FG007|Overall Study|Lost to Follow-up|0|||
49001498|NCT02118896|157842590|FG008|Overall Study|Lost to Follow-up|0|||
49001499|NCT02118896|157842591|FG009|Overall Study|Lost to Follow-up|0|||
49001500|NCT02118896|157842582|FG000|Overall Study|Immunosuppressive regimen (not MR4)|1|||
49001501|NCT02118896|157842583|FG001|Overall Study|Immunosuppressive regimen (not MR4)|5|||
49001502|NCT02118896|157842584|FG002|Overall Study|Immunosuppressive regimen (not MR4)|1|||
49001503|NCT02118896|157842585|FG003|Overall Study|Immunosuppressive regimen (not MR4)|2|||
49001504|NCT02118896|157842586|FG004|Overall Study|Immunosuppressive regimen (not MR4)|4|||
49001505|NCT02118896|157842587|FG005|Overall Study|Immunosuppressive regimen (not MR4)|2|||
49001506|NCT02118896|157842588|FG006|Overall Study|Immunosuppressive regimen (not MR4)|0|||
49001507|NCT02118896|157842589|FG007|Overall Study|Immunosuppressive regimen (not MR4)|0|||
49001508|NCT02118896|157842590|FG008|Overall Study|Immunosuppressive regimen (not MR4)|0|||
49001509|NCT02118896|157842591|FG009|Overall Study|Immunosuppressive regimen (not MR4)|2|||
49001510|NCT02118896|157842582|FG000|Overall Study|Prohibited medication|0|||
49001511|NCT02118896|157842583|FG001|Overall Study|Prohibited medication|0|||
49001512|NCT02118896|157842584|FG002|Overall Study|Prohibited medication|0|||
49001513|NCT02118896|157842585|FG003|Overall Study|Prohibited medication|0|||
49001514|NCT02118896|157842586|FG004|Overall Study|Prohibited medication|1|||
49001515|NCT02118896|157842587|FG005|Overall Study|Prohibited medication|3|||
49001516|NCT02118896|157842588|FG006|Overall Study|Prohibited medication|0|||
49001517|NCT02118896|157842589|FG007|Overall Study|Prohibited medication|0|||
49001518|NCT02118896|157842590|FG008|Overall Study|Prohibited medication|0|||
49001519|NCT02118896|157842591|FG009|Overall Study|Prohibited medication|0|||
49001520|NCT02118896|157842582|FG000|Overall Study|Miscellaneous|1|||
49001521|NCT02118896|157842583|FG001|Overall Study|Miscellaneous|2|||
49001522|NCT02118896|157842584|FG002|Overall Study|Miscellaneous|0|||
49001523|NCT02118896|157842585|FG003|Overall Study|Miscellaneous|2|||
49001524|NCT02118896|157842586|FG004|Overall Study|Miscellaneous|0|||
49001525|NCT02118896|157842587|FG005|Overall Study|Miscellaneous|4|||
49001526|NCT02118896|157842588|FG006|Overall Study|Miscellaneous|0|||
49001527|NCT02118896|157842589|FG007|Overall Study|Miscellaneous|0|||
49001528|NCT02118896|157842590|FG008|Overall Study|Miscellaneous|0|||
49001529|NCT02118896|157842591|FG009|Overall Study|Miscellaneous|0|||
49001530|NCT03130777|157842592|FG000|Overall Study|Death|0|||
49001531|NCT03130777|157842593|FG001|Overall Study|Death|1|||
49001532|NCT03130777|157842592|FG000|Overall Study|Did not meet eligibility criteria|1|||
49001533|NCT03130777|157842593|FG001|Overall Study|Did not meet eligibility criteria|0|||
49001534|NCT00713830|157842594|FG000|Overall Study|Adverse Event|23|||
49001535|NCT00713830|157842595|FG001|Overall Study|Adverse Event|71|||
49001536|NCT00713830|157842594|FG000|Overall Study|Lack of Efficacy|24|||
49001537|NCT00713830|157842595|FG001|Overall Study|Lack of Efficacy|16|||
49001538|NCT00713830|157842594|FG000|Overall Study|Lost to Follow-up|2|||
49001539|NCT00713830|157842595|FG001|Overall Study|Lost to Follow-up|9|||
49001540|NCT00713830|157842594|FG000|Overall Study|Withdrawal by Subject|13|||
49001541|NCT00713830|157842595|FG001|Overall Study|Withdrawal by Subject|23|||
49001542|NCT00713830|157842594|FG000|Overall Study|Poor Compliance to Protocol|7|||
49001543|NCT00713830|157842595|FG001|Overall Study|Poor Compliance to Protocol|14|||
49001544|NCT00713830|157842594|FG000|Overall Study|Familial and Personal Reasons|9|||
49001545|NCT00713830|157842595|FG001|Overall Study|Familial and Personal Reasons|34|||
49001546|NCT00713830|157842594|FG000|Overall Study|Sponsor Decision|4|||
49001547|NCT00713830|157842595|FG001|Overall Study|Sponsor Decision|10|||
49001548|NCT00455923|157842598|FG000|Overall Study|Pregnancy|0|||
49001549|NCT00455923|157842599|FG001|Overall Study|Pregnancy|2|||
49001550|NCT00455923|157842598|FG000|Overall Study|Other|3|||
49001551|NCT00455923|157842599|FG001|Overall Study|Other|1|||
49001552|NCT02860039|157842600|FG000|Overall Study|Death|4|||
49001553|NCT02860039|157842601|FG001|Overall Study|Death|0|||
49001554|NCT02860039|157842600|FG000|Overall Study|Lost to Follow-up|2|||
49001555|NCT02860039|157842601|FG001|Overall Study|Lost to Follow-up|2|||
49001556|NCT02860039|157842600|FG000|Overall Study|Protocol Violation|3|||
49001557|NCT02860039|157842601|FG001|Overall Study|Protocol Violation|1|||
49001558|NCT02860039|157842600|FG000|Overall Study|Withdrawal by Subject|1|||
49001559|NCT02860039|157842601|FG001|Overall Study|Withdrawal by Subject|0|||
49001560|NCT02860039|157842600|FG000|Overall Study|Not otherwise eligible|1|||
49001561|NCT02860039|157842601|FG001|Overall Study|Not otherwise eligible|1|||
49001562|NCT00244881|157842614|FG000|Overall Study|Withdrawal by Subject|3|||
49001563|NCT03345485|157842615|FG000|Overall Study|Do not have a post-dose tumour assessment|0|||
49001564|NCT03345485|157842616|FG001|Overall Study|Do not have a post-dose tumour assessment|0|||
49001565|NCT03345485|157842617|FG002|Overall Study|Do not have a post-dose tumour assessment|0|||
49001566|NCT03345485|157842618|FG003|Overall Study|Do not have a post-dose tumour assessment|0|||
49001567|NCT03345485|157842619|FG004|Overall Study|Do not have a post-dose tumour assessment|0|||
49001568|NCT03345485|157842620|FG005|Overall Study|Do not have a post-dose tumour assessment|0|||
49001569|NCT03345485|157842621|FG006|Overall Study|Do not have a post-dose tumour assessment|1|||
49001570|NCT03345485|157842622|FG007|Overall Study|Do not have a post-dose tumour assessment|2|||
49001571|NCT03345485|157842623|FG008|Overall Study|Do not have a post-dose tumour assessment|0|||
49001572|NCT03345485|157842624|FG009|Overall Study|Do not have a post-dose tumour assessment|0|||
49001573|NCT03345485|157842625|FG010|Overall Study|Do not have a post-dose tumour assessment|2|||
49001574|NCT03345485|157842626|FG011|Overall Study|Do not have a post-dose tumour assessment|3|||
49001575|NCT03345485|157842627|FG012|Overall Study|Do not have a post-dose tumour assessment|3|||
49001576|NCT02985515|157842628|FG000|Olfaction Testing|Lost to Follow-up|0|||
49001577|NCT02985515|157842629|FG001|Olfaction Testing|Lost to Follow-up|5|||
49001578|NCT02985515|157842628|FG000|Olfaction Testing|Protocol Violation|0|||
49001579|NCT02985515|157842629|FG001|Olfaction Testing|Protocol Violation|3|||
49001580|NCT03664024|157842632|FG000|Overall Study|Follow-up discontinued by sponsor|34|||
49001581|NCT03664024|157842632|FG000|Overall Study|Lost to Follow-up|2|||
49001582|NCT03664024|157842632|FG000|Overall Study|Withdrawal by Subject|2|||
49001583|NCT03664024|157842632|FG000|Overall Study|Death|80|||
49001584|NCT01125358|157842633|FG000|Overall Study|Adverse Event|3|||
49001585|NCT01125358|157842634|FG001|Overall Study|Adverse Event|0|||
49001586|NCT01125358|157842635|FG002|Overall Study|Adverse Event|0|||
49001587|NCT01125358|157842636|FG003|Overall Study|Adverse Event|2|||
49001588|NCT01125358|157842633|FG000|Overall Study|Perceived Lack of Efficacy|6|||
49001589|NCT01125358|157842634|FG001|Overall Study|Perceived Lack of Efficacy|3|||
49001590|NCT01125358|157842635|FG002|Overall Study|Perceived Lack of Efficacy|7|||
49001591|NCT01125358|157842636|FG003|Overall Study|Perceived Lack of Efficacy|4|||
49001592|NCT01125358|157842633|FG000|Overall Study|Protocol Violation|1|||
49001593|NCT01125358|157842634|FG001|Overall Study|Protocol Violation|0|||
49001594|NCT01125358|157842635|FG002|Overall Study|Protocol Violation|0|||
49001595|NCT01125358|157842636|FG003|Overall Study|Protocol Violation|0|||
49001596|NCT01125358|157842633|FG000|Overall Study|Sponsor Decision|0|||
49001597|NCT01125358|157842634|FG001|Overall Study|Sponsor Decision|0|||
49001598|NCT01125358|157842635|FG002|Overall Study|Sponsor Decision|1|||
49001599|NCT01125358|157842636|FG003|Overall Study|Sponsor Decision|1|||
49001600|NCT01125358|157842633|FG000|Overall Study|Withdrawal by Subject|2|||
49001601|NCT01125358|157842634|FG001|Overall Study|Withdrawal by Subject|1|||
49001602|NCT01125358|157842635|FG002|Overall Study|Withdrawal by Subject|1|||
49001603|NCT01125358|157842636|FG003|Overall Study|Withdrawal by Subject|1|||
49001604|NCT01640964|157842637|FG000|Overall Study|Lost to Follow-up|0|||
49001605|NCT01640964|157842638|FG001|Overall Study|Lost to Follow-up|0|||
49001606|NCT01640964|157842639|FG002|Overall Study|Lost to Follow-up|1|||
49001607|NCT01640964|157842637|FG000|Overall Study|Protocol Deviation|1|||
49001608|NCT01640964|157842638|FG001|Overall Study|Protocol Deviation|1|||
49001609|NCT01640964|157842639|FG002|Overall Study|Protocol Deviation|2|||
49001610|NCT04003103|157842640|FG000|Overall Study|Death|1|||
49001611|NCT04003103|157842641|FG001|Overall Study|Death|0|||
49001612|NCT04003103|157842642|FG002|Overall Study|Death|0|||
49001613|NCT04003103|157842640|FG000|Overall Study|Lost to Follow-up|4|||
49001614|NCT04003103|157842641|FG001|Overall Study|Lost to Follow-up|3|||
49001615|NCT04003103|157842642|FG002|Overall Study|Lost to Follow-up|2|||
49001616|NCT04003103|157842640|FG000|Overall Study|Withdrawal by Subject|10|||
49001617|NCT04003103|157842641|FG001|Overall Study|Withdrawal by Subject|1|||
49001618|NCT04003103|157842642|FG002|Overall Study|Withdrawal by Subject|1|||
49001619|NCT04003103|157842640|FG000|Overall Study|Status not recorded|0|||
49001620|NCT04003103|157842641|FG001|Overall Study|Status not recorded|2|||
49001621|NCT04003103|157842642|FG002|Overall Study|Status not recorded|0|||
49001622|NCT00742859|157842643|FG000|Overall Study|Adverse Event|5|||
49001623|NCT00742859|157842644|FG001|Overall Study|Adverse Event|6|||
49001624|NCT00742859|157842645|FG002|Overall Study|Adverse Event|3|||
49001625|NCT00742859|157842646|FG003|Overall Study|Adverse Event|1|||
49001626|NCT00742859|157842643|FG000|Overall Study|Death|1|||
49001627|NCT00742859|157842644|FG001|Overall Study|Death|0|||
49001628|NCT00742859|157842645|FG002|Overall Study|Death|0|||
49001629|NCT00742859|157842646|FG003|Overall Study|Death|1|||
49001630|NCT00742859|157842643|FG000|Overall Study|Physician Decision|1|||
49001631|NCT00742859|157842644|FG001|Overall Study|Physician Decision|2|||
49001632|NCT00742859|157842645|FG002|Overall Study|Physician Decision|0|||
49001633|NCT00742859|157842646|FG003|Overall Study|Physician Decision|0|||
49001634|NCT00742859|157842643|FG000|Overall Study|Withdrawal by Subject|4|||
49001635|NCT00742859|157842644|FG001|Overall Study|Withdrawal by Subject|2|||
49001636|NCT00742859|157842645|FG002|Overall Study|Withdrawal by Subject|4|||
49001637|NCT00742859|157842646|FG003|Overall Study|Withdrawal by Subject|1|||
49001638|NCT00742859|157842643|FG000|Overall Study|Endpoint|0|||
49001639|NCT00742859|157842644|FG001|Overall Study|Endpoint|1|||
49001640|NCT00742859|157842645|FG002|Overall Study|Endpoint|1|||
49001641|NCT00742859|157842646|FG003|Overall Study|Endpoint|2|||
49001642|NCT00742859|157842643|FG000|Overall Study|Amendment 2 patient off study drug >4wks|0|||
49001643|NCT00742859|157842644|FG001|Overall Study|Amendment 2 patient off study drug >4wks|1|||
49001644|NCT00742859|157842645|FG002|Overall Study|Amendment 2 patient off study drug >4wks|1|||
49001645|NCT00742859|157842646|FG003|Overall Study|Amendment 2 patient off study drug >4wks|0|||
49001646|NCT00742859|157842643|FG000|Overall Study|Sponsor req visit schedule noncompliance|0|||
49001647|NCT00742859|157842644|FG001|Overall Study|Sponsor req visit schedule noncompliance|0|||
49001648|NCT00742859|157842645|FG002|Overall Study|Sponsor req visit schedule noncompliance|0|||
49001649|NCT00742859|157842646|FG003|Overall Study|Sponsor req visit schedule noncompliance|1|||
49001650|NCT00742859|157842643|FG000|Overall Study|Sponsor request patient out of town|0|||
49001651|NCT00742859|157842644|FG001|Overall Study|Sponsor request patient out of town|0|||
49001652|NCT00742859|157842645|FG002|Overall Study|Sponsor request patient out of town|1|||
49001653|NCT00742859|157842646|FG003|Overall Study|Sponsor request patient out of town|1|||
49001654|NCT00742859|157842643|FG000|Overall Study|Site error|0|||
49001655|NCT00742859|157842644|FG001|Overall Study|Site error|0|||
49001656|NCT00742859|157842645|FG002|Overall Study|Site error|1|||
49001657|NCT00742859|157842646|FG003|Overall Study|Site error|1|||
49001658|NCT04935931|157842655|FG000|Overall Study|Withdrawal by Subject|1|||
49001659|NCT01346501|157842656|FG000|Overall Study|Initiated Other Biological Agents|3|||
49001660|NCT01346501|157842657|FG001|Overall Study|Initiated Other Biological Agents|1|||
49001661|NCT01346501|157842656|FG000|Overall Study|Other|8|||
49001662|NCT01346501|157842657|FG001|Overall Study|Other|12|||
49001663|NCT04101721|157842658|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
49001664|NCT04101721|157842659|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
49001665|NCT04101721|157842658|FG000|Overall Study|Death|0|||
49001666|NCT04101721|157842659|FG001|Overall Study|Death|1|||
49001667|NCT04101721|157842658|FG000|Overall Study|Lost to Follow-up|0|||
49001668|NCT04101721|157842659|FG001|Overall Study|Lost to Follow-up|3|||
49001669|NCT01265875|157842662|FG000|Overall Study|Uncooperative/unreliable|1|||
49001670|NCT02628418|157842665|FG000|Overall Study|Lost to Follow-up|1|||
49001671|NCT02628418|157842666|FG001|Overall Study|Lost to Follow-up|2|||
49001672|NCT00756652|157842667|FG000|Original Phase|Withdrawal by Subject|864|||
49001673|NCT00756652|157842668|FG001|Original Phase|Withdrawal by Subject|23|||
49001674|NCT00756652|157842667|FG000|Original Phase|Lost to Follow-up|601|||
49001675|NCT00756652|157842668|FG001|Original Phase|Lost to Follow-up|0|||
49001676|NCT00756652|157842667|FG000|Original Phase|Other Discontinuation|797|||
49001677|NCT00756652|157842668|FG001|Original Phase|Other Discontinuation|5|||
49001678|NCT00756652|157842667|FG000|Original Phase|Participant Noncompliance|18622|||
49001679|NCT00756652|157842668|FG001|Original Phase|Participant Noncompliance|424|||
49001680|NCT00756652|157842667|FG000|Original Phase|Unknown Discontinuation Reason|2|||
49001681|NCT00756652|157842668|FG001|Original Phase|Unknown Discontinuation Reason|0|||
49001682|NCT00756652|157842667|FG000|Original Phase|Participants without data|3259|||
49001683|NCT00756652|157842668|FG001|Original Phase|Participants without data|466|||
49001684|NCT00756652|157842667|FG000|Original Phase|Death|168|||
49001685|NCT00756652|157842668|FG001|Original Phase|Death|1|||
49001686|NCT00756652|157842667|FG000|Original Phase|Not due for F/U at Phase One closure|11076|||
49001687|NCT00756652|157842668|FG001|Original Phase|Not due for F/U at Phase One closure|2|||
49001688|NCT00756652|157842667|FG000|Re-Op Phase|Withdrawal by Subject|62|||
49001689|NCT00756652|157842668|FG001|Re-Op Phase|Withdrawal by Subject|0|||
49001690|NCT00756652|157842667|FG000|Re-Op Phase|Death|6|||
49001691|NCT00756652|157842668|FG001|Re-Op Phase|Death|0|||
49001692|NCT00756652|157842667|FG000|Re-Op Phase|Lost to Follow-up|340|||
49001693|NCT00756652|157842668|FG001|Re-Op Phase|Lost to Follow-up|0|||
49001694|NCT00756652|157842667|FG000|Re-Op Phase|Site Closed|2454|||
49001695|NCT00756652|157842668|FG001|Re-Op Phase|Site Closed|0|||
49001696|NCT00756652|157842667|FG000|Re-Op Phase|Withdrawn after explant|14|||
49001697|NCT00756652|157842668|FG001|Re-Op Phase|Withdrawn after explant|0|||
49001698|NCT00424632|157842669|FG000|Overall Study|Death|0|||
49001699|NCT00424632|157842670|FG001|Overall Study|Death|0|||
49001700|NCT00424632|157842671|FG002|Overall Study|Death|0|||
49001701|NCT00424632|157842672|FG003|Overall Study|Death|0|||
49001702|NCT00424632|157842673|FG004|Overall Study|Death|0|||
49001703|NCT00424632|157842674|FG005|Overall Study|Death|2|||
49001704|NCT00424632|157842675|FG006|Overall Study|Death|0|||
49001705|NCT00424632|157842676|FG007|Overall Study|Death|0|||
49001706|NCT00424632|157842677|FG008|Overall Study|Death|0|||
49001707|NCT00424632|157842678|FG009|Overall Study|Death|0|||
49001708|NCT00424632|157842669|FG000|Overall Study|Adverse Event|0|||
49001709|NCT00424632|157842670|FG001|Overall Study|Adverse Event|0|||
49001710|NCT00424632|157842671|FG002|Overall Study|Adverse Event|0|||
49001711|NCT00424632|157842672|FG003|Overall Study|Adverse Event|0|||
49001712|NCT00424632|157842673|FG004|Overall Study|Adverse Event|0|||
49001713|NCT00424632|157842674|FG005|Overall Study|Adverse Event|0|||
49001714|NCT00424632|157842675|FG006|Overall Study|Adverse Event|0|||
49001715|NCT00424632|157842676|FG007|Overall Study|Adverse Event|0|||
49001716|NCT00424632|157842677|FG008|Overall Study|Adverse Event|3|||
49001717|NCT00424632|157842678|FG009|Overall Study|Adverse Event|2|||
49001718|NCT00424632|157842669|FG000|Overall Study|Global deterioration of health status|0|||
49001719|NCT00424632|157842670|FG001|Overall Study|Global deterioration of health status|0|||
49001720|NCT00424632|157842671|FG002|Overall Study|Global deterioration of health status|0|||
49001721|NCT00424632|157842672|FG003|Overall Study|Global deterioration of health status|1|||
49001722|NCT00424632|157842673|FG004|Overall Study|Global deterioration of health status|1|||
49001723|NCT00424632|157842674|FG005|Overall Study|Global deterioration of health status|0|||
49001724|NCT00424632|157842675|FG006|Overall Study|Global deterioration of health status|0|||
49001725|NCT00424632|157842676|FG007|Overall Study|Global deterioration of health status|0|||
49001726|NCT00424632|157842677|FG008|Overall Study|Global deterioration of health status|0|||
49001727|NCT00424632|157842678|FG009|Overall Study|Global deterioration of health status|0|||
49001728|NCT00424632|157842669|FG000|Overall Study|Objective progression or relapse|1|||
49001729|NCT00424632|157842670|FG001|Overall Study|Objective progression or relapse|1|||
49001730|NCT00424632|157842671|FG002|Overall Study|Objective progression or relapse|1|||
49001731|NCT00424632|157842672|FG003|Overall Study|Objective progression or relapse|2|||
49001732|NCT00424632|157842673|FG004|Overall Study|Objective progression or relapse|2|||
49001733|NCT00424632|157842674|FG005|Overall Study|Objective progression or relapse|13|||
49001734|NCT00424632|157842675|FG006|Overall Study|Objective progression or relapse|7|||
49001735|NCT00424632|157842676|FG007|Overall Study|Objective progression or relapse|3|||
49001736|NCT00424632|157842677|FG008|Overall Study|Objective progression or relapse|12|||
49001737|NCT00424632|157842678|FG009|Overall Study|Objective progression or relapse|4|||
49001738|NCT00424632|157842669|FG000|Overall Study|Other|0|||
49001739|NCT00424632|157842670|FG001|Overall Study|Other|0|||
49001740|NCT00424632|157842671|FG002|Overall Study|Other|0|||
49001741|NCT00424632|157842672|FG003|Overall Study|Other|1|||
49001742|NCT00424632|157842673|FG004|Overall Study|Other|0|||
49001743|NCT00424632|157842674|FG005|Overall Study|Other|0|||
49001744|NCT00424632|157842675|FG006|Overall Study|Other|0|||
49001745|NCT00424632|157842676|FG007|Overall Study|Other|0|||
49001746|NCT00424632|157842677|FG008|Overall Study|Other|1|||
49001747|NCT00424632|157842678|FG009|Overall Study|Other|0|||
49001748|NCT02610842|157842679|FG000|Overall Study|Lost to Follow-up|5|||
49001749|NCT02564952|157842680|FG000|Overall Study|Adverse Event|6|||
49001750|NCT02564952|157842680|FG000|Overall Study|Lost to Follow-up|1|||
49001751|NCT02564952|157842680|FG000|Overall Study|Participant Withdrawn by Investigator|1|||
49001752|NCT02564952|157842680|FG000|Overall Study|Withdrawal by Subject|1|||
49001753|NCT02564952|157842680|FG000|Overall Study|Low Efficacy|1|||
49001754|NCT02564952|157842680|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
49001755|NCT02617446|157842692|FG000|Overall Study|Withdrawal by Subject|0|||
49001756|NCT02617446|157842693|FG001|Overall Study|Withdrawal by Subject|2|||
49001757|NCT02617446|157842694|FG002|Overall Study|Withdrawal by Subject|0|||
49001758|NCT02617446|157842692|FG000|Overall Study|Adverse Event|1|||
49001759|NCT02617446|157842693|FG001|Overall Study|Adverse Event|0|||
49001760|NCT02617446|157842694|FG002|Overall Study|Adverse Event|5|||
49001761|NCT02617446|157842692|FG000|Overall Study|Lost to Follow-up|3|||
49001762|NCT02617446|157842693|FG001|Overall Study|Lost to Follow-up|0|||
49001763|NCT02617446|157842694|FG002|Overall Study|Lost to Follow-up|0|||
49001764|NCT02617446|157842692|FG000|Overall Study|Death|0|||
49001765|NCT02617446|157842693|FG001|Overall Study|Death|0|||
49001766|NCT02617446|157842694|FG002|Overall Study|Death|2|||
49001767|NCT01556490|157842699|FG000|Randomized Patients Summary|Protocol Violation|22|||
49001768|NCT01556490|157842700|FG001|Randomized Patients Summary|Protocol Violation|23|||
49001769|NCT01556490|157842699|FG000|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|12|||
49001770|NCT01556490|157842700|FG001|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|18|||
49001771|NCT00358670|157842701|FG000|Overall Study|Adverse Event|26|||
49001772|NCT00358670|157842702|FG001|Overall Study|Adverse Event|29|||
49001773|NCT00358670|157842701|FG000|Overall Study|Lack of Efficacy|20|||
49001774|NCT00358670|157842702|FG001|Overall Study|Lack of Efficacy|23|||
49001775|NCT00358670|157842701|FG000|Overall Study|Protocol Violation|6|||
49001776|NCT00358670|157842702|FG001|Overall Study|Protocol Violation|9|||
49001777|NCT00358670|157842701|FG000|Overall Study|Lost to Follow-up|4|||
49001778|NCT00358670|157842702|FG001|Overall Study|Lost to Follow-up|5|||
49001779|NCT00358670|157842701|FG000|Overall Study|Withdrawal by Subject|13|||
49001780|NCT00358670|157842702|FG001|Overall Study|Withdrawal by Subject|24|||
49001781|NCT00358670|157842701|FG000|Overall Study|Protocol Defined Clinical Event|0|||
49001782|NCT00358670|157842702|FG001|Overall Study|Protocol Defined Clinical Event|1|||
49001783|NCT00358670|157842701|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
49001784|NCT00358670|157842702|FG001|Overall Study|Did Not Meet Protocol Eligibility|3|||
49001785|NCT00358670|157842701|FG000|Overall Study|Administrative|153|||
49001786|NCT00358670|157842702|FG001|Overall Study|Administrative|125|||
49001787|NCT04449354|157842703|FG000|Overall Study|Withdrawal by Subject|1|||
49001788|NCT05789420|157842704|FG000|Screening and Safety Assessments|Completed Alternate Status|1|||
49001789|NCT05789420|157842704|FG000|Randomization to Product Assessments|Failed alcohol breath test and urine test on day -1|1|||
49001790|NCT00391118|157842705|FG000|Overall Study|Adverse Event|3|||
49001791|NCT00391118|157842706|FG001|Overall Study|Adverse Event|10|||
49001792|NCT00391118|157842707|FG002|Overall Study|Adverse Event|7|||
49001793|NCT00391118|157842705|FG000|Overall Study|Lost to Follow-up|0|||
49001794|NCT00391118|157842706|FG001|Overall Study|Lost to Follow-up|2|||
49001795|NCT00391118|157842707|FG002|Overall Study|Lost to Follow-up|3|||
49001796|NCT00391118|157842705|FG000|Overall Study|Withdrawal by Subject|0|||
49001797|NCT00391118|157842706|FG001|Overall Study|Withdrawal by Subject|9|||
49001798|NCT00391118|157842707|FG002|Overall Study|Withdrawal by Subject|1|||
49001799|NCT00391118|157842705|FG000|Overall Study|Death|0|||
49001800|NCT00391118|157842706|FG001|Overall Study|Death|1|||
49001801|NCT00391118|157842707|FG002|Overall Study|Death|0|||
49001802|NCT00391118|157842705|FG000|Overall Study|Physician Decision|0|||
49001803|NCT00391118|157842706|FG001|Overall Study|Physician Decision|3|||
49001804|NCT00391118|157842707|FG002|Overall Study|Physician Decision|0|||
49001805|NCT00391118|157842705|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
49001806|NCT00391118|157842706|FG001|Overall Study|Protocol Entry Criteria Not Met|3|||
49001807|NCT00391118|157842707|FG002|Overall Study|Protocol Entry Criteria Not Met|1|||
49001808|NCT00391118|157842705|FG000|Overall Study|Progressive Disease|7|||
49001809|NCT00391118|157842706|FG001|Overall Study|Progressive Disease|26|||
49001810|NCT00391118|157842707|FG002|Overall Study|Progressive Disease|43|||
49001811|NCT00391118|157842705|FG000|Overall Study|Sponsor Decision|0|||
49001812|NCT00391118|157842706|FG001|Overall Study|Sponsor Decision|1|||
49001813|NCT00391118|157842707|FG002|Overall Study|Sponsor Decision|3|||
49001814|NCT00391118|157842705|FG000|Overall Study|Protocol Violation|1|||
49001815|NCT00391118|157842706|FG001|Overall Study|Protocol Violation|0|||
49001816|NCT00391118|157842707|FG002|Overall Study|Protocol Violation|0|||
49001817|NCT00797316|157842708|FG000|Overall Study|Administrative problems|1|||
49001818|NCT00797316|157842709|FG001|Overall Study|Administrative problems|0|||
49001819|NCT00797316|157842708|FG000|Overall Study|Adverse Event|5|||
49001820|NCT00797316|157842709|FG001|Overall Study|Adverse Event|3|||
49001821|NCT00797316|157842708|FG000|Overall Study|Lost to Follow-up|4|||
49001822|NCT00797316|157842709|FG001|Overall Study|Lost to Follow-up|8|||
49001823|NCT00797316|157842708|FG000|Overall Study|Protocol Deviation|1|||
49001824|NCT00797316|157842709|FG001|Overall Study|Protocol Deviation|2|||
49001825|NCT00797316|157842708|FG000|Overall Study|Patient withdrew consent|12|||
49001826|NCT00797316|157842709|FG001|Overall Study|Patient withdrew consent|6|||
49001827|NCT00797316|157842708|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
49001828|NCT00797316|157842709|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
49001829|NCT00944125|157842711|FG000|3 to 6 Months|Withdrawal by Subject|0|||
49001830|NCT00944125|157842712|FG001|3 to 6 Months|Withdrawal by Subject|2|||
49001831|NCT00944125|157842711|FG000|6 Months to Study Completion|Withdrawal by Subject|0|||
49001832|NCT00944125|157842712|FG001|6 Months to Study Completion|Withdrawal by Subject|2|||
49001833|NCT03751124|157842713|FG000|Overall Study|Adverse Event|4|||
49001834|NCT03751124|157842714|FG001|Overall Study|Adverse Event|3|||
49001835|NCT03751124|157842713|FG000|Overall Study|Protocol Deviation|0|||
49001836|NCT03751124|157842714|FG001|Overall Study|Protocol Deviation|1|||
49001837|NCT03751124|157842713|FG000|Overall Study|Lost to Follow-up|6|||
49001838|NCT03751124|157842714|FG001|Overall Study|Lost to Follow-up|4|||
49001839|NCT03751124|157842713|FG000|Overall Study|Withdrawal by Subject|6|||
49001840|NCT03751124|157842714|FG001|Overall Study|Withdrawal by Subject|8|||
49001841|NCT03751124|157842713|FG000|Overall Study|Lack of Efficacy|1|||
49001842|NCT03751124|157842714|FG001|Overall Study|Lack of Efficacy|1|||
49001843|NCT03751124|157842713|FG000|Overall Study|Pregnancy|0|||
49001844|NCT03751124|157842714|FG001|Overall Study|Pregnancy|1|||
49001845|NCT03751124|157842713|FG000|Overall Study|Other|9|||
49001846|NCT03751124|157842714|FG001|Overall Study|Other|9|||
49001847|NCT03751124|157842713|FG000|Overall Study|Participants who did not receive any study drug|0|||
49001848|NCT03751124|157842714|FG001|Overall Study|Participants who did not receive any study drug|1|||
49001849|NCT05037409|157842719|FG000|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
49001850|NCT05037409|157842720|FG001|Blinded Treatment (1 Day)|Failure to comply with site instruction|1|||
49001851|NCT05037409|157842721|FG002|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
49001852|NCT04489888|157842725|FG000|Overall Study|Death|61|||
49001853|NCT04489888|157842725|FG000|Overall Study|Participant On-going|40|||
49001854|NCT03494816|157842726|FG000|Overall Study|Protocol Violation|2|||
49001855|NCT03494816|157842726|FG000|Overall Study|Physician Decision|2|||
49001856|NCT03494816|157842726|FG000|Overall Study|Did not start trial treatment|1|||
49001857|NCT03494816|157842726|FG000|Overall Study|Adverse Event|1|||
49001858|NCT03256526|157844555|FG000|Overall Study|Adverse Event|1|||
49001859|NCT03256526|157844556|FG001|Overall Study|Adverse Event|0|||
49001860|NCT03256526|157844557|FG002|Overall Study|Adverse Event|1|||
49001861|NCT03256526|157844555|FG000|Overall Study|Lost to Follow-up|1|||
49001862|NCT03256526|157844556|FG001|Overall Study|Lost to Follow-up|0|||
49001863|NCT03256526|157844557|FG002|Overall Study|Lost to Follow-up|2|||
49001864|NCT00242567|157844560|FG000|Overall Study|Adverse Event|70|||
49001865|NCT00242567|157844561|FG001|Overall Study|Adverse Event|43|||
49001866|NCT00242567|157844560|FG000|Overall Study|Disease Progression|17|||
49001867|NCT00242567|157844561|FG001|Overall Study|Disease Progression|22|||
49001868|NCT00242567|157844560|FG000|Overall Study|Symptomatic deterioration|9|||
49001869|NCT00242567|157844561|FG001|Overall Study|Symptomatic deterioration|3|||
49001870|NCT00242567|157844560|FG000|Overall Study|Lack of Efficacy|2|||
49001871|NCT00242567|157844561|FG001|Overall Study|Lack of Efficacy|2|||
49001872|NCT00242567|157844560|FG000|Overall Study|Lost to Follow-up|9|||
49001873|NCT00242567|157844561|FG001|Overall Study|Lost to Follow-up|19|||
49001874|NCT00242567|157844560|FG000|Overall Study|Withdrawal by Subject|33|||
49001875|NCT00242567|157844561|FG001|Overall Study|Withdrawal by Subject|28|||
49001876|NCT00242567|157844560|FG000|Overall Study|Protocol Violation|12|||
49001877|NCT00242567|157844561|FG001|Overall Study|Protocol Violation|12|||
49001878|NCT00242567|157844560|FG000|Overall Study|Use of an inhibitor of bone resorption|0|||
49001879|NCT00242567|157844561|FG001|Overall Study|Use of an inhibitor of bone resorption|2|||
49001880|NCT00242567|157844560|FG000|Overall Study|Other|14|||
49001881|NCT00242567|157844561|FG001|Overall Study|Other|9|||
49001882|NCT01299272|157844562|FG000|Acute Open-label (OL) Period|Remission Criteria Not Met|140|||
49001883|NCT01299272|157844563|FG001|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
49001884|NCT01299272|157844564|FG002|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
49001885|NCT01299272|157844565|FG003|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
49001886|NCT01299272|157844562|FG000|Acute Open-label (OL) Period|Adverse Event|140|||
49001887|NCT01299272|157844563|FG001|Acute Open-label (OL) Period|Adverse Event|0|||
49001888|NCT01299272|157844564|FG002|Acute Open-label (OL) Period|Adverse Event|0|||
49001889|NCT01299272|157844565|FG003|Acute Open-label (OL) Period|Adverse Event|0|||
49001890|NCT01299272|157844562|FG000|Acute Open-label (OL) Period|Withdrawal by Subject|56|||
49001891|NCT01299272|157844563|FG001|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
49001892|NCT01299272|157844564|FG002|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
49001893|NCT01299272|157844565|FG003|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
49001894|NCT01299272|157844562|FG000|Acute Open-label (OL) Period|Protocol Violation|36|||
49001895|NCT01299272|157844563|FG001|Acute Open-label (OL) Period|Protocol Violation|0|||
49001896|NCT01299272|157844564|FG002|Acute Open-label (OL) Period|Protocol Violation|0|||
49001897|NCT01299272|157844565|FG003|Acute Open-label (OL) Period|Protocol Violation|0|||
49001898|NCT01299272|157844562|FG000|Acute Open-label (OL) Period|Lost to Follow-up|14|||
49001899|NCT01299272|157844563|FG001|Acute Open-label (OL) Period|Lost to Follow-up|0|||
49001900|NCT01299272|157844564|FG002|Acute Open-label (OL) Period|Lost to Follow-up|0|||
49001901|NCT01299272|157844565|FG003|Acute Open-label (OL) Period|Lost to Follow-up|0|||
49001902|NCT01299272|157844562|FG000|Acute Open-label (OL) Period|Sponsor Decision|13|||
49001903|NCT01299272|157844563|FG001|Acute Open-label (OL) Period|Sponsor Decision|0|||
49001904|NCT01299272|157844564|FG002|Acute Open-label (OL) Period|Sponsor Decision|0|||
49001905|NCT01299272|157844565|FG003|Acute Open-label (OL) Period|Sponsor Decision|0|||
49001906|NCT01299272|157844562|FG000|Acute Open-label (OL) Period|Lack of Efficacy|10|||
49001907|NCT01299272|157844563|FG001|Acute Open-label (OL) Period|Lack of Efficacy|0|||
49001908|NCT01299272|157844564|FG002|Acute Open-label (OL) Period|Lack of Efficacy|0|||
49001909|NCT01299272|157844565|FG003|Acute Open-label (OL) Period|Lack of Efficacy|0|||
49001910|NCT01299272|157844562|FG000|Acute Open-label (OL) Period|Physician Decision|5|||
49001911|NCT01299272|157844563|FG001|Acute Open-label (OL) Period|Physician Decision|0|||
49001912|NCT01299272|157844564|FG002|Acute Open-label (OL) Period|Physician Decision|0|||
49001913|NCT01299272|157844565|FG003|Acute Open-label (OL) Period|Physician Decision|0|||
49001914|NCT01299272|157844562|FG000|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
49001915|NCT01299272|157844563|FG001|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80|||
49001916|NCT01299272|157844564|FG002|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
49001917|NCT01299272|157844565|FG003|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
49001918|NCT01299272|157844562|FG000|Stabilization Open-label (OL) Period|Protocol Violation|0|||
49001919|NCT01299272|157844563|FG001|Stabilization Open-label (OL) Period|Protocol Violation|44|||
49001920|NCT01299272|157844564|FG002|Stabilization Open-label (OL) Period|Protocol Violation|0|||
49001921|NCT01299272|157844565|FG003|Stabilization Open-label (OL) Period|Protocol Violation|0|||
49001922|NCT01299272|157844562|FG000|Stabilization Open-label (OL) Period|Adverse Event|0|||
49001923|NCT01299272|157844563|FG001|Stabilization Open-label (OL) Period|Adverse Event|42|||
49001924|NCT01299272|157844564|FG002|Stabilization Open-label (OL) Period|Adverse Event|0|||
49001925|NCT01299272|157844565|FG003|Stabilization Open-label (OL) Period|Adverse Event|0|||
49001926|NCT01299272|157844562|FG000|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
49001927|NCT01299272|157844563|FG001|Stabilization Open-label (OL) Period|Withdrawal by Subject|42|||
49001928|NCT01299272|157844564|FG002|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
49001929|NCT01299272|157844565|FG003|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
49001930|NCT01299272|157844562|FG000|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
49001931|NCT01299272|157844563|FG001|Stabilization Open-label (OL) Period|Sponsor Decision|12|||
49045853|NCT00660387|158002030|FG000|Overall Study|Protocol Violation|1|||
49001932|NCT01299272|157844564|FG002|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
49001933|NCT01299272|157844565|FG003|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
49001934|NCT01299272|157844562|FG000|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
49001935|NCT01299272|157844563|FG001|Stabilization Open-label (OL) Period|Lack of Efficacy|11|||
49001936|NCT01299272|157844564|FG002|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
49001937|NCT01299272|157844565|FG003|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
49001938|NCT01299272|157844562|FG000|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
49001939|NCT01299272|157844563|FG001|Stabilization Open-label (OL) Period|Lost to Follow-up|9|||
49001940|NCT01299272|157844564|FG002|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
49001941|NCT01299272|157844565|FG003|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
49001942|NCT01299272|157844562|FG000|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
49001943|NCT01299272|157844563|FG001|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6|||
49001944|NCT01299272|157844564|FG002|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
49001945|NCT01299272|157844565|FG003|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
49001946|NCT01299272|157844562|FG000|Stabilization Open-label (OL) Period|Physician Decision|0|||
49001947|NCT01299272|157844563|FG001|Stabilization Open-label (OL) Period|Physician Decision|3|||
49001948|NCT01299272|157844564|FG002|Stabilization Open-label (OL) Period|Physician Decision|0|||
49001949|NCT01299272|157844565|FG003|Stabilization Open-label (OL) Period|Physician Decision|0|||
49001950|NCT01299272|157844562|FG000|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
49001951|NCT01299272|157844563|FG001|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
49001952|NCT01299272|157844564|FG002|Double-blind (DB) Randomized Period|Withdrawal by Subject|22|||
49001953|NCT01299272|157844565|FG003|Double-blind (DB) Randomized Period|Withdrawal by Subject|15|||
49001954|NCT01299272|157844562|FG000|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
49001955|NCT01299272|157844563|FG001|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
49001956|NCT01299272|157844564|FG002|Double-blind (DB) Randomized Period|Lack of Efficacy|20|||
49001957|NCT01299272|157844565|FG003|Double-blind (DB) Randomized Period|Lack of Efficacy|10|||
49001958|NCT01299272|157844562|FG000|Double-blind (DB) Randomized Period|Adverse Event|0|||
49001959|NCT01299272|157844563|FG001|Double-blind (DB) Randomized Period|Adverse Event|0|||
49001960|NCT01299272|157844564|FG002|Double-blind (DB) Randomized Period|Adverse Event|8|||
49001961|NCT01299272|157844565|FG003|Double-blind (DB) Randomized Period|Adverse Event|9|||
49001962|NCT01299272|157844562|FG000|Double-blind (DB) Randomized Period|Protocol Violation|0|||
49001963|NCT01299272|157844563|FG001|Double-blind (DB) Randomized Period|Protocol Violation|0|||
49001964|NCT01299272|157844564|FG002|Double-blind (DB) Randomized Period|Protocol Violation|8|||
49001965|NCT01299272|157844565|FG003|Double-blind (DB) Randomized Period|Protocol Violation|7|||
49001966|NCT01299272|157844562|FG000|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
49001967|NCT01299272|157844563|FG001|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
49001968|NCT01299272|157844564|FG002|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
49001969|NCT01299272|157844565|FG003|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
49001970|NCT01299272|157844562|FG000|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
49001971|NCT01299272|157844563|FG001|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
49001972|NCT01299272|157844564|FG002|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4|||
49001973|NCT01299272|157844565|FG003|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10|||
49001974|NCT01299272|157844562|FG000|Double-blind (DB) Randomized Period|Physician Decision|0|||
49001975|NCT01299272|157844563|FG001|Double-blind (DB) Randomized Period|Physician Decision|0|||
49001976|NCT01299272|157844564|FG002|Double-blind (DB) Randomized Period|Physician Decision|2|||
49001977|NCT01299272|157844565|FG003|Double-blind (DB) Randomized Period|Physician Decision|1|||
49001978|NCT01299272|157844562|FG000|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
49001979|NCT01299272|157844563|FG001|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
49001980|NCT01299272|157844564|FG002|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
49001981|NCT01299272|157844565|FG003|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
49001982|NCT00464308|157844566|FG000|Overall Study|Adverse Event|22|||
49001983|NCT00464308|157844567|FG001|Overall Study|Adverse Event|27|||
49001984|NCT00464308|157844568|FG002|Overall Study|Adverse Event|16|||
49001985|NCT00464308|157844566|FG000|Overall Study|Lost to Follow-up|29|||
49001986|NCT00464308|157844567|FG001|Overall Study|Lost to Follow-up|19|||
49001987|NCT00464308|157844568|FG002|Overall Study|Lost to Follow-up|20|||
49001988|NCT00464308|157844566|FG000|Overall Study|Patient discontinued and other reasons|17|||
49001989|NCT00464308|157844567|FG001|Overall Study|Patient discontinued and other reasons|17|||
49001990|NCT00464308|157844568|FG002|Overall Study|Patient discontinued and other reasons|23|||
49001991|NCT00464308|157844566|FG000|Overall Study|Physician Decision|1|||
49001992|NCT00464308|157844567|FG001|Overall Study|Physician Decision|0|||
49001993|NCT00464308|157844568|FG002|Overall Study|Physician Decision|0|||
49001994|NCT01721200|157844569|FG000|Overall Study|Lost to Follow-up|3|||
49001995|NCT01721200|157844570|FG001|Overall Study|Lost to Follow-up|5|||
49001996|NCT01513759|157844571|FG000|Overall Study|Protocol Violation|4|||
49001997|NCT01513759|157844571|FG000|Overall Study|Death during catheter placement|1|||
49001998|NCT01491737|157844575|FG000|Overall Study|Withdrawal by Subject|20|||
49001999|NCT01491737|157844576|FG001|Overall Study|Withdrawal by Subject|17|||
49002000|NCT01491737|157844575|FG000|Overall Study|Lost to Follow-up|2|||
49002001|NCT01491737|157844576|FG001|Overall Study|Lost to Follow-up|10|||
49002002|NCT01491737|157844575|FG000|Overall Study|Death|63|||
49002003|NCT01491737|157844576|FG001|Overall Study|Death|57|||
49002004|NCT01491737|157844575|FG000|Overall Study|Study Termination by Sponsor|36|||
49002005|NCT01491737|157844576|FG001|Overall Study|Study Termination by Sponsor|36|||
49002006|NCT01491737|157844575|FG000|Overall Study|Reason Not Specified|8|||
49002007|NCT01491737|157844576|FG001|Overall Study|Reason Not Specified|9|||
49002008|NCT04311411|157844577|FG000|Overall Study|Adverse Event|2|||
49002009|NCT04311411|157844578|FG001|Overall Study|Adverse Event|3|||
49002010|NCT04311411|157844579|FG002|Overall Study|Adverse Event|2|||
49002011|NCT04311411|157844577|FG000|Overall Study|Withdrawal by Subject|3|||
49002012|NCT04311411|157844578|FG001|Overall Study|Withdrawal by Subject|3|||
49002013|NCT04311411|157844579|FG002|Overall Study|Withdrawal by Subject|0|||
49002014|NCT03237481|157844580|FG000|Overall Study|Lost to Follow-up|1|||
49002015|NCT03237481|157844581|FG001|Overall Study|Lost to Follow-up|0|||
49002016|NCT03237481|157844582|FG002|Overall Study|Lost to Follow-up|0|||
49002017|NCT03237481|157844580|FG000|Overall Study|Protocol Violation|1|||
49002018|NCT03237481|157844581|FG001|Overall Study|Protocol Violation|0|||
49002019|NCT03237481|157844582|FG002|Overall Study|Protocol Violation|0|||
49002020|NCT03237481|157844580|FG000|Overall Study|Withdrawal by Subject|3|||
49002021|NCT03237481|157844581|FG001|Overall Study|Withdrawal by Subject|2|||
49002022|NCT03237481|157844582|FG002|Overall Study|Withdrawal by Subject|1|||
49002023|NCT03993288|157844583|FG000|Overall Study|Lost to Follow-up|2|||
49002024|NCT03993288|157844584|FG001|Overall Study|Lost to Follow-up|1|||
49002025|NCT03993288|157844583|FG000|Overall Study|non-compliance to the inclusion criteria|0|||
49002026|NCT03993288|157844584|FG001|Overall Study|non-compliance to the inclusion criteria|1|||
49002027|NCT03993288|157844583|FG000|Overall Study|wrong randomization|0|||
49002028|NCT03993288|157844584|FG001|Overall Study|wrong randomization|1|||
49002029|NCT03993288|157844583|FG000|Overall Study|improper enrollment|0|||
49002030|NCT03993288|157844584|FG001|Overall Study|improper enrollment|1|||
49002031|NCT03993288|157844583|FG000|Overall Study|prescribed with prohibited concomitant therapy|1|||
49002032|NCT03993288|157844584|FG001|Overall Study|prescribed with prohibited concomitant therapy|0|||
49002033|NCT03993288|157844583|FG000|Overall Study|developed SAE|2|||
49002034|NCT03993288|157844584|FG001|Overall Study|developed SAE|0|||
49002035|NCT03993288|157844583|FG000|Overall Study|consent withdrawal|1|||
49002036|NCT03993288|157844584|FG001|Overall Study|consent withdrawal|0|||
49002037|NCT03993288|157844583|FG000|Overall Study|did not follow the treatment schedule|1|||
49002038|NCT03993288|157844584|FG001|Overall Study|did not follow the treatment schedule|0|||
49002039|NCT03993288|157844583|FG000|Overall Study|did not follow the treatment regimen|1|||
49002040|NCT03993288|157844584|FG001|Overall Study|did not follow the treatment regimen|0|||
49002041|NCT03993288|157844583|FG000|Overall Study|Adverse Event|1|||
49002042|NCT03993288|157844584|FG001|Overall Study|Adverse Event|0|||
49002043|NCT03993288|157844583|FG000|Overall Study|Withdrawal by Subject|1|||
49002044|NCT03993288|157844584|FG001|Overall Study|Withdrawal by Subject|1|||
49002045|NCT02152631|157844587|FG000|Overall Study|Adverse Event|32|||
49002046|NCT02152631|157844588|FG001|Overall Study|Adverse Event|4|||
49002047|NCT02152631|157844587|FG000|Overall Study|Withdrawal by Subject|13|||
49002048|NCT02152631|157844588|FG001|Overall Study|Withdrawal by Subject|16|||
49002049|NCT02152631|157844587|FG000|Overall Study|Noncompliance with study drug|1|||
49002050|NCT02152631|157844588|FG001|Overall Study|Noncompliance with study drug|0|||
49002051|NCT02152631|157844587|FG000|Overall Study|Physician Decision|1|||
49002052|NCT02152631|157844588|FG001|Overall Study|Physician Decision|2|||
49002053|NCT02152631|157844587|FG000|Overall Study|Lost to Follow-up|0|||
49002054|NCT02152631|157844588|FG001|Overall Study|Lost to Follow-up|1|||
49002055|NCT02152631|157844587|FG000|Overall Study|On Treatment|19|||
49002056|NCT02152631|157844588|FG001|Overall Study|On Treatment|3|||
49002057|NCT03692078|157844589|FG000|Overall Study|Adverse Event|0|||
49002058|NCT03692078|157844590|FG001|Overall Study|Adverse Event|0|||
49002059|NCT03692078|157844591|FG002|Overall Study|Adverse Event|0|||
49002060|NCT03692078|157844592|FG003|Overall Study|Adverse Event|0|||
49002061|NCT03692078|157844593|FG004|Overall Study|Adverse Event|0|||
49002062|NCT03692078|157844594|FG005|Overall Study|Adverse Event|1|||
49002063|NCT03692078|157844595|FG006|Overall Study|Adverse Event|0|||
49002064|NCT03692078|157844589|FG000|Overall Study|Enrollment Closed|5|||
49002065|NCT03692078|157844590|FG001|Overall Study|Enrollment Closed|0|||
49002066|NCT03692078|157844591|FG002|Overall Study|Enrollment Closed|0|||
49002067|NCT03692078|157844592|FG003|Overall Study|Enrollment Closed|0|||
49002068|NCT03692078|157844593|FG004|Overall Study|Enrollment Closed|0|||
49002069|NCT03692078|157844594|FG005|Overall Study|Enrollment Closed|0|||
49002070|NCT03692078|157844595|FG006|Overall Study|Enrollment Closed|0|||
49002071|NCT03692078|157844589|FG000|Overall Study|Failure To Meet Randomization Criteria|13|||
49002072|NCT03692078|157844590|FG001|Overall Study|Failure To Meet Randomization Criteria|0|||
49002073|NCT03692078|157844591|FG002|Overall Study|Failure To Meet Randomization Criteria|0|||
49002074|NCT03692078|157844592|FG003|Overall Study|Failure To Meet Randomization Criteria|0|||
49002075|NCT03692078|157844593|FG004|Overall Study|Failure To Meet Randomization Criteria|0|||
49002076|NCT03692078|157844594|FG005|Overall Study|Failure To Meet Randomization Criteria|0|||
49002077|NCT03692078|157844595|FG006|Overall Study|Failure To Meet Randomization Criteria|0|||
49045854|NCT00660387|158002031|FG001|Overall Study|Protocol Violation|0|||
49002078|NCT03692078|157844589|FG000|Overall Study|Withdrawal by Subject|0|||
49002079|NCT03692078|157844590|FG001|Overall Study|Withdrawal by Subject|2|||
49002080|NCT03692078|157844591|FG002|Overall Study|Withdrawal by Subject|0|||
49002081|NCT03692078|157844592|FG003|Overall Study|Withdrawal by Subject|1|||
49002082|NCT03692078|157844593|FG004|Overall Study|Withdrawal by Subject|5|||
49002083|NCT03692078|157844594|FG005|Overall Study|Withdrawal by Subject|3|||
49002084|NCT03692078|157844595|FG006|Overall Study|Withdrawal by Subject|3|||
49002085|NCT00297882|157844598|FG000|Day 14|Lack of Efficacy|12|||
49002086|NCT00297882|157844599|FG001|Day 14|Lack of Efficacy|49|||
49002087|NCT00297882|157844598|FG000|Day 28|Lost to Follow-up|13|||
49002088|NCT00297882|157844599|FG001|Day 28|Lost to Follow-up|23|||
49002089|NCT00297882|157844598|FG000|Day 28|Lack of Efficacy|3|||
49002090|NCT00297882|157844599|FG001|Day 28|Lack of Efficacy|0|||
49002091|NCT03927989|157844600|FG000|Overall Study|Withdrawal by Subject|0|||
49002092|NCT03927989|157844601|FG001|Overall Study|Withdrawal by Subject|1|||
49002093|NCT01563029|157844602|FG000|Overall Study|Adverse Event|1|||
49002094|NCT01563029|157844603|FG001|Overall Study|Adverse Event|0|||
49002095|NCT01563029|157844604|FG002|Overall Study|Adverse Event|1|||
49002096|NCT01563029|157844605|FG003|Overall Study|Adverse Event|2|||
49002097|NCT01563029|157844606|FG004|Overall Study|Adverse Event|1|||
49002098|NCT01563029|157844602|FG000|Overall Study|Lack of Efficacy|42|||
49002099|NCT01563029|157844603|FG001|Overall Study|Lack of Efficacy|16|||
49002100|NCT01563029|157844604|FG002|Overall Study|Lack of Efficacy|23|||
49002101|NCT01563029|157844605|FG003|Overall Study|Lack of Efficacy|21|||
49002102|NCT01563029|157844606|FG004|Overall Study|Lack of Efficacy|19|||
49002103|NCT01563029|157844602|FG000|Overall Study|Protocol Violation|1|||
49002104|NCT01563029|157844603|FG001|Overall Study|Protocol Violation|2|||
49002105|NCT01563029|157844604|FG002|Overall Study|Protocol Violation|3|||
49002106|NCT01563029|157844605|FG003|Overall Study|Protocol Violation|1|||
49002107|NCT01563029|157844606|FG004|Overall Study|Protocol Violation|3|||
49002108|NCT01563029|157844602|FG000|Overall Study|Protocol defined stopping criteria|1|||
49002109|NCT01563029|157844603|FG001|Overall Study|Protocol defined stopping criteria|0|||
49002110|NCT01563029|157844604|FG002|Overall Study|Protocol defined stopping criteria|0|||
49002111|NCT01563029|157844605|FG003|Overall Study|Protocol defined stopping criteria|0|||
49002112|NCT01563029|157844606|FG004|Overall Study|Protocol defined stopping criteria|0|||
49002113|NCT01563029|157844602|FG000|Overall Study|Lost to Follow-up|1|||
49002114|NCT01563029|157844603|FG001|Overall Study|Lost to Follow-up|0|||
49002115|NCT01563029|157844604|FG002|Overall Study|Lost to Follow-up|1|||
49002116|NCT01563029|157844605|FG003|Overall Study|Lost to Follow-up|1|||
49002117|NCT01563029|157844606|FG004|Overall Study|Lost to Follow-up|1|||
49002118|NCT01563029|157844602|FG000|Overall Study|Physician Decision|3|||
49002119|NCT01563029|157844603|FG001|Overall Study|Physician Decision|5|||
49002120|NCT01563029|157844604|FG002|Overall Study|Physician Decision|2|||
49002121|NCT01563029|157844605|FG003|Overall Study|Physician Decision|4|||
49002122|NCT01563029|157844606|FG004|Overall Study|Physician Decision|2|||
49002123|NCT01563029|157844602|FG000|Overall Study|Withdrawal by Subject|4|||
49002124|NCT01563029|157844603|FG001|Overall Study|Withdrawal by Subject|1|||
49002125|NCT01563029|157844604|FG002|Overall Study|Withdrawal by Subject|3|||
49002126|NCT01563029|157844605|FG003|Overall Study|Withdrawal by Subject|4|||
49002127|NCT01563029|157844606|FG004|Overall Study|Withdrawal by Subject|3|||
49002128|NCT01179191|157844609|FG000|Titration Phase (up to 6 Weeks)|Adverse Event|47|||
49002129|NCT01179191|157844609|FG000|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19|||
49002130|NCT01179191|157844609|FG000|Titration Phase (up to 6 Weeks)|Physician Decision|30|||
49002131|NCT01179191|157844609|FG000|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162|||
49002132|NCT01179191|157844609|FG000|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13|||
49002133|NCT01179191|157844609|FG000|Titration Phase (up to 6 Weeks)|Other|62|||
49002134|NCT01179191|157844609|FG000|Maintenance Phase (8 Weeks)|Adverse Event|10|||
49002135|NCT01179191|157844609|FG000|Maintenance Phase (8 Weeks)|Lost to Follow-up|9|||
49002136|NCT01179191|157844609|FG000|Maintenance Phase (8 Weeks)|Physician Decision|3|||
49002137|NCT01179191|157844609|FG000|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29|||
49002138|NCT01179191|157844609|FG000|Maintenance Phase (8 Weeks)|Other|66|||
49002139|NCT00556166|157844612|FG000|Overall Study|Withdrawal by Subject|1|||
49002140|NCT01612780|157844613|FG000|Overall Study|Treatment not completed|1|||
49002141|NCT01612780|157844613|FG000|Overall Study|Withdrawal by Subject|5|||
49002142|NCT03020966|157844617|FG000|Overall Study|Withdrawal by Subject|2|||
49002143|NCT03020966|157844618|FG001|Overall Study|Withdrawal by Subject|0|||
49002144|NCT01102972|157844619|FG000|Overall Study|Adverse Event|8|||
49002145|NCT01102972|157844620|FG001|Overall Study|Adverse Event|2|||
49002146|NCT01102972|157844619|FG000|Overall Study|Lack of Efficacy|2|||
49002147|NCT01102972|157844620|FG001|Overall Study|Lack of Efficacy|1|||
49002148|NCT01102972|157844619|FG000|Overall Study|Protocol Violation|1|||
49002149|NCT01102972|157844620|FG001|Overall Study|Protocol Violation|0|||
49002150|NCT01102972|157844619|FG000|Overall Study|Lost to Follow-up|10|||
49002151|NCT01102972|157844620|FG001|Overall Study|Lost to Follow-up|5|||
49002152|NCT01102972|157844619|FG000|Overall Study|Investigator Discretion|2|||
49002153|NCT01102972|157844620|FG001|Overall Study|Investigator Discretion|0|||
49002154|NCT01102972|157844619|FG000|Overall Study|Withdrawal by Subject|6|||
49002155|NCT01102972|157844620|FG001|Overall Study|Withdrawal by Subject|6|||
49002156|NCT01306968|157844621|FG000|Overall Study|Lost to Follow-up|1|||
49002157|NCT01306968|157844622|FG001|Overall Study|Lost to Follow-up|1|||
49002158|NCT01306968|157844623|FG002|Overall Study|Lost to Follow-up|0|||
49002159|NCT01306968|157844624|FG003|Overall Study|Lost to Follow-up|0|||
49002160|NCT01306968|157844621|FG000|Overall Study|Physician Decision|0|||
49002161|NCT01306968|157844622|FG001|Overall Study|Physician Decision|1|||
49002162|NCT01306968|157844623|FG002|Overall Study|Physician Decision|0|||
49002163|NCT01306968|157844624|FG003|Overall Study|Physician Decision|0|||
49002164|NCT01306968|157844621|FG000|Overall Study|Relocated and left active duty|0|||
49002165|NCT01306968|157844622|FG001|Overall Study|Relocated and left active duty|1|||
49002166|NCT01306968|157844623|FG002|Overall Study|Relocated and left active duty|1|||
49002167|NCT01306968|157844624|FG003|Overall Study|Relocated and left active duty|1|||
49002168|NCT01306968|157844621|FG000|Overall Study|Withdrew - time commitment|0|||
49002169|NCT01306968|157844622|FG001|Overall Study|Withdrew - time commitment|0|||
49002170|NCT01306968|157844623|FG002|Overall Study|Withdrew - time commitment|0|||
49002171|NCT01306968|157844624|FG003|Overall Study|Withdrew - time commitment|2|||
49002172|NCT01306968|157844621|FG000|Overall Study|Withdrew over privacy concerns|0|||
49002173|NCT01306968|157844622|FG001|Overall Study|Withdrew over privacy concerns|0|||
49002174|NCT01306968|157844623|FG002|Overall Study|Withdrew over privacy concerns|0|||
49002175|NCT01306968|157844624|FG003|Overall Study|Withdrew over privacy concerns|1|||
49002176|NCT01856257|157844625|FG000|Overall Study|Death|2|||
49002177|NCT01856257|157844626|FG001|Overall Study|Death|0|||
49002178|NCT01856257|157844627|FG002|Overall Study|Death|0|||
49002179|NCT01856257|157844628|FG003|Overall Study|Death|0|||
49002180|NCT01856257|157844625|FG000|Overall Study|Physician Decision|0|||
49002181|NCT01856257|157844626|FG001|Overall Study|Physician Decision|0|||
49002182|NCT01856257|157844627|FG002|Overall Study|Physician Decision|0|||
49002183|NCT01856257|157844628|FG003|Overall Study|Physician Decision|1|||
49002184|NCT01856257|157844625|FG000|Overall Study|Withdrawal by Subject|1|||
49002185|NCT01856257|157844626|FG001|Overall Study|Withdrawal by Subject|1|||
49002186|NCT01856257|157844627|FG002|Overall Study|Withdrawal by Subject|0|||
49002187|NCT01856257|157844628|FG003|Overall Study|Withdrawal by Subject|0|||
49002188|NCT01856257|157844625|FG000|Overall Study|Donor complication|0|||
49002189|NCT01856257|157844626|FG001|Overall Study|Donor complication|0|||
49002190|NCT01856257|157844627|FG002|Overall Study|Donor complication|0|||
49002191|NCT01856257|157844628|FG003|Overall Study|Donor complication|1|||
49002192|NCT05168657|157844637|FG000|Overall Study|Adverse Event|0|||
49002193|NCT05168657|157844638|FG001|Overall Study|Adverse Event|0|||
49002194|NCT05168657|157844639|FG002|Overall Study|Adverse Event|1|||
49002195|NCT05168657|157844640|FG003|Overall Study|Adverse Event|0|||
49002196|NCT05168657|157844641|FG004|Overall Study|Adverse Event|0|||
49002197|NCT05168657|157844642|FG005|Overall Study|Adverse Event|0|||
49002198|NCT05168657|157844643|FG006|Overall Study|Adverse Event|0|||
49002199|NCT05168657|157844644|FG007|Overall Study|Adverse Event|0|||
49002200|NCT00962013|157844645|FG000|Overall Study|Did not have surgery|1|||
49002201|NCT00962013|157844645|FG000|Overall Study|Death|8|||
49002202|NCT00962013|157844645|FG000|Overall Study|Lost to Follow-up|12|||
49002203|NCT00962013|157844645|FG000|Overall Study|Unable/Unwilling to return|6|||
49002204|NCT00962013|157844645|FG000|Overall Study|Withdrawal by Subject|8|||
49002205|NCT00962013|157844645|FG000|Overall Study|Removal of study device|3|||
49002206|NCT00962013|157844645|FG000|Overall Study|Site Termination|24|||
49002207|NCT00962013|157844645|FG000|Overall Study|No 5 year evaluation|6|||
49002214|NCT04527549|157844650|FG000|Overall Study|Withdrawal by Subject|1|||
49002215|NCT04527549|157844651|FG001|Overall Study|Withdrawal by Subject|1|||
49002216|NCT04736576|157844654|FG000|Overall Study|Progressive disease|3|||
49002217|NCT04736576|157844655|FG001|Overall Study|Progressive disease|1|||
49002218|NCT04736576|157844654|FG000|Overall Study|Death|1|||
49002219|NCT04736576|157844655|FG001|Overall Study|Death|0|||
49002220|NCT00445458|157844660|FG000|Overall Study|Disease Progression|3|||
49002221|NCT00445458|157844661|FG001|Overall Study|Disease Progression|4|||
49002222|NCT00445458|157844662|FG002|Overall Study|Disease Progression|54|||
49002223|NCT00445458|157844663|FG003|Overall Study|Disease Progression|27|||
49002224|NCT00445458|157844660|FG000|Overall Study|Withdrawal by Subject|0|||
49002225|NCT00445458|157844661|FG001|Overall Study|Withdrawal by Subject|0|||
49002226|NCT00445458|157844662|FG002|Overall Study|Withdrawal by Subject|7|||
49002227|NCT00445458|157844663|FG003|Overall Study|Withdrawal by Subject|0|||
49002228|NCT00445458|157844660|FG000|Overall Study|Adverse Event|0|||
49002229|NCT00445458|157844661|FG001|Overall Study|Adverse Event|0|||
49002230|NCT00445458|157844662|FG002|Overall Study|Adverse Event|3|||
49002231|NCT00445458|157844663|FG003|Overall Study|Adverse Event|0|||
49002232|NCT00445458|157844660|FG000|Overall Study|Death|0|||
49002233|NCT00445458|157844661|FG001|Overall Study|Death|1|||
49002234|NCT00445458|157844662|FG002|Overall Study|Death|2|||
49002235|NCT00445458|157844663|FG003|Overall Study|Death|0|||
49002236|NCT00445458|157844660|FG000|Overall Study|Physician Decision|0|||
49002237|NCT00445458|157844661|FG001|Overall Study|Physician Decision|0|||
49002238|NCT00445458|157844662|FG002|Overall Study|Physician Decision|1|||
49002239|NCT00445458|157844663|FG003|Overall Study|Physician Decision|1|||
49002240|NCT00445458|157844660|FG000|Overall Study|Surgery|0|||
49002241|NCT00445458|157844661|FG001|Overall Study|Surgery|0|||
49002242|NCT00445458|157844662|FG002|Overall Study|Surgery|1|||
49002243|NCT00445458|157844663|FG003|Overall Study|Surgery|0|||
49002244|NCT01071083|157844664|FG000|Overall Study|Adverse Event|1|||
49002245|NCT01071083|157844665|FG001|Overall Study|Adverse Event|0|||
49002246|NCT01071083|157844666|FG002|Overall Study|Adverse Event|1|||
49002247|NCT01071083|157844667|FG003|Overall Study|Adverse Event|0|||
49002248|NCT01071083|157844668|FG004|Overall Study|Adverse Event|1|||
49002249|NCT01071083|157844664|FG000|Overall Study|Withdrawal by Subject|3|||
49002250|NCT01071083|157844665|FG001|Overall Study|Withdrawal by Subject|0|||
49002251|NCT01071083|157844666|FG002|Overall Study|Withdrawal by Subject|2|||
49002252|NCT01071083|157844667|FG003|Overall Study|Withdrawal by Subject|0|||
49002253|NCT01071083|157844668|FG004|Overall Study|Withdrawal by Subject|3|||
49002254|NCT01071083|157844664|FG000|Overall Study|Physician Decision|1|||
49002255|NCT01071083|157844665|FG001|Overall Study|Physician Decision|0|||
49002256|NCT01071083|157844666|FG002|Overall Study|Physician Decision|0|||
49002257|NCT01071083|157844667|FG003|Overall Study|Physician Decision|1|||
49002258|NCT01071083|157844668|FG004|Overall Study|Physician Decision|1|||
49002259|NCT01071083|157844664|FG000|Overall Study|Early Rescue|1|||
49002260|NCT01071083|157844665|FG001|Overall Study|Early Rescue|0|||
49002261|NCT01071083|157844666|FG002|Overall Study|Early Rescue|0|||
49002262|NCT01071083|157844667|FG003|Overall Study|Early Rescue|0|||
49002263|NCT01071083|157844668|FG004|Overall Study|Early Rescue|1|||
49002264|NCT01071083|157844664|FG000|Overall Study|Subject Moved|0|||
49002265|NCT01071083|157844665|FG001|Overall Study|Subject Moved|1|||
49002266|NCT01071083|157844666|FG002|Overall Study|Subject Moved|0|||
49002267|NCT01071083|157844667|FG003|Overall Study|Subject Moved|0|||
49002268|NCT01071083|157844668|FG004|Overall Study|Subject Moved|0|||
49002269|NCT01071083|157844664|FG000|Overall Study|Images Not Usable (Motion)|0|||
49002270|NCT01071083|157844665|FG001|Overall Study|Images Not Usable (Motion)|1|||
49002271|NCT01071083|157844666|FG002|Overall Study|Images Not Usable (Motion)|0|||
49002272|NCT01071083|157844667|FG003|Overall Study|Images Not Usable (Motion)|0|||
49002273|NCT01071083|157844668|FG004|Overall Study|Images Not Usable (Motion)|0|||
49002274|NCT01071083|157844664|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
49002275|NCT01071083|157844665|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
49002276|NCT01071083|157844666|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
49002277|NCT01071083|157844667|FG003|Overall Study|Did Not Meet Eligibility Criteria|1|||
49002278|NCT01071083|157844668|FG004|Overall Study|Did Not Meet Eligibility Criteria|1|||
49002279|NCT01071083|157844664|FG000|Overall Study|Did Not Want Per Protocol Treatment|0|||
49002280|NCT01071083|157844665|FG001|Overall Study|Did Not Want Per Protocol Treatment|0|||
49002281|NCT01071083|157844666|FG002|Overall Study|Did Not Want Per Protocol Treatment|1|||
49002282|NCT01071083|157844667|FG003|Overall Study|Did Not Want Per Protocol Treatment|0|||
49002283|NCT01071083|157844668|FG004|Overall Study|Did Not Want Per Protocol Treatment|1|||
49002284|NCT01071083|157844664|FG000|Overall Study|Subject Refused to Continue|1|||
49002285|NCT01071083|157844665|FG001|Overall Study|Subject Refused to Continue|0|||
49002286|NCT01071083|157844666|FG002|Overall Study|Subject Refused to Continue|0|||
49002287|NCT01071083|157844667|FG003|Overall Study|Subject Refused to Continue|0|||
49002288|NCT01071083|157844668|FG004|Overall Study|Subject Refused to Continue|0|||
49002289|NCT00038467|157844669|FG000|Overall Study|Adverse Event|170|||
49002290|NCT00038467|157844670|FG001|Overall Study|Adverse Event|145|||
49002291|NCT00038467|157844669|FG000|Overall Study|Withdrawal by Subject|150|||
49002292|NCT00038467|157844670|FG001|Overall Study|Withdrawal by Subject|107|||
49002293|NCT00038467|157844669|FG000|Overall Study|Protocol Violation|19|||
49002294|NCT00038467|157844670|FG001|Overall Study|Protocol Violation|22|||
49002295|NCT00038467|157844669|FG000|Overall Study|Death|22|||
49002296|NCT00038467|157844670|FG001|Overall Study|Death|16|||
49002297|NCT00038467|157844669|FG000|Overall Study|Lost to Follow-up|15|||
49002298|NCT00038467|157844670|FG001|Overall Study|Lost to Follow-up|10|||
49002299|NCT00038467|157844669|FG000|Overall Study|Recurrence|109|||
49002300|NCT00038467|157844670|FG001|Overall Study|Recurrence|179|||
49002301|NCT00038467|157844669|FG000|Overall Study|Randomized, but not treated|31|||
49002302|NCT00038467|157844670|FG001|Overall Study|Randomized, but not treated|35|||
49002303|NCT00038467|157844669|FG000|Overall Study|Other|26|||
49002304|NCT00038467|157844670|FG001|Overall Study|Other|28|||
49045855|NCT02129062|158002034|FG000|Overall Study|Death|1|||
49002305|NCT01988493|157844671|FG000|Overall Study|Randomized but not treated|0|||
49002306|NCT01988493|157844672|FG001|Overall Study|Randomized but not treated|0|||
49002307|NCT01988493|157844673|FG002|Overall Study|Randomized but not treated|0|||
49002308|NCT01988493|157844674|FG003|Overall Study|Randomized but not treated|0|||
49002309|NCT01988493|157844675|FG004|Overall Study|Randomized but not treated|1|||
49002310|NCT03972709|157844676|FG000|Overall Study|Withdrawal by Subject|18|||
49002311|NCT03972709|157844677|FG001|Overall Study|Withdrawal by Subject|7|||
49002312|NCT03972709|157844678|FG002|Overall Study|Withdrawal by Subject|14|||
49002313|NCT03972709|157844676|FG000|Overall Study|Study Terminated by Sponsor|48|||
49002314|NCT03972709|157844677|FG001|Overall Study|Study Terminated by Sponsor|25|||
49002315|NCT03972709|157844678|FG002|Overall Study|Study Terminated by Sponsor|50|||
49002316|NCT03972709|157844676|FG000|Overall Study|Physician Decision|1|||
49002317|NCT03972709|157844677|FG001|Overall Study|Physician Decision|0|||
49002318|NCT03972709|157844678|FG002|Overall Study|Physician Decision|0|||
49002319|NCT03972709|157844676|FG000|Overall Study|COVID-19|0|||
49002320|NCT03972709|157844677|FG001|Overall Study|COVID-19|1|||
49002321|NCT03972709|157844678|FG002|Overall Study|COVID-19|1|||
49002322|NCT03972709|157844676|FG000|Overall Study|Lost to Follow-up|6|||
49002323|NCT03972709|157844677|FG001|Overall Study|Lost to Follow-up|1|||
49002324|NCT03972709|157844678|FG002|Overall Study|Lost to Follow-up|2|||
49002325|NCT03972709|157844676|FG000|Overall Study|Death|5|||
49002326|NCT03972709|157844677|FG001|Overall Study|Death|1|||
49002327|NCT03972709|157844678|FG002|Overall Study|Death|4|||
49002328|NCT03972709|157844676|FG000|Overall Study|Adverse Event|3|||
49002329|NCT03972709|157844677|FG001|Overall Study|Adverse Event|1|||
49002330|NCT03972709|157844678|FG002|Overall Study|Adverse Event|4|||
49002331|NCT03972709|157844676|FG000|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
49002332|NCT03972709|157844677|FG001|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|1|||
49002333|NCT03972709|157844678|FG002|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
49002334|NCT03972709|157844676|FG000|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
49002335|NCT03972709|157844677|FG001|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
49002336|NCT03972709|157844678|FG002|Overall Study|Subject in Nursing Home, Unable to Attend Visit|1|||
49002337|NCT03972709|157844676|FG000|Overall Study|Subject Unable to be Contacted|0|||
49002338|NCT03972709|157844677|FG001|Overall Study|Subject Unable to be Contacted|1|||
49002339|NCT03972709|157844678|FG002|Overall Study|Subject Unable to be Contacted|0|||
49002340|NCT03972709|157844676|FG000|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
49002341|NCT03972709|157844677|FG001|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|1|||
49002342|NCT03972709|157844678|FG002|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
49002343|NCT03972709|157844676|FG000|Overall Study|Subject Moved|0|||
49002344|NCT03972709|157844677|FG001|Overall Study|Subject Moved|1|||
49002345|NCT03972709|157844678|FG002|Overall Study|Subject Moved|0|||
49002346|NCT03972709|157844676|FG000|Overall Study|Missed Study Visits|1|||
49002347|NCT03972709|157844677|FG001|Overall Study|Missed Study Visits|0|||
49002348|NCT03972709|157844678|FG002|Overall Study|Missed Study Visits|0|||
49002349|NCT03159611|157844679|FG000|Overall Study|Did Not Meet Inclusion Criteria|9|||
49002350|NCT03159611|157844680|FG001|Overall Study|Did Not Meet Inclusion Criteria|5|||
49002351|NCT03159611|157844679|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
49002352|NCT03159611|157844680|FG001|Overall Study|Did Not Meet Exclusion Criteria|3|||
49002353|NCT03159611|157844679|FG000|Overall Study|Protocol Violation|7|||
49002354|NCT03159611|157844680|FG001|Overall Study|Protocol Violation|4|||
49002355|NCT03159611|157844679|FG000|Overall Study|Adverse Event|1|||
49002356|NCT03159611|157844680|FG001|Overall Study|Adverse Event|0|||
49002357|NCT03159611|157844679|FG000|Overall Study|Withdrawal by Subject|1|||
49002358|NCT03159611|157844680|FG001|Overall Study|Withdrawal by Subject|1|||
49002359|NCT03159611|157844679|FG000|Overall Study|Non-compliance with protocol requirement|3|||
49002360|NCT03159611|157844680|FG001|Overall Study|Non-compliance with protocol requirement|2|||
49002361|NCT03159611|157844679|FG000|Overall Study|Inability to perform procedures|1|||
49002362|NCT03159611|157844680|FG001|Overall Study|Inability to perform procedures|0|||
49002363|NCT04732728|157844681|FG000|Overall Study|Death|12|||
49002364|NCT04732728|157844681|FG000|Overall Study|Withdrawn|136|||
49002365|NCT00720304|157844682|FG000|Overall Study|Withdrawal by Subject|14|||
49002366|NCT00720304|157844683|FG001|Overall Study|Withdrawal by Subject|1|||
49002367|NCT00720304|157844682|FG000|Overall Study|Death|1|||
49002368|NCT00720304|157844683|FG001|Overall Study|Death|0|||
49002369|NCT00720304|157844682|FG000|Overall Study|Physician Decision|5|||
49002370|NCT00720304|157844683|FG001|Overall Study|Physician Decision|2|||
49002371|NCT00720304|157844682|FG000|Overall Study|Adverse Event|3|||
49002372|NCT00720304|157844683|FG001|Overall Study|Adverse Event|1|||
49002373|NCT00720304|157844682|FG000|Overall Study|Disease progression|6|||
49002374|NCT00720304|157844683|FG001|Overall Study|Disease progression|1|||
49002375|NCT00185731|157844686|FG000|Overall Study|Withdrawal by Subject|1|||
49002376|NCT00185731|157844686|FG000|Overall Study|Not Eligible|1|||
49002377|NCT00996918|157844689|FG000|Overall Study|Lack of Efficacy|1|||
49002378|NCT00996918|157844690|FG001|Overall Study|Lack of Efficacy|1|||
49002379|NCT00996918|157844691|FG002|Overall Study|Lack of Efficacy|2|||
49002380|NCT00996918|157844692|FG003|Overall Study|Lack of Efficacy|2|||
49002381|NCT00996918|157844693|FG004|Overall Study|Lack of Efficacy|0|||
49002382|NCT00996918|157844689|FG000|Overall Study|Adverse Event|2|||
49002383|NCT00996918|157844690|FG001|Overall Study|Adverse Event|5|||
49002384|NCT00996918|157844691|FG002|Overall Study|Adverse Event|2|||
49002385|NCT00996918|157844692|FG003|Overall Study|Adverse Event|6|||
49002386|NCT00996918|157844693|FG004|Overall Study|Adverse Event|0|||
49002387|NCT00996918|157844689|FG000|Overall Study|Withdrawal by Subject|1|||
49002388|NCT00996918|157844690|FG001|Overall Study|Withdrawal by Subject|4|||
49002389|NCT00996918|157844691|FG002|Overall Study|Withdrawal by Subject|3|||
49002390|NCT00996918|157844692|FG003|Overall Study|Withdrawal by Subject|3|||
49002391|NCT00996918|157844693|FG004|Overall Study|Withdrawal by Subject|2|||
49002392|NCT00996918|157844689|FG000|Overall Study|Physician Decision|1|||
49002393|NCT00996918|157844690|FG001|Overall Study|Physician Decision|0|||
49002394|NCT00996918|157844691|FG002|Overall Study|Physician Decision|0|||
49002395|NCT00996918|157844692|FG003|Overall Study|Physician Decision|0|||
49002396|NCT00996918|157844693|FG004|Overall Study|Physician Decision|0|||
49002397|NCT00996918|157844689|FG000|Overall Study|Discontinuation of Study by Sponsor|31|||
49002398|NCT00996918|157844690|FG001|Overall Study|Discontinuation of Study by Sponsor|54|||
49002399|NCT00996918|157844691|FG002|Overall Study|Discontinuation of Study by Sponsor|30|||
49002400|NCT00996918|157844692|FG003|Overall Study|Discontinuation of Study by Sponsor|45|||
49002401|NCT00996918|157844693|FG004|Overall Study|Discontinuation of Study by Sponsor|2|||
49002402|NCT00996918|157844689|FG000|Overall Study|Loss of Caregiver|0|||
49002403|NCT00996918|157844690|FG001|Overall Study|Loss of Caregiver|1|||
49002404|NCT00996918|157844691|FG002|Overall Study|Loss of Caregiver|0|||
49002405|NCT00996918|157844692|FG003|Overall Study|Loss of Caregiver|0|||
49002406|NCT00996918|157844693|FG004|Overall Study|Loss of Caregiver|0|||
49002407|NCT00996918|157844689|FG000|Overall Study|Other|3|||
49002408|NCT00996918|157844690|FG001|Overall Study|Other|1|||
49002409|NCT00996918|157844691|FG002|Overall Study|Other|0|||
49002410|NCT00996918|157844692|FG003|Overall Study|Other|0|||
49002411|NCT00996918|157844693|FG004|Overall Study|Other|0|||
49002412|NCT01342367|157844699|FG000|Overall Study|Death|1|||
49002413|NCT01342367|157844700|FG001|Overall Study|Death|0|||
49002414|NCT01342367|157844699|FG000|Overall Study|Withdrawal by Subject|1|||
49002415|NCT01342367|157844700|FG001|Overall Study|Withdrawal by Subject|2|||
49002416|NCT02864953|157844701|FG000|Overall Study|Adverse Event|22|||
49002417|NCT02864953|157844702|FG001|Overall Study|Adverse Event|19|||
49002418|NCT02864953|157844701|FG000|Overall Study|Withdrawal by Subject|1|||
49002419|NCT02864953|157844702|FG001|Overall Study|Withdrawal by Subject|0|||
49002420|NCT02864953|157844701|FG000|Overall Study|Physician Decision|4|||
49002421|NCT02864953|157844702|FG001|Overall Study|Physician Decision|2|||
49002422|NCT02864953|157844701|FG000|Overall Study|Death|3|||
49002423|NCT02864953|157844702|FG001|Overall Study|Death|13|||
49002424|NCT02864953|157844701|FG000|Overall Study|Reason not specified|14|||
49002425|NCT02864953|157844702|FG001|Overall Study|Reason not specified|12|||
49002426|NCT02864953|157844701|FG000|Overall Study|Withdrew Prior to Dosing|9|||
49002427|NCT02864953|157844702|FG001|Overall Study|Withdrew Prior to Dosing|8|||
49002428|NCT00981019|157844704|FG000|Overall Study|Did not respond|65|||
49002429|NCT00981019|157844704|FG000|Overall Study|Did not match target population|94|||
49002430|NCT00981019|157844704|FG000|Overall Study|Inadvertent exclusion|239|||
49002431|NCT00981019|157844704|FG000|Overall Study|Hit the survey after closure|79|||
49002432|NCT00530088|157844705|FG000|Overall Study|Disease Progression|4|||
49002433|NCT00530088|157844705|FG000|Overall Study|Physician Decision|4|||
49002434|NCT00530088|157844705|FG000|Overall Study|Other Not Specified|2|||
49002435|NCT00902278|157844706|FG000|Overall Study|Physician Decision|1|||
49002436|NCT00902278|157844707|FG001|Overall Study|Physician Decision|0|||
49002437|NCT00902278|157844708|FG002|Overall Study|Physician Decision|2|||
49002438|NCT00902278|157844709|FG003|Overall Study|Physician Decision|0|||
49002439|NCT00902278|157844710|FG004|Overall Study|Physician Decision|1|||
49002440|NCT00902278|157844706|FG000|Overall Study|Lost to Follow-up|3|||
49002441|NCT00902278|157844707|FG001|Overall Study|Lost to Follow-up|2|||
49002442|NCT00902278|157844708|FG002|Overall Study|Lost to Follow-up|3|||
49002443|NCT00902278|157844709|FG003|Overall Study|Lost to Follow-up|0|||
49002444|NCT00902278|157844710|FG004|Overall Study|Lost to Follow-up|1|||
49002445|NCT03428217|157844711|FG000|Overall Study|Death|89|||
49002446|NCT03428217|157844712|FG001|Overall Study|Death|93|||
49002447|NCT03428217|157844711|FG000|Overall Study|Withdrawal by Subject|8|||
49002448|NCT03428217|157844712|FG001|Overall Study|Withdrawal by Subject|7|||
49002449|NCT03428217|157844711|FG000|Overall Study|Lost to Follow-up|1|||
49002450|NCT03428217|157844712|FG001|Overall Study|Lost to Follow-up|3|||
49002451|NCT03428217|157844711|FG000|Overall Study|Study terminated by sponsor|124|||
49002452|NCT03428217|157844712|FG001|Overall Study|Study terminated by sponsor|118|||
49002453|NCT03428217|157844711|FG000|Overall Study|Other, Not Specified|1|||
49002454|NCT03428217|157844712|FG001|Overall Study|Other, Not Specified|0|||
49002455|NCT03926728|157847117|FG000|Overall Study|Withdrawal by Subject|0|||
49002456|NCT03926728|157847118|FG001|Overall Study|Withdrawal by Subject|1|||
49002457|NCT03926728|157847119|FG002|Overall Study|Withdrawal by Subject|1|||
49002458|NCT03926728|157847120|FG003|Overall Study|Withdrawal by Subject|0|||
49002459|NCT03926728|157847121|FG004|Overall Study|Withdrawal by Subject|0|||
49002460|NCT03926728|157847122|FG005|Overall Study|Withdrawal by Subject|1|||
49002461|NCT03926728|157847123|FG006|Overall Study|Withdrawal by Subject|1|||
49002462|NCT03926728|157847124|FG007|Overall Study|Withdrawal by Subject|0|||
49002463|NCT03926728|157847125|FG008|Overall Study|Withdrawal by Subject|0|||
49002464|NCT03926728|157847126|FG009|Overall Study|Withdrawal by Subject|1|||
49002465|NCT03926728|157847127|FG010|Overall Study|Withdrawal by Subject|0|||
49002466|NCT03926728|157847128|FG011|Overall Study|Withdrawal by Subject|0|||
49002467|NCT00891527|157847129|FG000|Overall Study|Withdrawal by Subject|2|||
49002468|NCT00630994|157847134|FG000|Overall Study|Adverse Event|1|||
49002469|NCT00630994|157847134|FG000|Overall Study|Disease Progression|1|||
49002470|NCT00630994|157847134|FG000|Overall Study|Lack of Efficacy|1|||
49002471|NCT00630994|157847134|FG000|Overall Study|Other|1|||
49002472|NCT03669640|157847138|FG000|Overall Study|Study Terminated by Sponsor|0|||
49002473|NCT03669640|157847139|FG001|Overall Study|Study Terminated by Sponsor|0|||
49002474|NCT03669640|157847140|FG002|Overall Study|Study Terminated by Sponsor|0|||
49002475|NCT03669640|157847141|FG003|Overall Study|Study Terminated by Sponsor|0|||
49002476|NCT03669640|157847142|FG004|Overall Study|Study Terminated by Sponsor|1|||
49002477|NCT03669640|157847143|FG005|Overall Study|Study Terminated by Sponsor|0|||
49002478|NCT03669640|157847138|FG000|Overall Study|Lost to Follow-up|0|||
49002479|NCT03669640|157847139|FG001|Overall Study|Lost to Follow-up|0|||
49002480|NCT03669640|157847140|FG002|Overall Study|Lost to Follow-up|2|||
49002481|NCT03669640|157847141|FG003|Overall Study|Lost to Follow-up|0|||
49002482|NCT03669640|157847142|FG004|Overall Study|Lost to Follow-up|0|||
49002483|NCT03669640|157847143|FG005|Overall Study|Lost to Follow-up|0|||
49002484|NCT03669640|157847138|FG000|Overall Study|Death|0|||
49002485|NCT03669640|157847139|FG001|Overall Study|Death|0|||
49002486|NCT03669640|157847140|FG002|Overall Study|Death|1|||
49002487|NCT03669640|157847141|FG003|Overall Study|Death|0|||
49002488|NCT03669640|157847142|FG004|Overall Study|Death|0|||
49002489|NCT03669640|157847143|FG005|Overall Study|Death|0|||
49002490|NCT03669640|157847138|FG000|Overall Study|Withdrawal by Subject|1|||
49002491|NCT03669640|157847139|FG001|Overall Study|Withdrawal by Subject|2|||
49002492|NCT03669640|157847140|FG002|Overall Study|Withdrawal by Subject|1|||
49002493|NCT03669640|157847141|FG003|Overall Study|Withdrawal by Subject|0|||
49002494|NCT03669640|157847142|FG004|Overall Study|Withdrawal by Subject|1|||
49002495|NCT03669640|157847143|FG005|Overall Study|Withdrawal by Subject|3|||
49002496|NCT03669640|157847138|FG000|Overall Study|Protocol Violation|1|||
49002497|NCT03669640|157847139|FG001|Overall Study|Protocol Violation|0|||
49002498|NCT03669640|157847140|FG002|Overall Study|Protocol Violation|0|||
49002499|NCT03669640|157847141|FG003|Overall Study|Protocol Violation|0|||
49002500|NCT03669640|157847142|FG004|Overall Study|Protocol Violation|0|||
49002501|NCT03669640|157847143|FG005|Overall Study|Protocol Violation|0|||
49002502|NCT03669640|157847138|FG000|Overall Study|Physician Decision|0|||
49002503|NCT03669640|157847139|FG001|Overall Study|Physician Decision|2|||
49002504|NCT03669640|157847140|FG002|Overall Study|Physician Decision|0|||
49002505|NCT03669640|157847141|FG003|Overall Study|Physician Decision|0|||
49002506|NCT03669640|157847142|FG004|Overall Study|Physician Decision|0|||
49002507|NCT03669640|157847143|FG005|Overall Study|Physician Decision|0|||
49002508|NCT03669640|157847138|FG000|Overall Study|Disease Relapse|1|||
49002509|NCT03669640|157847139|FG001|Overall Study|Disease Relapse|0|||
49002510|NCT03669640|157847140|FG002|Overall Study|Disease Relapse|0|||
49002511|NCT03669640|157847141|FG003|Overall Study|Disease Relapse|0|||
49002512|NCT03669640|157847142|FG004|Overall Study|Disease Relapse|0|||
49002513|NCT03669640|157847143|FG005|Overall Study|Disease Relapse|0|||
49002514|NCT03669640|157847138|FG000|Overall Study|Adverse Event|2|||
49002515|NCT03669640|157847139|FG001|Overall Study|Adverse Event|1|||
49002516|NCT03669640|157847140|FG002|Overall Study|Adverse Event|0|||
49002517|NCT03669640|157847141|FG003|Overall Study|Adverse Event|0|||
49002518|NCT03669640|157847142|FG004|Overall Study|Adverse Event|1|||
49002519|NCT03669640|157847143|FG005|Overall Study|Adverse Event|0|||
49002520|NCT01186744|157847144|FG000|Overall Study|Lack of Efficacy|156|||
49002521|NCT01186744|157847145|FG001|Overall Study|Lack of Efficacy|99|||
49002522|NCT01186744|157847146|FG002|Overall Study|Lack of Efficacy|0|||
49002523|NCT01186744|157847147|FG003|Overall Study|Lack of Efficacy|2|||
49002524|NCT01186744|157847148|FG004|Overall Study|Lack of Efficacy|2|||
49002525|NCT01186744|157847149|FG005|Overall Study|Lack of Efficacy|5|||
49002526|NCT01186744|157847144|FG000|Overall Study|Protocol Violation|1|||
49002527|NCT01186744|157847145|FG001|Overall Study|Protocol Violation|2|||
49002528|NCT01186744|157847146|FG002|Overall Study|Protocol Violation|0|||
49002529|NCT01186744|157847147|FG003|Overall Study|Protocol Violation|1|||
49002530|NCT01186744|157847148|FG004|Overall Study|Protocol Violation|1|||
49002531|NCT01186744|157847149|FG005|Overall Study|Protocol Violation|2|||
49002532|NCT01186744|157847144|FG000|Overall Study|Lost to Follow-up|15|||
49002533|NCT01186744|157847145|FG001|Overall Study|Lost to Follow-up|16|||
49002534|NCT01186744|157847146|FG002|Overall Study|Lost to Follow-up|2|||
49002535|NCT01186744|157847147|FG003|Overall Study|Lost to Follow-up|1|||
49002536|NCT01186744|157847148|FG004|Overall Study|Lost to Follow-up|1|||
49002537|NCT01186744|157847149|FG005|Overall Study|Lost to Follow-up|4|||
49002538|NCT01186744|157847144|FG000|Overall Study|Screen failure|1|||
49002539|NCT01186744|157847145|FG001|Overall Study|Screen failure|1|||
49002540|NCT01186744|157847146|FG002|Overall Study|Screen failure|0|||
49002541|NCT01186744|157847147|FG003|Overall Study|Screen failure|1|||
49002542|NCT01186744|157847148|FG004|Overall Study|Screen failure|0|||
49002543|NCT01186744|157847149|FG005|Overall Study|Screen failure|0|||
49002544|NCT01186744|157847144|FG000|Overall Study|Withdrawal by Subject|14|||
49002545|NCT01186744|157847145|FG001|Overall Study|Withdrawal by Subject|10|||
49002546|NCT01186744|157847146|FG002|Overall Study|Withdrawal by Subject|2|||
49002547|NCT01186744|157847147|FG003|Overall Study|Withdrawal by Subject|5|||
49002548|NCT01186744|157847148|FG004|Overall Study|Withdrawal by Subject|0|||
49002549|NCT01186744|157847149|FG005|Overall Study|Withdrawal by Subject|6|||
49002550|NCT01186744|157847144|FG000|Overall Study|Study terminated by Sponsor|1|||
49002551|NCT01186744|157847145|FG001|Overall Study|Study terminated by Sponsor|0|||
49002552|NCT01186744|157847146|FG002|Overall Study|Study terminated by Sponsor|0|||
49002553|NCT01186744|157847147|FG003|Overall Study|Study terminated by Sponsor|0|||
49002554|NCT01186744|157847148|FG004|Overall Study|Study terminated by Sponsor|0|||
49002555|NCT01186744|157847149|FG005|Overall Study|Study terminated by Sponsor|0|||
49002556|NCT01186744|157847144|FG000|Overall Study|Other|9|||
49002557|NCT01186744|157847145|FG001|Overall Study|Other|10|||
49002558|NCT01186744|157847146|FG002|Overall Study|Other|1|||
49002559|NCT01186744|157847147|FG003|Overall Study|Other|2|||
49002560|NCT01186744|157847148|FG004|Overall Study|Other|1|||
49002561|NCT01186744|157847149|FG005|Overall Study|Other|5|||
49002562|NCT01186744|157847144|FG000|Overall Study|Adverse Event|10|||
49002563|NCT01186744|157847145|FG001|Overall Study|Adverse Event|14|||
49002564|NCT01186744|157847146|FG002|Overall Study|Adverse Event|1|||
49002565|NCT01186744|157847147|FG003|Overall Study|Adverse Event|0|||
49002566|NCT01186744|157847148|FG004|Overall Study|Adverse Event|1|||
49002567|NCT01186744|157847149|FG005|Overall Study|Adverse Event|4|||
49002568|NCT01186744|157847144|FG000|Overall Study|Death|1|||
49002569|NCT01186744|157847145|FG001|Overall Study|Death|0|||
49002570|NCT01186744|157847146|FG002|Overall Study|Death|0|||
49002571|NCT01186744|157847147|FG003|Overall Study|Death|0|||
49002572|NCT01186744|157847148|FG004|Overall Study|Death|0|||
49002573|NCT01186744|157847149|FG005|Overall Study|Death|0|||
49002574|NCT01211613|157847152|FG000|Overall Study|Lost to Follow-up|2|||
49002575|NCT01211613|157847153|FG001|Overall Study|Lost to Follow-up|2|||
49002576|NCT01211613|157847154|FG002|Overall Study|Lost to Follow-up|2|||
49002577|NCT01211613|157847152|FG000|Overall Study|Withdrawal by Subject|1|||
49002578|NCT01211613|157847153|FG001|Overall Study|Withdrawal by Subject|0|||
49002579|NCT01211613|157847154|FG002|Overall Study|Withdrawal by Subject|0|||
49002580|NCT03722849|157847155|FG000|Overall Study|Withdrawal by Subject|1|||
49002581|NCT03722849|157847156|FG001|Overall Study|Withdrawal by Subject|1|||
49002582|NCT02729545|157847159|FG000|Overall Study|Pregnancy|1|||
49002583|NCT02729545|157847160|FG001|Overall Study|Pregnancy|1|||
49002584|NCT02729545|157847159|FG000|Overall Study|Lost to Follow-up|0|||
49002585|NCT02729545|157847160|FG001|Overall Study|Lost to Follow-up|1|||
49002586|NCT02729545|157847159|FG000|Overall Study|Withdrawal by Subject|2|||
49002587|NCT02729545|157847160|FG001|Overall Study|Withdrawal by Subject|3|||
49002588|NCT03533608|157847162|FG000|Overall Study|Withdrawal by Subject|3|||
49002589|NCT03533608|157847162|FG000|Overall Study|Physician Decision|2|||
49002590|NCT00819091|157847163|FG000|Overall Study|Adverse Event|3|||
49002591|NCT00819091|157847164|FG001|Overall Study|Adverse Event|5|||
49002592|NCT00819091|157847163|FG000|Overall Study|Protocol Violation|0|||
49002593|NCT00819091|157847164|FG001|Overall Study|Protocol Violation|1|||
49002594|NCT00819091|157847163|FG000|Overall Study|Lost to Follow-up|2|||
49002595|NCT00819091|157847164|FG001|Overall Study|Lost to Follow-up|0|||
49002596|NCT00819091|157847163|FG000|Overall Study|Withdrawal by Subject|1|||
49002597|NCT00819091|157847164|FG001|Overall Study|Withdrawal by Subject|2|||
49002598|NCT00819091|157847163|FG000|Overall Study|Other|1|||
49002599|NCT00819091|157847164|FG001|Overall Study|Other|2|||
49002600|NCT03286426|157847166|FG000|Overall Study|Physician Decision|3|||
49002601|NCT02325401|157847171|FG000|Overall Study|Withdrawal by Subject|0|||
49002602|NCT02325401|157847172|FG001|Overall Study|Withdrawal by Subject|1|||
49002603|NCT02325401|157847173|FG002|Overall Study|Withdrawal by Subject|1|||
49002604|NCT01788163|157847174|FG000|Overall Study|Other|53|||
49002605|NCT01788163|157847175|FG001|Overall Study|Other|0|||
49002606|NCT01788163|157847176|FG002|Overall Study|Other|0|||
49002607|NCT01788163|157847177|FG003|Overall Study|Other|0|||
49002608|NCT01788163|157847178|FG004|Overall Study|Other|0|||
49002609|NCT01788163|157847179|FG005|Overall Study|Other|7|||
49002610|NCT01788163|157847180|FG006|Overall Study|Other|1|||
49002611|NCT01788163|157847181|FG007|Overall Study|Other|48|||
49002612|NCT01788163|157847182|FG008|Overall Study|Other|15|||
49002613|NCT01788163|157847174|FG000|Overall Study|Withdrawal by Subject|2|||
49002614|NCT01788163|157847175|FG001|Overall Study|Withdrawal by Subject|0|||
49002615|NCT01788163|157847176|FG002|Overall Study|Withdrawal by Subject|0|||
49002616|NCT01788163|157847177|FG003|Overall Study|Withdrawal by Subject|0|||
49002617|NCT01788163|157847178|FG004|Overall Study|Withdrawal by Subject|0|||
49002618|NCT01788163|157847179|FG005|Overall Study|Withdrawal by Subject|0|||
49002619|NCT01788163|157847180|FG006|Overall Study|Withdrawal by Subject|0|||
49002620|NCT01788163|157847181|FG007|Overall Study|Withdrawal by Subject|0|||
49045856|NCT02129062|158002034|FG000|Overall Study|Disease Progression|2|||
49002621|NCT01788163|157847182|FG008|Overall Study|Withdrawal by Subject|1|||
49002622|NCT05981365|157847185|FG000|Period 1|Adverse Event|1|||
49002623|NCT05981365|157847186|FG001|Period 1|Adverse Event|0|||
49002624|NCT03425331|157847189|FG000|Overall Study|Withdrawal by Subject|1|||
49002625|NCT03425331|157847189|FG000|Overall Study|Death|1|||
49002626|NCT03425331|157847189|FG000|Overall Study|Adverse Event|1|||
49002627|NCT03425331|157847189|FG000|Overall Study|Disease Progression|2|||
49002628|NCT03747939|157847190|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
49002629|NCT03747939|157847191|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Death|1|||
49002630|NCT03747939|157847192|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
49002631|NCT03747939|157847193|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
49002632|NCT03747939|157847190|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|8|||
49002633|NCT03747939|157847191|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|19|||
49002634|NCT03747939|157847192|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
49002635|NCT03747939|157847193|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
49002636|NCT03747939|157847190|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
49002637|NCT03747939|157847191|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|1|||
49002638|NCT03747939|157847192|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
49002639|NCT03747939|157847193|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
49002640|NCT03747939|157847190|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|4|||
49002641|NCT03747939|157847191|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|7|||
49002642|NCT03747939|157847192|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
49002643|NCT03747939|157847193|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
49002644|NCT03747939|157847190|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
49002645|NCT03747939|157847191|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
49002646|NCT03747939|157847192|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
49002647|NCT03747939|157847193|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
49002648|NCT03747939|157847190|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
49002649|NCT03747939|157847191|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|3|||
49002650|NCT03747939|157847192|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
49002651|NCT03747939|157847193|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
49002652|NCT03747939|157847190|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|1|||
49002653|NCT03747939|157847191|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
49002654|NCT03747939|157847192|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
49002655|NCT03747939|157847193|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
49002656|NCT03747939|157847190|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|4|||
49002657|NCT03747939|157847191|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|7|||
49002658|NCT03747939|157847192|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
49002659|NCT03747939|157847193|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
49002660|NCT03747939|157847190|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
49002661|NCT03747939|157847191|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|2|||
49002662|NCT03747939|157847192|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
49002663|NCT03747939|157847193|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
49002664|NCT03747939|157847190|FG000|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
49002665|NCT03747939|157847191|FG001|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
49002666|NCT03747939|157847192|FG002|Apremilast Extension (Weeks 24 - 48)|Adverse Event|2|||
49002667|NCT03747939|157847193|FG003|Apremilast Extension (Weeks 24 - 48)|Adverse Event|6|||
49002668|NCT03747939|157847190|FG000|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
49002669|NCT03747939|157847191|FG001|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
49002670|NCT03747939|157847192|FG002|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|3|||
49002671|NCT03747939|157847193|FG003|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|8|||
49002672|NCT03747939|157847190|FG000|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
49002673|NCT03747939|157847191|FG001|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
49002674|NCT03747939|157847192|FG002|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|4|||
49002675|NCT03747939|157847193|FG003|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|1|||
49002676|NCT03747939|157847190|FG000|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
49002677|NCT03747939|157847191|FG001|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
49002678|NCT03747939|157847192|FG002|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|1|||
49002679|NCT03747939|157847193|FG003|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|7|||
49002680|NCT03747939|157847190|FG000|Apremilast Extension (Weeks 24 - 48)|Other|0|||
49002681|NCT03747939|157847191|FG001|Apremilast Extension (Weeks 24 - 48)|Other|0|||
49002682|NCT03747939|157847192|FG002|Apremilast Extension (Weeks 24 - 48)|Other|0|||
49002683|NCT03747939|157847193|FG003|Apremilast Extension (Weeks 24 - 48)|Other|7|||
49002684|NCT01215955|157847194|FG000|Overall Study|Adverse Event|1|||
49002685|NCT01215955|157847195|FG001|Overall Study|Adverse Event|4|||
49002686|NCT01215955|157847196|FG002|Overall Study|Adverse Event|2|||
49045857|NCT04729101|158002035|FG000|Overall Study|Adverse Event|1|||
49002687|NCT01215955|157847197|FG003|Overall Study|Adverse Event|3|||
49002688|NCT01215955|157847194|FG000|Overall Study|Death|2|||
49002689|NCT01215955|157847195|FG001|Overall Study|Death|0|||
49002690|NCT01215955|157847196|FG002|Overall Study|Death|1|||
49002691|NCT01215955|157847197|FG003|Overall Study|Death|3|||
49002692|NCT01215955|157847194|FG000|Overall Study|Entry Criteria Not Met|1|||
49002693|NCT01215955|157847195|FG001|Overall Study|Entry Criteria Not Met|3|||
49002694|NCT01215955|157847196|FG002|Overall Study|Entry Criteria Not Met|4|||
49002695|NCT01215955|157847197|FG003|Overall Study|Entry Criteria Not Met|7|||
49002696|NCT01215955|157847194|FG000|Overall Study|Lack of Efficacy|1|||
49002697|NCT01215955|157847195|FG001|Overall Study|Lack of Efficacy|2|||
49002698|NCT01215955|157847196|FG002|Overall Study|Lack of Efficacy|1|||
49002699|NCT01215955|157847197|FG003|Overall Study|Lack of Efficacy|0|||
49002700|NCT01215955|157847194|FG000|Overall Study|Lost to Follow-up|4|||
49002701|NCT01215955|157847195|FG001|Overall Study|Lost to Follow-up|4|||
49002702|NCT01215955|157847196|FG002|Overall Study|Lost to Follow-up|8|||
49002703|NCT01215955|157847197|FG003|Overall Study|Lost to Follow-up|9|||
49002704|NCT01215955|157847194|FG000|Overall Study|Physician Decision|4|||
49002705|NCT01215955|157847195|FG001|Overall Study|Physician Decision|10|||
49002706|NCT01215955|157847196|FG002|Overall Study|Physician Decision|8|||
49002707|NCT01215955|157847197|FG003|Overall Study|Physician Decision|11|||
49002708|NCT01215955|157847194|FG000|Overall Study|Protocol Violation|17|||
49002709|NCT01215955|157847195|FG001|Overall Study|Protocol Violation|13|||
49002710|NCT01215955|157847196|FG002|Overall Study|Protocol Violation|8|||
49002711|NCT01215955|157847197|FG003|Overall Study|Protocol Violation|8|||
49002712|NCT01215955|157847194|FG000|Overall Study|Sponsor Decision|1|||
49002713|NCT01215955|157847195|FG001|Overall Study|Sponsor Decision|2|||
49002714|NCT01215955|157847196|FG002|Overall Study|Sponsor Decision|0|||
49002715|NCT01215955|157847197|FG003|Overall Study|Sponsor Decision|1|||
49002716|NCT01215955|157847194|FG000|Overall Study|Withdrawal by Subject|14|||
49002717|NCT01215955|157847195|FG001|Overall Study|Withdrawal by Subject|15|||
49002718|NCT01215955|157847196|FG002|Overall Study|Withdrawal by Subject|13|||
49002719|NCT01215955|157847197|FG003|Overall Study|Withdrawal by Subject|9|||
49002720|NCT01215955|157847194|FG000|Overall Study|Quality Issues|0|||
49002721|NCT01215955|157847195|FG001|Overall Study|Quality Issues|0|||
49002722|NCT01215955|157847196|FG002|Overall Study|Quality Issues|3|||
49002723|NCT01215955|157847197|FG003|Overall Study|Quality Issues|2|||
49002724|NCT01850108|157847201|FG000|Overall Study|Lost to Follow-up|4|||
49002725|NCT01850108|157847201|FG000|Overall Study|Not eligible|1|||
49002726|NCT01850108|157847201|FG000|Overall Study|Failed engraftment|2|||
49002727|NCT01850108|157847201|FG000|Overall Study|Physician Decision|1|||
49002728|NCT01447628|157847202|FG000|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
49002729|NCT01447628|157847203|FG001|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
49002730|NCT01447628|157847204|FG002|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
49002731|NCT01447628|157847205|FG003|Week 0 to Week 12 (1st Intervention)|Adverse Event|1|||
49002732|NCT04330482|157847206|FG000|Overall Study|Lost to Follow-up|2|||
49002733|NCT04330482|157847207|FG001|Overall Study|Lost to Follow-up|1|||
49002734|NCT04330482|157847206|FG000|Overall Study|Withdrawal by Subject|0|||
49002735|NCT04330482|157847207|FG001|Overall Study|Withdrawal by Subject|3|||
49002736|NCT03087773|157847208|FG000|Overall Study|Withdrawal by Subject|8|||
49002737|NCT03087773|157847209|FG001|Overall Study|Withdrawal by Subject|4|||
49002738|NCT03087773|157847208|FG000|Overall Study|Lost to Follow-up|12|||
49002739|NCT03087773|157847209|FG001|Overall Study|Lost to Follow-up|8|||
49002740|NCT05180630|157847211|FG000|First Intervention|Physician Decision|0|||
49002741|NCT05180630|157847212|FG001|First Intervention|Physician Decision|0|||
49002742|NCT05180630|157847213|FG002|First Intervention|Physician Decision|3|||
49002743|NCT00402779|157847214|FG000|Overall Study|Screen Failure|77|||
49002744|NCT00402779|157847215|FG001|Overall Study|Screen Failure|76|||
49002745|NCT02494583|157847216|FG000|Overall Study|Death|224|||
49002746|NCT02494583|157847217|FG001|Overall Study|Death|214|||
49002747|NCT02494583|157847218|FG002|Overall Study|Death|225|||
49002748|NCT02494583|157847216|FG000|Overall Study|Lost to Follow-up|1|||
49002749|NCT02494583|157847217|FG001|Overall Study|Lost to Follow-up|0|||
49002750|NCT02494583|157847218|FG002|Overall Study|Lost to Follow-up|0|||
49002751|NCT02494583|157847216|FG000|Overall Study|Protocol Violation|1|||
49002752|NCT02494583|157847217|FG001|Overall Study|Protocol Violation|2|||
49002753|NCT02494583|157847218|FG002|Overall Study|Protocol Violation|0|||
49002754|NCT02494583|157847216|FG000|Overall Study|Screen Failure|0|||
49002755|NCT02494583|157847217|FG001|Overall Study|Screen Failure|1|||
49002756|NCT02494583|157847218|FG002|Overall Study|Screen Failure|0|||
49002757|NCT02494583|157847216|FG000|Overall Study|Transferred to Extension Study|15|||
49002758|NCT02494583|157847217|FG001|Overall Study|Transferred to Extension Study|15|||
49002759|NCT02494583|157847218|FG002|Overall Study|Transferred to Extension Study|6|||
49002760|NCT02494583|157847216|FG000|Overall Study|Did Not Continue on Extension Study|8|||
49002761|NCT02494583|157847217|FG001|Overall Study|Did Not Continue on Extension Study|10|||
49002762|NCT02494583|157847218|FG002|Overall Study|Did Not Continue on Extension Study|4|||
49002763|NCT02494583|157847216|FG000|Overall Study|Withdrawal by Subject|7|||
49002764|NCT02494583|157847217|FG001|Overall Study|Withdrawal by Subject|15|||
49002765|NCT02494583|157847218|FG002|Overall Study|Withdrawal by Subject|15|||
49002766|NCT00960687|157847219|FG000|Washout Period of 7 Days|Adverse Event|3|||
49002767|NCT00960687|157847220|FG001|Washout Period of 7 Days|Adverse Event|2|||
49002768|NCT00960687|157847219|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
49002769|NCT00960687|157847220|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
49002770|NCT00865306|157847221|FG000|Controlled Trial|Lost to Follow-up|1|||
49002771|NCT00865306|157847222|FG001|Controlled Trial|Lost to Follow-up|1|||
49002772|NCT00865306|157847221|FG000|Controlled Trial|Difficulty commuting|2|||
49002773|NCT00865306|157847222|FG001|Controlled Trial|Difficulty commuting|0|||
49002774|NCT00865306|157847221|FG000|Controlled Trial|Improved btw baseline and first session|1|||
49002775|NCT00865306|157847222|FG001|Controlled Trial|Improved btw baseline and first session|0|||
49002776|NCT00865306|157847221|FG000|Controlled Trial|Sought treatment for conduct disorder|1|||
49002777|NCT00865306|157847222|FG001|Controlled Trial|Sought treatment for conduct disorder|0|||
49002778|NCT00865306|157847221|FG000|Controlled Trial|Withdrawal by Subject|0|||
49002779|NCT00865306|157847222|FG001|Controlled Trial|Withdrawal by Subject|1|||
49002780|NCT03151226|157847231|FG000|Overall Study|Withdrawal by Subject|2|||
49002781|NCT03151226|157847231|FG000|Overall Study|not wear device correctly|1|||
49002782|NCT03330847|157847232|FG000|Overall Study|Patients ongoing study|62|||
49002783|NCT03330847|157847233|FG001|Overall Study|Patients ongoing study|65|||
49002784|NCT03330847|157847234|FG002|Overall Study|Patients ongoing study|15|||
49002785|NCT04969263|157847235|FG000|Overall Study|Death|1|||
49002786|NCT04969263|157847235|FG000|Overall Study|Lost to Follow-up|2|||
49002787|NCT04969263|157847235|FG000|Overall Study|Withdrawal by Subject|5|||
49002788|NCT04969263|157847235|FG000|Overall Study|Physician decision due to both medical and non-medical considerations|1|||
49002789|NCT00928135|157847236|FG000|Overall Study|Withdrawal by Subject|1|||
49002790|NCT00928135|157847237|FG001|Overall Study|Withdrawal by Subject|0|||
49002791|NCT02200614|157847238|FG000|Double Blind Treatment|Adverse Event|86|||
49002792|NCT02200614|157847239|FG001|Double Blind Treatment|Adverse Event|48|||
49002793|NCT02200614|157847238|FG000|Double Blind Treatment|Confirmed metastasis|120|||
49002794|NCT02200614|157847239|FG001|Double Blind Treatment|Confirmed metastasis|140|||
49002795|NCT02200614|157847238|FG000|Double Blind Treatment|Judgment of the investigator|59|||
49002796|NCT02200614|157847239|FG001|Double Blind Treatment|Judgment of the investigator|99|||
49002797|NCT02200614|157847238|FG000|Double Blind Treatment|Metastasis by local reading|1|||
49002798|NCT02200614|157847239|FG001|Double Blind Treatment|Metastasis by local reading|3|||
49002799|NCT02200614|157847238|FG000|Double Blind Treatment|Other reason|6|||
49002800|NCT02200614|157847239|FG001|Double Blind Treatment|Other reason|2|||
49002801|NCT02200614|157847238|FG000|Double Blind Treatment|Personal reason|77|||
49002802|NCT02200614|157847239|FG001|Double Blind Treatment|Personal reason|85|||
49002803|NCT02200614|157847238|FG000|Double Blind Treatment|Protocol deviation|14|||
49002804|NCT02200614|157847239|FG001|Double Blind Treatment|Protocol deviation|7|||
49002805|NCT02200614|157847238|FG000|Double Blind Treatment|Not treated|1|||
49002806|NCT02200614|157847239|FG001|Double Blind Treatment|Not treated|0|||
49002807|NCT02200614|157847238|FG000|Open Label|Adverse Event|41|||
49002808|NCT02200614|157847239|FG001|Open Label|Adverse Event|11|||
49002809|NCT02200614|157847238|FG000|Open Label|Confirmed metastasis|1|||
49002810|NCT02200614|157847239|FG001|Open Label|Confirmed metastasis|0|||
49002811|NCT02200614|157847238|FG000|Open Label|Judgment of the investigator|29|||
49002812|NCT02200614|157847239|FG001|Open Label|Judgment of the investigator|2|||
49002813|NCT02200614|157847238|FG000|Open Label|Metastasis by local reading|138|||
49002814|NCT02200614|157847239|FG001|Open Label|Metastasis by local reading|27|||
49002815|NCT02200614|157847238|FG000|Open Label|Other reason|22|||
49002816|NCT02200614|157847239|FG001|Open Label|Other reason|4|||
49002817|NCT02200614|157847238|FG000|Open Label|Personal reason|60|||
49002818|NCT02200614|157847239|FG001|Open Label|Personal reason|8|||
49002819|NCT02200614|157847238|FG000|Open Label|Protocol deviation|3|||
49002820|NCT02200614|157847239|FG001|Open Label|Protocol deviation|2|||
49002821|NCT02200614|157847238|FG000|Open Label|Missing|2|||
49002822|NCT02200614|157847239|FG001|Open Label|Missing|2|||
49002823|NCT00005879|157847240|FG000|Overall Study|Withdrawal by Subject|8|||
49002824|NCT00005879|157847241|FG001|Overall Study|Withdrawal by Subject|10|||
49002825|NCT00689273|157847242|FG000|Overall Study|Adverse Event|3|||
49002826|NCT00689273|157847243|FG001|Overall Study|Adverse Event|1|||
49002827|NCT00689273|157847242|FG000|Overall Study|Lack of Efficacy|3|||
49002828|NCT00689273|157847243|FG001|Overall Study|Lack of Efficacy|0|||
49002829|NCT00689273|157847242|FG000|Overall Study|Lost to Follow-up|0|||
49002830|NCT00689273|157847243|FG001|Overall Study|Lost to Follow-up|2|||
49002831|NCT00689273|157847242|FG000|Overall Study|Other|6|||
49002832|NCT00689273|157847243|FG001|Overall Study|Other|2|||
49002833|NCT00689273|157847242|FG000|Overall Study|Randomized but not Treated|1|||
49002834|NCT00689273|157847243|FG001|Overall Study|Randomized but not Treated|0|||
49002835|NCT04980391|157847246|FG000|Overall Study|Death|0|||
49002836|NCT04980391|157847247|FG001|Overall Study|Death|0|||
49002837|NCT04980391|157847248|FG002|Overall Study|Death|1|||
49002838|NCT04980391|157847249|FG003|Overall Study|Death|1|||
49002839|NCT04980391|157847246|FG000|Overall Study|Lost to Follow-up|3|||
49002840|NCT04980391|157847247|FG001|Overall Study|Lost to Follow-up|3|||
49002841|NCT04980391|157847248|FG002|Overall Study|Lost to Follow-up|2|||
49002842|NCT04980391|157847249|FG003|Overall Study|Lost to Follow-up|3|||
49002843|NCT04980391|157847246|FG000|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|2|||
49002844|NCT04980391|157847247|FG001|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
49002845|NCT04980391|157847248|FG002|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
49002846|NCT04980391|157847249|FG003|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
49002847|NCT04980391|157847246|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
49002848|NCT04980391|157847247|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
49002849|NCT04980391|157847248|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
49002850|NCT04980391|157847249|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
49002851|NCT04980391|157847246|FG000|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
49002852|NCT04980391|157847247|FG001|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
49002853|NCT04980391|157847248|FG002|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|3|||
49002854|NCT04980391|157847249|FG003|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
49002855|NCT02531698|157847250|FG000|Overall Study|Adverse Event|2|||
49002856|NCT02531698|157847251|FG001|Overall Study|Adverse Event|1|||
49002857|NCT02531698|157847250|FG000|Overall Study|Withdrawal by Subject|6|||
49002858|NCT02531698|157847251|FG001|Overall Study|Withdrawal by Subject|1|||
49002859|NCT02531698|157847250|FG000|Overall Study|Protocol Violation|2|||
49002860|NCT02531698|157847251|FG001|Overall Study|Protocol Violation|0|||
49002861|NCT02531698|157847250|FG000|Overall Study|Lost to Follow-up|1|||
49002862|NCT02531698|157847251|FG001|Overall Study|Lost to Follow-up|0|||
49002863|NCT00701558|157847252|FG000|Overall Study|Death|7|||
49002864|NCT00701558|157847252|FG000|Overall Study|Lost to Follow-up|8|||
49002865|NCT02367781|157847253|FG000|Overall Study|Withdrawal by Subject|20|||
49002866|NCT02367781|157847254|FG001|Overall Study|Withdrawal by Subject|13|||
49002867|NCT02367781|157847253|FG000|Overall Study|Protocol Violation|0|||
49002868|NCT02367781|157847254|FG001|Overall Study|Protocol Violation|1|||
49002869|NCT02367781|157847253|FG000|Overall Study|Physician Decision|7|||
49002870|NCT02367781|157847254|FG001|Overall Study|Physician Decision|0|||
49002871|NCT02367781|157847253|FG000|Overall Study|Randomized in Error|5|||
49002872|NCT02367781|157847254|FG001|Overall Study|Randomized in Error|4|||
49002873|NCT02367781|157847253|FG000|Overall Study|Non-Compliance|1|||
49002874|NCT02367781|157847254|FG001|Overall Study|Non-Compliance|0|||
49002875|NCT02367781|157847253|FG000|Overall Study|Lost to Follow-up|1|||
49002876|NCT02367781|157847254|FG001|Overall Study|Lost to Follow-up|2|||
49002877|NCT02367781|157847253|FG000|Overall Study|Death|330|||
49002878|NCT02367781|157847254|FG001|Overall Study|Death|176|||
49002879|NCT02367781|157847253|FG000|Overall Study|Patient Moving to Roll-Over Study|17|||
49002880|NCT02367781|157847254|FG001|Overall Study|Patient Moving to Roll-Over Study|5|||
49002881|NCT02367781|157847253|FG000|Overall Study|Prolonged Hospitalization|1|||
49002882|NCT02367781|157847254|FG001|Overall Study|Prolonged Hospitalization|0|||
49002883|NCT02367781|157847253|FG000|Overall Study|Death Prior First Dose|1|||
49002884|NCT02367781|157847254|FG001|Overall Study|Death Prior First Dose|0|||
49002885|NCT02367781|157847253|FG000|Overall Study|Administrative-Change Facility|1|||
49002886|NCT02367781|157847254|FG001|Overall Study|Administrative-Change Facility|0|||
49002887|NCT02367781|157847253|FG000|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78|||
49002888|NCT02367781|157847254|FG001|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29|||
49002889|NCT02367781|157847253|FG000|Overall Study|Patient Moved to Commercial Atezolizumab Use|14|||
49002890|NCT02367781|157847254|FG001|Overall Study|Patient Moved to Commercial Atezolizumab Use|9|||
49002891|NCT02367781|157847253|FG000|Overall Study|Study Terminated by Sponsor|3|||
49002892|NCT02367781|157847254|FG001|Overall Study|Study Terminated by Sponsor|1|||
49002893|NCT02367781|157847253|FG000|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1|||
49002894|NCT02367781|157847254|FG001|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0|||
49002895|NCT02367781|157847253|FG000|Overall Study|Sponsor Decision|2|||
49002896|NCT02367781|157847254|FG001|Overall Study|Sponsor Decision|0|||
49002897|NCT02367781|157847253|FG000|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1|||
49002898|NCT02367781|157847254|FG001|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0|||
49002899|NCT02842086|157847255|FG000|Overall Study|Randomized but Never Treated|6|||
49002900|NCT02842086|157847256|FG001|Overall Study|Randomized but Never Treated|6|||
49002901|NCT02842086|157847255|FG000|Overall Study|Still in Double-Blind Phase|7|||
49002902|NCT02842086|157847256|FG001|Overall Study|Still in Double-Blind Phase|3|||
49002903|NCT02842086|157847255|FG000|Overall Study|Adverse Event|18|||
49002904|NCT02842086|157847256|FG001|Overall Study|Adverse Event|20|||
49002905|NCT02842086|157847255|FG000|Overall Study|Death|3|||
49002906|NCT02842086|157847256|FG001|Overall Study|Death|3|||
49002907|NCT02842086|157847255|FG000|Overall Study|Investigator's Discretion|9|||
49002908|NCT02842086|157847256|FG001|Overall Study|Investigator's Discretion|13|||
49002909|NCT02842086|157847255|FG000|Overall Study|Non-Compliance with Study Drug|9|||
49002910|NCT02842086|157847256|FG001|Overall Study|Non-Compliance with Study Drug|8|||
49002911|NCT02842086|157847255|FG000|Overall Study|Protocol Violation|8|||
49002912|NCT02842086|157847256|FG001|Overall Study|Protocol Violation|4|||
49002913|NCT02842086|157847255|FG000|Overall Study|Withdrew Consent|205|||
49002914|NCT02842086|157847256|FG001|Overall Study|Withdrew Consent|194|||
49002915|NCT02842086|157847255|FG000|Overall Study|Lost to Follow-up|274|||
49002916|NCT02842086|157847256|FG001|Overall Study|Lost to Follow-up|236|||
49045858|NCT04729101|158002036|FG001|Overall Study|Adverse Event|0|||
49045859|NCT04729101|158002035|FG000|Overall Study|Physician Decision|1|||
49045860|NCT04729101|158002036|FG001|Overall Study|Physician Decision|0|||
49045861|NCT04729101|158002035|FG000|Overall Study|Withdrawal by Subject|1|||
49045862|NCT04729101|158002036|FG001|Overall Study|Withdrawal by Subject|0|||
49045863|NCT04158687|158002040|FG000|Overall Study|Adverse Event|2|||
49045864|NCT04158687|158002041|FG001|Overall Study|Adverse Event|3|||
49045865|NCT04158687|158002042|FG002|Overall Study|Adverse Event|0|||
49045866|NCT04158687|158002043|FG003|Overall Study|Adverse Event|3|||
49045867|NCT04158687|158002040|FG000|Overall Study|Lost to Follow-up|5|||
49045868|NCT04158687|158002041|FG001|Overall Study|Lost to Follow-up|12|||
49045869|NCT04158687|158002042|FG002|Overall Study|Lost to Follow-up|4|||
49002917|NCT02842086|157847255|FG000|Overall Study|HIV-1 Infection|5|||
49002918|NCT02842086|157847256|FG001|Overall Study|HIV-1 Infection|6|||
49002919|NCT00545441|157848269|FG000|Overall Study|Fistula draining at 6 months|2|||
49002920|NCT00545441|157848270|FG001|Overall Study|Fistula draining at 6 months|4|||
49002921|NCT00545441|157848269|FG000|Overall Study|Lost to Follow-up|9|||
49002922|NCT00545441|157848270|FG001|Overall Study|Lost to Follow-up|5|||
49002923|NCT00545441|157848269|FG000|Overall Study|Technical failure|0|||
49002924|NCT00545441|157848270|FG001|Overall Study|Technical failure|1|||
49002925|NCT00545441|157848269|FG000|Overall Study|Withdrawal by Subject|1|||
49002926|NCT00545441|157848270|FG001|Overall Study|Withdrawal by Subject|1|||
49002927|NCT00545441|157848269|FG000|Overall Study|Persistence or recurrence of fistula|5|||
49002928|NCT00545441|157848270|FG001|Overall Study|Persistence or recurrence of fistula|2|||
49002929|NCT00545441|157848269|FG000|Overall Study|Patients were not treated|1|||
49002930|NCT00545441|157848270|FG001|Overall Study|Patients were not treated|3|||
49002931|NCT03526679|157848271|FG000|Overall Study|still under treatment|2|||
49002932|NCT01817764|157848272|FG000|Overall Study|Adverse Event|7|||
49002933|NCT01817764|157848273|FG001|Overall Study|Adverse Event|10|||
49002934|NCT01817764|157848272|FG000|Overall Study|Lack of Efficacy|9|||
49002935|NCT01817764|157848273|FG001|Overall Study|Lack of Efficacy|7|||
49002936|NCT01817764|157848272|FG000|Overall Study|Protocol Violation|7|||
49002937|NCT01817764|157848273|FG001|Overall Study|Protocol Violation|5|||
49002938|NCT01817764|157848272|FG000|Overall Study|Lost to Follow-up|1|||
49002939|NCT01817764|157848273|FG001|Overall Study|Lost to Follow-up|4|||
49002940|NCT01817764|157848272|FG000|Overall Study|Withdrawal by Subject|10|||
49002941|NCT01817764|157848273|FG001|Overall Study|Withdrawal by Subject|12|||
49002942|NCT03514121|157848274|FG000|Overall Study|Withdrawal by Subject|0|||
49002943|NCT03514121|157848275|FG001|Overall Study|Withdrawal by Subject|0|||
49002944|NCT03514121|157848276|FG002|Overall Study|Withdrawal by Subject|0|||
49002945|NCT03514121|157848277|FG003|Overall Study|Withdrawal by Subject|0|||
49002946|NCT03514121|157848278|FG004|Overall Study|Withdrawal by Subject|1|||
49002947|NCT03514121|157848279|FG005|Overall Study|Withdrawal by Subject|2|||
49002948|NCT03514121|157848280|FG006|Overall Study|Withdrawal by Subject|1|||
49002949|NCT03514121|157848281|FG007|Overall Study|Withdrawal by Subject|1|||
49002950|NCT03514121|157848282|FG008|Overall Study|Withdrawal by Subject|7|||
49002951|NCT03514121|157848283|FG009|Overall Study|Withdrawal by Subject|2|||
49002952|NCT03514121|157848274|FG000|Overall Study|Death|0|||
49002953|NCT03514121|157848275|FG001|Overall Study|Death|0|||
49002954|NCT03514121|157848276|FG002|Overall Study|Death|0|||
49002955|NCT03514121|157848277|FG003|Overall Study|Death|0|||
49002956|NCT03514121|157848278|FG004|Overall Study|Death|0|||
49002957|NCT03514121|157848279|FG005|Overall Study|Death|3|||
49002958|NCT03514121|157848280|FG006|Overall Study|Death|2|||
49002959|NCT03514121|157848281|FG007|Overall Study|Death|1|||
49002960|NCT03514121|157848282|FG008|Overall Study|Death|26|||
49002961|NCT03514121|157848283|FG009|Overall Study|Death|3|||
49002962|NCT03514121|157848274|FG000|Overall Study|Lost to Follow-up|0|||
49002963|NCT03514121|157848275|FG001|Overall Study|Lost to Follow-up|0|||
49002964|NCT03514121|157848276|FG002|Overall Study|Lost to Follow-up|1|||
49002965|NCT03514121|157848277|FG003|Overall Study|Lost to Follow-up|0|||
49002966|NCT03514121|157848278|FG004|Overall Study|Lost to Follow-up|0|||
49002967|NCT03514121|157848279|FG005|Overall Study|Lost to Follow-up|0|||
49002968|NCT03514121|157848280|FG006|Overall Study|Lost to Follow-up|0|||
49002969|NCT03514121|157848281|FG007|Overall Study|Lost to Follow-up|0|||
49045870|NCT04158687|158002043|FG003|Overall Study|Lost to Follow-up|5|||
49045871|NCT04158687|158002040|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
49045872|NCT04158687|158002041|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|3|||
49045873|NCT04158687|158002042|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
49045874|NCT04158687|158002043|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|0|||
49045875|NCT04158687|158002040|FG000|Overall Study|Non-Compliance with Study Medication|2|||
49045876|NCT04158687|158002041|FG001|Overall Study|Non-Compliance with Study Medication|2|||
49045877|NCT04158687|158002042|FG002|Overall Study|Non-Compliance with Study Medication|3|||
49045878|NCT04158687|158002043|FG003|Overall Study|Non-Compliance with Study Medication|0|||
49045879|NCT04158687|158002040|FG000|Overall Study|Investigator Decision|0|||
49045880|NCT04158687|158002041|FG001|Overall Study|Investigator Decision|0|||
49045881|NCT04158687|158002042|FG002|Overall Study|Investigator Decision|2|||
49045882|NCT04158687|158002043|FG003|Overall Study|Investigator Decision|0|||
49045883|NCT04158687|158002040|FG000|Overall Study|Protocol Violation|0|||
49045884|NCT04158687|158002041|FG001|Overall Study|Protocol Violation|2|||
49045885|NCT04158687|158002042|FG002|Overall Study|Protocol Violation|1|||
49045886|NCT04158687|158002043|FG003|Overall Study|Protocol Violation|0|||
49045887|NCT04158687|158002040|FG000|Overall Study|Withdrawal of Consent by Subject|3|||
49045888|NCT04158687|158002041|FG001|Overall Study|Withdrawal of Consent by Subject|3|||
49045889|NCT04158687|158002042|FG002|Overall Study|Withdrawal of Consent by Subject|4|||
49045890|NCT04158687|158002043|FG003|Overall Study|Withdrawal of Consent by Subject|1|||
49045891|NCT04158687|158002040|FG000|Overall Study|Reason not Specified|3|||
49045892|NCT04158687|158002041|FG001|Overall Study|Reason not Specified|2|||
49045893|NCT04158687|158002042|FG002|Overall Study|Reason not Specified|4|||
49045894|NCT04158687|158002043|FG003|Overall Study|Reason not Specified|4|||
49045895|NCT03414034|158002049|FG000|Overall Study|Adverse Event|6|||
49045896|NCT03414034|158002050|FG001|Overall Study|Adverse Event|1|||
49045897|NCT03414034|158002051|FG002|Overall Study|Adverse Event|1|||
49045898|NCT03414034|158002049|FG000|Overall Study|Death|0|||
49045899|NCT03414034|158002050|FG001|Overall Study|Death|0|||
49045900|NCT03414034|158002051|FG002|Overall Study|Death|1|||
49045901|NCT03414034|158002049|FG000|Overall Study|Non-compliance With Study Drug|0|||
49045902|NCT03414034|158002050|FG001|Overall Study|Non-compliance With Study Drug|0|||
49045903|NCT03414034|158002051|FG002|Overall Study|Non-compliance With Study Drug|1|||
49045904|NCT03414034|158002049|FG000|Overall Study|Physician Decision|1|||
49045905|NCT03414034|158002050|FG001|Overall Study|Physician Decision|3|||
49045906|NCT03414034|158002051|FG002|Overall Study|Physician Decision|2|||
49045907|NCT03414034|158002049|FG000|Overall Study|Withdrawal of Informed Consent|2|||
49045908|NCT03414034|158002050|FG001|Overall Study|Withdrawal of Informed Consent|1|||
49045909|NCT03414034|158002051|FG002|Overall Study|Withdrawal of Informed Consent|4|||
49045910|NCT03414034|158002049|FG000|Overall Study|Progressive Disease|15|||
49045911|NCT03414034|158002050|FG001|Overall Study|Progressive Disease|15|||
49045912|NCT03414034|158002051|FG002|Overall Study|Progressive Disease|17|||
49045913|NCT03414034|158002049|FG000|Overall Study|Miscellaneous|0|||
49045914|NCT03414034|158002050|FG001|Overall Study|Miscellaneous|0|||
49045915|NCT03414034|158002051|FG002|Overall Study|Miscellaneous|2|||
49045916|NCT00721955|158002053|FG000|Overall Study|Adverse Event|0|||
49045917|NCT00721955|158002054|FG001|Overall Study|Adverse Event|0|||
49045918|NCT00721955|158002055|FG002|Overall Study|Adverse Event|2|||
49045919|NCT01050764|158002056|FG000|Overall Study|Death, before HSCT|1|||
49045920|NCT01050764|158002056|FG000|Overall Study|Donor mobilization failure, death|1|||
49045921|NCT01050764|158002056|FG000|Overall Study|Death after HSCT, before T-cell infusion|1|||
49045922|NCT02174276|158002058|FG000|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1|||
49045923|NCT02174276|158002059|FG001|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
49045924|NCT02174276|158002060|FG002|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
49045925|NCT02174276|158002061|FG003|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
49045926|NCT02174276|158002058|FG000|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
49045927|NCT02174276|158002059|FG001|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
49045928|NCT02174276|158002060|FG002|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1|||
49045929|NCT02174276|158002061|FG003|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
49045930|NCT02174276|158002058|FG000|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
49045931|NCT02174276|158002059|FG001|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1|||
49045932|NCT02174276|158002060|FG002|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2|||
49045933|NCT02174276|158002061|FG003|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
49045934|NCT02174276|158002058|FG000|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
49045935|NCT02174276|158002059|FG001|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
49045936|NCT02174276|158002060|FG002|OTEP (Weeks 48 to 144)|Lost to Follow-up|1|||
49045937|NCT02174276|158002061|FG003|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
49045938|NCT02174276|158002058|FG000|OTEP (Weeks 48 to 144)|Pregnancy|0|||
49045939|NCT02174276|158002059|FG001|OTEP (Weeks 48 to 144)|Pregnancy|0|||
49045940|NCT02174276|158002060|FG002|OTEP (Weeks 48 to 144)|Pregnancy|1|||
49045941|NCT02174276|158002061|FG003|OTEP (Weeks 48 to 144)|Pregnancy|0|||
49045942|NCT02174276|158002058|FG000|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
49045943|NCT02174276|158002059|FG001|OTEP (Weeks 48 to 144)|Withdrew Consent|0|||
49045944|NCT02174276|158002060|FG002|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
49045945|NCT02174276|158002061|FG003|OTEP (Weeks 48 to 144)|Withdrew Consent|2|||
49045946|NCT02661022|158002064|FG000|Overall Study|Withdrawal by Subject|3|||
49045947|NCT02661022|158002065|FG001|Overall Study|Withdrawal by Subject|0|||
49045948|NCT02661022|158002064|FG000|Overall Study|Adverse Event|1|||
49045949|NCT02661022|158002065|FG001|Overall Study|Adverse Event|1|||
49045950|NCT02661022|158002064|FG000|Overall Study|Physician Decision|1|||
49045951|NCT02661022|158002065|FG001|Overall Study|Physician Decision|0|||
49045952|NCT02661022|158002064|FG000|Overall Study|Progressive Disease|2|||
49045953|NCT02661022|158002065|FG001|Overall Study|Progressive Disease|1|||
49045954|NCT05889039|158002066|FG000|Overall Study|error in completing survey|0|||
49045955|NCT05889039|158002067|FG001|Overall Study|error in completing survey|2|||
49045956|NCT05889039|158002068|FG002|Overall Study|error in completing survey|0|||
49045957|NCT05889039|158002069|FG003|Overall Study|error in completing survey|0|||
49045958|NCT05889039|158002066|FG000|Overall Study|Lost to Follow-up|4|||
49045959|NCT05889039|158002067|FG001|Overall Study|Lost to Follow-up|0|||
49045960|NCT05889039|158002068|FG002|Overall Study|Lost to Follow-up|0|||
49045961|NCT05889039|158002069|FG003|Overall Study|Lost to Follow-up|0|||
49045962|NCT01055886|158002070|FG000|Overall Study|Withdrawal by Subject|4|||
49045963|NCT01055886|158002071|FG001|Overall Study|Withdrawal by Subject|9|||
49045964|NCT01055886|158002070|FG000|Overall Study|Lost to Follow-up|1|||
49045965|NCT01055886|158002071|FG001|Overall Study|Lost to Follow-up|1|||
49045966|NCT01055886|158002070|FG000|Overall Study|Withdrawal by PI|0|||
49045967|NCT01055886|158002071|FG001|Overall Study|Withdrawal by PI|1|||
49045968|NCT02359864|158002072|FG000|Overall Study|Withdrawal by Subject|1|||
49045969|NCT02359864|158002073|FG001|Overall Study|Withdrawal by Subject|0|||
49045970|NCT00725764|158002074|FG000|Overall Study|Withdrawal by Subject|2|||
49045971|NCT00725764|158002074|FG000|Overall Study|Physician Decision|1|||
49045972|NCT00725764|158002074|FG000|Overall Study|Progressive Disease|7|||
49045973|NCT00725764|158002074|FG000|Overall Study|Lost to Follow-up|1|||
49045974|NCT00725764|158002074|FG000|Overall Study|Death|1|||
49045975|NCT00725764|158002074|FG000|Overall Study|Participant non compliant with protocol|1|||
49045976|NCT00725764|158002074|FG000|Overall Study|Decline in performance status|1|||
49045977|NCT00570128|158002075|FG000|Overall Study|Adverse Event|1|||
49045978|NCT00570128|158002076|FG001|Overall Study|Adverse Event|0|||
49045979|NCT00570128|158002075|FG000|Overall Study|Lost to Follow-up|1|||
49045980|NCT00570128|158002076|FG001|Overall Study|Lost to Follow-up|0|||
49045981|NCT00570128|158002075|FG000|Overall Study|Withdrawal by Subject|2|||
49045982|NCT00570128|158002076|FG001|Overall Study|Withdrawal by Subject|0|||
49045983|NCT00609154|158002077|FG000|Overall Study|Protocol Violation|1|||
49045984|NCT00609154|158002078|FG001|Overall Study|Protocol Violation|2|||
49045985|NCT00609154|158002077|FG000|Overall Study|Unable to establish IV access|0|||
49045986|NCT00609154|158002078|FG001|Overall Study|Unable to establish IV access|4|||
49045987|NCT00609154|158002077|FG000|Overall Study|Adverse Event|0|||
49045988|NCT00609154|158002078|FG001|Overall Study|Adverse Event|2|||
49045989|NCT01499160|158002083|FG000|Overall Study|Adverse Event|1|||
49045990|NCT01499160|158002083|FG000|Overall Study|Withdrawal by Subject|1|||
49045991|NCT03868631|158002088|FG000|Baseline to Week 6|Adverse Event|0|||
49045992|NCT03868631|158002089|FG001|Baseline to Week 6|Adverse Event|3|||
49045993|NCT03868631|158002088|FG000|Baseline to Week 6|Protocol Violation|1|||
49045994|NCT03868631|158002089|FG001|Baseline to Week 6|Protocol Violation|1|||
49045995|NCT03868631|158002088|FG000|Baseline to Week 6|Withdrawal by Subject|3|||
49045996|NCT03868631|158002089|FG001|Baseline to Week 6|Withdrawal by Subject|0|||
49045997|NCT03868631|158002088|FG000|Week 6 to Week 12 (Study Completion)|Adverse Event|2|||
49045998|NCT03868631|158002089|FG001|Week 6 to Week 12 (Study Completion)|Adverse Event|0|||
49045999|NCT03868631|158002088|FG000|Week 6 to Week 12 (Study Completion)|Protocol Violation|1|||
49046000|NCT03868631|158002089|FG001|Week 6 to Week 12 (Study Completion)|Protocol Violation|0|||
49046001|NCT03868631|158002088|FG000|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
49046002|NCT03868631|158002089|FG001|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
49046003|NCT03448692|158002093|FG000|Investigational Treatment Period:Upto24W|Adverse Event|1|||
49046004|NCT03448692|158002094|FG001|Investigational Treatment Period:Upto24W|Adverse Event|0|||
49046005|NCT03448692|158002093|FG000|Investigational Treatment Period:Upto24W|Lack of Efficacy|0|||
49046006|NCT03448692|158002094|FG001|Investigational Treatment Period:Upto24W|Lack of Efficacy|1|||
49046007|NCT03448692|158002093|FG000|Investigational Treatment Period:Upto24W|Physician's decision|0|||
49046008|NCT03448692|158002094|FG001|Investigational Treatment Period:Upto24W|Physician's decision|1|||
49046009|NCT03448692|158002093|FG000|Investigational Treatment Period:Upto24W|Study terminated by sponsor|0|||
49046010|NCT03448692|158002094|FG001|Investigational Treatment Period:Upto24W|Study terminated by sponsor|5|||
49046011|NCT03448692|158002093|FG000|Investigational Treatment Period:Upto24W|Withdrawal by Subject|0|||
49046012|NCT03448692|158002094|FG001|Investigational Treatment Period:Upto24W|Withdrawal by Subject|2|||
49046013|NCT01077258|158002099|FG000|Overall Study|Lost to Follow-up|1390|||
49046014|NCT01077258|158002099|FG000|Overall Study|Adverse drug reaction|218|||
49046015|NCT01077258|158002099|FG000|Overall Study|Lack of Efficacy|663|||
49046016|NCT01077258|158002099|FG000|Overall Study|Clinical remission|37|||
49046017|NCT01077258|158002099|FG000|Overall Study|Other reasons|260|||
49046018|NCT01685216|158002100|FG000|Overall Study|Did not receive study drug|1|||
49046019|NCT02911935|158002101|FG000|Overall Study|Lost to Follow-up|5|||
49046020|NCT02911935|158002102|FG001|Overall Study|Lost to Follow-up|7|||
49046021|NCT00515216|158002103|FG000|Overall Study|Withdrawal by Subject|1|||
49046022|NCT00726895|158002104|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
49046023|NCT00726895|158002105|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
49046024|NCT04194008|158002110|FG000|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19|||
49046025|NCT04194008|158002110|FG000|Baseline (Run-in) Phase|Withdrawal by Subject|6|||
49046026|NCT04194008|158002110|FG000|Baseline (Run-in) Phase|Lost to Follow-up|2|||
49046027|NCT04194008|158002110|FG000|Treatment Phase With Nerivio|Withdrawal by Subject|3|||
49046028|NCT04194008|158002110|FG000|Treatment Phase With Nerivio|Missing data|4|||
49046029|NCT04194008|158002110|FG000|Treatment Phase With Nerivio|Lost to Follow-up|1|||
49046030|NCT01785615|158002114|FG000|Dietary Phase|Lost to Follow-up|0|||
49046031|NCT01785615|158002115|FG001|Dietary Phase|Lost to Follow-up|0|||
49046032|NCT01785615|158002116|FG002|Dietary Phase|Lost to Follow-up|0|||
49046033|NCT01785615|158002117|FG003|Dietary Phase|Lost to Follow-up|24|||
49046034|NCT01881737|158002120|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
49046035|NCT01881737|158002120|FG000|Overall Study|Withdrawal by Subject|1|||
49046036|NCT01881737|158002120|FG000|Overall Study|Worsening of baseline behavior|1|||
49046037|NCT00982228|158002129|FG000|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12|||
49046038|NCT00982228|158002130|FG001|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2|||
49046039|NCT00982228|158002129|FG000|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2|||
49046040|NCT00982228|158002130|FG001|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0|||
49046041|NCT00982228|158002129|FG000|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11|||
49046042|NCT00982228|158002130|FG001|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2|||
49046043|NCT00982228|158002129|FG000|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15|||
49046044|NCT00982228|158002130|FG001|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3|||
49046045|NCT00982228|158002129|FG000|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28|||
49046046|NCT00982228|158002130|FG001|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13|||
49046047|NCT00982228|158002129|FG000|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3|||
49046048|NCT00982228|158002130|FG001|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2|||
49046049|NCT00982228|158002129|FG000|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1|||
49046050|NCT00982228|158002130|FG001|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0|||
49046051|NCT00982228|158002129|FG000|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1|||
49046052|NCT00982228|158002130|FG001|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2|||
49046053|NCT00982228|158002129|FG000|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5|||
49046054|NCT00982228|158002130|FG001|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0|||
49046055|NCT00982228|158002129|FG000|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11|||
49046056|NCT00982228|158002130|FG001|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1|||
49046057|NCT02941523|158002134|FG000|Monotherapy|Withdrawal by Subject|0|||
49046058|NCT02941523|158002135|FG001|Monotherapy|Withdrawal by Subject|1|||
49046059|NCT02941523|158002134|FG000|Carboplatin Combination Therapy|Adverse Event|0|||
49046060|NCT02941523|158002135|FG001|Carboplatin Combination Therapy|Adverse Event|1|||
49046061|NCT02941523|158002134|FG000|Carboplatin Combination Therapy|Death|1|||
49046062|NCT02941523|158002135|FG001|Carboplatin Combination Therapy|Death|2|||
49046063|NCT02941523|158002134|FG000|Carboplatin Combination Therapy|Disease progression|2|||
49046064|NCT02941523|158002135|FG001|Carboplatin Combination Therapy|Disease progression|0|||
49046065|NCT02941523|158002134|FG000|Carboplatin Combination Therapy|Withdrawal by Subject|2|||
49046066|NCT02941523|158002135|FG001|Carboplatin Combination Therapy|Withdrawal by Subject|1|||
49046067|NCT01183884|158002136|FG000|Overall Study|Progressive Disease|26|||
49046068|NCT01183884|158002136|FG000|Overall Study|Adverse Event|3|||
49046069|NCT01183884|158002136|FG000|Overall Study|Withdrawal by Subject|1|||
49046070|NCT01183884|158002136|FG000|Overall Study|Other Complicating Disease|3|||
49046071|NCT01183884|158002136|FG000|Overall Study|Not Treated|1|||
49046072|NCT01183884|158002136|FG000|Overall Study|Other|4|||
49046073|NCT01160640|158002137|FG000|Overall Study|Physician Decision|3|||
49046074|NCT01160640|158002138|FG001|Overall Study|Physician Decision|3|||
49046075|NCT01160640|158002137|FG000|Overall Study|Incarceration|1|||
49046076|NCT01160640|158002138|FG001|Overall Study|Incarceration|0|||
49046077|NCT01160640|158002137|FG000|Overall Study|Withdrawal by Subject|0|||
49046078|NCT01160640|158002138|FG001|Overall Study|Withdrawal by Subject|3|||
49046079|NCT02212457|158002139|FG000|Overall Study|Adverse Event|1|||
49046080|NCT02212457|158002140|FG001|Overall Study|Adverse Event|2|||
49046081|NCT02212457|158002141|FG002|Overall Study|Adverse Event|2|||
49046082|NCT02212457|158002142|FG003|Overall Study|Adverse Event|2|||
49046083|NCT02212457|158002143|FG004|Overall Study|Adverse Event|0|||
49046084|NCT02212457|158002144|FG005|Overall Study|Adverse Event|1|||
49046085|NCT02212457|158002139|FG000|Overall Study|Withdrawal by Subject|8|||
49046086|NCT02212457|158002140|FG001|Overall Study|Withdrawal by Subject|10|||
49046087|NCT02212457|158002141|FG002|Overall Study|Withdrawal by Subject|8|||
49046088|NCT02212457|158002142|FG003|Overall Study|Withdrawal by Subject|6|||
49046089|NCT02212457|158002143|FG004|Overall Study|Withdrawal by Subject|5|||
49046090|NCT02212457|158002144|FG005|Overall Study|Withdrawal by Subject|4|||
49046091|NCT02212457|158002139|FG000|Overall Study|Lost to Follow-up|6|||
49046092|NCT02212457|158002140|FG001|Overall Study|Lost to Follow-up|7|||
49046093|NCT02212457|158002141|FG002|Overall Study|Lost to Follow-up|4|||
49046094|NCT02212457|158002142|FG003|Overall Study|Lost to Follow-up|1|||
49046095|NCT02212457|158002143|FG004|Overall Study|Lost to Follow-up|8|||
49046096|NCT02212457|158002144|FG005|Overall Study|Lost to Follow-up|4|||
49046097|NCT02212457|158002139|FG000|Overall Study|Protocol Violation|2|||
49046098|NCT02212457|158002140|FG001|Overall Study|Protocol Violation|1|||
49046099|NCT02212457|158002141|FG002|Overall Study|Protocol Violation|0|||
49046100|NCT02212457|158002142|FG003|Overall Study|Protocol Violation|1|||
49046101|NCT02212457|158002143|FG004|Overall Study|Protocol Violation|2|||
49046102|NCT02212457|158002144|FG005|Overall Study|Protocol Violation|3|||
49046103|NCT02212457|158002139|FG000|Overall Study|Other|2|||
49046104|NCT02212457|158002140|FG001|Overall Study|Other|1|||
49046105|NCT02212457|158002141|FG002|Overall Study|Other|2|||
49046106|NCT02212457|158002142|FG003|Overall Study|Other|1|||
49046107|NCT02212457|158002143|FG004|Overall Study|Other|0|||
49046108|NCT02212457|158002144|FG005|Overall Study|Other|1|||
49046109|NCT04405739|158002145|FG000|Overall Study|Adverse Event|0|||
49046110|NCT04405739|158002146|FG001|Overall Study|Adverse Event|1|||
49046111|NCT04405739|158002147|FG002|Overall Study|Adverse Event|0|||
49046112|NCT04405739|158002148|FG003|Overall Study|Adverse Event|0|||
49046113|NCT04405739|158002145|FG000|Overall Study|Lost to Follow-up|0|||
49046114|NCT04405739|158002146|FG001|Overall Study|Lost to Follow-up|2|||
49046115|NCT04405739|158002147|FG002|Overall Study|Lost to Follow-up|1|||
49046116|NCT04405739|158002148|FG003|Overall Study|Lost to Follow-up|3|||
49046117|NCT04405739|158002145|FG000|Overall Study|Withdrawal by Subject|0|||
49046118|NCT04405739|158002146|FG001|Overall Study|Withdrawal by Subject|2|||
49046119|NCT04405739|158002147|FG002|Overall Study|Withdrawal by Subject|1|||
49046120|NCT04405739|158002148|FG003|Overall Study|Withdrawal by Subject|1|||
49046121|NCT04405739|158002145|FG000|Overall Study|Death|0|||
49046122|NCT04405739|158002146|FG001|Overall Study|Death|0|||
49046123|NCT04405739|158002147|FG002|Overall Study|Death|1|||
49046124|NCT04405739|158002148|FG003|Overall Study|Death|0|||
49046125|NCT04405739|158002145|FG000|Overall Study|Transferred to rehab|0|||
49046126|NCT04405739|158002146|FG001|Overall Study|Transferred to rehab|0|||
49046127|NCT04405739|158002147|FG002|Overall Study|Transferred to rehab|0|||
49046128|NCT04405739|158002148|FG003|Overall Study|Transferred to rehab|1|||
49046129|NCT04405739|158002145|FG000|Overall Study|Pt. refused IP after 1 dose|0|||
49046130|NCT04405739|158002146|FG001|Overall Study|Pt. refused IP after 1 dose|0|||
49046131|NCT04405739|158002147|FG002|Overall Study|Pt. refused IP after 1 dose|0|||
49046132|NCT04405739|158002148|FG003|Overall Study|Pt. refused IP after 1 dose|1|||
49046133|NCT00434590|158002157|FG000|Overall Study|Administrative problems|5|||
49046134|NCT00434590|158002158|FG001|Overall Study|Administrative problems|5|||
49046135|NCT02169336|158002159|FG000|Overall Study|Lack of Efficacy|1|||
49046136|NCT02169336|158002160|FG001|Overall Study|Lack of Efficacy|1|||
49046137|NCT02169336|158002161|FG002|Overall Study|Lack of Efficacy|0|||
49046138|NCT02169336|158002159|FG000|Overall Study|Adverse Event|2|||
49046139|NCT02169336|158002160|FG001|Overall Study|Adverse Event|3|||
49046140|NCT02169336|158002161|FG002|Overall Study|Adverse Event|1|||
49046141|NCT02169336|158002159|FG000|Overall Study|Withdrawal by Subject|1|||
49046142|NCT02169336|158002160|FG001|Overall Study|Withdrawal by Subject|0|||
49046143|NCT02169336|158002161|FG002|Overall Study|Withdrawal by Subject|0|||
49046144|NCT02169336|158002159|FG000|Overall Study|Physician Decision|0|||
49046145|NCT02169336|158002160|FG001|Overall Study|Physician Decision|0|||
49046146|NCT02169336|158002161|FG002|Overall Study|Physician Decision|1|||
49046147|NCT02169336|158002159|FG000|Overall Study|Subject declined to continue dosing|0|||
49046148|NCT02169336|158002160|FG001|Overall Study|Subject declined to continue dosing|0|||
49046149|NCT02169336|158002161|FG002|Overall Study|Subject declined to continue dosing|1|||
49046150|NCT03234608|158002164|FG000|Overall Study|Lost to Follow-up|23|||
49046151|NCT03234608|158002165|FG001|Overall Study|Lost to Follow-up|21|||
49046152|NCT02028455|158002166|FG000|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
49046153|NCT02028455|158002167|FG001|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
49046154|NCT02028455|158002168|FG002|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
49046155|NCT02028455|158002169|FG003|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
49046156|NCT02028455|158002170|FG004|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
49046157|NCT02028455|158002171|FG005|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
49046158|NCT02028455|158002172|FG006|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|4|||
49046159|NCT02028455|158002173|FG007|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|17|||
49046160|NCT02028455|158002166|FG000|Treatment(T Cell Infusion) and Follow up|Death|4|||
49046161|NCT02028455|158002167|FG001|Treatment(T Cell Infusion) and Follow up|Death|9|||
49046162|NCT02028455|158002168|FG002|Treatment(T Cell Infusion) and Follow up|Death|3|||
49046163|NCT02028455|158002169|FG003|Treatment(T Cell Infusion) and Follow up|Death|5|||
49046164|NCT02028455|158002170|FG004|Treatment(T Cell Infusion) and Follow up|Death|3|||
49046165|NCT02028455|158002171|FG005|Treatment(T Cell Infusion) and Follow up|Death|2|||
49046166|NCT02028455|158002172|FG006|Treatment(T Cell Infusion) and Follow up|Death|0|||
49046167|NCT02028455|158002173|FG007|Treatment(T Cell Infusion) and Follow up|Death|40|||
49046168|NCT02028455|158002166|FG000|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
49046169|NCT02028455|158002167|FG001|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
49046170|NCT02028455|158002168|FG002|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
49046171|NCT02028455|158002169|FG003|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
49046172|NCT02028455|158002170|FG004|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
49046173|NCT02028455|158002171|FG005|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|1|||
49046174|NCT02028455|158002172|FG006|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
49046175|NCT02028455|158002173|FG007|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|2|||
49046176|NCT02028455|158002166|FG000|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
49046177|NCT02028455|158002167|FG001|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
49046178|NCT02028455|158002168|FG002|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|4|||
49046179|NCT02028455|158002169|FG003|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
49046180|NCT02028455|158002170|FG004|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
49046181|NCT02028455|158002171|FG005|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
49046182|NCT02028455|158002172|FG006|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
49046183|NCT02028455|158002173|FG007|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|61|||
49046184|NCT01148225|158002175|FG000|Overall Study|Other|185|||
49046185|NCT01120691|158002176|FG000|Overall Study|Adverse Event|59|||
49046186|NCT01120691|158002177|FG001|Overall Study|Adverse Event|67|||
49046187|NCT01120691|158002178|FG002|Overall Study|Adverse Event|47|||
49046188|NCT01120691|158002176|FG000|Overall Study|Subject withdrew consent|33|||
49046189|NCT01120691|158002177|FG001|Overall Study|Subject withdrew consent|50|||
49046190|NCT01120691|158002178|FG002|Overall Study|Subject withdrew consent|44|||
49046191|NCT01120691|158002176|FG000|Overall Study|Death|21|||
49046192|NCT01120691|158002177|FG001|Overall Study|Death|22|||
49046193|NCT01120691|158002178|FG002|Overall Study|Death|24|||
49046194|NCT01120691|158002176|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
49046195|NCT01120691|158002177|FG001|Overall Study|Unsatisfactory therapeutic effect|32|||
49046196|NCT01120691|158002178|FG002|Overall Study|Unsatisfactory therapeutic effect|38|||
49046197|NCT01120691|158002176|FG000|Overall Study|Administrative problems|15|||
49046198|NCT01120691|158002177|FG001|Overall Study|Administrative problems|8|||
49046199|NCT01120691|158002178|FG002|Overall Study|Administrative problems|9|||
49046200|NCT01120691|158002176|FG000|Overall Study|Protocol deviation|13|||
49046201|NCT01120691|158002177|FG001|Overall Study|Protocol deviation|12|||
49046202|NCT01120691|158002178|FG002|Overall Study|Protocol deviation|12|||
49046203|NCT01120691|158002176|FG000|Overall Study|Lost to Follow-up|5|||
49046204|NCT01120691|158002177|FG001|Overall Study|Lost to Follow-up|6|||
49046205|NCT01120691|158002178|FG002|Overall Study|Lost to Follow-up|4|||
49046206|NCT01120691|158002176|FG000|Overall Study|Abnormal test procedure result(s)|3|||
49046207|NCT01120691|158002177|FG001|Overall Study|Abnormal test procedure result(s)|2|||
49046208|NCT01120691|158002178|FG002|Overall Study|Abnormal test procedure result(s)|1|||
49046209|NCT01120691|158002176|FG000|Overall Study|Patient's inability to use the device|3|||
49046210|NCT01120691|158002177|FG001|Overall Study|Patient's inability to use the device|1|||
49046211|NCT01120691|158002178|FG002|Overall Study|Patient's inability to use the device|0|||
49046212|NCT01120691|158002176|FG000|Overall Study|Abnormal laboratory value(s)|1|||
49046213|NCT01120691|158002177|FG001|Overall Study|Abnormal laboratory value(s)|3|||
49046214|NCT01120691|158002178|FG002|Overall Study|Abnormal laboratory value(s)|4|||
49046215|NCT01588548|158002181|FG000|Overall Study|Withdrawal by Subject|0|||
49046216|NCT01588548|158002182|FG001|Overall Study|Withdrawal by Subject|1|||
49046217|NCT01588548|158002183|FG002|Overall Study|Withdrawal by Subject|1|||
49046218|NCT01588548|158002184|FG003|Overall Study|Withdrawal by Subject|1|||
49046219|NCT01588548|158002185|FG004|Overall Study|Withdrawal by Subject|2|||
49046220|NCT01588548|158002186|FG005|Overall Study|Withdrawal by Subject|3|||
49046221|NCT01588548|158002181|FG000|Overall Study|Adverse Event|0|||
49046222|NCT01588548|158002182|FG001|Overall Study|Adverse Event|0|||
49046223|NCT01588548|158002183|FG002|Overall Study|Adverse Event|1|||
49046224|NCT01588548|158002184|FG003|Overall Study|Adverse Event|2|||
49046225|NCT01588548|158002185|FG004|Overall Study|Adverse Event|1|||
49046226|NCT01588548|158002186|FG005|Overall Study|Adverse Event|0|||
49046227|NCT01588548|158002181|FG000|Overall Study|Condition Under Investigation Worsened|3|||
49046228|NCT01588548|158002182|FG001|Overall Study|Condition Under Investigation Worsened|6|||
49046229|NCT01588548|158002183|FG002|Overall Study|Condition Under Investigation Worsened|4|||
49046230|NCT01588548|158002184|FG003|Overall Study|Condition Under Investigation Worsened|4|||
49046231|NCT01588548|158002185|FG004|Overall Study|Condition Under Investigation Worsened|3|||
49046232|NCT01588548|158002186|FG005|Overall Study|Condition Under Investigation Worsened|3|||
49046233|NCT00787605|158002193|FG000|Overall Study|Administrative Problems|3|||
49046234|NCT00787605|158002194|FG001|Overall Study|Administrative Problems|0|||
49046235|NCT00787605|158002193|FG000|Overall Study|Adverse Event|14|||
49046236|NCT00787605|158002194|FG001|Overall Study|Adverse Event|25|||
49046237|NCT00787605|158002193|FG000|Overall Study|Lost to Follow-up|3|||
49046238|NCT00787605|158002194|FG001|Overall Study|Lost to Follow-up|6|||
49046239|NCT00787605|158002193|FG000|Overall Study|Protocol Violation|7|||
49046240|NCT00787605|158002194|FG001|Overall Study|Protocol Violation|3|||
49046241|NCT00787605|158002193|FG000|Overall Study|Withdrawal by Subject|6|||
49046242|NCT00787605|158002194|FG001|Overall Study|Withdrawal by Subject|13|||
49046243|NCT00787605|158002193|FG000|Overall Study|Lack of Efficacy|13|||
49046244|NCT00787605|158002194|FG001|Overall Study|Lack of Efficacy|9|||
49046245|NCT00089973|158002195|FG000|Overall Study|Adverse Event|3|||
49046246|NCT00089973|158002195|FG000|Overall Study|Withdrawal by Subject|1|||
49046247|NCT00089973|158002195|FG000|Overall Study|Disease progression|45|||
49046248|NCT00089973|158002195|FG000|Overall Study|Death|1|||
49046249|NCT01109849|158003800|FG000|Initial Randomization: ADHD Treatment|Lost to Follow-up|9|||
49046250|NCT01109849|158003801|FG001|Initial Randomization: ADHD Treatment|Lost to Follow-up|35|||
49046251|NCT01109849|158003802|FG002|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
49046252|NCT01109849|158003803|FG003|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
49046253|NCT01109849|158003804|FG004|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
49046254|NCT01109849|158003800|FG000|Initial Randomization: ADHD Treatment|Protocol Violation|1|||
49046255|NCT01109849|158003801|FG001|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
49046256|NCT01109849|158003802|FG002|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
49046257|NCT01109849|158003803|FG003|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
49046258|NCT01109849|158003804|FG004|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
49046259|NCT01109849|158003800|FG000|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6|||
49046260|NCT01109849|158003801|FG001|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7|||
49046261|NCT01109849|158003802|FG002|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
49046262|NCT01109849|158003803|FG003|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
49046263|NCT01109849|158003804|FG004|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
49046264|NCT01109849|158003800|FG000|Initial Randomization: ADHD Treatment|move away|2|||
49046265|NCT01109849|158003801|FG001|Initial Randomization: ADHD Treatment|move away|7|||
49046266|NCT01109849|158003802|FG002|Initial Randomization: ADHD Treatment|move away|0|||
49046267|NCT01109849|158003803|FG003|Initial Randomization: ADHD Treatment|move away|0|||
49046268|NCT01109849|158003804|FG004|Initial Randomization: ADHD Treatment|move away|0|||
49046269|NCT01109849|158003800|FG000|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
49046270|NCT01109849|158003801|FG001|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
49046271|NCT01109849|158003802|FG002|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
49046272|NCT01109849|158003803|FG003|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
49046273|NCT01109849|158003804|FG004|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
49046274|NCT01109849|158003800|FG000|Adaptive Randomization: Weight Recovery|moved away|0|||
49046275|NCT01109849|158003801|FG001|Adaptive Randomization: Weight Recovery|moved away|0|||
49046276|NCT01109849|158003802|FG002|Adaptive Randomization: Weight Recovery|moved away|0|||
49046277|NCT01109849|158003803|FG003|Adaptive Randomization: Weight Recovery|moved away|2|||
49046278|NCT01109849|158003804|FG004|Adaptive Randomization: Weight Recovery|moved away|0|||
49046279|NCT02219009|158003808|FG000|Overall Study|Withdrawal by Subject|5|||
49046280|NCT02219009|158003809|FG001|Overall Study|Withdrawal by Subject|1|||
49046281|NCT02219009|158003808|FG000|Overall Study|Adverse Event|2|||
49046282|NCT02219009|158003809|FG001|Overall Study|Adverse Event|4|||
49046283|NCT02219009|158003808|FG000|Overall Study|Lost to Follow-up|2|||
49046284|NCT02219009|158003809|FG001|Overall Study|Lost to Follow-up|2|||
49046285|NCT02219009|158003808|FG000|Overall Study|Protocol deviation|1|||
49046286|NCT02219009|158003809|FG001|Overall Study|Protocol deviation|0|||
49046287|NCT02219009|158003808|FG000|Overall Study|Physician Decision|0|||
49046288|NCT02219009|158003809|FG001|Overall Study|Physician Decision|1|||
49046289|NCT02488109|158003810|FG000|Treatment in Hospital|Withdrawal by Subject|0|||
49046290|NCT02488109|158003811|FG001|Treatment in Hospital|Withdrawal by Subject|5|||
49046291|NCT02488109|158003810|FG000|12-month Follow-Up|Lost to Follow-up|4|||
49046292|NCT02488109|158003811|FG001|12-month Follow-Up|Lost to Follow-up|7|||
49046293|NCT05776901|158003814|FG000|Overall Study|Covid delays and grant termination without continuation.|3|||
49046294|NCT00559637|158003815|FG000|Overall Study|Adverse Event|22|||
49046295|NCT00559637|158003815|FG000|Overall Study|Withdrawal by Subject|4|||
49046296|NCT00559637|158003815|FG000|Overall Study|Protocol Violation|6|||
49046297|NCT00559637|158003815|FG000|Overall Study|Withdrawal criteria fulfilled|4|||
49046298|NCT00559637|158003815|FG000|Overall Study|Failure to return|6|||
49046299|NCT00559637|158003815|FG000|Overall Study|Insufficient response|3|||
49046300|NCT00559637|158003815|FG000|Overall Study|Started requiring dialysis after month 7|2|||
49046301|NCT00559637|158003815|FG000|Overall Study|Suspected lung cancer|1|||
49046302|NCT00559637|158003815|FG000|Overall Study|Participation in another study|1|||
49046303|NCT00559637|158003815|FG000|Overall Study|Delayed administration of C.E.R.A|1|||
49046304|NCT00559637|158003815|FG000|Overall Study|Change of center|1|||
49046305|NCT00559637|158003815|FG000|Overall Study|Change of home|1|||
49046306|NCT00559637|158003815|FG000|Overall Study|Inclusion or exclusion criteria violated|2|||
49046307|NCT01117987|158003816|FG000|Overall Study|Protocol deviation|0|||
49046308|NCT01117987|158003817|FG001|Overall Study|Protocol deviation|1|||
49046309|NCT01117987|158003816|FG000|Overall Study|Subject no longer requires study drug|1|||
49046310|NCT01117987|158003817|FG001|Overall Study|Subject no longer requires study drug|0|||
49046311|NCT01117987|158003816|FG000|Overall Study|Lost to Follow-up|1|||
49046312|NCT01117987|158003817|FG001|Overall Study|Lost to Follow-up|1|||
49046313|NCT01117987|158003816|FG000|Overall Study|Abnormal test procedure result|2|||
49046314|NCT01117987|158003817|FG001|Overall Study|Abnormal test procedure result|0|||
49046315|NCT01117987|158003816|FG000|Overall Study|Lack of Efficacy|3|||
49046316|NCT01117987|158003817|FG001|Overall Study|Lack of Efficacy|4|||
49046317|NCT01117987|158003816|FG000|Overall Study|Death|5|||
49046318|NCT01117987|158003817|FG001|Overall Study|Death|10|||
49046319|NCT01117987|158003816|FG000|Overall Study|Withdrawal by Subject|5|||
49046320|NCT01117987|158003817|FG001|Overall Study|Withdrawal by Subject|10|||
49046321|NCT01117987|158003816|FG000|Overall Study|Adverse Event|19|||
49046322|NCT01117987|158003817|FG001|Overall Study|Adverse Event|26|||
49046323|NCT01117987|158003816|FG000|Overall Study|Administrative problems|25|||
49046324|NCT01117987|158003817|FG001|Overall Study|Administrative problems|22|||
49046325|NCT00676650|158003818|FG000|Overall Study|Death|45|||
49046326|NCT00676650|158003819|FG001|Overall Study|Death|14|||
49046327|NCT00676650|158003818|FG000|Overall Study|Adverse Event|159|||
49046328|NCT00676650|158003819|FG001|Overall Study|Adverse Event|21|||
49046329|NCT00676650|158003818|FG000|Overall Study|Global deterioration of health status|66|||
49046330|NCT00676650|158003819|FG001|Overall Study|Global deterioration of health status|31|||
49046331|NCT00676650|158003818|FG000|Overall Study|Lost to Follow-up|0|||
49046332|NCT00676650|158003819|FG001|Overall Study|Lost to Follow-up|1|||
49046333|NCT00676650|158003818|FG000|Overall Study|Objective progression or relapse|189|||
49046334|NCT00676650|158003819|FG001|Overall Study|Objective progression or relapse|140|||
49046335|NCT00676650|158003818|FG000|Overall Study|Other|14|||
49046336|NCT00676650|158003819|FG001|Overall Study|Other|10|||
49046337|NCT00676650|158003818|FG000|Overall Study|Protocol Violation|3|||
49046338|NCT00676650|158003819|FG001|Overall Study|Protocol Violation|1|||
49046339|NCT00676650|158003818|FG000|Overall Study|Study terminated by sponsor|57|||
49046340|NCT00676650|158003819|FG001|Overall Study|Study terminated by sponsor|43|||
49046341|NCT00676650|158003818|FG000|Overall Study|Withdrawal by Subject|48|||
49046342|NCT00676650|158003819|FG001|Overall Study|Withdrawal by Subject|24|||
49046343|NCT00676650|158003818|FG000|Overall Study|Randomized but not treated|3|||
49046344|NCT00676650|158003819|FG001|Overall Study|Randomized but not treated|4|||
49046345|NCT01802216|158003820|FG000|4 Month Visit|Participant did not show to visit|3|||
49046346|NCT01802216|158003821|FG001|4 Month Visit|Participant did not show to visit|4|||
49046347|NCT01802216|158003820|FG000|8 Month Visit|Participant did not show to visit|3|||
49046348|NCT01802216|158003821|FG001|8 Month Visit|Participant did not show to visit|5|||
49046349|NCT01802216|158003820|FG000|12 Month Visit|Participant did not show to visit|3|||
49046350|NCT01802216|158003821|FG001|12 Month Visit|Participant did not show to visit|4|||
49046351|NCT00683592|158003825|FG000|Overall Study|Adverse Event|12|||
49046352|NCT00683592|158003826|FG001|Overall Study|Adverse Event|4|||
49046353|NCT00683592|158003825|FG000|Overall Study|Withdrawal by Subject|11|||
49046354|NCT00683592|158003826|FG001|Overall Study|Withdrawal by Subject|11|||
49046355|NCT00683592|158003825|FG000|Overall Study|Lost to Follow-up|17|||
49046356|NCT00683592|158003826|FG001|Overall Study|Lost to Follow-up|17|||
49046357|NCT00683592|158003825|FG000|Overall Study|Lack of Efficacy|3|||
49046358|NCT00683592|158003826|FG001|Overall Study|Lack of Efficacy|7|||
49046359|NCT00683592|158003825|FG000|Overall Study|Physician Decision|0|||
49046360|NCT00683592|158003826|FG001|Overall Study|Physician Decision|1|||
49046361|NCT00683592|158003825|FG000|Overall Study|Non-compliance|3|||
49046362|NCT00683592|158003826|FG001|Overall Study|Non-compliance|5|||
49046363|NCT00683592|158003825|FG000|Overall Study|Other|1|||
49046364|NCT00683592|158003826|FG001|Overall Study|Other|1|||
49046365|NCT05258630|158003827|FG000|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
49046366|NCT05258630|158003828|FG001|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
49046367|NCT05258630|158003827|FG000|Overall Study|Lost to Follow-up|0|||
49046368|NCT05258630|158003828|FG001|Overall Study|Lost to Follow-up|2|||
49046369|NCT03303417|158003837|FG000|Overall Study|Withdrawal by Subject|1|||
49046370|NCT03303417|158003838|FG001|Overall Study|Withdrawal by Subject|1|||
49046371|NCT02697617|158003841|FG000|Overall Study|Withdrawal by Subject|0|||
49046372|NCT02697617|158003842|FG001|Overall Study|Withdrawal by Subject|2|||
49046373|NCT02697617|158003841|FG000|Overall Study|Pregnancy|1|||
49046374|NCT02697617|158003842|FG001|Overall Study|Pregnancy|0|||
49046375|NCT02274558|158003843|FG000|Overall Study|Adverse Event|2|||
49046376|NCT02274558|158003844|FG001|Overall Study|Adverse Event|4|||
49046377|NCT02274558|158003845|FG002|Overall Study|Adverse Event|2|||
49046378|NCT02274558|158003843|FG000|Overall Study|Non-compliance|2|||
49046379|NCT02274558|158003844|FG001|Overall Study|Non-compliance|1|||
49046380|NCT02274558|158003845|FG002|Overall Study|Non-compliance|0|||
49046381|NCT02274558|158003843|FG000|Overall Study|Withdrawal by Subject|1|||
49046382|NCT02274558|158003844|FG001|Overall Study|Withdrawal by Subject|5|||
49002970|NCT03514121|157848282|FG008|Overall Study|Lost to Follow-up|1|||
49002971|NCT03514121|157848283|FG009|Overall Study|Lost to Follow-up|0|||
49002972|NCT03514121|157848274|FG000|Overall Study|Adverse Event|0|||
49002973|NCT03514121|157848275|FG001|Overall Study|Adverse Event|0|||
49002974|NCT03514121|157848276|FG002|Overall Study|Adverse Event|0|||
49002975|NCT03514121|157848277|FG003|Overall Study|Adverse Event|0|||
49002976|NCT03514121|157848278|FG004|Overall Study|Adverse Event|0|||
49002977|NCT03514121|157848279|FG005|Overall Study|Adverse Event|0|||
49002978|NCT03514121|157848280|FG006|Overall Study|Adverse Event|1|||
49002979|NCT03514121|157848281|FG007|Overall Study|Adverse Event|0|||
49002980|NCT03514121|157848282|FG008|Overall Study|Adverse Event|0|||
49002981|NCT03514121|157848283|FG009|Overall Study|Adverse Event|0|||
49002982|NCT03514121|157848274|FG000|Overall Study|Other|0|||
49002983|NCT03514121|157848275|FG001|Overall Study|Other|1|||
49002984|NCT03514121|157848276|FG002|Overall Study|Other|1|||
49002985|NCT03514121|157848277|FG003|Overall Study|Other|0|||
49002986|NCT03514121|157848278|FG004|Overall Study|Other|1|||
49002987|NCT03514121|157848279|FG005|Overall Study|Other|2|||
49002988|NCT03514121|157848280|FG006|Overall Study|Other|3|||
49002989|NCT03514121|157848281|FG007|Overall Study|Other|2|||
49002990|NCT03514121|157848282|FG008|Overall Study|Other|7|||
49002991|NCT03514121|157848283|FG009|Overall Study|Other|3|||
49002992|NCT03514121|157848274|FG000|Overall Study|Study termination by Sponsor|0|||
49002993|NCT03514121|157848275|FG001|Overall Study|Study termination by Sponsor|0|||
49002994|NCT03514121|157848276|FG002|Overall Study|Study termination by Sponsor|0|||
49002995|NCT03514121|157848277|FG003|Overall Study|Study termination by Sponsor|0|||
49002996|NCT03514121|157848278|FG004|Overall Study|Study termination by Sponsor|0|||
49002997|NCT03514121|157848279|FG005|Overall Study|Study termination by Sponsor|0|||
49002998|NCT03514121|157848280|FG006|Overall Study|Study termination by Sponsor|0|||
49002999|NCT03514121|157848281|FG007|Overall Study|Study termination by Sponsor|0|||
49003000|NCT03514121|157848282|FG008|Overall Study|Study termination by Sponsor|11|||
49003001|NCT03514121|157848283|FG009|Overall Study|Study termination by Sponsor|3|||
49003002|NCT03514121|157848274|FG000|Overall Study|Investigator decision|0|||
49003003|NCT03514121|157848275|FG001|Overall Study|Investigator decision|0|||
49003004|NCT03514121|157848276|FG002|Overall Study|Investigator decision|0|||
49003005|NCT03514121|157848277|FG003|Overall Study|Investigator decision|0|||
49003006|NCT03514121|157848278|FG004|Overall Study|Investigator decision|0|||
49003007|NCT03514121|157848279|FG005|Overall Study|Investigator decision|0|||
49003008|NCT03514121|157848280|FG006|Overall Study|Investigator decision|0|||
49003009|NCT03514121|157848281|FG007|Overall Study|Investigator decision|0|||
49003010|NCT03514121|157848282|FG008|Overall Study|Investigator decision|1|||
49003011|NCT03514121|157848283|FG009|Overall Study|Investigator decision|0|||
49003012|NCT05553600|157848284|FG000|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|4|||
49003013|NCT05553600|157848285|FG001|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|8|||
49003014|NCT05553600|157848286|FG002|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|6|||
49003015|NCT05553600|157848287|FG003|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|7|||
49003016|NCT05553600|157848284|FG000|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
49003017|NCT05553600|157848285|FG001|Prior to First Menstrual Cycle Starting|Protocol Violation|1|||
49003018|NCT05553600|157848286|FG002|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
49003019|NCT05553600|157848287|FG003|Prior to First Menstrual Cycle Starting|Protocol Violation|2|||
49003020|NCT05553600|157848284|FG000|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
49003021|NCT05553600|157848285|FG001|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
49003022|NCT05553600|157848286|FG002|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
49003023|NCT05553600|157848287|FG003|Prior to First Menstrual Cycle Starting|Physician Decision|1|||
49003024|NCT05553600|157848284|FG000|Prior to First Menstrual Cycle Starting|Lost to Follow-up|16|||
49003025|NCT05553600|157848285|FG001|Prior to First Menstrual Cycle Starting|Lost to Follow-up|13|||
49003026|NCT05553600|157848286|FG002|Prior to First Menstrual Cycle Starting|Lost to Follow-up|12|||
49003027|NCT05553600|157848287|FG003|Prior to First Menstrual Cycle Starting|Lost to Follow-up|10|||
49003028|NCT05553600|157848284|FG000|Prior to First Menstrual Cycle Starting|Other various reasons|7|||
49003029|NCT05553600|157848285|FG001|Prior to First Menstrual Cycle Starting|Other various reasons|8|||
49003030|NCT05553600|157848286|FG002|Prior to First Menstrual Cycle Starting|Other various reasons|3|||
49003031|NCT05553600|157848287|FG003|Prior to First Menstrual Cycle Starting|Other various reasons|2|||
49003032|NCT05553600|157848284|FG000|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
49003033|NCT05553600|157848285|FG001|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
49003034|NCT05553600|157848286|FG002|Prior to Second Menstrual Cycle Starting|Adverse Event|1|||
49003035|NCT05553600|157848287|FG003|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
49003036|NCT05553600|157848284|FG000|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
49003037|NCT05553600|157848285|FG001|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
49003038|NCT05553600|157848286|FG002|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|4|||
49003039|NCT05553600|157848287|FG003|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|1|||
49003040|NCT05553600|157848284|FG000|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
49003041|NCT05553600|157848285|FG001|Prior to Second Menstrual Cycle Starting|Protocol Violation|3|||
49003042|NCT05553600|157848286|FG002|Prior to Second Menstrual Cycle Starting|Protocol Violation|0|||
49003043|NCT05553600|157848287|FG003|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
49003044|NCT05553600|157848284|FG000|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
49003045|NCT05553600|157848285|FG001|Prior to Second Menstrual Cycle Starting|Physician Decision|4|||
49003046|NCT05553600|157848286|FG002|Prior to Second Menstrual Cycle Starting|Physician Decision|1|||
49003047|NCT05553600|157848287|FG003|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
49003048|NCT05553600|157848284|FG000|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|5|||
49003049|NCT05553600|157848285|FG001|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|6|||
49003050|NCT05553600|157848286|FG002|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|4|||
49003051|NCT05553600|157848287|FG003|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|3|||
49003052|NCT05553600|157848284|FG000|Prior to Second Menstrual Cycle Starting|Other various reasons|4|||
49003053|NCT05553600|157848285|FG001|Prior to Second Menstrual Cycle Starting|Other various reasons|7|||
49003054|NCT05553600|157848286|FG002|Prior to Second Menstrual Cycle Starting|Other various reasons|3|||
49003055|NCT05553600|157848287|FG003|Prior to Second Menstrual Cycle Starting|Other various reasons|8|||
49003056|NCT05553600|157848284|FG000|After Second Menstrual Cycle Began|Adverse Event|1|||
49003057|NCT05553600|157848285|FG001|After Second Menstrual Cycle Began|Adverse Event|0|||
49003058|NCT05553600|157848286|FG002|After Second Menstrual Cycle Began|Adverse Event|0|||
49003059|NCT05553600|157848287|FG003|After Second Menstrual Cycle Began|Adverse Event|0|||
49003060|NCT00833976|157848288|FG000|Overall Study|Withdrawal by Subject|5|||
49003061|NCT00833976|157848288|FG000|Overall Study|Lost to Follow-up|4|||
49003062|NCT00833976|157848288|FG000|Overall Study|Did not meet eligibility criteria|41|||
49003063|NCT00833976|157848288|FG000|Overall Study|Physician Decision|1|||
49003064|NCT03911960|157848289|FG000|Overall Study|Lost to Follow-up|5|||
49003065|NCT03911960|157848290|FG001|Overall Study|Lost to Follow-up|3|||
49003066|NCT01956123|157848291|FG000|COS Cycle 2|Protocol Violation|8|||
49003067|NCT01956123|157848292|FG001|COS Cycle 2|Protocol Violation|3|||
49003068|NCT01956123|157848293|FG002|COS Cycle 2|Protocol Violation|0|||
49003069|NCT01956123|157848294|FG003|COS Cycle 2|Protocol Violation|0|||
49003070|NCT01956123|157848291|FG000|COS Cycle 2|Adverse Event|3|||
49003071|NCT01956123|157848292|FG001|COS Cycle 2|Adverse Event|4|||
49003072|NCT01956123|157848293|FG002|COS Cycle 2|Adverse Event|0|||
49003073|NCT01956123|157848294|FG003|COS Cycle 2|Adverse Event|0|||
49003074|NCT01956123|157848291|FG000|COS Cycle 2|Personal Reasons|2|||
49003075|NCT01956123|157848292|FG001|COS Cycle 2|Personal Reasons|0|||
49003076|NCT01956123|157848293|FG002|COS Cycle 2|Personal Reasons|0|||
49003077|NCT01956123|157848294|FG003|COS Cycle 2|Personal Reasons|0|||
49003078|NCT01956123|157848291|FG000|COS Cycle 2|Withdrawal by Subject|1|||
49003079|NCT01956123|157848292|FG001|COS Cycle 2|Withdrawal by Subject|0|||
49003080|NCT01956123|157848293|FG002|COS Cycle 2|Withdrawal by Subject|0|||
49003081|NCT01956123|157848294|FG003|COS Cycle 2|Withdrawal by Subject|0|||
49003082|NCT01956123|157848291|FG000|COS Cycle 3|Protocol Violation|0|||
49003083|NCT01956123|157848292|FG001|COS Cycle 3|Protocol Violation|0|||
49003084|NCT01956123|157848293|FG002|COS Cycle 3|Protocol Violation|2|||
49003085|NCT01956123|157848294|FG003|COS Cycle 3|Protocol Violation|1|||
49003086|NCT01956123|157848291|FG000|COS Cycle 3|Adverse Event|0|||
49003087|NCT01956123|157848292|FG001|COS Cycle 3|Adverse Event|0|||
49003088|NCT01956123|157848293|FG002|COS Cycle 3|Adverse Event|3|||
49003089|NCT01956123|157848294|FG003|COS Cycle 3|Adverse Event|0|||
49003090|NCT01956123|157848291|FG000|COS Cycle 3|Personal Reasons|0|||
49003091|NCT01956123|157848292|FG001|COS Cycle 3|Personal Reasons|0|||
49003092|NCT01956123|157848293|FG002|COS Cycle 3|Personal Reasons|1|||
49003093|NCT01956123|157848294|FG003|COS Cycle 3|Personal Reasons|0|||
49003094|NCT01956123|157848291|FG000|COS Cycle 3|Withdrawal by Subject|0|||
49003095|NCT01956123|157848292|FG001|COS Cycle 3|Withdrawal by Subject|0|||
49003096|NCT01956123|157848293|FG002|COS Cycle 3|Withdrawal by Subject|0|||
49003097|NCT01956123|157848294|FG003|COS Cycle 3|Withdrawal by Subject|1|||
49003098|NCT04930536|157848295|FG000|Overall Study|Adverse Event|1|||
49003099|NCT04930536|157848296|FG001|Overall Study|Adverse Event|0|||
49003100|NCT04930536|157848295|FG000|Overall Study|Disease Progression|2|||
49003101|NCT04930536|157848296|FG001|Overall Study|Disease Progression|0|||
49003102|NCT04930536|157848295|FG000|Overall Study|Patient Decision|4|||
49003103|NCT04930536|157848296|FG001|Overall Study|Patient Decision|2|||
49003104|NCT04930536|157848295|FG000|Overall Study|Death, Serious Adverse Event, Screen Failure|1|||
49003105|NCT04930536|157848296|FG001|Overall Study|Death, Serious Adverse Event, Screen Failure|3|||
49003106|NCT02803138|157848299|FG000|Overall Study|Failure to return|38|||
49003107|NCT02803138|157848299|FG000|Overall Study|Insufficient virological response|2|||
49003108|NCT02803138|157848299|FG000|Overall Study|Withdrawn consent|1|||
49003109|NCT02803138|157848299|FG000|Overall Study|Death|1|||
49003110|NCT02803138|157848299|FG000|Overall Study|Other, not specified|28|||
49003111|NCT01432600|157848300|FG000|Overall Study|Rapid PD, allocated intv. not rec'd|0|||
49003112|NCT01432600|157848301|FG001|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
49003113|NCT01432600|157848302|FG002|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
49003114|NCT00398632|157848303|FG000|Overall Study|Withdrawal by Subject|1|||
49003115|NCT00398632|157848303|FG000|Overall Study|Lack of Efficacy|1|||
49003116|NCT00424515|157848304|FG000|Overall Study|Progressive Disease|10|||
49003117|NCT00424515|157848305|FG001|Overall Study|Progressive Disease|11|||
49003118|NCT00424515|157848304|FG000|Overall Study|Adverse Event|0|||
49003119|NCT00424515|157848305|FG001|Overall Study|Adverse Event|1|||
49003120|NCT00424515|157848304|FG000|Overall Study|Intercurrent Illness|0|||
49003121|NCT00424515|157848305|FG001|Overall Study|Intercurrent Illness|1|||
49003122|NCT00424515|157848304|FG000|Overall Study|Withdrawal by Subject|1|||
49003123|NCT00424515|157848305|FG001|Overall Study|Withdrawal by Subject|0|||
49003124|NCT03725722|157848306|FG000|Overall Study|Lack of Efficacy|2|||
49003125|NCT03725722|157848307|FG001|Overall Study|Lack of Efficacy|1|||
49003126|NCT03725722|157848308|FG002|Overall Study|Lack of Efficacy|2|||
49003127|NCT03725722|157848309|FG003|Overall Study|Lack of Efficacy|0|||
49003128|NCT03725722|157848310|FG004|Overall Study|Lack of Efficacy|2|||
49003129|NCT03725722|157848306|FG000|Overall Study|Adverse Event|2|||
49003130|NCT03725722|157848307|FG001|Overall Study|Adverse Event|2|||
49003131|NCT03725722|157848308|FG002|Overall Study|Adverse Event|1|||
49003132|NCT03725722|157848309|FG003|Overall Study|Adverse Event|0|||
49003133|NCT03725722|157848310|FG004|Overall Study|Adverse Event|6|||
49003134|NCT03725722|157848306|FG000|Overall Study|Withdrawal by Subject|4|||
49003135|NCT03725722|157848307|FG001|Overall Study|Withdrawal by Subject|1|||
49003136|NCT03725722|157848308|FG002|Overall Study|Withdrawal by Subject|0|||
49003137|NCT03725722|157848309|FG003|Overall Study|Withdrawal by Subject|4|||
49003138|NCT03725722|157848310|FG004|Overall Study|Withdrawal by Subject|4|||
49003139|NCT03725722|157848306|FG000|Overall Study|Lost to Follow-up|3|||
49003140|NCT03725722|157848307|FG001|Overall Study|Lost to Follow-up|1|||
49003141|NCT03725722|157848308|FG002|Overall Study|Lost to Follow-up|2|||
49003142|NCT03725722|157848309|FG003|Overall Study|Lost to Follow-up|2|||
49003143|NCT03725722|157848310|FG004|Overall Study|Lost to Follow-up|1|||
49003144|NCT03725722|157848306|FG000|Overall Study|Personal reasons|0|||
49003145|NCT03725722|157848307|FG001|Overall Study|Personal reasons|0|||
49003146|NCT03725722|157848308|FG002|Overall Study|Personal reasons|1|||
49003147|NCT03725722|157848309|FG003|Overall Study|Personal reasons|0|||
49003148|NCT03725722|157848310|FG004|Overall Study|Personal reasons|1|||
49003149|NCT03725722|157848306|FG000|Overall Study|COVID-19 situation|0|||
49003150|NCT03725722|157848307|FG001|Overall Study|COVID-19 situation|1|||
49003151|NCT03725722|157848308|FG002|Overall Study|COVID-19 situation|0|||
49003152|NCT03725722|157848309|FG003|Overall Study|COVID-19 situation|0|||
49003153|NCT03725722|157848310|FG004|Overall Study|COVID-19 situation|0|||
49003154|NCT01777191|157848311|FG000|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2|||
49003155|NCT01777191|157848312|FG001|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1|||
49003156|NCT01777191|157848311|FG000|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
49003157|NCT01777191|157848312|FG001|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
49003158|NCT01777191|157848311|FG000|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1|||
49003159|NCT01777191|157848312|FG001|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2|||
49003160|NCT01777191|157848311|FG000|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0|||
49003161|NCT01777191|157848312|FG001|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3|||
49003162|NCT01777191|157848311|FG000|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
49003163|NCT01777191|157848312|FG001|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
49003164|NCT01777191|157848311|FG000|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1|||
49003165|NCT01777191|157848312|FG001|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0|||
49003166|NCT01777191|157848311|FG000|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
49003167|NCT01777191|157848312|FG001|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
49003168|NCT01777191|157848311|FG000|Safety Extension Per (Week 12-Week 48)|Death|0|||
49003169|NCT01777191|157848312|FG001|Safety Extension Per (Week 12-Week 48)|Death|1|||
49003170|NCT01777191|157848311|FG000|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
49003171|NCT01777191|157848312|FG001|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
49003172|NCT01777191|157848311|FG000|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1|||
49003173|NCT01777191|157848312|FG001|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2|||
49003174|NCT01777191|157848311|FG000|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1|||
49003175|NCT01777191|157848312|FG001|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3|||
49003176|NCT04723173|157848313|FG000|Subjective Listening Effort Scaling|One participant was not able to perform the test as required by the study protocol.|1|||
49003177|NCT02996448|157848314|FG000|Overall Study|Study terminated due to adverse effects|3|||
49003178|NCT04465916|157848315|FG000|Overall Study|Withdrawal by Subject|0|||
49003179|NCT04465916|157848316|FG001|Overall Study|Withdrawal by Subject|1|||
49003180|NCT03286400|157848319|FG000|Overall Study|Death|10|||
49003181|NCT03286400|157848319|FG000|Overall Study|Lost to Follow-up|10|||
49003182|NCT03286400|157848319|FG000|Overall Study|Physician Decision|1|||
49003183|NCT03286400|157848319|FG000|Overall Study|Scheduling difficulty|4|||
49003184|NCT00791154|157848326|FG000|Overall Study|Noncompliance|0|||
49003185|NCT00791154|157848327|FG001|Overall Study|Noncompliance|1|||
49003186|NCT00791154|157848328|FG002|Overall Study|Noncompliance|0|||
49003187|NCT00791154|157848329|FG003|Overall Study|Noncompliance|0|||
49003188|NCT00791154|157848330|FG004|Overall Study|Noncompliance|1|||
49003189|NCT00791154|157848331|FG005|Overall Study|Noncompliance|1|||
49003190|NCT00791154|157848332|FG006|Overall Study|Noncompliance|1|||
49003191|NCT00791154|157848326|FG000|Overall Study|Adverse Event|0|||
49003192|NCT00791154|157848327|FG001|Overall Study|Adverse Event|0|||
49003193|NCT00791154|157848328|FG002|Overall Study|Adverse Event|0|||
49003194|NCT00791154|157848329|FG003|Overall Study|Adverse Event|0|||
49003195|NCT00791154|157848330|FG004|Overall Study|Adverse Event|2|||
49003196|NCT00791154|157848331|FG005|Overall Study|Adverse Event|0|||
49003197|NCT00791154|157848332|FG006|Overall Study|Adverse Event|1|||
49003198|NCT00791154|157848326|FG000|Overall Study|Full Consent withdrawn|1|||
49003199|NCT00791154|157848327|FG001|Overall Study|Full Consent withdrawn|3|||
49003200|NCT00791154|157848328|FG002|Overall Study|Full Consent withdrawn|0|||
49003201|NCT00791154|157848329|FG003|Overall Study|Full Consent withdrawn|0|||
49003202|NCT00791154|157848330|FG004|Overall Study|Full Consent withdrawn|1|||
49003203|NCT00791154|157848331|FG005|Overall Study|Full Consent withdrawn|3|||
49003204|NCT00791154|157848332|FG006|Overall Study|Full Consent withdrawn|1|||
49003205|NCT00791154|157848326|FG000|Overall Study|Lost to Follow-up|0|||
49003206|NCT00791154|157848327|FG001|Overall Study|Lost to Follow-up|0|||
49003207|NCT00791154|157848328|FG002|Overall Study|Lost to Follow-up|0|||
49003208|NCT00791154|157848329|FG003|Overall Study|Lost to Follow-up|1|||
49003209|NCT00791154|157848330|FG004|Overall Study|Lost to Follow-up|2|||
49003210|NCT00791154|157848331|FG005|Overall Study|Lost to Follow-up|0|||
49003211|NCT00791154|157848332|FG006|Overall Study|Lost to Follow-up|4|||
49003212|NCT00791154|157848326|FG000|Overall Study|Death|5|||
49003213|NCT00791154|157848327|FG001|Overall Study|Death|4|||
49003214|NCT00791154|157848328|FG002|Overall Study|Death|4|||
49003215|NCT00791154|157848329|FG003|Overall Study|Death|7|||
49003216|NCT00791154|157848330|FG004|Overall Study|Death|54|||
49003217|NCT00791154|157848331|FG005|Overall Study|Death|54|||
49003218|NCT00791154|157848332|FG006|Overall Study|Death|52|||
49003219|NCT00791154|157848326|FG000|Overall Study|Other event|0|||
49003220|NCT00791154|157848327|FG001|Overall Study|Other event|0|||
49003221|NCT00791154|157848328|FG002|Overall Study|Other event|2|||
49003222|NCT00791154|157848329|FG003|Overall Study|Other event|0|||
49003223|NCT00791154|157848330|FG004|Overall Study|Other event|2|||
49003224|NCT00791154|157848331|FG005|Overall Study|Other event|4|||
49003225|NCT00791154|157848332|FG006|Overall Study|Other event|2|||
49003226|NCT04840901|157848333|FG000|Overall Study|Lost to Follow-up|3|||
49003227|NCT04840901|157848334|FG001|Overall Study|Lost to Follow-up|1|||
49003228|NCT04840901|157848333|FG000|Overall Study|Moved|1|||
49003229|NCT04840901|157848334|FG001|Overall Study|Moved|0|||
49003230|NCT04840901|157848333|FG000|Overall Study|Unable to comply with study schedule|0|||
49003231|NCT04840901|157848334|FG001|Overall Study|Unable to comply with study schedule|1|||
49003232|NCT04840901|157848333|FG000|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|1|||
49003233|NCT04840901|157848334|FG001|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|0|||
49003234|NCT01268683|157848335|FG000|Overall Study|Lost to Follow-up|1|||
49003235|NCT01268683|157848335|FG000|Overall Study|Death|1|||
49003236|NCT01523301|157848336|FG000|Overall Study|Adverse Event|25|||
49003237|NCT01523301|157848337|FG001|Overall Study|Adverse Event|16|||
49003238|NCT01523301|157848336|FG000|Overall Study|Lack of Efficacy|0|||
49003239|NCT01523301|157848337|FG001|Overall Study|Lack of Efficacy|2|||
49003240|NCT01523301|157848336|FG000|Overall Study|Protocol Violation|3|||
49003241|NCT01523301|157848337|FG001|Overall Study|Protocol Violation|4|||
49003242|NCT01523301|157848336|FG000|Overall Study|Lost to Follow-up|1|||
49003243|NCT01523301|157848337|FG001|Overall Study|Lost to Follow-up|0|||
49003244|NCT01523301|157848336|FG000|Overall Study|Withdrawal by Subject|6|||
49003245|NCT01523301|157848337|FG001|Overall Study|Withdrawal by Subject|8|||
49003246|NCT01523301|157848336|FG000|Overall Study|Other Reason|0|||
49003247|NCT01523301|157848337|FG001|Overall Study|Other Reason|2|||
49003248|NCT02362646|157848349|FG000|Overall Study|Death|15|||
49003249|NCT02362646|157848350|FG001|Overall Study|Death|8|||
49003250|NCT02362646|157848349|FG000|Overall Study|Withdrawal by Subject|2|||
49003251|NCT02362646|157848350|FG001|Overall Study|Withdrawal by Subject|2|||
49003252|NCT02362646|157848349|FG000|Overall Study|received transplant|21|||
49003253|NCT02362646|157848350|FG001|Overall Study|received transplant|14|||
49003254|NCT02058368|157848351|FG000|Overall Study|Adverse Event|15|||
49003255|NCT02058368|157848352|FG001|Overall Study|Adverse Event|20|||
49003256|NCT02058368|157848351|FG000|Overall Study|Lack of Efficacy|0|||
49003257|NCT02058368|157848352|FG001|Overall Study|Lack of Efficacy|1|||
49003258|NCT02058368|157848351|FG000|Overall Study|Protocol Violation|0|||
49003259|NCT02058368|157848352|FG001|Overall Study|Protocol Violation|4|||
49003260|NCT02058368|157848351|FG000|Overall Study|Lost to Follow-up|2|||
49003261|NCT02058368|157848352|FG001|Overall Study|Lost to Follow-up|0|||
49003262|NCT02058368|157848351|FG000|Overall Study|Physician Decision|2|||
49003263|NCT02058368|157848352|FG001|Overall Study|Physician Decision|3|||
49003264|NCT02058368|157848351|FG000|Overall Study|Withdrawal by Subject|22|||
49003265|NCT02058368|157848352|FG001|Overall Study|Withdrawal by Subject|26|||
49003266|NCT05083559|157848354|FG000|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|4|||
49003267|NCT05083559|157848355|FG001|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|1|||
49003268|NCT05083559|157848354|FG000|Second at Home Period (3-30 Days)|Withdrawal by Subject|2|||
49003269|NCT05083559|157848355|FG001|Second at Home Period (3-30 Days)|Withdrawal by Subject|0|||
49003270|NCT05083559|157848354|FG000|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|1|||
49003271|NCT05083559|157848355|FG001|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|0|||
49003272|NCT02181842|157848357|FG000|Overall Study|Case Report Forms Uncollected|2|||
49003273|NCT06371079|157848358|FG000|Overall Study|Missing data|88|||
49003274|NCT06371079|157848359|FG001|Overall Study|Missing data|247|||
49003275|NCT01216319|157848360|FG000|Overall Study|Lost to Follow-up|2|||
49003276|NCT01216319|157848360|FG000|Overall Study|Unanticipated chemo for breast cancer|2|||
49003277|NCT00995488|157848361|FG000|Overall Study|Withdrawal by Subject|1|||
49003278|NCT03454672|157848362|FG000|Overall Study|Adverse Event|1|||
49003279|NCT03454672|157848363|FG001|Overall Study|Adverse Event|1|||
49003280|NCT03454672|157848362|FG000|Overall Study|Lost to Follow-up|1|||
49003281|NCT03454672|157848363|FG001|Overall Study|Lost to Follow-up|3|||
49003282|NCT03454672|157848362|FG000|Overall Study|painful|1|||
49003283|NCT03454672|157848363|FG001|Overall Study|painful|2|||
49003284|NCT03454672|157848362|FG000|Overall Study|Non-compliance|2|||
49003285|NCT03454672|157848363|FG001|Overall Study|Non-compliance|4|||
49003286|NCT03454672|157848362|FG000|Overall Study|personal reasons|3|||
49003287|NCT03454672|157848363|FG001|Overall Study|personal reasons|2|||
49003288|NCT03454672|157848362|FG000|Overall Study|Withdrawal by Subject|1|||
49003289|NCT03454672|157848363|FG001|Overall Study|Withdrawal by Subject|0|||
49003290|NCT02720094|157848364|FG000|Overall Study|Scheduled exit visit/end of study|2|||
49003291|NCT02720094|157848365|FG001|Overall Study|Scheduled exit visit/end of study|1|||
49003292|NCT02720094|157848364|FG000|Overall Study|Death|4|||
49003293|NCT02720094|157848365|FG001|Overall Study|Death|7|||
49003294|NCT02720094|157848364|FG000|Overall Study|Withdrawal by Subject|55|||
49003295|NCT02720094|157848365|FG001|Overall Study|Withdrawal by Subject|56|||
49003296|NCT02720094|157848364|FG000|Overall Study|Lost to Follow-up|2|||
49003297|NCT02720094|157848365|FG001|Overall Study|Lost to Follow-up|7|||
49003298|NCT02720094|157848364|FG000|Overall Study|Physician Decision|1|||
49003299|NCT02720094|157848365|FG001|Overall Study|Physician Decision|3|||
49003300|NCT02720094|157848364|FG000|Overall Study|Inappropriate enrollment|1|||
49003301|NCT02720094|157848365|FG001|Overall Study|Inappropriate enrollment|3|||
49003302|NCT02720094|157848364|FG000|Overall Study|Ongoing|2210|||
49003303|NCT02720094|157848365|FG001|Overall Study|Ongoing|2203|||
49003304|NCT02720094|157848364|FG000|Overall Study|Relocation|1|||
49003305|NCT02720094|157848365|FG001|Overall Study|Relocation|1|||
49003306|NCT01892020|157848366|FG000|Period 1|Adverse Event|1|||
49003307|NCT01892020|157848367|FG001|Period 1|Adverse Event|1|||
49003308|NCT01892020|157848366|FG000|Period 1|Protocol Violation|2|||
49003309|NCT01892020|157848367|FG001|Period 1|Protocol Violation|4|||
49003310|NCT01892020|157848366|FG000|Period 1|Unclassified|0|||
49003311|NCT01892020|157848367|FG001|Period 1|Unclassified|1|||
49003312|NCT01892020|157848366|FG000|Period 2|Protocol Violation|1|||
49003313|NCT01892020|157848367|FG001|Period 2|Protocol Violation|0|||
49003314|NCT03078192|157848368|FG000|Overall Study|Withdrawal by Subject|2|||
49003315|NCT03078192|157848369|FG001|Overall Study|Withdrawal by Subject|1|||
49003316|NCT03078192|157848368|FG000|Overall Study|screen failure|0|||
49003317|NCT03078192|157848369|FG001|Overall Study|screen failure|3|||
49003318|NCT01831596|157848370|FG000|Overall Study|Other|8|||
49003319|NCT00567996|157848374|FG000|Overall Study|Adverse Event|18|||
49003320|NCT00567996|157848375|FG001|Overall Study|Adverse Event|16|||
49003321|NCT00567996|157848376|FG002|Overall Study|Adverse Event|13|||
49003322|NCT00567996|157848374|FG000|Overall Study|Protocol Deviation|9|||
49003323|NCT00567996|157848375|FG001|Overall Study|Protocol Deviation|11|||
49003324|NCT00567996|157848376|FG002|Overall Study|Protocol Deviation|13|||
49003325|NCT00567996|157848374|FG000|Overall Study|Withdrawal by Subject|8|||
49003326|NCT00567996|157848375|FG001|Overall Study|Withdrawal by Subject|12|||
49003327|NCT00567996|157848376|FG002|Overall Study|Withdrawal by Subject|22|||
49003328|NCT00567996|157848374|FG000|Overall Study|Abnormal Lab value(s)|2|||
49003329|NCT00567996|157848375|FG001|Overall Study|Abnormal Lab value(s)|1|||
49003330|NCT00567996|157848376|FG002|Overall Study|Abnormal Lab value(s)|2|||
49003331|NCT00567996|157848374|FG000|Overall Study|Abnormal test procedure result(s)|2|||
49003332|NCT00567996|157848375|FG001|Overall Study|Abnormal test procedure result(s)|1|||
49003333|NCT00567996|157848376|FG002|Overall Study|Abnormal test procedure result(s)|1|||
49003334|NCT00567996|157848374|FG000|Overall Study|Lost to Follow-up|2|||
49003335|NCT00567996|157848375|FG001|Overall Study|Lost to Follow-up|5|||
49003336|NCT00567996|157848376|FG002|Overall Study|Lost to Follow-up|2|||
49003337|NCT00567996|157848374|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
49003338|NCT00567996|157848375|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
49003339|NCT00567996|157848376|FG002|Overall Study|Unsatisfactory therapeutic effect|15|||
49003340|NCT00567996|157848374|FG000|Overall Study|Administrative problems|1|||
49003341|NCT00567996|157848375|FG001|Overall Study|Administrative problems|1|||
49003342|NCT00567996|157848376|FG002|Overall Study|Administrative problems|0|||
49003343|NCT00567996|157848374|FG000|Overall Study|Death|1|||
49003344|NCT00567996|157848375|FG001|Overall Study|Death|0|||
49003345|NCT00567996|157848376|FG002|Overall Study|Death|2|||
49003346|NCT00567996|157848374|FG000|Overall Study|Patient's inability to use the device|0|||
49003347|NCT00567996|157848375|FG001|Overall Study|Patient's inability to use the device|1|||
49003348|NCT00567996|157848376|FG002|Overall Study|Patient's inability to use the device|0|||
49003349|NCT03338673|157848379|FG000|Overall Study|Lost to Follow-up|1|||
49003350|NCT03338673|157848380|FG001|Overall Study|Lost to Follow-up|1|||
49003351|NCT02173301|157848383|FG000|Overall Study|Adverse Event|7|||
49003352|NCT02173301|157848384|FG001|Overall Study|Adverse Event|8|||
49003353|NCT02173301|157848385|FG002|Overall Study|Adverse Event|13|||
49003354|NCT02173301|157848386|FG003|Overall Study|Adverse Event|5|||
49003355|NCT02173301|157848383|FG000|Overall Study|Withdrawal by Subject|8|||
49003356|NCT02173301|157848384|FG001|Overall Study|Withdrawal by Subject|10|||
49003357|NCT02173301|157848385|FG002|Overall Study|Withdrawal by Subject|4|||
49003358|NCT02173301|157848386|FG003|Overall Study|Withdrawal by Subject|8|||
49003359|NCT02173301|157848383|FG000|Overall Study|Lost to Follow-up|4|||
49003360|NCT02173301|157848384|FG001|Overall Study|Lost to Follow-up|4|||
49003361|NCT02173301|157848385|FG002|Overall Study|Lost to Follow-up|2|||
49003362|NCT02173301|157848386|FG003|Overall Study|Lost to Follow-up|2|||
49003363|NCT02173301|157848383|FG000|Overall Study|Protocol Violation|0|||
49003364|NCT02173301|157848384|FG001|Overall Study|Protocol Violation|1|||
49003365|NCT02173301|157848385|FG002|Overall Study|Protocol Violation|0|||
49003366|NCT02173301|157848386|FG003|Overall Study|Protocol Violation|0|||
49003367|NCT02173301|157848383|FG000|Overall Study|Physician Decision|0|||
49003368|NCT02173301|157848384|FG001|Overall Study|Physician Decision|0|||
49003369|NCT02173301|157848385|FG002|Overall Study|Physician Decision|1|||
49003370|NCT02173301|157848386|FG003|Overall Study|Physician Decision|0|||
49003371|NCT02173301|157848383|FG000|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|1|||
49003372|NCT02173301|157848384|FG001|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
49003373|NCT02173301|157848385|FG002|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
49003374|NCT02173301|157848386|FG003|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
49003375|NCT03120520|157848391|FG000|Overall Study|Lost to Follow-up|1|||
49003376|NCT03120520|157848392|FG001|Overall Study|Lost to Follow-up|1|||
49003377|NCT03120520|157848393|FG002|Overall Study|Lost to Follow-up|1|||
49003378|NCT03120520|157848394|FG003|Overall Study|Lost to Follow-up|1|||
49003379|NCT03120520|157848391|FG000|Overall Study|Withdrawal by Subject|3|||
49003380|NCT03120520|157848392|FG001|Overall Study|Withdrawal by Subject|2|||
49003381|NCT03120520|157848393|FG002|Overall Study|Withdrawal by Subject|3|||
49003382|NCT03120520|157848394|FG003|Overall Study|Withdrawal by Subject|2|||
49003383|NCT03120520|157848391|FG000|Overall Study|Other|0|||
49003384|NCT03120520|157848392|FG001|Overall Study|Other|1|||
49003385|NCT03120520|157848393|FG002|Overall Study|Other|0|||
49003386|NCT03120520|157848394|FG003|Overall Study|Other|0|||
49003387|NCT04578548|157848395|FG000|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
49003388|NCT04578548|157848396|FG001|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
49003389|NCT04578548|157848395|FG000|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
49003390|NCT04578548|157848396|FG001|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
49003391|NCT04578548|157848395|FG000|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
49003392|NCT04578548|157848396|FG001|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
49003393|NCT04578548|157848395|FG000|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
49003394|NCT04578548|157848396|FG001|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
49003395|NCT04578548|157848395|FG000|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
49003396|NCT04578548|157848396|FG001|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
49003397|NCT04578548|157848395|FG000|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|34|||
49003398|NCT04578548|157848396|FG001|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|15|||
49003399|NCT00391092|157849496|FG000|Overall Study|Death|78|||
49003400|NCT00391092|157849497|FG001|Overall Study|Death|81|||
49003401|NCT00391092|157849496|FG000|Overall Study|Lost to Follow-up|13|||
49003402|NCT00391092|157849497|FG001|Overall Study|Lost to Follow-up|18|||
49003403|NCT00391092|157849496|FG000|Overall Study|Alive on treatment|29|||
49003404|NCT00391092|157849497|FG001|Overall Study|Alive on treatment|33|||
49003405|NCT00391092|157849496|FG000|Overall Study|Alive in follow-up|88|||
49003406|NCT00391092|157849497|FG001|Overall Study|Alive in follow-up|84|||
49003407|NCT03443973|157849498|FG000|Double-blind Treatment Period|Adverse Event|5|||
49003408|NCT03443973|157849499|FG001|Double-blind Treatment Period|Adverse Event|19|||
49003409|NCT03443973|157849500|FG002|Double-blind Treatment Period|Adverse Event|0|||
49003410|NCT03443973|157849501|FG003|Double-blind Treatment Period|Adverse Event|0|||
49003411|NCT03443973|157849498|FG000|Double-blind Treatment Period|Death|5|||
49003412|NCT03443973|157849499|FG001|Double-blind Treatment Period|Death|7|||
49003413|NCT03443973|157849500|FG002|Double-blind Treatment Period|Death|0|||
49003414|NCT03443973|157849501|FG003|Double-blind Treatment Period|Death|0|||
49003415|NCT03443973|157849498|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
49003416|NCT03443973|157849499|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
49003417|NCT03443973|157849500|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
49003418|NCT03443973|157849501|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
49003419|NCT03443973|157849498|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
49003420|NCT03443973|157849499|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
49003421|NCT03443973|157849500|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
49003422|NCT03443973|157849501|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
49003423|NCT03443973|157849498|FG000|Double-blind Treatment Period|Reason Not Specified|9|||
49003424|NCT03443973|157849499|FG001|Double-blind Treatment Period|Reason Not Specified|11|||
49003425|NCT03443973|157849500|FG002|Double-blind Treatment Period|Reason Not Specified|0|||
49003426|NCT03443973|157849501|FG003|Double-blind Treatment Period|Reason Not Specified|0|||
49003427|NCT03443973|157849498|FG000|Double-blind Treatment Period|Physician Decision|5|||
49003428|NCT03443973|157849499|FG001|Double-blind Treatment Period|Physician Decision|6|||
49003429|NCT03443973|157849500|FG002|Double-blind Treatment Period|Physician Decision|0|||
49003430|NCT03443973|157849501|FG003|Double-blind Treatment Period|Physician Decision|0|||
49003431|NCT03443973|157849498|FG000|Double-blind Treatment Period|Protocol Deviation|1|||
49003432|NCT03443973|157849499|FG001|Double-blind Treatment Period|Protocol Deviation|2|||
49003433|NCT03443973|157849500|FG002|Double-blind Treatment Period|Protocol Deviation|0|||
49003434|NCT03443973|157849501|FG003|Double-blind Treatment Period|Protocol Deviation|0|||
49003435|NCT03443973|157849498|FG000|Double-blind Treatment Period|Withdrawal by Subject|54|||
49003436|NCT03443973|157849499|FG001|Double-blind Treatment Period|Withdrawal by Subject|79|||
49003437|NCT03443973|157849500|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
49003438|NCT03443973|157849501|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
49003439|NCT03443973|157849498|FG000|Open-label Extension Period|Reason Not Specified|0|||
49003440|NCT03443973|157849499|FG001|Open-label Extension Period|Reason Not Specified|0|||
49003441|NCT03443973|157849500|FG002|Open-label Extension Period|Reason Not Specified|3|||
49003442|NCT03443973|157849501|FG003|Open-label Extension Period|Reason Not Specified|0|||
49003443|NCT03443973|157849498|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
49003444|NCT03443973|157849499|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
49003445|NCT03443973|157849500|FG002|Open-label Extension Period|Withdrawal by Subject|2|||
49003446|NCT03443973|157849501|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
49003447|NCT00265239|157849502|FG000|Overall Study|Adverse Event|2|||
49003448|NCT00265239|157849503|FG001|Overall Study|Adverse Event|1|||
49003449|NCT02545868|157849516|FG000|Overall Study|Lack of Efficacy|1|||
49003450|NCT02545868|157849517|FG001|Overall Study|Lack of Efficacy|1|||
49003451|NCT02545868|157849518|FG002|Overall Study|Lack of Efficacy|0|||
49003452|NCT02545868|157849516|FG000|Overall Study|Lost to Follow-up|1|||
49003453|NCT02545868|157849517|FG001|Overall Study|Lost to Follow-up|5|||
49003454|NCT02545868|157849518|FG002|Overall Study|Lost to Follow-up|1|||
49003455|NCT02545868|157849516|FG000|Overall Study|Non-compliance|1|||
49003456|NCT02545868|157849517|FG001|Overall Study|Non-compliance|1|||
49003457|NCT02545868|157849518|FG002|Overall Study|Non-compliance|1|||
49003458|NCT02545868|157849516|FG000|Overall Study|Treatment change|21|||
49003459|NCT02545868|157849517|FG001|Overall Study|Treatment change|19|||
49003460|NCT02545868|157849518|FG002|Overall Study|Treatment change|22|||
49003461|NCT02545868|157849516|FG000|Overall Study|Physician Decision|1|||
49003462|NCT02545868|157849517|FG001|Overall Study|Physician Decision|1|||
49003463|NCT02545868|157849518|FG002|Overall Study|Physician Decision|1|||
49003464|NCT02545868|157849516|FG000|Overall Study|Withdrawal by Subject|6|||
49003465|NCT02545868|157849517|FG001|Overall Study|Withdrawal by Subject|7|||
49003466|NCT02545868|157849518|FG002|Overall Study|Withdrawal by Subject|9|||
49003467|NCT04057573|157849519|FG000|24-Week Double-Blind Period|Adverse Event|2|||
49003468|NCT04057573|157849520|FG001|24-Week Double-Blind Period|Adverse Event|0|||
49003469|NCT04057573|157849521|FG002|24-Week Double-Blind Period|Adverse Event|0|||
49003470|NCT04057573|157849522|FG003|24-Week Double-Blind Period|Adverse Event|0|||
49003471|NCT04057573|157849519|FG000|24-Week Double-Blind Period|Lack of Efficacy|0|||
49003472|NCT04057573|157849520|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
49003473|NCT04057573|157849521|FG002|24-Week Double-Blind Period|Lack of Efficacy|0|||
49003474|NCT04057573|157849522|FG003|24-Week Double-Blind Period|Lack of Efficacy|0|||
49003475|NCT04057573|157849519|FG000|24-Week Double-Blind Period|Lost to Follow-up|11|||
49003476|NCT04057573|157849520|FG001|24-Week Double-Blind Period|Lost to Follow-up|6|||
49003477|NCT04057573|157849521|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
49003478|NCT04057573|157849522|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
49003479|NCT04057573|157849519|FG000|24-Week Double-Blind Period|Physician Decision|1|||
49003480|NCT04057573|157849520|FG001|24-Week Double-Blind Period|Physician Decision|0|||
49003481|NCT04057573|157849521|FG002|24-Week Double-Blind Period|Physician Decision|0|||
49003482|NCT04057573|157849522|FG003|24-Week Double-Blind Period|Physician Decision|0|||
49003483|NCT04057573|157849519|FG000|24-Week Double-Blind Period|Pregnancy|1|||
49003484|NCT04057573|157849520|FG001|24-Week Double-Blind Period|Pregnancy|0|||
49003485|NCT04057573|157849521|FG002|24-Week Double-Blind Period|Pregnancy|0|||
49003486|NCT04057573|157849522|FG003|24-Week Double-Blind Period|Pregnancy|0|||
49003487|NCT04057573|157849519|FG000|24-Week Double-Blind Period|Withdrawal by Subject|10|||
49003488|NCT04057573|157849520|FG001|24-Week Double-Blind Period|Withdrawal by Subject|8|||
49003489|NCT04057573|157849521|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
49003490|NCT04057573|157849522|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
49003491|NCT04057573|157849519|FG000|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|3|||
49003492|NCT04057573|157849520|FG001|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|1|||
49003493|NCT04057573|157849521|FG002|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
49003494|NCT04057573|157849522|FG003|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
49003495|NCT04057573|157849519|FG000|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|1|||
49003496|NCT04057573|157849520|FG001|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
49003497|NCT04057573|157849521|FG002|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
49003498|NCT04057573|157849522|FG003|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
49003499|NCT04057573|157849519|FG000|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
49003500|NCT04057573|157849520|FG001|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|1|||
49003501|NCT04057573|157849521|FG002|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
49003502|NCT04057573|157849522|FG003|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
49003503|NCT04057573|157849519|FG000|24-Week Double-Blind Period|Not Treated|1|||
49003504|NCT04057573|157849520|FG001|24-Week Double-Blind Period|Not Treated|0|||
49003505|NCT04057573|157849521|FG002|24-Week Double-Blind Period|Not Treated|0|||
49003506|NCT04057573|157849522|FG003|24-Week Double-Blind Period|Not Treated|0|||
49003507|NCT04057573|157849519|FG000|28-Week Treatment Extension Period|Adverse Event|0|||
49003508|NCT04057573|157849520|FG001|28-Week Treatment Extension Period|Adverse Event|0|||
49003509|NCT04057573|157849521|FG002|28-Week Treatment Extension Period|Adverse Event|1|||
49003510|NCT04057573|157849522|FG003|28-Week Treatment Extension Period|Adverse Event|0|||
49003511|NCT04057573|157849519|FG000|28-Week Treatment Extension Period|Lack of Efficacy|0|||
49003512|NCT04057573|157849520|FG001|28-Week Treatment Extension Period|Lack of Efficacy|0|||
49003513|NCT04057573|157849521|FG002|28-Week Treatment Extension Period|Lack of Efficacy|1|||
49003514|NCT04057573|157849522|FG003|28-Week Treatment Extension Period|Lack of Efficacy|0|||
49003515|NCT04057573|157849519|FG000|28-Week Treatment Extension Period|Lost to Follow-up|0|||
49003516|NCT04057573|157849520|FG001|28-Week Treatment Extension Period|Lost to Follow-up|0|||
49003517|NCT04057573|157849521|FG002|28-Week Treatment Extension Period|Lost to Follow-up|9|||
49003518|NCT04057573|157849522|FG003|28-Week Treatment Extension Period|Lost to Follow-up|10|||
49003519|NCT04057573|157849519|FG000|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
49003520|NCT04057573|157849520|FG001|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
49003521|NCT04057573|157849521|FG002|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
49003522|NCT04057573|157849522|FG003|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
49003523|NCT04057573|157849519|FG000|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
49003524|NCT04057573|157849520|FG001|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
49003525|NCT04057573|157849521|FG002|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|1|||
49003526|NCT04057573|157849522|FG003|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
49003527|NCT03047031|157849523|FG000|Overall Study|Other than listed|1|||
49003528|NCT03047031|157849524|FG001|Overall Study|Other than listed|0|||
49003529|NCT03047031|157849525|FG002|Overall Study|Other than listed|0|||
49003530|NCT03047031|157849523|FG000|Overall Study|Lost to Follow-up|4|||
49003531|NCT03047031|157849524|FG001|Overall Study|Lost to Follow-up|0|||
49003532|NCT03047031|157849525|FG002|Overall Study|Lost to Follow-up|0|||
49003533|NCT03047031|157849523|FG000|Overall Study|Patient refusal to continue taking trial medication|2|||
49003534|NCT03047031|157849524|FG001|Overall Study|Patient refusal to continue taking trial medication|0|||
49003535|NCT03047031|157849525|FG002|Overall Study|Patient refusal to continue taking trial medication|0|||
49003536|NCT03047031|157849523|FG000|Overall Study|Adverse Event|1|||
49003537|NCT03047031|157849524|FG001|Overall Study|Adverse Event|0|||
49003538|NCT03047031|157849525|FG002|Overall Study|Adverse Event|0|||
49003539|NCT03047031|157849523|FG000|Overall Study|Withdrawal by Subject|2|||
49003540|NCT03047031|157849524|FG001|Overall Study|Withdrawal by Subject|0|||
49003541|NCT03047031|157849525|FG002|Overall Study|Withdrawal by Subject|0|||
49003542|NCT03047031|157849523|FG000|Overall Study|Change to other medication|2|||
49003543|NCT03047031|157849524|FG001|Overall Study|Change to other medication|0|||
49003544|NCT03047031|157849525|FG002|Overall Study|Change to other medication|0|||
49003545|NCT03047031|157849523|FG000|Overall Study|Patients were not followed as planned in the protocol|0|||
49003546|NCT03047031|157849524|FG001|Overall Study|Patients were not followed as planned in the protocol|4|||
49003547|NCT03047031|157849525|FG002|Overall Study|Patients were not followed as planned in the protocol|3|||
49003548|NCT00826176|157849534|FG000|Overall Study|Lost to Follow-up|1|||
49003549|NCT00826176|157849535|FG001|Overall Study|Lost to Follow-up|0|||
49003550|NCT00826176|157849534|FG000|Overall Study|Subject Withdrew Consent|3|||
49003551|NCT00826176|157849535|FG001|Overall Study|Subject Withdrew Consent|0|||
49003552|NCT00826176|157849534|FG000|Overall Study|Administrative|9|||
49003553|NCT00826176|157849535|FG001|Overall Study|Administrative|0|||
49003554|NCT01652573|157849536|FG000|Overall Study|Adverse Event|0|||
49003555|NCT01652573|157849537|FG001|Overall Study|Adverse Event|1|||
49003556|NCT00740480|157849538|FG000|Overall Study|Adverse Event|1|||
49003557|NCT00740480|157849538|FG000|Overall Study|Physician Decision|1|||
49003558|NCT00934622|157849540|FG000|Overall Study|Lost to Follow-up|7|||
49003559|NCT00934622|157849540|FG000|Overall Study|2nd Intraoperative exclusion criteria|1|||
49003560|NCT01856686|157849545|FG000|Overall Study|Lost to Follow-up|5|||
49003561|NCT01856686|157849546|FG001|Overall Study|Lost to Follow-up|11|||
49003562|NCT00602979|157849547|FG000|Overall Study|Lost to Follow-up|3|||
49003563|NCT00602979|157849548|FG001|Overall Study|Lost to Follow-up|2|||
49003564|NCT00602979|157849549|FG002|Overall Study|Lost to Follow-up|3|||
49003565|NCT00602979|157849550|FG003|Overall Study|Lost to Follow-up|2|||
49003566|NCT00602979|157849551|FG004|Overall Study|Lost to Follow-up|3|||
49003567|NCT00602979|157849547|FG000|Overall Study|Failed Intubation|0|||
49003568|NCT00602979|157849548|FG001|Overall Study|Failed Intubation|1|||
49003569|NCT00602979|157849549|FG002|Overall Study|Failed Intubation|0|||
49003570|NCT00602979|157849550|FG003|Overall Study|Failed Intubation|1|||
49003571|NCT00602979|157849551|FG004|Overall Study|Failed Intubation|0|||
49003572|NCT00468312|157849553|FG000|Overall Study|Adverse Event|2|||
49003573|NCT00468312|157849554|FG001|Overall Study|Adverse Event|1|||
49003574|NCT00468312|157849553|FG000|Overall Study|Lack of Efficacy|0|||
49003575|NCT00468312|157849554|FG001|Overall Study|Lack of Efficacy|1|||
49003576|NCT00468312|157849553|FG000|Overall Study|Withdrawal by Subject|0|||
49003577|NCT00468312|157849554|FG001|Overall Study|Withdrawal by Subject|1|||
49003578|NCT00468312|157849553|FG000|Overall Study|Protocol Violation|2|||
49003579|NCT00468312|157849554|FG001|Overall Study|Protocol Violation|1|||
49003580|NCT00468312|157849553|FG000|Overall Study|Did not meet protocol eligibility|0|||
49003581|NCT00468312|157849554|FG001|Overall Study|Did not meet protocol eligibility|1|||
49003582|NCT01052038|157849555|FG000|Overall Study|Lost to Follow-up|2|||
49003583|NCT01052038|157849556|FG001|Overall Study|Lost to Follow-up|3|||
49003584|NCT01052038|157849557|FG002|Overall Study|Lost to Follow-up|1|||
49003585|NCT01052038|157849555|FG000|Overall Study|Protocol Violation|2|||
49003586|NCT01052038|157849556|FG001|Overall Study|Protocol Violation|3|||
49003587|NCT01052038|157849557|FG002|Overall Study|Protocol Violation|3|||
49003588|NCT02499406|157849558|FG000|Overall Study|missed 3 treatment sessions|4|||
49003589|NCT02787785|157849559|FG000|Overall Study|Death|3|||
49003590|NCT02787785|157849560|FG001|Overall Study|Death|4|||
49003591|NCT02787785|157849559|FG000|Overall Study|Lost to Follow-up|1|||
49003592|NCT02787785|157849560|FG001|Overall Study|Lost to Follow-up|1|||
49003593|NCT02787785|157849559|FG000|Overall Study|Withdrawal by Subject|0|||
49003594|NCT02787785|157849560|FG001|Overall Study|Withdrawal by Subject|5|||
49003595|NCT03981614|157849561|FG000|Overall Study|Patient withdrawn prior to treatment|5|||
49003596|NCT03981614|157849562|FG001|Overall Study|Patient withdrawn prior to treatment|5|||
49003597|NCT03981614|157849563|FG002|Overall Study|Patient withdrawn prior to treatment|1|||
49003598|NCT00457418|157849564|FG000|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2|||
49003599|NCT00457418|157849564|FG000|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1|||
49003600|NCT00457418|157849564|FG000|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2|||
49003601|NCT00457418|157849564|FG000|Post PK Maintenance|Adverse Event|10|||
49003602|NCT00457418|157849564|FG000|Post PK Maintenance|Progression of Disease|6|||
49003603|NCT00457418|157849564|FG000|Post PK Maintenance|Withdrawal by Subject|11|||
49003604|NCT00457418|157849564|FG000|Post PK Maintenance|Lost to Follow-up|1|||
49003605|NCT05016765|157849568|FG000|Overall Study|Lost to Follow-up|4|||
49003606|NCT05144477|157849571|FG000|Overall Study|Withdrawal by Subject|1|||
49003607|NCT05144477|157849572|FG001|Overall Study|Withdrawal by Subject|1|||
49003608|NCT01339000|157849573|FG000|Overall Study|study closed due to lack of drug supply|1|||
49003609|NCT01339000|157849574|FG001|Overall Study|study closed due to lack of drug supply|0|||
49003610|NCT00728988|157849575|FG000|Overall Study|Not Treated|2|||
49003611|NCT00728988|157849576|FG001|Overall Study|Not Treated|2|||
49003612|NCT00728988|157849575|FG000|Overall Study|Death|1|||
49003613|NCT00728988|157849576|FG001|Overall Study|Death|1|||
49003614|NCT00728988|157849575|FG000|Overall Study|Adverse Event|3|||
49003615|NCT00728988|157849576|FG001|Overall Study|Adverse Event|2|||
49003616|NCT00728988|157849575|FG000|Overall Study|Other|85|||
49003617|NCT00728988|157849576|FG001|Overall Study|Other|77|||
49003618|NCT00728988|157849575|FG000|Overall Study|Withdrawal by Subject|2|||
49003619|NCT00728988|157849576|FG001|Overall Study|Withdrawal by Subject|6|||
49003620|NCT00835068|157849579|FG000|Overall Study|Death|1|||
49003621|NCT00835068|157849580|FG001|Overall Study|Death|0|||
49003622|NCT00835068|157849579|FG000|Overall Study|Adverse Event|0|||
49003623|NCT00835068|157849580|FG001|Overall Study|Adverse Event|1|||
49003624|NCT00835068|157849579|FG000|Overall Study|Other|8|||
49003625|NCT00835068|157849580|FG001|Overall Study|Other|0|||
49003626|NCT00835068|157849579|FG000|Overall Study|Withdrawal by Subject|1|||
49003627|NCT00835068|157849580|FG001|Overall Study|Withdrawal by Subject|0|||
49003628|NCT02704130|157849581|FG000|Overall Study|Physician Decision|5|||
49003629|NCT02704130|157849582|FG001|Overall Study|Physician Decision|3|||
49003630|NCT01652872|157849583|FG000|Overall Study|Death|36|||
49003631|NCT01652872|157849584|FG001|Overall Study|Death|39|||
49003632|NCT01652872|157849583|FG000|Overall Study|Lost to Follow-up|28|||
49003633|NCT01652872|157849584|FG001|Overall Study|Lost to Follow-up|23|||
49003634|NCT01652872|157849583|FG000|Overall Study|Decision by sponsor|5|||
49003635|NCT01652872|157849584|FG001|Overall Study|Decision by sponsor|7|||
49003636|NCT01652872|157849583|FG000|Overall Study|Withdrawal by Subject|76|||
49003637|NCT01652872|157849584|FG001|Overall Study|Withdrawal by Subject|84|||
49003638|NCT05473247|157849593|FG000|Overall Study|One participant ceased contact with the research study team after the initial, pre-testing appt.|1|||
49003639|NCT04816877|157849597|FG000|Overall Study|Withdrawal by Subject|1|||
49003640|NCT04816877|157849598|FG001|Overall Study|Withdrawal by Subject|0|||
49003641|NCT01374906|157849599|FG000|Overall Study|Abnormal laboratory value(s)|0|||
49003642|NCT01374906|157849600|FG001|Overall Study|Abnormal laboratory value(s)|3|||
49003643|NCT01374906|157849599|FG000|Overall Study|Administrative problems|2|||
49003644|NCT01374906|157849600|FG001|Overall Study|Administrative problems|2|||
49003645|NCT01374906|157849599|FG000|Overall Study|Adverse Event|10|||
49003646|NCT01374906|157849600|FG001|Overall Study|Adverse Event|11|||
49003647|NCT01374906|157849599|FG000|Overall Study|Death|0|||
49003648|NCT01374906|157849600|FG001|Overall Study|Death|2|||
49003649|NCT01374906|157849599|FG000|Overall Study|Protocol Violation|2|||
49003650|NCT01374906|157849600|FG001|Overall Study|Protocol Violation|2|||
49003651|NCT01374906|157849599|FG000|Overall Study|Withdrawal by Subject|15|||
49003652|NCT01374906|157849600|FG001|Overall Study|Withdrawal by Subject|9|||
49003653|NCT01374906|157849599|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
49003654|NCT01374906|157849600|FG001|Overall Study|Unsatisfactory therapeutic effect|19|||
49003655|NCT00434148|157849601|FG000|Overall Study|Adverse Event|18|||
49003656|NCT00434148|157849602|FG001|Overall Study|Adverse Event|18|||
49003657|NCT00434148|157849601|FG000|Overall Study|Lack of Efficacy|25|||
49003658|NCT00434148|157849602|FG001|Overall Study|Lack of Efficacy|28|||
49003659|NCT00434148|157849601|FG000|Overall Study|Withdrawal by Subject|15|||
49003660|NCT00434148|157849602|FG001|Overall Study|Withdrawal by Subject|15|||
49003661|NCT00434148|157849601|FG000|Overall Study|Protocol Violation|4|||
49003662|NCT00434148|157849602|FG001|Overall Study|Protocol Violation|0|||
49003663|NCT00434148|157849601|FG000|Overall Study|Administrative problems|6|||
49003664|NCT00434148|157849602|FG001|Overall Study|Administrative problems|10|||
49003665|NCT00434148|157849601|FG000|Overall Study|Lost to Follow-up|0|||
49003666|NCT00434148|157849602|FG001|Overall Study|Lost to Follow-up|1|||
49003667|NCT00434148|157849601|FG000|Overall Study|Condition no longer requires study drug|1|||
49003668|NCT00434148|157849602|FG001|Overall Study|Condition no longer requires study drug|0|||
49003669|NCT00434148|157849601|FG000|Overall Study|Abnormal test procedure result|0|||
49003670|NCT00434148|157849602|FG001|Overall Study|Abnormal test procedure result|1|||
49003671|NCT00828516|157849605|FG000|Clinical Phase: Series 1|Withdrawal by Subject|2|||
49003672|NCT00990093|157849606|FG000|Test Period 1 (1-14 Days)|Adverse Event|1|||
49003673|NCT00990093|157849607|FG001|Test Period 1 (1-14 Days)|Adverse Event|0|||
49003674|NCT00990093|157849606|FG000|Test Period 1 (1-14 Days)|Withdrawal by Subject|2|||
49003675|NCT00990093|157849607|FG001|Test Period 1 (1-14 Days)|Withdrawal by Subject|0|||
49003676|NCT00990093|157849606|FG000|Test Period 1 (1-14 Days)|Other|1|||
49003677|NCT00990093|157849607|FG001|Test Period 1 (1-14 Days)|Other|0|||
49003678|NCT00990093|157849606|FG000|Test Period 1 (1-14 Days)|Lack of Efficacy|0|||
49003679|NCT00990093|157849607|FG001|Test Period 1 (1-14 Days)|Lack of Efficacy|2|||
49003680|NCT00990093|157849606|FG000|Test Period 2 (15-28 Days)|Adverse Event|1|||
49003681|NCT00990093|157849607|FG001|Test Period 2 (15-28 Days)|Adverse Event|0|||
49003682|NCT00990093|157849606|FG000|Test Period 2 (15-28 Days)|Lack of Efficacy|1|||
49003683|NCT00990093|157849607|FG001|Test Period 2 (15-28 Days)|Lack of Efficacy|0|||
49003684|NCT00990093|157849606|FG000|Test Period 2 (15-28 Days)|Other|0|||
49003685|NCT00990093|157849607|FG001|Test Period 2 (15-28 Days)|Other|1|||
49003686|NCT01123980|157849609|FG000|Overall Study|Adverse Event|1|||
49003687|NCT01123980|157849610|FG001|Overall Study|Adverse Event|1|||
49003688|NCT01123980|157849609|FG000|Overall Study|Lack of Efficacy|1|||
49003689|NCT01123980|157849610|FG001|Overall Study|Lack of Efficacy|0|||
49003690|NCT01123980|157849609|FG000|Overall Study|Physician Decision|0|||
49003691|NCT01123980|157849610|FG001|Overall Study|Physician Decision|1|||
49003692|NCT01123980|157849609|FG000|Overall Study|Lost to Follow-up|0|||
49003693|NCT01123980|157849610|FG001|Overall Study|Lost to Follow-up|6|||
49003694|NCT01123980|157849609|FG000|Overall Study|Protocol Violation|6|||
49003695|NCT01123980|157849610|FG001|Overall Study|Protocol Violation|6|||
49003696|NCT01123980|157849609|FG000|Overall Study|Withdrawal by Subject|5|||
49003697|NCT01123980|157849610|FG001|Overall Study|Withdrawal by Subject|3|||
49003698|NCT01123980|157849609|FG000|Overall Study|Unclassified|6|||
49003699|NCT01123980|157849610|FG001|Overall Study|Unclassified|7|||
49003700|NCT02284373|157850665|FG000|Overall Study|Withdrawal by Subject|0|||
49003701|NCT02284373|157850666|FG001|Overall Study|Withdrawal by Subject|1|||
49003702|NCT02284373|157850667|FG002|Overall Study|Withdrawal by Subject|0|||
49003703|NCT02284373|157850665|FG000|Overall Study|Other|0|||
49003704|NCT02284373|157850666|FG001|Overall Study|Other|1|||
49003705|NCT02284373|157850667|FG002|Overall Study|Other|0|||
49003706|NCT02284373|157850665|FG000|Overall Study|Lost to Follow-up|0|||
49003707|NCT02284373|157850666|FG001|Overall Study|Lost to Follow-up|1|||
49003708|NCT02284373|157850667|FG002|Overall Study|Lost to Follow-up|0|||
49003709|NCT00953927|157850668|FG000|Overall Study|Lost to Follow-up|61|||
49003710|NCT00953927|157850669|FG001|Overall Study|Lost to Follow-up|65|||
49003711|NCT00953927|157850668|FG000|Overall Study|Withdrawal by Subject|36|||
49003712|NCT00953927|157850669|FG001|Overall Study|Withdrawal by Subject|25|||
49003713|NCT00953927|157850668|FG000|Overall Study|Death|7|||
49003714|NCT00953927|157850669|FG001|Overall Study|Death|4|||
49003715|NCT00953927|157850668|FG000|Overall Study|Other study discontinuation|1|||
49003716|NCT00953927|157850669|FG001|Overall Study|Other study discontinuation|1|||
49003717|NCT02953262|157850670|FG000|Overall Study|Used portal during 6 months prior to randomization|3|||
49003718|NCT02953262|157850671|FG001|Overall Study|Used portal during 6 months prior to randomization|6|||
49003719|NCT02953262|157850672|FG002|Overall Study|Used portal during 6 months prior to randomization|3|||
49003720|NCT02953262|157850673|FG003|Overall Study|Used portal during 6 months prior to randomization|3|||
49003721|NCT03284424|157850674|FG000|Overall Study|Death|70|||
49003722|NCT03284424|157850675|FG001|Overall Study|Death|24|||
49003723|NCT03284424|157850674|FG000|Overall Study|Lost to Follow-up|3|||
49003724|NCT03284424|157850675|FG001|Overall Study|Lost to Follow-up|1|||
49003725|NCT03284424|157850674|FG000|Overall Study|Physician Decision|1|||
49003726|NCT03284424|157850675|FG001|Overall Study|Physician Decision|2|||
49003727|NCT03284424|157850674|FG000|Overall Study|Withdrawal by Subject|4|||
49003728|NCT03284424|157850675|FG001|Overall Study|Withdrawal by Subject|5|||
49003729|NCT03284424|157850674|FG000|Overall Study|Sponsor's decision|27|||
49003730|NCT03284424|157850675|FG001|Overall Study|Sponsor's decision|22|||
49003731|NCT02016755|157850683|FG000|Overall Study|Major amputation of index limb|2|||
49003732|NCT02016755|157850683|FG000|Overall Study|Adverse Event|2|||
49003733|NCT02016755|157850683|FG000|Overall Study|Physician Decision|1|||
49003734|NCT02016755|157850683|FG000|Overall Study|Death|2|||
49003735|NCT01396161|157850691|FG000|Overall Study|Withdrawal by Subject|0|||
49003736|NCT01396161|157850692|FG001|Overall Study|Withdrawal by Subject|0|||
49003737|NCT01396161|157850693|FG002|Overall Study|Withdrawal by Subject|0|||
49003738|NCT01396161|157850694|FG003|Overall Study|Withdrawal by Subject|0|||
49003739|NCT01396161|157850695|FG004|Overall Study|Withdrawal by Subject|1|||
49003740|NCT01396161|157850696|FG005|Overall Study|Withdrawal by Subject|0|||
49003741|NCT01396161|157850697|FG006|Overall Study|Withdrawal by Subject|0|||
49003742|NCT01396161|157850691|FG000|Overall Study|Other|0|||
49003743|NCT01396161|157850692|FG001|Overall Study|Other|0|||
49003744|NCT01396161|157850693|FG002|Overall Study|Other|0|||
49003745|NCT01396161|157850694|FG003|Overall Study|Other|0|||
49003746|NCT01396161|157850695|FG004|Overall Study|Other|0|||
49003747|NCT01396161|157850696|FG005|Overall Study|Other|0|||
49003748|NCT01396161|157850697|FG006|Overall Study|Other|1|||
49003749|NCT03079869|157850698|FG000|Overall Study|Adverse Event|6|||
49003750|NCT03079869|157850699|FG001|Overall Study|Adverse Event|8|||
49003751|NCT03079869|157850698|FG000|Overall Study|Withdrawal by Subject|4|||
49003752|NCT03079869|157850699|FG001|Overall Study|Withdrawal by Subject|1|||
49003753|NCT03079869|157850698|FG000|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|3|||
49003754|NCT03079869|157850699|FG001|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|2|||
49003755|NCT03976076|157850700|FG000|Overall Study|Withdrawal by Subject|2|||
49003756|NCT01325701|157850703|FG000|Overall Study|Adverse Event|12|||
49003757|NCT01325701|157850704|FG001|Overall Study|Adverse Event|0|||
49003758|NCT01325701|157850703|FG000|Overall Study|Protocol Violation|1|||
49003759|NCT01325701|157850704|FG001|Overall Study|Protocol Violation|0|||
49003760|NCT01325701|157850703|FG000|Overall Study|Physician Decision|2|||
49003761|NCT01325701|157850704|FG001|Overall Study|Physician Decision|2|||
49003762|NCT01325701|157850703|FG000|Overall Study|Withdrawal by Subject|2|||
49003763|NCT01325701|157850704|FG001|Overall Study|Withdrawal by Subject|1|||
49003764|NCT01325701|157850703|FG000|Overall Study|Rollerover Extension Study|4|||
49003765|NCT01325701|157850704|FG001|Overall Study|Rollerover Extension Study|0|||
49003766|NCT00734617|157850711|FG000|Overall Study|Adverse Event|4|||
49003767|NCT00734617|157850712|FG001|Overall Study|Adverse Event|7|||
49003768|NCT00734617|157850711|FG000|Overall Study|Withdrawal by Subject|103|||
49003769|NCT00734617|157850712|FG001|Overall Study|Withdrawal by Subject|95|||
49003770|NCT00552617|157850713|FG000|Overall Study|Not Treated|0|||
49003771|NCT00552617|157850714|FG001|Overall Study|Not Treated|0|||
49003772|NCT00552617|157850715|FG002|Overall Study|Not Treated|1|||
49003773|NCT00552617|157850716|FG003|Overall Study|Not Treated|0|||
49003774|NCT00552617|157850717|FG004|Overall Study|Not Treated|0|||
49003775|NCT00552617|157850718|FG005|Overall Study|Not Treated|0|||
49003776|NCT00552617|157850719|FG006|Overall Study|Not Treated|0|||
49046383|NCT02274558|158003845|FG002|Overall Study|Withdrawal by Subject|4|||
49046384|NCT02274558|158003843|FG000|Overall Study|Death|0|||
49003777|NCT00552617|157850720|FG007|Overall Study|Not Treated|0|||
49003778|NCT00552617|157850721|FG008|Overall Study|Not Treated|0|||
49003779|NCT00552617|157850722|FG009|Overall Study|Not Treated|1|||
49003780|NCT00552617|157850713|FG000|Overall Study|Lost to Follow-up|0|||
49003781|NCT00552617|157850714|FG001|Overall Study|Lost to Follow-up|0|||
49003782|NCT00552617|157850715|FG002|Overall Study|Lost to Follow-up|0|||
49003783|NCT00552617|157850716|FG003|Overall Study|Lost to Follow-up|1|||
49003784|NCT00552617|157850717|FG004|Overall Study|Lost to Follow-up|0|||
49003785|NCT00552617|157850718|FG005|Overall Study|Lost to Follow-up|2|||
49003786|NCT00552617|157850719|FG006|Overall Study|Lost to Follow-up|0|||
49003787|NCT00552617|157850720|FG007|Overall Study|Lost to Follow-up|0|||
49003788|NCT00552617|157850721|FG008|Overall Study|Lost to Follow-up|2|||
49003789|NCT00552617|157850722|FG009|Overall Study|Lost to Follow-up|0|||
49003790|NCT02411110|157850725|FG000|Treatment Period 1|Adverse Event|4|||
49003791|NCT02411110|157850726|FG001|Treatment Period 1|Adverse Event|2|||
49003792|NCT02411110|157850725|FG000|Treatment Period 1|Lost to Follow-up|1|||
49003793|NCT02411110|157850726|FG001|Treatment Period 1|Lost to Follow-up|0|||
49003794|NCT02411110|157850725|FG000|Treatment Period 1|Personal Reasons|2|||
49003795|NCT02411110|157850726|FG001|Treatment Period 1|Personal Reasons|5|||
49003796|NCT02411110|157850725|FG000|Treatment Period 1|Other Miscellaneous Reasons|2|||
49003797|NCT02411110|157850726|FG001|Treatment Period 1|Other Miscellaneous Reasons|0|||
49003798|NCT02411110|157850725|FG000|Treatment Period 2|Adverse Event|1|||
49003799|NCT02411110|157850726|FG001|Treatment Period 2|Adverse Event|0|||
49003800|NCT02411110|157850725|FG000|Treatment Period 2|Lost to Follow-up|0|||
49003801|NCT02411110|157850726|FG001|Treatment Period 2|Lost to Follow-up|2|||
49003802|NCT02411110|157850725|FG000|Treatment Period 2|Personal Reasons|0|||
49003803|NCT02411110|157850726|FG001|Treatment Period 2|Personal Reasons|2|||
49003804|NCT02406742|157850727|FG000|Overall Study|Progression of Disease|5|||
49003805|NCT02406742|157850728|FG001|Overall Study|Progression of Disease|1|||
49003806|NCT02406742|157850729|FG002|Overall Study|Progression of Disease|6|||
49003807|NCT02406742|157850727|FG000|Overall Study|Adverse Event|3|||
49003808|NCT02406742|157850728|FG001|Overall Study|Adverse Event|0|||
49003809|NCT02406742|157850729|FG002|Overall Study|Adverse Event|2|||
49003810|NCT02406742|157850727|FG000|Overall Study|Death|1|||
49003811|NCT02406742|157850728|FG001|Overall Study|Death|0|||
49003812|NCT02406742|157850729|FG002|Overall Study|Death|0|||
49003813|NCT02406742|157850727|FG000|Overall Study|Lack of Efficacy|0|||
49003814|NCT02406742|157850728|FG001|Overall Study|Lack of Efficacy|0|||
49003815|NCT02406742|157850729|FG002|Overall Study|Lack of Efficacy|1|||
49003816|NCT02406742|157850727|FG000|Overall Study|Withdrawal by Participant|1|||
49003817|NCT02406742|157850728|FG001|Overall Study|Withdrawal by Participant|2|||
49003818|NCT02406742|157850729|FG002|Overall Study|Withdrawal by Participant|0|||
49003819|NCT02406742|157850727|FG000|Overall Study|Physician Decision|1|||
49003820|NCT02406742|157850728|FG001|Overall Study|Physician Decision|2|||
49003821|NCT02406742|157850729|FG002|Overall Study|Physician Decision|1|||
49003822|NCT02406742|157850727|FG000|Overall Study|Transition to other treatment|2|||
49003823|NCT02406742|157850728|FG001|Overall Study|Transition to other treatment|0|||
49003824|NCT02406742|157850729|FG002|Overall Study|Transition to other treatment|1|||
49003825|NCT02406742|157850727|FG000|Overall Study|Other Reasons|1|||
49003826|NCT02406742|157850728|FG001|Overall Study|Other Reasons|11|||
49003827|NCT02406742|157850729|FG002|Overall Study|Other Reasons|5|||
49003828|NCT04057118|157850730|FG000|Overall Study|Adverse Event|1|||
49003829|NCT04057118|157850731|FG001|Overall Study|Adverse Event|0|||
49003830|NCT04057118|157850732|FG002|Overall Study|Adverse Event|1|||
49003831|NCT04057118|157850733|FG003|Overall Study|Adverse Event|1|||
49003832|NCT04057118|157850730|FG000|Overall Study|Physician Decision|0|||
49003833|NCT04057118|157850731|FG001|Overall Study|Physician Decision|0|||
49003834|NCT04057118|157850732|FG002|Overall Study|Physician Decision|1|||
49003835|NCT04057118|157850733|FG003|Overall Study|Physician Decision|1|||
49003836|NCT04057118|157850730|FG000|Overall Study|Withdrawal by Subject|2|||
49003837|NCT04057118|157850731|FG001|Overall Study|Withdrawal by Subject|2|||
49003838|NCT04057118|157850732|FG002|Overall Study|Withdrawal by Subject|0|||
49003839|NCT04057118|157850733|FG003|Overall Study|Withdrawal by Subject|2|||
49003840|NCT04057118|157850730|FG000|Overall Study|Not Specific|0|||
49003841|NCT04057118|157850731|FG001|Overall Study|Not Specific|0|||
49003842|NCT04057118|157850732|FG002|Overall Study|Not Specific|1|||
49003843|NCT04057118|157850733|FG003|Overall Study|Not Specific|1|||
49003844|NCT02742818|157850734|FG000|Overall Study|Adverse Event|0|||
49003845|NCT02742818|157850735|FG001|Overall Study|Adverse Event|1|||
49003846|NCT02742818|157850734|FG000|Overall Study|Protocol Violation|0|||
49003847|NCT02742818|157850735|FG001|Overall Study|Protocol Violation|1|||
49003848|NCT04701658|157850736|FG000|Overall Study|Lost to Follow-up|6|||
49003849|NCT03273712|157850750|FG000|Overall Study|Death|5|||
49003850|NCT03273712|157850750|FG000|Overall Study|Adverse Event|1|||
49003851|NCT03273712|157850750|FG000|Overall Study|Disease Progression|1|||
49003852|NCT02487979|157850753|FG000|Overall Study|Physician Decision|2|||
49003853|NCT02487979|157850753|FG000|Overall Study|Withdrawal by Subject|2|||
49003854|NCT02487979|157850753|FG000|Overall Study|Progressive Disease|17|||
49003855|NCT04333199|157850754|FG000|Evaluated Patients|Lost to Follow-up|0|||
49003856|NCT04333199|157850755|FG001|Evaluated Patients|Lost to Follow-up|1|||
49003857|NCT04333199|157850756|FG002|Evaluated Patients|Lost to Follow-up|2|||
49003858|NCT00627458|157850759|FG000|Overall Study|Migrated from study area|1|||
49003859|NCT00627458|157850760|FG001|Overall Study|Migrated from study area|0|||
49003860|NCT00627458|157850761|FG002|Overall Study|Migrated from study area|1|||
49003861|NCT00627458|157850759|FG000|Overall Study|Withdrawal by Subject|2|||
49003862|NCT00627458|157850760|FG001|Overall Study|Withdrawal by Subject|6|||
49003863|NCT00627458|157850761|FG002|Overall Study|Withdrawal by Subject|5|||
49003864|NCT00627458|157850759|FG000|Overall Study|Lost to Follow-up|1|||
49003865|NCT00627458|157850760|FG001|Overall Study|Lost to Follow-up|1|||
49003866|NCT00627458|157850761|FG002|Overall Study|Lost to Follow-up|0|||
49003867|NCT04529499|157850766|FG000|Overall Study|Withdrawal by Subject|9|||
49003868|NCT04529499|157850767|FG001|Overall Study|Withdrawal by Subject|11|||
49003869|NCT04529499|157850766|FG000|Overall Study|Physician Decision|1|||
49003870|NCT04529499|157850767|FG001|Overall Study|Physician Decision|2|||
49003871|NCT04529499|157850766|FG000|Overall Study|Adverse Event|4|||
49003872|NCT04529499|157850767|FG001|Overall Study|Adverse Event|4|||
49003873|NCT04529499|157850766|FG000|Overall Study|Death|14|||
49003874|NCT04529499|157850767|FG001|Overall Study|Death|11|||
49003875|NCT04529499|157850766|FG000|Overall Study|Lost to Follow-up|1|||
49003876|NCT04529499|157850767|FG001|Overall Study|Lost to Follow-up|1|||
49003877|NCT04529499|157850766|FG000|Overall Study|Others|7|||
49003878|NCT04529499|157850767|FG001|Overall Study|Others|11|||
49003879|NCT00758706|157850768|FG000|Overall Study|Adverse Event|4|||
49003880|NCT00758706|157850769|FG001|Overall Study|Adverse Event|4|||
49003881|NCT02913261|157850770|FG000|Overall Study|Technical problems|0|||
49003882|NCT02913261|157850771|FG001|Overall Study|Technical problems|1|||
49003883|NCT02913261|157850770|FG000|Overall Study|Lack of Efficacy|32|||
49003884|NCT02913261|157850771|FG001|Overall Study|Lack of Efficacy|69|||
49003885|NCT02913261|157850770|FG000|Overall Study|Adverse Event|27|||
49003886|NCT02913261|157850771|FG001|Overall Study|Adverse Event|5|||
49003887|NCT02913261|157850770|FG000|Overall Study|Death|25|||
49003888|NCT02913261|157850771|FG001|Overall Study|Death|22|||
49003889|NCT02913261|157850770|FG000|Overall Study|Failure to meet protocol continuation criteria|13|||
49003890|NCT02913261|157850771|FG001|Overall Study|Failure to meet protocol continuation criteria|10|||
49003891|NCT02913261|157850770|FG000|Overall Study|Disease relapse|8|||
49003892|NCT02913261|157850771|FG001|Overall Study|Disease relapse|13|||
49003893|NCT02913261|157850770|FG000|Overall Study|Physician Decision|8|||
49003894|NCT02913261|157850771|FG001|Overall Study|Physician Decision|9|||
49003895|NCT02913261|157850770|FG000|Overall Study|Subject/guardian decision|4|||
49003896|NCT02913261|157850771|FG001|Overall Study|Subject/guardian decision|6|||
49003897|NCT02913261|157850770|FG000|Overall Study|Graft loss|2|||
49003898|NCT02913261|157850771|FG001|Overall Study|Graft loss|0|||
49003899|NCT00808015|157850773|FG000|Overall Study|Death|1|||
49003900|NCT00808015|157850773|FG000|Overall Study|Lack of Efficacy|58|||
49003901|NCT00808015|157850773|FG000|Overall Study|Lost to Follow-up|76|||
49003902|NCT00808015|157850773|FG000|Overall Study|Participants not willing to participate|158|||
49003903|NCT00808015|157850773|FG000|Overall Study|Adverse Event|22|||
49003904|NCT00808015|157850773|FG000|Overall Study|Other|25|||
49003905|NCT00808015|157850773|FG000|Overall Study|Enrolled but not treated|4|||
49003906|NCT00435825|157850776|FG000|Overall Study|Abnormality of Laboratory Test|0|||
49003907|NCT00435825|157850777|FG001|Overall Study|Abnormality of Laboratory Test|1|||
49003908|NCT00435825|157850778|FG002|Overall Study|Abnormality of Laboratory Test|0|||
49003909|NCT00435825|157850779|FG003|Overall Study|Abnormality of Laboratory Test|0|||
49003910|NCT00435825|157850776|FG000|Overall Study|Insufficient Therapeutic Response|3|||
49003911|NCT00435825|157850777|FG001|Overall Study|Insufficient Therapeutic Response|1|||
49003912|NCT00435825|157850778|FG002|Overall Study|Insufficient Therapeutic Response|0|||
49003913|NCT00435825|157850779|FG003|Overall Study|Insufficient Therapeutic Response|3|||
49003914|NCT00435825|157850776|FG000|Overall Study|Other Protocol Violation|1|||
49003915|NCT00435825|157850777|FG001|Overall Study|Other Protocol Violation|0|||
49003916|NCT00435825|157850778|FG002|Overall Study|Other Protocol Violation|0|||
49003917|NCT00435825|157850779|FG003|Overall Study|Other Protocol Violation|0|||
49003918|NCT00435825|157850776|FG000|Overall Study|Refused treatment|2|||
49003919|NCT00435825|157850777|FG001|Overall Study|Refused treatment|0|||
49003920|NCT00435825|157850778|FG002|Overall Study|Refused treatment|0|||
49003921|NCT00435825|157850779|FG003|Overall Study|Refused treatment|5|||
49003922|NCT00435825|157850776|FG000|Overall Study|Failure to return|5|||
49003923|NCT00435825|157850777|FG001|Overall Study|Failure to return|0|||
49003924|NCT00435825|157850778|FG002|Overall Study|Failure to return|4|||
49003925|NCT00435825|157850779|FG003|Overall Study|Failure to return|0|||
49003926|NCT00435825|157850776|FG000|Overall Study|Did not receive study drug|1|||
49003927|NCT00435825|157850777|FG001|Overall Study|Did not receive study drug|0|||
49003928|NCT00435825|157850778|FG002|Overall Study|Did not receive study drug|2|||
49003929|NCT00435825|157850779|FG003|Overall Study|Did not receive study drug|0|||
49003930|NCT00435825|157850776|FG000|Overall Study|Did not enter follow-up|0|||
49003931|NCT00435825|157850777|FG001|Overall Study|Did not enter follow-up|4|||
49003932|NCT00435825|157850778|FG002|Overall Study|Did not enter follow-up|1|||
49003933|NCT00435825|157850779|FG003|Overall Study|Did not enter follow-up|3|||
49003934|NCT00435825|157850776|FG000|Overall Study|Did not complete full follow-up period|6|||
49003935|NCT00435825|157850777|FG001|Overall Study|Did not complete full follow-up period|6|||
49003936|NCT00435825|157850778|FG002|Overall Study|Did not complete full follow-up period|4|||
49003937|NCT00435825|157850779|FG003|Overall Study|Did not complete full follow-up period|5|||
49003938|NCT00555399|157850782|FG000|Overall Study|Withdrawal by Subject|0|||
49003939|NCT00555399|157850783|FG001|Overall Study|Withdrawal by Subject|0|||
49003940|NCT00555399|157850784|FG002|Overall Study|Withdrawal by Subject|1|||
49003941|NCT00555399|157850785|FG003|Overall Study|Withdrawal by Subject|0|||
49003942|NCT00555399|157850786|FG004|Overall Study|Withdrawal by Subject|0|||
49003943|NCT00555399|157850787|FG005|Overall Study|Withdrawal by Subject|0|||
49003944|NCT00555399|157850788|FG006|Overall Study|Withdrawal by Subject|0|||
49003945|NCT00555399|157850789|FG007|Overall Study|Withdrawal by Subject|0|||
49003946|NCT00555399|157850790|FG008|Overall Study|Withdrawal by Subject|0|||
49003947|NCT00555399|157850791|FG009|Overall Study|Withdrawal by Subject|0|||
49003948|NCT00555399|157850792|FG010|Overall Study|Withdrawal by Subject|0|||
49003949|NCT00555399|157850793|FG011|Overall Study|Withdrawal by Subject|1|||
49003950|NCT00555399|157850782|FG000|Overall Study|Patient decided not to proceed with treatment|0|||
49003951|NCT00555399|157850783|FG001|Overall Study|Patient decided not to proceed with treatment|0|||
49003952|NCT00555399|157850784|FG002|Overall Study|Patient decided not to proceed with treatment|1|||
49003953|NCT00555399|157850785|FG003|Overall Study|Patient decided not to proceed with treatment|0|||
49003954|NCT00555399|157850786|FG004|Overall Study|Patient decided not to proceed with treatment|0|||
49003955|NCT00555399|157850787|FG005|Overall Study|Patient decided not to proceed with treatment|0|||
49003956|NCT00555399|157850788|FG006|Overall Study|Patient decided not to proceed with treatment|0|||
49003957|NCT00555399|157850789|FG007|Overall Study|Patient decided not to proceed with treatment|0|||
49003958|NCT00555399|157850790|FG008|Overall Study|Patient decided not to proceed with treatment|0|||
49003959|NCT00555399|157850791|FG009|Overall Study|Patient decided not to proceed with treatment|0|||
49003960|NCT00555399|157850792|FG010|Overall Study|Patient decided not to proceed with treatment|0|||
49003961|NCT00555399|157850793|FG011|Overall Study|Patient decided not to proceed with treatment|0|||
49003962|NCT04639310|157850794|FG000|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|0|||
49003963|NCT04639310|157850795|FG001|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|1|||
49003964|NCT02703454|157852185|FG000|Overall Study|Not treated|1|||
49003965|NCT02703454|157852186|FG001|Overall Study|Not treated|3|||
49003966|NCT02703454|157852185|FG000|Overall Study|Withdrawal by Subject|4|||
49003967|NCT02703454|157852186|FG001|Overall Study|Withdrawal by Subject|3|||
49003968|NCT02703454|157852185|FG000|Overall Study|Lost to Follow-up|1|||
49003969|NCT02703454|157852186|FG001|Overall Study|Lost to Follow-up|2|||
49003970|NCT02703454|157852185|FG000|Overall Study|Study discontinuation|5|||
49003971|NCT02703454|157852186|FG001|Overall Study|Study discontinuation|8|||
49003972|NCT03349437|157852187|FG000|Screening|Screen Fail|4|||
49003973|NCT03349437|157852188|FG001|Screening|Screen Fail|0|||
49003974|NCT03349437|157852189|FG002|Screening|Screen Fail|0|||
49003975|NCT03349437|157852187|FG000|Screening|Withdrawn|1|||
49003976|NCT03349437|157852188|FG001|Screening|Withdrawn|0|||
49003977|NCT03349437|157852189|FG002|Screening|Withdrawn|0|||
49003978|NCT01461369|157852190|FG000|Overall Study|Lack of Efficacy|2|||
49003979|NCT01461369|157852191|FG001|Overall Study|Lack of Efficacy|0|||
49003980|NCT01461369|157852192|FG002|Overall Study|Lack of Efficacy|6|||
49003981|NCT01461369|157852190|FG000|Overall Study|Lost to Follow-up|0|||
49003982|NCT01461369|157852191|FG001|Overall Study|Lost to Follow-up|0|||
49003983|NCT01461369|157852192|FG002|Overall Study|Lost to Follow-up|3|||
49003984|NCT01461369|157852190|FG000|Overall Study|Adverse Event|9|||
49003985|NCT01461369|157852191|FG001|Overall Study|Adverse Event|12|||
49003986|NCT01461369|157852192|FG002|Overall Study|Adverse Event|4|||
49003987|NCT01461369|157852190|FG000|Overall Study|Protocol Violation|1|||
49003988|NCT01461369|157852191|FG001|Overall Study|Protocol Violation|2|||
49003989|NCT01461369|157852192|FG002|Overall Study|Protocol Violation|2|||
49003990|NCT01461369|157852190|FG000|Overall Study|Withdrawal by Subject|1|||
49003991|NCT01461369|157852191|FG001|Overall Study|Withdrawal by Subject|3|||
49003992|NCT01461369|157852192|FG002|Overall Study|Withdrawal by Subject|2|||
49003993|NCT02962739|157852194|FG000|Overall Study|Withdrawal by Subject|0|||
49003994|NCT02962739|157852195|FG001|Overall Study|Withdrawal by Subject|1|||
49003995|NCT02962739|157852196|FG002|Overall Study|Withdrawal by Subject|0|||
49003996|NCT02962739|157852197|FG003|Overall Study|Withdrawal by Subject|0|||
49003997|NCT02962739|157852198|FG004|Overall Study|Withdrawal by Subject|0|||
49003998|NCT02962739|157852199|FG005|Overall Study|Withdrawal by Subject|0|||
49003999|NCT02962739|157852194|FG000|Overall Study|Protocol Violation|0|||
49004000|NCT02962739|157852195|FG001|Overall Study|Protocol Violation|0|||
49004001|NCT02962739|157852196|FG002|Overall Study|Protocol Violation|1|||
49004002|NCT02962739|157852197|FG003|Overall Study|Protocol Violation|0|||
49004003|NCT02962739|157852198|FG004|Overall Study|Protocol Violation|1|||
49004004|NCT02962739|157852199|FG005|Overall Study|Protocol Violation|0|||
49004005|NCT00817778|157852201|FG000|Overall Study|Adverse Event|1|||
49004006|NCT00817778|157852202|FG001|Overall Study|Adverse Event|0|||
49004007|NCT00817778|157852201|FG000|Overall Study|Withdrawal by Subject|1|||
49004008|NCT00817778|157852202|FG001|Overall Study|Withdrawal by Subject|1|||
49004009|NCT00817778|157852201|FG000|Overall Study|Protocol Violation|0|||
49004010|NCT00817778|157852202|FG001|Overall Study|Protocol Violation|1|||
49004011|NCT00817778|157852201|FG000|Overall Study|Study-specific discontinuation criteria|0|||
49004012|NCT00817778|157852202|FG001|Overall Study|Study-specific discontinuation criteria|1|||
49004013|NCT00817778|157852201|FG000|Overall Study|Poor venous access|1|||
49004014|NCT00817778|157852202|FG001|Overall Study|Poor venous access|0|||
49004015|NCT03343054|157852203|FG000|Dose Escalation Period (Up to 286 Days)|Progressive Disease|2|||
49004016|NCT03343054|157852204|FG001|Dose Escalation Period (Up to 286 Days)|Progressive Disease|6|||
49046385|NCT02274558|158003844|FG001|Overall Study|Death|0|||
49004017|NCT03343054|157852205|FG002|Dose Escalation Period (Up to 286 Days)|Progressive Disease|0|||
49004018|NCT03343054|157852203|FG000|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|1|||
49004019|NCT03343054|157852204|FG001|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
49004020|NCT03343054|157852205|FG002|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
49004021|NCT03343054|157852203|FG000|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
49004022|NCT03343054|157852204|FG001|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
49004023|NCT03343054|157852205|FG002|Dose Expansion Period (Up to 502 Days)|Progressive Disease|11|||
49004024|NCT03343054|157852203|FG000|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
49004025|NCT03343054|157852204|FG001|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
49004026|NCT03343054|157852205|FG002|Dose Expansion Period (Up to 502 Days)|Ongoing|8|||
49004027|NCT01787188|157852208|FG000|Overall Study|Adverse Event|2|||
49004028|NCT01787188|157852209|FG001|Overall Study|Adverse Event|4|||
49004029|NCT01787188|157852210|FG002|Overall Study|Adverse Event|6|||
49004030|NCT01787188|157852208|FG000|Overall Study|Lack of Efficacy|7|||
49004031|NCT01787188|157852209|FG001|Overall Study|Lack of Efficacy|3|||
49004032|NCT01787188|157852210|FG002|Overall Study|Lack of Efficacy|5|||
49004033|NCT01787188|157852208|FG000|Overall Study|Non-compliance with Study Drug|0|||
49004034|NCT01787188|157852209|FG001|Overall Study|Non-compliance with Study Drug|1|||
49004035|NCT01787188|157852210|FG002|Overall Study|Non-compliance with Study Drug|0|||
49004036|NCT01787188|157852208|FG000|Overall Study|Withdrawal by Subject|4|||
49004037|NCT01787188|157852209|FG001|Overall Study|Withdrawal by Subject|3|||
49004038|NCT01787188|157852210|FG002|Overall Study|Withdrawal by Subject|2|||
49004039|NCT01787188|157852208|FG000|Overall Study|Protocol Violation|3|||
49004040|NCT01787188|157852209|FG001|Overall Study|Protocol Violation|2|||
49004041|NCT01787188|157852210|FG002|Overall Study|Protocol Violation|3|||
49004042|NCT01787188|157852208|FG000|Overall Study|Lost to Follow-up|1|||
49004043|NCT01787188|157852209|FG001|Overall Study|Lost to Follow-up|2|||
49004044|NCT01787188|157852210|FG002|Overall Study|Lost to Follow-up|2|||
49004045|NCT01787188|157852208|FG000|Overall Study|Other, including patient moved|0|||
49004046|NCT01787188|157852209|FG001|Overall Study|Other, including patient moved|3|||
49004047|NCT01787188|157852210|FG002|Overall Study|Other, including patient moved|0|||
49004048|NCT00854607|157852211|FG000|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65|||
49004049|NCT01162135|157852217|FG000|Overall Study|Withdrawal by Subject|1|||
49004050|NCT01162135|157852217|FG000|Overall Study|Severe back pain|1|||
49004051|NCT01162135|157852217|FG000|Overall Study|Ineligible|1|||
49004052|NCT01393626|157852218|FG000|Overall Study|Adverse Event|2|||
49004053|NCT01393626|157852219|FG001|Overall Study|Adverse Event|1|||
49004054|NCT01393626|157852220|FG002|Overall Study|Adverse Event|5|||
49004055|NCT01393626|157852221|FG003|Overall Study|Adverse Event|0|||
49004056|NCT01393626|157852218|FG000|Overall Study|Did not meet entrance criteria|1|||
49004057|NCT01393626|157852219|FG001|Overall Study|Did not meet entrance criteria|0|||
49004058|NCT01393626|157852220|FG002|Overall Study|Did not meet entrance criteria|0|||
49004059|NCT01393626|157852221|FG003|Overall Study|Did not meet entrance criteria|0|||
49004060|NCT01393626|157852218|FG000|Overall Study|Lack of Efficacy|6|||
49004061|NCT01393626|157852219|FG001|Overall Study|Lack of Efficacy|6|||
49004062|NCT01393626|157852220|FG002|Overall Study|Lack of Efficacy|4|||
49004063|NCT01393626|157852221|FG003|Overall Study|Lack of Efficacy|1|||
49004064|NCT01393626|157852218|FG000|Overall Study|Lost to Follow-up|1|||
49004065|NCT01393626|157852219|FG001|Overall Study|Lost to Follow-up|1|||
49004066|NCT01393626|157852220|FG002|Overall Study|Lost to Follow-up|1|||
49004067|NCT01393626|157852221|FG003|Overall Study|Lost to Follow-up|0|||
49004068|NCT01393626|157852218|FG000|Overall Study|Withdrawal by Subject|6|||
49004069|NCT01393626|157852219|FG001|Overall Study|Withdrawal by Subject|4|||
49004070|NCT01393626|157852220|FG002|Overall Study|Withdrawal by Subject|0|||
49004071|NCT01393626|157852221|FG003|Overall Study|Withdrawal by Subject|0|||
49004072|NCT01393626|157852218|FG000|Overall Study|Other|1|||
49004073|NCT01393626|157852219|FG001|Overall Study|Other|0|||
49004074|NCT01393626|157852220|FG002|Overall Study|Other|0|||
49004075|NCT01393626|157852221|FG003|Overall Study|Other|0|||
49004076|NCT01393626|157852218|FG000|Overall Study|Protocol Violation|1|||
49004077|NCT01393626|157852219|FG001|Overall Study|Protocol Violation|0|||
49004078|NCT01393626|157852220|FG002|Overall Study|Protocol Violation|2|||
49004079|NCT01393626|157852221|FG003|Overall Study|Protocol Violation|0|||
49004080|NCT02426125|157852222|FG000|Overall Study|Lost to Follow-up|14|||
49004081|NCT02426125|157852223|FG001|Overall Study|Lost to Follow-up|12|||
49004082|NCT02426125|157852222|FG000|Overall Study|Withdrawal by Subject|13|||
49004083|NCT02426125|157852223|FG001|Overall Study|Withdrawal by Subject|14|||
49004084|NCT02426125|157852222|FG000|Overall Study|Death|185|||
49004085|NCT02426125|157852223|FG001|Overall Study|Death|200|||
49004086|NCT02426125|157852222|FG000|Overall Study|Randomized, But Never Treated|5|||
49004087|NCT02426125|157852223|FG001|Overall Study|Randomized, But Never Treated|2|||
49004088|NCT04529096|157852224|FG000|Overall Study|Adverse Event|6|||
49004089|NCT04529096|157852225|FG001|Overall Study|Adverse Event|1|||
49004090|NCT04529096|157852224|FG000|Overall Study|Lack of Efficacy|1|||
49004091|NCT04529096|157852225|FG001|Overall Study|Lack of Efficacy|0|||
49004092|NCT04529096|157852224|FG000|Overall Study|Lost to Follow-up|1|||
49004093|NCT04529096|157852225|FG001|Overall Study|Lost to Follow-up|1|||
49004094|NCT04529096|157852224|FG000|Overall Study|Non-Compliance With Study Drug|0|||
49004095|NCT04529096|157852225|FG001|Overall Study|Non-Compliance With Study Drug|1|||
49004096|NCT04529096|157852224|FG000|Overall Study|Physician Decision|1|||
49004097|NCT04529096|157852225|FG001|Overall Study|Physician Decision|3|||
49004098|NCT04529096|157852224|FG000|Overall Study|Withdrawal by Subject|5|||
49004099|NCT04529096|157852225|FG001|Overall Study|Withdrawal by Subject|0|||
49004100|NCT01256398|157852226|FG000|Overall Study|Withdrawal by Subject|1|||
49004101|NCT01289990|157852227|FG000|Overall Study|Death|0|||
49004102|NCT01289990|157852228|FG001|Overall Study|Death|0|||
49004103|NCT01289990|157852229|FG002|Overall Study|Death|0|||
49004104|NCT01289990|157852230|FG003|Overall Study|Death|1|||
49004105|NCT01289990|157852231|FG004|Overall Study|Death|2|||
49004106|NCT01289990|157852232|FG005|Overall Study|Death|1|||
49004107|NCT01289990|157852233|FG006|Overall Study|Death|0|||
49004108|NCT01289990|157852234|FG007|Overall Study|Death|0|||
49004109|NCT01289990|157852235|FG008|Overall Study|Death|0|||
49004110|NCT01289990|157852236|FG009|Overall Study|Death|0|||
49004111|NCT01289990|157852237|FG010|Overall Study|Death|0|||
49004112|NCT01289990|157852238|FG011|Overall Study|Death|1|||
49004113|NCT01289990|157852239|FG012|Overall Study|Death|0|||
49004114|NCT01289990|157852227|FG000|Overall Study|Lost to Follow-up|3|||
49004115|NCT01289990|157852228|FG001|Overall Study|Lost to Follow-up|2|||
49004116|NCT01289990|157852229|FG002|Overall Study|Lost to Follow-up|5|||
49004117|NCT01289990|157852230|FG003|Overall Study|Lost to Follow-up|5|||
49004118|NCT01289990|157852231|FG004|Overall Study|Lost to Follow-up|3|||
49004119|NCT01289990|157852232|FG005|Overall Study|Lost to Follow-up|4|||
49004120|NCT01289990|157852233|FG006|Overall Study|Lost to Follow-up|2|||
49004121|NCT01289990|157852234|FG007|Overall Study|Lost to Follow-up|2|||
49004122|NCT01289990|157852235|FG008|Overall Study|Lost to Follow-up|1|||
49004123|NCT01289990|157852236|FG009|Overall Study|Lost to Follow-up|4|||
49004124|NCT01289990|157852237|FG010|Overall Study|Lost to Follow-up|2|||
49004125|NCT01289990|157852238|FG011|Overall Study|Lost to Follow-up|1|||
49004126|NCT01289990|157852239|FG012|Overall Study|Lost to Follow-up|2|||
49004127|NCT01289990|157852227|FG000|Overall Study|Withdrawal by Subject|15|||
49004128|NCT01289990|157852228|FG001|Overall Study|Withdrawal by Subject|14|||
49004129|NCT01289990|157852229|FG002|Overall Study|Withdrawal by Subject|12|||
49004130|NCT01289990|157852230|FG003|Overall Study|Withdrawal by Subject|13|||
49004131|NCT01289990|157852231|FG004|Overall Study|Withdrawal by Subject|8|||
49004132|NCT01289990|157852232|FG005|Overall Study|Withdrawal by Subject|7|||
49004133|NCT01289990|157852233|FG006|Overall Study|Withdrawal by Subject|13|||
49004134|NCT01289990|157852234|FG007|Overall Study|Withdrawal by Subject|9|||
49004135|NCT01289990|157852235|FG008|Overall Study|Withdrawal by Subject|12|||
49004136|NCT01289990|157852236|FG009|Overall Study|Withdrawal by Subject|13|||
49004137|NCT01289990|157852237|FG010|Overall Study|Withdrawal by Subject|11|||
49004138|NCT01289990|157852238|FG011|Overall Study|Withdrawal by Subject|13|||
49004139|NCT01289990|157852239|FG012|Overall Study|Withdrawal by Subject|16|||
49004140|NCT01289990|157852227|FG000|Overall Study|discontinued in preceding trial|18|||
49004141|NCT01289990|157852228|FG001|Overall Study|discontinued in preceding trial|20|||
49004142|NCT01289990|157852229|FG002|Overall Study|discontinued in preceding trial|41|||
49004143|NCT01289990|157852230|FG003|Overall Study|discontinued in preceding trial|17|||
49004144|NCT01289990|157852231|FG004|Overall Study|discontinued in preceding trial|11|||
49004145|NCT01289990|157852232|FG005|Overall Study|discontinued in preceding trial|12|||
49004146|NCT01289990|157852233|FG006|Overall Study|discontinued in preceding trial|18|||
49004147|NCT01289990|157852234|FG007|Overall Study|discontinued in preceding trial|8|||
49004148|NCT01289990|157852235|FG008|Overall Study|discontinued in preceding trial|17|||
49004149|NCT01289990|157852236|FG009|Overall Study|discontinued in preceding trial|21|||
49004150|NCT01289990|157852237|FG010|Overall Study|discontinued in preceding trial|17|||
49004151|NCT01289990|157852238|FG011|Overall Study|discontinued in preceding trial|17|||
49004152|NCT01289990|157852239|FG012|Overall Study|discontinued in preceding trial|24|||
49004153|NCT01289990|157852227|FG000|Overall Study|did not continue in extension|41|||
49004154|NCT01289990|157852228|FG001|Overall Study|did not continue in extension|45|||
49004155|NCT01289990|157852229|FG002|Overall Study|did not continue in extension|51|||
49004156|NCT01289990|157852230|FG003|Overall Study|did not continue in extension|51|||
49004157|NCT01289990|157852231|FG004|Overall Study|did not continue in extension|48|||
49004158|NCT01289990|157852232|FG005|Overall Study|did not continue in extension|50|||
49004159|NCT01289990|157852233|FG006|Overall Study|did not continue in extension|54|||
49004160|NCT01289990|157852234|FG007|Overall Study|did not continue in extension|36|||
49004161|NCT01289990|157852235|FG008|Overall Study|did not continue in extension|44|||
49004162|NCT01289990|157852236|FG009|Overall Study|did not continue in extension|48|||
49004163|NCT01289990|157852237|FG010|Overall Study|did not continue in extension|45|||
49004164|NCT01289990|157852238|FG011|Overall Study|did not continue in extension|34|||
49004165|NCT01289990|157852239|FG012|Overall Study|did not continue in extension|56|||
49004166|NCT01289990|157852227|FG000|Overall Study|Not treated|0|||
49004167|NCT01289990|157852228|FG001|Overall Study|Not treated|0|||
49004168|NCT01289990|157852229|FG002|Overall Study|Not treated|0|||
49004169|NCT01289990|157852230|FG003|Overall Study|Not treated|0|||
49004170|NCT01289990|157852231|FG004|Overall Study|Not treated|0|||
49004171|NCT01289990|157852232|FG005|Overall Study|Not treated|0|||
49004172|NCT01289990|157852233|FG006|Overall Study|Not treated|1|||
49004173|NCT01289990|157852234|FG007|Overall Study|Not treated|0|||
49004174|NCT01289990|157852235|FG008|Overall Study|Not treated|1|||
49004175|NCT01289990|157852236|FG009|Overall Study|Not treated|0|||
49004176|NCT01289990|157852237|FG010|Overall Study|Not treated|1|||
49004177|NCT01289990|157852238|FG011|Overall Study|Not treated|2|||
49004178|NCT01289990|157852239|FG012|Overall Study|Not treated|0|||
49004179|NCT00061945|157852240|FG000|Registration Through Course 3|Not Alemtuzumab Eligible|18|||
49004180|NCT00061945|157852241|FG001|Registration Through Course 3|Not Alemtuzumab Eligible|25|||
49004181|NCT00061945|157852240|FG000|Registration Through Course 3|Early discontinuation during course I-IV|76|||
49004182|NCT00061945|157852241|FG001|Registration Through Course 3|Early discontinuation during course I-IV|90|||
49004183|NCT00061945|157852240|FG000|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
49004184|NCT00061945|157852241|FG001|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
49004185|NCT00061945|157852240|FG000|Course IV: Alemtuzumab|Early exits|6|||
49004186|NCT00061945|157852241|FG001|Course IV: Alemtuzumab|Early exits|15|||
49004187|NCT00683904|157852242|FG000|Dose Level 1|Disease progression|2|||
49004188|NCT00683904|157852243|FG001|Dose Level 1|Disease progression|0|||
49004189|NCT00683904|157852242|FG000|Dose Level 1|Adverse Event|1|||
49004190|NCT00683904|157852243|FG001|Dose Level 1|Adverse Event|0|||
49004191|NCT00683904|157852242|FG000|Dose Level 2|Adverse Event|0|||
49004192|NCT00683904|157852243|FG001|Dose Level 2|Adverse Event|2|||
49004193|NCT03276962|157852244|FG000|Overall Study|Serious Adverse Event And/Or Pimd|2|||
49004194|NCT03276962|157852245|FG001|Overall Study|Serious Adverse Event And/Or Pimd|1|||
49004195|NCT03276962|157852246|FG002|Overall Study|Serious Adverse Event And/Or Pimd|0|||
49004196|NCT03276962|157852247|FG003|Overall Study|Serious Adverse Event And/Or Pimd|4|||
49004197|NCT03276962|157852248|FG004|Overall Study|Serious Adverse Event And/Or Pimd|1|||
49004198|NCT03276962|157852244|FG000|Overall Study|Protocol Deviation|2|||
49004199|NCT03276962|157852245|FG001|Overall Study|Protocol Deviation|0|||
49004200|NCT03276962|157852246|FG002|Overall Study|Protocol Deviation|1|||
49004201|NCT03276962|157852247|FG003|Overall Study|Protocol Deviation|2|||
49004202|NCT03276962|157852248|FG004|Overall Study|Protocol Deviation|1|||
49004203|NCT03276962|157852244|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
49004204|NCT03276962|157852245|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
49004205|NCT03276962|157852246|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
49004206|NCT03276962|157852247|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
49004207|NCT03276962|157852248|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
49004208|NCT03276962|157852244|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
49004209|NCT03276962|157852245|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
49004210|NCT03276962|157852246|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
49004211|NCT03276962|157852247|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
49004212|NCT03276962|157852248|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
49004213|NCT03276962|157852244|FG000|Overall Study|Lost to Follow-up|10|||
49004214|NCT03276962|157852245|FG001|Overall Study|Lost to Follow-up|10|||
49004215|NCT03276962|157852246|FG002|Overall Study|Lost to Follow-up|4|||
49004216|NCT03276962|157852247|FG003|Overall Study|Lost to Follow-up|6|||
49004217|NCT03276962|157852248|FG004|Overall Study|Lost to Follow-up|10|||
49004218|NCT03276962|157852244|FG000|Overall Study|Other|0|||
49004219|NCT03276962|157852245|FG001|Overall Study|Other|2|||
49004220|NCT03276962|157852246|FG002|Overall Study|Other|0|||
49004221|NCT03276962|157852247|FG003|Overall Study|Other|2|||
49004222|NCT03276962|157852248|FG004|Overall Study|Other|1|||
49004223|NCT00411762|157852249|FG000|Overall Study|Withdrawal by Subject|5|||
49004224|NCT05246111|157852255|FG000|Period 01|NOT ELIGIBLE IC5|1|||
49004225|NCT05246111|157852256|FG001|Period 01|NOT ELIGIBLE IC5|0|||
49004226|NCT05293743|157852257|FG000|Overall Study|Withdrawal by Subject|1|||
49004227|NCT05293743|157852258|FG001|Overall Study|Withdrawal by Subject|0|||
49004228|NCT02587325|157852259|FG000|16-Week Dose-finding Safety Part|Adverse Event|1|||
49004229|NCT02587325|157852260|FG001|16-Week Dose-finding Safety Part|Adverse Event|0|||
49004230|NCT02587325|157852261|FG002|16-Week Dose-finding Safety Part|Adverse Event|0|||
49004231|NCT02587325|157852262|FG003|16-Week Dose-finding Safety Part|Adverse Event|0|||
49004232|NCT02587325|157852263|FG004|16-Week Dose-finding Safety Part|Adverse Event|0|||
49004233|NCT02587325|157852259|FG000|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
49004234|NCT02587325|157852260|FG001|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
49004235|NCT02587325|157852261|FG002|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
49004236|NCT02587325|157852262|FG003|16-Week Dose-finding Safety Part|COVID-19 risk|1|||
49004237|NCT02587325|157852263|FG004|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
49004238|NCT02587325|157852259|FG000|32-Week Optional Extension Part|Adverse Event|0|||
49004239|NCT02587325|157852260|FG001|32-Week Optional Extension Part|Adverse Event|0|||
49004240|NCT02587325|157852261|FG002|32-Week Optional Extension Part|Adverse Event|1|||
49004241|NCT02587325|157852262|FG003|32-Week Optional Extension Part|Adverse Event|0|||
49004242|NCT02587325|157852263|FG004|32-Week Optional Extension Part|Adverse Event|0|||
49004243|NCT02587325|157852259|FG000|32-Week Optional Extension Part|Lost to Follow-up|0|||
49004244|NCT02587325|157852260|FG001|32-Week Optional Extension Part|Lost to Follow-up|0|||
49004245|NCT02587325|157852261|FG002|32-Week Optional Extension Part|Lost to Follow-up|1|||
49004246|NCT02587325|157852262|FG003|32-Week Optional Extension Part|Lost to Follow-up|0|||
49004247|NCT02587325|157852263|FG004|32-Week Optional Extension Part|Lost to Follow-up|1|||
49004248|NCT02149199|157852265|FG000|Overall Study|Study specific withdrawal criteria|4|||
49004249|NCT02149199|157852266|FG001|Overall Study|Study specific withdrawal criteria|21|||
49004250|NCT02149199|157852267|FG002|Overall Study|Study specific withdrawal criteria|6|||
49004251|NCT02149199|157852265|FG000|Overall Study|Other|20|||
49004252|NCT02149199|157852266|FG001|Overall Study|Other|25|||
49004253|NCT02149199|157852267|FG002|Overall Study|Other|20|||
49004254|NCT02149199|157852265|FG000|Overall Study|Eligibility criteria not fulfilled|9|||
49004255|NCT02149199|157852266|FG001|Overall Study|Eligibility criteria not fulfilled|14|||
49004256|NCT02149199|157852267|FG002|Overall Study|Eligibility criteria not fulfilled|8|||
49004257|NCT02149199|157852265|FG000|Overall Study|Withdrawal by Subject|75|||
49004258|NCT02149199|157852266|FG001|Overall Study|Withdrawal by Subject|93|||
49004259|NCT02149199|157852267|FG002|Overall Study|Withdrawal by Subject|77|||
49004260|NCT02149199|157852265|FG000|Overall Study|Protocol Violation|16|||
49004261|NCT02149199|157852266|FG001|Overall Study|Protocol Violation|13|||
49004262|NCT02149199|157852267|FG002|Overall Study|Protocol Violation|15|||
49004263|NCT02149199|157852265|FG000|Overall Study|Lost to Follow-up|3|||
49004264|NCT02149199|157852266|FG001|Overall Study|Lost to Follow-up|12|||
49004265|NCT02149199|157852267|FG002|Overall Study|Lost to Follow-up|11|||
49004266|NCT02149199|157852265|FG000|Overall Study|Death|0|||
49004267|NCT02149199|157852266|FG001|Overall Study|Death|0|||
49004268|NCT02149199|157852267|FG002|Overall Study|Death|1|||
49004269|NCT02149199|157852265|FG000|Overall Study|Adverse Event|6|||
49004270|NCT02149199|157852266|FG001|Overall Study|Adverse Event|15|||
49004271|NCT02149199|157852267|FG002|Overall Study|Adverse Event|9|||
49004272|NCT03909971|157852268|FG000|Overall Study|Other Reasons Not Specified|0|||
49004273|NCT03909971|157852269|FG001|Overall Study|Other Reasons Not Specified|1|||
49004274|NCT03909971|157852268|FG000|Overall Study|Global Deterioration of Health Status|2|||
49004275|NCT03909971|157852269|FG001|Overall Study|Global Deterioration of Health Status|1|||
49004276|NCT03909971|157852268|FG000|Overall Study|Progressive Disease|6|||
49004277|NCT03909971|157852269|FG001|Overall Study|Progressive Disease|14|||
49004278|NCT03909971|157852268|FG000|Overall Study|Death|2|||
49004279|NCT03909971|157852269|FG001|Overall Study|Death|6|||
49004280|NCT02989610|157852270|FG000|Overall Study|Withdrawal by Subject|20|||
49004281|NCT02989610|157852270|FG000|Overall Study|Departure of PI from Site|8|||
49004282|NCT02989610|157852270|FG000|Overall Study|Subject Participation Terminated by Investigator|6|||
49004283|NCT02989610|157852270|FG000|Overall Study|Lost to Follow-up|3|||
49004284|NCT02989610|157852270|FG000|Overall Study|Death|3|||
49004285|NCT02989610|157852270|FG000|Overall Study|System Explant|3|||
49004286|NCT02989610|157852270|FG000|Overall Study|Subject Non-Compliance|2|||
49004287|NCT02989610|157852270|FG000|Overall Study|System Revision|2|||
49004288|NCT02989610|157852270|FG000|Overall Study|PI Left, Study Closing|1|||
49004289|NCT02989610|157852270|FG000|Overall Study|Site Discontinued Participation in the Study|1|||
49004290|NCT02989610|157852270|FG000|Overall Study|Unable to Complete Visit Due to PI Leaving University|1|||
49004291|NCT02602080|157852273|FG000|Overall Study|Protocol Violation|6|||
49004292|NCT02602080|157852274|FG001|Overall Study|Protocol Violation|1|||
49004293|NCT02602080|157852275|FG002|Overall Study|Protocol Violation|3|||
49004294|NCT00759759|157852279|FG000|Overall Study|didn't return for period 2|1|||
49004295|NCT00759759|157852280|FG001|Overall Study|didn't return for period 2|0|||
49004296|NCT00759759|157852279|FG000|Overall Study|Didn't receive drug in period 2|1|||
49004297|NCT00759759|157852280|FG001|Overall Study|Didn't receive drug in period 2|0|||
49004298|NCT00759759|157852279|FG000|Overall Study|Withdrawal by Subject|2|||
49004299|NCT00759759|157852280|FG001|Overall Study|Withdrawal by Subject|1|||
49004300|NCT00430638|157852282|FG000|Overall Study|Adverse Event|15|||
49004301|NCT00430638|157852283|FG001|Overall Study|Adverse Event|15|||
49004302|NCT00430638|157852282|FG000|Overall Study|Uncontrolled blood pressure|48|||
49004303|NCT00430638|157852283|FG001|Overall Study|Uncontrolled blood pressure|13|||
49004304|NCT00430638|157852282|FG000|Overall Study|Lost to Follow-up|1|||
49004305|NCT00430638|157852283|FG001|Overall Study|Lost to Follow-up|7|||
49004306|NCT00430638|157852282|FG000|Overall Study|Protocol Violation|6|||
49004307|NCT00430638|157852283|FG001|Overall Study|Protocol Violation|4|||
49004308|NCT00430638|157852282|FG000|Overall Study|Withdrawal by Subject|4|||
49004309|NCT00430638|157852283|FG001|Overall Study|Withdrawal by Subject|6|||
49004310|NCT00430638|157852282|FG000|Overall Study|Non-compliant|2|||
49004311|NCT00430638|157852283|FG001|Overall Study|Non-compliant|1|||
49004312|NCT00430638|157852282|FG000|Overall Study|Other|2|||
49004313|NCT00430638|157852283|FG001|Overall Study|Other|2|||
49004314|NCT04651218|157853633|FG000|Overall Study|Withdrawal by Subject|0|||
49004315|NCT04651218|157853634|FG001|Overall Study|Withdrawal by Subject|2|||
49004316|NCT00765999|157853635|FG000|Overall Study|Adverse Event|203|||
49004317|NCT00765999|157853635|FG000|Overall Study|Insufficient Therapeutic Response|100|||
49004318|NCT00765999|157853635|FG000|Overall Study|Protocol Violation|95|||
49004319|NCT00765999|157853635|FG000|Overall Study|Consent Withdrawn|202|||
49004320|NCT00765999|157853635|FG000|Overall Study|Lost to Follow-up|131|||
49004321|NCT00765999|157853635|FG000|Overall Study|Study Terminated by Sponsor|2|||
49004322|NCT00765999|157853635|FG000|Overall Study|Other Miscellaneous Reasons|51|||
49004323|NCT03591107|157853639|FG000|Overall Study|Same patient in both arms|1|||
49004324|NCT03591107|157853640|FG001|Overall Study|Same patient in both arms|1|||
49004325|NCT03591107|157853639|FG000|Overall Study|Sought care at other clinics|0|||
49004326|NCT03591107|157853640|FG001|Overall Study|Sought care at other clinics|2|||
49004327|NCT03591107|157853639|FG000|Overall Study|Discharged from clinic|0|||
49004328|NCT03591107|157853640|FG001|Overall Study|Discharged from clinic|1|||
49004329|NCT03591107|157853639|FG000|Overall Study|Withdrawal by Subject|0|||
49004330|NCT03591107|157853640|FG001|Overall Study|Withdrawal by Subject|1|||
49004331|NCT02476851|157853643|FG000|Overall Study|Protocol Violation|1|||
49004332|NCT02476851|157853644|FG001|Overall Study|Protocol Violation|1|||
49004333|NCT02367729|157853647|FG000|Overall Study|Organic disorder diagnosed|2|||
49004334|NCT02367729|157853648|FG001|Overall Study|Organic disorder diagnosed|1|||
49004335|NCT02367729|157853647|FG000|Overall Study|Adverse Event|1|||
49004336|NCT02367729|157853648|FG001|Overall Study|Adverse Event|2|||
49004337|NCT02367729|157853647|FG000|Overall Study|Withdrawal by Subject|0|||
49004338|NCT02367729|157853648|FG001|Overall Study|Withdrawal by Subject|5|||
49004339|NCT03954184|157853651|FG000|Overall Study|Lost to Follow-up|500|||
49004340|NCT03954184|157853652|FG001|Overall Study|Lost to Follow-up|0|||
49004341|NCT02239601|157853661|FG000|Overall Study|Withdrawal by Subject|3|||
49004342|NCT02239601|157853662|FG001|Overall Study|Withdrawal by Subject|4|||
49004343|NCT02239601|157853661|FG000|Overall Study|Protocol Violation|4|||
49004344|NCT02239601|157853662|FG001|Overall Study|Protocol Violation|2|||
49004345|NCT01392170|157853663|FG000|Overall Study|Withdrawal by Subject|1|||
49004346|NCT01392170|157853663|FG000|Overall Study|Ineligible|1|||
49004347|NCT01890109|157853664|FG000|Overall Study|Withdrawal by Subject|0|||
49004348|NCT01890109|157853665|FG001|Overall Study|Withdrawal by Subject|3|||
49004349|NCT01890109|157853664|FG000|Overall Study|Lost to Follow-up|1|||
49004350|NCT01890109|157853665|FG001|Overall Study|Lost to Follow-up|2|||
49004351|NCT01286207|157853666|FG000|Overall Study|Adverse Event|27|||
49004352|NCT01286207|157853667|FG001|Overall Study|Adverse Event|41|||
49004353|NCT01286207|157853668|FG002|Overall Study|Adverse Event|8|||
49004354|NCT01286207|157853666|FG000|Overall Study|Lost to Follow-up|49|||
49004355|NCT01286207|157853667|FG001|Overall Study|Lost to Follow-up|43|||
49004356|NCT01286207|157853668|FG002|Overall Study|Lost to Follow-up|20|||
49004357|NCT01286207|157853666|FG000|Overall Study|Withdrawal by Subject|93|||
49004358|NCT01286207|157853667|FG001|Overall Study|Withdrawal by Subject|79|||
49004359|NCT01286207|157853668|FG002|Overall Study|Withdrawal by Subject|41|||
49004360|NCT01286207|157853666|FG000|Overall Study|Lack of Response|92|||
49004361|NCT01286207|157853667|FG001|Overall Study|Lack of Response|38|||
49004362|NCT01286207|157853668|FG002|Overall Study|Lack of Response|8|||
49004363|NCT01286207|157853666|FG000|Overall Study|Other|37|||
49004364|NCT01286207|157853667|FG001|Overall Study|Other|47|||
49004365|NCT01286207|157853668|FG002|Overall Study|Other|13|||
49004366|NCT01383954|157853672|FG000|Overall Study|Lack of Efficacy|2|||
49004367|NCT01383954|157853672|FG000|Overall Study|Electronic Diary Too Cumbersome to Use|2|||
49004368|NCT01383954|157853672|FG000|Overall Study|Adverse Event|1|||
49004369|NCT01383954|157853672|FG000|Overall Study|Reason Not Specified|9|||
49004370|NCT01643928|157853673|FG000|Overall Study|Lost to Follow-up|1|||
49004371|NCT01643928|157853674|FG001|Overall Study|Lost to Follow-up|0|||
49004372|NCT01643928|157853675|FG002|Overall Study|Lost to Follow-up|2|||
49004373|NCT01643928|157853676|FG003|Overall Study|Lost to Follow-up|0|||
49004374|NCT01643928|157853677|FG004|Overall Study|Lost to Follow-up|0|||
49004375|NCT01643928|157853673|FG000|Overall Study|Withdrawal by Subject|2|||
49004376|NCT01643928|157853674|FG001|Overall Study|Withdrawal by Subject|0|||
49004377|NCT01643928|157853675|FG002|Overall Study|Withdrawal by Subject|0|||
49004378|NCT01643928|157853676|FG003|Overall Study|Withdrawal by Subject|1|||
49004379|NCT01643928|157853677|FG004|Overall Study|Withdrawal by Subject|0|||
49004380|NCT01643928|157853673|FG000|Overall Study|Pregnancy|0|||
49004381|NCT01643928|157853674|FG001|Overall Study|Pregnancy|0|||
49004382|NCT01643928|157853675|FG002|Overall Study|Pregnancy|0|||
49004383|NCT01643928|157853676|FG003|Overall Study|Pregnancy|1|||
49004384|NCT01643928|157853677|FG004|Overall Study|Pregnancy|0|||
49004385|NCT01643928|157853673|FG000|Overall Study|Other|5|||
49004386|NCT01643928|157853674|FG001|Overall Study|Other|1|||
49004387|NCT01643928|157853675|FG002|Overall Study|Other|1|||
49004388|NCT01643928|157853676|FG003|Overall Study|Other|0|||
49004389|NCT01643928|157853677|FG004|Overall Study|Other|0|||
49004390|NCT01643928|157853673|FG000|Overall Study|Adverse Event|2|||
49004391|NCT01643928|157853674|FG001|Overall Study|Adverse Event|1|||
49004392|NCT01643928|157853675|FG002|Overall Study|Adverse Event|0|||
49004393|NCT01643928|157853676|FG003|Overall Study|Adverse Event|1|||
49004394|NCT01643928|157853677|FG004|Overall Study|Adverse Event|2|||
49004395|NCT00450177|157853679|FG000|Overall Study|Adverse Event|7|||
49004396|NCT00450177|157853680|FG001|Overall Study|Adverse Event|4|||
49004397|NCT00450177|157853679|FG000|Overall Study|Withdrawal by Subject|1|||
49004398|NCT00450177|157853680|FG001|Overall Study|Withdrawal by Subject|6|||
49004399|NCT00450177|157853679|FG000|Overall Study|Withdrawal by Primary Team|1|||
49004400|NCT00450177|157853680|FG001|Overall Study|Withdrawal by Primary Team|1|||
49004401|NCT04725240|157853683|FG000|Overall Study|Adverse Event|2|||
49004402|NCT04991311|157853684|FG000|Overall Study|Adverse Event|1|||
49004403|NCT02261974|157853693|FG000|Overall Study|Withdrawal by Subject|3|||
49004404|NCT02261974|157853694|FG001|Overall Study|Withdrawal by Subject|2|||
49004405|NCT02261974|157853693|FG000|Overall Study|Pregnancy|0|||
49004406|NCT02261974|157853694|FG001|Overall Study|Pregnancy|1|||
49004407|NCT02261974|157853693|FG000|Overall Study|Missed treatment cut-off date|6|||
49004408|NCT02261974|157853694|FG001|Overall Study|Missed treatment cut-off date|3|||
49004409|NCT02261974|157853693|FG000|Overall Study|Received partial treatment; FU to 1 mo|3|||
49004410|NCT02261974|157853694|FG001|Overall Study|Received partial treatment; FU to 1 mo|1|||
49004411|NCT02261974|157853693|FG000|Overall Study|Lost to Follow-up|2|||
49004412|NCT02261974|157853694|FG001|Overall Study|Lost to Follow-up|0|||
49004413|NCT02261974|157853693|FG000|Overall Study|Adverse Event|1|||
49004414|NCT02261974|157853694|FG001|Overall Study|Adverse Event|0|||
49004415|NCT00447694|157853697|FG000|Overall Study|Adverse Event|2|||
49004416|NCT00447694|157853697|FG000|Overall Study|Abnormal laboratory value|1|||
49004417|NCT00447694|157853697|FG000|Overall Study|Abnormal test procedure result|1|||
49004418|NCT00447694|157853697|FG000|Overall Study|Withdrawal by Subject|2|||
49004419|NCT01984229|157853698|FG000|Safety Follow-up Period|Adverse Event|1|||
49004420|NCT01984229|157853699|FG001|Safety Follow-up Period|Adverse Event|1|||
49004421|NCT01984229|157853698|FG000|Safety Follow-up Period|Lost to Follow-up|1|||
49004422|NCT01984229|157853699|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
49004423|NCT02072174|157853700|FG000|Overall Study|Did Not Meet In-/Exclusion Criteria|14|||
49004424|NCT02072174|157853701|FG001|Overall Study|Did Not Meet In-/Exclusion Criteria|15|||
49004425|NCT02072174|157853700|FG000|Overall Study|Protocol Violation|16|||
49004426|NCT02072174|157853701|FG001|Overall Study|Protocol Violation|23|||
49004427|NCT02072174|157853700|FG000|Overall Study|Physician Decision|0|||
49004428|NCT02072174|157853701|FG001|Overall Study|Physician Decision|1|||
49004429|NCT02072174|157853700|FG000|Overall Study|Non-compliance with protocol requirement|2|||
49004430|NCT02072174|157853701|FG001|Overall Study|Non-compliance with protocol requirement|0|||
49004431|NCT00709735|157853703|FG000|Overall Study|Lost to Follow-up|1|||
49004432|NCT00709735|157853704|FG001|Overall Study|Lost to Follow-up|1|||
49004433|NCT00709735|157853703|FG000|Overall Study|Relapse into Opioid Abuse|0|||
49004434|NCT00709735|157853704|FG001|Overall Study|Relapse into Opioid Abuse|1|||
49004435|NCT00709735|157853703|FG000|Overall Study|Did not meet PTSD Diagnostic Criteria|2|||
49004436|NCT00709735|157853704|FG001|Overall Study|Did not meet PTSD Diagnostic Criteria|0|||
49004437|NCT05674721|157853705|FG000|Washout Period (Up to 7 Days)|Adverse Event|0|||
49004438|NCT05674721|157853706|FG001|Washout Period (Up to 7 Days)|Adverse Event|1|||
49004439|NCT05674721|157853705|FG000|Washout Period (Up to 7 Days)|Withdrawal by Subject|0|||
49004440|NCT05674721|157853706|FG001|Washout Period (Up to 7 Days)|Withdrawal by Subject|1|||
49004441|NCT01333475|157853707|FG000|Overall Study|pt withdrew-need emergent radiation trmt|1|||
49004442|NCT01333475|157853708|FG001|Overall Study|pt withdrew-need emergent radiation trmt|0|||
49004443|NCT01333475|157853707|FG000|Overall Study|Toxicity|1|||
49004444|NCT01333475|157853708|FG001|Overall Study|Toxicity|3|||
49004445|NCT03891875|157853709|FG000|Overall Study|Withdrawal by Subject|20|||
49004446|NCT03891875|157853710|FG001|Overall Study|Withdrawal by Subject|3|||
49004447|NCT03891875|157853709|FG000|Overall Study|Adverse Event|10|||
49004448|NCT03891875|157853710|FG001|Overall Study|Adverse Event|4|||
49004449|NCT03891875|157853709|FG000|Overall Study|Physician Decision|1|||
49004450|NCT03891875|157853710|FG001|Overall Study|Physician Decision|1|||
49004451|NCT03891875|157853709|FG000|Overall Study|Protocol Violation|1|||
49004452|NCT03891875|157853710|FG001|Overall Study|Protocol Violation|0|||
49004453|NCT03891875|157853709|FG000|Overall Study|Lost to Follow-up|1|||
49004454|NCT03891875|157853710|FG001|Overall Study|Lost to Follow-up|0|||
49004455|NCT03891875|157853709|FG000|Overall Study|COVID-19 infection|1|||
49004456|NCT03891875|157853710|FG001|Overall Study|COVID-19 infection|0|||
49004457|NCT04440007|157853715|FG000|Overall Study|Adverse Event|0|||
49004458|NCT04440007|157853716|FG001|Overall Study|Adverse Event|1|||
49004459|NCT04440007|157853715|FG000|Overall Study|Lost to Follow-up|1|||
49004460|NCT04440007|157853716|FG001|Overall Study|Lost to Follow-up|3|||
49004461|NCT04440007|157853715|FG000|Overall Study|Death|7|||
49004462|NCT04440007|157853716|FG001|Overall Study|Death|2|||
49004463|NCT04440007|157853715|FG000|Overall Study|Physician Decision|1|||
49004464|NCT04440007|157853716|FG001|Overall Study|Physician Decision|1|||
49004465|NCT04440007|157853715|FG000|Overall Study|Withdrawal by Subject|2|||
49004466|NCT04440007|157853716|FG001|Overall Study|Withdrawal by Subject|1|||
49004467|NCT04440007|157853715|FG000|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|1|||
49004468|NCT04440007|157853716|FG001|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|2|||
49004469|NCT04440007|157853715|FG000|Overall Study|Discontinued prior to dosing|0|||
49004470|NCT04440007|157853716|FG001|Overall Study|Discontinued prior to dosing|2|||
49004471|NCT04926740|157853719|FG000|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|2|||
49004472|NCT04926740|157853720|FG001|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|1|||
49004473|NCT04926740|157853719|FG000|Overall Study|Ineligible: subsequently found to not have true DKA|7|||
49004474|NCT04926740|157853720|FG001|Overall Study|Ineligible: subsequently found to not have true DKA|4|||
49004475|NCT00963599|157853721|FG000|Overall Study|Adverse Event|2|||
49004476|NCT00963599|157853722|FG001|Overall Study|Adverse Event|0|||
49004477|NCT00963599|157853723|FG002|Overall Study|Adverse Event|1|||
49004478|NCT00963599|157853724|FG003|Overall Study|Adverse Event|2|||
49004479|NCT00963599|157853721|FG000|Overall Study|Lack of Efficacy|0|||
49004480|NCT00963599|157853722|FG001|Overall Study|Lack of Efficacy|2|||
49004481|NCT00963599|157853723|FG002|Overall Study|Lack of Efficacy|1|||
49004482|NCT00963599|157853724|FG003|Overall Study|Lack of Efficacy|4|||
49004483|NCT00963599|157853721|FG000|Overall Study|Lost to Follow-up|0|||
49004484|NCT00963599|157853722|FG001|Overall Study|Lost to Follow-up|1|||
49004485|NCT00963599|157853723|FG002|Overall Study|Lost to Follow-up|1|||
49004486|NCT00963599|157853724|FG003|Overall Study|Lost to Follow-up|1|||
49004487|NCT00963599|157853721|FG000|Overall Study|Protocol Violation|2|||
49004488|NCT00963599|157853722|FG001|Overall Study|Protocol Violation|2|||
49004489|NCT00963599|157853723|FG002|Overall Study|Protocol Violation|3|||
49004490|NCT00963599|157853724|FG003|Overall Study|Protocol Violation|4|||
49004491|NCT00963599|157853721|FG000|Overall Study|Withdrawal by Subject|2|||
49004492|NCT00963599|157853722|FG001|Overall Study|Withdrawal by Subject|1|||
49004493|NCT00963599|157853723|FG002|Overall Study|Withdrawal by Subject|3|||
49004494|NCT00963599|157853724|FG003|Overall Study|Withdrawal by Subject|3|||
49004495|NCT01610167|157853725|FG000|Overall Study|Scheduling conflict.|0|||
49004496|NCT01610167|157853726|FG001|Overall Study|Scheduling conflict.|0|||
49004497|NCT01610167|157853727|FG002|Overall Study|Scheduling conflict.|2|||
49004498|NCT01039584|157853728|FG000|Overall Study|Withdrawal by Subject|4|||
49004499|NCT01039584|157853729|FG001|Overall Study|Withdrawal by Subject|2|||
49004500|NCT01039584|157853730|FG002|Overall Study|Withdrawal by Subject|1|||
49004501|NCT01039584|157853728|FG000|Overall Study|Protocol Violation|10|||
49004502|NCT01039584|157853729|FG001|Overall Study|Protocol Violation|4|||
49004503|NCT01039584|157853730|FG002|Overall Study|Protocol Violation|6|||
49004504|NCT01039584|157853728|FG000|Overall Study|Lost to Follow-up|5|||
49004505|NCT01039584|157853729|FG001|Overall Study|Lost to Follow-up|3|||
49004506|NCT01039584|157853730|FG002|Overall Study|Lost to Follow-up|4|||
49004507|NCT01039584|157853728|FG000|Overall Study|Negative Baseline culture for Candida|59|||
49004508|NCT01039584|157853729|FG001|Overall Study|Negative Baseline culture for Candida|59|||
49004509|NCT01039584|157853730|FG002|Overall Study|Negative Baseline culture for Candida|24|||
49004510|NCT01039584|157853728|FG000|Overall Study|Lack of Efficacy|7|||
49004511|NCT01039584|157853729|FG001|Overall Study|Lack of Efficacy|6|||
49004512|NCT01039584|157853730|FG002|Overall Study|Lack of Efficacy|10|||
49004513|NCT01039584|157853728|FG000|Overall Study|other|1|||
49004514|NCT01039584|157853729|FG001|Overall Study|other|3|||
49004515|NCT01039584|157853730|FG002|Overall Study|other|1|||
49004516|NCT01039584|157853728|FG000|Overall Study|Pap smear with significant pathology|10|||
49004517|NCT01039584|157853729|FG001|Overall Study|Pap smear with significant pathology|10|||
49004518|NCT01039584|157853730|FG002|Overall Study|Pap smear with significant pathology|3|||
49004519|NCT01039584|157853728|FG000|Overall Study|Positive for Chlamydia or gonorrhea|7|||
49004520|NCT01039584|157853729|FG001|Overall Study|Positive for Chlamydia or gonorrhea|10|||
49004521|NCT01039584|157853730|FG002|Overall Study|Positive for Chlamydia or gonorrhea|8|||
49004522|NCT03197662|157853731|FG000|Overall Study|Withdrawn by family|0|||
49004523|NCT03197662|157853732|FG001|Overall Study|Withdrawn by family|2|||
49004524|NCT03672396|157853733|FG000|Overall Study|Withdrawal by Subject|4|||
49004525|NCT03672396|157853733|FG000|Overall Study|Physician Decision|1|||
49004526|NCT03672396|157853733|FG000|Overall Study|Adverse Event|1|||
49004527|NCT00929864|157853734|FG000|Overall Study|Death|1|||
49004528|NCT00929864|157853735|FG001|Overall Study|Death|1|||
49004529|NCT00929864|157853734|FG000|Overall Study|Adverse Event|11|||
49004530|NCT00929864|157853735|FG001|Overall Study|Adverse Event|30|||
49004531|NCT00929864|157853734|FG000|Overall Study|Lack of Efficacy|19|||
49004532|NCT00929864|157853735|FG001|Overall Study|Lack of Efficacy|16|||
49004533|NCT00929864|157853734|FG000|Overall Study|Lost to Follow-up|7|||
49004534|NCT00929864|157853735|FG001|Overall Study|Lost to Follow-up|12|||
49004535|NCT00929864|157853734|FG000|Overall Study|Withdrawal by Subject|20|||
49004536|NCT00929864|157853735|FG001|Overall Study|Withdrawal by Subject|9|||
49004537|NCT00929864|157853734|FG000|Overall Study|No longer met criteria|2|||
49004538|NCT00929864|157853735|FG001|Overall Study|No longer met criteria|1|||
49004539|NCT00929864|157853734|FG000|Overall Study|Poor or non-compliance|3|||
49004540|NCT00929864|157853735|FG001|Overall Study|Poor or non-compliance|3|||
49004541|NCT00929864|157853734|FG000|Overall Study|Pregnancy|0|||
49004542|NCT00929864|157853735|FG001|Overall Study|Pregnancy|3|||
49004543|NCT00929864|157853734|FG000|Overall Study|Administrative reason by Sponsor|1|||
49004544|NCT00929864|157853735|FG001|Overall Study|Administrative reason by Sponsor|1|||
49004545|NCT00929864|157853734|FG000|Overall Study|Non-specified|2|||
49004546|NCT00929864|157853735|FG001|Overall Study|Non-specified|7|||
49004547|NCT01214616|157853736|FG000|Overall Study|Progressive disease|2|||
49004548|NCT01214616|157853737|FG001|Overall Study|Progressive disease|2|||
49004549|NCT01214616|157853738|FG002|Overall Study|Progressive disease|2|||
49004550|NCT01214616|157853739|FG003|Overall Study|Progressive disease|4|||
49004551|NCT01214616|157853736|FG000|Overall Study|Dose limiting toxicity|0|||
49004552|NCT01214616|157853737|FG001|Overall Study|Dose limiting toxicity|2|||
49004553|NCT01214616|157853738|FG002|Overall Study|Dose limiting toxicity|0|||
49004554|NCT01214616|157853739|FG003|Overall Study|Dose limiting toxicity|0|||
49004555|NCT01214616|157853736|FG000|Overall Study|Other adverse events|0|||
49004556|NCT01214616|157853737|FG001|Overall Study|Other adverse events|1|||
49004557|NCT01214616|157853738|FG002|Overall Study|Other adverse events|1|||
49004558|NCT01214616|157853739|FG003|Overall Study|Other adverse events|1|||
49004559|NCT01214616|157853736|FG000|Overall Study|Withdrawal by Subject|1|||
49004560|NCT01214616|157853737|FG001|Overall Study|Withdrawal by Subject|0|||
49004561|NCT01214616|157853738|FG002|Overall Study|Withdrawal by Subject|0|||
49004562|NCT01214616|157853739|FG003|Overall Study|Withdrawal by Subject|1|||
49004563|NCT00000135|157853740|FG000|Overall Study|Death|27|||
49004564|NCT00000135|157853741|FG001|Overall Study|Death|14|||
49004565|NCT04572854|157853743|FG000|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
49004566|NCT04572854|157853744|FG001|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
49004567|NCT04572854|157853745|FG002|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
49004568|NCT04572854|157853746|FG003|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
49004569|NCT04572854|157853743|FG000|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
49004570|NCT04572854|157853744|FG001|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
49004571|NCT04572854|157853745|FG002|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|1|||
49004572|NCT04572854|157853746|FG003|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
49004573|NCT00295620|157853747|FG000|Overall Study|Lost to Follow-up|9|||
49004574|NCT00295620|157853748|FG001|Overall Study|Lost to Follow-up|5|||
49004575|NCT00295620|157853747|FG000|Overall Study|Withdrawal by Subject|37|||
49004576|NCT00295620|157853748|FG001|Overall Study|Withdrawal by Subject|50|||
49004577|NCT00295620|157853747|FG000|Overall Study|Death|206|||
49004578|NCT00295620|157853748|FG001|Overall Study|Death|207|||
49004579|NCT00295620|157853747|FG000|Overall Study|Other reasons|10|||
49004580|NCT00295620|157853748|FG001|Overall Study|Other reasons|9|||
49004581|NCT00295620|157853747|FG000|Overall Study|Discontinuation by sponsor|580|||
49004582|NCT00295620|157853748|FG001|Overall Study|Discontinuation by sponsor|593|||
49004583|NCT00295620|157853747|FG000|Overall Study|Protocol Violation|30|||
49004584|NCT00295620|157853748|FG001|Overall Study|Protocol Violation|32|||
49004585|NCT01066039|157853749|FG000|Overall Study|Adverse Event|6|||
49004586|NCT01066039|157853749|FG000|Overall Study|Withdrawal by Subject|17|||
49004587|NCT01066039|157853749|FG000|Overall Study|Protocol Violation|2|||
49004588|NCT01066039|157853749|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|9|||
49004589|NCT01066039|157853749|FG000|Overall Study|Investigator's Request|1|||
49004590|NCT01066039|157853749|FG000|Overall Study|Dropout due to Insulin Administration|1|||
49004591|NCT01066039|157853749|FG000|Overall Study|Additional Antihypertensive Required|4|||
49004592|NCT01066039|157853749|FG000|Overall Study|Volunteer Failed to Make the Next Visit|2|||
49004593|NCT01066039|157853749|FG000|Overall Study|Failure to Control Blood Pressure|1|||
49004594|NCT01066039|157853749|FG000|Overall Study|Drug/Dose Adjustment Required|1|||
49004595|NCT04508621|157853750|FG000|Overall Study|Adverse Event|39|||
49004596|NCT04508621|157853751|FG001|Overall Study|Adverse Event|16|||
49004597|NCT04508621|157853750|FG000|Overall Study|Lack of Efficacy|2|||
49004598|NCT04508621|157853751|FG001|Overall Study|Lack of Efficacy|8|||
49004599|NCT04508621|157853750|FG000|Overall Study|Physician Decision|0|||
49004600|NCT04508621|157853751|FG001|Overall Study|Physician Decision|1|||
49004601|NCT04508621|157853750|FG000|Overall Study|Withdrawal by Subject|10|||
49004602|NCT04508621|157853751|FG001|Overall Study|Withdrawal by Subject|14|||
49004603|NCT04508621|157853750|FG000|Overall Study|Lost to Follow-up|12|||
49004604|NCT04508621|157853751|FG001|Overall Study|Lost to Follow-up|9|||
49004605|NCT04508621|157853750|FG000|Overall Study|COVID-19 related crisis|3|||
49004606|NCT04508621|157853751|FG001|Overall Study|COVID-19 related crisis|0|||
49004607|NCT04508621|157853750|FG000|Overall Study|Subject non-compliance|1|||
49004608|NCT04508621|157853751|FG001|Overall Study|Subject non-compliance|0|||
49004609|NCT00530439|157853755|FG000|Overall Study|GDM|9|||
49004610|NCT00530439|157853756|FG001|Overall Study|GDM|3|||
49004611|NCT00530439|157853755|FG000|Overall Study|Withdraw|18|||
49004612|NCT00530439|157853756|FG001|Overall Study|Withdraw|14|||
49004613|NCT00530439|157853755|FG000|Overall Study|Missed abortion|1|||
49004614|NCT00530439|157853756|FG001|Overall Study|Missed abortion|4|||
49004615|NCT00530439|157853755|FG000|Overall Study|Misclassification|2|||
49004616|NCT00530439|157853756|FG001|Overall Study|Misclassification|0|||
49004617|NCT00530439|157853755|FG000|Overall Study|Twin pregnancy|0|||
49004618|NCT00530439|157853756|FG001|Overall Study|Twin pregnancy|2|||
49004619|NCT00530439|157853755|FG000|Overall Study|Severe malformation/abortion|0|||
49004620|NCT00530439|157853756|FG001|Overall Study|Severe malformation/abortion|3|||
49004621|NCT00414011|157855116|FG000|Overall Study|Physician Decision|3|||
49004622|NCT00414011|157855116|FG000|Overall Study|Withdrawal by Subject|2|||
49004623|NCT00337129|157855117|FG000|Overall Study|Adverse Event|4|||
49004624|NCT00337129|157855117|FG000|Overall Study|Withdrawal by Subject|1|||
49004625|NCT00337129|157855117|FG000|Overall Study|Lack of Efficacy|32|||
49004626|NCT00337129|157855117|FG000|Overall Study|Death|2|||
49004627|NCT00337129|157855117|FG000|Overall Study|not protocol specified|1|||
49004628|NCT00647426|157855118|FG000|Overall Study|Withdrawal by Subject|2|||
49004629|NCT00388674|157855121|FG000|Initial Treatment|Administrative Reason by Sponsor|241|||
49004630|NCT00388674|157855122|FG001|Initial Treatment|Administrative Reason by Sponsor|158|||
49004631|NCT00388674|157855121|FG000|Initial Treatment|Adverse Event|22|||
49004632|NCT00388674|157855122|FG001|Initial Treatment|Adverse Event|87|||
49004633|NCT00388674|157855121|FG000|Initial Treatment|Death|215|||
49004634|NCT00388674|157855122|FG001|Initial Treatment|Death|216|||
49004635|NCT00388674|157855121|FG000|Initial Treatment|Non-HCC HBV Disease Progression|11|||
49004636|NCT00388674|157855122|FG001|Initial Treatment|Non-HCC HBV Disease Progression|17|||
49004637|NCT00388674|157855121|FG000|Initial Treatment|HCC|12|||
49004638|NCT00388674|157855122|FG001|Initial Treatment|HCC|20|||
49004639|NCT00388674|157855121|FG000|Initial Treatment|Lost to Follow-up|526|||
49004640|NCT00388674|157855122|FG001|Initial Treatment|Lost to Follow-up|624|||
49004641|NCT00388674|157855121|FG000|Initial Treatment|Malignancy (Non-HCC)|7|||
49004642|NCT00388674|157855122|FG001|Initial Treatment|Malignancy (Non-HCC)|3|||
49004643|NCT00388674|157855121|FG000|Initial Treatment|Never Treated with Study Medication|1|||
49004644|NCT00388674|157855122|FG001|Initial Treatment|Never Treated with Study Medication|7|||
49004645|NCT00388674|157855121|FG000|Initial Treatment|Non-Study related Comorbidities|3|||
49004646|NCT00388674|157855122|FG001|Initial Treatment|Non-Study related Comorbidities|4|||
49004647|NCT00388674|157855121|FG000|Initial Treatment|Not Defined|125|||
49004648|NCT00388674|157855122|FG001|Initial Treatment|Not Defined|172|||
49004649|NCT00388674|157855121|FG000|Initial Treatment|Partial or inadequate Treatment|112|||
49004650|NCT00388674|157855122|FG001|Initial Treatment|Partial or inadequate Treatment|472|||
49004651|NCT00388674|157855121|FG000|Initial Treatment|Pregnancy|26|||
49004652|NCT00388674|157855122|FG001|Initial Treatment|Pregnancy|16|||
49004653|NCT00388674|157855121|FG000|Initial Treatment|Study Drug Toxicity|5|||
49004654|NCT00388674|157855122|FG001|Initial Treatment|Study Drug Toxicity|92|||
49004655|NCT00388674|157855121|FG000|Initial Treatment|Participant Request|501|||
49004656|NCT00388674|157855122|FG001|Initial Treatment|Participant Request|673|||
49004657|NCT00388674|157855121|FG000|Initial Treatment|No Off-Treatment Status Data|11|||
49004658|NCT00388674|157855122|FG001|Initial Treatment|No Off-Treatment Status Data|13|||
49004659|NCT00388674|157855121|FG000|Initial Treatment|Not Reported|10|||
49004660|NCT00388674|157855122|FG001|Initial Treatment|Not Reported|12|||
49004661|NCT00388674|157855121|FG000|End of Study|Administrative Reason By Sponsor|299|||
49004662|NCT00388674|157855122|FG001|End of Study|Administrative Reason By Sponsor|253|||
49004663|NCT00388674|157855121|FG000|End of Study|Death|239|||
49004664|NCT00388674|157855122|FG001|End of Study|Death|262|||
49004665|NCT00388674|157855121|FG000|End of Study|HBV Disease Progression (Non-HCC)|3|||
49004666|NCT00388674|157855122|FG001|End of Study|HBV Disease Progression (Non-HCC)|9|||
49004667|NCT00388674|157855121|FG000|End of Study|HCC|8|||
49004668|NCT00388674|157855122|FG001|End of Study|HCC|7|||
49004669|NCT00388674|157855121|FG000|End of Study|Lost to Follow-up|587|||
49004670|NCT00388674|157855122|FG001|End of Study|Lost to Follow-up|715|||
49004671|NCT00388674|157855121|FG000|End of Study|Malignancy (Non-HCC)|1|||
49004672|NCT00388674|157855122|FG001|End of Study|Malignancy (Non-HCC)|1|||
49004673|NCT00388674|157855121|FG000|End of Study|Non-Study Related Comorbidities|3|||
49004674|NCT00388674|157855122|FG001|End of Study|Non-Study Related Comorbidities|4|||
49004675|NCT00388674|157855121|FG000|End of Study|Not Defined|135|||
49004676|NCT00388674|157855122|FG001|End of Study|Not Defined|214|||
49004677|NCT00388674|157855121|FG000|End of Study|Participant Withdrew Consent|437|||
49004678|NCT00388674|157855122|FG001|End of Study|Participant Withdrew Consent|673|||
49004679|NCT00388674|157855121|FG000|End of Study|No Off-Treatment Status Data|22|||
49004680|NCT00388674|157855122|FG001|End of Study|No Off-Treatment Status Data|30|||
49004681|NCT00388674|157855121|FG000|End of Study|Not Reported|0|||
49004682|NCT00388674|157855122|FG001|End of Study|Not Reported|1|||
49004683|NCT00563524|157855123|FG000|Overall Study|Adverse Event|0|||
49004684|NCT00563524|157855124|FG001|Overall Study|Adverse Event|1|||
49004685|NCT00563524|157855125|FG002|Overall Study|Adverse Event|0|||
49004686|NCT00563524|157855126|FG003|Overall Study|Adverse Event|0|||
49004687|NCT00563524|157855127|FG004|Overall Study|Adverse Event|2|||
49004688|NCT00563524|157855128|FG005|Overall Study|Adverse Event|0|||
49004689|NCT00563524|157855123|FG000|Overall Study|Lost to Follow-up|1|||
49004690|NCT00563524|157855124|FG001|Overall Study|Lost to Follow-up|0|||
49004691|NCT00563524|157855125|FG002|Overall Study|Lost to Follow-up|0|||
49004692|NCT00563524|157855126|FG003|Overall Study|Lost to Follow-up|0|||
49004693|NCT00563524|157855127|FG004|Overall Study|Lost to Follow-up|0|||
49004694|NCT00563524|157855128|FG005|Overall Study|Lost to Follow-up|0|||
49004695|NCT00563524|157855123|FG000|Overall Study|Protocol Violation|0|||
49004696|NCT00563524|157855124|FG001|Overall Study|Protocol Violation|1|||
49004697|NCT00563524|157855125|FG002|Overall Study|Protocol Violation|0|||
49004698|NCT00563524|157855126|FG003|Overall Study|Protocol Violation|0|||
49004699|NCT00563524|157855127|FG004|Overall Study|Protocol Violation|0|||
49004700|NCT00563524|157855128|FG005|Overall Study|Protocol Violation|0|||
49004701|NCT00563524|157855123|FG000|Overall Study|Withdrawal by Subject|1|||
49004702|NCT00563524|157855124|FG001|Overall Study|Withdrawal by Subject|1|||
49004703|NCT00563524|157855125|FG002|Overall Study|Withdrawal by Subject|3|||
49004704|NCT00563524|157855126|FG003|Overall Study|Withdrawal by Subject|0|||
49004705|NCT00563524|157855127|FG004|Overall Study|Withdrawal by Subject|0|||
49004706|NCT00563524|157855128|FG005|Overall Study|Withdrawal by Subject|1|||
49004707|NCT03398200|157855132|FG000|Overall Study|Withdrawal by Subject|0|||
49004708|NCT03398200|157855133|FG001|Overall Study|Withdrawal by Subject|1|||
49004709|NCT00306852|157855134|FG000|Overall Study|Death|14|||
49004710|NCT00306852|157855135|FG001|Overall Study|Death|14|||
49004711|NCT00306852|157855134|FG000|Overall Study|Lost to Follow-up|15|||
49004712|NCT00306852|157855135|FG001|Overall Study|Lost to Follow-up|24|||
49004713|NCT04139668|157855136|FG000|Overall Study|Withdrawal by Subject|1|||
49004714|NCT00759174|157855141|FG000|Overall Study|Other|0|||
49004715|NCT00759174|157855142|FG001|Overall Study|Other|2|||
49004716|NCT01508325|157855143|FG000|Overall Study|Withdrawal by Subject|8|||
49004717|NCT01508325|157855144|FG001|Overall Study|Withdrawal by Subject|9|||
49004718|NCT01508325|157855143|FG000|Overall Study|Protocol Violation|0|||
49004719|NCT01508325|157855144|FG001|Overall Study|Protocol Violation|3|||
49004720|NCT01508325|157855143|FG000|Overall Study|Physician Decision|2|||
49004721|NCT01508325|157855144|FG001|Overall Study|Physician Decision|1|||
49004722|NCT01508325|157855143|FG000|Overall Study|Adverse Event|1|||
49004723|NCT01508325|157855144|FG001|Overall Study|Adverse Event|0|||
49004724|NCT01508325|157855143|FG000|Overall Study|Lost to Follow-up|5|||
49004725|NCT01508325|157855144|FG001|Overall Study|Lost to Follow-up|6|||
49004726|NCT01508325|157855143|FG000|Overall Study|Other|2|||
49004727|NCT01508325|157855144|FG001|Overall Study|Other|2|||
49004728|NCT01843374|157855145|FG000|Overall Study|Death|155|||
49004729|NCT01843374|157855146|FG001|Overall Study|Death|313|||
49004730|NCT01843374|157855145|FG000|Overall Study|Withdrawal by Subject|14|||
49004731|NCT01843374|157855146|FG001|Overall Study|Withdrawal by Subject|20|||
49004732|NCT01843374|157855145|FG000|Overall Study|Withdrawing due to Other reason|20|||
49004733|NCT01843374|157855146|FG001|Overall Study|Withdrawing due to Other reason|46|||
49004734|NCT04682639|157855147|FG000|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
49004735|NCT04682639|157855148|FG001|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
49004736|NCT04682639|157855149|FG002|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
49004737|NCT04682639|157855150|FG003|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
49004738|NCT04682639|157855151|FG004|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
49004739|NCT04682639|157855147|FG000|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
49004740|NCT04682639|157855148|FG001|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
49004741|NCT04682639|157855149|FG002|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
49004742|NCT04682639|157855150|FG003|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
49004743|NCT04682639|157855151|FG004|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
49004744|NCT04682639|157855147|FG000|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|2|||
49004745|NCT04682639|157855148|FG001|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|1|||
49004746|NCT04682639|157855149|FG002|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
49004747|NCT04682639|157855150|FG003|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
49004748|NCT04682639|157855151|FG004|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
49004749|NCT04682639|157855147|FG000|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
49004750|NCT04682639|157855148|FG001|Double-Blind Treatment Period (24 Weeks)|Pregnancy|1|||
49004751|NCT04682639|157855149|FG002|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
49004752|NCT04682639|157855150|FG003|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
49004753|NCT04682639|157855151|FG004|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
49004754|NCT04682639|157855147|FG000|Double-Blind Treatment Period (24 Weeks)|Non-compliance|2|||
49004755|NCT04682639|157855148|FG001|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
49004756|NCT04682639|157855149|FG002|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
49004757|NCT04682639|157855150|FG003|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
49004758|NCT04682639|157855151|FG004|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
49004759|NCT04682639|157855147|FG000|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
49004760|NCT04682639|157855148|FG001|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
49004761|NCT04682639|157855149|FG002|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
49004762|NCT04682639|157855150|FG003|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
49004763|NCT04682639|157855151|FG004|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
49004764|NCT04682639|157855147|FG000|OLE Period (28 Weeks)|Non-compliance|1|||
49004765|NCT04682639|157855148|FG001|OLE Period (28 Weeks)|Non-compliance|0|||
49004766|NCT04682639|157855149|FG002|OLE Period (28 Weeks)|Non-compliance|0|||
49004767|NCT04682639|157855150|FG003|OLE Period (28 Weeks)|Non-compliance|0|||
49004768|NCT04682639|157855151|FG004|OLE Period (28 Weeks)|Non-compliance|1|||
49004769|NCT04682639|157855147|FG000|OLE Period (28 Weeks)|Other|1|||
49004770|NCT04682639|157855148|FG001|OLE Period (28 Weeks)|Other|2|||
49004771|NCT04682639|157855149|FG002|OLE Period (28 Weeks)|Other|0|||
49004772|NCT04682639|157855150|FG003|OLE Period (28 Weeks)|Other|0|||
49004773|NCT04682639|157855151|FG004|OLE Period (28 Weeks)|Other|1|||
49004774|NCT04682639|157855147|FG000|OLE Period (28 Weeks)|Lack of Efficacy|2|||
49004775|NCT04682639|157855148|FG001|OLE Period (28 Weeks)|Lack of Efficacy|1|||
49004776|NCT04682639|157855149|FG002|OLE Period (28 Weeks)|Lack of Efficacy|0|||
49004777|NCT04682639|157855150|FG003|OLE Period (28 Weeks)|Lack of Efficacy|0|||
49004778|NCT04682639|157855151|FG004|OLE Period (28 Weeks)|Lack of Efficacy|0|||
49004779|NCT04682639|157855147|FG000|OLE Period (28 Weeks)|Lost to Follow-up|1|||
49004780|NCT04682639|157855148|FG001|OLE Period (28 Weeks)|Lost to Follow-up|1|||
49004781|NCT04682639|157855149|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
49004782|NCT04682639|157855150|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
49004783|NCT04682639|157855151|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
49004784|NCT04682639|157855147|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
49004785|NCT04682639|157855148|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
49004786|NCT04682639|157855149|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
49004787|NCT04682639|157855150|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
49004788|NCT04682639|157855151|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
49004789|NCT04682639|157855147|FG000|OLE Period (28 Weeks)|Adverse Event|3|||
49004790|NCT04682639|157855148|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
49004791|NCT04682639|157855149|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
49004792|NCT04682639|157855150|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
49004793|NCT04682639|157855151|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
49004794|NCT00883740|157855152|FG000|First Intervention|Lost to Follow-up|1|||
49004795|NCT00883740|157855153|FG001|First Intervention|Lost to Follow-up|0|||
49004796|NCT00883740|157855152|FG000|First Intervention|No longer willing to participate|2|||
49004797|NCT00883740|157855153|FG001|First Intervention|No longer willing to participate|0|||
49004798|NCT00883740|157855152|FG000|First Intervention|Protocol Violation|3|||
49004799|NCT00883740|157855153|FG001|First Intervention|Protocol Violation|6|||
49004800|NCT00883740|157855152|FG000|First Intervention|Adverse Event|1|||
49004801|NCT00883740|157855153|FG001|First Intervention|Adverse Event|2|||
49004802|NCT00883740|157855152|FG000|Second Intervention|Protocol Violation|1|||
49004803|NCT00883740|157855153|FG001|Second Intervention|Protocol Violation|0|||
49004804|NCT00883740|157855152|FG000|Second Intervention|No longer willing to participate|0|||
49004805|NCT00883740|157855153|FG001|Second Intervention|No longer willing to participate|1|||
49004806|NCT02562235|157855154|FG000|Overall Study|Adverse Event|3|||
49004807|NCT00981409|157855157|FG000|Overall Study|Adverse Event|4|||
49004808|NCT00981409|157855158|FG001|Overall Study|Adverse Event|0|||
49004809|NCT00981409|157855157|FG000|Overall Study|Protocol Violation|0|||
49004810|NCT00981409|157855158|FG001|Overall Study|Protocol Violation|1|||
49004811|NCT00981409|157855157|FG000|Overall Study|Prostate Cancer Treatment before Trial|2|||
49004812|NCT00981409|157855158|FG001|Overall Study|Prostate Cancer Treatment before Trial|0|||
49004813|NCT02652260|157855161|FG000|Base Study|Pregnancy|0|||
49004814|NCT02652260|157855162|FG001|Base Study|Pregnancy|1|||
49004815|NCT02652260|157855161|FG000|Base Study|Withdrawal by Subject|0|||
49004816|NCT02652260|157855162|FG001|Base Study|Withdrawal by Subject|1|||
49004817|NCT02652260|157855161|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|1|||
49004818|NCT02652260|157855162|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|2|||
49004819|NCT02652260|157855161|FG000|Study Extension 1 (Open-Label)|Pregnancy|1|||
49004820|NCT02652260|157855162|FG001|Study Extension 1 (Open-Label)|Pregnancy|1|||
49004821|NCT02652260|157855161|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
49004822|NCT02652260|157855162|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
49004823|NCT02652260|157855161|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
49004824|NCT02652260|157855162|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
49004825|NCT02652260|157855161|FG000|Study Extension 1 (Open-Label)|Adverse Event|0|||
49004826|NCT02652260|157855162|FG001|Study Extension 1 (Open-Label)|Adverse Event|2|||
49004827|NCT02652260|157855161|FG000|Study Extension 2 (Open-Label)|Adverse Event|1|||
49004828|NCT02652260|157855162|FG001|Study Extension 2 (Open-Label)|Adverse Event|0|||
49004829|NCT02652260|157855161|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|18|||
49004830|NCT02652260|157855162|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|13|||
49004831|NCT02652260|157855161|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
49004832|NCT02652260|157855162|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|0|||
49004833|NCT02652260|157855161|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|1|||
49004834|NCT02652260|157855162|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
49004835|NCT02652260|157855161|FG000|Study Extension 2 (Open-Label)|Pregnancy|1|||
49004836|NCT02652260|157855162|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
49004837|NCT02652260|157855161|FG000|Study Extension 3 (Open-Label)|Physician Decision|7|||
49004838|NCT02652260|157855162|FG001|Study Extension 3 (Open-Label)|Physician Decision|10|||
49004839|NCT02652260|157855161|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
49004840|NCT02652260|157855162|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
49004841|NCT03203473|157855163|FG000|Induction Phase|Never started primary treatment|2|||
49004842|NCT03203473|157855164|FG001|Induction Phase|Never started primary treatment|0|||
49004843|NCT03203473|157855165|FG002|Induction Phase|Never started primary treatment|0|||
49004844|NCT03203473|157855163|FG000|Induction Phase|Withdrew from study due to progressive disease|7|||
49004845|NCT03203473|157855164|FG001|Induction Phase|Withdrew from study due to progressive disease|0|||
48692642|NCT03001557|156724546|FG005|Extension Phase|Lost to Follow-up|0|||
49004846|NCT03203473|157855165|FG002|Induction Phase|Withdrew from study due to progressive disease|0|||
49004847|NCT03203473|157855163|FG000|Induction Phase|Withdrew from study due to toxicity|7|||
49004848|NCT03203473|157855164|FG001|Induction Phase|Withdrew from study due to toxicity|0|||
49004849|NCT03203473|157855165|FG002|Induction Phase|Withdrew from study due to toxicity|0|||
49004850|NCT03203473|157855163|FG000|Arm Allocation Phase|Still on Arm A-observation|0|||
49004851|NCT03203473|157855164|FG001|Arm Allocation Phase|Still on Arm A-observation|7|||
49004852|NCT03203473|157855165|FG002|Arm Allocation Phase|Still on Arm A-observation|0|||
49004853|NCT03203473|157855163|FG000|Arm Allocation Phase|started salvage therapy|0|||
49004854|NCT03203473|157855164|FG001|Arm Allocation Phase|started salvage therapy|5|||
49004855|NCT03203473|157855165|FG002|Arm Allocation Phase|started salvage therapy|0|||
49004856|NCT03203473|157855163|FG000|Arm Allocation Phase|Disease progression|0|||
49004857|NCT03203473|157855164|FG001|Arm Allocation Phase|Disease progression|0|||
49004858|NCT03203473|157855165|FG002|Arm Allocation Phase|Disease progression|37|||
49004859|NCT03203473|157855163|FG000|Arm Allocation Phase|Adverse Event|0|||
49004860|NCT03203473|157855164|FG001|Arm Allocation Phase|Adverse Event|0|||
49004861|NCT03203473|157855165|FG002|Arm Allocation Phase|Adverse Event|11|||
49004862|NCT03203473|157855163|FG000|Arm Allocation Phase|Physician Decision|0|||
49004863|NCT03203473|157855164|FG001|Arm Allocation Phase|Physician Decision|0|||
49004864|NCT03203473|157855165|FG002|Arm Allocation Phase|Physician Decision|3|||
49004865|NCT03203473|157855163|FG000|Arm Allocation Phase|Death|0|||
49004866|NCT03203473|157855164|FG001|Arm Allocation Phase|Death|0|||
49004867|NCT03203473|157855165|FG002|Arm Allocation Phase|Death|1|||
49004868|NCT03203473|157855163|FG000|Arm Allocation Phase|Developed 2nd cancer|0|||
49004869|NCT03203473|157855164|FG001|Arm Allocation Phase|Developed 2nd cancer|0|||
49004870|NCT03203473|157855165|FG002|Arm Allocation Phase|Developed 2nd cancer|1|||
49004871|NCT03203473|157855163|FG000|Arm Allocation Phase|Intercurrent illness|0|||
49004872|NCT03203473|157855164|FG001|Arm Allocation Phase|Intercurrent illness|0|||
49004873|NCT03203473|157855165|FG002|Arm Allocation Phase|Intercurrent illness|1|||
49004874|NCT03203473|157855163|FG000|Arm Allocation Phase|Still on arm-B treatment|0|||
49004875|NCT03203473|157855164|FG001|Arm Allocation Phase|Still on arm-B treatment|0|||
49004876|NCT03203473|157855165|FG002|Arm Allocation Phase|Still on arm-B treatment|3|||
49004877|NCT02923115|157855174|FG000|Overall Study|Lost to Follow-up|0|||
49004878|NCT02923115|157855175|FG001|Overall Study|Lost to Follow-up|0|||
49004879|NCT02923115|157855176|FG002|Overall Study|Lost to Follow-up|0|||
49004880|NCT02923115|157855177|FG003|Overall Study|Lost to Follow-up|1|||
49004881|NCT02923115|157855178|FG004|Overall Study|Lost to Follow-up|0|||
49004882|NCT02923115|157855179|FG005|Overall Study|Lost to Follow-up|0|||
49004883|NCT02923115|157855174|FG000|Overall Study|Withdrawal by Subject|0|||
49004884|NCT02923115|157855175|FG001|Overall Study|Withdrawal by Subject|1|||
49004885|NCT02923115|157855176|FG002|Overall Study|Withdrawal by Subject|0|||
49004886|NCT02923115|157855177|FG003|Overall Study|Withdrawal by Subject|0|||
49004887|NCT02923115|157855178|FG004|Overall Study|Withdrawal by Subject|0|||
49004888|NCT02923115|157855179|FG005|Overall Study|Withdrawal by Subject|0|||
49004889|NCT02923115|157855174|FG000|Overall Study|Randomized, but not dosed|0|||
49004890|NCT02923115|157855175|FG001|Overall Study|Randomized, but not dosed|0|||
49004891|NCT02923115|157855176|FG002|Overall Study|Randomized, but not dosed|3|||
49004892|NCT02923115|157855177|FG003|Overall Study|Randomized, but not dosed|1|||
49004893|NCT02923115|157855178|FG004|Overall Study|Randomized, but not dosed|5|||
49004894|NCT02923115|157855179|FG005|Overall Study|Randomized, but not dosed|0|||
49004895|NCT04300647|157855180|FG000|Pre-Crossover|Death|19|||
49004896|NCT04300647|157855181|FG001|Pre-Crossover|Death|58|||
49004897|NCT04300647|157855182|FG002|Pre-Crossover|Death|0|||
49004898|NCT04300647|157855180|FG000|Pre-Crossover|Lost to Follow-up|0|||
49004899|NCT04300647|157855181|FG001|Pre-Crossover|Lost to Follow-up|3|||
49004900|NCT04300647|157855182|FG002|Pre-Crossover|Lost to Follow-up|0|||
49004901|NCT04300647|157855180|FG000|Pre-Crossover|Withdrawal by Subject|2|||
49004902|NCT04300647|157855181|FG001|Pre-Crossover|Withdrawal by Subject|4|||
49004903|NCT04300647|157855182|FG002|Pre-Crossover|Withdrawal by Subject|0|||
49004904|NCT04300647|157855180|FG000|Pre-Crossover|On-going in Study|24|||
49004905|NCT04300647|157855181|FG001|Pre-Crossover|On-going in Study|61|||
49004906|NCT04300647|157855182|FG002|Pre-Crossover|On-going in Study|0|||
49004907|NCT04300647|157855180|FG000|Post-Crossover|Death|0|||
49004908|NCT04300647|157855181|FG001|Post-Crossover|Death|0|||
49004909|NCT04300647|157855182|FG002|Post-Crossover|Death|3|||
49004910|NCT04300647|157855180|FG000|Post-Crossover|Lost to Follow-up|0|||
49004911|NCT04300647|157855181|FG001|Post-Crossover|Lost to Follow-up|0|||
49004912|NCT04300647|157855182|FG002|Post-Crossover|Lost to Follow-up|1|||
49004913|NCT04300647|157855180|FG000|Post-Crossover|Withdrawal by Subject|0|||
49004914|NCT04300647|157855181|FG001|Post-Crossover|Withdrawal by Subject|0|||
49004915|NCT04300647|157855182|FG002|Post-Crossover|Withdrawal by Subject|1|||
49004916|NCT04300647|157855180|FG000|Post-Crossover|On-going in Study|0|||
49004917|NCT04300647|157855181|FG001|Post-Crossover|On-going in Study|0|||
49004918|NCT04300647|157855182|FG002|Post-Crossover|On-going in Study|8|||
49004919|NCT00568776|157855185|FG000|Overall Study|Adverse Event|8|||
49004920|NCT00568776|157855186|FG001|Overall Study|Adverse Event|8|||
49004921|NCT00568776|157855187|FG002|Overall Study|Adverse Event|10|||
49004922|NCT00568776|157855188|FG003|Overall Study|Adverse Event|8|||
49004923|NCT00568776|157855185|FG000|Overall Study|Death|0|||
49004924|NCT00568776|157855186|FG001|Overall Study|Death|1|||
49004925|NCT00568776|157855187|FG002|Overall Study|Death|4|||
49004926|NCT00568776|157855188|FG003|Overall Study|Death|3|||
49004927|NCT00568776|157855185|FG000|Overall Study|Physician Decision|0|||
49004928|NCT00568776|157855186|FG001|Overall Study|Physician Decision|2|||
49004929|NCT00568776|157855187|FG002|Overall Study|Physician Decision|0|||
49004930|NCT00568776|157855188|FG003|Overall Study|Physician Decision|0|||
49004931|NCT00568776|157855185|FG000|Overall Study|Lack of Efficacy|2|||
49004932|NCT00568776|157855186|FG001|Overall Study|Lack of Efficacy|2|||
49004933|NCT00568776|157855187|FG002|Overall Study|Lack of Efficacy|2|||
49004934|NCT00568776|157855188|FG003|Overall Study|Lack of Efficacy|4|||
49004935|NCT00568776|157855185|FG000|Overall Study|Lost to Follow-up|1|||
49004936|NCT00568776|157855186|FG001|Overall Study|Lost to Follow-up|1|||
49004937|NCT00568776|157855187|FG002|Overall Study|Lost to Follow-up|1|||
49004938|NCT00568776|157855188|FG003|Overall Study|Lost to Follow-up|1|||
49004939|NCT00568776|157855185|FG000|Overall Study|Protocol Violation|1|||
49004940|NCT00568776|157855186|FG001|Overall Study|Protocol Violation|0|||
49004941|NCT00568776|157855187|FG002|Overall Study|Protocol Violation|1|||
49004942|NCT00568776|157855188|FG003|Overall Study|Protocol Violation|1|||
49004943|NCT00568776|157855185|FG000|Overall Study|Withdrawal by Subject|13|||
49004944|NCT00568776|157855186|FG001|Overall Study|Withdrawal by Subject|15|||
49004945|NCT00568776|157855187|FG002|Overall Study|Withdrawal by Subject|13|||
49004946|NCT00568776|157855188|FG003|Overall Study|Withdrawal by Subject|7|||
49004947|NCT00568776|157855185|FG000|Overall Study|Loss of Caregiver|0|||
49004948|NCT00568776|157855186|FG001|Overall Study|Loss of Caregiver|2|||
49004949|NCT00568776|157855187|FG002|Overall Study|Loss of Caregiver|1|||
49004950|NCT00568776|157855188|FG003|Overall Study|Loss of Caregiver|2|||
49004951|NCT00568776|157855185|FG000|Overall Study|Sponsor Decision|2|||
49004952|NCT00568776|157855186|FG001|Overall Study|Sponsor Decision|2|||
49004953|NCT00568776|157855187|FG002|Overall Study|Sponsor Decision|41|||
49004954|NCT00568776|157855188|FG003|Overall Study|Sponsor Decision|42|||
49004955|NCT00568776|157855185|FG000|Overall Study|Miscellaeneous|3|||
49004956|NCT00568776|157855186|FG001|Overall Study|Miscellaeneous|3|||
49004957|NCT00568776|157855187|FG002|Overall Study|Miscellaeneous|1|||
49004958|NCT00568776|157855188|FG003|Overall Study|Miscellaeneous|4|||
49004959|NCT02349412|157855195|FG000|Overall Study|Withdrawal by Subject|7|||
49004960|NCT02349412|157855196|FG001|Overall Study|Withdrawal by Subject|7|||
49004961|NCT04093362|157855197|FG000|Overall Study|Study Termination|1|||
49004962|NCT04093362|157855198|FG001|Overall Study|Study Termination|1|||
49004963|NCT04093362|157855197|FG000|Overall Study|Withdrawal of Consent|1|||
49004964|NCT04093362|157855198|FG001|Overall Study|Withdrawal of Consent|0|||
49004965|NCT04093362|157855197|FG000|Overall Study|Death|1|||
49004966|NCT04093362|157855198|FG001|Overall Study|Death|3|||
49004967|NCT04093362|157855197|FG000|Overall Study|Reason not Specified|1|||
49004968|NCT04093362|157855198|FG001|Overall Study|Reason not Specified|2|||
49004969|NCT00965263|157855206|FG000|Overall Study|Physician Decision|2|||
49004970|NCT00965263|157855207|FG001|Overall Study|Physician Decision|0|||
49004971|NCT00965263|157855206|FG000|Overall Study|Family emergency|0|||
49004972|NCT00965263|157855207|FG001|Overall Study|Family emergency|1|||
49004973|NCT00965263|157855206|FG000|Overall Study|Protocol Violation|0|||
49004974|NCT00965263|157855207|FG001|Overall Study|Protocol Violation|2|||
49004975|NCT00666718|157855211|FG000|Overall Study|Adverse Event|0|||
49004976|NCT00666718|157855212|FG001|Overall Study|Adverse Event|1|||
49004977|NCT00666718|157855211|FG000|Overall Study|Death|1|||
49004978|NCT00666718|157855212|FG001|Overall Study|Death|0|||
49004979|NCT00666718|157855211|FG000|Overall Study|Lost to Follow-up|1|||
49004980|NCT00666718|157855212|FG001|Overall Study|Lost to Follow-up|0|||
49004981|NCT00666718|157855211|FG000|Overall Study|Entry Criteria Not Met|2|||
49004982|NCT00666718|157855212|FG001|Overall Study|Entry Criteria Not Met|0|||
49004983|NCT00666718|157855211|FG000|Overall Study|Protocol Violation|1|||
49004984|NCT00666718|157855212|FG001|Overall Study|Protocol Violation|3|||
49004985|NCT00666718|157855211|FG000|Overall Study|Withdrawal by Subject|7|||
49004986|NCT00666718|157855212|FG001|Overall Study|Withdrawal by Subject|12|||
49004987|NCT00666718|157855211|FG000|Overall Study|Physician Decision|0|||
49004988|NCT00666718|157855212|FG001|Overall Study|Physician Decision|2|||
49004989|NCT05013749|157855213|FG000|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|7|||
49004990|NCT05013749|157855214|FG001|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|2|||
49004991|NCT05013749|157855213|FG000|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|0|||
49004992|NCT05013749|157855214|FG001|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|9|||
49004993|NCT02017535|157855215|FG000|Overall Study|Withdrawal by Subject|1|||
49004994|NCT02017535|157855216|FG001|Overall Study|Withdrawal by Subject|0|||
49004995|NCT02017535|157855217|FG002|Overall Study|Withdrawal by Subject|0|||
49004996|NCT02017535|157855218|FG003|Overall Study|Withdrawal by Subject|0|||
49004997|NCT03674827|157855221|FG000|Treatment Phase|Adverse Event|0|||
49004998|NCT03674827|157855222|FG001|Treatment Phase|Adverse Event|0|||
49004999|NCT03674827|157855223|FG002|Treatment Phase|Adverse Event|0|||
49005000|NCT03674827|157855224|FG003|Treatment Phase|Adverse Event|0|||
49005001|NCT03674827|157855225|FG004|Treatment Phase|Adverse Event|0|||
49005002|NCT03674827|157855226|FG005|Treatment Phase|Adverse Event|2|||
49005003|NCT03674827|157855221|FG000|Treatment Phase|Death|2|||
49005004|NCT03674827|157855222|FG001|Treatment Phase|Death|0|||
49005005|NCT03674827|157855223|FG002|Treatment Phase|Death|0|||
49005006|NCT03674827|157855224|FG003|Treatment Phase|Death|0|||
49005007|NCT03674827|157855225|FG004|Treatment Phase|Death|1|||
49005008|NCT03674827|157855226|FG005|Treatment Phase|Death|0|||
49005009|NCT03674827|157855221|FG000|Treatment Phase|Progressive Disease|0|||
49005010|NCT03674827|157855222|FG001|Treatment Phase|Progressive Disease|4|||
49005011|NCT03674827|157855223|FG002|Treatment Phase|Progressive Disease|3|||
49005012|NCT03674827|157855224|FG003|Treatment Phase|Progressive Disease|4|||
49005013|NCT03674827|157855225|FG004|Treatment Phase|Progressive Disease|4|||
49005014|NCT03674827|157855226|FG005|Treatment Phase|Progressive Disease|9|||
49005015|NCT03674827|157855221|FG000|Treatment Phase|Study Terminated by Sponsor|0|||
49005016|NCT03674827|157855222|FG001|Treatment Phase|Study Terminated by Sponsor|0|||
49005017|NCT03674827|157855223|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
49005018|NCT03674827|157855224|FG003|Treatment Phase|Study Terminated by Sponsor|0|||
49005019|NCT03674827|157855225|FG004|Treatment Phase|Study Terminated by Sponsor|0|||
49005020|NCT03674827|157855226|FG005|Treatment Phase|Study Terminated by Sponsor|1|||
49005021|NCT03674827|157855221|FG000|Treatment Phase|Withdrawal by Subject|0|||
49005022|NCT03674827|157855222|FG001|Treatment Phase|Withdrawal by Subject|0|||
49005023|NCT03674827|157855223|FG002|Treatment Phase|Withdrawal by Subject|0|||
49005024|NCT03674827|157855224|FG003|Treatment Phase|Withdrawal by Subject|0|||
49005025|NCT03674827|157855225|FG004|Treatment Phase|Withdrawal by Subject|0|||
49005026|NCT03674827|157855226|FG005|Treatment Phase|Withdrawal by Subject|1|||
49005027|NCT03674827|157855221|FG000|Treatment Phase|Global Deterioration of Health Status|1|||
49005028|NCT03674827|157855222|FG001|Treatment Phase|Global Deterioration of Health Status|0|||
49005029|NCT03674827|157855223|FG002|Treatment Phase|Global Deterioration of Health Status|0|||
49005030|NCT03674827|157855224|FG003|Treatment Phase|Global Deterioration of Health Status|0|||
49005031|NCT03674827|157855225|FG004|Treatment Phase|Global Deterioration of Health Status|0|||
49005032|NCT03674827|157855226|FG005|Treatment Phase|Global Deterioration of Health Status|2|||
49005033|NCT03674827|157855221|FG000|Treatment Phase|Other|0|||
49005034|NCT03674827|157855222|FG001|Treatment Phase|Other|1|||
49005035|NCT03674827|157855223|FG002|Treatment Phase|Other|0|||
49005036|NCT03674827|157855224|FG003|Treatment Phase|Other|0|||
49005037|NCT03674827|157855225|FG004|Treatment Phase|Other|0|||
49005038|NCT03674827|157855226|FG005|Treatment Phase|Other|1|||
49005039|NCT03674827|157855221|FG000|Long-Term Follow-up Phase|Death|2|||
49005040|NCT03674827|157855222|FG001|Long-Term Follow-up Phase|Death|4|||
49005041|NCT03674827|157855223|FG002|Long-Term Follow-up Phase|Death|2|||
49005042|NCT03674827|157855224|FG003|Long-Term Follow-up Phase|Death|3|||
49005043|NCT03674827|157855225|FG004|Long-Term Follow-up Phase|Death|2|||
49005044|NCT03674827|157855226|FG005|Long-Term Follow-up Phase|Death|6|||
49005045|NCT03674827|157855221|FG000|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
49005046|NCT03674827|157855222|FG001|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
49005047|NCT03674827|157855223|FG002|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
49005048|NCT03674827|157855224|FG003|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
49005049|NCT03674827|157855225|FG004|Long-Term Follow-up Phase|Study Terminated by Sponsor|2|||
49005050|NCT03674827|157855226|FG005|Long-Term Follow-up Phase|Study Terminated by Sponsor|8|||
49005051|NCT03674827|157855221|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
49005052|NCT03674827|157855222|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
49005053|NCT03674827|157855223|FG002|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
49005054|NCT03674827|157855224|FG003|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
49005055|NCT03674827|157855225|FG004|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
49005056|NCT03674827|157855226|FG005|Long-Term Follow-up Phase|Withdrawal by Subject|2|||
49005057|NCT03018288|157855227|FG000|Overall Study|Participants withdrew consent before surgery.|0|||
49005058|NCT03018288|157855228|FG001|Overall Study|Participants withdrew consent before surgery.|0|||
49005059|NCT03018288|157855229|FG002|Overall Study|Participants withdrew consent before surgery.|0|||
49005060|NCT03018288|157855230|FG003|Overall Study|Participants withdrew consent before surgery.|1|||
49005061|NCT03018288|157855227|FG000|Overall Study|Participant withdrew consent.|0|||
49005062|NCT03018288|157855228|FG001|Overall Study|Participant withdrew consent.|0|||
49005063|NCT03018288|157855229|FG002|Overall Study|Participant withdrew consent.|1|||
49005064|NCT03018288|157855230|FG003|Overall Study|Participant withdrew consent.|0|||
49005065|NCT03018288|157855227|FG000|Overall Study|Switched to alternative treatment.|0|||
49005066|NCT03018288|157855228|FG001|Overall Study|Switched to alternative treatment.|0|||
49005067|NCT03018288|157855229|FG002|Overall Study|Switched to alternative treatment.|1|||
49005068|NCT03018288|157855230|FG003|Overall Study|Switched to alternative treatment.|0|||
49005069|NCT03018288|157855227|FG000|Overall Study|Participant withdrew consent for personal reasons.|0|||
49005070|NCT03018288|157855228|FG001|Overall Study|Participant withdrew consent for personal reasons.|0|||
49005071|NCT03018288|157855229|FG002|Overall Study|Participant withdrew consent for personal reasons.|1|||
49005072|NCT03018288|157855230|FG003|Overall Study|Participant withdrew consent for personal reasons.|0|||
49005073|NCT03018288|157855227|FG000|Overall Study|Screen failures|0|||
49005074|NCT03018288|157855228|FG001|Overall Study|Screen failures|0|||
49005075|NCT03018288|157855229|FG002|Overall Study|Screen failures|0|||
49005076|NCT03018288|157855230|FG003|Overall Study|Screen failures|51|||
49005077|NCT03018288|157855227|FG000|Overall Study|Chose treatment outside of UNC|0|||
49005078|NCT03018288|157855228|FG001|Overall Study|Chose treatment outside of UNC|0|||
49005079|NCT03018288|157855229|FG002|Overall Study|Chose treatment outside of UNC|0|||
49005080|NCT03018288|157855230|FG003|Overall Study|Chose treatment outside of UNC|1|||
49005081|NCT03018288|157855227|FG000|Overall Study|Unable to comply with protocol requirements|1|||
49005082|NCT03018288|157855228|FG001|Overall Study|Unable to comply with protocol requirements|1|||
49005083|NCT03018288|157855229|FG002|Overall Study|Unable to comply with protocol requirements|0|||
49005084|NCT03018288|157855230|FG003|Overall Study|Unable to comply with protocol requirements|1|||
49005085|NCT03018288|157855227|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
49005086|NCT03018288|157855228|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
49005087|NCT03018288|157855229|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
49005088|NCT03018288|157855230|FG003|Overall Study|Participant declined to participate (before treatment started)|3|||
49005089|NCT03018288|157855227|FG000|Overall Study|Physician Decision|0|||
49005090|NCT03018288|157855228|FG001|Overall Study|Physician Decision|0|||
49005091|NCT03018288|157855229|FG002|Overall Study|Physician Decision|0|||
49005092|NCT03018288|157855230|FG003|Overall Study|Physician Decision|1|||
49005093|NCT03897465|157855231|FG000|Overall Study|Lost to Follow-up|2|||
49005094|NCT03897465|157855232|FG001|Overall Study|Lost to Follow-up|1|||
49005095|NCT03897465|157855231|FG000|Overall Study|Adverse Event|2|||
49005096|NCT03897465|157855232|FG001|Overall Study|Adverse Event|0|||
49005097|NCT03897465|157855231|FG000|Overall Study|complete healing by V2|1|||
49005098|NCT03897465|157855232|FG001|Overall Study|complete healing by V2|0|||
49005099|NCT03897465|157855231|FG000|Overall Study|occurence of exclusion criterion|1|||
49005100|NCT03897465|157855232|FG001|Overall Study|occurence of exclusion criterion|1|||
49005101|NCT03897465|157855231|FG000|Overall Study|Other|1|||
49005102|NCT03897465|157855232|FG001|Overall Study|Other|0|||
49005103|NCT03611751|157855233|FG000|Pre-treatment|Randomized but not treated|1|||
49005104|NCT03611751|157855234|FG001|Pre-treatment|Randomized but not treated|1|||
49005105|NCT03611751|157855235|FG002|Pre-treatment|Randomized but not treated|0|||
49005106|NCT03611751|157855233|FG000|Treatment Week 0 - Week 16|Adverse Event|11|||
49005107|NCT03611751|157855234|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
49005108|NCT03611751|157855235|FG002|Treatment Week 0 - Week 16|Adverse Event|12|||
49005109|NCT03611751|157855233|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|6|||
49005110|NCT03611751|157855234|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|9|||
49005111|NCT03611751|157855235|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|4|||
49005112|NCT03611751|157855233|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|5|||
49005113|NCT03611751|157855234|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|6|||
49005114|NCT03611751|157855235|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
49005115|NCT03611751|157855233|FG000|Treatment Week 0 - Week 16|Non-compliance with protocol|5|||
49005116|NCT03611751|157855234|FG001|Treatment Week 0 - Week 16|Non-compliance with protocol|2|||
49005117|NCT03611751|157855235|FG002|Treatment Week 0 - Week 16|Non-compliance with protocol|1|||
49005118|NCT03611751|157855233|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|14|||
49005119|NCT03611751|157855234|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
49005120|NCT03611751|157855235|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
49005121|NCT03611751|157855233|FG000|Treatment Week 0 - Week 16|Other reasons|13|||
49005122|NCT03611751|157855234|FG001|Treatment Week 0 - Week 16|Other reasons|9|||
49005123|NCT03611751|157855235|FG002|Treatment Week 0 - Week 16|Other reasons|7|||
49005124|NCT03611751|157855233|FG000|Treatment Week 0 - Week 16|Pregnancy|0|||
49005125|NCT03611751|157855234|FG001|Treatment Week 0 - Week 16|Pregnancy|0|||
49005126|NCT03611751|157855235|FG002|Treatment Week 0 - Week 16|Pregnancy|1|||
49005127|NCT03611751|157855233|FG000|Treatment Week 0 - Week 16|Death|0|||
49005128|NCT03611751|157855234|FG001|Treatment Week 0 - Week 16|Death|0|||
49005129|NCT03611751|157855235|FG002|Treatment Week 0 - Week 16|Death|1|||
49005130|NCT03611751|157855233|FG000|Treatment Week 16 - Week 24|Adverse Event|7|||
49005131|NCT03611751|157855234|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
49005132|NCT03611751|157855235|FG002|Treatment Week 16 - Week 24|Adverse Event|2|||
49005133|NCT03611751|157855233|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|8|||
49005134|NCT03611751|157855234|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
49005135|NCT03611751|157855235|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|1|||
49005136|NCT03611751|157855233|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
49005137|NCT03611751|157855234|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
49005138|NCT03611751|157855235|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
49005139|NCT03611751|157855233|FG000|Treatment Week 16 - Week 24|Non-compliance with protocol|3|||
49005140|NCT03611751|157855234|FG001|Treatment Week 16 - Week 24|Non-compliance with protocol|0|||
49005141|NCT03611751|157855235|FG002|Treatment Week 16 - Week 24|Non-compliance with protocol|1|||
49005142|NCT03611751|157855233|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
49005143|NCT03611751|157855234|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
49005144|NCT03611751|157855235|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
49005145|NCT03611751|157855233|FG000|Treatment Week 16 - Week 24|Other reasons|2|||
49005146|NCT03611751|157855234|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
49005147|NCT03611751|157855235|FG002|Treatment Week 16 - Week 24|Other reasons|3|||
49005148|NCT03611751|157855233|FG000|Treatment Week 16 - Week 24|Pregnancy|1|||
49005149|NCT03611751|157855234|FG001|Treatment Week 16 - Week 24|Pregnancy|0|||
49005150|NCT03611751|157855235|FG002|Treatment Week 16 - Week 24|Pregnancy|1|||
49005151|NCT03611751|157855233|FG000|Treatment Week 24 - Week 52|Adverse Event|14|||
49005152|NCT03611751|157855234|FG001|Treatment Week 24 - Week 52|Adverse Event|7|||
49005153|NCT03611751|157855235|FG002|Treatment Week 24 - Week 52|Adverse Event|0|||
49005154|NCT03611751|157855233|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
49005155|NCT03611751|157855234|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
49005156|NCT03611751|157855235|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
49005157|NCT03611751|157855233|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|9|||
49005158|NCT03611751|157855234|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|4|||
49005159|NCT03611751|157855235|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
49005160|NCT03611751|157855233|FG000|Treatment Week 24 - Week 52|Non-compliance with protocol|2|||
49005161|NCT03611751|157855234|FG001|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
49005162|NCT03611751|157855235|FG002|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
49005163|NCT03611751|157855233|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|8|||
49005164|NCT03611751|157855234|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|6|||
49005165|NCT03611751|157855235|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
49005166|NCT03611751|157855233|FG000|Treatment Week 24 - Week 52|Other reasons|28|||
49005167|NCT03611751|157855234|FG001|Treatment Week 24 - Week 52|Other reasons|7|||
49005168|NCT03611751|157855235|FG002|Treatment Week 24 - Week 52|Other reasons|0|||
49005169|NCT03611751|157855233|FG000|Treatment Week 24 - Week 52|Pregnancy|0|||
49005170|NCT03611751|157855234|FG001|Treatment Week 24 - Week 52|Pregnancy|1|||
49005171|NCT03611751|157855235|FG002|Treatment Week 24 - Week 52|Pregnancy|0|||
49005172|NCT02441179|157855237|FG000|Overall Study|Withdrawal by Subject|1|||
49005173|NCT02441179|157855238|FG001|Overall Study|Withdrawal by Subject|1|||
49005174|NCT02702271|157855239|FG000|Overall Study|Death|36|||
49005175|NCT02702271|157855240|FG001|Overall Study|Death|7|||
49005176|NCT02702271|157855239|FG000|Overall Study|Lost to Follow-up|12|||
49005177|NCT02702271|157855240|FG001|Overall Study|Lost to Follow-up|0|||
49005178|NCT02702271|157855239|FG000|Overall Study|Withdrawal by Subject|8|||
49005179|NCT02702271|157855240|FG001|Overall Study|Withdrawal by Subject|1|||
49005180|NCT02702271|157855239|FG000|Overall Study|Physician Decision|2|||
49005181|NCT02702271|157855240|FG001|Overall Study|Physician Decision|0|||
49005182|NCT02702271|157855239|FG000|Overall Study|Unsuccessful Implant Attempt|5|||
49005183|NCT02702271|157855240|FG001|Overall Study|Unsuccessful Implant Attempt|1|||
49005184|NCT01999322|157855243|FG000|Overall Study|Adverse Event|1|||
49005185|NCT01999322|157855244|FG001|Overall Study|Adverse Event|0|||
49005186|NCT05788237|157855245|FG000|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
49005187|NCT05788237|157855246|FG001|SSA (Approximately 2 Months)|No longer met eligibility criteria|1|||
49005188|NCT05788237|157855247|FG002|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
49005189|NCT05788237|157855248|FG003|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
49005190|NCT05788237|157855245|FG000|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
49005191|NCT05788237|157855246|FG001|SSA (Approximately 2 Months)|Lost to Follow-up|1|||
49005192|NCT05788237|157855247|FG002|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
49005193|NCT05788237|157855248|FG003|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
49005194|NCT05788237|157855245|FG000|SSA (Approximately 2 Months)|Withdrawal by Subject|4|||
49005195|NCT05788237|157855246|FG001|SSA (Approximately 2 Months)|Withdrawal by Subject|8|||
49005196|NCT05788237|157855247|FG002|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
49005197|NCT05788237|157855248|FG003|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
49005198|NCT05788237|157855245|FG000|SSA (Approximately 2 Months)|Adverse Event|1|||
49005199|NCT05788237|157855246|FG001|SSA (Approximately 2 Months)|Adverse Event|2|||
49005200|NCT05788237|157855247|FG002|SSA (Approximately 2 Months)|Adverse Event|0|||
49005201|NCT05788237|157855248|FG003|SSA (Approximately 2 Months)|Adverse Event|0|||
49005202|NCT05788237|157855245|FG000|SSA (Approximately 2 Months)|Death|0|||
49005203|NCT05788237|157855246|FG001|SSA (Approximately 2 Months)|Death|1|||
49005204|NCT05788237|157855247|FG002|SSA (Approximately 2 Months)|Death|0|||
49005205|NCT05788237|157855248|FG003|SSA (Approximately 2 Months)|Death|0|||
49005206|NCT05788237|157855245|FG000|SSB (Approximately 1 Month)|Not Vaccinated|0|||
49005207|NCT05788237|157855246|FG001|SSB (Approximately 1 Month)|Not Vaccinated|0|||
49005208|NCT05788237|157855247|FG002|SSB (Approximately 1 Month)|Not Vaccinated|1|||
49005209|NCT05788237|157855248|FG003|SSB (Approximately 1 Month)|Not Vaccinated|0|||
49005210|NCT05788237|157855245|FG000|SSB (Approximately 1 Month)|Refused further study procedures|0|||
49005211|NCT05788237|157855246|FG001|SSB (Approximately 1 Month)|Refused further study procedures|0|||
49005212|NCT05788237|157855247|FG002|SSB (Approximately 1 Month)|Refused further study procedures|0|||
49005213|NCT05788237|157855248|FG003|SSB (Approximately 1 Month)|Refused further study procedures|1|||
49005214|NCT05788237|157855245|FG000|SSB (Approximately 1 Month)|Other|0|||
49005215|NCT05788237|157855246|FG001|SSB (Approximately 1 Month)|Other|0|||
49005216|NCT05788237|157855247|FG002|SSB (Approximately 1 Month)|Other|0|||
49005217|NCT05788237|157855248|FG003|SSB (Approximately 1 Month)|Other|1|||
49005218|NCT05166421|157855249|FG000|Overall Study|Other|3|||
49046386|NCT02274558|158003845|FG002|Overall Study|Death|1|||
49005219|NCT05166421|157855250|FG001|Overall Study|Other|1|||
49005220|NCT05166421|157855251|FG002|Overall Study|Other|1|||
49005221|NCT05166421|157855249|FG000|Overall Study|Withdrawal by Subject|5|||
49005222|NCT05166421|157855250|FG001|Overall Study|Withdrawal by Subject|3|||
49005223|NCT05166421|157855251|FG002|Overall Study|Withdrawal by Subject|6|||
49005224|NCT05166421|157855249|FG000|Overall Study|Lost to Follow-up|4|||
49005225|NCT05166421|157855250|FG001|Overall Study|Lost to Follow-up|1|||
49005226|NCT05166421|157855251|FG002|Overall Study|Lost to Follow-up|7|||
49005227|NCT03869684|157856180|FG000|Overall Study|Adverse Event|0|||
49005228|NCT03869684|157856181|FG001|Overall Study|Adverse Event|3|||
49005229|NCT03869684|157856182|FG002|Overall Study|Adverse Event|1|||
49005230|NCT03869684|157856180|FG000|Overall Study|Withdrawal by Subject|1|||
49005231|NCT03869684|157856181|FG001|Overall Study|Withdrawal by Subject|0|||
49005232|NCT03869684|157856182|FG002|Overall Study|Withdrawal by Subject|0|||
49005233|NCT03869684|157856180|FG000|Overall Study|Lost to Follow-up|1|||
49005234|NCT03869684|157856181|FG001|Overall Study|Lost to Follow-up|0|||
49005235|NCT03869684|157856182|FG002|Overall Study|Lost to Follow-up|0|||
49005236|NCT03869684|157856180|FG000|Overall Study|Study prematurely terminated by sponsor|0|||
49005237|NCT03869684|157856181|FG001|Overall Study|Study prematurely terminated by sponsor|0|||
49005238|NCT03869684|157856182|FG002|Overall Study|Study prematurely terminated by sponsor|2|||
49005239|NCT01106352|157856190|FG000|Overall Study|Subjects untreated|0|||
49005240|NCT01106352|157856191|FG001|Overall Study|Subjects untreated|0|||
49005241|NCT01106352|157856192|FG002|Overall Study|Subjects untreated|0|||
49005242|NCT01106352|157856193|FG003|Overall Study|Subjects untreated|3|||
49005243|NCT01106352|157856194|FG004|Overall Study|Subjects untreated|4|||
49005244|NCT01106352|157856190|FG000|Overall Study|Sponsor Decision|1|||
49005245|NCT01106352|157856191|FG001|Overall Study|Sponsor Decision|0|||
49005246|NCT01106352|157856192|FG002|Overall Study|Sponsor Decision|0|||
49005247|NCT01106352|157856193|FG003|Overall Study|Sponsor Decision|0|||
49005248|NCT01106352|157856194|FG004|Overall Study|Sponsor Decision|0|||
49005249|NCT01106352|157856190|FG000|Overall Study|Too ill to come in for the visit|0|||
49005250|NCT01106352|157856191|FG001|Overall Study|Too ill to come in for the visit|0|||
49005251|NCT01106352|157856192|FG002|Overall Study|Too ill to come in for the visit|1|||
49005252|NCT01106352|157856193|FG003|Overall Study|Too ill to come in for the visit|0|||
49005253|NCT01106352|157856194|FG004|Overall Study|Too ill to come in for the visit|0|||
49005254|NCT01106352|157856190|FG000|Overall Study|Lost to Follow-up|0|||
49005255|NCT01106352|157856191|FG001|Overall Study|Lost to Follow-up|0|||
49005256|NCT01106352|157856192|FG002|Overall Study|Lost to Follow-up|0|||
49005257|NCT01106352|157856193|FG003|Overall Study|Lost to Follow-up|0|||
49005258|NCT01106352|157856194|FG004|Overall Study|Lost to Follow-up|1|||
49005259|NCT01106352|157856190|FG000|Overall Study|Death|0|||
49005260|NCT01106352|157856191|FG001|Overall Study|Death|0|||
49005261|NCT01106352|157856192|FG002|Overall Study|Death|1|||
49005262|NCT01106352|157856193|FG003|Overall Study|Death|3|||
49005263|NCT01106352|157856194|FG004|Overall Study|Death|1|||
49005264|NCT01106352|157856190|FG000|Overall Study|Disease progression|0|||
49005265|NCT01106352|157856191|FG001|Overall Study|Disease progression|0|||
49005266|NCT01106352|157856192|FG002|Overall Study|Disease progression|0|||
49005267|NCT01106352|157856193|FG003|Overall Study|Disease progression|1|||
49005268|NCT01106352|157856194|FG004|Overall Study|Disease progression|0|||
49005269|NCT01106352|157856190|FG000|Overall Study|Withdrawal by Subject|0|||
49005270|NCT01106352|157856191|FG001|Overall Study|Withdrawal by Subject|0|||
49005271|NCT01106352|157856192|FG002|Overall Study|Withdrawal by Subject|0|||
49005272|NCT01106352|157856193|FG003|Overall Study|Withdrawal by Subject|3|||
49005273|NCT01106352|157856194|FG004|Overall Study|Withdrawal by Subject|2|||
49005274|NCT01106352|157856190|FG000|Overall Study|Went on hospice|0|||
49005275|NCT01106352|157856191|FG001|Overall Study|Went on hospice|0|||
49005276|NCT01106352|157856192|FG002|Overall Study|Went on hospice|0|||
49005277|NCT01106352|157856193|FG003|Overall Study|Went on hospice|1|||
49005278|NCT01106352|157856194|FG004|Overall Study|Went on hospice|0|||
49005279|NCT01106352|157856190|FG000|Overall Study|Subject entered hospice|0|||
49005280|NCT01106352|157856191|FG001|Overall Study|Subject entered hospice|0|||
49005281|NCT01106352|157856192|FG002|Overall Study|Subject entered hospice|0|||
49005282|NCT01106352|157856193|FG003|Overall Study|Subject entered hospice|1|||
49005283|NCT01106352|157856194|FG004|Overall Study|Subject entered hospice|0|||
49005284|NCT01106352|157856190|FG000|Overall Study|Home hospice since July 2013|0|||
49005285|NCT01106352|157856191|FG001|Overall Study|Home hospice since July 2013|0|||
49005286|NCT01106352|157856192|FG002|Overall Study|Home hospice since July 2013|0|||
49005287|NCT01106352|157856193|FG003|Overall Study|Home hospice since July 2013|1|||
49005288|NCT01106352|157856194|FG004|Overall Study|Home hospice since July 2013|0|||
49005289|NCT03547531|157856195|FG000|Overall Study|not coming in data collection : sick|2|||
49046387|NCT02274558|158003843|FG000|Overall Study|Lost to Follow-up|2|||
49046388|NCT02274558|158003844|FG001|Overall Study|Lost to Follow-up|1|||
49046389|NCT02274558|158003845|FG002|Overall Study|Lost to Follow-up|1|||
49046390|NCT02274558|158003843|FG000|Overall Study|Physician Decision|0|||
49046391|NCT02274558|158003844|FG001|Overall Study|Physician Decision|2|||
49046392|NCT02274558|158003845|FG002|Overall Study|Physician Decision|1|||
49046393|NCT02460835|158003846|FG000|Overall Study|Disease progression prior to treatment|3|||
49046394|NCT02460835|158003846|FG000|Overall Study|Unable to complete planning scans|2|||
49046395|NCT02460835|158003846|FG000|Overall Study|Decrease in performance status|1|||
49046396|NCT02460835|158003846|FG000|Overall Study|Withdrawal by Subject|3|||
49046397|NCT02460835|158003846|FG000|Overall Study|Underwent fractionated RT|10|||
49046398|NCT02460835|158003846|FG000|Overall Study|Unable to complete follow-up lab draws|2|||
49046399|NCT02655224|158003847|FG000|Overall Study|Adverse Event|1|||
49046400|NCT02655224|158003848|FG001|Overall Study|Adverse Event|1|||
49046401|NCT02219308|158003849|FG000|Overall Study|Withdrawal by Subject|1|||
49046402|NCT02219308|158003850|FG001|Overall Study|Withdrawal by Subject|2|||
49046403|NCT01157234|158003851|FG000|Overall Study|Withdrawal by Subject|1|||
49046404|NCT01157234|158003852|FG001|Overall Study|Withdrawal by Subject|0|||
49046405|NCT00381849|158003853|FG000|Wash Out|Withdrawal by Subject|0|||
49046406|NCT00381849|158003854|FG001|Wash Out|Withdrawal by Subject|1|||
49046407|NCT01142908|158003859|FG000|Overall Study|Lost to Follow-up|19|||
49046408|NCT01142908|158003860|FG001|Overall Study|Lost to Follow-up|13|||
49046409|NCT01142908|158003859|FG000|Overall Study|Death|1|||
49046410|NCT01142908|158003860|FG001|Overall Study|Death|4|||
49046411|NCT01142908|158003859|FG000|Overall Study|Excluded - did not meet criteria|9|||
49046412|NCT01142908|158003860|FG001|Overall Study|Excluded - did not meet criteria|5|||
49046413|NCT01142908|158003859|FG000|Overall Study|Withdrawal by Subject|3|||
49046414|NCT01142908|158003860|FG001|Overall Study|Withdrawal by Subject|0|||
49046415|NCT01332968|158003862|FG000|Induction Period|Adverse Event|23|||
49046416|NCT01332968|158003863|FG001|Induction Period|Adverse Event|26|||
49046417|NCT01332968|158003864|FG002|Induction Period|Adverse Event|0|||
49046418|NCT01332968|158003865|FG003|Induction Period|Adverse Event|0|||
49046419|NCT01332968|158003866|FG004|Induction Period|Adverse Event|0|||
49046420|NCT01332968|158003867|FG005|Induction Period|Adverse Event|0|||
49046421|NCT01332968|158003868|FG006|Induction Period|Adverse Event|0|||
49046422|NCT01332968|158003869|FG007|Induction Period|Adverse Event|0|||
49046423|NCT01332968|158003862|FG000|Induction Period|Death|1|||
49046424|NCT01332968|158003863|FG001|Induction Period|Death|4|||
49046425|NCT01332968|158003864|FG002|Induction Period|Death|0|||
49046426|NCT01332968|158003865|FG003|Induction Period|Death|0|||
49046427|NCT01332968|158003866|FG004|Induction Period|Death|0|||
49046428|NCT01332968|158003867|FG005|Induction Period|Death|0|||
49046429|NCT01332968|158003868|FG006|Induction Period|Death|0|||
49046430|NCT01332968|158003869|FG007|Induction Period|Death|0|||
49046431|NCT01332968|158003862|FG000|Induction Period|Non-compliance|1|||
49046432|NCT01332968|158003863|FG001|Induction Period|Non-compliance|0|||
49046433|NCT01332968|158003864|FG002|Induction Period|Non-compliance|0|||
49046434|NCT01332968|158003865|FG003|Induction Period|Non-compliance|0|||
49046435|NCT01332968|158003866|FG004|Induction Period|Non-compliance|0|||
49046436|NCT01332968|158003867|FG005|Induction Period|Non-compliance|0|||
49046437|NCT01332968|158003868|FG006|Induction Period|Non-compliance|0|||
49046438|NCT01332968|158003869|FG007|Induction Period|Non-compliance|0|||
49046439|NCT01332968|158003862|FG000|Induction Period|Other|2|||
49046440|NCT01332968|158003863|FG001|Induction Period|Other|2|||
49046441|NCT01332968|158003864|FG002|Induction Period|Other|0|||
49046442|NCT01332968|158003865|FG003|Induction Period|Other|0|||
49046443|NCT01332968|158003866|FG004|Induction Period|Other|0|||
49046444|NCT01332968|158003867|FG005|Induction Period|Other|0|||
49046445|NCT01332968|158003868|FG006|Induction Period|Other|0|||
49046446|NCT01332968|158003869|FG007|Induction Period|Other|0|||
49046447|NCT01332968|158003862|FG000|Induction Period|Physician Decision|6|||
49046448|NCT01332968|158003863|FG001|Induction Period|Physician Decision|1|||
49046449|NCT01332968|158003864|FG002|Induction Period|Physician Decision|0|||
49046450|NCT01332968|158003865|FG003|Induction Period|Physician Decision|0|||
49046451|NCT01332968|158003866|FG004|Induction Period|Physician Decision|0|||
49046452|NCT01332968|158003867|FG005|Induction Period|Physician Decision|0|||
49046453|NCT01332968|158003868|FG006|Induction Period|Physician Decision|0|||
49046454|NCT01332968|158003869|FG007|Induction Period|Physician Decision|0|||
49046455|NCT01332968|158003862|FG000|Induction Period|Progressive Disease|15|||
49046456|NCT01332968|158003863|FG001|Induction Period|Progressive Disease|7|||
49046457|NCT01332968|158003864|FG002|Induction Period|Progressive Disease|0|||
49046458|NCT01332968|158003865|FG003|Induction Period|Progressive Disease|0|||
49046459|NCT01332968|158003866|FG004|Induction Period|Progressive Disease|0|||
49046460|NCT01332968|158003867|FG005|Induction Period|Progressive Disease|0|||
49046461|NCT01332968|158003868|FG006|Induction Period|Progressive Disease|0|||
49046462|NCT01332968|158003869|FG007|Induction Period|Progressive Disease|0|||
49046463|NCT01332968|158003862|FG000|Induction Period|Protocol Violation|3|||
49046464|NCT01332968|158003863|FG001|Induction Period|Protocol Violation|4|||
49046465|NCT01332968|158003864|FG002|Induction Period|Protocol Violation|0|||
49046466|NCT01332968|158003865|FG003|Induction Period|Protocol Violation|0|||
49046467|NCT01332968|158003866|FG004|Induction Period|Protocol Violation|0|||
49046468|NCT01332968|158003867|FG005|Induction Period|Protocol Violation|0|||
49046469|NCT01332968|158003868|FG006|Induction Period|Protocol Violation|0|||
49046470|NCT01332968|158003869|FG007|Induction Period|Protocol Violation|0|||
49046471|NCT01332968|158003862|FG000|Induction Period|Withdrawal by Subject|3|||
49046472|NCT01332968|158003863|FG001|Induction Period|Withdrawal by Subject|5|||
49046473|NCT01332968|158003864|FG002|Induction Period|Withdrawal by Subject|0|||
49046474|NCT01332968|158003865|FG003|Induction Period|Withdrawal by Subject|0|||
49046475|NCT01332968|158003866|FG004|Induction Period|Withdrawal by Subject|0|||
49046476|NCT01332968|158003867|FG005|Induction Period|Withdrawal by Subject|0|||
49046477|NCT01332968|158003868|FG006|Induction Period|Withdrawal by Subject|0|||
49046478|NCT01332968|158003869|FG007|Induction Period|Withdrawal by Subject|0|||
49046479|NCT01332968|158003862|FG000|Induction Period|Randomised but not treated|4|||
49046480|NCT01332968|158003863|FG001|Induction Period|Randomised but not treated|7|||
49046481|NCT01332968|158003864|FG002|Induction Period|Randomised but not treated|0|||
49046482|NCT01332968|158003865|FG003|Induction Period|Randomised but not treated|0|||
49046483|NCT01332968|158003866|FG004|Induction Period|Randomised but not treated|0|||
49046484|NCT01332968|158003867|FG005|Induction Period|Randomised but not treated|0|||
49046485|NCT01332968|158003868|FG006|Induction Period|Randomised but not treated|0|||
49046486|NCT01332968|158003869|FG007|Induction Period|Randomised but not treated|0|||
49046487|NCT01332968|158003862|FG000|Maintenance/Observation Period|Adverse Event|0|||
49046488|NCT01332968|158003863|FG001|Maintenance/Observation Period|Adverse Event|0|||
49046489|NCT01332968|158003864|FG002|Maintenance/Observation Period|Adverse Event|53|||
49046490|NCT01332968|158003865|FG003|Maintenance/Observation Period|Adverse Event|66|||
49046491|NCT01332968|158003866|FG004|Maintenance/Observation Period|Adverse Event|0|||
49046492|NCT01332968|158003867|FG005|Maintenance/Observation Period|Adverse Event|0|||
49046493|NCT01332968|158003868|FG006|Maintenance/Observation Period|Adverse Event|0|||
49046494|NCT01332968|158003869|FG007|Maintenance/Observation Period|Adverse Event|0|||
49046495|NCT01332968|158003862|FG000|Maintenance/Observation Period|Death|0|||
49046496|NCT01332968|158003863|FG001|Maintenance/Observation Period|Death|0|||
49046497|NCT01332968|158003864|FG002|Maintenance/Observation Period|Death|5|||
49046498|NCT01332968|158003865|FG003|Maintenance/Observation Period|Death|6|||
49046499|NCT01332968|158003866|FG004|Maintenance/Observation Period|Death|0|||
49046500|NCT01332968|158003867|FG005|Maintenance/Observation Period|Death|0|||
49046501|NCT01332968|158003868|FG006|Maintenance/Observation Period|Death|0|||
49046502|NCT01332968|158003869|FG007|Maintenance/Observation Period|Death|0|||
49046503|NCT01332968|158003862|FG000|Maintenance/Observation Period|Lost to Follow-up|0|||
49046504|NCT01332968|158003863|FG001|Maintenance/Observation Period|Lost to Follow-up|0|||
49046505|NCT01332968|158003864|FG002|Maintenance/Observation Period|Lost to Follow-up|1|||
49046506|NCT01332968|158003865|FG003|Maintenance/Observation Period|Lost to Follow-up|2|||
49046507|NCT01332968|158003866|FG004|Maintenance/Observation Period|Lost to Follow-up|0|||
49046508|NCT01332968|158003867|FG005|Maintenance/Observation Period|Lost to Follow-up|0|||
49046509|NCT01332968|158003868|FG006|Maintenance/Observation Period|Lost to Follow-up|0|||
49046510|NCT01332968|158003869|FG007|Maintenance/Observation Period|Lost to Follow-up|0|||
49046511|NCT01332968|158003862|FG000|Maintenance/Observation Period|Non-compliance|0|||
49046512|NCT01332968|158003863|FG001|Maintenance/Observation Period|Non-compliance|0|||
49046513|NCT01332968|158003864|FG002|Maintenance/Observation Period|Non-compliance|4|||
49046514|NCT01332968|158003865|FG003|Maintenance/Observation Period|Non-compliance|3|||
49046515|NCT01332968|158003866|FG004|Maintenance/Observation Period|Non-compliance|0|||
49046516|NCT01332968|158003867|FG005|Maintenance/Observation Period|Non-compliance|0|||
49046517|NCT01332968|158003868|FG006|Maintenance/Observation Period|Non-compliance|0|||
49046518|NCT01332968|158003869|FG007|Maintenance/Observation Period|Non-compliance|0|||
49046519|NCT01332968|158003862|FG000|Maintenance/Observation Period|Other|0|||
49046520|NCT01332968|158003863|FG001|Maintenance/Observation Period|Other|0|||
49046521|NCT01332968|158003864|FG002|Maintenance/Observation Period|Other|4|||
49046522|NCT01332968|158003865|FG003|Maintenance/Observation Period|Other|7|||
49046523|NCT01332968|158003866|FG004|Maintenance/Observation Period|Other|0|||
49046524|NCT01332968|158003867|FG005|Maintenance/Observation Period|Other|0|||
49046525|NCT01332968|158003868|FG006|Maintenance/Observation Period|Other|0|||
49046526|NCT01332968|158003869|FG007|Maintenance/Observation Period|Other|0|||
49046527|NCT01332968|158003862|FG000|Maintenance/Observation Period|Physician Decision|0|||
49046528|NCT01332968|158003863|FG001|Maintenance/Observation Period|Physician Decision|0|||
49046529|NCT01332968|158003864|FG002|Maintenance/Observation Period|Physician Decision|14|||
49046530|NCT01332968|158003865|FG003|Maintenance/Observation Period|Physician Decision|19|||
49046531|NCT01332968|158003866|FG004|Maintenance/Observation Period|Physician Decision|0|||
49046532|NCT01332968|158003867|FG005|Maintenance/Observation Period|Physician Decision|1|||
49046533|NCT01332968|158003868|FG006|Maintenance/Observation Period|Physician Decision|0|||
49046534|NCT01332968|158003869|FG007|Maintenance/Observation Period|Physician Decision|0|||
49046535|NCT01332968|158003862|FG000|Maintenance/Observation Period|Progressive Disease|0|||
49046536|NCT01332968|158003863|FG001|Maintenance/Observation Period|Progressive Disease|0|||
49046537|NCT01332968|158003864|FG002|Maintenance/Observation Period|Progressive Disease|72|||
49046538|NCT01332968|158003865|FG003|Maintenance/Observation Period|Progressive Disease|40|||
49046539|NCT01332968|158003866|FG004|Maintenance/Observation Period|Progressive Disease|0|||
49046540|NCT01332968|158003867|FG005|Maintenance/Observation Period|Progressive Disease|0|||
49046541|NCT01332968|158003868|FG006|Maintenance/Observation Period|Progressive Disease|0|||
49046542|NCT01332968|158003869|FG007|Maintenance/Observation Period|Progressive Disease|0|||
49046543|NCT01332968|158003862|FG000|Maintenance/Observation Period|Protocol Violation|0|||
49046544|NCT01332968|158003863|FG001|Maintenance/Observation Period|Protocol Violation|0|||
49046545|NCT01332968|158003864|FG002|Maintenance/Observation Period|Protocol Violation|1|||
49046546|NCT01332968|158003865|FG003|Maintenance/Observation Period|Protocol Violation|1|||
49046547|NCT01332968|158003866|FG004|Maintenance/Observation Period|Protocol Violation|0|||
49046548|NCT01332968|158003867|FG005|Maintenance/Observation Period|Protocol Violation|0|||
49046549|NCT01332968|158003868|FG006|Maintenance/Observation Period|Protocol Violation|0|||
49046550|NCT01332968|158003869|FG007|Maintenance/Observation Period|Protocol Violation|0|||
49046551|NCT01332968|158003862|FG000|Maintenance/Observation Period|Withdrawal by Subject|0|||
49046552|NCT01332968|158003863|FG001|Maintenance/Observation Period|Withdrawal by Subject|0|||
49046553|NCT01332968|158003864|FG002|Maintenance/Observation Period|Withdrawal by Subject|7|||
49046554|NCT01332968|158003865|FG003|Maintenance/Observation Period|Withdrawal by Subject|5|||
49046555|NCT01332968|158003866|FG004|Maintenance/Observation Period|Withdrawal by Subject|0|||
49046556|NCT01332968|158003867|FG005|Maintenance/Observation Period|Withdrawal by Subject|0|||
49046557|NCT01332968|158003868|FG006|Maintenance/Observation Period|Withdrawal by Subject|0|||
49046558|NCT01332968|158003869|FG007|Maintenance/Observation Period|Withdrawal by Subject|0|||
49046559|NCT01332968|158003862|FG000|Follow-Up Period|Adverse Event|0|||
49046560|NCT01332968|158003863|FG001|Follow-Up Period|Adverse Event|0|||
49046561|NCT01332968|158003864|FG002|Follow-Up Period|Adverse Event|0|||
49046562|NCT01332968|158003865|FG003|Follow-Up Period|Adverse Event|0|||
49046563|NCT01332968|158003866|FG004|Follow-Up Period|Adverse Event|0|||
49046564|NCT01332968|158003867|FG005|Follow-Up Period|Adverse Event|0|||
49046565|NCT01332968|158003868|FG006|Follow-Up Period|Adverse Event|0|||
49046566|NCT01332968|158003869|FG007|Follow-Up Period|Adverse Event|4|||
49046567|NCT01332968|158003862|FG000|Follow-Up Period|Death|0|||
49046568|NCT01332968|158003863|FG001|Follow-Up Period|Death|0|||
49046569|NCT01332968|158003864|FG002|Follow-Up Period|Death|0|||
49046570|NCT01332968|158003865|FG003|Follow-Up Period|Death|0|||
49046571|NCT01332968|158003866|FG004|Follow-Up Period|Death|0|||
49046572|NCT01332968|158003867|FG005|Follow-Up Period|Death|0|||
49046573|NCT01332968|158003868|FG006|Follow-Up Period|Death|27|||
49046574|NCT01332968|158003869|FG007|Follow-Up Period|Death|30|||
49046575|NCT01332968|158003862|FG000|Follow-Up Period|Lost to Follow-up|0|||
49046576|NCT01332968|158003863|FG001|Follow-Up Period|Lost to Follow-up|0|||
49046577|NCT01332968|158003864|FG002|Follow-Up Period|Lost to Follow-up|0|||
49046578|NCT01332968|158003865|FG003|Follow-Up Period|Lost to Follow-up|0|||
49046579|NCT01332968|158003866|FG004|Follow-Up Period|Lost to Follow-up|0|||
49046580|NCT01332968|158003867|FG005|Follow-Up Period|Lost to Follow-up|0|||
49046581|NCT01332968|158003868|FG006|Follow-Up Period|Lost to Follow-up|11|||
49046582|NCT01332968|158003869|FG007|Follow-Up Period|Lost to Follow-up|15|||
49046583|NCT01332968|158003862|FG000|Follow-Up Period|Non-compliance|0|||
49046584|NCT01332968|158003863|FG001|Follow-Up Period|Non-compliance|0|||
49046585|NCT01332968|158003864|FG002|Follow-Up Period|Non-compliance|0|||
49046586|NCT01332968|158003865|FG003|Follow-Up Period|Non-compliance|0|||
49046587|NCT01332968|158003866|FG004|Follow-Up Period|Non-compliance|0|||
49046588|NCT01332968|158003867|FG005|Follow-Up Period|Non-compliance|0|||
49046589|NCT01332968|158003868|FG006|Follow-Up Period|Non-compliance|4|||
49046590|NCT01332968|158003869|FG007|Follow-Up Period|Non-compliance|9|||
49046591|NCT01332968|158003862|FG000|Follow-Up Period|Other|0|||
49046592|NCT01332968|158003863|FG001|Follow-Up Period|Other|0|||
49046593|NCT01332968|158003864|FG002|Follow-Up Period|Other|0|||
49046594|NCT01332968|158003865|FG003|Follow-Up Period|Other|0|||
49046595|NCT01332968|158003866|FG004|Follow-Up Period|Other|0|||
49046596|NCT01332968|158003867|FG005|Follow-Up Period|Other|0|||
49046597|NCT01332968|158003868|FG006|Follow-Up Period|Other|18|||
49046598|NCT01332968|158003869|FG007|Follow-Up Period|Other|21|||
49046599|NCT01332968|158003862|FG000|Follow-Up Period|Physician Decision|0|||
49046600|NCT01332968|158003863|FG001|Follow-Up Period|Physician Decision|0|||
49046601|NCT01332968|158003864|FG002|Follow-Up Period|Physician Decision|0|||
49046602|NCT01332968|158003865|FG003|Follow-Up Period|Physician Decision|0|||
49046603|NCT01332968|158003866|FG004|Follow-Up Period|Physician Decision|0|||
49046604|NCT01332968|158003867|FG005|Follow-Up Period|Physician Decision|0|||
49046605|NCT01332968|158003868|FG006|Follow-Up Period|Physician Decision|12|||
49046606|NCT01332968|158003869|FG007|Follow-Up Period|Physician Decision|15|||
49046607|NCT01332968|158003862|FG000|Follow-Up Period|Progressive Disease|0|||
49046608|NCT01332968|158003863|FG001|Follow-Up Period|Progressive Disease|0|||
49046609|NCT01332968|158003864|FG002|Follow-Up Period|Progressive Disease|0|||
49046610|NCT01332968|158003865|FG003|Follow-Up Period|Progressive Disease|0|||
49046611|NCT01332968|158003866|FG004|Follow-Up Period|Progressive Disease|0|||
49046612|NCT01332968|158003867|FG005|Follow-Up Period|Progressive Disease|0|||
49046613|NCT01332968|158003868|FG006|Follow-Up Period|Progressive Disease|126|||
49046614|NCT01332968|158003869|FG007|Follow-Up Period|Progressive Disease|106|||
49046615|NCT01332968|158003862|FG000|Follow-Up Period|Protocol Violation|0|||
49046616|NCT01332968|158003863|FG001|Follow-Up Period|Protocol Violation|0|||
49046617|NCT01332968|158003864|FG002|Follow-Up Period|Protocol Violation|0|||
49046618|NCT01332968|158003865|FG003|Follow-Up Period|Protocol Violation|0|||
49046619|NCT01332968|158003866|FG004|Follow-Up Period|Protocol Violation|0|||
49046620|NCT01332968|158003867|FG005|Follow-Up Period|Protocol Violation|0|||
49046621|NCT01332968|158003868|FG006|Follow-Up Period|Protocol Violation|1|||
49005290|NCT03547531|157856196|FG001|Overall Study|not coming in data collection : sick|2|||
49005291|NCT03547531|157856195|FG000|Overall Study|having family occasion|0|||
49005292|NCT03547531|157856196|FG001|Overall Study|having family occasion|2|||
49005293|NCT03402126|157856197|FG000|Overall Study|Lost to Follow-up|6|||
49005294|NCT03402126|157856197|FG000|Overall Study|Protocol Violation|10|||
49005295|NCT03402126|157856197|FG000|Overall Study|Sponsor request/Study termination|29|||
49005296|NCT03402126|157856197|FG000|Overall Study|Study product no longer in use|1|||
49005297|NCT03402126|157856197|FG000|Overall Study|Technical problems|1|||
49005298|NCT03402126|157856197|FG000|Overall Study|Withdrawal by Subject|6|||
49005299|NCT03402126|157856197|FG000|Overall Study|Physician Decision|2|||
49005300|NCT03402126|157856197|FG000|Overall Study|upgrade to Cardiac Resynchronization Therapy-Defibrillator/stage IV cancer|3|||
49005301|NCT03402126|157856197|FG000|Overall Study|Death|4|||
49005302|NCT00572156|157856198|FG000|Overall Study|Adverse Event|3|||
49005303|NCT00572156|157856199|FG001|Overall Study|Adverse Event|1|||
49005304|NCT00572156|157856200|FG002|Overall Study|Adverse Event|5|||
49005305|NCT00572156|157856201|FG003|Overall Study|Adverse Event|1|||
49005306|NCT00572156|157856198|FG000|Overall Study|Lost to Follow-up|1|||
49005307|NCT00572156|157856199|FG001|Overall Study|Lost to Follow-up|1|||
49005308|NCT00572156|157856200|FG002|Overall Study|Lost to Follow-up|1|||
49005309|NCT00572156|157856201|FG003|Overall Study|Lost to Follow-up|0|||
49005310|NCT00572156|157856198|FG000|Overall Study|Protocol Violation|1|||
49005311|NCT00572156|157856199|FG001|Overall Study|Protocol Violation|2|||
49005312|NCT00572156|157856200|FG002|Overall Study|Protocol Violation|0|||
49005313|NCT00572156|157856201|FG003|Overall Study|Protocol Violation|2|||
49005314|NCT00572156|157856198|FG000|Overall Study|Patient/Parent Decision|1|||
49005315|NCT00572156|157856199|FG001|Overall Study|Patient/Parent Decision|6|||
49005316|NCT00572156|157856200|FG002|Overall Study|Patient/Parent Decision|4|||
49005317|NCT00572156|157856201|FG003|Overall Study|Patient/Parent Decision|3|||
49005318|NCT00572156|157856198|FG000|Overall Study|Sponsor Decision|20|||
49005319|NCT00572156|157856199|FG001|Overall Study|Sponsor Decision|16|||
49005320|NCT00572156|157856200|FG002|Overall Study|Sponsor Decision|17|||
49005321|NCT00572156|157856201|FG003|Overall Study|Sponsor Decision|19|||
49005322|NCT01959230|157856202|FG000|Overall Study|Failure to follow study procedures|0|||
49005323|NCT01959230|157856203|FG001|Overall Study|Failure to follow study procedures|1|||
49005324|NCT01959230|157856202|FG000|Overall Study|Administrative reasons|2|||
49005325|NCT01959230|157856203|FG001|Overall Study|Administrative reasons|0|||
49005326|NCT01959230|157856202|FG000|Overall Study|Withdrawal by Subject|2|||
49005327|NCT01959230|157856203|FG001|Overall Study|Withdrawal by Subject|0|||
49005328|NCT00127192|157856204|FG000|Overall Study|Adverse Event|0|||
49005329|NCT00127192|157856205|FG001|Overall Study|Adverse Event|1|||
49005330|NCT00127192|157856206|FG002|Overall Study|Adverse Event|1|||
49005331|NCT00127192|157856207|FG003|Overall Study|Adverse Event|1|||
49005332|NCT00127192|157856208|FG004|Overall Study|Adverse Event|0|||
49005333|NCT00127192|157856204|FG000|Overall Study|Lack of Efficacy|2|||
49005334|NCT00127192|157856205|FG001|Overall Study|Lack of Efficacy|0|||
49005335|NCT00127192|157856206|FG002|Overall Study|Lack of Efficacy|0|||
49005336|NCT00127192|157856207|FG003|Overall Study|Lack of Efficacy|0|||
49005337|NCT00127192|157856208|FG004|Overall Study|Lack of Efficacy|2|||
49005338|NCT00127192|157856204|FG000|Overall Study|Withdrawal by Subject|0|||
49005339|NCT00127192|157856205|FG001|Overall Study|Withdrawal by Subject|0|||
49005340|NCT00127192|157856206|FG002|Overall Study|Withdrawal by Subject|1|||
49005341|NCT00127192|157856207|FG003|Overall Study|Withdrawal by Subject|0|||
49005342|NCT00127192|157856208|FG004|Overall Study|Withdrawal by Subject|3|||
49005343|NCT00127192|157856204|FG000|Overall Study|Adverse event in pre-treatment period|1|||
49005344|NCT00127192|157856205|FG001|Overall Study|Adverse event in pre-treatment period|0|||
49005345|NCT00127192|157856206|FG002|Overall Study|Adverse event in pre-treatment period|0|||
49005346|NCT00127192|157856207|FG003|Overall Study|Adverse event in pre-treatment period|0|||
49005347|NCT00127192|157856208|FG004|Overall Study|Adverse event in pre-treatment period|0|||
49005348|NCT03907397|157856209|FG000|Overall Study|Lost to Follow-up|0|||
49005349|NCT03907397|157856210|FG001|Overall Study|Lost to Follow-up|1|||
49005350|NCT03907397|157856209|FG000|Overall Study|Physician Decision|2|||
49005351|NCT03907397|157856210|FG001|Overall Study|Physician Decision|1|||
49005352|NCT03907397|157856209|FG000|Overall Study|Withdrawal by Subject|5|||
49005353|NCT03907397|157856210|FG001|Overall Study|Withdrawal by Subject|4|||
49005354|NCT03907397|157856209|FG000|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|1|||
49005355|NCT03907397|157856210|FG001|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|0|||
49005356|NCT03611621|157856215|FG000|Overall Study|Graft loss|3|||
49005357|NCT03611621|157856215|FG000|Overall Study|Death|3|||
49005358|NCT03611621|157856215|FG000|Overall Study|Lost to Follow-up|1|||
49005359|NCT01466673|157856216|FG000|Overall Study|Non-compliance with study treatment|2|||
49005360|NCT01466673|157856217|FG001|Overall Study|Non-compliance with study treatment|0|||
49005361|NCT01466673|157856216|FG000|Overall Study|Lost to Follow-up|3|||
49046622|NCT01332968|158003869|FG007|Follow-Up Period|Protocol Violation|0|||
49046623|NCT01332968|158003862|FG000|Follow-Up Period|Withdrawal by Subject|0|||
49046624|NCT01332968|158003863|FG001|Follow-Up Period|Withdrawal by Subject|0|||
49046625|NCT01332968|158003864|FG002|Follow-Up Period|Withdrawal by Subject|0|||
49046626|NCT01332968|158003865|FG003|Follow-Up Period|Withdrawal by Subject|0|||
49046627|NCT01332968|158003866|FG004|Follow-Up Period|Withdrawal by Subject|0|||
49046628|NCT01332968|158003867|FG005|Follow-Up Period|Withdrawal by Subject|0|||
49046629|NCT01332968|158003868|FG006|Follow-Up Period|Withdrawal by Subject|29|||
49046630|NCT01332968|158003869|FG007|Follow-Up Period|Withdrawal by Subject|32|||
49046631|NCT01332968|158003862|FG000|Follow-Up Period|No reason provided|0|||
49046632|NCT01332968|158003863|FG001|Follow-Up Period|No reason provided|0|||
49046633|NCT01332968|158003864|FG002|Follow-Up Period|No reason provided|0|||
49046634|NCT01332968|158003865|FG003|Follow-Up Period|No reason provided|0|||
49046635|NCT01332968|158003866|FG004|Follow-Up Period|No reason provided|0|||
49046636|NCT01332968|158003867|FG005|Follow-Up Period|No reason provided|0|||
49046637|NCT01332968|158003868|FG006|Follow-Up Period|No reason provided|2|||
49046638|NCT01332968|158003869|FG007|Follow-Up Period|No reason provided|3|||
49046639|NCT02351167|158003872|FG000|Overall Study|Withdrawal by Subject|19|||
49046640|NCT02351167|158003873|FG001|Overall Study|Withdrawal by Subject|18|||
49046641|NCT02351167|158003874|FG002|Overall Study|Withdrawal by Subject|21|||
49046642|NCT04117945|158003875|FG000|Overall Study|Death|1|||
49046643|NCT04117945|158003876|FG001|Overall Study|Death|0|||
49046644|NCT04117945|158003875|FG000|Overall Study|Withdrawal by Subject|3|||
49046645|NCT04117945|158003876|FG001|Overall Study|Withdrawal by Subject|1|||
49046646|NCT04117945|158003875|FG000|Overall Study|Disease Progression|0|||
49046647|NCT04117945|158003876|FG001|Overall Study|Disease Progression|2|||
49046648|NCT04117945|158003875|FG000|Overall Study|Ineligible|8|||
49046649|NCT04117945|158003876|FG001|Overall Study|Ineligible|7|||
49046650|NCT03480022|158003877|FG000|Overall Study|Pregnancy|2|||
49046651|NCT03480022|158003878|FG001|Overall Study|Pregnancy|0|||
49046652|NCT03480022|158003877|FG000|Overall Study|Adverse Event|6|||
49046653|NCT03480022|158003878|FG001|Overall Study|Adverse Event|0|||
49046654|NCT03480022|158003877|FG000|Overall Study|Lack of Efficacy|0|||
49046655|NCT03480022|158003878|FG001|Overall Study|Lack of Efficacy|2|||
49046656|NCT03480022|158003877|FG000|Overall Study|Physician Decision|0|||
49046657|NCT03480022|158003878|FG001|Overall Study|Physician Decision|1|||
49046658|NCT03480022|158003877|FG000|Overall Study|Withdrawal by Subject|2|||
49046659|NCT03480022|158003878|FG001|Overall Study|Withdrawal by Subject|0|||
49046660|NCT03480022|158003877|FG000|Overall Study|Medication concerns|1|||
49046661|NCT03480022|158003878|FG001|Overall Study|Medication concerns|0|||
49046662|NCT03480022|158003877|FG000|Overall Study|Family member COVID exposure|0|||
49046663|NCT03480022|158003878|FG001|Overall Study|Family member COVID exposure|1|||
49046664|NCT01450800|158003880|FG000|Overall Study|Protocol Violation|1|||
49046665|NCT01450800|158003881|FG001|Overall Study|Protocol Violation|3|||
49046666|NCT03023137|158003884|FG000|Overall Study|Multiple pregnancy|2|||
49046667|NCT03023137|158003885|FG001|Overall Study|Multiple pregnancy|4|||
49046668|NCT03023137|158003884|FG000|Overall Study|Lost to Follow-up|1|||
49005362|NCT01466673|157856217|FG001|Overall Study|Lost to Follow-up|5|||
49005363|NCT01466673|157856216|FG000|Overall Study|Adverse Event|2|||
49005364|NCT01466673|157856217|FG001|Overall Study|Adverse Event|1|||
49005365|NCT05268393|157856218|FG000|Overall Study|Withdrawal by Subject|2|||
49005366|NCT05268393|157856219|FG001|Overall Study|Withdrawal by Subject|1|||
49005367|NCT02858076|157856222|FG000|Overall Study|Death|6|||
49005368|NCT02858076|157856223|FG001|Overall Study|Death|3|||
49005369|NCT02858076|157856222|FG000|Overall Study|Withdrawal by Subject|1|||
49005370|NCT02858076|157856223|FG001|Overall Study|Withdrawal by Subject|5|||
49005371|NCT02858076|157856222|FG000|Overall Study|Lost to Follow-up|2|||
49005372|NCT02858076|157856223|FG001|Overall Study|Lost to Follow-up|7|||
49005373|NCT02858076|157856222|FG000|Overall Study|Completed Out of Window|1|||
49005374|NCT02858076|157856223|FG001|Overall Study|Completed Out of Window|3|||
49005375|NCT03959137|157856226|FG000|Overall Study|Protocol Violation|6|||
49005376|NCT00190684|157856233|FG000|Overall Study|Adverse Event|86|||
49005377|NCT00190684|157856233|FG000|Overall Study|Satisfactory response|80|||
49005378|NCT00190684|157856233|FG000|Overall Study|Lack of efficacy|204|||
49005379|NCT00190684|157856233|FG000|Overall Study|Lost to Follow-up|232|||
49005380|NCT00190684|157856233|FG000|Overall Study|Patient moved|60|||
49005381|NCT00190684|157856233|FG000|Overall Study|Patient Decision|432|||
49005382|NCT00190684|157856233|FG000|Overall Study|Clinical relapse|67|||
49005383|NCT00190684|157856233|FG000|Overall Study|Sponsor's decision|17|||
49005384|NCT00190684|157856233|FG000|Overall Study|Physician Decision|84|||
49005385|NCT00190684|157856233|FG000|Overall Study|Protocol Violation|123|||
49005386|NCT00190684|157856233|FG000|Overall Study|Study Period III Completed|103|||
49005387|NCT00190684|157856233|FG000|Overall Study|Study Period V Completed|1|||
49005388|NCT02756078|157856234|FG000|Period 1|Unsatisfactory Lens Fitting|0|||
49005389|NCT02756078|157856235|FG001|Period 1|Unsatisfactory Lens Fitting|1|||
49005390|NCT02756078|157856234|FG000|Period 1|Lost to Follow-up|0|||
49005391|NCT02756078|157856235|FG001|Period 1|Lost to Follow-up|2|||
49005392|NCT02756078|157856234|FG000|Period 1|Protocol Violation|0|||
49005393|NCT02756078|157856235|FG001|Period 1|Protocol Violation|1|||
49005394|NCT02756078|157856234|FG000|Period 1|Adverse Event|1|||
49005395|NCT02756078|157856235|FG001|Period 1|Adverse Event|10|||
49005396|NCT02756078|157856234|FG000|Period 1|Withdrawal by Subject|6|||
49005397|NCT02756078|157856235|FG001|Period 1|Withdrawal by Subject|6|||
49005398|NCT02756078|157856234|FG000|Period 1|Lens Discomfort|2|||
49005399|NCT02756078|157856235|FG001|Period 1|Lens Discomfort|2|||
49005400|NCT02756078|157856234|FG000|Period 2|Adverse Event|3|||
49005401|NCT02756078|157856235|FG001|Period 2|Adverse Event|5|||
49005402|NCT02756078|157856234|FG000|Period 2|Unsatisfactory Lens Fitting|0|||
49005403|NCT02756078|157856235|FG001|Period 2|Unsatisfactory Lens Fitting|1|||
49005404|NCT02756078|157856234|FG000|Period 2|Withdrawal by Subject|3|||
49005405|NCT02756078|157856235|FG001|Period 2|Withdrawal by Subject|1|||
49005406|NCT03721952|157856236|FG000|Overall Study|Lost to Follow-up|0|||
49005407|NCT03721952|157856237|FG001|Overall Study|Lost to Follow-up|0|||
49005408|NCT03721952|157856238|FG002|Overall Study|Lost to Follow-up|2|||
49005409|NCT03721952|157856239|FG003|Overall Study|Lost to Follow-up|0|||
49005410|NCT03721952|157856240|FG004|Overall Study|Lost to Follow-up|0|||
49005411|NCT03721952|157856236|FG000|Overall Study|Protocol Violation|0|||
49005412|NCT03721952|157856237|FG001|Overall Study|Protocol Violation|1|||
49005413|NCT03721952|157856238|FG002|Overall Study|Protocol Violation|0|||
49005414|NCT03721952|157856239|FG003|Overall Study|Protocol Violation|0|||
49005415|NCT03721952|157856240|FG004|Overall Study|Protocol Violation|0|||
49005416|NCT03721952|157856236|FG000|Overall Study|Withdrawal by Subject|1|||
49005417|NCT03721952|157856237|FG001|Overall Study|Withdrawal by Subject|0|||
49005418|NCT03721952|157856238|FG002|Overall Study|Withdrawal by Subject|40|||
49005419|NCT03721952|157856239|FG003|Overall Study|Withdrawal by Subject|28|||
49005420|NCT03721952|157856240|FG004|Overall Study|Withdrawal by Subject|0|||
49005421|NCT01494649|157856241|FG000|Overall Study|Lost to Follow-up|0|||
49005422|NCT01494649|157856242|FG001|Overall Study|Lost to Follow-up|1|||
49005423|NCT05014412|157856246|FG000|Overall Study|Death|11|||
49005424|NCT05014412|157856247|FG001|Overall Study|Death|7|||
49005425|NCT05014412|157856248|FG002|Overall Study|Death|4|||
49005426|NCT05014412|157856249|FG003|Overall Study|Death|7|||
49005427|NCT05014412|157856246|FG000|Overall Study|Withdrawal by Subject|1|||
49005428|NCT05014412|157856247|FG001|Overall Study|Withdrawal by Subject|1|||
49005429|NCT05014412|157856248|FG002|Overall Study|Withdrawal by Subject|1|||
49005430|NCT05014412|157856249|FG003|Overall Study|Withdrawal by Subject|2|||
49005431|NCT05014412|157856246|FG000|Overall Study|Ongoing|21|||
49046669|NCT03023137|158003885|FG001|Overall Study|Lost to Follow-up|1|||
49046670|NCT03023137|158003884|FG000|Overall Study|Protocol Violation|0|||
49046671|NCT03023137|158003885|FG001|Overall Study|Protocol Violation|4|||
49046672|NCT03023137|158003884|FG000|Overall Study|Lost the baby in a car accident|1|||
49046673|NCT03023137|158003885|FG001|Overall Study|Lost the baby in a car accident|0|||
49046674|NCT03428945|158003886|FG000|Overall Study|Lost to Follow-up|5|||
49046675|NCT03428945|158003887|FG001|Overall Study|Lost to Follow-up|3|||
49046676|NCT03428945|158003886|FG000|Overall Study|Withdrawal by Subject|10|||
49046677|NCT03428945|158003887|FG001|Overall Study|Withdrawal by Subject|10|||
49046678|NCT02250651|158003888|FG000|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0|||
49046679|NCT02250651|158003889|FG001|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
49046680|NCT02250651|158003890|FG002|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
49046681|NCT02250651|158003888|FG000|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
49046682|NCT02250651|158003889|FG001|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
49005432|NCT05014412|157856247|FG001|Overall Study|Ongoing|4|||
49005433|NCT05014412|157856248|FG002|Overall Study|Ongoing|6|||
49005434|NCT05014412|157856249|FG003|Overall Study|Ongoing|20|||
49005435|NCT00659581|157856254|FG000|Overall Study|Adverse Event|1006|||
49005436|NCT00659581|157856254|FG000|Overall Study|Lack of Efficacy|1183|||
49005437|NCT00659581|157856254|FG000|Overall Study|Other|6393|||
49005438|NCT05478603|157856261|FG000|Overall Study|Withdrawal by Subject|0|||
49005439|NCT05478603|157856262|FG001|Overall Study|Withdrawal by Subject|1|||
49005440|NCT05478603|157856263|FG002|Overall Study|Withdrawal by Subject|0|||
49005441|NCT05478603|157856264|FG003|Overall Study|Withdrawal by Subject|0|||
49046683|NCT02250651|158003890|FG002|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
49005442|NCT01730937|157856271|FG000|Overall Study|Protocol Violation|5|||
49005443|NCT01730937|157856272|FG001|Overall Study|Protocol Violation|11|||
49005444|NCT03174275|157856273|FG000|Overall Study (Until End of Surgery)|Adverse Event|4|||
49005445|NCT03174275|157856273|FG000|Overall Study (Until End of Surgery)|Withdrawal by Subject|9|||
49005446|NCT03174275|157856273|FG000|Overall Study (Until End of Surgery)|Lack of Efficacy|1|||
49005447|NCT03174275|157856273|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|6|||
49005448|NCT03174275|157856273|FG000|Adjuvant Chemotherapy|Progression|1|||
49005449|NCT03174275|157856273|FG000|Adjuvant Chemotherapy|Adverse Event|1|||
49005450|NCT03174275|157856273|FG000|Adjuvant Durvalumab|Withdrawal by Subject|6|||
49005451|NCT03174275|157856273|FG000|Adjuvant Durvalumab|Progression|1|||
49005452|NCT03174275|157856273|FG000|Adjuvant Durvalumab|Adverse Event|3|||
49005453|NCT03174275|157856273|FG000|Adjuvant Radiotherapy|Withdrawal by Subject|5|||
49005454|NCT03174275|157856273|FG000|Adjuvant Radiotherapy|Progression|1|||
49005455|NCT03174275|157856273|FG000|Adjuvant Radiotherapy|Adverse Event|1|||
49005456|NCT02524665|157856274|FG000|Overall Study|Lost to Follow-up|1|||
49005457|NCT04136626|157856277|FG000|Treatment Phase|Withdrawal by Subject|1|||
49005458|NCT04136626|157856278|FG001|Treatment Phase|Withdrawal by Subject|9|||
49005459|NCT04136626|157856277|FG000|Treatment Phase|Adverse Event|1|||
49005460|NCT04136626|157856278|FG001|Treatment Phase|Adverse Event|0|||
49005461|NCT04136626|157856277|FG000|Treatment Phase|Lost to Follow-up|1|||
49005462|NCT04136626|157856278|FG001|Treatment Phase|Lost to Follow-up|5|||
49005463|NCT04136626|157856277|FG000|12-month Follow-up|Lost to Follow-up|8|||
49005464|NCT04136626|157856278|FG001|12-month Follow-up|Lost to Follow-up|7|||
49005465|NCT01458132|157857746|FG000|Overall Study|Other|15|||
49005466|NCT01458132|157857747|FG001|Overall Study|Other|3|||
49005467|NCT00763269|157857748|FG000|Overall Study|Lost to Follow-up|12|||
49005468|NCT00763269|157857749|FG001|Overall Study|Lost to Follow-up|13|||
49005469|NCT04056299|157857759|FG000|Overall Study|Sponsor discontinued study|3|||
49005470|NCT04056299|157857760|FG001|Overall Study|Sponsor discontinued study|3|||
49005471|NCT00068406|157857765|FG000|Overall Study|Ineligible-improper pre-protocol treatm|1|||
49005472|NCT00068406|157857765|FG000|Overall Study|Ineligible-Inadequate Pathology|2|||
49005473|NCT00589693|157857768|FG000|Overall Study|randomized in error|12|||
49005474|NCT00589693|157857769|FG001|Overall Study|randomized in error|6|||
49005475|NCT00589693|157857768|FG000|Overall Study|Adverse Event|4|||
49005476|NCT00589693|157857769|FG001|Overall Study|Adverse Event|4|||
49005477|NCT00589693|157857768|FG000|Overall Study|Death|26|||
49005478|NCT00589693|157857769|FG001|Overall Study|Death|16|||
49005479|NCT00589693|157857768|FG000|Overall Study|Lack of Efficacy|0|||
49005480|NCT00589693|157857769|FG001|Overall Study|Lack of Efficacy|1|||
49005481|NCT00589693|157857768|FG000|Overall Study|Lost to Follow-up|1|||
49005482|NCT00589693|157857769|FG001|Overall Study|Lost to Follow-up|0|||
49005483|NCT00589693|157857768|FG000|Overall Study|Physician Decision|0|||
49005484|NCT00589693|157857769|FG001|Overall Study|Physician Decision|1|||
49005485|NCT00589693|157857768|FG000|Overall Study|Protocol Violation|1|||
49005486|NCT00589693|157857769|FG001|Overall Study|Protocol Violation|1|||
49005487|NCT01128153|157857771|FG000|Overall Study|Adverse Event|1|||
49005488|NCT01128153|157857772|FG001|Overall Study|Adverse Event|3|||
49005489|NCT01128153|157857771|FG000|Overall Study|Condition under investigation worsened|8|||
49005490|NCT01128153|157857772|FG001|Overall Study|Condition under investigation worsened|7|||
49005491|NCT01128153|157857771|FG000|Overall Study|Withdrawal by Subject|2|||
49005492|NCT01128153|157857772|FG001|Overall Study|Withdrawal by Subject|3|||
49005493|NCT01128153|157857771|FG000|Overall Study|Incorrect enrolment to study|2|||
49005494|NCT01128153|157857772|FG001|Overall Study|Incorrect enrolment to study|1|||
49005495|NCT01128153|157857771|FG000|Overall Study|Protocol Violation|2|||
49005496|NCT01128153|157857772|FG001|Overall Study|Protocol Violation|0|||
49005497|NCT01128153|157857771|FG000|Overall Study|Developed discontinuation criteria|1|||
49005498|NCT01128153|157857772|FG001|Overall Study|Developed discontinuation criteria|1|||
49005499|NCT00755937|157857773|FG000|Recruitment|Unknown if infliximab received|164|||
49005500|NCT00755937|157857773|FG000|Observational Follow-up|Lost to Follow-up|148|||
49005501|NCT04060654|157857774|FG000|Overall Study|Withdrawal by Subject|1|||
49005502|NCT04060654|157857774|FG000|Overall Study|Lost to Follow-up|5|||
49005503|NCT05349188|157857775|FG000|Overall Study|Withdrawal by Subject|1|||
49005504|NCT05349188|157857776|FG001|Overall Study|Withdrawal by Subject|0|||
49005505|NCT03496207|157857777|FG000|Base Study|Adverse Event|0|||
49005506|NCT03496207|157857778|FG001|Base Study|Adverse Event|0|||
49005507|NCT03496207|157857779|FG002|Base Study|Adverse Event|1|||
49005508|NCT03496207|157857780|FG003|Base Study|Adverse Event|1|||
49005509|NCT03496207|157857781|FG004|Base Study|Adverse Event|4|||
49005510|NCT03496207|157857777|FG000|Base Study|Death|0|||
49005511|NCT03496207|157857778|FG001|Base Study|Death|0|||
49005512|NCT03496207|157857779|FG002|Base Study|Death|0|||
49005513|NCT03496207|157857780|FG003|Base Study|Death|0|||
49005514|NCT03496207|157857781|FG004|Base Study|Death|1|||
49005515|NCT03496207|157857777|FG000|Base Study|Withdrawal by Subject|0|||
49005516|NCT03496207|157857778|FG001|Base Study|Withdrawal by Subject|0|||
49005517|NCT03496207|157857779|FG002|Base Study|Withdrawal by Subject|1|||
49005518|NCT03496207|157857780|FG003|Base Study|Withdrawal by Subject|0|||
49005519|NCT03496207|157857781|FG004|Base Study|Withdrawal by Subject|1|||
49005520|NCT03496207|157857777|FG000|Extension Period|Adverse Event|0|||
49005521|NCT03496207|157857778|FG001|Extension Period|Adverse Event|0|||
49005522|NCT03496207|157857779|FG002|Extension Period|Adverse Event|0|||
49005523|NCT03496207|157857780|FG003|Extension Period|Adverse Event|1|||
49005524|NCT03496207|157857781|FG004|Extension Period|Adverse Event|1|||
49005525|NCT03496207|157857777|FG000|Extension Period|Death|1|||
49005526|NCT03496207|157857778|FG001|Extension Period|Death|0|||
49005527|NCT03496207|157857779|FG002|Extension Period|Death|0|||
49005528|NCT03496207|157857780|FG003|Extension Period|Death|1|||
49005529|NCT03496207|157857781|FG004|Extension Period|Death|2|||
49005530|NCT03496207|157857777|FG000|Extension Period|Withdrawal by Subject|1|||
49005531|NCT03496207|157857778|FG001|Extension Period|Withdrawal by Subject|0|||
49005532|NCT03496207|157857779|FG002|Extension Period|Withdrawal by Subject|0|||
49005533|NCT03496207|157857780|FG003|Extension Period|Withdrawal by Subject|1|||
49046684|NCT02250651|158003888|FG000|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2|||
49046685|NCT02250651|158003889|FG001|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3|||
49046686|NCT02250651|158003890|FG002|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5|||
49046687|NCT02250651|158003888|FG000|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1|||
49046688|NCT02250651|158003889|FG001|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
49046689|NCT02250651|158003890|FG002|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
49046690|NCT02250651|158003888|FG000|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
49046691|NCT02250651|158003889|FG001|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
49046692|NCT02250651|158003890|FG002|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1|||
49046693|NCT02250651|158003888|FG000|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
49046694|NCT02250651|158003889|FG001|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1|||
49046695|NCT02250651|158003890|FG002|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3|||
49046696|NCT02250651|158003888|FG000|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4|||
49046697|NCT02250651|158003889|FG001|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1|||
49046698|NCT02250651|158003890|FG002|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0|||
49046699|NCT02250651|158003888|FG000|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
49046700|NCT02250651|158003889|FG001|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
49046701|NCT02250651|158003890|FG002|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3|||
49046702|NCT02250651|158003888|FG000|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
49046703|NCT02250651|158003889|FG001|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3|||
49046704|NCT02250651|158003890|FG002|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
49046705|NCT02250651|158003888|FG000|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
49046706|NCT02250651|158003889|FG001|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1|||
49046707|NCT02250651|158003890|FG002|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
49046708|NCT02250651|158003888|FG000|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
49046709|NCT02250651|158003889|FG001|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1|||
49046710|NCT02250651|158003890|FG002|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
49046711|NCT02250651|158003888|FG000|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4|||
49046712|NCT02250651|158003889|FG001|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
49046713|NCT02250651|158003890|FG002|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
49046714|NCT02250651|158003888|FG000|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
49046715|NCT02250651|158003889|FG001|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2|||
49046716|NCT02250651|158003890|FG002|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
49046717|NCT02250651|158003888|FG000|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
49046718|NCT02250651|158003889|FG001|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0|||
49046719|NCT02250651|158003890|FG002|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
49046720|NCT02250651|158003888|FG000|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2|||
49046721|NCT02250651|158003889|FG001|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
49046722|NCT02250651|158003890|FG002|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
49046723|NCT03496298|158003891|FG000|Overall Study|Adverse Event|49|||
49046724|NCT03496298|158003892|FG001|Overall Study|Adverse Event|68|||
49046725|NCT03496298|158003893|FG002|Overall Study|Adverse Event|79|||
49046726|NCT03496298|158003891|FG000|Overall Study|Study terminated by Sponsor|1050|||
49046727|NCT03496298|158003892|FG001|Overall Study|Study terminated by Sponsor|1063|||
49046728|NCT03496298|158003893|FG002|Overall Study|Study terminated by Sponsor|1071|||
49046729|NCT03496298|158003891|FG000|Overall Study|Physician decision (other than Adverse event)|12|||
49046730|NCT03496298|158003892|FG001|Overall Study|Physician decision (other than Adverse event)|17|||
49046731|NCT03496298|158003893|FG002|Overall Study|Physician decision (other than Adverse event)|10|||
49046732|NCT03496298|158003891|FG000|Overall Study|Withdrawal by Subject|176|||
49046733|NCT03496298|158003892|FG001|Overall Study|Withdrawal by Subject|154|||
49046734|NCT03496298|158003893|FG002|Overall Study|Withdrawal by Subject|151|||
49046735|NCT03496298|158003891|FG000|Overall Study|Other|29|||
49046736|NCT03496298|158003892|FG001|Overall Study|Other|20|||
49046737|NCT03496298|158003893|FG002|Overall Study|Other|23|||
49046738|NCT03496298|158003891|FG000|Overall Study|Randomized and not treated|1|||
49046739|NCT03496298|158003892|FG001|Overall Study|Randomized and not treated|1|||
49046740|NCT03496298|158003893|FG002|Overall Study|Randomized and not treated|1|||
49046741|NCT01390948|158003895|FG000|Overall Study|End of Study|1|||
49046742|NCT01390948|158003896|FG001|Overall Study|End of Study|0|||
49046743|NCT01390948|158003897|FG002|Overall Study|End of Study|0|||
49046744|NCT01390948|158003895|FG000|Overall Study|Withdrew consent|2|||
49046745|NCT01390948|158003896|FG001|Overall Study|Withdrew consent|2|||
49046746|NCT01390948|158003897|FG002|Overall Study|Withdrew consent|0|||
49046747|NCT01390948|158003895|FG000|Overall Study|Progressive Disease|2|||
49046748|NCT01390948|158003896|FG001|Overall Study|Progressive Disease|5|||
49046749|NCT01390948|158003897|FG002|Overall Study|Progressive Disease|0|||
49046750|NCT01390948|158003895|FG000|Overall Study|Death during follow-up|10|||
49046751|NCT01390948|158003896|FG001|Overall Study|Death during follow-up|11|||
49046752|NCT01390948|158003897|FG002|Overall Study|Death during follow-up|1|||
49046753|NCT01438476|158003905|FG000|Overall Study|Protocol Violation|1|||
49046754|NCT01438476|158003906|FG001|Overall Study|Protocol Violation|0|||
49046755|NCT01438476|158003905|FG000|Overall Study|Withdrawal by Subject|1|||
49046756|NCT01438476|158003906|FG001|Overall Study|Withdrawal by Subject|0|||
49046757|NCT01438476|158003905|FG000|Overall Study|No Surgery- Disease|8|||
49046758|NCT01438476|158003906|FG001|Overall Study|No Surgery- Disease|10|||
49046759|NCT01438476|158003905|FG000|Overall Study|Communication barrier|0|||
49046760|NCT01438476|158003906|FG001|Overall Study|Communication barrier|1|||
49046761|NCT00676494|158003907|FG000|Overall Study|Missed Visit|8|||
49046762|NCT00676494|158003907|FG000|Overall Study|Withdrawal by Subject|6|||
49046763|NCT02608476|158003908|FG000|Overall Study|Withdrawal by Subject|30|||
49046764|NCT02608476|158003909|FG001|Overall Study|Withdrawal by Subject|37|||
49046765|NCT02608476|158003908|FG000|Overall Study|Lost to Follow-up|24|||
49046766|NCT02608476|158003909|FG001|Overall Study|Lost to Follow-up|24|||
49046767|NCT02608476|158003908|FG000|Overall Study|Adverse Event|2|||
49046768|NCT02608476|158003909|FG001|Overall Study|Adverse Event|8|||
49046769|NCT02608476|158003908|FG000|Overall Study|Withdrawal by Parent/Guardian|5|||
49046770|NCT02608476|158003909|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
49046771|NCT02608476|158003908|FG000|Overall Study|Noncompliance with treatment|1|||
49046772|NCT02608476|158003909|FG001|Overall Study|Noncompliance with treatment|5|||
49046773|NCT02608476|158003908|FG000|Overall Study|Lack of Efficacy|3|||
49046774|NCT02608476|158003909|FG001|Overall Study|Lack of Efficacy|1|||
49046775|NCT02608476|158003908|FG000|Overall Study|Other|0|||
49046776|NCT02608476|158003909|FG001|Overall Study|Other|1|||
49046777|NCT02608476|158003908|FG000|Overall Study|Physician Decision|1|||
49046778|NCT02608476|158003909|FG001|Overall Study|Physician Decision|0|||
49046779|NCT02608476|158003908|FG000|Overall Study|Pregnancy|0|||
49046780|NCT02608476|158003909|FG001|Overall Study|Pregnancy|1|||
49046781|NCT02608476|158003908|FG000|Overall Study|Progressive disease|1|||
49046782|NCT02608476|158003909|FG001|Overall Study|Progressive disease|0|||
49046783|NCT00732160|158003912|FG000|Overall Study|Adverse Event|1|||
49046784|NCT00732160|158003913|FG001|Overall Study|Adverse Event|0|||
49046785|NCT00732160|158003914|FG002|Overall Study|Adverse Event|1|||
49046786|NCT00732160|158003915|FG003|Overall Study|Adverse Event|1|||
49046787|NCT00732160|158003912|FG000|Overall Study|scheduling|4|||
49046788|NCT00732160|158003913|FG001|Overall Study|scheduling|4|||
49046789|NCT00732160|158003914|FG002|Overall Study|scheduling|2|||
49046790|NCT00732160|158003915|FG003|Overall Study|scheduling|1|||
49046791|NCT02795676|158003916|FG000|Overall Study|Adverse Event|2|||
49046792|NCT02795676|158003917|FG001|Overall Study|Adverse Event|0|||
49046793|NCT02795676|158003916|FG000|Overall Study|Withdrawal by Subject|3|||
49046794|NCT02795676|158003917|FG001|Overall Study|Withdrawal by Subject|1|||
49046795|NCT02522780|158003918|FG000|Overall Study|Consent withdrawn by subject|5|||
49046796|NCT02522780|158003919|FG001|Overall Study|Consent withdrawn by subject|7|||
49046797|NCT02522780|158003918|FG000|Overall Study|Protocol deviation|1|||
49046798|NCT02522780|158003919|FG001|Overall Study|Protocol deviation|3|||
49046799|NCT02522780|158003918|FG000|Overall Study|Subject refused endoscopic procedure|0|||
49046800|NCT02522780|158003919|FG001|Overall Study|Subject refused endoscopic procedure|1|||
49046801|NCT02522780|158003918|FG000|Overall Study|Adverse event, non-fatal|11|||
49046802|NCT02522780|158003919|FG001|Overall Study|Adverse event, non-fatal|16|||
49046803|NCT01115933|158003921|FG000|Overall Study|Did not receive XIENCE PRIME SV|1|||
49046804|NCT02289820|158003930|FG000|Overall Study|Withdrawal by Subject|2|||
49046805|NCT02289820|158003931|FG001|Overall Study|Withdrawal by Subject|1|||
49046806|NCT02289820|158003932|FG002|Overall Study|Withdrawal by Subject|2|||
49046807|NCT02289820|158003933|FG003|Overall Study|Withdrawal by Subject|1|||
49046808|NCT02289820|158003934|FG004|Overall Study|Withdrawal by Subject|0|||
49046809|NCT02289820|158003935|FG005|Overall Study|Withdrawal by Subject|0|||
49046810|NCT02289820|158003936|FG006|Overall Study|Withdrawal by Subject|1|||
49046811|NCT02289820|158003930|FG000|Overall Study|Death|0|||
49046812|NCT02289820|158003931|FG001|Overall Study|Death|0|||
49046813|NCT02289820|158003932|FG002|Overall Study|Death|1|||
49046814|NCT02289820|158003933|FG003|Overall Study|Death|0|||
49046815|NCT02289820|158003934|FG004|Overall Study|Death|0|||
49046816|NCT02289820|158003935|FG005|Overall Study|Death|0|||
49046817|NCT02289820|158003936|FG006|Overall Study|Death|0|||
49046818|NCT02289820|158003930|FG000|Overall Study|Lost to Follow-up|0|||
49046819|NCT02289820|158003931|FG001|Overall Study|Lost to Follow-up|0|||
49046820|NCT02289820|158003932|FG002|Overall Study|Lost to Follow-up|3|||
49046821|NCT02289820|158003933|FG003|Overall Study|Lost to Follow-up|1|||
49046822|NCT02289820|158003934|FG004|Overall Study|Lost to Follow-up|0|||
49046823|NCT02289820|158003935|FG005|Overall Study|Lost to Follow-up|1|||
49046824|NCT02289820|158003936|FG006|Overall Study|Lost to Follow-up|1|||
49046825|NCT02289820|158003930|FG000|Overall Study|withdrawal of consent|0|||
49046826|NCT02289820|158003931|FG001|Overall Study|withdrawal of consent|1|||
49046827|NCT02289820|158003932|FG002|Overall Study|withdrawal of consent|0|||
49046828|NCT02289820|158003933|FG003|Overall Study|withdrawal of consent|0|||
49046829|NCT02289820|158003934|FG004|Overall Study|withdrawal of consent|0|||
49046830|NCT02289820|158003935|FG005|Overall Study|withdrawal of consent|0|||
49046831|NCT02289820|158003936|FG006|Overall Study|withdrawal of consent|0|||
49046832|NCT00926367|158003937|FG000|Overall Study|Withdrawal by Subject|0|||
49046833|NCT00926367|158003938|FG001|Overall Study|Withdrawal by Subject|1|||
49046834|NCT00926367|158003937|FG000|Overall Study|Lost to Follow-up|1|||
49046835|NCT00926367|158003938|FG001|Overall Study|Lost to Follow-up|0|||
49046836|NCT00926367|158003937|FG000|Overall Study|Skin Irritation|1|||
49046837|NCT00926367|158003938|FG001|Overall Study|Skin Irritation|2|||
49046838|NCT01086969|158003942|FG000|Overall Study|Withdrawal by Subject|1|||
49046839|NCT01086969|158003943|FG001|Overall Study|Withdrawal by Subject|2|||
49046840|NCT01086969|158003944|FG002|Overall Study|Withdrawal by Subject|0|||
49046841|NCT03294317|158003945|FG000|Overall Study|Physician Decision|1|||
49046842|NCT03294317|158003945|FG000|Overall Study|Withdrawal by Subject|6|||
49046843|NCT03294317|158003945|FG000|Overall Study|Lost to Follow-up|1|||
49046844|NCT03294317|158003945|FG000|Overall Study|Did not meet inclusion/exclusion criteria|1|||
49046845|NCT03294317|158003945|FG000|Overall Study|Failed HB lead implant|8|||
49046846|NCT03294317|158003945|FG000|Overall Study|Received CRT instead|1|||
49046847|NCT03294317|158003945|FG000|Overall Study|Exited after lead revision|2|||
49046848|NCT00645944|158003956|FG000|Randomized|Withdrawal by Subject|1|||
49046849|NCT00645944|158003957|FG001|Randomized|Withdrawal by Subject|2|||
49046850|NCT00645944|158003956|FG000|Received Medication|Adverse Event|2|||
49046851|NCT00645944|158003957|FG001|Received Medication|Adverse Event|1|||
49046852|NCT00645944|158003956|FG000|Received Medication|Withdrawal by Subject|1|||
49046853|NCT00645944|158003957|FG001|Received Medication|Withdrawal by Subject|1|||
49046854|NCT00645944|158003956|FG000|Received Medication|Lost to Follow-up|1|||
49046855|NCT00645944|158003957|FG001|Received Medication|Lost to Follow-up|0|||
49046856|NCT00645944|158003956|FG000|Received Medication|Protocol Violation|2|||
49046857|NCT00645944|158003957|FG001|Received Medication|Protocol Violation|1|||
49046858|NCT02105701|158003958|FG000|Overall Study|Lost to Follow-up|1|||
49046859|NCT02105701|158003959|FG001|Overall Study|Lost to Follow-up|0|||
49046860|NCT02105701|158003960|FG002|Overall Study|Lost to Follow-up|2|||
49046861|NCT02105701|158003961|FG003|Overall Study|Lost to Follow-up|1|||
49046862|NCT02105701|158003958|FG000|Overall Study|Protocol Violation|0|||
49046863|NCT02105701|158003959|FG001|Overall Study|Protocol Violation|0|||
49046864|NCT02105701|158003960|FG002|Overall Study|Protocol Violation|1|||
49046865|NCT02105701|158003961|FG003|Overall Study|Protocol Violation|0|||
49046866|NCT02105701|158003958|FG000|Overall Study|Withdrawal by Subject|2|||
49046867|NCT02105701|158003959|FG001|Overall Study|Withdrawal by Subject|1|||
49046868|NCT02105701|158003960|FG002|Overall Study|Withdrawal by Subject|0|||
49046869|NCT02105701|158003961|FG003|Overall Study|Withdrawal by Subject|1|||
49046870|NCT02105701|158003958|FG000|Overall Study|Death|1|||
49046871|NCT02105701|158003959|FG001|Overall Study|Death|0|||
49046872|NCT02105701|158003960|FG002|Overall Study|Death|0|||
49046873|NCT02105701|158003961|FG003|Overall Study|Death|0|||
49046874|NCT00654641|158003962|FG000|Overall Study|Lost to Follow-up|2|||
49046875|NCT00654641|158003963|FG001|Overall Study|Lost to Follow-up|3|||
49046876|NCT03108820|158003964|FG000|Overall Study|Lost to Follow-up|30|||
49046877|NCT03108820|158003965|FG001|Overall Study|Lost to Follow-up|28|||
49046878|NCT03108820|158003964|FG000|Overall Study|Withdrawal by Subject|32|||
49046879|NCT03108820|158003965|FG001|Overall Study|Withdrawal by Subject|24|||
49046880|NCT03108820|158003964|FG000|Overall Study|Death|6|||
49046881|NCT03108820|158003965|FG001|Overall Study|Death|11|||
49046882|NCT00562120|158003968|FG000|First Intervention Period|Adverse Event|1|||
49046883|NCT00562120|158003969|FG001|First Intervention Period|Adverse Event|0|||
49046884|NCT00562120|158003970|FG002|First Intervention Period|Adverse Event|0|||
49046885|NCT00562120|158003971|FG003|First Intervention Period|Adverse Event|0|||
49046886|NCT00562120|158003968|FG000|First Intervention Period|Randomized but not Treated|1|||
49046887|NCT00562120|158003969|FG001|First Intervention Period|Randomized but not Treated|0|||
49046888|NCT00562120|158003970|FG002|First Intervention Period|Randomized but not Treated|0|||
49046889|NCT00562120|158003971|FG003|First Intervention Period|Randomized but not Treated|0|||
49046890|NCT01952691|158005512|FG000|Overall Study|Lost to Follow-up|2|||
49046891|NCT02940522|158005515|FG000|Overall Study|Lost to Follow-up|1|||
49046892|NCT02940522|158005516|FG001|Overall Study|Lost to Follow-up|2|||
49046893|NCT02940522|158005515|FG000|Overall Study|Withdrawal by Subject|1|||
49046894|NCT02940522|158005516|FG001|Overall Study|Withdrawal by Subject|0|||
49046895|NCT00274625|158005517|FG000|Overall Study|Lost to Follow-up|46|||
49046896|NCT00274625|158005518|FG001|Overall Study|Lost to Follow-up|54|||
49046897|NCT00274625|158005517|FG000|Overall Study|Excluded from analysis|14|||
49046898|NCT00274625|158005518|FG001|Overall Study|Excluded from analysis|8|||
49046899|NCT03086135|158005519|FG000|Overall Study|Adverse Event|1|||
49046900|NCT03086135|158005519|FG000|Overall Study|Lost to Follow-up|2|||
49046901|NCT03969641|158005522|FG000|Overall Study|Lost to Follow-up|5|||
49046902|NCT03969641|158005523|FG001|Overall Study|Lost to Follow-up|3|||
49046903|NCT03969641|158005522|FG000|Overall Study|Withdrawal by Subject|1|||
49046904|NCT03969641|158005523|FG001|Overall Study|Withdrawal by Subject|2|||
49046905|NCT03969641|158005522|FG000|Overall Study|Found to be ineligible|1|||
49046906|NCT03969641|158005523|FG001|Overall Study|Found to be ineligible|1|||
49046907|NCT03969641|158005522|FG000|Overall Study|Intrauterine fetal demise (IUFD)|0|||
49046908|NCT03969641|158005523|FG001|Overall Study|Intrauterine fetal demise (IUFD)|2|||
49046909|NCT03969641|158005522|FG000|Overall Study|Spontaneous abortion (SAB)|2|||
49046910|NCT03969641|158005523|FG001|Overall Study|Spontaneous abortion (SAB)|1|||
49046911|NCT03969641|158005522|FG000|Overall Study|Elective termination|0|||
49046912|NCT03969641|158005523|FG001|Overall Study|Elective termination|1|||
49046913|NCT00762411|158005526|FG000|Initial Treatment|Death|7|||
49046914|NCT00762411|158005527|FG001|Initial Treatment|Death|6|||
49046915|NCT00762411|158005526|FG000|Initial Treatment|Adverse Event|132|||
49046916|NCT00762411|158005527|FG001|Initial Treatment|Adverse Event|40|||
49046917|NCT00762411|158005526|FG000|Initial Treatment|Protocol Violation|4|||
49046918|NCT00762411|158005527|FG001|Initial Treatment|Protocol Violation|1|||
49046919|NCT00762411|158005526|FG000|Initial Treatment|Withdrawal by Subject|65|||
49046920|NCT00762411|158005527|FG001|Initial Treatment|Withdrawal by Subject|52|||
49046921|NCT00762411|158005526|FG000|Initial Treatment|Physician Decision|1|||
49046922|NCT00762411|158005527|FG001|Initial Treatment|Physician Decision|0|||
49046923|NCT00762411|158005526|FG000|Initial Treatment|Sponsor Decision|293|||
49046924|NCT00762411|158005527|FG001|Initial Treatment|Sponsor Decision|401|||
49046925|NCT00762411|158005526|FG000|Initial Treatment|Lost to Follow-up|5|||
49046926|NCT00762411|158005527|FG001|Initial Treatment|Lost to Follow-up|0|||
49046927|NCT00762411|158005526|FG000|Initial Treatment|Caregiver Decision|21|||
49046928|NCT00762411|158005527|FG001|Initial Treatment|Caregiver Decision|16|||
49046929|NCT00762411|158005526|FG000|Initial Treatment|Abnormal Lab/ECG Result|6|||
49046930|NCT00762411|158005527|FG001|Initial Treatment|Abnormal Lab/ECG Result|4|||
49046931|NCT00762411|158005526|FG000|Initial Treatment|Entry Criteria Exclusion|0|||
49046932|NCT00762411|158005527|FG001|Initial Treatment|Entry Criteria Exclusion|1|||
49046933|NCT00762411|158005526|FG000|Delayed Start|Adverse Event|0|||
49046934|NCT00762411|158005527|FG001|Delayed Start|Adverse Event|4|||
49046935|NCT00762411|158005526|FG000|Delayed Start|Protocol Violation|0|||
49046936|NCT00762411|158005527|FG001|Delayed Start|Protocol Violation|1|||
49046937|NCT00762411|158005526|FG000|Delayed Start|Sponsor Decision|16|||
49046938|NCT00762411|158005527|FG001|Delayed Start|Sponsor Decision|20|||
49046939|NCT00762411|158005526|FG000|Delayed Start|Caregiver Decision|1|||
49046940|NCT00762411|158005527|FG001|Delayed Start|Caregiver Decision|1|||
49046941|NCT00762411|158005526|FG000|Safety Follow Up (SFU)-Optional|Death|1|||
49046942|NCT00762411|158005527|FG001|Safety Follow Up (SFU)-Optional|Death|8|||
49046943|NCT00762411|158005526|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
49046944|NCT00762411|158005527|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|1|||
49046945|NCT00762411|158005526|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21|||
49046946|NCT00762411|158005527|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46|||
49046947|NCT00762411|158005526|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6|||
49046948|NCT00762411|158005527|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
49046949|NCT00762411|158005526|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
49046950|NCT00762411|158005527|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
49046951|NCT00762411|158005526|FG000|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48|||
49046952|NCT00762411|158005527|FG001|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54|||
49046953|NCT01023061|158005528|FG000|Overall Study|Withdrawal prior to treatment|2|||
49046954|NCT02966340|158005529|FG000|Overall Study|Adverse Event|0|||
49046955|NCT02966340|158005530|FG001|Overall Study|Adverse Event|1|||
49046956|NCT02966340|158005529|FG000|Overall Study|Lost to Follow-up|0|||
49046957|NCT02966340|158005530|FG001|Overall Study|Lost to Follow-up|1|||
49046958|NCT02966340|158005529|FG000|Overall Study|Withdrawal by Subject|1|||
49046959|NCT02966340|158005530|FG001|Overall Study|Withdrawal by Subject|0|||
49046960|NCT02966340|158005529|FG000|Overall Study|data acquisition error|1|||
49046961|NCT02966340|158005530|FG001|Overall Study|data acquisition error|0|||
49046962|NCT02966340|158005529|FG000|Overall Study|startle non-responder|1|||
49046963|NCT02966340|158005530|FG001|Overall Study|startle non-responder|1|||
49046964|NCT01541215|158005531|FG000|Treatment Period (52 Weeks)|Withdrawal criteria|6|||
49046965|NCT01541215|158005532|FG001|Treatment Period (52 Weeks)|Withdrawal criteria|8|||
49046966|NCT01541215|158005531|FG000|Treatment Period (52 Weeks)|Non-compliance|4|||
49046967|NCT01541215|158005532|FG001|Treatment Period (52 Weeks)|Non-compliance|4|||
49046968|NCT01541215|158005531|FG000|Treatment Period (52 Weeks)|Adverse Event|0|||
49046969|NCT01541215|158005532|FG001|Treatment Period (52 Weeks)|Adverse Event|1|||
49046970|NCT01541215|158005531|FG000|Treatment Period (52 Weeks)|Unclassified|0|||
49046971|NCT01541215|158005532|FG001|Treatment Period (52 Weeks)|Unclassified|3|||
49046972|NCT01541215|158005531|FG000|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1|||
49046973|NCT01541215|158005532|FG001|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0|||
49046974|NCT01541215|158005531|FG000|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1|||
49046975|NCT01541215|158005532|FG001|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0|||
49046976|NCT01622660|158005534|FG000|Overall Study|Adverse Event|1|||
49046977|NCT02259348|158005535|FG000|Overall Study|Donors|6|||
49046978|NCT02259348|158005535|FG000|Overall Study|Death|4|||
49046979|NCT05135273|158005536|FG000|Overall Study|Recruited into the army|0|||
49046980|NCT05135273|158005537|FG001|Overall Study|Recruited into the army|0|||
49046981|NCT05135273|158005538|FG002|Overall Study|Recruited into the army|0|||
49046982|NCT05135273|158005539|FG003|Overall Study|Recruited into the army|0|||
49046983|NCT05135273|158005540|FG004|Overall Study|Recruited into the army|1|||
49046984|NCT05135273|158005541|FG005|Overall Study|Recruited into the army|0|||
49046985|NCT05135273|158005542|FG006|Overall Study|Recruited into the army|0|||
49046986|NCT05135273|158005543|FG007|Overall Study|Recruited into the army|0|||
49046987|NCT05135273|158005536|FG000|Overall Study|Moved away from study site|0|||
49046988|NCT05135273|158005537|FG001|Overall Study|Moved away from study site|0|||
49046989|NCT05135273|158005538|FG002|Overall Study|Moved away from study site|0|||
49046990|NCT05135273|158005539|FG003|Overall Study|Moved away from study site|0|||
49046991|NCT05135273|158005540|FG004|Overall Study|Moved away from study site|0|||
49046992|NCT05135273|158005541|FG005|Overall Study|Moved away from study site|1|||
49046993|NCT05135273|158005542|FG006|Overall Study|Moved away from study site|1|||
49046994|NCT05135273|158005543|FG007|Overall Study|Moved away from study site|0|||
49046995|NCT05135273|158005536|FG000|Overall Study|Travel|0|||
49046996|NCT05135273|158005537|FG001|Overall Study|Travel|0|||
49046997|NCT05135273|158005538|FG002|Overall Study|Travel|0|||
49046998|NCT05135273|158005539|FG003|Overall Study|Travel|0|||
49046999|NCT05135273|158005540|FG004|Overall Study|Travel|0|||
49047000|NCT05135273|158005541|FG005|Overall Study|Travel|0|||
49047001|NCT05135273|158005542|FG006|Overall Study|Travel|0|||
49047002|NCT05135273|158005543|FG007|Overall Study|Travel|1|||
49047003|NCT02302716|158005544|FG000|Overall Study|Adverse Event|1|||
49047004|NCT02302716|158005545|FG001|Overall Study|Adverse Event|1|||
49047005|NCT02302716|158005544|FG000|Overall Study|Death|0|||
49047006|NCT02302716|158005545|FG001|Overall Study|Death|1|||
49047007|NCT02302716|158005544|FG000|Overall Study|Lack of Efficacy|0|||
49047008|NCT02302716|158005545|FG001|Overall Study|Lack of Efficacy|1|||
49047009|NCT02302716|158005544|FG000|Overall Study|Lost to Follow-up|2|||
49047010|NCT02302716|158005545|FG001|Overall Study|Lost to Follow-up|4|||
49047011|NCT02302716|158005544|FG000|Overall Study|Physician Decision|3|||
49047012|NCT02302716|158005545|FG001|Overall Study|Physician Decision|4|||
49047013|NCT02302716|158005544|FG000|Overall Study|Withdrawal by Subject|13|||
49047014|NCT02302716|158005545|FG001|Overall Study|Withdrawal by Subject|7|||
49047015|NCT02302716|158005544|FG000|Overall Study|Protocol Violation|0|||
49047016|NCT02302716|158005545|FG001|Overall Study|Protocol Violation|1|||
49047017|NCT04211766|158005546|FG000|Overall Study|Withdrawal by Subject|5|||
49047018|NCT04211766|158005547|FG001|Overall Study|Withdrawal by Subject|1|||
49047019|NCT02710214|158005548|FG000|Overall Study|Lost to Follow-up|1|||
49047020|NCT02710214|158005549|FG001|Overall Study|Lost to Follow-up|0|||
49047021|NCT02710214|158005548|FG000|Overall Study|Lack of Efficacy|0|||
49047022|NCT02710214|158005549|FG001|Overall Study|Lack of Efficacy|1|||
49047023|NCT02710214|158005548|FG000|Overall Study|Death|0|||
49047024|NCT02710214|158005549|FG001|Overall Study|Death|1|||
49047025|NCT03920280|158005566|FG000|Overall Study|Adverse Event|2|||
49047026|NCT03920280|158005567|FG001|Overall Study|Adverse Event|3|||
49047027|NCT03920280|158005566|FG000|Overall Study|Lost to Follow-up|0|||
49047028|NCT03920280|158005567|FG001|Overall Study|Lost to Follow-up|1|||
49047029|NCT03920280|158005566|FG000|Overall Study|Withdrawal by Subject|1|||
49047030|NCT03920280|158005567|FG001|Overall Study|Withdrawal by Subject|1|||
49047031|NCT03920280|158005566|FG000|Overall Study|Corneal cylinder greater than 1.00 diopter|0|||
49047032|NCT03920280|158005567|FG001|Overall Study|Corneal cylinder greater than 1.00 diopter|1|||
49047033|NCT02058160|158005568|FG000|Overall Study|Randomized but not treated|2|||
49047034|NCT02058160|158005569|FG001|Overall Study|Randomized but not treated|4|||
49047035|NCT02058160|158005568|FG000|Overall Study|Poor compliance to protocol|4|||
49047036|NCT02058160|158005569|FG001|Overall Study|Poor compliance to protocol|1|||
49047037|NCT02058160|158005568|FG000|Overall Study|Adverse Event|12|||
49047038|NCT02058160|158005569|FG001|Overall Study|Adverse Event|3|||
49047039|NCT02058160|158005568|FG000|Overall Study|Lost to Follow-up|1|||
49047040|NCT02058160|158005569|FG001|Overall Study|Lost to Follow-up|0|||
49047041|NCT02058160|158005568|FG000|Overall Study|Other than specified above|12|||
49047042|NCT02058160|158005569|FG001|Overall Study|Other than specified above|6|||
49047043|NCT03253744|158005570|FG000|Completion of Follow-Up|Continuing follow-up.|2|||
49047044|NCT03253744|158005571|FG001|Completion of Follow-Up|Continuing follow-up.|0|||
49047045|NCT03253744|158005572|FG002|Completion of Follow-Up|Continuing follow-up.|0|||
49047046|NCT03253744|158005573|FG003|Completion of Follow-Up|Continuing follow-up.|4|||
49047047|NCT01264835|158005576|FG000|Overall Study|Lost to Follow-up|1|||
49047048|NCT02260635|158005577|FG000|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1|||
49047049|NCT02260635|158005578|FG001|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2|||
49047050|NCT02260635|158005577|FG000|Open-Label Extension|Study Termination|25|||
49047051|NCT02260635|158005578|FG001|Open-Label Extension|Study Termination|25|||
49047052|NCT02260635|158005577|FG000|Open-Label Extension|Withdrawal by Subject|1|||
49047053|NCT02260635|158005578|FG001|Open-Label Extension|Withdrawal by Subject|0|||
49047054|NCT00942734|158005579|FG000|Overall Study|Adverse Event|2|||
49047055|NCT00942734|158005579|FG000|Overall Study|Protocol Violation|3|||
49047056|NCT00942734|158005579|FG000|Overall Study|Disease Progression|2|||
49047057|NCT00942734|158005579|FG000|Overall Study|Physician Decision|1|||
49047058|NCT01203917|158005580|FG000|Overall Study|Death|29|||
49047059|NCT01203917|158005580|FG000|Overall Study|Lost to Follow-up|2|||
49047060|NCT01203917|158005580|FG000|Overall Study|Withdrawal by Subject|3|||
49047061|NCT01203917|158005580|FG000|Overall Study|Due to objective disease progression|1|||
49047062|NCT01203917|158005580|FG000|Overall Study|Due to EGFR M+I patient|1|||
49047063|NCT04106817|158005581|FG000|Overall Study|Lost to Follow-up|1|||
49047064|NCT04106817|158005582|FG001|Overall Study|Lost to Follow-up|0|||
49047065|NCT04106817|158005583|FG002|Overall Study|Lost to Follow-up|0|||
49047066|NCT03183141|158005585|FG000|Overall Study|Withdrawal by Subject|2|||
49047067|NCT03183141|158005586|FG001|Overall Study|Withdrawal by Subject|4|||
49047068|NCT03183141|158005585|FG000|Overall Study|Death|0|||
49047069|NCT03183141|158005586|FG001|Overall Study|Death|8|||
49047070|NCT00152516|158005592|FG000|Overall Study|Adverse Event|18|||
49047071|NCT00152516|158005592|FG000|Overall Study|Lack and Loss of Efficacy|30|||
49047072|NCT00152516|158005592|FG000|Overall Study|Lost to Follow-up|5|||
49047073|NCT00152516|158005592|FG000|Overall Study|Withdrawal by Subject|8|||
49047074|NCT00152516|158005592|FG000|Overall Study|Protocol Violation|3|||
49047075|NCT00152516|158005592|FG000|Overall Study|Other: Mother Refused To Cooperate|1|||
49047076|NCT00152516|158005592|FG000|Overall Study|Other: Given Commercial Drug in Error|2|||
49047077|NCT00152516|158005592|FG000|Overall Study|Other: Parents Withdrew Consent|2|||
49047078|NCT00152516|158005592|FG000|Overall Study|Other: Non-Compliance|2|||
49047079|NCT00152516|158005592|FG000|Overall Study|Other: Primary Care Physician's Decision|1|||
49047080|NCT00152516|158005592|FG000|Overall Study|Other: Moved Out Of State|1|||
49047081|NCT00152516|158005592|FG000|Overall Study|Other: Underwent Surgery for Epilepsy|1|||
49047082|NCT00152516|158005592|FG000|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1|||
49047083|NCT02427399|158005595|FG000|Overall Study|Protocol Violation|14|||
49047084|NCT02427399|158005596|FG001|Overall Study|Protocol Violation|16|||
49047085|NCT02427399|158005597|FG002|Overall Study|Protocol Violation|12|||
49047086|NCT02427399|158005598|FG003|Overall Study|Protocol Violation|18|||
49047087|NCT02427399|158005599|FG004|Overall Study|Protocol Violation|15|||
49047088|NCT04660032|158005600|FG000|Overall Study|Protocol Violation|1|||
49047089|NCT04660032|158005601|FG001|Overall Study|Protocol Violation|1|||
49047090|NCT00090753|158005602|FG000|First Treatment Period|Adverse Event|20|||
49047091|NCT00090753|158005603|FG001|First Treatment Period|Adverse Event|8|||
49047092|NCT00090753|158005602|FG000|First Treatment Period|Death|88|||
49047093|NCT00090753|158005603|FG001|First Treatment Period|Death|62|||
49047094|NCT00090753|158005602|FG000|First Treatment Period|Lack of Efficacy|2|||
49047095|NCT00090753|158005603|FG001|First Treatment Period|Lack of Efficacy|1|||
49047096|NCT00090753|158005602|FG000|First Treatment Period|Refused Treatment|32|||
49047097|NCT00090753|158005603|FG001|First Treatment Period|Refused Treatment|25|||
49047098|NCT00090753|158005602|FG000|First Treatment Period|Lost to Follow-up|4|||
49047099|NCT00090753|158005603|FG001|First Treatment Period|Lost to Follow-up|4|||
49047100|NCT00090753|158005602|FG000|First Treatment Period|Renal Transplant|70|||
49047101|NCT00090753|158005603|FG001|First Treatment Period|Renal Transplant|50|||
49047102|NCT00090753|158005602|FG000|First Treatment Period|Mircera Commercialization|1|||
49047103|NCT00090753|158005603|FG001|First Treatment Period|Mircera Commercialization|0|||
49047104|NCT00090753|158005602|FG000|First Treatment Period|Other Unrelated to Safety and Efficacy|39|||
49047105|NCT00090753|158005603|FG001|First Treatment Period|Other Unrelated to Safety and Efficacy|28|||
49047106|NCT00090753|158005602|FG000|Extended Treatment Period|Adverse Event|11|||
49047107|NCT00090753|158005603|FG001|Extended Treatment Period|Adverse Event|0|||
49047108|NCT00090753|158005602|FG000|Extended Treatment Period|Death|58|||
49047109|NCT00090753|158005603|FG001|Extended Treatment Period|Death|30|||
49047110|NCT00090753|158005602|FG000|Extended Treatment Period|Lack of Efficacy|1|||
49047111|NCT00090753|158005603|FG001|Extended Treatment Period|Lack of Efficacy|0|||
49047112|NCT00090753|158005602|FG000|Extended Treatment Period|Refused Treatment|18|||
49047113|NCT00090753|158005603|FG001|Extended Treatment Period|Refused Treatment|12|||
49047114|NCT00090753|158005602|FG000|Extended Treatment Period|Lost to Follow-up|3|||
49047115|NCT00090753|158005603|FG001|Extended Treatment Period|Lost to Follow-up|1|||
49047116|NCT00090753|158005602|FG000|Extended Treatment Period|Renal Transplant|15|||
49047117|NCT00090753|158005603|FG001|Extended Treatment Period|Renal Transplant|12|||
49047118|NCT00090753|158005602|FG000|Extended Treatment Period|Mircera Commercialization|188|||
49047119|NCT00090753|158005603|FG001|Extended Treatment Period|Mircera Commercialization|93|||
49047120|NCT00090753|158005602|FG000|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65|||
49047121|NCT00090753|158005603|FG001|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43|||
49047122|NCT00605176|158005604|FG000|Overall Study|Adverse Event|2|||
49047123|NCT00605176|158005605|FG001|Overall Study|Adverse Event|1|||
49047124|NCT00605176|158005606|FG002|Overall Study|Adverse Event|3|||
49047125|NCT00605176|158005604|FG000|Overall Study|Withdrawal by Subject|4|||
49047126|NCT00605176|158005605|FG001|Overall Study|Withdrawal by Subject|2|||
49047127|NCT00605176|158005606|FG002|Overall Study|Withdrawal by Subject|4|||
49047128|NCT00605176|158005604|FG000|Overall Study|Lost to Follow-up|2|||
49047129|NCT00605176|158005605|FG001|Overall Study|Lost to Follow-up|2|||
49047130|NCT00605176|158005606|FG002|Overall Study|Lost to Follow-up|1|||
49047131|NCT00605176|158005604|FG000|Overall Study|Non-complicance with study procedures|1|||
49047132|NCT00605176|158005605|FG001|Overall Study|Non-complicance with study procedures|0|||
49047133|NCT00605176|158005606|FG002|Overall Study|Non-complicance with study procedures|0|||
49047134|NCT00605176|158005604|FG000|Overall Study|Use of concomitant therapy|1|||
49047135|NCT00605176|158005605|FG001|Overall Study|Use of concomitant therapy|0|||
49047136|NCT00605176|158005606|FG002|Overall Study|Use of concomitant therapy|1|||
49047137|NCT00605176|158005604|FG000|Overall Study|Other (not due to AE)|1|||
49047138|NCT00605176|158005605|FG001|Overall Study|Other (not due to AE)|1|||
49047139|NCT00605176|158005606|FG002|Overall Study|Other (not due to AE)|0|||
49047140|NCT01256060|158005607|FG000|Overall Study|Lost to Follow-up|0|||
49047141|NCT01256060|158005608|FG001|Overall Study|Lost to Follow-up|1|||
49047142|NCT01256060|158005609|FG002|Overall Study|Lost to Follow-up|0|||
49047143|NCT01256060|158005610|FG003|Overall Study|Lost to Follow-up|0|||
49047144|NCT01517867|158005615|FG000|Overall Study|never started treatment|29|||
49047145|NCT01517867|158005616|FG001|Overall Study|never started treatment|32|||
49047146|NCT01517867|158005615|FG000|Overall Study|Withdrawal by Subject|34|||
49047147|NCT01517867|158005616|FG001|Overall Study|Withdrawal by Subject|30|||
49047148|NCT01517867|158005615|FG000|Overall Study|Still in treatment at study end|0|||
49047149|NCT01517867|158005616|FG001|Overall Study|Still in treatment at study end|3|||
49047150|NCT01628549|158005625|FG000|Overall Study|Adverse Event|1|||
49047151|NCT01628549|158005626|FG001|Overall Study|Adverse Event|1|||
49047152|NCT01628549|158005627|FG002|Overall Study|Adverse Event|0|||
49047153|NCT01628549|158005628|FG003|Overall Study|Adverse Event|4|||
49047154|NCT01628549|158005625|FG000|Overall Study|Lost to Follow-up|3|||
49047155|NCT01628549|158005626|FG001|Overall Study|Lost to Follow-up|4|||
49047156|NCT01628549|158005627|FG002|Overall Study|Lost to Follow-up|3|||
49047157|NCT01628549|158005628|FG003|Overall Study|Lost to Follow-up|3|||
49047158|NCT01628549|158005625|FG000|Overall Study|Withdrawal by Subject|3|||
49047159|NCT01628549|158005626|FG001|Overall Study|Withdrawal by Subject|4|||
49047160|NCT01628549|158005627|FG002|Overall Study|Withdrawal by Subject|4|||
49047161|NCT01628549|158005628|FG003|Overall Study|Withdrawal by Subject|1|||
49047162|NCT01628549|158005625|FG000|Overall Study|Protocol Violation|2|||
49047163|NCT01628549|158005626|FG001|Overall Study|Protocol Violation|1|||
49047164|NCT01628549|158005627|FG002|Overall Study|Protocol Violation|1|||
49047165|NCT01628549|158005628|FG003|Overall Study|Protocol Violation|0|||
49047166|NCT01628549|158005625|FG000|Overall Study|withdrawn for noncompliance|0|||
49047167|NCT01628549|158005626|FG001|Overall Study|withdrawn for noncompliance|2|||
49047168|NCT01628549|158005627|FG002|Overall Study|withdrawn for noncompliance|1|||
49047169|NCT01628549|158005628|FG003|Overall Study|withdrawn for noncompliance|0|||
49047170|NCT01628549|158005625|FG000|Overall Study|abnormal laboratory test results|0|||
49047171|NCT01628549|158005626|FG001|Overall Study|abnormal laboratory test results|0|||
49047172|NCT01628549|158005627|FG002|Overall Study|abnormal laboratory test results|1|||
49047173|NCT01628549|158005628|FG003|Overall Study|abnormal laboratory test results|0|||
49047174|NCT01628549|158005625|FG000|Overall Study|positive pregnancy test|0|||
49047175|NCT01628549|158005626|FG001|Overall Study|positive pregnancy test|0|||
49047176|NCT01628549|158005627|FG002|Overall Study|positive pregnancy test|0|||
49047177|NCT01628549|158005628|FG003|Overall Study|positive pregnancy test|1|||
49047178|NCT05766787|158005631|FG000|First Wear Period, Approximately 7 Days|Adverse Event|0|||
49047179|NCT05766787|158005632|FG001|First Wear Period, Approximately 7 Days|Adverse Event|1|||
49047180|NCT05766787|158005631|FG000|First Wear Period, Approximately 7 Days|Withdrawal by Subject|1|||
49047181|NCT05766787|158005632|FG001|First Wear Period, Approximately 7 Days|Withdrawal by Subject|2|||
49047182|NCT05766787|158005631|FG000|Second Wear Period, Approximately 7 Days|Adverse Event|0|||
49047183|NCT05766787|158005632|FG001|Second Wear Period, Approximately 7 Days|Adverse Event|1|||
49047184|NCT01466036|158005635|FG000|Overall Study|Death|1|||
49047185|NCT01466036|158005636|FG001|Overall Study|Death|1|||
49047186|NCT01466036|158005635|FG000|Overall Study|Physician Decision|0|||
49047187|NCT01466036|158005636|FG001|Overall Study|Physician Decision|4|||
49047188|NCT01466036|158005635|FG000|Overall Study|Adverse Event|2|||
49047189|NCT01466036|158005636|FG001|Overall Study|Adverse Event|6|||
49047190|NCT01466036|158005635|FG000|Overall Study|Withdrawal by Subject|2|||
49047191|NCT01466036|158005636|FG001|Overall Study|Withdrawal by Subject|8|||
49047192|NCT01466036|158005635|FG000|Overall Study|progression/relapse|14|||
49047193|NCT01466036|158005636|FG001|Overall Study|progression/relapse|21|||
49047194|NCT01466036|158005635|FG000|Overall Study|prolonged treatment delay|1|||
49047195|NCT01466036|158005636|FG001|Overall Study|prolonged treatment delay|1|||
49047196|NCT04499482|158005639|FG000|Foods Containing 10 g Soy Flour|One subject dropped from the study at Day 3 as the subject could not meet the demands of the study|1|||
49047197|NCT02539368|158005640|FG000|Overall Study|Death|4|||
49047198|NCT02539368|158005641|FG001|Overall Study|Death|2|||
49047199|NCT02539368|158005642|FG002|Overall Study|Death|1|||
49047200|NCT02539368|158005643|FG003|Overall Study|Death|0|||
49047201|NCT02539368|158005644|FG004|Overall Study|Death|0|||
49047202|NCT02539368|158005640|FG000|Overall Study|Withdrawal by Subject|44|||
49047203|NCT02539368|158005641|FG001|Overall Study|Withdrawal by Subject|35|||
49047204|NCT02539368|158005642|FG002|Overall Study|Withdrawal by Subject|9|||
49047205|NCT02539368|158005643|FG003|Overall Study|Withdrawal by Subject|1|||
49047206|NCT02539368|158005644|FG004|Overall Study|Withdrawal by Subject|3|||
49047207|NCT02539368|158005640|FG000|Overall Study|Physician Decision|49|||
49047208|NCT02539368|158005641|FG001|Overall Study|Physician Decision|15|||
49047209|NCT02539368|158005642|FG002|Overall Study|Physician Decision|7|||
49047210|NCT02539368|158005643|FG003|Overall Study|Physician Decision|0|||
49047211|NCT02539368|158005644|FG004|Overall Study|Physician Decision|2|||
49047212|NCT02539368|158005640|FG000|Overall Study|Lost to Follow-up|96|||
49047213|NCT02539368|158005641|FG001|Overall Study|Lost to Follow-up|21|||
49047214|NCT02539368|158005642|FG002|Overall Study|Lost to Follow-up|16|||
49047215|NCT02539368|158005643|FG003|Overall Study|Lost to Follow-up|4|||
49047216|NCT02539368|158005644|FG004|Overall Study|Lost to Follow-up|3|||
49047217|NCT02539368|158005640|FG000|Overall Study|Adverse Event|44|||
49047218|NCT02539368|158005641|FG001|Overall Study|Adverse Event|5|||
49047219|NCT02539368|158005642|FG002|Overall Study|Adverse Event|9|||
49047220|NCT02539368|158005643|FG003|Overall Study|Adverse Event|0|||
49047221|NCT02539368|158005644|FG004|Overall Study|Adverse Event|3|||
49047222|NCT02539368|158005640|FG000|Overall Study|Participant Non-compliant|13|||
49047223|NCT02539368|158005641|FG001|Overall Study|Participant Non-compliant|2|||
49047224|NCT02539368|158005642|FG002|Overall Study|Participant Non-compliant|1|||
49047225|NCT02539368|158005643|FG003|Overall Study|Participant Non-compliant|1|||
49047226|NCT02539368|158005644|FG004|Overall Study|Participant Non-compliant|0|||
49047227|NCT02539368|158005640|FG000|Overall Study|Other|145|||
49047228|NCT02539368|158005641|FG001|Overall Study|Other|18|||
49047229|NCT02539368|158005642|FG002|Overall Study|Other|24|||
49047230|NCT02539368|158005643|FG003|Overall Study|Other|1|||
49047231|NCT02539368|158005644|FG004|Overall Study|Other|3|||
49047232|NCT02539368|158005640|FG000|Overall Study|Missing|10|||
49047233|NCT02539368|158005641|FG001|Overall Study|Missing|3|||
49047234|NCT02539368|158005642|FG002|Overall Study|Missing|0|||
49047235|NCT02539368|158005643|FG003|Overall Study|Missing|0|||
49047236|NCT02539368|158005644|FG004|Overall Study|Missing|0|||
49047237|NCT01198873|158005645|FG000|Overall Study|Adverse Event|4|||
49047238|NCT01198873|158005646|FG001|Overall Study|Adverse Event|7|||
49047239|NCT01198873|158005645|FG000|Overall Study|Study closure|29|||
49047240|NCT01198873|158005646|FG001|Overall Study|Study closure|23|||
49047241|NCT01198873|158005645|FG000|Overall Study|Other than above|4|||
49047242|NCT01198873|158005646|FG001|Overall Study|Other than above|2|||
49047243|NCT00398073|158005647|FG000|Overall Study|Withdrawal by Subject|1|||
49047244|NCT00398073|158005648|FG001|Overall Study|Withdrawal by Subject|0|||
49047245|NCT01263561|158005649|FG000|Overall Study|Death|1|||
49047246|NCT01263561|158005650|FG001|Overall Study|Death|2|||
49047247|NCT02339740|158005651|FG000|Overall Study|Death|1|||
49047248|NCT02339740|158005652|FG001|Overall Study|Death|0|||
49047249|NCT02339740|158005651|FG000|Overall Study|Physician Decision|0|||
49047250|NCT02339740|158005652|FG001|Overall Study|Physician Decision|2|||
49047251|NCT02339740|158005651|FG000|Overall Study|Withdrawal by Subject|5|||
49047252|NCT02339740|158005652|FG001|Overall Study|Withdrawal by Subject|1|||
49047253|NCT02339740|158005651|FG000|Overall Study|Inevaluable-RQPCR positive not confirmed|3|||
49047254|NCT02339740|158005652|FG001|Overall Study|Inevaluable-RQPCR positive not confirmed|1|||
49047255|NCT03450629|158005654|FG000|Overall Study|Adverse Event|15|||
49047256|NCT03450629|158005655|FG001|Overall Study|Adverse Event|14|||
49047257|NCT03450629|158005654|FG000|Overall Study|Physician Decision|2|||
49047258|NCT03450629|158005655|FG001|Overall Study|Physician Decision|2|||
49047259|NCT03450629|158005654|FG000|Overall Study|Lack of Efficacy|2|||
49047260|NCT03450629|158005655|FG001|Overall Study|Lack of Efficacy|0|||
49047261|NCT03450629|158005654|FG000|Overall Study|Lost to Follow-up|4|||
49047262|NCT03450629|158005655|FG001|Overall Study|Lost to Follow-up|2|||
49047263|NCT03450629|158005654|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
49047264|NCT03450629|158005655|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
49047265|NCT03450629|158005654|FG000|Overall Study|Non-Compliance With Study Drug|2|||
49047266|NCT03450629|158005655|FG001|Overall Study|Non-Compliance With Study Drug|1|||
49047267|NCT03450629|158005654|FG000|Overall Study|Protocol Violation|11|||
49047268|NCT03450629|158005655|FG001|Overall Study|Protocol Violation|8|||
49047269|NCT03450629|158005654|FG000|Overall Study|Withdrawal by Subject|12|||
49047270|NCT03450629|158005655|FG001|Overall Study|Withdrawal by Subject|6|||
49047271|NCT01337596|158005656|FG000|Overall Study|Withdrawal by Subject|0|||
49047272|NCT01337596|158005657|FG001|Overall Study|Withdrawal by Subject|0|||
49047273|NCT01337596|158005658|FG002|Overall Study|Withdrawal by Subject|0|||
49047274|NCT01337596|158005659|FG003|Overall Study|Withdrawal by Subject|0|||
49047275|NCT01337596|158005660|FG004|Overall Study|Withdrawal by Subject|2|||
49047276|NCT01337596|158005661|FG005|Overall Study|Withdrawal by Subject|0|||
49047277|NCT01337596|158005662|FG006|Overall Study|Withdrawal by Subject|0|||
49047278|NCT01337596|158005663|FG007|Overall Study|Withdrawal by Subject|0|||
49047279|NCT01337596|158005664|FG008|Overall Study|Withdrawal by Subject|0|||
49047280|NCT03366194|158005665|FG000|Overall Study|Lost to Follow-up|2|||
49047281|NCT01362296|158005666|FG000|Randomized Phase (RP)|PD including Death due to PD|56|||
49047282|NCT01362296|158005667|FG001|Randomized Phase (RP)|PD including Death due to PD|28|||
49047283|NCT01362296|158005668|FG002|Randomized Phase (RP)|PD including Death due to PD|0|||
49047284|NCT01362296|158005669|FG003|Randomized Phase (RP)|PD including Death due to PD|0|||
49047285|NCT01362296|158005666|FG000|Randomized Phase (RP)|Physician Decision|1|||
49047286|NCT01362296|158005667|FG001|Randomized Phase (RP)|Physician Decision|9|||
49047287|NCT01362296|158005668|FG002|Randomized Phase (RP)|Physician Decision|0|||
49047288|NCT01362296|158005669|FG003|Randomized Phase (RP)|Physician Decision|0|||
49047289|NCT01362296|158005666|FG000|Randomized Phase (RP)|Withdrawal by Subject|2|||
49047290|NCT01362296|158005667|FG001|Randomized Phase (RP)|Withdrawal by Subject|1|||
49047291|NCT01362296|158005668|FG002|Randomized Phase (RP)|Withdrawal by Subject|0|||
49047292|NCT01362296|158005669|FG003|Randomized Phase (RP)|Withdrawal by Subject|0|||
49047293|NCT01362296|158005666|FG000|Randomized Phase (RP)|Adverse Event|20|||
49047294|NCT01362296|158005667|FG001|Randomized Phase (RP)|Adverse Event|4|||
49047295|NCT01362296|158005668|FG002|Randomized Phase (RP)|Adverse Event|0|||
49047296|NCT01362296|158005669|FG003|Randomized Phase (RP)|Adverse Event|0|||
49047297|NCT01362296|158005666|FG000|Randomized Phase (RP)|Study Closed/Terminated|8|||
49047298|NCT01362296|158005667|FG001|Randomized Phase (RP)|Study Closed/Terminated|1|||
49047299|NCT01362296|158005668|FG002|Randomized Phase (RP)|Study Closed/Terminated|0|||
49047300|NCT01362296|158005669|FG003|Randomized Phase (RP)|Study Closed/Terminated|0|||
49047301|NCT01362296|158005666|FG000|Crossover Phase|PD including Death due to PD|0|||
49047302|NCT01362296|158005667|FG001|Crossover Phase|PD including Death due to PD|0|||
49047303|NCT01362296|158005668|FG002|Crossover Phase|PD including Death due to PD|16|||
49047304|NCT01362296|158005669|FG003|Crossover Phase|PD including Death due to PD|1|||
49047305|NCT01362296|158005666|FG000|Crossover Phase|Withdrawal by Subject|0|||
49047306|NCT01362296|158005667|FG001|Crossover Phase|Withdrawal by Subject|0|||
49047307|NCT01362296|158005668|FG002|Crossover Phase|Withdrawal by Subject|2|||
49047308|NCT01362296|158005669|FG003|Crossover Phase|Withdrawal by Subject|1|||
49047309|NCT01362296|158005666|FG000|Crossover Phase|Adverse Event|0|||
49047310|NCT01362296|158005667|FG001|Crossover Phase|Adverse Event|0|||
49047311|NCT01362296|158005668|FG002|Crossover Phase|Adverse Event|4|||
49047312|NCT01362296|158005669|FG003|Crossover Phase|Adverse Event|0|||
49047313|NCT01362296|158005666|FG000|Crossover Phase|Study Closed/Terminated|0|||
49047314|NCT01362296|158005667|FG001|Crossover Phase|Study Closed/Terminated|0|||
49047315|NCT01362296|158005668|FG002|Crossover Phase|Study Closed/Terminated|1|||
49047316|NCT01362296|158005669|FG003|Crossover Phase|Study Closed/Terminated|0|||
49047317|NCT03693950|158005670|FG000|Overall Study|Withdrawal by Subject|1|||
49047318|NCT03693950|158005671|FG001|Overall Study|Withdrawal by Subject|0|||
49047319|NCT04230876|158005672|FG000|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
49047320|NCT04230876|158005673|FG001|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
49047321|NCT01475487|158005675|FG000|Overall Study|had to leave early for personal reasons|2|||
49047322|NCT01475487|158005676|FG001|Overall Study|had to leave early for personal reasons|1|||
49047323|NCT01475786|158005680|FG000|Overall Study|Adverse Event|0|||
49047324|NCT01475786|158005681|FG001|Overall Study|Adverse Event|1|||
49047325|NCT01475786|158005682|FG002|Overall Study|Adverse Event|0|||
49047326|NCT01475786|158005680|FG000|Overall Study|Lost to Follow-up|1|||
49047327|NCT01475786|158005681|FG001|Overall Study|Lost to Follow-up|2|||
49047328|NCT01475786|158005682|FG002|Overall Study|Lost to Follow-up|1|||
49047329|NCT01475786|158005680|FG000|Overall Study|Withdrawal by Subject|0|||
49047330|NCT01475786|158005681|FG001|Overall Study|Withdrawal by Subject|1|||
49047331|NCT01475786|158005682|FG002|Overall Study|Withdrawal by Subject|1|||
49047332|NCT01475786|158005680|FG000|Overall Study|Subject discontinued prior to study treatment|1|||
49047333|NCT01475786|158005681|FG001|Overall Study|Subject discontinued prior to study treatment|0|||
49047334|NCT01475786|158005682|FG002|Overall Study|Subject discontinued prior to study treatment|0|||
49047335|NCT02093923|158005683|FG000|Overall Study|Lost to Follow-up|0|||
49047336|NCT02093923|158005684|FG001|Overall Study|Lost to Follow-up|0|||
49047337|NCT02093923|158005685|FG002|Overall Study|Lost to Follow-up|0|||
49047338|NCT02093923|158005686|FG003|Overall Study|Lost to Follow-up|1|||
49047339|NCT02093923|158005687|FG004|Overall Study|Lost to Follow-up|0|||
49047340|NCT02093923|158005683|FG000|Overall Study|Screen failure after randomization|0|||
49047341|NCT02093923|158005684|FG001|Overall Study|Screen failure after randomization|0|||
49047342|NCT02093923|158005685|FG002|Overall Study|Screen failure after randomization|0|||
49047343|NCT02093923|158005686|FG003|Overall Study|Screen failure after randomization|1|||
49047344|NCT02093923|158005687|FG004|Overall Study|Screen failure after randomization|0|||
49047345|NCT03168906|158005694|FG000|Overall Study|Lack of Efficacy|6|||
49047346|NCT03168906|158005695|FG001|Overall Study|Lack of Efficacy|6|||
49047347|NCT01321697|158005698|FG000|Overall Study|Study Terminated|7|||
49047348|NCT01977456|158005703|FG000|Overall Study|Death|5|||
49047349|NCT04556734|158007049|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|4|||
49047350|NCT04556734|158007050|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
49047351|NCT04556734|158007051|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
49047352|NCT04556734|158007052|FG003|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
49047353|NCT04556734|158007053|FG004|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
49047354|NCT04556734|158007054|FG005|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
49047355|NCT04556734|158007055|FG006|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
49047356|NCT04556734|158007056|FG007|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
49047357|NCT04556734|158007049|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
49047358|NCT04556734|158007050|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
49047359|NCT04556734|158007051|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
49047360|NCT04556734|158007052|FG003|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
49047361|NCT04556734|158007053|FG004|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
49047362|NCT04556734|158007054|FG005|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
49047363|NCT04556734|158007055|FG006|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
49047364|NCT04556734|158007056|FG007|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
49047365|NCT04556734|158007049|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
49047366|NCT04556734|158007050|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
49047367|NCT04556734|158007051|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
49047368|NCT04556734|158007052|FG003|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
49047369|NCT04556734|158007053|FG004|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
49047370|NCT04556734|158007054|FG005|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
49047371|NCT04556734|158007055|FG006|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
49047372|NCT04556734|158007056|FG007|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
49047373|NCT04556734|158007049|FG000|DB Treatment Period (24 Weeks)|Adverse Event|1|||
49047374|NCT04556734|158007050|FG001|DB Treatment Period (24 Weeks)|Adverse Event|0|||
49047375|NCT04556734|158007051|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
49047376|NCT04556734|158007052|FG003|DB Treatment Period (24 Weeks)|Adverse Event|0|||
49047377|NCT04556734|158007053|FG004|DB Treatment Period (24 Weeks)|Adverse Event|0|||
49047378|NCT04556734|158007054|FG005|DB Treatment Period (24 Weeks)|Adverse Event|0|||
49047379|NCT04556734|158007055|FG006|DB Treatment Period (24 Weeks)|Adverse Event|0|||
49047380|NCT04556734|158007056|FG007|DB Treatment Period (24 Weeks)|Adverse Event|0|||
49047381|NCT04556734|158007049|FG000|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
49047382|NCT04556734|158007050|FG001|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
49047383|NCT04556734|158007051|FG002|DB Treatment Period (24 Weeks)|Randomized but not treated|1|||
49047384|NCT04556734|158007052|FG003|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
49047385|NCT04556734|158007053|FG004|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
49047386|NCT04556734|158007054|FG005|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
49047387|NCT04556734|158007055|FG006|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
49047388|NCT04556734|158007056|FG007|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
49047389|NCT04556734|158007049|FG000|OLE Period (28 Weeks)|Not reported|0|||
49047390|NCT04556734|158007050|FG001|OLE Period (28 Weeks)|Not reported|0|||
49047391|NCT04556734|158007051|FG002|OLE Period (28 Weeks)|Not reported|0|||
49047392|NCT04556734|158007052|FG003|OLE Period (28 Weeks)|Not reported|0|||
49047393|NCT04556734|158007053|FG004|OLE Period (28 Weeks)|Not reported|0|||
49047394|NCT04556734|158007054|FG005|OLE Period (28 Weeks)|Not reported|1|||
49047395|NCT04556734|158007055|FG006|OLE Period (28 Weeks)|Not reported|0|||
49047396|NCT04556734|158007056|FG007|OLE Period (28 Weeks)|Not reported|0|||
49047397|NCT04556734|158007049|FG000|OLE Period (28 Weeks)|Lost to Follow-up|0|||
49047398|NCT04556734|158007050|FG001|OLE Period (28 Weeks)|Lost to Follow-up|0|||
49047399|NCT04556734|158007051|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
49047400|NCT04556734|158007052|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
49047401|NCT04556734|158007053|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
49047402|NCT04556734|158007054|FG005|OLE Period (28 Weeks)|Lost to Follow-up|0|||
49047403|NCT04556734|158007055|FG006|OLE Period (28 Weeks)|Lost to Follow-up|0|||
49047404|NCT04556734|158007056|FG007|OLE Period (28 Weeks)|Lost to Follow-up|2|||
49047405|NCT04556734|158007049|FG000|OLE Period (28 Weeks)|Adverse Event|0|||
49047406|NCT04556734|158007050|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
49047407|NCT04556734|158007051|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
49047408|NCT04556734|158007052|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
49047409|NCT04556734|158007053|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
49047410|NCT04556734|158007054|FG005|OLE Period (28 Weeks)|Adverse Event|0|||
49047411|NCT04556734|158007055|FG006|OLE Period (28 Weeks)|Adverse Event|0|||
49047412|NCT04556734|158007056|FG007|OLE Period (28 Weeks)|Adverse Event|2|||
49047413|NCT04556734|158007049|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
49047414|NCT04556734|158007050|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
49047415|NCT04556734|158007051|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
49047416|NCT04556734|158007052|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
49047417|NCT04556734|158007053|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
49047418|NCT04556734|158007054|FG005|OLE Period (28 Weeks)|Withdrawal by Subject|2|||
49047419|NCT04556734|158007055|FG006|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
49047420|NCT04556734|158007056|FG007|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
49047421|NCT04264819|158007062|FG000|Overall Study|Physician Decision|19|||
49047422|NCT04264819|158007062|FG000|Overall Study|Adverse Event|12|||
49047423|NCT04264819|158007062|FG000|Overall Study|Withdrawal by Subject|11|||
49047424|NCT04264819|158007062|FG000|Overall Study|Lost to Follow-up|2|||
49047425|NCT04264819|158007062|FG000|Overall Study|Death|2|||
49047426|NCT00557245|158007067|FG000|Overall Study|Lost to Follow-up|7|||
49047427|NCT00557245|158007068|FG001|Overall Study|Lost to Follow-up|8|||
49047428|NCT00557245|158007069|FG002|Overall Study|Lost to Follow-up|10|||
49047429|NCT00557245|158007067|FG000|Overall Study|Ineligible|5|||
49047430|NCT00557245|158007068|FG001|Overall Study|Ineligible|4|||
49047431|NCT00557245|158007069|FG002|Overall Study|Ineligible|2|||
49047432|NCT01848210|158007070|FG000|Overall Study|Informed Consent Form Withdrawal|28|||
49047433|NCT01848210|158007071|FG001|Overall Study|Informed Consent Form Withdrawal|24|||
49047434|NCT01848210|158007070|FG000|Overall Study|Lost to Follow-up|24|||
49047435|NCT01848210|158007071|FG001|Overall Study|Lost to Follow-up|12|||
49047436|NCT01848210|158007070|FG000|Overall Study|Protocol Violation|3|||
49047437|NCT01848210|158007071|FG001|Overall Study|Protocol Violation|5|||
49047438|NCT01848210|158007070|FG000|Overall Study|Use of Forbidden Drugs|9|||
49047439|NCT01848210|158007071|FG001|Overall Study|Use of Forbidden Drugs|10|||
49047440|NCT01848210|158007070|FG000|Overall Study|Impedition Condition|5|||
49047441|NCT01848210|158007071|FG001|Overall Study|Impedition Condition|9|||
49047442|NCT01848210|158007070|FG000|Overall Study|Adverse Event|7|||
49047443|NCT01848210|158007071|FG001|Overall Study|Adverse Event|9|||
49047444|NCT01848210|158007070|FG000|Overall Study|Discontinuation Criterion|5|||
49047445|NCT01848210|158007071|FG001|Overall Study|Discontinuation Criterion|7|||
49047446|NCT01848210|158007070|FG000|Overall Study|Hypesensitivity|1|||
49047447|NCT01848210|158007071|FG001|Overall Study|Hypesensitivity|0|||
49047448|NCT01848210|158007070|FG000|Overall Study|Hepatic Function Alteration|4|||
49047449|NCT01848210|158007071|FG001|Overall Study|Hepatic Function Alteration|0|||
49047450|NCT01848210|158007070|FG000|Overall Study|Chronic Venous Insufficiency Course|1|||
49047451|NCT01848210|158007071|FG001|Overall Study|Chronic Venous Insufficiency Course|2|||
49047452|NCT01848210|158007070|FG000|Overall Study|Administrative|1|||
49047453|NCT01848210|158007071|FG001|Overall Study|Administrative|0|||
49047454|NCT01257581|158007072|FG000|Overall Study|Early Termination|3|||
49047455|NCT01257581|158007073|FG001|Overall Study|Early Termination|1|||
49047456|NCT01257581|158007074|FG002|Overall Study|Early Termination|2|||
49047457|NCT01257581|158007072|FG000|Overall Study|Death|2|||
49047458|NCT01257581|158007073|FG001|Overall Study|Death|2|||
49047459|NCT01257581|158007074|FG002|Overall Study|Death|4|||
49047460|NCT04592419|158007077|FG000|Primary Study (Through Year 1)|Adverse Event|10|||
49047461|NCT04592419|158007078|FG001|Primary Study (Through Year 1)|Adverse Event|3|||
49047462|NCT04592419|158007077|FG000|Primary Study (Through Year 1)|Non-compliance with Study Schedule|0|||
49047463|NCT04592419|158007078|FG001|Primary Study (Through Year 1)|Non-compliance with Study Schedule|1|||
49047464|NCT04592419|158007077|FG000|Primary Study (Through Year 1)|Withdrawal by Subject|7|||
49047465|NCT04592419|158007078|FG001|Primary Study (Through Year 1)|Withdrawal by Subject|13|||
49047466|NCT04592419|158007077|FG000|Primary Study (Through Year 1)|Lost to Follow-up|5|||
49047467|NCT04592419|158007078|FG001|Primary Study (Through Year 1)|Lost to Follow-up|5|||
49047468|NCT04592419|158007077|FG000|Primary Study (Through Year 1)|Progressive Disease|1|||
49047469|NCT04592419|158007078|FG001|Primary Study (Through Year 1)|Progressive Disease|1|||
49047470|NCT04592419|158007077|FG000|Primary Study (Through Year 1)|Sponsor Request|4|||
49047471|NCT04592419|158007078|FG001|Primary Study (Through Year 1)|Sponsor Request|5|||
49047472|NCT04592419|158007077|FG000|Primary Study (Through Year 1)|Participant left the country|2|||
49047473|NCT04592419|158007078|FG001|Primary Study (Through Year 1)|Participant left the country|0|||
49047474|NCT04592419|158007077|FG000|Primary Study (Through Year 1)|Participant moved to another city with no available site|0|||
49047475|NCT04592419|158007078|FG001|Primary Study (Through Year 1)|Participant moved to another city with no available site|1|||
49047476|NCT04592419|158007077|FG000|Open-Label Extension Period|Adverse Event|1|||
49047477|NCT04592419|158007078|FG001|Open-Label Extension Period|Adverse Event|2|||
49047478|NCT04592419|158007077|FG000|Open-Label Extension Period|Non-compliance with Study Schedule|1|||
49047479|NCT04592419|158007078|FG001|Open-Label Extension Period|Non-compliance with Study Schedule|0|||
49047480|NCT04592419|158007077|FG000|Open-Label Extension Period|Withdrawal by Subject|5|||
49047481|NCT04592419|158007078|FG001|Open-Label Extension Period|Withdrawal by Subject|7|||
49047482|NCT04592419|158007077|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
49047483|NCT04592419|158007078|FG001|Open-Label Extension Period|Lost to Follow-up|5|||
49047484|NCT04592419|158007077|FG000|Open-Label Extension Period|Sponsor Request|73|||
49047485|NCT04592419|158007078|FG001|Open-Label Extension Period|Sponsor Request|84|||
49047486|NCT02998541|158007079|FG000|Overall Study|Adverse Event|4|||
49047487|NCT02998541|158007080|FG001|Overall Study|Adverse Event|5|||
49047488|NCT02998541|158007081|FG002|Overall Study|Adverse Event|1|||
49047489|NCT02998541|158007079|FG000|Overall Study|Protocol Violation|1|||
49047490|NCT02998541|158007080|FG001|Overall Study|Protocol Violation|0|||
49047491|NCT02998541|158007081|FG002|Overall Study|Protocol Violation|0|||
49047492|NCT02998541|158007079|FG000|Overall Study|Withdrawal by Subject|3|||
49047493|NCT02998541|158007080|FG001|Overall Study|Withdrawal by Subject|1|||
49047494|NCT02998541|158007081|FG002|Overall Study|Withdrawal by Subject|0|||
49047495|NCT02998541|158007079|FG000|Overall Study|Lost to Follow-up|0|||
49047496|NCT02998541|158007080|FG001|Overall Study|Lost to Follow-up|3|||
49047497|NCT02998541|158007081|FG002|Overall Study|Lost to Follow-up|1|||
49047498|NCT02998541|158007079|FG000|Overall Study|Physician Decision|0|||
49047499|NCT02998541|158007080|FG001|Overall Study|Physician Decision|0|||
49047500|NCT02998541|158007081|FG002|Overall Study|Physician Decision|3|||
49047501|NCT02998541|158007079|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
49047502|NCT02998541|158007080|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
49047503|NCT02998541|158007081|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
49047504|NCT01765270|158007089|FG000|Overall Study|Physician Decision|1|||
49047505|NCT01765270|158007090|FG001|Overall Study|Physician Decision|0|||
49047506|NCT01765270|158007089|FG000|Overall Study|Withdrawal by Subject|0|||
49047507|NCT01765270|158007090|FG001|Overall Study|Withdrawal by Subject|1|||
49047508|NCT00517192|158007091|FG000|Overall Study|Adverse Event|1|||
49047509|NCT00517192|158007092|FG001|Overall Study|Adverse Event|1|||
49047510|NCT00517192|158007091|FG000|Overall Study|Lost to Follow-up|1|||
49047511|NCT00517192|158007092|FG001|Overall Study|Lost to Follow-up|1|||
49047512|NCT00517192|158007091|FG000|Overall Study|Withdrawal by Subject|1|||
49047513|NCT00517192|158007092|FG001|Overall Study|Withdrawal by Subject|0|||
49047514|NCT00517192|158007091|FG000|Overall Study|Early termination of the trial|16|||
49047515|NCT00517192|158007092|FG001|Overall Study|Early termination of the trial|18|||
49047516|NCT04129944|158007093|FG000|Overall Study|Death|0|||
49047517|NCT04129944|158007094|FG001|Overall Study|Death|0|||
49047518|NCT04129944|158007095|FG002|Overall Study|Death|0|||
49047519|NCT04129944|158007096|FG003|Overall Study|Death|1|||
49047520|NCT04129944|158007093|FG000|Overall Study|Lost to Follow-up|1|||
49047521|NCT04129944|158007094|FG001|Overall Study|Lost to Follow-up|0|||
49047522|NCT04129944|158007095|FG002|Overall Study|Lost to Follow-up|0|||
49047523|NCT04129944|158007096|FG003|Overall Study|Lost to Follow-up|0|||
49047524|NCT04129944|158007093|FG000|Overall Study|Withdrawal by Subject|1|||
49047525|NCT04129944|158007094|FG001|Overall Study|Withdrawal by Subject|0|||
49047526|NCT04129944|158007095|FG002|Overall Study|Withdrawal by Subject|1|||
49047527|NCT04129944|158007096|FG003|Overall Study|Withdrawal by Subject|2|||
49047528|NCT04102345|158007104|FG000|Overall Study|Withdrawal by Subject|1|||
49047529|NCT04102345|158007105|FG001|Overall Study|Withdrawal by Subject|0|||
49047530|NCT04205162|158007110|FG000|Overall Study|Lost to Follow-up|1|||
49047531|NCT04205162|158007111|FG001|Overall Study|Lost to Follow-up|0|||
49047532|NCT04205162|158007110|FG000|Overall Study|Withdrawal by Subject|2|||
49047533|NCT04205162|158007111|FG001|Overall Study|Withdrawal by Subject|0|||
49047534|NCT04205162|158007110|FG000|Overall Study|University closure due to COVID-19|1|||
49047535|NCT04205162|158007111|FG001|Overall Study|University closure due to COVID-19|0|||
49047536|NCT02726386|158007116|FG000|Overall Study|Adverse Event|17|||
49047537|NCT02726386|158007117|FG001|Overall Study|Adverse Event|20|||
49047538|NCT02726386|158007116|FG000|Overall Study|Withdrawal by Subject|14|||
49047539|NCT02726386|158007117|FG001|Overall Study|Withdrawal by Subject|28|||
49047540|NCT02726386|158007116|FG000|Overall Study|Other reasons|7|||
49047541|NCT02726386|158007117|FG001|Overall Study|Other reasons|8|||
49047542|NCT01436643|158007122|FG000|2-week Pre-treatment|Abnormal test result|0|||
49047543|NCT01436643|158007123|FG001|2-week Pre-treatment|Abnormal test result|0|||
49047544|NCT01436643|158007124|FG002|2-week Pre-treatment|Abnormal test result|0|||
49047545|NCT01436643|158007125|FG003|2-week Pre-treatment|Abnormal test result|1|||
49047546|NCT01436643|158007122|FG000|2-week Pre-treatment|Adverse Event|0|||
49047547|NCT01436643|158007123|FG001|2-week Pre-treatment|Adverse Event|0|||
49047548|NCT01436643|158007124|FG002|2-week Pre-treatment|Adverse Event|0|||
49047549|NCT01436643|158007125|FG003|2-week Pre-treatment|Adverse Event|5|||
49047550|NCT01436643|158007122|FG000|2-week Pre-treatment|Protocol Violation|0|||
49047551|NCT01436643|158007123|FG001|2-week Pre-treatment|Protocol Violation|0|||
49047552|NCT01436643|158007124|FG002|2-week Pre-treatment|Protocol Violation|0|||
49047553|NCT01436643|158007125|FG003|2-week Pre-treatment|Protocol Violation|4|||
49047554|NCT01436643|158007122|FG000|Core Phase (16 Weeks)|Adverse Event|0|||
49047555|NCT01436643|158007123|FG001|Core Phase (16 Weeks)|Adverse Event|3|||
49047556|NCT01436643|158007124|FG002|Core Phase (16 Weeks)|Adverse Event|1|||
49047557|NCT01436643|158007125|FG003|Core Phase (16 Weeks)|Adverse Event|0|||
49047558|NCT01436643|158007122|FG000|Core Phase (16 Weeks)|Abnormal Test result|0|||
49047559|NCT01436643|158007123|FG001|Core Phase (16 Weeks)|Abnormal Test result|0|||
49047560|NCT01436643|158007124|FG002|Core Phase (16 Weeks)|Abnormal Test result|1|||
49047561|NCT01436643|158007125|FG003|Core Phase (16 Weeks)|Abnormal Test result|0|||
49047562|NCT01436643|158007122|FG000|Core Phase (16 Weeks)|Protocol Violation|1|||
49047563|NCT01436643|158007123|FG001|Core Phase (16 Weeks)|Protocol Violation|1|||
49047564|NCT01436643|158007124|FG002|Core Phase (16 Weeks)|Protocol Violation|1|||
49047565|NCT01436643|158007125|FG003|Core Phase (16 Weeks)|Protocol Violation|0|||
49047566|NCT01266603|158007126|FG000|Overall Study|Adverse Event|1|||
49047567|NCT01266603|158007126|FG000|Overall Study|Lack of Efficacy|14|||
49047568|NCT01266603|158007126|FG000|Overall Study|Withdrawal by Subject|1|||
49047569|NCT01266603|158007126|FG000|Overall Study|Failed screening; MAGE-A3 negative|26|||
49047570|NCT01801917|158007129|FG000|Period 1 - Randomized|Adverse Event|1|||
49047571|NCT01801917|158007130|FG001|Period 1 - Randomized|Adverse Event|0|||
49047572|NCT01801917|158007131|FG002|Period 1 - Randomized|Adverse Event|1|||
49047573|NCT01801917|158007132|FG003|Period 1 - Randomized|Adverse Event|0|||
49047574|NCT04307849|158007133|FG000|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
49047575|NCT04307849|158007134|FG001|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
49047576|NCT04307849|158007135|FG002|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
49047577|NCT04307849|158007136|FG003|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
49047578|NCT04307849|158007137|FG004|Overall Study|Took a paid position and/or work schedule no longer allowed participation|4|||
49047579|NCT04307849|158007138|FG005|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
49047580|NCT04307849|158007133|FG000|Overall Study|Travelled out of Mumbai to natal place/village|0|||
49047581|NCT04307849|158007134|FG001|Overall Study|Travelled out of Mumbai to natal place/village|0|||
49047582|NCT04307849|158007135|FG002|Overall Study|Travelled out of Mumbai to natal place/village|3|||
49047583|NCT04307849|158007136|FG003|Overall Study|Travelled out of Mumbai to natal place/village|0|||
49047584|NCT04307849|158007137|FG004|Overall Study|Travelled out of Mumbai to natal place/village|0|||
49047585|NCT04307849|158007138|FG005|Overall Study|Travelled out of Mumbai to natal place/village|0|||
49047586|NCT04307849|158007133|FG000|Overall Study|Family member did not want them to continue|0|||
49047587|NCT04307849|158007134|FG001|Overall Study|Family member did not want them to continue|0|||
49047588|NCT04307849|158007135|FG002|Overall Study|Family member did not want them to continue|1|||
49047589|NCT04307849|158007136|FG003|Overall Study|Family member did not want them to continue|0|||
49047590|NCT04307849|158007137|FG004|Overall Study|Family member did not want them to continue|0|||
49047591|NCT04307849|158007138|FG005|Overall Study|Family member did not want them to continue|0|||
49047592|NCT04307849|158007133|FG000|Overall Study|Medical reason (gave birth, became ill)|0|||
49047593|NCT04307849|158007134|FG001|Overall Study|Medical reason (gave birth, became ill)|0|||
49047594|NCT04307849|158007135|FG002|Overall Study|Medical reason (gave birth, became ill)|1|||
49047595|NCT04307849|158007136|FG003|Overall Study|Medical reason (gave birth, became ill)|1|||
49047596|NCT04307849|158007137|FG004|Overall Study|Medical reason (gave birth, became ill)|0|||
49047597|NCT04307849|158007138|FG005|Overall Study|Medical reason (gave birth, became ill)|0|||
49047598|NCT04220775|158007141|FG000|Overall Study|Adverse Event|1|||
49047599|NCT04220775|158007142|FG001|Overall Study|Adverse Event|0|||
49047600|NCT04220775|158007141|FG000|Overall Study|Disease Progression|1|||
49047601|NCT04220775|158007142|FG001|Overall Study|Disease Progression|0|||
49047602|NCT02654015|158007143|FG000|Overall Study|Death|12|||
49047603|NCT02654015|158007143|FG000|Overall Study|Lost to Follow-up|3|||
49047604|NCT01896505|158007146|FG000|Overall Study|Adverse Event|1|||
49047605|NCT01896505|158007147|FG001|Overall Study|Adverse Event|0|||
49047606|NCT01896505|158007148|FG002|Overall Study|Adverse Event|2|||
49047607|NCT01896505|158007149|FG003|Overall Study|Adverse Event|1|||
49047608|NCT01896505|158007150|FG004|Overall Study|Adverse Event|1|||
49047609|NCT01896505|158007151|FG005|Overall Study|Adverse Event|0|||
49047610|NCT01896505|158007146|FG000|Overall Study|Physician Decision|1|||
49047611|NCT01896505|158007147|FG001|Overall Study|Physician Decision|3|||
49047612|NCT01896505|158007148|FG002|Overall Study|Physician Decision|2|||
49047613|NCT01896505|158007149|FG003|Overall Study|Physician Decision|0|||
49047614|NCT01896505|158007150|FG004|Overall Study|Physician Decision|0|||
49047615|NCT01896505|158007151|FG005|Overall Study|Physician Decision|1|||
49047616|NCT01896505|158007146|FG000|Overall Study|Withdrawal by Subject|1|||
49047617|NCT01896505|158007147|FG001|Overall Study|Withdrawal by Subject|0|||
49047618|NCT01896505|158007148|FG002|Overall Study|Withdrawal by Subject|3|||
49047619|NCT01896505|158007149|FG003|Overall Study|Withdrawal by Subject|1|||
49047620|NCT01896505|158007150|FG004|Overall Study|Withdrawal by Subject|0|||
49047621|NCT01896505|158007151|FG005|Overall Study|Withdrawal by Subject|0|||
49047622|NCT01896505|158007146|FG000|Overall Study|Disease Progression|7|||
49047623|NCT01896505|158007147|FG001|Overall Study|Disease Progression|5|||
49047624|NCT01896505|158007148|FG002|Overall Study|Disease Progression|8|||
49047625|NCT01896505|158007149|FG003|Overall Study|Disease Progression|4|||
49047626|NCT01896505|158007150|FG004|Overall Study|Disease Progression|4|||
49047627|NCT01896505|158007151|FG005|Overall Study|Disease Progression|4|||
49047628|NCT01896505|158007146|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
49047629|NCT01896505|158007147|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
49047630|NCT01896505|158007148|FG002|Overall Study|Need of treatment not allowed per protocol|1|||
49047631|NCT01896505|158007149|FG003|Overall Study|Need of treatment not allowed per protocol|0|||
49047632|NCT01896505|158007150|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
49047633|NCT01896505|158007151|FG005|Overall Study|Need of treatment not allowed per protocol|0|||
49047634|NCT01896505|158007146|FG000|Overall Study|Intercurrent illness|0|||
49047635|NCT01896505|158007147|FG001|Overall Study|Intercurrent illness|1|||
49047636|NCT01896505|158007148|FG002|Overall Study|Intercurrent illness|0|||
49047637|NCT01896505|158007149|FG003|Overall Study|Intercurrent illness|0|||
49047638|NCT01896505|158007150|FG004|Overall Study|Intercurrent illness|0|||
49047639|NCT01896505|158007151|FG005|Overall Study|Intercurrent illness|0|||
49047640|NCT01896505|158007146|FG000|Overall Study|Death|0|||
49047641|NCT01896505|158007147|FG001|Overall Study|Death|0|||
49047642|NCT01896505|158007148|FG002|Overall Study|Death|1|||
49047643|NCT01896505|158007149|FG003|Overall Study|Death|1|||
49047644|NCT01896505|158007150|FG004|Overall Study|Death|0|||
49047645|NCT01896505|158007151|FG005|Overall Study|Death|1|||
49047646|NCT02418754|158007152|FG000|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
49047647|NCT02418754|158007153|FG001|Period 1 (Day 1 to Week 12)|Adverse Event|2|||
49047648|NCT02418754|158007154|FG002|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
49047649|NCT02418754|158007155|FG003|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
49047650|NCT02418754|158007156|FG004|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
49047651|NCT02418754|158007152|FG000|Period 1 (Day 1 to Week 12)|Death|1|||
49047652|NCT02418754|158007153|FG001|Period 1 (Day 1 to Week 12)|Death|0|||
49047653|NCT02418754|158007154|FG002|Period 1 (Day 1 to Week 12)|Death|0|||
49047654|NCT02418754|158007155|FG003|Period 1 (Day 1 to Week 12)|Death|0|||
49047655|NCT02418754|158007156|FG004|Period 1 (Day 1 to Week 12)|Death|0|||
49047656|NCT02418754|158007152|FG000|Period 1 (Day 1 to Week 12)|Physician Decision|1|||
49047657|NCT02418754|158007153|FG001|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
49047658|NCT02418754|158007154|FG002|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
49047659|NCT02418754|158007155|FG003|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
49047660|NCT02418754|158007156|FG004|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
49047661|NCT02418754|158007152|FG000|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
49047662|NCT02418754|158007153|FG001|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2|||
49047663|NCT02418754|158007154|FG002|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1|||
49047664|NCT02418754|158007155|FG003|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
49047665|NCT02418754|158007156|FG004|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
49047666|NCT02418754|158007152|FG000|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
49047667|NCT02418754|158007153|FG001|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
49047668|NCT02418754|158007154|FG002|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1|||
49047669|NCT02418754|158007155|FG003|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
49047670|NCT02418754|158007156|FG004|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
49047671|NCT02418754|158007152|FG000|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3|||
49047672|NCT02418754|158007153|FG001|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7|||
49047673|NCT02418754|158007154|FG002|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6|||
49047674|NCT02418754|158007155|FG003|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
49047675|NCT02418754|158007156|FG004|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
49047676|NCT02418754|158007152|FG000|Period 2 (Day 1 to Week 52/End of Study)|Death|1|||
49047677|NCT02418754|158007153|FG001|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
49047678|NCT02418754|158007154|FG002|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
49047679|NCT02418754|158007155|FG003|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
49047680|NCT02418754|158007156|FG004|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
49047681|NCT02418754|158007152|FG000|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
49047682|NCT02418754|158007153|FG001|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28|||
49047683|NCT02418754|158007154|FG002|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
49047684|NCT02418754|158007155|FG003|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21|||
49047685|NCT02418754|158007156|FG004|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24|||
49047686|NCT02418754|158007152|FG000|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3|||
49047687|NCT02418754|158007153|FG001|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
49047688|NCT02418754|158007154|FG002|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
49047689|NCT02418754|158007155|FG003|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1|||
49047690|NCT02418754|158007156|FG004|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0|||
49047691|NCT02418754|158007152|FG000|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0|||
49047692|NCT02418754|158007153|FG001|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
49047693|NCT02418754|158007154|FG002|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
49047694|NCT02418754|158007155|FG003|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
49047695|NCT02418754|158007156|FG004|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
49047696|NCT02418754|158007152|FG000|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
49047697|NCT02418754|158007153|FG001|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
49047698|NCT02418754|158007154|FG002|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
49047699|NCT02418754|158007155|FG003|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
49047700|NCT02418754|158007156|FG004|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
49047701|NCT05467982|158007158|FG000|Overall Study|Death|0|||
49047702|NCT05467982|158007159|FG001|Overall Study|Death|1|||
49047703|NCT05467982|158007158|FG000|Overall Study|Lost to Follow-up|3|||
49047704|NCT05467982|158007159|FG001|Overall Study|Lost to Follow-up|1|||
49047705|NCT02412722|158007164|FG000|Overall Study|Adverse Event|0|||
49047706|NCT02412722|158007165|FG001|Overall Study|Adverse Event|2|||
49047707|NCT02412722|158007166|FG002|Overall Study|Adverse Event|0|||
49047708|NCT02412722|158007167|FG003|Overall Study|Adverse Event|3|||
49047709|NCT02412722|158007168|FG004|Overall Study|Adverse Event|0|||
49047710|NCT02412722|158007169|FG005|Overall Study|Adverse Event|3|||
49047711|NCT02412722|158007164|FG000|Overall Study|Progressive Disease|6|||
49047712|NCT02412722|158007165|FG001|Overall Study|Progressive Disease|4|||
49047713|NCT02412722|158007166|FG002|Overall Study|Progressive Disease|4|||
49047714|NCT02412722|158007167|FG003|Overall Study|Progressive Disease|9|||
49047715|NCT02412722|158007168|FG004|Overall Study|Progressive Disease|3|||
49047716|NCT02412722|158007169|FG005|Overall Study|Progressive Disease|3|||
49047717|NCT02412722|158007164|FG000|Overall Study|Withdrawal by Subject|2|||
49047718|NCT02412722|158007165|FG001|Overall Study|Withdrawal by Subject|0|||
49047719|NCT02412722|158007166|FG002|Overall Study|Withdrawal by Subject|1|||
49047720|NCT02412722|158007167|FG003|Overall Study|Withdrawal by Subject|2|||
49047721|NCT02412722|158007168|FG004|Overall Study|Withdrawal by Subject|1|||
49047722|NCT02412722|158007169|FG005|Overall Study|Withdrawal by Subject|1|||
49047723|NCT02412722|158007164|FG000|Overall Study|Lost to Follow-up|0|||
49047724|NCT02412722|158007165|FG001|Overall Study|Lost to Follow-up|0|||
49047725|NCT02412722|158007166|FG002|Overall Study|Lost to Follow-up|0|||
49047726|NCT02412722|158007167|FG003|Overall Study|Lost to Follow-up|0|||
49047727|NCT02412722|158007168|FG004|Overall Study|Lost to Follow-up|1|||
49047728|NCT02412722|158007169|FG005|Overall Study|Lost to Follow-up|0|||
49047729|NCT02412722|158007164|FG000|Overall Study|Received drug in run-in and discontinued|0|||
49047730|NCT02412722|158007165|FG001|Overall Study|Received drug in run-in and discontinued|2|||
49047731|NCT02412722|158007166|FG002|Overall Study|Received drug in run-in and discontinued|0|||
49047732|NCT02412722|158007167|FG003|Overall Study|Received drug in run-in and discontinued|0|||
49047733|NCT02412722|158007168|FG004|Overall Study|Received drug in run-in and discontinued|0|||
49047734|NCT02412722|158007169|FG005|Overall Study|Received drug in run-in and discontinued|0|||
49047735|NCT02412722|158007164|FG000|Overall Study|Reason not Specified|3|||
49047736|NCT02412722|158007165|FG001|Overall Study|Reason not Specified|0|||
49047737|NCT02412722|158007166|FG002|Overall Study|Reason not Specified|2|||
49047738|NCT02412722|158007167|FG003|Overall Study|Reason not Specified|1|||
49047739|NCT02412722|158007168|FG004|Overall Study|Reason not Specified|2|||
49047740|NCT02412722|158007169|FG005|Overall Study|Reason not Specified|6|||
49047741|NCT04330157|158007170|FG000|Overall Study|Protocol Violation|4|||
49047742|NCT04330157|158007170|FG000|Overall Study|Not extubated within 24 h postoperatively|3|||
49047743|NCT02260258|158007175|FG000|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2|||
49047744|NCT02260258|158007176|FG001|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1|||
49047745|NCT00438659|158007177|FG000|Overall Study|Discontinued Mometasone/Placebo|1|||
49047746|NCT00438659|158007178|FG001|Overall Study|Discontinued Mometasone/Placebo|2|||
49047747|NCT00438659|158007177|FG000|Overall Study|Cancel|5|||
49047748|NCT00438659|158007178|FG001|Overall Study|Cancel|2|||
49047749|NCT01634854|158007180|FG000|Overall Study|Cesarean delivery|2|||
49047750|NCT01634854|158007181|FG001|Overall Study|Cesarean delivery|7|||
49047751|NCT03365791|158007182|FG000|Overall Study|Adverse Event|5|||
49047752|NCT03365791|158007182|FG000|Overall Study|Death|1|||
49047753|NCT03365791|158007182|FG000|Overall Study|Lost to Follow-up|1|||
49047754|NCT03365791|158007182|FG000|Overall Study|Physician Decision|9|||
49047755|NCT03365791|158007182|FG000|Overall Study|Progressive disease|51|||
49047756|NCT03365791|158007182|FG000|Overall Study|Subject/guardian decision|5|||
49047757|NCT01754376|158008569|FG000|Overall Study|Adverse Event|1|||
49047758|NCT01754376|158008569|FG000|Overall Study|Lack of Efficacy|2|||
49047759|NCT04590781|158008570|FG000|Overall Study|Death|0|||
49047760|NCT04590781|158008571|FG001|Overall Study|Death|2|||
49047761|NCT04590781|158008570|FG000|Overall Study|Withdrawal by Subject|2|||
49047762|NCT04590781|158008571|FG001|Overall Study|Withdrawal by Subject|0|||
49047763|NCT00754052|158008578|FG000|Overall Study|Study terminated by Sponsor|5|||
49047764|NCT00754052|158008579|FG001|Overall Study|Study terminated by Sponsor|3|||
49047765|NCT01680016|158008583|FG000|Overall Study|Adverse Event|0|||
49047766|NCT01680016|158008584|FG001|Overall Study|Adverse Event|0|||
49047767|NCT01680016|158008585|FG002|Overall Study|Adverse Event|1|||
49047768|NCT01680016|158008586|FG003|Overall Study|Adverse Event|4|||
49047769|NCT01680016|158008583|FG000|Overall Study|The Subject went out of The Trial|1|||
49047770|NCT01680016|158008584|FG001|Overall Study|The Subject went out of The Trial|0|||
49047771|NCT01680016|158008585|FG002|Overall Study|The Subject went out of The Trial|3|||
49047772|NCT01680016|158008586|FG003|Overall Study|The Subject went out of The Trial|0|||
49047773|NCT01680016|158008583|FG000|Overall Study|Protocol Violation|0|||
49047774|NCT01680016|158008584|FG001|Overall Study|Protocol Violation|1|||
49047775|NCT01680016|158008585|FG002|Overall Study|Protocol Violation|0|||
49047776|NCT01680016|158008586|FG003|Overall Study|Protocol Violation|0|||
49047777|NCT01680016|158008583|FG000|Overall Study|Withdrawal by Subject|5|||
49047778|NCT01680016|158008584|FG001|Overall Study|Withdrawal by Subject|7|||
49047779|NCT01680016|158008585|FG002|Overall Study|Withdrawal by Subject|1|||
49047780|NCT01680016|158008586|FG003|Overall Study|Withdrawal by Subject|1|||
49047781|NCT02658019|158008588|FG000|Overall Study|Adverse Event|1|||
49047782|NCT02722616|158008589|FG000|Overall Study|Sponsor closed study after one month|2|||
49047783|NCT02722616|158008590|FG001|Overall Study|Sponsor closed study after one month|0|||
49047784|NCT02722616|158008591|FG002|Overall Study|Sponsor closed study after one month|0|||
49047785|NCT01958060|158008593|FG000|Overall Study|Not treated|2|||
49047786|NCT01958060|158008594|FG001|Overall Study|Not treated|0|||
49047787|NCT01958060|158008595|FG002|Overall Study|Not treated|0|||
49047788|NCT01958060|158008596|FG003|Overall Study|Not treated|0|||
49047789|NCT01958060|158008597|FG004|Overall Study|Not treated|1|||
49047790|NCT01958060|158008598|FG005|Overall Study|Not treated|0|||
49047791|NCT01120899|158008601|FG000|Overall Study|Withdrawal by Subject|3|||
49047792|NCT00820599|158008602|FG000|Overall Study|Death|129|||
49047793|NCT00820599|158008602|FG000|Overall Study|Withdrawal by Subject|2|||
49047794|NCT00799708|158008603|FG000|Overall Study|non-compliance|1|||
49047795|NCT00799708|158008604|FG001|Overall Study|non-compliance|0|||
49047796|NCT00799708|158008605|FG002|Overall Study|non-compliance|0|||
49047797|NCT00880334|158008606|FG000|Randomized Phase|Physician Decision|1|||
49047798|NCT00880334|158008607|FG001|Randomized Phase|Physician Decision|0|||
49047799|NCT00880334|158008606|FG000|Randomized Phase|Withdrawal by Subject|2|||
49047800|NCT00880334|158008607|FG001|Randomized Phase|Withdrawal by Subject|1|||
49047801|NCT00880334|158008606|FG000|Randomized Phase|Inadequate Labs|1|||
49047802|NCT00880334|158008607|FG001|Randomized Phase|Inadequate Labs|1|||
49047803|NCT00880334|158008606|FG000|Randomized Phase|Brain Metastasis|0|||
49047804|NCT00880334|158008607|FG001|Randomized Phase|Brain Metastasis|1|||
49047805|NCT00880334|158008606|FG000|Randomized Phase|Crossover Participants|0|||
49047806|NCT00880334|158008607|FG001|Randomized Phase|Crossover Participants|37|||
49047807|NCT03343639|158008608|FG000|Overall Study|Withdrawal by Subject|10|||
49047808|NCT03343639|158008609|FG001|Overall Study|Withdrawal by Subject|6|||
49047809|NCT03343639|158008608|FG000|Overall Study|Lost to Follow-up|4|||
49047810|NCT03343639|158008609|FG001|Overall Study|Lost to Follow-up|5|||
49047811|NCT03343639|158008608|FG000|Overall Study|Protocol Violation|0|||
49047812|NCT03343639|158008609|FG001|Overall Study|Protocol Violation|1|||
49047813|NCT00329160|158008613|FG000|Overall Study|Adverse Event|27|||
49047814|NCT00329160|158008613|FG000|Overall Study|Withdrawal by Subject|13|||
49047815|NCT00329160|158008613|FG000|Overall Study|Protocol Violation|2|||
49047816|NCT00329160|158008613|FG000|Overall Study|Did not Receive Study Drug|1|||
49047817|NCT00329160|158008613|FG000|Overall Study|Incomplete IVUS|45|||
49047818|NCT00493792|158008614|FG000|Overall Study|Death|55|||
49047819|NCT00493792|158008615|FG001|Overall Study|Death|50|||
49047820|NCT00493792|158008614|FG000|Overall Study|Lost to Follow Up or Lack of Efficacy|36|||
49047821|NCT00493792|158008615|FG001|Overall Study|Lost to Follow Up or Lack of Efficacy|51|||
49047822|NCT04501094|158008616|FG000|Overall Study|Death (unrelated to research)|1|||
49047823|NCT04501094|158008617|FG001|Overall Study|Death (unrelated to research)|0|||
49047824|NCT02985398|158008635|FG000|Overall Study|Adverse Event|1|||
49047825|NCT02985398|158008635|FG000|Overall Study|Lost to Follow-up|4|||
49047826|NCT02985398|158008635|FG000|Overall Study|Withdrawal by Subject|8|||
49047827|NCT02985398|158008635|FG000|Overall Study|Study Burden|9|||
49047828|NCT01231373|158008636|FG000|Overall Study|Withdrew consent prior to randomization|2|||
49047829|NCT01231373|158008637|FG001|Overall Study|Withdrew consent prior to randomization|1|||
49047830|NCT01231373|158008638|FG002|Overall Study|Withdrew consent prior to randomization|0|||
49047831|NCT01231373|158008639|FG003|Overall Study|Withdrew consent prior to randomization|0|||
49047832|NCT01231373|158008636|FG000|Overall Study|Lost to Follow-up|0|||
49047833|NCT01231373|158008637|FG001|Overall Study|Lost to Follow-up|0|||
49047834|NCT01231373|158008638|FG002|Overall Study|Lost to Follow-up|0|||
49047835|NCT01231373|158008639|FG003|Overall Study|Lost to Follow-up|1|||
49047836|NCT01231373|158008636|FG000|Overall Study|Withdrew Consent|1|||
49047837|NCT01231373|158008637|FG001|Overall Study|Withdrew Consent|0|||
49047838|NCT01231373|158008638|FG002|Overall Study|Withdrew Consent|0|||
49047839|NCT01231373|158008639|FG003|Overall Study|Withdrew Consent|0|||
49047840|NCT01841073|158008640|FG000|Overall Study|Adverse Event|1|||
49047841|NCT01841073|158008641|FG001|Overall Study|Adverse Event|1|||
49047842|NCT01841073|158008640|FG000|Overall Study|Physician Decision|1|||
49047843|NCT01841073|158008641|FG001|Overall Study|Physician Decision|0|||
49047844|NCT01841073|158008640|FG000|Overall Study|Lost to Follow-up|0|||
49047845|NCT01841073|158008641|FG001|Overall Study|Lost to Follow-up|2|||
49047846|NCT03110380|158008642|FG000|Double-Blind Treatment Phase|Withdrew Consent|10|||
49047847|NCT03110380|158008643|FG001|Double-Blind Treatment Phase|Withdrew Consent|16|||
49047848|NCT03110380|158008644|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
49047849|NCT03110380|158008645|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
49047850|NCT03110380|158008642|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
49047851|NCT03110380|158008643|FG001|Double-Blind Treatment Phase|Lost to Follow-up|3|||
49047852|NCT03110380|158008644|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
49047853|NCT03110380|158008645|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
49047854|NCT03110380|158008642|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
49047855|NCT03110380|158008643|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
49047856|NCT03110380|158008644|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
49047857|NCT03110380|158008645|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
49047858|NCT03110380|158008642|FG000|Double-Blind Treatment Phase|Investigator's Discretion|1|||
49047859|NCT03110380|158008643|FG001|Double-Blind Treatment Phase|Investigator's Discretion|3|||
49047860|NCT03110380|158008644|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
49047861|NCT03110380|158008645|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
49047862|NCT03110380|158008642|FG000|Double-Blind Treatment Phase|Death|2|||
49047863|NCT03110380|158008643|FG001|Double-Blind Treatment Phase|Death|1|||
49047864|NCT03110380|158008644|FG002|Double-Blind Treatment Phase|Death|0|||
49047865|NCT03110380|158008645|FG003|Double-Blind Treatment Phase|Death|0|||
49047866|NCT03110380|158008642|FG000|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
49047867|NCT03110380|158008643|FG001|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
49047868|NCT03110380|158008644|FG002|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
49047869|NCT03110380|158008645|FG003|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
49047870|NCT03110380|158008642|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
49047871|NCT03110380|158008643|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
49047872|NCT03110380|158008644|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
49047873|NCT03110380|158008645|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
49047874|NCT03110380|158008642|FG000|Double-Blind Treatment Phase|Randomized but not Treated|0|||
49047875|NCT03110380|158008643|FG001|Double-Blind Treatment Phase|Randomized but not Treated|2|||
49047876|NCT03110380|158008644|FG002|Double-Blind Treatment Phase|Randomized but not Treated|0|||
49047877|NCT03110380|158008645|FG003|Double-Blind Treatment Phase|Randomized but not Treated|0|||
49047878|NCT03110380|158008642|FG000|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
49047879|NCT03110380|158008643|FG001|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
49047880|NCT03110380|158008644|FG002|Open-label B/F/TAF Extension Phase|Lost to Follow-up|3|||
49047881|NCT03110380|158008645|FG003|Open-label B/F/TAF Extension Phase|Lost to Follow-up|1|||
49047882|NCT03110380|158008642|FG000|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
49047883|NCT03110380|158008643|FG001|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
49047884|NCT03110380|158008644|FG002|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
49047885|NCT03110380|158008645|FG003|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
49047886|NCT03110380|158008642|FG000|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
49047887|NCT03110380|158008643|FG001|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
49047888|NCT03110380|158008644|FG002|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
49047889|NCT03110380|158008645|FG003|Open-label B/F/TAF Extension Phase|Adverse Event|1|||
49047890|NCT02725411|158008649|FG000|Treatment Period (56 Weeks)|Adverse Event|3|||
49047891|NCT02725411|158008650|FG001|Treatment Period (56 Weeks)|Adverse Event|5|||
49047892|NCT02725411|158008651|FG002|Treatment Period (56 Weeks)|Adverse Event|4|||
49047893|NCT02725411|158008649|FG000|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
49047894|NCT02725411|158008650|FG001|Treatment Period (56 Weeks)|Lack of Efficacy|4|||
49047895|NCT02725411|158008651|FG002|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
49047896|NCT02725411|158008649|FG000|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
49047897|NCT02725411|158008650|FG001|Treatment Period (56 Weeks)|Lost to Follow-up|1|||
49047898|NCT02725411|158008651|FG002|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
49047899|NCT02725411|158008649|FG000|Treatment Period (56 Weeks)|Other|1|||
49047900|NCT02725411|158008650|FG001|Treatment Period (56 Weeks)|Other|4|||
49047901|NCT02725411|158008651|FG002|Treatment Period (56 Weeks)|Other|5|||
49047902|NCT02725411|158008649|FG000|Treatment Period (56 Weeks)|Withdrawal by Subject|0|||
49047903|NCT02725411|158008650|FG001|Treatment Period (56 Weeks)|Withdrawal by Subject|1|||
49047904|NCT02725411|158008651|FG002|Treatment Period (56 Weeks)|Withdrawal by Subject|4|||
49047905|NCT02725411|158008649|FG000|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25|||
49047906|NCT02725411|158008650|FG001|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
49047907|NCT02725411|158008651|FG002|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
49047908|NCT02725411|158008649|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
49047909|NCT02725411|158008650|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
49047910|NCT02725411|158008651|FG002|Follow-up Period (24 Weeks)|Adverse Event|0|||
49047911|NCT02725411|158008649|FG000|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
49047912|NCT02725411|158008650|FG001|Follow-up Period (24 Weeks)|Lack of Efficacy|2|||
49047913|NCT02725411|158008651|FG002|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
49047914|NCT02725411|158008649|FG000|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
49047915|NCT02725411|158008650|FG001|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
49047916|NCT02725411|158008651|FG002|Follow-up Period (24 Weeks)|Lost to Follow-up|0|||
49047917|NCT02725411|158008649|FG000|Follow-up Period (24 Weeks)|Other|1|||
49047918|NCT02725411|158008650|FG001|Follow-up Period (24 Weeks)|Other|4|||
49047919|NCT02725411|158008651|FG002|Follow-up Period (24 Weeks)|Other|2|||
49047920|NCT02725411|158008649|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
49047921|NCT02725411|158008650|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
49047922|NCT02725411|158008651|FG002|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
49047923|NCT02786927|158008652|FG000|Overall Study|Adverse Event|1|||
49047924|NCT02786927|158008652|FG000|Overall Study|Protocol Violation|4|||
49047925|NCT00179673|158008653|FG000|Overall Study|Adverse Event|7|||
49047926|NCT00179673|158008653|FG000|Overall Study|Lack of Efficacy|15|||
49047927|NCT00179673|158008653|FG000|Overall Study|Withdrawal by Subject|3|||
49047928|NCT00179673|158008653|FG000|Overall Study|Death|4|||
49047929|NCT00179673|158008653|FG000|Overall Study|Other Observations and options|14|||
49047930|NCT01557920|158008654|FG000|Overall Study|Withdrawal by Subject|2|||
49047931|NCT01557920|158008655|FG001|Overall Study|Withdrawal by Subject|3|||
49047932|NCT01557920|158008654|FG000|Overall Study|Lack of Efficacy|1|||
49047933|NCT01557920|158008655|FG001|Overall Study|Lack of Efficacy|0|||
49047934|NCT03847974|158008656|FG000|Overall Study|relocated out of region|3|||
49047935|NCT03847974|158008656|FG000|Overall Study|Withdrawal by Subject|2|||
49047936|NCT03847974|158008656|FG000|Overall Study|Adverse Event|1|||
49047937|NCT02329431|158008657|FG000|Overall Study|Lost to Follow-up|20|||
49047938|NCT02329431|158008658|FG001|Overall Study|Lost to Follow-up|13|||
49047939|NCT01924364|158008661|FG000|Overall Study|Physician Decision|3|||
49047940|NCT01294449|158008662|FG000|Overall Study|Death|11|||
49047941|NCT01294449|158008663|FG001|Overall Study|Death|12|||
49047942|NCT01294449|158008662|FG000|Overall Study|Withdrawal by Subject|1|||
49047943|NCT01294449|158008663|FG001|Overall Study|Withdrawal by Subject|3|||
49047944|NCT04599166|158008664|FG000|Overall Study|Technological failure connecting to study app|80|||
49047945|NCT00265785|158008665|FG000|Overall Study|Adverse Event|4|||
49047946|NCT00265785|158008665|FG000|Overall Study|Withdrawal by Subject|3|||
49047947|NCT00265785|158008665|FG000|Overall Study|Progression/Relapse|15|||
49047948|NCT00265785|158008665|FG000|Overall Study|Not protocol specified|2|||
49047949|NCT00265785|158008665|FG000|Overall Study|Ineligible|1|||
49047950|NCT00265785|158008665|FG000|Overall Study|Did not receive protocol treatment|2|||
49047951|NCT00250705|158008666|FG000|Overall Study|Lack of Efficacy|2|||
49047952|NCT01609582|158008667|FG000|Overall Study|Adverse Event|20|||
49047953|NCT01609582|158008668|FG001|Overall Study|Adverse Event|18|||
49047954|NCT01609582|158008667|FG000|Overall Study|Lost to Follow-up|10|||
49047955|NCT01609582|158008668|FG001|Overall Study|Lost to Follow-up|10|||
49047956|NCT01609582|158008667|FG000|Overall Study|Withdrawal by Subject|21|||
49047957|NCT01609582|158008668|FG001|Overall Study|Withdrawal by Subject|15|||
49047958|NCT01609582|158008667|FG000|Overall Study|Study Terminated by Sponsor|1543|||
49047959|NCT01609582|158008668|FG001|Overall Study|Study Terminated by Sponsor|1548|||
49047960|NCT01609582|158008667|FG000|Overall Study|Other|9|||
49047961|NCT01609582|158008668|FG001|Overall Study|Other|10|||
49047962|NCT01609582|158008667|FG000|Overall Study|Randomized, but not treated|0|||
49047963|NCT01609582|158008668|FG001|Overall Study|Randomized, but not treated|3|||
49047964|NCT00985231|158008675|FG000|Overall Study|ineligible|1|||
49047965|NCT00985231|158008676|FG001|Overall Study|ineligible|0|||
49047966|NCT00985231|158008675|FG000|Overall Study|Protocol Violation|1|||
49047967|NCT00985231|158008676|FG001|Overall Study|Protocol Violation|0|||
49047968|NCT00985231|158008675|FG000|Overall Study|Withdrawal by Subject|1|||
49047969|NCT00985231|158008676|FG001|Overall Study|Withdrawal by Subject|0|||
49047970|NCT00985231|158008675|FG000|Overall Study|Lost to Follow-up|0|||
49047971|NCT00985231|158008676|FG001|Overall Study|Lost to Follow-up|1|||
49047972|NCT00985231|158008675|FG000|Overall Study|Study related symptoms & complaints|0|||
49047973|NCT00985231|158008676|FG001|Overall Study|Study related symptoms & complaints|2|||
49047974|NCT01740791|158008677|FG000|Overall Study|Randomized but never treated|5|||
49047975|NCT01740791|158008678|FG001|Overall Study|Randomized but never treated|3|||
49047976|NCT01740791|158008679|FG002|Overall Study|Randomized but never treated|2|||
49047977|NCT01740791|158008680|FG003|Overall Study|Randomized but never treated|2|||
49047978|NCT01740791|158008681|FG004|Overall Study|Randomized but never treated|1|||
49047979|NCT01740791|158008682|FG005|Overall Study|Randomized but never treated|3|||
49047980|NCT01740791|158008677|FG000|Overall Study|Lost to Follow-up|2|||
49047981|NCT01740791|158008678|FG001|Overall Study|Lost to Follow-up|0|||
49047982|NCT01740791|158008679|FG002|Overall Study|Lost to Follow-up|2|||
49047983|NCT01740791|158008680|FG003|Overall Study|Lost to Follow-up|3|||
49047984|NCT01740791|158008681|FG004|Overall Study|Lost to Follow-up|2|||
49047985|NCT01740791|158008682|FG005|Overall Study|Lost to Follow-up|3|||
49047986|NCT01740791|158008677|FG000|Overall Study|Withdrew Consent|4|||
49047987|NCT01740791|158008678|FG001|Overall Study|Withdrew Consent|0|||
49047988|NCT01740791|158008679|FG002|Overall Study|Withdrew Consent|1|||
49047989|NCT01740791|158008680|FG003|Overall Study|Withdrew Consent|2|||
49047990|NCT01740791|158008681|FG004|Overall Study|Withdrew Consent|0|||
49047991|NCT01740791|158008682|FG005|Overall Study|Withdrew Consent|3|||
49047992|NCT01740791|158008677|FG000|Overall Study|Investigator's discretion|1|||
49047993|NCT01740791|158008678|FG001|Overall Study|Investigator's discretion|0|||
49047994|NCT01740791|158008679|FG002|Overall Study|Investigator's discretion|1|||
49047995|NCT01740791|158008680|FG003|Overall Study|Investigator's discretion|0|||
49047996|NCT01740791|158008681|FG004|Overall Study|Investigator's discretion|0|||
49047997|NCT01740791|158008682|FG005|Overall Study|Investigator's discretion|1|||
49047998|NCT01740791|158008677|FG000|Overall Study|Adverse Event|0|||
49047999|NCT01740791|158008678|FG001|Overall Study|Adverse Event|0|||
49048000|NCT01740791|158008679|FG002|Overall Study|Adverse Event|0|||
49048001|NCT01740791|158008680|FG003|Overall Study|Adverse Event|0|||
49048002|NCT01740791|158008681|FG004|Overall Study|Adverse Event|0|||
49048003|NCT01740791|158008682|FG005|Overall Study|Adverse Event|1|||
49048004|NCT01808248|158008683|FG000|Overall Study|Lack of Efficacy|3|||
49048005|NCT01808248|158008683|FG000|Overall Study|Withdrawal by Subject|1|||
49048006|NCT01808248|158008683|FG000|Overall Study|Lost to Follow-up|1|||
49048007|NCT00819767|158008685|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
49048008|NCT00819767|158008686|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
49048009|NCT00756717|158008689|FG000|Overall Study|Withdrawal by Subject|2|||
49048010|NCT00603512|158008692|FG000|Overall Study|Adverse Event|0|||
49048011|NCT00603512|158008693|FG001|Overall Study|Adverse Event|2|||
49048012|NCT00603512|158008694|FG002|Overall Study|Adverse Event|4|||
49048013|NCT00603512|158008695|FG003|Overall Study|Adverse Event|4|||
49048014|NCT00603512|158008696|FG004|Overall Study|Adverse Event|2|||
49048015|NCT00603512|158008692|FG000|Overall Study|Lack of Efficacy|0|||
49048016|NCT00603512|158008693|FG001|Overall Study|Lack of Efficacy|1|||
49048017|NCT00603512|158008694|FG002|Overall Study|Lack of Efficacy|0|||
49048018|NCT00603512|158008695|FG003|Overall Study|Lack of Efficacy|0|||
49048019|NCT00603512|158008696|FG004|Overall Study|Lack of Efficacy|1|||
49048020|NCT00603512|158008692|FG000|Overall Study|Other|2|||
49048021|NCT00603512|158008693|FG001|Overall Study|Other|1|||
49048022|NCT00603512|158008694|FG002|Overall Study|Other|0|||
49048023|NCT00603512|158008695|FG003|Overall Study|Other|1|||
49048024|NCT00603512|158008696|FG004|Overall Study|Other|1|||
49048025|NCT00603512|158008692|FG000|Overall Study|Withdrawal by Subject|0|||
49048026|NCT00603512|158008693|FG001|Overall Study|Withdrawal by Subject|0|||
49048027|NCT00603512|158008694|FG002|Overall Study|Withdrawal by Subject|0|||
49048028|NCT00603512|158008695|FG003|Overall Study|Withdrawal by Subject|0|||
49048029|NCT00603512|158008696|FG004|Overall Study|Withdrawal by Subject|1|||
49048030|NCT00603512|158008692|FG000|Overall Study|Randomized but not treated|0|||
49048031|NCT00603512|158008693|FG001|Overall Study|Randomized but not treated|1|||
49048032|NCT00603512|158008694|FG002|Overall Study|Randomized but not treated|1|||
49048033|NCT00603512|158008695|FG003|Overall Study|Randomized but not treated|2|||
49048034|NCT00603512|158008696|FG004|Overall Study|Randomized but not treated|0|||
49048035|NCT04979858|158008697|FG000|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|1|||
49048036|NCT04979858|158008698|FG001|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|0|||
49048037|NCT02832167|158009838|FG000|Treatment Period 1|Disease progression|90|||
49048038|NCT02832167|158009838|FG000|Treatment Period 1|Adverse event unrelated to study drug|12|||
49048039|NCT02832167|158009838|FG000|Treatment Period 1|Death|2|||
49048040|NCT02832167|158009838|FG000|Treatment Period 1|Study Drug Toxicity|6|||
49048041|NCT02832167|158009838|FG000|Treatment Period 1|Participant request to discontinue|9|||
49048042|NCT02832167|158009838|FG000|Treatment Period 1|No longer meet study criteria|1|||
49048043|NCT02832167|158009838|FG000|Treatment Period 1|Participant withdrew consent|3|||
49048044|NCT02832167|158009838|FG000|Treatment Period 1|Other reasons|6|||
49048045|NCT02832167|158009838|FG000|Transition From Period 1 to Period 2|Other reasons|1|||
49048046|NCT02832167|158009838|FG000|Transition From Period 1 to Period 2|Participant withdrew consent|1|||
49048047|NCT02832167|158009838|FG000|Transition From Period 1 to Period 2|Death|2|||
49048048|NCT02832167|158009838|FG000|Transition From Period 1 to Period 2|Lost to Follow-up|3|||
49048049|NCT02832167|158009838|FG000|Treatment Period 2|Disease progression|69|||
49048050|NCT02832167|158009838|FG000|Treatment Period 2|Adverse event unrelated to study drug|1|||
49048051|NCT02832167|158009838|FG000|Treatment Period 2|Maximum clinical benefit|1|||
49048052|NCT02832167|158009838|FG000|Treatment Period 2|Study Drug Toxicity|5|||
49048053|NCT02832167|158009838|FG000|Treatment Period 2|Participant request to discontinue|2|||
49048054|NCT02832167|158009838|FG000|Treatment Period 2|Participant withdrew consent|3|||
49048055|NCT02832167|158009838|FG000|Treatment Period 2|Other reasons|3|||
49048056|NCT01705717|158009846|FG000|Overall Study|Adverse Event|2|||
49048057|NCT01705717|158009847|FG001|Overall Study|Adverse Event|2|||
49048058|NCT01705717|158009846|FG000|Overall Study|Lack of Efficacy|0|||
49048059|NCT01705717|158009847|FG001|Overall Study|Lack of Efficacy|1|||
49048060|NCT01705717|158009846|FG000|Overall Study|Other|0|||
49048061|NCT01705717|158009847|FG001|Overall Study|Other|2|||
49048062|NCT03686215|158009848|FG000|Overall Study|Adverse Event|0|||
49048063|NCT03686215|158009849|FG001|Overall Study|Adverse Event|0|||
49048064|NCT03686215|158009850|FG002|Overall Study|Adverse Event|7|||
49048065|NCT03686215|158009848|FG000|Overall Study|Physician Decision|0|||
49048066|NCT03686215|158009849|FG001|Overall Study|Physician Decision|0|||
49048067|NCT03686215|158009850|FG002|Overall Study|Physician Decision|1|||
49048068|NCT03686215|158009848|FG000|Overall Study|Protocol Violation|0|||
49048069|NCT03686215|158009849|FG001|Overall Study|Protocol Violation|0|||
49048070|NCT03686215|158009850|FG002|Overall Study|Protocol Violation|4|||
49048071|NCT03686215|158009848|FG000|Overall Study|Device issue|1|||
49048072|NCT03686215|158009849|FG001|Overall Study|Device issue|0|||
49048073|NCT03686215|158009850|FG002|Overall Study|Device issue|2|||
49048074|NCT01188226|158009855|FG000|Overall Study|Withdrawal by Subject|4|||
49048075|NCT00202839|158009856|FG000|Overall Study|Adverse Event|1|||
49048076|NCT00202839|158009857|FG001|Overall Study|Adverse Event|5|||
49048077|NCT00202839|158009856|FG000|Overall Study|Physician Decision|12|||
49048078|NCT00202839|158009857|FG001|Overall Study|Physician Decision|0|||
49048079|NCT00202839|158009856|FG000|Overall Study|Withdrawal by Subject|6|||
49048080|NCT00202839|158009857|FG001|Overall Study|Withdrawal by Subject|2|||
49048081|NCT00202839|158009856|FG000|Overall Study|Protocol Violation|2|||
49048082|NCT00202839|158009857|FG001|Overall Study|Protocol Violation|1|||
49048083|NCT00202839|158009856|FG000|Overall Study|Lost to Follow-up|3|||
49048084|NCT00202839|158009857|FG001|Overall Study|Lost to Follow-up|2|||
49048085|NCT04832971|158009861|FG000|Overall Study|Death|1|||
49048086|NCT04832971|158009862|FG001|Overall Study|Death|0|||
49048087|NCT04832971|158009863|FG002|Overall Study|Death|0|||
49048088|NCT04832971|158009864|FG003|Overall Study|Death|0|||
49048089|NCT04832971|158009861|FG000|Overall Study|Lost to Follow-up|1|||
49048090|NCT04832971|158009862|FG001|Overall Study|Lost to Follow-up|1|||
49048091|NCT04832971|158009863|FG002|Overall Study|Lost to Follow-up|1|||
49048092|NCT04832971|158009864|FG003|Overall Study|Lost to Follow-up|0|||
49048093|NCT04832971|158009861|FG000|Overall Study|Withdrawal by Subject|1|||
49048094|NCT04832971|158009862|FG001|Overall Study|Withdrawal by Subject|3|||
49048095|NCT04832971|158009863|FG002|Overall Study|Withdrawal by Subject|2|||
49048096|NCT04832971|158009864|FG003|Overall Study|Withdrawal by Subject|2|||
49048097|NCT04832971|158009861|FG000|Overall Study|Other, Not Specified|0|||
49048098|NCT04832971|158009862|FG001|Overall Study|Other, Not Specified|0|||
49048099|NCT04832971|158009863|FG002|Overall Study|Other, Not Specified|1|||
49048100|NCT04832971|158009864|FG003|Overall Study|Other, Not Specified|0|||
49048101|NCT00927251|158009865|FG000|Overall Study|Patients not implanted with 4296 lead|8|||
49048102|NCT01098851|158009866|FG000|Overall Study|Equipment failure|1|||
49048103|NCT01098851|158009867|FG001|Overall Study|Equipment failure|0|||
49048104|NCT02297841|158009868|FG000|Overall Study|Withdrawal by Subject|1|||
49048105|NCT02297841|158009868|FG000|Overall Study|Protocol Violation|7|||
49048106|NCT03431337|158009873|FG000|Overall Study|Lost to Follow-up|21|||
49048107|NCT03431337|158009874|FG001|Overall Study|Lost to Follow-up|19|||
49048108|NCT03431337|158009873|FG000|Overall Study|Withdrawal by Subject|8|||
49048109|NCT03431337|158009874|FG001|Overall Study|Withdrawal by Subject|3|||
49048110|NCT02419573|158009875|FG000|Overall Study|Lost to Follow-up|3|||
49048111|NCT02419573|158009876|FG001|Overall Study|Lost to Follow-up|0|||
49048112|NCT02419573|158009875|FG000|Overall Study|Withdrawal by Subject|1|||
49048113|NCT02419573|158009876|FG001|Overall Study|Withdrawal by Subject|0|||
49048114|NCT00401245|158009877|FG000|Double Blind Titration Phase|Adverse Event|3|||
49048115|NCT00401245|158009878|FG001|Double Blind Titration Phase|Adverse Event|2|||
49048116|NCT00401245|158009879|FG002|Double Blind Titration Phase|Adverse Event|5|||
49048117|NCT00401245|158009880|FG003|Double Blind Titration Phase|Adverse Event|12|||
49048118|NCT00401245|158009881|FG004|Double Blind Titration Phase|Adverse Event|0|||
49048119|NCT00401245|158009882|FG005|Double Blind Titration Phase|Adverse Event|0|||
49048120|NCT00401245|158009883|FG006|Double Blind Titration Phase|Adverse Event|0|||
49048121|NCT00401245|158009884|FG007|Double Blind Titration Phase|Adverse Event|0|||
49048122|NCT00401245|158009877|FG000|Double Blind Titration Phase|Other|0|||
49048123|NCT00401245|158009878|FG001|Double Blind Titration Phase|Other|0|||
49048124|NCT00401245|158009879|FG002|Double Blind Titration Phase|Other|1|||
49048125|NCT00401245|158009880|FG003|Double Blind Titration Phase|Other|0|||
49048126|NCT00401245|158009881|FG004|Double Blind Titration Phase|Other|0|||
49048127|NCT00401245|158009882|FG005|Double Blind Titration Phase|Other|0|||
49048128|NCT00401245|158009883|FG006|Double Blind Titration Phase|Other|0|||
49048129|NCT00401245|158009884|FG007|Double Blind Titration Phase|Other|0|||
49048130|NCT00401245|158009877|FG000|Double Blind Titration Phase|Protocol Violation|0|||
49048131|NCT00401245|158009878|FG001|Double Blind Titration Phase|Protocol Violation|0|||
49048132|NCT00401245|158009879|FG002|Double Blind Titration Phase|Protocol Violation|0|||
49048133|NCT00401245|158009880|FG003|Double Blind Titration Phase|Protocol Violation|1|||
49048134|NCT00401245|158009881|FG004|Double Blind Titration Phase|Protocol Violation|0|||
49048135|NCT00401245|158009882|FG005|Double Blind Titration Phase|Protocol Violation|0|||
49048136|NCT00401245|158009883|FG006|Double Blind Titration Phase|Protocol Violation|0|||
49048137|NCT00401245|158009884|FG007|Double Blind Titration Phase|Protocol Violation|0|||
49048138|NCT00401245|158009877|FG000|Double Blind Titration Phase|Withdrawal by Subject|1|||
49048139|NCT00401245|158009878|FG001|Double Blind Titration Phase|Withdrawal by Subject|1|||
49048140|NCT00401245|158009879|FG002|Double Blind Titration Phase|Withdrawal by Subject|0|||
49048141|NCT00401245|158009880|FG003|Double Blind Titration Phase|Withdrawal by Subject|2|||
49048142|NCT00401245|158009881|FG004|Double Blind Titration Phase|Withdrawal by Subject|0|||
49048143|NCT00401245|158009882|FG005|Double Blind Titration Phase|Withdrawal by Subject|0|||
49048144|NCT00401245|158009883|FG006|Double Blind Titration Phase|Withdrawal by Subject|0|||
49048145|NCT00401245|158009884|FG007|Double Blind Titration Phase|Withdrawal by Subject|0|||
49048146|NCT00401245|158009877|FG000|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
49048147|NCT00401245|158009878|FG001|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
49048148|NCT00401245|158009879|FG002|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
49048149|NCT00401245|158009880|FG003|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
49048150|NCT00401245|158009881|FG004|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
49048151|NCT00401245|158009882|FG005|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
49048152|NCT00401245|158009883|FG006|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
49048153|NCT00401245|158009884|FG007|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
49048154|NCT00401245|158009877|FG000|Open Label Phase|Adverse Event|5|||
49048155|NCT00401245|158009878|FG001|Open Label Phase|Adverse Event|14|||
49048156|NCT00401245|158009879|FG002|Open Label Phase|Adverse Event|6|||
49048157|NCT00401245|158009880|FG003|Open Label Phase|Adverse Event|7|||
49048158|NCT00401245|158009881|FG004|Open Label Phase|Adverse Event|0|||
49048159|NCT00401245|158009882|FG005|Open Label Phase|Adverse Event|0|||
49048160|NCT00401245|158009883|FG006|Open Label Phase|Adverse Event|0|||
49048161|NCT00401245|158009884|FG007|Open Label Phase|Adverse Event|0|||
49048162|NCT00401245|158009877|FG000|Open Label Phase|Lost to Follow-up|5|||
49048163|NCT00401245|158009878|FG001|Open Label Phase|Lost to Follow-up|7|||
49048164|NCT00401245|158009879|FG002|Open Label Phase|Lost to Follow-up|5|||
49048165|NCT00401245|158009880|FG003|Open Label Phase|Lost to Follow-up|4|||
49048166|NCT00401245|158009881|FG004|Open Label Phase|Lost to Follow-up|0|||
49048167|NCT00401245|158009882|FG005|Open Label Phase|Lost to Follow-up|0|||
49048168|NCT00401245|158009883|FG006|Open Label Phase|Lost to Follow-up|0|||
49048169|NCT00401245|158009884|FG007|Open Label Phase|Lost to Follow-up|0|||
49048170|NCT00401245|158009877|FG000|Open Label Phase|Other|4|||
49048171|NCT00401245|158009878|FG001|Open Label Phase|Other|8|||
49048172|NCT00401245|158009879|FG002|Open Label Phase|Other|7|||
49048173|NCT00401245|158009880|FG003|Open Label Phase|Other|8|||
49048174|NCT00401245|158009881|FG004|Open Label Phase|Other|0|||
49048175|NCT00401245|158009882|FG005|Open Label Phase|Other|0|||
49048176|NCT00401245|158009883|FG006|Open Label Phase|Other|0|||
49048177|NCT00401245|158009884|FG007|Open Label Phase|Other|0|||
49048178|NCT00401245|158009877|FG000|Open Label Phase|Protocol Violation|0|||
49048179|NCT00401245|158009878|FG001|Open Label Phase|Protocol Violation|1|||
49048180|NCT00401245|158009879|FG002|Open Label Phase|Protocol Violation|0|||
49048181|NCT00401245|158009880|FG003|Open Label Phase|Protocol Violation|1|||
49048182|NCT00401245|158009881|FG004|Open Label Phase|Protocol Violation|0|||
49048183|NCT00401245|158009882|FG005|Open Label Phase|Protocol Violation|0|||
49048184|NCT00401245|158009883|FG006|Open Label Phase|Protocol Violation|0|||
49048185|NCT00401245|158009884|FG007|Open Label Phase|Protocol Violation|0|||
49048186|NCT00401245|158009877|FG000|Open Label Phase|Withdrawal by Subject|3|||
49048187|NCT00401245|158009878|FG001|Open Label Phase|Withdrawal by Subject|3|||
49048188|NCT00401245|158009879|FG002|Open Label Phase|Withdrawal by Subject|2|||
49048189|NCT00401245|158009880|FG003|Open Label Phase|Withdrawal by Subject|1|||
49048190|NCT00401245|158009881|FG004|Open Label Phase|Withdrawal by Subject|0|||
49048191|NCT00401245|158009882|FG005|Open Label Phase|Withdrawal by Subject|0|||
49048192|NCT00401245|158009883|FG006|Open Label Phase|Withdrawal by Subject|0|||
49048193|NCT00401245|158009884|FG007|Open Label Phase|Withdrawal by Subject|0|||
49048194|NCT00401245|158009877|FG000|Open Label Phase|Lack of Efficacy|4|||
49048195|NCT00401245|158009878|FG001|Open Label Phase|Lack of Efficacy|2|||
49048196|NCT00401245|158009879|FG002|Open Label Phase|Lack of Efficacy|3|||
49048197|NCT00401245|158009880|FG003|Open Label Phase|Lack of Efficacy|0|||
49048198|NCT00401245|158009881|FG004|Open Label Phase|Lack of Efficacy|0|||
49048199|NCT00401245|158009882|FG005|Open Label Phase|Lack of Efficacy|0|||
49048200|NCT00401245|158009883|FG006|Open Label Phase|Lack of Efficacy|0|||
49048201|NCT00401245|158009884|FG007|Open Label Phase|Lack of Efficacy|0|||
49048202|NCT00401245|158009877|FG000|Double Blind Tapering Phase|Adverse Event|0|||
49048203|NCT00401245|158009878|FG001|Double Blind Tapering Phase|Adverse Event|0|||
49048204|NCT00401245|158009879|FG002|Double Blind Tapering Phase|Adverse Event|0|||
49048205|NCT00401245|158009880|FG003|Double Blind Tapering Phase|Adverse Event|0|||
49048206|NCT00401245|158009881|FG004|Double Blind Tapering Phase|Adverse Event|1|||
49048207|NCT00401245|158009882|FG005|Double Blind Tapering Phase|Adverse Event|1|||
49048208|NCT00401245|158009883|FG006|Double Blind Tapering Phase|Adverse Event|2|||
49048209|NCT00401245|158009884|FG007|Double Blind Tapering Phase|Adverse Event|4|||
49048210|NCT00401245|158009877|FG000|Double Blind Tapering Phase|Investigator request|0|||
49048211|NCT00401245|158009878|FG001|Double Blind Tapering Phase|Investigator request|0|||
49048212|NCT00401245|158009879|FG002|Double Blind Tapering Phase|Investigator request|0|||
49048213|NCT00401245|158009880|FG003|Double Blind Tapering Phase|Investigator request|0|||
49048214|NCT00401245|158009881|FG004|Double Blind Tapering Phase|Investigator request|0|||
49048215|NCT00401245|158009882|FG005|Double Blind Tapering Phase|Investigator request|0|||
49048216|NCT00401245|158009883|FG006|Double Blind Tapering Phase|Investigator request|0|||
49048217|NCT00401245|158009884|FG007|Double Blind Tapering Phase|Investigator request|1|||
49048218|NCT00401245|158009877|FG000|Double Blind Tapering Phase|Other|0|||
49048219|NCT00401245|158009878|FG001|Double Blind Tapering Phase|Other|0|||
49048220|NCT00401245|158009879|FG002|Double Blind Tapering Phase|Other|0|||
49048221|NCT00401245|158009880|FG003|Double Blind Tapering Phase|Other|0|||
49048222|NCT00401245|158009881|FG004|Double Blind Tapering Phase|Other|1|||
49048223|NCT00401245|158009882|FG005|Double Blind Tapering Phase|Other|0|||
49048224|NCT00401245|158009883|FG006|Double Blind Tapering Phase|Other|2|||
49048225|NCT00401245|158009884|FG007|Double Blind Tapering Phase|Other|2|||
49048226|NCT00401245|158009877|FG000|Double Blind Tapering Phase|Withdrawal by Subject|0|||
49048227|NCT00401245|158009878|FG001|Double Blind Tapering Phase|Withdrawal by Subject|0|||
49048228|NCT00401245|158009879|FG002|Double Blind Tapering Phase|Withdrawal by Subject|0|||
49048229|NCT00401245|158009880|FG003|Double Blind Tapering Phase|Withdrawal by Subject|0|||
49048230|NCT00401245|158009881|FG004|Double Blind Tapering Phase|Withdrawal by Subject|2|||
49048231|NCT00401245|158009882|FG005|Double Blind Tapering Phase|Withdrawal by Subject|2|||
49048232|NCT00401245|158009883|FG006|Double Blind Tapering Phase|Withdrawal by Subject|3|||
49048233|NCT00401245|158009884|FG007|Double Blind Tapering Phase|Withdrawal by Subject|0|||
49048234|NCT00401245|158009877|FG000|Double Blind Tapering Phase|Lack of Efficacy|0|||
49048235|NCT00401245|158009878|FG001|Double Blind Tapering Phase|Lack of Efficacy|0|||
49048236|NCT00401245|158009879|FG002|Double Blind Tapering Phase|Lack of Efficacy|0|||
49048237|NCT00401245|158009880|FG003|Double Blind Tapering Phase|Lack of Efficacy|0|||
49048238|NCT00401245|158009881|FG004|Double Blind Tapering Phase|Lack of Efficacy|0|||
49048239|NCT00401245|158009882|FG005|Double Blind Tapering Phase|Lack of Efficacy|1|||
49048240|NCT00401245|158009883|FG006|Double Blind Tapering Phase|Lack of Efficacy|0|||
49048241|NCT00401245|158009884|FG007|Double Blind Tapering Phase|Lack of Efficacy|0|||
49048242|NCT00685035|158009886|FG000|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1|||
49048243|NCT00685035|158009887|FG001|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0|||
49048244|NCT00979212|158009889|FG000|Overall Study|Protocol Violation|1|||
49048245|NCT00979212|158009890|FG001|Overall Study|Protocol Violation|8|||
49048246|NCT00979212|158009889|FG000|Overall Study|No protocol therapy received|1|||
49048247|NCT00979212|158009890|FG001|Overall Study|No protocol therapy received|0|||
49048248|NCT01463982|158009891|FG000|Overall Study|Withdrawal by Subject|0|||
49048249|NCT01463982|158009892|FG001|Overall Study|Withdrawal by Subject|1|||
49048250|NCT01463982|158009893|FG002|Overall Study|Withdrawal by Subject|1|||
49048251|NCT01463982|158009894|FG003|Overall Study|Withdrawal by Subject|0|||
49048252|NCT01463982|158009891|FG000|Overall Study|Treatment delay over 5 week|0|||
49048253|NCT01463982|158009892|FG001|Overall Study|Treatment delay over 5 week|0|||
49048254|NCT01463982|158009893|FG002|Overall Study|Treatment delay over 5 week|1|||
49048255|NCT01463982|158009894|FG003|Overall Study|Treatment delay over 5 week|0|||
49048256|NCT03069417|158009895|FG000|Overall Study|Lost to Follow-up|2|||
49048257|NCT03069417|158009896|FG001|Overall Study|Lost to Follow-up|0|||
49048258|NCT03069417|158009895|FG000|Overall Study|Reason Unknown|4|||
49048259|NCT03069417|158009896|FG001|Overall Study|Reason Unknown|7|||
49048260|NCT00685750|158009901|FG000|Overall Study|Tumor sampling failure|0|||
49048261|NCT00685750|158009902|FG001|Overall Study|Tumor sampling failure|0|||
49048262|NCT00685750|158009903|FG002|Overall Study|Tumor sampling failure|1|||
49048263|NCT00685750|158009904|FG003|Overall Study|Tumor sampling failure|0|||
49048264|NCT00685750|158009905|FG004|Overall Study|Tumor sampling failure|0|||
49048265|NCT00685750|158009906|FG005|Overall Study|Tumor sampling failure|0|||
49048266|NCT00685750|158009907|FG006|Overall Study|Tumor sampling failure|0|||
49048267|NCT00685750|158009901|FG000|Overall Study|Patient didn't receive the treatment|0|||
49048268|NCT00685750|158009902|FG001|Overall Study|Patient didn't receive the treatment|0|||
49048269|NCT00685750|158009903|FG002|Overall Study|Patient didn't receive the treatment|0|||
49048270|NCT00685750|158009904|FG003|Overall Study|Patient didn't receive the treatment|0|||
49048271|NCT00685750|158009905|FG004|Overall Study|Patient didn't receive the treatment|0|||
49048272|NCT00685750|158009906|FG005|Overall Study|Patient didn't receive the treatment|0|||
49048273|NCT00685750|158009907|FG006|Overall Study|Patient didn't receive the treatment|1|||
49048274|NCT00685750|158009901|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
49048275|NCT00685750|158009902|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
49048276|NCT00685750|158009903|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
49048277|NCT00685750|158009904|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
49048278|NCT00685750|158009905|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
49048279|NCT00685750|158009906|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
49048280|NCT00685750|158009907|FG006|Overall Study|Eligibility criteria not fulfilled|0|||
49048281|NCT04253236|158009908|FG000|Overall Study|Adverse Event|1|||
49048282|NCT04253236|158009909|FG001|Overall Study|Adverse Event|0|||
49048283|NCT04253236|158009908|FG000|Overall Study|Safety Concerns|1|||
49048284|NCT04253236|158009909|FG001|Overall Study|Safety Concerns|0|||
49048285|NCT04253236|158009908|FG000|Overall Study|Study Terminated by Sponsor|1|||
49048286|NCT04253236|158009909|FG001|Overall Study|Study Terminated by Sponsor|0|||
49048287|NCT00587431|158009914|FG000|Overall Study|Adverse Event|1|||
49048288|NCT00587431|158009915|FG001|Overall Study|Adverse Event|0|||
49048289|NCT00587431|158009914|FG000|Overall Study|Withdrawal by Subject|0|||
49048290|NCT00587431|158009915|FG001|Overall Study|Withdrawal by Subject|1|||
49048291|NCT02169791|158009918|FG000|Overall Study|Death|6|||
49048292|NCT02169791|158009918|FG000|Overall Study|patient withdrew consent|1|||
49048293|NCT03170869|158009919|FG000|Overall Study|Protocol Violation|5|||
49048294|NCT03170869|158009919|FG000|Overall Study|Early study termination|3|||
49048295|NCT02466386|158009935|FG000|Overall Study|Adverse Event|5|||
49048296|NCT02466386|158009935|FG000|Overall Study|Protocol Violation|2|||
49048297|NCT02466386|158009935|FG000|Overall Study|Withdrawal by Subject|14|||
49048298|NCT02466386|158009935|FG000|Overall Study|Lost to Follow-up|5|||
49048299|NCT02466386|158009935|FG000|Overall Study|Lack of Efficacy|8|||
49048300|NCT02466386|158009935|FG000|Overall Study|Other|10|||
49048301|NCT05317195|158009936|FG000|Randomization|Withdrawal by Subject|1|||
49048302|NCT05317195|158009936|FG000|Randomization|Discontinued|6|||
49048303|NCT05317195|158009936|FG000|Admission|Withdrawal by Subject|2|||
49048304|NCT05103657|158009953|FG000|Overall Study|Other reasons than listed|9|||
49048305|NCT05103657|158009954|FG001|Overall Study|Other reasons than listed|8|||
49048306|NCT05103657|158009953|FG000|Overall Study|Protocol deviation|2|||
49048307|NCT05103657|158009954|FG001|Overall Study|Protocol deviation|2|||
49048308|NCT05103657|158009953|FG000|Overall Study|No reason available|5|||
49048309|NCT05103657|158009954|FG001|Overall Study|No reason available|4|||
49048310|NCT05103657|158009953|FG000|Overall Study|Burden of study procedures|3|||
49048311|NCT05103657|158009954|FG001|Overall Study|Burden of study procedures|1|||
49048312|NCT05103657|158009953|FG000|Overall Study|Perceived lack of efficacy|1|||
49048313|NCT05103657|158009954|FG001|Overall Study|Perceived lack of efficacy|1|||
49048314|NCT05103657|158009953|FG000|Overall Study|Adverse Event|6|||
49048315|NCT05103657|158009954|FG001|Overall Study|Adverse Event|14|||
49048316|NCT05103657|158009953|FG000|Overall Study|Not Treated|1|||
49048317|NCT05103657|158009954|FG001|Overall Study|Not Treated|1|||
49048318|NCT01142661|158009955|FG000|Overall Study|Adverse Event|2|||
49048319|NCT01142661|158009955|FG000|Overall Study|Withdrawal by Subject|1|||
49048320|NCT01142661|158009955|FG000|Overall Study|Physician Decision|1|||
49048321|NCT02875028|158009956|FG000|Washout Period|Withdrawal by Subject|0|||
49048322|NCT02875028|158009957|FG001|Washout Period|Withdrawal by Subject|1|||
49048323|NCT03433703|158009958|FG000|Overall Study|Study terminated by Sponsor|2|||
49048324|NCT03689894|158009959|FG000|Overall Study|Adverse Event|1|||
49048325|NCT00569777|158009968|FG000|Overall Study|Withdrawal by Subject|4|||
49048326|NCT00569777|158009969|FG001|Overall Study|Withdrawal by Subject|0|||
49048327|NCT00569777|158009968|FG000|Overall Study|Adverse Event|3|||
49048328|NCT00569777|158009969|FG001|Overall Study|Adverse Event|0|||
49048329|NCT00569777|158009968|FG000|Overall Study|Lost to Follow-up|1|||
49048330|NCT00569777|158009969|FG001|Overall Study|Lost to Follow-up|0|||
49048331|NCT00569777|158009968|FG000|Overall Study|scheduled eye surgery|0|||
49048332|NCT00569777|158009969|FG001|Overall Study|scheduled eye surgery|1|||
49048333|NCT00569777|158009968|FG000|Overall Study|did not meet exclusion criteria|1|||
49048334|NCT00569777|158009969|FG001|Overall Study|did not meet exclusion criteria|2|||
49048335|NCT00569777|158009968|FG000|Overall Study|pregnant|1|||
49048336|NCT00569777|158009969|FG001|Overall Study|pregnant|0|||
49048337|NCT00537017|158009972|FG000|Treatment Phase|Adverse Event|19|||
49048338|NCT00537017|158009972|FG000|Treatment Phase|Withdrawal by Subject|13|||
49048339|NCT00537017|158009972|FG000|Treatment Phase|Protocol Violation|2|||
49048340|NCT00537017|158009972|FG000|Follow-up Phase|Withdrawal by Subject|9|||
49048341|NCT04980456|158011301|FG000|Period 1 (Approximately 30 Days)|Adverse Event|2|||
49048342|NCT04980456|158011302|FG001|Period 1 (Approximately 30 Days)|Adverse Event|0|||
49048343|NCT04980456|158011301|FG000|Period 1 (Approximately 30 Days)|Lost to Follow-up|0|||
49048344|NCT04980456|158011302|FG001|Period 1 (Approximately 30 Days)|Lost to Follow-up|1|||
49048345|NCT04980456|158011301|FG000|Period 1 (Approximately 30 Days)|Withdrawal by Subject|1|||
49048346|NCT04980456|158011302|FG001|Period 1 (Approximately 30 Days)|Withdrawal by Subject|2|||
49048347|NCT04980456|158011301|FG000|Period 2 (Approximately 30 Days)|Adverse Event|0|||
49048348|NCT04980456|158011302|FG001|Period 2 (Approximately 30 Days)|Adverse Event|1|||
49048349|NCT02846883|158011303|FG000|Overall Study|Death|0|||
49048350|NCT02846883|158011304|FG001|Overall Study|Death|1|||
49048351|NCT02846883|158011305|FG002|Overall Study|Death|1|||
49048352|NCT02846883|158011303|FG000|Overall Study|Lost to Follow-up|0|||
49048353|NCT02846883|158011304|FG001|Overall Study|Lost to Follow-up|0|||
49048354|NCT02846883|158011305|FG002|Overall Study|Lost to Follow-up|1|||
49048355|NCT02846883|158011303|FG000|Overall Study|Withdrawal by Subject|1|||
49048356|NCT02846883|158011304|FG001|Overall Study|Withdrawal by Subject|0|||
49048357|NCT02846883|158011305|FG002|Overall Study|Withdrawal by Subject|0|||
49048358|NCT02846883|158011303|FG000|Overall Study|Study terminated by VA DSMB due to low enrollment|5|||
49048359|NCT02846883|158011304|FG001|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
49048360|NCT02846883|158011305|FG002|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
49048361|NCT02846883|158011303|FG000|Overall Study|Primary endpoint - endovascular aortic repair|0|||
49048362|NCT02846883|158011304|FG001|Overall Study|Primary endpoint - endovascular aortic repair|0|||
49048363|NCT02846883|158011305|FG002|Overall Study|Primary endpoint - endovascular aortic repair|1|||
49048364|NCT00442351|158011308|FG000|Overall Study|Administrative|6|||
49048365|NCT00442351|158011309|FG001|Overall Study|Administrative|5|||
49048366|NCT00442351|158011308|FG000|Overall Study|Did not meet protocol eligibility|1|||
49048367|NCT00442351|158011309|FG001|Overall Study|Did not meet protocol eligibility|0|||
49048368|NCT00442351|158011308|FG000|Overall Study|Other|0|||
49048369|NCT00442351|158011309|FG001|Overall Study|Other|1|||
49048370|NCT03087786|158011310|FG000|Overall Study|Withdrawal by Subject|2|||
49048371|NCT03087786|158011311|FG001|Overall Study|Withdrawal by Subject|0|||
49048372|NCT00063258|158011336|FG000|Overall Study|Physician Decision|2|||
49048373|NCT00063258|158011337|FG001|Overall Study|Physician Decision|0|||
49048374|NCT00063258|158011336|FG000|Overall Study|Lack of Efficacy|2|||
49048375|NCT00063258|158011337|FG001|Overall Study|Lack of Efficacy|0|||
49048376|NCT00035555|158011341|FG000|Overall Study|Adverse Event|5|||
49048377|NCT00035555|158011342|FG001|Overall Study|Adverse Event|8|||
49048378|NCT00035555|158011343|FG002|Overall Study|Adverse Event|9|||
49048379|NCT00035555|158011341|FG000|Overall Study|Allograft loss|1|||
49048380|NCT00035555|158011342|FG001|Overall Study|Allograft loss|1|||
49048381|NCT00035555|158011343|FG002|Overall Study|Allograft loss|2|||
49048382|NCT00035555|158011341|FG000|Overall Study|Death|0|||
49048383|NCT00035555|158011342|FG001|Overall Study|Death|0|||
49048384|NCT00035555|158011343|FG002|Overall Study|Death|2|||
49048385|NCT00035555|158011341|FG000|Overall Study|Lost to Follow-up|0|||
49048386|NCT00035555|158011342|FG001|Overall Study|Lost to Follow-up|0|||
49048387|NCT00035555|158011343|FG002|Overall Study|Lost to Follow-up|1|||
49048388|NCT00035555|158011341|FG000|Overall Study|Noncompliance|0|||
49048389|NCT00035555|158011342|FG001|Overall Study|Noncompliance|1|||
49048390|NCT00035555|158011343|FG002|Overall Study|Noncompliance|1|||
49048391|NCT00035555|158011341|FG000|Overall Study|Prohibited medication|1|||
49048392|NCT00035555|158011342|FG001|Overall Study|Prohibited medication|1|||
49048393|NCT00035555|158011343|FG002|Overall Study|Prohibited medication|0|||
49048394|NCT00035555|158011341|FG000|Overall Study|Treatment failure/lack of efficacy|7|||
49048395|NCT00035555|158011342|FG001|Overall Study|Treatment failure/lack of efficacy|5|||
49048396|NCT00035555|158011343|FG002|Overall Study|Treatment failure/lack of efficacy|3|||
49048397|NCT00035555|158011341|FG000|Overall Study|Withdrawal by Subject|2|||
49048398|NCT00035555|158011342|FG001|Overall Study|Withdrawal by Subject|0|||
49048399|NCT00035555|158011343|FG002|Overall Study|Withdrawal by Subject|2|||
49048400|NCT00035555|158011341|FG000|Overall Study|Investigator deemed not a good candidate|0|||
49048401|NCT00035555|158011342|FG001|Overall Study|Investigator deemed not a good candidate|0|||
49048402|NCT00035555|158011343|FG002|Overall Study|Investigator deemed not a good candidate|1|||
49048403|NCT00035555|158011341|FG000|Overall Study|Received cyclosporin in error|0|||
49048404|NCT00035555|158011342|FG001|Overall Study|Received cyclosporin in error|0|||
49048405|NCT00035555|158011343|FG002|Overall Study|Received cyclosporin in error|1|||
49048406|NCT01957150|158011344|FG000|Overall Study|Adverse Event|23|||
49048407|NCT01957150|158011345|FG001|Overall Study|Adverse Event|20|||
49048408|NCT01957150|158011344|FG000|Overall Study|Withdrawal by Subject|13|||
49048409|NCT01957150|158011345|FG001|Overall Study|Withdrawal by Subject|17|||
49048410|NCT01957150|158011344|FG000|Overall Study|Physician Decision|3|||
49048411|NCT01957150|158011345|FG001|Overall Study|Physician Decision|6|||
49048412|NCT01957150|158011344|FG000|Overall Study|Lost to Follow-up|4|||
49048413|NCT01957150|158011345|FG001|Overall Study|Lost to Follow-up|4|||
49048414|NCT01957150|158011344|FG000|Overall Study|Protocol Violation|1|||
49048415|NCT01957150|158011345|FG001|Overall Study|Protocol Violation|0|||
49048416|NCT01957150|158011344|FG000|Overall Study|Lack of Efficacy|11|||
49048417|NCT01957150|158011345|FG001|Overall Study|Lack of Efficacy|11|||
49048418|NCT04164758|158011346|FG000|Overall Study|COVID-19 withdrawal of consent|1|||
49048419|NCT04164758|158011347|FG001|Overall Study|COVID-19 withdrawal of consent|0|||
49048420|NCT04164758|158011348|FG002|Overall Study|COVID-19 withdrawal of consent|0|||
49048421|NCT04164758|158011346|FG000|Overall Study|Adverse Event|0|||
49048422|NCT04164758|158011347|FG001|Overall Study|Adverse Event|1|||
49048423|NCT04164758|158011348|FG002|Overall Study|Adverse Event|0|||
49048424|NCT01011556|158011353|FG000|Overall Study|Adverse Event|1|||
49048425|NCT01011556|158011354|FG001|Overall Study|Adverse Event|3|||
49048426|NCT01011556|158011355|FG002|Overall Study|Adverse Event|2|||
49048427|NCT01011556|158011356|FG003|Overall Study|Adverse Event|1|||
49048428|NCT01011556|158011353|FG000|Overall Study|Lost to Follow-up|1|||
49048429|NCT01011556|158011354|FG001|Overall Study|Lost to Follow-up|0|||
49048430|NCT01011556|158011355|FG002|Overall Study|Lost to Follow-up|0|||
49048431|NCT01011556|158011356|FG003|Overall Study|Lost to Follow-up|0|||
49048432|NCT01011556|158011353|FG000|Overall Study|Physician Decision|1|||
49048433|NCT01011556|158011354|FG001|Overall Study|Physician Decision|0|||
49048434|NCT01011556|158011355|FG002|Overall Study|Physician Decision|0|||
49048435|NCT01011556|158011356|FG003|Overall Study|Physician Decision|1|||
49048436|NCT01011556|158011353|FG000|Overall Study|Protocol Violation|0|||
49048437|NCT01011556|158011354|FG001|Overall Study|Protocol Violation|1|||
49048438|NCT01011556|158011355|FG002|Overall Study|Protocol Violation|0|||
49048439|NCT01011556|158011356|FG003|Overall Study|Protocol Violation|0|||
49048440|NCT01011556|158011353|FG000|Overall Study|Withdrawal by Subject|1|||
49048441|NCT01011556|158011354|FG001|Overall Study|Withdrawal by Subject|2|||
49048442|NCT01011556|158011355|FG002|Overall Study|Withdrawal by Subject|4|||
49048443|NCT01011556|158011356|FG003|Overall Study|Withdrawal by Subject|4|||
49048444|NCT01011556|158011353|FG000|Overall Study|Sponsor decision|0|||
49048445|NCT01011556|158011354|FG001|Overall Study|Sponsor decision|1|||
49048446|NCT01011556|158011355|FG002|Overall Study|Sponsor decision|1|||
49048447|NCT01011556|158011356|FG003|Overall Study|Sponsor decision|2|||
49048448|NCT01011556|158011353|FG000|Overall Study|Inclusion/exclusion criteria not met|2|||
49048449|NCT01011556|158011354|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
49048450|NCT01011556|158011355|FG002|Overall Study|Inclusion/exclusion criteria not met|3|||
49048451|NCT01011556|158011356|FG003|Overall Study|Inclusion/exclusion criteria not met|5|||
49048452|NCT04149535|158011357|FG000|Overall Study|Death|11|||
49048453|NCT04149535|158011358|FG001|Overall Study|Death|7|||
49048454|NCT04149535|158011357|FG000|Overall Study|Physician Decision|10|||
49048455|NCT04149535|158011358|FG001|Overall Study|Physician Decision|4|||
49048456|NCT04149535|158011357|FG000|Overall Study|Withdrawal by Subject|6|||
49048457|NCT04149535|158011358|FG001|Overall Study|Withdrawal by Subject|7|||
49048458|NCT04149535|158011357|FG000|Overall Study|Not described|2|||
49048459|NCT04149535|158011358|FG001|Overall Study|Not described|0|||
49048460|NCT01009515|158011360|FG000|Overall Study|Withdrawal by Subject|3|||
49048461|NCT00983476|158011366|FG000|Overall Study|Did not receive intervention|17|||
49048462|NCT00983476|158011367|FG001|Overall Study|Did not receive intervention|22|||
49048463|NCT00983476|158011368|FG002|Overall Study|Did not receive intervention|0|||
49048464|NCT00220727|158011371|FG000|Second Infusion (Week <6)|Pt did not meet study requirement|1|||
49048465|NCT00220727|158011372|FG001|Second Infusion (Week <6)|Pt did not meet study requirement|0|||
49048466|NCT00761176|158011373|FG000|Overall Study|Death|1|||
49048467|NCT00761176|158011374|FG001|Overall Study|Death|0|||
49048468|NCT00761176|158011373|FG000|Overall Study|Withdrawal by Subject|1|||
49048469|NCT00761176|158011374|FG001|Overall Study|Withdrawal by Subject|1|||
49048470|NCT02762994|158011375|FG000|Overall Study|Withdrawal by Subject|0|||
49048471|NCT02762994|158011376|FG001|Overall Study|Withdrawal by Subject|1|||
49048472|NCT02762994|158011377|FG002|Overall Study|Withdrawal by Subject|2|||
49048473|NCT02762994|158011378|FG003|Overall Study|Withdrawal by Subject|0|||
49048474|NCT02762994|158011375|FG000|Overall Study|Protocol Violation|1|||
49048475|NCT02762994|158011376|FG001|Overall Study|Protocol Violation|0|||
49048476|NCT02762994|158011377|FG002|Overall Study|Protocol Violation|0|||
49048477|NCT02762994|158011378|FG003|Overall Study|Protocol Violation|2|||
49048478|NCT01175473|158011387|FG000|Overall Study|Adverse Event|2|||
49048479|NCT01175473|158011388|FG001|Overall Study|Adverse Event|2|||
49048480|NCT02020967|158011391|FG000|Overall Study|Withdrawal by Subject|51|||
49048481|NCT02674386|158011392|FG000|Overall Study|Lost to Follow-up|0|||
49048482|NCT02674386|158011393|FG001|Overall Study|Lost to Follow-up|1|||
49048483|NCT02674386|158011394|FG002|Overall Study|Lost to Follow-up|1|||
49048484|NCT02674386|158011392|FG000|Overall Study|Withdrawal by Subject|0|||
49048485|NCT02674386|158011393|FG001|Overall Study|Withdrawal by Subject|4|||
49048486|NCT02674386|158011394|FG002|Overall Study|Withdrawal by Subject|0|||
49048487|NCT02674386|158011392|FG000|Overall Study|Other|0|||
49048488|NCT02674386|158011393|FG001|Overall Study|Other|1|||
49048489|NCT02674386|158011394|FG002|Overall Study|Other|0|||
49048490|NCT02674386|158011392|FG000|Overall Study|Enrolled but not evaluated|0|||
49048491|NCT02674386|158011393|FG001|Overall Study|Enrolled but not evaluated|4|||
49048492|NCT02674386|158011394|FG002|Overall Study|Enrolled but not evaluated|0|||
49048493|NCT02462486|158011399|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
49048494|NCT02462486|158011400|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
49048495|NCT02462486|158011401|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|3|||
49048496|NCT02462486|158011399|FG000|Overall Study|Adverse Event|53|||
49048497|NCT02462486|158011400|FG001|Overall Study|Adverse Event|48|||
49048498|NCT02462486|158011401|FG002|Overall Study|Adverse Event|21|||
49048499|NCT02462486|158011399|FG000|Overall Study|Lack of Efficacy|6|||
49048500|NCT02462486|158011400|FG001|Overall Study|Lack of Efficacy|12|||
49048501|NCT02462486|158011401|FG002|Overall Study|Lack of Efficacy|3|||
49048502|NCT02462486|158011399|FG000|Overall Study|Lost to Follow-up|3|||
49048503|NCT02462486|158011400|FG001|Overall Study|Lost to Follow-up|4|||
49048504|NCT02462486|158011401|FG002|Overall Study|Lost to Follow-up|2|||
49048505|NCT02462486|158011399|FG000|Overall Study|Withdrawal by Subject|25|||
49048506|NCT02462486|158011400|FG001|Overall Study|Withdrawal by Subject|22|||
49048507|NCT02462486|158011401|FG002|Overall Study|Withdrawal by Subject|19|||
49048508|NCT02462486|158011399|FG000|Overall Study|Protocol Violation|3|||
49048509|NCT02462486|158011400|FG001|Overall Study|Protocol Violation|1|||
49048510|NCT02462486|158011401|FG002|Overall Study|Protocol Violation|1|||
49048511|NCT02462486|158011399|FG000|Overall Study|Reason not Specified|3|||
49048512|NCT02462486|158011400|FG001|Overall Study|Reason not Specified|4|||
49048513|NCT02462486|158011401|FG002|Overall Study|Reason not Specified|3|||
49048514|NCT00585312|158011402|FG000|Overall Study|Adverse Event|3|||
49048515|NCT00585312|158011403|FG001|Overall Study|Adverse Event|0|||
49048516|NCT00585312|158011402|FG000|Overall Study|Lack of Efficacy|6|||
49048517|NCT00585312|158011403|FG001|Overall Study|Lack of Efficacy|11|||
49048518|NCT00585312|158011402|FG000|Overall Study|Lost to Follow-up|1|||
49048519|NCT00585312|158011403|FG001|Overall Study|Lost to Follow-up|1|||
49048520|NCT00585312|158011402|FG000|Overall Study|Reason not specified|2|||
49048521|NCT00585312|158011403|FG001|Overall Study|Reason not specified|0|||
49048522|NCT00585312|158011402|FG000|Overall Study|Withdrawal by Subject|5|||
49048523|NCT00585312|158011403|FG001|Overall Study|Withdrawal by Subject|1|||
49048524|NCT00585312|158011402|FG000|Overall Study|Study terminated by the sponsor|34|||
49048525|NCT00585312|158011403|FG001|Overall Study|Study terminated by the sponsor|31|||
49048526|NCT00109850|158011410|FG000|Overall Study|Adverse Event|1|||
49048527|NCT00109850|158011410|FG000|Overall Study|Death|2|||
49048528|NCT00109850|158011410|FG000|Overall Study|Ineligible|1|||
49048529|NCT03430011|158011411|FG000|Pre-Treatment|Death|1|||
49048530|NCT03430011|158011412|FG001|Pre-Treatment|Death|0|||
49048531|NCT03430011|158011413|FG002|Pre-Treatment|Death|0|||
49048532|NCT03430011|158011414|FG003|Pre-Treatment|Death|0|||
49048533|NCT03430011|158011415|FG004|Pre-Treatment|Death|1|||
49048534|NCT03430011|158011416|FG005|Pre-Treatment|Death|0|||
49048535|NCT03430011|158011417|FG006|Pre-Treatment|Death|1|||
49048536|NCT03430011|158011418|FG007|Pre-Treatment|Death|0|||
49048537|NCT03430011|158011411|FG000|Pre-Treatment|Screen Fail|0|||
49048538|NCT03430011|158011412|FG001|Pre-Treatment|Screen Fail|0|||
49048539|NCT03430011|158011413|FG002|Pre-Treatment|Screen Fail|0|||
49048540|NCT03430011|158011414|FG003|Pre-Treatment|Screen Fail|0|||
49048541|NCT03430011|158011415|FG004|Pre-Treatment|Screen Fail|1|||
49048542|NCT03430011|158011416|FG005|Pre-Treatment|Screen Fail|0|||
49048543|NCT03430011|158011417|FG006|Pre-Treatment|Screen Fail|0|||
49048544|NCT03430011|158011418|FG007|Pre-Treatment|Screen Fail|0|||
49048545|NCT03430011|158011411|FG000|Pre-Treatment|No JCARH125 - disease related complications|0|||
49048546|NCT03430011|158011412|FG001|Pre-Treatment|No JCARH125 - disease related complications|0|||
49048547|NCT03430011|158011413|FG002|Pre-Treatment|No JCARH125 - disease related complications|1|||
49048548|NCT03430011|158011414|FG003|Pre-Treatment|No JCARH125 - disease related complications|0|||
49048549|NCT03430011|158011415|FG004|Pre-Treatment|No JCARH125 - disease related complications|0|||
49048550|NCT03430011|158011416|FG005|Pre-Treatment|No JCARH125 - disease related complications|0|||
49048551|NCT03430011|158011417|FG006|Pre-Treatment|No JCARH125 - disease related complications|0|||
49048552|NCT03430011|158011418|FG007|Pre-Treatment|No JCARH125 - disease related complications|0|||
49048553|NCT03430011|158011411|FG000|Pre-Treatment|Participant not eligible - other reasons|0|||
49048554|NCT03430011|158011412|FG001|Pre-Treatment|Participant not eligible - other reasons|0|||
49048555|NCT03430011|158011413|FG002|Pre-Treatment|Participant not eligible - other reasons|0|||
49048556|NCT03430011|158011414|FG003|Pre-Treatment|Participant not eligible - other reasons|1|||
49048557|NCT03430011|158011415|FG004|Pre-Treatment|Participant not eligible - other reasons|0|||
49048558|NCT03430011|158011416|FG005|Pre-Treatment|Participant not eligible - other reasons|0|||
49048559|NCT03430011|158011417|FG006|Pre-Treatment|Participant not eligible - other reasons|0|||
49048560|NCT03430011|158011418|FG007|Pre-Treatment|Participant not eligible - other reasons|0|||
49048561|NCT03430011|158011411|FG000|JCARH125 Treatment|Withdrawal by Subject|1|||
49048562|NCT03430011|158011412|FG001|JCARH125 Treatment|Withdrawal by Subject|1|||
49048563|NCT03430011|158011413|FG002|JCARH125 Treatment|Withdrawal by Subject|5|||
49048564|NCT03430011|158011414|FG003|JCARH125 Treatment|Withdrawal by Subject|5|||
49048565|NCT03430011|158011415|FG004|JCARH125 Treatment|Withdrawal by Subject|3|||
49048566|NCT03430011|158011416|FG005|JCARH125 Treatment|Withdrawal by Subject|4|||
49048567|NCT03430011|158011417|FG006|JCARH125 Treatment|Withdrawal by Subject|5|||
49048568|NCT03430011|158011418|FG007|JCARH125 Treatment|Withdrawal by Subject|3|||
49048569|NCT03430011|158011411|FG000|JCARH125 Treatment|Lost to Follow-up|0|||
49048570|NCT03430011|158011412|FG001|JCARH125 Treatment|Lost to Follow-up|1|||
49048571|NCT03430011|158011413|FG002|JCARH125 Treatment|Lost to Follow-up|0|||
49048572|NCT03430011|158011414|FG003|JCARH125 Treatment|Lost to Follow-up|0|||
49048573|NCT03430011|158011415|FG004|JCARH125 Treatment|Lost to Follow-up|1|||
49048574|NCT03430011|158011416|FG005|JCARH125 Treatment|Lost to Follow-up|0|||
49048575|NCT03430011|158011417|FG006|JCARH125 Treatment|Lost to Follow-up|1|||
49048576|NCT03430011|158011418|FG007|JCARH125 Treatment|Lost to Follow-up|0|||
49048577|NCT03430011|158011411|FG000|JCARH125 Treatment|Death|4|||
49048578|NCT03430011|158011412|FG001|JCARH125 Treatment|Death|19|||
49048579|NCT03430011|158011413|FG002|JCARH125 Treatment|Death|10|||
49048580|NCT03430011|158011414|FG003|JCARH125 Treatment|Death|8|||
49048581|NCT03430011|158011415|FG004|JCARH125 Treatment|Death|5|||
49048582|NCT03430011|158011416|FG005|JCARH125 Treatment|Death|3|||
49048583|NCT03430011|158011417|FG006|JCARH125 Treatment|Death|4|||
49048584|NCT03430011|158011418|FG007|JCARH125 Treatment|Death|2|||
49048585|NCT03430011|158011411|FG000|JCARH125 Treatment|Other reasons|1|||
49048586|NCT03430011|158011412|FG001|JCARH125 Treatment|Other reasons|0|||
49048587|NCT03430011|158011413|FG002|JCARH125 Treatment|Other reasons|4|||
49048588|NCT03430011|158011414|FG003|JCARH125 Treatment|Other reasons|2|||
49048589|NCT03430011|158011415|FG004|JCARH125 Treatment|Other reasons|2|||
49048590|NCT03430011|158011416|FG005|JCARH125 Treatment|Other reasons|1|||
49048591|NCT03430011|158011417|FG006|JCARH125 Treatment|Other reasons|3|||
49048592|NCT03430011|158011418|FG007|JCARH125 Treatment|Other reasons|2|||
49048593|NCT00402025|158011419|FG000|Overall Study|Adverse Event|0|||
49048594|NCT00402025|158011420|FG001|Overall Study|Adverse Event|0|||
49048595|NCT00402025|158011421|FG002|Overall Study|Adverse Event|2|||
49048596|NCT00402025|158011419|FG000|Overall Study|Death|0|||
49048597|NCT00402025|158011420|FG001|Overall Study|Death|1|||
49048598|NCT00402025|158011421|FG002|Overall Study|Death|5|||
49048599|NCT00402025|158011419|FG000|Overall Study|Disease Progression|1|||
49048600|NCT00402025|158011420|FG001|Overall Study|Disease Progression|1|||
49048601|NCT00402025|158011421|FG002|Overall Study|Disease Progression|2|||
49048602|NCT00402025|158011419|FG000|Overall Study|Physician Decision|1|||
49048603|NCT00402025|158011420|FG001|Overall Study|Physician Decision|1|||
49048604|NCT00402025|158011421|FG002|Overall Study|Physician Decision|0|||
49048605|NCT00402025|158011419|FG000|Overall Study|Participant Decision|0|||
49048606|NCT00402025|158011420|FG001|Overall Study|Participant Decision|0|||
49048607|NCT00402025|158011421|FG002|Overall Study|Participant Decision|1|||
49048608|NCT02310763|158011425|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
49048609|NCT02310763|158011426|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
49048610|NCT02310763|158011427|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
49048611|NCT02310763|158011425|FG000|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0|||
49048612|NCT02310763|158011426|FG001|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
49048613|NCT02310763|158011427|FG002|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
49048614|NCT02310763|158011425|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1|||
49048615|NCT02310763|158011426|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
49048616|NCT02310763|158011427|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
49048617|NCT02310763|158011425|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|1|||
49048618|NCT02310763|158011426|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
49048619|NCT02310763|158011427|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
49048620|NCT02310763|158011425|FG000|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
49048621|NCT02310763|158011426|FG001|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
49048622|NCT02310763|158011427|FG002|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
49048623|NCT02063217|158011428|FG000|Overall Study|Withdrawal by Subject|1|||
49048624|NCT02063217|158011429|FG001|Overall Study|Withdrawal by Subject|0|||
49048625|NCT02063217|158011430|FG002|Overall Study|Withdrawal by Subject|0|||
49048626|NCT00869440|158011432|FG000|Overall Study|Withdrawal by Subject|1|||
49048627|NCT00869440|158011433|FG001|Overall Study|Withdrawal by Subject|0|||
49048628|NCT00869440|158011434|FG002|Overall Study|Withdrawal by Subject|0|||
49048629|NCT00869440|158011435|FG003|Overall Study|Withdrawal by Subject|0|||
49048630|NCT00869440|158011432|FG000|Overall Study|Physician Decision|1|||
49048631|NCT00869440|158011433|FG001|Overall Study|Physician Decision|1|||
49048632|NCT00869440|158011434|FG002|Overall Study|Physician Decision|0|||
49048633|NCT00869440|158011435|FG003|Overall Study|Physician Decision|0|||
49048634|NCT01899326|158011436|FG000|Overall Study|Withdrawal by Subject|1|||
49048635|NCT01899326|158011436|FG000|Overall Study|Adverse Event|2|||
49048636|NCT01899326|158011436|FG000|Overall Study|Disease Relapse (patient with previously undiagnosed relapsing disease)|1|||
49048637|NCT03139240|158011437|FG000|Overall Study|Lost to Follow-up|0|||
49048638|NCT03139240|158011438|FG001|Overall Study|Lost to Follow-up|1|||
49048639|NCT03139240|158011439|FG002|Overall Study|Lost to Follow-up|1|||
49048640|NCT03139240|158011440|FG003|Overall Study|Lost to Follow-up|0|||
49048641|NCT00104247|158011450|FG000|Overall Study|Withdrawal by Subject|1|||
49048642|NCT00104247|158011451|FG001|Overall Study|Withdrawal by Subject|0|||
49048643|NCT00104247|158011450|FG000|Overall Study|Noncompliant with dosing|0|||
49048644|NCT00104247|158011451|FG001|Overall Study|Noncompliant with dosing|1|||
49048645|NCT01923311|158012902|FG000|Overall Study|Pregnancy|1|||
49048646|NCT01923311|158012903|FG001|Overall Study|Pregnancy|0|||
49048647|NCT01923311|158012902|FG000|Overall Study|Investigator's Discretion|1|||
49048648|NCT01923311|158012903|FG001|Overall Study|Investigator's Discretion|0|||
49048649|NCT01923311|158012902|FG000|Overall Study|Non-Compliance with Study Drug|2|||
49048650|NCT01923311|158012903|FG001|Overall Study|Non-Compliance with Study Drug|1|||
49048651|NCT01923311|158012902|FG000|Overall Study|Withdrew Consent|1|||
49048652|NCT01923311|158012903|FG001|Overall Study|Withdrew Consent|0|||
49048653|NCT01923311|158012902|FG000|Overall Study|Study Terminated by Sponsor|12|||
49048654|NCT01923311|158012903|FG001|Overall Study|Study Terminated by Sponsor|0|||
49048655|NCT02485158|158012904|FG000|Overall Study|Withdrawal by Subject|3|||
49048656|NCT02485158|158012904|FG000|Overall Study|expected drug side effect|1|||
49048657|NCT01662024|158012905|FG000|Overall Study|Pregnancy|2|||
49048658|NCT01662024|158012905|FG000|Overall Study|Withdrawal by Subject|3|||
49048659|NCT02031237|158012906|FG000|Overall Study|Death|1|||
49048660|NCT02031237|158012907|FG001|Overall Study|Death|5|||
49048661|NCT02031237|158012908|FG002|Overall Study|Death|0|||
49048662|NCT02031237|158012906|FG000|Overall Study|Physician Decision|0|||
49048663|NCT02031237|158012907|FG001|Overall Study|Physician Decision|1|||
49048664|NCT02031237|158012908|FG002|Overall Study|Physician Decision|0|||
49048665|NCT02031237|158012906|FG000|Overall Study|Withdrawal by Subject|2|||
49048666|NCT02031237|158012907|FG001|Overall Study|Withdrawal by Subject|2|||
49048667|NCT02031237|158012908|FG002|Overall Study|Withdrawal by Subject|0|||
49048668|NCT02031237|158012906|FG000|Overall Study|Protocol Violation|2|||
49048669|NCT02031237|158012907|FG001|Overall Study|Protocol Violation|6|||
49048670|NCT02031237|158012908|FG002|Overall Study|Protocol Violation|0|||
49048671|NCT02031237|158012906|FG000|Overall Study|Alternate Treatment Given|0|||
49048672|NCT02031237|158012907|FG001|Overall Study|Alternate Treatment Given|0|||
49048673|NCT02031237|158012908|FG002|Overall Study|Alternate Treatment Given|3|||
49048674|NCT04768296|158012910|FG000|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|1|||
49048675|NCT04768296|158012911|FG001|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|7|||
49048676|NCT02415387|158012912|FG000|Overall Study|Withdrawal by Subject|6|||
49048677|NCT02415387|158012913|FG001|Overall Study|Withdrawal by Subject|1|||
49048678|NCT02415387|158012912|FG000|Overall Study|blood draw problem|0|||
49048679|NCT02415387|158012913|FG001|Overall Study|blood draw problem|1|||
49048680|NCT02415387|158012912|FG000|Overall Study|Protocol Violation|1|||
49048681|NCT02415387|158012913|FG001|Overall Study|Protocol Violation|0|||
49048682|NCT03429049|158012914|FG000|Overall Study|Adverse Event|2|||
49048683|NCT03429049|158012915|FG001|Overall Study|Adverse Event|3|||
49048684|NCT03429049|158012914|FG000|Overall Study|Death|0|||
49048685|NCT03429049|158012915|FG001|Overall Study|Death|1|||
49048686|NCT03429049|158012914|FG000|Overall Study|Lack of Efficacy|4|||
49048687|NCT03429049|158012915|FG001|Overall Study|Lack of Efficacy|2|||
49048688|NCT03429049|158012914|FG000|Overall Study|Lost to Follow-up|9|||
49048689|NCT03429049|158012915|FG001|Overall Study|Lost to Follow-up|8|||
49048690|NCT03429049|158012914|FG000|Overall Study|Physician Decision|1|||
49048691|NCT03429049|158012915|FG001|Overall Study|Physician Decision|0|||
49048692|NCT03429049|158012914|FG000|Overall Study|Protocol Violation|3|||
49048693|NCT03429049|158012915|FG001|Overall Study|Protocol Violation|0|||
49048694|NCT03429049|158012914|FG000|Overall Study|Sponsor Decision|2|||
49048695|NCT03429049|158012915|FG001|Overall Study|Sponsor Decision|0|||
49048696|NCT03429049|158012914|FG000|Overall Study|Withdrawal by Subject|4|||
49048697|NCT03429049|158012915|FG001|Overall Study|Withdrawal by Subject|20|||
49048698|NCT03429049|158012914|FG000|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|3|||
49048699|NCT03429049|158012915|FG001|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|8|||
49048700|NCT02426541|158012920|FG000|Overall Study|Protocol Violation|1|||
49048701|NCT02426541|158012921|FG001|Overall Study|Protocol Violation|0|||
49048702|NCT00784979|158012922|FG000|Overall Study|incomplete data|6|||
49048703|NCT00894933|158012932|FG000|Overall Study|Lost to Follow-up|2|||
49048704|NCT00894933|158012932|FG000|Overall Study|Cancelled Procedure|1|||
49048705|NCT00894933|158012932|FG000|Overall Study|Did not meeting incl/excl criteria|1|||
49048706|NCT01867606|158012935|FG000|Overall Study|Withdrawal by Subject|10|||
49048707|NCT01867606|158012936|FG001|Overall Study|Withdrawal by Subject|14|||
49048708|NCT01867606|158012935|FG000|Overall Study|Protocol Violation|0|||
49048709|NCT01867606|158012936|FG001|Overall Study|Protocol Violation|1|||
49048710|NCT04252287|158012937|FG000|Overall Study|Death|5|||
49048711|NCT04252287|158012938|FG001|Overall Study|Death|3|||
49048712|NCT04252287|158012937|FG000|Overall Study|Lost to Follow-up|4|||
49048713|NCT04252287|158012938|FG001|Overall Study|Lost to Follow-up|6|||
49048714|NCT04252287|158012937|FG000|Overall Study|Withdrawal by Subject|19|||
49048715|NCT04252287|158012938|FG001|Overall Study|Withdrawal by Subject|16|||
49048716|NCT04252287|158012937|FG000|Overall Study|Protocol Violation|3|||
49048717|NCT04252287|158012938|FG001|Overall Study|Protocol Violation|4|||
49048718|NCT00440115|158012939|FG000|Overall Study|Death|7|||
49048719|NCT00440115|158012940|FG001|Overall Study|Death|9|||
49048720|NCT00440115|158012941|FG002|Overall Study|Death|5|||
49048721|NCT00440115|158012939|FG000|Overall Study|Incarceration|0|||
49048722|NCT00440115|158012940|FG001|Overall Study|Incarceration|2|||
49048723|NCT00440115|158012941|FG002|Overall Study|Incarceration|1|||
49048724|NCT01908205|158012942|FG000|Overall Study|Lost to Follow-up|2|||
49048725|NCT01908205|158012943|FG001|Overall Study|Lost to Follow-up|0|||
49048726|NCT01908205|158012942|FG000|Overall Study|Withdrawal by Subject|3|||
49048727|NCT01908205|158012943|FG001|Overall Study|Withdrawal by Subject|1|||
49048728|NCT00529217|158012945|FG000|Overall Study|Lack of Efficacy|2|||
49048729|NCT00529217|158012945|FG000|Overall Study|Unable to adhere to study schedule|2|||
49048730|NCT03507686|158012948|FG000|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|4|||
49048731|NCT03507686|158012949|FG001|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|0|||
49048732|NCT03507686|158012948|FG000|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|2|||
49048733|NCT03507686|158012949|FG001|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|0|||
49048734|NCT03507686|158012948|FG000|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|2|||
49048735|NCT03507686|158012949|FG001|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|0|||
49048736|NCT03507686|158012948|FG000|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|2|||
49048737|NCT03507686|158012949|FG001|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|0|||
49048738|NCT03507686|158012948|FG000|Treatment Period 2 (Month13 to Month24)|Death|0|||
49048739|NCT03507686|158012949|FG001|Treatment Period 2 (Month13 to Month24)|Death|1|||
49048740|NCT03507686|158012948|FG000|Treatment Period 2 (Month13 to Month24)|Reason not Specified|0|||
49048741|NCT03507686|158012949|FG001|Treatment Period 2 (Month13 to Month24)|Reason not Specified|2|||
49048742|NCT02056652|158012959|FG000|Overall Study|Withdrawal by Subject|1|||
49048743|NCT02056652|158012960|FG001|Overall Study|Withdrawal by Subject|0|||
49048744|NCT02056652|158012959|FG000|Overall Study|Lost to Follow-up|0|||
49048745|NCT02056652|158012960|FG001|Overall Study|Lost to Follow-up|3|||
49048746|NCT01857206|158012961|FG000|Overall Study|ADMINISTRATIVE REASON|0|||
49048747|NCT01857206|158012962|FG001|Overall Study|ADMINISTRATIVE REASON|1|||
49048748|NCT01857206|158012961|FG000|Overall Study|Lost to Follow-up|9|||
49048749|NCT01857206|158012962|FG001|Overall Study|Lost to Follow-up|6|||
49048750|NCT01857206|158012961|FG000|Overall Study|Unclassified|3|||
49048751|NCT01857206|158012962|FG001|Overall Study|Unclassified|3|||
49048752|NCT01857206|158012961|FG000|Overall Study|Withdrawal by Subject|1|||
49048753|NCT01857206|158012962|FG001|Overall Study|Withdrawal by Subject|0|||
49048754|NCT00476593|158012963|FG000|Overall Study|Lost to Follow-up|10|||
49048755|NCT00476593|158012964|FG001|Overall Study|Lost to Follow-up|2|||
49048756|NCT00476593|158012965|FG002|Overall Study|Lost to Follow-up|8|||
49048757|NCT00476593|158012966|FG003|Overall Study|Lost to Follow-up|22|||
49048758|NCT00889252|158012973|FG000|Overall Study|Adverse Event|2|||
49048759|NCT00889252|158012974|FG001|Overall Study|Adverse Event|4|||
49048760|NCT00889252|158012973|FG000|Overall Study|Withdrawal by Subject|3|||
49048761|NCT00889252|158012974|FG001|Overall Study|Withdrawal by Subject|0|||
49048762|NCT00889252|158012973|FG000|Overall Study|Protocol Violation|2|||
49048763|NCT00889252|158012974|FG001|Overall Study|Protocol Violation|0|||
49048764|NCT00330460|158012978|FG000|Overall Study|Physician Decision|1|||
49048765|NCT00330460|158012979|FG001|Overall Study|Physician Decision|0|||
49048766|NCT00330460|158012978|FG000|Overall Study|Adverse Event|10|||
49048767|NCT00330460|158012979|FG001|Overall Study|Adverse Event|8|||
49048768|NCT00330460|158012978|FG000|Overall Study|Withdrawal by Subject|18|||
49048769|NCT00330460|158012979|FG001|Overall Study|Withdrawal by Subject|17|||
49048770|NCT00330460|158012978|FG000|Overall Study|Death|1|||
49048771|NCT00330460|158012979|FG001|Overall Study|Death|1|||
49048772|NCT00330460|158012978|FG000|Overall Study|Ineligibility determined|1|||
49048773|NCT00330460|158012979|FG001|Overall Study|Ineligibility determined|3|||
49048774|NCT00330460|158012978|FG000|Overall Study|Lost to Follow-up|8|||
49048775|NCT00330460|158012979|FG001|Overall Study|Lost to Follow-up|3|||
49048776|NCT00330460|158012978|FG000|Overall Study|Noncompliance|2|||
49048777|NCT00330460|158012979|FG001|Overall Study|Noncompliance|1|||
49048778|NCT00330460|158012978|FG000|Overall Study|Other|1|||
49048779|NCT00330460|158012979|FG001|Overall Study|Other|0|||
49048780|NCT00089076|158012980|FG000|Overall Study|Alternate Therapy|1|||
49048781|NCT00089076|158012980|FG000|Overall Study|Withdrawal by Subject|2|||
49048782|NCT00089076|158012980|FG000|Overall Study|Progression|7|||
49048783|NCT02413294|158012985|FG000|Overall Study|Withdrawal by Subject|1|||
49048784|NCT01857973|158012986|FG000|Overall Study|Subject did not meet required BG range|3|||
49048785|NCT01857973|158012986|FG000|Overall Study|drop out after 3 failed attempts|1|||
49048786|NCT01857973|158012986|FG000|Overall Study|Physician Decision|1|||
49048787|NCT02663882|158012989|FG000|Overall Study|Lost to Follow-up|4|||
49048788|NCT02663882|158012990|FG001|Overall Study|Lost to Follow-up|2|||
49048789|NCT05444543|158012993|FG000|Overall Study|Withdrawal by Subject|1|||
49048790|NCT05444543|158012994|FG001|Overall Study|Withdrawal by Subject|0|||
49048791|NCT05444543|158012993|FG000|Overall Study|Failed to achieve initial remission on therapy|1|||
49048792|NCT05444543|158012994|FG001|Overall Study|Failed to achieve initial remission on therapy|0|||
49048793|NCT05444543|158012993|FG000|Overall Study|Adverse Event|0|||
49048794|NCT05444543|158012994|FG001|Overall Study|Adverse Event|1|||
49048795|NCT05444543|158012993|FG000|Overall Study|Family relocating at a distance from study site|0|||
49048796|NCT05444543|158012994|FG001|Overall Study|Family relocating at a distance from study site|1|||
49048797|NCT03712124|158012995|FG000|Overall Study|Protocol Violation|1|||
49048798|NCT03712124|158012996|FG001|Overall Study|Protocol Violation|0|||
49048799|NCT01040793|158013000|FG000|Overall Study|Adverse Event|5|||
49048800|NCT01040793|158013001|FG001|Overall Study|Adverse Event|3|||
49048801|NCT01040793|158013002|FG002|Overall Study|Adverse Event|0|||
49048802|NCT01040793|158013003|FG003|Overall Study|Adverse Event|2|||
49048803|NCT01040793|158013004|FG004|Overall Study|Adverse Event|2|||
49048804|NCT01040793|158013005|FG005|Overall Study|Adverse Event|1|||
49048805|NCT01040793|158013000|FG000|Overall Study|Protocol Violation|1|||
49048806|NCT01040793|158013001|FG001|Overall Study|Protocol Violation|1|||
49048807|NCT01040793|158013002|FG002|Overall Study|Protocol Violation|1|||
49048808|NCT01040793|158013003|FG003|Overall Study|Protocol Violation|0|||
49048809|NCT01040793|158013004|FG004|Overall Study|Protocol Violation|1|||
49048810|NCT01040793|158013005|FG005|Overall Study|Protocol Violation|0|||
49048811|NCT01040793|158013000|FG000|Overall Study|Lost to Follow-up|0|||
49048812|NCT01040793|158013001|FG001|Overall Study|Lost to Follow-up|1|||
49048813|NCT01040793|158013002|FG002|Overall Study|Lost to Follow-up|1|||
49048814|NCT01040793|158013003|FG003|Overall Study|Lost to Follow-up|0|||
49048815|NCT01040793|158013004|FG004|Overall Study|Lost to Follow-up|0|||
49048816|NCT01040793|158013005|FG005|Overall Study|Lost to Follow-up|0|||
49048817|NCT01040793|158013000|FG000|Overall Study|Withdrawal by Subject|0|||
49048818|NCT01040793|158013001|FG001|Overall Study|Withdrawal by Subject|0|||
49048819|NCT01040793|158013002|FG002|Overall Study|Withdrawal by Subject|0|||
49048820|NCT01040793|158013003|FG003|Overall Study|Withdrawal by Subject|2|||
49048821|NCT01040793|158013004|FG004|Overall Study|Withdrawal by Subject|0|||
49048822|NCT01040793|158013005|FG005|Overall Study|Withdrawal by Subject|0|||
49048823|NCT01040793|158013000|FG000|Overall Study|Other reasons not listed above|0|||
49048824|NCT01040793|158013001|FG001|Overall Study|Other reasons not listed above|0|||
49048825|NCT01040793|158013002|FG002|Overall Study|Other reasons not listed above|1|||
49048826|NCT01040793|158013003|FG003|Overall Study|Other reasons not listed above|0|||
49048827|NCT01040793|158013004|FG004|Overall Study|Other reasons not listed above|1|||
49048828|NCT01040793|158013005|FG005|Overall Study|Other reasons not listed above|0|||
49048829|NCT00388037|158013006|FG000|Overall Study|Protocol Violation|1|||
49048830|NCT00602537|158013009|FG000|12 Week Double Blind Comparison|Adverse Event|2|||
49048831|NCT00602537|158013010|FG001|12 Week Double Blind Comparison|Adverse Event|5|||
49048832|NCT00602537|158013009|FG000|12 Week Double Blind Comparison|Lack of Efficacy|13|||
49048833|NCT00602537|158013010|FG001|12 Week Double Blind Comparison|Lack of Efficacy|23|||
49048834|NCT00602537|158013009|FG000|12 Week Double Blind Comparison|Lost to Follow-up|5|||
49048835|NCT00602537|158013010|FG001|12 Week Double Blind Comparison|Lost to Follow-up|6|||
49048836|NCT00602537|158013009|FG000|12 Week Double Blind Comparison|Withdrawal by Subject|3|||
49048837|NCT00602537|158013010|FG001|12 Week Double Blind Comparison|Withdrawal by Subject|13|||
49048838|NCT00602537|158013009|FG000|Follow Up Study Comparison|Adverse Event|1|||
49048839|NCT00602537|158013010|FG001|Follow Up Study Comparison|Adverse Event|0|||
49048840|NCT00602537|158013009|FG000|Follow Up Study Comparison|Lost to Follow-up|8|||
49048841|NCT00602537|158013010|FG001|Follow Up Study Comparison|Lost to Follow-up|1|||
49048842|NCT00602537|158013009|FG000|Follow Up Study Comparison|Withdrawal by Subject|2|||
49048843|NCT00602537|158013010|FG001|Follow Up Study Comparison|Withdrawal by Subject|2|||
49048844|NCT02094261|158013011|FG000|Overall Study|Death|24|||
49048845|NCT02094261|158013011|FG000|Overall Study|Lost to Follow-up|1|||
49048846|NCT02094261|158013011|FG000|Overall Study|Withdrawal by Subject|4|||
49048847|NCT02094261|158013011|FG000|Overall Study|Ongoing Study at Data Cut-off|181|||
49048848|NCT00885677|158013012|FG000|Overall Study|Death|40|||
49048849|NCT00885677|158013013|FG001|Overall Study|Death|34|||
49048850|NCT00885677|158013012|FG000|Overall Study|Lost to Follow-up|15|||
49048851|NCT00885677|158013013|FG001|Overall Study|Lost to Follow-up|13|||
49048852|NCT00885677|158013012|FG000|Overall Study|Protocol Violation|54|||
49048853|NCT00885677|158013013|FG001|Overall Study|Protocol Violation|54|||
49048854|NCT00885677|158013012|FG000|Overall Study|premature study closure|41|||
49048855|NCT00885677|158013013|FG001|Overall Study|premature study closure|44|||
49048856|NCT00885677|158013012|FG000|Overall Study|device/lead revision or replacement|7|||
49048857|NCT00885677|158013013|FG001|Overall Study|device/lead revision or replacement|6|||
49048858|NCT00885677|158013012|FG000|Overall Study|Heart transplantation|1|||
49048859|NCT00885677|158013013|FG001|Overall Study|Heart transplantation|0|||
49048860|NCT00885677|158013012|FG000|Overall Study|Inclusion/exclusion not met|25|||
49048861|NCT00885677|158013013|FG001|Overall Study|Inclusion/exclusion not met|27|||
49048862|NCT04314843|158013014|FG000|Overall Study|Death|2|||
49048863|NCT04314843|158013015|FG001|Overall Study|Death|2|||
49048864|NCT04314843|158013014|FG000|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
49048865|NCT04314843|158013015|FG001|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
49048866|NCT01020526|158013016|FG000|Overall Study|Withdrawal by Subject|5|||
49048867|NCT01020526|158013016|FG000|Overall Study|Other reasons|3|||
49048868|NCT01020526|158013016|FG000|Overall Study|Insufficient clinical response|3|||
49048869|NCT01020526|158013016|FG000|Overall Study|Lost to Follow-up|1|||
49048870|NCT01020526|158013016|FG000|Overall Study|Adverse Event|2|||
49048871|NCT01644149|158013021|FG000|Overall Study|Withdrawal by Subject|1|||
49048872|NCT01644149|158013022|FG001|Overall Study|Withdrawal by Subject|0|||
49048873|NCT01644149|158013021|FG000|Overall Study|Lost to Follow-up|3|||
49048874|NCT01644149|158013022|FG001|Overall Study|Lost to Follow-up|1|||
49048875|NCT02148445|158013036|FG000|Overall Study|Death|1|||
49048876|NCT02148445|158013037|FG001|Overall Study|Death|3|||
49048877|NCT00810602|158013045|FG000|Overall Study|Withdrawal by Subject|8|||
49048878|NCT00810602|158013046|FG001|Overall Study|Withdrawal by Subject|3|||
49048879|NCT00442546|158013047|FG000|Overall Study|Adverse Event|11|||
49048880|NCT00442546|158013048|FG001|Overall Study|Adverse Event|17|||
49048881|NCT00442546|158013049|FG002|Overall Study|Adverse Event|13|||
49048882|NCT00442546|158013047|FG000|Overall Study|Lost to Follow-up|1|||
49048883|NCT00442546|158013048|FG001|Overall Study|Lost to Follow-up|2|||
49048884|NCT00442546|158013049|FG002|Overall Study|Lost to Follow-up|1|||
49048885|NCT00442546|158013047|FG000|Overall Study|Other|4|||
49048886|NCT00442546|158013048|FG001|Overall Study|Other|9|||
49048887|NCT00442546|158013049|FG002|Overall Study|Other|6|||
49048888|NCT00442546|158013047|FG000|Overall Study|Withdrawal by Subject|5|||
49048889|NCT00442546|158013048|FG001|Overall Study|Withdrawal by Subject|5|||
49048890|NCT00442546|158013049|FG002|Overall Study|Withdrawal by Subject|7|||
49048891|NCT00442546|158013047|FG000|Overall Study|Randomized But Not Treated|5|||
49048892|NCT00442546|158013048|FG001|Overall Study|Randomized But Not Treated|4|||
49048893|NCT00442546|158013049|FG002|Overall Study|Randomized But Not Treated|6|||
49048894|NCT02293460|158015193|FG000|Overall Study|Protocol Violation|1|||
49048895|NCT02293460|158015193|FG000|Overall Study|Lack of Efficacy|2|||
49048896|NCT02293460|158015193|FG000|Overall Study|Adverse Event|2|||
49048897|NCT02293460|158015193|FG000|Overall Study|Withdrawal by Subject|1|||
49048898|NCT00500318|158015195|FG000|Overall Study|Adverse Event|3|||
49048899|NCT00500318|158015196|FG001|Overall Study|Adverse Event|8|||
49048900|NCT00500318|158015195|FG000|Overall Study|Protocol Violation|1|||
49048901|NCT00500318|158015196|FG001|Overall Study|Protocol Violation|3|||
49048902|NCT00500318|158015195|FG000|Overall Study|Withdrawal by Subject|1|||
49048903|NCT00500318|158015196|FG001|Overall Study|Withdrawal by Subject|2|||
49048904|NCT00500318|158015195|FG000|Overall Study|Lack of Efficacy|0|||
49048905|NCT00500318|158015196|FG001|Overall Study|Lack of Efficacy|3|||
49048906|NCT00500318|158015195|FG000|Overall Study|Other Reason|0|||
49048907|NCT00500318|158015196|FG001|Overall Study|Other Reason|1|||
49048908|NCT01074008|158015206|FG000|Overall Study|Adverse Event|0|||
49048909|NCT01074008|158015207|FG001|Overall Study|Adverse Event|1|||
49048910|NCT01074008|158015208|FG002|Overall Study|Adverse Event|0|||
49048911|NCT01074008|158015209|FG003|Overall Study|Adverse Event|0|||
49048912|NCT01074008|158015210|FG004|Overall Study|Adverse Event|0|||
49048913|NCT01074008|158015211|FG005|Overall Study|Adverse Event|0|||
49048914|NCT01074008|158015212|FG006|Overall Study|Adverse Event|0|||
49048915|NCT01074008|158015213|FG007|Overall Study|Adverse Event|0|||
49048916|NCT01074008|158015214|FG008|Overall Study|Adverse Event|0|||
49048917|NCT01074008|158015206|FG000|Overall Study|Withdrawal by Subject|1|||
49048918|NCT01074008|158015207|FG001|Overall Study|Withdrawal by Subject|1|||
49048919|NCT01074008|158015208|FG002|Overall Study|Withdrawal by Subject|1|||
49048920|NCT01074008|158015209|FG003|Overall Study|Withdrawal by Subject|0|||
49048921|NCT01074008|158015210|FG004|Overall Study|Withdrawal by Subject|1|||
49048922|NCT01074008|158015211|FG005|Overall Study|Withdrawal by Subject|0|||
49048923|NCT01074008|158015212|FG006|Overall Study|Withdrawal by Subject|0|||
49048924|NCT01074008|158015213|FG007|Overall Study|Withdrawal by Subject|0|||
49048925|NCT01074008|158015214|FG008|Overall Study|Withdrawal by Subject|0|||
49048926|NCT01074008|158015206|FG000|Overall Study|Lost to Follow-up|0|||
49048927|NCT01074008|158015207|FG001|Overall Study|Lost to Follow-up|1|||
49048928|NCT01074008|158015208|FG002|Overall Study|Lost to Follow-up|1|||
49048929|NCT01074008|158015209|FG003|Overall Study|Lost to Follow-up|1|||
49048930|NCT01074008|158015210|FG004|Overall Study|Lost to Follow-up|1|||
49048931|NCT01074008|158015211|FG005|Overall Study|Lost to Follow-up|0|||
49048932|NCT01074008|158015212|FG006|Overall Study|Lost to Follow-up|1|||
49048933|NCT01074008|158015213|FG007|Overall Study|Lost to Follow-up|0|||
49048934|NCT01074008|158015214|FG008|Overall Study|Lost to Follow-up|4|||
49048935|NCT02805309|158015217|FG000|Overall Study|Lost to Follow-up|2|||
49048936|NCT02805309|158015218|FG001|Overall Study|Lost to Follow-up|2|||
49048937|NCT02805309|158015219|FG002|Overall Study|Lost to Follow-up|2|||
49048938|NCT02805309|158015217|FG000|Overall Study|Post-Randomization Exclusion|0|||
49048939|NCT02805309|158015218|FG001|Overall Study|Post-Randomization Exclusion|2|||
49048940|NCT02805309|158015219|FG002|Overall Study|Post-Randomization Exclusion|1|||
49048941|NCT01453153|158015224|FG000|Overall Study|Physician Decision|0|||
49048942|NCT01453153|158015225|FG001|Overall Study|Physician Decision|0|||
49048943|NCT01453153|158015226|FG002|Overall Study|Physician Decision|1|||
49048944|NCT01453153|158015224|FG000|Overall Study|Progressive Disease|3|||
49048945|NCT01453153|158015225|FG001|Overall Study|Progressive Disease|2|||
49048946|NCT01453153|158015226|FG002|Overall Study|Progressive Disease|16|||
49048947|NCT01453153|158015224|FG000|Overall Study|Withdrawal by Subject|0|||
49048948|NCT01453153|158015225|FG001|Overall Study|Withdrawal by Subject|1|||
49048949|NCT01453153|158015226|FG002|Overall Study|Withdrawal by Subject|2|||
49048950|NCT01453153|158015224|FG000|Overall Study|Adverse Event|1|||
49048951|NCT01453153|158015225|FG001|Overall Study|Adverse Event|1|||
49048952|NCT01453153|158015226|FG002|Overall Study|Adverse Event|1|||
49048953|NCT01813435|158015229|FG000|Overall Study|did not finish experimental regimen|1902|||
49048954|NCT01813435|158015230|FG001|Overall Study|did not finish experimental regimen|770|||
49048955|NCT01813435|158015229|FG000|Overall Study|Lost to Follow-up|268|||
49048956|NCT01813435|158015230|FG001|Overall Study|Lost to Follow-up|237|||
49048957|NCT03941834|158015236|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
49048958|NCT03941834|158015237|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|1|||
49048959|NCT03941834|158015238|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
49048960|NCT03941834|158015236|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|1|||
49048961|NCT03941834|158015237|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
49048962|NCT03941834|158015238|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
49048963|NCT03941834|158015236|FG000|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
49048964|NCT03941834|158015237|FG001|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
49048965|NCT03941834|158015238|FG002|OLE Phase (12 Weeks)|Study terminated by sponsor|1|||
49048966|NCT03941834|158015236|FG000|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
49048967|NCT03941834|158015237|FG001|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
49048968|NCT03941834|158015238|FG002|OLE Phase (12 Weeks)|Lack of Efficacy|1|||
49048969|NCT03941834|158015236|FG000|OLE Phase (12 Weeks)|Sponsor decision|0|||
49048970|NCT03941834|158015237|FG001|OLE Phase (12 Weeks)|Sponsor decision|0|||
49048971|NCT03941834|158015238|FG002|OLE Phase (12 Weeks)|Sponsor decision|1|||
49048972|NCT03941834|158015236|FG000|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
49048973|NCT03941834|158015237|FG001|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
49048974|NCT03941834|158015238|FG002|OLE Phase (12 Weeks)|Withdrawal by Subject|1|||
49048975|NCT01560819|158015239|FG000|Overall Study|Physician Decision|1|||
49048976|NCT01560819|158015240|FG001|Overall Study|Physician Decision|0|||
49048977|NCT00631007|158015246|FG000|Overall Study|Adverse Event|0|||
49048978|NCT00631007|158015247|FG001|Overall Study|Adverse Event|2|||
49048979|NCT00631007|158015248|FG002|Overall Study|Adverse Event|0|||
49048980|NCT00631007|158015249|FG003|Overall Study|Adverse Event|2|||
49048981|NCT00631007|158015250|FG004|Overall Study|Adverse Event|3|||
49048982|NCT00631007|158015251|FG005|Overall Study|Adverse Event|2|||
49048983|NCT00631007|158015246|FG000|Overall Study|Lost to Follow-up|2|||
49048984|NCT00631007|158015247|FG001|Overall Study|Lost to Follow-up|1|||
49048985|NCT00631007|158015248|FG002|Overall Study|Lost to Follow-up|2|||
49048986|NCT00631007|158015249|FG003|Overall Study|Lost to Follow-up|4|||
49048987|NCT00631007|158015250|FG004|Overall Study|Lost to Follow-up|5|||
49048988|NCT00631007|158015251|FG005|Overall Study|Lost to Follow-up|3|||
49048989|NCT00631007|158015246|FG000|Overall Study|Physician Decision|1|||
49048990|NCT00631007|158015247|FG001|Overall Study|Physician Decision|0|||
49048991|NCT00631007|158015248|FG002|Overall Study|Physician Decision|1|||
49048992|NCT00631007|158015249|FG003|Overall Study|Physician Decision|0|||
49048993|NCT00631007|158015250|FG004|Overall Study|Physician Decision|0|||
49048994|NCT00631007|158015251|FG005|Overall Study|Physician Decision|2|||
49048995|NCT00631007|158015246|FG000|Overall Study|Persistent Hyperglycemia|2|||
49048996|NCT00631007|158015247|FG001|Overall Study|Persistent Hyperglycemia|2|||
49048997|NCT00631007|158015248|FG002|Overall Study|Persistent Hyperglycemia|5|||
49048998|NCT00631007|158015249|FG003|Overall Study|Persistent Hyperglycemia|1|||
49048999|NCT00631007|158015250|FG004|Overall Study|Persistent Hyperglycemia|2|||
49049000|NCT00631007|158015251|FG005|Overall Study|Persistent Hyperglycemia|5|||
49049001|NCT00631007|158015246|FG000|Overall Study|Withdrawal by Subject|4|||
49049002|NCT00631007|158015247|FG001|Overall Study|Withdrawal by Subject|5|||
49049003|NCT00631007|158015248|FG002|Overall Study|Withdrawal by Subject|2|||
49049004|NCT00631007|158015249|FG003|Overall Study|Withdrawal by Subject|2|||
49049005|NCT00631007|158015250|FG004|Overall Study|Withdrawal by Subject|1|||
49049006|NCT00631007|158015251|FG005|Overall Study|Withdrawal by Subject|3|||
49049007|NCT00631007|158015246|FG000|Overall Study|Other|2|||
49049008|NCT00631007|158015247|FG001|Overall Study|Other|1|||
49049009|NCT00631007|158015248|FG002|Overall Study|Other|0|||
49049010|NCT00631007|158015249|FG003|Overall Study|Other|0|||
49049011|NCT00631007|158015250|FG004|Overall Study|Other|1|||
49049012|NCT00631007|158015251|FG005|Overall Study|Other|0|||
49049013|NCT00683787|158015252|FG000|Overall Study|Progression|3|||
49049014|NCT00683787|158015253|FG001|Overall Study|Progression|3|||
49049015|NCT00683787|158015254|FG002|Overall Study|Progression|0|||
49049016|NCT00683787|158015252|FG000|Overall Study|Adverse Event|0|||
49049017|NCT00683787|158015253|FG001|Overall Study|Adverse Event|0|||
49049018|NCT00683787|158015254|FG002|Overall Study|Adverse Event|2|||
49049019|NCT04167618|158015255|FG000|Overall Study|Trial terminated by sponsor|1|||
49049020|NCT04167618|158015256|FG001|Overall Study|Trial terminated by sponsor|1|||
49049021|NCT01235715|158015257|FG000|Overall Study|Physician Decision|0|||
49049022|NCT01235715|158015258|FG001|Overall Study|Physician Decision|2|||
49049023|NCT02994394|158015259|FG000|Period 1 (Days 1 to 3)|Adverse Event|0|||
49049024|NCT02994394|158015260|FG001|Period 1 (Days 1 to 3)|Adverse Event|0|||
49049025|NCT02994394|158015261|FG002|Period 1 (Days 1 to 3)|Adverse Event|1|||
49049026|NCT02994394|158015262|FG003|Period 1 (Days 1 to 3)|Adverse Event|0|||
49049027|NCT02994394|158015263|FG004|Period 1 (Days 1 to 3)|Adverse Event|0|||
49049028|NCT02994394|158015264|FG005|Period 1 (Days 1 to 3)|Adverse Event|0|||
49049029|NCT02994394|158015259|FG000|Period 2 (Days 4 to 6)|Adverse Event|0|||
49049030|NCT02994394|158015260|FG001|Period 2 (Days 4 to 6)|Adverse Event|1|||
49049031|NCT02994394|158015261|FG002|Period 2 (Days 4 to 6)|Adverse Event|0|||
49049032|NCT02994394|158015262|FG003|Period 2 (Days 4 to 6)|Adverse Event|0|||
49049033|NCT02994394|158015263|FG004|Period 2 (Days 4 to 6)|Adverse Event|1|||
49049034|NCT02994394|158015264|FG005|Period 2 (Days 4 to 6)|Adverse Event|0|||
49049035|NCT03619876|158015265|FG000|Overall Study|Withdrawal by Subject|1|||
49049036|NCT03619876|158015266|FG001|Overall Study|Withdrawal by Subject|2|||
49049037|NCT03619876|158015265|FG000|Overall Study|Withdrawal due to incidental finding|0|||
49049038|NCT03619876|158015266|FG001|Overall Study|Withdrawal due to incidental finding|2|||
49049039|NCT01396421|158015267|FG000|Overall Study|Lost to Follow-up|0|||
49049040|NCT01396421|158015268|FG001|Overall Study|Lost to Follow-up|0|||
49049041|NCT01396421|158015269|FG002|Overall Study|Lost to Follow-up|0|||
49049042|NCT01396421|158015270|FG003|Overall Study|Lost to Follow-up|1|||
49049043|NCT01396421|158015267|FG000|Overall Study|Adverse Event|17|||
49049044|NCT01396421|158015268|FG001|Overall Study|Adverse Event|15|||
49049045|NCT01396421|158015269|FG002|Overall Study|Adverse Event|12|||
49049046|NCT01396421|158015270|FG003|Overall Study|Adverse Event|32|||
49049047|NCT01396421|158015267|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
49049048|NCT01396421|158015268|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
49049049|NCT01396421|158015269|FG002|Overall Study|Participant Met Withdrawal Criteria|1|||
49049050|NCT01396421|158015270|FG003|Overall Study|Participant Met Withdrawal Criteria|0|||
49049051|NCT01396421|158015267|FG000|Overall Study|Physician Decision|1|||
49049052|NCT01396421|158015268|FG001|Overall Study|Physician Decision|1|||
49049053|NCT01396421|158015269|FG002|Overall Study|Physician Decision|0|||
49049054|NCT01396421|158015270|FG003|Overall Study|Physician Decision|3|||
49049055|NCT01396421|158015267|FG000|Overall Study|Withdrawal by Subject|31|||
49049056|NCT01396421|158015268|FG001|Overall Study|Withdrawal by Subject|24|||
49049057|NCT01396421|158015269|FG002|Overall Study|Withdrawal by Subject|13|||
49049058|NCT01396421|158015270|FG003|Overall Study|Withdrawal by Subject|21|||
49049059|NCT01396421|158015267|FG000|Overall Study|Protocol Deviation|2|||
49049060|NCT01396421|158015268|FG001|Overall Study|Protocol Deviation|1|||
49049061|NCT01396421|158015269|FG002|Overall Study|Protocol Deviation|1|||
49049062|NCT01396421|158015270|FG003|Overall Study|Protocol Deviation|0|||
49049063|NCT01396421|158015267|FG000|Overall Study|Lack of Efficacy|7|||
49049064|NCT01396421|158015268|FG001|Overall Study|Lack of Efficacy|17|||
49049065|NCT01396421|158015269|FG002|Overall Study|Lack of Efficacy|7|||
49049066|NCT01396421|158015270|FG003|Overall Study|Lack of Efficacy|18|||
49049067|NCT02576717|158015271|FG000|Overall Study|Other Reasons|16|||
49049068|NCT02576717|158015272|FG001|Overall Study|Other Reasons|18|||
49049069|NCT02576717|158015273|FG002|Overall Study|Other Reasons|15|||
49049070|NCT02576717|158015271|FG000|Overall Study|Covid-19 Pandemic|0|||
49049071|NCT02576717|158015272|FG001|Overall Study|Covid-19 Pandemic|1|||
49049072|NCT02576717|158015273|FG002|Overall Study|Covid-19 Pandemic|1|||
49049073|NCT02576717|158015271|FG000|Overall Study|Sponsor Decision|0|||
49049074|NCT02576717|158015272|FG001|Overall Study|Sponsor Decision|0|||
49049075|NCT02576717|158015273|FG002|Overall Study|Sponsor Decision|1|||
49049076|NCT02576717|158015271|FG000|Overall Study|Physician Decision|3|||
49049077|NCT02576717|158015272|FG001|Overall Study|Physician Decision|8|||
49049078|NCT02576717|158015273|FG002|Overall Study|Physician Decision|9|||
49049079|NCT02576717|158015271|FG000|Overall Study|Participant Voluntarily Withdrew from Study|91|||
49049080|NCT02576717|158015272|FG001|Overall Study|Participant Voluntarily Withdrew from Study|82|||
49049081|NCT02576717|158015273|FG002|Overall Study|Participant Voluntarily Withdrew from Study|85|||
49049082|NCT02576717|158015271|FG000|Overall Study|Death|3|||
49049083|NCT02576717|158015272|FG001|Overall Study|Death|5|||
49049084|NCT02576717|158015273|FG002|Overall Study|Death|3|||
49049085|NCT02576717|158015271|FG000|Overall Study|Lost to Follow-up|9|||
49049086|NCT02576717|158015272|FG001|Overall Study|Lost to Follow-up|10|||
49049087|NCT02576717|158015273|FG002|Overall Study|Lost to Follow-up|19|||
49049088|NCT02576717|158015271|FG000|Overall Study|Protocol Violation|4|||
49049089|NCT02576717|158015272|FG001|Overall Study|Protocol Violation|0|||
49049090|NCT02576717|158015273|FG002|Overall Study|Protocol Violation|5|||
49049091|NCT02576717|158015271|FG000|Overall Study|Lack of Efficacy|24|||
49049092|NCT02576717|158015272|FG001|Overall Study|Lack of Efficacy|28|||
49049093|NCT02576717|158015273|FG002|Overall Study|Lack of Efficacy|20|||
49049094|NCT02576717|158015271|FG000|Overall Study|Adverse Event|26|||
49049095|NCT02576717|158015272|FG001|Overall Study|Adverse Event|32|||
49049096|NCT02576717|158015273|FG002|Overall Study|Adverse Event|26|||
49049097|NCT01755975|158015274|FG000|Overall Study|Adverse Event|0|||
49049098|NCT01755975|158015275|FG001|Overall Study|Adverse Event|0|||
49049099|NCT01755975|158015276|FG002|Overall Study|Adverse Event|1|||
49049100|NCT01755975|158015277|FG003|Overall Study|Adverse Event|0|||
49049101|NCT01755975|158015278|FG004|Overall Study|Adverse Event|2|||
49049102|NCT01999894|158015279|FG000|Overall Study|Adverse Event|9|||
49049103|NCT01999894|158015279|FG000|Overall Study|Lack of Efficacy|5|||
49049104|NCT01999894|158015279|FG000|Overall Study|Protocol Violation|1|||
49049105|NCT01999894|158015279|FG000|Overall Study|Withdrawal by Subject|7|||
49049106|NCT01999894|158015279|FG000|Overall Study|Lost to Follow-up|10|||
49049107|NCT01999894|158015279|FG000|Overall Study|Other Reason|3|||
49049108|NCT01999894|158015279|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
49049109|NCT01098110|158015280|FG000|Overall Study|Withdrawal by Subject|14|||
49049110|NCT01098110|158015281|FG001|Overall Study|Withdrawal by Subject|24|||
49049111|NCT01098110|158015282|FG002|Overall Study|Withdrawal by Subject|19|||
49049112|NCT01098110|158015280|FG000|Overall Study|Adverse Event|30|||
49049113|NCT01098110|158015281|FG001|Overall Study|Adverse Event|32|||
49049114|NCT01098110|158015282|FG002|Overall Study|Adverse Event|43|||
49049115|NCT01098110|158015280|FG000|Overall Study|Lack of Efficacy|13|||
49049116|NCT01098110|158015281|FG001|Overall Study|Lack of Efficacy|9|||
49049117|NCT01098110|158015282|FG002|Overall Study|Lack of Efficacy|27|||
49049118|NCT01098110|158015280|FG000|Overall Study|Other|4|||
49049119|NCT01098110|158015281|FG001|Overall Study|Other|7|||
49049120|NCT01098110|158015282|FG002|Overall Study|Other|5|||
49049121|NCT01098110|158015280|FG000|Overall Study|Untreated|1|||
49049122|NCT01098110|158015281|FG001|Overall Study|Untreated|1|||
49049123|NCT01098110|158015282|FG002|Overall Study|Untreated|0|||
49049124|NCT02147587|158015283|FG000|Overall Study|Adverse Event|9|||
49049125|NCT02147587|158015284|FG001|Overall Study|Adverse Event|4|||
49049126|NCT02147587|158015283|FG000|Overall Study|Lack of Efficacy|2|||
49049127|NCT02147587|158015284|FG001|Overall Study|Lack of Efficacy|1|||
49049128|NCT01546519|158015286|FG000|Overall Study|Adverse Event|0|||
49049129|NCT01546519|158015287|FG001|Overall Study|Adverse Event|0|||
49049130|NCT01546519|158015288|FG002|Overall Study|Adverse Event|1|||
49049131|NCT01546519|158015289|FG003|Overall Study|Adverse Event|1|||
49049132|NCT01546519|158015286|FG000|Overall Study|Death|0|||
49049133|NCT01546519|158015287|FG001|Overall Study|Death|1|||
49049134|NCT01546519|158015288|FG002|Overall Study|Death|3|||
49049135|NCT01546519|158015289|FG003|Overall Study|Death|1|||
49049136|NCT01546519|158015286|FG000|Overall Study|related to disease progression|2|||
49049137|NCT01546519|158015287|FG001|Overall Study|related to disease progression|2|||
49049138|NCT01546519|158015288|FG002|Overall Study|related to disease progression|2|||
49049139|NCT01546519|158015289|FG003|Overall Study|related to disease progression|1|||
49049140|NCT01546519|158015286|FG000|Overall Study|Physician Decision|6|||
49049141|NCT01546519|158015287|FG001|Overall Study|Physician Decision|5|||
49049142|NCT01546519|158015288|FG002|Overall Study|Physician Decision|2|||
49049143|NCT01546519|158015289|FG003|Overall Study|Physician Decision|3|||
49049144|NCT01546519|158015286|FG000|Overall Study|Withdrawal by Subject|1|||
49049145|NCT01546519|158015287|FG001|Overall Study|Withdrawal by Subject|0|||
49049146|NCT01546519|158015288|FG002|Overall Study|Withdrawal by Subject|0|||
49049147|NCT01546519|158015289|FG003|Overall Study|Withdrawal by Subject|0|||
49049148|NCT01355302|158015290|FG000|Phase 1b|Death|4|||
49049149|NCT01355302|158015291|FG001|Phase 1b|Death|0|||
49049150|NCT01355302|158015292|FG002|Phase 1b|Death|0|||
49049151|NCT01355302|158015290|FG000|Phase 1b|Study terminated by sponsor|2|||
49049152|NCT01355302|158015291|FG001|Phase 1b|Study terminated by sponsor|0|||
49049153|NCT01355302|158015292|FG002|Phase 1b|Study terminated by sponsor|0|||
49049154|NCT01439724|158015293|FG000|Overall Study|missing consultation|9|||
49049155|NCT01439724|158015294|FG001|Overall Study|missing consultation|8|||
49049156|NCT02508116|158015295|FG000|Overall Study|Lost to Follow-up|2|||
49049157|NCT02508116|158015296|FG001|Overall Study|Lost to Follow-up|3|||
49049158|NCT02508116|158015295|FG000|Overall Study|Withdrawal by Subject|3|||
49049159|NCT02508116|158015296|FG001|Overall Study|Withdrawal by Subject|2|||
49049160|NCT02508116|158015295|FG000|Overall Study|Protocol Violation|1|||
49049161|NCT02508116|158015296|FG001|Overall Study|Protocol Violation|2|||
49049162|NCT02508116|158015295|FG000|Overall Study|Physician Decision|2|||
49049163|NCT02508116|158015296|FG001|Overall Study|Physician Decision|0|||
49049164|NCT04234464|158015298|FG000|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|1|||
49049165|NCT04234464|158015299|FG001|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|0|||
49049166|NCT00983528|158015304|FG000|Overall Study|Death|4|||
49049167|NCT00983528|158015304|FG000|Overall Study|Lost to Follow-up|1|||
49049168|NCT00983528|158015304|FG000|Overall Study|Study Terminated|1|||
49049169|NCT03635983|158015305|FG000|Pre-Treatment Period|Not yet treated at the time of database lock|1|||
49049170|NCT03635983|158015306|FG001|Pre-Treatment Period|Not yet treated at the time of database lock|0|||
49049171|NCT03635983|158015305|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
49049172|NCT03635983|158015306|FG001|Pre-Treatment Period|Withdrawal by Subject|7|||
49049173|NCT03635983|158015305|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
49049174|NCT03635983|158015306|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
49049175|NCT03635983|158015305|FG000|Pre-Treatment Period|Other reasons|1|||
49049176|NCT03635983|158015306|FG001|Pre-Treatment Period|Other reasons|2|||
49049177|NCT03635983|158015305|FG000|Pre-Treatment Period|Disease Progression|0|||
49049178|NCT03635983|158015306|FG001|Pre-Treatment Period|Disease Progression|1|||
49049179|NCT03635983|158015305|FG000|Pre-Treatment Period|Adverse Event unrelated to Study drug|1|||
49049180|NCT03635983|158015306|FG001|Pre-Treatment Period|Adverse Event unrelated to Study drug|0|||
49049181|NCT03635983|158015305|FG000|Treatment Period|Completed treatment period|13|||
49049182|NCT03635983|158015306|FG001|Treatment Period|Completed treatment period|20|||
49049183|NCT03635983|158015305|FG000|Treatment Period|Participant request to discontinue Study treatment|5|||
49049184|NCT03635983|158015306|FG001|Treatment Period|Participant request to discontinue Study treatment|5|||
49049185|NCT03635983|158015305|FG000|Treatment Period|Withdrawal by Subject|2|||
49049186|NCT03635983|158015306|FG001|Treatment Period|Withdrawal by Subject|4|||
49049187|NCT03635983|158015305|FG000|Treatment Period|Death|3|||
49049188|NCT03635983|158015306|FG001|Treatment Period|Death|4|||
49049189|NCT03635983|158015305|FG000|Treatment Period|Poor/Non-compliance|1|||
49049190|NCT03635983|158015306|FG001|Treatment Period|Poor/Non-compliance|0|||
49049191|NCT03635983|158015305|FG000|Treatment Period|Participant no longer meets Study criteria|0|||
49049192|NCT03635983|158015306|FG001|Treatment Period|Participant no longer meets Study criteria|2|||
49049193|NCT03635983|158015305|FG000|Treatment Period|Other reasons|5|||
49049194|NCT03635983|158015306|FG001|Treatment Period|Other reasons|2|||
49049195|NCT03635983|158015305|FG000|Treatment Period|Disease progression|184|||
49049196|NCT03635983|158015306|FG001|Treatment Period|Disease progression|168|||
49049197|NCT03635983|158015305|FG000|Treatment Period|Study drug toxicity|26|||
49049198|NCT03635983|158015306|FG001|Treatment Period|Study drug toxicity|29|||
49049199|NCT03635983|158015305|FG000|Treatment Period|Adverse event unrelated to Study drug|10|||
49049200|NCT03635983|158015306|FG001|Treatment Period|Adverse event unrelated to Study drug|11|||
49049201|NCT03635983|158015305|FG000|Treatment Period|Maximum clinical benefit|3|||
49049202|NCT03635983|158015306|FG001|Treatment Period|Maximum clinical benefit|2|||
49049203|NCT01483625|158015307|FG000|Overall Study|Adverse Event|1|||
49049204|NCT01483625|158015308|FG001|Overall Study|Adverse Event|1|||
49049205|NCT01483625|158015307|FG000|Overall Study|Refused to continue medication|2|||
49049206|NCT01483625|158015308|FG001|Overall Study|Refused to continue medication|1|||
49049207|NCT01483625|158015307|FG000|Overall Study|Due to other reason|1|||
49049208|NCT01483625|158015308|FG001|Overall Study|Due to other reason|0|||
49049209|NCT00575380|158015309|FG000|Overall Study|Withdrawal by Subject|1|||
49049210|NCT00575380|158015310|FG001|Overall Study|Withdrawal by Subject|0|||
49049211|NCT00575380|158015309|FG000|Overall Study|Adverse Event|0|||
49049212|NCT00575380|158015310|FG001|Overall Study|Adverse Event|1|||
49049213|NCT00575380|158015309|FG000|Overall Study|Various|0|||
49049214|NCT00575380|158015310|FG001|Overall Study|Various|2|||
49049215|NCT03259789|158015311|FG000|Overall Study|Adverse Event|3|||
49049216|NCT03259789|158015312|FG001|Overall Study|Adverse Event|2|||
49049217|NCT03259789|158015313|FG002|Overall Study|Adverse Event|1|||
49049218|NCT03259789|158015311|FG000|Overall Study|Withdrawal by Subject|9|||
49049219|NCT03259789|158015312|FG001|Overall Study|Withdrawal by Subject|5|||
49049220|NCT03259789|158015313|FG002|Overall Study|Withdrawal by Subject|1|||
49049221|NCT03259789|158015311|FG000|Overall Study|Lost to Follow-up|5|||
49049222|NCT03259789|158015312|FG001|Overall Study|Lost to Follow-up|9|||
49049223|NCT03259789|158015313|FG002|Overall Study|Lost to Follow-up|4|||
49049224|NCT03259789|158015311|FG000|Overall Study|Physician Decision|0|||
49049225|NCT03259789|158015312|FG001|Overall Study|Physician Decision|1|||
49049226|NCT03259789|158015313|FG002|Overall Study|Physician Decision|0|||
49049227|NCT04126343|158015314|FG000|Overall Study|Adverse Event|0|||
49049228|NCT04126343|158015315|FG001|Overall Study|Adverse Event|0|||
49049229|NCT04126343|158015316|FG002|Overall Study|Adverse Event|0|||
49049230|NCT04126343|158015317|FG003|Overall Study|Adverse Event|0|||
49049231|NCT04126343|158015318|FG004|Overall Study|Adverse Event|0|||
49049232|NCT04126343|158015319|FG005|Overall Study|Adverse Event|1|||
49049233|NCT04126343|158015314|FG000|Overall Study|Withdrawal by Subject|0|||
49049234|NCT04126343|158015315|FG001|Overall Study|Withdrawal by Subject|0|||
49049235|NCT04126343|158015316|FG002|Overall Study|Withdrawal by Subject|0|||
49049236|NCT04126343|158015317|FG003|Overall Study|Withdrawal by Subject|1|||
49049237|NCT04126343|158015318|FG004|Overall Study|Withdrawal by Subject|0|||
49049238|NCT04126343|158015319|FG005|Overall Study|Withdrawal by Subject|0|||
49049239|NCT04126343|158015314|FG000|Overall Study|Related to COVID-19 pandemic|3|||
49049240|NCT04126343|158015315|FG001|Overall Study|Related to COVID-19 pandemic|4|||
49049241|NCT04126343|158015316|FG002|Overall Study|Related to COVID-19 pandemic|3|||
49049242|NCT04126343|158015317|FG003|Overall Study|Related to COVID-19 pandemic|3|||
49049243|NCT04126343|158015318|FG004|Overall Study|Related to COVID-19 pandemic|3|||
49049244|NCT04126343|158015319|FG005|Overall Study|Related to COVID-19 pandemic|3|||
49049245|NCT00559364|158015320|FG000|Overall Study|Inclusion/exclusion criteria failure|1|||
49049246|NCT00559364|158015321|FG001|Overall Study|Inclusion/exclusion criteria failure|0|||
49049247|NCT01235442|158015322|FG000|Overall Study|Lost to Follow-up|12|||
49049248|NCT01235442|158015323|FG001|Overall Study|Lost to Follow-up|10|||
49049249|NCT01235442|158015322|FG000|Overall Study|Death|0|||
49049250|NCT01235442|158015323|FG001|Overall Study|Death|2|||
49049251|NCT01235442|158015322|FG000|Overall Study|Pregnancy|1|||
49049252|NCT01235442|158015323|FG001|Overall Study|Pregnancy|1|||
49049253|NCT01235442|158015322|FG000|Overall Study|Ineligibility determined|5|||
49049254|NCT01235442|158015323|FG001|Overall Study|Ineligibility determined|4|||
49049255|NCT01235442|158015322|FG000|Overall Study|Protocol Violation|3|||
49049256|NCT01235442|158015323|FG001|Overall Study|Protocol Violation|3|||
49049257|NCT01235442|158015322|FG000|Overall Study|Adverse Event|4|||
49049258|NCT01235442|158015323|FG001|Overall Study|Adverse Event|6|||
49049259|NCT01235442|158015322|FG000|Overall Study|Withdrawal by Subject|15|||
49049260|NCT01235442|158015323|FG001|Overall Study|Withdrawal by Subject|9|||
49049261|NCT01235442|158015322|FG000|Overall Study|Lack of Efficacy|1|||
49049262|NCT01235442|158015323|FG001|Overall Study|Lack of Efficacy|3|||
49049263|NCT01235442|158015322|FG000|Overall Study|Noncompliance|1|||
49049264|NCT01235442|158015323|FG001|Overall Study|Noncompliance|2|||
49049265|NCT01235442|158015322|FG000|Overall Study|Administrative decision|1|||
49049266|NCT01235442|158015323|FG001|Overall Study|Administrative decision|2|||
49049267|NCT01235442|158015322|FG000|Overall Study|Other unspecified|1|||
49049268|NCT01235442|158015323|FG001|Overall Study|Other unspecified|2|||
49049269|NCT00084799|158015324|FG000|Overall Study|Disease Progression|1|||
49049270|NCT00084799|158015325|FG001|Overall Study|Disease Progression|0|||
49049271|NCT04019054|158015328|FG000|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0|||
49049272|NCT04019054|158015329|FG001|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1|||
49049273|NCT04019054|158015328|FG000|Overall Study|Withdrawal by Subject|3|||
49049274|NCT04019054|158015329|FG001|Overall Study|Withdrawal by Subject|1|||
49049275|NCT01701973|158015330|FG000|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
49049276|NCT01701973|158015331|FG001|Aim 1: First Intervention (1 Day)|Adverse Event|1|||
49049277|NCT01701973|158015332|FG002|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
49049278|NCT01701973|158015333|FG003|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
49049279|NCT01701973|158015334|FG004|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
49049280|NCT01701973|158015335|FG005|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
49049281|NCT01701973|158015336|FG006|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
49049282|NCT01701973|158015337|FG007|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
49049283|NCT01876368|158015338|FG000|Overall Study|Adverse Event|2|||
49049284|NCT01876368|158015339|FG001|Overall Study|Adverse Event|5|||
49049285|NCT01876368|158015338|FG000|Overall Study|Lack of Efficacy|1|||
49049286|NCT01876368|158015339|FG001|Overall Study|Lack of Efficacy|0|||
49049287|NCT01876368|158015338|FG000|Overall Study|Lost to Follow-up|0|||
49049288|NCT01876368|158015339|FG001|Overall Study|Lost to Follow-up|1|||
49049289|NCT01876368|158015338|FG000|Overall Study|Non-compliance with study treatment|0|||
49049290|NCT01876368|158015339|FG001|Overall Study|Non-compliance with study treatment|1|||
49049291|NCT01876368|158015338|FG000|Overall Study|Physician Decision|0|||
49049292|NCT01876368|158015339|FG001|Overall Study|Physician Decision|2|||
49049293|NCT01876368|158015338|FG000|Overall Study|Protocol deviation|3|||
49049294|NCT01876368|158015339|FG001|Overall Study|Protocol deviation|3|||
49049295|NCT01876368|158015338|FG000|Overall Study|Subject/guardian decision|3|||
49049296|NCT01876368|158015339|FG001|Overall Study|Subject/guardian decision|1|||
49049297|NCT01731886|158015340|FG000|Overall Study|Death|1|||
49049298|NCT01731886|158015341|FG001|Overall Study|Death|0|||
49049299|NCT01731886|158015340|FG000|Overall Study|Never started treatment|0|||
49049300|NCT01731886|158015341|FG001|Overall Study|Never started treatment|1|||
49049301|NCT01731886|158015340|FG000|Overall Study|Non-compliant|1|||
49049302|NCT01731886|158015341|FG001|Overall Study|Non-compliant|0|||
49049303|NCT01261624|158015342|FG000|Week 0 to Week 12|Disease Progression|1|||
49049304|NCT01261624|158015343|FG001|Week 0 to Week 12|Disease Progression|1|||
49049305|NCT01261624|158015342|FG000|Week 0 to Week 12|Insufficient Response|0|||
49049306|NCT01261624|158015343|FG001|Week 0 to Week 12|Insufficient Response|2|||
49049307|NCT01261624|158015342|FG000|Week 13 to Week 24|Insufficient Response|0|||
49049308|NCT01261624|158015343|FG001|Week 13 to Week 24|Insufficient Response|1|||
49049309|NCT00129116|158015344|FG000|Primary Phase|Lost to Follow-up|1|||
49049310|NCT00129116|158015345|FG001|Primary Phase|Lost to Follow-up|1|||
49049311|NCT00129116|158015346|FG002|Primary Phase|Lost to Follow-up|0|||
49049312|NCT00129116|158015347|FG003|Primary Phase|Lost to Follow-up|1|||
49049313|NCT00129116|158015348|FG004|Primary Phase|Lost to Follow-up|1|||
49049314|NCT00129116|158015344|FG000|Primary Phase|Protocol Violation|0|||
49049315|NCT00129116|158015345|FG001|Primary Phase|Protocol Violation|1|||
49049316|NCT00129116|158015346|FG002|Primary Phase|Protocol Violation|0|||
49049317|NCT00129116|158015347|FG003|Primary Phase|Protocol Violation|0|||
49049318|NCT00129116|158015348|FG004|Primary Phase|Protocol Violation|0|||
49049319|NCT00129116|158015344|FG000|Primary Phase|Adverse Event|1|||
49049320|NCT00129116|158015345|FG001|Primary Phase|Adverse Event|1|||
49049321|NCT00129116|158015346|FG002|Primary Phase|Adverse Event|0|||
49049322|NCT00129116|158015347|FG003|Primary Phase|Adverse Event|0|||
49049323|NCT00129116|158015348|FG004|Primary Phase|Adverse Event|0|||
49049324|NCT00129116|158015344|FG000|Primary Phase|Withdrawal by Subject|0|||
49049325|NCT00129116|158015345|FG001|Primary Phase|Withdrawal by Subject|1|||
49049326|NCT00129116|158015346|FG002|Primary Phase|Withdrawal by Subject|0|||
49049327|NCT00129116|158015347|FG003|Primary Phase|Withdrawal by Subject|0|||
49049328|NCT00129116|158015348|FG004|Primary Phase|Withdrawal by Subject|0|||
49049329|NCT00129116|158015344|FG000|Primary Phase|Other|0|||
49049330|NCT00129116|158015345|FG001|Primary Phase|Other|0|||
49049331|NCT00129116|158015346|FG002|Primary Phase|Other|1|||
49049332|NCT00129116|158015347|FG003|Primary Phase|Other|0|||
49049333|NCT00129116|158015348|FG004|Primary Phase|Other|0|||
49049334|NCT00129116|158015344|FG000|Booster Phase|Lost to Follow-up|2|||
49049335|NCT00129116|158015345|FG001|Booster Phase|Lost to Follow-up|0|||
49049336|NCT00129116|158015346|FG002|Booster Phase|Lost to Follow-up|0|||
49049337|NCT00129116|158015347|FG003|Booster Phase|Lost to Follow-up|0|||
49049338|NCT00129116|158015348|FG004|Booster Phase|Lost to Follow-up|1|||
49049339|NCT00271024|158015349|FG000|Overall Study|Lost Interest|3|||
49049340|NCT00271024|158015350|FG001|Overall Study|Lost Interest|4|||
49049341|NCT00271024|158015351|FG002|Overall Study|Lost Interest|2|||
49049342|NCT00271024|158015352|FG003|Overall Study|Lost Interest|3|||
49049343|NCT00271024|158015349|FG000|Overall Study|Unknown/Unspecified|11|||
49049344|NCT00271024|158015350|FG001|Overall Study|Unknown/Unspecified|11|||
49049345|NCT00271024|158015351|FG002|Overall Study|Unknown/Unspecified|8|||
49049346|NCT00271024|158015352|FG003|Overall Study|Unknown/Unspecified|4|||
49049347|NCT00271024|158015349|FG000|Overall Study|Protocol Violation|1|||
49049348|NCT00271024|158015350|FG001|Overall Study|Protocol Violation|6|||
49049349|NCT00271024|158015351|FG002|Overall Study|Protocol Violation|5|||
49049350|NCT00271024|158015352|FG003|Overall Study|Protocol Violation|11|||
49049351|NCT00271024|158015349|FG000|Overall Study|Unpleasant Reaction To Tablet|1|||
49049352|NCT00271024|158015350|FG001|Overall Study|Unpleasant Reaction To Tablet|3|||
49049353|NCT00271024|158015351|FG002|Overall Study|Unpleasant Reaction To Tablet|4|||
49049354|NCT00271024|158015352|FG003|Overall Study|Unpleasant Reaction To Tablet|2|||
49049355|NCT00271024|158015349|FG000|Overall Study|Time Commitment, Scheduling, or Travel|6|||
49049356|NCT00271024|158015350|FG001|Overall Study|Time Commitment, Scheduling, or Travel|2|||
49049357|NCT00271024|158015351|FG002|Overall Study|Time Commitment, Scheduling, or Travel|4|||
49049358|NCT00271024|158015352|FG003|Overall Study|Time Commitment, Scheduling, or Travel|4|||
49049359|NCT03566238|158015355|FG000|Overall Study|Adverse Event|0|||
49049360|NCT03566238|158015356|FG001|Overall Study|Adverse Event|1|||
49049361|NCT03566238|158015357|FG002|Overall Study|Adverse Event|0|||
49049362|NCT03566238|158015355|FG000|Overall Study|Lack of Efficacy|4|||
49049363|NCT03566238|158015356|FG001|Overall Study|Lack of Efficacy|2|||
49049364|NCT03566238|158015357|FG002|Overall Study|Lack of Efficacy|5|||
49049365|NCT03566238|158015355|FG000|Overall Study|Other|1|||
49049366|NCT03566238|158015356|FG001|Overall Study|Other|0|||
49049367|NCT03566238|158015357|FG002|Overall Study|Other|0|||
49049368|NCT04034355|158015369|FG000|Overall Study|Study terminated by Sponsor|10|||
49049369|NCT04034355|158015370|FG001|Overall Study|Study terminated by Sponsor|17|||
49049370|NCT04034355|158015369|FG000|Overall Study|Withdrawal by Subject|12|||
49049371|NCT04034355|158015370|FG001|Overall Study|Withdrawal by Subject|11|||
49049372|NCT04034355|158015369|FG000|Overall Study|Site terminated by Sponsor|4|||
49049373|NCT04034355|158015370|FG001|Overall Study|Site terminated by Sponsor|5|||
49049374|NCT04034355|158015369|FG000|Overall Study|Adverse Event|2|||
49049375|NCT04034355|158015370|FG001|Overall Study|Adverse Event|0|||
49049376|NCT04034355|158015369|FG000|Overall Study|Death|1|||
49049377|NCT04034355|158015370|FG001|Overall Study|Death|1|||
49049378|NCT04034355|158015369|FG000|Overall Study|Not reported|2|||
49049379|NCT04034355|158015370|FG001|Overall Study|Not reported|0|||
49049380|NCT04034355|158015369|FG000|Overall Study|Lost to Follow-up|1|||
49049381|NCT04034355|158015370|FG001|Overall Study|Lost to Follow-up|0|||
49049382|NCT04034355|158015369|FG000|Overall Study|Physician Decision|1|||
49049383|NCT04034355|158015370|FG001|Overall Study|Physician Decision|0|||
49049384|NCT04034355|158015369|FG000|Overall Study|Protocol Violation|0|||
49049385|NCT04034355|158015370|FG001|Overall Study|Protocol Violation|1|||
49049386|NCT04034355|158015369|FG000|Overall Study|Progressive disease|1|||
49049387|NCT04034355|158015370|FG001|Overall Study|Progressive disease|0|||
49049388|NCT02010255|158015371|FG000|Overall Study|Death|0|||
49049389|NCT02010255|158015372|FG001|Overall Study|Death|1|||
49049390|NCT02010255|158015373|FG002|Overall Study|Death|4|||
49049391|NCT02010255|158015374|FG003|Overall Study|Death|4|||
49049392|NCT02010255|158015375|FG004|Overall Study|Death|2|||
49049393|NCT02010255|158015376|FG005|Overall Study|Death|0|||
49049394|NCT02010255|158015377|FG006|Overall Study|Death|1|||
49049395|NCT02010255|158015378|FG007|Overall Study|Death|1|||
49049396|NCT02010255|158015379|FG008|Overall Study|Death|1|||
49049397|NCT02010255|158015380|FG009|Overall Study|Death|0|||
49049398|NCT02010255|158015381|FG010|Overall Study|Death|1|||
49049399|NCT02010255|158015382|FG011|Overall Study|Death|1|||
49049400|NCT02010255|158015383|FG012|Overall Study|Death|0|||
49049401|NCT02010255|158015384|FG013|Overall Study|Death|0|||
49049402|NCT02010255|158015371|FG000|Overall Study|Lack of Efficacy|4|||
49049403|NCT02010255|158015372|FG001|Overall Study|Lack of Efficacy|1|||
49049404|NCT02010255|158015373|FG002|Overall Study|Lack of Efficacy|2|||
49049405|NCT02010255|158015374|FG003|Overall Study|Lack of Efficacy|1|||
49049406|NCT02010255|158015375|FG004|Overall Study|Lack of Efficacy|1|||
49049407|NCT02010255|158015376|FG005|Overall Study|Lack of Efficacy|0|||
49049408|NCT02010255|158015377|FG006|Overall Study|Lack of Efficacy|0|||
49049409|NCT02010255|158015378|FG007|Overall Study|Lack of Efficacy|0|||
49049410|NCT02010255|158015379|FG008|Overall Study|Lack of Efficacy|0|||
49049411|NCT02010255|158015380|FG009|Overall Study|Lack of Efficacy|0|||
49049412|NCT02010255|158015381|FG010|Overall Study|Lack of Efficacy|1|||
49049413|NCT02010255|158015382|FG011|Overall Study|Lack of Efficacy|0|||
49049414|NCT02010255|158015383|FG012|Overall Study|Lack of Efficacy|0|||
49049415|NCT02010255|158015384|FG013|Overall Study|Lack of Efficacy|0|||
49049416|NCT02010255|158015371|FG000|Overall Study|Withdrew Consent|1|||
49049417|NCT02010255|158015372|FG001|Overall Study|Withdrew Consent|0|||
49049418|NCT02010255|158015373|FG002|Overall Study|Withdrew Consent|0|||
49049419|NCT02010255|158015374|FG003|Overall Study|Withdrew Consent|1|||
49049420|NCT02010255|158015375|FG004|Overall Study|Withdrew Consent|0|||
49049421|NCT02010255|158015376|FG005|Overall Study|Withdrew Consent|0|||
49049422|NCT02010255|158015377|FG006|Overall Study|Withdrew Consent|0|||
49049423|NCT02010255|158015378|FG007|Overall Study|Withdrew Consent|0|||
49049424|NCT02010255|158015379|FG008|Overall Study|Withdrew Consent|0|||
49049425|NCT02010255|158015380|FG009|Overall Study|Withdrew Consent|0|||
49049426|NCT02010255|158015381|FG010|Overall Study|Withdrew Consent|0|||
49049427|NCT02010255|158015382|FG011|Overall Study|Withdrew Consent|0|||
49049428|NCT02010255|158015383|FG012|Overall Study|Withdrew Consent|0|||
49049429|NCT02010255|158015384|FG013|Overall Study|Withdrew Consent|0|||
49049430|NCT02010255|158015371|FG000|Overall Study|Adverse Event|1|||
49049431|NCT02010255|158015372|FG001|Overall Study|Adverse Event|0|||
49049432|NCT02010255|158015373|FG002|Overall Study|Adverse Event|0|||
49049433|NCT02010255|158015374|FG003|Overall Study|Adverse Event|0|||
49049434|NCT02010255|158015375|FG004|Overall Study|Adverse Event|0|||
49049435|NCT02010255|158015376|FG005|Overall Study|Adverse Event|0|||
49049436|NCT02010255|158015377|FG006|Overall Study|Adverse Event|0|||
49049437|NCT02010255|158015378|FG007|Overall Study|Adverse Event|0|||
49049438|NCT02010255|158015379|FG008|Overall Study|Adverse Event|0|||
49049439|NCT02010255|158015380|FG009|Overall Study|Adverse Event|0|||
49049440|NCT02010255|158015381|FG010|Overall Study|Adverse Event|0|||
49049441|NCT02010255|158015382|FG011|Overall Study|Adverse Event|0|||
49049442|NCT02010255|158015383|FG012|Overall Study|Adverse Event|0|||
49049443|NCT02010255|158015384|FG013|Overall Study|Adverse Event|0|||
49049444|NCT02010255|158015371|FG000|Overall Study|Lost to Follow-up|0|||
49049445|NCT02010255|158015372|FG001|Overall Study|Lost to Follow-up|0|||
49049446|NCT02010255|158015373|FG002|Overall Study|Lost to Follow-up|1|||
49049447|NCT02010255|158015374|FG003|Overall Study|Lost to Follow-up|0|||
49049448|NCT02010255|158015375|FG004|Overall Study|Lost to Follow-up|1|||
49049449|NCT02010255|158015376|FG005|Overall Study|Lost to Follow-up|0|||
49049450|NCT02010255|158015377|FG006|Overall Study|Lost to Follow-up|0|||
49049451|NCT02010255|158015378|FG007|Overall Study|Lost to Follow-up|0|||
49049452|NCT02010255|158015379|FG008|Overall Study|Lost to Follow-up|0|||
49049453|NCT02010255|158015380|FG009|Overall Study|Lost to Follow-up|0|||
49049454|NCT02010255|158015381|FG010|Overall Study|Lost to Follow-up|0|||
49049455|NCT02010255|158015382|FG011|Overall Study|Lost to Follow-up|0|||
49049456|NCT02010255|158015383|FG012|Overall Study|Lost to Follow-up|0|||
49049457|NCT02010255|158015384|FG013|Overall Study|Lost to Follow-up|0|||
49049458|NCT02010255|158015371|FG000|Overall Study|Randomized but Not Treated|0|||
49049459|NCT02010255|158015372|FG001|Overall Study|Randomized but Not Treated|0|||
49049460|NCT02010255|158015373|FG002|Overall Study|Randomized but Not Treated|0|||
49049461|NCT02010255|158015374|FG003|Overall Study|Randomized but Not Treated|0|||
49049462|NCT02010255|158015375|FG004|Overall Study|Randomized but Not Treated|0|||
49049463|NCT02010255|158015376|FG005|Overall Study|Randomized but Not Treated|0|||
49049464|NCT02010255|158015377|FG006|Overall Study|Randomized but Not Treated|0|||
49049465|NCT02010255|158015378|FG007|Overall Study|Randomized but Not Treated|0|||
49049466|NCT02010255|158015379|FG008|Overall Study|Randomized but Not Treated|0|||
49049467|NCT02010255|158015380|FG009|Overall Study|Randomized but Not Treated|0|||
49049468|NCT02010255|158015381|FG010|Overall Study|Randomized but Not Treated|0|||
49049469|NCT02010255|158015382|FG011|Overall Study|Randomized but Not Treated|0|||
49049470|NCT02010255|158015383|FG012|Overall Study|Randomized but Not Treated|0|||
49049471|NCT02010255|158015384|FG013|Overall Study|Randomized but Not Treated|1|||
49049472|NCT03573817|158015385|FG000|Overall Study|Adverse Event|0|||
49049473|NCT03573817|158015386|FG001|Overall Study|Adverse Event|2|||
49049474|NCT03573817|158015385|FG000|Overall Study|Protocol Violation|0|||
49049475|NCT03573817|158015386|FG001|Overall Study|Protocol Violation|1|||
49049476|NCT03573817|158015385|FG000|Overall Study|Withdrawal by Subject|1|||
49049477|NCT03573817|158015386|FG001|Overall Study|Withdrawal by Subject|1|||
49049478|NCT03078478|158015388|FG000|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
49049479|NCT03078478|158015389|FG001|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
49049480|NCT03078478|158015388|FG000|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7|||
49049481|NCT03078478|158015389|FG001|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4|||
49049482|NCT03078478|158015388|FG000|Maintenance Period 1 (36 Weeks)|Death|3|||
49049483|NCT03078478|158015389|FG001|Maintenance Period 1 (36 Weeks)|Death|3|||
49049484|NCT03078478|158015388|FG000|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1|||
49049485|NCT03078478|158015389|FG001|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0|||
49049486|NCT03078478|158015388|FG000|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18|||
49049487|NCT03078478|158015389|FG001|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13|||
49049488|NCT03078478|158015388|FG000|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3|||
49049489|NCT03078478|158015389|FG001|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6|||
49049490|NCT03078478|158015388|FG000|Maintencance Period 2 (36 Weeks)|Death|4|||
49049491|NCT03078478|158015389|FG001|Maintencance Period 2 (36 Weeks)|Death|6|||
49049492|NCT03078478|158015388|FG000|Maintencance Period 2 (36 Weeks)|Not reconsenting|0|||
49049493|NCT03078478|158015389|FG001|Maintencance Period 2 (36 Weeks)|Not reconsenting|2|||
49049494|NCT02339090|158015390|FG000|Overall Study|Adverse Event|1|||
49049495|NCT02339090|158015391|FG001|Overall Study|Adverse Event|0|||
49049496|NCT02339090|158015390|FG000|Overall Study|Lost to Follow-up|0|||
49049497|NCT02339090|158015391|FG001|Overall Study|Lost to Follow-up|1|||
49049498|NCT02339090|158015390|FG000|Overall Study|Non-compliance With Study Drug|0|||
49049499|NCT02339090|158015391|FG001|Overall Study|Non-compliance With Study Drug|1|||
49049500|NCT02339090|158015390|FG000|Overall Study|Withdrawal by Subject|2|||
49049501|NCT02339090|158015391|FG001|Overall Study|Withdrawal by Subject|1|||
49049502|NCT02339090|158015390|FG000|Overall Study|Poor Growth|3|||
49049503|NCT02339090|158015391|FG001|Overall Study|Poor Growth|0|||
49049504|NCT02339090|158015390|FG000|Overall Study|Randomized but not treated|0|||
49049505|NCT02339090|158015391|FG001|Overall Study|Randomized but not treated|2|||
49049506|NCT00224484|158017244|FG000|Overall Study|Serious Adverse Event|1|||
49049507|NCT00224484|158017245|FG001|Overall Study|Serious Adverse Event|1|||
49049508|NCT00224484|158017246|FG002|Overall Study|Serious Adverse Event|0|||
49049509|NCT00224484|158017244|FG000|Overall Study|Non-Serious Adverse Event|5|||
49049510|NCT00224484|158017245|FG001|Overall Study|Non-Serious Adverse Event|7|||
49049511|NCT00224484|158017246|FG002|Overall Study|Non-Serious Adverse Event|3|||
49049512|NCT00224484|158017244|FG000|Overall Study|Protocol Violation|2|||
49049513|NCT00224484|158017245|FG001|Overall Study|Protocol Violation|2|||
49049514|NCT00224484|158017246|FG002|Overall Study|Protocol Violation|0|||
49049515|NCT00224484|158017244|FG000|Overall Study|Withdrawal by Subject|49|||
49049516|NCT00224484|158017245|FG001|Overall Study|Withdrawal by Subject|18|||
49049517|NCT00224484|158017246|FG002|Overall Study|Withdrawal by Subject|16|||
49049518|NCT00224484|158017244|FG000|Overall Study|Migrated/moved from study area|18|||
49049519|NCT00224484|158017245|FG001|Overall Study|Migrated/moved from study area|5|||
49049520|NCT00224484|158017246|FG002|Overall Study|Migrated/moved from study area|5|||
49049521|NCT00224484|158017244|FG000|Overall Study|Lost to Follow-up|66|||
49049522|NCT00224484|158017245|FG001|Overall Study|Lost to Follow-up|28|||
49049523|NCT00224484|158017246|FG002|Overall Study|Lost to Follow-up|36|||
49049524|NCT00224484|158017244|FG000|Overall Study|Reason not specified|5|||
49049525|NCT00224484|158017245|FG001|Overall Study|Reason not specified|4|||
49049526|NCT00224484|158017246|FG002|Overall Study|Reason not specified|2|||
49049527|NCT00108628|158017252|FG000|Overall Study|Withdrawal by Subject|17|||
49049528|NCT00108628|158017253|FG001|Overall Study|Withdrawal by Subject|9|||
49049529|NCT00108628|158017252|FG000|Overall Study|Lack of Efficacy|2|||
49049530|NCT00108628|158017253|FG001|Overall Study|Lack of Efficacy|1|||
49049531|NCT00108628|158017252|FG000|Overall Study|Death|1|||
49049532|NCT00108628|158017253|FG001|Overall Study|Death|0|||
49049533|NCT01350934|158017254|FG000|Base Study|Adverse Event|6|||
49049534|NCT01350934|158017255|FG001|Base Study|Adverse Event|0|||
49049535|NCT01350934|158017254|FG000|Base Study|Lost to Follow-up|1|||
49049536|NCT01350934|158017255|FG001|Base Study|Lost to Follow-up|0|||
49049537|NCT01350934|158017254|FG000|Base Study|Protocol Violation|1|||
49049538|NCT01350934|158017255|FG001|Base Study|Protocol Violation|1|||
49049539|NCT01350934|158017254|FG000|Base Study|Withdrawal by Subject|1|||
49049540|NCT01350934|158017255|FG001|Base Study|Withdrawal by Subject|2|||
49049541|NCT01350934|158017254|FG000|Base Study|Non-Compliance With Study Drug|2|||
49049542|NCT01350934|158017255|FG001|Base Study|Non-Compliance With Study Drug|0|||
49049543|NCT01350934|158017254|FG000|Extension Study|Adverse Event|2|||
49049544|NCT01350934|158017255|FG001|Extension Study|Adverse Event|1|||
49049545|NCT01350934|158017254|FG000|Extension Study|Lost to Follow-up|2|||
49049546|NCT01350934|158017255|FG001|Extension Study|Lost to Follow-up|0|||
48692643|NCT03001557|156724547|FG006|Extension Phase|Lost to Follow-up|2|||
49049547|NCT01350934|158017254|FG000|Extension Study|Protocol Violation|1|||
49049548|NCT01350934|158017255|FG001|Extension Study|Protocol Violation|1|||
49049549|NCT01350934|158017254|FG000|Extension Study|Lack of Efficacy|0|||
49049550|NCT01350934|158017255|FG001|Extension Study|Lack of Efficacy|1|||
49049551|NCT01350934|158017254|FG000|Extension Study|Withdrawal by Subject|0|||
49049552|NCT01350934|158017255|FG001|Extension Study|Withdrawal by Subject|1|||
49049553|NCT03547635|158017256|FG000|Overall Study|Adverse Event|5|||
49049554|NCT03547635|158017257|FG001|Overall Study|Adverse Event|2|||
49049555|NCT03547635|158017258|FG002|Overall Study|Adverse Event|3|||
49049556|NCT03547635|158017256|FG000|Overall Study|Lost to Follow-up|1|||
49049557|NCT03547635|158017257|FG001|Overall Study|Lost to Follow-up|3|||
49049558|NCT03547635|158017258|FG002|Overall Study|Lost to Follow-up|4|||
49049559|NCT03547635|158017256|FG000|Overall Study|Withdrawal by Subject|1|||
49049560|NCT03547635|158017257|FG001|Overall Study|Withdrawal by Subject|0|||
49049561|NCT03547635|158017258|FG002|Overall Study|Withdrawal by Subject|0|||
49049562|NCT03547635|158017256|FG000|Overall Study|Withdrawal By PI|0|||
49049563|NCT03547635|158017257|FG001|Overall Study|Withdrawal By PI|1|||
49049564|NCT03547635|158017258|FG002|Overall Study|Withdrawal By PI|0|||
49049565|NCT03547635|158017256|FG000|Overall Study|Withdrawal by Sponsor|0|||
49049566|NCT03547635|158017257|FG001|Overall Study|Withdrawal by Sponsor|0|||
49049567|NCT03547635|158017258|FG002|Overall Study|Withdrawal by Sponsor|1|||
49049568|NCT03547635|158017256|FG000|Overall Study|Errant Randomization before Treatment|0|||
49049569|NCT03547635|158017257|FG001|Overall Study|Errant Randomization before Treatment|1|||
49049570|NCT03547635|158017258|FG002|Overall Study|Errant Randomization before Treatment|0|||
49049571|NCT03547635|158017256|FG000|Overall Study|Withdrawal by Subject|1|||
49049572|NCT03547635|158017257|FG001|Overall Study|Withdrawal by Subject|0|||
49049573|NCT03547635|158017258|FG002|Overall Study|Withdrawal by Subject|0|||
49049574|NCT01636934|158017259|FG000|Overall Study|Withdrawal by Subject|3|||
49049575|NCT01636934|158017260|FG001|Overall Study|Withdrawal by Subject|2|||
49049576|NCT01636934|158017259|FG000|Overall Study|Chemo cancel|1|||
49049577|NCT01636934|158017260|FG001|Overall Study|Chemo cancel|0|||
49049578|NCT01636934|158017259|FG000|Overall Study|Too ill to continue|1|||
49049579|NCT01636934|158017260|FG001|Overall Study|Too ill to continue|0|||
49049580|NCT01636934|158017259|FG000|Overall Study|Never started study medication|1|||
49049581|NCT01636934|158017260|FG001|Overall Study|Never started study medication|1|||
49049582|NCT01011335|158017263|FG000|Overall Study|Lost to Follow-up|0|||
49049583|NCT01011335|158017264|FG001|Overall Study|Lost to Follow-up|0|||
49049584|NCT01011335|158017265|FG002|Overall Study|Lost to Follow-up|1|||
49049585|NCT01011335|158017266|FG003|Overall Study|Lost to Follow-up|1|||
49049586|NCT01011335|158017267|FG004|Overall Study|Lost to Follow-up|1|||
49049587|NCT01011335|158017268|FG005|Overall Study|Lost to Follow-up|1|||
49049588|NCT01011335|158017269|FG006|Overall Study|Lost to Follow-up|2|||
49049589|NCT01011335|158017270|FG007|Overall Study|Lost to Follow-up|2|||
49049590|NCT01011335|158017271|FG008|Overall Study|Lost to Follow-up|1|||
49049591|NCT01011335|158017272|FG009|Overall Study|Lost to Follow-up|0|||
49049592|NCT01011335|158017273|FG010|Overall Study|Lost to Follow-up|0|||
49049593|NCT01011335|158017274|FG011|Overall Study|Lost to Follow-up|1|||
49049594|NCT01011335|158017275|FG012|Overall Study|Lost to Follow-up|2|||
49049595|NCT01011335|158017263|FG000|Overall Study|Protocol Violation|0|||
49049596|NCT01011335|158017264|FG001|Overall Study|Protocol Violation|1|||
49049597|NCT01011335|158017265|FG002|Overall Study|Protocol Violation|0|||
49049598|NCT01011335|158017266|FG003|Overall Study|Protocol Violation|0|||
49049599|NCT01011335|158017267|FG004|Overall Study|Protocol Violation|0|||
49049600|NCT01011335|158017268|FG005|Overall Study|Protocol Violation|0|||
49049601|NCT01011335|158017269|FG006|Overall Study|Protocol Violation|0|||
49049602|NCT01011335|158017270|FG007|Overall Study|Protocol Violation|0|||
49049603|NCT01011335|158017271|FG008|Overall Study|Protocol Violation|0|||
49049604|NCT01011335|158017272|FG009|Overall Study|Protocol Violation|0|||
49049605|NCT01011335|158017273|FG010|Overall Study|Protocol Violation|0|||
49049606|NCT01011335|158017274|FG011|Overall Study|Protocol Violation|0|||
49049607|NCT01011335|158017275|FG012|Overall Study|Protocol Violation|0|||
49049608|NCT01011335|158017263|FG000|Overall Study|Moved/deployed or no booster|1|||
49049609|NCT01011335|158017264|FG001|Overall Study|Moved/deployed or no booster|0|||
49049610|NCT01011335|158017265|FG002|Overall Study|Moved/deployed or no booster|0|||
49049611|NCT01011335|158017266|FG003|Overall Study|Moved/deployed or no booster|1|||
49049612|NCT01011335|158017267|FG004|Overall Study|Moved/deployed or no booster|0|||
49049613|NCT01011335|158017268|FG005|Overall Study|Moved/deployed or no booster|0|||
49049614|NCT01011335|158017269|FG006|Overall Study|Moved/deployed or no booster|1|||
49049615|NCT01011335|158017270|FG007|Overall Study|Moved/deployed or no booster|0|||
49049616|NCT01011335|158017271|FG008|Overall Study|Moved/deployed or no booster|1|||
49049617|NCT01011335|158017272|FG009|Overall Study|Moved/deployed or no booster|0|||
49049618|NCT01011335|158017273|FG010|Overall Study|Moved/deployed or no booster|2|||
49049619|NCT01011335|158017274|FG011|Overall Study|Moved/deployed or no booster|0|||
49049620|NCT01011335|158017275|FG012|Overall Study|Moved/deployed or no booster|0|||
49049621|NCT01011335|158017263|FG000|Overall Study|Adverse Event|0|||
49049622|NCT01011335|158017264|FG001|Overall Study|Adverse Event|0|||
49049623|NCT01011335|158017265|FG002|Overall Study|Adverse Event|0|||
49049624|NCT01011335|158017266|FG003|Overall Study|Adverse Event|0|||
49049625|NCT01011335|158017267|FG004|Overall Study|Adverse Event|0|||
49049626|NCT01011335|158017268|FG005|Overall Study|Adverse Event|0|||
49049627|NCT01011335|158017269|FG006|Overall Study|Adverse Event|0|||
49049628|NCT01011335|158017270|FG007|Overall Study|Adverse Event|0|||
49049629|NCT01011335|158017271|FG008|Overall Study|Adverse Event|0|||
49049630|NCT01011335|158017272|FG009|Overall Study|Adverse Event|0|||
49049631|NCT01011335|158017273|FG010|Overall Study|Adverse Event|4|||
49049632|NCT01011335|158017274|FG011|Overall Study|Adverse Event|0|||
49049633|NCT01011335|158017275|FG012|Overall Study|Adverse Event|1|||
49049634|NCT04974619|158017276|FG000|Overall Study|Lost to Follow-up|0|||
49049635|NCT04974619|158017277|FG001|Overall Study|Lost to Follow-up|0|||
49049636|NCT04974619|158017278|FG002|Overall Study|Lost to Follow-up|1|||
49049637|NCT04974619|158017276|FG000|Overall Study|Withdrawal by Subject|0|||
49049638|NCT04974619|158017277|FG001|Overall Study|Withdrawal by Subject|0|||
49049639|NCT04974619|158017278|FG002|Overall Study|Withdrawal by Subject|1|||
49049640|NCT04974619|158017276|FG000|Overall Study|Protocol Violation|0|||
49049641|NCT04974619|158017277|FG001|Overall Study|Protocol Violation|1|||
49049642|NCT04974619|158017278|FG002|Overall Study|Protocol Violation|0|||
49049643|NCT02447887|158017302|FG000|Overall Study|Study was terminated|3|||
49049644|NCT02839798|158017303|FG000|Overall Study|Withdrawal by Subject|2|||
49049645|NCT01765751|158017304|FG000|Overall Study|Lost to Follow-up|0|||
49049646|NCT01765751|158017305|FG001|Overall Study|Lost to Follow-up|2|||
49049647|NCT01765751|158017306|FG002|Overall Study|Lost to Follow-up|1|||
49049648|NCT03180528|158017307|FG000|Overall Study|Adverse Event|1|||
49049649|NCT03180528|158017307|FG000|Overall Study|Withdrawal by Subject|1|||
49049650|NCT03180528|158017307|FG000|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1|||
49049651|NCT01989676|158017308|FG000|Overall Study|Death|52|||
49049652|NCT01989676|158017309|FG001|Overall Study|Death|60|||
49049653|NCT01989676|158017308|FG000|Overall Study|Protocol Violation|2|||
49049654|NCT01989676|158017309|FG001|Overall Study|Protocol Violation|1|||
49049655|NCT01989676|158017308|FG000|Overall Study|Lost to Follow-up|8|||
49049656|NCT01989676|158017309|FG001|Overall Study|Lost to Follow-up|18|||
49049657|NCT01989676|158017308|FG000|Overall Study|No longer willing to participate in study|26|||
49049658|NCT01989676|158017309|FG001|Overall Study|No longer willing to participate in study|26|||
49049659|NCT01989676|158017308|FG000|Overall Study|Participants terminated from study by Sponsor|26|||
49049660|NCT01989676|158017309|FG001|Overall Study|Participants terminated from study by Sponsor|30|||
49049661|NCT01989676|158017308|FG000|Overall Study|Other|4|||
49049662|NCT01989676|158017309|FG001|Overall Study|Other|3|||
49049663|NCT04241133|158017310|FG000|Overall Study|COVID19 Precautions|14|||
49049664|NCT04241133|158017311|FG001|Overall Study|COVID19 Precautions|34|||
49049665|NCT00595335|158017312|FG000|Baseline to Six Months|Withdrawal by Subject|0|||
49049666|NCT00595335|158017313|FG001|Baseline to Six Months|Withdrawal by Subject|1|||
49049667|NCT00595335|158017312|FG000|Baseline to Six Months|Disease Progression|1|||
49049668|NCT00595335|158017313|FG001|Baseline to Six Months|Disease Progression|1|||
49049669|NCT00595335|158017312|FG000|Baseline to Six Months|Adverse Event|1|||
49049670|NCT00595335|158017313|FG001|Baseline to Six Months|Adverse Event|0|||
49049671|NCT00595335|158017312|FG000|Six Months to Twelve Months|Withdrawal by Subject|0|||
49049672|NCT00595335|158017313|FG001|Six Months to Twelve Months|Withdrawal by Subject|1|||
49049673|NCT00595335|158017312|FG000|Six Months to Twelve Months|Disease Progression|1|||
49049674|NCT00595335|158017313|FG001|Six Months to Twelve Months|Disease Progression|0|||
49049675|NCT02674633|158017315|FG000|Overall Study|Lost to Follow-up|3|||
49049676|NCT02674633|158017316|FG001|Overall Study|Lost to Follow-up|2|||
49049677|NCT02674633|158017315|FG000|Overall Study|Physician Decision|1|||
49049678|NCT02674633|158017316|FG001|Overall Study|Physician Decision|0|||
49049679|NCT02674633|158017315|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
49049680|NCT02674633|158017316|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
49049681|NCT00460109|158017317|FG000|Overall Study|Death|1|||
49049682|NCT02733627|158017318|FG000|Overall Study|Adverse Event|0|||
49049683|NCT02733627|158017319|FG001|Overall Study|Adverse Event|1|||
49049684|NCT02733627|158017320|FG002|Overall Study|Adverse Event|1|||
49049685|NCT02733627|158017321|FG003|Overall Study|Adverse Event|0|||
49049686|NCT02733627|158017318|FG000|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
49049687|NCT02733627|158017319|FG001|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
49049688|NCT02733627|158017320|FG002|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1|||
49049689|NCT02733627|158017321|FG003|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
49049690|NCT01619579|158017322|FG000|Overall Study|Withdrawal by Subject|0|||
49049691|NCT01619579|158017323|FG001|Overall Study|Withdrawal by Subject|3|||
49049692|NCT02344745|158017324|FG000|Overall Study|Data collection sheets were lost|2|||
49049693|NCT02344745|158017325|FG001|Overall Study|Data collection sheets were lost|0|||
49049694|NCT00183196|158017326|FG000|Overall Study|Withdrawal by Subject|18|||
49049695|NCT00183196|158017327|FG001|Overall Study|Withdrawal by Subject|11|||
49049696|NCT00183196|158017328|FG002|Overall Study|Withdrawal by Subject|13|||
49049697|NCT00183196|158017326|FG000|Overall Study|Adverse Event|1|||
49049698|NCT00183196|158017327|FG001|Overall Study|Adverse Event|2|||
49049699|NCT00183196|158017328|FG002|Overall Study|Adverse Event|2|||
49049700|NCT00183196|158017326|FG000|Overall Study|Legal event|1|||
49049701|NCT00183196|158017327|FG001|Overall Study|Legal event|1|||
49049702|NCT00183196|158017328|FG002|Overall Study|Legal event|1|||
49049703|NCT00183196|158017326|FG000|Overall Study|Required more intensive care|0|||
49049704|NCT00183196|158017327|FG001|Overall Study|Required more intensive care|1|||
49049705|NCT00183196|158017328|FG002|Overall Study|Required more intensive care|2|||
49049706|NCT02788513|158017329|FG000|Overall Study|Withdrawal by Subject|3|||
49049707|NCT02788513|158017330|FG001|Overall Study|Withdrawal by Subject|0|||
49049708|NCT02788513|158017331|FG002|Overall Study|Withdrawal by Subject|2|||
49049709|NCT02788513|158017332|FG003|Overall Study|Withdrawal by Subject|3|||
49049710|NCT02788513|158017333|FG004|Overall Study|Withdrawal by Subject|1|||
49049711|NCT02788513|158017329|FG000|Overall Study|Lost to Follow-up|1|||
49049712|NCT02788513|158017330|FG001|Overall Study|Lost to Follow-up|0|||
49049713|NCT02788513|158017331|FG002|Overall Study|Lost to Follow-up|0|||
49049714|NCT02788513|158017332|FG003|Overall Study|Lost to Follow-up|0|||
49049715|NCT02788513|158017333|FG004|Overall Study|Lost to Follow-up|1|||
49049716|NCT02788513|158017329|FG000|Overall Study|Adverse Event|5|||
49049717|NCT02788513|158017330|FG001|Overall Study|Adverse Event|8|||
49049718|NCT02788513|158017331|FG002|Overall Study|Adverse Event|4|||
49049719|NCT02788513|158017332|FG003|Overall Study|Adverse Event|2|||
49049720|NCT02788513|158017333|FG004|Overall Study|Adverse Event|2|||
49049721|NCT02788513|158017329|FG000|Overall Study|Protocol Violation|0|||
49049722|NCT02788513|158017330|FG001|Overall Study|Protocol Violation|0|||
49049723|NCT02788513|158017331|FG002|Overall Study|Protocol Violation|1|||
49049724|NCT02788513|158017332|FG003|Overall Study|Protocol Violation|1|||
49049725|NCT02788513|158017333|FG004|Overall Study|Protocol Violation|0|||
49049726|NCT02788513|158017329|FG000|Overall Study|Subject decided to stop taking treatment|0|||
49049727|NCT02788513|158017330|FG001|Overall Study|Subject decided to stop taking treatment|0|||
49049728|NCT02788513|158017331|FG002|Overall Study|Subject decided to stop taking treatment|1|||
49049729|NCT02788513|158017332|FG003|Overall Study|Subject decided to stop taking treatment|0|||
49049730|NCT02788513|158017333|FG004|Overall Study|Subject decided to stop taking treatment|0|||
49049731|NCT02788513|158017329|FG000|Overall Study|Decision by the study team|0|||
49049732|NCT02788513|158017330|FG001|Overall Study|Decision by the study team|0|||
49049733|NCT02788513|158017331|FG002|Overall Study|Decision by the study team|0|||
49049734|NCT02788513|158017332|FG003|Overall Study|Decision by the study team|0|||
49049735|NCT02788513|158017333|FG004|Overall Study|Decision by the study team|1|||
49049736|NCT02246764|158017334|FG000|Overall Study|Adverse Event|15|||
49049737|NCT02246764|158017335|FG001|Overall Study|Adverse Event|29|||
49049738|NCT02246764|158017336|FG002|Overall Study|Adverse Event|1|||
49049739|NCT02246764|158017334|FG000|Overall Study|Withdrawal by Subject|0|||
49049740|NCT02246764|158017335|FG001|Overall Study|Withdrawal by Subject|0|||
49049741|NCT02246764|158017336|FG002|Overall Study|Withdrawal by Subject|1|||
49049742|NCT02246764|158017334|FG000|Overall Study|Disallowed Concomitant Medication|1|||
49049743|NCT02246764|158017335|FG001|Overall Study|Disallowed Concomitant Medication|0|||
49049744|NCT02246764|158017336|FG002|Overall Study|Disallowed Concomitant Medication|0|||
49049745|NCT02246764|158017334|FG000|Overall Study|Physician Decision|0|||
49049746|NCT02246764|158017335|FG001|Overall Study|Physician Decision|2|||
49049747|NCT02246764|158017336|FG002|Overall Study|Physician Decision|1|||
49049748|NCT02246764|158017334|FG000|Overall Study|Protocol Violation|2|||
49049749|NCT02246764|158017335|FG001|Overall Study|Protocol Violation|1|||
49049750|NCT02246764|158017336|FG002|Overall Study|Protocol Violation|1|||
49049751|NCT02124902|158017337|FG000|Overall Study|Adverse Event|7|||
49049752|NCT02124902|158017338|FG001|Overall Study|Adverse Event|2|||
49049753|NCT02124902|158017337|FG000|Overall Study|Went to alternative treatment|4|||
49049754|NCT02124902|158017338|FG001|Overall Study|Went to alternative treatment|0|||
49049755|NCT02124902|158017337|FG000|Overall Study|Withdrawal by Subject|2|||
49049756|NCT02124902|158017338|FG001|Overall Study|Withdrawal by Subject|1|||
49049757|NCT02124902|158017337|FG000|Overall Study|Physician Decision|2|||
49049758|NCT02124902|158017338|FG001|Overall Study|Physician Decision|0|||
49049759|NCT02124902|158017337|FG000|Overall Study|Not eligible|1|||
49049760|NCT02124902|158017338|FG001|Overall Study|Not eligible|0|||
49049761|NCT02124902|158017337|FG000|Overall Study|Did not receive carboplatin in cycle 6|1|||
49049762|NCT02124902|158017338|FG001|Overall Study|Did not receive carboplatin in cycle 6|3|||
49049763|NCT01937351|158017339|FG000|Overall Study|Withdrawal by Subject|4|||
49049764|NCT01937351|158017340|FG001|Overall Study|Withdrawal by Subject|2|||
49049765|NCT01937351|158017339|FG000|Overall Study|Death|1|||
49049766|NCT01937351|158017340|FG001|Overall Study|Death|0|||
49049767|NCT01937351|158017339|FG000|Overall Study|Not treated w device, per protocol fail|4|||
49049768|NCT01937351|158017340|FG001|Overall Study|Not treated w device, per protocol fail|0|||
49049769|NCT01961687|158017342|FG000|Overall Study|Lost to Follow-up|19|||
49049770|NCT01961687|158017342|FG000|Overall Study|Re-operation|17|||
49049771|NCT01961687|158017342|FG000|Overall Study|Death|7|||
49049772|NCT01961687|158017342|FG000|Overall Study|Withdrawal by Subject|6|||
49049773|NCT01961687|158017342|FG000|Overall Study|Adverse Event|6|||
49049774|NCT01961687|158017342|FG000|Overall Study|Moved to area without study site|2|||
49049775|NCT01961687|158017342|FG000|Overall Study|Sponsor decision|2|||
49049776|NCT01961687|158017342|FG000|Overall Study|Physician Decision|1|||
49049777|NCT01961687|158017342|FG000|Overall Study|Unable to meet follow-up requirements|1|||
49049778|NCT02688387|158017343|FG000|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
49049779|NCT02688387|158017344|FG001|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
49049780|NCT02688387|158017345|FG002|Part 1, Period 1 (up to 6 Days)|Adverse Event|1|||
49049781|NCT02688387|158017346|FG003|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
49049782|NCT02688387|158017347|FG004|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
49049783|NCT02688387|158017348|FG005|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
49049784|NCT02688387|158017349|FG006|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
49049785|NCT02688387|158017350|FG007|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
49049786|NCT02688387|158017351|FG008|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
49049787|NCT02688387|158017352|FG009|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
49049788|NCT02688387|158017353|FG010|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
49049789|NCT02688387|158017354|FG011|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
49049790|NCT02688387|158017355|FG012|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
49049791|NCT02688387|158017356|FG013|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
49049792|NCT02688387|158017357|FG014|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
49049793|NCT02688387|158017358|FG015|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
49049794|NCT02688387|158017359|FG016|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
49049795|NCT02688387|158017360|FG017|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
49049796|NCT02688387|158017361|FG018|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
49049797|NCT02688387|158017362|FG019|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
49049798|NCT02688387|158017363|FG020|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
49049799|NCT02688387|158017364|FG021|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
49049800|NCT02688387|158017343|FG000|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
49049801|NCT02688387|158017344|FG001|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
49049802|NCT02688387|158017345|FG002|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
49049803|NCT02688387|158017346|FG003|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
49049804|NCT02688387|158017347|FG004|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
49049805|NCT02688387|158017348|FG005|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
49049806|NCT02688387|158017349|FG006|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
49049807|NCT02688387|158017350|FG007|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
49049808|NCT02688387|158017351|FG008|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
49049809|NCT02688387|158017352|FG009|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
49049810|NCT02688387|158017353|FG010|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
49049811|NCT02688387|158017354|FG011|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
49049812|NCT02688387|158017355|FG012|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
49049813|NCT02688387|158017356|FG013|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
49049814|NCT02688387|158017357|FG014|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
49049815|NCT02688387|158017358|FG015|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
49049816|NCT02688387|158017359|FG016|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
49049817|NCT02688387|158017360|FG017|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
49049818|NCT02688387|158017361|FG018|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
49049819|NCT02688387|158017362|FG019|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
49049820|NCT02688387|158017363|FG020|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
49049821|NCT02688387|158017364|FG021|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
49049822|NCT02688387|158017343|FG000|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
49049823|NCT02688387|158017344|FG001|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1|||
49049824|NCT02688387|158017345|FG002|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
49049825|NCT02688387|158017346|FG003|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
49049826|NCT02688387|158017347|FG004|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
49049827|NCT02688387|158017348|FG005|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
49049828|NCT02688387|158017349|FG006|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
49049829|NCT02688387|158017350|FG007|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
49049830|NCT02688387|158017351|FG008|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
49049831|NCT02688387|158017352|FG009|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
49049832|NCT02688387|158017353|FG010|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
49049833|NCT02688387|158017354|FG011|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
49049834|NCT02688387|158017355|FG012|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
49049835|NCT02688387|158017356|FG013|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
49049836|NCT02688387|158017357|FG014|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
49049837|NCT02688387|158017358|FG015|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
49049838|NCT02688387|158017359|FG016|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
49049839|NCT02688387|158017360|FG017|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
49049840|NCT02688387|158017361|FG018|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
49049841|NCT02688387|158017362|FG019|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
49049842|NCT02688387|158017363|FG020|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
49049843|NCT02688387|158017364|FG021|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
49049844|NCT02688387|158017343|FG000|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
49049845|NCT02688387|158017344|FG001|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
49049846|NCT02688387|158017345|FG002|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
49049847|NCT02688387|158017346|FG003|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
49049848|NCT02688387|158017347|FG004|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
49049849|NCT02688387|158017348|FG005|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
49049850|NCT02688387|158017349|FG006|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
49049851|NCT02688387|158017350|FG007|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
49049852|NCT02688387|158017351|FG008|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
49049853|NCT02688387|158017352|FG009|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
49049854|NCT02688387|158017353|FG010|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
49049855|NCT02688387|158017354|FG011|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
49049856|NCT02688387|158017355|FG012|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
49049857|NCT02688387|158017356|FG013|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
49049858|NCT02688387|158017357|FG014|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
49049859|NCT02688387|158017358|FG015|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
49049860|NCT02688387|158017359|FG016|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
49049861|NCT02688387|158017360|FG017|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
49049862|NCT02688387|158017361|FG018|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
49049863|NCT02688387|158017362|FG019|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
49049864|NCT02688387|158017363|FG020|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
49049865|NCT02688387|158017364|FG021|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
49049866|NCT02688387|158017343|FG000|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1|||
49049867|NCT02688387|158017344|FG001|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
49049868|NCT02688387|158017345|FG002|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
49049869|NCT02688387|158017346|FG003|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
49049870|NCT02688387|158017347|FG004|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
49049871|NCT02688387|158017348|FG005|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
49049872|NCT02688387|158017349|FG006|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
49049873|NCT02688387|158017350|FG007|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
49049874|NCT02688387|158017351|FG008|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
49049875|NCT02688387|158017352|FG009|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
49049876|NCT02688387|158017353|FG010|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
49049877|NCT02688387|158017354|FG011|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
49049878|NCT02688387|158017355|FG012|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
49049879|NCT02688387|158017356|FG013|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
49049880|NCT02688387|158017357|FG014|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
49049881|NCT02688387|158017358|FG015|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
49049882|NCT02688387|158017359|FG016|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
49049883|NCT02688387|158017360|FG017|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
49049884|NCT02688387|158017361|FG018|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
49049885|NCT02688387|158017362|FG019|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
49049886|NCT02688387|158017363|FG020|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
49049887|NCT02688387|158017364|FG021|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
49049888|NCT02688387|158017343|FG000|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
49049889|NCT02688387|158017344|FG001|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
49049890|NCT02688387|158017345|FG002|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
49049891|NCT02688387|158017346|FG003|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
49049892|NCT02688387|158017347|FG004|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
49049893|NCT02688387|158017348|FG005|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
49049894|NCT02688387|158017349|FG006|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
49049895|NCT02688387|158017350|FG007|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
49049896|NCT02688387|158017351|FG008|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
49049897|NCT02688387|158017352|FG009|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
49049898|NCT02688387|158017353|FG010|Part 2, Period 1 (up to 6 Days)|Adverse Event|1|||
49049899|NCT02688387|158017354|FG011|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
49049900|NCT02688387|158017355|FG012|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
49049901|NCT02688387|158017356|FG013|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
49049902|NCT02688387|158017357|FG014|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
49049903|NCT02688387|158017358|FG015|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
49049904|NCT02688387|158017359|FG016|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
49049905|NCT02688387|158017360|FG017|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
49049906|NCT02688387|158017361|FG018|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
49049907|NCT02688387|158017362|FG019|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
49049908|NCT02688387|158017363|FG020|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
49049909|NCT02688387|158017364|FG021|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
49049910|NCT02688387|158017343|FG000|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
48692644|NCT03001557|156724548|FG007|Extension Phase|Lost to Follow-up|1|||
49049911|NCT02688387|158017344|FG001|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
49049912|NCT02688387|158017345|FG002|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
49049913|NCT02688387|158017346|FG003|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
49049914|NCT02688387|158017347|FG004|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
49049915|NCT02688387|158017348|FG005|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
49049916|NCT02688387|158017349|FG006|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
49049917|NCT02688387|158017350|FG007|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
49049918|NCT02688387|158017351|FG008|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
49049919|NCT02688387|158017352|FG009|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
49049920|NCT02688387|158017353|FG010|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
49049921|NCT02688387|158017354|FG011|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
49049922|NCT02688387|158017355|FG012|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
49049923|NCT02688387|158017356|FG013|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
49049924|NCT02688387|158017357|FG014|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
49049925|NCT02688387|158017358|FG015|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
49049926|NCT02688387|158017359|FG016|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
49049927|NCT02688387|158017360|FG017|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
49049928|NCT02688387|158017361|FG018|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
49049929|NCT02688387|158017362|FG019|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
49049930|NCT02688387|158017363|FG020|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
49049931|NCT02688387|158017364|FG021|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
49049932|NCT02688387|158017343|FG000|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
49049933|NCT02688387|158017344|FG001|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
49049934|NCT02688387|158017345|FG002|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
49049935|NCT02688387|158017346|FG003|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
49049936|NCT02688387|158017347|FG004|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
49049937|NCT02688387|158017348|FG005|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
49049938|NCT02688387|158017349|FG006|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
49049939|NCT02688387|158017350|FG007|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
49049940|NCT02688387|158017351|FG008|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
49049941|NCT02688387|158017352|FG009|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
49049942|NCT02688387|158017353|FG010|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
49049943|NCT02688387|158017354|FG011|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
49049944|NCT02688387|158017355|FG012|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
49049945|NCT02688387|158017356|FG013|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
49049946|NCT02688387|158017357|FG014|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
49049947|NCT02688387|158017358|FG015|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
49049948|NCT02688387|158017359|FG016|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
49049949|NCT02688387|158017360|FG017|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
49049950|NCT02688387|158017361|FG018|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
49049951|NCT02688387|158017362|FG019|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
49049952|NCT02688387|158017363|FG020|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1|||
49049953|NCT02688387|158017364|FG021|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
49049954|NCT02688387|158017343|FG000|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
49049955|NCT02688387|158017344|FG001|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
49049956|NCT02688387|158017345|FG002|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
49049957|NCT02688387|158017346|FG003|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
49049958|NCT02688387|158017347|FG004|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
49049959|NCT02688387|158017348|FG005|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
49049960|NCT02688387|158017349|FG006|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
49049961|NCT02688387|158017350|FG007|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
49049962|NCT02688387|158017351|FG008|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
49049963|NCT02688387|158017352|FG009|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
49049964|NCT02688387|158017353|FG010|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
49049965|NCT02688387|158017354|FG011|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
49049966|NCT02688387|158017355|FG012|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
49049967|NCT02688387|158017356|FG013|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
49049968|NCT02688387|158017357|FG014|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
49049969|NCT02688387|158017358|FG015|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
49049970|NCT02688387|158017359|FG016|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
49049971|NCT02688387|158017360|FG017|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
49049972|NCT02688387|158017361|FG018|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
49049973|NCT02688387|158017362|FG019|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
49049974|NCT02688387|158017363|FG020|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
49049975|NCT02688387|158017364|FG021|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
49049976|NCT02688387|158017343|FG000|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
49049977|NCT02688387|158017344|FG001|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
49049978|NCT02688387|158017345|FG002|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
49049979|NCT02688387|158017346|FG003|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
49049980|NCT02688387|158017347|FG004|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
49049981|NCT02688387|158017348|FG005|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
49049982|NCT02688387|158017349|FG006|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
49049983|NCT02688387|158017350|FG007|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
49049984|NCT02688387|158017351|FG008|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
49049985|NCT02688387|158017352|FG009|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
49049986|NCT02688387|158017353|FG010|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
49049987|NCT02688387|158017354|FG011|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
49049988|NCT02688387|158017355|FG012|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
49049989|NCT02688387|158017356|FG013|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
49049990|NCT02688387|158017357|FG014|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
49049991|NCT02688387|158017358|FG015|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
49049992|NCT02688387|158017359|FG016|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
49049993|NCT02688387|158017360|FG017|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
49049994|NCT02688387|158017361|FG018|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
49049995|NCT02688387|158017362|FG019|Part 3B, Washout Period 3 (10 Days)|Study terminated|1|||
49049996|NCT02688387|158017363|FG020|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
49049997|NCT02688387|158017364|FG021|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
49049998|NCT00493779|158017365|FG000|Overall Study|Logistical issue at site|1|||
49049999|NCT00802178|158017367|FG000|Overall Study|Lack of Efficacy|36|||
49050000|NCT00802178|158017367|FG000|Overall Study|Insufficient tolerability (IT)|17|||
49050001|NCT00802178|158017367|FG000|Overall Study|Withdrawal by Subject|18|||
49050002|NCT00802178|158017367|FG000|Overall Study|Other|32|||
49050003|NCT00802178|158017367|FG000|Overall Study|Lack of efficacy and patient wish|1|||
49050004|NCT00802178|158017367|FG000|Overall Study|IT and patient wish|8|||
49050005|NCT00802178|158017367|FG000|Overall Study|Patients wish and other reason|1|||
49050006|NCT02284347|158017368|FG000|Overall Study|Lost to Follow-up|2|||
49050007|NCT02284347|158017368|FG000|Overall Study|Withdrawn prior to treatment|1|||
49050008|NCT00808509|158017369|FG000|Randomized Phase|Did not meet eligibility criteria|1|||
49050009|NCT00808509|158017370|FG001|Randomized Phase|Did not meet eligibility criteria|0|||
49050010|NCT00808509|158017369|FG000|Randomized Phase|Reduced methotrexate dose|1|||
49050011|NCT00808509|158017370|FG001|Randomized Phase|Reduced methotrexate dose|2|||
49050012|NCT00808509|158017369|FG000|Randomized Phase|Patient refused rescue therapy|0|||
49050013|NCT00808509|158017370|FG001|Randomized Phase|Patient refused rescue therapy|3|||
49050014|NCT00263887|158017373|FG000|Overall Study|Withdrawal by Subject|1|||
49050015|NCT00263887|158017374|FG001|Overall Study|Withdrawal by Subject|1|||
49050016|NCT00263887|158017373|FG000|Overall Study|Lung transplantation|1|||
49050017|NCT00263887|158017374|FG001|Overall Study|Lung transplantation|2|||
49050018|NCT00263887|158017373|FG000|Overall Study|Too ill to attend visit|1|||
49050019|NCT00263887|158017374|FG001|Overall Study|Too ill to attend visit|0|||
49050020|NCT00263887|158017373|FG000|Overall Study|Adverse Event|0|||
49050021|NCT00263887|158017374|FG001|Overall Study|Adverse Event|2|||
49050022|NCT00263887|158017373|FG000|Overall Study|Disease progression|0|||
49050023|NCT00263887|158017374|FG001|Overall Study|Disease progression|1|||
49050024|NCT00263887|158017373|FG000|Overall Study|Lack of Efficacy|0|||
49050025|NCT00263887|158017374|FG001|Overall Study|Lack of Efficacy|1|||
49050026|NCT01688882|158017375|FG000|Overall Study|Adverse Event|1|||
49050027|NCT01688882|158017376|FG001|Overall Study|Adverse Event|0|||
49050028|NCT01688882|158017375|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
49050029|NCT01688882|158017376|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
49050030|NCT01688882|158017375|FG000|Overall Study|Administrative problems|1|||
49050031|NCT01688882|158017376|FG001|Overall Study|Administrative problems|0|||
49050032|NCT04291508|158017377|FG000|Overall Study|Withdrawal by Subject|1|||
49050033|NCT04291508|158017378|FG001|Overall Study|Withdrawal by Subject|0|||
49050034|NCT04291508|158017379|FG002|Overall Study|Withdrawal by Subject|1|||
49050035|NCT04291508|158017380|FG003|Overall Study|Withdrawal by Subject|0|||
49050036|NCT04291508|158017377|FG000|Overall Study|lost to follow up|4|||
49050037|NCT04291508|158017378|FG001|Overall Study|lost to follow up|0|||
49050038|NCT04291508|158017379|FG002|Overall Study|lost to follow up|1|||
49050039|NCT04291508|158017380|FG003|Overall Study|lost to follow up|0|||
49050040|NCT01955044|158017381|FG000|Overall Study|Death|1|||
49050041|NCT01955044|158017382|FG001|Overall Study|Death|1|||
49050042|NCT01955044|158017383|FG002|Overall Study|Death|0|||
49050043|NCT02280187|158017388|FG000|Overall Study|Lost to Follow-up|218|||
49050044|NCT03840382|158017391|FG000|Overall Study|Lost to Follow-up|11|||
49050045|NCT04668274|158017394|FG000|Part 1 Study Period 1|Adverse Event|3|||
49050046|NCT04668274|158017395|FG001|Part 1 Study Period 1|Adverse Event|0|||
49050047|NCT04668274|158017396|FG002|Part 1 Study Period 1|Adverse Event|0|||
49050048|NCT04668274|158017397|FG003|Part 1 Study Period 1|Adverse Event|0|||
49050049|NCT04668274|158017394|FG000|Part 1 Study Period 1|Withdrawal by Subject|2|||
49050050|NCT04668274|158017395|FG001|Part 1 Study Period 1|Withdrawal by Subject|0|||
49050051|NCT04668274|158017396|FG002|Part 1 Study Period 1|Withdrawal by Subject|0|||
49050052|NCT04668274|158017397|FG003|Part 1 Study Period 1|Withdrawal by Subject|0|||
49050053|NCT04668274|158017394|FG000|Part 1 Study Period 2|Other|0|||
49050054|NCT04668274|158017395|FG001|Part 1 Study Period 2|Other|1|||
49050055|NCT04668274|158017396|FG002|Part 1 Study Period 2|Other|0|||
49050056|NCT04668274|158017397|FG003|Part 1 Study Period 2|Other|0|||
49050057|NCT04668274|158017394|FG000|Part 1 Study Period 3|Adverse Event|0|||
49050058|NCT04668274|158017395|FG001|Part 1 Study Period 3|Adverse Event|0|||
49050059|NCT04668274|158017396|FG002|Part 1 Study Period 3|Adverse Event|1|||
49050060|NCT04668274|158017397|FG003|Part 1 Study Period 3|Adverse Event|0|||
49050061|NCT04668274|158017394|FG000|Part 1 Study Period 3|Other|0|||
49050062|NCT04668274|158017395|FG001|Part 1 Study Period 3|Other|0|||
49050063|NCT04668274|158017396|FG002|Part 1 Study Period 3|Other|2|||
49050064|NCT04668274|158017397|FG003|Part 1 Study Period 3|Other|0|||
49050065|NCT04668274|158017394|FG000|Part 2 Study Period 4|Other|0|||
49050066|NCT04668274|158017395|FG001|Part 2 Study Period 4|Other|0|||
49050067|NCT04668274|158017396|FG002|Part 2 Study Period 4|Other|0|||
49050068|NCT04668274|158017397|FG003|Part 2 Study Period 4|Other|1|||
49050069|NCT00551616|158017402|FG000|Overall Study|Lost to Follow-up|48|||
49050070|NCT00551616|158017403|FG001|Overall Study|Lost to Follow-up|40|||
49050071|NCT02752802|158017404|FG000|Overall Study|Contrast Volume Not Collected|1|||
49050072|NCT02752802|158017405|FG001|Overall Study|Contrast Volume Not Collected|0|||
49050073|NCT02808819|158017406|FG000|Overall Study|eg. no treatment efficacy on asthma|5|||
49050074|NCT02808819|158017407|FG001|Overall Study|eg. no treatment efficacy on asthma|4|||
49050075|NCT02808819|158017406|FG000|Overall Study|Withdrawal by Subject|10|||
49050076|NCT02808819|158017407|FG001|Overall Study|Withdrawal by Subject|13|||
49050077|NCT02808819|158017406|FG000|Overall Study|Site terminated by sponsor|2|||
49050078|NCT02808819|158017407|FG001|Overall Study|Site terminated by sponsor|0|||
49050079|NCT02808819|158017406|FG000|Overall Study|Pregnancy|1|||
49050080|NCT02808819|158017407|FG001|Overall Study|Pregnancy|0|||
49050081|NCT02808819|158017406|FG000|Overall Study|Lost to Follow-up|1|||
49050082|NCT02808819|158017407|FG001|Overall Study|Lost to Follow-up|6|||
49050083|NCT02808819|158017406|FG000|Overall Study|Protocol Violation|0|||
49050084|NCT02808819|158017407|FG001|Overall Study|Protocol Violation|1|||
49050085|NCT02808819|158017406|FG000|Overall Study|Development of study-specific withdrawal criteria|8|||
49050086|NCT02808819|158017407|FG001|Overall Study|Development of study-specific withdrawal criteria|3|||
49050087|NCT02808819|158017406|FG000|Overall Study|Death|1|||
49050088|NCT02808819|158017407|FG001|Overall Study|Death|0|||
49050089|NCT02808819|158017406|FG000|Overall Study|Adverse Event|3|||
49050090|NCT02808819|158017407|FG001|Overall Study|Adverse Event|4|||
49050091|NCT01937117|158017410|FG000|Overall Study|Disease Progression|7|||
49050092|NCT01937117|158017410|FG000|Overall Study|Physician Decision|4|||
49050093|NCT01937117|158017410|FG000|Overall Study|Adverse Event|2|||
49050094|NCT01192399|158017411|FG000|Overall Study|Lack of Efficacy|2|||
49050095|NCT00436917|158017414|FG000|Overall Study|Withdrawal by Subject|13|||
49050096|NCT00436917|158017414|FG000|Overall Study|Adverse Event|2|||
49050097|NCT00436917|158017414|FG000|Overall Study|Physician Decision|1|||
49050098|NCT00436917|158017414|FG000|Overall Study|Death|1|||
49050099|NCT00436917|158017414|FG000|Overall Study|Lost to Follow-up|1|||
49050100|NCT00436917|158017414|FG000|Overall Study|Treatment for polymyalgia rheumatic|1|||
49050101|NCT00436917|158017414|FG000|Overall Study|Increased creatinine|1|||
49050102|NCT00436917|158017414|FG000|Overall Study|Personal conflicts of patient|1|||
49050103|NCT01029392|158017415|FG000|Overall Study|Withdrawal by Subject|18|||
49050104|NCT01029392|158017416|FG001|Overall Study|Withdrawal by Subject|11|||
49050105|NCT01029392|158017415|FG000|Overall Study|Physician Decision|2|||
49050106|NCT01029392|158017416|FG001|Overall Study|Physician Decision|0|||
49050107|NCT00931463|158017417|FG000|Overall Study|Death|8|||
49050108|NCT00931463|158017418|FG001|Overall Study|Death|4|||
49050109|NCT00931463|158017417|FG000|Overall Study|Withdrawal by Subject|5|||
49050110|NCT00931463|158017418|FG001|Overall Study|Withdrawal by Subject|0|||
49050111|NCT00931463|158017417|FG000|Overall Study|Lost to Follow-up|4|||
49050112|NCT00931463|158017418|FG001|Overall Study|Lost to Follow-up|1|||
49050113|NCT03438006|158017419|FG000|Overall Study|Adverse Event|1|||
49050114|NCT03438006|158017419|FG000|Overall Study|Lost to Follow-up|67|||
49050115|NCT03438006|158017419|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47|||
49050116|NCT03438006|158017419|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3|||
49050117|NCT00857818|158017430|FG000|Overall Study|Lack of Efficacy|1|||
49050118|NCT00857818|158017431|FG001|Overall Study|Lack of Efficacy|0|||
49050119|NCT00857818|158017430|FG000|Overall Study|Adverse Event|3|||
49050120|NCT00857818|158017431|FG001|Overall Study|Adverse Event|0|||
49050121|NCT00857818|158017430|FG000|Overall Study|Withdrawal by Subject|0|||
49050122|NCT00857818|158017431|FG001|Overall Study|Withdrawal by Subject|4|||
49050123|NCT00857818|158017430|FG000|Overall Study|Sponsor terminated study|6|||
49050124|NCT00857818|158017431|FG001|Overall Study|Sponsor terminated study|4|||
49050125|NCT00857818|158017430|FG000|Overall Study|Investigator decision|1|||
49050126|NCT00857818|158017431|FG001|Overall Study|Investigator decision|0|||
49050127|NCT01392326|158017432|FG000|Overall Study|Death|2|||
49050128|NCT01392326|158017433|FG001|Overall Study|Death|0|||
49050129|NCT01392326|158017434|FG002|Overall Study|Death|0|||
49050130|NCT01392326|158017432|FG000|Overall Study|Withdrawal by Subject|12|||
49050131|NCT01392326|158017433|FG001|Overall Study|Withdrawal by Subject|11|||
49050132|NCT01392326|158017434|FG002|Overall Study|Withdrawal by Subject|15|||
49050133|NCT01392326|158017432|FG000|Overall Study|Protocol Violation|2|||
49050134|NCT01392326|158017433|FG001|Overall Study|Protocol Violation|0|||
49050135|NCT01392326|158017434|FG002|Overall Study|Protocol Violation|0|||
49050136|NCT01392326|158017432|FG000|Overall Study|Pregnancy|0|||
49050137|NCT01392326|158017433|FG001|Overall Study|Pregnancy|0|||
49050138|NCT01392326|158017434|FG002|Overall Study|Pregnancy|1|||
49050139|NCT01392326|158017432|FG000|Overall Study|Physician Decision|7|||
49050140|NCT01392326|158017433|FG001|Overall Study|Physician Decision|5|||
49050141|NCT01392326|158017434|FG002|Overall Study|Physician Decision|2|||
49050142|NCT01392326|158017432|FG000|Overall Study|Lost to Follow-up|1|||
49050143|NCT01392326|158017433|FG001|Overall Study|Lost to Follow-up|3|||
49050144|NCT01392326|158017434|FG002|Overall Study|Lost to Follow-up|4|||
49050145|NCT01392326|158017432|FG000|Overall Study|Lack of Efficacy|14|||
49050146|NCT01392326|158017433|FG001|Overall Study|Lack of Efficacy|10|||
49050147|NCT01392326|158017434|FG002|Overall Study|Lack of Efficacy|15|||
49050148|NCT01392326|158017432|FG000|Overall Study|Adverse Event|9|||
49050149|NCT01392326|158017433|FG001|Overall Study|Adverse Event|6|||
49050150|NCT01392326|158017434|FG002|Overall Study|Adverse Event|11|||
49050151|NCT05816200|158017437|FG000|Overall Study|Lost to Follow-up|2|||
49050152|NCT05816200|158017438|FG001|Overall Study|Lost to Follow-up|1|||
49050153|NCT01557582|158017439|FG000|Overall Study|Protocol Violation|4|||
49050154|NCT01557582|158017439|FG000|Overall Study|Operator error|2|||
49050155|NCT02012452|158019132|FG000|Overall Study|Lost to Follow-up|2|||
49050156|NCT02012452|158019133|FG001|Overall Study|Lost to Follow-up|1|||
49050157|NCT02012452|158019132|FG000|Overall Study|Withdrawal by Subject|4|||
49050158|NCT02012452|158019133|FG001|Overall Study|Withdrawal by Subject|0|||
49050159|NCT02190279|158019134|FG000|Overall Study|Withdrawal consent|1|||
49050160|NCT02190279|158019135|FG001|Overall Study|Withdrawal consent|0|||
49050161|NCT02190279|158019136|FG002|Overall Study|Withdrawal consent|1|||
49050162|NCT02190279|158019134|FG000|Overall Study|Lost to Follow-up|2|||
49050163|NCT02190279|158019135|FG001|Overall Study|Lost to Follow-up|0|||
49050164|NCT02190279|158019136|FG002|Overall Study|Lost to Follow-up|0|||
49050165|NCT02190279|158019134|FG000|Overall Study|Refused further treatment|0|||
49050166|NCT02190279|158019135|FG001|Overall Study|Refused further treatment|0|||
49050167|NCT02190279|158019136|FG002|Overall Study|Refused further treatment|1|||
49050168|NCT02190279|158019134|FG000|Overall Study|Screening failure|0|||
49050169|NCT02190279|158019135|FG001|Overall Study|Screening failure|0|||
49050170|NCT02190279|158019136|FG002|Overall Study|Screening failure|1|||
49050171|NCT00337428|158019140|FG000|Overall Study|Withdrawal by Subject|1|||
49050172|NCT00337428|158019141|FG001|Overall Study|Withdrawal by Subject|2|||
49050173|NCT00337428|158019140|FG000|Overall Study|Lack of Time|1|||
49050174|NCT00337428|158019141|FG001|Overall Study|Lack of Time|1|||
49050175|NCT00337428|158019140|FG000|Overall Study|Unwilling to Continue|1|||
49050176|NCT00337428|158019141|FG001|Overall Study|Unwilling to Continue|0|||
49050177|NCT00337428|158019140|FG000|Overall Study|Anorexia|1|||
49050178|NCT00337428|158019141|FG001|Overall Study|Anorexia|0|||
49050179|NCT03756883|158019142|FG000|Overall Study|Adverse Event|2|||
49050180|NCT03756883|158019143|FG001|Overall Study|Adverse Event|2|||
49050181|NCT03756883|158019144|FG002|Overall Study|Adverse Event|2|||
49050182|NCT03756883|158019142|FG000|Overall Study|Lack of Efficacy|0|||
49050183|NCT03756883|158019143|FG001|Overall Study|Lack of Efficacy|1|||
49050184|NCT03756883|158019144|FG002|Overall Study|Lack of Efficacy|2|||
49050185|NCT03756883|158019142|FG000|Overall Study|Lost to Follow-up|3|||
49050186|NCT03756883|158019143|FG001|Overall Study|Lost to Follow-up|3|||
49050187|NCT03756883|158019144|FG002|Overall Study|Lost to Follow-up|0|||
49050188|NCT03756883|158019142|FG000|Overall Study|Protocol Violation|2|||
49050189|NCT03756883|158019143|FG001|Overall Study|Protocol Violation|0|||
49050190|NCT03756883|158019144|FG002|Overall Study|Protocol Violation|1|||
49050191|NCT03756883|158019142|FG000|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
49050192|NCT03756883|158019143|FG001|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
49050193|NCT03756883|158019144|FG002|Overall Study|Significant Worsening of Condition requiring Therapy|2|||
49050194|NCT03756883|158019142|FG000|Overall Study|Withdrawal by Subject|4|||
49050195|NCT03756883|158019143|FG001|Overall Study|Withdrawal by Subject|1|||
49050196|NCT03756883|158019144|FG002|Overall Study|Withdrawal by Subject|0|||
49050197|NCT03756883|158019142|FG000|Overall Study|Other Reasons|2|||
49050198|NCT03756883|158019143|FG001|Overall Study|Other Reasons|4|||
49050199|NCT03756883|158019144|FG002|Overall Study|Other Reasons|0|||
49050200|NCT00895037|158019145|FG000|Overall Study|Death|0|||
49050201|NCT00895037|158019146|FG001|Overall Study|Death|2|||
49050202|NCT00895037|158019147|FG002|Overall Study|Death|1|||
49050203|NCT02938442|158019148|FG000|Overall Study|Death|0|||
49050204|NCT02938442|158019149|FG001|Overall Study|Death|1|||
49050205|NCT02938442|158019148|FG000|Overall Study|Lost to Follow-up|0|||
49050206|NCT02938442|158019149|FG001|Overall Study|Lost to Follow-up|1|||
49050207|NCT02938442|158019148|FG000|Overall Study|Physician Decision|0|||
49050208|NCT02938442|158019149|FG001|Overall Study|Physician Decision|1|||
49050209|NCT02938442|158019148|FG000|Overall Study|Withdrawal by Subject|2|||
49050210|NCT02938442|158019149|FG001|Overall Study|Withdrawal by Subject|0|||
49050211|NCT04403399|158019150|FG000|Period 2|Physician Decision|0|||
49050212|NCT04403399|158019151|FG001|Period 2|Physician Decision|1|||
49050213|NCT02014441|158019152|FG000|Overall Study|Withdrawal by Subject|12|||
49050214|NCT01606228|158019155|FG000|Overall Study|Lost to Follow-up|20|||
49050215|NCT01606228|158019155|FG000|Overall Study|Withdrawal by Subject|3|||
49050216|NCT01606228|158019155|FG000|Overall Study|Non-compliant|3|||
49050217|NCT01606228|158019155|FG000|Overall Study|Lack of Efficacy|2|||
49050218|NCT01606228|158019155|FG000|Overall Study|Adverse Event|1|||
49050219|NCT04099641|158019158|FG000|Overall Study|Death|46|||
49050220|NCT04099641|158019159|FG001|Overall Study|Death|12|||
49050221|NCT04099641|158019158|FG000|Overall Study|Lost to Follow-up|1|||
49050222|NCT04099641|158019159|FG001|Overall Study|Lost to Follow-up|0|||
49050223|NCT04099641|158019158|FG000|Overall Study|Withdrawal by Subject|2|||
49050224|NCT04099641|158019159|FG001|Overall Study|Withdrawal by Subject|0|||
49050225|NCT00546910|158019160|FG000|Overall Study|Adverse Event|2|||
49050226|NCT00546910|158019161|FG001|Overall Study|Adverse Event|3|||
49050227|NCT00546910|158019160|FG000|Overall Study|Lack of Efficacy|5|||
49050228|NCT00546910|158019161|FG001|Overall Study|Lack of Efficacy|7|||
49050229|NCT00546910|158019160|FG000|Overall Study|Physician Decision|0|||
49050230|NCT00546910|158019161|FG001|Overall Study|Physician Decision|1|||
49050231|NCT00546910|158019160|FG000|Overall Study|Withdrawal by Subject|2|||
49050232|NCT00546910|158019161|FG001|Overall Study|Withdrawal by Subject|0|||
49050233|NCT01115855|158019162|FG000|Overall Study|Adverse Event|16|||
49050234|NCT01115855|158019163|FG001|Overall Study|Adverse Event|18|||
49050235|NCT01115855|158019162|FG000|Overall Study|Death|6|||
49050236|NCT01115855|158019163|FG001|Overall Study|Death|5|||
49050237|NCT01115855|158019162|FG000|Overall Study|Lab Abnormality|1|||
49050238|NCT01115855|158019163|FG001|Overall Study|Lab Abnormality|1|||
49050239|NCT01115855|158019162|FG000|Overall Study|Protocol Violation|0|||
49050240|NCT01115855|158019163|FG001|Overall Study|Protocol Violation|1|||
49050241|NCT01115855|158019162|FG000|Overall Study|Withdrawal by Subject|5|||
49050242|NCT01115855|158019163|FG001|Overall Study|Withdrawal by Subject|5|||
49050243|NCT01115855|158019162|FG000|Overall Study|Other|8|||
49050244|NCT01115855|158019163|FG001|Overall Study|Other|6|||
49050245|NCT00399893|158019164|FG000|Overall Study|Withdrawal by Subject|1|||
49050246|NCT00399893|158019165|FG001|Overall Study|Withdrawal by Subject|0|||
49050247|NCT01363011|158019166|FG000|Main Study|Adverse Event|2|||
49050248|NCT01363011|158019167|FG001|Main Study|Adverse Event|3|||
49050249|NCT01363011|158019166|FG000|Main Study|Investigator's Discretion|1|||
49050250|NCT01363011|158019167|FG001|Main Study|Investigator's Discretion|1|||
49050251|NCT01363011|158019166|FG000|Main Study|Withdrew Consent|1|||
49050252|NCT01363011|158019167|FG001|Main Study|Withdrew Consent|4|||
49050253|NCT01363011|158019166|FG000|Main Study|Protocol Violation|0|||
49050254|NCT01363011|158019167|FG001|Main Study|Protocol Violation|1|||
49050255|NCT01363011|158019166|FG000|Extension Phase|Adverse Event|1|||
49050256|NCT01363011|158019167|FG001|Extension Phase|Adverse Event|1|||
49050257|NCT01363011|158019166|FG000|Extension Phase|Lack of Efficacy|0|||
49050258|NCT01363011|158019167|FG001|Extension Phase|Lack of Efficacy|1|||
49050259|NCT01363011|158019166|FG000|Extension Phase|Investigator's Discretion|2|||
49050260|NCT01363011|158019167|FG001|Extension Phase|Investigator's Discretion|2|||
49050261|NCT01363011|158019166|FG000|Extension Phase|Withdrew Consent|0|||
49050262|NCT01363011|158019167|FG001|Extension Phase|Withdrew Consent|1|||
49050263|NCT01363011|158019166|FG000|Extension Phase|Lost to Follow-up|0|||
49050264|NCT01363011|158019167|FG001|Extension Phase|Lost to Follow-up|2|||
49050265|NCT01363011|158019166|FG000|Extension Phase|Rolled Over to Another Gilead Study|2|||
49050266|NCT01363011|158019167|FG001|Extension Phase|Rolled Over to Another Gilead Study|1|||
49050267|NCT04412057|158019177|FG000|Overall Study|Death|3|||
49050268|NCT04412057|158019178|FG001|Overall Study|Death|7|||
49050269|NCT04412057|158019177|FG000|Overall Study|Discharged prior to receiving study treatment|1|||
49050270|NCT04412057|158019178|FG001|Overall Study|Discharged prior to receiving study treatment|0|||
49050271|NCT03653026|158019179|FG000|Part 1: Placebo-controlled Period|Adverse Event|5|||
49050272|NCT03653026|158019180|FG001|Part 1: Placebo-controlled Period|Adverse Event|6|||
49050273|NCT03653026|158019181|FG002|Part 1: Placebo-controlled Period|Adverse Event|0|||
49050274|NCT03653026|158019182|FG003|Part 1: Placebo-controlled Period|Adverse Event|0|||
49050275|NCT03653026|158019179|FG000|Part 1: Placebo-controlled Period|Withdrawal by Subject|6|||
49050276|NCT03653026|158019180|FG001|Part 1: Placebo-controlled Period|Withdrawal by Subject|4|||
49050277|NCT03653026|158019181|FG002|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
49050278|NCT03653026|158019182|FG003|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
49050279|NCT03653026|158019179|FG000|Part 1: Placebo-controlled Period|Other|0|||
49050280|NCT03653026|158019180|FG001|Part 1: Placebo-controlled Period|Other|3|||
49050281|NCT03653026|158019181|FG002|Part 1: Placebo-controlled Period|Other|0|||
49050282|NCT03653026|158019182|FG003|Part 1: Placebo-controlled Period|Other|0|||
49050283|NCT03653026|158019179|FG000|Part 2: Open-label Extension|Adverse Event|0|||
49050284|NCT03653026|158019180|FG001|Part 2: Open-label Extension|Adverse Event|0|||
49050285|NCT03653026|158019181|FG002|Part 2: Open-label Extension|Adverse Event|1|||
49050286|NCT03653026|158019182|FG003|Part 2: Open-label Extension|Adverse Event|1|||
49050287|NCT03653026|158019179|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
49050288|NCT03653026|158019180|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
49050289|NCT03653026|158019181|FG002|Part 2: Open-label Extension|Withdrawal by Subject|1|||
49050290|NCT03653026|158019182|FG003|Part 2: Open-label Extension|Withdrawal by Subject|2|||
49050291|NCT03653026|158019179|FG000|Part 2: Open-label Extension|Other|0|||
49050292|NCT03653026|158019180|FG001|Part 2: Open-label Extension|Other|0|||
49050293|NCT03653026|158019181|FG002|Part 2: Open-label Extension|Other|1|||
49050294|NCT03653026|158019182|FG003|Part 2: Open-label Extension|Other|2|||
49050295|NCT04300023|158019183|FG000|Before Crossover to Social Group|Withdrawal by Subject|0|||
49050296|NCT04300023|158019184|FG001|Before Crossover to Social Group|Withdrawal by Subject|1|||
49050297|NCT03275285|158019185|FG000|Overall Study|Ongoing|45|||
49050298|NCT03275285|158019186|FG001|Overall Study|Ongoing|69|||
49050299|NCT01730040|158019187|FG000|Overall Study|Randomized but not treated|0|||
49050300|NCT01730040|158019188|FG001|Overall Study|Randomized but not treated|0|||
49050301|NCT01730040|158019189|FG002|Overall Study|Randomized but not treated|0|||
49050302|NCT01730040|158019190|FG003|Overall Study|Randomized but not treated|0|||
49050303|NCT01730040|158019191|FG004|Overall Study|Randomized but not treated|0|||
49050304|NCT01730040|158019192|FG005|Overall Study|Randomized but not treated|1|||
49050305|NCT01730040|158019193|FG006|Overall Study|Randomized but not treated|0|||
49050306|NCT01730040|158019187|FG000|Overall Study|Subject moved|0|||
49050307|NCT01730040|158019188|FG001|Overall Study|Subject moved|0|||
49050308|NCT01730040|158019189|FG002|Overall Study|Subject moved|1|||
49050309|NCT01730040|158019190|FG003|Overall Study|Subject moved|0|||
49050310|NCT01730040|158019191|FG004|Overall Study|Subject moved|0|||
49050311|NCT01730040|158019192|FG005|Overall Study|Subject moved|0|||
49050312|NCT01730040|158019193|FG006|Overall Study|Subject moved|1|||
49050313|NCT01730040|158019187|FG000|Overall Study|Physician Decision|0|||
49050314|NCT01730040|158019188|FG001|Overall Study|Physician Decision|0|||
49050315|NCT01730040|158019189|FG002|Overall Study|Physician Decision|0|||
49050316|NCT01730040|158019190|FG003|Overall Study|Physician Decision|0|||
49050317|NCT01730040|158019191|FG004|Overall Study|Physician Decision|0|||
49050318|NCT01730040|158019192|FG005|Overall Study|Physician Decision|1|||
49050319|NCT01730040|158019193|FG006|Overall Study|Physician Decision|1|||
49050320|NCT01730040|158019187|FG000|Overall Study|Other than specified|7|||
49050321|NCT01730040|158019188|FG001|Overall Study|Other than specified|8|||
49050322|NCT01730040|158019189|FG002|Overall Study|Other than specified|5|||
49050323|NCT01730040|158019190|FG003|Overall Study|Other than specified|5|||
49050324|NCT01730040|158019191|FG004|Overall Study|Other than specified|5|||
49050325|NCT01730040|158019192|FG005|Overall Study|Other than specified|4|||
49050326|NCT01730040|158019193|FG006|Overall Study|Other than specified|4|||
49050327|NCT01730040|158019187|FG000|Overall Study|Adverse Event|4|||
49050328|NCT01730040|158019188|FG001|Overall Study|Adverse Event|3|||
49050329|NCT01730040|158019189|FG002|Overall Study|Adverse Event|5|||
49050330|NCT01730040|158019190|FG003|Overall Study|Adverse Event|3|||
49050331|NCT01730040|158019191|FG004|Overall Study|Adverse Event|1|||
49050332|NCT01730040|158019192|FG005|Overall Study|Adverse Event|1|||
49050333|NCT01730040|158019193|FG006|Overall Study|Adverse Event|2|||
49050334|NCT01730040|158019187|FG000|Overall Study|Poor compliance to protocol|2|||
49050335|NCT01730040|158019188|FG001|Overall Study|Poor compliance to protocol|4|||
49050336|NCT01730040|158019189|FG002|Overall Study|Poor compliance to protocol|0|||
49050337|NCT01730040|158019190|FG003|Overall Study|Poor compliance to protocol|0|||
49050338|NCT01730040|158019191|FG004|Overall Study|Poor compliance to protocol|0|||
49050339|NCT01730040|158019192|FG005|Overall Study|Poor compliance to protocol|0|||
49050340|NCT01730040|158019193|FG006|Overall Study|Poor compliance to protocol|1|||
49050341|NCT00433329|158019195|FG000|Overall Study|Adverse Event|9|||
49050342|NCT00433329|158019195|FG000|Overall Study|Death|4|||
49050343|NCT00433329|158019195|FG000|Overall Study|Withdrew consent|3|||
49050344|NCT00433329|158019195|FG000|Overall Study|Discontinued sildenafil|2|||
49050345|NCT00433329|158019195|FG000|Overall Study|Moved out of state|1|||
49050346|NCT00433329|158019195|FG000|Overall Study|Lost to Follow-up|1|||
49050347|NCT00433329|158019195|FG000|Overall Study|Physician Decision|1|||
49050348|NCT02457819|158019201|FG000|Overall Study|reason not given|8|||
49050349|NCT02457819|158019201|FG000|Overall Study|Withdrawal by Subject|24|||
49050350|NCT02457819|158019201|FG000|Overall Study|Protocol Violation|1|||
49050351|NCT02457819|158019201|FG000|Overall Study|non compliance with study drug|4|||
49050352|NCT02457819|158019201|FG000|Overall Study|Lost to Follow-up|10|||
49050353|NCT02457819|158019201|FG000|Overall Study|Lack of Efficacy|19|||
49050354|NCT02457819|158019201|FG000|Overall Study|Adverse Event|33|||
49050355|NCT00969124|158019202|FG000|Overall Study|Protocol Violation|2|||
49050356|NCT00969124|158019202|FG000|Overall Study|Inadequate bowel preparation|15|||
49050357|NCT00969124|158019202|FG000|Overall Study|Inability to reach cecum|9|||
49050358|NCT00969124|158019202|FG000|Overall Study|Previously unrecognized disease|3|||
49050359|NCT00969124|158019202|FG000|Overall Study|Technical error|1|||
49050360|NCT01478828|158019204|FG000|Overall Study|Adverse Event|1|||
49050361|NCT03379675|158019205|FG000|Overall Study|Lost to Follow-up|0|||
49050362|NCT03379675|158019206|FG001|Overall Study|Lost to Follow-up|1|||
49050363|NCT03379675|158019207|FG002|Overall Study|Lost to Follow-up|0|||
49050364|NCT03379675|158019205|FG000|Overall Study|Adverse Event|2|||
49050365|NCT03379675|158019206|FG001|Overall Study|Adverse Event|0|||
49050366|NCT03379675|158019207|FG002|Overall Study|Adverse Event|0|||
49050367|NCT03379675|158019205|FG000|Overall Study|Withdrawal by Subject|2|||
49050368|NCT03379675|158019206|FG001|Overall Study|Withdrawal by Subject|1|||
49050369|NCT03379675|158019207|FG002|Overall Study|Withdrawal by Subject|2|||
49050370|NCT04625283|158019208|FG000|Overall Study|post randomization exclusion|28|||
49050371|NCT04625283|158019209|FG001|Overall Study|post randomization exclusion|20|||
49050372|NCT01790113|158019212|FG000|Overall Study|Adverse Event|2|||
49050373|NCT01790113|158019213|FG001|Overall Study|Adverse Event|7|||
49050374|NCT01790113|158019212|FG000|Overall Study|Study ended due to FDA clearance|1|||
49050375|NCT01790113|158019213|FG001|Overall Study|Study ended due to FDA clearance|68|||
49050376|NCT00779402|158019214|FG000|Treatment Phase 1|Disease Progression|1|||
49050377|NCT00779402|158019215|FG001|Treatment Phase 1|Disease Progression|0|||
49050378|NCT00779402|158019214|FG000|Treatment Phase 1|Adverse Event|2|||
49050379|NCT00779402|158019215|FG001|Treatment Phase 1|Adverse Event|0|||
49050380|NCT00779402|158019214|FG000|Treatment Phase 1|Protocol Violation|1|||
49050381|NCT00779402|158019215|FG001|Treatment Phase 1|Protocol Violation|0|||
49050382|NCT00779402|158019214|FG000|Treatment Phase 1|Patient Refused to Continue|17|||
49050383|NCT00779402|158019215|FG001|Treatment Phase 1|Patient Refused to Continue|2|||
49050384|NCT00779402|158019214|FG000|Treatment Phase 1|Lost to Follow-up|0|||
49050385|NCT00779402|158019215|FG001|Treatment Phase 1|Lost to Follow-up|1|||
49050386|NCT00779402|158019214|FG000|Treatment Phase 1|Death|0|||
49050387|NCT00779402|158019215|FG001|Treatment Phase 1|Death|1|||
49050388|NCT00779402|158019214|FG000|Treatment Phase 1|Intercurrent Illness|1|||
49050389|NCT00779402|158019215|FG001|Treatment Phase 1|Intercurrent Illness|1|||
49050390|NCT00779402|158019214|FG000|Treatment Phase 1|Withdrawal by Subject|1|||
49050391|NCT00779402|158019215|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
49050392|NCT00779402|158019214|FG000|Treatment Phase 1|Other|4|||
49050393|NCT00779402|158019215|FG001|Treatment Phase 1|Other|2|||
49050394|NCT00779402|158019214|FG000|Treatment Phase 1|Closure of Study|3|||
49050395|NCT00779402|158019215|FG001|Treatment Phase 1|Closure of Study|2|||
49050396|NCT00779402|158019214|FG000|Treatment Phase 1|Completed Protocol Visits|3|||
49050397|NCT00779402|158019215|FG001|Treatment Phase 1|Completed Protocol Visits|6|||
49050398|NCT00779402|158019214|FG000|Surveillance Phase|Protocol Violation|0|||
49050399|NCT00779402|158019215|FG001|Surveillance Phase|Protocol Violation|1|||
49050400|NCT00779402|158019214|FG000|Surveillance Phase|Patient refused to continue|22|||
49050401|NCT00779402|158019215|FG001|Surveillance Phase|Patient refused to continue|14|||
49050402|NCT00779402|158019214|FG000|Surveillance Phase|Lost to Follow-up|2|||
49050403|NCT00779402|158019215|FG001|Surveillance Phase|Lost to Follow-up|1|||
49050404|NCT00779402|158019214|FG000|Surveillance Phase|Death|0|||
49050405|NCT00779402|158019215|FG001|Surveillance Phase|Death|1|||
49050406|NCT00779402|158019214|FG000|Surveillance Phase|Intercurrent Illness|2|||
49050407|NCT00779402|158019215|FG001|Surveillance Phase|Intercurrent Illness|0|||
49050408|NCT00779402|158019214|FG000|Surveillance Phase|Other|5|||
49050409|NCT00779402|158019215|FG001|Surveillance Phase|Other|5|||
49050410|NCT00779402|158019214|FG000|Surveillance Phase|Withdrawal by Subject|4|||
49050411|NCT00779402|158019215|FG001|Surveillance Phase|Withdrawal by Subject|1|||
49050412|NCT00779402|158019214|FG000|Surveillance Phase|Closure of study|5|||
49050413|NCT00779402|158019215|FG001|Surveillance Phase|Closure of study|6|||
49050414|NCT00779402|158019214|FG000|Surveillance Phase|Completed Protocol Visits|3|||
49050415|NCT00779402|158019215|FG001|Surveillance Phase|Completed Protocol Visits|2|||
49050416|NCT00779402|158019214|FG000|Long-term Follow-up|Patient refused to continue|2|||
49050417|NCT00779402|158019215|FG001|Long-term Follow-up|Patient refused to continue|0|||
49050418|NCT00779402|158019214|FG000|Long-term Follow-up|Other|5|||
49050419|NCT00779402|158019215|FG001|Long-term Follow-up|Other|0|||
49050420|NCT00779402|158019214|FG000|Long-term Follow-up|Closure of Study|8|||
49050421|NCT00779402|158019215|FG001|Long-term Follow-up|Closure of Study|4|||
49050422|NCT00779402|158019214|FG000|Long-term Follow-up|Completed Protocol Visits|6|||
49050423|NCT00779402|158019215|FG001|Long-term Follow-up|Completed Protocol Visits|2|||
49050424|NCT03847194|158019221|FG000|Overall Study|Lost to Follow-up|2|||
49050425|NCT03847194|158019222|FG001|Overall Study|Lost to Follow-up|5|||
49050426|NCT03847194|158019221|FG000|Overall Study|Withdrawal by Subject|1|||
49050427|NCT03847194|158019222|FG001|Overall Study|Withdrawal by Subject|2|||
49050428|NCT03847194|158019221|FG000|Overall Study|Death|0|||
49050429|NCT03847194|158019222|FG001|Overall Study|Death|1|||
49050430|NCT04084574|158019223|FG000|Overall Study|Lost to Follow-up|1|||
49050431|NCT04084574|158019224|FG001|Overall Study|Lost to Follow-up|0|||
49050432|NCT04084574|158019223|FG000|Overall Study|Physician Decision|1|||
49050433|NCT04084574|158019224|FG001|Overall Study|Physician Decision|0|||
49050434|NCT04084574|158019223|FG000|Overall Study|Relocated out of state|1|||
49050435|NCT04084574|158019224|FG001|Overall Study|Relocated out of state|0|||
49050436|NCT02408120|158019227|FG000|Overall Study|Withdrawal by Subject|0|||
49050437|NCT02408120|158019228|FG001|Overall Study|Withdrawal by Subject|1|||
49050438|NCT02408120|158019227|FG000|Overall Study|Treatment Refusal|1|||
49050439|NCT02408120|158019228|FG001|Overall Study|Treatment Refusal|0|||
49050440|NCT02408120|158019227|FG000|Overall Study|Received Steroids|1|||
49050441|NCT02408120|158019228|FG001|Overall Study|Received Steroids|1|||
49050442|NCT02408120|158019227|FG000|Overall Study|Discharged same day|1|||
49050443|NCT02408120|158019228|FG001|Overall Study|Discharged same day|1|||
49050444|NCT02408120|158019227|FG000|Overall Study|Did not receive insulin|1|||
49050445|NCT02408120|158019228|FG001|Overall Study|Did not receive insulin|2|||
49050446|NCT02363439|158019229|FG000|Overall Study|Lack of Efficacy|4|||
49050447|NCT03558139|158019230|FG000|Overall Study|Consent Withdrawn|1|||
49050448|NCT03558139|158019231|FG001|Overall Study|Consent Withdrawn|1|||
49050449|NCT03558139|158019232|FG002|Overall Study|Consent Withdrawn|4|||
49050450|NCT03558139|158019230|FG000|Overall Study|Death|5|||
49050451|NCT03558139|158019231|FG001|Overall Study|Death|3|||
49050452|NCT03558139|158019232|FG002|Overall Study|Death|8|||
49050453|NCT03558139|158019230|FG000|Overall Study|Lost to Follow-up|0|||
49050454|NCT03558139|158019231|FG001|Overall Study|Lost to Follow-up|0|||
49050455|NCT03558139|158019232|FG002|Overall Study|Lost to Follow-up|3|||
49050456|NCT03558139|158019230|FG000|Overall Study|Study Ended Per Protocol|0|||
49050457|NCT03558139|158019231|FG001|Overall Study|Study Ended Per Protocol|3|||
49050458|NCT03558139|158019232|FG002|Overall Study|Study Ended Per Protocol|6|||
49050459|NCT00373425|158019233|FG000|Overall Study|Relapse of NSCLC|116|||
49050460|NCT00373425|158019234|FG001|Overall Study|Relapse of NSCLC|104|||
49050461|NCT00373425|158019235|FG002|Overall Study|Relapse of NSCLC|19|||
49050462|NCT00373425|158019236|FG003|Overall Study|Relapse of NSCLC|2|||
49050463|NCT00373425|158019237|FG004|Overall Study|Relapse of NSCLC|26|||
49050464|NCT00373425|158019233|FG000|Overall Study|Adverse Event|191|||
49050465|NCT00373425|158019234|FG001|Overall Study|Adverse Event|22|||
49050466|NCT00373425|158019235|FG002|Overall Study|Adverse Event|59|||
49050467|NCT00373425|158019236|FG003|Overall Study|Adverse Event|0|||
49050468|NCT00373425|158019237|FG004|Overall Study|Adverse Event|34|||
49050469|NCT00373425|158019233|FG000|Overall Study|Patient request|35|||
49050470|NCT00373425|158019234|FG001|Overall Study|Patient request|18|||
49050471|NCT00373425|158019235|FG002|Overall Study|Patient request|43|||
49050472|NCT00373425|158019236|FG003|Overall Study|Patient request|6|||
49050473|NCT00373425|158019237|FG004|Overall Study|Patient request|7|||
49050474|NCT00373425|158019233|FG000|Overall Study|Medical/ethical/noncompliance reason|21|||
49050475|NCT00373425|158019234|FG001|Overall Study|Medical/ethical/noncompliance reason|9|||
49050476|NCT00373425|158019235|FG002|Overall Study|Medical/ethical/noncompliance reason|10|||
49050477|NCT00373425|158019236|FG003|Overall Study|Medical/ethical/noncompliance reason|2|||
49050478|NCT00373425|158019237|FG004|Overall Study|Medical/ethical/noncompliance reason|5|||
49050479|NCT00373425|158019233|FG000|Overall Study|Death|7|||
49050480|NCT00373425|158019234|FG001|Overall Study|Death|0|||
49050481|NCT00373425|158019235|FG002|Overall Study|Death|3|||
49050482|NCT00373425|158019236|FG003|Overall Study|Death|1|||
49050483|NCT00373425|158019237|FG004|Overall Study|Death|0|||
49050484|NCT04439110|158019242|FG000|Overall Study|Ineligible|2|||
49050485|NCT04439110|158019242|FG000|Overall Study|Adverse Event|4|||
49050486|NCT04439110|158019242|FG000|Overall Study|Death|2|||
49050487|NCT04439110|158019242|FG000|Overall Study|Disease proression|25|||
49050488|NCT04439110|158019242|FG000|Overall Study|Withdrawal by Subject|1|||
49050489|NCT04439110|158019242|FG000|Overall Study|Alternative therapy|1|||
49050490|NCT04439110|158019242|FG000|Overall Study|Other complicating disease|1|||
49050491|NCT04439110|158019242|FG000|Overall Study|Personal reasons|1|||
49050492|NCT04439110|158019242|FG000|Overall Study|Still on treatment|1|||
49050493|NCT01134627|158019249|FG000|Overall Study|Adverse Event|47|||
49050494|NCT01134627|158019250|FG001|Overall Study|Adverse Event|31|||
49050495|NCT01134627|158019249|FG000|Overall Study|Lost to Follow-up|1|||
49050496|NCT01134627|158019250|FG001|Overall Study|Lost to Follow-up|2|||
49050497|NCT01134627|158019249|FG000|Overall Study|Protocol Violation|3|||
49050498|NCT01134627|158019250|FG001|Overall Study|Protocol Violation|5|||
49050499|NCT01134627|158019249|FG000|Overall Study|Lack of Efficacy|2|||
49050500|NCT01134627|158019250|FG001|Overall Study|Lack of Efficacy|12|||
49050501|NCT01134627|158019249|FG000|Overall Study|Withdrawal by Subject|4|||
49050502|NCT01134627|158019250|FG001|Overall Study|Withdrawal by Subject|3|||
49050503|NCT01134627|158019249|FG000|Overall Study|Planning to become pregnant/pregnancy|1|||
49050504|NCT01134627|158019250|FG001|Overall Study|Planning to become pregnant/pregnancy|0|||
49050505|NCT01134627|158019249|FG000|Overall Study|Other|11|||
49050506|NCT01134627|158019250|FG001|Overall Study|Other|14|||
49050507|NCT02618382|158019251|FG000|Overall Study|Physician Decision|1|||
49050508|NCT02618382|158019251|FG000|Overall Study|Withdrawal by Subject|1|||
49050509|NCT02618382|158019251|FG000|Overall Study|Protocol Violation|1|||
49050510|NCT01341587|158019252|FG000|Overall Study|Lost to Follow-up|2|||
49050511|NCT01341587|158019253|FG001|Overall Study|Lost to Follow-up|0|||
49050512|NCT01341587|158019252|FG000|Overall Study|stopped using the meters|2|||
49050513|NCT01341587|158019253|FG001|Overall Study|stopped using the meters|10|||
49050514|NCT00351351|158019254|FG000|Overall Study|surgical access pbs; device issues|9|||
49050515|NCT00351351|158019255|FG001|Overall Study|surgical access pbs; device issues|4|||
49050516|NCT01719562|158019256|FG000|Overall Study|Lost to Follow-up|1|||
49050517|NCT01719562|158019257|FG001|Overall Study|Lost to Follow-up|0|||
49050518|NCT01719562|158019256|FG000|Overall Study|Death|1|||
49050519|NCT01719562|158019257|FG001|Overall Study|Death|0|||
49050520|NCT01719562|158019256|FG000|Overall Study|New cancer diagnosis|1|||
49050521|NCT01719562|158019257|FG001|Overall Study|New cancer diagnosis|0|||
49050522|NCT00508027|158019261|FG000|Dose Level 1|Lost to Follow-up|4|||
49050523|NCT00508027|158019261|FG000|Dose Level 1|Withdrawal by Subject|2|||
49050524|NCT00508027|158019261|FG000|Dose Level 1|Physician Decision|2|||
49050525|NCT00508027|158019261|FG000|Dose Level 2|Lost to Follow-up|2|||
49050526|NCT00508027|158019261|FG000|Dose Level 2|Withdrawal by Subject|2|||
49050527|NCT01083680|158019265|FG000|Overall Study|Lost to Follow-up|2758|||
49050528|NCT01083680|158019265|FG000|Overall Study|Withdrawal by Subject|1086|||
49050529|NCT02013531|158019266|FG000|Overall Study|Lost to Follow-up|3|||
49050530|NCT02013531|158019266|FG000|Overall Study|Met Withdrawal Criteria|1|||
49050531|NCT02013531|158019266|FG000|Overall Study|Withdrawal by Subject|1|||
49050532|NCT03554317|158019267|FG000|Overall Study|Withdrawal by Subject|1|||
49050533|NCT03554317|158019267|FG000|Overall Study|PSA Progression|3|||
49050534|NCT03554317|158019267|FG000|Overall Study|Radiographic Progression|4|||
49050535|NCT02400476|158019268|FG000|Overall Study|Adverse Event|57|||
49050536|NCT02400476|158019269|FG001|Overall Study|Adverse Event|10|||
49050537|NCT02400476|158019270|FG002|Overall Study|Adverse Event|22|||
49050538|NCT02400476|158019271|FG003|Overall Study|Adverse Event|19|||
49050539|NCT02400476|158019272|FG004|Overall Study|Adverse Event|5|||
49050540|NCT02400476|158019273|FG005|Overall Study|Adverse Event|8|||
49050541|NCT02400476|158019268|FG000|Overall Study|Withdrawal by Subject|4|||
49050542|NCT02400476|158019269|FG001|Overall Study|Withdrawal by Subject|1|||
49050543|NCT02400476|158019270|FG002|Overall Study|Withdrawal by Subject|12|||
49050544|NCT02400476|158019271|FG003|Overall Study|Withdrawal by Subject|7|||
49050545|NCT02400476|158019272|FG004|Overall Study|Withdrawal by Subject|5|||
49050546|NCT02400476|158019273|FG005|Overall Study|Withdrawal by Subject|5|||
49050547|NCT02400476|158019268|FG000|Overall Study|Lost to Follow-up|0|||
49050548|NCT02400476|158019269|FG001|Overall Study|Lost to Follow-up|0|||
49050549|NCT02400476|158019270|FG002|Overall Study|Lost to Follow-up|0|||
49050550|NCT02400476|158019271|FG003|Overall Study|Lost to Follow-up|1|||
49050551|NCT02400476|158019272|FG004|Overall Study|Lost to Follow-up|3|||
49050552|NCT02400476|158019273|FG005|Overall Study|Lost to Follow-up|1|||
49050553|NCT02400476|158019268|FG000|Overall Study|Physician Decision|0|||
49050554|NCT02400476|158019269|FG001|Overall Study|Physician Decision|0|||
49050555|NCT02400476|158019270|FG002|Overall Study|Physician Decision|1|||
49050556|NCT02400476|158019271|FG003|Overall Study|Physician Decision|1|||
49050557|NCT02400476|158019272|FG004|Overall Study|Physician Decision|0|||
49050558|NCT02400476|158019273|FG005|Overall Study|Physician Decision|1|||
49050559|NCT02400476|158019268|FG000|Overall Study|Other, Disease Progression|0|||
49050560|NCT02400476|158019269|FG001|Overall Study|Other, Disease Progression|1|||
49050561|NCT02400476|158019270|FG002|Overall Study|Other, Disease Progression|2|||
49050562|NCT02400476|158019271|FG003|Overall Study|Other, Disease Progression|1|||
49050563|NCT02400476|158019272|FG004|Overall Study|Other, Disease Progression|2|||
49050564|NCT02400476|158019273|FG005|Overall Study|Other, Disease Progression|1|||
49050565|NCT02400476|158019268|FG000|Overall Study|Other, Decreased Quality of Life|0|||
49050566|NCT02400476|158019269|FG001|Overall Study|Other, Decreased Quality of Life|0|||
49050567|NCT02400476|158019270|FG002|Overall Study|Other, Decreased Quality of Life|2|||
49050568|NCT02400476|158019271|FG003|Overall Study|Other, Decreased Quality of Life|0|||
49050569|NCT02400476|158019272|FG004|Overall Study|Other, Decreased Quality of Life|0|||
49050570|NCT02400476|158019273|FG005|Overall Study|Other, Decreased Quality of Life|0|||
49050571|NCT02400476|158019268|FG000|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
49050572|NCT02400476|158019269|FG001|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
49050573|NCT02400476|158019270|FG002|Overall Study|Other, Noncompliance to Protocol Requirements|2|||
49050574|NCT02400476|158019271|FG003|Overall Study|Other, Noncompliance to Protocol Requirements|1|||
49050575|NCT02400476|158019272|FG004|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
49050576|NCT02400476|158019273|FG005|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
49050577|NCT02487082|158019277|FG000|Run-In Phase (5 Weeks)|Withdrawal by Subject|1|||
49050578|NCT02487082|158019278|FG001|Run-In Phase (5 Weeks)|Withdrawal by Subject|2|||
49050579|NCT02487082|158019277|FG000|Phase 1 (5 Weeks)|Withdrawal by Subject|1|||
49050580|NCT02487082|158019278|FG001|Phase 1 (5 Weeks)|Withdrawal by Subject|0|||
49050581|NCT04542694|158020872|FG000|Overall Study|The need for prohibited therapy|2|||
49050582|NCT04542694|158020873|FG001|Overall Study|The need for prohibited therapy|0|||
49050583|NCT04542694|158020872|FG000|Overall Study|Adverse Event|1|||
49050584|NCT04542694|158020873|FG001|Overall Study|Adverse Event|0|||
49050585|NCT04542694|158020872|FG000|Overall Study|Protocol Violation|1|||
49050586|NCT04542694|158020873|FG001|Overall Study|Protocol Violation|0|||
49050587|NCT03333915|158020874|FG000|Overall Study|Lost to Follow-up|0|||
49050588|NCT03333915|158020875|FG001|Overall Study|Lost to Follow-up|0|||
49050589|NCT03333915|158020876|FG002|Overall Study|Lost to Follow-up|1|||
49050590|NCT03333915|158020877|FG003|Overall Study|Lost to Follow-up|0|||
49050591|NCT03333915|158020878|FG004|Overall Study|Lost to Follow-up|0|||
49050592|NCT03333915|158020874|FG000|Overall Study|Disease Progression|0|||
49050593|NCT03333915|158020875|FG001|Overall Study|Disease Progression|1|||
49050594|NCT03333915|158020876|FG002|Overall Study|Disease Progression|0|||
49050595|NCT03333915|158020877|FG003|Overall Study|Disease Progression|0|||
49050596|NCT03333915|158020878|FG004|Overall Study|Disease Progression|0|||
49050597|NCT03333915|158020874|FG000|Overall Study|Death|0|||
49050598|NCT03333915|158020875|FG001|Overall Study|Death|0|||
49050599|NCT03333915|158020876|FG002|Overall Study|Death|0|||
49050600|NCT03333915|158020877|FG003|Overall Study|Death|37|||
49050601|NCT03333915|158020878|FG004|Overall Study|Death|18|||
49050602|NCT03333915|158020874|FG000|Overall Study|Sponsor's Decision|0|||
49050603|NCT03333915|158020875|FG001|Overall Study|Sponsor's Decision|0|||
49050604|NCT03333915|158020876|FG002|Overall Study|Sponsor's Decision|0|||
49050605|NCT03333915|158020877|FG003|Overall Study|Sponsor's Decision|48|||
49050606|NCT03333915|158020878|FG004|Overall Study|Sponsor's Decision|4|||
49050607|NCT03333915|158020874|FG000|Overall Study|Withdrawal by Subject|0|||
49050608|NCT03333915|158020875|FG001|Overall Study|Withdrawal by Subject|0|||
49050609|NCT03333915|158020876|FG002|Overall Study|Withdrawal by Subject|0|||
49050610|NCT03333915|158020877|FG003|Overall Study|Withdrawal by Subject|5|||
49050611|NCT03333915|158020878|FG004|Overall Study|Withdrawal by Subject|1|||
49050612|NCT00996437|158020879|FG000|Overall Study|Death|1|||
49050613|NCT00996437|158020880|FG001|Overall Study|Death|0|||
49050614|NCT00996437|158020879|FG000|Overall Study|Dropped|2|||
49050615|NCT00996437|158020880|FG001|Overall Study|Dropped|2|||
49050616|NCT00996437|158020879|FG000|Overall Study|Missed|2|||
49050617|NCT00996437|158020880|FG001|Overall Study|Missed|5|||
49050618|NCT04505722|158020881|FG000|DB Phase (Day 1 up to 6 Months)|Adverse Event|1|||
49050619|NCT04505722|158020882|FG001|DB Phase (Day 1 up to 6 Months)|Adverse Event|2|||
49050620|NCT04505722|158020883|FG002|DB Phase (Day 1 up to 6 Months)|Adverse Event|0|||
49050621|NCT04505722|158020881|FG000|DB Phase (Day 1 up to 6 Months)|Death|34|||
49050622|NCT04505722|158020882|FG001|DB Phase (Day 1 up to 6 Months)|Death|63|||
49050623|NCT04505722|158020883|FG002|DB Phase (Day 1 up to 6 Months)|Death|0|||
49050624|NCT04505722|158020881|FG000|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|271|||
49050625|NCT04505722|158020882|FG001|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|333|||
49050626|NCT04505722|158020883|FG002|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|0|||
49050627|NCT04505722|158020881|FG000|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
49050628|NCT04505722|158020882|FG001|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
49050629|NCT04505722|158020883|FG002|DB Phase (Day 1 up to 6 Months)|Physician Decision|0|||
49050630|NCT04505722|158020881|FG000|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
49050631|NCT04505722|158020882|FG001|DB Phase (Day 1 up to 6 Months)|Protocol Violation|1|||
49050632|NCT04505722|158020883|FG002|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
49050633|NCT04505722|158020881|FG000|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|376|||
49050634|NCT04505722|158020882|FG001|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|714|||
49050635|NCT04505722|158020883|FG002|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|0|||
49050636|NCT04505722|158020881|FG000|DB Phase (Day 1 up to 6 Months)|Other|61|||
49050637|NCT04505722|158020882|FG001|DB Phase (Day 1 up to 6 Months)|Other|98|||
49050638|NCT04505722|158020883|FG002|DB Phase (Day 1 up to 6 Months)|Other|0|||
49050639|NCT04505722|158020881|FG000|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|276|||
49050640|NCT04505722|158020882|FG001|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|260|||
49050641|NCT04505722|158020883|FG002|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|0|||
49050642|NCT04505722|158020881|FG000|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
49050643|NCT04505722|158020882|FG001|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
49050644|NCT04505722|158020883|FG002|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|6|||
49050645|NCT04505722|158020881|FG000|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
49050646|NCT04505722|158020882|FG001|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
49050647|NCT04505722|158020883|FG002|DB + OL Phase (2 Years 6.5 Months)|Death|324|||
49050648|NCT04505722|158020881|FG000|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
49050649|NCT04505722|158020882|FG001|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
49050650|NCT04505722|158020883|FG002|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|4978|||
49050651|NCT04505722|158020881|FG000|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
49050652|NCT04505722|158020882|FG001|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
49050653|NCT04505722|158020883|FG002|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|342|||
49050654|NCT04505722|158020881|FG000|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
49050655|NCT04505722|158020882|FG001|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
49050656|NCT04505722|158020883|FG002|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|2|||
49050657|NCT04505722|158020881|FG000|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
49050658|NCT04505722|158020882|FG001|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
49050659|NCT04505722|158020883|FG002|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|4332|||
49050660|NCT04505722|158020881|FG000|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
49050661|NCT04505722|158020882|FG001|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
49050662|NCT04505722|158020883|FG002|DB + OL Phase (2 Years 6.5 Months)|Other|2211|||
49050663|NCT03442569|158020884|FG000|Overall Study|Subject was ineligible after enrollment|1|||
49050664|NCT01961882|158020890|FG000|Overall Study|Adverse Event|3|||
49050665|NCT01961882|158020891|FG001|Overall Study|Adverse Event|2|||
49050666|NCT01961882|158020890|FG000|Overall Study|Physician Decision|1|||
49050667|NCT01961882|158020891|FG001|Overall Study|Physician Decision|0|||
49050668|NCT01961882|158020890|FG000|Overall Study|Withdrawal by Subject|4|||
49050669|NCT01961882|158020891|FG001|Overall Study|Withdrawal by Subject|1|||
49050670|NCT01961882|158020890|FG000|Overall Study|Relapse of AML|39|||
49050671|NCT01961882|158020891|FG001|Overall Study|Relapse of AML|37|||
49050672|NCT01961882|158020890|FG000|Overall Study|Use of prohibited concomitant drug or therapy|2|||
49050673|NCT01961882|158020891|FG001|Overall Study|Use of prohibited concomitant drug or therapy|2|||
49050674|NCT01961882|158020890|FG000|Overall Study|Subject found to be ineligible for the trial after registration|1|||
49050675|NCT01961882|158020891|FG001|Overall Study|Subject found to be ineligible for the trial after registration|0|||
49050676|NCT01301482|158020892|FG000|Overall Study|Withdrawal by Subject|1|||
49050677|NCT01901848|158020896|FG000|Randomized and Treated|Lost to Follow-up|3|||
49050678|NCT01901848|158020897|FG001|Randomized and Treated|Lost to Follow-up|6|||
49050679|NCT01901848|158020896|FG000|Removed From Analyses|CPT practice cases to establish fidelity|10|||
49050680|NCT01901848|158020897|FG001|Removed From Analyses|CPT practice cases to establish fidelity|0|||
49050681|NCT00763555|158020901|FG000|Overall Study|Adverse Event|2|||
49050682|NCT00763555|158020902|FG001|Overall Study|Adverse Event|1|||
49050683|NCT00763555|158020901|FG000|Overall Study|Withdrawal by Subject|2|||
49050684|NCT00763555|158020902|FG001|Overall Study|Withdrawal by Subject|6|||
49050685|NCT00763555|158020901|FG000|Overall Study|Lost to Follow-up|0|||
49050686|NCT00763555|158020902|FG001|Overall Study|Lost to Follow-up|3|||
49050687|NCT01647958|158020903|FG000|Initial Study|Lost to Follow-up|2|||
49050688|NCT01647958|158020904|FG001|Initial Study|Lost to Follow-up|3|||
49050689|NCT01647958|158020903|FG000|Continuation Phase|treatment received during Overall Study|39|||
49050690|NCT01647958|158020904|FG001|Continuation Phase|treatment received during Overall Study|0|||
49050691|NCT01647958|158020903|FG000|Extended Follow-up Phase|Lost to Follow-up|8|||
49050692|NCT01647958|158020904|FG001|Extended Follow-up Phase|Lost to Follow-up|0|||
49050693|NCT06424236|158020905|FG000|Overall Study|Adverse Event|0|||
49050694|NCT06424236|158020906|FG001|Overall Study|Adverse Event|1|||
49050695|NCT06424236|158020907|FG002|Overall Study|Adverse Event|0|||
49050696|NCT06424236|158020905|FG000|Overall Study|Withdrawal by Subject|3|||
49050697|NCT06424236|158020906|FG001|Overall Study|Withdrawal by Subject|1|||
49050698|NCT06424236|158020907|FG002|Overall Study|Withdrawal by Subject|2|||
49050699|NCT06424236|158020905|FG000|Overall Study|Physician Decision|0|||
49050700|NCT06424236|158020906|FG001|Overall Study|Physician Decision|1|||
49050701|NCT06424236|158020907|FG002|Overall Study|Physician Decision|0|||
49050702|NCT06424236|158020905|FG000|Overall Study|Study Terminated by Sponsor|11|||
49050703|NCT06424236|158020906|FG001|Overall Study|Study Terminated by Sponsor|20|||
49050704|NCT06424236|158020907|FG002|Overall Study|Study Terminated by Sponsor|16|||
49050705|NCT06424236|158020905|FG000|Overall Study|Lost to Follow-up|0|||
49050706|NCT06424236|158020906|FG001|Overall Study|Lost to Follow-up|1|||
49050707|NCT06424236|158020907|FG002|Overall Study|Lost to Follow-up|0|||
49050708|NCT06424236|158020905|FG000|Overall Study|Disease Progression|0|||
49050709|NCT06424236|158020906|FG001|Overall Study|Disease Progression|1|||
49050710|NCT06424236|158020907|FG002|Overall Study|Disease Progression|2|||
49050711|NCT06424236|158020905|FG000|Overall Study|Other|0|||
49050712|NCT06424236|158020906|FG001|Overall Study|Other|0|||
49050713|NCT06424236|158020907|FG002|Overall Study|Other|1|||
49050714|NCT04823130|158020910|FG000|Overall Study|Withdrawal by Subject|2|||
49050715|NCT04823130|158020911|FG001|Overall Study|Withdrawal by Subject|3|||
49050716|NCT04823130|158020910|FG000|Overall Study|Failure to meet inclusion criteria|6|||
49050717|NCT04823130|158020911|FG001|Overall Study|Failure to meet inclusion criteria|4|||
49050718|NCT04823130|158020910|FG000|Overall Study|Other-unspecified|1|||
49050719|NCT04823130|158020911|FG001|Overall Study|Other-unspecified|0|||
49050720|NCT00408005|158020912|FG000|Induction|Adverse Event|19|||
49050721|NCT00408005|158020913|FG001|Induction|Adverse Event|3|||
49050722|NCT00408005|158020914|FG002|Induction|Adverse Event|0|||
49050723|NCT00408005|158020915|FG003|Induction|Adverse Event|0|||
49050724|NCT00408005|158020916|FG004|Induction|Adverse Event|0|||
49050725|NCT00408005|158020917|FG005|Induction|Adverse Event|0|||
49050726|NCT00408005|158020918|FG006|Induction|Adverse Event|0|||
49050727|NCT00408005|158020919|FG007|Induction|Adverse Event|0|||
49050728|NCT00408005|158020912|FG000|Induction|Death|6|||
49050729|NCT00408005|158020913|FG001|Induction|Death|0|||
49050730|NCT00408005|158020914|FG002|Induction|Death|0|||
49050731|NCT00408005|158020915|FG003|Induction|Death|0|||
49050732|NCT00408005|158020916|FG004|Induction|Death|0|||
49050733|NCT00408005|158020917|FG005|Induction|Death|0|||
49050734|NCT00408005|158020918|FG006|Induction|Death|0|||
49050735|NCT00408005|158020919|FG007|Induction|Death|0|||
49050736|NCT00408005|158020912|FG000|Induction|Physician Decision|83|||
49050737|NCT00408005|158020913|FG001|Induction|Physician Decision|9|||
49050738|NCT00408005|158020914|FG002|Induction|Physician Decision|0|||
49050739|NCT00408005|158020915|FG003|Induction|Physician Decision|0|||
49050740|NCT00408005|158020916|FG004|Induction|Physician Decision|0|||
49050741|NCT00408005|158020917|FG005|Induction|Physician Decision|0|||
49050742|NCT00408005|158020918|FG006|Induction|Physician Decision|0|||
49050743|NCT00408005|158020919|FG007|Induction|Physician Decision|0|||
49050744|NCT00408005|158020912|FG000|Induction|Withdrawal by Subject|2|||
49050745|NCT00408005|158020913|FG001|Induction|Withdrawal by Subject|4|||
49050746|NCT00408005|158020914|FG002|Induction|Withdrawal by Subject|0|||
49050747|NCT00408005|158020915|FG003|Induction|Withdrawal by Subject|0|||
49050748|NCT00408005|158020916|FG004|Induction|Withdrawal by Subject|0|||
49050749|NCT00408005|158020917|FG005|Induction|Withdrawal by Subject|0|||
49050750|NCT00408005|158020918|FG006|Induction|Withdrawal by Subject|0|||
49050751|NCT00408005|158020919|FG007|Induction|Withdrawal by Subject|0|||
49050752|NCT00408005|158020912|FG000|Induction|Ineligible|33|||
49050753|NCT00408005|158020913|FG001|Induction|Ineligible|14|||
49050754|NCT00408005|158020914|FG002|Induction|Ineligible|0|||
49050755|NCT00408005|158020915|FG003|Induction|Ineligible|0|||
49050756|NCT00408005|158020916|FG004|Induction|Ineligible|0|||
49050757|NCT00408005|158020917|FG005|Induction|Ineligible|0|||
49050758|NCT00408005|158020918|FG006|Induction|Ineligible|0|||
49050759|NCT00408005|158020919|FG007|Induction|Ineligible|0|||
49050760|NCT00408005|158020912|FG000|Induction|Refusal of Further Protocol Therapy|225|||
49050761|NCT00408005|158020913|FG001|Induction|Refusal of Further Protocol Therapy|44|||
49050762|NCT00408005|158020914|FG002|Induction|Refusal of Further Protocol Therapy|0|||
49050763|NCT00408005|158020915|FG003|Induction|Refusal of Further Protocol Therapy|0|||
49050764|NCT00408005|158020916|FG004|Induction|Refusal of Further Protocol Therapy|0|||
49050765|NCT00408005|158020917|FG005|Induction|Refusal of Further Protocol Therapy|0|||
49050766|NCT00408005|158020918|FG006|Induction|Refusal of Further Protocol Therapy|0|||
49050767|NCT00408005|158020919|FG007|Induction|Refusal of Further Protocol Therapy|0|||
49050768|NCT00408005|158020912|FG000|Induction|Entered another COG therapeutic protocol|4|||
49050769|NCT00408005|158020913|FG001|Induction|Entered another COG therapeutic protocol|0|||
49050770|NCT00408005|158020914|FG002|Induction|Entered another COG therapeutic protocol|0|||
49050771|NCT00408005|158020915|FG003|Induction|Entered another COG therapeutic protocol|0|||
49050772|NCT00408005|158020916|FG004|Induction|Entered another COG therapeutic protocol|0|||
49050773|NCT00408005|158020917|FG005|Induction|Entered another COG therapeutic protocol|0|||
49050774|NCT00408005|158020918|FG006|Induction|Entered another COG therapeutic protocol|0|||
49050775|NCT00408005|158020919|FG007|Induction|Entered another COG therapeutic protocol|0|||
49050776|NCT00408005|158020912|FG000|Induction|Patient transferred Tx to Non-COG Site|3|||
49050777|NCT00408005|158020913|FG001|Induction|Patient transferred Tx to Non-COG Site|2|||
49050778|NCT00408005|158020914|FG002|Induction|Patient transferred Tx to Non-COG Site|0|||
49050779|NCT00408005|158020915|FG003|Induction|Patient transferred Tx to Non-COG Site|0|||
49050780|NCT00408005|158020916|FG004|Induction|Patient transferred Tx to Non-COG Site|0|||
49050781|NCT00408005|158020917|FG005|Induction|Patient transferred Tx to Non-COG Site|0|||
49050782|NCT00408005|158020918|FG006|Induction|Patient transferred Tx to Non-COG Site|0|||
49050783|NCT00408005|158020919|FG007|Induction|Patient transferred Tx to Non-COG Site|0|||
49050784|NCT00408005|158020912|FG000|Induction|Identified as Philadelphia Chr. Positive|6|||
49050785|NCT00408005|158020913|FG001|Induction|Identified as Philadelphia Chr. Positive|0|||
49050786|NCT00408005|158020914|FG002|Induction|Identified as Philadelphia Chr. Positive|0|||
49050787|NCT00408005|158020915|FG003|Induction|Identified as Philadelphia Chr. Positive|0|||
49050788|NCT00408005|158020916|FG004|Induction|Identified as Philadelphia Chr. Positive|0|||
49050789|NCT00408005|158020917|FG005|Induction|Identified as Philadelphia Chr. Positive|0|||
49050790|NCT00408005|158020918|FG006|Induction|Identified as Philadelphia Chr. Positive|0|||
49050791|NCT00408005|158020919|FG007|Induction|Identified as Philadelphia Chr. Positive|0|||
49050792|NCT00408005|158020912|FG000|Induction|Progressive Disease|0|||
49050793|NCT00408005|158020913|FG001|Induction|Progressive Disease|1|||
49050794|NCT00408005|158020914|FG002|Induction|Progressive Disease|0|||
49050795|NCT00408005|158020915|FG003|Induction|Progressive Disease|0|||
49050796|NCT00408005|158020916|FG004|Induction|Progressive Disease|0|||
49050797|NCT00408005|158020917|FG005|Induction|Progressive Disease|0|||
49050798|NCT00408005|158020918|FG006|Induction|Progressive Disease|0|||
49050799|NCT00408005|158020919|FG007|Induction|Progressive Disease|0|||
49050800|NCT00408005|158020912|FG000|Induction|Inevaluable|18|||
49050801|NCT00408005|158020913|FG001|Induction|Inevaluable|14|||
49050802|NCT00408005|158020914|FG002|Induction|Inevaluable|0|||
49050803|NCT00408005|158020915|FG003|Induction|Inevaluable|0|||
49050804|NCT00408005|158020916|FG004|Induction|Inevaluable|0|||
49050805|NCT00408005|158020917|FG005|Induction|Inevaluable|0|||
49050806|NCT00408005|158020918|FG006|Induction|Inevaluable|0|||
49050807|NCT00408005|158020919|FG007|Induction|Inevaluable|0|||
49050808|NCT00408005|158020912|FG000|Induction|Failed to Complete Randomization|3|||
49050809|NCT00408005|158020913|FG001|Induction|Failed to Complete Randomization|2|||
49050810|NCT00408005|158020914|FG002|Induction|Failed to Complete Randomization|0|||
49050811|NCT00408005|158020915|FG003|Induction|Failed to Complete Randomization|0|||
49050812|NCT00408005|158020916|FG004|Induction|Failed to Complete Randomization|0|||
49050813|NCT00408005|158020917|FG005|Induction|Failed to Complete Randomization|0|||
49050814|NCT00408005|158020918|FG006|Induction|Failed to Complete Randomization|0|||
49050815|NCT00408005|158020919|FG007|Induction|Failed to Complete Randomization|0|||
49050816|NCT00408005|158020912|FG000|Induction|Protocol Deviation|3|||
49050817|NCT00408005|158020913|FG001|Induction|Protocol Deviation|1|||
49050818|NCT00408005|158020914|FG002|Induction|Protocol Deviation|0|||
49050819|NCT00408005|158020915|FG003|Induction|Protocol Deviation|0|||
49050820|NCT00408005|158020916|FG004|Induction|Protocol Deviation|0|||
49050821|NCT00408005|158020917|FG005|Induction|Protocol Deviation|0|||
49050822|NCT00408005|158020918|FG006|Induction|Protocol Deviation|0|||
49050823|NCT00408005|158020919|FG007|Induction|Protocol Deviation|0|||
49050824|NCT00408005|158020912|FG000|Induction|Hematopoietic Stem Cell Transplantation|1|||
49050825|NCT00408005|158020913|FG001|Induction|Hematopoietic Stem Cell Transplantation|0|||
49050826|NCT00408005|158020914|FG002|Induction|Hematopoietic Stem Cell Transplantation|0|||
49050827|NCT00408005|158020915|FG003|Induction|Hematopoietic Stem Cell Transplantation|0|||
49050828|NCT00408005|158020916|FG004|Induction|Hematopoietic Stem Cell Transplantation|0|||
49050829|NCT00408005|158020917|FG005|Induction|Hematopoietic Stem Cell Transplantation|0|||
49050830|NCT00408005|158020918|FG006|Induction|Hematopoietic Stem Cell Transplantation|0|||
49050831|NCT00408005|158020919|FG007|Induction|Hematopoietic Stem Cell Transplantation|0|||
49050832|NCT00408005|158020912|FG000|Induction|Recurrent leukemia|1|||
49050833|NCT00408005|158020913|FG001|Induction|Recurrent leukemia|0|||
49050834|NCT00408005|158020914|FG002|Induction|Recurrent leukemia|0|||
49050835|NCT00408005|158020915|FG003|Induction|Recurrent leukemia|0|||
49050836|NCT00408005|158020916|FG004|Induction|Recurrent leukemia|0|||
49050837|NCT00408005|158020917|FG005|Induction|Recurrent leukemia|0|||
49050838|NCT00408005|158020918|FG006|Induction|Recurrent leukemia|0|||
49050839|NCT00408005|158020919|FG007|Induction|Recurrent leukemia|0|||
49050840|NCT00408005|158020912|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
49050841|NCT00408005|158020913|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
49050842|NCT00408005|158020914|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|7|||
49050843|NCT00408005|158020915|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|4|||
49050844|NCT00408005|158020916|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|8|||
49050845|NCT00408005|158020917|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|12|||
49050846|NCT00408005|158020918|FG006|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
49050847|NCT00408005|158020919|FG007|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
49050848|NCT00408005|158020912|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
49050849|NCT00408005|158020913|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
49050850|NCT00408005|158020914|FG002|Post Induction Therapy by Tx Assignment|Death|3|||
49050851|NCT00408005|158020915|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
49050852|NCT00408005|158020916|FG004|Post Induction Therapy by Tx Assignment|Death|5|||
49050853|NCT00408005|158020917|FG005|Post Induction Therapy by Tx Assignment|Death|5|||
49050854|NCT00408005|158020918|FG006|Post Induction Therapy by Tx Assignment|Death|3|||
49050855|NCT00408005|158020919|FG007|Post Induction Therapy by Tx Assignment|Death|1|||
49050856|NCT00408005|158020912|FG000|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
49050857|NCT00408005|158020913|FG001|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
49050858|NCT00408005|158020914|FG002|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2|||
49050859|NCT00408005|158020915|FG003|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
49050860|NCT00408005|158020916|FG004|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1|||
49050861|NCT00408005|158020917|FG005|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
49050862|NCT00408005|158020918|FG006|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
49050863|NCT00408005|158020919|FG007|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
49050864|NCT00408005|158020912|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
49050865|NCT00408005|158020913|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
49050866|NCT00408005|158020914|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|24|||
49050867|NCT00408005|158020915|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|19|||
49050868|NCT00408005|158020916|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|27|||
49050869|NCT00408005|158020917|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|45|||
49050870|NCT00408005|158020918|FG006|Post Induction Therapy by Tx Assignment|Physician Decision|10|||
49050871|NCT00408005|158020919|FG007|Post Induction Therapy by Tx Assignment|Physician Decision|4|||
49050872|NCT00408005|158020912|FG000|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
49050873|NCT00408005|158020913|FG001|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
49050874|NCT00408005|158020914|FG002|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
49050875|NCT00408005|158020915|FG003|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
49050876|NCT00408005|158020916|FG004|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
49050877|NCT00408005|158020917|FG005|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2|||
49050878|NCT00408005|158020918|FG006|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
49050879|NCT00408005|158020919|FG007|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
49050880|NCT00408005|158020912|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
49050881|NCT00408005|158020913|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
49050882|NCT00408005|158020914|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27|||
49050883|NCT00408005|158020915|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10|||
49050884|NCT00408005|158020916|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36|||
49050885|NCT00408005|158020917|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16|||
49050886|NCT00408005|158020918|FG006|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4|||
49050887|NCT00408005|158020919|FG007|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2|||
49050888|NCT00408005|158020912|FG000|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
49050889|NCT00408005|158020913|FG001|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
49050890|NCT00408005|158020914|FG002|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
49050891|NCT00408005|158020915|FG003|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
49050892|NCT00408005|158020916|FG004|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1|||
49050893|NCT00408005|158020917|FG005|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
49050894|NCT00408005|158020918|FG006|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
49050895|NCT00408005|158020919|FG007|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
49050896|NCT00408005|158020912|FG000|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
49050897|NCT00408005|158020913|FG001|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
49050898|NCT00408005|158020914|FG002|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3|||
49050899|NCT00408005|158020915|FG003|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
49050900|NCT00408005|158020916|FG004|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
49050901|NCT00408005|158020917|FG005|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
49050902|NCT00408005|158020918|FG006|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
49050903|NCT00408005|158020919|FG007|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
49050904|NCT00408005|158020912|FG000|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
49050905|NCT00408005|158020913|FG001|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
49050906|NCT00408005|158020914|FG002|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
49050907|NCT00408005|158020915|FG003|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
49050908|NCT00408005|158020916|FG004|Post Induction Therapy by Tx Assignment|Progressive Disease|1|||
49050909|NCT00408005|158020917|FG005|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
49050910|NCT00408005|158020918|FG006|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
49050911|NCT00408005|158020919|FG007|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
49050912|NCT00408005|158020912|FG000|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
49050913|NCT00408005|158020913|FG001|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
49050914|NCT00408005|158020914|FG002|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
49050915|NCT00408005|158020915|FG003|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
49050916|NCT00408005|158020916|FG004|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
49050917|NCT00408005|158020917|FG005|Post Induction Therapy by Tx Assignment|Inevaluable|1|||
49050918|NCT00408005|158020918|FG006|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
49050919|NCT00408005|158020919|FG007|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
49050920|NCT00408005|158020912|FG000|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
49050921|NCT00408005|158020913|FG001|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
49050922|NCT00408005|158020914|FG002|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
49050923|NCT00408005|158020915|FG003|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
49050924|NCT00408005|158020916|FG004|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
49050925|NCT00408005|158020917|FG005|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
49050926|NCT00408005|158020918|FG006|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
49050927|NCT00408005|158020919|FG007|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
49050928|NCT00408005|158020912|FG000|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
49050929|NCT00408005|158020913|FG001|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
49050930|NCT00408005|158020914|FG002|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
49050931|NCT00408005|158020915|FG003|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
49050932|NCT00408005|158020916|FG004|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1|||
49050933|NCT00408005|158020917|FG005|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2|||
49050934|NCT00408005|158020918|FG006|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
49050935|NCT00408005|158020919|FG007|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
49050936|NCT00408005|158020912|FG000|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
49050937|NCT00408005|158020913|FG001|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
49050938|NCT00408005|158020914|FG002|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13|||
49050939|NCT00408005|158020915|FG003|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7|||
49050940|NCT00408005|158020916|FG004|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49|||
49050941|NCT00408005|158020917|FG005|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15|||
49050942|NCT00408005|158020918|FG006|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1|||
49050943|NCT00408005|158020919|FG007|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
49050944|NCT00408005|158020912|FG000|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
49050945|NCT00408005|158020913|FG001|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
49050946|NCT00408005|158020914|FG002|Post Induction Therapy by Tx Assignment|Development of SMN|3|||
49050947|NCT00408005|158020915|FG003|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
49050948|NCT00408005|158020916|FG004|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
49050949|NCT00408005|158020917|FG005|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
49050950|NCT00408005|158020918|FG006|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
49050951|NCT00408005|158020919|FG007|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
49050952|NCT01959425|158020920|FG000|Overall Study|Withdrawal by Subject|5|||
49050953|NCT01959425|158020921|FG001|Overall Study|Withdrawal by Subject|4|||
49050954|NCT01959425|158020920|FG000|Overall Study|Lost to Follow-up|1|||
49050955|NCT01959425|158020921|FG001|Overall Study|Lost to Follow-up|0|||
49050956|NCT01959425|158020920|FG000|Overall Study|Discontinued Subjects|6|||
49050957|NCT01959425|158020921|FG001|Overall Study|Discontinued Subjects|4|||
49050958|NCT02575339|158020922|FG000|Study Treatment|Patient Withdrawal After Therapy Start|1|||
49050959|NCT02575339|158020923|FG001|Study Treatment|Patient Withdrawal After Therapy Start|0|||
49050960|NCT02575339|158020924|FG002|Study Treatment|Patient Withdrawal After Therapy Start|0|||
49050961|NCT02575339|158020922|FG000|Study Treatment|Disease Progression|5|||
49050962|NCT02575339|158020923|FG001|Study Treatment|Disease Progression|2|||
49050963|NCT02575339|158020924|FG002|Study Treatment|Disease Progression|0|||
49050964|NCT02575339|158020922|FG000|Study Treatment|Adverse Event|1|||
49050965|NCT02575339|158020923|FG001|Study Treatment|Adverse Event|2|||
49050966|NCT02575339|158020924|FG002|Study Treatment|Adverse Event|0|||
49050967|NCT02575339|158020922|FG000|Follow up|Death|6|||
49050968|NCT02575339|158020923|FG001|Follow up|Death|2|||
49050969|NCT02575339|158020924|FG002|Follow up|Death|0|||
49050970|NCT02575339|158020922|FG000|Follow up|Study Terminated|0|||
49050971|NCT02575339|158020923|FG001|Follow up|Study Terminated|2|||
49050972|NCT02575339|158020924|FG002|Follow up|Study Terminated|0|||
49050973|NCT02575339|158020922|FG000|Follow up|Death due to progressive disease after coming off treatment early|1|||
49050974|NCT02575339|158020923|FG001|Follow up|Death due to progressive disease after coming off treatment early|0|||
49050975|NCT02575339|158020924|FG002|Follow up|Death due to progressive disease after coming off treatment early|0|||
49050976|NCT01253317|158020925|FG000|Overall Study|Adverse Event|2|||
49050977|NCT00480324|158020926|FG000|Overall Study|Adverse Event|1|||
49050978|NCT00480324|158020927|FG001|Overall Study|Adverse Event|1|||
49050979|NCT00480324|158020926|FG000|Overall Study|Protocol Violation|0|||
49050980|NCT00480324|158020927|FG001|Overall Study|Protocol Violation|1|||
49050981|NCT00480324|158020926|FG000|Overall Study|Withdrawal by Subject|14|||
49050982|NCT00480324|158020927|FG001|Overall Study|Withdrawal by Subject|5|||
49050983|NCT00480324|158020926|FG000|Overall Study|Lost to Follow-up|17|||
49050984|NCT00480324|158020927|FG001|Overall Study|Lost to Follow-up|8|||
49050985|NCT00480324|158020926|FG000|Overall Study|Subject's mother pregnant|0|||
49050986|NCT00480324|158020927|FG001|Overall Study|Subject's mother pregnant|1|||
49050987|NCT02244424|158020933|FG000|Overall Study|Lost to Follow-up|20|||
49050988|NCT02244424|158020934|FG001|Overall Study|Lost to Follow-up|10|||
49050989|NCT02488824|158020935|FG000|Overall Study|Adverse Event|1|||
49050990|NCT02488824|158020936|FG001|Overall Study|Adverse Event|1|||
49050991|NCT00784134|158020937|FG000|Overall Study|Lost to Follow-up|3|||
49050992|NCT00784134|158020938|FG001|Overall Study|Lost to Follow-up|6|||
49050993|NCT04675775|158020939|FG000|Overall Study|Withdrawal by Subject|7|||
49050994|NCT01983683|158020940|FG000|Overall Study|Withdrawal by Subject|14|||
49050995|NCT01983683|158020941|FG001|Overall Study|Withdrawal by Subject|18|||
49050996|NCT01983683|158020940|FG000|Overall Study|Death|11|||
49050997|NCT01983683|158020941|FG001|Overall Study|Death|15|||
49050998|NCT01983683|158020940|FG000|Overall Study|Physician Decision|8|||
49050999|NCT01983683|158020941|FG001|Overall Study|Physician Decision|9|||
49051000|NCT01983683|158020940|FG000|Overall Study|Lost to Follow-up|4|||
49051001|NCT01983683|158020941|FG001|Overall Study|Lost to Follow-up|8|||
49051002|NCT01983683|158020940|FG000|Overall Study|Sponsor Decision|1|||
49051003|NCT01983683|158020941|FG001|Overall Study|Sponsor Decision|1|||
49051004|NCT02817776|158020942|FG000|Overall Study|Excluded|33|||
49051005|NCT02817776|158020942|FG000|Overall Study|Lost to Follow-up|20|||
49051006|NCT02817776|158020942|FG000|Overall Study|Withdrawal by Subject|33|||
49051007|NCT02817776|158020942|FG000|Overall Study|Death|2|||
49051008|NCT03546647|158020954|FG000|Overall Study|Adverse Event|1|||
49051009|NCT03546647|158020955|FG001|Overall Study|Adverse Event|0|||
49051010|NCT00939627|158020956|FG000|Overall Study|Disease Progression|16|||
49051011|NCT00939627|158020957|FG001|Overall Study|Disease Progression|12|||
49051012|NCT00939627|158020958|FG002|Overall Study|Disease Progression|0|||
49051013|NCT00939627|158020956|FG000|Overall Study|Adverse Event|6|||
49051014|NCT00939627|158020957|FG001|Overall Study|Adverse Event|7|||
49051015|NCT00939627|158020958|FG002|Overall Study|Adverse Event|0|||
49051016|NCT00939627|158020956|FG000|Overall Study|Death|0|||
49051017|NCT00939627|158020957|FG001|Overall Study|Death|2|||
49051018|NCT00939627|158020958|FG002|Overall Study|Death|0|||
49051019|NCT00939627|158020956|FG000|Overall Study|Withdrawal by Subject|2|||
49051020|NCT00939627|158020957|FG001|Overall Study|Withdrawal by Subject|4|||
49051021|NCT00939627|158020958|FG002|Overall Study|Withdrawal by Subject|0|||
49051022|NCT00939627|158020956|FG000|Overall Study|Other complicating disease|1|||
49051023|NCT00939627|158020957|FG001|Overall Study|Other complicating disease|1|||
49051024|NCT00939627|158020958|FG002|Overall Study|Other complicating disease|0|||
49051025|NCT00939627|158020956|FG000|Overall Study|Not compliant|2|||
49051026|NCT00939627|158020957|FG001|Overall Study|Not compliant|0|||
49051027|NCT00939627|158020958|FG002|Overall Study|Not compliant|0|||
49051028|NCT00939627|158020956|FG000|Overall Study|No off-tx reason given|0|||
49051029|NCT00939627|158020957|FG001|Overall Study|No off-tx reason given|2|||
49051030|NCT00939627|158020958|FG002|Overall Study|No off-tx reason given|0|||
49051031|NCT04339062|158020960|FG000|Overall Study|Death|0|||
49051032|NCT04339062|158020961|FG001|Overall Study|Death|1|||
49051033|NCT00124462|158020962|FG000|Overall Study|Lost to Follow-up|3|||
49051034|NCT00124462|158020963|FG001|Overall Study|Lost to Follow-up|3|||
49051035|NCT00124462|158020962|FG000|Overall Study|Physician Decision|3|||
49051036|NCT00124462|158020963|FG001|Overall Study|Physician Decision|4|||
49051037|NCT00124462|158020962|FG000|Overall Study|Withdrawal by Subject|4|||
49051038|NCT00124462|158020963|FG001|Overall Study|Withdrawal by Subject|5|||
49051039|NCT00124462|158020962|FG000|Overall Study|Device fitting, n=2, other hlth issues|1|||
49051040|NCT00124462|158020963|FG001|Overall Study|Device fitting, n=2, other hlth issues|1|||
49051041|NCT00003531|158020964|FG000|Overall Study|Not evaluable|10|||
49051042|NCT02944968|158020965|FG000|Overall Study|Subject excluded before study procedure|1|||
49051043|NCT02944968|158020965|FG000|Overall Study|Subject didn't meet eligibility criteria|2|||
49051044|NCT02563769|158020966|FG000|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
49051045|NCT02563769|158020967|FG001|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
49051046|NCT02563769|158020968|FG002|Added 750mg Dose of CLAV (Day 5)|Physician Decision|1|||
49051047|NCT01470417|158020969|FG000|Overall Study|Disease progression|0|||
49051048|NCT01470417|158020970|FG001|Overall Study|Disease progression|2|||
49051049|NCT00251316|158020971|FG000|Overall Study|Physician Decision|2|||
49051050|NCT00251316|158020972|FG001|Overall Study|Physician Decision|3|||
49051051|NCT01144403|158020976|FG000|Overall Study|Lost to Follow-up|3|||
49051052|NCT01144403|158020976|FG000|Overall Study|Death|1|||
49051053|NCT01144403|158020976|FG000|Overall Study|Adverse Event|1|||
49051054|NCT00346164|158020977|FG000|Overall Study|Adverse Event|0|||
49051055|NCT00346164|158020978|FG001|Overall Study|Adverse Event|0|||
49051056|NCT00346164|158020979|FG002|Overall Study|Adverse Event|0|||
49051057|NCT00346164|158020980|FG003|Overall Study|Adverse Event|1|||
49051058|NCT00346164|158020977|FG000|Overall Study|Lack of Efficacy|0|||
49051059|NCT00346164|158020978|FG001|Overall Study|Lack of Efficacy|1|||
49051060|NCT00346164|158020979|FG002|Overall Study|Lack of Efficacy|7|||
49051061|NCT00346164|158020980|FG003|Overall Study|Lack of Efficacy|25|||
49051062|NCT00346164|158020977|FG000|Overall Study|Physician Decision|0|||
49051063|NCT00346164|158020978|FG001|Overall Study|Physician Decision|1|||
49051064|NCT00346164|158020979|FG002|Overall Study|Physician Decision|2|||
49051065|NCT00346164|158020980|FG003|Overall Study|Physician Decision|27|||
49051066|NCT00346164|158020977|FG000|Overall Study|Protocol Violation|6|||
49051067|NCT00346164|158020978|FG001|Overall Study|Protocol Violation|2|||
49051068|NCT00346164|158020979|FG002|Overall Study|Protocol Violation|10|||
49051069|NCT00346164|158020980|FG003|Overall Study|Protocol Violation|4|||
49051070|NCT00346164|158020977|FG000|Overall Study|Withdrawal by Subject|0|||
49051071|NCT00346164|158020978|FG001|Overall Study|Withdrawal by Subject|0|||
49051072|NCT00346164|158020979|FG002|Overall Study|Withdrawal by Subject|2|||
49051073|NCT00346164|158020980|FG003|Overall Study|Withdrawal by Subject|0|||
49051074|NCT00346164|158020977|FG000|Overall Study|Ineligible|11|||
49051075|NCT00346164|158020978|FG001|Overall Study|Ineligible|2|||
49051076|NCT00346164|158020979|FG002|Overall Study|Ineligible|2|||
49051077|NCT00346164|158020980|FG003|Overall Study|Ineligible|23|||
49051078|NCT00346164|158020977|FG000|Overall Study|Refusal of further protocol therapy|0|||
49051079|NCT00346164|158020978|FG001|Overall Study|Refusal of further protocol therapy|1|||
49051080|NCT00346164|158020979|FG002|Overall Study|Refusal of further protocol therapy|3|||
49051081|NCT00346164|158020980|FG003|Overall Study|Refusal of further protocol therapy|15|||
49051082|NCT00346164|158020977|FG000|Overall Study|Inability to start week 16 tx on time|0|||
49051083|NCT00346164|158020978|FG001|Overall Study|Inability to start week 16 tx on time|0|||
49051084|NCT00346164|158020979|FG002|Overall Study|Inability to start week 16 tx on time|0|||
49051085|NCT00346164|158020980|FG003|Overall Study|Inability to start week 16 tx on time|11|||
49051086|NCT00955721|158020981|FG000|Overall Study|Physician Decision|1|||
49051087|NCT00955721|158020982|FG001|Overall Study|Physician Decision|0|||
49051088|NCT00955721|158020981|FG000|Overall Study|Death|1|||
49051089|NCT00955721|158020982|FG001|Overall Study|Death|0|||
49051090|NCT00955721|158020981|FG000|Overall Study|Withdrawal by Subject|1|||
49051091|NCT00955721|158020982|FG001|Overall Study|Withdrawal by Subject|0|||
49051092|NCT02756637|158020983|FG000|Overall Study|Not eligible for initial SWOG study|10|||
49051093|NCT02756637|158020984|FG001|Overall Study|Not eligible for initial SWOG study|10|||
49051094|NCT02756637|158020983|FG000|Overall Study|No available NLR value|44|||
49051095|NCT02756637|158020984|FG001|Overall Study|No available NLR value|44|||
49051096|NCT02756637|158020983|FG000|Overall Study|Did not complete curative therapy|33|||
49051097|NCT02756637|158020984|FG001|Overall Study|Did not complete curative therapy|0|||
49051098|NCT03823287|158020987|FG000|Overall Study|Withdrawal by Subject|25|||
49051099|NCT03823287|158020988|FG001|Overall Study|Withdrawal by Subject|17|||
49051100|NCT03823287|158020987|FG000|Overall Study|Death|13|||
49051101|NCT03823287|158020988|FG001|Overall Study|Death|7|||
49051102|NCT03823287|158020987|FG000|Overall Study|Lost to Follow-up|7|||
49051103|NCT03823287|158020988|FG001|Overall Study|Lost to Follow-up|8|||
49051104|NCT03823287|158020987|FG000|Overall Study|Adverse Event|6|||
49051105|NCT03823287|158020988|FG001|Overall Study|Adverse Event|8|||
49051106|NCT03823287|158020987|FG000|Overall Study|Physician Decision|5|||
49051107|NCT03823287|158020988|FG001|Overall Study|Physician Decision|2|||
49051108|NCT03823287|158020987|FG000|Overall Study|Lack of Efficacy|2|||
49051109|NCT03823287|158020988|FG001|Overall Study|Lack of Efficacy|0|||
49051110|NCT03823287|158020987|FG000|Overall Study|Other|2|||
49051111|NCT03823287|158020988|FG001|Overall Study|Other|4|||
49051112|NCT00749411|158020991|FG000|Overall Study|Adverse Event|0|||
49051113|NCT00749411|158020992|FG001|Overall Study|Adverse Event|2|||
49051114|NCT00749411|158020991|FG000|Overall Study|Lack of Efficacy|0|||
49051115|NCT00749411|158020992|FG001|Overall Study|Lack of Efficacy|1|||
49051116|NCT00749411|158020991|FG000|Overall Study|Protocol Violation|1|||
49051117|NCT00749411|158020992|FG001|Overall Study|Protocol Violation|1|||
49051118|NCT00749411|158020991|FG000|Overall Study|Protocol-defined stopping criteria|0|||
49051119|NCT00749411|158020992|FG001|Overall Study|Protocol-defined stopping criteria|1|||
49051120|NCT02457611|158020993|FG000|Overall Study|Lost to Follow-up|3|||
49051121|NCT02001051|158020994|FG000|Overall Study|Deemed not eligible following enrollment|0|||
49051122|NCT02001051|158020995|FG001|Overall Study|Deemed not eligible following enrollment|1|||
49051123|NCT01385202|158020996|FG000|Overall Study|Lost to Follow-up|6|||
49051124|NCT01385202|158020996|FG000|Overall Study|Not Eligible|11|||
49051125|NCT01385202|158020996|FG000|Overall Study|Withdrawn|1|||
49051126|NCT03891329|158020997|FG000|Overall Study|Death|5|||
49051127|NCT03891329|158020997|FG000|Overall Study|Lost to Follow-up|4|||
49051128|NCT03891329|158020997|FG000|Overall Study|Physician Decision|4|||
49051129|NCT03891329|158020997|FG000|Overall Study|Device explanted|3|||
49051130|NCT03891329|158020997|FG000|Overall Study|No study device implanted|3|||
49051131|NCT02039063|158020998|FG000|Treatment Phase|Inadequate therapeutic effect|3|||
49051132|NCT02039063|158020999|FG001|Treatment Phase|Inadequate therapeutic effect|2|||
49051133|NCT02039063|158021000|FG002|Treatment Phase|Inadequate therapeutic effect|1|||
49051134|NCT02039063|158021001|FG003|Treatment Phase|Inadequate therapeutic effect|1|||
49051135|NCT02039063|158020998|FG000|Treatment Phase|Progression of disease|0|||
49051136|NCT02039063|158020999|FG001|Treatment Phase|Progression of disease|0|||
49051137|NCT02039063|158021000|FG002|Treatment Phase|Progression of disease|1|||
49051138|NCT02039063|158021001|FG003|Treatment Phase|Progression of disease|1|||
49051139|NCT02039063|158020998|FG000|Extension Phase|Inadequate therapeutic effect|0|||
49051140|NCT02039063|158020999|FG001|Extension Phase|Inadequate therapeutic effect|1|||
49051141|NCT02039063|158021000|FG002|Extension Phase|Inadequate therapeutic effect|2|||
49051142|NCT02039063|158021001|FG003|Extension Phase|Inadequate therapeutic effect|0|||
49051143|NCT02039063|158020998|FG000|Extension Phase|Progression of disease|0|||
49051144|NCT02039063|158020999|FG001|Extension Phase|Progression of disease|0|||
49051145|NCT02039063|158021000|FG002|Extension Phase|Progression of disease|0|||
49051146|NCT02039063|158021001|FG003|Extension Phase|Progression of disease|1|||
49051147|NCT02039063|158020998|FG000|Extension Phase|Adverse Event|0|||
49051148|NCT02039063|158020999|FG001|Extension Phase|Adverse Event|0|||
49051149|NCT02039063|158021000|FG002|Extension Phase|Adverse Event|1|||
49051150|NCT02039063|158021001|FG003|Extension Phase|Adverse Event|0|||
49051151|NCT02990806|158021010|FG000|Stage 1 (22 Weeks)|Adverse Event|1|||
49051152|NCT02990806|158021011|FG001|Stage 1 (22 Weeks)|Adverse Event|15|||
49051153|NCT02990806|158021012|FG002|Stage 1 (22 Weeks)|Adverse Event|0|||
49051154|NCT02990806|158021013|FG003|Stage 1 (22 Weeks)|Adverse Event|0|||
49051155|NCT02990806|158021010|FG000|Stage 1 (22 Weeks)|Physician Decision|1|||
49051156|NCT02990806|158021011|FG001|Stage 1 (22 Weeks)|Physician Decision|1|||
49051157|NCT02990806|158021012|FG002|Stage 1 (22 Weeks)|Physician Decision|0|||
49051158|NCT02990806|158021013|FG003|Stage 1 (22 Weeks)|Physician Decision|0|||
49051159|NCT02990806|158021010|FG000|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
49051160|NCT02990806|158021011|FG001|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
49051161|NCT02990806|158021012|FG002|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
49051162|NCT02990806|158021013|FG003|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
49051163|NCT02990806|158021010|FG000|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
49051164|NCT02990806|158021011|FG001|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
49051165|NCT02990806|158021012|FG002|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
49051166|NCT02990806|158021013|FG003|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
49051167|NCT02990806|158021010|FG000|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
49051168|NCT02990806|158021011|FG001|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
49051169|NCT02990806|158021012|FG002|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
49051170|NCT02990806|158021013|FG003|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
49051171|NCT02990806|158021010|FG000|Stage 1 (22 Weeks)|Withdrawal by Subject|4|||
49051172|NCT02990806|158021011|FG001|Stage 1 (22 Weeks)|Withdrawal by Subject|26|||
49051173|NCT02990806|158021012|FG002|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
49051174|NCT02990806|158021013|FG003|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
49051175|NCT02990806|158021010|FG000|Stage 1 (22 Weeks)|Lack of Efficacy|1|||
49051176|NCT02990806|158021011|FG001|Stage 1 (22 Weeks)|Lack of Efficacy|2|||
49051177|NCT02990806|158021012|FG002|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
49051178|NCT02990806|158021013|FG003|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
49051179|NCT02990806|158021010|FG000|Stage 1 (22 Weeks)|Death|0|||
49051180|NCT02990806|158021011|FG001|Stage 1 (22 Weeks)|Death|1|||
49051181|NCT02990806|158021012|FG002|Stage 1 (22 Weeks)|Death|0|||
49051182|NCT02990806|158021013|FG003|Stage 1 (22 Weeks)|Death|0|||
49051183|NCT02990806|158021010|FG000|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
49051184|NCT02990806|158021011|FG001|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|1|||
49051185|NCT02990806|158021012|FG002|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
49051186|NCT02990806|158021013|FG003|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
49051187|NCT02990806|158021010|FG000|Stage 1 (22 Weeks)|Protocol deviation|0|||
49051188|NCT02990806|158021011|FG001|Stage 1 (22 Weeks)|Protocol deviation|1|||
49051189|NCT02990806|158021012|FG002|Stage 1 (22 Weeks)|Protocol deviation|0|||
49051190|NCT02990806|158021013|FG003|Stage 1 (22 Weeks)|Protocol deviation|0|||
49051191|NCT02990806|158021010|FG000|Stage 1 (22 Weeks)|Other|1|||
49051192|NCT02990806|158021011|FG001|Stage 1 (22 Weeks)|Other|3|||
49051193|NCT02990806|158021012|FG002|Stage 1 (22 Weeks)|Other|0|||
49051194|NCT02990806|158021013|FG003|Stage 1 (22 Weeks)|Other|0|||
49051195|NCT02990806|158021010|FG000|Stage 2 (32 Weeks)|Adverse Event|9|||
49051196|NCT02990806|158021011|FG001|Stage 2 (32 Weeks)|Adverse Event|0|||
49051197|NCT02990806|158021012|FG002|Stage 2 (32 Weeks)|Adverse Event|7|||
49051198|NCT02990806|158021013|FG003|Stage 2 (32 Weeks)|Adverse Event|7|||
49051199|NCT02990806|158021010|FG000|Stage 2 (32 Weeks)|Death|1|||
49051200|NCT02990806|158021011|FG001|Stage 2 (32 Weeks)|Death|0|||
49051201|NCT02990806|158021012|FG002|Stage 2 (32 Weeks)|Death|0|||
49051202|NCT02990806|158021013|FG003|Stage 2 (32 Weeks)|Death|0|||
49051203|NCT02990806|158021010|FG000|Stage 2 (32 Weeks)|Physician Decision|3|||
49051204|NCT02990806|158021011|FG001|Stage 2 (32 Weeks)|Physician Decision|0|||
49051205|NCT02990806|158021012|FG002|Stage 2 (32 Weeks)|Physician Decision|1|||
49051206|NCT02990806|158021013|FG003|Stage 2 (32 Weeks)|Physician Decision|0|||
49051207|NCT02990806|158021010|FG000|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
49051208|NCT02990806|158021011|FG001|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
49051209|NCT02990806|158021012|FG002|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
49051210|NCT02990806|158021013|FG003|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
49051211|NCT02990806|158021010|FG000|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
49051212|NCT02990806|158021011|FG001|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|0|||
49051213|NCT02990806|158021012|FG002|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
49051214|NCT02990806|158021013|FG003|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
49051215|NCT02990806|158021010|FG000|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|1|||
49051216|NCT02990806|158021011|FG001|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
49051217|NCT02990806|158021012|FG002|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
49051218|NCT02990806|158021013|FG003|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|2|||
49051219|NCT02990806|158021010|FG000|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
49051220|NCT02990806|158021011|FG001|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
49051221|NCT02990806|158021012|FG002|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|6|||
49051222|NCT02990806|158021013|FG003|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|5|||
49051223|NCT02990806|158021010|FG000|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
49051224|NCT02990806|158021011|FG001|Stage 2 (32 Weeks)|Lost to Follow-up|0|||
49051225|NCT02990806|158021012|FG002|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
49051226|NCT02990806|158021013|FG003|Stage 2 (32 Weeks)|Lost to Follow-up|2|||
49051227|NCT02990806|158021010|FG000|Stage 2 (32 Weeks)|Protocol deviation|2|||
49051228|NCT02990806|158021011|FG001|Stage 2 (32 Weeks)|Protocol deviation|0|||
49051229|NCT02990806|158021012|FG002|Stage 2 (32 Weeks)|Protocol deviation|2|||
49051230|NCT02990806|158021013|FG003|Stage 2 (32 Weeks)|Protocol deviation|3|||
49051231|NCT02990806|158021010|FG000|Stage 2 (32 Weeks)|Withdrawal by Subject|14|||
49051232|NCT02990806|158021011|FG001|Stage 2 (32 Weeks)|Withdrawal by Subject|0|||
49051233|NCT02990806|158021012|FG002|Stage 2 (32 Weeks)|Withdrawal by Subject|4|||
49051234|NCT02990806|158021013|FG003|Stage 2 (32 Weeks)|Withdrawal by Subject|8|||
49051235|NCT02990806|158021010|FG000|Stage 2 (32 Weeks)|Lack of Efficacy|4|||
49051236|NCT02990806|158021011|FG001|Stage 2 (32 Weeks)|Lack of Efficacy|0|||
49051237|NCT02990806|158021012|FG002|Stage 2 (32 Weeks)|Lack of Efficacy|2|||
49051238|NCT02990806|158021013|FG003|Stage 2 (32 Weeks)|Lack of Efficacy|3|||
49051239|NCT02990806|158021010|FG000|Stage 2 (32 Weeks)|Other|3|||
49051240|NCT02990806|158021011|FG001|Stage 2 (32 Weeks)|Other|0|||
49051241|NCT02990806|158021012|FG002|Stage 2 (32 Weeks)|Other|4|||
49051242|NCT02990806|158021013|FG003|Stage 2 (32 Weeks)|Other|1|||
49051243|NCT02990806|158021010|FG000|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
49051244|NCT02990806|158021011|FG001|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
49051245|NCT02990806|158021012|FG002|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
49051246|NCT02990806|158021013|FG003|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|1|||
49051247|NCT02990806|158021010|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|5|||
49051248|NCT02990806|158021011|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|0|||
49051249|NCT02990806|158021012|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|4|||
49051250|NCT02990806|158021013|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|3|||
49051251|NCT02990806|158021010|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
49051252|NCT02990806|158021011|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|0|||
49051253|NCT02990806|158021012|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
49051254|NCT02990806|158021013|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
49051255|NCT02990806|158021010|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
49051256|NCT02990806|158021011|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
49051257|NCT02990806|158021012|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
49051258|NCT02990806|158021013|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
49051259|NCT02990806|158021010|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
49051260|NCT02990806|158021011|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
49051261|NCT02990806|158021012|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
49051262|NCT02990806|158021013|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
49051263|NCT02990806|158021010|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
49051264|NCT02990806|158021011|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
49051265|NCT02990806|158021012|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|2|||
49051266|NCT02990806|158021013|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|1|||
49051267|NCT02990806|158021010|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
49051268|NCT02990806|158021011|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
49051269|NCT02990806|158021012|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|1|||
49051270|NCT02990806|158021013|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
49051271|NCT02990806|158021010|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
49051272|NCT02990806|158021011|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
49051273|NCT02990806|158021012|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
49051274|NCT02990806|158021013|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Other|2|||
49051275|NCT02990806|158021010|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
49051276|NCT02990806|158021011|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
49051277|NCT02990806|158021012|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|1|||
49051278|NCT02990806|158021013|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
49051279|NCT01210807|158021014|FG000|Overall Study|Lost to Follow-up|1|||
49051280|NCT01210807|158021015|FG001|Overall Study|Lost to Follow-up|2|||
49051281|NCT01210807|158021014|FG000|Overall Study|Not implanted bilaterally|2|||
49051282|NCT01210807|158021015|FG001|Overall Study|Not implanted bilaterally|1|||
49051283|NCT04102111|158021016|FG000|Overall Study|Withdrawal by Subject|2|||
49051284|NCT04102111|158021017|FG001|Overall Study|Withdrawal by Subject|3|||
49051285|NCT04102111|158021016|FG000|Overall Study|Adverse Event|1|||
49051286|NCT04102111|158021017|FG001|Overall Study|Adverse Event|1|||
49051287|NCT04102111|158021016|FG000|Overall Study|Study terminated by sponsor|1|||
49051288|NCT04102111|158021017|FG001|Overall Study|Study terminated by sponsor|3|||
49051289|NCT00887198|158021018|FG000|Randomized Period|Ongoing|42|||
49051290|NCT00887198|158021019|FG001|Randomized Period|Ongoing|0|||
49051291|NCT00887198|158021020|FG002|Randomized Period|Ongoing|0|||
49051292|NCT00887198|158021018|FG000|Randomized Period|Adverse Event|50|||
49051293|NCT00887198|158021019|FG001|Randomized Period|Adverse Event|33|||
49051294|NCT00887198|158021020|FG002|Randomized Period|Adverse Event|0|||
49051295|NCT00887198|158021018|FG000|Randomized Period|Lost to Follow-up|1|||
49051296|NCT00887198|158021019|FG001|Randomized Period|Lost to Follow-up|0|||
49051297|NCT00887198|158021020|FG002|Randomized Period|Lost to Follow-up|0|||
49051298|NCT00887198|158021018|FG000|Randomized Period|Cross-over to AA (under amendment 3)|0|||
49051299|NCT00887198|158021019|FG001|Randomized Period|Cross-over to AA (under amendment 3)|51|||
49051300|NCT00887198|158021020|FG002|Randomized Period|Cross-over to AA (under amendment 3)|0|||
49051301|NCT00887198|158021018|FG000|Randomized Period|Withdrawal by Subject|41|||
49051302|NCT00887198|158021019|FG001|Randomized Period|Withdrawal by Subject|56|||
49051303|NCT00887198|158021020|FG002|Randomized Period|Withdrawal by Subject|0|||
49051304|NCT00887198|158021018|FG000|Randomized Period|Progressive disease|366|||
49051305|NCT00887198|158021019|FG001|Randomized Period|Progressive disease|370|||
49051306|NCT00887198|158021020|FG002|Randomized Period|Progressive disease|0|||
49051307|NCT00887198|158021018|FG000|Randomized Period|Other|42|||
49051308|NCT00887198|158021019|FG001|Randomized Period|Other|30|||
49051309|NCT00887198|158021020|FG002|Randomized Period|Other|0|||
49051310|NCT00887198|158021018|FG000|Randomized Period|Randomized, Not treated|4|||
49051311|NCT00887198|158021019|FG001|Randomized Period|Randomized, Not treated|2|||
49051312|NCT00887198|158021020|FG002|Randomized Period|Randomized, Not treated|0|||
49051313|NCT00887198|158021018|FG000|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
49051314|NCT00887198|158021019|FG001|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
49051315|NCT00887198|158021020|FG002|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8|||
49051316|NCT00887198|158021018|FG000|Cross Over (Placebo to AA)|Ongoing|0|||
49051317|NCT00887198|158021019|FG001|Cross Over (Placebo to AA)|Ongoing|0|||
49051318|NCT00887198|158021020|FG002|Cross Over (Placebo to AA)|Ongoing|35|||
49051319|NCT00887198|158021018|FG000|Cross Over (Placebo to AA)|Adverse Event|0|||
49051320|NCT00887198|158021019|FG001|Cross Over (Placebo to AA)|Adverse Event|0|||
49051321|NCT00887198|158021020|FG002|Cross Over (Placebo to AA)|Adverse Event|9|||
49051322|NCT00887198|158021018|FG000|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
49051323|NCT00887198|158021019|FG001|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
49051324|NCT00887198|158021020|FG002|Cross Over (Placebo to AA)|Withdrawal by Subject|2|||
49051325|NCT00887198|158021018|FG000|Cross Over (Placebo to AA)|Progressive disease|0|||
49051326|NCT00887198|158021019|FG001|Cross Over (Placebo to AA)|Progressive disease|0|||
49051327|NCT00887198|158021020|FG002|Cross Over (Placebo to AA)|Progressive disease|20|||
49051328|NCT00887198|158021018|FG000|Cross Over (Placebo to AA)|Other|0|||
49051329|NCT00887198|158021019|FG001|Cross Over (Placebo to AA)|Other|0|||
49051330|NCT00887198|158021020|FG002|Cross Over (Placebo to AA)|Other|19|||
49051331|NCT00063882|158021021|FG000|Overall Study|Protocol Violation|3|||
49051332|NCT00063882|158021022|FG001|Overall Study|Protocol Violation|3|||
49051333|NCT00063882|158021021|FG000|Overall Study|Withdrawal by Subject|2|||
49051334|NCT00063882|158021022|FG001|Overall Study|Withdrawal by Subject|1|||
49051335|NCT02820740|158021023|FG000|Overall Study|Did not have procedure|2|||
49051336|NCT01610063|158021024|FG000|Overall Study|Lost to Follow-up|42|||
49051337|NCT01610063|158021025|FG001|Overall Study|Lost to Follow-up|20|||
49051338|NCT03166124|158021026|FG000|Treatment Period 1|Adverse Event|0|||
49051339|NCT03166124|158021027|FG001|Treatment Period 1|Adverse Event|0|||
49051340|NCT03166124|158021028|FG002|Treatment Period 1|Adverse Event|1|||
49051341|NCT03166124|158021029|FG003|Treatment Period 1|Adverse Event|0|||
49051342|NCT03166124|158021026|FG000|Wash-out Period|Withdrawal by Subject|0|||
49051343|NCT03166124|158021027|FG001|Wash-out Period|Withdrawal by Subject|1|||
49051344|NCT03166124|158021028|FG002|Wash-out Period|Withdrawal by Subject|0|||
49051345|NCT03166124|158021029|FG003|Wash-out Period|Withdrawal by Subject|1|||
49051346|NCT03166124|158021026|FG000|Wash-out Period|Adverse Event|0|||
49051347|NCT03166124|158021027|FG001|Wash-out Period|Adverse Event|1|||
49051348|NCT03166124|158021028|FG002|Wash-out Period|Adverse Event|1|||
49051349|NCT03166124|158021029|FG003|Wash-out Period|Adverse Event|0|||
49051350|NCT01467479|158023791|FG000|Overall Study|No Study Medication|1|||
49051351|NCT01467479|158023792|FG001|Overall Study|No Study Medication|0|||
49051352|NCT01467479|158023793|FG002|Overall Study|No Study Medication|2|||
49051353|NCT01467479|158023791|FG000|Overall Study|Adverse Event|1|||
49051354|NCT01467479|158023792|FG001|Overall Study|Adverse Event|2|||
49051355|NCT01467479|158023793|FG002|Overall Study|Adverse Event|0|||
49051356|NCT01467479|158023791|FG000|Overall Study|Death|0|||
49051357|NCT01467479|158023792|FG001|Overall Study|Death|0|||
49051358|NCT01467479|158023793|FG002|Overall Study|Death|1|||
49051359|NCT01467479|158023791|FG000|Overall Study|Lost to Follow-up|2|||
49051360|NCT01467479|158023792|FG001|Overall Study|Lost to Follow-up|5|||
49051361|NCT01467479|158023793|FG002|Overall Study|Lost to Follow-up|3|||
49051362|NCT01467479|158023791|FG000|Overall Study|Withdrawal of Consent|3|||
49051363|NCT01467479|158023792|FG001|Overall Study|Withdrawal of Consent|7|||
49051364|NCT01467479|158023793|FG002|Overall Study|Withdrawal of Consent|7|||
49051365|NCT01467479|158023791|FG000|Overall Study|Study Terminated by Sponsor|1|||
49051366|NCT01467479|158023792|FG001|Overall Study|Study Terminated by Sponsor|3|||
49051367|NCT01467479|158023793|FG002|Overall Study|Study Terminated by Sponsor|3|||
49051368|NCT01467479|158023791|FG000|Overall Study|Other|1|||
49051369|NCT01467479|158023792|FG001|Overall Study|Other|0|||
49051370|NCT01467479|158023793|FG002|Overall Study|Other|0|||
49051371|NCT04100096|158023797|FG000|Overall Study|Adverse Event|19|||
49051372|NCT04100096|158023798|FG001|Overall Study|Adverse Event|7|||
49051373|NCT04100096|158023797|FG000|Overall Study|Lack of Efficacy|0|||
49051374|NCT04100096|158023798|FG001|Overall Study|Lack of Efficacy|1|||
49051375|NCT04100096|158023797|FG000|Overall Study|Lost to Follow-up|13|||
49051376|NCT04100096|158023798|FG001|Overall Study|Lost to Follow-up|11|||
49051377|NCT04100096|158023797|FG000|Overall Study|Non-Compliance With Study Drug|1|||
49051378|NCT04100096|158023798|FG001|Overall Study|Non-Compliance With Study Drug|3|||
49051379|NCT04100096|158023797|FG000|Overall Study|Protocol Deviation|1|||
49051380|NCT04100096|158023798|FG001|Overall Study|Protocol Deviation|1|||
49051381|NCT04100096|158023797|FG000|Overall Study|Withdrawal by Participant|13|||
49051382|NCT04100096|158023798|FG001|Overall Study|Withdrawal by Participant|15|||
49051383|NCT02104817|158023799|FG000|Overall Study|Death|363|||
49051384|NCT02104817|158023800|FG001|Overall Study|Death|330|||
49051385|NCT02104817|158023799|FG000|Overall Study|Lost to Follow-up|3|||
49051386|NCT02104817|158023800|FG001|Overall Study|Lost to Follow-up|2|||
49051387|NCT02104817|158023799|FG000|Overall Study|Protocol Violation|0|||
49051388|NCT02104817|158023800|FG001|Overall Study|Protocol Violation|1|||
49051389|NCT02104817|158023799|FG000|Overall Study|Study terminated by sponsor|5854|||
49051390|NCT02104817|158023800|FG001|Overall Study|Study terminated by sponsor|5901|||
49051391|NCT02104817|158023799|FG000|Overall Study|Withdrawal by Subject|111|||
49051392|NCT02104817|158023800|FG001|Overall Study|Withdrawal by Subject|78|||
49051393|NCT02104817|158023799|FG000|Overall Study|Other reasons|128|||
49051394|NCT02104817|158023800|FG001|Overall Study|Other reasons|135|||
49051395|NCT02919306|158023804|FG000|Overall Study|Withdrawal by Subject|1|||
49051396|NCT02919306|158023805|FG001|Overall Study|Withdrawal by Subject|0|||
49051397|NCT02919306|158023804|FG000|Overall Study|Protocol Violation|1|||
49051398|NCT02919306|158023805|FG001|Overall Study|Protocol Violation|0|||
49051399|NCT00831233|158023808|FG000|Overall Study|Adverse Event|0|||
49051400|NCT00831233|158023809|FG001|Overall Study|Adverse Event|1|||
49051401|NCT00831233|158023808|FG000|Overall Study|Protocol Violation|1|||
49051402|NCT00831233|158023809|FG001|Overall Study|Protocol Violation|0|||
49051403|NCT00831233|158023808|FG000|Overall Study|Selection Criteria Not Met|2|||
49051404|NCT00831233|158023809|FG001|Overall Study|Selection Criteria Not Met|0|||
49051405|NCT04908722|158023810|FG000|Overall Study|Protocol deviation|1|||
49051406|NCT04908722|158023811|FG001|Overall Study|Protocol deviation|0|||
49051407|NCT04908722|158023812|FG002|Overall Study|Protocol deviation|0|||
49051408|NCT04908722|158023813|FG003|Overall Study|Protocol deviation|0|||
49051409|NCT04908722|158023814|FG004|Overall Study|Protocol deviation|0|||
49051410|NCT04908722|158023815|FG005|Overall Study|Protocol deviation|1|||
49051411|NCT04908722|158023810|FG000|Overall Study|Lost to Follow-up|33|||
49051412|NCT04908722|158023811|FG001|Overall Study|Lost to Follow-up|33|||
49051413|NCT04908722|158023812|FG002|Overall Study|Lost to Follow-up|36|||
49051414|NCT04908722|158023813|FG003|Overall Study|Lost to Follow-up|30|||
49051415|NCT04908722|158023814|FG004|Overall Study|Lost to Follow-up|32|||
49051416|NCT04908722|158023815|FG005|Overall Study|Lost to Follow-up|34|||
49051417|NCT04908722|158023810|FG000|Overall Study|Physician Decision|1|||
49051418|NCT04908722|158023811|FG001|Overall Study|Physician Decision|1|||
49051419|NCT04908722|158023812|FG002|Overall Study|Physician Decision|1|||
49051420|NCT04908722|158023813|FG003|Overall Study|Physician Decision|2|||
49051421|NCT04908722|158023814|FG004|Overall Study|Physician Decision|0|||
49051422|NCT04908722|158023815|FG005|Overall Study|Physician Decision|0|||
49051423|NCT04908722|158023810|FG000|Overall Study|Death|1|||
49051424|NCT04908722|158023811|FG001|Overall Study|Death|0|||
49051425|NCT04908722|158023812|FG002|Overall Study|Death|0|||
49051426|NCT04908722|158023813|FG003|Overall Study|Death|0|||
49051427|NCT04908722|158023814|FG004|Overall Study|Death|0|||
49051428|NCT04908722|158023815|FG005|Overall Study|Death|1|||
49051429|NCT04908722|158023810|FG000|Overall Study|Withdrawal by Subject|12|||
49051430|NCT04908722|158023811|FG001|Overall Study|Withdrawal by Subject|8|||
49051431|NCT04908722|158023812|FG002|Overall Study|Withdrawal by Subject|7|||
49051432|NCT04908722|158023813|FG003|Overall Study|Withdrawal by Subject|6|||
49051433|NCT04908722|158023814|FG004|Overall Study|Withdrawal by Subject|12|||
49051434|NCT04908722|158023815|FG005|Overall Study|Withdrawal by Subject|14|||
49051435|NCT04908722|158023810|FG000|Overall Study|Other|3|||
49051436|NCT04908722|158023811|FG001|Overall Study|Other|1|||
49051437|NCT04908722|158023812|FG002|Overall Study|Other|3|||
49051438|NCT04908722|158023813|FG003|Overall Study|Other|2|||
49051439|NCT04908722|158023814|FG004|Overall Study|Other|4|||
49051440|NCT04908722|158023815|FG005|Overall Study|Other|1|||
49051441|NCT04908722|158023810|FG000|Overall Study|Initiated prohibited medication|0|||
49051442|NCT04908722|158023811|FG001|Overall Study|Initiated prohibited medication|0|||
49051443|NCT04908722|158023812|FG002|Overall Study|Initiated prohibited medication|0|||
49051444|NCT04908722|158023813|FG003|Overall Study|Initiated prohibited medication|1|||
49051445|NCT04908722|158023814|FG004|Overall Study|Initiated prohibited medication|0|||
49051446|NCT04908722|158023815|FG005|Overall Study|Initiated prohibited medication|1|||
49051447|NCT04908722|158023810|FG000|Overall Study|Randomized but not vaccinated|3|||
49051448|NCT04908722|158023811|FG001|Overall Study|Randomized but not vaccinated|1|||
49051449|NCT04908722|158023812|FG002|Overall Study|Randomized but not vaccinated|2|||
49051450|NCT04908722|158023813|FG003|Overall Study|Randomized but not vaccinated|2|||
49051451|NCT04908722|158023814|FG004|Overall Study|Randomized but not vaccinated|3|||
49051452|NCT04908722|158023815|FG005|Overall Study|Randomized but not vaccinated|4|||
49051453|NCT00544817|158023816|FG000|Combined Modality|Lack of Efficacy|2|||
49051454|NCT00544817|158023816|FG000|Combined Modality|Worsening Neurologic Symptoms|2|||
49051455|NCT00544817|158023816|FG000|Combined Modality|Adverse Event|2|||
49051456|NCT00544817|158023816|FG000|Combined Modality|Intercurrent Illness - Pneumonia|1|||
49051457|NCT00544817|158023816|FG000|No Treatment Interval|Lack of Efficacy|8|||
49051458|NCT00544817|158023816|FG000|No Treatment Interval|Physician Decision|3|||
49051459|NCT00544817|158023816|FG000|No Treatment Interval|Adverse Event|1|||
49051460|NCT00544817|158023816|FG000|Follow-up Systemic Therapy|Lack of Efficacy|15|||
49051461|NCT00544817|158023816|FG000|Follow-up Systemic Therapy|Physician Decision|3|||
49051462|NCT00544817|158023816|FG000|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1|||
49051463|NCT04633642|158023820|FG000|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1|||
49051464|NCT04633642|158023821|FG001|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2|||
49051465|NCT01131299|158023822|FG000|Overall Study|Withdrawal by Subject|4|||
49051466|NCT01131299|158023823|FG001|Overall Study|Withdrawal by Subject|7|||
49051467|NCT04191499|158023824|FG000|Overall Study|Adverse Event|1|||
49051468|NCT04191499|158023825|FG001|Overall Study|Adverse Event|0|||
49051469|NCT04191499|158023824|FG000|Overall Study|Death|42|||
49051470|NCT04191499|158023825|FG001|Overall Study|Death|55|||
49051471|NCT04191499|158023824|FG000|Overall Study|Lost to Follow-up|4|||
49051472|NCT04191499|158023825|FG001|Overall Study|Lost to Follow-up|1|||
49051473|NCT04191499|158023824|FG000|Overall Study|Physician Decision|1|||
49051474|NCT04191499|158023825|FG001|Overall Study|Physician Decision|0|||
49051475|NCT04191499|158023824|FG000|Overall Study|Progressive Disease|1|||
49051476|NCT04191499|158023825|FG001|Overall Study|Progressive Disease|0|||
49051477|NCT04191499|158023824|FG000|Overall Study|Symptomatic Deterioration|1|||
49051478|NCT04191499|158023825|FG001|Overall Study|Symptomatic Deterioration|0|||
49051479|NCT04191499|158023824|FG000|Overall Study|Withdrawal by Subject|7|||
49051480|NCT04191499|158023825|FG001|Overall Study|Withdrawal by Subject|11|||
49051481|NCT04191499|158023824|FG000|Overall Study|Ongoing in the study|104|||
49051482|NCT04191499|158023825|FG001|Overall Study|Ongoing in the study|97|||
49051483|NCT02356211|158023828|FG000|Overall Study|Withdrawal by Subject|2|||
49051484|NCT02356211|158023829|FG001|Overall Study|Withdrawal by Subject|2|||
49051485|NCT02356211|158023828|FG000|Overall Study|ineligible|1|||
49051486|NCT02356211|158023829|FG001|Overall Study|ineligible|8|||
49051487|NCT02953678|158023830|FG000|Overall Study|Adverse Event|20|||
49051488|NCT02953678|158023830|FG000|Overall Study|Death|7|||
49051489|NCT02953678|158023830|FG000|Overall Study|Physician Decision|23|||
49051490|NCT02953678|158023830|FG000|Overall Study|Progressive Disease of GVHD|7|||
49051491|NCT02953678|158023830|FG000|Overall Study|Relapse of Underlying Malignancy|3|||
49051492|NCT02953678|158023830|FG000|Overall Study|Withdrawal by participant|3|||
49051493|NCT02953678|158023830|FG000|Overall Study|Includes 2 participants who discontinued ruxolitinib treatment because of clinical improvement|5|||
49051494|NCT02953678|158023830|FG000|Overall Study|Participants were transferred to commercial product.|3|||
49051495|NCT01976728|158023831|FG000|Overall Study|Subject missed multiple doses of IMP|1|||
49051496|NCT01976728|158023832|FG001|Overall Study|Subject missed multiple doses of IMP|0|||
49051497|NCT01976728|158023833|FG002|Overall Study|Subject missed multiple doses of IMP|0|||
49051498|NCT01976728|158023834|FG003|Overall Study|Subject missed multiple doses of IMP|0|||
49051499|NCT02262728|158023835|FG000|Follow-up Phase (3 Years)|Death|0|||
49051500|NCT02262728|158023836|FG001|Follow-up Phase (3 Years)|Death|1|||
49051501|NCT02262728|158023835|FG000|Follow-up Phase (3 Years)|Lost to Follow-up|4|||
49051502|NCT02262728|158023836|FG001|Follow-up Phase (3 Years)|Lost to Follow-up|1|||
49051503|NCT02262728|158023835|FG000|Follow-up Phase (3 Years)|Withdrawal by Subject|0|||
49051504|NCT02262728|158023836|FG001|Follow-up Phase (3 Years)|Withdrawal by Subject|1|||
49051505|NCT03785145|158023841|FG000|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|0|||
49051506|NCT03785145|158023842|FG001|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|1|||
49051507|NCT03785145|158023841|FG000|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|6|||
49051508|NCT03785145|158023842|FG001|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|9|||
49051509|NCT03785145|158023841|FG000|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
49051510|NCT03785145|158023842|FG001|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
49051511|NCT03785145|158023841|FG000|Cycle 1 - Double Blind (Days 1-180)|Death|0|||
49051512|NCT03785145|158023842|FG001|Cycle 1 - Double Blind (Days 1-180)|Death|1|||
49051513|NCT03785145|158023841|FG000|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|1|||
49051514|NCT03785145|158023842|FG001|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|0|||
49051515|NCT03785145|158023841|FG000|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|1|||
49051516|NCT03785145|158023842|FG001|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|5|||
49051517|NCT03785145|158023841|FG000|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|1|||
49051518|NCT03785145|158023842|FG001|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|6|||
49051519|NCT03785145|158023841|FG000|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|2|||
49051520|NCT03785145|158023842|FG001|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|3|||
49051521|NCT03785145|158023841|FG000|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|0|||
49051522|NCT03785145|158023842|FG001|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|1|||
49051523|NCT03785145|158023841|FG000|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|0|||
49051524|NCT03785145|158023842|FG001|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|1|||
49051525|NCT03785145|158023841|FG000|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|0|||
49051526|NCT03785145|158023842|FG001|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|1|||
49051527|NCT01824394|158023843|FG000|Overall Study|Early Termination|1|||
49051528|NCT01824394|158023844|FG001|Overall Study|Early Termination|1|||
49051529|NCT01824394|158023845|FG002|Overall Study|Early Termination|3|||
49051530|NCT01824394|158023843|FG000|Overall Study|Withdrawn due to Study Termination|91|||
49051531|NCT01824394|158023844|FG001|Overall Study|Withdrawn due to Study Termination|83|||
49051532|NCT01824394|158023845|FG002|Overall Study|Withdrawn due to Study Termination|41|||
49051533|NCT01824394|158023843|FG000|Overall Study|Lost to Follow-up|0|||
49051534|NCT01824394|158023844|FG001|Overall Study|Lost to Follow-up|9|||
49051535|NCT01824394|158023845|FG002|Overall Study|Lost to Follow-up|3|||
49051536|NCT01824394|158023843|FG000|Overall Study|Death|3|||
49051537|NCT01824394|158023844|FG001|Overall Study|Death|2|||
49051538|NCT01824394|158023845|FG002|Overall Study|Death|4|||
49051539|NCT01824394|158023843|FG000|Overall Study|Discontinued Subjects|1|||
49051540|NCT01824394|158023844|FG001|Overall Study|Discontinued Subjects|1|||
49051541|NCT01824394|158023845|FG002|Overall Study|Discontinued Subjects|2|||
49051542|NCT01824394|158023843|FG000|Overall Study|Excluded Subjects(No catheter inserted)|23|||
49051543|NCT01824394|158023844|FG001|Overall Study|Excluded Subjects(No catheter inserted)|20|||
49051544|NCT01824394|158023845|FG002|Overall Study|Excluded Subjects(No catheter inserted)|21|||
49051545|NCT00108082|158023846|FG000|Overall Study|Adverse Event|14|||
49051546|NCT00108082|158023847|FG001|Overall Study|Adverse Event|12|||
49051547|NCT00108082|158023848|FG002|Overall Study|Adverse Event|17|||
49051548|NCT00108082|158023846|FG000|Overall Study|Lost to Follow-up|6|||
49051549|NCT00108082|158023847|FG001|Overall Study|Lost to Follow-up|3|||
49051550|NCT00108082|158023848|FG002|Overall Study|Lost to Follow-up|7|||
49051551|NCT00108082|158023846|FG000|Overall Study|Consent Withdrawn|3|||
49051552|NCT00108082|158023847|FG001|Overall Study|Consent Withdrawn|3|||
49051553|NCT00108082|158023848|FG002|Overall Study|Consent Withdrawn|5|||
49051554|NCT00108082|158023846|FG000|Overall Study|Protocol Violation|1|||
49051555|NCT00108082|158023847|FG001|Overall Study|Protocol Violation|2|||
49051556|NCT00108082|158023848|FG002|Overall Study|Protocol Violation|0|||
49051557|NCT00108082|158023846|FG000|Overall Study|Lack of Efficacy|3|||
49051558|NCT00108082|158023847|FG001|Overall Study|Lack of Efficacy|1|||
49051559|NCT00108082|158023848|FG002|Overall Study|Lack of Efficacy|2|||
49051560|NCT00108082|158023846|FG000|Overall Study|Amendment 4: > Month 12|5|||
49051561|NCT00108082|158023847|FG001|Overall Study|Amendment 4: > Month 12|7|||
49051562|NCT00108082|158023848|FG002|Overall Study|Amendment 4: > Month 12|5|||
49051563|NCT00108082|158023846|FG000|Overall Study|Woman of Child-bearing Potential|2|||
49051564|NCT00108082|158023847|FG001|Overall Study|Woman of Child-bearing Potential|0|||
49051565|NCT00108082|158023848|FG002|Overall Study|Woman of Child-bearing Potential|2|||
49051566|NCT00108082|158023846|FG000|Overall Study|Incorrectly Randomized|0|||
49051567|NCT00108082|158023847|FG001|Overall Study|Incorrectly Randomized|0|||
49051568|NCT00108082|158023848|FG002|Overall Study|Incorrectly Randomized|2|||
49051569|NCT00108082|158023846|FG000|Overall Study|Non-compliance|1|||
49051570|NCT00108082|158023847|FG001|Overall Study|Non-compliance|0|||
49051571|NCT00108082|158023848|FG002|Overall Study|Non-compliance|2|||
49051572|NCT00108082|158023846|FG000|Overall Study|Stopped Study Medication|0|||
49051573|NCT00108082|158023847|FG001|Overall Study|Stopped Study Medication|0|||
49051574|NCT00108082|158023848|FG002|Overall Study|Stopped Study Medication|1|||
49051575|NCT00108082|158023846|FG000|Overall Study|Site Closed Study|0|||
49051576|NCT00108082|158023847|FG001|Overall Study|Site Closed Study|2|||
49051577|NCT00108082|158023848|FG002|Overall Study|Site Closed Study|0|||
49051578|NCT00108082|158023846|FG000|Overall Study|Protocol Amendment|0|||
49051579|NCT00108082|158023847|FG001|Overall Study|Protocol Amendment|1|||
49051580|NCT00108082|158023848|FG002|Overall Study|Protocol Amendment|0|||
49051581|NCT00108082|158023846|FG000|Overall Study|Study Medication Not Tapered|0|||
49051582|NCT00108082|158023847|FG001|Overall Study|Study Medication Not Tapered|1|||
49051583|NCT00108082|158023848|FG002|Overall Study|Study Medication Not Tapered|0|||
49051584|NCT00108082|158023846|FG000|Overall Study|Subject Left Site Location|1|||
49051585|NCT00108082|158023847|FG001|Overall Study|Subject Left Site Location|0|||
49051586|NCT00108082|158023848|FG002|Overall Study|Subject Left Site Location|0|||
49051587|NCT00108082|158023846|FG000|Overall Study|Investigator Not at Site|1|||
49051588|NCT00108082|158023847|FG001|Overall Study|Investigator Not at Site|0|||
49051589|NCT00108082|158023848|FG002|Overall Study|Investigator Not at Site|0|||
49051590|NCT00108082|158023846|FG000|Overall Study|Blood Pressure Not Controlled|1|||
49051591|NCT00108082|158023847|FG001|Overall Study|Blood Pressure Not Controlled|0|||
49051592|NCT00108082|158023848|FG002|Overall Study|Blood Pressure Not Controlled|0|||
49051593|NCT01715285|158023849|FG000|Double Blind Period (Up to 23 Months)|Adverse Event|53|||
49051594|NCT01715285|158023850|FG001|Double Blind Period (Up to 23 Months)|Adverse Event|31|||
49051595|NCT01715285|158023851|FG002|Double Blind Period (Up to 23 Months)|Adverse Event|0|||
49051596|NCT01715285|158023849|FG000|Double Blind Period (Up to 23 Months)|Death|43|||
49051597|NCT01715285|158023850|FG001|Double Blind Period (Up to 23 Months)|Death|25|||
49051598|NCT01715285|158023851|FG002|Double Blind Period (Up to 23 Months)|Death|0|||
49051599|NCT01715285|158023849|FG000|Double Blind Period (Up to 23 Months)|Lost to Follow-up|3|||
49051600|NCT01715285|158023850|FG001|Double Blind Period (Up to 23 Months)|Lost to Follow-up|2|||
49051601|NCT01715285|158023851|FG002|Double Blind Period (Up to 23 Months)|Lost to Follow-up|0|||
49051602|NCT01715285|158023849|FG000|Double Blind Period (Up to 23 Months)|Physician Decision|21|||
49051603|NCT01715285|158023850|FG001|Double Blind Period (Up to 23 Months)|Physician Decision|23|||
49051604|NCT01715285|158023851|FG002|Double Blind Period (Up to 23 Months)|Physician Decision|0|||
49051605|NCT01715285|158023849|FG000|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|52|||
49051606|NCT01715285|158023850|FG001|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|47|||
49051607|NCT01715285|158023851|FG002|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|0|||
49051608|NCT01715285|158023849|FG000|Double Blind Period (Up to 23 Months)|Progressive Disease|254|||
49051609|NCT01715285|158023850|FG001|Double Blind Period (Up to 23 Months)|Progressive Disease|388|||
49051610|NCT01715285|158023851|FG002|Double Blind Period (Up to 23 Months)|Progressive Disease|0|||
49051611|NCT01715285|158023849|FG000|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|4|||
49051612|NCT01715285|158023850|FG001|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|2|||
49051613|NCT01715285|158023851|FG002|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|0|||
49051614|NCT01715285|158023849|FG000|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
49051615|NCT01715285|158023850|FG001|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|72|||
49051616|NCT01715285|158023851|FG002|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
49051617|NCT01715285|158023849|FG000|Double Blind Period (Up to 23 Months)|Other|167|||
49051618|NCT01715285|158023850|FG001|Double Blind Period (Up to 23 Months)|Other|12|||
49051619|NCT01715285|158023851|FG002|Double Blind Period (Up to 23 Months)|Other|0|||
49051620|NCT01715285|158023849|FG000|OLE Phase (Up to 15.6 Months)|Death|0|||
49051621|NCT01715285|158023850|FG001|OLE Phase (Up to 15.6 Months)|Death|0|||
49051622|NCT01715285|158023851|FG002|OLE Phase (Up to 15.6 Months)|Death|4|||
49051623|NCT01715285|158023849|FG000|OLE Phase (Up to 15.6 Months)|Other|0|||
49051624|NCT01715285|158023850|FG001|OLE Phase (Up to 15.6 Months)|Other|0|||
49051625|NCT01715285|158023851|FG002|OLE Phase (Up to 15.6 Months)|Other|60|||
49051626|NCT01715285|158023849|FG000|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
49051627|NCT01715285|158023850|FG001|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
49051628|NCT01715285|158023851|FG002|OLE Phase (Up to 15.6 Months)|Progressive Disease|1|||
49051629|NCT01715285|158023849|FG000|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
49051630|NCT01715285|158023850|FG001|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
49051631|NCT01715285|158023851|FG002|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|6|||
49051632|NCT01715285|158023849|FG000|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
49051633|NCT01715285|158023850|FG001|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
49051634|NCT01715285|158023851|FG002|OLE Phase (Up to 15.6 Months)|Adverse Event|1|||
49051635|NCT02675751|158023852|FG000|Overall Study|Lost to Follow-up|16|||
49051636|NCT04436276|158023853|FG000|Overall Study|Adverse Event|0|||
49051637|NCT04436276|158023854|FG001|Overall Study|Adverse Event|0|||
49051638|NCT04436276|158023855|FG002|Overall Study|Adverse Event|0|||
49051639|NCT04436276|158023856|FG003|Overall Study|Adverse Event|0|||
49051640|NCT04436276|158023857|FG004|Overall Study|Adverse Event|0|||
49051641|NCT04436276|158023858|FG005|Overall Study|Adverse Event|0|||
49051642|NCT04436276|158023859|FG006|Overall Study|Adverse Event|0|||
49051643|NCT04436276|158023860|FG007|Overall Study|Adverse Event|0|||
49051644|NCT04436276|158023861|FG008|Overall Study|Adverse Event|0|||
49051645|NCT04436276|158023862|FG009|Overall Study|Adverse Event|0|||
49051646|NCT04436276|158023863|FG010|Overall Study|Adverse Event|0|||
49051647|NCT04436276|158023864|FG011|Overall Study|Adverse Event|0|||
49051648|NCT04436276|158023865|FG012|Overall Study|Adverse Event|0|||
49051649|NCT04436276|158023866|FG013|Overall Study|Adverse Event|0|||
49051650|NCT04436276|158023867|FG014|Overall Study|Adverse Event|0|||
49051651|NCT04436276|158023868|FG015|Overall Study|Adverse Event|0|||
49051652|NCT04436276|158023869|FG016|Overall Study|Adverse Event|1|||
49051653|NCT04436276|158023870|FG017|Overall Study|Adverse Event|0|||
49051654|NCT04436276|158023871|FG018|Overall Study|Adverse Event|0|||
49051655|NCT04436276|158023872|FG019|Overall Study|Adverse Event|0|||
49051656|NCT04436276|158023873|FG020|Overall Study|Adverse Event|0|||
49051657|NCT04436276|158023874|FG021|Overall Study|Adverse Event|0|||
49051658|NCT04436276|158023875|FG022|Overall Study|Adverse Event|0|||
49051659|NCT04436276|158023853|FG000|Overall Study|Death|0|||
49051660|NCT04436276|158023854|FG001|Overall Study|Death|0|||
49051661|NCT04436276|158023855|FG002|Overall Study|Death|0|||
49051662|NCT04436276|158023856|FG003|Overall Study|Death|0|||
49051663|NCT04436276|158023857|FG004|Overall Study|Death|0|||
49051664|NCT04436276|158023858|FG005|Overall Study|Death|0|||
49051665|NCT04436276|158023859|FG006|Overall Study|Death|0|||
49051666|NCT04436276|158023860|FG007|Overall Study|Death|0|||
49051667|NCT04436276|158023861|FG008|Overall Study|Death|0|||
49051668|NCT04436276|158023862|FG009|Overall Study|Death|0|||
49051669|NCT04436276|158023863|FG010|Overall Study|Death|0|||
49051670|NCT04436276|158023864|FG011|Overall Study|Death|0|||
49051671|NCT04436276|158023865|FG012|Overall Study|Death|1|||
49051672|NCT04436276|158023866|FG013|Overall Study|Death|0|||
49051673|NCT04436276|158023867|FG014|Overall Study|Death|1|||
49051674|NCT04436276|158023868|FG015|Overall Study|Death|0|||
49051675|NCT04436276|158023869|FG016|Overall Study|Death|0|||
49051676|NCT04436276|158023870|FG017|Overall Study|Death|0|||
49051677|NCT04436276|158023871|FG018|Overall Study|Death|0|||
49051678|NCT04436276|158023872|FG019|Overall Study|Death|2|||
49051679|NCT04436276|158023873|FG020|Overall Study|Death|0|||
49051680|NCT04436276|158023874|FG021|Overall Study|Death|1|||
49051681|NCT04436276|158023875|FG022|Overall Study|Death|0|||
49051682|NCT04436276|158023853|FG000|Overall Study|Lost to Follow-up|0|||
49051683|NCT04436276|158023854|FG001|Overall Study|Lost to Follow-up|2|||
49051684|NCT04436276|158023855|FG002|Overall Study|Lost to Follow-up|2|||
49051685|NCT04436276|158023856|FG003|Overall Study|Lost to Follow-up|1|||
49051686|NCT04436276|158023857|FG004|Overall Study|Lost to Follow-up|4|||
49051687|NCT04436276|158023858|FG005|Overall Study|Lost to Follow-up|1|||
49051688|NCT04436276|158023859|FG006|Overall Study|Lost to Follow-up|0|||
49051689|NCT04436276|158023860|FG007|Overall Study|Lost to Follow-up|0|||
49051690|NCT04436276|158023861|FG008|Overall Study|Lost to Follow-up|1|||
49051691|NCT04436276|158023862|FG009|Overall Study|Lost to Follow-up|0|||
49051692|NCT04436276|158023863|FG010|Overall Study|Lost to Follow-up|5|||
49051693|NCT04436276|158023864|FG011|Overall Study|Lost to Follow-up|5|||
49051694|NCT04436276|158023865|FG012|Overall Study|Lost to Follow-up|4|||
49051695|NCT04436276|158023866|FG013|Overall Study|Lost to Follow-up|1|||
49051696|NCT04436276|158023867|FG014|Overall Study|Lost to Follow-up|7|||
49051697|NCT04436276|158023868|FG015|Overall Study|Lost to Follow-up|7|||
49051698|NCT04436276|158023869|FG016|Overall Study|Lost to Follow-up|1|||
49051699|NCT04436276|158023870|FG017|Overall Study|Lost to Follow-up|0|||
49051700|NCT04436276|158023871|FG018|Overall Study|Lost to Follow-up|1|||
49051701|NCT04436276|158023872|FG019|Overall Study|Lost to Follow-up|1|||
49051702|NCT04436276|158023873|FG020|Overall Study|Lost to Follow-up|2|||
49051703|NCT04436276|158023874|FG021|Overall Study|Lost to Follow-up|1|||
49051704|NCT04436276|158023875|FG022|Overall Study|Lost to Follow-up|1|||
49051705|NCT04436276|158023853|FG000|Overall Study|Physician Decision|1|||
49051706|NCT04436276|158023854|FG001|Overall Study|Physician Decision|0|||
49051707|NCT04436276|158023855|FG002|Overall Study|Physician Decision|2|||
49051708|NCT04436276|158023856|FG003|Overall Study|Physician Decision|1|||
49051709|NCT04436276|158023857|FG004|Overall Study|Physician Decision|0|||
49051710|NCT04436276|158023858|FG005|Overall Study|Physician Decision|0|||
49051711|NCT04436276|158023859|FG006|Overall Study|Physician Decision|0|||
49051712|NCT04436276|158023860|FG007|Overall Study|Physician Decision|0|||
49051713|NCT04436276|158023861|FG008|Overall Study|Physician Decision|0|||
49051714|NCT04436276|158023862|FG009|Overall Study|Physician Decision|0|||
49051715|NCT04436276|158023863|FG010|Overall Study|Physician Decision|0|||
49051716|NCT04436276|158023864|FG011|Overall Study|Physician Decision|1|||
49051717|NCT04436276|158023865|FG012|Overall Study|Physician Decision|2|||
49051718|NCT04436276|158023866|FG013|Overall Study|Physician Decision|0|||
49051719|NCT04436276|158023867|FG014|Overall Study|Physician Decision|0|||
49051720|NCT04436276|158023868|FG015|Overall Study|Physician Decision|0|||
49051721|NCT04436276|158023869|FG016|Overall Study|Physician Decision|0|||
49051722|NCT04436276|158023870|FG017|Overall Study|Physician Decision|0|||
49051723|NCT04436276|158023871|FG018|Overall Study|Physician Decision|0|||
49051724|NCT04436276|158023872|FG019|Overall Study|Physician Decision|0|||
49051725|NCT04436276|158023873|FG020|Overall Study|Physician Decision|1|||
49051726|NCT04436276|158023874|FG021|Overall Study|Physician Decision|2|||
49051727|NCT04436276|158023875|FG022|Overall Study|Physician Decision|0|||
49051728|NCT04436276|158023853|FG000|Overall Study|Protocol Violation|0|||
49051729|NCT04436276|158023854|FG001|Overall Study|Protocol Violation|0|||
49051730|NCT04436276|158023855|FG002|Overall Study|Protocol Violation|0|||
49051731|NCT04436276|158023856|FG003|Overall Study|Protocol Violation|0|||
49051732|NCT04436276|158023857|FG004|Overall Study|Protocol Violation|0|||
49051733|NCT04436276|158023858|FG005|Overall Study|Protocol Violation|0|||
49051734|NCT04436276|158023859|FG006|Overall Study|Protocol Violation|0|||
49051735|NCT04436276|158023860|FG007|Overall Study|Protocol Violation|0|||
49051736|NCT04436276|158023861|FG008|Overall Study|Protocol Violation|0|||
49051737|NCT04436276|158023862|FG009|Overall Study|Protocol Violation|0|||
49051738|NCT04436276|158023863|FG010|Overall Study|Protocol Violation|0|||
49051739|NCT04436276|158023864|FG011|Overall Study|Protocol Violation|0|||
49051740|NCT04436276|158023865|FG012|Overall Study|Protocol Violation|0|||
49051741|NCT04436276|158023866|FG013|Overall Study|Protocol Violation|1|||
49051742|NCT04436276|158023867|FG014|Overall Study|Protocol Violation|0|||
49051743|NCT04436276|158023868|FG015|Overall Study|Protocol Violation|1|||
49051744|NCT04436276|158023869|FG016|Overall Study|Protocol Violation|0|||
49051745|NCT04436276|158023870|FG017|Overall Study|Protocol Violation|0|||
49051746|NCT04436276|158023871|FG018|Overall Study|Protocol Violation|0|||
49051747|NCT04436276|158023872|FG019|Overall Study|Protocol Violation|0|||
49051748|NCT04436276|158023873|FG020|Overall Study|Protocol Violation|0|||
49051749|NCT04436276|158023874|FG021|Overall Study|Protocol Violation|0|||
49051750|NCT04436276|158023875|FG022|Overall Study|Protocol Violation|0|||
49051751|NCT04436276|158023853|FG000|Overall Study|Withdrawal by Subject|25|||
49051752|NCT04436276|158023854|FG001|Overall Study|Withdrawal by Subject|22|||
49051753|NCT04436276|158023855|FG002|Overall Study|Withdrawal by Subject|24|||
49051754|NCT04436276|158023856|FG003|Overall Study|Withdrawal by Subject|23|||
49051755|NCT04436276|158023857|FG004|Overall Study|Withdrawal by Subject|14|||
49051756|NCT04436276|158023858|FG005|Overall Study|Withdrawal by Subject|0|||
49051757|NCT04436276|158023859|FG006|Overall Study|Withdrawal by Subject|0|||
49051758|NCT04436276|158023860|FG007|Overall Study|Withdrawal by Subject|1|||
49051759|NCT04436276|158023861|FG008|Overall Study|Withdrawal by Subject|0|||
49051760|NCT04436276|158023862|FG009|Overall Study|Withdrawal by Subject|1|||
49051761|NCT04436276|158023863|FG010|Overall Study|Withdrawal by Subject|17|||
49051762|NCT04436276|158023864|FG011|Overall Study|Withdrawal by Subject|7|||
49051763|NCT04436276|158023865|FG012|Overall Study|Withdrawal by Subject|10|||
49051764|NCT04436276|158023866|FG013|Overall Study|Withdrawal by Subject|6|||
49051765|NCT04436276|158023867|FG014|Overall Study|Withdrawal by Subject|20|||
49051766|NCT04436276|158023868|FG015|Overall Study|Withdrawal by Subject|6|||
49051767|NCT04436276|158023869|FG016|Overall Study|Withdrawal by Subject|11|||
49051768|NCT04436276|158023870|FG017|Overall Study|Withdrawal by Subject|4|||
49051769|NCT04436276|158023871|FG018|Overall Study|Withdrawal by Subject|14|||
49051770|NCT04436276|158023872|FG019|Overall Study|Withdrawal by Subject|24|||
49051771|NCT04436276|158023873|FG020|Overall Study|Withdrawal by Subject|24|||
49051772|NCT04436276|158023874|FG021|Overall Study|Withdrawal by Subject|16|||
49051773|NCT04436276|158023875|FG022|Overall Study|Withdrawal by Subject|14|||
49051774|NCT04436276|158023853|FG000|Overall Study|Other|3|||
49051775|NCT04436276|158023854|FG001|Overall Study|Other|2|||
49051776|NCT04436276|158023855|FG002|Overall Study|Other|5|||
49051777|NCT04436276|158023856|FG003|Overall Study|Other|9|||
49051778|NCT04436276|158023857|FG004|Overall Study|Other|23|||
49051779|NCT04436276|158023858|FG005|Overall Study|Other|1|||
49051780|NCT04436276|158023859|FG006|Overall Study|Other|0|||
49051781|NCT04436276|158023860|FG007|Overall Study|Other|0|||
49051782|NCT04436276|158023861|FG008|Overall Study|Other|0|||
49051783|NCT04436276|158023862|FG009|Overall Study|Other|0|||
49051784|NCT04436276|158023863|FG010|Overall Study|Other|3|||
49051785|NCT04436276|158023864|FG011|Overall Study|Other|1|||
49051786|NCT04436276|158023865|FG012|Overall Study|Other|1|||
49051787|NCT04436276|158023866|FG013|Overall Study|Other|2|||
49051788|NCT04436276|158023867|FG014|Overall Study|Other|3|||
49051789|NCT04436276|158023868|FG015|Overall Study|Other|0|||
49051790|NCT04436276|158023869|FG016|Overall Study|Other|0|||
49051791|NCT04436276|158023870|FG017|Overall Study|Other|6|||
49051792|NCT04436276|158023871|FG018|Overall Study|Other|1|||
49051793|NCT04436276|158023872|FG019|Overall Study|Other|0|||
49051794|NCT04436276|158023873|FG020|Overall Study|Other|2|||
49051795|NCT04436276|158023874|FG021|Overall Study|Other|2|||
49051796|NCT04436276|158023875|FG022|Overall Study|Other|60|||
49051797|NCT01470144|158023876|FG000|Overall Study|Adverse Event|2|||
49051798|NCT01470144|158023876|FG000|Overall Study|Death|1|||
49051799|NCT01470144|158023876|FG000|Overall Study|Lung transplant|6|||
49051800|NCT01470144|158023876|FG000|Overall Study|Patient's and investigator's decision|1|||
49051801|NCT04021862|158023877|FG000|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
49051802|NCT04021862|158023878|FG001|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|1|||
49051803|NCT04021862|158023879|FG002|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
49051804|NCT04021862|158023880|FG003|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
49051805|NCT04021862|158023881|FG004|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
49051806|NCT04021862|158023882|FG005|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
49051807|NCT04021862|158023877|FG000|Placebo Controlled Period (Week 0-16)|Adverse Event|2|||
49051808|NCT04021862|158023878|FG001|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
49051809|NCT04021862|158023879|FG002|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
49051810|NCT04021862|158023880|FG003|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
49051811|NCT04021862|158023881|FG004|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
49051812|NCT04021862|158023882|FG005|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
49051813|NCT04021862|158023877|FG000|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
49051814|NCT04021862|158023878|FG001|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
49051815|NCT04021862|158023879|FG002|Placebo Controlled Period (Week 0-16)|Pregnancy|1|||
49051816|NCT04021862|158023880|FG003|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
49051817|NCT04021862|158023881|FG004|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
49051818|NCT04021862|158023882|FG005|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
49051819|NCT04021862|158023877|FG000|Placebo Controlled Period (Week 0-16)|Other|0|||
49051820|NCT04021862|158023878|FG001|Placebo Controlled Period (Week 0-16)|Other|0|||
49051821|NCT04021862|158023879|FG002|Placebo Controlled Period (Week 0-16)|Other|1|||
49051822|NCT04021862|158023880|FG003|Placebo Controlled Period (Week 0-16)|Other|0|||
49051823|NCT04021862|158023881|FG004|Placebo Controlled Period (Week 0-16)|Other|0|||
49051824|NCT04021862|158023882|FG005|Placebo Controlled Period (Week 0-16)|Other|0|||
49051825|NCT04021862|158023877|FG000|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
49051826|NCT04021862|158023878|FG001|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
49051827|NCT04021862|158023879|FG002|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
49051828|NCT04021862|158023880|FG003|Active Treatment Period (Week 16-32)|Withdrawal by Subject|1|||
49051829|NCT04021862|158023881|FG004|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
49051830|NCT04021862|158023882|FG005|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
49051831|NCT02418455|158023883|FG000|48-Week Treatment Period|Other- Not Specified|1|||
49051832|NCT02418455|158023883|FG000|Continuation Period|Sponsor Decision|7|||
49051833|NCT03656510|158023884|FG000|Overall Study|Lost to Follow-up|1|||
49051834|NCT03656510|158023885|FG001|Overall Study|Lost to Follow-up|0|||
49051835|NCT03656510|158023886|FG002|Overall Study|Lost to Follow-up|0|||
49051836|NCT03656510|158023887|FG003|Overall Study|Lost to Follow-up|0|||
49051837|NCT03656510|158023888|FG004|Overall Study|Lost to Follow-up|0|||
49051838|NCT03656510|158023889|FG005|Overall Study|Lost to Follow-up|0|||
49051839|NCT03656510|158023884|FG000|Overall Study|Withdrawal by Subject|1|||
49051840|NCT03656510|158023885|FG001|Overall Study|Withdrawal by Subject|1|||
49051841|NCT03656510|158023886|FG002|Overall Study|Withdrawal by Subject|0|||
49051842|NCT03656510|158023887|FG003|Overall Study|Withdrawal by Subject|1|||
49051843|NCT03656510|158023888|FG004|Overall Study|Withdrawal by Subject|0|||
49051844|NCT03656510|158023889|FG005|Overall Study|Withdrawal by Subject|0|||
49051845|NCT03223909|158023890|FG000|Overall Study|Protocol Violation|48|||
49051846|NCT03223909|158023891|FG001|Overall Study|Protocol Violation|45|||
49051847|NCT03223909|158023892|FG002|Overall Study|Protocol Violation|16|||
49051848|NCT03519178|158023893|FG000|PF-06873600 Treatment|Adverse Event|0|||
49051849|NCT03519178|158023894|FG001|PF-06873600 Treatment|Adverse Event|0|||
49051850|NCT03519178|158023895|FG002|PF-06873600 Treatment|Adverse Event|0|||
49051851|NCT03519178|158023896|FG003|PF-06873600 Treatment|Adverse Event|0|||
49051852|NCT03519178|158023897|FG004|PF-06873600 Treatment|Adverse Event|0|||
49051853|NCT03519178|158023898|FG005|PF-06873600 Treatment|Adverse Event|0|||
49051854|NCT03519178|158023899|FG006|PF-06873600 Treatment|Adverse Event|0|||
49051855|NCT03519178|158023900|FG007|PF-06873600 Treatment|Adverse Event|2|||
49051856|NCT03519178|158023901|FG008|PF-06873600 Treatment|Adverse Event|1|||
49051857|NCT03519178|158023902|FG009|PF-06873600 Treatment|Adverse Event|0|||
49051858|NCT03519178|158023903|FG010|PF-06873600 Treatment|Adverse Event|0|||
49051859|NCT03519178|158023904|FG011|PF-06873600 Treatment|Adverse Event|0|||
49051860|NCT03519178|158023905|FG012|PF-06873600 Treatment|Adverse Event|1|||
49051861|NCT03519178|158023906|FG013|PF-06873600 Treatment|Adverse Event|3|||
49051862|NCT03519178|158023907|FG014|PF-06873600 Treatment|Adverse Event|2|||
49051863|NCT03519178|158023893|FG000|PF-06873600 Treatment|Death|0|||
49051864|NCT03519178|158023894|FG001|PF-06873600 Treatment|Death|0|||
49051865|NCT03519178|158023895|FG002|PF-06873600 Treatment|Death|0|||
49051866|NCT03519178|158023896|FG003|PF-06873600 Treatment|Death|0|||
49051867|NCT03519178|158023897|FG004|PF-06873600 Treatment|Death|0|||
49051868|NCT03519178|158023898|FG005|PF-06873600 Treatment|Death|0|||
49051869|NCT03519178|158023899|FG006|PF-06873600 Treatment|Death|0|||
49051870|NCT03519178|158023900|FG007|PF-06873600 Treatment|Death|0|||
49051871|NCT03519178|158023901|FG008|PF-06873600 Treatment|Death|1|||
49051872|NCT03519178|158023902|FG009|PF-06873600 Treatment|Death|1|||
49051873|NCT03519178|158023903|FG010|PF-06873600 Treatment|Death|0|||
49051874|NCT03519178|158023904|FG011|PF-06873600 Treatment|Death|0|||
49051875|NCT03519178|158023905|FG012|PF-06873600 Treatment|Death|0|||
49051876|NCT03519178|158023906|FG013|PF-06873600 Treatment|Death|0|||
49051877|NCT03519178|158023907|FG014|PF-06873600 Treatment|Death|1|||
49051878|NCT03519178|158023893|FG000|PF-06873600 Treatment|Physician Decision|0|||
49051879|NCT03519178|158023894|FG001|PF-06873600 Treatment|Physician Decision|0|||
49051880|NCT03519178|158023895|FG002|PF-06873600 Treatment|Physician Decision|0|||
49051881|NCT03519178|158023896|FG003|PF-06873600 Treatment|Physician Decision|0|||
49051882|NCT03519178|158023897|FG004|PF-06873600 Treatment|Physician Decision|0|||
49051883|NCT03519178|158023898|FG005|PF-06873600 Treatment|Physician Decision|0|||
49051884|NCT03519178|158023899|FG006|PF-06873600 Treatment|Physician Decision|0|||
49051885|NCT03519178|158023900|FG007|PF-06873600 Treatment|Physician Decision|1|||
49051886|NCT03519178|158023901|FG008|PF-06873600 Treatment|Physician Decision|0|||
49051887|NCT03519178|158023902|FG009|PF-06873600 Treatment|Physician Decision|0|||
49051888|NCT03519178|158023903|FG010|PF-06873600 Treatment|Physician Decision|1|||
49051889|NCT03519178|158023904|FG011|PF-06873600 Treatment|Physician Decision|0|||
49051890|NCT03519178|158023905|FG012|PF-06873600 Treatment|Physician Decision|0|||
49051891|NCT03519178|158023906|FG013|PF-06873600 Treatment|Physician Decision|4|||
49051892|NCT03519178|158023907|FG014|PF-06873600 Treatment|Physician Decision|1|||
49051893|NCT03519178|158023893|FG000|PF-06873600 Treatment|Progressive disease|1|||
49051894|NCT03519178|158023894|FG001|PF-06873600 Treatment|Progressive disease|1|||
49051895|NCT03519178|158023895|FG002|PF-06873600 Treatment|Progressive disease|1|||
49051896|NCT03519178|158023896|FG003|PF-06873600 Treatment|Progressive disease|1|||
49051897|NCT03519178|158023897|FG004|PF-06873600 Treatment|Progressive disease|6|||
49051898|NCT03519178|158023898|FG005|PF-06873600 Treatment|Progressive disease|7|||
49051899|NCT03519178|158023899|FG006|PF-06873600 Treatment|Progressive disease|3|||
49051900|NCT03519178|158023900|FG007|PF-06873600 Treatment|Progressive disease|7|||
49051901|NCT03519178|158023901|FG008|PF-06873600 Treatment|Progressive disease|3|||
49051902|NCT03519178|158023902|FG009|PF-06873600 Treatment|Progressive disease|5|||
49051903|NCT03519178|158023903|FG010|PF-06873600 Treatment|Progressive disease|4|||
49051904|NCT03519178|158023904|FG011|PF-06873600 Treatment|Progressive disease|3|||
49051905|NCT03519178|158023905|FG012|PF-06873600 Treatment|Progressive disease|4|||
49051906|NCT03519178|158023906|FG013|PF-06873600 Treatment|Progressive disease|28|||
49051907|NCT03519178|158023907|FG014|PF-06873600 Treatment|Progressive disease|7|||
49051908|NCT03519178|158023893|FG000|PF-06873600 Treatment|Withdrawal by Subject|0|||
49051909|NCT03519178|158023894|FG001|PF-06873600 Treatment|Withdrawal by Subject|0|||
49051910|NCT03519178|158023895|FG002|PF-06873600 Treatment|Withdrawal by Subject|1|||
49051911|NCT03519178|158023896|FG003|PF-06873600 Treatment|Withdrawal by Subject|0|||
49051912|NCT03519178|158023897|FG004|PF-06873600 Treatment|Withdrawal by Subject|2|||
49051913|NCT03519178|158023898|FG005|PF-06873600 Treatment|Withdrawal by Subject|0|||
49051914|NCT03519178|158023899|FG006|PF-06873600 Treatment|Withdrawal by Subject|0|||
49051915|NCT03519178|158023900|FG007|PF-06873600 Treatment|Withdrawal by Subject|1|||
49051916|NCT03519178|158023901|FG008|PF-06873600 Treatment|Withdrawal by Subject|3|||
49051917|NCT03519178|158023902|FG009|PF-06873600 Treatment|Withdrawal by Subject|2|||
49051918|NCT03519178|158023903|FG010|PF-06873600 Treatment|Withdrawal by Subject|0|||
49051919|NCT03519178|158023904|FG011|PF-06873600 Treatment|Withdrawal by Subject|2|||
49051920|NCT03519178|158023905|FG012|PF-06873600 Treatment|Withdrawal by Subject|1|||
49051921|NCT03519178|158023906|FG013|PF-06873600 Treatment|Withdrawal by Subject|1|||
49051922|NCT03519178|158023907|FG014|PF-06873600 Treatment|Withdrawal by Subject|2|||
49051923|NCT03519178|158023893|FG000|PF-06873600 Treatment|Global deterioration of health status|0|||
49051924|NCT03519178|158023894|FG001|PF-06873600 Treatment|Global deterioration of health status|0|||
49051925|NCT03519178|158023895|FG002|PF-06873600 Treatment|Global deterioration of health status|0|||
49051926|NCT03519178|158023896|FG003|PF-06873600 Treatment|Global deterioration of health status|2|||
49051927|NCT03519178|158023897|FG004|PF-06873600 Treatment|Global deterioration of health status|0|||
49051928|NCT03519178|158023898|FG005|PF-06873600 Treatment|Global deterioration of health status|0|||
49051929|NCT03519178|158023899|FG006|PF-06873600 Treatment|Global deterioration of health status|1|||
49051930|NCT03519178|158023900|FG007|PF-06873600 Treatment|Global deterioration of health status|2|||
49051931|NCT03519178|158023901|FG008|PF-06873600 Treatment|Global deterioration of health status|1|||
49051932|NCT03519178|158023902|FG009|PF-06873600 Treatment|Global deterioration of health status|1|||
49051933|NCT03519178|158023903|FG010|PF-06873600 Treatment|Global deterioration of health status|2|||
49051934|NCT03519178|158023904|FG011|PF-06873600 Treatment|Global deterioration of health status|0|||
49051935|NCT03519178|158023905|FG012|PF-06873600 Treatment|Global deterioration of health status|0|||
49051936|NCT03519178|158023906|FG013|PF-06873600 Treatment|Global deterioration of health status|3|||
49051937|NCT03519178|158023907|FG014|PF-06873600 Treatment|Global deterioration of health status|0|||
49051938|NCT03519178|158023893|FG000|PF-06873600 Treatment|Refused further treatment|0|||
49051939|NCT03519178|158023894|FG001|PF-06873600 Treatment|Refused further treatment|1|||
49051940|NCT03519178|158023895|FG002|PF-06873600 Treatment|Refused further treatment|0|||
49051941|NCT03519178|158023896|FG003|PF-06873600 Treatment|Refused further treatment|0|||
49051942|NCT03519178|158023897|FG004|PF-06873600 Treatment|Refused further treatment|1|||
49051943|NCT03519178|158023898|FG005|PF-06873600 Treatment|Refused further treatment|0|||
49051944|NCT03519178|158023899|FG006|PF-06873600 Treatment|Refused further treatment|0|||
49051945|NCT03519178|158023900|FG007|PF-06873600 Treatment|Refused further treatment|0|||
49051946|NCT03519178|158023901|FG008|PF-06873600 Treatment|Refused further treatment|0|||
49051947|NCT03519178|158023902|FG009|PF-06873600 Treatment|Refused further treatment|0|||
49051948|NCT03519178|158023903|FG010|PF-06873600 Treatment|Refused further treatment|0|||
49051949|NCT03519178|158023904|FG011|PF-06873600 Treatment|Refused further treatment|0|||
49051950|NCT03519178|158023905|FG012|PF-06873600 Treatment|Refused further treatment|0|||
49051951|NCT03519178|158023906|FG013|PF-06873600 Treatment|Refused further treatment|0|||
49051952|NCT03519178|158023907|FG014|PF-06873600 Treatment|Refused further treatment|1|||
49051953|NCT03519178|158023893|FG000|PF-06873600 Treatment|Other|0|||
49051954|NCT03519178|158023894|FG001|PF-06873600 Treatment|Other|0|||
49051955|NCT03519178|158023895|FG002|PF-06873600 Treatment|Other|0|||
49051956|NCT03519178|158023896|FG003|PF-06873600 Treatment|Other|0|||
49051957|NCT03519178|158023897|FG004|PF-06873600 Treatment|Other|0|||
49051958|NCT03519178|158023898|FG005|PF-06873600 Treatment|Other|0|||
49051959|NCT03519178|158023899|FG006|PF-06873600 Treatment|Other|0|||
49051960|NCT03519178|158023900|FG007|PF-06873600 Treatment|Other|0|||
49051961|NCT03519178|158023901|FG008|PF-06873600 Treatment|Other|1|||
49051962|NCT03519178|158023902|FG009|PF-06873600 Treatment|Other|0|||
49051963|NCT03519178|158023903|FG010|PF-06873600 Treatment|Other|0|||
49051964|NCT03519178|158023904|FG011|PF-06873600 Treatment|Other|0|||
49051965|NCT03519178|158023905|FG012|PF-06873600 Treatment|Other|0|||
49051966|NCT03519178|158023906|FG013|PF-06873600 Treatment|Other|1|||
49051967|NCT03519178|158023907|FG014|PF-06873600 Treatment|Other|3|||
49051968|NCT03519178|158023893|FG000|PF-06873600 Treatment|Lost to Follow-up|0|||
49051969|NCT03519178|158023894|FG001|PF-06873600 Treatment|Lost to Follow-up|0|||
49051970|NCT03519178|158023895|FG002|PF-06873600 Treatment|Lost to Follow-up|0|||
49051971|NCT03519178|158023896|FG003|PF-06873600 Treatment|Lost to Follow-up|0|||
49051972|NCT03519178|158023897|FG004|PF-06873600 Treatment|Lost to Follow-up|0|||
49051973|NCT03519178|158023898|FG005|PF-06873600 Treatment|Lost to Follow-up|0|||
49051974|NCT03519178|158023899|FG006|PF-06873600 Treatment|Lost to Follow-up|0|||
49051975|NCT03519178|158023900|FG007|PF-06873600 Treatment|Lost to Follow-up|0|||
49051976|NCT03519178|158023901|FG008|PF-06873600 Treatment|Lost to Follow-up|0|||
49051977|NCT03519178|158023902|FG009|PF-06873600 Treatment|Lost to Follow-up|0|||
49051978|NCT03519178|158023903|FG010|PF-06873600 Treatment|Lost to Follow-up|0|||
49051979|NCT03519178|158023904|FG011|PF-06873600 Treatment|Lost to Follow-up|0|||
49051980|NCT03519178|158023905|FG012|PF-06873600 Treatment|Lost to Follow-up|0|||
49051981|NCT03519178|158023906|FG013|PF-06873600 Treatment|Lost to Follow-up|0|||
49051982|NCT03519178|158023907|FG014|PF-06873600 Treatment|Lost to Follow-up|1|||
49051983|NCT03519178|158023893|FG000|PF-06873600 Treatment|Study terminated by sponsor|0|||
49051984|NCT03519178|158023894|FG001|PF-06873600 Treatment|Study terminated by sponsor|0|||
49051985|NCT03519178|158023895|FG002|PF-06873600 Treatment|Study terminated by sponsor|0|||
49051986|NCT03519178|158023896|FG003|PF-06873600 Treatment|Study terminated by sponsor|0|||
49051987|NCT03519178|158023897|FG004|PF-06873600 Treatment|Study terminated by sponsor|0|||
49051988|NCT03519178|158023898|FG005|PF-06873600 Treatment|Study terminated by sponsor|0|||
49051989|NCT03519178|158023899|FG006|PF-06873600 Treatment|Study terminated by sponsor|0|||
49051990|NCT03519178|158023900|FG007|PF-06873600 Treatment|Study terminated by sponsor|0|||
49051991|NCT03519178|158023901|FG008|PF-06873600 Treatment|Study terminated by sponsor|0|||
49051992|NCT03519178|158023902|FG009|PF-06873600 Treatment|Study terminated by sponsor|0|||
49051993|NCT03519178|158023903|FG010|PF-06873600 Treatment|Study terminated by sponsor|0|||
49051994|NCT03519178|158023904|FG011|PF-06873600 Treatment|Study terminated by sponsor|0|||
49051995|NCT03519178|158023905|FG012|PF-06873600 Treatment|Study terminated by sponsor|0|||
49051996|NCT03519178|158023906|FG013|PF-06873600 Treatment|Study terminated by sponsor|4|||
49051997|NCT03519178|158023907|FG014|PF-06873600 Treatment|Study terminated by sponsor|4|||
49051998|NCT03519178|158023893|FG000|PF-06873600 Treatment|Ongoing|0|||
49051999|NCT03519178|158023894|FG001|PF-06873600 Treatment|Ongoing|0|||
49052000|NCT03519178|158023895|FG002|PF-06873600 Treatment|Ongoing|0|||
49052001|NCT03519178|158023896|FG003|PF-06873600 Treatment|Ongoing|0|||
49052002|NCT03519178|158023897|FG004|PF-06873600 Treatment|Ongoing|0|||
49052003|NCT03519178|158023898|FG005|PF-06873600 Treatment|Ongoing|0|||
49052004|NCT03519178|158023899|FG006|PF-06873600 Treatment|Ongoing|0|||
49052005|NCT03519178|158023900|FG007|PF-06873600 Treatment|Ongoing|0|||
49052006|NCT03519178|158023901|FG008|PF-06873600 Treatment|Ongoing|0|||
49052007|NCT03519178|158023902|FG009|PF-06873600 Treatment|Ongoing|0|||
49052008|NCT03519178|158023903|FG010|PF-06873600 Treatment|Ongoing|0|||
49052009|NCT03519178|158023904|FG011|PF-06873600 Treatment|Ongoing|0|||
49052010|NCT03519178|158023905|FG012|PF-06873600 Treatment|Ongoing|0|||
49052011|NCT03519178|158023906|FG013|PF-06873600 Treatment|Ongoing|1|||
49052012|NCT03519178|158023907|FG014|PF-06873600 Treatment|Ongoing|6|||
49052013|NCT03519178|158023893|FG000|Disposition for Fluvestrant Treatment|Adverse Event|0|||
49052014|NCT03519178|158023894|FG001|Disposition for Fluvestrant Treatment|Adverse Event|0|||
49052015|NCT03519178|158023895|FG002|Disposition for Fluvestrant Treatment|Adverse Event|0|||
49052016|NCT03519178|158023896|FG003|Disposition for Fluvestrant Treatment|Adverse Event|0|||
49052017|NCT03519178|158023897|FG004|Disposition for Fluvestrant Treatment|Adverse Event|0|||
49052018|NCT03519178|158023898|FG005|Disposition for Fluvestrant Treatment|Adverse Event|0|||
49052019|NCT03519178|158023899|FG006|Disposition for Fluvestrant Treatment|Adverse Event|0|||
49052020|NCT03519178|158023900|FG007|Disposition for Fluvestrant Treatment|Adverse Event|0|||
49052021|NCT03519178|158023901|FG008|Disposition for Fluvestrant Treatment|Adverse Event|0|||
49052022|NCT03519178|158023902|FG009|Disposition for Fluvestrant Treatment|Adverse Event|0|||
49052023|NCT03519178|158023903|FG010|Disposition for Fluvestrant Treatment|Adverse Event|0|||
49052024|NCT03519178|158023904|FG011|Disposition for Fluvestrant Treatment|Adverse Event|0|||
49052025|NCT03519178|158023905|FG012|Disposition for Fluvestrant Treatment|Adverse Event|0|||
49052026|NCT03519178|158023906|FG013|Disposition for Fluvestrant Treatment|Adverse Event|1|||
49052027|NCT03519178|158023907|FG014|Disposition for Fluvestrant Treatment|Adverse Event|0|||
49052028|NCT03519178|158023893|FG000|Disposition for Fluvestrant Treatment|Death|0|||
49052029|NCT03519178|158023894|FG001|Disposition for Fluvestrant Treatment|Death|0|||
49052030|NCT03519178|158023895|FG002|Disposition for Fluvestrant Treatment|Death|0|||
49052031|NCT03519178|158023896|FG003|Disposition for Fluvestrant Treatment|Death|0|||
49052032|NCT03519178|158023897|FG004|Disposition for Fluvestrant Treatment|Death|0|||
49052033|NCT03519178|158023898|FG005|Disposition for Fluvestrant Treatment|Death|0|||
49052034|NCT03519178|158023899|FG006|Disposition for Fluvestrant Treatment|Death|0|||
49052035|NCT03519178|158023900|FG007|Disposition for Fluvestrant Treatment|Death|0|||
49052036|NCT03519178|158023901|FG008|Disposition for Fluvestrant Treatment|Death|0|||
49052037|NCT03519178|158023902|FG009|Disposition for Fluvestrant Treatment|Death|1|||
49052038|NCT03519178|158023903|FG010|Disposition for Fluvestrant Treatment|Death|0|||
49052039|NCT03519178|158023904|FG011|Disposition for Fluvestrant Treatment|Death|0|||
49052040|NCT03519178|158023905|FG012|Disposition for Fluvestrant Treatment|Death|0|||
49052041|NCT03519178|158023906|FG013|Disposition for Fluvestrant Treatment|Death|0|||
49052042|NCT03519178|158023907|FG014|Disposition for Fluvestrant Treatment|Death|1|||
49052043|NCT03519178|158023893|FG000|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
49052044|NCT03519178|158023894|FG001|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
49052045|NCT03519178|158023895|FG002|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
49052046|NCT03519178|158023896|FG003|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
49052047|NCT03519178|158023897|FG004|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
49052048|NCT03519178|158023898|FG005|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
49052049|NCT03519178|158023899|FG006|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
49052050|NCT03519178|158023900|FG007|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
49052051|NCT03519178|158023901|FG008|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
49052052|NCT03519178|158023902|FG009|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
49052053|NCT03519178|158023903|FG010|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
49052054|NCT03519178|158023904|FG011|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
49052055|NCT03519178|158023905|FG012|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
49052056|NCT03519178|158023906|FG013|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
49052057|NCT03519178|158023907|FG014|Disposition for Fluvestrant Treatment|Lost to Follow-up|1|||
49052058|NCT03519178|158023893|FG000|Disposition for Fluvestrant Treatment|Physician Decision|0|||
49052059|NCT03519178|158023894|FG001|Disposition for Fluvestrant Treatment|Physician Decision|0|||
49052060|NCT03519178|158023895|FG002|Disposition for Fluvestrant Treatment|Physician Decision|0|||
49052061|NCT03519178|158023896|FG003|Disposition for Fluvestrant Treatment|Physician Decision|0|||
49052062|NCT03519178|158023897|FG004|Disposition for Fluvestrant Treatment|Physician Decision|0|||
49052063|NCT03519178|158023898|FG005|Disposition for Fluvestrant Treatment|Physician Decision|0|||
49052064|NCT03519178|158023899|FG006|Disposition for Fluvestrant Treatment|Physician Decision|0|||
49052065|NCT03519178|158023900|FG007|Disposition for Fluvestrant Treatment|Physician Decision|0|||
49052066|NCT03519178|158023901|FG008|Disposition for Fluvestrant Treatment|Physician Decision|0|||
49052067|NCT03519178|158023902|FG009|Disposition for Fluvestrant Treatment|Physician Decision|0|||
49052068|NCT03519178|158023903|FG010|Disposition for Fluvestrant Treatment|Physician Decision|0|||
49052069|NCT03519178|158023904|FG011|Disposition for Fluvestrant Treatment|Physician Decision|0|||
49052070|NCT03519178|158023905|FG012|Disposition for Fluvestrant Treatment|Physician Decision|0|||
49052071|NCT03519178|158023906|FG013|Disposition for Fluvestrant Treatment|Physician Decision|4|||
49052072|NCT03519178|158023907|FG014|Disposition for Fluvestrant Treatment|Physician Decision|2|||
49052073|NCT03519178|158023893|FG000|Disposition for Fluvestrant Treatment|Progressive disease|0|||
49052074|NCT03519178|158023894|FG001|Disposition for Fluvestrant Treatment|Progressive disease|0|||
49052075|NCT03519178|158023895|FG002|Disposition for Fluvestrant Treatment|Progressive disease|0|||
49052076|NCT03519178|158023896|FG003|Disposition for Fluvestrant Treatment|Progressive disease|0|||
49052077|NCT03519178|158023897|FG004|Disposition for Fluvestrant Treatment|Progressive disease|0|||
49052078|NCT03519178|158023898|FG005|Disposition for Fluvestrant Treatment|Progressive disease|0|||
49052079|NCT03519178|158023899|FG006|Disposition for Fluvestrant Treatment|Progressive disease|0|||
49052080|NCT03519178|158023900|FG007|Disposition for Fluvestrant Treatment|Progressive disease|0|||
49052081|NCT03519178|158023901|FG008|Disposition for Fluvestrant Treatment|Progressive disease|0|||
49052082|NCT03519178|158023902|FG009|Disposition for Fluvestrant Treatment|Progressive disease|5|||
49052083|NCT03519178|158023903|FG010|Disposition for Fluvestrant Treatment|Progressive disease|0|||
49052084|NCT03519178|158023904|FG011|Disposition for Fluvestrant Treatment|Progressive disease|0|||
49052085|NCT03519178|158023905|FG012|Disposition for Fluvestrant Treatment|Progressive disease|0|||
49052086|NCT03519178|158023906|FG013|Disposition for Fluvestrant Treatment|Progressive disease|30|||
49052087|NCT03519178|158023907|FG014|Disposition for Fluvestrant Treatment|Progressive disease|7|||
49052088|NCT03519178|158023893|FG000|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
49052089|NCT03519178|158023894|FG001|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
49052090|NCT03519178|158023895|FG002|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
49052091|NCT03519178|158023896|FG003|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
49052092|NCT03519178|158023897|FG004|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
49052093|NCT03519178|158023898|FG005|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
49052094|NCT03519178|158023899|FG006|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
49052095|NCT03519178|158023900|FG007|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
49052096|NCT03519178|158023901|FG008|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
49052097|NCT03519178|158023902|FG009|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
49052098|NCT03519178|158023903|FG010|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
49052099|NCT03519178|158023904|FG011|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
49052100|NCT03519178|158023905|FG012|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
49052101|NCT03519178|158023906|FG013|Disposition for Fluvestrant Treatment|Study terminated by sponsor|4|||
49052102|NCT03519178|158023907|FG014|Disposition for Fluvestrant Treatment|Study terminated by sponsor|4|||
49052103|NCT03519178|158023893|FG000|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
49052104|NCT03519178|158023894|FG001|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
49052105|NCT03519178|158023895|FG002|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
49052106|NCT03519178|158023896|FG003|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
49052107|NCT03519178|158023897|FG004|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
49052108|NCT03519178|158023898|FG005|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
49052109|NCT03519178|158023899|FG006|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
49052110|NCT03519178|158023900|FG007|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
49052111|NCT03519178|158023901|FG008|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
49052112|NCT03519178|158023902|FG009|Disposition for Fluvestrant Treatment|Withdrawal by Subject|2|||
49052113|NCT03519178|158023903|FG010|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
49052114|NCT03519178|158023904|FG011|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
49052115|NCT03519178|158023905|FG012|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
49052116|NCT03519178|158023906|FG013|Disposition for Fluvestrant Treatment|Withdrawal by Subject|1|||
49052117|NCT03519178|158023907|FG014|Disposition for Fluvestrant Treatment|Withdrawal by Subject|2|||
49052118|NCT03519178|158023893|FG000|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
49052119|NCT03519178|158023894|FG001|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
49052120|NCT03519178|158023895|FG002|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
49052121|NCT03519178|158023896|FG003|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
49052122|NCT03519178|158023897|FG004|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
49052123|NCT03519178|158023898|FG005|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
49052124|NCT03519178|158023899|FG006|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
49052125|NCT03519178|158023900|FG007|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
49052126|NCT03519178|158023901|FG008|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
49052127|NCT03519178|158023902|FG009|Disposition for Fluvestrant Treatment|Global deterioration of health status|1|||
49052128|NCT03519178|158023903|FG010|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
49052129|NCT03519178|158023904|FG011|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
49052130|NCT03519178|158023905|FG012|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
49052131|NCT03519178|158023906|FG013|Disposition for Fluvestrant Treatment|Global deterioration of health status|3|||
49052132|NCT03519178|158023907|FG014|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
49052133|NCT03519178|158023893|FG000|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
49052134|NCT03519178|158023894|FG001|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
49052135|NCT03519178|158023895|FG002|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
49052136|NCT03519178|158023896|FG003|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
49052137|NCT03519178|158023897|FG004|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
49052138|NCT03519178|158023898|FG005|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
49052139|NCT03519178|158023899|FG006|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
49052140|NCT03519178|158023900|FG007|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
49052141|NCT03519178|158023901|FG008|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
49052142|NCT03519178|158023902|FG009|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
49052143|NCT03519178|158023903|FG010|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
49052144|NCT03519178|158023904|FG011|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
49052145|NCT03519178|158023905|FG012|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
49052146|NCT03519178|158023906|FG013|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
49052147|NCT03519178|158023907|FG014|Disposition for Fluvestrant Treatment|Refused further treatment|2|||
49052148|NCT03519178|158023893|FG000|Disposition for Fluvestrant Treatment|Other|0|||
49052149|NCT03519178|158023894|FG001|Disposition for Fluvestrant Treatment|Other|0|||
49052150|NCT03519178|158023895|FG002|Disposition for Fluvestrant Treatment|Other|0|||
49052151|NCT03519178|158023896|FG003|Disposition for Fluvestrant Treatment|Other|0|||
49052152|NCT03519178|158023897|FG004|Disposition for Fluvestrant Treatment|Other|0|||
49052153|NCT03519178|158023898|FG005|Disposition for Fluvestrant Treatment|Other|0|||
49052154|NCT03519178|158023899|FG006|Disposition for Fluvestrant Treatment|Other|0|||
49052155|NCT03519178|158023900|FG007|Disposition for Fluvestrant Treatment|Other|0|||
49052156|NCT03519178|158023901|FG008|Disposition for Fluvestrant Treatment|Other|0|||
49052157|NCT03519178|158023902|FG009|Disposition for Fluvestrant Treatment|Other|0|||
49052158|NCT03519178|158023903|FG010|Disposition for Fluvestrant Treatment|Other|0|||
49052159|NCT03519178|158023904|FG011|Disposition for Fluvestrant Treatment|Other|0|||
49052160|NCT03519178|158023905|FG012|Disposition for Fluvestrant Treatment|Other|0|||
49052161|NCT03519178|158023906|FG013|Disposition for Fluvestrant Treatment|Other|1|||
49052162|NCT03519178|158023907|FG014|Disposition for Fluvestrant Treatment|Other|3|||
49052163|NCT03519178|158023893|FG000|Disposition for Fluvestrant Treatment|Ongoing|0|||
49052164|NCT03519178|158023894|FG001|Disposition for Fluvestrant Treatment|Ongoing|0|||
49052165|NCT03519178|158023895|FG002|Disposition for Fluvestrant Treatment|Ongoing|0|||
49052166|NCT03519178|158023896|FG003|Disposition for Fluvestrant Treatment|Ongoing|0|||
49052167|NCT03519178|158023897|FG004|Disposition for Fluvestrant Treatment|Ongoing|0|||
49052168|NCT03519178|158023898|FG005|Disposition for Fluvestrant Treatment|Ongoing|0|||
49052169|NCT03519178|158023899|FG006|Disposition for Fluvestrant Treatment|Ongoing|0|||
49052170|NCT03519178|158023900|FG007|Disposition for Fluvestrant Treatment|Ongoing|0|||
49052171|NCT03519178|158023901|FG008|Disposition for Fluvestrant Treatment|Ongoing|0|||
49052172|NCT03519178|158023902|FG009|Disposition for Fluvestrant Treatment|Ongoing|0|||
49052173|NCT03519178|158023903|FG010|Disposition for Fluvestrant Treatment|Ongoing|0|||
49052174|NCT03519178|158023904|FG011|Disposition for Fluvestrant Treatment|Ongoing|0|||
49052175|NCT03519178|158023905|FG012|Disposition for Fluvestrant Treatment|Ongoing|0|||
49052176|NCT03519178|158023906|FG013|Disposition for Fluvestrant Treatment|Ongoing|1|||
49052177|NCT03519178|158023907|FG014|Disposition for Fluvestrant Treatment|Ongoing|6|||
49052178|NCT03519178|158023893|FG000|Disposition for Letrozole Treatment|Physician Decision|0|||
49052179|NCT03519178|158023894|FG001|Disposition for Letrozole Treatment|Physician Decision|0|||
49052180|NCT03519178|158023895|FG002|Disposition for Letrozole Treatment|Physician Decision|0|||
49052181|NCT03519178|158023896|FG003|Disposition for Letrozole Treatment|Physician Decision|0|||
49052182|NCT03519178|158023897|FG004|Disposition for Letrozole Treatment|Physician Decision|0|||
49052183|NCT03519178|158023898|FG005|Disposition for Letrozole Treatment|Physician Decision|0|||
49052184|NCT03519178|158023899|FG006|Disposition for Letrozole Treatment|Physician Decision|0|||
49052185|NCT03519178|158023900|FG007|Disposition for Letrozole Treatment|Physician Decision|0|||
49052186|NCT03519178|158023901|FG008|Disposition for Letrozole Treatment|Physician Decision|0|||
49052187|NCT03519178|158023902|FG009|Disposition for Letrozole Treatment|Physician Decision|0|||
49052188|NCT03519178|158023903|FG010|Disposition for Letrozole Treatment|Physician Decision|1|||
48692645|NCT03001557|156724541|FG000|Extension Phase|Administrative Reason|0|||
49052189|NCT03519178|158023904|FG011|Disposition for Letrozole Treatment|Physician Decision|0|||
49052190|NCT03519178|158023905|FG012|Disposition for Letrozole Treatment|Physician Decision|0|||
49052191|NCT03519178|158023906|FG013|Disposition for Letrozole Treatment|Physician Decision|0|||
49052192|NCT03519178|158023907|FG014|Disposition for Letrozole Treatment|Physician Decision|0|||
49052193|NCT03519178|158023893|FG000|Disposition for Letrozole Treatment|Progressive disease|0|||
49052194|NCT03519178|158023894|FG001|Disposition for Letrozole Treatment|Progressive disease|0|||
49052195|NCT03519178|158023895|FG002|Disposition for Letrozole Treatment|Progressive disease|0|||
49052196|NCT03519178|158023896|FG003|Disposition for Letrozole Treatment|Progressive disease|0|||
49052197|NCT03519178|158023897|FG004|Disposition for Letrozole Treatment|Progressive disease|0|||
49052198|NCT03519178|158023898|FG005|Disposition for Letrozole Treatment|Progressive disease|0|||
49052199|NCT03519178|158023899|FG006|Disposition for Letrozole Treatment|Progressive disease|0|||
49052200|NCT03519178|158023900|FG007|Disposition for Letrozole Treatment|Progressive disease|0|||
49052201|NCT03519178|158023901|FG008|Disposition for Letrozole Treatment|Progressive disease|0|||
49052202|NCT03519178|158023902|FG009|Disposition for Letrozole Treatment|Progressive disease|0|||
49052203|NCT03519178|158023903|FG010|Disposition for Letrozole Treatment|Progressive disease|4|||
49052204|NCT03519178|158023904|FG011|Disposition for Letrozole Treatment|Progressive disease|0|||
49052205|NCT03519178|158023905|FG012|Disposition for Letrozole Treatment|Progressive disease|0|||
49052206|NCT03519178|158023906|FG013|Disposition for Letrozole Treatment|Progressive disease|0|||
49052207|NCT03519178|158023907|FG014|Disposition for Letrozole Treatment|Progressive disease|0|||
49052208|NCT03519178|158023893|FG000|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
49052209|NCT03519178|158023894|FG001|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
49052210|NCT03519178|158023895|FG002|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
49052211|NCT03519178|158023896|FG003|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
49052212|NCT03519178|158023897|FG004|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
49052213|NCT03519178|158023898|FG005|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
49052214|NCT03519178|158023899|FG006|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
49052215|NCT03519178|158023900|FG007|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
49052216|NCT03519178|158023901|FG008|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
49052217|NCT03519178|158023902|FG009|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
49052218|NCT03519178|158023903|FG010|Disposition for Letrozole Treatment|Global deterioration of health status|2|||
49052219|NCT03519178|158023904|FG011|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
49052220|NCT03519178|158023905|FG012|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
49052221|NCT03519178|158023906|FG013|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
49052222|NCT03519178|158023907|FG014|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
49052223|NCT03519178|158023893|FG000|Follow-Up|Death|0|||
49052224|NCT03519178|158023894|FG001|Follow-Up|Death|0|||
49052225|NCT03519178|158023895|FG002|Follow-Up|Death|1|||
49052226|NCT03519178|158023896|FG003|Follow-Up|Death|0|||
49052227|NCT03519178|158023897|FG004|Follow-Up|Death|0|||
49052228|NCT03519178|158023898|FG005|Follow-Up|Death|0|||
49052229|NCT03519178|158023899|FG006|Follow-Up|Death|0|||
49052230|NCT03519178|158023900|FG007|Follow-Up|Death|0|||
49052231|NCT03519178|158023901|FG008|Follow-Up|Death|3|||
49052232|NCT03519178|158023902|FG009|Follow-Up|Death|1|||
49052233|NCT03519178|158023903|FG010|Follow-Up|Death|0|||
49052234|NCT03519178|158023904|FG011|Follow-Up|Death|0|||
49052235|NCT03519178|158023905|FG012|Follow-Up|Death|2|||
49052236|NCT03519178|158023906|FG013|Follow-Up|Death|0|||
49052237|NCT03519178|158023907|FG014|Follow-Up|Death|0|||
49052238|NCT03519178|158023893|FG000|Follow-Up|Lost to Follow-up|0|||
49052239|NCT03519178|158023894|FG001|Follow-Up|Lost to Follow-up|0|||
49052240|NCT03519178|158023895|FG002|Follow-Up|Lost to Follow-up|0|||
49052241|NCT03519178|158023896|FG003|Follow-Up|Lost to Follow-up|0|||
49052242|NCT03519178|158023897|FG004|Follow-Up|Lost to Follow-up|0|||
49052243|NCT03519178|158023898|FG005|Follow-Up|Lost to Follow-up|3|||
49052244|NCT03519178|158023899|FG006|Follow-Up|Lost to Follow-up|1|||
49052245|NCT03519178|158023900|FG007|Follow-Up|Lost to Follow-up|4|||
49052246|NCT03519178|158023901|FG008|Follow-Up|Lost to Follow-up|1|||
49052247|NCT03519178|158023902|FG009|Follow-Up|Lost to Follow-up|0|||
49052248|NCT03519178|158023903|FG010|Follow-Up|Lost to Follow-up|0|||
49052249|NCT03519178|158023904|FG011|Follow-Up|Lost to Follow-up|0|||
49052250|NCT03519178|158023905|FG012|Follow-Up|Lost to Follow-up|0|||
49052251|NCT03519178|158023906|FG013|Follow-Up|Lost to Follow-up|0|||
49052252|NCT03519178|158023907|FG014|Follow-Up|Lost to Follow-up|0|||
49052253|NCT03519178|158023893|FG000|Follow-Up|Withdrawal by Subject|1|||
49052254|NCT03519178|158023894|FG001|Follow-Up|Withdrawal by Subject|2|||
49052255|NCT03519178|158023895|FG002|Follow-Up|Withdrawal by Subject|2|||
49052256|NCT03519178|158023896|FG003|Follow-Up|Withdrawal by Subject|3|||
49052257|NCT03519178|158023897|FG004|Follow-Up|Withdrawal by Subject|5|||
49052258|NCT03519178|158023898|FG005|Follow-Up|Withdrawal by Subject|1|||
49052259|NCT03519178|158023899|FG006|Follow-Up|Withdrawal by Subject|2|||
49052260|NCT03519178|158023900|FG007|Follow-Up|Withdrawal by Subject|6|||
49052261|NCT03519178|158023901|FG008|Follow-Up|Withdrawal by Subject|5|||
49052262|NCT03519178|158023902|FG009|Follow-Up|Withdrawal by Subject|2|||
49052263|NCT03519178|158023903|FG010|Follow-Up|Withdrawal by Subject|3|||
49052264|NCT03519178|158023904|FG011|Follow-Up|Withdrawal by Subject|5|||
49052265|NCT03519178|158023905|FG012|Follow-Up|Withdrawal by Subject|2|||
49052266|NCT03519178|158023906|FG013|Follow-Up|Withdrawal by Subject|0|||
49052267|NCT03519178|158023907|FG014|Follow-Up|Withdrawal by Subject|0|||
49052268|NCT03519178|158023893|FG000|Follow-Up|Other|0|||
49052269|NCT03519178|158023894|FG001|Follow-Up|Other|0|||
49052270|NCT03519178|158023895|FG002|Follow-Up|Other|0|||
49052271|NCT03519178|158023896|FG003|Follow-Up|Other|0|||
49052272|NCT03519178|158023897|FG004|Follow-Up|Other|0|||
49052273|NCT03519178|158023898|FG005|Follow-Up|Other|0|||
49052274|NCT03519178|158023899|FG006|Follow-Up|Other|0|||
49052275|NCT03519178|158023900|FG007|Follow-Up|Other|1|||
49052276|NCT03519178|158023901|FG008|Follow-Up|Other|0|||
49052277|NCT03519178|158023902|FG009|Follow-Up|Other|0|||
49052278|NCT03519178|158023903|FG010|Follow-Up|Other|0|||
49052279|NCT03519178|158023904|FG011|Follow-Up|Other|0|||
49052280|NCT03519178|158023905|FG012|Follow-Up|Other|0|||
49052281|NCT03519178|158023906|FG013|Follow-Up|Other|0|||
49052282|NCT03519178|158023907|FG014|Follow-Up|Other|0|||
49052283|NCT03519178|158023893|FG000|Long-term Follow-up|Death|0|||
49052284|NCT03519178|158023894|FG001|Long-term Follow-up|Death|0|||
49052285|NCT03519178|158023895|FG002|Long-term Follow-up|Death|0|||
49052286|NCT03519178|158023896|FG003|Long-term Follow-up|Death|0|||
49052287|NCT03519178|158023897|FG004|Long-term Follow-up|Death|0|||
49052288|NCT03519178|158023898|FG005|Long-term Follow-up|Death|0|||
49052289|NCT03519178|158023899|FG006|Long-term Follow-up|Death|0|||
49052290|NCT03519178|158023900|FG007|Long-term Follow-up|Death|0|||
49052291|NCT03519178|158023901|FG008|Long-term Follow-up|Death|0|||
49052292|NCT03519178|158023902|FG009|Long-term Follow-up|Death|0|||
49052293|NCT03519178|158023903|FG010|Long-term Follow-up|Death|0|||
49052294|NCT03519178|158023904|FG011|Long-term Follow-up|Death|0|||
49052295|NCT03519178|158023905|FG012|Long-term Follow-up|Death|0|||
49052296|NCT03519178|158023906|FG013|Long-term Follow-up|Death|4|||
49052297|NCT03519178|158023907|FG014|Long-term Follow-up|Death|4|||
49052298|NCT03519178|158023893|FG000|Long-term Follow-up|Lost to Follow-up|0|||
49052299|NCT03519178|158023894|FG001|Long-term Follow-up|Lost to Follow-up|0|||
49052300|NCT03519178|158023895|FG002|Long-term Follow-up|Lost to Follow-up|0|||
49052301|NCT03519178|158023896|FG003|Long-term Follow-up|Lost to Follow-up|0|||
49052302|NCT03519178|158023897|FG004|Long-term Follow-up|Lost to Follow-up|0|||
49052303|NCT03519178|158023898|FG005|Long-term Follow-up|Lost to Follow-up|0|||
49052304|NCT03519178|158023899|FG006|Long-term Follow-up|Lost to Follow-up|0|||
49052305|NCT03519178|158023900|FG007|Long-term Follow-up|Lost to Follow-up|0|||
49052306|NCT03519178|158023901|FG008|Long-term Follow-up|Lost to Follow-up|0|||
49052307|NCT03519178|158023902|FG009|Long-term Follow-up|Lost to Follow-up|0|||
49052308|NCT03519178|158023903|FG010|Long-term Follow-up|Lost to Follow-up|0|||
49052309|NCT03519178|158023904|FG011|Long-term Follow-up|Lost to Follow-up|0|||
49052310|NCT03519178|158023905|FG012|Long-term Follow-up|Lost to Follow-up|0|||
49052311|NCT03519178|158023906|FG013|Long-term Follow-up|Lost to Follow-up|1|||
49052312|NCT03519178|158023907|FG014|Long-term Follow-up|Lost to Follow-up|1|||
49052313|NCT03519178|158023893|FG000|Long-term Follow-up|Study terminated by sponsor|0|||
49052314|NCT03519178|158023894|FG001|Long-term Follow-up|Study terminated by sponsor|0|||
49052315|NCT03519178|158023895|FG002|Long-term Follow-up|Study terminated by sponsor|0|||
49052316|NCT03519178|158023896|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
49052317|NCT03519178|158023897|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
49052318|NCT03519178|158023898|FG005|Long-term Follow-up|Study terminated by sponsor|0|||
49052319|NCT03519178|158023899|FG006|Long-term Follow-up|Study terminated by sponsor|0|||
49052320|NCT03519178|158023900|FG007|Long-term Follow-up|Study terminated by sponsor|0|||
49052321|NCT03519178|158023901|FG008|Long-term Follow-up|Study terminated by sponsor|0|||
49052322|NCT03519178|158023902|FG009|Long-term Follow-up|Study terminated by sponsor|0|||
49052323|NCT03519178|158023903|FG010|Long-term Follow-up|Study terminated by sponsor|0|||
49052324|NCT03519178|158023904|FG011|Long-term Follow-up|Study terminated by sponsor|0|||
49052325|NCT03519178|158023905|FG012|Long-term Follow-up|Study terminated by sponsor|0|||
49052326|NCT03519178|158023906|FG013|Long-term Follow-up|Study terminated by sponsor|31|||
49052327|NCT03519178|158023907|FG014|Long-term Follow-up|Study terminated by sponsor|13|||
49052328|NCT03519178|158023893|FG000|Long-term Follow-up|Withdrawal by Subject|0|||
49052329|NCT03519178|158023894|FG001|Long-term Follow-up|Withdrawal by Subject|0|||
49052330|NCT03519178|158023895|FG002|Long-term Follow-up|Withdrawal by Subject|0|||
49052331|NCT03519178|158023896|FG003|Long-term Follow-up|Withdrawal by Subject|0|||
49052332|NCT03519178|158023897|FG004|Long-term Follow-up|Withdrawal by Subject|0|||
49052333|NCT03519178|158023898|FG005|Long-term Follow-up|Withdrawal by Subject|0|||
49052334|NCT03519178|158023899|FG006|Long-term Follow-up|Withdrawal by Subject|0|||
49052335|NCT03519178|158023900|FG007|Long-term Follow-up|Withdrawal by Subject|0|||
49052336|NCT03519178|158023901|FG008|Long-term Follow-up|Withdrawal by Subject|0|||
49052337|NCT03519178|158023902|FG009|Long-term Follow-up|Withdrawal by Subject|0|||
49052338|NCT03519178|158023903|FG010|Long-term Follow-up|Withdrawal by Subject|0|||
49052339|NCT03519178|158023904|FG011|Long-term Follow-up|Withdrawal by Subject|0|||
49052340|NCT03519178|158023905|FG012|Long-term Follow-up|Withdrawal by Subject|0|||
49052341|NCT03519178|158023906|FG013|Long-term Follow-up|Withdrawal by Subject|7|||
49052342|NCT03519178|158023907|FG014|Long-term Follow-up|Withdrawal by Subject|3|||
49052343|NCT03519178|158023893|FG000|Long-term Follow-up|Other|0|||
49052344|NCT03519178|158023894|FG001|Long-term Follow-up|Other|0|||
49052345|NCT03519178|158023895|FG002|Long-term Follow-up|Other|0|||
49052346|NCT03519178|158023896|FG003|Long-term Follow-up|Other|0|||
49052347|NCT03519178|158023897|FG004|Long-term Follow-up|Other|0|||
49052348|NCT03519178|158023898|FG005|Long-term Follow-up|Other|0|||
49052349|NCT03519178|158023899|FG006|Long-term Follow-up|Other|0|||
49052350|NCT03519178|158023900|FG007|Long-term Follow-up|Other|0|||
49052351|NCT03519178|158023901|FG008|Long-term Follow-up|Other|0|||
49052352|NCT03519178|158023902|FG009|Long-term Follow-up|Other|0|||
49052353|NCT03519178|158023903|FG010|Long-term Follow-up|Other|0|||
49052354|NCT03519178|158023904|FG011|Long-term Follow-up|Other|0|||
49052355|NCT03519178|158023905|FG012|Long-term Follow-up|Other|0|||
49052356|NCT03519178|158023906|FG013|Long-term Follow-up|Other|0|||
49052357|NCT03519178|158023907|FG014|Long-term Follow-up|Other|1|||
49052358|NCT03519178|158023893|FG000|Long-term Follow-up|Ongoing|0|||
49052359|NCT03519178|158023894|FG001|Long-term Follow-up|Ongoing|0|||
49052360|NCT03519178|158023895|FG002|Long-term Follow-up|Ongoing|0|||
49052361|NCT03519178|158023896|FG003|Long-term Follow-up|Ongoing|0|||
49052362|NCT03519178|158023897|FG004|Long-term Follow-up|Ongoing|0|||
49052363|NCT03519178|158023898|FG005|Long-term Follow-up|Ongoing|0|||
49052364|NCT03519178|158023899|FG006|Long-term Follow-up|Ongoing|0|||
49052365|NCT03519178|158023900|FG007|Long-term Follow-up|Ongoing|0|||
49052366|NCT03519178|158023901|FG008|Long-term Follow-up|Ongoing|0|||
49052367|NCT03519178|158023902|FG009|Long-term Follow-up|Ongoing|0|||
49052368|NCT03519178|158023903|FG010|Long-term Follow-up|Ongoing|0|||
49052369|NCT03519178|158023904|FG011|Long-term Follow-up|Ongoing|0|||
49052370|NCT03519178|158023905|FG012|Long-term Follow-up|Ongoing|0|||
49052371|NCT03519178|158023906|FG013|Long-term Follow-up|Ongoing|1|||
49052372|NCT03519178|158023907|FG014|Long-term Follow-up|Ongoing|0|||
49052373|NCT00693225|158023911|FG000|Overall Study|Lost to Follow-up|1|||
49052374|NCT00693225|158023912|FG001|Overall Study|Lost to Follow-up|2|||
49052375|NCT00693225|158023911|FG000|Overall Study|Adverse Event|1|||
49052376|NCT00693225|158023912|FG001|Overall Study|Adverse Event|3|||
49052377|NCT04599634|158023913|FG000|Overall Study|Dose limiting toxicity|0|||
49052378|NCT04599634|158023914|FG001|Overall Study|Dose limiting toxicity|0|||
49052379|NCT04599634|158023915|FG002|Overall Study|Dose limiting toxicity|2|||
49052380|NCT04599634|158023916|FG003|Overall Study|Dose limiting toxicity|0|||
49052381|NCT03451006|158023917|FG000|Overall Study|Withdrawal by Subject|2|||
49052382|NCT03451006|158023918|FG001|Overall Study|Withdrawal by Subject|2|||
49052383|NCT03990883|158023919|FG000|Blinded Treatment Phase|Adverse Event|1|||
49052384|NCT03990883|158023920|FG001|Blinded Treatment Phase|Adverse Event|1|||
49052385|NCT03990883|158023921|FG002|Blinded Treatment Phase|Adverse Event|0|||
49052386|NCT03990883|158023919|FG000|Blinded Treatment Phase|Lost to Follow-up|7|||
49052387|NCT03990883|158023920|FG001|Blinded Treatment Phase|Lost to Follow-up|10|||
49052388|NCT03990883|158023921|FG002|Blinded Treatment Phase|Lost to Follow-up|0|||
49052389|NCT03990883|158023919|FG000|Blinded Treatment Phase|Physician Decision|1|||
49052390|NCT03990883|158023920|FG001|Blinded Treatment Phase|Physician Decision|0|||
49052391|NCT03990883|158023921|FG002|Blinded Treatment Phase|Physician Decision|0|||
49052392|NCT03990883|158023919|FG000|Blinded Treatment Phase|Withdrawal by Subject|2|||
49052393|NCT03990883|158023920|FG001|Blinded Treatment Phase|Withdrawal by Subject|5|||
49052394|NCT03990883|158023921|FG002|Blinded Treatment Phase|Withdrawal by Subject|0|||
49052395|NCT03990883|158023919|FG000|Blinded Treatment Phase|COVID-19|3|||
49052396|NCT03990883|158023920|FG001|Blinded Treatment Phase|COVID-19|2|||
49052397|NCT03990883|158023921|FG002|Blinded Treatment Phase|COVID-19|0|||
49052398|NCT03990883|158023919|FG000|Blinded Treatment Phase|Personal Reasons|6|||
49052399|NCT03990883|158023920|FG001|Blinded Treatment Phase|Personal Reasons|3|||
49052400|NCT03990883|158023921|FG002|Blinded Treatment Phase|Personal Reasons|0|||
49052401|NCT03990883|158023919|FG000|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|3|||
49052402|NCT03990883|158023920|FG001|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|2|||
49052403|NCT03990883|158023921|FG002|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|0|||
49052404|NCT03990883|158023919|FG000|Open Label Extension Phase|Lost to Follow-up|0|||
49052405|NCT03990883|158023920|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
49052406|NCT03990883|158023921|FG002|Open Label Extension Phase|Lost to Follow-up|1|||
49052407|NCT03990883|158023919|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
49052408|NCT03990883|158023920|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
49052409|NCT03990883|158023921|FG002|Open Label Extension Phase|Withdrawal by Subject|1|||
49052410|NCT01315028|158023922|FG000|Overall Study|Lost to Follow-up|1|||
49052411|NCT01315028|158023923|FG001|Overall Study|Lost to Follow-up|0|||
49052412|NCT01315028|158023922|FG000|Overall Study|Death|0|||
49052413|NCT01315028|158023923|FG001|Overall Study|Death|1|||
49052414|NCT00194792|158023928|FG000|Overall Study|Withdrawal by Subject|1|||
49052415|NCT00493454|158023929|FG000|Overall Study|Withdrawal by Subject|1|||
49052416|NCT03877926|158023930|FG000|Overall Study|Adverse Event|1|||
49052417|NCT03877926|158023931|FG001|Overall Study|Adverse Event|0|||
49052418|NCT03877926|158023932|FG002|Overall Study|Adverse Event|0|||
49052419|NCT03877926|158023933|FG003|Overall Study|Adverse Event|0|||
49052420|NCT03877926|158023930|FG000|Overall Study|Death|2|||
49052421|NCT03877926|158023931|FG001|Overall Study|Death|2|||
49052422|NCT03877926|158023932|FG002|Overall Study|Death|2|||
49052423|NCT03877926|158023933|FG003|Overall Study|Death|0|||
49052424|NCT03877926|158023930|FG000|Overall Study|Lost to Follow-up|41|||
49052425|NCT03877926|158023931|FG001|Overall Study|Lost to Follow-up|52|||
49052426|NCT03877926|158023932|FG002|Overall Study|Lost to Follow-up|45|||
49052427|NCT03877926|158023933|FG003|Overall Study|Lost to Follow-up|17|||
49052428|NCT03877926|158023930|FG000|Overall Study|Physician Decision|2|||
49052429|NCT03877926|158023931|FG001|Overall Study|Physician Decision|0|||
49052430|NCT03877926|158023932|FG002|Overall Study|Physician Decision|2|||
49052431|NCT03877926|158023933|FG003|Overall Study|Physician Decision|0|||
49052432|NCT03877926|158023930|FG000|Overall Study|Withdrawal by Subject|18|||
49052433|NCT03877926|158023931|FG001|Overall Study|Withdrawal by Subject|21|||
49052434|NCT03877926|158023932|FG002|Overall Study|Withdrawal by Subject|12|||
49052435|NCT03877926|158023933|FG003|Overall Study|Withdrawal by Subject|4|||
49052436|NCT03877926|158023930|FG000|Overall Study|Other - Various|4|||
49052437|NCT03877926|158023931|FG001|Overall Study|Other - Various|1|||
49052438|NCT03877926|158023932|FG002|Overall Study|Other - Various|1|||
49052439|NCT03877926|158023933|FG003|Overall Study|Other - Various|0|||
49052440|NCT03877926|158023930|FG000|Overall Study|Not Treated|3|||
49052441|NCT03877926|158023931|FG001|Overall Study|Not Treated|1|||
49052442|NCT03877926|158023932|FG002|Overall Study|Not Treated|1|||
49052443|NCT03877926|158023933|FG003|Overall Study|Not Treated|0|||
49052444|NCT00588731|158023934|FG000|Overall Study|Withdrawal by Subject|3|||
49052445|NCT00588731|158023935|FG001|Overall Study|Withdrawal by Subject|2|||
49052446|NCT01118117|158023936|FG000|Overall Study|Death|8|||
49052447|NCT01118117|158023937|FG001|Overall Study|Death|0|||
49052448|NCT01118117|158023936|FG000|Overall Study|Lost to Follow-up|6|||
49052449|NCT01118117|158023937|FG001|Overall Study|Lost to Follow-up|0|||
49052450|NCT01118117|158023936|FG000|Overall Study|Missed 12 Month Visit|7|||
49052451|NCT01118117|158023937|FG001|Overall Study|Missed 12 Month Visit|0|||
49052452|NCT00537199|158023940|FG000|Overall Study|Study Terminated|1|||
49052453|NCT02905331|158023941|FG000|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1|||
49052454|NCT02905331|158023942|FG001|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
49052455|NCT02905331|158023943|FG002|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
49052456|NCT02905331|158023941|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2|||
49052457|NCT02905331|158023942|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
49052458|NCT02905331|158023943|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
49052459|NCT02905331|158023941|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
49052460|NCT02905331|158023942|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1|||
49052461|NCT02905331|158023943|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
49052462|NCT02905331|158023941|FG000|Active Treatment and Follow up (wk16-40)|Other|0|||
49052463|NCT02905331|158023942|FG001|Active Treatment and Follow up (wk16-40)|Other|6|||
49052464|NCT02905331|158023943|FG002|Active Treatment and Follow up (wk16-40)|Other|0|||
49052465|NCT02905331|158023941|FG000|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
49052466|NCT02905331|158023942|FG001|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2|||
49052467|NCT02905331|158023943|FG002|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
49052468|NCT01675492|158023944|FG000|Overall Study|study completed early - product approval|42|||
49052469|NCT02095691|158023945|FG000|Overall Study|Physician Decision|1|||
49052470|NCT01371981|158023946|FG000|Overall Study|Adverse Event|12|||
49052471|NCT01371981|158023947|FG001|Overall Study|Adverse Event|17|||
49052472|NCT01371981|158023948|FG002|Overall Study|Adverse Event|0|||
49052473|NCT01371981|158023949|FG003|Overall Study|Adverse Event|4|||
49052474|NCT01371981|158023950|FG004|Overall Study|Adverse Event|1|||
49052475|NCT01371981|158023951|FG005|Overall Study|Adverse Event|0|||
49052476|NCT01371981|158023946|FG000|Overall Study|Death|22|||
49052477|NCT01371981|158023947|FG001|Overall Study|Death|16|||
49052478|NCT01371981|158023948|FG002|Overall Study|Death|0|||
49052479|NCT01371981|158023949|FG003|Overall Study|Death|0|||
49052480|NCT01371981|158023950|FG004|Overall Study|Death|2|||
49052481|NCT01371981|158023951|FG005|Overall Study|Death|2|||
49052482|NCT01371981|158023946|FG000|Overall Study|Lack of Efficacy|69|||
49052483|NCT01371981|158023947|FG001|Overall Study|Lack of Efficacy|61|||
49052484|NCT01371981|158023948|FG002|Overall Study|Lack of Efficacy|4|||
49052485|NCT01371981|158023949|FG003|Overall Study|Lack of Efficacy|8|||
49052486|NCT01371981|158023950|FG004|Overall Study|Lack of Efficacy|5|||
49052487|NCT01371981|158023951|FG005|Overall Study|Lack of Efficacy|0|||
49052488|NCT01371981|158023946|FG000|Overall Study|Physician Decision|48|||
49052489|NCT01371981|158023947|FG001|Overall Study|Physician Decision|63|||
49052490|NCT01371981|158023948|FG002|Overall Study|Physician Decision|1|||
49052491|NCT01371981|158023949|FG003|Overall Study|Physician Decision|7|||
49052492|NCT01371981|158023950|FG004|Overall Study|Physician Decision|14|||
49052493|NCT01371981|158023951|FG005|Overall Study|Physician Decision|3|||
49052494|NCT01371981|158023946|FG000|Overall Study|Withdrawal by Subject|12|||
49052495|NCT01371981|158023947|FG001|Overall Study|Withdrawal by Subject|19|||
49052496|NCT01371981|158023948|FG002|Overall Study|Withdrawal by Subject|1|||
49052497|NCT01371981|158023949|FG003|Overall Study|Withdrawal by Subject|2|||
49052498|NCT01371981|158023950|FG004|Overall Study|Withdrawal by Subject|10|||
49052499|NCT01371981|158023951|FG005|Overall Study|Withdrawal by Subject|3|||
49052500|NCT01371981|158023946|FG000|Overall Study|Ineligible|19|||
49052501|NCT01371981|158023947|FG001|Overall Study|Ineligible|13|||
49052502|NCT01371981|158023948|FG002|Overall Study|Ineligible|0|||
49052503|NCT01371981|158023949|FG003|Overall Study|Ineligible|0|||
49052504|NCT01371981|158023950|FG004|Overall Study|Ineligible|0|||
49052505|NCT01371981|158023951|FG005|Overall Study|Ineligible|4|||
49052506|NCT01371981|158023946|FG000|Overall Study|Did not start treatment|2|||
49052507|NCT01371981|158023947|FG001|Overall Study|Did not start treatment|3|||
49052508|NCT01371981|158023948|FG002|Overall Study|Did not start treatment|0|||
49052509|NCT01371981|158023949|FG003|Overall Study|Did not start treatment|0|||
49052510|NCT01371981|158023950|FG004|Overall Study|Did not start treatment|0|||
49052511|NCT01371981|158023951|FG005|Overall Study|Did not start treatment|2|||
49052512|NCT03681262|158023952|FG000|Overall Study|Continuing on study|3|||
49052513|NCT03681262|158023953|FG001|Overall Study|Continuing on study|3|||
49052514|NCT03681262|158023952|FG000|Overall Study|Lost to Follow-up|1|||
49052515|NCT03681262|158023953|FG001|Overall Study|Lost to Follow-up|0|||
49052548|NCT03176784|158023960|FG000|Overall Study|Lost to Follow-up|77|||
49052549|NCT03176784|158023961|FG001|Overall Study|Lost to Follow-up|79|||
49052550|NCT03176784|158023962|FG002|Overall Study|Lost to Follow-up|79|||
49052551|NCT03176784|158023963|FG003|Overall Study|Lost to Follow-up|49|||
49052552|NCT03176784|158023960|FG000|Overall Study|Withdrawal by Subject|28|||
49052553|NCT03176784|158023961|FG001|Overall Study|Withdrawal by Subject|34|||
49052554|NCT03176784|158023962|FG002|Overall Study|Withdrawal by Subject|34|||
49052555|NCT03176784|158023963|FG003|Overall Study|Withdrawal by Subject|21|||
49052556|NCT00026312|158023964|FG000|Overall Study|Adverse Event|0|||
49052557|NCT00026312|158023965|FG001|Overall Study|Adverse Event|32|||
49052558|NCT00026312|158023964|FG000|Overall Study|Death|1|||
49052559|NCT00026312|158023965|FG001|Overall Study|Death|7|||
49052560|NCT00026312|158023964|FG000|Overall Study|Lack of Efficacy|19|||
49052561|NCT00026312|158023965|FG001|Overall Study|Lack of Efficacy|114|||
49052562|NCT00026312|158023964|FG000|Overall Study|Lost to Follow-up|0|||
49052563|NCT00026312|158023965|FG001|Overall Study|Lost to Follow-up|5|||
49052564|NCT00026312|158023964|FG000|Overall Study|Physician Decision|1|||
49052565|NCT00026312|158023965|FG001|Overall Study|Physician Decision|37|||
49052566|NCT00026312|158023964|FG000|Overall Study|Protocol Violation|0|||
49052567|NCT00026312|158023965|FG001|Overall Study|Protocol Violation|3|||
49052568|NCT00026312|158023964|FG000|Overall Study|Withdrawal by Subject|1|||
49052569|NCT00026312|158023965|FG001|Overall Study|Withdrawal by Subject|6|||
49052570|NCT00026312|158023964|FG000|Overall Study|Ineligible|4|||
49052571|NCT00026312|158023965|FG001|Overall Study|Ineligible|5|||
49052572|NCT00026312|158023964|FG000|Overall Study|Entry onto another COG study|0|||
49052573|NCT00026312|158023965|FG001|Overall Study|Entry onto another COG study|1|||
49052574|NCT00026312|158023964|FG000|Overall Study|Refusal by patient/parent/guardian|8|||
49052575|NCT00026312|158023965|FG001|Overall Study|Refusal by patient/parent/guardian|59|||
49052576|NCT03334695|158023966|FG000|Overall Study|Lost to Follow-up|3|||
49052577|NCT03334695|158023967|FG001|Overall Study|Lost to Follow-up|3|||
49052578|NCT03334695|158023966|FG000|Overall Study|Physician Decision|1|||
49052579|NCT03334695|158023967|FG001|Overall Study|Physician Decision|2|||
49052580|NCT03334695|158023966|FG000|Overall Study|Protocol Violation|0|||
49052581|NCT03334695|158023967|FG001|Overall Study|Protocol Violation|1|||
49052582|NCT02806726|158023968|FG000|Overall Study|Lost to Follow-up|1|||
49052583|NCT00977431|158023969|FG000|Overall Study|Other than listed|1|||
49052584|NCT00977431|158023970|FG001|Overall Study|Other than listed|0|||
49052585|NCT00977431|158023971|FG002|Overall Study|Other than listed|0|||
49052586|NCT00977431|158023972|FG003|Overall Study|Other than listed|0|||
49052587|NCT00977431|158023973|FG004|Overall Study|Other than listed|2|||
49052588|NCT00977431|158023969|FG000|Overall Study|Protocol Violation|0|||
49052589|NCT00977431|158023970|FG001|Overall Study|Protocol Violation|0|||
49052590|NCT00977431|158023971|FG002|Overall Study|Protocol Violation|1|||
49052591|NCT00977431|158023972|FG003|Overall Study|Protocol Violation|0|||
49052592|NCT00977431|158023973|FG004|Overall Study|Protocol Violation|0|||
49052593|NCT00977431|158023969|FG000|Overall Study|Adverse Event|3|||
49052594|NCT00977431|158023970|FG001|Overall Study|Adverse Event|0|||
49052595|NCT00977431|158023971|FG002|Overall Study|Adverse Event|4|||
49052596|NCT00977431|158023972|FG003|Overall Study|Adverse Event|0|||
49052597|NCT00977431|158023973|FG004|Overall Study|Adverse Event|6|||
49052598|NCT00977431|158023969|FG000|Overall Study|Dose-limiting toxicity (DLT)|1|||
49052599|NCT00977431|158023970|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
49052600|NCT00977431|158023971|FG002|Overall Study|Dose-limiting toxicity (DLT)|1|||
49052601|NCT00977431|158023972|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
49052602|NCT00977431|158023973|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
49052603|NCT00977431|158023969|FG000|Overall Study|Progressive disease|2|||
49052604|NCT00977431|158023970|FG001|Overall Study|Progressive disease|6|||
49052605|NCT00977431|158023971|FG002|Overall Study|Progressive disease|1|||
49052606|NCT00977431|158023972|FG003|Overall Study|Progressive disease|3|||
49052607|NCT00977431|158023973|FG004|Overall Study|Progressive disease|5|||
49052608|NCT05158140|158023978|FG000|Overall Study|Death|0|||
49052609|NCT05158140|158023979|FG001|Overall Study|Death|0|||
49052610|NCT05158140|158023980|FG002|Overall Study|Death|0|||
49052611|NCT05158140|158023981|FG003|Overall Study|Death|1|||
49052612|NCT05158140|158023978|FG000|Overall Study|Lost to Follow-up|3|||
49052613|NCT05158140|158023979|FG001|Overall Study|Lost to Follow-up|6|||
49052614|NCT05158140|158023980|FG002|Overall Study|Lost to Follow-up|4|||
49052615|NCT05158140|158023981|FG003|Overall Study|Lost to Follow-up|3|||
49052616|NCT05158140|158023978|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
49052617|NCT05158140|158023979|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
49052618|NCT05158140|158023980|FG002|Overall Study|Randomized By Mistake Without Study Treatment|4|||
49052619|NCT05158140|158023981|FG003|Overall Study|Randomized By Mistake Without Study Treatment|1|||
49052620|NCT05158140|158023978|FG000|Overall Study|Withdrawal by Subject|3|||
49052621|NCT05158140|158023979|FG001|Overall Study|Withdrawal by Subject|7|||
49052622|NCT05158140|158023980|FG002|Overall Study|Withdrawal by Subject|3|||
49052623|NCT05158140|158023981|FG003|Overall Study|Withdrawal by Subject|7|||
49052624|NCT02413489|158023982|FG000|Overall Study|Death|11|||
49052625|NCT02413489|158023983|FG001|Overall Study|Death|3|||
49052626|NCT02413489|158023984|FG002|Overall Study|Death|4|||
49052627|NCT02413489|158023982|FG000|Overall Study|Withdrawal by Subject|2|||
49052628|NCT02413489|158023983|FG001|Overall Study|Withdrawal by Subject|0|||
49052629|NCT02413489|158023984|FG002|Overall Study|Withdrawal by Subject|0|||
49052630|NCT02413489|158023982|FG000|Overall Study|Study Terminated By Sponsor|2|||
49052631|NCT02413489|158023983|FG001|Overall Study|Study Terminated By Sponsor|13|||
49052632|NCT02413489|158023984|FG002|Overall Study|Study Terminated By Sponsor|1|||
49052633|NCT05007080|158023985|FG000|Overall Study|Lost to Follow-up|0|||
49052634|NCT05007080|158023986|FG001|Overall Study|Lost to Follow-up|1|||
49052635|NCT05007080|158023987|FG002|Overall Study|Lost to Follow-up|0|||
49052636|NCT05007080|158023988|FG003|Overall Study|Lost to Follow-up|1|||
49052637|NCT05007080|158023989|FG004|Overall Study|Lost to Follow-up|1|||
49052638|NCT05007080|158023990|FG005|Overall Study|Lost to Follow-up|1|||
49052639|NCT05007080|158023985|FG000|Overall Study|Death|0|||
49052640|NCT05007080|158023986|FG001|Overall Study|Death|1|||
49052641|NCT05007080|158023987|FG002|Overall Study|Death|0|||
49052642|NCT05007080|158023988|FG003|Overall Study|Death|0|||
49052643|NCT05007080|158023989|FG004|Overall Study|Death|0|||
49052644|NCT05007080|158023990|FG005|Overall Study|Death|0|||
49052645|NCT05007080|158023985|FG000|Overall Study|Withdrawal by Subject|1|||
49052646|NCT05007080|158023986|FG001|Overall Study|Withdrawal by Subject|2|||
49052647|NCT05007080|158023987|FG002|Overall Study|Withdrawal by Subject|0|||
49052648|NCT05007080|158023988|FG003|Overall Study|Withdrawal by Subject|2|||
49052649|NCT05007080|158023989|FG004|Overall Study|Withdrawal by Subject|1|||
49052650|NCT05007080|158023990|FG005|Overall Study|Withdrawal by Subject|1|||
49052651|NCT05007080|158023985|FG000|Overall Study|Other|1|||
49052652|NCT05007080|158023986|FG001|Overall Study|Other|0|||
49052653|NCT05007080|158023987|FG002|Overall Study|Other|1|||
49052654|NCT05007080|158023988|FG003|Overall Study|Other|1|||
49052655|NCT05007080|158023989|FG004|Overall Study|Other|0|||
49052656|NCT05007080|158023990|FG005|Overall Study|Other|2|||
49052657|NCT05007080|158023985|FG000|Overall Study|Randomized not vaccinated|0|||
49052658|NCT05007080|158023986|FG001|Overall Study|Randomized not vaccinated|0|||
49052659|NCT05007080|158023987|FG002|Overall Study|Randomized not vaccinated|0|||
49052660|NCT05007080|158023988|FG003|Overall Study|Randomized not vaccinated|0|||
49052661|NCT05007080|158023989|FG004|Overall Study|Randomized not vaccinated|0|||
49052662|NCT05007080|158023990|FG005|Overall Study|Randomized not vaccinated|1|||
49052663|NCT01662362|158023998|FG000|Overall Study|Lost to Follow-up|38|||
49052664|NCT01181531|158023999|FG000|Overall Study|Other|17|||
49052665|NCT01181531|158024000|FG001|Overall Study|Other|12|||
49052666|NCT01181531|158023999|FG000|Overall Study|Partial consent by subject withdrawn|0|||
49052667|NCT01181531|158024000|FG001|Overall Study|Partial consent by subject withdrawn|1|||
49052668|NCT01181531|158023999|FG000|Overall Study|Physician Decision|3|||
49052669|NCT01181531|158024000|FG001|Overall Study|Physician Decision|1|||
49052670|NCT01181531|158023999|FG000|Overall Study|Noncompliance|2|||
49052671|NCT01181531|158024000|FG001|Overall Study|Noncompliance|2|||
49052672|NCT01181531|158023999|FG000|Overall Study|Ineligibility determined|1|||
49052673|NCT01181531|158024000|FG001|Overall Study|Ineligibility determined|2|||
49052674|NCT01181531|158023999|FG000|Overall Study|Protocol Specified Criteria|15|||
49052675|NCT01181531|158024000|FG001|Overall Study|Protocol Specified Criteria|8|||
49052676|NCT01181531|158023999|FG000|Overall Study|Pregnancy|0|||
49052677|NCT01181531|158024000|FG001|Overall Study|Pregnancy|1|||
49052678|NCT01181531|158023999|FG000|Overall Study|Withdrawal by Subject|8|||
49052679|NCT01181531|158024000|FG001|Overall Study|Withdrawal by Subject|7|||
49052680|NCT01181531|158023999|FG000|Overall Study|Protocol Violation|6|||
49052681|NCT01181531|158024000|FG001|Overall Study|Protocol Violation|6|||
49052682|NCT01181531|158023999|FG000|Overall Study|Death|9|||
49052683|NCT01181531|158024000|FG001|Overall Study|Death|12|||
49052684|NCT01181531|158023999|FG000|Overall Study|Adverse Event|0|||
49052685|NCT01181531|158024000|FG001|Overall Study|Adverse Event|1|||
49052686|NCT00545688|158024002|FG000|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
49052687|NCT00545688|158024003|FG001|Neo-Adjuvant Treatment Period|Protocol Violation|2|||
49052688|NCT00545688|158024004|FG002|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
49052689|NCT00545688|158024005|FG003|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
49052690|NCT00545688|158024002|FG000|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
49052691|NCT00545688|158024003|FG001|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
49052692|NCT00545688|158024004|FG002|Neo-Adjuvant Treatment Period|Refused Treatment|4|||
49052693|NCT00545688|158024005|FG003|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
49052694|NCT00545688|158024002|FG000|Neo-Adjuvant Treatment Period|Lost to Follow-up|1|||
49052695|NCT00545688|158024003|FG001|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
49052696|NCT00545688|158024004|FG002|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
49052697|NCT00545688|158024005|FG003|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
49052698|NCT00545688|158024002|FG000|Neo-Adjuvant Treatment Period|Death|0|||
49052699|NCT00545688|158024003|FG001|Neo-Adjuvant Treatment Period|Death|1|||
49052700|NCT00545688|158024004|FG002|Neo-Adjuvant Treatment Period|Death|0|||
49052701|NCT00545688|158024005|FG003|Neo-Adjuvant Treatment Period|Death|0|||
49052702|NCT00545688|158024002|FG000|Neo-Adjuvant Treatment Period|Disease Progression|0|||
49052703|NCT00545688|158024003|FG001|Neo-Adjuvant Treatment Period|Disease Progression|1|||
49052704|NCT00545688|158024004|FG002|Neo-Adjuvant Treatment Period|Disease Progression|7|||
49052705|NCT00545688|158024005|FG003|Neo-Adjuvant Treatment Period|Disease Progression|2|||
49052706|NCT00545688|158024002|FG000|Neo-Adjuvant Treatment Period|Unknown Reason|1|||
49052707|NCT00545688|158024003|FG001|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
49052708|NCT00545688|158024004|FG002|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
49052709|NCT00545688|158024005|FG003|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
49052710|NCT00545688|158024002|FG000|Neo-Adjuvant Treatment Period|Adverse Event|0|||
49052711|NCT00545688|158024003|FG001|Neo-Adjuvant Treatment Period|Adverse Event|0|||
49052712|NCT00545688|158024004|FG002|Neo-Adjuvant Treatment Period|Adverse Event|2|||
49052713|NCT00545688|158024005|FG003|Neo-Adjuvant Treatment Period|Adverse Event|2|||
49052714|NCT00545688|158024002|FG000|Adjuvant Treatment Period|Disease Progression|3|||
49052715|NCT00545688|158024003|FG001|Adjuvant Treatment Period|Disease Progression|3|||
49052716|NCT00545688|158024004|FG002|Adjuvant Treatment Period|Disease Progression|0|||
49052717|NCT00545688|158024005|FG003|Adjuvant Treatment Period|Disease Progression|7|||
49052718|NCT00545688|158024002|FG000|Adjuvant Treatment Period|Refused Treatment|1|||
49052719|NCT00545688|158024003|FG001|Adjuvant Treatment Period|Refused Treatment|1|||
49052720|NCT00545688|158024004|FG002|Adjuvant Treatment Period|Refused Treatment|1|||
49052721|NCT00545688|158024005|FG003|Adjuvant Treatment Period|Refused Treatment|5|||
49052722|NCT00545688|158024002|FG000|Adjuvant Treatment Period|Lost to Follow-up|1|||
49052723|NCT00545688|158024003|FG001|Adjuvant Treatment Period|Lost to Follow-up|0|||
49052724|NCT00545688|158024004|FG002|Adjuvant Treatment Period|Lost to Follow-up|1|||
49052725|NCT00545688|158024005|FG003|Adjuvant Treatment Period|Lost to Follow-up|0|||
49052726|NCT00545688|158024002|FG000|Adjuvant Treatment Period|Adverse Event|0|||
49052727|NCT00545688|158024003|FG001|Adjuvant Treatment Period|Adverse Event|3|||
49052728|NCT00545688|158024004|FG002|Adjuvant Treatment Period|Adverse Event|2|||
49052729|NCT00545688|158024005|FG003|Adjuvant Treatment Period|Adverse Event|2|||
49052730|NCT00545688|158024002|FG000|Adjuvant Treatment Period|Unknown Reason|0|||
49052731|NCT00545688|158024003|FG001|Adjuvant Treatment Period|Unknown Reason|1|||
49052732|NCT00545688|158024004|FG002|Adjuvant Treatment Period|Unknown Reason|0|||
49052733|NCT00545688|158024005|FG003|Adjuvant Treatment Period|Unknown Reason|0|||
49052734|NCT00545688|158024002|FG000|Follow-Up Period|Death|4|||
49052735|NCT00545688|158024003|FG001|Follow-Up Period|Death|2|||
49052736|NCT00545688|158024004|FG002|Follow-Up Period|Death|2|||
49052737|NCT00545688|158024005|FG003|Follow-Up Period|Death|6|||
49052738|NCT00545688|158024002|FG000|Follow-Up Period|Disease Progression|6|||
49052739|NCT00545688|158024003|FG001|Follow-Up Period|Disease Progression|5|||
49052740|NCT00545688|158024004|FG002|Follow-Up Period|Disease Progression|9|||
49052741|NCT00545688|158024005|FG003|Follow-Up Period|Disease Progression|9|||
49052742|NCT00545688|158024002|FG000|Follow-Up Period|Refused Treatment|6|||
49052743|NCT00545688|158024003|FG001|Follow-Up Period|Refused Treatment|2|||
49052744|NCT00545688|158024004|FG002|Follow-Up Period|Refused Treatment|0|||
49052745|NCT00545688|158024005|FG003|Follow-Up Period|Refused Treatment|2|||
49052746|NCT00545688|158024002|FG000|Follow-Up Period|Lost to Follow-up|3|||
49052747|NCT00545688|158024003|FG001|Follow-Up Period|Lost to Follow-up|3|||
49052748|NCT00545688|158024004|FG002|Follow-Up Period|Lost to Follow-up|3|||
49052749|NCT00545688|158024005|FG003|Follow-Up Period|Lost to Follow-up|1|||
49052750|NCT00545688|158024002|FG000|Follow-Up Period|Unspecified Reason|2|||
49052751|NCT00545688|158024003|FG001|Follow-Up Period|Unspecified Reason|5|||
49052752|NCT00545688|158024004|FG002|Follow-Up Period|Unspecified Reason|6|||
49052753|NCT00545688|158024005|FG003|Follow-Up Period|Unspecified Reason|8|||
49052754|NCT00545688|158024002|FG000|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
49052755|NCT00545688|158024003|FG001|Follow-Up Period|Violation of Selection Criteria at Entry|2|||
49052756|NCT00545688|158024004|FG002|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
49052757|NCT00545688|158024005|FG003|Follow-Up Period|Violation of Selection Criteria at Entry|1|||
49052758|NCT00515034|158024008|FG000|Overall Study|Adverse Event|2|||
49052759|NCT00515034|158024009|FG001|Overall Study|Adverse Event|0|||
49052760|NCT00515034|158024010|FG002|Overall Study|Adverse Event|1|||
49052761|NCT00515034|158024011|FG003|Overall Study|Adverse Event|0|||
49052762|NCT00515034|158024008|FG000|Overall Study|Death|4|||
49052763|NCT00515034|158024009|FG001|Overall Study|Death|2|||
49052764|NCT00515034|158024010|FG002|Overall Study|Death|1|||
49052765|NCT00515034|158024011|FG003|Overall Study|Death|3|||
49052766|NCT00515034|158024008|FG000|Overall Study|Withdrawal by Subject|1|||
49052767|NCT00515034|158024009|FG001|Overall Study|Withdrawal by Subject|0|||
49052768|NCT00515034|158024010|FG002|Overall Study|Withdrawal by Subject|3|||
49052769|NCT00515034|158024011|FG003|Overall Study|Withdrawal by Subject|0|||
49052770|NCT00515034|158024008|FG000|Overall Study|Physician Decision|0|||
49052771|NCT00515034|158024009|FG001|Overall Study|Physician Decision|0|||
49052772|NCT00515034|158024010|FG002|Overall Study|Physician Decision|1|||
49052773|NCT00515034|158024011|FG003|Overall Study|Physician Decision|1|||
49052774|NCT00515034|158024008|FG000|Overall Study|Other|1|||
49052775|NCT00515034|158024009|FG001|Overall Study|Other|0|||
49052776|NCT00515034|158024010|FG002|Overall Study|Other|2|||
49052777|NCT00515034|158024011|FG003|Overall Study|Other|1|||
49052778|NCT03253094|158024012|FG000|Overall Study|Adverse Event|2|||
49052779|NCT03253094|158024013|FG001|Overall Study|Adverse Event|0|||
49052780|NCT03253094|158024014|FG002|Overall Study|Adverse Event|0|||
49052781|NCT03253094|158024015|FG003|Overall Study|Adverse Event|0|||
49052782|NCT03253094|158024016|FG004|Overall Study|Adverse Event|0|||
49052783|NCT03253094|158024017|FG005|Overall Study|Adverse Event|0|||
49052784|NCT03253094|158024012|FG000|Overall Study|Lack of Efficacy|0|||
49052785|NCT03253094|158024013|FG001|Overall Study|Lack of Efficacy|0|||
49052786|NCT03253094|158024014|FG002|Overall Study|Lack of Efficacy|2|||
49052787|NCT03253094|158024015|FG003|Overall Study|Lack of Efficacy|1|||
49052788|NCT03253094|158024016|FG004|Overall Study|Lack of Efficacy|2|||
49052789|NCT03253094|158024017|FG005|Overall Study|Lack of Efficacy|1|||
49052790|NCT03253094|158024012|FG000|Overall Study|Lost to Follow-up|0|||
49052791|NCT03253094|158024013|FG001|Overall Study|Lost to Follow-up|0|||
49052792|NCT03253094|158024014|FG002|Overall Study|Lost to Follow-up|1|||
49052793|NCT03253094|158024015|FG003|Overall Study|Lost to Follow-up|1|||
49052794|NCT03253094|158024016|FG004|Overall Study|Lost to Follow-up|0|||
49052795|NCT03253094|158024017|FG005|Overall Study|Lost to Follow-up|1|||
49052796|NCT03253094|158024012|FG000|Overall Study|Physician Decision|1|||
49052797|NCT03253094|158024013|FG001|Overall Study|Physician Decision|0|||
49052798|NCT03253094|158024014|FG002|Overall Study|Physician Decision|0|||
49052799|NCT03253094|158024015|FG003|Overall Study|Physician Decision|1|||
49052800|NCT03253094|158024016|FG004|Overall Study|Physician Decision|0|||
49052801|NCT03253094|158024017|FG005|Overall Study|Physician Decision|2|||
49052802|NCT03253094|158024012|FG000|Overall Study|Withdrawal by Subject|1|||
49052803|NCT03253094|158024013|FG001|Overall Study|Withdrawal by Subject|2|||
49052804|NCT03253094|158024014|FG002|Overall Study|Withdrawal by Subject|1|||
49052805|NCT03253094|158024015|FG003|Overall Study|Withdrawal by Subject|0|||
49052806|NCT03253094|158024016|FG004|Overall Study|Withdrawal by Subject|3|||
49052807|NCT03253094|158024017|FG005|Overall Study|Withdrawal by Subject|0|||
49052808|NCT03253094|158024012|FG000|Overall Study|Other|0|||
49052809|NCT03253094|158024013|FG001|Overall Study|Other|1|||
49052810|NCT03253094|158024014|FG002|Overall Study|Other|2|||
49052811|NCT03253094|158024015|FG003|Overall Study|Other|1|||
49052812|NCT03253094|158024016|FG004|Overall Study|Other|0|||
49052813|NCT03253094|158024017|FG005|Overall Study|Other|0|||
49052814|NCT02858726|158024018|FG000|Overall Study|Adverse Event|4|||
49052815|NCT02858726|158024019|FG001|Overall Study|Adverse Event|4|||
49052816|NCT02858726|158024020|FG002|Overall Study|Adverse Event|9|||
49052817|NCT02858726|158024021|FG003|Overall Study|Adverse Event|1|||
49052818|NCT02858726|158024018|FG000|Overall Study|Physician Decision|0|||
49052819|NCT02858726|158024019|FG001|Overall Study|Physician Decision|0|||
49052820|NCT02858726|158024020|FG002|Overall Study|Physician Decision|1|||
49052821|NCT02858726|158024021|FG003|Overall Study|Physician Decision|0|||
49052822|NCT02858726|158024018|FG000|Overall Study|Protocol Violation|0|||
49052823|NCT02858726|158024019|FG001|Overall Study|Protocol Violation|0|||
49052824|NCT02858726|158024020|FG002|Overall Study|Protocol Violation|0|||
49052825|NCT02858726|158024021|FG003|Overall Study|Protocol Violation|1|||
49052826|NCT02858726|158024018|FG000|Overall Study|Study Terminated by Sponsor|0|||
49052827|NCT02858726|158024019|FG001|Overall Study|Study Terminated by Sponsor|0|||
49052828|NCT02858726|158024020|FG002|Overall Study|Study Terminated by Sponsor|0|||
49052829|NCT02858726|158024021|FG003|Overall Study|Study Terminated by Sponsor|1|||
49052830|NCT02858726|158024018|FG000|Overall Study|Withdrawal by Subject|1|||
49052831|NCT02858726|158024019|FG001|Overall Study|Withdrawal by Subject|2|||
49052832|NCT02858726|158024020|FG002|Overall Study|Withdrawal by Subject|1|||
49052833|NCT02858726|158024021|FG003|Overall Study|Withdrawal by Subject|0|||
49052834|NCT02858726|158024018|FG000|Overall Study|Noncompliance|0|||
49052835|NCT02858726|158024019|FG001|Overall Study|Noncompliance|1|||
49052836|NCT02858726|158024020|FG002|Overall Study|Noncompliance|0|||
49052837|NCT02858726|158024021|FG003|Overall Study|Noncompliance|0|||
49052838|NCT00576303|158024022|FG000|Dose Titration Period|Early withdrawal|17|||
49052839|NCT00576303|158024022|FG000|Efficacy Evaluation Period|Early withdrawal|5|||
49052840|NCT00576303|158024022|FG000|Long Term Safety Period|Early withdrawal|16|||
49052841|NCT04703855|158025976|FG000|Overall Study|Heart Transplant|1|||
49052842|NCT02671903|158025977|FG000|Period 0 (Run-In)|Death|0|||
49052843|NCT02671903|158025978|FG001|Period 0 (Run-In)|Death|0|||
49052844|NCT02671903|158025979|FG002|Period 0 (Run-In)|Death|3|||
49052845|NCT02671903|158025977|FG000|Period 0 (Run-In)|Physician Decision|0|||
49052846|NCT02671903|158025978|FG001|Period 0 (Run-In)|Physician Decision|0|||
49052847|NCT02671903|158025979|FG002|Period 0 (Run-In)|Physician Decision|4|||
49052848|NCT02671903|158025977|FG000|Period 0 (Run-In)|Withdrawal by Subject|0|||
49052849|NCT02671903|158025978|FG001|Period 0 (Run-In)|Withdrawal by Subject|0|||
49052850|NCT02671903|158025979|FG002|Period 0 (Run-In)|Withdrawal by Subject|4|||
49052851|NCT02671903|158025977|FG000|Period 0 (Run-In)|Protocol Violation|0|||
49052852|NCT02671903|158025978|FG001|Period 0 (Run-In)|Protocol Violation|0|||
49052853|NCT02671903|158025979|FG002|Period 0 (Run-In)|Protocol Violation|1|||
49052854|NCT02671903|158025977|FG000|Period 0 (Run-In)|Adverse Event|0|||
49052855|NCT02671903|158025978|FG001|Period 0 (Run-In)|Adverse Event|0|||
49052856|NCT02671903|158025979|FG002|Period 0 (Run-In)|Adverse Event|1|||
49052857|NCT02671903|158025977|FG000|Period 0 (Run-In)|Implantation Failure|0|||
49052858|NCT02671903|158025978|FG001|Period 0 (Run-In)|Implantation Failure|0|||
49052859|NCT02671903|158025979|FG002|Period 0 (Run-In)|Implantation Failure|2|||
49052860|NCT02671903|158025977|FG000|Period 0 (Run-In)|Lost to Follow-up|0|||
49052861|NCT02671903|158025978|FG001|Period 0 (Run-In)|Lost to Follow-up|0|||
49052862|NCT02671903|158025979|FG002|Period 0 (Run-In)|Lost to Follow-up|1|||
49052863|NCT03376321|158025980|FG000|Overall Study|Other|5|||
49052864|NCT03376321|158025981|FG001|Overall Study|Other|1|||
49052865|NCT03376321|158025980|FG000|Overall Study|Withdrawal by Subject|8|||
49052866|NCT03376321|158025981|FG001|Overall Study|Withdrawal by Subject|14|||
49052867|NCT03376321|158025980|FG000|Overall Study|Lost to Follow-up|1|||
49052868|NCT03376321|158025981|FG001|Overall Study|Lost to Follow-up|7|||
49052869|NCT03376321|158025980|FG000|Overall Study|Death|4|||
49052870|NCT03376321|158025981|FG001|Overall Study|Death|0|||
49052871|NCT03376321|158025980|FG000|Overall Study|Randomized, not treated|5|||
49052872|NCT03376321|158025981|FG001|Overall Study|Randomized, not treated|3|||
49052873|NCT00114231|158025984|FG000|Overall Study|No consent|2|||
49052874|NCT00114231|158025985|FG001|Overall Study|No consent|0|||
49052875|NCT00114231|158025984|FG000|Overall Study|QARC requirement not met|1|||
49052876|NCT00114231|158025985|FG001|Overall Study|QARC requirement not met|0|||
49052877|NCT00114231|158025984|FG000|Overall Study|Suspected metastatic disease|1|||
49052878|NCT00114231|158025985|FG001|Overall Study|Suspected metastatic disease|0|||
49052879|NCT00114231|158025984|FG000|Overall Study|No adenocarcinoma|1|||
49052880|NCT00114231|158025985|FG001|Overall Study|No adenocarcinoma|0|||
49052881|NCT00114231|158025984|FG000|Overall Study|Low creatinine clearance|0|||
49052882|NCT00114231|158025985|FG001|Overall Study|Low creatinine clearance|1|||
49052883|NCT00114231|158025984|FG000|Overall Study|Tumor size > 4cm|1|||
49052884|NCT00114231|158025985|FG001|Overall Study|Tumor size > 4cm|0|||
49052885|NCT00114231|158025984|FG000|Overall Study|Tumor fixed on digital exam|0|||
49052886|NCT00114231|158025985|FG001|Overall Study|Tumor fixed on digital exam|1|||
49052887|NCT00114231|158025984|FG000|Overall Study|No Absolute Neutrophil Count|2|||
49052888|NCT00114231|158025985|FG001|Overall Study|No Absolute Neutrophil Count|0|||
49052889|NCT00114231|158025984|FG000|Overall Study|Biopsy done after registration|1|||
49052890|NCT00114231|158025985|FG001|Overall Study|Biopsy done after registration|0|||
49052891|NCT02566889|158025988|FG000|Overall Study|Withdrawal by Subject|3|||
49052892|NCT02566889|158025989|FG001|Overall Study|Withdrawal by Subject|1|||
49052893|NCT02566889|158025988|FG000|Overall Study|Adverse Event|4|||
49052894|NCT02566889|158025989|FG001|Overall Study|Adverse Event|2|||
49052895|NCT02566889|158025988|FG000|Overall Study|Other|6|||
49052896|NCT02566889|158025989|FG001|Overall Study|Other|2|||
49052897|NCT02510261|158025992|FG000|Overall Study|Adverse Event|5|||
49052898|NCT02510261|158025993|FG001|Overall Study|Adverse Event|8|||
49052899|NCT02510261|158025994|FG002|Overall Study|Adverse Event|0|||
49052900|NCT02510261|158025992|FG000|Overall Study|Physician Decision|1|||
49052901|NCT02510261|158025993|FG001|Overall Study|Physician Decision|5|||
49052902|NCT02510261|158025994|FG002|Overall Study|Physician Decision|0|||
49052903|NCT02510261|158025992|FG000|Overall Study|Death|19|||
49052904|NCT02510261|158025993|FG001|Overall Study|Death|19|||
49052905|NCT02510261|158025994|FG002|Overall Study|Death|0|||
49052906|NCT02510261|158025992|FG000|Overall Study|Withdrawal by Subject|3|||
49052907|NCT02510261|158025993|FG001|Overall Study|Withdrawal by Subject|10|||
49052908|NCT02510261|158025994|FG002|Overall Study|Withdrawal by Subject|3|||
49052909|NCT04767373|158025996|FG000|Overall Study|Death|6|||
49052910|NCT04767373|158025997|FG001|Overall Study|Death|3|||
49052911|NCT04767373|158025996|FG000|Overall Study|Lost to Follow-up|67|||
49052912|NCT04767373|158025997|FG001|Overall Study|Lost to Follow-up|35|||
49052913|NCT04767373|158025996|FG000|Overall Study|Physician Decision|15|||
49052914|NCT04767373|158025997|FG001|Overall Study|Physician Decision|4|||
49052915|NCT04767373|158025996|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
49052916|NCT04767373|158025997|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
49052917|NCT04767373|158025996|FG000|Overall Study|Withdrawal By Parent/Guardian|75|||
49052918|NCT04767373|158025997|FG001|Overall Study|Withdrawal By Parent/Guardian|40|||
49052919|NCT04767373|158025996|FG000|Overall Study|Other|1|||
49052920|NCT04767373|158025997|FG001|Overall Study|Other|2|||
49052921|NCT01915940|158025999|FG000|Pre-randomization Washout Period|Not Qualified for Randomization|39|||
49052922|NCT01915940|158026000|FG001|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
49052923|NCT01915940|158026001|FG002|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
49052924|NCT01915940|158025999|FG000|Treatment Period|Decision of Participant|0|||
49052925|NCT01915940|158026000|FG001|Treatment Period|Decision of Participant|1|||
49052926|NCT01915940|158026001|FG002|Treatment Period|Decision of Participant|3|||
49052927|NCT01915940|158025999|FG000|Treatment Period|Adverse Event|0|||
49052928|NCT01915940|158026000|FG001|Treatment Period|Adverse Event|9|||
49052929|NCT01915940|158026001|FG002|Treatment Period|Adverse Event|1|||
49052930|NCT01915940|158025999|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
49052931|NCT01915940|158026000|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
49052932|NCT01915940|158026001|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
49052933|NCT00097786|158026004|FG000|Overall Study|lost to follow-up for all-cause death|296|||
49052934|NCT00097786|158026005|FG001|Overall Study|lost to follow-up for all-cause death|292|||
49052935|NCT00097786|158026006|FG002|Overall Study|lost to follow-up for all-cause death|313|||
49052936|NCT00097786|158026007|FG003|Overall Study|lost to follow-up for all-cause death|310|||
49052937|NCT01987895|158026008|FG000|Overall Study|Withdrawal by Subject|12|||
49052938|NCT01987895|158026009|FG001|Overall Study|Withdrawal by Subject|7|||
49052939|NCT01987895|158026008|FG000|Overall Study|Physician Decision|8|||
49052940|NCT01987895|158026009|FG001|Overall Study|Physician Decision|10|||
49052941|NCT01987895|158026008|FG000|Overall Study|Death|7|||
49052942|NCT01987895|158026009|FG001|Overall Study|Death|7|||
49052943|NCT01987895|158026008|FG000|Overall Study|Lost to Follow-up|3|||
49052944|NCT01987895|158026009|FG001|Overall Study|Lost to Follow-up|5|||
49052945|NCT01987895|158026008|FG000|Overall Study|randomized before giving IC|0|||
49052946|NCT01987895|158026009|FG001|Overall Study|randomized before giving IC|1|||
49052947|NCT01106014|158026010|FG000|Overall Study|Morbidity or Mortality primary endpoint|155|||
49052948|NCT01106014|158026011|FG001|Overall Study|Morbidity or Mortality primary endpoint|242|||
49052949|NCT01106014|158026010|FG000|Overall Study|Adverse Event|78|||
49052950|NCT01106014|158026011|FG001|Overall Study|Adverse Event|42|||
49052951|NCT01106014|158026010|FG000|Overall Study|Withdrawal by Subject|43|||
49052952|NCT01106014|158026011|FG001|Overall Study|Withdrawal by Subject|37|||
49052953|NCT01106014|158026010|FG000|Overall Study|Administrative reason|7|||
49052954|NCT01106014|158026011|FG001|Overall Study|Administrative reason|6|||
49052955|NCT01106014|158026010|FG000|Overall Study|Lost to Follow-up|2|||
49052956|NCT01106014|158026011|FG001|Overall Study|Lost to Follow-up|3|||
49052957|NCT03371381|158026012|FG000|Overall Study|Death|5|||
49052958|NCT03371381|158026012|FG000|Overall Study|Study terminated by sponsor|3|||
49052959|NCT03371381|158026012|FG000|Overall Study|Other|4|||
49052960|NCT02598388|158026013|FG000|Overall Study|Lost to Follow-up|1|||
49052961|NCT02598388|158026014|FG001|Overall Study|Lost to Follow-up|0|||
49052962|NCT02598388|158026015|FG002|Overall Study|Lost to Follow-up|1|||
49052963|NCT02598388|158026016|FG003|Overall Study|Lost to Follow-up|0|||
49052964|NCT02598388|158026017|FG004|Overall Study|Lost to Follow-up|5|||
49052965|NCT02598388|158026018|FG005|Overall Study|Lost to Follow-up|1|||
49052966|NCT02598388|158026019|FG006|Overall Study|Lost to Follow-up|2|||
49052967|NCT02598388|158026020|FG007|Overall Study|Lost to Follow-up|1|||
49052968|NCT02598388|158026021|FG008|Overall Study|Lost to Follow-up|0|||
49052969|NCT02598388|158026022|FG009|Overall Study|Lost to Follow-up|0|||
49052970|NCT02598388|158026023|FG010|Overall Study|Lost to Follow-up|1|||
49052971|NCT02598388|158026024|FG011|Overall Study|Lost to Follow-up|0|||
49052972|NCT02598388|158026013|FG000|Overall Study|Withdrawal by Subject|0|||
49052973|NCT02598388|158026014|FG001|Overall Study|Withdrawal by Subject|0|||
49052974|NCT02598388|158026015|FG002|Overall Study|Withdrawal by Subject|0|||
49052975|NCT02598388|158026016|FG003|Overall Study|Withdrawal by Subject|0|||
49052976|NCT02598388|158026017|FG004|Overall Study|Withdrawal by Subject|2|||
49052977|NCT02598388|158026018|FG005|Overall Study|Withdrawal by Subject|0|||
49052978|NCT02598388|158026019|FG006|Overall Study|Withdrawal by Subject|2|||
49052979|NCT02598388|158026020|FG007|Overall Study|Withdrawal by Subject|0|||
49052980|NCT02598388|158026021|FG008|Overall Study|Withdrawal by Subject|0|||
49052981|NCT02598388|158026022|FG009|Overall Study|Withdrawal by Subject|1|||
49052982|NCT02598388|158026023|FG010|Overall Study|Withdrawal by Subject|0|||
49052983|NCT02598388|158026024|FG011|Overall Study|Withdrawal by Subject|0|||
49052984|NCT02598388|158026013|FG000|Overall Study|Other|0|||
49052985|NCT02598388|158026014|FG001|Overall Study|Other|0|||
49052986|NCT02598388|158026015|FG002|Overall Study|Other|1|||
49052987|NCT02598388|158026016|FG003|Overall Study|Other|0|||
49052988|NCT02598388|158026017|FG004|Overall Study|Other|3|||
49052989|NCT02598388|158026018|FG005|Overall Study|Other|0|||
49052990|NCT02598388|158026019|FG006|Overall Study|Other|1|||
49052991|NCT02598388|158026020|FG007|Overall Study|Other|0|||
49052992|NCT02598388|158026021|FG008|Overall Study|Other|0|||
49052993|NCT02598388|158026022|FG009|Overall Study|Other|0|||
49052994|NCT02598388|158026023|FG010|Overall Study|Other|0|||
49052995|NCT02598388|158026024|FG011|Overall Study|Other|0|||
49052996|NCT02443324|158026028|FG000|Overall Study|Death|4|||
49052997|NCT02443324|158026029|FG001|Overall Study|Death|1|||
49052998|NCT02443324|158026030|FG002|Overall Study|Death|0|||
49052999|NCT02443324|158026031|FG003|Overall Study|Death|3|||
49053000|NCT02443324|158026032|FG004|Overall Study|Death|1|||
49053001|NCT02443324|158026033|FG005|Overall Study|Death|3|||
49053002|NCT02443324|158026034|FG006|Overall Study|Death|2|||
49053003|NCT02443324|158026028|FG000|Overall Study|Lost to Follow-up|0|||
49053004|NCT02443324|158026029|FG001|Overall Study|Lost to Follow-up|0|||
49053005|NCT02443324|158026030|FG002|Overall Study|Lost to Follow-up|0|||
49053006|NCT02443324|158026031|FG003|Overall Study|Lost to Follow-up|1|||
49053007|NCT02443324|158026032|FG004|Overall Study|Lost to Follow-up|0|||
49053008|NCT02443324|158026033|FG005|Overall Study|Lost to Follow-up|1|||
49053009|NCT02443324|158026034|FG006|Overall Study|Lost to Follow-up|0|||
49053010|NCT02443324|158026028|FG000|Overall Study|Physician Decision|0|||
49053011|NCT02443324|158026029|FG001|Overall Study|Physician Decision|3|||
49053012|NCT02443324|158026030|FG002|Overall Study|Physician Decision|5|||
49053013|NCT02443324|158026031|FG003|Overall Study|Physician Decision|1|||
49053014|NCT02443324|158026032|FG004|Overall Study|Physician Decision|1|||
49053015|NCT02443324|158026033|FG005|Overall Study|Physician Decision|0|||
49053016|NCT02443324|158026034|FG006|Overall Study|Physician Decision|2|||
49053017|NCT02443324|158026028|FG000|Overall Study|Progressive Disease|20|||
49053018|NCT02443324|158026029|FG001|Overall Study|Progressive Disease|20|||
49053019|NCT02443324|158026030|FG002|Overall Study|Progressive Disease|13|||
49053020|NCT02443324|158026031|FG003|Overall Study|Progressive Disease|10|||
49053021|NCT02443324|158026032|FG004|Overall Study|Progressive Disease|13|||
49053022|NCT02443324|158026033|FG005|Overall Study|Progressive Disease|17|||
49053023|NCT02443324|158026034|FG006|Overall Study|Progressive Disease|10|||
49053024|NCT02443324|158026028|FG000|Overall Study|Withdrawal by Subject|0|||
49053025|NCT02443324|158026029|FG001|Overall Study|Withdrawal by Subject|0|||
49053026|NCT02443324|158026030|FG002|Overall Study|Withdrawal by Subject|3|||
49053027|NCT02443324|158026031|FG003|Overall Study|Withdrawal by Subject|1|||
49053028|NCT02443324|158026032|FG004|Overall Study|Withdrawal by Subject|1|||
49053029|NCT02443324|158026033|FG005|Overall Study|Withdrawal by Subject|0|||
49053030|NCT02443324|158026034|FG006|Overall Study|Withdrawal by Subject|1|||
49053031|NCT02443324|158026028|FG000|Overall Study|Adverse Event|0|||
49053032|NCT02443324|158026029|FG001|Overall Study|Adverse Event|1|||
49053033|NCT02443324|158026030|FG002|Overall Study|Adverse Event|3|||
49053034|NCT02443324|158026031|FG003|Overall Study|Adverse Event|0|||
49053035|NCT02443324|158026032|FG004|Overall Study|Adverse Event|4|||
49053036|NCT02443324|158026033|FG005|Overall Study|Adverse Event|3|||
49053037|NCT02443324|158026034|FG006|Overall Study|Adverse Event|3|||
49053038|NCT02443324|158026028|FG000|Overall Study|Enrolled but Never Treated|0|||
49053039|NCT02443324|158026029|FG001|Overall Study|Enrolled but Never Treated|0|||
49053040|NCT02443324|158026030|FG002|Overall Study|Enrolled but Never Treated|1|||
49053041|NCT02443324|158026031|FG003|Overall Study|Enrolled but Never Treated|0|||
49053042|NCT02443324|158026032|FG004|Overall Study|Enrolled but Never Treated|1|||
49053043|NCT02443324|158026033|FG005|Overall Study|Enrolled but Never Treated|0|||
49053044|NCT02443324|158026034|FG006|Overall Study|Enrolled but Never Treated|1|||
49053045|NCT03150862|158026037|FG000|Overall Study|Death|2|||
49053046|NCT03150862|158026038|FG001|Overall Study|Death|7|||
49053047|NCT03150862|158026039|FG002|Overall Study|Death|8|||
49053048|NCT03150862|158026040|FG003|Overall Study|Death|27|||
49053049|NCT03150862|158026041|FG004|Overall Study|Death|4|||
49053050|NCT03150862|158026042|FG005|Overall Study|Death|8|||
49053051|NCT03150862|158026043|FG006|Overall Study|Death|6|||
49053052|NCT03150862|158026044|FG007|Overall Study|Death|21|||
49053053|NCT03150862|158026037|FG000|Overall Study|Withdrawal by Subject|1|||
49053054|NCT03150862|158026038|FG001|Overall Study|Withdrawal by Subject|1|||
49053055|NCT03150862|158026039|FG002|Overall Study|Withdrawal by Subject|0|||
49053056|NCT03150862|158026040|FG003|Overall Study|Withdrawal by Subject|3|||
49053057|NCT03150862|158026041|FG004|Overall Study|Withdrawal by Subject|1|||
49053058|NCT03150862|158026042|FG005|Overall Study|Withdrawal by Subject|1|||
49053059|NCT03150862|158026043|FG006|Overall Study|Withdrawal by Subject|1|||
49053060|NCT03150862|158026044|FG007|Overall Study|Withdrawal by Subject|3|||
49053061|NCT03150862|158026037|FG000|Overall Study|Lost to Follow-up|0|||
49053062|NCT03150862|158026038|FG001|Overall Study|Lost to Follow-up|0|||
49053063|NCT03150862|158026039|FG002|Overall Study|Lost to Follow-up|1|||
49053064|NCT03150862|158026040|FG003|Overall Study|Lost to Follow-up|0|||
49053065|NCT03150862|158026041|FG004|Overall Study|Lost to Follow-up|0|||
49053066|NCT03150862|158026042|FG005|Overall Study|Lost to Follow-up|0|||
49053067|NCT03150862|158026043|FG006|Overall Study|Lost to Follow-up|0|||
49053068|NCT03150862|158026044|FG007|Overall Study|Lost to Follow-up|2|||
49053069|NCT03150862|158026037|FG000|Overall Study|Sponsor's decision|0|||
49053070|NCT03150862|158026038|FG001|Overall Study|Sponsor's decision|0|||
49053071|NCT03150862|158026039|FG002|Overall Study|Sponsor's decision|0|||
49053072|NCT03150862|158026040|FG003|Overall Study|Sponsor's decision|10|||
49053073|NCT03150862|158026041|FG004|Overall Study|Sponsor's decision|3|||
49053074|NCT03150862|158026042|FG005|Overall Study|Sponsor's decision|0|||
49053075|NCT03150862|158026043|FG006|Overall Study|Sponsor's decision|1|||
49053076|NCT03150862|158026044|FG007|Overall Study|Sponsor's decision|1|||
49053077|NCT03150862|158026037|FG000|Overall Study|Change in Methylation status|0|||
49053078|NCT03150862|158026038|FG001|Overall Study|Change in Methylation status|0|||
49053079|NCT03150862|158026039|FG002|Overall Study|Change in Methylation status|0|||
49053080|NCT03150862|158026040|FG003|Overall Study|Change in Methylation status|0|||
49053081|NCT03150862|158026041|FG004|Overall Study|Change in Methylation status|1|||
49053082|NCT03150862|158026042|FG005|Overall Study|Change in Methylation status|0|||
49053083|NCT03150862|158026043|FG006|Overall Study|Change in Methylation status|0|||
49053084|NCT03150862|158026044|FG007|Overall Study|Change in Methylation status|0|||
49053085|NCT03150862|158026037|FG000|Overall Study|Roll over in to Long Term Extension|0|||
49053086|NCT03150862|158026038|FG001|Overall Study|Roll over in to Long Term Extension|0|||
49053087|NCT03150862|158026039|FG002|Overall Study|Roll over in to Long Term Extension|0|||
49053088|NCT03150862|158026040|FG003|Overall Study|Roll over in to Long Term Extension|0|||
49053089|NCT03150862|158026041|FG004|Overall Study|Roll over in to Long Term Extension|0|||
49053090|NCT03150862|158026042|FG005|Overall Study|Roll over in to Long Term Extension|0|||
49053091|NCT03150862|158026043|FG006|Overall Study|Roll over in to Long Term Extension|0|||
49053092|NCT03150862|158026044|FG007|Overall Study|Roll over in to Long Term Extension|1|||
49053093|NCT03150862|158026037|FG000|Overall Study|Progressive Disease|0|||
49053094|NCT03150862|158026038|FG001|Overall Study|Progressive Disease|0|||
49053095|NCT03150862|158026039|FG002|Overall Study|Progressive Disease|0|||
49053096|NCT03150862|158026040|FG003|Overall Study|Progressive Disease|0|||
49053097|NCT03150862|158026041|FG004|Overall Study|Progressive Disease|0|||
49053098|NCT03150862|158026042|FG005|Overall Study|Progressive Disease|0|||
49053099|NCT03150862|158026043|FG006|Overall Study|Progressive Disease|0|||
49053100|NCT03150862|158026044|FG007|Overall Study|Progressive Disease|2|||
49053101|NCT02315703|158026045|FG000|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
49053102|NCT02315703|158026046|FG001|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
49053103|NCT02315703|158026047|FG002|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
49053104|NCT02315703|158026048|FG003|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
49053105|NCT02315703|158026049|FG004|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
49053106|NCT02315703|158026050|FG005|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
49053107|NCT02315703|158026051|FG006|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
49053108|NCT02315703|158026052|FG007|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
49053109|NCT02315703|158026045|FG000|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
49053110|NCT02315703|158026046|FG001|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|5|||
49053111|NCT02315703|158026047|FG002|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
49053112|NCT02315703|158026048|FG003|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
49053113|NCT02315703|158026049|FG004|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
49053114|NCT02315703|158026050|FG005|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
49053115|NCT02315703|158026051|FG006|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
49053116|NCT02315703|158026052|FG007|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
49053117|NCT02315703|158026045|FG000|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
49053118|NCT02315703|158026046|FG001|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
49053119|NCT02315703|158026047|FG002|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
49053120|NCT02315703|158026048|FG003|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
49053121|NCT02315703|158026049|FG004|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
49053122|NCT02315703|158026050|FG005|Main Study (From Week 0 up to Week 96)|Physician Decision|2|||
49053123|NCT02315703|158026051|FG006|Main Study (From Week 0 up to Week 96)|Physician Decision|1|||
49053124|NCT02315703|158026052|FG007|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
49053125|NCT02315703|158026045|FG000|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
49053126|NCT02315703|158026046|FG001|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
49053127|NCT02315703|158026047|FG002|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
49053128|NCT02315703|158026048|FG003|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
49053129|NCT02315703|158026049|FG004|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
49053130|NCT02315703|158026050|FG005|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
49053131|NCT02315703|158026051|FG006|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
49053132|NCT02315703|158026052|FG007|Main Study (From Week 0 up to Week 96)|Pregnancy|1|||
49053133|NCT02315703|158026045|FG000|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
49053134|NCT02315703|158026046|FG001|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
49053135|NCT02315703|158026047|FG002|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|0|||
49053136|NCT02315703|158026048|FG003|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
49053137|NCT02315703|158026049|FG004|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|4|||
49053138|NCT02315703|158026050|FG005|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
49053139|NCT02315703|158026051|FG006|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
49053140|NCT02315703|158026052|FG007|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|2|||
49053141|NCT02315703|158026045|FG000|Main Study (From Week 0 up to Week 96)|Other|4|||
49053142|NCT02315703|158026046|FG001|Main Study (From Week 0 up to Week 96)|Other|2|||
49053143|NCT02315703|158026047|FG002|Main Study (From Week 0 up to Week 96)|Other|2|||
49053144|NCT02315703|158026048|FG003|Main Study (From Week 0 up to Week 96)|Other|2|||
49053145|NCT02315703|158026049|FG004|Main Study (From Week 0 up to Week 96)|Other|1|||
49053146|NCT02315703|158026050|FG005|Main Study (From Week 0 up to Week 96)|Other|2|||
49053147|NCT02315703|158026051|FG006|Main Study (From Week 0 up to Week 96)|Other|8|||
49053148|NCT02315703|158026052|FG007|Main Study (From Week 0 up to Week 96)|Other|2|||
49053149|NCT02315703|158026045|FG000|LTE (After Week 96 up to Week 336)|Lost to Follow-up|1|||
49053150|NCT02315703|158026046|FG001|LTE (After Week 96 up to Week 336)|Lost to Follow-up|2|||
49053151|NCT02315703|158026047|FG002|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
49053152|NCT02315703|158026048|FG003|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
49053153|NCT02315703|158026049|FG004|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
49053154|NCT02315703|158026050|FG005|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
49053155|NCT02315703|158026051|FG006|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
49053156|NCT02315703|158026052|FG007|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
49053157|NCT02315703|158026045|FG000|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
49053158|NCT02315703|158026046|FG001|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|3|||
49053159|NCT02315703|158026047|FG002|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
49053160|NCT02315703|158026048|FG003|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
49053161|NCT02315703|158026049|FG004|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
49053162|NCT02315703|158026050|FG005|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
49053163|NCT02315703|158026051|FG006|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
49053164|NCT02315703|158026052|FG007|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
49053165|NCT02315703|158026045|FG000|LTE (After Week 96 up to Week 336)|Other|1|||
49053166|NCT02315703|158026046|FG001|LTE (After Week 96 up to Week 336)|Other|0|||
49053167|NCT02315703|158026047|FG002|LTE (After Week 96 up to Week 336)|Other|0|||
49053168|NCT02315703|158026048|FG003|LTE (After Week 96 up to Week 336)|Other|0|||
49053169|NCT02315703|158026049|FG004|LTE (After Week 96 up to Week 336)|Other|0|||
49053170|NCT02315703|158026050|FG005|LTE (After Week 96 up to Week 336)|Other|0|||
49053171|NCT02315703|158026051|FG006|LTE (After Week 96 up to Week 336)|Other|0|||
49053172|NCT02315703|158026052|FG007|LTE (After Week 96 up to Week 336)|Other|0|||
49053173|NCT00949988|158026053|FG000|Overall Study|Withdrawal by Subject|3|||
49053174|NCT03714815|158026054|FG000|Overall Study|Physician Decision|2|||
49053175|NCT03714815|158026054|FG000|Overall Study|Withdrawal by Subject|2|||
49053176|NCT03714815|158026054|FG000|Overall Study|Death|11|||
49053177|NCT04999111|158026055|FG000|Overall Study|Lost to Follow-up|21|||
49053178|NCT04999111|158026056|FG001|Overall Study|Lost to Follow-up|16|||
49053179|NCT04999111|158026057|FG002|Overall Study|Lost to Follow-up|2|||
49053180|NCT04999111|158026058|FG003|Overall Study|Lost to Follow-up|26|||
49053181|NCT04999111|158026059|FG004|Overall Study|Lost to Follow-up|30|||
49053182|NCT04999111|158026060|FG005|Overall Study|Lost to Follow-up|6|||
49053183|NCT04999111|158026055|FG000|Overall Study|Physician Decision|1|||
49053184|NCT04999111|158026056|FG001|Overall Study|Physician Decision|3|||
49053185|NCT04999111|158026057|FG002|Overall Study|Physician Decision|0|||
49053186|NCT04999111|158026058|FG003|Overall Study|Physician Decision|1|||
49053187|NCT04999111|158026059|FG004|Overall Study|Physician Decision|2|||
49053188|NCT04999111|158026060|FG005|Overall Study|Physician Decision|0|||
49053189|NCT04999111|158026055|FG000|Overall Study|Withdrawal by Subject|23|||
49053190|NCT04999111|158026056|FG001|Overall Study|Withdrawal by Subject|29|||
49053191|NCT04999111|158026057|FG002|Overall Study|Withdrawal by Subject|15|||
49053192|NCT04999111|158026058|FG003|Overall Study|Withdrawal by Subject|30|||
49053193|NCT04999111|158026059|FG004|Overall Study|Withdrawal by Subject|35|||
49053194|NCT04999111|158026060|FG005|Overall Study|Withdrawal by Subject|10|||
49053195|NCT04999111|158026055|FG000|Overall Study|Other|6|||
49053196|NCT04999111|158026056|FG001|Overall Study|Other|6|||
49053197|NCT04999111|158026057|FG002|Overall Study|Other|3|||
49053198|NCT04999111|158026058|FG003|Overall Study|Other|8|||
49053199|NCT04999111|158026059|FG004|Overall Study|Other|8|||
49053200|NCT04999111|158026060|FG005|Overall Study|Other|5|||
49053201|NCT04999111|158026055|FG000|Overall Study|Non-compliance with study schedule|1|||
49053202|NCT04999111|158026056|FG001|Overall Study|Non-compliance with study schedule|0|||
49053203|NCT04999111|158026057|FG002|Overall Study|Non-compliance with study schedule|0|||
49053204|NCT04999111|158026058|FG003|Overall Study|Non-compliance with study schedule|1|||
49053205|NCT04999111|158026059|FG004|Overall Study|Non-compliance with study schedule|1|||
49053206|NCT04999111|158026060|FG005|Overall Study|Non-compliance with study schedule|1|||
49053207|NCT04999111|158026055|FG000|Overall Study|Randomized but not vaccinated|1|||
49053208|NCT04999111|158026056|FG001|Overall Study|Randomized but not vaccinated|2|||
49053209|NCT04999111|158026057|FG002|Overall Study|Randomized but not vaccinated|0|||
49053210|NCT04999111|158026058|FG003|Overall Study|Randomized but not vaccinated|3|||
49053211|NCT04999111|158026059|FG004|Overall Study|Randomized but not vaccinated|3|||
49053212|NCT04999111|158026060|FG005|Overall Study|Randomized but not vaccinated|0|||
49053213|NCT04999111|158026055|FG000|Overall Study|Adverse Event|1|||
49053214|NCT04999111|158026056|FG001|Overall Study|Adverse Event|1|||
49053215|NCT04999111|158026057|FG002|Overall Study|Adverse Event|0|||
49053216|NCT04999111|158026058|FG003|Overall Study|Adverse Event|0|||
49053217|NCT04999111|158026059|FG004|Overall Study|Adverse Event|0|||
49053218|NCT04999111|158026060|FG005|Overall Study|Adverse Event|0|||
49053219|NCT04999111|158026055|FG000|Overall Study|Initiated prohibited medication|0|||
49053220|NCT04999111|158026056|FG001|Overall Study|Initiated prohibited medication|0|||
49053221|NCT04999111|158026057|FG002|Overall Study|Initiated prohibited medication|0|||
49053222|NCT04999111|158026058|FG003|Overall Study|Initiated prohibited medication|0|||
49053223|NCT04999111|158026059|FG004|Overall Study|Initiated prohibited medication|1|||
49053224|NCT04999111|158026060|FG005|Overall Study|Initiated prohibited medication|0|||
49053225|NCT01714739|158026066|FG000|Overall Study|Disease progression|3|||
49053226|NCT01714739|158026067|FG001|Overall Study|Disease progression|5|||
49053227|NCT01714739|158026068|FG002|Overall Study|Disease progression|5|||
49053228|NCT01714739|158026069|FG003|Overall Study|Disease progression|204|||
49053229|NCT01714739|158026070|FG004|Overall Study|Disease progression|1|||
49053230|NCT01714739|158026071|FG005|Overall Study|Disease progression|3|||
49053231|NCT01714739|158026072|FG006|Overall Study|Disease progression|5|||
49053232|NCT01714739|158026066|FG000|Overall Study|Study drug toxicity|1|||
49053233|NCT01714739|158026067|FG001|Overall Study|Study drug toxicity|1|||
49053234|NCT01714739|158026068|FG002|Overall Study|Study drug toxicity|1|||
49053235|NCT01714739|158026069|FG003|Overall Study|Study drug toxicity|15|||
49053236|NCT01714739|158026070|FG004|Overall Study|Study drug toxicity|0|||
49053237|NCT01714739|158026071|FG005|Overall Study|Study drug toxicity|0|||
49053238|NCT01714739|158026072|FG006|Overall Study|Study drug toxicity|5|||
49053239|NCT01714739|158026066|FG000|Overall Study|Death|0|||
49053240|NCT01714739|158026067|FG001|Overall Study|Death|0|||
49053241|NCT01714739|158026068|FG002|Overall Study|Death|0|||
49053242|NCT01714739|158026069|FG003|Overall Study|Death|1|||
49053243|NCT01714739|158026070|FG004|Overall Study|Death|0|||
49053244|NCT01714739|158026071|FG005|Overall Study|Death|0|||
49053245|NCT01714739|158026072|FG006|Overall Study|Death|0|||
49053246|NCT01714739|158026066|FG000|Overall Study|Adverse Event unrelated to drug|0|||
49053247|NCT01714739|158026067|FG001|Overall Study|Adverse Event unrelated to drug|0|||
49053248|NCT01714739|158026068|FG002|Overall Study|Adverse Event unrelated to drug|3|||
49053249|NCT01714739|158026069|FG003|Overall Study|Adverse Event unrelated to drug|21|||
49053250|NCT01714739|158026070|FG004|Overall Study|Adverse Event unrelated to drug|0|||
49053251|NCT01714739|158026071|FG005|Overall Study|Adverse Event unrelated to drug|0|||
49053252|NCT01714739|158026072|FG006|Overall Study|Adverse Event unrelated to drug|0|||
49053253|NCT01714739|158026066|FG000|Overall Study|Participant request to stop therapy|0|||
49053254|NCT01714739|158026067|FG001|Overall Study|Participant request to stop therapy|1|||
49053255|NCT01714739|158026068|FG002|Overall Study|Participant request to stop therapy|0|||
49053256|NCT01714739|158026069|FG003|Overall Study|Participant request to stop therapy|6|||
49053257|NCT01714739|158026070|FG004|Overall Study|Participant request to stop therapy|0|||
49053258|NCT01714739|158026071|FG005|Overall Study|Participant request to stop therapy|0|||
49053259|NCT01714739|158026072|FG006|Overall Study|Participant request to stop therapy|0|||
49053260|NCT01714739|158026066|FG000|Overall Study|Participant withdrew consent|0|||
49053261|NCT01714739|158026067|FG001|Overall Study|Participant withdrew consent|1|||
49053262|NCT01714739|158026068|FG002|Overall Study|Participant withdrew consent|0|||
49053263|NCT01714739|158026069|FG003|Overall Study|Participant withdrew consent|8|||
49053264|NCT01714739|158026070|FG004|Overall Study|Participant withdrew consent|0|||
49053265|NCT01714739|158026071|FG005|Overall Study|Participant withdrew consent|0|||
49053266|NCT01714739|158026072|FG006|Overall Study|Participant withdrew consent|0|||
49053267|NCT01714739|158026066|FG000|Overall Study|Lost to Follow-up|0|||
49053268|NCT01714739|158026067|FG001|Overall Study|Lost to Follow-up|0|||
49053269|NCT01714739|158026068|FG002|Overall Study|Lost to Follow-up|0|||
49053270|NCT01714739|158026069|FG003|Overall Study|Lost to Follow-up|1|||
49053271|NCT01714739|158026070|FG004|Overall Study|Lost to Follow-up|0|||
49053272|NCT01714739|158026071|FG005|Overall Study|Lost to Follow-up|0|||
49053273|NCT01714739|158026072|FG006|Overall Study|Lost to Follow-up|0|||
49053274|NCT01714739|158026066|FG000|Overall Study|Maximum clinical benefit|0|||
49053275|NCT01714739|158026067|FG001|Overall Study|Maximum clinical benefit|1|||
49053276|NCT01714739|158026068|FG002|Overall Study|Maximum clinical benefit|1|||
49053277|NCT01714739|158026069|FG003|Overall Study|Maximum clinical benefit|3|||
49053278|NCT01714739|158026070|FG004|Overall Study|Maximum clinical benefit|0|||
49053279|NCT01714739|158026071|FG005|Overall Study|Maximum clinical benefit|0|||
49053280|NCT01714739|158026072|FG006|Overall Study|Maximum clinical benefit|0|||
49053281|NCT01714739|158026066|FG000|Overall Study|Poor/non-comliance|0|||
49053282|NCT01714739|158026067|FG001|Overall Study|Poor/non-comliance|1|||
49053283|NCT01714739|158026068|FG002|Overall Study|Poor/non-comliance|0|||
49053284|NCT01714739|158026069|FG003|Overall Study|Poor/non-comliance|1|||
49053285|NCT01714739|158026070|FG004|Overall Study|Poor/non-comliance|0|||
49053286|NCT01714739|158026071|FG005|Overall Study|Poor/non-comliance|0|||
49053287|NCT01714739|158026072|FG006|Overall Study|Poor/non-comliance|0|||
49053288|NCT01714739|158026066|FG000|Overall Study|No longer meets study criteria|0|||
49053289|NCT01714739|158026067|FG001|Overall Study|No longer meets study criteria|0|||
49053290|NCT01714739|158026068|FG002|Overall Study|No longer meets study criteria|0|||
49053291|NCT01714739|158026069|FG003|Overall Study|No longer meets study criteria|1|||
49053292|NCT01714739|158026070|FG004|Overall Study|No longer meets study criteria|0|||
49053293|NCT01714739|158026071|FG005|Overall Study|No longer meets study criteria|0|||
49053294|NCT01714739|158026072|FG006|Overall Study|No longer meets study criteria|0|||
49053295|NCT01714739|158026066|FG000|Overall Study|Other reason|0|||
49053296|NCT01714739|158026067|FG001|Overall Study|Other reason|0|||
49053297|NCT01714739|158026068|FG002|Overall Study|Other reason|0|||
49053298|NCT01714739|158026069|FG003|Overall Study|Other reason|3|||
49053299|NCT01714739|158026070|FG004|Overall Study|Other reason|1|||
49053300|NCT01714739|158026071|FG005|Overall Study|Other reason|0|||
49053301|NCT01714739|158026072|FG006|Overall Study|Other reason|0|||
49053302|NCT03297294|158026080|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30|||
49053303|NCT03297294|158026081|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31|||
49053304|NCT03297294|158026082|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
49053305|NCT03297294|158026083|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
49053306|NCT03297294|158026084|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
49053307|NCT03297294|158026080|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
49053308|NCT03297294|158026081|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
49053309|NCT03297294|158026082|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
49053310|NCT03297294|158026083|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
49053311|NCT03297294|158026084|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
49053312|NCT03297294|158026080|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
49053313|NCT03297294|158026081|FG001|Double-Blind Treatment Period (DB)|Adverse Event|1|||
49053314|NCT03297294|158026082|FG002|Double-Blind Treatment Period (DB)|Adverse Event|0|||
49053315|NCT03297294|158026083|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
49053316|NCT03297294|158026084|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
49053317|NCT03297294|158026080|FG000|Double-Blind Treatment Period (DB)|Physician Decision|1|||
49053318|NCT03297294|158026081|FG001|Double-Blind Treatment Period (DB)|Physician Decision|1|||
49053319|NCT03297294|158026082|FG002|Double-Blind Treatment Period (DB)|Physician Decision|0|||
49053320|NCT03297294|158026083|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
49053321|NCT03297294|158026084|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
49053322|NCT03297294|158026080|FG000|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
49053323|NCT03297294|158026081|FG001|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
49053324|NCT03297294|158026082|FG002|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
49053325|NCT03297294|158026083|FG003|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1|||
49053326|NCT03297294|158026084|FG004|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
49053327|NCT05147584|158026088|FG000|Overall Study|Subjects consented but did not fully meet inclusion /exclusion criteria|8|||
49053328|NCT02938923|158026089|FG000|Overall Study|Death|1|||
49053329|NCT02938923|158026090|FG001|Overall Study|Death|0|||
49053330|NCT02938923|158026091|FG002|Overall Study|Death|0|||
49053331|NCT02938923|158026089|FG000|Overall Study|Physician Decision|0|||
49053332|NCT02938923|158026090|FG001|Overall Study|Physician Decision|2|||
49053333|NCT02938923|158026091|FG002|Overall Study|Physician Decision|0|||
49053334|NCT02938923|158026089|FG000|Overall Study|Withdrawal by Subject|0|||
49053335|NCT02938923|158026090|FG001|Overall Study|Withdrawal by Subject|1|||
49053336|NCT02938923|158026091|FG002|Overall Study|Withdrawal by Subject|1|||
49053337|NCT00721149|158026092|FG000|Overall Study|Physician Decision|1|||
49053338|NCT02874742|158026093|FG000|Overall Study|Death|0|||
49053339|NCT02874742|158026094|FG001|Overall Study|Death|1|||
49053340|NCT02874742|158026095|FG002|Overall Study|Death|0|||
49053341|NCT02874742|158026093|FG000|Overall Study|Lost to Follow-up|5|||
49053342|NCT02874742|158026094|FG001|Overall Study|Lost to Follow-up|4|||
49053343|NCT02874742|158026095|FG002|Overall Study|Lost to Follow-up|1|||
49053344|NCT02874742|158026093|FG000|Overall Study|Withdrawal by Subject|17|||
49053345|NCT02874742|158026094|FG001|Overall Study|Withdrawal by Subject|8|||
49053346|NCT02874742|158026095|FG002|Overall Study|Withdrawal by Subject|0|||
49053347|NCT02874742|158026093|FG000|Overall Study|Other|4|||
49053348|NCT02874742|158026094|FG001|Overall Study|Other|1|||
49053349|NCT02874742|158026095|FG002|Overall Study|Other|0|||
49053350|NCT02874742|158026093|FG000|Overall Study|Progressive Disease|1|||
49053351|NCT02874742|158026094|FG001|Overall Study|Progressive Disease|0|||
49053352|NCT02874742|158026095|FG002|Overall Study|Progressive Disease|0|||
49053353|NCT02874742|158026093|FG000|Overall Study|Screen Failure|0|||
49053354|NCT02874742|158026094|FG001|Overall Study|Screen Failure|2|||
49053355|NCT02874742|158026095|FG002|Overall Study|Screen Failure|0|||
49053356|NCT01527188|158026100|FG000|Overall Study|Adverse Event|5|||
49053357|NCT01527188|158026101|FG001|Overall Study|Adverse Event|5|||
49053358|NCT01527188|158026102|FG002|Overall Study|Adverse Event|11|||
49053359|NCT01527188|158026103|FG003|Overall Study|Adverse Event|0|||
49053360|NCT01527188|158026100|FG000|Overall Study|Withdrawal by Subject|3|||
49053361|NCT01527188|158026101|FG001|Overall Study|Withdrawal by Subject|6|||
49053362|NCT01527188|158026102|FG002|Overall Study|Withdrawal by Subject|4|||
49053363|NCT01527188|158026103|FG003|Overall Study|Withdrawal by Subject|4|||
49053364|NCT01527188|158026100|FG000|Overall Study|Any other reason not above-mentioned|6|||
49053365|NCT01527188|158026101|FG001|Overall Study|Any other reason not above-mentioned|7|||
49053366|NCT01527188|158026102|FG002|Overall Study|Any other reason not above-mentioned|8|||
49053367|NCT01527188|158026103|FG003|Overall Study|Any other reason not above-mentioned|8|||
49053368|NCT00612677|158026108|FG000|Overall Study|study closed before treatment started|1|||
49053369|NCT04583280|158026112|FG000|Overall Study|Consent withdrawn by parent/caregiver|0|||
49053370|NCT04583280|158026113|FG001|Overall Study|Consent withdrawn by parent/caregiver|1|||
49053371|NCT00964392|158026114|FG000|Overall Study|Withdrawal by Subject|4|||
49053372|NCT00964392|158026115|FG001|Overall Study|Withdrawal by Subject|6|||
49053373|NCT00964392|158026114|FG000|Overall Study|Lost to Follow-up|4|||
49053374|NCT00964392|158026115|FG001|Overall Study|Lost to Follow-up|10|||
49053375|NCT00964392|158026114|FG000|Overall Study|Early Termination, non-study arrhythmia|1|||
49053376|NCT00964392|158026115|FG001|Overall Study|Early Termination, non-study arrhythmia|6|||
49053377|NCT00964392|158026114|FG000|Overall Study|Not completed|44|||
49053378|NCT00964392|158026115|FG001|Overall Study|Not completed|168|||
49053379|NCT00860743|158026121|FG000|Overall Study|Withdrawal by Subject|3|||
49053380|NCT00860743|158026122|FG001|Overall Study|Withdrawal by Subject|0|||
49053381|NCT04129554|158026123|FG000|Overall Study|Withdrawal by Subject|4|||
49053382|NCT04129554|158026124|FG001|Overall Study|Withdrawal by Subject|3|||
49053383|NCT04129554|158026123|FG000|Overall Study|Other|0|||
49053384|NCT04129554|158026124|FG001|Overall Study|Other|2|||
49053385|NCT01570361|158026125|FG000|Overall Study|Subject discontinued|1|||
49053386|NCT01570361|158026126|FG001|Overall Study|Subject discontinued|2|||
49053387|NCT01570361|158026125|FG000|Overall Study|Sponsor closing the study|51|||
49053388|NCT01570361|158026126|FG001|Overall Study|Sponsor closing the study|50|||
49053389|NCT01570361|158026125|FG000|Overall Study|Subject excluded|5|||
49053390|NCT01570361|158026126|FG001|Overall Study|Subject excluded|3|||
49053391|NCT01570361|158026125|FG000|Overall Study|Subject withdrew consent|14|||
49053392|NCT01570361|158026126|FG001|Overall Study|Subject withdrew consent|9|||
49053393|NCT01570361|158026125|FG000|Overall Study|Adverse Event|2|||
49053394|NCT01570361|158026126|FG001|Overall Study|Adverse Event|1|||
49053395|NCT01570361|158026125|FG000|Overall Study|Lost to Follow-up|4|||
49053396|NCT01570361|158026126|FG001|Overall Study|Lost to Follow-up|4|||
49053397|NCT01570361|158026125|FG000|Overall Study|Death|5|||
49053398|NCT01570361|158026126|FG001|Overall Study|Death|4|||
49053399|NCT01570361|158026125|FG000|Overall Study|Other|0|||
49053400|NCT01570361|158026126|FG001|Overall Study|Other|2|||
49053401|NCT01998243|158026127|FG000|Overall Study|Pregnancy|0|||
49053402|NCT01998243|158026128|FG001|Overall Study|Pregnancy|1|||
49053403|NCT01998243|158026127|FG000|Overall Study|Protocol Violation|5|||
49053404|NCT01998243|158026128|FG001|Overall Study|Protocol Violation|2|||
49053405|NCT01998243|158026127|FG000|Overall Study|Withdrawal by Subject|3|||
49053406|NCT01998243|158026128|FG001|Overall Study|Withdrawal by Subject|4|||
49053407|NCT02846545|158026129|FG000|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
49053408|NCT02846545|158026130|FG001|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
49053409|NCT02846545|158026129|FG000|Active Treatment Period: Week 0-52|Non-compliance with study drug|1|||
49053410|NCT02846545|158026130|FG001|Active Treatment Period: Week 0-52|Non-compliance with study drug|0|||
49053411|NCT02846545|158026129|FG000|Active Treatment Period: Week 0-52|Withdrawal by Subject|1|||
49053412|NCT02846545|158026130|FG001|Active Treatment Period: Week 0-52|Withdrawal by Subject|5|||
49053413|NCT02846545|158026129|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
49053414|NCT02846545|158026130|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
49053415|NCT02846545|158026129|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
49053416|NCT02846545|158026130|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
49053417|NCT02181296|158026131|FG000|Overall Study|Lost to Follow-up|7|||
49053418|NCT02181296|158026132|FG001|Overall Study|Lost to Follow-up|6|||
49053419|NCT02461134|158026133|FG000|Overall Study|Adverse Event|1|||
49053420|NCT00233987|158026134|FG000|Overall Study|Withdrawal by Subject|1|||
49053421|NCT00233987|158026134|FG000|Overall Study|Lack of Efficacy|2|||
49053422|NCT00233987|158026134|FG000|Overall Study|Reason Under Review|1|||
49053423|NCT00233987|158026134|FG000|Overall Study|Other - Not Protocol Specified|5|||
49053424|NCT00233987|158026134|FG000|Overall Study|Eligible but No Treatment Received|2|||
49053425|NCT00233987|158026134|FG000|Overall Study|Ineligible|4|||
49053426|NCT02427984|158026135|FG000|Overall Study|Lost to Follow-up|13|||
49053427|NCT02427984|158026136|FG001|Overall Study|Lost to Follow-up|5|||
49053428|NCT02427984|158026137|FG002|Overall Study|Lost to Follow-up|18|||
49053429|NCT02310672|158028437|FG000|Overall Study|Death|1|||
49053430|NCT02310672|158028437|FG000|Overall Study|Lost to Follow-up|1|||
49053431|NCT02310672|158028437|FG000|Overall Study|Withdrawal by Subject|1|||
49053432|NCT02310672|158028437|FG000|Overall Study|Sponsor's decision|12|||
49053433|NCT01098812|158028438|FG000|Overall Study|Death|2|||
49053434|NCT01098812|158028439|FG001|Overall Study|Death|0|||
49053435|NCT01098812|158028440|FG002|Overall Study|Death|1|||
49053436|NCT01098812|158028438|FG000|Overall Study|Lost to Follow-up|0|||
49053437|NCT01098812|158028439|FG001|Overall Study|Lost to Follow-up|1|||
49053438|NCT01098812|158028440|FG002|Overall Study|Lost to Follow-up|0|||
49053439|NCT01855750|158028442|FG000|Overall Study|Death|78|||
49053440|NCT01855750|158028443|FG001|Overall Study|Death|78|||
49053441|NCT01855750|158028442|FG000|Overall Study|Lost to Follow-up|9|||
49053442|NCT01855750|158028443|FG001|Overall Study|Lost to Follow-up|23|||
49053443|NCT01855750|158028442|FG000|Overall Study|Withdrawal by Subject|35|||
49053444|NCT01855750|158028443|FG001|Overall Study|Withdrawal by Subject|28|||
49053445|NCT01855750|158028442|FG000|Overall Study|Sponsor ends the study|297|||
49053446|NCT01855750|158028443|FG001|Overall Study|Sponsor ends the study|290|||
49053447|NCT01933919|158028444|FG000|Double-blind Placebo-controlled Phase|Adverse Event|0|||
49053448|NCT01933919|158028445|FG001|Double-blind Placebo-controlled Phase|Adverse Event|1|||
49053449|NCT01933919|158028444|FG000|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0|||
49053450|NCT01933919|158028445|FG001|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1|||
49053451|NCT01933919|158028444|FG000|Double-blind Placebo-controlled Phase|Lack of Efficacy|0|||
49053452|NCT01933919|158028445|FG001|Double-blind Placebo-controlled Phase|Lack of Efficacy|2|||
49053453|NCT01933919|158028444|FG000|Open-label Long-term Phase|Adverse Event|2|||
49053454|NCT01933919|158028445|FG001|Open-label Long-term Phase|Adverse Event|0|||
49053455|NCT01933919|158028444|FG000|Open-label Long-term Phase|Withdrawal by Subject|3|||
49053456|NCT01933919|158028445|FG001|Open-label Long-term Phase|Withdrawal by Subject|4|||
49053457|NCT01933919|158028444|FG000|Open-label Long-term Phase|Lost to Follow-up|1|||
49053458|NCT01933919|158028445|FG001|Open-label Long-term Phase|Lost to Follow-up|0|||
49053459|NCT01933919|158028444|FG000|Open-label Long-term Phase|Other|1|||
49053460|NCT01933919|158028445|FG001|Open-label Long-term Phase|Other|2|||
49053461|NCT03330236|158028446|FG000|Overall Study|Death|2|||
49053462|NCT03330236|158028447|FG001|Overall Study|Death|1|||
49053463|NCT03330236|158028446|FG000|Overall Study|Withdrawal by Subject|2|||
49053464|NCT03330236|158028447|FG001|Overall Study|Withdrawal by Subject|4|||
49053465|NCT03330236|158028446|FG000|Overall Study|Lost to Follow-up|0|||
49053466|NCT03330236|158028447|FG001|Overall Study|Lost to Follow-up|2|||
49053467|NCT03330236|158028446|FG000|Overall Study|Physician Decision|2|||
49053468|NCT03330236|158028447|FG001|Overall Study|Physician Decision|0|||
49053469|NCT03330236|158028446|FG000|Overall Study|Protocol Violation|4|||
49053470|NCT03330236|158028447|FG001|Overall Study|Protocol Violation|3|||
49053471|NCT03330236|158028446|FG000|Overall Study|SedLine malfunction/blinding|19|||
49053472|NCT03330236|158028447|FG001|Overall Study|SedLine malfunction/blinding|14|||
49053473|NCT03330236|158028446|FG000|Overall Study|Volatile anesthetics used|11|||
49053474|NCT03330236|158028447|FG001|Overall Study|Volatile anesthetics used|8|||
49053475|NCT03330236|158028446|FG000|Overall Study|Surgery aborted/converted to open|60|||
49053476|NCT03330236|158028447|FG001|Overall Study|Surgery aborted/converted to open|52|||
49053477|NCT01684215|158028448|FG000|Phase 1, Part 1|Adverse Event|1|||
49053478|NCT01684215|158028449|FG001|Phase 1, Part 1|Adverse Event|0|||
49053479|NCT01684215|158028450|FG002|Phase 1, Part 1|Adverse Event|0|||
49053480|NCT01684215|158028451|FG003|Phase 1, Part 1|Adverse Event|0|||
49053481|NCT01684215|158028448|FG000|Phase 1, Part 1|Objective progression or relapse|5|||
49053482|NCT01684215|158028449|FG001|Phase 1, Part 1|Objective progression or relapse|6|||
49053483|NCT01684215|158028450|FG002|Phase 1, Part 1|Objective progression or relapse|0|||
49053484|NCT01684215|158028451|FG003|Phase 1, Part 1|Objective progression or relapse|0|||
49053485|NCT01684215|158028448|FG000|Phase 1, Part 2|Adverse Event|0|||
49053486|NCT01684215|158028449|FG001|Phase 1, Part 2|Adverse Event|0|||
49053487|NCT01684215|158028450|FG002|Phase 1, Part 2|Adverse Event|1|||
49053488|NCT01684215|158028451|FG003|Phase 1, Part 2|Adverse Event|0|||
49053489|NCT01684215|158028448|FG000|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
49053490|NCT01684215|158028449|FG001|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
49053491|NCT01684215|158028450|FG002|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4|||
49053492|NCT01684215|158028451|FG003|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
49053493|NCT01684215|158028448|FG000|Phase 1, Part 2|Withdrawal by Subject|0|||
49053494|NCT01684215|158028449|FG001|Phase 1, Part 2|Withdrawal by Subject|0|||
49053495|NCT01684215|158028450|FG002|Phase 1, Part 2|Withdrawal by Subject|1|||
49053496|NCT01684215|158028451|FG003|Phase 1, Part 2|Withdrawal by Subject|0|||
49053497|NCT01684215|158028448|FG000|Phase 2|Death|0|||
49053498|NCT01684215|158028449|FG001|Phase 2|Death|0|||
49053499|NCT01684215|158028450|FG002|Phase 2|Death|0|||
49053500|NCT01684215|158028451|FG003|Phase 2|Death|8|||
49053501|NCT01684215|158028448|FG000|Phase 2|Study terminated by sponsor|0|||
49053502|NCT01684215|158028449|FG001|Phase 2|Study terminated by sponsor|0|||
49053503|NCT01684215|158028450|FG002|Phase 2|Study terminated by sponsor|0|||
49053504|NCT01684215|158028451|FG003|Phase 2|Study terminated by sponsor|30|||
49053505|NCT01684215|158028448|FG000|Phase 2|Enrolled but not treated|0|||
49053506|NCT01684215|158028449|FG001|Phase 2|Enrolled but not treated|0|||
49053507|NCT01684215|158028450|FG002|Phase 2|Enrolled but not treated|0|||
49053508|NCT01684215|158028451|FG003|Phase 2|Enrolled but not treated|1|||
49053509|NCT01684215|158028448|FG000|Phase 2|Lost to Follow-up|0|||
49053510|NCT01684215|158028449|FG001|Phase 2|Lost to Follow-up|0|||
49053511|NCT01684215|158028450|FG002|Phase 2|Lost to Follow-up|0|||
49053512|NCT01684215|158028451|FG003|Phase 2|Lost to Follow-up|4|||
49053513|NCT04288778|158028452|FG000|Overall Study|Withdrawal by Subject|2|||
49053514|NCT04288778|158028452|FG000|Overall Study|Adverse Event|5|||
49053515|NCT04288778|158028452|FG000|Overall Study|Non-Compliance With Study Drug|1|||
49053516|NCT04288778|158028452|FG000|Overall Study|Other|1|||
49053517|NCT04288778|158028452|FG000|Overall Study|Started but not treated|2|||
49053518|NCT01105091|158028453|FG000|Overall Study|Death|2|||
49053519|NCT01105091|158028454|FG001|Overall Study|Death|0|||
49053520|NCT00709956|158028455|FG000|Overall Study|Withdrawal by Subject|1|||
49053521|NCT00709956|158028456|FG001|Overall Study|Withdrawal by Subject|1|||
49053522|NCT00709956|158028455|FG000|Overall Study|Inclusion/exclusion criteria violation|2|||
49053523|NCT00709956|158028456|FG001|Overall Study|Inclusion/exclusion criteria violation|3|||
49053524|NCT02319759|158028457|FG000|Week 0 - 16|Lack of Efficacy|1|||
49053525|NCT02319759|158028458|FG001|Week 0 - 16|Lack of Efficacy|0|||
49053526|NCT02319759|158028459|FG002|Week 0 - 16|Lack of Efficacy|0|||
49053527|NCT02319759|158028460|FG003|Week 0 - 16|Lack of Efficacy|0|||
49053528|NCT02319759|158028461|FG004|Week 0 - 16|Lack of Efficacy|0|||
49053529|NCT02319759|158028457|FG000|Week 0 - 16|Not met all Inclusion Criteria|0|||
49053530|NCT02319759|158028458|FG001|Week 0 - 16|Not met all Inclusion Criteria|0|||
49053531|NCT02319759|158028459|FG002|Week 0 - 16|Not met all Inclusion Criteria|1|||
49053532|NCT02319759|158028460|FG003|Week 0 - 16|Not met all Inclusion Criteria|0|||
49053533|NCT02319759|158028461|FG004|Week 0 - 16|Not met all Inclusion Criteria|0|||
49053534|NCT02319759|158028457|FG000|Week 16 - 24|Lack of Efficacy|1|||
49053535|NCT02319759|158028458|FG001|Week 16 - 24|Lack of Efficacy|0|||
49053536|NCT02319759|158028459|FG002|Week 16 - 24|Lack of Efficacy|1|||
49053537|NCT02319759|158028460|FG003|Week 16 - 24|Lack of Efficacy|0|||
49053538|NCT02319759|158028461|FG004|Week 16 - 24|Lack of Efficacy|0|||
49053539|NCT02319759|158028457|FG000|Week 16 - 24|Lost to Follow-up|1|||
49053540|NCT02319759|158028458|FG001|Week 16 - 24|Lost to Follow-up|0|||
49053541|NCT02319759|158028459|FG002|Week 16 - 24|Lost to Follow-up|0|||
49053542|NCT02319759|158028460|FG003|Week 16 - 24|Lost to Follow-up|0|||
49053543|NCT02319759|158028461|FG004|Week 16 - 24|Lost to Follow-up|0|||
49053544|NCT02319759|158028457|FG000|Week 16 - 24|Withdrawal by Subject|0|||
49053545|NCT02319759|158028458|FG001|Week 16 - 24|Withdrawal by Subject|0|||
49053546|NCT02319759|158028459|FG002|Week 16 - 24|Withdrawal by Subject|2|||
49053547|NCT02319759|158028460|FG003|Week 16 - 24|Withdrawal by Subject|0|||
49053548|NCT02319759|158028461|FG004|Week 16 - 24|Withdrawal by Subject|0|||
49053549|NCT02319759|158028457|FG000|Week 24 - 56|Adverse Event|0|||
49053550|NCT02319759|158028458|FG001|Week 24 - 56|Adverse Event|0|||
49053551|NCT02319759|158028459|FG002|Week 24 - 56|Adverse Event|2|||
49053552|NCT02319759|158028460|FG003|Week 24 - 56|Adverse Event|0|||
49053553|NCT02319759|158028461|FG004|Week 24 - 56|Adverse Event|0|||
49053554|NCT02319759|158028457|FG000|Week 24 - 56|Lack of Efficacy|0|||
49053555|NCT02319759|158028458|FG001|Week 24 - 56|Lack of Efficacy|0|||
49053556|NCT02319759|158028459|FG002|Week 24 - 56|Lack of Efficacy|0|||
49053557|NCT02319759|158028460|FG003|Week 24 - 56|Lack of Efficacy|2|||
49053558|NCT02319759|158028461|FG004|Week 24 - 56|Lack of Efficacy|1|||
49053559|NCT02319759|158028457|FG000|Week 24 - 56|Withdrawal by Subject|0|||
49053560|NCT02319759|158028458|FG001|Week 24 - 56|Withdrawal by Subject|1|||
49053561|NCT02319759|158028459|FG002|Week 24 - 56|Withdrawal by Subject|0|||
49053562|NCT02319759|158028460|FG003|Week 24 - 56|Withdrawal by Subject|0|||
49053563|NCT02319759|158028461|FG004|Week 24 - 56|Withdrawal by Subject|0|||
49053564|NCT02319759|158028457|FG000|Week 24 - 56|Lost to Follow-up|0|||
49053565|NCT02319759|158028458|FG001|Week 24 - 56|Lost to Follow-up|0|||
49053566|NCT02319759|158028459|FG002|Week 24 - 56|Lost to Follow-up|0|||
49053567|NCT02319759|158028460|FG003|Week 24 - 56|Lost to Follow-up|0|||
49053568|NCT02319759|158028461|FG004|Week 24 - 56|Lost to Follow-up|1|||
49053569|NCT03339713|158028462|FG000|Overall Study|Lost to Follow-up|2|||
49053570|NCT03339713|158028463|FG001|Overall Study|Lost to Follow-up|1|||
49053571|NCT03339713|158028462|FG000|Overall Study|Protocol Violation|1|||
49053572|NCT03339713|158028463|FG001|Overall Study|Protocol Violation|0|||
49053573|NCT03339713|158028462|FG000|Overall Study|Withdrawal by Subject|1|||
49053574|NCT03339713|158028463|FG001|Overall Study|Withdrawal by Subject|1|||
49053575|NCT01660022|158028464|FG000|First Sequence (7 Days)|Withdrawal by Subject|0|||
49053576|NCT01660022|158028465|FG001|First Sequence (7 Days)|Withdrawal by Subject|1|||
49053577|NCT01660022|158028466|FG002|First Sequence (7 Days)|Withdrawal by Subject|0|||
49053578|NCT01660022|158028467|FG003|First Sequence (7 Days)|Withdrawal by Subject|1|||
49053579|NCT01660022|158028468|FG004|First Sequence (7 Days)|Withdrawal by Subject|0|||
49053580|NCT01660022|158028469|FG005|First Sequence (7 Days)|Withdrawal by Subject|0|||
49053581|NCT01660022|158028464|FG000|First Sequence (7 Days)|Adverse Event|0|||
49053582|NCT01660022|158028465|FG001|First Sequence (7 Days)|Adverse Event|0|||
49053583|NCT01660022|158028466|FG002|First Sequence (7 Days)|Adverse Event|0|||
49053584|NCT01660022|158028467|FG003|First Sequence (7 Days)|Adverse Event|0|||
49053585|NCT01660022|158028468|FG004|First Sequence (7 Days)|Adverse Event|1|||
49053586|NCT01660022|158028469|FG005|First Sequence (7 Days)|Adverse Event|3|||
49053587|NCT01660022|158028464|FG000|First Sequence (7 Days)|Protocol Violation|0|||
49053588|NCT01660022|158028465|FG001|First Sequence (7 Days)|Protocol Violation|0|||
49053589|NCT01660022|158028466|FG002|First Sequence (7 Days)|Protocol Violation|0|||
49053590|NCT01660022|158028467|FG003|First Sequence (7 Days)|Protocol Violation|0|||
49053591|NCT01660022|158028468|FG004|First Sequence (7 Days)|Protocol Violation|0|||
49053592|NCT01660022|158028469|FG005|First Sequence (7 Days)|Protocol Violation|1|||
49053593|NCT02879695|158028470|FG000|Overall Study|Did not start study treatment|2|||
49053594|NCT02879695|158028471|FG001|Overall Study|Did not start study treatment|0|||
49053595|NCT02879695|158028472|FG002|Overall Study|Did not start study treatment|3|||
49053596|NCT02879695|158028473|FG003|Overall Study|Did not start study treatment|0|||
49053597|NCT03462030|158028474|FG000|Overall Study|Withdrawal by Subject|1|||
49053598|NCT03462030|158028475|FG001|Overall Study|Withdrawal by Subject|1|||
49053599|NCT03381196|158028476|FG000|Overall Study|Withdrawal by Subject|7|||
49053600|NCT03381196|158028477|FG001|Overall Study|Withdrawal by Subject|7|||
49053601|NCT03381196|158028476|FG000|Overall Study|Other|0|||
49053602|NCT03381196|158028477|FG001|Overall Study|Other|1|||
49053603|NCT03381196|158028476|FG000|Overall Study|Lost to Follow-up|5|||
49053604|NCT03381196|158028477|FG001|Overall Study|Lost to Follow-up|4|||
49053605|NCT03381196|158028476|FG000|Overall Study|Death|0|||
49053606|NCT03381196|158028477|FG001|Overall Study|Death|1|||
49053607|NCT03381196|158028476|FG000|Overall Study|Adverse Event|1|||
49053608|NCT03381196|158028477|FG001|Overall Study|Adverse Event|0|||
49053609|NCT03381196|158028476|FG000|Overall Study|Randomized, not treated|3|||
49053610|NCT03381196|158028477|FG001|Overall Study|Randomized, not treated|6|||
49053611|NCT01885182|158028478|FG000|Overall Study|Adverse Event|11|||
49053612|NCT01885182|158028479|FG001|Overall Study|Adverse Event|13|||
49053613|NCT01885182|158028478|FG000|Overall Study|Withdrawal by Subject|13|||
49053614|NCT01885182|158028479|FG001|Overall Study|Withdrawal by Subject|6|||
49053615|NCT01885182|158028478|FG000|Overall Study|Lost to Follow-up|2|||
49053616|NCT01885182|158028479|FG001|Overall Study|Lost to Follow-up|2|||
49053617|NCT01885182|158028478|FG000|Overall Study|Lack of Efficacy|8|||
49053618|NCT01885182|158028479|FG001|Overall Study|Lack of Efficacy|1|||
49053619|NCT00227344|158028480|FG000|Overall Study|study terminated early|12|||
49053620|NCT00227344|158028481|FG001|Overall Study|study terminated early|5|||
49053621|NCT02359890|158028484|FG000|Overall Study|Not meeting eligibility|4|||
49053622|NCT02359890|158028484|FG000|Overall Study|Never treated with study catheter|6|||
49053623|NCT02999984|158028485|FG000|Overall Study|Treatment Failure|1|||
49053624|NCT03524092|158028486|FG000|Blinded Maintenance Period (Wk 0-40)|Adverse Event|16|||
49053625|NCT03524092|158028487|FG001|Blinded Maintenance Period (Wk 0-40)|Adverse Event|6|||
49053626|NCT03524092|158028488|FG002|Blinded Maintenance Period (Wk 0-40)|Adverse Event|1|||
49053627|NCT03524092|158028489|FG003|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
49053628|NCT03524092|158028490|FG004|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
49053629|NCT03524092|158028491|FG005|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
49053630|NCT03524092|158028486|FG000|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|8|||
49053631|NCT03524092|158028487|FG001|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|6|||
49053632|NCT03524092|158028488|FG002|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|7|||
49053633|NCT03524092|158028489|FG003|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
49053634|NCT03524092|158028490|FG004|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
49053635|NCT03524092|158028491|FG005|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
49053636|NCT03524092|158028486|FG000|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
49053637|NCT03524092|158028487|FG001|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|1|||
49053638|NCT03524092|158028488|FG002|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
49053639|NCT03524092|158028489|FG003|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
49053640|NCT03524092|158028490|FG004|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
49053641|NCT03524092|158028491|FG005|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
49053642|NCT03524092|158028486|FG000|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
49053643|NCT03524092|158028487|FG001|Blinded Maintenance Period (Wk 0-40)|Physician Decision|1|||
49053644|NCT03524092|158028488|FG002|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
49053645|NCT03524092|158028489|FG003|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
49053646|NCT03524092|158028490|FG004|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
49053647|NCT03524092|158028491|FG005|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
49053648|NCT03524092|158028486|FG000|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
49053649|NCT03524092|158028487|FG001|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
49053650|NCT03524092|158028488|FG002|Blinded Maintenance Period (Wk 0-40)|Pregnancy|1|||
49053651|NCT03524092|158028489|FG003|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
49053652|NCT03524092|158028490|FG004|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
49053653|NCT03524092|158028491|FG005|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
49053654|NCT03524092|158028486|FG000|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
49053655|NCT03524092|158028487|FG001|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
49053656|NCT03524092|158028488|FG002|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
49053657|NCT03524092|158028489|FG003|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
49053658|NCT03524092|158028490|FG004|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
49053659|NCT03524092|158028491|FG005|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
49053660|NCT03524092|158028486|FG000|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|7|||
49053661|NCT03524092|158028487|FG001|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|8|||
49053662|NCT03524092|158028488|FG002|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|6|||
49053663|NCT03524092|158028489|FG003|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
49053664|NCT03524092|158028490|FG004|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
49053665|NCT03524092|158028491|FG005|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
49053666|NCT03524092|158028486|FG000|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|42|||
49053667|NCT03524092|158028487|FG001|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|19|||
49053668|NCT03524092|158028488|FG002|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|29|||
49053669|NCT03524092|158028489|FG003|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
49053670|NCT03524092|158028490|FG004|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
49053671|NCT03524092|158028491|FG005|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
49053672|NCT03524092|158028486|FG000|Loss of Response Rescue Period|Adverse Event|0|||
49053673|NCT03524092|158028487|FG001|Loss of Response Rescue Period|Adverse Event|0|||
49053674|NCT03524092|158028488|FG002|Loss of Response Rescue Period|Adverse Event|0|||
49053675|NCT03524092|158028489|FG003|Loss of Response Rescue Period|Adverse Event|2|||
49053676|NCT03524092|158028490|FG004|Loss of Response Rescue Period|Adverse Event|0|||
49053677|NCT03524092|158028491|FG005|Loss of Response Rescue Period|Adverse Event|0|||
49053678|NCT03524092|158028486|FG000|Loss of Response Rescue Period|Lack of Efficacy|0|||
49053679|NCT03524092|158028487|FG001|Loss of Response Rescue Period|Lack of Efficacy|0|||
49053680|NCT03524092|158028488|FG002|Loss of Response Rescue Period|Lack of Efficacy|0|||
49053681|NCT03524092|158028489|FG003|Loss of Response Rescue Period|Lack of Efficacy|5|||
49053682|NCT03524092|158028490|FG004|Loss of Response Rescue Period|Lack of Efficacy|0|||
49053683|NCT03524092|158028491|FG005|Loss of Response Rescue Period|Lack of Efficacy|0|||
49053684|NCT03524092|158028486|FG000|Loss of Response Rescue Period|Pregnancy|0|||
49053685|NCT03524092|158028487|FG001|Loss of Response Rescue Period|Pregnancy|0|||
49053686|NCT03524092|158028488|FG002|Loss of Response Rescue Period|Pregnancy|0|||
49053687|NCT03524092|158028489|FG003|Loss of Response Rescue Period|Pregnancy|1|||
49053688|NCT03524092|158028490|FG004|Loss of Response Rescue Period|Pregnancy|0|||
49053689|NCT03524092|158028491|FG005|Loss of Response Rescue Period|Pregnancy|0|||
49053690|NCT03524092|158028486|FG000|Loss of Response Rescue Period|Withdrawal by Subject|0|||
49053691|NCT03524092|158028487|FG001|Loss of Response Rescue Period|Withdrawal by Subject|0|||
49053692|NCT03524092|158028488|FG002|Loss of Response Rescue Period|Withdrawal by Subject|0|||
49053693|NCT03524092|158028489|FG003|Loss of Response Rescue Period|Withdrawal by Subject|1|||
49053694|NCT03524092|158028490|FG004|Loss of Response Rescue Period|Withdrawal by Subject|0|||
49053695|NCT03524092|158028491|FG005|Loss of Response Rescue Period|Withdrawal by Subject|0|||
49053696|NCT03524092|158028486|FG000|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
49053697|NCT03524092|158028487|FG001|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
49053698|NCT03524092|158028488|FG002|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
49053699|NCT03524092|158028489|FG003|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
49053700|NCT03524092|158028490|FG004|Open Label Extended Induction (Wk 0-12)|Adverse Event|11|||
49053701|NCT03524092|158028491|FG005|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
49053702|NCT03524092|158028486|FG000|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
49053703|NCT03524092|158028487|FG001|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
49053704|NCT03524092|158028488|FG002|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
49053705|NCT03524092|158028489|FG003|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
49053706|NCT03524092|158028490|FG004|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|4|||
49053707|NCT03524092|158028491|FG005|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
49053708|NCT03524092|158028486|FG000|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
49053709|NCT03524092|158028487|FG001|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
49053710|NCT03524092|158028488|FG002|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
49053711|NCT03524092|158028489|FG003|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
49053712|NCT03524092|158028490|FG004|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|162|||
49053713|NCT03524092|158028491|FG005|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
49053714|NCT03524092|158028486|FG000|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
49053715|NCT03524092|158028487|FG001|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
49053716|NCT03524092|158028488|FG002|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
49053717|NCT03524092|158028489|FG003|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
49053718|NCT03524092|158028490|FG004|Open Label Extended Induction (Wk 0-12)|Physician Decision|1|||
49053719|NCT03524092|158028491|FG005|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
49053720|NCT03524092|158028486|FG000|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
49053721|NCT03524092|158028487|FG001|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
49053722|NCT03524092|158028488|FG002|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
49053723|NCT03524092|158028489|FG003|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
49053724|NCT03524092|158028490|FG004|Open Label Extended Induction (Wk 0-12)|Protocol Violation|5|||
49053725|NCT03524092|158028491|FG005|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
49053726|NCT03524092|158028486|FG000|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
49053727|NCT03524092|158028487|FG001|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
49053728|NCT03524092|158028488|FG002|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
49053729|NCT03524092|158028489|FG003|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
49053730|NCT03524092|158028490|FG004|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|6|||
49053731|NCT03524092|158028491|FG005|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
49053732|NCT03524092|158028486|FG000|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
49053733|NCT03524092|158028487|FG001|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
49053734|NCT03524092|158028488|FG002|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
49053735|NCT03524092|158028489|FG003|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
49053736|NCT03524092|158028490|FG004|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|1|||
49053737|NCT03524092|158028491|FG005|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
49053738|NCT03524092|158028486|FG000|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
49053739|NCT03524092|158028487|FG001|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
49053740|NCT03524092|158028488|FG002|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
49053741|NCT03524092|158028489|FG003|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
49053742|NCT03524092|158028490|FG004|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
49053743|NCT03524092|158028491|FG005|Open Label Maintenance Period (Wk 12-40)|Adverse Event|4|||
49053744|NCT03524092|158028486|FG000|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
49053745|NCT03524092|158028487|FG001|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
49053746|NCT03524092|158028488|FG002|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
49053747|NCT03524092|158028489|FG003|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
49053748|NCT03524092|158028490|FG004|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
49053749|NCT03524092|158028491|FG005|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|1|||
49053750|NCT03524092|158028486|FG000|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
49053751|NCT03524092|158028487|FG001|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
49053752|NCT03524092|158028488|FG002|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
49053753|NCT03524092|158028489|FG003|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
49053754|NCT03524092|158028490|FG004|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
49053755|NCT03524092|158028491|FG005|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|9|||
49053756|NCT03524092|158028486|FG000|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
49053757|NCT03524092|158028487|FG001|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
49053758|NCT03524092|158028488|FG002|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
49053759|NCT03524092|158028489|FG003|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
49053760|NCT03524092|158028490|FG004|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
49053761|NCT03524092|158028491|FG005|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|1|||
49053762|NCT03449199|158028497|FG000|Overall Study|Lost to Follow-up|1|||
49053763|NCT03449199|158028498|FG001|Overall Study|Lost to Follow-up|1|||
49053764|NCT03449199|158028499|FG002|Overall Study|Lost to Follow-up|0|||
49053765|NCT03449199|158028497|FG000|Overall Study|Protocol Deviation|0|||
49053766|NCT03449199|158028498|FG001|Overall Study|Protocol Deviation|0|||
49053767|NCT03449199|158028499|FG002|Overall Study|Protocol Deviation|1|||
49053768|NCT03449199|158028497|FG000|Overall Study|Withdrawal by Subject|0|||
49053769|NCT03449199|158028498|FG001|Overall Study|Withdrawal by Subject|0|||
49053770|NCT03449199|158028499|FG002|Overall Study|Withdrawal by Subject|1|||
49053771|NCT04442737|158028500|FG000|Overall Study|Lost to Follow-up|1|||
49053772|NCT04442737|158028501|FG001|Overall Study|Lost to Follow-up|3|||
49053773|NCT04442737|158028500|FG000|Overall Study|Withdrawal by Subject|3|||
49053774|NCT04442737|158028501|FG001|Overall Study|Withdrawal by Subject|2|||
49053775|NCT04442737|158028500|FG000|Overall Study|Adverse Event|3|||
49053776|NCT04442737|158028501|FG001|Overall Study|Adverse Event|2|||
49053777|NCT04442737|158028500|FG000|Overall Study|Death|0|||
49053778|NCT04442737|158028501|FG001|Overall Study|Death|1|||
49053779|NCT04442737|158028500|FG000|Overall Study|Protocol Violation|0|||
49053780|NCT04442737|158028501|FG001|Overall Study|Protocol Violation|2|||
49053781|NCT04442737|158028500|FG000|Overall Study|Other|1|||
49053782|NCT04442737|158028501|FG001|Overall Study|Other|1|||
49053783|NCT05780437|158028502|FG000|Overall Study|Withdrawal by Subject|22|||
49053784|NCT05780437|158028503|FG001|Overall Study|Withdrawal by Subject|16|||
49053785|NCT02096588|158028506|FG000|Overall Study|Lack of Efficacy|2|||
49053786|NCT02096588|158028507|FG001|Overall Study|Lack of Efficacy|0|||
49053787|NCT02096588|158028506|FG000|Overall Study|Withdrawal by Subject|0|||
49053788|NCT02096588|158028507|FG001|Overall Study|Withdrawal by Subject|1|||
49053789|NCT01756300|158028508|FG000|Overall Study|Death|1|||
49053790|NCT01756300|158028508|FG000|Overall Study|Withdrawal by Subject|1|||
49053791|NCT00384293|158028509|FG000|MK0524A Active Run-In, Pre-randomization|Adverse Event|120|||
49053792|NCT00384293|158028510|FG001|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
49053793|NCT00384293|158028511|FG002|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
49053794|NCT00384293|158028509|FG000|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1|||
49053795|NCT00384293|158028510|FG001|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
49053796|NCT00384293|158028511|FG002|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
49053797|NCT00384293|158028509|FG000|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24|||
49053798|NCT00384293|158028510|FG001|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
49053799|NCT00384293|158028511|FG002|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
49053800|NCT00384293|158028509|FG000|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340|||
49053801|NCT00384293|158028510|FG001|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
49053802|NCT00384293|158028511|FG002|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
49053803|NCT00384293|158028509|FG000|MK0524A Active Run-In, Pre-randomization|Trial Termination|16|||
49053804|NCT00384293|158028510|FG001|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
49053805|NCT00384293|158028511|FG002|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
49053806|NCT00384293|158028509|FG000|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2|||
49053807|NCT00384293|158028510|FG001|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
49053808|NCT00384293|158028511|FG002|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
49053809|NCT00384293|158028509|FG000|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1|||
49053810|NCT00384293|158028510|FG001|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
49053811|NCT00384293|158028511|FG002|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
49053812|NCT00384293|158028509|FG000|Post-randomization Period|Adverse Event|0|||
49053813|NCT00384293|158028510|FG001|Post-randomization Period|Adverse Event|23|||
49053814|NCT00384293|158028511|FG002|Post-randomization Period|Adverse Event|7|||
49053815|NCT00384293|158028509|FG000|Post-randomization Period|Lost to Follow-up|0|||
49053816|NCT00384293|158028510|FG001|Post-randomization Period|Lost to Follow-up|2|||
49053817|NCT00384293|158028511|FG002|Post-randomization Period|Lost to Follow-up|1|||
49053818|NCT00384293|158028509|FG000|Post-randomization Period|Protocol Violation|0|||
49053819|NCT00384293|158028510|FG001|Post-randomization Period|Protocol Violation|1|||
49053820|NCT00384293|158028511|FG002|Post-randomization Period|Protocol Violation|0|||
49053821|NCT00384293|158028509|FG000|Post-randomization Period|Withdrawal by Subject|0|||
49053822|NCT00384293|158028510|FG001|Post-randomization Period|Withdrawal by Subject|8|||
49053823|NCT00384293|158028511|FG002|Post-randomization Period|Withdrawal by Subject|6|||
49053824|NCT00384293|158028509|FG000|Post-randomization Period|Trial Termination|0|||
49053825|NCT00384293|158028510|FG001|Post-randomization Period|Trial Termination|180|||
49053826|NCT00384293|158028511|FG002|Post-randomization Period|Trial Termination|204|||
49053827|NCT00384293|158028509|FG000|Post-randomization Period|Patient Randomized in Error|0|||
49053828|NCT00384293|158028510|FG001|Post-randomization Period|Patient Randomized in Error|0|||
49053829|NCT00384293|158028511|FG002|Post-randomization Period|Patient Randomized in Error|1|||
49053830|NCT04056611|158028512|FG000|Overall Study|Physician Decision|1|||
49053831|NCT03153111|158028513|FG000|Overall Study|Death|2|||
49053832|NCT03153111|158028514|FG001|Overall Study|Death|5|||
49053833|NCT03153111|158028513|FG000|Overall Study|Lost to Follow-up|1|||
49053834|NCT03153111|158028514|FG001|Overall Study|Lost to Follow-up|0|||
49053835|NCT03153111|158028513|FG000|Overall Study|Physician Decision|5|||
49053836|NCT03153111|158028514|FG001|Overall Study|Physician Decision|1|||
49053837|NCT03153111|158028513|FG000|Overall Study|Withdrawal by Subject|3|||
49053838|NCT03153111|158028514|FG001|Overall Study|Withdrawal by Subject|3|||
49053839|NCT03227861|158028515|FG000|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4|||
49053840|NCT03227861|158028515|FG000|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
49053841|NCT03227861|158028515|FG000|Main Study Period (Week 0 to Week 48)|Adverse Event|1|||
49053842|NCT03227861|158028515|FG000|Main Study Period (Week 0 to Week 48)|Protocol Violation|1|||
49053843|NCT03227861|158028515|FG000|Main Study Period (Week 0 to Week 48)|Other|5|||
49053844|NCT03227861|158028515|FG000|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55|||
49053845|NCT03227861|158028515|FG000|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16|||
49053846|NCT03227861|158028515|FG000|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6|||
49053847|NCT03227861|158028515|FG000|Extension Period (Week 48 to Week 96)|Adverse Event|1|||
49053848|NCT03227861|158028515|FG000|Extension Period (Week 48 to Week 96)|Other|2|||
49053849|NCT02782676|158028517|FG000|Overall Study|Lost to Follow-up|0|||
49053850|NCT02782676|158028518|FG001|Overall Study|Lost to Follow-up|1|||
49053851|NCT01093326|158028519|FG000|Overall Study|Death|0|||
49053852|NCT01093326|158028520|FG001|Overall Study|Death|1|||
49053853|NCT01093326|158028521|FG002|Overall Study|Death|0|||
49053854|NCT01093326|158028519|FG000|Overall Study|Lack of Efficacy|7|||
49053855|NCT01093326|158028520|FG001|Overall Study|Lack of Efficacy|6|||
49053856|NCT01093326|158028521|FG002|Overall Study|Lack of Efficacy|3|||
49053857|NCT01093326|158028519|FG000|Overall Study|Lost to Follow-up|2|||
49053858|NCT01093326|158028520|FG001|Overall Study|Lost to Follow-up|5|||
49053859|NCT01093326|158028521|FG002|Overall Study|Lost to Follow-up|4|||
49053860|NCT01093326|158028519|FG000|Overall Study|Physician Decision|3|||
49053861|NCT01093326|158028520|FG001|Overall Study|Physician Decision|1|||
49053862|NCT01093326|158028521|FG002|Overall Study|Physician Decision|3|||
49053863|NCT01093326|158028519|FG000|Overall Study|Withdrawal by Subject|30|||
49053864|NCT01093326|158028520|FG001|Overall Study|Withdrawal by Subject|27|||
49053865|NCT01093326|158028521|FG002|Overall Study|Withdrawal by Subject|26|||
49053866|NCT01093326|158028519|FG000|Overall Study|Adverse Event|2|||
49053867|NCT01093326|158028520|FG001|Overall Study|Adverse Event|1|||
49053868|NCT01093326|158028521|FG002|Overall Study|Adverse Event|4|||
49053869|NCT01093326|158028519|FG000|Overall Study|Other|0|||
49053870|NCT01093326|158028520|FG001|Overall Study|Other|0|||
49053871|NCT01093326|158028521|FG002|Overall Study|Other|1|||
49053872|NCT02641730|158028522|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
49053873|NCT02641730|158028523|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
49053874|NCT02641730|158028524|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
49053875|NCT02641730|158028525|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
49053876|NCT02641730|158028526|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
49053877|NCT02641730|158028522|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
49053878|NCT02641730|158028523|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
49053879|NCT02641730|158028524|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
49053880|NCT02641730|158028525|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|5|||
49053881|NCT02641730|158028526|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|4|||
49053882|NCT02641730|158028522|FG000|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
49053883|NCT02641730|158028523|FG001|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
49053884|NCT02641730|158028524|FG002|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
49053885|NCT02641730|158028525|FG003|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
49053886|NCT02641730|158028526|FG004|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
49053887|NCT02641730|158028522|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
49053888|NCT02641730|158028523|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
49053889|NCT02641730|158028524|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
49053890|NCT02641730|158028525|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
49053891|NCT02641730|158028526|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
49053892|NCT02641730|158028522|FG000|After Controlled Period (Week 16 - 52)|Other|0|||
49053893|NCT02641730|158028523|FG001|After Controlled Period (Week 16 - 52)|Other|1|||
49053894|NCT02641730|158028524|FG002|After Controlled Period (Week 16 - 52)|Other|1|||
49053895|NCT02641730|158028525|FG003|After Controlled Period (Week 16 - 52)|Other|0|||
49053896|NCT02641730|158028526|FG004|After Controlled Period (Week 16 - 52)|Other|1|||
49053897|NCT02641730|158028522|FG000|Observational Period (Week 60 - Week 84)|Other|0|||
49053898|NCT02641730|158028523|FG001|Observational Period (Week 60 - Week 84)|Other|0|||
49053899|NCT02641730|158028524|FG002|Observational Period (Week 60 - Week 84)|Other|0|||
49053900|NCT02641730|158028525|FG003|Observational Period (Week 60 - Week 84)|Other|0|||
49053901|NCT02641730|158028526|FG004|Observational Period (Week 60 - Week 84)|Other|1|||
49053902|NCT00319046|158028527|FG000|Overall Study|withdrawal of subject's consent|7|||
49053903|NCT00319046|158028527|FG000|Overall Study|administrative reason|1|||
49053904|NCT01832402|158028528|FG000|Overall Study|Lost to Follow-up|2|||
49053905|NCT01832402|158028529|FG001|Overall Study|Lost to Follow-up|0|||
49053906|NCT01832402|158028528|FG000|Overall Study|Withdrawal by Subject|3|||
49053907|NCT01832402|158028529|FG001|Overall Study|Withdrawal by Subject|3|||
49053908|NCT01832402|158028528|FG000|Overall Study|Declining Performance status|2|||
49053909|NCT01832402|158028529|FG001|Overall Study|Declining Performance status|1|||
49053910|NCT01010750|158028530|FG000|Second Intervention|Adverse Event|0|||
49053911|NCT01010750|158028531|FG001|Second Intervention|Adverse Event|1|||
49053912|NCT01010750|158028532|FG002|Second Intervention|Adverse Event|0|||
49053913|NCT01010750|158028533|FG003|Second Intervention|Adverse Event|0|||
49053914|NCT01010750|158028534|FG004|Second Intervention|Adverse Event|0|||
49053915|NCT01010750|158028535|FG005|Second Intervention|Adverse Event|0|||
49053916|NCT00412607|158028536|FG000|Overall Study|Withdrawal by Subject|9|||
49053917|NCT00412607|158028536|FG000|Overall Study|Lost to Follow-up|19|||
49053918|NCT00412607|158028536|FG000|Overall Study|Death|61|||
49053919|NCT00412607|158028536|FG000|Overall Study|Not meet inclusion/exclusion Criteria|15|||
49053920|NCT00319020|158028539|FG000|Overall Study|Death|2|||
49053921|NCT00319020|158028540|FG001|Overall Study|Death|2|||
49053922|NCT00319020|158028539|FG000|Overall Study|Withdrawal by Subject|4|||
49053923|NCT00319020|158028540|FG001|Overall Study|Withdrawal by Subject|1|||
49053924|NCT00319020|158028539|FG000|Overall Study|F-1 completed but not enrolled in F-2|1|||
49053925|NCT00319020|158028540|FG001|Overall Study|F-1 completed but not enrolled in F-2|0|||
49053926|NCT00319020|158028539|FG000|Overall Study|Administrative reason|0|||
49053927|NCT00319020|158028540|FG001|Overall Study|Administrative reason|5|||
49053928|NCT00319020|158028539|FG000|Overall Study|Disease progression|0|||
49053929|NCT00319020|158028540|FG001|Overall Study|Disease progression|2|||
49053930|NCT00319020|158028539|FG000|Overall Study|Transplant|0|||
49053931|NCT00319020|158028540|FG001|Overall Study|Transplant|1|||
49053932|NCT00319020|158028539|FG000|Overall Study|Treatment failure|0|||
49053933|NCT00319020|158028540|FG001|Overall Study|Treatment failure|1|||
49053934|NCT00319020|158028539|FG000|Overall Study|Adverse Event|0|||
49053935|NCT00319020|158028540|FG001|Overall Study|Adverse Event|1|||
49053936|NCT00747565|158028545|FG000|Overall Study|Withdrawal by Subject|10|||
49053937|NCT00747565|158028546|FG001|Overall Study|Withdrawal by Subject|6|||
49053938|NCT00747565|158028545|FG000|Overall Study|Lost to Follow-up|4|||
49053939|NCT00747565|158028546|FG001|Overall Study|Lost to Follow-up|1|||
49053940|NCT03417830|158028547|FG000|Part A (up to 26 Days)|Study Closed/Terminated|1|||
49053941|NCT03417830|158028548|FG001|Part A (up to 26 Days)|Study Closed/Terminated|0|||
49053942|NCT04614948|158028549|FG000|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|5|||
49053943|NCT04614948|158028550|FG001|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|10|||
49053944|NCT04614948|158028551|FG002|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|0|||
49053945|NCT04614948|158028549|FG000|DB Phase (Day 1 up to 7.2 Months)|Death|6|||
49053946|NCT04614948|158028550|FG001|DB Phase (Day 1 up to 7.2 Months)|Death|13|||
49053947|NCT04614948|158028551|FG002|DB Phase (Day 1 up to 7.2 Months)|Death|0|||
49053948|NCT04614948|158028549|FG000|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|170|||
49053949|NCT04614948|158028550|FG001|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|219|||
49053950|NCT04614948|158028551|FG002|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|0|||
49053951|NCT04614948|158028549|FG000|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|15|||
49053952|NCT04614948|158028550|FG001|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|6|||
49053953|NCT04614948|158028551|FG002|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|0|||
49053954|NCT04614948|158028549|FG000|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
49053955|NCT04614948|158028550|FG001|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|1|||
49053956|NCT04614948|158028551|FG002|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
49053957|NCT04614948|158028549|FG000|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|1|||
49053958|NCT04614948|158028550|FG001|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|7|||
49053959|NCT04614948|158028551|FG002|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|0|||
49053960|NCT04614948|158028549|FG000|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|468|||
49053961|NCT04614948|158028550|FG001|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|1273|||
49053962|NCT04614948|158028551|FG002|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|0|||
49053963|NCT04614948|158028549|FG000|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|10|||
49053964|NCT04614948|158028550|FG001|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|75|||
49053965|NCT04614948|158028551|FG002|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|0|||
49053966|NCT04614948|158028549|FG000|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
49053967|NCT04614948|158028550|FG001|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|3|||
49053968|NCT04614948|158028551|FG002|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
49053969|NCT04614948|158028549|FG000|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
49053970|NCT04614948|158028550|FG001|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|2|||
49053971|NCT04614948|158028551|FG002|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
49053972|NCT04614948|158028549|FG000|DB Phase (Day 1 up to 7.2 Months)|Other|26|||
49053973|NCT04614948|158028550|FG001|DB Phase (Day 1 up to 7.2 Months)|Other|149|||
49053974|NCT04614948|158028551|FG002|DB Phase (Day 1 up to 7.2 Months)|Other|0|||
49053975|NCT04614948|158028549|FG000|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
49053976|NCT04614948|158028550|FG001|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
49053977|NCT04614948|158028551|FG002|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|14|||
49053978|NCT04614948|158028549|FG000|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
49053979|NCT04614948|158028550|FG001|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
49053980|NCT04614948|158028551|FG002|DB + Open-label Phase (2 Years 6 Months)|Death|131|||
49053981|NCT04614948|158028549|FG000|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
49053982|NCT04614948|158028550|FG001|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
49053983|NCT04614948|158028551|FG002|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|3796|||
49053984|NCT04614948|158028549|FG000|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
49053985|NCT04614948|158028550|FG001|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
49053986|NCT04614948|158028551|FG002|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|178|||
49053987|NCT04614948|158028549|FG000|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
49053988|NCT04614948|158028550|FG001|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
49053989|NCT04614948|158028551|FG002|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|2|||
49053990|NCT04614948|158028549|FG000|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
49053991|NCT04614948|158028550|FG001|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
49053992|NCT04614948|158028551|FG002|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|9|||
49053993|NCT04614948|158028549|FG000|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
49053994|NCT04614948|158028550|FG001|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
49053995|NCT04614948|158028551|FG002|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|5922|||
49053996|NCT04614948|158028549|FG000|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
49053997|NCT04614948|158028550|FG001|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
49053998|NCT04614948|158028551|FG002|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|92|||
49053999|NCT04614948|158028549|FG000|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
49054000|NCT04614948|158028550|FG001|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
49054001|NCT04614948|158028551|FG002|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|48|||
49054002|NCT04614948|158028549|FG000|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
49054003|NCT04614948|158028550|FG001|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
49054004|NCT04614948|158028551|FG002|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|17|||
49054005|NCT04614948|158028549|FG000|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
49054006|NCT04614948|158028550|FG001|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
49054007|NCT04614948|158028551|FG002|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|1|||
49054008|NCT04614948|158028549|FG000|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
49054009|NCT04614948|158028550|FG001|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
49054010|NCT04614948|158028551|FG002|DB + Open-label Phase (2 Years 6 Months)|Other|477|||
49054011|NCT00319696|158028552|FG000|Overall Study|Adverse Event|36|||
49054012|NCT00319696|158028552|FG000|Overall Study|withdrawal of consent|14|||
49054013|NCT00319696|158028552|FG000|Overall Study|administrative|7|||
49054014|NCT00319696|158028552|FG000|Overall Study|Lost to Follow-up|3|||
49054015|NCT03498521|158028553|FG000|Overall Study|Death|191|||
49054016|NCT03498521|158028554|FG001|Overall Study|Death|64|||
49054017|NCT03498521|158028555|FG002|Overall Study|Death|72|||
49054018|NCT03498521|158028553|FG000|Overall Study|Exclusion criteria|1|||
49054019|NCT03498521|158028554|FG001|Overall Study|Exclusion criteria|0|||
49054020|NCT03498521|158028555|FG002|Overall Study|Exclusion criteria|0|||
49054021|NCT03498521|158028553|FG000|Overall Study|Lost to Follow-up|3|||
49054022|NCT03498521|158028554|FG001|Overall Study|Lost to Follow-up|3|||
49054023|NCT03498521|158028555|FG002|Overall Study|Lost to Follow-up|3|||
49054024|NCT03498521|158028553|FG000|Overall Study|No profile due to technical failure|1|||
49054025|NCT03498521|158028554|FG001|Overall Study|No profile due to technical failure|0|||
49054026|NCT03498521|158028555|FG002|Overall Study|No profile due to technical failure|0|||
49054027|NCT03498521|158028553|FG000|Overall Study|Physician Decision|0|||
49054028|NCT03498521|158028554|FG001|Overall Study|Physician Decision|1|||
49054029|NCT03498521|158028555|FG002|Overall Study|Physician Decision|0|||
49054030|NCT03498521|158028553|FG000|Overall Study|Withdrawal by Subject|9|||
49054031|NCT03498521|158028554|FG001|Overall Study|Withdrawal by Subject|6|||
49054032|NCT03498521|158028555|FG002|Overall Study|Withdrawal by Subject|2|||
49054033|NCT03498521|158028553|FG000|Overall Study|Study ongoing|121|||
49054034|NCT03498521|158028554|FG001|Overall Study|Study ongoing|36|||
49054035|NCT03498521|158028555|FG002|Overall Study|Study ongoing|15|||
49054036|NCT03357952|158028556|FG000|Overall Study|Withdrawal by Subject|0|||
49054037|NCT03357952|158028557|FG001|Overall Study|Withdrawal by Subject|1|||
49054038|NCT03357952|158028556|FG000|Overall Study|Sponsor Decision|9|||
49054039|NCT03357952|158028557|FG001|Overall Study|Sponsor Decision|0|||
49054040|NCT02654587|158028558|FG000|Overall Study|patient alive at end of study|22|||
49054041|NCT02654587|158028559|FG001|Overall Study|patient alive at end of study|8|||
49054042|NCT02654587|158028558|FG000|Overall Study|Withdrawal by Subject|1|||
49054043|NCT02654587|158028559|FG001|Overall Study|Withdrawal by Subject|7|||
49054044|NCT00303459|158028560|FG000|Overall Study|Death|33|||
49054045|NCT00303459|158028561|FG001|Overall Study|Death|44|||
49054046|NCT00303459|158028560|FG000|Overall Study|Withdrawal of consent|32|||
49054047|NCT00303459|158028561|FG001|Overall Study|Withdrawal of consent|26|||
49054048|NCT00303459|158028560|FG000|Overall Study|Lost to Follow-up|5|||
49054049|NCT00303459|158028561|FG001|Overall Study|Lost to Follow-up|4|||
49054050|NCT00303459|158028560|FG000|Overall Study|Administrative reason|7|||
49054051|NCT00303459|158028561|FG001|Overall Study|Administrative reason|7|||
49054052|NCT00303459|158028560|FG000|Overall Study|Decision by the investigator|5|||
49054053|NCT00303459|158028561|FG001|Overall Study|Decision by the investigator|7|||
49054054|NCT00303459|158028560|FG000|Overall Study|Lung transplantation|1|||
49054055|NCT00303459|158028561|FG001|Overall Study|Lung transplantation|1|||
49054056|NCT02776553|158028562|FG000|Overall Study|Lost to Follow-up|1|||
49054057|NCT02776553|158028563|FG001|Overall Study|Lost to Follow-up|0|||
49054058|NCT02776553|158028562|FG000|Overall Study|got liver transplant|1|||
49054059|NCT02776553|158028563|FG001|Overall Study|got liver transplant|2|||
49054060|NCT02776553|158028562|FG000|Overall Study|had other surgery|1|||
49054061|NCT02776553|158028563|FG001|Overall Study|had other surgery|0|||
49054062|NCT02776553|158028562|FG000|Overall Study|Protocol Violation|0|||
49054063|NCT02776553|158028563|FG001|Overall Study|Protocol Violation|1|||
49054064|NCT02746627|158028564|FG000|Overall Study|Withdrawal by Subject|1|||
49054065|NCT02746627|158028565|FG001|Overall Study|Withdrawal by Subject|1|||
49054066|NCT02746627|158028566|FG002|Overall Study|Withdrawal by Subject|1|||
49054067|NCT00171340|158028569|FG000|Overall Study|Adverse Event|46|||
49054068|NCT00171340|158028570|FG001|Overall Study|Adverse Event|42|||
49054069|NCT00171340|158028569|FG000|Overall Study|Lack of Efficacy|29|||
49054070|NCT00171340|158028570|FG001|Overall Study|Lack of Efficacy|41|||
49054071|NCT00171340|158028569|FG000|Overall Study|Protocol Violation|7|||
49054072|NCT00171340|158028570|FG001|Overall Study|Protocol Violation|8|||
49054073|NCT00171340|158028569|FG000|Overall Study|Withdrawal by Subject|22|||
49054074|NCT00171340|158028570|FG001|Overall Study|Withdrawal by Subject|19|||
49054075|NCT00171340|158028569|FG000|Overall Study|Lost to Follow-up|0|||
49054076|NCT00171340|158028570|FG001|Overall Study|Lost to Follow-up|5|||
49054077|NCT00171340|158028569|FG000|Overall Study|Abnormal Laboratory Results|2|||
49054078|NCT00171340|158028570|FG001|Overall Study|Abnormal Laboratory Results|0|||
49054079|NCT00171340|158028569|FG000|Overall Study|Abnormal Test Procedure Results|6|||
49054080|NCT00171340|158028570|FG001|Overall Study|Abnormal Test Procedure Results|11|||
49054081|NCT00171340|158028569|FG000|Overall Study|No Longer Required Study Drug|1|||
49054082|NCT00171340|158028570|FG001|Overall Study|No Longer Required Study Drug|1|||
49054083|NCT00171340|158028569|FG000|Overall Study|Administrative Problems|5|||
49054084|NCT00171340|158028570|FG001|Overall Study|Administrative Problems|2|||
49054085|NCT00171340|158028569|FG000|Overall Study|Death|6|||
49054086|NCT00171340|158028570|FG001|Overall Study|Death|6|||
49054087|NCT03606512|158028575|FG000|Overall Study|Lost to Follow-up|0|||
49054088|NCT03606512|158028576|FG001|Overall Study|Lost to Follow-up|1|||
49054089|NCT03606512|158028575|FG000|Overall Study|'moved from study area|0|||
49054090|NCT03606512|158028576|FG001|Overall Study|'moved from study area|1|||
49054091|NCT03827018|158028582|FG000|Overall Study|Adverse Event|1|||
49054092|NCT03827018|158028583|FG001|Overall Study|Adverse Event|0|||
49054093|NCT03827018|158028582|FG000|Overall Study|Withdrawal by Subject|2|||
49054094|NCT03827018|158028583|FG001|Overall Study|Withdrawal by Subject|2|||
49054095|NCT03827018|158028582|FG000|Overall Study|Lack of Efficacy|0|||
49054096|NCT03827018|158028583|FG001|Overall Study|Lack of Efficacy|1|||
49054097|NCT05513937|158028584|FG000|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
49054098|NCT05513937|158028585|FG001|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|1|||
49054099|NCT05513937|158028586|FG002|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
49054100|NCT05513937|158028587|FG003|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
49054101|NCT05513937|158028584|FG000|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|2|||
49054102|NCT05513937|158028585|FG001|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|5|||
49054103|NCT05513937|158028586|FG002|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
49054104|NCT05513937|158028587|FG003|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
49054105|NCT05513937|158028584|FG000|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|1|||
49054106|NCT05513937|158028585|FG001|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
49054107|NCT05513937|158028586|FG002|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
49054108|NCT05513937|158028587|FG003|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
49054109|NCT05513937|158028584|FG000|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|1|||
49054110|NCT05513937|158028585|FG001|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
49054111|NCT05513937|158028586|FG002|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
49054112|NCT05513937|158028587|FG003|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
49054113|NCT05513937|158028584|FG000|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
49054114|NCT05513937|158028585|FG001|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
49054115|NCT05513937|158028586|FG002|Combination Therapy (4 to 8 Weeks)|Adverse Event|2|||
49054116|NCT05513937|158028587|FG003|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
49054117|NCT05513937|158028584|FG000|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
49054118|NCT05513937|158028585|FG001|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
49054119|NCT05513937|158028586|FG002|Combination Therapy (4 to 8 Weeks)|Protocol Violation|1|||
49054120|NCT05513937|158028587|FG003|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
49054121|NCT01065454|158028588|FG000|Treatment|Adverse Event|7|||
49054122|NCT01065454|158028589|FG001|Treatment|Adverse Event|4|||
49054123|NCT01065454|158028590|FG002|Treatment|Adverse Event|3|||
49054124|NCT01065454|158028591|FG003|Treatment|Adverse Event|6|||
49054125|NCT01065454|158028588|FG000|Treatment|Death|1|||
49054126|NCT01065454|158028589|FG001|Treatment|Death|0|||
49054127|NCT01065454|158028590|FG002|Treatment|Death|0|||
49054128|NCT01065454|158028591|FG003|Treatment|Death|0|||
49054129|NCT01065454|158028588|FG000|Treatment|Non-compliance|1|||
49054130|NCT01065454|158028589|FG001|Treatment|Non-compliance|0|||
49054131|NCT01065454|158028590|FG002|Treatment|Non-compliance|0|||
49054132|NCT01065454|158028591|FG003|Treatment|Non-compliance|1|||
49054133|NCT01065454|158028588|FG000|Treatment|Protocol Decision|0|||
49054134|NCT01065454|158028589|FG001|Treatment|Protocol Decision|0|||
49054135|NCT01065454|158028590|FG002|Treatment|Protocol Decision|3|||
49054136|NCT01065454|158028591|FG003|Treatment|Protocol Decision|2|||
49054137|NCT01065454|158028588|FG000|Treatment|Protocol Violation|1|||
49054138|NCT01065454|158028589|FG001|Treatment|Protocol Violation|0|||
49054139|NCT01065454|158028590|FG002|Treatment|Protocol Violation|1|||
49054140|NCT01065454|158028591|FG003|Treatment|Protocol Violation|0|||
49054141|NCT01065454|158028588|FG000|Treatment|Withdrawal by Subject|3|||
49054142|NCT01065454|158028589|FG001|Treatment|Withdrawal by Subject|1|||
49054143|NCT01065454|158028590|FG002|Treatment|Withdrawal by Subject|2|||
49054144|NCT01065454|158028591|FG003|Treatment|Withdrawal by Subject|3|||
49054145|NCT01065454|158028588|FG000|Follow up|Adverse Event|1|||
49054146|NCT01065454|158028589|FG001|Follow up|Adverse Event|0|||
49054147|NCT01065454|158028590|FG002|Follow up|Adverse Event|0|||
49054148|NCT01065454|158028591|FG003|Follow up|Adverse Event|1|||
49054149|NCT01065454|158028588|FG000|Follow up|Death|0|||
49054150|NCT01065454|158028589|FG001|Follow up|Death|1|||
49054151|NCT01065454|158028590|FG002|Follow up|Death|1|||
49054152|NCT01065454|158028591|FG003|Follow up|Death|0|||
49054153|NCT01065454|158028588|FG000|Follow up|Lost to Follow-up|0|||
49054154|NCT01065454|158028589|FG001|Follow up|Lost to Follow-up|0|||
49054155|NCT01065454|158028590|FG002|Follow up|Lost to Follow-up|0|||
49054156|NCT01065454|158028591|FG003|Follow up|Lost to Follow-up|1|||
49054157|NCT01065454|158028588|FG000|Follow up|Progressive disease|0|||
49054158|NCT01065454|158028589|FG001|Follow up|Progressive disease|0|||
49054159|NCT01065454|158028590|FG002|Follow up|Progressive disease|0|||
49054160|NCT01065454|158028591|FG003|Follow up|Progressive disease|1|||
49054161|NCT01065454|158028588|FG000|Follow up|Withdrawal by Subject|1|||
49054162|NCT01065454|158028589|FG001|Follow up|Withdrawal by Subject|1|||
49054163|NCT01065454|158028590|FG002|Follow up|Withdrawal by Subject|1|||
49054164|NCT01065454|158028591|FG003|Follow up|Withdrawal by Subject|0|||
49054165|NCT01065454|158028588|FG000|Follow up|study ongoing|37|||
49054166|NCT01065454|158028589|FG001|Follow up|study ongoing|22|||
49054167|NCT01065454|158028590|FG002|Follow up|study ongoing|15|||
49054168|NCT01065454|158028591|FG003|Follow up|study ongoing|41|||
49054169|NCT03691298|158028592|FG000|Overall Study|Lost to Follow-up|8|||
49054170|NCT03691298|158028592|FG000|Overall Study|Sponsor terminated study|2|||
49054171|NCT03982186|158028594|FG000|Overall Study|Lost to Follow-up|0|||
49054172|NCT03982186|158028595|FG001|Overall Study|Lost to Follow-up|1|||
49054173|NCT03982186|158028596|FG002|Overall Study|Lost to Follow-up|2|||
49054174|NCT03982186|158028597|FG003|Overall Study|Lost to Follow-up|1|||
49054175|NCT03982186|158028598|FG004|Overall Study|Lost to Follow-up|1|||
49054176|NCT03982186|158028599|FG005|Overall Study|Lost to Follow-up|0|||
49054177|NCT03982186|158028594|FG000|Overall Study|Physician Decision|0|||
49054178|NCT03982186|158028595|FG001|Overall Study|Physician Decision|1|||
49054179|NCT03982186|158028596|FG002|Overall Study|Physician Decision|0|||
49054180|NCT03982186|158028597|FG003|Overall Study|Physician Decision|0|||
49054181|NCT03982186|158028598|FG004|Overall Study|Physician Decision|0|||
49054182|NCT03982186|158028599|FG005|Overall Study|Physician Decision|0|||
49054183|NCT03982186|158028594|FG000|Overall Study|Withdrawal by Subject|3|||
49054184|NCT03982186|158028595|FG001|Overall Study|Withdrawal by Subject|4|||
49054185|NCT03982186|158028596|FG002|Overall Study|Withdrawal by Subject|1|||
49054186|NCT03982186|158028597|FG003|Overall Study|Withdrawal by Subject|7|||
49054187|NCT03982186|158028598|FG004|Overall Study|Withdrawal by Subject|2|||
49054188|NCT03982186|158028599|FG005|Overall Study|Withdrawal by Subject|0|||
49054189|NCT03982186|158028594|FG000|Overall Study|Randomized and not treated|0|||
49054190|NCT03982186|158028595|FG001|Overall Study|Randomized and not treated|0|||
48692646|NCT03001557|156724542|FG001|Extension Phase|Administrative Reason|0|||
49054191|NCT03982186|158028596|FG002|Overall Study|Randomized and not treated|0|||
49054192|NCT03982186|158028597|FG003|Overall Study|Randomized and not treated|1|||
49054193|NCT03982186|158028598|FG004|Overall Study|Randomized and not treated|0|||
49054194|NCT03982186|158028599|FG005|Overall Study|Randomized and not treated|0|||
49054195|NCT00739973|158028600|FG000|Single-blind Period (2 to 4 Weeks)|Adverse Event|35|||
49054196|NCT00739973|158028601|FG001|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
49054197|NCT00739973|158028602|FG002|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
49054198|NCT00739973|158028603|FG003|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
49054199|NCT00739973|158028604|FG004|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
49054200|NCT00739973|158028605|FG005|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
49054201|NCT00739973|158028606|FG006|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
49054202|NCT00739973|158028607|FG007|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
49054203|NCT00739973|158028608|FG008|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
49054204|NCT00739973|158028600|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38|||
49054205|NCT00739973|158028601|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
49054206|NCT00739973|158028602|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
49054207|NCT00739973|158028603|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
49054208|NCT00739973|158028604|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
49054209|NCT00739973|158028605|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
49054210|NCT00739973|158028606|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
49054211|NCT00739973|158028607|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
49054212|NCT00739973|158028608|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
49054213|NCT00739973|158028600|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810|||
49054214|NCT00739973|158028601|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
49054215|NCT00739973|158028602|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
49054216|NCT00739973|158028603|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
49054217|NCT00739973|158028604|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
49054218|NCT00739973|158028605|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
49054219|NCT00739973|158028606|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
49054220|NCT00739973|158028607|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
49054221|NCT00739973|158028608|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
49054222|NCT00739973|158028600|FG000|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86|||
49054223|NCT00739973|158028601|FG001|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
49054224|NCT00739973|158028602|FG002|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
49054225|NCT00739973|158028603|FG003|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
49054226|NCT00739973|158028604|FG004|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
49054227|NCT00739973|158028605|FG005|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
49054228|NCT00739973|158028606|FG006|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
49054229|NCT00739973|158028607|FG007|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
49054230|NCT00739973|158028608|FG008|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
49054231|NCT00739973|158028600|FG000|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17|||
49054232|NCT00739973|158028601|FG001|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
49054233|NCT00739973|158028602|FG002|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
49054234|NCT00739973|158028603|FG003|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
49054235|NCT00739973|158028604|FG004|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
49054236|NCT00739973|158028605|FG005|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
49054237|NCT00739973|158028606|FG006|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
49054238|NCT00739973|158028607|FG007|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
49054239|NCT00739973|158028608|FG008|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
49054240|NCT00739973|158028600|FG000|Single-blind Period (2 to 4 Weeks)|Administrative problems|12|||
49054241|NCT00739973|158028601|FG001|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
49054242|NCT00739973|158028602|FG002|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
49054243|NCT00739973|158028603|FG003|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
49054244|NCT00739973|158028604|FG004|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
49054245|NCT00739973|158028605|FG005|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
49054246|NCT00739973|158028606|FG006|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
49054247|NCT00739973|158028607|FG007|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
49054248|NCT00739973|158028608|FG008|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
49054249|NCT00739973|158028600|FG000|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11|||
49054250|NCT00739973|158028601|FG001|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
49054251|NCT00739973|158028602|FG002|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
49054252|NCT00739973|158028603|FG003|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
49054253|NCT00739973|158028604|FG004|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
49054254|NCT00739973|158028605|FG005|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
49054255|NCT00739973|158028606|FG006|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
49054256|NCT00739973|158028607|FG007|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
49054257|NCT00739973|158028608|FG008|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
49054258|NCT00739973|158028600|FG000|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
49054259|NCT00739973|158028601|FG001|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
49054260|NCT00739973|158028602|FG002|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
49054261|NCT00739973|158028603|FG003|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2|||
49054262|NCT00739973|158028604|FG004|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7|||
49054263|NCT00739973|158028605|FG005|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
49054264|NCT00739973|158028606|FG006|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
49054265|NCT00739973|158028607|FG007|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
49054266|NCT00739973|158028608|FG008|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
49054267|NCT00739973|158028600|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
49054268|NCT00739973|158028601|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
49054269|NCT00739973|158028602|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
49054270|NCT00739973|158028603|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
49054271|NCT00739973|158028604|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
49054272|NCT00739973|158028605|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
49054273|NCT00739973|158028606|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
49054274|NCT00739973|158028607|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
49054275|NCT00739973|158028608|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
49054276|NCT00739973|158028600|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
49054277|NCT00739973|158028601|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
49054278|NCT00739973|158028602|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
49054279|NCT00739973|158028603|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
49054280|NCT00739973|158028604|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
49054281|NCT00739973|158028605|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
49054282|NCT00739973|158028606|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
49054283|NCT00739973|158028607|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
49054284|NCT00739973|158028608|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
49054285|NCT00739973|158028600|FG000|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17|||
49054286|NCT00739973|158028601|FG001|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
49054287|NCT00739973|158028602|FG002|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
49054288|NCT00739973|158028603|FG003|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4|||
49054289|NCT00739973|158028604|FG004|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
49054290|NCT00739973|158028605|FG005|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
49054291|NCT00739973|158028606|FG006|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
49054292|NCT00739973|158028607|FG007|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
49054293|NCT00739973|158028608|FG008|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
49054294|NCT00739973|158028600|FG000|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
49054295|NCT00739973|158028601|FG001|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
49054296|NCT00739973|158028602|FG002|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1|||
49054297|NCT00739973|158028603|FG003|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
49054298|NCT00739973|158028604|FG004|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
49054299|NCT00739973|158028605|FG005|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
49054300|NCT00739973|158028606|FG006|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
49054301|NCT00739973|158028607|FG007|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
49054302|NCT00739973|158028608|FG008|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
49054303|NCT00739973|158028600|FG000|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
49054304|NCT00739973|158028601|FG001|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
49054305|NCT00739973|158028602|FG002|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
49054306|NCT00739973|158028603|FG003|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
49054307|NCT00739973|158028604|FG004|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
49054308|NCT00739973|158028605|FG005|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
49054309|NCT00739973|158028606|FG006|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
49054310|NCT00739973|158028607|FG007|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
49054311|NCT00739973|158028608|FG008|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
49054312|NCT00739973|158028600|FG000|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
49054313|NCT00739973|158028601|FG001|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
49054314|NCT00739973|158028602|FG002|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4|||
49054315|NCT00739973|158028603|FG003|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
49054316|NCT00739973|158028604|FG004|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
49054317|NCT00739973|158028605|FG005|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
49054318|NCT00739973|158028606|FG006|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
49054319|NCT00739973|158028607|FG007|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3|||
49054320|NCT00739973|158028608|FG008|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
49054321|NCT00739973|158028600|FG000|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
49054322|NCT00739973|158028601|FG001|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
49054323|NCT00739973|158028602|FG002|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
49054324|NCT00739973|158028603|FG003|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
49054325|NCT00739973|158028604|FG004|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
49054326|NCT00739973|158028605|FG005|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
49054327|NCT00739973|158028606|FG006|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1|||
49054328|NCT00739973|158028607|FG007|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
49054329|NCT00739973|158028608|FG008|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
49054330|NCT00739973|158028600|FG000|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5|||
49054331|NCT00739973|158028601|FG001|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
49054332|NCT00739973|158028602|FG002|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
49054333|NCT00739973|158028603|FG003|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
49054334|NCT00739973|158028604|FG004|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
49054335|NCT00739973|158028605|FG005|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
49054336|NCT00739973|158028606|FG006|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
49054337|NCT00739973|158028607|FG007|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
49054338|NCT00739973|158028608|FG008|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
49054339|NCT00739973|158028600|FG000|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
49054340|NCT00739973|158028601|FG001|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1|||
49054341|NCT00739973|158028602|FG002|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
49054342|NCT00739973|158028603|FG003|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
49054343|NCT00739973|158028604|FG004|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
49054344|NCT00739973|158028605|FG005|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
49054345|NCT00739973|158028606|FG006|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2|||
49054346|NCT00739973|158028607|FG007|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
49054347|NCT00739973|158028608|FG008|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
49054348|NCT00980460|158028612|FG000|Overall Study|Death|0|||
49054349|NCT00980460|158028613|FG001|Overall Study|Death|0|||
49054350|NCT00980460|158028614|FG002|Overall Study|Death|1|||
49054351|NCT00980460|158028615|FG003|Overall Study|Death|2|||
49054352|NCT00980460|158028616|FG004|Overall Study|Death|1|||
49054353|NCT00980460|158028612|FG000|Overall Study|Lack of Efficacy|0|||
49054354|NCT00980460|158028613|FG001|Overall Study|Lack of Efficacy|0|||
49054355|NCT00980460|158028614|FG002|Overall Study|Lack of Efficacy|10|||
49054356|NCT00980460|158028615|FG003|Overall Study|Lack of Efficacy|6|||
49054357|NCT00980460|158028616|FG004|Overall Study|Lack of Efficacy|8|||
49054358|NCT00980460|158028612|FG000|Overall Study|Lost to Follow-up|0|||
49054359|NCT00980460|158028613|FG001|Overall Study|Lost to Follow-up|0|||
49054360|NCT00980460|158028614|FG002|Overall Study|Lost to Follow-up|0|||
49054361|NCT00980460|158028615|FG003|Overall Study|Lost to Follow-up|1|||
49054362|NCT00980460|158028616|FG004|Overall Study|Lost to Follow-up|0|||
49054363|NCT00980460|158028612|FG000|Overall Study|Physician Decision|0|||
49054364|NCT00980460|158028613|FG001|Overall Study|Physician Decision|0|||
49054365|NCT00980460|158028614|FG002|Overall Study|Physician Decision|11|||
49054366|NCT00980460|158028615|FG003|Overall Study|Physician Decision|5|||
49054367|NCT00980460|158028616|FG004|Overall Study|Physician Decision|3|||
49054368|NCT00980460|158028612|FG000|Overall Study|Withdrawal by Subject|0|||
49054369|NCT00980460|158028613|FG001|Overall Study|Withdrawal by Subject|0|||
49054370|NCT00980460|158028614|FG002|Overall Study|Withdrawal by Subject|1|||
49054371|NCT00980460|158028615|FG003|Overall Study|Withdrawal by Subject|0|||
49054372|NCT00980460|158028616|FG004|Overall Study|Withdrawal by Subject|0|||
49054373|NCT00980460|158028612|FG000|Overall Study|Ineligible|0|||
49054374|NCT00980460|158028613|FG001|Overall Study|Ineligible|2|||
49054375|NCT00980460|158028614|FG002|Overall Study|Ineligible|3|||
49054376|NCT00980460|158028615|FG003|Overall Study|Ineligible|1|||
49054377|NCT00980460|158028616|FG004|Overall Study|Ineligible|4|||
49054378|NCT00980460|158028612|FG000|Overall Study|Refusal of further therapy|0|||
49054379|NCT00980460|158028613|FG001|Overall Study|Refusal of further therapy|2|||
49054380|NCT00980460|158028614|FG002|Overall Study|Refusal of further therapy|3|||
49054381|NCT00980460|158028615|FG003|Overall Study|Refusal of further therapy|2|||
49054382|NCT00980460|158028616|FG004|Overall Study|Refusal of further therapy|0|||
49054383|NCT00980460|158028612|FG000|Overall Study|No therapy within 42 days of resection|0|||
49054384|NCT00980460|158028613|FG001|Overall Study|No therapy within 42 days of resection|0|||
49054385|NCT00980460|158028614|FG002|Overall Study|No therapy within 42 days of resection|3|||
49054386|NCT00980460|158028615|FG003|Overall Study|No therapy within 42 days of resection|1|||
49054387|NCT00980460|158028616|FG004|Overall Study|No therapy within 42 days of resection|0|||
49054388|NCT00980460|158028612|FG000|Overall Study|No transplant by protocol timepoints|0|||
49054389|NCT00980460|158028613|FG001|Overall Study|No transplant by protocol timepoints|0|||
49054390|NCT00980460|158028614|FG002|Overall Study|No transplant by protocol timepoints|3|||
49054391|NCT00980460|158028615|FG003|Overall Study|No transplant by protocol timepoints|0|||
49054392|NCT00980460|158028616|FG004|Overall Study|No transplant by protocol timepoints|0|||
49054393|NCT00302211|158028617|FG000|Double Blind Period (New Patients)|Withdrawal by Subject|2|||
49054394|NCT00302211|158028618|FG001|Double Blind Period (New Patients)|Withdrawal by Subject|1|||
49054395|NCT00302211|158028619|FG002|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
49054396|NCT00302211|158028620|FG003|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
49054397|NCT00302211|158028621|FG004|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
49054398|NCT00302211|158028617|FG000|Double Blind Period (New Patients)|Adverse Event|0|||
49054399|NCT00302211|158028618|FG001|Double Blind Period (New Patients)|Adverse Event|0|||
49054400|NCT00302211|158028619|FG002|Double Blind Period (New Patients)|Adverse Event|3|||
49054401|NCT00302211|158028620|FG003|Double Blind Period (New Patients)|Adverse Event|0|||
49054402|NCT00302211|158028621|FG004|Double Blind Period (New Patients)|Adverse Event|0|||
49054403|NCT00302211|158028617|FG000|Double Blind Period (New Patients)|Investigator's judgement|1|||
49054404|NCT00302211|158028618|FG001|Double Blind Period (New Patients)|Investigator's judgement|0|||
49054405|NCT00302211|158028619|FG002|Double Blind Period (New Patients)|Investigator's judgement|0|||
49054406|NCT00302211|158028620|FG003|Double Blind Period (New Patients)|Investigator's judgement|0|||
49054407|NCT00302211|158028621|FG004|Double Blind Period (New Patients)|Investigator's judgement|0|||
49054408|NCT00302211|158028617|FG000|Double Blind Period (New Patients)|Disease progression|0|||
49054409|NCT00302211|158028618|FG001|Double Blind Period (New Patients)|Disease progression|1|||
49054410|NCT00302211|158028619|FG002|Double Blind Period (New Patients)|Disease progression|1|||
49054411|NCT00302211|158028620|FG003|Double Blind Period (New Patients)|Disease progression|0|||
49054412|NCT00302211|158028621|FG004|Double Blind Period (New Patients)|Disease progression|0|||
49054413|NCT00302211|158028617|FG000|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
49054414|NCT00302211|158028618|FG001|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
49054415|NCT00302211|158028619|FG002|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
49054416|NCT00302211|158028620|FG003|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
49054417|NCT00302211|158028621|FG004|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
49054418|NCT00302211|158028617|FG000|Open Label-Patients From Double-Blind|Adverse Event|0|||
49054419|NCT00302211|158028618|FG001|Open Label-Patients From Double-Blind|Adverse Event|0|||
49054420|NCT00302211|158028619|FG002|Open Label-Patients From Double-Blind|Adverse Event|0|||
49054421|NCT00302211|158028620|FG003|Open Label-Patients From Double-Blind|Adverse Event|1|||
49054422|NCT00302211|158028621|FG004|Open Label-Patients From Double-Blind|Adverse Event|0|||
49054423|NCT00302211|158028617|FG000|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
49054424|NCT00302211|158028618|FG001|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
49054425|NCT00302211|158028619|FG002|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
49054426|NCT00302211|158028620|FG003|Open Label-Patients From Double-Blind|Investigator's judgement|1|||
49054427|NCT00302211|158028621|FG004|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
49054428|NCT00302211|158028617|FG000|Open Label-Patients From Double-Blind|Disease progression|0|||
49054429|NCT00302211|158028618|FG001|Open Label-Patients From Double-Blind|Disease progression|0|||
49054430|NCT00302211|158028619|FG002|Open Label-Patients From Double-Blind|Disease progression|0|||
49054431|NCT00302211|158028620|FG003|Open Label-Patients From Double-Blind|Disease progression|1|||
49054432|NCT00302211|158028621|FG004|Open Label-Patients From Double-Blind|Disease progression|2|||
49054433|NCT00302211|158028617|FG000|Open Label-Patients From Double-Blind|Death|0|||
49054434|NCT00302211|158028618|FG001|Open Label-Patients From Double-Blind|Death|0|||
49054435|NCT00302211|158028619|FG002|Open Label-Patients From Double-Blind|Death|0|||
49054436|NCT00302211|158028620|FG003|Open Label-Patients From Double-Blind|Death|1|||
49054437|NCT00302211|158028621|FG004|Open Label-Patients From Double-Blind|Death|1|||
49054438|NCT00302211|158028617|FG000|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
49054439|NCT00302211|158028618|FG001|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
49054440|NCT00302211|158028619|FG002|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
49054441|NCT00302211|158028620|FG003|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
49054442|NCT00302211|158028621|FG004|Open Label-Patients From Double-Blind|Lost to Follow-up|1|||
49054443|NCT00302211|158028617|FG000|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
49054444|NCT00302211|158028618|FG001|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
49054445|NCT00302211|158028619|FG002|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
49054446|NCT00302211|158028620|FG003|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
49054447|NCT00302211|158028621|FG004|Open Label-Patients From Double-Blind|PH requiring lung transplant|1|||
49054448|NCT00302211|158028617|FG000|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
49054449|NCT00302211|158028618|FG001|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
49054450|NCT00302211|158028619|FG002|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
49054451|NCT00302211|158028620|FG003|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1|||
49054452|NCT00302211|158028621|FG004|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
49054453|NCT01338415|158030610|FG000|Core + Extension|Adverse Event|8|||
49054454|NCT01338415|158030611|FG001|Core + Extension|Adverse Event|6|||
49054455|NCT01338415|158030612|FG002|Core + Extension|Adverse Event|0|||
49054456|NCT01338415|158030610|FG000|Core + Extension|Withdrawal by Subject|1|||
49054457|NCT01338415|158030611|FG001|Core + Extension|Withdrawal by Subject|1|||
49054458|NCT01338415|158030612|FG002|Core + Extension|Withdrawal by Subject|0|||
49054459|NCT01338415|158030610|FG000|Core + Extension|Other (PAH not the main etiology of PH)|0|||
49054460|NCT01338415|158030611|FG001|Core + Extension|Other (PAH not the main etiology of PH)|2|||
49054461|NCT01338415|158030612|FG002|Core + Extension|Other (PAH not the main etiology of PH)|0|||
49054462|NCT01338415|158030610|FG000|Core + Extension|Other (administrative reason)|1|||
49054463|NCT01338415|158030611|FG001|Core + Extension|Other (administrative reason)|0|||
49054464|NCT01338415|158030612|FG002|Core + Extension|Other (administrative reason)|0|||
49054465|NCT01338415|158030610|FG000|Exceptional Use Treatment Period|Administrative decision|0|||
49054466|NCT01338415|158030611|FG001|Exceptional Use Treatment Period|Administrative decision|0|||
49054467|NCT01338415|158030612|FG002|Exceptional Use Treatment Period|Administrative decision|1|||
49054468|NCT01338415|158030610|FG000|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
49054469|NCT01338415|158030611|FG001|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
49054470|NCT01338415|158030612|FG002|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3|||
49054471|NCT01338415|158030610|FG000|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
49054472|NCT01338415|158030611|FG001|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
49054473|NCT01338415|158030612|FG002|Exceptional Use Treatment Period|Withdrawal by Subject|1|||
49054474|NCT01338415|158030610|FG000|Exceptional Use Treatment Period|Death|0|||
49054475|NCT01338415|158030611|FG001|Exceptional Use Treatment Period|Death|0|||
49054476|NCT01338415|158030612|FG002|Exceptional Use Treatment Period|Death|1|||
49054477|NCT04774380|158030616|FG000|Overall Study|Patients ongoing study at data cut-off|75|||
49054478|NCT00991510|158030617|FG000|Period I (Days 1-14)|Adverse Event|1|||
49054479|NCT00991510|158030618|FG001|Period I (Days 1-14)|Adverse Event|0|||
49054480|NCT00991510|158030617|FG000|Period III (Days 29-112)|Adverse Event|1|||
49054481|NCT00991510|158030618|FG001|Period III (Days 29-112)|Adverse Event|1|||
49054482|NCT01369355|158030621|FG000|Week 0 - Week 44 (Maintenance)|Adverse Event|9|||
49054483|NCT01369355|158030622|FG001|Week 0 - Week 44 (Maintenance)|Adverse Event|12|||
49054484|NCT01369355|158030623|FG002|Week 0 - Week 44 (Maintenance)|Adverse Event|6|||
49054485|NCT01369355|158030624|FG003|Week 0 - Week 44 (Maintenance)|Adverse Event|7|||
49054486|NCT01369355|158030625|FG004|Week 0 - Week 44 (Maintenance)|Adverse Event|14|||
49054487|NCT01369355|158030626|FG005|Week 0 - Week 44 (Maintenance)|Adverse Event|25|||
49054488|NCT01369355|158030627|FG006|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
49054489|NCT01369355|158030628|FG007|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
49054490|NCT01369355|158030629|FG008|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
49054491|NCT01369355|158030621|FG000|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
49054492|NCT01369355|158030622|FG001|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14|||
49054493|NCT01369355|158030623|FG002|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
49054494|NCT01369355|158030624|FG003|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
49054495|NCT01369355|158030625|FG004|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126|||
49054496|NCT01369355|158030626|FG005|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217|||
49054497|NCT01369355|158030627|FG006|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
49054498|NCT01369355|158030628|FG007|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
49054499|NCT01369355|158030629|FG008|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
49054500|NCT01369355|158030621|FG000|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
49054501|NCT01369355|158030622|FG001|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
49054502|NCT01369355|158030623|FG002|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
49054503|NCT01369355|158030624|FG003|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
49054504|NCT01369355|158030625|FG004|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
49054505|NCT01369355|158030626|FG005|Week 0 - Week 44 (Maintenance)|Protocol Violation|2|||
49054506|NCT01369355|158030627|FG006|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
49054507|NCT01369355|158030628|FG007|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
49054508|NCT01369355|158030629|FG008|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
49054509|NCT01369355|158030621|FG000|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
49054510|NCT01369355|158030622|FG001|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
49054511|NCT01369355|158030623|FG002|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
49054512|NCT01369355|158030624|FG003|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2|||
49054513|NCT01369355|158030625|FG004|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5|||
49054514|NCT01369355|158030626|FG005|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6|||
49054515|NCT01369355|158030627|FG006|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
49054516|NCT01369355|158030628|FG007|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
49054517|NCT01369355|158030629|FG008|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
49054518|NCT01369355|158030621|FG000|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
49054519|NCT01369355|158030622|FG001|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2|||
49054520|NCT01369355|158030623|FG002|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7|||
49054521|NCT01369355|158030624|FG003|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
49054522|NCT01369355|158030625|FG004|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8|||
49054523|NCT01369355|158030626|FG005|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22|||
49054524|NCT01369355|158030627|FG006|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
49054525|NCT01369355|158030628|FG007|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
49054526|NCT01369355|158030629|FG008|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
49054527|NCT01369355|158030621|FG000|Week 0 - Week 44 (Maintenance)|Other|0|||
49054528|NCT01369355|158030622|FG001|Week 0 - Week 44 (Maintenance)|Other|0|||
49054529|NCT01369355|158030623|FG002|Week 0 - Week 44 (Maintenance)|Other|1|||
49054530|NCT01369355|158030624|FG003|Week 0 - Week 44 (Maintenance)|Other|0|||
49054531|NCT01369355|158030625|FG004|Week 0 - Week 44 (Maintenance)|Other|1|||
49054532|NCT01369355|158030626|FG005|Week 0 - Week 44 (Maintenance)|Other|0|||
49054533|NCT01369355|158030627|FG006|Week 0 - Week 44 (Maintenance)|Other|0|||
49054534|NCT01369355|158030628|FG007|Week 0 - Week 44 (Maintenance)|Other|0|||
49054535|NCT01369355|158030629|FG008|Week 0 - Week 44 (Maintenance)|Other|0|||
49054536|NCT01369355|158030621|FG000|Long-term Extension (Week 44-272)|Adverse Event|0|||
49054537|NCT01369355|158030622|FG001|Long-term Extension (Week 44-272)|Adverse Event|0|||
49054538|NCT01369355|158030623|FG002|Long-term Extension (Week 44-272)|Adverse Event|0|||
49054539|NCT01369355|158030624|FG003|Long-term Extension (Week 44-272)|Adverse Event|0|||
49054540|NCT01369355|158030625|FG004|Long-term Extension (Week 44-272)|Adverse Event|0|||
49054541|NCT01369355|158030626|FG005|Long-term Extension (Week 44-272)|Adverse Event|0|||
49054542|NCT01369355|158030627|FG006|Long-term Extension (Week 44-272)|Adverse Event|15|||
49054543|NCT01369355|158030628|FG007|Long-term Extension (Week 44-272)|Adverse Event|29|||
49054544|NCT01369355|158030629|FG008|Long-term Extension (Week 44-272)|Adverse Event|53|||
49054545|NCT01369355|158030621|FG000|Long-term Extension (Week 44-272)|Death|0|||
49054546|NCT01369355|158030622|FG001|Long-term Extension (Week 44-272)|Death|0|||
49054547|NCT01369355|158030623|FG002|Long-term Extension (Week 44-272)|Death|0|||
49054548|NCT01369355|158030624|FG003|Long-term Extension (Week 44-272)|Death|0|||
49054549|NCT01369355|158030625|FG004|Long-term Extension (Week 44-272)|Death|0|||
49054550|NCT01369355|158030626|FG005|Long-term Extension (Week 44-272)|Death|0|||
49054551|NCT01369355|158030627|FG006|Long-term Extension (Week 44-272)|Death|0|||
49054552|NCT01369355|158030628|FG007|Long-term Extension (Week 44-272)|Death|1|||
49054553|NCT01369355|158030629|FG008|Long-term Extension (Week 44-272)|Death|3|||
49054554|NCT01369355|158030621|FG000|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
49054555|NCT01369355|158030622|FG001|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
49054556|NCT01369355|158030623|FG002|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
49054557|NCT01369355|158030624|FG003|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
49054558|NCT01369355|158030625|FG004|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
49054559|NCT01369355|158030626|FG005|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
49054560|NCT01369355|158030627|FG006|Long-term Extension (Week 44-272)|Lack of Efficacy|12|||
49054561|NCT01369355|158030628|FG007|Long-term Extension (Week 44-272)|Lack of Efficacy|26|||
49054562|NCT01369355|158030629|FG008|Long-term Extension (Week 44-272)|Lack of Efficacy|29|||
49054563|NCT01369355|158030621|FG000|Long-term Extension (Week 44-272)|Protocol Violation|0|||
49054564|NCT01369355|158030622|FG001|Long-term Extension (Week 44-272)|Protocol Violation|0|||
49054565|NCT01369355|158030623|FG002|Long-term Extension (Week 44-272)|Protocol Violation|0|||
49054566|NCT01369355|158030624|FG003|Long-term Extension (Week 44-272)|Protocol Violation|0|||
49054567|NCT01369355|158030625|FG004|Long-term Extension (Week 44-272)|Protocol Violation|0|||
49054568|NCT01369355|158030626|FG005|Long-term Extension (Week 44-272)|Protocol Violation|0|||
49054569|NCT01369355|158030627|FG006|Long-term Extension (Week 44-272)|Protocol Violation|0|||
49054570|NCT01369355|158030628|FG007|Long-term Extension (Week 44-272)|Protocol Violation|1|||
49054571|NCT01369355|158030629|FG008|Long-term Extension (Week 44-272)|Protocol Violation|2|||
49054572|NCT01369355|158030621|FG000|Long-term Extension (Week 44-272)|Physician Decision|0|||
49054573|NCT01369355|158030622|FG001|Long-term Extension (Week 44-272)|Physician Decision|0|||
49054574|NCT01369355|158030623|FG002|Long-term Extension (Week 44-272)|Physician Decision|0|||
49054575|NCT01369355|158030624|FG003|Long-term Extension (Week 44-272)|Physician Decision|0|||
49054576|NCT01369355|158030625|FG004|Long-term Extension (Week 44-272)|Physician Decision|0|||
49054577|NCT01369355|158030626|FG005|Long-term Extension (Week 44-272)|Physician Decision|0|||
49054578|NCT01369355|158030627|FG006|Long-term Extension (Week 44-272)|Physician Decision|1|||
49054579|NCT01369355|158030628|FG007|Long-term Extension (Week 44-272)|Physician Decision|5|||
49054580|NCT01369355|158030629|FG008|Long-term Extension (Week 44-272)|Physician Decision|11|||
49054581|NCT01369355|158030621|FG000|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
49054582|NCT01369355|158030622|FG001|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
49054583|NCT01369355|158030623|FG002|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
49054584|NCT01369355|158030624|FG003|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
49054585|NCT01369355|158030625|FG004|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
49054586|NCT01369355|158030626|FG005|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
49054587|NCT01369355|158030627|FG006|Long-term Extension (Week 44-272)|Lost to Follow-up|1|||
49054588|NCT01369355|158030628|FG007|Long-term Extension (Week 44-272)|Lost to Follow-up|5|||
49054589|NCT01369355|158030629|FG008|Long-term Extension (Week 44-272)|Lost to Follow-up|9|||
49054590|NCT01369355|158030621|FG000|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
49054591|NCT01369355|158030622|FG001|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
49054592|NCT01369355|158030623|FG002|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
49054593|NCT01369355|158030624|FG003|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
49054594|NCT01369355|158030625|FG004|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
49054595|NCT01369355|158030626|FG005|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
49054596|NCT01369355|158030627|FG006|Long-term Extension (Week 44-272)|Withdrawal by Subject|12|||
49054597|NCT01369355|158030628|FG007|Long-term Extension (Week 44-272)|Withdrawal by Subject|30|||
49054598|NCT01369355|158030629|FG008|Long-term Extension (Week 44-272)|Withdrawal by Subject|47|||
49054599|NCT01369355|158030621|FG000|Long-term Extension (Week 44-272)|Other|0|||
49054600|NCT01369355|158030622|FG001|Long-term Extension (Week 44-272)|Other|0|||
49054601|NCT01369355|158030623|FG002|Long-term Extension (Week 44-272)|Other|0|||
49054602|NCT01369355|158030624|FG003|Long-term Extension (Week 44-272)|Other|0|||
49054603|NCT01369355|158030625|FG004|Long-term Extension (Week 44-272)|Other|0|||
49054604|NCT01369355|158030626|FG005|Long-term Extension (Week 44-272)|Other|0|||
49054605|NCT01369355|158030627|FG006|Long-term Extension (Week 44-272)|Other|110|||
49054606|NCT01369355|158030628|FG007|Long-term Extension (Week 44-272)|Other|9|||
49054607|NCT01369355|158030629|FG008|Long-term Extension (Week 44-272)|Other|17|||
49054608|NCT01729026|158030630|FG000|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
49054609|NCT01729026|158030631|FG001|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
49054610|NCT01729026|158030630|FG000|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1|||
49054611|NCT01729026|158030631|FG001|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2|||
49054612|NCT00852917|158030637|FG000|Overall Study|Adverse Event|13|||
49054613|NCT00852917|158030638|FG001|Overall Study|Adverse Event|20|||
49054614|NCT00852917|158030639|FG002|Overall Study|Adverse Event|35|||
49054615|NCT00852917|158030640|FG003|Overall Study|Adverse Event|17|||
49054616|NCT00852917|158030637|FG000|Overall Study|Lack of Efficacy|21|||
49054617|NCT00852917|158030638|FG001|Overall Study|Lack of Efficacy|11|||
49054618|NCT00852917|158030639|FG002|Overall Study|Lack of Efficacy|11|||
49054619|NCT00852917|158030640|FG003|Overall Study|Lack of Efficacy|47|||
49054620|NCT00852917|158030637|FG000|Overall Study|Withdrawal by Subject|4|||
49054621|NCT00852917|158030638|FG001|Overall Study|Withdrawal by Subject|8|||
49054622|NCT00852917|158030639|FG002|Overall Study|Withdrawal by Subject|10|||
49054623|NCT00852917|158030640|FG003|Overall Study|Withdrawal by Subject|9|||
49054624|NCT00852917|158030637|FG000|Overall Study|Physician Decision|6|||
49054625|NCT00852917|158030638|FG001|Overall Study|Physician Decision|7|||
49054626|NCT00852917|158030639|FG002|Overall Study|Physician Decision|2|||
49054627|NCT00852917|158030640|FG003|Overall Study|Physician Decision|19|||
49054628|NCT00852917|158030637|FG000|Overall Study|Death|0|||
49054629|NCT00852917|158030638|FG001|Overall Study|Death|0|||
49054630|NCT00852917|158030639|FG002|Overall Study|Death|0|||
49054631|NCT00852917|158030640|FG003|Overall Study|Death|1|||
49054632|NCT03710590|158030641|FG000|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10|||
49054633|NCT03710590|158030642|FG001|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8|||
49054634|NCT00407745|158030644|FG000|Overall Study|Lack of Efficacy|1|||
49054635|NCT00407745|158030645|FG001|Overall Study|Lack of Efficacy|2|||
49054636|NCT00407745|158030644|FG000|Overall Study|Withdrawal by Subject|3|||
49054637|NCT00407745|158030645|FG001|Overall Study|Withdrawal by Subject|3|||
49054638|NCT00407745|158030644|FG000|Overall Study|Protocol Violation|5|||
49054639|NCT00407745|158030645|FG001|Overall Study|Protocol Violation|3|||
49054640|NCT00407745|158030644|FG000|Overall Study|Adverse Event|8|||
49054641|NCT00407745|158030645|FG001|Overall Study|Adverse Event|8|||
49054642|NCT00407745|158030644|FG000|Overall Study|Other|2|||
49054643|NCT00407745|158030645|FG001|Overall Study|Other|0|||
49054644|NCT00407745|158030644|FG000|Overall Study|Randomized, unknown if treated|0|||
49054645|NCT00407745|158030645|FG001|Overall Study|Randomized, unknown if treated|1|||
49054670|NCT05364671|158030650|FG000|Overall Study|Negative PCR result for SARS-CoV-2|20|||
49054671|NCT05364671|158030651|FG001|Overall Study|Negative PCR result for SARS-CoV-2|26|||
49054672|NCT05364671|158030650|FG000|Overall Study|Patient's inability or refusal to comply with protocol requirements|3|||
49054673|NCT05364671|158030651|FG001|Overall Study|Patient's inability or refusal to comply with protocol requirements|1|||
49054674|NCT05364671|158030650|FG000|Overall Study|Need to prescribe prohibited drugs in this study|1|||
49054675|NCT05364671|158030651|FG001|Overall Study|Need to prescribe prohibited drugs in this study|3|||
49054676|NCT05364671|158030650|FG000|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|2|||
49054677|NCT05364671|158030651|FG001|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|0|||
49054678|NCT05364671|158030650|FG000|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|0|||
49054679|NCT05364671|158030651|FG001|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|1|||
49054680|NCT04281498|158030652|FG000|Overall Study|Progression of disease|1|||
49054681|NCT04281498|158030652|FG000|Overall Study|Planned SCT|1|||
49054682|NCT04281498|158030652|FG000|Overall Study|Alternative Treatment|1|||
49054683|NCT01647711|158030653|FG000|Overall Study|Progressive disease|6|||
49054684|NCT01647711|158030654|FG001|Overall Study|Progressive disease|2|||
49054685|NCT01647711|158030655|FG002|Overall Study|Progressive disease|6|||
49054686|NCT01647711|158030656|FG003|Overall Study|Progressive disease|8|||
49054687|NCT01647711|158030657|FG004|Overall Study|Progressive disease|2|||
49054688|NCT01647711|158030653|FG000|Overall Study|Other adverse event|0|||
49054689|NCT01647711|158030654|FG001|Overall Study|Other adverse event|0|||
49054690|NCT01647711|158030655|FG002|Overall Study|Other adverse event|2|||
49054691|NCT01647711|158030656|FG003|Overall Study|Other adverse event|0|||
49054692|NCT01647711|158030657|FG004|Overall Study|Other adverse event|2|||
49054693|NCT01647711|158030653|FG000|Overall Study|Protocol Violation|0|||
49054694|NCT01647711|158030654|FG001|Overall Study|Protocol Violation|0|||
49054695|NCT01647711|158030655|FG002|Overall Study|Protocol Violation|0|||
49054696|NCT01647711|158030656|FG003|Overall Study|Protocol Violation|0|||
49054697|NCT01647711|158030657|FG004|Overall Study|Protocol Violation|1|||
49054698|NCT01647711|158030653|FG000|Overall Study|Refused to continue taking medication|0|||
49054699|NCT01647711|158030654|FG001|Overall Study|Refused to continue taking medication|0|||
49054700|NCT01647711|158030655|FG002|Overall Study|Refused to continue taking medication|0|||
49054701|NCT01647711|158030656|FG003|Overall Study|Refused to continue taking medication|2|||
49054702|NCT01647711|158030657|FG004|Overall Study|Refused to continue taking medication|1|||
49054703|NCT01647711|158030653|FG000|Overall Study|Other reason not defined|0|||
49054704|NCT01647711|158030654|FG001|Overall Study|Other reason not defined|1|||
49054705|NCT01647711|158030655|FG002|Overall Study|Other reason not defined|1|||
49054706|NCT01647711|158030656|FG003|Overall Study|Other reason not defined|1|||
49054707|NCT01647711|158030657|FG004|Overall Study|Other reason not defined|0|||
49054708|NCT03628924|158030666|FG000|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2|||
49054709|NCT03628924|158030667|FG001|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
49054710|NCT03628924|158030668|FG002|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
49054711|NCT03628924|158030669|FG003|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
49054712|NCT03628924|158030670|FG004|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
49054713|NCT03628924|158030671|FG005|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
49054714|NCT03628924|158030672|FG006|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
49054715|NCT03628924|158030666|FG000|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
49054716|NCT03628924|158030667|FG001|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
49054717|NCT03628924|158030668|FG002|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
49054718|NCT03628924|158030669|FG003|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
49054719|NCT03628924|158030670|FG004|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
49054720|NCT03628924|158030671|FG005|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
49054721|NCT03628924|158030672|FG006|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
49054722|NCT03628924|158030666|FG000|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
49054723|NCT03628924|158030667|FG001|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2|||
49054724|NCT03628924|158030668|FG002|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
49054725|NCT03628924|158030669|FG003|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
49054726|NCT03628924|158030670|FG004|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
49054727|NCT03628924|158030671|FG005|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
49054728|NCT03628924|158030672|FG006|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
49054729|NCT03628924|158030666|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
49054730|NCT03628924|158030667|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
49054731|NCT03628924|158030668|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
49054732|NCT03628924|158030669|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
49054733|NCT03628924|158030670|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
49054734|NCT03628924|158030671|FG005|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
49054735|NCT03628924|158030672|FG006|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
49054736|NCT03628924|158030666|FG000|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3|||
49054737|NCT03628924|158030667|FG001|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
49054738|NCT03628924|158030668|FG002|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1|||
49054739|NCT03628924|158030669|FG003|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
49054740|NCT03628924|158030670|FG004|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
49054741|NCT03628924|158030671|FG005|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
49054742|NCT03628924|158030672|FG006|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
49054743|NCT03628924|158030666|FG000|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
49054744|NCT03628924|158030667|FG001|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
49054745|NCT03628924|158030668|FG002|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
49054746|NCT03628924|158030669|FG003|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
49054747|NCT03628924|158030670|FG004|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
49054748|NCT03628924|158030671|FG005|Active Treatment Period (Week 16-48)|Lost to Follow-up|2|||
49054749|NCT03628924|158030672|FG006|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
49054750|NCT03628924|158030666|FG000|Active Treatment Period (Week 16-48)|Adverse Event|0|||
49054751|NCT03628924|158030667|FG001|Active Treatment Period (Week 16-48)|Adverse Event|0|||
49054752|NCT03628924|158030668|FG002|Active Treatment Period (Week 16-48)|Adverse Event|0|||
49054753|NCT03628924|158030669|FG003|Active Treatment Period (Week 16-48)|Adverse Event|1|||
49054754|NCT03628924|158030670|FG004|Active Treatment Period (Week 16-48)|Adverse Event|0|||
49054755|NCT03628924|158030671|FG005|Active Treatment Period (Week 16-48)|Adverse Event|2|||
49054756|NCT03628924|158030672|FG006|Active Treatment Period (Week 16-48)|Adverse Event|4|||
49054757|NCT03628924|158030666|FG000|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
49054758|NCT03628924|158030667|FG001|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
49054759|NCT03628924|158030668|FG002|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
49054760|NCT03628924|158030669|FG003|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
49054761|NCT03628924|158030670|FG004|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
49054762|NCT03628924|158030671|FG005|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
49054763|NCT03628924|158030672|FG006|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
49054764|NCT03628924|158030666|FG000|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
49054765|NCT03628924|158030667|FG001|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
49054766|NCT03628924|158030668|FG002|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
49054767|NCT03628924|158030669|FG003|Active Treatment Period (Week 16-48)|Lack of Efficacy|5|||
49054768|NCT03628924|158030670|FG004|Active Treatment Period (Week 16-48)|Lack of Efficacy|1|||
49054769|NCT03628924|158030671|FG005|Active Treatment Period (Week 16-48)|Lack of Efficacy|4|||
49054770|NCT03628924|158030672|FG006|Active Treatment Period (Week 16-48)|Lack of Efficacy|2|||
49054771|NCT03628924|158030666|FG000|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
49054772|NCT03628924|158030667|FG001|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
49054773|NCT03628924|158030668|FG002|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
49054774|NCT03628924|158030669|FG003|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
49054775|NCT03628924|158030670|FG004|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1|||
49054776|NCT03628924|158030671|FG005|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5|||
49054777|NCT03628924|158030672|FG006|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3|||
49054778|NCT03042468|158030673|FG000|Overall Study|Death|0|||
49054779|NCT03042468|158030674|FG001|Overall Study|Death|1|||
49054780|NCT03042468|158030675|FG002|Overall Study|Death|1|||
49054781|NCT03042468|158030676|FG003|Overall Study|Death|0|||
49054782|NCT03042468|158030677|FG004|Overall Study|Death|0|||
49054783|NCT03042468|158030678|FG005|Overall Study|Death|0|||
49054784|NCT03042468|158030673|FG000|Overall Study|Withdrawal by Subject|0|||
49054785|NCT03042468|158030674|FG001|Overall Study|Withdrawal by Subject|0|||
49054786|NCT03042468|158030675|FG002|Overall Study|Withdrawal by Subject|0|||
49054787|NCT03042468|158030676|FG003|Overall Study|Withdrawal by Subject|0|||
49054788|NCT03042468|158030677|FG004|Overall Study|Withdrawal by Subject|0|||
49054789|NCT03042468|158030678|FG005|Overall Study|Withdrawal by Subject|1|||
49054790|NCT03042468|158030673|FG000|Overall Study|Lost to Follow-up|0|||
49054791|NCT03042468|158030674|FG001|Overall Study|Lost to Follow-up|0|||
49054792|NCT03042468|158030675|FG002|Overall Study|Lost to Follow-up|0|||
49054793|NCT03042468|158030676|FG003|Overall Study|Lost to Follow-up|0|||
49054794|NCT03042468|158030677|FG004|Overall Study|Lost to Follow-up|1|||
49054795|NCT03042468|158030678|FG005|Overall Study|Lost to Follow-up|1|||
49054796|NCT01592721|158030679|FG000|Long-term Follow-up|Death|1|||
49054797|NCT01073566|158030680|FG000|Period 2 (6 Weeks)|Adverse Event|1|||
49054798|NCT01073566|158030681|FG001|Period 2 (6 Weeks)|Adverse Event|0|||
49054799|NCT00298740|158030687|FG000|Overall Study|Lack of Efficacy|6|||
49054800|NCT00298740|158030687|FG000|Overall Study|Withdrawal by Subject|3|||
49054801|NCT01270620|158030690|FG000|Overall Study|Withdrawal by Subject|1|||
49054802|NCT01270620|158030691|FG001|Overall Study|Withdrawal by Subject|3|||
49054803|NCT04015167|158030692|FG000|Overall Study|Lost to Follow-up|40|||
49054804|NCT04015167|158030692|FG000|Overall Study|Adverse Event|5|||
49054805|NCT04015167|158030692|FG000|Overall Study|Withdrawal by Subject|2|||
49054806|NCT04015167|158030692|FG000|Overall Study|Subject went to jail|1|||
49054807|NCT00684567|158030693|FG000|Concomitant Radiotherapy Period|Adverse Event|2|||
49054808|NCT00684567|158030693|FG000|Monotherapy Period|Adverse Event|2|||
49054809|NCT00684567|158030693|FG000|Monotherapy Period|Death|1|||
49054810|NCT00684567|158030693|FG000|Monotherapy Period|Progression of primary disease|11|||
49054811|NCT05132569|158030701|FG000|DB Period: 26 Weeks|Withdrawal by Subject|0|||
49054812|NCT05132569|158030702|FG001|DB Period: 26 Weeks|Withdrawal by Subject|1|||
49054813|NCT05132569|158030701|FG000|DB Period: 26 Weeks|Study terminated by sponsor|1|||
49054814|NCT05132569|158030702|FG001|DB Period: 26 Weeks|Study terminated by sponsor|1|||
49054815|NCT05132569|158030701|FG000|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|2|||
49054816|NCT05132569|158030702|FG001|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|1|||
49054817|NCT03382652|158030708|FG000|Overall Study|Lost to Follow-up|6|||
49054818|NCT03382652|158030708|FG000|Overall Study|Death|4|||
49054819|NCT03382652|158030708|FG000|Overall Study|Revision|5|||
49054820|NCT03382652|158030708|FG000|Overall Study|Patient withdrew|3|||
49054821|NCT03382652|158030708|FG000|Overall Study|Other reasons|21|||
49054822|NCT00977548|158030711|FG000|Overall Study|Ineligible|4|||
49054823|NCT00977548|158030711|FG000|Overall Study|Adverse Event|8|||
49054824|NCT00977548|158030711|FG000|Overall Study|Withdrawal by Subject|1|||
49054825|NCT00988208|158030713|FG000|Overall Study|Adverse Event|71|||
49054826|NCT00988208|158030714|FG001|Overall Study|Adverse Event|122|||
49054827|NCT00988208|158030713|FG000|Overall Study|Disease Progression|103|||
49054828|NCT00988208|158030714|FG001|Overall Study|Disease Progression|89|||
49054829|NCT00988208|158030713|FG000|Overall Study|Withdrawal by Subject|50|||
49054830|NCT00988208|158030714|FG001|Overall Study|Withdrawal by Subject|57|||
49054831|NCT00988208|158030713|FG000|Overall Study|Death|9|||
49054832|NCT00988208|158030714|FG001|Overall Study|Death|15|||
49054833|NCT00988208|158030713|FG000|Overall Study|Lost to Follow-up|2|||
49054834|NCT00988208|158030714|FG001|Overall Study|Lost to Follow-up|3|||
49054835|NCT00988208|158030713|FG000|Overall Study|Protocol Violation|9|||
49054836|NCT00988208|158030714|FG001|Overall Study|Protocol Violation|2|||
49054837|NCT00988208|158030713|FG000|Overall Study|Sponsor Decision|102|||
49054838|NCT00988208|158030714|FG001|Overall Study|Sponsor Decision|78|||
49054839|NCT00988208|158030713|FG000|Overall Study|Clinical Progression|17|||
49054840|NCT00988208|158030714|FG001|Overall Study|Clinical Progression|16|||
49054841|NCT00988208|158030713|FG000|Overall Study|Biochemical Progression|21|||
49054842|NCT00988208|158030714|FG001|Overall Study|Biochemical Progression|7|||
49054843|NCT00988208|158030713|FG000|Overall Study|Clinical Deterioration|7|||
49054844|NCT00988208|158030714|FG001|Overall Study|Clinical Deterioration|14|||
49054845|NCT00988208|158030713|FG000|Overall Study|Subject Decision/Investigator Discretion|32|||
49054846|NCT00988208|158030714|FG001|Overall Study|Subject Decision/Investigator Discretion|32|||
49054847|NCT00988208|158030713|FG000|Overall Study|Other|8|||
49054848|NCT00988208|158030714|FG001|Overall Study|Other|3|||
49054849|NCT01796964|158030715|FG000|Overall Study|Adverse Event|1|||
49054850|NCT01796964|158030716|FG001|Overall Study|Adverse Event|1|||
49054851|NCT01796964|158030715|FG000|Overall Study|Death|1|||
49054852|NCT01796964|158030716|FG001|Overall Study|Death|0|||
49054853|NCT01796964|158030715|FG000|Overall Study|Protocol Violation|0|||
49054854|NCT01796964|158030716|FG001|Overall Study|Protocol Violation|1|||
49054855|NCT01796964|158030715|FG000|Overall Study|Withdrawal by Subject|1|||
49054856|NCT01796964|158030716|FG001|Overall Study|Withdrawal by Subject|1|||
49054857|NCT04858321|158030717|FG000|Overall Study|Withdrawal by Subject|3|||
49054858|NCT04025684|158030718|FG000|Overall Study|Withdrawal by Subject|1|||
49054859|NCT04025684|158030719|FG001|Overall Study|Withdrawal by Subject|1|||
49054860|NCT04025684|158030720|FG002|Overall Study|Withdrawal by Subject|0|||
49054861|NCT04025684|158030721|FG003|Overall Study|Withdrawal by Subject|0|||
49054862|NCT04025684|158030718|FG000|Overall Study|Multiple reasons|1|||
49054863|NCT04025684|158030719|FG001|Overall Study|Multiple reasons|3|||
49054864|NCT04025684|158030720|FG002|Overall Study|Multiple reasons|0|||
49054865|NCT04025684|158030721|FG003|Overall Study|Multiple reasons|1|||
49054866|NCT00981799|158030722|FG000|Overall Study|Adverse Event|1|||
49054867|NCT00981799|158030723|FG001|Overall Study|Adverse Event|1|||
49054868|NCT00981799|158030724|FG002|Overall Study|Adverse Event|0|||
49054869|NCT00981799|158030725|FG003|Overall Study|Adverse Event|0|||
49054870|NCT01201759|158030726|FG000|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2|||
49054871|NCT01201759|158030727|FG001|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1|||
49054872|NCT01201759|158030726|FG000|Visit 3 - Washout|Adverse Event|0|||
49054873|NCT01201759|158030727|FG001|Visit 3 - Washout|Adverse Event|3|||
49054874|NCT01201759|158030726|FG000|Visit 3 - Washout|Lost to Follow-up|1|||
49054875|NCT01201759|158030727|FG001|Visit 3 - Washout|Lost to Follow-up|0|||
49054876|NCT01201759|158030726|FG000|Visit 4 Crossover|Lost to Follow-up|0|||
49054877|NCT01201759|158030727|FG001|Visit 4 Crossover|Lost to Follow-up|1|||
49054878|NCT01539083|158030730|FG000|Before Randomization (VCD Induction)|Withdrawal by Subject|4|||
49054879|NCT01539083|158030731|FG001|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
49054880|NCT01539083|158030732|FG002|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
49054881|NCT01539083|158030730|FG000|Before Randomization (VCD Induction)|Adverse Event|14|||
49054882|NCT01539083|158030731|FG001|Before Randomization (VCD Induction)|Adverse Event|0|||
49054883|NCT01539083|158030732|FG002|Before Randomization (VCD Induction)|Adverse Event|0|||
49054884|NCT01539083|158030730|FG000|Before Randomization (VCD Induction)|Death|6|||
49054885|NCT01539083|158030731|FG001|Before Randomization (VCD Induction)|Death|0|||
49054886|NCT01539083|158030732|FG002|Before Randomization (VCD Induction)|Death|0|||
49054887|NCT01539083|158030730|FG000|Before Randomization (VCD Induction)|Protocol Violation|2|||
49054888|NCT01539083|158030731|FG001|Before Randomization (VCD Induction)|Protocol Violation|0|||
49054889|NCT01539083|158030732|FG002|Before Randomization (VCD Induction)|Protocol Violation|0|||
49054890|NCT01539083|158030730|FG000|Before Randomization (VCD Induction)|Physician Decision|14|||
49054891|NCT01539083|158030731|FG001|Before Randomization (VCD Induction)|Physician Decision|0|||
49054892|NCT01539083|158030732|FG002|Before Randomization (VCD Induction)|Physician Decision|0|||
49054893|NCT01539083|158030730|FG000|Before Randomization (VCD Induction)|Progressive Disease|8|||
49054894|NCT01539083|158030731|FG001|Before Randomization (VCD Induction)|Progressive Disease|0|||
49054895|NCT01539083|158030732|FG002|Before Randomization (VCD Induction)|Progressive Disease|0|||
49054896|NCT01539083|158030730|FG000|Before Randomization (VCD Induction)|Other|5|||
49054897|NCT01539083|158030731|FG001|Before Randomization (VCD Induction)|Other|0|||
49054898|NCT01539083|158030732|FG002|Before Randomization (VCD Induction)|Other|0|||
49054899|NCT01539083|158030730|FG000|After Randomization (TP and VTP)|Physician Decision|0|||
49054900|NCT01539083|158030731|FG001|After Randomization (TP and VTP)|Physician Decision|0|||
49054901|NCT01539083|158030732|FG002|After Randomization (TP and VTP)|Physician Decision|1|||
49054902|NCT01539083|158030730|FG000|After Randomization (TP and VTP)|Other|0|||
49054903|NCT01539083|158030731|FG001|After Randomization (TP and VTP)|Other|1|||
49054904|NCT01539083|158030732|FG002|After Randomization (TP and VTP)|Other|1|||
49054905|NCT01539083|158030730|FG000|After Randomization (TP and VTP)|Adverse Event|0|||
49054906|NCT01539083|158030731|FG001|After Randomization (TP and VTP)|Adverse Event|1|||
49054907|NCT01539083|158030732|FG002|After Randomization (TP and VTP)|Adverse Event|1|||
49054908|NCT01539083|158030730|FG000|After Randomization (TP and VTP)|Lost to Follow-up|0|||
49054909|NCT01539083|158030731|FG001|After Randomization (TP and VTP)|Lost to Follow-up|2|||
49054910|NCT01539083|158030732|FG002|After Randomization (TP and VTP)|Lost to Follow-up|2|||
49054911|NCT01539083|158030730|FG000|After Randomization (TP and VTP)|Withdrawal by Subject|0|||
49054912|NCT01539083|158030731|FG001|After Randomization (TP and VTP)|Withdrawal by Subject|5|||
49054913|NCT01539083|158030732|FG002|After Randomization (TP and VTP)|Withdrawal by Subject|4|||
49054914|NCT01539083|158030730|FG000|After Randomization (TP and VTP)|Progressive Disease|0|||
49054915|NCT01539083|158030731|FG001|After Randomization (TP and VTP)|Progressive Disease|6|||
49054916|NCT01539083|158030732|FG002|After Randomization (TP and VTP)|Progressive Disease|3|||
49054917|NCT01539083|158030730|FG000|After Randomization (TP and VTP)|Death|0|||
49054918|NCT01539083|158030731|FG001|After Randomization (TP and VTP)|Death|6|||
49054919|NCT01539083|158030732|FG002|After Randomization (TP and VTP)|Death|11|||
49054920|NCT00906373|158030733|FG000|Overall Study|Withdrawal by Subject|0|||
49054921|NCT00906373|158030734|FG001|Overall Study|Withdrawal by Subject|5|||
49054922|NCT00906373|158030733|FG000|Overall Study|Other|0|||
49054923|NCT00906373|158030734|FG001|Overall Study|Other|1|||
49054924|NCT00906373|158030733|FG000|Overall Study|Still on treatment at cutoff date|0|||
49054925|NCT00906373|158030734|FG001|Overall Study|Still on treatment at cutoff date|2|||
49054926|NCT01844531|158030735|FG000|Overall Study|Withdrawal by Subject|0|||
49054927|NCT01844531|158030736|FG001|Overall Study|Withdrawal by Subject|1|||
49054928|NCT01844531|158030737|FG002|Overall Study|Withdrawal by Subject|0|||
49054929|NCT01844531|158030738|FG003|Overall Study|Withdrawal by Subject|0|||
49054930|NCT02070757|158030739|FG000|Overall Study|Adverse Event|107|||
49054931|NCT02070757|158030740|FG001|Overall Study|Adverse Event|99|||
49054932|NCT02070757|158030739|FG000|Overall Study|Lost to Follow-up|7|||
49054933|NCT02070757|158030740|FG001|Overall Study|Lost to Follow-up|4|||
49054934|NCT02070757|158030739|FG000|Overall Study|Protocol Violation|0|||
49054935|NCT02070757|158030740|FG001|Overall Study|Protocol Violation|4|||
49054936|NCT02070757|158030739|FG000|Overall Study|Withdrawal by Subject|1|||
49054937|NCT02070757|158030740|FG001|Overall Study|Withdrawal by Subject|3|||
49054938|NCT02070757|158030739|FG000|Overall Study|Investigator Decision|0|||
49054939|NCT02070757|158030740|FG001|Overall Study|Investigator Decision|2|||
49054940|NCT02070757|158030739|FG000|Overall Study|Discharged from Study Hospital|2|||
49054941|NCT02070757|158030740|FG001|Overall Study|Discharged from Study Hospital|2|||
49054942|NCT03733925|158030743|FG000|Overall Study|Lost to Follow-up|1|||
49054943|NCT03733925|158030743|FG000|Overall Study|Withdrawal by Subject|2|||
49054944|NCT03733925|158030743|FG000|Overall Study|Adverse Event|2|||
49054945|NCT03733925|158030743|FG000|Overall Study|Non-Compliance with Study Drug|1|||
49054946|NCT01501110|158030748|FG000|Overall Study|Death|0|||
49054947|NCT01501110|158030749|FG001|Overall Study|Death|1|||
49054948|NCT04780581|158030750|FG000|Full Modified Intention-to-treat Anal.|Protocol Violation|1|||
49054949|NCT04780581|158030751|FG001|Full Modified Intention-to-treat Anal.|Protocol Violation|2|||
49054950|NCT04780581|158030750|FG000|Overall Study (90 Days)|Lost to Follow-up|0|||
49054951|NCT04780581|158030751|FG001|Overall Study (90 Days)|Lost to Follow-up|2|||
49054952|NCT02274948|158030752|FG000|Overall Study|Lost to Follow-up|28|||
49054953|NCT02274948|158030753|FG001|Overall Study|Lost to Follow-up|25|||
49054954|NCT02274948|158030752|FG000|Overall Study|Withdrawal by Subject|64|||
49054955|NCT02274948|158030753|FG001|Overall Study|Withdrawal by Subject|58|||
49054956|NCT02274948|158030752|FG000|Overall Study|Stopped on family Practitioner advice|2|||
49054957|NCT02274948|158030753|FG001|Overall Study|Stopped on family Practitioner advice|5|||
49054958|NCT02274948|158030752|FG000|Overall Study|Left the area|4|||
49054959|NCT02274948|158030753|FG001|Overall Study|Left the area|3|||
49054960|NCT02751827|158030754|FG000|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
49054961|NCT02751827|158030755|FG001|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
49054962|NCT02751827|158030756|FG002|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1|||
49054963|NCT00467831|158030757|FG000|Overall Study|Death|2|||
49054964|NCT00467831|158030757|FG000|Overall Study|Withdrawal by Subject|1|||
49054965|NCT00823199|158030758|FG000|Overall Study|Withdrawal by Subject|2|||
49054966|NCT00631475|158030759|FG000|Overall Study|Death|18|||
49054967|NCT00631475|158030759|FG000|Overall Study|Adverse Event|14|||
49054968|NCT00631475|158030759|FG000|Overall Study|Withdrew consent|5|||
49054969|NCT00631475|158030759|FG000|Overall Study|Preparation for lung transplant|8|||
49054970|NCT01825837|158030760|FG000|PART I|Withdrawal by Subject|0|||
49054971|NCT01825837|158030761|FG001|PART I|Withdrawal by Subject|0|||
49054972|NCT01825837|158030762|FG002|PART I|Withdrawal by Subject|0|||
49054973|NCT01825837|158030763|FG003|PART I|Withdrawal by Subject|6|||
49054974|NCT01825837|158030760|FG000|PART I|Patient non-compliance|0|||
49054975|NCT01825837|158030761|FG001|PART I|Patient non-compliance|0|||
49054976|NCT01825837|158030762|FG002|PART I|Patient non-compliance|0|||
49054977|NCT01825837|158030763|FG003|PART I|Patient non-compliance|1|||
49054978|NCT01825837|158030760|FG000|PART I|Treatment failure|0|||
49054979|NCT01825837|158030761|FG001|PART I|Treatment failure|0|||
49054980|NCT01825837|158030762|FG002|PART I|Treatment failure|0|||
49054981|NCT01825837|158030763|FG003|PART I|Treatment failure|7|||
49054982|NCT01825837|158030760|FG000|PART I|reason unspecified|0|||
49054983|NCT01825837|158030761|FG001|PART I|reason unspecified|0|||
49054984|NCT01825837|158030762|FG002|PART I|reason unspecified|0|||
49054985|NCT01825837|158030763|FG003|PART I|reason unspecified|3|||
49054986|NCT01825837|158030760|FG000|PART II|Withdrawal by Subject|3|||
49054987|NCT01825837|158030761|FG001|PART II|Withdrawal by Subject|3|||
49054988|NCT01825837|158030762|FG002|PART II|Withdrawal by Subject|7|||
49054989|NCT01825837|158030763|FG003|PART II|Withdrawal by Subject|0|||
49054990|NCT01825837|158030760|FG000|PART II|Patient non-compliance|5|||
49054991|NCT01825837|158030761|FG001|PART II|Patient non-compliance|2|||
49054992|NCT01825837|158030762|FG002|PART II|Patient non-compliance|4|||
49054993|NCT01825837|158030763|FG003|PART II|Patient non-compliance|0|||
49054994|NCT01825837|158030760|FG000|PART II|Adverse Event|3|||
49054995|NCT01825837|158030761|FG001|PART II|Adverse Event|3|||
49054996|NCT01825837|158030762|FG002|PART II|Adverse Event|1|||
49054997|NCT01825837|158030763|FG003|PART II|Adverse Event|0|||
49054998|NCT01825837|158030760|FG000|PART II|Treatment failure|6|||
49054999|NCT01825837|158030761|FG001|PART II|Treatment failure|4|||
49055000|NCT01825837|158030762|FG002|PART II|Treatment failure|5|||
49055001|NCT01825837|158030763|FG003|PART II|Treatment failure|0|||
49055002|NCT01825837|158030760|FG000|PART II|reason unspecified|2|||
49055003|NCT01825837|158030761|FG001|PART II|reason unspecified|2|||
49055004|NCT01825837|158030762|FG002|PART II|reason unspecified|2|||
49055005|NCT01825837|158030763|FG003|PART II|reason unspecified|0|||
49055006|NCT00941720|158030766|FG000|Overall Study|Withdrawal by Subject|1|||
49055007|NCT00941720|158030766|FG000|Overall Study|Insurance denied participation|11|||
49055008|NCT00941720|158030766|FG000|Overall Study|ineligible|2|||
49055009|NCT01682148|158030767|FG000|Overall Study|Withdrawal by Subject|2|||
49055010|NCT01682148|158030768|FG001|Overall Study|Withdrawal by Subject|0|||
49055011|NCT01682148|158030767|FG000|Overall Study|Lost to Follow-up|1|||
49055012|NCT01682148|158030768|FG001|Overall Study|Lost to Follow-up|2|||
49055013|NCT01682148|158030767|FG000|Overall Study|Protocol Violation|1|||
49055014|NCT01682148|158030768|FG001|Overall Study|Protocol Violation|1|||
49055015|NCT00319111|158030771|FG000|Overall Study|Adverse Event|20|||
49055016|NCT00319111|158030771|FG000|Overall Study|Withdrawal of consent|11|||
49055017|NCT00319111|158030771|FG000|Overall Study|Death|9|||
49055018|NCT00319111|158030771|FG000|Overall Study|Lack of clinical improvement|4|||
49055019|NCT00319111|158030771|FG000|Overall Study|Administrative|2|||
49055020|NCT00319111|158030771|FG000|Overall Study|Treatment failure|1|||
49055021|NCT02792218|158030772|FG000|Overall Study|Patient/guardian decision|15|||
49055022|NCT02792218|158030773|FG001|Overall Study|Patient/guardian decision|42|||
49055023|NCT02792218|158030772|FG000|Overall Study|Adverse Event|15|||
49055024|NCT02792218|158030773|FG001|Overall Study|Adverse Event|14|||
49055025|NCT02792218|158030772|FG000|Overall Study|Lost to Follow-up|10|||
49055026|NCT02792218|158030773|FG001|Overall Study|Lost to Follow-up|5|||
49055027|NCT02792218|158030772|FG000|Overall Study|Lack of Efficacy|1|||
49055028|NCT02792218|158030773|FG001|Overall Study|Lack of Efficacy|12|||
49055029|NCT02792218|158030772|FG000|Overall Study|Physician Decision|4|||
49055030|NCT02792218|158030773|FG001|Overall Study|Physician Decision|4|||
49055031|NCT02792218|158030772|FG000|Overall Study|Protocol deviation|3|||
49055032|NCT02792218|158030773|FG001|Overall Study|Protocol deviation|2|||
49055033|NCT02792218|158030772|FG000|Overall Study|New therapy for study indication|0|||
49055034|NCT02792218|158030773|FG001|Overall Study|New therapy for study indication|1|||
49055035|NCT02792218|158030772|FG000|Overall Study|Non-compliance with study treatment|0|||
49055036|NCT02792218|158030773|FG001|Overall Study|Non-compliance with study treatment|1|||
49055037|NCT02792218|158030772|FG000|Overall Study|Pregnancy|1|||
49055038|NCT02792218|158030773|FG001|Overall Study|Pregnancy|0|||
49055039|NCT03610581|158030774|FG000|Overall Study|Study terminated by sponsor|2|||
49055040|NCT03610581|158030775|FG001|Overall Study|Study terminated by sponsor|0|||
49055041|NCT03610581|158030774|FG000|Overall Study|Other|0|||
49055042|NCT03610581|158030775|FG001|Overall Study|Other|1|||
49055043|NCT03610581|158030774|FG000|Overall Study|Withdrawal by Subject|1|||
49055044|NCT03610581|158030775|FG001|Overall Study|Withdrawal by Subject|0|||
49055045|NCT02485925|158030776|FG000|Overall Study|Withdrawal by Subject|3|||
49055046|NCT02485925|158030776|FG000|Overall Study|Death|1|||
49055047|NCT02485925|158030776|FG000|Overall Study|Lost to Follow-up|11|||
49055048|NCT04376827|158030778|FG000|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
49055049|NCT04376827|158030779|FG001|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
49055050|NCT04376827|158030778|FG000|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|6|||
49055051|NCT04376827|158030779|FG001|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|8|||
49055052|NCT04376827|158030778|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|1|||
49055053|NCT04376827|158030779|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|0|||
49055054|NCT04376827|158030778|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|0|||
49055055|NCT04376827|158030779|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|1|||
49055056|NCT04376827|158030778|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|3|||
49055057|NCT04376827|158030779|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|0|||
49055058|NCT02310789|158033137|FG000|Overall Study|Adverse Event|1|||
49055059|NCT03474679|158033144|FG000|Overall Study|Death|7|||
49055060|NCT03474679|158033144|FG000|Overall Study|Withdrawal by Subject|1|||
49055061|NCT03136406|158033145|FG000|Overall Study|Treatment Discontinued-Investigator Decision|3|||
49055062|NCT00611884|158033149|FG000|Overall Study|Adverse Event|1|||
49055063|NCT00611884|158033150|FG001|Overall Study|Adverse Event|0|||
49055064|NCT00611884|158033151|FG002|Overall Study|Adverse Event|0|||
49055065|NCT00611884|158033152|FG003|Overall Study|Adverse Event|1|||
49055066|NCT00611884|158033149|FG000|Overall Study|Non-Compliance|1|||
49055067|NCT00611884|158033150|FG001|Overall Study|Non-Compliance|4|||
49055068|NCT00611884|158033151|FG002|Overall Study|Non-Compliance|2|||
49055069|NCT00611884|158033152|FG003|Overall Study|Non-Compliance|2|||
49055070|NCT00611884|158033149|FG000|Overall Study|Lack of Efficacy|0|||
49055071|NCT00611884|158033150|FG001|Overall Study|Lack of Efficacy|1|||
49055072|NCT00611884|158033151|FG002|Overall Study|Lack of Efficacy|0|||
49055073|NCT00611884|158033152|FG003|Overall Study|Lack of Efficacy|0|||
49055074|NCT00611884|158033149|FG000|Overall Study|Unclassified|7|||
49055075|NCT00611884|158033150|FG001|Overall Study|Unclassified|4|||
49055076|NCT00611884|158033151|FG002|Overall Study|Unclassified|2|||
49055077|NCT00611884|158033152|FG003|Overall Study|Unclassified|3|||
49055078|NCT03135899|158033153|FG000|Overall Study|Failed spirometry,unable to repeat visit|0|||
49055079|NCT03135899|158033154|FG001|Overall Study|Failed spirometry,unable to repeat visit|0|||
49055080|NCT03135899|158033155|FG002|Overall Study|Failed spirometry,unable to repeat visit|0|||
49055081|NCT03135899|158033156|FG003|Overall Study|Failed spirometry,unable to repeat visit|0|||
49055082|NCT03135899|158033157|FG004|Overall Study|Failed spirometry,unable to repeat visit|0|||
49055083|NCT03135899|158033158|FG005|Overall Study|Failed spirometry,unable to repeat visit|0|||
49055084|NCT03135899|158033159|FG006|Overall Study|Failed spirometry,unable to repeat visit|1|||
49055085|NCT03135899|158033160|FG007|Overall Study|Failed spirometry,unable to repeat visit|0|||
49055086|NCT03135899|158033153|FG000|Overall Study|Withdrawal by Subject|0|||
49055087|NCT03135899|158033154|FG001|Overall Study|Withdrawal by Subject|0|||
49055088|NCT03135899|158033155|FG002|Overall Study|Withdrawal by Subject|0|||
49055089|NCT03135899|158033156|FG003|Overall Study|Withdrawal by Subject|0|||
49055090|NCT03135899|158033157|FG004|Overall Study|Withdrawal by Subject|0|||
49055091|NCT03135899|158033158|FG005|Overall Study|Withdrawal by Subject|2|||
49055092|NCT03135899|158033159|FG006|Overall Study|Withdrawal by Subject|0|||
49055093|NCT03135899|158033160|FG007|Overall Study|Withdrawal by Subject|0|||
49055094|NCT04889209|158033168|FG000|All Cohorts Except 15E|Adverse Event|0|||
49055095|NCT04889209|158033169|FG001|All Cohorts Except 15E|Adverse Event|0|||
49055096|NCT04889209|158033170|FG002|All Cohorts Except 15E|Adverse Event|0|||
49055097|NCT04889209|158033171|FG003|All Cohorts Except 15E|Adverse Event|0|||
49055098|NCT04889209|158033172|FG004|All Cohorts Except 15E|Adverse Event|0|||
49055099|NCT04889209|158033173|FG005|All Cohorts Except 15E|Adverse Event|0|||
49055100|NCT04889209|158033174|FG006|All Cohorts Except 15E|Adverse Event|1|||
49055101|NCT04889209|158033175|FG007|All Cohorts Except 15E|Adverse Event|0|||
49055102|NCT04889209|158033176|FG008|All Cohorts Except 15E|Adverse Event|0|||
49055103|NCT04889209|158033177|FG009|All Cohorts Except 15E|Adverse Event|0|||
49055104|NCT04889209|158033178|FG010|All Cohorts Except 15E|Adverse Event|0|||
49055105|NCT04889209|158033179|FG011|All Cohorts Except 15E|Adverse Event|0|||
49055106|NCT04889209|158033180|FG012|All Cohorts Except 15E|Adverse Event|0|||
49055107|NCT04889209|158033181|FG013|All Cohorts Except 15E|Adverse Event|0|||
49055108|NCT04889209|158033182|FG014|All Cohorts Except 15E|Adverse Event|0|||
49055109|NCT04889209|158033183|FG015|All Cohorts Except 15E|Adverse Event|0|||
49055110|NCT04889209|158033184|FG016|All Cohorts Except 15E|Adverse Event|0|||
49055111|NCT04889209|158033185|FG017|All Cohorts Except 15E|Adverse Event|0|||
49055112|NCT04889209|158033168|FG000|All Cohorts Except 15E|Death|0|||
49055113|NCT04889209|158033169|FG001|All Cohorts Except 15E|Death|1|||
49055114|NCT04889209|158033170|FG002|All Cohorts Except 15E|Death|0|||
49055115|NCT04889209|158033171|FG003|All Cohorts Except 15E|Death|0|||
49055116|NCT04889209|158033172|FG004|All Cohorts Except 15E|Death|0|||
49055117|NCT04889209|158033173|FG005|All Cohorts Except 15E|Death|0|||
49055118|NCT04889209|158033174|FG006|All Cohorts Except 15E|Death|0|||
49055119|NCT04889209|158033175|FG007|All Cohorts Except 15E|Death|0|||
49055120|NCT04889209|158033176|FG008|All Cohorts Except 15E|Death|0|||
49055121|NCT04889209|158033177|FG009|All Cohorts Except 15E|Death|0|||
49055122|NCT04889209|158033178|FG010|All Cohorts Except 15E|Death|0|||
49055123|NCT04889209|158033179|FG011|All Cohorts Except 15E|Death|0|||
49055124|NCT04889209|158033180|FG012|All Cohorts Except 15E|Death|0|||
49055125|NCT04889209|158033181|FG013|All Cohorts Except 15E|Death|0|||
49055126|NCT04889209|158033182|FG014|All Cohorts Except 15E|Death|0|||
49055127|NCT04889209|158033183|FG015|All Cohorts Except 15E|Death|0|||
49055128|NCT04889209|158033184|FG016|All Cohorts Except 15E|Death|0|||
49055129|NCT04889209|158033185|FG017|All Cohorts Except 15E|Death|0|||
49055130|NCT04889209|158033168|FG000|All Cohorts Except 15E|Lost to Follow-up|0|||
49055131|NCT04889209|158033169|FG001|All Cohorts Except 15E|Lost to Follow-up|0|||
49055132|NCT04889209|158033170|FG002|All Cohorts Except 15E|Lost to Follow-up|1|||
49055133|NCT04889209|158033171|FG003|All Cohorts Except 15E|Lost to Follow-up|2|||
49055134|NCT04889209|158033172|FG004|All Cohorts Except 15E|Lost to Follow-up|4|||
49055135|NCT04889209|158033173|FG005|All Cohorts Except 15E|Lost to Follow-up|1|||
49055136|NCT04889209|158033174|FG006|All Cohorts Except 15E|Lost to Follow-up|0|||
49055137|NCT04889209|158033175|FG007|All Cohorts Except 15E|Lost to Follow-up|1|||
49055138|NCT04889209|158033176|FG008|All Cohorts Except 15E|Lost to Follow-up|2|||
49055139|NCT04889209|158033177|FG009|All Cohorts Except 15E|Lost to Follow-up|2|||
49055140|NCT04889209|158033178|FG010|All Cohorts Except 15E|Lost to Follow-up|2|||
49055141|NCT04889209|158033179|FG011|All Cohorts Except 15E|Lost to Follow-up|4|||
49055142|NCT04889209|158033180|FG012|All Cohorts Except 15E|Lost to Follow-up|2|||
49055143|NCT04889209|158033181|FG013|All Cohorts Except 15E|Lost to Follow-up|2|||
49055144|NCT04889209|158033182|FG014|All Cohorts Except 15E|Lost to Follow-up|0|||
49055145|NCT04889209|158033183|FG015|All Cohorts Except 15E|Lost to Follow-up|5|||
49055146|NCT04889209|158033184|FG016|All Cohorts Except 15E|Lost to Follow-up|5|||
49055147|NCT04889209|158033185|FG017|All Cohorts Except 15E|Lost to Follow-up|28|||
49055148|NCT04889209|158033168|FG000|All Cohorts Except 15E|Physician Decision|0|||
49055149|NCT04889209|158033169|FG001|All Cohorts Except 15E|Physician Decision|0|||
49055150|NCT04889209|158033170|FG002|All Cohorts Except 15E|Physician Decision|0|||
49055151|NCT04889209|158033171|FG003|All Cohorts Except 15E|Physician Decision|0|||
49055152|NCT04889209|158033172|FG004|All Cohorts Except 15E|Physician Decision|1|||
49055153|NCT04889209|158033173|FG005|All Cohorts Except 15E|Physician Decision|0|||
49055154|NCT04889209|158033174|FG006|All Cohorts Except 15E|Physician Decision|0|||
49055155|NCT04889209|158033175|FG007|All Cohorts Except 15E|Physician Decision|1|||
49055156|NCT04889209|158033176|FG008|All Cohorts Except 15E|Physician Decision|0|||
49055157|NCT04889209|158033177|FG009|All Cohorts Except 15E|Physician Decision|1|||
49055158|NCT04889209|158033178|FG010|All Cohorts Except 15E|Physician Decision|0|||
49055159|NCT04889209|158033179|FG011|All Cohorts Except 15E|Physician Decision|1|||
49055160|NCT04889209|158033180|FG012|All Cohorts Except 15E|Physician Decision|1|||
49055161|NCT04889209|158033181|FG013|All Cohorts Except 15E|Physician Decision|0|||
49055162|NCT04889209|158033182|FG014|All Cohorts Except 15E|Physician Decision|0|||
49055163|NCT04889209|158033183|FG015|All Cohorts Except 15E|Physician Decision|0|||
49055164|NCT04889209|158033184|FG016|All Cohorts Except 15E|Physician Decision|0|||
49055165|NCT04889209|158033185|FG017|All Cohorts Except 15E|Physician Decision|0|||
49055166|NCT04889209|158033168|FG000|All Cohorts Except 15E|Withdrawal by Subject|1|||
49055167|NCT04889209|158033169|FG001|All Cohorts Except 15E|Withdrawal by Subject|1|||
49055168|NCT04889209|158033170|FG002|All Cohorts Except 15E|Withdrawal by Subject|2|||
49055169|NCT04889209|158033171|FG003|All Cohorts Except 15E|Withdrawal by Subject|5|||
49055170|NCT04889209|158033172|FG004|All Cohorts Except 15E|Withdrawal by Subject|2|||
49055171|NCT04889209|158033173|FG005|All Cohorts Except 15E|Withdrawal by Subject|3|||
49055172|NCT04889209|158033174|FG006|All Cohorts Except 15E|Withdrawal by Subject|3|||
49055173|NCT04889209|158033175|FG007|All Cohorts Except 15E|Withdrawal by Subject|1|||
49055174|NCT04889209|158033176|FG008|All Cohorts Except 15E|Withdrawal by Subject|3|||
49055175|NCT04889209|158033177|FG009|All Cohorts Except 15E|Withdrawal by Subject|3|||
49055176|NCT04889209|158033178|FG010|All Cohorts Except 15E|Withdrawal by Subject|3|||
49055177|NCT04889209|158033179|FG011|All Cohorts Except 15E|Withdrawal by Subject|3|||
49055178|NCT04889209|158033180|FG012|All Cohorts Except 15E|Withdrawal by Subject|3|||
49055179|NCT04889209|158033181|FG013|All Cohorts Except 15E|Withdrawal by Subject|0|||
49055180|NCT04889209|158033182|FG014|All Cohorts Except 15E|Withdrawal by Subject|0|||
49055181|NCT04889209|158033183|FG015|All Cohorts Except 15E|Withdrawal by Subject|1|||
49055182|NCT04889209|158033184|FG016|All Cohorts Except 15E|Withdrawal by Subject|3|||
49055183|NCT04889209|158033185|FG017|All Cohorts Except 15E|Withdrawal by Subject|16|||
49055184|NCT04889209|158033168|FG000|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
49055185|NCT04889209|158033169|FG001|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
49055186|NCT04889209|158033170|FG002|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
49055187|NCT04889209|158033171|FG003|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
49055188|NCT04889209|158033172|FG004|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
49055189|NCT04889209|158033173|FG005|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
49055190|NCT04889209|158033174|FG006|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
49055191|NCT04889209|158033175|FG007|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
49055192|NCT04889209|158033176|FG008|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
49055193|NCT04889209|158033177|FG009|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
49055194|NCT04889209|158033178|FG010|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
49055195|NCT04889209|158033179|FG011|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
49055196|NCT04889209|158033180|FG012|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
49055197|NCT04889209|158033181|FG013|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
49055198|NCT04889209|158033182|FG014|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
49055199|NCT04889209|158033183|FG015|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
49055200|NCT04889209|158033184|FG016|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
49055201|NCT04889209|158033185|FG017|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
49055202|NCT04889209|158033168|FG000|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
49055203|NCT04889209|158033169|FG001|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
49055204|NCT04889209|158033170|FG002|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
49055205|NCT04889209|158033171|FG003|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|12|||
49055206|NCT04889209|158033172|FG004|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
49055207|NCT04889209|158033173|FG005|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
49055208|NCT04889209|158033174|FG006|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
49055209|NCT04889209|158033175|FG007|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
49055210|NCT04889209|158033176|FG008|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
49055211|NCT04889209|158033177|FG009|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
49055212|NCT04889209|158033178|FG010|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
49055213|NCT04889209|158033179|FG011|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
49055214|NCT04889209|158033180|FG012|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
49055215|NCT04889209|158033181|FG013|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
49055216|NCT04889209|158033182|FG014|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
49055217|NCT04889209|158033183|FG015|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
49055218|NCT04889209|158033184|FG016|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
49055219|NCT04889209|158033185|FG017|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
49055220|NCT04889209|158033168|FG000|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
49055221|NCT04889209|158033169|FG001|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
49055222|NCT04889209|158033170|FG002|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
49055223|NCT04889209|158033171|FG003|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
49055224|NCT04889209|158033172|FG004|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
49055225|NCT04889209|158033173|FG005|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
49055226|NCT04889209|158033174|FG006|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
49055227|NCT04889209|158033175|FG007|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
49055228|NCT04889209|158033176|FG008|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
49055229|NCT04889209|158033177|FG009|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
49055230|NCT04889209|158033178|FG010|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
49055231|NCT04889209|158033179|FG011|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
49055232|NCT04889209|158033180|FG012|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
49055233|NCT04889209|158033181|FG013|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
49055234|NCT04889209|158033182|FG014|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
49055235|NCT04889209|158033183|FG015|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
49055236|NCT04889209|158033184|FG016|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
49055237|NCT04889209|158033185|FG017|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
49055238|NCT04889209|158033168|FG000|All Cohorts Except 15E|Became ineligible after enrollment|0|||
49055239|NCT04889209|158033169|FG001|All Cohorts Except 15E|Became ineligible after enrollment|0|||
49055240|NCT04889209|158033170|FG002|All Cohorts Except 15E|Became ineligible after enrollment|0|||
49055241|NCT04889209|158033171|FG003|All Cohorts Except 15E|Became ineligible after enrollment|0|||
49055242|NCT04889209|158033172|FG004|All Cohorts Except 15E|Became ineligible after enrollment|0|||
49055243|NCT04889209|158033173|FG005|All Cohorts Except 15E|Became ineligible after enrollment|0|||
49055244|NCT04889209|158033174|FG006|All Cohorts Except 15E|Became ineligible after enrollment|0|||
49055245|NCT04889209|158033175|FG007|All Cohorts Except 15E|Became ineligible after enrollment|0|||
49055246|NCT04889209|158033176|FG008|All Cohorts Except 15E|Became ineligible after enrollment|0|||
49055247|NCT04889209|158033177|FG009|All Cohorts Except 15E|Became ineligible after enrollment|0|||
49055248|NCT04889209|158033178|FG010|All Cohorts Except 15E|Became ineligible after enrollment|0|||
49055249|NCT04889209|158033179|FG011|All Cohorts Except 15E|Became ineligible after enrollment|0|||
49055250|NCT04889209|158033180|FG012|All Cohorts Except 15E|Became ineligible after enrollment|0|||
49055251|NCT04889209|158033181|FG013|All Cohorts Except 15E|Became ineligible after enrollment|0|||
49055252|NCT04889209|158033182|FG014|All Cohorts Except 15E|Became ineligible after enrollment|0|||
49055253|NCT04889209|158033183|FG015|All Cohorts Except 15E|Became ineligible after enrollment|0|||
49055254|NCT04889209|158033184|FG016|All Cohorts Except 15E|Became ineligible after enrollment|0|||
49055255|NCT04889209|158033185|FG017|All Cohorts Except 15E|Became ineligible after enrollment|1|||
49055256|NCT04889209|158033168|FG000|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
49055257|NCT04889209|158033169|FG001|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
49055258|NCT04889209|158033170|FG002|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
49055259|NCT04889209|158033171|FG003|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
49055260|NCT04889209|158033172|FG004|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
49055261|NCT04889209|158033173|FG005|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
49055262|NCT04889209|158033174|FG006|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
49055263|NCT04889209|158033175|FG007|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
49055264|NCT04889209|158033176|FG008|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
49055265|NCT04889209|158033177|FG009|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
49055266|NCT04889209|158033178|FG010|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
49055267|NCT04889209|158033179|FG011|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
49055268|NCT04889209|158033180|FG012|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
49055269|NCT04889209|158033181|FG013|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
49055270|NCT04889209|158033182|FG014|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
49055271|NCT04889209|158033183|FG015|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
49055272|NCT04889209|158033184|FG016|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
49055273|NCT04889209|158033185|FG017|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|4|||
49055274|NCT04889209|158033168|FG000|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
49055275|NCT04889209|158033169|FG001|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
49055276|NCT04889209|158033170|FG002|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
49055277|NCT04889209|158033171|FG003|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
49055278|NCT04889209|158033172|FG004|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
49055279|NCT04889209|158033173|FG005|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
49055280|NCT04889209|158033174|FG006|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
49055281|NCT04889209|158033175|FG007|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
49055282|NCT04889209|158033176|FG008|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
49055283|NCT04889209|158033177|FG009|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
49055284|NCT04889209|158033178|FG010|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
49055285|NCT04889209|158033179|FG011|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
49055286|NCT04889209|158033180|FG012|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
49055287|NCT04889209|158033181|FG013|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
49055288|NCT04889209|158033182|FG014|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|2|||
49055289|NCT04889209|158033183|FG015|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
49055290|NCT04889209|158033184|FG016|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
49055291|NCT04889209|158033185|FG017|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
49055292|NCT02000531|158033186|FG000|Overall Study|Lost to Follow-up|1|||
49055293|NCT02000531|158033187|FG001|Overall Study|Lost to Follow-up|0|||
49055294|NCT02000531|158033186|FG000|Overall Study|Discontinued due to data cut-off|3|||
49055295|NCT02000531|158033187|FG001|Overall Study|Discontinued due to data cut-off|8|||
49055296|NCT00794417|158033192|FG000|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
49055297|NCT00794417|158033193|FG001|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
49055298|NCT00794417|158033194|FG002|Phase 1: Baseline (Day 1) up to Day 751|Death|2|||
49055299|NCT00794417|158033195|FG003|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
49055300|NCT00794417|158033192|FG000|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
49055301|NCT00794417|158033193|FG001|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
49055302|NCT00794417|158033194|FG002|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1|||
49055303|NCT00794417|158033195|FG003|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0|||
49055304|NCT00794417|158033192|FG000|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
49055305|NCT00794417|158033193|FG001|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
49055306|NCT00794417|158033194|FG002|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
49055307|NCT00794417|158033195|FG003|Phase 2: Baseline (Day 421) to Day 972|Death|7|||
49055308|NCT00794417|158033192|FG000|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
49055309|NCT00794417|158033193|FG001|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
49055310|NCT00794417|158033194|FG002|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
49055311|NCT00794417|158033195|FG003|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11|||
49055312|NCT00794417|158033192|FG000|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
49055313|NCT00794417|158033193|FG001|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
49055314|NCT00794417|158033194|FG002|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
49055315|NCT00794417|158033195|FG003|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4|||
49055316|NCT00794417|158033192|FG000|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
49055317|NCT00794417|158033193|FG001|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
49055318|NCT00794417|158033194|FG002|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
49055319|NCT00794417|158033195|FG003|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13|||
49055320|NCT00348816|158033198|FG000|Overall Study|Noncompliance with radiation treatment|1|||
49055321|NCT01042535|158033199|FG000|Overall Study|disease progression prior to treatment|3|||
49055322|NCT01042535|158033199|FG000|Overall Study|disease progression during treatment|3|||
49055323|NCT01042535|158033199|FG000|Overall Study|complications from other disease|2|||
49055324|NCT01345318|158033203|FG000|Overall Study|Adverse Event|16|||
49055325|NCT01345318|158033203|FG000|Overall Study|Lack of Efficacy|17|||
49055326|NCT01345318|158033203|FG000|Overall Study|Lost to Follow-up|2|||
49055327|NCT01345318|158033203|FG000|Overall Study|Protocol Violation|1|||
49055328|NCT01345318|158033203|FG000|Overall Study|Withdrawal by Subject|41|||
49055329|NCT01345318|158033203|FG000|Overall Study|Other|3|||
49055330|NCT00317642|158033204|FG000|Overall Study|Not Received Either Study Drug|1|||
49055331|NCT00317642|158033205|FG001|Overall Study|Not Received Either Study Drug|3|||
49055332|NCT00317642|158033204|FG000|Overall Study|Physician Decision|15|||
49055333|NCT00317642|158033205|FG001|Overall Study|Physician Decision|7|||
49055334|NCT00317642|158033204|FG000|Overall Study|Participant declined treatment|14|||
49055335|NCT00317642|158033205|FG001|Overall Study|Participant declined treatment|3|||
49055336|NCT00317642|158033204|FG000|Overall Study|Adverse Event|17|||
49055337|NCT00317642|158033205|FG001|Overall Study|Adverse Event|5|||
49055338|NCT00317642|158033204|FG000|Overall Study|Treatment Failure|56|||
49055339|NCT00317642|158033205|FG001|Overall Study|Treatment Failure|102|||
49055340|NCT00317642|158033204|FG000|Overall Study|Disease Recurrence|1|||
49055341|NCT00317642|158033205|FG001|Overall Study|Disease Recurrence|2|||
49055342|NCT00317642|158033204|FG000|Overall Study|Death|14|||
49055343|NCT00317642|158033205|FG001|Overall Study|Death|7|||
49055344|NCT00317642|158033204|FG000|Overall Study|Not Continue to Consolidation|2|||
49055345|NCT00317642|158033205|FG001|Overall Study|Not Continue to Consolidation|0|||
49055346|NCT00317642|158033204|FG000|Overall Study|Withdrawal by Subject|0|||
49055347|NCT00317642|158033205|FG001|Overall Study|Withdrawal by Subject|1|||
49055348|NCT00317642|158033204|FG000|Overall Study|Referred For Transplantation|1|||
49055349|NCT00317642|158033205|FG001|Overall Study|Referred For Transplantation|0|||
49055350|NCT00317642|158033204|FG000|Overall Study|AML Not Centrally Confirmed|1|||
49055351|NCT00317642|158033205|FG001|Overall Study|AML Not Centrally Confirmed|5|||
49055352|NCT01546142|158033206|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
49055353|NCT01546142|158033207|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
49055354|NCT01546142|158033206|FG000|Overall Study|Subject Noncompliance|1|||
49055355|NCT01546142|158033207|FG001|Overall Study|Subject Noncompliance|1|||
49055356|NCT01546142|158033206|FG000|Overall Study|Adverse Event|6|||
49055357|NCT01546142|158033207|FG001|Overall Study|Adverse Event|3|||
49055358|NCT01546142|158033206|FG000|Overall Study|Lost to Follow-up|20|||
49055359|NCT01546142|158033207|FG001|Overall Study|Lost to Follow-up|15|||
49055360|NCT01546142|158033206|FG000|Overall Study|Consent Withdrawn (Subject Discomfort)|1|||
49055361|NCT01546142|158033207|FG001|Overall Study|Consent Withdrawn (Subject Discomfort)|0|||
49055362|NCT01546142|158033206|FG000|Overall Study|Subject Randomized but Not Treated|1|||
49055363|NCT01546142|158033207|FG001|Overall Study|Subject Randomized but Not Treated|0|||
49055364|NCT00848042|158033210|FG000|Overall Study|Death|1|||
49055365|NCT00848042|158033211|FG001|Overall Study|Death|2|||
49055366|NCT00848042|158033212|FG002|Overall Study|Death|0|||
49055367|NCT00848042|158033210|FG000|Overall Study|Other Therapy|3|||
49055368|NCT00848042|158033211|FG001|Overall Study|Other Therapy|0|||
49055369|NCT00848042|158033212|FG002|Overall Study|Other Therapy|0|||
48692647|NCT03001557|156724543|FG002|Extension Phase|Administrative Reason|0|||
49055370|NCT00707434|158033216|FG000|Overall Study|Adverse Event|1|||
49055371|NCT03585959|158033217|FG000|Overall Study|Physician Decision|1|||
49055372|NCT03585959|158033217|FG000|Overall Study|Unsuccessful Procedure|2|||
49055373|NCT02531594|158033223|FG000|Overall Study|Withdrawal by Subject|7|||
49055374|NCT02531594|158033224|FG001|Overall Study|Withdrawal by Subject|8|||
49055375|NCT00775606|158033225|FG000|Overall Study|Study sponsor terminated funding|3|||
49055376|NCT00775606|158033226|FG001|Overall Study|Study sponsor terminated funding|0|||
49055377|NCT02542631|158033229|FG000|Overall Study|Adverse Event|1|||
49055378|NCT02542631|158033230|FG001|Overall Study|Adverse Event|1|||
49055379|NCT02542631|158033229|FG000|Overall Study|Sponsor Termination|1|||
49055380|NCT02542631|158033230|FG001|Overall Study|Sponsor Termination|0|||
49055381|NCT02542631|158033229|FG000|Overall Study|Withdrawal by Subject|11|||
49055382|NCT02542631|158033230|FG001|Overall Study|Withdrawal by Subject|16|||
49055383|NCT02542631|158033229|FG000|Overall Study|Protocol Violation|1|||
49055384|NCT02542631|158033230|FG001|Overall Study|Protocol Violation|1|||
49055385|NCT02542631|158033229|FG000|Overall Study|Physician Decision|6|||
49055386|NCT02542631|158033230|FG001|Overall Study|Physician Decision|4|||
49055387|NCT02542631|158033229|FG000|Overall Study|Lost to Follow-up|6|||
49055388|NCT02542631|158033230|FG001|Overall Study|Lost to Follow-up|5|||
49055389|NCT02542631|158033229|FG000|Overall Study|Death|1|||
49055390|NCT02542631|158033230|FG001|Overall Study|Death|2|||
49055391|NCT02542631|158033229|FG000|Overall Study|Other|2|||
49055392|NCT02542631|158033230|FG001|Overall Study|Other|1|||
49055393|NCT02542631|158033229|FG000|Overall Study|Used Prohibited Medication|2|||
49055394|NCT02542631|158033230|FG001|Overall Study|Used Prohibited Medication|1|||
49055395|NCT04271046|158033233|FG000|Overall Study|Death|0|||
49055396|NCT04271046|158033234|FG001|Overall Study|Death|2|||
49055397|NCT04271046|158033235|FG002|Overall Study|Death|0|||
49055398|NCT04271046|158033236|FG003|Overall Study|Death|2|||
49055399|NCT04271046|158033233|FG000|Overall Study|Lost to Follow-up|12|||
49055400|NCT04271046|158033234|FG001|Overall Study|Lost to Follow-up|12|||
49055401|NCT04271046|158033235|FG002|Overall Study|Lost to Follow-up|11|||
49055402|NCT04271046|158033236|FG003|Overall Study|Lost to Follow-up|11|||
49055403|NCT04271046|158033233|FG000|Overall Study|Patient with Dementia Died|2|||
49055404|NCT04271046|158033234|FG001|Overall Study|Patient with Dementia Died|0|||
49055405|NCT04271046|158033235|FG002|Overall Study|Patient with Dementia Died|2|||
49055406|NCT04271046|158033236|FG003|Overall Study|Patient with Dementia Died|0|||
49055407|NCT04271046|158033233|FG000|Overall Study|Patient with dementia were not administered surveys|0|||
49055408|NCT04271046|158033234|FG001|Overall Study|Patient with dementia were not administered surveys|18|||
49055409|NCT04271046|158033235|FG002|Overall Study|Patient with dementia were not administered surveys|0|||
49055410|NCT04271046|158033236|FG003|Overall Study|Patient with dementia were not administered surveys|22|||
49055411|NCT03739138|158033237|FG000|Overall Study|Death|0|||
49055412|NCT03739138|158033238|FG001|Overall Study|Death|7|||
49055413|NCT03739138|158033239|FG002|Overall Study|Death|4|||
49055414|NCT03739138|158033240|FG003|Overall Study|Death|13|||
49055415|NCT03739138|158033241|FG004|Overall Study|Death|0|||
49055416|NCT03739138|158033237|FG000|Overall Study|Lost to Follow-up|0|||
49055417|NCT03739138|158033238|FG001|Overall Study|Lost to Follow-up|0|||
49055418|NCT03739138|158033239|FG002|Overall Study|Lost to Follow-up|1|||
49055419|NCT03739138|158033240|FG003|Overall Study|Lost to Follow-up|0|||
49055420|NCT03739138|158033241|FG004|Overall Study|Lost to Follow-up|0|||
49055421|NCT03739138|158033237|FG000|Overall Study|Study Terminated By Sponsor|0|||
49055422|NCT03739138|158033238|FG001|Overall Study|Study Terminated By Sponsor|0|||
49055423|NCT03739138|158033239|FG002|Overall Study|Study Terminated By Sponsor|0|||
49055424|NCT03739138|158033240|FG003|Overall Study|Study Terminated By Sponsor|4|||
49055425|NCT03739138|158033241|FG004|Overall Study|Study Terminated By Sponsor|0|||
49055426|NCT03739138|158033237|FG000|Overall Study|Withdrawal by Subject|0|||
49055427|NCT03739138|158033238|FG001|Overall Study|Withdrawal by Subject|0|||
49055428|NCT03739138|158033239|FG002|Overall Study|Withdrawal by Subject|0|||
49055429|NCT03739138|158033240|FG003|Overall Study|Withdrawal by Subject|1|||
49055430|NCT03739138|158033241|FG004|Overall Study|Withdrawal by Subject|0|||
49055431|NCT04435782|158033245|FG000|Overall Study|Study terminated by sponsor|4|||
49055432|NCT03218826|158033248|FG000|Overall Study|Non-compliance with protocol|1|||
49055433|NCT03218826|158033249|FG001|Overall Study|Non-compliance with protocol|0|||
49055434|NCT03218826|158033250|FG002|Overall Study|Non-compliance with protocol|2|||
49055435|NCT03218826|158033251|FG003|Overall Study|Non-compliance with protocol|1|||
49055436|NCT03218826|158033252|FG004|Overall Study|Non-compliance with protocol|1|||
49055437|NCT00904748|158033253|FG000|Overall Study|Withdrawal by Subject|1|||
49055438|NCT00904748|158033254|FG001|Overall Study|Withdrawal by Subject|1|||
49055439|NCT00904748|158033255|FG002|Overall Study|Withdrawal by Subject|1|||
49055440|NCT00904748|158033256|FG003|Overall Study|Withdrawal by Subject|2|||
49055441|NCT00904748|158033257|FG004|Overall Study|Withdrawal by Subject|0|||
49055442|NCT00904748|158033258|FG005|Overall Study|Withdrawal by Subject|0|||
49055443|NCT00904748|158033253|FG000|Overall Study|Adverse Event|0|||
49055444|NCT00904748|158033254|FG001|Overall Study|Adverse Event|0|||
49055445|NCT00904748|158033255|FG002|Overall Study|Adverse Event|0|||
49055446|NCT00904748|158033256|FG003|Overall Study|Adverse Event|0|||
49055447|NCT00904748|158033257|FG004|Overall Study|Adverse Event|1|||
49055448|NCT00904748|158033258|FG005|Overall Study|Adverse Event|0|||
49055449|NCT05158504|158033259|FG000|Overall Study|Lost to Follow-up|2|||
49055450|NCT05158504|158033260|FG001|Overall Study|Lost to Follow-up|3|||
49055451|NCT01056640|158033261|FG000|Overall Study|Withdrawal by Subject|11|||
49055452|NCT01056640|158033262|FG001|Overall Study|Withdrawal by Subject|8|||
49055453|NCT01056640|158033261|FG000|Overall Study|Death|15|||
49055454|NCT01056640|158033262|FG001|Overall Study|Death|4|||
49055455|NCT04569786|158033271|FG000|Overall Study|Lost to Follow-up|1|||
49055456|NCT04569786|158033272|FG001|Overall Study|Lost to Follow-up|0|||
49055457|NCT04569786|158033273|FG002|Overall Study|Lost to Follow-up|4|||
49055458|NCT04569786|158033274|FG003|Overall Study|Lost to Follow-up|1|||
49055459|NCT04569786|158033275|FG004|Overall Study|Lost to Follow-up|0|||
49055460|NCT04569786|158033271|FG000|Overall Study|Withdrawal by Subject|0|||
49055461|NCT04569786|158033272|FG001|Overall Study|Withdrawal by Subject|0|||
49055462|NCT04569786|158033273|FG002|Overall Study|Withdrawal by Subject|0|||
49055463|NCT04569786|158033274|FG003|Overall Study|Withdrawal by Subject|5|||
49055464|NCT04569786|158033275|FG004|Overall Study|Withdrawal by Subject|1|||
49055465|NCT04569786|158033271|FG000|Overall Study|Physician Decision|0|||
49055466|NCT04569786|158033272|FG001|Overall Study|Physician Decision|0|||
49055467|NCT04569786|158033273|FG002|Overall Study|Physician Decision|0|||
49055468|NCT04569786|158033274|FG003|Overall Study|Physician Decision|1|||
49055469|NCT04569786|158033275|FG004|Overall Study|Physician Decision|0|||
49055470|NCT03164616|158033277|FG000|Overall Study|Death|250|||
49055471|NCT03164616|158033278|FG001|Overall Study|Death|264|||
49055472|NCT03164616|158033279|FG002|Overall Study|Death|279|||
49055473|NCT03164616|158033277|FG000|Overall Study|Lost to Follow-up|2|||
49055474|NCT03164616|158033278|FG001|Overall Study|Lost to Follow-up|2|||
49055475|NCT03164616|158033279|FG002|Overall Study|Lost to Follow-up|2|||
49055476|NCT03164616|158033277|FG000|Overall Study|Withdrawal by Subject|6|||
49055477|NCT03164616|158033278|FG001|Overall Study|Withdrawal by Subject|7|||
49055478|NCT03164616|158033279|FG002|Overall Study|Withdrawal by Subject|16|||
49055479|NCT01640184|158033280|FG000|Overall Study|Death|1|||
49055480|NCT01640184|158033281|FG001|Overall Study|Death|0|||
49055481|NCT01640184|158033282|FG002|Overall Study|Death|0|||
49055482|NCT01640184|158033280|FG000|Overall Study|Lost to Follow-up|4|||
49055483|NCT01640184|158033281|FG001|Overall Study|Lost to Follow-up|1|||
49055484|NCT01640184|158033282|FG002|Overall Study|Lost to Follow-up|0|||
49055485|NCT01640184|158033280|FG000|Overall Study|Physician Decision|3|||
49055486|NCT01640184|158033281|FG001|Overall Study|Physician Decision|0|||
49055487|NCT01640184|158033282|FG002|Overall Study|Physician Decision|0|||
49055488|NCT01640184|158033280|FG000|Overall Study|Withdrawal by Subject|0|||
49055489|NCT01640184|158033281|FG001|Overall Study|Withdrawal by Subject|1|||
49055490|NCT01640184|158033282|FG002|Overall Study|Withdrawal by Subject|1|||
49055491|NCT01640184|158033280|FG000|Overall Study|Protocol Violation|0|||
49055492|NCT01640184|158033281|FG001|Overall Study|Protocol Violation|0|||
49055493|NCT01640184|158033282|FG002|Overall Study|Protocol Violation|1|||
49055494|NCT03718117|158033283|FG000|Overall Study|Death|12|||
49055495|NCT03718117|158033284|FG001|Overall Study|Death|11|||
49055496|NCT03718117|158033285|FG002|Overall Study|Death|0|||
49055497|NCT03718117|158033283|FG000|Overall Study|Other|0|||
49055498|NCT03718117|158033284|FG001|Overall Study|Other|1|||
49055499|NCT03718117|158033285|FG002|Overall Study|Other|0|||
49055500|NCT03718117|158033283|FG000|Overall Study|Withdrawn due to adverse event (AE)|2|||
49055501|NCT03718117|158033284|FG001|Overall Study|Withdrawn due to adverse event (AE)|0|||
49055502|NCT03718117|158033285|FG002|Overall Study|Withdrawn due to adverse event (AE)|0|||
49055503|NCT03718117|158033283|FG000|Overall Study|Participant not met eligibility criteria|0|||
49055504|NCT03718117|158033284|FG001|Overall Study|Participant not met eligibility criteria|0|||
49055505|NCT03718117|158033285|FG002|Overall Study|Participant not met eligibility criteria|2|||
49055506|NCT01435031|158033288|FG000|ITT at 1 Month|Withdrawal by Subject|1|||
49055507|NCT01435031|158033288|FG000|ITT at 1 Month|Death|1|||
49055508|NCT01435031|158033288|FG000|ITT at 1 Month|Lost to Follow-up|4|||
49055509|NCT01435031|158033288|FG000|ITT at 6 Months|Death|2|||
49055510|NCT01435031|158033288|FG000|ITT at 6 Months|Lost to Follow-up|3|||
49055511|NCT01435031|158033288|FG000|ITT at 1 Year|Death|1|||
49055512|NCT01435031|158033288|FG000|ITT at 1 Year|Withdrawal by Subject|2|||
49055513|NCT01435031|158033288|FG000|ITT at 1 Year|Lost to Follow-up|6|||
49055514|NCT01435031|158033288|FG000|ITT at 2 Years|Death|7|||
49055515|NCT01435031|158033288|FG000|ITT at 2 Years|Withdrawal by Subject|2|||
49055516|NCT01435031|158033288|FG000|ITT at 2 Years|Lost to Follow-up|4|||
49055517|NCT01435031|158033288|FG000|ITT at 3 Years|Death|5|||
49055518|NCT01435031|158033288|FG000|ITT at 3 Years|Withdrawal by Subject|2|||
49055519|NCT01435031|158033288|FG000|ITT at 3 Years|Lost to Follow-up|4|||
49055520|NCT01435031|158033288|FG000|ITT at 4 Years|Death|4|||
49055521|NCT01435031|158033288|FG000|ITT at 4 Years|Withdrawal by Subject|2|||
49055522|NCT01435031|158033288|FG000|ITT at 4 Years|Lost to Follow-up|1|||
49055523|NCT02927834|158033292|FG000|Overall Study|Lost to Follow-up|1|||
49055524|NCT02927834|158033293|FG001|Overall Study|Lost to Follow-up|2|||
49055525|NCT02927834|158033294|FG002|Overall Study|Lost to Follow-up|2|||
49055526|NCT00605917|158033295|FG000|Overall Study|Protocol Violation|79|||
49055527|NCT02985879|158033296|FG000|Overall Study|Adverse Event|7|||
49055528|NCT02985879|158033297|FG001|Overall Study|Adverse Event|9|||
49055529|NCT02985879|158033298|FG002|Overall Study|Adverse Event|7|||
49055530|NCT02985879|158033296|FG000|Overall Study|Withdrew consent|6|||
49055531|NCT02985879|158033297|FG001|Overall Study|Withdrew consent|8|||
49055532|NCT02985879|158033298|FG002|Overall Study|Withdrew consent|10|||
49055533|NCT02985879|158033296|FG000|Overall Study|Lost to Follow-up|1|||
49055534|NCT02985879|158033297|FG001|Overall Study|Lost to Follow-up|0|||
49055535|NCT02985879|158033298|FG002|Overall Study|Lost to Follow-up|2|||
49055536|NCT02985879|158033296|FG000|Overall Study|Other, not specified|62|||
49055537|NCT02985879|158033297|FG001|Overall Study|Other, not specified|58|||
49055538|NCT02985879|158033298|FG002|Overall Study|Other, not specified|58|||
49055539|NCT00890552|158033299|FG000|Enrollment and Pre-treatment|Death/ lost to follow up|1|||
49055540|NCT00890552|158033299|FG000|On-treatment|Early prog disease/ death|10|||
49055541|NCT00987831|158033302|FG000|Overall Study|Never flared in 12 months|1|||
49055542|NCT00987831|158033303|FG001|Overall Study|Never flared in 12 months|0|||
49055543|NCT00987831|158033304|FG002|Overall Study|Never flared in 12 months|0|||
49055544|NCT00987831|158033302|FG000|Overall Study|Lost to Follow-up|0|||
49055545|NCT00987831|158033303|FG001|Overall Study|Lost to Follow-up|3|||
49055546|NCT00987831|158033304|FG002|Overall Study|Lost to Follow-up|0|||
49055547|NCT00518622|158033305|FG000|Overall Study|Lost to Follow-up|0|||
49055548|NCT00518622|158033306|FG001|Overall Study|Lost to Follow-up|0|||
49055549|NCT00518622|158033307|FG002|Overall Study|Lost to Follow-up|1|||
49055550|NCT00518622|158033308|FG003|Overall Study|Lost to Follow-up|0|||
49055551|NCT00518622|158033309|FG004|Overall Study|Lost to Follow-up|0|||
49055552|NCT00518622|158033310|FG005|Overall Study|Lost to Follow-up|0|||
49055553|NCT00518622|158033311|FG006|Overall Study|Lost to Follow-up|0|||
49055554|NCT00518622|158033312|FG007|Overall Study|Lost to Follow-up|0|||
49055555|NCT00518622|158033305|FG000|Overall Study|Study medication taken incorrectly|0|||
49055556|NCT00518622|158033306|FG001|Overall Study|Study medication taken incorrectly|1|||
49055557|NCT00518622|158033307|FG002|Overall Study|Study medication taken incorrectly|0|||
49055558|NCT00518622|158033308|FG003|Overall Study|Study medication taken incorrectly|0|||
49055559|NCT00518622|158033309|FG004|Overall Study|Study medication taken incorrectly|0|||
49055560|NCT00518622|158033310|FG005|Overall Study|Study medication taken incorrectly|0|||
49055561|NCT00518622|158033311|FG006|Overall Study|Study medication taken incorrectly|0|||
49055562|NCT00518622|158033312|FG007|Overall Study|Study medication taken incorrectly|0|||
49055563|NCT01688726|158033313|FG000|Overall Study|Adverse Event|1|||
49055564|NCT01688726|158033314|FG001|Overall Study|Adverse Event|0|||
49055565|NCT01688726|158033313|FG000|Overall Study|Relocated abroad|0|||
49055566|NCT01688726|158033314|FG001|Overall Study|Relocated abroad|1|||
49055567|NCT00824369|158033315|FG000|Overall Study|Nolonger willing to participate in study|1|||
49055568|NCT00824369|158033316|FG001|Overall Study|Nolonger willing to participate in study|0|||
49055569|NCT00824369|158033317|FG002|Overall Study|Nolonger willing to participate in study|1|||
49055570|NCT00824369|158033318|FG003|Overall Study|Nolonger willing to participate in study|2|||
49055571|NCT00824369|158033319|FG004|Overall Study|Nolonger willing to participate in study|0|||
49055572|NCT00824369|158033320|FG005|Overall Study|Nolonger willing to participate in study|1|||
49055573|NCT00824369|158033315|FG000|Overall Study|Lost to Follow-up|0|||
49055574|NCT00824369|158033316|FG001|Overall Study|Lost to Follow-up|0|||
49055575|NCT00824369|158033317|FG002|Overall Study|Lost to Follow-up|0|||
49055576|NCT00824369|158033318|FG003|Overall Study|Lost to Follow-up|0|||
49055577|NCT00824369|158033319|FG004|Overall Study|Lost to Follow-up|1|||
49055578|NCT00824369|158033320|FG005|Overall Study|Lost to Follow-up|0|||
49055579|NCT00206102|158034757|FG000|Overall Study|Adverse Event|119|||
49055580|NCT00206102|158034758|FG001|Overall Study|Adverse Event|82|||
49055581|NCT00206102|158034757|FG000|Overall Study|Protocol Violation|0|||
49055582|NCT00206102|158034758|FG001|Overall Study|Protocol Violation|2|||
49055583|NCT00206102|158034757|FG000|Overall Study|Lack of therapeutic response|16|||
49055584|NCT00206102|158034758|FG001|Overall Study|Lack of therapeutic response|11|||
49055585|NCT00206102|158034757|FG000|Overall Study|Lost to Follow-up|95|||
49055586|NCT00206102|158034758|FG001|Overall Study|Lost to Follow-up|66|||
49055587|NCT00206102|158034757|FG000|Overall Study|Withdrawal by Subject|118|||
49055588|NCT00206102|158034758|FG001|Overall Study|Withdrawal by Subject|101|||
49055589|NCT00206102|158034757|FG000|Overall Study|Study-specific discontinuation criteria|18|||
49055590|NCT00206102|158034758|FG001|Overall Study|Study-specific discontinuation criteria|17|||
49055591|NCT00206102|158034757|FG000|Overall Study|None of those categories|42|||
49055592|NCT00206102|158034758|FG001|Overall Study|None of those categories|36|||
49055593|NCT01563237|158034768|FG000|Overall Study|Lost to Follow-up|6|||
49055594|NCT01563237|158034769|FG001|Overall Study|Lost to Follow-up|0|||
49055595|NCT01563237|158034768|FG000|Overall Study|Withdrawal by Subject|1|||
49055596|NCT01563237|158034769|FG001|Overall Study|Withdrawal by Subject|0|||
49055597|NCT01563237|158034768|FG000|Overall Study|Adverse Event|1|||
49055598|NCT01563237|158034769|FG001|Overall Study|Adverse Event|0|||
49055599|NCT01563237|158034768|FG000|Overall Study|Medical Reasons|1|||
49055600|NCT01563237|158034769|FG001|Overall Study|Medical Reasons|0|||
49055601|NCT01563237|158034768|FG000|Overall Study|Death|1|||
49055602|NCT01563237|158034769|FG001|Overall Study|Death|0|||
49055603|NCT01552369|158034770|FG000|Overall Study|Did not consent to extended follow up|8|||
49055604|NCT01552369|158034771|FG001|Overall Study|Did not consent to extended follow up|9|||
49055605|NCT04142242|158034772|FG000|Stage I|Non-compliance with the protocol|1|||
49055606|NCT04142242|158034773|FG001|Stage I|Non-compliance with the protocol|0|||
49055607|NCT04142242|158034774|FG002|Stage I|Non-compliance with the protocol|0|||
49055608|NCT04142242|158034775|FG003|Stage I|Non-compliance with the protocol|0|||
49055609|NCT04142242|158034776|FG004|Stage I|Non-compliance with the protocol|0|||
49055610|NCT04142242|158034777|FG005|Stage I|Non-compliance with the protocol|1|||
49055611|NCT04142242|158034772|FG000|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
49055612|NCT04142242|158034773|FG001|Stage I|Voluntary withdrawal not due to an adverse event (AE)|1|||
49055613|NCT04142242|158034774|FG002|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
49055614|NCT04142242|158034775|FG003|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
49055615|NCT04142242|158034776|FG004|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
49055616|NCT04142242|158034777|FG005|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
49055617|NCT04142242|158034772|FG000|Stage II|Non-compliance with the protocol|0|||
49055618|NCT04142242|158034773|FG001|Stage II|Non-compliance with the protocol|0|||
49055619|NCT04142242|158034774|FG002|Stage II|Non-compliance with the protocol|0|||
49055620|NCT04142242|158034775|FG003|Stage II|Non-compliance with the protocol|2|||
49055621|NCT04142242|158034776|FG004|Stage II|Non-compliance with the protocol|0|||
49055622|NCT04142242|158034777|FG005|Stage II|Non-compliance with the protocol|0|||
49055623|NCT04142242|158034772|FG000|Stage II|Lost to Follow-up|0|||
49055624|NCT04142242|158034773|FG001|Stage II|Lost to Follow-up|0|||
49055625|NCT04142242|158034774|FG002|Stage II|Lost to Follow-up|1|||
49055626|NCT04142242|158034775|FG003|Stage II|Lost to Follow-up|2|||
49055627|NCT04142242|158034776|FG004|Stage II|Lost to Follow-up|0|||
49055628|NCT04142242|158034777|FG005|Stage II|Lost to Follow-up|0|||
49055629|NCT04142242|158034772|FG000|Stage II|Withdrawal by Subject|0|||
49055630|NCT04142242|158034773|FG001|Stage II|Withdrawal by Subject|0|||
49055631|NCT04142242|158034774|FG002|Stage II|Withdrawal by Subject|5|||
49055632|NCT04142242|158034775|FG003|Stage II|Withdrawal by Subject|9|||
49055633|NCT04142242|158034776|FG004|Stage II|Withdrawal by Subject|0|||
49055634|NCT04142242|158034777|FG005|Stage II|Withdrawal by Subject|0|||
49055635|NCT01546922|158034779|FG000|First Period of 10 Weeks|Protocol Violation|3|||
49055636|NCT01546922|158034780|FG001|First Period of 10 Weeks|Protocol Violation|1|||
49055637|NCT01546922|158034779|FG000|First Period of 10 Weeks|Withdrawal by Subject|1|||
49055638|NCT01546922|158034780|FG001|First Period of 10 Weeks|Withdrawal by Subject|1|||
49055639|NCT01546922|158034779|FG000|First Period of 10 Weeks|Investigator's judgment|1|||
49055640|NCT01546922|158034780|FG001|First Period of 10 Weeks|Investigator's judgment|0|||
49055641|NCT01546922|158034779|FG000|Second Period of 10 Weeks|Protocol Violation|3|||
49055642|NCT01546922|158034780|FG001|Second Period of 10 Weeks|Protocol Violation|1|||
49055643|NCT01546922|158034779|FG000|Second Period of 10 Weeks|Withdrawal by Subject|0|||
49055644|NCT01546922|158034780|FG001|Second Period of 10 Weeks|Withdrawal by Subject|2|||
49055645|NCT04086641|158034781|FG000|Foot 1 (Two Week Utilization)|COVID-19|1|||
49055646|NCT04086641|158034782|FG001|Foot 1 (Two Week Utilization)|COVID-19|2|||
49055647|NCT01597479|158034783|FG000|Overall Study|Protocol Violation|1|||
49055648|NCT01597479|158034784|FG001|Overall Study|Protocol Violation|0|||
49055649|NCT01597479|158034783|FG000|Overall Study|Lost to Follow-up|1|||
49055650|NCT01597479|158034784|FG001|Overall Study|Lost to Follow-up|0|||
49055651|NCT01045707|158034788|FG000|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5|||
49055652|NCT01045707|158034789|FG001|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3|||
49055653|NCT01045707|158034788|FG000|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4|||
49055654|NCT01045707|158034789|FG001|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2|||
49055655|NCT01045707|158034788|FG000|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6|||
49055656|NCT01045707|158034789|FG001|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5|||
49055657|NCT01045707|158034788|FG000|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22|||
49055658|NCT01045707|158034789|FG001|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11|||
49055659|NCT01045707|158034788|FG000|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10|||
49055660|NCT01045707|158034789|FG001|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11|||
49055661|NCT01045707|158034788|FG000|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
49055662|NCT01045707|158034789|FG001|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
49055663|NCT01045707|158034788|FG000|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2|||
49055664|NCT01045707|158034789|FG001|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3|||
49055665|NCT01045707|158034788|FG000|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2|||
49055666|NCT01045707|158034789|FG001|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1|||
49055667|NCT01045707|158034788|FG000|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6|||
49055668|NCT01045707|158034789|FG001|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5|||
49055669|NCT01613378|158034790|FG000|Overall Study|Lack of Efficacy|13|||
49055670|NCT01613378|158034790|FG000|Overall Study|Adverse Event|11|||
49055671|NCT01613378|158034790|FG000|Overall Study|Withdrawal by Subject|8|||
49055672|NCT01613378|158034790|FG000|Overall Study|Death|2|||
49055673|NCT01613378|158034790|FG000|Overall Study|Lost to Follow-up|1|||
49055674|NCT01613378|158034790|FG000|Overall Study|Other Reason|4|||
49055675|NCT01213836|158034791|FG000|Period 1, First Intervention|Adverse Event|2|||
49055676|NCT01213836|158034792|FG001|Period 1, First Intervention|Adverse Event|1|||
49055677|NCT01213836|158034791|FG000|Period 1, First Intervention|Protocol Violation|0|||
49055678|NCT01213836|158034792|FG001|Period 1, First Intervention|Protocol Violation|1|||
49055679|NCT01213836|158034791|FG000|Period 1, First Intervention|Withdrawal by Subject|1|||
49055680|NCT01213836|158034792|FG001|Period 1, First Intervention|Withdrawal by Subject|1|||
49055681|NCT00255151|158034793|FG000|Overall Study|Adverse Event|10|||
49055682|NCT00255151|158034794|FG001|Overall Study|Adverse Event|6|||
49055683|NCT00255151|158034795|FG002|Overall Study|Adverse Event|9|||
49055684|NCT00255151|158034793|FG000|Overall Study|Lost to Follow-up|4|||
49055685|NCT00255151|158034794|FG001|Overall Study|Lost to Follow-up|3|||
49055686|NCT00255151|158034795|FG002|Overall Study|Lost to Follow-up|4|||
49055687|NCT00255151|158034793|FG000|Overall Study|Withdrawal by Subject|18|||
49055688|NCT00255151|158034794|FG001|Overall Study|Withdrawal by Subject|17|||
49055689|NCT00255151|158034795|FG002|Overall Study|Withdrawal by Subject|8|||
49055690|NCT00255151|158034793|FG000|Overall Study|Noncompliance|0|||
49055691|NCT00255151|158034794|FG001|Overall Study|Noncompliance|1|||
49055692|NCT00255151|158034795|FG002|Overall Study|Noncompliance|2|||
49055693|NCT00255151|158034793|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
49055694|NCT00255151|158034794|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
49055695|NCT00255151|158034795|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
49055696|NCT00255151|158034793|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
49055697|NCT00255151|158034794|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
49055698|NCT00255151|158034795|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
49055699|NCT00255151|158034793|FG000|Overall Study|Possible Barrett's Esophagus|1|||
49055700|NCT00255151|158034794|FG001|Overall Study|Possible Barrett's Esophagus|3|||
49055701|NCT00255151|158034795|FG002|Overall Study|Possible Barrett's Esophagus|8|||
49055702|NCT00255151|158034793|FG000|Overall Study|Esophageal Stricture|0|||
49055703|NCT00255151|158034794|FG001|Overall Study|Esophageal Stricture|0|||
49055704|NCT00255151|158034795|FG002|Overall Study|Esophageal Stricture|1|||
49055705|NCT00255151|158034793|FG000|Overall Study|Therapeutic Failure|11|||
49055706|NCT00255151|158034794|FG001|Overall Study|Therapeutic Failure|2|||
49055707|NCT00255151|158034795|FG002|Overall Study|Therapeutic Failure|3|||
49055708|NCT02744755|158034796|FG000|Study Period 1|Protocol Violation|2|||
49055709|NCT02744755|158034797|FG001|Study Period 1|Protocol Violation|1|||
49055710|NCT02744755|158034796|FG000|Study Period 1|not defined|0|||
49055711|NCT02744755|158034797|FG001|Study Period 1|not defined|1|||
49055712|NCT02744755|158034796|FG000|Study Period 1|Pregnancy|1|||
49055713|NCT02744755|158034797|FG001|Study Period 1|Pregnancy|0|||
49055714|NCT02744755|158034796|FG000|Study Period 1|Adverse Event|1|||
49055715|NCT02744755|158034797|FG001|Study Period 1|Adverse Event|1|||
49055716|NCT02744755|158034796|FG000|Study Period 1|Lost to Follow-up|1|||
49055717|NCT02744755|158034797|FG001|Study Period 1|Lost to Follow-up|1|||
49055718|NCT02744755|158034796|FG000|Study Period 1|Lack of Efficacy|1|||
49055719|NCT02744755|158034797|FG001|Study Period 1|Lack of Efficacy|0|||
49055720|NCT02744755|158034796|FG000|Study Period 1|Withdrawal by Subject|8|||
49055721|NCT02744755|158034797|FG001|Study Period 1|Withdrawal by Subject|4|||
49055722|NCT02744755|158034796|FG000|Study Period 2|Adverse Event|5|||
49055723|NCT02744755|158034797|FG001|Study Period 2|Adverse Event|0|||
49055724|NCT02744755|158034796|FG000|Study Period 2|Protocol Violation|1|||
49055725|NCT02744755|158034797|FG001|Study Period 2|Protocol Violation|0|||
49055726|NCT02744755|158034796|FG000|Study Period 2|not defined|3|||
49055727|NCT02744755|158034797|FG001|Study Period 2|not defined|2|||
49055728|NCT02744755|158034796|FG000|Study Period 2|Lost to Follow-up|0|||
49055729|NCT02744755|158034797|FG001|Study Period 2|Lost to Follow-up|2|||
49055730|NCT02744755|158034796|FG000|Study Period 2|Withdrawal by Subject|2|||
49055731|NCT02744755|158034797|FG001|Study Period 2|Withdrawal by Subject|2|||
49055732|NCT02744755|158034796|FG000|Study Period 2|Lack of Efficacy|3|||
49055733|NCT02744755|158034797|FG001|Study Period 2|Lack of Efficacy|2|||
49055734|NCT00792623|158034798|FG000|Overall Study|Adverse Event|2|||
49055735|NCT00792623|158034798|FG000|Overall Study|Withdrawal by Subject|5|||
49055736|NCT01559935|158034799|FG000|Car Phase|Toxicity|4|||
49055737|NCT01559935|158034799|FG000|Car Phase|Death|1|||
49055738|NCT01559935|158034799|FG000|Car Phase|Lack of Efficacy|2|||
49055739|NCT01559935|158034799|FG000|Car Phase|Lost to Follow-up|1|||
49055740|NCT01559935|158034799|FG000|Car Phase|Physician Decision|1|||
49055741|NCT01559935|158034799|FG000|Car Phase|Withdrawal by Subject|2|||
49055742|NCT01559935|158034799|FG000|Car Phase|Per protocol|1|||
49055743|NCT01559935|158034799|FG000|Car Phase|Insurance|1|||
49055744|NCT01559935|158034799|FG000|Car Phase|non-compliance|1|||
49055745|NCT01559935|158034799|FG000|BiRD Phase|Toxicity|1|||
49055746|NCT01559935|158034799|FG000|BiRD Phase|Lack of Efficacy|1|||
49055747|NCT01559935|158034799|FG000|BiRD Phase|Withdrawal by Subject|2|||
49055748|NCT01559935|158034799|FG000|Maintenance Phase|Remains on study|28|||
49055749|NCT01559935|158034799|FG000|Maintenance Phase|Toxicity|1|||
49055750|NCT01559935|158034799|FG000|Maintenance Phase|Lack of Efficacy|18|||
49055751|NCT01559935|158034799|FG000|Maintenance Phase|Withdrawal by Subject|5|||
49055752|NCT01559935|158034799|FG000|Maintenance Phase|Non-compliance|2|||
49055753|NCT04317599|158034802|FG000|Overall Study|ineligible due to inclusion/exclusion criteria|15|||
49055754|NCT04317599|158034802|FG000|Overall Study|treatment outside standard of care|4|||
49055755|NCT04059549|158034803|FG000|Overall Study|Withdrawal by Subject|2|||
49055756|NCT04059549|158034804|FG001|Overall Study|Withdrawal by Subject|0|||
49055757|NCT03919448|158034807|FG000|Overall Study|Withdrawal by Subject|1|||
49055758|NCT03919448|158034808|FG001|Overall Study|Withdrawal by Subject|0|||
49055759|NCT03919448|158034809|FG002|Overall Study|Withdrawal by Subject|0|||
49055760|NCT03438539|158034814|FG000|Overall Study|Lost to Follow-up|8|||
49055761|NCT03438539|158034815|FG001|Overall Study|Lost to Follow-up|4|||
49055762|NCT03438539|158034816|FG002|Overall Study|Lost to Follow-up|10|||
49055763|NCT03438539|158034817|FG003|Overall Study|Lost to Follow-up|9|||
49055764|NCT03438539|158034818|FG004|Overall Study|Lost to Follow-up|3|||
49055765|NCT03438539|158034819|FG005|Overall Study|Lost to Follow-up|8|||
49055766|NCT01221090|158034820|FG000|Overall Study|Non-Compliant or Unable to Contact|15|||
49055767|NCT01221090|158034821|FG001|Overall Study|Non-Compliant or Unable to Contact|12|||
49055768|NCT01221090|158034822|FG002|Overall Study|Non-Compliant or Unable to Contact|15|||
49055769|NCT01221090|158034823|FG003|Overall Study|Non-Compliant or Unable to Contact|20|||
49055770|NCT01221090|158034820|FG000|Overall Study|Withdrawal by Subject|0|||
49055771|NCT01221090|158034821|FG001|Overall Study|Withdrawal by Subject|22|||
49055772|NCT01221090|158034822|FG002|Overall Study|Withdrawal by Subject|27|||
49055773|NCT01221090|158034823|FG003|Overall Study|Withdrawal by Subject|2|||
49055774|NCT00708708|158034826|FG000|Overall Study|Another therapy instead of Enbrel|141|||
49055775|NCT00708708|158034826|FG000|Overall Study|Lost to Follow-up|52|||
49055776|NCT00708708|158034826|FG000|Overall Study|Withdrawal by Subject|51|||
49055777|NCT00708708|158034826|FG000|Overall Study|Intolerance|42|||
49055778|NCT00708708|158034826|FG000|Overall Study|Another therapy along with Enbrel|15|||
49055779|NCT00708708|158034826|FG000|Overall Study|Other unspecified|11|||
49055780|NCT00708708|158034826|FG000|Overall Study|Good effectiveness|9|||
49055781|NCT00708708|158034826|FG000|Overall Study|Ineffectiveness (no systemic therapy)|9|||
49055782|NCT00708708|158034826|FG000|Overall Study|Administrative reasons|7|||
49055783|NCT00708708|158034826|FG000|Overall Study|Lack of effectiveness|4|||
49055784|NCT00708708|158034826|FG000|Overall Study|Lack of compliance|3|||
49055785|NCT00708708|158034826|FG000|Overall Study|Pregnancy|3|||
49055786|NCT00708708|158034826|FG000|Overall Study|Adverse Event|3|||
49055787|NCT00708708|158034826|FG000|Overall Study|Missing values|392|||
49055788|NCT04213209|158034827|FG000|Overall Study|Protocol Violation|1|||
49055789|NCT04213209|158034828|FG001|Overall Study|Protocol Violation|0|||
49055790|NCT04213209|158034829|FG002|Overall Study|Protocol Violation|0|||
49055791|NCT04213209|158034830|FG003|Overall Study|Protocol Violation|0|||
49055792|NCT04213209|158034831|FG004|Overall Study|Protocol Violation|0|||
49055793|NCT04213209|158034832|FG005|Overall Study|Protocol Violation|0|||
49055794|NCT00743509|158034836|FG000|Overall Study|Withdrawal by Subject|2|||
49055795|NCT02278718|158034838|FG000|Overall Study|Adverse Event|1|||
49055796|NCT02278718|158034839|FG001|Overall Study|Adverse Event|0|||
49055797|NCT02278718|158034838|FG000|Overall Study|Lost to Follow-up|2|||
49055798|NCT02278718|158034839|FG001|Overall Study|Lost to Follow-up|4|||
49055799|NCT02278718|158034838|FG000|Overall Study|Withdrawal by Subject|1|||
49055800|NCT02278718|158034839|FG001|Overall Study|Withdrawal by Subject|4|||
49055801|NCT02278718|158034838|FG000|Overall Study|The patient was randomised but did not receive study drug treatment|2|||
49055802|NCT02278718|158034839|FG001|Overall Study|The patient was randomised but did not receive study drug treatment|1|||
49055803|NCT02278718|158034838|FG000|Overall Study|Missing|0|||
49055804|NCT02278718|158034839|FG001|Overall Study|Missing|1|||
49055805|NCT01615263|158034842|FG000|Overall Study|Post-randomization exclusion|0|||
49055806|NCT01615263|158034843|FG001|Overall Study|Post-randomization exclusion|2|||
49055807|NCT01546649|158034847|FG000|Overall Study|Adverse Event|4|||
49055808|NCT01546649|158034848|FG001|Overall Study|Adverse Event|5|||
49055809|NCT01546649|158034847|FG000|Overall Study|Protocol Violation|1|||
49055810|NCT01546649|158034848|FG001|Overall Study|Protocol Violation|0|||
49055811|NCT01546649|158034847|FG000|Overall Study|Lack of Efficacy|1|||
49055812|NCT01546649|158034848|FG001|Overall Study|Lack of Efficacy|0|||
49055813|NCT01546649|158034847|FG000|Overall Study|Recurrence|1|||
49055814|NCT01546649|158034848|FG001|Overall Study|Recurrence|1|||
49055815|NCT01546649|158034847|FG000|Overall Study|Discovery of secondary cancer|0|||
49055816|NCT01546649|158034848|FG001|Overall Study|Discovery of secondary cancer|1|||
49055817|NCT01546649|158034847|FG000|Overall Study|Withdrawal by Subject|1|||
49055818|NCT01546649|158034848|FG001|Overall Study|Withdrawal by Subject|2|||
49055819|NCT02075606|158034850|FG000|Overall Study|Adverse Event|5|||
49055820|NCT02075606|158034850|FG000|Overall Study|Withdrawal by Subject|1|||
49055821|NCT02075606|158034850|FG000|Overall Study|Death|1|||
49055822|NCT02075606|158034850|FG000|Overall Study|Investigator's decision|1|||
49055823|NCT02075606|158034850|FG000|Overall Study|Symptom management|1|||
49055824|NCT02075606|158034850|FG000|Overall Study|Increasing Symptoms|1|||
49055825|NCT04440449|158034851|FG000|Overall Study|Lost to Follow-up|2|||
49055826|NCT04440449|158034852|FG001|Overall Study|Lost to Follow-up|0|||
49055827|NCT00857259|158034853|FG000|Overall Study|Protocol Violation|1|||
49055828|NCT00857259|158034854|FG001|Overall Study|Protocol Violation|0|||
49055829|NCT00857259|158034855|FG002|Overall Study|Protocol Violation|1|||
49055830|NCT01929395|158034856|FG000|Overall Study|Did not complete - non-related toxicity|1|||
49055831|NCT01929395|158034857|FG001|Overall Study|Did not complete - non-related toxicity|0|||
49055832|NCT01929395|158034858|FG002|Overall Study|Did not complete - non-related toxicity|0|||
49055833|NCT01929395|158034856|FG000|Overall Study|Withdrawal by Subject|0|||
49055834|NCT01929395|158034857|FG001|Overall Study|Withdrawal by Subject|1|||
49055835|NCT01929395|158034858|FG002|Overall Study|Withdrawal by Subject|0|||
49055836|NCT01929395|158034856|FG000|Overall Study|Screen Fail|0|||
49055837|NCT01929395|158034857|FG001|Overall Study|Screen Fail|0|||
49055838|NCT01929395|158034858|FG002|Overall Study|Screen Fail|1|||
49055839|NCT01803269|158034861|FG000|Overall Study|Withdrawal by Subject|3|||
49055840|NCT01803269|158034862|FG001|Overall Study|Withdrawal by Subject|0|||
49055841|NCT01803269|158034863|FG002|Overall Study|Withdrawal by Subject|0|||
49055842|NCT00268892|158034867|FG000|Overall Study|Adverse Event|14|||
49055843|NCT00268892|158034868|FG001|Overall Study|Adverse Event|17|||
49055844|NCT00268892|158034869|FG002|Overall Study|Adverse Event|20|||
49055845|NCT00268892|158034867|FG000|Overall Study|Lack of Efficacy|1|||
49055846|NCT00268892|158034868|FG001|Overall Study|Lack of Efficacy|3|||
49055847|NCT00268892|158034869|FG002|Overall Study|Lack of Efficacy|0|||
49055848|NCT00268892|158034867|FG000|Overall Study|Withdrawal by Subject|14|||
49055849|NCT00268892|158034868|FG001|Overall Study|Withdrawal by Subject|15|||
49055850|NCT00268892|158034869|FG002|Overall Study|Withdrawal by Subject|13|||
49055851|NCT00268892|158034867|FG000|Overall Study|Physician Decision|0|||
49055852|NCT00268892|158034868|FG001|Overall Study|Physician Decision|1|||
49055853|NCT00268892|158034869|FG002|Overall Study|Physician Decision|0|||
49055854|NCT00268892|158034867|FG000|Overall Study|Lost to Follow-up|5|||
49055855|NCT00268892|158034868|FG001|Overall Study|Lost to Follow-up|2|||
49055856|NCT00268892|158034869|FG002|Overall Study|Lost to Follow-up|4|||
49055857|NCT00268892|158034867|FG000|Overall Study|Protocol Violation|0|||
49055858|NCT00268892|158034868|FG001|Overall Study|Protocol Violation|1|||
49055859|NCT00268892|158034869|FG002|Overall Study|Protocol Violation|0|||
49055860|NCT00268892|158034867|FG000|Overall Study|Disease Progression|1|||
49055861|NCT00268892|158034868|FG001|Overall Study|Disease Progression|1|||
49055862|NCT00268892|158034869|FG002|Overall Study|Disease Progression|0|||
49055863|NCT00268892|158034867|FG000|Overall Study|Trial Site Closed|4|||
49055864|NCT00268892|158034868|FG001|Overall Study|Trial Site Closed|2|||
49055865|NCT00268892|158034869|FG002|Overall Study|Trial Site Closed|2|||
49055866|NCT05830799|158034875|FG000|Overall Study|Withdrawal by Subject|1|||
49055867|NCT03663205|158034876|FG000|Overall Study|Death|144|||
49055868|NCT03663205|158034877|FG001|Overall Study|Death|69|||
49055869|NCT03663205|158034876|FG000|Overall Study|Sponsor decision|53|||
49055870|NCT03663205|158034877|FG001|Overall Study|Sponsor decision|19|||
49055871|NCT03663205|158034876|FG000|Overall Study|Withdrawal by Subject|8|||
49055872|NCT03663205|158034877|FG001|Overall Study|Withdrawal by Subject|11|||
49055873|NCT03663205|158034876|FG000|Overall Study|Lost to Follow-up|7|||
49055874|NCT03663205|158034877|FG001|Overall Study|Lost to Follow-up|9|||
49055875|NCT03663205|158034876|FG000|Overall Study|Transferred to long term extension study|11|||
49055876|NCT03663205|158034877|FG001|Overall Study|Transferred to long term extension study|3|||
49055877|NCT01202877|158034878|FG000|Overall Study|Disease Progression|0|||
49055878|NCT01202877|158034879|FG001|Overall Study|Disease Progression|1|||
49055879|NCT01202877|158034880|FG002|Overall Study|Disease Progression|2|||
49055880|NCT01202877|158034878|FG000|Overall Study|Adverse Event|0|||
49055881|NCT01202877|158034879|FG001|Overall Study|Adverse Event|0|||
49055882|NCT01202877|158034880|FG002|Overall Study|Adverse Event|2|||
49055883|NCT01202877|158034878|FG000|Overall Study|Withdrawal by Subject|0|||
49055884|NCT01202877|158034879|FG001|Overall Study|Withdrawal by Subject|0|||
49055885|NCT01202877|158034880|FG002|Overall Study|Withdrawal by Subject|1|||
49055886|NCT01202877|158034878|FG000|Overall Study|Death|0|||
49055887|NCT01202877|158034879|FG001|Overall Study|Death|0|||
49055888|NCT01202877|158034880|FG002|Overall Study|Death|1|||
49055889|NCT00396331|158034883|FG000|Overall Study|Failed to mobilize - no transplant|8|||
49055890|NCT00396331|158034883|FG000|Overall Study|Did not go on to transplant|5|||
49055891|NCT00396331|158034883|FG000|Overall Study|Lost to Follow-up|3|||
49055892|NCT00396331|158034883|FG000|Overall Study|Death|16|||
49055893|NCT00518882|158034884|FG000|Double-Blind, Week 0-26|Adverse Event|23|||
49055894|NCT00518882|158034885|FG001|Double-Blind, Week 0-26|Adverse Event|31|||
49055895|NCT00518882|158034884|FG000|Double-Blind, Week 0-26|Lack of Efficacy|1|||
49055896|NCT00518882|158034885|FG001|Double-Blind, Week 0-26|Lack of Efficacy|0|||
49055897|NCT00518882|158034884|FG000|Double-Blind, Week 0-26|Protocol Violation|4|||
49055898|NCT00518882|158034885|FG001|Double-Blind, Week 0-26|Protocol Violation|3|||
49055899|NCT00518882|158034884|FG000|Double-Blind, Week 0-26|Withdrawal criteria|1|||
49055900|NCT00518882|158034885|FG001|Double-Blind, Week 0-26|Withdrawal criteria|1|||
49055901|NCT00518882|158034884|FG000|Double-Blind, Week 0-26|Lost to follow up|2|||
49055902|NCT00518882|158034885|FG001|Double-Blind, Week 0-26|Lost to follow up|1|||
49055903|NCT00518882|158034884|FG000|Double-Blind, Week 0-26|Subject decision|1|||
49055904|NCT00518882|158034885|FG001|Double-Blind, Week 0-26|Subject decision|1|||
49055905|NCT00518882|158034884|FG000|Double-Blind, Week 0-26|Withdrawal of consent|1|||
49055906|NCT00518882|158034885|FG001|Double-Blind, Week 0-26|Withdrawal of consent|3|||
49055907|NCT00518882|158034884|FG000|Double-Blind, Week 0-26|Loss of trust|0|||
49055908|NCT00518882|158034885|FG001|Double-Blind, Week 0-26|Loss of trust|1|||
49055909|NCT00518882|158034884|FG000|Double-Blind, Week 0-26|Fear of hypoglycaemia|0|||
49055910|NCT00518882|158034885|FG001|Double-Blind, Week 0-26|Fear of hypoglycaemia|1|||
49055911|NCT00518882|158034884|FG000|Double-Blind, Week 0-26|Hypoglycaemia|0|||
49055912|NCT00518882|158034885|FG001|Double-Blind, Week 0-26|Hypoglycaemia|2|||
49055913|NCT00518882|158034884|FG000|Double-Blind, Week 0-26|Mutual consent|0|||
49055914|NCT00518882|158034885|FG001|Double-Blind, Week 0-26|Mutual consent|1|||
49055915|NCT00518882|158034884|FG000|Open-Label Extension, Week 26-78|Adverse Event|3|||
49055916|NCT00518882|158034885|FG001|Open-Label Extension, Week 26-78|Adverse Event|9|||
49055917|NCT00518882|158034884|FG000|Open-Label Extension, Week 26-78|Lack of Efficacy|6|||
49055918|NCT00518882|158034885|FG001|Open-Label Extension, Week 26-78|Lack of Efficacy|5|||
49055919|NCT00518882|158034884|FG000|Open-Label Extension, Week 26-78|Protocol Violation|3|||
49055920|NCT00518882|158034885|FG001|Open-Label Extension, Week 26-78|Protocol Violation|4|||
49055921|NCT00518882|158034884|FG000|Open-Label Extension, Week 26-78|Withdrawel criteria|1|||
49055922|NCT00518882|158034885|FG001|Open-Label Extension, Week 26-78|Withdrawel criteria|2|||
49055923|NCT00518882|158034884|FG000|Open-Label Extension, Week 26-78|Hypoglycaemia|0|||
49055924|NCT00518882|158034885|FG001|Open-Label Extension, Week 26-78|Hypoglycaemia|1|||
49055925|NCT00518882|158034884|FG000|Open-Label Extension, Week 26-78|Lost to follow up|1|||
49055926|NCT00518882|158034885|FG001|Open-Label Extension, Week 26-78|Lost to follow up|1|||
49055927|NCT00518882|158034884|FG000|Open-Label Extension, Week 26-78|Consent withdrawn|2|||
49055928|NCT00518882|158034885|FG001|Open-Label Extension, Week 26-78|Consent withdrawn|1|||
49055929|NCT00518882|158034884|FG000|Open-Label Extension, Week 26-78|Change in treatment|1|||
49055930|NCT00518882|158034885|FG001|Open-Label Extension, Week 26-78|Change in treatment|1|||
49055931|NCT00518882|158034884|FG000|Open-Label Extension, Week 26-78|Creatine increased|1|||
49055932|NCT00518882|158034885|FG001|Open-Label Extension, Week 26-78|Creatine increased|0|||
49055933|NCT00518882|158034884|FG000|Open-Label Extension, Week 26-78|Decreased kidney function|1|||
49055934|NCT00518882|158034885|FG001|Open-Label Extension, Week 26-78|Decreased kidney function|0|||
49055935|NCT00518882|158034884|FG000|Open-Label Extension, Week 26-78|Exclusion criteria|2|||
49055936|NCT00518882|158034885|FG001|Open-Label Extension, Week 26-78|Exclusion criteria|0|||
49055937|NCT00518882|158034884|FG000|Open-Label Extension, Week 26-78|Subject decision|2|||
49055938|NCT00518882|158034885|FG001|Open-Label Extension, Week 26-78|Subject decision|0|||
49055939|NCT00518882|158034884|FG000|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18|||
49055940|NCT00518882|158034885|FG001|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25|||
49055941|NCT04647383|158034886|FG000|Treatment Period 2 (8 Days)|Adverse Event|0|||
49055942|NCT04647383|158034887|FG001|Treatment Period 2 (8 Days)|Adverse Event|1|||
49055943|NCT04647383|158034888|FG002|Treatment Period 2 (8 Days)|Adverse Event|0|||
49055944|NCT04647383|158034889|FG003|Treatment Period 2 (8 Days)|Adverse Event|0|||
49055945|NCT02087176|158034894|FG000|Overall Study|Withdrawal by Subject|1|||
49055946|NCT02087176|158034894|FG000|Overall Study|Death|10|||
49055947|NCT02087176|158034894|FG000|Overall Study|Censored|19|||
49055948|NCT02087176|158034894|FG000|Overall Study|Study Terminated by Sponsor|2|||
49055949|NCT02326974|158034895|FG000|Overall Study|Withdrawal by Subject|2|||
49055950|NCT02326974|158034895|FG000|Overall Study|failed heterogenity evaluation|5|||
49055951|NCT02903238|158034896|FG000|Overall Study|Lost to Follow-up|4|||
49055952|NCT02220725|158034898|FG000|Overall Study|Lost to Follow-up|0|||
49055953|NCT02220725|158034899|FG001|Overall Study|Lost to Follow-up|0|||
49055954|NCT02220725|158034900|FG002|Overall Study|Lost to Follow-up|0|||
49055955|NCT02220725|158034901|FG003|Overall Study|Lost to Follow-up|1|||
49055956|NCT02220725|158034898|FG000|Overall Study|Withdrawal by Subject|0|||
49055957|NCT02220725|158034899|FG001|Overall Study|Withdrawal by Subject|0|||
49055958|NCT02220725|158034900|FG002|Overall Study|Withdrawal by Subject|0|||
49055959|NCT02220725|158034901|FG003|Overall Study|Withdrawal by Subject|1|||
49055960|NCT02211014|158036318|FG000|Overall Study|Adverse Event|0|||
49055961|NCT02211014|158036319|FG001|Overall Study|Adverse Event|2|||
49055962|NCT02211014|158036318|FG000|Overall Study|Physician Decision|1|||
49055963|NCT02211014|158036319|FG001|Overall Study|Physician Decision|2|||
49055964|NCT02211014|158036318|FG000|Overall Study|Started another cancer therapy|1|||
49055965|NCT02211014|158036319|FG001|Overall Study|Started another cancer therapy|0|||
49055966|NCT02211014|158036318|FG000|Overall Study|Withdrawal by Subject|0|||
49055967|NCT02211014|158036319|FG001|Overall Study|Withdrawal by Subject|1|||
49055968|NCT02211014|158036318|FG000|Overall Study|In agreement with patient, no benefit|0|||
49055969|NCT02211014|158036319|FG001|Overall Study|In agreement with patient, no benefit|1|||
49055970|NCT00966381|158036320|FG000|Overall Study|Withdrawal by Subject|2|||
49055971|NCT00966381|158036321|FG001|Overall Study|Withdrawal by Subject|2|||
49055972|NCT03581188|158036322|FG000|Overall Study|Inclusion criteria not met|3|||
49055973|NCT03581188|158036323|FG001|Overall Study|Inclusion criteria not met|2|||
49055974|NCT03581188|158036322|FG000|Overall Study|Lost to Follow-up|5|||
49055975|NCT03581188|158036323|FG001|Overall Study|Lost to Follow-up|5|||
49055976|NCT03581188|158036322|FG000|Overall Study|Discontinued intervention|11|||
49055977|NCT03581188|158036323|FG001|Overall Study|Discontinued intervention|8|||
49055978|NCT01124695|158036325|FG000|Overall Study|Disease progression|77|||
49055979|NCT01124695|158036325|FG000|Overall Study|Adverse Event|11|||
49055980|NCT01124695|158036325|FG000|Overall Study|Death|1|||
49055981|NCT01124695|158036325|FG000|Overall Study|Withdrawal by Subject|7|||
49055982|NCT01124695|158036325|FG000|Overall Study|Physician Decision|3|||
49055983|NCT01124695|158036325|FG000|Overall Study|Alternative therapy|9|||
49055984|NCT01124695|158036325|FG000|Overall Study|No documentation that patient went off treatment|4|||
49055985|NCT01124695|158036325|FG000|Overall Study|Ineligible|9|||
49055986|NCT01124695|158036325|FG000|Overall Study|Ineligible and never start treatment|2|||
49055987|NCT00115934|158036336|FG000|Overall Study|Lost to Follow-up|1|||
49055988|NCT00115934|158036337|FG001|Overall Study|Lost to Follow-up|0|||
49055989|NCT00115934|158036336|FG000|Overall Study|Did not receive intervention|3|||
49055990|NCT00115934|158036337|FG001|Overall Study|Did not receive intervention|2|||
49055991|NCT03891758|158036338|FG000|Overall Study|Adverse Event|2|||
49055992|NCT03891758|158036339|FG001|Overall Study|Adverse Event|0|||
49055993|NCT03891758|158036338|FG000|Overall Study|Withdrawal by parent/guardian|0|||
49055994|NCT03891758|158036339|FG001|Overall Study|Withdrawal by parent/guardian|2|||
49055995|NCT02676284|158036340|FG000|Overall Study|Withdrawal by Subject|1|||
49055996|NCT00107042|158036341|FG000|Overall Study|Lost to Follow-up|9|||
49055997|NCT00107042|158036342|FG001|Overall Study|Lost to Follow-up|7|||
49055998|NCT00107042|158036341|FG000|Overall Study|Withdrawal by Subject|6|||
49055999|NCT00107042|158036342|FG001|Overall Study|Withdrawal by Subject|1|||
49056000|NCT00107042|158036341|FG000|Overall Study|Moved out of area|5|||
49056001|NCT00107042|158036342|FG001|Overall Study|Moved out of area|3|||
49056002|NCT00107042|158036341|FG000|Overall Study|Pregnancy|1|||
49056003|NCT00107042|158036342|FG001|Overall Study|Pregnancy|1|||
49056004|NCT00107042|158036341|FG000|Overall Study|Inadvertent enrollment|0|||
49056005|NCT00107042|158036342|FG001|Overall Study|Inadvertent enrollment|1|||
49056006|NCT00107042|158036341|FG000|Overall Study|vaccinated outside window|1|||
49056007|NCT00107042|158036342|FG001|Overall Study|vaccinated outside window|1|||
49056008|NCT00107042|158036341|FG000|Overall Study|Disallowed medications|0|||
49056009|NCT00107042|158036342|FG001|Overall Study|Disallowed medications|2|||
49056010|NCT00880087|158036347|FG000|Overall Study|Lost to Follow-up|0|||
49056011|NCT00880087|158036348|FG001|Overall Study|Lost to Follow-up|2|||
49056012|NCT00754442|158036349|FG000|Overall Study|Withdrawal by Subject|5|||
49056013|NCT00754442|158036350|FG001|Overall Study|Withdrawal by Subject|3|||
49056014|NCT02780167|158036351|FG000|Overall Study|Adverse Event|9|||
49056015|NCT02780167|158036352|FG001|Overall Study|Adverse Event|8|||
49056016|NCT02780167|158036353|FG002|Overall Study|Adverse Event|8|||
49056017|NCT02780167|158036354|FG003|Overall Study|Adverse Event|12|||
49056018|NCT02780167|158036355|FG004|Overall Study|Adverse Event|8|||
49056019|NCT02780167|158036351|FG000|Overall Study|Lack of Efficacy|6|||
49056020|NCT02780167|158036352|FG001|Overall Study|Lack of Efficacy|5|||
49056021|NCT02780167|158036353|FG002|Overall Study|Lack of Efficacy|6|||
49056022|NCT02780167|158036354|FG003|Overall Study|Lack of Efficacy|1|||
49056023|NCT02780167|158036355|FG004|Overall Study|Lack of Efficacy|0|||
49056024|NCT02780167|158036351|FG000|Overall Study|Lost to Follow-up|2|||
49056025|NCT02780167|158036352|FG001|Overall Study|Lost to Follow-up|0|||
49056026|NCT02780167|158036353|FG002|Overall Study|Lost to Follow-up|1|||
49056027|NCT02780167|158036354|FG003|Overall Study|Lost to Follow-up|0|||
49056028|NCT02780167|158036355|FG004|Overall Study|Lost to Follow-up|0|||
49056029|NCT02780167|158036351|FG000|Overall Study|Does not meet entrance criteria|0|||
49056030|NCT02780167|158036352|FG001|Overall Study|Does not meet entrance criteria|0|||
49056031|NCT02780167|158036353|FG002|Overall Study|Does not meet entrance criteria|1|||
49056032|NCT02780167|158036354|FG003|Overall Study|Does not meet entrance criteria|0|||
49056033|NCT02780167|158036355|FG004|Overall Study|Does not meet entrance criteria|0|||
49056034|NCT02780167|158036351|FG000|Overall Study|No longer meets eligibility criteria|0|||
49056035|NCT02780167|158036352|FG001|Overall Study|No longer meets eligibility criteria|0|||
49056036|NCT02780167|158036353|FG002|Overall Study|No longer meets eligibility criteria|0|||
49056037|NCT02780167|158036354|FG003|Overall Study|No longer meets eligibility criteria|1|||
49056038|NCT02780167|158036355|FG004|Overall Study|No longer meets eligibility criteria|1|||
49056039|NCT02780167|158036351|FG000|Overall Study|Protocol Violation|5|||
49056040|NCT02780167|158036352|FG001|Overall Study|Protocol Violation|5|||
49056041|NCT02780167|158036353|FG002|Overall Study|Protocol Violation|1|||
49056042|NCT02780167|158036354|FG003|Overall Study|Protocol Violation|1|||
49056043|NCT02780167|158036355|FG004|Overall Study|Protocol Violation|2|||
49056044|NCT02780167|158036351|FG000|Overall Study|Withdrawal by Subject|6|||
49056045|NCT02780167|158036352|FG001|Overall Study|Withdrawal by Subject|4|||
49056046|NCT02780167|158036353|FG002|Overall Study|Withdrawal by Subject|4|||
49056047|NCT02780167|158036354|FG003|Overall Study|Withdrawal by Subject|3|||
49056048|NCT02780167|158036355|FG004|Overall Study|Withdrawal by Subject|4|||
49056049|NCT02780167|158036351|FG000|Overall Study|Other|0|||
49056050|NCT02780167|158036352|FG001|Overall Study|Other|0|||
49056051|NCT02780167|158036353|FG002|Overall Study|Other|3|||
49056052|NCT02780167|158036354|FG003|Overall Study|Other|1|||
49056053|NCT02780167|158036355|FG004|Overall Study|Other|2|||
49056054|NCT00126126|158036356|FG000|Overall Study|Lost to Follow-up|0|||
49056055|NCT00126126|158036357|FG001|Overall Study|Lost to Follow-up|2|||
49056056|NCT02547766|158036360|FG000|Overall Study|Withdrawal by Subject|1|||
49056057|NCT03212794|158036361|FG000|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|1|||
49056058|NCT03212794|158036362|FG001|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|0|||
49056059|NCT03212794|158036361|FG000|Overall Study|Lost to Follow-up|5|||
49056060|NCT03212794|158036362|FG001|Overall Study|Lost to Follow-up|6|||
49056061|NCT03212794|158036361|FG000|Overall Study|Incarcerated; unable to participate|2|||
49056062|NCT03212794|158036362|FG001|Overall Study|Incarcerated; unable to participate|0|||
49056063|NCT03212794|158036361|FG000|Overall Study|Withdrawal by Subject|1|||
49056064|NCT03212794|158036362|FG001|Overall Study|Withdrawal by Subject|0|||
49056065|NCT03212794|158036361|FG000|Overall Study|Death|0|||
49056066|NCT03212794|158036362|FG001|Overall Study|Death|1|||
49056067|NCT03212794|158036361|FG000|Overall Study|Found to be ineligible after allocation|0|||
49056068|NCT03212794|158036362|FG001|Overall Study|Found to be ineligible after allocation|1|||
49056069|NCT03212794|158036361|FG000|Overall Study|Relocated out of area|2|||
49056070|NCT03212794|158036362|FG001|Overall Study|Relocated out of area|0|||
49056071|NCT00103038|158036368|FG000|Overall Study|Withdrawal by Subject|8|||
49056072|NCT00103038|158036368|FG000|Overall Study|Screen failure|3|||
49056073|NCT00103038|158036368|FG000|Overall Study|Death|1|||
49056074|NCT00103038|158036368|FG000|Overall Study|Physician Decision|1|||
49056075|NCT03395639|158036372|FG000|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
49056076|NCT03395639|158036373|FG001|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
49056077|NCT03395639|158036374|FG002|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|0|||
49056078|NCT03395639|158036372|FG000|Main Treatment Period (0 to 4 Months)|Adverse Event|1|||
49056079|NCT03395639|158036373|FG001|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
49056080|NCT03395639|158036374|FG002|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
49056081|NCT03395639|158036372|FG000|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
49056082|NCT03395639|158036373|FG001|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|1|||
49056083|NCT03395639|158036374|FG002|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
49056084|NCT03395639|158036372|FG000|Extension Period (4-13 Months)|Adverse Event|0|||
49056085|NCT03395639|158036373|FG001|Extension Period (4-13 Months)|Adverse Event|0|||
49056086|NCT03395639|158036374|FG002|Extension Period (4-13 Months)|Adverse Event|2|||
49056087|NCT03395639|158036372|FG000|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
49056088|NCT03395639|158036373|FG001|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
49056089|NCT03395639|158036374|FG002|Extension Period (4-13 Months)|Subject discontinued at PI discretion|1|||
49056090|NCT00680186|158036375|FG000|Overall Study|Adverse Event|47|||
49056091|NCT00680186|158036376|FG001|Overall Study|Adverse Event|44|||
49056092|NCT00680186|158036375|FG000|Overall Study|Protocol Violation|31|||
49056093|NCT00680186|158036376|FG001|Overall Study|Protocol Violation|26|||
49056094|NCT00680186|158036375|FG000|Overall Study|Lost to Follow-up|11|||
49056095|NCT00680186|158036376|FG001|Overall Study|Lost to Follow-up|6|||
49056096|NCT00680186|158036375|FG000|Overall Study|Withdrawal by Subject|32|||
49056097|NCT00680186|158036376|FG001|Overall Study|Withdrawal by Subject|39|||
49056098|NCT00680186|158036375|FG000|Overall Study|Other|4|||
49056099|NCT00680186|158036376|FG001|Overall Study|Other|1|||
49056100|NCT01351350|158036379|FG000|Overall Study|Disease Progression|5|||
49056101|NCT01351350|158036380|FG001|Overall Study|Disease Progression|13|||
49056102|NCT01351350|158036381|FG002|Overall Study|Disease Progression|6|||
49056103|NCT01351350|158036382|FG003|Overall Study|Disease Progression|8|||
49056104|NCT01351350|158036383|FG004|Overall Study|Disease Progression|5|||
49056105|NCT01351350|158036379|FG000|Overall Study|Adverse Event|1|||
49056106|NCT01351350|158036380|FG001|Overall Study|Adverse Event|10|||
49056107|NCT01351350|158036381|FG002|Overall Study|Adverse Event|1|||
49056108|NCT01351350|158036382|FG003|Overall Study|Adverse Event|2|||
49056109|NCT01351350|158036383|FG004|Overall Study|Adverse Event|0|||
49056110|NCT01351350|158036379|FG000|Overall Study|Participant Decision|2|||
49056111|NCT01351350|158036380|FG001|Overall Study|Participant Decision|6|||
49056112|NCT01351350|158036381|FG002|Overall Study|Participant Decision|3|||
49056113|NCT01351350|158036382|FG003|Overall Study|Participant Decision|3|||
49056114|NCT01351350|158036383|FG004|Overall Study|Participant Decision|2|||
49056115|NCT01351350|158036379|FG000|Overall Study|Enrolled but not Treated|0|||
49056116|NCT01351350|158036380|FG001|Overall Study|Enrolled but not Treated|0|||
49056117|NCT01351350|158036381|FG002|Overall Study|Enrolled but not Treated|1|||
49056118|NCT01351350|158036382|FG003|Overall Study|Enrolled but not Treated|0|||
49056119|NCT01351350|158036383|FG004|Overall Study|Enrolled but not Treated|0|||
49056120|NCT01684878|158036387|FG000|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
49056121|NCT01684878|158036388|FG001|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
49056122|NCT01684878|158036389|FG002|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
49056123|NCT01684878|158036390|FG003|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
49056124|NCT01684878|158036387|FG000|Part 1: Safety Run in Phase|Death|15|||
49056125|NCT01684878|158036388|FG001|Part 1: Safety Run in Phase|Death|20|||
49056126|NCT01684878|158036389|FG002|Part 1: Safety Run in Phase|Death|0|||
49056127|NCT01684878|158036390|FG003|Part 1: Safety Run in Phase|Death|0|||
49056128|NCT01684878|158036387|FG000|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
49056129|NCT01684878|158036388|FG001|Part 1: Safety Run in Phase|Lost to Follow-up|2|||
49056130|NCT01684878|158036389|FG002|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
49056131|NCT01684878|158036390|FG003|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
49056132|NCT01684878|158036387|FG000|Part 2: Randomized Phase|Participant withdrew consent|0|||
49056133|NCT01684878|158036388|FG001|Part 2: Randomized Phase|Participant withdrew consent|0|||
49056134|NCT01684878|158036389|FG002|Part 2: Randomized Phase|Participant withdrew consent|1|||
49056135|NCT01684878|158036390|FG003|Part 2: Randomized Phase|Participant withdrew consent|2|||
49056136|NCT01684878|158036387|FG000|Part 2: Randomized Phase|Lost to Follow-up|0|||
49056137|NCT01684878|158036388|FG001|Part 2: Randomized Phase|Lost to Follow-up|0|||
49056138|NCT01684878|158036389|FG002|Part 2: Randomized Phase|Lost to Follow-up|2|||
49056139|NCT01684878|158036390|FG003|Part 2: Randomized Phase|Lost to Follow-up|0|||
49056140|NCT01684878|158036387|FG000|Part 2: Randomized Phase|Death|0|||
49056141|NCT01684878|158036388|FG001|Part 2: Randomized Phase|Death|0|||
49056142|NCT01684878|158036389|FG002|Part 2: Randomized Phase|Death|62|||
49056143|NCT01684878|158036390|FG003|Part 2: Randomized Phase|Death|68|||
49056144|NCT01684878|158036387|FG000|Part 2: Randomized Phase|Alive at data-cut|0|||
49056145|NCT01684878|158036388|FG001|Part 2: Randomized Phase|Alive at data-cut|0|||
49056146|NCT01684878|158036389|FG002|Part 2: Randomized Phase|Alive at data-cut|13|||
49056147|NCT01684878|158036390|FG003|Part 2: Randomized Phase|Alive at data-cut|7|||
49056148|NCT01684878|158036387|FG000|Part 2: Randomized Phase|Participant noncompliance|0|||
49056149|NCT01684878|158036388|FG001|Part 2: Randomized Phase|Participant noncompliance|0|||
49056150|NCT01684878|158036389|FG002|Part 2: Randomized Phase|Participant noncompliance|0|||
49056151|NCT01684878|158036390|FG003|Part 2: Randomized Phase|Participant noncompliance|1|||
49056152|NCT00775528|158036391|FG000|Overall Study|Protocol Violation|1|||
49056153|NCT00942331|158036392|FG000|Overall Study|Did not start treatment|15|||
49056154|NCT00942331|158036393|FG001|Overall Study|Did not start treatment|22|||
49056155|NCT00873119|158036395|FG000|Overall Study|Patient request|4|||
49056156|NCT00873119|158036396|FG001|Overall Study|Patient request|2|||
49056157|NCT00873119|158036395|FG000|Overall Study|Adverse Event|8|||
49056158|NCT00873119|158036396|FG001|Overall Study|Adverse Event|0|||
49056159|NCT00873119|158036395|FG000|Overall Study|Progressive disease|26|||
49056160|NCT00873119|158036396|FG001|Overall Study|Progressive disease|18|||
49056161|NCT00873119|158036395|FG000|Overall Study|Death|2|||
49056162|NCT00873119|158036396|FG001|Overall Study|Death|1|||
49056163|NCT00873119|158036395|FG000|Overall Study|Other|2|||
49056164|NCT00873119|158036396|FG001|Overall Study|Other|5|||
49056165|NCT00873119|158036395|FG000|Overall Study|Not treated|2|||
49056166|NCT00873119|158036396|FG001|Overall Study|Not treated|0|||
49056167|NCT02492841|158036399|FG000|Overall Study|Lost to Follow-up|34|||
49056168|NCT02492841|158036400|FG001|Overall Study|Lost to Follow-up|31|||
49056169|NCT02492841|158036401|FG002|Overall Study|Lost to Follow-up|35|||
49056170|NCT03648879|158036404|FG000|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1|||
49056171|NCT00285584|158036407|FG000|Month 3|Lost to Follow-up|3|||
49056172|NCT00285584|158036408|FG001|Month 3|Lost to Follow-up|3|||
49056173|NCT00285584|158036407|FG000|Month 3|Withdrawal by Subject|1|||
49056174|NCT00285584|158036408|FG001|Month 3|Withdrawal by Subject|0|||
49056175|NCT00285584|158036407|FG000|Month 6|Lost to Follow-up|0|||
49056176|NCT00285584|158036408|FG001|Month 6|Lost to Follow-up|1|||
49056177|NCT03812991|158036409|FG000|Overall Study|Lost to Follow-up|3|||
49056178|NCT03812991|158036410|FG001|Overall Study|Lost to Follow-up|1|||
49056179|NCT04740931|158036411|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
49056180|NCT04740931|158036412|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|4|||
49056181|NCT04740931|158036411|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
49056182|NCT04740931|158036412|FG001|Part 1 (Baseline up to Week 24)|Death|2|||
49056183|NCT04740931|158036411|FG000|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|2|||
49056184|NCT04740931|158036412|FG001|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|0|||
49056185|NCT04740931|158036411|FG000|Part 1 (Baseline up to Week 24)|Reason Not Specified|2|||
49056186|NCT04740931|158036412|FG001|Part 1 (Baseline up to Week 24)|Reason Not Specified|0|||
49056187|NCT04740931|158036411|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
49056188|NCT04740931|158036412|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
49056189|NCT04740931|158036411|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
49056190|NCT04740931|158036412|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|1|||
49056191|NCT04740931|158036411|FG000|Part 1 (Baseline up to Week 24)|Physician Decision|0|||
49056192|NCT04740931|158036412|FG001|Part 1 (Baseline up to Week 24)|Physician Decision|1|||
49056193|NCT04740931|158036411|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
49056194|NCT04740931|158036412|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|1|||
49056195|NCT04740931|158036411|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
49056196|NCT04740931|158036412|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
49056197|NCT04740931|158036411|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|3|||
49056198|NCT04740931|158036412|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|9|||
49056199|NCT04740931|158036411|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
49056200|NCT04740931|158036412|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
49056201|NCT04740931|158036411|FG000|Part 2 (Week 24 to Week 72)|Death|4|||
49056202|NCT04740931|158036412|FG001|Part 2 (Week 24 to Week 72)|Death|1|||
49056203|NCT04740931|158036411|FG000|Part 2 (Week 24 to Week 72)|Other|1|||
49056204|NCT04740931|158036412|FG001|Part 2 (Week 24 to Week 72)|Other|3|||
49056205|NCT04740931|158036411|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|2|||
49056206|NCT04740931|158036412|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|1|||
49056207|NCT04740931|158036411|FG000|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|1|||
49056208|NCT04740931|158036412|FG001|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|0|||
49056209|NCT04403763|158036413|FG000|Stage 1|Participant did not dose due to Sponsor decision|1|||
49056210|NCT04403763|158036414|FG001|Stage 1|Participant did not dose due to Sponsor decision|1|||
49056211|NCT04403763|158036415|FG002|Stage 1|Participant did not dose due to Sponsor decision|0|||
49056212|NCT04403763|158036416|FG003|Stage 1|Participant did not dose due to Sponsor decision|0|||
49056213|NCT04403763|158036417|FG004|Stage 1|Participant did not dose due to Sponsor decision|0|||
49056214|NCT04403763|158036418|FG005|Stage 1|Participant did not dose due to Sponsor decision|0|||
49056215|NCT04403763|158036419|FG006|Stage 1|Participant did not dose due to Sponsor decision|0|||
49056216|NCT04403763|158036413|FG000|Stage 1|Early termination due to PK tube failure|0|||
49056217|NCT04403763|158036414|FG001|Stage 1|Early termination due to PK tube failure|0|||
49056218|NCT04403763|158036415|FG002|Stage 1|Early termination due to PK tube failure|1|||
49056219|NCT04403763|158036416|FG003|Stage 1|Early termination due to PK tube failure|0|||
49056220|NCT04403763|158036417|FG004|Stage 1|Early termination due to PK tube failure|0|||
49056221|NCT04403763|158036418|FG005|Stage 1|Early termination due to PK tube failure|0|||
49056222|NCT04403763|158036419|FG006|Stage 1|Early termination due to PK tube failure|0|||
49056223|NCT04403763|158036413|FG000|Stage 2A|Adverse Event|0|||
49056224|NCT04403763|158036414|FG001|Stage 2A|Adverse Event|0|||
49056225|NCT04403763|158036415|FG002|Stage 2A|Adverse Event|0|||
49056226|NCT04403763|158036416|FG003|Stage 2A|Adverse Event|0|||
49056227|NCT04403763|158036417|FG004|Stage 2A|Adverse Event|0|||
49056228|NCT04403763|158036418|FG005|Stage 2A|Adverse Event|0|||
49056229|NCT04403763|158036419|FG006|Stage 2A|Adverse Event|1|||
49056230|NCT00227266|158036420|FG000|Overall Study|Withdrawal by Subject|0|||
49056231|NCT00227266|158036421|FG001|Overall Study|Withdrawal by Subject|0|||
49056232|NCT00227266|158036422|FG002|Overall Study|Withdrawal by Subject|1|||
49056233|NCT00227266|158036420|FG000|Overall Study|Protocol Violation|1|||
49056234|NCT00227266|158036421|FG001|Overall Study|Protocol Violation|0|||
49056235|NCT00227266|158036422|FG002|Overall Study|Protocol Violation|1|||
49056236|NCT00227266|158036420|FG000|Overall Study|Excessive weight gain|0|||
49056237|NCT00227266|158036421|FG001|Overall Study|Excessive weight gain|0|||
49056238|NCT00227266|158036422|FG002|Overall Study|Excessive weight gain|2|||
49056239|NCT00479388|158036436|FG000|Overall Study|Adverse Event|90|||
49056240|NCT00479388|158036437|FG001|Overall Study|Adverse Event|45|||
49056241|NCT00479388|158036436|FG000|Overall Study|Lost to Follow-up|0|||
49056242|NCT00479388|158036437|FG001|Overall Study|Lost to Follow-up|2|||
49056243|NCT00479388|158036436|FG000|Overall Study|Protocol Violation|10|||
49056244|NCT00479388|158036437|FG001|Overall Study|Protocol Violation|9|||
49056245|NCT00479388|158036436|FG000|Overall Study|Withdrawal by Subject|32|||
49056246|NCT00479388|158036437|FG001|Overall Study|Withdrawal by Subject|17|||
49056247|NCT01917968|158036441|FG000|Overall Study|Death|3|||
49056248|NCT01917968|158036442|FG001|Overall Study|Death|2|||
49056249|NCT01917968|158036441|FG000|Overall Study|Lost to Follow-up|21|||
49056250|NCT01917968|158036442|FG001|Overall Study|Lost to Follow-up|39|||
49056251|NCT01917968|158036441|FG000|Overall Study|Physician Decision|1|||
49056252|NCT01917968|158036442|FG001|Overall Study|Physician Decision|2|||
49056253|NCT01917968|158036441|FG000|Overall Study|Withdrawal by Subject|20|||
49056254|NCT01917968|158036442|FG001|Overall Study|Withdrawal by Subject|35|||
49056255|NCT01917968|158036441|FG000|Overall Study|Subject Relocation|5|||
49056256|NCT01917968|158036442|FG001|Overall Study|Subject Relocation|1|||
49056257|NCT01917968|158036441|FG000|Overall Study|36M Missed Visit|3|||
49056258|NCT01917968|158036442|FG001|Overall Study|36M Missed Visit|2|||
49056259|NCT01917968|158036441|FG000|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1|||
49056260|NCT01917968|158036442|FG001|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0|||
49056261|NCT01917968|158036441|FG000|Overall Study|Change in Family Circumstances|0|||
49056262|NCT01917968|158036442|FG001|Overall Study|Change in Family Circumstances|1|||
49056263|NCT01917968|158036441|FG000|Overall Study|No Data Available|0|||
49056264|NCT01917968|158036442|FG001|Overall Study|No Data Available|2|||
49056265|NCT02843659|158036443|FG000|Overall Study|Subject Withdrew Consent|0|||
49056266|NCT02843659|158036444|FG001|Overall Study|Subject Withdrew Consent|0|||
49056267|NCT02843659|158036445|FG002|Overall Study|Subject Withdrew Consent|1|||
49056268|NCT02843659|158036443|FG000|Overall Study|Administrative Reason by Sponsor|4|||
49056269|NCT02843659|158036444|FG001|Overall Study|Administrative Reason by Sponsor|5|||
49056270|NCT02843659|158036445|FG002|Overall Study|Administrative Reason by Sponsor|4|||
49056271|NCT02843659|158036443|FG000|Overall Study|Adverse Event|0|||
49056272|NCT02843659|158036444|FG001|Overall Study|Adverse Event|1|||
49056273|NCT02843659|158036445|FG002|Overall Study|Adverse Event|0|||
49056274|NCT03351231|158036452|FG000|Combination Therapy Period|Administrative reason by the Sponsor|1|||
49056275|NCT03351231|158036452|FG000|Combination Therapy Period|Disease progression|2|||
49056276|NCT03351231|158036452|FG000|Combination Therapy Period|Study drug toxicity|1|||
49056277|NCT03351231|158036452|FG000|Combination Therapy Period|Adverse Event unrelated to study drug|1|||
49056278|NCT03351231|158036452|FG000|Safety Follow-Up Period|Participant withdrew consent|1|||
49056279|NCT03351231|158036452|FG000|Safety Follow-Up Period|Other reason|2|||
49056280|NCT00248170|158036455|FG000|Overall Study|Withdrawal by Subject|71|||
49056281|NCT00248170|158036456|FG001|Overall Study|Withdrawal by Subject|79|||
49056282|NCT00248170|158036455|FG000|Overall Study|Protocol Violation|35|||
49056283|NCT00248170|158036456|FG001|Overall Study|Protocol Violation|30|||
49056284|NCT00248170|158036455|FG000|Overall Study|Lost to Follow-up|28|||
49056285|NCT00248170|158036456|FG001|Overall Study|Lost to Follow-up|35|||
49056286|NCT00248170|158036455|FG000|Overall Study|Disease progression|196|||
49056287|NCT00248170|158036456|FG001|Overall Study|Disease progression|216|||
49056288|NCT00248170|158036455|FG000|Overall Study|Death|28|||
49056289|NCT00248170|158036456|FG001|Overall Study|Death|47|||
49056290|NCT00248170|158036455|FG000|Overall Study|Adverse Event|311|||
49056291|NCT00248170|158036456|FG001|Overall Study|Adverse Event|296|||
49056292|NCT00248170|158036455|FG000|Overall Study|Administrative problems|22|||
49056293|NCT00248170|158036456|FG001|Overall Study|Administrative problems|25|||
49056294|NCT00248170|158036455|FG000|Overall Study|Abnormal test procedure(s) result|49|||
49056295|NCT00248170|158036456|FG001|Overall Study|Abnormal test procedure(s) result|61|||
49056296|NCT00248170|158036455|FG000|Overall Study|Abnormal laboratory values|4|||
49056297|NCT00248170|158036456|FG001|Overall Study|Abnormal laboratory values|0|||
49056298|NCT00248170|158036455|FG000|Overall Study|Protocol deviation|17|||
49056299|NCT00248170|158036456|FG001|Overall Study|Protocol deviation|19|||
49056300|NCT04553913|158036457|FG000|Overall Study|patient's block resolved prior to PACU|1|||
49056301|NCT04553913|158036457|FG000|Overall Study|did not use the device properly|5|||
49056302|NCT03123783|158036458|FG000|Phase 1b|Removed from treatment prior to APX005M administration|0|||
49056303|NCT03123783|158036459|FG001|Phase 1b|Removed from treatment prior to APX005M administration|1|||
49056304|NCT03123783|158036460|FG002|Phase 1b|Removed from treatment prior to APX005M administration|0|||
49056305|NCT03123783|158036461|FG003|Phase 1b|Removed from treatment prior to APX005M administration|0|||
49056306|NCT03123783|158036462|FG004|Phase 1b|Removed from treatment prior to APX005M administration|0|||
49056307|NCT03123783|158036463|FG005|Phase 1b|Removed from treatment prior to APX005M administration|0|||
49056308|NCT03123783|158036464|FG006|Phase 1b|Removed from treatment prior to APX005M administration|0|||
49056309|NCT03123783|158036458|FG000|Phase 1b|Participants rolled over to Phase 2|0|||
49056310|NCT03123783|158036459|FG001|Phase 1b|Participants rolled over to Phase 2|0|||
49056311|NCT03123783|158036460|FG002|Phase 1b|Participants rolled over to Phase 2|3|||
49056312|NCT03123783|158036461|FG003|Phase 1b|Participants rolled over to Phase 2|0|||
49056313|NCT03123783|158036462|FG004|Phase 1b|Participants rolled over to Phase 2|0|||
49056314|NCT03123783|158036463|FG005|Phase 1b|Participants rolled over to Phase 2|0|||
49056315|NCT03123783|158036464|FG006|Phase 1b|Participants rolled over to Phase 2|0|||
49056316|NCT03123783|158036458|FG000|Phase 2|No post baseline tumor assesment on treatment period|0|||
49056317|NCT03123783|158036459|FG001|Phase 2|No post baseline tumor assesment on treatment period|0|||
49056318|NCT03123783|158036460|FG002|Phase 2|No post baseline tumor assesment on treatment period|0|||
49056319|NCT03123783|158036461|FG003|Phase 2|No post baseline tumor assesment on treatment period|5|||
49056320|NCT03123783|158036462|FG004|Phase 2|No post baseline tumor assesment on treatment period|2|||
49056321|NCT03123783|158036463|FG005|Phase 2|No post baseline tumor assesment on treatment period|2|||
49056322|NCT03123783|158036464|FG006|Phase 2|No post baseline tumor assesment on treatment period|3|||
49056323|NCT03123783|158036458|FG000|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
49056324|NCT03123783|158036459|FG001|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
49056325|NCT03123783|158036460|FG002|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
49056326|NCT03123783|158036461|FG003|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
49056327|NCT03123783|158036462|FG004|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|3|||
49056328|NCT03123783|158036463|FG005|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
49056329|NCT03123783|158036464|FG006|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
49056330|NCT02450526|158038108|FG000|DB Period (Cycle 1)|Adverse Event|0|||
49056331|NCT02450526|158038109|FG001|DB Period (Cycle 1)|Adverse Event|0|||
49056332|NCT02450526|158038110|FG002|DB Period (Cycle 1)|Adverse Event|2|||
49056333|NCT02450526|158038111|FG003|DB Period (Cycle 1)|Adverse Event|0|||
49056334|NCT02450526|158038112|FG004|DB Period (Cycle 1)|Adverse Event|0|||
49056335|NCT02450526|158038108|FG000|DB Period (Cycle 1)|Withdrawal by Subject|28|||
49056336|NCT02450526|158038109|FG001|DB Period (Cycle 1)|Withdrawal by Subject|3|||
49056337|NCT02450526|158038110|FG002|DB Period (Cycle 1)|Withdrawal by Subject|8|||
49056338|NCT02450526|158038111|FG003|DB Period (Cycle 1)|Withdrawal by Subject|1|||
49056339|NCT02450526|158038112|FG004|DB Period (Cycle 1)|Withdrawal by Subject|0|||
49056340|NCT02450526|158038108|FG000|DB Period (Cycle 1)|Lost to Follow-up|1|||
49056341|NCT02450526|158038109|FG001|DB Period (Cycle 1)|Lost to Follow-up|0|||
49056342|NCT02450526|158038110|FG002|DB Period (Cycle 1)|Lost to Follow-up|0|||
49056343|NCT02450526|158038111|FG003|DB Period (Cycle 1)|Lost to Follow-up|0|||
49056344|NCT02450526|158038112|FG004|DB Period (Cycle 1)|Lost to Follow-up|0|||
49056345|NCT02450526|158038108|FG000|DB Period (Cycle 1)|Protocol Violation|2|||
49056346|NCT02450526|158038109|FG001|DB Period (Cycle 1)|Protocol Violation|0|||
49056347|NCT02450526|158038110|FG002|DB Period (Cycle 1)|Protocol Violation|0|||
49056348|NCT02450526|158038111|FG003|DB Period (Cycle 1)|Protocol Violation|1|||
49056349|NCT02450526|158038112|FG004|DB Period (Cycle 1)|Protocol Violation|0|||
49056350|NCT02450526|158038108|FG000|OL Period (Cycles 2-5)|Adverse Event|0|||
49056351|NCT02450526|158038109|FG001|OL Period (Cycles 2-5)|Adverse Event|0|||
49056352|NCT02450526|158038110|FG002|OL Period (Cycles 2-5)|Adverse Event|0|||
49056353|NCT02450526|158038111|FG003|OL Period (Cycles 2-5)|Adverse Event|0|||
49056354|NCT02450526|158038112|FG004|OL Period (Cycles 2-5)|Adverse Event|2|||
49056355|NCT02450526|158038108|FG000|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
49056356|NCT02450526|158038109|FG001|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
49056357|NCT02450526|158038110|FG002|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
49056358|NCT02450526|158038111|FG003|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
49056359|NCT02450526|158038112|FG004|OL Period (Cycles 2-5)|Withdrawal by Subject|31|||
49056360|NCT02450526|158038108|FG000|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
49056361|NCT02450526|158038109|FG001|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
49056362|NCT02450526|158038110|FG002|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
49056363|NCT02450526|158038111|FG003|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
49056364|NCT02450526|158038112|FG004|OL Period (Cycles 2-5)|Lack of Efficacy|1|||
49056365|NCT02450526|158038108|FG000|OL Period (Cycles 2-5)|Protocol Violation|0|||
49056366|NCT02450526|158038109|FG001|OL Period (Cycles 2-5)|Protocol Violation|0|||
49056367|NCT02450526|158038110|FG002|OL Period (Cycles 2-5)|Protocol Violation|0|||
49056368|NCT02450526|158038111|FG003|OL Period (Cycles 2-5)|Protocol Violation|0|||
49056369|NCT02450526|158038112|FG004|OL Period (Cycles 2-5)|Protocol Violation|7|||
49056370|NCT02737592|158038113|FG000|Overall Study|Withdrawal by Subject|1|||
49056371|NCT02940730|158038114|FG000|Intervention 2|Physician Decision|7|||
49056372|NCT02940730|158038115|FG001|Intervention 2|Physician Decision|0|||
49056373|NCT02668822|158038116|FG000|Overall Study|Protocol Violation|2|||
49056374|NCT02668822|158038117|FG001|Overall Study|Protocol Violation|0|||
49056375|NCT02668822|158038116|FG000|Overall Study|Study Terminated by Sponsor|7|||
49056376|NCT02668822|158038117|FG001|Overall Study|Study Terminated by Sponsor|9|||
49056377|NCT02960438|158038118|FG000|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
49056378|NCT02960438|158038119|FG001|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1|||
49056379|NCT02960438|158038120|FG002|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
49056380|NCT02960438|158038121|FG003|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5|||
49056381|NCT02960438|158038118|FG000|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2|||
49056382|NCT02960438|158038119|FG001|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1|||
49056383|NCT02960438|158038120|FG002|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0|||
49056384|NCT02960438|158038121|FG003|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3|||
49056385|NCT02960438|158038118|FG000|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2|||
49056386|NCT02960438|158038119|FG001|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
49056387|NCT02960438|158038120|FG002|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
49056388|NCT02960438|158038121|FG003|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
49056389|NCT02960438|158038118|FG000|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
49056390|NCT02960438|158038119|FG001|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
49056391|NCT02960438|158038120|FG002|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
49056392|NCT02960438|158038121|FG003|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
49056393|NCT02960438|158038118|FG000|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
49056394|NCT02960438|158038119|FG001|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
49056395|NCT02960438|158038120|FG002|Treatment Phase (Double-blind): 24 Weeks|Other|1|||
49056396|NCT02960438|158038121|FG003|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
49056397|NCT02960438|158038118|FG000|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2|||
49056398|NCT02960438|158038119|FG001|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
49056399|NCT02960438|158038120|FG002|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0|||
49056400|NCT02960438|158038121|FG003|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
49056401|NCT02960438|158038118|FG000|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
49056402|NCT02960438|158038119|FG001|Extension Phase (Open-label): 80 Weeks|Adverse Event|2|||
49056403|NCT02960438|158038120|FG002|Extension Phase (Open-label): 80 Weeks|Adverse Event|4|||
49056404|NCT02960438|158038121|FG003|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
49056405|NCT02960438|158038118|FG000|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
49056406|NCT02960438|158038119|FG001|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
49056407|NCT02960438|158038120|FG002|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1|||
49056408|NCT02960438|158038121|FG003|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
49056409|NCT02960438|158038118|FG000|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
49056410|NCT02960438|158038119|FG001|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
49056411|NCT02960438|158038120|FG002|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0|||
49056412|NCT02960438|158038121|FG003|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
49056413|NCT02960438|158038118|FG000|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
49056414|NCT02960438|158038119|FG001|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5|||
49056415|NCT02960438|158038120|FG002|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
49056416|NCT02960438|158038121|FG003|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6|||
49056417|NCT02960438|158038118|FG000|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
49056418|NCT02960438|158038119|FG001|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
49056419|NCT02960438|158038120|FG002|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
49056420|NCT02960438|158038121|FG003|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
49056421|NCT02960438|158038118|FG000|Extension Phase (Open-label): 80 Weeks|Other|0|||
49056422|NCT02960438|158038119|FG001|Extension Phase (Open-label): 80 Weeks|Other|0|||
49056423|NCT02960438|158038120|FG002|Extension Phase (Open-label): 80 Weeks|Other|1|||
49056424|NCT02960438|158038121|FG003|Extension Phase (Open-label): 80 Weeks|Other|1|||
49056425|NCT04776746|158038127|FG000|Overall Study|Study terminated by sponsor|61|||
49056426|NCT04776746|158038127|FG000|Overall Study|Adverse Event|5|||
49056427|NCT04776746|158038127|FG000|Overall Study|Death|4|||
49056428|NCT04776746|158038127|FG000|Overall Study|Lack of Efficacy|3|||
49056429|NCT04776746|158038127|FG000|Overall Study|Noncompliance with study drug|2|||
49056430|NCT04776746|158038127|FG000|Overall Study|Not related to COVID-19|2|||
49056431|NCT01557842|158038128|FG000|Overall Study|Lost to Follow-up|0|||
49056432|NCT01557842|158038129|FG001|Overall Study|Lost to Follow-up|1|||
49056433|NCT01557842|158038128|FG000|Overall Study|Death|1|||
49056434|NCT01557842|158038129|FG001|Overall Study|Death|0|||
49056435|NCT01557842|158038128|FG000|Overall Study|Lack of Efficacy|0|||
49056436|NCT01557842|158038129|FG001|Overall Study|Lack of Efficacy|1|||
49056437|NCT01557842|158038128|FG000|Overall Study|Not Meet Inclusion/Exclusion Criteria|3|||
49056438|NCT01557842|158038129|FG001|Overall Study|Not Meet Inclusion/Exclusion Criteria|0|||
49056439|NCT01557842|158038128|FG000|Overall Study|Study Terminated by Sponsor|3|||
49056440|NCT01557842|158038129|FG001|Overall Study|Study Terminated by Sponsor|4|||
49056441|NCT01557842|158038128|FG000|Overall Study|Not Ablated|2|||
49056442|NCT01557842|158038129|FG001|Overall Study|Not Ablated|0|||
49056443|NCT00809965|158038139|FG000|Overall Study|Death|194|||
49056444|NCT00809965|158038140|FG001|Overall Study|Death|147|||
49056445|NCT00809965|158038141|FG002|Overall Study|Death|196|||
49056446|NCT00809965|158038139|FG000|Overall Study|Lost to Follow-up|17|||
49056447|NCT00809965|158038140|FG001|Overall Study|Lost to Follow-up|10|||
49056448|NCT00809965|158038141|FG002|Overall Study|Lost to Follow-up|18|||
49056449|NCT00809965|158038139|FG000|Overall Study|Withdrawal by Subject|405|||
49056450|NCT00809965|158038140|FG001|Overall Study|Withdrawal by Subject|448|||
49056451|NCT00809965|158038141|FG002|Overall Study|Withdrawal by Subject|441|||
49056452|NCT00809965|158038139|FG000|Overall Study|Other Reason|167|||
49056453|NCT00809965|158038140|FG001|Overall Study|Other Reason|170|||
49056454|NCT00809965|158038141|FG002|Overall Study|Other Reason|189|||
49056455|NCT02133001|158038142|FG000|Double Blind (Day 1-25)|Adverse Event|1|||
49056456|NCT02133001|158038143|FG001|Double Blind (Day 1-25)|Adverse Event|5|||
49056457|NCT02133001|158038142|FG000|Double Blind (Day 1-25)|Lack of Efficacy|4|||
49056458|NCT02133001|158038143|FG001|Double Blind (Day 1-25)|Lack of Efficacy|1|||
49056459|NCT02133001|158038142|FG000|Double Blind (Day 1-25)|Lost to Follow-up|2|||
49056460|NCT02133001|158038143|FG001|Double Blind (Day 1-25)|Lost to Follow-up|0|||
49056461|NCT02133001|158038142|FG000|Double Blind (Day 1-25)|Other|2|||
49056462|NCT02133001|158038143|FG001|Double Blind (Day 1-25)|Other|2|||
49056463|NCT02133001|158038142|FG000|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
49056464|NCT02133001|158038143|FG001|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
49056465|NCT02133001|158038142|FG000|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
49056466|NCT02133001|158038143|FG001|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
49056467|NCT02133001|158038142|FG000|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
49056468|NCT02133001|158038143|FG001|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
49056469|NCT02133001|158038142|FG000|Follow-Up Phase (Day 26-81)|Other|0|||
49056470|NCT02133001|158038143|FG001|Follow-Up Phase (Day 26-81)|Other|1|||
49056471|NCT01239472|158038146|FG000|Overall Study|Withdrawal by Subject|5|||
49056472|NCT01239472|158038147|FG001|Overall Study|Withdrawal by Subject|1|||
49056473|NCT01239472|158038146|FG000|Overall Study|Adverse Event|0|||
49056474|NCT01239472|158038147|FG001|Overall Study|Adverse Event|1|||
49056475|NCT01239472|158038146|FG000|Overall Study|Lack of Efficacy|0|||
49056476|NCT01239472|158038147|FG001|Overall Study|Lack of Efficacy|1|||
49056477|NCT00094458|158038148|FG000|Main Study: Through Week 30|Eligibility criteria not met|3|||
49056478|NCT00094458|158038149|FG001|Main Study: Through Week 30|Eligibility criteria not met|8|||
49056479|NCT00094458|158038150|FG002|Main Study: Through Week 30|Eligibility criteria not met|2|||
49056480|NCT00094458|158038151|FG003|Main Study: Through Week 30|Eligibility criteria not met|0|||
49056481|NCT00094458|158038152|FG004|Main Study: Through Week 30|Eligibility criteria not met|0|||
49056482|NCT00094458|158038153|FG005|Main Study: Through Week 30|Eligibility criteria not met|0|||
49056483|NCT00094458|158038148|FG000|Main Study: Through Week 30|Lost to Follow-up|5|||
49056484|NCT00094458|158038149|FG001|Main Study: Through Week 30|Lost to Follow-up|5|||
49056485|NCT00094458|158038150|FG002|Main Study: Through Week 30|Lost to Follow-up|2|||
49056486|NCT00094458|158038151|FG003|Main Study: Through Week 30|Lost to Follow-up|0|||
49056487|NCT00094458|158038152|FG004|Main Study: Through Week 30|Lost to Follow-up|0|||
49056488|NCT00094458|158038153|FG005|Main Study: Through Week 30|Lost to Follow-up|0|||
49056489|NCT00094458|158038148|FG000|Main Study: Through Week 30|Withdrawal by Subject|18|||
49056490|NCT00094458|158038149|FG001|Main Study: Through Week 30|Withdrawal by Subject|9|||
49056491|NCT00094458|158038150|FG002|Main Study: Through Week 30|Withdrawal by Subject|7|||
49056492|NCT00094458|158038151|FG003|Main Study: Through Week 30|Withdrawal by Subject|0|||
49056493|NCT00094458|158038152|FG004|Main Study: Through Week 30|Withdrawal by Subject|0|||
49056494|NCT00094458|158038153|FG005|Main Study: Through Week 30|Withdrawal by Subject|0|||
49056495|NCT00094458|158038148|FG000|Main Study: Through Week 30|Adverse Event|38|||
49056496|NCT00094458|158038149|FG001|Main Study: Through Week 30|Adverse Event|20|||
49056497|NCT00094458|158038150|FG002|Main Study: Through Week 30|Adverse Event|28|||
49056498|NCT00094458|158038151|FG003|Main Study: Through Week 30|Adverse Event|0|||
49056499|NCT00094458|158038152|FG004|Main Study: Through Week 30|Adverse Event|0|||
49056500|NCT00094458|158038153|FG005|Main Study: Through Week 30|Adverse Event|0|||
49056501|NCT00094458|158038148|FG000|Main Study: Through Week 30|Death|1|||
49056502|NCT00094458|158038149|FG001|Main Study: Through Week 30|Death|0|||
49056503|NCT00094458|158038150|FG002|Main Study: Through Week 30|Death|0|||
49056504|NCT00094458|158038151|FG003|Main Study: Through Week 30|Death|0|||
49056505|NCT00094458|158038152|FG004|Main Study: Through Week 30|Death|0|||
49056506|NCT00094458|158038153|FG005|Main Study: Through Week 30|Death|0|||
49056507|NCT00094458|158038148|FG000|Main Study: Through Week 30|Other|19|||
49056508|NCT00094458|158038149|FG001|Main Study: Through Week 30|Other|16|||
49056509|NCT00094458|158038150|FG002|Main Study: Through Week 30|Other|9|||
49056510|NCT00094458|158038151|FG003|Main Study: Through Week 30|Other|0|||
49056511|NCT00094458|158038152|FG004|Main Study: Through Week 30|Other|0|||
49056512|NCT00094458|158038153|FG005|Main Study: Through Week 30|Other|0|||
49056513|NCT00094458|158038148|FG000|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2|||
49056514|NCT00094458|158038149|FG001|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1|||
49056515|NCT00094458|158038150|FG002|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4|||
49056516|NCT00094458|158038151|FG003|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
49056517|NCT00094458|158038152|FG004|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
49056518|NCT00094458|158038153|FG005|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
49056519|NCT00094458|158038148|FG000|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2|||
49056520|NCT00094458|158038149|FG001|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
49056521|NCT00094458|158038150|FG002|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4|||
49056522|NCT00094458|158038151|FG003|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
49056523|NCT00094458|158038152|FG004|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
49056524|NCT00094458|158038153|FG005|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
49056525|NCT00094458|158038148|FG000|Study Extension: Week 30 Through Week 50|Adverse Event|3|||
49056526|NCT00094458|158038149|FG001|Study Extension: Week 30 Through Week 50|Adverse Event|9|||
49056527|NCT00094458|158038150|FG002|Study Extension: Week 30 Through Week 50|Adverse Event|7|||
49056528|NCT00094458|158038151|FG003|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
49056529|NCT00094458|158038152|FG004|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
49056530|NCT00094458|158038153|FG005|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
49056531|NCT00094458|158038148|FG000|Study Extension: Week 30 Through Week 50|Other|1|||
49056532|NCT00094458|158038149|FG001|Study Extension: Week 30 Through Week 50|Other|2|||
49056533|NCT00094458|158038150|FG002|Study Extension: Week 30 Through Week 50|Other|3|||
49056534|NCT00094458|158038151|FG003|Study Extension: Week 30 Through Week 50|Other|0|||
49056535|NCT00094458|158038152|FG004|Study Extension: Week 30 Through Week 50|Other|0|||
49056536|NCT00094458|158038153|FG005|Study Extension: Week 30 Through Week 50|Other|0|||
49056537|NCT00094458|158038148|FG000|OLE: Open-Label Extension|Adverse Event|0|||
49056538|NCT00094458|158038149|FG001|OLE: Open-Label Extension|Adverse Event|0|||
49056539|NCT00094458|158038150|FG002|OLE: Open-Label Extension|Adverse Event|0|||
49056540|NCT00094458|158038151|FG003|OLE: Open-Label Extension|Adverse Event|0|||
49056541|NCT00094458|158038152|FG004|OLE: Open-Label Extension|Adverse Event|3|||
49056542|NCT00094458|158038153|FG005|OLE: Open-Label Extension|Adverse Event|4|||
49056543|NCT00094458|158038148|FG000|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
49056544|NCT00094458|158038149|FG001|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
49056545|NCT00094458|158038150|FG002|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
49056546|NCT00094458|158038151|FG003|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
49056547|NCT00094458|158038152|FG004|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
49056548|NCT00094458|158038153|FG005|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
49056549|NCT00094458|158038148|FG000|OLE: Open-Label Extension|Patient decision|0|||
49056550|NCT00094458|158038149|FG001|OLE: Open-Label Extension|Patient decision|0|||
49056551|NCT00094458|158038150|FG002|OLE: Open-Label Extension|Patient decision|0|||
49056552|NCT00094458|158038151|FG003|OLE: Open-Label Extension|Patient decision|0|||
49056553|NCT00094458|158038152|FG004|OLE: Open-Label Extension|Patient decision|1|||
49056554|NCT00094458|158038153|FG005|OLE: Open-Label Extension|Patient decision|0|||
49056555|NCT01286558|158038154|FG000|Overall Study|Adverse Event|1|||
49056556|NCT01286558|158038155|FG001|Overall Study|Adverse Event|1|||
49056557|NCT01286558|158038154|FG000|Overall Study|Withdrawal by Subject|0|||
49056558|NCT01286558|158038155|FG001|Overall Study|Withdrawal by Subject|1|||
49056559|NCT04376502|158038157|FG000|Overall Study|Deemed ineligible after being enrolled|1|||
49056560|NCT01787279|158038161|FG000|Overall Study|Lost to Follow-up|2|||
49056561|NCT01787279|158038161|FG000|Overall Study|Lack of Efficacy|1|||
49056562|NCT02065713|158038162|FG000|Overall Study|Adverse Event|0|||
49056563|NCT02065713|158038163|FG001|Overall Study|Adverse Event|1|||
49056564|NCT02065713|158038162|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
49056565|NCT02065713|158038163|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
49056566|NCT04035499|158038164|FG000|Overall Study|Death|2|||
49056567|NCT04035499|158038164|FG000|Overall Study|Withdrawal by Subject|1|||
49056568|NCT02268253|158038171|FG000|Stage 1|Withdrawal by Subject|1|||
49056569|NCT02268253|158038172|FG001|Stage 1|Withdrawal by Subject|0|||
49056570|NCT02268253|158038173|FG002|Stage 1|Withdrawal by Subject|0|||
49056571|NCT02268253|158038174|FG003|Stage 1|Withdrawal by Subject|0|||
49056572|NCT02268253|158038175|FG004|Stage 1|Withdrawal by Subject|0|||
49056573|NCT02268253|158038176|FG005|Stage 1|Withdrawal by Subject|0|||
49056574|NCT02268253|158038177|FG006|Stage 1|Withdrawal by Subject|0|||
49056575|NCT02268253|158038171|FG000|Stage 1|Death|0|||
49056576|NCT02268253|158038172|FG001|Stage 1|Death|2|||
49056577|NCT02268253|158038173|FG002|Stage 1|Death|2|||
49056578|NCT02268253|158038174|FG003|Stage 1|Death|2|||
49056579|NCT02268253|158038175|FG004|Stage 1|Death|1|||
49056580|NCT02268253|158038176|FG005|Stage 1|Death|1|||
49056581|NCT02268253|158038177|FG006|Stage 1|Death|0|||
49056582|NCT02268253|158038171|FG000|Stage 2|Disease Recurrence/ Progression|0|||
49056583|NCT02268253|158038172|FG001|Stage 2|Disease Recurrence/ Progression|0|||
49056584|NCT02268253|158038173|FG002|Stage 2|Disease Recurrence/ Progression|1|||
49056585|NCT02268253|158038174|FG003|Stage 2|Disease Recurrence/ Progression|0|||
49056586|NCT02268253|158038175|FG004|Stage 2|Disease Recurrence/ Progression|0|||
49056587|NCT02268253|158038176|FG005|Stage 2|Disease Recurrence/ Progression|0|||
49056588|NCT02268253|158038177|FG006|Stage 2|Disease Recurrence/ Progression|0|||
49056589|NCT02268253|158038171|FG000|Stage 2|Withdrawal by Subject|0|||
49056590|NCT02268253|158038172|FG001|Stage 2|Withdrawal by Subject|0|||
49056591|NCT02268253|158038173|FG002|Stage 2|Withdrawal by Subject|2|||
49056592|NCT02268253|158038174|FG003|Stage 2|Withdrawal by Subject|0|||
49056593|NCT02268253|158038175|FG004|Stage 2|Withdrawal by Subject|0|||
49056594|NCT02268253|158038176|FG005|Stage 2|Withdrawal by Subject|2|||
49056595|NCT02268253|158038177|FG006|Stage 2|Withdrawal by Subject|0|||
49056596|NCT02268253|158038171|FG000|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
49056597|NCT02268253|158038172|FG001|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
49056598|NCT02268253|158038173|FG002|Stage 2|Completion of 7 or More Cycles of Treatment|2|||
49056599|NCT02268253|158038174|FG003|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
49056600|NCT02268253|158038175|FG004|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
49056601|NCT02268253|158038176|FG005|Stage 2|Completion of 7 or More Cycles of Treatment|7|||
49056602|NCT02268253|158038177|FG006|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
49056603|NCT02268253|158038171|FG000|Stage 2|Death|0|||
49056604|NCT02268253|158038172|FG001|Stage 2|Death|0|||
49056605|NCT02268253|158038173|FG002|Stage 2|Death|19|||
49056606|NCT02268253|158038174|FG003|Stage 2|Death|0|||
49056607|NCT02268253|158038175|FG004|Stage 2|Death|0|||
49056608|NCT02268253|158038176|FG005|Stage 2|Death|20|||
49056609|NCT02268253|158038177|FG006|Stage 2|Death|1|||
49056610|NCT02268253|158038171|FG000|Stage 2|Lost to Follow-up|0|||
49056611|NCT02268253|158038172|FG001|Stage 2|Lost to Follow-up|0|||
49056612|NCT02268253|158038173|FG002|Stage 2|Lost to Follow-up|0|||
49056613|NCT02268253|158038174|FG003|Stage 2|Lost to Follow-up|0|||
49056614|NCT02268253|158038175|FG004|Stage 2|Lost to Follow-up|0|||
49056615|NCT02268253|158038176|FG005|Stage 2|Lost to Follow-up|4|||
49056616|NCT02268253|158038177|FG006|Stage 2|Lost to Follow-up|0|||
49056617|NCT02268253|158038171|FG000|Stage 2|Transferred to Hospice|0|||
49056618|NCT02268253|158038172|FG001|Stage 2|Transferred to Hospice|0|||
49056619|NCT02268253|158038173|FG002|Stage 2|Transferred to Hospice|0|||
49056620|NCT02268253|158038174|FG003|Stage 2|Transferred to Hospice|0|||
49056621|NCT02268253|158038175|FG004|Stage 2|Transferred to Hospice|0|||
49056622|NCT02268253|158038176|FG005|Stage 2|Transferred to Hospice|2|||
49056623|NCT02268253|158038177|FG006|Stage 2|Transferred to Hospice|0|||
49056624|NCT02268253|158038171|FG000|Stage 3A|Disease Recurrence/ Progression|0|||
49056625|NCT02268253|158038172|FG001|Stage 3A|Disease Recurrence/ Progression|0|||
49056626|NCT02268253|158038173|FG002|Stage 3A|Disease Recurrence/ Progression|1|||
49056627|NCT02268253|158038174|FG003|Stage 3A|Disease Recurrence/ Progression|0|||
49056628|NCT02268253|158038175|FG004|Stage 3A|Disease Recurrence/ Progression|0|||
49056629|NCT02268253|158038176|FG005|Stage 3A|Disease Recurrence/ Progression|0|||
49056630|NCT02268253|158038177|FG006|Stage 3A|Disease Recurrence/ Progression|0|||
49056631|NCT02268253|158038171|FG000|Stage 3A|Withdrawal by Subject|0|||
49056632|NCT02268253|158038172|FG001|Stage 3A|Withdrawal by Subject|0|||
49056633|NCT02268253|158038173|FG002|Stage 3A|Withdrawal by Subject|2|||
49056634|NCT02268253|158038174|FG003|Stage 3A|Withdrawal by Subject|0|||
49056635|NCT02268253|158038175|FG004|Stage 3A|Withdrawal by Subject|0|||
49056636|NCT02268253|158038176|FG005|Stage 3A|Withdrawal by Subject|0|||
49056637|NCT02268253|158038177|FG006|Stage 3A|Withdrawal by Subject|0|||
49056638|NCT02268253|158038171|FG000|Stage 3A|Physician Decision|0|||
49056639|NCT02268253|158038172|FG001|Stage 3A|Physician Decision|0|||
49056640|NCT02268253|158038173|FG002|Stage 3A|Physician Decision|2|||
49056641|NCT02268253|158038174|FG003|Stage 3A|Physician Decision|0|||
49056642|NCT02268253|158038175|FG004|Stage 3A|Physician Decision|0|||
49056643|NCT02268253|158038176|FG005|Stage 3A|Physician Decision|0|||
49056644|NCT02268253|158038177|FG006|Stage 3A|Physician Decision|0|||
49056645|NCT02268253|158038171|FG000|Stage 3A|Study Terminated by Sponsor|0|||
49056646|NCT02268253|158038172|FG001|Stage 3A|Study Terminated by Sponsor|0|||
49056647|NCT02268253|158038173|FG002|Stage 3A|Study Terminated by Sponsor|2|||
49056648|NCT02268253|158038174|FG003|Stage 3A|Study Terminated by Sponsor|0|||
49056649|NCT02268253|158038175|FG004|Stage 3A|Study Terminated by Sponsor|0|||
49056650|NCT02268253|158038176|FG005|Stage 3A|Study Terminated by Sponsor|0|||
49056651|NCT02268253|158038177|FG006|Stage 3A|Study Terminated by Sponsor|0|||
49056652|NCT02268253|158038171|FG000|Stage 3A|Lost to Follow-up|0|||
49056653|NCT02268253|158038172|FG001|Stage 3A|Lost to Follow-up|0|||
49056654|NCT02268253|158038173|FG002|Stage 3A|Lost to Follow-up|1|||
49056655|NCT02268253|158038174|FG003|Stage 3A|Lost to Follow-up|0|||
49056656|NCT02268253|158038175|FG004|Stage 3A|Lost to Follow-up|0|||
49056657|NCT02268253|158038176|FG005|Stage 3A|Lost to Follow-up|0|||
49056658|NCT02268253|158038177|FG006|Stage 3A|Lost to Follow-up|0|||
49056659|NCT02268253|158038171|FG000|Stage 3A|Death|0|||
49056660|NCT02268253|158038172|FG001|Stage 3A|Death|0|||
49056661|NCT02268253|158038173|FG002|Stage 3A|Death|5|||
49056662|NCT02268253|158038174|FG003|Stage 3A|Death|0|||
49056663|NCT02268253|158038175|FG004|Stage 3A|Death|0|||
49056664|NCT02268253|158038176|FG005|Stage 3A|Death|0|||
49056665|NCT02268253|158038177|FG006|Stage 3A|Death|0|||
49056666|NCT02315066|158038178|FG000|Overall Study|Lost to Follow-up|0|||
49056667|NCT02315066|158038179|FG001|Overall Study|Lost to Follow-up|1|||
49056668|NCT02315066|158038180|FG002|Overall Study|Lost to Follow-up|1|||
49056669|NCT02315066|158038181|FG003|Overall Study|Lost to Follow-up|0|||
49056670|NCT02315066|158038182|FG004|Overall Study|Lost to Follow-up|1|||
49056671|NCT02315066|158038183|FG005|Overall Study|Lost to Follow-up|0|||
49056672|NCT02315066|158038184|FG006|Overall Study|Lost to Follow-up|2|||
49056673|NCT02315066|158038185|FG007|Overall Study|Lost to Follow-up|1|||
49056674|NCT02315066|158038186|FG008|Overall Study|Lost to Follow-up|0|||
49056675|NCT02315066|158038187|FG009|Overall Study|Lost to Follow-up|0|||
49056676|NCT02315066|158038188|FG010|Overall Study|Lost to Follow-up|1|||
49056677|NCT02315066|158038189|FG011|Overall Study|Lost to Follow-up|2|||
49056678|NCT02315066|158038190|FG012|Overall Study|Lost to Follow-up|0|||
49056679|NCT02315066|158038191|FG013|Overall Study|Lost to Follow-up|4|||
49056680|NCT02315066|158038178|FG000|Overall Study|Death|2|||
49056681|NCT02315066|158038179|FG001|Overall Study|Death|7|||
49056682|NCT02315066|158038180|FG002|Overall Study|Death|6|||
49056683|NCT02315066|158038181|FG003|Overall Study|Death|11|||
49056684|NCT02315066|158038182|FG004|Overall Study|Death|10|||
49056685|NCT02315066|158038183|FG005|Overall Study|Death|3|||
49056686|NCT02315066|158038184|FG006|Overall Study|Death|9|||
49056687|NCT02315066|158038185|FG007|Overall Study|Death|9|||
49056688|NCT02315066|158038186|FG008|Overall Study|Death|10|||
49056689|NCT02315066|158038187|FG009|Overall Study|Death|8|||
49056690|NCT02315066|158038188|FG010|Overall Study|Death|10|||
49056691|NCT02315066|158038189|FG011|Overall Study|Death|7|||
49056692|NCT02315066|158038190|FG012|Overall Study|Death|8|||
49056693|NCT02315066|158038191|FG013|Overall Study|Death|21|||
49056694|NCT02315066|158038178|FG000|Overall Study|Other|0|||
49056695|NCT02315066|158038179|FG001|Overall Study|Other|0|||
49056696|NCT02315066|158038180|FG002|Overall Study|Other|0|||
49056697|NCT02315066|158038181|FG003|Overall Study|Other|0|||
49056698|NCT02315066|158038182|FG004|Overall Study|Other|0|||
49056699|NCT02315066|158038183|FG005|Overall Study|Other|0|||
48902216|NCT00687973|157477643|FG000|Overall Study|Adverse Event|18|||
48902217|NCT00687973|157477644|FG001|Overall Study|Adverse Event|28|||
48902218|NCT00687973|157477643|FG000|Overall Study|Lack of Efficacy|2|||
48902219|NCT00687973|157477644|FG001|Overall Study|Lack of Efficacy|3|||
48902220|NCT00687973|157477643|FG000|Overall Study|Protocol Violation|1|||
48902221|NCT00687973|157477644|FG001|Overall Study|Protocol Violation|2|||
48902222|NCT00687973|157477643|FG000|Overall Study|Administrative Reasons|0|||
48902223|NCT00687973|157477644|FG001|Overall Study|Administrative Reasons|2|||
49056700|NCT02315066|158038184|FG006|Overall Study|Other|0|||
49056701|NCT02315066|158038185|FG007|Overall Study|Other|1|||
49056702|NCT02315066|158038186|FG008|Overall Study|Other|1|||
49056703|NCT02315066|158038187|FG009|Overall Study|Other|2|||
48902224|NCT00687973|157477643|FG000|Overall Study|Withdrawal by Subject|3|||
48902225|NCT00687973|157477644|FG001|Overall Study|Withdrawal by Subject|3|||
49056704|NCT02315066|158038188|FG010|Overall Study|Other|0|||
49056705|NCT02315066|158038189|FG011|Overall Study|Other|0|||
49056706|NCT02315066|158038190|FG012|Overall Study|Other|0|||
49056707|NCT02315066|158038191|FG013|Overall Study|Other|0|||
49056708|NCT02315066|158038178|FG000|Overall Study|Subject refused further follow-up|0|||
49056709|NCT02315066|158038179|FG001|Overall Study|Subject refused further follow-up|2|||
49056710|NCT02315066|158038180|FG002|Overall Study|Subject refused further follow-up|2|||
49056711|NCT02315066|158038181|FG003|Overall Study|Subject refused further follow-up|0|||
49056712|NCT02315066|158038182|FG004|Overall Study|Subject refused further follow-up|0|||
49056713|NCT02315066|158038183|FG005|Overall Study|Subject refused further follow-up|0|||
48902226|NCT01442779|157477647|FG000|Overall Study|Withdrawal by Subject|3|||
48902227|NCT01442779|157477647|FG000|Overall Study|Death|3|||
48902228|NCT01442779|157477647|FG000|Overall Study|Non-compliance|1|||
48902229|NCT00887432|157477648|FG000|Overall Study|Start Excluded Therapy|3|||
48902230|NCT00887432|157477649|FG001|Overall Study|Start Excluded Therapy|0|||
48902231|NCT00887432|157477648|FG000|Overall Study|Did not complete treatment|6|||
48902232|NCT00887432|157477649|FG001|Overall Study|Did not complete treatment|8|||
48902233|NCT00887432|157477648|FG000|Overall Study|Protocol Violation|2|||
48902234|NCT00887432|157477649|FG001|Overall Study|Protocol Violation|3|||
48902235|NCT00887432|157477648|FG000|Overall Study|Withdrawal by Subject|3|||
48902236|NCT00887432|157477649|FG001|Overall Study|Withdrawal by Subject|2|||
48902237|NCT00887432|157477648|FG000|Overall Study|Lost to Follow-up|1|||
48902238|NCT00887432|157477649|FG001|Overall Study|Lost to Follow-up|0|||
48902239|NCT00887432|157477648|FG000|Overall Study|No reason provided|0|||
48902240|NCT00887432|157477649|FG001|Overall Study|No reason provided|1|||
48902241|NCT01337115|157477650|FG000|Overall Study|Protocol Violation|2|||
48902242|NCT01337115|157477651|FG001|Overall Study|Protocol Violation|0|||
48902243|NCT00551460|157477652|FG000|Overall Study|Adverse Event|1|||
48902244|NCT00551460|157477652|FG000|Overall Study|Withdrawal by Subject|1|||
48902245|NCT00551460|157477652|FG000|Overall Study|Physician Decision|1|||
48902246|NCT00551460|157477652|FG000|Overall Study|Death|7|||
48902247|NCT00551460|157477652|FG000|Overall Study|Ineligible|4|||
48902248|NCT00551460|157477652|FG000|Overall Study|Not analyzable (did not start treatment)|4|||
48902249|NCT00609765|157477653|FG000|Overall Study|Study ended prior to 12 months|1|||
48902250|NCT00866723|157477656|FG000|Overall Study|Withdrawal by Subject|1|||
48902251|NCT00866723|157477656|FG000|Overall Study|Disease Progression|4|||
48902252|NCT02308020|157477664|FG000|Overall Study|Lost to Follow-up|1|||
48902253|NCT02308020|157477665|FG001|Overall Study|Lost to Follow-up|7|||
48902254|NCT02308020|157477666|FG002|Overall Study|Lost to Follow-up|0|||
48902255|NCT02308020|157477667|FG003|Overall Study|Lost to Follow-up|0|||
48902256|NCT02308020|157477668|FG004|Overall Study|Lost to Follow-up|1|||
48902257|NCT02308020|157477669|FG005|Overall Study|Lost to Follow-up|2|||
48902258|NCT02308020|157477664|FG000|Overall Study|Sponsor Decision|0|||
48902259|NCT02308020|157477665|FG001|Overall Study|Sponsor Decision|8|||
48902260|NCT02308020|157477666|FG002|Overall Study|Sponsor Decision|0|||
48902261|NCT02308020|157477667|FG003|Overall Study|Sponsor Decision|2|||
48902262|NCT02308020|157477668|FG004|Overall Study|Sponsor Decision|2|||
48902263|NCT02308020|157477669|FG005|Overall Study|Sponsor Decision|1|||
48902264|NCT02308020|157477664|FG000|Overall Study|Withdrawal by Subject|3|||
48902265|NCT02308020|157477665|FG001|Overall Study|Withdrawal by Subject|5|||
48902266|NCT02308020|157477666|FG002|Overall Study|Withdrawal by Subject|3|||
48902267|NCT02308020|157477667|FG003|Overall Study|Withdrawal by Subject|2|||
48902268|NCT02308020|157477668|FG004|Overall Study|Withdrawal by Subject|1|||
48902269|NCT02308020|157477669|FG005|Overall Study|Withdrawal by Subject|2|||
48902270|NCT00400985|157477673|FG000|Overall Study|Withdrawal by Subject|5|||
48902271|NCT00400985|157477673|FG000|Overall Study|system modification|8|||
48902272|NCT00400985|157477673|FG000|Overall Study|Death|30|||
48902273|NCT00400985|157477673|FG000|Overall Study|Lost to Follow-up|9|||
48902274|NCT02893930|157477674|FG000|Overall Study|Adverse Event|3|||
48902275|NCT02893930|157477674|FG000|Overall Study|Death|1|||
48902276|NCT02893930|157477674|FG000|Overall Study|Disease progression|5|||
48902277|NCT02893930|157477674|FG000|Overall Study|Withdrawal by Subject|2|||
48902278|NCT02893930|157477674|FG000|Overall Study|Physician Decision|1|||
48902279|NCT02893930|157477674|FG000|Overall Study|Ineligible|1|||
48902280|NCT02446886|157477677|FG000|Overall Study|Adverse Event|1|||
48902281|NCT02446886|157477678|FG001|Overall Study|Adverse Event|3|||
48902282|NCT02446886|157477677|FG000|Overall Study|Withdrawal by Subject|1|||
48902283|NCT02446886|157477678|FG001|Overall Study|Withdrawal by Subject|1|||
48902284|NCT01013285|157477679|FG000|Overall Study|Death|48|||
48902285|NCT01013285|157477680|FG001|Overall Study|Death|89|||
48902286|NCT01794923|157477681|FG000|Overall Study|Adverse Event|0|||
48902287|NCT01794923|157477682|FG001|Overall Study|Adverse Event|0|||
48902288|NCT01794923|157477683|FG002|Overall Study|Adverse Event|1|||
48902289|NCT00561951|157477684|FG000|Overall Study|Adverse Event|11|||
48902290|NCT00561951|157477685|FG001|Overall Study|Adverse Event|14|||
48902291|NCT00561951|157477686|FG002|Overall Study|Adverse Event|14|||
48902292|NCT00561951|157477684|FG000|Overall Study|Lack of Efficacy|5|||
48902293|NCT00561951|157477685|FG001|Overall Study|Lack of Efficacy|3|||
48902294|NCT00561951|157477686|FG002|Overall Study|Lack of Efficacy|2|||
48902295|NCT00561951|157477684|FG000|Overall Study|Lost to Follow-up|1|||
48902296|NCT00561951|157477685|FG001|Overall Study|Lost to Follow-up|1|||
48902297|NCT00561951|157477686|FG002|Overall Study|Lost to Follow-up|0|||
48902298|NCT00561951|157477684|FG000|Overall Study|Withdrawal by Subject|10|||
48902299|NCT00561951|157477685|FG001|Overall Study|Withdrawal by Subject|9|||
48902300|NCT00561951|157477686|FG002|Overall Study|Withdrawal by Subject|10|||
48902301|NCT00561951|157477684|FG000|Overall Study|Protocol Violation|4|||
48902302|NCT00561951|157477685|FG001|Overall Study|Protocol Violation|3|||
48902303|NCT00561951|157477686|FG002|Overall Study|Protocol Violation|4|||
48902304|NCT00561951|157477684|FG000|Overall Study|Physician Decision|1|||
48902305|NCT00561951|157477685|FG001|Overall Study|Physician Decision|0|||
48902306|NCT00561951|157477686|FG002|Overall Study|Physician Decision|0|||
48902307|NCT00561951|157477684|FG000|Overall Study|Pregnancy|0|||
48902308|NCT00561951|157477685|FG001|Overall Study|Pregnancy|1|||
48902309|NCT00561951|157477686|FG002|Overall Study|Pregnancy|0|||
48902310|NCT00561951|157477684|FG000|Overall Study|Meet Withdrawal Criterion|0|||
48902311|NCT00561951|157477685|FG001|Overall Study|Meet Withdrawal Criterion|1|||
48902312|NCT00561951|157477686|FG002|Overall Study|Meet Withdrawal Criterion|1|||
48902313|NCT00561951|157477684|FG000|Overall Study|Adverse Event Occured Before Treatment|1|||
48902314|NCT00561951|157477685|FG001|Overall Study|Adverse Event Occured Before Treatment|2|||
48902315|NCT00561951|157477686|FG002|Overall Study|Adverse Event Occured Before Treatment|1|||
48902316|NCT00368992|157477687|FG000|Overall Study|Ineligible|5|||
48902317|NCT00368992|157477687|FG000|Overall Study|Refused treatment|3|||
48902318|NCT00368992|157477687|FG000|Overall Study|Lack of Efficacy|63|||
48902319|NCT00368992|157477687|FG000|Overall Study|Adverse Event|26|||
48902320|NCT00368992|157477687|FG000|Overall Study|Death|4|||
48902321|NCT00368992|157477687|FG000|Overall Study|Other|9|||
48902322|NCT02520284|157477688|FG000|Blinded Induction Phase: Up to Week 8|Adverse Event|1|||
48902323|NCT02520284|157477689|FG001|Blinded Induction Phase: Up to Week 8|Adverse Event|3|||
48902324|NCT02520284|157477690|FG002|Blinded Induction Phase: Up to Week 8|Adverse Event|0|||
48902325|NCT02520284|157477688|FG000|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
48902326|NCT02520284|157477689|FG001|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
48902327|NCT02520284|157477690|FG002|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
48902328|NCT02520284|157477688|FG000|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
48902329|NCT02520284|157477689|FG001|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
48902330|NCT02520284|157477690|FG002|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1|||
48902331|NCT02520284|157477688|FG000|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17|||
48902332|NCT02520284|157477689|FG001|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11|||
48902333|NCT02520284|157477690|FG002|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15|||
48902334|NCT02520284|157477688|FG000|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
48902335|NCT02520284|157477689|FG001|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
48902336|NCT02520284|157477690|FG002|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3|||
48902337|NCT02520284|157477688|FG000|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
48902338|NCT02520284|157477689|FG001|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
48902339|NCT02520284|157477690|FG002|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0|||
48902340|NCT02520284|157477688|FG000|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
48902341|NCT02520284|157477689|FG001|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2|||
48902342|NCT02520284|157477690|FG002|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
48902343|NCT02520284|157477688|FG000|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25|||
48902344|NCT02520284|157477689|FG001|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29|||
48902345|NCT02520284|157477690|FG002|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28|||
48902346|NCT02520284|157477688|FG000|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3|||
48902347|NCT02520284|157477689|FG001|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4|||
48902348|NCT02520284|157477690|FG002|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2|||
48902349|NCT02520284|157477688|FG000|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2|||
48902350|NCT02520284|157477689|FG001|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1|||
48902351|NCT02520284|157477690|FG002|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3|||
48902352|NCT02520284|157477688|FG000|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2|||
48902353|NCT02520284|157477689|FG001|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
48902354|NCT02520284|157477690|FG002|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
48902355|NCT02668185|157477691|FG000|First Intervention (4 Weeks)|Physician Decision|2|||
48902356|NCT02668185|157477692|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
48902357|NCT02668185|157477691|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
48902358|NCT02668185|157477692|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
48902359|NCT02668185|157477691|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
48902360|NCT02668185|157477692|FG001|Washout Period (2 Weeks)|Physician Decision|2|||
48902361|NCT02668185|157477691|FG000|Second Intervention (4 Weeks)|Physician Decision|1|||
48902362|NCT02668185|157477692|FG001|Second Intervention (4 Weeks)|Physician Decision|3|||
48902363|NCT01013597|157477693|FG000|Overall Study|Withdrawal by Subject|1|||
48902364|NCT01898923|157477696|FG000|Overall Study|Lack of Efficacy|5|||
48902365|NCT01898923|157477697|FG001|Overall Study|Lack of Efficacy|6|||
48902366|NCT01898923|157477696|FG000|Overall Study|Adverse Event|3|||
48902367|NCT01898923|157477697|FG001|Overall Study|Adverse Event|1|||
48902368|NCT01898923|157477696|FG000|Overall Study|Lost to Follow-up|0|||
48902369|NCT01898923|157477697|FG001|Overall Study|Lost to Follow-up|1|||
48902370|NCT01898923|157477696|FG000|Overall Study|Withdrawal by Subject|4|||
48902371|NCT01898923|157477697|FG001|Overall Study|Withdrawal by Subject|7|||
48902372|NCT01898923|157477696|FG000|Overall Study|Physician Decision|3|||
48902373|NCT01898923|157477697|FG001|Overall Study|Physician Decision|4|||
49005534|NCT03496207|157857781|FG004|Extension Period|Withdrawal by Subject|1|||
48902374|NCT01898923|157477696|FG000|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1|||
48902375|NCT01898923|157477697|FG001|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2|||
48902376|NCT00381303|157477698|FG000|Overall Study|Lost to Follow-up|25|||
48902377|NCT00381303|157477699|FG001|Overall Study|Lost to Follow-up|9|||
48902378|NCT00381303|157477698|FG000|Overall Study|AE/HIV-related event|22|||
48902379|NCT00381303|157477699|FG001|Overall Study|AE/HIV-related event|6|||
48902380|NCT00381303|157477698|FG000|Overall Study|Non-Adherence|13|||
48902381|NCT00381303|157477699|FG001|Overall Study|Non-Adherence|6|||
48902382|NCT00381303|157477698|FG000|Overall Study|Withdrawal by Subject|13|||
48902383|NCT00381303|157477699|FG001|Overall Study|Withdrawal by Subject|6|||
48902384|NCT00381303|157477698|FG000|Overall Study|Virologic failure|6|||
48902385|NCT00381303|157477699|FG001|Overall Study|Virologic failure|4|||
48902386|NCT00381303|157477698|FG000|Overall Study|Ineligible to continue the trial|2|||
48902387|NCT00381303|157477699|FG001|Overall Study|Ineligible to continue the trial|1|||
48902388|NCT00381303|157477698|FG000|Overall Study|Pregnancy|2|||
48902389|NCT00381303|157477699|FG001|Overall Study|Pregnancy|0|||
48902390|NCT00381303|157477698|FG000|Overall Study|Physician Decision|1|||
48902391|NCT00381303|157477699|FG001|Overall Study|Physician Decision|0|||
48902392|NCT00381303|157477698|FG000|Overall Study|Physician's decision to close the site|3|||
48902393|NCT00381303|157477699|FG001|Overall Study|Physician's decision to close the site|1|||
48902394|NCT00381303|157477698|FG000|Overall Study|Subject moved out of state|2|||
48902395|NCT00381303|157477699|FG001|Overall Study|Subject moved out of state|0|||
48902396|NCT00381303|157477698|FG000|Overall Study|Subject taking too many different meds|1|||
48902397|NCT00381303|157477699|FG001|Overall Study|Subject taking too many different meds|0|||
48902398|NCT00381303|157477698|FG000|Overall Study|No virologic response by week 12|1|||
48902399|NCT00381303|157477699|FG001|Overall Study|No virologic response by week 12|0|||
48902400|NCT00381303|157477698|FG000|Overall Study|Subject was too busy for appointments|1|||
48902401|NCT00381303|157477699|FG001|Overall Study|Subject was too busy for appointments|0|||
48902402|NCT00381303|157477698|FG000|Overall Study|Subject did not continue visits|1|||
48902403|NCT00381303|157477699|FG001|Overall Study|Subject did not continue visits|0|||
48902404|NCT00381303|157477698|FG000|Overall Study|Subject primary physician's decision|1|||
48902405|NCT00381303|157477699|FG001|Overall Study|Subject primary physician's decision|0|||
49056714|NCT02315066|158038184|FG006|Overall Study|Subject refused further follow-up|2|||
49056715|NCT02315066|158038185|FG007|Overall Study|Subject refused further follow-up|3|||
49056716|NCT02315066|158038186|FG008|Overall Study|Subject refused further follow-up|0|||
49056717|NCT02315066|158038187|FG009|Overall Study|Subject refused further follow-up|1|||
49056718|NCT02315066|158038188|FG010|Overall Study|Subject refused further follow-up|1|||
49056719|NCT02315066|158038189|FG011|Overall Study|Subject refused further follow-up|2|||
49056720|NCT02315066|158038190|FG012|Overall Study|Subject refused further follow-up|2|||
49056721|NCT02315066|158038191|FG013|Overall Study|Subject refused further follow-up|4|||
49056722|NCT02315066|158038178|FG000|Overall Study|Study ongoing at date of cut-off|0|||
49056723|NCT02315066|158038179|FG001|Overall Study|Study ongoing at date of cut-off|0|||
49056724|NCT02315066|158038180|FG002|Overall Study|Study ongoing at date of cut-off|0|||
49056725|NCT02315066|158038181|FG003|Overall Study|Study ongoing at date of cut-off|0|||
49056726|NCT02315066|158038182|FG004|Overall Study|Study ongoing at date of cut-off|0|||
49056727|NCT02315066|158038183|FG005|Overall Study|Study ongoing at date of cut-off|0|||
49056728|NCT02315066|158038184|FG006|Overall Study|Study ongoing at date of cut-off|0|||
49056729|NCT02315066|158038185|FG007|Overall Study|Study ongoing at date of cut-off|0|||
48902406|NCT01211522|157477700|FG000|Overall Study|Withdrawal by Subject|3|||
48902407|NCT01211522|157477701|FG001|Overall Study|Withdrawal by Subject|7|||
48902408|NCT01211522|157477702|FG002|Overall Study|Withdrawal by Subject|5|||
48902409|NCT00372385|157477703|FG000|Overall Study|Adverse Event|6|||
48902410|NCT00372385|157477704|FG001|Overall Study|Adverse Event|11|||
48902411|NCT00372385|157477705|FG002|Overall Study|Adverse Event|9|||
48902412|NCT00372385|157477706|FG003|Overall Study|Adverse Event|7|||
48902413|NCT00372385|157477703|FG000|Overall Study|Noncompliance|0|||
48902414|NCT00372385|157477704|FG001|Overall Study|Noncompliance|1|||
48902415|NCT00372385|157477705|FG002|Overall Study|Noncompliance|1|||
48902416|NCT00372385|157477706|FG003|Overall Study|Noncompliance|1|||
48902417|NCT00372385|157477703|FG000|Overall Study|Physician Decision|1|||
48902418|NCT00372385|157477704|FG001|Overall Study|Physician Decision|0|||
48902419|NCT00372385|157477705|FG002|Overall Study|Physician Decision|0|||
48902420|NCT00372385|157477706|FG003|Overall Study|Physician Decision|0|||
48902421|NCT00372385|157477703|FG000|Overall Study|Lost to Follow-up|2|||
48902422|NCT00372385|157477704|FG001|Overall Study|Lost to Follow-up|0|||
48902423|NCT00372385|157477705|FG002|Overall Study|Lost to Follow-up|0|||
48902424|NCT00372385|157477706|FG003|Overall Study|Lost to Follow-up|0|||
48902425|NCT00372385|157477703|FG000|Overall Study|Withdrawal by Subject|2|||
48902426|NCT00372385|157477704|FG001|Overall Study|Withdrawal by Subject|1|||
48902427|NCT00372385|157477705|FG002|Overall Study|Withdrawal by Subject|0|||
48902428|NCT00372385|157477706|FG003|Overall Study|Withdrawal by Subject|0|||
48902429|NCT00372385|157477703|FG000|Overall Study|Refusal of Treatment|3|||
48902430|NCT00372385|157477704|FG001|Overall Study|Refusal of Treatment|6|||
48902431|NCT00372385|157477705|FG002|Overall Study|Refusal of Treatment|0|||
48902432|NCT00372385|157477706|FG003|Overall Study|Refusal of Treatment|0|||
48902433|NCT00372385|157477703|FG000|Overall Study|No Response|1|||
48902434|NCT00372385|157477704|FG001|Overall Study|No Response|1|||
48902435|NCT00372385|157477705|FG002|Overall Study|No Response|0|||
48902436|NCT00372385|157477706|FG003|Overall Study|No Response|0|||
48902437|NCT00372385|157477703|FG000|Overall Study|Ineligibility due to Exclusion Criterion|1|||
48902438|NCT00372385|157477704|FG001|Overall Study|Ineligibility due to Exclusion Criterion|0|||
48902439|NCT00372385|157477705|FG002|Overall Study|Ineligibility due to Exclusion Criterion|0|||
48902440|NCT00372385|157477706|FG003|Overall Study|Ineligibility due to Exclusion Criterion|0|||
48902441|NCT00372385|157477703|FG000|Overall Study|Virologic Stopping Rule|17|||
48902442|NCT00372385|157477704|FG001|Overall Study|Virologic Stopping Rule|0|||
48902443|NCT00372385|157477705|FG002|Overall Study|Virologic Stopping Rule|0|||
48902444|NCT00372385|157477706|FG003|Overall Study|Virologic Stopping Rule|0|||
48902445|NCT00409773|157479162|FG000|Overall Study|Adverse Event|3|||
48902446|NCT00409773|157479163|FG001|Overall Study|Adverse Event|4|||
48902447|NCT00409773|157479164|FG002|Overall Study|Adverse Event|4|||
48902448|NCT00409773|157479165|FG003|Overall Study|Adverse Event|2|||
48902449|NCT00409773|157479166|FG004|Overall Study|Adverse Event|6|||
48902450|NCT00409773|157479162|FG000|Overall Study|Lost to Follow-up|6|||
48902451|NCT00409773|157479163|FG001|Overall Study|Lost to Follow-up|1|||
48902452|NCT00409773|157479164|FG002|Overall Study|Lost to Follow-up|2|||
48902453|NCT00409773|157479165|FG003|Overall Study|Lost to Follow-up|3|||
48902454|NCT00409773|157479166|FG004|Overall Study|Lost to Follow-up|1|||
48902455|NCT00409773|157479162|FG000|Overall Study|Physician Decision|0|||
48902456|NCT00409773|157479163|FG001|Overall Study|Physician Decision|0|||
48902457|NCT00409773|157479164|FG002|Overall Study|Physician Decision|0|||
48902458|NCT00409773|157479165|FG003|Overall Study|Physician Decision|2|||
48902459|NCT00409773|157479166|FG004|Overall Study|Physician Decision|0|||
48902460|NCT00409773|157479162|FG000|Overall Study|Protocol Violation|0|||
48902461|NCT00409773|157479163|FG001|Overall Study|Protocol Violation|2|||
48902462|NCT00409773|157479164|FG002|Overall Study|Protocol Violation|3|||
48902463|NCT00409773|157479165|FG003|Overall Study|Protocol Violation|3|||
48902464|NCT00409773|157479166|FG004|Overall Study|Protocol Violation|1|||
48902465|NCT00409773|157479162|FG000|Overall Study|Withdrawal by Subject|0|||
48902466|NCT00409773|157479163|FG001|Overall Study|Withdrawal by Subject|0|||
48902467|NCT00409773|157479164|FG002|Overall Study|Withdrawal by Subject|0|||
48902468|NCT00409773|157479165|FG003|Overall Study|Withdrawal by Subject|2|||
49056730|NCT02315066|158038186|FG008|Overall Study|Study ongoing at date of cut-off|0|||
49056731|NCT02315066|158038187|FG009|Overall Study|Study ongoing at date of cut-off|0|||
48902469|NCT00409773|157479166|FG004|Overall Study|Withdrawal by Subject|1|||
48902470|NCT00409773|157479162|FG000|Overall Study|Lack of Eligibility|0|||
48902471|NCT00409773|157479163|FG001|Overall Study|Lack of Eligibility|0|||
48902472|NCT00409773|157479164|FG002|Overall Study|Lack of Eligibility|0|||
48902473|NCT00409773|157479165|FG003|Overall Study|Lack of Eligibility|0|||
48902474|NCT00409773|157479166|FG004|Overall Study|Lack of Eligibility|1|||
48902475|NCT01828073|157479171|FG000|Overall Study|Lost to Follow-up|1|||
48902476|NCT01828073|157479172|FG001|Overall Study|Lost to Follow-up|2|||
48902477|NCT01060540|157479173|FG000|Overall Study|Withdrawal by Subject|10|||
48902478|NCT01060540|157479174|FG001|Overall Study|Withdrawal by Subject|20|||
48902479|NCT01060540|157479173|FG000|Overall Study|Lost to Follow-up|52|||
48902480|NCT01060540|157479174|FG001|Overall Study|Lost to Follow-up|43|||
48902481|NCT01060540|157479173|FG000|Overall Study|Death|2|||
48902482|NCT01060540|157479174|FG001|Overall Study|Death|1|||
48902483|NCT01060540|157479173|FG000|Overall Study|Physician Decision|0|||
48902484|NCT01060540|157479174|FG001|Overall Study|Physician Decision|1|||
48902485|NCT00107120|157479177|FG000|Overall Study|Adverse Event|4|||
48902486|NCT00107120|157479178|FG001|Overall Study|Adverse Event|1|||
48902487|NCT00107120|157479177|FG000|Overall Study|Lack of Efficacy|5|||
48902488|NCT00107120|157479178|FG001|Overall Study|Lack of Efficacy|5|||
48902489|NCT00107120|157479177|FG000|Overall Study|Protocol Violation|3|||
48902490|NCT00107120|157479178|FG001|Overall Study|Protocol Violation|0|||
48902491|NCT00107120|157479177|FG000|Overall Study|Withdrawal by Subject|8|||
48902492|NCT00107120|157479178|FG001|Overall Study|Withdrawal by Subject|9|||
48902493|NCT00107120|157479177|FG000|Overall Study|Lost to Follow-up|8|||
48902494|NCT00107120|157479178|FG001|Overall Study|Lost to Follow-up|6|||
48902495|NCT00107120|157479177|FG000|Overall Study|Pregnancy|0|||
48902496|NCT00107120|157479178|FG001|Overall Study|Pregnancy|1|||
48902497|NCT00107120|157479177|FG000|Overall Study|moving away from site|1|||
48902498|NCT00107120|157479178|FG001|Overall Study|moving away from site|1|||
48902499|NCT00107120|157479177|FG000|Overall Study|death of parent|0|||
48902500|NCT00107120|157479178|FG001|Overall Study|death of parent|1|||
48902501|NCT02245672|157479179|FG000|Overall Study|Adverse Event|4|||
48902502|NCT02245672|157479180|FG001|Overall Study|Adverse Event|4|||
48902503|NCT02245672|157479181|FG002|Overall Study|Adverse Event|4|||
48902504|NCT02245672|157479179|FG000|Overall Study|Lost to Follow-up|3|||
48902505|NCT02245672|157479180|FG001|Overall Study|Lost to Follow-up|5|||
48902506|NCT02245672|157479181|FG002|Overall Study|Lost to Follow-up|1|||
48902507|NCT02245672|157479179|FG000|Overall Study|Withdrawal by Subject|6|||
48902508|NCT02245672|157479180|FG001|Overall Study|Withdrawal by Subject|3|||
48902509|NCT02245672|157479181|FG002|Overall Study|Withdrawal by Subject|0|||
48902510|NCT02245672|157479179|FG000|Overall Study|Randomized in error (not treated)|0|||
48902511|NCT02245672|157479180|FG001|Overall Study|Randomized in error (not treated)|1|||
48902512|NCT02245672|157479181|FG002|Overall Study|Randomized in error (not treated)|0|||
48902513|NCT01620255|157479182|FG000|Overall Study|Withdrawal by Subject|4|||
48902514|NCT01620255|157479183|FG001|Overall Study|Withdrawal by Subject|1|||
48902515|NCT01620255|157479184|FG002|Overall Study|Withdrawal by Subject|1|||
48902516|NCT01620255|157479185|FG003|Overall Study|Withdrawal by Subject|2|||
48902517|NCT01620255|157479186|FG004|Overall Study|Withdrawal by Subject|4|||
48902518|NCT01620255|157479182|FG000|Overall Study|Participant underwent fecal transplant|0|||
48902519|NCT01620255|157479183|FG001|Overall Study|Participant underwent fecal transplant|0|||
48902520|NCT01620255|157479184|FG002|Overall Study|Participant underwent fecal transplant|1|||
48902521|NCT01620255|157479185|FG003|Overall Study|Participant underwent fecal transplant|0|||
48902522|NCT01620255|157479186|FG004|Overall Study|Participant underwent fecal transplant|0|||
48902523|NCT01620255|157479182|FG000|Overall Study|Non-compliance|0|||
49056732|NCT02315066|158038188|FG010|Overall Study|Study ongoing at date of cut-off|0|||
49056733|NCT02315066|158038189|FG011|Overall Study|Study ongoing at date of cut-off|0|||
49056734|NCT02315066|158038190|FG012|Overall Study|Study ongoing at date of cut-off|0|||
49056735|NCT02315066|158038191|FG013|Overall Study|Study ongoing at date of cut-off|1|||
49056736|NCT02459665|158038192|FG000|Overall Study|Withdrawal by Subject|0|||
49056737|NCT02459665|158038193|FG001|Overall Study|Withdrawal by Subject|1|||
49056738|NCT02459665|158038194|FG002|Overall Study|Withdrawal by Subject|1|||
49056739|NCT02459665|158038195|FG003|Overall Study|Withdrawal by Subject|2|||
49056740|NCT01567826|158038196|FG000|Overall Study|Lost to Follow-up|3|||
49056741|NCT01567826|158038197|FG001|Overall Study|Lost to Follow-up|2|||
49056742|NCT00567476|158038207|FG000|Overall Study|Adverse Event|2|||
49056743|NCT00567476|158038208|FG001|Overall Study|Adverse Event|0|||
49056744|NCT00567476|158038207|FG000|Overall Study|Pregnancy|1|||
49056745|NCT00567476|158038208|FG001|Overall Study|Pregnancy|0|||
49056746|NCT00567476|158038207|FG000|Overall Study|Protocol Violation|4|||
48902524|NCT01620255|157479183|FG001|Overall Study|Non-compliance|1|||
48902525|NCT01620255|157479184|FG002|Overall Study|Non-compliance|0|||
48902526|NCT01620255|157479185|FG003|Overall Study|Non-compliance|0|||
48902527|NCT01620255|157479186|FG004|Overall Study|Non-compliance|0|||
48902528|NCT01620255|157479182|FG000|Overall Study|Adverse Event|0|||
48902529|NCT01620255|157479183|FG001|Overall Study|Adverse Event|4|||
48902530|NCT01620255|157479184|FG002|Overall Study|Adverse Event|0|||
48902531|NCT01620255|157479185|FG003|Overall Study|Adverse Event|1|||
48902532|NCT01620255|157479186|FG004|Overall Study|Adverse Event|1|||
48902533|NCT01620255|157479182|FG000|Overall Study|Withdrawn at discretion of investigator|0|||
48902534|NCT01620255|157479183|FG001|Overall Study|Withdrawn at discretion of investigator|0|||
48902535|NCT01620255|157479184|FG002|Overall Study|Withdrawn at discretion of investigator|0|||
48902536|NCT01620255|157479185|FG003|Overall Study|Withdrawn at discretion of investigator|0|||
48902537|NCT01620255|157479186|FG004|Overall Study|Withdrawn at discretion of investigator|1|||
48902538|NCT03602066|157479187|FG000|Overall Study|Withdrawal by Subject|2|||
48902539|NCT03602066|157479188|FG001|Overall Study|Withdrawal by Subject|0|||
48902540|NCT03602066|157479187|FG000|Overall Study|Physician Decision|1|||
48902541|NCT03602066|157479188|FG001|Overall Study|Physician Decision|0|||
48902542|NCT00440700|157479189|FG000|Overall Study|Withdrawal by Subject|8|||
48902543|NCT00440700|157479190|FG001|Overall Study|Withdrawal by Subject|8|||
48902544|NCT00440700|157479191|FG002|Overall Study|Withdrawal by Subject|4|||
48902545|NCT03310268|157479192|FG000|Overall Study|(Not specified)|1|||
48902546|NCT03310268|157479193|FG001|Overall Study|(Not specified)|5|||
48902547|NCT03310268|157479194|FG002|Overall Study|(Not specified)|0|||
48902548|NCT01155375|157479199|FG000|Overall Study|Adverse Event|1|||
48902549|NCT01155375|157479200|FG001|Overall Study|Adverse Event|0|||
48902550|NCT01637623|157479203|FG000|Overall Study|Lost to Follow-up|0|||
48902551|NCT01637623|157479204|FG001|Overall Study|Lost to Follow-up|0|||
48902552|NCT01637623|157479205|FG002|Overall Study|Lost to Follow-up|2|||
48902553|NCT01637623|157479203|FG000|Overall Study|Physician Decision|1|||
48902554|NCT01637623|157479204|FG001|Overall Study|Physician Decision|0|||
48902555|NCT01637623|157479205|FG002|Overall Study|Physician Decision|1|||
48902556|NCT03249714|157479206|FG000|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
48902557|NCT03249714|157479207|FG001|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
48902558|NCT03249714|157479206|FG000|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
48902559|NCT03249714|157479207|FG001|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
48902560|NCT03249714|157479206|FG000|Double-blind Treatment (Core Part)|Lost to Follow-up|1|||
48902561|NCT03249714|157479207|FG001|Double-blind Treatment (Core Part)|Lost to Follow-up|0|||
48902562|NCT03249714|157479206|FG000|Open-label Treatment (Extension Part)|Adverse Event|2|||
48902563|NCT03249714|157479207|FG001|Open-label Treatment (Extension Part)|Adverse Event|0|||
48902564|NCT02634346|157479208|FG000|Overall Study|Withdrawal by Subject|8|||
48902565|NCT02634346|157479209|FG001|Overall Study|Withdrawal by Subject|9|||
49056747|NCT00567476|158038208|FG001|Overall Study|Protocol Violation|1|||
49056748|NCT00567476|158038207|FG000|Overall Study|Lost to Follow-up|0|||
49056749|NCT00567476|158038208|FG001|Overall Study|Lost to Follow-up|1|||
49056750|NCT00567476|158038207|FG000|Overall Study|Administrative issues|1|||
49056751|NCT00567476|158038208|FG001|Overall Study|Administrative issues|0|||
49056752|NCT00567476|158038207|FG000|Overall Study|Medical Decision|0|||
49056753|NCT00567476|158038208|FG001|Overall Study|Medical Decision|1|||
49056754|NCT00567476|158038207|FG000|Overall Study|Non-adherence to protocol|0|||
49056755|NCT00567476|158038208|FG001|Overall Study|Non-adherence to protocol|1|||
49056756|NCT00597116|158038209|FG000|Overall Study|Adverse Event|2|||
49056757|NCT00597116|158038210|FG001|Overall Study|Adverse Event|1|||
49056758|NCT00597116|158038209|FG000|Overall Study|Withdrawal by Subject|0|||
49056759|NCT00597116|158038210|FG001|Overall Study|Withdrawal by Subject|2|||
49056760|NCT00597116|158038209|FG000|Overall Study|Physician Decision|0|||
49056761|NCT00597116|158038210|FG001|Overall Study|Physician Decision|1|||
49056762|NCT00597116|158038209|FG000|Overall Study|Death|0|||
49056763|NCT00597116|158038210|FG001|Overall Study|Death|1|||
49056764|NCT00597116|158038209|FG000|Overall Study|Lost to Follow-up|1|||
49056765|NCT00597116|158038210|FG001|Overall Study|Lost to Follow-up|0|||
49056766|NCT00597116|158038209|FG000|Overall Study|Progressive disease|11|||
49056767|NCT00597116|158038210|FG001|Overall Study|Progressive disease|6|||
49056768|NCT00350402|158038211|FG000|Overall Study|Lost to Follow-up|1|||
49056769|NCT00350402|158038212|FG001|Overall Study|Lost to Follow-up|1|||
48902566|NCT02634346|157479210|FG002|Overall Study|Withdrawal by Subject|8|||
48902567|NCT02634346|157479208|FG000|Overall Study|Adverse Event|2|||
48902568|NCT02634346|157479209|FG001|Overall Study|Adverse Event|2|||
48902569|NCT02634346|157479210|FG002|Overall Study|Adverse Event|7|||
48902570|NCT02634346|157479208|FG000|Overall Study|Lack of Efficacy|1|||
48902571|NCT02634346|157479209|FG001|Overall Study|Lack of Efficacy|2|||
48902572|NCT02634346|157479210|FG002|Overall Study|Lack of Efficacy|8|||
48902573|NCT02634346|157479208|FG000|Overall Study|Lost to Follow-up|1|||
48902574|NCT02634346|157479209|FG001|Overall Study|Lost to Follow-up|0|||
48902575|NCT02634346|157479210|FG002|Overall Study|Lost to Follow-up|0|||
48902576|NCT02634346|157479208|FG000|Overall Study|Protocol Violation|0|||
48902577|NCT02634346|157479209|FG001|Overall Study|Protocol Violation|1|||
48902578|NCT02634346|157479210|FG002|Overall Study|Protocol Violation|0|||
48902579|NCT01933113|157479218|FG000|Overall Study|Fractured nonfunctioning lead.|1|||
48902580|NCT03587974|157479219|FG000|Overall Study|caregiver demented, care recipient died|3|||
48902581|NCT03587974|157479220|FG001|Overall Study|caregiver demented, care recipient died|3|||
48902582|NCT03587974|157479219|FG000|Overall Study|Withdrawal by Subject|2|||
48902583|NCT03587974|157479220|FG001|Overall Study|Withdrawal by Subject|1|||
48902584|NCT03486457|157479221|FG000|Up to Month 3|Adverse Event|2|||
48902585|NCT03486457|157479222|FG001|Up to Month 3|Adverse Event|5|||
48902586|NCT03486457|157479221|FG000|Up to Month 3|Lack of Efficacy|1|||
48902587|NCT03486457|157479222|FG001|Up to Month 3|Lack of Efficacy|0|||
48902588|NCT03486457|157479221|FG000|Up to Month 3|Withdrawal by Subject|1|||
48902589|NCT03486457|157479222|FG001|Up to Month 3|Withdrawal by Subject|0|||
48902590|NCT03486457|157479221|FG000|Up to Month 3|Failure to Meet Randomization Criteria|2|||
48902591|NCT03486457|157479222|FG001|Up to Month 3|Failure to Meet Randomization Criteria|0|||
48902592|NCT03486457|157479221|FG000|Up to Month 3|Other|1|||
48902593|NCT03486457|157479222|FG001|Up to Month 3|Other|0|||
48902594|NCT03486457|157479221|FG000|Month 3 to Month 6|Adverse Event|2|||
48902595|NCT03486457|157479222|FG001|Month 3 to Month 6|Adverse Event|0|||
48902596|NCT03486457|157479221|FG000|Month 3 to Month 6|Lost to Follow-up|0|||
48902597|NCT03486457|157479222|FG001|Month 3 to Month 6|Lost to Follow-up|1|||
48902598|NCT03486457|157479221|FG000|Month 3 to Month 6|Pregnancy|0|||
48902599|NCT03486457|157479222|FG001|Month 3 to Month 6|Pregnancy|1|||
48902600|NCT03486457|157479221|FG000|Month 3 to Month 6|Other|1|||
48902601|NCT03486457|157479222|FG001|Month 3 to Month 6|Other|0|||
48902602|NCT04754477|157479223|FG000|Overall Study|Withdrawal by Subject|1|||
48902603|NCT02960854|157479224|FG000|Overall Study|Not Disclosed|2|||
48902604|NCT02960854|157479225|FG001|Overall Study|Not Disclosed|2|||
48902605|NCT02960854|157479224|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
48902606|NCT02960854|157479225|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
48902607|NCT02960854|157479224|FG000|Overall Study|Subject Withdrew Consent|0|||
48902608|NCT02960854|157479225|FG001|Overall Study|Subject Withdrew Consent|1|||
48902609|NCT02960854|157479224|FG000|Overall Study|Death|4|||
48902610|NCT02960854|157479225|FG001|Overall Study|Death|6|||
48902611|NCT00221195|157479226|FG000|Therapy 1 (Months 1-6)|Withdrawal by Subject|3|||
48902612|NCT00221195|157479227|FG001|Therapy 1 (Months 1-6)|Withdrawal by Subject|1|||
48902613|NCT00221195|157479226|FG000|Therapy 1 (Months 1-6)|Lost to Follow-up|0|||
48902614|NCT00221195|157479227|FG001|Therapy 1 (Months 1-6)|Lost to Follow-up|1|||
48902615|NCT00221195|157479226|FG000|Washout Period (Months 7-9)|Death|0|||
49056770|NCT04349631|158038213|FG000|Overall Study|Lost to Follow-up|3|||
49056771|NCT04349631|158038213|FG000|Overall Study|Withdrawal by Subject|7|||
49056772|NCT00690482|158038214|FG000|Overall Study|Adverse Event|2|||
49056773|NCT00690482|158038215|FG001|Overall Study|Adverse Event|1|||
49056774|NCT00690482|158038214|FG000|Overall Study|Incorrect enrolment|0|||
48902616|NCT00221195|157479227|FG001|Washout Period (Months 7-9)|Death|1|||
48902617|NCT00221195|157479226|FG000|Therapy 2 (Months 10-15)|Death|1|||
48902618|NCT00221195|157479227|FG001|Therapy 2 (Months 10-15)|Death|0|||
48902619|NCT00221195|157479226|FG000|Therapy 2 (Months 10-15)|Adverse Event|1|||
48902620|NCT00221195|157479227|FG001|Therapy 2 (Months 10-15)|Adverse Event|0|||
48902621|NCT00093808|157479228|FG000|Overall Study|Cancel participation before receiving tx|1|||
48902622|NCT00093808|157479228|FG000|Overall Study|Protocol Violation|1|||
48902623|NCT02647866|157479229|FG000|Overall Study|Adverse Event|0|||
48902624|NCT02647866|157479230|FG001|Overall Study|Adverse Event|0|||
48902625|NCT02647866|157479231|FG002|Overall Study|Adverse Event|2|||
48902626|NCT02647866|157479232|FG003|Overall Study|Adverse Event|2|||
48902627|NCT02647866|157479233|FG004|Overall Study|Adverse Event|1|||
48902628|NCT02647866|157479229|FG000|Overall Study|Disease Worsening|3|||
48902629|NCT02647866|157479230|FG001|Overall Study|Disease Worsening|1|||
48902630|NCT02647866|157479231|FG002|Overall Study|Disease Worsening|0|||
48902631|NCT02647866|157479232|FG003|Overall Study|Disease Worsening|0|||
48902632|NCT02647866|157479233|FG004|Overall Study|Disease Worsening|1|||
48902633|NCT02647866|157479229|FG000|Overall Study|Withdrawal by Subject|1|||
48902634|NCT02647866|157479230|FG001|Overall Study|Withdrawal by Subject|1|||
48902635|NCT02647866|157479231|FG002|Overall Study|Withdrawal by Subject|2|||
48902636|NCT02647866|157479232|FG003|Overall Study|Withdrawal by Subject|4|||
48902637|NCT02647866|157479233|FG004|Overall Study|Withdrawal by Subject|4|||
48902638|NCT02647866|157479229|FG000|Overall Study|Physician Decision|0|||
48902639|NCT02647866|157479230|FG001|Overall Study|Physician Decision|1|||
48902640|NCT02647866|157479231|FG002|Overall Study|Physician Decision|1|||
48902641|NCT02647866|157479232|FG003|Overall Study|Physician Decision|0|||
48902642|NCT02647866|157479233|FG004|Overall Study|Physician Decision|2|||
48902643|NCT02647866|157479229|FG000|Overall Study|Death|0|||
48902644|NCT02647866|157479230|FG001|Overall Study|Death|1|||
48902645|NCT02647866|157479231|FG002|Overall Study|Death|0|||
48902646|NCT02647866|157479232|FG003|Overall Study|Death|0|||
48902647|NCT02647866|157479233|FG004|Overall Study|Death|0|||
48902648|NCT02647866|157479229|FG000|Overall Study|Subject moved to different country|1|||
48902649|NCT02647866|157479230|FG001|Overall Study|Subject moved to different country|0|||
48902650|NCT02647866|157479231|FG002|Overall Study|Subject moved to different country|0|||
48902651|NCT02647866|157479232|FG003|Overall Study|Subject moved to different country|0|||
48902652|NCT02647866|157479233|FG004|Overall Study|Subject moved to different country|0|||
48902653|NCT00701220|157479234|FG000|Overall Study|Withdrawal by Subject|0|||
48902654|NCT00701220|157479235|FG001|Overall Study|Withdrawal by Subject|2|||
48902655|NCT00701220|157479234|FG000|Overall Study|Protocol Violation|2|||
48902656|NCT00701220|157479235|FG001|Overall Study|Protocol Violation|0|||
48902657|NCT01180998|157479236|FG000|Overall Study|Poor Vision|0|||
48902658|NCT01180998|157479237|FG001|Overall Study|Poor Vision|2|||
48902659|NCT01180998|157479238|FG002|Overall Study|Poor Vision|2|||
48902660|NCT01180998|157479236|FG000|Overall Study|Lost to Follow-up|0|||
48902661|NCT01180998|157479237|FG001|Overall Study|Lost to Follow-up|0|||
48902662|NCT01180998|157479238|FG002|Overall Study|Lost to Follow-up|1|||
48902663|NCT01180998|157479236|FG000|Overall Study|Protocol Violation|1|||
48902664|NCT01180998|157479237|FG001|Overall Study|Protocol Violation|2|||
48902665|NCT01180998|157479238|FG002|Overall Study|Protocol Violation|0|||
48902666|NCT01180998|157479236|FG000|Overall Study|Withdrawal by Subject|0|||
48902667|NCT01180998|157479237|FG001|Overall Study|Withdrawal by Subject|0|||
48902668|NCT01180998|157479238|FG002|Overall Study|Withdrawal by Subject|1|||
48902669|NCT01180998|157479236|FG000|Overall Study|Poor comfort|3|||
48902670|NCT01180998|157479237|FG001|Overall Study|Poor comfort|0|||
48902671|NCT01180998|157479238|FG002|Overall Study|Poor comfort|4|||
48902672|NCT01180998|157479236|FG000|Overall Study|Poor lens handling|0|||
48902673|NCT01180998|157479237|FG001|Overall Study|Poor lens handling|0|||
48902674|NCT01180998|157479238|FG002|Overall Study|Poor lens handling|2|||
48902675|NCT00162032|157479239|FG000|Overall Study|Lost to Follow-up|4|||
48902676|NCT00162032|157479240|FG001|Overall Study|Lost to Follow-up|2|||
48902677|NCT00162032|157479239|FG000|Overall Study|Reason not specified|1|||
48902678|NCT00162032|157479240|FG001|Overall Study|Reason not specified|0|||
48902679|NCT00718640|157479245|FG000|Overall Study|Adverse Event|4|||
49056775|NCT00690482|158038215|FG001|Overall Study|Incorrect enrolment|1|||
49056776|NCT00690482|158038214|FG000|Overall Study|Study-specific discontinuation criteria|1|||
49056777|NCT00690482|158038215|FG001|Overall Study|Study-specific discontinuation criteria|0|||
49056778|NCT00690482|158038214|FG000|Overall Study|Intake of prohibited medicine|1|||
49056779|NCT00690482|158038215|FG001|Overall Study|Intake of prohibited medicine|0|||
49056780|NCT00690482|158038214|FG000|Overall Study|withdrew consent at rand.day|0|||
49056781|NCT00690482|158038215|FG001|Overall Study|withdrew consent at rand.day|1|||
49056782|NCT01258101|158038216|FG000|Overall Study|Adverse Event|5|||
49056783|NCT01258101|158038217|FG001|Overall Study|Adverse Event|6|||
48902680|NCT00718640|157479245|FG000|Overall Study|Death|1|||
48902681|NCT00718640|157479245|FG000|Overall Study|Unresolved toxicity after 2 weeks|2|||
48902682|NCT00655486|157479246|FG000|Overall Study|Adverse Event|10|||
48902683|NCT00655486|157479246|FG000|Overall Study|Lack of Efficacy|8|||
48902684|NCT00655486|157479246|FG000|Overall Study|Withdrawal by Subject|4|||
48902685|NCT00655486|157479246|FG000|Overall Study|Protocol Violation|1|||
49056784|NCT01258101|158038218|FG002|Overall Study|Adverse Event|0|||
49056785|NCT01258101|158038219|FG003|Overall Study|Adverse Event|0|||
49056786|NCT01258101|158038216|FG000|Overall Study|Extra exclusion criterion amended|2|||
49056787|NCT01258101|158038217|FG001|Overall Study|Extra exclusion criterion amended|1|||
49056788|NCT01258101|158038218|FG002|Overall Study|Extra exclusion criterion amended|1|||
49056789|NCT01258101|158038219|FG003|Overall Study|Extra exclusion criterion amended|1|||
49056790|NCT01258101|158038216|FG000|Overall Study|Informed consent has been withdrawn|2|||
49056791|NCT01258101|158038217|FG001|Overall Study|Informed consent has been withdrawn|2|||
49056792|NCT01258101|158038218|FG002|Overall Study|Informed consent has been withdrawn|1|||
49056793|NCT01258101|158038219|FG003|Overall Study|Informed consent has been withdrawn|1|||
49056794|NCT01258101|158038216|FG000|Overall Study|Patient is not able to attend visits|8|||
49056795|NCT01258101|158038217|FG001|Overall Study|Patient is not able to attend visits|9|||
49056796|NCT01258101|158038218|FG002|Overall Study|Patient is not able to attend visits|7|||
49056797|NCT01258101|158038219|FG003|Overall Study|Patient is not able to attend visits|6|||
49056798|NCT01258101|158038216|FG000|Overall Study|Patient´s compliance|4|||
49056799|NCT01258101|158038217|FG001|Overall Study|Patient´s compliance|3|||
49056800|NCT01258101|158038218|FG002|Overall Study|Patient´s compliance|1|||
49056801|NCT01258101|158038219|FG003|Overall Study|Patient´s compliance|2|||
49056802|NCT01258101|158038216|FG000|Overall Study|Lost to Follow-up|5|||
49056803|NCT01258101|158038217|FG001|Overall Study|Lost to Follow-up|5|||
49056804|NCT01258101|158038218|FG002|Overall Study|Lost to Follow-up|0|||
49056805|NCT01258101|158038219|FG003|Overall Study|Lost to Follow-up|6|||
49056806|NCT01258101|158038216|FG000|Overall Study|PCR positive at week 24|0|||
49056807|NCT01258101|158038217|FG001|Overall Study|PCR positive at week 24|0|||
49056808|NCT01258101|158038218|FG002|Overall Study|PCR positive at week 24|0|||
49056809|NCT01258101|158038219|FG003|Overall Study|PCR positive at week 24|1|||
49056810|NCT01258101|158038216|FG000|Overall Study|Other reason|7|||
49056811|NCT01258101|158038217|FG001|Overall Study|Other reason|8|||
49056812|NCT01258101|158038218|FG002|Overall Study|Other reason|1|||
49056813|NCT01258101|158038219|FG003|Overall Study|Other reason|8|||
49056814|NCT00303667|158038220|FG000|Overall Study|Death|0|||
49056815|NCT00303667|158038221|FG001|Overall Study|Death|4|||
49056816|NCT00058214|158038222|FG000|Overall Study|Adverse Event|1|||
49056817|NCT00606502|158038223|FG000|Randomization|Randomized but not treated|3|||
49056818|NCT00606502|158038224|FG001|Randomization|Randomized but not treated|0|||
49056819|NCT00606502|158038223|FG000|Treatment|Treatment ongoing at time of data cutoff|0|||
49056820|NCT00606502|158038224|FG001|Treatment|Treatment ongoing at time of data cutoff|3|||
49056821|NCT02377921|158038225|FG000|Overall Study|Subject non-compliance|1|||
49056822|NCT02377921|158038226|FG001|Overall Study|Subject non-compliance|1|||
49056823|NCT03903159|158038229|FG000|Overall Study|Discharged with Staff Approval|2|||
49056824|NCT03903159|158038229|FG000|Overall Study|Discharged at Staff Request|2|||
49056825|NCT03903159|158038229|FG000|Overall Study|Discharged Against Staff Advice|1|||
49056826|NCT02333487|158038242|FG000|Overall Study|Adverse Event|0|||
49056827|NCT02333487|158038243|FG001|Overall Study|Adverse Event|2|||
49056828|NCT02333487|158038244|FG002|Overall Study|Adverse Event|0|||
49056829|NCT01297322|158038246|FG000|Overall Study|Lost to Follow-up|1|||
49056830|NCT01297322|158038247|FG001|Overall Study|Lost to Follow-up|0|||
49056831|NCT01297322|158038246|FG000|Overall Study|Withdrawal by Subject|0|||
49056832|NCT01297322|158038247|FG001|Overall Study|Withdrawal by Subject|1|||
49056833|NCT01297322|158038246|FG000|Overall Study|Protocol Violation|0|||
49056834|NCT01297322|158038247|FG001|Overall Study|Protocol Violation|3|||
49056835|NCT05020249|158039669|FG000|Overall Study|Protocol Violation|1|||
49056836|NCT05020249|158039670|FG001|Overall Study|Protocol Violation|0|||
49056837|NCT00614926|158039671|FG000|Overall Study|Burden of travel|1|||
49056838|NCT00614926|158039672|FG001|Overall Study|Burden of travel|0|||
48902686|NCT00655486|157479246|FG000|Overall Study|Unsatisfactory compliance|2|||
48902687|NCT00655486|157479246|FG000|Overall Study|Other: Pregnancy|1|||
48902688|NCT00655486|157479246|FG000|Overall Study|Other: Could not tolerate BID dosing|1|||
48902689|NCT00655486|157479246|FG000|Overall Study|Other: Abnormal electrocardiogram (ECG)|1|||
48902690|NCT00744523|157479252|FG000|30 Days After the Procedure|Insufficient follow-up|0|||
48902691|NCT00744523|157479253|FG001|30 Days After the Procedure|Insufficient follow-up|5|||
48902692|NCT01139021|157479254|FG000|Overall Study|Adverse Event|0|||
48902693|NCT01139021|157479255|FG001|Overall Study|Adverse Event|0|||
48902694|NCT01139021|157479256|FG002|Overall Study|Adverse Event|0|||
48902695|NCT01139021|157479257|FG003|Overall Study|Adverse Event|0|||
48902696|NCT01139021|157479258|FG004|Overall Study|Adverse Event|1|||
48902697|NCT01139021|157479259|FG005|Overall Study|Adverse Event|0|||
48902698|NCT01139021|157479254|FG000|Overall Study|Lost to Follow-up|0|||
48902699|NCT01139021|157479255|FG001|Overall Study|Lost to Follow-up|0|||
48902700|NCT01139021|157479256|FG002|Overall Study|Lost to Follow-up|0|||
48902701|NCT01139021|157479257|FG003|Overall Study|Lost to Follow-up|0|||
48902702|NCT01139021|157479258|FG004|Overall Study|Lost to Follow-up|2|||
48902703|NCT01139021|157479259|FG005|Overall Study|Lost to Follow-up|0|||
48902704|NCT01139021|157479254|FG000|Overall Study|Protocol Violation|1|||
48902705|NCT01139021|157479255|FG001|Overall Study|Protocol Violation|0|||
48902706|NCT01139021|157479256|FG002|Overall Study|Protocol Violation|0|||
48902707|NCT01139021|157479257|FG003|Overall Study|Protocol Violation|0|||
48902708|NCT01139021|157479258|FG004|Overall Study|Protocol Violation|2|||
48902709|NCT01139021|157479259|FG005|Overall Study|Protocol Violation|0|||
48902710|NCT01139021|157479254|FG000|Overall Study|Withdrawal by Subject|0|||
48902711|NCT01139021|157479255|FG001|Overall Study|Withdrawal by Subject|0|||
48902712|NCT01139021|157479256|FG002|Overall Study|Withdrawal by Subject|0|||
48902713|NCT01139021|157479257|FG003|Overall Study|Withdrawal by Subject|1|||
48902714|NCT01139021|157479258|FG004|Overall Study|Withdrawal by Subject|4|||
48902715|NCT01139021|157479259|FG005|Overall Study|Withdrawal by Subject|0|||
48902716|NCT03603028|157479260|FG000|Overall Study|Withdrawal by Subject|1|||
48902717|NCT01037244|157479261|FG000|Overall Study|Adverse Event|3|||
48902718|NCT01037244|157479262|FG001|Overall Study|Adverse Event|2|||
48902719|NCT01037244|157479263|FG002|Overall Study|Adverse Event|6|||
48902720|NCT01037244|157479264|FG003|Overall Study|Adverse Event|3|||
48902721|NCT01037244|157479261|FG000|Overall Study|Lack of Efficacy|1|||
48902722|NCT01037244|157479262|FG001|Overall Study|Lack of Efficacy|1|||
48902723|NCT01037244|157479263|FG002|Overall Study|Lack of Efficacy|0|||
48902724|NCT01037244|157479264|FG003|Overall Study|Lack of Efficacy|1|||
48902725|NCT01037244|157479261|FG000|Overall Study|Lost to Follow-up|3|||
48902726|NCT01037244|157479262|FG001|Overall Study|Lost to Follow-up|3|||
48902727|NCT01037244|157479263|FG002|Overall Study|Lost to Follow-up|4|||
48902728|NCT01037244|157479264|FG003|Overall Study|Lost to Follow-up|4|||
48902729|NCT01037244|157479261|FG000|Overall Study|Withdrawal by Subject|1|||
48902730|NCT01037244|157479262|FG001|Overall Study|Withdrawal by Subject|5|||
48902731|NCT01037244|157479263|FG002|Overall Study|Withdrawal by Subject|3|||
48902732|NCT01037244|157479264|FG003|Overall Study|Withdrawal by Subject|5|||
48902733|NCT01037244|157479261|FG000|Overall Study|Partner Withdrew Consent|2|||
48902734|NCT01037244|157479262|FG001|Overall Study|Partner Withdrew Consent|1|||
48902735|NCT01037244|157479263|FG002|Overall Study|Partner Withdrew Consent|0|||
48902736|NCT01037244|157479264|FG003|Overall Study|Partner Withdrew Consent|0|||
48902737|NCT01037244|157479261|FG000|Overall Study|Various|3|||
48902738|NCT01037244|157479262|FG001|Overall Study|Various|2|||
48902739|NCT01037244|157479263|FG002|Overall Study|Various|1|||
48902740|NCT01037244|157479264|FG003|Overall Study|Various|1|||
48902741|NCT00690820|157479265|FG000|Period 1|Withdrawal by Subject|0|||
48902742|NCT00690820|157479266|FG001|Period 1|Withdrawal by Subject|1|||
48902743|NCT03658668|157479272|FG000|Overall Study|Time Commitment|1|||
48902744|NCT03658668|157479273|FG001|Overall Study|Time Commitment|1|||
48902745|NCT00756470|157479276|FG000|Overall Study|Withdrawal by Subject|1|||
49056839|NCT00614926|158039671|FG000|Overall Study|Adverse Event|3|||
49056840|NCT00614926|158039672|FG001|Overall Study|Adverse Event|0|||
49056841|NCT01207440|158039677|FG000|Overall Study|Adverse Event|46|||
49056842|NCT01207440|158039678|FG001|Overall Study|Adverse Event|11|||
49056843|NCT01207440|158039679|FG002|Overall Study|Adverse Event|7|||
49056844|NCT01207440|158039680|FG003|Overall Study|Adverse Event|2|||
49056845|NCT01207440|158039681|FG004|Overall Study|Adverse Event|6|||
49056846|NCT01207440|158039682|FG005|Overall Study|Adverse Event|6|||
49056847|NCT01207440|158039683|FG006|Overall Study|Adverse Event|2|||
48902746|NCT00756470|157479276|FG000|Overall Study|Adverse Event|4|||
48902747|NCT01978262|157479280|FG000|Overall Study|Withdrawal by Subject|9|||
48902748|NCT01978262|157479280|FG000|Overall Study|Lost to Follow-up|2|||
48902749|NCT03118674|157479281|FG000|Overall Study|Lost to Follow-up|2|||
48902750|NCT03118674|157479281|FG000|Overall Study|Screen Faliure|8|||
48902751|NCT03118674|157479281|FG000|Overall Study|Withdrawal by Subject|5|||
48902752|NCT03285178|157479282|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|3|||
48902753|NCT03285178|157479283|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
49056848|NCT01207440|158039677|FG000|Overall Study|Death|6|||
49056849|NCT01207440|158039678|FG001|Overall Study|Death|3|||
49056850|NCT01207440|158039679|FG002|Overall Study|Death|2|||
49056851|NCT01207440|158039680|FG003|Overall Study|Death|2|||
49056852|NCT01207440|158039681|FG004|Overall Study|Death|7|||
49056853|NCT01207440|158039682|FG005|Overall Study|Death|5|||
49056854|NCT01207440|158039683|FG006|Overall Study|Death|1|||
49056855|NCT01207440|158039677|FG000|Overall Study|Lack of Efficacy|13|||
49056856|NCT01207440|158039678|FG001|Overall Study|Lack of Efficacy|2|||
49056857|NCT01207440|158039679|FG002|Overall Study|Lack of Efficacy|5|||
49056858|NCT01207440|158039680|FG003|Overall Study|Lack of Efficacy|1|||
49056859|NCT01207440|158039681|FG004|Overall Study|Lack of Efficacy|2|||
48902754|NCT03285178|157479284|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
48902755|NCT03285178|157479285|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
48902756|NCT03285178|157479286|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
48902757|NCT03285178|157479287|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
48902758|NCT03285178|157479288|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
49056860|NCT01207440|158039682|FG005|Overall Study|Lack of Efficacy|3|||
49056861|NCT01207440|158039683|FG006|Overall Study|Lack of Efficacy|0|||
49056862|NCT01207440|158039677|FG000|Overall Study|Lost to Follow-up|0|||
48902759|NCT03285178|157479282|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|1|||
48902760|NCT03285178|157479283|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
48902761|NCT03285178|157479284|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
48902762|NCT03285178|157479285|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
48902763|NCT03285178|157479286|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
49056863|NCT01207440|158039678|FG001|Overall Study|Lost to Follow-up|0|||
49056864|NCT01207440|158039679|FG002|Overall Study|Lost to Follow-up|2|||
49056865|NCT01207440|158039680|FG003|Overall Study|Lost to Follow-up|1|||
49056866|NCT01207440|158039681|FG004|Overall Study|Lost to Follow-up|0|||
49056867|NCT01207440|158039682|FG005|Overall Study|Lost to Follow-up|0|||
49056868|NCT01207440|158039683|FG006|Overall Study|Lost to Follow-up|0|||
49056869|NCT01207440|158039677|FG000|Overall Study|Non-compliance with Study Drug|3|||
49056870|NCT01207440|158039678|FG001|Overall Study|Non-compliance with Study Drug|0|||
49056871|NCT01207440|158039679|FG002|Overall Study|Non-compliance with Study Drug|1|||
49056872|NCT01207440|158039680|FG003|Overall Study|Non-compliance with Study Drug|0|||
49056873|NCT01207440|158039681|FG004|Overall Study|Non-compliance with Study Drug|0|||
49056874|NCT01207440|158039682|FG005|Overall Study|Non-compliance with Study Drug|0|||
48902764|NCT03285178|157479287|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
48902765|NCT03285178|157479288|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
48902766|NCT03285178|157479282|FG000|Single-Blind Run-In Period|Protocol Violation|11|||
48902767|NCT03285178|157479283|FG001|Single-Blind Run-In Period|Protocol Violation|0|||
48902768|NCT03285178|157479284|FG002|Single-Blind Run-In Period|Protocol Violation|0|||
48902769|NCT03285178|157479285|FG003|Single-Blind Run-In Period|Protocol Violation|0|||
48902770|NCT03285178|157479286|FG004|Single-Blind Run-In Period|Protocol Violation|0|||
48902771|NCT03285178|157479287|FG005|Single-Blind Run-In Period|Protocol Violation|0|||
48902772|NCT03285178|157479288|FG006|Single-Blind Run-In Period|Protocol Violation|0|||
48902773|NCT03285178|157479282|FG000|Single-Blind Run-In Period|Withdrawal by Subject|1|||
48902774|NCT03285178|157479283|FG001|Single-Blind Run-In Period|Withdrawal by Subject|0|||
48902775|NCT03285178|157479284|FG002|Single-Blind Run-In Period|Withdrawal by Subject|0|||
48902776|NCT03285178|157479285|FG003|Single-Blind Run-In Period|Withdrawal by Subject|0|||
48902777|NCT03285178|157479286|FG004|Single-Blind Run-In Period|Withdrawal by Subject|0|||
48902778|NCT03285178|157479287|FG005|Single-Blind Run-In Period|Withdrawal by Subject|0|||
48902779|NCT03285178|157479288|FG006|Single-Blind Run-In Period|Withdrawal by Subject|0|||
48902780|NCT03285178|157479282|FG000|Single-Blind Run-In Period|Physician Decision|2|||
48902781|NCT03285178|157479283|FG001|Single-Blind Run-In Period|Physician Decision|0|||
48902782|NCT03285178|157479284|FG002|Single-Blind Run-In Period|Physician Decision|0|||
48902783|NCT03285178|157479285|FG003|Single-Blind Run-In Period|Physician Decision|0|||
48902784|NCT03285178|157479286|FG004|Single-Blind Run-In Period|Physician Decision|0|||
48902785|NCT03285178|157479287|FG005|Single-Blind Run-In Period|Physician Decision|0|||
48902786|NCT03285178|157479288|FG006|Single-Blind Run-In Period|Physician Decision|0|||
48902787|NCT03285178|157479282|FG000|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
48902788|NCT03285178|157479283|FG001|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
48902789|NCT03285178|157479284|FG002|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
48902790|NCT03285178|157479285|FG003|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
48902791|NCT03285178|157479286|FG004|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
48902792|NCT03285178|157479287|FG005|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
48902793|NCT03285178|157479288|FG006|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
48902794|NCT03285178|157479282|FG000|Double-Blind Treatment Period|Adverse Event|0|||
48902795|NCT03285178|157479283|FG001|Double-Blind Treatment Period|Adverse Event|0|||
48902796|NCT03285178|157479284|FG002|Double-Blind Treatment Period|Adverse Event|0|||
48902797|NCT03285178|157479285|FG003|Double-Blind Treatment Period|Adverse Event|0|||
48902798|NCT03285178|157479286|FG004|Double-Blind Treatment Period|Adverse Event|0|||
48902799|NCT03285178|157479287|FG005|Double-Blind Treatment Period|Adverse Event|0|||
48902800|NCT03285178|157479288|FG006|Double-Blind Treatment Period|Adverse Event|2|||
48902801|NCT03285178|157479282|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
48902802|NCT03285178|157479283|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
48902803|NCT03285178|157479284|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
48902804|NCT03285178|157479285|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
48902805|NCT03285178|157479286|FG004|Double-Blind Treatment Period|Lost to Follow-up|2|||
48902806|NCT03285178|157479287|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
48902807|NCT03285178|157479288|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
48902808|NCT03285178|157479282|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
48902809|NCT03285178|157479283|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
49056875|NCT01207440|158039683|FG006|Overall Study|Non-compliance with Study Drug|0|||
49056876|NCT01207440|158039677|FG000|Overall Study|Physician Decision|6|||
48902810|NCT03285178|157479284|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
48902811|NCT03285178|157479285|FG003|Double-Blind Treatment Period|Withdrawal by Subject|1|||
48902812|NCT03285178|157479286|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
48902813|NCT03285178|157479287|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
48902814|NCT03285178|157479288|FG006|Double-Blind Treatment Period|Withdrawal by Subject|1|||
48902815|NCT03285178|157479282|FG000|Double-Blind Treatment Period|COVID-19|0|||
48902816|NCT03285178|157479283|FG001|Double-Blind Treatment Period|COVID-19|0|||
48902817|NCT03285178|157479284|FG002|Double-Blind Treatment Period|COVID-19|1|||
48902818|NCT03285178|157479285|FG003|Double-Blind Treatment Period|COVID-19|0|||
48902819|NCT03285178|157479286|FG004|Double-Blind Treatment Period|COVID-19|0|||
48902820|NCT03285178|157479287|FG005|Double-Blind Treatment Period|COVID-19|0|||
48902821|NCT03285178|157479288|FG006|Double-Blind Treatment Period|COVID-19|0|||
48902822|NCT02196714|157479291|FG000|Overall Study|Protocol Violation|0|||
48902823|NCT02196714|157479292|FG001|Overall Study|Protocol Violation|0|||
48902824|NCT02196714|157479293|FG002|Overall Study|Protocol Violation|1|||
48902825|NCT02196714|157479294|FG003|Overall Study|Protocol Violation|0|||
48902826|NCT00705523|157479295|FG000|Overall Study|Lost to Follow-up|2|||
48902827|NCT00705523|157479296|FG001|Overall Study|Lost to Follow-up|3|||
48902828|NCT04217590|157479298|FG000|Overall Study|Other|1|||
48902829|NCT04217590|157479299|FG001|Overall Study|Other|1|||
48902830|NCT04217590|157479298|FG000|Overall Study|Withdrawal by Subject|3|||
48902831|NCT04217590|157479299|FG001|Overall Study|Withdrawal by Subject|1|||
48902832|NCT04217590|157479298|FG000|Overall Study|Death|0|||
48902833|NCT04217590|157479299|FG001|Overall Study|Death|1|||
48902834|NCT01117857|157479300|FG000|Overall Study|Lost to Follow-up|4|||
48902835|NCT01117857|157479300|FG000|Overall Study|Withdrawal by Subject|4|||
48902836|NCT01117857|157479300|FG000|Overall Study|Physician Decision|1|||
48902837|NCT00292461|157479301|FG000|Overall Study|Adverse Event|4|||
48902838|NCT00292461|157479302|FG001|Overall Study|Adverse Event|2|||
48902839|NCT00292461|157479301|FG000|Overall Study|Lack of Efficacy|1|||
48902840|NCT00292461|157479302|FG001|Overall Study|Lack of Efficacy|0|||
48902841|NCT00292461|157479301|FG000|Overall Study|Withdrawal by Subject|0|||
48902842|NCT00292461|157479302|FG001|Overall Study|Withdrawal by Subject|1|||
48902843|NCT00292461|157479301|FG000|Overall Study|Protocol Violation|4|||
48902844|NCT00292461|157479302|FG001|Overall Study|Protocol Violation|3|||
48902845|NCT00292461|157479301|FG000|Overall Study|Lost to Follow-up|1|||
48902846|NCT00292461|157479302|FG001|Overall Study|Lost to Follow-up|0|||
48902847|NCT03406260|157480938|FG000|Period 1|Adverse Event|0|||
48902848|NCT03406260|157480939|FG001|Period 1|Adverse Event|0|||
48902849|NCT03406260|157480940|FG002|Period 1|Adverse Event|0|||
48902850|NCT03406260|157480941|FG003|Period 1|Adverse Event|0|||
48902851|NCT03406260|157480942|FG004|Period 1|Adverse Event|1|||
48902852|NCT03406260|157480943|FG005|Period 1|Adverse Event|0|||
48902853|NCT00881608|157480944|FG000|Overall Study|Study prematurely terminated|11|||
48902854|NCT03575143|157480953|FG000|Overall Study|Lost to Follow-up|0|||
48902855|NCT03575143|157480954|FG001|Overall Study|Lost to Follow-up|0|||
48902856|NCT03575143|157480955|FG002|Overall Study|Lost to Follow-up|4|||
48902857|NCT03575143|157480953|FG000|Overall Study|Withdrawal by Subject|0|||
48902858|NCT03575143|157480954|FG001|Overall Study|Withdrawal by Subject|0|||
48902859|NCT03575143|157480955|FG002|Overall Study|Withdrawal by Subject|5|||
48902860|NCT03575143|157480953|FG000|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
48902861|NCT03575143|157480954|FG001|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
48902862|NCT03575143|157480955|FG002|Overall Study|new information provide after consent, no longer met inclusion criteria|2|||
48902863|NCT00141726|157480958|FG000|Overall Study|Completed <50% Scheduled Dosing|3|||
48902864|NCT00892723|157480963|FG000|Overall Study|Lost to Follow-up|1|||
48902865|NCT00892723|157480964|FG001|Overall Study|Lost to Follow-up|3|||
48902866|NCT00892723|157480965|FG002|Overall Study|Lost to Follow-up|1|||
48902867|NCT00892723|157480963|FG000|Overall Study|Withdrawal by Subject|1|||
48902868|NCT00892723|157480964|FG001|Overall Study|Withdrawal by Subject|1|||
48902869|NCT00892723|157480965|FG002|Overall Study|Withdrawal by Subject|1|||
48902870|NCT00150969|157480968|FG000|24 Month Main Study|Adverse Event|3|||
48902871|NCT00150969|157480969|FG001|24 Month Main Study|Adverse Event|4|||
48902872|NCT00150969|157480968|FG000|24 Month Main Study|Death|1|||
48902873|NCT00150969|157480969|FG001|24 Month Main Study|Death|1|||
48902874|NCT00150969|157480968|FG000|24 Month Main Study|Lack of Efficacy|1|||
48902875|NCT00150969|157480969|FG001|24 Month Main Study|Lack of Efficacy|8|||
48902876|NCT00150969|157480968|FG000|24 Month Main Study|Lost to Follow-up|3|||
48902877|NCT00150969|157480969|FG001|24 Month Main Study|Lost to Follow-up|2|||
48902878|NCT00150969|157480968|FG000|24 Month Main Study|Protocol Violation|4|||
48902879|NCT00150969|157480969|FG001|24 Month Main Study|Protocol Violation|2|||
48902880|NCT00150969|157480968|FG000|24 Month Main Study|Withdrawal by Subject|7|||
48902881|NCT00150969|157480969|FG001|24 Month Main Study|Withdrawal by Subject|4|||
48902882|NCT00150969|157480968|FG000|24-48 Month Extension|Withdrawal by Subject|6|||
48902883|NCT00150969|157480969|FG001|24-48 Month Extension|Withdrawal by Subject|5|||
48902884|NCT00150969|157480968|FG000|24-48 Month Extension|Lack of Efficacy|0|||
48902885|NCT00150969|157480969|FG001|24-48 Month Extension|Lack of Efficacy|1|||
48902886|NCT00150969|157480968|FG000|24-48 Month Extension|Adverse Event|1|||
49056877|NCT01207440|158039678|FG001|Overall Study|Physician Decision|5|||
49056878|NCT01207440|158039679|FG002|Overall Study|Physician Decision|5|||
49056879|NCT01207440|158039680|FG003|Overall Study|Physician Decision|0|||
49056880|NCT01207440|158039681|FG004|Overall Study|Physician Decision|1|||
48902887|NCT00150969|157480969|FG001|24-48 Month Extension|Adverse Event|3|||
48902888|NCT00150969|157480968|FG000|24-48 Month Extension|Other Reason|81|||
48902889|NCT00150969|157480969|FG001|24-48 Month Extension|Other Reason|91|||
48902890|NCT00615836|157480973|FG000|Extension Study (FE992026 CS31)|Adverse Event|7|||
48902891|NCT00615836|157480974|FG001|Extension Study (FE992026 CS31)|Adverse Event|12|||
48902892|NCT00615836|157480975|FG002|Extension Study (FE992026 CS31)|Adverse Event|15|||
48902893|NCT00615836|157480976|FG003|Extension Study (FE992026 CS31)|Adverse Event|13|||
48902894|NCT00615836|157480977|FG004|Extension Study (FE992026 CS31)|Adverse Event|0|||
48902895|NCT00615836|157480973|FG000|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1|||
48902896|NCT00615836|157480974|FG001|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
48902897|NCT00615836|157480975|FG002|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
48902898|NCT00615836|157480976|FG003|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
49056881|NCT01207440|158039682|FG005|Overall Study|Physician Decision|0|||
49056882|NCT01207440|158039683|FG006|Overall Study|Physician Decision|0|||
49056883|NCT01207440|158039677|FG000|Overall Study|Progressive Disease|19|||
49056884|NCT01207440|158039678|FG001|Overall Study|Progressive Disease|10|||
49056885|NCT01207440|158039679|FG002|Overall Study|Progressive Disease|19|||
49056886|NCT01207440|158039680|FG003|Overall Study|Progressive Disease|7|||
48902899|NCT00615836|157480977|FG004|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
48902900|NCT00615836|157480973|FG000|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
48902901|NCT00615836|157480974|FG001|Extension Study (FE992026 CS31)|Use of exclusionary medication|2|||
48902902|NCT00615836|157480975|FG002|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
48902903|NCT00615836|157480976|FG003|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
48902904|NCT00615836|157480977|FG004|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
48902905|NCT00615836|157480973|FG000|Extension Study (FE992026 CS31)|Protocol Violation|4|||
48902906|NCT00615836|157480974|FG001|Extension Study (FE992026 CS31)|Protocol Violation|5|||
48902907|NCT00615836|157480975|FG002|Extension Study (FE992026 CS31)|Protocol Violation|2|||
48902908|NCT00615836|157480976|FG003|Extension Study (FE992026 CS31)|Protocol Violation|3|||
48902909|NCT00615836|157480977|FG004|Extension Study (FE992026 CS31)|Protocol Violation|0|||
48902910|NCT00615836|157480973|FG000|Extension Study (FE992026 CS31)|Withdrawal by Subject|37|||
48902911|NCT00615836|157480974|FG001|Extension Study (FE992026 CS31)|Withdrawal by Subject|42|||
48902912|NCT00615836|157480975|FG002|Extension Study (FE992026 CS31)|Withdrawal by Subject|38|||
48902913|NCT00615836|157480976|FG003|Extension Study (FE992026 CS31)|Withdrawal by Subject|43|||
48902914|NCT00615836|157480977|FG004|Extension Study (FE992026 CS31)|Withdrawal by Subject|0|||
48902915|NCT00615836|157480973|FG000|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
48902916|NCT00615836|157480974|FG001|Extension Study (FE992026 CS31)|Lost to Follow-up|14|||
48902917|NCT00615836|157480975|FG002|Extension Study (FE992026 CS31)|Lost to Follow-up|5|||
48902918|NCT00615836|157480976|FG003|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
48902919|NCT00615836|157480977|FG004|Extension Study (FE992026 CS31)|Lost to Follow-up|0|||
48902920|NCT00615836|157480973|FG000|Extension Study (FE992026 CS31)|Other|10|||
48902921|NCT00615836|157480974|FG001|Extension Study (FE992026 CS31)|Other|7|||
49056887|NCT01207440|158039681|FG004|Overall Study|Progressive Disease|23|||
49056888|NCT01207440|158039682|FG005|Overall Study|Progressive Disease|27|||
49056889|NCT01207440|158039683|FG006|Overall Study|Progressive Disease|0|||
49056890|NCT01207440|158039677|FG000|Overall Study|Protocol Violation|2|||
49056891|NCT01207440|158039678|FG001|Overall Study|Protocol Violation|0|||
49056892|NCT01207440|158039679|FG002|Overall Study|Protocol Violation|0|||
49056893|NCT01207440|158039680|FG003|Overall Study|Protocol Violation|0|||
49056894|NCT01207440|158039681|FG004|Overall Study|Protocol Violation|0|||
49056895|NCT01207440|158039682|FG005|Overall Study|Protocol Violation|0|||
49056896|NCT01207440|158039683|FG006|Overall Study|Protocol Violation|0|||
49056897|NCT01207440|158039677|FG000|Overall Study|Site Terminated by Sponsor|69|||
49056898|NCT01207440|158039678|FG001|Overall Study|Site Terminated by Sponsor|19|||
49056899|NCT01207440|158039679|FG002|Overall Study|Site Terminated by Sponsor|12|||
49056900|NCT01207440|158039680|FG003|Overall Study|Site Terminated by Sponsor|2|||
49056901|NCT01207440|158039681|FG004|Overall Study|Site Terminated by Sponsor|3|||
49056902|NCT01207440|158039682|FG005|Overall Study|Site Terminated by Sponsor|0|||
49056903|NCT01207440|158039683|FG006|Overall Study|Site Terminated by Sponsor|2|||
49056904|NCT01207440|158039677|FG000|Overall Study|Withdrawal by Subject|29|||
49056905|NCT01207440|158039678|FG001|Overall Study|Withdrawal by Subject|4|||
49056906|NCT01207440|158039679|FG002|Overall Study|Withdrawal by Subject|5|||
49056907|NCT01207440|158039680|FG003|Overall Study|Withdrawal by Subject|3|||
48902922|NCT00615836|157480975|FG002|Extension Study (FE992026 CS31)|Other|8|||
48902923|NCT00615836|157480976|FG003|Extension Study (FE992026 CS31)|Other|8|||
48902924|NCT00615836|157480977|FG004|Extension Study (FE992026 CS31)|Other|0|||
49056908|NCT01207440|158039681|FG004|Overall Study|Withdrawal by Subject|2|||
49056909|NCT01207440|158039682|FG005|Overall Study|Withdrawal by Subject|2|||
48902925|NCT00615836|157480973|FG000|Extension Study (FE992026 CS31)|Not reported|6|||
48902926|NCT00615836|157480974|FG001|Extension Study (FE992026 CS31)|Not reported|4|||
48902927|NCT00615836|157480975|FG002|Extension Study (FE992026 CS31)|Not reported|1|||
48902928|NCT00615836|157480976|FG003|Extension Study (FE992026 CS31)|Not reported|4|||
48902929|NCT00615836|157480977|FG004|Extension Study (FE992026 CS31)|Not reported|0|||
48902930|NCT00615836|157480973|FG000|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65|||
48902931|NCT00615836|157480974|FG001|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
48902932|NCT00615836|157480975|FG002|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
48902933|NCT00615836|157480976|FG003|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
48902934|NCT00615836|157480977|FG004|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
48902935|NCT01272804|157480978|FG000|Overall Study|Adverse Event|1|||
48902936|NCT01272804|157480979|FG001|Overall Study|Adverse Event|0|||
48902937|NCT01272804|157480980|FG002|Overall Study|Adverse Event|0|||
48902938|NCT01272804|157480981|FG003|Overall Study|Adverse Event|0|||
48902939|NCT01272804|157480982|FG004|Overall Study|Adverse Event|2|||
48902940|NCT01272804|157480983|FG005|Overall Study|Adverse Event|1|||
48902941|NCT00406653|157480984|FG000|Induction Period|Adverse Event|1|||
48902942|NCT00406653|157480985|FG001|Induction Period|Adverse Event|10|||
48902943|NCT00406653|157480986|FG002|Induction Period|Adverse Event|4|||
48902944|NCT00406653|157480987|FG003|Induction Period|Adverse Event|11|||
48902945|NCT00406653|157480988|FG004|Induction Period|Adverse Event|0|||
48902946|NCT00406653|157480989|FG005|Induction Period|Adverse Event|0|||
48902947|NCT00406653|157480990|FG006|Induction Period|Adverse Event|0|||
48902948|NCT00406653|157480984|FG000|Induction Period|Lack of Efficacy|11|||
48902949|NCT00406653|157480985|FG001|Induction Period|Lack of Efficacy|14|||
48902950|NCT00406653|157480986|FG002|Induction Period|Lack of Efficacy|8|||
48902951|NCT00406653|157480987|FG003|Induction Period|Lack of Efficacy|10|||
48902952|NCT00406653|157480988|FG004|Induction Period|Lack of Efficacy|0|||
48902953|NCT00406653|157480989|FG005|Induction Period|Lack of Efficacy|0|||
48902954|NCT00406653|157480990|FG006|Induction Period|Lack of Efficacy|0|||
48902955|NCT00406653|157480984|FG000|Induction Period|Lost to Follow-up|0|||
48902956|NCT00406653|157480985|FG001|Induction Period|Lost to Follow-up|2|||
48902957|NCT00406653|157480986|FG002|Induction Period|Lost to Follow-up|0|||
48902958|NCT00406653|157480987|FG003|Induction Period|Lost to Follow-up|0|||
48902959|NCT00406653|157480988|FG004|Induction Period|Lost to Follow-up|0|||
48902960|NCT00406653|157480989|FG005|Induction Period|Lost to Follow-up|0|||
48902961|NCT00406653|157480990|FG006|Induction Period|Lost to Follow-up|0|||
48902962|NCT00406653|157480984|FG000|Induction Period|Withdrawal of Consent|2|||
48902963|NCT00406653|157480985|FG001|Induction Period|Withdrawal of Consent|5|||
48902964|NCT00406653|157480986|FG002|Induction Period|Withdrawal of Consent|1|||
48902965|NCT00406653|157480987|FG003|Induction Period|Withdrawal of Consent|2|||
48902966|NCT00406653|157480988|FG004|Induction Period|Withdrawal of Consent|0|||
48902967|NCT00406653|157480989|FG005|Induction Period|Withdrawal of Consent|0|||
48902968|NCT00406653|157480990|FG006|Induction Period|Withdrawal of Consent|0|||
48902969|NCT00406653|157480984|FG000|Induction Period|Subject No Longer Meets Study Criteria|0|||
48902970|NCT00406653|157480985|FG001|Induction Period|Subject No Longer Meets Study Criteria|0|||
48902971|NCT00406653|157480986|FG002|Induction Period|Subject No Longer Meets Study Criteria|0|||
48902972|NCT00406653|157480987|FG003|Induction Period|Subject No Longer Meets Study Criteria|2|||
48902973|NCT00406653|157480988|FG004|Induction Period|Subject No Longer Meets Study Criteria|0|||
48902974|NCT00406653|157480989|FG005|Induction Period|Subject No Longer Meets Study Criteria|0|||
48902975|NCT00406653|157480990|FG006|Induction Period|Subject No Longer Meets Study Criteria|0|||
48902976|NCT00406653|157480984|FG000|Induction Period|Pregnancy|1|||
48902977|NCT00406653|157480985|FG001|Induction Period|Pregnancy|0|||
48902978|NCT00406653|157480986|FG002|Induction Period|Pregnancy|0|||
48902979|NCT00406653|157480987|FG003|Induction Period|Pregnancy|0|||
48902980|NCT00406653|157480988|FG004|Induction Period|Pregnancy|0|||
48902981|NCT00406653|157480989|FG005|Induction Period|Pregnancy|0|||
48902982|NCT00406653|157480990|FG006|Induction Period|Pregnancy|0|||
48902983|NCT00406653|157480984|FG000|Induction Period|Declined participation but followup done|0|||
48902984|NCT00406653|157480985|FG001|Induction Period|Declined participation but followup done|2|||
48902985|NCT00406653|157480986|FG002|Induction Period|Declined participation but followup done|1|||
48902986|NCT00406653|157480987|FG003|Induction Period|Declined participation but followup done|1|||
48902987|NCT00406653|157480988|FG004|Induction Period|Declined participation but followup done|0|||
48902988|NCT00406653|157480989|FG005|Induction Period|Declined participation but followup done|0|||
48902989|NCT00406653|157480990|FG006|Induction Period|Declined participation but followup done|0|||
48902990|NCT00406653|157480984|FG000|Induction Period|Given prohibited drug|0|||
48902991|NCT00406653|157480985|FG001|Induction Period|Given prohibited drug|1|||
48902992|NCT00406653|157480986|FG002|Induction Period|Given prohibited drug|2|||
48902993|NCT00406653|157480987|FG003|Induction Period|Given prohibited drug|0|||
48902994|NCT00406653|157480988|FG004|Induction Period|Given prohibited drug|0|||
48902995|NCT00406653|157480989|FG005|Induction Period|Given prohibited drug|0|||
48902996|NCT00406653|157480990|FG006|Induction Period|Given prohibited drug|0|||
48902997|NCT00406653|157480984|FG000|Induction Period|Incarcerated|0|||
48902998|NCT00406653|157480985|FG001|Induction Period|Incarcerated|0|||
48902999|NCT00406653|157480986|FG002|Induction Period|Incarcerated|1|||
48903000|NCT00406653|157480987|FG003|Induction Period|Incarcerated|0|||
48903001|NCT00406653|157480988|FG004|Induction Period|Incarcerated|0|||
48903002|NCT00406653|157480989|FG005|Induction Period|Incarcerated|0|||
48903003|NCT00406653|157480990|FG006|Induction Period|Incarcerated|0|||
48903004|NCT00406653|157480984|FG000|Induction Period|Patient relocated|0|||
48903005|NCT00406653|157480985|FG001|Induction Period|Patient relocated|0|||
48903006|NCT00406653|157480986|FG002|Induction Period|Patient relocated|1|||
48903007|NCT00406653|157480987|FG003|Induction Period|Patient relocated|0|||
48903008|NCT00406653|157480988|FG004|Induction Period|Patient relocated|0|||
48903009|NCT00406653|157480989|FG005|Induction Period|Patient relocated|0|||
48903010|NCT00406653|157480990|FG006|Induction Period|Patient relocated|0|||
48903011|NCT00406653|157480984|FG000|Maintenance Period|Adverse Event|0|||
48903012|NCT00406653|157480985|FG001|Maintenance Period|Adverse Event|0|||
48903013|NCT00406653|157480986|FG002|Maintenance Period|Adverse Event|0|||
48903014|NCT00406653|157480987|FG003|Maintenance Period|Adverse Event|0|||
48903015|NCT00406653|157480988|FG004|Maintenance Period|Adverse Event|1|||
48903016|NCT00406653|157480989|FG005|Maintenance Period|Adverse Event|1|||
48903017|NCT00406653|157480990|FG006|Maintenance Period|Adverse Event|0|||
48903018|NCT00406653|157480984|FG000|Maintenance Period|Lack of Efficacy|0|||
48903019|NCT00406653|157480985|FG001|Maintenance Period|Lack of Efficacy|0|||
48903020|NCT00406653|157480986|FG002|Maintenance Period|Lack of Efficacy|0|||
48903021|NCT00406653|157480987|FG003|Maintenance Period|Lack of Efficacy|0|||
48903022|NCT00406653|157480988|FG004|Maintenance Period|Lack of Efficacy|20|||
48903023|NCT00406653|157480989|FG005|Maintenance Period|Lack of Efficacy|26|||
48903024|NCT00406653|157480990|FG006|Maintenance Period|Lack of Efficacy|0|||
48903025|NCT00406653|157480984|FG000|Maintenance Period|Lost to Follow-up|0|||
48903026|NCT00406653|157480985|FG001|Maintenance Period|Lost to Follow-up|0|||
48903027|NCT00406653|157480986|FG002|Maintenance Period|Lost to Follow-up|0|||
48903028|NCT00406653|157480987|FG003|Maintenance Period|Lost to Follow-up|0|||
48903029|NCT00406653|157480988|FG004|Maintenance Period|Lost to Follow-up|2|||
48903030|NCT00406653|157480989|FG005|Maintenance Period|Lost to Follow-up|1|||
48903031|NCT00406653|157480990|FG006|Maintenance Period|Lost to Follow-up|0|||
48903032|NCT00406653|157480984|FG000|Maintenance Period|Withdrawal of Consent|0|||
48903033|NCT00406653|157480985|FG001|Maintenance Period|Withdrawal of Consent|0|||
48903034|NCT00406653|157480986|FG002|Maintenance Period|Withdrawal of Consent|0|||
48903035|NCT00406653|157480987|FG003|Maintenance Period|Withdrawal of Consent|0|||
48903036|NCT00406653|157480988|FG004|Maintenance Period|Withdrawal of Consent|2|||
48903037|NCT00406653|157480989|FG005|Maintenance Period|Withdrawal of Consent|0|||
48903038|NCT00406653|157480990|FG006|Maintenance Period|Withdrawal of Consent|0|||
48903039|NCT00406653|157480984|FG000|Maintenance Period|Pregnancy|0|||
48903040|NCT00406653|157480985|FG001|Maintenance Period|Pregnancy|0|||
48903041|NCT00406653|157480986|FG002|Maintenance Period|Pregnancy|0|||
48903042|NCT00406653|157480987|FG003|Maintenance Period|Pregnancy|0|||
48903043|NCT00406653|157480988|FG004|Maintenance Period|Pregnancy|0|||
48903044|NCT00406653|157480989|FG005|Maintenance Period|Pregnancy|1|||
48903045|NCT00406653|157480990|FG006|Maintenance Period|Pregnancy|0|||
48903046|NCT00406653|157480984|FG000|Maintenance Period|Administrative Reason By Sponsor|0|||
48903047|NCT00406653|157480985|FG001|Maintenance Period|Administrative Reason By Sponsor|0|||
48903048|NCT00406653|157480986|FG002|Maintenance Period|Administrative Reason By Sponsor|0|||
48903049|NCT00406653|157480987|FG003|Maintenance Period|Administrative Reason By Sponsor|0|||
48903050|NCT00406653|157480988|FG004|Maintenance Period|Administrative Reason By Sponsor|4|||
48903051|NCT00406653|157480989|FG005|Maintenance Period|Administrative Reason By Sponsor|7|||
48903052|NCT00406653|157480990|FG006|Maintenance Period|Administrative Reason By Sponsor|0|||
48903053|NCT00406653|157480984|FG000|Maintenance Period|Error in disease score evaluation|0|||
48903054|NCT00406653|157480985|FG001|Maintenance Period|Error in disease score evaluation|0|||
48903055|NCT00406653|157480986|FG002|Maintenance Period|Error in disease score evaluation|0|||
48903056|NCT00406653|157480987|FG003|Maintenance Period|Error in disease score evaluation|0|||
48903057|NCT00406653|157480988|FG004|Maintenance Period|Error in disease score evaluation|1|||
48903058|NCT00406653|157480989|FG005|Maintenance Period|Error in disease score evaluation|0|||
48903059|NCT00406653|157480990|FG006|Maintenance Period|Error in disease score evaluation|0|||
48903060|NCT00406653|157480984|FG000|Open-Label Period|Death|0|||
48903061|NCT00406653|157480985|FG001|Open-Label Period|Death|0|||
48903062|NCT00406653|157480986|FG002|Open-Label Period|Death|0|||
48903063|NCT00406653|157480987|FG003|Open-Label Period|Death|0|||
48903064|NCT00406653|157480988|FG004|Open-Label Period|Death|0|||
48903065|NCT00406653|157480989|FG005|Open-Label Period|Death|0|||
48903066|NCT00406653|157480990|FG006|Open-Label Period|Death|1|||
48903067|NCT00406653|157480984|FG000|Open-Label Period|Adverse Event|0|||
48903068|NCT00406653|157480985|FG001|Open-Label Period|Adverse Event|0|||
48903069|NCT00406653|157480986|FG002|Open-Label Period|Adverse Event|0|||
48903070|NCT00406653|157480987|FG003|Open-Label Period|Adverse Event|0|||
48903071|NCT00406653|157480988|FG004|Open-Label Period|Adverse Event|0|||
48903072|NCT00406653|157480989|FG005|Open-Label Period|Adverse Event|0|||
48903073|NCT00406653|157480990|FG006|Open-Label Period|Adverse Event|18|||
48903074|NCT00406653|157480984|FG000|Open-Label Period|Lack of Efficacy|0|||
48903075|NCT00406653|157480985|FG001|Open-Label Period|Lack of Efficacy|0|||
48903076|NCT00406653|157480986|FG002|Open-Label Period|Lack of Efficacy|0|||
48903077|NCT00406653|157480987|FG003|Open-Label Period|Lack of Efficacy|0|||
48903078|NCT00406653|157480988|FG004|Open-Label Period|Lack of Efficacy|0|||
48903079|NCT00406653|157480989|FG005|Open-Label Period|Lack of Efficacy|0|||
48903080|NCT00406653|157480990|FG006|Open-Label Period|Lack of Efficacy|160|||
48903081|NCT00406653|157480984|FG000|Open-Label Period|Lost to Follow-up|0|||
48903082|NCT00406653|157480985|FG001|Open-Label Period|Lost to Follow-up|0|||
48903083|NCT00406653|157480986|FG002|Open-Label Period|Lost to Follow-up|0|||
48903084|NCT00406653|157480987|FG003|Open-Label Period|Lost to Follow-up|0|||
48903085|NCT00406653|157480988|FG004|Open-Label Period|Lost to Follow-up|0|||
48903086|NCT00406653|157480989|FG005|Open-Label Period|Lost to Follow-up|0|||
48903087|NCT00406653|157480990|FG006|Open-Label Period|Lost to Follow-up|6|||
48903088|NCT00406653|157480984|FG000|Open-Label Period|Withdrawal of Consent|0|||
48903089|NCT00406653|157480985|FG001|Open-Label Period|Withdrawal of Consent|0|||
48903090|NCT00406653|157480986|FG002|Open-Label Period|Withdrawal of Consent|0|||
48903091|NCT00406653|157480987|FG003|Open-Label Period|Withdrawal of Consent|0|||
48903092|NCT00406653|157480988|FG004|Open-Label Period|Withdrawal of Consent|0|||
48903093|NCT00406653|157480989|FG005|Open-Label Period|Withdrawal of Consent|0|||
48903094|NCT00406653|157480990|FG006|Open-Label Period|Withdrawal of Consent|11|||
48903095|NCT00406653|157480984|FG000|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
48903096|NCT00406653|157480985|FG001|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
48903097|NCT00406653|157480986|FG002|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
48903098|NCT00406653|157480987|FG003|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
48903099|NCT00406653|157480988|FG004|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
48903100|NCT00406653|157480989|FG005|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
48903101|NCT00406653|157480990|FG006|Open-Label Period|Subject No Longer Meets Study Criteria|1|||
48903102|NCT00406653|157480984|FG000|Open-Label Period|Pregnancy|0|||
48903103|NCT00406653|157480985|FG001|Open-Label Period|Pregnancy|0|||
48903104|NCT00406653|157480986|FG002|Open-Label Period|Pregnancy|0|||
48903105|NCT00406653|157480987|FG003|Open-Label Period|Pregnancy|0|||
48903106|NCT00406653|157480988|FG004|Open-Label Period|Pregnancy|0|||
48903107|NCT00406653|157480989|FG005|Open-Label Period|Pregnancy|0|||
48903108|NCT00406653|157480990|FG006|Open-Label Period|Pregnancy|2|||
48903109|NCT00406653|157480984|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
48903110|NCT00406653|157480985|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
48903111|NCT00406653|157480986|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
48903112|NCT00406653|157480987|FG003|Open-Label Period|Administrative Reason By Sponsor|0|||
48903113|NCT00406653|157480988|FG004|Open-Label Period|Administrative Reason By Sponsor|0|||
48903114|NCT00406653|157480989|FG005|Open-Label Period|Administrative Reason By Sponsor|0|||
48903115|NCT00406653|157480990|FG006|Open-Label Period|Administrative Reason By Sponsor|115|||
48903116|NCT00406653|157480984|FG000|Open-Label Period|Declined participation but followup done|0|||
48903117|NCT00406653|157480985|FG001|Open-Label Period|Declined participation but followup done|0|||
48903118|NCT00406653|157480986|FG002|Open-Label Period|Declined participation but followup done|0|||
48903119|NCT00406653|157480987|FG003|Open-Label Period|Declined participation but followup done|0|||
48903120|NCT00406653|157480988|FG004|Open-Label Period|Declined participation but followup done|0|||
48903121|NCT00406653|157480989|FG005|Open-Label Period|Declined participation but followup done|0|||
48903122|NCT00406653|157480990|FG006|Open-Label Period|Declined participation but followup done|8|||
48903123|NCT00406653|157480984|FG000|Open-Label Period|Discontinued by Sponsor|0|||
48903124|NCT00406653|157480985|FG001|Open-Label Period|Discontinued by Sponsor|0|||
48903125|NCT00406653|157480986|FG002|Open-Label Period|Discontinued by Sponsor|0|||
48903126|NCT00406653|157480987|FG003|Open-Label Period|Discontinued by Sponsor|0|||
48903127|NCT00406653|157480988|FG004|Open-Label Period|Discontinued by Sponsor|0|||
48903128|NCT00406653|157480989|FG005|Open-Label Period|Discontinued by Sponsor|0|||
48903129|NCT00406653|157480990|FG006|Open-Label Period|Discontinued by Sponsor|1|||
48903130|NCT00406653|157480984|FG000|Open-Label Period|Refused followup|0|||
48903131|NCT00406653|157480985|FG001|Open-Label Period|Refused followup|0|||
48903132|NCT00406653|157480986|FG002|Open-Label Period|Refused followup|0|||
48903133|NCT00406653|157480987|FG003|Open-Label Period|Refused followup|0|||
48903134|NCT00406653|157480988|FG004|Open-Label Period|Refused followup|0|||
48903135|NCT00406653|157480989|FG005|Open-Label Period|Refused followup|0|||
48903136|NCT00406653|157480990|FG006|Open-Label Period|Refused followup|1|||
48903137|NCT01592864|157480999|FG000|Overall Study|Withdrawal by Subject|0|||
48903138|NCT01592864|157481000|FG001|Overall Study|Withdrawal by Subject|1|||
48903139|NCT01020448|157481006|FG000|Pre-assignment|Adverse Event|6|||
48903140|NCT01020448|157481006|FG000|Pre-assignment|Withdrawal by Subject|5|||
48903141|NCT01020448|157481006|FG000|Pre-assignment|Does Not Meet Entry Criteria|2|||
48903142|NCT01020448|157481006|FG000|Treatment|Adverse Event|11|||
48903143|NCT01020448|157481006|FG000|Treatment|Consent Withdrawn|3|||
48903144|NCT01020448|157481006|FG000|Treatment|Disease Progression|2|||
48903145|NCT01020448|157481006|FG000|Treatment|Lack of Efficacy|8|||
48903146|NCT01020448|157481006|FG000|Treatment|Lost to Follow-up|2|||
48903147|NCT03294109|157481007|FG000|Overall Study|Withdrawal by Subject|6|||
48903148|NCT03294109|157481008|FG001|Overall Study|Withdrawal by Subject|5|||
48903149|NCT01881750|157481009|FG000|Overall Study|Changes in concomitant therapies|2|||
48903150|NCT01881750|157481010|FG001|Overall Study|Changes in concomitant therapies|3|||
48903151|NCT01881750|157481009|FG000|Overall Study|Lost to Follow-up|0|||
48903152|NCT01881750|157481010|FG001|Overall Study|Lost to Follow-up|1|||
48903153|NCT01505010|157481013|FG000|Overall Study|Protocol Violation|0|||
48903154|NCT01505010|157481014|FG001|Overall Study|Protocol Violation|1|||
48903155|NCT01505010|157481013|FG000|Overall Study|Lost to Follow-up|0|||
48903156|NCT01505010|157481014|FG001|Overall Study|Lost to Follow-up|1|||
48903157|NCT01106404|157481018|FG000|Period I (First 6 Weeks)|Adverse Event|2|||
48903158|NCT01106404|157481019|FG001|Period I (First 6 Weeks)|Adverse Event|0|||
48903159|NCT01106404|157481018|FG000|Period I (First 6 Weeks)|Physician Decision|1|||
48903160|NCT01106404|157481019|FG001|Period I (First 6 Weeks)|Physician Decision|0|||
48903161|NCT01106404|157481018|FG000|Period I (First 6 Weeks)|Lost to Follow-up|0|||
48903162|NCT01106404|157481019|FG001|Period I (First 6 Weeks)|Lost to Follow-up|1|||
48903163|NCT01106404|157481018|FG000|Period I (First 6 Weeks)|Lack of Efficacy|0|||
48903164|NCT01106404|157481019|FG001|Period I (First 6 Weeks)|Lack of Efficacy|1|||
48903165|NCT00388154|157481022|FG000|Overall Study|Withdrawal by Subject|1|||
48903166|NCT02240693|157481023|FG000|Overall Study|Adverse Event|0|||
48903167|NCT02240693|157481024|FG001|Overall Study|Adverse Event|0|||
48903168|NCT02240693|157481025|FG002|Overall Study|Adverse Event|0|||
48903169|NCT02240693|157481026|FG003|Overall Study|Adverse Event|0|||
48903170|NCT02240693|157481027|FG004|Overall Study|Adverse Event|1|||
48903171|NCT02240693|157481023|FG000|Overall Study|Withdrawal by Subject|0|||
48903172|NCT02240693|157481024|FG001|Overall Study|Withdrawal by Subject|0|||
48903173|NCT02240693|157481025|FG002|Overall Study|Withdrawal by Subject|2|||
48903174|NCT02240693|157481026|FG003|Overall Study|Withdrawal by Subject|1|||
48903175|NCT02240693|157481027|FG004|Overall Study|Withdrawal by Subject|0|||
48903176|NCT02240693|157481023|FG000|Overall Study|Other than specified|0|||
48903177|NCT02240693|157481024|FG001|Overall Study|Other than specified|0|||
48903178|NCT02240693|157481025|FG002|Overall Study|Other than specified|2|||
48903179|NCT02240693|157481026|FG003|Overall Study|Other than specified|0|||
48903180|NCT02240693|157481027|FG004|Overall Study|Other than specified|0|||
48903181|NCT02092220|157481030|FG000|Period 1|Unrelated Illness|0|||
48903182|NCT02092220|157481031|FG001|Period 1|Unrelated Illness|2|||
48903183|NCT02092220|157481030|FG000|Period 2|Severe Hypoglycaemia|1|||
48903184|NCT02092220|157481031|FG001|Period 2|Severe Hypoglycaemia|0|||
48903185|NCT02092220|157481030|FG000|Period 2|Nausea, Anxiety, Inconvenience|0|||
48903186|NCT02092220|157481031|FG001|Period 2|Nausea, Anxiety, Inconvenience|1|||
48903187|NCT03240874|157481032|FG000|Overall Study|Lost to Follow-up|0|||
48903188|NCT03240874|157481033|FG001|Overall Study|Lost to Follow-up|2|||
48903189|NCT03240874|157481034|FG002|Overall Study|Lost to Follow-up|4|||
48903190|NCT03240874|157481035|FG003|Overall Study|Lost to Follow-up|1|||
48903191|NCT02973048|157481036|FG000|Overall Study|Epidural catheter insertion failure|1|||
48903192|NCT02973048|157481037|FG001|Overall Study|Epidural catheter insertion failure|0|||
48903193|NCT02973048|157481036|FG000|Overall Study|Withdrawal by Subject|0|||
48903194|NCT02973048|157481037|FG001|Overall Study|Withdrawal by Subject|3|||
48903195|NCT00332189|157481038|FG000|Overall Study|Adverse Event|3|||
48903196|NCT00332189|157481038|FG000|Overall Study|Uncooperative/Noncompliant|3|||
48903197|NCT00332189|157481038|FG000|Overall Study|Withdrawal by Subject|9|||
48903198|NCT00332189|157481038|FG000|Overall Study|Lack of Efficacy|4|||
48903199|NCT00332189|157481038|FG000|Overall Study|Moved out of country|2|||
48903200|NCT02370043|157481039|FG000|Overall Study|Withdrawal by Subject|0|||
48903201|NCT02370043|157481040|FG001|Overall Study|Withdrawal by Subject|0|||
48903202|NCT02370043|157481041|FG002|Overall Study|Withdrawal by Subject|0|||
48903203|NCT02370043|157481042|FG003|Overall Study|Withdrawal by Subject|0|||
48903204|NCT02370043|157481043|FG004|Overall Study|Withdrawal by Subject|1|||
48903205|NCT02370043|157481044|FG005|Overall Study|Withdrawal by Subject|1|||
48903206|NCT01313650|157481046|FG000|Overall Study|Adverse Event|9|||
48903207|NCT01313650|157481047|FG001|Overall Study|Adverse Event|34|||
48903208|NCT01313650|157481048|FG002|Overall Study|Adverse Event|24|||
48903209|NCT01313650|157481049|FG003|Overall Study|Adverse Event|23|||
48903210|NCT01313650|157481046|FG000|Overall Study|Lack of Efficacy|37|||
48903211|NCT01313650|157481047|FG001|Overall Study|Lack of Efficacy|20|||
48903212|NCT01313650|157481048|FG002|Overall Study|Lack of Efficacy|32|||
48903213|NCT01313650|157481049|FG003|Overall Study|Lack of Efficacy|20|||
48903214|NCT01313650|157481046|FG000|Overall Study|Lost to Follow-up|1|||
48903215|NCT01313650|157481047|FG001|Overall Study|Lost to Follow-up|0|||
48903216|NCT01313650|157481048|FG002|Overall Study|Lost to Follow-up|3|||
48903217|NCT01313650|157481049|FG003|Overall Study|Lost to Follow-up|2|||
48903218|NCT01313650|157481046|FG000|Overall Study|Withdrawal by Subject|16|||
48903219|NCT01313650|157481047|FG001|Overall Study|Withdrawal by Subject|20|||
48903220|NCT01313650|157481048|FG002|Overall Study|Withdrawal by Subject|15|||
48903221|NCT01313650|157481049|FG003|Overall Study|Withdrawal by Subject|15|||
48903222|NCT01313650|157481046|FG000|Overall Study|Protocol Violation|4|||
48903223|NCT01313650|157481047|FG001|Overall Study|Protocol Violation|7|||
48903224|NCT01313650|157481048|FG002|Overall Study|Protocol Violation|5|||
48903225|NCT01313650|157481049|FG003|Overall Study|Protocol Violation|6|||
48903226|NCT01313650|157481046|FG000|Overall Study|Met Protocol-defined Stopping Criteria|9|||
48903227|NCT01313650|157481047|FG001|Overall Study|Met Protocol-defined Stopping Criteria|13|||
48903228|NCT01313650|157481048|FG002|Overall Study|Met Protocol-defined Stopping Criteria|24|||
48903229|NCT01313650|157481049|FG003|Overall Study|Met Protocol-defined Stopping Criteria|15|||
48903230|NCT04427501|157481050|FG000|Overall Study|Death|0|||
48903231|NCT04427501|157481051|FG001|Overall Study|Death|0|||
48903232|NCT04427501|157481052|FG002|Overall Study|Death|0|||
48903233|NCT04427501|157481053|FG003|Overall Study|Death|0|||
48903234|NCT04427501|157481054|FG004|Overall Study|Death|0|||
48903235|NCT04427501|157481055|FG005|Overall Study|Death|15|||
48903236|NCT04427501|157481056|FG006|Overall Study|Death|0|||
48903237|NCT04427501|157481057|FG007|Overall Study|Death|0|||
48903238|NCT04427501|157481058|FG008|Overall Study|Death|0|||
48903239|NCT04427501|157481059|FG009|Overall Study|Death|0|||
48903240|NCT04427501|157481060|FG010|Overall Study|Death|0|||
48903241|NCT04427501|157481061|FG011|Overall Study|Death|0|||
48903242|NCT04427501|157481050|FG000|Overall Study|Lost to Follow-up|5|||
48903243|NCT04427501|157481051|FG001|Overall Study|Lost to Follow-up|1|||
48903244|NCT04427501|157481052|FG002|Overall Study|Lost to Follow-up|2|||
48903245|NCT04427501|157481053|FG003|Overall Study|Lost to Follow-up|0|||
48903246|NCT04427501|157481054|FG004|Overall Study|Lost to Follow-up|2|||
48903247|NCT04427501|157481055|FG005|Overall Study|Lost to Follow-up|11|||
48903248|NCT04427501|157481056|FG006|Overall Study|Lost to Follow-up|10|||
48903249|NCT04427501|157481057|FG007|Overall Study|Lost to Follow-up|10|||
48903250|NCT04427501|157481058|FG008|Overall Study|Lost to Follow-up|2|||
48903251|NCT04427501|157481059|FG009|Overall Study|Lost to Follow-up|5|||
48903252|NCT04427501|157481060|FG010|Overall Study|Lost to Follow-up|2|||
48903253|NCT04427501|157481061|FG011|Overall Study|Lost to Follow-up|0|||
48903254|NCT04427501|157481050|FG000|Overall Study|Physician Decision|0|||
48903255|NCT04427501|157481051|FG001|Overall Study|Physician Decision|3|||
48903256|NCT04427501|157481052|FG002|Overall Study|Physician Decision|0|||
48903257|NCT04427501|157481053|FG003|Overall Study|Physician Decision|0|||
48903258|NCT04427501|157481054|FG004|Overall Study|Physician Decision|0|||
48903259|NCT04427501|157481055|FG005|Overall Study|Physician Decision|0|||
48903260|NCT04427501|157481056|FG006|Overall Study|Physician Decision|2|||
48903261|NCT04427501|157481057|FG007|Overall Study|Physician Decision|0|||
48903262|NCT04427501|157481058|FG008|Overall Study|Physician Decision|0|||
48903263|NCT04427501|157481059|FG009|Overall Study|Physician Decision|0|||
48903264|NCT04427501|157481060|FG010|Overall Study|Physician Decision|0|||
48903265|NCT04427501|157481061|FG011|Overall Study|Physician Decision|0|||
48903266|NCT04427501|157481050|FG000|Overall Study|Withdrawal by Subject|9|||
48903267|NCT04427501|157481051|FG001|Overall Study|Withdrawal by Subject|2|||
48903268|NCT04427501|157481052|FG002|Overall Study|Withdrawal by Subject|2|||
48903269|NCT04427501|157481053|FG003|Overall Study|Withdrawal by Subject|3|||
48903270|NCT04427501|157481054|FG004|Overall Study|Withdrawal by Subject|7|||
48903271|NCT04427501|157481055|FG005|Overall Study|Withdrawal by Subject|25|||
48903272|NCT04427501|157481056|FG006|Overall Study|Withdrawal by Subject|15|||
48903273|NCT04427501|157481057|FG007|Overall Study|Withdrawal by Subject|7|||
48903274|NCT04427501|157481058|FG008|Overall Study|Withdrawal by Subject|4|||
48903275|NCT04427501|157481059|FG009|Overall Study|Withdrawal by Subject|1|||
48903276|NCT04427501|157481060|FG010|Overall Study|Withdrawal by Subject|4|||
48903277|NCT04427501|157481061|FG011|Overall Study|Withdrawal by Subject|0|||
48903278|NCT04427501|157481050|FG000|Overall Study|Other - as reported by the investigator|1|||
48903279|NCT04427501|157481051|FG001|Overall Study|Other - as reported by the investigator|0|||
48903280|NCT04427501|157481052|FG002|Overall Study|Other - as reported by the investigator|0|||
48903281|NCT04427501|157481053|FG003|Overall Study|Other - as reported by the investigator|0|||
48903282|NCT04427501|157481054|FG004|Overall Study|Other - as reported by the investigator|0|||
48903283|NCT04427501|157481055|FG005|Overall Study|Other - as reported by the investigator|6|||
48903284|NCT04427501|157481056|FG006|Overall Study|Other - as reported by the investigator|6|||
48903285|NCT04427501|157481057|FG007|Overall Study|Other - as reported by the investigator|0|||
48903286|NCT04427501|157481058|FG008|Overall Study|Other - as reported by the investigator|0|||
48903287|NCT04427501|157481059|FG009|Overall Study|Other - as reported by the investigator|0|||
48903288|NCT04427501|157481060|FG010|Overall Study|Other - as reported by the investigator|0|||
48903289|NCT04427501|157481061|FG011|Overall Study|Other - as reported by the investigator|0|||
48903290|NCT04427501|157481050|FG000|Overall Study|Other|0|||
48903291|NCT04427501|157481051|FG001|Overall Study|Other|0|||
48903292|NCT04427501|157481052|FG002|Overall Study|Other|0|||
48903293|NCT04427501|157481053|FG003|Overall Study|Other|0|||
48903294|NCT04427501|157481054|FG004|Overall Study|Other|0|||
48903295|NCT04427501|157481055|FG005|Overall Study|Other|0|||
48903296|NCT04427501|157481056|FG006|Overall Study|Other|0|||
48903297|NCT04427501|157481057|FG007|Overall Study|Other|0|||
48903298|NCT04427501|157481058|FG008|Overall Study|Other|0|||
48903299|NCT04427501|157481059|FG009|Overall Study|Other|0|||
48903300|NCT04427501|157481060|FG010|Overall Study|Other|0|||
48903301|NCT04427501|157481061|FG011|Overall Study|Other|1|||
48903302|NCT00026208|157481062|FG000|Overall Study|Complications of auto accident|1|||
48903303|NCT00026208|157481063|FG001|Overall Study|Complications of auto accident|0|||
48903304|NCT03346057|157481064|FG000|Overall Study|Death|1|||
48903305|NCT03346057|157481065|FG001|Overall Study|Death|2|||
48903306|NCT03346057|157481066|FG002|Overall Study|Death|0|||
48903307|NCT03346057|157481067|FG003|Overall Study|Death|0|||
48903308|NCT03346057|157481064|FG000|Overall Study|Lost to Follow-up|0|||
48903309|NCT03346057|157481065|FG001|Overall Study|Lost to Follow-up|2|||
48903310|NCT03346057|157481066|FG002|Overall Study|Lost to Follow-up|1|||
48903311|NCT03346057|157481067|FG003|Overall Study|Lost to Follow-up|0|||
48903312|NCT03346057|157481064|FG000|Overall Study|Ineligible For Study - Not Treated|0|||
48903313|NCT03346057|157481065|FG001|Overall Study|Ineligible For Study - Not Treated|1|||
48903314|NCT03346057|157481066|FG002|Overall Study|Ineligible For Study - Not Treated|0|||
48903315|NCT03346057|157481067|FG003|Overall Study|Ineligible For Study - Not Treated|0|||
48903316|NCT03346057|157481064|FG000|Overall Study|Renal Insufficiency - Not Treated|1|||
48903317|NCT03346057|157481065|FG001|Overall Study|Renal Insufficiency - Not Treated|0|||
48903318|NCT03346057|157481066|FG002|Overall Study|Renal Insufficiency - Not Treated|0|||
48903319|NCT03346057|157481067|FG003|Overall Study|Renal Insufficiency - Not Treated|0|||
48903320|NCT03346057|157481064|FG000|Overall Study|Physician Decision|3|||
48903321|NCT03346057|157481065|FG001|Overall Study|Physician Decision|2|||
48903322|NCT03346057|157481066|FG002|Overall Study|Physician Decision|0|||
48903323|NCT03346057|157481067|FG003|Overall Study|Physician Decision|2|||
48903324|NCT03346057|157481064|FG000|Overall Study|Randomization Mistake - Not Treated|1|||
48903325|NCT03346057|157481065|FG001|Overall Study|Randomization Mistake - Not Treated|1|||
48903326|NCT03346057|157481066|FG002|Overall Study|Randomization Mistake - Not Treated|0|||
48903327|NCT03346057|157481067|FG003|Overall Study|Randomization Mistake - Not Treated|0|||
48903328|NCT03346057|157481064|FG000|Overall Study|Withdrawal by Subject|1|||
48903329|NCT03346057|157481065|FG001|Overall Study|Withdrawal by Subject|0|||
48903330|NCT03346057|157481066|FG002|Overall Study|Withdrawal by Subject|0|||
48903331|NCT03346057|157481067|FG003|Overall Study|Withdrawal by Subject|0|||
48903332|NCT03739437|157481070|FG000|Overall Study|Lost to Follow-up|2|||
48903333|NCT03739437|157481071|FG001|Overall Study|Lost to Follow-up|5|||
48903334|NCT01163721|157481072|FG000|Overall Study|Adverse Event|5|||
48903335|NCT01163721|157481073|FG001|Overall Study|Adverse Event|6|||
48903336|NCT01163721|157481072|FG000|Overall Study|Withdrawal by Subject|3|||
48903337|NCT01163721|157481073|FG001|Overall Study|Withdrawal by Subject|4|||
48903338|NCT01163721|157481072|FG000|Overall Study|Lost to Follow-up|0|||
48903339|NCT01163721|157481073|FG001|Overall Study|Lost to Follow-up|1|||
48903340|NCT01163721|157481072|FG000|Overall Study|Physician Decision|0|||
48903341|NCT01163721|157481073|FG001|Overall Study|Physician Decision|1|||
48903342|NCT00364156|157481074|FG000|Overall Study|Withdrawal by Subject|73|||
48903343|NCT00364156|157481075|FG001|Overall Study|Withdrawal by Subject|80|||
48903344|NCT00364156|157481074|FG000|Overall Study|Protocol Violation|6|||
48903345|NCT00364156|157481075|FG001|Overall Study|Protocol Violation|1|||
48903346|NCT01210118|157481078|FG000|Overall Study|Lost to Follow-up|1|||
48903347|NCT01210118|157481079|FG001|Overall Study|Lost to Follow-up|1|||
48903348|NCT01210118|157481078|FG000|Overall Study|Protocol Violation|1|||
48903349|NCT01210118|157481079|FG001|Overall Study|Protocol Violation|1|||
48903350|NCT01210118|157481078|FG000|Overall Study|Spontaneous abortion|1|||
48903351|NCT01210118|157481079|FG001|Overall Study|Spontaneous abortion|3|||
48903352|NCT00835120|157481082|FG000|Overall Study|Lack of Efficacy|1|||
48903353|NCT00835120|157481082|FG000|Overall Study|Lost to Follow-up|3|||
48903354|NCT00835120|157481082|FG000|Overall Study|Adverse Event|2|||
48903355|NCT00835120|157481082|FG000|Overall Study|Withdrawal by Subject|2|||
48903356|NCT00232141|157481089|FG000|Overall Study|Adverse Event|9|||
48903357|NCT00232141|157481090|FG001|Overall Study|Adverse Event|4|||
48903358|NCT00232141|157481089|FG000|Overall Study|Lack of Efficacy|0|||
48903359|NCT00232141|157481090|FG001|Overall Study|Lack of Efficacy|3|||
48903360|NCT00232141|157481089|FG000|Overall Study|Lost to Follow-up|9|||
48903361|NCT00232141|157481090|FG001|Overall Study|Lost to Follow-up|6|||
48903362|NCT00232141|157481089|FG000|Overall Study|Other|8|||
48903363|NCT00232141|157481090|FG001|Overall Study|Other|10|||
48903364|NCT00232141|157481089|FG000|Overall Study|Withdrawal by Subject|5|||
48903365|NCT00232141|157481090|FG001|Overall Study|Withdrawal by Subject|3|||
49005535|NCT03496207|157857777|FG000|Extension Period|Elevated hemoglobin levels|0|||
49005536|NCT03496207|157857778|FG001|Extension Period|Elevated hemoglobin levels|0|||
49005537|NCT03496207|157857779|FG002|Extension Period|Elevated hemoglobin levels|0|||
49005538|NCT03496207|157857780|FG003|Extension Period|Elevated hemoglobin levels|0|||
49005539|NCT03496207|157857781|FG004|Extension Period|Elevated hemoglobin levels|1|||
49005540|NCT01169987|157857782|FG000|Overall Study|Withdrawal by Subject|3|||
49005541|NCT01169987|157857782|FG000|Overall Study|Lost to Follow-up|24|||
49005542|NCT01169987|157857782|FG000|Overall Study|Other|4|||
49005543|NCT00943384|157857783|FG000|Overall Study|Dispositioned prior to treatment|23|||
49056910|NCT01207440|158039683|FG006|Overall Study|Withdrawal by Subject|0|||
49056911|NCT01207440|158039677|FG000|Overall Study|Reason Not Specified|10|||
49056912|NCT01207440|158039678|FG001|Overall Study|Reason Not Specified|10|||
49056913|NCT01207440|158039679|FG002|Overall Study|Reason Not Specified|7|||
49056914|NCT01207440|158039680|FG003|Overall Study|Reason Not Specified|0|||
49056915|NCT01207440|158039681|FG004|Overall Study|Reason Not Specified|4|||
49056916|NCT01207440|158039682|FG005|Overall Study|Reason Not Specified|3|||
49056917|NCT01207440|158039683|FG006|Overall Study|Reason Not Specified|0|||
49056918|NCT02698865|158039684|FG000|Overall Study|Other|11|||
49056919|NCT02698865|158039685|FG001|Overall Study|Other|11|||
49056920|NCT02698865|158039684|FG000|Overall Study|Withdrawal by Subject|20|||
49056921|NCT02698865|158039685|FG001|Overall Study|Withdrawal by Subject|16|||
49056922|NCT02698865|158039684|FG000|Overall Study|Physician Decision|0|||
49056923|NCT02698865|158039685|FG001|Overall Study|Physician Decision|4|||
49056924|NCT02698865|158039684|FG000|Overall Study|Lost to Follow-up|4|||
49056925|NCT02698865|158039685|FG001|Overall Study|Lost to Follow-up|2|||
49056926|NCT00418522|158039688|FG000|Overall Study|Adverse Event|7|||
49056927|NCT00418522|158039689|FG001|Overall Study|Adverse Event|1|||
49056928|NCT00418522|158039688|FG000|Overall Study|Lack of Efficacy|1|||
49056929|NCT00418522|158039689|FG001|Overall Study|Lack of Efficacy|3|||
49056930|NCT00418522|158039688|FG000|Overall Study|Lost to Follow-up|10|||
49056931|NCT00418522|158039689|FG001|Overall Study|Lost to Follow-up|4|||
49056932|NCT00418522|158039688|FG000|Overall Study|Withdrawal by Subject|31|||
49056933|NCT00418522|158039689|FG001|Overall Study|Withdrawal by Subject|7|||
49056934|NCT00418522|158039688|FG000|Overall Study|Other|27|||
49056935|NCT00418522|158039689|FG001|Overall Study|Other|23|||
49056936|NCT00418522|158039688|FG000|Overall Study|Randomized but did not receive treatment|7|||
49056937|NCT00418522|158039689|FG001|Overall Study|Randomized but did not receive treatment|4|||
49056938|NCT02695719|158039690|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
49056939|NCT02695719|158039691|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
49056940|NCT02695719|158039690|FG000|Overall Study|Significant Protocol Deviation|0|||
49056941|NCT02695719|158039691|FG001|Overall Study|Significant Protocol Deviation|1|||
49056942|NCT02695719|158039690|FG000|Overall Study|Voluntary Withdrawal|1|||
49056943|NCT02695719|158039691|FG001|Overall Study|Voluntary Withdrawal|0|||
49056944|NCT02148913|158039692|FG000|Overall Study|Death|0|||
49056945|NCT02148913|158039693|FG001|Overall Study|Death|1|||
49056946|NCT02148913|158039694|FG002|Overall Study|Death|0|||
49056947|NCT02148913|158039695|FG003|Overall Study|Death|0|||
49056948|NCT01652729|158039699|FG000|Overall Study|Withdrawal by Subject|14|||
49056949|NCT01652729|158039700|FG001|Overall Study|Withdrawal by Subject|7|||
49056950|NCT01652729|158039701|FG002|Overall Study|Withdrawal by Subject|7|||
49056951|NCT01652729|158039699|FG000|Overall Study|Adverse Event|4|||
49056952|NCT01652729|158039700|FG001|Overall Study|Adverse Event|0|||
49056953|NCT01652729|158039701|FG002|Overall Study|Adverse Event|3|||
49056954|NCT01652729|158039699|FG000|Overall Study|Physician Decision|1|||
49056955|NCT01652729|158039700|FG001|Overall Study|Physician Decision|0|||
49056956|NCT01652729|158039701|FG002|Overall Study|Physician Decision|1|||
49056957|NCT01652729|158039699|FG000|Overall Study|Protocol Violation|1|||
49056958|NCT01652729|158039700|FG001|Overall Study|Protocol Violation|0|||
49056959|NCT01652729|158039701|FG002|Overall Study|Protocol Violation|0|||
49056960|NCT01652729|158039699|FG000|Overall Study|Lost to Follow-up|6|||
49056961|NCT01652729|158039700|FG001|Overall Study|Lost to Follow-up|6|||
49056962|NCT01652729|158039701|FG002|Overall Study|Lost to Follow-up|3|||
49056963|NCT01652729|158039699|FG000|Overall Study|Administrative|1|||
49056964|NCT01652729|158039700|FG001|Overall Study|Administrative|0|||
49056965|NCT01652729|158039701|FG002|Overall Study|Administrative|0|||
49056966|NCT01005329|158039702|FG000|Overall Study|Ineligible or received no protocol trt.|4|||
49056967|NCT01272921|158039708|FG000|Overall Study|Protocol Violation|2|||
49056968|NCT01272921|158039709|FG001|Overall Study|Protocol Violation|1|||
49056969|NCT01132664|158039710|FG000|Phase lb|Adverse Event|0|||
49056970|NCT01132664|158039711|FG001|Phase lb|Adverse Event|1|||
49056971|NCT01132664|158039712|FG002|Phase lb|Adverse Event|0|||
49056972|NCT01132664|158039713|FG003|Phase lb|Adverse Event|0|||
49056973|NCT01132664|158039714|FG004|Phase lb|Adverse Event|0|||
49056974|NCT01132664|158039710|FG000|Phase lb|Withdrawal by Subject|1|||
49056975|NCT01132664|158039711|FG001|Phase lb|Withdrawal by Subject|2|||
49056976|NCT01132664|158039712|FG002|Phase lb|Withdrawal by Subject|0|||
49056977|NCT01132664|158039713|FG003|Phase lb|Withdrawal by Subject|0|||
49056978|NCT01132664|158039714|FG004|Phase lb|Withdrawal by Subject|0|||
49056979|NCT01132664|158039710|FG000|Phase lb|Disease Progression|4|||
49056980|NCT01132664|158039711|FG001|Phase lb|Disease Progression|9|||
49056981|NCT01132664|158039712|FG002|Phase lb|Disease Progression|0|||
49056982|NCT01132664|158039713|FG003|Phase lb|Disease Progression|0|||
49056983|NCT01132664|158039714|FG004|Phase lb|Disease Progression|0|||
49056984|NCT01132664|158039710|FG000|Phase ll|Death|0|||
49056985|NCT01132664|158039711|FG001|Phase ll|Death|0|||
49056986|NCT01132664|158039712|FG002|Phase ll|Death|2|||
49056987|NCT01132664|158039713|FG003|Phase ll|Death|0|||
49056988|NCT01132664|158039714|FG004|Phase ll|Death|0|||
49056989|NCT01132664|158039710|FG000|Phase ll|Adverse Event|0|||
49056990|NCT01132664|158039711|FG001|Phase ll|Adverse Event|0|||
49056991|NCT01132664|158039712|FG002|Phase ll|Adverse Event|10|||
49056992|NCT01132664|158039713|FG003|Phase ll|Adverse Event|0|||
49056993|NCT01132664|158039714|FG004|Phase ll|Adverse Event|0|||
49056994|NCT01132664|158039710|FG000|Phase ll|Withdrawal by Subject|0|||
49056995|NCT01132664|158039711|FG001|Phase ll|Withdrawal by Subject|0|||
49056996|NCT01132664|158039712|FG002|Phase ll|Withdrawal by Subject|3|||
49056997|NCT01132664|158039713|FG003|Phase ll|Withdrawal by Subject|0|||
49056998|NCT01132664|158039714|FG004|Phase ll|Withdrawal by Subject|0|||
49056999|NCT01132664|158039710|FG000|Phase ll|Disease progression|0|||
49057000|NCT01132664|158039711|FG001|Phase ll|Disease progression|0|||
49057001|NCT01132664|158039712|FG002|Phase ll|Disease progression|35|||
49057002|NCT01132664|158039713|FG003|Phase ll|Disease progression|0|||
49057003|NCT01132664|158039714|FG004|Phase ll|Disease progression|0|||
49057004|NCT01132664|158039710|FG000|BM Cohort|Disease progression|0|||
49057005|NCT01132664|158039711|FG001|BM Cohort|Disease progression|0|||
49057006|NCT01132664|158039712|FG002|BM Cohort|Disease progression|0|||
49057007|NCT01132664|158039713|FG003|BM Cohort|Disease progression|3|||
49057008|NCT01132664|158039714|FG004|BM Cohort|Disease progression|4|||
49057009|NCT01132664|158039710|FG000|BM Cohort|Adverse Event|0|||
49057010|NCT01132664|158039711|FG001|BM Cohort|Adverse Event|0|||
49057011|NCT01132664|158039712|FG002|BM Cohort|Adverse Event|0|||
49057012|NCT01132664|158039713|FG003|BM Cohort|Adverse Event|0|||
49057013|NCT01132664|158039714|FG004|BM Cohort|Adverse Event|1|||
49057014|NCT01132664|158039710|FG000|BM Cohort|Withdrawal by Subject|0|||
49057015|NCT01132664|158039711|FG001|BM Cohort|Withdrawal by Subject|0|||
49057016|NCT01132664|158039712|FG002|BM Cohort|Withdrawal by Subject|0|||
49057017|NCT01132664|158039713|FG003|BM Cohort|Withdrawal by Subject|0|||
49057018|NCT01132664|158039714|FG004|BM Cohort|Withdrawal by Subject|1|||
49057019|NCT00655850|158039715|FG000|Overall Study|Death|2|||
49057020|NCT00655850|158039715|FG000|Overall Study|Withdrawal by Subject|1|||
49057021|NCT00140413|158039716|FG000|Overall Study|Lost to Follow-up|1|||
49057022|NCT00140413|158039717|FG001|Overall Study|Lost to Follow-up|0|||
49057023|NCT00140413|158039716|FG000|Overall Study|Withdrawal by Subject|2|||
49057024|NCT00140413|158039717|FG001|Overall Study|Withdrawal by Subject|0|||
49057025|NCT02694549|158039720|FG000|Overall Study|screen failures|2|||
49057026|NCT01534078|158039721|FG000|Overall Study|Death|1|||
49057027|NCT01534078|158039721|FG000|Overall Study|Withdrawal by Subject|1|||
49057028|NCT02916693|158039722|FG000|Overall Study|Lost to Follow-up|7|||
49057029|NCT03180801|158039725|FG000|Overall Study|Physician Decision|3|||
49057030|NCT03180801|158039726|FG001|Overall Study|Physician Decision|3|||
49057031|NCT03180801|158039727|FG002|Overall Study|Physician Decision|1|||
49057032|NCT03180801|158039725|FG000|Overall Study|Non-compliance|1|||
49057033|NCT03180801|158039726|FG001|Overall Study|Non-compliance|4|||
49057034|NCT03180801|158039727|FG002|Overall Study|Non-compliance|0|||
49057035|NCT03180801|158039725|FG000|Overall Study|Inoculation Target Reached|1|||
49057036|NCT03180801|158039726|FG001|Overall Study|Inoculation Target Reached|1|||
49057037|NCT03180801|158039727|FG002|Overall Study|Inoculation Target Reached|3|||
49057038|NCT03180801|158039725|FG000|Overall Study|Adverse Event|1|||
49057039|NCT03180801|158039726|FG001|Overall Study|Adverse Event|0|||
49057040|NCT03180801|158039727|FG002|Overall Study|Adverse Event|2|||
49057041|NCT03180801|158039725|FG000|Overall Study|Withdrawal by Subject|2|||
49057042|NCT03180801|158039726|FG001|Overall Study|Withdrawal by Subject|2|||
49057043|NCT03180801|158039727|FG002|Overall Study|Withdrawal by Subject|1|||
49057044|NCT03180801|158039725|FG000|Overall Study|Lost to Follow-up|0|||
49057045|NCT03180801|158039726|FG001|Overall Study|Lost to Follow-up|2|||
49057046|NCT03180801|158039727|FG002|Overall Study|Lost to Follow-up|3|||
49057047|NCT01049412|158039728|FG000|Period I|Withdrawal by Subject|4|||
49057048|NCT01049412|158039729|FG001|Period I|Withdrawal by Subject|6|||
49057049|NCT01049412|158039728|FG000|Period I|Lost to Follow-up|2|||
49057050|NCT01049412|158039729|FG001|Period I|Lost to Follow-up|2|||
49057051|NCT01049412|158039728|FG000|Period I|Physician Decision|0|||
49057052|NCT01049412|158039729|FG001|Period I|Physician Decision|3|||
49057053|NCT01049412|158039728|FG000|Period I|Protocol Violation|1|||
49057054|NCT01049412|158039729|FG001|Period I|Protocol Violation|2|||
49057055|NCT01049412|158039728|FG000|Period I|Adverse Event|1|||
49057056|NCT01049412|158039729|FG001|Period I|Adverse Event|0|||
49057057|NCT01049412|158039728|FG000|Period II|Withdrawal by Subject|2|||
49057058|NCT01049412|158039729|FG001|Period II|Withdrawal by Subject|3|||
49057059|NCT01049412|158039728|FG000|Period II|Adverse Event|1|||
49057060|NCT01049412|158039729|FG001|Period II|Adverse Event|0|||
49057061|NCT01049412|158039728|FG000|Period II|Lost to Follow-up|1|||
49057062|NCT01049412|158039729|FG001|Period II|Lost to Follow-up|0|||
49057063|NCT01223235|158039731|FG000|Overall Study|Withdrawal by Subject|1|||
49057064|NCT04364737|158039732|FG000|Overall Study|Withdrawal by Subject|4|||
49057065|NCT04364737|158039733|FG001|Overall Study|Withdrawal by Subject|9|||
49057066|NCT04364737|158039732|FG000|Overall Study|Lost to Follow-up|1|||
49057067|NCT04364737|158039733|FG001|Overall Study|Lost to Follow-up|1|||
49057068|NCT01507090|158039734|FG000|Overall Study|incomplete dataset|18|||
49057069|NCT00484419|158039735|FG000|Overall Study|Adverse Event|3|||
49057070|NCT00484419|158039736|FG001|Overall Study|Adverse Event|0|||
49057071|NCT00484419|158039737|FG002|Overall Study|Adverse Event|0|||
49057072|NCT00484419|158039735|FG000|Overall Study|Lost to Follow-up|1|||
49057073|NCT00484419|158039736|FG001|Overall Study|Lost to Follow-up|0|||
49057074|NCT00484419|158039737|FG002|Overall Study|Lost to Follow-up|2|||
49057075|NCT00484419|158039735|FG000|Overall Study|Withdrawal by Subject|3|||
49057076|NCT00484419|158039736|FG001|Overall Study|Withdrawal by Subject|1|||
49057077|NCT00484419|158039737|FG002|Overall Study|Withdrawal by Subject|1|||
49057078|NCT00484419|158039735|FG000|Overall Study|subject met discontinuation criteria|2|||
49057079|NCT00484419|158039736|FG001|Overall Study|subject met discontinuation criteria|2|||
49057080|NCT00484419|158039737|FG002|Overall Study|subject met discontinuation criteria|4|||
49057081|NCT00484419|158039735|FG000|Overall Study|required restricted medication|1|||
49057082|NCT00484419|158039736|FG001|Overall Study|required restricted medication|0|||
49057083|NCT00484419|158039737|FG002|Overall Study|required restricted medication|1|||
49057084|NCT00484419|158039735|FG000|Overall Study|Physician Decision|1|||
49057085|NCT00484419|158039736|FG001|Overall Study|Physician Decision|1|||
49057086|NCT00484419|158039737|FG002|Overall Study|Physician Decision|1|||
49057087|NCT00484419|158039735|FG000|Overall Study|subject unable to receive medication|1|||
49057088|NCT00484419|158039736|FG001|Overall Study|subject unable to receive medication|0|||
49057089|NCT00484419|158039737|FG002|Overall Study|subject unable to receive medication|0|||
49057090|NCT00484419|158039735|FG000|Overall Study|subject relocated|0|||
49057091|NCT00484419|158039736|FG001|Overall Study|subject relocated|1|||
49057092|NCT00484419|158039737|FG002|Overall Study|subject relocated|0|||
49057093|NCT00484419|158039735|FG000|Overall Study|sponsor decision, randomized in error|0|||
49057094|NCT00484419|158039736|FG001|Overall Study|sponsor decision, randomized in error|0|||
49057095|NCT00484419|158039737|FG002|Overall Study|sponsor decision, randomized in error|2|||
49057096|NCT03604341|158039738|FG000|Overall Study|Withdrawal by Subject|1|||
49057097|NCT03604341|158039739|FG001|Overall Study|Withdrawal by Subject|1|||
49057098|NCT03604341|158039738|FG000|Overall Study|Adverse Event|1|||
49057099|NCT03604341|158039739|FG001|Overall Study|Adverse Event|0|||
49057100|NCT03604341|158039738|FG000|Overall Study|Protocol Violation|0|||
49057101|NCT03604341|158039739|FG001|Overall Study|Protocol Violation|1|||
49057102|NCT00466726|158039740|FG000|Overall Study|Not evaluable for response|14|||
49057103|NCT02696031|158039742|FG000|Up to Week 24|Adverse Event|2|||
49057104|NCT02696031|158039743|FG001|Up to Week 24|Adverse Event|4|||
49057105|NCT02696031|158039744|FG002|Up to Week 24|Adverse Event|2|||
49057106|NCT02696031|158039745|FG003|Up to Week 24|Adverse Event|0|||
49057107|NCT02696031|158039746|FG004|Up to Week 24|Adverse Event|0|||
49057108|NCT02696031|158039747|FG005|Up to Week 24|Adverse Event|0|||
49057109|NCT02696031|158039742|FG000|Up to Week 24|Lack of Efficacy|2|||
49057110|NCT02696031|158039743|FG001|Up to Week 24|Lack of Efficacy|1|||
49057111|NCT02696031|158039744|FG002|Up to Week 24|Lack of Efficacy|2|||
49057112|NCT02696031|158039745|FG003|Up to Week 24|Lack of Efficacy|0|||
49057113|NCT02696031|158039746|FG004|Up to Week 24|Lack of Efficacy|0|||
49057114|NCT02696031|158039747|FG005|Up to Week 24|Lack of Efficacy|0|||
49057115|NCT02696031|158039742|FG000|Up to Week 24|Lost to Follow-up|0|||
49057116|NCT02696031|158039743|FG001|Up to Week 24|Lost to Follow-up|1|||
49057117|NCT02696031|158039744|FG002|Up to Week 24|Lost to Follow-up|1|||
49057118|NCT02696031|158039745|FG003|Up to Week 24|Lost to Follow-up|0|||
49057119|NCT02696031|158039746|FG004|Up to Week 24|Lost to Follow-up|0|||
49057120|NCT02696031|158039747|FG005|Up to Week 24|Lost to Follow-up|0|||
49057121|NCT02696031|158039742|FG000|Up to Week 24|Physician Decision|1|||
49057122|NCT02696031|158039743|FG001|Up to Week 24|Physician Decision|0|||
49057123|NCT02696031|158039744|FG002|Up to Week 24|Physician Decision|1|||
49057124|NCT02696031|158039745|FG003|Up to Week 24|Physician Decision|0|||
49057125|NCT02696031|158039746|FG004|Up to Week 24|Physician Decision|0|||
49057126|NCT02696031|158039747|FG005|Up to Week 24|Physician Decision|0|||
49057127|NCT02696031|158039742|FG000|Up to Week 24|Protocol Violation|1|||
49057128|NCT02696031|158039743|FG001|Up to Week 24|Protocol Violation|0|||
49057129|NCT02696031|158039744|FG002|Up to Week 24|Protocol Violation|0|||
49057130|NCT02696031|158039745|FG003|Up to Week 24|Protocol Violation|0|||
49057131|NCT02696031|158039746|FG004|Up to Week 24|Protocol Violation|0|||
49057132|NCT02696031|158039747|FG005|Up to Week 24|Protocol Violation|0|||
49057133|NCT02696031|158039742|FG000|Up to Week 24|Withdrawal by Subject|4|||
49057134|NCT02696031|158039743|FG001|Up to Week 24|Withdrawal by Subject|1|||
49057135|NCT02696031|158039744|FG002|Up to Week 24|Withdrawal by Subject|5|||
49057136|NCT02696031|158039745|FG003|Up to Week 24|Withdrawal by Subject|0|||
49057137|NCT02696031|158039746|FG004|Up to Week 24|Withdrawal by Subject|0|||
49057138|NCT02696031|158039747|FG005|Up to Week 24|Withdrawal by Subject|0|||
49057139|NCT02696031|158039742|FG000|Up to Week 52|Adverse Event|4|||
49057140|NCT02696031|158039743|FG001|Up to Week 52|Adverse Event|5|||
49057141|NCT02696031|158039744|FG002|Up to Week 52|Adverse Event|3|||
49057142|NCT02696031|158039745|FG003|Up to Week 52|Adverse Event|0|||
49057143|NCT02696031|158039746|FG004|Up to Week 52|Adverse Event|0|||
49057144|NCT02696031|158039747|FG005|Up to Week 52|Adverse Event|0|||
49057145|NCT02696031|158039742|FG000|Up to Week 52|Lack of Efficacy|10|||
49057146|NCT02696031|158039743|FG001|Up to Week 52|Lack of Efficacy|7|||
49057147|NCT02696031|158039744|FG002|Up to Week 52|Lack of Efficacy|11|||
49057148|NCT02696031|158039745|FG003|Up to Week 52|Lack of Efficacy|0|||
49057149|NCT02696031|158039746|FG004|Up to Week 52|Lack of Efficacy|0|||
49057150|NCT02696031|158039747|FG005|Up to Week 52|Lack of Efficacy|0|||
49057151|NCT02696031|158039742|FG000|Up to Week 52|Lost to Follow-up|1|||
49057152|NCT02696031|158039743|FG001|Up to Week 52|Lost to Follow-up|1|||
49057153|NCT02696031|158039744|FG002|Up to Week 52|Lost to Follow-up|1|||
49057154|NCT02696031|158039745|FG003|Up to Week 52|Lost to Follow-up|0|||
49057155|NCT02696031|158039746|FG004|Up to Week 52|Lost to Follow-up|0|||
49057156|NCT02696031|158039747|FG005|Up to Week 52|Lost to Follow-up|0|||
49057157|NCT02696031|158039742|FG000|Up to Week 52|Physician Decision|1|||
49057158|NCT02696031|158039743|FG001|Up to Week 52|Physician Decision|1|||
49057159|NCT02696031|158039744|FG002|Up to Week 52|Physician Decision|2|||
49057160|NCT02696031|158039745|FG003|Up to Week 52|Physician Decision|0|||
49057161|NCT02696031|158039746|FG004|Up to Week 52|Physician Decision|0|||
49057162|NCT02696031|158039747|FG005|Up to Week 52|Physician Decision|0|||
49057163|NCT02696031|158039742|FG000|Up to Week 52|Pregnancy|0|||
49057164|NCT02696031|158039743|FG001|Up to Week 52|Pregnancy|2|||
49057165|NCT02696031|158039744|FG002|Up to Week 52|Pregnancy|0|||
49057166|NCT02696031|158039745|FG003|Up to Week 52|Pregnancy|0|||
49057167|NCT02696031|158039746|FG004|Up to Week 52|Pregnancy|0|||
49057168|NCT02696031|158039747|FG005|Up to Week 52|Pregnancy|0|||
49057169|NCT02696031|158039742|FG000|Up to Week 52|Protocol Violation|1|||
49057170|NCT02696031|158039743|FG001|Up to Week 52|Protocol Violation|0|||
49057171|NCT02696031|158039744|FG002|Up to Week 52|Protocol Violation|0|||
49057172|NCT02696031|158039745|FG003|Up to Week 52|Protocol Violation|0|||
49057173|NCT02696031|158039746|FG004|Up to Week 52|Protocol Violation|0|||
49057174|NCT02696031|158039747|FG005|Up to Week 52|Protocol Violation|0|||
49057175|NCT02696031|158039742|FG000|Up to Week 52|Withdrawal by Subject|12|||
49057176|NCT02696031|158039743|FG001|Up to Week 52|Withdrawal by Subject|3|||
49057177|NCT02696031|158039744|FG002|Up to Week 52|Withdrawal by Subject|9|||
49057178|NCT02696031|158039745|FG003|Up to Week 52|Withdrawal by Subject|0|||
49057179|NCT02696031|158039746|FG004|Up to Week 52|Withdrawal by Subject|0|||
49057180|NCT02696031|158039747|FG005|Up to Week 52|Withdrawal by Subject|0|||
49057181|NCT02696031|158039742|FG000|Up to Week 104|Pregnancy|0|||
49057182|NCT02696031|158039743|FG001|Up to Week 104|Pregnancy|2|||
49057183|NCT02696031|158039744|FG002|Up to Week 104|Pregnancy|1|||
49057184|NCT02696031|158039745|FG003|Up to Week 104|Pregnancy|0|||
49057185|NCT02696031|158039746|FG004|Up to Week 104|Pregnancy|0|||
49057186|NCT02696031|158039747|FG005|Up to Week 104|Pregnancy|0|||
49057187|NCT02696031|158039742|FG000|Up to Week 104|Withdrawal by Subject|15|||
49057188|NCT02696031|158039743|FG001|Up to Week 104|Withdrawal by Subject|10|||
49057189|NCT02696031|158039744|FG002|Up to Week 104|Withdrawal by Subject|16|||
49057190|NCT02696031|158039745|FG003|Up to Week 104|Withdrawal by Subject|0|||
49057191|NCT02696031|158039746|FG004|Up to Week 104|Withdrawal by Subject|0|||
49057192|NCT02696031|158039747|FG005|Up to Week 104|Withdrawal by Subject|0|||
49057193|NCT02696031|158039742|FG000|Up to Week 104|Protocol Violation|1|||
49057194|NCT02696031|158039743|FG001|Up to Week 104|Protocol Violation|0|||
49057195|NCT02696031|158039744|FG002|Up to Week 104|Protocol Violation|0|||
49057196|NCT02696031|158039745|FG003|Up to Week 104|Protocol Violation|0|||
49057197|NCT02696031|158039746|FG004|Up to Week 104|Protocol Violation|0|||
49057198|NCT02696031|158039747|FG005|Up to Week 104|Protocol Violation|0|||
49057199|NCT02696031|158039742|FG000|Up to Week 104|Physician Decision|1|||
49057200|NCT02696031|158039743|FG001|Up to Week 104|Physician Decision|2|||
49057201|NCT02696031|158039744|FG002|Up to Week 104|Physician Decision|3|||
49057202|NCT02696031|158039745|FG003|Up to Week 104|Physician Decision|0|||
49057203|NCT02696031|158039746|FG004|Up to Week 104|Physician Decision|0|||
49057204|NCT02696031|158039747|FG005|Up to Week 104|Physician Decision|0|||
49057205|NCT02696031|158039742|FG000|Up to Week 104|Lost to Follow-up|2|||
49057206|NCT02696031|158039743|FG001|Up to Week 104|Lost to Follow-up|3|||
49057207|NCT02696031|158039744|FG002|Up to Week 104|Lost to Follow-up|1|||
49057208|NCT02696031|158039745|FG003|Up to Week 104|Lost to Follow-up|0|||
49057209|NCT02696031|158039746|FG004|Up to Week 104|Lost to Follow-up|0|||
49057210|NCT02696031|158039747|FG005|Up to Week 104|Lost to Follow-up|0|||
49057211|NCT02696031|158039742|FG000|Up to Week 104|Lack of Efficacy|13|||
49057212|NCT02696031|158039743|FG001|Up to Week 104|Lack of Efficacy|12|||
49057213|NCT02696031|158039744|FG002|Up to Week 104|Lack of Efficacy|11|||
49057214|NCT02696031|158039745|FG003|Up to Week 104|Lack of Efficacy|0|||
49057215|NCT02696031|158039746|FG004|Up to Week 104|Lack of Efficacy|0|||
49057216|NCT02696031|158039747|FG005|Up to Week 104|Lack of Efficacy|0|||
49057217|NCT02696031|158039742|FG000|Up to Week 104|Adverse Event|7|||
49057218|NCT02696031|158039743|FG001|Up to Week 104|Adverse Event|11|||
49057219|NCT02696031|158039744|FG002|Up to Week 104|Adverse Event|5|||
49057220|NCT02696031|158039745|FG003|Up to Week 104|Adverse Event|0|||
49057221|NCT02696031|158039746|FG004|Up to Week 104|Adverse Event|0|||
49057222|NCT02696031|158039747|FG005|Up to Week 104|Adverse Event|0|||
49057223|NCT02696031|158039742|FG000|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
49057224|NCT02696031|158039743|FG001|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|1|||
49057225|NCT02696031|158039744|FG002|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
49057226|NCT02696031|158039745|FG003|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
49057227|NCT02696031|158039746|FG004|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
49057228|NCT02696031|158039747|FG005|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
49057229|NCT02696031|158039742|FG000|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
49057230|NCT02696031|158039743|FG001|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
49057231|NCT02696031|158039744|FG002|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
49057232|NCT02696031|158039745|FG003|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|6|||
49057233|NCT02696031|158039746|FG004|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|8|||
49057234|NCT02696031|158039747|FG005|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|2|||
49057235|NCT02696031|158039742|FG000|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
49057236|NCT02696031|158039743|FG001|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
49057237|NCT02696031|158039744|FG002|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
49057238|NCT02696031|158039745|FG003|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
49057239|NCT02696031|158039746|FG004|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
49057240|NCT02696031|158039747|FG005|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
49057241|NCT02696031|158039742|FG000|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
49057242|NCT02696031|158039743|FG001|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
49057243|NCT02696031|158039744|FG002|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
49057244|NCT02696031|158039745|FG003|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|1|||
49057245|NCT02696031|158039746|FG004|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
49057246|NCT02696031|158039747|FG005|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
49057247|NCT02696031|158039742|FG000|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
49057248|NCT02696031|158039743|FG001|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
49057249|NCT02696031|158039744|FG002|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
49057250|NCT02696031|158039745|FG003|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
49057251|NCT02696031|158039746|FG004|Extension Phase From wk 104 to wk 208|Lost to Follow-up|1|||
49057252|NCT02696031|158039747|FG005|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
49057253|NCT02696031|158039742|FG000|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
49057254|NCT02696031|158039743|FG001|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
49057255|NCT02696031|158039744|FG002|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
49057256|NCT02696031|158039745|FG003|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
49057257|NCT02696031|158039746|FG004|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
49057258|NCT02696031|158039747|FG005|Extension Phase From wk 104 to wk 208|Lack of Efficacy|3|||
49057259|NCT02696031|158039742|FG000|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
49057260|NCT02696031|158039743|FG001|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
49057261|NCT02696031|158039744|FG002|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
49057262|NCT02696031|158039745|FG003|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
49057263|NCT02696031|158039746|FG004|Extension Phase From wk 104 to wk 208|Adverse Event|4|||
49057264|NCT02696031|158039747|FG005|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
49057265|NCT01376310|158039750|FG000|Overall Study|Study closed/terminated|1|||
49057266|NCT01376310|158039751|FG001|Overall Study|Study closed/terminated|2|||
49057267|NCT01376310|158039750|FG000|Overall Study|Withdrawal by Subject|8|||
49057268|NCT01376310|158039751|FG001|Overall Study|Withdrawal by Subject|2|||
49057269|NCT01376310|158039750|FG000|Overall Study|Physician Decision|26|||
49057270|NCT01376310|158039751|FG001|Overall Study|Physician Decision|7|||
49057271|NCT01376310|158039750|FG000|Overall Study|Lost to Follow-up|1|||
49057272|NCT01376310|158039751|FG001|Overall Study|Lost to Follow-up|0|||
49057273|NCT01884688|158039754|FG000|Overall Study|Screen Failure|2|||
49057274|NCT00296491|158039757|FG000|Overall Study|Low Pollen Counts|18|||
49057275|NCT00296491|158039758|FG001|Overall Study|Low Pollen Counts|26|||
49057276|NCT00296491|158039759|FG002|Overall Study|Low Pollen Counts|25|||
49057277|NCT00296491|158039760|FG003|Overall Study|Low Pollen Counts|16|||
49057278|NCT00296491|158039757|FG000|Overall Study|Protocol Violation|4|||
49057279|NCT00296491|158039758|FG001|Overall Study|Protocol Violation|6|||
49057280|NCT00296491|158039759|FG002|Overall Study|Protocol Violation|2|||
49057281|NCT00296491|158039760|FG003|Overall Study|Protocol Violation|3|||
49057282|NCT00296491|158039757|FG000|Overall Study|Adverse Event|1|||
49057283|NCT00296491|158039758|FG001|Overall Study|Adverse Event|3|||
49057284|NCT00296491|158039759|FG002|Overall Study|Adverse Event|1|||
49057285|NCT00296491|158039760|FG003|Overall Study|Adverse Event|4|||
49057286|NCT00296491|158039757|FG000|Overall Study|Withdrawn due to Asthma|0|||
49057287|NCT00296491|158039758|FG001|Overall Study|Withdrawn due to Asthma|0|||
49057288|NCT00296491|158039759|FG002|Overall Study|Withdrawn due to Asthma|0|||
49057289|NCT00296491|158039760|FG003|Overall Study|Withdrawn due to Asthma|4|||
49057290|NCT00296491|158039757|FG000|Overall Study|Withdrawal by Subject|7|||
49057291|NCT00296491|158039758|FG001|Overall Study|Withdrawal by Subject|3|||
49057292|NCT00296491|158039759|FG002|Overall Study|Withdrawal by Subject|3|||
49057293|NCT00296491|158039760|FG003|Overall Study|Withdrawal by Subject|2|||
49057294|NCT00296491|158039757|FG000|Overall Study|Non-Compliance|12|||
49057295|NCT00296491|158039758|FG001|Overall Study|Non-Compliance|13|||
49057296|NCT00296491|158039759|FG002|Overall Study|Non-Compliance|10|||
49057297|NCT00296491|158039760|FG003|Overall Study|Non-Compliance|14|||
49057298|NCT00296491|158039757|FG000|Overall Study|Lost to Follow-up|0|||
49057299|NCT00296491|158039758|FG001|Overall Study|Lost to Follow-up|2|||
49057300|NCT00296491|158039759|FG002|Overall Study|Lost to Follow-up|2|||
49057301|NCT00296491|158039760|FG003|Overall Study|Lost to Follow-up|0|||
49057302|NCT04798482|158039763|FG000|Overall Study|Physician Decision|1|||
49057303|NCT04798482|158039763|FG000|Overall Study|Lost eligibility|1|||
49057304|NCT03005067|158039765|FG000|Overall Study|Withdrawal by Subject|3|||
49057305|NCT03005067|158039766|FG001|Overall Study|Withdrawal by Subject|2|||
49057306|NCT03005067|158039765|FG000|Overall Study|Adverse Event|4|||
49057307|NCT03005067|158039766|FG001|Overall Study|Adverse Event|3|||
49057308|NCT03005067|158039765|FG000|Overall Study|Other (reason not specified)|3|||
49057309|NCT03005067|158039766|FG001|Overall Study|Other (reason not specified)|1|||
49057310|NCT03005067|158039765|FG000|Overall Study|Protocol Violation|0|||
49057311|NCT03005067|158039766|FG001|Overall Study|Protocol Violation|1|||
49057312|NCT01807117|158039768|FG000|Overall Study|Physician Decision|2|||
49057313|NCT01807117|158039768|FG000|Overall Study|Disease diagnosis not a study disease|1|||
49057314|NCT01930175|158039770|FG000|Core Study|Lost to Follow-up|0|||
49057315|NCT01930175|158039771|FG001|Core Study|Lost to Follow-up|1|||
49057316|NCT01930175|158039772|FG002|Core Study|Lost to Follow-up|0|||
49057317|NCT01930175|158039770|FG000|Core Study|Adverse Event|0|||
49057318|NCT01930175|158039771|FG001|Core Study|Adverse Event|0|||
49057319|NCT01930175|158039772|FG002|Core Study|Adverse Event|1|||
49057320|NCT01298778|158039773|FG000|Overall Study|Lost to Follow-up|2|||
49057321|NCT01298778|158039774|FG001|Overall Study|Lost to Follow-up|3|||
49057322|NCT01298778|158039773|FG000|Overall Study|Incorrect use of VAS|1|||
49057323|NCT01298778|158039774|FG001|Overall Study|Incorrect use of VAS|0|||
49057324|NCT01298778|158039773|FG000|Overall Study|Withdrawal by Subject|0|||
49057325|NCT01298778|158039774|FG001|Overall Study|Withdrawal by Subject|1|||
49057326|NCT01298778|158039773|FG000|Overall Study|Protocol Violation|0|||
49057327|NCT01298778|158039774|FG001|Overall Study|Protocol Violation|1|||
49057328|NCT01298778|158039773|FG000|Overall Study|not meet inclusion/exclusion criteria|0|||
49057329|NCT01298778|158039774|FG001|Overall Study|not meet inclusion/exclusion criteria|1|||
49057330|NCT00767520|158039775|FG000|Overall Study|Participants still on treatment|11|||
49057331|NCT00767520|158039776|FG001|Overall Study|Participants still on treatment|15|||
49057332|NCT00767520|158039775|FG000|Overall Study|Randomized in error and Never treated|0|||
49057333|NCT00767520|158039776|FG001|Overall Study|Randomized in error and Never treated|2|||
49057334|NCT00094094|158039777|FG000|Overall Study|Death|2|||
49057335|NCT00094094|158039777|FG000|Overall Study|Lack of Efficacy|23|||
49057336|NCT00094094|158039777|FG000|Overall Study|Adverse Event|7|||
49057337|NCT04965389|158039778|FG000|Overall Study|Other reasons|1|||
49057338|NCT04965389|158039779|FG001|Overall Study|Other reasons|0|||
49057339|NCT04965389|158039780|FG002|Overall Study|Other reasons|0|||
49057340|NCT04965389|158039781|FG003|Overall Study|Other reasons|0|||
49057341|NCT04965389|158039778|FG000|Overall Study|Participant withdrew consent|0|||
49057342|NCT04965389|158039779|FG001|Overall Study|Participant withdrew consent|1|||
49057343|NCT04965389|158039780|FG002|Overall Study|Participant withdrew consent|0|||
49057344|NCT04965389|158039781|FG003|Overall Study|Participant withdrew consent|0|||
49057345|NCT04965389|158039778|FG000|Overall Study|Poor/Non-compliance|0|||
49057346|NCT04965389|158039779|FG001|Overall Study|Poor/Non-compliance|1|||
49057347|NCT04965389|158039780|FG002|Overall Study|Poor/Non-compliance|0|||
49057348|NCT04965389|158039781|FG003|Overall Study|Poor/Non-compliance|0|||
49057349|NCT02709486|158039782|FG000|Overall Study|Adverse Event|2|||
49057350|NCT02709486|158039783|FG001|Overall Study|Adverse Event|5|||
49057351|NCT02709486|158039784|FG002|Overall Study|Adverse Event|3|||
49057352|NCT02709486|158039782|FG000|Overall Study|Death|0|||
49057353|NCT02709486|158039783|FG001|Overall Study|Death|0|||
49057354|NCT02709486|158039784|FG002|Overall Study|Death|2|||
49057355|NCT02709486|158039782|FG000|Overall Study|Insufficient clinical response|7|||
49057356|NCT02709486|158039783|FG001|Overall Study|Insufficient clinical response|3|||
49057357|NCT02709486|158039784|FG002|Overall Study|Insufficient clinical response|3|||
49057358|NCT02709486|158039782|FG000|Overall Study|Lost to Follow-up|3|||
49057359|NCT02709486|158039783|FG001|Overall Study|Lost to Follow-up|2|||
49057360|NCT02709486|158039784|FG002|Overall Study|Lost to Follow-up|2|||
49057361|NCT02709486|158039782|FG000|Overall Study|Other|0|||
49057362|NCT02709486|158039783|FG001|Overall Study|Other|2|||
49057363|NCT02709486|158039784|FG002|Overall Study|Other|3|||
49057364|NCT02709486|158039782|FG000|Overall Study|Withdrawal by Subject|32|||
49057365|NCT02709486|158039783|FG001|Overall Study|Withdrawal by Subject|22|||
49057366|NCT02709486|158039784|FG002|Overall Study|Withdrawal by Subject|32|||
49057367|NCT02443545|158039787|FG000|Overall Study|Adverse Event|1|||
49057368|NCT02443545|158039788|FG001|Overall Study|Adverse Event|1|||
49057369|NCT02443545|158039787|FG000|Overall Study|Lost to Follow-up|0|||
49057370|NCT02443545|158039788|FG001|Overall Study|Lost to Follow-up|2|||
49057371|NCT02443545|158039787|FG000|Overall Study|Physician Decision|3|||
49057372|NCT02443545|158039788|FG001|Overall Study|Physician Decision|0|||
49057373|NCT02443545|158039787|FG000|Overall Study|Protocol Violation|8|||
49057374|NCT02443545|158039788|FG001|Overall Study|Protocol Violation|1|||
49057375|NCT02443545|158039787|FG000|Overall Study|Pregnancy|1|||
49057376|NCT02443545|158039788|FG001|Overall Study|Pregnancy|1|||
49057377|NCT02443545|158039787|FG000|Overall Study|Withdrawal by Subject|6|||
49057378|NCT02443545|158039788|FG001|Overall Study|Withdrawal by Subject|3|||
49057379|NCT02443545|158039787|FG000|Overall Study|Termination of study|20|||
49057380|NCT02443545|158039788|FG001|Overall Study|Termination of study|11|||
49057381|NCT03499119|158039789|FG000|Initial Treatment Phase|Protocol Specified Criteria|0|||
49057382|NCT03499119|158039790|FG001|Initial Treatment Phase|Protocol Specified Criteria|0|||
49057383|NCT03499119|158039791|FG002|Initial Treatment Phase|Protocol Specified Criteria|0|||
49057384|NCT03499119|158039792|FG003|Initial Treatment Phase|Protocol Specified Criteria|1|||
49057385|NCT03499119|158039789|FG000|Initial Treatment Phase|Withdrawal by Subject|0|||
49057386|NCT03499119|158039790|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
49057387|NCT03499119|158039791|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
49057388|NCT03499119|158039792|FG003|Initial Treatment Phase|Withdrawal by Subject|1|||
49057389|NCT03499119|158039789|FG000|Initial Treatment Phase|Decision by Sponsor|1|||
49057390|NCT03499119|158039790|FG001|Initial Treatment Phase|Decision by Sponsor|0|||
49057391|NCT03499119|158039791|FG002|Initial Treatment Phase|Decision by Sponsor|1|||
49057392|NCT03499119|158039792|FG003|Initial Treatment Phase|Decision by Sponsor|1|||
49057393|NCT03499119|158039789|FG000|Optional Extension Phase|Lost to Follow-up|0|||
49057394|NCT03499119|158039790|FG001|Optional Extension Phase|Lost to Follow-up|0|||
49057395|NCT03499119|158039791|FG002|Optional Extension Phase|Lost to Follow-up|0|||
49057396|NCT03499119|158039792|FG003|Optional Extension Phase|Lost to Follow-up|1|||
49057397|NCT03499119|158039789|FG000|Optional Extension Phase|Withdrawal by Subject|0|||
49057398|NCT03499119|158039790|FG001|Optional Extension Phase|Withdrawal by Subject|0|||
49057399|NCT03499119|158039791|FG002|Optional Extension Phase|Withdrawal by Subject|0|||
49057400|NCT03499119|158039792|FG003|Optional Extension Phase|Withdrawal by Subject|5|||
49057401|NCT03499119|158039789|FG000|Optional Extension Phase|Protocol Specified Criteria|0|||
49057402|NCT03499119|158039790|FG001|Optional Extension Phase|Protocol Specified Criteria|1|||
49057403|NCT03499119|158039791|FG002|Optional Extension Phase|Protocol Specified Criteria|0|||
49057404|NCT03499119|158039792|FG003|Optional Extension Phase|Protocol Specified Criteria|0|||
49057405|NCT02459418|158041360|FG000|Overall Study|Exclusion Criteria|4|||
49057406|NCT02459418|158041361|FG001|Overall Study|Exclusion Criteria|0|||
49057407|NCT02459418|158041360|FG000|Overall Study|Protocol Violation|0|||
49057408|NCT02459418|158041361|FG001|Overall Study|Protocol Violation|2|||
49057409|NCT02459418|158041360|FG000|Overall Study|Physician Decision|0|||
49057410|NCT02459418|158041361|FG001|Overall Study|Physician Decision|2|||
49057411|NCT02459418|158041360|FG000|Overall Study|Endometrial thickness of >5 mm|1|||
49057412|NCT02459418|158041361|FG001|Overall Study|Endometrial thickness of >5 mm|0|||
49057413|NCT02459418|158041360|FG000|Overall Study|Adverse Event|0|||
49057414|NCT02459418|158041361|FG001|Overall Study|Adverse Event|1|||
49057415|NCT02459418|158041360|FG000|Overall Study|Withdrawal by Subject|1|||
49057416|NCT02459418|158041361|FG001|Overall Study|Withdrawal by Subject|1|||
49057417|NCT02459418|158041360|FG000|Overall Study|Elevated Creatine Kinase|1|||
49057418|NCT02459418|158041361|FG001|Overall Study|Elevated Creatine Kinase|0|||
49057419|NCT02459418|158041360|FG000|Overall Study|Abnormal Transvaginal Ultrasound|1|||
49057420|NCT02459418|158041361|FG001|Overall Study|Abnormal Transvaginal Ultrasound|0|||
49057421|NCT00653159|158041362|FG000|Overall Study|Adverse Event|4|||
49057422|NCT00653159|158041363|FG001|Overall Study|Adverse Event|1|||
49057423|NCT00653159|158041362|FG000|Overall Study|Lost to Follow-up|1|||
49057424|NCT00653159|158041363|FG001|Overall Study|Lost to Follow-up|2|||
49057425|NCT03686150|158041367|FG000|Overall Study|Withdrawal by Subject|1|||
49057426|NCT03686150|158041368|FG001|Overall Study|Withdrawal by Subject|1|||
49057427|NCT03686150|158041369|FG002|Overall Study|Withdrawal by Subject|1|||
49057428|NCT03686150|158041370|FG003|Overall Study|Withdrawal by Subject|0|||
49057429|NCT03686150|158041371|FG004|Overall Study|Withdrawal by Subject|1|||
49057430|NCT03686150|158041372|FG005|Overall Study|Withdrawal by Subject|2|||
49057431|NCT03686150|158041367|FG000|Overall Study|Physician Decision|1|||
49057432|NCT03686150|158041368|FG001|Overall Study|Physician Decision|0|||
49057433|NCT03686150|158041369|FG002|Overall Study|Physician Decision|0|||
49057434|NCT03686150|158041370|FG003|Overall Study|Physician Decision|0|||
49057435|NCT03686150|158041371|FG004|Overall Study|Physician Decision|0|||
49057436|NCT03686150|158041372|FG005|Overall Study|Physician Decision|1|||
49057437|NCT03686150|158041367|FG000|Overall Study|Lost to Follow-up|0|||
49057438|NCT03686150|158041368|FG001|Overall Study|Lost to Follow-up|1|||
49057439|NCT03686150|158041369|FG002|Overall Study|Lost to Follow-up|0|||
49057440|NCT03686150|158041370|FG003|Overall Study|Lost to Follow-up|0|||
49057441|NCT03686150|158041371|FG004|Overall Study|Lost to Follow-up|0|||
49057442|NCT03686150|158041372|FG005|Overall Study|Lost to Follow-up|0|||
49057443|NCT01522950|158041373|FG000|Overall Study|Withdrawal by Subject|3|||
49057444|NCT01522950|158041374|FG001|Overall Study|Withdrawal by Subject|2|||
49057445|NCT01522950|158041375|FG002|Overall Study|Withdrawal by Subject|1|||
49057446|NCT01522950|158041373|FG000|Overall Study|Adverse Event|3|||
49057447|NCT01522950|158041374|FG001|Overall Study|Adverse Event|1|||
49057448|NCT01522950|158041375|FG002|Overall Study|Adverse Event|1|||
49057449|NCT01522950|158041373|FG000|Overall Study|Protocol Violation|0|||
49057450|NCT01522950|158041374|FG001|Overall Study|Protocol Violation|0|||
49057451|NCT01522950|158041375|FG002|Overall Study|Protocol Violation|2|||
49057452|NCT01522950|158041373|FG000|Overall Study|Death|0|||
49057453|NCT01522950|158041374|FG001|Overall Study|Death|1|||
49057454|NCT01522950|158041375|FG002|Overall Study|Death|1|||
49057455|NCT01522950|158041373|FG000|Overall Study|Study Medication Sensitivity|0|||
49057456|NCT01522950|158041374|FG001|Overall Study|Study Medication Sensitivity|1|||
49057457|NCT01522950|158041375|FG002|Overall Study|Study Medication Sensitivity|0|||
49057458|NCT06191679|158041376|FG000|Baseline|Lost to Follow-up|1|||
49057459|NCT06191679|158041377|FG001|Baseline|Lost to Follow-up|0|||
49057460|NCT06191679|158041378|FG002|Baseline|Lost to Follow-up|1|||
49057461|NCT06191679|158041379|FG003|Baseline|Lost to Follow-up|0|||
49057462|NCT06191679|158041376|FG000|Allocation to Group|Withdrawal by Subject|0|||
49057463|NCT06191679|158041377|FG001|Allocation to Group|Withdrawal by Subject|1|||
49057464|NCT06191679|158041378|FG002|Allocation to Group|Withdrawal by Subject|2|||
49057465|NCT06191679|158041379|FG003|Allocation to Group|Withdrawal by Subject|0|||
49057466|NCT06191679|158041376|FG000|Post-Intervention Assessment|Lost to Follow-up|2|||
49057467|NCT06191679|158041377|FG001|Post-Intervention Assessment|Lost to Follow-up|3|||
49057468|NCT06191679|158041378|FG002|Post-Intervention Assessment|Lost to Follow-up|0|||
49057469|NCT06191679|158041379|FG003|Post-Intervention Assessment|Lost to Follow-up|0|||
49057470|NCT06191679|158041376|FG000|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
49057471|NCT06191679|158041377|FG001|Post-Intervention Qualitative Interview|Lost to Follow-up|7|||
49057472|NCT06191679|158041378|FG002|Post-Intervention Qualitative Interview|Lost to Follow-up|5|||
49057473|NCT06191679|158041379|FG003|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
49057474|NCT06191679|158041376|FG000|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
49057475|NCT06191679|158041377|FG001|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
49057476|NCT06191679|158041378|FG002|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
49057477|NCT06191679|158041379|FG003|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|2|||
49057478|NCT03036839|158041382|FG000|Overall Study|Adverse Event|0|||
49057479|NCT03036839|158041383|FG001|Overall Study|Adverse Event|0|||
49057480|NCT03036839|158041384|FG002|Overall Study|Adverse Event|1|||
49057481|NCT03036839|158041382|FG000|Overall Study|Death|3|||
49057482|NCT03036839|158041383|FG001|Overall Study|Death|0|||
49057483|NCT03036839|158041384|FG002|Overall Study|Death|3|||
49057484|NCT03036839|158041382|FG000|Overall Study|Withdrew Consent|0|||
49057485|NCT03036839|158041383|FG001|Overall Study|Withdrew Consent|0|||
49057486|NCT03036839|158041384|FG002|Overall Study|Withdrew Consent|1|||
49057487|NCT01333072|158041385|FG000|Overall Study|Lost to Follow-up|3|||
49057488|NCT01333072|158041386|FG001|Overall Study|Lost to Follow-up|0|||
49057489|NCT01333072|158041385|FG000|Overall Study|Adverse Event|2|||
49057490|NCT01333072|158041386|FG001|Overall Study|Adverse Event|4|||
49057491|NCT01333072|158041385|FG000|Overall Study|Physician Decision|1|||
49057492|NCT01333072|158041386|FG001|Overall Study|Physician Decision|0|||
49057493|NCT01316419|158041387|FG000|Overall Study|Not treated|103|||
49057494|NCT01316419|158041387|FG000|Overall Study|Violated inclusion/exclusion criterion|143|||
49057495|NCT01316419|158041387|FG000|Overall Study|Lost to Follow-up|19|||
49057496|NCT00412737|158041391|FG000|Overall Study|Death|1|||
49057497|NCT00412737|158041392|FG001|Overall Study|Death|0|||
49057498|NCT00412737|158041391|FG000|Overall Study|Adverse Event|3|||
49057499|NCT00412737|158041392|FG001|Overall Study|Adverse Event|2|||
49057500|NCT00412737|158041391|FG000|Overall Study|Refused Treatment|6|||
49057501|NCT00412737|158041392|FG001|Overall Study|Refused Treatment|2|||
49057502|NCT00412737|158041391|FG000|Overall Study|Failure to Return|6|||
49057503|NCT00412737|158041392|FG001|Overall Study|Failure to Return|2|||
49057504|NCT03341000|158041393|FG000|Overall Study|Adverse Event|1|||
49057505|NCT01064531|158041394|FG000|Overall Study|Lost to Follow-up|0|||
49057506|NCT01064531|158041395|FG001|Overall Study|Lost to Follow-up|2|||
49057507|NCT01064531|158041394|FG000|Overall Study|Physician Decision|0|||
49057508|NCT01064531|158041395|FG001|Overall Study|Physician Decision|1|||
49057509|NCT01064531|158041394|FG000|Overall Study|Withdrawal by Subject|2|||
49057510|NCT01064531|158041395|FG001|Overall Study|Withdrawal by Subject|2|||
49057511|NCT01064531|158041394|FG000|Overall Study|Revision due to femoral stem loosening|1|||
49057512|NCT01064531|158041395|FG001|Overall Study|Revision due to femoral stem loosening|0|||
49057513|NCT01064531|158041394|FG000|Overall Study|Revision due to dislocation|0|||
49057514|NCT01064531|158041395|FG001|Overall Study|Revision due to dislocation|1|||
49057515|NCT01064531|158041394|FG000|Overall Study|Death|0|||
49057516|NCT01064531|158041395|FG001|Overall Study|Death|1|||
49057517|NCT00754013|158041397|FG000|Overall Study|Lost to Follow-up|1|||
49057518|NCT00754013|158041398|FG001|Overall Study|Lost to Follow-up|1|||
49057519|NCT00754013|158041397|FG000|Overall Study|didn't return after study termed|3|||
49057520|NCT00754013|158041398|FG001|Overall Study|didn't return after study termed|4|||
49057521|NCT01091103|158041399|FG000|Overall Study|Adverse Event|1|||
49057522|NCT01091103|158041399|FG000|Overall Study|Progressive Disease|3|||
49057523|NCT04039919|158041400|FG000|Treatment Period 1|Withdrawal by Subject|1|||
49057524|NCT04039919|158041401|FG001|Treatment Period 1|Withdrawal by Subject|0|||
49057525|NCT04039919|158041402|FG002|Treatment Period 1|Withdrawal by Subject|0|||
49057526|NCT04039919|158041403|FG003|Treatment Period 1|Withdrawal by Subject|0|||
49057527|NCT04039919|158041404|FG004|Treatment Period 1|Withdrawal by Subject|0|||
49057528|NCT04039919|158041400|FG000|Treatment Period 1|Sponsor's decision|0|||
49057529|NCT04039919|158041401|FG001|Treatment Period 1|Sponsor's decision|0|||
49057530|NCT04039919|158041402|FG002|Treatment Period 1|Sponsor's decision|0|||
49057531|NCT04039919|158041403|FG003|Treatment Period 1|Sponsor's decision|0|||
49057532|NCT04039919|158041404|FG004|Treatment Period 1|Sponsor's decision|16|||
49057533|NCT04039919|158041400|FG000|Treatment Period 5|Withdrawal by Subject|1|||
49057534|NCT04039919|158041401|FG001|Treatment Period 5|Withdrawal by Subject|0|||
49057535|NCT04039919|158041402|FG002|Treatment Period 5|Withdrawal by Subject|0|||
49057536|NCT04039919|158041403|FG003|Treatment Period 5|Withdrawal by Subject|0|||
49057537|NCT04039919|158041404|FG004|Treatment Period 5|Withdrawal by Subject|0|||
49057538|NCT00483548|158041405|FG000|Overall Study|Randomized; not treated with study drug|1|||
49057539|NCT00483548|158041406|FG001|Overall Study|Randomized; not treated with study drug|3|||
49057540|NCT00483548|158041405|FG000|Overall Study|Adverse Event|25|||
49057541|NCT00483548|158041406|FG001|Overall Study|Adverse Event|14|||
49057542|NCT00483548|158041405|FG000|Overall Study|Laboratory abnormality|1|||
49057543|NCT00483548|158041406|FG001|Overall Study|Laboratory abnormality|2|||
49057544|NCT00483548|158041405|FG000|Overall Study|Lack of Efficacy|4|||
49057545|NCT00483548|158041406|FG001|Overall Study|Lack of Efficacy|8|||
49057546|NCT00483548|158041405|FG000|Overall Study|Protocol Violation|11|||
49057547|NCT00483548|158041406|FG001|Overall Study|Protocol Violation|7|||
49057548|NCT00483548|158041405|FG000|Overall Study|Pregnancy|1|||
49057549|NCT00483548|158041406|FG001|Overall Study|Pregnancy|0|||
49057550|NCT00483548|158041405|FG000|Overall Study|Protocol required discontinuation|6|||
49057551|NCT00483548|158041406|FG001|Overall Study|Protocol required discontinuation|6|||
49057552|NCT00483548|158041405|FG000|Overall Study|Unable to comply with protocol schedule|1|||
49057553|NCT00483548|158041406|FG001|Overall Study|Unable to comply with protocol schedule|0|||
49057554|NCT00483548|158041405|FG000|Overall Study|Non-compliance with medication|2|||
49057555|NCT00483548|158041406|FG001|Overall Study|Non-compliance with medication|0|||
49057556|NCT00483548|158041405|FG000|Overall Study|Lost to Follow-up|3|||
49057557|NCT00483548|158041406|FG001|Overall Study|Lost to Follow-up|4|||
49057558|NCT00483548|158041405|FG000|Overall Study|Withdrawal by Subject|5|||
49057559|NCT00483548|158041406|FG001|Overall Study|Withdrawal by Subject|2|||
49057560|NCT04109313|158041407|FG000|Overall Study|Pregnancy|1|||
49057561|NCT04109313|158041407|FG000|Overall Study|Adverse Event|11|||
49057562|NCT04109313|158041407|FG000|Overall Study|Lack of Efficacy|11|||
49057563|NCT04109313|158041407|FG000|Overall Study|Lost to Follow-up|1|||
49057564|NCT04109313|158041407|FG000|Overall Study|Physician Decision|2|||
49057565|NCT04109313|158041407|FG000|Overall Study|Subject Decision|13|||
49057566|NCT04109313|158041407|FG000|Overall Study|Covid-19 situation|2|||
49057567|NCT00892281|158041408|FG000|Overall Study|Adverse Event|65|||
49057568|NCT00892281|158041409|FG001|Overall Study|Adverse Event|8|||
49057569|NCT00892281|158041408|FG000|Overall Study|Lost to Follow-up|81|||
49057570|NCT00892281|158041409|FG001|Overall Study|Lost to Follow-up|8|||
49057571|NCT00892281|158041408|FG000|Overall Study|Pregnancy|1|||
49057572|NCT00892281|158041409|FG001|Overall Study|Pregnancy|0|||
49057573|NCT00892281|158041408|FG000|Overall Study|Protocol Violation|7|||
49057574|NCT00892281|158041409|FG001|Overall Study|Protocol Violation|2|||
49057575|NCT00892281|158041408|FG000|Overall Study|Withdrawal by Subject|86|||
49057576|NCT00892281|158041409|FG001|Overall Study|Withdrawal by Subject|14|||
49057577|NCT00892281|158041408|FG000|Overall Study|Subject failed to return for final visit|2|||
49057578|NCT00892281|158041409|FG001|Overall Study|Subject failed to return for final visit|0|||
49057579|NCT00892281|158041408|FG000|Overall Study|Subject unable to keep follow-up visits|1|||
49057580|NCT00892281|158041409|FG001|Overall Study|Subject unable to keep follow-up visits|0|||
49057581|NCT00892281|158041408|FG000|Overall Study|Final visit completed 4 weeks late|0|||
49057582|NCT00892281|158041409|FG001|Overall Study|Final visit completed 4 weeks late|1|||
49057583|NCT00892281|158041408|FG000|Overall Study|Subject completed day after study closed|1|||
49057584|NCT00892281|158041409|FG001|Overall Study|Subject completed day after study closed|0|||
49057585|NCT00892281|158041408|FG000|Overall Study|Family emergency|1|||
49057586|NCT00892281|158041409|FG001|Overall Study|Family emergency|0|||
49057587|NCT00892281|158041408|FG000|Overall Study|Last visit not done - death in family|1|||
49057588|NCT00892281|158041409|FG001|Overall Study|Last visit not done - death in family|0|||
49057589|NCT00892281|158041408|FG000|Overall Study|Did not meet incl/excl criteria|1|||
49057590|NCT00892281|158041409|FG001|Overall Study|Did not meet incl/excl criteria|0|||
49057591|NCT00892281|158041408|FG000|Overall Study|Rosacea cleared; subject D/C'd self|1|||
49057592|NCT00892281|158041409|FG001|Overall Study|Rosacea cleared; subject D/C'd self|0|||
49057593|NCT00892281|158041408|FG000|Overall Study|Unable to redeem the drug voucher|1|||
49057594|NCT00892281|158041409|FG001|Overall Study|Unable to redeem the drug voucher|0|||
49057595|NCT00892281|158041408|FG000|Overall Study|Subject not good candidate for study|1|||
49057596|NCT00892281|158041409|FG001|Overall Study|Subject not good candidate for study|0|||
49057597|NCT00892281|158041408|FG000|Overall Study|Subject did not return for any visits|1|||
49057598|NCT00892281|158041409|FG001|Overall Study|Subject did not return for any visits|0|||
49057599|NCT00892281|158041408|FG000|Overall Study|Subject missed several visits/lost meds|1|||
49057600|NCT00892281|158041409|FG001|Overall Study|Subject missed several visits/lost meds|0|||
49057601|NCT00892281|158041408|FG000|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
49057602|NCT00892281|158041409|FG001|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
49057603|NCT00892281|158041408|FG000|Overall Study|Scheduled for knee replacement|0|||
49057604|NCT00892281|158041409|FG001|Overall Study|Scheduled for knee replacement|1|||
49057605|NCT00892281|158041408|FG000|Overall Study|PI complained of inadequate compensation|3|||
49057606|NCT00892281|158041409|FG001|Overall Study|PI complained of inadequate compensation|0|||
49057607|NCT00892281|158041408|FG000|Overall Study|Subject lost interest in program|0|||
49057608|NCT00892281|158041409|FG001|Overall Study|Subject lost interest in program|1|||
49057609|NCT00892281|158041408|FG000|Overall Study|Bad taste in mouth after taking Oracea®|0|||
49057610|NCT00892281|158041409|FG001|Overall Study|Bad taste in mouth after taking Oracea®|1|||
49057611|NCT00892281|158041408|FG000|Overall Study|Death in family|1|||
49057612|NCT00892281|158041409|FG001|Overall Study|Death in family|0|||
49057613|NCT00892281|158041408|FG000|Overall Study|Lack of efficacy of study product|2|||
49057614|NCT00892281|158041409|FG001|Overall Study|Lack of efficacy of study product|0|||
49057615|NCT00892281|158041408|FG000|Overall Study|Subject not seen by PI at final visit|1|||
49057616|NCT00892281|158041409|FG001|Overall Study|Subject not seen by PI at final visit|0|||
49057617|NCT00892281|158041408|FG000|Overall Study|No show Visit 2; prescription not filled|1|||
49057618|NCT00892281|158041409|FG001|Overall Study|No show Visit 2; prescription not filled|0|||
49057619|NCT00892281|158041408|FG000|Overall Study|Missed multiple visits|1|||
49057620|NCT00892281|158041409|FG001|Overall Study|Missed multiple visits|0|||
49057621|NCT00892281|158041408|FG000|Overall Study|Missed visits rescheduled out of window|1|||
49057622|NCT00892281|158041409|FG001|Overall Study|Missed visits rescheduled out of window|0|||
49057623|NCT00892281|158041408|FG000|Overall Study|Non-compliant with visits as scheduled|1|||
49057624|NCT00892281|158041409|FG001|Overall Study|Non-compliant with visits as scheduled|0|||
49057625|NCT00892281|158041408|FG000|Overall Study|Subject had history of drug abuse|1|||
49057626|NCT00892281|158041409|FG001|Overall Study|Subject had history of drug abuse|0|||
49057627|NCT00892281|158041408|FG000|Overall Study|Rash on hand|1|||
49057628|NCT00892281|158041409|FG001|Overall Study|Rash on hand|0|||
49057629|NCT00892281|158041408|FG000|Overall Study|Visit 4 date out of window|1|||
49057630|NCT00892281|158041409|FG001|Overall Study|Visit 4 date out of window|0|||
49057631|NCT02973321|158041415|FG000|Overall Study|Other than specified|0|||
49057632|NCT02973321|158041416|FG001|Overall Study|Other than specified|5|||
49057633|NCT02973321|158041417|FG002|Overall Study|Other than specified|3|||
49057634|NCT02973321|158041418|FG003|Overall Study|Other than specified|3|||
49057635|NCT02973321|158041419|FG004|Overall Study|Other than specified|1|||
49057636|NCT02973321|158041415|FG000|Overall Study|Lack of Efficacy|0|||
49057637|NCT02973321|158041416|FG001|Overall Study|Lack of Efficacy|0|||
49057638|NCT02973321|158041417|FG002|Overall Study|Lack of Efficacy|0|||
49057639|NCT02973321|158041418|FG003|Overall Study|Lack of Efficacy|0|||
49057640|NCT02973321|158041419|FG004|Overall Study|Lack of Efficacy|1|||
49057641|NCT02973321|158041415|FG000|Overall Study|Adverse Event|1|||
49057642|NCT02973321|158041416|FG001|Overall Study|Adverse Event|10|||
49057643|NCT02973321|158041417|FG002|Overall Study|Adverse Event|11|||
49057644|NCT02973321|158041418|FG003|Overall Study|Adverse Event|13|||
49057645|NCT02973321|158041419|FG004|Overall Study|Adverse Event|3|||
49057646|NCT01048502|158041420|FG000|Overall Study|Lost to Follow-up|2|||
49057647|NCT01048502|158041421|FG001|Overall Study|Lost to Follow-up|0|||
49057648|NCT01048502|158041422|FG002|Overall Study|Lost to Follow-up|0|||
49057649|NCT01048502|158041423|FG003|Overall Study|Lost to Follow-up|0|||
49057650|NCT01048502|158041420|FG000|Overall Study|Adverse Event|1|||
49057651|NCT01048502|158041421|FG001|Overall Study|Adverse Event|0|||
49057652|NCT01048502|158041422|FG002|Overall Study|Adverse Event|0|||
49057653|NCT01048502|158041423|FG003|Overall Study|Adverse Event|0|||
49057654|NCT01048502|158041420|FG000|Overall Study|Withdrawal by Subject|1|||
49057655|NCT01048502|158041421|FG001|Overall Study|Withdrawal by Subject|4|||
49057656|NCT01048502|158041422|FG002|Overall Study|Withdrawal by Subject|5|||
49057657|NCT01048502|158041423|FG003|Overall Study|Withdrawal by Subject|3|||
49057658|NCT01048502|158041420|FG000|Overall Study|Physician Decision|0|||
49057659|NCT01048502|158041421|FG001|Overall Study|Physician Decision|3|||
49057660|NCT01048502|158041422|FG002|Overall Study|Physician Decision|0|||
49057661|NCT01048502|158041423|FG003|Overall Study|Physician Decision|1|||
49057662|NCT03235479|158041424|FG000|Overall Study|Lost to Follow-up|8|||
49057663|NCT03235479|158041425|FG001|Overall Study|Lost to Follow-up|11|||
49057664|NCT03235479|158041424|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|23|||
49057665|NCT03235479|158041425|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|17|||
49057666|NCT03235479|158041424|FG000|Overall Study|Pregnancy|1|||
49057667|NCT03235479|158041425|FG001|Overall Study|Pregnancy|0|||
49057668|NCT03235479|158041424|FG000|Overall Study|Protocol Deviation|1|||
49057669|NCT03235479|158041425|FG001|Overall Study|Protocol Deviation|3|||
49057670|NCT03235479|158041424|FG000|Overall Study|Technical Problems|3|||
49057671|NCT03235479|158041425|FG001|Overall Study|Technical Problems|2|||
49057672|NCT03235479|158041424|FG000|Overall Study|Withdrawal by Subject|2|||
49057673|NCT03235479|158041425|FG001|Overall Study|Withdrawal by Subject|2|||
49057674|NCT03235479|158041424|FG000|Overall Study|Other Reasons|3|||
49057675|NCT03235479|158041425|FG001|Overall Study|Other Reasons|5|||
49057676|NCT00685802|158041426|FG000|Washout Period of 7 Days|Protocol Violation|2|||
49057677|NCT00685802|158041427|FG001|Washout Period of 7 Days|Protocol Violation|0|||
49057678|NCT00685802|158041426|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
49057679|NCT00685802|158041427|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
49057680|NCT05212883|158041433|FG000|Overall Study|Invalid test result|125|||
49057681|NCT02470091|158041434|FG000|Overall Study|Withdrawal by Subject|1|||
49057682|NCT02470091|158041435|FG001|Overall Study|Withdrawal by Subject|0|||
49057683|NCT02470091|158041434|FG000|Overall Study|Ineligible|0|||
49057684|NCT02470091|158041435|FG001|Overall Study|Ineligible|2|||
49057685|NCT01103479|158041438|FG000|Overall Study|Up to date with CRC screening|1|||
49057686|NCT01103479|158041439|FG001|Overall Study|Up to date with CRC screening|9|||
49057687|NCT01103479|158041440|FG002|Overall Study|Up to date with CRC screening|12|||
49057688|NCT01103479|158041438|FG000|Overall Study|Family history of CRC|1|||
49057689|NCT01103479|158041439|FG001|Overall Study|Family history of CRC|0|||
49057690|NCT01103479|158041440|FG002|Overall Study|Family history of CRC|2|||
49057691|NCT01103479|158041438|FG000|Overall Study|Active cancer|1|||
49057692|NCT01103479|158041439|FG001|Overall Study|Active cancer|0|||
49057693|NCT01103479|158041440|FG002|Overall Study|Active cancer|0|||
49057694|NCT01103479|158041438|FG000|Overall Study|Saw non-study physician|2|||
49057695|NCT01103479|158041439|FG001|Overall Study|Saw non-study physician|0|||
49057696|NCT01103479|158041440|FG002|Overall Study|Saw non-study physician|0|||
49057697|NCT01355159|158041441|FG000|Overall Study|Withdrew consent|39|||
49057698|NCT01355159|158041442|FG001|Overall Study|Withdrew consent|47|||
49057699|NCT01355159|158041441|FG000|Overall Study|No primary outcome data|17|||
49057700|NCT01355159|158041442|FG001|Overall Study|No primary outcome data|11|||
49057701|NCT01355159|158041441|FG000|Overall Study|Spontaneous abortion (<20 weeks)|22|||
49057702|NCT01355159|158041442|FG001|Overall Study|Spontaneous abortion (<20 weeks)|15|||
49057703|NCT01355159|158041441|FG000|Overall Study|Early intrauterine fetal death|6|||
49057704|NCT01355159|158041442|FG001|Overall Study|Early intrauterine fetal death|6|||
49057705|NCT00834899|158041443|FG000|Overall Study|Withdrawal by Subject|1|||
49057706|NCT00834899|158041444|FG001|Overall Study|Withdrawal by Subject|1|||
49057707|NCT01534637|158041445|FG000|Overall Study|Physician Decision|3|||
49057708|NCT01534637|158041445|FG000|Overall Study|Lack of Efficacy|3|||
49057709|NCT01534637|158041445|FG000|Overall Study|Withdrawal by Subject|1|||
49057710|NCT01534637|158041445|FG000|Overall Study|Adverse Event|1|||
49057711|NCT01534637|158041445|FG000|Overall Study|Liver Mets before treatment|1|||
49057712|NCT01523587|158041446|FG000|Overall Study|Other than listed|5|||
49057713|NCT01523587|158041447|FG001|Overall Study|Other than listed|5|||
49057714|NCT01523587|158041446|FG000|Overall Study|Worsening of underlying cancer disease|19|||
49057715|NCT01523587|158041447|FG001|Overall Study|Worsening of underlying cancer disease|34|||
49057716|NCT01523587|158041446|FG000|Overall Study|Adverse Event|68|||
49057717|NCT01523587|158041447|FG001|Overall Study|Adverse Event|52|||
49057718|NCT01523587|158041446|FG000|Overall Study|Protocol Violation|5|||
49057719|NCT01523587|158041447|FG001|Overall Study|Protocol Violation|3|||
49057720|NCT01523587|158041446|FG000|Overall Study|Lost to Follow-up|2|||
49057721|NCT01523587|158041447|FG001|Overall Study|Lost to Follow-up|2|||
49057722|NCT01523587|158041446|FG000|Overall Study|Withdrawal by Subject|28|||
49057723|NCT01523587|158041447|FG001|Overall Study|Withdrawal by Subject|20|||
49057724|NCT01523587|158041446|FG000|Overall Study|Withdrew due to Progressive disease|265|||
49057725|NCT01523587|158041447|FG001|Overall Study|Withdrew due to Progressive disease|279|||
49057726|NCT01523587|158041446|FG000|Overall Study|Randomised but bot treated|6|||
49057727|NCT01523587|158041447|FG001|Overall Study|Randomised but bot treated|2|||
49057728|NCT01194973|158041454|FG000|Screening Period|Screen Failure|3|||
49057729|NCT01194973|158041454|FG000|26 Week Treatment Period|Adverse Event|1|||
49057730|NCT01194973|158041454|FG000|26 Week Treatment Period|Lack of Efficacy|1|||
49057731|NCT01194973|158041454|FG000|26 Week Treatment Period|Pregnancy|1|||
49057732|NCT01663727|158041455|FG000|Overall Study|Death|161|||
49057733|NCT01663727|158041456|FG001|Overall Study|Death|155|||
49057734|NCT01663727|158041455|FG000|Overall Study|Lost to Follow-up|10|||
49057735|NCT01663727|158041456|FG001|Overall Study|Lost to Follow-up|8|||
49057736|NCT01663727|158041455|FG000|Overall Study|Withdrawal by Subject|18|||
49057737|NCT01663727|158041456|FG001|Overall Study|Withdrawal by Subject|25|||
49057738|NCT01663727|158041455|FG000|Overall Study|Study Terminated|51|||
49057739|NCT01663727|158041456|FG001|Overall Study|Study Terminated|50|||
49057740|NCT01663727|158041455|FG000|Overall Study|Withdrawal by subject and Adverse Event.|1|||
49057741|NCT01663727|158041456|FG001|Overall Study|Withdrawal by subject and Adverse Event.|0|||
49057742|NCT01663727|158041455|FG000|Overall Study|Withdrawal prior to dosing.|1|||
49057743|NCT01663727|158041456|FG001|Overall Study|Withdrawal prior to dosing.|0|||
49057744|NCT02924376|158041463|FG000|Overall Study|Progressive Disease|4|||
49057745|NCT02924376|158041464|FG001|Overall Study|Progressive Disease|0|||
49057746|NCT02924376|158041465|FG002|Overall Study|Progressive Disease|1|||
49057747|NCT02924376|158041466|FG003|Overall Study|Progressive Disease|0|||
49057748|NCT02924376|158041463|FG000|Overall Study|Death|73|||
49057749|NCT02924376|158041464|FG001|Overall Study|Death|18|||
49057750|NCT02924376|158041465|FG002|Overall Study|Death|15|||
49057751|NCT02924376|158041466|FG003|Overall Study|Death|2|||
49057752|NCT02924376|158041463|FG000|Overall Study|Lost to Follow-up|3|||
49057753|NCT02924376|158041464|FG001|Overall Study|Lost to Follow-up|0|||
49057754|NCT02924376|158041465|FG002|Overall Study|Lost to Follow-up|0|||
49057755|NCT02924376|158041466|FG003|Overall Study|Lost to Follow-up|0|||
49057756|NCT02924376|158041463|FG000|Overall Study|Study Terminated by Sponsor|19|||
49057757|NCT02924376|158041464|FG001|Overall Study|Study Terminated by Sponsor|0|||
49057758|NCT02924376|158041465|FG002|Overall Study|Study Terminated by Sponsor|0|||
49057759|NCT02924376|158041466|FG003|Overall Study|Study Terminated by Sponsor|0|||
49057760|NCT02924376|158041463|FG000|Overall Study|Physician Decision|1|||
49057761|NCT02924376|158041464|FG001|Overall Study|Physician Decision|0|||
49057762|NCT02924376|158041465|FG002|Overall Study|Physician Decision|0|||
49057763|NCT02924376|158041466|FG003|Overall Study|Physician Decision|0|||
49057764|NCT02924376|158041463|FG000|Overall Study|Withdrawal by Subject|7|||
49057765|NCT02924376|158041464|FG001|Overall Study|Withdrawal by Subject|2|||
49057766|NCT02924376|158041465|FG002|Overall Study|Withdrawal by Subject|1|||
49057767|NCT02924376|158041466|FG003|Overall Study|Withdrawal by Subject|0|||
49057768|NCT02924376|158041463|FG000|Overall Study|Rolled Over to Another Study|1|||
49057769|NCT02924376|158041464|FG001|Overall Study|Rolled Over to Another Study|0|||
49057770|NCT02924376|158041465|FG002|Overall Study|Rolled Over to Another Study|0|||
49057771|NCT02924376|158041466|FG003|Overall Study|Rolled Over to Another Study|0|||
49057772|NCT01640873|158041467|FG000|Overall Study|Protocol Violation|2|||
49057773|NCT01640873|158041468|FG001|Overall Study|Protocol Violation|1|||
49057774|NCT00720226|158041469|FG000|Overall Study|Withdrawal by Subject|7|||
49057775|NCT00720226|158041470|FG001|Overall Study|Withdrawal by Subject|4|||
49057776|NCT00958126|158041471|FG000|Overall Study|Serious Adverse Event|0|||
49057777|NCT00958126|158041472|FG001|Overall Study|Serious Adverse Event|2|||
49057778|NCT00958126|158041473|FG002|Overall Study|Serious Adverse Event|0|||
49057779|NCT00958126|158041474|FG003|Overall Study|Serious Adverse Event|0|||
49057780|NCT00958126|158041475|FG004|Overall Study|Serious Adverse Event|0|||
49057781|NCT00958126|158041476|FG005|Overall Study|Serious Adverse Event|0|||
49057782|NCT00958126|158041477|FG006|Overall Study|Serious Adverse Event|1|||
49057783|NCT00958126|158041478|FG007|Overall Study|Serious Adverse Event|0|||
49057784|NCT00958126|158041471|FG000|Overall Study|Withdrawal by Subject|0|||
49057785|NCT00958126|158041472|FG001|Overall Study|Withdrawal by Subject|2|||
49057786|NCT00958126|158041473|FG002|Overall Study|Withdrawal by Subject|0|||
49057787|NCT00958126|158041474|FG003|Overall Study|Withdrawal by Subject|0|||
49057788|NCT00958126|158041475|FG004|Overall Study|Withdrawal by Subject|0|||
49057789|NCT00958126|158041476|FG005|Overall Study|Withdrawal by Subject|0|||
49057790|NCT00958126|158041477|FG006|Overall Study|Withdrawal by Subject|0|||
49057791|NCT00958126|158041478|FG007|Overall Study|Withdrawal by Subject|0|||
49057792|NCT00958126|158041471|FG000|Overall Study|Moved away from study area|0|||
49057793|NCT00958126|158041472|FG001|Overall Study|Moved away from study area|0|||
49057794|NCT00958126|158041473|FG002|Overall Study|Moved away from study area|1|||
49057795|NCT00958126|158041474|FG003|Overall Study|Moved away from study area|1|||
49057796|NCT00958126|158041475|FG004|Overall Study|Moved away from study area|0|||
49057797|NCT00958126|158041476|FG005|Overall Study|Moved away from study area|0|||
49057798|NCT00958126|158041477|FG006|Overall Study|Moved away from study area|0|||
49057799|NCT00958126|158041478|FG007|Overall Study|Moved away from study area|0|||
49057800|NCT00958126|158041471|FG000|Overall Study|Lost to Follow-up|1|||
49057801|NCT00958126|158041472|FG001|Overall Study|Lost to Follow-up|5|||
49057802|NCT00958126|158041473|FG002|Overall Study|Lost to Follow-up|9|||
49057803|NCT00958126|158041474|FG003|Overall Study|Lost to Follow-up|8|||
49057804|NCT00958126|158041475|FG004|Overall Study|Lost to Follow-up|0|||
49057805|NCT00958126|158041476|FG005|Overall Study|Lost to Follow-up|0|||
49057806|NCT00958126|158041477|FG006|Overall Study|Lost to Follow-up|0|||
49057807|NCT00958126|158041478|FG007|Overall Study|Lost to Follow-up|0|||
49057808|NCT00958126|158041471|FG000|Overall Study|Sponsor/Investigator decision|0|||
49057809|NCT00958126|158041472|FG001|Overall Study|Sponsor/Investigator decision|0|||
49057810|NCT00958126|158041473|FG002|Overall Study|Sponsor/Investigator decision|0|||
49057811|NCT00958126|158041474|FG003|Overall Study|Sponsor/Investigator decision|1|||
49057812|NCT00958126|158041475|FG004|Overall Study|Sponsor/Investigator decision|0|||
49057813|NCT00958126|158041476|FG005|Overall Study|Sponsor/Investigator decision|0|||
49057814|NCT00958126|158041477|FG006|Overall Study|Sponsor/Investigator decision|0|||
49057815|NCT00958126|158041478|FG007|Overall Study|Sponsor/Investigator decision|0|||
49057816|NCT00958126|158041471|FG000|Overall Study|Other Reason|0|||
49057817|NCT00958126|158041472|FG001|Overall Study|Other Reason|0|||
49057818|NCT00958126|158041473|FG002|Overall Study|Other Reason|0|||
49057819|NCT00958126|158041474|FG003|Overall Study|Other Reason|1|||
49057820|NCT00958126|158041475|FG004|Overall Study|Other Reason|0|||
49057821|NCT00958126|158041476|FG005|Overall Study|Other Reason|1|||
49057822|NCT00958126|158041477|FG006|Overall Study|Other Reason|0|||
49057823|NCT00958126|158041478|FG007|Overall Study|Other Reason|0|||
49057824|NCT03401073|158041479|FG000|Overall Study|Lost to Follow-up|1|||
49057825|NCT03401073|158041480|FG001|Overall Study|Lost to Follow-up|2|||
49057826|NCT01470612|158041481|FG000|Overall Study|Adverse Event|20|||
49057827|NCT01470612|158041482|FG001|Overall Study|Adverse Event|80|||
49057828|NCT01470612|158041481|FG000|Overall Study|Death|0|||
49057829|NCT01470612|158041482|FG001|Overall Study|Death|1|||
49057830|NCT01470612|158041481|FG000|Overall Study|Lack of Efficacy|20|||
49057831|NCT01470612|158041482|FG001|Overall Study|Lack of Efficacy|326|||
49057832|NCT01470612|158041481|FG000|Overall Study|Lost to Follow-up|2|||
49057833|NCT01470612|158041482|FG001|Overall Study|Lost to Follow-up|5|||
49057834|NCT01470612|158041481|FG000|Overall Study|Did not meet entrance criteria|0|||
49057835|NCT01470612|158041482|FG001|Overall Study|Did not meet entrance criteria|1|||
49057836|NCT01470612|158041481|FG000|Overall Study|Pregnancy|2|||
49057837|NCT01470612|158041482|FG001|Overall Study|Pregnancy|10|||
49057838|NCT01470612|158041481|FG000|Overall Study|Protocol Violation|2|||
49057839|NCT01470612|158041482|FG001|Overall Study|Protocol Violation|7|||
49057840|NCT01470612|158041481|FG000|Overall Study|Withdrawal by Subject|24|||
49057841|NCT01470612|158041482|FG001|Overall Study|Withdrawal by Subject|79|||
49057842|NCT01470612|158041481|FG000|Overall Study|Other|14|||
49057843|NCT01470612|158041482|FG001|Overall Study|Other|156|||
49057844|NCT00706355|158041483|FG000|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1|||
49057845|NCT00706355|158041484|FG001|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
49057846|NCT00706355|158041485|FG002|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
49057847|NCT00706355|158041486|FG003|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
49057848|NCT00706355|158041483|FG000|Period 1: PF-04217903 50 mg|Objective progression or relapse|2|||
49057849|NCT00706355|158041484|FG001|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
49057850|NCT00706355|158041485|FG002|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
49057851|NCT00706355|158041486|FG003|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
49057852|NCT00706355|158041483|FG000|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
49057853|NCT00706355|158041484|FG001|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1|||
49057854|NCT00706355|158041485|FG002|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
49057855|NCT00706355|158041486|FG003|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
49057856|NCT00706355|158041483|FG000|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
49057857|NCT00706355|158041484|FG001|Period 2: PF-04217903 100 mg|Global deterioration of health status|1|||
49057858|NCT00706355|158041485|FG002|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
49057859|NCT00706355|158041486|FG003|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
49057860|NCT00706355|158041483|FG000|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
49057861|NCT00706355|158041484|FG001|Period 2: PF-04217903 100 mg|Objective progression or relapse|5|||
49057862|NCT00706355|158041485|FG002|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
49057863|NCT00706355|158041486|FG003|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
49057864|NCT00706355|158041483|FG000|Period 3: PF-04217903 200 mg|Adverse Event|0|||
49057865|NCT00706355|158041484|FG001|Period 3: PF-04217903 200 mg|Adverse Event|0|||
49057866|NCT00706355|158041485|FG002|Period 3: PF-04217903 200 mg|Adverse Event|1|||
49057867|NCT00706355|158041486|FG003|Period 3: PF-04217903 200 mg|Adverse Event|0|||
49057868|NCT00706355|158041483|FG000|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
49057869|NCT00706355|158041484|FG001|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
49057870|NCT00706355|158041485|FG002|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1|||
49057871|NCT00706355|158041486|FG003|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
49057872|NCT00706355|158041483|FG000|Period 4: PF-04217903 150 mg|Adverse Event|0|||
49057873|NCT00706355|158041484|FG001|Period 4: PF-04217903 150 mg|Adverse Event|0|||
49057874|NCT00706355|158041485|FG002|Period 4: PF-04217903 150 mg|Adverse Event|0|||
49057875|NCT00706355|158041486|FG003|Period 4: PF-04217903 150 mg|Adverse Event|2|||
49057876|NCT00706355|158041483|FG000|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
49057877|NCT00706355|158041484|FG001|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
49057878|NCT00706355|158041485|FG002|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
49057879|NCT00706355|158041486|FG003|Period 4: PF-04217903 150 mg|Objective progression or relapse|2|||
49057880|NCT01506908|158041487|FG000|Overall Study|Adverse Event|1|||
49057881|NCT01506908|158041488|FG001|Overall Study|Adverse Event|0|||
49057882|NCT02510014|158041489|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
49057883|NCT02510014|158041490|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
49057884|NCT02510014|158041489|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1|||
49057885|NCT02510014|158041490|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0|||
49057886|NCT02510014|158041489|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44|||
49057887|NCT02510014|158041490|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3|||
49057888|NCT02510014|158041489|FG000|Run-In Period (Days -14 to Day -1)|Physician Decision|0|||
49057889|NCT02510014|158041490|FG001|Run-In Period (Days -14 to Day -1)|Physician Decision|1|||
49057890|NCT02510014|158041489|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22|||
49057891|NCT02510014|158041490|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3|||
49057892|NCT02510014|158041489|FG000|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7|||
49057893|NCT02510014|158041490|FG001|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1|||
49057894|NCT02510014|158041489|FG000|Run-In Period (Days -14 to Day -1)|Protocol Violation|2|||
49057895|NCT02510014|158041490|FG001|Run-In Period (Days -14 to Day -1)|Protocol Violation|0|||
49057896|NCT02510014|158041489|FG000|Run-In Period (Days -14 to Day -1)|Other|19|||
49057897|NCT02510014|158041490|FG001|Run-In Period (Days -14 to Day -1)|Other|1|||
49057898|NCT02510014|158041489|FG000|Treatment Period|Adverse Event|11|||
49057899|NCT02510014|158041490|FG001|Treatment Period|Adverse Event|4|||
49057900|NCT02510014|158041489|FG000|Treatment Period|Withdrawal symptoms|3|||
49057901|NCT02510014|158041490|FG001|Treatment Period|Withdrawal symptoms|0|||
49057902|NCT02510014|158041489|FG000|Treatment Period|Lost to Follow-up|80|||
49057903|NCT02510014|158041490|FG001|Treatment Period|Lost to Follow-up|19|||
49057904|NCT02510014|158041489|FG000|Treatment Period|Physician Decision|5|||
49057905|NCT02510014|158041490|FG001|Treatment Period|Physician Decision|0|||
49057906|NCT02510014|158041489|FG000|Treatment Period|Withdrawal by Subject|67|||
49057907|NCT02510014|158041490|FG001|Treatment Period|Withdrawal by Subject|24|||
49057908|NCT02510014|158041489|FG000|Treatment Period|Withdrawn by the investigator|7|||
49057909|NCT02510014|158041490|FG001|Treatment Period|Withdrawn by the investigator|1|||
49057910|NCT02510014|158041489|FG000|Treatment Period|Protocol Violation|4|||
49057911|NCT02510014|158041490|FG001|Treatment Period|Protocol Violation|4|||
49057912|NCT02510014|158041489|FG000|Treatment Period|Incarceration, pregnancy, misc|29|||
49057913|NCT02510014|158041490|FG001|Treatment Period|Incarceration, pregnancy, misc|5|||
49057914|NCT03336242|158041491|FG000|Overall Study|Adverse Event|0|||
49057915|NCT03336242|158041492|FG001|Overall Study|Adverse Event|1|||
49057916|NCT00359632|158041493|FG000|Overall Study|Death|2|||
49057917|NCT00359632|158041494|FG001|Overall Study|Death|0|||
49057918|NCT00359632|158041493|FG000|Overall Study|Adverse Event|1|||
49057919|NCT00359632|158041494|FG001|Overall Study|Adverse Event|0|||
49057920|NCT00359632|158041493|FG000|Overall Study|Non-compliance with visit schedule|1|||
49057921|NCT00359632|158041494|FG001|Overall Study|Non-compliance with visit schedule|0|||
49057922|NCT01875471|158041499|FG000|Overall Study|Adverse Event|0|||
49057923|NCT01875471|158041500|FG001|Overall Study|Adverse Event|1|||
49057924|NCT01875471|158041499|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
49057925|NCT01875471|158041500|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
49057926|NCT02610816|158041506|FG000|Phase 1|Withdrawal by Subject|2|||
49057927|NCT02610816|158041507|FG001|Phase 1|Withdrawal by Subject|6|||
49057928|NCT02610816|158041508|FG002|Phase 1|Withdrawal by Subject|0|||
49057929|NCT02610816|158041509|FG003|Phase 1|Withdrawal by Subject|0|||
49057930|NCT02610816|158041506|FG000|Phase 1|Lost to Follow-up|2|||
49057931|NCT02610816|158041507|FG001|Phase 1|Lost to Follow-up|1|||
49057932|NCT02610816|158041508|FG002|Phase 1|Lost to Follow-up|0|||
49057933|NCT02610816|158041509|FG003|Phase 1|Lost to Follow-up|0|||
49057934|NCT02610816|158041506|FG000|Phase 1|Physician Decision|0|||
49057935|NCT02610816|158041507|FG001|Phase 1|Physician Decision|1|||
49057936|NCT02610816|158041508|FG002|Phase 1|Physician Decision|0|||
49057937|NCT02610816|158041509|FG003|Phase 1|Physician Decision|0|||
49057938|NCT02610816|158041506|FG000|Phase 2|Withdrawal by Subject|0|||
49057939|NCT02610816|158041507|FG001|Phase 2|Withdrawal by Subject|0|||
49057940|NCT02610816|158041508|FG002|Phase 2|Withdrawal by Subject|9|||
49057941|NCT02610816|158041509|FG003|Phase 2|Withdrawal by Subject|3|||
49057942|NCT02610816|158041506|FG000|Phase 2|Lost to Follow-up|0|||
49057943|NCT02610816|158041507|FG001|Phase 2|Lost to Follow-up|0|||
49057944|NCT02610816|158041508|FG002|Phase 2|Lost to Follow-up|2|||
49057945|NCT02610816|158041509|FG003|Phase 2|Lost to Follow-up|0|||
49057946|NCT02610816|158041506|FG000|Phase 2|Physician Decision|0|||
49057947|NCT02610816|158041507|FG001|Phase 2|Physician Decision|0|||
49057948|NCT02610816|158041508|FG002|Phase 2|Physician Decision|0|||
49057949|NCT02610816|158041509|FG003|Phase 2|Physician Decision|2|||
49057950|NCT02610816|158041506|FG000|Phase 2|Pregnancy|0|||
49057951|NCT02610816|158041507|FG001|Phase 2|Pregnancy|0|||
49057952|NCT02610816|158041508|FG002|Phase 2|Pregnancy|0|||
49057953|NCT02610816|158041509|FG003|Phase 2|Pregnancy|1|||
49057954|NCT03629028|158041512|FG000|Overall Study|Lost to Follow-up|26|||
49057955|NCT03629028|158041513|FG001|Overall Study|Lost to Follow-up|23|||
49057956|NCT03629028|158041512|FG000|Overall Study|Pregnancy|4|||
49057957|NCT03629028|158041513|FG001|Overall Study|Pregnancy|2|||
49057958|NCT03629028|158041512|FG000|Overall Study|intolerance to examination|2|||
49057959|NCT03629028|158041513|FG001|Overall Study|intolerance to examination|0|||
49057960|NCT00766831|158041514|FG000|Overall Study|Withdrawal by Subject|4|||
49057961|NCT00766831|158041514|FG000|Overall Study|Lost to Follow-up|3|||
49057962|NCT00766831|158041514|FG000|Overall Study|Adverse Event|20|||
49057963|NCT00766831|158041514|FG000|Overall Study|Protocol Violation|15|||
49057964|NCT00766831|158041514|FG000|Overall Study|Physician Decision|5|||
49057965|NCT00766831|158041514|FG000|Overall Study|Withdrawal of consent|26|||
49057966|NCT00766831|158041514|FG000|Overall Study|Non cooperation by participants|14|||
49057967|NCT00766831|158041514|FG000|Overall Study|Other|28|||
49057968|NCT00502801|158041515|FG000|Treatment Period|Withdrawal by Subject|3|||
49057969|NCT00502801|158041515|FG000|Treatment Period|Adverse Event|7|||
49057970|NCT00502801|158041515|FG000|Treatment Period|Death|14|||
49057971|NCT00502801|158041515|FG000|Treatment Period|OTHER|30|||
49057972|NCT00502801|158041515|FG000|End of Therapy to Test of Cure|Withdrawal by Subject|1|||
49057973|NCT00502801|158041515|FG000|End of Therapy to Test of Cure|Lost to Follow-up|2|||
49057974|NCT00502801|158041515|FG000|End of Therapy to Test of Cure|Death|3|||
49057975|NCT00502801|158041515|FG000|End of Therapy to Test of Cure|OTHER|2|||
49057976|NCT00731549|158041518|FG000|Overall Study|Lost to Follow-up|19|||
49057977|NCT00731549|158041518|FG000|Overall Study|Met withdrawal criteria|24|||
49057978|NCT00731549|158041518|FG000|Overall Study|Physician Decision|16|||
49057979|NCT00731549|158041518|FG000|Overall Study|Withdrawal by Subject|89|||
49057980|NCT00731549|158041518|FG000|Overall Study|Protocol deviation|1|||
49057981|NCT00731549|158041518|FG000|Overall Study|Adverse Event|31|||
49057982|NCT00731549|158041518|FG000|Overall Study|Lack of efficacy with AE|37|||
49057983|NCT00731549|158041518|FG000|Overall Study|Lack of efficacy without AE|6|||
49057984|NCT01393730|158041519|FG000|Overall Study|Withdrawal by Subject|3|||
49057985|NCT01393730|158041519|FG000|Overall Study|Other|2|||
49057986|NCT01393730|158041519|FG000|Overall Study|Adverse Event|1|||
49057987|NCT00103402|158041520|FG000|Overall Study|Adverse Event|3|||
49057988|NCT00103402|158041521|FG001|Overall Study|Adverse Event|4|||
49057989|NCT00103402|158041520|FG000|Overall Study|Lost to Follow-up|8|||
49057990|NCT00103402|158041521|FG001|Overall Study|Lost to Follow-up|7|||
49057991|NCT00103402|158041520|FG000|Overall Study|Dissatisfied/No longer interested|6|||
49057992|NCT00103402|158041521|FG001|Overall Study|Dissatisfied/No longer interested|6|||
49057993|NCT00103402|158041520|FG000|Overall Study|Personal constraints/Other|5|||
49057994|NCT00103402|158041521|FG001|Overall Study|Personal constraints/Other|0|||
49057995|NCT05810285|158041524|FG000|Overall Study|Death|4|||
49057996|NCT05810285|158041525|FG001|Overall Study|Death|21|||
49057997|NCT05810285|158041524|FG000|Overall Study|Adverse Event|18|||
49057998|NCT05810285|158041525|FG001|Overall Study|Adverse Event|16|||
49057999|NCT01000610|158043241|FG000|Overall Study|Adverse Event|1|||
49058000|NCT01000610|158043241|FG000|Overall Study|Lost to Follow-up|4|||
49058001|NCT01000610|158043241|FG000|Overall Study|Treatment failure|1|||
49058002|NCT03064438|158043242|FG000|Overall Study|Lost to Follow-up|1|||
49058003|NCT03064438|158043243|FG001|Overall Study|Lost to Follow-up|0|||
49058004|NCT03064438|158043242|FG000|Overall Study|Withdrawal by Subject|0|||
49058005|NCT03064438|158043243|FG001|Overall Study|Withdrawal by Subject|1|||
49058006|NCT00109837|158043244|FG000|Overall Study|Adverse Event|2|||
49058007|NCT00109837|158043244|FG000|Overall Study|Refusal unrelated to adverse effects|1|||
49058008|NCT00109837|158043244|FG000|Overall Study|Death|1|||
49058009|NCT00109837|158043244|FG000|Overall Study|BCR/ABL+ or Ph+|17|||
49058010|NCT00109837|158043244|FG000|Overall Study|Not treated|1|||
49058011|NCT00109837|158043244|FG000|Overall Study|Ineligible|1|||
49058012|NCT01220609|158043250|FG000|Overall Study|Ineligible-Wrong primary cancer site|1|||
49058013|NCT01220609|158043250|FG000|Overall Study|Ineligible- Wrong cell type|1|||
49058014|NCT01220609|158043250|FG000|Overall Study|Ineligible-Never treated|1|||
49058015|NCT00865098|158043251|FG000|Overall Study|Progressive disease|1|||
49058016|NCT00868296|158043261|FG000|Overall Study|Adverse Event|0|||
49058017|NCT00868296|158043262|FG001|Overall Study|Adverse Event|2|||
49058018|NCT00868296|158043261|FG000|Overall Study|Withdrawal by Subject|0|||
49058019|NCT00868296|158043262|FG001|Overall Study|Withdrawal by Subject|1|||
49058020|NCT00112294|158043263|FG000|Overall Study|Still on study|5|||
49058021|NCT00112294|158043264|FG001|Overall Study|Still on study|0|||
49058022|NCT01360866|158043265|FG000|Overall Study|Lost to Follow-up|11|||
49058023|NCT01360866|158043266|FG001|Overall Study|Lost to Follow-up|28|||
49058024|NCT01360866|158043267|FG002|Overall Study|Lost to Follow-up|41|||
49058025|NCT01360866|158043268|FG003|Overall Study|Lost to Follow-up|0|||
49058026|NCT01360866|158043265|FG000|Overall Study|Adverse Event|56|||
49058027|NCT01360866|158043266|FG001|Overall Study|Adverse Event|61|||
49058028|NCT01360866|158043267|FG002|Overall Study|Adverse Event|134|||
49058029|NCT01360866|158043268|FG003|Overall Study|Adverse Event|6|||
49058030|NCT01360866|158043265|FG000|Overall Study|Paticipant met withdrawal criteria|11|||
49058031|NCT01360866|158043266|FG001|Overall Study|Paticipant met withdrawal criteria|28|||
49058032|NCT01360866|158043267|FG002|Overall Study|Paticipant met withdrawal criteria|54|||
49058033|NCT01360866|158043268|FG003|Overall Study|Paticipant met withdrawal criteria|0|||
49058034|NCT01360866|158043265|FG000|Overall Study|Withdrawn by Investigator|9|||
49058035|NCT01360866|158043266|FG001|Overall Study|Withdrawn by Investigator|8|||
49058036|NCT01360866|158043267|FG002|Overall Study|Withdrawn by Investigator|31|||
49058037|NCT01360866|158043268|FG003|Overall Study|Withdrawn by Investigator|2|||
49058038|NCT01360866|158043265|FG000|Overall Study|Withdrawal by participant|79|||
49058039|NCT01360866|158043266|FG001|Overall Study|Withdrawal by participant|89|||
49058040|NCT01360866|158043267|FG002|Overall Study|Withdrawal by participant|168|||
49058041|NCT01360866|158043268|FG003|Overall Study|Withdrawal by participant|8|||
49058042|NCT01360866|158043265|FG000|Overall Study|Protocol Deviation|25|||
49058043|NCT01360866|158043266|FG001|Overall Study|Protocol Deviation|33|||
49058044|NCT01360866|158043267|FG002|Overall Study|Protocol Deviation|61|||
49058045|NCT01360866|158043268|FG003|Overall Study|Protocol Deviation|2|||
49058046|NCT01360866|158043265|FG000|Overall Study|Lack of Efficacy|30|||
49058047|NCT01360866|158043266|FG001|Overall Study|Lack of Efficacy|40|||
49058048|NCT01360866|158043267|FG002|Overall Study|Lack of Efficacy|30|||
49058049|NCT01360866|158043268|FG003|Overall Study|Lack of Efficacy|4|||
49058050|NCT00099268|158043269|FG000|Overall Study|Withdrawal by Subject|46|||
49058051|NCT00099268|158043270|FG001|Overall Study|Withdrawal by Subject|28|||
49058052|NCT00099268|158043269|FG000|Overall Study|Adverse Event|19|||
49058053|NCT00099268|158043270|FG001|Overall Study|Adverse Event|19|||
49058054|NCT00099268|158043269|FG000|Overall Study|Protocol Violation|9|||
49058055|NCT00099268|158043270|FG001|Overall Study|Protocol Violation|8|||
49058056|NCT00099268|158043269|FG000|Overall Study|Lost to Follow-up|6|||
49058057|NCT00099268|158043270|FG001|Overall Study|Lost to Follow-up|4|||
49058058|NCT00099268|158043269|FG000|Overall Study|Lack of Efficacy|5|||
49058059|NCT00099268|158043270|FG001|Overall Study|Lack of Efficacy|18|||
49058060|NCT00099268|158043269|FG000|Overall Study|Administrative problems|4|||
49058061|NCT00099268|158043270|FG001|Overall Study|Administrative problems|4|||
49058062|NCT00099268|158043269|FG000|Overall Study|Death|3|||
49058063|NCT00099268|158043270|FG001|Overall Study|Death|1|||
49058064|NCT03702049|158043274|FG000|Overall Study|Lost to Follow-up|4|||
49058065|NCT03702049|158043274|FG000|Overall Study|Physician Decision|1|||
49058066|NCT01280617|158043275|FG000|Overall Study|Adverse Event|0|||
49058067|NCT01280617|158043276|FG001|Overall Study|Adverse Event|1|||
49058068|NCT03197558|158043277|FG000|Overall Study|Tubes not placed|1|||
49058069|NCT00573170|158043288|FG000|First Treatment Period|Did Not Treat Attack 1|0|||
49058070|NCT00573170|158043289|FG001|First Treatment Period|Did Not Treat Attack 1|0|||
49058071|NCT00573170|158043290|FG002|First Treatment Period|Did Not Treat Attack 1|0|||
49058072|NCT00573170|158043291|FG003|First Treatment Period|Did Not Treat Attack 1|0|||
49058073|NCT00573170|158043292|FG004|First Treatment Period|Did Not Treat Attack 1|1|||
49058074|NCT00573170|158043293|FG005|First Treatment Period|Did Not Treat Attack 1|0|||
49058075|NCT00573170|158043288|FG000|First Washout Period|Adverse Event|1|||
49058076|NCT00573170|158043289|FG001|First Washout Period|Adverse Event|1|||
49058077|NCT00573170|158043290|FG002|First Washout Period|Adverse Event|0|||
49058078|NCT00573170|158043291|FG003|First Washout Period|Adverse Event|0|||
49058079|NCT00573170|158043292|FG004|First Washout Period|Adverse Event|0|||
49058080|NCT00573170|158043293|FG005|First Washout Period|Adverse Event|1|||
49058081|NCT00573170|158043288|FG000|First Washout Period|Lack of Efficacy|0|||
49058082|NCT00573170|158043289|FG001|First Washout Period|Lack of Efficacy|0|||
49058083|NCT00573170|158043290|FG002|First Washout Period|Lack of Efficacy|0|||
49058084|NCT00573170|158043291|FG003|First Washout Period|Lack of Efficacy|0|||
49058085|NCT00573170|158043292|FG004|First Washout Period|Lack of Efficacy|0|||
49058086|NCT00573170|158043293|FG005|First Washout Period|Lack of Efficacy|1|||
49058087|NCT00573170|158043288|FG000|First Washout Period|Lost to Follow-up|1|||
49058088|NCT00573170|158043289|FG001|First Washout Period|Lost to Follow-up|1|||
49058089|NCT00573170|158043290|FG002|First Washout Period|Lost to Follow-up|0|||
49058090|NCT00573170|158043291|FG003|First Washout Period|Lost to Follow-up|2|||
49058091|NCT00573170|158043292|FG004|First Washout Period|Lost to Follow-up|0|||
49058092|NCT00573170|158043293|FG005|First Washout Period|Lost to Follow-up|2|||
49058093|NCT00573170|158043288|FG000|First Washout Period|Withdrawal by Subject|2|||
49058094|NCT00573170|158043289|FG001|First Washout Period|Withdrawal by Subject|0|||
49058095|NCT00573170|158043290|FG002|First Washout Period|Withdrawal by Subject|0|||
49058096|NCT00573170|158043291|FG003|First Washout Period|Withdrawal by Subject|2|||
49058097|NCT00573170|158043292|FG004|First Washout Period|Withdrawal by Subject|3|||
49058098|NCT00573170|158043293|FG005|First Washout Period|Withdrawal by Subject|3|||
49058099|NCT00573170|158043288|FG000|First Washout Period|Other|4|||
49058100|NCT00573170|158043289|FG001|First Washout Period|Other|0|||
49058101|NCT00573170|158043290|FG002|First Washout Period|Other|1|||
49058102|NCT00573170|158043291|FG003|First Washout Period|Other|1|||
49058103|NCT00573170|158043292|FG004|First Washout Period|Other|0|||
49058104|NCT00573170|158043293|FG005|First Washout Period|Other|0|||
49058105|NCT00573170|158043288|FG000|Second Washout Period|Adverse Event|1|||
49058106|NCT00573170|158043289|FG001|Second Washout Period|Adverse Event|0|||
49058107|NCT00573170|158043290|FG002|Second Washout Period|Adverse Event|0|||
49058108|NCT00573170|158043291|FG003|Second Washout Period|Adverse Event|0|||
49058109|NCT00573170|158043292|FG004|Second Washout Period|Adverse Event|1|||
49058110|NCT00573170|158043293|FG005|Second Washout Period|Adverse Event|0|||
49058111|NCT00573170|158043288|FG000|Second Washout Period|Protocol Violation|2|||
49058112|NCT00573170|158043289|FG001|Second Washout Period|Protocol Violation|1|||
49058113|NCT00573170|158043290|FG002|Second Washout Period|Protocol Violation|1|||
49058114|NCT00573170|158043291|FG003|Second Washout Period|Protocol Violation|0|||
49058115|NCT00573170|158043292|FG004|Second Washout Period|Protocol Violation|0|||
49058116|NCT00573170|158043293|FG005|Second Washout Period|Protocol Violation|0|||
49058117|NCT00573170|158043288|FG000|Second Washout Period|Withdrawal by Subject|1|||
49058118|NCT00573170|158043289|FG001|Second Washout Period|Withdrawal by Subject|1|||
49058119|NCT00573170|158043290|FG002|Second Washout Period|Withdrawal by Subject|2|||
49058120|NCT00573170|158043291|FG003|Second Washout Period|Withdrawal by Subject|0|||
49058121|NCT00573170|158043292|FG004|Second Washout Period|Withdrawal by Subject|1|||
49058122|NCT00573170|158043293|FG005|Second Washout Period|Withdrawal by Subject|0|||
49058123|NCT00573170|158043288|FG000|Second Washout Period|Lost to Follow-up|0|||
49058124|NCT00573170|158043289|FG001|Second Washout Period|Lost to Follow-up|0|||
49058125|NCT00573170|158043290|FG002|Second Washout Period|Lost to Follow-up|0|||
49058126|NCT00573170|158043291|FG003|Second Washout Period|Lost to Follow-up|1|||
49058127|NCT00573170|158043292|FG004|Second Washout Period|Lost to Follow-up|0|||
49058128|NCT00573170|158043293|FG005|Second Washout Period|Lost to Follow-up|0|||
49058129|NCT00573170|158043288|FG000|Second Washout Period|Other|1|||
49058130|NCT00573170|158043289|FG001|Second Washout Period|Other|2|||
49058131|NCT00573170|158043290|FG002|Second Washout Period|Other|1|||
49058132|NCT00573170|158043291|FG003|Second Washout Period|Other|4|||
49058133|NCT00573170|158043292|FG004|Second Washout Period|Other|6|||
49058134|NCT00573170|158043293|FG005|Second Washout Period|Other|2|||
49058135|NCT00573170|158043288|FG000|Third Treatment Period|Withdrawal by Subject|1|||
49058136|NCT00573170|158043289|FG001|Third Treatment Period|Withdrawal by Subject|0|||
49058137|NCT00573170|158043290|FG002|Third Treatment Period|Withdrawal by Subject|0|||
49058138|NCT00573170|158043291|FG003|Third Treatment Period|Withdrawal by Subject|0|||
49058139|NCT00573170|158043292|FG004|Third Treatment Period|Withdrawal by Subject|0|||
49058140|NCT00573170|158043293|FG005|Third Treatment Period|Withdrawal by Subject|0|||
49058141|NCT00573170|158043288|FG000|Third Treatment Period|Lost to Follow-up|0|||
49058142|NCT00573170|158043289|FG001|Third Treatment Period|Lost to Follow-up|0|||
49058143|NCT00573170|158043290|FG002|Third Treatment Period|Lost to Follow-up|0|||
49058144|NCT00573170|158043291|FG003|Third Treatment Period|Lost to Follow-up|0|||
49058145|NCT00573170|158043292|FG004|Third Treatment Period|Lost to Follow-up|0|||
49058146|NCT00573170|158043293|FG005|Third Treatment Period|Lost to Follow-up|2|||
49058147|NCT02129647|158043294|FG000|Overall Study|Adverse Event|2|||
49058148|NCT02129647|158043294|FG000|Overall Study|surgical intervention for clinically progressive disease|1|||
49058149|NCT01715896|158043298|FG000|Overall Study|Lost to Follow-up|0|||
49058150|NCT01715896|158043299|FG001|Overall Study|Lost to Follow-up|2|||
49058151|NCT01715896|158043298|FG000|Overall Study|Withdrawal by Subject|1|||
49058152|NCT01715896|158043299|FG001|Overall Study|Withdrawal by Subject|4|||
49058153|NCT01715896|158043298|FG000|Overall Study|Other|2|||
49058154|NCT01715896|158043299|FG001|Overall Study|Other|5|||
49058155|NCT02100319|158043301|FG000|Overall Study|Case Report Forms Uncollected|11|||
49058156|NCT02100319|158043301|FG000|Overall Study|Protocol Deviation|5|||
49058157|NCT03463993|158043304|FG000|Overall Study|Lost to Follow-up|7|||
49058158|NCT03463993|158043305|FG001|Overall Study|Lost to Follow-up|8|||
49058159|NCT03463993|158043304|FG000|Overall Study|Withdrawal by Subject|2|||
49058160|NCT03463993|158043305|FG001|Overall Study|Withdrawal by Subject|0|||
49058161|NCT03463993|158043304|FG000|Overall Study|Protocol Violation|4|||
49058162|NCT03463993|158043305|FG001|Overall Study|Protocol Violation|1|||
49058163|NCT03463993|158043304|FG000|Overall Study|Had a vaginal delivery prior to caesarean delivery|9|||
49058164|NCT03463993|158043305|FG001|Overall Study|Had a vaginal delivery prior to caesarean delivery|11|||
49058165|NCT03463993|158043304|FG000|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|7|||
49058166|NCT03463993|158043305|FG001|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|6|||
49058167|NCT02502734|158043306|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
49058168|NCT02502734|158043307|FG001|Double-blind Treatment Period 1|Adverse Event|0|||
49058169|NCT02502734|158043306|FG000|Washout Period|Adverse Event|1|||
49058170|NCT02502734|158043307|FG001|Washout Period|Adverse Event|0|||
49058171|NCT00614822|158043308|FG000|Overall Study|Adverse Event|3|||
49058172|NCT00700817|158043320|FG000|Week 0-26 (Main Period)|Adverse Event|14|||
49058173|NCT00700817|158043321|FG001|Week 0-26 (Main Period)|Adverse Event|15|||
49058174|NCT00700817|158043322|FG002|Week 0-26 (Main Period)|Adverse Event|4|||
49058175|NCT00700817|158043323|FG003|Week 0-26 (Main Period)|Adverse Event|0|||
49058176|NCT00700817|158043324|FG004|Week 0-26 (Main Period)|Adverse Event|0|||
49058177|NCT00700817|158043320|FG000|Week 0-26 (Main Period)|Lack of Efficacy|4|||
49058178|NCT00700817|158043321|FG001|Week 0-26 (Main Period)|Lack of Efficacy|0|||
49058179|NCT00700817|158043322|FG002|Week 0-26 (Main Period)|Lack of Efficacy|4|||
49058180|NCT00700817|158043323|FG003|Week 0-26 (Main Period)|Lack of Efficacy|0|||
49058181|NCT00700817|158043324|FG004|Week 0-26 (Main Period)|Lack of Efficacy|0|||
49058182|NCT00700817|158043320|FG000|Week 0-26 (Main Period)|Protocol Violation|14|||
49058183|NCT00700817|158043321|FG001|Week 0-26 (Main Period)|Protocol Violation|4|||
49058184|NCT00700817|158043322|FG002|Week 0-26 (Main Period)|Protocol Violation|4|||
49058185|NCT00700817|158043323|FG003|Week 0-26 (Main Period)|Protocol Violation|0|||
49058186|NCT00700817|158043324|FG004|Week 0-26 (Main Period)|Protocol Violation|0|||
49058187|NCT00700817|158043320|FG000|Week 0-26 (Main Period)|Withdrawal criteria|10|||
49058188|NCT00700817|158043321|FG001|Week 0-26 (Main Period)|Withdrawal criteria|7|||
49058189|NCT00700817|158043322|FG002|Week 0-26 (Main Period)|Withdrawal criteria|5|||
49058190|NCT00700817|158043323|FG003|Week 0-26 (Main Period)|Withdrawal criteria|0|||
49058191|NCT00700817|158043324|FG004|Week 0-26 (Main Period)|Withdrawal criteria|0|||
49058192|NCT00700817|158043320|FG000|Week 0-26 (Main Period)|Unclassified|14|||
49058193|NCT00700817|158043321|FG001|Week 0-26 (Main Period)|Unclassified|4|||
49058194|NCT00700817|158043322|FG002|Week 0-26 (Main Period)|Unclassified|8|||
49058195|NCT00700817|158043323|FG003|Week 0-26 (Main Period)|Unclassified|0|||
49058196|NCT00700817|158043324|FG004|Week 0-26 (Main Period)|Unclassified|0|||
49058197|NCT00700817|158043320|FG000|Week 26-52 (Extension Period 1)|Adverse Event|5|||
49058198|NCT00700817|158043321|FG001|Week 26-52 (Extension Period 1)|Adverse Event|10|||
49058199|NCT00700817|158043322|FG002|Week 26-52 (Extension Period 1)|Adverse Event|3|||
49058200|NCT00700817|158043323|FG003|Week 26-52 (Extension Period 1)|Adverse Event|0|||
49058201|NCT00700817|158043324|FG004|Week 26-52 (Extension Period 1)|Adverse Event|0|||
49058202|NCT00700817|158043320|FG000|Week 26-52 (Extension Period 1)|Protocol Violation|3|||
49058203|NCT00700817|158043321|FG001|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
49058204|NCT00700817|158043322|FG002|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
49058205|NCT00700817|158043323|FG003|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
49058206|NCT00700817|158043324|FG004|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
49058207|NCT00700817|158043320|FG000|Week 26-52 (Extension Period 1)|Lack of Efficacy|2|||
49058208|NCT00700817|158043321|FG001|Week 26-52 (Extension Period 1)|Lack of Efficacy|3|||
49058209|NCT00700817|158043322|FG002|Week 26-52 (Extension Period 1)|Lack of Efficacy|7|||
49058210|NCT00700817|158043323|FG003|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
49058211|NCT00700817|158043324|FG004|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
49058212|NCT00700817|158043320|FG000|Week 26-52 (Extension Period 1)|Withdrawal criteria|6|||
49058213|NCT00700817|158043321|FG001|Week 26-52 (Extension Period 1)|Withdrawal criteria|8|||
49058214|NCT00700817|158043322|FG002|Week 26-52 (Extension Period 1)|Withdrawal criteria|2|||
49058215|NCT00700817|158043323|FG003|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
49058216|NCT00700817|158043324|FG004|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
49058217|NCT00700817|158043320|FG000|Week 26-52 (Extension Period 1)|Unclassified|4|||
49058218|NCT00700817|158043321|FG001|Week 26-52 (Extension Period 1)|Unclassified|3|||
49058219|NCT00700817|158043322|FG002|Week 26-52 (Extension Period 1)|Unclassified|1|||
49058220|NCT00700817|158043323|FG003|Week 26-52 (Extension Period 1)|Unclassified|0|||
49058221|NCT00700817|158043324|FG004|Week 26-52 (Extension Period 1)|Unclassified|0|||
49058222|NCT00700817|158043320|FG000|Week 52-78 (Extension Period 2)|Adverse Event|0|||
49058223|NCT00700817|158043321|FG001|Week 52-78 (Extension Period 2)|Adverse Event|3|||
49058224|NCT00700817|158043322|FG002|Week 52-78 (Extension Period 2)|Adverse Event|0|||
49058225|NCT00700817|158043323|FG003|Week 52-78 (Extension Period 2)|Adverse Event|6|||
49058226|NCT00700817|158043324|FG004|Week 52-78 (Extension Period 2)|Adverse Event|0|||
49058227|NCT00700817|158043320|FG000|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
49058228|NCT00700817|158043321|FG001|Week 52-78 (Extension Period 2)|Protocol Violation|2|||
49058229|NCT00700817|158043322|FG002|Week 52-78 (Extension Period 2)|Protocol Violation|0|||
49058230|NCT00700817|158043323|FG003|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
49058231|NCT00700817|158043324|FG004|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
49058232|NCT00700817|158043320|FG000|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
49058233|NCT00700817|158043321|FG001|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
49058234|NCT00700817|158043322|FG002|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
49058235|NCT00700817|158043323|FG003|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
49058236|NCT00700817|158043324|FG004|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
49058237|NCT00700817|158043320|FG000|Week 52-78 (Extension Period 2)|Withdrawal criteria|4|||
49058238|NCT00700817|158043321|FG001|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
49058239|NCT00700817|158043322|FG002|Week 52-78 (Extension Period 2)|Withdrawal criteria|0|||
49058240|NCT00700817|158043323|FG003|Week 52-78 (Extension Period 2)|Withdrawal criteria|1|||
49058241|NCT00700817|158043324|FG004|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
49058242|NCT00700817|158043320|FG000|Week 52-78 (Extension Period 2)|Unclassified|2|||
49058243|NCT00700817|158043321|FG001|Week 52-78 (Extension Period 2)|Unclassified|4|||
49058244|NCT00700817|158043322|FG002|Week 52-78 (Extension Period 2)|Unclassified|0|||
49058245|NCT00700817|158043323|FG003|Week 52-78 (Extension Period 2)|Unclassified|0|||
49058246|NCT00700817|158043324|FG004|Week 52-78 (Extension Period 2)|Unclassified|1|||
49058247|NCT02631876|158043325|FG000|Overall Study|Death|96|||
49058248|NCT02631876|158043326|FG001|Overall Study|Death|50|||
49058249|NCT02631876|158043325|FG000|Overall Study|Investigator's discretion|1|||
49058250|NCT02631876|158043326|FG001|Overall Study|Investigator's discretion|0|||
49058251|NCT02631876|158043325|FG000|Overall Study|Lost to Follow-up|2|||
49058252|NCT02631876|158043326|FG001|Overall Study|Lost to Follow-up|0|||
49058253|NCT02631876|158043325|FG000|Overall Study|Withdrawal by Subject|16|||
49058254|NCT02631876|158043326|FG001|Overall Study|Withdrawal by Subject|9|||
49058255|NCT02631876|158043325|FG000|Overall Study|Other than specified|4|||
49058256|NCT02631876|158043326|FG001|Overall Study|Other than specified|4|||
49058257|NCT00375492|158043327|FG000|Overall Study|Adverse Event|4|||
49058258|NCT00375492|158043328|FG001|Overall Study|Adverse Event|5|||
49058259|NCT00375492|158043327|FG000|Overall Study|Entry Criteria Not Met|0|||
49058260|NCT00375492|158043328|FG001|Overall Study|Entry Criteria Not Met|1|||
49058261|NCT00375492|158043327|FG000|Overall Study|Loss of Glucose Control|0|||
49058262|NCT00375492|158043328|FG001|Overall Study|Loss of Glucose Control|1|||
49058263|NCT00375492|158043327|FG000|Overall Study|Lost to Follow-up|10|||
49058264|NCT00375492|158043328|FG001|Overall Study|Lost to Follow-up|5|||
49058265|NCT00375492|158043327|FG000|Overall Study|Physician Decision|0|||
49058266|NCT00375492|158043328|FG001|Overall Study|Physician Decision|4|||
49058267|NCT00375492|158043327|FG000|Overall Study|Protocol Violation|6|||
49058268|NCT00375492|158043328|FG001|Overall Study|Protocol Violation|3|||
49058269|NCT00375492|158043327|FG000|Overall Study|Sponsor Decision|0|||
49058270|NCT00375492|158043328|FG001|Overall Study|Sponsor Decision|1|||
49058271|NCT00375492|158043327|FG000|Overall Study|Withdrawal by Subject|6|||
49058272|NCT00375492|158043328|FG001|Overall Study|Withdrawal by Subject|6|||
49058273|NCT01232491|158043337|FG000|Overall Study|Adverse Event|13|||
49058274|NCT01232491|158043338|FG001|Overall Study|Adverse Event|8|||
49058275|NCT01232491|158043337|FG000|Overall Study|Lack of Efficacy|1|||
49058276|NCT01232491|158043338|FG001|Overall Study|Lack of Efficacy|5|||
49058277|NCT01232491|158043337|FG000|Overall Study|Protocol Violation|13|||
49058278|NCT01232491|158043338|FG001|Overall Study|Protocol Violation|11|||
49058279|NCT01232491|158043337|FG000|Overall Study|Withdrawal Criteria|12|||
49058280|NCT01232491|158043338|FG001|Overall Study|Withdrawal Criteria|21|||
49058281|NCT01232491|158043337|FG000|Overall Study|Other|21|||
49058282|NCT01232491|158043338|FG001|Overall Study|Other|18|||
49058283|NCT00724373|158043339|FG000|Overall Study|Adverse Event|41|||
49058284|NCT00724373|158043339|FG000|Overall Study|Lack of Efficacy|82|||
49058285|NCT00724373|158043339|FG000|Overall Study|Lost to Follow-up|7|||
49058286|NCT00724373|158043339|FG000|Overall Study|Non-compliance|2|||
49058287|NCT00724373|158043339|FG000|Overall Study|HCV RNA negative after 4 weeks|9|||
49058288|NCT00724373|158043339|FG000|Overall Study|Participant moved away|1|||
49058289|NCT00724373|158043339|FG000|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2|||
49058290|NCT00724373|158043339|FG000|Overall Study|Only to have 24 week regimen|1|||
49058291|NCT00724373|158043339|FG000|Overall Study|Viral Relapse|1|||
49058292|NCT00724373|158043339|FG000|Overall Study|Acute HCV infection|1|||
49058293|NCT00724373|158043339|FG000|Overall Study|Drug Relapse|1|||
49058294|NCT00724373|158043339|FG000|Overall Study|Tolerability|23|||
49058295|NCT00842530|158043340|FG000|Overall Study|Serious adverse event|0|||
49058296|NCT00842530|158043341|FG001|Overall Study|Serious adverse event|6|||
49058297|NCT00842530|158043340|FG000|Overall Study|Other adverse event|6|||
49058298|NCT00842530|158043341|FG001|Overall Study|Other adverse event|1|||
49058299|NCT00842530|158043340|FG000|Overall Study|Protocol Violation|32|||
49058300|NCT00842530|158043341|FG001|Overall Study|Protocol Violation|14|||
49058301|NCT00842530|158043340|FG000|Overall Study|Lost to Follow-up|6|||
49058302|NCT00842530|158043341|FG001|Overall Study|Lost to Follow-up|8|||
49058303|NCT00842530|158043340|FG000|Overall Study|Withdrawal by Subject|73|||
49058304|NCT00842530|158043341|FG001|Overall Study|Withdrawal by Subject|28|||
49058305|NCT00733369|158043347|FG000|Overall Study|Lost to Follow-up|2|||
49058306|NCT00733369|158043348|FG001|Overall Study|Lost to Follow-up|1|||
49058307|NCT00733369|158043347|FG000|Overall Study|Adverse Event|4|||
49058308|NCT00733369|158043348|FG001|Overall Study|Adverse Event|4|||
49058309|NCT00733369|158043347|FG000|Overall Study|Protocol Violation|4|||
49058310|NCT00733369|158043348|FG001|Overall Study|Protocol Violation|4|||
49058311|NCT00536484|158043349|FG000|Overall Study|Adverse Event|21|||
49058312|NCT00536484|158043350|FG001|Overall Study|Adverse Event|34|||
49058313|NCT00536484|158043349|FG000|Overall Study|Withdrawal by Subject|11|||
49058314|NCT00536484|158043350|FG001|Overall Study|Withdrawal by Subject|11|||
49058315|NCT00536484|158043349|FG000|Overall Study|Lost to Follow-up|8|||
49058316|NCT00536484|158043350|FG001|Overall Study|Lost to Follow-up|6|||
49058317|NCT00536484|158043349|FG000|Overall Study|Lack of Efficacy|16|||
49058318|NCT00536484|158043350|FG001|Overall Study|Lack of Efficacy|5|||
49058319|NCT00536484|158043349|FG000|Overall Study|Other|4|||
49058320|NCT00536484|158043350|FG001|Overall Study|Other|0|||
49058321|NCT01334710|158043354|FG000|Overall Study|Trial was terminated|3|||
49058322|NCT00710749|158043361|FG000|First Intervention|Withdrawal by Subject|1|||
49058323|NCT00710749|158043362|FG001|First Intervention|Withdrawal by Subject|0|||
49058324|NCT01020799|158043366|FG000|Overall Study|Adverse Event|4|||
49058325|NCT01020799|158043367|FG001|Overall Study|Adverse Event|3|||
49058326|NCT01020799|158043368|FG002|Overall Study|Adverse Event|2|||
49058327|NCT01020799|158043366|FG000|Overall Study|non-compliance; lack of efficacy; etc.|4|||
49058328|NCT01020799|158043367|FG001|Overall Study|non-compliance; lack of efficacy; etc.|3|||
49058329|NCT01020799|158043368|FG002|Overall Study|non-compliance; lack of efficacy; etc.|0|||
49058330|NCT01020799|158043366|FG000|Overall Study|Protocol Violation|3|||
49058331|NCT01020799|158043367|FG001|Overall Study|Protocol Violation|2|||
49058332|NCT01020799|158043368|FG002|Overall Study|Protocol Violation|0|||
49058333|NCT01020799|158043366|FG000|Overall Study|Withdrawal by Subject|2|||
49058334|NCT01020799|158043367|FG001|Overall Study|Withdrawal by Subject|2|||
49058335|NCT01020799|158043368|FG002|Overall Study|Withdrawal by Subject|3|||
49058336|NCT01020799|158043366|FG000|Overall Study|Lost to Follow-up|6|||
49058337|NCT01020799|158043367|FG001|Overall Study|Lost to Follow-up|4|||
49058338|NCT01020799|158043368|FG002|Overall Study|Lost to Follow-up|2|||
49058339|NCT03856593|158043369|FG000|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|15|||
49058340|NCT03856593|158043370|FG001|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|16|||
49058341|NCT02370914|158043372|FG000|Overall Study|Protocol Violation|2|||
49058342|NCT02595008|158043373|FG000|Overall Study|Enrolled In Error|1|||
49058343|NCT02595008|158043374|FG001|Overall Study|Enrolled In Error|0|||
49058344|NCT01010126|158045083|FG000|Overall Study|Withdrawal by Subject|1|||
49058345|NCT01010126|158045084|FG001|Overall Study|Withdrawal by Subject|0|||
49058346|NCT01010126|158045085|FG002|Overall Study|Withdrawal by Subject|1|||
49058347|NCT01010126|158045086|FG003|Overall Study|Withdrawal by Subject|0|||
49058348|NCT01010126|158045087|FG004|Overall Study|Withdrawal by Subject|3|||
49058349|NCT01010126|158045088|FG005|Overall Study|Withdrawal by Subject|0|||
49058350|NCT00493246|158045091|FG000|Overall Study|Withdrawal by Subject|0|||
49058351|NCT00493246|158045092|FG001|Overall Study|Withdrawal by Subject|0|||
49058352|NCT00493246|158045093|FG002|Overall Study|Withdrawal by Subject|0|||
49058353|NCT00493246|158045094|FG003|Overall Study|Withdrawal by Subject|0|||
49058354|NCT00493246|158045095|FG004|Overall Study|Withdrawal by Subject|1|||
49058355|NCT00493246|158045096|FG005|Overall Study|Withdrawal by Subject|0|||
49058356|NCT00493246|158045097|FG006|Overall Study|Withdrawal by Subject|0|||
49058357|NCT00493246|158045098|FG007|Overall Study|Withdrawal by Subject|0|||
49058358|NCT00493246|158045091|FG000|Overall Study|No access to draw blood|0|||
49058359|NCT00493246|158045092|FG001|Overall Study|No access to draw blood|0|||
49058360|NCT00493246|158045093|FG002|Overall Study|No access to draw blood|0|||
49058361|NCT00493246|158045094|FG003|Overall Study|No access to draw blood|0|||
49058362|NCT00493246|158045095|FG004|Overall Study|No access to draw blood|0|||
49058363|NCT00493246|158045096|FG005|Overall Study|No access to draw blood|1|||
49058364|NCT00493246|158045097|FG006|Overall Study|No access to draw blood|0|||
49058365|NCT00493246|158045098|FG007|Overall Study|No access to draw blood|0|||
49058366|NCT00493246|158045091|FG000|Overall Study|Lost to Follow-up|0|||
49058367|NCT00493246|158045092|FG001|Overall Study|Lost to Follow-up|0|||
49058368|NCT00493246|158045093|FG002|Overall Study|Lost to Follow-up|0|||
49058369|NCT00493246|158045094|FG003|Overall Study|Lost to Follow-up|0|||
49058370|NCT00493246|158045095|FG004|Overall Study|Lost to Follow-up|0|||
49058371|NCT00493246|158045096|FG005|Overall Study|Lost to Follow-up|0|||
49058372|NCT00493246|158045097|FG006|Overall Study|Lost to Follow-up|1|||
49058373|NCT00493246|158045098|FG007|Overall Study|Lost to Follow-up|0|||
49058374|NCT00983918|158045103|FG000|Overall Study|conversion to open cholecystectomy|0|||
49058375|NCT00983918|158045104|FG001|Overall Study|conversion to open cholecystectomy|2|||
49058376|NCT00983918|158045105|FG002|Overall Study|conversion to open cholecystectomy|2|||
49058377|NCT00983918|158045106|FG003|Overall Study|conversion to open cholecystectomy|2|||
49058378|NCT05016622|158045113|FG000|1st Booster: 4-6 Month Follow up Visit|Lost to Follow-up|59|||
49058379|NCT05016622|158045113|FG000|2nd Booster: 4 Week Follow up Visit|Declined to Participate|2|||
49058380|NCT01304693|158045118|FG000|Overall Study|Adverse Event|0|||
49058381|NCT01304693|158045119|FG001|Overall Study|Adverse Event|0|||
49058382|NCT01304693|158045120|FG002|Overall Study|Adverse Event|0|||
49058383|NCT01304693|158045121|FG003|Overall Study|Adverse Event|0|||
49058384|NCT01304693|158045122|FG004|Overall Study|Adverse Event|1|||
49058385|NCT01304693|158045118|FG000|Overall Study|Decision Unrelated to an Adverse Event|0|||
49058386|NCT01304693|158045119|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
49058387|NCT01304693|158045120|FG002|Overall Study|Decision Unrelated to an Adverse Event|1|||
49058388|NCT01304693|158045121|FG003|Overall Study|Decision Unrelated to an Adverse Event|1|||
49058389|NCT01304693|158045122|FG004|Overall Study|Decision Unrelated to an Adverse Event|0|||
49058390|NCT01829113|158045128|FG000|Overall Study|Disease Progression|37|||
49058391|NCT01829113|158045129|FG001|Overall Study|Disease Progression|48|||
49058392|NCT01829113|158045128|FG000|Overall Study|Adverse Event|14|||
49058393|NCT01829113|158045129|FG001|Overall Study|Adverse Event|10|||
49058394|NCT01829113|158045128|FG000|Overall Study|Withdrawal by Subject|17|||
49058395|NCT01829113|158045129|FG001|Overall Study|Withdrawal by Subject|10|||
49058396|NCT01829113|158045128|FG000|Overall Study|Death|4|||
49058397|NCT01829113|158045129|FG001|Overall Study|Death|6|||
49058398|NCT01829113|158045128|FG000|Overall Study|Sponsor Decision|1|||
49058399|NCT01829113|158045129|FG001|Overall Study|Sponsor Decision|1|||
49058400|NCT01829113|158045128|FG000|Overall Study|No Study Treatment Received|3|||
49058401|NCT01829113|158045129|FG001|Overall Study|No Study Treatment Received|2|||
49058402|NCT01829113|158045128|FG000|Overall Study|Physician Decision|1|||
49058403|NCT01829113|158045129|FG001|Overall Study|Physician Decision|1|||
49058404|NCT01370213|158045132|FG000|Overall Study|Early Death|1|||
49058405|NCT01370213|158045133|FG001|Overall Study|Early Death|0|||
49058406|NCT01370213|158045134|FG002|Overall Study|Early Death|0|||
49058407|NCT01370213|158045132|FG000|Overall Study|Not evaluable|0|||
49058408|NCT01370213|158045133|FG001|Overall Study|Not evaluable|2|||
49058409|NCT01370213|158045134|FG002|Overall Study|Not evaluable|0|||
49058410|NCT02701413|158045135|FG000|Overall Study|Withdrawal by Subject|7|||
49058411|NCT02701413|158045136|FG001|Overall Study|Withdrawal by Subject|11|||
49058412|NCT01763918|158045137|FG000|Overall Study|Withdrawal by Subject|2|||
49058413|NCT01763918|158045138|FG001|Overall Study|Withdrawal by Subject|1|||
49058414|NCT01763918|158045139|FG002|Overall Study|Withdrawal by Subject|1|||
49058415|NCT01763918|158045140|FG003|Overall Study|Withdrawal by Subject|2|||
49058416|NCT01763918|158045137|FG000|Overall Study|Sponsor Decision|4|||
49058417|NCT01763918|158045138|FG001|Overall Study|Sponsor Decision|0|||
49058418|NCT01763918|158045139|FG002|Overall Study|Sponsor Decision|9|||
49058419|NCT01763918|158045140|FG003|Overall Study|Sponsor Decision|0|||
49058420|NCT00897949|158045141|FG000|Overall Study|Adverse Event|1|||
49058421|NCT00897949|158045142|FG001|Overall Study|Adverse Event|1|||
49058422|NCT00897949|158045143|FG002|Overall Study|Adverse Event|0|||
49058423|NCT00897949|158045141|FG000|Overall Study|Lost to Follow-up|0|||
49058424|NCT00897949|158045142|FG001|Overall Study|Lost to Follow-up|2|||
49058425|NCT00897949|158045143|FG002|Overall Study|Lost to Follow-up|1|||
49058426|NCT00897949|158045141|FG000|Overall Study|Protocol Violation|6|||
49058427|NCT00897949|158045142|FG001|Overall Study|Protocol Violation|3|||
49058428|NCT00897949|158045143|FG002|Overall Study|Protocol Violation|1|||
49058429|NCT00897949|158045141|FG000|Overall Study|Withdrawal by Subject|1|||
49058430|NCT00897949|158045142|FG001|Overall Study|Withdrawal by Subject|2|||
49058431|NCT00897949|158045143|FG002|Overall Study|Withdrawal by Subject|0|||
49058432|NCT00897949|158045141|FG000|Overall Study|Patient Uncoorperative|0|||
49058433|NCT00897949|158045142|FG001|Overall Study|Patient Uncoorperative|2|||
49058434|NCT00897949|158045143|FG002|Overall Study|Patient Uncoorperative|1|||
49058435|NCT00897949|158045141|FG000|Overall Study|Lost to Follow-up|30|||
49058436|NCT00897949|158045142|FG001|Overall Study|Lost to Follow-up|23|||
49058437|NCT00897949|158045143|FG002|Overall Study|Lost to Follow-up|17|||
49058438|NCT00897949|158045141|FG000|Overall Study|Withdrawal by Subject|24|||
49058439|NCT00897949|158045142|FG001|Overall Study|Withdrawal by Subject|31|||
49058440|NCT00897949|158045143|FG002|Overall Study|Withdrawal by Subject|17|||
49058441|NCT00897949|158045141|FG000|Overall Study|Abnormal Prestudy Labs|2|||
49058442|NCT00897949|158045142|FG001|Overall Study|Abnormal Prestudy Labs|3|||
49058443|NCT00897949|158045143|FG002|Overall Study|Abnormal Prestudy Labs|4|||
49058444|NCT00897949|158045141|FG000|Overall Study|Abnormal Baseline ECG|2|||
49058445|NCT00897949|158045142|FG001|Overall Study|Abnormal Baseline ECG|2|||
49058446|NCT00897949|158045143|FG002|Overall Study|Abnormal Baseline ECG|4|||
49058447|NCT00897949|158045141|FG000|Overall Study|Need for Concom. Med.|0|||
49058448|NCT00897949|158045142|FG001|Overall Study|Need for Concom. Med.|1|||
49058449|NCT00897949|158045143|FG002|Overall Study|Need for Concom. Med.|1|||
49058450|NCT00897949|158045141|FG000|Overall Study|Lack of Migraine Attack|29|||
49058451|NCT00897949|158045142|FG001|Overall Study|Lack of Migraine Attack|30|||
49058452|NCT00897949|158045143|FG002|Overall Study|Lack of Migraine Attack|19|||
49058453|NCT00897949|158045141|FG000|Overall Study|Did not take study drug|9|||
49058454|NCT00897949|158045142|FG001|Overall Study|Did not take study drug|3|||
49058455|NCT00897949|158045143|FG002|Overall Study|Did not take study drug|4|||
49058456|NCT01553747|158045144|FG000|Overall Study|Protocol Violation|0|||
49058457|NCT01553747|158045145|FG001|Overall Study|Protocol Violation|2|||
49058458|NCT01553747|158045146|FG002|Overall Study|Protocol Violation|0|||
49058459|NCT01553747|158045144|FG000|Overall Study|Voluntarily withdrew|70|||
49058460|NCT01553747|158045145|FG001|Overall Study|Voluntarily withdrew|66|||
49058461|NCT01553747|158045146|FG002|Overall Study|Voluntarily withdrew|74|||
49058462|NCT01553747|158045144|FG000|Overall Study|Adverse event or SAE|32|||
49058463|NCT01553747|158045145|FG001|Overall Study|Adverse event or SAE|28|||
49058464|NCT01553747|158045146|FG002|Overall Study|Adverse event or SAE|19|||
49058465|NCT01553747|158045144|FG000|Overall Study|Physician decision: other|10|||
49058466|NCT01553747|158045145|FG001|Overall Study|Physician decision: other|8|||
49058467|NCT01553747|158045146|FG002|Overall Study|Physician decision: other|7|||
49058468|NCT01553747|158045144|FG000|Overall Study|Lost to Follow-up|11|||
49058469|NCT01553747|158045145|FG001|Overall Study|Lost to Follow-up|5|||
49058470|NCT01553747|158045146|FG002|Overall Study|Lost to Follow-up|6|||
49058471|NCT01553747|158045144|FG000|Overall Study|Sponsor decision, specify|7|||
49058472|NCT01553747|158045145|FG001|Overall Study|Sponsor decision, specify|5|||
49058473|NCT01553747|158045146|FG002|Overall Study|Sponsor decision, specify|0|||
49058474|NCT01553747|158045144|FG000|Overall Study|Physician decision: lack of efficacy|1|||
49058475|NCT01553747|158045145|FG001|Overall Study|Physician decision: lack of efficacy|5|||
49058476|NCT01553747|158045146|FG002|Overall Study|Physician decision: lack of efficacy|3|||
49058477|NCT02938520|158045147|FG000|Overall Study|On-going at the time of analysis|258|||
49058478|NCT02938520|158045148|FG001|Overall Study|On-going at the time of analysis|261|||
49058479|NCT02938520|158045147|FG000|Overall Study|Physician Decision|2|||
49058480|NCT02938520|158045148|FG001|Overall Study|Physician Decision|5|||
49058481|NCT02938520|158045147|FG000|Overall Study|Lost to Follow-up|2|||
49058482|NCT02938520|158045148|FG001|Overall Study|Lost to Follow-up|2|||
49058483|NCT02938520|158045147|FG000|Overall Study|Withdrawal by Subject|7|||
49058484|NCT02938520|158045148|FG001|Overall Study|Withdrawal by Subject|7|||
49058485|NCT02938520|158045147|FG000|Overall Study|Protocol Violation|0|||
49058486|NCT02938520|158045148|FG001|Overall Study|Protocol Violation|1|||
49058487|NCT02938520|158045147|FG000|Overall Study|Lack of Efficacy|5|||
49058488|NCT02938520|158045148|FG001|Overall Study|Lack of Efficacy|3|||
49058489|NCT02938520|158045147|FG000|Overall Study|Adverse Event|9|||
49058490|NCT02938520|158045148|FG001|Overall Study|Adverse Event|4|||
49058491|NCT02224573|158045149|FG000|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|0|||
49058492|NCT02224573|158045150|FG001|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|1|||
49058493|NCT02224573|158045149|FG000|Treatment Phase|Started on Other IMP|1|||
49058494|NCT02224573|158045150|FG001|Treatment Phase|Started on Other IMP|0|||
49058495|NCT02224573|158045149|FG000|Treatment Phase|Participant Discontinued IMP|0|||
49058496|NCT02224573|158045150|FG001|Treatment Phase|Participant Discontinued IMP|1|||
49058497|NCT02224573|158045149|FG000|Treatment Phase|Lack of Efficacy|15|||
49058498|NCT02224573|158045150|FG001|Treatment Phase|Lack of Efficacy|8|||
49058499|NCT02224573|158045149|FG000|Treatment Phase|Began Commercial Product|1|||
49058500|NCT02224573|158045150|FG001|Treatment Phase|Began Commercial Product|0|||
49058501|NCT02224573|158045149|FG000|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
49058502|NCT02224573|158045150|FG001|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
49058503|NCT02224573|158045149|FG000|Treatment Phase|Met Withdrawal Criteria|5|||
49058504|NCT02224573|158045150|FG001|Treatment Phase|Met Withdrawal Criteria|7|||
49058505|NCT02224573|158045149|FG000|Treatment Phase|Participant Did Not Return for Visits|0|||
49058506|NCT02224573|158045150|FG001|Treatment Phase|Participant Did Not Return for Visits|1|||
49058507|NCT02224573|158045149|FG000|Treatment Phase|Continued Compassionate Use|1|||
49058508|NCT02224573|158045150|FG001|Treatment Phase|Continued Compassionate Use|0|||
49058509|NCT02224573|158045149|FG000|Treatment Phase|Lack of Efficiency|2|||
49058510|NCT02224573|158045150|FG001|Treatment Phase|Lack of Efficiency|1|||
49058511|NCT02224573|158045149|FG000|Treatment Phase|Participant with Protocol-Excluded Treatment|0|||
49058512|NCT02224573|158045150|FG001|Treatment Phase|Participant with Protocol-Excluded Treatment|1|||
49058513|NCT02224573|158045149|FG000|Treatment Phase|Participant Moved|2|||
49058514|NCT02224573|158045150|FG001|Treatment Phase|Participant Moved|0|||
49058515|NCT02224573|158045149|FG000|Treatment Phase|Withdrawal by Participant or Parent/Guardian|62|||
49058516|NCT02224573|158045150|FG001|Treatment Phase|Withdrawal by Participant or Parent/Guardian|48|||
49058517|NCT02224573|158045149|FG000|Treatment Phase|Refused Medication|1|||
49058518|NCT02224573|158045150|FG001|Treatment Phase|Refused Medication|1|||
49058519|NCT02224573|158045149|FG000|Treatment Phase|Adverse Event|26|||
49058520|NCT02224573|158045150|FG001|Treatment Phase|Adverse Event|38|||
49058521|NCT02224573|158045149|FG000|Treatment Phase|Placed in Group Home|0|||
49058522|NCT02224573|158045150|FG001|Treatment Phase|Placed in Group Home|1|||
49058523|NCT02224573|158045149|FG000|Treatment Phase|Pursued Other Trials|1|||
49058524|NCT02224573|158045150|FG001|Treatment Phase|Pursued Other Trials|0|||
49058525|NCT02224573|158045149|FG000|Treatment Phase|Withdrawn by the Investigator|23|||
49058526|NCT02224573|158045150|FG001|Treatment Phase|Withdrawn by the Investigator|11|||
49058527|NCT02224573|158045149|FG000|Treatment Phase|Lost to Follow-up|2|||
49058528|NCT02224573|158045150|FG001|Treatment Phase|Lost to Follow-up|1|||
49058529|NCT02224573|158045149|FG000|Taper Phase|Completed Incorrect Number of Taper Days|1|||
49058530|NCT02224573|158045150|FG001|Taper Phase|Completed Incorrect Number of Taper Days|0|||
49058531|NCT02224573|158045149|FG000|Taper Phase|Hospitalization/Dose Reduction|1|||
49058532|NCT02224573|158045150|FG001|Taper Phase|Hospitalization/Dose Reduction|0|||
49058533|NCT02224573|158045149|FG000|Taper Phase|Withdrawn by participants or parent/guardian|0|||
49058534|NCT02224573|158045150|FG001|Taper Phase|Withdrawn by participants or parent/guardian|3|||
49058535|NCT02224573|158045149|FG000|Taper Phase|Adverse Event|1|||
49058536|NCT02224573|158045150|FG001|Taper Phase|Adverse Event|1|||
49058537|NCT00252174|158045153|FG000|Overall Study|Withdrawal by Subject|0|||
49058538|NCT00252174|158045154|FG001|Overall Study|Withdrawal by Subject|1|||
49058539|NCT00252174|158045155|FG002|Overall Study|Withdrawal by Subject|0|||
49058540|NCT02549573|158045157|FG000|Overall Study|Withdrawal by Subject|0|||
49058541|NCT02549573|158045158|FG001|Overall Study|Withdrawal by Subject|2|||
49058542|NCT02549573|158045157|FG000|Overall Study|Protocol Violation|0|||
49058543|NCT02549573|158045158|FG001|Overall Study|Protocol Violation|1|||
49058544|NCT03407118|158045166|FG000|Period 2|Withdrawal by Subject|1|||
49058545|NCT03407118|158045167|FG001|Period 2|Withdrawal by Subject|0|||
49058546|NCT00619359|158045173|FG000|Overall Study|Adverse Event|32|||
49058547|NCT00619359|158045174|FG001|Overall Study|Adverse Event|36|||
49058548|NCT00619359|158045173|FG000|Overall Study|Lost to Follow-up|12|||
49058549|NCT00619359|158045174|FG001|Overall Study|Lost to Follow-up|16|||
49058550|NCT00619359|158045173|FG000|Overall Study|Physician Decision|0|||
49058551|NCT00619359|158045174|FG001|Overall Study|Physician Decision|7|||
49058552|NCT00619359|158045173|FG000|Overall Study|Protocol Violation|1|||
49058553|NCT00619359|158045174|FG001|Overall Study|Protocol Violation|1|||
49058554|NCT00619359|158045173|FG000|Overall Study|Withdrawal by Subject|19|||
49058555|NCT00619359|158045174|FG001|Overall Study|Withdrawal by Subject|20|||
49058556|NCT00619359|158045173|FG000|Overall Study|Progressive Disease|3|||
49058557|NCT00619359|158045174|FG001|Overall Study|Progressive Disease|1|||
49058558|NCT02556307|158045181|FG000|Overall Study|Premature treatment interruption|11|||
49058559|NCT02556307|158045181|FG000|Overall Study|Lost to Follow-up|36|||
49058560|NCT02556307|158045181|FG000|Overall Study|Change to triple therapy|4|||
49058561|NCT02556307|158045181|FG000|Overall Study|Enrolled but not treated|2|||
49058562|NCT04969861|158045182|FG000|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|1|||
49058563|NCT04969861|158045183|FG001|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|0|||
49058564|NCT00290251|158045184|FG000|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
49058565|NCT00290251|158045185|FG001|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
49058566|NCT00290251|158045186|FG002|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
49058567|NCT00290251|158045187|FG003|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
49058568|NCT00290251|158045188|FG004|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
49058569|NCT00290251|158045189|FG005|Treatment 1 (Months 2-4)|Withdrawal by Subject|2|||
49058570|NCT00290251|158045184|FG000|Treatment 1 (Months 2-4)|headache|0|||
49058571|NCT00290251|158045185|FG001|Treatment 1 (Months 2-4)|headache|0|||
49058572|NCT00290251|158045186|FG002|Treatment 1 (Months 2-4)|headache|0|||
49058573|NCT00290251|158045187|FG003|Treatment 1 (Months 2-4)|headache|0|||
49058574|NCT00290251|158045188|FG004|Treatment 1 (Months 2-4)|headache|1|||
49058575|NCT00290251|158045189|FG005|Treatment 1 (Months 2-4)|headache|0|||
49058576|NCT00290251|158045184|FG000|Treatment 1 (Months 2-4)|Out of body experience|0|||
49058577|NCT00290251|158045185|FG001|Treatment 1 (Months 2-4)|Out of body experience|0|||
49058578|NCT00290251|158045186|FG002|Treatment 1 (Months 2-4)|Out of body experience|0|||
49058579|NCT00290251|158045187|FG003|Treatment 1 (Months 2-4)|Out of body experience|1|||
49058580|NCT00290251|158045188|FG004|Treatment 1 (Months 2-4)|Out of body experience|0|||
49058581|NCT00290251|158045189|FG005|Treatment 1 (Months 2-4)|Out of body experience|0|||
49058582|NCT00384176|158045191|FG000|Overall Study|Death|239|||
49058583|NCT00384176|158045192|FG001|Overall Study|Death|247|||
49058584|NCT00384176|158045193|FG002|Overall Study|Death|105|||
49058585|NCT00384176|158045191|FG000|Overall Study|Withdrawal by Subject|52|||
49058586|NCT00384176|158045192|FG001|Overall Study|Withdrawal by Subject|48|||
49058587|NCT00384176|158045193|FG002|Overall Study|Withdrawal by Subject|22|||
49058588|NCT00384176|158045191|FG000|Overall Study|Lost to Follow-up|16|||
49058589|NCT00384176|158045192|FG001|Overall Study|Lost to Follow-up|18|||
49058590|NCT00384176|158045193|FG002|Overall Study|Lost to Follow-up|4|||
49058591|NCT00384176|158045191|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|2|||
49058592|NCT00384176|158045192|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|3|||
49058593|NCT00384176|158045193|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|0|||
49058594|NCT00384176|158045191|FG000|Overall Study|Longer QTC as Visit 1|1|||
49058595|NCT00384176|158045192|FG001|Overall Study|Longer QTC as Visit 1|0|||
49058596|NCT00384176|158045193|FG002|Overall Study|Longer QTC as Visit 1|0|||
49058597|NCT00384176|158045191|FG000|Overall Study|Toxicity of treatment|1|||
49058598|NCT00384176|158045192|FG001|Overall Study|Toxicity of treatment|0|||
49058599|NCT00384176|158045193|FG002|Overall Study|Toxicity of treatment|0|||
49058600|NCT00384176|158045191|FG000|Overall Study|Did not receive study treatment|0|||
49058601|NCT00384176|158045192|FG001|Overall Study|Did not receive study treatment|1|||
49058602|NCT00384176|158045193|FG002|Overall Study|Did not receive study treatment|1|||
49058603|NCT00384176|158045191|FG000|Overall Study|Physician Decision|0|||
49058604|NCT00384176|158045192|FG001|Overall Study|Physician Decision|2|||
49058605|NCT00384176|158045193|FG002|Overall Study|Physician Decision|0|||
49058606|NCT00384176|158045191|FG000|Overall Study|Liver metastases, colon resec. planned|1|||
49058607|NCT00384176|158045192|FG001|Overall Study|Liver metastases, colon resec. planned|0|||
49058608|NCT00384176|158045193|FG002|Overall Study|Liver metastases, colon resec. planned|0|||
49058609|NCT03438227|158045194|FG000|Overall Study|Withdrawal by Subject|10|||
49058610|NCT03438227|158045195|FG001|Overall Study|Withdrawal by Subject|5|||
49058611|NCT02458092|158045197|FG000|Overall Study|Withdrawal by Subject|1|||
49058612|NCT02458092|158045198|FG001|Overall Study|Withdrawal by Subject|0|||
49058613|NCT01855048|158045199|FG000|Overall Study|Withdrawal by Subject|0|||
49058614|NCT01855048|158045200|FG001|Overall Study|Withdrawal by Subject|1|||
49058615|NCT01855048|158045201|FG002|Overall Study|Withdrawal by Subject|0|||
49058616|NCT01855048|158045202|FG003|Overall Study|Withdrawal by Subject|0|||
49058617|NCT01855048|158045203|FG004|Overall Study|Withdrawal by Subject|1|||
49058618|NCT01855048|158045204|FG005|Overall Study|Withdrawal by Subject|0|||
49058619|NCT00876018|158045211|FG000|Overall Study|Lost to Follow-up|0|||
49058620|NCT00876018|158045212|FG001|Overall Study|Lost to Follow-up|1|||
49058621|NCT00876018|158045213|FG002|Overall Study|Lost to Follow-up|1|||
49058622|NCT00876018|158045211|FG000|Overall Study|Withdrew Consent due to Adverse Event|5|||
49058623|NCT00876018|158045212|FG001|Overall Study|Withdrew Consent due to Adverse Event|4|||
49058624|NCT00876018|158045213|FG002|Overall Study|Withdrew Consent due to Adverse Event|2|||
49058625|NCT00257920|158045214|FG000|Period: Washout Period of Two Weeks|Lost to Follow-up|0|||
49058626|NCT00257920|158045215|FG001|Period: Washout Period of Two Weeks|Lost to Follow-up|1|||
49058627|NCT00257920|158045214|FG000|Period: Second Intervention|Other|2|||
49058628|NCT00257920|158045215|FG001|Period: Second Intervention|Other|1|||
49058629|NCT02692482|158045216|FG000|Overall Study|Death|2|||
49058630|NCT02692482|158045217|FG001|Overall Study|Death|2|||
49058631|NCT02692482|158045216|FG000|Overall Study|Withdrawal by Subject|1|||
49058632|NCT02692482|158045217|FG001|Overall Study|Withdrawal by Subject|2|||
49058633|NCT00925301|158045218|FG000|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
49058634|NCT00925301|158045219|FG001|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2|||
49058635|NCT00925301|158045220|FG002|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
49058636|NCT00925301|158045221|FG003|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
49058637|NCT00925301|158045218|FG000|6-Month Double-blind (Stage 1)|Pregnancy|0|||
49058638|NCT00925301|158045219|FG001|6-Month Double-blind (Stage 1)|Pregnancy|1|||
49058639|NCT00925301|158045220|FG002|6-Month Double-blind (Stage 1)|Pregnancy|0|||
49058640|NCT00925301|158045221|FG003|6-Month Double-blind (Stage 1)|Pregnancy|0|||
49058641|NCT00925301|158045218|FG000|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
49058642|NCT00925301|158045219|FG001|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
49058643|NCT00925301|158045220|FG002|6-Month Open-label (Stage 2)|Withdrawal by Subject|1|||
49058644|NCT00925301|158045221|FG003|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
49058645|NCT00925301|158045218|FG000|6-Month Open-label (Stage 2)|Adverse Event|0|||
49058646|NCT00925301|158045219|FG001|6-Month Open-label (Stage 2)|Adverse Event|0|||
49058647|NCT00925301|158045220|FG002|6-Month Open-label (Stage 2)|Adverse Event|2|||
49058648|NCT00925301|158045221|FG003|6-Month Open-label (Stage 2)|Adverse Event|0|||
49058649|NCT00925301|158045218|FG000|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
49058650|NCT00925301|158045219|FG001|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
49058651|NCT00925301|158045220|FG002|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
49058652|NCT00925301|158045221|FG003|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1|||
49058653|NCT00925301|158045218|FG000|12-Month Open-label Extension (Optional)|Pregnancy|0|||
49058654|NCT00925301|158045219|FG001|12-Month Open-label Extension (Optional)|Pregnancy|0|||
49058655|NCT00925301|158045220|FG002|12-Month Open-label Extension (Optional)|Pregnancy|0|||
49058656|NCT00925301|158045221|FG003|12-Month Open-label Extension (Optional)|Pregnancy|1|||
49058657|NCT00925301|158045218|FG000|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
49058658|NCT00925301|158045219|FG001|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
49058659|NCT00925301|158045220|FG002|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
49058660|NCT00925301|158045221|FG003|12-Month Open-label Extension (Optional)|Lost to Follow-up|1|||
49058661|NCT03977701|158045222|FG000|Overall Study|COVID-19 pandemic|0|||
49058662|NCT03977701|158045223|FG001|Overall Study|COVID-19 pandemic|0|||
49058663|NCT03977701|158045224|FG002|Overall Study|COVID-19 pandemic|0|||
49058664|NCT03977701|158045225|FG003|Overall Study|COVID-19 pandemic|0|||
49058665|NCT03977701|158045226|FG004|Overall Study|COVID-19 pandemic|0|||
49058666|NCT03977701|158045227|FG005|Overall Study|COVID-19 pandemic|1|||
49058667|NCT03977701|158045228|FG006|Overall Study|COVID-19 pandemic|0|||
49058668|NCT03977701|158045229|FG007|Overall Study|COVID-19 pandemic|1|||
49058669|NCT03977701|158045230|FG008|Overall Study|COVID-19 pandemic|0|||
49058670|NCT03977701|158045231|FG009|Overall Study|COVID-19 pandemic|0|||
49058671|NCT03043560|158045232|FG000|Overall Study|Discontinued Intervention|1|||
49058672|NCT03043560|158045233|FG001|Overall Study|Discontinued Intervention|2|||
49058673|NCT03043560|158045232|FG000|Overall Study|Lost to Follow-up|0|||
49058674|NCT03043560|158045233|FG001|Overall Study|Lost to Follow-up|1|||
49058675|NCT00770692|158045234|FG000|Overall Study|Withdrawal by Subject|7|||
49058676|NCT00770692|158045235|FG001|Overall Study|Withdrawal by Subject|9|||
49058677|NCT00770692|158045236|FG002|Overall Study|Withdrawal by Subject|9|||
49058678|NCT00770692|158045237|FG003|Overall Study|Withdrawal by Subject|6|||
49058679|NCT00770692|158045234|FG000|Overall Study|Adverse Event|3|||
49058680|NCT00770692|158045235|FG001|Overall Study|Adverse Event|0|||
49058681|NCT00770692|158045236|FG002|Overall Study|Adverse Event|4|||
49058682|NCT00770692|158045237|FG003|Overall Study|Adverse Event|4|||
49058683|NCT00770692|158045234|FG000|Overall Study|Investigator judgment|2|||
49058684|NCT00770692|158045235|FG001|Overall Study|Investigator judgment|0|||
49058685|NCT00770692|158045236|FG002|Overall Study|Investigator judgment|1|||
49058686|NCT00770692|158045237|FG003|Overall Study|Investigator judgment|1|||
49058687|NCT00293202|158045238|FG000|Overall Study|Withdrawal by Subject|1|||
49058688|NCT00293202|158045239|FG001|Overall Study|Withdrawal by Subject|2|||
49058689|NCT00293202|158045238|FG000|Overall Study|positive ANA (antinuclear antibody)|1|||
49058690|NCT00293202|158045239|FG001|Overall Study|positive ANA (antinuclear antibody)|0|||
49058691|NCT00293202|158045238|FG000|Overall Study|on-hold due to fistula maturation time|1|||
49058692|NCT00293202|158045239|FG001|Overall Study|on-hold due to fistula maturation time|0|||
49058693|NCT00831623|158045243|FG000|Overall Study|Withdrawal by Subject|9|||
49058694|NCT00831623|158045243|FG000|Overall Study|Lost to Follow-up|1|||
49058695|NCT00831623|158045243|FG000|Overall Study|Not 2 years post-treatment|12|||
49058696|NCT04932941|158045245|FG000|Overall Study|Lost to Follow-up|3|||
49058697|NCT04932941|158045246|FG001|Overall Study|Lost to Follow-up|1|||
49058698|NCT04932941|158045245|FG000|Overall Study|Withdrawal by Subject|7|||
49058699|NCT04932941|158045246|FG001|Overall Study|Withdrawal by Subject|4|||
49058700|NCT04932941|158045245|FG000|Overall Study|Other|4|||
49058701|NCT04932941|158045246|FG001|Overall Study|Other|2|||
49058702|NCT01408563|158047539|FG000|Overall Study|Ineligible after consent/ registration|2|||
49058703|NCT01197417|158047540|FG000|Overall Study|Physician Decision|3|||
49058704|NCT01197417|158047541|FG001|Overall Study|Physician Decision|2|||
49058705|NCT01197417|158047540|FG000|Overall Study|Withdrawal by Subject|2|||
49058706|NCT01197417|158047541|FG001|Overall Study|Withdrawal by Subject|4|||
49058707|NCT01197417|158047540|FG000|Overall Study|Site miscommunication|0|||
49058708|NCT01197417|158047541|FG001|Overall Study|Site miscommunication|1|||
49058709|NCT01197417|158047540|FG000|Overall Study|Subject transferred to intensive care|0|||
49058710|NCT01197417|158047541|FG001|Overall Study|Subject transferred to intensive care|1|||
49058711|NCT01197417|158047540|FG000|Overall Study|Not consented in time to receive drug|0|||
49058712|NCT01197417|158047541|FG001|Overall Study|Not consented in time to receive drug|1|||
49058713|NCT01197417|158047540|FG000|Overall Study|Hypotension|1|||
49058714|NCT01197417|158047541|FG001|Overall Study|Hypotension|2|||
49058715|NCT01197417|158047540|FG000|Overall Study|Found to be ineligible|2|||
49058716|NCT01197417|158047541|FG001|Overall Study|Found to be ineligible|5|||
49058717|NCT01197417|158047540|FG000|Overall Study|No 25-hour magnesium level|0|||
49058718|NCT01197417|158047541|FG001|Overall Study|No 25-hour magnesium level|2|||
49058719|NCT01432574|158047542|FG000|Overall Study|Moved|2|||
49058720|NCT01432574|158047542|FG000|Overall Study|Not interested|1|||
49058721|NCT02516410|158047543|FG000|Overall Study|Adverse Event|0|||
49058722|NCT02516410|158047544|FG001|Overall Study|Adverse Event|1|||
49058723|NCT02516410|158047543|FG000|Overall Study|Withdrawal by Subject|0|||
49058724|NCT02516410|158047544|FG001|Overall Study|Withdrawal by Subject|1|||
49058725|NCT01014624|158047545|FG000|Overall Study|Adverse Event|0|||
49058726|NCT01014624|158047546|FG001|Overall Study|Adverse Event|1|||
49058727|NCT01014624|158047545|FG000|Overall Study|Protocol Violation|1|||
49058728|NCT01014624|158047546|FG001|Overall Study|Protocol Violation|0|||
49058729|NCT01014624|158047545|FG000|Overall Study|Withdrawal by Subject|1|||
49058730|NCT01014624|158047546|FG001|Overall Study|Withdrawal by Subject|0|||
49058731|NCT00706992|158047549|FG000|Overall Study|Study termination|5|||
49058732|NCT00706992|158047550|FG001|Overall Study|Study termination|5|||
49058733|NCT00706992|158047551|FG002|Overall Study|Study termination|6|||
49058734|NCT00706992|158047552|FG003|Overall Study|Study termination|2|||
49058735|NCT00706992|158047553|FG004|Overall Study|Study termination|3|||
49058736|NCT00706992|158047554|FG005|Overall Study|Study termination|2|||
49058737|NCT00706992|158047555|FG006|Overall Study|Study termination|3|||
49058738|NCT00706992|158047549|FG000|Overall Study|Disease progression before treatment|0|||
49058739|NCT00706992|158047550|FG001|Overall Study|Disease progression before treatment|0|||
49058740|NCT00706992|158047551|FG002|Overall Study|Disease progression before treatment|0|||
49058741|NCT00706992|158047552|FG003|Overall Study|Disease progression before treatment|0|||
49058742|NCT00706992|158047553|FG004|Overall Study|Disease progression before treatment|1|||
49058743|NCT00706992|158047554|FG005|Overall Study|Disease progression before treatment|0|||
49058744|NCT00706992|158047555|FG006|Overall Study|Disease progression before treatment|0|||
49058745|NCT02777918|158047556|FG000|Overall Study|Medical reasons|1|||
49058746|NCT02777918|158047557|FG001|Overall Study|Medical reasons|2|||
49058747|NCT02777918|158047556|FG000|Overall Study|Too busy / stressed|1|||
49058748|NCT02777918|158047557|FG001|Overall Study|Too busy / stressed|1|||
49058749|NCT02777918|158047556|FG000|Overall Study|Withdrawal by Subject|1|||
49058750|NCT02777918|158047557|FG001|Overall Study|Withdrawal by Subject|1|||
49058751|NCT01901874|158047558|FG000|Screening Committee Retrospective Review|Protocol Violation|47|||
49058752|NCT01901874|158047558|FG000|30-Day MAE Evaluation|Insufficient Follow-up|1|||
49058753|NCT01901874|158047558|FG000|1-Year (365-Day) MAE Evaluation|Death|7|||
49058754|NCT01901874|158047558|FG000|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5|||
49058755|NCT01901874|158047558|FG000|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2|||
49058756|NCT01901874|158047558|FG000|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6|||
49058757|NCT03314662|158047559|FG000|Overall Study|Withdrawal by Subject|1|||
49058758|NCT03314662|158047560|FG001|Overall Study|Withdrawal by Subject|1|||
49058759|NCT03314662|158047561|FG002|Overall Study|Withdrawal by Subject|1|||
49058760|NCT03314662|158047559|FG000|Overall Study|Lost to Follow-up|5|||
49058761|NCT03314662|158047560|FG001|Overall Study|Lost to Follow-up|4|||
49058762|NCT03314662|158047561|FG002|Overall Study|Lost to Follow-up|4|||
49058763|NCT03314662|158047559|FG000|Overall Study|Death|2|||
49058764|NCT03314662|158047560|FG001|Overall Study|Death|0|||
49058765|NCT03314662|158047561|FG002|Overall Study|Death|0|||
49058766|NCT03978091|158047562|FG000|Overall Study|Lost to Follow-up|0|||
49058767|NCT03978091|158047563|FG001|Overall Study|Lost to Follow-up|0|||
49058768|NCT03978091|158047564|FG002|Overall Study|Lost to Follow-up|1|||
49058769|NCT03978091|158047565|FG003|Overall Study|Lost to Follow-up|0|||
49058770|NCT03978091|158047566|FG004|Overall Study|Lost to Follow-up|0|||
49058771|NCT03978091|158047567|FG005|Overall Study|Lost to Follow-up|0|||
49058772|NCT03978091|158047562|FG000|Overall Study|Withdrawal by Subject|0|||
49058773|NCT03978091|158047563|FG001|Overall Study|Withdrawal by Subject|0|||
49058774|NCT03978091|158047564|FG002|Overall Study|Withdrawal by Subject|0|||
49058775|NCT03978091|158047565|FG003|Overall Study|Withdrawal by Subject|1|||
49058776|NCT03978091|158047566|FG004|Overall Study|Withdrawal by Subject|1|||
49058777|NCT03978091|158047567|FG005|Overall Study|Withdrawal by Subject|0|||
49058778|NCT02083926|158047570|FG000|Overall Study|Withdrawal by Subject|1|||
49058779|NCT02083926|158047571|FG001|Overall Study|Withdrawal by Subject|0|||
49058780|NCT01949116|158047575|FG000|Overall Study|Death|2|||
49058781|NCT01949116|158047576|FG001|Overall Study|Death|0|||
49058782|NCT01949116|158047575|FG000|Overall Study|Lost to Follow-up|1|||
49058783|NCT01949116|158047576|FG001|Overall Study|Lost to Follow-up|3|||
49058784|NCT01949116|158047575|FG000|Overall Study|Withdrawal by Subject|5|||
49058785|NCT01949116|158047576|FG001|Overall Study|Withdrawal by Subject|3|||
49058786|NCT02201290|158047577|FG000|Overall Study|Withdrawal by Subject|2|||
49058787|NCT02201290|158047577|FG000|Overall Study|Lack of Efficacy|2|||
49058788|NCT02201290|158047577|FG000|Overall Study|Adverse Event|1|||
49058789|NCT01564459|158047578|FG000|Run-In|Adverse Event|7|||
49058790|NCT01564459|158047579|FG001|Run-In|Adverse Event|0|||
49058791|NCT01564459|158047580|FG002|Run-In|Adverse Event|0|||
49058792|NCT01564459|158047578|FG000|Run-In|Lost to Follow-up|1|||
49058793|NCT01564459|158047579|FG001|Run-In|Lost to Follow-up|0|||
49058794|NCT01564459|158047580|FG002|Run-In|Lost to Follow-up|0|||
49058795|NCT01564459|158047578|FG000|Run-In|Non-compliance with study drug|2|||
49058796|NCT01564459|158047579|FG001|Run-In|Non-compliance with study drug|0|||
49058797|NCT01564459|158047580|FG002|Run-In|Non-compliance with study drug|0|||
49058798|NCT01564459|158047578|FG000|Run-In|Protocol Violation|1|||
49058799|NCT01564459|158047579|FG001|Run-In|Protocol Violation|0|||
49058800|NCT01564459|158047580|FG002|Run-In|Protocol Violation|0|||
49058801|NCT01564459|158047578|FG000|Run-In|Withdrawal by Subject|1|||
49058802|NCT01564459|158047579|FG001|Run-In|Withdrawal by Subject|0|||
49058803|NCT01564459|158047580|FG002|Run-In|Withdrawal by Subject|0|||
49058804|NCT01564459|158047578|FG000|Double-blind Treatment|Adverse Event|0|||
49058805|NCT01564459|158047579|FG001|Double-blind Treatment|Adverse Event|0|||
49058806|NCT01564459|158047580|FG002|Double-blind Treatment|Adverse Event|1|||
49058807|NCT00952276|158047581|FG000|Overall Study|Withdrawal by Subject|1|||
49058808|NCT00952276|158047582|FG001|Overall Study|Withdrawal by Subject|0|||
49058809|NCT00952276|158047583|FG002|Overall Study|Withdrawal by Subject|0|||
49058810|NCT00952276|158047584|FG003|Overall Study|Withdrawal by Subject|1|||
49058811|NCT00952276|158047585|FG004|Overall Study|Withdrawal by Subject|0|||
49058812|NCT03078582|158047588|FG000|Overall Study|Adverse Event|0|||
49058813|NCT03078582|158047589|FG001|Overall Study|Adverse Event|8|||
49058814|NCT01230892|158047590|FG000|Overall Study|Withdrawal by Subject|1|||
49058815|NCT01230892|158047591|FG001|Overall Study|Withdrawal by Subject|1|||
49058816|NCT01230892|158047590|FG000|Overall Study|Lost to Follow-up|2|||
49058817|NCT01230892|158047591|FG001|Overall Study|Lost to Follow-up|0|||
49058818|NCT04700280|158047592|FG000|Overall Study|Adverse Event|4|||
49058819|NCT04700280|158047593|FG001|Overall Study|Adverse Event|0|||
49058820|NCT04700280|158047592|FG000|Overall Study|Lack of Efficacy|1|||
49058821|NCT04700280|158047593|FG001|Overall Study|Lack of Efficacy|0|||
49058822|NCT04700280|158047592|FG000|Overall Study|Study terminated by sponsor|5|||
49058823|NCT04700280|158047593|FG001|Overall Study|Study terminated by sponsor|3|||
49058824|NCT04700280|158047592|FG000|Overall Study|Other than specified|1|||
49058825|NCT04700280|158047593|FG001|Overall Study|Other than specified|0|||
49058826|NCT01843348|158047596|FG000|Overall Study|Withdrawal by Subject|4|||
49058827|NCT01843348|158047597|FG001|Overall Study|Withdrawal by Subject|16|||
49058828|NCT01843348|158047598|FG002|Overall Study|Withdrawal by Subject|18|||
49058829|NCT01843348|158047596|FG000|Overall Study|Lost to Follow-up|5|||
49058830|NCT01843348|158047597|FG001|Overall Study|Lost to Follow-up|4|||
49058831|NCT01843348|158047598|FG002|Overall Study|Lost to Follow-up|2|||
49058832|NCT01843348|158047596|FG000|Overall Study|Death|5|||
49058833|NCT01843348|158047597|FG001|Overall Study|Death|3|||
49058834|NCT01843348|158047598|FG002|Overall Study|Death|4|||
49058835|NCT01843348|158047596|FG000|Overall Study|Graft loss/retransplantation|5|||
49058836|NCT01843348|158047597|FG001|Overall Study|Graft loss/retransplantation|8|||
49058837|NCT01843348|158047598|FG002|Overall Study|Graft loss/retransplantation|11|||
49058838|NCT01843348|158047596|FG000|Overall Study|Various reasons|4|||
49058839|NCT01843348|158047597|FG001|Overall Study|Various reasons|9|||
49058840|NCT01843348|158047598|FG002|Overall Study|Various reasons|6|||
49058841|NCT02139124|158047599|FG000|Overall Study|Adverse Event|2|||
49058842|NCT02139124|158047600|FG001|Overall Study|Adverse Event|0|||
49058843|NCT02139124|158047601|FG002|Overall Study|Adverse Event|1|||
49058844|NCT02139124|158047602|FG003|Overall Study|Adverse Event|2|||
49058845|NCT02139124|158047603|FG004|Overall Study|Adverse Event|5|||
49058846|NCT02139124|158047599|FG000|Overall Study|Withdrawal by Subject|2|||
49058847|NCT02139124|158047600|FG001|Overall Study|Withdrawal by Subject|2|||
49058848|NCT02139124|158047601|FG002|Overall Study|Withdrawal by Subject|2|||
49058849|NCT02139124|158047602|FG003|Overall Study|Withdrawal by Subject|2|||
49058850|NCT02139124|158047603|FG004|Overall Study|Withdrawal by Subject|3|||
49058851|NCT02139124|158047599|FG000|Overall Study|Protocol Violation|0|||
49058852|NCT02139124|158047600|FG001|Overall Study|Protocol Violation|0|||
49058853|NCT02139124|158047601|FG002|Overall Study|Protocol Violation|0|||
49058854|NCT02139124|158047602|FG003|Overall Study|Protocol Violation|1|||
49058855|NCT02139124|158047603|FG004|Overall Study|Protocol Violation|1|||
49058856|NCT02139124|158047599|FG000|Overall Study|non-compliant|1|||
49058857|NCT02139124|158047600|FG001|Overall Study|non-compliant|0|||
49058858|NCT02139124|158047601|FG002|Overall Study|non-compliant|0|||
49058859|NCT02139124|158047602|FG003|Overall Study|non-compliant|2|||
49058860|NCT02139124|158047603|FG004|Overall Study|non-compliant|0|||
49058861|NCT02139124|158047599|FG000|Overall Study|incarceration|0|||
49058862|NCT02139124|158047600|FG001|Overall Study|incarceration|0|||
49058863|NCT02139124|158047601|FG002|Overall Study|incarceration|1|||
49058864|NCT02139124|158047602|FG003|Overall Study|incarceration|0|||
49058865|NCT02139124|158047603|FG004|Overall Study|incarceration|0|||
49058866|NCT02139124|158047599|FG000|Overall Study|subject moved|1|||
49058867|NCT02139124|158047600|FG001|Overall Study|subject moved|0|||
49058868|NCT02139124|158047601|FG002|Overall Study|subject moved|0|||
49058869|NCT02139124|158047602|FG003|Overall Study|subject moved|0|||
49058870|NCT02139124|158047603|FG004|Overall Study|subject moved|0|||
49058871|NCT02139124|158047599|FG000|Overall Study|Lost to Follow-up|3|||
49058872|NCT02139124|158047600|FG001|Overall Study|Lost to Follow-up|2|||
49058873|NCT02139124|158047601|FG002|Overall Study|Lost to Follow-up|0|||
49058874|NCT02139124|158047602|FG003|Overall Study|Lost to Follow-up|5|||
49058875|NCT02139124|158047603|FG004|Overall Study|Lost to Follow-up|4|||
49058876|NCT00251641|158047604|FG000|Overall Study|Adverse Event|80|||
49058877|NCT00251641|158047605|FG001|Overall Study|Adverse Event|8|||
49058878|NCT00251641|158047604|FG000|Overall Study|Lack of Efficacy|2|||
49058879|NCT00251641|158047605|FG001|Overall Study|Lack of Efficacy|1|||
49058880|NCT00251641|158047604|FG000|Overall Study|Progression of Disease|0|||
49058881|NCT00251641|158047605|FG001|Overall Study|Progression of Disease|2|||
49058882|NCT00251641|158047604|FG000|Overall Study|Lost to Follow-up|3|||
49058883|NCT00251641|158047605|FG001|Overall Study|Lost to Follow-up|3|||
49058884|NCT00251641|158047604|FG000|Overall Study|Withdrawal by Subject|6|||
49058885|NCT00251641|158047605|FG001|Overall Study|Withdrawal by Subject|8|||
49058886|NCT00251641|158047604|FG000|Overall Study|Protocol Violation|10|||
49058887|NCT00251641|158047605|FG001|Overall Study|Protocol Violation|2|||
49058888|NCT00251641|158047604|FG000|Overall Study|Did not Meet protocol Eligibility|2|||
49058889|NCT00251641|158047605|FG001|Overall Study|Did not Meet protocol Eligibility|1|||
49058890|NCT00251641|158047604|FG000|Overall Study|Switched Treatment|9|||
49058891|NCT00251641|158047605|FG001|Overall Study|Switched Treatment|63|||
49058892|NCT02691741|158047606|FG000|Overall Study|Adverse Event|0|||
49058893|NCT02691741|158047607|FG001|Overall Study|Adverse Event|2|||
49058894|NCT02691741|158047606|FG000|Overall Study|Lost to Follow-up|1|||
49058895|NCT02691741|158047607|FG001|Overall Study|Lost to Follow-up|0|||
49058896|NCT02691741|158047606|FG000|Overall Study|Physician Decision|0|||
49058897|NCT02691741|158047607|FG001|Overall Study|Physician Decision|1|||
49058898|NCT02691741|158047606|FG000|Overall Study|Withdrawal by Subject|0|||
49058899|NCT02691741|158047607|FG001|Overall Study|Withdrawal by Subject|4|||
49058900|NCT02093221|158047610|FG000|Overall Study|Adverse Event|1|||
49058901|NCT02093221|158047611|FG001|Overall Study|Adverse Event|0|||
49058902|NCT02093221|158047612|FG002|Overall Study|Adverse Event|0|||
49058903|NCT02093221|158047613|FG003|Overall Study|Adverse Event|0|||
49058904|NCT02093221|158047614|FG004|Overall Study|Adverse Event|0|||
49058905|NCT02093221|158047610|FG000|Overall Study|Withdrawal by Subject|1|||
49058906|NCT02093221|158047611|FG001|Overall Study|Withdrawal by Subject|1|||
49058907|NCT02093221|158047612|FG002|Overall Study|Withdrawal by Subject|4|||
49058908|NCT02093221|158047613|FG003|Overall Study|Withdrawal by Subject|1|||
49058909|NCT02093221|158047614|FG004|Overall Study|Withdrawal by Subject|1|||
49058910|NCT02093221|158047610|FG000|Overall Study|Lost to Follow-up|2|||
49058911|NCT02093221|158047611|FG001|Overall Study|Lost to Follow-up|0|||
49058912|NCT02093221|158047612|FG002|Overall Study|Lost to Follow-up|1|||
49058913|NCT02093221|158047613|FG003|Overall Study|Lost to Follow-up|1|||
49058914|NCT02093221|158047614|FG004|Overall Study|Lost to Follow-up|0|||
49058915|NCT02093221|158047610|FG000|Overall Study|Death|0|||
49058916|NCT02093221|158047611|FG001|Overall Study|Death|1|||
49058917|NCT02093221|158047612|FG002|Overall Study|Death|0|||
49058918|NCT02093221|158047613|FG003|Overall Study|Death|0|||
49058919|NCT02093221|158047614|FG004|Overall Study|Death|0|||
49058920|NCT02093221|158047610|FG000|Overall Study|Protocol Violation|0|||
49058921|NCT02093221|158047611|FG001|Overall Study|Protocol Violation|1|||
49058922|NCT02093221|158047612|FG002|Overall Study|Protocol Violation|0|||
49058923|NCT02093221|158047613|FG003|Overall Study|Protocol Violation|0|||
49058924|NCT02093221|158047614|FG004|Overall Study|Protocol Violation|0|||
49058925|NCT02093221|158047610|FG000|Overall Study|Study termination|6|||
49058926|NCT02093221|158047611|FG001|Overall Study|Study termination|5|||
49058927|NCT02093221|158047612|FG002|Overall Study|Study termination|4|||
49058928|NCT02093221|158047613|FG003|Overall Study|Study termination|6|||
49058929|NCT02093221|158047614|FG004|Overall Study|Study termination|7|||
49058930|NCT02039414|158047615|FG000|Overall Study|Delivered|1|||
49058931|NCT02039414|158047616|FG001|Overall Study|Delivered|1|||
49058932|NCT02039414|158047615|FG000|Overall Study|Lost to Follow-up|2|||
49058933|NCT02039414|158047616|FG001|Overall Study|Lost to Follow-up|0|||
49058934|NCT02039414|158047615|FG000|Overall Study|Protocol Violation|3|||
49058935|NCT02039414|158047616|FG001|Overall Study|Protocol Violation|1|||
49058936|NCT02340221|158047619|FG000|Overall Study|Death|100|||
49058937|NCT02340221|158047620|FG001|Overall Study|Death|197|||
49058938|NCT02340221|158047619|FG000|Overall Study|Withdrawal by Participant|24|||
49058939|NCT02340221|158047620|FG001|Overall Study|Withdrawal by Participant|37|||
49058940|NCT02340221|158047619|FG000|Overall Study|Lost to Follow-up|4|||
49058941|NCT02340221|158047620|FG001|Overall Study|Lost to Follow-up|15|||
49058942|NCT02340221|158047619|FG000|Overall Study|Reason Not Specified|85|||
49058943|NCT02340221|158047620|FG001|Overall Study|Reason Not Specified|165|||
49058944|NCT02340221|158047619|FG000|Overall Study|Study Terminated by Sponsor|1|||
49058945|NCT02340221|158047620|FG001|Overall Study|Study Terminated by Sponsor|3|||
49058946|NCT03465436|158047621|FG000|Period 1|Protocol Violation|0|||
49058947|NCT03465436|158047622|FG001|Period 1|Protocol Violation|0|||
49058948|NCT03465436|158047623|FG002|Period 1|Protocol Violation|1|||
49058949|NCT03465436|158047624|FG003|Period 1|Protocol Violation|0|||
49058950|NCT03465436|158047621|FG000|Period 2|Protocol Violation|0|||
49058951|NCT03465436|158047622|FG001|Period 2|Protocol Violation|1|||
49058952|NCT03465436|158047623|FG002|Period 2|Protocol Violation|0|||
49058953|NCT03465436|158047624|FG003|Period 2|Protocol Violation|0|||
49058954|NCT03465436|158047621|FG000|Period 3|Protocol Violation|1|||
49058955|NCT03465436|158047622|FG001|Period 3|Protocol Violation|1|||
49058956|NCT03465436|158047623|FG002|Period 3|Protocol Violation|0|||
49058957|NCT03465436|158047624|FG003|Period 3|Protocol Violation|0|||
49058958|NCT03465436|158047621|FG000|Period 4|Protocol Violation|0|||
49058959|NCT03465436|158047622|FG001|Period 4|Protocol Violation|0|||
49058960|NCT03465436|158047623|FG002|Period 4|Protocol Violation|1|||
49058961|NCT03465436|158047624|FG003|Period 4|Protocol Violation|0|||
49058962|NCT02972502|158047625|FG000|Overall Study|Lost to Follow-up|3|||
49058963|NCT02972502|158047626|FG001|Overall Study|Lost to Follow-up|1|||
49058964|NCT02972502|158047625|FG000|Overall Study|Withdrawal by Subject|1|||
49058965|NCT02972502|158047626|FG001|Overall Study|Withdrawal by Subject|1|||
49058966|NCT03832738|158047629|FG000|Overall Study|Withdrawal by Subject|6|||
49058967|NCT03832738|158047630|FG001|Overall Study|Withdrawal by Subject|7|||
49058968|NCT03832738|158047631|FG002|Overall Study|Withdrawal by Subject|16|||
49058969|NCT03832738|158047629|FG000|Overall Study|Physician Decision|0|||
49058970|NCT03832738|158047630|FG001|Overall Study|Physician Decision|1|||
49058971|NCT03832738|158047631|FG002|Overall Study|Physician Decision|2|||
49058972|NCT03832738|158047629|FG000|Overall Study|Adverse Event|2|||
49058973|NCT03832738|158047630|FG001|Overall Study|Adverse Event|3|||
49058974|NCT03832738|158047631|FG002|Overall Study|Adverse Event|1|||
49058975|NCT03832738|158047629|FG000|Overall Study|Pregnancy|0|||
49058976|NCT03832738|158047630|FG001|Overall Study|Pregnancy|1|||
49058977|NCT03832738|158047631|FG002|Overall Study|Pregnancy|0|||
49058978|NCT03852459|158047632|FG000|Overall Study|Adverse Event|2|||
49058979|NCT03852459|158047633|FG001|Overall Study|Adverse Event|2|||
49058980|NCT03852459|158047632|FG000|Overall Study|Withdrawal by Subject|1|||
49058981|NCT03852459|158047633|FG001|Overall Study|Withdrawal by Subject|1|||
49058982|NCT01079832|158047634|FG000|Overall Study|Withdrawal by Subject|1|||
49058983|NCT00049842|158047635|FG000|Treatment Phase|Adverse Event|47|||
49058984|NCT00049842|158047636|FG001|Treatment Phase|Adverse Event|12|||
49058985|NCT00049842|158047635|FG000|Treatment Phase|Withdrawal by Subject|35|||
49058986|NCT00049842|158047636|FG001|Treatment Phase|Withdrawal by Subject|46|||
49058987|NCT00049842|158047635|FG000|Treatment Phase|Non-compliance with protocol|7|||
49058988|NCT00049842|158047636|FG001|Treatment Phase|Non-compliance with protocol|8|||
49058989|NCT00049842|158047635|FG000|Treatment Phase|Lost to Follow-up|4|||
49058990|NCT00049842|158047636|FG001|Treatment Phase|Lost to Follow-up|8|||
49058991|NCT00049842|158047635|FG000|Treatment Phase|Administrative|0|||
49058992|NCT00049842|158047636|FG001|Treatment Phase|Administrative|3|||
49058993|NCT00049842|158047635|FG000|Treatment Phase|Did not meet protocol eligibility|0|||
49058994|NCT00049842|158047636|FG001|Treatment Phase|Did not meet protocol eligibility|1|||
49058995|NCT00049842|158047635|FG000|Follow-up Phase|Adverse Event|6|||
49058996|NCT00049842|158047636|FG001|Follow-up Phase|Adverse Event|1|||
49058997|NCT00049842|158047635|FG000|Follow-up Phase|Other|1|||
49058998|NCT00049842|158047636|FG001|Follow-up Phase|Other|4|||
49058999|NCT02442271|158047639|FG000|Overall Study|Adverse Event|1|||
49059000|NCT02442271|158047639|FG000|Overall Study|Withdrew Consent|1|||
49059001|NCT02442271|158047639|FG000|Overall Study|Lost to Follow-up|1|||
49059002|NCT02442271|158047639|FG000|Overall Study|Other|1|||
49059003|NCT01813071|158047640|FG000|Overall Study|Protocol Violation|0|||
49059004|NCT01813071|158047641|FG001|Overall Study|Protocol Violation|0|||
49059005|NCT01813071|158047642|FG002|Overall Study|Protocol Violation|0|||
49059006|NCT01813071|158047643|FG003|Overall Study|Protocol Violation|0|||
49059007|NCT01813071|158047644|FG004|Overall Study|Protocol Violation|1|||
49059008|NCT01813071|158047645|FG005|Overall Study|Protocol Violation|4|||
49059009|NCT01813071|158047646|FG006|Overall Study|Protocol Violation|2|||
49059010|NCT01813071|158047647|FG007|Overall Study|Protocol Violation|4|||
49059011|NCT01813071|158047648|FG008|Overall Study|Protocol Violation|2|||
49059012|NCT01813071|158047640|FG000|Overall Study|Withdrawal by Subject|0|||
49059013|NCT01813071|158047641|FG001|Overall Study|Withdrawal by Subject|0|||
49059014|NCT01813071|158047642|FG002|Overall Study|Withdrawal by Subject|0|||
49059015|NCT01813071|158047643|FG003|Overall Study|Withdrawal by Subject|0|||
49059016|NCT01813071|158047644|FG004|Overall Study|Withdrawal by Subject|0|||
49059017|NCT01813071|158047645|FG005|Overall Study|Withdrawal by Subject|1|||
49059018|NCT01813071|158047646|FG006|Overall Study|Withdrawal by Subject|0|||
49059019|NCT01813071|158047647|FG007|Overall Study|Withdrawal by Subject|0|||
49059020|NCT01813071|158047648|FG008|Overall Study|Withdrawal by Subject|0|||
49059021|NCT01813071|158047640|FG000|Overall Study|Adverse Event|0|||
49059022|NCT01813071|158047641|FG001|Overall Study|Adverse Event|0|||
49059023|NCT01813071|158047642|FG002|Overall Study|Adverse Event|0|||
49059024|NCT01813071|158047643|FG003|Overall Study|Adverse Event|0|||
49059025|NCT01813071|158047644|FG004|Overall Study|Adverse Event|0|||
49059026|NCT01813071|158047645|FG005|Overall Study|Adverse Event|1|||
49059027|NCT01813071|158047646|FG006|Overall Study|Adverse Event|0|||
49059028|NCT01813071|158047647|FG007|Overall Study|Adverse Event|0|||
49059029|NCT01813071|158047648|FG008|Overall Study|Adverse Event|0|||
49059030|NCT01813071|158047640|FG000|Overall Study|Physician Decision|0|||
49059031|NCT01813071|158047641|FG001|Overall Study|Physician Decision|0|||
49059032|NCT01813071|158047642|FG002|Overall Study|Physician Decision|0|||
49059033|NCT01813071|158047643|FG003|Overall Study|Physician Decision|0|||
49059034|NCT01813071|158047644|FG004|Overall Study|Physician Decision|0|||
49059035|NCT01813071|158047645|FG005|Overall Study|Physician Decision|0|||
49059036|NCT01813071|158047646|FG006|Overall Study|Physician Decision|1|||
49059037|NCT01813071|158047647|FG007|Overall Study|Physician Decision|0|||
49059038|NCT01813071|158047648|FG008|Overall Study|Physician Decision|0|||
49059039|NCT01813071|158047640|FG000|Overall Study|Met inc/exc criteria|0|||
49059040|NCT01813071|158047641|FG001|Overall Study|Met inc/exc criteria|0|||
49059041|NCT01813071|158047642|FG002|Overall Study|Met inc/exc criteria|0|||
49059042|NCT01813071|158047643|FG003|Overall Study|Met inc/exc criteria|0|||
49059043|NCT01813071|158047644|FG004|Overall Study|Met inc/exc criteria|0|||
49059044|NCT01813071|158047645|FG005|Overall Study|Met inc/exc criteria|1|||
49059045|NCT01813071|158047646|FG006|Overall Study|Met inc/exc criteria|0|||
49059046|NCT01813071|158047647|FG007|Overall Study|Met inc/exc criteria|1|||
49059047|NCT01813071|158047648|FG008|Overall Study|Met inc/exc criteria|1|||
49059048|NCT02615171|158047650|FG000|Overall Study|Lost to Follow-up|2|||
49059049|NCT02615171|158047651|FG001|Overall Study|Lost to Follow-up|1|||
49059050|NCT01902628|158047654|FG000|Overall Study|Withdrawal of participant's consent|7|||
49059051|NCT01902628|158047654|FG000|Overall Study|Adverse Event|41|||
49059052|NCT01902628|158047654|FG000|Overall Study|Lost to Follow-up|35|||
49059053|NCT01347866|158047656|FG000|Overall Study|Death|0|||
49059054|NCT01347866|158047657|FG001|Overall Study|Death|0|||
49059055|NCT01347866|158047658|FG002|Overall Study|Death|0|||
49059056|NCT01347866|158047659|FG003|Overall Study|Death|1|||
49059057|NCT01347866|158047660|FG004|Overall Study|Death|2|||
49059058|NCT01347866|158047661|FG005|Overall Study|Death|2|||
49059059|NCT01347866|158047662|FG006|Overall Study|Death|1|||
49059060|NCT01347866|158047663|FG007|Overall Study|Death|0|||
49059061|NCT01347866|158047664|FG008|Overall Study|Death|4|||
49059062|NCT01347866|158047665|FG009|Overall Study|Death|1|||
49059063|NCT01347866|158047666|FG010|Overall Study|Death|3|||
49059064|NCT01347866|158047667|FG011|Overall Study|Death|1|||
49059065|NCT01347866|158047668|FG012|Overall Study|Death|2|||
49059066|NCT01347866|158047669|FG013|Overall Study|Death|0|||
49059067|NCT01347866|158047670|FG014|Overall Study|Death|0|||
49059068|NCT01347866|158047671|FG015|Overall Study|Death|1|||
49059069|NCT01347866|158047672|FG016|Overall Study|Death|0|||
49059070|NCT01347866|158047656|FG000|Overall Study|Lost to Follow-up|0|||
49059071|NCT01347866|158047657|FG001|Overall Study|Lost to Follow-up|0|||
49059072|NCT01347866|158047658|FG002|Overall Study|Lost to Follow-up|0|||
49059073|NCT01347866|158047659|FG003|Overall Study|Lost to Follow-up|0|||
49059074|NCT01347866|158047660|FG004|Overall Study|Lost to Follow-up|0|||
49059075|NCT01347866|158047661|FG005|Overall Study|Lost to Follow-up|0|||
49059076|NCT01347866|158047662|FG006|Overall Study|Lost to Follow-up|0|||
49059077|NCT01347866|158047663|FG007|Overall Study|Lost to Follow-up|1|||
49059078|NCT01347866|158047664|FG008|Overall Study|Lost to Follow-up|1|||
49059079|NCT01347866|158047665|FG009|Overall Study|Lost to Follow-up|0|||
49059080|NCT01347866|158047666|FG010|Overall Study|Lost to Follow-up|0|||
49059081|NCT01347866|158047667|FG011|Overall Study|Lost to Follow-up|0|||
49059082|NCT01347866|158047668|FG012|Overall Study|Lost to Follow-up|0|||
49059083|NCT01347866|158047669|FG013|Overall Study|Lost to Follow-up|0|||
49059084|NCT01347866|158047670|FG014|Overall Study|Lost to Follow-up|0|||
49059085|NCT01347866|158047671|FG015|Overall Study|Lost to Follow-up|0|||
49059086|NCT01347866|158047672|FG016|Overall Study|Lost to Follow-up|0|||
49059087|NCT01347866|158047656|FG000|Overall Study|Other|3|||
49059088|NCT01347866|158047657|FG001|Overall Study|Other|1|||
49059089|NCT01347866|158047658|FG002|Overall Study|Other|1|||
49059090|NCT01347866|158047659|FG003|Overall Study|Other|4|||
49059091|NCT01347866|158047660|FG004|Overall Study|Other|5|||
49059092|NCT01347866|158047661|FG005|Overall Study|Other|0|||
49059093|NCT01347866|158047662|FG006|Overall Study|Other|5|||
49059094|NCT01347866|158047663|FG007|Overall Study|Other|3|||
49059095|NCT01347866|158047664|FG008|Overall Study|Other|22|||
49059096|NCT01347866|158047665|FG009|Overall Study|Other|5|||
49059097|NCT01347866|158047666|FG010|Overall Study|Other|0|||
49059098|NCT01347866|158047667|FG011|Overall Study|Other|3|||
49059099|NCT01347866|158047668|FG012|Overall Study|Other|4|||
49059100|NCT01347866|158047669|FG013|Overall Study|Other|4|||
49059101|NCT01347866|158047670|FG014|Overall Study|Other|2|||
49059102|NCT01347866|158047671|FG015|Overall Study|Other|3|||
49059103|NCT01347866|158047672|FG016|Overall Study|Other|0|||
49059104|NCT01347866|158047656|FG000|Overall Study|Subject refused further follow-up|2|||
49059105|NCT01347866|158047657|FG001|Overall Study|Subject refused further follow-up|0|||
49059106|NCT01347866|158047658|FG002|Overall Study|Subject refused further follow-up|0|||
49059107|NCT01347866|158047659|FG003|Overall Study|Subject refused further follow-up|2|||
49059108|NCT01347866|158047660|FG004|Overall Study|Subject refused further follow-up|0|||
49059109|NCT01347866|158047661|FG005|Overall Study|Subject refused further follow-up|1|||
49059110|NCT01347866|158047662|FG006|Overall Study|Subject refused further follow-up|0|||
49059111|NCT01347866|158047663|FG007|Overall Study|Subject refused further follow-up|0|||
49059112|NCT01347866|158047664|FG008|Overall Study|Subject refused further follow-up|4|||
49059113|NCT01347866|158047665|FG009|Overall Study|Subject refused further follow-up|1|||
49059114|NCT01347866|158047666|FG010|Overall Study|Subject refused further follow-up|0|||
49059115|NCT01347866|158047667|FG011|Overall Study|Subject refused further follow-up|0|||
49059116|NCT01347866|158047668|FG012|Overall Study|Subject refused further follow-up|1|||
49059117|NCT01347866|158047669|FG013|Overall Study|Subject refused further follow-up|3|||
49059118|NCT01347866|158047670|FG014|Overall Study|Subject refused further follow-up|1|||
49059119|NCT01347866|158047671|FG015|Overall Study|Subject refused further follow-up|0|||
49059120|NCT01347866|158047672|FG016|Overall Study|Subject refused further follow-up|2|||
49059121|NCT01117766|158047673|FG000|First Intervention|Adverse Event|0|||
49059122|NCT01117766|158047674|FG001|First Intervention|Adverse Event|1|||
49059123|NCT01117766|158047673|FG000|First Intervention|Protocol Violation|1|||
49059124|NCT01117766|158047674|FG001|First Intervention|Protocol Violation|0|||
49059125|NCT01117766|158047673|FG000|Washout Period|Protocol Violation|0|||
49059126|NCT01117766|158047674|FG001|Washout Period|Protocol Violation|2|||
49059127|NCT01117766|158047673|FG000|Second Intervention|Lost to Follow-up|1|||
49059128|NCT01117766|158047674|FG001|Second Intervention|Lost to Follow-up|0|||
49059129|NCT01117766|158047673|FG000|Second Intervention|Other|1|||
49059130|NCT01117766|158047674|FG001|Second Intervention|Other|2|||
49059131|NCT01117766|158047673|FG000|Second Intervention|Adverse Event|0|||
49059132|NCT01117766|158047674|FG001|Second Intervention|Adverse Event|2|||
49059133|NCT01117766|158047673|FG000|Second Intervention|Withdrawal by Subject|0|||
49059134|NCT01117766|158047674|FG001|Second Intervention|Withdrawal by Subject|1|||
49059135|NCT00854373|158047675|FG000|Overall Study|Withdrawal by Subject|1|||
49059136|NCT00854373|158047676|FG001|Overall Study|Withdrawal by Subject|3|||
49059137|NCT00854373|158047675|FG000|Overall Study|Forgot to take study drug|1|||
49059138|NCT00854373|158047676|FG001|Overall Study|Forgot to take study drug|1|||
49059139|NCT00307931|158047677|FG000|Overall Study|Adverse Event|1|||
49059140|NCT02429934|158047678|FG000|Overall Study|Withdrawal by Subject|0|||
49059141|NCT02429934|158047679|FG001|Overall Study|Withdrawal by Subject|2|||
49059142|NCT02429934|158047678|FG000|Overall Study|Adverse Event|2|||
49059143|NCT02429934|158047679|FG001|Overall Study|Adverse Event|0|||
49059144|NCT02429934|158047678|FG000|Overall Study|Lost to Follow-up|1|||
49059145|NCT02429934|158047679|FG001|Overall Study|Lost to Follow-up|1|||
49059146|NCT02429934|158047678|FG000|Overall Study|Physician Decision|1|||
49059147|NCT02429934|158047679|FG001|Overall Study|Physician Decision|0|||
49059148|NCT00869024|158047680|FG000|Overall Study|Death|2|||
49059149|NCT00869024|158047681|FG001|Overall Study|Death|3|||
49059150|NCT00869024|158047680|FG000|Overall Study|Lost to Follow-up|0|||
49059151|NCT00869024|158047681|FG001|Overall Study|Lost to Follow-up|1|||
49059152|NCT00869024|158047680|FG000|Overall Study|Protocol Violation|0|||
49059153|NCT00869024|158047681|FG001|Overall Study|Protocol Violation|1|||
49059154|NCT02939950|158047682|FG000|Overall Study|Lost to Follow-up|13|||
49059155|NCT02939950|158047683|FG001|Overall Study|Lost to Follow-up|16|||
49059156|NCT02939950|158047682|FG000|Overall Study|Positive slit lamp findings|0|||
49059157|NCT02939950|158047683|FG001|Overall Study|Positive slit lamp findings|1|||
49059158|NCT02939950|158047682|FG000|Overall Study|Chalazion upper lid|0|||
49059159|NCT02939950|158047683|FG001|Overall Study|Chalazion upper lid|1|||
49059160|NCT02939950|158047682|FG000|Overall Study|Lack of motivation|0|||
49059161|NCT02939950|158047683|FG001|Overall Study|Lack of motivation|2|||
49059162|NCT02939950|158047682|FG000|Overall Study|Unacceptable distance lens visual acuity|1|||
49059163|NCT02939950|158047683|FG001|Overall Study|Unacceptable distance lens visual acuity|1|||
49059164|NCT02939950|158047682|FG000|Overall Study|Military orders|1|||
49059165|NCT02939950|158047683|FG001|Overall Study|Military orders|0|||
49059166|NCT02939950|158047682|FG000|Overall Study|Participant Relocated|5|||
49059167|NCT02939950|158047683|FG001|Overall Study|Participant Relocated|3|||
49059168|NCT02939950|158047682|FG000|Overall Study|Study related symptoms|8|||
49059169|NCT02939950|158047683|FG001|Overall Study|Study related symptoms|8|||
49059170|NCT02939950|158047682|FG000|Overall Study|Unacceptable lens movement|2|||
49059171|NCT02939950|158047683|FG001|Overall Study|Unacceptable lens movement|0|||
49059172|NCT02939950|158047682|FG000|Overall Study|Protocol Violation|6|||
49059173|NCT02939950|158047683|FG001|Overall Study|Protocol Violation|3|||
49059174|NCT02939950|158047682|FG000|Overall Study|Physician Decision|2|||
49059175|NCT02939950|158047683|FG001|Overall Study|Physician Decision|0|||
49059176|NCT02939950|158047682|FG000|Overall Study|Pregnancy|6|||
49059177|NCT02939950|158047683|FG001|Overall Study|Pregnancy|7|||
49059178|NCT02939950|158047682|FG000|Overall Study|Withdrawal by Subject|12|||
49059179|NCT02939950|158047683|FG001|Overall Study|Withdrawal by Subject|28|||
49059180|NCT02939950|158047682|FG000|Overall Study|Adverse Event|7|||
49059181|NCT02939950|158047683|FG001|Overall Study|Adverse Event|3|||
49059182|NCT02939950|158047682|FG000|Overall Study|Randomized, not dispensed|1|||
49059183|NCT02939950|158047683|FG001|Overall Study|Randomized, not dispensed|0|||
49059184|NCT02939950|158047682|FG000|Overall Study|Ineligible at Baseline|2|||
49059185|NCT02939950|158047683|FG001|Overall Study|Ineligible at Baseline|8|||
49059186|NCT00725621|158047698|FG000|Overall Study|Adverse Event|25|||
49059187|NCT00725621|158047698|FG000|Overall Study|Lack of Efficacy|46|||
49059188|NCT00725621|158047698|FG000|Overall Study|Withdrawal by Subject|57|||
49059189|NCT00725621|158047698|FG000|Overall Study|Physician Decision|19|||
49059190|NCT00725621|158047698|FG000|Overall Study|Lost to Follow-up|52|||
49059191|NCT00725621|158047698|FG000|Overall Study|Non-compliance|8|||
49059192|NCT00725621|158047698|FG000|Overall Study|Continued treatment by other physician|6|||
49059193|NCT00725621|158047698|FG000|Overall Study|Switched to other study|1|||
49059194|NCT00725621|158047698|FG000|Overall Study|Switched to other drug|1|||
49059195|NCT00725621|158047698|FG000|Overall Study|Prepared for elective surgery|1|||
49059196|NCT00725621|158047698|FG000|Overall Study|Reason not specified|55|||
49059197|NCT01560507|158047703|FG000|Overall Study|Lost to Follow-up|3|||
49059198|NCT01560507|158047704|FG001|Overall Study|Lost to Follow-up|1|||
49059199|NCT01560507|158047705|FG002|Overall Study|Lost to Follow-up|2|||
49059200|NCT01560507|158047703|FG000|Overall Study|Withdrawal by Subject|1|||
49059201|NCT01560507|158047704|FG001|Overall Study|Withdrawal by Subject|1|||
49059202|NCT01560507|158047705|FG002|Overall Study|Withdrawal by Subject|0|||
49059203|NCT02080832|158047706|FG000|Overall Study|Excluded from analysis by MRI|9|||
49059204|NCT02080832|158047707|FG001|Overall Study|Excluded from analysis by MRI|10|||
49059205|NCT02080832|158047708|FG002|Overall Study|Excluded from analysis by MRI|14|||
49059206|NCT02080832|158047706|FG000|Overall Study|Lost to Follow-up|0|||
49059207|NCT02080832|158047707|FG001|Overall Study|Lost to Follow-up|2|||
49059208|NCT02080832|158047708|FG002|Overall Study|Lost to Follow-up|2|||
49059209|NCT00560937|158047709|FG000|Overall Study|Withdrawal by Subject|0|||
49059210|NCT00560937|158047710|FG001|Overall Study|Withdrawal by Subject|1|||
49059211|NCT00560937|158047709|FG000|Overall Study|Physician Decision|1|||
49059212|NCT00560937|158047710|FG001|Overall Study|Physician Decision|1|||
49059213|NCT01138111|158047711|FG000|Overall Study|Withdrawal by Subject|5|||
49059214|NCT01138111|158047711|FG000|Overall Study|Adverse Event|1|||
49059215|NCT01138111|158047711|FG000|Overall Study|Death|1|||
49059216|NCT01138111|158047711|FG000|Overall Study|Lost to Follow-up|2|||
49059217|NCT01000493|158047712|FG000|Overall Study|Adverse Event|3|||
49059218|NCT01000493|158047713|FG001|Overall Study|Adverse Event|6|||
49059219|NCT01000493|158047712|FG000|Overall Study|Lack of Efficacy|1|||
49059220|NCT01000493|158047713|FG001|Overall Study|Lack of Efficacy|1|||
49059221|NCT01000493|158047712|FG000|Overall Study|Protocol Violation|1|||
49059222|NCT01000493|158047713|FG001|Overall Study|Protocol Violation|8|||
49059223|NCT01000493|158047712|FG000|Overall Study|Study closed/terminated|25|||
49059224|NCT01000493|158047713|FG001|Overall Study|Study closed/terminated|23|||
49059225|NCT01000493|158047712|FG000|Overall Study|Lost to Follow-up|5|||
49059226|NCT01000493|158047713|FG001|Overall Study|Lost to Follow-up|9|||
49059227|NCT01000493|158047712|FG000|Overall Study|Physician Decision|1|||
49059228|NCT01000493|158047713|FG001|Overall Study|Physician Decision|1|||
49059229|NCT01000493|158047712|FG000|Overall Study|Withdrawal by Subject|3|||
49059230|NCT01000493|158047713|FG001|Overall Study|Withdrawal by Subject|7|||
49059231|NCT01558297|158047714|FG000|Overall Study|Withdrawal by Subject|2|||
49059232|NCT01558297|158047715|FG001|Overall Study|Withdrawal by Subject|2|||
49059233|NCT01558297|158047716|FG002|Overall Study|Withdrawal by Subject|1|||
49059234|NCT01382251|158047717|FG000|Overall Study|Surgeries cancelled or delayed|16|||
49059235|NCT01382251|158047718|FG001|Overall Study|Surgeries cancelled or delayed|16|||
49059236|NCT01382251|158047717|FG000|Overall Study|Lost to Follow-up|4|||
49059237|NCT01382251|158047718|FG001|Overall Study|Lost to Follow-up|4|||
49059238|NCT01382251|158047717|FG000|Overall Study|Contacted after study closed|1|||
49059239|NCT01382251|158047718|FG001|Overall Study|Contacted after study closed|1|||
49059240|NCT00788593|158047719|FG000|Placebo Run-in Phase|Adverse Event|2|||
49059241|NCT00788593|158047720|FG001|Placebo Run-in Phase|Adverse Event|0|||
49059242|NCT00788593|158047721|FG002|Placebo Run-in Phase|Adverse Event|0|||
49059243|NCT00788593|158047719|FG000|Placebo Run-in Phase|Withdrawal by Subject|2|||
49059244|NCT00788593|158047720|FG001|Placebo Run-in Phase|Withdrawal by Subject|0|||
49059245|NCT00788593|158047721|FG002|Placebo Run-in Phase|Withdrawal by Subject|0|||
49059246|NCT00788593|158047719|FG000|Placebo Run-in Phase|Protocol Violation|2|||
49059247|NCT00788593|158047720|FG001|Placebo Run-in Phase|Protocol Violation|0|||
49059248|NCT00788593|158047721|FG002|Placebo Run-in Phase|Protocol Violation|0|||
49059249|NCT00788593|158047719|FG000|First Intervention Period|Adverse Event|0|||
49059250|NCT00788593|158047720|FG001|First Intervention Period|Adverse Event|1|||
49059251|NCT00788593|158047721|FG002|First Intervention Period|Adverse Event|0|||
49059252|NCT00788593|158047719|FG000|Second Intervention Period|Lost to Follow-up|0|||
49059253|NCT00788593|158047720|FG001|Second Intervention Period|Lost to Follow-up|1|||
49059254|NCT00788593|158047721|FG002|Second Intervention Period|Lost to Follow-up|0|||
49059255|NCT00788593|158047719|FG000|Second Intervention Period|Other|0|||
49059256|NCT00788593|158047720|FG001|Second Intervention Period|Other|0|||
49059257|NCT00788593|158047721|FG002|Second Intervention Period|Other|1|||
49059258|NCT01366443|158047722|FG000|Overall Study|Lost to Follow-up|2|||
49059259|NCT01366443|158047722|FG000|Overall Study|Under 18 yo|1|||
49059260|NCT00911807|158047723|FG000|Overall Study|Adverse Event|2|||
49059261|NCT00911807|158047724|FG001|Overall Study|Adverse Event|1|||
49059262|NCT00911807|158047725|FG002|Overall Study|Adverse Event|5|||
49059263|NCT00911807|158047723|FG000|Overall Study|Death|0|||
49059264|NCT00911807|158047724|FG001|Overall Study|Death|0|||
49059265|NCT00911807|158047725|FG002|Overall Study|Death|1|||
49059266|NCT00911807|158047723|FG000|Overall Study|Protocol Violation|6|||
49059267|NCT00911807|158047724|FG001|Overall Study|Protocol Violation|4|||
49059268|NCT00911807|158047725|FG002|Overall Study|Protocol Violation|9|||
49059269|NCT00911807|158047723|FG000|Overall Study|Withdrawal by Subject|8|||
49059270|NCT00911807|158047724|FG001|Overall Study|Withdrawal by Subject|10|||
49059271|NCT00911807|158047725|FG002|Overall Study|Withdrawal by Subject|7|||
49059272|NCT00911807|158047723|FG000|Overall Study|Organizational reasons|1|||
49059273|NCT00911807|158047724|FG001|Overall Study|Organizational reasons|3|||
49059274|NCT00911807|158047725|FG002|Overall Study|Organizational reasons|1|||
49059275|NCT03346070|158049614|FG000|Overall Study|Death|0|||
49059276|NCT03346070|158049615|FG001|Overall Study|Death|0|||
49059277|NCT03346070|158049616|FG002|Overall Study|Death|0|||
49059278|NCT03346070|158049617|FG003|Overall Study|Death|0|||
49059279|NCT03346070|158049618|FG004|Overall Study|Death|1|||
49059280|NCT03346070|158049614|FG000|Overall Study|Lost to Follow-up|0|||
49059281|NCT03346070|158049615|FG001|Overall Study|Lost to Follow-up|1|||
49059282|NCT03346070|158049616|FG002|Overall Study|Lost to Follow-up|2|||
49059283|NCT03346070|158049617|FG003|Overall Study|Lost to Follow-up|0|||
49059284|NCT03346070|158049618|FG004|Overall Study|Lost to Follow-up|0|||
49059285|NCT03346070|158049614|FG000|Overall Study|Physician Decision|0|||
49059286|NCT03346070|158049615|FG001|Overall Study|Physician Decision|0|||
49059287|NCT03346070|158049616|FG002|Overall Study|Physician Decision|0|||
49059288|NCT03346070|158049617|FG003|Overall Study|Physician Decision|1|||
49059289|NCT03346070|158049618|FG004|Overall Study|Physician Decision|1|||
49059290|NCT03346070|158049614|FG000|Overall Study|Withdrawal by Subject|1|||
49059291|NCT03346070|158049615|FG001|Overall Study|Withdrawal by Subject|0|||
49059292|NCT03346070|158049616|FG002|Overall Study|Withdrawal by Subject|0|||
49059293|NCT03346070|158049617|FG003|Overall Study|Withdrawal by Subject|1|||
49059294|NCT03346070|158049618|FG004|Overall Study|Withdrawal by Subject|0|||
49059295|NCT03346070|158049614|FG000|Overall Study|Study medication not received as planned|2|||
49059296|NCT03346070|158049615|FG001|Overall Study|Study medication not received as planned|3|||
49059297|NCT03346070|158049616|FG002|Overall Study|Study medication not received as planned|2|||
49059298|NCT03346070|158049617|FG003|Overall Study|Study medication not received as planned|3|||
49059299|NCT03346070|158049618|FG004|Overall Study|Study medication not received as planned|2|||
49059300|NCT03346070|158049614|FG000|Overall Study|Screen Failure|0|||
49059301|NCT03346070|158049615|FG001|Overall Study|Screen Failure|0|||
49059302|NCT03346070|158049616|FG002|Overall Study|Screen Failure|0|||
49059303|NCT03346070|158049617|FG003|Overall Study|Screen Failure|1|||
49059304|NCT03346070|158049618|FG004|Overall Study|Screen Failure|1|||
49059305|NCT00918463|158049619|FG000|Overall Study|Death|1|||
49059306|NCT00918463|158049619|FG000|Overall Study|Lack of Efficacy|1|||
49059307|NCT02954159|158049623|FG000|Overall Study|Study ended prematurely due to low enrol|1|||
49059308|NCT02954159|158049624|FG001|Overall Study|Study ended prematurely due to low enrol|0|||
49059309|NCT02954159|158049623|FG000|Overall Study|Withdrawal by Subject|0|||
49059310|NCT02954159|158049624|FG001|Overall Study|Withdrawal by Subject|1|||
49059311|NCT00986570|158049625|FG000|Overall Study|Lost to Follow-up|6|||
49059312|NCT00986570|158049625|FG000|Overall Study|Potential bias for objective assessment|1|||
49059313|NCT02225665|158049626|FG000|Overall Study|Subject moved from area and finds it difficult to return for visits.|1|||
49059314|NCT02225665|158049627|FG001|Overall Study|Subject moved from area and finds it difficult to return for visits.|0|||
49059315|NCT02225665|158049626|FG000|Overall Study|Subject restarted HAART prior to month 18.|0|||
49059316|NCT02225665|158049627|FG001|Overall Study|Subject restarted HAART prior to month 18.|1|||
49059317|NCT01311557|158049637|FG000|Overall Study|Serious adverse event|0|||
49059318|NCT01311557|158049638|FG001|Overall Study|Serious adverse event|1|||
49059319|NCT01311557|158049637|FG000|Overall Study|Protocol Violation|4|||
49059320|NCT01311557|158049638|FG001|Overall Study|Protocol Violation|2|||
49059321|NCT01311557|158049637|FG000|Overall Study|Lost to Follow-up|0|||
49059322|NCT01311557|158049638|FG001|Overall Study|Lost to Follow-up|1|||
49059323|NCT01311557|158049637|FG000|Overall Study|Withdrawal by Subject|1|||
49059324|NCT01311557|158049638|FG001|Overall Study|Withdrawal by Subject|2|||
49059325|NCT05855616|158049639|FG000|Overall Study|Lost to Follow-up|1|||
49059326|NCT05855616|158049640|FG001|Overall Study|Lost to Follow-up|2|||
49059327|NCT04032158|158049643|FG000|Overall Study|Study Termination|2|||
49059328|NCT04032158|158049644|FG001|Overall Study|Study Termination|1|||
49059329|NCT04322149|158049645|FG000|Overall Study|Adverse Event|1|||
49059330|NCT04322149|158049646|FG001|Overall Study|Adverse Event|1|||
49059331|NCT04322149|158049647|FG002|Overall Study|Adverse Event|0|||
49059332|NCT04322149|158049648|FG003|Overall Study|Adverse Event|0|||
49059333|NCT04322149|158049645|FG000|Overall Study|Withdrawal by Subject|0|||
49059334|NCT04322149|158049646|FG001|Overall Study|Withdrawal by Subject|0|||
49059335|NCT04322149|158049647|FG002|Overall Study|Withdrawal by Subject|0|||
49059336|NCT04322149|158049648|FG003|Overall Study|Withdrawal by Subject|2|||
49059337|NCT04322149|158049645|FG000|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
49059338|NCT04322149|158049646|FG001|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|1|||
49059339|NCT04322149|158049647|FG002|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
49059340|NCT04322149|158049648|FG003|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
49059341|NCT00652028|158049650|FG000|Overall Study|Adverse Event|1|||
49059342|NCT00652028|158049651|FG001|Overall Study|Adverse Event|0|||
49059343|NCT00652028|158049652|FG002|Overall Study|Adverse Event|0|||
49059344|NCT00652028|158049653|FG003|Overall Study|Adverse Event|0|||
49059345|NCT00652028|158049650|FG000|Overall Study|No Longer Meets Entry Criteria|0|||
49059346|NCT00652028|158049651|FG001|Overall Study|No Longer Meets Entry Criteria|1|||
49059347|NCT00652028|158049652|FG002|Overall Study|No Longer Meets Entry Criteria|0|||
49059348|NCT00652028|158049653|FG003|Overall Study|No Longer Meets Entry Criteria|0|||
49059349|NCT00652028|158049650|FG000|Overall Study|Physician Decision|0|||
49059350|NCT00652028|158049651|FG001|Overall Study|Physician Decision|0|||
49059351|NCT00652028|158049652|FG002|Overall Study|Physician Decision|1|||
49059352|NCT00652028|158049653|FG003|Overall Study|Physician Decision|0|||
49059353|NCT02546362|158049654|FG000|4-week Treatment Period|Lost to Follow-up|1|||
49059354|NCT02546362|158049654|FG000|4-week Treatment Period|Change in medication|2|||
49059355|NCT02546362|158049654|FG000|12-week Treatment Period|Withdrawal by Subject|6|||
49059356|NCT02546362|158049654|FG000|12-week Treatment Period|Lost to Follow-up|2|||
49059357|NCT02546362|158049654|FG000|12-week Treatment Period|Change in medication|1|||
49059358|NCT02932228|158049661|FG000|Overall Study|Death|8|||
49059359|NCT02932228|158049662|FG001|Overall Study|Death|23|||
49059360|NCT02932228|158049661|FG000|Overall Study|not eligible upon chart review|2|||
49059361|NCT02932228|158049662|FG001|Overall Study|not eligible upon chart review|5|||
49059362|NCT00102687|158049666|FG000|Initial Period|Withdrawal by Subject|6|||
49059363|NCT00102687|158049667|FG001|Initial Period|Withdrawal by Subject|3|||
49059364|NCT00102687|158049668|FG002|Initial Period|Withdrawal by Subject|5|||
49059365|NCT00102687|158049669|FG003|Initial Period|Withdrawal by Subject|0|||
49059366|NCT00102687|158049670|FG004|Initial Period|Withdrawal by Subject|0|||
49059367|NCT00102687|158049666|FG000|Initial Period|Adverse Event|4|||
49059368|NCT00102687|158049667|FG001|Initial Period|Adverse Event|7|||
49059369|NCT00102687|158049668|FG002|Initial Period|Adverse Event|9|||
49059370|NCT00102687|158049669|FG003|Initial Period|Adverse Event|0|||
49059371|NCT00102687|158049670|FG004|Initial Period|Adverse Event|0|||
49059372|NCT00102687|158049666|FG000|Initial Period|Transformation to AML (blast > 30%)|1|||
49059373|NCT00102687|158049667|FG001|Initial Period|Transformation to AML (blast > 30%)|3|||
49059374|NCT00102687|158049668|FG002|Initial Period|Transformation to AML (blast > 30%)|0|||
49059375|NCT00102687|158049669|FG003|Initial Period|Transformation to AML (blast > 30%)|0|||
49059376|NCT00102687|158049670|FG004|Initial Period|Transformation to AML (blast > 30%)|0|||
49059377|NCT00102687|158049666|FG000|Initial Period|Protocol Violation|0|||
49059378|NCT00102687|158049667|FG001|Initial Period|Protocol Violation|0|||
49059379|NCT00102687|158049668|FG002|Initial Period|Protocol Violation|2|||
49059380|NCT00102687|158049669|FG003|Initial Period|Protocol Violation|0|||
49059381|NCT00102687|158049670|FG004|Initial Period|Protocol Violation|0|||
49059382|NCT00102687|158049666|FG000|Initial Period|Physician Decision|2|||
49059383|NCT00102687|158049667|FG001|Initial Period|Physician Decision|9|||
49059384|NCT00102687|158049668|FG002|Initial Period|Physician Decision|6|||
49059385|NCT00102687|158049669|FG003|Initial Period|Physician Decision|0|||
49059386|NCT00102687|158049670|FG004|Initial Period|Physician Decision|0|||
49059387|NCT00102687|158049666|FG000|Initial Period|Sponsor's decision|0|||
49059388|NCT00102687|158049667|FG001|Initial Period|Sponsor's decision|1|||
49059389|NCT00102687|158049668|FG002|Initial Period|Sponsor's decision|1|||
49059390|NCT00102687|158049669|FG003|Initial Period|Sponsor's decision|0|||
49059391|NCT00102687|158049670|FG004|Initial Period|Sponsor's decision|0|||
49059392|NCT00102687|158049666|FG000|Initial Period|Failed Treatments (relapse,disease prog)|4|||
49059393|NCT00102687|158049667|FG001|Initial Period|Failed Treatments (relapse,disease prog)|4|||
49059394|NCT00102687|158049668|FG002|Initial Period|Failed Treatments (relapse,disease prog)|2|||
49059395|NCT00102687|158049669|FG003|Initial Period|Failed Treatments (relapse,disease prog)|0|||
49059396|NCT00102687|158049670|FG004|Initial Period|Failed Treatments (relapse,disease prog)|0|||
49059397|NCT00102687|158049666|FG000|Initial Period|Death|1|||
49059398|NCT00102687|158049667|FG001|Initial Period|Death|1|||
49059399|NCT00102687|158049668|FG002|Initial Period|Death|1|||
49059400|NCT00102687|158049669|FG003|Initial Period|Death|0|||
49059401|NCT00102687|158049670|FG004|Initial Period|Death|0|||
49059402|NCT00102687|158049666|FG000|Maintenance Period|Withdrawal by Subject|4|||
49059403|NCT00102687|158049667|FG001|Maintenance Period|Withdrawal by Subject|0|||
49059404|NCT00102687|158049668|FG002|Maintenance Period|Withdrawal by Subject|2|||
49059405|NCT00102687|158049669|FG003|Maintenance Period|Withdrawal by Subject|3|||
49059406|NCT00102687|158049670|FG004|Maintenance Period|Withdrawal by Subject|1|||
49059407|NCT00102687|158049666|FG000|Maintenance Period|Adverse Event|1|||
49059408|NCT00102687|158049667|FG001|Maintenance Period|Adverse Event|0|||
49059409|NCT00102687|158049668|FG002|Maintenance Period|Adverse Event|0|||
49059410|NCT00102687|158049669|FG003|Maintenance Period|Adverse Event|1|||
49059411|NCT00102687|158049670|FG004|Maintenance Period|Adverse Event|3|||
49059412|NCT00102687|158049666|FG000|Maintenance Period|Transformation to AML (blast > 30%)|0|||
49059413|NCT00102687|158049667|FG001|Maintenance Period|Transformation to AML (blast > 30%)|1|||
49059414|NCT00102687|158049668|FG002|Maintenance Period|Transformation to AML (blast > 30%)|0|||
49059415|NCT00102687|158049669|FG003|Maintenance Period|Transformation to AML (blast > 30%)|2|||
49059416|NCT00102687|158049670|FG004|Maintenance Period|Transformation to AML (blast > 30%)|0|||
49059417|NCT00102687|158049666|FG000|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
49059418|NCT00102687|158049667|FG001|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
49059419|NCT00102687|158049668|FG002|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
49059420|NCT00102687|158049669|FG003|Maintenance Period|Failed Treatment (relapse,disease prog)|3|||
49059421|NCT00102687|158049670|FG004|Maintenance Period|Failed Treatment (relapse,disease prog)|4|||
49059422|NCT00102687|158049666|FG000|Maintenance Period|Death|0|||
49059423|NCT00102687|158049667|FG001|Maintenance Period|Death|0|||
49059424|NCT00102687|158049668|FG002|Maintenance Period|Death|0|||
49059425|NCT00102687|158049669|FG003|Maintenance Period|Death|1|||
49059426|NCT00102687|158049670|FG004|Maintenance Period|Death|1|||
49059427|NCT00102687|158049666|FG000|Maintenance Period|Physician Decision|1|||
49059428|NCT00102687|158049667|FG001|Maintenance Period|Physician Decision|2|||
49059429|NCT00102687|158049668|FG002|Maintenance Period|Physician Decision|3|||
49059430|NCT00102687|158049669|FG003|Maintenance Period|Physician Decision|0|||
49059431|NCT00102687|158049670|FG004|Maintenance Period|Physician Decision|4|||
49059432|NCT00355472|158049673|FG000|Overall Study|Physician Decision|1|||
49059433|NCT03649412|158049678|FG000|Part A, Washout Period 1 (7 Days)|Physician Decision|1|||
49059434|NCT03649412|158049679|FG001|Part A, Washout Period 1 (7 Days)|Physician Decision|0|||
49059435|NCT03649412|158049678|FG000|Part A, Washout Period 4 (7 Days)|Adverse Event|1|||
49059436|NCT03649412|158049679|FG001|Part A, Washout Period 4 (7 Days)|Adverse Event|0|||
49059437|NCT03649412|158049678|FG000|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
49059438|NCT03649412|158049679|FG001|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
49059439|NCT03649412|158049678|FG000|Part A, Washout Period 5 (7 Days)|Adverse Event|1|||
49059440|NCT03649412|158049679|FG001|Part A, Washout Period 5 (7 Days)|Adverse Event|0|||
49059441|NCT03649412|158049678|FG000|Part B, Washout Period 1 (7 Days)|Adverse Event|0|||
49059442|NCT03649412|158049679|FG001|Part B, Washout Period 1 (7 Days)|Adverse Event|1|||
49059443|NCT03649412|158049678|FG000|Part B, Washout Period 5 (7 Days)|Adverse Event|0|||
49059444|NCT03649412|158049679|FG001|Part B, Washout Period 5 (7 Days)|Adverse Event|1|||
49059445|NCT00865514|158049680|FG000|Overall Study|Infusion cost exceeded funding|2|||
49059446|NCT03096847|158049681|FG000|Overall Study|Other|2|||
49059447|NCT03096847|158049682|FG001|Overall Study|Other|1|||
49059448|NCT03096847|158049683|FG002|Overall Study|Other|2|||
49059449|NCT03096847|158049681|FG000|Overall Study|Lost to Follow-up|1|||
49059450|NCT03096847|158049682|FG001|Overall Study|Lost to Follow-up|0|||
49059451|NCT03096847|158049683|FG002|Overall Study|Lost to Follow-up|1|||
49059452|NCT03096847|158049681|FG000|Overall Study|Death|6|||
49059453|NCT03096847|158049682|FG001|Overall Study|Death|0|||
49059454|NCT03096847|158049683|FG002|Overall Study|Death|2|||
49059455|NCT03096847|158049681|FG000|Overall Study|Protocol Violation|3|||
49059456|NCT03096847|158049682|FG001|Overall Study|Protocol Violation|0|||
49059457|NCT03096847|158049683|FG002|Overall Study|Protocol Violation|6|||
49059458|NCT03096847|158049681|FG000|Overall Study|Physician Decision|12|||
49059459|NCT03096847|158049682|FG001|Overall Study|Physician Decision|2|||
49059460|NCT03096847|158049683|FG002|Overall Study|Physician Decision|8|||
49059461|NCT03096847|158049681|FG000|Overall Study|Withdrawal by Subject|24|||
49059462|NCT03096847|158049682|FG001|Overall Study|Withdrawal by Subject|1|||
49059463|NCT03096847|158049683|FG002|Overall Study|Withdrawal by Subject|12|||
49059464|NCT03096847|158049681|FG000|Overall Study|Adverse Event|72|||
49059465|NCT03096847|158049682|FG001|Overall Study|Adverse Event|6|||
49059466|NCT03096847|158049683|FG002|Overall Study|Adverse Event|28|||
49059467|NCT03096847|158049681|FG000|Overall Study|Progressive disease|97|||
49059468|NCT03096847|158049682|FG001|Overall Study|Progressive disease|10|||
49059469|NCT03096847|158049683|FG002|Overall Study|Progressive disease|78|||
49059470|NCT03096847|158049681|FG000|Overall Study|Non-compliance with study medication|1|||
49059471|NCT03096847|158049682|FG001|Overall Study|Non-compliance with study medication|0|||
49059472|NCT03096847|158049683|FG002|Overall Study|Non-compliance with study medication|0|||
49059473|NCT03096847|158049681|FG000|Overall Study|New therapy for study indication|1|||
49059474|NCT03096847|158049682|FG001|Overall Study|New therapy for study indication|0|||
49059475|NCT03096847|158049683|FG002|Overall Study|New therapy for study indication|1|||
49059476|NCT01157897|158049684|FG000|Overall Study|Lost to Follow-up|2|||
49059477|NCT01157897|158049685|FG001|Overall Study|Lost to Follow-up|0|||
49059478|NCT01157897|158049686|FG002|Overall Study|Lost to Follow-up|0|||
49059479|NCT01157897|158049687|FG003|Overall Study|Lost to Follow-up|1|||
49059480|NCT01157897|158049684|FG000|Overall Study|Relocated|0|||
49059481|NCT01157897|158049685|FG001|Overall Study|Relocated|2|||
49059482|NCT01157897|158049686|FG002|Overall Study|Relocated|0|||
49059483|NCT01157897|158049687|FG003|Overall Study|Relocated|0|||
49059484|NCT02749292|158049690|FG000|Overall Study|Physician Decision|1|||
49059485|NCT02749292|158049691|FG001|Overall Study|Physician Decision|0|||
49059486|NCT02749292|158049690|FG000|Overall Study|Withdrawal by Subject|5|||
49059487|NCT02749292|158049691|FG001|Overall Study|Withdrawal by Subject|7|||
49059488|NCT02749292|158049690|FG000|Overall Study|Minor relapse, BVAS-WG = 2|1|||
49059489|NCT02749292|158049691|FG001|Overall Study|Minor relapse, BVAS-WG = 2|7|||
49059490|NCT02749292|158049690|FG000|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|2|||
49059491|NCT02749292|158049691|FG001|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|4|||
49059492|NCT02749292|158049690|FG000|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|2|||
49059493|NCT02749292|158049691|FG001|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|3|||
49059494|NCT02749292|158049690|FG000|Overall Study|Adverse Event|4|||
49059495|NCT02749292|158049691|FG001|Overall Study|Adverse Event|1|||
49059496|NCT02749292|158049690|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|2|||
49059497|NCT02749292|158049691|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|0|||
49059498|NCT02749292|158049690|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|4|||
49059499|NCT02749292|158049691|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|1|||
49059500|NCT02749292|158049690|FG000|Overall Study|Requiring glucocorticoids|0|||
49059501|NCT02749292|158049691|FG001|Overall Study|Requiring glucocorticoids|3|||
49059502|NCT02749292|158049690|FG000|Overall Study|Cancer|1|||
49059503|NCT02749292|158049691|FG001|Overall Study|Cancer|0|||
49059504|NCT01791153|158049696|FG000|Part 1: Blinded Period|Adverse Event|7|||
49059505|NCT01791153|158049697|FG001|Part 1: Blinded Period|Adverse Event|3|||
49059506|NCT01791153|158049698|FG002|Part 1: Blinded Period|Adverse Event|2|||
49059507|NCT01791153|158049699|FG003|Part 1: Blinded Period|Adverse Event|0|||
49059508|NCT01791153|158049700|FG004|Part 1: Blinded Period|Adverse Event|0|||
49059509|NCT01791153|158049701|FG005|Part 1: Blinded Period|Adverse Event|0|||
49059510|NCT01791153|158049702|FG006|Part 1: Blinded Period|Adverse Event|0|||
49059511|NCT01791153|158049703|FG007|Part 1: Blinded Period|Adverse Event|0|||
49059512|NCT01791153|158049696|FG000|Part 1: Blinded Period|Lack of Efficacy|1|||
49059513|NCT01791153|158049697|FG001|Part 1: Blinded Period|Lack of Efficacy|3|||
49059514|NCT01791153|158049698|FG002|Part 1: Blinded Period|Lack of Efficacy|2|||
49059515|NCT01791153|158049699|FG003|Part 1: Blinded Period|Lack of Efficacy|2|||
49059516|NCT01791153|158049700|FG004|Part 1: Blinded Period|Lack of Efficacy|0|||
49059517|NCT01791153|158049701|FG005|Part 1: Blinded Period|Lack of Efficacy|0|||
49059518|NCT01791153|158049702|FG006|Part 1: Blinded Period|Lack of Efficacy|0|||
49059519|NCT01791153|158049703|FG007|Part 1: Blinded Period|Lack of Efficacy|0|||
49059520|NCT01791153|158049696|FG000|Part 1: Blinded Period|Non-Compliance|1|||
49059521|NCT01791153|158049697|FG001|Part 1: Blinded Period|Non-Compliance|0|||
49059522|NCT01791153|158049698|FG002|Part 1: Blinded Period|Non-Compliance|0|||
49059523|NCT01791153|158049699|FG003|Part 1: Blinded Period|Non-Compliance|0|||
49059524|NCT01791153|158049700|FG004|Part 1: Blinded Period|Non-Compliance|0|||
49059525|NCT01791153|158049701|FG005|Part 1: Blinded Period|Non-Compliance|0|||
49059526|NCT01791153|158049702|FG006|Part 1: Blinded Period|Non-Compliance|0|||
49059527|NCT01791153|158049703|FG007|Part 1: Blinded Period|Non-Compliance|0|||
49059528|NCT01791153|158049696|FG000|Part 1: Blinded Period|Physician Decision|0|||
49059529|NCT01791153|158049697|FG001|Part 1: Blinded Period|Physician Decision|0|||
49059530|NCT01791153|158049698|FG002|Part 1: Blinded Period|Physician Decision|0|||
49059531|NCT01791153|158049699|FG003|Part 1: Blinded Period|Physician Decision|1|||
49059532|NCT01791153|158049700|FG004|Part 1: Blinded Period|Physician Decision|0|||
49059533|NCT01791153|158049701|FG005|Part 1: Blinded Period|Physician Decision|0|||
49059534|NCT01791153|158049702|FG006|Part 1: Blinded Period|Physician Decision|0|||
49059535|NCT01791153|158049703|FG007|Part 1: Blinded Period|Physician Decision|0|||
49059536|NCT01791153|158049696|FG000|Part 1: Blinded Period|Protocol Violation|0|||
49059537|NCT01791153|158049697|FG001|Part 1: Blinded Period|Protocol Violation|0|||
49059538|NCT01791153|158049698|FG002|Part 1: Blinded Period|Protocol Violation|0|||
49059539|NCT01791153|158049699|FG003|Part 1: Blinded Period|Protocol Violation|1|||
49059540|NCT01791153|158049700|FG004|Part 1: Blinded Period|Protocol Violation|0|||
49059541|NCT01791153|158049701|FG005|Part 1: Blinded Period|Protocol Violation|0|||
49059542|NCT01791153|158049702|FG006|Part 1: Blinded Period|Protocol Violation|0|||
49059543|NCT01791153|158049703|FG007|Part 1: Blinded Period|Protocol Violation|0|||
49059544|NCT01791153|158049696|FG000|Part 1: Blinded Period|Withdrawal by Subject|6|||
49059545|NCT01791153|158049697|FG001|Part 1: Blinded Period|Withdrawal by Subject|2|||
49059546|NCT01791153|158049698|FG002|Part 1: Blinded Period|Withdrawal by Subject|2|||
49059547|NCT01791153|158049699|FG003|Part 1: Blinded Period|Withdrawal by Subject|1|||
49059548|NCT01791153|158049700|FG004|Part 1: Blinded Period|Withdrawal by Subject|0|||
49059549|NCT01791153|158049701|FG005|Part 1: Blinded Period|Withdrawal by Subject|0|||
49059550|NCT01791153|158049702|FG006|Part 1: Blinded Period|Withdrawal by Subject|0|||
49059551|NCT01791153|158049703|FG007|Part 1: Blinded Period|Withdrawal by Subject|0|||
49059552|NCT01791153|158049696|FG000|Part 2: Open-label Period|Adverse Event|0|||
49059553|NCT01791153|158049697|FG001|Part 2: Open-label Period|Adverse Event|0|||
49059554|NCT01791153|158049698|FG002|Part 2: Open-label Period|Adverse Event|0|||
49059555|NCT01791153|158049699|FG003|Part 2: Open-label Period|Adverse Event|0|||
49059556|NCT01791153|158049700|FG004|Part 2: Open-label Period|Adverse Event|0|||
49059557|NCT01791153|158049701|FG005|Part 2: Open-label Period|Adverse Event|1|||
49059558|NCT01791153|158049702|FG006|Part 2: Open-label Period|Adverse Event|1|||
49059559|NCT01791153|158049703|FG007|Part 2: Open-label Period|Adverse Event|2|||
49059560|NCT01791153|158049696|FG000|Part 2: Open-label Period|Death|0|||
49059561|NCT01791153|158049697|FG001|Part 2: Open-label Period|Death|0|||
49059562|NCT01791153|158049698|FG002|Part 2: Open-label Period|Death|0|||
49059563|NCT01791153|158049699|FG003|Part 2: Open-label Period|Death|0|||
49059564|NCT01791153|158049700|FG004|Part 2: Open-label Period|Death|0|||
49059565|NCT01791153|158049701|FG005|Part 2: Open-label Period|Death|1|||
49059566|NCT01791153|158049702|FG006|Part 2: Open-label Period|Death|1|||
49059567|NCT01791153|158049703|FG007|Part 2: Open-label Period|Death|1|||
49059568|NCT01791153|158049696|FG000|Part 2: Open-label Period|Lost to Follow-up|0|||
49059569|NCT01791153|158049697|FG001|Part 2: Open-label Period|Lost to Follow-up|0|||
49059570|NCT01791153|158049698|FG002|Part 2: Open-label Period|Lost to Follow-up|0|||
49059571|NCT01791153|158049699|FG003|Part 2: Open-label Period|Lost to Follow-up|0|||
49059572|NCT01791153|158049700|FG004|Part 2: Open-label Period|Lost to Follow-up|0|||
49059573|NCT01791153|158049701|FG005|Part 2: Open-label Period|Lost to Follow-up|0|||
49059574|NCT01791153|158049702|FG006|Part 2: Open-label Period|Lost to Follow-up|1|||
49059575|NCT01791153|158049703|FG007|Part 2: Open-label Period|Lost to Follow-up|0|||
49059576|NCT01791153|158049696|FG000|Part 2: Open-label Period|Lack of Efficacy|0|||
49059577|NCT01791153|158049697|FG001|Part 2: Open-label Period|Lack of Efficacy|0|||
49059578|NCT01791153|158049698|FG002|Part 2: Open-label Period|Lack of Efficacy|0|||
49059579|NCT01791153|158049699|FG003|Part 2: Open-label Period|Lack of Efficacy|0|||
49059580|NCT01791153|158049700|FG004|Part 2: Open-label Period|Lack of Efficacy|0|||
49059581|NCT01791153|158049701|FG005|Part 2: Open-label Period|Lack of Efficacy|0|||
49059582|NCT01791153|158049702|FG006|Part 2: Open-label Period|Lack of Efficacy|0|||
49059583|NCT01791153|158049703|FG007|Part 2: Open-label Period|Lack of Efficacy|1|||
49059584|NCT01791153|158049696|FG000|Part 2: Open-label Period|Withdrawal by Subject|0|||
49059585|NCT01791153|158049697|FG001|Part 2: Open-label Period|Withdrawal by Subject|0|||
49059586|NCT01791153|158049698|FG002|Part 2: Open-label Period|Withdrawal by Subject|0|||
49059587|NCT01791153|158049699|FG003|Part 2: Open-label Period|Withdrawal by Subject|0|||
49059588|NCT01791153|158049700|FG004|Part 2: Open-label Period|Withdrawal by Subject|1|||
49059589|NCT01791153|158049701|FG005|Part 2: Open-label Period|Withdrawal by Subject|1|||
49059590|NCT01791153|158049702|FG006|Part 2: Open-label Period|Withdrawal by Subject|3|||
49059591|NCT01791153|158049703|FG007|Part 2: Open-label Period|Withdrawal by Subject|2|||
49059592|NCT01791153|158049696|FG000|Part 2: Open-label Period|Physician Decision|0|||
49059593|NCT01791153|158049697|FG001|Part 2: Open-label Period|Physician Decision|0|||
49059594|NCT01791153|158049698|FG002|Part 2: Open-label Period|Physician Decision|0|||
49059595|NCT01791153|158049699|FG003|Part 2: Open-label Period|Physician Decision|0|||
49059596|NCT01791153|158049700|FG004|Part 2: Open-label Period|Physician Decision|1|||
49059597|NCT01791153|158049701|FG005|Part 2: Open-label Period|Physician Decision|1|||
49059598|NCT01791153|158049702|FG006|Part 2: Open-label Period|Physician Decision|0|||
49059599|NCT01791153|158049703|FG007|Part 2: Open-label Period|Physician Decision|0|||
49059600|NCT02562482|158049704|FG000|Overall Study|Enrolled, but did not receive product|4|||
49059601|NCT02562482|158049705|FG001|Overall Study|Enrolled, but did not receive product|0|||
49059602|NCT02562482|158049704|FG000|Overall Study|Lost to Follow-up|9|||
49059603|NCT02562482|158049705|FG001|Overall Study|Lost to Follow-up|6|||
49059604|NCT02562482|158049704|FG000|Overall Study|Moved from area|2|||
49059605|NCT02562482|158049705|FG001|Overall Study|Moved from area|3|||
49059606|NCT02562482|158049704|FG000|Overall Study|Withdrawal by Subject|5|||
49059607|NCT02562482|158049705|FG001|Overall Study|Withdrawal by Subject|3|||
49059608|NCT02562482|158049704|FG000|Overall Study|Physician Decision|1|||
49059609|NCT02562482|158049705|FG001|Overall Study|Physician Decision|3|||
49059610|NCT02562482|158049704|FG000|Overall Study|Illness/Injury unrelated to product|0|||
49059611|NCT02562482|158049705|FG001|Overall Study|Illness/Injury unrelated to product|1|||
49059612|NCT00430950|158049709|FG000|Overall Study|Adverse Event|7|||
49059613|NCT00430950|158049710|FG001|Overall Study|Adverse Event|6|||
49059614|NCT00430950|158049709|FG000|Overall Study|Withdrawal by Subject|1|||
49059615|NCT00430950|158049710|FG001|Overall Study|Withdrawal by Subject|0|||
49059616|NCT00430950|158049709|FG000|Overall Study|concomitant medication,etc.|5|||
49059617|NCT00430950|158049710|FG001|Overall Study|concomitant medication,etc.|7|||
49059618|NCT00613834|158049711|FG000|Overall Study|Withdrawal by Subject|0|||
49059619|NCT00613834|158049712|FG001|Overall Study|Withdrawal by Subject|3|||
49059620|NCT00679913|158049713|FG000|Overall Study|Protocol Violation|18|||
49059621|NCT00679913|158049714|FG001|Overall Study|Protocol Violation|13|||
49059622|NCT00038649|158049715|FG000|Overall Study|Adverse Event|9|||
49059623|NCT00975286|158049716|FG000|Overall Study|Adverse Event|9|||
49059624|NCT00975286|158049717|FG001|Overall Study|Adverse Event|19|||
49059625|NCT00975286|158049716|FG000|Overall Study|Protocol Violation|1|||
49059626|NCT00975286|158049717|FG001|Overall Study|Protocol Violation|2|||
49059627|NCT00975286|158049716|FG000|Overall Study|Withdrawal by Subject|0|||
49059628|NCT00975286|158049717|FG001|Overall Study|Withdrawal by Subject|2|||
49059629|NCT00975286|158049716|FG000|Overall Study|Familial and Personal Reasons|2|||
49059630|NCT00975286|158049717|FG001|Overall Study|Familial and Personal Reasons|2|||
49059631|NCT00975286|158049716|FG000|Overall Study|Poor Compliance to Protocol|0|||
49059632|NCT00975286|158049717|FG001|Overall Study|Poor Compliance to Protocol|2|||
49059633|NCT00975286|158049716|FG000|Overall Study|Sponsor Decision|0|||
49059634|NCT00975286|158049717|FG001|Overall Study|Sponsor Decision|2|||
49059635|NCT01189500|158049720|FG000|Period 1: TAMOX Alone|Adverse Event|1|||
49059636|NCT01189500|158049720|FG000|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1|||
49059637|NCT02243293|158049721|FG000|Overall Study|Adverse Event|1|||
49059638|NCT02243293|158049722|FG001|Overall Study|Adverse Event|0|||
49059639|NCT02243293|158049723|FG002|Overall Study|Adverse Event|0|||
49059640|NCT02243293|158049724|FG003|Overall Study|Adverse Event|0|||
49059641|NCT02243293|158049725|FG004|Overall Study|Adverse Event|0|||
49059642|NCT02243293|158049726|FG005|Overall Study|Adverse Event|0|||
49059643|NCT02243293|158049727|FG006|Overall Study|Adverse Event|0|||
49059644|NCT02243293|158049728|FG007|Overall Study|Adverse Event|0|||
49059645|NCT02243293|158049729|FG008|Overall Study|Adverse Event|0|||
49059646|NCT02243293|158049730|FG009|Overall Study|Adverse Event|0|||
49059647|NCT02243293|158049731|FG010|Overall Study|Adverse Event|0|||
49059648|NCT02243293|158049732|FG011|Overall Study|Adverse Event|0|||
49059649|NCT02243293|158049733|FG012|Overall Study|Adverse Event|0|||
49059650|NCT02243293|158049734|FG013|Overall Study|Adverse Event|0|||
49059651|NCT02243293|158049735|FG014|Overall Study|Adverse Event|0|||
49059652|NCT02243293|158049736|FG015|Overall Study|Adverse Event|1|||
49059653|NCT02243293|158049737|FG016|Overall Study|Adverse Event|0|||
49059654|NCT02243293|158049738|FG017|Overall Study|Adverse Event|0|||
49059655|NCT02243293|158049739|FG018|Overall Study|Adverse Event|0|||
49059656|NCT02243293|158049740|FG019|Overall Study|Adverse Event|0|||
49059657|NCT02243293|158049741|FG020|Overall Study|Adverse Event|1|||
49059658|NCT02243293|158049742|FG021|Overall Study|Adverse Event|0|||
49059659|NCT02243293|158049721|FG000|Overall Study|Withdrawal by Subject|1|||
49059660|NCT02243293|158049722|FG001|Overall Study|Withdrawal by Subject|0|||
49059661|NCT02243293|158049723|FG002|Overall Study|Withdrawal by Subject|0|||
49059662|NCT02243293|158049724|FG003|Overall Study|Withdrawal by Subject|0|||
49059663|NCT02243293|158049725|FG004|Overall Study|Withdrawal by Subject|0|||
49059664|NCT02243293|158049726|FG005|Overall Study|Withdrawal by Subject|0|||
49059665|NCT02243293|158049727|FG006|Overall Study|Withdrawal by Subject|0|||
49059666|NCT02243293|158049728|FG007|Overall Study|Withdrawal by Subject|0|||
49059667|NCT02243293|158049729|FG008|Overall Study|Withdrawal by Subject|0|||
49059668|NCT02243293|158049730|FG009|Overall Study|Withdrawal by Subject|1|||
49059669|NCT02243293|158049731|FG010|Overall Study|Withdrawal by Subject|0|||
49059670|NCT02243293|158049732|FG011|Overall Study|Withdrawal by Subject|1|||
49059671|NCT02243293|158049733|FG012|Overall Study|Withdrawal by Subject|0|||
49059672|NCT02243293|158049734|FG013|Overall Study|Withdrawal by Subject|0|||
49059673|NCT02243293|158049735|FG014|Overall Study|Withdrawal by Subject|0|||
49059674|NCT02243293|158049736|FG015|Overall Study|Withdrawal by Subject|0|||
49059675|NCT02243293|158049737|FG016|Overall Study|Withdrawal by Subject|0|||
49059676|NCT02243293|158049738|FG017|Overall Study|Withdrawal by Subject|0|||
49059677|NCT02243293|158049739|FG018|Overall Study|Withdrawal by Subject|0|||
49059678|NCT02243293|158049740|FG019|Overall Study|Withdrawal by Subject|0|||
49059679|NCT02243293|158049741|FG020|Overall Study|Withdrawal by Subject|0|||
49059680|NCT02243293|158049742|FG021|Overall Study|Withdrawal by Subject|1|||
49059681|NCT02243293|158049721|FG000|Overall Study|Lost to Follow-up|0|||
49059682|NCT02243293|158049722|FG001|Overall Study|Lost to Follow-up|1|||
49059683|NCT02243293|158049723|FG002|Overall Study|Lost to Follow-up|1|||
49059684|NCT02243293|158049724|FG003|Overall Study|Lost to Follow-up|1|||
49059685|NCT02243293|158049725|FG004|Overall Study|Lost to Follow-up|0|||
49059686|NCT02243293|158049726|FG005|Overall Study|Lost to Follow-up|0|||
49059687|NCT02243293|158049727|FG006|Overall Study|Lost to Follow-up|3|||
49059688|NCT02243293|158049728|FG007|Overall Study|Lost to Follow-up|0|||
49059689|NCT02243293|158049729|FG008|Overall Study|Lost to Follow-up|0|||
49059690|NCT02243293|158049730|FG009|Overall Study|Lost to Follow-up|0|||
49059691|NCT02243293|158049731|FG010|Overall Study|Lost to Follow-up|0|||
49059692|NCT02243293|158049732|FG011|Overall Study|Lost to Follow-up|2|||
49059693|NCT02243293|158049733|FG012|Overall Study|Lost to Follow-up|0|||
49059694|NCT02243293|158049734|FG013|Overall Study|Lost to Follow-up|0|||
49059695|NCT02243293|158049735|FG014|Overall Study|Lost to Follow-up|0|||
49059696|NCT02243293|158049736|FG015|Overall Study|Lost to Follow-up|0|||
49059697|NCT02243293|158049737|FG016|Overall Study|Lost to Follow-up|3|||
49059698|NCT02243293|158049738|FG017|Overall Study|Lost to Follow-up|1|||
49059699|NCT02243293|158049739|FG018|Overall Study|Lost to Follow-up|0|||
49059700|NCT02243293|158049740|FG019|Overall Study|Lost to Follow-up|0|||
49059701|NCT02243293|158049741|FG020|Overall Study|Lost to Follow-up|1|||
49059702|NCT02243293|158049742|FG021|Overall Study|Lost to Follow-up|2|||
49059703|NCT02243293|158049721|FG000|Overall Study|Enrolled into a Re-treatment Study|0|||
49059704|NCT02243293|158049722|FG001|Overall Study|Enrolled into a Re-treatment Study|0|||
49059705|NCT02243293|158049723|FG002|Overall Study|Enrolled into a Re-treatment Study|0|||
49059706|NCT02243293|158049724|FG003|Overall Study|Enrolled into a Re-treatment Study|0|||
49059707|NCT02243293|158049725|FG004|Overall Study|Enrolled into a Re-treatment Study|0|||
49059708|NCT02243293|158049726|FG005|Overall Study|Enrolled into a Re-treatment Study|0|||
49059709|NCT02243293|158049727|FG006|Overall Study|Enrolled into a Re-treatment Study|0|||
49059710|NCT02243293|158049728|FG007|Overall Study|Enrolled into a Re-treatment Study|0|||
49059711|NCT02243293|158049729|FG008|Overall Study|Enrolled into a Re-treatment Study|0|||
49059712|NCT02243293|158049730|FG009|Overall Study|Enrolled into a Re-treatment Study|0|||
49059713|NCT02243293|158049731|FG010|Overall Study|Enrolled into a Re-treatment Study|0|||
49059714|NCT02243293|158049732|FG011|Overall Study|Enrolled into a Re-treatment Study|0|||
49059715|NCT02243293|158049733|FG012|Overall Study|Enrolled into a Re-treatment Study|0|||
49059716|NCT02243293|158049734|FG013|Overall Study|Enrolled into a Re-treatment Study|0|||
49059717|NCT02243293|158049735|FG014|Overall Study|Enrolled into a Re-treatment Study|1|||
49059718|NCT02243293|158049736|FG015|Overall Study|Enrolled into a Re-treatment Study|0|||
49059719|NCT02243293|158049737|FG016|Overall Study|Enrolled into a Re-treatment Study|0|||
49059720|NCT02243293|158049738|FG017|Overall Study|Enrolled into a Re-treatment Study|0|||
49059721|NCT02243293|158049739|FG018|Overall Study|Enrolled into a Re-treatment Study|0|||
49059722|NCT02243293|158049740|FG019|Overall Study|Enrolled into a Re-treatment Study|0|||
49059723|NCT02243293|158049741|FG020|Overall Study|Enrolled into a Re-treatment Study|0|||
49059724|NCT02243293|158049742|FG021|Overall Study|Enrolled into a Re-treatment Study|0|||
49059725|NCT02243293|158049721|FG000|Overall Study|Randomized but did'nt receive study drug|0|||
49059726|NCT02243293|158049722|FG001|Overall Study|Randomized but did'nt receive study drug|0|||
49059727|NCT02243293|158049723|FG002|Overall Study|Randomized but did'nt receive study drug|0|||
49059728|NCT02243293|158049724|FG003|Overall Study|Randomized but did'nt receive study drug|0|||
49059729|NCT02243293|158049725|FG004|Overall Study|Randomized but did'nt receive study drug|1|||
49059730|NCT02243293|158049726|FG005|Overall Study|Randomized but did'nt receive study drug|0|||
49059731|NCT02243293|158049727|FG006|Overall Study|Randomized but did'nt receive study drug|0|||
49059732|NCT02243293|158049728|FG007|Overall Study|Randomized but did'nt receive study drug|0|||
49059733|NCT02243293|158049729|FG008|Overall Study|Randomized but did'nt receive study drug|0|||
49059734|NCT02243293|158049730|FG009|Overall Study|Randomized but did'nt receive study drug|1|||
49059735|NCT02243293|158049731|FG010|Overall Study|Randomized but did'nt receive study drug|0|||
49059736|NCT02243293|158049732|FG011|Overall Study|Randomized but did'nt receive study drug|0|||
49059737|NCT02243293|158049733|FG012|Overall Study|Randomized but did'nt receive study drug|0|||
49059738|NCT02243293|158049734|FG013|Overall Study|Randomized but did'nt receive study drug|0|||
49059739|NCT02243293|158049735|FG014|Overall Study|Randomized but did'nt receive study drug|0|||
49059740|NCT02243293|158049736|FG015|Overall Study|Randomized but did'nt receive study drug|0|||
49059741|NCT02243293|158049737|FG016|Overall Study|Randomized but did'nt receive study drug|0|||
49059742|NCT02243293|158049738|FG017|Overall Study|Randomized but did'nt receive study drug|0|||
49059743|NCT02243293|158049739|FG018|Overall Study|Randomized but did'nt receive study drug|0|||
49059744|NCT02243293|158049740|FG019|Overall Study|Randomized but did'nt receive study drug|1|||
49059745|NCT02243293|158049741|FG020|Overall Study|Randomized but did'nt receive study drug|0|||
49059746|NCT02243293|158049742|FG021|Overall Study|Randomized but did'nt receive study drug|0|||
49059747|NCT01674647|158049745|FG000|Treatment Period|Death|4|||
49059748|NCT01674647|158049746|FG001|Treatment Period|Death|1|||
49059749|NCT01674647|158049745|FG000|Treatment Period|Efficacy outcome reached|0|||
49059750|NCT01674647|158049746|FG001|Treatment Period|Efficacy outcome reached|1|||
49059751|NCT01674647|158049745|FG000|Treatment Period|Physician Decision|3|||
49059752|NCT01674647|158049746|FG001|Treatment Period|Physician Decision|1|||
49059753|NCT01674647|158049745|FG000|Treatment Period|Adverse Event|60|||
49059754|NCT01674647|158049746|FG001|Treatment Period|Adverse Event|22|||
49059755|NCT01674647|158049745|FG000|Treatment Period|Non-compliance with study drug|3|||
49059756|NCT01674647|158049746|FG001|Treatment Period|Non-compliance with study drug|0|||
49059757|NCT01674647|158049745|FG000|Treatment Period|Lost to Follow-up|1|||
49059758|NCT01674647|158049746|FG001|Treatment Period|Lost to Follow-up|1|||
49059759|NCT01674647|158049745|FG000|Treatment Period|Withdrawal by Subject|19|||
49059760|NCT01674647|158049746|FG001|Treatment Period|Withdrawal by Subject|16|||
49059761|NCT01674647|158049745|FG000|Treatment Period|Switching to other therapy|5|||
49059762|NCT01674647|158049746|FG001|Treatment Period|Switching to other therapy|2|||
49059763|NCT01674647|158049745|FG000|Treatment Period|Logistical difficulties|5|||
49059764|NCT01674647|158049746|FG001|Treatment Period|Logistical difficulties|8|||
49059765|NCT01674647|158049745|FG000|Treatment Period|Treatment failure|0|||
49059766|NCT01674647|158049746|FG001|Treatment Period|Treatment failure|14|||
49059767|NCT01674647|158049745|FG000|Treatment Period|Protocol Violation|56|||
49059768|NCT01674647|158049746|FG001|Treatment Period|Protocol Violation|36|||
49059769|NCT01674647|158049745|FG000|30-day Safety Follow-up Period|Death|3|||
49059770|NCT01674647|158049746|FG001|30-day Safety Follow-up Period|Death|2|||
49059771|NCT01674647|158049745|FG000|30-day Safety Follow-up Period|Non-compliance with study drug|0|||
49059772|NCT01674647|158049746|FG001|30-day Safety Follow-up Period|Non-compliance with study drug|1|||
49059773|NCT01674647|158049745|FG000|30-day Safety Follow-up Period|Protocol Violation|39|||
49059774|NCT01674647|158049746|FG001|30-day Safety Follow-up Period|Protocol Violation|22|||
49059775|NCT01674647|158049745|FG000|30-day Safety Follow-up Period|Logistical difficulties|1|||
49059776|NCT01674647|158049746|FG001|30-day Safety Follow-up Period|Logistical difficulties|3|||
49059777|NCT01674647|158049745|FG000|30-day Safety Follow-up Period|Withdrawal by Subject|7|||
49059778|NCT01674647|158049746|FG001|30-day Safety Follow-up Period|Withdrawal by Subject|8|||
49059779|NCT01674647|158049745|FG000|30-day Safety Follow-up Period|Lost to Follow-up|8|||
49059780|NCT01674647|158049746|FG001|30-day Safety Follow-up Period|Lost to Follow-up|5|||
49059781|NCT03870477|158049747|FG000|Overall Study|Early Study Termination|1|||
49059782|NCT03545191|158049748|FG000|Overall Study|Death|1|||
49059783|NCT03545191|158049749|FG001|Overall Study|Death|0|||
49059784|NCT03545191|158049750|FG002|Overall Study|Death|0|||
49059785|NCT03545191|158049748|FG000|Overall Study|Adverse Event|4|||
49059786|NCT03545191|158049749|FG001|Overall Study|Adverse Event|2|||
49059787|NCT03545191|158049750|FG002|Overall Study|Adverse Event|7|||
49059788|NCT03545191|158049748|FG000|Overall Study|Other reasons|3|||
49059789|NCT03545191|158049749|FG001|Overall Study|Other reasons|11|||
49059790|NCT03545191|158049750|FG002|Overall Study|Other reasons|8|||
49059791|NCT03545191|158049748|FG000|Overall Study|Withdrawal by Subject|13|||
49059792|NCT03545191|158049749|FG001|Overall Study|Withdrawal by Subject|10|||
49059793|NCT03545191|158049750|FG002|Overall Study|Withdrawal by Subject|12|||
49059794|NCT03545191|158049748|FG000|Overall Study|Lost to Follow-up|1|||
49059795|NCT03545191|158049749|FG001|Overall Study|Lost to Follow-up|2|||
49059796|NCT03545191|158049750|FG002|Overall Study|Lost to Follow-up|3|||
49059797|NCT01490866|158049758|FG000|FOLFOX/Bevacizumab Treatment|Disease Progression|6|||
49059798|NCT01490866|158049758|FG000|FOLFOX/Bevacizumab Treatment|Adverse Event|6|||
49059799|NCT01490866|158049758|FG000|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5|||
49059800|NCT01490866|158049758|FG000|FOLFOX/Bevacizumab Treatment|Protocol Violation|1|||
49059801|NCT01490866|158049758|FG000|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1|||
49059802|NCT01490866|158049758|FG000|FOLFOX/Bevacizumab Treatment|Physician Decision|2|||
49059803|NCT01490866|158049758|FG000|Axitinib Maintenance Therapy|Disease Progression|30|||
49059804|NCT01490866|158049758|FG000|Axitinib Maintenance Therapy|Adverse Event|12|||
49059805|NCT01490866|158049758|FG000|Axitinib Maintenance Therapy|Withdrawal by Subject|3|||
49059806|NCT01490866|158049758|FG000|Axitinib Maintenance Therapy|Protocol Violation|2|||
49059807|NCT01490866|158049758|FG000|Axitinib Maintenance Therapy|Intercurrent illness|2|||
49059808|NCT03923530|158049759|FG000|Overall Study|Withdrawal by Subject|1|||
49059809|NCT03923530|158049759|FG000|Overall Study|screen failure|3|||
49059810|NCT01491035|158049766|FG000|Overall Study|Lost to Follow-up|0|||
49059811|NCT01491035|158049767|FG001|Overall Study|Lost to Follow-up|0|||
49059812|NCT01491035|158049768|FG002|Overall Study|Lost to Follow-up|0|||
49059813|NCT01491035|158049769|FG003|Overall Study|Lost to Follow-up|0|||
49059814|NCT01491035|158049770|FG004|Overall Study|Lost to Follow-up|1|||
49059815|NCT01491035|158049771|FG005|Overall Study|Lost to Follow-up|0|||
49059816|NCT01491035|158049772|FG006|Overall Study|Lost to Follow-up|0|||
49059817|NCT01491035|158049773|FG007|Overall Study|Lost to Follow-up|0|||
49059818|NCT01181271|158049780|FG000|Evaluation for Allogeneic Transplant|Lack of Efficacy|6|||
49059819|NCT01181271|158049780|FG000|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4|||
49059820|NCT01181271|158049780|FG000|Evaluation for Allogeneic Transplant|No suitable donor|2|||
49059821|NCT01181271|158049780|FG000|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1|||
49059822|NCT01408628|158049781|FG000|Consented|Withdrawal by Subject|12|||
49059823|NCT01408628|158049781|FG000|Completed 6 Month Follow-Up|Lost to Follow-up|3|||
49059824|NCT01408628|158049781|FG000|Completed 6 Month Follow-Up|Protocol Violation|6|||
49059825|NCT01408628|158049781|FG000|Completed 6 Month Follow-Up|Withdrawal by Subject|5|||
49059826|NCT03165955|158049782|FG000|Treatment|Withdrawal by Subject|3|||
49059827|NCT03165955|158049782|FG000|Treatment|Death|1|||
49059828|NCT03165955|158049782|FG000|Treatment|Adverse Event|1|||
49059829|NCT03165955|158049782|FG000|Treatment|Progressive disease|3|||
49059830|NCT01673698|158049783|FG000|Overall Study|Lost to Follow-up|51|||
49059831|NCT01673698|158049784|FG001|Overall Study|Lost to Follow-up|13|||
49059832|NCT00444457|158049785|FG000|Infant Series|Other|0|||
49059833|NCT00444457|158049786|FG001|Infant Series|Other|1|||
49059834|NCT00444457|158049787|FG002|Infant Series|Other|0|||
49059835|NCT00444457|158049788|FG003|Infant Series|Other|0|||
49059836|NCT00444457|158049785|FG000|Infant Series|Parent or legal guardian request|18|||
49059837|NCT00444457|158049786|FG001|Infant Series|Parent or legal guardian request|29|||
49059838|NCT00444457|158049787|FG002|Infant Series|Parent or legal guardian request|34|||
49059839|NCT00444457|158049788|FG003|Infant Series|Parent or legal guardian request|14|||
49059840|NCT00444457|158049785|FG000|Infant Series|Lost to Follow-up|10|||
49059841|NCT00444457|158049786|FG001|Infant Series|Lost to Follow-up|11|||
49059842|NCT00444457|158049787|FG002|Infant Series|Lost to Follow-up|7|||
49059843|NCT00444457|158049788|FG003|Infant Series|Lost to Follow-up|6|||
49059844|NCT00444457|158049785|FG000|Infant Series|Protocol Violation|16|||
49059845|NCT00444457|158049786|FG001|Infant Series|Protocol Violation|8|||
49059846|NCT00444457|158049787|FG002|Infant Series|Protocol Violation|6|||
49059847|NCT00444457|158049788|FG003|Infant Series|Protocol Violation|3|||
49059848|NCT00444457|158049785|FG000|Infant Series|Failed to return|5|||
49059849|NCT00444457|158049786|FG001|Infant Series|Failed to return|4|||
49059850|NCT00444457|158049787|FG002|Infant Series|Failed to return|4|||
49059851|NCT00444457|158049788|FG003|Infant Series|Failed to return|2|||
49059852|NCT00444457|158049785|FG000|Infant Series|Investigator request|4|||
49059853|NCT00444457|158049786|FG001|Infant Series|Investigator request|3|||
49059854|NCT00444457|158049787|FG002|Infant Series|Investigator request|3|||
49059855|NCT00444457|158049788|FG003|Infant Series|Investigator request|2|||
49059856|NCT00444457|158049785|FG000|Infant Series|Other|0|||
49059857|NCT00444457|158049786|FG001|Infant Series|Other|2|||
49059858|NCT00444457|158049787|FG002|Infant Series|Other|4|||
49059859|NCT00444457|158049788|FG003|Infant Series|Other|0|||
49059860|NCT00444457|158049785|FG000|Infant Series|Adverse Event|1|||
49059861|NCT00444457|158049786|FG001|Infant Series|Adverse Event|2|||
49059862|NCT00444457|158049787|FG002|Infant Series|Adverse Event|2|||
49059863|NCT00444457|158049788|FG003|Infant Series|Adverse Event|0|||
49059864|NCT00444457|158049785|FG000|Infant Series|Death|0|||
49059865|NCT00444457|158049786|FG001|Infant Series|Death|1|||
49059866|NCT00444457|158049787|FG002|Infant Series|Death|1|||
49059867|NCT00444457|158049788|FG003|Infant Series|Death|1|||
49059868|NCT00444457|158049785|FG000|After Infant Series|Other|0|||
49059869|NCT00444457|158049786|FG001|After Infant Series|Other|1|||
49059870|NCT00444457|158049787|FG002|After Infant Series|Other|1|||
49059871|NCT00444457|158049788|FG003|After Infant Series|Other|1|||
49059872|NCT00444457|158049785|FG000|After Infant Series|Parent or legal guardian request|4|||
49059873|NCT00444457|158049786|FG001|After Infant Series|Parent or legal guardian request|11|||
49059874|NCT00444457|158049787|FG002|After Infant Series|Parent or legal guardian request|6|||
49059875|NCT00444457|158049788|FG003|After Infant Series|Parent or legal guardian request|3|||
49059876|NCT00444457|158049785|FG000|After Infant Series|Failed to return|7|||
49059877|NCT00444457|158049786|FG001|After Infant Series|Failed to return|6|||
49059878|NCT00444457|158049787|FG002|After Infant Series|Failed to return|5|||
49059879|NCT00444457|158049788|FG003|After Infant Series|Failed to return|1|||
49059880|NCT00444457|158049785|FG000|After Infant Series|Lost to Follow-up|5|||
49059881|NCT00444457|158049786|FG001|After Infant Series|Lost to Follow-up|5|||
49059882|NCT00444457|158049787|FG002|After Infant Series|Lost to Follow-up|5|||
49059883|NCT00444457|158049788|FG003|After Infant Series|Lost to Follow-up|2|||
49059884|NCT00444457|158049785|FG000|After Infant Series|Protocol Violation|2|||
49059885|NCT00444457|158049786|FG001|After Infant Series|Protocol Violation|4|||
49059886|NCT00444457|158049787|FG002|After Infant Series|Protocol Violation|2|||
49059887|NCT00444457|158049788|FG003|After Infant Series|Protocol Violation|2|||
49059888|NCT00444457|158049785|FG000|After Infant Series|Adverse Event|2|||
49059889|NCT00444457|158049786|FG001|After Infant Series|Adverse Event|2|||
49059890|NCT00444457|158049787|FG002|After Infant Series|Adverse Event|0|||
49059891|NCT00444457|158049788|FG003|After Infant Series|Adverse Event|0|||
49059892|NCT00444457|158049785|FG000|After Infant Series|Investigator request|0|||
49059893|NCT00444457|158049786|FG001|After Infant Series|Investigator request|0|||
49059894|NCT00444457|158049787|FG002|After Infant Series|Investigator request|0|||
49059895|NCT00444457|158049788|FG003|After Infant Series|Investigator request|1|||
49059896|NCT00444457|158049785|FG000|After Infant Series|Other|0|||
49059897|NCT00444457|158049786|FG001|After Infant Series|Other|1|||
49059898|NCT00444457|158049787|FG002|After Infant Series|Other|0|||
49059899|NCT00444457|158049788|FG003|After Infant Series|Other|0|||
49059900|NCT00444457|158049785|FG000|Toddler Dose|Lost to Follow-up|4|||
49059901|NCT00444457|158049786|FG001|Toddler Dose|Lost to Follow-up|1|||
49059902|NCT00444457|158049787|FG002|Toddler Dose|Lost to Follow-up|1|||
49059903|NCT00444457|158049788|FG003|Toddler Dose|Lost to Follow-up|3|||
49059904|NCT00444457|158049785|FG000|Toddler Dose|Failed to return|2|||
49059905|NCT00444457|158049786|FG001|Toddler Dose|Failed to return|2|||
49059906|NCT00444457|158049787|FG002|Toddler Dose|Failed to return|1|||
49059907|NCT00444457|158049788|FG003|Toddler Dose|Failed to return|3|||
49059908|NCT00444457|158049785|FG000|Toddler Dose|Parent or legal guardian request|0|||
49059909|NCT00444457|158049786|FG001|Toddler Dose|Parent or legal guardian request|3|||
49059910|NCT00444457|158049787|FG002|Toddler Dose|Parent or legal guardian request|2|||
49059911|NCT00444457|158049788|FG003|Toddler Dose|Parent or legal guardian request|1|||
49059912|NCT00444457|158049785|FG000|Toddler Dose|Protocol Violation|1|||
49059913|NCT00444457|158049786|FG001|Toddler Dose|Protocol Violation|0|||
49059914|NCT00444457|158049787|FG002|Toddler Dose|Protocol Violation|0|||
49059915|NCT00444457|158049788|FG003|Toddler Dose|Protocol Violation|1|||
49059916|NCT03250299|158051462|FG000|BAL101553 6 mg Cohort|Disease progression|0|||
49059917|NCT03250299|158051463|FG001|BAL101553 6 mg Cohort|Disease progression|1|||
49059918|NCT03250299|158051464|FG002|BAL101553 6 mg Cohort|Disease progression|0|||
49059919|NCT03250299|158051465|FG003|BAL101553 6 mg Cohort|Disease progression|0|||
49059920|NCT03250299|158051466|FG004|BAL101553 6 mg Cohort|Disease progression|0|||
49059921|NCT03250299|158051462|FG000|BAL101553 8 mg Cohort|Adverse Event|0|||
49059922|NCT03250299|158051463|FG001|BAL101553 8 mg Cohort|Adverse Event|0|||
49059923|NCT03250299|158051464|FG002|BAL101553 8 mg Cohort|Adverse Event|1|||
49059924|NCT03250299|158051465|FG003|BAL101553 8 mg Cohort|Adverse Event|0|||
49059925|NCT03250299|158051466|FG004|BAL101553 8 mg Cohort|Adverse Event|0|||
49059926|NCT03250299|158051462|FG000|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
49059927|NCT03250299|158051463|FG001|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
49059928|NCT03250299|158051464|FG002|BAL101553 8 mg Cohort|Withdrawal by Subject|1|||
49059929|NCT03250299|158051465|FG003|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
49059930|NCT03250299|158051466|FG004|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
49059931|NCT03250299|158051462|FG000|BAL101553 12 mg Cohort|Adverse Event|0|||
49059932|NCT03250299|158051463|FG001|BAL101553 12 mg Cohort|Adverse Event|0|||
49059933|NCT03250299|158051464|FG002|BAL101553 12 mg Cohort|Adverse Event|0|||
49059934|NCT03250299|158051465|FG003|BAL101553 12 mg Cohort|Adverse Event|2|||
49059935|NCT03250299|158051466|FG004|BAL101553 12 mg Cohort|Adverse Event|0|||
49059936|NCT02813421|158051471|FG000|Overall Study|Withdrawal by Subject|1|||
49059937|NCT02813421|158051472|FG001|Overall Study|Withdrawal by Subject|2|||
49059938|NCT02813421|158051471|FG000|Overall Study|Lost to Follow-up|1|||
49059939|NCT02813421|158051472|FG001|Overall Study|Lost to Follow-up|1|||
49059940|NCT05142566|158051475|FG000|Overall Study|Protocol Violation|1|||
49059941|NCT02221037|158051477|FG000|Overall Study|Physician Decision|0|||
49059942|NCT02221037|158051478|FG001|Overall Study|Physician Decision|0|||
49059943|NCT02221037|158051479|FG002|Overall Study|Physician Decision|1|||
49059944|NCT02221037|158051480|FG003|Overall Study|Physician Decision|0|||
49059945|NCT03188718|158051481|FG000|Overall Study|Participant noncompliance|4|||
49059946|NCT03188718|158051481|FG000|Overall Study|Withdrawal by Subject|1|||
49059947|NCT03188718|158051481|FG000|Overall Study|Device failure|3|||
49059948|NCT00871741|158051482|FG000|Overall Study|Premature study termination|9|||
49059949|NCT00871741|158051483|FG001|Overall Study|Premature study termination|7|||
49059950|NCT01117337|158051484|FG000|Overall Study|Lost to Follow-up|4|||
49059951|NCT01117337|158051485|FG001|Overall Study|Lost to Follow-up|0|||
49059952|NCT00059787|158051486|FG000|Overall Study|Adverse Event|13|||
49059953|NCT00059787|158051486|FG000|Overall Study|disease progression|2|||
49059954|NCT00059787|158051486|FG000|Overall Study|ineligible|1|||
49059955|NCT00059787|158051486|FG000|Overall Study|Other|4|||
49059956|NCT00292188|158051487|FG000|Single-Blind|Adverse Event|14|||
49059957|NCT00292188|158051488|FG001|Single-Blind|Adverse Event|0|||
49059958|NCT00292188|158051489|FG002|Single-Blind|Adverse Event|0|||
49059959|NCT00292188|158051487|FG000|Single-Blind|Lack of Efficacy|2|||
49059960|NCT00292188|158051488|FG001|Single-Blind|Lack of Efficacy|0|||
49059961|NCT00292188|158051489|FG002|Single-Blind|Lack of Efficacy|0|||
49059962|NCT00292188|158051487|FG000|Single-Blind|Laboratory Abnormality|5|||
49059963|NCT00292188|158051488|FG001|Single-Blind|Laboratory Abnormality|0|||
49059964|NCT00292188|158051489|FG002|Single-Blind|Laboratory Abnormality|0|||
49059965|NCT00292188|158051487|FG000|Single-Blind|Lost to Follow-up|3|||
49059966|NCT00292188|158051488|FG001|Single-Blind|Lost to Follow-up|0|||
49059967|NCT00292188|158051489|FG002|Single-Blind|Lost to Follow-up|0|||
49059968|NCT00292188|158051487|FG000|Single-Blind|Other|77|||
49059969|NCT00292188|158051488|FG001|Single-Blind|Other|0|||
49059970|NCT00292188|158051489|FG002|Single-Blind|Other|0|||
49059971|NCT00292188|158051487|FG000|Single-Blind|Withdrawal by Subject|12|||
49059972|NCT00292188|158051488|FG001|Single-Blind|Withdrawal by Subject|0|||
49059973|NCT00292188|158051489|FG002|Single-Blind|Withdrawal by Subject|0|||
49059974|NCT00292188|158051487|FG000|Single-Blind|Did not receive treatment|1|||
49059975|NCT00292188|158051488|FG001|Single-Blind|Did not receive treatment|0|||
49059976|NCT00292188|158051489|FG002|Single-Blind|Did not receive treatment|0|||
49059977|NCT00292188|158051487|FG000|Double-Blind|Adverse Event|0|||
49059978|NCT00292188|158051488|FG001|Double-Blind|Adverse Event|25|||
49059979|NCT00292188|158051489|FG002|Double-Blind|Adverse Event|9|||
49059980|NCT00292188|158051487|FG000|Double-Blind|Lack of Efficacy|0|||
49059981|NCT00292188|158051488|FG001|Double-Blind|Lack of Efficacy|2|||
49059982|NCT00292188|158051489|FG002|Double-Blind|Lack of Efficacy|12|||
49059983|NCT00292188|158051487|FG000|Double-Blind|Lost to Follow-up|0|||
49059984|NCT00292188|158051488|FG001|Double-Blind|Lost to Follow-up|1|||
49059985|NCT00292188|158051489|FG002|Double-Blind|Lost to Follow-up|0|||
49059986|NCT00292188|158051487|FG000|Double-Blind|Other|0|||
49059987|NCT00292188|158051488|FG001|Double-Blind|Other|3|||
49059988|NCT00292188|158051489|FG002|Double-Blind|Other|4|||
49059989|NCT00292188|158051487|FG000|Double-Blind|Withdrawal by Subject|0|||
49059990|NCT00292188|158051488|FG001|Double-Blind|Withdrawal by Subject|0|||
49059991|NCT00292188|158051489|FG002|Double-Blind|Withdrawal by Subject|3|||
49059992|NCT00292188|158051487|FG000|Double-Blind|Laboratory Abnormality|0|||
49059993|NCT00292188|158051488|FG001|Double-Blind|Laboratory Abnormality|0|||
49059994|NCT00292188|158051489|FG002|Double-Blind|Laboratory Abnormality|1|||
49060003|NCT03575871|158051494|FG000|Overall Study|Adverse Event|5|||
49060004|NCT03575871|158051495|FG001|Overall Study|Adverse Event|5|||
49060005|NCT03575871|158051496|FG002|Overall Study|Adverse Event|8|||
49060006|NCT03575871|158051494|FG000|Overall Study|Death|1|||
49060007|NCT03575871|158051495|FG001|Overall Study|Death|0|||
49060008|NCT03575871|158051496|FG002|Overall Study|Death|0|||
49060009|NCT03575871|158051494|FG000|Overall Study|Lack of Efficacy|5|||
49060010|NCT03575871|158051495|FG001|Overall Study|Lack of Efficacy|4|||
49060011|NCT03575871|158051496|FG002|Overall Study|Lack of Efficacy|7|||
49060012|NCT03575871|158051494|FG000|Overall Study|Lost to Follow-up|1|||
49060013|NCT03575871|158051495|FG001|Overall Study|Lost to Follow-up|1|||
49060014|NCT03575871|158051496|FG002|Overall Study|Lost to Follow-up|1|||
49060015|NCT03575871|158051494|FG000|Overall Study|Protocol Deviation|1|||
49060016|NCT03575871|158051495|FG001|Overall Study|Protocol Deviation|1|||
49060017|NCT03575871|158051496|FG002|Overall Study|Protocol Deviation|1|||
49060018|NCT03575871|158051494|FG000|Overall Study|Withdrawal by Subject|6|||
49060019|NCT03575871|158051495|FG001|Overall Study|Withdrawal by Subject|1|||
49060020|NCT03575871|158051496|FG002|Overall Study|Withdrawal by Subject|9|||
49060021|NCT03575871|158051494|FG000|Overall Study|Other than specified|2|||
49060022|NCT03575871|158051495|FG001|Overall Study|Other than specified|2|||
49060023|NCT03575871|158051496|FG002|Overall Study|Other than specified|0|||
49060024|NCT01045993|158051497|FG000|Overall Study|Treated-later found eligibility not met|0|||
49060025|NCT01045993|158051498|FG001|Overall Study|Treated-later found eligibility not met|1|||
49060026|NCT01045993|158051499|FG002|Overall Study|Treated-later found eligibility not met|0|||
49060027|NCT01045993|158051500|FG003|Overall Study|Treated-later found eligibility not met|0|||
49060028|NCT01659736|158051501|FG000|Treatment Period|Adverse Event|1|||
49060029|NCT01659736|158051502|FG001|Treatment Period|Adverse Event|1|||
49060030|NCT01659736|158051501|FG000|Treatment Period|Protocol Violation|3|||
49060031|NCT01659736|158051502|FG001|Treatment Period|Protocol Violation|1|||
49060032|NCT01659736|158051501|FG000|Treatment Period|Withdrawal by Subject|1|||
49060033|NCT01659736|158051502|FG001|Treatment Period|Withdrawal by Subject|0|||
49060034|NCT01659736|158051501|FG000|3-month Follow-up|Lost to Follow-up|0|||
49060035|NCT01659736|158051502|FG001|3-month Follow-up|Lost to Follow-up|1|||
49060036|NCT02138136|158051512|FG000|Overall Study|Protocol Violation|4|||
49060037|NCT02138136|158051512|FG000|Overall Study|Physician Decision|7|||
49060038|NCT02138136|158051512|FG000|Overall Study|Lack of Efficacy|35|||
49060039|NCT02138136|158051512|FG000|Overall Study|Pregnancy|2|||
49060040|NCT02138136|158051512|FG000|Overall Study|Adverse Event|18|||
49060041|NCT02138136|158051512|FG000|Overall Study|Withdrawal by Subject|36|||
49060042|NCT02138136|158051512|FG000|Overall Study|Lost to Follow-up|32|||
49060043|NCT02138136|158051512|FG000|Overall Study|Withdrawn by Sponsor|5|||
49060044|NCT01300052|158051513|FG000|Overall Study|Adverse Event|3|||
49060045|NCT01300052|158051514|FG001|Overall Study|Adverse Event|0|||
49060046|NCT01300052|158051513|FG000|Overall Study|Withdrawal by Subject|2|||
49060047|NCT01300052|158051514|FG001|Overall Study|Withdrawal by Subject|2|||
49060048|NCT01300052|158051513|FG000|Overall Study|Protocol Violation|1|||
49060049|NCT01300052|158051514|FG001|Overall Study|Protocol Violation|1|||
49060050|NCT01338987|158051515|FG000|Overall Study|enrolled on new protocol|0|||
49060051|NCT01338987|158051516|FG001|Overall Study|enrolled on new protocol|0|||
49060052|NCT01338987|158051517|FG002|Overall Study|enrolled on new protocol|1|||
49060053|NCT01338987|158051518|FG003|Overall Study|enrolled on new protocol|0|||
49060054|NCT01338987|158051519|FG004|Overall Study|enrolled on new protocol|0|||
49060055|NCT01338987|158051515|FG000|Overall Study|Disease progression on study|2|||
49060056|NCT01338987|158051516|FG001|Overall Study|Disease progression on study|1|||
49060057|NCT01338987|158051517|FG002|Overall Study|Disease progression on study|1|||
49060058|NCT01338987|158051518|FG003|Overall Study|Disease progression on study|0|||
49060059|NCT01338987|158051519|FG004|Overall Study|Disease progression on study|0|||
49060060|NCT02697773|158051525|FG000|Overall Study|Adverse Event|2|||
49060061|NCT02697773|158051526|FG001|Overall Study|Adverse Event|1|||
49060062|NCT02697773|158051527|FG002|Overall Study|Adverse Event|2|||
49060063|NCT02697773|158051525|FG000|Overall Study|Death|0|||
49060064|NCT02697773|158051526|FG001|Overall Study|Death|0|||
49060065|NCT02697773|158051527|FG002|Overall Study|Death|2|||
49060066|NCT02697773|158051525|FG000|Overall Study|Lack of Efficacy|4|||
49060067|NCT02697773|158051526|FG001|Overall Study|Lack of Efficacy|6|||
49060068|NCT02697773|158051527|FG002|Overall Study|Lack of Efficacy|6|||
49060069|NCT02697773|158051525|FG000|Overall Study|Lost to Follow-up|5|||
49060070|NCT02697773|158051526|FG001|Overall Study|Lost to Follow-up|5|||
49060071|NCT02697773|158051527|FG002|Overall Study|Lost to Follow-up|7|||
49060072|NCT02697773|158051525|FG000|Overall Study|Other|15|||
49060073|NCT02697773|158051526|FG001|Overall Study|Other|11|||
49060074|NCT02697773|158051527|FG002|Overall Study|Other|10|||
49060075|NCT02697773|158051525|FG000|Overall Study|Protocol Violation|1|||
49060076|NCT02697773|158051526|FG001|Overall Study|Protocol Violation|1|||
49060077|NCT02697773|158051527|FG002|Overall Study|Protocol Violation|0|||
49060078|NCT02697773|158051525|FG000|Overall Study|Withdrawal by Subject|10|||
49060079|NCT02697773|158051526|FG001|Overall Study|Withdrawal by Subject|13|||
49060080|NCT02697773|158051527|FG002|Overall Study|Withdrawal by Subject|13|||
49060081|NCT02697773|158051525|FG000|Overall Study|Randomized but not treated|1|||
49060082|NCT02697773|158051526|FG001|Overall Study|Randomized but not treated|1|||
49060083|NCT02697773|158051527|FG002|Overall Study|Randomized but not treated|0|||
49060084|NCT02357342|158051530|FG000|First 6 Months|Death|2|||
49060085|NCT02357342|158051531|FG001|First 6 Months|Death|0|||
49060086|NCT00062751|158051532|FG000|Overall Study|Disease progression|24|||
49060087|NCT00062751|158051533|FG001|Overall Study|Disease progression|17|||
49060088|NCT00062751|158051534|FG002|Overall Study|Disease progression|24|||
49060089|NCT00062751|158051535|FG003|Overall Study|Disease progression|2|||
49060090|NCT00062751|158051536|FG004|Overall Study|Disease progression|2|||
49060091|NCT00062751|158051532|FG000|Overall Study|Adverse Event|4|||
49060092|NCT00062751|158051533|FG001|Overall Study|Adverse Event|7|||
49060093|NCT00062751|158051534|FG002|Overall Study|Adverse Event|2|||
49060094|NCT00062751|158051535|FG003|Overall Study|Adverse Event|2|||
49060095|NCT00062751|158051536|FG004|Overall Study|Adverse Event|2|||
49060096|NCT00062751|158051532|FG000|Overall Study|Other|2|||
49060097|NCT00062751|158051533|FG001|Overall Study|Other|3|||
49060098|NCT00062751|158051534|FG002|Overall Study|Other|1|||
49060099|NCT00062751|158051535|FG003|Overall Study|Other|0|||
49060100|NCT00062751|158051536|FG004|Overall Study|Other|1|||
49060101|NCT00062751|158051532|FG000|Overall Study|Withdrawal by Subject|1|||
49060102|NCT00062751|158051533|FG001|Overall Study|Withdrawal by Subject|2|||
49060103|NCT00062751|158051534|FG002|Overall Study|Withdrawal by Subject|2|||
49060104|NCT00062751|158051535|FG003|Overall Study|Withdrawal by Subject|1|||
49060105|NCT00062751|158051536|FG004|Overall Study|Withdrawal by Subject|0|||
49060106|NCT00062751|158051532|FG000|Overall Study|Symptomatic deterioration|1|||
49060107|NCT00062751|158051533|FG001|Overall Study|Symptomatic deterioration|1|||
49060108|NCT00062751|158051534|FG002|Overall Study|Symptomatic deterioration|0|||
49060109|NCT00062751|158051535|FG003|Overall Study|Symptomatic deterioration|0|||
49060110|NCT00062751|158051536|FG004|Overall Study|Symptomatic deterioration|1|||
49060111|NCT00062751|158051532|FG000|Overall Study|Death|1|||
49060112|NCT00062751|158051533|FG001|Overall Study|Death|0|||
49060113|NCT00062751|158051534|FG002|Overall Study|Death|1|||
49060114|NCT00062751|158051535|FG003|Overall Study|Death|0|||
49060115|NCT00062751|158051536|FG004|Overall Study|Death|0|||
49060116|NCT01782482|158051545|FG000|Overall Study|Adverse Event|2|||
49060117|NCT01782482|158051546|FG001|Overall Study|Adverse Event|1|||
49060118|NCT01782482|158051545|FG000|Overall Study|Lost to Follow-up|2|||
49060119|NCT01782482|158051546|FG001|Overall Study|Lost to Follow-up|3|||
49060120|NCT01782482|158051545|FG000|Overall Study|Physician Decision|1|||
49060121|NCT01782482|158051546|FG001|Overall Study|Physician Decision|0|||
49060122|NCT01782482|158051545|FG000|Overall Study|Protocol Violation|1|||
49060123|NCT01782482|158051546|FG001|Overall Study|Protocol Violation|0|||
49060124|NCT01782482|158051545|FG000|Overall Study|Withdrawal by Subject|2|||
49060125|NCT01782482|158051546|FG001|Overall Study|Withdrawal by Subject|3|||
49060126|NCT01782482|158051545|FG000|Overall Study|Randomized in Error|2|||
49060127|NCT01782482|158051546|FG001|Overall Study|Randomized in Error|2|||
49060128|NCT01782482|158051545|FG000|Overall Study|Habitually wearing toric lens OS|0|||
49060129|NCT01782482|158051546|FG001|Overall Study|Habitually wearing toric lens OS|1|||
49060130|NCT00407758|158051547|FG000|Overall Study|ineligible -improper prior treatment|1|||
49060131|NCT02377063|158051551|FG000|Overall Study|Non-compliance|5|||
49060132|NCT01277718|158051552|FG000|Period 2 - Second Intervention|Protocol Violation|0|||
49060133|NCT01277718|158051553|FG001|Period 2 - Second Intervention|Protocol Violation|1|||
49060134|NCT01277718|158051552|FG000|Period 2 - Second Intervention|Physician Decision|0|||
49060135|NCT01277718|158051553|FG001|Period 2 - Second Intervention|Physician Decision|2|||
49060136|NCT01524913|158051557|FG000|Overall Study|Lost to Follow-up|4|||
49060137|NCT01524913|158051558|FG001|Overall Study|Lost to Follow-up|0|||
49060138|NCT01524913|158051559|FG002|Overall Study|Lost to Follow-up|0|||
49060139|NCT00702208|158051560|FG000|Overall Study|Lost to Follow-up|28|||
49060140|NCT00702208|158051560|FG000|Overall Study|Did not self-lavage|1|||
49060141|NCT00702208|158051560|FG000|Overall Study|Unsatisfactory colposcopy|2|||
49060142|NCT00741936|158051563|FG000|Overall Study|Lost to Follow-up|1|||
49060143|NCT00741936|158051564|FG001|Overall Study|Lost to Follow-up|1|||
49060144|NCT00741936|158051563|FG000|Overall Study|Adverse Event|3|||
49060145|NCT00741936|158051564|FG001|Overall Study|Adverse Event|4|||
49060146|NCT00741936|158051563|FG000|Overall Study|Pregnancy|0|||
49060147|NCT00741936|158051564|FG001|Overall Study|Pregnancy|1|||
49060148|NCT00741936|158051563|FG000|Overall Study|Protocol Violation|2|||
49060149|NCT00741936|158051564|FG001|Overall Study|Protocol Violation|0|||
49060150|NCT00741936|158051563|FG000|Overall Study|Lack of Efficacy|0|||
49060151|NCT00741936|158051564|FG001|Overall Study|Lack of Efficacy|2|||
49060152|NCT00741936|158051563|FG000|Overall Study|Low compliance|3|||
49060153|NCT00741936|158051564|FG001|Overall Study|Low compliance|0|||
49060154|NCT00321737|158051565|FG000|Overall Study|Relapse of Erosive Esophagitis|76|||
49060155|NCT00321737|158051566|FG001|Overall Study|Relapse of Erosive Esophagitis|25|||
49060156|NCT00321737|158051567|FG002|Overall Study|Relapse of Erosive Esophagitis|19|||
49060157|NCT00321737|158051565|FG000|Overall Study|Adverse Event|11|||
49060158|NCT00321737|158051566|FG001|Overall Study|Adverse Event|3|||
49060159|NCT00321737|158051567|FG002|Overall Study|Adverse Event|6|||
49060160|NCT00321737|158051565|FG000|Overall Study|Lost to Follow-up|5|||
49060161|NCT00321737|158051566|FG001|Overall Study|Lost to Follow-up|5|||
49060162|NCT00321737|158051567|FG002|Overall Study|Lost to Follow-up|6|||
49060163|NCT00321737|158051565|FG000|Overall Study|Withdrawal by Subject|19|||
49060164|NCT00321737|158051566|FG001|Overall Study|Withdrawal by Subject|12|||
49060165|NCT00321737|158051567|FG002|Overall Study|Withdrawal by Subject|17|||
49060166|NCT00321737|158051565|FG000|Overall Study|Protocol Violation|0|||
49060167|NCT00321737|158051566|FG001|Overall Study|Protocol Violation|0|||
49060168|NCT00321737|158051567|FG002|Overall Study|Protocol Violation|1|||
49060169|NCT00321737|158051565|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
49060170|NCT00321737|158051566|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
49060171|NCT00321737|158051567|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
49060172|NCT00321737|158051565|FG000|Overall Study|Possible Barrett's Esophagus|2|||
49060173|NCT00321737|158051566|FG001|Overall Study|Possible Barrett's Esophagus|1|||
49060174|NCT00321737|158051567|FG002|Overall Study|Possible Barrett's Esophagus|1|||
49060175|NCT00321737|158051565|FG000|Overall Study|Therapeutic Failure|6|||
49060176|NCT00321737|158051566|FG001|Overall Study|Therapeutic Failure|0|||
49060177|NCT00321737|158051567|FG002|Overall Study|Therapeutic Failure|2|||
49060178|NCT00321737|158051565|FG000|Overall Study|Pregnancy|0|||
49060179|NCT00321737|158051566|FG001|Overall Study|Pregnancy|2|||
49060180|NCT00321737|158051567|FG002|Overall Study|Pregnancy|0|||
49060181|NCT00321737|158051565|FG000|Overall Study|Noncompliance|2|||
49060182|NCT00321737|158051566|FG001|Overall Study|Noncompliance|0|||
49060183|NCT00321737|158051567|FG002|Overall Study|Noncompliance|0|||
49060184|NCT00321737|158051565|FG000|Overall Study|Subject Request/ Subject Unavailable|0|||
49060185|NCT00321737|158051566|FG001|Overall Study|Subject Request/ Subject Unavailable|0|||
49060186|NCT00321737|158051567|FG002|Overall Study|Subject Request/ Subject Unavailable|2|||
49060187|NCT03097588|158051568|FG000|Overall Study|Adverse Event|1|||
49060188|NCT02989168|158051572|FG000|Overall Study|Withdrawal by Subject|2|||
49060189|NCT02989168|158051573|FG001|Overall Study|Withdrawal by Subject|0|||
49060190|NCT02989168|158051572|FG000|Overall Study|Physician Decision|0|||
49060191|NCT02989168|158051573|FG001|Overall Study|Physician Decision|1|||
49060192|NCT02989168|158051572|FG000|Overall Study|Adverse Event|1|||
49060193|NCT02989168|158051573|FG001|Overall Study|Adverse Event|2|||
49060194|NCT02989168|158051572|FG000|Overall Study|Sponsor stopped study.|1|||
49060195|NCT02989168|158051573|FG001|Overall Study|Sponsor stopped study.|0|||
49060196|NCT00456495|158051575|FG000|Overall Study|Physician Decision|2|||
49060197|NCT01300923|158051576|FG000|Overall Study|Physician Decision|0|||
49060198|NCT01300923|158051577|FG001|Overall Study|Physician Decision|2|||
49060199|NCT03864042|158051580|FG000|DDI Phase|Adverse Event|2|||
49060200|NCT03864042|158051581|FG001|DDI Phase|Adverse Event|0|||
49060201|NCT03864042|158051582|FG002|DDI Phase|Adverse Event|0|||
49060202|NCT03864042|158051580|FG000|DDI Phase|Physician Decision|1|||
49060203|NCT03864042|158051581|FG001|DDI Phase|Physician Decision|0|||
49060204|NCT03864042|158051582|FG002|DDI Phase|Physician Decision|0|||
49060205|NCT03864042|158051580|FG000|DDI Phase|Progressive Disease|1|||
49060206|NCT03864042|158051581|FG001|DDI Phase|Progressive Disease|0|||
49060207|NCT03864042|158051582|FG002|DDI Phase|Progressive Disease|0|||
49060208|NCT03864042|158051580|FG000|Post-DDI Phase|Adverse Event|5|||
49060209|NCT03864042|158051581|FG001|Post-DDI Phase|Adverse Event|3|||
49060210|NCT03864042|158051582|FG002|Post-DDI Phase|Adverse Event|2|||
49060211|NCT03864042|158051580|FG000|Post-DDI Phase|Progressive Disease|11|||
49060212|NCT03864042|158051581|FG001|Post-DDI Phase|Progressive Disease|6|||
49060213|NCT03864042|158051582|FG002|Post-DDI Phase|Progressive Disease|13|||
49060214|NCT03864042|158051580|FG000|Post-DDI Phase|Discretion of investigator|1|||
49060215|NCT03864042|158051581|FG001|Post-DDI Phase|Discretion of investigator|1|||
49060216|NCT03864042|158051582|FG002|Post-DDI Phase|Discretion of investigator|0|||
49060217|NCT03864042|158051580|FG000|Post-DDI Phase|Study terminated by sponsor|7|||
49060218|NCT03864042|158051581|FG001|Post-DDI Phase|Study terminated by sponsor|0|||
49060219|NCT03864042|158051582|FG002|Post-DDI Phase|Study terminated by sponsor|0|||
49060220|NCT03864042|158051580|FG000|Post-DDI Phase|Withdrawal of consent|1|||
49060221|NCT03864042|158051581|FG001|Post-DDI Phase|Withdrawal of consent|2|||
49060222|NCT03864042|158051582|FG002|Post-DDI Phase|Withdrawal of consent|0|||
49060223|NCT01698775|158051583|FG000|Phase A|Adverse Event|2|||
49060224|NCT01698775|158051584|FG001|Phase A|Adverse Event|1|||
49060225|NCT01698775|158051583|FG000|Phase A|Death|1|||
49060226|NCT01698775|158051584|FG001|Phase A|Death|1|||
49060227|NCT01698775|158051583|FG000|Phase A|Lack of Efficacy|1|||
49060228|NCT01698775|158051584|FG001|Phase A|Lack of Efficacy|0|||
49060229|NCT01698775|158051583|FG000|Phase A|Lost to Follow-up|1|||
49060230|NCT01698775|158051584|FG001|Phase A|Lost to Follow-up|2|||
49060231|NCT01698775|158051583|FG000|Phase A|Protocol Violation|1|||
49060232|NCT01698775|158051584|FG001|Phase A|Protocol Violation|0|||
49060233|NCT01698775|158051583|FG000|Phase A|Withdrawal by Subject|3|||
49060234|NCT01698775|158051584|FG001|Phase A|Withdrawal by Subject|4|||
49060235|NCT01698775|158051583|FG000|Phase A|Kidney [transplant]|0|||
49060236|NCT01698775|158051584|FG001|Phase A|Kidney [transplant]|1|||
49060237|NCT01698775|158051583|FG000|Phase B|Hyperglycemia Discontinuation Criteria|0|||
49060238|NCT01698775|158051584|FG001|Phase B|Hyperglycemia Discontinuation Criteria|1|||
49060239|NCT01698775|158051583|FG000|Phase B|Adverse Event|6|||
49060240|NCT01698775|158051584|FG001|Phase B|Adverse Event|3|||
49060241|NCT01698775|158051583|FG000|Phase B|Death|0|||
49060242|NCT01698775|158051584|FG001|Phase B|Death|1|||
49060243|NCT01698775|158051583|FG000|Phase B|Lack of Efficacy|0|||
49060244|NCT01698775|158051584|FG001|Phase B|Lack of Efficacy|1|||
49060245|NCT01698775|158051583|FG000|Phase B|Lost to Follow-up|0|||
49060246|NCT01698775|158051584|FG001|Phase B|Lost to Follow-up|1|||
49060247|NCT01698775|158051583|FG000|Phase B|Physician Decision|1|||
49060248|NCT01698775|158051584|FG001|Phase B|Physician Decision|1|||
49060249|NCT01698775|158051583|FG000|Phase B|Protocol Violation|1|||
49060250|NCT01698775|158051584|FG001|Phase B|Protocol Violation|1|||
49060251|NCT01698775|158051583|FG000|Phase B|Withdrawal by Subject|6|||
49060252|NCT01698775|158051584|FG001|Phase B|Withdrawal by Subject|2|||
49060253|NCT00995085|158051585|FG000|Overall Study|Withdrawal by Subject|5|||
49060254|NCT02143583|158051588|FG000|Overall Study|Withdrawal by Subject|1|||
49060255|NCT02143583|158051589|FG001|Overall Study|Withdrawal by Subject|0|||
49060256|NCT02143583|158051590|FG002|Overall Study|Withdrawal by Subject|1|||
49060257|NCT02143583|158051588|FG000|Overall Study|husband illness|0|||
49060258|NCT02143583|158051589|FG001|Overall Study|husband illness|0|||
49060259|NCT02143583|158051590|FG002|Overall Study|husband illness|1|||
49060260|NCT02707861|158051591|FG000|Overall Study|Went onto commercial drug|30|||
49060261|NCT02707861|158051592|FG001|Overall Study|Went onto commercial drug|23|||
49060262|NCT02707861|158051591|FG000|Overall Study|Adverse Event|2|||
49060263|NCT02707861|158051592|FG001|Overall Study|Adverse Event|3|||
49060264|NCT02707861|158051591|FG000|Overall Study|Death|5|||
49060265|NCT02707861|158051592|FG001|Overall Study|Death|2|||
49060266|NCT02707861|158051591|FG000|Overall Study|Lack of Efficacy|0|||
49060267|NCT02707861|158051592|FG001|Overall Study|Lack of Efficacy|2|||
49060268|NCT02707861|158051591|FG000|Overall Study|Physician Decision|1|||
49060269|NCT02707861|158051592|FG001|Overall Study|Physician Decision|4|||
49060270|NCT02707861|158051591|FG000|Overall Study|Withdrawal by Subject|2|||
49060271|NCT02707861|158051592|FG001|Overall Study|Withdrawal by Subject|1|||
49060272|NCT02707861|158051591|FG000|Overall Study|Lost to Follow-up|1|||
49060273|NCT02707861|158051592|FG001|Overall Study|Lost to Follow-up|3|||
49060274|NCT01244061|158051595|FG000|Overall Study|Death|1|||
49060275|NCT01244061|158051596|FG001|Overall Study|Death|0|||
49060276|NCT01244061|158051595|FG000|Overall Study|Did not meet entrance criteria|1|||
49060277|NCT01244061|158051596|FG001|Overall Study|Did not meet entrance criteria|0|||
49060278|NCT01244061|158051595|FG000|Overall Study|Lack of Efficacy|1|||
49060279|NCT01244061|158051596|FG001|Overall Study|Lack of Efficacy|3|||
49060280|NCT01244061|158051595|FG000|Overall Study|Lost to Follow-up|34|||
49060281|NCT01244061|158051596|FG001|Overall Study|Lost to Follow-up|30|||
49060282|NCT01244061|158051595|FG000|Overall Study|Withdrawal by Subject|29|||
49060283|NCT01244061|158051596|FG001|Overall Study|Withdrawal by Subject|46|||
49060284|NCT01244061|158051595|FG000|Overall Study|Other|8|||
49060285|NCT01244061|158051596|FG001|Overall Study|Other|19|||
49060286|NCT01244061|158051595|FG000|Overall Study|Protocol Violation|1|||
49060287|NCT01244061|158051596|FG001|Overall Study|Protocol Violation|1|||
49060288|NCT01244061|158051595|FG000|Overall Study|Adverse Event|5|||
49060289|NCT01244061|158051596|FG001|Overall Study|Adverse Event|2|||
49060290|NCT01244061|158051595|FG000|Overall Study|Randomized but not treated|2|||
49060291|NCT01244061|158051596|FG001|Overall Study|Randomized but not treated|2|||
49060292|NCT01641133|158051597|FG000|Overall Study|Protocol Violation|0|||
49060293|NCT01641133|158051598|FG001|Overall Study|Protocol Violation|1|||
49060294|NCT01641133|158051599|FG002|Overall Study|Protocol Violation|1|||
49060295|NCT01641133|158051597|FG000|Overall Study|Migrated/moved from study area|5|||
49060296|NCT01641133|158051598|FG001|Overall Study|Migrated/moved from study area|3|||
49060297|NCT01641133|158051599|FG002|Overall Study|Migrated/moved from study area|1|||
49060298|NCT01641133|158051597|FG000|Overall Study|Adverse Event|0|||
49060299|NCT01641133|158051598|FG001|Overall Study|Adverse Event|0|||
49060300|NCT01641133|158051599|FG002|Overall Study|Adverse Event|1|||
49060301|NCT01641133|158051597|FG000|Overall Study|Withdrawal by Subject|5|||
49060302|NCT01641133|158051598|FG001|Overall Study|Withdrawal by Subject|3|||
49060303|NCT01641133|158051599|FG002|Overall Study|Withdrawal by Subject|3|||
49060304|NCT01641133|158051597|FG000|Overall Study|Lost to Follow-up|0|||
49060305|NCT01641133|158051598|FG001|Overall Study|Lost to Follow-up|2|||
49060306|NCT01641133|158051599|FG002|Overall Study|Lost to Follow-up|2|||
49060307|NCT03123861|158051600|FG000|Overall Study|Protocol Violation|1|||
49060308|NCT03123861|158051601|FG001|Overall Study|Protocol Violation|1|||
49060309|NCT03123861|158051600|FG000|Overall Study|Withdrawal by Subject|2|||
49060310|NCT03123861|158051601|FG001|Overall Study|Withdrawal by Subject|2|||
49060311|NCT05069155|158051602|FG000|Overall Study|Withdrawal by Subject|1|||
49060312|NCT05069155|158051603|FG001|Overall Study|Withdrawal by Subject|3|||
49060313|NCT02980874|158051604|FG000|Overall Study|Adverse Event|2|||
49060314|NCT02980874|158051605|FG001|Overall Study|Adverse Event|7|||
49060315|NCT02980874|158051604|FG000|Overall Study|Withdrawal by Subject|7|||
49060316|NCT02980874|158051605|FG001|Overall Study|Withdrawal by Subject|2|||
49060317|NCT02980874|158051604|FG000|Overall Study|Lost to Follow-up|5|||
49060318|NCT02980874|158051605|FG001|Overall Study|Lost to Follow-up|5|||
49060319|NCT02980874|158051604|FG000|Overall Study|Includes premature discontinuation due to study termination.|88|||
49060320|NCT02980874|158051605|FG001|Overall Study|Includes premature discontinuation due to study termination.|88|||
49060321|NCT02980874|158051604|FG000|Overall Study|Unknown study completion status|1|||
49060322|NCT02980874|158051605|FG001|Overall Study|Unknown study completion status|0|||
49060323|NCT01346774|158051606|FG000|Overall Study|Did not take a single dose|6|||
49060324|NCT01346774|158051607|FG001|Overall Study|Did not take a single dose|4|||
49060325|NCT01346774|158051606|FG000|Overall Study|Lost to Follow-up|3|||
49060326|NCT01346774|158051607|FG001|Overall Study|Lost to Follow-up|4|||
49060327|NCT01346774|158051606|FG000|Overall Study|Withdrawal by Subject|1|||
49060328|NCT01346774|158051607|FG001|Overall Study|Withdrawal by Subject|4|||
49060329|NCT01346774|158051606|FG000|Overall Study|Protocol Violation|2|||
49060330|NCT01346774|158051607|FG001|Overall Study|Protocol Violation|3|||
49060331|NCT01346774|158051606|FG000|Overall Study|Adverse Event|1|||
49060332|NCT01346774|158051607|FG001|Overall Study|Adverse Event|2|||
49060333|NCT00507546|158051610|FG000|Overall Study|Withdrawal by Subject|1|||
49060334|NCT00507546|158051611|FG001|Overall Study|Withdrawal by Subject|0|||
49060335|NCT00507546|158051610|FG000|Overall Study|Protocol Violation|1|||
49060336|NCT00507546|158051611|FG001|Overall Study|Protocol Violation|0|||
49060337|NCT00507546|158051610|FG000|Overall Study|Physician Decision|0|||
49060338|NCT00507546|158051611|FG001|Overall Study|Physician Decision|1|||
49060339|NCT02522403|158054040|FG000|Overall Study|Lost to Follow-up|2|||
49060340|NCT02522403|158054041|FG001|Overall Study|Lost to Follow-up|2|||
49060341|NCT02522403|158054040|FG000|Overall Study|Withdrawal by Subject|2|||
49060342|NCT02522403|158054041|FG001|Overall Study|Withdrawal by Subject|4|||
49060343|NCT03340064|158054042|FG000|First Period|Adverse Event, non-fatal|2|||
49060344|NCT03340064|158054043|FG001|First Period|Adverse Event, non-fatal|0|||
49060345|NCT03340064|158054042|FG000|First Period|Lack of Efficacy|3|||
49060346|NCT03340064|158054043|FG001|First Period|Lack of Efficacy|0|||
49060347|NCT03340064|158054042|FG000|Second Period|Adverse Event, non-fatal|1|||
49060348|NCT03340064|158054043|FG001|Second Period|Adverse Event, non-fatal|1|||
49060349|NCT03340064|158054042|FG000|Second Period|Lack of Efficacy|11|||
49060350|NCT03340064|158054043|FG001|Second Period|Lack of Efficacy|0|||
49060351|NCT03340064|158054042|FG000|Second Period|Physician Decision|3|||
49060352|NCT03340064|158054043|FG001|Second Period|Physician Decision|0|||
49060353|NCT03340064|158054042|FG000|Second Period|Withdrawal by Subject|2|||
49060354|NCT03340064|158054043|FG001|Second Period|Withdrawal by Subject|1|||
49060355|NCT03340064|158054042|FG000|Second Period|Approved Drug Available For Indication|1|||
49060356|NCT03340064|158054043|FG001|Second Period|Approved Drug Available For Indication|0|||
49060357|NCT03340064|158054042|FG000|Second Period|Protocol-Specified Withdrawal Criterion Met|1|||
49060358|NCT03340064|158054043|FG001|Second Period|Protocol-Specified Withdrawal Criterion Met|0|||
49060359|NCT01045421|158054044|FG000|Phase 1|Progressive Disease|0|||
49060360|NCT01045421|158054045|FG001|Phase 1|Progressive Disease|0|||
49060361|NCT01045421|158054046|FG002|Phase 1|Progressive Disease|0|||
49060362|NCT01045421|158054047|FG003|Phase 1|Progressive Disease|0|||
49060363|NCT01045421|158054048|FG004|Phase 1|Progressive Disease|1|||
49060364|NCT01045421|158054049|FG005|Phase 1|Progressive Disease|0|||
49060365|NCT01045421|158054050|FG006|Phase 1|Progressive Disease|0|||
49060366|NCT01045421|158054051|FG007|Phase 1|Progressive Disease|0|||
49060367|NCT01045421|158054052|FG008|Phase 1|Progressive Disease|0|||
49060368|NCT01045421|158054053|FG009|Phase 1|Progressive Disease|0|||
49060369|NCT01045421|158054054|FG010|Phase 1|Progressive Disease|0|||
49060370|NCT01045421|158054044|FG000|Phase 1|Withdrawal by Subject|0|||
49060371|NCT01045421|158054045|FG001|Phase 1|Withdrawal by Subject|0|||
49060372|NCT01045421|158054046|FG002|Phase 1|Withdrawal by Subject|0|||
49060373|NCT01045421|158054047|FG003|Phase 1|Withdrawal by Subject|1|||
49060374|NCT01045421|158054048|FG004|Phase 1|Withdrawal by Subject|0|||
49060375|NCT01045421|158054049|FG005|Phase 1|Withdrawal by Subject|0|||
49060376|NCT01045421|158054050|FG006|Phase 1|Withdrawal by Subject|0|||
49060377|NCT01045421|158054051|FG007|Phase 1|Withdrawal by Subject|0|||
49060378|NCT01045421|158054052|FG008|Phase 1|Withdrawal by Subject|0|||
49060379|NCT01045421|158054053|FG009|Phase 1|Withdrawal by Subject|0|||
49060380|NCT01045421|158054054|FG010|Phase 1|Withdrawal by Subject|0|||
49060381|NCT01045421|158054044|FG000|Phase 2|Progressive Disease|0|||
49060382|NCT01045421|158054045|FG001|Phase 2|Progressive Disease|0|||
49060383|NCT01045421|158054046|FG002|Phase 2|Progressive Disease|0|||
49060384|NCT01045421|158054047|FG003|Phase 2|Progressive Disease|0|||
49060385|NCT01045421|158054048|FG004|Phase 2|Progressive Disease|0|||
49060386|NCT01045421|158054049|FG005|Phase 2|Progressive Disease|0|||
49060387|NCT01045421|158054050|FG006|Phase 2|Progressive Disease|0|||
49060388|NCT01045421|158054051|FG007|Phase 2|Progressive Disease|1|||
49060389|NCT01045421|158054052|FG008|Phase 2|Progressive Disease|1|||
49060390|NCT01045421|158054053|FG009|Phase 2|Progressive Disease|1|||
49060391|NCT01045421|158054054|FG010|Phase 2|Progressive Disease|1|||
49060392|NCT01045421|158054044|FG000|Phase 2|Death|0|||
49060393|NCT01045421|158054045|FG001|Phase 2|Death|0|||
49060394|NCT01045421|158054046|FG002|Phase 2|Death|0|||
49060395|NCT01045421|158054047|FG003|Phase 2|Death|0|||
49060396|NCT01045421|158054048|FG004|Phase 2|Death|0|||
49060397|NCT01045421|158054049|FG005|Phase 2|Death|0|||
49060398|NCT01045421|158054050|FG006|Phase 2|Death|0|||
49060399|NCT01045421|158054051|FG007|Phase 2|Death|1|||
49060400|NCT01045421|158054052|FG008|Phase 2|Death|1|||
49060401|NCT01045421|158054053|FG009|Phase 2|Death|2|||
49060402|NCT01045421|158054054|FG010|Phase 2|Death|0|||
49060403|NCT01045421|158054044|FG000|Phase 2|Other|0|||
49060404|NCT01045421|158054045|FG001|Phase 2|Other|0|||
49060405|NCT01045421|158054046|FG002|Phase 2|Other|0|||
49060406|NCT01045421|158054047|FG003|Phase 2|Other|0|||
49060407|NCT01045421|158054048|FG004|Phase 2|Other|0|||
49060408|NCT01045421|158054049|FG005|Phase 2|Other|0|||
49060409|NCT01045421|158054050|FG006|Phase 2|Other|0|||
49060410|NCT01045421|158054051|FG007|Phase 2|Other|3|||
49060411|NCT01045421|158054052|FG008|Phase 2|Other|0|||
49060412|NCT01045421|158054053|FG009|Phase 2|Other|0|||
49060413|NCT01045421|158054054|FG010|Phase 2|Other|1|||
49060414|NCT01475253|158054055|FG000|Randomized, Blinded Study|Withdrawal by Subject|1|||
49060415|NCT01475253|158054056|FG001|Randomized, Blinded Study|Withdrawal by Subject|1|||
49060416|NCT01475253|158054057|FG002|Randomized, Blinded Study|Withdrawal by Subject|0|||
49060417|NCT01475253|158054058|FG003|Randomized, Blinded Study|Withdrawal by Subject|0|||
49060418|NCT01475253|158054055|FG000|Randomized, Blinded Study|Lost to Follow-up|1|||
49060419|NCT01475253|158054056|FG001|Randomized, Blinded Study|Lost to Follow-up|0|||
49060420|NCT01475253|158054057|FG002|Randomized, Blinded Study|Lost to Follow-up|0|||
49060421|NCT01475253|158054058|FG003|Randomized, Blinded Study|Lost to Follow-up|0|||
49060422|NCT05506358|158054070|FG000|Overall Study|Sickle cell disease with transfusion within 3 months|2|||
49060423|NCT05506358|158054071|FG001|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
49060424|NCT05506358|158054072|FG002|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
49060425|NCT05506358|158054073|FG003|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
49060426|NCT05506358|158054074|FG004|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
49060427|NCT05506358|158054070|FG000|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|2|||
49060428|NCT05506358|158054071|FG001|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
49060429|NCT05506358|158054072|FG002|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
49060430|NCT05506358|158054073|FG003|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
49060431|NCT05506358|158054074|FG004|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
49060432|NCT05506358|158054070|FG000|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
49060433|NCT05506358|158054071|FG001|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
49060434|NCT05506358|158054072|FG002|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
49060435|NCT05506358|158054073|FG003|Overall Study|Beta-thalassemia major with transfusion within 2 months|1|||
49060436|NCT05506358|158054074|FG004|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
49060437|NCT05506358|158054070|FG000|Overall Study|Sample hemolysis observed under the microscope|0|||
49060438|NCT05506358|158054071|FG001|Overall Study|Sample hemolysis observed under the microscope|0|||
49060439|NCT05506358|158054072|FG002|Overall Study|Sample hemolysis observed under the microscope|0|||
49060440|NCT05506358|158054073|FG003|Overall Study|Sample hemolysis observed under the microscope|1|||
49060441|NCT05506358|158054074|FG004|Overall Study|Sample hemolysis observed under the microscope|0|||
49060442|NCT05506358|158054070|FG000|Overall Study|HbE trait|0|||
49060443|NCT05506358|158054071|FG001|Overall Study|HbE trait|0|||
49060444|NCT05506358|158054072|FG002|Overall Study|HbE trait|0|||
49060445|NCT05506358|158054073|FG003|Overall Study|HbE trait|1|||
49060446|NCT05506358|158054074|FG004|Overall Study|HbE trait|0|||
49060447|NCT00804141|158054075|FG000|Overall Study|Adverse Event|157|||
49060448|NCT00804141|158054075|FG000|Overall Study|Death|4|||
49060449|NCT00804141|158054075|FG000|Overall Study|Failed to return|96|||
49060450|NCT00804141|158054075|FG000|Overall Study|Investigator request|8|||
49060451|NCT00804141|158054075|FG000|Overall Study|Protocol Violation|85|||
49060452|NCT00804141|158054075|FG000|Overall Study|Withdrawal by Subject|131|||
49060453|NCT00804141|158054075|FG000|Overall Study|Lack of Efficacy|46|||
49060454|NCT00804141|158054075|FG000|Overall Study|Other than specified|30|||
49060455|NCT00804141|158054075|FG000|Overall Study|Enrolled but not treated|6|||
49060456|NCT00608517|158054077|FG000|Overall Study|Death|1|||
49060457|NCT00608517|158054078|FG001|Overall Study|Death|0|||
49060458|NCT00608517|158054079|FG002|Overall Study|Death|0|||
49060459|NCT01460901|158054080|FG000|Overall Study|Withdrawal by Subject|2|||
49060460|NCT02865395|158054085|FG000|Overall Study|Physician Decision|6|||
49060461|NCT02865395|158054086|FG001|Overall Study|Physician Decision|10|||
49060462|NCT02865395|158054087|FG002|Overall Study|Physician Decision|7|||
49060463|NCT00653991|158054088|FG000|3 Month Follow-up|Participant would not respond|150|||
49060464|NCT00653991|158054089|FG001|3 Month Follow-up|Participant would not respond|157|||
49060465|NCT00653991|158054088|FG000|6 Month Follow-up|Participant would not respond|133|||
49060466|NCT00653991|158054089|FG001|6 Month Follow-up|Participant would not respond|141|||
49060467|NCT00629265|158054090|FG000|Overall Study|Lost to Follow-up|4|||
49060468|NCT00629265|158054091|FG001|Overall Study|Lost to Follow-up|5|||
49060469|NCT00629265|158054090|FG000|Overall Study|Withdrawal by Subject|11|||
49060470|NCT00629265|158054091|FG001|Overall Study|Withdrawal by Subject|8|||
49060471|NCT00629265|158054090|FG000|Overall Study|Death|1|||
49060472|NCT00629265|158054091|FG001|Overall Study|Death|0|||
49060473|NCT00629265|158054090|FG000|Overall Study|Adverse Event|2|||
49060474|NCT00629265|158054091|FG001|Overall Study|Adverse Event|0|||
49060475|NCT00629265|158054090|FG000|Overall Study|HNC Recurrence|4|||
49060476|NCT00629265|158054091|FG001|Overall Study|HNC Recurrence|0|||
49060477|NCT00629265|158054090|FG000|Overall Study|Other CA Requiring Treatment|1|||
49060478|NCT00629265|158054091|FG001|Overall Study|Other CA Requiring Treatment|3|||
49060479|NCT00629265|158054090|FG000|Overall Study|Needed Esophageal Dilation|4|||
49060480|NCT00629265|158054091|FG001|Overall Study|Needed Esophageal Dilation|1|||
49060481|NCT00629265|158054090|FG000|Overall Study|Unrelated Medical Complications|3|||
49060482|NCT00629265|158054091|FG001|Overall Study|Unrelated Medical Complications|1|||
49060483|NCT00629265|158054090|FG000|Overall Study|Unknown Reason|2|||
49060484|NCT00629265|158054091|FG001|Overall Study|Unknown Reason|2|||
49060485|NCT01138826|158054092|FG000|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
49060486|NCT01138826|158054093|FG001|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
49060487|NCT01138826|158054094|FG002|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
49060488|NCT01138826|158054095|FG003|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
49060489|NCT01138826|158054096|FG004|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
49060490|NCT01138826|158054097|FG005|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
49060491|NCT01846273|158054102|FG000|Overall Study|Adverse Event|9|||
49060492|NCT01846273|158054103|FG001|Overall Study|Adverse Event|7|||
49060493|NCT01846273|158054104|FG002|Overall Study|Adverse Event|0|||
49060494|NCT01846273|158054102|FG000|Overall Study|Subject withdrew consent|5|||
49060495|NCT01846273|158054103|FG001|Overall Study|Subject withdrew consent|8|||
49060496|NCT01846273|158054104|FG002|Overall Study|Subject withdrew consent|0|||
49060497|NCT01846273|158054102|FG000|Overall Study|Lost to Follow-up|2|||
49060498|NCT01846273|158054103|FG001|Overall Study|Lost to Follow-up|1|||
49060499|NCT01846273|158054104|FG002|Overall Study|Lost to Follow-up|0|||
49060500|NCT01846273|158054102|FG000|Overall Study|Administrative problems|1|||
49060501|NCT01846273|158054103|FG001|Overall Study|Administrative problems|0|||
49060502|NCT01846273|158054104|FG002|Overall Study|Administrative problems|0|||
49060503|NCT01846273|158054102|FG000|Overall Study|Death|2|||
49060504|NCT01846273|158054103|FG001|Overall Study|Death|1|||
49060505|NCT01846273|158054104|FG002|Overall Study|Death|0|||
49060506|NCT01846273|158054102|FG000|Overall Study|Disease Progression|0|||
49060507|NCT01846273|158054103|FG001|Overall Study|Disease Progression|4|||
49060508|NCT01846273|158054104|FG002|Overall Study|Disease Progression|0|||
49060509|NCT01846273|158054102|FG000|Overall Study|Protocol Deviation|2|||
49060510|NCT01846273|158054103|FG001|Overall Study|Protocol Deviation|3|||
49060511|NCT01846273|158054104|FG002|Overall Study|Protocol Deviation|0|||
49060512|NCT01846273|158054102|FG000|Overall Study|Physician Decision|1|||
49060513|NCT01846273|158054103|FG001|Overall Study|Physician Decision|2|||
49060514|NCT01846273|158054104|FG002|Overall Study|Physician Decision|0|||
49060515|NCT01941940|158054105|FG000|Overall Study|Adverse Event|11|||
49060516|NCT01941940|158054105|FG000|Overall Study|Lost to Follow-up|2|||
49060517|NCT01941940|158054105|FG000|Overall Study|Physician Decision|2|||
49060518|NCT01941940|158054105|FG000|Overall Study|Withdrawal by Subject|15|||
49060519|NCT01941940|158054105|FG000|Overall Study|Death|1|||
49060520|NCT01941940|158054105|FG000|Overall Study|Other|1|||
49060521|NCT01941940|158054105|FG000|Overall Study|Other|1|||
49060522|NCT03828448|158054106|FG000|Overall Study|Sponsor's Discretion|34|||
49060523|NCT02037165|158054109|FG000|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
49060524|NCT02037165|158054110|FG001|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
49060525|NCT02037165|158054111|FG002|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
49060526|NCT02037165|158054112|FG003|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
49060527|NCT02037165|158054113|FG004|Washout Period 4 (6 Days)|Withdrawal by Subject|1|||
49060528|NCT00532935|158054114|FG000|Overall Study|Adverse Event|11|||
49060529|NCT00532935|158054115|FG001|Overall Study|Adverse Event|12|||
49060530|NCT00532935|158054114|FG000|Overall Study|Lack of Efficacy|0|||
49060531|NCT00532935|158054115|FG001|Overall Study|Lack of Efficacy|3|||
49060532|NCT00532935|158054114|FG000|Overall Study|Lost to Follow-up|10|||
49060533|NCT00532935|158054115|FG001|Overall Study|Lost to Follow-up|6|||
49060534|NCT00532935|158054114|FG000|Overall Study|Physician Decision|4|||
49060535|NCT00532935|158054115|FG001|Overall Study|Physician Decision|5|||
49060536|NCT00532935|158054114|FG000|Overall Study|Pregnancy|1|||
49060537|NCT00532935|158054115|FG001|Overall Study|Pregnancy|0|||
49060538|NCT00532935|158054114|FG000|Overall Study|Protocol Violation|4|||
49060539|NCT00532935|158054115|FG001|Overall Study|Protocol Violation|2|||
49060540|NCT00532935|158054114|FG000|Overall Study|Withdrawal by Subject|10|||
49060541|NCT00532935|158054115|FG001|Overall Study|Withdrawal by Subject|9|||
49060542|NCT00532935|158054114|FG000|Overall Study|Protocol Specific Criteria|11|||
49060543|NCT00532935|158054115|FG001|Overall Study|Protocol Specific Criteria|15|||
49060544|NCT03433755|158054119|FG000|Overall Study|Lost to Follow-up|1|||
49060545|NCT03433755|158054120|FG001|Overall Study|Lost to Follow-up|0|||
49060546|NCT03433755|158054121|FG002|Overall Study|Lost to Follow-up|0|||
49060547|NCT03433755|158054122|FG003|Overall Study|Lost to Follow-up|0|||
49060548|NCT03433755|158054119|FG000|Overall Study|Decision by Sponsor|1|||
49060549|NCT03433755|158054120|FG001|Overall Study|Decision by Sponsor|0|||
49060550|NCT03433755|158054121|FG002|Overall Study|Decision by Sponsor|0|||
49060551|NCT03433755|158054122|FG003|Overall Study|Decision by Sponsor|0|||
49060552|NCT00594646|158054123|FG000|Overall Study|Withdrawal by Subject|1|||
49060553|NCT00594646|158054123|FG000|Overall Study|Lost to Follow-up|15|||
49060554|NCT02939014|158054124|FG000|Overall Study|Lost to Follow-up|1|||
49060555|NCT02939014|158054125|FG001|Overall Study|Lost to Follow-up|0|||
49060556|NCT02939014|158054124|FG000|Overall Study|Death|4|||
49060557|NCT02939014|158054125|FG001|Overall Study|Death|3|||
49060558|NCT01301508|158054126|FG000|Overall Study|Withdrawal by Subject|1|||
49060559|NCT01301508|158054127|FG001|Overall Study|Withdrawal by Subject|2|||
49060560|NCT01301508|158054126|FG000|Overall Study|Lost to Follow-up|0|||
49060561|NCT01301508|158054127|FG001|Overall Study|Lost to Follow-up|1|||
49060562|NCT02192164|158054128|FG000|Overall Study|Other|8|||
49060563|NCT02192164|158054128|FG000|Overall Study|Withdrawal by Subject|1|||
49060564|NCT02192164|158054128|FG000|Overall Study|Physician Decision|4|||
49060565|NCT02192164|158054128|FG000|Overall Study|Did not meet the exclusion criteria|1|||
49060566|NCT00750308|158054129|FG000|First Treatment|Adverse Event|0|||
49060567|NCT00750308|158054130|FG001|First Treatment|Adverse Event|1|||
49060568|NCT00750308|158054131|FG002|First Treatment|Adverse Event|0|||
49060569|NCT00750308|158054132|FG003|First Treatment|Adverse Event|0|||
49060570|NCT00750308|158054133|FG004|First Treatment|Adverse Event|0|||
49060571|NCT00750308|158054134|FG005|First Treatment|Adverse Event|0|||
49060572|NCT00750308|158054135|FG006|First Treatment|Adverse Event|0|||
49060573|NCT00750308|158054136|FG007|First Treatment|Adverse Event|0|||
49060574|NCT00750308|158054137|FG008|First Treatment|Adverse Event|0|||
49060575|NCT00750308|158054138|FG009|First Treatment|Adverse Event|0|||
49060576|NCT00750308|158054139|FG010|First Treatment|Adverse Event|1|||
49060577|NCT00750308|158054140|FG011|First Treatment|Adverse Event|1|||
49060578|NCT00750308|158054129|FG000|First Treatment|Withdrawal by Subject|0|||
49060579|NCT00750308|158054130|FG001|First Treatment|Withdrawal by Subject|0|||
49060580|NCT00750308|158054131|FG002|First Treatment|Withdrawal by Subject|0|||
49060581|NCT00750308|158054132|FG003|First Treatment|Withdrawal by Subject|1|||
49060582|NCT00750308|158054133|FG004|First Treatment|Withdrawal by Subject|0|||
49060583|NCT00750308|158054134|FG005|First Treatment|Withdrawal by Subject|0|||
49060584|NCT00750308|158054135|FG006|First Treatment|Withdrawal by Subject|0|||
49060585|NCT00750308|158054136|FG007|First Treatment|Withdrawal by Subject|1|||
49060586|NCT00750308|158054137|FG008|First Treatment|Withdrawal by Subject|0|||
49060587|NCT00750308|158054138|FG009|First Treatment|Withdrawal by Subject|0|||
49060588|NCT00750308|158054139|FG010|First Treatment|Withdrawal by Subject|0|||
49060589|NCT00750308|158054140|FG011|First Treatment|Withdrawal by Subject|0|||
49060590|NCT00750308|158054129|FG000|Second Treatment|Adverse Event|0|||
49060591|NCT00750308|158054130|FG001|Second Treatment|Adverse Event|0|||
49060592|NCT00750308|158054131|FG002|Second Treatment|Adverse Event|0|||
49060593|NCT00750308|158054132|FG003|Second Treatment|Adverse Event|0|||
49060594|NCT00750308|158054133|FG004|Second Treatment|Adverse Event|0|||
49060595|NCT00750308|158054134|FG005|Second Treatment|Adverse Event|1|||
49060596|NCT00750308|158054135|FG006|Second Treatment|Adverse Event|0|||
49060597|NCT00750308|158054136|FG007|Second Treatment|Adverse Event|0|||
49060598|NCT00750308|158054137|FG008|Second Treatment|Adverse Event|1|||
49060599|NCT00750308|158054138|FG009|Second Treatment|Adverse Event|0|||
49060600|NCT00750308|158054139|FG010|Second Treatment|Adverse Event|0|||
49060601|NCT00750308|158054140|FG011|Second Treatment|Adverse Event|0|||
49060602|NCT00750308|158054129|FG000|Second Treatment|Withdrawal by Subject|0|||
49060603|NCT00750308|158054130|FG001|Second Treatment|Withdrawal by Subject|0|||
49060604|NCT00750308|158054131|FG002|Second Treatment|Withdrawal by Subject|0|||
49060605|NCT00750308|158054132|FG003|Second Treatment|Withdrawal by Subject|0|||
49060606|NCT00750308|158054133|FG004|Second Treatment|Withdrawal by Subject|1|||
49060607|NCT00750308|158054134|FG005|Second Treatment|Withdrawal by Subject|0|||
49060608|NCT00750308|158054135|FG006|Second Treatment|Withdrawal by Subject|0|||
49060609|NCT00750308|158054136|FG007|Second Treatment|Withdrawal by Subject|0|||
49060610|NCT00750308|158054137|FG008|Second Treatment|Withdrawal by Subject|0|||
49060611|NCT00750308|158054138|FG009|Second Treatment|Withdrawal by Subject|0|||
49060612|NCT00750308|158054139|FG010|Second Treatment|Withdrawal by Subject|0|||
49060613|NCT00750308|158054140|FG011|Second Treatment|Withdrawal by Subject|0|||
49060614|NCT00750308|158054129|FG000|Third Treatment|Withdrawal by Subject|0|||
49060615|NCT00750308|158054130|FG001|Third Treatment|Withdrawal by Subject|1|||
49060616|NCT00750308|158054131|FG002|Third Treatment|Withdrawal by Subject|0|||
49060617|NCT00750308|158054132|FG003|Third Treatment|Withdrawal by Subject|0|||
49060618|NCT00750308|158054133|FG004|Third Treatment|Withdrawal by Subject|0|||
49060619|NCT00750308|158054134|FG005|Third Treatment|Withdrawal by Subject|0|||
49060620|NCT00750308|158054135|FG006|Third Treatment|Withdrawal by Subject|0|||
49060621|NCT00750308|158054136|FG007|Third Treatment|Withdrawal by Subject|0|||
49060622|NCT00750308|158054137|FG008|Third Treatment|Withdrawal by Subject|0|||
49060623|NCT00750308|158054138|FG009|Third Treatment|Withdrawal by Subject|0|||
49060624|NCT00750308|158054139|FG010|Third Treatment|Withdrawal by Subject|0|||
49060625|NCT00750308|158054140|FG011|Third Treatment|Withdrawal by Subject|0|||
49060626|NCT02149121|158054141|FG000|Main Study Period|Lack of Efficacy|2|||
49060627|NCT02149121|158054142|FG001|Main Study Period|Lack of Efficacy|2|||
49060628|NCT02149121|158054143|FG002|Main Study Period|Lack of Efficacy|1|||
49060629|NCT02149121|158054144|FG003|Main Study Period|Lack of Efficacy|0|||
49060630|NCT02149121|158054145|FG004|Main Study Period|Lack of Efficacy|0|||
49060631|NCT02149121|158054146|FG005|Main Study Period|Lack of Efficacy|0|||
49060632|NCT02149121|158054147|FG006|Main Study Period|Lack of Efficacy|0|||
49060633|NCT02149121|158054141|FG000|Main Study Period|Withdrawal by Subject|9|||
49060634|NCT02149121|158054142|FG001|Main Study Period|Withdrawal by Subject|5|||
49060635|NCT02149121|158054143|FG002|Main Study Period|Withdrawal by Subject|1|||
49060636|NCT02149121|158054144|FG003|Main Study Period|Withdrawal by Subject|0|||
49060637|NCT02149121|158054145|FG004|Main Study Period|Withdrawal by Subject|0|||
49060638|NCT02149121|158054146|FG005|Main Study Period|Withdrawal by Subject|0|||
49060639|NCT02149121|158054147|FG006|Main Study Period|Withdrawal by Subject|0|||
49060640|NCT02149121|158054141|FG000|Main Study Period|Adverse Event|2|||
49060641|NCT02149121|158054142|FG001|Main Study Period|Adverse Event|5|||
49060642|NCT02149121|158054143|FG002|Main Study Period|Adverse Event|1|||
49060643|NCT02149121|158054144|FG003|Main Study Period|Adverse Event|0|||
49060644|NCT02149121|158054145|FG004|Main Study Period|Adverse Event|0|||
49060645|NCT02149121|158054146|FG005|Main Study Period|Adverse Event|0|||
49060646|NCT02149121|158054147|FG006|Main Study Period|Adverse Event|0|||
49060647|NCT02149121|158054141|FG000|Main Study Period|Protocol Violation|2|||
49060648|NCT02149121|158054142|FG001|Main Study Period|Protocol Violation|0|||
49060649|NCT02149121|158054143|FG002|Main Study Period|Protocol Violation|0|||
49060650|NCT02149121|158054144|FG003|Main Study Period|Protocol Violation|0|||
49060651|NCT02149121|158054145|FG004|Main Study Period|Protocol Violation|0|||
49060652|NCT02149121|158054146|FG005|Main Study Period|Protocol Violation|0|||
49060653|NCT02149121|158054147|FG006|Main Study Period|Protocol Violation|0|||
49060654|NCT02149121|158054141|FG000|Main Study Period|Lost to Follow-up|2|||
49060655|NCT02149121|158054142|FG001|Main Study Period|Lost to Follow-up|1|||
49060656|NCT02149121|158054143|FG002|Main Study Period|Lost to Follow-up|0|||
49060657|NCT02149121|158054144|FG003|Main Study Period|Lost to Follow-up|0|||
49060658|NCT02149121|158054145|FG004|Main Study Period|Lost to Follow-up|0|||
49060659|NCT02149121|158054146|FG005|Main Study Period|Lost to Follow-up|0|||
49060660|NCT02149121|158054147|FG006|Main Study Period|Lost to Follow-up|0|||
49060661|NCT02149121|158054141|FG000|Main Study Period|Death|1|||
49060662|NCT02149121|158054142|FG001|Main Study Period|Death|0|||
49060663|NCT02149121|158054143|FG002|Main Study Period|Death|0|||
49060664|NCT02149121|158054144|FG003|Main Study Period|Death|0|||
49060665|NCT02149121|158054145|FG004|Main Study Period|Death|0|||
49060666|NCT02149121|158054146|FG005|Main Study Period|Death|0|||
49060667|NCT02149121|158054147|FG006|Main Study Period|Death|0|||
49060668|NCT02149121|158054141|FG000|Main Study Period|Physician Decision|1|||
49060669|NCT02149121|158054142|FG001|Main Study Period|Physician Decision|0|||
49060670|NCT02149121|158054143|FG002|Main Study Period|Physician Decision|0|||
49060671|NCT02149121|158054144|FG003|Main Study Period|Physician Decision|0|||
49060672|NCT02149121|158054145|FG004|Main Study Period|Physician Decision|0|||
49060673|NCT02149121|158054146|FG005|Main Study Period|Physician Decision|0|||
49060674|NCT02149121|158054147|FG006|Main Study Period|Physician Decision|0|||
49060675|NCT02149121|158054141|FG000|Main Study Period|Developed any malignancy|0|||
49060676|NCT02149121|158054142|FG001|Main Study Period|Developed any malignancy|1|||
49060677|NCT02149121|158054143|FG002|Main Study Period|Developed any malignancy|1|||
49060678|NCT02149121|158054144|FG003|Main Study Period|Developed any malignancy|0|||
49060679|NCT02149121|158054145|FG004|Main Study Period|Developed any malignancy|0|||
49060680|NCT02149121|158054146|FG005|Main Study Period|Developed any malignancy|0|||
49060681|NCT02149121|158054147|FG006|Main Study Period|Developed any malignancy|0|||
49060682|NCT02149121|158054141|FG000|Main Study Period|Unmet predefined eligibility criteria|2|||
49060683|NCT02149121|158054142|FG001|Main Study Period|Unmet predefined eligibility criteria|2|||
49060684|NCT02149121|158054143|FG002|Main Study Period|Unmet predefined eligibility criteria|0|||
49060685|NCT02149121|158054144|FG003|Main Study Period|Unmet predefined eligibility criteria|0|||
49060686|NCT02149121|158054145|FG004|Main Study Period|Unmet predefined eligibility criteria|0|||
49060687|NCT02149121|158054146|FG005|Main Study Period|Unmet predefined eligibility criteria|0|||
49060688|NCT02149121|158054147|FG006|Main Study Period|Unmet predefined eligibility criteria|0|||
49060689|NCT02149121|158054141|FG000|Main Study Period|Disease progression|0|||
49060690|NCT02149121|158054142|FG001|Main Study Period|Disease progression|1|||
49060691|NCT02149121|158054143|FG002|Main Study Period|Disease progression|0|||
49060692|NCT02149121|158054144|FG003|Main Study Period|Disease progression|0|||
49060693|NCT02149121|158054145|FG004|Main Study Period|Disease progression|0|||
49060694|NCT02149121|158054146|FG005|Main Study Period|Disease progression|0|||
49060695|NCT02149121|158054147|FG006|Main Study Period|Disease progression|0|||
49060696|NCT02149121|158054141|FG000|Extension Study Period|Withdrawal by Subject|0|||
49060697|NCT02149121|158054142|FG001|Extension Study Period|Withdrawal by Subject|0|||
49060698|NCT02149121|158054143|FG002|Extension Study Period|Withdrawal by Subject|0|||
49060699|NCT02149121|158054144|FG003|Extension Study Period|Withdrawal by Subject|1|||
49060700|NCT02149121|158054145|FG004|Extension Study Period|Withdrawal by Subject|0|||
49060701|NCT02149121|158054146|FG005|Extension Study Period|Withdrawal by Subject|2|||
49060702|NCT02149121|158054147|FG006|Extension Study Period|Withdrawal by Subject|0|||
49060703|NCT00851643|158054150|FG000|Base Study (Up to 12 Months)|Withdrawal by Subject|1|||
49060704|NCT00851643|158054151|FG001|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
49060705|NCT00851643|158054152|FG002|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
49060706|NCT00851643|158054153|FG003|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
49060707|NCT00851643|158054154|FG004|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
49060708|NCT00851643|158054155|FG005|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
49060709|NCT00851643|158054150|FG000|Base Study (Up to 12 Months)|Other|0|||
49060710|NCT00851643|158054151|FG001|Base Study (Up to 12 Months)|Other|0|||
49060711|NCT00851643|158054152|FG002|Base Study (Up to 12 Months)|Other|0|||
49060712|NCT00851643|158054153|FG003|Base Study (Up to 12 Months)|Other|0|||
49060713|NCT00851643|158054154|FG004|Base Study (Up to 12 Months)|Other|0|||
49060714|NCT00851643|158054155|FG005|Base Study (Up to 12 Months)|Other|1|||
49060715|NCT00851643|158054150|FG000|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
49060716|NCT00851643|158054151|FG001|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
49060717|NCT00851643|158054152|FG002|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
49060718|NCT00851643|158054153|FG003|Extension Study (Up to 36 Months)|Lost to Follow-up|1|||
49060719|NCT00851643|158054154|FG004|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
49060720|NCT00851643|158054155|FG005|Extension Study (Up to 36 Months)|Lost to Follow-up|0|||
49060721|NCT00851643|158054150|FG000|Extension Study (Up to 36 Months)|Moved|0|||
49060722|NCT00851643|158054151|FG001|Extension Study (Up to 36 Months)|Moved|2|||
49060723|NCT00851643|158054152|FG002|Extension Study (Up to 36 Months)|Moved|1|||
49060724|NCT00851643|158054153|FG003|Extension Study (Up to 36 Months)|Moved|1|||
49060725|NCT00851643|158054154|FG004|Extension Study (Up to 36 Months)|Moved|0|||
49060726|NCT00851643|158054155|FG005|Extension Study (Up to 36 Months)|Moved|1|||
49060727|NCT01568866|158054156|FG000|Overall Study|Disease Progression|208|||
49060728|NCT01568866|158054157|FG001|Overall Study|Disease Progression|183|||
49060729|NCT01568866|158054156|FG000|Overall Study|Adverse Event|94|||
49060730|NCT01568866|158054157|FG001|Overall Study|Adverse Event|96|||
49060731|NCT01568866|158054156|FG000|Overall Study|Patient Request|55|||
49060732|NCT01568866|158054157|FG001|Overall Study|Patient Request|71|||
49060733|NCT01568866|158054156|FG000|Overall Study|Physician Decision|40|||
49060734|NCT01568866|158054157|FG001|Overall Study|Physician Decision|32|||
49060735|NCT01568866|158054156|FG000|Overall Study|Withdrawal by Subject|19|||
49060736|NCT01568866|158054157|FG001|Overall Study|Withdrawal by Subject|11|||
49060737|NCT01568866|158054156|FG000|Overall Study|Death|10|||
49060738|NCT01568866|158054157|FG001|Overall Study|Death|18|||
49060739|NCT01568866|158054156|FG000|Overall Study|Protocol Non-compliance|2|||
49060740|NCT01568866|158054157|FG001|Overall Study|Protocol Non-compliance|4|||
49060741|NCT01568866|158054156|FG000|Overall Study|Lost to Follow-up|1|||
49060742|NCT01568866|158054157|FG001|Overall Study|Lost to Follow-up|0|||
49060743|NCT01568866|158054156|FG000|Overall Study|Randomized but Not Dosed|9|||
49060744|NCT01568866|158054157|FG001|Overall Study|Randomized but Not Dosed|1|||
49060745|NCT00359788|158054160|FG000|Overall Study|Adverse Event|11|||
49060746|NCT00359788|158054161|FG001|Overall Study|Adverse Event|10|||
49060747|NCT00359788|158054160|FG000|Overall Study|Lack of Efficacy|1|||
49060748|NCT00359788|158054161|FG001|Overall Study|Lack of Efficacy|2|||
49060749|NCT00359788|158054160|FG000|Overall Study|Lost to Follow-up|3|||
49060750|NCT00359788|158054161|FG001|Overall Study|Lost to Follow-up|2|||
49060751|NCT00359788|158054160|FG000|Overall Study|Withdrawal by Subject|4|||
49060752|NCT00359788|158054161|FG001|Overall Study|Withdrawal by Subject|1|||
49060753|NCT00359788|158054160|FG000|Overall Study|Protocol Violation|4|||
49060754|NCT00359788|158054161|FG001|Overall Study|Protocol Violation|2|||
49060755|NCT00673933|158054162|FG000|Overall Study|Withdrawal by Subject|2|||
49060756|NCT00673933|158054162|FG000|Overall Study|Lost to Follow-up|1|||
49060757|NCT04156620|158054165|FG000|Overall Study|Adverse event - TP 1|5|||
49060758|NCT04156620|158054166|FG001|Overall Study|Adverse event - TP 1|2|||
49060759|NCT04156620|158054165|FG000|Overall Study|Lost to follow-up TP 1|1|||
49060760|NCT04156620|158054166|FG001|Overall Study|Lost to follow-up TP 1|1|||
49060761|NCT04156620|158054165|FG000|Overall Study|Progressive disease - TP 1|0|||
49060762|NCT04156620|158054166|FG001|Overall Study|Progressive disease - TP 1|1|||
49060763|NCT04156620|158054165|FG000|Overall Study|Subject decision - TP 1|3|||
49060764|NCT04156620|158054166|FG001|Overall Study|Subject decision - TP 1|5|||
49060765|NCT04156620|158054165|FG000|Overall Study|Adverse event - TP 2|5|||
49060766|NCT04156620|158054166|FG001|Overall Study|Adverse event - TP 2|6|||
49060767|NCT04156620|158054165|FG000|Overall Study|Death - TP 2|1|||
49060768|NCT04156620|158054166|FG001|Overall Study|Death - TP 2|0|||
49060769|NCT04156620|158054165|FG000|Overall Study|Lost to follow-up - TP 2|5|||
49060770|NCT04156620|158054166|FG001|Overall Study|Lost to follow-up - TP 2|2|||
49060771|NCT04156620|158054165|FG000|Overall Study|Physician decision - TP 2|4|||
49060772|NCT04156620|158054166|FG001|Overall Study|Physician decision - TP 2|2|||
49060773|NCT04156620|158054165|FG000|Overall Study|Pregnancy - TP 2|1|||
49060774|NCT04156620|158054166|FG001|Overall Study|Pregnancy - TP 2|1|||
49060775|NCT04156620|158054165|FG000|Overall Study|Subject decision - TP 2|11|||
49060776|NCT04156620|158054166|FG001|Overall Study|Subject decision - TP 2|9|||
49060777|NCT04156620|158054165|FG000|Overall Study|New therapy for study indication - TP 2|1|||
49060778|NCT04156620|158054166|FG001|Overall Study|New therapy for study indication - TP 2|0|||
49060779|NCT01929031|158054167|FG000|Overall Study|Adverse Event|3|||
49060780|NCT01929031|158054168|FG001|Overall Study|Adverse Event|1|||
49060781|NCT01929031|158054169|FG002|Overall Study|Adverse Event|1|||
49060782|NCT01929031|158054170|FG003|Overall Study|Adverse Event|0|||
49060783|NCT01929031|158054171|FG004|Overall Study|Adverse Event|0|||
49060784|NCT01929031|158054172|FG005|Overall Study|Adverse Event|0|||
49060785|NCT01929031|158054167|FG000|Overall Study|Protocol Violation|1|||
49060786|NCT01929031|158054168|FG001|Overall Study|Protocol Violation|0|||
49060787|NCT01929031|158054169|FG002|Overall Study|Protocol Violation|0|||
49060788|NCT01929031|158054170|FG003|Overall Study|Protocol Violation|0|||
49060789|NCT01929031|158054171|FG004|Overall Study|Protocol Violation|0|||
49060790|NCT01929031|158054172|FG005|Overall Study|Protocol Violation|1|||
49060791|NCT01929031|158054167|FG000|Overall Study|Reason other than specified above|0|||
49060792|NCT01929031|158054168|FG001|Overall Study|Reason other than specified above|1|||
49060793|NCT01929031|158054169|FG002|Overall Study|Reason other than specified above|0|||
49060794|NCT01929031|158054170|FG003|Overall Study|Reason other than specified above|0|||
49060795|NCT01929031|158054171|FG004|Overall Study|Reason other than specified above|1|||
49060796|NCT01929031|158054172|FG005|Overall Study|Reason other than specified above|0|||
49060797|NCT00389831|158054173|FG000|Overall Study|Lack of Efficacy|0|||
49060798|NCT00389831|158054174|FG001|Overall Study|Lack of Efficacy|2|||
49060799|NCT00389831|158054173|FG000|Overall Study|Did not receive treatment.|0|||
49060800|NCT00389831|158054174|FG001|Overall Study|Did not receive treatment.|2|||
49060801|NCT00389831|158054173|FG000|Overall Study|Other reasons|0|||
49060802|NCT00389831|158054174|FG001|Overall Study|Other reasons|2|||
49060803|NCT00389831|158054173|FG000|Overall Study|Lost to Follow-up|0|||
49060804|NCT00389831|158054174|FG001|Overall Study|Lost to Follow-up|1|||
49060805|NCT01970865|158054175|FG000|Overall Study|Death|3|||
49060806|NCT01970865|158054176|FG001|Overall Study|Death|2|||
49060807|NCT01970865|158054177|FG002|Overall Study|Death|3|||
49060808|NCT01970865|158054178|FG003|Overall Study|Death|6|||
49060809|NCT01970865|158054179|FG004|Overall Study|Death|9|||
49060810|NCT01970865|158054180|FG005|Overall Study|Death|3|||
49060811|NCT01970865|158054181|FG006|Overall Study|Death|2|||
49060812|NCT01970865|158054182|FG007|Overall Study|Death|3|||
49060813|NCT01970865|158054183|FG008|Overall Study|Death|2|||
49060814|NCT01970865|158054184|FG009|Overall Study|Death|2|||
49060815|NCT01970865|158054185|FG010|Overall Study|Death|8|||
49060816|NCT01970865|158054186|FG011|Overall Study|Death|13|||
49060817|NCT01970865|158054187|FG012|Overall Study|Death|25|||
49060818|NCT01970865|158054188|FG013|Overall Study|Death|46|||
49060819|NCT01970865|158054189|FG014|Overall Study|Death|37|||
49060820|NCT01970865|158054190|FG015|Overall Study|Death|22|||
49060821|NCT01970865|158054191|FG016|Overall Study|Death|1|||
49060822|NCT01970865|158054192|FG017|Overall Study|Death|17|||
49060823|NCT01970865|158054175|FG000|Overall Study|Lost to Follow-up|0|||
49060824|NCT01970865|158054176|FG001|Overall Study|Lost to Follow-up|0|||
49060825|NCT01970865|158054177|FG002|Overall Study|Lost to Follow-up|0|||
49060826|NCT01970865|158054178|FG003|Overall Study|Lost to Follow-up|1|||
49060827|NCT01970865|158054179|FG004|Overall Study|Lost to Follow-up|1|||
49060828|NCT01970865|158054180|FG005|Overall Study|Lost to Follow-up|0|||
49060829|NCT01970865|158054181|FG006|Overall Study|Lost to Follow-up|0|||
49060830|NCT01970865|158054182|FG007|Overall Study|Lost to Follow-up|0|||
49060831|NCT01970865|158054183|FG008|Overall Study|Lost to Follow-up|0|||
49060832|NCT01970865|158054184|FG009|Overall Study|Lost to Follow-up|0|||
49060833|NCT01970865|158054185|FG010|Overall Study|Lost to Follow-up|1|||
49060834|NCT01970865|158054186|FG011|Overall Study|Lost to Follow-up|0|||
49060835|NCT01970865|158054187|FG012|Overall Study|Lost to Follow-up|2|||
49060836|NCT01970865|158054188|FG013|Overall Study|Lost to Follow-up|0|||
49060837|NCT01970865|158054189|FG014|Overall Study|Lost to Follow-up|1|||
49060838|NCT01970865|158054190|FG015|Overall Study|Lost to Follow-up|4|||
49060839|NCT01970865|158054191|FG016|Overall Study|Lost to Follow-up|0|||
49060840|NCT01970865|158054192|FG017|Overall Study|Lost to Follow-up|1|||
49060841|NCT01970865|158054175|FG000|Overall Study|Other|0|||
49060842|NCT01970865|158054176|FG001|Overall Study|Other|1|||
49060843|NCT01970865|158054177|FG002|Overall Study|Other|0|||
49060844|NCT01970865|158054178|FG003|Overall Study|Other|1|||
49060845|NCT01970865|158054179|FG004|Overall Study|Other|1|||
49060846|NCT01970865|158054180|FG005|Overall Study|Other|0|||
49060847|NCT01970865|158054181|FG006|Overall Study|Other|1|||
49060848|NCT01970865|158054182|FG007|Overall Study|Other|0|||
49060849|NCT01970865|158054183|FG008|Overall Study|Other|0|||
49060850|NCT01970865|158054184|FG009|Overall Study|Other|0|||
49060851|NCT01970865|158054185|FG010|Overall Study|Other|2|||
49060852|NCT01970865|158054186|FG011|Overall Study|Other|3|||
49060853|NCT01970865|158054187|FG012|Overall Study|Other|8|||
49060854|NCT01970865|158054188|FG013|Overall Study|Other|3|||
49060855|NCT01970865|158054189|FG014|Overall Study|Other|2|||
49060856|NCT01970865|158054190|FG015|Overall Study|Other|3|||
49060857|NCT01970865|158054191|FG016|Overall Study|Other|0|||
49060858|NCT01970865|158054192|FG017|Overall Study|Other|2|||
49060859|NCT01970865|158054175|FG000|Overall Study|Participant refused further follow-up|0|||
49060860|NCT01970865|158054176|FG001|Overall Study|Participant refused further follow-up|0|||
49060861|NCT01970865|158054177|FG002|Overall Study|Participant refused further follow-up|0|||
49060862|NCT01970865|158054178|FG003|Overall Study|Participant refused further follow-up|2|||
49060863|NCT01970865|158054179|FG004|Overall Study|Participant refused further follow-up|3|||
49060864|NCT01970865|158054180|FG005|Overall Study|Participant refused further follow-up|0|||
49060865|NCT01970865|158054181|FG006|Overall Study|Participant refused further follow-up|0|||
49060866|NCT01970865|158054182|FG007|Overall Study|Participant refused further follow-up|0|||
49060867|NCT01970865|158054183|FG008|Overall Study|Participant refused further follow-up|0|||
49060868|NCT01970865|158054184|FG009|Overall Study|Participant refused further follow-up|0|||
49060869|NCT01970865|158054185|FG010|Overall Study|Participant refused further follow-up|1|||
49060870|NCT01970865|158054186|FG011|Overall Study|Participant refused further follow-up|4|||
49060871|NCT01970865|158054187|FG012|Overall Study|Participant refused further follow-up|7|||
49060872|NCT01970865|158054188|FG013|Overall Study|Participant refused further follow-up|8|||
49060873|NCT01970865|158054189|FG014|Overall Study|Participant refused further follow-up|3|||
49060874|NCT01970865|158054190|FG015|Overall Study|Participant refused further follow-up|11|||
49060875|NCT01970865|158054191|FG016|Overall Study|Participant refused further follow-up|0|||
49060876|NCT01970865|158054192|FG017|Overall Study|Participant refused further follow-up|6|||
49060877|NCT04135196|158054193|FG000|Overall Study|Lost to Follow-up|8|||
49060878|NCT04135196|158054194|FG001|Overall Study|Lost to Follow-up|7|||
49060879|NCT04135196|158054195|FG002|Overall Study|Lost to Follow-up|8|||
49060880|NCT04135196|158054196|FG003|Overall Study|Lost to Follow-up|9|||
49060881|NCT04135196|158054197|FG004|Overall Study|Lost to Follow-up|1|||
49060882|NCT04135196|158054193|FG000|Overall Study|Pregnancy|0|||
49060883|NCT04135196|158054194|FG001|Overall Study|Pregnancy|0|||
49060884|NCT04135196|158054195|FG002|Overall Study|Pregnancy|1|||
49060885|NCT04135196|158054196|FG003|Overall Study|Pregnancy|0|||
49060886|NCT04135196|158054197|FG004|Overall Study|Pregnancy|0|||
49060887|NCT04135196|158054193|FG000|Overall Study|Withdrawal by Subject|0|||
49060888|NCT04135196|158054194|FG001|Overall Study|Withdrawal by Subject|0|||
49060889|NCT04135196|158054195|FG002|Overall Study|Withdrawal by Subject|0|||
49060890|NCT04135196|158054196|FG003|Overall Study|Withdrawal by Subject|0|||
49060891|NCT04135196|158054197|FG004|Overall Study|Withdrawal by Subject|1|||
49060892|NCT03212521|158054200|FG000|Overall Study|Adverse Event|1|||
49060893|NCT03212521|158054200|FG000|Overall Study|Lost to Follow-up|4|||
49060894|NCT03212521|158054200|FG000|Overall Study|Withdrawal by Subject|1|||
49060895|NCT03212521|158054200|FG000|Overall Study|Other|1|||
49060896|NCT01111019|158054202|FG000|Overall Study|Withdrew Prematurely|2|||
49060897|NCT01111019|158054202|FG000|Overall Study|Other|1|||
49060898|NCT01583218|158054205|FG000|Overall Study|Withdrawal by Subject|43|||
49060899|NCT01583218|158054206|FG001|Overall Study|Withdrawal by Subject|29|||
49060900|NCT01583218|158054205|FG000|Overall Study|Death|206|||
49060901|NCT01583218|158054206|FG001|Overall Study|Death|211|||
49060902|NCT01583218|158054205|FG000|Overall Study|Lost to Follow-up|11|||
49060903|NCT01583218|158054206|FG001|Overall Study|Lost to Follow-up|17|||
49060904|NCT01583218|158054205|FG000|Overall Study|Adverse event or serious adverse event|3|||
49060905|NCT01583218|158054206|FG001|Overall Study|Adverse event or serious adverse event|3|||
49060906|NCT01583218|158054205|FG000|Overall Study|Patient /Family decision|3|||
49060907|NCT01583218|158054206|FG001|Overall Study|Patient /Family decision|0|||
49060908|NCT01583218|158054205|FG000|Overall Study|Cannot contact patient directly|1|||
49060909|NCT01583218|158054206|FG001|Overall Study|Cannot contact patient directly|2|||
49060910|NCT01583218|158054205|FG000|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0|||
49060911|NCT01583218|158054206|FG001|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2|||
49060912|NCT01583218|158054205|FG000|Overall Study|Patient did not wish to attend visits|0|||
49060913|NCT01583218|158054206|FG001|Overall Study|Patient did not wish to attend visits|1|||
49060914|NCT01583218|158054205|FG000|Overall Study|Patient randomized but not dosed|17|||
49060915|NCT01583218|158054206|FG001|Overall Study|Patient randomized but not dosed|16|||
49060916|NCT01583218|158054205|FG000|Overall Study|Patient was assessed via phone in person|1|||
49060917|NCT01583218|158054206|FG001|Overall Study|Patient was assessed via phone in person|0|||
49060918|NCT01583218|158054205|FG000|Overall Study|Patient deemed ineligible after random|2|||
49060919|NCT01583218|158054206|FG001|Overall Study|Patient deemed ineligible after random|0|||
49060920|NCT01583218|158054205|FG000|Overall Study|Patient was early terminated from study|0|||
49060921|NCT01583218|158054206|FG001|Overall Study|Patient was early terminated from study|1|||
49060922|NCT01583218|158054205|FG000|Overall Study|Patient was randomized due to mistake|1|||
49060923|NCT01583218|158054206|FG001|Overall Study|Patient was randomized due to mistake|0|||
49060924|NCT01583218|158054205|FG000|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0|||
49060925|NCT01583218|158054206|FG001|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1|||
49060926|NCT01583218|158054205|FG000|Overall Study|Withdraw of consent on day of random|1|||
49060927|NCT01583218|158054206|FG001|Overall Study|Withdraw of consent on day of random|0|||
49060928|NCT02435836|158054208|FG000|Overall Study|Lost to Follow-up|21|||
49060929|NCT02435836|158054208|FG000|Overall Study|Lack of Efficacy|1|||
49060930|NCT02435836|158054208|FG000|Overall Study|Withdrawal by Subject|236|||
49060931|NCT02435836|158054208|FG000|Overall Study|Insufficient Clinical Response|26|||
49060932|NCT02435836|158054208|FG000|Overall Study|Adverse Event|44|||
49060933|NCT02435836|158054208|FG000|Overall Study|Sponsor discontinued trial|167|||
49060934|NCT02435836|158054208|FG000|Overall Study|Noncompliance|27|||
49060935|NCT02435836|158054208|FG000|Overall Study|Protocol Violation|6|||
49060936|NCT02435836|158054208|FG000|Overall Study|Met Withdrawal Criteria|7|||
49060937|NCT02435836|158054208|FG000|Overall Study|AE of Worsening Schizophrenia|96|||
49060938|NCT01661179|158054211|FG000|Overall Study|Death|1|||
49060939|NCT01661179|158054211|FG000|Overall Study|Withdrawal by Subject|1|||
49060940|NCT01661179|158054211|FG000|Overall Study|Other Eligibility criteria|4|||
49060941|NCT00914459|158054212|FG000|Overall Study|Protocol Violation|0|||
49060942|NCT00914459|158054213|FG001|Overall Study|Protocol Violation|1|||
49060943|NCT00914459|158054212|FG000|Overall Study|Parent/Legal guardian request|1|||
49060944|NCT00914459|158054213|FG001|Overall Study|Parent/Legal guardian request|0|||
49060945|NCT00809159|158054214|FG000|Part 1|Adverse Event|1|||
49060946|NCT00809159|158054215|FG001|Part 1|Adverse Event|1|||
49060947|NCT00809159|158054216|FG002|Part 1|Adverse Event|0|||
49060948|NCT00809159|158054217|FG003|Part 1|Adverse Event|0|||
49060949|NCT00809159|158054218|FG004|Part 1|Adverse Event|0|||
49060950|NCT00809159|158054219|FG005|Part 1|Adverse Event|0|||
49060951|NCT00809159|158054214|FG000|Part 1|Lost to Follow-up|1|||
49060952|NCT00809159|158054215|FG001|Part 1|Lost to Follow-up|0|||
49060953|NCT00809159|158054216|FG002|Part 1|Lost to Follow-up|0|||
49060954|NCT00809159|158054217|FG003|Part 1|Lost to Follow-up|0|||
49060955|NCT00809159|158054218|FG004|Part 1|Lost to Follow-up|0|||
49060956|NCT00809159|158054219|FG005|Part 1|Lost to Follow-up|0|||
49060957|NCT00809159|158054214|FG000|Part 1|Withdrawal by Subject|3|||
49060958|NCT00809159|158054215|FG001|Part 1|Withdrawal by Subject|1|||
49060959|NCT00809159|158054216|FG002|Part 1|Withdrawal by Subject|0|||
49060960|NCT00809159|158054217|FG003|Part 1|Withdrawal by Subject|0|||
49060961|NCT00809159|158054218|FG004|Part 1|Withdrawal by Subject|0|||
49060962|NCT00809159|158054219|FG005|Part 1|Withdrawal by Subject|0|||
49060963|NCT00809159|158054214|FG000|Part 1|Unsatisfactory therapeutic effect|3|||
49060964|NCT00809159|158054215|FG001|Part 1|Unsatisfactory therapeutic effect|1|||
49060965|NCT00809159|158054216|FG002|Part 1|Unsatisfactory therapeutic effect|0|||
49060966|NCT00809159|158054217|FG003|Part 1|Unsatisfactory therapeutic effect|0|||
49060967|NCT00809159|158054218|FG004|Part 1|Unsatisfactory therapeutic effect|0|||
49060968|NCT00809159|158054219|FG005|Part 1|Unsatisfactory therapeutic effect|0|||
49060969|NCT00809159|158054214|FG000|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
49060970|NCT00809159|158054215|FG001|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
49060971|NCT00809159|158054216|FG002|Part 1 and 2|Unsatisfactory therapeutic effect|4|||
49060972|NCT00809159|158054217|FG003|Part 1 and 2|Unsatisfactory therapeutic effect|3|||
49060973|NCT00809159|158054218|FG004|Part 1 and 2|Unsatisfactory therapeutic effect|5|||
49060974|NCT00809159|158054219|FG005|Part 1 and 2|Unsatisfactory therapeutic effect|1|||
49060975|NCT00809159|158054214|FG000|Part 1 and 2|Administrative problems|0|||
49060976|NCT00809159|158054215|FG001|Part 1 and 2|Administrative problems|0|||
49060977|NCT00809159|158054216|FG002|Part 1 and 2|Administrative problems|0|||
49060978|NCT00809159|158054217|FG003|Part 1 and 2|Administrative problems|1|||
49060979|NCT00809159|158054218|FG004|Part 1 and 2|Administrative problems|0|||
49060980|NCT00809159|158054219|FG005|Part 1 and 2|Administrative problems|0|||
49060981|NCT00809159|158054214|FG000|Part 1 and 2|Adverse Event|0|||
49060982|NCT00809159|158054215|FG001|Part 1 and 2|Adverse Event|0|||
49060983|NCT00809159|158054216|FG002|Part 1 and 2|Adverse Event|1|||
49060984|NCT00809159|158054217|FG003|Part 1 and 2|Adverse Event|0|||
49060985|NCT00809159|158054218|FG004|Part 1 and 2|Adverse Event|1|||
49060986|NCT00809159|158054219|FG005|Part 1 and 2|Adverse Event|1|||
49060987|NCT00809159|158054214|FG000|Part 1 and 2|Lost to Follow-up|0|||
49060988|NCT00809159|158054215|FG001|Part 1 and 2|Lost to Follow-up|0|||
49060989|NCT00809159|158054216|FG002|Part 1 and 2|Lost to Follow-up|1|||
49060990|NCT00809159|158054217|FG003|Part 1 and 2|Lost to Follow-up|1|||
49060991|NCT00809159|158054218|FG004|Part 1 and 2|Lost to Follow-up|0|||
49060992|NCT00809159|158054219|FG005|Part 1 and 2|Lost to Follow-up|0|||
49060993|NCT00809159|158054214|FG000|Part 1 and 2|Withdrawal by Subject|0|||
49060994|NCT00809159|158054215|FG001|Part 1 and 2|Withdrawal by Subject|0|||
49060995|NCT00809159|158054216|FG002|Part 1 and 2|Withdrawal by Subject|4|||
49060996|NCT00809159|158054217|FG003|Part 1 and 2|Withdrawal by Subject|0|||
49060997|NCT00809159|158054218|FG004|Part 1 and 2|Withdrawal by Subject|0|||
49060998|NCT00809159|158054219|FG005|Part 1 and 2|Withdrawal by Subject|1|||
49060999|NCT03176459|158054220|FG000|Overall Study|Lost to Follow-up|5|||
49061000|NCT03176459|158054221|FG001|Overall Study|Lost to Follow-up|7|||
49061001|NCT03512262|158054222|FG000|Overall Study|Adverse Event|8|||
49061002|NCT03512262|158054223|FG001|Overall Study|Adverse Event|3|||
49061003|NCT03512262|158054222|FG000|Overall Study|Death (non-treatment emergent)|1|||
49061004|NCT03512262|158054223|FG001|Overall Study|Death (non-treatment emergent)|0|||
49061005|NCT03512262|158054222|FG000|Overall Study|Withdrawal by Subject|17|||
49061006|NCT03512262|158054223|FG001|Overall Study|Withdrawal by Subject|9|||
49061007|NCT03512262|158054222|FG000|Overall Study|Lost to Follow-up|7|||
49061008|NCT03512262|158054223|FG001|Overall Study|Lost to Follow-up|1|||
49061009|NCT03512262|158054222|FG000|Overall Study|Other than Specified|2|||
49061010|NCT03512262|158054223|FG001|Overall Study|Other than Specified|2|||
49061011|NCT00712985|158054230|FG000|Overall Study|1 withdrew prior to start of drug|1|||
49061012|NCT00712985|158054230|FG000|Overall Study|1 patient moved out of state|1|||
49061013|NCT00712985|158054230|FG000|Overall Study|Lack of Efficacy|3|||
49061014|NCT03201211|158054235|FG000|Overall Study|Adverse Event|1|||
49061015|NCT03201211|158054236|FG001|Overall Study|Adverse Event|0|||
49061016|NCT03201211|158054237|FG002|Overall Study|Adverse Event|0|||
49061017|NCT03201211|158054235|FG000|Overall Study|Protocol Violation|1|||
49061018|NCT03201211|158054236|FG001|Overall Study|Protocol Violation|0|||
49061019|NCT03201211|158054237|FG002|Overall Study|Protocol Violation|0|||
49061020|NCT03201211|158054235|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
49061021|NCT03201211|158054236|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
49061022|NCT03201211|158054237|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
49061023|NCT03201211|158054235|FG000|Overall Study|OTHER unknown reasons|0|||
49061024|NCT03201211|158054236|FG001|Overall Study|OTHER unknown reasons|1|||
49061025|NCT03201211|158054237|FG002|Overall Study|OTHER unknown reasons|0|||
49061026|NCT02674061|158054240|FG000|Overall Study|Death|229|||
49061027|NCT02674061|158054241|FG001|Overall Study|Death|77|||
49061028|NCT02674061|158054240|FG000|Overall Study|Lost to Follow-up|3|||
49061029|NCT02674061|158054241|FG001|Overall Study|Lost to Follow-up|3|||
49061030|NCT02674061|158054240|FG000|Overall Study|Withdrawal by Subject|9|||
49061031|NCT02674061|158054241|FG001|Overall Study|Withdrawal by Subject|1|||
49061032|NCT02674061|158054240|FG000|Overall Study|Participation in Study Discontinued by Sponsor|44|||
49061033|NCT02674061|158054241|FG001|Overall Study|Participation in Study Discontinued by Sponsor|10|||
49061034|NCT01299805|158054242|FG000|Overall Study|Adverse Event|2|||
49061035|NCT01299805|158054243|FG001|Overall Study|Adverse Event|0|||
49099004|NCT02419612|158197016|FG001|Short-term Treatment Period|Withdrawal by Subject|9|||
49099005|NCT02419612|158197015|FG000|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
49099006|NCT02419612|158197016|FG001|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
49099007|NCT02419612|158197015|FG000|Short-term Treatment Period|Non-compliance with Study Drug|0|||
49099008|NCT02419612|158197016|FG001|Short-term Treatment Period|Non-compliance with Study Drug|2|||
49061036|NCT04146363|158055747|FG000|Induction Period|Adverse Event|1|||
49061037|NCT04146363|158055748|FG001|Induction Period|Adverse Event|2|||
49061038|NCT04146363|158055749|FG002|Induction Period|Adverse Event|0|||
49061039|NCT04146363|158055750|FG003|Induction Period|Adverse Event|0|||
49061040|NCT04146363|158055751|FG004|Induction Period|Adverse Event|0|||
49061041|NCT04146363|158055752|FG005|Induction Period|Adverse Event|0|||
49061042|NCT04146363|158055753|FG006|Induction Period|Adverse Event|0|||
49061043|NCT04146363|158055754|FG007|Induction Period|Adverse Event|0|||
49061044|NCT04146363|158055755|FG008|Induction Period|Adverse Event|0|||
49061045|NCT04146363|158055756|FG009|Induction Period|Adverse Event|0|||
49061046|NCT04146363|158055757|FG010|Induction Period|Adverse Event|0|||
49061047|NCT04146363|158055747|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
49061048|NCT04146363|158055748|FG001|Induction Period|Due to Epidemic/Pandemic|2|||
49061049|NCT04146363|158055749|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
49061050|NCT04146363|158055750|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
49061051|NCT04146363|158055751|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
49061052|NCT04146363|158055752|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
49061053|NCT04146363|158055753|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
49061054|NCT04146363|158055754|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
49061055|NCT04146363|158055755|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
49061056|NCT04146363|158055756|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
49061057|NCT04146363|158055757|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
49061058|NCT04146363|158055747|FG000|Induction Period|Lack of Efficacy|7|||
49061059|NCT04146363|158055748|FG001|Induction Period|Lack of Efficacy|2|||
49061060|NCT04146363|158055749|FG002|Induction Period|Lack of Efficacy|0|||
49061061|NCT04146363|158055750|FG003|Induction Period|Lack of Efficacy|0|||
49061062|NCT04146363|158055751|FG004|Induction Period|Lack of Efficacy|0|||
49061063|NCT04146363|158055752|FG005|Induction Period|Lack of Efficacy|0|||
49061064|NCT04146363|158055753|FG006|Induction Period|Lack of Efficacy|0|||
49061065|NCT04146363|158055754|FG007|Induction Period|Lack of Efficacy|0|||
49061066|NCT04146363|158055755|FG008|Induction Period|Lack of Efficacy|0|||
49061067|NCT04146363|158055756|FG009|Induction Period|Lack of Efficacy|0|||
49061068|NCT04146363|158055757|FG010|Induction Period|Lack of Efficacy|0|||
49061069|NCT04146363|158055747|FG000|Induction Period|Lost to Follow-up|1|||
49061070|NCT04146363|158055748|FG001|Induction Period|Lost to Follow-up|4|||
49061071|NCT04146363|158055749|FG002|Induction Period|Lost to Follow-up|0|||
49061072|NCT04146363|158055750|FG003|Induction Period|Lost to Follow-up|0|||
49061073|NCT04146363|158055751|FG004|Induction Period|Lost to Follow-up|0|||
49061074|NCT04146363|158055752|FG005|Induction Period|Lost to Follow-up|0|||
49061075|NCT04146363|158055753|FG006|Induction Period|Lost to Follow-up|0|||
49061076|NCT04146363|158055754|FG007|Induction Period|Lost to Follow-up|0|||
49061077|NCT04146363|158055755|FG008|Induction Period|Lost to Follow-up|0|||
49061078|NCT04146363|158055756|FG009|Induction Period|Lost to Follow-up|0|||
49061079|NCT04146363|158055757|FG010|Induction Period|Lost to Follow-up|0|||
49061080|NCT04146363|158055747|FG000|Induction Period|Positive quantiferon test|0|||
49061081|NCT04146363|158055748|FG001|Induction Period|Positive quantiferon test|1|||
49061082|NCT04146363|158055749|FG002|Induction Period|Positive quantiferon test|0|||
49061083|NCT04146363|158055750|FG003|Induction Period|Positive quantiferon test|0|||
49061084|NCT04146363|158055751|FG004|Induction Period|Positive quantiferon test|0|||
49061085|NCT04146363|158055752|FG005|Induction Period|Positive quantiferon test|0|||
49061086|NCT04146363|158055753|FG006|Induction Period|Positive quantiferon test|0|||
49061087|NCT04146363|158055754|FG007|Induction Period|Positive quantiferon test|0|||
49061088|NCT04146363|158055755|FG008|Induction Period|Positive quantiferon test|0|||
49061089|NCT04146363|158055756|FG009|Induction Period|Positive quantiferon test|0|||
49061090|NCT04146363|158055757|FG010|Induction Period|Positive quantiferon test|0|||
49061091|NCT04146363|158055747|FG000|Induction Period|Protocol Deviation|5|||
49061092|NCT04146363|158055748|FG001|Induction Period|Protocol Deviation|6|||
49061093|NCT04146363|158055749|FG002|Induction Period|Protocol Deviation|0|||
49061094|NCT04146363|158055750|FG003|Induction Period|Protocol Deviation|0|||
49061095|NCT04146363|158055751|FG004|Induction Period|Protocol Deviation|0|||
49061096|NCT04146363|158055752|FG005|Induction Period|Protocol Deviation|0|||
49061097|NCT04146363|158055753|FG006|Induction Period|Protocol Deviation|0|||
49061098|NCT04146363|158055754|FG007|Induction Period|Protocol Deviation|0|||
49061099|NCT04146363|158055755|FG008|Induction Period|Protocol Deviation|0|||
49061100|NCT04146363|158055756|FG009|Induction Period|Protocol Deviation|0|||
49061101|NCT04146363|158055757|FG010|Induction Period|Protocol Deviation|0|||
49061102|NCT04146363|158055747|FG000|Induction Period|Withdrawal by Subject|6|||
49061103|NCT04146363|158055748|FG001|Induction Period|Withdrawal by Subject|3|||
49061104|NCT04146363|158055749|FG002|Induction Period|Withdrawal by Subject|0|||
49061105|NCT04146363|158055750|FG003|Induction Period|Withdrawal by Subject|0|||
49061106|NCT04146363|158055751|FG004|Induction Period|Withdrawal by Subject|0|||
49061107|NCT04146363|158055752|FG005|Induction Period|Withdrawal by Subject|0|||
49061108|NCT04146363|158055753|FG006|Induction Period|Withdrawal by Subject|0|||
49061109|NCT04146363|158055754|FG007|Induction Period|Withdrawal by Subject|0|||
49061110|NCT04146363|158055755|FG008|Induction Period|Withdrawal by Subject|0|||
49061111|NCT04146363|158055756|FG009|Induction Period|Withdrawal by Subject|0|||
49061112|NCT04146363|158055757|FG010|Induction Period|Withdrawal by Subject|0|||
49061113|NCT04146363|158055747|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
49061114|NCT04146363|158055748|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
49061115|NCT04146363|158055749|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
49061116|NCT04146363|158055750|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
49061117|NCT04146363|158055751|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
49061118|NCT04146363|158055752|FG005|Maintenance Blinded Treatment Period|Adverse Event|0|||
49061119|NCT04146363|158055753|FG006|Maintenance Blinded Treatment Period|Adverse Event|1|||
49061120|NCT04146363|158055754|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
49061121|NCT04146363|158055755|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
49061122|NCT04146363|158055756|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
49061123|NCT04146363|158055757|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
49061124|NCT04146363|158055747|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
49061125|NCT04146363|158055748|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
49061126|NCT04146363|158055749|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
49061127|NCT04146363|158055750|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
49061128|NCT04146363|158055751|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
49061129|NCT04146363|158055752|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
49061130|NCT04146363|158055753|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
49061131|NCT04146363|158055754|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
49061132|NCT04146363|158055755|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
49061133|NCT04146363|158055756|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
49061134|NCT04146363|158055757|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
49061135|NCT04146363|158055747|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
49061136|NCT04146363|158055748|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
49061137|NCT04146363|158055749|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
49061138|NCT04146363|158055750|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
49061139|NCT04146363|158055751|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
49061140|NCT04146363|158055752|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
49061141|NCT04146363|158055753|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
49061142|NCT04146363|158055754|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
49061143|NCT04146363|158055755|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
49061144|NCT04146363|158055756|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
49061145|NCT04146363|158055757|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
49061146|NCT04146363|158055747|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
49061147|NCT04146363|158055748|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
49061148|NCT04146363|158055749|FG002|Maintenance Blinded Treatment Period|Physician Decision|1|||
49061149|NCT04146363|158055750|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
49061150|NCT04146363|158055751|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
49061151|NCT04146363|158055752|FG005|Maintenance Blinded Treatment Period|Physician Decision|1|||
49061152|NCT04146363|158055753|FG006|Maintenance Blinded Treatment Period|Physician Decision|0|||
49061153|NCT04146363|158055754|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
49061154|NCT04146363|158055755|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
49061155|NCT04146363|158055756|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
49061156|NCT04146363|158055757|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
49061157|NCT04146363|158055747|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
49061158|NCT04146363|158055748|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
49061159|NCT04146363|158055749|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
49061160|NCT04146363|158055750|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
49061161|NCT04146363|158055751|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
49061162|NCT04146363|158055752|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
49061163|NCT04146363|158055753|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|3|||
49061164|NCT04146363|158055754|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|5|||
49061165|NCT04146363|158055755|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
49061166|NCT04146363|158055756|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
49061167|NCT04146363|158055757|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
49061168|NCT04146363|158055747|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
49061169|NCT04146363|158055748|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
49061170|NCT04146363|158055749|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
49061171|NCT04146363|158055750|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
49061172|NCT04146363|158055751|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
49061173|NCT04146363|158055752|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|7|||
49061174|NCT04146363|158055753|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|4|||
49061175|NCT04146363|158055754|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
49061176|NCT04146363|158055755|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
49061177|NCT04146363|158055756|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
49061178|NCT04146363|158055757|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
49061179|NCT04146363|158055747|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
49061180|NCT04146363|158055748|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
49061181|NCT04146363|158055749|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
49061182|NCT04146363|158055750|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
49061183|NCT04146363|158055751|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
49061184|NCT04146363|158055752|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
49061185|NCT04146363|158055753|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
49061186|NCT04146363|158055754|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
49061187|NCT04146363|158055755|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
49061188|NCT04146363|158055756|FG009|Maintenance Open Label Escape Arm|Adverse Event|4|||
49061189|NCT04146363|158055757|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
49061190|NCT04146363|158055747|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
49061191|NCT04146363|158055748|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
49061192|NCT04146363|158055749|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
49061193|NCT04146363|158055750|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
49061194|NCT04146363|158055751|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
49061195|NCT04146363|158055752|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
49061196|NCT04146363|158055753|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
49061197|NCT04146363|158055754|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
49061198|NCT04146363|158055755|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|11|||
49061199|NCT04146363|158055756|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|17|||
49061200|NCT04146363|158055757|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
49061201|NCT04146363|158055747|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
49061202|NCT04146363|158055748|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
49061203|NCT04146363|158055749|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
49061204|NCT04146363|158055750|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
49061205|NCT04146363|158055751|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
49061206|NCT04146363|158055752|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
49061207|NCT04146363|158055753|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
49061208|NCT04146363|158055754|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
49061209|NCT04146363|158055755|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
49061210|NCT04146363|158055756|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
49061211|NCT04146363|158055757|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
49061212|NCT04146363|158055747|FG000|Maintenance Open Label Escape Arm|Physician Decision|0|||
49061213|NCT04146363|158055748|FG001|Maintenance Open Label Escape Arm|Physician Decision|0|||
49061214|NCT04146363|158055749|FG002|Maintenance Open Label Escape Arm|Physician Decision|0|||
49061215|NCT04146363|158055750|FG003|Maintenance Open Label Escape Arm|Physician Decision|0|||
49061216|NCT04146363|158055751|FG004|Maintenance Open Label Escape Arm|Physician Decision|0|||
49061217|NCT04146363|158055752|FG005|Maintenance Open Label Escape Arm|Physician Decision|0|||
49061218|NCT04146363|158055753|FG006|Maintenance Open Label Escape Arm|Physician Decision|0|||
49061219|NCT04146363|158055754|FG007|Maintenance Open Label Escape Arm|Physician Decision|0|||
49061220|NCT04146363|158055755|FG008|Maintenance Open Label Escape Arm|Physician Decision|1|||
49061221|NCT04146363|158055756|FG009|Maintenance Open Label Escape Arm|Physician Decision|1|||
49061222|NCT04146363|158055757|FG010|Maintenance Open Label Escape Arm|Physician Decision|0|||
49061223|NCT04146363|158055747|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
49061224|NCT04146363|158055748|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
49061225|NCT04146363|158055749|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
49061226|NCT04146363|158055750|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
49061227|NCT04146363|158055751|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
49061228|NCT04146363|158055752|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
49061229|NCT04146363|158055753|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
49061230|NCT04146363|158055754|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
49061231|NCT04146363|158055755|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|5|||
49061232|NCT04146363|158055756|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
49061233|NCT04146363|158055757|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
49061234|NCT04146363|158055747|FG000|Maintenance Open Label Escape Arm|Pregnancy|0|||
49061235|NCT04146363|158055748|FG001|Maintenance Open Label Escape Arm|Pregnancy|0|||
49061236|NCT04146363|158055749|FG002|Maintenance Open Label Escape Arm|Pregnancy|0|||
49061237|NCT04146363|158055750|FG003|Maintenance Open Label Escape Arm|Pregnancy|0|||
49061238|NCT04146363|158055751|FG004|Maintenance Open Label Escape Arm|Pregnancy|0|||
49061239|NCT04146363|158055752|FG005|Maintenance Open Label Escape Arm|Pregnancy|0|||
49061240|NCT04146363|158055753|FG006|Maintenance Open Label Escape Arm|Pregnancy|0|||
49061241|NCT04146363|158055754|FG007|Maintenance Open Label Escape Arm|Pregnancy|0|||
49061242|NCT04146363|158055755|FG008|Maintenance Open Label Escape Arm|Pregnancy|0|||
49061243|NCT04146363|158055756|FG009|Maintenance Open Label Escape Arm|Pregnancy|1|||
49061244|NCT04146363|158055757|FG010|Maintenance Open Label Escape Arm|Pregnancy|0|||
49061245|NCT04146363|158055747|FG000|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
49061246|NCT04146363|158055748|FG001|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
49061247|NCT04146363|158055749|FG002|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
49061248|NCT04146363|158055750|FG003|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
49061249|NCT04146363|158055751|FG004|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
49061250|NCT04146363|158055752|FG005|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
49061251|NCT04146363|158055753|FG006|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
49061252|NCT04146363|158055754|FG007|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
49061253|NCT04146363|158055755|FG008|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
49061254|NCT04146363|158055756|FG009|Maintenance Open Label Escape Arm|EASI Scoring Error|2|||
49061255|NCT04146363|158055757|FG010|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
49061256|NCT02914236|158055761|FG000|Overall Study|Lost to Follow-up|1|||
49061257|NCT00856973|158055766|FG000|Overall Study|Adverse Event|5|||
49061258|NCT00856973|158055767|FG001|Overall Study|Adverse Event|5|||
49061259|NCT00856973|158055768|FG002|Overall Study|Adverse Event|3|||
49061260|NCT00856973|158055766|FG000|Overall Study|Lost to Follow-up|6|||
49061261|NCT00856973|158055767|FG001|Overall Study|Lost to Follow-up|3|||
49061262|NCT00856973|158055768|FG002|Overall Study|Lost to Follow-up|5|||
49061263|NCT00856973|158055766|FG000|Overall Study|Physician Decision|0|||
49061264|NCT00856973|158055767|FG001|Overall Study|Physician Decision|3|||
49061265|NCT00856973|158055768|FG002|Overall Study|Physician Decision|1|||
49061266|NCT00856973|158055766|FG000|Overall Study|Protocol Violation|1|||
49061267|NCT00856973|158055767|FG001|Overall Study|Protocol Violation|2|||
49061268|NCT00856973|158055768|FG002|Overall Study|Protocol Violation|1|||
49061269|NCT00856973|158055766|FG000|Overall Study|Withdrawal by Subject|13|||
49061270|NCT00856973|158055767|FG001|Overall Study|Withdrawal by Subject|16|||
49061271|NCT00856973|158055768|FG002|Overall Study|Withdrawal by Subject|15|||
49061272|NCT00856973|158055766|FG000|Overall Study|Other|11|||
49061273|NCT00856973|158055767|FG001|Overall Study|Other|12|||
49061274|NCT00856973|158055768|FG002|Overall Study|Other|13|||
49061275|NCT02551666|158055769|FG000|Overall Study|Withdrawal by Subject|1|||
49061276|NCT02551666|158055770|FG001|Overall Study|Withdrawal by Subject|3|||
49061277|NCT04718194|158055771|FG000|Overall Study|Withdrawal by Subject|3|||
49061278|NCT04718194|158055772|FG001|Overall Study|Withdrawal by Subject|0|||
49061279|NCT04718194|158055771|FG000|Overall Study|Lost to Follow-up|3|||
49061280|NCT04718194|158055772|FG001|Overall Study|Lost to Follow-up|0|||
49061281|NCT02581163|158055777|FG000|Overall Study|Failure to return|15|||
49061282|NCT02581163|158055777|FG000|Overall Study|Insufficient virological response|3|||
49061283|NCT02581163|158055777|FG000|Overall Study|Withdrew consent|1|||
49061284|NCT02581163|158055777|FG000|Overall Study|Death|1|||
49061285|NCT02581163|158055777|FG000|Overall Study|Other, not specified|9|||
49061286|NCT02072824|158055778|FG000|Overall Study|Insufficient clinical response|1|||
49061287|NCT02072824|158055779|FG001|Overall Study|Insufficient clinical response|0|||
49061288|NCT02072824|158055780|FG002|Overall Study|Insufficient clinical response|1|||
49061289|NCT02072824|158055778|FG000|Overall Study|No longer willing to participate|1|||
49061290|NCT02072824|158055779|FG001|Overall Study|No longer willing to participate|0|||
49061291|NCT02072824|158055780|FG002|Overall Study|No longer willing to participate|1|||
49061292|NCT02072824|158055778|FG000|Overall Study|Medication error|0|||
49061293|NCT02072824|158055779|FG001|Overall Study|Medication error|1|||
49061294|NCT02072824|158055780|FG002|Overall Study|Medication error|0|||
49061295|NCT02072824|158055778|FG000|Overall Study|Adverse Event|0|||
49061296|NCT02072824|158055779|FG001|Overall Study|Adverse Event|0|||
49061297|NCT02072824|158055780|FG002|Overall Study|Adverse Event|1|||
49061298|NCT00931268|158055782|FG000|Overall Study|Lost to Follow-up|6|||
49061299|NCT02566993|158055788|FG000|Overall Study|Randomized but not treated|5|||
49061300|NCT02566993|158055789|FG001|Overall Study|Randomized but not treated|16|||
49061301|NCT02566993|158055788|FG000|Overall Study|Progressive disease|213|||
49061302|NCT02566993|158055789|FG001|Overall Study|Progressive disease|152|||
49061303|NCT02566993|158055788|FG000|Overall Study|Withdrawal by Subject|12|||
49061304|NCT02566993|158055789|FG001|Overall Study|Withdrawal by Subject|28|||
49061305|NCT02566993|158055788|FG000|Overall Study|Death|17|||
49061306|NCT02566993|158055789|FG001|Overall Study|Death|23|||
49061307|NCT02566993|158055788|FG000|Overall Study|Physician Decision|10|||
49061308|NCT02566993|158055789|FG001|Overall Study|Physician Decision|17|||
49061309|NCT02566993|158055788|FG000|Overall Study|Study drug-related adverse event|20|||
49061310|NCT02566993|158055789|FG001|Overall Study|Study drug-related adverse event|41|||
49061311|NCT02566993|158055788|FG000|Overall Study|Non study drug-related adverse event|9|||
49061312|NCT02566993|158055789|FG001|Overall Study|Non study drug-related adverse event|9|||
49061313|NCT02566993|158055788|FG000|Overall Study|Symptomatic deterioration|9|||
49061314|NCT02566993|158055789|FG001|Overall Study|Symptomatic deterioration|16|||
49061315|NCT02566993|158055788|FG000|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9|||
49061316|NCT02566993|158055789|FG001|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1|||
49061317|NCT02566993|158055788|FG000|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
49061318|NCT02566993|158055789|FG001|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
49061319|NCT02566993|158055788|FG000|Overall Study|Screening failure|2|||
49061320|NCT02566993|158055789|FG001|Overall Study|Screening failure|0|||
49061321|NCT02566993|158055788|FG000|Overall Study|Lost to Follow-up|0|||
49061322|NCT02566993|158055789|FG001|Overall Study|Lost to Follow-up|1|||
49061323|NCT02566993|158055788|FG000|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0|||
49061324|NCT02566993|158055789|FG001|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1|||
49061325|NCT03095118|158055790|FG000|Overall Study|Adverse Event|1|||
49061326|NCT03095118|158055790|FG000|Overall Study|Diagnosis not associated with monoclonal gammopathy|1|||
49061327|NCT00669071|158055795|FG000|Overall Study|Lost to Follow-up|3|||
49061328|NCT00669071|158055795|FG000|Overall Study|Final visit 40 days out of window|1|||
49061329|NCT01616953|158055798|FG000|Overall Study|Lost to Follow-up|1|||
49061330|NCT01616953|158055799|FG001|Overall Study|Lost to Follow-up|0|||
49061331|NCT01616953|158055798|FG000|Overall Study|lack of bone and soft tissue|1|||
49061332|NCT01616953|158055799|FG001|Overall Study|lack of bone and soft tissue|0|||
49061333|NCT02025751|158055804|FG000|Overall Study|Lost to Follow-up|1|||
49061334|NCT02025751|158055805|FG001|Overall Study|Lost to Follow-up|0|||
49061335|NCT02025751|158055804|FG000|Overall Study|Adverse Event|0|||
49061336|NCT02025751|158055805|FG001|Overall Study|Adverse Event|1|||
49061337|NCT02025751|158055804|FG000|Overall Study|Physician Decision|0|||
49061338|NCT02025751|158055805|FG001|Overall Study|Physician Decision|1|||
49061339|NCT02025751|158055804|FG000|Overall Study|Withdrawal by Subject|0|||
49061340|NCT02025751|158055805|FG001|Overall Study|Withdrawal by Subject|1|||
49061341|NCT03456960|158055806|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
49061342|NCT03456960|158055807|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
49061343|NCT03456960|158055808|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
49061344|NCT03456960|158055809|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|2|||
49061345|NCT03456960|158055810|FG004|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
49061346|NCT03456960|158055811|FG005|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
49061347|NCT03456960|158055806|FG000|Period 2 (1 Day)|Adverse Event|1|||
49061348|NCT03456960|158055807|FG001|Period 2 (1 Day)|Adverse Event|0|||
49061349|NCT03456960|158055808|FG002|Period 2 (1 Day)|Adverse Event|0|||
49061350|NCT03456960|158055809|FG003|Period 2 (1 Day)|Adverse Event|1|||
49061351|NCT03456960|158055810|FG004|Period 2 (1 Day)|Adverse Event|0|||
49061352|NCT03456960|158055811|FG005|Period 2 (1 Day)|Adverse Event|0|||
49061353|NCT01940497|158055816|FG000|Overall Study|Adverse Event/Intercurrent Illness|11|||
49061354|NCT01940497|158055817|FG001|Overall Study|Adverse Event/Intercurrent Illness|8|||
49061355|NCT01940497|158055816|FG000|Overall Study|Recurrence of Disease Postsurgery|1|||
49061356|NCT01940497|158055817|FG001|Overall Study|Recurrence of Disease Postsurgery|3|||
49061357|NCT01940497|158055816|FG000|Overall Study|Violation of Entry Criteria|1|||
49061358|NCT01940497|158055817|FG001|Overall Study|Violation of Entry Criteria|1|||
49061359|NCT01940497|158055816|FG000|Overall Study|Refused Treatment|1|||
49061360|NCT01940497|158055817|FG001|Overall Study|Refused Treatment|3|||
49061361|NCT01940497|158055816|FG000|Overall Study|Withdrew Consent|6|||
49061362|NCT01940497|158055817|FG001|Overall Study|Withdrew Consent|2|||
49061363|NCT01940497|158055816|FG000|Overall Study|Administrative/Other|1|||
49061364|NCT01940497|158055817|FG001|Overall Study|Administrative/Other|1|||
49061365|NCT00513682|158055818|FG000|Washout Phase|Adverse Event|2|||
49061366|NCT02206620|158055819|FG000|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
49061367|NCT02206620|158055820|FG001|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
49061368|NCT02206620|158055819|FG000|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
49061369|NCT02206620|158055820|FG001|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2|||
49061370|NCT00369382|158055823|FG000|Overall Study|Death|0|||
49061371|NCT00369382|158055824|FG001|Overall Study|Death|2|||
49061372|NCT00369382|158055823|FG000|Overall Study|Physician Decision|2|||
49061373|NCT00369382|158055824|FG001|Overall Study|Physician Decision|1|||
49061374|NCT00369382|158055823|FG000|Overall Study|Withdrawal by Subject|5|||
49061375|NCT00369382|158055824|FG001|Overall Study|Withdrawal by Subject|0|||
49061376|NCT00369382|158055823|FG000|Overall Study|Randomized, not treated|2|||
49061377|NCT00369382|158055824|FG001|Overall Study|Randomized, not treated|0|||
49061378|NCT00369382|158055823|FG000|Overall Study|Other|1|||
49061379|NCT00369382|158055824|FG001|Overall Study|Other|0|||
49061380|NCT03487848|158055825|FG000|Overall Study|Lost to Follow-up|1|||
49061381|NCT04465630|158055826|FG000|Overall Study|Sponsor Decision to terminate the study|54|||
49061382|NCT04465630|158055826|FG000|Overall Study|Screen failure|8|||
49061383|NCT04465630|158055826|FG000|Overall Study|Baseline failure|16|||
49061384|NCT02394730|158055827|FG000|Overall Study|Lost to Follow-up|1|||
49061385|NCT02394730|158055828|FG001|Overall Study|Lost to Follow-up|0|||
49061386|NCT02394730|158055827|FG000|Overall Study|Withdrawal by Subject|0|||
49061387|NCT02394730|158055828|FG001|Overall Study|Withdrawal by Subject|1|||
49061388|NCT00588640|158055830|FG000|Overall Study|Physician Decision|1|||
49061389|NCT00588640|158055830|FG000|Overall Study|Ineligible Patient|1|||
49061390|NCT00448136|158055833|FG000|Overall Study|Death|3|||
49061391|NCT00448136|158055834|FG001|Overall Study|Death|8|||
49061392|NCT00448136|158055833|FG000|Overall Study|Investigator's decision (progression)|1|||
49061393|NCT00448136|158055834|FG001|Overall Study|Investigator's decision (progression)|0|||
49061394|NCT01121666|158055835|FG000|Overall Study|Protocol Violation|29|||
49061395|NCT01121666|158055836|FG001|Overall Study|Protocol Violation|10|||
49061396|NCT00609466|158055837|FG000|Overall Study|Withdrawal by Subject|0|||
49061397|NCT00609466|158055838|FG001|Overall Study|Withdrawal by Subject|1|||
49061398|NCT00609466|158055839|FG002|Overall Study|Withdrawal by Subject|1|||
49061399|NCT00609466|158055837|FG000|Overall Study|Adverse Event|2|||
49061400|NCT00609466|158055838|FG001|Overall Study|Adverse Event|3|||
49061401|NCT00609466|158055839|FG002|Overall Study|Adverse Event|1|||
49061402|NCT00609466|158055837|FG000|Overall Study|Lack of Efficacy|0|||
49061403|NCT00609466|158055838|FG001|Overall Study|Lack of Efficacy|2|||
49061404|NCT00609466|158055839|FG002|Overall Study|Lack of Efficacy|2|||
49061405|NCT01144364|158055840|FG000|Induction Phase|Disease progression|14|||
49061406|NCT01144364|158055841|FG001|Induction Phase|Disease progression|0|||
49061407|NCT01144364|158055842|FG002|Induction Phase|Disease progression|0|||
49061408|NCT01144364|158055840|FG000|Induction Phase|Adverse Event|9|||
49061409|NCT01144364|158055841|FG001|Induction Phase|Adverse Event|0|||
49061410|NCT01144364|158055842|FG002|Induction Phase|Adverse Event|0|||
49061411|NCT01144364|158055840|FG000|Induction Phase|Death|1|||
49061412|NCT01144364|158055841|FG001|Induction Phase|Death|0|||
49061413|NCT01144364|158055842|FG002|Induction Phase|Death|0|||
49061414|NCT01144364|158055840|FG000|Induction Phase|Withdrawal by Subject|1|||
49061415|NCT01144364|158055841|FG001|Induction Phase|Withdrawal by Subject|0|||
49061416|NCT01144364|158055842|FG002|Induction Phase|Withdrawal by Subject|0|||
49061417|NCT01144364|158055840|FG000|Induction Phase|Lost to Follow-up|2|||
49061418|NCT01144364|158055841|FG001|Induction Phase|Lost to Follow-up|0|||
49061419|NCT01144364|158055842|FG002|Induction Phase|Lost to Follow-up|0|||
49061420|NCT01144364|158055840|FG000|Induction Phase|Physician Decision|1|||
49061421|NCT01144364|158055841|FG001|Induction Phase|Physician Decision|0|||
49061422|NCT01144364|158055842|FG002|Induction Phase|Physician Decision|0|||
49061423|NCT01144364|158055840|FG000|Induction Phase|Stable disease|2|||
49061424|NCT01144364|158055841|FG001|Induction Phase|Stable disease|0|||
49061425|NCT01144364|158055842|FG002|Induction Phase|Stable disease|0|||
49061426|NCT01144364|158055840|FG000|Induction Phase|Secondary neoplasia|1|||
49061427|NCT01144364|158055841|FG001|Induction Phase|Secondary neoplasia|0|||
49061428|NCT01144364|158055842|FG002|Induction Phase|Secondary neoplasia|0|||
49061429|NCT01144364|158055840|FG000|Induction Phase|Protocol Violation|1|||
49061430|NCT01144364|158055841|FG001|Induction Phase|Protocol Violation|0|||
49061431|NCT01144364|158055842|FG002|Induction Phase|Protocol Violation|0|||
49061432|NCT01144364|158055840|FG000|Follow-Up/Maintenance Phase|Disease progression|0|||
49061433|NCT01144364|158055841|FG001|Follow-Up/Maintenance Phase|Disease progression|23|||
49061434|NCT01144364|158055842|FG002|Follow-Up/Maintenance Phase|Disease progression|29|||
49061435|NCT01144364|158055840|FG000|Follow-Up/Maintenance Phase|Adverse Event|0|||
49061436|NCT01144364|158055841|FG001|Follow-Up/Maintenance Phase|Adverse Event|3|||
49061437|NCT01144364|158055842|FG002|Follow-Up/Maintenance Phase|Adverse Event|1|||
49061438|NCT01144364|158055840|FG000|Follow-Up/Maintenance Phase|Death|0|||
49061439|NCT01144364|158055841|FG001|Follow-Up/Maintenance Phase|Death|2|||
49061440|NCT01144364|158055842|FG002|Follow-Up/Maintenance Phase|Death|0|||
49061441|NCT01144364|158055840|FG000|Follow-Up/Maintenance Phase|Withdrawal by Subject|0|||
49061442|NCT01144364|158055841|FG001|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
49061443|NCT01144364|158055842|FG002|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
49061444|NCT01144364|158055840|FG000|Follow-Up/Maintenance Phase|Lost to Follow-up|0|||
49061445|NCT01144364|158055841|FG001|Follow-Up/Maintenance Phase|Lost to Follow-up|1|||
49061446|NCT01144364|158055842|FG002|Follow-Up/Maintenance Phase|Lost to Follow-up|4|||
49061447|NCT01144364|158055840|FG000|Follow-Up/Maintenance Phase|Relapse|0|||
49061448|NCT01144364|158055841|FG001|Follow-Up/Maintenance Phase|Relapse|5|||
49061449|NCT01144364|158055842|FG002|Follow-Up/Maintenance Phase|Relapse|5|||
49061450|NCT01144364|158055840|FG000|Follow-Up/Maintenance Phase|Physician Decision|0|||
49061451|NCT01144364|158055841|FG001|Follow-Up/Maintenance Phase|Physician Decision|0|||
49061452|NCT01144364|158055842|FG002|Follow-Up/Maintenance Phase|Physician Decision|1|||
49061453|NCT01946191|158055845|FG000|Allocation|Did not complete orientation|1|||
49061454|NCT01946191|158055846|FG001|Allocation|Did not complete orientation|1|||
49061455|NCT01946191|158055845|FG000|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4|||
49061456|NCT01946191|158055846|FG001|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2|||
49061457|NCT01946191|158055845|FG000|Follow-Up, 24-mo Endpoint|Protocol Violation|0|||
49061458|NCT01946191|158055846|FG001|Follow-Up, 24-mo Endpoint|Protocol Violation|1|||
49061459|NCT01946191|158055845|FG000|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13|||
49061460|NCT01946191|158055846|FG001|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15|||
49061461|NCT01629966|158055848|FG000|Overall Study|Pregnancy|0|||
49061462|NCT01629966|158055849|FG001|Overall Study|Pregnancy|1|||
49061463|NCT01629966|158055850|FG002|Overall Study|Pregnancy|0|||
49061464|NCT01629966|158055848|FG000|Overall Study|Lost to Follow-up|10|||
49061465|NCT01629966|158055849|FG001|Overall Study|Lost to Follow-up|13|||
49061466|NCT01629966|158055850|FG002|Overall Study|Lost to Follow-up|9|||
49061467|NCT01629966|158055848|FG000|Overall Study|Withdrawal by Subject|8|||
49061468|NCT01629966|158055849|FG001|Overall Study|Withdrawal by Subject|9|||
49061469|NCT01629966|158055850|FG002|Overall Study|Withdrawal by Subject|16|||
49061470|NCT01629966|158055848|FG000|Overall Study|Protocol Violation|7|||
49061471|NCT01629966|158055849|FG001|Overall Study|Protocol Violation|9|||
49061472|NCT01629966|158055850|FG002|Overall Study|Protocol Violation|7|||
49061473|NCT01629966|158055848|FG000|Overall Study|Lack of Efficacy|5|||
49061474|NCT01629966|158055849|FG001|Overall Study|Lack of Efficacy|2|||
49061475|NCT01629966|158055850|FG002|Overall Study|Lack of Efficacy|4|||
49061476|NCT01629966|158055848|FG000|Overall Study|Adverse Event|11|||
49061477|NCT01629966|158055849|FG001|Overall Study|Adverse Event|18|||
49061478|NCT01629966|158055850|FG002|Overall Study|Adverse Event|30|||
49061479|NCT01855074|158055851|FG000|Overall Study|Adverse Event|1|||
49061480|NCT01855074|158055851|FG000|Overall Study|Lost to Follow-up|4|||
49061481|NCT01855074|158055851|FG000|Overall Study|Withdrawal by Subject|8|||
49061482|NCT01855074|158055851|FG000|Overall Study|Started but not treated|1|||
49061483|NCT01602965|158055852|FG000|Overall Study|Lost to Follow-up|4|||
49061484|NCT01602965|158055853|FG001|Overall Study|Lost to Follow-up|2|||
49061485|NCT03407430|158055854|FG000|Washout|Protocol Violation|1|||
49061486|NCT03407430|158055855|FG001|Washout|Protocol Violation|0|||
49061487|NCT02991430|158055856|FG000|Treatment Period 1|Adverse Event|1|||
49061488|NCT02991430|158055857|FG001|Treatment Period 1|Adverse Event|0|||
49061489|NCT02991430|158055858|FG002|Treatment Period 1|Adverse Event|2|||
49061490|NCT02991430|158055856|FG000|Treatment Period 1|Withdrawal by Subject|0|||
49061491|NCT02991430|158055857|FG001|Treatment Period 1|Withdrawal by Subject|4|||
49061492|NCT02991430|158055858|FG002|Treatment Period 1|Withdrawal by Subject|0|||
49061493|NCT02991430|158055856|FG000|Treatment Period 2|Study Termination|6|||
49061494|NCT02991430|158055857|FG001|Treatment Period 2|Study Termination|3|||
49061495|NCT02991430|158055858|FG002|Treatment Period 2|Study Termination|3|||
49061496|NCT02991430|158055856|FG000|Treatment Period 2|Lost to Follow-up|0|||
49061497|NCT02991430|158055857|FG001|Treatment Period 2|Lost to Follow-up|0|||
49061498|NCT02991430|158055858|FG002|Treatment Period 2|Lost to Follow-up|1|||
49061499|NCT02991430|158055856|FG000|Post-treatment Observation Period|Study Termination|3|||
49061500|NCT02991430|158055857|FG001|Post-treatment Observation Period|Study Termination|6|||
49061501|NCT02991430|158055858|FG002|Post-treatment Observation Period|Study Termination|5|||
49061502|NCT00891839|158055860|FG000|Overall Study|Adverse Event|2|||
49061503|NCT00891839|158055860|FG000|Overall Study|Withdrawal by Subject|2|||
49061504|NCT00891839|158055860|FG000|Overall Study|Disease progression|3|||
49061505|NCT01150890|158055865|FG000|Overall Study|Other|0|||
49061506|NCT01150890|158055866|FG001|Overall Study|Other|1|||
49061507|NCT01150890|158055867|FG002|Overall Study|Other|0|||
49061508|NCT01150890|158055868|FG003|Overall Study|Other|2|||
49061509|NCT01150890|158055865|FG000|Overall Study|Pregnancy|0|||
49061510|NCT01150890|158055866|FG001|Overall Study|Pregnancy|0|||
49061511|NCT01150890|158055867|FG002|Overall Study|Pregnancy|0|||
49061512|NCT01150890|158055868|FG003|Overall Study|Pregnancy|1|||
49061513|NCT01150890|158055865|FG000|Overall Study|Administrative Decision|4|||
49061514|NCT01150890|158055866|FG001|Overall Study|Administrative Decision|4|||
49061515|NCT01150890|158055867|FG002|Overall Study|Administrative Decision|5|||
49061516|NCT01150890|158055868|FG003|Overall Study|Administrative Decision|6|||
49061517|NCT01150890|158055865|FG000|Overall Study|Ineligibility determined|0|||
49061518|NCT01150890|158055866|FG001|Overall Study|Ineligibility determined|1|||
49061519|NCT01150890|158055867|FG002|Overall Study|Ineligibility determined|0|||
49061520|NCT01150890|158055868|FG003|Overall Study|Ineligibility determined|0|||
49061521|NCT01150890|158055865|FG000|Overall Study|Adverse Event|0|||
49061522|NCT01150890|158055866|FG001|Overall Study|Adverse Event|0|||
49061523|NCT01150890|158055867|FG002|Overall Study|Adverse Event|2|||
49061524|NCT01150890|158055868|FG003|Overall Study|Adverse Event|0|||
49061525|NCT01150890|158055865|FG000|Overall Study|Withdrawal by Subject|0|||
49061526|NCT01150890|158055866|FG001|Overall Study|Withdrawal by Subject|0|||
49061527|NCT01150890|158055867|FG002|Overall Study|Withdrawal by Subject|2|||
49061528|NCT01150890|158055868|FG003|Overall Study|Withdrawal by Subject|1|||
49061529|NCT01150890|158055865|FG000|Overall Study|Disease progression|0|||
49061530|NCT01150890|158055866|FG001|Overall Study|Disease progression|7|||
49061531|NCT01150890|158055867|FG002|Overall Study|Disease progression|3|||
49061532|NCT01150890|158055868|FG003|Overall Study|Disease progression|7|||
49061533|NCT01172821|158055869|FG000|Overall Study|Adverse Event|5|||
49061534|NCT01172821|158055870|FG001|Overall Study|Adverse Event|2|||
49061535|NCT01172821|158055871|FG002|Overall Study|Adverse Event|2|||
49061536|NCT01172821|158055872|FG003|Overall Study|Adverse Event|7|||
49061537|NCT01172821|158055869|FG000|Overall Study|Protocol Violation|0|||
49061538|NCT01172821|158055870|FG001|Overall Study|Protocol Violation|2|||
49061539|NCT01172821|158055871|FG002|Overall Study|Protocol Violation|1|||
49061540|NCT01172821|158055872|FG003|Overall Study|Protocol Violation|2|||
49061541|NCT01172821|158055869|FG000|Overall Study|Lost to Follow-up|4|||
49061542|NCT01172821|158055870|FG001|Overall Study|Lost to Follow-up|1|||
49061543|NCT01172821|158055871|FG002|Overall Study|Lost to Follow-up|2|||
49061544|NCT01172821|158055872|FG003|Overall Study|Lost to Follow-up|2|||
49061545|NCT01172821|158055869|FG000|Overall Study|Withdrawal by Subject|2|||
49061546|NCT01172821|158055870|FG001|Overall Study|Withdrawal by Subject|3|||
49061547|NCT01172821|158055871|FG002|Overall Study|Withdrawal by Subject|3|||
49061548|NCT01172821|158055872|FG003|Overall Study|Withdrawal by Subject|3|||
49061549|NCT01172821|158055869|FG000|Overall Study|Other|3|||
49061550|NCT01172821|158055870|FG001|Overall Study|Other|4|||
49061551|NCT01172821|158055871|FG002|Overall Study|Other|5|||
49061552|NCT01172821|158055872|FG003|Overall Study|Other|3|||
49061553|NCT00123955|158055873|FG000|Overall Study|Adverse Event|1|||
49061554|NCT00123955|158055874|FG001|Overall Study|Adverse Event|0|||
49061555|NCT00123955|158055873|FG000|Overall Study|Withdrawal by Subject|4|||
49061556|NCT00123955|158055874|FG001|Overall Study|Withdrawal by Subject|3|||
49061557|NCT00123955|158055873|FG000|Overall Study|Death|0|||
49061558|NCT00123955|158055874|FG001|Overall Study|Death|1|||
49061559|NCT04223778|158055877|FG000|Overall Study|Ongoing|322|||
49061560|NCT04223778|158055878|FG001|Overall Study|Ongoing|326|||
49061561|NCT04223778|158055877|FG000|Overall Study|Death|0|||
49061562|NCT04223778|158055878|FG001|Overall Study|Death|1|||
49061563|NCT04223778|158055877|FG000|Overall Study|Lost to Follow-up|1|||
49061564|NCT04223778|158055878|FG001|Overall Study|Lost to Follow-up|5|||
49061565|NCT04223778|158055877|FG000|Overall Study|Physician Decision|3|||
49061566|NCT04223778|158055878|FG001|Overall Study|Physician Decision|1|||
49061567|NCT04223778|158055877|FG000|Overall Study|Withdrawal by Subject|10|||
49061568|NCT04223778|158055878|FG001|Overall Study|Withdrawal by Subject|1|||
49061569|NCT04223778|158055877|FG000|Overall Study|Lack of Efficacy|0|||
49061570|NCT04223778|158055878|FG001|Overall Study|Lack of Efficacy|2|||
49061571|NCT02091141|158057311|FG000|Overall Study|Death|280|||
49061572|NCT02091141|158057312|FG001|Overall Study|Death|118|||
49061573|NCT02091141|158057313|FG002|Overall Study|Death|46|||
49061574|NCT02091141|158057314|FG003|Overall Study|Death|13|||
49061575|NCT02091141|158057315|FG004|Overall Study|Death|31|||
49061576|NCT02091141|158057316|FG005|Overall Study|Death|16|||
49061577|NCT02091141|158057317|FG006|Overall Study|Death|12|||
49061578|NCT02091141|158057311|FG000|Overall Study|Withdrawal by Subject|21|||
49061579|NCT02091141|158057312|FG001|Overall Study|Withdrawal by Subject|13|||
49061580|NCT02091141|158057313|FG002|Overall Study|Withdrawal by Subject|3|||
49061581|NCT02091141|158057314|FG003|Overall Study|Withdrawal by Subject|2|||
49061582|NCT02091141|158057315|FG004|Overall Study|Withdrawal by Subject|2|||
49061583|NCT02091141|158057316|FG005|Overall Study|Withdrawal by Subject|3|||
49061584|NCT02091141|158057317|FG006|Overall Study|Withdrawal by Subject|0|||
49061585|NCT02091141|158057311|FG000|Overall Study|Lost to Follow-up|21|||
49061586|NCT02091141|158057312|FG001|Overall Study|Lost to Follow-up|5|||
49061587|NCT02091141|158057313|FG002|Overall Study|Lost to Follow-up|1|||
49061588|NCT02091141|158057314|FG003|Overall Study|Lost to Follow-up|0|||
49061589|NCT02091141|158057315|FG004|Overall Study|Lost to Follow-up|1|||
49061590|NCT02091141|158057316|FG005|Overall Study|Lost to Follow-up|2|||
49061591|NCT02091141|158057317|FG006|Overall Study|Lost to Follow-up|0|||
49061592|NCT02091141|158057311|FG000|Overall Study|Reason Not Specified|6|||
49061593|NCT02091141|158057312|FG001|Overall Study|Reason Not Specified|5|||
49061594|NCT02091141|158057313|FG002|Overall Study|Reason Not Specified|2|||
49061595|NCT02091141|158057314|FG003|Overall Study|Reason Not Specified|0|||
49061596|NCT02091141|158057315|FG004|Overall Study|Reason Not Specified|0|||
49061597|NCT02091141|158057316|FG005|Overall Study|Reason Not Specified|0|||
49061598|NCT02091141|158057317|FG006|Overall Study|Reason Not Specified|1|||
49061599|NCT02091141|158057311|FG000|Overall Study|Study Ended by Sponsor|1|||
49061600|NCT02091141|158057312|FG001|Overall Study|Study Ended by Sponsor|9|||
49061601|NCT02091141|158057313|FG002|Overall Study|Study Ended by Sponsor|0|||
49061602|NCT02091141|158057314|FG003|Overall Study|Study Ended by Sponsor|0|||
49061603|NCT02091141|158057315|FG004|Overall Study|Study Ended by Sponsor|0|||
49061604|NCT02091141|158057316|FG005|Overall Study|Study Ended by Sponsor|0|||
49061605|NCT02091141|158057317|FG006|Overall Study|Study Ended by Sponsor|0|||
49061606|NCT02091141|158057311|FG000|Overall Study|Withdrew informed consent before receiving study drug|0|||
49061607|NCT02091141|158057312|FG001|Overall Study|Withdrew informed consent before receiving study drug|1|||
49061608|NCT02091141|158057313|FG002|Overall Study|Withdrew informed consent before receiving study drug|0|||
49061609|NCT02091141|158057314|FG003|Overall Study|Withdrew informed consent before receiving study drug|0|||
49061610|NCT02091141|158057315|FG004|Overall Study|Withdrew informed consent before receiving study drug|0|||
49061611|NCT02091141|158057316|FG005|Overall Study|Withdrew informed consent before receiving study drug|0|||
49061612|NCT02091141|158057317|FG006|Overall Study|Withdrew informed consent before receiving study drug|0|||
49061613|NCT02246439|158057318|FG000|Overall Study|Adverse Event|3|||
49061614|NCT02246439|158057319|FG001|Overall Study|Adverse Event|0|||
49061615|NCT02246439|158057318|FG000|Overall Study|Lost to Follow-up|7|||
49061616|NCT02246439|158057319|FG001|Overall Study|Lost to Follow-up|5|||
49061617|NCT02246439|158057318|FG000|Overall Study|Protocol Violation|0|||
49061618|NCT02246439|158057319|FG001|Overall Study|Protocol Violation|2|||
49061619|NCT02246439|158057318|FG000|Overall Study|Physician Decision|0|||
49061620|NCT02246439|158057319|FG001|Overall Study|Physician Decision|1|||
49061621|NCT02246439|158057318|FG000|Overall Study|Unkonwn|1|||
49061622|NCT02246439|158057319|FG001|Overall Study|Unkonwn|3|||
49061623|NCT02246439|158057318|FG000|Overall Study|Withdrawal by Subject|1|||
49061624|NCT02246439|158057319|FG001|Overall Study|Withdrawal by Subject|0|||
49061625|NCT03439852|158057322|FG000|Baseline to 12 Weeks|Failed complete 12 wk survey|4|||
49061626|NCT03439852|158057323|FG001|Baseline to 12 Weeks|Failed complete 12 wk survey|7|||
49061627|NCT03439852|158057322|FG000|12weeks to 24weeks|failed complete 12 or 24 wk surveys|2|||
49061628|NCT03439852|158057323|FG001|12weeks to 24weeks|failed complete 12 or 24 wk surveys|0|||
49061629|NCT03439852|158057322|FG000|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|1|||
49061630|NCT03439852|158057323|FG001|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|0|||
49061631|NCT04556552|158057324|FG000|Overall Study|Lost to Follow-up|1|||
49061632|NCT04556552|158057325|FG001|Overall Study|Lost to Follow-up|0|||
49061633|NCT04556552|158057324|FG000|Overall Study|Claustrophobia|0|||
49061634|NCT04556552|158057325|FG001|Overall Study|Claustrophobia|1|||
49061635|NCT04556552|158057324|FG000|Overall Study|Inability to continue|0|||
49061636|NCT04556552|158057325|FG001|Overall Study|Inability to continue|1|||
49061637|NCT04551911|158057326|FG000|Overall Study|Lost to Follow-up|2|||
49061638|NCT04551911|158057327|FG001|Overall Study|Lost to Follow-up|1|||
49061639|NCT04551911|158057326|FG000|Overall Study|Withdrawal by Subject|10|||
49061640|NCT04551911|158057327|FG001|Overall Study|Withdrawal by Subject|10|||
49061641|NCT04551911|158057326|FG000|Overall Study|Did not receive the study drug|3|||
49061642|NCT04551911|158057327|FG001|Overall Study|Did not receive the study drug|4|||
49061643|NCT01215513|158057328|FG000|Overall Study|Not completed CS42|9|||
49061644|NCT01215513|158057328|FG000|Overall Study|Not enrolled from CS42 to CS42A|21|||
49061645|NCT01215513|158057328|FG000|Overall Study|Adverse event (CS42A)|2|||
49061646|NCT01215513|158057328|FG000|Overall Study|Physician decision (CS42A)|6|||
49061647|NCT01215513|158057328|FG000|Overall Study|Withdrawal by subject (CS42A)|5|||
49061648|NCT01215513|158057328|FG000|Overall Study|Miscellaneous reasons (CS42A)|2|||
49061649|NCT01553279|158057329|FG000|Part 1 (Infant Vaccinations)|Lost to Follow-up|1|||
49061650|NCT01553279|158057330|FG001|Part 1 (Infant Vaccinations)|Lost to Follow-up|0|||
49061651|NCT01553279|158057329|FG000|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
49061652|NCT01553279|158057330|FG001|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
49061653|NCT01553279|158057329|FG000|Interim Period|Withdrawal by Subject|2|||
49061654|NCT01553279|158057330|FG001|Interim Period|Withdrawal by Subject|2|||
49061655|NCT01553279|158057329|FG000|Interim Period|Lost to Follow-up|1|||
49061656|NCT01553279|158057330|FG001|Interim Period|Lost to Follow-up|0|||
49061657|NCT01553279|158057329|FG000|Period 2: Toddler Vaccinations|Withdrawal by Subject|0|||
49061658|NCT01553279|158057330|FG001|Period 2: Toddler Vaccinations|Withdrawal by Subject|5|||
49061659|NCT01553279|158057329|FG000|Period 2: Toddler Vaccinations|Lost to Follow-up|3|||
49061660|NCT01553279|158057330|FG001|Period 2: Toddler Vaccinations|Lost to Follow-up|2|||
49061661|NCT00380692|158057338|FG000|Study Period II - Double Blind|Adverse Event|1|||
49061662|NCT00380692|158057339|FG001|Study Period II - Double Blind|Adverse Event|0|||
49061663|NCT00380692|158057338|FG000|Study Period II - Double Blind|Protocol Violation|2|||
49061664|NCT00380692|158057339|FG001|Study Period II - Double Blind|Protocol Violation|2|||
49061665|NCT00380692|158057338|FG000|Study Period II - Double Blind|Withdrawal by Subject|0|||
49061666|NCT00380692|158057339|FG001|Study Period II - Double Blind|Withdrawal by Subject|0|||
49061667|NCT00380692|158057338|FG000|Study Period II - Double Blind|Physician Decision|0|||
49061668|NCT00380692|158057339|FG001|Study Period II - Double Blind|Physician Decision|1|||
49061669|NCT00380692|158057338|FG000|Study Period II - Double Blind|Lack of Efficacy|1|||
49061670|NCT00380692|158057339|FG001|Study Period II - Double Blind|Lack of Efficacy|0|||
49061671|NCT00380692|158057338|FG000|Study Period II - Double Blind|Parent/Caregiver Decision|1|||
49061672|NCT00380692|158057339|FG001|Study Period II - Double Blind|Parent/Caregiver Decision|0|||
49061673|NCT00380692|158057338|FG000|Study Period III - Open Label|Adverse Event|5|||
49061674|NCT00380692|158057339|FG001|Study Period III - Open Label|Adverse Event|3|||
49061675|NCT00380692|158057338|FG000|Study Period III - Open Label|Protocol Violation|0|||
49061676|NCT00380692|158057339|FG001|Study Period III - Open Label|Protocol Violation|0|||
49061677|NCT00380692|158057338|FG000|Study Period III - Open Label|Withdrawal by Subject|0|||
49061678|NCT00380692|158057339|FG001|Study Period III - Open Label|Withdrawal by Subject|1|||
49061679|NCT00380692|158057338|FG000|Study Period III - Open Label|Physician Decision|0|||
49061680|NCT00380692|158057339|FG001|Study Period III - Open Label|Physician Decision|3|||
49061681|NCT00380692|158057338|FG000|Study Period III - Open Label|Lack of Efficacy|0|||
49061682|NCT00380692|158057339|FG001|Study Period III - Open Label|Lack of Efficacy|4|||
49061683|NCT00380692|158057338|FG000|Study Period III - Open Label|Parent/Caregiver Decision|1|||
49061684|NCT00380692|158057339|FG001|Study Period III - Open Label|Parent/Caregiver Decision|1|||
49061685|NCT00605865|158057340|FG000|Overall Study|Protocol Violation|115|||
49061686|NCT01769339|158057341|FG000|Overall Study|Lost to Follow-up|42|||
49061687|NCT01769339|158057341|FG000|Overall Study|Adverse Event|1|||
49061688|NCT00704730|158057342|FG000|Overall Study|Adverse Event|35|||
49061689|NCT00704730|158057343|FG001|Overall Study|Adverse Event|9|||
49061690|NCT00704730|158057342|FG000|Overall Study|Death|11|||
49061691|NCT00704730|158057343|FG001|Overall Study|Death|5|||
49061692|NCT00704730|158057342|FG000|Overall Study|Physician Decision|2|||
49061693|NCT00704730|158057343|FG001|Overall Study|Physician Decision|0|||
49061694|NCT00704730|158057342|FG000|Overall Study|Did not receive drug|5|||
49061695|NCT00704730|158057343|FG001|Overall Study|Did not receive drug|2|||
49061696|NCT00704730|158057342|FG000|Overall Study|Disease progression per PI|58|||
49061697|NCT00704730|158057343|FG001|Overall Study|Disease progression per PI|67|||
49061698|NCT00704730|158057342|FG000|Overall Study|data unavailable|1|||
49061699|NCT00704730|158057343|FG001|Overall Study|data unavailable|0|||
49061700|NCT00704730|158057342|FG000|Overall Study|Withdrawal by Subject|9|||
49061701|NCT00704730|158057343|FG001|Overall Study|Withdrawal by Subject|13|||
49061702|NCT01195272|158057344|FG000|Overall Study|Adverse Event|1|||
49061703|NCT01195272|158057344|FG000|Overall Study|Lack of Efficacy|3|||
49061706|NCT03955471|158057349|FG000|Overall Study|Death|22|||
49061707|NCT03955471|158057349|FG000|Overall Study|Lost to Follow-up|1|||
49061708|NCT03955471|158057349|FG000|Overall Study|Withdrawal by Subject|6|||
49061709|NCT03955471|158057349|FG000|Overall Study|Sponsor Decision to Terminate Study|11|||
49061710|NCT00706095|158057353|FG000|Overall Study|Progressive Disease|4|||
49061711|NCT00706095|158057354|FG001|Overall Study|Progressive Disease|5|||
49061712|NCT00706095|158057355|FG002|Overall Study|Progressive Disease|3|||
49061713|NCT00706095|158057353|FG000|Overall Study|Clinical Progression|1|||
49061714|NCT00706095|158057354|FG001|Overall Study|Clinical Progression|2|||
49061715|NCT00706095|158057355|FG002|Overall Study|Clinical Progression|2|||
49061716|NCT00706095|158057353|FG000|Overall Study|Withdrawal by Subject|1|||
49061717|NCT00706095|158057354|FG001|Overall Study|Withdrawal by Subject|0|||
49061718|NCT00706095|158057355|FG002|Overall Study|Withdrawal by Subject|0|||
49061719|NCT01700049|158057362|FG000|Overall Study|Withdrawal by Subject|1|||
49061720|NCT02791893|158057363|FG000|Blinded Phase|Lost to Follow-up|2|||
49061721|NCT02791893|158057364|FG001|Blinded Phase|Lost to Follow-up|2|||
49061722|NCT02791893|158057363|FG000|Blinded Phase|Withdrawal by Subject|1|||
49061723|NCT02791893|158057364|FG001|Blinded Phase|Withdrawal by Subject|2|||
49061724|NCT02791893|158057363|FG000|Open Label Phase|Lost to Follow-up|3|||
49061725|NCT02791893|158057364|FG001|Open Label Phase|Lost to Follow-up|0|||
49061726|NCT02791893|158057363|FG000|Open Label Phase|Withdrawal by Subject|0|||
49061727|NCT02791893|158057364|FG001|Open Label Phase|Withdrawal by Subject|2|||
49061728|NCT01859130|158057367|FG000|Overall Study|Death|4|||
49061729|NCT01859130|158057367|FG000|Overall Study|Lost to Follow-up|16|||
49061730|NCT01859130|158057367|FG000|Overall Study|Sponsor terminated: 47 Not specified: 3|53|||
49061731|NCT01859130|158057367|FG000|Overall Study|Physician Decision|6|||
49061732|NCT01859130|158057367|FG000|Overall Study|Withdrawal by Subject|17|||
49061733|NCT01859130|158057367|FG000|Overall Study|Adverse Event|11|||
49061734|NCT01388166|158057368|FG000|Overall Study|Adverse Event|16|||
49061735|NCT01388166|158057368|FG000|Overall Study|Lost to Follow-up|30|||
49061736|NCT01388166|158057368|FG000|Overall Study|Others than specified above|13|||
49061737|NCT03438396|158057369|FG000|Overall Study|Reason Not Specified|9|||
49061738|NCT03438396|158057369|FG000|Overall Study|Withdrawal by Subject|5|||
49061739|NCT03438396|158057369|FG000|Overall Study|Lost to Follow-up|2|||
49061740|NCT03438396|158057369|FG000|Overall Study|Death|85|||
49061741|NCT03438396|158057369|FG000|Overall Study|Not treated|1|||
49061742|NCT00136318|158057370|FG000|Overall Study|Adverse Event|5|||
49061743|NCT00136318|158057371|FG001|Overall Study|Adverse Event|5|||
49061744|NCT00136318|158057370|FG000|Overall Study|Withdrawal by Subject|2|||
49061745|NCT00136318|158057371|FG001|Overall Study|Withdrawal by Subject|2|||
49061746|NCT01744093|158057372|FG000|Overall Study|Withdrawal by Subject|6|||
49061747|NCT01744093|158057373|FG001|Overall Study|Withdrawal by Subject|1|||
49061748|NCT02006628|158057374|FG000|Overall Study|Adverse Event|1|||
49061749|NCT02006628|158057375|FG001|Overall Study|Adverse Event|1|||
49061750|NCT02006628|158057374|FG000|Overall Study|Withdrawal by Subject|2|||
49061751|NCT02006628|158057375|FG001|Overall Study|Withdrawal by Subject|1|||
49061752|NCT01570283|158057376|FG000|Cohort 1: Dose Level 1|Death|0|||
49061753|NCT01570283|158057377|FG001|Cohort 1: Dose Level 1|Death|1|||
49061754|NCT01570283|158057378|FG002|Cohort 1: Dose Level 1|Death|0|||
49061755|NCT01570283|158057379|FG003|Cohort 1: Dose Level 1|Death|0|||
49061756|NCT01570283|158057380|FG004|Cohort 1: Dose Level 1|Death|0|||
49061757|NCT01570283|158057381|FG005|Cohort 1: Dose Level 1|Death|0|||
49061758|NCT01570283|158057376|FG000|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
49061759|NCT01570283|158057377|FG001|Cohort 1: Dose Level 1|Received other hematopoietic cells|1|||
49061760|NCT01570283|158057378|FG002|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
49061761|NCT01570283|158057379|FG003|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
49061762|NCT01570283|158057380|FG004|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
49061763|NCT01570283|158057381|FG005|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
49061764|NCT01570283|158057376|FG000|Cohort 2: Dose Level 2|Death|0|||
49061765|NCT01570283|158057377|FG001|Cohort 2: Dose Level 2|Death|0|||
49061766|NCT01570283|158057378|FG002|Cohort 2: Dose Level 2|Death|1|||
49061767|NCT01570283|158057379|FG003|Cohort 2: Dose Level 2|Death|0|||
49061768|NCT01570283|158057380|FG004|Cohort 2: Dose Level 2|Death|0|||
49061769|NCT01570283|158057381|FG005|Cohort 2: Dose Level 2|Death|0|||
49061770|NCT01570283|158057376|FG000|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
49061771|NCT01570283|158057377|FG001|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
49061772|NCT01570283|158057378|FG002|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
49061773|NCT01570283|158057379|FG003|Cohort 2: Dose Level 2|Received other hematopoietic cells|1|||
49061774|NCT01570283|158057380|FG004|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
49061775|NCT01570283|158057381|FG005|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
49061776|NCT01570283|158057376|FG000|Cohort 3: Dose Level 3|Death|0|||
49061777|NCT01570283|158057377|FG001|Cohort 3: Dose Level 3|Death|0|||
49061778|NCT01570283|158057378|FG002|Cohort 3: Dose Level 3|Death|0|||
49061779|NCT01570283|158057379|FG003|Cohort 3: Dose Level 3|Death|0|||
49061780|NCT01570283|158057380|FG004|Cohort 3: Dose Level 3|Death|0|||
49061781|NCT01570283|158057381|FG005|Cohort 3: Dose Level 3|Death|1|||
49061782|NCT01570283|158057376|FG000|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
49061783|NCT01570283|158057377|FG001|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
49061784|NCT01570283|158057378|FG002|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
49061785|NCT01570283|158057379|FG003|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
49061786|NCT01570283|158057380|FG004|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
49061787|NCT01570283|158057381|FG005|Cohort 3: Dose Level 3|Received other hematopoietic cells|1|||
49061788|NCT00841906|158057384|FG000|Overall Study|Withdrawal by Subject|2|||
49061789|NCT00841906|158057385|FG001|Overall Study|Withdrawal by Subject|0|||
49061790|NCT02072148|158057386|FG000|Overall Study|withdrew prior to surgery|23|||
49061791|NCT02072148|158057387|FG001|Overall Study|withdrew prior to surgery|0|||
49061792|NCT02072148|158057388|FG002|Overall Study|withdrew prior to surgery|0|||
49061793|NCT02072148|158057386|FG000|Overall Study|Death|0|||
49061794|NCT02072148|158057387|FG001|Overall Study|Death|0|||
49061795|NCT02072148|158057388|FG002|Overall Study|Death|1|||
49061796|NCT02072148|158057386|FG000|Overall Study|Withdrawal by Subject|0|||
49061797|NCT02072148|158057387|FG001|Overall Study|Withdrawal by Subject|13|||
49061798|NCT02072148|158057388|FG002|Overall Study|Withdrawal by Subject|12|||
49061799|NCT00430495|158057392|FG000|Overall Study|Adverse Event|2|||
49061800|NCT00430495|158057393|FG001|Overall Study|Adverse Event|3|||
49061801|NCT00430495|158057394|FG002|Overall Study|Adverse Event|2|||
49061802|NCT00430495|158057395|FG003|Overall Study|Adverse Event|0|||
49061803|NCT00430495|158057392|FG000|Overall Study|Death|0|||
49061804|NCT00430495|158057393|FG001|Overall Study|Death|0|||
49061805|NCT00430495|158057394|FG002|Overall Study|Death|1|||
49061806|NCT00430495|158057395|FG003|Overall Study|Death|0|||
49061807|NCT00430495|158057392|FG000|Overall Study|Lost to Follow-up|0|||
49061808|NCT00430495|158057393|FG001|Overall Study|Lost to Follow-up|1|||
49061809|NCT00430495|158057394|FG002|Overall Study|Lost to Follow-up|4|||
49061810|NCT00430495|158057395|FG003|Overall Study|Lost to Follow-up|0|||
49061811|NCT00430495|158057392|FG000|Overall Study|Protocol Violation|1|||
49061812|NCT00430495|158057393|FG001|Overall Study|Protocol Violation|0|||
49061813|NCT00430495|158057394|FG002|Overall Study|Protocol Violation|1|||
49061814|NCT00430495|158057395|FG003|Overall Study|Protocol Violation|0|||
49061815|NCT00430495|158057392|FG000|Overall Study|Disease Progression|1|||
49061816|NCT00430495|158057393|FG001|Overall Study|Disease Progression|1|||
49061817|NCT00430495|158057394|FG002|Overall Study|Disease Progression|0|||
49061818|NCT00430495|158057395|FG003|Overall Study|Disease Progression|0|||
49061819|NCT00430495|158057392|FG000|Overall Study|Other|8|||
49061820|NCT00430495|158057393|FG001|Overall Study|Other|2|||
49061821|NCT00430495|158057394|FG002|Overall Study|Other|5|||
49061822|NCT00430495|158057395|FG003|Overall Study|Other|4|||
49061823|NCT00430495|158057392|FG000|Overall Study|Randomized but not Treated|2|||
49061824|NCT00430495|158057393|FG001|Overall Study|Randomized but not Treated|0|||
49061825|NCT00430495|158057394|FG002|Overall Study|Randomized but not Treated|0|||
49061826|NCT00430495|158057395|FG003|Overall Study|Randomized but not Treated|0|||
49061827|NCT02751359|158057402|FG000|Overall Study|Lost to Follow-up|1|||
49061828|NCT02145026|158057406|FG000|Overall Study|Adverse Event|2|||
49061829|NCT02145026|158057406|FG000|Overall Study|Death|4|||
49061830|NCT02145026|158057406|FG000|Overall Study|Withdrawal by Subject|2|||
49061831|NCT02145026|158057406|FG000|Overall Study|Physician Decision|4|||
49061832|NCT00262041|158057409|FG000|Overall Study|Withdrawal by Subject|0|||
49061833|NCT00262041|158057410|FG001|Overall Study|Withdrawal by Subject|3|||
49061834|NCT00262041|158057411|FG002|Overall Study|Withdrawal by Subject|1|||
49061835|NCT00262041|158057409|FG000|Overall Study|Lost to Follow-up|1|||
49061836|NCT00262041|158057410|FG001|Overall Study|Lost to Follow-up|1|||
49061837|NCT00262041|158057411|FG002|Overall Study|Lost to Follow-up|5|||
49061838|NCT00262041|158057409|FG000|Overall Study|Unable to classify|1|||
49061839|NCT00262041|158057410|FG001|Overall Study|Unable to classify|0|||
49061840|NCT00262041|158057411|FG002|Overall Study|Unable to classify|0|||
49061841|NCT00127036|158057414|FG000|Overall Study|Insufficient Data for Analysis|6|||
49061842|NCT00127036|158057415|FG001|Overall Study|Insufficient Data for Analysis|11|||
49061843|NCT00127036|158057414|FG000|Overall Study|Screen Failure|2|||
49061844|NCT00127036|158057415|FG001|Overall Study|Screen Failure|0|||
49061845|NCT01462318|158057416|FG000|Main Study / TP-DI Study|Other|2|||
49061846|NCT01462318|158057417|FG001|Main Study / TP-DI Study|Other|0|||
49061847|NCT01462318|158057418|FG002|Main Study / TP-DI Study|Other|0|||
49061848|NCT01462318|158057416|FG000|Main Study / TP-DI Study|Withdrawal by Subject|2|||
49061849|NCT01462318|158057417|FG001|Main Study / TP-DI Study|Withdrawal by Subject|0|||
49061850|NCT01462318|158057418|FG002|Main Study / TP-DI Study|Withdrawal by Subject|0|||
49061851|NCT01462318|158057416|FG000|Main Study / TP-DI Study|Adverse Event|4|||
49061852|NCT01462318|158057417|FG001|Main Study / TP-DI Study|Adverse Event|0|||
49061853|NCT01462318|158057418|FG002|Main Study / TP-DI Study|Adverse Event|0|||
49061854|NCT01462318|158057416|FG000|Extension Phase|Lost to Follow-up|0|||
49061855|NCT01462318|158057417|FG001|Extension Phase|Lost to Follow-up|0|||
49061856|NCT01462318|158057418|FG002|Extension Phase|Lost to Follow-up|1|||
49061857|NCT01462318|158057416|FG000|Extension Phase|Other|0|||
49061858|NCT01462318|158057417|FG001|Extension Phase|Other|0|||
49061859|NCT01462318|158057418|FG002|Extension Phase|Other|1|||
49061860|NCT01462318|158057416|FG000|Extension Phase|Disease Progression|0|||
49061861|NCT01462318|158057417|FG001|Extension Phase|Disease Progression|0|||
49061862|NCT01462318|158057418|FG002|Extension Phase|Disease Progression|1|||
49061863|NCT01462318|158057416|FG000|Extension Phase|Withdrawal by Subject|0|||
49061864|NCT01462318|158057417|FG001|Extension Phase|Withdrawal by Subject|0|||
49061865|NCT01462318|158057418|FG002|Extension Phase|Withdrawal by Subject|15|||
49061866|NCT01462318|158057416|FG000|Extension Phase|Investigator Decision|0|||
49061867|NCT01462318|158057417|FG001|Extension Phase|Investigator Decision|0|||
49061868|NCT01462318|158057418|FG002|Extension Phase|Investigator Decision|5|||
49061869|NCT01462318|158057416|FG000|Extension Phase|Adverse Event|0|||
49061870|NCT01462318|158057417|FG001|Extension Phase|Adverse Event|0|||
49061871|NCT01462318|158057418|FG002|Extension Phase|Adverse Event|22|||
49061872|NCT03827564|158057419|FG000|Overall Study|Discontinued due to Study Termination|1|||
49061873|NCT03827564|158057420|FG001|Overall Study|Discontinued due to Study Termination|0|||
49061874|NCT00270257|158057421|FG000|Overall Study|Data Safety Monitoring Board (DSMB) halt|412|||
49061875|NCT00270257|158057422|FG001|Overall Study|Data Safety Monitoring Board (DSMB) halt|424|||
49061876|NCT04053465|158057429|FG000|Overall Study|Withdrawal by Subject|4|||
49061877|NCT04053465|158057430|FG001|Overall Study|Withdrawal by Subject|4|||
49061878|NCT01732484|158057435|FG000|Overall Study|Death|7|||
49061879|NCT01732484|158057435|FG000|Overall Study|Lost to Follow-up|14|||
49061880|NCT01732484|158057435|FG000|Overall Study|chronical illness|5|||
49061881|NCT01568320|158057436|FG000|Overall Study|Death|20|||
49061882|NCT01568320|158057436|FG000|Overall Study|Lost to Follow-up|9|||
49061883|NCT01568320|158057436|FG000|Overall Study|Withdrawal by Subject|10|||
49061884|NCT01568320|158057436|FG000|Overall Study|Conversion to open repair|1|||
49061885|NCT01568320|158057436|FG000|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1|||
49061886|NCT01359644|158057437|FG000|Treatment Period|Lack of Efficacy|0|||
49061887|NCT01359644|158057438|FG001|Treatment Period|Lack of Efficacy|1|||
49061888|NCT01359644|158057439|FG002|Treatment Period|Lack of Efficacy|0|||
49061889|NCT01359644|158057440|FG003|Treatment Period|Lack of Efficacy|0|||
49061890|NCT01359644|158057441|FG004|Treatment Period|Lack of Efficacy|0|||
49061891|NCT01359644|158057442|FG005|Treatment Period|Lack of Efficacy|0|||
49061892|NCT01359644|158057443|FG006|Treatment Period|Lack of Efficacy|0|||
49061893|NCT01359644|158057444|FG007|Treatment Period|Lack of Efficacy|0|||
49061894|NCT01359644|158057445|FG008|Treatment Period|Lack of Efficacy|0|||
49061895|NCT01359644|158057446|FG009|Treatment Period|Lack of Efficacy|0|||
49061896|NCT01359644|158057437|FG000|Treatment Period|Adverse Event|0|||
49061897|NCT01359644|158057438|FG001|Treatment Period|Adverse Event|0|||
49061898|NCT01359644|158057439|FG002|Treatment Period|Adverse Event|1|||
49061899|NCT01359644|158057440|FG003|Treatment Period|Adverse Event|0|||
49061900|NCT01359644|158057441|FG004|Treatment Period|Adverse Event|0|||
49061901|NCT01359644|158057442|FG005|Treatment Period|Adverse Event|1|||
49061902|NCT01359644|158057443|FG006|Treatment Period|Adverse Event|0|||
49061903|NCT01359644|158057444|FG007|Treatment Period|Adverse Event|0|||
49061904|NCT01359644|158057445|FG008|Treatment Period|Adverse Event|0|||
49061905|NCT01359644|158057446|FG009|Treatment Period|Adverse Event|0|||
49061906|NCT01359644|158057437|FG000|Treatment Period|Lost to Follow-up|0|||
49061907|NCT01359644|158057438|FG001|Treatment Period|Lost to Follow-up|0|||
49061908|NCT01359644|158057439|FG002|Treatment Period|Lost to Follow-up|0|||
49061909|NCT01359644|158057440|FG003|Treatment Period|Lost to Follow-up|0|||
49061910|NCT01359644|158057441|FG004|Treatment Period|Lost to Follow-up|0|||
49061911|NCT01359644|158057442|FG005|Treatment Period|Lost to Follow-up|1|||
49061912|NCT01359644|158057443|FG006|Treatment Period|Lost to Follow-up|0|||
49061913|NCT01359644|158057444|FG007|Treatment Period|Lost to Follow-up|0|||
49061914|NCT01359644|158057445|FG008|Treatment Period|Lost to Follow-up|0|||
49061915|NCT01359644|158057446|FG009|Treatment Period|Lost to Follow-up|0|||
49061916|NCT01359644|158057437|FG000|Follow-up Period|Withdrawal by Subject|0|||
49061917|NCT01359644|158057438|FG001|Follow-up Period|Withdrawal by Subject|0|||
49061918|NCT01359644|158057439|FG002|Follow-up Period|Withdrawal by Subject|0|||
49061919|NCT01359644|158057440|FG003|Follow-up Period|Withdrawal by Subject|0|||
49061920|NCT01359644|158057441|FG004|Follow-up Period|Withdrawal by Subject|0|||
49061921|NCT01359644|158057442|FG005|Follow-up Period|Withdrawal by Subject|1|||
49061922|NCT01359644|158057443|FG006|Follow-up Period|Withdrawal by Subject|0|||
49061923|NCT01359644|158057444|FG007|Follow-up Period|Withdrawal by Subject|0|||
49061924|NCT01359644|158057445|FG008|Follow-up Period|Withdrawal by Subject|0|||
49061925|NCT01359644|158057446|FG009|Follow-up Period|Withdrawal by Subject|0|||
49061926|NCT01359644|158057437|FG000|Follow-up Period|Lost to Follow-up|0|||
49061927|NCT01359644|158057438|FG001|Follow-up Period|Lost to Follow-up|0|||
49061928|NCT01359644|158057439|FG002|Follow-up Period|Lost to Follow-up|0|||
49061929|NCT01359644|158057440|FG003|Follow-up Period|Lost to Follow-up|0|||
49061930|NCT01359644|158057441|FG004|Follow-up Period|Lost to Follow-up|0|||
49061931|NCT01359644|158057442|FG005|Follow-up Period|Lost to Follow-up|0|||
49061932|NCT01359644|158057443|FG006|Follow-up Period|Lost to Follow-up|1|||
49061933|NCT01359644|158057444|FG007|Follow-up Period|Lost to Follow-up|2|||
49061934|NCT01359644|158057445|FG008|Follow-up Period|Lost to Follow-up|0|||
49061935|NCT01359644|158057446|FG009|Follow-up Period|Lost to Follow-up|0|||
49061936|NCT01621191|158057447|FG000|Overall Study|Adverse Event|9|||
49061937|NCT01621191|158057447|FG000|Overall Study|Withdrawal by Subject|8|||
49061938|NCT01621191|158057447|FG000|Overall Study|Lack of Efficacy|6|||
49061939|NCT01621191|158057447|FG000|Overall Study|Lost to Follow-up|1|||
49061940|NCT01621191|158057447|FG000|Overall Study|Site Removed From Study|1|||
49061941|NCT01550744|158057450|FG000|Open-Label|Lost to Follow-up|7|||
49061942|NCT01550744|158057451|FG001|Open-Label|Lost to Follow-up|0|||
49061943|NCT01550744|158057452|FG002|Open-Label|Lost to Follow-up|0|||
49061944|NCT01550744|158057450|FG000|Open-Label|Withdrawal by Subject|13|||
49061945|NCT01550744|158057451|FG001|Open-Label|Withdrawal by Subject|0|||
49061946|NCT01550744|158057452|FG002|Open-Label|Withdrawal by Subject|0|||
49061947|NCT01550744|158057450|FG000|Open-Label|Adverse Event|11|||
49061948|NCT01550744|158057451|FG001|Open-Label|Adverse Event|0|||
49061949|NCT01550744|158057452|FG002|Open-Label|Adverse Event|0|||
49061950|NCT01550744|158057450|FG000|Open-Label|Lack of Efficacy|4|||
49061951|NCT01550744|158057451|FG001|Open-Label|Lack of Efficacy|0|||
49061952|NCT01550744|158057452|FG002|Open-Label|Lack of Efficacy|0|||
49061953|NCT01550744|158057450|FG000|Open-Label|Protocol Violation|4|||
49061954|NCT01550744|158057451|FG001|Open-Label|Protocol Violation|0|||
49061955|NCT01550744|158057452|FG002|Open-Label|Protocol Violation|0|||
49061956|NCT01550744|158057450|FG000|Open-Label|Not all 3 study drug injections received|2|||
49061957|NCT01550744|158057451|FG001|Open-Label|Not all 3 study drug injections received|0|||
49061958|NCT01550744|158057452|FG002|Open-Label|Not all 3 study drug injections received|0|||
49061959|NCT01550744|158057450|FG000|Open-Label|Static PGA-cleared/minimal not achieved|58|||
49061960|NCT01550744|158057451|FG001|Open-Label|Static PGA-cleared/minimal not achieved|0|||
49061961|NCT01550744|158057452|FG002|Open-Label|Static PGA-cleared/minimal not achieved|0|||
49061962|NCT01550744|158057450|FG000|Open-Label|Other|1|||
49061963|NCT01550744|158057451|FG001|Open-Label|Other|0|||
49061964|NCT01550744|158057452|FG002|Open-Label|Other|0|||
49061965|NCT01550744|158057450|FG000|Double-Blind|Lost to Follow-up|0|||
49061966|NCT01550744|158057451|FG001|Double-Blind|Lost to Follow-up|6|||
49061967|NCT01550744|158057452|FG002|Double-Blind|Lost to Follow-up|12|||
49061968|NCT01550744|158057450|FG000|Double-Blind|Withdrawal by Subject|0|||
49061969|NCT01550744|158057451|FG001|Double-Blind|Withdrawal by Subject|2|||
49061970|NCT01550744|158057452|FG002|Double-Blind|Withdrawal by Subject|15|||
49061971|NCT01550744|158057450|FG000|Double-Blind|Adverse Event|0|||
49061972|NCT01550744|158057451|FG001|Double-Blind|Adverse Event|4|||
49061973|NCT01550744|158057452|FG002|Double-Blind|Adverse Event|15|||
49061974|NCT01550744|158057450|FG000|Double-Blind|Death|0|||
49061975|NCT01550744|158057451|FG001|Double-Blind|Death|1|||
49061976|NCT01550744|158057452|FG002|Double-Blind|Death|0|||
49061977|NCT01550744|158057450|FG000|Double-Blind|Lack of Efficacy|0|||
49061978|NCT01550744|158057451|FG001|Double-Blind|Lack of Efficacy|2|||
49061979|NCT01550744|158057452|FG002|Double-Blind|Lack of Efficacy|8|||
49061980|NCT01550744|158057450|FG000|Double-Blind|Protocol Violation|0|||
49061981|NCT01550744|158057451|FG001|Double-Blind|Protocol Violation|0|||
49061982|NCT01550744|158057452|FG002|Double-Blind|Protocol Violation|4|||
49061983|NCT01550744|158057450|FG000|Double-Blind|Pregnancy|0|||
49061984|NCT01550744|158057451|FG001|Double-Blind|Pregnancy|0|||
49061985|NCT01550744|158057452|FG002|Double-Blind|Pregnancy|3|||
49061986|NCT01550744|158057450|FG000|Double-Blind|Other|0|||
49061987|NCT01550744|158057451|FG001|Double-Blind|Other|2|||
49061988|NCT01550744|158057452|FG002|Double-Blind|Other|10|||
49061989|NCT03734666|158057455|FG000|Overall Study|Other|7|||
49061990|NCT03734666|158057456|FG001|Overall Study|Other|4|||
49061991|NCT03734666|158057455|FG000|Overall Study|Lost to Follow-up|12|||
49061992|NCT03734666|158057456|FG001|Overall Study|Lost to Follow-up|12|||
49061993|NCT00757848|158057457|FG000|Overall Study|Voluntary discontinuation|1|||
49061994|NCT00757848|158057458|FG001|Overall Study|Voluntary discontinuation|0|||
49061995|NCT00757848|158057457|FG000|Overall Study|Adverse Event|1|||
49061996|NCT00757848|158057458|FG001|Overall Study|Adverse Event|2|||
49061997|NCT00757848|158057457|FG000|Overall Study|Incorrect enrolment|1|||
49061998|NCT00757848|158057458|FG001|Overall Study|Incorrect enrolment|0|||
49061999|NCT02722148|158057463|FG000|Overall Study|Lost to Follow-up|2|||
49062000|NCT02722148|158057463|FG000|Overall Study|Non compliant with treatment regimen|3|||
49062001|NCT02384850|158057464|FG000|Overall Study|Withdrawal by Subject|2|||
49062002|NCT02384850|158057465|FG001|Overall Study|Withdrawal by Subject|2|||
49062003|NCT01458106|158057466|FG000|Overall Study|Withdrawal by Subject|2|||
49062004|NCT01458106|158057467|FG001|Overall Study|Withdrawal by Subject|0|||
49062005|NCT01458106|158057466|FG000|Overall Study|Pre-rFVIIIFc Adverse Event|1|||
49062006|NCT01458106|158057467|FG001|Overall Study|Pre-rFVIIIFc Adverse Event|0|||
49062007|NCT01458106|158057466|FG000|Overall Study|Withdrawn Per Protocol|0|||
49062008|NCT01458106|158057467|FG001|Overall Study|Withdrawn Per Protocol|1|||
49062009|NCT00073021|158057468|FG000|Overall Study|Protocol Violation|2|||
49062010|NCT00073021|158057469|FG001|Overall Study|Protocol Violation|1|||
49062011|NCT00073021|158057468|FG000|Overall Study|Adverse Event|4|||
49062012|NCT00073021|158057469|FG001|Overall Study|Adverse Event|4|||
49062013|NCT00073021|158057468|FG000|Overall Study|Withdrawal by Subject|6|||
49062014|NCT00073021|158057469|FG001|Overall Study|Withdrawal by Subject|5|||
49062015|NCT00073021|158057468|FG000|Overall Study|Physician Decision|3|||
49062016|NCT00073021|158057469|FG001|Overall Study|Physician Decision|1|||
49062017|NCT00073021|158057468|FG000|Overall Study|Lack of Efficacy|11|||
49062018|NCT00073021|158057469|FG001|Overall Study|Lack of Efficacy|5|||
49062019|NCT01753336|158057470|FG000|Overall Study|Patient decision|12|||
49062020|NCT01753336|158057470|FG000|Overall Study|Lost to Follow-up|3|||
49062021|NCT01753336|158057470|FG000|Overall Study|Physician Decision|2|||
49062022|NCT01753336|158057470|FG000|Overall Study|Sponsor's decision|2|||
49062023|NCT01753336|158057470|FG000|Overall Study|Withdrawal by Subject|1|||
49062024|NCT00855803|158057471|FG000|Overall Study|Death|2|||
49062025|NCT00855803|158057471|FG000|Overall Study|Lost to Follow-up|2|||
49062026|NCT00855803|158057471|FG000|Overall Study|Technical inability to undergo procedure|2|||
49062027|NCT00855803|158057471|FG000|Overall Study|Not evaluable at 3 month timepoint|2|||
49062028|NCT00855803|158057471|FG000|Overall Study|Withdrawal by Subject|3|||
49062029|NCT00855803|158057471|FG000|Overall Study|Physician Decision|3|||
49062030|NCT02013375|158057474|FG000|Overall Study|Did not engraft|1|||
49062031|NCT02013375|158057474|FG000|Overall Study|Did not engraft|1|||
49062032|NCT02478320|158057476|FG000|Overall Study|Adverse Event|2|||
49062033|NCT02478320|158057477|FG001|Overall Study|Adverse Event|0|||
49062034|NCT02478320|158057476|FG000|Overall Study|Death|1|||
49062035|NCT02478320|158057477|FG001|Overall Study|Death|0|||
49062036|NCT02478320|158057476|FG000|Overall Study|Lack of Efficacy|4|||
49062037|NCT02478320|158057477|FG001|Overall Study|Lack of Efficacy|0|||
49062038|NCT02478320|158057476|FG000|Overall Study|Withdrawal by Subject|2|||
49062039|NCT02478320|158057477|FG001|Overall Study|Withdrawal by Subject|0|||
49062040|NCT02478320|158057476|FG000|Overall Study|Screen Failure|3|||
49062041|NCT02478320|158057477|FG001|Overall Study|Screen Failure|0|||
49062042|NCT02041091|158057478|FG000|Treatment|Adverse Event|3|||
49062043|NCT02041091|158057479|FG001|Treatment|Adverse Event|3|||
49062044|NCT02041091|158057478|FG000|Treatment|Withdrawal by Subject|2|||
49062045|NCT02041091|158057479|FG001|Treatment|Withdrawal by Subject|4|||
49062046|NCT02041091|158057478|FG000|Treatment|Physician Decision|1|||
49062047|NCT02041091|158057479|FG001|Treatment|Physician Decision|0|||
49062048|NCT02041091|158057478|FG000|Treatment|Sponsor Decision|15|||
49062049|NCT02041091|158057479|FG001|Treatment|Sponsor Decision|16|||
49062050|NCT02041091|158057478|FG000|Treatment|Lost to Follow-up|1|||
49062051|NCT02041091|158057479|FG001|Treatment|Lost to Follow-up|0|||
49062052|NCT02041091|158057478|FG000|Optional Safety Extension Period|Adverse Event|4|||
49062053|NCT02041091|158057479|FG001|Optional Safety Extension Period|Adverse Event|2|||
49062054|NCT02041091|158057478|FG000|Optional Safety Extension Period|Withdrawal by Subject|5|||
49062055|NCT02041091|158057479|FG001|Optional Safety Extension Period|Withdrawal by Subject|2|||
49062056|NCT02041091|158057478|FG000|Optional Safety Extension Period|Protocol Violation|2|||
49062057|NCT02041091|158057479|FG001|Optional Safety Extension Period|Protocol Violation|0|||
49062058|NCT02041091|158057478|FG000|Optional Safety Extension Period|Physician Decision|2|||
49062059|NCT02041091|158057479|FG001|Optional Safety Extension Period|Physician Decision|1|||
49062060|NCT02041091|158057478|FG000|Optional Safety Extension Period|Sponsor Decision|70|||
49062061|NCT02041091|158057479|FG001|Optional Safety Extension Period|Sponsor Decision|74|||
49062062|NCT02041091|158057478|FG000|Optional Safety Extension Period|Lost to Follow-up|2|||
49062063|NCT02041091|158057479|FG001|Optional Safety Extension Period|Lost to Follow-up|3|||
49062064|NCT01833533|158060339|FG000|Overall Study|Adverse Event|0|||
49062065|NCT01833533|158060340|FG001|Overall Study|Adverse Event|1|||
49062066|NCT01833533|158060339|FG000|Overall Study|Lost to Follow-up|4|||
49062067|NCT01833533|158060340|FG001|Overall Study|Lost to Follow-up|9|||
49062068|NCT01833533|158060339|FG000|Overall Study|To Enter an Extension Study|0|||
49062069|NCT01833533|158060340|FG001|Overall Study|To Enter an Extension Study|4|||
49062070|NCT01833533|158060339|FG000|Overall Study|Other|2|||
49062071|NCT01833533|158060340|FG001|Overall Study|Other|7|||
49062072|NCT01196078|158060341|FG000|Overall Study|Withdrawal by Subject|3|||
49062073|NCT01196078|158060342|FG001|Overall Study|Withdrawal by Subject|5|||
49062074|NCT01196078|158060341|FG000|Overall Study|Adverse Event|4|||
49062075|NCT01196078|158060342|FG001|Overall Study|Adverse Event|4|||
49062076|NCT01196078|158060341|FG000|Overall Study|Protocol Violation|2|||
49062077|NCT01196078|158060342|FG001|Overall Study|Protocol Violation|1|||
49062078|NCT01196078|158060341|FG000|Overall Study|Lack of Efficacy|17|||
49062079|NCT01196078|158060342|FG001|Overall Study|Lack of Efficacy|23|||
49062080|NCT01196078|158060341|FG000|Overall Study|Lost to Follow-up|1|||
49062081|NCT01196078|158060342|FG001|Overall Study|Lost to Follow-up|0|||
49062082|NCT01196078|158060341|FG000|Overall Study|Death|6|||
49062083|NCT01196078|158060342|FG001|Overall Study|Death|4|||
49062084|NCT02667288|158060343|FG000|Overall Study|Protocol Violation|5|||
49062085|NCT02667288|158060343|FG000|Overall Study|Lost to Follow-up|3|||
49062086|NCT02667288|158060343|FG000|Overall Study|Withdrawal by Subject|5|||
49062087|NCT00912093|158060344|FG000|The Controlled Phase|Death|0|||
49062088|NCT00912093|158060345|FG001|The Controlled Phase|Death|1|||
49062089|NCT00912093|158060346|FG002|The Controlled Phase|Death|0|||
49062090|NCT00912093|158060347|FG003|The Controlled Phase|Death|0|||
49062091|NCT00912093|158060348|FG004|The Controlled Phase|Death|0|||
49062092|NCT00912093|158060344|FG000|The Controlled Phase|Medical Condition|0|||
49062093|NCT00912093|158060345|FG001|The Controlled Phase|Medical Condition|1|||
49062094|NCT00912093|158060346|FG002|The Controlled Phase|Medical Condition|0|||
49062095|NCT00912093|158060347|FG003|The Controlled Phase|Medical Condition|0|||
49062096|NCT00912093|158060348|FG004|The Controlled Phase|Medical Condition|0|||
49062097|NCT00912093|158060344|FG000|The Controlled Phase|Lost to Follow-up|0|||
49062098|NCT00912093|158060345|FG001|The Controlled Phase|Lost to Follow-up|0|||
49062099|NCT00912093|158060346|FG002|The Controlled Phase|Lost to Follow-up|0|||
49062100|NCT00912093|158060347|FG003|The Controlled Phase|Lost to Follow-up|0|||
49062101|NCT00912093|158060348|FG004|The Controlled Phase|Lost to Follow-up|1|||
49062102|NCT00103311|158060349|FG000|Overall Study|Lost to Follow-up|1|||
49062103|NCT00103311|158060350|FG001|Overall Study|Lost to Follow-up|0|||
49062104|NCT00103311|158060349|FG000|Overall Study|Withdrawal by Subject|2|||
49062105|NCT00103311|158060350|FG001|Overall Study|Withdrawal by Subject|1|||
49062106|NCT00103311|158060349|FG000|Overall Study|Adverse Event|1|||
49062107|NCT00103311|158060350|FG001|Overall Study|Adverse Event|0|||
49062108|NCT02400671|158060351|FG000|Overall Study|Death|5|||
49062109|NCT02400671|158060352|FG001|Overall Study|Death|3|||
49062110|NCT02400671|158060353|FG002|Overall Study|Death|4|||
49062111|NCT02400671|158060351|FG000|Overall Study|Lost to Follow-up|20|||
49062112|NCT02400671|158060352|FG001|Overall Study|Lost to Follow-up|27|||
49062113|NCT02400671|158060353|FG002|Overall Study|Lost to Follow-up|24|||
49062114|NCT02400671|158060351|FG000|Overall Study|Withdrawal by Subject|2|||
49062115|NCT02400671|158060352|FG001|Overall Study|Withdrawal by Subject|2|||
49062116|NCT02400671|158060353|FG002|Overall Study|Withdrawal by Subject|0|||
49062117|NCT01421342|158060354|FG000|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49|||
49062118|NCT01421342|158060355|FG001|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28|||
49062119|NCT01421342|158060356|FG002|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13|||
49062120|NCT01421342|158060354|FG000|Acute Treatment Phase (12 Weeks)|Adverse Event|53|||
49062121|NCT01421342|158060355|FG001|Acute Treatment Phase (12 Weeks)|Adverse Event|38|||
49062122|NCT01421342|158060356|FG002|Acute Treatment Phase (12 Weeks)|Adverse Event|27|||
49062123|NCT01421342|158060354|FG000|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23|||
49062124|NCT01421342|158060355|FG001|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20|||
49062125|NCT01421342|158060356|FG002|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13|||
49062126|NCT01421342|158060354|FG000|Acute Treatment Phase (12 Weeks)|Death|0|||
49062127|NCT01421342|158060355|FG001|Acute Treatment Phase (12 Weeks)|Death|0|||
49062128|NCT01421342|158060356|FG002|Acute Treatment Phase (12 Weeks)|Death|3|||
49062129|NCT01421342|158060354|FG000|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6|||
49062130|NCT01421342|158060355|FG001|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18|||
49062131|NCT01421342|158060356|FG002|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21|||
49062132|NCT01421342|158060354|FG000|Acute Treatment Phase (12 Weeks)|Non-adherence|15|||
49062133|NCT01421342|158060355|FG001|Acute Treatment Phase (12 Weeks)|Non-adherence|7|||
49062134|NCT01421342|158060356|FG002|Acute Treatment Phase (12 Weeks)|Non-adherence|13|||
49062135|NCT01421342|158060354|FG000|Acute Treatment Phase (12 Weeks)|Dure to other illness|3|||
49062136|NCT01421342|158060355|FG001|Acute Treatment Phase (12 Weeks)|Dure to other illness|2|||
49062137|NCT01421342|158060356|FG002|Acute Treatment Phase (12 Weeks)|Dure to other illness|4|||
49062138|NCT01421342|158060354|FG000|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
49062139|NCT01421342|158060355|FG001|Acute Treatment Phase (12 Weeks)|Participant moved away|6|||
49062140|NCT01421342|158060356|FG002|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
49062141|NCT01421342|158060354|FG000|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8|||
49062142|NCT01421342|158060355|FG001|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9|||
49062143|NCT01421342|158060356|FG002|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4|||
49062144|NCT01421342|158060354|FG000|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111|||
49062145|NCT01421342|158060355|FG001|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93|||
49062146|NCT01421342|158060356|FG002|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88|||
49062147|NCT01421342|158060354|FG000|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7|||
49062148|NCT01421342|158060355|FG001|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10|||
49062149|NCT01421342|158060356|FG002|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12|||
49062150|NCT01421342|158060354|FG000|Completed to Week 12 But Then Withdrawn|Adverse Event|4|||
49062151|NCT01421342|158060355|FG001|Completed to Week 12 But Then Withdrawn|Adverse Event|3|||
49062152|NCT01421342|158060356|FG002|Completed to Week 12 But Then Withdrawn|Adverse Event|6|||
49062153|NCT01421342|158060354|FG000|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13|||
49062154|NCT01421342|158060355|FG001|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4|||
49062155|NCT01421342|158060356|FG002|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11|||
49062156|NCT01421342|158060354|FG000|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4|||
49062157|NCT01421342|158060355|FG001|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
49062158|NCT01421342|158060356|FG002|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
49062159|NCT01421342|158060354|FG000|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
49062160|NCT01421342|158060355|FG001|Completed to Week 12 But Then Withdrawn|Non-adherence|4|||
49062161|NCT01421342|158060356|FG002|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
49062162|NCT01421342|158060354|FG000|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1|||
49062163|NCT01421342|158060355|FG001|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0|||
49062164|NCT01421342|158060356|FG002|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2|||
49062165|NCT01421342|158060354|FG000|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1|||
49062166|NCT01421342|158060355|FG001|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
49062167|NCT01421342|158060356|FG002|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
49062168|NCT01421342|158060354|FG000|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
49062169|NCT01421342|158060355|FG001|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
49062170|NCT01421342|158060356|FG002|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4|||
49062171|NCT01421342|158060354|FG000|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
49062172|NCT01421342|158060355|FG001|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
49062173|NCT01421342|158060356|FG002|Completed to Week 12 But Then Withdrawn|End of Study Time|2|||
49062174|NCT01421342|158060354|FG000|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
49062175|NCT01421342|158060355|FG001|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5|||
49062176|NCT01421342|158060356|FG002|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
49062177|NCT01421342|158060354|FG000|Continuation of Treatment (Week 12 - 36)|Adverse Event|0|||
49062178|NCT01421342|158060355|FG001|Continuation of Treatment (Week 12 - 36)|Adverse Event|6|||
49062179|NCT01421342|158060356|FG002|Continuation of Treatment (Week 12 - 36)|Adverse Event|11|||
49062180|NCT01421342|158060354|FG000|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7|||
49062181|NCT01421342|158060355|FG001|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6|||
49062182|NCT01421342|158060356|FG002|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4|||
49062183|NCT01421342|158060354|FG000|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4|||
49062184|NCT01421342|158060355|FG001|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11|||
49062185|NCT01421342|158060356|FG002|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9|||
49062186|NCT01421342|158060354|FG000|Continuation of Treatment (Week 12 - 36)|Non-adherence|3|||
49062187|NCT01421342|158060355|FG001|Continuation of Treatment (Week 12 - 36)|Non-adherence|8|||
49062188|NCT01421342|158060356|FG002|Continuation of Treatment (Week 12 - 36)|Non-adherence|4|||
49062189|NCT01421342|158060354|FG000|Continuation of Treatment (Week 12 - 36)|End of Study Time|15|||
49062190|NCT01421342|158060355|FG001|Continuation of Treatment (Week 12 - 36)|End of Study Time|20|||
49062191|NCT01421342|158060356|FG002|Continuation of Treatment (Week 12 - 36)|End of Study Time|14|||
49062192|NCT01421342|158060354|FG000|Continuation of Treatment (Week 12 - 36)|Participant moved away|4|||
49062193|NCT01421342|158060355|FG001|Continuation of Treatment (Week 12 - 36)|Participant moved away|1|||
49062194|NCT01421342|158060356|FG002|Continuation of Treatment (Week 12 - 36)|Participant moved away|3|||
49062195|NCT01421342|158060354|FG000|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
49062196|NCT01421342|158060355|FG001|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
49062197|NCT01421342|158060356|FG002|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
49062198|NCT01421342|158060354|FG000|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6|||
49062199|NCT01421342|158060355|FG001|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0|||
49062200|NCT01421342|158060356|FG002|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7|||
49062201|NCT03578237|158060357|FG000|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|14|||
49062202|NCT03578237|158060358|FG001|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|16|||
49062203|NCT04397445|158060361|FG000|Overall Study|Withdrawal by Subject|1|||
49062204|NCT04397445|158060362|FG001|Overall Study|Withdrawal by Subject|0|||
49062205|NCT04397445|158060363|FG002|Overall Study|Withdrawal by Subject|0|||
49062206|NCT04397445|158060364|FG003|Overall Study|Withdrawal by Subject|0|||
49062207|NCT02310646|158060366|FG000|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1|||
49062208|NCT02310646|158060367|FG001|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0|||
49062209|NCT02310646|158060366|FG000|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1|||
49062210|NCT02310646|158060367|FG001|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0|||
49062211|NCT00584844|158060371|FG000|Overall Study|Withdrawal by Subject|59|||
49062212|NCT00584844|158060371|FG000|Overall Study|Screen Failure|20|||
49062213|NCT00857792|158060372|FG000|Overall Study|inadequate image quality for analysis|12|||
49062214|NCT02238626|158060377|FG000|Overall Study|Adverse Event|3|||
49062215|NCT02238626|158060378|FG001|Overall Study|Adverse Event|5|||
49062216|NCT02238626|158060379|FG002|Overall Study|Adverse Event|0|||
49062217|NCT02238626|158060380|FG003|Overall Study|Adverse Event|3|||
49062218|NCT02238626|158060377|FG000|Overall Study|Lost to Follow-up|2|||
49062219|NCT02238626|158060378|FG001|Overall Study|Lost to Follow-up|4|||
49062220|NCT02238626|158060379|FG002|Overall Study|Lost to Follow-up|2|||
49062221|NCT02238626|158060380|FG003|Overall Study|Lost to Follow-up|2|||
49062222|NCT02238626|158060377|FG000|Overall Study|Withdrawal by Subject|0|||
49062223|NCT02238626|158060378|FG001|Overall Study|Withdrawal by Subject|3|||
49062224|NCT02238626|158060379|FG002|Overall Study|Withdrawal by Subject|0|||
49062225|NCT02238626|158060380|FG003|Overall Study|Withdrawal by Subject|1|||
49062226|NCT02238626|158060377|FG000|Overall Study|Death|0|||
49062227|NCT02238626|158060378|FG001|Overall Study|Death|0|||
49062228|NCT02238626|158060379|FG002|Overall Study|Death|1|||
49062229|NCT02238626|158060380|FG003|Overall Study|Death|1|||
49062230|NCT02238626|158060377|FG000|Overall Study|Other|0|||
49062231|NCT02238626|158060378|FG001|Overall Study|Other|2|||
49062232|NCT02238626|158060379|FG002|Overall Study|Other|0|||
49062233|NCT02238626|158060380|FG003|Overall Study|Other|0|||
49062234|NCT01797835|158060384|FG000|Overall Study|Lost to Follow-up|31|||
49062235|NCT01797835|158060385|FG001|Overall Study|Lost to Follow-up|27|||
49062236|NCT03001219|158060386|FG000|Proof of Concept|Study Termination by Sponsor|0|||
49062237|NCT03001219|158060387|FG001|Proof of Concept|Study Termination by Sponsor|1|||
49062238|NCT03001219|158060386|FG000|Proof of Concept|Withdrawal by Subject|0|||
49062239|NCT03001219|158060387|FG001|Proof of Concept|Withdrawal by Subject|4|||
49062240|NCT03001219|158060386|FG000|Proof of Concept|Protocol Deviation|0|||
49062241|NCT03001219|158060387|FG001|Proof of Concept|Protocol Deviation|1|||
49062242|NCT03001219|158060386|FG000|Proof of Concept|Adverse Event|1|||
49062243|NCT03001219|158060387|FG001|Proof of Concept|Adverse Event|1|||
49062244|NCT03001219|158060386|FG000|Proof of Concept|Physician Decision|1|||
49062245|NCT03001219|158060387|FG001|Proof of Concept|Physician Decision|0|||
49062246|NCT03001219|158060386|FG000|Extension Period Analysis|Study Termination by Sponsor|0|||
49062247|NCT03001219|158060387|FG001|Extension Period Analysis|Study Termination by Sponsor|36|||
49062248|NCT03001219|158060386|FG000|Extension Period Analysis|Participant Non-Compliance|0|||
49062249|NCT03001219|158060387|FG001|Extension Period Analysis|Participant Non-Compliance|1|||
49062250|NCT03001219|158060386|FG000|Extension Period Analysis|Physician Decision|0|||
49062251|NCT03001219|158060387|FG001|Extension Period Analysis|Physician Decision|1|||
49062252|NCT03001219|158060386|FG000|Extension Period Analysis|Adverse Event|1|||
49062253|NCT03001219|158060387|FG001|Extension Period Analysis|Adverse Event|1|||
49062254|NCT03001219|158060386|FG000|Extension Period Analysis|Protocol Deviation|0|||
49062255|NCT03001219|158060387|FG001|Extension Period Analysis|Protocol Deviation|1|||
49062256|NCT03001219|158060386|FG000|Extension Period Analysis|Withdrawal by Subject|4|||
49062257|NCT03001219|158060387|FG001|Extension Period Analysis|Withdrawal by Subject|5|||
49062258|NCT01660334|158060392|FG000|Overall Study|Lost to Follow-up|1|||
49062259|NCT00311311|158060393|FG000|Overall Study|Adverse Event|3|||
49062260|NCT00311311|158060394|FG001|Overall Study|Adverse Event|2|||
49062261|NCT00311311|158060393|FG000|Overall Study|Withdrawal by Subject|1|||
49062262|NCT00311311|158060394|FG001|Overall Study|Withdrawal by Subject|1|||
49062263|NCT00311311|158060393|FG000|Overall Study|Noncompliance|0|||
49062264|NCT00311311|158060394|FG001|Overall Study|Noncompliance|1|||
49062265|NCT00311311|158060393|FG000|Overall Study|Study Termination by Sponsor|3|||
49062266|NCT00311311|158060394|FG001|Overall Study|Study Termination by Sponsor|4|||
49062267|NCT00311311|158060393|FG000|Overall Study|Death|1|||
49062268|NCT00311311|158060394|FG001|Overall Study|Death|0|||
49062269|NCT00311311|158060393|FG000|Overall Study|Lack of ancillary assistance|0|||
49062270|NCT00311311|158060394|FG001|Overall Study|Lack of ancillary assistance|1|||
49062271|NCT00816361|158060395|FG000|Overall Study|Withdrawal by Subject|0|||
49062272|NCT00816361|158060396|FG001|Overall Study|Withdrawal by Subject|0|||
49062273|NCT00816361|158060397|FG002|Overall Study|Withdrawal by Subject|0|||
49062274|NCT00816361|158060398|FG003|Overall Study|Withdrawal by Subject|0|||
49062275|NCT00816361|158060399|FG004|Overall Study|Withdrawal by Subject|1|||
49062276|NCT00816361|158060400|FG005|Overall Study|Withdrawal by Subject|2|||
49062277|NCT00816361|158060401|FG006|Overall Study|Withdrawal by Subject|0|||
49062278|NCT00816361|158060402|FG007|Overall Study|Withdrawal by Subject|2|||
49062279|NCT00816361|158060403|FG008|Overall Study|Withdrawal by Subject|1|||
49062280|NCT00816361|158060395|FG000|Overall Study|Death|4|||
49062281|NCT00816361|158060396|FG001|Overall Study|Death|3|||
49062282|NCT00816361|158060397|FG002|Overall Study|Death|3|||
49062283|NCT00816361|158060398|FG003|Overall Study|Death|3|||
49062284|NCT00816361|158060399|FG004|Overall Study|Death|1|||
49062285|NCT00816361|158060400|FG005|Overall Study|Death|1|||
49062286|NCT00816361|158060401|FG006|Overall Study|Death|3|||
49062287|NCT00816361|158060402|FG007|Overall Study|Death|7|||
49062288|NCT00816361|158060403|FG008|Overall Study|Death|8|||
49062289|NCT00816361|158060395|FG000|Overall Study|Other|0|||
49062290|NCT00816361|158060396|FG001|Overall Study|Other|0|||
49062291|NCT00816361|158060397|FG002|Overall Study|Other|0|||
49062292|NCT00816361|158060398|FG003|Overall Study|Other|0|||
49062293|NCT00816361|158060399|FG004|Overall Study|Other|0|||
49062294|NCT00816361|158060400|FG005|Overall Study|Other|0|||
49062295|NCT00816361|158060401|FG006|Overall Study|Other|0|||
49062296|NCT00816361|158060402|FG007|Overall Study|Other|0|||
49062297|NCT00816361|158060403|FG008|Overall Study|Other|1|||
49062298|NCT00546572|158060407|FG000|Vax 1 / Year 0|Randomized, not treated|1|||
49062299|NCT00546572|158060408|FG001|Vax 1 / Year 0|Randomized, not treated|1|||
49062300|NCT00546572|158060407|FG000|Vax 1 / Year 0|Withdrawal by Subject|3|||
49062301|NCT00546572|158060408|FG001|Vax 1 / Year 0|Withdrawal by Subject|2|||
49062302|NCT00546572|158060407|FG000|Vax 1 / Year 0|Protocol Violation|3|||
49062303|NCT00546572|158060408|FG001|Vax 1 / Year 0|Protocol Violation|4|||
49062304|NCT00546572|158060407|FG000|Vax 1 / Year 0|Death|2|||
49062305|NCT00546572|158060408|FG001|Vax 1 / Year 0|Death|2|||
49062306|NCT00546572|158060407|FG000|Vax 1 / Year 0|Adverse Event|0|||
49062307|NCT00546572|158060408|FG001|Vax 1 / Year 0|Adverse Event|1|||
49062308|NCT00546572|158060407|FG000|Vax 1 / Year 0|Lost to Follow-up|0|||
49062309|NCT00546572|158060408|FG001|Vax 1 / Year 0|Lost to Follow-up|1|||
49062310|NCT00546572|158060407|FG000|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64|||
49062311|NCT00546572|158060408|FG001|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59|||
49062312|NCT00546572|158060407|FG000|Vax 2 / Year 1|Other|1|||
49062313|NCT00546572|158060408|FG001|Vax 2 / Year 1|Other|1|||
49062314|NCT00546572|158060407|FG000|Vax 2 / Year 1|Adverse Event|1|||
49062315|NCT00546572|158060408|FG001|Vax 2 / Year 1|Adverse Event|0|||
49062316|NCT00546572|158060407|FG000|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2|||
49062317|NCT00546572|158060408|FG001|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1|||
49062318|NCT01394952|158060409|FG000|Overall Study|Lost to Follow-up|0|||
49062319|NCT01394952|158060410|FG001|Overall Study|Lost to Follow-up|5|||
49062320|NCT01394952|158060409|FG000|Overall Study|Withdrawal by Subject|10|||
49062321|NCT01394952|158060410|FG001|Overall Study|Withdrawal by Subject|5|||
49062322|NCT01394952|158060409|FG000|Overall Study|Physician Decision|2|||
49062323|NCT01394952|158060410|FG001|Overall Study|Physician Decision|0|||
49062324|NCT01394952|158060409|FG000|Overall Study|Sponsor Decision|5|||
49062325|NCT01394952|158060410|FG001|Overall Study|Sponsor Decision|7|||
49062326|NCT01986010|158060411|FG000|Overall Study|Adverse Event|0|||
49062327|NCT01986010|158060412|FG001|Overall Study|Adverse Event|1|||
49062328|NCT01986010|158060413|FG002|Overall Study|Adverse Event|0|||
49062329|NCT01986010|158060414|FG003|Overall Study|Adverse Event|0|||
49062330|NCT01986010|158060415|FG004|Overall Study|Adverse Event|0|||
49062331|NCT01986010|158060416|FG005|Overall Study|Adverse Event|0|||
49062332|NCT01986010|158060417|FG006|Overall Study|Adverse Event|0|||
49062333|NCT01986010|158060418|FG007|Overall Study|Adverse Event|0|||
49062334|NCT01986010|158060419|FG008|Overall Study|Adverse Event|0|||
49062335|NCT01986010|158060420|FG009|Overall Study|Adverse Event|0|||
49062336|NCT01986010|158060421|FG010|Overall Study|Adverse Event|0|||
49062337|NCT01986010|158060422|FG011|Overall Study|Adverse Event|0|||
49062338|NCT01986010|158060423|FG012|Overall Study|Adverse Event|0|||
49062339|NCT01986010|158060424|FG013|Overall Study|Adverse Event|0|||
49062340|NCT01986010|158060425|FG014|Overall Study|Adverse Event|0|||
49062341|NCT01986010|158060426|FG015|Overall Study|Adverse Event|1|||
49062342|NCT01986010|158060427|FG016|Overall Study|Adverse Event|0|||
49062343|NCT01986010|158060411|FG000|Overall Study|Lost to Follow-up|2|||
49062344|NCT01986010|158060412|FG001|Overall Study|Lost to Follow-up|1|||
49062345|NCT01986010|158060413|FG002|Overall Study|Lost to Follow-up|2|||
49062346|NCT01986010|158060414|FG003|Overall Study|Lost to Follow-up|2|||
49062347|NCT01986010|158060415|FG004|Overall Study|Lost to Follow-up|2|||
49062348|NCT01986010|158060416|FG005|Overall Study|Lost to Follow-up|2|||
49062349|NCT01986010|158060417|FG006|Overall Study|Lost to Follow-up|0|||
49062350|NCT01986010|158060418|FG007|Overall Study|Lost to Follow-up|0|||
49062351|NCT01986010|158060419|FG008|Overall Study|Lost to Follow-up|4|||
49062352|NCT01986010|158060420|FG009|Overall Study|Lost to Follow-up|2|||
49062353|NCT01986010|158060421|FG010|Overall Study|Lost to Follow-up|0|||
49062354|NCT01986010|158060422|FG011|Overall Study|Lost to Follow-up|1|||
49062355|NCT01986010|158060423|FG012|Overall Study|Lost to Follow-up|1|||
49062356|NCT01986010|158060424|FG013|Overall Study|Lost to Follow-up|1|||
49062357|NCT01986010|158060425|FG014|Overall Study|Lost to Follow-up|2|||
49062358|NCT01986010|158060426|FG015|Overall Study|Lost to Follow-up|0|||
49062359|NCT01986010|158060427|FG016|Overall Study|Lost to Follow-up|0|||
49062360|NCT01986010|158060411|FG000|Overall Study|Physician Decision|0|||
49062361|NCT01986010|158060412|FG001|Overall Study|Physician Decision|0|||
49062362|NCT01986010|158060413|FG002|Overall Study|Physician Decision|0|||
49062363|NCT01986010|158060414|FG003|Overall Study|Physician Decision|0|||
49062364|NCT01986010|158060415|FG004|Overall Study|Physician Decision|0|||
49062365|NCT01986010|158060416|FG005|Overall Study|Physician Decision|0|||
49062366|NCT01986010|158060417|FG006|Overall Study|Physician Decision|0|||
49062367|NCT01986010|158060418|FG007|Overall Study|Physician Decision|0|||
49062368|NCT01986010|158060419|FG008|Overall Study|Physician Decision|0|||
49062369|NCT01986010|158060420|FG009|Overall Study|Physician Decision|0|||
49062370|NCT01986010|158060421|FG010|Overall Study|Physician Decision|0|||
49062371|NCT01986010|158060422|FG011|Overall Study|Physician Decision|0|||
49062372|NCT01986010|158060423|FG012|Overall Study|Physician Decision|0|||
49062373|NCT01986010|158060424|FG013|Overall Study|Physician Decision|0|||
49062374|NCT01986010|158060425|FG014|Overall Study|Physician Decision|1|||
49062375|NCT01986010|158060426|FG015|Overall Study|Physician Decision|0|||
49062376|NCT01986010|158060427|FG016|Overall Study|Physician Decision|0|||
49062377|NCT01986010|158060411|FG000|Overall Study|Withdrawal by Subject|2|||
49062378|NCT01986010|158060412|FG001|Overall Study|Withdrawal by Subject|2|||
49062379|NCT01986010|158060413|FG002|Overall Study|Withdrawal by Subject|3|||
49062380|NCT01986010|158060414|FG003|Overall Study|Withdrawal by Subject|0|||
49062381|NCT01986010|158060415|FG004|Overall Study|Withdrawal by Subject|2|||
49062382|NCT01986010|158060416|FG005|Overall Study|Withdrawal by Subject|4|||
49062383|NCT01986010|158060417|FG006|Overall Study|Withdrawal by Subject|0|||
49062384|NCT01986010|158060418|FG007|Overall Study|Withdrawal by Subject|0|||
49062385|NCT01986010|158060419|FG008|Overall Study|Withdrawal by Subject|0|||
49062386|NCT01986010|158060420|FG009|Overall Study|Withdrawal by Subject|0|||
49062387|NCT01986010|158060421|FG010|Overall Study|Withdrawal by Subject|0|||
49062388|NCT01986010|158060422|FG011|Overall Study|Withdrawal by Subject|2|||
49062389|NCT01986010|158060423|FG012|Overall Study|Withdrawal by Subject|0|||
49062390|NCT01986010|158060424|FG013|Overall Study|Withdrawal by Subject|1|||
49062391|NCT01986010|158060425|FG014|Overall Study|Withdrawal by Subject|2|||
49062392|NCT01986010|158060426|FG015|Overall Study|Withdrawal by Subject|0|||
49062393|NCT01986010|158060427|FG016|Overall Study|Withdrawal by Subject|0|||
49062394|NCT01986010|158060411|FG000|Overall Study|Status Not Recorded|2|||
49062395|NCT01986010|158060412|FG001|Overall Study|Status Not Recorded|4|||
49062396|NCT01986010|158060413|FG002|Overall Study|Status Not Recorded|2|||
49062397|NCT01986010|158060414|FG003|Overall Study|Status Not Recorded|0|||
49062398|NCT01986010|158060415|FG004|Overall Study|Status Not Recorded|1|||
49062399|NCT01986010|158060416|FG005|Overall Study|Status Not Recorded|2|||
49062400|NCT01986010|158060417|FG006|Overall Study|Status Not Recorded|0|||
49062401|NCT01986010|158060418|FG007|Overall Study|Status Not Recorded|0|||
49062402|NCT01986010|158060419|FG008|Overall Study|Status Not Recorded|2|||
49062403|NCT01986010|158060420|FG009|Overall Study|Status Not Recorded|1|||
49062404|NCT01986010|158060421|FG010|Overall Study|Status Not Recorded|7|||
49062405|NCT01986010|158060422|FG011|Overall Study|Status Not Recorded|7|||
49062406|NCT01986010|158060423|FG012|Overall Study|Status Not Recorded|9|||
49062407|NCT01986010|158060424|FG013|Overall Study|Status Not Recorded|9|||
49062408|NCT01986010|158060425|FG014|Overall Study|Status Not Recorded|5|||
49062409|NCT01986010|158060426|FG015|Overall Study|Status Not Recorded|10|||
49062410|NCT01986010|158060427|FG016|Overall Study|Status Not Recorded|4|||
49062411|NCT01481324|158060434|FG000|Overall Study|Missing Data|0|||
49062412|NCT01481324|158060435|FG001|Overall Study|Missing Data|2|||
49062413|NCT01481324|158060436|FG002|Overall Study|Missing Data|2|||
49062414|NCT03334721|158060438|FG000|Overall Study|Withdrawal by Subject|1|||
49062415|NCT03334721|158060439|FG001|Overall Study|Withdrawal by Subject|0|||
49062416|NCT03334721|158060438|FG000|Overall Study|No longer met inclusion/exclusion criter|1|||
49062417|NCT03334721|158060439|FG001|Overall Study|No longer met inclusion/exclusion criter|0|||
49062418|NCT00922987|158060440|FG000|Overall Study|Insufficient clinical response|1|||
49062419|NCT00922987|158060440|FG000|Overall Study|Protocol Violation|2|||
49062420|NCT00922987|158060440|FG000|Overall Study|Adverse Event|1|||
49062421|NCT01672970|158060441|FG000|Overall Study|Lack of Efficacy|12|||
49062422|NCT01672970|158060441|FG000|Overall Study|Adverse Event|18|||
49062423|NCT01672970|158060441|FG000|Overall Study|Withdrawal by Subject|2|||
49062424|NCT01672970|158060441|FG000|Overall Study|Lost to Follow-up|5|||
49062425|NCT01672970|158060441|FG000|Overall Study|Other|9|||
49062426|NCT01672970|158060441|FG000|Overall Study|Enrolled but not treated|1|||
49062427|NCT03118570|158060442|FG000|Overall Study|Adverse Event|2|||
49062428|NCT03118570|158060443|FG001|Overall Study|Adverse Event|0|||
49062429|NCT03118570|158060444|FG002|Overall Study|Adverse Event|0|||
49062430|NCT03118570|158060445|FG003|Overall Study|Adverse Event|0|||
49062431|NCT03118570|158060446|FG004|Overall Study|Adverse Event|3|||
49062432|NCT03118570|158060442|FG000|Overall Study|Withdrawal by Subject|0|||
49062433|NCT03118570|158060443|FG001|Overall Study|Withdrawal by Subject|1|||
49062434|NCT03118570|158060444|FG002|Overall Study|Withdrawal by Subject|4|||
49062435|NCT03118570|158060445|FG003|Overall Study|Withdrawal by Subject|0|||
49062436|NCT03118570|158060446|FG004|Overall Study|Withdrawal by Subject|1|||
49062437|NCT03118570|158060442|FG000|Overall Study|Lost to Follow-up|2|||
49062438|NCT03118570|158060443|FG001|Overall Study|Lost to Follow-up|3|||
49062439|NCT03118570|158060444|FG002|Overall Study|Lost to Follow-up|1|||
49062440|NCT03118570|158060445|FG003|Overall Study|Lost to Follow-up|0|||
49062441|NCT03118570|158060446|FG004|Overall Study|Lost to Follow-up|1|||
49062442|NCT03118570|158060442|FG000|Overall Study|Other, Not Specified|1|||
49062443|NCT03118570|158060443|FG001|Overall Study|Other, Not Specified|3|||
49062444|NCT03118570|158060444|FG002|Overall Study|Other, Not Specified|0|||
49062445|NCT03118570|158060445|FG003|Overall Study|Other, Not Specified|0|||
49062446|NCT03118570|158060446|FG004|Overall Study|Other, Not Specified|0|||
49062447|NCT03918109|158060447|FG000|Overall Study|Withdrawal by Subject|0|||
49062448|NCT03918109|158060448|FG001|Overall Study|Withdrawal by Subject|0|||
49062449|NCT03918109|158060449|FG002|Overall Study|Withdrawal by Subject|2|||
49062450|NCT03918109|158060450|FG003|Overall Study|Withdrawal by Subject|1|||
49062451|NCT03918109|158060447|FG000|Overall Study|Lost to Follow-up|0|||
49062452|NCT03918109|158060448|FG001|Overall Study|Lost to Follow-up|0|||
49062453|NCT03918109|158060449|FG002|Overall Study|Lost to Follow-up|0|||
49062454|NCT03918109|158060450|FG003|Overall Study|Lost to Follow-up|1|||
49062455|NCT03970837|158060451|FG000|Overall Study|Adverse Event|23|||
49062456|NCT03970837|158060452|FG001|Overall Study|Adverse Event|20|||
49062457|NCT03970837|158060453|FG002|Overall Study|Adverse Event|16|||
49062458|NCT03970837|158060454|FG003|Overall Study|Adverse Event|6|||
49062459|NCT03970837|158060455|FG004|Overall Study|Adverse Event|4|||
49062460|NCT03970837|158060456|FG005|Overall Study|Adverse Event|5|||
49062461|NCT03970837|158060457|FG006|Overall Study|Adverse Event|1|||
49062462|NCT03970837|158060458|FG007|Overall Study|Adverse Event|5|||
49062463|NCT03970837|158060459|FG008|Overall Study|Adverse Event|0|||
49062464|NCT03970837|158060460|FG009|Overall Study|Adverse Event|0|||
49062465|NCT03970837|158060461|FG010|Overall Study|Adverse Event|1|||
49062466|NCT03970837|158060462|FG011|Overall Study|Adverse Event|1|||
49062467|NCT03970837|158060451|FG000|Overall Study|Lack of Efficacy|14|||
49062468|NCT03970837|158060452|FG001|Overall Study|Lack of Efficacy|12|||
49062469|NCT03970837|158060453|FG002|Overall Study|Lack of Efficacy|1|||
49062470|NCT03970837|158060454|FG003|Overall Study|Lack of Efficacy|2|||
49062471|NCT03970837|158060455|FG004|Overall Study|Lack of Efficacy|3|||
49062472|NCT03970837|158060456|FG005|Overall Study|Lack of Efficacy|4|||
49062473|NCT03970837|158060457|FG006|Overall Study|Lack of Efficacy|6|||
49062474|NCT03970837|158060458|FG007|Overall Study|Lack of Efficacy|1|||
49062475|NCT03970837|158060459|FG008|Overall Study|Lack of Efficacy|1|||
49062476|NCT03970837|158060460|FG009|Overall Study|Lack of Efficacy|0|||
49062477|NCT03970837|158060461|FG010|Overall Study|Lack of Efficacy|0|||
49062478|NCT03970837|158060462|FG011|Overall Study|Lack of Efficacy|0|||
49062479|NCT03970837|158060451|FG000|Overall Study|Lost to Follow-up|6|||
49062480|NCT03970837|158060452|FG001|Overall Study|Lost to Follow-up|5|||
49062481|NCT03970837|158060453|FG002|Overall Study|Lost to Follow-up|5|||
49062482|NCT03970837|158060454|FG003|Overall Study|Lost to Follow-up|1|||
49062483|NCT03970837|158060455|FG004|Overall Study|Lost to Follow-up|0|||
49062484|NCT03970837|158060456|FG005|Overall Study|Lost to Follow-up|2|||
49062485|NCT03970837|158060457|FG006|Overall Study|Lost to Follow-up|0|||
49062486|NCT03970837|158060458|FG007|Overall Study|Lost to Follow-up|0|||
49062487|NCT03970837|158060459|FG008|Overall Study|Lost to Follow-up|0|||
49062488|NCT03970837|158060460|FG009|Overall Study|Lost to Follow-up|0|||
49062489|NCT03970837|158060461|FG010|Overall Study|Lost to Follow-up|0|||
49062490|NCT03970837|158060462|FG011|Overall Study|Lost to Follow-up|0|||
49062491|NCT03970837|158060451|FG000|Overall Study|Protocol Violation|1|||
49062492|NCT03970837|158060452|FG001|Overall Study|Protocol Violation|0|||
49062493|NCT03970837|158060453|FG002|Overall Study|Protocol Violation|0|||
49062494|NCT03970837|158060454|FG003|Overall Study|Protocol Violation|0|||
49062495|NCT03970837|158060455|FG004|Overall Study|Protocol Violation|0|||
49062496|NCT03970837|158060456|FG005|Overall Study|Protocol Violation|0|||
49062497|NCT03970837|158060457|FG006|Overall Study|Protocol Violation|0|||
49062498|NCT03970837|158060458|FG007|Overall Study|Protocol Violation|0|||
49062499|NCT03970837|158060459|FG008|Overall Study|Protocol Violation|0|||
49062500|NCT03970837|158060460|FG009|Overall Study|Protocol Violation|0|||
49062501|NCT03970837|158060461|FG010|Overall Study|Protocol Violation|0|||
49062502|NCT03970837|158060462|FG011|Overall Study|Protocol Violation|0|||
49062503|NCT03970837|158060451|FG000|Overall Study|Physician Decision|5|||
49062504|NCT03970837|158060452|FG001|Overall Study|Physician Decision|8|||
49062505|NCT03970837|158060453|FG002|Overall Study|Physician Decision|4|||
49062506|NCT03970837|158060454|FG003|Overall Study|Physician Decision|1|||
49062507|NCT03970837|158060455|FG004|Overall Study|Physician Decision|5|||
49062508|NCT03970837|158060456|FG005|Overall Study|Physician Decision|2|||
49062509|NCT03970837|158060457|FG006|Overall Study|Physician Decision|4|||
49062510|NCT03970837|158060458|FG007|Overall Study|Physician Decision|5|||
49062511|NCT03970837|158060459|FG008|Overall Study|Physician Decision|0|||
49062512|NCT03970837|158060460|FG009|Overall Study|Physician Decision|1|||
49062513|NCT03970837|158060461|FG010|Overall Study|Physician Decision|0|||
49062514|NCT03970837|158060462|FG011|Overall Study|Physician Decision|0|||
49062515|NCT03970837|158060451|FG000|Overall Study|Withdrawal by Subject|32|||
49062516|NCT03970837|158060452|FG001|Overall Study|Withdrawal by Subject|35|||
49062517|NCT03970837|158060453|FG002|Overall Study|Withdrawal by Subject|12|||
49062518|NCT03970837|158060454|FG003|Overall Study|Withdrawal by Subject|8|||
49062519|NCT03970837|158060455|FG004|Overall Study|Withdrawal by Subject|6|||
49062520|NCT03970837|158060456|FG005|Overall Study|Withdrawal by Subject|8|||
49062521|NCT03970837|158060457|FG006|Overall Study|Withdrawal by Subject|2|||
49062522|NCT03970837|158060458|FG007|Overall Study|Withdrawal by Subject|3|||
49062523|NCT03970837|158060459|FG008|Overall Study|Withdrawal by Subject|0|||
49062524|NCT03970837|158060460|FG009|Overall Study|Withdrawal by Subject|0|||
49062525|NCT03970837|158060461|FG010|Overall Study|Withdrawal by Subject|0|||
49062526|NCT03970837|158060462|FG011|Overall Study|Withdrawal by Subject|1|||
49062527|NCT03970837|158060451|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|3|||
49062528|NCT03970837|158060452|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|12|||
49062529|NCT03970837|158060453|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
49062530|NCT03970837|158060454|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
49062531|NCT03970837|158060455|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
49062532|NCT03970837|158060456|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
49062533|NCT03970837|158060457|FG006|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
49062534|NCT03970837|158060458|FG007|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
49062535|NCT03970837|158060459|FG008|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
49062536|NCT03970837|158060460|FG009|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
49062537|NCT03970837|158060461|FG010|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
49062538|NCT03970837|158060462|FG011|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
49062539|NCT03970837|158060451|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
49062540|NCT03970837|158060452|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
49062541|NCT03970837|158060453|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
49062542|NCT03970837|158060454|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
49062543|NCT03970837|158060455|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
49062544|NCT03970837|158060456|FG005|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
49062545|NCT03970837|158060457|FG006|Overall Study|STUDY TERMINATED BY SPONSOR|8|||
49062546|NCT03970837|158060458|FG007|Overall Study|STUDY TERMINATED BY SPONSOR|11|||
49062547|NCT03970837|158060459|FG008|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
49062548|NCT03970837|158060460|FG009|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
49062549|NCT03970837|158060461|FG010|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
49062550|NCT03970837|158060462|FG011|Overall Study|STUDY TERMINATED BY SPONSOR|3|||
49062551|NCT02132754|158060464|FG000|Overall Study|Adverse Event|0|||
49062552|NCT02132754|158060465|FG001|Overall Study|Adverse Event|0|||
49062553|NCT02132754|158060466|FG002|Overall Study|Adverse Event|0|||
49062554|NCT02132754|158060467|FG003|Overall Study|Adverse Event|0|||
49062555|NCT02132754|158060468|FG004|Overall Study|Adverse Event|0|||
49062556|NCT02132754|158060469|FG005|Overall Study|Adverse Event|0|||
49062557|NCT02132754|158060470|FG006|Overall Study|Adverse Event|0|||
49062558|NCT02132754|158060471|FG007|Overall Study|Adverse Event|0|||
49062559|NCT02132754|158060472|FG008|Overall Study|Adverse Event|0|||
49062560|NCT02132754|158060473|FG009|Overall Study|Adverse Event|0|||
49062561|NCT02132754|158060474|FG010|Overall Study|Adverse Event|0|||
49062562|NCT02132754|158060475|FG011|Overall Study|Adverse Event|0|||
49062563|NCT02132754|158060476|FG012|Overall Study|Adverse Event|0|||
49062564|NCT02132754|158060477|FG013|Overall Study|Adverse Event|0|||
49062565|NCT02132754|158060478|FG014|Overall Study|Adverse Event|0|||
49062566|NCT02132754|158060479|FG015|Overall Study|Adverse Event|0|||
49062567|NCT02132754|158060480|FG016|Overall Study|Adverse Event|0|||
49062568|NCT02132754|158060481|FG017|Overall Study|Adverse Event|1|||
49062569|NCT02132754|158060482|FG018|Overall Study|Adverse Event|0|||
49062570|NCT02132754|158060483|FG019|Overall Study|Adverse Event|0|||
49062571|NCT02132754|158060484|FG020|Overall Study|Adverse Event|0|||
49062572|NCT02132754|158060485|FG021|Overall Study|Adverse Event|0|||
49062573|NCT02132754|158060486|FG022|Overall Study|Adverse Event|0|||
49062574|NCT02132754|158060487|FG023|Overall Study|Adverse Event|0|||
49062575|NCT02132754|158060488|FG024|Overall Study|Adverse Event|0|||
49062576|NCT02132754|158060489|FG025|Overall Study|Adverse Event|1|||
49062577|NCT02132754|158060490|FG026|Overall Study|Adverse Event|1|||
49062578|NCT02132754|158060491|FG027|Overall Study|Adverse Event|0|||
49062579|NCT02132754|158060492|FG028|Overall Study|Adverse Event|0|||
49062580|NCT02132754|158060493|FG029|Overall Study|Adverse Event|0|||
49062581|NCT02132754|158060494|FG030|Overall Study|Adverse Event|1|||
49062582|NCT02132754|158060495|FG031|Overall Study|Adverse Event|0|||
49062583|NCT02132754|158060496|FG032|Overall Study|Adverse Event|1|||
49062584|NCT02132754|158060497|FG033|Overall Study|Adverse Event|1|||
49062585|NCT02132754|158060464|FG000|Overall Study|Clinical Progression|0|||
49062586|NCT02132754|158060465|FG001|Overall Study|Clinical Progression|0|||
49062587|NCT02132754|158060466|FG002|Overall Study|Clinical Progression|0|||
49062588|NCT02132754|158060467|FG003|Overall Study|Clinical Progression|0|||
49062589|NCT02132754|158060468|FG004|Overall Study|Clinical Progression|0|||
49062590|NCT02132754|158060469|FG005|Overall Study|Clinical Progression|0|||
49062591|NCT02132754|158060470|FG006|Overall Study|Clinical Progression|0|||
49062592|NCT02132754|158060471|FG007|Overall Study|Clinical Progression|0|||
49062593|NCT02132754|158060472|FG008|Overall Study|Clinical Progression|0|||
49062594|NCT02132754|158060473|FG009|Overall Study|Clinical Progression|1|||
49062595|NCT02132754|158060474|FG010|Overall Study|Clinical Progression|0|||
49062596|NCT02132754|158060475|FG011|Overall Study|Clinical Progression|0|||
49062597|NCT02132754|158060476|FG012|Overall Study|Clinical Progression|0|||
49062598|NCT02132754|158060477|FG013|Overall Study|Clinical Progression|0|||
49062599|NCT02132754|158060478|FG014|Overall Study|Clinical Progression|0|||
49062600|NCT02132754|158060479|FG015|Overall Study|Clinical Progression|0|||
49062601|NCT02132754|158060480|FG016|Overall Study|Clinical Progression|1|||
49062602|NCT02132754|158060481|FG017|Overall Study|Clinical Progression|1|||
49062603|NCT02132754|158060482|FG018|Overall Study|Clinical Progression|0|||
49062604|NCT02132754|158060483|FG019|Overall Study|Clinical Progression|1|||
49062605|NCT02132754|158060484|FG020|Overall Study|Clinical Progression|0|||
49062606|NCT02132754|158060485|FG021|Overall Study|Clinical Progression|0|||
49062607|NCT02132754|158060486|FG022|Overall Study|Clinical Progression|1|||
49062608|NCT02132754|158060487|FG023|Overall Study|Clinical Progression|0|||
49062609|NCT02132754|158060488|FG024|Overall Study|Clinical Progression|1|||
49062610|NCT02132754|158060489|FG025|Overall Study|Clinical Progression|1|||
49062611|NCT02132754|158060490|FG026|Overall Study|Clinical Progression|0|||
49062612|NCT02132754|158060491|FG027|Overall Study|Clinical Progression|1|||
49062613|NCT02132754|158060492|FG028|Overall Study|Clinical Progression|1|||
49062614|NCT02132754|158060493|FG029|Overall Study|Clinical Progression|0|||
49062615|NCT02132754|158060494|FG030|Overall Study|Clinical Progression|1|||
49062616|NCT02132754|158060495|FG031|Overall Study|Clinical Progression|0|||
49062617|NCT02132754|158060496|FG032|Overall Study|Clinical Progression|0|||
49062618|NCT02132754|158060497|FG033|Overall Study|Clinical Progression|2|||
49062619|NCT02132754|158060464|FG000|Overall Study|Death|0|||
49062620|NCT02132754|158060465|FG001|Overall Study|Death|0|||
49062621|NCT02132754|158060466|FG002|Overall Study|Death|0|||
49062622|NCT02132754|158060467|FG003|Overall Study|Death|0|||
49062623|NCT02132754|158060468|FG004|Overall Study|Death|0|||
49062624|NCT02132754|158060469|FG005|Overall Study|Death|0|||
49062625|NCT02132754|158060470|FG006|Overall Study|Death|0|||
49062626|NCT02132754|158060471|FG007|Overall Study|Death|0|||
49062627|NCT02132754|158060472|FG008|Overall Study|Death|0|||
49062628|NCT02132754|158060473|FG009|Overall Study|Death|0|||
49062629|NCT02132754|158060474|FG010|Overall Study|Death|0|||
49062630|NCT02132754|158060475|FG011|Overall Study|Death|0|||
49062631|NCT02132754|158060476|FG012|Overall Study|Death|0|||
49062632|NCT02132754|158060477|FG013|Overall Study|Death|0|||
49062633|NCT02132754|158060478|FG014|Overall Study|Death|0|||
49062634|NCT02132754|158060479|FG015|Overall Study|Death|1|||
49062635|NCT02132754|158060480|FG016|Overall Study|Death|0|||
49062636|NCT02132754|158060481|FG017|Overall Study|Death|0|||
49062637|NCT02132754|158060482|FG018|Overall Study|Death|0|||
49062638|NCT02132754|158060483|FG019|Overall Study|Death|1|||
49062639|NCT02132754|158060484|FG020|Overall Study|Death|0|||
49062640|NCT02132754|158060485|FG021|Overall Study|Death|1|||
49062641|NCT02132754|158060486|FG022|Overall Study|Death|0|||
49062642|NCT02132754|158060487|FG023|Overall Study|Death|0|||
49062643|NCT02132754|158060488|FG024|Overall Study|Death|0|||
49062644|NCT02132754|158060489|FG025|Overall Study|Death|0|||
49062645|NCT02132754|158060490|FG026|Overall Study|Death|1|||
49062646|NCT02132754|158060491|FG027|Overall Study|Death|0|||
49062647|NCT02132754|158060492|FG028|Overall Study|Death|0|||
49062648|NCT02132754|158060493|FG029|Overall Study|Death|0|||
49062649|NCT02132754|158060494|FG030|Overall Study|Death|0|||
49062650|NCT02132754|158060495|FG031|Overall Study|Death|0|||
49062651|NCT02132754|158060496|FG032|Overall Study|Death|0|||
49062652|NCT02132754|158060497|FG033|Overall Study|Death|2|||
49062653|NCT02132754|158060464|FG000|Overall Study|Excluded Medication|0|||
49062654|NCT02132754|158060465|FG001|Overall Study|Excluded Medication|0|||
49062655|NCT02132754|158060466|FG002|Overall Study|Excluded Medication|0|||
49062656|NCT02132754|158060467|FG003|Overall Study|Excluded Medication|0|||
49062657|NCT02132754|158060468|FG004|Overall Study|Excluded Medication|0|||
49062658|NCT02132754|158060469|FG005|Overall Study|Excluded Medication|0|||
49062659|NCT02132754|158060470|FG006|Overall Study|Excluded Medication|0|||
49062660|NCT02132754|158060471|FG007|Overall Study|Excluded Medication|0|||
49062661|NCT02132754|158060472|FG008|Overall Study|Excluded Medication|0|||
49062662|NCT02132754|158060473|FG009|Overall Study|Excluded Medication|0|||
49062663|NCT02132754|158060474|FG010|Overall Study|Excluded Medication|0|||
49062664|NCT02132754|158060475|FG011|Overall Study|Excluded Medication|0|||
49062665|NCT02132754|158060476|FG012|Overall Study|Excluded Medication|0|||
49062666|NCT02132754|158060477|FG013|Overall Study|Excluded Medication|0|||
49062667|NCT02132754|158060478|FG014|Overall Study|Excluded Medication|0|||
49062668|NCT02132754|158060479|FG015|Overall Study|Excluded Medication|0|||
49062669|NCT02132754|158060480|FG016|Overall Study|Excluded Medication|0|||
49062670|NCT02132754|158060481|FG017|Overall Study|Excluded Medication|0|||
49062671|NCT02132754|158060482|FG018|Overall Study|Excluded Medication|0|||
49062672|NCT02132754|158060483|FG019|Overall Study|Excluded Medication|0|||
49062673|NCT02132754|158060484|FG020|Overall Study|Excluded Medication|1|||
49062674|NCT02132754|158060485|FG021|Overall Study|Excluded Medication|0|||
49062675|NCT02132754|158060486|FG022|Overall Study|Excluded Medication|0|||
49062676|NCT02132754|158060487|FG023|Overall Study|Excluded Medication|0|||
49062677|NCT02132754|158060488|FG024|Overall Study|Excluded Medication|0|||
49062678|NCT02132754|158060489|FG025|Overall Study|Excluded Medication|0|||
49062679|NCT02132754|158060490|FG026|Overall Study|Excluded Medication|0|||
49062680|NCT02132754|158060491|FG027|Overall Study|Excluded Medication|0|||
49062681|NCT02132754|158060492|FG028|Overall Study|Excluded Medication|0|||
49062682|NCT02132754|158060493|FG029|Overall Study|Excluded Medication|0|||
49062683|NCT02132754|158060494|FG030|Overall Study|Excluded Medication|0|||
49062684|NCT02132754|158060495|FG031|Overall Study|Excluded Medication|0|||
49062685|NCT02132754|158060496|FG032|Overall Study|Excluded Medication|0|||
49062686|NCT02132754|158060497|FG033|Overall Study|Excluded Medication|1|||
49062687|NCT02132754|158060464|FG000|Overall Study|Physician Decision|0|||
49062688|NCT02132754|158060465|FG001|Overall Study|Physician Decision|0|||
49062689|NCT02132754|158060466|FG002|Overall Study|Physician Decision|0|||
49062690|NCT02132754|158060467|FG003|Overall Study|Physician Decision|0|||
49062691|NCT02132754|158060468|FG004|Overall Study|Physician Decision|0|||
49062692|NCT02132754|158060469|FG005|Overall Study|Physician Decision|0|||
49062693|NCT02132754|158060470|FG006|Overall Study|Physician Decision|0|||
49062694|NCT02132754|158060471|FG007|Overall Study|Physician Decision|0|||
49062695|NCT02132754|158060472|FG008|Overall Study|Physician Decision|0|||
49062696|NCT02132754|158060473|FG009|Overall Study|Physician Decision|1|||
49062697|NCT02132754|158060474|FG010|Overall Study|Physician Decision|0|||
49062698|NCT02132754|158060475|FG011|Overall Study|Physician Decision|1|||
49062699|NCT02132754|158060476|FG012|Overall Study|Physician Decision|1|||
49062700|NCT02132754|158060477|FG013|Overall Study|Physician Decision|0|||
49062701|NCT02132754|158060478|FG014|Overall Study|Physician Decision|0|||
49062702|NCT02132754|158060479|FG015|Overall Study|Physician Decision|1|||
49062703|NCT02132754|158060480|FG016|Overall Study|Physician Decision|0|||
49062704|NCT02132754|158060481|FG017|Overall Study|Physician Decision|0|||
49062705|NCT02132754|158060482|FG018|Overall Study|Physician Decision|0|||
49062706|NCT02132754|158060483|FG019|Overall Study|Physician Decision|0|||
49062707|NCT02132754|158060484|FG020|Overall Study|Physician Decision|0|||
49062708|NCT02132754|158060485|FG021|Overall Study|Physician Decision|0|||
49062709|NCT02132754|158060486|FG022|Overall Study|Physician Decision|0|||
49062710|NCT02132754|158060487|FG023|Overall Study|Physician Decision|0|||
49062711|NCT02132754|158060488|FG024|Overall Study|Physician Decision|1|||
49062712|NCT02132754|158060489|FG025|Overall Study|Physician Decision|0|||
49062713|NCT02132754|158060490|FG026|Overall Study|Physician Decision|0|||
49062714|NCT02132754|158060491|FG027|Overall Study|Physician Decision|0|||
49062715|NCT02132754|158060492|FG028|Overall Study|Physician Decision|0|||
49062716|NCT02132754|158060493|FG029|Overall Study|Physician Decision|0|||
49062717|NCT02132754|158060494|FG030|Overall Study|Physician Decision|0|||
49062718|NCT02132754|158060495|FG031|Overall Study|Physician Decision|1|||
49062719|NCT02132754|158060496|FG032|Overall Study|Physician Decision|0|||
49062720|NCT02132754|158060497|FG033|Overall Study|Physician Decision|3|||
49062721|NCT02132754|158060464|FG000|Overall Study|Progressive Disease|1|||
49062722|NCT02132754|158060465|FG001|Overall Study|Progressive Disease|1|||
49062723|NCT02132754|158060466|FG002|Overall Study|Progressive Disease|1|||
49062724|NCT02132754|158060467|FG003|Overall Study|Progressive Disease|1|||
49062725|NCT02132754|158060468|FG004|Overall Study|Progressive Disease|1|||
49062726|NCT02132754|158060469|FG005|Overall Study|Progressive Disease|1|||
49062727|NCT02132754|158060470|FG006|Overall Study|Progressive Disease|1|||
49062728|NCT02132754|158060471|FG007|Overall Study|Progressive Disease|1|||
49062729|NCT02132754|158060472|FG008|Overall Study|Progressive Disease|1|||
49062730|NCT02132754|158060473|FG009|Overall Study|Progressive Disease|3|||
49062731|NCT02132754|158060474|FG010|Overall Study|Progressive Disease|3|||
49062732|NCT02132754|158060475|FG011|Overall Study|Progressive Disease|2|||
49062733|NCT02132754|158060476|FG012|Overall Study|Progressive Disease|2|||
49062734|NCT02132754|158060477|FG013|Overall Study|Progressive Disease|3|||
49062735|NCT02132754|158060478|FG014|Overall Study|Progressive Disease|2|||
49062736|NCT02132754|158060479|FG015|Overall Study|Progressive Disease|1|||
49062737|NCT02132754|158060480|FG016|Overall Study|Progressive Disease|2|||
49062738|NCT02132754|158060481|FG017|Overall Study|Progressive Disease|1|||
49062739|NCT02132754|158060482|FG018|Overall Study|Progressive Disease|3|||
49062740|NCT02132754|158060483|FG019|Overall Study|Progressive Disease|1|||
49062741|NCT02132754|158060484|FG020|Overall Study|Progressive Disease|1|||
49062742|NCT02132754|158060485|FG021|Overall Study|Progressive Disease|3|||
49062743|NCT02132754|158060486|FG022|Overall Study|Progressive Disease|2|||
49062744|NCT02132754|158060487|FG023|Overall Study|Progressive Disease|3|||
49062745|NCT02132754|158060488|FG024|Overall Study|Progressive Disease|0|||
49062746|NCT02132754|158060489|FG025|Overall Study|Progressive Disease|1|||
49062747|NCT02132754|158060490|FG026|Overall Study|Progressive Disease|2|||
49062748|NCT02132754|158060491|FG027|Overall Study|Progressive Disease|1|||
49062749|NCT02132754|158060492|FG028|Overall Study|Progressive Disease|2|||
49062750|NCT02132754|158060493|FG029|Overall Study|Progressive Disease|3|||
49062751|NCT02132754|158060494|FG030|Overall Study|Progressive Disease|1|||
49062752|NCT02132754|158060495|FG031|Overall Study|Progressive Disease|1|||
49062753|NCT02132754|158060496|FG032|Overall Study|Progressive Disease|3|||
49062754|NCT02132754|158060497|FG033|Overall Study|Progressive Disease|6|||
49062755|NCT02132754|158060464|FG000|Overall Study|Screen Failure|0|||
49062756|NCT02132754|158060465|FG001|Overall Study|Screen Failure|0|||
49062757|NCT02132754|158060466|FG002|Overall Study|Screen Failure|0|||
49062758|NCT02132754|158060467|FG003|Overall Study|Screen Failure|0|||
49062759|NCT02132754|158060468|FG004|Overall Study|Screen Failure|0|||
49062760|NCT02132754|158060469|FG005|Overall Study|Screen Failure|0|||
49062761|NCT02132754|158060470|FG006|Overall Study|Screen Failure|0|||
49062762|NCT02132754|158060471|FG007|Overall Study|Screen Failure|0|||
49062763|NCT02132754|158060472|FG008|Overall Study|Screen Failure|0|||
49062764|NCT02132754|158060473|FG009|Overall Study|Screen Failure|0|||
49062765|NCT02132754|158060474|FG010|Overall Study|Screen Failure|0|||
49062766|NCT02132754|158060475|FG011|Overall Study|Screen Failure|0|||
49062767|NCT02132754|158060476|FG012|Overall Study|Screen Failure|0|||
49062768|NCT02132754|158060477|FG013|Overall Study|Screen Failure|0|||
49062769|NCT02132754|158060478|FG014|Overall Study|Screen Failure|0|||
49062770|NCT02132754|158060479|FG015|Overall Study|Screen Failure|0|||
49062771|NCT02132754|158060480|FG016|Overall Study|Screen Failure|0|||
49062772|NCT02132754|158060481|FG017|Overall Study|Screen Failure|0|||
49062773|NCT02132754|158060482|FG018|Overall Study|Screen Failure|0|||
49062774|NCT02132754|158060483|FG019|Overall Study|Screen Failure|1|||
49062775|NCT02132754|158060484|FG020|Overall Study|Screen Failure|0|||
49062776|NCT02132754|158060485|FG021|Overall Study|Screen Failure|1|||
49062777|NCT02132754|158060486|FG022|Overall Study|Screen Failure|0|||
49062778|NCT02132754|158060487|FG023|Overall Study|Screen Failure|0|||
49062779|NCT02132754|158060488|FG024|Overall Study|Screen Failure|0|||
49062780|NCT02132754|158060489|FG025|Overall Study|Screen Failure|0|||
49062781|NCT02132754|158060490|FG026|Overall Study|Screen Failure|0|||
49062782|NCT02132754|158060491|FG027|Overall Study|Screen Failure|0|||
49062783|NCT02132754|158060492|FG028|Overall Study|Screen Failure|0|||
49062784|NCT02132754|158060493|FG029|Overall Study|Screen Failure|0|||
49062785|NCT02132754|158060494|FG030|Overall Study|Screen Failure|0|||
49062786|NCT02132754|158060495|FG031|Overall Study|Screen Failure|0|||
49062787|NCT02132754|158060496|FG032|Overall Study|Screen Failure|0|||
49062788|NCT02132754|158060497|FG033|Overall Study|Screen Failure|0|||
49062789|NCT02132754|158060464|FG000|Overall Study|Transferred to Extension Study|0|||
49062790|NCT02132754|158060465|FG001|Overall Study|Transferred to Extension Study|0|||
49062791|NCT02132754|158060466|FG002|Overall Study|Transferred to Extension Study|0|||
49062792|NCT02132754|158060467|FG003|Overall Study|Transferred to Extension Study|0|||
49062793|NCT02132754|158060468|FG004|Overall Study|Transferred to Extension Study|0|||
49062794|NCT02132754|158060469|FG005|Overall Study|Transferred to Extension Study|0|||
49062795|NCT02132754|158060470|FG006|Overall Study|Transferred to Extension Study|0|||
49062796|NCT02132754|158060471|FG007|Overall Study|Transferred to Extension Study|0|||
49062797|NCT02132754|158060472|FG008|Overall Study|Transferred to Extension Study|0|||
49062798|NCT02132754|158060473|FG009|Overall Study|Transferred to Extension Study|0|||
49062799|NCT02132754|158060474|FG010|Overall Study|Transferred to Extension Study|0|||
49062800|NCT02132754|158060475|FG011|Overall Study|Transferred to Extension Study|0|||
49062801|NCT02132754|158060476|FG012|Overall Study|Transferred to Extension Study|0|||
49062802|NCT02132754|158060477|FG013|Overall Study|Transferred to Extension Study|0|||
49062803|NCT02132754|158060478|FG014|Overall Study|Transferred to Extension Study|0|||
49062804|NCT02132754|158060479|FG015|Overall Study|Transferred to Extension Study|0|||
49062805|NCT02132754|158060480|FG016|Overall Study|Transferred to Extension Study|0|||
49062806|NCT02132754|158060481|FG017|Overall Study|Transferred to Extension Study|0|||
49062807|NCT02132754|158060482|FG018|Overall Study|Transferred to Extension Study|0|||
49062808|NCT02132754|158060483|FG019|Overall Study|Transferred to Extension Study|0|||
49062809|NCT02132754|158060484|FG020|Overall Study|Transferred to Extension Study|0|||
49062810|NCT02132754|158060485|FG021|Overall Study|Transferred to Extension Study|0|||
49062811|NCT02132754|158060486|FG022|Overall Study|Transferred to Extension Study|0|||
49062812|NCT02132754|158060487|FG023|Overall Study|Transferred to Extension Study|0|||
49062813|NCT02132754|158060488|FG024|Overall Study|Transferred to Extension Study|0|||
49062814|NCT02132754|158060489|FG025|Overall Study|Transferred to Extension Study|0|||
49062815|NCT02132754|158060490|FG026|Overall Study|Transferred to Extension Study|0|||
49062816|NCT02132754|158060491|FG027|Overall Study|Transferred to Extension Study|0|||
49062817|NCT02132754|158060492|FG028|Overall Study|Transferred to Extension Study|0|||
49062818|NCT02132754|158060493|FG029|Overall Study|Transferred to Extension Study|0|||
49062819|NCT02132754|158060494|FG030|Overall Study|Transferred to Extension Study|0|||
49062820|NCT02132754|158060495|FG031|Overall Study|Transferred to Extension Study|0|||
49062821|NCT02132754|158060496|FG032|Overall Study|Transferred to Extension Study|0|||
49062822|NCT02132754|158060497|FG033|Overall Study|Transferred to Extension Study|6|||
49062823|NCT02132754|158060464|FG000|Overall Study|Withdrawal by Subject|0|||
49062824|NCT02132754|158060465|FG001|Overall Study|Withdrawal by Subject|0|||
49062825|NCT02132754|158060466|FG002|Overall Study|Withdrawal by Subject|0|||
49062826|NCT02132754|158060467|FG003|Overall Study|Withdrawal by Subject|0|||
49062827|NCT02132754|158060468|FG004|Overall Study|Withdrawal by Subject|0|||
49062828|NCT02132754|158060469|FG005|Overall Study|Withdrawal by Subject|0|||
49062829|NCT02132754|158060470|FG006|Overall Study|Withdrawal by Subject|0|||
49062830|NCT02132754|158060471|FG007|Overall Study|Withdrawal by Subject|0|||
49062831|NCT02132754|158060472|FG008|Overall Study|Withdrawal by Subject|0|||
49062832|NCT02132754|158060473|FG009|Overall Study|Withdrawal by Subject|1|||
49062833|NCT02132754|158060474|FG010|Overall Study|Withdrawal by Subject|0|||
49062834|NCT02132754|158060475|FG011|Overall Study|Withdrawal by Subject|0|||
49062835|NCT02132754|158060476|FG012|Overall Study|Withdrawal by Subject|1|||
49062836|NCT02132754|158060477|FG013|Overall Study|Withdrawal by Subject|0|||
49062837|NCT02132754|158060478|FG014|Overall Study|Withdrawal by Subject|1|||
49062838|NCT02132754|158060479|FG015|Overall Study|Withdrawal by Subject|2|||
49062839|NCT02132754|158060480|FG016|Overall Study|Withdrawal by Subject|1|||
49062840|NCT02132754|158060481|FG017|Overall Study|Withdrawal by Subject|0|||
49062841|NCT02132754|158060482|FG018|Overall Study|Withdrawal by Subject|0|||
49062842|NCT02132754|158060483|FG019|Overall Study|Withdrawal by Subject|0|||
49062843|NCT02132754|158060484|FG020|Overall Study|Withdrawal by Subject|1|||
49062844|NCT02132754|158060485|FG021|Overall Study|Withdrawal by Subject|0|||
49062845|NCT02132754|158060486|FG022|Overall Study|Withdrawal by Subject|0|||
49062846|NCT02132754|158060487|FG023|Overall Study|Withdrawal by Subject|0|||
49062847|NCT02132754|158060488|FG024|Overall Study|Withdrawal by Subject|1|||
49062848|NCT02132754|158060489|FG025|Overall Study|Withdrawal by Subject|0|||
49062849|NCT02132754|158060490|FG026|Overall Study|Withdrawal by Subject|0|||
49062850|NCT02132754|158060491|FG027|Overall Study|Withdrawal by Subject|1|||
49062851|NCT02132754|158060492|FG028|Overall Study|Withdrawal by Subject|0|||
49062852|NCT02132754|158060493|FG029|Overall Study|Withdrawal by Subject|0|||
49062853|NCT02132754|158060494|FG030|Overall Study|Withdrawal by Subject|0|||
49062854|NCT02132754|158060495|FG031|Overall Study|Withdrawal by Subject|1|||
49062855|NCT02132754|158060496|FG032|Overall Study|Withdrawal by Subject|0|||
49062856|NCT02132754|158060497|FG033|Overall Study|Withdrawal by Subject|2|||
49062857|NCT03510182|158060498|FG000|Overall Study|Withdrawal by Subject|2|||
49062858|NCT00289874|158060502|FG000|Overall Study|Adverse Event|1|||
49062859|NCT00289874|158060503|FG001|Overall Study|Adverse Event|5|||
49062860|NCT00289874|158060502|FG000|Overall Study|Lost to Follow-up|1|||
49062861|NCT00289874|158060503|FG001|Overall Study|Lost to Follow-up|1|||
49062862|NCT00289874|158060502|FG000|Overall Study|Protocol Violation|3|||
49062863|NCT00289874|158060503|FG001|Overall Study|Protocol Violation|2|||
49062864|NCT00289874|158060502|FG000|Overall Study|Did not meet eligibility|1|||
49062865|NCT00289874|158060503|FG001|Overall Study|Did not meet eligibility|0|||
49062866|NCT01425723|158060506|FG000|Overall Study|Lack of Efficacy|0|||
49062867|NCT01425723|158060507|FG001|Overall Study|Lack of Efficacy|1|||
49062868|NCT01425723|158060506|FG000|Overall Study|Withdrawal by Subject|1|||
49062869|NCT01425723|158060507|FG001|Overall Study|Withdrawal by Subject|4|||
49062870|NCT01425723|158060506|FG000|Overall Study|Lost to Follow-up|0|||
49062871|NCT01425723|158060507|FG001|Overall Study|Lost to Follow-up|3|||
49062872|NCT01425723|158060506|FG000|Overall Study|Physician Decision|2|||
49062873|NCT01425723|158060507|FG001|Overall Study|Physician Decision|0|||
49062874|NCT01425723|158060506|FG000|Overall Study|Other|1|||
49062875|NCT01425723|158060507|FG001|Overall Study|Other|10|||
49062876|NCT01565850|158060508|FG000|Overall Study|Adverse Event|0|||
49062877|NCT01565850|158060509|FG001|Overall Study|Adverse Event|1|||
49062878|NCT01565850|158060508|FG000|Overall Study|Lost to Follow-up|12|||
49062879|NCT01565850|158060509|FG001|Overall Study|Lost to Follow-up|4|||
49062880|NCT01565850|158060508|FG000|Overall Study|Investigator's Discretion|2|||
49062881|NCT01565850|158060509|FG001|Overall Study|Investigator's Discretion|1|||
49062882|NCT01565850|158060508|FG000|Overall Study|Participant noncompliance|2|||
49062883|NCT01565850|158060509|FG001|Overall Study|Participant noncompliance|0|||
49062884|NCT01565850|158060508|FG000|Overall Study|Withdrew Consent|4|||
49062885|NCT01565850|158060509|FG001|Overall Study|Withdrew Consent|2|||
49062886|NCT00446199|158060510|FG000|Overall Study|Adverse Event|7|||
49062887|NCT00446199|158060511|FG001|Overall Study|Adverse Event|4|||
49062888|NCT00446199|158060512|FG002|Overall Study|Adverse Event|6|||
49062889|NCT00446199|158060513|FG003|Overall Study|Adverse Event|4|||
49062890|NCT00446199|158060510|FG000|Overall Study|Lost to Follow-up|4|||
49062891|NCT00446199|158060511|FG001|Overall Study|Lost to Follow-up|5|||
49062892|NCT00446199|158060512|FG002|Overall Study|Lost to Follow-up|2|||
49062893|NCT00446199|158060513|FG003|Overall Study|Lost to Follow-up|6|||
49062894|NCT00446199|158060510|FG000|Overall Study|Protocol Violation|1|||
49062895|NCT00446199|158060511|FG001|Overall Study|Protocol Violation|2|||
49062896|NCT00446199|158060512|FG002|Overall Study|Protocol Violation|1|||
49062897|NCT00446199|158060513|FG003|Overall Study|Protocol Violation|3|||
49062898|NCT00446199|158060510|FG000|Overall Study|Withdrawal by Subject|2|||
49062899|NCT00446199|158060511|FG001|Overall Study|Withdrawal by Subject|5|||
49062900|NCT00446199|158060512|FG002|Overall Study|Withdrawal by Subject|9|||
49062901|NCT00446199|158060513|FG003|Overall Study|Withdrawal by Subject|10|||
49062902|NCT00446199|158060510|FG000|Overall Study|Site termination|2|||
49062903|NCT00446199|158060511|FG001|Overall Study|Site termination|0|||
49062904|NCT00446199|158060512|FG002|Overall Study|Site termination|0|||
49062905|NCT00446199|158060513|FG003|Overall Study|Site termination|1|||
49062906|NCT00446199|158060510|FG000|Overall Study|Randomization in Error|2|||
49062907|NCT00446199|158060511|FG001|Overall Study|Randomization in Error|0|||
49062908|NCT00446199|158060512|FG002|Overall Study|Randomization in Error|1|||
49062909|NCT00446199|158060513|FG003|Overall Study|Randomization in Error|1|||
49062910|NCT00446199|158060510|FG000|Overall Study|Lack of Efficacy|1|||
49062911|NCT00446199|158060511|FG001|Overall Study|Lack of Efficacy|0|||
49062912|NCT00446199|158060512|FG002|Overall Study|Lack of Efficacy|0|||
49062913|NCT00446199|158060513|FG003|Overall Study|Lack of Efficacy|1|||
49062914|NCT00446199|158060510|FG000|Overall Study|Non-compliant with study drug|1|||
49062915|NCT00446199|158060511|FG001|Overall Study|Non-compliant with study drug|0|||
49062916|NCT00446199|158060512|FG002|Overall Study|Non-compliant with study drug|5|||
49062917|NCT00446199|158060513|FG003|Overall Study|Non-compliant with study drug|0|||
49062918|NCT00446199|158060510|FG000|Overall Study|Non-compliant with visit schedule|1|||
49062919|NCT00446199|158060511|FG001|Overall Study|Non-compliant with visit schedule|1|||
49062920|NCT00446199|158060512|FG002|Overall Study|Non-compliant with visit schedule|1|||
49062921|NCT00446199|158060513|FG003|Overall Study|Non-compliant with visit schedule|2|||
49062922|NCT00446199|158060510|FG000|Overall Study|Hormone fear|0|||
49062923|NCT00446199|158060511|FG001|Overall Study|Hormone fear|0|||
49062924|NCT00446199|158060512|FG002|Overall Study|Hormone fear|0|||
49062925|NCT00446199|158060513|FG003|Overall Study|Hormone fear|1|||
49062926|NCT00446199|158060510|FG000|Overall Study|Lost interest in study participation|0|||
49005544|NCT00943384|157857783|FG000|Overall Study|Treated off protocol-protocol violation|5|||
49005545|NCT00943384|157857783|FG000|Overall Study|Lost to Follow-up|16|||
49005546|NCT00943384|157857783|FG000|Overall Study|Withdrawal by Subject|5|||
49005547|NCT01396278|157857784|FG000|Overall Study|Adverse Event|0|||
49005548|NCT01396278|157857785|FG001|Overall Study|Adverse Event|0|||
49005549|NCT01396278|157857786|FG002|Overall Study|Adverse Event|0|||
49005550|NCT01396278|157857787|FG003|Overall Study|Adverse Event|2|||
49005551|NCT01396278|157857788|FG004|Overall Study|Adverse Event|0|||
49062927|NCT00446199|158060511|FG001|Overall Study|Lost interest in study participation|1|||
49062928|NCT00446199|158060512|FG002|Overall Study|Lost interest in study participation|0|||
49062929|NCT00446199|158060513|FG003|Overall Study|Lost interest in study participation|0|||
49062930|NCT00446199|158060510|FG000|Overall Study|In-/Exclusion criterion violated|2|||
49062931|NCT00446199|158060511|FG001|Overall Study|In-/Exclusion criterion violated|1|||
49062932|NCT00446199|158060512|FG002|Overall Study|In-/Exclusion criterion violated|2|||
49062933|NCT00446199|158060513|FG003|Overall Study|In-/Exclusion criterion violated|1|||
49062934|NCT00446199|158060510|FG000|Overall Study|Move|0|||
49062935|NCT00446199|158060511|FG001|Overall Study|Move|1|||
49062936|NCT00446199|158060512|FG002|Overall Study|Move|0|||
49062937|NCT00446199|158060513|FG003|Overall Study|Move|0|||
49062938|NCT01169532|158060514|FG000|Overall Study|Withdrawal by Subject|1|||
49062939|NCT00960115|158060517|FG000|Overall Study|Ongoing treatment at data cut-off date|19|||
49062940|NCT00960115|158060518|FG001|Overall Study|Ongoing treatment at data cut-off date|15|||
49062941|NCT03258853|158060519|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
49062942|NCT03258853|158060520|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
49062943|NCT01030341|158062129|FG000|Overall Study|Withdrawal by Subject|1|||
49062944|NCT01030341|158062129|FG000|Overall Study|Lost to Follow-up|2|||
49062945|NCT01685073|158062130|FG000|Overall Study|Lost to Follow-up|6|||
49062946|NCT01685073|158062131|FG001|Overall Study|Lost to Follow-up|8|||
49062947|NCT01685073|158062130|FG000|Overall Study|Withdrawal by Subject|24|||
49062948|NCT01685073|158062131|FG001|Overall Study|Withdrawal by Subject|24|||
49062949|NCT00821873|158062134|FG000|Overall Study|Lost to Follow-up|4|||
49062950|NCT00759902|158062137|FG000|Overall Study|Adverse Event|0|||
49062951|NCT00759902|158062138|FG001|Overall Study|Adverse Event|1|||
49062952|NCT00158756|158062143|FG000|Overall Study|Withdrawal by Subject|5|||
49062953|NCT00158756|158062144|FG001|Overall Study|Withdrawal by Subject|0|||
49062954|NCT00158756|158062145|FG002|Overall Study|Withdrawal by Subject|6|||
49062955|NCT00158756|158062146|FG003|Overall Study|Withdrawal by Subject|1|||
49062956|NCT00158756|158062147|FG004|Overall Study|Withdrawal by Subject|3|||
49062957|NCT00158756|158062143|FG000|Overall Study|Adverse Event|0|||
49062958|NCT00158756|158062144|FG001|Overall Study|Adverse Event|0|||
49062959|NCT00158756|158062145|FG002|Overall Study|Adverse Event|1|||
49062960|NCT00158756|158062146|FG003|Overall Study|Adverse Event|0|||
49062961|NCT00158756|158062147|FG004|Overall Study|Adverse Event|0|||
49062962|NCT00158756|158062143|FG000|Overall Study|Serious adverse event|0|||
49062963|NCT00158756|158062144|FG001|Overall Study|Serious adverse event|0|||
49062964|NCT00158756|158062145|FG002|Overall Study|Serious adverse event|1|||
49062965|NCT00158756|158062146|FG003|Overall Study|Serious adverse event|0|||
49062966|NCT00158756|158062147|FG004|Overall Study|Serious adverse event|0|||
49062967|NCT01173471|158062150|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
49062968|NCT01173471|158062151|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
49062969|NCT01173471|158062152|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
49062970|NCT01173471|158062153|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
49062971|NCT01173471|158062150|FG000|Overall Study|Condition under investigation worsened|2|||
49062972|NCT01173471|158062151|FG001|Overall Study|Condition under investigation worsened|0|||
49062973|NCT01173471|158062152|FG002|Overall Study|Condition under investigation worsened|0|||
49062974|NCT01173471|158062153|FG003|Overall Study|Condition under investigation worsened|0|||
49062975|NCT01173471|158062150|FG000|Overall Study|Lost to Follow-up|0|||
49062976|NCT01173471|158062151|FG001|Overall Study|Lost to Follow-up|0|||
49062977|NCT01173471|158062152|FG002|Overall Study|Lost to Follow-up|1|||
49062978|NCT01173471|158062153|FG003|Overall Study|Lost to Follow-up|0|||
49062979|NCT01173471|158062150|FG000|Overall Study|Reason given as Other|0|||
49062980|NCT01173471|158062151|FG001|Overall Study|Reason given as Other|0|||
49062981|NCT01173471|158062152|FG002|Overall Study|Reason given as Other|1|||
49062982|NCT01173471|158062153|FG003|Overall Study|Reason given as Other|0|||
49062983|NCT03921151|158062154|FG000|Overall Study|Withdrawal by Subject|11|||
49062984|NCT03921151|158062155|FG001|Overall Study|Withdrawal by Subject|16|||
49062985|NCT01429051|158062156|FG000|Titration Phase|Death|1|||
49062986|NCT01429051|158062156|FG000|Titration Phase|Withdrawal by Subject|7|||
49062987|NCT01429051|158062156|FG000|Titration Phase|Physician Decision|1|||
49062988|NCT01429051|158062156|FG000|Titration Phase|Unsuccessful titration at any dose|1|||
49062989|NCT01429051|158062156|FG000|Titration Phase|Less than 3 BTP episodes per week|2|||
49062990|NCT01429051|158062156|FG000|Efficacy Phase|Adverse Event|1|||
49062991|NCT01429051|158062156|FG000|Efficacy Phase|Death|1|||
49062992|NCT01429051|158062156|FG000|Tolerability Phase|Death|5|||
49062993|NCT01429051|158062156|FG000|Tolerability Phase|Adverse Event|2|||
49062994|NCT01429051|158062156|FG000|Tolerability Phase|Withdrawal by Subject|5|||
49062995|NCT01429051|158062156|FG000|Tolerability Phase|Physician Decision|1|||
49062996|NCT01429051|158062156|FG000|Tolerability Phase|Other|2|||
49062997|NCT00891371|158062162|FG000|Pre-assignment|Inclusion/exclusion|5|||
49062998|NCT00891371|158062162|FG000|Pre-assignment|Consent withdrawal|1|||
49062999|NCT00891371|158062162|FG000|Treatment|Lack of Efficacy|5|||
49063000|NCT00891371|158062162|FG000|Treatment|Adverse Event|2|||
49063001|NCT00891371|158062162|FG000|Treatment|Death|1|||
49063002|NCT00891371|158062162|FG000|Treatment|Lost to Follow-up|1|||
49063003|NCT03656874|158062163|FG000|Overall Study|Lost to Follow-up|3|||
49063004|NCT03656874|158062164|FG001|Overall Study|Lost to Follow-up|17|||
49063005|NCT02488330|158062165|FG000|Overall Study|Adverse Event|1|||
49063006|NCT02488330|158062165|FG000|Overall Study|Physician Decision|2|||
49063007|NCT02488330|158062165|FG000|Overall Study|Death|2|||
49063008|NCT02488330|158062165|FG000|Overall Study|Disease Progression|3|||
49063009|NCT02488330|158062165|FG000|Overall Study|Study Termination by Sponsor|4|||
49063010|NCT01206816|158062166|FG000|Overall Study|Protocol Violation|0|||
49063011|NCT01206816|158062167|FG001|Overall Study|Protocol Violation|0|||
49063012|NCT01206816|158062168|FG002|Overall Study|Protocol Violation|1|||
49063013|NCT01206816|158062169|FG003|Overall Study|Protocol Violation|0|||
49063014|NCT01206816|158062170|FG004|Overall Study|Protocol Violation|0|||
49063015|NCT01206816|158062171|FG005|Overall Study|Protocol Violation|0|||
49063016|NCT01206816|158062172|FG006|Overall Study|Protocol Violation|0|||
49063017|NCT01206816|158062166|FG000|Overall Study|Withdrawal by Subject|0|||
49063018|NCT01206816|158062167|FG001|Overall Study|Withdrawal by Subject|0|||
49063019|NCT01206816|158062168|FG002|Overall Study|Withdrawal by Subject|1|||
49063020|NCT01206816|158062169|FG003|Overall Study|Withdrawal by Subject|0|||
49063021|NCT01206816|158062170|FG004|Overall Study|Withdrawal by Subject|0|||
49063022|NCT01206816|158062171|FG005|Overall Study|Withdrawal by Subject|0|||
49063023|NCT01206816|158062172|FG006|Overall Study|Withdrawal by Subject|0|||
49063024|NCT01206816|158062166|FG000|Overall Study|Progressive disease|3|||
49063025|NCT01206816|158062167|FG001|Overall Study|Progressive disease|3|||
49063026|NCT01206816|158062168|FG002|Overall Study|Progressive disease|13|||
49063027|NCT01206816|158062169|FG003|Overall Study|Progressive disease|3|||
49063028|NCT01206816|158062170|FG004|Overall Study|Progressive disease|3|||
49063029|NCT01206816|158062171|FG005|Overall Study|Progressive disease|16|||
49063030|NCT01206816|158062172|FG006|Overall Study|Progressive disease|3|||
49063031|NCT01206816|158062166|FG000|Overall Study|Other AE|0|||
49063032|NCT01206816|158062167|FG001|Overall Study|Other AE|0|||
49063033|NCT01206816|158062168|FG002|Overall Study|Other AE|4|||
49063034|NCT01206816|158062169|FG003|Overall Study|Other AE|0|||
49063035|NCT01206816|158062170|FG004|Overall Study|Other AE|0|||
49063036|NCT01206816|158062171|FG005|Overall Study|Other AE|3|||
49063037|NCT01206816|158062172|FG006|Overall Study|Other AE|2|||
49063038|NCT01206816|158062166|FG000|Overall Study|other than stated above|0|||
49063039|NCT01206816|158062167|FG001|Overall Study|other than stated above|0|||
49063040|NCT01206816|158062168|FG002|Overall Study|other than stated above|1|||
49063041|NCT01206816|158062169|FG003|Overall Study|other than stated above|0|||
49063042|NCT01206816|158062170|FG004|Overall Study|other than stated above|0|||
49063043|NCT01206816|158062171|FG005|Overall Study|other than stated above|0|||
49063044|NCT01206816|158062172|FG006|Overall Study|other than stated above|1|||
49063045|NCT01403064|158062173|FG000|Overall Study|Death|0|||
49063046|NCT01403064|158062174|FG001|Overall Study|Death|0|||
49063047|NCT01403064|158062175|FG002|Overall Study|Death|1|||
49063048|NCT01403064|158062176|FG003|Overall Study|Death|1|||
49063049|NCT01403064|158062173|FG000|Overall Study|Withdrawal by Subject|0|||
49063050|NCT01403064|158062174|FG001|Overall Study|Withdrawal by Subject|0|||
49063051|NCT01403064|158062175|FG002|Overall Study|Withdrawal by Subject|1|||
49063052|NCT01403064|158062176|FG003|Overall Study|Withdrawal by Subject|1|||
49063053|NCT01403064|158062173|FG000|Overall Study|Other|1|||
49063054|NCT01403064|158062174|FG001|Overall Study|Other|0|||
49063055|NCT01403064|158062175|FG002|Overall Study|Other|2|||
49063056|NCT01403064|158062176|FG003|Overall Study|Other|1|||
49063057|NCT02622113|158062177|FG000|Overall Study|Adverse Event|4|||
49063058|NCT02622113|158062178|FG001|Overall Study|Adverse Event|4|||
49063059|NCT02622113|158062177|FG000|Overall Study|Physician Decision|0|||
49063060|NCT02622113|158062178|FG001|Overall Study|Physician Decision|1|||
49063061|NCT02622113|158062177|FG000|Overall Study|Withdrawal by Subject|0|||
49063062|NCT02622113|158062178|FG001|Overall Study|Withdrawal by Subject|2|||
49063063|NCT02622113|158062177|FG000|Overall Study|Stopping Criteria|1|||
49063064|NCT02622113|158062178|FG001|Overall Study|Stopping Criteria|3|||
49063065|NCT01195103|158062179|FG000|Overall Study|Withdrawal by Subject|1|||
49063066|NCT01195103|158062180|FG001|Overall Study|Withdrawal by Subject|0|||
49063067|NCT01195103|158062181|FG002|Overall Study|Withdrawal by Subject|0|||
49063068|NCT00302081|158062182|FG000|Overall Study|Adverse Event|6|||
49063069|NCT00302081|158062183|FG001|Overall Study|Adverse Event|5|||
49063070|NCT00302081|158062184|FG002|Overall Study|Adverse Event|4|||
49063071|NCT00302081|158062182|FG000|Overall Study|Lost to Follow-up|21|||
49063072|NCT00302081|158062183|FG001|Overall Study|Lost to Follow-up|18|||
49063073|NCT00302081|158062184|FG002|Overall Study|Lost to Follow-up|28|||
49063074|NCT00302081|158062182|FG000|Overall Study|Withdrawal by Subject|8|||
49063075|NCT00302081|158062183|FG001|Overall Study|Withdrawal by Subject|12|||
49063076|NCT00302081|158062184|FG002|Overall Study|Withdrawal by Subject|8|||
49063077|NCT00302081|158062182|FG000|Overall Study|Protocol Violation|5|||
49063078|NCT00302081|158062183|FG001|Overall Study|Protocol Violation|1|||
49063079|NCT00302081|158062184|FG002|Overall Study|Protocol Violation|2|||
49063080|NCT00302081|158062182|FG000|Overall Study|Lack of Efficacy|1|||
49063081|NCT00302081|158062183|FG001|Overall Study|Lack of Efficacy|0|||
49063082|NCT00302081|158062184|FG002|Overall Study|Lack of Efficacy|5|||
49063083|NCT00302081|158062182|FG000|Overall Study|Death|2|||
49063084|NCT00302081|158062183|FG001|Overall Study|Death|1|||
49063085|NCT00302081|158062184|FG002|Overall Study|Death|0|||
49063086|NCT00302081|158062182|FG000|Overall Study|Other|13|||
49063087|NCT00302081|158062183|FG001|Overall Study|Other|6|||
49063088|NCT00302081|158062184|FG002|Overall Study|Other|5|||
49063089|NCT03760250|158062186|FG000|Overall Study|Withdrawal by Subject|1|||
49063090|NCT03760250|158062186|FG000|Overall Study|Physician Decision|1|||
49063091|NCT02621034|158062187|FG000|Overall Study|Lost to Follow-up|3|||
49063092|NCT02621034|158062188|FG001|Overall Study|Lost to Follow-up|2|||
49063093|NCT02621034|158062189|FG002|Overall Study|Lost to Follow-up|5|||
49063094|NCT00307034|158062190|FG000|Overall Study|Adverse Event|1|||
49063095|NCT00307034|158062191|FG001|Overall Study|Adverse Event|2|||
49063096|NCT00307034|158062190|FG000|Overall Study|Withdrawal by Subject|1|||
49063097|NCT00307034|158062191|FG001|Overall Study|Withdrawal by Subject|2|||
49063098|NCT00307034|158062190|FG000|Overall Study|Lost to Follow-up|0|||
49063099|NCT00307034|158062191|FG001|Overall Study|Lost to Follow-up|3|||
49063100|NCT01939496|158062194|FG000|Overall Study|Adverse Event|2|||
49063101|NCT01939496|158062195|FG001|Overall Study|Adverse Event|0|||
49063102|NCT01939496|158062196|FG002|Overall Study|Adverse Event|0|||
49063103|NCT01939496|158062194|FG000|Overall Study|Lost to Follow-up|1|||
49063104|NCT01939496|158062195|FG001|Overall Study|Lost to Follow-up|1|||
49063105|NCT01939496|158062196|FG002|Overall Study|Lost to Follow-up|0|||
49063106|NCT01939496|158062194|FG000|Overall Study|Physician Decision|1|||
49063107|NCT01939496|158062195|FG001|Overall Study|Physician Decision|0|||
49063108|NCT01939496|158062196|FG002|Overall Study|Physician Decision|0|||
49063109|NCT01939496|158062194|FG000|Overall Study|Protocol Violation|3|||
49063110|NCT01939496|158062195|FG001|Overall Study|Protocol Violation|0|||
49063111|NCT01939496|158062196|FG002|Overall Study|Protocol Violation|0|||
49063112|NCT01939496|158062194|FG000|Overall Study|Withdrawal by Subject|0|||
49063113|NCT01939496|158062195|FG001|Overall Study|Withdrawal by Subject|1|||
49063114|NCT01939496|158062196|FG002|Overall Study|Withdrawal by Subject|1|||
49063115|NCT01939496|158062194|FG000|Overall Study|Blood Pressure Withdrawal Criteria|0|||
49063116|NCT01939496|158062195|FG001|Overall Study|Blood Pressure Withdrawal Criteria|1|||
49063117|NCT01939496|158062196|FG002|Overall Study|Blood Pressure Withdrawal Criteria|0|||
49063118|NCT01939496|158062194|FG000|Overall Study|Other|2|||
49063119|NCT01939496|158062195|FG001|Overall Study|Other|0|||
49063120|NCT01939496|158062196|FG002|Overall Study|Other|1|||
49063121|NCT03052322|158062199|FG000|Overall Study|Other un-specified|1|||
49063122|NCT03052322|158062200|FG001|Overall Study|Other un-specified|2|||
49063123|NCT03052322|158062199|FG000|Overall Study|Withdrawal by Subject|10|||
49063124|NCT03052322|158062200|FG001|Overall Study|Withdrawal by Subject|9|||
49063125|NCT03052322|158062199|FG000|Overall Study|Death|0|||
49063126|NCT03052322|158062200|FG001|Overall Study|Death|2|||
49063127|NCT03052322|158062199|FG000|Overall Study|Lack of Efficacy|1|||
49063128|NCT03052322|158062200|FG001|Overall Study|Lack of Efficacy|2|||
49063129|NCT03052322|158062199|FG000|Overall Study|Protocol Violation|1|||
49063130|NCT03052322|158062200|FG001|Overall Study|Protocol Violation|0|||
49063131|NCT03052322|158062199|FG000|Overall Study|Lost to Follow-up|2|||
49063132|NCT03052322|158062200|FG001|Overall Study|Lost to Follow-up|4|||
49063133|NCT03052322|158062199|FG000|Overall Study|Adverse Event|6|||
49063134|NCT03052322|158062200|FG001|Overall Study|Adverse Event|13|||
49063135|NCT02384941|158062201|FG000|Overall Study|Adverse Event|11|||
49063136|NCT02384941|158062202|FG001|Overall Study|Adverse Event|13|||
49063137|NCT02384941|158062203|FG002|Overall Study|Adverse Event|17|||
49063138|NCT02384941|158062201|FG000|Overall Study|Lost to Follow-up|3|||
49063139|NCT02384941|158062202|FG001|Overall Study|Lost to Follow-up|2|||
49063140|NCT02384941|158062203|FG002|Overall Study|Lost to Follow-up|1|||
49063141|NCT02384941|158062201|FG000|Overall Study|Non-Compliance With Study Drug|2|||
49063142|NCT02384941|158062202|FG001|Overall Study|Non-Compliance With Study Drug|0|||
49063143|NCT02384941|158062203|FG002|Overall Study|Non-Compliance With Study Drug|1|||
49063144|NCT02384941|158062201|FG000|Overall Study|Physician Decision|1|||
49063145|NCT02384941|158062202|FG001|Overall Study|Physician Decision|1|||
49063146|NCT02384941|158062203|FG002|Overall Study|Physician Decision|0|||
49063147|NCT02384941|158062201|FG000|Overall Study|Protocol Violation|3|||
49063148|NCT02384941|158062202|FG001|Overall Study|Protocol Violation|0|||
49063149|NCT02384941|158062203|FG002|Overall Study|Protocol Violation|0|||
49063150|NCT02384941|158062201|FG000|Overall Study|Withdrawal by Subject|26|||
49063151|NCT02384941|158062202|FG001|Overall Study|Withdrawal by Subject|19|||
49063152|NCT02384941|158062203|FG002|Overall Study|Withdrawal by Subject|20|||
49063153|NCT02384941|158062201|FG000|Overall Study|Pregnancy|0|||
49063154|NCT02384941|158062202|FG001|Overall Study|Pregnancy|0|||
49063155|NCT02384941|158062203|FG002|Overall Study|Pregnancy|1|||
49063156|NCT02384941|158062201|FG000|Overall Study|Other than specified above|4|||
49063157|NCT02384941|158062202|FG001|Overall Study|Other than specified above|0|||
49063158|NCT02384941|158062203|FG002|Overall Study|Other than specified above|1|||
49063159|NCT02011113|158062204|FG000|Overall Study|Adverse Event|4|||
49063160|NCT02011113|158062204|FG000|Overall Study|Disease Progression (DP)|16|||
49063161|NCT02011113|158062204|FG000|Overall Study|Death|1|||
49063162|NCT02011113|158062204|FG000|Overall Study|Insufficient effect of Pomalidomide|1|||
49063163|NCT02011113|158062204|FG000|Overall Study|Investigator's judgement- DP|3|||
49063164|NCT02011113|158062204|FG000|Overall Study|Study terminated by sponsor|11|||
49063165|NCT02034058|158062207|FG000|Overall Study|Death|3|||
49063166|NCT05304611|158062215|FG000|Pediatric Efficacy Study|Lost to Follow-up|0|||
49063167|NCT05304611|158062216|FG001|Pediatric Efficacy Study|Lost to Follow-up|0|||
49063168|NCT05304611|158062217|FG002|Pediatric Efficacy Study|Lost to Follow-up|0|||
49063169|NCT05304611|158062218|FG003|Pediatric Efficacy Study|Lost to Follow-up|0|||
49063170|NCT05304611|158062219|FG004|Pediatric Efficacy Study|Lost to Follow-up|0|||
49063171|NCT05304611|158062220|FG005|Pediatric Efficacy Study|Lost to Follow-up|0|||
49063172|NCT05304611|158062221|FG006|Pediatric Efficacy Study|Lost to Follow-up|1|||
49063173|NCT05304611|158062222|FG007|Pediatric Efficacy Study|Lost to Follow-up|0|||
49063174|NCT05304611|158062223|FG008|Pediatric Efficacy Study|Lost to Follow-up|1|||
49063175|NCT05304611|158062215|FG000|Pediatric Efficacy Study|Withdrew consent|0|||
49063176|NCT05304611|158062216|FG001|Pediatric Efficacy Study|Withdrew consent|0|||
49063177|NCT05304611|158062217|FG002|Pediatric Efficacy Study|Withdrew consent|0|||
49063178|NCT05304611|158062218|FG003|Pediatric Efficacy Study|Withdrew consent|0|||
49063179|NCT05304611|158062219|FG004|Pediatric Efficacy Study|Withdrew consent|0|||
49063180|NCT05304611|158062220|FG005|Pediatric Efficacy Study|Withdrew consent|0|||
49063181|NCT05304611|158062221|FG006|Pediatric Efficacy Study|Withdrew consent|1|||
49063182|NCT05304611|158062222|FG007|Pediatric Efficacy Study|Withdrew consent|1|||
49063183|NCT05304611|158062223|FG008|Pediatric Efficacy Study|Withdrew consent|2|||
49063184|NCT01335997|158062224|FG000|Period I and II|Adverse Event|63|||
49063185|NCT01335997|158062225|FG001|Period I and II|Adverse Event|43|||
49063186|NCT01335997|158062224|FG000|Period I and II|Noncompliance with Study Drug|1|||
49063187|NCT01335997|158062225|FG001|Period I and II|Noncompliance with Study Drug|1|||
49063188|NCT01335997|158062224|FG000|Period I and II|Lost to Follow-up|3|||
49063189|NCT01335997|158062225|FG001|Period I and II|Lost to Follow-up|5|||
49063190|NCT01335997|158062224|FG000|Period I and II|Withdrawal by Subject|9|||
49063191|NCT01335997|158062225|FG001|Period I and II|Withdrawal by Subject|4|||
49063192|NCT01335997|158062224|FG000|Period I and II|Study Terminated by Sponsor|406|||
49063193|NCT01335997|158062225|FG001|Period I and II|Study Terminated by Sponsor|415|||
49063194|NCT01335997|158062224|FG000|Period I and II|Protocol Violation|9|||
49063195|NCT01335997|158062225|FG001|Period I and II|Protocol Violation|10|||
49063196|NCT01335997|158062224|FG000|Period I and II|Physician Decision|2|||
49063197|NCT01335997|158062225|FG001|Period I and II|Physician Decision|1|||
49063198|NCT01335997|158062224|FG000|Period III|Adverse Event|0|||
49063199|NCT01335997|158062225|FG001|Period III|Adverse Event|2|||
49063200|NCT01335997|158062224|FG000|Period III|Study Terminated by Sponsor|77|||
49063201|NCT01335997|158062225|FG001|Period III|Study Terminated by Sponsor|76|||
49063202|NCT01335997|158062224|FG000|Period III|Protocol Violation|0|||
49063203|NCT01335997|158062225|FG001|Period III|Protocol Violation|1|||
49063204|NCT01335997|158062224|FG000|Period III|Lost to Follow-up|1|||
49063205|NCT01335997|158062225|FG001|Period III|Lost to Follow-up|0|||
49063206|NCT03979820|158062229|FG000|Overall Study|Protocol Violation|1|||
49063207|NCT03979820|158062230|FG001|Overall Study|Protocol Violation|0|||
49063208|NCT03979820|158062231|FG002|Overall Study|Protocol Violation|0|||
49063209|NCT03979820|158062232|FG003|Overall Study|Protocol Violation|0|||
49063210|NCT03979820|158062229|FG000|Overall Study|Withdrawal by Subject|0|||
49063211|NCT03979820|158062230|FG001|Overall Study|Withdrawal by Subject|0|||
49063212|NCT03979820|158062231|FG002|Overall Study|Withdrawal by Subject|1|||
49063213|NCT03979820|158062232|FG003|Overall Study|Withdrawal by Subject|0|||
49063214|NCT03979820|158062229|FG000|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5|||
49063215|NCT03979820|158062230|FG001|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
49063216|NCT03979820|158062231|FG002|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
49063217|NCT03979820|158062232|FG003|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10|||
49063218|NCT00988065|158062233|FG000|Overall Study|Adverse Event|4|||
49063219|NCT00988065|158062234|FG001|Overall Study|Adverse Event|10|||
49063220|NCT00988065|158062235|FG002|Overall Study|Adverse Event|2|||
49063221|NCT00988065|158062233|FG000|Overall Study|Lost to Follow-up|1|||
49063222|NCT00988065|158062234|FG001|Overall Study|Lost to Follow-up|2|||
49063223|NCT00988065|158062235|FG002|Overall Study|Lost to Follow-up|2|||
49063224|NCT00988065|158062233|FG000|Overall Study|Subject withdrew consent|3|||
49063225|NCT00988065|158062234|FG001|Overall Study|Subject withdrew consent|5|||
49063226|NCT00988065|158062235|FG002|Overall Study|Subject withdrew consent|2|||
49063227|NCT00988065|158062233|FG000|Overall Study|Noncompliance with protocol|5|||
49063228|NCT00988065|158062234|FG001|Overall Study|Noncompliance with protocol|6|||
49063229|NCT00988065|158062235|FG002|Overall Study|Noncompliance with protocol|9|||
49063230|NCT01229735|158062237|FG000|Overall Study|Lack of Efficacy|8|||
49063231|NCT01229735|158062238|FG001|Overall Study|Lack of Efficacy|8|||
49063232|NCT01229735|158062237|FG000|Overall Study|Protocol Violation|13|||
49063233|NCT01229735|158062238|FG001|Overall Study|Protocol Violation|8|||
49063234|NCT01229735|158062237|FG000|Overall Study|Lost to Follow-up|0|||
49063235|NCT01229735|158062238|FG001|Overall Study|Lost to Follow-up|2|||
49063236|NCT01229735|158062237|FG000|Overall Study|Withdrawal by Subject|18|||
49063237|NCT01229735|158062238|FG001|Overall Study|Withdrawal by Subject|17|||
49063238|NCT01229735|158062237|FG000|Overall Study|Other Reason|13|||
49063239|NCT01229735|158062238|FG001|Overall Study|Other Reason|10|||
49063240|NCT01229735|158062237|FG000|Overall Study|SAE, non-fatal|0|||
49063241|NCT01229735|158062238|FG001|Overall Study|SAE, non-fatal|4|||
49063242|NCT01229735|158062237|FG000|Overall Study|AE, non-serious non-fatal|13|||
49063243|NCT01229735|158062238|FG001|Overall Study|AE, non-serious non-fatal|17|||
49063244|NCT01229735|158062237|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
49063245|NCT01229735|158062238|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
49063246|NCT02685202|158062239|FG000|Overall Study|Lost to Follow-up|9|||
49063247|NCT02130882|158062241|FG000|Overall Study|Withdrawal by Subject|0|||
49063248|NCT02130882|158062242|FG001|Overall Study|Withdrawal by Subject|1|||
49063249|NCT04740814|158062243|FG000|Overall Study|Adverse Event|3|||
49063250|NCT04740814|158062243|FG000|Overall Study|Protocol Violation|2|||
49063251|NCT04740814|158062243|FG000|Overall Study|Lost to Follow-up|2|||
49063252|NCT04740814|158062243|FG000|Overall Study|Withdrawal by Subject|3|||
49063253|NCT00085423|158062244|FG000|Overall Study|Withdrawal by Subject|1|||
49063254|NCT00085423|158062244|FG000|Overall Study|screen failure|1|||
49063255|NCT00706381|158062245|FG000|Overall Study|Lost to Follow-up|0|||
49063256|NCT00706381|158062246|FG001|Overall Study|Lost to Follow-up|1|||
49063257|NCT00706381|158062247|FG002|Overall Study|Lost to Follow-up|1|||
49063258|NCT00706381|158062248|FG003|Overall Study|Lost to Follow-up|0|||
49063259|NCT01321008|158062249|FG000|Overall Study|Early Study Termination|1|||
49063260|NCT00477295|158062261|FG000|Overall Study|Adverse Event|31|||
49063261|NCT00477295|158062262|FG001|Overall Study|Adverse Event|35|||
49063262|NCT00477295|158062261|FG000|Overall Study|Withdrawal by Subject|35|||
49063263|NCT00477295|158062262|FG001|Overall Study|Withdrawal by Subject|24|||
49063264|NCT00477295|158062261|FG000|Overall Study|Lack of Efficacy|23|||
49063265|NCT00477295|158062262|FG001|Overall Study|Lack of Efficacy|23|||
49063266|NCT00477295|158062261|FG000|Overall Study|Protocol Violation|3|||
49063267|NCT00477295|158062262|FG001|Overall Study|Protocol Violation|8|||
49063268|NCT00477295|158062261|FG000|Overall Study|Physician Decision|4|||
49063269|NCT00477295|158062262|FG001|Overall Study|Physician Decision|5|||
49063270|NCT00477295|158062261|FG000|Overall Study|Lost to Follow-up|21|||
49063271|NCT00477295|158062262|FG001|Overall Study|Lost to Follow-up|11|||
49063272|NCT00477295|158062261|FG000|Overall Study|Other|4|||
49063273|NCT00477295|158062262|FG001|Overall Study|Other|3|||
49063274|NCT03185013|158062263|FG000|Overall Study|Withdrawal by Subject|5|||
49063275|NCT03185013|158062264|FG001|Overall Study|Withdrawal by Subject|3|||
49063276|NCT03185013|158062263|FG000|Overall Study|Adverse Event|1|||
49063277|NCT03185013|158062264|FG001|Overall Study|Adverse Event|0|||
49063278|NCT03185013|158062263|FG000|Overall Study|Progressive Disease|1|||
49063279|NCT03185013|158062264|FG001|Overall Study|Progressive Disease|0|||
49063280|NCT03185013|158062263|FG000|Overall Study|Lost to Follow-up|8|||
49063281|NCT03185013|158062264|FG001|Overall Study|Lost to Follow-up|2|||
49063282|NCT03185013|158062263|FG000|Overall Study|Physician Decision|1|||
49063283|NCT03185013|158062264|FG001|Overall Study|Physician Decision|0|||
49063284|NCT03185013|158062263|FG000|Overall Study|Protocol Deviation|2|||
49063285|NCT03185013|158062264|FG001|Overall Study|Protocol Deviation|0|||
49063286|NCT03185013|158062263|FG000|Overall Study|Reason not Specified|3|||
49063287|NCT03185013|158062264|FG001|Overall Study|Reason not Specified|2|||
49063288|NCT03185013|158062263|FG000|Overall Study|Death|1|||
49063289|NCT03185013|158062264|FG001|Overall Study|Death|0|||
49063290|NCT03050060|158062265|FG000|Overall Study|Adverse Event|7|||
49063291|NCT03050060|158062265|FG000|Overall Study|Withdrawal by Subject|1|||
49063292|NCT03050060|158062265|FG000|Overall Study|Progression|7|||
49063293|NCT03276780|158062270|FG000|Overall Study|Withdrawal by Subject|5|||
49063294|NCT03276780|158062271|FG001|Overall Study|Withdrawal by Subject|3|||
49063295|NCT03276780|158062270|FG000|Overall Study|Lost to Follow-up|3|||
49063296|NCT03276780|158062271|FG001|Overall Study|Lost to Follow-up|5|||
49063297|NCT03276780|158062270|FG000|Overall Study|Moved out of state|1|||
49063298|NCT03276780|158062271|FG001|Overall Study|Moved out of state|1|||
49063299|NCT03276780|158062270|FG000|Overall Study|Already enrolled in another smoking cessation study providing NRT|1|||
49063300|NCT03276780|158062271|FG001|Overall Study|Already enrolled in another smoking cessation study providing NRT|0|||
49063301|NCT03276780|158062270|FG000|Overall Study|No show to appointments after baseline through Week 5|8|||
49063302|NCT03276780|158062271|FG001|Overall Study|No show to appointments after baseline through Week 5|1|||
49063303|NCT00510289|158062274|FG000|Overall Study|Withdrawal by Subject|7|||
49063304|NCT00510289|158062274|FG000|Overall Study|Refused bone marrow biopsy|2|||
49063305|NCT00510289|158062274|FG000|Overall Study|Lost to Follow-up|1|||
49063306|NCT00510289|158062274|FG000|Overall Study|Progressed prior to starting drug|2|||
49063307|NCT02283294|158062275|FG000|Overall Study|Lost to Follow-up|1|||
49063308|NCT02283294|158062276|FG001|Overall Study|Lost to Follow-up|1|||
49063309|NCT02283294|158062275|FG000|Overall Study|Withdrawal by Subject|1|||
49063310|NCT02283294|158062276|FG001|Overall Study|Withdrawal by Subject|6|||
49063311|NCT02283294|158062275|FG000|Overall Study|Protocol Violation|1|||
49063312|NCT02283294|158062276|FG001|Overall Study|Protocol Violation|0|||
49063313|NCT02283294|158062275|FG000|Overall Study|Thrombus on transesophageal echocardiogram|0|||
49063314|NCT02283294|158062276|FG001|Overall Study|Thrombus on transesophageal echocardiogram|1|||
49063315|NCT04568031|158062277|FG000|Overall Study|Lost to Follow-up|1|||
49063316|NCT04568031|158062278|FG001|Overall Study|Lost to Follow-up|0|||
49063317|NCT04568031|158062279|FG002|Overall Study|Lost to Follow-up|0|||
49063318|NCT04568031|158062280|FG003|Overall Study|Lost to Follow-up|0|||
49063319|NCT04568031|158062277|FG000|Overall Study|Physician Decision|1|||
49063320|NCT04568031|158062278|FG001|Overall Study|Physician Decision|0|||
49063321|NCT04568031|158062279|FG002|Overall Study|Physician Decision|1|||
49063322|NCT04568031|158062280|FG003|Overall Study|Physician Decision|0|||
49063323|NCT04568031|158062277|FG000|Overall Study|Withdrawal by Subject|1|||
49063324|NCT04568031|158062278|FG001|Overall Study|Withdrawal by Subject|0|||
49063325|NCT04568031|158062279|FG002|Overall Study|Withdrawal by Subject|4|||
49063326|NCT04568031|158062280|FG003|Overall Study|Withdrawal by Subject|1|||
49063327|NCT00186043|158062281|FG000|Overall Study|Lack of Efficacy|1|||
49063328|NCT00186043|158062282|FG001|Overall Study|Lack of Efficacy|3|||
49063329|NCT00186043|158062281|FG000|Overall Study|Lost to Follow-up|4|||
49063330|NCT00186043|158062282|FG001|Overall Study|Lost to Follow-up|6|||
49063331|NCT00186043|158062281|FG000|Overall Study|Withdrawal by Subject|1|||
49063332|NCT00186043|158062282|FG001|Overall Study|Withdrawal by Subject|0|||
49063333|NCT00186043|158062281|FG000|Overall Study|Adverse Event|7|||
49063334|NCT00186043|158062282|FG001|Overall Study|Adverse Event|3|||
49063335|NCT00186043|158062281|FG000|Overall Study|Protocol Violation|2|||
49063336|NCT00186043|158062282|FG001|Overall Study|Protocol Violation|1|||
49063337|NCT03835221|158062283|FG000|Methafilcon A|Withdrawal by Subject|1|||
49063338|NCT04874636|158062285|FG000|Overall Study|Adverse Event|17|||
49063339|NCT04874636|158062286|FG001|Overall Study|Adverse Event|7|||
49063340|NCT04874636|158062285|FG000|Overall Study|Lost to Follow-up|1|||
49063341|NCT04874636|158062286|FG001|Overall Study|Lost to Follow-up|0|||
49063342|NCT04874636|158062285|FG000|Overall Study|Non-Compliance with Study Drug|2|||
49063343|NCT04874636|158062286|FG001|Overall Study|Non-Compliance with Study Drug|0|||
49063344|NCT04874636|158062285|FG000|Overall Study|Physician Decision|1|||
49063345|NCT04874636|158062286|FG001|Overall Study|Physician Decision|0|||
49063346|NCT04874636|158062285|FG000|Overall Study|Withdrawal by Subject|6|||
49063347|NCT04874636|158062286|FG001|Overall Study|Withdrawal by Subject|5|||
49063348|NCT02823652|158062298|FG000|Step 1: On-line Genetic Education Study|Baseline survey not done|58|||
49063349|NCT02823652|158062299|FG001|Step 1: On-line Genetic Education Study|Baseline survey not done|64|||
49063350|NCT02823652|158062300|FG002|Step 1: On-line Genetic Education Study|Baseline survey not done|7|||
49063351|NCT02823652|158062298|FG000|Step 2: Genetic Counseling Substudy|Ineligible|2|||
49063352|NCT02823652|158062299|FG001|Step 2: Genetic Counseling Substudy|Ineligible|0|||
49063353|NCT02823652|158062300|FG002|Step 2: Genetic Counseling Substudy|Ineligible|0|||
49063354|NCT02823652|158062298|FG000|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|2|||
49063355|NCT02823652|158062299|FG001|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|0|||
49063356|NCT02823652|158062300|FG002|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|1|||
49063357|NCT02823652|158062298|FG000|Step 2: Genetic Counseling Substudy|Other|2|||
49063358|NCT02823652|158062299|FG001|Step 2: Genetic Counseling Substudy|Other|2|||
49063359|NCT02823652|158062300|FG002|Step 2: Genetic Counseling Substudy|Other|1|||
49063360|NCT02128217|158064766|FG000|Overall Study|Lost to Follow-up|0|||
49063361|NCT02128217|158064767|FG001|Overall Study|Lost to Follow-up|1|||
49063362|NCT00541970|158064771|FG000|Month 7|Protocol Violation|9|||
49063363|NCT00541970|158064772|FG001|Month 7|Protocol Violation|13|||
49063364|NCT00541970|158064773|FG002|Month 7|Protocol Violation|11|||
49063365|NCT00541970|158064774|FG003|Month 7|Protocol Violation|5|||
49063366|NCT00541970|158064771|FG000|Month 12|Adverse Event|0|||
49063367|NCT00541970|158064772|FG001|Month 12|Adverse Event|1|||
49063368|NCT00541970|158064773|FG002|Month 12|Adverse Event|1|||
49063369|NCT00541970|158064774|FG003|Month 12|Adverse Event|1|||
49063370|NCT00541970|158064771|FG000|Month 12|Protocol Violation|12|||
49063371|NCT00541970|158064772|FG001|Month 12|Protocol Violation|21|||
49063372|NCT00541970|158064773|FG002|Month 12|Protocol Violation|20|||
49063373|NCT00541970|158064774|FG003|Month 12|Protocol Violation|15|||
49063374|NCT00541970|158064771|FG000|Month 18|Adverse Event|0|||
49063375|NCT00541970|158064772|FG001|Month 18|Adverse Event|1|||
49063376|NCT00541970|158064773|FG002|Month 18|Adverse Event|1|||
49063377|NCT00541970|158064774|FG003|Month 18|Adverse Event|1|||
49063378|NCT00541970|158064771|FG000|Month 18|Protocol Violation|14|||
49063379|NCT00541970|158064772|FG001|Month 18|Protocol Violation|23|||
49063380|NCT00541970|158064773|FG002|Month 18|Protocol Violation|24|||
49063381|NCT00541970|158064774|FG003|Month 18|Protocol Violation|16|||
49063382|NCT00541970|158064771|FG000|Month 24|Adverse Event|0|||
49063383|NCT00541970|158064772|FG001|Month 24|Adverse Event|1|||
49063384|NCT00541970|158064773|FG002|Month 24|Adverse Event|1|||
49063385|NCT00541970|158064774|FG003|Month 24|Adverse Event|1|||
49063386|NCT00541970|158064771|FG000|Month 24|Protocol Violation|29|||
49063387|NCT00541970|158064772|FG001|Month 24|Protocol Violation|31|||
49063388|NCT00541970|158064773|FG002|Month 24|Protocol Violation|31|||
49063389|NCT00541970|158064774|FG003|Month 24|Protocol Violation|21|||
49063390|NCT00541970|158064771|FG000|Month 36|Protocol Violation|61|||
49063391|NCT00541970|158064772|FG001|Month 36|Protocol Violation|66|||
49063392|NCT00541970|158064773|FG002|Month 36|Protocol Violation|66|||
49063393|NCT00541970|158064774|FG003|Month 36|Protocol Violation|60|||
49063394|NCT00541970|158064771|FG000|Month 48|Withdrawal by Subject|2|||
49063395|NCT00541970|158064772|FG001|Month 48|Withdrawal by Subject|4|||
49063396|NCT00541970|158064773|FG002|Month 48|Withdrawal by Subject|4|||
49063397|NCT00541970|158064774|FG003|Month 48|Withdrawal by Subject|2|||
49063398|NCT00541970|158064771|FG000|Month 48|Other|3|||
49063399|NCT00541970|158064772|FG001|Month 48|Other|1|||
49063400|NCT00541970|158064773|FG002|Month 48|Other|1|||
49063401|NCT00541970|158064774|FG003|Month 48|Other|0|||
49063402|NCT00541970|158064771|FG000|Month 48|Lost to Follow-up|66|||
49063403|NCT00541970|158064772|FG001|Month 48|Lost to Follow-up|68|||
49063404|NCT00541970|158064773|FG002|Month 48|Lost to Follow-up|68|||
49063405|NCT00541970|158064774|FG003|Month 48|Lost to Follow-up|73|||
49063406|NCT00541970|158064771|FG000|Month 60|Protocol Violation|78|||
49063407|NCT00541970|158064772|FG001|Month 60|Protocol Violation|77|||
49063408|NCT00541970|158064773|FG002|Month 60|Protocol Violation|82|||
49063409|NCT00541970|158064774|FG003|Month 60|Protocol Violation|72|||
49063410|NCT01884311|158064777|FG000|Overall Study|Withdrawal by Subject|3|||
49063411|NCT01884311|158064777|FG000|Overall Study|withdrew consent due to AEs|1|||
49063412|NCT01884311|158064777|FG000|Overall Study|Precautionary measure|1|||
49063413|NCT03107026|158064778|FG000|Overall Study|Adverse Event|2|||
49063414|NCT03107026|158064779|FG001|Overall Study|Adverse Event|14|||
49063415|NCT03107026|158064780|FG002|Overall Study|Adverse Event|23|||
49063416|NCT03107026|158064778|FG000|Overall Study|Lost to Follow-up|12|||
49063417|NCT03107026|158064779|FG001|Overall Study|Lost to Follow-up|12|||
49063418|NCT03107026|158064780|FG002|Overall Study|Lost to Follow-up|13|||
49063419|NCT03107026|158064778|FG000|Overall Study|Protocol Violation|1|||
49063420|NCT03107026|158064779|FG001|Overall Study|Protocol Violation|2|||
49063421|NCT03107026|158064780|FG002|Overall Study|Protocol Violation|0|||
49063422|NCT03107026|158064778|FG000|Overall Study|Pregnancy|1|||
49063423|NCT03107026|158064779|FG001|Overall Study|Pregnancy|0|||
49063424|NCT03107026|158064780|FG002|Overall Study|Pregnancy|0|||
49063425|NCT03107026|158064778|FG000|Overall Study|Withdrawal by Subject|13|||
49063426|NCT03107026|158064779|FG001|Overall Study|Withdrawal by Subject|5|||
49063427|NCT03107026|158064780|FG002|Overall Study|Withdrawal by Subject|17|||
49063428|NCT03107026|158064778|FG000|Overall Study|non compliance with study visits|1|||
49063429|NCT03107026|158064779|FG001|Overall Study|non compliance with study visits|2|||
49063430|NCT03107026|158064780|FG002|Overall Study|non compliance with study visits|0|||
49063431|NCT03107026|158064778|FG000|Overall Study|non-compliance with study drug|2|||
49063432|NCT03107026|158064779|FG001|Overall Study|non-compliance with study drug|2|||
49063433|NCT03107026|158064780|FG002|Overall Study|non-compliance with study drug|3|||
49063434|NCT03107026|158064778|FG000|Overall Study|Physician Decision|0|||
49063435|NCT03107026|158064779|FG001|Overall Study|Physician Decision|1|||
49063436|NCT03107026|158064780|FG002|Overall Study|Physician Decision|0|||
49063437|NCT00112866|158064781|FG000|Overall Study|Protocol Violation|1|||
49063438|NCT00112866|158064782|FG001|Overall Study|Protocol Violation|0|||
49063439|NCT00112866|158064781|FG000|Overall Study|did not start treatment post-op|1|||
49063440|NCT00112866|158064782|FG001|Overall Study|did not start treatment post-op|2|||
49063441|NCT02307266|158064783|FG000|Overall Study|Adverse Event|3|||
49063442|NCT02307266|158064784|FG001|Overall Study|Adverse Event|1|||
49063443|NCT02307266|158064785|FG002|Overall Study|Adverse Event|5|||
49063444|NCT02307266|158064783|FG000|Overall Study|Withdrawal by Subject|2|||
49063445|NCT02307266|158064784|FG001|Overall Study|Withdrawal by Subject|0|||
49063446|NCT02307266|158064785|FG002|Overall Study|Withdrawal by Subject|1|||
49063447|NCT02307266|158064783|FG000|Overall Study|Lost to Follow-up|3|||
49063448|NCT02307266|158064784|FG001|Overall Study|Lost to Follow-up|0|||
49063449|NCT02307266|158064785|FG002|Overall Study|Lost to Follow-up|0|||
49063450|NCT00773734|158064786|FG000|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5|||
49063451|NCT00773734|158064787|FG001|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1|||
49063452|NCT00773734|158064788|FG002|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8|||
49063453|NCT00773734|158064789|FG003|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10|||
49063454|NCT00773734|158064790|FG004|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
49063455|NCT00773734|158064791|FG005|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
49063456|NCT00773734|158064786|FG000|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4|||
49063457|NCT00773734|158064787|FG001|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3|||
49063458|NCT00773734|158064788|FG002|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
49063459|NCT00773734|158064789|FG003|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
49063460|NCT00773734|158064790|FG004|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
49063461|NCT00773734|158064791|FG005|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
49063462|NCT00773734|158064786|FG000|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
49063463|NCT00773734|158064787|FG001|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
49063464|NCT00773734|158064788|FG002|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6|||
49063465|NCT00773734|158064789|FG003|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4|||
49063466|NCT00773734|158064790|FG004|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
49063467|NCT00773734|158064791|FG005|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
49063468|NCT00773734|158064786|FG000|Core: Placebo Controlled Phase Week 0-16|Death|1|||
49063469|NCT00773734|158064787|FG001|Core: Placebo Controlled Phase Week 0-16|Death|0|||
49063470|NCT00773734|158064788|FG002|Core: Placebo Controlled Phase Week 0-16|Death|0|||
49063471|NCT00773734|158064789|FG003|Core: Placebo Controlled Phase Week 0-16|Death|0|||
49063472|NCT00773734|158064790|FG004|Core: Placebo Controlled Phase Week 0-16|Death|0|||
49063473|NCT00773734|158064791|FG005|Core: Placebo Controlled Phase Week 0-16|Death|0|||
49063474|NCT00773734|158064786|FG000|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2|||
49063475|NCT00773734|158064787|FG001|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
49063476|NCT00773734|158064788|FG002|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
49063477|NCT00773734|158064789|FG003|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1|||
49063478|NCT00773734|158064790|FG004|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
49063479|NCT00773734|158064791|FG005|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
49063480|NCT00773734|158064786|FG000|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1|||
49063481|NCT00773734|158064787|FG001|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3|||
49063482|NCT00773734|158064788|FG002|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4|||
49063483|NCT00773734|158064789|FG003|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
49063484|NCT00773734|158064790|FG004|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
49063485|NCT00773734|158064791|FG005|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
49063486|NCT00773734|158064786|FG000|Core: Placebo Controlled Phase Week 0-16|Other|1|||
49063487|NCT00773734|158064787|FG001|Core: Placebo Controlled Phase Week 0-16|Other|1|||
49063488|NCT00773734|158064788|FG002|Core: Placebo Controlled Phase Week 0-16|Other|1|||
49063489|NCT00773734|158064789|FG003|Core: Placebo Controlled Phase Week 0-16|Other|1|||
49063490|NCT00773734|158064790|FG004|Core: Placebo Controlled Phase Week 0-16|Other|0|||
49063491|NCT00773734|158064791|FG005|Core: Placebo Controlled Phase Week 0-16|Other|0|||
49063492|NCT00773734|158064786|FG000|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
49063493|NCT00773734|158064787|FG001|Core: Active Treatment Phase Week 16-24|Adverse Event|4|||
49063494|NCT00773734|158064788|FG002|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
49063495|NCT00773734|158064789|FG003|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
49063496|NCT00773734|158064790|FG004|Core: Active Treatment Phase Week 16-24|Adverse Event|1|||
49063497|NCT00773734|158064791|FG005|Core: Active Treatment Phase Week 16-24|Adverse Event|2|||
49063498|NCT00773734|158064786|FG000|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
49063499|NCT00773734|158064787|FG001|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
49063500|NCT00773734|158064788|FG002|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
49063501|NCT00773734|158064789|FG003|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1|||
49063502|NCT00773734|158064790|FG004|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
49063503|NCT00773734|158064791|FG005|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
49063504|NCT00773734|158064786|FG000|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
49063505|NCT00773734|158064787|FG001|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
49063506|NCT00773734|158064788|FG002|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
49063507|NCT00773734|158064789|FG003|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
49063508|NCT00773734|158064790|FG004|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
49063509|NCT00773734|158064791|FG005|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2|||
49063510|NCT00773734|158064786|FG000|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
49063511|NCT00773734|158064787|FG001|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
49063512|NCT00773734|158064788|FG002|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
49063513|NCT00773734|158064789|FG003|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
49063514|NCT00773734|158064790|FG004|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
49063515|NCT00773734|158064791|FG005|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
49063516|NCT00773734|158064786|FG000|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
49063517|NCT00773734|158064787|FG001|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
49063518|NCT00773734|158064788|FG002|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
49063519|NCT00773734|158064789|FG003|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
49063520|NCT00773734|158064790|FG004|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
49063521|NCT00773734|158064791|FG005|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
49063522|NCT00773734|158064786|FG000|Core: Active Treatment Phase Week 16-24|Other|0|||
49063523|NCT00773734|158064787|FG001|Core: Active Treatment Phase Week 16-24|Other|1|||
49063524|NCT00773734|158064788|FG002|Core: Active Treatment Phase Week 16-24|Other|0|||
49063525|NCT00773734|158064789|FG003|Core: Active Treatment Phase Week 16-24|Other|0|||
49063526|NCT00773734|158064790|FG004|Core: Active Treatment Phase Week 16-24|Other|0|||
49063527|NCT00773734|158064791|FG005|Core: Active Treatment Phase Week 16-24|Other|0|||
49063528|NCT00773734|158064786|FG000|Extension: Active Treatment Week 24-52|Adverse Event|0|||
49063529|NCT00773734|158064787|FG001|Extension: Active Treatment Week 24-52|Adverse Event|0|||
49063530|NCT00773734|158064788|FG002|Extension: Active Treatment Week 24-52|Adverse Event|0|||
49063531|NCT00773734|158064789|FG003|Extension: Active Treatment Week 24-52|Adverse Event|0|||
49063532|NCT00773734|158064790|FG004|Extension: Active Treatment Week 24-52|Adverse Event|2|||
49063533|NCT00773734|158064791|FG005|Extension: Active Treatment Week 24-52|Adverse Event|1|||
49063534|NCT00773734|158064786|FG000|Extension: Active Treatment Week 24-52|Lack of Efficacy|0|||
49063535|NCT00773734|158064787|FG001|Extension: Active Treatment Week 24-52|Lack of Efficacy|8|||
49063536|NCT00773734|158064788|FG002|Extension: Active Treatment Week 24-52|Lack of Efficacy|10|||
49063537|NCT00773734|158064789|FG003|Extension: Active Treatment Week 24-52|Lack of Efficacy|3|||
49063538|NCT00773734|158064790|FG004|Extension: Active Treatment Week 24-52|Lack of Efficacy|1|||
49063539|NCT00773734|158064791|FG005|Extension: Active Treatment Week 24-52|Lack of Efficacy|2|||
49063540|NCT00773734|158064786|FG000|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0|||
49063541|NCT00773734|158064787|FG001|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
49063542|NCT00773734|158064788|FG002|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1|||
49063543|NCT00773734|158064789|FG003|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
49063544|NCT00773734|158064790|FG004|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
49063545|NCT00773734|158064791|FG005|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
49063546|NCT00773734|158064786|FG000|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
49063547|NCT00773734|158064787|FG001|Extension: Active Treatment Week 24-52|Lost to Follow-up|2|||
49063548|NCT00773734|158064788|FG002|Extension: Active Treatment Week 24-52|Lost to Follow-up|5|||
49063549|NCT00773734|158064789|FG003|Extension: Active Treatment Week 24-52|Lost to Follow-up|3|||
49063550|NCT00773734|158064790|FG004|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
49063551|NCT00773734|158064791|FG005|Extension: Active Treatment Week 24-52|Lost to Follow-up|1|||
49063552|NCT00773734|158064786|FG000|Extension: Active Treatment Week 24-52|Other|0|||
49063553|NCT00773734|158064787|FG001|Extension: Active Treatment Week 24-52|Other|0|||
49063554|NCT00773734|158064788|FG002|Extension: Active Treatment Week 24-52|Other|1|||
49063555|NCT00773734|158064789|FG003|Extension: Active Treatment Week 24-52|Other|2|||
49063556|NCT00773734|158064790|FG004|Extension: Active Treatment Week 24-52|Other|0|||
49063557|NCT00773734|158064791|FG005|Extension: Active Treatment Week 24-52|Other|1|||
49063558|NCT00773734|158064786|FG000|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
49063559|NCT00773734|158064787|FG001|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
49063560|NCT00773734|158064788|FG002|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
49063561|NCT00773734|158064789|FG003|LTE Period: Week 52 to 6 Years|Adverse Event|1|||
49063562|NCT00773734|158064790|FG004|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
49063563|NCT00773734|158064791|FG005|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
49063564|NCT00773734|158064786|FG000|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
49063565|NCT00773734|158064787|FG001|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
49063566|NCT00773734|158064788|FG002|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2|||
49063567|NCT00773734|158064789|FG003|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4|||
49063568|NCT00773734|158064790|FG004|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
49063569|NCT00773734|158064791|FG005|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
49063570|NCT00773734|158064786|FG000|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
49063571|NCT00773734|158064787|FG001|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
49063572|NCT00773734|158064788|FG002|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6|||
49063573|NCT00773734|158064789|FG003|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3|||
49063574|NCT00773734|158064790|FG004|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
49063575|NCT00773734|158064791|FG005|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
49063576|NCT00773734|158064786|FG000|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
49063577|NCT00773734|158064787|FG001|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
49063578|NCT00773734|158064788|FG002|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
49063579|NCT00773734|158064789|FG003|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
49063580|NCT00773734|158064790|FG004|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
49063581|NCT00773734|158064791|FG005|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
49063582|NCT00062010|158064792|FG000|Overall Study|Ineligible|3|||
49063583|NCT02177136|158064796|FG000|DB Phase|Withdrawal by Subject|2|||
49063584|NCT02177136|158064797|FG001|DB Phase|Withdrawal by Subject|0|||
49063585|NCT02177136|158064798|FG002|DB Phase|Withdrawal by Subject|0|||
49063586|NCT02177136|158064799|FG003|DB Phase|Withdrawal by Subject|0|||
49063587|NCT02177136|158064796|FG000|DB Phase|Discontinued Due to Pruritus|1|||
49063588|NCT02177136|158064797|FG001|DB Phase|Discontinued Due to Pruritus|3|||
49063589|NCT02177136|158064798|FG002|DB Phase|Discontinued Due to Pruritus|0|||
49063590|NCT02177136|158064799|FG003|DB Phase|Discontinued Due to Pruritus|0|||
49063591|NCT02177136|158064796|FG000|DB Phase|Adverse Event|3|||
49063592|NCT02177136|158064797|FG001|DB Phase|Adverse Event|2|||
49063593|NCT02177136|158064798|FG002|DB Phase|Adverse Event|3|||
49063594|NCT02177136|158064799|FG003|DB Phase|Adverse Event|0|||
49063595|NCT02177136|158064796|FG000|DB Phase|Protocol Violation|0|||
49063596|NCT02177136|158064797|FG001|DB Phase|Protocol Violation|0|||
49063597|NCT02177136|158064798|FG002|DB Phase|Protocol Violation|1|||
49063598|NCT02177136|158064799|FG003|DB Phase|Protocol Violation|0|||
49063599|NCT02177136|158064796|FG000|DB Phase|Withdrew Consent Prior to Dosing|1|||
49063600|NCT02177136|158064797|FG001|DB Phase|Withdrew Consent Prior to Dosing|0|||
49063601|NCT02177136|158064798|FG002|DB Phase|Withdrew Consent Prior to Dosing|0|||
49063602|NCT02177136|158064799|FG003|DB Phase|Withdrew Consent Prior to Dosing|0|||
49063603|NCT02177136|158064796|FG000|LTSE Phase|Withdrawal by Subject|0|||
49063604|NCT02177136|158064797|FG001|LTSE Phase|Withdrawal by Subject|0|||
49063605|NCT02177136|158064798|FG002|LTSE Phase|Withdrawal by Subject|0|||
49063606|NCT02177136|158064799|FG003|LTSE Phase|Withdrawal by Subject|6|||
49063607|NCT02177136|158064796|FG000|LTSE Phase|Adverse Event|0|||
49063608|NCT02177136|158064797|FG001|LTSE Phase|Adverse Event|0|||
49063609|NCT02177136|158064798|FG002|LTSE Phase|Adverse Event|0|||
49063610|NCT02177136|158064799|FG003|LTSE Phase|Adverse Event|10|||
49063611|NCT02177136|158064796|FG000|LTSE Phase|Discontinued Due to Pruritus|0|||
49063612|NCT02177136|158064797|FG001|LTSE Phase|Discontinued Due to Pruritus|0|||
49063613|NCT02177136|158064798|FG002|LTSE Phase|Discontinued Due to Pruritus|0|||
49063614|NCT02177136|158064799|FG003|LTSE Phase|Discontinued Due to Pruritus|4|||
49063615|NCT02177136|158064796|FG000|LTSE Phase|Physician Decision|0|||
49063616|NCT02177136|158064797|FG001|LTSE Phase|Physician Decision|0|||
49063617|NCT02177136|158064798|FG002|LTSE Phase|Physician Decision|0|||
49063618|NCT02177136|158064799|FG003|LTSE Phase|Physician Decision|2|||
49063619|NCT02177136|158064796|FG000|LTSE Phase|Lost to Follow-up|0|||
49063620|NCT02177136|158064797|FG001|LTSE Phase|Lost to Follow-up|0|||
49063621|NCT02177136|158064798|FG002|LTSE Phase|Lost to Follow-up|0|||
49063622|NCT02177136|158064799|FG003|LTSE Phase|Lost to Follow-up|1|||
49063623|NCT02177136|158064796|FG000|LTSE Phase|Participant Moved|0|||
49063624|NCT02177136|158064797|FG001|LTSE Phase|Participant Moved|0|||
49063625|NCT02177136|158064798|FG002|LTSE Phase|Participant Moved|0|||
49063626|NCT02177136|158064799|FG003|LTSE Phase|Participant Moved|1|||
49063627|NCT04132336|158064800|FG000|Overall Study|Investigator Decision|0|||
49063628|NCT04132336|158064801|FG001|Overall Study|Investigator Decision|1|||
49063629|NCT04132336|158064802|FG002|Overall Study|Investigator Decision|0|||
49063630|NCT04132336|158064803|FG003|Overall Study|Investigator Decision|0|||
49063631|NCT04132336|158064804|FG004|Overall Study|Investigator Decision|0|||
49063632|NCT04132336|158064805|FG005|Overall Study|Investigator Decision|0|||
49063633|NCT04132336|158064806|FG006|Overall Study|Investigator Decision|0|||
49063634|NCT02017860|158064807|FG000|Overall Study|Adverse Event|1|||
49063635|NCT02017860|158064807|FG000|Overall Study|Withdrawal by Subject|1|||
49063636|NCT02528123|158064808|FG000|Overall Study|Lost to Follow-up|1|||
49063637|NCT03733210|158064809|FG000|Overall Study|Lymph nodes not collected or not evaluable|4|||
49063638|NCT03733210|158064810|FG001|Overall Study|Lymph nodes not collected or not evaluable|2|||
49063639|NCT04421586|158064828|FG000|Overall Study|Death|0|||
49063640|NCT04421586|158064829|FG001|Overall Study|Death|1|||
49063641|NCT04421586|158064828|FG000|Overall Study|Lost to Follow-up|2|||
49063642|NCT04421586|158064829|FG001|Overall Study|Lost to Follow-up|2|||
49063643|NCT04421586|158064828|FG000|Overall Study|Withdrawn by PI|1|||
49063644|NCT04421586|158064829|FG001|Overall Study|Withdrawn by PI|0|||
49063645|NCT04421586|158064828|FG000|Overall Study|Infant death (no follow up data or vaccination outcomes)|2|||
49063646|NCT04421586|158064829|FG001|Overall Study|Infant death (no follow up data or vaccination outcomes)|3|||
49063647|NCT00973765|158064830|FG000|Overall Study|Lost to Follow-up|8|||
49063648|NCT00973765|158064831|FG001|Overall Study|Lost to Follow-up|14|||
49063649|NCT02963441|158064832|FG000|Overall Study|Protocol violation or withdrawn|8|||
49063650|NCT02963441|158064832|FG000|Overall Study|Ungradeable by FPRC or IDx|40|||
49063651|NCT02963441|158064832|FG000|Overall Study|IDx-DR insufficient quality|33|||
49063652|NCT04920916|158064833|FG000|Phase IIa 60 Day Study|Death|2|||
49063653|NCT04920916|158064834|FG001|Phase IIa 60 Day Study|Death|5|||
49063654|NCT04920916|158064833|FG000|1 Year Follow up (Phone Call)|Death|1|||
49063655|NCT04920916|158064834|FG001|1 Year Follow up (Phone Call)|Death|3|||
49063656|NCT04920916|158064833|FG000|1 Year Follow up Visits|Lost to Follow-up|6|||
49063657|NCT04920916|158064834|FG001|1 Year Follow up Visits|Lost to Follow-up|7|||
49063658|NCT02493777|158064835|FG000|Overall Study|Lost to Follow-up|0|||
49063659|NCT02493777|158064836|FG001|Overall Study|Lost to Follow-up|1|||
49063660|NCT04688931|158064837|FG000|Overall Study|Adverse Event|4|||
49063661|NCT04688931|158064838|FG001|Overall Study|Adverse Event|1|||
49063662|NCT04688931|158064837|FG000|Overall Study|Withdrawal by Subject|5|||
49063663|NCT04688931|158064838|FG001|Overall Study|Withdrawal by Subject|16|||
49063664|NCT04688931|158064837|FG000|Overall Study|Physician Decision|3|||
49063665|NCT04688931|158064838|FG001|Overall Study|Physician Decision|5|||
49063666|NCT04688931|158064837|FG000|Overall Study|Noncompliance|0|||
49063667|NCT04688931|158064838|FG001|Overall Study|Noncompliance|1|||
49063668|NCT04688931|158064837|FG000|Overall Study|Lost to Follow-up|1|||
49063669|NCT04688931|158064838|FG001|Overall Study|Lost to Follow-up|3|||
49063670|NCT04688931|158064837|FG000|Overall Study|Randomization Error|3|||
49063671|NCT04688931|158064838|FG001|Overall Study|Randomization Error|0|||
49063672|NCT04688931|158064837|FG000|Overall Study|Not Eligible|1|||
49063673|NCT04688931|158064838|FG001|Overall Study|Not Eligible|3|||
49063674|NCT04688931|158064837|FG000|Overall Study|Disease Progression|0|||
49063675|NCT04688931|158064838|FG001|Overall Study|Disease Progression|2|||
49063676|NCT04688931|158064837|FG000|Overall Study|Sponsor Requirement|1|||
49063677|NCT04688931|158064838|FG001|Overall Study|Sponsor Requirement|1|||
49063678|NCT04688931|158064837|FG000|Overall Study|Other Reason|1|||
49063679|NCT04688931|158064838|FG001|Overall Study|Other Reason|2|||
49063680|NCT00667810|158064841|FG000|Overall Study|Adverse Event|13|||
49063681|NCT00667810|158064842|FG001|Overall Study|Adverse Event|14|||
49063682|NCT00667810|158064843|FG002|Overall Study|Adverse Event|19|||
49063683|NCT00667810|158064844|FG003|Overall Study|Adverse Event|1|||
49063684|NCT00667810|158064841|FG000|Overall Study|Death|1|||
49063685|NCT00667810|158064842|FG001|Overall Study|Death|1|||
49063686|NCT00667810|158064843|FG002|Overall Study|Death|3|||
49063687|NCT00667810|158064844|FG003|Overall Study|Death|0|||
49063688|NCT00667810|158064841|FG000|Overall Study|Lack of Efficacy|1|||
49063689|NCT00667810|158064842|FG001|Overall Study|Lack of Efficacy|0|||
49063690|NCT00667810|158064843|FG002|Overall Study|Lack of Efficacy|2|||
49063691|NCT00667810|158064844|FG003|Overall Study|Lack of Efficacy|0|||
49063692|NCT00667810|158064841|FG000|Overall Study|Lost to Follow-up|1|||
49063693|NCT00667810|158064842|FG001|Overall Study|Lost to Follow-up|4|||
49063694|NCT00667810|158064843|FG002|Overall Study|Lost to Follow-up|2|||
49063695|NCT00667810|158064844|FG003|Overall Study|Lost to Follow-up|0|||
49063696|NCT00667810|158064841|FG000|Overall Study|Physician Decision|1|||
49063697|NCT00667810|158064842|FG001|Overall Study|Physician Decision|1|||
49063698|NCT00667810|158064843|FG002|Overall Study|Physician Decision|2|||
49063699|NCT00667810|158064844|FG003|Overall Study|Physician Decision|0|||
49063700|NCT00667810|158064841|FG000|Overall Study|Protocol Violation|0|||
49063701|NCT00667810|158064842|FG001|Overall Study|Protocol Violation|2|||
49063702|NCT00667810|158064843|FG002|Overall Study|Protocol Violation|0|||
49063703|NCT00667810|158064844|FG003|Overall Study|Protocol Violation|0|||
49063704|NCT00667810|158064841|FG000|Overall Study|Withdrawal by Subject|14|||
49063705|NCT00667810|158064842|FG001|Overall Study|Withdrawal by Subject|20|||
49063706|NCT00667810|158064843|FG002|Overall Study|Withdrawal by Subject|29|||
49063707|NCT00667810|158064844|FG003|Overall Study|Withdrawal by Subject|1|||
49063708|NCT00667810|158064841|FG000|Overall Study|Discontinuation of Study by Sponsor|130|||
49063709|NCT00667810|158064842|FG001|Overall Study|Discontinuation of Study by Sponsor|118|||
49063710|NCT00667810|158064843|FG002|Overall Study|Discontinuation of Study by Sponsor|155|||
49063711|NCT00667810|158064844|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
49063712|NCT00667810|158064841|FG000|Overall Study|Failed to Return|0|||
49063713|NCT00667810|158064842|FG001|Overall Study|Failed to Return|0|||
49063714|NCT00667810|158064843|FG002|Overall Study|Failed to Return|2|||
49063715|NCT00667810|158064844|FG003|Overall Study|Failed to Return|0|||
49063716|NCT00667810|158064841|FG000|Overall Study|Loss of Caregiver|0|||
49063717|NCT00667810|158064842|FG001|Overall Study|Loss of Caregiver|1|||
49063718|NCT00667810|158064843|FG002|Overall Study|Loss of Caregiver|3|||
49063719|NCT00667810|158064844|FG003|Overall Study|Loss of Caregiver|0|||
49063720|NCT00667810|158064841|FG000|Overall Study|Vasogenic Edema Recurrence|0|||
49063721|NCT00667810|158064842|FG001|Overall Study|Vasogenic Edema Recurrence|3|||
49063722|NCT00667810|158064843|FG002|Overall Study|Vasogenic Edema Recurrence|0|||
49063723|NCT00667810|158064844|FG003|Overall Study|Vasogenic Edema Recurrence|0|||
49063724|NCT00667810|158064841|FG000|Overall Study|Other|6|||
49063725|NCT00667810|158064842|FG001|Overall Study|Other|6|||
49063726|NCT00667810|158064843|FG002|Overall Study|Other|5|||
49063727|NCT00667810|158064844|FG003|Overall Study|Other|0|||
49063728|NCT01959035|158064845|FG000|Overall Study|Adverse Event|5|||
49063729|NCT01959035|158064845|FG000|Overall Study|Withdrawal by Subject|4|||
49063730|NCT01959035|158064845|FG000|Overall Study|Lost to Follow-up|1|||
49063731|NCT01959035|158064845|FG000|Overall Study|Other (no primary reason given)|1|||
49063732|NCT00361335|158064846|FG000|IV Period: Baseline to E0|Adverse Event|9|||
49063733|NCT00361335|158064847|FG001|IV Period: Baseline to E0|Adverse Event|4|||
49063734|NCT00361335|158064848|FG002|IV Period: Baseline to E0|Adverse Event|5|||
49063735|NCT00361335|158064849|FG003|IV Period: Baseline to E0|Adverse Event|9|||
49063736|NCT00361335|158064850|FG004|IV Period: Baseline to E0|Adverse Event|8|||
49063737|NCT00361335|158064851|FG005|IV Period: Baseline to E0|Adverse Event|0|||
49063738|NCT00361335|158064852|FG006|IV Period: Baseline to E0|Adverse Event|0|||
49063739|NCT00361335|158064846|FG000|IV Period: Baseline to E0|Lost to Follow-up|1|||
49063740|NCT00361335|158064847|FG001|IV Period: Baseline to E0|Lost to Follow-up|0|||
49063741|NCT00361335|158064848|FG002|IV Period: Baseline to E0|Lost to Follow-up|0|||
49063742|NCT00361335|158064849|FG003|IV Period: Baseline to E0|Lost to Follow-up|2|||
49063743|NCT00361335|158064850|FG004|IV Period: Baseline to E0|Lost to Follow-up|2|||
49063744|NCT00361335|158064851|FG005|IV Period: Baseline to E0|Lost to Follow-up|0|||
49063745|NCT00361335|158064852|FG006|IV Period: Baseline to E0|Lost to Follow-up|0|||
49063746|NCT00361335|158064846|FG000|IV Period: Baseline to E0|Death|1|||
49063747|NCT00361335|158064847|FG001|IV Period: Baseline to E0|Death|1|||
49063748|NCT00361335|158064848|FG002|IV Period: Baseline to E0|Death|1|||
49063749|NCT00361335|158064849|FG003|IV Period: Baseline to E0|Death|1|||
49063750|NCT00361335|158064850|FG004|IV Period: Baseline to E0|Death|0|||
49063751|NCT00361335|158064851|FG005|IV Period: Baseline to E0|Death|0|||
49063752|NCT00361335|158064852|FG006|IV Period: Baseline to E0|Death|0|||
49063753|NCT00361335|158064846|FG000|IV Period: Baseline to E0|Discontinued oral study agent|2|||
49063754|NCT00361335|158064847|FG001|IV Period: Baseline to E0|Discontinued oral study agent|1|||
49063755|NCT00361335|158064848|FG002|IV Period: Baseline to E0|Discontinued oral study agent|1|||
49063756|NCT00361335|158064849|FG003|IV Period: Baseline to E0|Discontinued oral study agent|1|||
49063757|NCT00361335|158064850|FG004|IV Period: Baseline to E0|Discontinued oral study agent|2|||
49063758|NCT00361335|158064851|FG005|IV Period: Baseline to E0|Discontinued oral study agent|0|||
49063759|NCT00361335|158064852|FG006|IV Period: Baseline to E0|Discontinued oral study agent|0|||
49063760|NCT00361335|158064846|FG000|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
49063761|NCT00361335|158064847|FG001|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
49063762|NCT00361335|158064848|FG002|IV Period: Baseline to E0|Protocol-prohibited medications|1|||
49063763|NCT00361335|158064849|FG003|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
49063764|NCT00361335|158064850|FG004|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
49063765|NCT00361335|158064851|FG005|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
49063766|NCT00361335|158064852|FG006|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
49063767|NCT00361335|158064846|FG000|IV Period: Baseline to E0|Worsening of RA|0|||
49063768|NCT00361335|158064847|FG001|IV Period: Baseline to E0|Worsening of RA|5|||
49063769|NCT00361335|158064848|FG002|IV Period: Baseline to E0|Worsening of RA|1|||
49063770|NCT00361335|158064849|FG003|IV Period: Baseline to E0|Worsening of RA|4|||
49063771|NCT00361335|158064850|FG004|IV Period: Baseline to E0|Worsening of RA|2|||
49063772|NCT00361335|158064851|FG005|IV Period: Baseline to E0|Worsening of RA|0|||
49063773|NCT00361335|158064852|FG006|IV Period: Baseline to E0|Worsening of RA|0|||
49063774|NCT00361335|158064846|FG000|IV Period: Baseline to E0|Other|2|||
49063775|NCT00361335|158064847|FG001|IV Period: Baseline to E0|Other|9|||
49063776|NCT00361335|158064848|FG002|IV Period: Baseline to E0|Other|9|||
49063777|NCT00361335|158064849|FG003|IV Period: Baseline to E0|Other|3|||
49063778|NCT00361335|158064850|FG004|IV Period: Baseline to E0|Other|2|||
49063779|NCT00361335|158064851|FG005|IV Period: Baseline to E0|Other|0|||
49063780|NCT00361335|158064852|FG006|IV Period: Baseline to E0|Other|0|||
49063781|NCT00361335|158064846|FG000|IV Period: Baseline to E0|Lack of Efficacy|5|||
49063782|NCT00361335|158064847|FG001|IV Period: Baseline to E0|Lack of Efficacy|9|||
49063783|NCT00361335|158064848|FG002|IV Period: Baseline to E0|Lack of Efficacy|3|||
49063784|NCT00361335|158064849|FG003|IV Period: Baseline to E0|Lack of Efficacy|7|||
49063785|NCT00361335|158064850|FG004|IV Period: Baseline to E0|Lack of Efficacy|8|||
49063786|NCT00361335|158064851|FG005|IV Period: Baseline to E0|Lack of Efficacy|0|||
49063787|NCT00361335|158064852|FG006|IV Period: Baseline to E0|Lack of Efficacy|0|||
49063788|NCT00361335|158064846|FG000|SC Period: Week E0 to Week E24|Adverse Event|0|||
49063789|NCT00361335|158064847|FG001|SC Period: Week E0 to Week E24|Adverse Event|2|||
49063790|NCT00361335|158064848|FG002|SC Period: Week E0 to Week E24|Adverse Event|1|||
49063791|NCT00361335|158064849|FG003|SC Period: Week E0 to Week E24|Adverse Event|2|||
49063792|NCT00361335|158064850|FG004|SC Period: Week E0 to Week E24|Adverse Event|0|||
49063793|NCT00361335|158064851|FG005|SC Period: Week E0 to Week E24|Adverse Event|0|||
49063794|NCT00361335|158064852|FG006|SC Period: Week E0 to Week E24|Adverse Event|2|||
49063795|NCT00361335|158064846|FG000|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
49063796|NCT00361335|158064847|FG001|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
49063797|NCT00361335|158064848|FG002|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
49063798|NCT00361335|158064849|FG003|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
49063799|NCT00361335|158064850|FG004|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
49063800|NCT00361335|158064851|FG005|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
49063801|NCT00361335|158064852|FG006|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
49063802|NCT00361335|158064846|FG000|SC Period: Week E0 to Week E24|Death|0|||
49063803|NCT00361335|158064847|FG001|SC Period: Week E0 to Week E24|Death|0|||
49063804|NCT00361335|158064848|FG002|SC Period: Week E0 to Week E24|Death|0|||
49063805|NCT00361335|158064849|FG003|SC Period: Week E0 to Week E24|Death|0|||
49063806|NCT00361335|158064850|FG004|SC Period: Week E0 to Week E24|Death|0|||
49063807|NCT00361335|158064851|FG005|SC Period: Week E0 to Week E24|Death|0|||
49063808|NCT00361335|158064852|FG006|SC Period: Week E0 to Week E24|Death|1|||
49063809|NCT00361335|158064846|FG000|SC Period: Week E0 to Week E24|Worsening of RA|0|||
49063810|NCT00361335|158064847|FG001|SC Period: Week E0 to Week E24|Worsening of RA|1|||
49063811|NCT00361335|158064848|FG002|SC Period: Week E0 to Week E24|Worsening of RA|1|||
49063812|NCT00361335|158064849|FG003|SC Period: Week E0 to Week E24|Worsening of RA|1|||
49063813|NCT00361335|158064850|FG004|SC Period: Week E0 to Week E24|Worsening of RA|0|||
49063814|NCT00361335|158064851|FG005|SC Period: Week E0 to Week E24|Worsening of RA|0|||
49063815|NCT00361335|158064852|FG006|SC Period: Week E0 to Week E24|Worsening of RA|0|||
49063816|NCT00361335|158064846|FG000|SC Period: Week E0 to Week E24|Other|1|||
49063817|NCT00361335|158064847|FG001|SC Period: Week E0 to Week E24|Other|0|||
49063818|NCT00361335|158064848|FG002|SC Period: Week E0 to Week E24|Other|0|||
49063819|NCT00361335|158064849|FG003|SC Period: Week E0 to Week E24|Other|1|||
49063820|NCT00361335|158064850|FG004|SC Period: Week E0 to Week E24|Other|0|||
49063821|NCT00361335|158064851|FG005|SC Period: Week E0 to Week E24|Other|1|||
49063822|NCT00361335|158064852|FG006|SC Period: Week E0 to Week E24|Other|2|||
49063823|NCT00361335|158064846|FG000|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
49063824|NCT00361335|158064847|FG001|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
49063825|NCT00361335|158064848|FG002|SC Period: Week E0 to Week E24|Lack of Efficacy|2|||
49063826|NCT00361335|158064849|FG003|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
49063827|NCT00361335|158064850|FG004|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
49063828|NCT00361335|158064851|FG005|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
49063829|NCT00361335|158064852|FG006|SC Period: Week E0 to Week E24|Lack of Efficacy|3|||
49063830|NCT00450619|158064853|FG000|Overall Study|refused treatment after randomization|2|||
49063831|NCT00450619|158064854|FG001|Overall Study|refused treatment after randomization|0|||
49063832|NCT00450619|158064853|FG000|Overall Study|did not progress; refused further trmt|1|||
49063833|NCT00450619|158064854|FG001|Overall Study|did not progress; refused further trmt|1|||
49063834|NCT00450619|158064853|FG000|Overall Study|Adverse Event|1|||
49063835|NCT00450619|158064854|FG001|Overall Study|Adverse Event|0|||
49063836|NCT03254602|158064857|FG000|Overall Study|Lost to Follow-up|4|||
49063837|NCT00986180|158064860|FG000|Overall Study|Adverse Event|21|||
49063838|NCT00986180|158064861|FG001|Overall Study|Adverse Event|23|||
49063839|NCT00986180|158064860|FG000|Overall Study|Lack of Efficacy|4|||
49063840|NCT00986180|158064861|FG001|Overall Study|Lack of Efficacy|3|||
49063841|NCT00986180|158064860|FG000|Overall Study|Lost to Follow-up|5|||
49063842|NCT00986180|158064861|FG001|Overall Study|Lost to Follow-up|7|||
49063843|NCT00986180|158064860|FG000|Overall Study|Physician Decision|1|||
49063844|NCT00986180|158064861|FG001|Overall Study|Physician Decision|3|||
49063845|NCT00986180|158064860|FG000|Overall Study|Protocol Violation|2|||
49063846|NCT00986180|158064861|FG001|Overall Study|Protocol Violation|0|||
49063847|NCT00986180|158064860|FG000|Overall Study|Withdrawal by Subject|1|||
49063848|NCT00986180|158064861|FG001|Overall Study|Withdrawal by Subject|9|||
49063849|NCT00986180|158064860|FG000|Overall Study|Miscellanies|10|||
49063850|NCT00986180|158064861|FG001|Overall Study|Miscellanies|11|||
49063851|NCT01765582|158064862|FG000|Overall Study|Other|3|||
49063852|NCT01765582|158064863|FG001|Overall Study|Other|6|||
49063853|NCT01765582|158064864|FG002|Overall Study|Other|9|||
49063854|NCT01765582|158064862|FG000|Overall Study|Lost to Follow-up|2|||
49063855|NCT01765582|158064863|FG001|Overall Study|Lost to Follow-up|2|||
49063856|NCT01765582|158064864|FG002|Overall Study|Lost to Follow-up|1|||
49063857|NCT01765582|158064862|FG000|Overall Study|Death|31|||
49063858|NCT01765582|158064863|FG001|Overall Study|Death|36|||
49063859|NCT01765582|158064864|FG002|Overall Study|Death|33|||
49063860|NCT01765582|158064862|FG000|Overall Study|Sponsor Decision|46|||
49063861|NCT01765582|158064863|FG001|Overall Study|Sponsor Decision|42|||
49063862|NCT01765582|158064864|FG002|Overall Study|Sponsor Decision|42|||
49063863|NCT01765582|158064862|FG000|Overall Study|Withdrawal of Consent|11|||
49063864|NCT01765582|158064863|FG001|Overall Study|Withdrawal of Consent|6|||
49063865|NCT01765582|158064864|FG002|Overall Study|Withdrawal of Consent|10|||
49063866|NCT01691820|158064865|FG000|Overall Study|Consent withdrawal (not due to an AE)|9|||
49063867|NCT01691820|158064866|FG001|Overall Study|Consent withdrawal (not due to an AE)|15|||
49063868|NCT01691820|158064865|FG000|Overall Study|Migrated/moved from study area|7|||
49063869|NCT01691820|158064866|FG001|Overall Study|Migrated/moved from study area|4|||
49063870|NCT01691820|158064865|FG000|Overall Study|Lost to Follow-up|6|||
49063871|NCT01691820|158064866|FG001|Overall Study|Lost to Follow-up|17|||
49063872|NCT01691820|158064865|FG000|Overall Study|Other (unspecified)|4|||
49063873|NCT01691820|158064866|FG001|Overall Study|Other (unspecified)|1|||
49063874|NCT00616941|158064868|FG000|Overall Study|Progressive Disease|1|||
49063875|NCT00616941|158064869|FG001|Overall Study|Progressive Disease|2|||
49063876|NCT00616941|158064870|FG002|Overall Study|Progressive Disease|1|||
49063877|NCT00616941|158064868|FG000|Overall Study|Adverse Event|0|||
49063878|NCT00616941|158064869|FG001|Overall Study|Adverse Event|1|||
49063879|NCT00616941|158064870|FG002|Overall Study|Adverse Event|1|||
49063880|NCT00616941|158064868|FG000|Overall Study|Subject Non-compliance|0|||
49063881|NCT00616941|158064869|FG001|Overall Study|Subject Non-compliance|0|||
49063882|NCT00616941|158064870|FG002|Overall Study|Subject Non-compliance|1|||
49063883|NCT00616941|158064868|FG000|Overall Study|Unrelated Medical Illness/Complication|0|||
49063884|NCT00616941|158064869|FG001|Overall Study|Unrelated Medical Illness/Complication|2|||
49063885|NCT00616941|158064870|FG002|Overall Study|Unrelated Medical Illness/Complication|0|||
49063886|NCT00616941|158064868|FG000|Overall Study|Vaccination Suspended|0|||
49063887|NCT00616941|158064869|FG001|Overall Study|Vaccination Suspended|0|||
49063888|NCT00616941|158064870|FG002|Overall Study|Vaccination Suspended|3|||
49063889|NCT02771795|158064871|FG000|Overall Study|Withdrawal by Subject|47|||
49063890|NCT02771795|158064872|FG001|Overall Study|Withdrawal by Subject|37|||
49063891|NCT02771795|158064871|FG000|Overall Study|Termination by premature discontinuation of study|168|||
49063892|NCT02771795|158064872|FG001|Overall Study|Termination by premature discontinuation of study|185|||
49063893|NCT04442490|158064873|FG000|Overall Study|Withdrawal by Subject|18|||
49063894|NCT04442490|158064874|FG001|Overall Study|Withdrawal by Subject|10|||
49063895|NCT04442490|158064873|FG000|Overall Study|Lost to Follow-up|7|||
49063896|NCT04442490|158064874|FG001|Overall Study|Lost to Follow-up|7|||
49063897|NCT04442490|158064873|FG000|Overall Study|Adverse Event|2|||
49063898|NCT04442490|158064874|FG001|Overall Study|Adverse Event|6|||
49063899|NCT04442490|158064873|FG000|Overall Study|Noncompliance|3|||
49063900|NCT04442490|158064874|FG001|Overall Study|Noncompliance|1|||
49063901|NCT04442490|158064873|FG000|Overall Study|Physician Decision|2|||
49063902|NCT04442490|158064874|FG001|Overall Study|Physician Decision|1|||
49063903|NCT04442490|158064873|FG000|Overall Study|Reason not Specified|2|||
49063904|NCT04442490|158064874|FG001|Overall Study|Reason not Specified|1|||
49063905|NCT04442490|158064873|FG000|Overall Study|Randomized but not Treated|3|||
49063906|NCT04442490|158064874|FG001|Overall Study|Randomized but not Treated|3|||
49063907|NCT00076804|158064875|FG000|Overall Study|Death|9|||
49063908|NCT00076804|158064876|FG001|Overall Study|Death|20|||
49063909|NCT00076804|158064875|FG000|Overall Study|Lost to Follow-up|9|||
49063910|NCT00076804|158064876|FG001|Overall Study|Lost to Follow-up|9|||
49063911|NCT00076804|158064875|FG000|Overall Study|Withdrawal by Subject|10|||
49063912|NCT00076804|158064876|FG001|Overall Study|Withdrawal by Subject|8|||
49063913|NCT00076804|158064875|FG000|Overall Study|Early study Closure|32|||
49063914|NCT00076804|158064876|FG001|Overall Study|Early study Closure|32|||
49063915|NCT02836496|158064879|FG000|Overall Study|Adverse Event|2|||
49063916|NCT02836496|158064880|FG001|Overall Study|Adverse Event|1|||
49063917|NCT02836496|158064879|FG000|Overall Study|Withdrawal by Subject|0|||
49063918|NCT02836496|158064880|FG001|Overall Study|Withdrawal by Subject|1|||
49063919|NCT00354341|158064881|FG000|Overall Study|Adverse Event|1|||
49063920|NCT00354341|158064882|FG001|Overall Study|Adverse Event|0|||
49063921|NCT00354341|158064881|FG000|Overall Study|Death|0|||
49063922|NCT00354341|158064882|FG001|Overall Study|Death|2|||
49063923|NCT00354341|158064881|FG000|Overall Study|Refused treatment|1|||
49063924|NCT00354341|158064882|FG001|Overall Study|Refused treatment|2|||
49063925|NCT00354341|158064881|FG000|Overall Study|Failure to return|0|||
49063926|NCT00354341|158064882|FG001|Overall Study|Failure to return|1|||
49063927|NCT00354341|158064881|FG000|Overall Study|Other|1|||
49063928|NCT00354341|158064882|FG001|Overall Study|Other|2|||
49063929|NCT01642914|158064883|FG000|Overall Study|Adverse Event|11|||
49063930|NCT01642914|158064884|FG001|Overall Study|Adverse Event|7|||
49063931|NCT01642914|158064885|FG002|Overall Study|Adverse Event|15|||
49063932|NCT01642914|158064883|FG000|Overall Study|Lack of Efficacy|9|||
49063933|NCT01642914|158064884|FG001|Overall Study|Lack of Efficacy|4|||
49063934|NCT01642914|158064885|FG002|Overall Study|Lack of Efficacy|2|||
49063935|NCT01642914|158064883|FG000|Overall Study|Protocol Violation|15|||
49063936|NCT01642914|158064884|FG001|Overall Study|Protocol Violation|13|||
49063937|NCT01642914|158064885|FG002|Overall Study|Protocol Violation|6|||
49063938|NCT01642914|158064883|FG000|Overall Study|Withdrawal by Subject|5|||
49063939|NCT01642914|158064884|FG001|Overall Study|Withdrawal by Subject|5|||
49063940|NCT01642914|158064885|FG002|Overall Study|Withdrawal by Subject|10|||
49063941|NCT01642914|158064883|FG000|Overall Study|Lost to Follow-up|5|||
49063942|NCT01642914|158064884|FG001|Overall Study|Lost to Follow-up|3|||
49063943|NCT01642914|158064885|FG002|Overall Study|Lost to Follow-up|7|||
49063944|NCT01642914|158064883|FG000|Overall Study|Other Reason|1|||
49063945|NCT01642914|158064884|FG001|Overall Study|Other Reason|0|||
49063946|NCT01642914|158064885|FG002|Overall Study|Other Reason|0|||
49063959|NCT01400919|158064890|FG000|Overall Study|Withdrawal by Subject|4|||
49063960|NCT01400919|158064890|FG000|Overall Study|Lost to Follow-up|2|||
49063961|NCT01400919|158064890|FG000|Overall Study|Missed visit|2|||
49063962|NCT04112173|158064894|FG000|Overall Study|Study terminated due to COVID-19 pandemic|1|||
49063963|NCT01561430|158064895|FG000|Overall Study|Adverse Event|0|||
49063964|NCT01561430|158064896|FG001|Overall Study|Adverse Event|0|||
49063965|NCT01561430|158064897|FG002|Overall Study|Adverse Event|3|||
49063966|NCT01561430|158064898|FG003|Overall Study|Adverse Event|1|||
49063967|NCT01561430|158064895|FG000|Overall Study|Withdrawal by Subject|0|||
49063968|NCT01561430|158064896|FG001|Overall Study|Withdrawal by Subject|0|||
49063969|NCT01561430|158064897|FG002|Overall Study|Withdrawal by Subject|1|||
49063970|NCT01561430|158064898|FG003|Overall Study|Withdrawal by Subject|0|||
49063971|NCT01561430|158064895|FG000|Overall Study|Physician Decision|0|||
49063972|NCT01561430|158064896|FG001|Overall Study|Physician Decision|1|||
49063973|NCT01561430|158064897|FG002|Overall Study|Physician Decision|0|||
49063974|NCT01561430|158064898|FG003|Overall Study|Physician Decision|0|||
49063975|NCT01561430|158064895|FG000|Overall Study|Sponsor Decision|1|||
49063976|NCT01561430|158064896|FG001|Overall Study|Sponsor Decision|14|||
49063977|NCT01561430|158064897|FG002|Overall Study|Sponsor Decision|13|||
49063978|NCT01561430|158064898|FG003|Overall Study|Sponsor Decision|12|||
49063979|NCT03028740|158064899|FG000|Overall Study|Did not Receive Study Drug|4|||
49063980|NCT03028740|158064900|FG001|Overall Study|Did not Receive Study Drug|5|||
49063981|NCT03028740|158064899|FG000|Overall Study|Adverse Event|8|||
49063982|NCT03028740|158064900|FG001|Overall Study|Adverse Event|26|||
49063983|NCT03028740|158064899|FG000|Overall Study|Lack of Efficacy|0|||
49063984|NCT03028740|158064900|FG001|Overall Study|Lack of Efficacy|1|||
49063985|NCT03028740|158064899|FG000|Overall Study|Withdrawal by Subject|48|||
49063986|NCT03028740|158064900|FG001|Overall Study|Withdrawal by Subject|101|||
49063987|NCT03028740|158064899|FG000|Overall Study|Lost to Follow-up|30|||
49063988|NCT03028740|158064900|FG001|Overall Study|Lost to Follow-up|54|||
49063989|NCT03028740|158064899|FG000|Overall Study|Physician Decision|4|||
49063990|NCT03028740|158064900|FG001|Overall Study|Physician Decision|11|||
49063991|NCT03028740|158064899|FG000|Overall Study|Protocol Violation|4|||
49063992|NCT03028740|158064900|FG001|Overall Study|Protocol Violation|8|||
49063993|NCT03028740|158064899|FG000|Overall Study|Non-compliance with Study Drug|0|||
49063994|NCT03028740|158064900|FG001|Overall Study|Non-compliance with Study Drug|2|||
49063995|NCT03028740|158064899|FG000|Overall Study|Study Terminated by Sponsor|467|||
49063996|NCT03028740|158064900|FG001|Overall Study|Study Terminated by Sponsor|917|||
49063997|NCT03028740|158064899|FG000|Overall Study|Protocol-specified Withdrawal Criteria Met|27|||
49063998|NCT03028740|158064900|FG001|Overall Study|Protocol-specified Withdrawal Criteria Met|55|||
49063999|NCT03028740|158064899|FG000|Overall Study|Reason not Specified|1|||
49064000|NCT03028740|158064900|FG001|Overall Study|Reason not Specified|5|||
49064001|NCT03347422|158064901|FG000|Part A (26 Weeks)|Adverse Event|3|||
49064002|NCT03347422|158064902|FG001|Part A (26 Weeks)|Adverse Event|0|||
49064003|NCT03347422|158064901|FG000|Part B (149 Weeks)|Lack of Efficacy|1|||
49064004|NCT03347422|158064902|FG001|Part B (149 Weeks)|Lack of Efficacy|2|||
49064005|NCT03347422|158064901|FG000|Part B (149 Weeks)|Adverse Event|0|||
49064006|NCT03347422|158064902|FG001|Part B (149 Weeks)|Adverse Event|1|||
49064007|NCT03347422|158064901|FG000|Part B (149 Weeks)|Withdrawal by Subject|1|||
49064008|NCT03347422|158064902|FG001|Part B (149 Weeks)|Withdrawal by Subject|1|||
49064009|NCT03347422|158064901|FG000|Part B (149 Weeks)|Other|1|||
49064010|NCT03347422|158064902|FG001|Part B (149 Weeks)|Other|0|||
49064011|NCT01059539|158064903|FG000|Overall Study|Adverse Event|66|||
49064012|NCT01059539|158064903|FG000|Overall Study|Insufficient Therapeutic Response|26|||
49064013|NCT01059539|158064903|FG000|Overall Study|Protocol Violation|55|||
49064014|NCT01059539|158064903|FG000|Overall Study|Withdrawal of Consent|80|||
49064015|NCT01059539|158064903|FG000|Overall Study|Lost to Follow-up|42|||
49064016|NCT01059539|158064903|FG000|Overall Study|Reason Not Specified|2|||
49064017|NCT00536263|158064904|FG000|Overall Study|Adverse Event|5|||
49064018|NCT00536263|158064905|FG001|Overall Study|Adverse Event|5|||
49064019|NCT00536263|158064906|FG002|Overall Study|Adverse Event|7|||
49064020|NCT00536263|158064904|FG000|Overall Study|Lost to Follow-up|3|||
49064021|NCT00536263|158064905|FG001|Overall Study|Lost to Follow-up|4|||
49064022|NCT00536263|158064906|FG002|Overall Study|Lost to Follow-up|4|||
49064023|NCT00536263|158064904|FG000|Overall Study|Subject withdrew - not treatment related|2|||
49064024|NCT00536263|158064905|FG001|Overall Study|Subject withdrew - not treatment related|0|||
49064025|NCT00536263|158064906|FG002|Overall Study|Subject withdrew - not treatment related|5|||
49064026|NCT00536263|158064904|FG000|Overall Study|Subject withdrew - treatment related|0|||
49064027|NCT00536263|158064905|FG001|Overall Study|Subject withdrew - treatment related|3|||
49064028|NCT00536263|158064906|FG002|Overall Study|Subject withdrew - treatment related|2|||
49064029|NCT00536263|158064904|FG000|Overall Study|Noncompliance with protocol|0|||
49064030|NCT00536263|158064905|FG001|Overall Study|Noncompliance with protocol|0|||
49064031|NCT00536263|158064906|FG002|Overall Study|Noncompliance with protocol|1|||
49064032|NCT00536263|158064904|FG000|Overall Study|Did not meet protocol eligibility|1|||
49064033|NCT00536263|158064905|FG001|Overall Study|Did not meet protocol eligibility|2|||
49064034|NCT00536263|158064906|FG002|Overall Study|Did not meet protocol eligibility|2|||
49064035|NCT02304458|158064908|FG000|Overall Study|Adverse Event|0|||
49064036|NCT02304458|158064909|FG001|Overall Study|Adverse Event|0|||
49064037|NCT02304458|158064910|FG002|Overall Study|Adverse Event|7|||
49064038|NCT02304458|158064911|FG003|Overall Study|Adverse Event|0|||
49064039|NCT02304458|158064912|FG004|Overall Study|Adverse Event|0|||
49064040|NCT02304458|158064913|FG005|Overall Study|Adverse Event|0|||
49064041|NCT02304458|158064914|FG006|Overall Study|Adverse Event|3|||
49064042|NCT02304458|158064915|FG007|Overall Study|Adverse Event|4|||
49064043|NCT02304458|158064908|FG000|Overall Study|Death|0|||
49064044|NCT02304458|158064909|FG001|Overall Study|Death|0|||
49064045|NCT02304458|158064910|FG002|Overall Study|Death|2|||
49064046|NCT02304458|158064911|FG003|Overall Study|Death|0|||
49064047|NCT02304458|158064912|FG004|Overall Study|Death|0|||
49064048|NCT02304458|158064913|FG005|Overall Study|Death|0|||
49064049|NCT02304458|158064914|FG006|Overall Study|Death|1|||
49064050|NCT02304458|158064915|FG007|Overall Study|Death|0|||
49064051|NCT02304458|158064908|FG000|Overall Study|Lack of Efficacy|4|||
49064052|NCT02304458|158064909|FG001|Overall Study|Lack of Efficacy|6|||
49064053|NCT02304458|158064910|FG002|Overall Study|Lack of Efficacy|38|||
49064054|NCT02304458|158064911|FG003|Overall Study|Lack of Efficacy|5|||
49064055|NCT02304458|158064912|FG004|Overall Study|Lack of Efficacy|6|||
49064056|NCT02304458|158064913|FG005|Overall Study|Lack of Efficacy|6|||
49064057|NCT02304458|158064914|FG006|Overall Study|Lack of Efficacy|21|||
49064058|NCT02304458|158064915|FG007|Overall Study|Lack of Efficacy|4|||
49064059|NCT02304458|158064908|FG000|Overall Study|Physician Decision|2|||
49064060|NCT02304458|158064909|FG001|Overall Study|Physician Decision|0|||
49064061|NCT02304458|158064910|FG002|Overall Study|Physician Decision|16|||
49064062|NCT02304458|158064911|FG003|Overall Study|Physician Decision|1|||
49064063|NCT02304458|158064912|FG004|Overall Study|Physician Decision|0|||
49064064|NCT02304458|158064913|FG005|Overall Study|Physician Decision|0|||
49064065|NCT02304458|158064914|FG006|Overall Study|Physician Decision|3|||
49064066|NCT02304458|158064915|FG007|Overall Study|Physician Decision|0|||
49064067|NCT02304458|158064908|FG000|Overall Study|Protocol Violation|0|||
49064068|NCT02304458|158064909|FG001|Overall Study|Protocol Violation|0|||
49064069|NCT02304458|158064910|FG002|Overall Study|Protocol Violation|1|||
49064070|NCT02304458|158064911|FG003|Overall Study|Protocol Violation|0|||
49064071|NCT02304458|158064912|FG004|Overall Study|Protocol Violation|0|||
49064072|NCT02304458|158064913|FG005|Overall Study|Protocol Violation|0|||
49064073|NCT02304458|158064914|FG006|Overall Study|Protocol Violation|0|||
49064074|NCT02304458|158064915|FG007|Overall Study|Protocol Violation|0|||
49064075|NCT02304458|158064908|FG000|Overall Study|Withdrawal by Subject|1|||
49064076|NCT02304458|158064909|FG001|Overall Study|Withdrawal by Subject|0|||
49064077|NCT02304458|158064910|FG002|Overall Study|Withdrawal by Subject|7|||
49064078|NCT02304458|158064911|FG003|Overall Study|Withdrawal by Subject|0|||
49064079|NCT02304458|158064912|FG004|Overall Study|Withdrawal by Subject|0|||
49064080|NCT02304458|158064913|FG005|Overall Study|Withdrawal by Subject|0|||
49064081|NCT02304458|158064914|FG006|Overall Study|Withdrawal by Subject|1|||
49064082|NCT02304458|158064915|FG007|Overall Study|Withdrawal by Subject|0|||
49064083|NCT00197496|158064916|FG000|Baseline to Discharge|not interested|1|||
49064084|NCT00197496|158064917|FG001|Baseline to Discharge|not interested|0|||
49064085|NCT00197496|158064916|FG000|Baseline to Discharge|MRSA|1|||
49064086|NCT00197496|158064917|FG001|Baseline to Discharge|MRSA|0|||
49064087|NCT00197496|158064916|FG000|Baseline to Discharge|Physician Decision|0|||
49064088|NCT00197496|158064917|FG001|Baseline to Discharge|Physician Decision|1|||
49064089|NCT00197496|158064916|FG000|Baseline to Discharge|Protocol Violation|0|||
49064090|NCT00197496|158064917|FG001|Baseline to Discharge|Protocol Violation|1|||
49064091|NCT00197496|158064916|FG000|Follow-up|Lost to Follow-up|2|||
49064092|NCT00197496|158064917|FG001|Follow-up|Lost to Follow-up|1|||
49064093|NCT04430855|158064918|FG000|Period 1 (Weeks 1-12)|Adverse Event|1|||
49064094|NCT04430855|158064919|FG001|Period 1 (Weeks 1-12)|Adverse Event|0|||
49064095|NCT04430855|158064918|FG000|Period 1 (Weeks 1-12)|Withdrawal by Subject|1|||
49064096|NCT04430855|158064919|FG001|Period 1 (Weeks 1-12)|Withdrawal by Subject|2|||
49064097|NCT04430855|158064918|FG000|Period 1 (Weeks 1-12)|Lost to Follow-up|0|||
49064098|NCT04430855|158064919|FG001|Period 1 (Weeks 1-12)|Lost to Follow-up|2|||
49064099|NCT04430855|158064918|FG000|Period 1 (Weeks 1-12)|Lack of Efficacy|0|||
49064100|NCT04430855|158064919|FG001|Period 1 (Weeks 1-12)|Lack of Efficacy|1|||
49064101|NCT04430855|158064918|FG000|Period 1 (Weeks 1-12)|Other|0|||
49064102|NCT04430855|158064919|FG001|Period 1 (Weeks 1-12)|Other|1|||
49064103|NCT04430855|158064918|FG000|Period 2 (Weeks 12-48)|Withdrawal by Subject|2|||
49064104|NCT04430855|158064919|FG001|Period 2 (Weeks 12-48)|Withdrawal by Subject|5|||
49064105|NCT04430855|158064918|FG000|Period 2 (Weeks 12-48)|Lost to Follow-up|1|||
49064106|NCT04430855|158064919|FG001|Period 2 (Weeks 12-48)|Lost to Follow-up|2|||
49064107|NCT04430855|158064918|FG000|Period 2 (Weeks 12-48)|Lack of Efficacy|2|||
49064108|NCT04430855|158064919|FG001|Period 2 (Weeks 12-48)|Lack of Efficacy|3|||
49064109|NCT03071094|158064934|FG000|Overall Study|Death|1|||
49064110|NCT03071094|158064935|FG001|Overall Study|Death|1|||
49064111|NCT03071094|158064934|FG000|Overall Study|Adverse Event|1|||
49064112|NCT03071094|158064935|FG001|Overall Study|Adverse Event|0|||
49064113|NCT01770392|158064936|FG000|Washout Period of at Least 14 Days|Adverse Event|1|||
49064114|NCT04188301|158064937|FG000|Month 3|Lost to Follow-up|0|||
49064115|NCT04188301|158064938|FG001|Month 3|Lost to Follow-up|0|||
49064116|NCT04188301|158064939|FG002|Month 3|Lost to Follow-up|1|||
49064117|NCT04188301|158064937|FG000|Month 12|Lost to Follow-up|0|||
49064118|NCT04188301|158064938|FG001|Month 12|Lost to Follow-up|0|||
49064119|NCT04188301|158064939|FG002|Month 12|Lost to Follow-up|2|||
49064120|NCT04188301|158064937|FG000|Month 12|Death|1|||
49064121|NCT04188301|158064938|FG001|Month 12|Death|1|||
49064122|NCT04188301|158064939|FG002|Month 12|Death|0|||
49064123|NCT04188301|158064937|FG000|Month 18|Lost to Follow-up|6|||
49064124|NCT04188301|158064938|FG001|Month 18|Lost to Follow-up|0|||
49064125|NCT04188301|158064939|FG002|Month 18|Lost to Follow-up|0|||
49064126|NCT02312063|158064940|FG000|Overall Study|Withdrawal by Subject|0|||
49064127|NCT02312063|158064941|FG001|Overall Study|Withdrawal by Subject|1|||
49064128|NCT00857584|158064945|FG000|Overall Study|Lack of Efficacy|1|||
49064129|NCT00857584|158064946|FG001|Overall Study|Lack of Efficacy|2|||
49064130|NCT00857584|158064945|FG000|Overall Study|Adverse Event|2|||
49064131|NCT00857584|158064946|FG001|Overall Study|Adverse Event|2|||
49064132|NCT00857584|158064945|FG000|Overall Study|Physician Decision|1|||
49064133|NCT00857584|158064946|FG001|Overall Study|Physician Decision|1|||
49064134|NCT00861198|158064947|FG000|Overall Study|SpyGlass Failed|5|||
49064135|NCT00003138|158067116|FG000|Step 1|Reasons off treatment not documented|60|||
49064136|NCT00003138|158067117|FG001|Step 1|Reasons off treatment not documented|57|||
49064137|NCT00003138|158067116|FG000|Step 1|Never started treatment|1|||
49064138|NCT00003138|158067117|FG001|Step 1|Never started treatment|0|||
49064139|NCT00003138|158067116|FG000|Step 2 (Cross Over)|Reasons off treatment not documented|26|||
49064140|NCT00003138|158067117|FG001|Step 2 (Cross Over)|Reasons off treatment not documented|0|||
49064141|NCT00003138|158067116|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12|||
49064142|NCT00003138|158067117|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19|||
49064143|NCT00003138|158067116|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0|||
49064144|NCT00003138|158067117|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1|||
49064145|NCT00003138|158067116|FG000|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6|||
49064146|NCT00003138|158067117|FG001|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7|||
49064147|NCT00321828|158067118|FG000|Overall Study|Ineligible|3|||
49064148|NCT00321828|158067118|FG000|Overall Study|No follow up data|1|||
49064149|NCT00440466|158067124|FG000|Overall Study|Death|3|||
49064150|NCT00440466|158067125|FG001|Overall Study|Death|2|||
49064151|NCT00440466|158067126|FG002|Overall Study|Death|9|||
49064152|NCT00440466|158067124|FG000|Overall Study|Adverse Event|3|||
49064153|NCT00440466|158067125|FG001|Overall Study|Adverse Event|4|||
49064154|NCT00440466|158067126|FG002|Overall Study|Adverse Event|11|||
49064155|NCT00440466|158067124|FG000|Overall Study|Lost to Follow-up|1|||
49064156|NCT00440466|158067125|FG001|Overall Study|Lost to Follow-up|0|||
49064157|NCT00440466|158067126|FG002|Overall Study|Lost to Follow-up|2|||
49064158|NCT00440466|158067124|FG000|Overall Study|Physician Decision|2|||
49064159|NCT00440466|158067125|FG001|Overall Study|Physician Decision|0|||
49064160|NCT00440466|158067126|FG002|Overall Study|Physician Decision|1|||
49064161|NCT00440466|158067124|FG000|Overall Study|Protocol Violation|2|||
49064162|NCT00440466|158067125|FG001|Overall Study|Protocol Violation|0|||
49064163|NCT00440466|158067126|FG002|Overall Study|Protocol Violation|4|||
49064164|NCT00440466|158067124|FG000|Overall Study|Withdrawal by Subject|2|||
49064165|NCT00440466|158067125|FG001|Overall Study|Withdrawal by Subject|5|||
49064166|NCT00440466|158067126|FG002|Overall Study|Withdrawal by Subject|9|||
49064167|NCT00440466|158067124|FG000|Overall Study|Began Dialysis|0|||
49064168|NCT00440466|158067125|FG001|Overall Study|Began Dialysis|0|||
49064169|NCT00440466|158067126|FG002|Overall Study|Began Dialysis|1|||
49064170|NCT00440466|158067124|FG000|Overall Study|Met Hemoglobin Withdrawal Criteria|0|||
49064171|NCT00440466|158067125|FG001|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
49064172|NCT00440466|158067126|FG002|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
49064173|NCT03861481|158067127|FG000|Overall Study|COVID-19 pandemic circumstances|0|||
49064174|NCT03861481|158067128|FG001|Overall Study|COVID-19 pandemic circumstances|1|||
49064175|NCT03861481|158067127|FG000|Overall Study|Participant not plan to participate in the study CIDP04|1|||
49064176|NCT03861481|158067128|FG001|Overall Study|Participant not plan to participate in the study CIDP04|0|||
49064177|NCT03861481|158067127|FG000|Overall Study|Relapse|1|||
49064178|NCT03861481|158067128|FG001|Overall Study|Relapse|0|||
49064179|NCT03861481|158067127|FG000|Overall Study|Withdrawal by Subject|0|||
49064180|NCT03861481|158067128|FG001|Overall Study|Withdrawal by Subject|1|||
49064181|NCT03861481|158067127|FG000|Overall Study|Lack of Efficacy|4|||
49064182|NCT03861481|158067128|FG001|Overall Study|Lack of Efficacy|5|||
49064183|NCT02856880|158067133|FG000|Overall Study|Withdrawal of consent|1|||
49064184|NCT00856830|158067136|FG000|Irinotecan & Bendamustine|Death|0|||
49064185|NCT00856830|158067137|FG001|Irinotecan & Bendamustine|Death|0|||
49064186|NCT00856830|158067138|FG002|Irinotecan & Bendamustine|Death|0|||
49064187|NCT00856830|158067139|FG003|Irinotecan & Bendamustine|Death|2|||
49064188|NCT00856830|158067136|FG000|Irinotecan & Bendamustine|Physician Decision|0|||
49064189|NCT00856830|158067137|FG001|Irinotecan & Bendamustine|Physician Decision|0|||
49064190|NCT00856830|158067138|FG002|Irinotecan & Bendamustine|Physician Decision|0|||
49064191|NCT00856830|158067139|FG003|Irinotecan & Bendamustine|Physician Decision|1|||
49064192|NCT02054130|158067140|FG000|Overall Study|Withdrawal by Subject|4|||
49064193|NCT02054130|158067141|FG001|Overall Study|Withdrawal by Subject|4|||
49064194|NCT02054130|158067142|FG002|Overall Study|Withdrawal by Subject|7|||
49064195|NCT02054130|158067143|FG003|Overall Study|Withdrawal by Subject|10|||
49064196|NCT02054130|158067140|FG000|Overall Study|Death|0|||
49064197|NCT02054130|158067141|FG001|Overall Study|Death|1|||
49064198|NCT02054130|158067142|FG002|Overall Study|Death|0|||
49064199|NCT02054130|158067143|FG003|Overall Study|Death|0|||
49064200|NCT02054130|158067140|FG000|Overall Study|Lost to Follow-up|0|||
49064201|NCT02054130|158067141|FG001|Overall Study|Lost to Follow-up|0|||
49064202|NCT02054130|158067142|FG002|Overall Study|Lost to Follow-up|1|||
49064203|NCT02054130|158067143|FG003|Overall Study|Lost to Follow-up|2|||
49064204|NCT02054130|158067140|FG000|Overall Study|Missed dose|4|||
49064205|NCT02054130|158067141|FG001|Overall Study|Missed dose|6|||
49064206|NCT02054130|158067142|FG002|Overall Study|Missed dose|7|||
49064207|NCT02054130|158067143|FG003|Overall Study|Missed dose|10|||
49064208|NCT00793780|158067146|FG000|Overall Study|Withdrawal by Subject|2|||
49064209|NCT00793780|158067147|FG001|Overall Study|Withdrawal by Subject|1|||
49064210|NCT02669940|158067150|FG000|Overall Study|Failure to return|0|||
49064211|NCT02669940|158067151|FG001|Overall Study|Failure to return|3|||
49064212|NCT02669940|158067150|FG000|Overall Study|Insufficient follow-up data|1|||
49064213|NCT02669940|158067151|FG001|Overall Study|Insufficient follow-up data|0|||
49064214|NCT00974974|158067153|FG000|IR CD-LD Dose Adjustment|Adverse Event|0|||
49064215|NCT00974974|158067154|FG001|IR CD-LD Dose Adjustment|Adverse Event|3|||
49064216|NCT00974974|158067153|FG000|IR CD-LD Dose Adjustment|Protocol Violation|0|||
49064217|NCT00974974|158067154|FG001|IR CD-LD Dose Adjustment|Protocol Violation|1|||
49064218|NCT00974974|158067153|FG000|IR CD-LD Dose Adjustment|Noncompliance with study drug|0|||
49064219|NCT00974974|158067154|FG001|IR CD-LD Dose Adjustment|Noncompliance with study drug|1|||
49064220|NCT00974974|158067153|FG000|IR CD-LD Dose Adjustment|Withdrawal by Subject|0|||
49064221|NCT00974974|158067154|FG001|IR CD-LD Dose Adjustment|Withdrawal by Subject|7|||
49064222|NCT00974974|158067153|FG000|IR CD-LD Dose Adjustment|Various|0|||
49064223|NCT00974974|158067154|FG001|IR CD-LD Dose Adjustment|Various|9|||
49064224|NCT00974974|158067153|FG000|IPX066 Dose Conversion|Adverse Event|23|||
49064225|NCT00974974|158067154|FG001|IPX066 Dose Conversion|Adverse Event|0|||
49064226|NCT00974974|158067153|FG000|IPX066 Dose Conversion|Death|2|||
49064227|NCT00974974|158067154|FG001|IPX066 Dose Conversion|Death|0|||
49064228|NCT00974974|158067153|FG000|IPX066 Dose Conversion|Lack of Efficacy|13|||
49064229|NCT00974974|158067154|FG001|IPX066 Dose Conversion|Lack of Efficacy|0|||
49064230|NCT00974974|158067153|FG000|IPX066 Dose Conversion|Withdrawal by Subject|12|||
49064231|NCT00974974|158067154|FG001|IPX066 Dose Conversion|Withdrawal by Subject|0|||
49064232|NCT00974974|158067153|FG000|IPX066 Dose Conversion|Various|3|||
49064233|NCT00974974|158067154|FG001|IPX066 Dose Conversion|Various|0|||
49064234|NCT00974974|158067153|FG000|IPX066 Dose Conversion|Protocol Violation|4|||
49064235|NCT00974974|158067154|FG001|IPX066 Dose Conversion|Protocol Violation|0|||
49064236|NCT00974974|158067153|FG000|Maintenance - Double Blind Treatment|Adverse Event|3|||
49064237|NCT00974974|158067154|FG001|Maintenance - Double Blind Treatment|Adverse Event|3|||
49064238|NCT00974974|158067153|FG000|Maintenance - Double Blind Treatment|Protocol Violation|1|||
49064239|NCT00974974|158067154|FG001|Maintenance - Double Blind Treatment|Protocol Violation|1|||
49064240|NCT00974974|158067153|FG000|Maintenance - Double Blind Treatment|Noncompliance with study drug|0|||
49064241|NCT00974974|158067154|FG001|Maintenance - Double Blind Treatment|Noncompliance with study drug|1|||
49064242|NCT00974974|158067153|FG000|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
49064243|NCT00974974|158067154|FG001|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
49064244|NCT00974974|158067153|FG000|Maintenance - Double Blind Treatment|Lost to Follow-up|0|||
49064245|NCT00974974|158067154|FG001|Maintenance - Double Blind Treatment|Lost to Follow-up|1|||
49064246|NCT00974974|158067153|FG000|Maintenance - Double Blind Treatment|Withdrawal by Subject|5|||
49064247|NCT00974974|158067154|FG001|Maintenance - Double Blind Treatment|Withdrawal by Subject|2|||
49064248|NCT00974974|158067153|FG000|Maintenance - Double Blind Treatment|Various|4|||
49064249|NCT00974974|158067154|FG001|Maintenance - Double Blind Treatment|Various|0|||
49064250|NCT01892657|158067155|FG000|Overall Study|Withdrawal by Subject|6|||
49064251|NCT01892657|158067155|FG000|Overall Study|Protocol Violation|12|||
49064252|NCT05065983|158067156|FG000|Overall Study|Lost to Follow-up|2|||
49064253|NCT00714493|158067159|FG000|Overall Study|Adverse Event|11|||
49064254|NCT00714493|158067159|FG000|Overall Study|Death|3|||
49064255|NCT00714493|158067159|FG000|Overall Study|Lack of Efficacy|10|||
49064256|NCT00714493|158067159|FG000|Overall Study|Lost to Follow-up|3|||
49064257|NCT00714493|158067159|FG000|Overall Study|Protocol Violation|12|||
49064258|NCT00714493|158067159|FG000|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8|||
49064259|NCT00714493|158067159|FG000|Overall Study|OTHER|2|||
49064260|NCT02372071|158067160|FG000|Overall Study|Protocol Violation|18|||
49064261|NCT04505293|158067161|FG000|Overall Study|Lost to Follow-up|2|||
49064262|NCT04505293|158067161|FG000|Overall Study|Withdrawal by Subject|6|||
49064263|NCT04505293|158067161|FG000|Overall Study|CT scan unreadable|277|||
49064264|NCT02227147|158067162|FG000|Controlled Treatment Period|Adverse Event|4|||
49064265|NCT02227147|158067163|FG001|Controlled Treatment Period|Adverse Event|3|||
49064266|NCT02227147|158067162|FG000|Controlled Treatment Period|Other|2|||
49064267|NCT02227147|158067163|FG001|Controlled Treatment Period|Other|0|||
49064268|NCT02227147|158067162|FG000|Follow-up Period|Other|3|||
49064269|NCT02227147|158067163|FG001|Follow-up Period|Other|5|||
49064270|NCT01968694|158067167|FG000|Washout (1 Month)|Lost to Follow-up|0|||
49064271|NCT01968694|158067168|FG001|Washout (1 Month)|Lost to Follow-up|1|||
49064272|NCT03514641|158067170|FG000|603A: 0-12 Week Study Period|Protocol Violation|3|||
49064273|NCT03514641|158067171|FG001|603A: 0-12 Week Study Period|Protocol Violation|3|||
49064274|NCT03514641|158067172|FG002|603A: 0-12 Week Study Period|Protocol Violation|0|||
49064275|NCT03514641|158067173|FG003|603A: 0-12 Week Study Period|Protocol Violation|0|||
49064276|NCT03514641|158067170|FG000|603A: 0-12 Week Study Period|Adverse Event|5|||
49064277|NCT03514641|158067171|FG001|603A: 0-12 Week Study Period|Adverse Event|2|||
49064278|NCT03514641|158067172|FG002|603A: 0-12 Week Study Period|Adverse Event|0|||
49064279|NCT03514641|158067173|FG003|603A: 0-12 Week Study Period|Adverse Event|0|||
49064280|NCT03514641|158067170|FG000|603A: 0-12 Week Study Period|Withdrawal by Subject|7|||
49064281|NCT03514641|158067171|FG001|603A: 0-12 Week Study Period|Withdrawal by Subject|5|||
49064282|NCT03514641|158067172|FG002|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
49064283|NCT03514641|158067173|FG003|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
49064284|NCT03514641|158067170|FG000|603A: 0-12 Week Study Period|Lost to Follow-up|10|||
49064285|NCT03514641|158067171|FG001|603A: 0-12 Week Study Period|Lost to Follow-up|9|||
49064286|NCT03514641|158067172|FG002|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
49064287|NCT03514641|158067173|FG003|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
49064288|NCT03514641|158067170|FG000|603A: 0-12 Week Study Period|Physician Decision|1|||
49064289|NCT03514641|158067171|FG001|603A: 0-12 Week Study Period|Physician Decision|0|||
49064290|NCT03514641|158067172|FG002|603A: 0-12 Week Study Period|Physician Decision|0|||
49064291|NCT03514641|158067173|FG003|603A: 0-12 Week Study Period|Physician Decision|0|||
49064292|NCT03514641|158067170|FG000|603A: 0-12 Week Study Period|Lack of Efficacy|1|||
49064293|NCT03514641|158067171|FG001|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
49064294|NCT03514641|158067172|FG002|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
49064295|NCT03514641|158067173|FG003|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
49064296|NCT03514641|158067170|FG000|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
49064297|NCT03514641|158067171|FG001|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1|||
49064298|NCT03514641|158067172|FG002|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
49064299|NCT03514641|158067173|FG003|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
49064300|NCT03514641|158067170|FG000|603B: 24-36 Week Study Period|Protocol Violation|0|||
49064301|NCT03514641|158067171|FG001|603B: 24-36 Week Study Period|Protocol Violation|0|||
49064302|NCT03514641|158067172|FG002|603B: 24-36 Week Study Period|Protocol Violation|0|||
49064303|NCT03514641|158067173|FG003|603B: 24-36 Week Study Period|Protocol Violation|2|||
49064304|NCT03514641|158067170|FG000|603B: 24-36 Week Study Period|Adverse Event|0|||
49064305|NCT03514641|158067171|FG001|603B: 24-36 Week Study Period|Adverse Event|0|||
49064306|NCT03514641|158067172|FG002|603B: 24-36 Week Study Period|Adverse Event|3|||
49064307|NCT03514641|158067173|FG003|603B: 24-36 Week Study Period|Adverse Event|1|||
49064308|NCT03514641|158067170|FG000|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
49064309|NCT03514641|158067171|FG001|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
49064310|NCT03514641|158067172|FG002|603B: 24-36 Week Study Period|Withdrawal by Subject|2|||
49064311|NCT03514641|158067173|FG003|603B: 24-36 Week Study Period|Withdrawal by Subject|3|||
49064312|NCT03514641|158067170|FG000|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
49064313|NCT03514641|158067171|FG001|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
49064314|NCT03514641|158067172|FG002|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
49064315|NCT03514641|158067173|FG003|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
49064316|NCT03514641|158067170|FG000|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
49064317|NCT03514641|158067171|FG001|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
49064318|NCT03514641|158067172|FG002|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
49064319|NCT03514641|158067173|FG003|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
49064320|NCT04295135|158067174|FG000|Overall Study|Withdrawal by Subject|2|||
49064321|NCT04295135|158067175|FG001|Overall Study|Withdrawal by Subject|1|||
49064322|NCT04295135|158067174|FG000|Overall Study|Subject left organization|8|||
49064323|NCT04295135|158067175|FG001|Overall Study|Subject left organization|4|||
49064324|NCT01732874|158067179|FG000|Overall Study|Withdrawal by Subject|5|||
49064325|NCT01732874|158067180|FG001|Overall Study|Withdrawal by Subject|1|||
49064326|NCT01732874|158067179|FG000|Overall Study|Death of Infant|3|||
49064327|NCT01732874|158067180|FG001|Overall Study|Death of Infant|2|||
49064328|NCT02923674|158067181|FG000|Overall Study|Clinic Closed Due to COVID-19|14|||
49064329|NCT02923674|158067182|FG001|Overall Study|Clinic Closed Due to COVID-19|11|||
49064330|NCT02923674|158067183|FG002|Overall Study|Clinic Closed Due to COVID-19|14|||
49064331|NCT02923674|158067181|FG000|Overall Study|Lost to Follow-up|7|||
49064332|NCT02923674|158067182|FG001|Overall Study|Lost to Follow-up|12|||
49064333|NCT02923674|158067183|FG002|Overall Study|Lost to Follow-up|7|||
49064334|NCT02923674|158067181|FG000|Overall Study|Problem with intervention|2|||
49064335|NCT02923674|158067182|FG001|Overall Study|Problem with intervention|2|||
49064336|NCT02923674|158067183|FG002|Overall Study|Problem with intervention|1|||
49064337|NCT02923674|158067181|FG000|Overall Study|Adverse Event|3|||
49064338|NCT02923674|158067182|FG001|Overall Study|Adverse Event|1|||
49064339|NCT02923674|158067183|FG002|Overall Study|Adverse Event|1|||
49064340|NCT02923674|158067181|FG000|Overall Study|Withdrawal by Subject|2|||
49064341|NCT02923674|158067182|FG001|Overall Study|Withdrawal by Subject|2|||
49064342|NCT02923674|158067183|FG002|Overall Study|Withdrawal by Subject|2|||
49064343|NCT02906930|158067186|FG000|Overall Study|Withdrawal by Subject|0|||
49064344|NCT02906930|158067187|FG001|Overall Study|Withdrawal by Subject|5|||
49064345|NCT02906930|158067188|FG002|Overall Study|Withdrawal by Subject|5|||
49064346|NCT02906930|158067189|FG003|Overall Study|Withdrawal by Subject|4|||
49064347|NCT02906930|158067186|FG000|Overall Study|Lost to Follow-up|5|||
49064348|NCT02906930|158067187|FG001|Overall Study|Lost to Follow-up|7|||
49064349|NCT02906930|158067188|FG002|Overall Study|Lost to Follow-up|5|||
49064350|NCT02906930|158067189|FG003|Overall Study|Lost to Follow-up|2|||
49064351|NCT02906930|158067186|FG000|Overall Study|Death|0|||
49064352|NCT02906930|158067187|FG001|Overall Study|Death|0|||
49064353|NCT02906930|158067188|FG002|Overall Study|Death|1|||
49064354|NCT02906930|158067189|FG003|Overall Study|Death|0|||
49064355|NCT02906930|158067186|FG000|Overall Study|Other|1|||
49064356|NCT02906930|158067187|FG001|Overall Study|Other|2|||
49064357|NCT02906930|158067188|FG002|Overall Study|Other|1|||
49064358|NCT02906930|158067189|FG003|Overall Study|Other|2|||
49064359|NCT00557076|158067197|FG000|Overall Study|Unblinding|0|||
49064360|NCT00557076|158067198|FG001|Overall Study|Unblinding|1|||
49064361|NCT00688376|158067199|FG000|Double-Blind Phase|Adverse Event|4|||
49064362|NCT00688376|158067200|FG001|Double-Blind Phase|Adverse Event|4|||
49064363|NCT00688376|158067199|FG000|Double-Blind Phase|Protocol Violation|1|||
49064364|NCT00688376|158067200|FG001|Double-Blind Phase|Protocol Violation|2|||
49064365|NCT00688376|158067199|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
49064366|NCT00688376|158067200|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
49064367|NCT00688376|158067199|FG000|Double-Blind Phase|Not treated|0|||
49064368|NCT00688376|158067200|FG001|Double-Blind Phase|Not treated|1|||
49064369|NCT00688376|158067199|FG000|Blinded Extension Phase|Adverse Event|3|||
49064370|NCT00688376|158067200|FG001|Blinded Extension Phase|Adverse Event|4|||
49064371|NCT00688376|158067199|FG000|Blinded Extension Phase|Withdrawal by Subject|0|||
49064372|NCT00688376|158067200|FG001|Blinded Extension Phase|Withdrawal by Subject|1|||
49064373|NCT00688376|158067199|FG000|Blinded Extension Phase|Physician Decision|1|||
49064374|NCT00688376|158067200|FG001|Blinded Extension Phase|Physician Decision|0|||
49064375|NCT00688376|158067199|FG000|Blinded Extension Phase|Other|1|||
49064376|NCT00688376|158067200|FG001|Blinded Extension Phase|Other|0|||
49064377|NCT04492020|158067206|FG000|Overall Study|Adverse Event|1|||
49064378|NCT04492020|158067207|FG001|Overall Study|Adverse Event|3|||
49064379|NCT04492020|158067206|FG000|Overall Study|Withdrawal by Subject|4|||
49064380|NCT04492020|158067207|FG001|Overall Study|Withdrawal by Subject|3|||
49064381|NCT04492020|158067206|FG000|Overall Study|Lost to Follow-up|4|||
49064382|NCT04492020|158067207|FG001|Overall Study|Lost to Follow-up|3|||
49064383|NCT04492020|158067206|FG000|Overall Study|Protocol Violation|5|||
49064384|NCT04492020|158067207|FG001|Overall Study|Protocol Violation|2|||
49064385|NCT04492020|158067206|FG000|Overall Study|Lack of Qualifying Event|25|||
49064386|NCT04492020|158067207|FG001|Overall Study|Lack of Qualifying Event|27|||
49064387|NCT04492020|158067206|FG000|Overall Study|Non-compliance with Study Drug|2|||
49064388|NCT04492020|158067207|FG001|Overall Study|Non-compliance with Study Drug|1|||
49064389|NCT00171301|158067208|FG000|Overall Study|Death|1|||
49064390|NCT00171301|158067209|FG001|Overall Study|Death|2|||
49064391|NCT00171301|158067208|FG000|Overall Study|Adverse Event|1|||
49064392|NCT00171301|158067209|FG001|Overall Study|Adverse Event|2|||
49064393|NCT00171301|158067208|FG000|Overall Study|Lost to Follow-up|6|||
49064394|NCT00171301|158067209|FG001|Overall Study|Lost to Follow-up|2|||
49064395|NCT00171301|158067208|FG000|Overall Study|Protocol Violation|0|||
49064396|NCT00171301|158067209|FG001|Overall Study|Protocol Violation|2|||
49064397|NCT00171301|158067208|FG000|Overall Study|Withdrawal by Subject|0|||
49064398|NCT00171301|158067209|FG001|Overall Study|Withdrawal by Subject|1|||
49064399|NCT04594707|158067210|FG000|Overall Study|Adverse Event|0|||
49064400|NCT04594707|158067211|FG001|Overall Study|Adverse Event|0|||
49064401|NCT04594707|158067212|FG002|Overall Study|Adverse Event|1|||
49064402|NCT04594707|158067210|FG000|Overall Study|Death|0|||
49064403|NCT04594707|158067211|FG001|Overall Study|Death|2|||
49064404|NCT04594707|158067212|FG002|Overall Study|Death|2|||
49064405|NCT04594707|158067210|FG000|Overall Study|Lung Transplant|0|||
49064406|NCT04594707|158067211|FG001|Overall Study|Lung Transplant|0|||
49064407|NCT04594707|158067212|FG002|Overall Study|Lung Transplant|1|||
49064408|NCT04594707|158067210|FG000|Overall Study|Grade 4 infusion related reaction (IRR)|1|||
49064409|NCT04594707|158067211|FG001|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
49064410|NCT04594707|158067212|FG002|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
49064411|NCT04594707|158067210|FG000|Overall Study|Study Terminated By Sponsor|19|||
49064412|NCT04594707|158067211|FG001|Overall Study|Study Terminated By Sponsor|47|||
49064413|NCT04594707|158067212|FG002|Overall Study|Study Terminated By Sponsor|41|||
49064414|NCT04594707|158067210|FG000|Overall Study|Withdrawal by Subject|1|||
49064415|NCT04594707|158067211|FG001|Overall Study|Withdrawal by Subject|0|||
49064416|NCT04594707|158067212|FG002|Overall Study|Withdrawal by Subject|2|||
49064417|NCT03127644|158067213|FG000|Overall Study|Study-specific withdrawal criteria|0|||
49064418|NCT03127644|158067214|FG001|Overall Study|Study-specific withdrawal criteria|0|||
49064419|NCT03127644|158067215|FG002|Overall Study|Study-specific withdrawal criteria|2|||
49064420|NCT02500641|158067221|FG000|Overall Study|Adverse Event|0|||
49064421|NCT02500641|158067222|FG001|Overall Study|Adverse Event|2|||
49064422|NCT02500641|158067221|FG000|Overall Study|Withdrawal by Subject|4|||
49064423|NCT02500641|158067222|FG001|Overall Study|Withdrawal by Subject|5|||
49064424|NCT02500641|158067221|FG000|Overall Study|Unable to follow study procedures|3|||
49064425|NCT02500641|158067222|FG001|Overall Study|Unable to follow study procedures|2|||
49064426|NCT02500641|158067221|FG000|Overall Study|Protocol Violation|1|||
49064427|NCT02500641|158067222|FG001|Overall Study|Protocol Violation|2|||
49064428|NCT02500641|158067221|FG000|Overall Study|Lost to Follow-up|1|||
49064429|NCT02500641|158067222|FG001|Overall Study|Lost to Follow-up|0|||
49064430|NCT02500641|158067221|FG000|Overall Study|Sponsor decision|1|||
49064431|NCT02500641|158067222|FG001|Overall Study|Sponsor decision|0|||
49064432|NCT02500641|158067221|FG000|Overall Study|Non compliance to study drug|0|||
49064433|NCT02500641|158067222|FG001|Overall Study|Non compliance to study drug|1|||
49064434|NCT02440568|158067225|FG000|Overall Study|Death|1|||
49064435|NCT02440568|158067226|FG001|Overall Study|Death|3|||
49064436|NCT02440568|158067227|FG002|Overall Study|Death|4|||
49064437|NCT02440568|158067228|FG003|Overall Study|Death|2|||
49064438|NCT02440568|158067225|FG000|Overall Study|Lack of Efficacy|2|||
49064439|NCT02440568|158067226|FG001|Overall Study|Lack of Efficacy|0|||
49064440|NCT02440568|158067227|FG002|Overall Study|Lack of Efficacy|1|||
49064441|NCT02440568|158067228|FG003|Overall Study|Lack of Efficacy|0|||
49064442|NCT02440568|158067225|FG000|Overall Study|Lost to Follow-up|1|||
49064443|NCT02440568|158067226|FG001|Overall Study|Lost to Follow-up|0|||
49064444|NCT02440568|158067227|FG002|Overall Study|Lost to Follow-up|0|||
49064445|NCT02440568|158067228|FG003|Overall Study|Lost to Follow-up|0|||
49064446|NCT04355663|158067229|FG000|Overall Study|Physician Decision|2|||
49064447|NCT04355663|158067230|FG001|Overall Study|Physician Decision|7|||
49064448|NCT04355663|158067231|FG002|Overall Study|Physician Decision|0|||
49064449|NCT04355663|158067229|FG000|Overall Study|Adverse Event|0|||
49064450|NCT04355663|158067230|FG001|Overall Study|Adverse Event|0|||
49064451|NCT04355663|158067231|FG002|Overall Study|Adverse Event|1|||
49064452|NCT04355663|158067229|FG000|Overall Study|Withdrawal by Subject|0|||
49064453|NCT04355663|158067230|FG001|Overall Study|Withdrawal by Subject|8|||
49064454|NCT04355663|158067231|FG002|Overall Study|Withdrawal by Subject|3|||
49064455|NCT00826449|158067239|FG000|Overall Study|Disease Progression|4|||
49064456|NCT00826449|158067239|FG000|Overall Study|Withdrawal by Subject|1|||
49064457|NCT02994940|158067242|FG000|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6|||
49064458|NCT02994940|158067243|FG001|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0|||
49064459|NCT02994940|158067242|FG000|Overall Study|Did not receive study medications: vomited after ingestion|1|||
49064460|NCT02994940|158067243|FG001|Overall Study|Did not receive study medications: vomited after ingestion|0|||
49064461|NCT02994940|158067242|FG000|Overall Study|Did not receive study medications: red dye allergy|0|||
49064462|NCT02994940|158067243|FG001|Overall Study|Did not receive study medications: red dye allergy|1|||
49064463|NCT01103466|158067244|FG000|First Period (14 +/- 3 Days)|Protocol Violation|2|||
49064464|NCT01103466|158067245|FG001|First Period (14 +/- 3 Days)|Protocol Violation|0|||
49064465|NCT01103466|158067246|FG002|First Period (14 +/- 3 Days)|Protocol Violation|0|||
49064466|NCT01103466|158067244|FG000|Second Period (14 +/- 3 Days)|Adverse Event|2|||
49064467|NCT01103466|158067245|FG001|Second Period (14 +/- 3 Days)|Adverse Event|1|||
49064468|NCT01103466|158067246|FG002|Second Period (14 +/- 3 Days)|Adverse Event|0|||
49064469|NCT01103466|158067244|FG000|Second Period (14 +/- 3 Days)|Lack of Efficacy|0|||
49064470|NCT01103466|158067245|FG001|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
49064471|NCT01103466|158067246|FG002|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
49064472|NCT01103466|158067244|FG000|Third Period (14 +/- 3 Days)|Adverse Event|1|||
49064473|NCT01103466|158067245|FG001|Third Period (14 +/- 3 Days)|Adverse Event|0|||
49064474|NCT01103466|158067246|FG002|Third Period (14 +/- 3 Days)|Adverse Event|0|||
49064475|NCT01103466|158067244|FG000|Third Period (14 +/- 3 Days)|Lack of Efficacy|1|||
49064476|NCT01103466|158067245|FG001|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
49064477|NCT01103466|158067246|FG002|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
49064478|NCT01103466|158067244|FG000|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
49064479|NCT01103466|158067245|FG001|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
49064480|NCT01103466|158067246|FG002|Third Period (14 +/- 3 Days)|not satisfied with product|1|||
49064481|NCT03233230|158067247|FG000|Overall Study|Adverse Event|6|||
49064482|NCT03233230|158067248|FG001|Overall Study|Adverse Event|3|||
49064483|NCT03233230|158067249|FG002|Overall Study|Adverse Event|6|||
49064484|NCT03233230|158067250|FG003|Overall Study|Adverse Event|3|||
49064485|NCT03233230|158067247|FG000|Overall Study|Protocol Violation|1|||
49064486|NCT03233230|158067248|FG001|Overall Study|Protocol Violation|2|||
49064487|NCT03233230|158067249|FG002|Overall Study|Protocol Violation|1|||
49064488|NCT03233230|158067250|FG003|Overall Study|Protocol Violation|1|||
49064489|NCT03233230|158067247|FG000|Overall Study|Lack of Efficacy|1|||
49064490|NCT03233230|158067248|FG001|Overall Study|Lack of Efficacy|0|||
49064491|NCT03233230|158067249|FG002|Overall Study|Lack of Efficacy|0|||
49064492|NCT03233230|158067250|FG003|Overall Study|Lack of Efficacy|0|||
49064493|NCT03233230|158067247|FG000|Overall Study|Other|5|||
49064494|NCT03233230|158067248|FG001|Overall Study|Other|5|||
49064495|NCT03233230|158067249|FG002|Overall Study|Other|5|||
49064496|NCT03233230|158067250|FG003|Overall Study|Other|3|||
49064497|NCT03233230|158067247|FG000|Overall Study|Withdrawal by Subject|2|||
49064498|NCT03233230|158067248|FG001|Overall Study|Withdrawal by Subject|2|||
49064499|NCT03233230|158067249|FG002|Overall Study|Withdrawal by Subject|0|||
49064500|NCT03233230|158067250|FG003|Overall Study|Withdrawal by Subject|1|||
49064501|NCT03233230|158067247|FG000|Overall Study|Lost to Follow-up|0|||
49064502|NCT03233230|158067248|FG001|Overall Study|Lost to Follow-up|3|||
49064503|NCT03233230|158067249|FG002|Overall Study|Lost to Follow-up|0|||
49064504|NCT03233230|158067250|FG003|Overall Study|Lost to Follow-up|0|||
49064505|NCT02331368|158067251|FG000|Overall Study|Withdrawal by Subject|3|||
49064506|NCT00468650|158067256|FG000|Overall Study|Lost to Follow-up|4|||
49064507|NCT00468650|158067256|FG000|Overall Study|Withdrawal by Subject|2|||
49064508|NCT00468650|158067256|FG000|Overall Study|Protocol Violation|1|||
49064509|NCT04209205|158067260|FG000|Overall Study|Adverse Event|2|||
49064510|NCT04209205|158067261|FG001|Overall Study|Adverse Event|3|||
49064511|NCT04209205|158067260|FG000|Overall Study|Lost to Follow-up|3|||
49064512|NCT04209205|158067261|FG001|Overall Study|Lost to Follow-up|1|||
49064513|NCT04209205|158067260|FG000|Overall Study|Physician Decision|1|||
49064514|NCT04209205|158067261|FG001|Overall Study|Physician Decision|1|||
49064515|NCT04209205|158067260|FG000|Overall Study|Subject decision|10|||
49064516|NCT04209205|158067261|FG001|Overall Study|Subject decision|10|||
49064517|NCT04209205|158067260|FG000|Overall Study|Progressive disease|1|||
49064518|NCT04209205|158067261|FG001|Overall Study|Progressive disease|0|||
49064519|NCT04209205|158067260|FG000|Overall Study|Protocol deviation|0|||
49064520|NCT04209205|158067261|FG001|Overall Study|Protocol deviation|1|||
49064521|NCT04209205|158067260|FG000|Overall Study|New therapy for study indication|1|||
49064522|NCT04209205|158067261|FG001|Overall Study|New therapy for study indication|0|||
49064523|NCT04209205|158067260|FG000|Overall Study|Adverse event - placebo not switched|0|||
49064524|NCT04209205|158067261|FG001|Overall Study|Adverse event - placebo not switched|1|||
49064525|NCT04209205|158067260|FG000|Overall Study|Subject decision - placebo not switched|0|||
49064526|NCT04209205|158067261|FG001|Overall Study|Subject decision - placebo not switched|5|||
49064527|NCT04209205|158067260|FG000|Overall Study|Death - placebo not switched|0|||
49064528|NCT04209205|158067261|FG001|Overall Study|Death - placebo not switched|1|||
49064529|NCT01083810|158067265|FG000|Overall Study|Lost to Follow-up|23|||
49064530|NCT01083810|158067266|FG001|Overall Study|Lost to Follow-up|11|||
49064531|NCT01083810|158067267|FG002|Overall Study|Lost to Follow-up|4|||
49064532|NCT01083810|158067265|FG000|Overall Study|Adverse Event|15|||
49064533|NCT01083810|158067266|FG001|Overall Study|Adverse Event|11|||
49064534|NCT01083810|158067267|FG002|Overall Study|Adverse Event|4|||
49064535|NCT01083810|158067265|FG000|Overall Study|Withdrawal by Subject|7|||
49064536|NCT01083810|158067266|FG001|Overall Study|Withdrawal by Subject|2|||
49064537|NCT01083810|158067267|FG002|Overall Study|Withdrawal by Subject|4|||
49064538|NCT01083810|158067265|FG000|Overall Study|Reason not reported|6|||
49064539|NCT01083810|158067266|FG001|Overall Study|Reason not reported|1|||
49064540|NCT01083810|158067267|FG002|Overall Study|Reason not reported|1|||
49064541|NCT01083810|158067265|FG000|Overall Study|Non-compliance|4|||
49064542|NCT01083810|158067266|FG001|Overall Study|Non-compliance|7|||
49064543|NCT01083810|158067267|FG002|Overall Study|Non-compliance|2|||
49064544|NCT01083810|158067265|FG000|Overall Study|Simplification|4|||
49064545|NCT01083810|158067266|FG001|Overall Study|Simplification|1|||
49064546|NCT01083810|158067267|FG002|Overall Study|Simplification|0|||
49064547|NCT01083810|158067265|FG000|Overall Study|Death|2|||
49064548|NCT01083810|158067266|FG001|Overall Study|Death|2|||
49064549|NCT01083810|158067267|FG002|Overall Study|Death|3|||
49064550|NCT01083810|158067265|FG000|Overall Study|Co-morbidities|1|||
49064551|NCT01083810|158067266|FG001|Overall Study|Co-morbidities|0|||
49064552|NCT01083810|158067267|FG002|Overall Study|Co-morbidities|0|||
49064553|NCT01083810|158067265|FG000|Overall Study|Participation in study|1|||
49064554|NCT01083810|158067266|FG001|Overall Study|Participation in study|0|||
49064555|NCT01083810|158067267|FG002|Overall Study|Participation in study|0|||
49064556|NCT01083810|158067265|FG000|Overall Study|Therapy break|1|||
49064557|NCT01083810|158067266|FG001|Overall Study|Therapy break|2|||
49064558|NCT01083810|158067267|FG002|Overall Study|Therapy break|2|||
49064559|NCT01083810|158067265|FG000|Overall Study|Virologic failure|1|||
49064560|NCT01083810|158067266|FG001|Overall Study|Virologic failure|8|||
49064561|NCT01083810|158067267|FG002|Overall Study|Virologic failure|0|||
49064562|NCT00228423|158067268|FG000|Overall Study|Adverse Event|2|||
49064563|NCT00228423|158067269|FG001|Overall Study|Adverse Event|5|||
49064564|NCT00228423|158067268|FG000|Overall Study|Withdrawal by Subject|7|||
49064565|NCT00228423|158067269|FG001|Overall Study|Withdrawal by Subject|3|||
49064566|NCT00228423|158067268|FG000|Overall Study|Protocol Violation|1|||
49064567|NCT00228423|158067269|FG001|Overall Study|Protocol Violation|3|||
49064568|NCT00228423|158067268|FG000|Overall Study|Physician Decision|0|||
49064569|NCT00228423|158067269|FG001|Overall Study|Physician Decision|1|||
49064570|NCT04639713|158067270|FG000|Overall Study|Protocol Noncompliance|2|||
49064571|NCT04639713|158067270|FG000|Overall Study|Withdrawal by Subject|1|||
49064572|NCT03401450|158067271|FG000|Overall Study|Lost to Follow-up|4|||
49064573|NCT03401450|158067272|FG001|Overall Study|Lost to Follow-up|6|||
49064574|NCT03401450|158067271|FG000|Overall Study|Anesthesia plan changed|2|||
49064575|NCT03401450|158067272|FG001|Overall Study|Anesthesia plan changed|2|||
49064576|NCT03401450|158067271|FG000|Overall Study|Did not complete medication diary|4|||
49064577|NCT03401450|158067272|FG001|Overall Study|Did not complete medication diary|2|||
49064578|NCT03401450|158067271|FG000|Overall Study|post surgery medication change|2|||
49064579|NCT03401450|158067272|FG001|Overall Study|post surgery medication change|1|||
49064580|NCT03401450|158067271|FG000|Overall Study|Cancelled surgery|0|||
49064581|NCT03401450|158067272|FG001|Overall Study|Cancelled surgery|2|||
49064582|NCT00390221|158067279|FG000|Overall Study|Lost to Follow-up|0|||
49064583|NCT00390221|158067280|FG001|Overall Study|Lost to Follow-up|3|||
49064584|NCT00390221|158067281|FG002|Overall Study|Lost to Follow-up|0|||
49064585|NCT00390221|158067279|FG000|Overall Study|Adverse Event|1|||
49064586|NCT00390221|158067280|FG001|Overall Study|Adverse Event|4|||
49064587|NCT00390221|158067281|FG002|Overall Study|Adverse Event|3|||
49064588|NCT00390221|158067279|FG000|Overall Study|Investigator Decision|0|||
49064589|NCT00390221|158067280|FG001|Overall Study|Investigator Decision|0|||
49064590|NCT00390221|158067281|FG002|Overall Study|Investigator Decision|1|||
49064591|NCT00390221|158067279|FG000|Overall Study|Withdrawal by Subject|13|||
49064592|NCT00390221|158067280|FG001|Overall Study|Withdrawal by Subject|9|||
49064593|NCT00390221|158067281|FG002|Overall Study|Withdrawal by Subject|7|||
49064594|NCT00390221|158067279|FG000|Overall Study|Subject Non-compliance|1|||
49064595|NCT00390221|158067280|FG001|Overall Study|Subject Non-compliance|0|||
49064596|NCT00390221|158067281|FG002|Overall Study|Subject Non-compliance|2|||
49064597|NCT00390221|158067279|FG000|Overall Study|Other|3|||
49064598|NCT00390221|158067280|FG001|Overall Study|Other|4|||
49064599|NCT00390221|158067281|FG002|Overall Study|Other|2|||
49064600|NCT02533375|158067284|FG000|Overall Study|Lack of Efficacy|3|||
49064601|NCT02533375|158067284|FG000|Overall Study|Adverse Event|2|||
49064602|NCT01177059|158067285|FG000|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30|||
49064603|NCT01177059|158067285|FG000|Overall Study|Withdrew consent|2|||
49064604|NCT01177059|158067285|FG000|Overall Study|Lost to Follow-up|18|||
49064605|NCT00673387|158067286|FG000|Overall Study|Withdrawal by Subject|15|||
49064606|NCT00673387|158067287|FG001|Overall Study|Withdrawal by Subject|16|||
49064607|NCT00673387|158067288|FG002|Overall Study|Withdrawal by Subject|20|||
49064608|NCT00673387|158067289|FG003|Overall Study|Withdrawal by Subject|16|||
49064609|NCT00673387|158067290|FG004|Overall Study|Withdrawal by Subject|18|||
49064610|NCT00673387|158067291|FG005|Overall Study|Withdrawal by Subject|21|||
49064611|NCT00673387|158067292|FG006|Overall Study|Withdrawal by Subject|15|||
49064612|NCT00673387|158067293|FG007|Overall Study|Withdrawal by Subject|21|||
49064613|NCT00673387|158067286|FG000|Overall Study|Adverse Event|3|||
49064614|NCT00673387|158067287|FG001|Overall Study|Adverse Event|1|||
49064615|NCT00673387|158067288|FG002|Overall Study|Adverse Event|5|||
49064616|NCT00673387|158067289|FG003|Overall Study|Adverse Event|2|||
49064617|NCT00673387|158067290|FG004|Overall Study|Adverse Event|6|||
49064618|NCT00673387|158067291|FG005|Overall Study|Adverse Event|2|||
49064619|NCT00673387|158067292|FG006|Overall Study|Adverse Event|5|||
49064620|NCT00673387|158067293|FG007|Overall Study|Adverse Event|5|||
49064621|NCT00673387|158067286|FG000|Overall Study|Physician Decision|0|||
49064622|NCT00673387|158067287|FG001|Overall Study|Physician Decision|0|||
49064623|NCT00673387|158067288|FG002|Overall Study|Physician Decision|0|||
49064624|NCT00673387|158067289|FG003|Overall Study|Physician Decision|0|||
49064625|NCT00673387|158067290|FG004|Overall Study|Physician Decision|0|||
49064626|NCT00673387|158067291|FG005|Overall Study|Physician Decision|5|||
49064627|NCT00673387|158067292|FG006|Overall Study|Physician Decision|1|||
49064628|NCT00673387|158067293|FG007|Overall Study|Physician Decision|1|||
49064629|NCT00673387|158067286|FG000|Overall Study|Protocol Violation|3|||
49064630|NCT00673387|158067287|FG001|Overall Study|Protocol Violation|0|||
49064631|NCT00673387|158067288|FG002|Overall Study|Protocol Violation|1|||
49064632|NCT00673387|158067289|FG003|Overall Study|Protocol Violation|2|||
49064633|NCT00673387|158067290|FG004|Overall Study|Protocol Violation|0|||
49064634|NCT00673387|158067291|FG005|Overall Study|Protocol Violation|1|||
49064635|NCT00673387|158067292|FG006|Overall Study|Protocol Violation|1|||
49064636|NCT00673387|158067293|FG007|Overall Study|Protocol Violation|3|||
49064637|NCT00673387|158067286|FG000|Overall Study|Lost to Follow-up|8|||
49064638|NCT00673387|158067287|FG001|Overall Study|Lost to Follow-up|6|||
49064639|NCT00673387|158067288|FG002|Overall Study|Lost to Follow-up|5|||
49064640|NCT00673387|158067289|FG003|Overall Study|Lost to Follow-up|6|||
49064641|NCT00673387|158067290|FG004|Overall Study|Lost to Follow-up|6|||
49064642|NCT00673387|158067291|FG005|Overall Study|Lost to Follow-up|5|||
49064643|NCT00673387|158067292|FG006|Overall Study|Lost to Follow-up|8|||
49064644|NCT00673387|158067293|FG007|Overall Study|Lost to Follow-up|5|||
49064645|NCT02005887|158067294|FG000|Overall Study|Protocol Violation|0|||
49064646|NCT02005887|158067295|FG001|Overall Study|Protocol Violation|2|||
49064647|NCT04319718|158069402|FG000|Overall Study|Adverse Event|0|||
49064648|NCT04319718|158069403|FG001|Overall Study|Adverse Event|2|||
49064649|NCT04319718|158069402|FG000|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|1|||
49064650|NCT04319718|158069403|FG001|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|0|||
49064651|NCT02858492|158069404|FG000|Overall Study|Withdrawal by Subject|0|||
49064652|NCT02858492|158069405|FG001|Overall Study|Withdrawal by Subject|1|||
49064653|NCT02858492|158069406|FG002|Overall Study|Withdrawal by Subject|0|||
49064654|NCT02858492|158069407|FG003|Overall Study|Withdrawal by Subject|1|||
49064655|NCT02858492|158069404|FG000|Overall Study|Adverse Event|0|||
49064656|NCT02858492|158069405|FG001|Overall Study|Adverse Event|0|||
49064657|NCT02858492|158069406|FG002|Overall Study|Adverse Event|0|||
49064658|NCT02858492|158069407|FG003|Overall Study|Adverse Event|3|||
49064659|NCT02858492|158069404|FG000|Overall Study|Lack of Efficacy|0|||
49064660|NCT02858492|158069405|FG001|Overall Study|Lack of Efficacy|0|||
49064661|NCT02858492|158069406|FG002|Overall Study|Lack of Efficacy|0|||
49064662|NCT02858492|158069407|FG003|Overall Study|Lack of Efficacy|1|||
49064663|NCT02858492|158069404|FG000|Overall Study|Protocol defined stopping criteria|0|||
49064664|NCT02858492|158069405|FG001|Overall Study|Protocol defined stopping criteria|0|||
49064665|NCT02858492|158069406|FG002|Overall Study|Protocol defined stopping criteria|0|||
49064666|NCT02858492|158069407|FG003|Overall Study|Protocol defined stopping criteria|1|||
49064667|NCT01386684|158069408|FG000|Overall Study|Lost to Follow-up|51|||
49064668|NCT01386684|158069408|FG000|Overall Study|Other|51|||
49064669|NCT01386684|158069408|FG000|Overall Study|Death|47|||
49064670|NCT01386684|158069408|FG000|Overall Study|Withdrawal of Consent|44|||
49064671|NCT01386684|158069408|FG000|Overall Study|Alternative Therapy Required|37|||
49064672|NCT01386684|158069408|FG000|Overall Study|Disease Progression|28|||
49064673|NCT01386684|158069408|FG000|Overall Study|Adverse Event|20|||
49064674|NCT01386684|158069408|FG000|Overall Study|Noncompliance|8|||
49064675|NCT01386684|158069408|FG000|Overall Study|Protocol Violation|4|||
49064676|NCT01386684|158069408|FG000|Overall Study|Missing|3|||
49064677|NCT02944383|158069409|FG000|Overall Study|Lost to Follow-up|0|||
49064678|NCT02944383|158069410|FG001|Overall Study|Lost to Follow-up|0|||
49064679|NCT02944383|158069411|FG002|Overall Study|Lost to Follow-up|1|||
49064680|NCT02944383|158069409|FG000|Overall Study|Withdrawal by Subject|1|||
49064681|NCT02944383|158069410|FG001|Overall Study|Withdrawal by Subject|0|||
49064682|NCT02944383|158069411|FG002|Overall Study|Withdrawal by Subject|0|||
49064683|NCT01032018|158069414|FG000|Overall Study|Lost to Follow-up|6|||
49064684|NCT01032018|158069415|FG001|Overall Study|Lost to Follow-up|5|||
49064685|NCT01032018|158069414|FG000|Overall Study|Death|0|||
49064686|NCT01032018|158069415|FG001|Overall Study|Death|1|||
49064687|NCT02963311|158069422|FG000|Overall Study|Withdrawal by Subject|1|||
49064688|NCT02963311|158069422|FG000|Overall Study|Screen Failure|4|||
49064689|NCT00468728|158069423|FG000|Treatment|criteria for mITT population|4|||
49064690|NCT00468728|158069424|FG001|Treatment|criteria for mITT population|11|||
49064691|NCT00468728|158069423|FG000|Follow-up|mITT failure|34|||
49064692|NCT00468728|158069424|FG001|Follow-up|mITT failure|31|||
49064693|NCT03251963|158069429|FG000|Overall Study|inappropriate Xa level timing|6|||
49064694|NCT03251963|158069430|FG001|Overall Study|inappropriate Xa level timing|3|||
49064695|NCT03251963|158069429|FG000|Overall Study|no peak Xa level drawn|2|||
49064696|NCT03251963|158069430|FG001|Overall Study|no peak Xa level drawn|0|||
49064697|NCT03251963|158069429|FG000|Overall Study|bled prior to Xa level|1|||
49064698|NCT03251963|158069430|FG001|Overall Study|bled prior to Xa level|2|||
49064699|NCT00506129|158069446|FG000|Overall Study|Disease Progression/Relapse|15|||
49064700|NCT00506129|158069446|FG000|Overall Study|Death|7|||
49064701|NCT00251719|158069447|FG000|Overall Study|Adverse Event|14|||
49064702|NCT00251719|158069448|FG001|Overall Study|Adverse Event|8|||
49064703|NCT00251719|158069449|FG002|Overall Study|Adverse Event|7|||
49064704|NCT00251719|158069447|FG000|Overall Study|Protocol Violation|1|||
49064705|NCT00251719|158069448|FG001|Overall Study|Protocol Violation|1|||
49064706|NCT00251719|158069449|FG002|Overall Study|Protocol Violation|1|||
49064707|NCT00251719|158069447|FG000|Overall Study|Lost to Follow-up|5|||
49064708|NCT00251719|158069448|FG001|Overall Study|Lost to Follow-up|11|||
49064709|NCT00251719|158069449|FG002|Overall Study|Lost to Follow-up|8|||
49064710|NCT00251719|158069447|FG000|Overall Study|Withdrawal by Subject|14|||
49064711|NCT00251719|158069448|FG001|Overall Study|Withdrawal by Subject|12|||
49064712|NCT00251719|158069449|FG002|Overall Study|Withdrawal by Subject|11|||
49064713|NCT00251719|158069447|FG000|Overall Study|Lack of Efficacy|2|||
49064714|NCT00251719|158069448|FG001|Overall Study|Lack of Efficacy|1|||
49064715|NCT00251719|158069449|FG002|Overall Study|Lack of Efficacy|0|||
49064716|NCT00251719|158069447|FG000|Overall Study|Inclusion/exclusion criteria not met|12|||
49064717|NCT00251719|158069448|FG001|Overall Study|Inclusion/exclusion criteria not met|6|||
49064718|NCT00251719|158069449|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
49064719|NCT00251719|158069447|FG000|Overall Study|Investigator decision|1|||
49064720|NCT00251719|158069448|FG001|Overall Study|Investigator decision|1|||
49064721|NCT00251719|158069449|FG002|Overall Study|Investigator decision|0|||
49064722|NCT00251719|158069447|FG000|Overall Study|Noncompliance|2|||
49064723|NCT00251719|158069448|FG001|Overall Study|Noncompliance|3|||
49064724|NCT00251719|158069449|FG002|Overall Study|Noncompliance|1|||
49064725|NCT00251719|158069447|FG000|Overall Study|Barrett's esophagus|2|||
49064726|NCT00251719|158069448|FG001|Overall Study|Barrett's esophagus|2|||
49064727|NCT00251719|158069449|FG002|Overall Study|Barrett's esophagus|0|||
49064728|NCT01449279|158069452|FG000|Overall Study|Lack of Efficacy|5|||
49064729|NCT01449279|158069452|FG000|Overall Study|Toxicity|2|||
49064730|NCT01345175|158069453|FG000|Overall Study|Physician Decision|0|||
49064731|NCT01345175|158069454|FG001|Overall Study|Physician Decision|1|||
49064732|NCT01345175|158069453|FG000|Overall Study|Withdrawal by Subject|1|||
49064733|NCT01345175|158069454|FG001|Overall Study|Withdrawal by Subject|1|||
49064734|NCT01345175|158069453|FG000|Overall Study|Failed to complete BFI|3|||
49064735|NCT01345175|158069454|FG001|Overall Study|Failed to complete BFI|2|||
49064736|NCT01345175|158069453|FG000|Overall Study|Stopped taking medication|2|||
49064737|NCT01345175|158069454|FG001|Overall Study|Stopped taking medication|2|||
49064738|NCT00505375|158069455|FG000|Overall Study|Death|1|||
49064739|NCT00505375|158069456|FG001|Overall Study|Death|0|||
49064740|NCT00505375|158069455|FG000|Overall Study|Withdrawal by Subject|2|||
49064741|NCT00505375|158069456|FG001|Overall Study|Withdrawal by Subject|2|||
49064742|NCT00505375|158069455|FG000|Overall Study|Lost to Follow-up|0|||
49064743|NCT00505375|158069456|FG001|Overall Study|Lost to Follow-up|2|||
49064744|NCT00505375|158069455|FG000|Overall Study|Pregnancy|1|||
49064745|NCT00505375|158069456|FG001|Overall Study|Pregnancy|0|||
49064746|NCT00505375|158069455|FG000|Overall Study|Travel issues|0|||
49064747|NCT00505375|158069456|FG001|Overall Study|Travel issues|1|||
49064748|NCT03822832|158069457|FG000|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
49064749|NCT03822832|158069458|FG001|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
49064750|NCT03822832|158069457|FG000|Period 1 - Double Blind Period|Lost to Follow-up|1|||
49064751|NCT03822832|158069458|FG001|Period 1 - Double Blind Period|Lost to Follow-up|1|||
49064752|NCT03822832|158069457|FG000|Period 1 - Double Blind Period|Protocol Violation|1|||
49064753|NCT03822832|158069458|FG001|Period 1 - Double Blind Period|Protocol Violation|1|||
49064754|NCT03822832|158069457|FG000|Period 1 - Double Blind Period|Lack of Efficacy|2|||
49064755|NCT03822832|158069458|FG001|Period 1 - Double Blind Period|Lack of Efficacy|1|||
49064756|NCT03822832|158069457|FG000|Period 1 - Double Blind Period|Adverse Event|3|||
49064757|NCT03822832|158069458|FG001|Period 1 - Double Blind Period|Adverse Event|5|||
49064758|NCT03822832|158069457|FG000|Re-allocation|Not re-allocated to open label period|2|||
49064759|NCT03822832|158069458|FG001|Re-allocation|Not re-allocated to open label period|6|||
49064760|NCT03822832|158069457|FG000|Period 2 - Open Label Period|Lost to Follow-up|1|||
49064761|NCT03822832|158069458|FG001|Period 2 - Open Label Period|Lost to Follow-up|0|||
49064762|NCT03822832|158069457|FG000|Period 2 - Open Label Period|Adverse Event|0|||
49064763|NCT03822832|158069458|FG001|Period 2 - Open Label Period|Adverse Event|3|||
49064764|NCT01705236|158069459|FG000|Overall Study|Lost to Follow-up|1|||
49064765|NCT01705236|158069459|FG000|Overall Study|Administrative problems|2|||
49064766|NCT01705236|158069459|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
49064767|NCT01705236|158069459|FG000|Overall Study|Protocol Violation|3|||
49064768|NCT01705236|158069459|FG000|Overall Study|Abnormal test procedure result(s)|4|||
49064769|NCT01705236|158069459|FG000|Overall Study|Abnormal laboratory value(s)|4|||
49064770|NCT01705236|158069459|FG000|Overall Study|Withdrawal by Subject|5|||
49064771|NCT01705236|158069459|FG000|Overall Study|Adverse Event|5|||
49064772|NCT03709823|158069460|FG000|Overall Study|Adverse Event|0|||
49064773|NCT03709823|158069461|FG001|Overall Study|Adverse Event|0|||
49064774|NCT03709823|158069462|FG002|Overall Study|Adverse Event|1|||
49064775|NCT03709823|158069463|FG003|Overall Study|Adverse Event|0|||
49064776|NCT03709823|158069464|FG004|Overall Study|Adverse Event|0|||
49064777|NCT03709823|158069465|FG005|Overall Study|Adverse Event|0|||
49064778|NCT03709823|158069460|FG000|Overall Study|Lost to Follow-up|2|||
49064779|NCT03709823|158069461|FG001|Overall Study|Lost to Follow-up|2|||
49064780|NCT03709823|158069462|FG002|Overall Study|Lost to Follow-up|2|||
49064781|NCT03709823|158069463|FG003|Overall Study|Lost to Follow-up|1|||
49064782|NCT03709823|158069464|FG004|Overall Study|Lost to Follow-up|1|||
49064783|NCT03709823|158069465|FG005|Overall Study|Lost to Follow-up|0|||
49064784|NCT03709823|158069460|FG000|Overall Study|Withdrawal by Subject|1|||
49064785|NCT03709823|158069461|FG001|Overall Study|Withdrawal by Subject|3|||
49064786|NCT03709823|158069462|FG002|Overall Study|Withdrawal by Subject|0|||
49064787|NCT03709823|158069463|FG003|Overall Study|Withdrawal by Subject|0|||
49064788|NCT03709823|158069464|FG004|Overall Study|Withdrawal by Subject|0|||
49064789|NCT03709823|158069465|FG005|Overall Study|Withdrawal by Subject|0|||
49064790|NCT03709823|158069460|FG000|Overall Study|Other, Not Specified|0|||
49064791|NCT03709823|158069461|FG001|Overall Study|Other, Not Specified|0|||
49064792|NCT03709823|158069462|FG002|Overall Study|Other, Not Specified|0|||
49064793|NCT03709823|158069463|FG003|Overall Study|Other, Not Specified|1|||
49064794|NCT03709823|158069464|FG004|Overall Study|Other, Not Specified|0|||
49064795|NCT03709823|158069465|FG005|Overall Study|Other, Not Specified|0|||
49064796|NCT04234984|158069470|FG000|Follow-up at 6 Weeks|Lost to Follow-up|2|||
49064797|NCT04234984|158069470|FG000|Follow-up at the Second Time Point|Death|1|||
49064798|NCT04234984|158069470|FG000|Follow-up at the Second Time Point|Mentally unable to fill in the questionnaire|1|||
49064799|NCT01055132|158069471|FG000|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1|||
49064800|NCT01055132|158069472|FG001|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0|||
49064801|NCT01055132|158069471|FG000|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0|||
49064802|NCT01055132|158069472|FG001|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1|||
49064803|NCT00324649|158069473|FG000|Overall Study|Adverse Event|1|||
49064804|NCT00324649|158069474|FG001|Overall Study|Adverse Event|4|||
49064805|NCT00324649|158069473|FG000|Overall Study|Withdrawal by Subject|0|||
49064806|NCT00324649|158069474|FG001|Overall Study|Withdrawal by Subject|1|||
49064807|NCT00324649|158069473|FG000|Overall Study|Noncompliance|1|||
49064808|NCT00324649|158069474|FG001|Overall Study|Noncompliance|0|||
49064809|NCT00158600|158069475|FG000|Overall Study|unable to commit time to study|0|||
49064810|NCT00158600|158069476|FG001|Overall Study|unable to commit time to study|1|||
49064811|NCT00158600|158069475|FG000|Overall Study|Adverse Event|2|||
49064812|NCT00158600|158069476|FG001|Overall Study|Adverse Event|1|||
49064813|NCT00158600|158069475|FG000|Overall Study|Death|1|||
49064814|NCT00158600|158069476|FG001|Overall Study|Death|0|||
49064815|NCT00158600|158069475|FG000|Overall Study|Withdrawal by Subject|2|||
49064816|NCT00158600|158069476|FG001|Overall Study|Withdrawal by Subject|2|||
49064817|NCT02570113|158069477|FG000|Overall Study|Withdrawal by Subject|3|||
49064818|NCT02038907|158069478|FG000|Overall Study|Protocol Violation|0|||
49064819|NCT02038907|158069479|FG001|Overall Study|Protocol Violation|0|||
49064820|NCT02038907|158069480|FG002|Overall Study|Protocol Violation|0|||
49064821|NCT02038907|158069481|FG003|Overall Study|Protocol Violation|0|||
49064822|NCT02038907|158069482|FG004|Overall Study|Protocol Violation|0|||
49064823|NCT02038907|158069483|FG005|Overall Study|Protocol Violation|0|||
49064824|NCT02038907|158069484|FG006|Overall Study|Protocol Violation|0|||
49064825|NCT02038907|158069485|FG007|Overall Study|Protocol Violation|0|||
49064826|NCT02038907|158069486|FG008|Overall Study|Protocol Violation|0|||
49064827|NCT02038907|158069487|FG009|Overall Study|Protocol Violation|0|||
49064828|NCT02038907|158069488|FG010|Overall Study|Protocol Violation|1|||
49064829|NCT02038907|158069489|FG011|Overall Study|Protocol Violation|0|||
49064830|NCT02038907|158069490|FG012|Overall Study|Protocol Violation|0|||
49064831|NCT02038907|158069491|FG013|Overall Study|Protocol Violation|0|||
49064832|NCT02038907|158069478|FG000|Overall Study|Withdrawal by Subject|0|||
49064833|NCT02038907|158069479|FG001|Overall Study|Withdrawal by Subject|0|||
49064834|NCT02038907|158069480|FG002|Overall Study|Withdrawal by Subject|0|||
49064835|NCT02038907|158069481|FG003|Overall Study|Withdrawal by Subject|0|||
49064836|NCT02038907|158069482|FG004|Overall Study|Withdrawal by Subject|0|||
49064837|NCT02038907|158069483|FG005|Overall Study|Withdrawal by Subject|0|||
49064838|NCT02038907|158069484|FG006|Overall Study|Withdrawal by Subject|0|||
49064839|NCT02038907|158069485|FG007|Overall Study|Withdrawal by Subject|0|||
49064840|NCT02038907|158069486|FG008|Overall Study|Withdrawal by Subject|0|||
49064841|NCT02038907|158069487|FG009|Overall Study|Withdrawal by Subject|0|||
49064842|NCT02038907|158069488|FG010|Overall Study|Withdrawal by Subject|1|||
49064843|NCT02038907|158069489|FG011|Overall Study|Withdrawal by Subject|0|||
49064844|NCT02038907|158069490|FG012|Overall Study|Withdrawal by Subject|0|||
49064845|NCT02038907|158069491|FG013|Overall Study|Withdrawal by Subject|0|||
49064846|NCT00540293|158069492|FG000|Overall Study|Adverse event related to study drug|10|||
49064847|NCT00540293|158069492|FG000|Overall Study|Adverse event not related to study drug|7|||
49064848|NCT00540293|158069492|FG000|Overall Study|Withdrawal by Subject|6|||
49064849|NCT00540293|158069492|FG000|Overall Study|Protocol violation, & subject schedule|12|||
49064850|NCT02746471|158069493|FG000|Overall Study|Death|43|||
49064851|NCT02746471|158069493|FG000|Overall Study|Exited before 36 months|1119|||
49064852|NCT02564211|158069496|FG000|Overall Study|Adverse Event|4|||
49064853|NCT02558231|158069497|FG000|Overall Study|Death|4|||
49064854|NCT02558231|158069498|FG001|Overall Study|Death|12|||
49064855|NCT02558231|158069497|FG000|Overall Study|Lost to Follow-up|7|||
49064856|NCT02558231|158069498|FG001|Overall Study|Lost to Follow-up|4|||
49064857|NCT02558231|158069497|FG000|Overall Study|Withdrawal by Subject|7|||
49064858|NCT02558231|158069498|FG001|Overall Study|Withdrawal by Subject|4|||
49064859|NCT02558231|158069497|FG000|Overall Study|Physician Decision|7|||
49064860|NCT02558231|158069498|FG001|Overall Study|Physician Decision|5|||
49064861|NCT02558231|158069497|FG000|Overall Study|Sponsor Decision|0|||
49064862|NCT02558231|158069498|FG001|Overall Study|Sponsor Decision|1|||
49064863|NCT00910091|158069499|FG000|Pre-assignment|Withdrawal by Subject|0|||
49064864|NCT00910091|158069500|FG001|Pre-assignment|Withdrawal by Subject|2|||
49064865|NCT00910091|158069499|FG000|Treatment and Survival|Withdrawal by Subject|3|||
49064866|NCT00910091|158069500|FG001|Treatment and Survival|Withdrawal by Subject|4|||
49064867|NCT00910091|158069499|FG000|Treatment and Survival|Adverse Event|1|||
49064868|NCT00910091|158069500|FG001|Treatment and Survival|Adverse Event|0|||
49064869|NCT01246011|158069503|FG000|Overall Study|If needed warfarin clinically, withdrawn|0|||
49064870|NCT01246011|158069504|FG001|Overall Study|If needed warfarin clinically, withdrawn|0|||
49064871|NCT01246011|158069505|FG002|Overall Study|If needed warfarin clinically, withdrawn|3|||
49064872|NCT01246011|158069503|FG000|Overall Study|Withdrawal by Subject|0|||
49064873|NCT01246011|158069504|FG001|Overall Study|Withdrawal by Subject|0|||
49064874|NCT01246011|158069505|FG002|Overall Study|Withdrawal by Subject|1|||
49064875|NCT01007942|158069506|FG000|Overall Study|Adverse Event|29|||
49064876|NCT01007942|158069507|FG001|Overall Study|Adverse Event|14|||
49064877|NCT01007942|158069506|FG000|Overall Study|Abnormal test procedure|0|||
49064878|NCT01007942|158069507|FG001|Overall Study|Abnormal test procedure|1|||
49064879|NCT01007942|158069506|FG000|Overall Study|Disease progression|217|||
49064880|NCT01007942|158069507|FG001|Overall Study|Disease progression|242|||
49064881|NCT01007942|158069506|FG000|Overall Study|New cancer therapy|5|||
49064882|NCT01007942|158069507|FG001|Overall Study|New cancer therapy|1|||
49064883|NCT01007942|158069506|FG000|Overall Study|Protocol Violation|1|||
49064884|NCT01007942|158069507|FG001|Overall Study|Protocol Violation|1|||
49064885|NCT01007942|158069506|FG000|Overall Study|Withdrawal by Subject|19|||
49064886|NCT01007942|158069507|FG001|Overall Study|Withdrawal by Subject|14|||
49064887|NCT01007942|158069506|FG000|Overall Study|Lost to Follow-up|1|||
49064888|NCT01007942|158069507|FG001|Overall Study|Lost to Follow-up|0|||
49064889|NCT01007942|158069506|FG000|Overall Study|Administrative problems|2|||
49064890|NCT01007942|158069507|FG001|Overall Study|Administrative problems|0|||
49064891|NCT01007942|158069506|FG000|Overall Study|Death|3|||
49064892|NCT01007942|158069507|FG001|Overall Study|Death|2|||
49064893|NCT01007942|158069506|FG000|Overall Study|Patients untreated|4|||
49064894|NCT01007942|158069507|FG001|Overall Study|Patients untreated|3|||
49064895|NCT00325195|158069508|FG000|Randomized|Not dosed|5|||
49064896|NCT00325195|158069509|FG001|Randomized|Not dosed|5|||
49064897|NCT00325195|158069510|FG002|Randomized|Not dosed|3|||
49064898|NCT00325195|158069508|FG000|Received Intervention: ITT Population|Adverse Event|15|||
49064899|NCT00325195|158069509|FG001|Received Intervention: ITT Population|Adverse Event|17|||
49064900|NCT00325195|158069510|FG002|Received Intervention: ITT Population|Adverse Event|1|||
49064901|NCT00325195|158069508|FG000|Received Intervention: ITT Population|Death|3|||
49064902|NCT00325195|158069509|FG001|Received Intervention: ITT Population|Death|1|||
49064903|NCT00325195|158069510|FG002|Received Intervention: ITT Population|Death|0|||
49064904|NCT00325195|158069508|FG000|Received Intervention: ITT Population|Withdrawal by Subject|7|||
49064905|NCT00325195|158069509|FG001|Received Intervention: ITT Population|Withdrawal by Subject|6|||
49064906|NCT00325195|158069510|FG002|Received Intervention: ITT Population|Withdrawal by Subject|1|||
49064907|NCT00325195|158069508|FG000|Received Intervention: ITT Population|Lost to Follow-up|0|||
49064908|NCT00325195|158069509|FG001|Received Intervention: ITT Population|Lost to Follow-up|0|||
49064909|NCT00325195|158069510|FG002|Received Intervention: ITT Population|Lost to Follow-up|2|||
49064910|NCT00325195|158069508|FG000|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
49064911|NCT00325195|158069509|FG001|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
49064912|NCT00325195|158069510|FG002|Received Intervention: ITT Population|Protocol violation/non-compliance|0|||
49064913|NCT02032706|158069521|FG000|Overall Study|Did not qualify|5|||
49064914|NCT02032706|158069521|FG000|Overall Study|Protocol Violation|1|||
49064915|NCT02288182|158069528|FG000|Overall Study|Adverse Event|0|||
49064916|NCT02288182|158069529|FG001|Overall Study|Adverse Event|1|||
49064917|NCT02288182|158069528|FG000|Overall Study|Lost to Follow-up|0|||
49064918|NCT02288182|158069529|FG001|Overall Study|Lost to Follow-up|1|||
49064919|NCT04619992|158069543|FG000|Overall Study|Withdrawal by Subject|1|||
49064920|NCT04619992|158069544|FG001|Overall Study|Withdrawal by Subject|0|||
49064921|NCT03255655|158069545|FG000|Overall Study|Lost to Follow-up|7|||
49064922|NCT03255655|158069546|FG001|Overall Study|Lost to Follow-up|4|||
49064923|NCT01197755|158069547|FG000|Overall Study|Adverse Event|8|||
49064924|NCT01197755|158069548|FG001|Overall Study|Adverse Event|10|||
49064925|NCT01197755|158069549|FG002|Overall Study|Adverse Event|10|||
49064926|NCT01197755|158069547|FG000|Overall Study|Study-specific discontinuation criteria|2|||
49064927|NCT01197755|158069548|FG001|Overall Study|Study-specific discontinuation criteria|1|||
49064928|NCT01197755|158069549|FG002|Overall Study|Study-specific discontinuation criteria|0|||
49064929|NCT01197755|158069547|FG000|Overall Study|Entered the long-term extension study|18|||
49064930|NCT01197755|158069548|FG001|Overall Study|Entered the long-term extension study|21|||
49064931|NCT01197755|158069549|FG002|Overall Study|Entered the long-term extension study|35|||
49064932|NCT01197755|158069547|FG000|Overall Study|Lack of therapeutic response|0|||
49064933|NCT01197755|158069548|FG001|Overall Study|Lack of therapeutic response|7|||
49064934|NCT01197755|158069549|FG002|Overall Study|Lack of therapeutic response|4|||
49064935|NCT01197755|158069547|FG000|Overall Study|Severe non-compliance to the protocol|2|||
49064936|NCT01197755|158069548|FG001|Overall Study|Severe non-compliance to the protocol|1|||
49064937|NCT01197755|158069549|FG002|Overall Study|Severe non-compliance to the protocol|2|||
49064938|NCT01197755|158069547|FG000|Overall Study|Withdrawal by Subject|1|||
49064939|NCT01197755|158069548|FG001|Overall Study|Withdrawal by Subject|0|||
49064940|NCT01197755|158069549|FG002|Overall Study|Withdrawal by Subject|0|||
49064941|NCT01197755|158069547|FG000|Overall Study|Lost to Follow-up|0|||
49064942|NCT01197755|158069548|FG001|Overall Study|Lost to Follow-up|0|||
49064943|NCT01197755|158069549|FG002|Overall Study|Lost to Follow-up|1|||
49064944|NCT01197755|158069547|FG000|Overall Study|eg, change in circumstances|7|||
49064945|NCT01197755|158069548|FG001|Overall Study|eg, change in circumstances|3|||
49064946|NCT01197755|158069549|FG002|Overall Study|eg, change in circumstances|2|||
49064947|NCT01709838|158069552|FG000|Overall Study|Withdrawal by Subject|21|||
49064948|NCT01709838|158069552|FG000|Overall Study|Lost to Follow-up|16|||
49064949|NCT01709838|158069552|FG000|Overall Study|Pregnancy|10|||
49064950|NCT01709838|158069552|FG000|Overall Study|Subject/guardian decision|8|||
49064951|NCT01709838|158069552|FG000|Overall Study|Adverse Event|4|||
49064952|NCT01709838|158069552|FG000|Overall Study|Physician Decision|4|||
49064953|NCT01709838|158069552|FG000|Overall Study|Death|3|||
49064954|NCT01709838|158069552|FG000|Overall Study|Protocol Violation|1|||
49064955|NCT00620659|158069553|FG000|Treatment Period 1|Adverse Event|1|||
49064956|NCT00620659|158069554|FG001|Treatment Period 1|Adverse Event|0|||
49064957|NCT00620659|158069555|FG002|Treatment Period 1|Adverse Event|0|||
49064958|NCT00620659|158069556|FG003|Treatment Period 1|Adverse Event|3|||
49064959|NCT00620659|158069557|FG004|Treatment Period 1|Adverse Event|0|||
49064960|NCT00620659|158069558|FG005|Treatment Period 1|Adverse Event|0|||
49064961|NCT00620659|158069553|FG000|Treatment Period 1|Protocol Violation|1|||
49064962|NCT00620659|158069554|FG001|Treatment Period 1|Protocol Violation|0|||
49064963|NCT00620659|158069555|FG002|Treatment Period 1|Protocol Violation|0|||
49064964|NCT00620659|158069556|FG003|Treatment Period 1|Protocol Violation|0|||
49064965|NCT00620659|158069557|FG004|Treatment Period 1|Protocol Violation|0|||
49064966|NCT00620659|158069558|FG005|Treatment Period 1|Protocol Violation|0|||
49064967|NCT00620659|158069553|FG000|Treatment Period 1|Withdrawal by Subject|1|||
49064968|NCT00620659|158069554|FG001|Treatment Period 1|Withdrawal by Subject|0|||
49064969|NCT00620659|158069555|FG002|Treatment Period 1|Withdrawal by Subject|1|||
49064970|NCT00620659|158069556|FG003|Treatment Period 1|Withdrawal by Subject|0|||
49064971|NCT00620659|158069557|FG004|Treatment Period 1|Withdrawal by Subject|1|||
49064972|NCT00620659|158069558|FG005|Treatment Period 1|Withdrawal by Subject|0|||
49064973|NCT00620659|158069553|FG000|Placebo Washout Period 1|Withdrawal by Subject|0|||
49064974|NCT00620659|158069554|FG001|Placebo Washout Period 1|Withdrawal by Subject|0|||
49064975|NCT00620659|158069555|FG002|Placebo Washout Period 1|Withdrawal by Subject|0|||
49064976|NCT00620659|158069556|FG003|Placebo Washout Period 1|Withdrawal by Subject|1|||
49064977|NCT00620659|158069557|FG004|Placebo Washout Period 1|Withdrawal by Subject|0|||
49064978|NCT00620659|158069558|FG005|Placebo Washout Period 1|Withdrawal by Subject|0|||
49064979|NCT00620659|158069553|FG000|Treatment Period 2|Adverse Event|0|||
49064980|NCT00620659|158069554|FG001|Treatment Period 2|Adverse Event|3|||
49064981|NCT00620659|158069555|FG002|Treatment Period 2|Adverse Event|0|||
49064982|NCT00620659|158069556|FG003|Treatment Period 2|Adverse Event|0|||
49064983|NCT00620659|158069557|FG004|Treatment Period 2|Adverse Event|2|||
49064984|NCT00620659|158069558|FG005|Treatment Period 2|Adverse Event|0|||
49064985|NCT00620659|158069553|FG000|Treatment Period 2|Withdrawal by Subject|0|||
49064986|NCT00620659|158069554|FG001|Treatment Period 2|Withdrawal by Subject|0|||
49064987|NCT00620659|158069555|FG002|Treatment Period 2|Withdrawal by Subject|1|||
49064988|NCT00620659|158069556|FG003|Treatment Period 2|Withdrawal by Subject|0|||
49064989|NCT00620659|158069557|FG004|Treatment Period 2|Withdrawal by Subject|3|||
49064990|NCT00620659|158069558|FG005|Treatment Period 2|Withdrawal by Subject|0|||
49064991|NCT00620659|158069553|FG000|Placebo Washout Period 2|Adverse Event|2|||
49064992|NCT00620659|158069554|FG001|Placebo Washout Period 2|Adverse Event|0|||
49064993|NCT00620659|158069555|FG002|Placebo Washout Period 2|Adverse Event|0|||
49064994|NCT00620659|158069556|FG003|Placebo Washout Period 2|Adverse Event|0|||
49064995|NCT00620659|158069557|FG004|Placebo Washout Period 2|Adverse Event|0|||
49064996|NCT00620659|158069558|FG005|Placebo Washout Period 2|Adverse Event|0|||
49064997|NCT00620659|158069553|FG000|Treatment Period 3|Adverse Event|0|||
49064998|NCT00620659|158069554|FG001|Treatment Period 3|Adverse Event|2|||
49064999|NCT00620659|158069555|FG002|Treatment Period 3|Adverse Event|0|||
49065000|NCT00620659|158069556|FG003|Treatment Period 3|Adverse Event|0|||
49065001|NCT00620659|158069557|FG004|Treatment Period 3|Adverse Event|0|||
49065002|NCT00620659|158069558|FG005|Treatment Period 3|Adverse Event|0|||
49065003|NCT00620659|158069553|FG000|Treatment Period 3|Withdrawal by Subject|0|||
49065004|NCT00620659|158069554|FG001|Treatment Period 3|Withdrawal by Subject|0|||
49065005|NCT00620659|158069555|FG002|Treatment Period 3|Withdrawal by Subject|0|||
49065006|NCT00620659|158069556|FG003|Treatment Period 3|Withdrawal by Subject|1|||
49065007|NCT00620659|158069557|FG004|Treatment Period 3|Withdrawal by Subject|0|||
49065008|NCT00620659|158069558|FG005|Treatment Period 3|Withdrawal by Subject|0|||
49065009|NCT04428333|158069559|FG000|Overall Study|Physician Decision|5|||
49065010|NCT04428333|158069560|FG001|Overall Study|Physician Decision|6|||
49065011|NCT04428333|158069559|FG000|Overall Study|Withdrawal by Subject|1|||
49065012|NCT04428333|158069560|FG001|Overall Study|Withdrawal by Subject|3|||
49065013|NCT04428333|158069559|FG000|Overall Study|Study Terminated By Sponsor|14|||
49065014|NCT04428333|158069560|FG001|Overall Study|Study Terminated By Sponsor|16|||
49065015|NCT02269163|158069561|FG000|Overall Study|Lost to Follow-up|1|||
49065016|NCT02269163|158069562|FG001|Overall Study|Lost to Follow-up|0|||
49065017|NCT02269163|158069561|FG000|Overall Study|Major protocol violation|0|||
49065018|NCT02269163|158069562|FG001|Overall Study|Major protocol violation|1|||
49065019|NCT02269163|158069561|FG000|Overall Study|Other|2|||
49065020|NCT02269163|158069562|FG001|Overall Study|Other|2|||
49065021|NCT02269163|158069561|FG000|Overall Study|Withdrawal by Subject|0|||
49065022|NCT02269163|158069562|FG001|Overall Study|Withdrawal by Subject|3|||
49065023|NCT02269163|158069561|FG000|Overall Study|Physician Decision|0|||
49065024|NCT02269163|158069562|FG001|Overall Study|Physician Decision|1|||
49065025|NCT02352779|158069569|FG000|Overall Study|Personal Issues|1|||
49065026|NCT02352779|158069570|FG001|Overall Study|Personal Issues|1|||
49065027|NCT02352779|158069571|FG002|Overall Study|Personal Issues|0|||
49065028|NCT02352779|158069569|FG000|Overall Study|Too Many Forms|2|||
49065029|NCT02352779|158069570|FG001|Overall Study|Too Many Forms|0|||
49065030|NCT02352779|158069571|FG002|Overall Study|Too Many Forms|0|||
49065031|NCT02352779|158069569|FG000|Overall Study|Feeling Overwhelmed|1|||
49065032|NCT02352779|158069570|FG001|Overall Study|Feeling Overwhelmed|0|||
49065033|NCT02352779|158069571|FG002|Overall Study|Feeling Overwhelmed|0|||
49065034|NCT02352779|158069569|FG000|Overall Study|Disliked Intervention|1|||
49065035|NCT02352779|158069570|FG001|Overall Study|Disliked Intervention|0|||
49065036|NCT02352779|158069571|FG002|Overall Study|Disliked Intervention|0|||
49065037|NCT02352779|158069569|FG000|Overall Study|Changed Mind|1|||
49065038|NCT02352779|158069570|FG001|Overall Study|Changed Mind|0|||
49065039|NCT02352779|158069571|FG002|Overall Study|Changed Mind|0|||
49065040|NCT02352779|158069569|FG000|Overall Study|Study Related Symptoms|1|||
49065041|NCT02352779|158069570|FG001|Overall Study|Study Related Symptoms|0|||
49065042|NCT02352779|158069571|FG002|Overall Study|Study Related Symptoms|0|||
49065043|NCT02352779|158069569|FG000|Overall Study|Absence of Symptoms|1|||
49065044|NCT02352779|158069570|FG001|Overall Study|Absence of Symptoms|0|||
49065045|NCT02352779|158069571|FG002|Overall Study|Absence of Symptoms|0|||
49065046|NCT02352779|158069569|FG000|Overall Study|Other Medical Reason|0|||
49065047|NCT02352779|158069570|FG001|Overall Study|Other Medical Reason|0|||
49065048|NCT02352779|158069571|FG002|Overall Study|Other Medical Reason|1|||
49065049|NCT02352779|158069569|FG000|Overall Study|No Reason|0|||
49065050|NCT02352779|158069570|FG001|Overall Study|No Reason|0|||
49065051|NCT02352779|158069571|FG002|Overall Study|No Reason|1|||
49065052|NCT01214915|158069575|FG000|Overall Study|Adverse Event|8|||
49065053|NCT01214915|158069575|FG000|Overall Study|Lack of Efficacy|3|||
49065054|NCT00416884|158069576|FG000|Overall Study|Study terminated due to low accrual|1|||
49065055|NCT04495283|158070976|FG000|Overall Study|Physician Decision|0|||
49065056|NCT04495283|158070977|FG001|Overall Study|Physician Decision|0|||
49065057|NCT04495283|158070978|FG002|Overall Study|Physician Decision|1|||
49065058|NCT04495283|158070976|FG000|Overall Study|Withdrawal by Subject|0|||
49065059|NCT04495283|158070977|FG001|Overall Study|Withdrawal by Subject|1|||
49065060|NCT04495283|158070978|FG002|Overall Study|Withdrawal by Subject|1|||
49065061|NCT04495283|158070976|FG000|Overall Study|Other|1|||
49065062|NCT04495283|158070977|FG001|Overall Study|Other|0|||
49065063|NCT04495283|158070978|FG002|Overall Study|Other|1|||
49065064|NCT03768726|158070979|FG000|Treatment Phase|Adverse Event|2|||
49065065|NCT03768726|158070980|FG001|Treatment Phase|Adverse Event|2|||
49065066|NCT03768726|158070979|FG000|Treatment Phase|Lost to Follow-up|1|||
49065067|NCT03768726|158070980|FG001|Treatment Phase|Lost to Follow-up|0|||
49065068|NCT03768726|158070979|FG000|Treatment Phase|Withdrawal By Parent/Guardian|2|||
49065069|NCT03768726|158070980|FG001|Treatment Phase|Withdrawal By Parent/Guardian|0|||
49065070|NCT03768726|158070979|FG000|Treatment Phase|Withdrawal by Subject|3|||
49065071|NCT03768726|158070980|FG001|Treatment Phase|Withdrawal by Subject|1|||
49065072|NCT03768726|158070979|FG000|Follow-Up|Adverse Event|2|||
49065073|NCT03768726|158070980|FG001|Follow-Up|Adverse Event|2|||
49065074|NCT03768726|158070979|FG000|Follow-Up|Withdrawal By Parent/Guardian|1|||
49065075|NCT03768726|158070980|FG001|Follow-Up|Withdrawal By Parent/Guardian|1|||
49065076|NCT03768726|158070979|FG000|Follow-Up|Withdrawal by Subject|2|||
49065077|NCT03768726|158070980|FG001|Follow-Up|Withdrawal by Subject|0|||
49065078|NCT03768726|158070979|FG000|Follow-Up|Other|1|||
49065079|NCT03768726|158070980|FG001|Follow-Up|Other|0|||
49065080|NCT00573157|158070981|FG000|Overall Study|Adverse Event|3|||
49065081|NCT00573157|158070982|FG001|Overall Study|Adverse Event|1|||
49065082|NCT00573157|158070981|FG000|Overall Study|Other|1|||
49065083|NCT00573157|158070982|FG001|Overall Study|Other|1|||
49065084|NCT01183221|158070985|FG000|3 Weeks Wash Out|Lost to Follow-up|1|||
49065085|NCT01183221|158070986|FG001|3 Weeks Wash Out|Lost to Follow-up|1|||
49065086|NCT01220297|158070987|FG000|Overall Study|Death|2|||
49065087|NCT01220297|158070987|FG000|Overall Study|Lost to Follow-up|1|||
49065088|NCT00858143|158070992|FG000|Overall Study|Adverse Event|16|||
49065089|NCT00858143|158070992|FG000|Overall Study|Lack of Efficacy|4|||
49065090|NCT00858143|158070992|FG000|Overall Study|Death|7|||
49065091|NCT00858143|158070992|FG000|Overall Study|Other|23|||
49065092|NCT00622466|158071006|FG000|Overall Study|Death|1|||
49065093|NCT00622466|158071006|FG000|Overall Study|Adverse Event|1|||
49065094|NCT00622466|158071006|FG000|Overall Study|Withdrawal by Subject|2|||
49065095|NCT02618408|158071010|FG000|Overall Study|Withdrawal by Subject|1|||
49065096|NCT02618408|158071011|FG001|Overall Study|Withdrawal by Subject|0|||
49065097|NCT02618408|158071012|FG002|Overall Study|Withdrawal by Subject|4|||
49065098|NCT02618408|158071010|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
49065099|NCT02618408|158071011|FG001|Overall Study|Withdrawal By Parent/Guardian|3|||
49065100|NCT02618408|158071012|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
49065101|NCT02618408|158071010|FG000|Overall Study|Lost to Follow-up|4|||
49065102|NCT02618408|158071011|FG001|Overall Study|Lost to Follow-up|2|||
49065103|NCT02618408|158071012|FG002|Overall Study|Lost to Follow-up|6|||
49065104|NCT02618408|158071010|FG000|Overall Study|Adverse Event|4|||
49065105|NCT02618408|158071011|FG001|Overall Study|Adverse Event|0|||
49065106|NCT02618408|158071012|FG002|Overall Study|Adverse Event|10|||
49065107|NCT02618408|158071010|FG000|Overall Study|Physician Decision|1|||
49065108|NCT02618408|158071011|FG001|Overall Study|Physician Decision|1|||
49065109|NCT02618408|158071012|FG002|Overall Study|Physician Decision|2|||
49065110|NCT02618408|158071010|FG000|Overall Study|Protocol Violation|1|||
49065111|NCT02618408|158071011|FG001|Overall Study|Protocol Violation|1|||
49065112|NCT02618408|158071012|FG002|Overall Study|Protocol Violation|2|||
49065113|NCT02618408|158071010|FG000|Overall Study|Other, Multiple Categories|0|||
49065114|NCT02618408|158071011|FG001|Overall Study|Other, Multiple Categories|0|||
49065115|NCT02618408|158071012|FG002|Overall Study|Other, Multiple Categories|4|||
49065116|NCT04319159|158071016|FG000|Overall Study|Screening failure|13|||
49065117|NCT04319159|158071016|FG000|Overall Study|Re-screening due to COVID-19 implications|2|||
49065118|NCT04319159|158071016|FG000|Overall Study|Withdrawal by Subject|1|||
49065119|NCT02792959|158071017|FG000|Overall Study|Protocol Violation|1|||
49065120|NCT04392583|158071018|FG000|Overall Study|Participant declined follow-up and subsequently withdrawn|1|||
49065121|NCT03914950|158071020|FG000|Overall Study|Physician Decision|54|||
49065122|NCT01155024|158071021|FG000|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0|||
49065123|NCT01155024|158071022|FG001|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2|||
49065124|NCT01155024|158071021|FG000|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0|||
49065125|NCT01155024|158071022|FG001|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2|||
49065126|NCT01155024|158071021|FG000|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0|||
49065127|NCT01155024|158071022|FG001|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2|||
49065128|NCT01593696|158071023|FG000|Dose Escalation|Progressive Disease|2|||
49065129|NCT01593696|158071024|FG001|Dose Escalation|Progressive Disease|0|||
49065130|NCT01593696|158071025|FG002|Dose Escalation|Progressive Disease|0|||
49065131|NCT01593696|158071026|FG003|Dose Escalation|Progressive Disease|0|||
49065132|NCT01593696|158071023|FG000|Dose Expansion|Fungal infection|0|||
49065133|NCT01593696|158071024|FG001|Dose Expansion|Fungal infection|0|||
49065134|NCT01593696|158071025|FG002|Dose Expansion|Fungal infection|1|||
49065135|NCT01593696|158071026|FG003|Dose Expansion|Fungal infection|0|||
49065136|NCT03201250|158071038|FG000|Overall Study|screen failures|3|||
49065137|NCT03201250|158071039|FG001|Overall Study|screen failures|0|||
49065138|NCT03201250|158071040|FG002|Overall Study|screen failures|0|||
49065139|NCT01936623|158071041|FG000|Overall Study|Lost to Follow-up|0|||
49065140|NCT01936623|158071042|FG001|Overall Study|Lost to Follow-up|5|||
49065141|NCT01383135|158071045|FG000|Overall Study|Not Scanned / Imaged|1|||
49065142|NCT01383135|158071046|FG001|Overall Study|Not Scanned / Imaged|0|||
49065143|NCT01383135|158071047|FG002|Overall Study|Not Scanned / Imaged|1|||
49065144|NCT01383135|158071048|FG003|Overall Study|Not Scanned / Imaged|0|||
49065145|NCT03167723|158071052|FG000|Overall Study|Protocol Violation|4|||
49065146|NCT03167723|158071053|FG001|Overall Study|Protocol Violation|6|||
49065147|NCT01175811|158071055|FG000|Overall Study|Adverse Event|1|||
49065148|NCT01175811|158071056|FG001|Overall Study|Adverse Event|1|||
49065149|NCT01175811|158071055|FG000|Overall Study|Entry criteria not met|3|||
49065150|NCT01175811|158071056|FG001|Overall Study|Entry criteria not met|1|||
49065151|NCT01175811|158071055|FG000|Overall Study|Lack of Efficacy|1|||
49065152|NCT01175811|158071056|FG001|Overall Study|Lack of Efficacy|0|||
49065153|NCT01175811|158071055|FG000|Overall Study|Lost to Follow-up|3|||
49065154|NCT01175811|158071056|FG001|Overall Study|Lost to Follow-up|2|||
49065155|NCT01175811|158071055|FG000|Overall Study|Physician Decision|1|||
49065156|NCT01175811|158071056|FG001|Overall Study|Physician Decision|1|||
49065157|NCT01175811|158071055|FG000|Overall Study|Protocol Violation|1|||
49065158|NCT01175811|158071056|FG001|Overall Study|Protocol Violation|2|||
49065159|NCT01175811|158071055|FG000|Overall Study|Withdrawal by Subject|6|||
49065160|NCT01175811|158071056|FG001|Overall Study|Withdrawal by Subject|7|||
49065161|NCT02575911|158071057|FG000|Overall Study|Lost to Follow-up|1|||
49065162|NCT03052959|158071058|FG000|Overall Study|Lost to Follow-up|4|||
49065163|NCT03052959|158071059|FG001|Overall Study|Lost to Follow-up|5|||
49065164|NCT01822275|158071062|FG000|Overall Study|Withdrawal by Subject|3|||
49065165|NCT01822275|158071062|FG000|Overall Study|Adverse Event|3|||
49065166|NCT01822275|158071062|FG000|Overall Study|Progression|14|||
49065167|NCT01822275|158071062|FG000|Overall Study|Physician Decision|2|||
49065168|NCT04126213|158071067|FG000|Overall Study|Lost to Follow-up|9|||
49065169|NCT04126213|158071068|FG001|Overall Study|Lost to Follow-up|1|||
49065170|NCT04126213|158071069|FG002|Overall Study|Lost to Follow-up|5|||
49065171|NCT04126213|158071070|FG003|Overall Study|Lost to Follow-up|10|||
49065172|NCT04126213|158071071|FG004|Overall Study|Lost to Follow-up|4|||
49065173|NCT04126213|158071072|FG005|Overall Study|Lost to Follow-up|7|||
49065174|NCT04126213|158071067|FG000|Overall Study|Withdrawal by Subject|3|||
49065175|NCT04126213|158071068|FG001|Overall Study|Withdrawal by Subject|2|||
49065176|NCT04126213|158071069|FG002|Overall Study|Withdrawal by Subject|1|||
49065177|NCT04126213|158071070|FG003|Overall Study|Withdrawal by Subject|1|||
49065178|NCT04126213|158071071|FG004|Overall Study|Withdrawal by Subject|1|||
49065179|NCT04126213|158071072|FG005|Overall Study|Withdrawal by Subject|1|||
49065180|NCT04126213|158071067|FG000|Overall Study|Other|0|||
49065181|NCT04126213|158071068|FG001|Overall Study|Other|0|||
49065182|NCT04126213|158071069|FG002|Overall Study|Other|2|||
49065183|NCT04126213|158071070|FG003|Overall Study|Other|2|||
49065184|NCT04126213|158071071|FG004|Overall Study|Other|0|||
49065185|NCT04126213|158071072|FG005|Overall Study|Other|1|||
49065186|NCT04126213|158071067|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
49065187|NCT04126213|158071068|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
49065188|NCT04126213|158071069|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
49065189|NCT04126213|158071070|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
49065190|NCT04126213|158071071|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
49065191|NCT04126213|158071072|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
49065192|NCT02302859|158071073|FG000|Overall Study|Lost Phone|1|||
49065193|NCT02302859|158071074|FG001|Overall Study|Lost Phone|1|||
49065194|NCT02302859|158071073|FG000|Overall Study|Withdrawal by Subject|0|||
49065195|NCT02302859|158071074|FG001|Overall Study|Withdrawal by Subject|1|||
49065196|NCT02853370|158071077|FG000|Overall Study|Physician Decision|1|||
49065197|NCT02853370|158071077|FG000|Overall Study|Lack of Efficacy|2|||
49065198|NCT02853370|158071077|FG000|Overall Study|Death|1|||
49065199|NCT02853370|158071077|FG000|Overall Study|Adverse Event|4|||
49065200|NCT02853370|158071077|FG000|Overall Study|Withdrawal by Subject|3|||
49065201|NCT03276221|158071079|FG000|Overall Study|Lost to Follow-up|6|||
49065202|NCT03276221|158071080|FG001|Overall Study|Lost to Follow-up|2|||
49065203|NCT03276221|158071081|FG002|Overall Study|Lost to Follow-up|0|||
49065204|NCT03276221|158071079|FG000|Overall Study|Did not abstain from cannabis as per protocol|4|||
49065205|NCT03276221|158071080|FG001|Overall Study|Did not abstain from cannabis as per protocol|0|||
49065206|NCT03276221|158071081|FG002|Overall Study|Did not abstain from cannabis as per protocol|0|||
49065207|NCT01102374|158071089|FG000|Overall Study|Death|9|||
49065208|NCT01102374|158071090|FG001|Overall Study|Death|13|||
49065209|NCT01102374|158071089|FG000|Overall Study|Lost to Follow-up|7|||
49065210|NCT01102374|158071090|FG001|Overall Study|Lost to Follow-up|6|||
49065211|NCT01104792|158071091|FG000|Overall Study|Adverse Event|77|||
49065212|NCT01104792|158071091|FG000|Overall Study|Insufficient Therapeutic Response|22|||
49065213|NCT01104792|158071091|FG000|Overall Study|Protocol Violation|45|||
49065214|NCT01104792|158071091|FG000|Overall Study|Withdrawal of Consent|179|||
49065215|NCT01104792|158071091|FG000|Overall Study|Lost to Follow-up|43|||
49065216|NCT01104792|158071091|FG000|Overall Study|Reasons Not Specified|27|||
49065217|NCT01104792|158071091|FG000|Overall Study|Did Not Meet Eligibility Criteria|133|||
49065218|NCT00418821|158071092|FG000|Overall Study|Fulfils one of the exclusion criteria|1|||
49065219|NCT02582866|158071094|FG000|Overall Study|Death|1|||
49065220|NCT02582866|158071094|FG000|Overall Study|Lack of Efficacy|2|||
49065221|NCT02582866|158071094|FG000|Overall Study|Lost to Follow-up|2|||
49065222|NCT02582866|158071094|FG000|Overall Study|Withdrawal by Subject|7|||
49065223|NCT02582866|158071094|FG000|Overall Study|Investigator decision|5|||
49065224|NCT02582866|158071094|FG000|Overall Study|Participant wants to get pregnant|1|||
49065225|NCT02582866|158071094|FG000|Overall Study|Pregnancy|2|||
49065226|NCT02582866|158071094|FG000|Overall Study|Sponsor decision|1|||
49065227|NCT02582866|158071094|FG000|Overall Study|Withdrawal due to personal reasons|1|||
49065228|NCT02071849|158071095|FG000|6-month Primary Endpoint|Did not receive device|4|||
49065229|NCT02071849|158071095|FG000|6-month Primary Endpoint|Adverse Event|1|||
49065230|NCT02071849|158071095|FG000|2-year Extended Follow-up|Adverse Event|1|||
49065231|NCT03567382|158071099|FG000|Overall Study|Lost to Follow-up|1|||
49065232|NCT03567382|158071100|FG001|Overall Study|Lost to Follow-up|21|||
49065233|NCT03567382|158071101|FG002|Overall Study|Lost to Follow-up|1|||
49065234|NCT03567382|158071102|FG003|Overall Study|Lost to Follow-up|21|||
49065235|NCT03567382|158071099|FG000|Overall Study|Withdrawal by Subject|2|||
49065236|NCT03567382|158071100|FG001|Overall Study|Withdrawal by Subject|14|||
49065237|NCT03567382|158071101|FG002|Overall Study|Withdrawal by Subject|1|||
49065238|NCT03567382|158071102|FG003|Overall Study|Withdrawal by Subject|12|||
49065239|NCT00985712|158071111|FG000|Overall Study|Adverse Event|0|||
49065240|NCT00985712|158071112|FG001|Overall Study|Adverse Event|1|||
49065241|NCT00985712|158071111|FG000|Overall Study|Lost to Follow-up|2|||
49065242|NCT00985712|158071112|FG001|Overall Study|Lost to Follow-up|2|||
49065243|NCT00985712|158071111|FG000|Overall Study|Protocol Violation|0|||
49065244|NCT00985712|158071112|FG001|Overall Study|Protocol Violation|1|||
49065245|NCT00985712|158071111|FG000|Overall Study|Withdrawal by Subject|4|||
49065246|NCT00985712|158071112|FG001|Overall Study|Withdrawal by Subject|1|||
49065247|NCT00985712|158071111|FG000|Overall Study|Sponsor decision|0|||
49065248|NCT00985712|158071112|FG001|Overall Study|Sponsor decision|2|||
49065249|NCT00678041|158072281|FG000|Overall Study|Physician Decision|5|||
49065250|NCT00678041|158072282|FG001|Overall Study|Physician Decision|5|||
49065251|NCT03596151|158072283|FG000|Overall Study|Withdrawal by Subject|1|||
49065252|NCT01908816|158072284|FG000|Overall Study|Subject's no longer requires study drug|0|||
49065253|NCT01908816|158072285|FG001|Overall Study|Subject's no longer requires study drug|0|||
49065254|NCT01908816|158072286|FG002|Overall Study|Subject's no longer requires study drug|0|||
49065255|NCT01908816|158072287|FG003|Overall Study|Subject's no longer requires study drug|1|||
49065256|NCT01908816|158072284|FG000|Overall Study|Protocol deviation|1|||
49065257|NCT01908816|158072285|FG001|Overall Study|Protocol deviation|2|||
49065258|NCT01908816|158072286|FG002|Overall Study|Protocol deviation|1|||
49065259|NCT01908816|158072287|FG003|Overall Study|Protocol deviation|1|||
49065260|NCT01908816|158072284|FG000|Overall Study|Withdrawal by Subject|0|||
49065261|NCT01908816|158072285|FG001|Overall Study|Withdrawal by Subject|4|||
49065262|NCT01908816|158072286|FG002|Overall Study|Withdrawal by Subject|2|||
49065263|NCT01908816|158072287|FG003|Overall Study|Withdrawal by Subject|2|||
49065264|NCT01908816|158072284|FG000|Overall Study|Lost to Follow-up|3|||
49065265|NCT01908816|158072285|FG001|Overall Study|Lost to Follow-up|5|||
49065266|NCT01908816|158072286|FG002|Overall Study|Lost to Follow-up|4|||
49065267|NCT01908816|158072287|FG003|Overall Study|Lost to Follow-up|2|||
49065268|NCT01908816|158072284|FG000|Overall Study|Death|1|||
49065269|NCT01908816|158072285|FG001|Overall Study|Death|0|||
49065270|NCT01908816|158072286|FG002|Overall Study|Death|7|||
49065271|NCT01908816|158072287|FG003|Overall Study|Death|1|||
49065272|NCT01908816|158072284|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
49065273|NCT01908816|158072285|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
49065274|NCT01908816|158072286|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
49065275|NCT01908816|158072287|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
49065276|NCT01908816|158072284|FG000|Overall Study|Early termination|87|||
49065277|NCT01908816|158072285|FG001|Overall Study|Early termination|60|||
49065278|NCT01908816|158072286|FG002|Overall Study|Early termination|43|||
49065279|NCT01908816|158072287|FG003|Overall Study|Early termination|28|||
49065280|NCT00846521|158072289|FG000|Overall Study|Withdrawal by Subject|5|||
49065281|NCT00846521|158072289|FG000|Overall Study|Did not meet OGTT/ CGMS criteria|5|||
49065282|NCT00846521|158072289|FG000|Overall Study|Protocol Violation|1|||
49065283|NCT03579966|158072290|FG000|Overall Study|Adverse Event|6|||
49065284|NCT03579966|158072290|FG000|Overall Study|Lost to Follow-up|4|||
49065285|NCT03579966|158072290|FG000|Overall Study|Physician Decision|10|||
49065286|NCT03579966|158072290|FG000|Overall Study|Pregnancy|1|||
49065287|NCT03579966|158072290|FG000|Overall Study|Withdrawal by Subject|16|||
49065288|NCT03579966|158072290|FG000|Overall Study|Study terminated by Sponsor|22|||
49065289|NCT03579966|158072290|FG000|Overall Study|Protocol Violation|1|||
49065290|NCT01249365|158072291|FG000|Overall Study|Lost to Follow-up|1|||
49065291|NCT03484117|158072295|FG000|Overall Study|Lost to Follow-up|1|||
49065292|NCT03484117|158072296|FG001|Overall Study|Lost to Follow-up|3|||
49065293|NCT03484117|158072295|FG000|Overall Study|Declined participation in exit assess|1|||
49065294|NCT03484117|158072296|FG001|Overall Study|Declined participation in exit assess|1|||
49065295|NCT00415194|158072297|FG000|Overall Study|Adverse Event|37|||
49065296|NCT00415194|158072298|FG001|Overall Study|Adverse Event|32|||
49065297|NCT00415194|158072297|FG000|Overall Study|Entry Criteria Not Met|4|||
49065298|NCT00415194|158072298|FG001|Overall Study|Entry Criteria Not Met|8|||
49065299|NCT00415194|158072297|FG000|Overall Study|Lost to Follow-up|1|||
49065300|NCT00415194|158072298|FG001|Overall Study|Lost to Follow-up|0|||
49065301|NCT00415194|158072297|FG000|Overall Study|Physician Decision|10|||
49065302|NCT00415194|158072298|FG001|Overall Study|Physician Decision|16|||
49065303|NCT00415194|158072297|FG000|Overall Study|Progressive Disease|180|||
49065304|NCT00415194|158072298|FG001|Overall Study|Progressive Disease|217|||
49065305|NCT00415194|158072297|FG000|Overall Study|Protocol Violation|4|||
49065306|NCT00415194|158072298|FG001|Overall Study|Protocol Violation|2|||
49065307|NCT00415194|158072297|FG000|Overall Study|Withdrawal by Subject|28|||
49065308|NCT00415194|158072298|FG001|Overall Study|Withdrawal by Subject|21|||
49065309|NCT00415194|158072297|FG000|Overall Study|Death Due to Study Disease|26|||
49065310|NCT00415194|158072298|FG001|Overall Study|Death Due to Study Disease|29|||
49065311|NCT00415194|158072297|FG000|Overall Study|Death Due to Study Drug Related AE|11|||
49065312|NCT00415194|158072298|FG001|Overall Study|Death Due to Study Drug Related AE|1|||
49065313|NCT00415194|158072297|FG000|Overall Study|Death Due to Procedural Related AE|0|||
49065314|NCT00415194|158072298|FG001|Overall Study|Death Due to Procedural Related AE|1|||
49065315|NCT00415194|158072297|FG000|Overall Study|Death Due to AE (Other Causes)|27|||
49065316|NCT00415194|158072298|FG001|Overall Study|Death Due to AE (Other Causes)|15|||
49065317|NCT00114166|158072299|FG000|Overall Study|Wrong primary|0|||
49065318|NCT00114166|158072300|FG001|Overall Study|Wrong primary|1|||
49065319|NCT01297465|158072301|FG000|Overall Study|Lack of Ovarian Response|1|||
49065320|NCT01297465|158072302|FG001|Overall Study|Lack of Ovarian Response|1|||
49065321|NCT01297465|158072301|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
49065322|NCT01297465|158072302|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
49065323|NCT01297465|158072301|FG000|Overall Study|No Oocytes Retrieved|1|||
49065324|NCT01297465|158072302|FG001|Overall Study|No Oocytes Retrieved|1|||
49065325|NCT01297465|158072301|FG000|Overall Study|Poor oocyte quality|0|||
49065326|NCT01297465|158072302|FG001|Overall Study|Poor oocyte quality|1|||
49065327|NCT01297465|158072301|FG000|Overall Study|No Fertilization|6|||
49065328|NCT01297465|158072302|FG001|Overall Study|No Fertilization|4|||
49065329|NCT01297465|158072301|FG000|Overall Study|All Embryos Discarded|0|||
49065330|NCT01297465|158072302|FG001|Overall Study|All Embryos Discarded|1|||
49065331|NCT01297465|158072301|FG000|Overall Study|Intention to Freeze all Embryos|0|||
49065332|NCT01297465|158072302|FG001|Overall Study|Intention to Freeze all Embryos|1|||
49065333|NCT02397408|158072303|FG000|Overall Study|Physician Decision|4|||
49065334|NCT02397408|158072303|FG000|Overall Study|Surgery not completed within protocol timeframe|2|||
49065335|NCT05256134|158072304|FG000|Overall Study|Study Terminated by Sponsor|11|||
49065336|NCT05256134|158072305|FG001|Overall Study|Study Terminated by Sponsor|10|||
49065337|NCT05256134|158072304|FG000|Overall Study|Withdrawal by Subject|1|||
49065338|NCT05256134|158072305|FG001|Overall Study|Withdrawal by Subject|3|||
49065339|NCT01646138|158072306|FG000|Overall Study|Lost to Follow-up|0|||
49065340|NCT01646138|158072307|FG001|Overall Study|Lost to Follow-up|0|||
49065341|NCT01646138|158072308|FG002|Overall Study|Lost to Follow-up|0|||
49065342|NCT01646138|158072309|FG003|Overall Study|Lost to Follow-up|0|||
49065343|NCT01646138|158072310|FG004|Overall Study|Lost to Follow-up|2|||
49065344|NCT01683838|158072311|FG000|Overall Study|Adverse Event|12|||
49065345|NCT01683838|158072312|FG001|Overall Study|Adverse Event|2|||
49065346|NCT01683838|158072311|FG000|Overall Study|Protocol Violation|3|||
49065347|NCT01683838|158072312|FG001|Overall Study|Protocol Violation|1|||
49065348|NCT01683838|158072311|FG000|Overall Study|Withdrawal by Subject|6|||
49065349|NCT01683838|158072312|FG001|Overall Study|Withdrawal by Subject|5|||
49065350|NCT01683838|158072311|FG000|Overall Study|Lost to Follow-up|1|||
49065351|NCT01683838|158072312|FG001|Overall Study|Lost to Follow-up|1|||
49065352|NCT01683838|158072311|FG000|Overall Study|Other|4|||
49065353|NCT01683838|158072312|FG001|Overall Study|Other|3|||
49065354|NCT04049617|158072313|FG000|Overall Study|Adverse Event|0|||
49065355|NCT04049617|158072314|FG001|Overall Study|Adverse Event|0|||
49065356|NCT04049617|158072315|FG002|Overall Study|Adverse Event|0|||
49065357|NCT04049617|158072316|FG003|Overall Study|Adverse Event|1|||
49065358|NCT04049617|158072317|FG004|Overall Study|Adverse Event|0|||
49065359|NCT04049617|158072318|FG005|Overall Study|Adverse Event|0|||
49065360|NCT04049617|158072313|FG000|Overall Study|Death|0|||
49065361|NCT04049617|158072314|FG001|Overall Study|Death|0|||
49065362|NCT04049617|158072315|FG002|Overall Study|Death|0|||
49065363|NCT04049617|158072316|FG003|Overall Study|Death|0|||
49065364|NCT04049617|158072317|FG004|Overall Study|Death|0|||
49065365|NCT04049617|158072318|FG005|Overall Study|Death|1|||
49065366|NCT04049617|158072313|FG000|Overall Study|Lost to Follow-up|0|||
49065367|NCT04049617|158072314|FG001|Overall Study|Lost to Follow-up|0|||
49065368|NCT04049617|158072315|FG002|Overall Study|Lost to Follow-up|0|||
49065369|NCT04049617|158072316|FG003|Overall Study|Lost to Follow-up|1|||
49065370|NCT04049617|158072317|FG004|Overall Study|Lost to Follow-up|0|||
49065371|NCT04049617|158072318|FG005|Overall Study|Lost to Follow-up|0|||
49065372|NCT04049617|158072313|FG000|Overall Study|Withdrew consent|0|||
49065373|NCT04049617|158072314|FG001|Overall Study|Withdrew consent|0|||
49065374|NCT04049617|158072315|FG002|Overall Study|Withdrew consent|1|||
49065375|NCT04049617|158072316|FG003|Overall Study|Withdrew consent|0|||
49065376|NCT04049617|158072317|FG004|Overall Study|Withdrew consent|0|||
49065377|NCT04049617|158072318|FG005|Overall Study|Withdrew consent|0|||
49065378|NCT03551496|158072319|FG000|Overall Study|Death|11|||
49065379|NCT03551496|158072320|FG001|Overall Study|Death|7|||
49065380|NCT03551496|158072319|FG000|Overall Study|Withdrawal by Subject|4|||
49065381|NCT03551496|158072320|FG001|Overall Study|Withdrawal by Subject|3|||
49065382|NCT03551496|158072319|FG000|Overall Study|Other Reasons|1|||
49065383|NCT03551496|158072320|FG001|Overall Study|Other Reasons|0|||
49065384|NCT01524679|158072321|FG000|Overall Study|Lost to Follow-up|1|||
49065385|NCT01524679|158072322|FG001|Overall Study|Lost to Follow-up|4|||
49065386|NCT01524679|158072321|FG000|Overall Study|Withdrawal by Subject|4|||
49065387|NCT01524679|158072322|FG001|Overall Study|Withdrawal by Subject|4|||
49065388|NCT01524679|158072321|FG000|Overall Study|Adverse Event|9|||
49065389|NCT01524679|158072322|FG001|Overall Study|Adverse Event|0|||
49065390|NCT01524679|158072321|FG000|Overall Study|Protocol Violation|1|||
49065391|NCT01524679|158072322|FG001|Overall Study|Protocol Violation|0|||
49065392|NCT01524679|158072321|FG000|Overall Study|Lack of Efficacy|2|||
49065393|NCT01524679|158072322|FG001|Overall Study|Lack of Efficacy|0|||
49065394|NCT01524679|158072321|FG000|Overall Study|e.g.wish for children, relocation|6|||
49065395|NCT01524679|158072322|FG001|Overall Study|e.g.wish for children, relocation|1|||
49065396|NCT01154816|158072323|FG000|Overall Study|Withdrawal by Subject|1|||
49065397|NCT01154816|158072324|FG001|Overall Study|Withdrawal by Subject|0|||
49065398|NCT01154816|158072325|FG002|Overall Study|Withdrawal by Subject|0|||
49065399|NCT01154816|158072326|FG003|Overall Study|Withdrawal by Subject|1|||
49065400|NCT01154816|158072327|FG004|Overall Study|Withdrawal by Subject|0|||
49065401|NCT01154816|158072328|FG005|Overall Study|Withdrawal by Subject|0|||
49065402|NCT01154816|158072329|FG006|Overall Study|Withdrawal by Subject|0|||
49065403|NCT01154816|158072330|FG007|Overall Study|Withdrawal by Subject|0|||
49065404|NCT01154816|158072331|FG008|Overall Study|Withdrawal by Subject|1|||
49065405|NCT01154816|158072332|FG009|Overall Study|Withdrawal by Subject|3|||
49065406|NCT01154816|158072333|FG010|Overall Study|Withdrawal by Subject|0|||
49065407|NCT01154816|158072334|FG011|Overall Study|Withdrawal by Subject|0|||
49065408|NCT01154816|158072323|FG000|Overall Study|Progressive Disease|13|||
49065409|NCT01154816|158072324|FG001|Overall Study|Progressive Disease|8|||
49065410|NCT01154816|158072325|FG002|Overall Study|Progressive Disease|9|||
49065411|NCT01154816|158072326|FG003|Overall Study|Progressive Disease|9|||
49065412|NCT01154816|158072327|FG004|Overall Study|Progressive Disease|8|||
49065413|NCT01154816|158072328|FG005|Overall Study|Progressive Disease|8|||
49065414|NCT01154816|158072329|FG006|Overall Study|Progressive Disease|5|||
49065415|NCT01154816|158072330|FG007|Overall Study|Progressive Disease|6|||
49065416|NCT01154816|158072331|FG008|Overall Study|Progressive Disease|8|||
49065417|NCT01154816|158072332|FG009|Overall Study|Progressive Disease|6|||
49065418|NCT01154816|158072333|FG010|Overall Study|Progressive Disease|10|||
49065419|NCT01154816|158072334|FG011|Overall Study|Progressive Disease|3|||
49065420|NCT01154816|158072323|FG000|Overall Study|Physician Decision|1|||
49065421|NCT01154816|158072324|FG001|Overall Study|Physician Decision|0|||
49065422|NCT01154816|158072325|FG002|Overall Study|Physician Decision|1|||
49065423|NCT01154816|158072326|FG003|Overall Study|Physician Decision|0|||
49065424|NCT01154816|158072327|FG004|Overall Study|Physician Decision|2|||
49065425|NCT01154816|158072328|FG005|Overall Study|Physician Decision|0|||
49065426|NCT01154816|158072329|FG006|Overall Study|Physician Decision|0|||
49065427|NCT01154816|158072330|FG007|Overall Study|Physician Decision|0|||
49065428|NCT01154816|158072331|FG008|Overall Study|Physician Decision|0|||
49065429|NCT01154816|158072332|FG009|Overall Study|Physician Decision|1|||
49065430|NCT01154816|158072333|FG010|Overall Study|Physician Decision|1|||
49065431|NCT01154816|158072334|FG011|Overall Study|Physician Decision|1|||
49065432|NCT01154816|158072323|FG000|Overall Study|Adverse Event|5|||
49065433|NCT01154816|158072324|FG001|Overall Study|Adverse Event|2|||
49065434|NCT01154816|158072325|FG002|Overall Study|Adverse Event|0|||
49065435|NCT01154816|158072326|FG003|Overall Study|Adverse Event|0|||
49065436|NCT01154816|158072327|FG004|Overall Study|Adverse Event|0|||
49065437|NCT01154816|158072328|FG005|Overall Study|Adverse Event|0|||
49065438|NCT01154816|158072329|FG006|Overall Study|Adverse Event|1|||
49065439|NCT01154816|158072330|FG007|Overall Study|Adverse Event|1|||
49065440|NCT01154816|158072331|FG008|Overall Study|Adverse Event|0|||
49065441|NCT01154816|158072332|FG009|Overall Study|Adverse Event|0|||
49065442|NCT01154816|158072333|FG010|Overall Study|Adverse Event|0|||
49065443|NCT01154816|158072334|FG011|Overall Study|Adverse Event|0|||
49065444|NCT00801099|158072335|FG000|Overall Study|Lost to Follow-up|101|||
49065445|NCT01780987|158072339|FG000|Overall Study|Adverse Event|0|||
49065446|NCT01780987|158072340|FG001|Overall Study|Adverse Event|4|||
49065447|NCT01780987|158072339|FG000|Overall Study|Withdrawal by Subject|2|||
49065448|NCT01780987|158072340|FG001|Overall Study|Withdrawal by Subject|0|||
49065449|NCT01780987|158072339|FG000|Overall Study|Request of Changing Hospital|0|||
49065450|NCT01780987|158072340|FG001|Overall Study|Request of Changing Hospital|1|||
49065451|NCT01780987|158072339|FG000|Overall Study|Changing Residence|1|||
49065452|NCT01780987|158072340|FG001|Overall Study|Changing Residence|0|||
49065453|NCT01780987|158072339|FG000|Overall Study|Not Receiving any Study Medication|0|||
49065454|NCT01780987|158072340|FG001|Overall Study|Not Receiving any Study Medication|1|||
49065455|NCT02303041|158072341|FG000|Overall Study|Adverse Event|1|||
49065456|NCT02303041|158072342|FG001|Overall Study|Adverse Event|2|||
49065457|NCT04771403|158072345|FG000|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|0|||
49065458|NCT04771403|158072346|FG001|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|1|||
49065459|NCT04771403|158072345|FG000|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|1|||
49065460|NCT04771403|158072346|FG001|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|0|||
49065461|NCT04771403|158072345|FG000|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|1|||
49065462|NCT04771403|158072346|FG001|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|0|||
49065463|NCT04771403|158072345|FG000|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|1|||
49065464|NCT04771403|158072346|FG001|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|0|||
49065465|NCT04771403|158072345|FG000|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|1|||
49065466|NCT04771403|158072346|FG001|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|0|||
49065467|NCT04771403|158072345|FG000|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|0|||
49065468|NCT04771403|158072346|FG001|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|1|||
49065469|NCT04771403|158072345|FG000|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|1|||
49065470|NCT04771403|158072346|FG001|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|0|||
49065471|NCT04771403|158072345|FG000|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|1|||
49065472|NCT04771403|158072346|FG001|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|0|||
49065473|NCT02387983|158072347|FG000|Overall Study|Adverse Event|4|||
49065474|NCT02387983|158072347|FG000|Overall Study|Protocol Violation|1|||
49065475|NCT02387983|158072347|FG000|Overall Study|Withdrawal by Subject|2|||
49065476|NCT00423319|158072348|FG000|Overall Study|Death|2|||
49065477|NCT00423319|158072349|FG001|Overall Study|Death|0|||
49065478|NCT00423319|158072348|FG000|Overall Study|Adverse Event|93|||
49065479|NCT00423319|158072349|FG001|Overall Study|Adverse Event|112|||
49065480|NCT00423319|158072348|FG000|Overall Study|Withdrawal by Subject|86|||
49065481|NCT00423319|158072349|FG001|Overall Study|Withdrawal by Subject|99|||
49065482|NCT00423319|158072348|FG000|Overall Study|Lost to Follow-up|4|||
49065483|NCT00423319|158072349|FG001|Overall Study|Lost to Follow-up|3|||
49065484|NCT00423319|158072348|FG000|Overall Study|Poor compliance or noncompliance|1|||
49065485|NCT00423319|158072349|FG001|Overall Study|Poor compliance or noncompliance|1|||
49065486|NCT00423319|158072348|FG000|Overall Study|No longer meets study criteria|15|||
49065487|NCT00423319|158072349|FG001|Overall Study|No longer meets study criteria|15|||
49065488|NCT00423319|158072348|FG000|Overall Study|Other|23|||
49065489|NCT00423319|158072349|FG001|Overall Study|Other|22|||
49065490|NCT01584843|158072352|FG000|First Treatment Period|Adverse Event|0|||
49065491|NCT01584843|158072353|FG001|First Treatment Period|Adverse Event|0|||
49065492|NCT01584843|158072354|FG002|First Treatment Period|Adverse Event|1|||
49065493|NCT01584843|158072355|FG003|First Treatment Period|Adverse Event|0|||
49065494|NCT01584843|158072356|FG004|First Treatment Period|Adverse Event|0|||
49065495|NCT01584843|158072357|FG005|First Treatment Period|Adverse Event|0|||
49065496|NCT01584843|158072352|FG000|First Treatment Period|Protocol Violation|0|||
49065497|NCT01584843|158072353|FG001|First Treatment Period|Protocol Violation|0|||
49065498|NCT01584843|158072354|FG002|First Treatment Period|Protocol Violation|0|||
49065499|NCT01584843|158072355|FG003|First Treatment Period|Protocol Violation|0|||
49065500|NCT01584843|158072356|FG004|First Treatment Period|Protocol Violation|0|||
49065501|NCT01584843|158072357|FG005|First Treatment Period|Protocol Violation|1|||
49065502|NCT01584843|158072352|FG000|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
49065503|NCT01584843|158072353|FG001|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
49065504|NCT01584843|158072354|FG002|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
49065505|NCT01584843|158072355|FG003|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
49065506|NCT01584843|158072356|FG004|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
49065507|NCT01584843|158072357|FG005|First Treatment Period|Met Protocol-defined Stopping Criteria|1|||
49065508|NCT01584843|158072352|FG000|Second Treatment Period|Withdrawal by Subject|0|||
49065509|NCT01584843|158072353|FG001|Second Treatment Period|Withdrawal by Subject|0|||
49065510|NCT01584843|158072354|FG002|Second Treatment Period|Withdrawal by Subject|0|||
49065511|NCT01584843|158072355|FG003|Second Treatment Period|Withdrawal by Subject|0|||
49065512|NCT01584843|158072356|FG004|Second Treatment Period|Withdrawal by Subject|0|||
49065513|NCT01584843|158072357|FG005|Second Treatment Period|Withdrawal by Subject|1|||
49065514|NCT01763684|158072358|FG000|Overall Study|Study terminated early due to low enrollment|126|||
49065515|NCT01763684|158072359|FG001|Overall Study|Study terminated early due to low enrollment|127|||
49065516|NCT01763684|158072358|FG000|Overall Study|Study surgery not performed|7|||
49065517|NCT01763684|158072359|FG001|Overall Study|Study surgery not performed|6|||
49065518|NCT02987959|158072360|FG000|Overall Study|Grantor stopped supply of drugs|6|||
49065519|NCT02639052|158072361|FG000|Overall Study|Lost to Follow-up|1|||
49065520|NCT02196701|158072369|FG000|Overall Study|Adverse Event|1|||
49065521|NCT02196701|158072369|FG000|Overall Study|Lost to Follow-up|1|||
49065522|NCT02196701|158072369|FG000|Overall Study|Non-adherence to Protocol|1|||
49065523|NCT00643565|158072373|FG000|Overall Study|Death|12|||
49065524|NCT00643565|158072374|FG001|Overall Study|Death|11|||
49065525|NCT00643565|158072373|FG000|Overall Study|Withdrawal by Subject|4|||
49065526|NCT00643565|158072374|FG001|Overall Study|Withdrawal by Subject|1|||
49065527|NCT00643565|158072373|FG000|Overall Study|Lost to Follow-up|0|||
49065528|NCT00643565|158072374|FG001|Overall Study|Lost to Follow-up|6|||
49065529|NCT00643565|158072373|FG000|Overall Study|Other|7|||
49065530|NCT00643565|158072374|FG001|Overall Study|Other|8|||
49065531|NCT00643565|158072373|FG000|Overall Study|Refused Treatment / Did Not Cooperate|0|||
49065532|NCT00643565|158072374|FG001|Overall Study|Refused Treatment / Did Not Cooperate|1|||
49065533|NCT00643565|158072373|FG000|Overall Study|Recurrence of Disease|2|||
49065534|NCT00643565|158072374|FG001|Overall Study|Recurrence of Disease|1|||
49065535|NCT00643565|158072373|FG000|Overall Study|Progression of Disease|18|||
49065536|NCT00643565|158072374|FG001|Overall Study|Progression of Disease|14|||
49065537|NCT00643565|158072373|FG000|Overall Study|Protocol Violation|3|||
49065538|NCT00643565|158072374|FG001|Overall Study|Protocol Violation|0|||
49065539|NCT00643565|158072373|FG000|Overall Study|Did Not Cooperate|0|||
49065540|NCT00643565|158072374|FG001|Overall Study|Did Not Cooperate|1|||
49065541|NCT00643565|158072373|FG000|Overall Study|Administrative|22|||
49065542|NCT00643565|158072374|FG001|Overall Study|Administrative|16|||
49065543|NCT00643565|158072373|FG000|Overall Study|Adverse Event|5|||
49065544|NCT00643565|158072374|FG001|Overall Study|Adverse Event|8|||
49065545|NCT01910389|158072376|FG000|Overall Study|Withdrawal by Subject|2|||
49065546|NCT01910389|158072377|FG001|Overall Study|Withdrawal by Subject|0|||
49065547|NCT01910389|158072376|FG000|Overall Study|Study Closed|13|||
49065548|NCT01910389|158072377|FG001|Overall Study|Study Closed|8|||
49065549|NCT04853992|158072378|FG000|Treatment Period A|Adverse Event|0|||
49065550|NCT04853992|158072379|FG001|Treatment Period A|Adverse Event|1|||
49065551|NCT04853992|158072378|FG000|Wash Out|Met exclusion criteria for next treatment phase|1|||
49065552|NCT04853992|158072379|FG001|Wash Out|Met exclusion criteria for next treatment phase|0|||
49065553|NCT03582826|158072383|FG000|Overall Study|Lost to Follow-up|39|||
49065554|NCT03582826|158072384|FG001|Overall Study|Lost to Follow-up|0|||
49065555|NCT03582826|158072383|FG000|Overall Study|Withdrawal by Subject|2|||
49065556|NCT03582826|158072384|FG001|Overall Study|Withdrawal by Subject|0|||
49065557|NCT00499174|158072385|FG000|Overall Study|Physician Decision|78|||
49065558|NCT00499174|158072386|FG001|Overall Study|Physician Decision|9|||
49065559|NCT00719849|158072388|FG000|Overall Study|Death|0|||
49065560|NCT00719849|158072389|FG001|Overall Study|Death|1|||
49065561|NCT04007991|158072390|FG000|Overall Study|Withdrawal by Subject|1|||
49065562|NCT04007991|158072391|FG001|Overall Study|Withdrawal by Subject|1|||
49065563|NCT04007991|158072390|FG000|Overall Study|Physician Decision|1|||
49065564|NCT04007991|158072391|FG001|Overall Study|Physician Decision|1|||
49065565|NCT04007991|158072390|FG000|Overall Study|Non-compliance with Study Drug|0|||
49065566|NCT04007991|158072391|FG001|Overall Study|Non-compliance with Study Drug|1|||
49065567|NCT04007991|158072390|FG000|Overall Study|Withdrawal by Parent/Caregiver|1|||
49065568|NCT04007991|158072391|FG001|Overall Study|Withdrawal by Parent/Caregiver|2|||
49065569|NCT04007991|158072390|FG000|Overall Study|Adverse event, non-fatal|5|||
49065570|NCT04007991|158072391|FG001|Overall Study|Adverse event, non-fatal|0|||
49065571|NCT04007991|158072390|FG000|Overall Study|Lost to Follow-up|2|||
49065572|NCT04007991|158072391|FG001|Overall Study|Lost to Follow-up|1|||
49065573|NCT01372774|158072395|FG000|Overall Study|Withdrawal prior to treatment|4|||
49065574|NCT01372774|158072396|FG001|Overall Study|Withdrawal prior to treatment|5|||
49065575|NCT04669691|158072397|FG000|Overall Study|Death|0|||
49065576|NCT04669691|158072398|FG001|Overall Study|Death|1|||
49065577|NCT04669691|158072399|FG002|Overall Study|Death|0|||
49065578|NCT04669691|158072400|FG003|Overall Study|Death|0|||
49065579|NCT04669691|158072401|FG004|Overall Study|Death|0|||
49065580|NCT04669691|158072402|FG005|Overall Study|Death|0|||
49065581|NCT04555720|158072405|FG000|Overall Study|Lost to Follow-up|2|||
49065582|NCT04555720|158072406|FG001|Overall Study|Lost to Follow-up|0|||
49065583|NCT04555720|158072407|FG002|Overall Study|Lost to Follow-up|0|||
49065584|NCT04555720|158072408|FG003|Overall Study|Lost to Follow-up|0|||
49065585|NCT04555720|158072405|FG000|Overall Study|Withdrawal by Subject|4|||
49065586|NCT04555720|158072406|FG001|Overall Study|Withdrawal by Subject|6|||
49065587|NCT04555720|158072407|FG002|Overall Study|Withdrawal by Subject|0|||
49065588|NCT04555720|158072408|FG003|Overall Study|Withdrawal by Subject|0|||
49065589|NCT00278889|158072409|FG000|Overall Study|Withdrawal by Subject|0|||
49065590|NCT00278889|158072410|FG001|Overall Study|Withdrawal by Subject|5|||
49065591|NCT00278889|158072411|FG002|Overall Study|Withdrawal by Subject|3|||
49065592|NCT00278889|158072409|FG000|Overall Study|Lost to Follow-up|1|||
49065593|NCT00278889|158072410|FG001|Overall Study|Lost to Follow-up|1|||
49065594|NCT00278889|158072411|FG002|Overall Study|Lost to Follow-up|0|||
49065595|NCT00278889|158072409|FG000|Overall Study|Death|24|||
49065596|NCT00278889|158072410|FG001|Overall Study|Death|21|||
49065597|NCT00278889|158072411|FG002|Overall Study|Death|17|||
49065598|NCT01287039|158074152|FG000|Overall Study|Noncompliance with study procedures|0|||
49065599|NCT01287039|158074153|FG001|Overall Study|Noncompliance with study procedures|1|||
49065600|NCT01287039|158074152|FG000|Overall Study|Change of location/residence|0|||
49065601|NCT01287039|158074153|FG001|Overall Study|Change of location/residence|3|||
49065602|NCT01287039|158074152|FG000|Overall Study|Elective surgery|0|||
49065603|NCT01287039|158074153|FG001|Overall Study|Elective surgery|1|||
49065604|NCT01287039|158074152|FG000|Overall Study|Protocol Violation|2|||
49065605|NCT01287039|158074153|FG001|Overall Study|Protocol Violation|3|||
49065606|NCT01287039|158074152|FG000|Overall Study|Excluded medication taken|1|||
49065607|NCT01287039|158074153|FG001|Overall Study|Excluded medication taken|0|||
49065608|NCT01287039|158074152|FG000|Overall Study|Noncompliance with study medication|0|||
49065609|NCT01287039|158074153|FG001|Overall Study|Noncompliance with study medication|1|||
49065610|NCT01287039|158074152|FG000|Overall Study|Problem with travel|0|||
49065611|NCT01287039|158074153|FG001|Overall Study|Problem with travel|1|||
49065612|NCT01287039|158074152|FG000|Overall Study|Death|1|||
49065613|NCT01287039|158074153|FG001|Overall Study|Death|0|||
49065614|NCT01287039|158074152|FG000|Overall Study|Change of residence|1|||
49065615|NCT01287039|158074153|FG001|Overall Study|Change of residence|0|||
49065616|NCT01287039|158074152|FG000|Overall Study|Adverse Event|7|||
49065617|NCT01287039|158074153|FG001|Overall Study|Adverse Event|4|||
49065618|NCT01287039|158074152|FG000|Overall Study|Withdrawal by Subject|14|||
49065619|NCT01287039|158074153|FG001|Overall Study|Withdrawal by Subject|11|||
49065620|NCT01287039|158074152|FG000|Overall Study|Lost to Follow-up|3|||
49065621|NCT01287039|158074153|FG001|Overall Study|Lost to Follow-up|2|||
49065622|NCT01995266|158074158|FG000|Overall Study|Death|1|||
49065623|NCT01995266|158074158|FG000|Overall Study|Lack of Efficacy|6|||
49065624|NCT01995266|158074158|FG000|Overall Study|Adverse Event|2|||
49065625|NCT00852969|158074159|FG000|Overall Study|Adverse Event|0|||
49065626|NCT00852969|158074160|FG001|Overall Study|Adverse Event|1|||
49065627|NCT00852969|158074159|FG000|Overall Study|Lost to Follow-up|0|||
49065628|NCT00852969|158074160|FG001|Overall Study|Lost to Follow-up|1|||
49065629|NCT03853148|158074161|FG000|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
49065630|NCT03853148|158074162|FG001|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
49065631|NCT03853148|158074163|FG002|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
49065632|NCT03853148|158074164|FG003|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
49065633|NCT02119286|158074165|FG000|Overall Study|Adverse Event|9|||
49065634|NCT02119286|158074166|FG001|Overall Study|Adverse Event|7|||
49065635|NCT02119286|158074167|FG002|Overall Study|Adverse Event|2|||
49065636|NCT02119286|158074165|FG000|Overall Study|Lack of Efficacy|11|||
49065637|NCT02119286|158074166|FG001|Overall Study|Lack of Efficacy|3|||
49065638|NCT02119286|158074167|FG002|Overall Study|Lack of Efficacy|4|||
49065639|NCT02119286|158074165|FG000|Overall Study|Lost to Follow-up|2|||
49065640|NCT02119286|158074166|FG001|Overall Study|Lost to Follow-up|0|||
49065641|NCT02119286|158074167|FG002|Overall Study|Lost to Follow-up|1|||
49065642|NCT02119286|158074165|FG000|Overall Study|Withdrawal by Subject|4|||
49065643|NCT02119286|158074166|FG001|Overall Study|Withdrawal by Subject|1|||
49065644|NCT02119286|158074167|FG002|Overall Study|Withdrawal by Subject|0|||
49065645|NCT00658658|158074173|FG000|Overall Study|Withdrawal by Subject|0|||
49065646|NCT00658658|158074174|FG001|Overall Study|Withdrawal by Subject|1|||
49065647|NCT00658658|158074175|FG002|Overall Study|Withdrawal by Subject|0|||
49065648|NCT00658658|158074176|FG003|Overall Study|Withdrawal by Subject|0|||
49065649|NCT00658658|158074177|FG004|Overall Study|Withdrawal by Subject|0|||
49065650|NCT00658658|158074173|FG000|Overall Study|Death|4|||
49065651|NCT00658658|158074174|FG001|Overall Study|Death|0|||
49065652|NCT00658658|158074175|FG002|Overall Study|Death|0|||
49065653|NCT00658658|158074176|FG003|Overall Study|Death|1|||
49065654|NCT00658658|158074177|FG004|Overall Study|Death|1|||
49065655|NCT00658658|158074173|FG000|Overall Study|Disease Progression|0|||
49065656|NCT00658658|158074174|FG001|Overall Study|Disease Progression|1|||
49065657|NCT00658658|158074175|FG002|Overall Study|Disease Progression|0|||
49065658|NCT00658658|158074176|FG003|Overall Study|Disease Progression|1|||
49065659|NCT00658658|158074177|FG004|Overall Study|Disease Progression|3|||
49065660|NCT00658658|158074173|FG000|Overall Study|Protocol-specified Criteria|1|||
49065661|NCT00658658|158074174|FG001|Overall Study|Protocol-specified Criteria|0|||
49065662|NCT00658658|158074175|FG002|Overall Study|Protocol-specified Criteria|0|||
49065663|NCT00658658|158074176|FG003|Overall Study|Protocol-specified Criteria|0|||
49065664|NCT00658658|158074177|FG004|Overall Study|Protocol-specified Criteria|0|||
49065665|NCT00658658|158074173|FG000|Overall Study|Other|0|||
49065666|NCT00658658|158074174|FG001|Overall Study|Other|0|||
49065667|NCT00658658|158074175|FG002|Overall Study|Other|0|||
49065668|NCT00658658|158074176|FG003|Overall Study|Other|0|||
49065669|NCT00658658|158074177|FG004|Overall Study|Other|1|||
49065670|NCT03247517|158074178|FG000|Overall Study|Adverse Event|0|||
49065671|NCT03247517|158074179|FG001|Overall Study|Adverse Event|4|||
49065672|NCT03247517|158074180|FG002|Overall Study|Adverse Event|2|||
49065673|NCT03247517|158074178|FG000|Overall Study|Lost to Follow-up|2|||
49065674|NCT03247517|158074179|FG001|Overall Study|Lost to Follow-up|6|||
49065675|NCT03247517|158074180|FG002|Overall Study|Lost to Follow-up|4|||
49065676|NCT03247517|158074178|FG000|Overall Study|Consent withdrawn by caregiver|1|||
49065677|NCT03247517|158074179|FG001|Overall Study|Consent withdrawn by caregiver|4|||
49065678|NCT03247517|158074180|FG002|Overall Study|Consent withdrawn by caregiver|7|||
49065679|NCT03247517|158074178|FG000|Overall Study|Assent/consent withdrawn by subject|2|||
49065680|NCT03247517|158074179|FG001|Overall Study|Assent/consent withdrawn by subject|3|||
49065681|NCT03247517|158074180|FG002|Overall Study|Assent/consent withdrawn by subject|1|||
49065682|NCT03247517|158074178|FG000|Overall Study|Protocol Violation|0|||
49065683|NCT03247517|158074179|FG001|Overall Study|Protocol Violation|2|||
49065684|NCT03247517|158074180|FG002|Overall Study|Protocol Violation|0|||
49065685|NCT03247517|158074178|FG000|Overall Study|Multiple reasons|3|||
49065686|NCT03247517|158074179|FG001|Overall Study|Multiple reasons|1|||
49065687|NCT03247517|158074180|FG002|Overall Study|Multiple reasons|0|||
49065688|NCT02358343|158074181|FG000|Screening Intervention|Death|0|||
49065689|NCT02358343|158074182|FG001|Screening Intervention|Death|2|||
49065690|NCT02358343|158074183|FG002|Screening Intervention|Death|0|||
49065691|NCT02358343|158074184|FG003|Screening Intervention|Death|0|||
49065692|NCT02358343|158074185|FG004|Screening Intervention|Death|0|||
49065693|NCT02358343|158074181|FG000|Screening Intervention|Withdrawal by Subject|1|||
49065694|NCT02358343|158074182|FG001|Screening Intervention|Withdrawal by Subject|0|||
49065695|NCT02358343|158074183|FG002|Screening Intervention|Withdrawal by Subject|0|||
49065696|NCT02358343|158074184|FG003|Screening Intervention|Withdrawal by Subject|0|||
49065697|NCT02358343|158074185|FG004|Screening Intervention|Withdrawal by Subject|0|||
49065698|NCT02358343|158074181|FG000|Screening Intervention|Determined Ineligible|5|||
49065699|NCT02358343|158074182|FG001|Screening Intervention|Determined Ineligible|6|||
49065700|NCT02358343|158074183|FG002|Screening Intervention|Determined Ineligible|0|||
49065701|NCT02358343|158074184|FG003|Screening Intervention|Determined Ineligible|0|||
49065702|NCT02358343|158074185|FG004|Screening Intervention|Determined Ineligible|0|||
49065703|NCT02358343|158074181|FG000|Comparative Efficacy Trial / Observation|Death|0|||
49065704|NCT02358343|158074182|FG001|Comparative Efficacy Trial / Observation|Death|0|||
49065705|NCT02358343|158074183|FG002|Comparative Efficacy Trial / Observation|Death|2|||
49065706|NCT02358343|158074184|FG003|Comparative Efficacy Trial / Observation|Death|0|||
49065707|NCT02358343|158074185|FG004|Comparative Efficacy Trial / Observation|Death|0|||
49065708|NCT02358343|158074181|FG000|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
49065709|NCT02358343|158074182|FG001|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
49065710|NCT02358343|158074183|FG002|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
49065711|NCT02358343|158074184|FG003|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
49065712|NCT02358343|158074185|FG004|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
49065713|NCT02358343|158074181|FG000|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
49065714|NCT02358343|158074182|FG001|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
49065715|NCT02358343|158074183|FG002|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1|||
49065716|NCT02358343|158074184|FG003|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
49065717|NCT02358343|158074185|FG004|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
49065718|NCT03310411|158074188|FG000|Period 1|Adverse Event|0|||
49065719|NCT03310411|158074189|FG001|Period 1|Adverse Event|0|||
49065720|NCT03310411|158074190|FG002|Period 1|Adverse Event|0|||
49065721|NCT03310411|158074191|FG003|Period 1|Adverse Event|1|||
49065722|NCT00090610|158074192|FG000|Overall Study|Withdrawal by Subject|1|||
49065723|NCT00090610|158074193|FG001|Overall Study|Withdrawal by Subject|1|||
49065724|NCT00729248|158074197|FG000|Overall Study|Physician Decision|2|||
49065725|NCT02408068|158074198|FG000|Treatment 3 (1.5 Days)|Adverse Event|0|||
49065726|NCT02408068|158074199|FG001|Treatment 3 (1.5 Days)|Adverse Event|0|||
49065727|NCT02408068|158074200|FG002|Treatment 3 (1.5 Days)|Adverse Event|1|||
49065728|NCT02408068|158074201|FG003|Treatment 3 (1.5 Days)|Adverse Event|0|||
49065729|NCT02408068|158074202|FG004|Treatment 3 (1.5 Days)|Adverse Event|0|||
49065730|NCT02408068|158074203|FG005|Treatment 3 (1.5 Days)|Adverse Event|0|||
49065731|NCT01340768|158074204|FG000|Overall Study|Lost to Follow-up|10|||
49065732|NCT01340768|158074205|FG001|Overall Study|Lost to Follow-up|4|||
49065733|NCT01340768|158074204|FG000|Overall Study|Withdrawal by Subject|5|||
49065734|NCT01340768|158074205|FG001|Overall Study|Withdrawal by Subject|1|||
49065735|NCT01340768|158074204|FG000|Overall Study|Other|2|||
49065736|NCT01340768|158074205|FG001|Overall Study|Other|0|||
49065737|NCT02712333|158074210|FG000|First Period|Withdrawal by Subject|3|||
49065738|NCT02712333|158074211|FG001|First Period|Withdrawal by Subject|2|||
49065739|NCT00003875|158074212|FG000|Overall Study|Screen Failed|1|||
49065740|NCT00969540|158074213|FG000|Overall Study|Lost to Follow-up|1|||
49065741|NCT00969540|158074214|FG001|Overall Study|Lost to Follow-up|1|||
49065742|NCT00369655|158074215|FG000|Overall Study|Refusal of further treatment|2|||
49065743|NCT03397771|158074216|FG000|Overall Study|2 erroneously randomized, never treated|3|||
49065744|NCT03397771|158074217|FG001|Overall Study|2 erroneously randomized, never treated|1|||
49065745|NCT03397771|158074216|FG000|Overall Study|Withdrawal by Subject|1|||
49065746|NCT03397771|158074217|FG001|Overall Study|Withdrawal by Subject|3|||
49065747|NCT03397771|158074216|FG000|Overall Study|Protocol Violation|2|||
49065748|NCT03397771|158074217|FG001|Overall Study|Protocol Violation|2|||
49065749|NCT03397771|158074216|FG000|Overall Study|Adverse Event|2|||
49065750|NCT03397771|158074217|FG001|Overall Study|Adverse Event|1|||
49065751|NCT03321630|158074220|FG000|Overall Study|Adverse Event|1|||
49065752|NCT03321630|158074220|FG000|Overall Study|Investigator Discretion|2|||
49065753|NCT03321630|158074220|FG000|Overall Study|Withdrawal by Subject|1|||
49065754|NCT00140426|158074221|FG000|Overall Study|Withdrawal by Subject|0|||
49065755|NCT00140426|158074222|FG001|Overall Study|Withdrawal by Subject|3|||
49065756|NCT02669758|158074223|FG000|Overall Study|Withdrawal by Subject|43|||
49065757|NCT02669758|158074223|FG000|Overall Study|Lost to Follow-up|19|||
49065758|NCT02669758|158074223|FG000|Overall Study|Adverse Event|16|||
49065759|NCT02669758|158074223|FG000|Overall Study|Non-Compliance with Study Drug|8|||
49065760|NCT02669758|158074223|FG000|Overall Study|Lack of Efficacy|5|||
49065761|NCT02669758|158074223|FG000|Overall Study|Pregnancy|1|||
49065762|NCT02669758|158074223|FG000|Overall Study|Study noncompliance|1|||
49065763|NCT02669758|158074223|FG000|Overall Study|Protocol Violation|1|||
49065764|NCT02149108|158074224|FG000|Overall Study|Not treated|1|||
49065765|NCT02149108|158074225|FG001|Overall Study|Not treated|2|||
49065766|NCT02149108|158074224|FG000|Overall Study|Progressive Disease (PD)|324|||
49065767|NCT02149108|158074225|FG001|Overall Study|Progressive Disease (PD)|318|||
49065768|NCT02149108|158074224|FG000|Overall Study|Worsening/adverse event cancer disease|31|||
49065769|NCT02149108|158074225|FG001|Overall Study|Worsening/adverse event cancer disease|32|||
49065770|NCT02149108|158074224|FG000|Overall Study|Other Adverse Event (AE)|8|||
49065771|NCT02149108|158074225|FG001|Overall Study|Other Adverse Event (AE)|18|||
49065772|NCT02149108|158074224|FG000|Overall Study|Other not defined above|0|||
49065773|NCT02149108|158074225|FG001|Overall Study|Other not defined above|2|||
49065774|NCT02149108|158074224|FG000|Overall Study|Refusal to continue trial medication|15|||
49065775|NCT02149108|158074225|FG001|Overall Study|Refusal to continue trial medication|11|||
49065776|NCT02149108|158074224|FG000|Overall Study|Lost to Follow-up|1|||
49065777|NCT02149108|158074225|FG001|Overall Study|Lost to Follow-up|0|||
49065778|NCT00950963|158074226|FG000|Overall Study|Lost to Follow-up|29|||
49065779|NCT00950963|158074227|FG001|Overall Study|Lost to Follow-up|24|||
49065780|NCT02455050|158074228|FG000|Treatment Period 1|Lost to Follow-up|1|||
49065781|NCT02455050|158074229|FG001|Treatment Period 1|Lost to Follow-up|1|||
49065782|NCT02455050|158074230|FG002|Treatment Period 1|Lost to Follow-up|1|||
49065783|NCT02455050|158074231|FG003|Treatment Period 1|Lost to Follow-up|2|||
49065784|NCT02455050|158074228|FG000|Treatment Period 2|Lost to Follow-up|1|||
49065785|NCT02455050|158074229|FG001|Treatment Period 2|Lost to Follow-up|0|||
49065786|NCT02455050|158074230|FG002|Treatment Period 2|Lost to Follow-up|2|||
49065787|NCT02455050|158074231|FG003|Treatment Period 2|Lost to Follow-up|1|||
49065788|NCT03402750|158074232|FG000|Overall Study|Lost to Follow-up|2|||
49065789|NCT03402750|158074233|FG001|Overall Study|Lost to Follow-up|1|||
49065790|NCT04168190|158074234|FG000|Overall Study|Lost to Follow-up|0|||
49065791|NCT04168190|158074235|FG001|Overall Study|Lost to Follow-up|1|||
49065792|NCT04168190|158074236|FG002|Overall Study|Lost to Follow-up|0|||
49065793|NCT04168190|158074237|FG003|Overall Study|Lost to Follow-up|7|||
49065794|NCT04168190|158074238|FG004|Overall Study|Lost to Follow-up|5|||
49065795|NCT04168190|158074234|FG000|Overall Study|Withdrawal by Subject|1|||
49065796|NCT04168190|158074235|FG001|Overall Study|Withdrawal by Subject|0|||
49065797|NCT04168190|158074236|FG002|Overall Study|Withdrawal by Subject|0|||
49065798|NCT04168190|158074237|FG003|Overall Study|Withdrawal by Subject|2|||
49065799|NCT04168190|158074238|FG004|Overall Study|Withdrawal by Subject|4|||
49065800|NCT04168190|158074234|FG000|Overall Study|Death|0|||
49065801|NCT04168190|158074235|FG001|Overall Study|Death|0|||
49065802|NCT04168190|158074236|FG002|Overall Study|Death|0|||
49065803|NCT04168190|158074237|FG003|Overall Study|Death|1|||
49065804|NCT04168190|158074238|FG004|Overall Study|Death|0|||
49065805|NCT03469336|158074239|FG000|Overall Study|Adverse Event|1|||
49065806|NCT00886288|158074240|FG000|Overall Study|no respect of the 12 weeks period|657|||
49065807|NCT00886288|158074241|FG001|Overall Study|no respect of the 12 weeks period|227|||
49065808|NCT00886288|158074240|FG000|Overall Study|Lost to Follow-up|86|||
49065809|NCT00886288|158074241|FG001|Overall Study|Lost to Follow-up|0|||
49065810|NCT00080938|158074242|FG000|Overall Study|Adverse Event|3|||
49065811|NCT00080938|158074242|FG000|Overall Study|Withdrawal by Subject|6|||
49065812|NCT00080938|158074242|FG000|Overall Study|Death|2|||
49065813|NCT00080938|158074242|FG000|Overall Study|Lack of Efficacy|7|||
49065814|NCT00080938|158074242|FG000|Overall Study|other disease|1|||
49065815|NCT00080938|158074242|FG000|Overall Study|Not started protocol therapy|1|||
49065816|NCT00080938|158074242|FG000|Overall Study|Ineligible|4|||
49065817|NCT00742924|158074249|FG000|Overall Study|Adverse Event|0|||
49065818|NCT00742924|158074250|FG001|Overall Study|Adverse Event|0|||
49065819|NCT00742924|158074251|FG002|Overall Study|Adverse Event|1|||
49065820|NCT00742924|158074252|FG003|Overall Study|Adverse Event|1|||
49065821|NCT00742924|158074249|FG000|Overall Study|Lack of Efficacy|5|||
49065822|NCT00742924|158074250|FG001|Overall Study|Lack of Efficacy|1|||
49065823|NCT00742924|158074251|FG002|Overall Study|Lack of Efficacy|2|||
49065824|NCT00742924|158074252|FG003|Overall Study|Lack of Efficacy|4|||
49065825|NCT00742924|158074249|FG000|Overall Study|Physician Decision|0|||
49065826|NCT00742924|158074250|FG001|Overall Study|Physician Decision|0|||
49065827|NCT00742924|158074251|FG002|Overall Study|Physician Decision|0|||
49065828|NCT00742924|158074252|FG003|Overall Study|Physician Decision|1|||
49065829|NCT00742924|158074249|FG000|Overall Study|Withdrawal by Subject|0|||
49065830|NCT00742924|158074250|FG001|Overall Study|Withdrawal by Subject|1|||
49065831|NCT00742924|158074251|FG002|Overall Study|Withdrawal by Subject|1|||
49065832|NCT00742924|158074252|FG003|Overall Study|Withdrawal by Subject|0|||
49065833|NCT00160641|158074254|FG000|Overall Study|Adverse Event|102|||
49065834|NCT00160641|158074254|FG000|Overall Study|Withdrawal by Subject|87|||
49065835|NCT00160641|158074254|FG000|Overall Study|Lost to Follow-up|8|||
49065836|NCT00160641|158074254|FG000|Overall Study|Lack of Efficacy|12|||
49065837|NCT00160641|158074254|FG000|Overall Study|Protocol Violation|3|||
49065838|NCT00160641|158074254|FG000|Overall Study|Other|9|||
49065839|NCT02365558|158074257|FG000|Period 1 (Day 1 Through Day 7)|Adverse Event|1|||
49065840|NCT02365558|158074258|FG001|Period 1 (Day 1 Through Day 7)|Adverse Event|0|||
49065841|NCT02365558|158074257|FG000|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0|||
49065842|NCT02365558|158074258|FG001|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1|||
49065843|NCT00369317|158074259|FG000|Overall Study|Adverse Event|3|||
49065844|NCT00369317|158074259|FG000|Overall Study|Death|1|||
49065845|NCT00369317|158074259|FG000|Overall Study|Lack of Efficacy|5|||
49065846|NCT00369317|158074259|FG000|Overall Study|Physician Decision|2|||
49065847|NCT00369317|158074259|FG000|Overall Study|Withdrawal by Subject|8|||
49065848|NCT00369317|158074259|FG000|Overall Study|Ineligible|1|||
49065849|NCT02011386|158074260|FG000|Overall Study|Non-compliance|2|||
49065850|NCT02011386|158074260|FG000|Overall Study|Lack of Efficacy|3|||
49065851|NCT03365011|158074261|FG000|Overall Study|Withdrawal by Subject|1|||
49065852|NCT03365011|158074262|FG001|Overall Study|Withdrawal by Subject|2|||
49065853|NCT01193127|158074265|FG000|Randomized|Surgery Cancelled|0|||
49065854|NCT01193127|158074266|FG001|Randomized|Surgery Cancelled|0|||
49065855|NCT01193127|158074267|FG002|Randomized|Surgery Cancelled|0|||
49065856|NCT01193127|158074268|FG003|Randomized|Surgery Cancelled|1|||
49065857|NCT01193127|158074265|FG000|Treated|Withdrawal by Subject|0|||
49065858|NCT01193127|158074266|FG001|Treated|Withdrawal by Subject|0|||
49065859|NCT01193127|158074267|FG002|Treated|Withdrawal by Subject|0|||
49065860|NCT01193127|158074268|FG003|Treated|Withdrawal by Subject|1|||
49065861|NCT03246646|158074271|FG000|Overall Study|deemed ineligible and administratively withdrawn|1|||
49065862|NCT03246646|158074272|FG001|Overall Study|deemed ineligible and administratively withdrawn|0|||
49065863|NCT03246646|158074271|FG000|Overall Study|Withdrawal by Subject|3|||
49065864|NCT03246646|158074272|FG001|Overall Study|Withdrawal by Subject|0|||
49065865|NCT03246646|158074271|FG000|Overall Study|Lost to Follow-up|7|||
49065866|NCT03246646|158074272|FG001|Overall Study|Lost to Follow-up|0|||
49065867|NCT00319982|158074273|FG000|Overall Study|Withdrawal by Subject|1|||
49065868|NCT00319982|158074274|FG001|Overall Study|Withdrawal by Subject|0|||
49065869|NCT00761865|158074277|FG000|Overall Study|Lost to Follow-up|8|||
49065870|NCT00761865|158074278|FG001|Overall Study|Lost to Follow-up|7|||
49065871|NCT00259272|158074279|FG000|Overall Study|Adverse Event|2|||
49065872|NCT00259272|158074280|FG001|Overall Study|Adverse Event|1|||
49065873|NCT00259272|158074281|FG002|Overall Study|Adverse Event|0|||
49065874|NCT00259272|158074282|FG003|Overall Study|Adverse Event|3|||
49065875|NCT00259272|158074279|FG000|Overall Study|Lack of Efficacy|5|||
49065876|NCT00259272|158074280|FG001|Overall Study|Lack of Efficacy|1|||
49065877|NCT00259272|158074281|FG002|Overall Study|Lack of Efficacy|2|||
49065878|NCT00259272|158074282|FG003|Overall Study|Lack of Efficacy|6|||
49065879|NCT00259272|158074279|FG000|Overall Study|Physician Decision|1|||
49065880|NCT00259272|158074280|FG001|Overall Study|Physician Decision|2|||
49065881|NCT00259272|158074281|FG002|Overall Study|Physician Decision|1|||
49065882|NCT00259272|158074282|FG003|Overall Study|Physician Decision|3|||
49065883|NCT00259272|158074279|FG000|Overall Study|Protocol Violation|2|||
49065884|NCT00259272|158074280|FG001|Overall Study|Protocol Violation|0|||
49065885|NCT00259272|158074281|FG002|Overall Study|Protocol Violation|0|||
49065886|NCT00259272|158074282|FG003|Overall Study|Protocol Violation|1|||
49065887|NCT00259272|158074279|FG000|Overall Study|Sponsor Decision|0|||
49065888|NCT00259272|158074280|FG001|Overall Study|Sponsor Decision|1|||
49065889|NCT00259272|158074281|FG002|Overall Study|Sponsor Decision|0|||
49065890|NCT00259272|158074282|FG003|Overall Study|Sponsor Decision|0|||
49065891|NCT00259272|158074279|FG000|Overall Study|Withdrawal by Subject|4|||
49065892|NCT00259272|158074280|FG001|Overall Study|Withdrawal by Subject|2|||
49065893|NCT00259272|158074281|FG002|Overall Study|Withdrawal by Subject|2|||
49065894|NCT00259272|158074282|FG003|Overall Study|Withdrawal by Subject|7|||
49065895|NCT00259272|158074279|FG000|Overall Study|Lost to Follow-up|1|||
49065896|NCT00259272|158074280|FG001|Overall Study|Lost to Follow-up|0|||
49065897|NCT00259272|158074281|FG002|Overall Study|Lost to Follow-up|0|||
49065898|NCT00259272|158074282|FG003|Overall Study|Lost to Follow-up|1|||
49065899|NCT02351960|158074283|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
49065900|NCT02351960|158074284|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
49065901|NCT02351960|158074283|FG000|Overall Study|Voluntary Withdrawal|5|||
49065902|NCT02351960|158074284|FG001|Overall Study|Voluntary Withdrawal|4|||
49065903|NCT02351960|158074283|FG000|Overall Study|Significant Protocol Deviation|0|||
49065904|NCT02351960|158074284|FG001|Overall Study|Significant Protocol Deviation|5|||
49065905|NCT00574912|158074285|FG000|Overall Study|Could not place IV lines.|3|||
49065906|NCT00574912|158074285|FG000|Overall Study|scheduling conflicts|3|||
49065907|NCT00574912|158074285|FG000|Overall Study|Physician Decision|2|||
49065908|NCT00103610|158074286|FG000|Overall Study|Entered Rescue Procedure|10|||
49065909|NCT00103610|158074287|FG001|Overall Study|Entered Rescue Procedure|52|||
49065910|NCT00103610|158074286|FG000|Overall Study|Death|16|||
49065911|NCT00103610|158074287|FG001|Overall Study|Death|12|||
49065912|NCT00103610|158074286|FG000|Overall Study|Elective Withdrawal|4|||
49065913|NCT00103610|158074287|FG001|Overall Study|Elective Withdrawal|0|||
49065914|NCT00103610|158074286|FG000|Overall Study|Lost to Follow-up|3|||
49065915|NCT00103610|158074287|FG001|Overall Study|Lost to Follow-up|1|||
49065916|NCT00103610|158074286|FG000|Overall Study|Adverse Event|2|||
49065917|NCT00103610|158074287|FG001|Overall Study|Adverse Event|2|||
49065918|NCT00103610|158074286|FG000|Overall Study|Other|2|||
49065919|NCT00103610|158074287|FG001|Overall Study|Other|7|||
49065920|NCT00103610|158074286|FG000|Overall Study|Failed mobilization|1|||
49065921|NCT00103610|158074287|FG001|Overall Study|Failed mobilization|5|||
49065922|NCT00103610|158074286|FG000|Overall Study|Noncompliance|0|||
49065923|NCT00103610|158074287|FG001|Overall Study|Noncompliance|1|||
49065924|NCT03301623|158074290|FG000|Overall Study|Death|3|||
49065925|NCT03301623|158074291|FG001|Overall Study|Death|1|||
49065926|NCT03301623|158074290|FG000|Overall Study|Withdrawal by Subject|11|||
49065927|NCT03301623|158074291|FG001|Overall Study|Withdrawal by Subject|13|||
49065928|NCT03301623|158074290|FG000|Overall Study|Lost to Follow-up|3|||
49065929|NCT03301623|158074291|FG001|Overall Study|Lost to Follow-up|1|||
49065930|NCT03866902|158074293|FG000|Overall Study|Lost to Follow-up|98|||
49065931|NCT03866902|158074294|FG001|Overall Study|Lost to Follow-up|82|||
49065932|NCT03866902|158074293|FG000|Overall Study|Pregnancy|18|||
49065933|NCT03866902|158074294|FG001|Overall Study|Pregnancy|24|||
49065934|NCT01806506|158074298|FG000|Overall Study|Lost to Follow-up|2|||
49065935|NCT01806506|158074299|FG001|Overall Study|Lost to Follow-up|1|||
49065936|NCT01288053|158077579|FG000|Overall Study|Death|1|||
49065937|NCT03188666|158077580|FG000|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
49065938|NCT03188666|158077581|FG001|Period 1 (28 Weeks Double-blind)|Adverse Event|1|||
49065939|NCT03188666|158077582|FG002|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
49065940|NCT03188666|158077583|FG003|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
49065941|NCT03188666|158077580|FG000|Period 2 (28 Weeks Open-label)|Death|0|||
49065942|NCT03188666|158077581|FG001|Period 2 (28 Weeks Open-label)|Death|0|||
49065943|NCT03188666|158077582|FG002|Period 2 (28 Weeks Open-label)|Death|0|||
49065944|NCT03188666|158077583|FG003|Period 2 (28 Weeks Open-label)|Death|1|||
49065945|NCT03188666|158077580|FG000|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
49065946|NCT03188666|158077581|FG001|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
49065947|NCT03188666|158077582|FG002|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|2|||
49065948|NCT03188666|158077583|FG003|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
49065949|NCT03188666|158077580|FG000|Period 3 (20 Weeks Follow-up)|Death|0|||
49065950|NCT03188666|158077581|FG001|Period 3 (20 Weeks Follow-up)|Death|0|||
49065951|NCT03188666|158077582|FG002|Period 3 (20 Weeks Follow-up)|Death|1|||
49065952|NCT03188666|158077583|FG003|Period 3 (20 Weeks Follow-up)|Death|2|||
49065953|NCT00619112|158077584|FG000|Overall Study|Adverse Event|1|||
49065954|NCT00619112|158077585|FG001|Overall Study|Adverse Event|2|||
49065955|NCT00807248|158077586|FG000|Overall Study|Adverse Event|1|||
49065956|NCT00807248|158077587|FG001|Overall Study|Adverse Event|2|||
49065957|NCT00807248|158077588|FG002|Overall Study|Adverse Event|2|||
49065958|NCT00807248|158077589|FG003|Overall Study|Adverse Event|6|||
49065959|NCT00807248|158077586|FG000|Overall Study|Lack of Efficacy|14|||
49065960|NCT00807248|158077587|FG001|Overall Study|Lack of Efficacy|4|||
49065961|NCT00807248|158077588|FG002|Overall Study|Lack of Efficacy|8|||
49065962|NCT00807248|158077589|FG003|Overall Study|Lack of Efficacy|3|||
49065963|NCT00807248|158077586|FG000|Overall Study|Protocol Violation|0|||
49065964|NCT00807248|158077587|FG001|Overall Study|Protocol Violation|1|||
49065965|NCT00807248|158077588|FG002|Overall Study|Protocol Violation|1|||
49065966|NCT00807248|158077589|FG003|Overall Study|Protocol Violation|0|||
49065967|NCT00807248|158077586|FG000|Overall Study|Withdrawal of Consent|5|||
49065968|NCT00807248|158077587|FG001|Overall Study|Withdrawal of Consent|5|||
49065969|NCT00807248|158077588|FG002|Overall Study|Withdrawal of Consent|5|||
49065970|NCT00807248|158077589|FG003|Overall Study|Withdrawal of Consent|5|||
49065971|NCT00807248|158077586|FG000|Overall Study|Lost to Follow-up|1|||
49065972|NCT00807248|158077587|FG001|Overall Study|Lost to Follow-up|0|||
49065973|NCT00807248|158077588|FG002|Overall Study|Lost to Follow-up|0|||
49065974|NCT00807248|158077589|FG003|Overall Study|Lost to Follow-up|0|||
49065975|NCT00807248|158077586|FG000|Overall Study|Other Reason|0|||
49065976|NCT00807248|158077587|FG001|Overall Study|Other Reason|0|||
49065977|NCT00807248|158077588|FG002|Overall Study|Other Reason|2|||
49065978|NCT00807248|158077589|FG003|Overall Study|Other Reason|0|||
49065979|NCT02444793|158077590|FG000|Overall Study|Lost to Follow-up|2|||
49065980|NCT02444793|158077591|FG001|Overall Study|Lost to Follow-up|2|||
49065981|NCT02444793|158077592|FG002|Overall Study|Lost to Follow-up|0|||
49065982|NCT02444793|158077593|FG003|Overall Study|Lost to Follow-up|0|||
49065983|NCT02444793|158077590|FG000|Overall Study|Death|0|||
49065984|NCT02444793|158077591|FG001|Overall Study|Death|3|||
49065985|NCT02444793|158077592|FG002|Overall Study|Death|0|||
49065986|NCT02444793|158077593|FG003|Overall Study|Death|0|||
49065987|NCT02444793|158077590|FG000|Overall Study|Other|0|||
49065988|NCT02444793|158077591|FG001|Overall Study|Other|0|||
49065989|NCT02444793|158077592|FG002|Overall Study|Other|2|||
49065990|NCT02444793|158077593|FG003|Overall Study|Other|0|||
49065991|NCT02444793|158077590|FG000|Overall Study|Objective progression or relapse|9|||
49065992|NCT02444793|158077591|FG001|Overall Study|Objective progression or relapse|1|||
49065993|NCT02444793|158077592|FG002|Overall Study|Objective progression or relapse|2|||
49065994|NCT02444793|158077593|FG003|Overall Study|Objective progression or relapse|3|||
49065995|NCT03623386|158077595|FG000|Overall Study|Protocol Violation|3|||
49065996|NCT03623386|158077596|FG001|Overall Study|Protocol Violation|2|||
49065997|NCT03623386|158077597|FG002|Overall Study|Protocol Violation|0|||
49065998|NCT03623386|158077595|FG000|Overall Study|Physician Decision|1|||
49065999|NCT03623386|158077596|FG001|Overall Study|Physician Decision|1|||
49066000|NCT03623386|158077597|FG002|Overall Study|Physician Decision|0|||
49066001|NCT03623386|158077595|FG000|Overall Study|Lost to Follow-up|0|||
49066002|NCT03623386|158077596|FG001|Overall Study|Lost to Follow-up|2|||
49066003|NCT03623386|158077597|FG002|Overall Study|Lost to Follow-up|0|||
49066004|NCT03623386|158077595|FG000|Overall Study|COVID-19|0|||
49066005|NCT03623386|158077596|FG001|Overall Study|COVID-19|1|||
49066006|NCT03623386|158077597|FG002|Overall Study|COVID-19|0|||
49066007|NCT01996332|158077607|FG000|Overall Study|Adverse Event|117|||
49066008|NCT01996332|158077607|FG000|Overall Study|Lack of Efficacy|1245|||
49066009|NCT01996332|158077607|FG000|Overall Study|Death|264|||
49066010|NCT01996332|158077607|FG000|Overall Study|Protocol Violation|9|||
49066011|NCT01996332|158077607|FG000|Overall Study|Withdrawal by Subject|71|||
49066012|NCT01996332|158077607|FG000|Overall Study|Other|20|||
49066013|NCT01996332|158077607|FG000|Overall Study|Clinical Deterioration|28|||
49066014|NCT01996332|158077607|FG000|Overall Study|Physician Decision|17|||
49066015|NCT01996332|158077607|FG000|Overall Study|Lost to Follow-up|34|||
49066016|NCT02504671|158077608|FG000|Overall Study|Withdrawal by Subject|1|||
49066017|NCT02504671|158077609|FG001|Overall Study|Withdrawal by Subject|5|||
49066018|NCT02504671|158077610|FG002|Overall Study|Withdrawal by Subject|4|||
49066019|NCT02504671|158077611|FG003|Overall Study|Withdrawal by Subject|4|||
49066020|NCT02504671|158077612|FG004|Overall Study|Withdrawal by Subject|5|||
49066021|NCT02504671|158077613|FG005|Overall Study|Withdrawal by Subject|3|||
49066022|NCT02504671|158077608|FG000|Overall Study|Lack of Efficacy|1|||
49066023|NCT02504671|158077609|FG001|Overall Study|Lack of Efficacy|3|||
49066024|NCT02504671|158077610|FG002|Overall Study|Lack of Efficacy|1|||
49066025|NCT02504671|158077611|FG003|Overall Study|Lack of Efficacy|0|||
49066026|NCT02504671|158077612|FG004|Overall Study|Lack of Efficacy|4|||
49066027|NCT02504671|158077613|FG005|Overall Study|Lack of Efficacy|4|||
49066028|NCT02504671|158077608|FG000|Overall Study|Adverse Event|1|||
49066029|NCT02504671|158077609|FG001|Overall Study|Adverse Event|1|||
49066030|NCT02504671|158077610|FG002|Overall Study|Adverse Event|0|||
49066031|NCT02504671|158077611|FG003|Overall Study|Adverse Event|1|||
49066032|NCT02504671|158077612|FG004|Overall Study|Adverse Event|0|||
49066033|NCT02504671|158077613|FG005|Overall Study|Adverse Event|2|||
49066034|NCT02504671|158077608|FG000|Overall Study|Protocol Violation|2|||
49066035|NCT02504671|158077609|FG001|Overall Study|Protocol Violation|1|||
49066036|NCT02504671|158077610|FG002|Overall Study|Protocol Violation|0|||
49066037|NCT02504671|158077611|FG003|Overall Study|Protocol Violation|0|||
49066038|NCT02504671|158077612|FG004|Overall Study|Protocol Violation|0|||
49066039|NCT02504671|158077613|FG005|Overall Study|Protocol Violation|1|||
49066040|NCT02504671|158077608|FG000|Overall Study|Lost to Follow-up|0|||
49066041|NCT02504671|158077609|FG001|Overall Study|Lost to Follow-up|0|||
49066042|NCT02504671|158077610|FG002|Overall Study|Lost to Follow-up|2|||
49066043|NCT02504671|158077611|FG003|Overall Study|Lost to Follow-up|0|||
49066044|NCT02504671|158077612|FG004|Overall Study|Lost to Follow-up|0|||
49066045|NCT02504671|158077613|FG005|Overall Study|Lost to Follow-up|1|||
49066046|NCT02504671|158077608|FG000|Overall Study|Protocol defined stopping criteria|7|||
49066047|NCT02504671|158077609|FG001|Overall Study|Protocol defined stopping criteria|4|||
49066048|NCT02504671|158077610|FG002|Overall Study|Protocol defined stopping criteria|3|||
49066049|NCT02504671|158077611|FG003|Overall Study|Protocol defined stopping criteria|5|||
49066050|NCT02504671|158077612|FG004|Overall Study|Protocol defined stopping criteria|3|||
49066051|NCT02504671|158077613|FG005|Overall Study|Protocol defined stopping criteria|3|||
49066052|NCT02113189|158077614|FG000|Overall Study|Lost to follow up|2|||
49066053|NCT02113189|158077615|FG001|Overall Study|Lost to follow up|1|||
49066054|NCT02113189|158077616|FG002|Overall Study|Lost to follow up|3|||
49066055|NCT00210249|158077617|FG000|Overall Study|Lost to Follow-up|5|||
49066056|NCT00210249|158077617|FG000|Overall Study|Protocol Violation|11|||
49066057|NCT03222583|158077618|FG000|Overall Study|Withdrawal by Subject|3|||
49066058|NCT03222583|158077619|FG001|Overall Study|Withdrawal by Subject|3|||
49066059|NCT03222583|158077618|FG000|Overall Study|Lost to Follow-up|1|||
49066060|NCT03222583|158077619|FG001|Overall Study|Lost to Follow-up|0|||
49066061|NCT03222583|158077618|FG000|Overall Study|Other|1|||
49066062|NCT03222583|158077619|FG001|Overall Study|Other|3|||
49066063|NCT04280705|158077620|FG000|Overall Study|Enrolled but not treated|4|||
49066064|NCT04280705|158077621|FG001|Overall Study|Enrolled but not treated|10|||
49066065|NCT04280705|158077620|FG000|Overall Study|Physician Decision|1|||
49066066|NCT04280705|158077621|FG001|Overall Study|Physician Decision|0|||
49066067|NCT04280705|158077620|FG000|Overall Study|Withdrawal by Subject|7|||
49066068|NCT04280705|158077621|FG001|Overall Study|Withdrawal by Subject|9|||
49066069|NCT04280705|158077620|FG000|Overall Study|Adverse Event|0|||
49066070|NCT04280705|158077621|FG001|Overall Study|Adverse Event|4|||
49066071|NCT04280705|158077620|FG000|Overall Study|Transferred to another hospital|1|||
49066072|NCT04280705|158077621|FG001|Overall Study|Transferred to another hospital|1|||
49066073|NCT03573505|158077624|FG000|Overall Study|Adverse Event|1|||
49066074|NCT03573505|158077625|FG001|Overall Study|Adverse Event|1|||
49066075|NCT03573505|158077624|FG000|Overall Study|Consent withdrawn|0|||
49066076|NCT03573505|158077625|FG001|Overall Study|Consent withdrawn|1|||
49066077|NCT03573505|158077624|FG000|Overall Study|Disease progression|0|||
49066078|NCT03573505|158077625|FG001|Overall Study|Disease progression|1|||
49066079|NCT03573505|158077624|FG000|Overall Study|Site Terminated by Sponsor|1|||
49066080|NCT03573505|158077625|FG001|Overall Study|Site Terminated by Sponsor|1|||
49066081|NCT03573505|158077624|FG000|Overall Study|Study terminated by sponsor|50|||
49066082|NCT03573505|158077625|FG001|Overall Study|Study terminated by sponsor|45|||
49066083|NCT03573505|158077624|FG000|Overall Study|Reason not specified|0|||
49066084|NCT03573505|158077625|FG001|Overall Study|Reason not specified|1|||
49066085|NCT03573505|158077624|FG000|Overall Study|Death|0|||
49066086|NCT03573505|158077625|FG001|Overall Study|Death|4|||
49066087|NCT04078126|158077628|FG000|Washout|Study put on hold due to COVID-19|0|||
49066088|NCT04078126|158077629|FG001|Washout|Study put on hold due to COVID-19|2|||
49066089|NCT04078126|158077628|FG000|Period 2|Study put on hold due to COVID-19|1|||
49066090|NCT04078126|158077629|FG001|Period 2|Study put on hold due to COVID-19|1|||
49066091|NCT00806286|158077630|FG000|Overall Study|Adverse Event|5|||
49066092|NCT00806286|158077631|FG001|Overall Study|Adverse Event|2|||
49066093|NCT00806286|158077632|FG002|Overall Study|Adverse Event|0|||
49066094|NCT00806286|158077630|FG000|Overall Study|Disease progression|31|||
49066095|NCT00806286|158077631|FG001|Overall Study|Disease progression|38|||
49066096|NCT00806286|158077632|FG002|Overall Study|Disease progression|1|||
49066097|NCT00806286|158077630|FG000|Overall Study|Death|1|||
49066098|NCT00806286|158077631|FG001|Overall Study|Death|6|||
49066099|NCT00806286|158077632|FG002|Overall Study|Death|0|||
49066100|NCT00806286|158077630|FG000|Overall Study|Lost to Follow-up|0|||
49066101|NCT00806286|158077631|FG001|Overall Study|Lost to Follow-up|1|||
49066102|NCT00806286|158077632|FG002|Overall Study|Lost to Follow-up|0|||
49066103|NCT00806286|158077630|FG000|Overall Study|Withdrawal by Subject|8|||
49066104|NCT00806286|158077631|FG001|Overall Study|Withdrawal by Subject|3|||
49066105|NCT00806286|158077632|FG002|Overall Study|Withdrawal by Subject|1|||
49066106|NCT00806286|158077630|FG000|Overall Study|Physician Decision|2|||
49066107|NCT00806286|158077631|FG001|Overall Study|Physician Decision|2|||
49066108|NCT00806286|158077632|FG002|Overall Study|Physician Decision|0|||
49066109|NCT00806286|158077630|FG000|Overall Study|Due to a variety of reasons|7|||
49066110|NCT00806286|158077631|FG001|Overall Study|Due to a variety of reasons|2|||
49066111|NCT00806286|158077632|FG002|Overall Study|Due to a variety of reasons|1|||
49066112|NCT02628743|158077635|FG000|Overall Study|Other|3|||
49066113|NCT02628743|158077635|FG000|Overall Study|Withdrawal by Subject|50|||
49066114|NCT02628743|158077635|FG000|Overall Study|Study Terminated by Sponsor|76|||
49066115|NCT02628743|158077635|FG000|Overall Study|Physician Decision|2|||
49066116|NCT02981303|158077636|FG000|Overall Study|Progressive Disease|17|||
49066117|NCT02981303|158077637|FG001|Overall Study|Progressive Disease|37|||
49066118|NCT02981303|158077636|FG000|Overall Study|Adverse Event|1|||
49066119|NCT02981303|158077637|FG001|Overall Study|Adverse Event|4|||
49066120|NCT02981303|158077636|FG000|Overall Study|Withdrawal by Subject|0|||
49066121|NCT02981303|158077637|FG001|Overall Study|Withdrawal by Subject|1|||
49066122|NCT02932306|158077638|FG000|Overall Study|Withdrawal by Subject|16|||
49066123|NCT02932306|158077639|FG001|Overall Study|Withdrawal by Subject|25|||
49066124|NCT02932306|158077638|FG000|Overall Study|Adverse Event|3|||
49066125|NCT02932306|158077639|FG001|Overall Study|Adverse Event|0|||
49066126|NCT02932306|158077638|FG000|Overall Study|Pregnancy|2|||
49066127|NCT02932306|158077639|FG001|Overall Study|Pregnancy|0|||
49066128|NCT02932306|158077638|FG000|Overall Study|Protocol Violation|1|||
49066129|NCT02932306|158077639|FG001|Overall Study|Protocol Violation|1|||
49066130|NCT02932306|158077638|FG000|Overall Study|Noncompliance with Study Drug|1|||
49066131|NCT02932306|158077639|FG001|Overall Study|Noncompliance with Study Drug|1|||
49066132|NCT02932306|158077638|FG000|Overall Study|Lost to Follow-up|36|||
49066133|NCT02932306|158077639|FG001|Overall Study|Lost to Follow-up|40|||
49066134|NCT02932306|158077638|FG000|Overall Study|Withdrawal by Parent or Guardian|6|||
49066135|NCT02932306|158077639|FG001|Overall Study|Withdrawal by Parent or Guardian|8|||
49066136|NCT02932306|158077638|FG000|Overall Study|Lack of Efficacy|0|||
49066137|NCT02932306|158077639|FG001|Overall Study|Lack of Efficacy|2|||
49066138|NCT02932306|158077638|FG000|Overall Study|Worsening condition|2|||
49066139|NCT02932306|158077639|FG001|Overall Study|Worsening condition|0|||
49066140|NCT02932306|158077638|FG000|Overall Study|Withdrew due to burning,itching,stinging|1|||
49066141|NCT02932306|158077639|FG001|Overall Study|Withdrew due to burning,itching,stinging|0|||
49066142|NCT00686075|158077640|FG000|Overall Study|Withdrawal by Subject|4|||
49066143|NCT00686075|158077641|FG001|Overall Study|Withdrawal by Subject|3|||
49066144|NCT00686075|158077642|FG002|Overall Study|Withdrawal by Subject|3|||
49066145|NCT00686075|158077643|FG003|Overall Study|Withdrawal by Subject|7|||
49066146|NCT00686075|158077644|FG004|Overall Study|Withdrawal by Subject|1|||
49066147|NCT00686075|158077645|FG005|Overall Study|Withdrawal by Subject|0|||
49066148|NCT00686075|158077646|FG006|Overall Study|Withdrawal by Subject|0|||
49066149|NCT00686075|158077647|FG007|Overall Study|Withdrawal by Subject|2|||
49066150|NCT00686075|158077648|FG008|Overall Study|Withdrawal by Subject|4|||
49066151|NCT00686075|158077649|FG009|Overall Study|Withdrawal by Subject|6|||
49066152|NCT00686075|158077640|FG000|Overall Study|Lost to Follow-up|3|||
49066153|NCT00686075|158077641|FG001|Overall Study|Lost to Follow-up|6|||
49066154|NCT00686075|158077642|FG002|Overall Study|Lost to Follow-up|3|||
49066155|NCT00686075|158077643|FG003|Overall Study|Lost to Follow-up|2|||
49066156|NCT00686075|158077644|FG004|Overall Study|Lost to Follow-up|3|||
49066157|NCT00686075|158077645|FG005|Overall Study|Lost to Follow-up|3|||
49066158|NCT00686075|158077646|FG006|Overall Study|Lost to Follow-up|0|||
49066159|NCT00686075|158077647|FG007|Overall Study|Lost to Follow-up|0|||
49066160|NCT00686075|158077648|FG008|Overall Study|Lost to Follow-up|2|||
49066161|NCT00686075|158077649|FG009|Overall Study|Lost to Follow-up|3|||
49066162|NCT00686075|158077640|FG000|Overall Study|Other|1|||
49066163|NCT00686075|158077641|FG001|Overall Study|Other|1|||
49066164|NCT00686075|158077642|FG002|Overall Study|Other|0|||
49066165|NCT00686075|158077643|FG003|Overall Study|Other|0|||
49066166|NCT00686075|158077644|FG004|Overall Study|Other|0|||
49066167|NCT00686075|158077645|FG005|Overall Study|Other|0|||
49066168|NCT00686075|158077646|FG006|Overall Study|Other|0|||
49066169|NCT00686075|158077647|FG007|Overall Study|Other|0|||
49066170|NCT00686075|158077648|FG008|Overall Study|Other|0|||
49066171|NCT00686075|158077649|FG009|Overall Study|Other|1|||
49066172|NCT02325518|158077650|FG000|Overall Study|Adverse Event|4|||
49066173|NCT02325518|158077651|FG001|Overall Study|Adverse Event|1|||
49066174|NCT02325518|158077650|FG000|Overall Study|Physician Decision|0|||
49066175|NCT02325518|158077651|FG001|Overall Study|Physician Decision|1|||
49066176|NCT02325518|158077650|FG000|Overall Study|Withdrawal by Subject|0|||
49066177|NCT02325518|158077651|FG001|Overall Study|Withdrawal by Subject|1|||
49066178|NCT04715932|158077652|FG000|Overall Study|Lost to Follow-up|1|||
49066179|NCT04715932|158077653|FG001|Overall Study|Lost to Follow-up|0|||
49066180|NCT02740699|158077667|FG000|Overall Study|Lost to Follow-up|5|||
49066181|NCT02740699|158077667|FG000|Overall Study|Withdrawal by Subject|14|||
49066182|NCT02740699|158077667|FG000|Overall Study|Physician Decision|5|||
49066183|NCT03393806|158077668|FG000|Overall Study|Physician Decision|1|||
49066184|NCT03393806|158077669|FG001|Overall Study|Physician Decision|0|||
49066185|NCT01259115|158077670|FG000|Period 1|Adverse Event|1|||
49066186|NCT01259115|158077671|FG001|Period 1|Adverse Event|0|||
49066187|NCT01259115|158077670|FG000|Period 1|Protocol Violation|2|||
49066188|NCT01259115|158077671|FG001|Period 1|Protocol Violation|0|||
49066189|NCT01259115|158077670|FG000|Period 1|Lost to Follow-up|0|||
49066190|NCT01259115|158077671|FG001|Period 1|Lost to Follow-up|1|||
49066191|NCT01259115|158077670|FG000|Period 2|Adverse Event|1|||
49066192|NCT01259115|158077671|FG001|Period 2|Adverse Event|0|||
49066193|NCT01675661|158077672|FG000|Overall Study|Lost to Follow-up|22|||
49066194|NCT01675661|158077673|FG001|Overall Study|Lost to Follow-up|23|||
49066195|NCT01675661|158077672|FG000|Overall Study|Practical problems|9|||
49066196|NCT01675661|158077673|FG001|Overall Study|Practical problems|5|||
49066197|NCT01675661|158077672|FG000|Overall Study|Moved away|5|||
49066198|NCT01675661|158077673|FG001|Overall Study|Moved away|6|||
49066199|NCT01675661|158077672|FG000|Overall Study|Withdrawal by Subject|3|||
49066200|NCT01675661|158077673|FG001|Overall Study|Withdrawal by Subject|7|||
49066201|NCT01675661|158077672|FG000|Overall Study|Physician Decision|0|||
49066202|NCT01675661|158077673|FG001|Overall Study|Physician Decision|2|||
49066203|NCT01675661|158077672|FG000|Overall Study|Death|0|||
49066204|NCT01675661|158077673|FG001|Overall Study|Death|1|||
49066205|NCT01675661|158077672|FG000|Overall Study|Other reason|1|||
49066206|NCT01675661|158077673|FG001|Overall Study|Other reason|2|||
49066207|NCT02534844|158077674|FG000|Part B|Withdrawal by Subject|0|||
49066208|NCT02534844|158077675|FG001|Part B|Withdrawal by Subject|0|||
49066209|NCT02534844|158077676|FG002|Part B|Withdrawal by Subject|0|||
49066210|NCT02534844|158077677|FG003|Part B|Withdrawal by Subject|0|||
49066211|NCT02534844|158077678|FG004|Part B|Withdrawal by Subject|2|||
49066212|NCT02534844|158077679|FG005|Part B|Withdrawal by Subject|1|||
49066213|NCT02393248|158077680|FG000|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
49066214|NCT02393248|158077681|FG001|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
49066215|NCT02393248|158077682|FG002|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
49066216|NCT02393248|158077683|FG003|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
49066217|NCT02393248|158077684|FG004|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
49066218|NCT02393248|158077685|FG005|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
49066219|NCT02393248|158077686|FG006|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
49066220|NCT02393248|158077687|FG007|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
49066221|NCT02393248|158077688|FG008|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
49066222|NCT02393248|158077689|FG009|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
49066223|NCT02393248|158077690|FG010|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
49066224|NCT02393248|158077691|FG011|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
49066225|NCT02393248|158077692|FG012|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
49066226|NCT02393248|158077693|FG013|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
49066227|NCT02393248|158077694|FG014|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
49066228|NCT02393248|158077695|FG015|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
49066229|NCT02393248|158077696|FG016|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
49066230|NCT02393248|158077697|FG017|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
49066231|NCT02393248|158077698|FG018|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
49066232|NCT02393248|158077699|FG019|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
49066233|NCT02393248|158077700|FG020|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
49066234|NCT02393248|158077701|FG021|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
49066235|NCT02393248|158077702|FG022|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
49066236|NCT02393248|158077703|FG023|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
49066237|NCT02393248|158077704|FG024|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
49066238|NCT02393248|158077680|FG000|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
49066239|NCT02393248|158077681|FG001|Part 1: Monotherapy Dose Escalation|Disease Progression|1|||
49066240|NCT02393248|158077682|FG002|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
49066241|NCT02393248|158077683|FG003|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
49066242|NCT02393248|158077684|FG004|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
49066243|NCT02393248|158077685|FG005|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
49066244|NCT02393248|158077686|FG006|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
49066245|NCT02393248|158077687|FG007|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
49066246|NCT02393248|158077688|FG008|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
49066247|NCT02393248|158077689|FG009|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
49066248|NCT02393248|158077690|FG010|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
49066249|NCT02393248|158077691|FG011|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
49066250|NCT02393248|158077692|FG012|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
49066251|NCT02393248|158077693|FG013|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
49066252|NCT02393248|158077694|FG014|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
49066253|NCT02393248|158077695|FG015|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
49066254|NCT02393248|158077696|FG016|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
49066255|NCT02393248|158077697|FG017|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
49066256|NCT02393248|158077698|FG018|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
49066257|NCT02393248|158077699|FG019|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
49066258|NCT02393248|158077700|FG020|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
49066259|NCT02393248|158077701|FG021|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
49066260|NCT02393248|158077702|FG022|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
49066261|NCT02393248|158077703|FG023|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
49066262|NCT02393248|158077704|FG024|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
49066263|NCT02393248|158077680|FG000|Part 1: Monotherapy Dose Escalation|Death|2|||
49066264|NCT02393248|158077681|FG001|Part 1: Monotherapy Dose Escalation|Death|2|||
49066265|NCT02393248|158077682|FG002|Part 1: Monotherapy Dose Escalation|Death|3|||
49066266|NCT02393248|158077683|FG003|Part 1: Monotherapy Dose Escalation|Death|6|||
49066267|NCT02393248|158077684|FG004|Part 1: Monotherapy Dose Escalation|Death|6|||
49066268|NCT02393248|158077685|FG005|Part 1: Monotherapy Dose Escalation|Death|6|||
49066269|NCT02393248|158077686|FG006|Part 1: Monotherapy Dose Escalation|Death|5|||
49066270|NCT02393248|158077687|FG007|Part 1: Monotherapy Dose Escalation|Death|8|||
49066271|NCT02393248|158077688|FG008|Part 1: Monotherapy Dose Escalation|Death|4|||
49066272|NCT02393248|158077689|FG009|Part 1: Monotherapy Dose Escalation|Death|2|||
49066273|NCT02393248|158077690|FG010|Part 1: Monotherapy Dose Escalation|Death|0|||
49066274|NCT02393248|158077691|FG011|Part 1: Monotherapy Dose Escalation|Death|0|||
49066275|NCT02393248|158077692|FG012|Part 1: Monotherapy Dose Escalation|Death|0|||
49066276|NCT02393248|158077693|FG013|Part 1: Monotherapy Dose Escalation|Death|0|||
49066277|NCT02393248|158077694|FG014|Part 1: Monotherapy Dose Escalation|Death|0|||
49066278|NCT02393248|158077695|FG015|Part 1: Monotherapy Dose Escalation|Death|0|||
49066279|NCT02393248|158077696|FG016|Part 1: Monotherapy Dose Escalation|Death|0|||
49066280|NCT02393248|158077697|FG017|Part 1: Monotherapy Dose Escalation|Death|0|||
49066281|NCT02393248|158077698|FG018|Part 1: Monotherapy Dose Escalation|Death|0|||
49066282|NCT02393248|158077699|FG019|Part 1: Monotherapy Dose Escalation|Death|0|||
49066283|NCT02393248|158077700|FG020|Part 1: Monotherapy Dose Escalation|Death|0|||
49066284|NCT02393248|158077701|FG021|Part 1: Monotherapy Dose Escalation|Death|0|||
49066285|NCT02393248|158077702|FG022|Part 1: Monotherapy Dose Escalation|Death|0|||
49066286|NCT02393248|158077703|FG023|Part 1: Monotherapy Dose Escalation|Death|0|||
49066287|NCT02393248|158077704|FG024|Part 1: Monotherapy Dose Escalation|Death|0|||
49066288|NCT02393248|158077680|FG000|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|1|||
49066289|NCT02393248|158077681|FG001|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
49066290|NCT02393248|158077682|FG002|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
49066291|NCT02393248|158077683|FG003|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
49066292|NCT02393248|158077684|FG004|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
49066293|NCT02393248|158077685|FG005|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
49066294|NCT02393248|158077686|FG006|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
49066295|NCT02393248|158077687|FG007|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
49066296|NCT02393248|158077688|FG008|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
49066297|NCT02393248|158077689|FG009|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
49066298|NCT02393248|158077690|FG010|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
49066299|NCT02393248|158077691|FG011|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
49066300|NCT02393248|158077692|FG012|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
49066301|NCT02393248|158077693|FG013|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
49066302|NCT02393248|158077694|FG014|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
49066303|NCT02393248|158077695|FG015|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
49066304|NCT02393248|158077696|FG016|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
49066305|NCT02393248|158077697|FG017|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
49066306|NCT02393248|158077698|FG018|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
49066307|NCT02393248|158077699|FG019|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
49066308|NCT02393248|158077700|FG020|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
49066309|NCT02393248|158077701|FG021|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
49066310|NCT02393248|158077702|FG022|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
49066311|NCT02393248|158077703|FG023|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
49066312|NCT02393248|158077704|FG024|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
49066313|NCT02393248|158077680|FG000|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
49066314|NCT02393248|158077681|FG001|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
49066315|NCT02393248|158077682|FG002|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
49066316|NCT02393248|158077683|FG003|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
49066317|NCT02393248|158077684|FG004|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
49066318|NCT02393248|158077685|FG005|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
49066319|NCT02393248|158077686|FG006|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
49066320|NCT02393248|158077687|FG007|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
49066321|NCT02393248|158077688|FG008|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
49066322|NCT02393248|158077689|FG009|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|1|||
49066323|NCT02393248|158077690|FG010|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
49066324|NCT02393248|158077691|FG011|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
49066325|NCT02393248|158077692|FG012|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
49066326|NCT02393248|158077693|FG013|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
49066327|NCT02393248|158077694|FG014|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
49066328|NCT02393248|158077695|FG015|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
49066329|NCT02393248|158077696|FG016|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
49066330|NCT02393248|158077697|FG017|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
49066331|NCT02393248|158077698|FG018|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
49066332|NCT02393248|158077699|FG019|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
49066333|NCT02393248|158077700|FG020|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
49066334|NCT02393248|158077701|FG021|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
49066335|NCT02393248|158077702|FG022|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
49066336|NCT02393248|158077703|FG023|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
49066337|NCT02393248|158077704|FG024|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
49066338|NCT02393248|158077680|FG000|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
49066339|NCT02393248|158077681|FG001|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
49066340|NCT02393248|158077682|FG002|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
49066341|NCT02393248|158077683|FG003|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
49066342|NCT02393248|158077684|FG004|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
49066343|NCT02393248|158077685|FG005|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
49066344|NCT02393248|158077686|FG006|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|1|||
49066345|NCT02393248|158077687|FG007|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
49066346|NCT02393248|158077688|FG008|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
49066347|NCT02393248|158077689|FG009|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
49066348|NCT02393248|158077690|FG010|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
49066349|NCT02393248|158077691|FG011|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
49066350|NCT02393248|158077692|FG012|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
49066351|NCT02393248|158077693|FG013|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
49066352|NCT02393248|158077694|FG014|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
49066353|NCT02393248|158077695|FG015|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
49066354|NCT02393248|158077696|FG016|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
49066355|NCT02393248|158077697|FG017|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
49066356|NCT02393248|158077698|FG018|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
49066357|NCT02393248|158077699|FG019|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
49066358|NCT02393248|158077700|FG020|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
49066359|NCT02393248|158077701|FG021|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
49066360|NCT02393248|158077702|FG022|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
49066361|NCT02393248|158077703|FG023|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
49066362|NCT02393248|158077704|FG024|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
49066363|NCT02393248|158077680|FG000|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
49066364|NCT02393248|158077681|FG001|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
49066365|NCT02393248|158077682|FG002|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
49066366|NCT02393248|158077683|FG003|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
49066367|NCT02393248|158077684|FG004|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
49066368|NCT02393248|158077685|FG005|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
49066369|NCT02393248|158077686|FG006|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
49066370|NCT02393248|158077687|FG007|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
49066371|NCT02393248|158077688|FG008|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
49066372|NCT02393248|158077689|FG009|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
49066373|NCT02393248|158077690|FG010|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
49066374|NCT02393248|158077691|FG011|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|13|||
49066375|NCT02393248|158077692|FG012|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|1|||
49066376|NCT02393248|158077693|FG013|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|2|||
49066377|NCT02393248|158077694|FG014|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|3|||
49066378|NCT02393248|158077695|FG015|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
49066379|NCT02393248|158077696|FG016|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
49066380|NCT02393248|158077697|FG017|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
49066381|NCT02393248|158077698|FG018|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
49066382|NCT02393248|158077699|FG019|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
49066383|NCT02393248|158077700|FG020|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
49066384|NCT02393248|158077701|FG021|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
49066385|NCT02393248|158077702|FG022|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
49066386|NCT02393248|158077703|FG023|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
49066387|NCT02393248|158077704|FG024|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
49066388|NCT02393248|158077680|FG000|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
49066389|NCT02393248|158077681|FG001|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
49066390|NCT02393248|158077682|FG002|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
49066391|NCT02393248|158077683|FG003|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
49066392|NCT02393248|158077684|FG004|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
49066393|NCT02393248|158077685|FG005|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
49066394|NCT02393248|158077686|FG006|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
49066395|NCT02393248|158077687|FG007|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
49066396|NCT02393248|158077688|FG008|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
49066397|NCT02393248|158077689|FG009|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
49066398|NCT02393248|158077690|FG010|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
49066399|NCT02393248|158077691|FG011|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
49066400|NCT02393248|158077692|FG012|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
49066401|NCT02393248|158077693|FG013|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
49066402|NCT02393248|158077694|FG014|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
49066403|NCT02393248|158077695|FG015|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
49066404|NCT02393248|158077696|FG016|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
49066405|NCT02393248|158077697|FG017|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
49066406|NCT02393248|158077698|FG018|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
49066407|NCT02393248|158077699|FG019|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
49066408|NCT02393248|158077700|FG020|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
49066409|NCT02393248|158077701|FG021|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
49066410|NCT02393248|158077702|FG022|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
49066411|NCT02393248|158077703|FG023|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
49066412|NCT02393248|158077704|FG024|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
49066413|NCT02393248|158077680|FG000|Part 2: Monotherapy Dose Expansion|Death|0|||
49066414|NCT02393248|158077681|FG001|Part 2: Monotherapy Dose Expansion|Death|0|||
49066415|NCT02393248|158077682|FG002|Part 2: Monotherapy Dose Expansion|Death|0|||
49066416|NCT02393248|158077683|FG003|Part 2: Monotherapy Dose Expansion|Death|0|||
49066417|NCT02393248|158077684|FG004|Part 2: Monotherapy Dose Expansion|Death|0|||
49066418|NCT02393248|158077685|FG005|Part 2: Monotherapy Dose Expansion|Death|0|||
49066419|NCT02393248|158077686|FG006|Part 2: Monotherapy Dose Expansion|Death|0|||
49066420|NCT02393248|158077687|FG007|Part 2: Monotherapy Dose Expansion|Death|0|||
49066421|NCT02393248|158077688|FG008|Part 2: Monotherapy Dose Expansion|Death|0|||
49066422|NCT02393248|158077689|FG009|Part 2: Monotherapy Dose Expansion|Death|0|||
49066423|NCT02393248|158077690|FG010|Part 2: Monotherapy Dose Expansion|Death|3|||
49066424|NCT02393248|158077691|FG011|Part 2: Monotherapy Dose Expansion|Death|29|||
49066425|NCT02393248|158077692|FG012|Part 2: Monotherapy Dose Expansion|Death|4|||
49066426|NCT02393248|158077693|FG013|Part 2: Monotherapy Dose Expansion|Death|15|||
49066427|NCT02393248|158077694|FG014|Part 2: Monotherapy Dose Expansion|Death|2|||
49066428|NCT02393248|158077695|FG015|Part 2: Monotherapy Dose Expansion|Death|0|||
49066429|NCT02393248|158077696|FG016|Part 2: Monotherapy Dose Expansion|Death|0|||
49066430|NCT02393248|158077697|FG017|Part 2: Monotherapy Dose Expansion|Death|0|||
49066431|NCT02393248|158077698|FG018|Part 2: Monotherapy Dose Expansion|Death|0|||
49066432|NCT02393248|158077699|FG019|Part 2: Monotherapy Dose Expansion|Death|0|||
49066433|NCT02393248|158077700|FG020|Part 2: Monotherapy Dose Expansion|Death|0|||
49066434|NCT02393248|158077701|FG021|Part 2: Monotherapy Dose Expansion|Death|0|||
49066435|NCT02393248|158077702|FG022|Part 2: Monotherapy Dose Expansion|Death|0|||
49066436|NCT02393248|158077703|FG023|Part 2: Monotherapy Dose Expansion|Death|0|||
49066437|NCT02393248|158077704|FG024|Part 2: Monotherapy Dose Expansion|Death|0|||
49066438|NCT02393248|158077680|FG000|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
49066439|NCT02393248|158077681|FG001|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
49066440|NCT02393248|158077682|FG002|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
49066441|NCT02393248|158077683|FG003|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
49066442|NCT02393248|158077684|FG004|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
49066443|NCT02393248|158077685|FG005|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
49066444|NCT02393248|158077686|FG006|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
49066445|NCT02393248|158077687|FG007|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
49066446|NCT02393248|158077688|FG008|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
49066447|NCT02393248|158077689|FG009|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
49066448|NCT02393248|158077690|FG010|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
49066449|NCT02393248|158077691|FG011|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|1|||
49066450|NCT02393248|158077692|FG012|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
49066451|NCT02393248|158077693|FG013|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|3|||
49066452|NCT02393248|158077694|FG014|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
49066453|NCT02393248|158077695|FG015|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
49066454|NCT02393248|158077696|FG016|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
49066455|NCT02393248|158077697|FG017|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
49066456|NCT02393248|158077698|FG018|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
49066457|NCT02393248|158077699|FG019|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
49066458|NCT02393248|158077700|FG020|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
49066459|NCT02393248|158077701|FG021|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
49066460|NCT02393248|158077702|FG022|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
49066461|NCT02393248|158077703|FG023|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
49066462|NCT02393248|158077704|FG024|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
49066463|NCT02393248|158077680|FG000|Part 3: Combination Therapy|Withdrawal by Subject|0|||
49066464|NCT02393248|158077681|FG001|Part 3: Combination Therapy|Withdrawal by Subject|0|||
49066465|NCT02393248|158077682|FG002|Part 3: Combination Therapy|Withdrawal by Subject|0|||
49066466|NCT02393248|158077683|FG003|Part 3: Combination Therapy|Withdrawal by Subject|0|||
49066467|NCT02393248|158077684|FG004|Part 3: Combination Therapy|Withdrawal by Subject|0|||
49066468|NCT02393248|158077685|FG005|Part 3: Combination Therapy|Withdrawal by Subject|0|||
49066469|NCT02393248|158077686|FG006|Part 3: Combination Therapy|Withdrawal by Subject|0|||
49066470|NCT02393248|158077687|FG007|Part 3: Combination Therapy|Withdrawal by Subject|0|||
49066471|NCT02393248|158077688|FG008|Part 3: Combination Therapy|Withdrawal by Subject|0|||
49066472|NCT02393248|158077689|FG009|Part 3: Combination Therapy|Withdrawal by Subject|0|||
49066473|NCT02393248|158077690|FG010|Part 3: Combination Therapy|Withdrawal by Subject|0|||
49066474|NCT02393248|158077691|FG011|Part 3: Combination Therapy|Withdrawal by Subject|0|||
49066475|NCT02393248|158077692|FG012|Part 3: Combination Therapy|Withdrawal by Subject|0|||
49066476|NCT02393248|158077693|FG013|Part 3: Combination Therapy|Withdrawal by Subject|0|||
49066477|NCT02393248|158077694|FG014|Part 3: Combination Therapy|Withdrawal by Subject|0|||
49066478|NCT02393248|158077695|FG015|Part 3: Combination Therapy|Withdrawal by Subject|0|||
49066479|NCT02393248|158077696|FG016|Part 3: Combination Therapy|Withdrawal by Subject|0|||
49066480|NCT02393248|158077697|FG017|Part 3: Combination Therapy|Withdrawal by Subject|0|||
49066481|NCT02393248|158077698|FG018|Part 3: Combination Therapy|Withdrawal by Subject|1|||
49066482|NCT02393248|158077699|FG019|Part 3: Combination Therapy|Withdrawal by Subject|0|||
49066483|NCT02393248|158077700|FG020|Part 3: Combination Therapy|Withdrawal by Subject|2|||
49066484|NCT02393248|158077701|FG021|Part 3: Combination Therapy|Withdrawal by Subject|1|||
49066485|NCT02393248|158077702|FG022|Part 3: Combination Therapy|Withdrawal by Subject|0|||
49066486|NCT02393248|158077703|FG023|Part 3: Combination Therapy|Withdrawal by Subject|1|||
49066487|NCT02393248|158077704|FG024|Part 3: Combination Therapy|Withdrawal by Subject|0|||
49066488|NCT02393248|158077680|FG000|Part 3: Combination Therapy|Death|0|||
49066489|NCT02393248|158077681|FG001|Part 3: Combination Therapy|Death|0|||
49066490|NCT02393248|158077682|FG002|Part 3: Combination Therapy|Death|0|||
49066491|NCT02393248|158077683|FG003|Part 3: Combination Therapy|Death|0|||
49066492|NCT02393248|158077684|FG004|Part 3: Combination Therapy|Death|0|||
49066493|NCT02393248|158077685|FG005|Part 3: Combination Therapy|Death|0|||
49066494|NCT02393248|158077686|FG006|Part 3: Combination Therapy|Death|0|||
49066495|NCT02393248|158077687|FG007|Part 3: Combination Therapy|Death|0|||
49066496|NCT02393248|158077688|FG008|Part 3: Combination Therapy|Death|0|||
49066497|NCT02393248|158077689|FG009|Part 3: Combination Therapy|Death|0|||
49066498|NCT02393248|158077690|FG010|Part 3: Combination Therapy|Death|0|||
49066499|NCT02393248|158077691|FG011|Part 3: Combination Therapy|Death|0|||
49066500|NCT02393248|158077692|FG012|Part 3: Combination Therapy|Death|0|||
49066501|NCT02393248|158077693|FG013|Part 3: Combination Therapy|Death|0|||
49066502|NCT02393248|158077694|FG014|Part 3: Combination Therapy|Death|0|||
49066503|NCT02393248|158077695|FG015|Part 3: Combination Therapy|Death|1|||
49066504|NCT02393248|158077696|FG016|Part 3: Combination Therapy|Death|7|||
49066505|NCT02393248|158077697|FG017|Part 3: Combination Therapy|Death|5|||
49066506|NCT02393248|158077698|FG018|Part 3: Combination Therapy|Death|5|||
49066507|NCT02393248|158077699|FG019|Part 3: Combination Therapy|Death|3|||
49066508|NCT02393248|158077700|FG020|Part 3: Combination Therapy|Death|7|||
49066509|NCT02393248|158077701|FG021|Part 3: Combination Therapy|Death|5|||
49066510|NCT02393248|158077702|FG022|Part 3: Combination Therapy|Death|6|||
49066511|NCT02393248|158077703|FG023|Part 3: Combination Therapy|Death|3|||
49066512|NCT02393248|158077704|FG024|Part 3: Combination Therapy|Death|0|||
49066513|NCT02393248|158077680|FG000|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
49066514|NCT02393248|158077681|FG001|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
49066515|NCT02393248|158077682|FG002|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
49066516|NCT02393248|158077683|FG003|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
49066517|NCT02393248|158077684|FG004|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
49066518|NCT02393248|158077685|FG005|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
49066519|NCT02393248|158077686|FG006|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
49066520|NCT02393248|158077687|FG007|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
49066521|NCT02393248|158077688|FG008|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
49066522|NCT02393248|158077689|FG009|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
49066523|NCT02393248|158077690|FG010|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
49066524|NCT02393248|158077691|FG011|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
49066525|NCT02393248|158077692|FG012|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
49066526|NCT02393248|158077693|FG013|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
49066527|NCT02393248|158077694|FG014|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
49066528|NCT02393248|158077695|FG015|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
49066529|NCT02393248|158077696|FG016|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
49066530|NCT02393248|158077697|FG017|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
49066531|NCT02393248|158077698|FG018|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
49066532|NCT02393248|158077699|FG019|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
49066533|NCT02393248|158077700|FG020|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
49066534|NCT02393248|158077701|FG021|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
49066535|NCT02393248|158077702|FG022|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
49066536|NCT02393248|158077703|FG023|Part 3: Combination Therapy|Study Terminated by Sponsor|2|||
49066537|NCT02393248|158077704|FG024|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
49066538|NCT02393248|158077680|FG000|Part 3: Combination Therapy|Disease Progression|0|||
49066539|NCT02393248|158077681|FG001|Part 3: Combination Therapy|Disease Progression|0|||
49066540|NCT02393248|158077682|FG002|Part 3: Combination Therapy|Disease Progression|0|||
49066541|NCT02393248|158077683|FG003|Part 3: Combination Therapy|Disease Progression|0|||
49066542|NCT02393248|158077684|FG004|Part 3: Combination Therapy|Disease Progression|0|||
49066543|NCT02393248|158077685|FG005|Part 3: Combination Therapy|Disease Progression|0|||
49066544|NCT02393248|158077686|FG006|Part 3: Combination Therapy|Disease Progression|0|||
49066545|NCT02393248|158077687|FG007|Part 3: Combination Therapy|Disease Progression|0|||
49066546|NCT02393248|158077688|FG008|Part 3: Combination Therapy|Disease Progression|0|||
49066547|NCT02393248|158077689|FG009|Part 3: Combination Therapy|Disease Progression|0|||
49066548|NCT02393248|158077690|FG010|Part 3: Combination Therapy|Disease Progression|0|||
49066549|NCT02393248|158077691|FG011|Part 3: Combination Therapy|Disease Progression|0|||
49066550|NCT02393248|158077692|FG012|Part 3: Combination Therapy|Disease Progression|0|||
49066551|NCT02393248|158077693|FG013|Part 3: Combination Therapy|Disease Progression|0|||
49066552|NCT02393248|158077694|FG014|Part 3: Combination Therapy|Disease Progression|0|||
49066553|NCT02393248|158077695|FG015|Part 3: Combination Therapy|Disease Progression|0|||
49066554|NCT02393248|158077696|FG016|Part 3: Combination Therapy|Disease Progression|0|||
49066555|NCT02393248|158077697|FG017|Part 3: Combination Therapy|Disease Progression|0|||
49066556|NCT02393248|158077698|FG018|Part 3: Combination Therapy|Disease Progression|0|||
49066557|NCT02393248|158077699|FG019|Part 3: Combination Therapy|Disease Progression|0|||
49066558|NCT02393248|158077700|FG020|Part 3: Combination Therapy|Disease Progression|2|||
49066559|NCT02393248|158077701|FG021|Part 3: Combination Therapy|Disease Progression|1|||
49066560|NCT02393248|158077702|FG022|Part 3: Combination Therapy|Disease Progression|0|||
49066561|NCT02393248|158077703|FG023|Part 3: Combination Therapy|Disease Progression|0|||
49066562|NCT02393248|158077704|FG024|Part 3: Combination Therapy|Disease Progression|0|||
49066563|NCT02393248|158077680|FG000|Part 3: Combination Therapy|Lost to Follow-up|0|||
49066564|NCT02393248|158077681|FG001|Part 3: Combination Therapy|Lost to Follow-up|0|||
49066565|NCT02393248|158077682|FG002|Part 3: Combination Therapy|Lost to Follow-up|0|||
49066566|NCT02393248|158077683|FG003|Part 3: Combination Therapy|Lost to Follow-up|0|||
49066567|NCT02393248|158077684|FG004|Part 3: Combination Therapy|Lost to Follow-up|0|||
49066568|NCT02393248|158077685|FG005|Part 3: Combination Therapy|Lost to Follow-up|0|||
49066569|NCT02393248|158077686|FG006|Part 3: Combination Therapy|Lost to Follow-up|0|||
49066570|NCT02393248|158077687|FG007|Part 3: Combination Therapy|Lost to Follow-up|0|||
49066571|NCT02393248|158077688|FG008|Part 3: Combination Therapy|Lost to Follow-up|0|||
49066572|NCT02393248|158077689|FG009|Part 3: Combination Therapy|Lost to Follow-up|0|||
49066573|NCT02393248|158077690|FG010|Part 3: Combination Therapy|Lost to Follow-up|0|||
49066574|NCT02393248|158077691|FG011|Part 3: Combination Therapy|Lost to Follow-up|0|||
49066575|NCT02393248|158077692|FG012|Part 3: Combination Therapy|Lost to Follow-up|0|||
49066576|NCT02393248|158077693|FG013|Part 3: Combination Therapy|Lost to Follow-up|0|||
49066577|NCT02393248|158077694|FG014|Part 3: Combination Therapy|Lost to Follow-up|0|||
49066578|NCT02393248|158077695|FG015|Part 3: Combination Therapy|Lost to Follow-up|0|||
49066579|NCT02393248|158077696|FG016|Part 3: Combination Therapy|Lost to Follow-up|0|||
49066580|NCT02393248|158077697|FG017|Part 3: Combination Therapy|Lost to Follow-up|0|||
49066581|NCT02393248|158077698|FG018|Part 3: Combination Therapy|Lost to Follow-up|0|||
49066582|NCT02393248|158077699|FG019|Part 3: Combination Therapy|Lost to Follow-up|0|||
49066583|NCT02393248|158077700|FG020|Part 3: Combination Therapy|Lost to Follow-up|1|||
49066584|NCT02393248|158077701|FG021|Part 3: Combination Therapy|Lost to Follow-up|1|||
49066585|NCT02393248|158077702|FG022|Part 3: Combination Therapy|Lost to Follow-up|0|||
49066586|NCT02393248|158077703|FG023|Part 3: Combination Therapy|Lost to Follow-up|0|||
49066587|NCT02393248|158077704|FG024|Part 3: Combination Therapy|Lost to Follow-up|0|||
49066588|NCT02393248|158077680|FG000|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
49066589|NCT02393248|158077681|FG001|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
49066590|NCT02393248|158077682|FG002|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
49066591|NCT02393248|158077683|FG003|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
49066592|NCT02393248|158077684|FG004|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
49066593|NCT02393248|158077685|FG005|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
49066594|NCT02393248|158077686|FG006|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
49066595|NCT02393248|158077687|FG007|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
49066596|NCT02393248|158077688|FG008|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
49066597|NCT02393248|158077689|FG009|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
49066598|NCT02393248|158077690|FG010|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
49066599|NCT02393248|158077691|FG011|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
49066600|NCT02393248|158077692|FG012|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
49066601|NCT02393248|158077693|FG013|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
49066602|NCT02393248|158077694|FG014|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
49066603|NCT02393248|158077695|FG015|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
49066604|NCT02393248|158077696|FG016|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
49066605|NCT02393248|158077697|FG017|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
49066606|NCT02393248|158077698|FG018|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
49066607|NCT02393248|158077699|FG019|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
49066608|NCT02393248|158077700|FG020|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|1|||
49066609|NCT02393248|158077701|FG021|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
49066610|NCT02393248|158077702|FG022|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
49066611|NCT02393248|158077703|FG023|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
49066612|NCT02393248|158077704|FG024|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
49066613|NCT02393248|158077680|FG000|Part 3: Combination Therapy|Adverse Event|0|||
49066614|NCT02393248|158077681|FG001|Part 3: Combination Therapy|Adverse Event|0|||
49066615|NCT02393248|158077682|FG002|Part 3: Combination Therapy|Adverse Event|0|||
49066616|NCT02393248|158077683|FG003|Part 3: Combination Therapy|Adverse Event|0|||
49066617|NCT02393248|158077684|FG004|Part 3: Combination Therapy|Adverse Event|0|||
49066618|NCT02393248|158077685|FG005|Part 3: Combination Therapy|Adverse Event|0|||
49066619|NCT02393248|158077686|FG006|Part 3: Combination Therapy|Adverse Event|0|||
49066620|NCT02393248|158077687|FG007|Part 3: Combination Therapy|Adverse Event|0|||
49066621|NCT02393248|158077688|FG008|Part 3: Combination Therapy|Adverse Event|0|||
49066622|NCT02393248|158077689|FG009|Part 3: Combination Therapy|Adverse Event|0|||
49066623|NCT02393248|158077690|FG010|Part 3: Combination Therapy|Adverse Event|0|||
49066624|NCT02393248|158077691|FG011|Part 3: Combination Therapy|Adverse Event|0|||
49066625|NCT02393248|158077692|FG012|Part 3: Combination Therapy|Adverse Event|0|||
49066626|NCT02393248|158077693|FG013|Part 3: Combination Therapy|Adverse Event|0|||
49066627|NCT02393248|158077694|FG014|Part 3: Combination Therapy|Adverse Event|0|||
49066628|NCT02393248|158077695|FG015|Part 3: Combination Therapy|Adverse Event|0|||
49066629|NCT02393248|158077696|FG016|Part 3: Combination Therapy|Adverse Event|0|||
49066630|NCT02393248|158077697|FG017|Part 3: Combination Therapy|Adverse Event|0|||
49066631|NCT02393248|158077698|FG018|Part 3: Combination Therapy|Adverse Event|0|||
49066632|NCT02393248|158077699|FG019|Part 3: Combination Therapy|Adverse Event|0|||
49066633|NCT02393248|158077700|FG020|Part 3: Combination Therapy|Adverse Event|0|||
49066634|NCT02393248|158077701|FG021|Part 3: Combination Therapy|Adverse Event|0|||
49066635|NCT02393248|158077702|FG022|Part 3: Combination Therapy|Adverse Event|0|||
49066636|NCT02393248|158077703|FG023|Part 3: Combination Therapy|Adverse Event|1|||
49066637|NCT02393248|158077704|FG024|Part 3: Combination Therapy|Adverse Event|0|||
49066638|NCT02393248|158077680|FG000|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
49066639|NCT02393248|158077681|FG001|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
49066640|NCT02393248|158077682|FG002|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
49066641|NCT02393248|158077683|FG003|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
49066642|NCT02393248|158077684|FG004|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
49066643|NCT02393248|158077685|FG005|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
49066644|NCT02393248|158077686|FG006|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
49066645|NCT02393248|158077687|FG007|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
49066646|NCT02393248|158077688|FG008|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
49066647|NCT02393248|158077689|FG009|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
49066648|NCT02393248|158077690|FG010|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
49066649|NCT02393248|158077691|FG011|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
49066650|NCT02393248|158077692|FG012|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
49066651|NCT02393248|158077693|FG013|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
49066652|NCT02393248|158077694|FG014|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
49066653|NCT02393248|158077695|FG015|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
49066654|NCT02393248|158077696|FG016|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
49066655|NCT02393248|158077697|FG017|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
49066656|NCT02393248|158077698|FG018|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
49066657|NCT02393248|158077699|FG019|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
49066658|NCT02393248|158077700|FG020|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
49066659|NCT02393248|158077701|FG021|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
49066660|NCT02393248|158077702|FG022|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
49066661|NCT02393248|158077703|FG023|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|1|||
49066662|NCT02393248|158077704|FG024|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
49066663|NCT03560986|158077705|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
49066664|NCT03560986|158077706|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
49066665|NCT03560986|158077705|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
49066666|NCT03560986|158077706|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
49066667|NCT03560986|158077705|FG000|Treatment Period A/Follow-up Period 1|Protocol Violation|0|||
49066668|NCT03560986|158077706|FG001|Treatment Period A/Follow-up Period 1|Protocol Violation|1|||
49066669|NCT03560986|158077705|FG000|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32|||
49066670|NCT03560986|158077706|FG001|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35|||
49066671|NCT03560986|158077705|FG000|Treatment Period B/Follow-up Period 2|Adverse Event|1|||
49066672|NCT03560986|158077706|FG001|Treatment Period B/Follow-up Period 2|Adverse Event|0|||
49066673|NCT03560986|158077705|FG000|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0|||
49066674|NCT03560986|158077706|FG001|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1|||
49066675|NCT03560986|158077705|FG000|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
49066676|NCT03560986|158077706|FG001|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
49066677|NCT02585934|158077707|FG000|Overall Study|Lost to Follow-up|2|||
49066678|NCT02585934|158077708|FG001|Overall Study|Lost to Follow-up|2|||
49066679|NCT02585934|158077707|FG000|Overall Study|Protocol Violation|14|||
49066680|NCT02585934|158077708|FG001|Overall Study|Protocol Violation|11|||
49066681|NCT02585934|158077707|FG000|Overall Study|Adverse Event|21|||
49066682|NCT02585934|158077708|FG001|Overall Study|Adverse Event|22|||
49066683|NCT02585934|158077707|FG000|Overall Study|Physician Decision|3|||
49066684|NCT02585934|158077708|FG001|Overall Study|Physician Decision|2|||
49066685|NCT02585934|158077707|FG000|Overall Study|Withdrawal by Subject|7|||
49066686|NCT02585934|158077708|FG001|Overall Study|Withdrawal by Subject|21|||
49066687|NCT02585934|158077707|FG000|Overall Study|Lack of Efficacy|2|||
49066688|NCT02585934|158077708|FG001|Overall Study|Lack of Efficacy|1|||
49066689|NCT02585934|158077707|FG000|Overall Study|Death|2|||
49066690|NCT02585934|158077708|FG001|Overall Study|Death|0|||
49066691|NCT02585934|158077707|FG000|Overall Study|Caregiver Withdrew Consent|7|||
49066692|NCT02585934|158077708|FG001|Overall Study|Caregiver Withdrew Consent|7|||
49066693|NCT02585934|158077707|FG000|Overall Study|Sponsor Termination|1|||
49066694|NCT02585934|158077708|FG001|Overall Study|Sponsor Termination|2|||
49066695|NCT02585934|158077707|FG000|Overall Study|Another Reason|10|||
49066696|NCT02585934|158077708|FG001|Overall Study|Another Reason|5|||
49066697|NCT01971970|158077709|FG000|Baseline Until Week 6|Stopped anti-TNF use|1|||
49066698|NCT01971970|158077710|FG001|Baseline Until Week 6|Stopped anti-TNF use|0|||
49066699|NCT01971970|158077709|FG000|Week 6 Until Week 8|Stopped anti-TNF use|0|||
49066700|NCT01971970|158077710|FG001|Week 6 Until Week 8|Stopped anti-TNF use|1|||
49066701|NCT01971970|158077709|FG000|Week 14 Until Week 22|Lost to Follow-up|0|||
49066702|NCT01971970|158077710|FG001|Week 14 Until Week 22|Lost to Follow-up|1|||
49066703|NCT01971970|158077709|FG000|Week 22 Until Week 52|Stopped anti-TNF use|7|||
49066704|NCT01971970|158077710|FG001|Week 22 Until Week 52|Stopped anti-TNF use|3|||
49066705|NCT01971970|158077709|FG000|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|1|||
49066706|NCT01971970|158077710|FG001|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|0|||
49066707|NCT01971970|158077709|FG000|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|0|||
49066708|NCT01971970|158077710|FG001|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|1|||
49066709|NCT01971970|158077709|FG000|Week 52 Until Week 78|Stopped anti-TNF use|1|||
49066710|NCT01971970|158077710|FG001|Week 52 Until Week 78|Stopped anti-TNF use|3|||
49066711|NCT00186888|158077711|FG000|Overall Study|Toxicity|0|||
49066712|NCT00186888|158077712|FG001|Overall Study|Toxicity|1|||
49066713|NCT00186888|158077713|FG002|Overall Study|Toxicity|0|||
49066714|NCT00186888|158077711|FG000|Overall Study|Relapse or progression of disease|4|||
49066715|NCT00186888|158077712|FG001|Overall Study|Relapse or progression of disease|2|||
49066716|NCT00186888|158077713|FG002|Overall Study|Relapse or progression of disease|0|||
49066717|NCT00848107|158077714|FG000|Overall Study|Lost to Follow-up|2|||
49066718|NCT00848107|158077714|FG000|Overall Study|Withdrawal by Subject|8|||
49066719|NCT00848107|158077714|FG000|Overall Study|Adverse Event|9|||
49066720|NCT00848107|158077714|FG000|Overall Study|Death|1|||
49066721|NCT00848107|158077714|FG000|Overall Study|Pregnancy|1|||
49066722|NCT02335983|158077715|FG000|Overall Study|Sponsor Decision|0|||
49066723|NCT02335983|158077716|FG001|Overall Study|Sponsor Decision|0|||
49066724|NCT02335983|158077717|FG002|Overall Study|Sponsor Decision|1|||
49066725|NCT02335983|158077718|FG003|Overall Study|Sponsor Decision|1|||
49066726|NCT02335983|158077719|FG004|Overall Study|Sponsor Decision|0|||
49066727|NCT02335983|158077720|FG005|Overall Study|Sponsor Decision|1|||
49066728|NCT02335983|158077715|FG000|Overall Study|Withdrawal by Subject|3|||
49066729|NCT02335983|158077716|FG001|Overall Study|Withdrawal by Subject|2|||
49066730|NCT02335983|158077717|FG002|Overall Study|Withdrawal by Subject|2|||
49066731|NCT02335983|158077718|FG003|Overall Study|Withdrawal by Subject|1|||
49066732|NCT02335983|158077719|FG004|Overall Study|Withdrawal by Subject|3|||
49066733|NCT02335983|158077720|FG005|Overall Study|Withdrawal by Subject|9|||
49066734|NCT02335983|158077715|FG000|Overall Study|Death|0|||
49066735|NCT02335983|158077716|FG001|Overall Study|Death|0|||
49066736|NCT02335983|158077717|FG002|Overall Study|Death|2|||
49066737|NCT02335983|158077718|FG003|Overall Study|Death|0|||
49066738|NCT02335983|158077719|FG004|Overall Study|Death|0|||
49066739|NCT02335983|158077720|FG005|Overall Study|Death|0|||
49066740|NCT02335983|158077715|FG000|Overall Study|Lost to Follow-up|0|||
49066741|NCT02335983|158077716|FG001|Overall Study|Lost to Follow-up|0|||
49066742|NCT02335983|158077717|FG002|Overall Study|Lost to Follow-up|0|||
49066743|NCT02335983|158077718|FG003|Overall Study|Lost to Follow-up|0|||
49066744|NCT02335983|158077719|FG004|Overall Study|Lost to Follow-up|0|||
49066745|NCT02335983|158077720|FG005|Overall Study|Lost to Follow-up|1|||
49066746|NCT02335983|158077715|FG000|Overall Study|Protocol Specified Criteria|5|||
49066747|NCT02335983|158077716|FG001|Overall Study|Protocol Specified Criteria|7|||
49066748|NCT02335983|158077717|FG002|Overall Study|Protocol Specified Criteria|27|||
49066749|NCT02335983|158077718|FG003|Overall Study|Protocol Specified Criteria|7|||
49066750|NCT02335983|158077719|FG004|Overall Study|Protocol Specified Criteria|5|||
49066751|NCT02335983|158077720|FG005|Overall Study|Protocol Specified Criteria|21|||
49066752|NCT04713553|158077721|FG000|Primary Study (2 Months)|Withdrawal by Subject|2|||
49066753|NCT04713553|158077722|FG001|Primary Study (2 Months)|Withdrawal by Subject|3|||
49066754|NCT04713553|158077723|FG002|Primary Study (2 Months)|Withdrawal by Subject|0|||
49066755|NCT04713553|158077724|FG003|Primary Study (2 Months)|Withdrawal by Subject|0|||
49066756|NCT04713553|158077725|FG004|Primary Study (2 Months)|Withdrawal by Subject|1|||
49066757|NCT04713553|158077726|FG005|Primary Study (2 Months)|Withdrawal by Subject|0|||
49066758|NCT04713553|158077727|FG006|Primary Study (2 Months)|Withdrawal by Subject|0|||
49066759|NCT04713553|158077721|FG000|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
49066760|NCT04713553|158077722|FG001|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
49066761|NCT04713553|158077723|FG002|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
49066762|NCT04713553|158077724|FG003|Primary Study (2 Months)|Withdrawal by parent/guardian|1|||
49066763|NCT04713553|158077725|FG004|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
49066764|NCT04713553|158077726|FG005|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
49066765|NCT04713553|158077727|FG006|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
49066766|NCT04713553|158077721|FG000|Primary Study (2 Months)|Other|1|||
49066767|NCT04713553|158077722|FG001|Primary Study (2 Months)|Other|2|||
49066768|NCT04713553|158077723|FG002|Primary Study (2 Months)|Other|0|||
49066769|NCT04713553|158077724|FG003|Primary Study (2 Months)|Other|0|||
49066770|NCT04713553|158077725|FG004|Primary Study (2 Months)|Other|1|||
49066771|NCT04713553|158077726|FG005|Primary Study (2 Months)|Other|0|||
49066772|NCT04713553|158077727|FG006|Primary Study (2 Months)|Other|0|||
49066773|NCT04713553|158077721|FG000|Primary Study (2 Months)|Lost to Follow-up|1|||
49066774|NCT04713553|158077722|FG001|Primary Study (2 Months)|Lost to Follow-up|1|||
49066775|NCT04713553|158077723|FG002|Primary Study (2 Months)|Lost to Follow-up|2|||
49066776|NCT04713553|158077724|FG003|Primary Study (2 Months)|Lost to Follow-up|1|||
49066777|NCT04713553|158077725|FG004|Primary Study (2 Months)|Lost to Follow-up|0|||
49066778|NCT04713553|158077726|FG005|Primary Study (2 Months)|Lost to Follow-up|0|||
49066779|NCT04713553|158077727|FG006|Primary Study (2 Months)|Lost to Follow-up|0|||
49066780|NCT04713553|158077721|FG000|Primary Study (2 Months)|Inclusion criteria not met|0|||
49066781|NCT04713553|158077722|FG001|Primary Study (2 Months)|Inclusion criteria not met|0|||
49066782|NCT04713553|158077723|FG002|Primary Study (2 Months)|Inclusion criteria not met|1|||
49066783|NCT04713553|158077724|FG003|Primary Study (2 Months)|Inclusion criteria not met|0|||
49066784|NCT04713553|158077725|FG004|Primary Study (2 Months)|Inclusion criteria not met|0|||
49066785|NCT04713553|158077726|FG005|Primary Study (2 Months)|Inclusion criteria not met|0|||
49066786|NCT04713553|158077727|FG006|Primary Study (2 Months)|Inclusion criteria not met|0|||
49066787|NCT00987389|158077739|FG000|Overall Study|Ineligible|0|||
49066788|NCT00987389|158077740|FG001|Overall Study|Ineligible|3|||
49066789|NCT00987389|158077741|FG002|Overall Study|Ineligible|0|||
49066790|NCT00987389|158077742|FG003|Overall Study|Ineligible|0|||
49066791|NCT00987389|158077739|FG000|Overall Study|Lost to Follow-up|4|||
49066792|NCT00987389|158077740|FG001|Overall Study|Lost to Follow-up|1|||
49066793|NCT00987389|158077741|FG002|Overall Study|Lost to Follow-up|3|||
49066794|NCT00987389|158077742|FG003|Overall Study|Lost to Follow-up|1|||
49066795|NCT00987389|158077739|FG000|Overall Study|Withdrawal by Subject|4|||
49066796|NCT00987389|158077740|FG001|Overall Study|Withdrawal by Subject|3|||
49066797|NCT00987389|158077741|FG002|Overall Study|Withdrawal by Subject|2|||
49066798|NCT00987389|158077742|FG003|Overall Study|Withdrawal by Subject|1|||
49066799|NCT00987389|158077739|FG000|Overall Study|Withdrawn from Treatment|0|||
49066800|NCT00987389|158077740|FG001|Overall Study|Withdrawn from Treatment|1|||
49066801|NCT00987389|158077741|FG002|Overall Study|Withdrawn from Treatment|0|||
49066802|NCT00987389|158077742|FG003|Overall Study|Withdrawn from Treatment|0|||
49066803|NCT00987389|158077739|FG000|Overall Study|Multiple different reasons|1|||
49066804|NCT00987389|158077740|FG001|Overall Study|Multiple different reasons|0|||
49066805|NCT00987389|158077741|FG002|Overall Study|Multiple different reasons|3|||
49066806|NCT00987389|158077742|FG003|Overall Study|Multiple different reasons|1|||
49066807|NCT00655876|158077743|FG000|Overall Study|Protocol Violation|9|||
49066808|NCT00655876|158077744|FG001|Overall Study|Protocol Violation|7|||
49066809|NCT00326963|158077745|FG000|Overall Study|Adverse Event|2|||
49066810|NCT00326963|158077745|FG000|Overall Study|Injection site reaction|1|||
49066811|NCT00326963|158077745|FG000|Overall Study|Death|1|||
49066812|NCT00326963|158077745|FG000|Overall Study|Failure to return|10|||
49066813|NCT00326963|158077745|FG000|Overall Study|Withdrawal by Subject|10|||
49066814|NCT00326963|158077745|FG000|Overall Study|Refused treatment / did not cooperate|5|||
49066815|NCT00326963|158077745|FG000|Overall Study|Violation of selection criteria at entry|2|||
49066816|NCT00326963|158077745|FG000|Overall Study|Other protocol violation|1|||
49066817|NCT00326963|158077745|FG000|Overall Study|Administrative / other|1|||
49066818|NCT00859586|158077746|FG000|Overall Study|Donors|4|||
49066819|NCT00507130|158077747|FG000|Overall Study|Lost to Follow-up|0|||
49066820|NCT00507130|158077748|FG001|Overall Study|Lost to Follow-up|0|||
49066821|NCT00507130|158077749|FG002|Overall Study|Lost to Follow-up|1|||
49066822|NCT00507130|158077750|FG003|Overall Study|Lost to Follow-up|1|||
49066823|NCT00507130|158077747|FG000|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1|||
49066824|NCT00507130|158077748|FG001|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
49066825|NCT00507130|158077749|FG002|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
49066826|NCT00507130|158077750|FG003|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
49066827|NCT01682863|158077751|FG000|Overall Study|Subject/guardian decision|19|||
49066828|NCT01682863|158077752|FG001|Overall Study|Subject/guardian decision|12|||
49066829|NCT01682863|158077753|FG002|Overall Study|Subject/guardian decision|10|||
49066830|NCT01682863|158077751|FG000|Overall Study|Lost to Follow-up|5|||
49066831|NCT01682863|158077752|FG001|Overall Study|Lost to Follow-up|1|||
49066832|NCT01682863|158077753|FG002|Overall Study|Lost to Follow-up|6|||
49066833|NCT01682863|158077751|FG000|Overall Study|Death|1|||
49066834|NCT01682863|158077752|FG001|Overall Study|Death|3|||
49066835|NCT01682863|158077753|FG002|Overall Study|Death|4|||
49066836|NCT01682863|158077751|FG000|Overall Study|Protocol deviation|1|||
49066837|NCT01682863|158077752|FG001|Overall Study|Protocol deviation|0|||
49066838|NCT01682863|158077753|FG002|Overall Study|Protocol deviation|1|||
49066839|NCT01682863|158077751|FG000|Overall Study|Technical problems|1|||
49066840|NCT01682863|158077752|FG001|Overall Study|Technical problems|0|||
49066841|NCT01682863|158077753|FG002|Overall Study|Technical problems|0|||
49066842|NCT01682863|158077751|FG000|Overall Study|Adverse Event|0|||
49066843|NCT01682863|158077752|FG001|Overall Study|Adverse Event|1|||
49066844|NCT01682863|158077753|FG002|Overall Study|Adverse Event|2|||
49066845|NCT01682863|158077751|FG000|Overall Study|Physician Decision|0|||
49066846|NCT01682863|158077752|FG001|Overall Study|Physician Decision|0|||
49066847|NCT01682863|158077753|FG002|Overall Study|Physician Decision|1|||
49066848|NCT02731326|158077765|FG000|Overall Study|Withdrawal by Subject|4|||
49066849|NCT02731326|158077766|FG001|Overall Study|Withdrawal by Subject|1|||
49066850|NCT02731326|158077765|FG000|Overall Study|No Cardioversion or Ablation Procedure|1|||
49066851|NCT02731326|158077766|FG001|Overall Study|No Cardioversion or Ablation Procedure|6|||
49066852|NCT02731326|158077765|FG000|Overall Study|Discharged without AliveCor|10|||
49066853|NCT02731326|158077766|FG001|Overall Study|Discharged without AliveCor|0|||
49066854|NCT02731326|158077765|FG000|Overall Study|Duplicate Participant|1|||
49066855|NCT02731326|158077766|FG001|Overall Study|Duplicate Participant|1|||
49066856|NCT04620135|158077768|FG000|Study Completion|Adverse Event|2|||
49066857|NCT04620135|158077769|FG001|Study Completion|Adverse Event|3|||
49066858|NCT04620135|158077768|FG000|Study Completion|Withdrawal by Subject|2|||
49066859|NCT04620135|158077769|FG001|Study Completion|Withdrawal by Subject|0|||
49066860|NCT02317614|158077770|FG000|Overall Study|Lost to Follow-up|1|||
49066861|NCT02317614|158077771|FG001|Overall Study|Lost to Follow-up|1|||
49066862|NCT02317614|158077770|FG000|Overall Study|Withdrawal by Subject|1|||
49066863|NCT02317614|158077771|FG001|Overall Study|Withdrawal by Subject|0|||
49066864|NCT02317614|158077770|FG000|Overall Study|Death|1|||
49066865|NCT02317614|158077771|FG001|Overall Study|Death|1|||
49066866|NCT00827632|158077774|FG000|Overall Study|Lost to Follow-up|8|||
49066867|NCT00827632|158077775|FG001|Overall Study|Lost to Follow-up|12|||
49066868|NCT00827632|158077774|FG000|Overall Study|Early withdrawal|14|||
49066869|NCT00827632|158077775|FG001|Overall Study|Early withdrawal|11|||
49066870|NCT00128830|158077779|FG000|Overall Study|Adverse Event|10|||
49066871|NCT00128830|158077779|FG000|Overall Study|Withdrawal by Subject|14|||
49066872|NCT00128830|158077779|FG000|Overall Study|Lost to Follow-up|4|||
49066873|NCT00128830|158077779|FG000|Overall Study|Reached a virologic endpoint|29|||
49066874|NCT00128830|158077779|FG000|Overall Study|Non-compliant|4|||
49066875|NCT00128830|158077779|FG000|Overall Study|Discontinued or ineligible for study|2|||
49066876|NCT00128830|158077779|FG000|Overall Study|Other|9|||
49066877|NCT02730351|158077780|FG000|Treatment Period 1 (2 Weeks)|Adverse Event|1|||
49066878|NCT02730351|158077781|FG001|Treatment Period 1 (2 Weeks)|Adverse Event|0|||
49066879|NCT02730351|158077780|FG000|Wash-out Period (2 Weeks)|Protocol Violation|0|||
49066880|NCT02730351|158077781|FG001|Wash-out Period (2 Weeks)|Protocol Violation|1|||
49066881|NCT02730351|158077780|FG000|Wash-out Period (2 Weeks)|Withdrawal by Subject|1|||
49066882|NCT02730351|158077781|FG001|Wash-out Period (2 Weeks)|Withdrawal by Subject|0|||
49066883|NCT02730351|158077780|FG000|Treatment Period 2 (2 Weeks)|Adverse Event|1|||
49066884|NCT02730351|158077781|FG001|Treatment Period 2 (2 Weeks)|Adverse Event|0|||
49066885|NCT02730351|158077780|FG000|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1|||
49066886|NCT02730351|158077781|FG001|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0|||
49066887|NCT00838435|158077782|FG000|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1|||
49066888|NCT00838435|158077782|FG000|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2|||
49066889|NCT00838435|158077782|FG000|Part 2 (7 Years)|Adverse Event|2|||
49066890|NCT00838435|158077782|FG000|Part 2 (7 Years)|Lost to Follow-up|2|||
49066891|NCT00838435|158077782|FG000|Part 2 (7 Years)|Physician Decision|1|||
49066892|NCT00838435|158077782|FG000|Part 2 (7 Years)|Sponsor Decision|6|||
49066893|NCT00838435|158077782|FG000|Part 2 (7 Years)|Withdrawal by Subject|5|||
49066894|NCT02640053|158077783|FG000|Overall Study|Withdrawal by Subject|2|||
49066895|NCT02640053|158077784|FG001|Overall Study|Withdrawal by Subject|1|||
49066896|NCT02640053|158077783|FG000|Overall Study|Adverse Event|1|||
49066897|NCT02640053|158077784|FG001|Overall Study|Adverse Event|1|||
49066898|NCT02640053|158077783|FG000|Overall Study|Alternative Therapy|1|||
49066899|NCT02640053|158077784|FG001|Overall Study|Alternative Therapy|1|||
49066900|NCT02640053|158077783|FG000|Overall Study|Chemo regimen changed after 1st Rx|0|||
49066901|NCT02640053|158077784|FG001|Overall Study|Chemo regimen changed after 1st Rx|1|||
49066902|NCT00424775|158077785|FG000|Overall Study|Adverse Event|2|||
49066903|NCT00424775|158077786|FG001|Overall Study|Adverse Event|0|||
49066904|NCT00424775|158077785|FG000|Overall Study|Lack of Efficacy|1|||
49066905|NCT00424775|158077786|FG001|Overall Study|Lack of Efficacy|0|||
49066906|NCT00758680|158077791|FG000|Overall Study|Adverse Event|0|||
49066907|NCT00758680|158077792|FG001|Overall Study|Adverse Event|0|||
49066908|NCT00758680|158077793|FG002|Overall Study|Adverse Event|0|||
49066909|NCT00758680|158077794|FG003|Overall Study|Adverse Event|0|||
49066910|NCT00758680|158077795|FG004|Overall Study|Adverse Event|0|||
49066911|NCT00758680|158077796|FG005|Overall Study|Adverse Event|0|||
49066912|NCT00758680|158077797|FG006|Overall Study|Adverse Event|0|||
49066913|NCT00758680|158077798|FG007|Overall Study|Adverse Event|1|||
49066914|NCT00758680|158077799|FG008|Overall Study|Adverse Event|0|||
49066915|NCT00758680|158077800|FG009|Overall Study|Adverse Event|1|||
49066916|NCT00758680|158077791|FG000|Overall Study|Laboratory Adverse Event|0|||
49066917|NCT00758680|158077792|FG001|Overall Study|Laboratory Adverse Event|0|||
49066918|NCT00758680|158077793|FG002|Overall Study|Laboratory Adverse Event|0|||
49066919|NCT00758680|158077794|FG003|Overall Study|Laboratory Adverse Event|0|||
49066920|NCT00758680|158077795|FG004|Overall Study|Laboratory Adverse Event|0|||
49066921|NCT00758680|158077796|FG005|Overall Study|Laboratory Adverse Event|0|||
49066922|NCT00758680|158077797|FG006|Overall Study|Laboratory Adverse Event|0|||
49066923|NCT00758680|158077798|FG007|Overall Study|Laboratory Adverse Event|0|||
49066924|NCT00758680|158077799|FG008|Overall Study|Laboratory Adverse Event|1|||
49066925|NCT00758680|158077800|FG009|Overall Study|Laboratory Adverse Event|0|||
49066926|NCT00758680|158077791|FG000|Overall Study|Withdrawal by Subject|0|||
49066927|NCT00758680|158077792|FG001|Overall Study|Withdrawal by Subject|0|||
49066928|NCT00758680|158077793|FG002|Overall Study|Withdrawal by Subject|0|||
49066929|NCT00758680|158077794|FG003|Overall Study|Withdrawal by Subject|0|||
49066930|NCT00758680|158077795|FG004|Overall Study|Withdrawal by Subject|0|||
49066931|NCT00758680|158077796|FG005|Overall Study|Withdrawal by Subject|0|||
49066932|NCT00758680|158077797|FG006|Overall Study|Withdrawal by Subject|1|||
49066933|NCT00758680|158077798|FG007|Overall Study|Withdrawal by Subject|0|||
49066934|NCT00758680|158077799|FG008|Overall Study|Withdrawal by Subject|1|||
49066935|NCT00758680|158077800|FG009|Overall Study|Withdrawal by Subject|0|||
49066936|NCT02056392|158077801|FG000|Overall Study|Lost to Follow-up|0|||
49066937|NCT02056392|158077802|FG001|Overall Study|Lost to Follow-up|1|||
49066938|NCT02056392|158077803|FG002|Overall Study|Lost to Follow-up|2|||
49066939|NCT02056392|158077804|FG003|Overall Study|Lost to Follow-up|0|||
49066940|NCT02056392|158077805|FG004|Overall Study|Lost to Follow-up|0|||
49066941|NCT02056392|158077806|FG005|Overall Study|Lost to Follow-up|0|||
49066942|NCT02056392|158077801|FG000|Overall Study|Protocol Violation|1|||
49066943|NCT02056392|158077802|FG001|Overall Study|Protocol Violation|0|||
49066944|NCT02056392|158077803|FG002|Overall Study|Protocol Violation|1|||
49066945|NCT02056392|158077804|FG003|Overall Study|Protocol Violation|0|||
49066946|NCT02056392|158077805|FG004|Overall Study|Protocol Violation|0|||
49066947|NCT02056392|158077806|FG005|Overall Study|Protocol Violation|0|||
49066948|NCT02056392|158077801|FG000|Overall Study|Withdrawal by Subject|1|||
49066949|NCT02056392|158077802|FG001|Overall Study|Withdrawal by Subject|0|||
49066950|NCT02056392|158077803|FG002|Overall Study|Withdrawal by Subject|0|||
49066951|NCT02056392|158077804|FG003|Overall Study|Withdrawal by Subject|0|||
49066952|NCT02056392|158077805|FG004|Overall Study|Withdrawal by Subject|1|||
49066953|NCT02056392|158077806|FG005|Overall Study|Withdrawal by Subject|0|||
49066954|NCT03480386|158077807|FG000|Overall Study|Did not complete measures at 3-months|17|||
49066955|NCT03480386|158077808|FG001|Overall Study|Did not complete measures at 3-months|14|||
49066956|NCT03480386|158077807|FG000|Overall Study|No baseline measures|11|||
49066957|NCT03480386|158077808|FG001|Overall Study|No baseline measures|14|||
49066958|NCT03480386|158077807|FG000|Overall Study|Death|0|||
49066959|NCT03480386|158077808|FG001|Overall Study|Death|5|||
49066960|NCT03480386|158077807|FG000|Overall Study|Withdrawal by Subject|12|||
49066961|NCT03480386|158077808|FG001|Overall Study|Withdrawal by Subject|8|||
49066962|NCT03480386|158077807|FG000|Overall Study|Lost to Follow-up|2|||
49066963|NCT03480386|158077808|FG001|Overall Study|Lost to Follow-up|1|||
49066964|NCT03480386|158077807|FG000|Overall Study|Complicating disease|0|||
49066965|NCT03480386|158077808|FG001|Overall Study|Complicating disease|1|||
49066966|NCT03480386|158077807|FG000|Overall Study|Disease progression|3|||
49066967|NCT03480386|158077808|FG001|Overall Study|Disease progression|0|||
49066968|NCT03480386|158077807|FG000|Overall Study|Became ineligible|0|||
49066969|NCT03480386|158077808|FG001|Overall Study|Became ineligible|2|||
49066970|NCT01094886|158077809|FG000|Overall Study|Adverse Event|2|||
49066971|NCT01094886|158077809|FG000|Overall Study|Withdrawal by Subject|5|||
49066972|NCT00658021|158077810|FG000|28-Week Treatment Period|Adverse Event|3|||
49066973|NCT00658021|158077811|FG001|28-Week Treatment Period|Adverse Event|1|||
49066974|NCT00658021|158077812|FG002|28-Week Treatment Period|Adverse Event|0|||
49066975|NCT00658021|158077810|FG000|28-Week Treatment Period|Developed study withdrawal criteria|0|||
49066976|NCT00658021|158077811|FG001|28-Week Treatment Period|Developed study withdrawal criteria|2|||
49066977|NCT00658021|158077812|FG002|28-Week Treatment Period|Developed study withdrawal criteria|0|||
49066978|NCT00658021|158077810|FG000|28-Week Treatment Period|Protocol Violation|0|||
49066979|NCT00658021|158077811|FG001|28-Week Treatment Period|Protocol Violation|2|||
49066980|NCT00658021|158077812|FG002|28-Week Treatment Period|Protocol Violation|1|||
49066981|NCT00658021|158077810|FG000|28-Week Treatment Period|Withdrawal by Subject|1|||
49066982|NCT00658021|158077811|FG001|28-Week Treatment Period|Withdrawal by Subject|1|||
49066983|NCT00658021|158077812|FG002|28-Week Treatment Period|Withdrawal by Subject|3|||
49066984|NCT00658021|158077810|FG000|28-Week Treatment Period|Physician Decision|1|||
49066985|NCT00658021|158077811|FG001|28-Week Treatment Period|Physician Decision|2|||
49066986|NCT00658021|158077812|FG002|28-Week Treatment Period|Physician Decision|1|||
49066987|NCT00658021|158077810|FG000|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
49066988|NCT00658021|158077811|FG001|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
49066989|NCT00658021|158077812|FG002|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
49066990|NCT00658021|158077810|FG000|28-Week Treatment Period|Loss of glucose control|1|||
49066991|NCT00658021|158077811|FG001|28-Week Treatment Period|Loss of glucose control|1|||
49066992|NCT00658021|158077812|FG002|28-Week Treatment Period|Loss of glucose control|10|||
49066993|NCT00658021|158077810|FG000|28-Week Treatment Period|Other|2|||
49066994|NCT00658021|158077811|FG001|28-Week Treatment Period|Other|3|||
49066995|NCT00658021|158077812|FG002|28-Week Treatment Period|Other|1|||
49066996|NCT00658021|158077810|FG000|28-Week Treatment Period|Did not receive treatment|2|||
49066997|NCT00658021|158077811|FG001|28-Week Treatment Period|Did not receive treatment|0|||
49066998|NCT00658021|158077812|FG002|28-Week Treatment Period|Did not receive treatment|0|||
49066999|NCT00658021|158077810|FG000|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
49067000|NCT00658021|158077811|FG001|Long-term Safety Follow-up Period|Withdrawal by Subject|1|||
49067001|NCT00658021|158077812|FG002|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
49067002|NCT00658021|158077810|FG000|Long-term Safety Follow-up Period|Physician Decision|0|||
49067003|NCT00658021|158077811|FG001|Long-term Safety Follow-up Period|Physician Decision|2|||
49067004|NCT00658021|158077812|FG002|Long-term Safety Follow-up Period|Physician Decision|0|||
49067005|NCT00548093|158077813|FG000|Overall Study|Death|33|||
49067006|NCT00548093|158077814|FG001|Overall Study|Death|13|||
49067007|NCT00548093|158077813|FG000|Overall Study|Lost to Follow-up|3|||
49067008|NCT00548093|158077814|FG001|Overall Study|Lost to Follow-up|1|||
49067009|NCT00548093|158077813|FG000|Overall Study|Objective progression or relapse|1|||
49067010|NCT00548093|158077814|FG001|Overall Study|Objective progression or relapse|1|||
49067011|NCT00548093|158077813|FG000|Overall Study|Other|11|||
49067012|NCT00548093|158077814|FG001|Overall Study|Other|1|||
49067013|NCT00548093|158077813|FG000|Overall Study|Withdrawal by Subject|1|||
49067014|NCT00548093|158077814|FG001|Overall Study|Withdrawal by Subject|0|||
49067015|NCT00548093|158077813|FG000|Overall Study|Completed post-treatment follow-up|1|||
49067016|NCT00548093|158077814|FG001|Overall Study|Completed post-treatment follow-up|0|||
49067017|NCT00968799|158077815|FG000|Overall Study|Advanced disease, HIPEC not applicable|2|||
49067018|NCT02516553|158077818|FG000|Overall Study|Progressive disease|2|||
49067019|NCT02516553|158077819|FG001|Overall Study|Progressive disease|2|||
49067020|NCT02516553|158077820|FG002|Overall Study|Progressive disease|3|||
49067021|NCT02516553|158077821|FG003|Overall Study|Progressive disease|5|||
49067022|NCT02516553|158077822|FG004|Overall Study|Progressive disease|3|||
49067023|NCT02516553|158077823|FG005|Overall Study|Progressive disease|0|||
49067024|NCT02516553|158077824|FG006|Overall Study|Progressive disease|5|||
49067025|NCT02516553|158077825|FG007|Overall Study|Progressive disease|5|||
49067026|NCT02516553|158077826|FG008|Overall Study|Progressive disease|11|||
49067027|NCT02516553|158077827|FG009|Overall Study|Progressive disease|3|||
49067028|NCT02516553|158077828|FG010|Overall Study|Progressive disease|10|||
49067029|NCT02516553|158077829|FG011|Overall Study|Progressive disease|8|||
49067030|NCT02516553|158077830|FG012|Overall Study|Progressive disease|8|||
49067031|NCT02516553|158077831|FG013|Overall Study|Progressive disease|2|||
49067032|NCT02516553|158077832|FG014|Overall Study|Progressive disease|2|||
49067033|NCT02516553|158077833|FG015|Overall Study|Progressive disease|2|||
49067034|NCT02516553|158077834|FG016|Overall Study|Progressive disease|1|||
49067035|NCT02516553|158077835|FG017|Overall Study|Progressive disease|9|||
49067036|NCT02516553|158077836|FG018|Overall Study|Progressive disease|12|||
49067037|NCT02516553|158077837|FG019|Overall Study|Progressive disease|7|||
49067038|NCT02516553|158077838|FG020|Overall Study|Progressive disease|16|||
49067039|NCT02516553|158077839|FG021|Overall Study|Progressive disease|18|||
49067040|NCT02516553|158077818|FG000|Overall Study|Dose limiting toxicity|0|||
49067041|NCT02516553|158077819|FG001|Overall Study|Dose limiting toxicity|0|||
49067042|NCT02516553|158077820|FG002|Overall Study|Dose limiting toxicity|0|||
49067043|NCT02516553|158077821|FG003|Overall Study|Dose limiting toxicity|0|||
49067044|NCT02516553|158077822|FG004|Overall Study|Dose limiting toxicity|3|||
49067045|NCT02516553|158077823|FG005|Overall Study|Dose limiting toxicity|1|||
49067046|NCT02516553|158077824|FG006|Overall Study|Dose limiting toxicity|1|||
49067047|NCT02516553|158077825|FG007|Overall Study|Dose limiting toxicity|0|||
49067048|NCT02516553|158077826|FG008|Overall Study|Dose limiting toxicity|1|||
49067049|NCT02516553|158077827|FG009|Overall Study|Dose limiting toxicity|0|||
49067050|NCT02516553|158077828|FG010|Overall Study|Dose limiting toxicity|0|||
49067051|NCT02516553|158077829|FG011|Overall Study|Dose limiting toxicity|1|||
49067052|NCT02516553|158077830|FG012|Overall Study|Dose limiting toxicity|0|||
49067053|NCT02516553|158077831|FG013|Overall Study|Dose limiting toxicity|1|||
49067054|NCT02516553|158077832|FG014|Overall Study|Dose limiting toxicity|0|||
49067055|NCT02516553|158077833|FG015|Overall Study|Dose limiting toxicity|0|||
49067056|NCT02516553|158077834|FG016|Overall Study|Dose limiting toxicity|1|||
49067057|NCT02516553|158077835|FG017|Overall Study|Dose limiting toxicity|1|||
49067058|NCT02516553|158077836|FG018|Overall Study|Dose limiting toxicity|0|||
49067059|NCT02516553|158077837|FG019|Overall Study|Dose limiting toxicity|2|||
49067060|NCT02516553|158077838|FG020|Overall Study|Dose limiting toxicity|0|||
49067061|NCT02516553|158077839|FG021|Overall Study|Dose limiting toxicity|0|||
49067062|NCT02516553|158077818|FG000|Overall Study|Other Adverse Events|0|||
49067063|NCT02516553|158077819|FG001|Overall Study|Other Adverse Events|0|||
49067064|NCT02516553|158077820|FG002|Overall Study|Other Adverse Events|0|||
49067065|NCT02516553|158077821|FG003|Overall Study|Other Adverse Events|1|||
49067066|NCT02516553|158077822|FG004|Overall Study|Other Adverse Events|0|||
49067067|NCT02516553|158077823|FG005|Overall Study|Other Adverse Events|1|||
49067068|NCT02516553|158077824|FG006|Overall Study|Other Adverse Events|0|||
49067069|NCT02516553|158077825|FG007|Overall Study|Other Adverse Events|0|||
49067070|NCT02516553|158077826|FG008|Overall Study|Other Adverse Events|0|||
49067071|NCT02516553|158077827|FG009|Overall Study|Other Adverse Events|1|||
49067072|NCT02516553|158077828|FG010|Overall Study|Other Adverse Events|3|||
49067073|NCT02516553|158077829|FG011|Overall Study|Other Adverse Events|2|||
49067074|NCT02516553|158077830|FG012|Overall Study|Other Adverse Events|0|||
49067075|NCT02516553|158077831|FG013|Overall Study|Other Adverse Events|1|||
49067076|NCT02516553|158077832|FG014|Overall Study|Other Adverse Events|0|||
49067077|NCT02516553|158077833|FG015|Overall Study|Other Adverse Events|0|||
49067078|NCT02516553|158077834|FG016|Overall Study|Other Adverse Events|0|||
49067079|NCT02516553|158077835|FG017|Overall Study|Other Adverse Events|2|||
49067080|NCT02516553|158077836|FG018|Overall Study|Other Adverse Events|1|||
49067081|NCT02516553|158077837|FG019|Overall Study|Other Adverse Events|2|||
49067082|NCT02516553|158077838|FG020|Overall Study|Other Adverse Events|2|||
49067083|NCT02516553|158077839|FG021|Overall Study|Other Adverse Events|1|||
49067084|NCT02516553|158077818|FG000|Overall Study|Refused to continue trial medication|0|||
49067085|NCT02516553|158077819|FG001|Overall Study|Refused to continue trial medication|0|||
49067086|NCT02516553|158077820|FG002|Overall Study|Refused to continue trial medication|0|||
49067087|NCT02516553|158077821|FG003|Overall Study|Refused to continue trial medication|0|||
49067088|NCT02516553|158077822|FG004|Overall Study|Refused to continue trial medication|0|||
49067089|NCT02516553|158077823|FG005|Overall Study|Refused to continue trial medication|0|||
49067090|NCT02516553|158077824|FG006|Overall Study|Refused to continue trial medication|0|||
49067091|NCT02516553|158077825|FG007|Overall Study|Refused to continue trial medication|0|||
49067092|NCT02516553|158077826|FG008|Overall Study|Refused to continue trial medication|0|||
49067093|NCT02516553|158077827|FG009|Overall Study|Refused to continue trial medication|0|||
49067094|NCT02516553|158077828|FG010|Overall Study|Refused to continue trial medication|1|||
49067095|NCT02516553|158077829|FG011|Overall Study|Refused to continue trial medication|0|||
49067096|NCT02516553|158077830|FG012|Overall Study|Refused to continue trial medication|0|||
49067097|NCT02516553|158077831|FG013|Overall Study|Refused to continue trial medication|0|||
49067098|NCT02516553|158077832|FG014|Overall Study|Refused to continue trial medication|0|||
49067099|NCT02516553|158077833|FG015|Overall Study|Refused to continue trial medication|0|||
49067100|NCT02516553|158077834|FG016|Overall Study|Refused to continue trial medication|0|||
49067101|NCT02516553|158077835|FG017|Overall Study|Refused to continue trial medication|0|||
49067102|NCT02516553|158077836|FG018|Overall Study|Refused to continue trial medication|1|||
49067103|NCT02516553|158077837|FG019|Overall Study|Refused to continue trial medication|0|||
49067104|NCT02516553|158077838|FG020|Overall Study|Refused to continue trial medication|0|||
49067105|NCT02516553|158077839|FG021|Overall Study|Refused to continue trial medication|1|||
49067106|NCT02516553|158077818|FG000|Overall Study|other reasons than listed|0|||
49067107|NCT02516553|158077819|FG001|Overall Study|other reasons than listed|0|||
49067108|NCT02516553|158077820|FG002|Overall Study|other reasons than listed|0|||
49067109|NCT02516553|158077821|FG003|Overall Study|other reasons than listed|0|||
49067110|NCT02516553|158077822|FG004|Overall Study|other reasons than listed|0|||
49067111|NCT02516553|158077823|FG005|Overall Study|other reasons than listed|0|||
49067112|NCT02516553|158077824|FG006|Overall Study|other reasons than listed|0|||
49067113|NCT02516553|158077825|FG007|Overall Study|other reasons than listed|1|||
49067114|NCT02516553|158077826|FG008|Overall Study|other reasons than listed|1|||
49067115|NCT02516553|158077827|FG009|Overall Study|other reasons than listed|0|||
49067116|NCT02516553|158077828|FG010|Overall Study|other reasons than listed|1|||
49067117|NCT02516553|158077829|FG011|Overall Study|other reasons than listed|1|||
49067118|NCT02516553|158077830|FG012|Overall Study|other reasons than listed|0|||
49067119|NCT02516553|158077831|FG013|Overall Study|other reasons than listed|0|||
49067120|NCT02516553|158077832|FG014|Overall Study|other reasons than listed|0|||
49067121|NCT02516553|158077833|FG015|Overall Study|other reasons than listed|0|||
49067122|NCT02516553|158077834|FG016|Overall Study|other reasons than listed|0|||
49067123|NCT02516553|158077835|FG017|Overall Study|other reasons than listed|0|||
49067124|NCT02516553|158077836|FG018|Overall Study|other reasons than listed|0|||
49067125|NCT02516553|158077837|FG019|Overall Study|other reasons than listed|0|||
49067126|NCT02516553|158077838|FG020|Overall Study|other reasons than listed|2|||
49067127|NCT02516553|158077839|FG021|Overall Study|other reasons than listed|2|||
49067128|NCT02447744|158077842|FG000|Overall Study|Withdrawal by Subject|3|||
49067129|NCT02447744|158077843|FG001|Overall Study|Withdrawal by Subject|1|||
49067130|NCT02447744|158077842|FG000|Overall Study|Data not collected b/c logistic reasons|3|||
49067131|NCT02447744|158077843|FG001|Overall Study|Data not collected b/c logistic reasons|0|||
49067132|NCT04730349|158077846|FG000|Overall Study|Participant withdrew consent|1|||
49067133|NCT04730349|158077847|FG001|Overall Study|Participant withdrew consent|0|||
49067134|NCT04730349|158077846|FG000|Overall Study|Disease progression|6|||
49067135|NCT04730349|158077847|FG001|Overall Study|Disease progression|4|||
49067136|NCT04730349|158077846|FG000|Overall Study|Study drug toxicity|0|||
49067137|NCT04730349|158077847|FG001|Overall Study|Study drug toxicity|1|||
49067138|NCT04271735|158079811|FG000|Overall Study|Physician Decision|2|||
49067139|NCT04271735|158079812|FG001|Overall Study|Physician Decision|0|||
49067140|NCT04268316|158079813|FG000|Overall Study|Withdrawal by Subject|2|||
49067141|NCT04268316|158079814|FG001|Overall Study|Withdrawal by Subject|1|||
49067142|NCT04268316|158079815|FG002|Overall Study|Withdrawal by Subject|0|||
49067143|NCT00515541|158079816|FG000|Overall Study|Physician Decision|0|||
49067144|NCT00515541|158079817|FG001|Overall Study|Physician Decision|2|||
49067145|NCT00515541|158079818|FG002|Overall Study|Physician Decision|0|||
49067146|NCT00515541|158079819|FG003|Overall Study|Physician Decision|1|||
49067147|NCT00515541|158079816|FG000|Overall Study|No show for appointments|0|||
49067148|NCT00515541|158079817|FG001|Overall Study|No show for appointments|1|||
49067149|NCT00515541|158079818|FG002|Overall Study|No show for appointments|0|||
49067150|NCT00515541|158079819|FG003|Overall Study|No show for appointments|2|||
49067151|NCT00515541|158079816|FG000|Overall Study|Withdrawal by Subject|0|||
49067152|NCT00515541|158079817|FG001|Overall Study|Withdrawal by Subject|2|||
49067153|NCT00515541|158079818|FG002|Overall Study|Withdrawal by Subject|0|||
49067154|NCT00515541|158079819|FG003|Overall Study|Withdrawal by Subject|2|||
49067155|NCT02518919|158079820|FG000|Overall Study|Protocol Violation|1|||
49067156|NCT02518919|158079821|FG001|Overall Study|Protocol Violation|1|||
49067157|NCT02518919|158079822|FG002|Overall Study|Protocol Violation|2|||
49067158|NCT00599521|158079824|FG000|Overall Study|Lack of Efficacy|4|||
49067159|NCT00599521|158079825|FG001|Overall Study|Lack of Efficacy|8|||
49067160|NCT00599521|158079824|FG000|Overall Study|Adverse Event|4|||
49067161|NCT00599521|158079825|FG001|Overall Study|Adverse Event|1|||
49067162|NCT00599521|158079824|FG000|Overall Study|Withdrawal by Subject|28|||
49067163|NCT00599521|158079825|FG001|Overall Study|Withdrawal by Subject|34|||
49067164|NCT00599521|158079824|FG000|Overall Study|Protocol Violation|1|||
49067165|NCT00599521|158079825|FG001|Overall Study|Protocol Violation|1|||
49067166|NCT00599521|158079824|FG000|Overall Study|Lost to Follow-up|23|||
49067167|NCT00599521|158079825|FG001|Overall Study|Lost to Follow-up|23|||
49067168|NCT00599521|158079824|FG000|Overall Study|Pregnancy|0|||
49067169|NCT00599521|158079825|FG001|Overall Study|Pregnancy|2|||
49067170|NCT02040779|158079826|FG000|Overall Study|Adverse Event|1|||
49067171|NCT02040779|158079827|FG001|Overall Study|Adverse Event|0|||
49067172|NCT02040779|158079828|FG002|Overall Study|Adverse Event|0|||
49067173|NCT02040779|158079826|FG000|Overall Study|Withdrawal by Subject|4|||
49067174|NCT02040779|158079827|FG001|Overall Study|Withdrawal by Subject|1|||
49067175|NCT02040779|158079828|FG002|Overall Study|Withdrawal by Subject|3|||
49067176|NCT02040779|158079826|FG000|Overall Study|Non-compliance|0|||
49067177|NCT02040779|158079827|FG001|Overall Study|Non-compliance|1|||
49067178|NCT02040779|158079828|FG002|Overall Study|Non-compliance|0|||
49067179|NCT02040779|158079826|FG000|Overall Study|Protocol Violation|2|||
49067180|NCT02040779|158079827|FG001|Overall Study|Protocol Violation|1|||
49067181|NCT02040779|158079828|FG002|Overall Study|Protocol Violation|0|||
49067182|NCT02040779|158079826|FG000|Overall Study|Lost to Follow-up|1|||
49067183|NCT02040779|158079827|FG001|Overall Study|Lost to Follow-up|2|||
49067184|NCT02040779|158079828|FG002|Overall Study|Lost to Follow-up|1|||
49067185|NCT02040779|158079826|FG000|Overall Study|Lack of Efficacy|4|||
49067186|NCT02040779|158079827|FG001|Overall Study|Lack of Efficacy|2|||
49067187|NCT02040779|158079828|FG002|Overall Study|Lack of Efficacy|0|||
49067188|NCT04498403|158079829|FG000|Overall Study|Adverse Event|1|||
49067189|NCT04498403|158079830|FG001|Overall Study|Adverse Event|0|||
49067190|NCT04498403|158079829|FG000|Overall Study|Study Terminated By Sponsor|29|||
49067191|NCT04498403|158079830|FG001|Overall Study|Study Terminated By Sponsor|10|||
49067192|NCT02968849|158079832|FG000|Overall Study|Death|8|||
49067193|NCT02968849|158079833|FG001|Overall Study|Death|10|||
49067194|NCT02968849|158079832|FG000|Overall Study|Lost to Follow-up|31|||
49067195|NCT02968849|158079833|FG001|Overall Study|Lost to Follow-up|29|||
49067196|NCT02968849|158079832|FG000|Overall Study|Withdrawal by Subject|73|||
49067197|NCT02968849|158079833|FG001|Overall Study|Withdrawal by Subject|64|||
49067198|NCT02968849|158079832|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
49067199|NCT02968849|158079833|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
49067200|NCT02968849|158079832|FG000|Overall Study|Physician Decision|6|||
49067201|NCT02968849|158079833|FG001|Overall Study|Physician Decision|9|||
49067202|NCT02968849|158079832|FG000|Overall Study|Other|16|||
49067203|NCT02968849|158079833|FG001|Overall Study|Other|10|||
49067204|NCT01951885|158079834|FG000|Overall Study|ineligible due to a change in conditioning regimen|0|||
49067205|NCT01951885|158079835|FG001|Overall Study|ineligible due to a change in conditioning regimen|1|||
49067206|NCT01951885|158079834|FG000|Overall Study|Adverse Event|1|||
49067207|NCT01951885|158079835|FG001|Overall Study|Adverse Event|0|||
49067208|NCT01951885|158079834|FG000|Overall Study|Withdrawal by Subject|0|||
49067209|NCT01951885|158079835|FG001|Overall Study|Withdrawal by Subject|1|||
49067210|NCT01951885|158079834|FG000|Overall Study|ineligible due to a change in donor|0|||
49067211|NCT01951885|158079835|FG001|Overall Study|ineligible due to a change in donor|1|||
49067212|NCT01951885|158079834|FG000|Overall Study|ineligible after experiencing cardiac issues|0|||
49067213|NCT01951885|158079835|FG001|Overall Study|ineligible after experiencing cardiac issues|1|||
49067214|NCT01831765|158079838|FG000|Overall Study|Lack of Efficacy|1|||
49067215|NCT01831765|158079839|FG001|Overall Study|Lack of Efficacy|0|||
49067216|NCT01831765|158079840|FG002|Overall Study|Lack of Efficacy|0|||
49067217|NCT01831765|158079838|FG000|Overall Study|Other, sponsor withdrew subject|0|||
49067218|NCT01831765|158079839|FG001|Overall Study|Other, sponsor withdrew subject|1|||
49067219|NCT01831765|158079840|FG002|Overall Study|Other, sponsor withdrew subject|0|||
49067220|NCT01831765|158079838|FG000|Overall Study|Pregnancy|1|||
49067221|NCT01831765|158079839|FG001|Overall Study|Pregnancy|1|||
49067222|NCT01831765|158079840|FG002|Overall Study|Pregnancy|2|||
49067223|NCT01831765|158079838|FG000|Overall Study|Death|0|||
49067224|NCT01831765|158079839|FG001|Overall Study|Death|1|||
49067225|NCT01831765|158079840|FG002|Overall Study|Death|1|||
49067226|NCT01831765|158079838|FG000|Overall Study|Other, site closed|1|||
49067227|NCT01831765|158079839|FG001|Overall Study|Other, site closed|1|||
49067228|NCT01831765|158079840|FG002|Overall Study|Other, site closed|0|||
49067229|NCT01831765|158079838|FG000|Overall Study|Adverse Event|5|||
49067230|NCT01831765|158079839|FG001|Overall Study|Adverse Event|3|||
49067231|NCT01831765|158079840|FG002|Overall Study|Adverse Event|3|||
49067232|NCT01831765|158079838|FG000|Overall Study|Withdrawal by Subject|22|||
49067233|NCT01831765|158079839|FG001|Overall Study|Withdrawal by Subject|7|||
49067234|NCT01831765|158079840|FG002|Overall Study|Withdrawal by Subject|17|||
49067235|NCT01831765|158079838|FG000|Overall Study|Withdrawal criteria|12|||
49067236|NCT01831765|158079839|FG001|Overall Study|Withdrawal criteria|10|||
49067237|NCT01831765|158079840|FG002|Overall Study|Withdrawal criteria|16|||
49067238|NCT01831765|158079838|FG000|Overall Study|Lost to Follow-up|2|||
49067239|NCT01831765|158079839|FG001|Overall Study|Lost to Follow-up|3|||
49067240|NCT01831765|158079840|FG002|Overall Study|Lost to Follow-up|3|||
49067241|NCT02524730|158079841|FG000|Overall Study|Lost to Follow-up|5|||
49067242|NCT02524730|158079841|FG000|Overall Study|Withdrawal by Subject|18|||
49067243|NCT02524730|158079841|FG000|Overall Study|Death|10|||
49067244|NCT02524730|158079841|FG000|Overall Study|Adverse Event|8|||
49067245|NCT02524730|158079841|FG000|Overall Study|Protocol Violation|1|||
49067246|NCT02524730|158079841|FG000|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4|||
49067247|NCT03783039|158079842|FG000|Overall Study|Death|2|||
49067248|NCT03783039|158079843|FG001|Overall Study|Death|1|||
49067249|NCT00977379|158079844|FG000|Overall Study|Withdrawal by Subject|1|||
49067250|NCT00977379|158079845|FG001|Overall Study|Withdrawal by Subject|1|||
49067251|NCT00977379|158079844|FG000|Overall Study|Death|7|||
49067252|NCT00977379|158079845|FG001|Overall Study|Death|9|||
49067253|NCT00977379|158079844|FG000|Overall Study|Premature Study Termination|4|||
49067254|NCT00977379|158079845|FG001|Overall Study|Premature Study Termination|0|||
49067255|NCT00977379|158079844|FG000|Overall Study|Participant Moving House|0|||
49067256|NCT00977379|158079845|FG001|Overall Study|Participant Moving House|1|||
49067257|NCT00977379|158079844|FG000|Overall Study|Randomization Error|0|||
49067258|NCT00977379|158079845|FG001|Overall Study|Randomization Error|1|||
49067259|NCT00918138|158079846|FG000|Overall Study|Subject withdrew consent|1|||
49067260|NCT00918138|158079847|FG001|Overall Study|Subject withdrew consent|1|||
49067261|NCT00918138|158079846|FG000|Overall Study|Death|1|||
49067262|NCT00918138|158079847|FG001|Overall Study|Death|0|||
49067263|NCT02448706|158079848|FG000|Overall Study|Withdrawal by Subject|4|||
49067264|NCT02448706|158079849|FG001|Overall Study|Withdrawal by Subject|3|||
49067265|NCT02448706|158079848|FG000|Overall Study|Protocol Violation|1|||
49067266|NCT02448706|158079849|FG001|Overall Study|Protocol Violation|1|||
49067267|NCT00706511|158079852|FG000|Overall Study|Withdrawal by Subject|1|||
49067268|NCT00706511|158079853|FG001|Overall Study|Withdrawal by Subject|0|||
49067269|NCT00706511|158079854|FG002|Overall Study|Withdrawal by Subject|0|||
49067270|NCT00706511|158079855|FG003|Overall Study|Withdrawal by Subject|0|||
49067271|NCT02605993|158079856|FG000|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
49067272|NCT02605993|158079857|FG001|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
49067273|NCT02605993|158079858|FG002|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|1|||
49067274|NCT02605993|158079859|FG003|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
49067275|NCT02603393|158079861|FG000|Overall Study|Patient/guardian decision|32|||
49067276|NCT02603393|158079862|FG001|Overall Study|Patient/guardian decision|18|||
49067277|NCT02603393|158079861|FG000|Overall Study|Adverse Event|17|||
49067278|NCT02603393|158079862|FG001|Overall Study|Adverse Event|15|||
49067279|NCT02603393|158079861|FG000|Overall Study|Technical problems|4|||
49067280|NCT02603393|158079862|FG001|Overall Study|Technical problems|7|||
49067281|NCT02603393|158079861|FG000|Overall Study|Lack of Efficacy|7|||
49067282|NCT02603393|158079862|FG001|Overall Study|Lack of Efficacy|2|||
49067283|NCT02603393|158079861|FG000|Overall Study|Death|3|||
49067284|NCT02603393|158079862|FG001|Overall Study|Death|4|||
49067285|NCT02603393|158079861|FG000|Overall Study|Physician Decision|3|||
49067286|NCT02603393|158079862|FG001|Overall Study|Physician Decision|3|||
49067287|NCT02603393|158079861|FG000|Overall Study|Protocol deviation|2|||
49067288|NCT02603393|158079862|FG001|Overall Study|Protocol deviation|3|||
49067289|NCT02603393|158079861|FG000|Overall Study|Lost to Follow-up|1|||
49067290|NCT02603393|158079862|FG001|Overall Study|Lost to Follow-up|2|||
49067291|NCT02603393|158079861|FG000|Overall Study|Non-compliance with study treatment|1|||
49067292|NCT02603393|158079862|FG001|Overall Study|Non-compliance with study treatment|0|||
49067293|NCT02603393|158079861|FG000|Overall Study|Sponsor decision|1|||
49067294|NCT02603393|158079862|FG001|Overall Study|Sponsor decision|0|||
49067295|NCT02425904|158079863|FG000|Overall Study|Lost to Follow-up|1|||
49067296|NCT02425904|158079864|FG001|Overall Study|Lost to Follow-up|0|||
49067297|NCT02425904|158079863|FG000|Overall Study|Withdrawal by Subject|2|||
49067298|NCT02425904|158079864|FG001|Overall Study|Withdrawal by Subject|0|||
49067299|NCT02425904|158079863|FG000|Overall Study|Death|0|||
49067300|NCT02425904|158079864|FG001|Overall Study|Death|3|||
49067301|NCT01359969|158079869|FG000|Overall Study|Study continued until at least 20 patients had been treated for at least one treatment.|37|||
49067302|NCT00593736|158079872|FG000|Screening Period and Placebo Run-in|Adverse Event|0|||
49067303|NCT00593736|158079873|FG001|Screening Period and Placebo Run-in|Adverse Event|0|||
49067304|NCT00593736|158079874|FG002|Screening Period and Placebo Run-in|Adverse Event|0|||
49067305|NCT00593736|158079875|FG003|Screening Period and Placebo Run-in|Adverse Event|3|||
49067306|NCT00593736|158079872|FG000|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
49067307|NCT00593736|158079873|FG001|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
49067308|NCT00593736|158079874|FG002|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
49067309|NCT00593736|158079875|FG003|Screening Period and Placebo Run-in|Lost to Follow-up|9|||
49067310|NCT00593736|158079872|FG000|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
49067311|NCT00593736|158079873|FG001|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
49067312|NCT00593736|158079874|FG002|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
49067313|NCT00593736|158079875|FG003|Screening Period and Placebo Run-in|Withdrawal by Subject|43|||
49067314|NCT00593736|158079872|FG000|Screening Period and Placebo Run-in|Study Termination|0|||
49067315|NCT00593736|158079873|FG001|Screening Period and Placebo Run-in|Study Termination|0|||
49067316|NCT00593736|158079874|FG002|Screening Period and Placebo Run-in|Study Termination|0|||
49067317|NCT00593736|158079875|FG003|Screening Period and Placebo Run-in|Study Termination|15|||
49067318|NCT00593736|158079872|FG000|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
49067319|NCT00593736|158079873|FG001|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
49067320|NCT00593736|158079874|FG002|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
49067321|NCT00593736|158079875|FG003|Screening Period and Placebo Run-in|Did Not Meet Criteria|322|||
49067322|NCT00593736|158079872|FG000|Screening Period and Placebo Run-in|Various|0|||
49067323|NCT00593736|158079873|FG001|Screening Period and Placebo Run-in|Various|0|||
49067324|NCT00593736|158079874|FG002|Screening Period and Placebo Run-in|Various|0|||
49067325|NCT00593736|158079875|FG003|Screening Period and Placebo Run-in|Various|25|||
49067326|NCT00593736|158079872|FG000|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
49067327|NCT00593736|158079873|FG001|Treatment Period and Placebo Run-out|Lost to Follow-up|1|||
49067328|NCT00593736|158079874|FG002|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
49067329|NCT00593736|158079875|FG003|Treatment Period and Placebo Run-out|Lost to Follow-up|0|||
49067330|NCT00593736|158079872|FG000|Treatment Period and Placebo Run-out|Protocol Violation|0|||
49067331|NCT00593736|158079873|FG001|Treatment Period and Placebo Run-out|Protocol Violation|0|||
49067332|NCT00593736|158079874|FG002|Treatment Period and Placebo Run-out|Protocol Violation|1|||
49067333|NCT00593736|158079875|FG003|Treatment Period and Placebo Run-out|Protocol Violation|1|||
49067334|NCT00593736|158079872|FG000|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
49067335|NCT00593736|158079873|FG001|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
49067336|NCT00593736|158079874|FG002|Treatment Period and Placebo Run-out|Withdrawal by Subject|1|||
49067337|NCT00593736|158079875|FG003|Treatment Period and Placebo Run-out|Withdrawal by Subject|3|||
49067338|NCT00593736|158079872|FG000|Treatment Period and Placebo Run-out|Various|1|||
49067339|NCT00593736|158079873|FG001|Treatment Period and Placebo Run-out|Various|1|||
49067340|NCT00593736|158079874|FG002|Treatment Period and Placebo Run-out|Various|1|||
49067341|NCT00593736|158079875|FG003|Treatment Period and Placebo Run-out|Various|0|||
49067342|NCT01868893|158079876|FG000|Overall Study|Adverse Event|2|||
49067343|NCT01868893|158079876|FG000|Overall Study|Commercial availability of study drug|17|||
49067344|NCT01868893|158079876|FG000|Overall Study|Neutropenia|1|||
49067345|NCT01070771|158079877|FG000|Overall Study|Adverse Event|2|||
49067346|NCT01070771|158079877|FG000|Overall Study|Protocol Violation|1|||
49067347|NCT01857271|158079878|FG000|Overall Study|Lost to Follow-up|1|||
49067348|NCT01199471|158079879|FG000|Overall Study|Protocol Violation|4|||
49067349|NCT01199471|158079879|FG000|Overall Study|Withdrawal by Subject|1|||
49067350|NCT01199471|158079879|FG000|Overall Study|Physician Decision|1|||
49067351|NCT04645966|158079882|FG000|Vaccination Phase|Adverse Event|1|||
49067352|NCT04645966|158079883|FG001|Vaccination Phase|Adverse Event|0|||
49067353|NCT04645966|158079884|FG002|Vaccination Phase|Adverse Event|0|||
49067354|NCT04645966|158079885|FG003|Vaccination Phase|Adverse Event|0|||
49067355|NCT04645966|158079886|FG004|Vaccination Phase|Adverse Event|0|||
49067356|NCT04645966|158079887|FG005|Vaccination Phase|Adverse Event|0|||
49067357|NCT04645966|158079888|FG006|Vaccination Phase|Adverse Event|1|||
49067358|NCT04645966|158079889|FG007|Vaccination Phase|Adverse Event|0|||
49067359|NCT04645966|158079890|FG008|Vaccination Phase|Adverse Event|0|||
49067360|NCT04645966|158079882|FG000|Vaccination Phase|Death|0|||
49067361|NCT04645966|158079883|FG001|Vaccination Phase|Death|0|||
49067362|NCT04645966|158079884|FG002|Vaccination Phase|Death|0|||
49067363|NCT04645966|158079885|FG003|Vaccination Phase|Death|0|||
49067364|NCT04645966|158079886|FG004|Vaccination Phase|Death|0|||
49067365|NCT04645966|158079887|FG005|Vaccination Phase|Death|1|||
49067366|NCT04645966|158079888|FG006|Vaccination Phase|Death|0|||
49067367|NCT04645966|158079889|FG007|Vaccination Phase|Death|0|||
49067368|NCT04645966|158079890|FG008|Vaccination Phase|Death|0|||
49067369|NCT04645966|158079882|FG000|Vaccination Phase|Protocol Violation|0|||
49067370|NCT04645966|158079883|FG001|Vaccination Phase|Protocol Violation|0|||
49067371|NCT04645966|158079884|FG002|Vaccination Phase|Protocol Violation|0|||
49067372|NCT04645966|158079885|FG003|Vaccination Phase|Protocol Violation|0|||
49067373|NCT04645966|158079886|FG004|Vaccination Phase|Protocol Violation|1|||
49067374|NCT04645966|158079887|FG005|Vaccination Phase|Protocol Violation|0|||
49067375|NCT04645966|158079888|FG006|Vaccination Phase|Protocol Violation|0|||
49067376|NCT04645966|158079889|FG007|Vaccination Phase|Protocol Violation|0|||
49067377|NCT04645966|158079890|FG008|Vaccination Phase|Protocol Violation|0|||
49067378|NCT04645966|158079882|FG000|Vaccination Phase|Study terminated by sponsor|0|||
49067379|NCT04645966|158079883|FG001|Vaccination Phase|Study terminated by sponsor|0|||
49067380|NCT04645966|158079884|FG002|Vaccination Phase|Study terminated by sponsor|14|||
49067381|NCT04645966|158079885|FG003|Vaccination Phase|Study terminated by sponsor|15|||
49067382|NCT04645966|158079886|FG004|Vaccination Phase|Study terminated by sponsor|47|||
49067383|NCT04645966|158079887|FG005|Vaccination Phase|Study terminated by sponsor|43|||
49067384|NCT04645966|158079888|FG006|Vaccination Phase|Study terminated by sponsor|29|||
49067385|NCT04645966|158079889|FG007|Vaccination Phase|Study terminated by sponsor|29|||
49067386|NCT04645966|158079890|FG008|Vaccination Phase|Study terminated by sponsor|12|||
49067387|NCT04645966|158079882|FG000|Vaccination Phase|Withdrawal by parent/guardian|0|||
49067388|NCT04645966|158079883|FG001|Vaccination Phase|Withdrawal by parent/guardian|0|||
49067389|NCT04645966|158079884|FG002|Vaccination Phase|Withdrawal by parent/guardian|2|||
49067390|NCT04645966|158079885|FG003|Vaccination Phase|Withdrawal by parent/guardian|1|||
49067391|NCT04645966|158079886|FG004|Vaccination Phase|Withdrawal by parent/guardian|3|||
49067392|NCT04645966|158079887|FG005|Vaccination Phase|Withdrawal by parent/guardian|4|||
49067393|NCT04645966|158079888|FG006|Vaccination Phase|Withdrawal by parent/guardian|0|||
49067394|NCT04645966|158079889|FG007|Vaccination Phase|Withdrawal by parent/guardian|2|||
49067395|NCT04645966|158079890|FG008|Vaccination Phase|Withdrawal by parent/guardian|0|||
49067396|NCT04645966|158079882|FG000|Vaccination Phase|Other|0|||
49067397|NCT04645966|158079883|FG001|Vaccination Phase|Other|0|||
49067398|NCT04645966|158079884|FG002|Vaccination Phase|Other|0|||
49067399|NCT04645966|158079885|FG003|Vaccination Phase|Other|0|||
49067400|NCT04645966|158079886|FG004|Vaccination Phase|Other|0|||
49067401|NCT04645966|158079887|FG005|Vaccination Phase|Other|2|||
49067402|NCT04645966|158079888|FG006|Vaccination Phase|Other|0|||
49067403|NCT04645966|158079889|FG007|Vaccination Phase|Other|0|||
49067404|NCT04645966|158079890|FG008|Vaccination Phase|Other|0|||
49067405|NCT04645966|158079882|FG000|Vaccination Phase|Lost to Follow-up|0|||
49067406|NCT04645966|158079883|FG001|Vaccination Phase|Lost to Follow-up|0|||
49067407|NCT04645966|158079884|FG002|Vaccination Phase|Lost to Follow-up|0|||
49067408|NCT04645966|158079885|FG003|Vaccination Phase|Lost to Follow-up|0|||
49067409|NCT04645966|158079886|FG004|Vaccination Phase|Lost to Follow-up|0|||
49067410|NCT04645966|158079887|FG005|Vaccination Phase|Lost to Follow-up|0|||
49067411|NCT04645966|158079888|FG006|Vaccination Phase|Lost to Follow-up|0|||
49067412|NCT04645966|158079889|FG007|Vaccination Phase|Lost to Follow-up|1|||
49067413|NCT04645966|158079890|FG008|Vaccination Phase|Lost to Follow-up|0|||
49067414|NCT04645966|158079882|FG000|Vaccination Phase|No longer meets eligibility criteria|0|||
49067415|NCT04645966|158079883|FG001|Vaccination Phase|No longer meets eligibility criteria|0|||
49067416|NCT04645966|158079884|FG002|Vaccination Phase|No longer meets eligibility criteria|0|||
49067417|NCT04645966|158079885|FG003|Vaccination Phase|No longer meets eligibility criteria|0|||
49067418|NCT04645966|158079886|FG004|Vaccination Phase|No longer meets eligibility criteria|0|||
49067419|NCT04645966|158079887|FG005|Vaccination Phase|No longer meets eligibility criteria|0|||
49067420|NCT04645966|158079888|FG006|Vaccination Phase|No longer meets eligibility criteria|0|||
49067421|NCT04645966|158079889|FG007|Vaccination Phase|No longer meets eligibility criteria|1|||
49067422|NCT04645966|158079890|FG008|Vaccination Phase|No longer meets eligibility criteria|0|||
49067423|NCT04645966|158079882|FG000|Follow-up Phase|Lost to Follow-up|0|||
49067424|NCT04645966|158079883|FG001|Follow-up Phase|Lost to Follow-up|0|||
49067425|NCT04645966|158079884|FG002|Follow-up Phase|Lost to Follow-up|0|||
49067426|NCT04645966|158079885|FG003|Follow-up Phase|Lost to Follow-up|0|||
49067427|NCT04645966|158079886|FG004|Follow-up Phase|Lost to Follow-up|0|||
49067428|NCT04645966|158079887|FG005|Follow-up Phase|Lost to Follow-up|0|||
49067429|NCT04645966|158079888|FG006|Follow-up Phase|Lost to Follow-up|0|||
49067430|NCT04645966|158079889|FG007|Follow-up Phase|Lost to Follow-up|1|||
49067431|NCT04645966|158079890|FG008|Follow-up Phase|Lost to Follow-up|0|||
49067432|NCT03825341|158079893|FG000|Overall Study|Withdrawal by Subject|0|||
49067433|NCT03825341|158079894|FG001|Overall Study|Withdrawal by Subject|1|||
49067434|NCT02992418|158079895|FG000|Overall Study|Withdrawal by Subject|11|||
49067435|NCT02992418|158079896|FG001|Overall Study|Withdrawal by Subject|12|||
49067436|NCT02992418|158079895|FG000|Overall Study|Non-compliance with the protocol|308|||
49067437|NCT02992418|158079896|FG001|Overall Study|Non-compliance with the protocol|308|||
49067438|NCT02992418|158079895|FG000|Overall Study|Lost to Follow-up|27|||
49067439|NCT02992418|158079896|FG001|Overall Study|Lost to Follow-up|22|||
49067440|NCT00777036|158079897|FG000|On Treatment|Reason Not Specified|4|||
49067441|NCT00777036|158079898|FG001|On Treatment|Reason Not Specified|7|||
49067442|NCT00777036|158079899|FG002|On Treatment|Reason Not Specified|12|||
49067443|NCT00777036|158079897|FG000|On Treatment|Failure to Meet Study Criteria|0|||
49067444|NCT00777036|158079898|FG001|On Treatment|Failure to Meet Study Criteria|1|||
49067445|NCT00777036|158079899|FG002|On Treatment|Failure to Meet Study Criteria|0|||
49067446|NCT00777036|158079897|FG000|On Treatment|Non-compliance with Study Drug|1|||
49067447|NCT00777036|158079898|FG001|On Treatment|Non-compliance with Study Drug|0|||
49067448|NCT00777036|158079899|FG002|On Treatment|Non-compliance with Study Drug|0|||
49067449|NCT00777036|158079897|FG000|On Treatment|Maximum Clinical Benefit|2|||
49067450|NCT00777036|158079898|FG001|On Treatment|Maximum Clinical Benefit|0|||
49067451|NCT00777036|158079899|FG002|On Treatment|Maximum Clinical Benefit|1|||
49067452|NCT00777036|158079897|FG000|On Treatment|Withdrawal by Subject|3|||
49067453|NCT00777036|158079898|FG001|On Treatment|Withdrawal by Subject|2|||
49067454|NCT00777036|158079899|FG002|On Treatment|Withdrawal by Subject|3|||
49067455|NCT00777036|158079897|FG000|On Treatment|Death|0|||
49067456|NCT00777036|158079898|FG001|On Treatment|Death|2|||
49067457|NCT00777036|158079899|FG002|On Treatment|Death|0|||
49067458|NCT00777036|158079897|FG000|On Treatment|Study Drug Toxicity|0|||
49067459|NCT00777036|158079898|FG001|On Treatment|Study Drug Toxicity|0|||
49067460|NCT00777036|158079899|FG002|On Treatment|Study Drug Toxicity|1|||
49067461|NCT00777036|158079897|FG000|On Treatment|Progressive Disease|5|||
49067462|NCT00777036|158079898|FG001|On Treatment|Progressive Disease|4|||
49067463|NCT00777036|158079899|FG002|On Treatment|Progressive Disease|6|||
49067464|NCT00777036|158079897|FG000|Follow-Up|Lost to Follow-up|1|||
49067465|NCT00777036|158079898|FG001|Follow-Up|Lost to Follow-up|0|||
49067466|NCT00777036|158079899|FG002|Follow-Up|Lost to Follow-up|0|||
49067467|NCT00777036|158079897|FG000|Follow-Up|Reason Not Specified|2|||
49067468|NCT00777036|158079898|FG001|Follow-Up|Reason Not Specified|0|||
49067469|NCT00777036|158079899|FG002|Follow-Up|Reason Not Specified|0|||
49067470|NCT00777036|158079897|FG000|Follow-Up|Withdrawal by Subject|1|||
49067471|NCT00777036|158079898|FG001|Follow-Up|Withdrawal by Subject|0|||
49067472|NCT00777036|158079899|FG002|Follow-Up|Withdrawal by Subject|4|||
49067473|NCT00777036|158079897|FG000|Follow-Up|Death|1|||
49067474|NCT00777036|158079898|FG001|Follow-Up|Death|8|||
49067475|NCT00777036|158079899|FG002|Follow-Up|Death|0|||
49067476|NCT00289536|158079902|FG000|Period 3|Lost to Follow-up|0|||
49067477|NCT00289536|158079903|FG001|Period 3|Lost to Follow-up|0|||
49067478|NCT00289536|158079904|FG002|Period 3|Lost to Follow-up|1|||
49067479|NCT02116608|158079910|FG000|Overall Study|Lost to Follow-up|0|||
49067480|NCT02116608|158079911|FG001|Overall Study|Lost to Follow-up|0|||
49067481|NCT02116608|158079912|FG002|Overall Study|Lost to Follow-up|1|||
49067482|NCT02116608|158079910|FG000|Overall Study|Physician Decision|0|||
49067483|NCT02116608|158079911|FG001|Overall Study|Physician Decision|1|||
49067484|NCT02116608|158079912|FG002|Overall Study|Physician Decision|0|||
49067485|NCT02116608|158079910|FG000|Overall Study|Death|0|||
49067486|NCT02116608|158079911|FG001|Overall Study|Death|1|||
49067487|NCT02116608|158079912|FG002|Overall Study|Death|0|||
49067488|NCT02065700|158079913|FG000|Overall Study|Adverse Event|165|||
49067489|NCT02065700|158079914|FG001|Overall Study|Adverse Event|101|||
49067490|NCT02065700|158079913|FG000|Overall Study|Withdrawal by Subject|90|||
49067491|NCT02065700|158079914|FG001|Overall Study|Withdrawal by Subject|29|||
49067492|NCT02065700|158079913|FG000|Overall Study|Lost to Follow-up|12|||
49067493|NCT02065700|158079914|FG001|Overall Study|Lost to Follow-up|9|||
49067494|NCT02065700|158079913|FG000|Overall Study|Physician Decision|2|||
49067495|NCT02065700|158079914|FG001|Overall Study|Physician Decision|0|||
49067496|NCT02065700|158079913|FG000|Overall Study|Sponsor Request|38|||
49067497|NCT02065700|158079914|FG001|Overall Study|Sponsor Request|15|||
49067498|NCT02065700|158079913|FG000|Overall Study|Treatment Failure|3|||
49067499|NCT02065700|158079914|FG001|Overall Study|Treatment Failure|2|||
49067500|NCT02065700|158079913|FG000|Overall Study|Use of Non-permitted Concurrent Therapy|3|||
49067501|NCT02065700|158079914|FG001|Overall Study|Use of Non-permitted Concurrent Therapy|0|||
49067502|NCT02065700|158079913|FG000|Overall Study|Adverse Event and Treatment Failure|0|||
49067503|NCT02065700|158079914|FG001|Overall Study|Adverse Event and Treatment Failure|2|||
49067504|NCT02065700|158079913|FG000|Overall Study|Non-compliance with Study Procedures|2|||
49067505|NCT02065700|158079914|FG001|Overall Study|Non-compliance with Study Procedures|0|||
49067506|NCT02065700|158079913|FG000|Overall Study|Not Defined|21|||
49067507|NCT02065700|158079914|FG001|Overall Study|Not Defined|3|||
49067508|NCT04283500|158079915|FG000|Overall Study|Lost to Follow-up|8|||
49067509|NCT04283500|158079915|FG000|Overall Study|Withdrawn by study team prior to intervention for not meeting post-enrollment inclusion criteria|1|||
49067510|NCT00988442|158079917|FG000|Overall Study|Death|1|||
49067511|NCT00988442|158079918|FG001|Overall Study|Death|2|||
49067512|NCT00988442|158079917|FG000|Overall Study|Lost to Follow-up|0|||
49067513|NCT00988442|158079918|FG001|Overall Study|Lost to Follow-up|1|||
49067514|NCT00988442|158079917|FG000|Overall Study|Early Study Closure|29|||
49067515|NCT00988442|158079918|FG001|Overall Study|Early Study Closure|25|||
49067516|NCT01635218|158079928|FG000|Overall Study|Lost to Follow-up|3|||
49067517|NCT01635218|158079929|FG001|Overall Study|Lost to Follow-up|7|||
49067518|NCT01635218|158079930|FG002|Overall Study|Lost to Follow-up|6|||
49067519|NCT01006135|158079931|FG000|Overall Study|Adverse Event|22|||
49067520|NCT01006135|158079931|FG000|Overall Study|Protocol Violation|14|||
49067521|NCT01006135|158079931|FG000|Overall Study|Lost to Follow-up|32|||
49067522|NCT01006135|158079931|FG000|Overall Study|Other|72|||
49067523|NCT05297578|158079937|FG000|Overall Study|Lost to Follow-up|1|||
49067524|NCT05297578|158079938|FG001|Overall Study|Lost to Follow-up|1|||
49067525|NCT05297578|158079939|FG002|Overall Study|Lost to Follow-up|2|||
49067526|NCT05297578|158079940|FG003|Overall Study|Lost to Follow-up|1|||
49067527|NCT05297578|158079937|FG000|Overall Study|Death|0|||
49067528|NCT05297578|158079938|FG001|Overall Study|Death|1|||
49067529|NCT05297578|158079939|FG002|Overall Study|Death|0|||
49067530|NCT05297578|158079940|FG003|Overall Study|Death|0|||
49067531|NCT05297578|158079937|FG000|Overall Study|Withdrawal by Subject|0|||
49067532|NCT05297578|158079938|FG001|Overall Study|Withdrawal by Subject|0|||
49067533|NCT05297578|158079939|FG002|Overall Study|Withdrawal by Subject|1|||
49067534|NCT05297578|158079940|FG003|Overall Study|Withdrawal by Subject|0|||
49067535|NCT01777620|158079943|FG000|Overall Study|Subject Withdrawal|1|||
49067536|NCT01777620|158079944|FG001|Overall Study|Subject Withdrawal|0|||
49067537|NCT02272634|158079945|FG000|Overall Study|Adverse Event|1|||
49067538|NCT02272634|158079946|FG001|Overall Study|Adverse Event|0|||
49067539|NCT02272634|158079947|FG002|Overall Study|Adverse Event|0|||
49067540|NCT02272634|158079945|FG000|Overall Study|Protocol Violation|0|||
49067541|NCT02272634|158079946|FG001|Overall Study|Protocol Violation|0|||
49067542|NCT02272634|158079947|FG002|Overall Study|Protocol Violation|1|||
49067543|NCT02272634|158079945|FG000|Overall Study|Withdrawal by Subject|0|||
49067544|NCT02272634|158079946|FG001|Overall Study|Withdrawal by Subject|1|||
49067545|NCT02272634|158079947|FG002|Overall Study|Withdrawal by Subject|0|||
49067546|NCT01437943|158079949|FG000|Overall Study|Aliskiren trials terminated by Novartis|4|||
49067547|NCT01437943|158079950|FG001|Overall Study|Aliskiren trials terminated by Novartis|2|||
49067548|NCT01437943|158079949|FG000|Overall Study|Subject expressed pregnancy plans|1|||
49067549|NCT01437943|158079950|FG001|Overall Study|Subject expressed pregnancy plans|0|||
49067550|NCT01437943|158079949|FG000|Overall Study|Adverse Event|2|||
49067551|NCT01437943|158079950|FG001|Overall Study|Adverse Event|0|||
49067552|NCT01267994|158079951|FG000|Overall Study|Adverse Event|2|||
49067553|NCT02655666|158079952|FG000|Overall Study|Sponsor stopped this clinical research.|12|||
49067554|NCT00311402|158079953|FG000|Overall Study|Adverse Event|118|||
49067555|NCT00311402|158079954|FG001|Overall Study|Adverse Event|105|||
49067556|NCT00311402|158079953|FG000|Overall Study|Lost to Follow-up|0|||
49067557|NCT00311402|158079954|FG001|Overall Study|Lost to Follow-up|3|||
49067558|NCT00311402|158079953|FG000|Overall Study|Withdrawal by Subject|17|||
49067559|NCT00311402|158079954|FG001|Overall Study|Withdrawal by Subject|18|||
49067560|NCT00311402|158079953|FG000|Overall Study|Lack of Efficacy|58|||
49067561|NCT00311402|158079954|FG001|Overall Study|Lack of Efficacy|42|||
49067562|NCT00311402|158079953|FG000|Overall Study|Protocol Violation|7|||
49067563|NCT00311402|158079954|FG001|Overall Study|Protocol Violation|6|||
49067564|NCT00311402|158079953|FG000|Overall Study|IRB's rejection etc.|10|||
49067565|NCT00311402|158079954|FG001|Overall Study|IRB's rejection etc.|3|||
49067566|NCT03837743|158079957|FG000|Overall Study|Adverse Event|1|||
49067567|NCT03837743|158079957|FG000|Overall Study|Withdrawal by Subject|2|||
49067568|NCT00681590|158079964|FG000|Overall Study|Withdrawal by Subject|2|||
49067569|NCT00681590|158079965|FG001|Overall Study|Withdrawal by Subject|12|||
49067570|NCT02912650|158079967|FG000|Overall Study|Withdrawal by Subject|1|||
49067571|NCT02912650|158079968|FG001|Overall Study|Withdrawal by Subject|0|||
49067572|NCT02912650|158079969|FG002|Overall Study|Withdrawal by Subject|1|||
49067573|NCT02912650|158079970|FG003|Overall Study|Withdrawal by Subject|5|||
49067574|NCT02912650|158079967|FG000|Overall Study|Adverse Event|0|||
49067575|NCT02912650|158079968|FG001|Overall Study|Adverse Event|0|||
49067576|NCT02912650|158079969|FG002|Overall Study|Adverse Event|1|||
49067577|NCT02912650|158079970|FG003|Overall Study|Adverse Event|0|||
49067578|NCT02132637|158081299|FG000|Study Period 1|Withdrawal by Subject|0|||
49067579|NCT02132637|158081300|FG001|Study Period 1|Withdrawal by Subject|4|||
49067580|NCT02132637|158081299|FG000|Study Period 1|Physician Decision|1|||
49067581|NCT02132637|158081300|FG001|Study Period 1|Physician Decision|0|||
49067582|NCT02132637|158081299|FG000|Study Period 2 (Crossover)|Adverse Event|0|||
49067583|NCT02132637|158081300|FG001|Study Period 2 (Crossover)|Adverse Event|1|||
49067584|NCT02132637|158081299|FG000|Study Period 2 (Crossover)|Physician Decision|2|||
49067585|NCT02132637|158081300|FG001|Study Period 2 (Crossover)|Physician Decision|0|||
49067586|NCT03265288|158081301|FG000|Overall Study|Adverse Event|0|||
49067587|NCT03265288|158081302|FG001|Overall Study|Adverse Event|1|||
49067588|NCT03265288|158081301|FG000|Overall Study|Withdrawal by Subject|13|||
49067589|NCT03265288|158081302|FG001|Overall Study|Withdrawal by Subject|5|||
49067590|NCT03265288|158081301|FG000|Overall Study|Drug Withdrawn|3|||
49067591|NCT03265288|158081302|FG001|Overall Study|Drug Withdrawn|3|||
49067592|NCT03265288|158081301|FG000|Overall Study|Any Other Reason|7|||
49067593|NCT03265288|158081302|FG001|Overall Study|Any Other Reason|3|||
49067594|NCT00922272|158081303|FG000|Open-label Phase|Adverse Event|5|||
49067595|NCT00922272|158081304|FG001|Open-label Phase|Adverse Event|0|||
49067596|NCT00922272|158081303|FG000|Open-label Phase|Protocol Violation|1|||
49067597|NCT00922272|158081304|FG001|Open-label Phase|Protocol Violation|0|||
49067598|NCT00922272|158081303|FG000|Open-label Phase|Withdrawal by Subject|11|||
49067599|NCT00922272|158081304|FG001|Open-label Phase|Withdrawal by Subject|0|||
49067600|NCT00922272|158081303|FG000|Open-label Phase|Failure to meet randomization criteria|1|||
49067601|NCT00922272|158081304|FG001|Open-label Phase|Failure to meet randomization criteria|0|||
49067602|NCT00922272|158081303|FG000|Open-label Phase|Withdrawal criteria met|5|||
49067603|NCT00922272|158081304|FG001|Open-label Phase|Withdrawal criteria met|0|||
49067604|NCT00922272|158081303|FG000|Double-blind Phase|Adverse Event|1|||
49067605|NCT00922272|158081304|FG001|Double-blind Phase|Adverse Event|1|||
49067606|NCT00922272|158081303|FG000|Double-blind Phase|Withdrawal by Subject|1|||
49067607|NCT00922272|158081304|FG001|Double-blind Phase|Withdrawal by Subject|1|||
49067608|NCT00922272|158081303|FG000|Double-blind Phase|Lost to Follow-up|2|||
49067609|NCT00922272|158081304|FG001|Double-blind Phase|Lost to Follow-up|1|||
49067610|NCT00922272|158081303|FG000|Double-blind Phase|Withdrawal criteria met|1|||
49067611|NCT00922272|158081304|FG001|Double-blind Phase|Withdrawal criteria met|1|||
49067612|NCT00922272|158081303|FG000|Double-blind Phase|Noncompliance|1|||
49067613|NCT00922272|158081304|FG001|Double-blind Phase|Noncompliance|1|||
49067614|NCT00922272|158081303|FG000|Double-blind Phase|Positive urine drug screen|1|||
49067615|NCT00922272|158081304|FG001|Double-blind Phase|Positive urine drug screen|1|||
49067616|NCT01293539|158081305|FG000|Overall Study|Physician Decision|1|||
49067617|NCT01167257|158081312|FG000|Overall Study|Lost to Follow-up|2|||
49067618|NCT01167257|158081313|FG001|Overall Study|Lost to Follow-up|2|||
49067619|NCT01167257|158081312|FG000|Overall Study|Withdrew consent|1|||
49067620|NCT01167257|158081313|FG001|Overall Study|Withdrew consent|1|||
49067621|NCT00699374|158081315|FG000|Overall Study|Death|93|||
49067622|NCT00699374|158081316|FG001|Overall Study|Death|83|||
49067623|NCT00699374|158081315|FG000|Overall Study|Adverse Event|70|||
49067624|NCT00699374|158081316|FG001|Overall Study|Adverse Event|67|||
49067625|NCT00699374|158081315|FG000|Overall Study|Global deterioration of health status|7|||
49067626|NCT00699374|158081316|FG001|Overall Study|Global deterioration of health status|8|||
49067627|NCT00699374|158081315|FG000|Overall Study|Lost to Follow-up|3|||
49067628|NCT00699374|158081316|FG001|Overall Study|Lost to Follow-up|5|||
49067629|NCT00699374|158081315|FG000|Overall Study|Withdrawal by Subject|34|||
49067630|NCT00699374|158081316|FG001|Overall Study|Withdrawal by Subject|44|||
49067631|NCT00699374|158081315|FG000|Overall Study|Objective progression or relapse|281|||
49067632|NCT00699374|158081316|FG001|Overall Study|Objective progression or relapse|277|||
49067633|NCT00699374|158081315|FG000|Overall Study|Other|18|||
49067634|NCT00699374|158081316|FG001|Overall Study|Other|15|||
49067635|NCT00699374|158081315|FG000|Overall Study|Protocol Violation|2|||
49067636|NCT00699374|158081316|FG001|Overall Study|Protocol Violation|6|||
49067637|NCT00699374|158081315|FG000|Overall Study|Study terminated by sponsor|13|||
49067638|NCT00699374|158081316|FG001|Overall Study|Study terminated by sponsor|28|||
49067639|NCT00699374|158081315|FG000|Overall Study|Randomized but not treated|4|||
49067640|NCT00699374|158081316|FG001|Overall Study|Randomized but not treated|2|||
49067641|NCT00699374|158081315|FG000|Overall Study|Died 28 days after last dose|5|||
49067642|NCT00699374|158081316|FG001|Overall Study|Died 28 days after last dose|9|||
49067643|NCT02006693|158081318|FG000|Overall Study|No Reason Specified|6|||
49067644|NCT02006693|158081319|FG001|Overall Study|No Reason Specified|8|||
49067645|NCT02006693|158081318|FG000|Overall Study|Another Glaucoma-related Surgery|12|||
49067646|NCT02006693|158081319|FG001|Overall Study|Another Glaucoma-related Surgery|1|||
49067647|NCT02006693|158081318|FG000|Overall Study|XEN Implant Explantation|0|||
49067648|NCT02006693|158081319|FG001|Overall Study|XEN Implant Explantation|1|||
49067649|NCT02006693|158081318|FG000|Overall Study|Death|2|||
49067650|NCT02006693|158081319|FG001|Overall Study|Death|2|||
49067651|NCT02006693|158081318|FG000|Overall Study|Lost to Follow-up|4|||
49067652|NCT02006693|158081319|FG001|Overall Study|Lost to Follow-up|1|||
49067653|NCT02006693|158081318|FG000|Overall Study|Patient Decision|4|||
49067654|NCT02006693|158081319|FG001|Overall Study|Patient Decision|0|||
49067655|NCT00552578|158081322|FG000|Overall Study|Lost to Follow-up|1|||
49067656|NCT00552578|158081323|FG001|Overall Study|Lost to Follow-up|1|||
49067657|NCT04729309|158081324|FG000|Period 1|Subject unable to return for Period 2|3|||
49067658|NCT04729309|158081325|FG001|Period 1|Subject unable to return for Period 2|0|||
49067659|NCT04729309|158081324|FG000|Period 1|Lost to Follow-up|1|||
49067660|NCT04729309|158081325|FG001|Period 1|Lost to Follow-up|0|||
49067661|NCT01212588|158081330|FG000|Overall Study|Physician Decision|0|||
49067662|NCT01212588|158081331|FG001|Overall Study|Physician Decision|1|||
49067663|NCT01212588|158081330|FG000|Overall Study|Protocol Violation|1|||
49067664|NCT01212588|158081331|FG001|Overall Study|Protocol Violation|1|||
49067665|NCT02338193|158081332|FG000|Overall Study|Withdrawal by Subject|0|||
49067666|NCT02338193|158081333|FG001|Overall Study|Withdrawal by Subject|0|||
49067667|NCT02338193|158081334|FG002|Overall Study|Withdrawal by Subject|2|||
49067668|NCT02338193|158081332|FG000|Overall Study|Pregnancy|0|||
49067669|NCT02338193|158081333|FG001|Overall Study|Pregnancy|1|||
49067670|NCT02338193|158081334|FG002|Overall Study|Pregnancy|1|||
49067671|NCT02338193|158081332|FG000|Overall Study|Noncompliant with visits|2|||
49067672|NCT02338193|158081333|FG001|Overall Study|Noncompliant with visits|2|||
49067673|NCT02338193|158081334|FG002|Overall Study|Noncompliant with visits|7|||
49067674|NCT02338193|158081332|FG000|Overall Study|moved out of state|0|||
49067675|NCT02338193|158081333|FG001|Overall Study|moved out of state|1|||
49067676|NCT02338193|158081334|FG002|Overall Study|moved out of state|0|||
49067677|NCT02338193|158081332|FG000|Overall Study|intolerant of side effects|1|||
49067678|NCT02338193|158081333|FG001|Overall Study|intolerant of side effects|0|||
49067679|NCT02338193|158081334|FG002|Overall Study|intolerant of side effects|0|||
49067680|NCT02140411|158081335|FG000|Overall Study|Adverse Event|1|||
49067681|NCT03981419|158081341|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|0|||
49067682|NCT03981419|158081342|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|1|||
49067683|NCT03839823|158081343|FG000|Overall Study|Adverse Event|8|||
49067684|NCT03839823|158081344|FG001|Overall Study|Adverse Event|4|||
49067685|NCT03839823|158081343|FG000|Overall Study|Death|1|||
49067686|NCT03839823|158081344|FG001|Overall Study|Death|0|||
49067687|NCT03839823|158081343|FG000|Overall Study|Physician Decision|1|||
49067688|NCT03839823|158081344|FG001|Overall Study|Physician Decision|5|||
49067689|NCT03839823|158081343|FG000|Overall Study|Progressive Disease (PD)|65|||
49067690|NCT03839823|158081344|FG001|Overall Study|Progressive Disease (PD)|65|||
49067691|NCT03839823|158081343|FG000|Overall Study|Subject Decision|2|||
49067692|NCT03839823|158081344|FG001|Overall Study|Subject Decision|9|||
49067693|NCT03839823|158081343|FG000|Overall Study|Not Treated|0|||
49067694|NCT03839823|158081344|FG001|Overall Study|Not Treated|10|||
49067695|NCT03285308|158081345|FG000|Overall Study|Adverse Event|3|||
49067696|NCT03285308|158081346|FG001|Overall Study|Adverse Event|7|||
49067697|NCT03285308|158081345|FG000|Overall Study|Withdrawal by Subject|8|||
49067698|NCT03285308|158081346|FG001|Overall Study|Withdrawal by Subject|9|||
49067699|NCT03285308|158081345|FG000|Overall Study|Lost to Follow-up|3|||
49067700|NCT03285308|158081346|FG001|Overall Study|Lost to Follow-up|1|||
49067701|NCT03285308|158081345|FG000|Overall Study|Protocol Deviation|6|||
49067702|NCT03285308|158081346|FG001|Overall Study|Protocol Deviation|5|||
49067703|NCT03285308|158081345|FG000|Overall Study|Reason not Specified|0|||
49067704|NCT03285308|158081346|FG001|Overall Study|Reason not Specified|1|||
49067705|NCT02283983|158081347|FG000|Overall Study|Inclusion criteria not met|0|||
49067706|NCT02283983|158081348|FG001|Overall Study|Inclusion criteria not met|1|||
49067707|NCT02283983|158081347|FG000|Overall Study|Withdrawal by Subject|4|||
49067708|NCT02283983|158081348|FG001|Overall Study|Withdrawal by Subject|2|||
49067709|NCT02283983|158081347|FG000|Overall Study|Protocol Violation|0|||
49067710|NCT02283983|158081348|FG001|Overall Study|Protocol Violation|4|||
49067711|NCT02283983|158081347|FG000|Overall Study|Physician Decision|2|||
49067712|NCT02283983|158081348|FG001|Overall Study|Physician Decision|4|||
49067713|NCT02283983|158081347|FG000|Overall Study|Death|1|||
49067714|NCT02283983|158081348|FG001|Overall Study|Death|0|||
49067715|NCT02283983|158081347|FG000|Overall Study|Adverse Event|1|||
49067716|NCT02283983|158081348|FG001|Overall Study|Adverse Event|0|||
49067717|NCT02283983|158081347|FG000|Overall Study|Lost to Follow-up|9|||
49067718|NCT02283983|158081348|FG001|Overall Study|Lost to Follow-up|8|||
49067719|NCT02283983|158081347|FG000|Overall Study|Relapse|1|||
49067720|NCT02283983|158081348|FG001|Overall Study|Relapse|0|||
49067721|NCT03283761|158081349|FG000|Study Treatment|Patient Non-Compliance|1|||
49067722|NCT03283761|158081349|FG000|Study Treatment|Alternative Cancer Therapy|7|||
49067723|NCT03283761|158081349|FG000|Study Treatment|Disease progression|21|||
49067724|NCT03283761|158081349|FG000|Study Treatment|Adverse Event|3|||
49067725|NCT03283761|158081349|FG000|Study Treatment|Withdrawal by Subject|4|||
49067726|NCT03283761|158081349|FG000|Study Treatment|Pre-existing GI bleed and chronic anemia from that led to hospitalization and going off trial.|1|||
49067727|NCT03283761|158081349|FG000|Study Treatment|Symptomatic Deterioration|1|||
49067728|NCT03283761|158081349|FG000|Study Treatment|Screen Failure Before Therapy Start|1|||
49067729|NCT03283761|158081349|FG000|Follow up|Lost to Follow-up|1|||
49067730|NCT03283761|158081349|FG000|Follow up|Symptomatic Deterioration|1|||
49067731|NCT03283761|158081349|FG000|Follow up|Death|29|||
49067732|NCT03283761|158081349|FG000|Follow up|study terminated|4|||
49067733|NCT03283761|158081349|FG000|Follow up|Primary Investigator Withdrawal|1|||
49067734|NCT03283761|158081349|FG000|Follow up|Switched to alternative therapy|1|||
49067735|NCT03283761|158081349|FG000|Follow up|Subject is now in Hospice|1|||
49067736|NCT03275064|158081350|FG000|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
49067737|NCT03275064|158081351|FG001|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
49067738|NCT03275064|158081352|FG002|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
49067739|NCT03275064|158081353|FG003|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|1|||
49067740|NCT03275064|158081354|FG004|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
49067741|NCT03275064|158081350|FG000|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|1|||
49067742|NCT03275064|158081351|FG001|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
49067743|NCT03275064|158081352|FG002|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
49067744|NCT03275064|158081353|FG003|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
49067745|NCT03275064|158081354|FG004|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
49067746|NCT03275064|158081350|FG000|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
49067747|NCT03275064|158081351|FG001|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
49067748|NCT03275064|158081352|FG002|Post-treatment Follow-up Parts A and B|Lost to Follow-up|2|||
49067749|NCT03275064|158081353|FG003|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
49067750|NCT03275064|158081354|FG004|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
49067751|NCT03275064|158081350|FG000|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
49067752|NCT03275064|158081351|FG001|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
49067753|NCT03275064|158081352|FG002|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
49067754|NCT03275064|158081353|FG003|Post-treatment Follow-up Parts A and B|No longer required treatment|1|||
49067755|NCT03275064|158081354|FG004|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
49067756|NCT03275064|158081350|FG000|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
49067757|NCT03275064|158081351|FG001|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
49067758|NCT03275064|158081352|FG002|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
49067759|NCT03275064|158081353|FG003|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
49067760|NCT03275064|158081354|FG004|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
49067761|NCT01898650|158081359|FG000|Overall Study|the subject would not lie still for imaging|1|||
49067762|NCT00426361|158081360|FG000|Overall Study|Lost to Follow-up|3|||
49067763|NCT00426361|158081361|FG001|Overall Study|Lost to Follow-up|2|||
49067764|NCT00426361|158081362|FG002|Overall Study|Lost to Follow-up|5|||
49067765|NCT00426361|158081360|FG000|Overall Study|Withdrawal by Subject|1|||
49067766|NCT00426361|158081361|FG001|Overall Study|Withdrawal by Subject|3|||
49067767|NCT00426361|158081362|FG002|Overall Study|Withdrawal by Subject|0|||
49067768|NCT02924727|158081365|FG000|Overall Study|Withdrawal by Subject|2|||
49067769|NCT02924727|158081366|FG001|Overall Study|Withdrawal by Subject|4|||
49067770|NCT02924727|158081365|FG000|Overall Study|Lost to Follow-up|2|||
49067771|NCT02924727|158081366|FG001|Overall Study|Lost to Follow-up|5|||
49067772|NCT02924727|158081365|FG000|Overall Study|Death|221|||
49067773|NCT02924727|158081366|FG001|Overall Study|Death|247|||
49067774|NCT02924727|158081365|FG000|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|4|||
49067775|NCT02924727|158081366|FG001|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|3|||
49067776|NCT03052127|158081370|FG000|Overall Study|Withdrawal by Subject|0|||
49067777|NCT03052127|158081371|FG001|Overall Study|Withdrawal by Subject|0|||
49067778|NCT03052127|158081372|FG002|Overall Study|Withdrawal by Subject|0|||
49067779|NCT03052127|158081373|FG003|Overall Study|Withdrawal by Subject|0|||
49067780|NCT03052127|158081374|FG004|Overall Study|Withdrawal by Subject|0|||
49067781|NCT03052127|158081375|FG005|Overall Study|Withdrawal by Subject|0|||
49067782|NCT03052127|158081376|FG006|Overall Study|Withdrawal by Subject|0|||
49067783|NCT03052127|158081377|FG007|Overall Study|Withdrawal by Subject|1|||
49067784|NCT03052127|158081378|FG008|Overall Study|Withdrawal by Subject|1|||
49067785|NCT03052127|158081379|FG009|Overall Study|Withdrawal by Subject|1|||
49067786|NCT03052127|158081380|FG010|Overall Study|Withdrawal by Subject|0|||
49067787|NCT03052127|158081381|FG011|Overall Study|Withdrawal by Subject|0|||
49067788|NCT03052127|158081370|FG000|Overall Study|Discontinuation by Sponsor|0|||
49067789|NCT03052127|158081371|FG001|Overall Study|Discontinuation by Sponsor|0|||
49067790|NCT03052127|158081372|FG002|Overall Study|Discontinuation by Sponsor|0|||
49067791|NCT03052127|158081373|FG003|Overall Study|Discontinuation by Sponsor|0|||
49067792|NCT03052127|158081374|FG004|Overall Study|Discontinuation by Sponsor|0|||
49067793|NCT03052127|158081375|FG005|Overall Study|Discontinuation by Sponsor|0|||
49067794|NCT03052127|158081376|FG006|Overall Study|Discontinuation by Sponsor|0|||
49067795|NCT03052127|158081377|FG007|Overall Study|Discontinuation by Sponsor|0|||
49067796|NCT03052127|158081378|FG008|Overall Study|Discontinuation by Sponsor|4|||
49067797|NCT03052127|158081379|FG009|Overall Study|Discontinuation by Sponsor|2|||
49067798|NCT03052127|158081380|FG010|Overall Study|Discontinuation by Sponsor|5|||
49067799|NCT03052127|158081381|FG011|Overall Study|Discontinuation by Sponsor|13|||
49067800|NCT03052127|158081370|FG000|Overall Study|Inability to comply with trial requirements|0|||
49067801|NCT03052127|158081371|FG001|Overall Study|Inability to comply with trial requirements|0|||
49067802|NCT03052127|158081372|FG002|Overall Study|Inability to comply with trial requirements|1|||
49067803|NCT03052127|158081373|FG003|Overall Study|Inability to comply with trial requirements|0|||
49067804|NCT03052127|158081374|FG004|Overall Study|Inability to comply with trial requirements|0|||
49067805|NCT03052127|158081375|FG005|Overall Study|Inability to comply with trial requirements|0|||
49067806|NCT03052127|158081376|FG006|Overall Study|Inability to comply with trial requirements|0|||
49067807|NCT03052127|158081377|FG007|Overall Study|Inability to comply with trial requirements|0|||
49067808|NCT03052127|158081378|FG008|Overall Study|Inability to comply with trial requirements|0|||
49067809|NCT03052127|158081379|FG009|Overall Study|Inability to comply with trial requirements|0|||
49067810|NCT03052127|158081380|FG010|Overall Study|Inability to comply with trial requirements|0|||
49067811|NCT03052127|158081381|FG011|Overall Study|Inability to comply with trial requirements|0|||
49067812|NCT03052127|158081370|FG000|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
49067813|NCT03052127|158081371|FG001|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
49067814|NCT03052127|158081372|FG002|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
49067815|NCT03052127|158081373|FG003|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
49067816|NCT03052127|158081374|FG004|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
49067817|NCT03052127|158081375|FG005|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
49067818|NCT03052127|158081376|FG006|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
49067819|NCT03052127|158081377|FG007|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
49067820|NCT03052127|158081378|FG008|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
49067821|NCT03052127|158081379|FG009|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
49067822|NCT03052127|158081380|FG010|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
49067823|NCT03052127|158081381|FG011|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
49067824|NCT00638027|158081385|FG000|Overall Study|Adverse Event|0|||
49067825|NCT00638027|158081386|FG001|Overall Study|Adverse Event|2|||
49067826|NCT03694327|158081390|FG000|Overall Study|Lost to Follow-up|13|||
49067827|NCT03694327|158081391|FG001|Overall Study|Lost to Follow-up|23|||
49067828|NCT01957176|158081392|FG000|Overall Study|Adverse Event|2|||
49067829|NCT01957176|158081393|FG001|Overall Study|Adverse Event|0|||
49067830|NCT01957176|158081392|FG000|Overall Study|Physician Decision|2|||
49067831|NCT01957176|158081393|FG001|Overall Study|Physician Decision|1|||
49067832|NCT01957176|158081392|FG000|Overall Study|Withdrawal by Subject|1|||
49067833|NCT01957176|158081393|FG001|Overall Study|Withdrawal by Subject|0|||
49067834|NCT00315731|158081397|FG000|Overall Study|Lost to Follow-up|1|||
49067835|NCT00315731|158081397|FG000|Overall Study|Death|5|||
49067836|NCT02092467|158081400|FG000|Overall Study|Death|49|||
49067837|NCT02092467|158081401|FG001|Overall Study|Death|66|||
49067838|NCT02092467|158081402|FG002|Overall Study|Death|38|||
49067839|NCT02092467|158081400|FG000|Overall Study|Lost to Follow-up|38|||
49067840|NCT02092467|158081401|FG001|Overall Study|Lost to Follow-up|35|||
49067841|NCT02092467|158081402|FG002|Overall Study|Lost to Follow-up|40|||
49067842|NCT02092467|158081400|FG000|Overall Study|Global Deterioration of Health Status|1|||
49067843|NCT02092467|158081401|FG001|Overall Study|Global Deterioration of Health Status|0|||
49067844|NCT02092467|158081402|FG002|Overall Study|Global Deterioration of Health Status|0|||
49067845|NCT02092467|158081400|FG000|Overall Study|Other|32|||
49067846|NCT02092467|158081401|FG001|Overall Study|Other|30|||
49067847|NCT02092467|158081402|FG002|Overall Study|Other|24|||
49067848|NCT02092467|158081400|FG000|Overall Study|Withdrawal by Subject|282|||
49067849|NCT02092467|158081401|FG001|Overall Study|Withdrawal by Subject|327|||
49067850|NCT02092467|158081402|FG002|Overall Study|Withdrawal by Subject|289|||
49067851|NCT02092467|158081400|FG000|Overall Study|Randomized but not treated|2|||
49067852|NCT02092467|158081401|FG001|Overall Study|Randomized but not treated|1|||
49067853|NCT02092467|158081402|FG002|Overall Study|Randomized but not treated|7|||
49067854|NCT04614246|158081405|FG000|Overall Study|Adverse Event|0|||
49067855|NCT04614246|158081406|FG001|Overall Study|Adverse Event|1|||
49067856|NCT04614246|158081407|FG002|Overall Study|Adverse Event|1|||
49067857|NCT04614246|158081408|FG003|Overall Study|Adverse Event|2|||
49067858|NCT04614246|158081409|FG004|Overall Study|Adverse Event|1|||
49067859|NCT04614246|158081405|FG000|Overall Study|Lost to Follow-up|0|||
49067860|NCT04614246|158081406|FG001|Overall Study|Lost to Follow-up|1|||
49067861|NCT04614246|158081407|FG002|Overall Study|Lost to Follow-up|0|||
49067862|NCT04614246|158081408|FG003|Overall Study|Lost to Follow-up|1|||
49067863|NCT04614246|158081409|FG004|Overall Study|Lost to Follow-up|3|||
49067864|NCT04614246|158081405|FG000|Overall Study|Other reason|0|||
49067865|NCT04614246|158081406|FG001|Overall Study|Other reason|1|||
49067866|NCT04614246|158081407|FG002|Overall Study|Other reason|2|||
49067867|NCT04614246|158081408|FG003|Overall Study|Other reason|0|||
49067868|NCT04614246|158081409|FG004|Overall Study|Other reason|0|||
49067869|NCT04614246|158081405|FG000|Overall Study|Withdrawal by Subject|4|||
49067870|NCT04614246|158081406|FG001|Overall Study|Withdrawal by Subject|2|||
49067871|NCT04614246|158081407|FG002|Overall Study|Withdrawal by Subject|4|||
49067872|NCT04614246|158081408|FG003|Overall Study|Withdrawal by Subject|3|||
49067873|NCT04614246|158081409|FG004|Overall Study|Withdrawal by Subject|4|||
49067874|NCT04614246|158081405|FG000|Overall Study|Physician Decision|0|||
49067875|NCT04614246|158081406|FG001|Overall Study|Physician Decision|2|||
49067876|NCT04614246|158081407|FG002|Overall Study|Physician Decision|1|||
49067877|NCT04614246|158081408|FG003|Overall Study|Physician Decision|0|||
49067878|NCT04614246|158081409|FG004|Overall Study|Physician Decision|0|||
49067879|NCT04614246|158081405|FG000|Overall Study|Study terminated by sponsor|10|||
49067880|NCT04614246|158081406|FG001|Overall Study|Study terminated by sponsor|15|||
49067881|NCT04614246|158081407|FG002|Overall Study|Study terminated by sponsor|12|||
49067882|NCT04614246|158081408|FG003|Overall Study|Study terminated by sponsor|13|||
49067883|NCT04614246|158081409|FG004|Overall Study|Study terminated by sponsor|9|||
49067884|NCT04614246|158081405|FG000|Overall Study|Pregnancy|2|||
49067885|NCT04614246|158081406|FG001|Overall Study|Pregnancy|0|||
49067886|NCT04614246|158081407|FG002|Overall Study|Pregnancy|1|||
49067887|NCT04614246|158081408|FG003|Overall Study|Pregnancy|0|||
49067888|NCT04614246|158081409|FG004|Overall Study|Pregnancy|0|||
49067889|NCT00371397|158081413|FG000|Session 1|Withdrawal by Subject|1|||
49067890|NCT00371397|158081414|FG001|Session 1|Withdrawal by Subject|0|||
49067891|NCT00371397|158081415|FG002|Session 1|Withdrawal by Subject|0|||
49067892|NCT00371397|158081416|FG003|Session 1|Withdrawal by Subject|0|||
49067893|NCT00371397|158081417|FG004|Session 1|Withdrawal by Subject|0|||
49067894|NCT00371397|158081418|FG005|Session 1|Withdrawal by Subject|0|||
49067895|NCT00371397|158081419|FG006|Session 1|Withdrawal by Subject|0|||
49067896|NCT00371397|158081420|FG007|Session 1|Withdrawal by Subject|1|||
49067897|NCT00371397|158081421|FG008|Session 1|Withdrawal by Subject|0|||
49067898|NCT00371397|158081422|FG009|Session 1|Withdrawal by Subject|0|||
49067899|NCT00371397|158081423|FG010|Session 1|Withdrawal by Subject|0|||
49067900|NCT00371397|158081424|FG011|Session 1|Withdrawal by Subject|0|||
49067901|NCT01680497|158081425|FG000|Overall Study|Lost to Follow-up|2|||
49067902|NCT00725205|158081426|FG000|Overall Study|Adverse Event|22|||
49067903|NCT00725205|158081426|FG000|Overall Study|Investigator Discontinued|1|||
49067904|NCT00725205|158081426|FG000|Overall Study|Non-compliance With Protocol|14|||
49067905|NCT00725205|158081426|FG000|Overall Study|Other|8|||
49067906|NCT00725205|158081426|FG000|Overall Study|Protocol Defined Clinical Event|1|||
49067907|NCT00725205|158081426|FG000|Overall Study|Treatment Failure|41|||
49067908|NCT03014180|158081428|FG000|Overall Study|Protocol Violation|2|||
49067909|NCT03654599|158081429|FG000|Overall Study|Lost to Follow-up|14|||
49067910|NCT03654599|158081430|FG001|Overall Study|Lost to Follow-up|12|||
49067911|NCT03654599|158081429|FG000|Overall Study|Death|8|||
49067912|NCT03654599|158081430|FG001|Overall Study|Death|6|||
49067913|NCT03654599|158081429|FG000|Overall Study|Withdrawal by Subject|6|||
49067914|NCT03654599|158081430|FG001|Overall Study|Withdrawal by Subject|4|||
49067915|NCT05422625|158081431|FG000|Overall Study|Withdrawal by Subject|1|||
49067916|NCT05422625|158081432|FG001|Overall Study|Withdrawal by Subject|0|||
49067917|NCT02588950|158083246|FG000|Period 2 (Part A)|Withdrawal by Subject|0|||
49067918|NCT02588950|158083247|FG001|Period 2 (Part A)|Withdrawal by Subject|0|||
49067919|NCT02588950|158083248|FG002|Period 2 (Part A)|Withdrawal by Subject|1|||
49067920|NCT02588950|158083249|FG003|Period 2 (Part A)|Withdrawal by Subject|0|||
49067921|NCT02588950|158083246|FG000|Period 3 (Part B)|Withdrawal by Subject|0|||
49067922|NCT02588950|158083247|FG001|Period 3 (Part B)|Withdrawal by Subject|0|||
49067923|NCT02588950|158083248|FG002|Period 3 (Part B)|Withdrawal by Subject|0|||
49067924|NCT02588950|158083249|FG003|Period 3 (Part B)|Withdrawal by Subject|1|||
49067925|NCT02031458|158083251|FG000|May 8, 2015 to January 11, 2019|Death|89|||
49067926|NCT02031458|158083252|FG001|May 8, 2015 to January 11, 2019|Death|193|||
49067927|NCT02031458|158083253|FG002|May 8, 2015 to January 11, 2019|Death|198|||
49067928|NCT02031458|158083251|FG000|May 8, 2015 to January 11, 2019|Lost to Follow-up|2|||
49067929|NCT02031458|158083252|FG001|May 8, 2015 to January 11, 2019|Lost to Follow-up|5|||
49067930|NCT02031458|158083253|FG002|May 8, 2015 to January 11, 2019|Lost to Follow-up|8|||
49067931|NCT02031458|158083251|FG000|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1|||
49067932|NCT02031458|158083252|FG001|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
49067933|NCT02031458|158083253|FG002|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
49067934|NCT02031458|158083251|FG000|May 8, 2015 to January 11, 2019|Physician Decision|2|||
49067935|NCT02031458|158083252|FG001|May 8, 2015 to January 11, 2019|Physician Decision|3|||
49067936|NCT02031458|158083253|FG002|May 8, 2015 to January 11, 2019|Physician Decision|3|||
49067937|NCT02031458|158083251|FG000|May 8, 2015 to January 11, 2019|Protocol Violation|7|||
49067938|NCT02031458|158083252|FG001|May 8, 2015 to January 11, 2019|Protocol Violation|4|||
49067939|NCT02031458|158083253|FG002|May 8, 2015 to January 11, 2019|Protocol Violation|0|||
49067940|NCT02031458|158083251|FG000|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24|||
49067941|NCT02031458|158083252|FG001|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42|||
49067942|NCT02031458|158083253|FG002|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23|||
49067943|NCT02031458|158083251|FG000|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13|||
49067944|NCT02031458|158083252|FG001|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16|||
49067945|NCT02031458|158083253|FG002|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14|||
49067946|NCT02031458|158083251|FG000|Baseline to May 8, 2015|Death|36|||
49067947|NCT02031458|158083252|FG001|Baseline to May 8, 2015|Death|87|||
49067948|NCT02031458|158083253|FG002|Baseline to May 8, 2015|Death|100|||
49067949|NCT02031458|158083251|FG000|Baseline to May 8, 2015|Protocol Violation|7|||
49067950|NCT02031458|158083252|FG001|Baseline to May 8, 2015|Protocol Violation|4|||
49067951|NCT02031458|158083253|FG002|Baseline to May 8, 2015|Protocol Violation|0|||
49067952|NCT02031458|158083251|FG000|Baseline to May 8, 2015|Physician Decision|0|||
49067953|NCT02031458|158083252|FG001|Baseline to May 8, 2015|Physician Decision|1|||
49067954|NCT02031458|158083253|FG002|Baseline to May 8, 2015|Physician Decision|0|||
49067955|NCT02031458|158083251|FG000|Baseline to May 8, 2015|Unknown Reason|0|||
49067956|NCT02031458|158083252|FG001|Baseline to May 8, 2015|Unknown Reason|1|||
49067957|NCT02031458|158083253|FG002|Baseline to May 8, 2015|Unknown Reason|2|||
49067958|NCT02031458|158083251|FG000|Baseline to May 8, 2015|Withdrawal by Subject|6|||
49067959|NCT02031458|158083252|FG001|Baseline to May 8, 2015|Withdrawal by Subject|9|||
49067960|NCT02031458|158083253|FG002|Baseline to May 8, 2015|Withdrawal by Subject|3|||
49067961|NCT02031458|158083251|FG000|Baseline to May 8, 2015|On Survival Follow-Up|46|||
49067962|NCT02031458|158083252|FG001|Baseline to May 8, 2015|On Survival Follow-Up|83|||
49067963|NCT02031458|158083253|FG002|Baseline to May 8, 2015|On Survival Follow-Up|73|||
49067964|NCT02031458|158083251|FG000|Baseline to May 8, 2015|On Treatment|43|||
49067965|NCT02031458|158083252|FG001|Baseline to May 8, 2015|On Treatment|81|||
49067966|NCT02031458|158083253|FG002|Baseline to May 8, 2015|On Treatment|73|||
49067967|NCT02031458|158083251|FG000|Baseline to May 8, 2015|Lost to Follow-up|1|||
49067968|NCT02031458|158083252|FG001|Baseline to May 8, 2015|Lost to Follow-up|1|||
49067969|NCT02031458|158083253|FG002|Baseline to May 8, 2015|Lost to Follow-up|2|||
49067970|NCT00866658|158083254|FG000|Overall Study|Adverse Event|5|||
49067971|NCT00866658|158083255|FG001|Overall Study|Adverse Event|14|||
49067972|NCT00866658|158083254|FG000|Overall Study|Lack of Efficacy|2|||
49067973|NCT00866658|158083255|FG001|Overall Study|Lack of Efficacy|1|||
49067974|NCT00866658|158083254|FG000|Overall Study|Withdrawal by Subject|1|||
49067975|NCT00866658|158083255|FG001|Overall Study|Withdrawal by Subject|0|||
49067976|NCT00866658|158083254|FG000|Overall Study|Protocol Violation|1|||
49067977|NCT00866658|158083255|FG001|Overall Study|Protocol Violation|1|||
49067978|NCT00866658|158083254|FG000|Overall Study|Familial and Personal Reasons|4|||
49067979|NCT00866658|158083255|FG001|Overall Study|Familial and Personal Reasons|5|||
49067980|NCT04305587|158083259|FG000|Overall Study|Withdrawal by Subject|0|||
49067981|NCT04305587|158083260|FG001|Overall Study|Withdrawal by Subject|0|||
49067982|NCT04305587|158083261|FG002|Overall Study|Withdrawal by Subject|0|||
49067983|NCT04305587|158083262|FG003|Overall Study|Withdrawal by Subject|1|||
49067984|NCT04305587|158083263|FG004|Overall Study|Withdrawal by Subject|0|||
49067985|NCT04305587|158083264|FG005|Overall Study|Withdrawal by Subject|0|||
49067986|NCT04305587|158083265|FG006|Overall Study|Withdrawal by Subject|0|||
49067987|NCT04305587|158083266|FG007|Overall Study|Withdrawal by Subject|0|||
49067988|NCT04305587|158083267|FG008|Overall Study|Withdrawal by Subject|0|||
49067989|NCT01523457|158083269|FG000|Overall Study|Withdrawal by Subject|7|||
49067990|NCT01523457|158083270|FG001|Overall Study|Withdrawal by Subject|2|||
49067991|NCT01367665|158083271|FG000|Overall Study|Death|102|||
49067992|NCT01367665|158083272|FG001|Overall Study|Death|19|||
49067993|NCT01367665|158083271|FG000|Overall Study|Lost to Follow-up|222|||
49067994|NCT01367665|158083272|FG001|Overall Study|Lost to Follow-up|22|||
49067995|NCT01367665|158083271|FG000|Overall Study|Not Done|118|||
49067996|NCT01367665|158083272|FG001|Overall Study|Not Done|14|||
49067997|NCT02752906|158083273|FG000|Overall Study|Protocol Violation|2|||
49067998|NCT02752906|158083274|FG001|Overall Study|Protocol Violation|1|||
49067999|NCT02752906|158083273|FG000|Overall Study|Withdrawal by Subject|2|||
49068000|NCT02752906|158083274|FG001|Overall Study|Withdrawal by Subject|2|||
49068001|NCT02752906|158083273|FG000|Overall Study|Lost to Follow-up|3|||
49068002|NCT02752906|158083274|FG001|Overall Study|Lost to Follow-up|2|||
49068003|NCT00609518|158083275|FG000|Overall Study|Death from Study Disease|32|||
49068004|NCT00609518|158083276|FG001|Overall Study|Death from Study Disease|32|||
49068005|NCT00609518|158083275|FG000|Overall Study|Withdrawal by Subject|5|||
49068006|NCT00609518|158083276|FG001|Overall Study|Withdrawal by Subject|3|||
49068007|NCT00609518|158083275|FG000|Overall Study|Lost to Follow-up|3|||
49068008|NCT00609518|158083276|FG001|Overall Study|Lost to Follow-up|0|||
49068009|NCT00609518|158083275|FG000|Overall Study|Physician Decision|1|||
49068010|NCT00609518|158083276|FG001|Overall Study|Physician Decision|3|||
49068011|NCT00609518|158083275|FG000|Overall Study|Death from Adverse Event|2|||
49068012|NCT00609518|158083276|FG001|Overall Study|Death from Adverse Event|2|||
49068013|NCT01687478|158083277|FG000|Overall Study|Adverse Event|3|||
49068014|NCT01687478|158083278|FG001|Overall Study|Adverse Event|10|||
49068015|NCT01687478|158083277|FG000|Overall Study|Lost to Follow-up|1|||
49068016|NCT01687478|158083278|FG001|Overall Study|Lost to Follow-up|3|||
49068017|NCT01687478|158083277|FG000|Overall Study|Protocol Violation|0|||
49068018|NCT01687478|158083278|FG001|Overall Study|Protocol Violation|2|||
49068019|NCT01687478|158083277|FG000|Overall Study|Withdrawal by Subject|21|||
49068020|NCT01687478|158083278|FG001|Overall Study|Withdrawal by Subject|19|||
49068021|NCT01687478|158083277|FG000|Overall Study|Physician Decision|1|||
49068022|NCT01687478|158083278|FG001|Overall Study|Physician Decision|3|||
49068023|NCT01687478|158083277|FG000|Overall Study|Entry Criteria Not Met|6|||
49068024|NCT01687478|158083278|FG001|Overall Study|Entry Criteria Not Met|2|||
49068025|NCT02049450|158083281|FG000|Overall Study|Adverse Event|2|||
49068026|NCT02049450|158083281|FG000|Overall Study|Withdrawal by Subject|1|||
49068027|NCT02049450|158083281|FG000|Overall Study|Patients/guardian decision|1|||
49068028|NCT01783548|158083282|FG000|Overall Study|Adverse Event|8|||
49068029|NCT01783548|158083283|FG001|Overall Study|Adverse Event|4|||
49068030|NCT01783548|158083282|FG000|Overall Study|Withdrawal by Subject|11|||
49068031|NCT01783548|158083283|FG001|Overall Study|Withdrawal by Subject|8|||
49068032|NCT01783548|158083282|FG000|Overall Study|Non-compliance|4|||
49068033|NCT01783548|158083283|FG001|Overall Study|Non-compliance|0|||
49068034|NCT01783548|158083282|FG000|Overall Study|Protocol Violation|2|||
49068035|NCT01783548|158083283|FG001|Overall Study|Protocol Violation|2|||
49068036|NCT01783548|158083282|FG000|Overall Study|Lost to Follow-up|8|||
49068037|NCT01783548|158083283|FG001|Overall Study|Lost to Follow-up|3|||
49068038|NCT01783548|158083282|FG000|Overall Study|Lack of Efficacy|1|||
49068039|NCT01783548|158083283|FG001|Overall Study|Lack of Efficacy|1|||
49068040|NCT03493386|158083286|FG000|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
49068041|NCT03493386|158083287|FG001|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
49068042|NCT03493386|158083288|FG002|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
49068043|NCT03493386|158083289|FG003|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
49068044|NCT03246126|158083290|FG000|Overall Study|Withdrawal by Subject|0|||
49068045|NCT03246126|158083291|FG001|Overall Study|Withdrawal by Subject|1|||
49068046|NCT01119508|158083294|FG000|Overall Study|Adverse Event|56|||
49068047|NCT01119508|158083294|FG000|Overall Study|Withdrawal by Subject|2|||
49068048|NCT01119508|158083294|FG000|Overall Study|Died before tumor response evaluation|1|||
49068049|NCT03151408|158083295|FG000|Overall Study|Adverse Event|24|||
49068050|NCT03151408|158083296|FG001|Overall Study|Adverse Event|23|||
49068051|NCT03151408|158083295|FG000|Overall Study|Death|46|||
49068052|NCT03151408|158083296|FG001|Overall Study|Death|26|||
49068053|NCT03151408|158083295|FG000|Overall Study|Physician Decision|13|||
49068054|NCT03151408|158083296|FG001|Overall Study|Physician Decision|19|||
49068055|NCT03151408|158083295|FG000|Overall Study|Withdrawal by Subject|16|||
49068056|NCT03151408|158083296|FG001|Overall Study|Withdrawal by Subject|20|||
49068057|NCT03151408|158083295|FG000|Overall Study|Progressive disease|45|||
49068058|NCT03151408|158083296|FG001|Overall Study|Progressive disease|61|||
49068059|NCT03151408|158083295|FG000|Overall Study|non-compliance by patient|1|||
49068060|NCT03151408|158083296|FG001|Overall Study|non-compliance by patient|0|||
49068061|NCT03151408|158083295|FG000|Overall Study|other reasons|56|||
49068062|NCT03151408|158083296|FG001|Overall Study|other reasons|52|||
49068063|NCT03151408|158083295|FG000|Overall Study|randomized and not treated|2|||
49068064|NCT03151408|158083296|FG001|Overall Study|randomized and not treated|2|||
49068065|NCT00265395|158083297|FG000|Overall Study|Adverse Event|3|||
49068066|NCT00265395|158083298|FG001|Overall Study|Adverse Event|6|||
49068067|NCT00265395|158083297|FG000|Overall Study|Lost to Follow-up|2|||
49068068|NCT00265395|158083298|FG001|Overall Study|Lost to Follow-up|1|||
49068069|NCT00265395|158083297|FG000|Overall Study|Withdrawal by Subject|1|||
49068070|NCT00265395|158083298|FG001|Overall Study|Withdrawal by Subject|6|||
49068071|NCT00265395|158083297|FG000|Overall Study|Protocol Violation|2|||
49068072|NCT00265395|158083298|FG001|Overall Study|Protocol Violation|2|||
49068073|NCT00265395|158083297|FG000|Overall Study|Lack of Efficacy|0|||
49068074|NCT00265395|158083298|FG001|Overall Study|Lack of Efficacy|1|||
49068075|NCT00265395|158083297|FG000|Overall Study|Administrative|0|||
49068076|NCT00265395|158083298|FG001|Overall Study|Administrative|1|||
49068077|NCT02315196|158083303|FG000|Overall Study|Withdrew consent|9|||
49068078|NCT00837473|158083313|FG000|Overall Study|Lost to Follow-up|1|||
49068079|NCT00837473|158083313|FG000|Overall Study|Withdrawal by Subject|2|||
49068080|NCT00470067|158083314|FG000|Overall Study|Death|1|||
49068081|NCT00470067|158083314|FG000|Overall Study|Disease Progression|6|||
49068082|NCT03400943|158083317|FG000|Treatment Period 1|Adverse Event|0|||
49068083|NCT03400943|158083318|FG001|Treatment Period 1|Adverse Event|0|||
49068084|NCT03400943|158083319|FG002|Treatment Period 1|Adverse Event|0|||
49068085|NCT03400943|158083320|FG003|Treatment Period 1|Adverse Event|1|||
49068086|NCT03400943|158083317|FG000|Treatment Period 1|Lost to Follow-up|1|||
49068087|NCT03400943|158083318|FG001|Treatment Period 1|Lost to Follow-up|0|||
49068088|NCT03400943|158083319|FG002|Treatment Period 1|Lost to Follow-up|0|||
49068089|NCT03400943|158083320|FG003|Treatment Period 1|Lost to Follow-up|0|||
49068090|NCT03400943|158083317|FG000|Treatment Period 1|Protocol Violation|0|||
49068091|NCT03400943|158083318|FG001|Treatment Period 1|Protocol Violation|1|||
49068092|NCT03400943|158083319|FG002|Treatment Period 1|Protocol Violation|1|||
49068093|NCT03400943|158083320|FG003|Treatment Period 1|Protocol Violation|0|||
49068094|NCT03400943|158083317|FG000|Treatment Period 1|Study terminated by sponsor|2|||
49068095|NCT03400943|158083318|FG001|Treatment Period 1|Study terminated by sponsor|0|||
49068096|NCT03400943|158083319|FG002|Treatment Period 1|Study terminated by sponsor|0|||
49068097|NCT03400943|158083320|FG003|Treatment Period 1|Study terminated by sponsor|1|||
49068098|NCT03400943|158083317|FG000|Treatment Period 1|Withdrawal by Subject|0|||
49068099|NCT03400943|158083318|FG001|Treatment Period 1|Withdrawal by Subject|0|||
49068100|NCT03400943|158083319|FG002|Treatment Period 1|Withdrawal by Subject|3|||
49068101|NCT03400943|158083320|FG003|Treatment Period 1|Withdrawal by Subject|1|||
49068102|NCT03400943|158083317|FG000|Treatment Period 1|Other|2|||
49068103|NCT03400943|158083318|FG001|Treatment Period 1|Other|1|||
49068104|NCT03400943|158083319|FG002|Treatment Period 1|Other|2|||
49068105|NCT03400943|158083320|FG003|Treatment Period 1|Other|2|||
49068106|NCT03400943|158083317|FG000|Post-treatment Period 1|Adverse Event|2|||
49068107|NCT03400943|158083318|FG001|Post-treatment Period 1|Adverse Event|0|||
49068108|NCT03400943|158083319|FG002|Post-treatment Period 1|Adverse Event|0|||
49068109|NCT03400943|158083320|FG003|Post-treatment Period 1|Adverse Event|0|||
49068110|NCT03400943|158083317|FG000|Post-treatment Period 1|Protocol Violation|1|||
49068111|NCT03400943|158083318|FG001|Post-treatment Period 1|Protocol Violation|0|||
49068112|NCT03400943|158083319|FG002|Post-treatment Period 1|Protocol Violation|0|||
49068113|NCT03400943|158083320|FG003|Post-treatment Period 1|Protocol Violation|0|||
49068114|NCT03400943|158083317|FG000|Post-treatment Period 1|Study terminated by sponsor|5|||
49068115|NCT03400943|158083318|FG001|Post-treatment Period 1|Study terminated by sponsor|0|||
49068116|NCT03400943|158083319|FG002|Post-treatment Period 1|Study terminated by sponsor|5|||
49068117|NCT03400943|158083320|FG003|Post-treatment Period 1|Study terminated by sponsor|6|||
49068118|NCT03400943|158083317|FG000|Post-treatment Period 1|Withdrawal by Subject|1|||
49068119|NCT03400943|158083318|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
49068120|NCT03400943|158083319|FG002|Post-treatment Period 1|Withdrawal by Subject|2|||
49068121|NCT03400943|158083320|FG003|Post-treatment Period 1|Withdrawal by Subject|2|||
49068122|NCT03400943|158083317|FG000|Post-treatment Period 1|Other|2|||
49068123|NCT03400943|158083318|FG001|Post-treatment Period 1|Other|0|||
49068124|NCT03400943|158083319|FG002|Post-treatment Period 1|Other|4|||
49068125|NCT03400943|158083320|FG003|Post-treatment Period 1|Other|5|||
49068126|NCT03400943|158083317|FG000|Treatment Period 2|Study terminated by sponsor|0|||
49068127|NCT03400943|158083318|FG001|Treatment Period 2|Study terminated by sponsor|1|||
49068128|NCT03400943|158083319|FG002|Treatment Period 2|Study terminated by sponsor|0|||
49068129|NCT03400943|158083320|FG003|Treatment Period 2|Study terminated by sponsor|0|||
49068130|NCT03400943|158083317|FG000|Treatment Period 2|Withdrawal by Subject|0|||
49068131|NCT03400943|158083318|FG001|Treatment Period 2|Withdrawal by Subject|1|||
49068132|NCT03400943|158083319|FG002|Treatment Period 2|Withdrawal by Subject|0|||
49068133|NCT03400943|158083320|FG003|Treatment Period 2|Withdrawal by Subject|0|||
49068134|NCT03400943|158083317|FG000|Treatment Period 2|Other|1|||
49068135|NCT03400943|158083318|FG001|Treatment Period 2|Other|6|||
49068136|NCT03400943|158083319|FG002|Treatment Period 2|Other|0|||
49068137|NCT03400943|158083320|FG003|Treatment Period 2|Other|0|||
49068138|NCT03400943|158083317|FG000|Follow-up Period|Withdrawal by Subject|1|||
49068139|NCT03400943|158083318|FG001|Follow-up Period|Withdrawal by Subject|0|||
49068140|NCT03400943|158083319|FG002|Follow-up Period|Withdrawal by Subject|0|||
49068141|NCT03400943|158083320|FG003|Follow-up Period|Withdrawal by Subject|0|||
49068142|NCT00117325|158083321|FG000|Overall Study|Adverse Event|3|||
49068143|NCT00117325|158083322|FG001|Overall Study|Adverse Event|3|||
49068144|NCT00117325|158083321|FG000|Overall Study|Lost to Follow-up|1|||
49068145|NCT00117325|158083322|FG001|Overall Study|Lost to Follow-up|1|||
49068146|NCT00117325|158083321|FG000|Overall Study|Protocol Violation|2|||
49068147|NCT00117325|158083322|FG001|Overall Study|Protocol Violation|3|||
49068148|NCT00117325|158083321|FG000|Overall Study|Withdrawal by Subject|3|||
49068149|NCT00117325|158083322|FG001|Overall Study|Withdrawal by Subject|2|||
49068150|NCT00117325|158083321|FG000|Overall Study|Lack of Efficacy|1|||
49068151|NCT00117325|158083322|FG001|Overall Study|Lack of Efficacy|0|||
49068152|NCT00117325|158083321|FG000|Overall Study|Use of prohibited medicine|1|||
49068153|NCT00117325|158083322|FG001|Overall Study|Use of prohibited medicine|2|||
49068154|NCT00117325|158083321|FG000|Overall Study|Early termination|1|||
49068155|NCT00117325|158083322|FG001|Overall Study|Early termination|1|||
49068156|NCT00117325|158083321|FG000|Overall Study|Admisnitrative|1|||
49068157|NCT00117325|158083322|FG001|Overall Study|Admisnitrative|0|||
49068158|NCT03262038|158083323|FG000|Overall Study|Withdrawal by Subject|0|||
49068159|NCT03262038|158083324|FG001|Overall Study|Withdrawal by Subject|1|||
49068160|NCT02085135|158083325|FG000|Overall Study|Adverse Event|4|||
49068161|NCT02085135|158083326|FG001|Overall Study|Adverse Event|7|||
49068162|NCT02085135|158083325|FG000|Overall Study|Lost to Follow-up|2|||
49068163|NCT02085135|158083326|FG001|Overall Study|Lost to Follow-up|2|||
49068164|NCT02085135|158083325|FG000|Overall Study|Withdrawal by Subject|3|||
49068165|NCT02085135|158083326|FG001|Overall Study|Withdrawal by Subject|0|||
49068166|NCT02085135|158083325|FG000|Overall Study|Lack of Efficacy|2|||
49068167|NCT02085135|158083326|FG001|Overall Study|Lack of Efficacy|0|||
49068168|NCT01468818|158083330|FG000|Overall Study|Death during treatment|2|||
49068169|NCT01156142|158083331|FG000|Overall Study|Withdrawal by Subject|8|||
49068170|NCT01156142|158083332|FG001|Overall Study|Withdrawal by Subject|6|||
49068171|NCT01156142|158083331|FG000|Overall Study|Ineligible|0|||
49068172|NCT01156142|158083332|FG001|Overall Study|Ineligible|1|||
49068173|NCT04091659|158083339|FG000|Overall Study|Protocol Violation|3|||
49068174|NCT04091659|158083340|FG001|Overall Study|Protocol Violation|0|||
49068175|NCT04091659|158083339|FG000|Overall Study|Lost to Follow-up|0|||
49068176|NCT04091659|158083340|FG001|Overall Study|Lost to Follow-up|1|||
49068177|NCT01330459|158083341|FG000|Overall Study|Physician Decision|0|||
49068178|NCT01330459|158083342|FG001|Overall Study|Physician Decision|2|||
49068179|NCT04647721|158083345|FG000|Overall Study|Withdrawal by Subject|0|||
49068180|NCT04647721|158083346|FG001|Overall Study|Withdrawal by Subject|2|||
49068181|NCT04647721|158083345|FG000|Overall Study|Lost to Follow-up|2|||
49068182|NCT04647721|158083346|FG001|Overall Study|Lost to Follow-up|0|||
49068183|NCT04159935|158083347|FG000|Overall Study|Study terminated due to COVID-19|1|||
49068184|NCT04159935|158083348|FG001|Overall Study|Study terminated due to COVID-19|3|||
49068185|NCT02787408|158083349|FG000|Overall Study|Death|16|||
49068186|NCT02787408|158083349|FG000|Overall Study|Withdrawal by Subject|1|||
49068187|NCT02787408|158083349|FG000|Overall Study|Non-implanted patient exited post 6 month follow-up visit per protocol|1|||
49068188|NCT01341782|158083354|FG000|Overall Study|Adverse Event|1|||
49068189|NCT01341782|158083355|FG001|Overall Study|Adverse Event|1|||
49068190|NCT01341782|158083354|FG000|Overall Study|Withdrawal by Subject|6|||
49068191|NCT01341782|158083355|FG001|Overall Study|Withdrawal by Subject|5|||
49068192|NCT01341782|158083354|FG000|Overall Study|Missed 3 consecutive doses|0|||
49068193|NCT01341782|158083355|FG001|Overall Study|Missed 3 consecutive doses|4|||
49068194|NCT01341782|158083354|FG000|Overall Study|2 consecutive calcium values >11.5 mg/dL|0|||
49068195|NCT01341782|158083355|FG001|Overall Study|2 consecutive calcium values >11.5 mg/dL|1|||
49068196|NCT01341782|158083354|FG000|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
49068197|NCT01341782|158083355|FG001|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
49068198|NCT01341782|158083354|FG000|Overall Study|Other|5|||
49068199|NCT01341782|158083355|FG001|Overall Study|Other|0|||
49068200|NCT00620555|158083359|FG000|Overall Study|Adverse Event|4|||
49068201|NCT00620555|158083359|FG000|Overall Study|Protocol Violation|2|||
49068202|NCT00620555|158083359|FG000|Overall Study|Lack of Efficacy|12|||
49068203|NCT00620555|158083359|FG000|Overall Study|Withdrawal by Subject|1|||
49068204|NCT00620555|158083359|FG000|Overall Study|Choice of other treatment|1|||
49068205|NCT00620555|158083359|FG000|Overall Study|Visit failure against planned|1|||
49068206|NCT00895414|158083360|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
49068207|NCT00895414|158083361|FG001|First Intervention (14 Days)|Withdrawal by Subject|0|||
49068208|NCT00895414|158083360|FG000|First Intervention (14 Days)|Physician Decision|0|||
49068209|NCT00895414|158083361|FG001|First Intervention (14 Days)|Physician Decision|1|||
49068210|NCT02348723|158083362|FG000|Overall Study|No ablation|21|||
49068211|NCT02348723|158083363|FG001|Overall Study|No ablation|20|||
49068212|NCT02348723|158083362|FG000|Overall Study|Non-compliant with Protocol|1|||
49068213|NCT02348723|158083363|FG001|Overall Study|Non-compliant with Protocol|0|||
49068214|NCT02348723|158083362|FG000|Overall Study|Lost to Follow-up|1|||
49068215|NCT02348723|158083363|FG001|Overall Study|Lost to Follow-up|1|||
49068216|NCT02348723|158083362|FG000|Overall Study|Consent withdrawn|1|||
49068217|NCT02348723|158083363|FG001|Overall Study|Consent withdrawn|3|||
49068218|NCT02348723|158083362|FG000|Overall Study|Reason other than specified|1|||
49068219|NCT02348723|158083363|FG001|Overall Study|Reason other than specified|1|||
49068220|NCT02348723|158083362|FG000|Overall Study|Adverse Event|3|||
49068221|NCT02348723|158083363|FG001|Overall Study|Adverse Event|1|||
49068222|NCT02036775|158083364|FG000|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
49068223|NCT02036775|158083365|FG001|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
49068224|NCT02036775|158083366|FG002|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
49068225|NCT02036775|158083367|FG003|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
49068226|NCT02036775|158083368|FG004|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
49068227|NCT02036775|158083369|FG005|Treatment Period 2 (6 Days)|Withdrawal by Subject|1|||
49068228|NCT01140503|158083370|FG000|Overall Study|Withdrawal by Subject|1|||
49068229|NCT00724048|158083377|FG000|Overall Study|Adverse Event|1|||
49068230|NCT00724048|158083378|FG001|Overall Study|Adverse Event|1|||
49068231|NCT00724048|158083379|FG002|Overall Study|Adverse Event|1|||
49068232|NCT00724048|158083380|FG003|Overall Study|Adverse Event|0|||
49068233|NCT00724048|158083377|FG000|Overall Study|Lost to Follow-up|0|||
49068234|NCT00724048|158083378|FG001|Overall Study|Lost to Follow-up|1|||
49068235|NCT00724048|158083379|FG002|Overall Study|Lost to Follow-up|0|||
49068236|NCT00724048|158083380|FG003|Overall Study|Lost to Follow-up|0|||
49068237|NCT00724048|158083377|FG000|Overall Study|Withdrawal by Subject|1|||
49068238|NCT00724048|158083378|FG001|Overall Study|Withdrawal by Subject|2|||
49068239|NCT00724048|158083379|FG002|Overall Study|Withdrawal by Subject|1|||
49068240|NCT00724048|158083380|FG003|Overall Study|Withdrawal by Subject|2|||
49068241|NCT00724048|158083377|FG000|Overall Study|Investigator decision|0|||
49068242|NCT00724048|158083378|FG001|Overall Study|Investigator decision|0|||
49068243|NCT00724048|158083379|FG002|Overall Study|Investigator decision|1|||
49068244|NCT00724048|158083380|FG003|Overall Study|Investigator decision|0|||
49068245|NCT00724048|158083377|FG000|Overall Study|Did not tolerate study drug|0|||
49068246|NCT00724048|158083378|FG001|Overall Study|Did not tolerate study drug|0|||
49068247|NCT00724048|158083379|FG002|Overall Study|Did not tolerate study drug|0|||
49068248|NCT00724048|158083380|FG003|Overall Study|Did not tolerate study drug|1|||
49068249|NCT00724048|158083377|FG000|Overall Study|Other than specified|1|||
49068250|NCT00724048|158083378|FG001|Overall Study|Other than specified|1|||
49068251|NCT00724048|158083379|FG002|Overall Study|Other than specified|0|||
49068252|NCT00724048|158083380|FG003|Overall Study|Other than specified|0|||
49068253|NCT02087189|158083381|FG000|Overall Study|enrolled but did not receive a TD01 as implant|2|||
49068254|NCT02257385|158083382|FG000|Overall Study|Adverse Event|12|||
49068255|NCT02257385|158083383|FG001|Overall Study|Adverse Event|8|||
49068256|NCT02257385|158083382|FG000|Overall Study|Lack of Efficacy|1|||
49068257|NCT02257385|158083383|FG001|Overall Study|Lack of Efficacy|2|||
49068258|NCT02257385|158083382|FG000|Overall Study|Protocol Violation|5|||
49068259|NCT02257385|158083383|FG001|Overall Study|Protocol Violation|7|||
49068260|NCT02257385|158083382|FG000|Overall Study|Lost to Follow-up|0|||
49068261|NCT02257385|158083383|FG001|Overall Study|Lost to Follow-up|1|||
49068262|NCT02257385|158083382|FG000|Overall Study|Withdrawal by Subject|4|||
49068263|NCT02257385|158083383|FG001|Overall Study|Withdrawal by Subject|4|||
49068264|NCT00077857|158083385|FG000|Overall Study|Adverse Event|30|||
49068265|NCT00077857|158083386|FG001|Overall Study|Adverse Event|32|||
49068266|NCT00077857|158083385|FG000|Overall Study|Death|7|||
49068267|NCT00077857|158083386|FG001|Overall Study|Death|3|||
49068268|NCT00077857|158083385|FG000|Overall Study|Insufficient therapeutic response|112|||
49068269|NCT00077857|158083386|FG001|Overall Study|Insufficient therapeutic response|128|||
49068270|NCT00077857|158083385|FG000|Overall Study|Violation of selection criteria at entry|3|||
49068271|NCT00077857|158083386|FG001|Overall Study|Violation of selection criteria at entry|1|||
49068272|NCT00077857|158083385|FG000|Overall Study|Other protocol violation|0|||
49068273|NCT00077857|158083386|FG001|Overall Study|Other protocol violation|1|||
49068274|NCT00077857|158083385|FG000|Overall Study|Refused treatment|29|||
49068275|NCT00077857|158083386|FG001|Overall Study|Refused treatment|21|||
49068276|NCT00077857|158083385|FG000|Overall Study|Failure to return|5|||
49068277|NCT00077857|158083386|FG001|Overall Study|Failure to return|5|||
49068278|NCT00077857|158083385|FG000|Overall Study|Other|15|||
49068279|NCT00077857|158083386|FG001|Overall Study|Other|13|||
49068280|NCT00896480|158083387|FG000|Overall Study|Disease progression/recurrence|21|||
49068281|NCT03753763|158083388|FG000|Overall Study|Adverse Event|2|||
49068282|NCT03753763|158083389|FG001|Overall Study|Adverse Event|0|||
49068283|NCT03753763|158083388|FG000|Overall Study|Withdrawal by Subject|3|||
49068284|NCT03753763|158083389|FG001|Overall Study|Withdrawal by Subject|1|||
49068285|NCT03753763|158083388|FG000|Overall Study|clinical deterioration|1|||
49068286|NCT03753763|158083389|FG001|Overall Study|clinical deterioration|0|||
49068287|NCT01104779|158083390|FG000|Overall Study|Protocol Violation|1|||
49068288|NCT01104779|158083391|FG001|Overall Study|Protocol Violation|2|||
49068289|NCT01104779|158083392|FG002|Overall Study|Protocol Violation|2|||
49068290|NCT01104779|158083390|FG000|Overall Study|Lack of Efficacy|26|||
49068291|NCT01104779|158083391|FG001|Overall Study|Lack of Efficacy|12|||
49068292|NCT01104779|158083392|FG002|Overall Study|Lack of Efficacy|13|||
49068293|NCT01104779|158083390|FG000|Overall Study|Adverse Event|13|||
49068294|NCT01104779|158083391|FG001|Overall Study|Adverse Event|14|||
49068295|NCT01104779|158083392|FG002|Overall Study|Adverse Event|13|||
49068296|NCT01104779|158083390|FG000|Overall Study|Did not meet inc/exc criteria|1|||
49068297|NCT01104779|158083391|FG001|Overall Study|Did not meet inc/exc criteria|1|||
49068298|NCT01104779|158083392|FG002|Overall Study|Did not meet inc/exc criteria|1|||
49068299|NCT01104779|158083390|FG000|Overall Study|Other reasons|0|||
49068300|NCT01104779|158083391|FG001|Overall Study|Other reasons|1|||
49068301|NCT01104779|158083392|FG002|Overall Study|Other reasons|0|||
49068302|NCT01104779|158083390|FG000|Overall Study|Lost to Follow-up|2|||
49068303|NCT01104779|158083391|FG001|Overall Study|Lost to Follow-up|0|||
49068304|NCT01104779|158083392|FG002|Overall Study|Lost to Follow-up|1|||
49068305|NCT01104779|158083390|FG000|Overall Study|Withdrawal by Subject|16|||
49068306|NCT01104779|158083391|FG001|Overall Study|Withdrawal by Subject|25|||
49068307|NCT01104779|158083392|FG002|Overall Study|Withdrawal by Subject|32|||
49068308|NCT01284621|158083393|FG000|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
49068309|NCT01284621|158083394|FG001|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
49068310|NCT01284621|158083395|FG002|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
49068311|NCT01284621|158083396|FG003|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
49068312|NCT01284621|158083397|FG004|Washout Period 1 (7 Days)|Required unexpected medical treatment|1|||
49068313|NCT01284621|158083398|FG005|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
49068314|NCT04597632|158083399|FG000|Overall Study|Withdrawal by Subject|10|||
49068315|NCT04597632|158083399|FG000|Overall Study|Lost to Follow-up|1|||
49068316|NCT04597632|158083399|FG000|Overall Study|Death|1|||
49068317|NCT04597632|158083399|FG000|Overall Study|Adverse Event|5|||
49068318|NCT00307437|158083400|FG000|Controlled Period|Adverse Event|7|||
49068319|NCT00307437|158083401|FG001|Controlled Period|Adverse Event|2|||
49068320|NCT00307437|158083402|FG002|Controlled Period|Adverse Event|5|||
49068321|NCT00307437|158083403|FG003|Controlled Period|Adverse Event|0|||
49068322|NCT00307437|158083404|FG004|Controlled Period|Adverse Event|0|||
49068323|NCT00307437|158083405|FG005|Controlled Period|Adverse Event|0|||
49068324|NCT00307437|158083406|FG006|Controlled Period|Adverse Event|0|||
49068325|NCT00307437|158083400|FG000|Controlled Period|Death|0|||
49068326|NCT00307437|158083401|FG001|Controlled Period|Death|0|||
49068327|NCT00307437|158083402|FG002|Controlled Period|Death|1|||
49068328|NCT00307437|158083403|FG003|Controlled Period|Death|0|||
49068329|NCT00307437|158083404|FG004|Controlled Period|Death|0|||
49068330|NCT00307437|158083405|FG005|Controlled Period|Death|0|||
49068331|NCT00307437|158083406|FG006|Controlled Period|Death|0|||
49068332|NCT00307437|158083400|FG000|Controlled Period|Lack of Efficacy|2|||
49068333|NCT00307437|158083401|FG001|Controlled Period|Lack of Efficacy|0|||
49068334|NCT00307437|158083402|FG002|Controlled Period|Lack of Efficacy|0|||
49068335|NCT00307437|158083403|FG003|Controlled Period|Lack of Efficacy|0|||
49068336|NCT00307437|158083404|FG004|Controlled Period|Lack of Efficacy|0|||
49068337|NCT00307437|158083405|FG005|Controlled Period|Lack of Efficacy|0|||
49068338|NCT00307437|158083406|FG006|Controlled Period|Lack of Efficacy|0|||
49068339|NCT00307437|158083400|FG000|Controlled Period|Lost to Follow-up|2|||
49068340|NCT00307437|158083401|FG001|Controlled Period|Lost to Follow-up|3|||
49068341|NCT00307437|158083402|FG002|Controlled Period|Lost to Follow-up|0|||
49068342|NCT00307437|158083403|FG003|Controlled Period|Lost to Follow-up|0|||
49068343|NCT00307437|158083404|FG004|Controlled Period|Lost to Follow-up|0|||
49068344|NCT00307437|158083405|FG005|Controlled Period|Lost to Follow-up|0|||
49068345|NCT00307437|158083406|FG006|Controlled Period|Lost to Follow-up|0|||
49068346|NCT00307437|158083400|FG000|Controlled Period|Other|5|||
49068347|NCT00307437|158083401|FG001|Controlled Period|Other|1|||
49068348|NCT00307437|158083402|FG002|Controlled Period|Other|3|||
49068349|NCT00307437|158083403|FG003|Controlled Period|Other|0|||
49068350|NCT00307437|158083404|FG004|Controlled Period|Other|0|||
49068351|NCT00307437|158083405|FG005|Controlled Period|Other|0|||
49068352|NCT00307437|158083406|FG006|Controlled Period|Other|0|||
49068353|NCT00307437|158083400|FG000|After Controlled Period|Adverse Event|0|||
49068354|NCT00307437|158083401|FG001|After Controlled Period|Adverse Event|0|||
49068355|NCT00307437|158083402|FG002|After Controlled Period|Adverse Event|0|||
49068356|NCT00307437|158083403|FG003|After Controlled Period|Adverse Event|18|||
49068357|NCT00307437|158083404|FG004|After Controlled Period|Adverse Event|16|||
49068358|NCT00307437|158083405|FG005|After Controlled Period|Adverse Event|31|||
49068359|NCT00307437|158083406|FG006|After Controlled Period|Adverse Event|40|||
49068360|NCT00307437|158083400|FG000|After Controlled Period|Death|0|||
49068361|NCT00307437|158083401|FG001|After Controlled Period|Death|0|||
49068362|NCT00307437|158083402|FG002|After Controlled Period|Death|0|||
49068363|NCT00307437|158083403|FG003|After Controlled Period|Death|3|||
49068364|NCT00307437|158083404|FG004|After Controlled Period|Death|1|||
49068365|NCT00307437|158083405|FG005|After Controlled Period|Death|1|||
49068366|NCT00307437|158083406|FG006|After Controlled Period|Death|3|||
49068367|NCT00307437|158083400|FG000|After Controlled Period|Lack of Efficacy|0|||
49068368|NCT00307437|158083401|FG001|After Controlled Period|Lack of Efficacy|0|||
49068369|NCT00307437|158083402|FG002|After Controlled Period|Lack of Efficacy|0|||
49068370|NCT00307437|158083403|FG003|After Controlled Period|Lack of Efficacy|15|||
49068371|NCT00307437|158083404|FG004|After Controlled Period|Lack of Efficacy|17|||
49068372|NCT00307437|158083405|FG005|After Controlled Period|Lack of Efficacy|37|||
49068373|NCT00307437|158083406|FG006|After Controlled Period|Lack of Efficacy|24|||
49068374|NCT00307437|158083400|FG000|After Controlled Period|Lost to Follow-up|0|||
49068375|NCT00307437|158083401|FG001|After Controlled Period|Lost to Follow-up|0|||
49068376|NCT00307437|158083402|FG002|After Controlled Period|Lost to Follow-up|0|||
49068377|NCT00307437|158083403|FG003|After Controlled Period|Lost to Follow-up|7|||
49068378|NCT00307437|158083404|FG004|After Controlled Period|Lost to Follow-up|12|||
49068379|NCT00307437|158083405|FG005|After Controlled Period|Lost to Follow-up|13|||
49068380|NCT00307437|158083406|FG006|After Controlled Period|Lost to Follow-up|18|||
49068381|NCT00307437|158083400|FG000|After Controlled Period|Other|0|||
49068382|NCT00307437|158083401|FG001|After Controlled Period|Other|0|||
49068383|NCT00307437|158083402|FG002|After Controlled Period|Other|0|||
49068384|NCT00307437|158083403|FG003|After Controlled Period|Other|15|||
49068385|NCT00307437|158083404|FG004|After Controlled Period|Other|9|||
49068386|NCT00307437|158083405|FG005|After Controlled Period|Other|40|||
49068387|NCT00307437|158083406|FG006|After Controlled Period|Other|28|||
49068388|NCT02952898|158083411|FG000|Overall Study|Withdrawal by Subject|10|||
49068389|NCT02952898|158083412|FG001|Overall Study|Withdrawal by Subject|8|||
49068390|NCT02952898|158083413|FG002|Overall Study|Withdrawal by Subject|8|||
49068391|NCT02952898|158083411|FG000|Overall Study|Adverse Event|8|||
49068392|NCT02952898|158083412|FG001|Overall Study|Adverse Event|8|||
49068393|NCT02952898|158083413|FG002|Overall Study|Adverse Event|3|||
49068394|NCT02952898|158083411|FG000|Overall Study|Lost to Follow-up|3|||
49068395|NCT02952898|158083412|FG001|Overall Study|Lost to Follow-up|2|||
49068396|NCT02952898|158083413|FG002|Overall Study|Lost to Follow-up|2|||
49068397|NCT02952898|158083411|FG000|Overall Study|Non-compliance with study drug|1|||
49068398|NCT02952898|158083412|FG001|Overall Study|Non-compliance with study drug|1|||
49068399|NCT02952898|158083413|FG002|Overall Study|Non-compliance with study drug|2|||
49068400|NCT04844762|158083414|FG000|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
49068401|NCT04844762|158083415|FG001|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
49068402|NCT04844762|158083416|FG002|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|2|||
49068403|NCT04844762|158083417|FG003|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
49068404|NCT04844762|158083418|FG004|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
49068405|NCT04844762|158083419|FG005|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
49068406|NCT04844762|158083414|FG000|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
49068407|NCT04844762|158083415|FG001|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
49068408|NCT04844762|158083416|FG002|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
49068409|NCT04844762|158083417|FG003|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
49068410|NCT04844762|158083418|FG004|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
49068411|NCT04844762|158083419|FG005|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
49068412|NCT04844762|158083414|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
49068413|NCT04844762|158083415|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
49068414|NCT04844762|158083416|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
49068415|NCT04844762|158083417|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|3|||
49068416|NCT04844762|158083418|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
49068417|NCT04844762|158083419|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
49068418|NCT04844762|158083414|FG000|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
49068419|NCT04844762|158083415|FG001|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
49068420|NCT04844762|158083416|FG002|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
49068421|NCT04844762|158083417|FG003|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
49068422|NCT04844762|158083418|FG004|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|2|||
49068423|NCT04844762|158083419|FG005|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
49068424|NCT04844762|158083414|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
49068425|NCT04844762|158083415|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|2|||
49068426|NCT04844762|158083416|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
49068427|NCT04844762|158083417|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
49068428|NCT04844762|158083418|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
49068429|NCT04844762|158083419|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
49068430|NCT04844762|158083414|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
49068431|NCT04844762|158083415|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
49068432|NCT04844762|158083416|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
49068433|NCT04844762|158083417|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
49068434|NCT04844762|158083418|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
49068435|NCT04844762|158083419|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
49068436|NCT04844762|158083414|FG000|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
49068437|NCT04844762|158083415|FG001|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
49068438|NCT04844762|158083416|FG002|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
49068439|NCT04844762|158083417|FG003|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
49068440|NCT04844762|158083418|FG004|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|1|||
49068441|NCT04844762|158083419|FG005|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
49068442|NCT04844762|158083414|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
49068443|NCT04844762|158083415|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
49068444|NCT04844762|158083416|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
49068445|NCT04844762|158083417|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
49068446|NCT04844762|158083418|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
49068447|NCT04844762|158083419|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
49068448|NCT04844762|158083414|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
49068449|NCT04844762|158083415|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
49068450|NCT04844762|158083416|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
49068451|NCT04844762|158083417|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
49068452|NCT04844762|158083418|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
49068453|NCT04844762|158083419|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
49068454|NCT04844762|158083414|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
49068455|NCT04844762|158083415|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|1|||
49068456|NCT04844762|158083416|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
49068457|NCT04844762|158083417|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
49068458|NCT04844762|158083418|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
49068459|NCT04844762|158083419|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
49068460|NCT04844762|158083414|FG000|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
49068461|NCT04844762|158083415|FG001|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
49068462|NCT04844762|158083416|FG002|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
49068463|NCT04844762|158083417|FG003|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|1|||
49068464|NCT04844762|158083418|FG004|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
49068465|NCT04844762|158083419|FG005|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
49068466|NCT02099682|158083422|FG000|Overall Study|Data Not Available|51|||
49068467|NCT02099682|158083422|FG000|Overall Study|Lost to Follow-up|31|||
49068468|NCT02099682|158083422|FG000|Overall Study|Other|29|||
49068469|NCT02185053|158083423|FG000|Solifenacin Dose Escalation Phase|Cardiac symptoms|1|||
49068470|NCT02185053|158083424|FG001|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
49068471|NCT02185053|158083425|FG002|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
49068472|NCT02185053|158083423|FG000|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2|||
49068473|NCT02185053|158083424|FG001|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
49068474|NCT02185053|158083425|FG002|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
49068475|NCT02185053|158083423|FG000|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
49068476|NCT02185053|158083424|FG001|Donepezil Dose Escalation Phase|Cardiac symptoms|1|||
49068477|NCT02185053|158083425|FG002|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
49068478|NCT02185053|158083423|FG000|Donepezil Dose Escalation Phase|Adverse Event|0|||
49068479|NCT02185053|158083424|FG001|Donepezil Dose Escalation Phase|Adverse Event|1|||
49068480|NCT02185053|158083425|FG002|Donepezil Dose Escalation Phase|Adverse Event|0|||
49068481|NCT02185053|158083423|FG000|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
49068482|NCT02185053|158083424|FG001|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2|||
49068483|NCT02185053|158083425|FG002|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
49068484|NCT02185053|158083423|FG000|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
49068485|NCT02185053|158083424|FG001|Donepezil Dose Escalation Phase|Withdrawal by Subject|1|||
49068486|NCT02185053|158083425|FG002|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
49068487|NCT02185053|158083423|FG000|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
49068488|NCT02185053|158083424|FG001|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
49068489|NCT02185053|158083425|FG002|Donepezil Dose Maintenance Phase|Cardiac symptoms|1|||
49068490|NCT02185053|158083423|FG000|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
49068491|NCT02185053|158083424|FG001|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
49068492|NCT02185053|158083425|FG002|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2|||
49068493|NCT00839254|158083426|FG000|Overall Study|Protocol Violation|0|||
49068494|NCT00839254|158083427|FG001|Overall Study|Protocol Violation|1|||
49068495|NCT00839254|158083428|FG002|Overall Study|Protocol Violation|1|||
49068496|NCT00839254|158083429|FG003|Overall Study|Protocol Violation|1|||
49068497|NCT00839254|158083430|FG004|Overall Study|Protocol Violation|0|||
49068498|NCT00839254|158083431|FG005|Overall Study|Protocol Violation|0|||
49068499|NCT00839254|158083432|FG006|Overall Study|Protocol Violation|1|||
49068500|NCT00839254|158083433|FG007|Overall Study|Protocol Violation|2|||
49068501|NCT00839254|158083426|FG000|Overall Study|Physician Decision|0|||
49068502|NCT00839254|158083427|FG001|Overall Study|Physician Decision|1|||
49068503|NCT00839254|158083428|FG002|Overall Study|Physician Decision|0|||
49068504|NCT00839254|158083429|FG003|Overall Study|Physician Decision|0|||
49068505|NCT00839254|158083430|FG004|Overall Study|Physician Decision|0|||
49068506|NCT00839254|158083431|FG005|Overall Study|Physician Decision|0|||
49068507|NCT00839254|158083432|FG006|Overall Study|Physician Decision|0|||
49068508|NCT00839254|158083433|FG007|Overall Study|Physician Decision|1|||
49068509|NCT00839254|158083426|FG000|Overall Study|Wrong treatment number allocation|0|||
49068510|NCT00839254|158083427|FG001|Overall Study|Wrong treatment number allocation|1|||
49068511|NCT00839254|158083428|FG002|Overall Study|Wrong treatment number allocation|0|||
49068512|NCT00839254|158083429|FG003|Overall Study|Wrong treatment number allocation|0|||
49068513|NCT00839254|158083430|FG004|Overall Study|Wrong treatment number allocation|0|||
49068514|NCT00839254|158083431|FG005|Overall Study|Wrong treatment number allocation|1|||
49068515|NCT00839254|158083432|FG006|Overall Study|Wrong treatment number allocation|0|||
49068516|NCT00839254|158083433|FG007|Overall Study|Wrong treatment number allocation|0|||
49068517|NCT00839254|158083426|FG000|Overall Study|Adverse Event|12|||
49068518|NCT00839254|158083427|FG001|Overall Study|Adverse Event|6|||
49068519|NCT00839254|158083428|FG002|Overall Study|Adverse Event|3|||
49068520|NCT00839254|158083429|FG003|Overall Study|Adverse Event|5|||
49068521|NCT00839254|158083430|FG004|Overall Study|Adverse Event|2|||
49068522|NCT00839254|158083431|FG005|Overall Study|Adverse Event|1|||
49068523|NCT00839254|158083432|FG006|Overall Study|Adverse Event|0|||
49068524|NCT00839254|158083433|FG007|Overall Study|Adverse Event|1|||
49068525|NCT00839254|158083426|FG000|Overall Study|Withdrawal by Subject|87|||
49068526|NCT00839254|158083427|FG001|Overall Study|Withdrawal by Subject|53|||
49068527|NCT00839254|158083428|FG002|Overall Study|Withdrawal by Subject|54|||
49068528|NCT00839254|158083429|FG003|Overall Study|Withdrawal by Subject|32|||
49068529|NCT00839254|158083430|FG004|Overall Study|Withdrawal by Subject|27|||
49068530|NCT00839254|158083431|FG005|Overall Study|Withdrawal by Subject|15|||
49068531|NCT00839254|158083432|FG006|Overall Study|Withdrawal by Subject|22|||
49068532|NCT00839254|158083433|FG007|Overall Study|Withdrawal by Subject|9|||
49068533|NCT00839254|158083426|FG000|Overall Study|Wrong group allocation|0|||
49068534|NCT00839254|158083427|FG001|Overall Study|Wrong group allocation|0|||
49068535|NCT00839254|158083428|FG002|Overall Study|Wrong group allocation|0|||
49068536|NCT00839254|158083429|FG003|Overall Study|Wrong group allocation|0|||
49068537|NCT00839254|158083430|FG004|Overall Study|Wrong group allocation|0|||
49068538|NCT00839254|158083431|FG005|Overall Study|Wrong group allocation|0|||
49068539|NCT00839254|158083432|FG006|Overall Study|Wrong group allocation|1|||
49068540|NCT00839254|158083433|FG007|Overall Study|Wrong group allocation|0|||
49068541|NCT00839254|158083426|FG000|Overall Study|Parents wanted pneumococcal vaccine|1|||
49068542|NCT00839254|158083427|FG001|Overall Study|Parents wanted pneumococcal vaccine|0|||
49068543|NCT00839254|158083428|FG002|Overall Study|Parents wanted pneumococcal vaccine|0|||
49068544|NCT00839254|158083429|FG003|Overall Study|Parents wanted pneumococcal vaccine|0|||
49068545|NCT00839254|158083430|FG004|Overall Study|Parents wanted pneumococcal vaccine|0|||
49068546|NCT00839254|158083431|FG005|Overall Study|Parents wanted pneumococcal vaccine|1|||
49068547|NCT00839254|158083432|FG006|Overall Study|Parents wanted pneumococcal vaccine|0|||
49068548|NCT00839254|158083433|FG007|Overall Study|Parents wanted pneumococcal vaccine|0|||
49068549|NCT00839254|158083426|FG000|Overall Study|Withdrawn due to non-compliance|2|||
49068550|NCT00839254|158083427|FG001|Overall Study|Withdrawn due to non-compliance|0|||
49068551|NCT00839254|158083428|FG002|Overall Study|Withdrawn due to non-compliance|0|||
49068552|NCT00839254|158083429|FG003|Overall Study|Withdrawn due to non-compliance|0|||
49068553|NCT00839254|158083430|FG004|Overall Study|Withdrawn due to non-compliance|0|||
49068554|NCT00839254|158083431|FG005|Overall Study|Withdrawn due to non-compliance|0|||
49068555|NCT00839254|158083432|FG006|Overall Study|Withdrawn due to non-compliance|0|||
49068556|NCT00839254|158083433|FG007|Overall Study|Withdrawn due to non-compliance|0|||
49068557|NCT00839254|158083426|FG000|Overall Study|Lost to Follow-up|51|||
49068558|NCT00839254|158083427|FG001|Overall Study|Lost to Follow-up|30|||
49068559|NCT00839254|158083428|FG002|Overall Study|Lost to Follow-up|32|||
49068560|NCT00839254|158083429|FG003|Overall Study|Lost to Follow-up|24|||
49068561|NCT00839254|158083430|FG004|Overall Study|Lost to Follow-up|8|||
49068562|NCT00839254|158083431|FG005|Overall Study|Lost to Follow-up|8|||
49068563|NCT00839254|158083432|FG006|Overall Study|Lost to Follow-up|4|||
49068564|NCT00839254|158083433|FG007|Overall Study|Lost to Follow-up|2|||
49068565|NCT03559400|158084850|FG000|Overall Study|Lost to Follow-up|9|||
49068566|NCT03559400|158084851|FG001|Overall Study|Lost to Follow-up|7|||
49068567|NCT03559400|158084850|FG000|Overall Study|Death|0|||
49068568|NCT03559400|158084851|FG001|Overall Study|Death|2|||
49068569|NCT02563106|158084852|FG000|Overall Study|Withdrawal by Subject|7|||
49068570|NCT02563106|158084853|FG001|Overall Study|Withdrawal by Subject|8|||
49068571|NCT02563106|158084852|FG000|Overall Study|Adverse Event|17|||
49068572|NCT02563106|158084853|FG001|Overall Study|Adverse Event|15|||
49068573|NCT02563106|158084852|FG000|Overall Study|Protocol Violation|1|||
49068574|NCT02563106|158084853|FG001|Overall Study|Protocol Violation|0|||
49068575|NCT02563106|158084852|FG000|Overall Study|Use of non-permitted concurrent therapy|1|||
49068576|NCT02563106|158084853|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
49068577|NCT02563106|158084852|FG000|Overall Study|Lost to Follow-up|3|||
49068578|NCT02563106|158084853|FG001|Overall Study|Lost to Follow-up|2|||
49068579|NCT02563106|158084852|FG000|Overall Study|Physician Decision|3|||
49068580|NCT02563106|158084853|FG001|Overall Study|Physician Decision|1|||
49068581|NCT02563106|158084852|FG000|Overall Study|Other reason - not specified|2|||
49068582|NCT02563106|158084853|FG001|Overall Study|Other reason - not specified|1|||
49068583|NCT01087489|158084854|FG000|Overall Study|enrolled in another VA study|0|||
49068584|NCT01087489|158084855|FG001|Overall Study|enrolled in another VA study|1|||
49068585|NCT01087489|158084854|FG000|Overall Study|Death|0|||
49068586|NCT01087489|158084855|FG001|Overall Study|Death|1|||
49068587|NCT01087489|158084854|FG000|Overall Study|unable to survey by telephone|0|||
49068588|NCT01087489|158084855|FG001|Overall Study|unable to survey by telephone|1|||
49068589|NCT00537303|158084856|FG000|Overall Study|Adverse Event|1|||
49068590|NCT00537303|158084857|FG001|Overall Study|Adverse Event|4|||
49068591|NCT00537303|158084856|FG000|Overall Study|Lack of Efficacy|6|||
49068592|NCT00537303|158084857|FG001|Overall Study|Lack of Efficacy|7|||
49068593|NCT00537303|158084856|FG000|Overall Study|Protocol Violation|8|||
49068594|NCT00537303|158084857|FG001|Overall Study|Protocol Violation|4|||
49068595|NCT00537303|158084856|FG000|Overall Study|Withdrawal criteria|3|||
49068596|NCT00537303|158084857|FG001|Overall Study|Withdrawal criteria|3|||
49068597|NCT00537303|158084856|FG000|Overall Study|Unclassified|8|||
49068598|NCT00537303|158084857|FG001|Overall Study|Unclassified|7|||
49068599|NCT00893737|158084858|FG000|Overall Study|Adverse Event|4|||
49068600|NCT00893737|158084858|FG000|Overall Study|Withdrawal by Subject|2|||
49068601|NCT00893737|158084858|FG000|Overall Study|Lost to Follow-up|6|||
49068602|NCT00928707|158084859|FG000|Overall Study|Protocol Violation|1|||
49068603|NCT00928707|158084860|FG001|Overall Study|Protocol Violation|0|||
49068604|NCT00132028|158084861|FG000|Overall Study|Adverse Event|7|||
49068605|NCT00132028|158084861|FG000|Overall Study|Death|2|||
49068606|NCT00132028|158084861|FG000|Overall Study|Lack of Efficacy|11|||
49068607|NCT00132028|158084861|FG000|Overall Study|Withdrawal by Subject|2|||
49068608|NCT00132028|158084861|FG000|Overall Study|not eligible|2|||
49068609|NCT00132028|158084861|FG000|Overall Study|Physician Decision|3|||
49068610|NCT01136967|158084862|FG000|Overall Study|Adverse Event|9|||
49068611|NCT01136967|158084863|FG001|Overall Study|Adverse Event|12|||
49068612|NCT01136967|158084862|FG000|Overall Study|Participant Choice|8|||
49068613|NCT01136967|158084863|FG001|Overall Study|Participant Choice|3|||
49068614|NCT01136967|158084862|FG000|Overall Study|Lost to Follow-up|0|||
49068615|NCT01136967|158084863|FG001|Overall Study|Lost to Follow-up|1|||
49068616|NCT01136967|158084862|FG000|Overall Study|Withdrawal by Subject|1|||
49068617|NCT01136967|158084863|FG001|Overall Study|Withdrawal by Subject|2|||
49068618|NCT01136967|158084862|FG000|Overall Study|Clinical Progression|3|||
49068619|NCT01136967|158084863|FG001|Overall Study|Clinical Progression|5|||
49068620|NCT01136967|158084862|FG000|Overall Study|Radiation|1|||
49068621|NCT01136967|158084863|FG001|Overall Study|Radiation|0|||
49068622|NCT01136967|158084862|FG000|Overall Study|Non-compliance|1|||
49068623|NCT01136967|158084863|FG001|Overall Study|Non-compliance|0|||
49068624|NCT01136967|158084862|FG000|Overall Study|Investigator's Choice|1|||
49068625|NCT01136967|158084863|FG001|Overall Study|Investigator's Choice|1|||
49068626|NCT01136967|158084862|FG000|Overall Study|Increase in Lesion Size|0|||
49068627|NCT01136967|158084863|FG001|Overall Study|Increase in Lesion Size|2|||
49068628|NCT01136967|158084862|FG000|Overall Study|Diagnosis of Second Primary Cancer|0|||
49068629|NCT01136967|158084863|FG001|Overall Study|Diagnosis of Second Primary Cancer|1|||
49068630|NCT04933968|158084864|FG000|Overall Study|Adverse Event|0|||
49068631|NCT04933968|158084865|FG001|Overall Study|Adverse Event|0|||
49068632|NCT04933968|158084866|FG002|Overall Study|Adverse Event|1|||
49068633|NCT04933968|158084867|FG003|Overall Study|Adverse Event|1|||
49068634|NCT04933968|158084868|FG004|Overall Study|Adverse Event|0|||
49068635|NCT04933968|158084869|FG005|Overall Study|Adverse Event|0|||
49068636|NCT04933968|158084864|FG000|Overall Study|Lost to Follow-up|1|||
49068637|NCT04933968|158084865|FG001|Overall Study|Lost to Follow-up|0|||
49068638|NCT04933968|158084866|FG002|Overall Study|Lost to Follow-up|1|||
49068639|NCT04933968|158084867|FG003|Overall Study|Lost to Follow-up|0|||
49068640|NCT04933968|158084868|FG004|Overall Study|Lost to Follow-up|0|||
49068641|NCT04933968|158084869|FG005|Overall Study|Lost to Follow-up|0|||
49068642|NCT04933968|158084864|FG000|Overall Study|Randomized not treated|1|||
49068643|NCT04933968|158084865|FG001|Overall Study|Randomized not treated|0|||
49068644|NCT04933968|158084866|FG002|Overall Study|Randomized not treated|0|||
49068645|NCT04933968|158084867|FG003|Overall Study|Randomized not treated|0|||
49068646|NCT04933968|158084868|FG004|Overall Study|Randomized not treated|0|||
49068647|NCT04933968|158084869|FG005|Overall Study|Randomized not treated|0|||
49068648|NCT04933968|158084864|FG000|Overall Study|Sponsor terminated study|0|||
49068649|NCT04933968|158084865|FG001|Overall Study|Sponsor terminated study|0|||
49068650|NCT04933968|158084866|FG002|Overall Study|Sponsor terminated study|0|||
49068651|NCT04933968|158084867|FG003|Overall Study|Sponsor terminated study|1|||
49068652|NCT04933968|158084868|FG004|Overall Study|Sponsor terminated study|2|||
49068653|NCT04933968|158084869|FG005|Overall Study|Sponsor terminated study|0|||
49068654|NCT04933968|158084864|FG000|Overall Study|Other|0|||
49068655|NCT04933968|158084865|FG001|Overall Study|Other|0|||
49068656|NCT04933968|158084866|FG002|Overall Study|Other|0|||
49068657|NCT04933968|158084867|FG003|Overall Study|Other|1|||
49068658|NCT04933968|158084868|FG004|Overall Study|Other|0|||
49068659|NCT04933968|158084869|FG005|Overall Study|Other|0|||
49068660|NCT04933968|158084864|FG000|Overall Study|Missing|1|||
49068661|NCT04933968|158084865|FG001|Overall Study|Missing|3|||
49068662|NCT04933968|158084866|FG002|Overall Study|Missing|2|||
49068663|NCT04933968|158084867|FG003|Overall Study|Missing|1|||
49068664|NCT04933968|158084868|FG004|Overall Study|Missing|1|||
49068665|NCT04933968|158084869|FG005|Overall Study|Missing|0|||
49068666|NCT05386030|158084870|FG000|Overall Study|Death|1|||
49068667|NCT05386030|158084871|FG001|Overall Study|Death|0|||
49068668|NCT05386030|158084870|FG000|Overall Study|Physician Decision|2|||
49068669|NCT05386030|158084871|FG001|Overall Study|Physician Decision|1|||
49068670|NCT05386030|158084870|FG000|Overall Study|Lost to Follow-up|19|||
49068671|NCT05386030|158084871|FG001|Overall Study|Lost to Follow-up|7|||
49068672|NCT05386030|158084870|FG000|Overall Study|Withdrawal by Subject|20|||
49068673|NCT05386030|158084871|FG001|Overall Study|Withdrawal by Subject|10|||
49068674|NCT05386030|158084870|FG000|Overall Study|Eligibility criteria violation|1|||
49068675|NCT05386030|158084871|FG001|Overall Study|Eligibility criteria violation|1|||
49068676|NCT05386030|158084870|FG000|Overall Study|Personal Reasons|1|||
49068677|NCT05386030|158084871|FG001|Overall Study|Personal Reasons|0|||
49068678|NCT01735955|158084872|FG000|Overall Study|Administrative problems|1|||
49068679|NCT01735955|158084872|FG000|Overall Study|Patient/guardian decision|1|||
49068680|NCT01735955|158084872|FG000|Overall Study|Patient withdrew consent|2|||
49068681|NCT01735955|158084872|FG000|Overall Study|Physician Decision|4|||
49068682|NCT01735955|158084872|FG000|Overall Study|Disease progression|24|||
49068683|NCT01735955|158084872|FG000|Overall Study|Adverse Event|5|||
49068684|NCT03317834|158084875|FG000|Overall Study|Death|2|||
49068685|NCT03317834|158084875|FG000|Overall Study|Device Revision|5|||
49068686|NCT03317834|158084875|FG000|Overall Study|Withdrawal by Subject|13|||
49068687|NCT03317834|158084875|FG000|Overall Study|Lost to Follow-up|13|||
49068688|NCT01716715|158084878|FG000|Overall Study|Never Treated|2|||
49068689|NCT01716715|158084879|FG001|Overall Study|Never Treated|4|||
49068690|NCT00895947|158084880|FG000|Overall Study|Adverse Event|3|||
49068691|NCT00895947|158084881|FG001|Overall Study|Adverse Event|4|||
49068692|NCT00895947|158084880|FG000|Overall Study|Lost to Follow-up|3|||
49068693|NCT00895947|158084881|FG001|Overall Study|Lost to Follow-up|4|||
49068694|NCT00895947|158084880|FG000|Overall Study|Protocol Violation|4|||
49068695|NCT00895947|158084881|FG001|Overall Study|Protocol Violation|2|||
49068696|NCT00895947|158084880|FG000|Overall Study|Withdrawal by Subject|2|||
49068697|NCT00895947|158084881|FG001|Overall Study|Withdrawal by Subject|0|||
49068698|NCT03327792|158084882|FG000|Overall Study|Adverse Event|4|||
49068699|NCT03327792|158084883|FG001|Overall Study|Adverse Event|0|||
49068700|NCT03327792|158084882|FG000|Overall Study|Family/Personal issues|3|||
49068701|NCT03327792|158084883|FG001|Overall Study|Family/Personal issues|2|||
49068702|NCT03327792|158084882|FG000|Overall Study|Lost to Follow-up|0|||
49068703|NCT03327792|158084883|FG001|Overall Study|Lost to Follow-up|1|||
49068704|NCT00626392|158084884|FG000|Run-in Period|Adverse Event|0|||
49068705|NCT00626392|158084885|FG001|Run-in Period|Adverse Event|0|||
49068706|NCT00626392|158084886|FG002|Run-in Period|Adverse Event|1|||
49068707|NCT00626392|158084887|FG003|Run-in Period|Adverse Event|0|||
49068708|NCT00626392|158084888|FG004|Run-in Period|Adverse Event|1|||
49068709|NCT00626392|158084889|FG005|Run-in Period|Adverse Event|0|||
49068710|NCT00626392|158084884|FG000|Run-in Period|Withdrawal by Subject|0|||
49068711|NCT00626392|158084885|FG001|Run-in Period|Withdrawal by Subject|1|||
49068712|NCT00626392|158084886|FG002|Run-in Period|Withdrawal by Subject|1|||
49068713|NCT00626392|158084887|FG003|Run-in Period|Withdrawal by Subject|1|||
49068714|NCT00626392|158084888|FG004|Run-in Period|Withdrawal by Subject|3|||
49068715|NCT00626392|158084889|FG005|Run-in Period|Withdrawal by Subject|1|||
49068716|NCT00626392|158084884|FG000|Run-in Period|Noncompliance|1|||
49068717|NCT00626392|158084885|FG001|Run-in Period|Noncompliance|0|||
49068718|NCT00626392|158084886|FG002|Run-in Period|Noncompliance|1|||
49068719|NCT00626392|158084887|FG003|Run-in Period|Noncompliance|0|||
49068720|NCT00626392|158084888|FG004|Run-in Period|Noncompliance|0|||
49068721|NCT00626392|158084889|FG005|Run-in Period|Noncompliance|0|||
49068722|NCT00626392|158084884|FG000|Coadministration Period|Adverse Event|3|||
49068723|NCT00626392|158084885|FG001|Coadministration Period|Adverse Event|1|||
49068724|NCT00626392|158084886|FG002|Coadministration Period|Adverse Event|7|||
49068725|NCT00626392|158084887|FG003|Coadministration Period|Adverse Event|4|||
49068726|NCT00626392|158084888|FG004|Coadministration Period|Adverse Event|3|||
49068727|NCT00626392|158084889|FG005|Coadministration Period|Adverse Event|4|||
49068728|NCT00626392|158084884|FG000|Coadministration Period|Withdrawal by Subject|1|||
49068729|NCT00626392|158084885|FG001|Coadministration Period|Withdrawal by Subject|1|||
49068730|NCT00626392|158084886|FG002|Coadministration Period|Withdrawal by Subject|0|||
49068731|NCT00626392|158084887|FG003|Coadministration Period|Withdrawal by Subject|1|||
49068732|NCT00626392|158084888|FG004|Coadministration Period|Withdrawal by Subject|0|||
49068733|NCT00626392|158084889|FG005|Coadministration Period|Withdrawal by Subject|1|||
49068734|NCT00626392|158084884|FG000|Coadministration Period|Protocol Violation|0|||
49068735|NCT00626392|158084885|FG001|Coadministration Period|Protocol Violation|1|||
49068736|NCT00626392|158084886|FG002|Coadministration Period|Protocol Violation|0|||
49068737|NCT00626392|158084887|FG003|Coadministration Period|Protocol Violation|1|||
49068738|NCT00626392|158084888|FG004|Coadministration Period|Protocol Violation|1|||
49068739|NCT00626392|158084889|FG005|Coadministration Period|Protocol Violation|0|||
49068740|NCT00626392|158084884|FG000|Coadministration Period|Other|0|||
49068741|NCT00626392|158084885|FG001|Coadministration Period|Other|2|||
49068742|NCT00626392|158084886|FG002|Coadministration Period|Other|3|||
49068743|NCT00626392|158084887|FG003|Coadministration Period|Other|1|||
49068744|NCT00626392|158084888|FG004|Coadministration Period|Other|1|||
49068745|NCT00626392|158084889|FG005|Coadministration Period|Other|1|||
49068746|NCT04576923|158084890|FG000|Overall Study|15 had scans that were determined to be invalid and these are not reported within the results.|15|||
49068747|NCT00338455|158084891|FG000|Overall Study|Death|2|||
49068748|NCT00338455|158084892|FG001|Overall Study|Death|1|||
49068749|NCT00338455|158084891|FG000|Overall Study|Physician Decision|1|||
49068750|NCT00338455|158084892|FG001|Overall Study|Physician Decision|0|||
49068751|NCT02266134|158084895|FG000|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|6|||
49068752|NCT02266134|158084896|FG001|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|3|||
49068753|NCT02266134|158084897|FG002|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
49068754|NCT02266134|158084898|FG003|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
49068755|NCT02266134|158084895|FG000|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|8|||
49068756|NCT02266134|158084896|FG001|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|2|||
49068757|NCT02266134|158084897|FG002|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
49068758|NCT02266134|158084898|FG003|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
49068759|NCT02266134|158084895|FG000|Clinics #7-10: Beginning May 2016|Lost to Follow-up|10|||
49068760|NCT02266134|158084896|FG001|Clinics #7-10: Beginning May 2016|Lost to Follow-up|5|||
49068761|NCT02266134|158084897|FG002|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
49068762|NCT02266134|158084898|FG003|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
49068763|NCT02266134|158084895|FG000|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|3|||
49068764|NCT02266134|158084896|FG001|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
49068765|NCT02266134|158084897|FG002|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
49068766|NCT02266134|158084898|FG003|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
49068767|NCT02266134|158084895|FG000|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|6|||
49068768|NCT02266134|158084896|FG001|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|2|||
49068769|NCT02266134|158084897|FG002|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
49068770|NCT02266134|158084898|FG003|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
49068771|NCT02266134|158084895|FG000|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|3|||
49068772|NCT02266134|158084896|FG001|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
49068773|NCT02266134|158084897|FG002|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
49068774|NCT02266134|158084898|FG003|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
49068775|NCT03151811|158084904|FG000|Overall Study|Randomized But Not Treated|18|||
49068776|NCT03151811|158084905|FG001|Overall Study|Randomized But Not Treated|3|||
49068777|NCT03151811|158084904|FG000|Overall Study|Progressive Disease|130|||
49068778|NCT03151811|158084905|FG001|Overall Study|Progressive Disease|170|||
49068779|NCT03151811|158084904|FG000|Overall Study|Adverse Event|49|||
49068780|NCT03151811|158084905|FG001|Overall Study|Adverse Event|40|||
49068781|NCT03151811|158084904|FG000|Overall Study|Lack of Efficacy|6|||
49068782|NCT03151811|158084905|FG001|Overall Study|Lack of Efficacy|8|||
49068783|NCT03151811|158084904|FG000|Overall Study|Physician Decision|21|||
49068784|NCT03151811|158084905|FG001|Overall Study|Physician Decision|9|||
49068785|NCT03151811|158084904|FG000|Overall Study|Withdrawal by Subject|17|||
49068786|NCT03151811|158084905|FG001|Overall Study|Withdrawal by Subject|7|||
49068787|NCT03151811|158084904|FG000|Overall Study|Lost to Follow-up|0|||
49068788|NCT03151811|158084905|FG001|Overall Study|Lost to Follow-up|1|||
49068789|NCT03151811|158084904|FG000|Overall Study|Study Terminated by Sponsor|5|||
49068790|NCT03151811|158084905|FG001|Overall Study|Study Terminated by Sponsor|11|||
49068791|NCT01517373|158084906|FG000|Run-in Period|Death|1|||
49068792|NCT01517373|158084907|FG001|Run-in Period|Death|0|||
49068793|NCT01517373|158084908|FG002|Run-in Period|Death|0|||
49068794|NCT01517373|158084909|FG003|Run-in Period|Death|0|||
49068795|NCT01517373|158084910|FG004|Run-in Period|Death|0|||
49068796|NCT01517373|158084911|FG005|Run-in Period|Death|0|||
49068797|NCT01517373|158084906|FG000|Run-in Period|Adverse Event|5|||
49068798|NCT01517373|158084907|FG001|Run-in Period|Adverse Event|0|||
49068799|NCT01517373|158084908|FG002|Run-in Period|Adverse Event|0|||
49068800|NCT01517373|158084909|FG003|Run-in Period|Adverse Event|0|||
49068801|NCT01517373|158084910|FG004|Run-in Period|Adverse Event|0|||
49068802|NCT01517373|158084911|FG005|Run-in Period|Adverse Event|0|||
49068803|NCT01517373|158084906|FG000|Run-in Period|Did not meet eligibility criteria|34|||
49068804|NCT01517373|158084907|FG001|Run-in Period|Did not meet eligibility criteria|0|||
49068805|NCT01517373|158084908|FG002|Run-in Period|Did not meet eligibility criteria|0|||
49068806|NCT01517373|158084909|FG003|Run-in Period|Did not meet eligibility criteria|0|||
49068807|NCT01517373|158084910|FG004|Run-in Period|Did not meet eligibility criteria|0|||
49068808|NCT01517373|158084911|FG005|Run-in Period|Did not meet eligibility criteria|0|||
49068809|NCT01517373|158084906|FG000|Run-in Period|Lost to Follow-up|1|||
49068810|NCT01517373|158084907|FG001|Run-in Period|Lost to Follow-up|0|||
49068811|NCT01517373|158084908|FG002|Run-in Period|Lost to Follow-up|0|||
49068812|NCT01517373|158084909|FG003|Run-in Period|Lost to Follow-up|0|||
49068813|NCT01517373|158084910|FG004|Run-in Period|Lost to Follow-up|0|||
49068814|NCT01517373|158084911|FG005|Run-in Period|Lost to Follow-up|0|||
49068815|NCT01517373|158084906|FG000|Run-in Period|Withdrawal by Subject|12|||
49068816|NCT01517373|158084907|FG001|Run-in Period|Withdrawal by Subject|0|||
49068817|NCT01517373|158084908|FG002|Run-in Period|Withdrawal by Subject|0|||
49068818|NCT01517373|158084909|FG003|Run-in Period|Withdrawal by Subject|0|||
49068819|NCT01517373|158084910|FG004|Run-in Period|Withdrawal by Subject|0|||
49068820|NCT01517373|158084911|FG005|Run-in Period|Withdrawal by Subject|0|||
49068821|NCT01517373|158084906|FG000|Run-in Period|Sponsor Decision|3|||
49068822|NCT01517373|158084907|FG001|Run-in Period|Sponsor Decision|0|||
49068823|NCT01517373|158084908|FG002|Run-in Period|Sponsor Decision|0|||
49068824|NCT01517373|158084909|FG003|Run-in Period|Sponsor Decision|0|||
49068825|NCT01517373|158084910|FG004|Run-in Period|Sponsor Decision|0|||
49068826|NCT01517373|158084911|FG005|Run-in Period|Sponsor Decision|0|||
49068827|NCT01517373|158084906|FG000|Run-in Period|Other|1|||
49068828|NCT01517373|158084907|FG001|Run-in Period|Other|0|||
49068829|NCT01517373|158084908|FG002|Run-in Period|Other|0|||
49068830|NCT01517373|158084909|FG003|Run-in Period|Other|0|||
49068831|NCT01517373|158084910|FG004|Run-in Period|Other|0|||
49068832|NCT01517373|158084911|FG005|Run-in Period|Other|0|||
49068833|NCT01517373|158084906|FG000|Treatment Period|Adverse Event|0|||
49068834|NCT01517373|158084907|FG001|Treatment Period|Adverse Event|0|||
49068835|NCT01517373|158084908|FG002|Treatment Period|Adverse Event|0|||
49068836|NCT01517373|158084909|FG003|Treatment Period|Adverse Event|0|||
49068837|NCT01517373|158084910|FG004|Treatment Period|Adverse Event|0|||
49068838|NCT01517373|158084911|FG005|Treatment Period|Adverse Event|2|||
49068839|NCT01517373|158084906|FG000|Treatment Period|Lost to Follow-up|0|||
49068840|NCT01517373|158084907|FG001|Treatment Period|Lost to Follow-up|0|||
49068841|NCT01517373|158084908|FG002|Treatment Period|Lost to Follow-up|1|||
49068842|NCT01517373|158084909|FG003|Treatment Period|Lost to Follow-up|1|||
49068843|NCT01517373|158084910|FG004|Treatment Period|Lost to Follow-up|0|||
49068844|NCT01517373|158084911|FG005|Treatment Period|Lost to Follow-up|0|||
49068845|NCT01517373|158084906|FG000|Treatment Period|Withdrawal by Subject|0|||
49068846|NCT01517373|158084907|FG001|Treatment Period|Withdrawal by Subject|3|||
49068847|NCT01517373|158084908|FG002|Treatment Period|Withdrawal by Subject|2|||
49068848|NCT01517373|158084909|FG003|Treatment Period|Withdrawal by Subject|2|||
49068849|NCT01517373|158084910|FG004|Treatment Period|Withdrawal by Subject|2|||
49068850|NCT01517373|158084911|FG005|Treatment Period|Withdrawal by Subject|3|||
49068851|NCT01517373|158084906|FG000|Treatment Period|Other|0|||
49068852|NCT01517373|158084907|FG001|Treatment Period|Other|0|||
49068853|NCT01517373|158084908|FG002|Treatment Period|Other|0|||
49068854|NCT01517373|158084909|FG003|Treatment Period|Other|0|||
49068855|NCT01517373|158084910|FG004|Treatment Period|Other|1|||
49068856|NCT01517373|158084911|FG005|Treatment Period|Other|0|||
49068857|NCT01517373|158084906|FG000|Treatment Period|Protocol Violation|0|||
49068858|NCT01517373|158084907|FG001|Treatment Period|Protocol Violation|0|||
49068859|NCT01517373|158084908|FG002|Treatment Period|Protocol Violation|0|||
49068860|NCT01517373|158084909|FG003|Treatment Period|Protocol Violation|0|||
49068861|NCT01517373|158084910|FG004|Treatment Period|Protocol Violation|1|||
49068862|NCT01517373|158084911|FG005|Treatment Period|Protocol Violation|0|||
49068863|NCT01517373|158084906|FG000|Treatment Period|Lack of Efficacy|0|||
49068864|NCT01517373|158084907|FG001|Treatment Period|Lack of Efficacy|1|||
49068865|NCT01517373|158084908|FG002|Treatment Period|Lack of Efficacy|1|||
49068866|NCT01517373|158084909|FG003|Treatment Period|Lack of Efficacy|3|||
49068867|NCT01517373|158084910|FG004|Treatment Period|Lack of Efficacy|2|||
49068868|NCT01517373|158084911|FG005|Treatment Period|Lack of Efficacy|0|||
49068869|NCT01517373|158084906|FG000|Treatment Period|Medication error without AEs|0|||
49068870|NCT01517373|158084907|FG001|Treatment Period|Medication error without AEs|0|||
49068871|NCT01517373|158084908|FG002|Treatment Period|Medication error without AEs|2|||
49068872|NCT01517373|158084909|FG003|Treatment Period|Medication error without AEs|1|||
49068873|NCT01517373|158084910|FG004|Treatment Period|Medication error without AEs|0|||
49068874|NCT01517373|158084911|FG005|Treatment Period|Medication error without AEs|2|||
49068875|NCT01664130|158084917|FG000|Overall Study|competing secondary disease|2|||
49068876|NCT00205803|158084925|FG000|Infant Series|Lost to Follow-up|10|||
49068877|NCT00205803|158084926|FG001|Infant Series|Lost to Follow-up|4|||
49068878|NCT00205803|158084925|FG000|Infant Series|Withdrawal by Subject|2|||
49068879|NCT00205803|158084926|FG001|Infant Series|Withdrawal by Subject|5|||
49068880|NCT00205803|158084925|FG000|Infant Series|Physician Decision|3|||
49068881|NCT00205803|158084926|FG001|Infant Series|Physician Decision|1|||
49068882|NCT00205803|158084925|FG000|Infant Series|Protocol Violation|1|||
49068883|NCT00205803|158084926|FG001|Infant Series|Protocol Violation|0|||
49068884|NCT00205803|158084925|FG000|Infant Series|Lost Kaiser coverage|0|||
49068885|NCT00205803|158084926|FG001|Infant Series|Lost Kaiser coverage|1|||
49068886|NCT00205803|158084925|FG000|Infant Series|Non-compliant|1|||
49068887|NCT00205803|158084926|FG001|Infant Series|Non-compliant|0|||
49068888|NCT00205803|158084925|FG000|Infant Series|Sponsor request|1|||
49068889|NCT00205803|158084926|FG001|Infant Series|Sponsor request|0|||
49068890|NCT00205803|158084925|FG000|After Infant Series|Adverse Event|1|||
49068891|NCT00205803|158084926|FG001|After Infant Series|Adverse Event|1|||
49068892|NCT00205803|158084925|FG000|After Infant Series|Protocol Violation|1|||
49068893|NCT00205803|158084926|FG001|After Infant Series|Protocol Violation|1|||
49068894|NCT00205803|158084925|FG000|After Infant Series|Lost to Follow-up|2|||
49068895|NCT00205803|158084926|FG001|After Infant Series|Lost to Follow-up|1|||
49068896|NCT00205803|158084925|FG000|After Infant Series|Physician Decision|3|||
49068897|NCT00205803|158084926|FG001|After Infant Series|Physician Decision|2|||
49068898|NCT00205803|158084925|FG000|After Infant Series|Withdrawal by Subject|1|||
49068899|NCT00205803|158084926|FG001|After Infant Series|Withdrawal by Subject|4|||
49068900|NCT00205803|158084925|FG000|After Infant Series|Other|10|||
49068901|NCT00205803|158084926|FG001|After Infant Series|Other|4|||
49068902|NCT00205803|158084925|FG000|Toddler Dose|Lost to Follow-up|2|||
49068903|NCT00205803|158084926|FG001|Toddler Dose|Lost to Follow-up|3|||
49068904|NCT02728843|158084927|FG000|Overall Study|Adverse Event|0|||
49068905|NCT02728843|158084928|FG001|Overall Study|Adverse Event|2|||
49068906|NCT02728843|158084929|FG002|Overall Study|Adverse Event|3|||
49068907|NCT02728843|158084930|FG003|Overall Study|Adverse Event|1|||
49068908|NCT02728843|158084931|FG004|Overall Study|Adverse Event|2|||
49068909|NCT02728843|158084927|FG000|Overall Study|Lack of Efficacy|0|||
49068910|NCT02728843|158084928|FG001|Overall Study|Lack of Efficacy|1|||
49068911|NCT02728843|158084929|FG002|Overall Study|Lack of Efficacy|1|||
49068912|NCT02728843|158084930|FG003|Overall Study|Lack of Efficacy|0|||
49068913|NCT02728843|158084931|FG004|Overall Study|Lack of Efficacy|0|||
49068914|NCT02728843|158084927|FG000|Overall Study|Protocol Violation|2|||
49068915|NCT02728843|158084928|FG001|Overall Study|Protocol Violation|0|||
49068916|NCT02728843|158084929|FG002|Overall Study|Protocol Violation|4|||
49068917|NCT02728843|158084930|FG003|Overall Study|Protocol Violation|2|||
49068918|NCT02728843|158084931|FG004|Overall Study|Protocol Violation|2|||
49068919|NCT02728843|158084927|FG000|Overall Study|Withdrawal by Subject|1|||
49068920|NCT02728843|158084928|FG001|Overall Study|Withdrawal by Subject|0|||
49068921|NCT02728843|158084929|FG002|Overall Study|Withdrawal by Subject|0|||
49068922|NCT02728843|158084930|FG003|Overall Study|Withdrawal by Subject|1|||
49068923|NCT02728843|158084931|FG004|Overall Study|Withdrawal by Subject|0|||
49068924|NCT02728843|158084927|FG000|Overall Study|Use of rescue medication|0|||
49068925|NCT02728843|158084928|FG001|Overall Study|Use of rescue medication|2|||
49068926|NCT02728843|158084929|FG002|Overall Study|Use of rescue medication|0|||
49068927|NCT02728843|158084930|FG003|Overall Study|Use of rescue medication|2|||
49068928|NCT02728843|158084931|FG004|Overall Study|Use of rescue medication|1|||
49068929|NCT00554606|158084933|FG000|Overall Study|Adverse Event|3|||
49068930|NCT00554606|158084933|FG000|Overall Study|Abnormal laboratory values|1|||
49068931|NCT00554606|158084933|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
49068932|NCT00554606|158084933|FG000|Overall Study|Subject withdrew consent|2|||
49068933|NCT00554606|158084933|FG000|Overall Study|Lost to Follow-up|2|||
49068934|NCT00554606|158084933|FG000|Overall Study|Administrative problems|60|||
49068935|NCT00554606|158084933|FG000|Overall Study|Death|1|||
49068936|NCT00554606|158084933|FG000|Overall Study|Protocol deviation|2|||
49068937|NCT02648932|158084939|FG000|Overall Study|No transplant|3|||
49068938|NCT02648932|158084940|FG001|Overall Study|No transplant|1|||
49068939|NCT03323437|158084941|FG000|Overall Study|Withdrawal by Subject|0|||
49068940|NCT03323437|158084942|FG001|Overall Study|Withdrawal by Subject|4|||
49068941|NCT03678285|158084943|FG000|Overall Study|Adverse Event|2|||
49068942|NCT03678285|158084943|FG000|Overall Study|Withdrawal by subject prior to start of workout|1|||
49068943|NCT03678285|158084943|FG000|Overall Study|Dehydrated prior to start of workout|1|||
49068944|NCT00123474|158084944|FG000|Randomized to Treatment|Randomized, never treated|1|||
49068945|NCT00123474|158084945|FG001|Randomized to Treatment|Randomized, never treated|4|||
49068946|NCT00123474|158084946|FG002|Randomized to Treatment|Randomized, never treated|2|||
49068947|NCT00123474|158084947|FG003|Randomized to Treatment|Randomized, never treated|1|||
49068948|NCT00123474|158084944|FG000|As Treated at Study Closure|not reported when site closed|1|||
49068949|NCT00123474|158084945|FG001|As Treated at Study Closure|not reported when site closed|0|||
49068950|NCT00123474|158084946|FG002|As Treated at Study Closure|not reported when site closed|1|||
49068951|NCT00123474|158084947|FG003|As Treated at Study Closure|not reported when site closed|0|||
49068952|NCT00123474|158084944|FG000|As Treated at Study Closure|Adverse Event|10|||
49068953|NCT00123474|158084945|FG001|As Treated at Study Closure|Adverse Event|4|||
49068954|NCT00123474|158084946|FG002|As Treated at Study Closure|Adverse Event|10|||
49068955|NCT00123474|158084947|FG003|As Treated at Study Closure|Adverse Event|8|||
49068956|NCT00123474|158084944|FG000|As Treated at Study Closure|Disease Progression|35|||
49068957|NCT00123474|158084945|FG001|As Treated at Study Closure|Disease Progression|42|||
49068958|NCT00123474|158084946|FG002|As Treated at Study Closure|Disease Progression|29|||
49068959|NCT00123474|158084947|FG003|As Treated at Study Closure|Disease Progression|27|||
49068960|NCT00123474|158084944|FG000|As Treated at Study Closure|Investigator Request|12|||
49068961|NCT00123474|158084945|FG001|As Treated at Study Closure|Investigator Request|6|||
49068962|NCT00123474|158084946|FG002|As Treated at Study Closure|Investigator Request|7|||
49068963|NCT00123474|158084947|FG003|As Treated at Study Closure|Investigator Request|5|||
49068964|NCT00123474|158084944|FG000|As Treated at Study Closure|non-specified|54|||
49068965|NCT00123474|158084945|FG001|As Treated at Study Closure|non-specified|47|||
49068966|NCT00123474|158084946|FG002|As Treated at Study Closure|non-specified|57|||
49068967|NCT00123474|158084947|FG003|As Treated at Study Closure|non-specified|60|||
49068968|NCT00123474|158084944|FG000|As Treated at Study Closure|Study Drug Toxicity|39|||
49068969|NCT00123474|158084945|FG001|As Treated at Study Closure|Study Drug Toxicity|45|||
49068970|NCT00123474|158084946|FG002|As Treated at Study Closure|Study Drug Toxicity|45|||
49068971|NCT00123474|158084947|FG003|As Treated at Study Closure|Study Drug Toxicity|51|||
49068972|NCT00123474|158084944|FG000|As Treated at Study Closure|Withdrawal by Subject|14|||
49068973|NCT00123474|158084945|FG001|As Treated at Study Closure|Withdrawal by Subject|19|||
49068974|NCT00123474|158084946|FG002|As Treated at Study Closure|Withdrawal by Subject|18|||
49068975|NCT00123474|158084947|FG003|As Treated at Study Closure|Withdrawal by Subject|16|||
49068976|NCT01268501|158084948|FG000|Overall Study|Lost to Follow-up|1|||
49068977|NCT01268501|158084948|FG000|Overall Study|Withdrawal by Subject|3|||
49068978|NCT01268501|158084948|FG000|Overall Study|Unacceptable Subjective Vision|3|||
49068979|NCT01268501|158084948|FG000|Overall Study|Handling Difficulties|2|||
49068980|NCT00252239|158084949|FG000|Overall Study|Withdrawal by Subject|1|||
49068981|NCT00252239|158084950|FG001|Overall Study|Withdrawal by Subject|0|||
49068982|NCT00252239|158084951|FG002|Overall Study|Withdrawal by Subject|0|||
49068983|NCT00252239|158084952|FG003|Overall Study|Withdrawal by Subject|1|||
49068984|NCT00252239|158084949|FG000|Overall Study|Lost to Follow-up|0|||
49068985|NCT00252239|158084950|FG001|Overall Study|Lost to Follow-up|0|||
49068986|NCT00252239|158084951|FG002|Overall Study|Lost to Follow-up|2|||
49068987|NCT00252239|158084952|FG003|Overall Study|Lost to Follow-up|0|||
49068988|NCT02927366|158084953|FG000|Overall Study|Adverse Event|1|||
49068989|NCT02927366|158084954|FG001|Overall Study|Adverse Event|0|||
49068990|NCT02927366|158084953|FG000|Overall Study|Patient schedule|1|||
49068991|NCT02927366|158084954|FG001|Overall Study|Patient schedule|0|||
49068992|NCT02828241|158084957|FG000|Overall Study|Adverse Event|7|||
49068993|NCT02828241|158084958|FG001|Overall Study|Adverse Event|2|||
49068994|NCT02828241|158084957|FG000|Overall Study|Protocol Violation|1|||
49068995|NCT02828241|158084958|FG001|Overall Study|Protocol Violation|0|||
49068996|NCT02552212|158084960|FG000|Double-Blind Period (Week 0 - 52)|Adverse Event|6|||
49068997|NCT02552212|158084961|FG001|Double-Blind Period (Week 0 - 52)|Adverse Event|3|||
49068998|NCT02552212|158084962|FG002|Double-Blind Period (Week 0 - 52)|Adverse Event|0|||
49068999|NCT02552212|158084960|FG000|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
49069000|NCT02552212|158084961|FG001|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
49069001|NCT02552212|158084962|FG002|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0|||
49069002|NCT02552212|158084960|FG000|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
49069003|NCT02552212|158084961|FG001|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
49069004|NCT02552212|158084962|FG002|Double-Blind Period (Week 0 - 52)|Protocol Violation|0|||
49069005|NCT02552212|158084960|FG000|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1|||
49069006|NCT02552212|158084961|FG001|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
49069007|NCT02552212|158084962|FG002|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
49069008|NCT02552212|158084960|FG000|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3|||
49069009|NCT02552212|158084961|FG001|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7|||
49069010|NCT02552212|158084962|FG002|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0|||
49069011|NCT02552212|158084960|FG000|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
49069012|NCT02552212|158084961|FG001|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
49069013|NCT02552212|158084962|FG002|Double-Blind Period (Week 0 - 52)|Study non-compliance|0|||
49069014|NCT02552212|158084960|FG000|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
49069015|NCT02552212|158084961|FG001|Double-Blind Period (Week 0 - 52)|Patient's decision|1|||
49069016|NCT02552212|158084962|FG002|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
49069017|NCT02552212|158084960|FG000|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
49069018|NCT02552212|158084961|FG001|Double-Blind Period (Week 0 - 52)|As per suggestion|1|||
49069019|NCT02552212|158084962|FG002|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
49069020|NCT02552212|158084960|FG000|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
49069021|NCT02552212|158084961|FG001|Double-Blind Period (Week 0 - 52)|Not eligible|1|||
49069022|NCT02552212|158084962|FG002|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
49069023|NCT02552212|158084960|FG000|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1|||
49069024|NCT02552212|158084961|FG001|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
49069025|NCT02552212|158084962|FG002|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
49069026|NCT02552212|158084960|FG000|SFE Period (Week 52 - 156)|Adverse Event|0|||
49069027|NCT02552212|158084961|FG001|SFE Period (Week 52 - 156)|Adverse Event|0|||
49069028|NCT02552212|158084962|FG002|SFE Period (Week 52 - 156)|Adverse Event|5|||
49069029|NCT02552212|158084960|FG000|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
49069030|NCT02552212|158084961|FG001|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
49069031|NCT02552212|158084962|FG002|SFE Period (Week 52 - 156)|Lack of Efficacy|4|||
49069032|NCT02552212|158084960|FG000|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
49069033|NCT02552212|158084961|FG001|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
49069034|NCT02552212|158084962|FG002|SFE Period (Week 52 - 156)|Lost to Follow-up|2|||
49069035|NCT02552212|158084960|FG000|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
49069036|NCT02552212|158084961|FG001|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
49069037|NCT02552212|158084962|FG002|SFE Period (Week 52 - 156)|Withdrawal by Subject|18|||
49069038|NCT02552212|158084960|FG000|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
49069039|NCT02552212|158084961|FG001|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
49069040|NCT02552212|158084962|FG002|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1|||
49069041|NCT02552212|158084960|FG000|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
49069042|NCT02552212|158084961|FG001|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
49069043|NCT02552212|158084962|FG002|SFE Period (Week 52 - 156)|Patient's personal reason|1|||
49069044|NCT02552212|158084960|FG000|SFE Period (Week 52 - 156)|Investigator decision|0|||
49069045|NCT02552212|158084961|FG001|SFE Period (Week 52 - 156)|Investigator decision|0|||
49069046|NCT02552212|158084962|FG002|SFE Period (Week 52 - 156)|Investigator decision|1|||
49069047|NCT02552212|158084960|FG000|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
49069048|NCT02552212|158084961|FG001|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
49069049|NCT02552212|158084962|FG002|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1|||
49069050|NCT02552212|158084960|FG000|SFE Period (Week 52 - 156)|Compassionate access|0|||
49069051|NCT02552212|158084961|FG001|SFE Period (Week 52 - 156)|Compassionate access|0|||
49069052|NCT02552212|158084962|FG002|SFE Period (Week 52 - 156)|Compassionate access|2|||
49069053|NCT02552212|158084960|FG000|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
49069054|NCT02552212|158084961|FG001|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
49069055|NCT02552212|158084962|FG002|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1|||
49069056|NCT02552212|158084960|FG000|SFE Period (Week 52 - 156)|Decision of Patient|0|||
49069057|NCT02552212|158084961|FG001|SFE Period (Week 52 - 156)|Decision of Patient|0|||
49069058|NCT02552212|158084962|FG002|SFE Period (Week 52 - 156)|Decision of Patient|1|||
49069059|NCT05819203|158084968|FG000|Overall Study|Protocol Violation|1|||
49069060|NCT05819203|158084969|FG001|Overall Study|Protocol Violation|2|||
49069061|NCT05819203|158084968|FG000|Overall Study|Withdrawal by Subject|1|||
49069062|NCT05819203|158084969|FG001|Overall Study|Withdrawal by Subject|0|||
49069063|NCT02802631|158084972|FG000|Overall Study|Withdrawal by Subject|1|||
49069064|NCT02802631|158084973|FG001|Overall Study|Withdrawal by Subject|0|||
49069065|NCT02802631|158084974|FG002|Overall Study|Withdrawal by Subject|0|||
49069066|NCT02802631|158084975|FG003|Overall Study|Withdrawal by Subject|0|||
49069067|NCT02802631|158084976|FG004|Overall Study|Withdrawal by Subject|0|||
49069068|NCT02802631|158084977|FG005|Overall Study|Withdrawal by Subject|0|||
49069069|NCT02802631|158084978|FG006|Overall Study|Withdrawal by Subject|0|||
49069070|NCT02802631|158084979|FG007|Overall Study|Withdrawal by Subject|0|||
49069071|NCT02802631|158084972|FG000|Overall Study|Physician Decision|1|||
49069072|NCT02802631|158084973|FG001|Overall Study|Physician Decision|0|||
49069073|NCT02802631|158084974|FG002|Overall Study|Physician Decision|0|||
49069074|NCT02802631|158084975|FG003|Overall Study|Physician Decision|0|||
49069075|NCT02802631|158084976|FG004|Overall Study|Physician Decision|0|||
49069076|NCT02802631|158084977|FG005|Overall Study|Physician Decision|0|||
49069077|NCT02802631|158084978|FG006|Overall Study|Physician Decision|1|||
49069078|NCT02802631|158084979|FG007|Overall Study|Physician Decision|0|||
49069079|NCT02802631|158084972|FG000|Overall Study|Adverse Event|0|||
49069080|NCT02802631|158084973|FG001|Overall Study|Adverse Event|2|||
49069081|NCT02802631|158084974|FG002|Overall Study|Adverse Event|0|||
49069082|NCT02802631|158084975|FG003|Overall Study|Adverse Event|1|||
49069083|NCT02802631|158084976|FG004|Overall Study|Adverse Event|6|||
49069084|NCT02802631|158084977|FG005|Overall Study|Adverse Event|1|||
49069085|NCT02802631|158084978|FG006|Overall Study|Adverse Event|4|||
49069086|NCT02802631|158084979|FG007|Overall Study|Adverse Event|0|||
49069087|NCT02802631|158084972|FG000|Overall Study|Sponsor Decision|0|||
49069088|NCT02802631|158084973|FG001|Overall Study|Sponsor Decision|0|||
49069089|NCT02802631|158084974|FG002|Overall Study|Sponsor Decision|6|||
49069090|NCT02802631|158084975|FG003|Overall Study|Sponsor Decision|0|||
49069091|NCT02802631|158084976|FG004|Overall Study|Sponsor Decision|2|||
49069092|NCT02802631|158084977|FG005|Overall Study|Sponsor Decision|0|||
49069093|NCT02802631|158084978|FG006|Overall Study|Sponsor Decision|0|||
49069094|NCT02802631|158084979|FG007|Overall Study|Sponsor Decision|4|||
49069095|NCT01982812|158084980|FG000|Overall Study|Death|1|||
49069096|NCT01982812|158084981|FG001|Overall Study|Death|5|||
49069097|NCT01982812|158084980|FG000|Overall Study|Adverse Event|0|||
49069098|NCT01982812|158084981|FG001|Overall Study|Adverse Event|5|||
49069099|NCT04400682|158084982|FG000|Period 1|Withdrawal by Subject|1|||
49069100|NCT04400682|158084983|FG001|Period 1|Withdrawal by Subject|4|||
49069101|NCT02377427|158084984|FG000|Part A (Up to Week 20)|Physician Decision|1|||
49069102|NCT02377427|158084985|FG001|Part A (Up to Week 20)|Physician Decision|0|||
49069103|NCT02377427|158084986|FG002|Part A (Up to Week 20)|Physician Decision|0|||
49069104|NCT02377427|158084987|FG003|Part A (Up to Week 20)|Physician Decision|0|||
49069105|NCT02377427|158084988|FG004|Part A (Up to Week 20)|Physician Decision|0|||
49069106|NCT02377427|158084984|FG000|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1|||
49069107|NCT02377427|158084985|FG001|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
49069108|NCT02377427|158084986|FG002|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
49069109|NCT02377427|158084987|FG003|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
49069110|NCT02377427|158084988|FG004|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
49069111|NCT02377427|158084984|FG000|Part A (Up to Week 20)|Withdrawal by Subject|2|||
49069112|NCT02377427|158084985|FG001|Part A (Up to Week 20)|Withdrawal by Subject|0|||
49069113|NCT02377427|158084986|FG002|Part A (Up to Week 20)|Withdrawal by Subject|0|||
49069114|NCT02377427|158084987|FG003|Part A (Up to Week 20)|Withdrawal by Subject|0|||
49069115|NCT02377427|158084988|FG004|Part A (Up to Week 20)|Withdrawal by Subject|0|||
49069116|NCT02377427|158084984|FG000|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
49069117|NCT02377427|158084985|FG001|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
49069118|NCT02377427|158084986|FG002|Part B (From Week 20 and up to Week 80)|Protocol Violation|1|||
49069119|NCT02377427|158084987|FG003|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
49069120|NCT02377427|158084988|FG004|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
49069121|NCT02342639|158084995|FG000|Overall Study|Acute illness, unrelated to study drug|2|||
49069122|NCT02342639|158084996|FG001|Overall Study|Acute illness, unrelated to study drug|3|||
49069123|NCT02342639|158084995|FG000|Overall Study|Protocol Violation|0|||
49069124|NCT02342639|158084996|FG001|Overall Study|Protocol Violation|2|||
49069125|NCT03283319|158087234|FG000|Overall Study|Lost to Follow-up|5|||
49069126|NCT03283319|158087235|FG001|Overall Study|Lost to Follow-up|4|||
49069127|NCT03283319|158087236|FG002|Overall Study|Lost to Follow-up|5|||
49069128|NCT03283319|158087237|FG003|Overall Study|Lost to Follow-up|5|||
49069129|NCT03283319|158087238|FG004|Overall Study|Lost to Follow-up|4|||
49069130|NCT03283319|158087239|FG005|Overall Study|Lost to Follow-up|3|||
49069131|NCT03283319|158087234|FG000|Overall Study|Withdrawal by Subject|2|||
49069132|NCT03283319|158087235|FG001|Overall Study|Withdrawal by Subject|2|||
49069133|NCT03283319|158087236|FG002|Overall Study|Withdrawal by Subject|2|||
49069134|NCT03283319|158087237|FG003|Overall Study|Withdrawal by Subject|1|||
49069135|NCT03283319|158087238|FG004|Overall Study|Withdrawal by Subject|0|||
49069136|NCT03283319|158087239|FG005|Overall Study|Withdrawal by Subject|1|||
49069137|NCT03283319|158087234|FG000|Overall Study|BARDA regulatory agency or IRB decision|0|||
49069138|NCT03283319|158087235|FG001|Overall Study|BARDA regulatory agency or IRB decision|0|||
49069139|NCT03283319|158087236|FG002|Overall Study|BARDA regulatory agency or IRB decision|0|||
49069140|NCT03283319|158087237|FG003|Overall Study|BARDA regulatory agency or IRB decision|1|||
49069141|NCT03283319|158087238|FG004|Overall Study|BARDA regulatory agency or IRB decision|0|||
49069142|NCT03283319|158087239|FG005|Overall Study|BARDA regulatory agency or IRB decision|0|||
49069143|NCT02492880|158087240|FG000|Overall Study|Lost to Follow-up|1|||
49069144|NCT02492880|158087240|FG000|Overall Study|Protocol Violation|1|||
49069145|NCT03858634|158087241|FG000|Overall Study|Withdrawal by Subject|1|||
49069146|NCT03858634|158087242|FG001|Overall Study|Withdrawal by Subject|0|||
49069147|NCT03858634|158087241|FG000|Overall Study|Adverse Event|1|||
49069148|NCT03858634|158087242|FG001|Overall Study|Adverse Event|0|||
49069149|NCT03858634|158087241|FG000|Overall Study|Lost to Follow-up|0|||
49069150|NCT03858634|158087242|FG001|Overall Study|Lost to Follow-up|1|||
49069151|NCT03858634|158087241|FG000|Overall Study|Other, Not Specified|1|||
49069152|NCT03858634|158087242|FG001|Overall Study|Other, Not Specified|1|||
49069153|NCT00824616|158087243|FG000|Overall Study|Adverse Event|2|||
49069154|NCT00824616|158087244|FG001|Overall Study|Adverse Event|1|||
49069155|NCT00824616|158087243|FG000|Overall Study|Creatinine/Creatinine Clearance|0|||
49069156|NCT00824616|158087244|FG001|Overall Study|Creatinine/Creatinine Clearance|2|||
49069157|NCT00824616|158087243|FG000|Overall Study|Hyperglycemia|1|||
49069158|NCT00824616|158087244|FG001|Overall Study|Hyperglycemia|1|||
49069159|NCT00824616|158087243|FG000|Overall Study|Lack of Efficacy|2|||
49069160|NCT00824616|158087244|FG001|Overall Study|Lack of Efficacy|1|||
49069161|NCT00824616|158087243|FG000|Overall Study|Lost to Follow-up|0|||
49069162|NCT00824616|158087244|FG001|Overall Study|Lost to Follow-up|1|||
49069163|NCT00824616|158087243|FG000|Overall Study|Withdrawal by Subject|1|||
49069164|NCT00824616|158087244|FG001|Overall Study|Withdrawal by Subject|1|||
49069165|NCT00577395|158087245|FG000|Overall Study|Study was terminated early by Sponsor|7|||
49069166|NCT00577395|158087246|FG001|Overall Study|Study was terminated early by Sponsor|6|||
49069167|NCT01200992|158087247|FG000|Overall Study|Study terminated early|35|||
49069168|NCT01200992|158087248|FG001|Overall Study|Study terminated early|41|||
49069169|NCT01200992|158087247|FG000|Overall Study|Randomized but not treated|2|||
49069170|NCT01200992|158087248|FG001|Overall Study|Randomized but not treated|0|||
49069171|NCT03186781|158087251|FG000|Overall Study|Lost to Follow-up|0|||
49069172|NCT03186781|158087252|FG001|Overall Study|Lost to Follow-up|0|||
49069173|NCT03186781|158087253|FG002|Overall Study|Lost to Follow-up|1|||
49069174|NCT03186781|158087254|FG003|Overall Study|Lost to Follow-up|0|||
49069175|NCT03186781|158087255|FG004|Overall Study|Lost to Follow-up|1|||
49069176|NCT03186781|158087256|FG005|Overall Study|Lost to Follow-up|0|||
49069177|NCT03186781|158087251|FG000|Overall Study|Moved from Area|0|||
49069178|NCT03186781|158087252|FG001|Overall Study|Moved from Area|0|||
49069179|NCT03186781|158087253|FG002|Overall Study|Moved from Area|0|||
49069180|NCT03186781|158087254|FG003|Overall Study|Moved from Area|0|||
49069181|NCT03186781|158087255|FG004|Overall Study|Moved from Area|1|||
49069182|NCT03186781|158087256|FG005|Overall Study|Moved from Area|0|||
49069183|NCT03186781|158087251|FG000|Overall Study|Withdrawal by Subject|0|||
49069184|NCT03186781|158087252|FG001|Overall Study|Withdrawal by Subject|0|||
49069185|NCT03186781|158087253|FG002|Overall Study|Withdrawal by Subject|0|||
49069186|NCT03186781|158087254|FG003|Overall Study|Withdrawal by Subject|0|||
49069187|NCT03186781|158087255|FG004|Overall Study|Withdrawal by Subject|1|||
49069188|NCT03186781|158087256|FG005|Overall Study|Withdrawal by Subject|0|||
49069189|NCT04663295|158087258|FG000|Run-in Period|Withdrawal by Subject|3|||
49069190|NCT04663295|158087258|FG000|Overall Study Period|Pregnancy|1|||
49069191|NCT04663295|158087258|FG000|Overall Study Period|Withdrawn by Parent/Guardian|1|||
49069192|NCT03665441|158087266|FG000|Overall Study|survival follow up ongoing|23|||
49069193|NCT03665441|158087267|FG001|Overall Study|survival follow up ongoing|0|||
49069194|NCT03665441|158087266|FG000|Overall Study|Patients ongoing on treatment|9|||
49069195|NCT03665441|158087267|FG001|Overall Study|Patients ongoing on treatment|6|||
49069196|NCT03665441|158087266|FG000|Overall Study|Randomized but not treated|7|||
49069197|NCT03665441|158087267|FG001|Overall Study|Randomized but not treated|11|||
49069198|NCT00554190|158087270|FG000|Overall Study|Termination forms not completed|10|||
49069199|NCT02885181|158087277|FG000|Overall Study|Investigator's Discretion|0|||
49069200|NCT02885181|158087278|FG001|Overall Study|Investigator's Discretion|1|||
49069201|NCT02885181|158087279|FG002|Overall Study|Investigator's Discretion|0|||
49069202|NCT02885181|158087280|FG003|Overall Study|Investigator's Discretion|1|||
49069203|NCT02885181|158087277|FG000|Overall Study|Adverse Event|0|||
49069204|NCT02885181|158087278|FG001|Overall Study|Adverse Event|0|||
49069205|NCT02885181|158087279|FG002|Overall Study|Adverse Event|0|||
49069206|NCT02885181|158087280|FG003|Overall Study|Adverse Event|1|||
49069207|NCT02885181|158087277|FG000|Overall Study|Withdrawal by Subject|0|||
49069208|NCT02885181|158087278|FG001|Overall Study|Withdrawal by Subject|0|||
49069209|NCT02885181|158087279|FG002|Overall Study|Withdrawal by Subject|0|||
49069210|NCT02885181|158087280|FG003|Overall Study|Withdrawal by Subject|1|||
49069211|NCT00121134|158087281|FG000|Overall Study|Progression of Disease|5|||
49069212|NCT00121134|158087282|FG001|Overall Study|Progression of Disease|3|||
49069213|NCT00121134|158087283|FG002|Overall Study|Progression of Disease|4|||
49069214|NCT00121134|158087284|FG003|Overall Study|Progression of Disease|2|||
49069215|NCT00121134|158087281|FG000|Overall Study|Toxicity|4|||
49069216|NCT00121134|158087282|FG001|Overall Study|Toxicity|7|||
49069217|NCT00121134|158087283|FG002|Overall Study|Toxicity|13|||
49069218|NCT00121134|158087284|FG003|Overall Study|Toxicity|5|||
49069219|NCT00121134|158087281|FG000|Overall Study|Physician Decision|6|||
49069220|NCT00121134|158087282|FG001|Overall Study|Physician Decision|4|||
49069221|NCT00121134|158087283|FG002|Overall Study|Physician Decision|4|||
49069222|NCT00121134|158087284|FG003|Overall Study|Physician Decision|1|||
49069223|NCT00121134|158087281|FG000|Overall Study|Treatment Delay|1|||
49069224|NCT00121134|158087282|FG001|Overall Study|Treatment Delay|0|||
49069225|NCT00121134|158087283|FG002|Overall Study|Treatment Delay|0|||
49069226|NCT00121134|158087284|FG003|Overall Study|Treatment Delay|0|||
49069227|NCT00121134|158087281|FG000|Overall Study|Intercurrent Illness|0|||
49069228|NCT00121134|158087282|FG001|Overall Study|Intercurrent Illness|0|||
49069229|NCT00121134|158087283|FG002|Overall Study|Intercurrent Illness|0|||
49069230|NCT00121134|158087284|FG003|Overall Study|Intercurrent Illness|1|||
49069231|NCT00121134|158087281|FG000|Overall Study|Patient Personal Reasons|0|||
49069232|NCT00121134|158087282|FG001|Overall Study|Patient Personal Reasons|1|||
49069233|NCT00121134|158087283|FG002|Overall Study|Patient Personal Reasons|0|||
49069234|NCT00121134|158087284|FG003|Overall Study|Patient Personal Reasons|0|||
49069235|NCT01085734|158087285|FG000|Overall Study|Adverse Event|0|||
49069236|NCT01085734|158087286|FG001|Overall Study|Adverse Event|2|||
49069237|NCT01085734|158087285|FG000|Overall Study|Death|1|||
49069238|NCT01085734|158087286|FG001|Overall Study|Death|0|||
49069239|NCT01085734|158087285|FG000|Overall Study|Lost to Follow-up|0|||
49069240|NCT01085734|158087286|FG001|Overall Study|Lost to Follow-up|1|||
49069241|NCT01085734|158087285|FG000|Overall Study|Withdrawal by Subject|0|||
49069242|NCT01085734|158087286|FG001|Overall Study|Withdrawal by Subject|1|||
49069243|NCT01081834|158087287|FG000|Core Period: Baseline to Week 26|Pregnancy|1|||
49069244|NCT01081834|158087288|FG001|Core Period: Baseline to Week 26|Pregnancy|0|||
49069245|NCT01081834|158087289|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
49069246|NCT01081834|158087290|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
49069247|NCT01081834|158087291|FG004|Core Period: Baseline to Week 26|Pregnancy|0|||
49069248|NCT01081834|158087287|FG000|Core Period: Baseline to Week 26|Adverse Event|2|||
49069249|NCT01081834|158087288|FG001|Core Period: Baseline to Week 26|Adverse Event|5|||
49069250|NCT01081834|158087289|FG002|Core Period: Baseline to Week 26|Adverse Event|3|||
49069251|NCT01081834|158087290|FG003|Core Period: Baseline to Week 26|Adverse Event|1|||
49069252|NCT01081834|158087291|FG004|Core Period: Baseline to Week 26|Adverse Event|1|||
49069253|NCT01081834|158087287|FG000|Core Period: Baseline to Week 26|Death|1|||
49069254|NCT01081834|158087288|FG001|Core Period: Baseline to Week 26|Death|0|||
49069255|NCT01081834|158087289|FG002|Core Period: Baseline to Week 26|Death|0|||
49069256|NCT01081834|158087290|FG003|Core Period: Baseline to Week 26|Death|0|||
49069257|NCT01081834|158087291|FG004|Core Period: Baseline to Week 26|Death|0|||
49069258|NCT01081834|158087287|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
49069259|NCT01081834|158087288|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
49069260|NCT01081834|158087289|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
49069261|NCT01081834|158087290|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
49069262|NCT01081834|158087291|FG004|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
49069263|NCT01081834|158087287|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
49069264|NCT01081834|158087288|FG001|Core Period: Baseline to Week 26|Protocol Violation|4|||
49069265|NCT01081834|158087289|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
49069266|NCT01081834|158087290|FG003|Core Period: Baseline to Week 26|Protocol Violation|0|||
49069267|NCT01081834|158087291|FG004|Core Period: Baseline to Week 26|Protocol Violation|2|||
49069268|NCT01081834|158087287|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
49069269|NCT01081834|158087288|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
49069270|NCT01081834|158087289|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
49069271|NCT01081834|158087290|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
49069272|NCT01081834|158087291|FG004|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
49069273|NCT01081834|158087287|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
49069274|NCT01081834|158087288|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|4|||
49069275|NCT01081834|158087289|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
49069276|NCT01081834|158087290|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
49069277|NCT01081834|158087291|FG004|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
49069278|NCT01081834|158087287|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
49069279|NCT01081834|158087288|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
49069280|NCT01081834|158087289|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
49069281|NCT01081834|158087290|FG003|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
49069282|NCT01081834|158087291|FG004|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
49069283|NCT01081834|158087287|FG000|Core Period: Baseline to Week 26|Other|4|||
49069284|NCT01081834|158087288|FG001|Core Period: Baseline to Week 26|Other|4|||
49069285|NCT01081834|158087289|FG002|Core Period: Baseline to Week 26|Other|3|||
49069286|NCT01081834|158087290|FG003|Core Period: Baseline to Week 26|Other|1|||
49069287|NCT01081834|158087291|FG004|Core Period: Baseline to Week 26|Other|0|||
49069288|NCT01081834|158087287|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3|||
49069289|NCT01081834|158087288|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
49069290|NCT01081834|158087289|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
49069291|NCT01081834|158087290|FG003|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
49069292|NCT01081834|158087291|FG004|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
49069293|NCT01081834|158087287|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
49069294|NCT01081834|158087288|FG001|Extension Period: Week 26 to Week 52|Adverse Event|0|||
49069295|NCT01081834|158087289|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
49069296|NCT01081834|158087290|FG003|Extension Period: Week 26 to Week 52|Adverse Event|0|||
49069297|NCT01081834|158087291|FG004|Extension Period: Week 26 to Week 52|Adverse Event|0|||
49069298|NCT01081834|158087287|FG000|Extension Period: Week 26 to Week 52|Death|1|||
49069299|NCT01081834|158087288|FG001|Extension Period: Week 26 to Week 52|Death|0|||
49069300|NCT01081834|158087289|FG002|Extension Period: Week 26 to Week 52|Death|0|||
49069301|NCT01081834|158087290|FG003|Extension Period: Week 26 to Week 52|Death|0|||
49069302|NCT01081834|158087291|FG004|Extension Period: Week 26 to Week 52|Death|0|||
49069303|NCT01081834|158087287|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
49069304|NCT01081834|158087288|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
49069305|NCT01081834|158087289|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
49069306|NCT01081834|158087290|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
49069307|NCT01081834|158087291|FG004|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
49069308|NCT01081834|158087287|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
49069309|NCT01081834|158087288|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
49069310|NCT01081834|158087289|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
49069311|NCT01081834|158087290|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
49069312|NCT01081834|158087291|FG004|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
49069313|NCT01081834|158087287|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
49069314|NCT01081834|158087288|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
49069315|NCT01081834|158087289|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
49069316|NCT01081834|158087290|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
49069317|NCT01081834|158087291|FG004|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
49069318|NCT01081834|158087287|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
49069319|NCT01081834|158087288|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
49069320|NCT01081834|158087289|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
49069321|NCT01081834|158087290|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
49069322|NCT01081834|158087291|FG004|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
49069323|NCT01081834|158087287|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
49069324|NCT01081834|158087288|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
49069325|NCT01081834|158087289|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
49069326|NCT01081834|158087290|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
49069327|NCT01081834|158087291|FG004|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
49069328|NCT01081834|158087287|FG000|Extension Period: Week 26 to Week 52|Other|4|||
49069329|NCT01081834|158087288|FG001|Extension Period: Week 26 to Week 52|Other|5|||
49069330|NCT01081834|158087289|FG002|Extension Period: Week 26 to Week 52|Other|4|||
49069331|NCT01081834|158087290|FG003|Extension Period: Week 26 to Week 52|Other|0|||
49069332|NCT01081834|158087291|FG004|Extension Period: Week 26 to Week 52|Other|0|||
49069333|NCT01081834|158087287|FG000|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7|||
49069334|NCT01081834|158087288|FG001|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1|||
49069335|NCT01081834|158087289|FG002|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
49069336|NCT01081834|158087290|FG003|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
49069337|NCT01081834|158087291|FG004|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
49069338|NCT01081834|158087287|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
49069339|NCT01081834|158087288|FG001|Extension Period: Week 26 to Week 52|Physician Decision|1|||
49069340|NCT01081834|158087289|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
49069341|NCT01081834|158087290|FG003|Extension Period: Week 26 to Week 52|Physician Decision|0|||
49069342|NCT01081834|158087291|FG004|Extension Period: Week 26 to Week 52|Physician Decision|0|||
49069343|NCT00565617|158087294|FG000|Overall Study|Withdrawal by Subject|1|||
49069344|NCT02679235|158087295|FG000|Overall Study|Withdrawal by Subject|3|||
49069345|NCT02679235|158087295|FG000|Overall Study|Adverse Event|1|||
49069346|NCT00616629|158087296|FG000|Overall Study|Protocol Violation|1|||
49069347|NCT00616629|158087297|FG001|Overall Study|Protocol Violation|2|||
49069348|NCT00616629|158087298|FG002|Overall Study|Protocol Violation|1|||
49069349|NCT00616629|158087299|FG003|Overall Study|Protocol Violation|0|||
49069350|NCT00616629|158087300|FG004|Overall Study|Protocol Violation|0|||
49069351|NCT00616629|158087296|FG000|Overall Study|AV-block|1|||
49069352|NCT00616629|158087297|FG001|Overall Study|AV-block|0|||
49069353|NCT00616629|158087298|FG002|Overall Study|AV-block|0|||
49069354|NCT00616629|158087299|FG003|Overall Study|AV-block|0|||
49069355|NCT00616629|158087300|FG004|Overall Study|AV-block|0|||
49069356|NCT01059344|158087301|FG000|Overall Study|Adverse Event|12|||
49069357|NCT01059344|158087302|FG001|Overall Study|Adverse Event|30|||
49069358|NCT01059344|158087301|FG000|Overall Study|Withdrawal by Subject|6|||
49069359|NCT01059344|158087302|FG001|Overall Study|Withdrawal by Subject|9|||
49069360|NCT01059344|158087301|FG000|Overall Study|Lost to Follow-up|1|||
49069361|NCT01059344|158087302|FG001|Overall Study|Lost to Follow-up|1|||
49069362|NCT01059344|158087301|FG000|Overall Study|Other|3|||
49069363|NCT01059344|158087302|FG001|Overall Study|Other|6|||
49069364|NCT01161407|158087303|FG000|Overall Study|Protocol Violation|3|||
49069365|NCT01161407|158087304|FG001|Overall Study|Protocol Violation|1|||
49069366|NCT01473524|158087305|FG000|DB Phase|Adverse Event|4|||
49069367|NCT01473524|158087306|FG001|DB Phase|Adverse Event|8|||
49069368|NCT01473524|158087307|FG002|DB Phase|Adverse Event|2|||
49069369|NCT01473524|158087308|FG003|DB Phase|Adverse Event|0|||
49069370|NCT01473524|158087309|FG004|DB Phase|Adverse Event|0|||
49069371|NCT01473524|158087310|FG005|DB Phase|Adverse Event|0|||
49069372|NCT01473524|158087305|FG000|DB Phase|Death|1|||
49069373|NCT01473524|158087306|FG001|DB Phase|Death|0|||
49069374|NCT01473524|158087307|FG002|DB Phase|Death|0|||
49069375|NCT01473524|158087308|FG003|DB Phase|Death|0|||
49069376|NCT01473524|158087309|FG004|DB Phase|Death|0|||
49069377|NCT01473524|158087310|FG005|DB Phase|Death|0|||
49069378|NCT01473524|158087305|FG000|DB Phase|Withdrawal by Subject|2|||
49069379|NCT01473524|158087306|FG001|DB Phase|Withdrawal by Subject|1|||
49069380|NCT01473524|158087307|FG002|DB Phase|Withdrawal by Subject|1|||
49069381|NCT01473524|158087308|FG003|DB Phase|Withdrawal by Subject|0|||
49069382|NCT01473524|158087309|FG004|DB Phase|Withdrawal by Subject|0|||
49069383|NCT01473524|158087310|FG005|DB Phase|Withdrawal by Subject|0|||
49069384|NCT01473524|158087305|FG000|LTSE Phase|Withdrawal by Subject|0|||
49069385|NCT01473524|158087306|FG001|LTSE Phase|Withdrawal by Subject|0|||
49069386|NCT01473524|158087307|FG002|LTSE Phase|Withdrawal by Subject|0|||
49069387|NCT01473524|158087308|FG003|LTSE Phase|Withdrawal by Subject|3|||
49069388|NCT01473524|158087309|FG004|LTSE Phase|Withdrawal by Subject|3|||
49069389|NCT01473524|158087310|FG005|LTSE Phase|Withdrawal by Subject|6|||
49069390|NCT01473524|158087305|FG000|LTSE Phase|Death|0|||
49069391|NCT01473524|158087306|FG001|LTSE Phase|Death|0|||
49069392|NCT01473524|158087307|FG002|LTSE Phase|Death|0|||
49069393|NCT01473524|158087308|FG003|LTSE Phase|Death|0|||
49069394|NCT01473524|158087309|FG004|LTSE Phase|Death|1|||
49069395|NCT01473524|158087310|FG005|LTSE Phase|Death|0|||
49069396|NCT01473524|158087305|FG000|LTSE Phase|Adverse Event of Pruritus|0|||
49069397|NCT01473524|158087306|FG001|LTSE Phase|Adverse Event of Pruritus|0|||
49069398|NCT01473524|158087307|FG002|LTSE Phase|Adverse Event of Pruritus|0|||
49069399|NCT01473524|158087308|FG003|LTSE Phase|Adverse Event of Pruritus|1|||
49069400|NCT01473524|158087309|FG004|LTSE Phase|Adverse Event of Pruritus|5|||
49069401|NCT01473524|158087310|FG005|LTSE Phase|Adverse Event of Pruritus|2|||
49069402|NCT01473524|158087305|FG000|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
49069403|NCT01473524|158087306|FG001|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
49069404|NCT01473524|158087307|FG002|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
49069405|NCT01473524|158087308|FG003|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2|||
49069406|NCT01473524|158087309|FG004|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4|||
49069407|NCT01473524|158087310|FG005|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6|||
49069408|NCT01473524|158087305|FG000|LTSE Phase|Lost to Follow-up|0|||
49069409|NCT01473524|158087306|FG001|LTSE Phase|Lost to Follow-up|0|||
49069410|NCT01473524|158087307|FG002|LTSE Phase|Lost to Follow-up|0|||
49069411|NCT01473524|158087308|FG003|LTSE Phase|Lost to Follow-up|1|||
49069412|NCT01473524|158087309|FG004|LTSE Phase|Lost to Follow-up|3|||
49069413|NCT01473524|158087310|FG005|LTSE Phase|Lost to Follow-up|2|||
49069414|NCT01473524|158087305|FG000|LTSE Phase|Principal Investigator Decision|0|||
49069415|NCT01473524|158087306|FG001|LTSE Phase|Principal Investigator Decision|0|||
49069416|NCT01473524|158087307|FG002|LTSE Phase|Principal Investigator Decision|0|||
49069417|NCT01473524|158087308|FG003|LTSE Phase|Principal Investigator Decision|1|||
49069418|NCT01473524|158087309|FG004|LTSE Phase|Principal Investigator Decision|1|||
49069419|NCT01473524|158087310|FG005|LTSE Phase|Principal Investigator Decision|3|||
49069420|NCT01473524|158087305|FG000|LTSE Phase|Liver Transplantation|0|||
49069421|NCT01473524|158087306|FG001|LTSE Phase|Liver Transplantation|0|||
49069422|NCT01473524|158087307|FG002|LTSE Phase|Liver Transplantation|0|||
49069423|NCT01473524|158087308|FG003|LTSE Phase|Liver Transplantation|0|||
49069424|NCT01473524|158087309|FG004|LTSE Phase|Liver Transplantation|0|||
49069425|NCT01473524|158087310|FG005|LTSE Phase|Liver Transplantation|1|||
49069426|NCT01473524|158087305|FG000|LTSE Phase|Pregnancy|0|||
49069427|NCT01473524|158087306|FG001|LTSE Phase|Pregnancy|0|||
49069428|NCT01473524|158087307|FG002|LTSE Phase|Pregnancy|0|||
49069429|NCT01473524|158087308|FG003|LTSE Phase|Pregnancy|1|||
49069430|NCT01473524|158087309|FG004|LTSE Phase|Pregnancy|0|||
49069431|NCT01473524|158087310|FG005|LTSE Phase|Pregnancy|0|||
49069432|NCT01473524|158087305|FG000|LTSE Phase|Protocol Violation|0|||
49069433|NCT01473524|158087306|FG001|LTSE Phase|Protocol Violation|0|||
49069434|NCT01473524|158087307|FG002|LTSE Phase|Protocol Violation|0|||
49069435|NCT01473524|158087308|FG003|LTSE Phase|Protocol Violation|0|||
49069436|NCT01473524|158087309|FG004|LTSE Phase|Protocol Violation|0|||
49069437|NCT01473524|158087310|FG005|LTSE Phase|Protocol Violation|1|||
49069438|NCT02906358|158087311|FG000|Overall Study|Withdrawal by Subject|10|||
49069439|NCT02906358|158087312|FG001|Overall Study|Withdrawal by Subject|7|||
49069440|NCT02906358|158087311|FG000|Overall Study|Lost to Follow-up|12|||
49069441|NCT02906358|158087312|FG001|Overall Study|Lost to Follow-up|15|||
49069442|NCT01315132|158087313|FG000|Overall Study|not treated due to disease progression|1|||
49069443|NCT03893565|158087320|FG000|Double-blind Induction Phase (10 Weeks)|Other|1|||
49069444|NCT03893565|158087321|FG001|Double-blind Induction Phase (10 Weeks)|Other|3|||
49069445|NCT03893565|158087322|FG002|Double-blind Induction Phase (10 Weeks)|Other|0|||
49069446|NCT03893565|158087323|FG003|Double-blind Induction Phase (10 Weeks)|Other|0|||
49069447|NCT03893565|158087324|FG004|Double-blind Induction Phase (10 Weeks)|Other|1|||
49069448|NCT03893565|158087325|FG005|Double-blind Induction Phase (10 Weeks)|Other|0|||
49069449|NCT03893565|158087326|FG006|Double-blind Induction Phase (10 Weeks)|Other|0|||
49069450|NCT03893565|158087327|FG007|Double-blind Induction Phase (10 Weeks)|Other|0|||
49069451|NCT03893565|158087328|FG008|Double-blind Induction Phase (10 Weeks)|Other|0|||
49069452|NCT03893565|158087320|FG000|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
49069453|NCT03893565|158087321|FG001|Double-blind Induction Phase (10 Weeks)|Physician Decision|1|||
49069454|NCT03893565|158087322|FG002|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
49069455|NCT03893565|158087323|FG003|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
49069456|NCT03893565|158087324|FG004|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
49069457|NCT03893565|158087325|FG005|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
49069458|NCT03893565|158087326|FG006|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
49069459|NCT03893565|158087327|FG007|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
49069460|NCT03893565|158087328|FG008|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
49069461|NCT03893565|158087320|FG000|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
49069462|NCT03893565|158087321|FG001|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|2|||
49069463|NCT03893565|158087322|FG002|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
49069464|NCT03893565|158087323|FG003|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|1|||
49069465|NCT03893565|158087324|FG004|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
49069466|NCT03893565|158087325|FG005|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
49069467|NCT03893565|158087326|FG006|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
49069468|NCT03893565|158087327|FG007|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
49069469|NCT03893565|158087328|FG008|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
49069470|NCT03893565|158087320|FG000|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
49069471|NCT03893565|158087321|FG001|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|1|||
49069472|NCT03893565|158087322|FG002|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
49069473|NCT03893565|158087323|FG003|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|6|||
49069474|NCT03893565|158087324|FG004|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
49069475|NCT03893565|158087325|FG005|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
49069476|NCT03893565|158087326|FG006|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
49069477|NCT03893565|158087327|FG007|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
49069478|NCT03893565|158087328|FG008|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
49069479|NCT03893565|158087320|FG000|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
49069480|NCT03893565|158087321|FG001|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
49069481|NCT03893565|158087322|FG002|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|9|||
49069482|NCT03893565|158087323|FG003|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
49069483|NCT03893565|158087324|FG004|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|6|||
49069484|NCT03893565|158087325|FG005|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
49069485|NCT03893565|158087326|FG006|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
49069486|NCT03893565|158087327|FG007|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
49069487|NCT03893565|158087328|FG008|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
49069488|NCT03893565|158087320|FG000|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
49069489|NCT03893565|158087321|FG001|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|2|||
49069490|NCT03893565|158087322|FG002|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
49069491|NCT03893565|158087323|FG003|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
49069492|NCT03893565|158087324|FG004|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
49069493|NCT03893565|158087325|FG005|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
49069494|NCT03893565|158087326|FG006|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
49069495|NCT03893565|158087327|FG007|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
49069496|NCT03893565|158087328|FG008|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
49069497|NCT03893565|158087320|FG000|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
49069498|NCT03893565|158087321|FG001|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
49069499|NCT03893565|158087322|FG002|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
49069500|NCT03893565|158087323|FG003|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|1|||
49069501|NCT03893565|158087324|FG004|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
49069502|NCT03893565|158087325|FG005|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
49069503|NCT03893565|158087326|FG006|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
49069504|NCT03893565|158087327|FG007|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
49069505|NCT03893565|158087328|FG008|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
49069506|NCT03893565|158087320|FG000|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
49069507|NCT03893565|158087321|FG001|Double-blind Induction Phase (10 Weeks)|Adverse Event|2|||
49069508|NCT03893565|158087322|FG002|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
49069509|NCT03893565|158087323|FG003|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
49069510|NCT03893565|158087324|FG004|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
49069511|NCT03893565|158087325|FG005|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
49069512|NCT03893565|158087326|FG006|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
49069513|NCT03893565|158087327|FG007|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
49069514|NCT03893565|158087328|FG008|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
49069515|NCT03893565|158087320|FG000|Double-blind Extended Treatment(20weeks)|Other|0|||
49069516|NCT03893565|158087321|FG001|Double-blind Extended Treatment(20weeks)|Other|0|||
49069517|NCT03893565|158087322|FG002|Double-blind Extended Treatment(20weeks)|Other|0|||
49069518|NCT03893565|158087323|FG003|Double-blind Extended Treatment(20weeks)|Other|0|||
49069519|NCT03893565|158087324|FG004|Double-blind Extended Treatment(20weeks)|Other|0|||
49069520|NCT03893565|158087325|FG005|Double-blind Extended Treatment(20weeks)|Other|1|||
49069521|NCT03893565|158087326|FG006|Double-blind Extended Treatment(20weeks)|Other|1|||
49069522|NCT03893565|158087327|FG007|Double-blind Extended Treatment(20weeks)|Other|0|||
49069523|NCT03893565|158087328|FG008|Double-blind Extended Treatment(20weeks)|Other|0|||
49069524|NCT03893565|158087320|FG000|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
49069525|NCT03893565|158087321|FG001|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
49069526|NCT03893565|158087322|FG002|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
49069527|NCT03893565|158087323|FG003|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
49069528|NCT03893565|158087324|FG004|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
49069529|NCT03893565|158087325|FG005|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
49069530|NCT03893565|158087326|FG006|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|1|||
49069531|NCT03893565|158087327|FG007|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
49069532|NCT03893565|158087328|FG008|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
49069533|NCT03893565|158087320|FG000|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
49069534|NCT03893565|158087321|FG001|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
49069535|NCT03893565|158087322|FG002|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
49069536|NCT03893565|158087323|FG003|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
49069537|NCT03893565|158087324|FG004|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
49069538|NCT03893565|158087325|FG005|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
49069539|NCT03893565|158087326|FG006|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
49069540|NCT03893565|158087327|FG007|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
49069541|NCT03893565|158087328|FG008|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
49069542|NCT03893565|158087320|FG000|Open-label Induction Phase (10 Weeks)|Other|0|||
49069543|NCT03893565|158087321|FG001|Open-label Induction Phase (10 Weeks)|Other|0|||
49069544|NCT03893565|158087322|FG002|Open-label Induction Phase (10 Weeks)|Other|0|||
49069545|NCT03893565|158087323|FG003|Open-label Induction Phase (10 Weeks)|Other|0|||
49069546|NCT03893565|158087324|FG004|Open-label Induction Phase (10 Weeks)|Other|0|||
49069547|NCT03893565|158087325|FG005|Open-label Induction Phase (10 Weeks)|Other|0|||
49069548|NCT03893565|158087326|FG006|Open-label Induction Phase (10 Weeks)|Other|0|||
49069549|NCT03893565|158087327|FG007|Open-label Induction Phase (10 Weeks)|Other|3|||
49069550|NCT03893565|158087328|FG008|Open-label Induction Phase (10 Weeks)|Other|0|||
49069551|NCT03893565|158087320|FG000|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
49069552|NCT03893565|158087321|FG001|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
49069553|NCT03893565|158087322|FG002|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
49069554|NCT03893565|158087323|FG003|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
49069555|NCT03893565|158087324|FG004|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
49069556|NCT03893565|158087325|FG005|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
49069557|NCT03893565|158087326|FG006|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
49069558|NCT03893565|158087327|FG007|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|5|||
49069559|NCT03893565|158087328|FG008|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
49069560|NCT03893565|158087320|FG000|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
49069561|NCT03893565|158087321|FG001|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
49069562|NCT03893565|158087322|FG002|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
49069563|NCT03893565|158087323|FG003|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
49069564|NCT03893565|158087324|FG004|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
49069565|NCT03893565|158087325|FG005|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
49069566|NCT03893565|158087326|FG006|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
49069567|NCT03893565|158087327|FG007|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|15|||
49069568|NCT03893565|158087328|FG008|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
49069569|NCT03893565|158087320|FG000|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
49069570|NCT03893565|158087321|FG001|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
49069571|NCT03893565|158087322|FG002|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
49069572|NCT03893565|158087323|FG003|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
49069573|NCT03893565|158087324|FG004|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
49069574|NCT03893565|158087325|FG005|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
49069575|NCT03893565|158087326|FG006|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
49069576|NCT03893565|158087327|FG007|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|7|||
49069577|NCT03893565|158087328|FG008|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
49069578|NCT03893565|158087320|FG000|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
49069579|NCT03893565|158087321|FG001|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
49069580|NCT03893565|158087322|FG002|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
49069581|NCT03893565|158087323|FG003|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
49069582|NCT03893565|158087324|FG004|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
49069583|NCT03893565|158087325|FG005|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
49069584|NCT03893565|158087326|FG006|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
49069585|NCT03893565|158087327|FG007|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
49069586|NCT03893565|158087328|FG008|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|4|||
49069587|NCT03207867|158087329|FG000|Overall Study|Adverse Event|1|||
49069588|NCT03207867|158087330|FG001|Overall Study|Adverse Event|0|||
49069589|NCT03207867|158087331|FG002|Overall Study|Adverse Event|1|||
49069590|NCT03207867|158087332|FG003|Overall Study|Adverse Event|0|||
49069591|NCT03207867|158087333|FG004|Overall Study|Adverse Event|0|||
49069592|NCT03207867|158087334|FG005|Overall Study|Adverse Event|2|||
49069593|NCT03207867|158087335|FG006|Overall Study|Adverse Event|1|||
49069594|NCT03207867|158087336|FG007|Overall Study|Adverse Event|1|||
49069595|NCT03207867|158087337|FG008|Overall Study|Adverse Event|2|||
49069596|NCT03207867|158087338|FG009|Overall Study|Adverse Event|2|||
49069597|NCT03207867|158087339|FG010|Overall Study|Adverse Event|0|||
49069598|NCT03207867|158087340|FG011|Overall Study|Adverse Event|0|||
49069599|NCT03207867|158087341|FG012|Overall Study|Adverse Event|0|||
49069600|NCT03207867|158087342|FG013|Overall Study|Adverse Event|0|||
49069601|NCT03207867|158087343|FG014|Overall Study|Adverse Event|0|||
49069602|NCT03207867|158087344|FG015|Overall Study|Adverse Event|0|||
49069603|NCT03207867|158087345|FG016|Overall Study|Adverse Event|3|||
49069604|NCT03207867|158087346|FG017|Overall Study|Adverse Event|1|||
49069605|NCT03207867|158087347|FG018|Overall Study|Adverse Event|2|||
49069606|NCT03207867|158087348|FG019|Overall Study|Adverse Event|1|||
49069607|NCT03207867|158087349|FG020|Overall Study|Adverse Event|0|||
49069608|NCT03207867|158087350|FG021|Overall Study|Adverse Event|0|||
49069609|NCT03207867|158087351|FG022|Overall Study|Adverse Event|0|||
49069610|NCT03207867|158087352|FG023|Overall Study|Adverse Event|0|||
49069611|NCT03207867|158087329|FG000|Overall Study|Death|0|||
49069612|NCT03207867|158087330|FG001|Overall Study|Death|0|||
49069613|NCT03207867|158087331|FG002|Overall Study|Death|0|||
49069614|NCT03207867|158087332|FG003|Overall Study|Death|0|||
49069615|NCT03207867|158087333|FG004|Overall Study|Death|0|||
49069616|NCT03207867|158087334|FG005|Overall Study|Death|1|||
49069617|NCT03207867|158087335|FG006|Overall Study|Death|0|||
49069618|NCT03207867|158087336|FG007|Overall Study|Death|3|||
49069619|NCT03207867|158087337|FG008|Overall Study|Death|1|||
49069620|NCT03207867|158087338|FG009|Overall Study|Death|2|||
49069621|NCT03207867|158087339|FG010|Overall Study|Death|0|||
49069622|NCT03207867|158087340|FG011|Overall Study|Death|1|||
49069623|NCT03207867|158087341|FG012|Overall Study|Death|0|||
49069624|NCT03207867|158087342|FG013|Overall Study|Death|1|||
49069625|NCT03207867|158087343|FG014|Overall Study|Death|0|||
49069626|NCT03207867|158087344|FG015|Overall Study|Death|0|||
49069627|NCT03207867|158087345|FG016|Overall Study|Death|0|||
49069628|NCT03207867|158087346|FG017|Overall Study|Death|2|||
49069629|NCT03207867|158087347|FG018|Overall Study|Death|0|||
49069630|NCT03207867|158087348|FG019|Overall Study|Death|1|||
49069631|NCT03207867|158087349|FG020|Overall Study|Death|0|||
49069632|NCT03207867|158087350|FG021|Overall Study|Death|0|||
49069633|NCT03207867|158087351|FG022|Overall Study|Death|0|||
49069634|NCT03207867|158087352|FG023|Overall Study|Death|0|||
49069635|NCT03207867|158087329|FG000|Overall Study|Physician Decision|3|||
49069636|NCT03207867|158087330|FG001|Overall Study|Physician Decision|5|||
49069637|NCT03207867|158087331|FG002|Overall Study|Physician Decision|0|||
49069638|NCT03207867|158087332|FG003|Overall Study|Physician Decision|3|||
49069639|NCT03207867|158087333|FG004|Overall Study|Physician Decision|2|||
49069640|NCT03207867|158087334|FG005|Overall Study|Physician Decision|0|||
49069641|NCT03207867|158087335|FG006|Overall Study|Physician Decision|0|||
49069642|NCT03207867|158087336|FG007|Overall Study|Physician Decision|0|||
49069643|NCT03207867|158087337|FG008|Overall Study|Physician Decision|4|||
49069644|NCT03207867|158087338|FG009|Overall Study|Physician Decision|2|||
49069645|NCT03207867|158087339|FG010|Overall Study|Physician Decision|0|||
49069646|NCT03207867|158087340|FG011|Overall Study|Physician Decision|4|||
49069647|NCT03207867|158087341|FG012|Overall Study|Physician Decision|0|||
49069648|NCT03207867|158087342|FG013|Overall Study|Physician Decision|0|||
49069649|NCT03207867|158087343|FG014|Overall Study|Physician Decision|2|||
49069650|NCT03207867|158087344|FG015|Overall Study|Physician Decision|1|||
49069651|NCT03207867|158087345|FG016|Overall Study|Physician Decision|1|||
49069652|NCT03207867|158087346|FG017|Overall Study|Physician Decision|2|||
49069653|NCT03207867|158087347|FG018|Overall Study|Physician Decision|1|||
49069654|NCT03207867|158087348|FG019|Overall Study|Physician Decision|3|||
49069655|NCT03207867|158087349|FG020|Overall Study|Physician Decision|0|||
49069656|NCT03207867|158087350|FG021|Overall Study|Physician Decision|0|||
49069657|NCT03207867|158087351|FG022|Overall Study|Physician Decision|0|||
49069658|NCT03207867|158087352|FG023|Overall Study|Physician Decision|0|||
49069659|NCT03207867|158087329|FG000|Overall Study|Progressive Disease|7|||
49069660|NCT03207867|158087330|FG001|Overall Study|Progressive Disease|7|||
49069661|NCT03207867|158087331|FG002|Overall Study|Progressive Disease|9|||
49069662|NCT03207867|158087332|FG003|Overall Study|Progressive Disease|10|||
49069663|NCT03207867|158087333|FG004|Overall Study|Progressive Disease|11|||
49069664|NCT03207867|158087334|FG005|Overall Study|Progressive Disease|10|||
49069665|NCT03207867|158087335|FG006|Overall Study|Progressive Disease|9|||
49069666|NCT03207867|158087336|FG007|Overall Study|Progressive Disease|8|||
49069667|NCT03207867|158087337|FG008|Overall Study|Progressive Disease|19|||
49069668|NCT03207867|158087338|FG009|Overall Study|Progressive Disease|23|||
49069669|NCT03207867|158087339|FG010|Overall Study|Progressive Disease|2|||
49069670|NCT03207867|158087340|FG011|Overall Study|Progressive Disease|24|||
49069671|NCT03207867|158087341|FG012|Overall Study|Progressive Disease|3|||
49069672|NCT03207867|158087342|FG013|Overall Study|Progressive Disease|11|||
49069673|NCT03207867|158087343|FG014|Overall Study|Progressive Disease|9|||
49069674|NCT03207867|158087344|FG015|Overall Study|Progressive Disease|5|||
49069675|NCT03207867|158087345|FG016|Overall Study|Progressive Disease|10|||
49069676|NCT03207867|158087346|FG017|Overall Study|Progressive Disease|14|||
49069677|NCT03207867|158087347|FG018|Overall Study|Progressive Disease|13|||
49069678|NCT03207867|158087348|FG019|Overall Study|Progressive Disease|14|||
49069679|NCT03207867|158087349|FG020|Overall Study|Progressive Disease|6|||
49069680|NCT03207867|158087350|FG021|Overall Study|Progressive Disease|3|||
49069681|NCT03207867|158087351|FG022|Overall Study|Progressive Disease|3|||
49069682|NCT03207867|158087352|FG023|Overall Study|Progressive Disease|3|||
49069683|NCT03207867|158087329|FG000|Overall Study|Patient/guardian Decision|0|||
49069684|NCT03207867|158087330|FG001|Overall Study|Patient/guardian Decision|0|||
49069685|NCT03207867|158087331|FG002|Overall Study|Patient/guardian Decision|1|||
49069686|NCT03207867|158087332|FG003|Overall Study|Patient/guardian Decision|1|||
49069687|NCT03207867|158087333|FG004|Overall Study|Patient/guardian Decision|1|||
49069688|NCT03207867|158087334|FG005|Overall Study|Patient/guardian Decision|2|||
49069689|NCT03207867|158087335|FG006|Overall Study|Patient/guardian Decision|1|||
49069690|NCT03207867|158087336|FG007|Overall Study|Patient/guardian Decision|0|||
49069691|NCT03207867|158087337|FG008|Overall Study|Patient/guardian Decision|1|||
49069692|NCT03207867|158087338|FG009|Overall Study|Patient/guardian Decision|0|||
49069693|NCT03207867|158087339|FG010|Overall Study|Patient/guardian Decision|0|||
49069694|NCT03207867|158087340|FG011|Overall Study|Patient/guardian Decision|1|||
49069695|NCT03207867|158087341|FG012|Overall Study|Patient/guardian Decision|0|||
49069696|NCT03207867|158087342|FG013|Overall Study|Patient/guardian Decision|1|||
49069697|NCT03207867|158087343|FG014|Overall Study|Patient/guardian Decision|2|||
49069698|NCT03207867|158087344|FG015|Overall Study|Patient/guardian Decision|0|||
49069699|NCT03207867|158087345|FG016|Overall Study|Patient/guardian Decision|1|||
49069700|NCT03207867|158087346|FG017|Overall Study|Patient/guardian Decision|3|||
49069701|NCT03207867|158087347|FG018|Overall Study|Patient/guardian Decision|4|||
49069702|NCT03207867|158087348|FG019|Overall Study|Patient/guardian Decision|1|||
49069703|NCT03207867|158087349|FG020|Overall Study|Patient/guardian Decision|0|||
49069704|NCT03207867|158087350|FG021|Overall Study|Patient/guardian Decision|0|||
49069705|NCT03207867|158087351|FG022|Overall Study|Patient/guardian Decision|0|||
49069706|NCT03207867|158087352|FG023|Overall Study|Patient/guardian Decision|0|||
49069707|NCT03511326|158087353|FG000|Overall Study|Withdrawal by Subject|1|||
49069708|NCT04497948|158087354|FG000|Overall Study|Death|2|||
49069709|NCT00492024|158087355|FG000|Treatment|Adverse Event|3|||
49069710|NCT00492024|158087356|FG001|Treatment|Adverse Event|1|||
49069711|NCT00492024|158087355|FG000|Treatment|Lack of Efficacy|21|||
49069712|NCT00492024|158087356|FG001|Treatment|Lack of Efficacy|20|||
49069713|NCT00492024|158087355|FG000|Treatment|Lost to Follow-up|3|||
49069714|NCT00492024|158087356|FG001|Treatment|Lost to Follow-up|1|||
49069715|NCT00492024|158087355|FG000|Treatment|Withdrawal by Subject|2|||
49069716|NCT00492024|158087356|FG001|Treatment|Withdrawal by Subject|0|||
49069717|NCT00492024|158087355|FG000|Follow up|Lack of Efficacy|0|||
49069718|NCT00492024|158087356|FG001|Follow up|Lack of Efficacy|1|||
49069719|NCT00492024|158087355|FG000|Follow up|Lost to Follow-up|1|||
49069720|NCT00492024|158087356|FG001|Follow up|Lost to Follow-up|1|||
49069721|NCT03247816|158087359|FG000|Overall Study|Adverse Event|12|||
49069722|NCT03247816|158087359|FG000|Overall Study|Physician Decision|3|||
49069723|NCT03247816|158087359|FG000|Overall Study|Lack of Efficacy|1|||
49069724|NCT03247816|158087359|FG000|Overall Study|Lost to Follow-up|10|||
49069725|NCT03247816|158087359|FG000|Overall Study|Missing Feraccru stop date|3|||
49069726|NCT01439009|158087360|FG000|Overall Study|Physician Decision|5|||
49069727|NCT01439009|158087361|FG001|Overall Study|Physician Decision|3|||
49069728|NCT01439009|158087360|FG000|Overall Study|Protocol Violation|2|||
49069729|NCT01439009|158087361|FG001|Overall Study|Protocol Violation|0|||
49069730|NCT01439009|158087360|FG000|Overall Study|Deviation of exclusion criteria|1|||
49069731|NCT01439009|158087361|FG001|Overall Study|Deviation of exclusion criteria|0|||
49069732|NCT00936897|158087362|FG000|Overall Study|Withdrawal by Subject|9|||
49069733|NCT00936897|158087363|FG001|Overall Study|Withdrawal by Subject|19|||
49069734|NCT00936897|158087362|FG000|Overall Study|Adverse Event|4|||
49069735|NCT00936897|158087363|FG001|Overall Study|Adverse Event|13|||
49069736|NCT00936897|158087362|FG000|Overall Study|Other|3|||
49069737|NCT00936897|158087363|FG001|Overall Study|Other|9|||
49069738|NCT00936897|158087362|FG000|Overall Study|Lost to Follow-up|1|||
49069739|NCT00936897|158087363|FG001|Overall Study|Lost to Follow-up|10|||
49069740|NCT00936897|158087362|FG000|Overall Study|Administrative Decision|1|||
49069741|NCT00936897|158087363|FG001|Overall Study|Administrative Decision|2|||
49069742|NCT00936897|158087362|FG000|Overall Study|Protocol Violation|1|||
49069743|NCT00936897|158087363|FG001|Overall Study|Protocol Violation|1|||
49069744|NCT00936897|158087362|FG000|Overall Study|Ineligibility Determined|0|||
49069745|NCT00936897|158087363|FG001|Overall Study|Ineligibility Determined|3|||
49069746|NCT00936897|158087362|FG000|Overall Study|Noncompliance|0|||
49069747|NCT00936897|158087363|FG001|Overall Study|Noncompliance|2|||
49069748|NCT00936897|158087362|FG000|Overall Study|Death|0|||
49069749|NCT00936897|158087363|FG001|Overall Study|Death|1|||
49069750|NCT00926783|158087364|FG000|Overall Study|Incomplete CFAE Procedures|3|||
49069751|NCT00926783|158087365|FG001|Overall Study|Incomplete CFAE Procedures|3|||
49069752|NCT03796039|158087366|FG000|Overall Study|Death|2|||
49069753|NCT03796039|158087367|FG001|Overall Study|Death|1|||
49069754|NCT03796039|158087366|FG000|Overall Study|Withdrawal by Subject|7|||
49069755|NCT03796039|158087367|FG001|Overall Study|Withdrawal by Subject|4|||
49069756|NCT00478426|158087368|FG000|Overall Study|Withdrawal by Subject|1|||
49069757|NCT00789737|158087375|FG000|Overall Study|Withdrawal by Subject|13|||
49069758|NCT00789737|158087376|FG001|Overall Study|Withdrawal by Subject|22|||
49069759|NCT00789737|158087375|FG000|Overall Study|Lost to Follow-up|10|||
49069760|NCT00789737|158087376|FG001|Overall Study|Lost to Follow-up|14|||
49069761|NCT00789737|158087375|FG000|Overall Study|Adverse Event|8|||
49069762|NCT00789737|158087376|FG001|Overall Study|Adverse Event|8|||
49069763|NCT00789737|158087375|FG000|Overall Study|Protocol Violation|3|||
49069764|NCT00789737|158087376|FG001|Overall Study|Protocol Violation|0|||
49069765|NCT00789737|158087375|FG000|Overall Study|Lack of Efficacy|3|||
49069766|NCT00789737|158087376|FG001|Overall Study|Lack of Efficacy|0|||
49069767|NCT00789737|158087375|FG000|Overall Study|hyperglycemia that met protocol-specifie|0|||
49069768|NCT00789737|158087376|FG001|Overall Study|hyperglycemia that met protocol-specifie|4|||
49069769|NCT00789737|158087375|FG000|Overall Study|Other|11|||
49069770|NCT00789737|158087376|FG001|Overall Study|Other|7|||
49069771|NCT00813800|158087379|FG000|Overall Study|Screen Failure after Consent|2|||
49069772|NCT00813800|158087379|FG000|Overall Study|Adverse Event|1|||
49069773|NCT00813800|158087379|FG000|Overall Study|Worsening of depression|2|||
49069774|NCT00813800|158087379|FG000|Overall Study|Physician Decision|1|||
49069775|NCT01189487|158087380|FG000|Overall Study|Lack of Efficacy|2|||
49069776|NCT01189487|158087380|FG000|Overall Study|Adverse Event|1|||
49069777|NCT04630158|158087387|FG000|Overall Study|Adverse Event|1|||
49069778|NCT04630158|158087388|FG001|Overall Study|Adverse Event|1|||
49069779|NCT04630158|158087389|FG002|Overall Study|Adverse Event|1|||
49069780|NCT04630158|158087387|FG000|Overall Study|Physician Decision|0|||
49069781|NCT04630158|158087388|FG001|Overall Study|Physician Decision|2|||
49069782|NCT04630158|158087389|FG002|Overall Study|Physician Decision|0|||
49069783|NCT04630158|158087387|FG000|Overall Study|Protocol Violation|1|||
49069784|NCT04630158|158087388|FG001|Overall Study|Protocol Violation|0|||
49069785|NCT04630158|158087389|FG002|Overall Study|Protocol Violation|1|||
49069786|NCT04630158|158087387|FG000|Overall Study|Withdrawal by Subject|2|||
49069787|NCT04630158|158087388|FG001|Overall Study|Withdrawal by Subject|1|||
49069788|NCT04630158|158087389|FG002|Overall Study|Withdrawal by Subject|2|||
49069789|NCT01822366|158087390|FG000|Overall Study|Lost to Follow-up|5|||
49069790|NCT01822366|158087391|FG001|Overall Study|Lost to Follow-up|1|||
49069791|NCT01822366|158087392|FG002|Overall Study|Lost to Follow-up|5|||
49069792|NCT01822366|158087393|FG003|Overall Study|Lost to Follow-up|1|||
49069793|NCT01822366|158087390|FG000|Overall Study|Withdrawal by Subject|0|||
49069794|NCT01822366|158087391|FG001|Overall Study|Withdrawal by Subject|6|||
49069795|NCT01822366|158087392|FG002|Overall Study|Withdrawal by Subject|0|||
49069796|NCT01822366|158087393|FG003|Overall Study|Withdrawal by Subject|6|||
49069797|NCT01822366|158087390|FG000|Overall Study|Partial Intervention Completion|0|||
49069798|NCT01822366|158087391|FG001|Overall Study|Partial Intervention Completion|15|||
49069799|NCT01822366|158087392|FG002|Overall Study|Partial Intervention Completion|0|||
49069800|NCT01822366|158087393|FG003|Overall Study|Partial Intervention Completion|15|||
49069801|NCT04874155|158087394|FG000|Overall Study|Lost to Follow-up|1|||
49069802|NCT04874155|158087395|FG001|Overall Study|Lost to Follow-up|1|||
49069803|NCT04874155|158087394|FG000|Overall Study|Withdrawal by Subject|2|||
49069804|NCT04874155|158087395|FG001|Overall Study|Withdrawal by Subject|2|||
49069805|NCT01004003|158087402|FG000|Overall Study|Progressive disease|2|||
49069806|NCT01004003|158087403|FG001|Overall Study|Progressive disease|1|||
49069807|NCT01004003|158087404|FG002|Overall Study|Progressive disease|1|||
49069808|NCT01004003|158087405|FG003|Overall Study|Progressive disease|0|||
49069809|NCT01004003|158087406|FG004|Overall Study|Progressive disease|2|||
49069810|NCT01004003|158087407|FG005|Overall Study|Progressive disease|1|||
49069811|NCT01004003|158087408|FG006|Overall Study|Progressive disease|1|||
49069812|NCT01004003|158087409|FG007|Overall Study|Progressive disease|39|||
49069813|NCT01004003|158087410|FG008|Overall Study|Progressive disease|22|||
49069814|NCT01004003|158087402|FG000|Overall Study|Adverse Event|4|||
49069815|NCT01004003|158087403|FG001|Overall Study|Adverse Event|2|||
49069816|NCT01004003|158087404|FG002|Overall Study|Adverse Event|3|||
49069817|NCT01004003|158087405|FG003|Overall Study|Adverse Event|3|||
49069818|NCT01004003|158087406|FG004|Overall Study|Adverse Event|2|||
49069819|NCT01004003|158087407|FG005|Overall Study|Adverse Event|2|||
49069820|NCT01004003|158087408|FG006|Overall Study|Adverse Event|7|||
49069821|NCT01004003|158087409|FG007|Overall Study|Adverse Event|21|||
49069822|NCT01004003|158087410|FG008|Overall Study|Adverse Event|6|||
49069823|NCT01004003|158087402|FG000|Overall Study|Refused to continue taking trial med.|0|||
49069824|NCT01004003|158087403|FG001|Overall Study|Refused to continue taking trial med.|0|||
49069825|NCT01004003|158087404|FG002|Overall Study|Refused to continue taking trial med.|0|||
49069826|NCT01004003|158087405|FG003|Overall Study|Refused to continue taking trial med.|0|||
49069827|NCT01004003|158087406|FG004|Overall Study|Refused to continue taking trial med.|0|||
49069828|NCT01004003|158087407|FG005|Overall Study|Refused to continue taking trial med.|0|||
49069829|NCT01004003|158087408|FG006|Overall Study|Refused to continue taking trial med.|0|||
49069830|NCT01004003|158087409|FG007|Overall Study|Refused to continue taking trial med.|0|||
49069831|NCT01004003|158087410|FG008|Overall Study|Refused to continue taking trial med.|2|||
49069832|NCT01004003|158087402|FG000|Overall Study|Other|0|||
49069833|NCT01004003|158087403|FG001|Overall Study|Other|0|||
49069834|NCT01004003|158087404|FG002|Overall Study|Other|0|||
49069835|NCT01004003|158087405|FG003|Overall Study|Other|0|||
49069836|NCT01004003|158087406|FG004|Overall Study|Other|0|||
49069837|NCT01004003|158087407|FG005|Overall Study|Other|1|||
49069838|NCT01004003|158087408|FG006|Overall Study|Other|0|||
49069839|NCT01004003|158087409|FG007|Overall Study|Other|0|||
49069840|NCT01004003|158087410|FG008|Overall Study|Other|0|||
49069841|NCT00642278|158087411|FG000|Overall Study|Adverse Event|2|||
49069842|NCT00642278|158087412|FG001|Overall Study|Adverse Event|1|||
49069843|NCT00642278|158087413|FG002|Overall Study|Adverse Event|3|||
49069844|NCT00642278|158087414|FG003|Overall Study|Adverse Event|1|||
49069845|NCT00642278|158087415|FG004|Overall Study|Adverse Event|2|||
49069846|NCT00642278|158087416|FG005|Overall Study|Adverse Event|2|||
49069847|NCT00642278|158087417|FG006|Overall Study|Adverse Event|0|||
49069848|NCT00642278|158087411|FG000|Overall Study|Lack of Efficacy|0|||
49069849|NCT00642278|158087412|FG001|Overall Study|Lack of Efficacy|1|||
49069850|NCT00642278|158087413|FG002|Overall Study|Lack of Efficacy|0|||
49069851|NCT00642278|158087414|FG003|Overall Study|Lack of Efficacy|0|||
49069852|NCT00642278|158087415|FG004|Overall Study|Lack of Efficacy|0|||
49069853|NCT00642278|158087416|FG005|Overall Study|Lack of Efficacy|0|||
49069854|NCT00642278|158087417|FG006|Overall Study|Lack of Efficacy|0|||
49069855|NCT00642278|158087411|FG000|Overall Study|Lost to Follow-up|5|||
49069856|NCT00642278|158087412|FG001|Overall Study|Lost to Follow-up|1|||
49069857|NCT00642278|158087413|FG002|Overall Study|Lost to Follow-up|0|||
49069858|NCT00642278|158087414|FG003|Overall Study|Lost to Follow-up|1|||
49069859|NCT00642278|158087415|FG004|Overall Study|Lost to Follow-up|0|||
49069860|NCT00642278|158087416|FG005|Overall Study|Lost to Follow-up|1|||
49069861|NCT00642278|158087417|FG006|Overall Study|Lost to Follow-up|1|||
49069862|NCT00642278|158087411|FG000|Overall Study|Physician Decision|0|||
49069863|NCT00642278|158087412|FG001|Overall Study|Physician Decision|0|||
49069864|NCT00642278|158087413|FG002|Overall Study|Physician Decision|0|||
49069865|NCT00642278|158087414|FG003|Overall Study|Physician Decision|1|||
49069866|NCT00642278|158087415|FG004|Overall Study|Physician Decision|0|||
49069867|NCT00642278|158087416|FG005|Overall Study|Physician Decision|0|||
49069868|NCT00642278|158087417|FG006|Overall Study|Physician Decision|0|||
49069869|NCT00642278|158087411|FG000|Overall Study|Protocol Violation|0|||
49069870|NCT00642278|158087412|FG001|Overall Study|Protocol Violation|0|||
49069871|NCT00642278|158087413|FG002|Overall Study|Protocol Violation|1|||
49069872|NCT00642278|158087414|FG003|Overall Study|Protocol Violation|1|||
49069873|NCT00642278|158087415|FG004|Overall Study|Protocol Violation|0|||
49069874|NCT00642278|158087416|FG005|Overall Study|Protocol Violation|1|||
49069875|NCT00642278|158087417|FG006|Overall Study|Protocol Violation|2|||
49069876|NCT00642278|158087411|FG000|Overall Study|Withdrawal by Subject|1|||
49069877|NCT00642278|158087412|FG001|Overall Study|Withdrawal by Subject|1|||
49069878|NCT00642278|158087413|FG002|Overall Study|Withdrawal by Subject|1|||
49069879|NCT00642278|158087414|FG003|Overall Study|Withdrawal by Subject|3|||
49069880|NCT00642278|158087415|FG004|Overall Study|Withdrawal by Subject|6|||
49069881|NCT00642278|158087416|FG005|Overall Study|Withdrawal by Subject|2|||
49069882|NCT00642278|158087417|FG006|Overall Study|Withdrawal by Subject|2|||
49069883|NCT00642278|158087411|FG000|Overall Study|Noncompliance with study drug regimen|0|||
49069884|NCT00642278|158087412|FG001|Overall Study|Noncompliance with study drug regimen|0|||
49069885|NCT00642278|158087413|FG002|Overall Study|Noncompliance with study drug regimen|0|||
49069886|NCT00642278|158087414|FG003|Overall Study|Noncompliance with study drug regimen|1|||
49069887|NCT00642278|158087415|FG004|Overall Study|Noncompliance with study drug regimen|0|||
49069888|NCT00642278|158087416|FG005|Overall Study|Noncompliance with study drug regimen|0|||
49069889|NCT00642278|158087417|FG006|Overall Study|Noncompliance with study drug regimen|0|||
49069890|NCT00642278|158087411|FG000|Overall Study|Other|2|||
49069891|NCT00642278|158087412|FG001|Overall Study|Other|1|||
49069892|NCT00642278|158087413|FG002|Overall Study|Other|0|||
49069893|NCT00642278|158087414|FG003|Overall Study|Other|1|||
49069894|NCT00642278|158087415|FG004|Overall Study|Other|0|||
49069895|NCT00642278|158087416|FG005|Overall Study|Other|1|||
49069896|NCT00642278|158087417|FG006|Overall Study|Other|0|||
49069897|NCT01464931|158087418|FG000|Overall Study|Withdrawal by Subject|1|||
49069898|NCT01464931|158087419|FG001|Overall Study|Withdrawal by Subject|0|||
49069899|NCT02293863|158087421|FG000|Overall Study|Death|4|||
49069900|NCT02293863|158087422|FG001|Overall Study|Death|6|||
49069901|NCT02293863|158087423|FG002|Overall Study|Death|4|||
49069902|NCT02293863|158087421|FG000|Overall Study|Lost to Follow-up|2|||
49069903|NCT02293863|158087422|FG001|Overall Study|Lost to Follow-up|2|||
49069904|NCT02293863|158087423|FG002|Overall Study|Lost to Follow-up|2|||
49069905|NCT02293863|158087421|FG000|Overall Study|Withdrawal by Subject|3|||
49069906|NCT02293863|158087422|FG001|Overall Study|Withdrawal by Subject|3|||
49069907|NCT02293863|158087423|FG002|Overall Study|Withdrawal by Subject|1|||
49069908|NCT02293863|158087421|FG000|Overall Study|Reason Not Specified|0|||
49069909|NCT02293863|158087422|FG001|Overall Study|Reason Not Specified|2|||
49069910|NCT02293863|158087423|FG002|Overall Study|Reason Not Specified|2|||
49069911|NCT02212379|158087424|FG000|From Baseline to Week 48|Lack of Efficacy|1|||
49069912|NCT02212379|158087424|FG000|From Baseline to Week 48|Adverse Event|7|||
49069913|NCT02212379|158087424|FG000|From Baseline to Week 48|Withdrawal by Subject|1|||
49069914|NCT02212379|158087424|FG000|From Week 48 to Week 96|Lack of Efficacy|1|||
49069915|NCT02212379|158087424|FG000|From Week 48 to Week 96|Adverse Event|1|||
49069916|NCT02212379|158087424|FG000|From Week 48 to Week 96|Withdrawal by Subject|2|||
49069917|NCT04784533|158087425|FG000|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|6|||
49069918|NCT04784533|158087426|FG001|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|3|||
49069919|NCT04784533|158087427|FG002|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
49069920|NCT04784533|158087428|FG003|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
49069921|NCT04784533|158087429|FG004|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
49069922|NCT04784533|158087430|FG005|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
49069923|NCT04784533|158087431|FG006|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
49069924|NCT04784533|158087432|FG007|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
49069925|NCT04784533|158087433|FG008|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
49069926|NCT04784533|158087434|FG009|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
49069927|NCT04784533|158087425|FG000|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
49069928|NCT04784533|158087426|FG001|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
49069929|NCT04784533|158087427|FG002|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
49069930|NCT04784533|158087428|FG003|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
49069931|NCT04784533|158087429|FG004|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
49069932|NCT04784533|158087430|FG005|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
49069933|NCT04784533|158087431|FG006|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
49069934|NCT04784533|158087432|FG007|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
49069935|NCT04784533|158087433|FG008|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
49069936|NCT04784533|158087434|FG009|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
49069937|NCT04784533|158087425|FG000|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
49069938|NCT04784533|158087426|FG001|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|2|||
49069939|NCT04784533|158087427|FG002|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
49069940|NCT04784533|158087428|FG003|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
49069941|NCT04784533|158087429|FG004|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
49069942|NCT04784533|158087430|FG005|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
49069943|NCT04784533|158087431|FG006|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
49069944|NCT04784533|158087432|FG007|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
49069945|NCT04784533|158087433|FG008|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
49069946|NCT04784533|158087434|FG009|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
49069947|NCT04784533|158087425|FG000|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|1|||
49069948|NCT04784533|158087426|FG001|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
49069949|NCT04784533|158087427|FG002|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
49069950|NCT04784533|158087428|FG003|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
49069951|NCT04784533|158087429|FG004|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
49069952|NCT04784533|158087430|FG005|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
49069953|NCT04784533|158087431|FG006|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
49069954|NCT04784533|158087432|FG007|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
49069955|NCT04784533|158087433|FG008|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
49069956|NCT04784533|158087434|FG009|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
49069957|NCT04784533|158087425|FG000|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|5|||
49069958|NCT04784533|158087426|FG001|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|7|||
49069959|NCT04784533|158087427|FG002|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
49069960|NCT04784533|158087428|FG003|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
49069961|NCT04784533|158087429|FG004|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
49069962|NCT04784533|158087430|FG005|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
49069963|NCT04784533|158087431|FG006|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
49069964|NCT04784533|158087432|FG007|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
49069965|NCT04784533|158087433|FG008|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
49069966|NCT04784533|158087434|FG009|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
49069967|NCT04784533|158087425|FG000|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|5|||
49069968|NCT04784533|158087426|FG001|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|6|||
49069969|NCT04784533|158087427|FG002|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
49069970|NCT04784533|158087428|FG003|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
49069971|NCT04784533|158087429|FG004|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
49069972|NCT04784533|158087430|FG005|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
49069973|NCT04784533|158087431|FG006|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
49069974|NCT04784533|158087432|FG007|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
49069975|NCT04784533|158087433|FG008|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
49069976|NCT04784533|158087434|FG009|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
49069977|NCT04784533|158087425|FG000|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
49069978|NCT04784533|158087426|FG001|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
49069979|NCT04784533|158087427|FG002|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|1|||
49069980|NCT04784533|158087428|FG003|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
49069981|NCT04784533|158087429|FG004|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
49069982|NCT04784533|158087430|FG005|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
49069983|NCT04784533|158087431|FG006|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
49069984|NCT04784533|158087432|FG007|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
49069985|NCT04784533|158087433|FG008|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
49069986|NCT04784533|158087434|FG009|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
49069987|NCT04784533|158087425|FG000|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
49069988|NCT04784533|158087426|FG001|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
49069989|NCT04784533|158087427|FG002|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
49069990|NCT04784533|158087428|FG003|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
49069991|NCT04784533|158087429|FG004|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
49069992|NCT04784533|158087430|FG005|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
49069993|NCT04784533|158087431|FG006|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
49069994|NCT04784533|158087432|FG007|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
49069995|NCT04784533|158087433|FG008|Part B (Day 1 to Week 24)|Lost to Follow-up|1|||
49069996|NCT04784533|158087434|FG009|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
49069997|NCT04784533|158087425|FG000|Part B (Day 1 to Week 24)|Reason not Specified|0|||
49069998|NCT04784533|158087426|FG001|Part B (Day 1 to Week 24)|Reason not Specified|0|||
49069999|NCT04784533|158087427|FG002|Part B (Day 1 to Week 24)|Reason not Specified|0|||
49070000|NCT04784533|158087428|FG003|Part B (Day 1 to Week 24)|Reason not Specified|0|||
49070001|NCT04784533|158087429|FG004|Part B (Day 1 to Week 24)|Reason not Specified|0|||
49070002|NCT04784533|158087430|FG005|Part B (Day 1 to Week 24)|Reason not Specified|0|||
49070003|NCT04784533|158087431|FG006|Part B (Day 1 to Week 24)|Reason not Specified|0|||
49070004|NCT04784533|158087432|FG007|Part B (Day 1 to Week 24)|Reason not Specified|0|||
49070005|NCT04784533|158087433|FG008|Part B (Day 1 to Week 24)|Reason not Specified|1|||
49070006|NCT04784533|158087434|FG009|Part B (Day 1 to Week 24)|Reason not Specified|1|||
49070007|NCT00174954|158087435|FG000|Overall Study|Adverse Event|2|||
49070008|NCT00174954|158087435|FG000|Overall Study|No tophi found in MRI|1|||
49070009|NCT00174954|158087435|FG000|Overall Study|Physician Decision|1|||
49070010|NCT00721630|158089172|FG000|Overall Study|Participant found to be ineligible|1|||
49070011|NCT00792935|158089173|FG000|Overall Study|Adverse Event|2|||
49070012|NCT00792935|158089174|FG001|Overall Study|Adverse Event|1|||
49070013|NCT00792935|158089173|FG000|Overall Study|Lost to Follow-up|0|||
49070014|NCT00792935|158089174|FG001|Overall Study|Lost to Follow-up|1|||
49070015|NCT00792935|158089173|FG000|Overall Study|Protocol Violation|2|||
49070016|NCT00792935|158089174|FG001|Overall Study|Protocol Violation|0|||
49070017|NCT00792935|158089173|FG000|Overall Study|Withdrawal by Subject|0|||
49070018|NCT00792935|158089174|FG001|Overall Study|Withdrawal by Subject|1|||
49070019|NCT00090363|158089175|FG000|Overall Study|Lost to Follow-up|1|||
49070020|NCT00090363|158089176|FG001|Overall Study|Lost to Follow-up|2|||
49070021|NCT00090363|158089177|FG002|Overall Study|Lost to Follow-up|1|||
49070022|NCT00090363|158089175|FG000|Overall Study|Withdrawal by Subject|7|||
49070023|NCT00090363|158089176|FG001|Overall Study|Withdrawal by Subject|7|||
49070024|NCT00090363|158089177|FG002|Overall Study|Withdrawal by Subject|6|||
49070025|NCT00090363|158089175|FG000|Overall Study|Study-specific discontinuation criteria|75|||
49070026|NCT00090363|158089176|FG001|Overall Study|Study-specific discontinuation criteria|74|||
49070027|NCT00090363|158089177|FG002|Overall Study|Study-specific discontinuation criteria|62|||
49070028|NCT00090363|158089175|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
49070029|NCT00090363|158089176|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
49070030|NCT00090363|158089177|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
49070031|NCT00090363|158089175|FG000|Overall Study|Consent expired|7|||
49070032|NCT00090363|158089176|FG001|Overall Study|Consent expired|10|||
49070033|NCT00090363|158089177|FG002|Overall Study|Consent expired|9|||
49070034|NCT00090363|158089175|FG000|Overall Study|Reasons not specified|2|||
49070035|NCT00090363|158089176|FG001|Overall Study|Reasons not specified|1|||
49070036|NCT00090363|158089177|FG002|Overall Study|Reasons not specified|1|||
49070037|NCT00090363|158089175|FG000|Overall Study|Continuing on study off treatment|14|||
49070038|NCT00090363|158089176|FG001|Overall Study|Continuing on study off treatment|13|||
49070039|NCT00090363|158089177|FG002|Overall Study|Continuing on study off treatment|16|||
49070040|NCT00191113|158089178|FG000|Core Study|Withdrawal by Subject|25|||
49070041|NCT00191113|158089179|FG001|Core Study|Withdrawal by Subject|9|||
49070042|NCT00191113|158089178|FG000|Core Study|Protocol Violation|6|||
49070043|NCT00191113|158089179|FG001|Core Study|Protocol Violation|2|||
49070044|NCT00191113|158089178|FG000|Core Study|Lost to Follow-up|3|||
49070045|NCT00191113|158089179|FG001|Core Study|Lost to Follow-up|0|||
49070046|NCT00191113|158089178|FG000|Core Study|Adverse Event|0|||
49070047|NCT00191113|158089179|FG001|Core Study|Adverse Event|2|||
49070048|NCT00191113|158089178|FG000|Core Study|Lack of Efficacy|0|||
49070049|NCT00191113|158089179|FG001|Core Study|Lack of Efficacy|2|||
49070050|NCT00191113|158089178|FG000|Core Study|Death|1|||
49070051|NCT00191113|158089179|FG001|Core Study|Death|0|||
49070052|NCT03084367|158089180|FG000|Overall Study|Lost to Follow-up|32|||
49070053|NCT03084367|158089180|FG000|Overall Study|Withdrawal by Subject|4|||
49070054|NCT03084367|158089180|FG000|Overall Study|Other|1|||
49070055|NCT01206101|158089181|FG000|Overall Study|Adverse Event|1|||
49070056|NCT01206101|158089182|FG001|Overall Study|Adverse Event|0|||
49070057|NCT01206101|158089181|FG000|Overall Study|Physician Decision|0|||
49070058|NCT01206101|158089182|FG001|Overall Study|Physician Decision|1|||
49070059|NCT01206101|158089181|FG000|Overall Study|Unclassified|1|||
49070060|NCT01206101|158089182|FG001|Overall Study|Unclassified|0|||
49070061|NCT05307510|158089185|FG000|Overall Study|Lost to Follow-up|3|||
49070062|NCT05307510|158089186|FG001|Overall Study|Lost to Follow-up|6|||
49070063|NCT05307510|158089185|FG000|Overall Study|Withdrawal by Subject|0|||
49070064|NCT05307510|158089186|FG001|Overall Study|Withdrawal by Subject|1|||
49070065|NCT02213510|158089187|FG000|Overall Study|Death|0|||
49070066|NCT02213510|158089188|FG001|Overall Study|Death|1|||
49070067|NCT02213510|158089187|FG000|Overall Study|Lost to Follow-up|1|||
49070068|NCT02213510|158089188|FG001|Overall Study|Lost to Follow-up|0|||
49070069|NCT01248013|158089190|FG000|Overall Study|Withdrawal by Subject|14|||
49070070|NCT01724489|158089193|FG000|Overall Study|Adverse Event|8|||
49070071|NCT01724489|158089194|FG001|Overall Study|Adverse Event|3|||
49070072|NCT01724489|158089193|FG000|Overall Study|Surgery, medication|1|||
49070073|NCT01724489|158089194|FG001|Overall Study|Surgery, medication|1|||
49070074|NCT01724489|158089193|FG000|Overall Study|Lost to Follow-up|1|||
49070075|NCT01724489|158089194|FG001|Overall Study|Lost to Follow-up|2|||
49070076|NCT01724489|158089193|FG000|Overall Study|Withdrawal by Subject|6|||
49070077|NCT01724489|158089194|FG001|Overall Study|Withdrawal by Subject|6|||
49070078|NCT00923273|158089195|FG000|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
49070079|NCT00923273|158089196|FG001|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
49070080|NCT00923273|158089197|FG002|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
49070081|NCT00923273|158089198|FG003|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1|||
49070082|NCT00923273|158089199|FG004|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
49070083|NCT00923273|158089195|FG000|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
49070084|NCT00923273|158089196|FG001|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
49070085|NCT00923273|158089197|FG002|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
49070086|NCT00923273|158089198|FG003|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6|||
49070087|NCT00923273|158089199|FG004|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
49070088|NCT00605540|158089200|FG000|Overall Study|Death|15|||
49070089|NCT00605540|158089200|FG000|Overall Study|Lost to Follow-up|23|||
49070090|NCT01739348|158089201|FG000|Part I (Base Study)|Adverse Event|41|||
49070091|NCT01739348|158089202|FG001|Part I (Base Study)|Adverse Event|52|||
49070092|NCT01739348|158089203|FG002|Part I (Base Study)|Adverse Event|8|||
49070093|NCT01739348|158089204|FG003|Part I (Base Study)|Adverse Event|33|||
49070094|NCT01739348|158089201|FG000|Part I (Base Study)|Death|10|||
49070095|NCT01739348|158089202|FG001|Part I (Base Study)|Death|7|||
49070096|NCT01739348|158089203|FG002|Part I (Base Study)|Death|2|||
49070097|NCT01739348|158089204|FG003|Part I (Base Study)|Death|8|||
49070098|NCT01739348|158089201|FG000|Part I (Base Study)|Lack of Efficacy|3|||
49070099|NCT01739348|158089202|FG001|Part I (Base Study)|Lack of Efficacy|8|||
49070100|NCT01739348|158089203|FG002|Part I (Base Study)|Lack of Efficacy|0|||
49070101|NCT01739348|158089204|FG003|Part I (Base Study)|Lack of Efficacy|7|||
49070102|NCT01739348|158089201|FG000|Part I (Base Study)|Lost to Follow-up|4|||
49070103|NCT01739348|158089202|FG001|Part I (Base Study)|Lost to Follow-up|2|||
49070104|NCT01739348|158089203|FG002|Part I (Base Study)|Lost to Follow-up|4|||
49070105|NCT01739348|158089204|FG003|Part I (Base Study)|Lost to Follow-up|4|||
49070106|NCT01739348|158089201|FG000|Part I (Base Study)|Non-Compliance with Study Drug|3|||
49070107|NCT01739348|158089202|FG001|Part I (Base Study)|Non-Compliance with Study Drug|2|||
49070108|NCT01739348|158089203|FG002|Part I (Base Study)|Non-Compliance with Study Drug|0|||
49070109|NCT01739348|158089204|FG003|Part I (Base Study)|Non-Compliance with Study Drug|0|||
49070110|NCT01739348|158089201|FG000|Part I (Base Study)|Physician Decision|10|||
49070111|NCT01739348|158089202|FG001|Part I (Base Study)|Physician Decision|7|||
49070112|NCT01739348|158089203|FG002|Part I (Base Study)|Physician Decision|1|||
49070113|NCT01739348|158089204|FG003|Part I (Base Study)|Physician Decision|4|||
49070114|NCT01739348|158089201|FG000|Part I (Base Study)|Protocol Violation|2|||
49070115|NCT01739348|158089202|FG001|Part I (Base Study)|Protocol Violation|0|||
49070116|NCT01739348|158089203|FG002|Part I (Base Study)|Protocol Violation|1|||
49070117|NCT01739348|158089204|FG003|Part I (Base Study)|Protocol Violation|2|||
49070118|NCT01739348|158089201|FG000|Part I (Base Study)|Screen Failure|2|||
49070119|NCT01739348|158089202|FG001|Part I (Base Study)|Screen Failure|0|||
49070120|NCT01739348|158089203|FG002|Part I (Base Study)|Screen Failure|0|||
49070121|NCT01739348|158089204|FG003|Part I (Base Study)|Screen Failure|0|||
49070122|NCT01739348|158089201|FG000|Part I (Base Study)|Site Discontinued Study Participation|1|||
49070123|NCT01739348|158089202|FG001|Part I (Base Study)|Site Discontinued Study Participation|3|||
49070124|NCT01739348|158089203|FG002|Part I (Base Study)|Site Discontinued Study Participation|0|||
49070125|NCT01739348|158089204|FG003|Part I (Base Study)|Site Discontinued Study Participation|0|||
49070126|NCT01739348|158089201|FG000|Part I (Base Study)|Study Terminated by Sponsor|72|||
49070127|NCT01739348|158089202|FG001|Part I (Base Study)|Study Terminated by Sponsor|73|||
49070128|NCT01739348|158089203|FG002|Part I (Base Study)|Study Terminated by Sponsor|0|||
49070129|NCT01739348|158089204|FG003|Part I (Base Study)|Study Terminated by Sponsor|86|||
49070130|NCT01739348|158089201|FG000|Part I (Base Study)|Participant Moved|4|||
49070131|NCT01739348|158089202|FG001|Part I (Base Study)|Participant Moved|3|||
49070132|NCT01739348|158089203|FG002|Part I (Base Study)|Participant Moved|1|||
49070133|NCT01739348|158089204|FG003|Part I (Base Study)|Participant Moved|7|||
49070134|NCT01739348|158089201|FG000|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27|||
49070135|NCT01739348|158089202|FG001|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25|||
49070136|NCT01739348|158089203|FG002|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2|||
49070137|NCT01739348|158089204|FG003|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18|||
49070138|NCT01739348|158089201|FG000|Part I (Base Study)|Withdrawal by Subject|23|||
49070139|NCT01739348|158089202|FG001|Part I (Base Study)|Withdrawal by Subject|21|||
49070140|NCT01739348|158089203|FG002|Part I (Base Study)|Withdrawal by Subject|7|||
49070141|NCT01739348|158089204|FG003|Part I (Base Study)|Withdrawal by Subject|20|||
49070142|NCT01739348|158089201|FG000|Part II (Extension Study)|Adverse Event|10|||
49070143|NCT01739348|158089202|FG001|Part II (Extension Study)|Adverse Event|11|||
49070144|NCT01739348|158089203|FG002|Part II (Extension Study)|Adverse Event|7|||
49070145|NCT01739348|158089204|FG003|Part II (Extension Study)|Adverse Event|26|||
49070146|NCT01739348|158089201|FG000|Part II (Extension Study)|Death|3|||
49070147|NCT01739348|158089202|FG001|Part II (Extension Study)|Death|3|||
49070148|NCT01739348|158089203|FG002|Part II (Extension Study)|Death|2|||
49070149|NCT01739348|158089204|FG003|Part II (Extension Study)|Death|6|||
49070150|NCT01739348|158089201|FG000|Part II (Extension Study)|Lack of Efficacy|1|||
49070151|NCT01739348|158089202|FG001|Part II (Extension Study)|Lack of Efficacy|5|||
49070152|NCT01739348|158089203|FG002|Part II (Extension Study)|Lack of Efficacy|0|||
49070153|NCT01739348|158089204|FG003|Part II (Extension Study)|Lack of Efficacy|1|||
49070154|NCT01739348|158089201|FG000|Part II (Extension Study)|Lost to Follow-up|3|||
49070155|NCT01739348|158089202|FG001|Part II (Extension Study)|Lost to Follow-up|4|||
49070156|NCT01739348|158089203|FG002|Part II (Extension Study)|Lost to Follow-up|0|||
49070157|NCT01739348|158089204|FG003|Part II (Extension Study)|Lost to Follow-up|1|||
49070158|NCT01739348|158089201|FG000|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
49070159|NCT01739348|158089202|FG001|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
49070160|NCT01739348|158089203|FG002|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
49070161|NCT01739348|158089204|FG003|Part II (Extension Study)|Non-Compliance with Study Drug|1|||
49070162|NCT01739348|158089201|FG000|Part II (Extension Study)|Physician Decision|7|||
49070163|NCT01739348|158089202|FG001|Part II (Extension Study)|Physician Decision|11|||
49070164|NCT01739348|158089203|FG002|Part II (Extension Study)|Physician Decision|6|||
49070165|NCT01739348|158089204|FG003|Part II (Extension Study)|Physician Decision|12|||
49070166|NCT01739348|158089201|FG000|Part II (Extension Study)|Study Terminated by Sponsor|329|||
49070167|NCT01739348|158089202|FG001|Part II (Extension Study)|Study Terminated by Sponsor|315|||
49070168|NCT01739348|158089203|FG002|Part II (Extension Study)|Study Terminated by Sponsor|34|||
49070169|NCT01739348|158089204|FG003|Part II (Extension Study)|Study Terminated by Sponsor|323|||
49070170|NCT01739348|158089201|FG000|Part II (Extension Study)|Participant Moved|3|||
49070171|NCT01739348|158089202|FG001|Part II (Extension Study)|Participant Moved|3|||
49070172|NCT01739348|158089203|FG002|Part II (Extension Study)|Participant Moved|0|||
49070173|NCT01739348|158089204|FG003|Part II (Extension Study)|Participant Moved|3|||
49070174|NCT01739348|158089201|FG000|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18|||
49070175|NCT01739348|158089202|FG001|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12|||
49070176|NCT01739348|158089203|FG002|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8|||
49070177|NCT01739348|158089204|FG003|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16|||
49070178|NCT01739348|158089201|FG000|Part II (Extension Study)|Withdrawal by Subject|5|||
49070179|NCT01739348|158089202|FG001|Part II (Extension Study)|Withdrawal by Subject|2|||
49070180|NCT01739348|158089203|FG002|Part II (Extension Study)|Withdrawal by Subject|4|||
49070181|NCT01739348|158089204|FG003|Part II (Extension Study)|Withdrawal by Subject|7|||
49070182|NCT00660400|158089210|FG000|Overall Study|Lack of insurance approval|1|||
49070183|NCT00660400|158089210|FG000|Overall Study|Suboptimal organ function|1|||
49070184|NCT00660400|158089210|FG000|Overall Study|Intracranial hemorrhage|1|||
49070185|NCT00660400|158089210|FG000|Overall Study|Withdrawal by Subject|1|||
49070186|NCT00094861|158089211|FG000|Overall Study|Adverse Event|5|||
49070187|NCT00094861|158089212|FG001|Overall Study|Adverse Event|2|||
49070188|NCT00094861|158089211|FG000|Overall Study|Withdrawal by Subject|5|||
49070189|NCT00094861|158089212|FG001|Overall Study|Withdrawal by Subject|3|||
49070190|NCT00094861|158089211|FG000|Overall Study|Physician Decision|1|||
49070191|NCT00094861|158089212|FG001|Overall Study|Physician Decision|1|||
49070192|NCT00094861|158089211|FG000|Overall Study|Lost to Follow-up|0|||
49070193|NCT00094861|158089212|FG001|Overall Study|Lost to Follow-up|1|||
49070194|NCT00094861|158089211|FG000|Overall Study|Death|4|||
49070195|NCT00094861|158089212|FG001|Overall Study|Death|2|||
49070196|NCT00094861|158089211|FG000|Overall Study|Other|3|||
49070197|NCT00094861|158089212|FG001|Overall Study|Other|0|||
49070198|NCT01447420|158089213|FG000|Overall Study|Adverse Event|2|||
49070199|NCT01447420|158089214|FG001|Overall Study|Adverse Event|4|||
49070200|NCT01447420|158089215|FG002|Overall Study|Adverse Event|2|||
49070201|NCT01447420|158089213|FG000|Overall Study|Protocol Violation|3|||
49070202|NCT01447420|158089214|FG001|Overall Study|Protocol Violation|3|||
49070203|NCT01447420|158089215|FG002|Overall Study|Protocol Violation|0|||
49070204|NCT01447420|158089213|FG000|Overall Study|Withdrawal by Subject|4|||
49070205|NCT01447420|158089214|FG001|Overall Study|Withdrawal by Subject|1|||
49070206|NCT01447420|158089215|FG002|Overall Study|Withdrawal by Subject|0|||
49070207|NCT01447420|158089213|FG000|Overall Study|Lack of Efficacy|1|||
49070208|NCT01447420|158089214|FG001|Overall Study|Lack of Efficacy|19|||
49070209|NCT01447420|158089215|FG002|Overall Study|Lack of Efficacy|8|||
49070210|NCT00509366|158089218|FG000|Overall Study|Not Treated (Screen Failure)|1|||
49070211|NCT00509366|158089219|FG001|Overall Study|Not Treated (Screen Failure)|1|||
49070212|NCT00509366|158089220|FG002|Overall Study|Not Treated (Screen Failure)|1|||
49070213|NCT00509366|158089221|FG003|Overall Study|Not Treated (Screen Failure)|0|||
49070214|NCT00509366|158089222|FG004|Overall Study|Not Treated (Screen Failure)|0|||
49070215|NCT04562155|158089223|FG000|Overall Study|COVID-19 pandemic|0|||
49070216|NCT04562155|158089224|FG001|Overall Study|COVID-19 pandemic|0|||
49070217|NCT04562155|158089225|FG002|Overall Study|COVID-19 pandemic|0|||
49070218|NCT04562155|158089226|FG003|Overall Study|COVID-19 pandemic|1|||
49070219|NCT04562155|158089223|FG000|Overall Study|Adverse Event|7|||
49070220|NCT04562155|158089224|FG001|Overall Study|Adverse Event|3|||
49070221|NCT04562155|158089225|FG002|Overall Study|Adverse Event|8|||
49070222|NCT04562155|158089226|FG003|Overall Study|Adverse Event|1|||
49070223|NCT04562155|158089223|FG000|Overall Study|Withdrawal by Subject|3|||
49070224|NCT04562155|158089224|FG001|Overall Study|Withdrawal by Subject|6|||
49070225|NCT04562155|158089225|FG002|Overall Study|Withdrawal by Subject|3|||
49070226|NCT04562155|158089226|FG003|Overall Study|Withdrawal by Subject|3|||
49070227|NCT04562155|158089223|FG000|Overall Study|Participant personal reason|1|||
49070228|NCT04562155|158089224|FG001|Overall Study|Participant personal reason|0|||
49070229|NCT04562155|158089225|FG002|Overall Study|Participant personal reason|2|||
49070230|NCT04562155|158089226|FG003|Overall Study|Participant personal reason|1|||
49070231|NCT02119819|158089229|FG000|Overall Study|Adverse Event|3|||
49070232|NCT02119819|158089230|FG001|Overall Study|Adverse Event|1|||
49070233|NCT02119819|158089231|FG002|Overall Study|Adverse Event|2|||
49070234|NCT02119819|158089232|FG003|Overall Study|Adverse Event|3|||
49070235|NCT02119819|158089233|FG004|Overall Study|Adverse Event|0|||
49070236|NCT02119819|158089234|FG005|Overall Study|Adverse Event|1|||
49070237|NCT02119819|158089229|FG000|Overall Study|Lack of Efficacy|0|||
49070238|NCT02119819|158089230|FG001|Overall Study|Lack of Efficacy|0|||
49070239|NCT02119819|158089231|FG002|Overall Study|Lack of Efficacy|0|||
49070240|NCT02119819|158089232|FG003|Overall Study|Lack of Efficacy|0|||
49070241|NCT02119819|158089233|FG004|Overall Study|Lack of Efficacy|0|||
49070242|NCT02119819|158089234|FG005|Overall Study|Lack of Efficacy|1|||
49070243|NCT02119819|158089229|FG000|Overall Study|Lost to Follow-up|0|||
49070244|NCT02119819|158089230|FG001|Overall Study|Lost to Follow-up|0|||
49070245|NCT02119819|158089231|FG002|Overall Study|Lost to Follow-up|1|||
49070246|NCT02119819|158089232|FG003|Overall Study|Lost to Follow-up|2|||
49070247|NCT02119819|158089233|FG004|Overall Study|Lost to Follow-up|1|||
49070248|NCT02119819|158089234|FG005|Overall Study|Lost to Follow-up|2|||
49070249|NCT02119819|158089229|FG000|Overall Study|Physician Decision|1|||
49070250|NCT02119819|158089230|FG001|Overall Study|Physician Decision|1|||
49070251|NCT02119819|158089231|FG002|Overall Study|Physician Decision|0|||
49070252|NCT02119819|158089232|FG003|Overall Study|Physician Decision|0|||
49070253|NCT02119819|158089233|FG004|Overall Study|Physician Decision|0|||
49070254|NCT02119819|158089234|FG005|Overall Study|Physician Decision|1|||
49070255|NCT02119819|158089229|FG000|Overall Study|Withdrawal by Subject|5|||
49070256|NCT02119819|158089230|FG001|Overall Study|Withdrawal by Subject|3|||
49070257|NCT02119819|158089231|FG002|Overall Study|Withdrawal by Subject|0|||
49070258|NCT02119819|158089232|FG003|Overall Study|Withdrawal by Subject|0|||
49070259|NCT02119819|158089233|FG004|Overall Study|Withdrawal by Subject|6|||
49070260|NCT02119819|158089234|FG005|Overall Study|Withdrawal by Subject|10|||
49070261|NCT02119819|158089229|FG000|Overall Study|Jury Duty|0|||
49070262|NCT02119819|158089230|FG001|Overall Study|Jury Duty|0|||
49070263|NCT02119819|158089231|FG002|Overall Study|Jury Duty|1|||
49070264|NCT02119819|158089232|FG003|Overall Study|Jury Duty|0|||
49070265|NCT02119819|158089233|FG004|Overall Study|Jury Duty|0|||
49070266|NCT02119819|158089234|FG005|Overall Study|Jury Duty|0|||
49070267|NCT02119819|158089229|FG000|Overall Study|Protocol Violation|0|||
49070268|NCT02119819|158089230|FG001|Overall Study|Protocol Violation|0|||
49070269|NCT02119819|158089231|FG002|Overall Study|Protocol Violation|0|||
49070270|NCT02119819|158089232|FG003|Overall Study|Protocol Violation|1|||
49070271|NCT02119819|158089233|FG004|Overall Study|Protocol Violation|0|||
49070272|NCT02119819|158089234|FG005|Overall Study|Protocol Violation|0|||
49070273|NCT02119819|158089229|FG000|Overall Study|Left the city to get a job|0|||
49070274|NCT02119819|158089230|FG001|Overall Study|Left the city to get a job|0|||
49070275|NCT02119819|158089231|FG002|Overall Study|Left the city to get a job|0|||
49070276|NCT02119819|158089232|FG003|Overall Study|Left the city to get a job|1|||
49070277|NCT02119819|158089233|FG004|Overall Study|Left the city to get a job|0|||
49070278|NCT02119819|158089234|FG005|Overall Study|Left the city to get a job|0|||
49070279|NCT01544179|158089235|FG000|Overall Study|Death|50|||
49070280|NCT01544179|158089236|FG001|Overall Study|Death|37|||
49070281|NCT01544179|158089235|FG000|Overall Study|Lost to Follow-up|0|||
49070282|NCT01544179|158089236|FG001|Overall Study|Lost to Follow-up|1|||
49070283|NCT01544179|158089235|FG000|Overall Study|Adverse Event|0|||
49070284|NCT01544179|158089236|FG001|Overall Study|Adverse Event|1|||
49070285|NCT01544179|158089235|FG000|Overall Study|Withdrawal by Subject|12|||
49070286|NCT01544179|158089236|FG001|Overall Study|Withdrawal by Subject|7|||
49070287|NCT01544179|158089235|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
49070288|NCT01544179|158089236|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
49070289|NCT01475097|158089240|FG000|Overall Study|Protocol Violation|1|||
49070290|NCT01475097|158089241|FG001|Overall Study|Protocol Violation|1|||
49070291|NCT01085201|158089242|FG000|Overall Study|Scheduling conflict|1|||
49070292|NCT01085201|158089243|FG001|Overall Study|Scheduling conflict|0|||
49070293|NCT01085201|158089244|FG002|Overall Study|Scheduling conflict|1|||
49070294|NCT01085201|158089245|FG003|Overall Study|Scheduling conflict|0|||
49070295|NCT01085201|158089246|FG004|Overall Study|Scheduling conflict|0|||
49070296|NCT01085201|158089242|FG000|Overall Study|Unknown- no study drug|2|||
49070297|NCT01085201|158089243|FG001|Overall Study|Unknown- no study drug|0|||
49070298|NCT01085201|158089244|FG002|Overall Study|Unknown- no study drug|0|||
49070299|NCT01085201|158089245|FG003|Overall Study|Unknown- no study drug|0|||
49070300|NCT01085201|158089246|FG004|Overall Study|Unknown- no study drug|0|||
49070301|NCT01085201|158089242|FG000|Overall Study|Fond ineligible after consent|0|||
49070302|NCT01085201|158089243|FG001|Overall Study|Fond ineligible after consent|1|||
49070303|NCT01085201|158089244|FG002|Overall Study|Fond ineligible after consent|1|||
49070304|NCT01085201|158089245|FG003|Overall Study|Fond ineligible after consent|0|||
49070305|NCT01085201|158089246|FG004|Overall Study|Fond ineligible after consent|0|||
49070306|NCT03146962|158089247|FG000|Overall Study|Lost to Follow-up|1|||
49070307|NCT03146962|158089248|FG001|Overall Study|Lost to Follow-up|1|||
49070308|NCT03146962|158089249|FG002|Overall Study|Lost to Follow-up|0|||
49070309|NCT03146962|158089250|FG003|Overall Study|Lost to Follow-up|0|||
49070310|NCT03146962|158089251|FG004|Overall Study|Lost to Follow-up|0|||
49070311|NCT03146962|158089252|FG005|Overall Study|Lost to Follow-up|0|||
49070312|NCT03146962|158089253|FG006|Overall Study|Lost to Follow-up|0|||
49070313|NCT03146962|158089254|FG007|Overall Study|Lost to Follow-up|0|||
49070314|NCT03146962|158089255|FG008|Overall Study|Lost to Follow-up|0|||
49070315|NCT03146962|158089256|FG009|Overall Study|Lost to Follow-up|0|||
49070316|NCT03146962|158089247|FG000|Overall Study|Adverse Event|0|||
49070317|NCT03146962|158089248|FG001|Overall Study|Adverse Event|3|||
49070318|NCT03146962|158089249|FG002|Overall Study|Adverse Event|0|||
49070319|NCT03146962|158089250|FG003|Overall Study|Adverse Event|0|||
49070320|NCT03146962|158089251|FG004|Overall Study|Adverse Event|0|||
49070321|NCT03146962|158089252|FG005|Overall Study|Adverse Event|0|||
49070322|NCT03146962|158089253|FG006|Overall Study|Adverse Event|0|||
49070323|NCT03146962|158089254|FG007|Overall Study|Adverse Event|1|||
49070324|NCT03146962|158089255|FG008|Overall Study|Adverse Event|0|||
49070325|NCT03146962|158089256|FG009|Overall Study|Adverse Event|0|||
49070326|NCT03146962|158089247|FG000|Overall Study|Withdrawal by Subject|0|||
49070327|NCT03146962|158089248|FG001|Overall Study|Withdrawal by Subject|0|||
49070328|NCT03146962|158089249|FG002|Overall Study|Withdrawal by Subject|0|||
49070329|NCT03146962|158089250|FG003|Overall Study|Withdrawal by Subject|0|||
49070330|NCT03146962|158089251|FG004|Overall Study|Withdrawal by Subject|1|||
49070331|NCT03146962|158089252|FG005|Overall Study|Withdrawal by Subject|0|||
49070332|NCT03146962|158089253|FG006|Overall Study|Withdrawal by Subject|0|||
49070333|NCT03146962|158089254|FG007|Overall Study|Withdrawal by Subject|0|||
49070334|NCT03146962|158089255|FG008|Overall Study|Withdrawal by Subject|0|||
49070335|NCT03146962|158089256|FG009|Overall Study|Withdrawal by Subject|0|||
49070336|NCT03146962|158089247|FG000|Overall Study|Death|0|||
49070337|NCT03146962|158089248|FG001|Overall Study|Death|1|||
49070338|NCT03146962|158089249|FG002|Overall Study|Death|0|||
49070339|NCT03146962|158089250|FG003|Overall Study|Death|0|||
49070340|NCT03146962|158089251|FG004|Overall Study|Death|0|||
49070341|NCT03146962|158089252|FG005|Overall Study|Death|0|||
49070342|NCT03146962|158089253|FG006|Overall Study|Death|0|||
49070343|NCT03146962|158089254|FG007|Overall Study|Death|0|||
49070344|NCT03146962|158089255|FG008|Overall Study|Death|0|||
49070345|NCT03146962|158089256|FG009|Overall Study|Death|0|||
49070346|NCT03146962|158089247|FG000|Overall Study|COVID Precautions|1|||
49070347|NCT03146962|158089248|FG001|Overall Study|COVID Precautions|0|||
49070348|NCT03146962|158089249|FG002|Overall Study|COVID Precautions|0|||
49070349|NCT03146962|158089250|FG003|Overall Study|COVID Precautions|0|||
49070350|NCT03146962|158089251|FG004|Overall Study|COVID Precautions|0|||
49070351|NCT03146962|158089252|FG005|Overall Study|COVID Precautions|0|||
49070352|NCT03146962|158089253|FG006|Overall Study|COVID Precautions|0|||
49070353|NCT03146962|158089254|FG007|Overall Study|COVID Precautions|0|||
49070354|NCT03146962|158089255|FG008|Overall Study|COVID Precautions|0|||
49070355|NCT03146962|158089256|FG009|Overall Study|COVID Precautions|0|||
49070356|NCT03146962|158089247|FG000|Overall Study|Physician Decision|0|||
49070357|NCT03146962|158089248|FG001|Overall Study|Physician Decision|0|||
49070358|NCT03146962|158089249|FG002|Overall Study|Physician Decision|0|||
49070359|NCT03146962|158089250|FG003|Overall Study|Physician Decision|0|||
49070360|NCT03146962|158089251|FG004|Overall Study|Physician Decision|0|||
49070361|NCT03146962|158089252|FG005|Overall Study|Physician Decision|0|||
49070362|NCT03146962|158089253|FG006|Overall Study|Physician Decision|0|||
49070363|NCT03146962|158089254|FG007|Overall Study|Physician Decision|0|||
49070364|NCT03146962|158089255|FG008|Overall Study|Physician Decision|0|||
49070365|NCT03146962|158089256|FG009|Overall Study|Physician Decision|1|||
49070366|NCT03146962|158089247|FG000|Overall Study|Started New Treatment|0|||
49070367|NCT03146962|158089248|FG001|Overall Study|Started New Treatment|1|||
49070368|NCT03146962|158089249|FG002|Overall Study|Started New Treatment|0|||
49070369|NCT03146962|158089250|FG003|Overall Study|Started New Treatment|0|||
49070370|NCT03146962|158089251|FG004|Overall Study|Started New Treatment|0|||
49070371|NCT03146962|158089252|FG005|Overall Study|Started New Treatment|0|||
49070372|NCT03146962|158089253|FG006|Overall Study|Started New Treatment|0|||
49070373|NCT03146962|158089254|FG007|Overall Study|Started New Treatment|0|||
49070374|NCT03146962|158089255|FG008|Overall Study|Started New Treatment|0|||
49070375|NCT03146962|158089256|FG009|Overall Study|Started New Treatment|0|||
49070376|NCT02383810|158089257|FG000|Overall Study|Physician Decision|1|||
49070377|NCT02383810|158089258|FG001|Overall Study|Physician Decision|1|||
49070378|NCT02383810|158089259|FG002|Overall Study|Physician Decision|0|||
49070379|NCT02383810|158089260|FG003|Overall Study|Physician Decision|0|||
49070380|NCT02383810|158089261|FG004|Overall Study|Physician Decision|0|||
49070381|NCT02383810|158089262|FG005|Overall Study|Physician Decision|0|||
49070382|NCT02383810|158089263|FG006|Overall Study|Physician Decision|0|||
49070383|NCT02383810|158089264|FG007|Overall Study|Physician Decision|0|||
49070384|NCT02383810|158089257|FG000|Overall Study|Withdrawal by Subject|2|||
49070385|NCT02383810|158089258|FG001|Overall Study|Withdrawal by Subject|3|||
49070386|NCT02383810|158089259|FG002|Overall Study|Withdrawal by Subject|3|||
49070387|NCT02383810|158089260|FG003|Overall Study|Withdrawal by Subject|3|||
49070388|NCT02383810|158089261|FG004|Overall Study|Withdrawal by Subject|0|||
49070389|NCT02383810|158089262|FG005|Overall Study|Withdrawal by Subject|0|||
49070390|NCT02383810|158089263|FG006|Overall Study|Withdrawal by Subject|0|||
49070391|NCT02383810|158089264|FG007|Overall Study|Withdrawal by Subject|0|||
49070392|NCT02383810|158089257|FG000|Overall Study|Adverse Event|0|||
49070393|NCT02383810|158089258|FG001|Overall Study|Adverse Event|2|||
49070394|NCT02383810|158089259|FG002|Overall Study|Adverse Event|4|||
49070395|NCT02383810|158089260|FG003|Overall Study|Adverse Event|5|||
49070396|NCT02383810|158089261|FG004|Overall Study|Adverse Event|0|||
49070397|NCT02383810|158089262|FG005|Overall Study|Adverse Event|1|||
49070398|NCT02383810|158089263|FG006|Overall Study|Adverse Event|1|||
49070399|NCT02383810|158089264|FG007|Overall Study|Adverse Event|0|||
49070400|NCT02383810|158089257|FG000|Overall Study|Lost to Follow-up|0|||
49070401|NCT02383810|158089258|FG001|Overall Study|Lost to Follow-up|1|||
49070402|NCT02383810|158089259|FG002|Overall Study|Lost to Follow-up|0|||
49070403|NCT02383810|158089260|FG003|Overall Study|Lost to Follow-up|1|||
49070404|NCT02383810|158089261|FG004|Overall Study|Lost to Follow-up|0|||
49070405|NCT02383810|158089262|FG005|Overall Study|Lost to Follow-up|0|||
49070406|NCT02383810|158089263|FG006|Overall Study|Lost to Follow-up|0|||
49070407|NCT02383810|158089264|FG007|Overall Study|Lost to Follow-up|0|||
49070408|NCT02383810|158089257|FG000|Overall Study|other|0|||
49070409|NCT02383810|158089258|FG001|Overall Study|other|0|||
49070410|NCT02383810|158089259|FG002|Overall Study|other|0|||
49070411|NCT02383810|158089260|FG003|Overall Study|other|2|||
49070412|NCT02383810|158089261|FG004|Overall Study|other|0|||
49070413|NCT02383810|158089262|FG005|Overall Study|other|0|||
49070414|NCT02383810|158089263|FG006|Overall Study|other|0|||
49070415|NCT02383810|158089264|FG007|Overall Study|other|0|||
49070416|NCT02383810|158089257|FG000|Overall Study|subject did not receive study treatment|0|||
49070417|NCT02383810|158089258|FG001|Overall Study|subject did not receive study treatment|1|||
49070418|NCT02383810|158089259|FG002|Overall Study|subject did not receive study treatment|0|||
49070419|NCT02383810|158089260|FG003|Overall Study|subject did not receive study treatment|0|||
49070420|NCT02383810|158089261|FG004|Overall Study|subject did not receive study treatment|0|||
49070421|NCT02383810|158089262|FG005|Overall Study|subject did not receive study treatment|0|||
49070422|NCT02383810|158089263|FG006|Overall Study|subject did not receive study treatment|0|||
49070423|NCT02383810|158089264|FG007|Overall Study|subject did not receive study treatment|0|||
49070424|NCT01438996|158089265|FG000|Overall Study|Not meeting Inclusion Criteria|4|||
49070425|NCT01438996|158089266|FG001|Overall Study|Not meeting Inclusion Criteria|1|||
49070426|NCT01438996|158089267|FG002|Overall Study|Not meeting Inclusion Criteria|0|||
49070427|NCT00528411|158089268|FG000|Overall Study|Adverse Event|4|||
49070428|NCT00528411|158089269|FG001|Overall Study|Adverse Event|0|||
49070429|NCT00528411|158089270|FG002|Overall Study|Adverse Event|1|||
49070430|NCT00528411|158089268|FG000|Overall Study|Incorrect Enrolment|1|||
49070431|NCT00528411|158089269|FG001|Overall Study|Incorrect Enrolment|1|||
49070432|NCT00528411|158089270|FG002|Overall Study|Incorrect Enrolment|0|||
49070433|NCT00528411|158089268|FG000|Overall Study|Severe non-compliance to protocol|0|||
49070434|NCT00528411|158089269|FG001|Overall Study|Severe non-compliance to protocol|1|||
49070435|NCT00528411|158089270|FG002|Overall Study|Severe non-compliance to protocol|0|||
49070436|NCT00528411|158089268|FG000|Overall Study|Prior commitment medication|0|||
49070437|NCT00528411|158089269|FG001|Overall Study|Prior commitment medication|1|||
49070438|NCT00528411|158089270|FG002|Overall Study|Prior commitment medication|0|||
49070439|NCT00912912|158089271|FG000|Overall Study|Withdrawal by Subject|1|||
49070440|NCT00912912|158089271|FG000|Overall Study|Disease Progression|3|||
49070441|NCT00587990|158089278|FG000|Overall Study|Death|0|||
49070442|NCT00587990|158089279|FG001|Overall Study|Death|0|||
49070443|NCT00587990|158089280|FG002|Overall Study|Death|1|||
49070444|NCT02754856|158089281|FG000|Overall Study|Withdrawal by Subject|1|||
49070445|NCT00530218|158089284|FG000|Overall Study|CMV Not Detected|13|||
49070446|NCT00530218|158089284|FG000|Overall Study|Death|12|||
49070447|NCT05199090|158089285|FG000|Overall Study|Adverse Event|1|||
49070448|NCT05199090|158089286|FG001|Overall Study|Adverse Event|4|||
49070449|NCT05199090|158089287|FG002|Overall Study|Adverse Event|0|||
49070450|NCT05199090|158089288|FG003|Overall Study|Adverse Event|0|||
49070451|NCT05199090|158089289|FG004|Overall Study|Adverse Event|0|||
49070452|NCT05199090|158089290|FG005|Overall Study|Adverse Event|0|||
49070453|NCT05199090|158089285|FG000|Overall Study|Lost to Follow-up|1|||
49070454|NCT05199090|158089286|FG001|Overall Study|Lost to Follow-up|0|||
49070455|NCT05199090|158089287|FG002|Overall Study|Lost to Follow-up|1|||
49070456|NCT05199090|158089288|FG003|Overall Study|Lost to Follow-up|4|||
49070457|NCT05199090|158089289|FG004|Overall Study|Lost to Follow-up|0|||
49070458|NCT05199090|158089290|FG005|Overall Study|Lost to Follow-up|5|||
49070459|NCT05199090|158089285|FG000|Overall Study|Physician Decision|0|||
49070460|NCT05199090|158089286|FG001|Overall Study|Physician Decision|0|||
49070461|NCT05199090|158089287|FG002|Overall Study|Physician Decision|0|||
49070462|NCT05199090|158089288|FG003|Overall Study|Physician Decision|0|||
49070463|NCT05199090|158089289|FG004|Overall Study|Physician Decision|0|||
49070464|NCT05199090|158089290|FG005|Overall Study|Physician Decision|1|||
49070465|NCT05199090|158089285|FG000|Overall Study|Study terminated by sponsor|0|||
49070466|NCT05199090|158089286|FG001|Overall Study|Study terminated by sponsor|6|||
49070467|NCT05199090|158089287|FG002|Overall Study|Study terminated by sponsor|0|||
49070468|NCT05199090|158089288|FG003|Overall Study|Study terminated by sponsor|0|||
49070469|NCT05199090|158089289|FG004|Overall Study|Study terminated by sponsor|0|||
49070470|NCT05199090|158089290|FG005|Overall Study|Study terminated by sponsor|5|||
49070471|NCT05199090|158089285|FG000|Overall Study|Subject decision|0|||
49070472|NCT05199090|158089286|FG001|Overall Study|Subject decision|4|||
49070473|NCT05199090|158089287|FG002|Overall Study|Subject decision|0|||
49070474|NCT05199090|158089288|FG003|Overall Study|Subject decision|2|||
49070475|NCT05199090|158089289|FG004|Overall Study|Subject decision|5|||
49070476|NCT05199090|158089290|FG005|Overall Study|Subject decision|2|||
49070477|NCT03136965|158089291|FG000|Overall Study|Lost to Follow-up|0|||
49070478|NCT03136965|158089292|FG001|Overall Study|Lost to Follow-up|1|||
49070479|NCT03136965|158089293|FG002|Overall Study|Lost to Follow-up|0|||
49070480|NCT03485365|158089295|FG000|Overall Study|Protocol Violation|0|||
49070481|NCT03485365|158089296|FG001|Overall Study|Protocol Violation|0|||
49070482|NCT03485365|158089297|FG002|Overall Study|Protocol Violation|0|||
49070483|NCT03485365|158089298|FG003|Overall Study|Protocol Violation|1|||
49070484|NCT03485365|158089299|FG004|Overall Study|Protocol Violation|0|||
49070485|NCT03485365|158089300|FG005|Overall Study|Protocol Violation|0|||
49070486|NCT03485365|158089301|FG006|Overall Study|Protocol Violation|1|||
49070487|NCT03485365|158089302|FG007|Overall Study|Protocol Violation|0|||
49070488|NCT03485365|158089303|FG008|Overall Study|Protocol Violation|0|||
49070489|NCT03489109|158089304|FG000|Overall Study|Lost to Follow-up|1|||
49070490|NCT03489109|158089305|FG001|Overall Study|Lost to Follow-up|2|||
49070491|NCT04868968|158089306|FG000|Overall Study|Lost to Follow-up|1|||
49070492|NCT00384930|158089311|FG000|Overall Study|Adverse Event|5|||
49070493|NCT00384930|158089312|FG001|Overall Study|Adverse Event|4|||
49070494|NCT00384930|158089313|FG002|Overall Study|Adverse Event|12|||
49070495|NCT00384930|158089314|FG003|Overall Study|Adverse Event|11|||
49070496|NCT00384930|158089315|FG004|Overall Study|Adverse Event|14|||
49070497|NCT00384930|158089311|FG000|Overall Study|Entry Criteria Not Met|2|||
49070498|NCT00384930|158089312|FG001|Overall Study|Entry Criteria Not Met|6|||
49070499|NCT00384930|158089313|FG002|Overall Study|Entry Criteria Not Met|7|||
49070500|NCT00384930|158089314|FG003|Overall Study|Entry Criteria Not Met|8|||
49070501|NCT00384930|158089315|FG004|Overall Study|Entry Criteria Not Met|4|||
49070502|NCT00384930|158089311|FG000|Overall Study|Lack of Efficacy|1|||
49070503|NCT00384930|158089312|FG001|Overall Study|Lack of Efficacy|1|||
49070504|NCT00384930|158089313|FG002|Overall Study|Lack of Efficacy|2|||
49070505|NCT00384930|158089314|FG003|Overall Study|Lack of Efficacy|1|||
49070506|NCT00384930|158089315|FG004|Overall Study|Lack of Efficacy|2|||
49070507|NCT00384930|158089311|FG000|Overall Study|Lost to Follow-up|5|||
49070508|NCT00384930|158089312|FG001|Overall Study|Lost to Follow-up|3|||
49070509|NCT00384930|158089313|FG002|Overall Study|Lost to Follow-up|0|||
49070510|NCT00384930|158089314|FG003|Overall Study|Lost to Follow-up|4|||
49070511|NCT00384930|158089315|FG004|Overall Study|Lost to Follow-up|6|||
49070512|NCT00384930|158089311|FG000|Overall Study|Physician Decision|0|||
49070513|NCT00384930|158089312|FG001|Overall Study|Physician Decision|1|||
49070514|NCT00384930|158089313|FG002|Overall Study|Physician Decision|1|||
49070515|NCT00384930|158089314|FG003|Overall Study|Physician Decision|0|||
49070516|NCT00384930|158089315|FG004|Overall Study|Physician Decision|1|||
49070517|NCT00384930|158089311|FG000|Overall Study|Protocol Violation|1|||
49070518|NCT00384930|158089312|FG001|Overall Study|Protocol Violation|0|||
49070519|NCT00384930|158089313|FG002|Overall Study|Protocol Violation|1|||
49070520|NCT00384930|158089314|FG003|Overall Study|Protocol Violation|6|||
49070521|NCT00384930|158089315|FG004|Overall Study|Protocol Violation|4|||
49070522|NCT00384930|158089311|FG000|Overall Study|Sponsor Decision|3|||
49070523|NCT00384930|158089312|FG001|Overall Study|Sponsor Decision|4|||
49070524|NCT00384930|158089313|FG002|Overall Study|Sponsor Decision|0|||
49070525|NCT00384930|158089314|FG003|Overall Study|Sponsor Decision|5|||
49070526|NCT00384930|158089315|FG004|Overall Study|Sponsor Decision|0|||
49070527|NCT00384930|158089311|FG000|Overall Study|Withdrawal by Subject|9|||
49070528|NCT00384930|158089312|FG001|Overall Study|Withdrawal by Subject|7|||
49070529|NCT00384930|158089313|FG002|Overall Study|Withdrawal by Subject|7|||
49070530|NCT00384930|158089314|FG003|Overall Study|Withdrawal by Subject|6|||
49070531|NCT00384930|158089315|FG004|Overall Study|Withdrawal by Subject|16|||
49070532|NCT00384930|158089311|FG000|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
49070533|NCT00384930|158089312|FG001|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
49070534|NCT00384930|158089313|FG002|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
49070535|NCT00384930|158089314|FG003|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
49070536|NCT00384930|158089315|FG004|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
49070537|NCT00678886|158089316|FG000|Overall Study|Withdrawal by Subject|0|||
49070538|NCT00678886|158089317|FG001|Overall Study|Withdrawal by Subject|0|||
49070539|NCT00678886|158089318|FG002|Overall Study|Withdrawal by Subject|4|||
49070540|NCT00678886|158089319|FG003|Overall Study|Withdrawal by Subject|6|||
49070541|NCT00678886|158089316|FG000|Overall Study|Physician Decision|0|||
49070542|NCT00678886|158089317|FG001|Overall Study|Physician Decision|0|||
49070543|NCT00678886|158089318|FG002|Overall Study|Physician Decision|1|||
49070544|NCT00678886|158089319|FG003|Overall Study|Physician Decision|1|||
49070545|NCT00678886|158089316|FG000|Overall Study|Lost to Follow-up|0|||
49070546|NCT00678886|158089317|FG001|Overall Study|Lost to Follow-up|0|||
49070547|NCT00678886|158089318|FG002|Overall Study|Lost to Follow-up|3|||
49070548|NCT00678886|158089319|FG003|Overall Study|Lost to Follow-up|2|||
49070549|NCT00678886|158089316|FG000|Overall Study|Other|0|||
49070550|NCT00678886|158089317|FG001|Overall Study|Other|0|||
49070551|NCT00678886|158089318|FG002|Overall Study|Other|1|||
49070552|NCT00678886|158089319|FG003|Overall Study|Other|0|||
49070553|NCT00951496|158089320|FG000|Overall Study|Did not initiate study treatment|10|||
49070554|NCT00951496|158089321|FG001|Overall Study|Did not initiate study treatment|8|||
49070555|NCT00951496|158089322|FG002|Overall Study|Did not initiate study treatment|13|||
49070556|NCT03713619|158089327|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
49070557|NCT03713619|158089328|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
49070558|NCT03713619|158089329|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
49070559|NCT03713619|158089330|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
49070560|NCT03713619|158089331|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
49070561|NCT03713619|158089327|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|3|||
49070562|NCT03713619|158089328|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
49070563|NCT03713619|158089329|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
49070564|NCT03713619|158089330|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
49070565|NCT03713619|158089331|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
49070566|NCT03713619|158089327|FG000|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
49070567|NCT03713619|158089328|FG001|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
49070568|NCT03713619|158089329|FG002|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
49070569|NCT03713619|158089330|FG003|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
49070570|NCT03713619|158089331|FG004|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
49070571|NCT03713619|158089327|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
49070572|NCT03713619|158089328|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
49070573|NCT03713619|158089329|FG002|Treatment Period 1 (Until Week 16)|Technical problems|0|||
49070574|NCT03713619|158089330|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
49070575|NCT03713619|158089331|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
49070576|NCT03713619|158089327|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|4|||
49070577|NCT03713619|158089328|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|9|||
49070578|NCT03713619|158089329|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|5|||
49070579|NCT03713619|158089330|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
49070580|NCT03713619|158089331|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
49070581|NCT03713619|158089327|FG000|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
49070582|NCT03713619|158089328|FG001|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
49070583|NCT03713619|158089329|FG002|Treatment Period 1 (Until Week 16)|Misrandomized|1|||
49070584|NCT03713619|158089330|FG003|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
49070585|NCT03713619|158089331|FG004|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
49070586|NCT03713619|158089327|FG000|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
49070587|NCT03713619|158089328|FG001|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
49070588|NCT03713619|158089329|FG002|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
49070589|NCT03713619|158089330|FG003|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
49070590|NCT03713619|158089331|FG004|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
49070591|NCT03713619|158089327|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
49070592|NCT03713619|158089328|FG001|Treatment Period 2 (After Week 16)|Adverse Event|5|||
49070593|NCT03713619|158089329|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
49070594|NCT03713619|158089330|FG003|Treatment Period 2 (After Week 16)|Adverse Event|1|||
49070595|NCT03713619|158089331|FG004|Treatment Period 2 (After Week 16)|Adverse Event|2|||
49070596|NCT03713619|158089327|FG000|Treatment Period 2 (After Week 16)|Pregnancy|1|||
49070597|NCT03713619|158089328|FG001|Treatment Period 2 (After Week 16)|Pregnancy|0|||
49070598|NCT03713619|158089329|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
49070599|NCT03713619|158089330|FG003|Treatment Period 2 (After Week 16)|Pregnancy|1|||
49070600|NCT03713619|158089331|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
49070601|NCT03713619|158089327|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|26|||
49070602|NCT03713619|158089328|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|20|||
49070603|NCT03713619|158089329|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
49070604|NCT03713619|158089330|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|10|||
49070605|NCT03713619|158089331|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|6|||
49070606|NCT03713619|158089327|FG000|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
49070607|NCT03713619|158089328|FG001|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
49070608|NCT03713619|158089329|FG002|Treatment Period 2 (After Week 16)|Poor efficacy|0|||
49070609|NCT03713619|158089330|FG003|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
49070610|NCT03713619|158089331|FG004|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
49070611|NCT03713619|158089327|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
49070612|NCT03713619|158089328|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
49070613|NCT03713619|158089329|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
49070614|NCT03713619|158089330|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
49070615|NCT03713619|158089331|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
49070616|NCT03713619|158089327|FG000|Treatment Period 2 (After Week 16)|Physician Decision|0|||
49070617|NCT03713619|158089328|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
49070618|NCT03713619|158089329|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
49070619|NCT03713619|158089330|FG003|Treatment Period 2 (After Week 16)|Physician Decision|1|||
49070620|NCT03713619|158089331|FG004|Treatment Period 2 (After Week 16)|Physician Decision|1|||
49070621|NCT03371459|158089333|FG000|Washout|Lost to Follow-up|0|||
49070622|NCT03371459|158089334|FG001|Washout|Lost to Follow-up|1|||
49070623|NCT01671332|158089335|FG000|Overall Study|Withdrawal by Subject|1|||
49070624|NCT01671332|158089336|FG001|Overall Study|Withdrawal by Subject|1|||
49070625|NCT02105974|158089338|FG000|2 Week Run-in Period|Withdrew during pre-screen period|158|||
49070626|NCT02105974|158089339|FG001|2 Week Run-in Period|Withdrew during pre-screen period|0|||
49070627|NCT02105974|158089340|FG002|2 Week Run-in Period|Withdrew during pre-screen period|0|||
49070628|NCT02105974|158089338|FG000|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603|||
49070629|NCT02105974|158089339|FG001|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
49070630|NCT02105974|158089340|FG002|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
49070631|NCT02105974|158089338|FG000|2 Week Run-in Period|Adverse Event|6|||
49070632|NCT02105974|158089339|FG001|2 Week Run-in Period|Adverse Event|0|||
49070633|NCT02105974|158089340|FG002|2 Week Run-in Period|Adverse Event|0|||
49070634|NCT02105974|158089338|FG000|2 Week Run-in Period|Study closed/terminated|1|||
49070635|NCT02105974|158089339|FG001|2 Week Run-in Period|Study closed/terminated|0|||
49070636|NCT02105974|158089340|FG002|2 Week Run-in Period|Study closed/terminated|0|||
49070637|NCT02105974|158089338|FG000|2 Week Run-in Period|Lost to Follow-up|2|||
49070638|NCT02105974|158089339|FG001|2 Week Run-in Period|Lost to Follow-up|0|||
49070639|NCT02105974|158089340|FG002|2 Week Run-in Period|Lost to Follow-up|0|||
49070640|NCT02105974|158089338|FG000|2 Week Run-in Period|Withdrew consent|23|||
49070641|NCT02105974|158089339|FG001|2 Week Run-in Period|Withdrew consent|0|||
49070642|NCT02105974|158089340|FG002|2 Week Run-in Period|Withdrew consent|0|||
49070643|NCT02105974|158089338|FG000|2 Week Run-in Period|Investigator discretion|8|||
49070644|NCT02105974|158089339|FG001|2 Week Run-in Period|Investigator discretion|0|||
49070645|NCT02105974|158089340|FG002|2 Week Run-in Period|Investigator discretion|0|||
49070646|NCT02105974|158089338|FG000|12 Week (Wk) Treatment Period (TP)|Adverse Event|0|||
49070647|NCT02105974|158089339|FG001|12 Week (Wk) Treatment Period (TP)|Adverse Event|14|||
49070648|NCT02105974|158089340|FG002|12 Week (Wk) Treatment Period (TP)|Adverse Event|18|||
49070649|NCT02105974|158089338|FG000|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0|||
49070650|NCT02105974|158089339|FG001|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6|||
49070651|NCT02105974|158089340|FG002|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9|||
49070652|NCT02105974|158089338|FG000|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0|||
49070653|NCT02105974|158089339|FG001|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2|||
49070654|NCT02105974|158089340|FG002|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6|||
49070655|NCT02105974|158089338|FG000|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0|||
49070656|NCT02105974|158089339|FG001|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1|||
49070657|NCT02105974|158089340|FG002|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2|||
49070658|NCT02105974|158089338|FG000|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
49070659|NCT02105974|158089339|FG001|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
49070660|NCT02105974|158089340|FG002|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1|||
49070661|NCT02105974|158089338|FG000|12 Week (Wk) Treatment Period (TP)|Physician Decision|0|||
49070662|NCT02105974|158089339|FG001|12 Week (Wk) Treatment Period (TP)|Physician Decision|7|||
49070663|NCT02105974|158089340|FG002|12 Week (Wk) Treatment Period (TP)|Physician Decision|4|||
49070664|NCT02105974|158089338|FG000|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0|||
49070665|NCT02105974|158089339|FG001|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12|||
49070666|NCT02105974|158089340|FG002|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18|||
49070667|NCT00477633|158089341|FG000|Overall Study|Did not receive treatment|23|||
49070668|NCT00477633|158089341|FG000|Overall Study|Adverse Event|143|||
49070669|NCT00477633|158089341|FG000|Overall Study|Pregnancy|23|||
49070670|NCT00477633|158089341|FG000|Overall Study|Lost to Follow-up|271|||
49070671|NCT00477633|158089341|FG000|Overall Study|Withdrawal by Subject|149|||
49070672|NCT00477633|158089341|FG000|Overall Study|Protocol Violation|25|||
49070673|NCT00477633|158089341|FG000|Overall Study|Various (Moving, Enrollment closed)|75|||
49070674|NCT03155945|158089342|FG000|Overall Study|Lost to Follow-up|0|||
49070675|NCT03155945|158089343|FG001|Overall Study|Lost to Follow-up|1|||
49070676|NCT03155945|158089342|FG000|Overall Study|Withdrawal by Subject|0|||
49070677|NCT03155945|158089343|FG001|Overall Study|Withdrawal by Subject|1|||
49070678|NCT03155945|158089342|FG000|Overall Study|Other Reason|0|||
49070679|NCT03155945|158089343|FG001|Overall Study|Other Reason|1|||
49070680|NCT02013674|158089347|FG000|Overall Study|Death|0|||
49070681|NCT02013674|158089348|FG001|Overall Study|Death|1|||
49070682|NCT02013674|158089347|FG000|Overall Study|Lost to Follow-up|1|||
49070683|NCT02013674|158089348|FG001|Overall Study|Lost to Follow-up|0|||
49070684|NCT02359994|158089349|FG000|Overall Population Study|Adverse Event|1|||
49070685|NCT02359994|158089350|FG001|Overall Population Study|Adverse Event|1|||
49070686|NCT02359994|158089349|FG000|Overall Population Study|Death|1|||
49070687|NCT02359994|158089350|FG001|Overall Population Study|Death|5|||
49070688|NCT02359994|158089349|FG000|Overall Population Study|Lost to Follow-up|1|||
49070689|NCT02359994|158089350|FG001|Overall Population Study|Lost to Follow-up|1|||
49070690|NCT02359994|158089349|FG000|Overall Population Study|Withdrawal by Subject|1|||
49070691|NCT02359994|158089350|FG001|Overall Population Study|Withdrawal by Subject|0|||
49070692|NCT02359994|158089349|FG000|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|1|||
49070693|NCT02359994|158089350|FG001|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|0|||
49070694|NCT02359994|158089349|FG000|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|0|||
49070695|NCT02359994|158089350|FG001|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|1|||
49070696|NCT02359994|158089349|FG000|Extended Oncology 24-Month Survival|Death|19|||
49070697|NCT02359994|158089350|FG001|Extended Oncology 24-Month Survival|Death|21|||
49070698|NCT02359994|158089349|FG000|Extended Oncology 24-Month Survival|Lost to Follow-up|1|||
49070699|NCT02359994|158089350|FG001|Extended Oncology 24-Month Survival|Lost to Follow-up|0|||
49070700|NCT01823835|158089352|FG000|Overall Study|Adverse Event|0|||
49070701|NCT01823835|158089353|FG001|Overall Study|Adverse Event|0|||
49070702|NCT01823835|158089354|FG002|Overall Study|Adverse Event|0|||
49070703|NCT01823835|158089355|FG003|Overall Study|Adverse Event|0|||
49070704|NCT01823835|158089356|FG004|Overall Study|Adverse Event|1|||
49070705|NCT01823835|158089357|FG005|Overall Study|Adverse Event|0|||
49070706|NCT01823835|158089358|FG006|Overall Study|Adverse Event|1|||
49070707|NCT01823835|158089359|FG007|Overall Study|Adverse Event|0|||
49070708|NCT01823835|158089360|FG008|Overall Study|Adverse Event|0|||
49070709|NCT01823835|158089361|FG009|Overall Study|Adverse Event|0|||
49070710|NCT01823835|158089362|FG010|Overall Study|Adverse Event|1|||
49070711|NCT01823835|158089363|FG011|Overall Study|Adverse Event|2|||
49070712|NCT01823835|158089364|FG012|Overall Study|Adverse Event|0|||
49070713|NCT01823835|158089365|FG013|Overall Study|Adverse Event|0|||
49070714|NCT01823835|158089366|FG014|Overall Study|Adverse Event|0|||
49070715|NCT01823835|158089352|FG000|Overall Study|Physician Decision|0|||
49070716|NCT01823835|158089353|FG001|Overall Study|Physician Decision|0|||
49070717|NCT01823835|158089354|FG002|Overall Study|Physician Decision|0|||
49070718|NCT01823835|158089355|FG003|Overall Study|Physician Decision|0|||
49070719|NCT01823835|158089356|FG004|Overall Study|Physician Decision|0|||
49070720|NCT01823835|158089357|FG005|Overall Study|Physician Decision|0|||
49070721|NCT01823835|158089358|FG006|Overall Study|Physician Decision|0|||
49070722|NCT01823835|158089359|FG007|Overall Study|Physician Decision|0|||
49070723|NCT01823835|158089360|FG008|Overall Study|Physician Decision|0|||
49070724|NCT01823835|158089361|FG009|Overall Study|Physician Decision|0|||
49070725|NCT01823835|158089362|FG010|Overall Study|Physician Decision|0|||
49070726|NCT01823835|158089363|FG011|Overall Study|Physician Decision|2|||
49070727|NCT01823835|158089364|FG012|Overall Study|Physician Decision|0|||
49070728|NCT01823835|158089365|FG013|Overall Study|Physician Decision|0|||
49070729|NCT01823835|158089366|FG014|Overall Study|Physician Decision|0|||
49070730|NCT01823835|158089352|FG000|Overall Study|Progressive Disease|3|||
49070731|NCT01823835|158089353|FG001|Overall Study|Progressive Disease|4|||
49070732|NCT01823835|158089354|FG002|Overall Study|Progressive Disease|3|||
49070733|NCT01823835|158089355|FG003|Overall Study|Progressive Disease|6|||
49070734|NCT01823835|158089356|FG004|Overall Study|Progressive Disease|4|||
49070735|NCT01823835|158089357|FG005|Overall Study|Progressive Disease|6|||
49070736|NCT01823835|158089358|FG006|Overall Study|Progressive Disease|5|||
49070737|NCT01823835|158089359|FG007|Overall Study|Progressive Disease|3|||
49070738|NCT01823835|158089360|FG008|Overall Study|Progressive Disease|3|||
49070739|NCT01823835|158089361|FG009|Overall Study|Progressive Disease|18|||
49070740|NCT01823835|158089362|FG010|Overall Study|Progressive Disease|8|||
49070741|NCT01823835|158089363|FG011|Overall Study|Progressive Disease|46|||
49070742|NCT01823835|158089364|FG012|Overall Study|Progressive Disease|18|||
49070743|NCT01823835|158089365|FG013|Overall Study|Progressive Disease|4|||
49070744|NCT01823835|158089366|FG014|Overall Study|Progressive Disease|6|||
49070745|NCT01823835|158089352|FG000|Overall Study|Study Termination|0|||
49070746|NCT01823835|158089353|FG001|Overall Study|Study Termination|0|||
49070747|NCT01823835|158089354|FG002|Overall Study|Study Termination|0|||
49070748|NCT01823835|158089355|FG003|Overall Study|Study Termination|0|||
49070749|NCT01823835|158089356|FG004|Overall Study|Study Termination|1|||
49070750|NCT01823835|158089357|FG005|Overall Study|Study Termination|0|||
49070751|NCT01823835|158089358|FG006|Overall Study|Study Termination|0|||
49070752|NCT01823835|158089359|FG007|Overall Study|Study Termination|0|||
49070753|NCT01823835|158089360|FG008|Overall Study|Study Termination|0|||
49070754|NCT01823835|158089361|FG009|Overall Study|Study Termination|0|||
49070755|NCT01823835|158089362|FG010|Overall Study|Study Termination|0|||
49070756|NCT01823835|158089363|FG011|Overall Study|Study Termination|1|||
49070757|NCT01823835|158089364|FG012|Overall Study|Study Termination|0|||
49070758|NCT01823835|158089365|FG013|Overall Study|Study Termination|0|||
49070759|NCT01823835|158089366|FG014|Overall Study|Study Termination|0|||
49070760|NCT01823835|158089352|FG000|Overall Study|Withdrawal by Subject|0|||
49070761|NCT01823835|158089353|FG001|Overall Study|Withdrawal by Subject|0|||
49070762|NCT01823835|158089354|FG002|Overall Study|Withdrawal by Subject|1|||
49070763|NCT01823835|158089355|FG003|Overall Study|Withdrawal by Subject|0|||
49070764|NCT01823835|158089356|FG004|Overall Study|Withdrawal by Subject|0|||
49070765|NCT01823835|158089357|FG005|Overall Study|Withdrawal by Subject|0|||
49070766|NCT01823835|158089358|FG006|Overall Study|Withdrawal by Subject|0|||
49070767|NCT01823835|158089359|FG007|Overall Study|Withdrawal by Subject|0|||
49070768|NCT01823835|158089360|FG008|Overall Study|Withdrawal by Subject|0|||
49070769|NCT01823835|158089361|FG009|Overall Study|Withdrawal by Subject|1|||
49070770|NCT01823835|158089362|FG010|Overall Study|Withdrawal by Subject|1|||
49070771|NCT01823835|158089363|FG011|Overall Study|Withdrawal by Subject|2|||
49070772|NCT01823835|158089364|FG012|Overall Study|Withdrawal by Subject|1|||
49070773|NCT01823835|158089365|FG013|Overall Study|Withdrawal by Subject|0|||
49070774|NCT01823835|158089366|FG014|Overall Study|Withdrawal by Subject|0|||
49070775|NCT01987479|158089372|FG000|Overall Study|Protocol Violation|1|||
49070776|NCT01987479|158089372|FG000|Overall Study|Physician Decision|2|||
49070777|NCT01987479|158089372|FG000|Overall Study|Participant/legal guardian decision|1|||
49070778|NCT01987479|158089372|FG000|Overall Study|Other|5|||
49070779|NCT01987479|158089372|FG000|Overall Study|Lost to Follow-up|1|||
49070780|NCT01987479|158089372|FG000|Overall Study|Adverse Event|7|||
49070781|NCT00144781|158090832|FG000|Overall Study|Adverse Event|0|||
49070782|NCT00144781|158090833|FG001|Overall Study|Adverse Event|1|||
49070783|NCT00144781|158090834|FG002|Overall Study|Adverse Event|0|||
49070784|NCT00144781|158090835|FG003|Overall Study|Adverse Event|0|||
49070785|NCT00144781|158090832|FG000|Overall Study|Non-compliant|0|||
49070786|NCT00144781|158090833|FG001|Overall Study|Non-compliant|1|||
49070787|NCT00144781|158090834|FG002|Overall Study|Non-compliant|0|||
49070788|NCT00144781|158090835|FG003|Overall Study|Non-compliant|0|||
49070789|NCT04709835|158090836|FG000|Overall Study|Withdrawal by Subject|0|||
49070790|NCT04709835|158090837|FG001|Overall Study|Withdrawal by Subject|1|||
49070791|NCT04709835|158090838|FG002|Overall Study|Withdrawal by Subject|0|||
49070792|NCT03954834|158090839|FG000|Overall Study|Adverse Event|1|||
49070793|NCT03954834|158090840|FG001|Overall Study|Adverse Event|3|||
49070794|NCT03954834|158090841|FG002|Overall Study|Adverse Event|1|||
49070795|NCT03954834|158090842|FG003|Overall Study|Adverse Event|1|||
49070796|NCT03954834|158090839|FG000|Overall Study|Death|0|||
49070797|NCT03954834|158090840|FG001|Overall Study|Death|0|||
49070798|NCT03954834|158090841|FG002|Overall Study|Death|0|||
49070799|NCT03954834|158090842|FG003|Overall Study|Death|1|||
49070800|NCT03954834|158090839|FG000|Overall Study|Physician Decision|0|||
49070801|NCT03954834|158090840|FG001|Overall Study|Physician Decision|1|||
49070802|NCT03954834|158090841|FG002|Overall Study|Physician Decision|0|||
49070803|NCT03954834|158090842|FG003|Overall Study|Physician Decision|2|||
49070804|NCT03954834|158090839|FG000|Overall Study|Protocol Violation|1|||
49070805|NCT03954834|158090840|FG001|Overall Study|Protocol Violation|0|||
49070806|NCT03954834|158090841|FG002|Overall Study|Protocol Violation|0|||
49070807|NCT03954834|158090842|FG003|Overall Study|Protocol Violation|1|||
49070808|NCT03954834|158090839|FG000|Overall Study|Withdrawal by Subject|2|||
49070809|NCT03954834|158090840|FG001|Overall Study|Withdrawal by Subject|3|||
49070810|NCT03954834|158090841|FG002|Overall Study|Withdrawal by Subject|13|||
49070811|NCT03954834|158090842|FG003|Overall Study|Withdrawal by Subject|6|||
49070812|NCT03954834|158090839|FG000|Overall Study|Participant left the country|0|||
49070813|NCT03954834|158090840|FG001|Overall Study|Participant left the country|0|||
49070814|NCT03954834|158090841|FG002|Overall Study|Participant left the country|1|||
49070815|NCT03954834|158090842|FG003|Overall Study|Participant left the country|0|||
49070816|NCT03954834|158090839|FG000|Overall Study|Lost to Follow-up|3|||
49070817|NCT03954834|158090840|FG001|Overall Study|Lost to Follow-up|2|||
49070818|NCT03954834|158090841|FG002|Overall Study|Lost to Follow-up|3|||
49070819|NCT03954834|158090842|FG003|Overall Study|Lost to Follow-up|5|||
49070820|NCT02903030|158090846|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
49070821|NCT02903030|158090847|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
49070822|NCT01502410|158090848|FG000|Overall Study|Adverse Event|1|||
49070823|NCT01502410|158090849|FG001|Overall Study|Adverse Event|2|||
49070824|NCT01502410|158090850|FG002|Overall Study|Adverse Event|0|||
49070825|NCT01502410|158090851|FG003|Overall Study|Adverse Event|0|||
49070826|NCT01502410|158090848|FG000|Overall Study|Lack of Efficacy|7|||
49070827|NCT01502410|158090849|FG001|Overall Study|Lack of Efficacy|7|||
49070828|NCT01502410|158090850|FG002|Overall Study|Lack of Efficacy|0|||
49070829|NCT01502410|158090851|FG003|Overall Study|Lack of Efficacy|0|||
49070830|NCT01502410|158090848|FG000|Overall Study|Physician Decision|0|||
49070831|NCT01502410|158090849|FG001|Overall Study|Physician Decision|1|||
49070832|NCT01502410|158090850|FG002|Overall Study|Physician Decision|0|||
49070833|NCT01502410|158090851|FG003|Overall Study|Physician Decision|0|||
49070834|NCT01502410|158090848|FG000|Overall Study|Withdrawal by Subject|2|||
49070835|NCT01502410|158090849|FG001|Overall Study|Withdrawal by Subject|0|||
49070836|NCT01502410|158090850|FG002|Overall Study|Withdrawal by Subject|0|||
49070837|NCT01502410|158090851|FG003|Overall Study|Withdrawal by Subject|0|||
49070838|NCT04325204|158090852|FG000|Overall Study|Death|0|||
49070839|NCT04325204|158090853|FG001|Overall Study|Death|1|||
49070840|NCT04325204|158090852|FG000|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|1|||
49070841|NCT04325204|158090853|FG001|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|0|||
49070842|NCT04325204|158090852|FG000|Overall Study|Lost to Follow-up|8|||
49070843|NCT04325204|158090853|FG001|Overall Study|Lost to Follow-up|8|||
49070844|NCT04325204|158090852|FG000|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
49070845|NCT04325204|158090853|FG001|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
49070846|NCT04345601|158090854|FG000|Overall Study|Death|0|||
49070847|NCT04345601|158090855|FG001|Overall Study|Death|3|||
49070848|NCT04345601|158090856|FG002|Overall Study|Death|2|||
49070849|NCT04345601|158090854|FG000|Overall Study|Lost to Follow-up|0|||
49070850|NCT04345601|158090855|FG001|Overall Study|Lost to Follow-up|0|||
49070851|NCT04345601|158090856|FG002|Overall Study|Lost to Follow-up|2|||
49070852|NCT03610516|158090860|FG000|Treatment Epoch|Adverse Event|3|||
49070853|NCT03610516|158090861|FG001|Treatment Epoch|Adverse Event|1|||
49070854|NCT03610516|158090860|FG000|Treatment Epoch|Death|1|||
49070855|NCT03610516|158090861|FG001|Treatment Epoch|Death|0|||
49070856|NCT03610516|158090860|FG000|Treatment Epoch|Lack of Efficacy|0|||
49070857|NCT03610516|158090861|FG001|Treatment Epoch|Lack of Efficacy|1|||
49070858|NCT03610516|158090860|FG000|Treatment Epoch|No longer requires treatment|1|||
49070859|NCT03610516|158090861|FG001|Treatment Epoch|No longer requires treatment|0|||
49070860|NCT03610516|158090860|FG000|Treatment Epoch|Non-Compliance with study treatment|1|||
49070861|NCT03610516|158090861|FG001|Treatment Epoch|Non-Compliance with study treatment|0|||
49070862|NCT03610516|158090860|FG000|Treatment Epoch|Physician Decision|8|||
49070863|NCT03610516|158090861|FG001|Treatment Epoch|Physician Decision|5|||
49070864|NCT03610516|158090860|FG000|Treatment Epoch|Protocol Deviation|1|||
49070865|NCT03610516|158090861|FG001|Treatment Epoch|Protocol Deviation|0|||
49070866|NCT03610516|158090860|FG000|Treatment Epoch|Withdrawal by Subject|3|||
49070867|NCT03610516|158090861|FG001|Treatment Epoch|Withdrawal by Subject|1|||
49070868|NCT03610516|158090860|FG000|Post-Treatment Follow-up|Subject/Guardian Decision|1|||
49070869|NCT03610516|158090861|FG001|Post-Treatment Follow-up|Subject/Guardian Decision|0|||
49070870|NCT03610516|158090860|FG000|Post-Treatment Follow-up|Death|1|||
49070871|NCT03610516|158090861|FG001|Post-Treatment Follow-up|Death|0|||
49070872|NCT02699684|158090866|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
49070873|NCT02699684|158090867|FG001|Period 2, Second 30 Days of Wear|Adverse Event|0|||
49070874|NCT01145508|158090868|FG000|Overall Study|Adverse Event|1|||
49070875|NCT01145508|158090869|FG001|Overall Study|Adverse Event|0|||
49070876|NCT01145508|158090868|FG000|Overall Study|Death|1|||
49070877|NCT01145508|158090869|FG001|Overall Study|Death|0|||
49070878|NCT01145508|158090868|FG000|Overall Study|Physician Decision|2|||
49070879|NCT01145508|158090869|FG001|Overall Study|Physician Decision|1|||
49070880|NCT01145508|158090868|FG000|Overall Study|Never started treatment|1|||
49070881|NCT01145508|158090869|FG001|Overall Study|Never started treatment|1|||
49070882|NCT02045147|158090878|FG000|Overall Study|Withdrawal by Subject|2|||
49070883|NCT02045147|158090879|FG001|Overall Study|Withdrawal by Subject|0|||
49070884|NCT02045147|158090880|FG002|Overall Study|Withdrawal by Subject|0|||
49070885|NCT02045147|158090881|FG003|Overall Study|Withdrawal by Subject|0|||
49070886|NCT02045147|158090882|FG004|Overall Study|Withdrawal by Subject|0|||
49070887|NCT02045147|158090883|FG005|Overall Study|Withdrawal by Subject|0|||
49070888|NCT02045147|158090884|FG006|Overall Study|Withdrawal by Subject|0|||
49070889|NCT02045147|158090885|FG007|Overall Study|Withdrawal by Subject|1|||
49070890|NCT02045147|158090878|FG000|Overall Study|Did not meet inclusion criteria at hospital discharge|9|||
49070891|NCT02045147|158090879|FG001|Overall Study|Did not meet inclusion criteria at hospital discharge|12|||
49070892|NCT02045147|158090880|FG002|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
49070893|NCT02045147|158090881|FG003|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
49070894|NCT02045147|158090882|FG004|Overall Study|Did not meet inclusion criteria at hospital discharge|3|||
49070895|NCT02045147|158090883|FG005|Overall Study|Did not meet inclusion criteria at hospital discharge|10|||
49070896|NCT02045147|158090884|FG006|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
49070897|NCT02045147|158090885|FG007|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
49070898|NCT04839692|158090886|FG000|Overall Study|Withdrawal by Subject|0|||
49070899|NCT04839692|158090887|FG001|Overall Study|Withdrawal by Subject|3|||
49070900|NCT04839692|158090886|FG000|Overall Study|Physician Decision|1|||
49070901|NCT04839692|158090887|FG001|Overall Study|Physician Decision|0|||
49070902|NCT00049530|158090890|FG000|Overall Study|Lack of Efficacy|25|||
49070903|NCT00049530|158090890|FG000|Overall Study|Adverse Event|2|||
49070904|NCT00049530|158090890|FG000|Overall Study|Death|1|||
49070905|NCT00049530|158090890|FG000|Overall Study|symptomatic deterioration|1|||
49070906|NCT00049530|158090890|FG000|Overall Study|ineligible|3|||
49070907|NCT01433549|158090895|FG000|Phase 2: Second Study Product|Adverse Event|0|||
49070908|NCT01433549|158090896|FG001|Phase 2: Second Study Product|Adverse Event|1|||
49070909|NCT01860677|158090901|FG000|Second Intervention (1 Day)|Lost to Follow-up|7|||
49070910|NCT01860677|158090902|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
49070911|NCT03456453|158090903|FG000|Overall Study|Withdrawal by Subject|2|||
49070912|NCT03456453|158090904|FG001|Overall Study|Withdrawal by Subject|0|||
49070913|NCT03456453|158090903|FG000|Overall Study|Not released to community|1|||
49070914|NCT03456453|158090904|FG001|Overall Study|Not released to community|5|||
49070915|NCT03456453|158090903|FG000|Overall Study|Lost to Follow-up|0|||
49070916|NCT03456453|158090904|FG001|Overall Study|Lost to Follow-up|2|||
49070917|NCT04762277|158090905|FG000|Overall Study|Withdrawal by Subject|0|||
49070918|NCT04762277|158090906|FG001|Overall Study|Withdrawal by Subject|2|||
49070919|NCT04762277|158090905|FG000|Overall Study|Protocol Violation|0|||
49070920|NCT04762277|158090906|FG001|Overall Study|Protocol Violation|1|||
49070921|NCT04762277|158090905|FG000|Overall Study|Adverse Event|1|||
49070922|NCT04762277|158090906|FG001|Overall Study|Adverse Event|0|||
49070923|NCT02542293|158090907|FG000|Overall Study|Death|367|||
49070924|NCT02542293|158090908|FG001|Overall Study|Death|377|||
49070925|NCT02542293|158090907|FG000|Overall Study|Withdrawal by Subject|8|||
49070926|NCT02542293|158090908|FG001|Overall Study|Withdrawal by Subject|19|||
49070927|NCT00849186|158090914|FG000|Overall Study|Adverse Event|2|||
49070928|NCT00849186|158090914|FG000|Overall Study|Withdrawal by Subject|1|||
49070929|NCT00849186|158090914|FG000|Overall Study|not treated|6|||
49070930|NCT00849186|158090914|FG000|Overall Study|Other|1|||
49070931|NCT00447993|158090915|FG000|Overall Study|Lost to Follow-up|0|||
49070932|NCT00447993|158090916|FG001|Overall Study|Lost to Follow-up|0|||
49070933|NCT00447993|158090917|FG002|Overall Study|Lost to Follow-up|2|||
49070934|NCT00447993|158090918|FG003|Overall Study|Lost to Follow-up|2|||
49070935|NCT00447993|158090915|FG000|Overall Study|Withdrawal by Subject|0|||
49070936|NCT00447993|158090916|FG001|Overall Study|Withdrawal by Subject|0|||
49070937|NCT00447993|158090917|FG002|Overall Study|Withdrawal by Subject|2|||
49070938|NCT00447993|158090918|FG003|Overall Study|Withdrawal by Subject|2|||
49070939|NCT04058067|158090953|FG000|Overall Study|Adverse Event|2|||
49070940|NCT04058067|158090954|FG001|Overall Study|Adverse Event|0|||
49070941|NCT04058067|158090953|FG000|Overall Study|Death|0|||
49070942|NCT04058067|158090954|FG001|Overall Study|Death|1|||
49070943|NCT04058067|158090953|FG000|Overall Study|Physician Decision|3|||
49070944|NCT04058067|158090954|FG001|Overall Study|Physician Decision|1|||
49070945|NCT04058067|158090953|FG000|Overall Study|Protocol Violation|0|||
49070946|NCT04058067|158090954|FG001|Overall Study|Protocol Violation|1|||
49070947|NCT04058067|158090953|FG000|Overall Study|Withdrawal by Subject|7|||
49070948|NCT04058067|158090954|FG001|Overall Study|Withdrawal by Subject|8|||
49070949|NCT01283035|158090956|FG000|Overall Study|Subject later found ineligible|1|||
49070950|NCT00927394|158090960|FG000|Overall Study|Adverse Event|14|||
49070951|NCT00927394|158090961|FG001|Overall Study|Adverse Event|9|||
49070952|NCT00927394|158090960|FG000|Overall Study|Unsatisfactory therapeutic effect|17|||
49070953|NCT00927394|158090961|FG001|Overall Study|Unsatisfactory therapeutic effect|23|||
49070954|NCT00927394|158090960|FG000|Overall Study|Withdrawal by Subject|20|||
49070955|NCT00927394|158090961|FG001|Overall Study|Withdrawal by Subject|24|||
49070956|NCT00927394|158090960|FG000|Overall Study|Lost to Follow-up|8|||
49070957|NCT00927394|158090961|FG001|Overall Study|Lost to Follow-up|14|||
49070958|NCT00927394|158090960|FG000|Overall Study|Administrative Problem|1|||
49070959|NCT00927394|158090961|FG001|Overall Study|Administrative Problem|0|||
49070960|NCT00927394|158090960|FG000|Overall Study|Death|1|||
49070961|NCT00927394|158090961|FG001|Overall Study|Death|1|||
49070962|NCT00927394|158090960|FG000|Overall Study|Protocol deviation|16|||
49070963|NCT00927394|158090961|FG001|Overall Study|Protocol deviation|13|||
49070964|NCT00927394|158090960|FG000|Overall Study|Randomized in error|0|||
49070965|NCT00927394|158090961|FG001|Overall Study|Randomized in error|1|||
49070966|NCT03257865|158090963|FG000|Overall Study|Adverse Event|4|||
49070967|NCT03257865|158090964|FG001|Overall Study|Adverse Event|8|||
49070968|NCT03257865|158090963|FG000|Overall Study|Lack of Efficacy|1|||
49070969|NCT03257865|158090964|FG001|Overall Study|Lack of Efficacy|2|||
49070970|NCT03257865|158090963|FG000|Overall Study|Non-compliance with Study Drug|0|||
49070971|NCT03257865|158090964|FG001|Overall Study|Non-compliance with Study Drug|2|||
49070972|NCT03257865|158090963|FG000|Overall Study|Withdrawal by Subject|23|||
49070973|NCT03257865|158090964|FG001|Overall Study|Withdrawal by Subject|17|||
49070974|NCT03257865|158090963|FG000|Overall Study|Physician Decision|3|||
49070975|NCT03257865|158090964|FG001|Overall Study|Physician Decision|1|||
49070976|NCT03257865|158090963|FG000|Overall Study|Other|0|||
49070977|NCT03257865|158090964|FG001|Overall Study|Other|1|||
49070978|NCT03257865|158090963|FG000|Overall Study|Lost to Follow-up|4|||
49070979|NCT03257865|158090964|FG001|Overall Study|Lost to Follow-up|4|||
49070980|NCT01221363|158090965|FG000|Overall Study|Pregnancy|1|||
49070981|NCT01221363|158090966|FG001|Overall Study|Pregnancy|0|||
49070982|NCT01221363|158090965|FG000|Overall Study|Withdrawal by Subject|11|||
49070983|NCT01221363|158090966|FG001|Overall Study|Withdrawal by Subject|5|||
49070984|NCT04480710|158090967|FG000|Overall Study|Adverse Event|0|||
49070985|NCT04480710|158090968|FG001|Overall Study|Adverse Event|2|||
49070986|NCT04480710|158090969|FG002|Overall Study|Adverse Event|0|||
49070987|NCT04480710|158090970|FG003|Overall Study|Adverse Event|0|||
49070988|NCT04480710|158090967|FG000|Overall Study|Withdrawal by Subject|0|||
49070989|NCT04480710|158090968|FG001|Overall Study|Withdrawal by Subject|1|||
49070990|NCT04480710|158090969|FG002|Overall Study|Withdrawal by Subject|0|||
49070991|NCT04480710|158090970|FG003|Overall Study|Withdrawal by Subject|0|||
49070992|NCT04480710|158090967|FG000|Overall Study|Physician Decision|0|||
49070993|NCT04480710|158090968|FG001|Overall Study|Physician Decision|0|||
49070994|NCT04480710|158090969|FG002|Overall Study|Physician Decision|1|||
49070995|NCT04480710|158090970|FG003|Overall Study|Physician Decision|0|||
49070996|NCT01934335|158090972|FG000|Overall Study|Withdrawal by Subject|1|||
49070997|NCT01934335|158090973|FG001|Overall Study|Withdrawal by Subject|1|||
49070998|NCT04480021|158090976|FG000|Overall Study|Lost to Follow-up|3|||
49070999|NCT04480021|158090977|FG001|Overall Study|Lost to Follow-up|4|||
49071000|NCT02242045|158090978|FG000|Overall Study|Investigator's Discretion|1|||
49071001|NCT02242045|158090978|FG000|Overall Study|Progressive Disease|2|||
49071002|NCT02242045|158090978|FG000|Overall Study|Unable to tolerate rechallenge with idelalisib|1|||
49071003|NCT02242045|158090978|FG000|Overall Study|Initiated another anti-cancer or experimental therapy|2|||
49071004|NCT03279692|158090979|FG000|Overall Study|Withdrawal by Subject|1|||
49071005|NCT00351533|158090982|FG000|Overall Study|Extubated before first BAL|1|||
49071006|NCT00351533|158090983|FG001|Overall Study|Extubated before first BAL|0|||
49071007|NCT00351533|158090982|FG000|Overall Study|Lost to Follow-up|1|||
49071008|NCT00351533|158090983|FG001|Overall Study|Lost to Follow-up|3|||
49071009|NCT00351533|158090982|FG000|Overall Study|Physician Decision|0|||
49071010|NCT00351533|158090983|FG001|Overall Study|Physician Decision|1|||
49071011|NCT00351533|158090982|FG000|Overall Study|Withdrawal by Subject|0|||
49071012|NCT00351533|158090983|FG001|Overall Study|Withdrawal by Subject|1|||
49071013|NCT04123561|158090988|FG000|Overall Study|Lost to Follow-up|20|||
49071014|NCT04123561|158090989|FG001|Overall Study|Lost to Follow-up|12|||
49071015|NCT04123561|158090990|FG002|Overall Study|Lost to Follow-up|5|||
49071016|NCT04123561|158090988|FG000|Overall Study|Withdrawal by Subject|9|||
49071017|NCT04123561|158090989|FG001|Overall Study|Withdrawal by Subject|7|||
49071018|NCT04123561|158090990|FG002|Overall Study|Withdrawal by Subject|9|||
49071019|NCT04123561|158090988|FG000|Overall Study|Lack of Efficacy|7|||
49071020|NCT04123561|158090989|FG001|Overall Study|Lack of Efficacy|8|||
49071021|NCT04123561|158090990|FG002|Overall Study|Lack of Efficacy|6|||
49071022|NCT04123561|158090988|FG000|Overall Study|Adverse Event|5|||
49071023|NCT04123561|158090989|FG001|Overall Study|Adverse Event|2|||
49071024|NCT04123561|158090990|FG002|Overall Study|Adverse Event|3|||
49071025|NCT04123561|158090988|FG000|Overall Study|A surgical procedure or IA administration in the index knee|3|||
49071026|NCT04123561|158090989|FG001|Overall Study|A surgical procedure or IA administration in the index knee|0|||
49071027|NCT04123561|158090990|FG002|Overall Study|A surgical procedure or IA administration in the index knee|1|||
49071028|NCT04123561|158090988|FG000|Overall Study|Death|0|||
49071029|NCT04123561|158090989|FG001|Overall Study|Death|0|||
49071030|NCT04123561|158090990|FG002|Overall Study|Death|1|||
49071031|NCT04123561|158090988|FG000|Overall Study|Protocol Violation|0|||
49071032|NCT04123561|158090989|FG001|Overall Study|Protocol Violation|1|||
49071033|NCT04123561|158090990|FG002|Overall Study|Protocol Violation|0|||
49071034|NCT02521376|158090991|FG000|Overall Study|Enrolled, But Not Treated|1|||
49071035|NCT02521376|158090992|FG001|Overall Study|Enrolled, But Not Treated|0|||
49071036|NCT02521376|158090993|FG002|Overall Study|Enrolled, But Not Treated|0|||
49071037|NCT02521376|158090994|FG003|Overall Study|Enrolled, But Not Treated|0|||
49071038|NCT00509795|158090999|FG000|Overall Study|Adverse Event|4|||
49071039|NCT00509795|158091000|FG001|Overall Study|Adverse Event|3|||
49071040|NCT00509795|158091001|FG002|Overall Study|Adverse Event|5|||
49071041|NCT00509795|158091002|FG003|Overall Study|Adverse Event|4|||
49071042|NCT00509795|158090999|FG000|Overall Study|Death|3|||
49071043|NCT00509795|158091000|FG001|Overall Study|Death|1|||
49071044|NCT00509795|158091001|FG002|Overall Study|Death|2|||
49071045|NCT00509795|158091002|FG003|Overall Study|Death|7|||
49071046|NCT00509795|158090999|FG000|Overall Study|Lack of Efficacy|0|||
49071047|NCT00509795|158091000|FG001|Overall Study|Lack of Efficacy|0|||
49071048|NCT00509795|158091001|FG002|Overall Study|Lack of Efficacy|2|||
49071049|NCT00509795|158091002|FG003|Overall Study|Lack of Efficacy|2|||
49071050|NCT00509795|158090999|FG000|Overall Study|Lost to Follow-up|1|||
49071051|NCT00509795|158091000|FG001|Overall Study|Lost to Follow-up|2|||
49071052|NCT00509795|158091001|FG002|Overall Study|Lost to Follow-up|4|||
49071053|NCT00509795|158091002|FG003|Overall Study|Lost to Follow-up|4|||
49071054|NCT00509795|158090999|FG000|Overall Study|OTHER|1|||
49071055|NCT00509795|158091000|FG001|Overall Study|OTHER|0|||
49071056|NCT00509795|158091001|FG002|Overall Study|OTHER|4|||
49071057|NCT00509795|158091002|FG003|Overall Study|OTHER|1|||
49071058|NCT00509795|158090999|FG000|Overall Study|Protocol Violation|3|||
49071059|NCT00509795|158091000|FG001|Overall Study|Protocol Violation|0|||
49071060|NCT00509795|158091001|FG002|Overall Study|Protocol Violation|3|||
49071061|NCT00509795|158091002|FG003|Overall Study|Protocol Violation|1|||
49071062|NCT00509795|158090999|FG000|Overall Study|Withdrawal by Subject|10|||
49071063|NCT00509795|158091000|FG001|Overall Study|Withdrawal by Subject|5|||
49071064|NCT00509795|158091001|FG002|Overall Study|Withdrawal by Subject|7|||
49071065|NCT00509795|158091002|FG003|Overall Study|Withdrawal by Subject|8|||
49071066|NCT04710979|158092607|FG000|Overall Study|Lost to Follow-up|2|||
49071067|NCT04710979|158092608|FG001|Overall Study|Lost to Follow-up|4|||
49071068|NCT04710979|158092607|FG000|Overall Study|Withdrawal by Subject|1|||
49071069|NCT04710979|158092608|FG001|Overall Study|Withdrawal by Subject|0|||
49071070|NCT05005312|158092612|FG000|Overall Study|Enrolled, but not treated|0|||
49071071|NCT05005312|158092613|FG001|Overall Study|Enrolled, but not treated|1|||
49071072|NCT00867503|158092615|FG000|Overall Study|Withdrawal by Subject|1|||
49071073|NCT02704403|158092616|FG000|Overall Study|Randomized and not treated (due to non-compliance with protocol)|4|||
49071074|NCT02704403|158092617|FG001|Overall Study|Randomized and not treated (due to non-compliance with protocol)|3|||
49071075|NCT02704403|158092616|FG000|Overall Study|Administrative reasons by sponsor|1251|||
49071076|NCT02704403|158092617|FG001|Overall Study|Administrative reasons by sponsor|616|||
49071077|NCT02704403|158092616|FG000|Overall Study|Death|4|||
49071078|NCT02704403|158092617|FG001|Overall Study|Death|3|||
49071079|NCT02704403|158092616|FG000|Overall Study|Endpoint event|52|||
49071080|NCT02704403|158092617|FG001|Overall Study|Endpoint event|24|||
49071081|NCT02704403|158092616|FG000|Overall Study|Lost to Follow-up|22|||
49071082|NCT02704403|158092617|FG001|Overall Study|Lost to Follow-up|11|||
49071083|NCT02704403|158092616|FG000|Overall Study|Protocol Violation|15|||
49071084|NCT02704403|158092617|FG001|Overall Study|Protocol Violation|15|||
49071085|NCT02704403|158092616|FG000|Overall Study|Adverse Event|2|||
49071086|NCT02704403|158092617|FG001|Overall Study|Adverse Event|0|||
49071087|NCT02704403|158092616|FG000|Overall Study|Withdrawal by Subject|85|||
49071088|NCT02704403|158092617|FG001|Overall Study|Withdrawal by Subject|45|||
49071089|NCT02704403|158092616|FG000|Overall Study|Investigator decision|1|||
49071090|NCT02704403|158092617|FG001|Overall Study|Investigator decision|1|||
49071091|NCT02704403|158092616|FG000|Overall Study|Follow-up not possible|1|||
49071092|NCT02704403|158092617|FG001|Overall Study|Follow-up not possible|2|||
49071093|NCT00851318|158092618|FG000|Overall Study|Withdrawal by Subject|7|||
49071094|NCT00851318|158092619|FG001|Overall Study|Withdrawal by Subject|1|||
49071095|NCT00851318|158092620|FG002|Overall Study|Withdrawal by Subject|5|||
49071096|NCT00851318|158092621|FG003|Overall Study|Withdrawal by Subject|3|||
49071097|NCT00851318|158092618|FG000|Overall Study|Adverse Event|13|||
49071098|NCT00851318|158092619|FG001|Overall Study|Adverse Event|2|||
49071099|NCT00851318|158092620|FG002|Overall Study|Adverse Event|9|||
49071100|NCT00851318|158092621|FG003|Overall Study|Adverse Event|12|||
49071101|NCT00851318|158092618|FG000|Overall Study|Pregnancy|0|||
49071102|NCT00851318|158092619|FG001|Overall Study|Pregnancy|0|||
49071103|NCT00851318|158092620|FG002|Overall Study|Pregnancy|1|||
49071104|NCT00851318|158092621|FG003|Overall Study|Pregnancy|1|||
49071105|NCT00851318|158092618|FG000|Overall Study|Lack of Efficacy|8|||
49071106|NCT00851318|158092619|FG001|Overall Study|Lack of Efficacy|2|||
49071107|NCT00851318|158092620|FG002|Overall Study|Lack of Efficacy|4|||
49071108|NCT00851318|158092621|FG003|Overall Study|Lack of Efficacy|2|||
49071109|NCT00851318|158092618|FG000|Overall Study|Non-compliance with Study Procedures|2|||
49071110|NCT00851318|158092619|FG001|Overall Study|Non-compliance with Study Procedures|0|||
49071111|NCT00851318|158092620|FG002|Overall Study|Non-compliance with Study Procedures|1|||
49071112|NCT00851318|158092621|FG003|Overall Study|Non-compliance with Study Procedures|0|||
49071113|NCT00851318|158092618|FG000|Overall Study|Physician Decision|0|||
49071114|NCT00851318|158092619|FG001|Overall Study|Physician Decision|0|||
49071115|NCT00851318|158092620|FG002|Overall Study|Physician Decision|1|||
49071116|NCT00851318|158092621|FG003|Overall Study|Physician Decision|1|||
49071117|NCT01844856|158092634|FG000|Overall Study|Lost to Follow-up|15|||
49071118|NCT01844856|158092635|FG001|Overall Study|Lost to Follow-up|3|||
49071119|NCT01844856|158092634|FG000|Overall Study|Adverse Event|3|||
49071120|NCT01844856|158092635|FG001|Overall Study|Adverse Event|6|||
49071121|NCT01844856|158092634|FG000|Overall Study|Withdrawal by Subject|3|||
49071122|NCT01844856|158092635|FG001|Overall Study|Withdrawal by Subject|2|||
49071123|NCT01844856|158092634|FG000|Overall Study|Noncompliance|2|||
49071124|NCT01844856|158092635|FG001|Overall Study|Noncompliance|3|||
49071125|NCT01844856|158092634|FG000|Overall Study|Enterococcus Resistant|0|||
49071126|NCT01844856|158092635|FG001|Overall Study|Enterococcus Resistant|1|||
49071127|NCT01844856|158092634|FG000|Overall Study|Inadvertently Not Scheduled|1|||
49071128|NCT01844856|158092635|FG001|Overall Study|Inadvertently Not Scheduled|0|||
49071129|NCT01844856|158092634|FG000|Overall Study|Randomized but was a Screen Failure|0|||
49071130|NCT01844856|158092635|FG001|Overall Study|Randomized but was a Screen Failure|1|||
49071131|NCT01001988|158092636|FG000|Overall Study|Protocol Violation|84|||
49071132|NCT01001988|158092636|FG000|Overall Study|Withdrawal by Subject|18|||
49071133|NCT01001988|158092636|FG000|Overall Study|Lost to Follow-up|15|||
49071134|NCT01442688|158092637|FG000|First Intervention|Withdrawal by Subject|1|||
49071135|NCT01442688|158092638|FG001|First Intervention|Withdrawal by Subject|0|||
49071136|NCT01442688|158092637|FG000|First Intervention|subject incarcerated|1|||
49071137|NCT01442688|158092638|FG001|First Intervention|subject incarcerated|0|||
49071138|NCT01442688|158092637|FG000|Second Intervention|Adverse Event|1|||
49071139|NCT01442688|158092638|FG001|Second Intervention|Adverse Event|0|||
49071140|NCT02677714|158092639|FG000|Overall Study|Withdrawal by Subject|2|||
49071141|NCT02677714|158092640|FG001|Overall Study|Withdrawal by Subject|0|||
49071142|NCT04628793|158092643|FG000|Overall Study|Study terminated by sponsor|0|||
49071143|NCT04628793|158092644|FG001|Overall Study|Study terminated by sponsor|0|||
49071144|NCT04628793|158092645|FG002|Overall Study|Study terminated by sponsor|8|||
49071145|NCT04628793|158092643|FG000|Overall Study|Withdrawal by Subject|2|||
49071146|NCT04628793|158092644|FG001|Overall Study|Withdrawal by Subject|3|||
49071147|NCT04628793|158092645|FG002|Overall Study|Withdrawal by Subject|0|||
49071148|NCT04628793|158092643|FG000|Overall Study|Lost to Follow-up|0|||
49071149|NCT04628793|158092644|FG001|Overall Study|Lost to Follow-up|1|||
49071150|NCT04628793|158092645|FG002|Overall Study|Lost to Follow-up|0|||
49071151|NCT01421511|158092646|FG000|Overall Study|Lost to Follow-up|11|||
49071152|NCT01421511|158092647|FG001|Overall Study|Lost to Follow-up|14|||
49071153|NCT01421511|158092646|FG000|Overall Study|Randomized but didn't receive study drug|1|||
49071154|NCT01421511|158092647|FG001|Overall Study|Randomized but didn't receive study drug|7|||
49071155|NCT01421511|158092646|FG000|Overall Study|Physician Decision|0|||
49071156|NCT01421511|158092647|FG001|Overall Study|Physician Decision|1|||
49071157|NCT01421511|158092646|FG000|Overall Study|Withdrawal by Subject|6|||
49071158|NCT01421511|158092647|FG001|Overall Study|Withdrawal by Subject|5|||
49071159|NCT01421511|158092646|FG000|Overall Study|Death|1|||
49071160|NCT01421511|158092647|FG001|Overall Study|Death|1|||
49071161|NCT01756079|158092648|FG000|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4|||
49071162|NCT01756079|158092648|FG000|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5|||
49071163|NCT01756079|158092648|FG000|Treatment / Follow-up: Week 4 to Week 72|No information available|2|||
49071164|NCT01756079|158092648|FG000|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20|||
49071165|NCT01756079|158092648|FG000|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4|||
49071166|NCT00106964|158092649|FG000|Overall Study|Lost to Follow-up|8|||
49071167|NCT00106964|158092650|FG001|Overall Study|Lost to Follow-up|6|||
49071168|NCT00106964|158092651|FG002|Overall Study|Lost to Follow-up|2|||
49071169|NCT00106964|158092649|FG000|Overall Study|Pregnancy|2|||
49071170|NCT00106964|158092650|FG001|Overall Study|Pregnancy|3|||
49071171|NCT00106964|158092651|FG002|Overall Study|Pregnancy|2|||
49071172|NCT00106964|158092649|FG000|Overall Study|Death|1|||
49071173|NCT00106964|158092650|FG001|Overall Study|Death|1|||
49071174|NCT00106964|158092651|FG002|Overall Study|Death|0|||
49071175|NCT00106964|158092649|FG000|Overall Study|Incarceration|0|||
49071176|NCT00106964|158092650|FG001|Overall Study|Incarceration|1|||
49071177|NCT00106964|158092651|FG002|Overall Study|Incarceration|0|||
49071178|NCT00106964|158092649|FG000|Overall Study|Site Funding Terminated|0|||
49071179|NCT00106964|158092650|FG001|Overall Study|Site Funding Terminated|1|||
49071180|NCT00106964|158092651|FG002|Overall Study|Site Funding Terminated|1|||
49071181|NCT00106964|158092649|FG000|Overall Study|Failure to adhere|2|||
49071182|NCT00106964|158092650|FG001|Overall Study|Failure to adhere|0|||
49071183|NCT00106964|158092651|FG002|Overall Study|Failure to adhere|0|||
49071184|NCT00106964|158092649|FG000|Overall Study|Did not meet eligibility criteria|0|||
49071185|NCT00106964|158092650|FG001|Overall Study|Did not meet eligibility criteria|2|||
49071186|NCT00106964|158092651|FG002|Overall Study|Did not meet eligibility criteria|2|||
49071187|NCT00106964|158092649|FG000|Overall Study|Required disallowed medication|0|||
49071188|NCT00106964|158092650|FG001|Overall Study|Required disallowed medication|1|||
49071189|NCT00106964|158092651|FG002|Overall Study|Required disallowed medication|0|||
49071190|NCT02181790|158092652|FG000|Overall Study|study terminated|2|||
49071191|NCT02181790|158092653|FG001|Overall Study|study terminated|0|||
49071192|NCT03276078|158092654|FG000|Overall Study|Adverse Event|1|||
49071193|NCT01210612|158092656|FG000|Overall Study|Withdrawal by Subject|0|||
49071194|NCT01210612|158092657|FG001|Overall Study|Withdrawal by Subject|2|||
49071195|NCT00206323|158092658|FG000|Overall Study|Lack of Efficacy|4|||
49071196|NCT00206323|158092659|FG001|Overall Study|Lack of Efficacy|1|||
49071197|NCT00206323|158092658|FG000|Overall Study|Adverse Event|1|||
49071198|NCT00206323|158092659|FG001|Overall Study|Adverse Event|1|||
49071199|NCT00206323|158092658|FG000|Overall Study|Lost to Follow-up|1|||
49071200|NCT00206323|158092659|FG001|Overall Study|Lost to Follow-up|1|||
49071201|NCT03477903|158092660|FG000|Overall Study|Study Terminated by Sponsor|1|||
49071202|NCT02552732|158092661|FG000|Overall Study|Lost to Follow-up|2|||
49071203|NCT02552732|158092661|FG000|Overall Study|Physician Decision|1|||
49071204|NCT02552732|158092661|FG000|Overall Study|Day 1 SpO2 > 96%|1|||
49071205|NCT02552732|158092661|FG000|Overall Study|Withdrawal by Subject|6|||
49071206|NCT01147107|158092662|FG000|Overall Study|Lack of Efficacy|5|||
49071207|NCT01147107|158092663|FG001|Overall Study|Lack of Efficacy|0|||
49071208|NCT01147107|158092662|FG000|Overall Study|Withdrawal by Subject|1|||
49071209|NCT01147107|158092663|FG001|Overall Study|Withdrawal by Subject|1|||
49071210|NCT02458287|158092665|FG000|Overall Study|Adverse Event|0|||
49071211|NCT02458287|158092666|FG001|Overall Study|Adverse Event|0|||
49071212|NCT02458287|158092667|FG002|Overall Study|Adverse Event|0|||
49071213|NCT02458287|158092668|FG003|Overall Study|Adverse Event|1|||
49071214|NCT02458287|158092665|FG000|Overall Study|Lost to Follow-up|0|||
49071215|NCT02458287|158092666|FG001|Overall Study|Lost to Follow-up|1|||
49071216|NCT02458287|158092667|FG002|Overall Study|Lost to Follow-up|1|||
49071217|NCT02458287|158092668|FG003|Overall Study|Lost to Follow-up|0|||
49071218|NCT02458287|158092665|FG000|Overall Study|Protocol Violation|0|||
49071219|NCT02458287|158092666|FG001|Overall Study|Protocol Violation|1|||
49071220|NCT02458287|158092667|FG002|Overall Study|Protocol Violation|0|||
49071221|NCT02458287|158092668|FG003|Overall Study|Protocol Violation|0|||
49071222|NCT02458287|158092665|FG000|Overall Study|Withdrawal by Subject|0|||
49071223|NCT02458287|158092666|FG001|Overall Study|Withdrawal by Subject|2|||
49071224|NCT02458287|158092667|FG002|Overall Study|Withdrawal by Subject|2|||
49071225|NCT02458287|158092668|FG003|Overall Study|Withdrawal by Subject|1|||
49071226|NCT02458287|158092665|FG000|Overall Study|Relocated Out of State|0|||
49071227|NCT02458287|158092666|FG001|Overall Study|Relocated Out of State|0|||
49071228|NCT02458287|158092667|FG002|Overall Study|Relocated Out of State|0|||
49071229|NCT02458287|158092668|FG003|Overall Study|Relocated Out of State|1|||
49071230|NCT02613182|158092669|FG000|Overall Study|Death|6|||
49071231|NCT02613182|158092669|FG000|Overall Study|Physician Decision|1|||
49071232|NCT02613182|158092669|FG000|Overall Study|Study Terminated by Sponsor|21|||
49071233|NCT02613182|158092669|FG000|Overall Study|Withdrawal by Subject|6|||
49071234|NCT01659151|158092673|FG000|Overall Study|Inadequate TIL growth|1|||
49071235|NCT03249792|158092679|FG000|Arms 1, 2, and 4|Death|1|||
49071236|NCT03249792|158092680|FG001|Arms 1, 2, and 4|Death|1|||
49071237|NCT03249792|158092681|FG002|Arms 1, 2, and 4|Death|0|||
49071238|NCT03249792|158092682|FG003|Arms 1, 2, and 4|Death|2|||
49071239|NCT03249792|158092683|FG004|Arms 1, 2, and 4|Death|3|||
49071240|NCT03249792|158092684|FG005|Arms 1, 2, and 4|Death|2|||
49071241|NCT03249792|158092685|FG006|Arms 1, 2, and 4|Death|2|||
49071242|NCT03249792|158092686|FG007|Arms 1, 2, and 4|Death|4|||
49071243|NCT03249792|158092687|FG008|Arms 1, 2, and 4|Death|2|||
49071244|NCT03249792|158092688|FG009|Arms 1, 2, and 4|Death|1|||
49071245|NCT03249792|158092689|FG010|Arms 1, 2, and 4|Death|7|||
49071246|NCT03249792|158092690|FG011|Arms 1, 2, and 4|Death|7|||
49071247|NCT03249792|158092691|FG012|Arms 1, 2, and 4|Death|12|||
49071248|NCT03249792|158092692|FG013|Arms 1, 2, and 4|Death|7|||
49071249|NCT03249792|158092693|FG014|Arms 1, 2, and 4|Death|0|||
49071250|NCT03249792|158092694|FG015|Arms 1, 2, and 4|Death|4|||
49071251|NCT03249792|158092695|FG016|Arms 1, 2, and 4|Death|4|||
49071252|NCT03249792|158092696|FG017|Arms 1, 2, and 4|Death|12|||
49071253|NCT03249792|158092697|FG018|Arms 1, 2, and 4|Death|6|||
49071254|NCT03249792|158092698|FG019|Arms 1, 2, and 4|Death|4|||
49071255|NCT03249792|158092699|FG020|Arms 1, 2, and 4|Death|2|||
49071256|NCT03249792|158092700|FG021|Arms 1, 2, and 4|Death|3|||
49071257|NCT03249792|158092701|FG022|Arms 1, 2, and 4|Death|1|||
49071258|NCT03249792|158092702|FG023|Arms 1, 2, and 4|Death|1|||
49071259|NCT03249792|158092703|FG024|Arms 1, 2, and 4|Death|4|||
49071260|NCT03249792|158092704|FG025|Arms 1, 2, and 4|Death|0|||
49071261|NCT03249792|158092705|FG026|Arms 1, 2, and 4|Death|0|||
49071262|NCT03249792|158092706|FG027|Arms 1, 2, and 4|Death|0|||
49071263|NCT03249792|158092707|FG028|Arms 1, 2, and 4|Death|0|||
49071264|NCT03249792|158092708|FG029|Arms 1, 2, and 4|Death|0|||
49071265|NCT03249792|158092709|FG030|Arms 1, 2, and 4|Death|0|||
49071266|NCT03249792|158092710|FG031|Arms 1, 2, and 4|Death|0|||
49071267|NCT03249792|158092711|FG032|Arms 1, 2, and 4|Death|0|||
49071268|NCT03249792|158092679|FG000|Arms 1, 2, and 4|Withdrawal by Subject|0|||
49071269|NCT03249792|158092680|FG001|Arms 1, 2, and 4|Withdrawal by Subject|0|||
49071270|NCT03249792|158092681|FG002|Arms 1, 2, and 4|Withdrawal by Subject|1|||
49071271|NCT03249792|158092682|FG003|Arms 1, 2, and 4|Withdrawal by Subject|0|||
49071272|NCT03249792|158092683|FG004|Arms 1, 2, and 4|Withdrawal by Subject|0|||
49071273|NCT03249792|158092684|FG005|Arms 1, 2, and 4|Withdrawal by Subject|1|||
49071274|NCT03249792|158092685|FG006|Arms 1, 2, and 4|Withdrawal by Subject|4|||
49071275|NCT03249792|158092686|FG007|Arms 1, 2, and 4|Withdrawal by Subject|0|||
49071276|NCT03249792|158092687|FG008|Arms 1, 2, and 4|Withdrawal by Subject|2|||
49071277|NCT03249792|158092688|FG009|Arms 1, 2, and 4|Withdrawal by Subject|1|||
49071278|NCT03249792|158092689|FG010|Arms 1, 2, and 4|Withdrawal by Subject|4|||
49071279|NCT03249792|158092690|FG011|Arms 1, 2, and 4|Withdrawal by Subject|3|||
49071280|NCT03249792|158092691|FG012|Arms 1, 2, and 4|Withdrawal by Subject|5|||
49071281|NCT03249792|158092692|FG013|Arms 1, 2, and 4|Withdrawal by Subject|3|||
49071282|NCT03249792|158092693|FG014|Arms 1, 2, and 4|Withdrawal by Subject|0|||
49071283|NCT03249792|158092694|FG015|Arms 1, 2, and 4|Withdrawal by Subject|0|||
49071284|NCT03249792|158092695|FG016|Arms 1, 2, and 4|Withdrawal by Subject|3|||
49071285|NCT03249792|158092696|FG017|Arms 1, 2, and 4|Withdrawal by Subject|0|||
49071286|NCT03249792|158092697|FG018|Arms 1, 2, and 4|Withdrawal by Subject|1|||
49071287|NCT03249792|158092698|FG019|Arms 1, 2, and 4|Withdrawal by Subject|0|||
49071288|NCT03249792|158092699|FG020|Arms 1, 2, and 4|Withdrawal by Subject|0|||
49071289|NCT03249792|158092700|FG021|Arms 1, 2, and 4|Withdrawal by Subject|0|||
49071290|NCT03249792|158092701|FG022|Arms 1, 2, and 4|Withdrawal by Subject|1|||
49071291|NCT03249792|158092702|FG023|Arms 1, 2, and 4|Withdrawal by Subject|1|||
49071292|NCT03249792|158092703|FG024|Arms 1, 2, and 4|Withdrawal by Subject|0|||
49071293|NCT03249792|158092704|FG025|Arms 1, 2, and 4|Withdrawal by Subject|0|||
49071294|NCT03249792|158092705|FG026|Arms 1, 2, and 4|Withdrawal by Subject|0|||
49071295|NCT03249792|158092706|FG027|Arms 1, 2, and 4|Withdrawal by Subject|0|||
49071296|NCT03249792|158092707|FG028|Arms 1, 2, and 4|Withdrawal by Subject|0|||
49071297|NCT03249792|158092708|FG029|Arms 1, 2, and 4|Withdrawal by Subject|0|||
49071298|NCT03249792|158092709|FG030|Arms 1, 2, and 4|Withdrawal by Subject|0|||
49071299|NCT03249792|158092710|FG031|Arms 1, 2, and 4|Withdrawal by Subject|0|||
49071300|NCT03249792|158092711|FG032|Arms 1, 2, and 4|Withdrawal by Subject|0|||
49071301|NCT03249792|158092679|FG000|Arms 1, 2, and 4|Sponsor Decision|0|||
49071302|NCT03249792|158092680|FG001|Arms 1, 2, and 4|Sponsor Decision|0|||
49071303|NCT03249792|158092681|FG002|Arms 1, 2, and 4|Sponsor Decision|0|||
49071304|NCT03249792|158092682|FG003|Arms 1, 2, and 4|Sponsor Decision|0|||
49071305|NCT03249792|158092683|FG004|Arms 1, 2, and 4|Sponsor Decision|0|||
49071306|NCT03249792|158092684|FG005|Arms 1, 2, and 4|Sponsor Decision|0|||
49071307|NCT03249792|158092685|FG006|Arms 1, 2, and 4|Sponsor Decision|0|||
49071308|NCT03249792|158092686|FG007|Arms 1, 2, and 4|Sponsor Decision|0|||
49071309|NCT03249792|158092687|FG008|Arms 1, 2, and 4|Sponsor Decision|1|||
49071310|NCT03249792|158092688|FG009|Arms 1, 2, and 4|Sponsor Decision|0|||
49071311|NCT03249792|158092689|FG010|Arms 1, 2, and 4|Sponsor Decision|2|||
49071312|NCT03249792|158092690|FG011|Arms 1, 2, and 4|Sponsor Decision|1|||
49071313|NCT03249792|158092691|FG012|Arms 1, 2, and 4|Sponsor Decision|1|||
49071314|NCT03249792|158092692|FG013|Arms 1, 2, and 4|Sponsor Decision|3|||
49071315|NCT03249792|158092693|FG014|Arms 1, 2, and 4|Sponsor Decision|0|||
49071316|NCT03249792|158092694|FG015|Arms 1, 2, and 4|Sponsor Decision|0|||
49071317|NCT03249792|158092695|FG016|Arms 1, 2, and 4|Sponsor Decision|0|||
49071318|NCT03249792|158092696|FG017|Arms 1, 2, and 4|Sponsor Decision|0|||
49071319|NCT03249792|158092697|FG018|Arms 1, 2, and 4|Sponsor Decision|0|||
49071320|NCT03249792|158092698|FG019|Arms 1, 2, and 4|Sponsor Decision|1|||
49071321|NCT03249792|158092699|FG020|Arms 1, 2, and 4|Sponsor Decision|1|||
49071322|NCT03249792|158092700|FG021|Arms 1, 2, and 4|Sponsor Decision|0|||
49071323|NCT03249792|158092701|FG022|Arms 1, 2, and 4|Sponsor Decision|1|||
49071324|NCT03249792|158092702|FG023|Arms 1, 2, and 4|Sponsor Decision|2|||
49071325|NCT03249792|158092703|FG024|Arms 1, 2, and 4|Sponsor Decision|0|||
49071326|NCT03249792|158092704|FG025|Arms 1, 2, and 4|Sponsor Decision|0|||
49071327|NCT03249792|158092705|FG026|Arms 1, 2, and 4|Sponsor Decision|0|||
49071328|NCT03249792|158092706|FG027|Arms 1, 2, and 4|Sponsor Decision|0|||
49071329|NCT03249792|158092707|FG028|Arms 1, 2, and 4|Sponsor Decision|0|||
49071330|NCT03249792|158092708|FG029|Arms 1, 2, and 4|Sponsor Decision|0|||
49071331|NCT03249792|158092709|FG030|Arms 1, 2, and 4|Sponsor Decision|0|||
49071332|NCT03249792|158092710|FG031|Arms 1, 2, and 4|Sponsor Decision|0|||
49071333|NCT03249792|158092711|FG032|Arms 1, 2, and 4|Sponsor Decision|0|||
49071334|NCT03249792|158092679|FG000|Arms 1, 2, and 4|Lost to Follow-up|0|||
49071335|NCT03249792|158092680|FG001|Arms 1, 2, and 4|Lost to Follow-up|0|||
49071336|NCT03249792|158092681|FG002|Arms 1, 2, and 4|Lost to Follow-up|0|||
49071337|NCT03249792|158092682|FG003|Arms 1, 2, and 4|Lost to Follow-up|0|||
49071338|NCT03249792|158092683|FG004|Arms 1, 2, and 4|Lost to Follow-up|0|||
49071339|NCT03249792|158092684|FG005|Arms 1, 2, and 4|Lost to Follow-up|0|||
49071340|NCT03249792|158092685|FG006|Arms 1, 2, and 4|Lost to Follow-up|0|||
49071341|NCT03249792|158092686|FG007|Arms 1, 2, and 4|Lost to Follow-up|0|||
49071342|NCT03249792|158092687|FG008|Arms 1, 2, and 4|Lost to Follow-up|1|||
49071343|NCT03249792|158092688|FG009|Arms 1, 2, and 4|Lost to Follow-up|0|||
49071344|NCT03249792|158092689|FG010|Arms 1, 2, and 4|Lost to Follow-up|0|||
49071345|NCT03249792|158092690|FG011|Arms 1, 2, and 4|Lost to Follow-up|0|||
49071346|NCT03249792|158092691|FG012|Arms 1, 2, and 4|Lost to Follow-up|0|||
49071347|NCT03249792|158092692|FG013|Arms 1, 2, and 4|Lost to Follow-up|0|||
49071348|NCT03249792|158092693|FG014|Arms 1, 2, and 4|Lost to Follow-up|0|||
49071349|NCT03249792|158092694|FG015|Arms 1, 2, and 4|Lost to Follow-up|0|||
49071350|NCT03249792|158092695|FG016|Arms 1, 2, and 4|Lost to Follow-up|1|||
49071351|NCT03249792|158092696|FG017|Arms 1, 2, and 4|Lost to Follow-up|2|||
49071352|NCT03249792|158092697|FG018|Arms 1, 2, and 4|Lost to Follow-up|0|||
49071353|NCT03249792|158092698|FG019|Arms 1, 2, and 4|Lost to Follow-up|1|||
49071354|NCT03249792|158092699|FG020|Arms 1, 2, and 4|Lost to Follow-up|0|||
49071355|NCT03249792|158092700|FG021|Arms 1, 2, and 4|Lost to Follow-up|0|||
49071356|NCT03249792|158092701|FG022|Arms 1, 2, and 4|Lost to Follow-up|0|||
49071357|NCT03249792|158092702|FG023|Arms 1, 2, and 4|Lost to Follow-up|0|||
49071358|NCT03249792|158092703|FG024|Arms 1, 2, and 4|Lost to Follow-up|0|||
49071359|NCT03249792|158092704|FG025|Arms 1, 2, and 4|Lost to Follow-up|0|||
49071360|NCT03249792|158092705|FG026|Arms 1, 2, and 4|Lost to Follow-up|0|||
49071361|NCT03249792|158092706|FG027|Arms 1, 2, and 4|Lost to Follow-up|0|||
49071362|NCT03249792|158092707|FG028|Arms 1, 2, and 4|Lost to Follow-up|0|||
49071363|NCT03249792|158092708|FG029|Arms 1, 2, and 4|Lost to Follow-up|0|||
49071364|NCT03249792|158092709|FG030|Arms 1, 2, and 4|Lost to Follow-up|0|||
49071365|NCT03249792|158092710|FG031|Arms 1, 2, and 4|Lost to Follow-up|0|||
49071366|NCT03249792|158092711|FG032|Arms 1, 2, and 4|Lost to Follow-up|0|||
49071367|NCT03249792|158092679|FG000|Switch Over Period|Withdrawal by Subject|0|||
49071368|NCT03249792|158092680|FG001|Switch Over Period|Withdrawal by Subject|0|||
49071369|NCT03249792|158092681|FG002|Switch Over Period|Withdrawal by Subject|0|||
49071370|NCT03249792|158092682|FG003|Switch Over Period|Withdrawal by Subject|0|||
49071371|NCT03249792|158092683|FG004|Switch Over Period|Withdrawal by Subject|0|||
49071372|NCT03249792|158092684|FG005|Switch Over Period|Withdrawal by Subject|0|||
49071373|NCT03249792|158092685|FG006|Switch Over Period|Withdrawal by Subject|0|||
49071374|NCT03249792|158092686|FG007|Switch Over Period|Withdrawal by Subject|0|||
49071375|NCT03249792|158092687|FG008|Switch Over Period|Withdrawal by Subject|0|||
49071376|NCT03249792|158092688|FG009|Switch Over Period|Withdrawal by Subject|0|||
49071377|NCT03249792|158092689|FG010|Switch Over Period|Withdrawal by Subject|0|||
49071378|NCT03249792|158092690|FG011|Switch Over Period|Withdrawal by Subject|0|||
49071379|NCT03249792|158092691|FG012|Switch Over Period|Withdrawal by Subject|0|||
49071380|NCT03249792|158092692|FG013|Switch Over Period|Withdrawal by Subject|0|||
49071381|NCT03249792|158092693|FG014|Switch Over Period|Withdrawal by Subject|0|||
49071382|NCT03249792|158092694|FG015|Switch Over Period|Withdrawal by Subject|0|||
49071383|NCT03249792|158092695|FG016|Switch Over Period|Withdrawal by Subject|0|||
49071384|NCT03249792|158092696|FG017|Switch Over Period|Withdrawal by Subject|0|||
49071385|NCT03249792|158092697|FG018|Switch Over Period|Withdrawal by Subject|0|||
49071386|NCT03249792|158092698|FG019|Switch Over Period|Withdrawal by Subject|0|||
49071387|NCT03249792|158092699|FG020|Switch Over Period|Withdrawal by Subject|0|||
49071388|NCT03249792|158092700|FG021|Switch Over Period|Withdrawal by Subject|0|||
49071389|NCT03249792|158092701|FG022|Switch Over Period|Withdrawal by Subject|0|||
49071390|NCT03249792|158092702|FG023|Switch Over Period|Withdrawal by Subject|0|||
49071391|NCT03249792|158092703|FG024|Switch Over Period|Withdrawal by Subject|0|||
49071392|NCT03249792|158092704|FG025|Switch Over Period|Withdrawal by Subject|0|||
49071393|NCT03249792|158092705|FG026|Switch Over Period|Withdrawal by Subject|0|||
49071394|NCT03249792|158092706|FG027|Switch Over Period|Withdrawal by Subject|0|||
49071395|NCT03249792|158092707|FG028|Switch Over Period|Withdrawal by Subject|0|||
49071396|NCT03249792|158092708|FG029|Switch Over Period|Withdrawal by Subject|0|||
49071397|NCT03249792|158092709|FG030|Switch Over Period|Withdrawal by Subject|0|||
49071398|NCT03249792|158092710|FG031|Switch Over Period|Withdrawal by Subject|1|||
49071399|NCT03249792|158092711|FG032|Switch Over Period|Withdrawal by Subject|0|||
49071400|NCT03249792|158092679|FG000|Switch Over Period|Progressive Disease|0|||
49071401|NCT03249792|158092680|FG001|Switch Over Period|Progressive Disease|0|||
49071402|NCT03249792|158092681|FG002|Switch Over Period|Progressive Disease|0|||
49071403|NCT03249792|158092682|FG003|Switch Over Period|Progressive Disease|0|||
49071404|NCT03249792|158092683|FG004|Switch Over Period|Progressive Disease|0|||
49071405|NCT03249792|158092684|FG005|Switch Over Period|Progressive Disease|0|||
49071406|NCT03249792|158092685|FG006|Switch Over Period|Progressive Disease|0|||
49071407|NCT03249792|158092686|FG007|Switch Over Period|Progressive Disease|0|||
49071408|NCT03249792|158092687|FG008|Switch Over Period|Progressive Disease|0|||
49071409|NCT03249792|158092688|FG009|Switch Over Period|Progressive Disease|0|||
49071410|NCT03249792|158092689|FG010|Switch Over Period|Progressive Disease|0|||
49071411|NCT03249792|158092690|FG011|Switch Over Period|Progressive Disease|0|||
49071412|NCT03249792|158092691|FG012|Switch Over Period|Progressive Disease|0|||
49071413|NCT03249792|158092692|FG013|Switch Over Period|Progressive Disease|0|||
49071414|NCT03249792|158092693|FG014|Switch Over Period|Progressive Disease|0|||
49071415|NCT03249792|158092694|FG015|Switch Over Period|Progressive Disease|0|||
49071416|NCT03249792|158092695|FG016|Switch Over Period|Progressive Disease|0|||
49071417|NCT03249792|158092696|FG017|Switch Over Period|Progressive Disease|0|||
49071418|NCT03249792|158092697|FG018|Switch Over Period|Progressive Disease|0|||
49071419|NCT03249792|158092698|FG019|Switch Over Period|Progressive Disease|0|||
49071420|NCT03249792|158092699|FG020|Switch Over Period|Progressive Disease|0|||
49071421|NCT03249792|158092700|FG021|Switch Over Period|Progressive Disease|0|||
49071422|NCT03249792|158092701|FG022|Switch Over Period|Progressive Disease|0|||
49071423|NCT03249792|158092702|FG023|Switch Over Period|Progressive Disease|0|||
49071424|NCT03249792|158092703|FG024|Switch Over Period|Progressive Disease|0|||
49071425|NCT03249792|158092704|FG025|Switch Over Period|Progressive Disease|0|||
49071426|NCT03249792|158092705|FG026|Switch Over Period|Progressive Disease|1|||
49071427|NCT03249792|158092706|FG027|Switch Over Period|Progressive Disease|0|||
49071428|NCT03249792|158092707|FG028|Switch Over Period|Progressive Disease|1|||
49071429|NCT03249792|158092708|FG029|Switch Over Period|Progressive Disease|2|||
49071430|NCT03249792|158092709|FG030|Switch Over Period|Progressive Disease|1|||
49071431|NCT03249792|158092710|FG031|Switch Over Period|Progressive Disease|0|||
49071432|NCT03249792|158092711|FG032|Switch Over Period|Progressive Disease|1|||
49071433|NCT03249792|158092679|FG000|Switch Over Period|Adverse Event|0|||
49071434|NCT03249792|158092680|FG001|Switch Over Period|Adverse Event|0|||
49071435|NCT03249792|158092681|FG002|Switch Over Period|Adverse Event|0|||
49071436|NCT03249792|158092682|FG003|Switch Over Period|Adverse Event|0|||
49071437|NCT03249792|158092683|FG004|Switch Over Period|Adverse Event|0|||
49071438|NCT03249792|158092684|FG005|Switch Over Period|Adverse Event|0|||
49071439|NCT03249792|158092685|FG006|Switch Over Period|Adverse Event|0|||
49071440|NCT03249792|158092686|FG007|Switch Over Period|Adverse Event|0|||
49071441|NCT03249792|158092687|FG008|Switch Over Period|Adverse Event|0|||
49071442|NCT03249792|158092688|FG009|Switch Over Period|Adverse Event|0|||
49071443|NCT03249792|158092689|FG010|Switch Over Period|Adverse Event|0|||
49071444|NCT03249792|158092690|FG011|Switch Over Period|Adverse Event|0|||
49071445|NCT03249792|158092691|FG012|Switch Over Period|Adverse Event|0|||
49071446|NCT03249792|158092692|FG013|Switch Over Period|Adverse Event|0|||
49071447|NCT03249792|158092693|FG014|Switch Over Period|Adverse Event|0|||
49071448|NCT03249792|158092694|FG015|Switch Over Period|Adverse Event|0|||
49071449|NCT03249792|158092695|FG016|Switch Over Period|Adverse Event|0|||
49071450|NCT03249792|158092696|FG017|Switch Over Period|Adverse Event|0|||
49071451|NCT03249792|158092697|FG018|Switch Over Period|Adverse Event|0|||
49071452|NCT03249792|158092698|FG019|Switch Over Period|Adverse Event|0|||
49071453|NCT03249792|158092699|FG020|Switch Over Period|Adverse Event|0|||
49071454|NCT03249792|158092700|FG021|Switch Over Period|Adverse Event|0|||
49071455|NCT03249792|158092701|FG022|Switch Over Period|Adverse Event|0|||
49071456|NCT03249792|158092702|FG023|Switch Over Period|Adverse Event|0|||
49071457|NCT03249792|158092703|FG024|Switch Over Period|Adverse Event|0|||
49071458|NCT03249792|158092704|FG025|Switch Over Period|Adverse Event|1|||
49071459|NCT03249792|158092705|FG026|Switch Over Period|Adverse Event|0|||
49071460|NCT03249792|158092706|FG027|Switch Over Period|Adverse Event|1|||
49071461|NCT03249792|158092707|FG028|Switch Over Period|Adverse Event|0|||
49071462|NCT03249792|158092708|FG029|Switch Over Period|Adverse Event|0|||
49071463|NCT03249792|158092709|FG030|Switch Over Period|Adverse Event|0|||
49071464|NCT03249792|158092710|FG031|Switch Over Period|Adverse Event|0|||
49071465|NCT03249792|158092711|FG032|Switch Over Period|Adverse Event|0|||
49071466|NCT01499368|158092712|FG000|Overall Study|Did not meet I/E criteria|8|||
49071467|NCT01499368|158092713|FG001|Overall Study|Did not meet I/E criteria|4|||
49071468|NCT01499368|158092714|FG002|Overall Study|Did not meet I/E criteria|4|||
49071469|NCT01499368|158092712|FG000|Overall Study|Prohibited Concomitant medication|1|||
49071470|NCT01499368|158092713|FG001|Overall Study|Prohibited Concomitant medication|1|||
49071471|NCT01499368|158092714|FG002|Overall Study|Prohibited Concomitant medication|0|||
49071472|NCT01499368|158092712|FG000|Overall Study|Withdrawal by Subject|11|||
49071473|NCT01499368|158092713|FG001|Overall Study|Withdrawal by Subject|10|||
49071474|NCT01499368|158092714|FG002|Overall Study|Withdrawal by Subject|8|||
49071475|NCT01499368|158092712|FG000|Overall Study|Lost to Follow-up|3|||
49071476|NCT01499368|158092713|FG001|Overall Study|Lost to Follow-up|2|||
49071477|NCT01499368|158092714|FG002|Overall Study|Lost to Follow-up|5|||
49071478|NCT01499368|158092712|FG000|Overall Study|Adverse Event|4|||
49071479|NCT01499368|158092713|FG001|Overall Study|Adverse Event|0|||
49071480|NCT01499368|158092714|FG002|Overall Study|Adverse Event|2|||
49071481|NCT01499368|158092712|FG000|Overall Study|Physician Decision|0|||
49071482|NCT01499368|158092713|FG001|Overall Study|Physician Decision|1|||
49071483|NCT01499368|158092714|FG002|Overall Study|Physician Decision|0|||
49071484|NCT01499368|158092712|FG000|Overall Study|Deviation from visit window|0|||
49071485|NCT01499368|158092713|FG001|Overall Study|Deviation from visit window|0|||
49071486|NCT01499368|158092714|FG002|Overall Study|Deviation from visit window|1|||
49071487|NCT01499368|158092712|FG000|Overall Study|Error of Prescriptions|0|||
49071488|NCT01499368|158092713|FG001|Overall Study|Error of Prescriptions|0|||
49071489|NCT01499368|158092714|FG002|Overall Study|Error of Prescriptions|1|||
49071490|NCT00952731|158092715|FG000|Overall Study|Drug supply expired|1|||
49071491|NCT00952731|158092716|FG001|Overall Study|Drug supply expired|0|||
49071492|NCT02203331|158092720|FG000|Overall Study|Pregnancy|1|||
49071493|NCT02203331|158092721|FG001|Overall Study|Pregnancy|0|||
49071494|NCT02203331|158092722|FG002|Overall Study|Pregnancy|0|||
49071495|NCT02203331|158092723|FG003|Overall Study|Pregnancy|0|||
49071496|NCT02203331|158092724|FG004|Overall Study|Pregnancy|2|||
49071497|NCT02203331|158092725|FG005|Overall Study|Pregnancy|0|||
49071498|NCT02203331|158092720|FG000|Overall Study|Withdrawal by Subject|1|||
49071499|NCT02203331|158092721|FG001|Overall Study|Withdrawal by Subject|0|||
49071500|NCT02203331|158092722|FG002|Overall Study|Withdrawal by Subject|1|||
49071501|NCT02203331|158092723|FG003|Overall Study|Withdrawal by Subject|0|||
49071502|NCT02203331|158092724|FG004|Overall Study|Withdrawal by Subject|0|||
49071503|NCT02203331|158092725|FG005|Overall Study|Withdrawal by Subject|3|||
49071504|NCT02203331|158092720|FG000|Overall Study|Adverse Event|4|||
49071505|NCT02203331|158092721|FG001|Overall Study|Adverse Event|8|||
49071506|NCT02203331|158092722|FG002|Overall Study|Adverse Event|3|||
49071507|NCT02203331|158092723|FG003|Overall Study|Adverse Event|4|||
49071508|NCT02203331|158092724|FG004|Overall Study|Adverse Event|3|||
49071509|NCT02203331|158092725|FG005|Overall Study|Adverse Event|3|||
49071510|NCT02203331|158092720|FG000|Overall Study|Other Reasons|1|||
49071511|NCT02203331|158092721|FG001|Overall Study|Other Reasons|2|||
49071512|NCT02203331|158092722|FG002|Overall Study|Other Reasons|0|||
49071513|NCT02203331|158092723|FG003|Overall Study|Other Reasons|2|||
49071514|NCT02203331|158092724|FG004|Overall Study|Other Reasons|0|||
49071515|NCT02203331|158092725|FG005|Overall Study|Other Reasons|0|||
49071516|NCT02203331|158092720|FG000|Overall Study|Lack of Efficacy|0|||
49071517|NCT02203331|158092721|FG001|Overall Study|Lack of Efficacy|2|||
49071518|NCT02203331|158092722|FG002|Overall Study|Lack of Efficacy|1|||
49071519|NCT02203331|158092723|FG003|Overall Study|Lack of Efficacy|0|||
49071520|NCT02203331|158092724|FG004|Overall Study|Lack of Efficacy|0|||
49071521|NCT02203331|158092725|FG005|Overall Study|Lack of Efficacy|1|||
49071522|NCT02203331|158092720|FG000|Overall Study|Protocol Violation|0|||
49071523|NCT02203331|158092721|FG001|Overall Study|Protocol Violation|2|||
49071524|NCT02203331|158092722|FG002|Overall Study|Protocol Violation|0|||
49071525|NCT02203331|158092723|FG003|Overall Study|Protocol Violation|1|||
49071526|NCT02203331|158092724|FG004|Overall Study|Protocol Violation|1|||
49071527|NCT02203331|158092725|FG005|Overall Study|Protocol Violation|0|||
49071528|NCT02203331|158092720|FG000|Overall Study|Lost to Follow-up|0|||
49071529|NCT02203331|158092721|FG001|Overall Study|Lost to Follow-up|0|||
49071530|NCT02203331|158092722|FG002|Overall Study|Lost to Follow-up|0|||
49071531|NCT02203331|158092723|FG003|Overall Study|Lost to Follow-up|0|||
49071532|NCT02203331|158092724|FG004|Overall Study|Lost to Follow-up|1|||
49071533|NCT02203331|158092725|FG005|Overall Study|Lost to Follow-up|0|||
49071534|NCT03017612|158092726|FG000|Overall Study|Adverse Event|2|||
49071535|NCT01320150|158092732|FG000|Overall Study|Protocol Violation|15|||
49071536|NCT01320150|158092732|FG000|Overall Study|Withdrawal by Subject|5|||
49071537|NCT01320150|158092732|FG000|Overall Study|Death|2|||
49071538|NCT01320150|158092732|FG000|Overall Study|Lost to Follow-up|44|||
49071539|NCT03597464|158092735|FG000|Overall Study|Withdrawal by Subject|4|||
49071540|NCT03597464|158092736|FG001|Overall Study|Withdrawal by Subject|5|||
49071541|NCT03597464|158092735|FG000|Overall Study|Lost to Follow-up|3|||
49071542|NCT03597464|158092736|FG001|Overall Study|Lost to Follow-up|1|||
49071543|NCT03597464|158092735|FG000|Overall Study|Pregnancy|3|||
49071544|NCT03597464|158092736|FG001|Overall Study|Pregnancy|1|||
49071545|NCT03597464|158092735|FG000|Overall Study|Lack of Efficacy|2|||
49071546|NCT03597464|158092736|FG001|Overall Study|Lack of Efficacy|0|||
49071547|NCT03597464|158092735|FG000|Overall Study|Physician Decision|2|||
49071548|NCT03597464|158092736|FG001|Overall Study|Physician Decision|2|||
49071549|NCT03597464|158092735|FG000|Overall Study|Protocol Violation|1|||
49071550|NCT03597464|158092736|FG001|Overall Study|Protocol Violation|1|||
49071551|NCT03597464|158092735|FG000|Overall Study|Adverse Event|0|||
49071552|NCT03597464|158092736|FG001|Overall Study|Adverse Event|2|||
49071553|NCT03597464|158092735|FG000|Overall Study|Death|0|||
49071554|NCT03597464|158092736|FG001|Overall Study|Death|3|||
49071555|NCT00338728|158092737|FG000|Overall Study|Screen Failure|14|||
49071556|NCT03092674|158092742|FG000|Overall Study|Adverse Event or Side Effects|1|||
49071557|NCT03092674|158092743|FG001|Overall Study|Adverse Event or Side Effects|4|||
49071558|NCT03092674|158092744|FG002|Overall Study|Adverse Event or Side Effects|4|||
49071559|NCT03092674|158092742|FG000|Overall Study|Refusal Unrelated to Adverse Event|5|||
49071560|NCT03092674|158092743|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
49071561|NCT03092674|158092744|FG002|Overall Study|Refusal Unrelated to Adverse Event|3|||
49071562|NCT03092674|158092742|FG000|Overall Study|Progression/Relapse|5|||
49071563|NCT03092674|158092743|FG001|Overall Study|Progression/Relapse|4|||
49071564|NCT03092674|158092744|FG002|Overall Study|Progression/Relapse|8|||
49071565|NCT03092674|158092742|FG000|Overall Study|Death|4|||
49071566|NCT03092674|158092743|FG001|Overall Study|Death|8|||
49071567|NCT03092674|158092744|FG002|Overall Study|Death|2|||
49071568|NCT03092674|158092742|FG000|Overall Study|Other - Not Protocol Specified|11|||
49071569|NCT03092674|158092743|FG001|Overall Study|Other - Not Protocol Specified|8|||
49071570|NCT03092674|158092744|FG002|Overall Study|Other - Not Protocol Specified|8|||
49071571|NCT04895982|158092745|FG000|Overall Study|Withdrawal by Subject|0|||
49071572|NCT04895982|158092746|FG001|Overall Study|Withdrawal by Subject|0|||
49071573|NCT04895982|158092747|FG002|Overall Study|Withdrawal by Subject|0|||
49071574|NCT04895982|158092748|FG003|Overall Study|Withdrawal by Subject|0|||
49071575|NCT04895982|158092749|FG004|Overall Study|Withdrawal by Subject|0|||
49071576|NCT04895982|158092750|FG005|Overall Study|Withdrawal by Subject|1|||
49071577|NCT04895982|158092751|FG006|Overall Study|Withdrawal by Subject|1|||
49071578|NCT04895982|158092752|FG007|Overall Study|Withdrawal by Subject|0|||
49071579|NCT04895982|158092753|FG008|Overall Study|Withdrawal by Subject|0|||
49071580|NCT04895982|158092754|FG009|Overall Study|Withdrawal by Subject|1|||
49071581|NCT04895982|158092755|FG010|Overall Study|Withdrawal by Subject|0|||
49071582|NCT04895982|158092756|FG011|Overall Study|Withdrawal by Subject|1|||
49071583|NCT04895982|158092745|FG000|Overall Study|Withdrawal by parent/guardian|2|||
49071584|NCT04895982|158092746|FG001|Overall Study|Withdrawal by parent/guardian|3|||
49071585|NCT04895982|158092747|FG002|Overall Study|Withdrawal by parent/guardian|3|||
49071586|NCT04895982|158092748|FG003|Overall Study|Withdrawal by parent/guardian|1|||
49071587|NCT04895982|158092749|FG004|Overall Study|Withdrawal by parent/guardian|3|||
49071588|NCT04895982|158092750|FG005|Overall Study|Withdrawal by parent/guardian|2|||
49071589|NCT04895982|158092751|FG006|Overall Study|Withdrawal by parent/guardian|1|||
49071590|NCT04895982|158092752|FG007|Overall Study|Withdrawal by parent/guardian|0|||
49071591|NCT04895982|158092753|FG008|Overall Study|Withdrawal by parent/guardian|3|||
49071592|NCT04895982|158092754|FG009|Overall Study|Withdrawal by parent/guardian|0|||
49071593|NCT04895982|158092755|FG010|Overall Study|Withdrawal by parent/guardian|0|||
49071594|NCT04895982|158092756|FG011|Overall Study|Withdrawal by parent/guardian|0|||
49071595|NCT04895982|158092745|FG000|Overall Study|Other|0|||
49071596|NCT04895982|158092746|FG001|Overall Study|Other|0|||
49071597|NCT04895982|158092747|FG002|Overall Study|Other|1|||
49071598|NCT04895982|158092748|FG003|Overall Study|Other|1|||
49071599|NCT04895982|158092749|FG004|Overall Study|Other|0|||
49071600|NCT04895982|158092750|FG005|Overall Study|Other|0|||
49071601|NCT04895982|158092751|FG006|Overall Study|Other|0|||
49071602|NCT04895982|158092752|FG007|Overall Study|Other|0|||
49071603|NCT04895982|158092753|FG008|Overall Study|Other|0|||
49071604|NCT04895982|158092754|FG009|Overall Study|Other|1|||
49071605|NCT04895982|158092755|FG010|Overall Study|Other|0|||
49071606|NCT04895982|158092756|FG011|Overall Study|Other|0|||
49071607|NCT04895982|158092745|FG000|Overall Study|Protocol Violation|0|||
49071608|NCT04895982|158092746|FG001|Overall Study|Protocol Violation|0|||
49071609|NCT04895982|158092747|FG002|Overall Study|Protocol Violation|1|||
49071610|NCT04895982|158092748|FG003|Overall Study|Protocol Violation|1|||
49071611|NCT04895982|158092749|FG004|Overall Study|Protocol Violation|1|||
49071612|NCT04895982|158092750|FG005|Overall Study|Protocol Violation|0|||
49071613|NCT04895982|158092751|FG006|Overall Study|Protocol Violation|0|||
49071614|NCT04895982|158092752|FG007|Overall Study|Protocol Violation|1|||
49071615|NCT04895982|158092753|FG008|Overall Study|Protocol Violation|0|||
49071616|NCT04895982|158092754|FG009|Overall Study|Protocol Violation|0|||
49071617|NCT04895982|158092755|FG010|Overall Study|Protocol Violation|0|||
49071618|NCT04895982|158092756|FG011|Overall Study|Protocol Violation|0|||
49071619|NCT04895982|158092745|FG000|Overall Study|Lost to Follow-up|0|||
49071620|NCT04895982|158092746|FG001|Overall Study|Lost to Follow-up|0|||
49071621|NCT04895982|158092747|FG002|Overall Study|Lost to Follow-up|1|||
49071622|NCT04895982|158092748|FG003|Overall Study|Lost to Follow-up|0|||
49071623|NCT04895982|158092749|FG004|Overall Study|Lost to Follow-up|0|||
49071624|NCT04895982|158092750|FG005|Overall Study|Lost to Follow-up|1|||
49071625|NCT04895982|158092751|FG006|Overall Study|Lost to Follow-up|0|||
49071626|NCT04895982|158092752|FG007|Overall Study|Lost to Follow-up|0|||
49071627|NCT04895982|158092753|FG008|Overall Study|Lost to Follow-up|1|||
49071628|NCT04895982|158092754|FG009|Overall Study|Lost to Follow-up|0|||
49071629|NCT04895982|158092755|FG010|Overall Study|Lost to Follow-up|0|||
49071630|NCT04895982|158092756|FG011|Overall Study|Lost to Follow-up|0|||
49071631|NCT04895982|158092745|FG000|Overall Study|Refused further study procedures|0|||
49071632|NCT04895982|158092746|FG001|Overall Study|Refused further study procedures|0|||
49071633|NCT04895982|158092747|FG002|Overall Study|Refused further study procedures|1|||
49071634|NCT04895982|158092748|FG003|Overall Study|Refused further study procedures|0|||
49071635|NCT04895982|158092749|FG004|Overall Study|Refused further study procedures|0|||
49071636|NCT04895982|158092750|FG005|Overall Study|Refused further study procedures|0|||
49071637|NCT04895982|158092751|FG006|Overall Study|Refused further study procedures|0|||
49071638|NCT04895982|158092752|FG007|Overall Study|Refused further study procedures|0|||
49071639|NCT04895982|158092753|FG008|Overall Study|Refused further study procedures|0|||
49071640|NCT04895982|158092754|FG009|Overall Study|Refused further study procedures|0|||
49071641|NCT04895982|158092755|FG010|Overall Study|Refused further study procedures|0|||
49071642|NCT04895982|158092756|FG011|Overall Study|Refused further study procedures|0|||
49071643|NCT01329900|158092759|FG000|Overall Study|Elevated creatinine/renal function|1|||
49071644|NCT02831049|158092760|FG000|Overall Study|Lost to Follow-up|0|||
49071645|NCT02831049|158092761|FG001|Overall Study|Lost to Follow-up|0|||
49071646|NCT02831049|158092762|FG002|Overall Study|Lost to Follow-up|1|||
49071647|NCT02831049|158092760|FG000|Overall Study|Withdrawal by Subject|0|||
49071648|NCT02831049|158092761|FG001|Overall Study|Withdrawal by Subject|1|||
49071649|NCT02831049|158092762|FG002|Overall Study|Withdrawal by Subject|1|||
49071650|NCT02831049|158092760|FG000|Overall Study|Pandemic shutdown|1|||
49071651|NCT02831049|158092761|FG001|Overall Study|Pandemic shutdown|0|||
49071652|NCT02831049|158092762|FG002|Overall Study|Pandemic shutdown|0|||
49071653|NCT04711902|158094791|FG000|Treatment Period 2 (From Week 16)|Participant decision|0|||
49071654|NCT04711902|158094792|FG001|Treatment Period 2 (From Week 16)|Participant decision|0|||
49071655|NCT04711902|158094793|FG002|Treatment Period 2 (From Week 16)|Participant decision|2|||
49071656|NCT04711902|158094794|FG003|Treatment Period 2 (From Week 16)|Participant decision|0|||
49071657|NCT04711902|158094795|FG004|Treatment Period 2 (From Week 16)|Participant decision|0|||
49071658|NCT04711902|158094796|FG005|Treatment Period 2 (From Week 16)|Participant decision|0|||
49071659|NCT04171141|158094799|FG000|Overall Study|Adverse Event|0|||
49071660|NCT04171141|158094800|FG001|Overall Study|Adverse Event|0|||
49071661|NCT04171141|158094801|FG002|Overall Study|Adverse Event|2|||
49071662|NCT04171141|158094802|FG003|Overall Study|Adverse Event|0|||
49071663|NCT04171141|158094803|FG004|Overall Study|Adverse Event|0|||
49071664|NCT04171141|158094804|FG005|Overall Study|Adverse Event|0|||
49071665|NCT04171141|158094805|FG006|Overall Study|Adverse Event|0|||
49071666|NCT04171141|158094806|FG007|Overall Study|Adverse Event|0|||
49071667|NCT04171141|158094807|FG008|Overall Study|Adverse Event|0|||
49071668|NCT04171141|158094808|FG009|Overall Study|Adverse Event|0|||
49071669|NCT04171141|158094809|FG010|Overall Study|Adverse Event|0|||
49071670|NCT04171141|158094810|FG011|Overall Study|Adverse Event|0|||
49071671|NCT04171141|158094811|FG012|Overall Study|Adverse Event|0|||
49071672|NCT04171141|158094812|FG013|Overall Study|Adverse Event|2|||
49071673|NCT04171141|158094813|FG014|Overall Study|Adverse Event|0|||
49071674|NCT04171141|158094814|FG015|Overall Study|Adverse Event|0|||
49071675|NCT04171141|158094799|FG000|Overall Study|Physician Decision|0|||
49071676|NCT04171141|158094800|FG001|Overall Study|Physician Decision|0|||
49071677|NCT04171141|158094801|FG002|Overall Study|Physician Decision|0|||
49071678|NCT04171141|158094802|FG003|Overall Study|Physician Decision|0|||
49071679|NCT04171141|158094803|FG004|Overall Study|Physician Decision|1|||
49071680|NCT04171141|158094804|FG005|Overall Study|Physician Decision|0|||
49071681|NCT04171141|158094805|FG006|Overall Study|Physician Decision|0|||
49071682|NCT04171141|158094806|FG007|Overall Study|Physician Decision|0|||
49071683|NCT04171141|158094807|FG008|Overall Study|Physician Decision|0|||
49071684|NCT04171141|158094808|FG009|Overall Study|Physician Decision|0|||
49071685|NCT04171141|158094809|FG010|Overall Study|Physician Decision|0|||
49071686|NCT04171141|158094810|FG011|Overall Study|Physician Decision|0|||
49071687|NCT04171141|158094811|FG012|Overall Study|Physician Decision|0|||
49071688|NCT04171141|158094812|FG013|Overall Study|Physician Decision|0|||
49071689|NCT04171141|158094813|FG014|Overall Study|Physician Decision|0|||
49071690|NCT04171141|158094814|FG015|Overall Study|Physician Decision|1|||
49071691|NCT04171141|158094799|FG000|Overall Study|Progressive disease|2|||
49071692|NCT04171141|158094800|FG001|Overall Study|Progressive disease|3|||
49071693|NCT04171141|158094801|FG002|Overall Study|Progressive disease|4|||
49071694|NCT04171141|158094802|FG003|Overall Study|Progressive disease|7|||
49071695|NCT04171141|158094803|FG004|Overall Study|Progressive disease|1|||
49071696|NCT04171141|158094804|FG005|Overall Study|Progressive disease|8|||
49071697|NCT04171141|158094805|FG006|Overall Study|Progressive disease|4|||
49071698|NCT04171141|158094806|FG007|Overall Study|Progressive disease|6|||
49071699|NCT04171141|158094807|FG008|Overall Study|Progressive disease|7|||
49071700|NCT04171141|158094808|FG009|Overall Study|Progressive disease|3|||
49071701|NCT04171141|158094809|FG010|Overall Study|Progressive disease|4|||
49071702|NCT04171141|158094810|FG011|Overall Study|Progressive disease|3|||
49071703|NCT04171141|158094811|FG012|Overall Study|Progressive disease|4|||
49071704|NCT04171141|158094812|FG013|Overall Study|Progressive disease|2|||
49071705|NCT04171141|158094813|FG014|Overall Study|Progressive disease|4|||
49071706|NCT04171141|158094814|FG015|Overall Study|Progressive disease|1|||
49071707|NCT04171141|158094799|FG000|Overall Study|Withdrawal by Subject|0|||
49071708|NCT04171141|158094800|FG001|Overall Study|Withdrawal by Subject|0|||
49071709|NCT04171141|158094801|FG002|Overall Study|Withdrawal by Subject|0|||
49071710|NCT04171141|158094802|FG003|Overall Study|Withdrawal by Subject|1|||
49071711|NCT04171141|158094803|FG004|Overall Study|Withdrawal by Subject|0|||
49071712|NCT04171141|158094804|FG005|Overall Study|Withdrawal by Subject|0|||
49071713|NCT04171141|158094805|FG006|Overall Study|Withdrawal by Subject|1|||
49071714|NCT04171141|158094806|FG007|Overall Study|Withdrawal by Subject|0|||
49071715|NCT04171141|158094807|FG008|Overall Study|Withdrawal by Subject|0|||
49071716|NCT04171141|158094808|FG009|Overall Study|Withdrawal by Subject|1|||
49071717|NCT04171141|158094809|FG010|Overall Study|Withdrawal by Subject|0|||
49071718|NCT04171141|158094810|FG011|Overall Study|Withdrawal by Subject|0|||
49071719|NCT04171141|158094811|FG012|Overall Study|Withdrawal by Subject|0|||
49071720|NCT04171141|158094812|FG013|Overall Study|Withdrawal by Subject|0|||
49071721|NCT04171141|158094813|FG014|Overall Study|Withdrawal by Subject|0|||
49071722|NCT04171141|158094814|FG015|Overall Study|Withdrawal by Subject|0|||
49071723|NCT04171141|158094799|FG000|Overall Study|Global deterioration of health status|0|||
49071724|NCT04171141|158094800|FG001|Overall Study|Global deterioration of health status|0|||
49071725|NCT04171141|158094801|FG002|Overall Study|Global deterioration of health status|0|||
49071726|NCT04171141|158094802|FG003|Overall Study|Global deterioration of health status|1|||
49071727|NCT04171141|158094803|FG004|Overall Study|Global deterioration of health status|0|||
49071728|NCT04171141|158094804|FG005|Overall Study|Global deterioration of health status|2|||
49071729|NCT04171141|158094805|FG006|Overall Study|Global deterioration of health status|1|||
49071730|NCT04171141|158094806|FG007|Overall Study|Global deterioration of health status|0|||
49071731|NCT04171141|158094807|FG008|Overall Study|Global deterioration of health status|1|||
49071732|NCT04171141|158094808|FG009|Overall Study|Global deterioration of health status|0|||
49071733|NCT04171141|158094809|FG010|Overall Study|Global deterioration of health status|0|||
49071734|NCT04171141|158094810|FG011|Overall Study|Global deterioration of health status|0|||
49071735|NCT04171141|158094811|FG012|Overall Study|Global deterioration of health status|0|||
49071736|NCT04171141|158094812|FG013|Overall Study|Global deterioration of health status|0|||
49071737|NCT04171141|158094813|FG014|Overall Study|Global deterioration of health status|1|||
49071738|NCT04171141|158094814|FG015|Overall Study|Global deterioration of health status|1|||
49071739|NCT00213135|158094815|FG000|Overall Study|Adverse Event|9|||
49071740|NCT00213135|158094816|FG001|Overall Study|Adverse Event|5|||
49071741|NCT00213135|158094817|FG002|Overall Study|Adverse Event|5|||
49071742|NCT00213135|158094815|FG000|Overall Study|Lost to Follow-up|11|||
49071743|NCT00213135|158094816|FG001|Overall Study|Lost to Follow-up|8|||
49071744|NCT00213135|158094817|FG002|Overall Study|Lost to Follow-up|4|||
49071745|NCT00213135|158094815|FG000|Overall Study|Protocol Violation|4|||
49071746|NCT00213135|158094816|FG001|Overall Study|Protocol Violation|4|||
49071747|NCT00213135|158094817|FG002|Overall Study|Protocol Violation|10|||
49071748|NCT00213135|158094815|FG000|Overall Study|Death|1|||
49071749|NCT00213135|158094816|FG001|Overall Study|Death|1|||
49071750|NCT00213135|158094817|FG002|Overall Study|Death|2|||
49071751|NCT00213135|158094815|FG000|Overall Study|Disease progression|4|||
49071752|NCT00213135|158094816|FG001|Overall Study|Disease progression|5|||
49071753|NCT00213135|158094817|FG002|Overall Study|Disease progression|21|||
49071754|NCT00213135|158094815|FG000|Overall Study|Other|21|||
49071755|NCT00213135|158094816|FG001|Overall Study|Other|12|||
49071756|NCT00213135|158094817|FG002|Overall Study|Other|15|||
49071757|NCT03786718|158094821|FG000|Overall Study|Lost to Follow-up|3|||
49071758|NCT03786718|158094821|FG000|Overall Study|Withdrawal by Subject|1|||
49071759|NCT03786718|158094821|FG000|Overall Study|Did not use the intervention|2|||
49071760|NCT03786718|158094821|FG000|Overall Study|diagnosis changed from type 2 to type 1|1|||
49071761|NCT00368979|158094822|FG000|Overall Study|Adverse Event|9|||
49071762|NCT00368979|158094823|FG001|Overall Study|Adverse Event|16|||
49071763|NCT00368979|158094822|FG000|Overall Study|Lack of Efficacy|5|||
49071764|NCT00368979|158094823|FG001|Overall Study|Lack of Efficacy|3|||
49071765|NCT00368979|158094822|FG000|Overall Study|Other|3|||
49071766|NCT00368979|158094823|FG001|Overall Study|Other|1|||
49071767|NCT00368979|158094822|FG000|Overall Study|Lost to Follow-up|1|||
49071768|NCT00368979|158094823|FG001|Overall Study|Lost to Follow-up|0|||
49071769|NCT00368979|158094822|FG000|Overall Study|Protocol Violation|2|||
49071770|NCT00368979|158094823|FG001|Overall Study|Protocol Violation|1|||
49071771|NCT00368979|158094822|FG000|Overall Study|Withdrawal by Subject|5|||
49071772|NCT00368979|158094823|FG001|Overall Study|Withdrawal by Subject|9|||
49071773|NCT05526430|158094834|FG000|Overall Study|Withdrawal by Subject|0|||
49071774|NCT05526430|158094835|FG001|Overall Study|Withdrawal by Subject|2|||
49071775|NCT05526430|158094836|FG002|Overall Study|Withdrawal by Subject|0|||
49071776|NCT05526430|158094837|FG003|Overall Study|Withdrawal by Subject|0|||
49071777|NCT01696058|158094838|FG000|Overall Study|Adverse Event|21|||
49071778|NCT01696058|158094839|FG001|Overall Study|Adverse Event|11|||
49071779|NCT01696058|158094838|FG000|Overall Study|Lack of Efficacy|2|||
49071780|NCT01696058|158094839|FG001|Overall Study|Lack of Efficacy|3|||
49071781|NCT01696058|158094838|FG000|Overall Study|Protocol Violation|9|||
49071782|NCT01696058|158094839|FG001|Overall Study|Protocol Violation|3|||
49071783|NCT01696058|158094838|FG000|Overall Study|Lost to Follow-up|2|||
49071784|NCT01696058|158094839|FG001|Overall Study|Lost to Follow-up|5|||
49071785|NCT01696058|158094838|FG000|Overall Study|Withdrawal by Subject|4|||
49071786|NCT01696058|158094839|FG001|Overall Study|Withdrawal by Subject|6|||
49071787|NCT01696058|158094838|FG000|Overall Study|Other reason prematurely discontinued|5|||
49071788|NCT01696058|158094839|FG001|Overall Study|Other reason prematurely discontinued|3|||
49071789|NCT01884337|158094845|FG000|Treatment|Adverse Event|2|||
49071790|NCT01884337|158094846|FG001|Treatment|Adverse Event|2|||
49071791|NCT01884337|158094845|FG000|Treatment|Subj. request to discont. treatment|2|||
49071792|NCT01884337|158094846|FG001|Treatment|Subj. request to discont. treatment|0|||
49071793|NCT01884337|158094845|FG000|Follow-up Period|Lost to Follow-up|1|||
49071794|NCT01884337|158094846|FG001|Follow-up Period|Lost to Follow-up|1|||
49071795|NCT02549027|158094851|FG000|Washout After Period 4|Withdrawal by Subject|0|||
49071796|NCT02549027|158094852|FG001|Washout After Period 4|Withdrawal by Subject|1|||
49071797|NCT02549027|158094853|FG002|Washout After Period 4|Withdrawal by Subject|1|||
49071798|NCT02549027|158094854|FG003|Washout After Period 4|Withdrawal by Subject|1|||
49071799|NCT02549027|158094855|FG004|Washout After Period 4|Withdrawal by Subject|0|||
49071800|NCT02549027|158094856|FG005|Washout After Period 4|Withdrawal by Subject|0|||
49071801|NCT02549027|158094851|FG000|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
49071802|NCT02549027|158094852|FG001|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
49071803|NCT02549027|158094853|FG002|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
49071804|NCT02549027|158094854|FG003|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
49071805|NCT02549027|158094855|FG004|Period 5 - MK-6096 or Placebo|Protocol Violation|2|||
49071806|NCT02549027|158094856|FG005|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
49071807|NCT05314816|158094860|FG000|Overall Study|Lost to Follow-up|5|||
49071808|NCT05314816|158094861|FG001|Overall Study|Lost to Follow-up|0|||
49071809|NCT05314816|158094862|FG002|Overall Study|Lost to Follow-up|1|||
49071810|NCT05314816|158094860|FG000|Overall Study|Protocol Violation|13|||
49071811|NCT05314816|158094861|FG001|Overall Study|Protocol Violation|8|||
49071812|NCT05314816|158094862|FG002|Overall Study|Protocol Violation|0|||
49071813|NCT01885195|158094863|FG000|Overall Study|Adverse Event|29|||
49071814|NCT01885195|158094863|FG000|Overall Study|Death|1|||
49071815|NCT01885195|158094863|FG000|Overall Study|Disease Progression|67|||
49071816|NCT01885195|158094863|FG000|Overall Study|Protocol Deviation|2|||
49071817|NCT01885195|158094863|FG000|Overall Study|Physician Decision|3|||
49071818|NCT01885195|158094863|FG000|Overall Study|Patient/guardian decision|8|||
49071819|NCT02186834|158094864|FG000|Dose Escalation|Death|0|||
49071820|NCT02186834|158094865|FG001|Dose Escalation|Death|0|||
49071821|NCT02186834|158094866|FG002|Dose Escalation|Death|0|||
49071822|NCT02186834|158094867|FG003|Dose Escalation|Death|1|||
49071823|NCT02186834|158094868|FG004|Dose Escalation|Death|0|||
49071824|NCT02186834|158094869|FG005|Dose Escalation|Death|0|||
49071825|NCT02186834|158094864|FG000|Treatment at RP2D|Died prior to treatment|0|||
49071826|NCT02186834|158094865|FG001|Treatment at RP2D|Died prior to treatment|0|||
49071827|NCT02186834|158094866|FG002|Treatment at RP2D|Died prior to treatment|0|||
49071828|NCT02186834|158094867|FG003|Treatment at RP2D|Died prior to treatment|0|||
49071829|NCT02186834|158094868|FG004|Treatment at RP2D|Died prior to treatment|0|||
49071830|NCT02186834|158094869|FG005|Treatment at RP2D|Died prior to treatment|1|||
49071831|NCT02278055|158094870|FG000|Overall Study|Adverse Event|1|||
49071832|NCT02278055|158094870|FG000|Overall Study|Lost to Follow-up|1|||
49071833|NCT02278055|158094870|FG000|Overall Study|Withdrawal by Subject|2|||
49071834|NCT02278055|158094870|FG000|Overall Study|Progressive Disease|4|||
49071835|NCT01329549|158094878|FG000|Overall Study|Withdrawal by Subject|1|||
49071836|NCT01329549|158094878|FG000|Overall Study|Adverse Event|1|||
49071837|NCT03760185|158094879|FG000|Overall Study|Lost to Follow-up|1|||
49071838|NCT03760185|158094880|FG001|Overall Study|Lost to Follow-up|1|||
49071839|NCT05384171|158094881|FG000|Overall Study|Lost to Follow-up|9|||
49071840|NCT05384171|158094882|FG001|Overall Study|Lost to Follow-up|9|||
49071841|NCT05384171|158094881|FG000|Overall Study|Withdrawal by Subject|3|||
49071842|NCT05384171|158094882|FG001|Overall Study|Withdrawal by Subject|0|||
49071843|NCT00749892|158094883|FG000|Overall Study|Withdrawal by Subject|3|||
49071844|NCT00603837|158094888|FG000|Overall Study|Physician Decision|3|||
49071845|NCT00603837|158094889|FG001|Overall Study|Physician Decision|0|||
49071846|NCT01275430|158094895|FG000|Overall Study|Adverse Event|1|||
49071847|NCT01275430|158094895|FG000|Overall Study|No Contrast Injection|6|||
49071848|NCT01275430|158094895|FG000|Overall Study|Device Malfunction|1|||
49071849|NCT01275430|158094895|FG000|Overall Study|Inability to achieve maximum p-wave|1|||
49071850|NCT02910063|158094896|FG000|Phase 2|Withdrawal by Subject|3|||
49071851|NCT02910063|158094897|FG001|Phase 2|Withdrawal by Subject|0|||
49071852|NCT02910063|158094898|FG002|Phase 2|Withdrawal by Subject|0|||
49071853|NCT02910063|158094896|FG000|Phase 2|Lost to Follow-up|1|||
49071854|NCT02910063|158094897|FG001|Phase 2|Lost to Follow-up|0|||
49071855|NCT02910063|158094898|FG002|Phase 2|Lost to Follow-up|0|||
49071856|NCT02910063|158094896|FG000|Phase 2|Death|24|||
49071857|NCT02910063|158094897|FG001|Phase 2|Death|0|||
49071858|NCT02910063|158094898|FG002|Phase 2|Death|0|||
49071859|NCT04988087|158094899|FG000|Overall Study|Adverse Event|4|||
49071860|NCT04988087|158094900|FG001|Overall Study|Adverse Event|0|||
49071861|NCT04988087|158094901|FG002|Overall Study|Adverse Event|0|||
49071862|NCT04988087|158094902|FG003|Overall Study|Adverse Event|0|||
49071863|NCT04988087|158094899|FG000|Overall Study|Withdrawal by Subject|1|||
49071864|NCT04988087|158094900|FG001|Overall Study|Withdrawal by Subject|1|||
49071865|NCT04988087|158094901|FG002|Overall Study|Withdrawal by Subject|0|||
49071866|NCT04988087|158094902|FG003|Overall Study|Withdrawal by Subject|0|||
49071867|NCT04988087|158094899|FG000|Overall Study|Technical problems|7|||
49071868|NCT04988087|158094900|FG001|Overall Study|Technical problems|9|||
49071869|NCT04988087|158094901|FG002|Overall Study|Technical problems|1|||
49071870|NCT04988087|158094902|FG003|Overall Study|Technical problems|2|||
49071871|NCT00323856|158094903|FG000|Overall Study|Withdrawal by Subject|1|||
49071872|NCT00323856|158094903|FG000|Overall Study|Was uncooperative and noncompliant|1|||
49071873|NCT00323856|158094903|FG000|Overall Study|Reason not specified|1|||
49071874|NCT00323856|158094903|FG000|Overall Study|Missing|2|||
49071875|NCT02752087|158094904|FG000|Washout|Physician Decision|1|||
49071876|NCT02752087|158094905|FG001|Washout|Physician Decision|0|||
49071877|NCT00843635|158094906|FG000|Overall Study|Adverse Event|2|||
49071878|NCT00843635|158094907|FG001|Overall Study|Adverse Event|2|||
49071879|NCT00843635|158094908|FG002|Overall Study|Adverse Event|0|||
49071880|NCT03968978|158094909|FG000|Overall Study|Adverse Event|1|||
49071881|NCT03968978|158094910|FG001|Overall Study|Adverse Event|0|||
49071882|NCT02542605|158094913|FG000|Part B: Challenge Phase|Sponsor decision|1|||
49071883|NCT02542605|158094914|FG001|Part B: Challenge Phase|Sponsor decision|0|||
49071884|NCT02542605|158094915|FG002|Part B: Challenge Phase|Sponsor decision|0|||
49071885|NCT02542605|158094913|FG000|Part B: Randomization Phase|Withdrawal by Subject|0|||
49071886|NCT02542605|158094914|FG001|Part B: Randomization Phase|Withdrawal by Subject|0|||
49071887|NCT02542605|158094915|FG002|Part B: Randomization Phase|Withdrawal by Subject|1|||
49071888|NCT00919854|158094916|FG000|Overall Study|Adverse Event|1|||
49071889|NCT02682927|158094919|FG000|Overall Study|Adverse Event|0|||
49071890|NCT02682927|158094920|FG001|Overall Study|Adverse Event|0|||
49071891|NCT02682927|158094921|FG002|Overall Study|Adverse Event|5|||
49071892|NCT02682927|158094922|FG003|Overall Study|Adverse Event|1|||
49071893|NCT02682927|158094923|FG004|Overall Study|Adverse Event|0|||
49071894|NCT02682927|158094924|FG005|Overall Study|Adverse Event|2|||
49071895|NCT02682927|158094919|FG000|Overall Study|Death|0|||
49071896|NCT02682927|158094920|FG001|Overall Study|Death|0|||
49071897|NCT02682927|158094921|FG002|Overall Study|Death|0|||
49071898|NCT02682927|158094922|FG003|Overall Study|Death|1|||
49071899|NCT02682927|158094923|FG004|Overall Study|Death|0|||
49071900|NCT02682927|158094924|FG005|Overall Study|Death|0|||
49071901|NCT02682927|158094919|FG000|Overall Study|Lack of Efficacy|1|||
49071902|NCT02682927|158094920|FG001|Overall Study|Lack of Efficacy|0|||
49071903|NCT02682927|158094921|FG002|Overall Study|Lack of Efficacy|0|||
49071904|NCT02682927|158094922|FG003|Overall Study|Lack of Efficacy|1|||
49071905|NCT02682927|158094923|FG004|Overall Study|Lack of Efficacy|0|||
49071906|NCT02682927|158094924|FG005|Overall Study|Lack of Efficacy|0|||
49071907|NCT02682927|158094919|FG000|Overall Study|Other|0|||
49071908|NCT02682927|158094920|FG001|Overall Study|Other|0|||
49071909|NCT02682927|158094921|FG002|Overall Study|Other|0|||
49071910|NCT02682927|158094922|FG003|Overall Study|Other|2|||
49071911|NCT02682927|158094923|FG004|Overall Study|Other|0|||
49071912|NCT02682927|158094924|FG005|Overall Study|Other|0|||
49071913|NCT02682927|158094919|FG000|Overall Study|Withdrawal by Subject|2|||
49071914|NCT02682927|158094920|FG001|Overall Study|Withdrawal by Subject|0|||
49071915|NCT02682927|158094921|FG002|Overall Study|Withdrawal by Subject|1|||
49071916|NCT02682927|158094922|FG003|Overall Study|Withdrawal by Subject|0|||
49071917|NCT02682927|158094923|FG004|Overall Study|Withdrawal by Subject|1|||
49071918|NCT02682927|158094924|FG005|Overall Study|Withdrawal by Subject|1|||
49071919|NCT00985491|158094928|FG000|Overall Study|Adverse Event|8|||
49071920|NCT00985491|158094928|FG000|Overall Study|device migration|7|||
49071921|NCT00985491|158094928|FG000|Overall Study|Withdrawal by Subject|1|||
49071922|NCT00985491|158094928|FG000|Overall Study|implant failure|3|||
49071923|NCT04102189|158094931|FG000|Overall Study|Withdrawal by Subject|1|||
49071924|NCT04102189|158094932|FG001|Overall Study|Withdrawal by Subject|2|||
49071925|NCT04102189|158094931|FG000|Overall Study|Withdrawal by parent/guardian|0|||
49071926|NCT04102189|158094932|FG001|Overall Study|Withdrawal by parent/guardian|1|||
49071927|NCT04102189|158094931|FG000|Overall Study|Lost to Follow-up|1|||
49071928|NCT04102189|158094932|FG001|Overall Study|Lost to Follow-up|0|||
49071929|NCT01449812|158094933|FG000|Overall Study|Migrated/moved from study area|1|||
49071930|NCT01449812|158094934|FG001|Overall Study|Migrated/moved from study area|0|||
49071931|NCT01449812|158094935|FG002|Overall Study|Migrated/moved from study area|0|||
49071932|NCT01449812|158094933|FG000|Overall Study|Withdrawal by Subject|0|||
49071933|NCT01449812|158094934|FG001|Overall Study|Withdrawal by Subject|0|||
49071934|NCT01449812|158094935|FG002|Overall Study|Withdrawal by Subject|1|||
49071935|NCT01449812|158094933|FG000|Overall Study|Lost to Follow-up|1|||
49071936|NCT01449812|158094934|FG001|Overall Study|Lost to Follow-up|0|||
49071937|NCT01449812|158094935|FG002|Overall Study|Lost to Follow-up|0|||
49071938|NCT01292226|158094936|FG000|Overall Study|Adverse Event|5|||
49071939|NCT01292226|158094936|FG000|Overall Study|Death|1|||
49071940|NCT01292226|158094936|FG000|Overall Study|Graft loss|1|||
49071941|NCT01292226|158094936|FG000|Overall Study|Protocol Violation|3|||
49071942|NCT01292226|158094936|FG000|Overall Study|Withdrawal by Subject|1|||
49071943|NCT01292226|158094936|FG000|Overall Study|Other|2|||
49071944|NCT03587805|158094939|FG000|Overall Study|Adverse Event|72|||
49071945|NCT03587805|158094939|FG000|Overall Study|Death|1|||
49071946|NCT03587805|158094939|FG000|Overall Study|Lost to Follow-up|78|||
49071947|NCT03587805|158094939|FG000|Overall Study|Withdrawal by Subject|105|||
49071948|NCT03587805|158094939|FG000|Overall Study|Lack of Efficacy|119|||
49071949|NCT03587805|158094939|FG000|Overall Study|Reason unknown|26|||
49071950|NCT03587805|158094939|FG000|Overall Study|COVID_19 pandemic|4|||
49071951|NCT03587805|158094939|FG000|Overall Study|Various reasons|121|||
49071952|NCT03587805|158094939|FG000|Overall Study|Withdrawal by parent/guardian|3|||
49071953|NCT01855828|158094940|FG000|Overall Study|Adverse Event|1|||
49071954|NCT01855828|158094940|FG000|Overall Study|Withdrawal by Subject|1|||
49071955|NCT03568461|158094942|FG000|Overall Study|Death|7|||
49071956|NCT03568461|158094942|FG000|Overall Study|Physician Decision|5|||
49071957|NCT03568461|158094942|FG000|Overall Study|Subject decision|5|||
49071958|NCT03568461|158094942|FG000|Overall Study|Lost to Follow-up|1|||
49071959|NCT01866098|158094943|FG000|Overall Study|Lost to Follow-up|11|||
49071960|NCT01866098|158094944|FG001|Overall Study|Lost to Follow-up|18|||
49071961|NCT01866098|158094945|FG002|Overall Study|Lost to Follow-up|13|||
49071962|NCT01866098|158094943|FG000|Overall Study|Physician Decision|0|||
49071963|NCT01866098|158094944|FG001|Overall Study|Physician Decision|1|||
49071964|NCT01866098|158094945|FG002|Overall Study|Physician Decision|2|||
49071965|NCT01866098|158094943|FG000|Overall Study|Adverse Event|1|||
49071966|NCT01866098|158094944|FG001|Overall Study|Adverse Event|5|||
49071967|NCT01866098|158094945|FG002|Overall Study|Adverse Event|4|||
49071968|NCT01866098|158094943|FG000|Overall Study|Protocol Violation|1|||
49071969|NCT01866098|158094944|FG001|Overall Study|Protocol Violation|0|||
49071970|NCT01866098|158094945|FG002|Overall Study|Protocol Violation|0|||
49071971|NCT01866098|158094943|FG000|Overall Study|Withdrawal by Subject|1|||
49071972|NCT01866098|158094944|FG001|Overall Study|Withdrawal by Subject|2|||
49071973|NCT01866098|158094945|FG002|Overall Study|Withdrawal by Subject|0|||
49071974|NCT01866098|158094943|FG000|Overall Study|Unrelated Hospitalization|2|||
49071975|NCT01866098|158094944|FG001|Overall Study|Unrelated Hospitalization|0|||
49071976|NCT01866098|158094945|FG002|Overall Study|Unrelated Hospitalization|1|||
49071977|NCT01866098|158094943|FG000|Overall Study|Non-compliance|1|||
49071978|NCT01866098|158094944|FG001|Overall Study|Non-compliance|0|||
49071979|NCT01866098|158094945|FG002|Overall Study|Non-compliance|1|||
49071980|NCT01866098|158094943|FG000|Overall Study|Pregnancy|2|||
49071981|NCT01866098|158094944|FG001|Overall Study|Pregnancy|0|||
49071982|NCT01866098|158094945|FG002|Overall Study|Pregnancy|0|||
49071983|NCT01866098|158094943|FG000|Overall Study|Death|0|||
49071984|NCT01866098|158094944|FG001|Overall Study|Death|1|||
49071985|NCT01866098|158094945|FG002|Overall Study|Death|0|||
49071986|NCT01374269|158094950|FG000|Overall Study|Withdrawal by Subject|4|||
49071987|NCT01374269|158094951|FG001|Overall Study|Withdrawal by Subject|0|||
49071988|NCT01374269|158094950|FG000|Overall Study|Lost to Follow-up|1|||
49071989|NCT01374269|158094951|FG001|Overall Study|Lost to Follow-up|3|||
49071990|NCT01374269|158094950|FG000|Overall Study|closed research|1|||
49071991|NCT01374269|158094951|FG001|Overall Study|closed research|2|||
49071992|NCT00143247|158094955|FG000|Overall Study|Death|8|||
49071993|NCT00143247|158094955|FG000|Overall Study|Adverse Event|19|||
49071994|NCT00143247|158094955|FG000|Overall Study|Lack of Efficacy|3|||
49071995|NCT00143247|158094955|FG000|Overall Study|Withdrawal by Subject|55|||
49071996|NCT00143247|158094955|FG000|Overall Study|Study terminated by sponsor|31|||
49071997|NCT00143247|158094955|FG000|Overall Study|Protocol Violation|15|||
49071998|NCT00143247|158094955|FG000|Overall Study|Lost to Follow-up|12|||
49071999|NCT00143247|158094955|FG000|Overall Study|following inaccurate lab adverse event|1|||
49072000|NCT00143247|158094955|FG000|Overall Study|Other|12|||
49072001|NCT02068092|158096657|FG000|Overall Study|Physician Decision|2|||
49072002|NCT02068092|158096657|FG000|Overall Study|Adverse Event|2|||
49072003|NCT02068092|158096657|FG000|Overall Study|Lost to Follow-up|4|||
49072004|NCT02068092|158096657|FG000|Overall Study|Withdrawal by Subject|2|||
49072005|NCT04024813|158096658|FG000|Overall Study|Study terminated by Sponsor|1|||
49072006|NCT04241315|158096659|FG000|Overall Study|Withdrawal by Subject|0|||
49072007|NCT04241315|158096660|FG001|Overall Study|Withdrawal by Subject|1|||
49072008|NCT01555671|158096663|FG000|Overall Study|Physician Decision|20|||
49072009|NCT01555671|158096664|FG001|Overall Study|Physician Decision|25|||
49072010|NCT00372411|158096665|FG000|Overall Study|Withdrawal by Subject|3|||
49072011|NCT00372411|158096666|FG001|Overall Study|Withdrawal by Subject|4|||
49072012|NCT00372411|158096667|FG002|Overall Study|Withdrawal by Subject|1|||
49072013|NCT00372411|158096665|FG000|Overall Study|Death|0|||
49072014|NCT00372411|158096666|FG001|Overall Study|Death|2|||
49072015|NCT00372411|158096667|FG002|Overall Study|Death|1|||
49072016|NCT00372411|158096665|FG000|Overall Study|Lost to Follow-up|1|||
49072017|NCT00372411|158096666|FG001|Overall Study|Lost to Follow-up|1|||
49072018|NCT00372411|158096667|FG002|Overall Study|Lost to Follow-up|1|||
49072019|NCT00372411|158096665|FG000|Overall Study|Adverse Event|1|||
49072020|NCT00372411|158096666|FG001|Overall Study|Adverse Event|1|||
49072021|NCT00372411|158096667|FG002|Overall Study|Adverse Event|0|||
49072022|NCT04016662|158096668|FG000|Run-In Phase|Death|1|||
49072023|NCT04016662|158096668|FG000|Run-In Phase|Withdrawal by Subject|11|||
49072024|NCT04016662|158096668|FG000|Run-In Phase|Not meeting screening eligibility|9|||
49072025|NCT04016662|158096668|FG000|Run-In Phase|Physician Decision|3|||
49072026|NCT04016662|158096668|FG000|HCL (12 Weeks)|Withdrawal by Subject|1|||
49072027|NCT04016662|158096668|FG000|PLGS (12 Weeks)|Death|1|||
49072028|NCT04016662|158096668|FG000|SAP (12 Weeks)|Death|1|||
49072029|NCT00394524|158096669|FG000|Overall Study|Protocol Violation|2|||
49072030|NCT00394524|158096670|FG001|Overall Study|Protocol Violation|3|||
49072031|NCT00394524|158096669|FG000|Overall Study|Death|1|||
49072032|NCT00394524|158096670|FG001|Overall Study|Death|0|||
49072033|NCT00394524|158096669|FG000|Overall Study|Withdrawal by Subject|0|||
49072034|NCT00394524|158096670|FG001|Overall Study|Withdrawal by Subject|1|||
49072035|NCT00282919|158096672|FG000|Overall Study|Lack of Efficacy|4|||
49072036|NCT00282919|158096672|FG000|Overall Study|Withdrawal by Subject|1|||
49072037|NCT00282919|158096672|FG000|Overall Study|Asymptomatic Parasitemia|2|||
49072038|NCT01635283|158096673|FG000|Overall Study|Tumor Progression|3|||
49072039|NCT01635283|158096673|FG000|Overall Study|Lost to Follow-up|1|||
49072040|NCT02643355|158096674|FG000|Overall Study|Withdrawal by Subject|1|||
49072041|NCT02643355|158096675|FG001|Overall Study|Withdrawal by Subject|3|||
49072042|NCT02643355|158096674|FG000|Overall Study|Protocol Violation|0|||
49072043|NCT02643355|158096675|FG001|Overall Study|Protocol Violation|2|||
49072044|NCT00339144|158096676|FG000|Overall Study|Disease progression|5|||
49072045|NCT00339144|158096677|FG001|Overall Study|Disease progression|2|||
49072046|NCT00339144|158096678|FG002|Overall Study|Disease progression|2|||
49072047|NCT00339144|158096676|FG000|Overall Study|Study drug toxicity|3|||
49072048|NCT00339144|158096677|FG001|Overall Study|Study drug toxicity|1|||
49072049|NCT00339144|158096678|FG002|Overall Study|Study drug toxicity|1|||
49072050|NCT00339144|158096676|FG000|Overall Study|Participant's request to discontinuation|1|||
49072051|NCT00339144|158096677|FG001|Overall Study|Participant's request to discontinuation|0|||
49072052|NCT00339144|158096678|FG002|Overall Study|Participant's request to discontinuation|1|||
49072053|NCT04581369|158096679|FG000|Overall Study|Death|7|||
49072054|NCT04581369|158096680|FG001|Overall Study|Death|6|||
49072055|NCT04581369|158096681|FG002|Overall Study|Death|0|||
49072056|NCT04581369|158096679|FG000|Overall Study|Lost to Follow-up|7|||
49072057|NCT04581369|158096680|FG001|Overall Study|Lost to Follow-up|3|||
49072058|NCT04581369|158096681|FG002|Overall Study|Lost to Follow-up|0|||
49072059|NCT04581369|158096679|FG000|Overall Study|liver transplant|2|||
49072060|NCT04581369|158096680|FG001|Overall Study|liver transplant|2|||
49072061|NCT04581369|158096681|FG002|Overall Study|liver transplant|0|||
49072062|NCT04581369|158096679|FG000|Overall Study|transitioned to hospice care|0|||
49072063|NCT04581369|158096680|FG001|Overall Study|transitioned to hospice care|5|||
49072064|NCT04581369|158096681|FG002|Overall Study|transitioned to hospice care|0|||
49072065|NCT00780910|158096682|FG000|Overall Study|Adverse Event|2|||
49072066|NCT02473523|158096683|FG000|Overall Study|Death|1|||
49072067|NCT02473523|158096683|FG000|Overall Study|Lost to Follow-up|1|||
49072068|NCT05940194|158096692|FG000|Overall Study|Adverse Event|0|||
49072069|NCT05940194|158096693|FG001|Overall Study|Adverse Event|1|||
49072070|NCT05940194|158096694|FG002|Overall Study|Adverse Event|0|||
49072071|NCT05940194|158096692|FG000|Overall Study|Migrated/Moved from the study area|2|||
49072072|NCT05940194|158096693|FG001|Overall Study|Migrated/Moved from the study area|2|||
49072073|NCT05940194|158096694|FG002|Overall Study|Migrated/Moved from the study area|4|||
49072074|NCT01111825|158096695|FG000|Overall Study|Withdrawal by Subject|0|||
49072075|NCT01111825|158096696|FG001|Overall Study|Withdrawal by Subject|0|||
49072076|NCT01111825|158096697|FG002|Overall Study|Withdrawal by Subject|1|||
49072077|NCT01111825|158096698|FG003|Overall Study|Withdrawal by Subject|0|||
49072078|NCT01111825|158096695|FG000|Overall Study|Lost to Follow-up|0|||
49072079|NCT01111825|158096696|FG001|Overall Study|Lost to Follow-up|0|||
49072080|NCT01111825|158096697|FG002|Overall Study|Lost to Follow-up|3|||
49072081|NCT01111825|158096698|FG003|Overall Study|Lost to Follow-up|1|||
49072082|NCT01111825|158096695|FG000|Overall Study|Adverse Event|2|||
49072083|NCT01111825|158096696|FG001|Overall Study|Adverse Event|1|||
49072084|NCT01111825|158096697|FG002|Overall Study|Adverse Event|4|||
49072085|NCT01111825|158096698|FG003|Overall Study|Adverse Event|0|||
49072086|NCT01111825|158096695|FG000|Overall Study|Disease Progression|1|||
49072087|NCT01111825|158096696|FG001|Overall Study|Disease Progression|0|||
49072088|NCT01111825|158096697|FG002|Overall Study|Disease Progression|0|||
49072089|NCT01111825|158096698|FG003|Overall Study|Disease Progression|0|||
49072090|NCT01111825|158096695|FG000|Overall Study|Discontinuation by Sponsor|0|||
49072091|NCT01111825|158096696|FG001|Overall Study|Discontinuation by Sponsor|0|||
49072092|NCT01111825|158096697|FG002|Overall Study|Discontinuation by Sponsor|0|||
49072093|NCT01111825|158096698|FG003|Overall Study|Discontinuation by Sponsor|20|||
49072094|NCT02111603|158096699|FG000|Overall Study|Withdrawal by Subject|1|||
49072095|NCT00976911|158096700|FG000|Overall Study|Withdrawal by Subject|4|||
49072096|NCT00976911|158096701|FG001|Overall Study|Withdrawal by Subject|6|||
49072097|NCT00976911|158096700|FG000|Overall Study|Death|138|||
49072098|NCT00976911|158096701|FG001|Overall Study|Death|126|||
49072099|NCT00976911|158096700|FG000|Overall Study|Adverse Event|0|||
49072100|NCT00976911|158096701|FG001|Overall Study|Adverse Event|1|||
49072101|NCT00976911|158096700|FG000|Overall Study|Protocol Violation|2|||
49072102|NCT00976911|158096701|FG001|Overall Study|Protocol Violation|0|||
49072103|NCT00976911|158096700|FG000|Overall Study|Other|8|||
49072104|NCT00976911|158096701|FG001|Overall Study|Other|9|||
49072105|NCT00976911|158096700|FG000|Overall Study|In Follow-Up as of 25 Jan 2013|30|||
49072106|NCT00976911|158096701|FG001|Overall Study|In Follow-Up as of 25 Jan 2013|37|||
49072107|NCT01191944|158096702|FG000|Overall Study|Adverse Event|11|||
49072108|NCT01191944|158096703|FG001|Overall Study|Adverse Event|12|||
49072109|NCT01191944|158096702|FG000|Overall Study|Protocol Violation|1|||
49072110|NCT01191944|158096703|FG001|Overall Study|Protocol Violation|2|||
49072111|NCT01191944|158096702|FG000|Overall Study|Withdrawal by Subject|4|||
49072112|NCT01191944|158096703|FG001|Overall Study|Withdrawal by Subject|2|||
49072113|NCT01191944|158096702|FG000|Overall Study|Other|1|||
49072114|NCT01191944|158096703|FG001|Overall Study|Other|3|||
49072115|NCT04914676|158096704|FG000|Overall Study|Study termination|3|||
49072116|NCT04914676|158096705|FG001|Overall Study|Study termination|0|||
49072117|NCT04040192|158096708|FG000|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|18|||
49072118|NCT04040192|158096709|FG001|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
49072119|NCT04040192|158096710|FG002|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
49072120|NCT04040192|158096708|FG000|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|14|||
49072121|NCT04040192|158096709|FG001|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
49072122|NCT04040192|158096710|FG002|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
49072123|NCT04040192|158096708|FG000|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|3|||
49072124|NCT04040192|158096709|FG001|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
49072125|NCT04040192|158096710|FG002|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
49072126|NCT04040192|158096708|FG000|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|3|||
49072127|NCT04040192|158096709|FG001|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
49072128|NCT04040192|158096710|FG002|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
49072129|NCT04040192|158096708|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|8|||
49072130|NCT04040192|158096709|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
49072131|NCT04040192|158096710|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
49072132|NCT04040192|158096708|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|18|||
49072133|NCT04040192|158096709|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
49072134|NCT04040192|158096710|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
49072135|NCT04040192|158096708|FG000|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|152|||
49072136|NCT04040192|158096709|FG001|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
49072137|NCT04040192|158096710|FG002|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
49072138|NCT04040192|158096708|FG000|Open Label Run-in Period (up to 8 Weeks)|Other|11|||
49072139|NCT04040192|158096709|FG001|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
49072140|NCT04040192|158096710|FG002|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
49072141|NCT04040192|158096708|FG000|Double Blind Period (up to 52 Weeks)|Adverse Event|0|||
49072142|NCT04040192|158096709|FG001|Double Blind Period (up to 52 Weeks)|Adverse Event|3|||
49072143|NCT04040192|158096710|FG002|Double Blind Period (up to 52 Weeks)|Adverse Event|1|||
49072144|NCT04040192|158096708|FG000|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|0|||
49072145|NCT04040192|158096709|FG001|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|6|||
49072146|NCT04040192|158096710|FG002|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|10|||
49072147|NCT04040192|158096708|FG000|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
49072148|NCT04040192|158096709|FG001|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
49072149|NCT04040192|158096710|FG002|Double Blind Period (up to 52 Weeks)|Physician Decision|2|||
49072150|NCT04040192|158096708|FG000|Double Blind Period (up to 52 Weeks)|Protocol Violation|0|||
49072151|NCT04040192|158096709|FG001|Double Blind Period (up to 52 Weeks)|Protocol Violation|1|||
49072152|NCT04040192|158096710|FG002|Double Blind Period (up to 52 Weeks)|Protocol Violation|3|||
49072153|NCT04040192|158096708|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|0|||
49072154|NCT04040192|158096709|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|6|||
49072155|NCT04040192|158096710|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|11|||
49072156|NCT04040192|158096708|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|0|||
49072157|NCT04040192|158096709|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|8|||
49072158|NCT04040192|158096710|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|7|||
49072159|NCT04040192|158096708|FG000|Double Blind Period (up to 52 Weeks)|Other|0|||
49072160|NCT04040192|158096709|FG001|Double Blind Period (up to 52 Weeks)|Other|29|||
49072161|NCT04040192|158096710|FG002|Double Blind Period (up to 52 Weeks)|Other|18|||
49072162|NCT04040192|158096708|FG000|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
49072163|NCT04040192|158096709|FG001|Double Blind Period (up to 52 Weeks)|Pregnancy|2|||
49072164|NCT04040192|158096710|FG002|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
49072165|NCT04040192|158096708|FG000|Double Blind Period (up to 52 Weeks)|Missing|0|||
49072166|NCT04040192|158096709|FG001|Double Blind Period (up to 52 Weeks)|Missing|2|||
49072167|NCT04040192|158096710|FG002|Double Blind Period (up to 52 Weeks)|Missing|5|||
49072168|NCT03207243|158096711|FG000|Overall Study|Adverse Event|2|||
49072169|NCT03207243|158096712|FG001|Overall Study|Adverse Event|2|||
49072170|NCT03207243|158096711|FG000|Overall Study|Loss of Asthma Control|47|||
49072171|NCT03207243|158096712|FG001|Overall Study|Loss of Asthma Control|31|||
49072172|NCT03207243|158096711|FG000|Overall Study|Withdrawal by Subject|2|||
49072173|NCT03207243|158096712|FG001|Overall Study|Withdrawal by Subject|4|||
49072174|NCT03207243|158096711|FG000|Overall Study|Physician Decision|1|||
49072175|NCT03207243|158096712|FG001|Overall Study|Physician Decision|1|||
49072176|NCT03207243|158096711|FG000|Overall Study|Lost to Follow-up|0|||
49072177|NCT03207243|158096712|FG001|Overall Study|Lost to Follow-up|1|||
49072178|NCT03207243|158096711|FG000|Overall Study|Protocol Specified Withdrawal Criteria|7|||
49072179|NCT03207243|158096712|FG001|Overall Study|Protocol Specified Withdrawal Criteria|2|||
49072180|NCT03207243|158096711|FG000|Overall Study|Protocol Violation|0|||
49072181|NCT03207243|158096712|FG001|Overall Study|Protocol Violation|3|||
49072182|NCT02552303|158096732|FG000|Allocation|Withdrawal by Subject|2|||
49072183|NCT02552303|158096733|FG001|Allocation|Withdrawal by Subject|1|||
49072184|NCT02552303|158096734|FG002|Allocation|Withdrawal by Subject|1|||
49072185|NCT02552303|158096735|FG003|Allocation|Withdrawal by Subject|1|||
49072186|NCT02552303|158096732|FG000|Allocation|ineligible|1|||
49072187|NCT02552303|158096733|FG001|Allocation|ineligible|1|||
49072188|NCT02552303|158096734|FG002|Allocation|ineligible|0|||
49072189|NCT02552303|158096735|FG003|Allocation|ineligible|0|||
49072190|NCT02552303|158096732|FG000|Follow-Up|Lost to Follow-up|0|||
49072191|NCT02552303|158096733|FG001|Follow-Up|Lost to Follow-up|0|||
49072192|NCT02552303|158096734|FG002|Follow-Up|Lost to Follow-up|1|||
49072193|NCT02552303|158096735|FG003|Follow-Up|Lost to Follow-up|0|||
49072194|NCT02552303|158096732|FG000|Follow-Up|ineligible|0|||
49072195|NCT02552303|158096733|FG001|Follow-Up|ineligible|2|||
49072196|NCT02552303|158096734|FG002|Follow-Up|ineligible|0|||
49072197|NCT02552303|158096735|FG003|Follow-Up|ineligible|0|||
49072198|NCT03240016|158096736|FG000|Overall Study|Adverse Event|9|||
49072199|NCT03240016|158096736|FG000|Overall Study|Withdrawal by Subject|7|||
49072200|NCT03240016|158096736|FG000|Overall Study|Death|1|||
49072201|NCT03240016|158096736|FG000|Overall Study|Physician Decision|2|||
49072202|NCT02695537|158096737|FG000|Overall Study|Adverse Event|3|||
49072203|NCT02695537|158096737|FG000|Overall Study|Lack of Efficacy|28|||
49072204|NCT02695537|158096737|FG000|Overall Study|Withdrawal by Subject|4|||
49072205|NCT02695537|158096737|FG000|Overall Study|Protocol Violation|3|||
49072206|NCT02794246|158096740|FG000|Overall Study|Withdrawal by Subject|2|||
49072207|NCT02794246|158096740|FG000|Overall Study|Physician Decision|4|||
49072208|NCT04602546|158096741|FG000|Overall Study|Training|2|||
49072209|NCT04602546|158096742|FG001|Overall Study|Training|2|||
49072210|NCT04602546|158096743|FG002|Overall Study|Training|1|||
49072211|NCT04602546|158096744|FG003|Overall Study|Training|2|||
49072212|NCT04602546|158096745|FG004|Overall Study|Training|0|||
49072213|NCT04602546|158096741|FG000|Overall Study|Randomized with disqualified data|2|||
49072214|NCT04602546|158096742|FG001|Overall Study|Randomized with disqualified data|0|||
49072215|NCT04602546|158096743|FG002|Overall Study|Randomized with disqualified data|2|||
49072216|NCT04602546|158096744|FG003|Overall Study|Randomized with disqualified data|5|||
49072217|NCT04602546|158096745|FG004|Overall Study|Randomized with disqualified data|3|||
49072218|NCT04501614|158096748|FG000|Overall Study|Study Terminated by Sponsor|6|||
49072219|NCT04501614|158096749|FG001|Overall Study|Study Terminated by Sponsor|3|||
49072220|NCT04501614|158096748|FG000|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
49072221|NCT04501614|158096749|FG001|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
49072222|NCT04015908|158096750|FG000|Overall Study|Lost to Follow-up|0|||
49072223|NCT04015908|158096751|FG001|Overall Study|Lost to Follow-up|1|||
49072224|NCT01547130|158096760|FG000|Overall Study|Lost to Follow-up|9|||
49072225|NCT01547130|158096761|FG001|Overall Study|Lost to Follow-up|5|||
49072226|NCT03496610|158096762|FG000|Overall Study|Lost to Follow-up|3|||
49072227|NCT03496610|158096763|FG001|Overall Study|Lost to Follow-up|2|||
49072228|NCT03496610|158096762|FG000|Overall Study|Physician Decision|1|||
49072229|NCT03496610|158096763|FG001|Overall Study|Physician Decision|0|||
49072230|NCT03496610|158096762|FG000|Overall Study|Withdrawal by Subject|1|||
49072231|NCT03496610|158096763|FG001|Overall Study|Withdrawal by Subject|0|||
49072232|NCT02714426|158096767|FG000|Overall Study|Withdrawal by Subject|2|||
49072233|NCT02714426|158096768|FG001|Overall Study|Withdrawal by Subject|2|||
49072234|NCT05524116|158096769|FG000|Baseline to Postintervention (Week 8)|Brain tumor flare up|0|||
49072235|NCT05524116|158096770|FG001|Baseline to Postintervention (Week 8)|Brain tumor flare up|1|||
49072236|NCT05524116|158096769|FG000|Baseline to Postintervention (Week 8)|concussion|0|||
49072237|NCT05524116|158096770|FG001|Baseline to Postintervention (Week 8)|concussion|1|||
49072238|NCT05524116|158096769|FG000|Baseline to Postintervention (Week 8)|hernia surgery|0|||
49072239|NCT05524116|158096770|FG001|Baseline to Postintervention (Week 8)|hernia surgery|1|||
49072240|NCT05524116|158096769|FG000|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|1|||
49072241|NCT05524116|158096770|FG001|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|0|||
49072242|NCT05524116|158096769|FG000|Week 8 to Follow-up (Week 14)|Lost to Follow-up|0|||
49072243|NCT05524116|158096770|FG001|Week 8 to Follow-up (Week 14)|Lost to Follow-up|1|||
49072244|NCT04435184|158096771|FG000|Overall Study|follow-up blood draws missing|3|||
49072245|NCT04435184|158096772|FG001|Overall Study|follow-up blood draws missing|5|||
49072246|NCT03548337|158096773|FG000|Infant Series|Withdrawal by Parent/Guardian|8|||
49072247|NCT03548337|158096774|FG001|Infant Series|Withdrawal by Parent/Guardian|8|||
49072248|NCT03548337|158096773|FG000|Infant Series|No Longer Met Eligibility Criteria|1|||
49072249|NCT03548337|158096774|FG001|Infant Series|No Longer Met Eligibility Criteria|0|||
49072250|NCT03548337|158096773|FG000|Infant Series|Lost to Follow-up|2|||
49072251|NCT03548337|158096774|FG001|Infant Series|Lost to Follow-up|1|||
49072252|NCT03548337|158096773|FG000|Infant Series|Adverse Event|0|||
49072253|NCT03548337|158096774|FG001|Infant Series|Adverse Event|2|||
49072254|NCT03548337|158096773|FG000|Infant Series|Randomized but Not Vaccinated|1|||
49072255|NCT03548337|158096774|FG001|Infant Series|Randomized but Not Vaccinated|0|||
49072256|NCT03548337|158096773|FG000|Toddler Dose|Withdrawal by parent/guardian|1|||
49072257|NCT03548337|158096774|FG001|Toddler Dose|Withdrawal by parent/guardian|1|||
49072258|NCT01893346|158096775|FG000|Overall Study|Lost to Follow-up|0|||
49072259|NCT01893346|158096776|FG001|Overall Study|Lost to Follow-up|1|||
49072260|NCT01893346|158096777|FG002|Overall Study|Lost to Follow-up|0|||
49072261|NCT01893346|158096778|FG003|Overall Study|Lost to Follow-up|0|||
49072262|NCT01893346|158096775|FG000|Overall Study|Protocol Violation|1|||
49072263|NCT01893346|158096776|FG001|Overall Study|Protocol Violation|0|||
49072264|NCT01893346|158096777|FG002|Overall Study|Protocol Violation|0|||
49072265|NCT01893346|158096778|FG003|Overall Study|Protocol Violation|0|||
49072266|NCT01893346|158096775|FG000|Overall Study|Withdrawal by Subject|2|||
49072267|NCT01893346|158096776|FG001|Overall Study|Withdrawal by Subject|0|||
49072268|NCT01893346|158096777|FG002|Overall Study|Withdrawal by Subject|0|||
49072269|NCT01893346|158096778|FG003|Overall Study|Withdrawal by Subject|0|||
49072270|NCT02517463|158096782|FG000|Overall Study|Lost to Follow-up|5|||
49072271|NCT02517463|158096783|FG001|Overall Study|Lost to Follow-up|2|||
49072272|NCT03510598|158096790|FG000|Overall Study|Withdrawal by Subject|1|||
49072273|NCT02307682|158096793|FG000|Overall Study|Adverse Event|9|||
49072274|NCT02307682|158096794|FG001|Overall Study|Adverse Event|8|||
49072275|NCT02307682|158096795|FG002|Overall Study|Adverse Event|12|||
49072276|NCT02307682|158096793|FG000|Overall Study|Lack of Efficacy|1|||
49072277|NCT02307682|158096794|FG001|Overall Study|Lack of Efficacy|0|||
49072278|NCT02307682|158096795|FG002|Overall Study|Lack of Efficacy|1|||
49072279|NCT02307682|158096793|FG000|Overall Study|Physician Decision|2|||
49072280|NCT02307682|158096794|FG001|Overall Study|Physician Decision|2|||
49072281|NCT02307682|158096795|FG002|Overall Study|Physician Decision|8|||
49072282|NCT02307682|158096793|FG000|Overall Study|Progressive Disease|1|||
49072283|NCT02307682|158096794|FG001|Overall Study|Progressive Disease|0|||
49072284|NCT02307682|158096795|FG002|Overall Study|Progressive Disease|0|||
49072285|NCT02307682|158096793|FG000|Overall Study|Withdrawal by Subject|26|||
49072286|NCT02307682|158096794|FG001|Overall Study|Withdrawal by Subject|34|||
49072287|NCT02307682|158096795|FG002|Overall Study|Withdrawal by Subject|23|||
49072288|NCT02307682|158096793|FG000|Overall Study|Death|9|||
49072289|NCT02307682|158096794|FG001|Overall Study|Death|7|||
49072290|NCT02307682|158096795|FG002|Overall Study|Death|12|||
49072291|NCT02307682|158096793|FG000|Overall Study|Lost to Follow-up|1|||
49072292|NCT02307682|158096794|FG001|Overall Study|Lost to Follow-up|5|||
49072293|NCT02307682|158096795|FG002|Overall Study|Lost to Follow-up|6|||
49072294|NCT02307682|158096793|FG000|Overall Study|Protocol Deviation|0|||
49072295|NCT02307682|158096794|FG001|Overall Study|Protocol Deviation|0|||
49072296|NCT02307682|158096795|FG002|Overall Study|Protocol Deviation|2|||
49072297|NCT02307682|158096793|FG000|Overall Study|Other|1|||
49072298|NCT02307682|158096794|FG001|Overall Study|Other|1|||
49072299|NCT02307682|158096795|FG002|Overall Study|Other|0|||
49072300|NCT03999749|158096799|FG000|Overall Study|Toxicity|16|||
49072301|NCT03999749|158096799|FG000|Overall Study|Withdrawal by Subject|3|||
49072302|NCT03999749|158096799|FG000|Overall Study|Disease progression|26|||
49072303|NCT03999749|158096799|FG000|Overall Study|Physician Decision|4|||
49072304|NCT03999749|158096799|FG000|Overall Study|Death|5|||
49072305|NCT03999749|158096799|FG000|Overall Study|Patient deemed ineligible after treatment|1|||
49072306|NCT01184079|158096800|FG000|Overall Study|Lost to Follow-up|14|||
49072307|NCT01184079|158096801|FG001|Overall Study|Lost to Follow-up|2|||
49072308|NCT00340678|158096802|FG000|Overall Study|Lost to Follow-up|1|||
49072309|NCT00340678|158096803|FG001|Overall Study|Lost to Follow-up|0|||
49072310|NCT00340678|158096804|FG002|Overall Study|Lost to Follow-up|0|||
49072311|NCT00340678|158096805|FG003|Overall Study|Lost to Follow-up|0|||
49072312|NCT02766283|158096806|FG000|Overall Study|Lost to Follow-up|27|||
49072313|NCT01590277|158096808|FG000|Overall Study|Withdrawal by Subject|3|||
49072314|NCT01590277|158096808|FG000|Overall Study|Withdrawal by Subject|2|||
49072315|NCT01590277|158096808|FG000|Overall Study|Withdrawal by Subject|1|||
49072316|NCT01590277|158096808|FG000|Overall Study|Withdrawal by Subject|1|||
49072317|NCT01377012|158096809|FG000|Core Study|Study terminated by Sponsor|47|||
49072318|NCT01377012|158096810|FG001|Core Study|Study terminated by Sponsor|54|||
49072319|NCT01377012|158096811|FG002|Core Study|Study terminated by Sponsor|46|||
49072320|NCT01377012|158096809|FG000|Core Study|Technical problems|1|||
49072321|NCT01377012|158096810|FG001|Core Study|Technical problems|0|||
49072322|NCT01377012|158096811|FG002|Core Study|Technical problems|0|||
49072323|NCT01377012|158096809|FG000|Core Study|Withdrawal by Subject|15|||
49072324|NCT01377012|158096810|FG001|Core Study|Withdrawal by Subject|23|||
49072325|NCT01377012|158096811|FG002|Core Study|Withdrawal by Subject|18|||
49072326|NCT01377012|158096809|FG000|Core Study|Protocol Violation|7|||
49072327|NCT01377012|158096810|FG001|Core Study|Protocol Violation|3|||
49072328|NCT01377012|158096811|FG002|Core Study|Protocol Violation|2|||
49072329|NCT01377012|158096809|FG000|Core Study|Pregnancy|0|||
49072330|NCT01377012|158096810|FG001|Core Study|Pregnancy|0|||
49072331|NCT01377012|158096811|FG002|Core Study|Pregnancy|1|||
49072332|NCT01377012|158096809|FG000|Core Study|Physician Decision|5|||
49072333|NCT01377012|158096810|FG001|Core Study|Physician Decision|4|||
49072334|NCT01377012|158096811|FG002|Core Study|Physician Decision|10|||
49072335|NCT01377012|158096809|FG000|Core Study|Non-Compliant with study treatment|0|||
49072336|NCT01377012|158096810|FG001|Core Study|Non-Compliant with study treatment|0|||
49072337|NCT01377012|158096811|FG002|Core Study|Non-Compliant with study treatment|1|||
49072338|NCT01377012|158096809|FG000|Core Study|No Longer require treatment|0|||
49072339|NCT01377012|158096810|FG001|Core Study|No Longer require treatment|0|||
49072340|NCT01377012|158096811|FG002|Core Study|No Longer require treatment|1|||
49072341|NCT01377012|158096809|FG000|Core Study|Lost to Follow-up|7|||
49072342|NCT01377012|158096810|FG001|Core Study|Lost to Follow-up|5|||
49072343|NCT01377012|158096811|FG002|Core Study|Lost to Follow-up|4|||
49072344|NCT01377012|158096809|FG000|Core Study|Lack of Efficacy|41|||
49072345|NCT01377012|158096810|FG001|Core Study|Lack of Efficacy|28|||
49072346|NCT01377012|158096811|FG002|Core Study|Lack of Efficacy|37|||
49072347|NCT01377012|158096809|FG000|Core Study|Death|1|||
49072348|NCT01377012|158096810|FG001|Core Study|Death|1|||
49072349|NCT01377012|158096811|FG002|Core Study|Death|1|||
49072350|NCT01377012|158096809|FG000|Core Study|Adverse Event|10|||
49072351|NCT01377012|158096810|FG001|Core Study|Adverse Event|14|||
49072352|NCT01377012|158096811|FG002|Core Study|Adverse Event|13|||
49072353|NCT01377012|158096809|FG000|Extension Study, Weeks 104-260|Lack of Efficacy|3|||
49072354|NCT01377012|158096810|FG001|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
49072355|NCT01377012|158096811|FG002|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
49072356|NCT01377012|158096809|FG000|Extension Study, Weeks 104-260|Study terminated by sponsor|52|||
49072357|NCT01377012|158096810|FG001|Extension Study, Weeks 104-260|Study terminated by sponsor|69|||
49072358|NCT01377012|158096811|FG002|Extension Study, Weeks 104-260|Study terminated by sponsor|63|||
49072359|NCT01377012|158096809|FG000|Extension Study, Weeks 104-260|Withdrawal by Subject|1|||
49072360|NCT01377012|158096810|FG001|Extension Study, Weeks 104-260|Withdrawal by Subject|0|||
49072361|NCT01377012|158096811|FG002|Extension Study, Weeks 104-260|Withdrawal by Subject|3|||
49072362|NCT01377012|158096809|FG000|Extension Study, Weeks 104-260|Physician Decision|1|||
49072363|NCT01377012|158096810|FG001|Extension Study, Weeks 104-260|Physician Decision|0|||
49072364|NCT01377012|158096811|FG002|Extension Study, Weeks 104-260|Physician Decision|0|||
49072365|NCT01377012|158096809|FG000|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
49072366|NCT01377012|158096810|FG001|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
49072367|NCT01377012|158096811|FG002|Extension Study, Weeks 104-260|Lost to Follow-up|1|||
49072368|NCT01377012|158096809|FG000|Extension Study, Weeks 104-260|Adverse Event|0|||
49072369|NCT01377012|158096810|FG001|Extension Study, Weeks 104-260|Adverse Event|2|||
49072370|NCT01377012|158096811|FG002|Extension Study, Weeks 104-260|Adverse Event|1|||
49072371|NCT01589497|158098235|FG000|Overall Study|Withdrawal by Subject|0|||
49072372|NCT01589497|158098236|FG001|Overall Study|Withdrawal by Subject|1|||
49072373|NCT01589497|158098237|FG002|Overall Study|Withdrawal by Subject|0|||
49072374|NCT01589497|158098238|FG003|Overall Study|Withdrawal by Subject|1|||
49072375|NCT01589497|158098235|FG000|Overall Study|Death|1|||
49072376|NCT01589497|158098236|FG001|Overall Study|Death|0|||
49072377|NCT01589497|158098237|FG002|Overall Study|Death|0|||
49072378|NCT01589497|158098238|FG003|Overall Study|Death|0|||
49072379|NCT01589497|158098235|FG000|Overall Study|Pre-entry overnight sputum< 10ML|0|||
49072380|NCT01589497|158098236|FG001|Overall Study|Pre-entry overnight sputum< 10ML|0|||
49072381|NCT01589497|158098237|FG002|Overall Study|Pre-entry overnight sputum< 10ML|1|||
49072382|NCT01589497|158098238|FG003|Overall Study|Pre-entry overnight sputum< 10ML|0|||
49072383|NCT03696953|158098239|FG000|Overall Study|Withdrawal by Subject|6|||
49072384|NCT03696953|158098240|FG001|Overall Study|Withdrawal by Subject|1|||
49072385|NCT03696953|158098239|FG000|Overall Study|missed GBS swabs|2|||
49072386|NCT03696953|158098240|FG001|Overall Study|missed GBS swabs|2|||
49072387|NCT03696953|158098239|FG000|Overall Study|lost study bottle containing capsules|2|||
49072388|NCT03696953|158098240|FG001|Overall Study|lost study bottle containing capsules|0|||
49072389|NCT03696953|158098239|FG000|Overall Study|Premature birth|1|||
49072390|NCT03696953|158098240|FG001|Overall Study|Premature birth|4|||
49072391|NCT03696953|158098239|FG000|Overall Study|Gestational hypertension|1|||
49072392|NCT03696953|158098240|FG001|Overall Study|Gestational hypertension|1|||
49072393|NCT03696953|158098239|FG000|Overall Study|Gestational diabetes|2|||
49072394|NCT03696953|158098240|FG001|Overall Study|Gestational diabetes|1|||
49072395|NCT03696953|158098239|FG000|Overall Study|Fetal demise-Genetic abnormality|1|||
49072396|NCT03696953|158098240|FG001|Overall Study|Fetal demise-Genetic abnormality|0|||
49072397|NCT03696953|158098239|FG000|Overall Study|Changed prenatal provider|1|||
49072398|NCT03696953|158098240|FG001|Overall Study|Changed prenatal provider|1|||
49072399|NCT03700385|158098244|FG000|Overall Study|Lost to Follow-up|1|||
49072400|NCT04663737|158098245|FG000|Overall Study|Withdrawal by Subject|2|||
49072401|NCT04663737|158098246|FG001|Overall Study|Withdrawal by Subject|0|||
49072402|NCT00699283|158098248|FG000|Overall Study|Lack of Efficacy|15|||
49072403|NCT00699283|158098249|FG001|Overall Study|Lack of Efficacy|5|||
49072404|NCT00699283|158098248|FG000|Overall Study|Lost to Follow-up|2|||
49072405|NCT00699283|158098249|FG001|Overall Study|Lost to Follow-up|0|||
49072406|NCT00699283|158098248|FG000|Overall Study|Withdrawal by Subject|1|||
49072407|NCT00699283|158098249|FG001|Overall Study|Withdrawal by Subject|0|||
49072408|NCT00699283|158098248|FG000|Overall Study|Other Reason|5|||
49072409|NCT00699283|158098249|FG001|Overall Study|Other Reason|1|||
49072410|NCT00699283|158098248|FG000|Overall Study|SAE, non-fatal|1|||
49072411|NCT00699283|158098249|FG001|Overall Study|SAE, non-fatal|1|||
49072412|NCT00699283|158098248|FG000|Overall Study|AE, non-serious non-fatal|8|||
49072413|NCT00699283|158098249|FG001|Overall Study|AE, non-serious non-fatal|1|||
49072414|NCT00699283|158098248|FG000|Overall Study|AE of unknown type|1|||
49072415|NCT00699283|158098249|FG001|Overall Study|AE of unknown type|0|||
49072416|NCT03047330|158098253|FG000|Sleep Block 1|Withdrawal by Subject|3|||
49072417|NCT04590040|158098254|FG000|Treatment Period|Lost to Follow-up|2|||
49072418|NCT04590040|158098255|FG001|Treatment Period|Lost to Follow-up|5|||
49072419|NCT04590040|158098256|FG002|Treatment Period|Lost to Follow-up|0|||
49072420|NCT04590040|158098254|FG000|Treatment Period|Physician Decision|0|||
49072421|NCT04590040|158098255|FG001|Treatment Period|Physician Decision|0|||
49072422|NCT04590040|158098256|FG002|Treatment Period|Physician Decision|2|||
49072423|NCT01398514|158098264|FG000|Overall Study|Adverse Event|1|||
49072424|NCT01398514|158098265|FG001|Overall Study|Adverse Event|0|||
49072425|NCT01398514|158098264|FG000|Overall Study|Non-compliance with study procedures|2|||
49072426|NCT01398514|158098265|FG001|Overall Study|Non-compliance with study procedures|0|||
49072427|NCT01398514|158098264|FG000|Overall Study|Physiologic non-responsiveness|1|||
49072428|NCT01398514|158098265|FG001|Overall Study|Physiologic non-responsiveness|3|||
49072429|NCT01398514|158098264|FG000|Overall Study|Failure to show a conditioned response|4|||
49072430|NCT01398514|158098265|FG001|Overall Study|Failure to show a conditioned response|3|||
49072431|NCT00000378|158098269|FG000|Overall Study|Lack of Efficacy|16|||
49072432|NCT00000378|158098270|FG001|Overall Study|Lack of Efficacy|14|||
49072433|NCT04516759|158098271|FG000|Overall Study|Withdrawal by Subject|1|||
49072434|NCT04516759|158098272|FG001|Overall Study|Withdrawal by Subject|1|||
49072435|NCT04516759|158098271|FG000|Overall Study|Other|0|||
49072436|NCT04516759|158098272|FG001|Overall Study|Other|1|||
49072437|NCT04746794|158098277|FG000|Overall Study|Did not complete any study assessment|50303|||
49072438|NCT04746794|158098278|FG001|Overall Study|Did not complete any study assessment|44997|||
49072439|NCT02838420|158098279|FG000|Overall Study|Ongoing in Study|113|||
49072440|NCT02838420|158098280|FG001|Overall Study|Ongoing in Study|45|||
49072441|NCT02838420|158098279|FG000|Overall Study|Lost to Follow-up|1|||
49072442|NCT02838420|158098280|FG001|Overall Study|Lost to Follow-up|0|||
49072443|NCT02838420|158098279|FG000|Overall Study|Withdrawal by Subject|3|||
49072444|NCT02838420|158098280|FG001|Overall Study|Withdrawal by Subject|4|||
49072445|NCT02838420|158098279|FG000|Overall Study|Death|8|||
49072446|NCT02838420|158098280|FG001|Overall Study|Death|13|||
49072447|NCT02954991|158098281|FG000|Overall Study|Death|92|||
49072448|NCT02954991|158098282|FG001|Overall Study|Death|11|||
49072449|NCT02954991|158098283|FG002|Overall Study|Death|2|||
49072450|NCT02954991|158098281|FG000|Overall Study|Lost to Follow-up|3|||
49072451|NCT02954991|158098282|FG001|Overall Study|Lost to Follow-up|2|||
49072452|NCT02954991|158098283|FG002|Overall Study|Lost to Follow-up|0|||
49072453|NCT02954991|158098281|FG000|Overall Study|Withdrawal by Subject|9|||
49072454|NCT02954991|158098282|FG001|Overall Study|Withdrawal by Subject|8|||
49072455|NCT02954991|158098283|FG002|Overall Study|Withdrawal by Subject|1|||
49072456|NCT02954991|158098281|FG000|Overall Study|Study Terminated by Sponsor|18|||
49072457|NCT02954991|158098282|FG001|Overall Study|Study Terminated by Sponsor|10|||
49072458|NCT02954991|158098283|FG002|Overall Study|Study Terminated by Sponsor|1|||
49072459|NCT02954991|158098281|FG000|Overall Study|Miscellaneous|2|||
49072460|NCT02954991|158098282|FG001|Overall Study|Miscellaneous|1|||
49072461|NCT02954991|158098283|FG002|Overall Study|Miscellaneous|1|||
49072462|NCT00576316|158098284|FG000|Overall Study|Adverse Event|9|||
49072463|NCT00576316|158098284|FG000|Overall Study|Withdrawal by Subject|2|||
49072464|NCT00576316|158098284|FG000|Overall Study|Protocol Violation|9|||
49072465|NCT01422187|158098285|FG000|Overall Study|Personal reason|1|||
49072466|NCT01422187|158098286|FG001|Overall Study|Personal reason|0|||
49072467|NCT01422187|158098287|FG002|Overall Study|Personal reason|0|||
49072468|NCT01422187|158098285|FG000|Overall Study|Lost to Follow-up|0|||
49072469|NCT01422187|158098286|FG001|Overall Study|Lost to Follow-up|1|||
49072470|NCT01422187|158098287|FG002|Overall Study|Lost to Follow-up|0|||
49072471|NCT01377987|158098288|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
49072472|NCT01377987|158098289|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
49072473|NCT00168818|158098290|FG000|Overall Study|Adverse Event|23|||
49072474|NCT00168818|158098291|FG001|Overall Study|Adverse Event|29|||
49072475|NCT00168818|158098292|FG002|Overall Study|Adverse Event|31|||
49072476|NCT00168818|158098290|FG000|Overall Study|Protocol Violation|16|||
49072477|NCT00168818|158098291|FG001|Overall Study|Protocol Violation|11|||
49072478|NCT00168818|158098292|FG002|Overall Study|Protocol Violation|11|||
49072479|NCT00168818|158098290|FG000|Overall Study|Lost to Follow-up|13|||
49072480|NCT00168818|158098291|FG001|Overall Study|Lost to Follow-up|4|||
49072481|NCT00168818|158098292|FG002|Overall Study|Lost to Follow-up|15|||
49072482|NCT00168818|158098290|FG000|Overall Study|Withdrawal by Subject|43|||
49072483|NCT00168818|158098291|FG001|Overall Study|Withdrawal by Subject|41|||
49072484|NCT00168818|158098292|FG002|Overall Study|Withdrawal by Subject|37|||
49072485|NCT00168818|158098290|FG000|Overall Study|Other|22|||
49072486|NCT00168818|158098291|FG001|Overall Study|Other|24|||
49072487|NCT00168818|158098292|FG002|Overall Study|Other|30|||
49072488|NCT00168818|158098290|FG000|Treatment|Adverse Event|77|||
49072489|NCT00168818|158098291|FG001|Treatment|Adverse Event|89|||
49072490|NCT00168818|158098292|FG002|Treatment|Adverse Event|68|||
49072491|NCT00168818|158098290|FG000|Treatment|Protocol Violation|8|||
49072492|NCT00168818|158098291|FG001|Treatment|Protocol Violation|11|||
49072493|NCT00168818|158098292|FG002|Treatment|Protocol Violation|11|||
49072494|NCT00168818|158098290|FG000|Treatment|Lost to Follow-up|0|||
49072495|NCT00168818|158098291|FG001|Treatment|Lost to Follow-up|2|||
49072496|NCT00168818|158098292|FG002|Treatment|Lost to Follow-up|1|||
49072497|NCT00168818|158098290|FG000|Treatment|Withdrawal by Subject|25|||
49072498|NCT00168818|158098291|FG001|Treatment|Withdrawal by Subject|20|||
49072499|NCT00168818|158098292|FG002|Treatment|Withdrawal by Subject|22|||
49072500|NCT00168818|158098290|FG000|Treatment|Other|23|||
49072501|NCT00168818|158098291|FG001|Treatment|Other|29|||
49072502|NCT00168818|158098292|FG002|Treatment|Other|31|||
49072503|NCT01959607|158098293|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
49072504|NCT01959607|158098294|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
49072505|NCT01959607|158098295|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
49072506|NCT01959607|158098296|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
49072507|NCT03597529|158098297|FG000|Overall Study|Lost to Follow-up|10|||
49072508|NCT03597529|158098298|FG001|Overall Study|Lost to Follow-up|12|||
49072509|NCT03597529|158098297|FG000|Overall Study|Physician Decision|3|||
49072510|NCT03597529|158098298|FG001|Overall Study|Physician Decision|1|||
49072511|NCT03597529|158098297|FG000|Overall Study|Withdrawal by Subject|6|||
49072512|NCT03597529|158098298|FG001|Overall Study|Withdrawal by Subject|3|||
49072513|NCT03597529|158098297|FG000|Overall Study|Non-compliant with study activities|1|||
49072514|NCT03597529|158098298|FG001|Overall Study|Non-compliant with study activities|2|||
49072515|NCT00469144|158098299|FG000|Overall Study|Death|0|||
49072516|NCT00469144|158098300|FG001|Overall Study|Death|1|||
49072517|NCT00469144|158098299|FG000|Overall Study|No Response|5|||
49072518|NCT00469144|158098300|FG001|Overall Study|No Response|5|||
49072519|NCT00469144|158098299|FG000|Overall Study|Progressive Disease|1|||
49072520|NCT00469144|158098300|FG001|Overall Study|Progressive Disease|0|||
49072521|NCT02792699|158098303|FG000|Overall Study|Adverse Event|1|||
49072522|NCT02792699|158098304|FG001|Overall Study|Adverse Event|2|||
49072523|NCT02792699|158098305|FG002|Overall Study|Adverse Event|4|||
49072524|NCT02792699|158098303|FG000|Overall Study|Withdrawal by Subject|4|||
49072525|NCT02792699|158098304|FG001|Overall Study|Withdrawal by Subject|4|||
49072526|NCT02792699|158098305|FG002|Overall Study|Withdrawal by Subject|3|||
49072527|NCT02792699|158098303|FG000|Overall Study|Lost to Follow-up|0|||
49072528|NCT02792699|158098304|FG001|Overall Study|Lost to Follow-up|1|||
49072529|NCT02792699|158098305|FG002|Overall Study|Lost to Follow-up|2|||
49072530|NCT02792699|158098303|FG000|Overall Study|Physician Decision|2|||
49072531|NCT02792699|158098304|FG001|Overall Study|Physician Decision|0|||
49072532|NCT02792699|158098305|FG002|Overall Study|Physician Decision|0|||
49072533|NCT02792699|158098303|FG000|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
49072534|NCT02792699|158098304|FG001|Overall Study|Dissatisfaction with Treatment Efficacy|3|||
49072535|NCT02792699|158098305|FG002|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
49072536|NCT02792699|158098303|FG000|Overall Study|Other|1|||
49072537|NCT02792699|158098304|FG001|Overall Study|Other|0|||
49072538|NCT02792699|158098305|FG002|Overall Study|Other|0|||
49072539|NCT01582152|158098306|FG000|Overall Study|Disease Progression|4|||
49072540|NCT01582152|158098307|FG001|Overall Study|Disease Progression|5|||
49072541|NCT01582152|158098306|FG000|Overall Study|Adverse Event|2|||
49072542|NCT01582152|158098307|FG001|Overall Study|Adverse Event|1|||
49072543|NCT03390426|158098308|FG000|Overall Study|Protocol Violation|0|||
49072544|NCT03390426|158098309|FG001|Overall Study|Protocol Violation|1|||
49072545|NCT05566639|158098373|FG000|Overall Study|Adverse Event|1|||
49072546|NCT05566639|158098374|FG001|Overall Study|Adverse Event|1|||
49072547|NCT05566639|158098373|FG000|Overall Study|Serious Adverse Event|1|||
49072548|NCT05566639|158098374|FG001|Overall Study|Serious Adverse Event|3|||
49072549|NCT05566639|158098373|FG000|Overall Study|Death|44|||
49072550|NCT05566639|158098374|FG001|Overall Study|Death|45|||
49072551|NCT05566639|158098373|FG000|Overall Study|Lost to Follow-up|467|||
49072552|NCT05566639|158098374|FG001|Overall Study|Lost to Follow-up|461|||
49072553|NCT05566639|158098373|FG000|Overall Study|Physician Decision|45|||
49072554|NCT05566639|158098374|FG001|Overall Study|Physician Decision|44|||
49072555|NCT05566639|158098373|FG000|Overall Study|Protocol Deviation|4|||
49072556|NCT05566639|158098374|FG001|Overall Study|Protocol Deviation|4|||
49072557|NCT05566639|158098373|FG000|Overall Study|Withdrawal by Subject|277|||
49072558|NCT05566639|158098374|FG001|Overall Study|Withdrawal by Subject|271|||
49072559|NCT05566639|158098373|FG000|Overall Study|Other Than Specified|52|||
49072560|NCT05566639|158098374|FG001|Overall Study|Other Than Specified|64|||
49072561|NCT01890434|158098375|FG000|Overall Study|Adverse Event|8|||
49072562|NCT01890434|158098375|FG000|Overall Study|PCI at external hospital|1|||
49072563|NCT01890434|158098375|FG000|Overall Study|Assessment discrepancy|1|||
49072564|NCT01890434|158098375|FG000|Overall Study|CRC didn't contact participant for FU|1|||
49072565|NCT01890434|158098375|FG000|Overall Study|Could not get whole set of images|1|||
49072566|NCT01890434|158098375|FG000|Overall Study|Decline to return for GSPECT|1|||
49072567|NCT01890434|158098375|FG000|Overall Study|GSPECT at rest was not done|1|||
49072568|NCT01890434|158098375|FG000|Overall Study|Participant didn't complete MRI|1|||
49072569|NCT01890434|158098375|FG000|Overall Study|Uncontactable by phone|1|||
49072570|NCT01890434|158098375|FG000|Overall Study|Moved out of position|1|||
49072571|NCT01890434|158098375|FG000|Overall Study|Unable to contact|1|||
49072572|NCT01890434|158098375|FG000|Overall Study|Withdrawal by PI for ICA not performed|2|||
49072573|NCT02227446|158098382|FG000|Overall Study|not eligible post randomization|18|||
49072574|NCT02227446|158098383|FG001|Overall Study|not eligible post randomization|29|||
49072575|NCT02227446|158098382|FG000|Overall Study|Withdrawal by Subject|4|||
49072576|NCT02227446|158098383|FG001|Overall Study|Withdrawal by Subject|5|||
49072577|NCT04623086|158098384|FG000|Overall Study|Withdrawal by Subject|0|||
49072578|NCT04623086|158098385|FG001|Overall Study|Withdrawal by Subject|0|||
49072579|NCT04623086|158098386|FG002|Overall Study|Withdrawal by Subject|10|||
49072580|NCT02538965|158098387|FG000|Treatment Period|Other = Death due to disease progression|1|||
49072581|NCT02538965|158098387|FG000|Treatment Period|Adverse Event|2|||
49072582|NCT02538965|158098387|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
49072583|NCT02538965|158098387|FG000|Treatment Period|Treatment Failure|9|||
49072584|NCT02538965|158098387|FG000|Treatment Period|Disease Progression|1|||
49072585|NCT02538965|158098387|FG000|Treatment Period|Physician Decision|2|||
49072586|NCT02538965|158098387|FG000|Follow-Up Period|Other = Death due to disease progression|13|||
49072587|NCT02538965|158098387|FG000|Follow-Up Period|Withdrawal by Parent|4|||
49072588|NCT00875797|158098389|FG000|Overall Study|Protocol Violation|6|||
49072589|NCT00875797|158098390|FG001|Overall Study|Protocol Violation|3|||
49072590|NCT01715571|158098391|FG000|Overall Study|Lost to Follow-up|8|||
49072591|NCT04054193|158098392|FG000|Cycle 1|Physician Decision|1|||
49072592|NCT04054193|158098392|FG000|Cycle 1|Consent withdrawn by parent/guardian|1|||
49072593|NCT04054193|158098392|FG000|Cycle 1|Allocated but not treated|3|||
49072594|NCT04054193|158098392|FG000|Cycles 2-3|Physician Decision|2|||
49072595|NCT04054193|158098392|FG000|Cycles 2-3|Consent withdrawn by parent/guardian|2|||
49072596|NCT04054193|158098392|FG000|Cycles 2-3|Various reasons|17|||
49072597|NCT03464630|158098393|FG000|Overall Study|Lost to Follow-up|62|||
49072598|NCT03464630|158098394|FG001|Overall Study|Lost to Follow-up|52|||
49072599|NCT03464630|158098393|FG000|Overall Study|Withdrawal by Subject|16|||
49072600|NCT03464630|158098394|FG001|Overall Study|Withdrawal by Subject|10|||
49072601|NCT03464630|158098393|FG000|Overall Study|Passive Disengagement|8|||
49072602|NCT03464630|158098394|FG001|Overall Study|Passive Disengagement|4|||
49072603|NCT02121392|158098400|FG000|Prior to Intervention|Protocol Violation|40|||
49072604|NCT02121392|158098401|FG001|Prior to Intervention|Protocol Violation|35|||
49072605|NCT02121392|158098400|FG000|Prior to Intervention|Withdrawal by Subject|8|||
49072606|NCT02121392|158098401|FG001|Prior to Intervention|Withdrawal by Subject|6|||
49072607|NCT02121392|158098400|FG000|After Placement of AC Block vs Sham|Protocol Violation|3|||
49072608|NCT02121392|158098401|FG001|After Placement of AC Block vs Sham|Protocol Violation|2|||
49072609|NCT02121392|158098400|FG000|After Placement of AC Block vs Sham|Lost to Follow-up|0|||
49072610|NCT02121392|158098401|FG001|After Placement of AC Block vs Sham|Lost to Follow-up|1|||
49072611|NCT02364557|158098404|FG000|Overall Study|Protocol Violation|3|||
49072612|NCT02364557|158098405|FG001|Overall Study|Protocol Violation|1|||
49072613|NCT00741286|158098406|FG000|Overall Study|Lost to Follow-up|15|||
49072614|NCT00741286|158098407|FG001|Overall Study|Lost to Follow-up|10|||
49072615|NCT00741286|158098406|FG000|Overall Study|Adverse Event|1|||
49072616|NCT00741286|158098407|FG001|Overall Study|Adverse Event|6|||
49072617|NCT00741286|158098406|FG000|Overall Study|Protocol Violation|3|||
49072618|NCT00741286|158098407|FG001|Overall Study|Protocol Violation|2|||
49072619|NCT00741286|158098406|FG000|Overall Study|Primary Outcome|1|||
49072620|NCT00741286|158098407|FG001|Overall Study|Primary Outcome|1|||
49072621|NCT02455518|158098408|FG000|Overall Study|Protocol Violation|0|||
49072622|NCT02455518|158098409|FG001|Overall Study|Protocol Violation|1|||
49072623|NCT02455518|158098410|FG002|Overall Study|Protocol Violation|1|||
49072624|NCT02455518|158098411|FG003|Overall Study|Protocol Violation|3|||
49072625|NCT00025259|158098413|FG000|Overall Study|Death|1|||
49072626|NCT00025259|158098414|FG001|Overall Study|Death|3|||
49072627|NCT00025259|158098415|FG002|Overall Study|Death|0|||
49072628|NCT00025259|158098416|FG003|Overall Study|Death|3|||
49072629|NCT00025259|158098417|FG004|Overall Study|Death|0|||
49072630|NCT00025259|158098418|FG005|Overall Study|Death|1|||
49072631|NCT00025259|158098419|FG006|Overall Study|Death|2|||
49072632|NCT00025259|158098413|FG000|Overall Study|Lack of Efficacy|2|||
49072633|NCT00025259|158098414|FG001|Overall Study|Lack of Efficacy|46|||
49072634|NCT00025259|158098415|FG002|Overall Study|Lack of Efficacy|60|||
49072635|NCT00025259|158098416|FG003|Overall Study|Lack of Efficacy|78|||
49072636|NCT00025259|158098417|FG004|Overall Study|Lack of Efficacy|11|||
49072637|NCT00025259|158098418|FG005|Overall Study|Lack of Efficacy|30|||
49072638|NCT00025259|158098419|FG006|Overall Study|Lack of Efficacy|38|||
49072639|NCT00025259|158098413|FG000|Overall Study|Lost to Follow-up|2|||
49072640|NCT00025259|158098414|FG001|Overall Study|Lost to Follow-up|9|||
49072641|NCT00025259|158098415|FG002|Overall Study|Lost to Follow-up|13|||
49072642|NCT00025259|158098416|FG003|Overall Study|Lost to Follow-up|13|||
49072643|NCT00025259|158098417|FG004|Overall Study|Lost to Follow-up|1|||
49072644|NCT00025259|158098418|FG005|Overall Study|Lost to Follow-up|3|||
49072645|NCT00025259|158098419|FG006|Overall Study|Lost to Follow-up|1|||
49072646|NCT00025259|158098413|FG000|Overall Study|Physician Decision|12|||
49072647|NCT00025259|158098414|FG001|Overall Study|Physician Decision|1|||
49072648|NCT00025259|158098415|FG002|Overall Study|Physician Decision|0|||
49072649|NCT00025259|158098416|FG003|Overall Study|Physician Decision|5|||
49072650|NCT00025259|158098417|FG004|Overall Study|Physician Decision|4|||
49072651|NCT00025259|158098418|FG005|Overall Study|Physician Decision|2|||
49072652|NCT00025259|158098419|FG006|Overall Study|Physician Decision|1|||
49072653|NCT00025259|158098413|FG000|Overall Study|Protocol Violation|3|||
49072654|NCT00025259|158098414|FG001|Overall Study|Protocol Violation|2|||
49072655|NCT00025259|158098415|FG002|Overall Study|Protocol Violation|2|||
49072656|NCT00025259|158098416|FG003|Overall Study|Protocol Violation|1|||
49072657|NCT00025259|158098417|FG004|Overall Study|Protocol Violation|2|||
49072658|NCT00025259|158098418|FG005|Overall Study|Protocol Violation|1|||
49072659|NCT00025259|158098419|FG006|Overall Study|Protocol Violation|3|||
49072660|NCT00025259|158098413|FG000|Overall Study|Withdrawal by Subject|9|||
49072661|NCT00025259|158098414|FG001|Overall Study|Withdrawal by Subject|27|||
49072662|NCT00025259|158098415|FG002|Overall Study|Withdrawal by Subject|6|||
49072663|NCT00025259|158098416|FG003|Overall Study|Withdrawal by Subject|14|||
49072664|NCT00025259|158098417|FG004|Overall Study|Withdrawal by Subject|11|||
49072665|NCT00025259|158098418|FG005|Overall Study|Withdrawal by Subject|8|||
49072666|NCT00025259|158098419|FG006|Overall Study|Withdrawal by Subject|3|||
49072667|NCT00025259|158098413|FG000|Overall Study|Ineligible|14|||
49072668|NCT00025259|158098414|FG001|Overall Study|Ineligible|1|||
49072669|NCT00025259|158098415|FG002|Overall Study|Ineligible|0|||
49072670|NCT00025259|158098416|FG003|Overall Study|Ineligible|0|||
49072671|NCT00025259|158098417|FG004|Overall Study|Ineligible|6|||
49072672|NCT00025259|158098418|FG005|Overall Study|Ineligible|0|||
49072673|NCT00025259|158098419|FG006|Overall Study|Ineligible|1|||
49072674|NCT00025259|158098413|FG000|Overall Study|Randomization error|1|||
49072675|NCT00025259|158098414|FG001|Overall Study|Randomization error|0|||
49072676|NCT00025259|158098415|FG002|Overall Study|Randomization error|0|||
49072677|NCT00025259|158098416|FG003|Overall Study|Randomization error|0|||
49072678|NCT00025259|158098417|FG004|Overall Study|Randomization error|1|||
49072679|NCT00025259|158098418|FG005|Overall Study|Randomization error|7|||
49072680|NCT00025259|158098419|FG006|Overall Study|Randomization error|2|||
49072681|NCT00025259|158098413|FG000|Overall Study|Adverse Event|1|||
49072682|NCT00025259|158098414|FG001|Overall Study|Adverse Event|0|||
49072683|NCT00025259|158098415|FG002|Overall Study|Adverse Event|0|||
49072684|NCT00025259|158098416|FG003|Overall Study|Adverse Event|0|||
49072685|NCT00025259|158098417|FG004|Overall Study|Adverse Event|0|||
49072686|NCT00025259|158098418|FG005|Overall Study|Adverse Event|0|||
49072687|NCT00025259|158098419|FG006|Overall Study|Adverse Event|0|||
49072688|NCT04811716|158098420|FG000|Overall Study|Withdrawal by Subject|2|||
49072689|NCT04811716|158098421|FG001|Overall Study|Withdrawal by Subject|0|||
49072690|NCT04693416|158098422|FG000|Overall Study|Lost to Follow-up|13|||
49072691|NCT04693416|158098423|FG001|Overall Study|Lost to Follow-up|0|||
49072692|NCT01144715|158098424|FG000|Overall Study|Lost to Follow-up|2|||
49072693|NCT01144715|158098425|FG001|Overall Study|Lost to Follow-up|1|||
49072694|NCT01144715|158098424|FG000|Overall Study|Withdrawal by Subject|2|||
49072695|NCT01144715|158098425|FG001|Overall Study|Withdrawal by Subject|1|||
49072696|NCT01144715|158098424|FG000|Overall Study|Adverse Event|0|||
49072697|NCT01144715|158098425|FG001|Overall Study|Adverse Event|1|||
49072698|NCT02774642|158098427|FG000|Overall Study|Lost to Follow-up|9|||
49072699|NCT02774642|158098428|FG001|Overall Study|Lost to Follow-up|7|||
49072700|NCT01814553|158098429|FG000|Overall Study|PD per clinical progression|6|||
49072701|NCT01814553|158098430|FG001|Overall Study|PD per clinical progression|8|||
49072702|NCT01814553|158098429|FG000|Overall Study|Other Adverse Event|4|||
49072703|NCT01814553|158098430|FG001|Overall Study|Other Adverse Event|5|||
49072704|NCT01814553|158098429|FG000|Overall Study|Withdrawal by Subject|1|||
49072705|NCT01814553|158098430|FG001|Overall Study|Withdrawal by Subject|1|||
49072706|NCT01814553|158098429|FG000|Overall Study|Other than stated|7|||
49072707|NCT01814553|158098430|FG001|Overall Study|Other than stated|8|||
49072708|NCT04239027|158098438|FG000|Overall Study|Adverse Event|4|||
49072709|NCT04239027|158098438|FG000|Overall Study|Withdrawal by Subject|9|||
49072710|NCT04239027|158098438|FG000|Overall Study|Death|1|||
49072711|NCT04239027|158098438|FG000|Overall Study|Physician Decision|9|||
49072712|NCT04239027|158098438|FG000|Overall Study|Lost to Follow-up|2|||
49072713|NCT04239027|158098438|FG000|Overall Study|Lack of Efficacy|1|||
49072714|NCT02500576|158098439|FG000|Overall Study|Adverse Event|0|||
49072715|NCT02500576|158098440|FG001|Overall Study|Adverse Event|1|||
49072716|NCT02500576|158098439|FG000|Overall Study|Death|2|||
49072717|NCT02500576|158098440|FG001|Overall Study|Death|1|||
49072718|NCT02500576|158098439|FG000|Overall Study|Lack of Efficacy|5|||
49072719|NCT02500576|158098440|FG001|Overall Study|Lack of Efficacy|5|||
49072720|NCT02500576|158098439|FG000|Overall Study|Withdrawal by Subject|1|||
49072721|NCT02500576|158098440|FG001|Overall Study|Withdrawal by Subject|1|||
49072722|NCT01908907|158100389|FG000|Overall Study|Physician Decision|1|||
49072723|NCT01908907|158100390|FG001|Overall Study|Physician Decision|0|||
49072724|NCT01908907|158100389|FG000|Overall Study|Protocol Violation|1|||
49072725|NCT01908907|158100390|FG001|Overall Study|Protocol Violation|0|||
49072726|NCT00660907|158100391|FG000|Overall Study|Incorrect Enrollment|1|||
49072727|NCT00660907|158100392|FG001|Overall Study|Incorrect Enrollment|1|||
49072728|NCT00660907|158100391|FG000|Overall Study|Adverse Event|33|||
49072729|NCT00660907|158100392|FG001|Overall Study|Adverse Event|19|||
49072730|NCT00660907|158100391|FG000|Overall Study|Subject No Longer Meets Study Criteria|6|||
49072731|NCT00660907|158100392|FG001|Overall Study|Subject No Longer Meets Study Criteria|27|||
49072732|NCT00660907|158100391|FG000|Overall Study|Withdrawal by Subject|23|||
49072733|NCT00660907|158100392|FG001|Overall Study|Withdrawal by Subject|32|||
49072734|NCT00660907|158100391|FG000|Overall Study|Lost to Follow-up|3|||
49072735|NCT00660907|158100392|FG001|Overall Study|Lost to Follow-up|3|||
49072736|NCT00660907|158100391|FG000|Overall Study|Poor/Non-Compliance|5|||
49072737|NCT00660907|158100392|FG001|Overall Study|Poor/Non-Compliance|1|||
49072738|NCT00660907|158100391|FG000|Overall Study|Safety|1|||
49072739|NCT00660907|158100392|FG001|Overall Study|Safety|0|||
49072740|NCT00660907|158100391|FG000|Overall Study|Death|1|||
49072741|NCT00660907|158100392|FG001|Overall Study|Death|3|||
49072742|NCT00660907|158100391|FG000|Overall Study|Various|11|||
49072743|NCT00660907|158100392|FG001|Overall Study|Various|8|||
49072744|NCT04975191|158100395|FG000|Overall Study|Protocol Violation|1|||
49072745|NCT04975191|158100396|FG001|Overall Study|Protocol Violation|2|||
49072746|NCT04975191|158100397|FG002|Overall Study|Protocol Violation|2|||
49072747|NCT04975191|158100398|FG003|Overall Study|Protocol Violation|2|||
49072748|NCT04975191|158100395|FG000|Overall Study|Lost to Follow-up|13|||
49072749|NCT04975191|158100396|FG001|Overall Study|Lost to Follow-up|3|||
49072750|NCT04975191|158100397|FG002|Overall Study|Lost to Follow-up|8|||
49072751|NCT04975191|158100398|FG003|Overall Study|Lost to Follow-up|8|||
49072752|NCT03976362|158100399|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|198|||
49072753|NCT03976362|158100400|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
49072754|NCT03976362|158100401|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
49072755|NCT03976362|158100399|FG000|Induction Phase|Death|62|||
49072756|NCT03976362|158100400|FG001|Induction Phase|Death|0|||
49072757|NCT03976362|158100401|FG002|Induction Phase|Death|0|||
49072758|NCT03976362|158100399|FG000|Maintenance Phase|Participants Ongoing|0|||
49072759|NCT03976362|158100400|FG001|Maintenance Phase|Participants Ongoing|106|||
49072760|NCT03976362|158100401|FG002|Maintenance Phase|Participants Ongoing|103|||
49072761|NCT03976362|158100399|FG000|Maintenance Phase|Withdrawal by Subject|0|||
49072762|NCT03976362|158100400|FG001|Maintenance Phase|Withdrawal by Subject|4|||
49072763|NCT03976362|158100401|FG002|Maintenance Phase|Withdrawal by Subject|4|||
49072764|NCT03976362|158100399|FG000|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
49072765|NCT03976362|158100400|FG001|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
49072766|NCT03976362|158100401|FG002|Maintenance Phase|Failure To Meet Randomization Criteria|1|||
49072767|NCT03976362|158100399|FG000|Maintenance Phase|Death|0|||
49072768|NCT03976362|158100400|FG001|Maintenance Phase|Death|186|||
49072769|NCT03976362|158100401|FG002|Maintenance Phase|Death|187|||
49072770|NCT03848065|158100402|FG000|Overall Study|Death|0|||
49072771|NCT03848065|158100403|FG001|Overall Study|Death|1|||
49072772|NCT03848065|158100404|FG002|Overall Study|Death|0|||
49072773|NCT03848065|158100402|FG000|Overall Study|Lost to Follow-up|0|||
49072774|NCT03848065|158100403|FG001|Overall Study|Lost to Follow-up|0|||
49072775|NCT03848065|158100404|FG002|Overall Study|Lost to Follow-up|1|||
49072776|NCT03848065|158100402|FG000|Overall Study|Physician Decision|0|||
49072777|NCT03848065|158100403|FG001|Overall Study|Physician Decision|0|||
49072778|NCT03848065|158100404|FG002|Overall Study|Physician Decision|1|||
49072779|NCT00631657|158100405|FG000|6-Month Treatment Period|Adverse Event|47|||
49072780|NCT00631657|158100406|FG001|6-Month Treatment Period|Adverse Event|0|||
49072781|NCT00631657|158100407|FG002|6-Month Treatment Period|Adverse Event|7|||
49072782|NCT00631657|158100405|FG000|6-Month Treatment Period|Withdrawal by Subject|14|||
49072783|NCT00631657|158100406|FG001|6-Month Treatment Period|Withdrawal by Subject|0|||
49072784|NCT00631657|158100407|FG002|6-Month Treatment Period|Withdrawal by Subject|5|||
49072785|NCT00631657|158100405|FG000|6-Month Treatment Period|Lack of Efficacy|34|||
49072786|NCT00631657|158100406|FG001|6-Month Treatment Period|Lack of Efficacy|0|||
49072787|NCT00631657|158100407|FG002|6-Month Treatment Period|Lack of Efficacy|25|||
49072788|NCT00631657|158100405|FG000|6-Month Treatment Period|Lost to Follow-up|7|||
49072789|NCT00631657|158100406|FG001|6-Month Treatment Period|Lost to Follow-up|0|||
49072790|NCT00631657|158100407|FG002|6-Month Treatment Period|Lost to Follow-up|2|||
49072791|NCT00631657|158100405|FG000|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21|||
49072792|NCT00631657|158100406|FG001|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0|||
49072793|NCT00631657|158100407|FG002|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6|||
49072794|NCT00631657|158100405|FG000|6-Month Treatment Period|Other|16|||
49072795|NCT00631657|158100406|FG001|6-Month Treatment Period|Other|0|||
49072796|NCT00631657|158100407|FG002|6-Month Treatment Period|Other|4|||
49072797|NCT00631657|158100405|FG000|6-Month Treatment Period|Not Treated|2|||
49072798|NCT00631657|158100406|FG001|6-Month Treatment Period|Not Treated|0|||
49072799|NCT00631657|158100407|FG002|6-Month Treatment Period|Not Treated|1|||
49072800|NCT00631657|158100405|FG000|7-Day Discontinuation Period|Not Treated|1|||
49072801|NCT00631657|158100406|FG001|7-Day Discontinuation Period|Not Treated|1|||
49072802|NCT00631657|158100407|FG002|7-Day Discontinuation Period|Not Treated|1|||
49072803|NCT00631657|158100405|FG000|7-Day Discontinuation Period|Other|1|||
49072804|NCT00631657|158100406|FG001|7-Day Discontinuation Period|Other|0|||
49072805|NCT00631657|158100407|FG002|7-Day Discontinuation Period|Other|0|||
49072806|NCT01994291|158100410|FG000|Overall Study|Adverse Event|4|||
49072807|NCT01994291|158100411|FG001|Overall Study|Adverse Event|1|||
49072808|NCT01994291|158100412|FG002|Overall Study|Adverse Event|3|||
49072809|NCT01994291|158100410|FG000|Overall Study|Lost to Follow-up|1|||
49072810|NCT01994291|158100411|FG001|Overall Study|Lost to Follow-up|1|||
49072811|NCT01994291|158100412|FG002|Overall Study|Lost to Follow-up|0|||
49072812|NCT01994291|158100410|FG000|Overall Study|Does not meet entrance criteria|1|||
49072813|NCT01994291|158100411|FG001|Overall Study|Does not meet entrance criteria|0|||
49072814|NCT01994291|158100412|FG002|Overall Study|Does not meet entrance criteria|0|||
49072815|NCT01994291|158100410|FG000|Overall Study|Medication error without associated AE|1|||
49072816|NCT01994291|158100411|FG001|Overall Study|Medication error without associated AE|0|||
49072817|NCT01994291|158100412|FG002|Overall Study|Medication error without associated AE|1|||
49072818|NCT01994291|158100410|FG000|Overall Study|Protocol Violation|1|||
49072819|NCT01994291|158100411|FG001|Overall Study|Protocol Violation|0|||
49072820|NCT01994291|158100412|FG002|Overall Study|Protocol Violation|0|||
49072821|NCT01994291|158100410|FG000|Overall Study|Withdrawal by Subject|6|||
49072822|NCT01994291|158100411|FG001|Overall Study|Withdrawal by Subject|3|||
49072823|NCT01994291|158100412|FG002|Overall Study|Withdrawal by Subject|5|||
49072824|NCT01994291|158100410|FG000|Overall Study|Other|1|||
49072825|NCT01994291|158100411|FG001|Overall Study|Other|2|||
49072826|NCT01994291|158100412|FG002|Overall Study|Other|0|||
49072827|NCT04611529|158100413|FG000|2-day Follow up|Lost to Follow-up|5|||
49072828|NCT04611529|158100414|FG001|2-day Follow up|Lost to Follow-up|6|||
49072829|NCT04611529|158100415|FG002|2-day Follow up|Lost to Follow-up|3|||
49072830|NCT01775189|158100416|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
49072831|NCT01775189|158100417|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
49072832|NCT01775189|158100418|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
49072833|NCT01775189|158100419|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
49072834|NCT01775189|158100420|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
49072835|NCT01775189|158100421|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
49072836|NCT01775189|158100422|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
49072837|NCT01775189|158100416|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
49072838|NCT01775189|158100417|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|1|||
49072839|NCT01775189|158100418|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
49072840|NCT01775189|158100419|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
49072841|NCT01775189|158100420|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
49072842|NCT01775189|158100421|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
49072843|NCT01775189|158100422|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
49072844|NCT01775189|158100416|FG000|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
49072845|NCT01775189|158100417|FG001|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2|||
49072846|NCT01775189|158100418|FG002|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7|||
49072847|NCT01775189|158100419|FG003|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
49072848|NCT01775189|158100420|FG004|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
49072849|NCT01775189|158100421|FG005|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
49072850|NCT01775189|158100422|FG006|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
49072851|NCT01775189|158100416|FG000|Treatment Phase: Washout Period 1|Protocol Violation|0|||
49072852|NCT01775189|158100417|FG001|Treatment Phase: Washout Period 1|Protocol Violation|0|||
49072853|NCT01775189|158100418|FG002|Treatment Phase: Washout Period 1|Protocol Violation|0|||
49072854|NCT01775189|158100419|FG003|Treatment Phase: Washout Period 1|Protocol Violation|0|||
49072855|NCT01775189|158100420|FG004|Treatment Phase: Washout Period 1|Protocol Violation|0|||
49072856|NCT01775189|158100421|FG005|Treatment Phase: Washout Period 1|Protocol Violation|1|||
49072857|NCT01775189|158100422|FG006|Treatment Phase: Washout Period 1|Protocol Violation|0|||
49072858|NCT01775189|158100416|FG000|Treatment Phase: Washout Period 2|Protocol Violation|0|||
49072859|NCT01775189|158100417|FG001|Treatment Phase: Washout Period 2|Protocol Violation|0|||
49072860|NCT01775189|158100418|FG002|Treatment Phase: Washout Period 2|Protocol Violation|0|||
49072861|NCT01775189|158100419|FG003|Treatment Phase: Washout Period 2|Protocol Violation|1|||
49072862|NCT01775189|158100420|FG004|Treatment Phase: Washout Period 2|Protocol Violation|0|||
49072863|NCT01775189|158100421|FG005|Treatment Phase: Washout Period 2|Protocol Violation|0|||
49072864|NCT01775189|158100422|FG006|Treatment Phase: Washout Period 2|Protocol Violation|0|||
49072865|NCT01775189|158100416|FG000|Treatment Phase: Washout Period 3|Protocol Violation|0|||
49072866|NCT01775189|158100417|FG001|Treatment Phase: Washout Period 3|Protocol Violation|0|||
49072867|NCT01775189|158100418|FG002|Treatment Phase: Washout Period 3|Protocol Violation|0|||
49072868|NCT01775189|158100419|FG003|Treatment Phase: Washout Period 3|Protocol Violation|1|||
49072869|NCT01775189|158100420|FG004|Treatment Phase: Washout Period 3|Protocol Violation|0|||
49072870|NCT01775189|158100421|FG005|Treatment Phase: Washout Period 3|Protocol Violation|0|||
49072871|NCT01775189|158100422|FG006|Treatment Phase: Washout Period 3|Protocol Violation|1|||
49072872|NCT00856375|158100424|FG000|Overall Study|Other|0|||
49072873|NCT00856375|158100425|FG001|Overall Study|Other|1|||
49072874|NCT00856375|158100424|FG000|Overall Study|Death|32|||
49072875|NCT00856375|158100425|FG001|Overall Study|Death|30|||
49072876|NCT00856375|158100424|FG000|Overall Study|Sponsor Terminated Study|7|||
49072877|NCT00856375|158100425|FG001|Overall Study|Sponsor Terminated Study|7|||
49072878|NCT00856375|158100424|FG000|Overall Study|Withdrawal by Subject|2|||
49072879|NCT00856375|158100425|FG001|Overall Study|Withdrawal by Subject|1|||
49072880|NCT00856375|158100424|FG000|Overall Study|Lost to Follow-up|1|||
49072881|NCT00856375|158100425|FG001|Overall Study|Lost to Follow-up|2|||
49072882|NCT00715624|158100426|FG000|Overall Study|Adverse Event|12|||
49072883|NCT00715624|158100427|FG001|Overall Study|Adverse Event|37|||
49072884|NCT00715624|158100426|FG000|Overall Study|Lack of Efficacy|11|||
49072885|NCT00715624|158100427|FG001|Overall Study|Lack of Efficacy|11|||
49072886|NCT00715624|158100426|FG000|Overall Study|Lost to Follow-up|1|||
49072887|NCT00715624|158100427|FG001|Overall Study|Lost to Follow-up|2|||
49072888|NCT00715624|158100426|FG000|Overall Study|Protocol Violation|1|||
49072889|NCT00715624|158100427|FG001|Overall Study|Protocol Violation|0|||
49072890|NCT00715624|158100426|FG000|Overall Study|Withdrawal by Subject|11|||
49072891|NCT00715624|158100427|FG001|Overall Study|Withdrawal by Subject|25|||
49072892|NCT00715624|158100426|FG000|Overall Study|Familial and personal reasons|10|||
49072893|NCT00715624|158100427|FG001|Overall Study|Familial and personal reasons|22|||
49072894|NCT00715624|158100426|FG000|Overall Study|Poor compliance|6|||
49072895|NCT00715624|158100427|FG001|Overall Study|Poor compliance|13|||
49072896|NCT00715624|158100426|FG000|Overall Study|Sponsor decision|0|||
49072897|NCT00715624|158100427|FG001|Overall Study|Sponsor decision|4|||
49072898|NCT00715624|158100426|FG000|Overall Study|Incorrect randomization (not treated)|0|||
49072899|NCT00715624|158100427|FG001|Overall Study|Incorrect randomization (not treated)|1|||
49072900|NCT00715624|158100426|FG000|Overall Study|Other|0|||
49072901|NCT00715624|158100427|FG001|Overall Study|Other|1|||
49072902|NCT00428116|158100428|FG000|Overall Study|Death|1|||
49072903|NCT00428116|158100429|FG001|Overall Study|Death|0|||
49072904|NCT00428116|158100428|FG000|Overall Study|Withdrawal by Subject|1|||
49072905|NCT00428116|158100429|FG001|Overall Study|Withdrawal by Subject|0|||
49072906|NCT00428116|158100428|FG000|Overall Study|Lost to Follow-up|1|||
49072907|NCT00428116|158100429|FG001|Overall Study|Lost to Follow-up|0|||
49072908|NCT03200912|158100430|FG000|Overall Study|Adverse Event|3|||
49072909|NCT03200912|158100431|FG001|Overall Study|Adverse Event|0|||
49072910|NCT03200912|158100432|FG002|Overall Study|Adverse Event|0|||
49072911|NCT03200912|158100430|FG000|Overall Study|Withdrawal by Subject|1|||
49072912|NCT03200912|158100431|FG001|Overall Study|Withdrawal by Subject|2|||
49072913|NCT03200912|158100432|FG002|Overall Study|Withdrawal by Subject|4|||
49072914|NCT03200912|158100430|FG000|Overall Study|Non-compliance with study drug|0|||
49072915|NCT03200912|158100431|FG001|Overall Study|Non-compliance with study drug|1|||
49072916|NCT03200912|158100432|FG002|Overall Study|Non-compliance with study drug|0|||
49072917|NCT03196635|158100434|FG000|Overall Study|Withdrawal by Subject|1|||
49072918|NCT01831258|158100435|FG000|Overall Study|Withdrawal by Subject|2|||
49072919|NCT01831258|158100436|FG001|Overall Study|Withdrawal by Subject|1|||
49072920|NCT01831258|158100435|FG000|Overall Study|Lost to Follow-up|3|||
49072921|NCT01831258|158100436|FG001|Overall Study|Lost to Follow-up|2|||
49072922|NCT00425373|158100444|FG000|Overall Study|Adverse Event|2|||
49072923|NCT00425373|158100445|FG001|Overall Study|Adverse Event|2|||
49072924|NCT00425373|158100446|FG002|Overall Study|Adverse Event|0|||
49072925|NCT00425373|158100447|FG003|Overall Study|Adverse Event|1|||
49072926|NCT00425373|158100448|FG004|Overall Study|Adverse Event|4|||
49072927|NCT00425373|158100449|FG005|Overall Study|Adverse Event|6|||
49072928|NCT00425373|158100450|FG006|Overall Study|Adverse Event|2|||
49072929|NCT00425373|158100451|FG007|Overall Study|Adverse Event|3|||
49072930|NCT00425373|158100452|FG008|Overall Study|Adverse Event|8|||
49072931|NCT00425373|158100444|FG000|Overall Study|Lost to Follow-up|0|||
49072932|NCT00425373|158100445|FG001|Overall Study|Lost to Follow-up|1|||
49072933|NCT00425373|158100446|FG002|Overall Study|Lost to Follow-up|0|||
49072934|NCT00425373|158100447|FG003|Overall Study|Lost to Follow-up|0|||
49072935|NCT00425373|158100448|FG004|Overall Study|Lost to Follow-up|1|||
49072936|NCT00425373|158100449|FG005|Overall Study|Lost to Follow-up|0|||
49072937|NCT00425373|158100450|FG006|Overall Study|Lost to Follow-up|0|||
49072938|NCT00425373|158100451|FG007|Overall Study|Lost to Follow-up|0|||
49072939|NCT00425373|158100452|FG008|Overall Study|Lost to Follow-up|0|||
49072940|NCT00425373|158100444|FG000|Overall Study|Protocol Violation|1|||
49072941|NCT00425373|158100445|FG001|Overall Study|Protocol Violation|0|||
49072942|NCT00425373|158100446|FG002|Overall Study|Protocol Violation|1|||
49072943|NCT00425373|158100447|FG003|Overall Study|Protocol Violation|0|||
49072944|NCT00425373|158100448|FG004|Overall Study|Protocol Violation|0|||
49072945|NCT00425373|158100449|FG005|Overall Study|Protocol Violation|0|||
49072946|NCT00425373|158100450|FG006|Overall Study|Protocol Violation|0|||
49072947|NCT00425373|158100451|FG007|Overall Study|Protocol Violation|5|||
49072948|NCT00425373|158100452|FG008|Overall Study|Protocol Violation|3|||
49072949|NCT00425373|158100444|FG000|Overall Study|Withdrawal by Subject|2|||
49072950|NCT00425373|158100445|FG001|Overall Study|Withdrawal by Subject|0|||
49072951|NCT00425373|158100446|FG002|Overall Study|Withdrawal by Subject|2|||
49072952|NCT00425373|158100447|FG003|Overall Study|Withdrawal by Subject|1|||
49072953|NCT00425373|158100448|FG004|Overall Study|Withdrawal by Subject|4|||
49072954|NCT00425373|158100449|FG005|Overall Study|Withdrawal by Subject|0|||
49072955|NCT00425373|158100450|FG006|Overall Study|Withdrawal by Subject|2|||
49072956|NCT00425373|158100451|FG007|Overall Study|Withdrawal by Subject|2|||
49072957|NCT00425373|158100452|FG008|Overall Study|Withdrawal by Subject|2|||
49072958|NCT00425373|158100444|FG000|Overall Study|Lack of Efficacy|0|||
49072959|NCT00425373|158100445|FG001|Overall Study|Lack of Efficacy|0|||
49072960|NCT00425373|158100446|FG002|Overall Study|Lack of Efficacy|0|||
49072961|NCT00425373|158100447|FG003|Overall Study|Lack of Efficacy|0|||
49072962|NCT00425373|158100448|FG004|Overall Study|Lack of Efficacy|1|||
49072963|NCT00425373|158100449|FG005|Overall Study|Lack of Efficacy|3|||
49072964|NCT00425373|158100450|FG006|Overall Study|Lack of Efficacy|3|||
49072965|NCT00425373|158100451|FG007|Overall Study|Lack of Efficacy|0|||
49072966|NCT00425373|158100452|FG008|Overall Study|Lack of Efficacy|5|||
49072967|NCT00253448|158100453|FG000|Overall Study|Withdrawal by Subject|1|||
49072968|NCT00229723|158100455|FG000|Concomitant Phase|Adverse Event|4|||
49072969|NCT00229723|158100456|FG001|Concomitant Phase|Adverse Event|2|||
49072970|NCT00229723|158100457|FG002|Concomitant Phase|Adverse Event|5|||
49072971|NCT00229723|158100458|FG003|Concomitant Phase|Adverse Event|2|||
49072972|NCT00229723|158100459|FG004|Concomitant Phase|Adverse Event|0|||
49072973|NCT00229723|158100460|FG005|Concomitant Phase|Adverse Event|1|||
49072974|NCT00229723|158100461|FG006|Concomitant Phase|Adverse Event|2|||
49072975|NCT00229723|158100455|FG000|Concomitant Phase|Objective disease progression|0|||
49072976|NCT00229723|158100456|FG001|Concomitant Phase|Objective disease progression|0|||
49072977|NCT00229723|158100457|FG002|Concomitant Phase|Objective disease progression|0|||
49072978|NCT00229723|158100458|FG003|Concomitant Phase|Objective disease progression|0|||
49072979|NCT00229723|158100459|FG004|Concomitant Phase|Objective disease progression|0|||
49072980|NCT00229723|158100460|FG005|Concomitant Phase|Objective disease progression|0|||
49072981|NCT00229723|158100461|FG006|Concomitant Phase|Objective disease progression|0|||
49072982|NCT00229723|158100455|FG000|Concomitant Phase|Clinical progression|0|||
49072983|NCT00229723|158100456|FG001|Concomitant Phase|Clinical progression|0|||
49072984|NCT00229723|158100457|FG002|Concomitant Phase|Clinical progression|0|||
49072985|NCT00229723|158100458|FG003|Concomitant Phase|Clinical progression|0|||
49072986|NCT00229723|158100459|FG004|Concomitant Phase|Clinical progression|0|||
49072987|NCT00229723|158100460|FG005|Concomitant Phase|Clinical progression|0|||
49072988|NCT00229723|158100461|FG006|Concomitant Phase|Clinical progression|1|||
49072989|NCT00229723|158100455|FG000|Concomitant Phase|Lost to Follow-up|0|||
49072990|NCT00229723|158100456|FG001|Concomitant Phase|Lost to Follow-up|0|||
49072991|NCT00229723|158100457|FG002|Concomitant Phase|Lost to Follow-up|0|||
49072992|NCT00229723|158100458|FG003|Concomitant Phase|Lost to Follow-up|0|||
49072993|NCT00229723|158100459|FG004|Concomitant Phase|Lost to Follow-up|1|||
49072994|NCT00229723|158100460|FG005|Concomitant Phase|Lost to Follow-up|0|||
49072995|NCT00229723|158100461|FG006|Concomitant Phase|Lost to Follow-up|0|||
49072996|NCT00229723|158100455|FG000|Concomitant Phase|Informed consent withdrawn|3|||
49072997|NCT00229723|158100456|FG001|Concomitant Phase|Informed consent withdrawn|2|||
49072998|NCT00229723|158100457|FG002|Concomitant Phase|Informed consent withdrawn|0|||
49072999|NCT00229723|158100458|FG003|Concomitant Phase|Informed consent withdrawn|2|||
49073000|NCT00229723|158100459|FG004|Concomitant Phase|Informed consent withdrawn|0|||
49073001|NCT00229723|158100460|FG005|Concomitant Phase|Informed consent withdrawn|0|||
49073002|NCT00229723|158100461|FG006|Concomitant Phase|Informed consent withdrawn|0|||
49073003|NCT00229723|158100455|FG000|Concomitant Phase|Severe non-compliance|0|||
49073004|NCT00229723|158100456|FG001|Concomitant Phase|Severe non-compliance|1|||
49073005|NCT00229723|158100457|FG002|Concomitant Phase|Severe non-compliance|0|||
49073006|NCT00229723|158100458|FG003|Concomitant Phase|Severe non-compliance|0|||
49073007|NCT00229723|158100459|FG004|Concomitant Phase|Severe non-compliance|1|||
49073008|NCT00229723|158100460|FG005|Concomitant Phase|Severe non-compliance|0|||
49073009|NCT00229723|158100461|FG006|Concomitant Phase|Severe non-compliance|0|||
49073010|NCT00229723|158100455|FG000|Concomitant Phase|Other|3|||
49073011|NCT00229723|158100456|FG001|Concomitant Phase|Other|0|||
49073012|NCT00229723|158100457|FG002|Concomitant Phase|Other|1|||
49073013|NCT00229723|158100458|FG003|Concomitant Phase|Other|1|||
49073014|NCT00229723|158100459|FG004|Concomitant Phase|Other|0|||
49073015|NCT00229723|158100460|FG005|Concomitant Phase|Other|2|||
49073016|NCT00229723|158100461|FG006|Concomitant Phase|Other|0|||
49073017|NCT00229723|158100455|FG000|Maintenance Phase|Adverse Event|7|||
49073018|NCT00229723|158100456|FG001|Maintenance Phase|Adverse Event|2|||
49073019|NCT00229723|158100457|FG002|Maintenance Phase|Adverse Event|1|||
49073020|NCT00229723|158100458|FG003|Maintenance Phase|Adverse Event|4|||
49073021|NCT00229723|158100459|FG004|Maintenance Phase|Adverse Event|7|||
49073022|NCT00229723|158100460|FG005|Maintenance Phase|Adverse Event|5|||
49073023|NCT00229723|158100461|FG006|Maintenance Phase|Adverse Event|2|||
49073024|NCT00229723|158100455|FG000|Maintenance Phase|Objective disease progression|5|||
49073025|NCT00229723|158100456|FG001|Maintenance Phase|Objective disease progression|5|||
49073026|NCT00229723|158100457|FG002|Maintenance Phase|Objective disease progression|3|||
49073027|NCT00229723|158100458|FG003|Maintenance Phase|Objective disease progression|6|||
49073028|NCT00229723|158100459|FG004|Maintenance Phase|Objective disease progression|2|||
49073029|NCT00229723|158100460|FG005|Maintenance Phase|Objective disease progression|9|||
49073030|NCT00229723|158100461|FG006|Maintenance Phase|Objective disease progression|5|||
49073031|NCT00229723|158100455|FG000|Maintenance Phase|Clinical progression|4|||
49073032|NCT00229723|158100456|FG001|Maintenance Phase|Clinical progression|1|||
49073033|NCT00229723|158100457|FG002|Maintenance Phase|Clinical progression|2|||
49073034|NCT00229723|158100458|FG003|Maintenance Phase|Clinical progression|2|||
49073035|NCT00229723|158100459|FG004|Maintenance Phase|Clinical progression|1|||
49073036|NCT00229723|158100460|FG005|Maintenance Phase|Clinical progression|1|||
49073037|NCT00229723|158100461|FG006|Maintenance Phase|Clinical progression|1|||
49073038|NCT00229723|158100455|FG000|Maintenance Phase|Lost to Follow-up|0|||
49073039|NCT00229723|158100456|FG001|Maintenance Phase|Lost to Follow-up|1|||
49073040|NCT00229723|158100457|FG002|Maintenance Phase|Lost to Follow-up|2|||
49073041|NCT00229723|158100458|FG003|Maintenance Phase|Lost to Follow-up|2|||
49073042|NCT00229723|158100459|FG004|Maintenance Phase|Lost to Follow-up|0|||
49073043|NCT00229723|158100460|FG005|Maintenance Phase|Lost to Follow-up|0|||
49073044|NCT00229723|158100461|FG006|Maintenance Phase|Lost to Follow-up|1|||
49073045|NCT00229723|158100455|FG000|Maintenance Phase|Informed consent withdrawn|1|||
49073046|NCT00229723|158100456|FG001|Maintenance Phase|Informed consent withdrawn|0|||
49073047|NCT00229723|158100457|FG002|Maintenance Phase|Informed consent withdrawn|0|||
49073048|NCT00229723|158100458|FG003|Maintenance Phase|Informed consent withdrawn|1|||
49073049|NCT00229723|158100459|FG004|Maintenance Phase|Informed consent withdrawn|1|||
49073050|NCT00229723|158100460|FG005|Maintenance Phase|Informed consent withdrawn|1|||
49073051|NCT00229723|158100461|FG006|Maintenance Phase|Informed consent withdrawn|0|||
49073052|NCT00229723|158100455|FG000|Maintenance Phase|Severe non-compliance|3|||
49073053|NCT00229723|158100456|FG001|Maintenance Phase|Severe non-compliance|1|||
49073054|NCT00229723|158100457|FG002|Maintenance Phase|Severe non-compliance|0|||
49073055|NCT00229723|158100458|FG003|Maintenance Phase|Severe non-compliance|0|||
49073056|NCT00229723|158100459|FG004|Maintenance Phase|Severe non-compliance|1|||
49073057|NCT00229723|158100460|FG005|Maintenance Phase|Severe non-compliance|0|||
49073058|NCT00229723|158100461|FG006|Maintenance Phase|Severe non-compliance|0|||
49073059|NCT00229723|158100455|FG000|Maintenance Phase|Other|5|||
49073060|NCT00229723|158100456|FG001|Maintenance Phase|Other|4|||
49073061|NCT00229723|158100457|FG002|Maintenance Phase|Other|1|||
49073062|NCT00229723|158100458|FG003|Maintenance Phase|Other|2|||
49073063|NCT00229723|158100459|FG004|Maintenance Phase|Other|3|||
49073064|NCT00229723|158100460|FG005|Maintenance Phase|Other|3|||
49073065|NCT00229723|158100461|FG006|Maintenance Phase|Other|1|||
49073066|NCT02309138|158100462|FG000|Overall Study|Withdrawal by Subject|44|||
49073067|NCT02309138|158100463|FG001|Overall Study|Withdrawal by Subject|15|||
49073068|NCT02309138|158100462|FG000|Overall Study|Protocol Violation|4|||
49073069|NCT02309138|158100463|FG001|Overall Study|Protocol Violation|2|||
49073070|NCT02309138|158100462|FG000|Overall Study|delivered before visit 2|0|||
49073071|NCT02309138|158100463|FG001|Overall Study|delivered before visit 2|1|||
49073072|NCT02564887|158100469|FG000|Overall Study|Lost to Follow-up|6|||
49073073|NCT02564887|158100470|FG001|Overall Study|Lost to Follow-up|0|||
49073074|NCT00998309|158100476|FG000|Overall Study|Protocol Violation|4|||
49073075|NCT02052011|158100482|FG000|Overall Study|Lost to Follow-up|3|||
49073076|NCT02052011|158100483|FG001|Overall Study|Lost to Follow-up|0|||
49073077|NCT02052011|158100482|FG000|Overall Study|Withdrawal by Subject|1|||
49073078|NCT02052011|158100483|FG001|Overall Study|Withdrawal by Subject|2|||
49073079|NCT02960490|158100484|FG000|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3|||
49073080|NCT02960490|158100485|FG001|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2|||
49073081|NCT02960490|158100486|FG002|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
49073082|NCT02960490|158100487|FG003|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
49073083|NCT02960490|158100488|FG004|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
49073084|NCT02960490|158100489|FG005|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
49073085|NCT02960490|158100490|FG006|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
49073086|NCT02960490|158100491|FG007|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
49073087|NCT02960490|158100492|FG008|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
49073088|NCT02960490|158100493|FG009|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
49073089|NCT02960490|158100484|FG000|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
49073090|NCT02960490|158100485|FG001|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1|||
49073091|NCT02960490|158100486|FG002|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
49073092|NCT02960490|158100487|FG003|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
49073093|NCT02960490|158100488|FG004|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
49073094|NCT02960490|158100489|FG005|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
49073095|NCT02960490|158100490|FG006|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
49073096|NCT02960490|158100491|FG007|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
49073097|NCT02960490|158100492|FG008|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
49073098|NCT02960490|158100493|FG009|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
49073099|NCT02960490|158100484|FG000|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1|||
49073100|NCT02960490|158100485|FG001|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2|||
49073101|NCT02960490|158100486|FG002|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
49073102|NCT02960490|158100487|FG003|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
49073103|NCT02960490|158100488|FG004|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
49073104|NCT02960490|158100489|FG005|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
49073105|NCT02960490|158100490|FG006|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
49073106|NCT02960490|158100491|FG007|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
49073107|NCT02960490|158100492|FG008|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
49073108|NCT02960490|158100493|FG009|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
49073109|NCT02960490|158100484|FG000|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
49073110|NCT02960490|158100485|FG001|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
49073111|NCT02960490|158100486|FG002|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
49073112|NCT02960490|158100487|FG003|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
49073113|NCT02960490|158100488|FG004|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
49073114|NCT02960490|158100489|FG005|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
49073115|NCT02960490|158100490|FG006|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
49073116|NCT02960490|158100491|FG007|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
49073117|NCT02960490|158100492|FG008|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
49073118|NCT02960490|158100493|FG009|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
49073119|NCT02960490|158100484|FG000|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
49073120|NCT02960490|158100485|FG001|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
49073121|NCT02960490|158100486|FG002|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
49073122|NCT02960490|158100487|FG003|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
49073123|NCT02960490|158100488|FG004|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
49073124|NCT02960490|158100489|FG005|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2|||
49073125|NCT02960490|158100490|FG006|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
49073126|NCT02960490|158100491|FG007|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
49073127|NCT02960490|158100492|FG008|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
49073128|NCT02960490|158100493|FG009|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
49073129|NCT02960490|158100484|FG000|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
49073130|NCT02960490|158100485|FG001|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
49073131|NCT02960490|158100486|FG002|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
49073132|NCT02960490|158100487|FG003|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
49073133|NCT02960490|158100488|FG004|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
49073134|NCT02960490|158100489|FG005|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
49073135|NCT02960490|158100490|FG006|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
49073136|NCT02960490|158100491|FG007|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
49073137|NCT02960490|158100492|FG008|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
49073138|NCT02960490|158100493|FG009|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
49073139|NCT02960490|158100484|FG000|Re-randomized Participants: 12 Weeks|Other|0|||
49073140|NCT02960490|158100485|FG001|Re-randomized Participants: 12 Weeks|Other|0|||
49073141|NCT02960490|158100486|FG002|Re-randomized Participants: 12 Weeks|Other|0|||
49073142|NCT02960490|158100487|FG003|Re-randomized Participants: 12 Weeks|Other|1|||
49073143|NCT02960490|158100488|FG004|Re-randomized Participants: 12 Weeks|Other|0|||
49073144|NCT02960490|158100489|FG005|Re-randomized Participants: 12 Weeks|Other|0|||
49073145|NCT02960490|158100490|FG006|Re-randomized Participants: 12 Weeks|Other|0|||
49073146|NCT02960490|158100491|FG007|Re-randomized Participants: 12 Weeks|Other|0|||
49073147|NCT02960490|158100492|FG008|Re-randomized Participants: 12 Weeks|Other|0|||
49073148|NCT02960490|158100493|FG009|Re-randomized Participants: 12 Weeks|Other|0|||
49073149|NCT02960490|158100484|FG000|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
49073150|NCT02960490|158100485|FG001|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
49073151|NCT02960490|158100486|FG002|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
49073152|NCT02960490|158100487|FG003|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
49073153|NCT02960490|158100488|FG004|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
49073154|NCT02960490|158100489|FG005|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
49073155|NCT02960490|158100490|FG006|Extension Phase(Open-label): 80 Weeks|Adverse Event|3|||
49073156|NCT02960490|158100491|FG007|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
49073157|NCT02960490|158100492|FG008|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
49073158|NCT02960490|158100493|FG009|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
49073159|NCT02960490|158100484|FG000|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
49073160|NCT02960490|158100485|FG001|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
49073161|NCT02960490|158100486|FG002|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
49073162|NCT02960490|158100487|FG003|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
49073163|NCT02960490|158100488|FG004|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
49073164|NCT02960490|158100489|FG005|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
49073165|NCT02960490|158100490|FG006|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
49073166|NCT02960490|158100491|FG007|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1|||
49073167|NCT02960490|158100492|FG008|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
49073168|NCT02960490|158100493|FG009|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
49073169|NCT02960490|158100484|FG000|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
49073170|NCT02960490|158100485|FG001|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
49073171|NCT02960490|158100486|FG002|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
49073172|NCT02960490|158100487|FG003|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
49073173|NCT02960490|158100488|FG004|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
49073174|NCT02960490|158100489|FG005|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
49073175|NCT02960490|158100490|FG006|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4|||
49073176|NCT02960490|158100491|FG007|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
49073177|NCT02960490|158100492|FG008|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
49073178|NCT02960490|158100493|FG009|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7|||
49073179|NCT02960490|158100484|FG000|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
49073180|NCT02960490|158100485|FG001|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
49073181|NCT02960490|158100486|FG002|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
49073182|NCT02960490|158100487|FG003|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
49073183|NCT02960490|158100488|FG004|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
49073184|NCT02960490|158100489|FG005|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
49073185|NCT02960490|158100490|FG006|Extension Phase(Open-label): 80 Weeks|Disease Progression|2|||
49073186|NCT02960490|158100491|FG007|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
49073187|NCT02960490|158100492|FG008|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
49073188|NCT02960490|158100493|FG009|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
49073189|NCT02960490|158100484|FG000|Extension Phase(Open-label): 80 Weeks|Other|0|||
49073190|NCT02960490|158100485|FG001|Extension Phase(Open-label): 80 Weeks|Other|0|||
49073191|NCT02960490|158100486|FG002|Extension Phase(Open-label): 80 Weeks|Other|0|||
49073192|NCT02960490|158100487|FG003|Extension Phase(Open-label): 80 Weeks|Other|0|||
49073193|NCT02960490|158100488|FG004|Extension Phase(Open-label): 80 Weeks|Other|0|||
49073194|NCT02960490|158100489|FG005|Extension Phase(Open-label): 80 Weeks|Other|0|||
49073195|NCT02960490|158100490|FG006|Extension Phase(Open-label): 80 Weeks|Other|0|||
49073196|NCT02960490|158100491|FG007|Extension Phase(Open-label): 80 Weeks|Other|1|||
49073197|NCT02960490|158100492|FG008|Extension Phase(Open-label): 80 Weeks|Other|0|||
49073198|NCT02960490|158100493|FG009|Extension Phase(Open-label): 80 Weeks|Other|0|||
49073199|NCT00863772|158100494|FG000|Overall Study|Adverse Event|1|||
49073200|NCT00863772|158100495|FG001|Overall Study|Adverse Event|4|||
49073201|NCT00863772|158100496|FG002|Overall Study|Adverse Event|0|||
49073202|NCT00863772|158100494|FG000|Overall Study|Lack of Efficacy|4|||
49073203|NCT00863772|158100495|FG001|Overall Study|Lack of Efficacy|2|||
49073204|NCT00863772|158100496|FG002|Overall Study|Lack of Efficacy|4|||
49073205|NCT00863772|158100494|FG000|Overall Study|Lost to Follow-up|5|||
49073206|NCT00863772|158100495|FG001|Overall Study|Lost to Follow-up|1|||
49073207|NCT00863772|158100496|FG002|Overall Study|Lost to Follow-up|1|||
49073208|NCT00863772|158100494|FG000|Overall Study|Protocol Violation|2|||
49073209|NCT00863772|158100495|FG001|Overall Study|Protocol Violation|0|||
49073210|NCT00863772|158100496|FG002|Overall Study|Protocol Violation|2|||
49073211|NCT00863772|158100494|FG000|Overall Study|Withdrawal by Subject|4|||
49073212|NCT00863772|158100495|FG001|Overall Study|Withdrawal by Subject|7|||
49073213|NCT00863772|158100496|FG002|Overall Study|Withdrawal by Subject|5|||
49073214|NCT00863772|158100494|FG000|Overall Study|Study terminated by sponsor|44|||
49073215|NCT00863772|158100495|FG001|Overall Study|Study terminated by sponsor|45|||
49073216|NCT00863772|158100496|FG002|Overall Study|Study terminated by sponsor|36|||
49073217|NCT00863772|158100494|FG000|Overall Study|Entered extension study|6|||
49073218|NCT00863772|158100495|FG001|Overall Study|Entered extension study|4|||
49073219|NCT00863772|158100496|FG002|Overall Study|Entered extension study|9|||
49073220|NCT00863772|158100494|FG000|Overall Study|Other|1|||
49073221|NCT00863772|158100495|FG001|Overall Study|Other|2|||
49073222|NCT00863772|158100496|FG002|Overall Study|Other|4|||
49073223|NCT00863772|158100494|FG000|Overall Study|Randomized but not Treated|1|||
49073224|NCT00863772|158100495|FG001|Overall Study|Randomized but not Treated|0|||
49073225|NCT00863772|158100496|FG002|Overall Study|Randomized but not Treated|0|||
49073226|NCT01685840|158100500|FG000|Overall Study|Death|77|||
49073227|NCT01685840|158100501|FG001|Overall Study|Death|66|||
49073228|NCT01685840|158100500|FG000|Overall Study|Lost to Follow-up|27|||
49073229|NCT01685840|158100501|FG001|Overall Study|Lost to Follow-up|25|||
49073230|NCT01685840|158100500|FG000|Overall Study|Physician Decision|3|||
49073231|NCT01685840|158100501|FG001|Overall Study|Physician Decision|7|||
49073232|NCT01685840|158100500|FG000|Overall Study|Withdrawal by Subject|14|||
49073233|NCT01685840|158100501|FG001|Overall Study|Withdrawal by Subject|17|||
49073234|NCT01685840|158100500|FG000|Overall Study|Futility|197|||
49073235|NCT01685840|158100501|FG001|Overall Study|Futility|200|||
49073236|NCT01685840|158100500|FG000|Overall Study|Had VAD, Dialysis or Transplant|11|||
49073237|NCT01685840|158100501|FG001|Overall Study|Had VAD, Dialysis or Transplant|17|||
49073238|NCT04580914|158100502|FG000|Overall Study|Withdrawal by Subject|6|||
49073239|NCT04580914|158100502|FG000|Overall Study|Lost to Follow-up|2|||
49073240|NCT00489827|158100512|FG000|Overall Study|Intraoperative exclusion criteria|1|||
49073241|NCT00489827|158100513|FG001|Overall Study|Intraoperative exclusion criteria|1|||
49073242|NCT00489827|158100512|FG000|Overall Study|Intraoperative exclusion criteria|1|||
49073243|NCT00489827|158100513|FG001|Overall Study|Intraoperative exclusion criteria|1|||
49073244|NCT02296931|158100517|FG000|Overall Study|Protocol Violation|0|||
49073245|NCT02296931|158100518|FG001|Overall Study|Protocol Violation|2|||
49073246|NCT05771467|158100521|FG000|Overall Study|Lost to Follow-up|6|||
49073247|NCT05771467|158100522|FG001|Overall Study|Lost to Follow-up|3|||
49073248|NCT02933255|158100525|FG000|Overall Study|Discontinued due to study closure.|1|||
49073249|NCT02933255|158100526|FG001|Overall Study|Discontinued due to study closure.|0|||
49073250|NCT04386616|158100535|FG000|Overall Study|Death|22|||
49073251|NCT04386616|158100536|FG001|Overall Study|Death|22|||
49073252|NCT04386616|158100537|FG002|Overall Study|Death|21|||
49073253|NCT04386616|158100535|FG000|Overall Study|Lost to Follow-up|5|||
49073254|NCT04386616|158100536|FG001|Overall Study|Lost to Follow-up|8|||
49073255|NCT04386616|158100537|FG002|Overall Study|Lost to Follow-up|6|||
49073256|NCT04386616|158100535|FG000|Overall Study|Withdrawal by Subject|2|||
49073257|NCT04386616|158100536|FG001|Overall Study|Withdrawal by Subject|4|||
49073258|NCT04386616|158100537|FG002|Overall Study|Withdrawal by Subject|1|||
49073259|NCT04386616|158100535|FG000|Overall Study|Adverse Event|1|||
49073260|NCT04386616|158100536|FG001|Overall Study|Adverse Event|1|||
49073261|NCT04386616|158100537|FG002|Overall Study|Adverse Event|0|||
49073262|NCT03449446|158100538|FG000|Overall Study|Randomized but Never Treated|0|||
49073263|NCT03449446|158100539|FG001|Overall Study|Randomized but Never Treated|0|||
49073264|NCT03449446|158100540|FG002|Overall Study|Randomized but Never Treated|1|||
49073265|NCT03449446|158100541|FG003|Overall Study|Randomized but Never Treated|1|||
49073266|NCT03449446|158100542|FG004|Overall Study|Randomized but Never Treated|1|||
49073267|NCT03449446|158100543|FG005|Overall Study|Randomized but Never Treated|0|||
49073268|NCT03449446|158100544|FG006|Overall Study|Randomized but Never Treated|0|||
49073269|NCT03449446|158100538|FG000|Overall Study|Unknown Reason|33|||
49073270|NCT03449446|158100539|FG001|Overall Study|Unknown Reason|1|||
49073271|NCT03449446|158100540|FG002|Overall Study|Unknown Reason|1|||
49073272|NCT03449446|158100541|FG003|Overall Study|Unknown Reason|1|||
49073273|NCT03449446|158100542|FG004|Overall Study|Unknown Reason|2|||
49073274|NCT03449446|158100543|FG005|Overall Study|Unknown Reason|2|||
49073275|NCT03449446|158100544|FG006|Overall Study|Unknown Reason|0|||
49073276|NCT03449446|158100538|FG000|Overall Study|Withdrew Consent|1|||
49073277|NCT03449446|158100539|FG001|Overall Study|Withdrew Consent|3|||
49073278|NCT03449446|158100540|FG002|Overall Study|Withdrew Consent|1|||
49073279|NCT03449446|158100541|FG003|Overall Study|Withdrew Consent|4|||
49073280|NCT03449446|158100542|FG004|Overall Study|Withdrew Consent|4|||
49073281|NCT03449446|158100543|FG005|Overall Study|Withdrew Consent|4|||
49073282|NCT03449446|158100544|FG006|Overall Study|Withdrew Consent|1|||
49073283|NCT03449446|158100538|FG000|Overall Study|Adverse Event|1|||
49073284|NCT03449446|158100539|FG001|Overall Study|Adverse Event|2|||
49073285|NCT03449446|158100540|FG002|Overall Study|Adverse Event|1|||
49073286|NCT03449446|158100541|FG003|Overall Study|Adverse Event|0|||
49073287|NCT03449446|158100542|FG004|Overall Study|Adverse Event|0|||
49073288|NCT03449446|158100543|FG005|Overall Study|Adverse Event|2|||
49073289|NCT03449446|158100544|FG006|Overall Study|Adverse Event|0|||
49073290|NCT03449446|158100538|FG000|Overall Study|Lost to Follow-up|0|||
49073291|NCT03449446|158100539|FG001|Overall Study|Lost to Follow-up|0|||
49073292|NCT03449446|158100540|FG002|Overall Study|Lost to Follow-up|2|||
49073293|NCT03449446|158100541|FG003|Overall Study|Lost to Follow-up|1|||
49073294|NCT03449446|158100542|FG004|Overall Study|Lost to Follow-up|3|||
49073295|NCT03449446|158100543|FG005|Overall Study|Lost to Follow-up|0|||
49073296|NCT03449446|158100544|FG006|Overall Study|Lost to Follow-up|0|||
49073297|NCT03449446|158100538|FG000|Overall Study|Investigator's Discretion|0|||
49073298|NCT03449446|158100539|FG001|Overall Study|Investigator's Discretion|1|||
49073299|NCT03449446|158100540|FG002|Overall Study|Investigator's Discretion|1|||
49073300|NCT03449446|158100541|FG003|Overall Study|Investigator's Discretion|2|||
49073301|NCT03449446|158100542|FG004|Overall Study|Investigator's Discretion|0|||
49073302|NCT03449446|158100543|FG005|Overall Study|Investigator's Discretion|0|||
49073303|NCT03449446|158100544|FG006|Overall Study|Investigator's Discretion|0|||
49073304|NCT03449446|158100538|FG000|Overall Study|Non Compliance with Study Drug|1|||
49073305|NCT03449446|158100539|FG001|Overall Study|Non Compliance with Study Drug|0|||
49073306|NCT03449446|158100540|FG002|Overall Study|Non Compliance with Study Drug|0|||
49073307|NCT03449446|158100541|FG003|Overall Study|Non Compliance with Study Drug|0|||
49073308|NCT03449446|158100542|FG004|Overall Study|Non Compliance with Study Drug|0|||
49073309|NCT03449446|158100543|FG005|Overall Study|Non Compliance with Study Drug|0|||
49073310|NCT03449446|158100544|FG006|Overall Study|Non Compliance with Study Drug|0|||
49073311|NCT03449446|158100538|FG000|Overall Study|Protocol Violation|0|||
49073312|NCT03449446|158100539|FG001|Overall Study|Protocol Violation|0|||
49073313|NCT03449446|158100540|FG002|Overall Study|Protocol Violation|0|||
49073314|NCT03449446|158100541|FG003|Overall Study|Protocol Violation|0|||
49073315|NCT03449446|158100542|FG004|Overall Study|Protocol Violation|1|||
49073316|NCT03449446|158100543|FG005|Overall Study|Protocol Violation|1|||
49073317|NCT03449446|158100544|FG006|Overall Study|Protocol Violation|0|||
49073318|NCT03449446|158100538|FG000|Overall Study|Death|0|||
49073319|NCT03449446|158100539|FG001|Overall Study|Death|0|||
49073320|NCT03449446|158100540|FG002|Overall Study|Death|0|||
49073321|NCT03449446|158100541|FG003|Overall Study|Death|0|||
49073322|NCT03449446|158100542|FG004|Overall Study|Death|1|||
49073323|NCT03449446|158100543|FG005|Overall Study|Death|0|||
49073324|NCT03449446|158100544|FG006|Overall Study|Death|0|||
49073325|NCT04873232|158100549|FG000|Overall Study|Lost to Follow-up|1|||
49073326|NCT04873232|158100550|FG001|Overall Study|Lost to Follow-up|4|||
49073327|NCT04873232|158100549|FG000|Overall Study|Withdrawal by Subject|1|||
49073328|NCT04873232|158100550|FG001|Overall Study|Withdrawal by Subject|0|||
49073329|NCT00805961|158100551|FG000|Modality Therapy|Withdrawal by Subject|1|||
49073330|NCT00805961|158100551|FG000|Modality Therapy|Adverse Event|1|||
49073331|NCT00805961|158100551|FG000|Modality Therapy|Disease Progression|2|||
49073332|NCT00805961|158100551|FG000|Treatment-Free Interval|Adverse Event|3|||
49073333|NCT00805961|158100551|FG000|Treatment-Free Interval|Intercurrent Illness|2|||
49073334|NCT00805961|158100551|FG000|Treatment-Free Interval|Physician Decision|1|||
49073335|NCT00805961|158100551|FG000|Treatment-Free Interval|Lack of Efficacy|1|||
49073336|NCT00805961|158100551|FG000|Maintenance Treatment|Lack of Efficacy|13|||
49073337|NCT00805961|158100551|FG000|Maintenance Treatment|Intercurrent Illness|7|||
49073338|NCT00805961|158100551|FG000|Maintenance Treatment|Adverse Event|6|||
49073339|NCT00805961|158100551|FG000|Maintenance Treatment|Withdrawal by Subject|5|||
49073340|NCT00805961|158100551|FG000|Maintenance Treatment|Symptomatic Deterioration|2|||
49073341|NCT00805961|158100551|FG000|Maintenance Treatment|Withdrawn Consent|1|||
49073342|NCT05325294|158100552|FG000|Overall Study|Adverse Event|3|||
49073343|NCT05325294|158100553|FG001|Overall Study|Adverse Event|3|||
49073344|NCT05325294|158100552|FG000|Overall Study|Physician Decision|0|||
49073345|NCT05325294|158100553|FG001|Overall Study|Physician Decision|1|||
49073346|NCT05325294|158100552|FG000|Overall Study|Withdrawal by Subject|0|||
49073347|NCT05325294|158100553|FG001|Overall Study|Withdrawal by Subject|3|||
49073348|NCT05325294|158100552|FG000|Overall Study|Lost to Follow-up|1|||
49073349|NCT05325294|158100553|FG001|Overall Study|Lost to Follow-up|0|||
49073350|NCT05325294|158100552|FG000|Overall Study|Sponsor Request|0|||
49073351|NCT05325294|158100553|FG001|Overall Study|Sponsor Request|2|||
49073352|NCT00761657|158102656|FG000|Part 1 (up to Day 57)|Adverse Event|0|||
49073353|NCT00761657|158102657|FG001|Part 1 (up to Day 57)|Adverse Event|0|||
49073354|NCT00761657|158102658|FG002|Part 1 (up to Day 57)|Adverse Event|0|||
49073355|NCT00761657|158102659|FG003|Part 1 (up to Day 57)|Adverse Event|1|||
49073356|NCT00761657|158102660|FG004|Part 1 (up to Day 57)|Adverse Event|0|||
49073357|NCT00761657|158102661|FG005|Part 1 (up to Day 57)|Adverse Event|0|||
49073358|NCT00761657|158102662|FG006|Part 1 (up to Day 57)|Adverse Event|0|||
49073359|NCT00761657|158102663|FG007|Part 1 (up to Day 57)|Adverse Event|0|||
49073360|NCT00761657|158102664|FG008|Part 1 (up to Day 57)|Adverse Event|0|||
49073361|NCT00761657|158102656|FG000|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
49073362|NCT00761657|158102657|FG001|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
49073363|NCT00761657|158102658|FG002|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
49073364|NCT00761657|158102659|FG003|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
49073365|NCT00761657|158102660|FG004|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
49073366|NCT00761657|158102661|FG005|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
49073367|NCT00761657|158102662|FG006|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
49073368|NCT00761657|158102663|FG007|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
49073369|NCT00761657|158102664|FG008|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
49073370|NCT00761657|158102656|FG000|Part 1 (up to Day 57)|Sponsor Decision|0|||
49073371|NCT00761657|158102657|FG001|Part 1 (up to Day 57)|Sponsor Decision|0|||
49073372|NCT00761657|158102658|FG002|Part 1 (up to Day 57)|Sponsor Decision|3|||
49073373|NCT00761657|158102659|FG003|Part 1 (up to Day 57)|Sponsor Decision|4|||
49073374|NCT00761657|158102660|FG004|Part 1 (up to Day 57)|Sponsor Decision|0|||
49073375|NCT00761657|158102661|FG005|Part 1 (up to Day 57)|Sponsor Decision|0|||
49073376|NCT00761657|158102662|FG006|Part 1 (up to Day 57)|Sponsor Decision|1|||
49073377|NCT00761657|158102663|FG007|Part 1 (up to Day 57)|Sponsor Decision|1|||
49073378|NCT00761657|158102664|FG008|Part 1 (up to Day 57)|Sponsor Decision|1|||
49073379|NCT00761657|158102656|FG000|Part 2 (up to Day 114)|Adverse Event|0|||
49073380|NCT00761657|158102657|FG001|Part 2 (up to Day 114)|Adverse Event|0|||
49073381|NCT00761657|158102658|FG002|Part 2 (up to Day 114)|Adverse Event|0|||
49073382|NCT00761657|158102659|FG003|Part 2 (up to Day 114)|Adverse Event|0|||
49073383|NCT00761657|158102660|FG004|Part 2 (up to Day 114)|Adverse Event|0|||
49073384|NCT00761657|158102661|FG005|Part 2 (up to Day 114)|Adverse Event|0|||
49073385|NCT00761657|158102662|FG006|Part 2 (up to Day 114)|Adverse Event|0|||
49073386|NCT00761657|158102663|FG007|Part 2 (up to Day 114)|Adverse Event|0|||
49073387|NCT00761657|158102664|FG008|Part 2 (up to Day 114)|Adverse Event|1|||
49073388|NCT00478244|158102673|FG000|Overall Study|Did not receive transplant|1|||
49073389|NCT02540850|158102674|FG000|Overall Study|Lost to Follow-up|69|||
49073390|NCT02540850|158102675|FG001|Overall Study|Lost to Follow-up|66|||
49073391|NCT02540850|158102676|FG002|Overall Study|Lost to Follow-up|34|||
49073392|NCT03190915|158102683|FG000|Overall Study|Physician Determines It Is In Patient's Best Interest|4|||
49073393|NCT03190915|158102683|FG000|Overall Study|Progressive Disease|3|||
49073394|NCT01755767|158102684|FG000|Overall Study|Progressive Disease|8|||
49073395|NCT01755767|158102685|FG001|Overall Study|Progressive Disease|7|||
49073396|NCT01755767|158102686|FG002|Overall Study|Progressive Disease|91|||
49073397|NCT01755767|158102687|FG003|Overall Study|Progressive Disease|43|||
49073398|NCT01755767|158102684|FG000|Overall Study|Clinical Disease Progression|4|||
49073399|NCT01755767|158102685|FG001|Overall Study|Clinical Disease Progression|2|||
49073400|NCT01755767|158102686|FG002|Overall Study|Clinical Disease Progression|29|||
49073401|NCT01755767|158102687|FG003|Overall Study|Clinical Disease Progression|20|||
49073402|NCT01755767|158102684|FG000|Overall Study|Radiographic Disease Progression|9|||
49073403|NCT01755767|158102685|FG001|Overall Study|Radiographic Disease Progression|4|||
49073404|NCT01755767|158102686|FG002|Overall Study|Radiographic Disease Progression|44|||
49073405|NCT01755767|158102687|FG003|Overall Study|Radiographic Disease Progression|27|||
49073406|NCT01755767|158102684|FG000|Overall Study|Adverse Event|6|||
49073407|NCT01755767|158102685|FG001|Overall Study|Adverse Event|0|||
49073408|NCT01755767|158102686|FG002|Overall Study|Adverse Event|28|||
49073409|NCT01755767|158102687|FG003|Overall Study|Adverse Event|11|||
49073410|NCT01755767|158102684|FG000|Overall Study|Death|1|||
49073411|NCT01755767|158102685|FG001|Overall Study|Death|2|||
49073412|NCT01755767|158102686|FG002|Overall Study|Death|15|||
49073413|NCT01755767|158102687|FG003|Overall Study|Death|4|||
49073414|NCT01755767|158102684|FG000|Overall Study|Subject Decision|0|||
49073415|NCT01755767|158102685|FG001|Overall Study|Subject Decision|0|||
49073416|NCT01755767|158102686|FG002|Overall Study|Subject Decision|10|||
49073417|NCT01755767|158102687|FG003|Overall Study|Subject Decision|3|||
49073418|NCT01755767|158102684|FG000|Overall Study|Withdrawal by Subject|0|||
49073419|NCT01755767|158102685|FG001|Overall Study|Withdrawal by Subject|0|||
49073420|NCT01755767|158102686|FG002|Overall Study|Withdrawal by Subject|2|||
49073421|NCT01755767|158102687|FG003|Overall Study|Withdrawal by Subject|1|||
49073422|NCT01755767|158102684|FG000|Overall Study|Other|0|||
49073423|NCT01755767|158102685|FG001|Overall Study|Other|0|||
49073424|NCT01755767|158102686|FG002|Overall Study|Other|2|||
49073425|NCT01755767|158102687|FG003|Overall Study|Other|3|||
49073426|NCT01755767|158102684|FG000|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
49073427|NCT01755767|158102685|FG001|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
49073428|NCT01755767|158102686|FG002|Overall Study|Ongoing Treatment as of 06 Jan 2017|5|||
49073429|NCT01755767|158102687|FG003|Overall Study|Ongoing Treatment as of 06 Jan 2017|2|||
49073430|NCT03459729|158102689|FG000|Overall Study|Physician Decision|2|||
49073431|NCT00191165|158102690|FG000|Overall Study|Adverse Event|2|||
49073432|NCT00191165|158102691|FG001|Overall Study|Adverse Event|0|||
49073433|NCT00191165|158102690|FG000|Overall Study|Protocol Violation|0|||
49073434|NCT00191165|158102691|FG001|Overall Study|Protocol Violation|1|||
49073435|NCT00191165|158102690|FG000|Overall Study|Participant Moved Away|0|||
49073436|NCT00191165|158102691|FG001|Overall Study|Participant Moved Away|1|||
49073437|NCT01352416|158102694|FG000|Overall Study|Physician Decision|1|||
49073438|NCT01352416|158102695|FG001|Overall Study|Physician Decision|2|||
49073439|NCT01352416|158102696|FG002|Overall Study|Physician Decision|2|||
49073440|NCT01352416|158102697|FG003|Overall Study|Physician Decision|1|||
49073441|NCT00735397|158102708|FG000|Overall Study|Adverse Event|194|||
49073442|NCT00735397|158102708|FG000|Overall Study|Lost to Follow-up|33|||
49073443|NCT00735397|158102708|FG000|Overall Study|Participant choice|252|||
49073444|NCT00735397|158102708|FG000|Overall Study|Inadequate therapeutic effect|202|||
49073445|NCT00735397|158102708|FG000|Overall Study|Administrative/Other|502|||
49073446|NCT01982448|158102711|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
49073447|NCT01982448|158102712|FG001|Preoperative Chemotherapy|Withdrawal by Subject|2|||
49073448|NCT01982448|158102711|FG000|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1|||
49073449|NCT01982448|158102712|FG001|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0|||
49073450|NCT01982448|158102711|FG000|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0|||
49073451|NCT01982448|158102712|FG001|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2|||
49073452|NCT01982448|158102711|FG000|Preoperative Chemotherapy|Lost to Follow-up|0|||
49073453|NCT01982448|158102712|FG001|Preoperative Chemotherapy|Lost to Follow-up|1|||
49073454|NCT03421730|158102713|FG000|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
49073455|NCT03421730|158102714|FG001|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2|||
49073456|NCT03421730|158102715|FG002|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
49073457|NCT03421730|158102716|FG003|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
49073458|NCT03421730|158102717|FG004|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
49073459|NCT03421730|158102718|FG005|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
49073460|NCT03421730|158102719|FG006|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
49073461|NCT03421730|158102720|FG007|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
49073462|NCT03421730|158102721|FG008|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
49073463|NCT03421730|158102722|FG009|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
49073464|NCT03421730|158102723|FG010|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
49073465|NCT03421730|158102724|FG011|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
49073466|NCT03421730|158102713|FG000|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
49073467|NCT03421730|158102714|FG001|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
49073468|NCT03421730|158102715|FG002|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
49073469|NCT03421730|158102716|FG003|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
49073470|NCT03421730|158102717|FG004|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2|||
49073471|NCT03421730|158102718|FG005|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
49073472|NCT03421730|158102719|FG006|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
49073473|NCT03421730|158102720|FG007|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
49073474|NCT03421730|158102721|FG008|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
49073475|NCT03421730|158102722|FG009|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
49073476|NCT03421730|158102723|FG010|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
49073477|NCT03421730|158102724|FG011|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
49073478|NCT01199016|158102727|FG000|Overall Study|No longer meets eligibility criteria|4|||
49073479|NCT01199016|158102727|FG000|Overall Study|Entrance criteria|5|||
49073480|NCT01199016|158102727|FG000|Overall Study|Protocol Violation|9|||
49073481|NCT01199016|158102727|FG000|Overall Study|Other|13|||
49073482|NCT01199016|158102727|FG000|Overall Study|Withdrawal by Subject|21|||
49073483|NCT01199016|158102727|FG000|Overall Study|Lost to Follow-up|25|||
49073484|NCT03016975|158102739|FG000|At 30 Days Follow-up|Subject is a Screen failure|1|||
49073485|NCT03016975|158102740|FG001|At 30 Days Follow-up|Subject is a Screen failure|0|||
49073486|NCT03016975|158102741|FG002|At 30 Days Follow-up|Subject is a Screen failure|0|||
49073487|NCT03016975|158102739|FG000|At 6 Months Follow-up|Death|2|||
49073488|NCT03016975|158102740|FG001|At 6 Months Follow-up|Death|0|||
49073489|NCT03016975|158102741|FG002|At 6 Months Follow-up|Death|0|||
49073490|NCT03016975|158102739|FG000|At 6 Months Follow-up|Subject withdrawn by investigator|1|||
49073491|NCT03016975|158102740|FG001|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
49073492|NCT03016975|158102741|FG002|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
49073493|NCT03016975|158102739|FG000|At 6 Months Follow-up|Re-attempt procedure|1|||
49073494|NCT03016975|158102740|FG001|At 6 Months Follow-up|Re-attempt procedure|0|||
49073495|NCT03016975|158102741|FG002|At 6 Months Follow-up|Re-attempt procedure|0|||
49073496|NCT03016975|158102739|FG000|At 6 Months Follow-up|Aborted implant|1|||
49073497|NCT03016975|158102740|FG001|At 6 Months Follow-up|Aborted implant|0|||
49073498|NCT03016975|158102741|FG002|At 6 Months Follow-up|Aborted implant|0|||
49073499|NCT03016975|158102739|FG000|At 2 Year Follow-up|Death|1|||
49073500|NCT03016975|158102740|FG001|At 2 Year Follow-up|Death|0|||
49073501|NCT03016975|158102741|FG002|At 2 Year Follow-up|Death|0|||
49073502|NCT03016975|158102739|FG000|At 3 Year Follow-up|Death|1|||
49073503|NCT03016975|158102740|FG001|At 3 Year Follow-up|Death|0|||
49073504|NCT03016975|158102741|FG002|At 3 Year Follow-up|Death|0|||
49073505|NCT03016975|158102739|FG000|At 3 Year Follow-up|Withdrawal by Subject|1|||
49073506|NCT03016975|158102740|FG001|At 3 Year Follow-up|Withdrawal by Subject|0|||
49073507|NCT03016975|158102741|FG002|At 3 Year Follow-up|Withdrawal by Subject|0|||
49073508|NCT03016975|158102739|FG000|At 4-year Follow-up|Exited Study for other reasons|1|||
49073509|NCT03016975|158102740|FG001|At 4-year Follow-up|Exited Study for other reasons|0|||
49073510|NCT03016975|158102741|FG002|At 4-year Follow-up|Exited Study for other reasons|0|||
49073511|NCT04106661|158102742|FG000|Overall Study|Protocol Violation|3|||
49073512|NCT04106661|158102743|FG001|Overall Study|Protocol Violation|0|||
49073513|NCT04106661|158102742|FG000|Overall Study|Scheduling difficulties|1|||
49073514|NCT04106661|158102743|FG001|Overall Study|Scheduling difficulties|1|||
49073515|NCT01038297|158102744|FG000|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1|||
49073516|NCT01038297|158102745|FG001|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
49073517|NCT01038297|158102746|FG002|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
49073518|NCT02794870|158102759|FG000|Overall Study|Withdrawal by Subject|2|||
49073519|NCT02794870|158102760|FG001|Overall Study|Withdrawal by Subject|0|||
49073520|NCT03336528|158102763|FG000|Overall Study|Protocol Violation|1|||
49073521|NCT03336528|158102764|FG001|Overall Study|Protocol Violation|1|||
49073522|NCT03336528|158102763|FG000|Overall Study|Discharged within 48 hours of study medication|8|||
49073523|NCT03336528|158102764|FG001|Overall Study|Discharged within 48 hours of study medication|6|||
49073524|NCT03336528|158102763|FG000|Overall Study|Did not receive study medication|1|||
49073525|NCT03336528|158102764|FG001|Overall Study|Did not receive study medication|2|||
49073526|NCT01955083|158102765|FG000|Overall Study|Lost to Follow-up|1|||
49073527|NCT01955083|158102766|FG001|Overall Study|Lost to Follow-up|1|||
49073528|NCT02437903|158102767|FG000|Overall Study|Adverse Event|1|||
49073529|NCT02437903|158102767|FG000|Overall Study|Withdrawal by Subject|1|||
49073530|NCT02437903|158102767|FG000|Overall Study|Lost to Follow-up|3|||
49073531|NCT01333397|158102768|FG000|Overall Study|Lost to Follow-up|1|||
49073532|NCT01333397|158102769|FG001|Overall Study|Lost to Follow-up|0|||
49073533|NCT01333397|158102770|FG002|Overall Study|Lost to Follow-up|0|||
49073534|NCT01333397|158102771|FG003|Overall Study|Lost to Follow-up|1|||
49073535|NCT01333397|158102772|FG004|Overall Study|Lost to Follow-up|0|||
49073536|NCT00474266|158102773|FG000|Overall Study|Withdrawal by Subject|7|||
49073537|NCT00474266|158102774|FG001|Overall Study|Withdrawal by Subject|20|||
49073538|NCT00474266|158102775|FG002|Overall Study|Withdrawal by Subject|4|||
49073539|NCT00474266|158102776|FG003|Overall Study|Withdrawal by Subject|7|||
49073540|NCT01449370|158102781|FG000|Overall Study|Disease Progression|5|||
49073541|NCT01449370|158102782|FG001|Overall Study|Disease Progression|4|||
49073542|NCT01449370|158102783|FG002|Overall Study|Disease Progression|8|||
49073543|NCT01449370|158102784|FG003|Overall Study|Disease Progression|3|||
49073544|NCT01449370|158102785|FG004|Overall Study|Disease Progression|3|||
49073545|NCT01449370|158102786|FG005|Overall Study|Disease Progression|3|||
49073546|NCT01449370|158102787|FG006|Overall Study|Disease Progression|3|||
49073547|NCT01449370|158102788|FG007|Overall Study|Disease Progression|2|||
49073548|NCT01449370|158102789|FG008|Overall Study|Disease Progression|9|||
49073549|NCT01449370|158102790|FG009|Overall Study|Disease Progression|1|||
49073550|NCT01449370|158102791|FG010|Overall Study|Disease Progression|3|||
49073551|NCT01449370|158102792|FG011|Overall Study|Disease Progression|3|||
49073552|NCT01449370|158102793|FG012|Overall Study|Disease Progression|2|||
49073553|NCT01449370|158102794|FG013|Overall Study|Disease Progression|8|||
49073554|NCT01449370|158102795|FG014|Overall Study|Disease Progression|3|||
49073555|NCT01449370|158102796|FG015|Overall Study|Disease Progression|1|||
49073556|NCT01449370|158102797|FG016|Overall Study|Disease Progression|4|||
49073557|NCT01449370|158102798|FG017|Overall Study|Disease Progression|3|||
49073558|NCT01449370|158102799|FG018|Overall Study|Disease Progression|1|||
49073559|NCT01449370|158102800|FG019|Overall Study|Disease Progression|2|||
49073560|NCT01449370|158102801|FG020|Overall Study|Disease Progression|5|||
49073561|NCT01449370|158102802|FG021|Overall Study|Disease Progression|2|||
49073562|NCT01449370|158102803|FG022|Overall Study|Disease Progression|3|||
49073563|NCT01449370|158102804|FG023|Overall Study|Disease Progression|7|||
49073564|NCT01449370|158102805|FG024|Overall Study|Disease Progression|3|||
49073565|NCT01449370|158102781|FG000|Overall Study|Adverse Event|1|||
49073566|NCT01449370|158102782|FG001|Overall Study|Adverse Event|2|||
49073567|NCT01449370|158102783|FG002|Overall Study|Adverse Event|0|||
49073568|NCT01449370|158102784|FG003|Overall Study|Adverse Event|1|||
49073569|NCT01449370|158102785|FG004|Overall Study|Adverse Event|0|||
49073570|NCT01449370|158102786|FG005|Overall Study|Adverse Event|0|||
49073571|NCT01449370|158102787|FG006|Overall Study|Adverse Event|0|||
49073572|NCT01449370|158102788|FG007|Overall Study|Adverse Event|0|||
49073573|NCT01449370|158102789|FG008|Overall Study|Adverse Event|1|||
49073574|NCT01449370|158102790|FG009|Overall Study|Adverse Event|1|||
49073575|NCT01449370|158102791|FG010|Overall Study|Adverse Event|0|||
49073576|NCT01449370|158102792|FG011|Overall Study|Adverse Event|0|||
49073577|NCT01449370|158102793|FG012|Overall Study|Adverse Event|0|||
49073578|NCT01449370|158102794|FG013|Overall Study|Adverse Event|2|||
49073579|NCT01449370|158102795|FG014|Overall Study|Adverse Event|0|||
49073580|NCT01449370|158102796|FG015|Overall Study|Adverse Event|1|||
49073581|NCT01449370|158102797|FG016|Overall Study|Adverse Event|0|||
49073582|NCT01449370|158102798|FG017|Overall Study|Adverse Event|0|||
49073583|NCT01449370|158102799|FG018|Overall Study|Adverse Event|1|||
49073584|NCT01449370|158102800|FG019|Overall Study|Adverse Event|1|||
49073585|NCT01449370|158102801|FG020|Overall Study|Adverse Event|0|||
49073586|NCT01449370|158102802|FG021|Overall Study|Adverse Event|1|||
49073587|NCT01449370|158102803|FG022|Overall Study|Adverse Event|0|||
49073588|NCT01449370|158102804|FG023|Overall Study|Adverse Event|1|||
49073589|NCT01449370|158102805|FG024|Overall Study|Adverse Event|3|||
49073590|NCT01449370|158102781|FG000|Overall Study|Participant Decision|0|||
49073591|NCT01449370|158102782|FG001|Overall Study|Participant Decision|0|||
49073592|NCT01449370|158102783|FG002|Overall Study|Participant Decision|0|||
49073593|NCT01449370|158102784|FG003|Overall Study|Participant Decision|0|||
49073594|NCT01449370|158102785|FG004|Overall Study|Participant Decision|0|||
49073595|NCT01449370|158102786|FG005|Overall Study|Participant Decision|0|||
49073596|NCT01449370|158102787|FG006|Overall Study|Participant Decision|0|||
49073597|NCT01449370|158102788|FG007|Overall Study|Participant Decision|1|||
49073598|NCT01449370|158102789|FG008|Overall Study|Participant Decision|1|||
49073599|NCT01449370|158102790|FG009|Overall Study|Participant Decision|0|||
49073600|NCT01449370|158102791|FG010|Overall Study|Participant Decision|0|||
49073601|NCT01449370|158102792|FG011|Overall Study|Participant Decision|0|||
49073602|NCT01449370|158102793|FG012|Overall Study|Participant Decision|1|||
49073603|NCT01449370|158102794|FG013|Overall Study|Participant Decision|1|||
49073604|NCT01449370|158102795|FG014|Overall Study|Participant Decision|0|||
49073605|NCT01449370|158102796|FG015|Overall Study|Participant Decision|1|||
49073606|NCT01449370|158102797|FG016|Overall Study|Participant Decision|3|||
49073607|NCT01449370|158102798|FG017|Overall Study|Participant Decision|0|||
49073608|NCT01449370|158102799|FG018|Overall Study|Participant Decision|1|||
49073609|NCT01449370|158102800|FG019|Overall Study|Participant Decision|0|||
49073610|NCT01449370|158102801|FG020|Overall Study|Participant Decision|0|||
49073611|NCT01449370|158102802|FG021|Overall Study|Participant Decision|1|||
49073612|NCT01449370|158102803|FG022|Overall Study|Participant Decision|0|||
49073613|NCT01449370|158102804|FG023|Overall Study|Participant Decision|0|||
49073614|NCT01449370|158102805|FG024|Overall Study|Participant Decision|1|||
49073615|NCT01449370|158102781|FG000|Overall Study|Lost to Follow-up|0|||
49073616|NCT01449370|158102782|FG001|Overall Study|Lost to Follow-up|0|||
49073617|NCT01449370|158102783|FG002|Overall Study|Lost to Follow-up|0|||
49073618|NCT01449370|158102784|FG003|Overall Study|Lost to Follow-up|0|||
49073619|NCT01449370|158102785|FG004|Overall Study|Lost to Follow-up|0|||
49073620|NCT01449370|158102786|FG005|Overall Study|Lost to Follow-up|0|||
49073621|NCT01449370|158102787|FG006|Overall Study|Lost to Follow-up|0|||
49073622|NCT01449370|158102788|FG007|Overall Study|Lost to Follow-up|0|||
49073623|NCT01449370|158102789|FG008|Overall Study|Lost to Follow-up|0|||
49073624|NCT01449370|158102790|FG009|Overall Study|Lost to Follow-up|0|||
49073625|NCT01449370|158102791|FG010|Overall Study|Lost to Follow-up|0|||
49073626|NCT01449370|158102792|FG011|Overall Study|Lost to Follow-up|0|||
49073627|NCT01449370|158102793|FG012|Overall Study|Lost to Follow-up|0|||
49073628|NCT01449370|158102794|FG013|Overall Study|Lost to Follow-up|0|||
49073629|NCT01449370|158102795|FG014|Overall Study|Lost to Follow-up|0|||
49073630|NCT01449370|158102796|FG015|Overall Study|Lost to Follow-up|0|||
49073631|NCT01449370|158102797|FG016|Overall Study|Lost to Follow-up|0|||
49073632|NCT01449370|158102798|FG017|Overall Study|Lost to Follow-up|0|||
49073633|NCT01449370|158102799|FG018|Overall Study|Lost to Follow-up|0|||
49073634|NCT01449370|158102800|FG019|Overall Study|Lost to Follow-up|0|||
49073635|NCT01449370|158102801|FG020|Overall Study|Lost to Follow-up|1|||
49073636|NCT01449370|158102802|FG021|Overall Study|Lost to Follow-up|0|||
49073637|NCT01449370|158102803|FG022|Overall Study|Lost to Follow-up|0|||
49073638|NCT01449370|158102804|FG023|Overall Study|Lost to Follow-up|0|||
49073639|NCT01449370|158102805|FG024|Overall Study|Lost to Follow-up|0|||
49073640|NCT01449370|158102781|FG000|Overall Study|Other|0|||
49073641|NCT01449370|158102782|FG001|Overall Study|Other|0|||
49073642|NCT01449370|158102783|FG002|Overall Study|Other|0|||
49073643|NCT01449370|158102784|FG003|Overall Study|Other|0|||
49073644|NCT01449370|158102785|FG004|Overall Study|Other|0|||
49073645|NCT01449370|158102786|FG005|Overall Study|Other|0|||
49073646|NCT01449370|158102787|FG006|Overall Study|Other|0|||
49073647|NCT01449370|158102788|FG007|Overall Study|Other|0|||
49073648|NCT01449370|158102789|FG008|Overall Study|Other|1|||
49073649|NCT01449370|158102790|FG009|Overall Study|Other|1|||
49073650|NCT01449370|158102791|FG010|Overall Study|Other|0|||
49073651|NCT01449370|158102792|FG011|Overall Study|Other|0|||
49073652|NCT01449370|158102793|FG012|Overall Study|Other|0|||
49073653|NCT01449370|158102794|FG013|Overall Study|Other|0|||
49073654|NCT01449370|158102795|FG014|Overall Study|Other|0|||
49073655|NCT01449370|158102796|FG015|Overall Study|Other|0|||
49073656|NCT01449370|158102797|FG016|Overall Study|Other|0|||
49073657|NCT01449370|158102798|FG017|Overall Study|Other|0|||
49073658|NCT01449370|158102799|FG018|Overall Study|Other|0|||
49073659|NCT01449370|158102800|FG019|Overall Study|Other|0|||
49073660|NCT01449370|158102801|FG020|Overall Study|Other|0|||
49073661|NCT01449370|158102802|FG021|Overall Study|Other|0|||
49073662|NCT01449370|158102803|FG022|Overall Study|Other|1|||
49073663|NCT01449370|158102804|FG023|Overall Study|Other|1|||
49073664|NCT01449370|158102805|FG024|Overall Study|Other|0|||
49073665|NCT01449370|158102781|FG000|Overall Study|Medication Prohibited by Protocol|0|||
49073666|NCT01449370|158102782|FG001|Overall Study|Medication Prohibited by Protocol|0|||
49073667|NCT01449370|158102783|FG002|Overall Study|Medication Prohibited by Protocol|0|||
49073668|NCT01449370|158102784|FG003|Overall Study|Medication Prohibited by Protocol|0|||
49073669|NCT01449370|158102785|FG004|Overall Study|Medication Prohibited by Protocol|0|||
49073670|NCT01449370|158102786|FG005|Overall Study|Medication Prohibited by Protocol|0|||
49073671|NCT01449370|158102787|FG006|Overall Study|Medication Prohibited by Protocol|0|||
49073672|NCT01449370|158102788|FG007|Overall Study|Medication Prohibited by Protocol|0|||
49073673|NCT01449370|158102789|FG008|Overall Study|Medication Prohibited by Protocol|0|||
49073674|NCT01449370|158102790|FG009|Overall Study|Medication Prohibited by Protocol|0|||
49073675|NCT01449370|158102791|FG010|Overall Study|Medication Prohibited by Protocol|0|||
49073676|NCT01449370|158102792|FG011|Overall Study|Medication Prohibited by Protocol|0|||
49073677|NCT01449370|158102793|FG012|Overall Study|Medication Prohibited by Protocol|0|||
49073678|NCT01449370|158102794|FG013|Overall Study|Medication Prohibited by Protocol|0|||
49073679|NCT01449370|158102795|FG014|Overall Study|Medication Prohibited by Protocol|0|||
49073680|NCT01449370|158102796|FG015|Overall Study|Medication Prohibited by Protocol|0|||
49073681|NCT01449370|158102797|FG016|Overall Study|Medication Prohibited by Protocol|0|||
49073682|NCT01449370|158102798|FG017|Overall Study|Medication Prohibited by Protocol|0|||
49073683|NCT01449370|158102799|FG018|Overall Study|Medication Prohibited by Protocol|0|||
49073684|NCT01449370|158102800|FG019|Overall Study|Medication Prohibited by Protocol|0|||
49073685|NCT01449370|158102801|FG020|Overall Study|Medication Prohibited by Protocol|0|||
49073686|NCT01449370|158102802|FG021|Overall Study|Medication Prohibited by Protocol|0|||
49073687|NCT01449370|158102803|FG022|Overall Study|Medication Prohibited by Protocol|0|||
49073688|NCT01449370|158102804|FG023|Overall Study|Medication Prohibited by Protocol|1|||
49073689|NCT01449370|158102805|FG024|Overall Study|Medication Prohibited by Protocol|0|||
49073690|NCT01449370|158102781|FG000|Overall Study|Death|0|||
49073691|NCT01449370|158102782|FG001|Overall Study|Death|0|||
49073692|NCT01449370|158102783|FG002|Overall Study|Death|0|||
49073693|NCT01449370|158102784|FG003|Overall Study|Death|0|||
49073694|NCT01449370|158102785|FG004|Overall Study|Death|0|||
49073695|NCT01449370|158102786|FG005|Overall Study|Death|0|||
49073696|NCT01449370|158102787|FG006|Overall Study|Death|0|||
49073697|NCT01449370|158102788|FG007|Overall Study|Death|0|||
49073698|NCT01449370|158102789|FG008|Overall Study|Death|0|||
49073699|NCT01449370|158102790|FG009|Overall Study|Death|0|||
49073700|NCT01449370|158102791|FG010|Overall Study|Death|0|||
49073701|NCT01449370|158102792|FG011|Overall Study|Death|0|||
49073702|NCT01449370|158102793|FG012|Overall Study|Death|0|||
49073703|NCT01449370|158102794|FG013|Overall Study|Death|0|||
49073704|NCT01449370|158102795|FG014|Overall Study|Death|0|||
49073705|NCT01449370|158102796|FG015|Overall Study|Death|0|||
49073706|NCT01449370|158102797|FG016|Overall Study|Death|0|||
49073707|NCT01449370|158102798|FG017|Overall Study|Death|0|||
49073708|NCT01449370|158102799|FG018|Overall Study|Death|0|||
49073709|NCT01449370|158102800|FG019|Overall Study|Death|0|||
49073710|NCT01449370|158102801|FG020|Overall Study|Death|0|||
49073711|NCT01449370|158102802|FG021|Overall Study|Death|0|||
49073712|NCT01449370|158102803|FG022|Overall Study|Death|0|||
49073713|NCT01449370|158102804|FG023|Overall Study|Death|0|||
49073714|NCT01449370|158102805|FG024|Overall Study|Death|1|||
49073715|NCT00710866|158102806|FG000|Overall Study|Protocol Violation|5|||
49073716|NCT00710866|158102807|FG001|Overall Study|Protocol Violation|4|||
49073717|NCT00710866|158102806|FG000|Overall Study|Withdrawal by Subject|2|||
49073718|NCT00710866|158102807|FG001|Overall Study|Withdrawal by Subject|1|||
49073719|NCT00710866|158102806|FG000|Overall Study|Lost to Follow-up|1|||
49073720|NCT00710866|158102807|FG001|Overall Study|Lost to Follow-up|0|||
49073721|NCT00710866|158102806|FG000|Overall Study|Failed to meet eligibility|1|||
49073722|NCT00710866|158102807|FG001|Overall Study|Failed to meet eligibility|1|||
49073723|NCT00086281|158102809|FG000|Phase 1|Adverse Event|0|||
49073724|NCT00086281|158102810|FG001|Phase 1|Adverse Event|0|||
49073725|NCT00086281|158102811|FG002|Phase 1|Adverse Event|0|||
49073726|NCT00086281|158102812|FG003|Phase 1|Adverse Event|0|||
49073727|NCT00086281|158102813|FG004|Phase 1|Adverse Event|0|||
49073728|NCT00086281|158102814|FG005|Phase 1|Adverse Event|0|||
49073729|NCT00086281|158102815|FG006|Phase 1|Adverse Event|0|||
49073730|NCT00086281|158102816|FG007|Phase 1|Adverse Event|0|||
49073731|NCT00086281|158102817|FG008|Phase 1|Adverse Event|0|||
49073732|NCT00086281|158102818|FG009|Phase 1|Adverse Event|1|||
49073733|NCT00086281|158102819|FG010|Phase 1|Adverse Event|2|||
49073734|NCT00086281|158102820|FG011|Phase 1|Adverse Event|1|||
49073735|NCT00086281|158102821|FG012|Phase 1|Adverse Event|1|||
49073736|NCT00086281|158102822|FG013|Phase 1|Adverse Event|1|||
49073737|NCT00086281|158102823|FG014|Phase 1|Adverse Event|2|||
49073738|NCT00086281|158102809|FG000|Phase 1|Protocol Violation|0|||
49073739|NCT00086281|158102810|FG001|Phase 1|Protocol Violation|0|||
49073740|NCT00086281|158102811|FG002|Phase 1|Protocol Violation|0|||
49073741|NCT00086281|158102812|FG003|Phase 1|Protocol Violation|0|||
49073742|NCT00086281|158102813|FG004|Phase 1|Protocol Violation|0|||
49073743|NCT00086281|158102814|FG005|Phase 1|Protocol Violation|0|||
49073744|NCT00086281|158102815|FG006|Phase 1|Protocol Violation|0|||
49073745|NCT00086281|158102816|FG007|Phase 1|Protocol Violation|0|||
49073746|NCT00086281|158102817|FG008|Phase 1|Protocol Violation|0|||
49073747|NCT00086281|158102818|FG009|Phase 1|Protocol Violation|0|||
49073748|NCT00086281|158102819|FG010|Phase 1|Protocol Violation|1|||
49073749|NCT00086281|158102820|FG011|Phase 1|Protocol Violation|0|||
49073750|NCT00086281|158102821|FG012|Phase 1|Protocol Violation|0|||
49073751|NCT00086281|158102822|FG013|Phase 1|Protocol Violation|0|||
49073752|NCT00086281|158102823|FG014|Phase 1|Protocol Violation|0|||
49073753|NCT00086281|158102809|FG000|Phase 1|Serious Adverse Event|0|||
49073754|NCT00086281|158102810|FG001|Phase 1|Serious Adverse Event|0|||
49073755|NCT00086281|158102811|FG002|Phase 1|Serious Adverse Event|0|||
49073756|NCT00086281|158102812|FG003|Phase 1|Serious Adverse Event|0|||
49073757|NCT00086281|158102813|FG004|Phase 1|Serious Adverse Event|0|||
49073758|NCT00086281|158102814|FG005|Phase 1|Serious Adverse Event|0|||
49073759|NCT00086281|158102815|FG006|Phase 1|Serious Adverse Event|0|||
49073760|NCT00086281|158102816|FG007|Phase 1|Serious Adverse Event|0|||
49073761|NCT00086281|158102817|FG008|Phase 1|Serious Adverse Event|0|||
49073762|NCT00086281|158102818|FG009|Phase 1|Serious Adverse Event|0|||
49073763|NCT00086281|158102819|FG010|Phase 1|Serious Adverse Event|0|||
49073764|NCT00086281|158102820|FG011|Phase 1|Serious Adverse Event|0|||
49073765|NCT00086281|158102821|FG012|Phase 1|Serious Adverse Event|0|||
49073766|NCT00086281|158102822|FG013|Phase 1|Serious Adverse Event|0|||
49073767|NCT00086281|158102823|FG014|Phase 1|Serious Adverse Event|1|||
49073768|NCT00086281|158102809|FG000|Phase 2|Adverse Event|0|||
49073769|NCT00086281|158102810|FG001|Phase 2|Adverse Event|0|||
49073770|NCT00086281|158102811|FG002|Phase 2|Adverse Event|0|||
49073771|NCT00086281|158102812|FG003|Phase 2|Adverse Event|0|||
49073772|NCT00086281|158102813|FG004|Phase 2|Adverse Event|0|||
49073773|NCT00086281|158102814|FG005|Phase 2|Adverse Event|0|||
49073774|NCT00086281|158102815|FG006|Phase 2|Adverse Event|0|||
49073775|NCT00086281|158102816|FG007|Phase 2|Adverse Event|0|||
49073776|NCT00086281|158102817|FG008|Phase 2|Adverse Event|0|||
49073777|NCT00086281|158102818|FG009|Phase 2|Adverse Event|0|||
49073778|NCT00086281|158102819|FG010|Phase 2|Adverse Event|0|||
49073779|NCT00086281|158102820|FG011|Phase 2|Adverse Event|0|||
49073780|NCT00086281|158102821|FG012|Phase 2|Adverse Event|1|||
49073781|NCT00086281|158102822|FG013|Phase 2|Adverse Event|1|||
49073782|NCT00086281|158102823|FG014|Phase 2|Adverse Event|0|||
49073783|NCT04138823|158102826|FG000|Overall Study|Clinical disease progression|0|||
49073784|NCT04138823|158102827|FG001|Overall Study|Clinical disease progression|0|||
49073785|NCT04138823|158102828|FG002|Overall Study|Clinical disease progression|1|||
49073786|NCT04138823|158102826|FG000|Overall Study|Objective disease progression|3|||
49073787|NCT04138823|158102827|FG001|Overall Study|Objective disease progression|2|||
49073788|NCT04138823|158102828|FG002|Overall Study|Objective disease progression|5|||
49073789|NCT03138655|158102832|FG000|Overall Study|Adverse Event|2|||
49073790|NCT03138655|158102833|FG001|Overall Study|Adverse Event|1|||
49073791|NCT03138655|158102834|FG002|Overall Study|Adverse Event|2|||
49073792|NCT03138655|158102835|FG003|Overall Study|Adverse Event|1|||
49073793|NCT03138655|158102836|FG004|Overall Study|Adverse Event|1|||
49073794|NCT03138655|158102837|FG005|Overall Study|Adverse Event|4|||
49073795|NCT03138655|158102838|FG006|Overall Study|Adverse Event|2|||
49073796|NCT03138655|158102839|FG007|Overall Study|Adverse Event|2|||
49073797|NCT03138655|158102832|FG000|Overall Study|Withdrawal by Subject|0|||
49073798|NCT03138655|158102833|FG001|Overall Study|Withdrawal by Subject|1|||
49073799|NCT03138655|158102834|FG002|Overall Study|Withdrawal by Subject|0|||
49073800|NCT03138655|158102835|FG003|Overall Study|Withdrawal by Subject|0|||
49073801|NCT03138655|158102836|FG004|Overall Study|Withdrawal by Subject|0|||
49073802|NCT03138655|158102837|FG005|Overall Study|Withdrawal by Subject|0|||
49073803|NCT03138655|158102838|FG006|Overall Study|Withdrawal by Subject|1|||
49073804|NCT03138655|158102839|FG007|Overall Study|Withdrawal by Subject|0|||
49073805|NCT03138655|158102832|FG000|Overall Study|Reason not Specified|1|||
49073806|NCT03138655|158102833|FG001|Overall Study|Reason not Specified|0|||
49073807|NCT03138655|158102834|FG002|Overall Study|Reason not Specified|0|||
49073808|NCT03138655|158102835|FG003|Overall Study|Reason not Specified|2|||
49073809|NCT03138655|158102836|FG004|Overall Study|Reason not Specified|1|||
49073810|NCT03138655|158102837|FG005|Overall Study|Reason not Specified|1|||
49073811|NCT03138655|158102838|FG006|Overall Study|Reason not Specified|0|||
49073812|NCT03138655|158102839|FG007|Overall Study|Reason not Specified|0|||
49073813|NCT00908310|158102840|FG000|Overall Study|Death|37|||
49073814|NCT00908310|158102840|FG000|Overall Study|Withdrawal by Subject|7|||
49073815|NCT00908310|158102840|FG000|Overall Study|Lost to Follow-up|7|||
49073816|NCT00908310|158102840|FG000|Overall Study|Screening failure|5|||
49073817|NCT00908310|158102840|FG000|Overall Study|Other reasons|4|||
49073818|NCT03151304|158102841|FG000|Overall Study|Termination of study by Sponsor|23|||
49073819|NCT03151304|158102841|FG000|Overall Study|missing|3|||
49073820|NCT03151304|158102841|FG000|Overall Study|Withdrawal by Subject|8|||
49073821|NCT03151304|158102841|FG000|Overall Study|multiple reasons|30|||
49073822|NCT01220531|158102852|FG000|Overall Study|Death|7|||
49073823|NCT01220531|158102852|FG000|Overall Study|Lost to Follow-up|1|||
49073824|NCT04380961|158102855|FG000|Overall Study|Lost to Follow-up|17|||
49073825|NCT04380961|158102856|FG001|Overall Study|Lost to Follow-up|11|||
49073826|NCT04380961|158102855|FG000|Overall Study|Withdrawal by Subject|3|||
49073827|NCT04380961|158102856|FG001|Overall Study|Withdrawal by Subject|0|||
49073828|NCT04380961|158102855|FG000|Overall Study|Death|22|||
49073829|NCT04380961|158102856|FG001|Overall Study|Death|16|||
49073830|NCT04380961|158102855|FG000|Overall Study|Other|1|||
49073831|NCT04380961|158102856|FG001|Overall Study|Other|0|||
49073832|NCT04380961|158102855|FG000|Overall Study|Randomized but Not Treated|1|||
49073833|NCT04380961|158102856|FG001|Overall Study|Randomized but Not Treated|2|||
49073834|NCT04803305|158102858|FG000|Part A: 6-week Double-blind Treatment|Death|0|||
49073835|NCT04803305|158102859|FG001|Part A: 6-week Double-blind Treatment|Death|2|||
49073836|NCT04803305|158102858|FG000|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|0|||
49073837|NCT04803305|158102859|FG001|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|1|||
49073838|NCT04803305|158102858|FG000|Part A: 6-week Double-blind Treatment|Physician Decision|1|||
49073839|NCT04803305|158102859|FG001|Part A: 6-week Double-blind Treatment|Physician Decision|0|||
49073840|NCT04803305|158102858|FG000|Part B: OLT Period up to 18 Weeks|Other|0|||
49073841|NCT04803305|158102859|FG001|Part B: OLT Period up to 18 Weeks|Other|1|||
49073842|NCT04803305|158102858|FG000|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|1|||
49073843|NCT04803305|158102859|FG001|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|0|||
49073844|NCT04803305|158102858|FG000|Part B: OLT Period up to 18 Weeks|Physician Decision|0|||
49073845|NCT04803305|158102859|FG001|Part B: OLT Period up to 18 Weeks|Physician Decision|1|||
49073846|NCT04803305|158102858|FG000|Part B: OLT Period up to 18 Weeks|Death|1|||
49073847|NCT04803305|158102859|FG001|Part B: OLT Period up to 18 Weeks|Death|2|||
49073848|NCT04803305|158102858|FG000|Part B: OLT Period up to 18 Weeks|Adverse Event|1|||
49073849|NCT04803305|158102859|FG001|Part B: OLT Period up to 18 Weeks|Adverse Event|0|||
49073850|NCT01954745|158102863|FG000|Overall Study|Radiological Progression|11|||
49073851|NCT01954745|158102863|FG000|Overall Study|Clinical Progression|5|||
49073852|NCT01954745|158102863|FG000|Overall Study|Adverse Event|2|||
49073853|NCT01954745|158102863|FG000|Overall Study|Death|1|||
49073854|NCT02434328|158102864|FG000|Overall Study|Adverse Event|9|||
49073855|NCT02434328|158102865|FG001|Overall Study|Adverse Event|4|||
49073856|NCT02434328|158102864|FG000|Overall Study|Lack of Efficacy|0|||
49073857|NCT02434328|158102865|FG001|Overall Study|Lack of Efficacy|2|||
49073858|NCT02434328|158102864|FG000|Overall Study|Physician Decision|0|||
49073859|NCT02434328|158102865|FG001|Overall Study|Physician Decision|1|||
49073860|NCT02434328|158102864|FG000|Overall Study|Withdrawal by Subject|12|||
49073861|NCT02434328|158102865|FG001|Overall Study|Withdrawal by Subject|21|||
49073862|NCT02434328|158102864|FG000|Overall Study|Death|4|||
49073863|NCT02434328|158102865|FG001|Overall Study|Death|7|||
49073864|NCT02434328|158102864|FG000|Overall Study|Lost to Follow-up|1|||
49073865|NCT02434328|158102865|FG001|Overall Study|Lost to Follow-up|6|||
49073866|NCT02434328|158102864|FG000|Overall Study|Other|4|||
49073867|NCT02434328|158102865|FG001|Overall Study|Other|1|||
49073868|NCT04520256|158102866|FG000|Overall Study|Lost to Follow-up|6|||
49073869|NCT04520256|158102867|FG001|Overall Study|Lost to Follow-up|4|||
49073870|NCT04520256|158102868|FG002|Overall Study|Lost to Follow-up|2|||
49073871|NCT04520256|158102869|FG003|Overall Study|Lost to Follow-up|3|||
49073872|NCT04520256|158102870|FG004|Overall Study|Lost to Follow-up|6|||
49073873|NCT04520256|158102871|FG005|Overall Study|Lost to Follow-up|6|||
49073874|NCT04520256|158102872|FG006|Overall Study|Lost to Follow-up|4|||
49073875|NCT04520256|158102873|FG007|Overall Study|Lost to Follow-up|6|||
49073876|NCT04520256|158102874|FG008|Overall Study|Lost to Follow-up|1|||
49073877|NCT04520256|158102875|FG009|Overall Study|Lost to Follow-up|3|||
49073878|NCT04520256|158102876|FG010|Overall Study|Lost to Follow-up|3|||
49073879|NCT04520256|158102877|FG011|Overall Study|Lost to Follow-up|2|||
49073880|NCT04520256|158102878|FG012|Overall Study|Lost to Follow-up|5|||
49073881|NCT04520256|158102879|FG013|Overall Study|Lost to Follow-up|3|||
49073882|NCT04520256|158102880|FG014|Overall Study|Lost to Follow-up|3|||
49073883|NCT04520256|158102881|FG015|Overall Study|Lost to Follow-up|6|||
49073884|NCT04520256|158102882|FG016|Overall Study|Lost to Follow-up|6|||
49073885|NCT04520256|158102883|FG017|Overall Study|Lost to Follow-up|4|||
49073886|NCT04520256|158102884|FG018|Overall Study|Lost to Follow-up|3|||
49073887|NCT04520256|158102885|FG019|Overall Study|Lost to Follow-up|3|||
49073888|NCT04520256|158102886|FG020|Overall Study|Lost to Follow-up|7|||
49073889|NCT04520256|158102887|FG021|Overall Study|Lost to Follow-up|3|||
49073890|NCT04520256|158102888|FG022|Overall Study|Lost to Follow-up|3|||
49073891|NCT04520256|158102889|FG023|Overall Study|Lost to Follow-up|8|||
49073892|NCT04520256|158102890|FG024|Overall Study|Lost to Follow-up|5|||
49073893|NCT04520256|158102891|FG025|Overall Study|Lost to Follow-up|4|||
49073894|NCT04520256|158102892|FG026|Overall Study|Lost to Follow-up|3|||
49073895|NCT04520256|158102893|FG027|Overall Study|Lost to Follow-up|4|||
49073896|NCT04520256|158102894|FG028|Overall Study|Lost to Follow-up|3|||
49073897|NCT04520256|158102895|FG029|Overall Study|Lost to Follow-up|4|||
49073898|NCT04520256|158102896|FG030|Overall Study|Lost to Follow-up|4|||
49073899|NCT04520256|158102897|FG031|Overall Study|Lost to Follow-up|4|||
49073900|NCT00633243|158104924|FG000|Overall Study|Withdrawal by Subject|0|||
49073901|NCT00633243|158104925|FG001|Overall Study|Withdrawal by Subject|1|||
49073902|NCT00633243|158104924|FG000|Overall Study|incarceration|0|||
49073903|NCT00633243|158104925|FG001|Overall Study|incarceration|2|||
49073904|NCT00633243|158104924|FG000|Overall Study|Homeless--no refrigeration for meds|0|||
49073905|NCT00633243|158104925|FG001|Overall Study|Homeless--no refrigeration for meds|1|||
49073906|NCT00633243|158104924|FG000|Overall Study|Not comfortable with self-injecting|0|||
49073907|NCT00633243|158104925|FG001|Overall Study|Not comfortable with self-injecting|1|||
49073908|NCT00633243|158104924|FG000|Overall Study|Mental Health--Depression|0|||
49073909|NCT00633243|158104925|FG001|Overall Study|Mental Health--Depression|1|||
49073910|NCT00633243|158104924|FG000|Overall Study|Couldn't tolerate side-effects|1|||
49073911|NCT00633243|158104925|FG001|Overall Study|Couldn't tolerate side-effects|1|||
49073912|NCT05794503|158104926|FG000|Overall Study|Operation Cancelled|2|||
49073913|NCT05794503|158104927|FG001|Overall Study|Operation Cancelled|0|||
49073914|NCT05794503|158104926|FG000|Overall Study|Received Neostigmine + Sugammadex|2|||
49073915|NCT05794503|158104927|FG001|Overall Study|Received Neostigmine + Sugammadex|0|||
49073916|NCT05794503|158104926|FG000|Overall Study|Protocol Violation|1|||
49073917|NCT05794503|158104927|FG001|Overall Study|Protocol Violation|0|||
49073918|NCT02886624|158104929|FG000|12-week Post Treatment Follow-up|Death|1|||
49073919|NCT02886624|158104929|FG000|48-week Post Treatment Follow-up|Lost to Follow-up|1|||
49073920|NCT03865498|158104930|FG000|Overall Study|Lack of Efficacy|12|||
49073921|NCT03865498|158104931|FG001|Overall Study|Lack of Efficacy|11|||
49073922|NCT03865498|158104930|FG000|Overall Study|Lost to Follow-up|125|||
49073923|NCT03865498|158104931|FG001|Overall Study|Lost to Follow-up|133|||
49073924|NCT03865498|158104930|FG000|Overall Study|Withdrawal by Subject|2|||
49073925|NCT03865498|158104931|FG001|Overall Study|Withdrawal by Subject|4|||
49073926|NCT00000620|158104933|FG000|Overall Study|Death|86|||
49073927|NCT00000620|158104934|FG001|Overall Study|Death|67|||
49073928|NCT00000620|158104935|FG002|Overall Study|Death|112|||
49073929|NCT00000620|158104936|FG003|Overall Study|Death|126|||
49073930|NCT00000620|158104937|FG004|Overall Study|Death|64|||
49073931|NCT00000620|158104938|FG005|Overall Study|Death|77|||
49073932|NCT00000620|158104939|FG006|Overall Study|Death|91|||
49073933|NCT00000620|158104940|FG007|Overall Study|Death|95|||
49073934|NCT00000620|158104933|FG000|Overall Study|Lost to Follow-up|14|||
49073935|NCT00000620|158104934|FG001|Overall Study|Lost to Follow-up|14|||
49073936|NCT00000620|158104935|FG002|Overall Study|Lost to Follow-up|14|||
49073937|NCT00000620|158104936|FG003|Overall Study|Lost to Follow-up|14|||
49073938|NCT00000620|158104937|FG004|Overall Study|Lost to Follow-up|15|||
49073939|NCT00000620|158104938|FG005|Overall Study|Lost to Follow-up|15|||
49073940|NCT00000620|158104939|FG006|Overall Study|Lost to Follow-up|13|||
49073941|NCT00000620|158104940|FG007|Overall Study|Lost to Follow-up|14|||
49073942|NCT00000620|158104933|FG000|Overall Study|Withdrawal by Subject|40|||
49073943|NCT00000620|158104934|FG001|Overall Study|Withdrawal by Subject|27|||
49073944|NCT00000620|158104935|FG002|Overall Study|Withdrawal by Subject|28|||
49073945|NCT00000620|158104936|FG003|Overall Study|Withdrawal by Subject|27|||
49073946|NCT00000620|158104937|FG004|Overall Study|Withdrawal by Subject|30|||
49073947|NCT00000620|158104938|FG005|Overall Study|Withdrawal by Subject|32|||
49073948|NCT00000620|158104939|FG006|Overall Study|Withdrawal by Subject|32|||
49073949|NCT00000620|158104940|FG007|Overall Study|Withdrawal by Subject|21|||
49073950|NCT00000620|158104933|FG000|Overall Study|missed closeout visit|22|||
49073951|NCT00000620|158104934|FG001|Overall Study|missed closeout visit|28|||
49073952|NCT00000620|158104935|FG002|Overall Study|missed closeout visit|16|||
49073953|NCT00000620|158104936|FG003|Overall Study|missed closeout visit|11|||
49073954|NCT00000620|158104937|FG004|Overall Study|missed closeout visit|26|||
49073955|NCT00000620|158104938|FG005|Overall Study|missed closeout visit|28|||
49073956|NCT00000620|158104939|FG006|Overall Study|missed closeout visit|13|||
49073957|NCT00000620|158104940|FG007|Overall Study|missed closeout visit|16|||
49073958|NCT02901548|158104941|FG000|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4|||
49073959|NCT01851330|158104942|FG000|Overall Study|Lack of Efficacy|10|||
49073960|NCT01851330|158104943|FG001|Overall Study|Lack of Efficacy|9|||
49073961|NCT01851330|158104944|FG002|Overall Study|Lack of Efficacy|2|||
49073962|NCT01851330|158104942|FG000|Overall Study|Lost to Follow-up|1|||
49073963|NCT01851330|158104943|FG001|Overall Study|Lost to Follow-up|6|||
49073964|NCT01851330|158104944|FG002|Overall Study|Lost to Follow-up|9|||
49073965|NCT01851330|158104942|FG000|Overall Study|Withdrew Consent|2|||
49073966|NCT01851330|158104943|FG001|Overall Study|Withdrew Consent|1|||
49073967|NCT01851330|158104944|FG002|Overall Study|Withdrew Consent|0|||
49073968|NCT01851330|158104942|FG000|Overall Study|Investigator's Discretion|0|||
49073969|NCT01851330|158104943|FG001|Overall Study|Investigator's Discretion|0|||
49073970|NCT01851330|158104944|FG002|Overall Study|Investigator's Discretion|1|||
49073971|NCT00264550|158104947|FG000|Overall Study|Death|0|||
49073972|NCT00264550|158104948|FG001|Overall Study|Death|3|||
49073973|NCT00264550|158104949|FG002|Overall Study|Death|0|||
49073974|NCT00264550|158104950|FG003|Overall Study|Death|0|||
49073975|NCT00264550|158104947|FG000|Overall Study|Lost to Follow-up|3|||
49073976|NCT00264550|158104948|FG001|Overall Study|Lost to Follow-up|1|||
49073977|NCT00264550|158104949|FG002|Overall Study|Lost to Follow-up|1|||
49073978|NCT00264550|158104950|FG003|Overall Study|Lost to Follow-up|1|||
49073979|NCT00264550|158104947|FG000|Overall Study|Adverse Event|23|||
49073980|NCT00264550|158104948|FG001|Overall Study|Adverse Event|18|||
49073981|NCT00264550|158104949|FG002|Overall Study|Adverse Event|9|||
49073982|NCT00264550|158104950|FG003|Overall Study|Adverse Event|14|||
49073983|NCT00264550|158104947|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
49073984|NCT00264550|158104948|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
49073985|NCT00264550|158104949|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
49073986|NCT00264550|158104950|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
49073987|NCT00264550|158104947|FG000|Overall Study|Discontinued oral study agent|0|||
49073988|NCT00264550|158104948|FG001|Overall Study|Discontinued oral study agent|1|||
49073989|NCT00264550|158104949|FG002|Overall Study|Discontinued oral study agent|0|||
49073990|NCT00264550|158104950|FG003|Overall Study|Discontinued oral study agent|0|||
49073991|NCT00264550|158104947|FG000|Overall Study|Other|13|||
49073992|NCT00264550|158104948|FG001|Overall Study|Other|7|||
49073993|NCT00264550|158104949|FG002|Overall Study|Other|3|||
49073994|NCT00264550|158104950|FG003|Overall Study|Other|9|||
49073995|NCT01590797|158104954|FG000|Overall Study|Adverse Event|4|||
49073996|NCT01590797|158104955|FG001|Overall Study|Adverse Event|3|||
49073997|NCT01590797|158104954|FG000|Overall Study|Lack of Efficacy|0|||
49073998|NCT01590797|158104955|FG001|Overall Study|Lack of Efficacy|2|||
49073999|NCT01590797|158104954|FG000|Overall Study|Lost to Follow-up|0|||
49074000|NCT01590797|158104955|FG001|Overall Study|Lost to Follow-up|1|||
49074001|NCT01590797|158104954|FG000|Overall Study|Protocol Violation|4|||
49074002|NCT01590797|158104955|FG001|Overall Study|Protocol Violation|1|||
49074003|NCT01590797|158104954|FG000|Overall Study|Withdrawal by Subject|7|||
49074004|NCT01590797|158104955|FG001|Overall Study|Withdrawal by Subject|5|||
49074005|NCT01590797|158104954|FG000|Overall Study|Other Protocol Specified Criteria|2|||
49074006|NCT01590797|158104955|FG001|Overall Study|Other Protocol Specified Criteria|4|||
49074007|NCT01266031|158104958|FG000|Overall Study|Not treated|0|||
49074008|NCT01266031|158104959|FG001|Overall Study|Not treated|3|||
49074009|NCT01266031|158104960|FG002|Overall Study|Not treated|2|||
49074010|NCT02865460|158104961|FG000|Overall Study|Adverse Event|1|||
49074011|NCT02865460|158104962|FG001|Overall Study|Adverse Event|0|||
49074012|NCT02865460|158104961|FG000|Overall Study|Withdrawal by Subject|1|||
49074013|NCT02865460|158104962|FG001|Overall Study|Withdrawal by Subject|1|||
49074014|NCT02865460|158104961|FG000|Overall Study|Lost to Follow-up|7|||
49074015|NCT02865460|158104962|FG001|Overall Study|Lost to Follow-up|4|||
49074016|NCT02865460|158104961|FG000|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
49074017|NCT02865460|158104962|FG001|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
49074018|NCT00380744|158104965|FG000|Overall Study|Death|0|||
49074019|NCT00380744|158104966|FG001|Overall Study|Death|0|||
49074020|NCT00380744|158104967|FG002|Overall Study|Death|0|||
49074021|NCT00380744|158104968|FG003|Overall Study|Death|0|||
49074022|NCT00380744|158104969|FG004|Overall Study|Death|0|||
49074023|NCT00380744|158104970|FG005|Overall Study|Death|0|||
49074024|NCT00380744|158104971|FG006|Overall Study|Death|1|||
49074025|NCT00380744|158104965|FG000|Overall Study|Withdrawal by Subject|1|||
49074026|NCT00380744|158104966|FG001|Overall Study|Withdrawal by Subject|0|||
49074027|NCT00380744|158104967|FG002|Overall Study|Withdrawal by Subject|0|||
49074028|NCT00380744|158104968|FG003|Overall Study|Withdrawal by Subject|0|||
49074029|NCT00380744|158104969|FG004|Overall Study|Withdrawal by Subject|0|||
49074030|NCT00380744|158104970|FG005|Overall Study|Withdrawal by Subject|0|||
49074031|NCT00380744|158104971|FG006|Overall Study|Withdrawal by Subject|0|||
49074032|NCT01434810|158104972|FG000|Overall Study|Did not receive treatment|11|||
49074033|NCT01434810|158104973|FG001|Overall Study|Did not receive treatment|3|||
49074034|NCT01434810|158104972|FG000|Overall Study|Missing data/received <5hr phototherapy|12|||
49074035|NCT01434810|158104973|FG001|Overall Study|Missing data/received <5hr phototherapy|7|||
49074036|NCT02508935|158104975|FG000|Overall Study|Withdrawal by Subject|1|||
49074037|NCT02508935|158104975|FG000|Overall Study|Withdrawal by Caregiver|8|||
49074038|NCT02508935|158104975|FG000|Overall Study|Pain Score <4|1|||
49074039|NCT02508935|158104975|FG000|Overall Study|Emesis|3|||
49074040|NCT02508935|158104975|FG000|Overall Study|Adverse Event|3|||
49074041|NCT02508935|158104975|FG000|Overall Study|Protocol Violation|1|||
49074042|NCT02508935|158104975|FG000|Overall Study|Physician Decision|1|||
49074043|NCT02508935|158104975|FG000|Overall Study|Trial terminated by sponsor|5|||
49074044|NCT03106987|158104983|FG000|Overall Study|Death|37|||
49074045|NCT03106987|158104984|FG001|Overall Study|Death|22|||
49074046|NCT03106987|158104985|FG002|Overall Study|Death|12|||
49074047|NCT03106987|158104986|FG003|Overall Study|Death|8|||
49074048|NCT03106987|158104983|FG000|Overall Study|Lost to Follow-up|2|||
49074049|NCT03106987|158104984|FG001|Overall Study|Lost to Follow-up|0|||
49074050|NCT03106987|158104985|FG002|Overall Study|Lost to Follow-up|2|||
49074051|NCT03106987|158104986|FG003|Overall Study|Lost to Follow-up|2|||
49074052|NCT03106987|158104983|FG000|Overall Study|Withdrawal by Subject|5|||
49074053|NCT03106987|158104984|FG001|Overall Study|Withdrawal by Subject|1|||
49074054|NCT03106987|158104985|FG002|Overall Study|Withdrawal by Subject|4|||
49074055|NCT03106987|158104986|FG003|Overall Study|Withdrawal by Subject|1|||
49074056|NCT01338870|158104987|FG000|Overall Study|Lost to Follow-up|0|||
49074057|NCT01338870|158104988|FG001|Overall Study|Lost to Follow-up|0|||
49074058|NCT01338870|158104989|FG002|Overall Study|Lost to Follow-up|1|||
49074059|NCT01338870|158104990|FG003|Overall Study|Lost to Follow-up|0|||
49074060|NCT01338870|158104991|FG004|Overall Study|Lost to Follow-up|1|||
49074061|NCT01338870|158104992|FG005|Overall Study|Lost to Follow-up|0|||
49074062|NCT01338870|158104987|FG000|Overall Study|Withdrawal by Subject|2|||
49074063|NCT01338870|158104988|FG001|Overall Study|Withdrawal by Subject|3|||
49074064|NCT01338870|158104989|FG002|Overall Study|Withdrawal by Subject|4|||
49074065|NCT01338870|158104990|FG003|Overall Study|Withdrawal by Subject|0|||
49074066|NCT01338870|158104991|FG004|Overall Study|Withdrawal by Subject|0|||
49074067|NCT01338870|158104992|FG005|Overall Study|Withdrawal by Subject|2|||
49074068|NCT01338870|158104987|FG000|Overall Study|Other|3|||
49074069|NCT01338870|158104988|FG001|Overall Study|Other|3|||
49074070|NCT01338870|158104989|FG002|Overall Study|Other|3|||
49074071|NCT01338870|158104990|FG003|Overall Study|Other|2|||
49074072|NCT01338870|158104991|FG004|Overall Study|Other|0|||
49074073|NCT01338870|158104992|FG005|Overall Study|Other|2|||
49074074|NCT01338870|158104987|FG000|Overall Study|Protocol Violation|0|||
49074075|NCT01338870|158104988|FG001|Overall Study|Protocol Violation|2|||
49074076|NCT01338870|158104989|FG002|Overall Study|Protocol Violation|2|||
49074077|NCT01338870|158104990|FG003|Overall Study|Protocol Violation|2|||
49074078|NCT01338870|158104991|FG004|Overall Study|Protocol Violation|1|||
49074079|NCT01338870|158104992|FG005|Overall Study|Protocol Violation|1|||
49074080|NCT01338870|158104987|FG000|Overall Study|Adverse Event|4|||
49074081|NCT01338870|158104988|FG001|Overall Study|Adverse Event|4|||
49074082|NCT01338870|158104989|FG002|Overall Study|Adverse Event|1|||
49074083|NCT01338870|158104990|FG003|Overall Study|Adverse Event|5|||
49074084|NCT01338870|158104991|FG004|Overall Study|Adverse Event|4|||
49074085|NCT01338870|158104992|FG005|Overall Study|Adverse Event|1|||
49074086|NCT01307111|158104993|FG000|IUD Insertion|Lost to Follow-up|2|||
49074087|NCT01307111|158104994|FG001|IUD Insertion|Lost to Follow-up|0|||
49074088|NCT01307111|158104993|FG000|1-2 Week IUD Check up|IUD expulsion/removal|2|||
49074089|NCT01307111|158104994|FG001|1-2 Week IUD Check up|IUD expulsion/removal|2|||
49074090|NCT02015065|158104998|FG000|Overall Study|Death on study|1|||
49074091|NCT02015065|158104999|FG001|Overall Study|Death on study|2|||
49074092|NCT02015065|158105000|FG002|Overall Study|Death on study|1|||
49074093|NCT01420965|158105001|FG000|Overall Study|Withdrawal by Subject|1|||
49074094|NCT01420965|158105002|FG001|Overall Study|Withdrawal by Subject|0|||
49074095|NCT01420965|158105003|FG002|Overall Study|Withdrawal by Subject|0|||
49074096|NCT01420965|158105001|FG000|Overall Study|Adverse Event|0|||
49074097|NCT01420965|158105002|FG001|Overall Study|Adverse Event|1|||
49074098|NCT01420965|158105003|FG002|Overall Study|Adverse Event|0|||
49074099|NCT00879411|158105004|FG000|Overall Study|lost to follow-up (non-AE)|162|||
49074100|NCT02694328|158105017|FG000|Overall Study|Adverse Event|27|||
49074101|NCT02694328|158105018|FG001|Overall Study|Adverse Event|33|||
49074102|NCT02694328|158105017|FG000|Overall Study|Withdrawal by Subject|27|||
49074103|NCT02694328|158105018|FG001|Overall Study|Withdrawal by Subject|23|||
49074104|NCT02694328|158105017|FG000|Overall Study|Lost to Follow-up|26|||
49074105|NCT02694328|158105018|FG001|Overall Study|Lost to Follow-up|22|||
49074106|NCT02694328|158105017|FG000|Overall Study|Noncompliant with study drug|11|||
49074107|NCT02694328|158105018|FG001|Overall Study|Noncompliant with study drug|8|||
49074108|NCT02694328|158105017|FG000|Overall Study|Incarceration|1|||
49074109|NCT02694328|158105018|FG001|Overall Study|Incarceration|1|||
49074110|NCT02694328|158105017|FG000|Overall Study|Lack of Efficacy|1|||
49074111|NCT02694328|158105018|FG001|Overall Study|Lack of Efficacy|2|||
49074112|NCT02694328|158105017|FG000|Overall Study|Pregnancy|1|||
49074113|NCT02694328|158105018|FG001|Overall Study|Pregnancy|1|||
49074114|NCT02694328|158105017|FG000|Overall Study|Protocol Violation|6|||
49074115|NCT02694328|158105018|FG001|Overall Study|Protocol Violation|5|||
49074116|NCT02694328|158105017|FG000|Overall Study|Abnormal Laboratory Value|0|||
49074117|NCT02694328|158105018|FG001|Overall Study|Abnormal Laboratory Value|3|||
49074118|NCT02125877|158105019|FG000|Overall Study|Physician Decision|1|||
49074119|NCT02125877|158105020|FG001|Overall Study|Physician Decision|0|||
49074120|NCT02125877|158105019|FG000|Overall Study|Death|0|||
49074121|NCT02125877|158105020|FG001|Overall Study|Death|1|||
49074122|NCT02125877|158105019|FG000|Overall Study|Administrative problems|0|||
49074123|NCT02125877|158105020|FG001|Overall Study|Administrative problems|1|||
49074124|NCT02125877|158105019|FG000|Overall Study|Participant/guardian decision|0|||
49074125|NCT02125877|158105020|FG001|Overall Study|Participant/guardian decision|2|||
49074126|NCT02125877|158105019|FG000|Overall Study|Withdrawal by Subject|2|||
49074127|NCT02125877|158105020|FG001|Overall Study|Withdrawal by Subject|1|||
49074128|NCT02125877|158105019|FG000|Overall Study|Protocol deviation|4|||
49074129|NCT02125877|158105020|FG001|Overall Study|Protocol deviation|1|||
49074130|NCT02125877|158105019|FG000|Overall Study|Adverse Event|6|||
49074131|NCT02125877|158105020|FG001|Overall Study|Adverse Event|4|||
49074132|NCT01275729|158105021|FG000|Overall Study|Death|3|||
49074133|NCT01275729|158105021|FG000|Overall Study|Withdrawal by Subject|1|||
49074134|NCT02842073|158105023|FG000|Overall Study|Withdrawal by Subject|1|||
49074135|NCT02871492|158105024|FG000|Overall Study|Lost to Follow-up|6|||
49074136|NCT02871492|158105025|FG001|Overall Study|Lost to Follow-up|3|||
49074137|NCT02871492|158105026|FG002|Overall Study|Lost to Follow-up|5|||
49074138|NCT02871492|158105024|FG000|Overall Study|Withdrawal by Subject|0|||
49074139|NCT02871492|158105025|FG001|Overall Study|Withdrawal by Subject|0|||
49074140|NCT02871492|158105026|FG002|Overall Study|Withdrawal by Subject|1|||
49074141|NCT04546724|158105031|FG000|Overall Study|Withdrawal by Subject|145|||
49074142|NCT04546724|158105032|FG001|Overall Study|Withdrawal by Subject|41|||
49074143|NCT04546724|158105031|FG000|Overall Study|Adverse Event|1|||
49074144|NCT04546724|158105032|FG001|Overall Study|Adverse Event|1|||
49074145|NCT04546724|158105031|FG000|Overall Study|Lost to Follow-up|186|||
49074146|NCT04546724|158105032|FG001|Overall Study|Lost to Follow-up|63|||
49074147|NCT04546724|158105031|FG000|Overall Study|Physician Decision|8|||
49074148|NCT04546724|158105032|FG001|Overall Study|Physician Decision|2|||
49074149|NCT04546724|158105031|FG000|Overall Study|Death|2|||
49074150|NCT04546724|158105032|FG001|Overall Study|Death|1|||
49074151|NCT04546724|158105031|FG000|Overall Study|subject has been out of town|1|||
49074152|NCT04546724|158105032|FG001|Overall Study|subject has been out of town|0|||
49074153|NCT04546724|158105031|FG000|Overall Study|subject is incarcerated|2|||
49074154|NCT04546724|158105032|FG001|Overall Study|subject is incarcerated|0|||
49074155|NCT04546724|158105031|FG000|Overall Study|subject is relocating|12|||
49074156|NCT04546724|158105032|FG001|Overall Study|subject is relocating|4|||
49074157|NCT04546724|158105031|FG000|Overall Study|Subject in another study|1|||
49074158|NCT04546724|158105032|FG001|Overall Study|Subject in another study|1|||
49074159|NCT02256436|158105033|FG000|Overall Study|Adverse Event|9|||
49074160|NCT02256436|158105034|FG001|Overall Study|Adverse Event|14|||
49074161|NCT02256436|158105033|FG000|Overall Study|Death|216|||
49074162|NCT02256436|158105034|FG001|Overall Study|Death|208|||
49074163|NCT02256436|158105033|FG000|Overall Study|Lost to Follow-up|1|||
49074164|NCT02256436|158105034|FG001|Overall Study|Lost to Follow-up|2|||
49074165|NCT02256436|158105033|FG000|Overall Study|Physician Decision|1|||
49074166|NCT02256436|158105034|FG001|Overall Study|Physician Decision|0|||
49074167|NCT02256436|158105033|FG000|Overall Study|Protocol Violation|0|||
49074168|NCT02256436|158105034|FG001|Overall Study|Protocol Violation|1|||
49074169|NCT02256436|158105033|FG000|Overall Study|Withdrawal by Subject|26|||
49074170|NCT02256436|158105034|FG001|Overall Study|Withdrawal by Subject|10|||
49074171|NCT02256436|158105033|FG000|Overall Study|Transferred to Extension Study|11|||
49074172|NCT02256436|158105034|FG001|Overall Study|Transferred to Extension Study|23|||
49074173|NCT02256436|158105033|FG000|Overall Study|Did Not Continue on Extension Study|8|||
49074174|NCT02256436|158105034|FG001|Overall Study|Did Not Continue on Extension Study|12|||
49074175|NCT00811928|158105035|FG000|Overall Study|AEs and SAEs Including Death|7|||
49074176|NCT00811928|158105036|FG001|Overall Study|AEs and SAEs Including Death|11|||
49074177|NCT00811928|158105035|FG000|Overall Study|Withdrawal by Subject|18|||
49074178|NCT00811928|158105036|FG001|Overall Study|Withdrawal by Subject|12|||
49074179|NCT00811928|158105035|FG000|Overall Study|Did Not Take Study Drug|3|||
49074180|NCT00811928|158105036|FG001|Overall Study|Did Not Take Study Drug|0|||
49074181|NCT00811928|158105035|FG000|Overall Study|Without Primary Efficacy Endpoint Data|7|||
49074182|NCT00811928|158105036|FG001|Overall Study|Without Primary Efficacy Endpoint Data|4|||
49074183|NCT00811928|158105035|FG000|Overall Study|Investigator Decision|2|||
49074184|NCT00811928|158105036|FG001|Overall Study|Investigator Decision|1|||
49074185|NCT00811928|158105035|FG000|Overall Study|Poor Compliance|2|||
49074186|NCT00811928|158105036|FG001|Overall Study|Poor Compliance|5|||
49074187|NCT04172597|158105039|FG000|Overall Study|Disease Progression|0|||
49074188|NCT04172597|158105040|FG001|Overall Study|Disease Progression|0|||
49074189|NCT04172597|158105041|FG002|Overall Study|Disease Progression|0|||
49074190|NCT04172597|158105042|FG003|Overall Study|Disease Progression|0|||
49074191|NCT04172597|158105043|FG004|Overall Study|Disease Progression|1|||
49074192|NCT00171951|158105044|FG000|Overall Study|Adverse Event|1|||
49074193|NCT00171951|158105044|FG000|Overall Study|Abnormal Laboratory Values|2|||
49074194|NCT00171951|158105044|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
49074195|NCT00171951|158105044|FG000|Overall Study|Participants Withdrew Consent|3|||
49074196|NCT00171951|158105044|FG000|Overall Study|New Cancer Therapy|5|||
49074197|NCT00171951|158105044|FG000|Overall Study|Reason not Specified|2|||
49074198|NCT00535405|158105046|FG000|Overall Study|Adverse Event|6|||
49074199|NCT00535405|158105047|FG001|Overall Study|Adverse Event|8|||
49074200|NCT00535405|158105048|FG002|Overall Study|Adverse Event|3|||
49074201|NCT00535405|158105049|FG003|Overall Study|Adverse Event|8|||
49074202|NCT00535405|158105050|FG004|Overall Study|Adverse Event|6|||
49074203|NCT00535405|158105046|FG000|Overall Study|Lost to Follow-up|1|||
49074204|NCT00535405|158105047|FG001|Overall Study|Lost to Follow-up|3|||
49074205|NCT00535405|158105048|FG002|Overall Study|Lost to Follow-up|3|||
49074206|NCT00535405|158105049|FG003|Overall Study|Lost to Follow-up|2|||
49074207|NCT00535405|158105050|FG004|Overall Study|Lost to Follow-up|1|||
49074208|NCT00535405|158105046|FG000|Overall Study|Physician Decision|3|||
49074209|NCT00535405|158105047|FG001|Overall Study|Physician Decision|2|||
49074210|NCT00535405|158105048|FG002|Overall Study|Physician Decision|0|||
49074211|NCT00535405|158105049|FG003|Overall Study|Physician Decision|1|||
49074212|NCT00535405|158105050|FG004|Overall Study|Physician Decision|1|||
49074213|NCT00535405|158105046|FG000|Overall Study|Protocol Violation|2|||
49074214|NCT00535405|158105047|FG001|Overall Study|Protocol Violation|2|||
49074215|NCT00535405|158105048|FG002|Overall Study|Protocol Violation|2|||
49074216|NCT00535405|158105049|FG003|Overall Study|Protocol Violation|1|||
49074217|NCT00535405|158105050|FG004|Overall Study|Protocol Violation|0|||
49074218|NCT00535405|158105046|FG000|Overall Study|Withdrawal by Subject|5|||
49074219|NCT00535405|158105047|FG001|Overall Study|Withdrawal by Subject|11|||
49074220|NCT00535405|158105048|FG002|Overall Study|Withdrawal by Subject|10|||
49074221|NCT00535405|158105049|FG003|Overall Study|Withdrawal by Subject|10|||
49074222|NCT00535405|158105050|FG004|Overall Study|Withdrawal by Subject|8|||
49074223|NCT02290223|158105053|FG000|6 Months|Lost to Follow-up|9|||
49074224|NCT02290223|158105054|FG001|6 Months|Lost to Follow-up|6|||
49074225|NCT02290223|158105053|FG000|6 Months|Withdrawal by Subject|5|||
49074226|NCT02290223|158105054|FG001|6 Months|Withdrawal by Subject|0|||
49074227|NCT02290223|158105053|FG000|6 Months|deceased (not related to study)|2|||
49074228|NCT02290223|158105054|FG001|6 Months|deceased (not related to study)|0|||
49074229|NCT02290223|158105053|FG000|12 Months|Lost to Follow-up|16|||
49074230|NCT02290223|158105054|FG001|12 Months|Lost to Follow-up|10|||
49074231|NCT02290223|158105053|FG000|12 Months|Refusal|0|||
49074232|NCT02290223|158105054|FG001|12 Months|Refusal|1|||
49074233|NCT04036110|158105060|FG000|Overall Study|Lost to Follow-up|3|||
49074234|NCT04036110|158105061|FG001|Overall Study|Lost to Follow-up|2|||
49074235|NCT04036110|158105062|FG002|Overall Study|Lost to Follow-up|1|||
49074236|NCT04036110|158105060|FG000|Overall Study|Study Suspended|4|||
49074237|NCT04036110|158105061|FG001|Overall Study|Study Suspended|5|||
49074238|NCT04036110|158105062|FG002|Overall Study|Study Suspended|1|||
49074239|NCT00534404|158105065|FG000|Overall Study|Death|0|||
49074240|NCT00534404|158105066|FG001|Overall Study|Death|0|||
49074241|NCT00534404|158105067|FG002|Overall Study|Death|2|||
49074242|NCT00534404|158105065|FG000|Overall Study|Withdrawal by Subject|8|||
49074243|NCT00534404|158105066|FG001|Overall Study|Withdrawal by Subject|2|||
49074244|NCT00534404|158105067|FG002|Overall Study|Withdrawal by Subject|38|||
49074245|NCT00534404|158105065|FG000|Overall Study|Removed by study staff|2|||
49074246|NCT00534404|158105066|FG001|Overall Study|Removed by study staff|3|||
49074247|NCT00534404|158105067|FG002|Overall Study|Removed by study staff|1|||
49074248|NCT00534404|158105065|FG000|Overall Study|Lost to Follow-up|170|||
49074249|NCT00534404|158105066|FG001|Overall Study|Lost to Follow-up|138|||
49074250|NCT00534404|158105067|FG002|Overall Study|Lost to Follow-up|201|||
49074251|NCT04759768|158105068|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
49074252|NCT04759768|158105069|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
49074253|NCT04759768|158105068|FG000|Washout (7 Days)|Physician Decision|0|||
49074254|NCT04759768|158105069|FG001|Washout (7 Days)|Physician Decision|1|||
49074255|NCT02996487|158105072|FG000|Overall Study|Lost to Follow-up|1|||
49074256|NCT02996487|158105073|FG001|Overall Study|Lost to Follow-up|1|||
49074257|NCT02996487|158105074|FG002|Overall Study|Lost to Follow-up|0|||
49074258|NCT02996487|158105072|FG000|Overall Study|Death|0|||
49074259|NCT02996487|158105073|FG001|Overall Study|Death|1|||
49074260|NCT02996487|158105074|FG002|Overall Study|Death|0|||
49074261|NCT02996487|158105072|FG000|Overall Study|Withdrawal by Subject|2|||
49074262|NCT02996487|158105073|FG001|Overall Study|Withdrawal by Subject|3|||
49074263|NCT02996487|158105074|FG002|Overall Study|Withdrawal by Subject|0|||
49074264|NCT01130597|158105075|FG000|Overall Study|Protocol-specified (High K+)|1|||
49074265|NCT01130597|158105075|FG000|Overall Study|Adverse Event|4|||
49074266|NCT01130597|158105075|FG000|Overall Study|Death|1|||
49074267|NCT01130597|158105075|FG000|Overall Study|Protocol Violation|1|||
49074268|NCT02759692|158105079|FG000|Period 1|Test article no longer available|1|||
49074269|NCT02759692|158105080|FG001|Period 1|Test article no longer available|1|||
49074270|NCT02759692|158105079|FG000|Period 1|No longer meets eligibility criteria.|1|||
49074271|NCT02759692|158105080|FG001|Period 1|No longer meets eligibility criteria.|0|||
49074272|NCT02759692|158105079|FG000|Period 1|Miss-Randomized|1|||
49074273|NCT02759692|158105080|FG001|Period 1|Miss-Randomized|1|||
49074274|NCT02759692|158105079|FG000|Period 2|Lost to Follow-up|1|||
49074275|NCT02759692|158105080|FG001|Period 2|Lost to Follow-up|0|||
49074276|NCT02759692|158105079|FG000|Period 2|Test article no longer available|0|||
49074277|NCT02759692|158105080|FG001|Period 2|Test article no longer available|1|||
49074278|NCT05513391|158105081|FG000|Overall Study|Adverse Event|1|||
49074279|NCT05513391|158105082|FG001|Overall Study|Adverse Event|0|||
49074280|NCT05513391|158105081|FG000|Overall Study|Protocol Deviation|0|||
49074281|NCT05513391|158105082|FG001|Overall Study|Protocol Deviation|1|||
49074282|NCT05513391|158105081|FG000|Overall Study|Withdrawal by Subject|3|||
49074283|NCT05513391|158105082|FG001|Overall Study|Withdrawal by Subject|1|||
49074284|NCT05513391|158105081|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
49074285|NCT05513391|158105082|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
49074286|NCT05513391|158105081|FG000|Overall Study|Lost to Follow-up|0|||
49074287|NCT05513391|158105082|FG001|Overall Study|Lost to Follow-up|2|||
49074288|NCT01862484|158105084|FG000|Overall Study|Lack of Efficacy|1|||
49074289|NCT01862484|158105085|FG001|Overall Study|Lack of Efficacy|1|||
49074290|NCT01862484|158105084|FG000|Overall Study|Lost to Follow-up|1|||
49074291|NCT01862484|158105085|FG001|Overall Study|Lost to Follow-up|2|||
49074292|NCT01862484|158105084|FG000|Overall Study|Protocol Violation|0|||
49074293|NCT01862484|158105085|FG001|Overall Study|Protocol Violation|2|||
49074294|NCT01862484|158105084|FG000|Overall Study|Withdrawal by Subject|0|||
49074295|NCT01862484|158105085|FG001|Overall Study|Withdrawal by Subject|3|||
49074296|NCT03316547|158105090|FG000|Overall Study|Death|3|||
49074297|NCT03316547|158105091|FG001|Overall Study|Death|1|||
49074298|NCT03316547|158105090|FG000|Overall Study|Lost to Follow-up|6|||
49074299|NCT03316547|158105091|FG001|Overall Study|Lost to Follow-up|6|||
49074300|NCT03316547|158105090|FG000|Overall Study|Withdrawal by Subject|3|||
49074301|NCT03316547|158105091|FG001|Overall Study|Withdrawal by Subject|2|||
49074302|NCT03316547|158105090|FG000|Overall Study|Transfer to another hospital|6|||
49074303|NCT03316547|158105091|FG001|Overall Study|Transfer to another hospital|4|||
49074304|NCT00721227|158105096|FG000|Overall Study|Lost to Follow-up|3|||
49074305|NCT00721227|158105097|FG001|Overall Study|Lost to Follow-up|0|||
49074306|NCT00721227|158105096|FG000|Overall Study|Noncompliance with scheduled visits.|1|||
49074307|NCT00721227|158105097|FG001|Overall Study|Noncompliance with scheduled visits.|0|||
49074308|NCT03172494|158105116|FG000|Overall Study|Adverse Event|5|||
49074309|NCT03172494|158105117|FG001|Overall Study|Adverse Event|1|||
49074310|NCT03172494|158105118|FG002|Overall Study|Adverse Event|15|||
49074311|NCT03172494|158105116|FG000|Overall Study|Protocol Violation|3|||
49074312|NCT03172494|158105117|FG001|Overall Study|Protocol Violation|2|||
49074313|NCT03172494|158105118|FG002|Overall Study|Protocol Violation|1|||
49074314|NCT03172494|158105116|FG000|Overall Study|Lack of Efficacy|0|||
49074315|NCT03172494|158105117|FG001|Overall Study|Lack of Efficacy|0|||
49074316|NCT03172494|158105118|FG002|Overall Study|Lack of Efficacy|4|||
49074317|NCT03172494|158105116|FG000|Overall Study|Pregnancy|0|||
49074318|NCT03172494|158105117|FG001|Overall Study|Pregnancy|1|||
49074319|NCT03172494|158105118|FG002|Overall Study|Pregnancy|0|||
49074320|NCT03172494|158105116|FG000|Overall Study|Withdrawal by Subject|10|||
49074321|NCT03172494|158105117|FG001|Overall Study|Withdrawal by Subject|8|||
49074322|NCT03172494|158105118|FG002|Overall Study|Withdrawal by Subject|8|||
49074323|NCT03172494|158105116|FG000|Overall Study|Severe hypoglycaemic episode|0|||
49074324|NCT03172494|158105117|FG001|Overall Study|Severe hypoglycaemic episode|0|||
49074325|NCT03172494|158105118|FG002|Overall Study|Severe hypoglycaemic episode|1|||
49074326|NCT03172494|158105116|FG000|Overall Study|Non-compliance towards treatment|2|||
49074327|NCT03172494|158105117|FG001|Overall Study|Non-compliance towards treatment|0|||
49074328|NCT03172494|158105118|FG002|Overall Study|Non-compliance towards treatment|0|||
49074329|NCT04233073|158105119|FG000|Overall Study|Death|5|||
49074330|NCT01653912|158105120|FG000|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
49074331|NCT01653912|158105121|FG001|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1|||
49074332|NCT01653912|158105122|FG002|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
49074333|NCT01653912|158105123|FG003|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
49074334|NCT01653912|158105124|FG004|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
49074335|NCT01653912|158105125|FG005|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
49074336|NCT01653912|158105120|FG000|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
49074337|NCT01653912|158105121|FG001|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
49074338|NCT01653912|158105122|FG002|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2|||
49074339|NCT01653912|158105123|FG003|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
49074340|NCT01653912|158105124|FG004|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
49074341|NCT01653912|158105125|FG005|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
49074342|NCT01653912|158105120|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
49074343|NCT01653912|158105121|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
49074344|NCT01653912|158105122|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
49074345|NCT01653912|158105123|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1|||
49074346|NCT01653912|158105124|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
49074347|NCT01653912|158105125|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
49074348|NCT01653912|158105120|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
49074349|NCT01653912|158105121|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
49074350|NCT01653912|158105122|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
49074351|NCT01653912|158105123|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1|||
49074352|NCT01653912|158105124|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
49074353|NCT01653912|158105125|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
49074354|NCT01653912|158105120|FG000|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
49074355|NCT01653912|158105121|FG001|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
49074356|NCT01653912|158105122|FG002|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
49074357|NCT01653912|158105123|FG003|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
49074358|NCT01653912|158105124|FG004|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
49074359|NCT01653912|158105125|FG005|Phase 2: GSK2110183 125 mg|Adverse Event|1|||
49074360|NCT01653912|158105120|FG000|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
49074361|NCT01653912|158105121|FG001|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
49074362|NCT01653912|158105122|FG002|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
49074363|NCT01653912|158105123|FG003|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
49074364|NCT01653912|158105124|FG004|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
49074365|NCT01653912|158105125|FG005|Phase 2: GSK2110183 125 mg|Clinical Progression|6|||
49074366|NCT01653912|158105120|FG000|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
49074367|NCT01653912|158105121|FG001|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
49074368|NCT01653912|158105122|FG002|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
49074369|NCT01653912|158105123|FG003|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
49074370|NCT01653912|158105124|FG004|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
49074371|NCT01653912|158105125|FG005|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1|||
49074372|NCT00993421|158105126|FG000|Overall Study|Adverse Event|2|||
49074373|NCT00993421|158105127|FG001|Overall Study|Adverse Event|7|||
49074374|NCT00993421|158105128|FG002|Overall Study|Adverse Event|6|||
49074375|NCT00993421|158105129|FG003|Overall Study|Adverse Event|9|||
49074376|NCT00993421|158105130|FG004|Overall Study|Adverse Event|5|||
49074377|NCT00993421|158105131|FG005|Overall Study|Adverse Event|7|||
49074378|NCT00993421|158105132|FG006|Overall Study|Adverse Event|1|||
49074379|NCT00993421|158105126|FG000|Overall Study|Sponsor Decision|36|||
49074380|NCT00993421|158105127|FG001|Overall Study|Sponsor Decision|31|||
49074381|NCT00993421|158105128|FG002|Overall Study|Sponsor Decision|28|||
49074382|NCT00993421|158105129|FG003|Overall Study|Sponsor Decision|30|||
49074383|NCT00993421|158105130|FG004|Overall Study|Sponsor Decision|38|||
49074384|NCT00993421|158105131|FG005|Overall Study|Sponsor Decision|30|||
49074385|NCT00993421|158105132|FG006|Overall Study|Sponsor Decision|29|||
49074386|NCT00993421|158105126|FG000|Overall Study|Lost to Follow-up|3|||
49074387|NCT00993421|158105127|FG001|Overall Study|Lost to Follow-up|5|||
49074388|NCT00993421|158105128|FG002|Overall Study|Lost to Follow-up|5|||
49074389|NCT00993421|158105129|FG003|Overall Study|Lost to Follow-up|0|||
49074390|NCT00993421|158105130|FG004|Overall Study|Lost to Follow-up|0|||
49074391|NCT00993421|158105131|FG005|Overall Study|Lost to Follow-up|0|||
49074392|NCT00993421|158105132|FG006|Overall Study|Lost to Follow-up|6|||
49074393|NCT00993421|158105126|FG000|Overall Study|Withdrawal by Subject|3|||
49074394|NCT00993421|158105127|FG001|Overall Study|Withdrawal by Subject|2|||
49074395|NCT00993421|158105128|FG002|Overall Study|Withdrawal by Subject|3|||
49074396|NCT00993421|158105129|FG003|Overall Study|Withdrawal by Subject|3|||
49074397|NCT00993421|158105130|FG004|Overall Study|Withdrawal by Subject|3|||
49074398|NCT00993421|158105131|FG005|Overall Study|Withdrawal by Subject|5|||
49074399|NCT00993421|158105132|FG006|Overall Study|Withdrawal by Subject|3|||
49074400|NCT00993421|158105126|FG000|Overall Study|Death|0|||
49074401|NCT00993421|158105127|FG001|Overall Study|Death|0|||
49074402|NCT00993421|158105128|FG002|Overall Study|Death|0|||
49074403|NCT00993421|158105129|FG003|Overall Study|Death|0|||
49074404|NCT00993421|158105130|FG004|Overall Study|Death|0|||
49074405|NCT00993421|158105131|FG005|Overall Study|Death|0|||
49074406|NCT00993421|158105132|FG006|Overall Study|Death|1|||
49074407|NCT00993421|158105126|FG000|Overall Study|Entry Criteria Exclusion|0|||
49074408|NCT00993421|158105127|FG001|Overall Study|Entry Criteria Exclusion|0|||
49074409|NCT00993421|158105128|FG002|Overall Study|Entry Criteria Exclusion|1|||
49074410|NCT00993421|158105129|FG003|Overall Study|Entry Criteria Exclusion|3|||
49074411|NCT00993421|158105130|FG004|Overall Study|Entry Criteria Exclusion|0|||
49074412|NCT00993421|158105131|FG005|Overall Study|Entry Criteria Exclusion|1|||
49074413|NCT00993421|158105132|FG006|Overall Study|Entry Criteria Exclusion|0|||
49074414|NCT00993421|158105126|FG000|Overall Study|Physician Decision|0|||
49074415|NCT00993421|158105127|FG001|Overall Study|Physician Decision|0|||
49074416|NCT00993421|158105128|FG002|Overall Study|Physician Decision|0|||
49074417|NCT00993421|158105129|FG003|Overall Study|Physician Decision|0|||
49074418|NCT00993421|158105130|FG004|Overall Study|Physician Decision|0|||
49074419|NCT00993421|158105131|FG005|Overall Study|Physician Decision|1|||
49074420|NCT00993421|158105132|FG006|Overall Study|Physician Decision|1|||
49074421|NCT00993421|158105126|FG000|Overall Study|Protocol Violation|0|||
49074422|NCT00993421|158105127|FG001|Overall Study|Protocol Violation|0|||
49074423|NCT00993421|158105128|FG002|Overall Study|Protocol Violation|0|||
49074424|NCT00993421|158105129|FG003|Overall Study|Protocol Violation|0|||
49074425|NCT00993421|158105130|FG004|Overall Study|Protocol Violation|0|||
49074426|NCT00993421|158105131|FG005|Overall Study|Protocol Violation|2|||
49074427|NCT00993421|158105132|FG006|Overall Study|Protocol Violation|1|||
49074428|NCT00143390|158105133|FG000|Overall Study|Death|2|||
49074429|NCT00143390|158105134|FG001|Overall Study|Death|0|||
49074430|NCT00143390|158105133|FG000|Overall Study|Not meeting entry criteria|2|||
49074431|NCT00143390|158105134|FG001|Overall Study|Not meeting entry criteria|5|||
49074432|NCT00143390|158105133|FG000|Overall Study|Withdrawal by Subject|4|||
49074433|NCT00143390|158105134|FG001|Overall Study|Withdrawal by Subject|4|||
49074434|NCT00143390|158105133|FG000|Overall Study|Progressive disease|119|||
49074435|NCT00143390|158105134|FG001|Overall Study|Progressive disease|115|||
49074436|NCT00143390|158105133|FG000|Overall Study|Protocol Violation|2|||
49074437|NCT00143390|158105134|FG001|Overall Study|Protocol Violation|0|||
49074438|NCT00143390|158105133|FG000|Overall Study|Study termination|10|||
49074439|NCT00143390|158105134|FG001|Overall Study|Study termination|15|||
49074440|NCT00143390|158105133|FG000|Overall Study|Adverse Event|9|||
49074441|NCT00143390|158105134|FG001|Overall Study|Adverse Event|8|||
49074442|NCT00143390|158105133|FG000|Overall Study|Other|1|||
49074443|NCT00143390|158105134|FG001|Overall Study|Other|2|||
49074444|NCT00041132|158105135|FG000|Overall Study|Adverse Event|19|||
49074445|NCT00041132|158105135|FG000|Overall Study|Death|1|||
49074446|NCT00041132|158105135|FG000|Overall Study|Not Eligible|7|||
49074447|NCT00041132|158105135|FG000|Overall Study|Withdrawal by Subject|1|||
49074448|NCT00041132|158105135|FG000|Overall Study|Physician Decision|2|||
49074449|NCT03086551|158105139|FG000|First Intervention|Failure to meet inclusion criterion|1|||
49074450|NCT03086551|158105140|FG001|First Intervention|Failure to meet inclusion criterion|0|||
49074451|NCT03086551|158105139|FG000|First Intervention|Lost to Follow-up|0|||
49074452|NCT03086551|158105140|FG001|First Intervention|Lost to Follow-up|1|||
49074453|NCT03086551|158105139|FG000|Washout|Lost to Follow-up|1|||
49074454|NCT03086551|158105140|FG001|Washout|Lost to Follow-up|2|||
49074455|NCT03086551|158105139|FG000|Washout|Withdrawal by Subject|2|||
49074456|NCT03086551|158105140|FG001|Washout|Withdrawal by Subject|1|||
49074457|NCT02022748|158106944|FG000|Overall Study|Adverse Event|1|||
49074458|NCT02022748|158106945|FG001|Overall Study|Adverse Event|1|||
49074459|NCT02022748|158106946|FG002|Overall Study|Adverse Event|0|||
49074460|NCT02022748|158106944|FG000|Overall Study|Withdrawal by Subject|0|||
49074461|NCT02022748|158106945|FG001|Overall Study|Withdrawal by Subject|1|||
49074462|NCT02022748|158106946|FG002|Overall Study|Withdrawal by Subject|0|||
49074463|NCT01305044|158106951|FG000|Overall Study|Withdrawal by Subject|3|||
49074464|NCT01305044|158106952|FG001|Overall Study|Withdrawal by Subject|6|||
49074465|NCT04893018|158106957|FG000|Overall Study|Lost to Follow-up|1|||
49074466|NCT04893018|158106958|FG001|Overall Study|Lost to Follow-up|0|||
49074467|NCT04893018|158106957|FG000|Overall Study|Withdrawal by Subject|2|||
49074468|NCT04893018|158106958|FG001|Overall Study|Withdrawal by Subject|0|||
49074469|NCT04893018|158106957|FG000|Overall Study|Study Terminated|1|||
49074470|NCT04893018|158106958|FG001|Overall Study|Study Terminated|2|||
49074471|NCT01973595|158106962|FG000|Washout|Withdrawal by Subject|1|||
49074472|NCT01973595|158106963|FG001|Washout|Withdrawal by Subject|0|||
49074473|NCT01973595|158106964|FG002|Washout|Withdrawal by Subject|1|||
49074474|NCT01973595|158106965|FG003|Washout|Withdrawal by Subject|0|||
49074475|NCT00233402|158106971|FG000|Overall Study|No pathology data|12|||
49074476|NCT00233402|158106972|FG001|Overall Study|No pathology data|9|||
49074477|NCT00233402|158106971|FG000|Overall Study|No Ta/T1|89|||
49074478|NCT00233402|158106972|FG001|Overall Study|No Ta/T1|94|||
49074479|NCT00233402|158106971|FG000|Overall Study|Lost to follow up etc|3|||
49074480|NCT00233402|158106972|FG001|Overall Study|Lost to follow up etc|21|||
49074481|NCT01243775|158106976|FG000|Overall Study|Withdrawal by Subject|2|||
49074482|NCT01260701|158106981|FG000|Overall Study|Adverse Event|9|||
49074483|NCT01260701|158106981|FG000|Overall Study|Withdrawal by Subject|2|||
49074484|NCT01260701|158106981|FG000|Overall Study|Progression|53|||
49074485|NCT01260701|158106981|FG000|Overall Study|Death|2|||
49074486|NCT01260701|158106981|FG000|Overall Study|Not protocol specified|3|||
49074487|NCT01260701|158106981|FG000|Overall Study|Under review|1|||
49074488|NCT01260701|158106981|FG000|Overall Study|Ineligible|4|||
49074489|NCT01260701|158106981|FG000|Overall Study|Did not begin protocol therapy|1|||
49074490|NCT01753297|158106984|FG000|Overall Study|Lost to Follow-up|7|||
49074491|NCT01753297|158106985|FG001|Overall Study|Lost to Follow-up|2|||
49074492|NCT01753297|158106984|FG000|Overall Study|Withdrawal by Subject|26|||
49074493|NCT01753297|158106985|FG001|Overall Study|Withdrawal by Subject|23|||
49074494|NCT01753297|158106984|FG000|Overall Study|Adverse Event (up to Month 36)|1|||
49074495|NCT01753297|158106985|FG001|Overall Study|Adverse Event (up to Month 36)|1|||
49074496|NCT01753297|158106984|FG000|Overall Study|Death|0|||
49074497|NCT01753297|158106985|FG001|Overall Study|Death|2|||
49074498|NCT01753297|158106984|FG000|Overall Study|Did not attend end of study visit|7|||
49074499|NCT01753297|158106985|FG001|Overall Study|Did not attend end of study visit|8|||
49074500|NCT00230178|158106986|FG000|Overall Study|Adverse Event|1|||
49074501|NCT00230178|158106987|FG001|Overall Study|Adverse Event|5|||
49074502|NCT00230178|158106988|FG002|Overall Study|Adverse Event|2|||
49074503|NCT00230178|158106986|FG000|Overall Study|Withdrawal by Subject|0|||
49074504|NCT00230178|158106987|FG001|Overall Study|Withdrawal by Subject|0|||
49074505|NCT00230178|158106988|FG002|Overall Study|Withdrawal by Subject|1|||
49074506|NCT00230178|158106986|FG000|Overall Study|Various other reasons|3|||
49074507|NCT00230178|158106987|FG001|Overall Study|Various other reasons|2|||
49074508|NCT00230178|158106988|FG002|Overall Study|Various other reasons|4|||
49074509|NCT00901576|158106991|FG000|Second Intervention|Withdrawal by Subject|0|||
49074510|NCT00901576|158106992|FG001|Second Intervention|Withdrawal by Subject|0|||
49074511|NCT00901576|158106993|FG002|Second Intervention|Withdrawal by Subject|0|||
49074512|NCT00901576|158106994|FG003|Second Intervention|Withdrawal by Subject|1|||
49074513|NCT00901576|158106995|FG004|Second Intervention|Withdrawal by Subject|0|||
49074514|NCT00901576|158106996|FG005|Second Intervention|Withdrawal by Subject|1|||
49074515|NCT00901576|158106991|FG000|Second Intervention|Physician Decision|1|||
49074516|NCT00901576|158106992|FG001|Second Intervention|Physician Decision|0|||
49074517|NCT00901576|158106993|FG002|Second Intervention|Physician Decision|0|||
49074518|NCT00901576|158106994|FG003|Second Intervention|Physician Decision|0|||
49074519|NCT00901576|158106995|FG004|Second Intervention|Physician Decision|0|||
49074520|NCT00901576|158106996|FG005|Second Intervention|Physician Decision|0|||
49074521|NCT01559389|158106997|FG000|Overall Study|Withdrawal by Subject|20|||
49074522|NCT01559389|158106998|FG001|Overall Study|Withdrawal by Subject|20|||
49074523|NCT00005957|158106999|FG000|Overall Study|No treated|3|||
49074524|NCT00005957|158107000|FG001|Overall Study|No treated|9|||
49074525|NCT00005957|158106999|FG000|Overall Study|Crossover to the other arm|5|||
49074526|NCT00005957|158107000|FG001|Overall Study|Crossover to the other arm|19|||
49074527|NCT01609023|158107001|FG000|Overall Study|Lack of Efficacy|3|||
49074528|NCT01609023|158107001|FG000|Overall Study|Withdrawal by Subject|4|||
49074529|NCT01609023|158107001|FG000|Overall Study|Lost to Follow-up|8|||
49074530|NCT01609023|158107001|FG000|Overall Study|Toxicity|3|||
49074531|NCT01609023|158107001|FG000|Overall Study|Disease progression|10|||
49074532|NCT01609023|158107001|FG000|Overall Study|Physician Decision|2|||
49074533|NCT01609023|158107001|FG000|Overall Study|Death|2|||
49074534|NCT01609023|158107001|FG000|Overall Study|Personal reasons|1|||
49074535|NCT02047734|158107002|FG000|Overall Study|Adverse Event|18|||
49074536|NCT02047734|158107003|FG001|Overall Study|Adverse Event|13|||
49074537|NCT02047734|158107004|FG002|Overall Study|Adverse Event|13|||
49074538|NCT02047734|158107002|FG000|Overall Study|Lack of Efficacy|4|||
49074539|NCT02047734|158107003|FG001|Overall Study|Lack of Efficacy|5|||
49074540|NCT02047734|158107004|FG002|Overall Study|Lack of Efficacy|1|||
49074541|NCT02047734|158107002|FG000|Overall Study|Protocol Violation|3|||
49074542|NCT02047734|158107003|FG001|Overall Study|Protocol Violation|1|||
49074543|NCT02047734|158107004|FG002|Overall Study|Protocol Violation|1|||
49074544|NCT02047734|158107002|FG000|Overall Study|Lost to Follow-up|1|||
49074545|NCT02047734|158107003|FG001|Overall Study|Lost to Follow-up|4|||
49074546|NCT02047734|158107004|FG002|Overall Study|Lost to Follow-up|0|||
49074547|NCT02047734|158107002|FG000|Overall Study|Death|0|||
49074548|NCT02047734|158107003|FG001|Overall Study|Death|1|||
49074549|NCT02047734|158107004|FG002|Overall Study|Death|0|||
49074550|NCT02047734|158107002|FG000|Overall Study|Withdrawal by Subject|30|||
49074551|NCT02047734|158107003|FG001|Overall Study|Withdrawal by Subject|31|||
49074552|NCT02047734|158107004|FG002|Overall Study|Withdrawal by Subject|19|||
49074553|NCT02047734|158107002|FG000|Overall Study|Physician Decision|7|||
49074554|NCT02047734|158107003|FG001|Overall Study|Physician Decision|6|||
49074555|NCT02047734|158107004|FG002|Overall Study|Physician Decision|5|||
49074556|NCT02047734|158107002|FG000|Overall Study|Miscellaneous|2|||
49074557|NCT02047734|158107003|FG001|Overall Study|Miscellaneous|4|||
49074558|NCT02047734|158107004|FG002|Overall Study|Miscellaneous|6|||
49074559|NCT02047734|158107002|FG000|Overall Study|Did Not Receive Study Drug|2|||
49074560|NCT02047734|158107003|FG001|Overall Study|Did Not Receive Study Drug|4|||
49074561|NCT02047734|158107004|FG002|Overall Study|Did Not Receive Study Drug|1|||
49074562|NCT01696279|158107006|FG000|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1|||
49074563|NCT01696279|158107007|FG001|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
49074564|NCT01696279|158107008|FG002|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
49074565|NCT01696279|158107009|FG003|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
49074566|NCT01696279|158107006|FG000|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
49074567|NCT01696279|158107007|FG001|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5|||
49074568|NCT01696279|158107008|FG002|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
49074569|NCT01696279|158107009|FG003|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
49074570|NCT01696279|158107006|FG000|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
49074571|NCT01696279|158107007|FG001|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1|||
49074572|NCT01696279|158107008|FG002|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
49074573|NCT01696279|158107009|FG003|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
49074574|NCT01696279|158107006|FG000|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
49074575|NCT01696279|158107007|FG001|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1|||
49074576|NCT01696279|158107008|FG002|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
49074577|NCT01696279|158107009|FG003|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
49074578|NCT01696279|158107006|FG000|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
49074579|NCT01696279|158107007|FG001|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3|||
49074580|NCT01696279|158107008|FG002|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
49074581|NCT01696279|158107009|FG003|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
49074582|NCT01696279|158107006|FG000|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
49074583|NCT01696279|158107007|FG001|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7|||
49074584|NCT01696279|158107008|FG002|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
49074585|NCT01696279|158107009|FG003|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
49074586|NCT01696279|158107006|FG000|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
49074587|NCT01696279|158107007|FG001|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2|||
49074588|NCT01696279|158107008|FG002|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
49074589|NCT01696279|158107009|FG003|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
49074590|NCT01696279|158107006|FG000|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
49074591|NCT01696279|158107007|FG001|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
49074592|NCT01696279|158107008|FG002|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1|||
49074593|NCT01696279|158107009|FG003|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
49074594|NCT01696279|158107006|FG000|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
49074595|NCT01696279|158107007|FG001|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
49074596|NCT01696279|158107008|FG002|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
49074597|NCT01696279|158107009|FG003|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6|||
49074598|NCT01696279|158107006|FG000|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
49074599|NCT01696279|158107007|FG001|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
49074600|NCT01696279|158107008|FG002|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
49074601|NCT01696279|158107009|FG003|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1|||
49074602|NCT01696279|158107006|FG000|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
49074603|NCT01696279|158107007|FG001|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
49074604|NCT01696279|158107008|FG002|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
49074605|NCT01696279|158107009|FG003|Part 3: Lanthanum Carbonate (6 Months)|Missing|1|||
49074606|NCT00799825|158107013|FG000|Overall Study|Adverse Event|1|||
49074607|NCT00799825|158107013|FG000|Overall Study|Withdrawal by Subject|6|||
49074608|NCT00799825|158107013|FG000|Overall Study|Lost to Follow-up|38|||
49074609|NCT00799825|158107013|FG000|Overall Study|Pregnancy|3|||
49074610|NCT02439970|158107022|FG000|Overall Study|Study Terminated|2|||
49074611|NCT02439970|158107023|FG001|Overall Study|Study Terminated|3|||
49074612|NCT03201445|158107024|FG000|Part A DB Phase (Through Week 13)|Lost to Follow-up|1|||
49074613|NCT03201445|158107025|FG001|Part A DB Phase (Through Week 13)|Lost to Follow-up|0|||
49074614|NCT03201445|158107024|FG000|Part A DB Phase (Through Week 13)|Protocol Violation|0|||
49074615|NCT03201445|158107025|FG001|Part A DB Phase (Through Week 13)|Protocol Violation|1|||
49074616|NCT03201445|158107024|FG000|Part A DB Phase (Through Week 13)|Withdrawal by Subject|0|||
49074617|NCT03201445|158107025|FG001|Part A DB Phase (Through Week 13)|Withdrawal by Subject|2|||
49074618|NCT03201445|158107024|FG000|Part B DB Phase (Week 13 to 26)|Adverse Event|1|||
49074619|NCT03201445|158107025|FG001|Part B DB Phase (Week 13 to 26)|Adverse Event|0|||
49074620|NCT03201445|158107024|FG000|Part B DB Phase (Week 13 to 26)|Progressive Disease|2|||
49074621|NCT03201445|158107025|FG001|Part B DB Phase (Week 13 to 26)|Progressive Disease|0|||
49074622|NCT03201445|158107024|FG000|OL Phase (13 Weeks)|Adverse Event|0|||
49074623|NCT03201445|158107025|FG001|OL Phase (13 Weeks)|Adverse Event|2|||
49074624|NCT03201445|158107024|FG000|OL Phase (13 Weeks)|Withdrawal by Subject|2|||
49074625|NCT03201445|158107025|FG001|OL Phase (13 Weeks)|Withdrawal by Subject|1|||
49074626|NCT03201445|158107024|FG000|LTE: DB Study Drug (up to Week 195)|Adverse Event|9|||
49074627|NCT03201445|158107025|FG001|LTE: DB Study Drug (up to Week 195)|Adverse Event|10|||
49074628|NCT03201445|158107024|FG000|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|0|||
49074629|NCT03201445|158107025|FG001|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|1|||
49074630|NCT03201445|158107024|FG000|LTE: DB Study Drug (up to Week 195)|Physician Decision|0|||
49074631|NCT03201445|158107025|FG001|LTE: DB Study Drug (up to Week 195)|Physician Decision|2|||
49074632|NCT03201445|158107024|FG000|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
49074633|NCT03201445|158107025|FG001|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
49074634|NCT03201445|158107024|FG000|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|6|||
49074635|NCT03201445|158107025|FG001|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|7|||
49074636|NCT03201445|158107024|FG000|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|11|||
49074637|NCT03201445|158107025|FG001|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|5|||
49074638|NCT03201445|158107024|FG000|LTE: OL Study Drug (Up to Week 195)|Adverse Event|3|||
49074639|NCT03201445|158107025|FG001|LTE: OL Study Drug (Up to Week 195)|Adverse Event|2|||
49074640|NCT03201445|158107024|FG000|LTE: OL Study Drug (Up to Week 195)|Physician Decision|1|||
49074641|NCT03201445|158107025|FG001|LTE: OL Study Drug (Up to Week 195)|Physician Decision|2|||
49074642|NCT03201445|158107024|FG000|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
49074643|NCT03201445|158107025|FG001|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
49074644|NCT03201445|158107024|FG000|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|5|||
49074645|NCT03201445|158107025|FG001|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|3|||
49074646|NCT03201445|158107024|FG000|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|2|||
49074647|NCT03201445|158107025|FG001|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|0|||
49074648|NCT03201445|158107024|FG000|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
49074649|NCT03201445|158107025|FG001|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
49074650|NCT03201445|158107024|FG000|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
49074651|NCT03201445|158107025|FG001|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
49074652|NCT03201445|158107024|FG000|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|0|||
49074653|NCT03201445|158107025|FG001|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|1|||
49074654|NCT02952586|158107027|FG000|Lead-In Phase (7 Days)|Death|0|||
49074655|NCT02952586|158107028|FG001|Lead-In Phase (7 Days)|Death|1|||
49074656|NCT02952586|158107027|FG000|Lead-In Phase (7 Days)|Adverse Event|3|||
49074657|NCT02952586|158107028|FG001|Lead-In Phase (7 Days)|Adverse Event|0|||
49074658|NCT02952586|158107027|FG000|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0|||
49074659|NCT02952586|158107028|FG001|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1|||
49074660|NCT02952586|158107027|FG000|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
49074661|NCT02952586|158107028|FG001|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
49074662|NCT02952586|158107027|FG000|CRT for Avelumab or Placebo (63 Days)|Death|5|||
49074663|NCT02952586|158107028|FG001|CRT for Avelumab or Placebo (63 Days)|Death|8|||
49074664|NCT02952586|158107027|FG000|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
49074665|NCT02952586|158107028|FG001|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
49074666|NCT02952586|158107027|FG000|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2|||
49074667|NCT02952586|158107028|FG001|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1|||
49074668|NCT02952586|158107027|FG000|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1|||
49074669|NCT02952586|158107028|FG001|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0|||
49074670|NCT02952586|158107027|FG000|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10|||
49074671|NCT02952586|158107028|FG001|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4|||
49074672|NCT02952586|158107027|FG000|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
49074673|NCT02952586|158107028|FG001|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
49074674|NCT02952586|158107027|FG000|CRT for Avelumab or Placebo (63 Days)|Other|2|||
49074675|NCT02952586|158107028|FG001|CRT for Avelumab or Placebo (63 Days)|Other|1|||
49074676|NCT02952586|158107027|FG000|CRT for Cisplatin (63 Days)|Death|3|||
49074677|NCT02952586|158107028|FG001|CRT for Cisplatin (63 Days)|Death|8|||
49074678|NCT02952586|158107027|FG000|CRT for Cisplatin (63 Days)|Adverse Event|82|||
49074679|NCT02952586|158107028|FG001|CRT for Cisplatin (63 Days)|Adverse Event|81|||
49074680|NCT02952586|158107027|FG000|CRT for Cisplatin (63 Days)|Physician Decision|12|||
49074681|NCT02952586|158107028|FG001|CRT for Cisplatin (63 Days)|Physician Decision|10|||
49074682|NCT02952586|158107027|FG000|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1|||
49074683|NCT02952586|158107028|FG001|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0|||
49074684|NCT02952586|158107027|FG000|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11|||
49074685|NCT02952586|158107028|FG001|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3|||
49074686|NCT02952586|158107027|FG000|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
49074687|NCT02952586|158107028|FG001|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
49074688|NCT02952586|158107027|FG000|CRT for Cisplatin (63 Days)|Other|1|||
49074689|NCT02952586|158107028|FG001|CRT for Cisplatin (63 Days)|Other|1|||
49074690|NCT02952586|158107027|FG000|CRT for IMRT (63 Days)|Death|5|||
49074691|NCT02952586|158107028|FG001|CRT for IMRT (63 Days)|Death|8|||
49074692|NCT02952586|158107027|FG000|CRT for IMRT (63 Days)|Adverse Event|5|||
49074693|NCT02952586|158107028|FG001|CRT for IMRT (63 Days)|Adverse Event|5|||
49074694|NCT02952586|158107027|FG000|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1|||
49074695|NCT02952586|158107028|FG001|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0|||
49074696|NCT02952586|158107027|FG000|CRT for IMRT (63 Days)|Withdrawal by Subject|10|||
49074697|NCT02952586|158107028|FG001|CRT for IMRT (63 Days)|Withdrawal by Subject|6|||
49074698|NCT02952586|158107027|FG000|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
49074699|NCT02952586|158107028|FG001|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
49074700|NCT02952586|158107027|FG000|CRT for IMRT (63 Days)|Other|1|||
49074701|NCT02952586|158107028|FG001|CRT for IMRT (63 Days)|Other|0|||
49074702|NCT02952586|158107027|FG000|Maintenance Phase (12 Months)|Death|17|||
49074703|NCT02952586|158107028|FG001|Maintenance Phase (12 Months)|Death|11|||
49074704|NCT02952586|158107027|FG000|Maintenance Phase (12 Months)|Progressive disease|60|||
49074705|NCT02952586|158107028|FG001|Maintenance Phase (12 Months)|Progressive disease|54|||
49074706|NCT02952586|158107027|FG000|Maintenance Phase (12 Months)|Adverse Event|24|||
49074707|NCT02952586|158107028|FG001|Maintenance Phase (12 Months)|Adverse Event|21|||
49074708|NCT02952586|158107027|FG000|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
49074709|NCT02952586|158107028|FG001|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
49074710|NCT02952586|158107027|FG000|Maintenance Phase (12 Months)|Physician Decision|1|||
49074711|NCT02952586|158107028|FG001|Maintenance Phase (12 Months)|Physician Decision|1|||
49074712|NCT02952586|158107027|FG000|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14|||
49074713|NCT02952586|158107028|FG001|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5|||
49074714|NCT02952586|158107027|FG000|Maintenance Phase (12 Months)|Withdrawal by Subject|31|||
49074715|NCT02952586|158107028|FG001|Maintenance Phase (12 Months)|Withdrawal by Subject|25|||
49074716|NCT02952586|158107027|FG000|Maintenance Phase (12 Months)|Lost to Follow-up|1|||
49074717|NCT02952586|158107028|FG001|Maintenance Phase (12 Months)|Lost to Follow-up|2|||
49074718|NCT02952586|158107027|FG000|Maintenance Phase (12 Months)|Other|2|||
49074719|NCT02952586|158107028|FG001|Maintenance Phase (12 Months)|Other|1|||
49074720|NCT02952586|158107027|FG000|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1|||
49074721|NCT02952586|158107028|FG001|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6|||
49074722|NCT02952586|158107027|FG000|Follow-Up Phase (90 Days)|Death|12|||
49074723|NCT02952586|158107028|FG001|Follow-Up Phase (90 Days)|Death|10|||
49074724|NCT02952586|158107027|FG000|Follow-Up Phase (90 Days)|Withdrawal by Subject|6|||
49074725|NCT02952586|158107028|FG001|Follow-Up Phase (90 Days)|Withdrawal by Subject|2|||
49074726|NCT02952586|158107027|FG000|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
49074727|NCT02952586|158107028|FG001|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
49074728|NCT02952586|158107027|FG000|Follow-Up Phase (90 Days)|Other|7|||
49074729|NCT02952586|158107028|FG001|Follow-Up Phase (90 Days)|Other|5|||
49074730|NCT02952586|158107027|FG000|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32|||
49074731|NCT02952586|158107028|FG001|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50|||
49074732|NCT02952586|158107027|FG000|LT Follow-up (up to 45 Months)|Death|51|||
49074733|NCT02952586|158107028|FG001|LT Follow-up (up to 45 Months)|Death|31|||
49074734|NCT02952586|158107027|FG000|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7|||
49074735|NCT02952586|158107028|FG001|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1|||
49074736|NCT02952586|158107027|FG000|LT Follow-up (up to 45 Months)|Lost to Follow-up|2|||
49074737|NCT02952586|158107028|FG001|LT Follow-up (up to 45 Months)|Lost to Follow-up|4|||
49074738|NCT02952586|158107027|FG000|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187|||
49074739|NCT02952586|158107028|FG001|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201|||
49074740|NCT00492778|158107031|FG000|Overall Study|Ineligible by Pathology Review|8|||
49074741|NCT00492778|158107032|FG001|Overall Study|Ineligible by Pathology Review|1|||
49074742|NCT00920790|158107033|FG000|Overall Study|aggravation of general condition|14|||
49074743|NCT02800642|158107034|FG000|Overall Study|Death|3|||
49074744|NCT02800642|158107034|FG000|Overall Study|Other|10|||
49074745|NCT02800642|158107034|FG000|Overall Study|Physician Decision|2|||
49074746|NCT02800642|158107034|FG000|Overall Study|Adverse Event|6|||
49074747|NCT02800642|158107034|FG000|Overall Study|Withdrawal by Subject|3|||
49074748|NCT02800642|158107034|FG000|Overall Study|Lost to Follow-up|1|||
49074749|NCT00996892|158107036|FG000|Dose-Escalation Stage 1|Adverse Event|0|||
49074750|NCT00996892|158107037|FG001|Dose-Escalation Stage 1|Adverse Event|0|||
49074751|NCT00996892|158107038|FG002|Dose-Escalation Stage 1|Adverse Event|0|||
49074752|NCT00996892|158107039|FG003|Dose-Escalation Stage 1|Adverse Event|2|||
49074753|NCT00996892|158107040|FG004|Dose-Escalation Stage 1|Adverse Event|0|||
49074754|NCT00996892|158107041|FG005|Dose-Escalation Stage 1|Adverse Event|0|||
49074755|NCT00996892|158107042|FG006|Dose-Escalation Stage 1|Adverse Event|1|||
49074756|NCT00996892|158107043|FG007|Dose-Escalation Stage 1|Adverse Event|0|||
49074757|NCT00996892|158107044|FG008|Dose-Escalation Stage 1|Adverse Event|0|||
49074758|NCT00996892|158107045|FG009|Dose-Escalation Stage 1|Adverse Event|0|||
49074759|NCT00996892|158107046|FG010|Dose-Escalation Stage 1|Adverse Event|0|||
49074760|NCT00996892|158107047|FG011|Dose-Escalation Stage 1|Adverse Event|0|||
49074761|NCT00996892|158107048|FG012|Dose-Escalation Stage 1|Adverse Event|0|||
49074762|NCT00996892|158107049|FG013|Dose-Escalation Stage 1|Adverse Event|0|||
49074763|NCT00996892|158107050|FG014|Dose-Escalation Stage 1|Adverse Event|0|||
49074764|NCT00996892|158107051|FG015|Dose-Escalation Stage 1|Adverse Event|0|||
49074765|NCT00996892|158107052|FG016|Dose-Escalation Stage 1|Adverse Event|0|||
49074766|NCT00996892|158107053|FG017|Dose-Escalation Stage 1|Adverse Event|0|||
49074767|NCT00996892|158107054|FG018|Dose-Escalation Stage 1|Adverse Event|0|||
49074768|NCT00996892|158107055|FG019|Dose-Escalation Stage 1|Adverse Event|0|||
49074769|NCT00996892|158107036|FG000|Dose-Escalation Stage 1|Death|1|||
49074770|NCT00996892|158107037|FG001|Dose-Escalation Stage 1|Death|0|||
49074771|NCT00996892|158107038|FG002|Dose-Escalation Stage 1|Death|0|||
49074772|NCT00996892|158107039|FG003|Dose-Escalation Stage 1|Death|0|||
49074773|NCT00996892|158107040|FG004|Dose-Escalation Stage 1|Death|0|||
49074774|NCT00996892|158107041|FG005|Dose-Escalation Stage 1|Death|1|||
49074775|NCT00996892|158107042|FG006|Dose-Escalation Stage 1|Death|0|||
49074776|NCT00996892|158107043|FG007|Dose-Escalation Stage 1|Death|0|||
49074777|NCT00996892|158107044|FG008|Dose-Escalation Stage 1|Death|0|||
49074778|NCT00996892|158107045|FG009|Dose-Escalation Stage 1|Death|0|||
49074779|NCT00996892|158107046|FG010|Dose-Escalation Stage 1|Death|0|||
49074780|NCT00996892|158107047|FG011|Dose-Escalation Stage 1|Death|0|||
49074781|NCT00996892|158107048|FG012|Dose-Escalation Stage 1|Death|0|||
49074782|NCT00996892|158107049|FG013|Dose-Escalation Stage 1|Death|0|||
49074783|NCT00996892|158107050|FG014|Dose-Escalation Stage 1|Death|0|||
49074784|NCT00996892|158107051|FG015|Dose-Escalation Stage 1|Death|0|||
49074785|NCT00996892|158107052|FG016|Dose-Escalation Stage 1|Death|0|||
49074786|NCT00996892|158107053|FG017|Dose-Escalation Stage 1|Death|0|||
49074787|NCT00996892|158107054|FG018|Dose-Escalation Stage 1|Death|0|||
49074788|NCT00996892|158107055|FG019|Dose-Escalation Stage 1|Death|0|||
49074789|NCT00996892|158107036|FG000|Dose-Escalation Stage 1|Physician Decision|1|||
49074790|NCT00996892|158107037|FG001|Dose-Escalation Stage 1|Physician Decision|0|||
49074791|NCT00996892|158107038|FG002|Dose-Escalation Stage 1|Physician Decision|0|||
49074792|NCT00996892|158107039|FG003|Dose-Escalation Stage 1|Physician Decision|1|||
49074793|NCT00996892|158107040|FG004|Dose-Escalation Stage 1|Physician Decision|0|||
49074794|NCT00996892|158107041|FG005|Dose-Escalation Stage 1|Physician Decision|1|||
49074795|NCT00996892|158107042|FG006|Dose-Escalation Stage 1|Physician Decision|2|||
49074796|NCT00996892|158107043|FG007|Dose-Escalation Stage 1|Physician Decision|0|||
49074797|NCT00996892|158107044|FG008|Dose-Escalation Stage 1|Physician Decision|0|||
49074798|NCT00996892|158107045|FG009|Dose-Escalation Stage 1|Physician Decision|0|||
49074799|NCT00996892|158107046|FG010|Dose-Escalation Stage 1|Physician Decision|0|||
49074800|NCT00996892|158107047|FG011|Dose-Escalation Stage 1|Physician Decision|0|||
49074801|NCT00996892|158107048|FG012|Dose-Escalation Stage 1|Physician Decision|0|||
49074802|NCT00996892|158107049|FG013|Dose-Escalation Stage 1|Physician Decision|0|||
49074803|NCT00996892|158107050|FG014|Dose-Escalation Stage 1|Physician Decision|0|||
49074804|NCT00996892|158107051|FG015|Dose-Escalation Stage 1|Physician Decision|0|||
49074805|NCT00996892|158107052|FG016|Dose-Escalation Stage 1|Physician Decision|0|||
49074806|NCT00996892|158107053|FG017|Dose-Escalation Stage 1|Physician Decision|0|||
49074807|NCT00996892|158107054|FG018|Dose-Escalation Stage 1|Physician Decision|0|||
49074808|NCT00996892|158107055|FG019|Dose-Escalation Stage 1|Physician Decision|0|||
49074809|NCT00996892|158107036|FG000|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
49074810|NCT00996892|158107037|FG001|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
49074811|NCT00996892|158107038|FG002|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
49074812|NCT00996892|158107039|FG003|Dose-Escalation Stage 1|Withdrawal by Subject|2|||
49074813|NCT00996892|158107040|FG004|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
49074814|NCT00996892|158107041|FG005|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
49074815|NCT00996892|158107042|FG006|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
49074816|NCT00996892|158107043|FG007|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
49074817|NCT00996892|158107044|FG008|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
49074818|NCT00996892|158107045|FG009|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
49074819|NCT00996892|158107046|FG010|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
49074820|NCT00996892|158107047|FG011|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
49074821|NCT00996892|158107048|FG012|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
49074822|NCT00996892|158107049|FG013|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
49074823|NCT00996892|158107050|FG014|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
49074824|NCT00996892|158107051|FG015|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
49074825|NCT00996892|158107052|FG016|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
49074826|NCT00996892|158107053|FG017|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
49074827|NCT00996892|158107054|FG018|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
49074828|NCT00996892|158107055|FG019|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
49074829|NCT00996892|158107036|FG000|Dose-Escalation Stage 1|Disease Progression|2|||
49074830|NCT00996892|158107037|FG001|Dose-Escalation Stage 1|Disease Progression|2|||
49074831|NCT00996892|158107038|FG002|Dose-Escalation Stage 1|Disease Progression|3|||
49074832|NCT00996892|158107039|FG003|Dose-Escalation Stage 1|Disease Progression|4|||
49074833|NCT00996892|158107040|FG004|Dose-Escalation Stage 1|Disease Progression|10|||
49074834|NCT00996892|158107041|FG005|Dose-Escalation Stage 1|Disease Progression|7|||
49074835|NCT00996892|158107042|FG006|Dose-Escalation Stage 1|Disease Progression|0|||
49074836|NCT00996892|158107043|FG007|Dose-Escalation Stage 1|Disease Progression|0|||
49074837|NCT00996892|158107044|FG008|Dose-Escalation Stage 1|Disease Progression|0|||
49074838|NCT00996892|158107045|FG009|Dose-Escalation Stage 1|Disease Progression|0|||
49074839|NCT00996892|158107046|FG010|Dose-Escalation Stage 1|Disease Progression|0|||
49074840|NCT00996892|158107047|FG011|Dose-Escalation Stage 1|Disease Progression|0|||
49074841|NCT00996892|158107048|FG012|Dose-Escalation Stage 1|Disease Progression|0|||
49074842|NCT00996892|158107049|FG013|Dose-Escalation Stage 1|Disease Progression|0|||
49074843|NCT00996892|158107050|FG014|Dose-Escalation Stage 1|Disease Progression|0|||
49074844|NCT00996892|158107051|FG015|Dose-Escalation Stage 1|Disease Progression|0|||
49074845|NCT00996892|158107052|FG016|Dose-Escalation Stage 1|Disease Progression|0|||
49074846|NCT00996892|158107053|FG017|Dose-Escalation Stage 1|Disease Progression|0|||
49074847|NCT00996892|158107054|FG018|Dose-Escalation Stage 1|Disease Progression|0|||
49074848|NCT00996892|158107055|FG019|Dose-Escalation Stage 1|Disease Progression|0|||
49074849|NCT00996892|158107036|FG000|Dose-Escalation Stage 1A|Adverse Event|0|||
49074850|NCT00996892|158107037|FG001|Dose-Escalation Stage 1A|Adverse Event|0|||
49074851|NCT00996892|158107038|FG002|Dose-Escalation Stage 1A|Adverse Event|0|||
49074852|NCT00996892|158107039|FG003|Dose-Escalation Stage 1A|Adverse Event|0|||
49074853|NCT00996892|158107040|FG004|Dose-Escalation Stage 1A|Adverse Event|0|||
49074854|NCT00996892|158107041|FG005|Dose-Escalation Stage 1A|Adverse Event|0|||
49074855|NCT00996892|158107042|FG006|Dose-Escalation Stage 1A|Adverse Event|0|||
49074856|NCT00996892|158107043|FG007|Dose-Escalation Stage 1A|Adverse Event|0|||
49074857|NCT00996892|158107044|FG008|Dose-Escalation Stage 1A|Adverse Event|0|||
49074858|NCT00996892|158107045|FG009|Dose-Escalation Stage 1A|Adverse Event|0|||
49074859|NCT00996892|158107046|FG010|Dose-Escalation Stage 1A|Adverse Event|1|||
49074860|NCT00996892|158107047|FG011|Dose-Escalation Stage 1A|Adverse Event|0|||
49074861|NCT00996892|158107048|FG012|Dose-Escalation Stage 1A|Adverse Event|0|||
49074862|NCT00996892|158107049|FG013|Dose-Escalation Stage 1A|Adverse Event|1|||
49074863|NCT00996892|158107050|FG014|Dose-Escalation Stage 1A|Adverse Event|0|||
49074864|NCT00996892|158107051|FG015|Dose-Escalation Stage 1A|Adverse Event|0|||
49074865|NCT00996892|158107052|FG016|Dose-Escalation Stage 1A|Adverse Event|0|||
49074866|NCT00996892|158107053|FG017|Dose-Escalation Stage 1A|Adverse Event|0|||
49074867|NCT00996892|158107054|FG018|Dose-Escalation Stage 1A|Adverse Event|0|||
49074868|NCT00996892|158107055|FG019|Dose-Escalation Stage 1A|Adverse Event|0|||
49074869|NCT00996892|158107036|FG000|Dose-Escalation Stage 1A|Death|0|||
49074870|NCT00996892|158107037|FG001|Dose-Escalation Stage 1A|Death|0|||
49074871|NCT00996892|158107038|FG002|Dose-Escalation Stage 1A|Death|0|||
49074872|NCT00996892|158107039|FG003|Dose-Escalation Stage 1A|Death|0|||
49074873|NCT00996892|158107040|FG004|Dose-Escalation Stage 1A|Death|0|||
49074874|NCT00996892|158107041|FG005|Dose-Escalation Stage 1A|Death|0|||
49074875|NCT00996892|158107042|FG006|Dose-Escalation Stage 1A|Death|0|||
49074876|NCT00996892|158107043|FG007|Dose-Escalation Stage 1A|Death|0|||
49074877|NCT00996892|158107044|FG008|Dose-Escalation Stage 1A|Death|0|||
49074878|NCT00996892|158107045|FG009|Dose-Escalation Stage 1A|Death|2|||
49074879|NCT00996892|158107046|FG010|Dose-Escalation Stage 1A|Death|0|||
49074880|NCT00996892|158107047|FG011|Dose-Escalation Stage 1A|Death|1|||
49074881|NCT00996892|158107048|FG012|Dose-Escalation Stage 1A|Death|1|||
49074882|NCT00996892|158107049|FG013|Dose-Escalation Stage 1A|Death|0|||
49074883|NCT00996892|158107050|FG014|Dose-Escalation Stage 1A|Death|0|||
49074884|NCT00996892|158107051|FG015|Dose-Escalation Stage 1A|Death|0|||
49074885|NCT00996892|158107052|FG016|Dose-Escalation Stage 1A|Death|0|||
49074886|NCT00996892|158107053|FG017|Dose-Escalation Stage 1A|Death|0|||
49074887|NCT00996892|158107054|FG018|Dose-Escalation Stage 1A|Death|0|||
49074888|NCT00996892|158107055|FG019|Dose-Escalation Stage 1A|Death|0|||
49074889|NCT00996892|158107036|FG000|Dose-Escalation Stage 1A|Physician Decision|0|||
49074890|NCT00996892|158107037|FG001|Dose-Escalation Stage 1A|Physician Decision|0|||
49074891|NCT00996892|158107038|FG002|Dose-Escalation Stage 1A|Physician Decision|0|||
49074892|NCT00996892|158107039|FG003|Dose-Escalation Stage 1A|Physician Decision|0|||
49074893|NCT00996892|158107040|FG004|Dose-Escalation Stage 1A|Physician Decision|0|||
49074894|NCT00996892|158107041|FG005|Dose-Escalation Stage 1A|Physician Decision|0|||
49074895|NCT00996892|158107042|FG006|Dose-Escalation Stage 1A|Physician Decision|0|||
49074896|NCT00996892|158107043|FG007|Dose-Escalation Stage 1A|Physician Decision|1|||
49074897|NCT00996892|158107044|FG008|Dose-Escalation Stage 1A|Physician Decision|0|||
49074898|NCT00996892|158107045|FG009|Dose-Escalation Stage 1A|Physician Decision|0|||
49074899|NCT00996892|158107046|FG010|Dose-Escalation Stage 1A|Physician Decision|0|||
49074900|NCT00996892|158107047|FG011|Dose-Escalation Stage 1A|Physician Decision|0|||
49074901|NCT00996892|158107048|FG012|Dose-Escalation Stage 1A|Physician Decision|0|||
49074902|NCT00996892|158107049|FG013|Dose-Escalation Stage 1A|Physician Decision|0|||
49074903|NCT00996892|158107050|FG014|Dose-Escalation Stage 1A|Physician Decision|0|||
49074904|NCT00996892|158107051|FG015|Dose-Escalation Stage 1A|Physician Decision|0|||
49074905|NCT00996892|158107052|FG016|Dose-Escalation Stage 1A|Physician Decision|0|||
49074906|NCT00996892|158107053|FG017|Dose-Escalation Stage 1A|Physician Decision|0|||
49074907|NCT00996892|158107054|FG018|Dose-Escalation Stage 1A|Physician Decision|0|||
49074908|NCT00996892|158107055|FG019|Dose-Escalation Stage 1A|Physician Decision|0|||
49074909|NCT00996892|158107036|FG000|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
49074910|NCT00996892|158107037|FG001|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
49074911|NCT00996892|158107038|FG002|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
49074912|NCT00996892|158107039|FG003|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
49074913|NCT00996892|158107040|FG004|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
49074914|NCT00996892|158107041|FG005|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
49074915|NCT00996892|158107042|FG006|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
49074916|NCT00996892|158107043|FG007|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
49074917|NCT00996892|158107044|FG008|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
49074918|NCT00996892|158107045|FG009|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
49074919|NCT00996892|158107046|FG010|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
49074920|NCT00996892|158107047|FG011|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
49074921|NCT00996892|158107048|FG012|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
49074922|NCT00996892|158107049|FG013|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
49074923|NCT00996892|158107050|FG014|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
49074924|NCT00996892|158107051|FG015|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
49074925|NCT00996892|158107052|FG016|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
49074926|NCT00996892|158107053|FG017|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
49074927|NCT00996892|158107054|FG018|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
49074928|NCT00996892|158107055|FG019|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
49074929|NCT00996892|158107036|FG000|Dose-Escalation Stage 1A|Disease Progression|0|||
49074930|NCT00996892|158107037|FG001|Dose-Escalation Stage 1A|Disease Progression|0|||
49074931|NCT00996892|158107038|FG002|Dose-Escalation Stage 1A|Disease Progression|0|||
49074932|NCT00996892|158107039|FG003|Dose-Escalation Stage 1A|Disease Progression|0|||
49074933|NCT00996892|158107040|FG004|Dose-Escalation Stage 1A|Disease Progression|0|||
49074934|NCT00996892|158107041|FG005|Dose-Escalation Stage 1A|Disease Progression|0|||
49074935|NCT00996892|158107042|FG006|Dose-Escalation Stage 1A|Disease Progression|0|||
49074936|NCT00996892|158107043|FG007|Dose-Escalation Stage 1A|Disease Progression|2|||
49074937|NCT00996892|158107044|FG008|Dose-Escalation Stage 1A|Disease Progression|3|||
49074938|NCT00996892|158107045|FG009|Dose-Escalation Stage 1A|Disease Progression|1|||
49074939|NCT00996892|158107046|FG010|Dose-Escalation Stage 1A|Disease Progression|5|||
49074940|NCT00996892|158107047|FG011|Dose-Escalation Stage 1A|Disease Progression|7|||
49074941|NCT00996892|158107048|FG012|Dose-Escalation Stage 1A|Disease Progression|6|||
49074942|NCT00996892|158107049|FG013|Dose-Escalation Stage 1A|Disease Progression|4|||
49074943|NCT00996892|158107050|FG014|Dose-Escalation Stage 1A|Disease Progression|0|||
49074944|NCT00996892|158107051|FG015|Dose-Escalation Stage 1A|Disease Progression|0|||
49074945|NCT00996892|158107052|FG016|Dose-Escalation Stage 1A|Disease Progression|0|||
49074946|NCT00996892|158107053|FG017|Dose-Escalation Stage 1A|Disease Progression|0|||
49074947|NCT00996892|158107054|FG018|Dose-Escalation Stage 1A|Disease Progression|0|||
49074948|NCT00996892|158107055|FG019|Dose-Escalation Stage 1A|Disease Progression|0|||
49074949|NCT00996892|158107036|FG000|Dose-Escalation Stage 1B|Physician Decision|0|||
49074950|NCT00996892|158107037|FG001|Dose-Escalation Stage 1B|Physician Decision|0|||
49074951|NCT00996892|158107038|FG002|Dose-Escalation Stage 1B|Physician Decision|0|||
49074952|NCT00996892|158107039|FG003|Dose-Escalation Stage 1B|Physician Decision|0|||
49074953|NCT00996892|158107040|FG004|Dose-Escalation Stage 1B|Physician Decision|0|||
49074954|NCT00996892|158107041|FG005|Dose-Escalation Stage 1B|Physician Decision|0|||
49074955|NCT00996892|158107042|FG006|Dose-Escalation Stage 1B|Physician Decision|0|||
49074956|NCT00996892|158107043|FG007|Dose-Escalation Stage 1B|Physician Decision|0|||
49074957|NCT00996892|158107044|FG008|Dose-Escalation Stage 1B|Physician Decision|0|||
49074958|NCT00996892|158107045|FG009|Dose-Escalation Stage 1B|Physician Decision|0|||
49074959|NCT00996892|158107046|FG010|Dose-Escalation Stage 1B|Physician Decision|0|||
49074960|NCT00996892|158107047|FG011|Dose-Escalation Stage 1B|Physician Decision|0|||
49074961|NCT00996892|158107048|FG012|Dose-Escalation Stage 1B|Physician Decision|0|||
49074962|NCT00996892|158107049|FG013|Dose-Escalation Stage 1B|Physician Decision|0|||
49074963|NCT00996892|158107050|FG014|Dose-Escalation Stage 1B|Physician Decision|0|||
49074964|NCT00996892|158107051|FG015|Dose-Escalation Stage 1B|Physician Decision|0|||
49074965|NCT00996892|158107052|FG016|Dose-Escalation Stage 1B|Physician Decision|0|||
49074966|NCT00996892|158107053|FG017|Dose-Escalation Stage 1B|Physician Decision|2|||
49074967|NCT00996892|158107054|FG018|Dose-Escalation Stage 1B|Physician Decision|0|||
49074968|NCT00996892|158107055|FG019|Dose-Escalation Stage 1B|Physician Decision|0|||
49074969|NCT00996892|158107036|FG000|Dose-Escalation Stage 1B|Disease Progression|0|||
49074970|NCT00996892|158107037|FG001|Dose-Escalation Stage 1B|Disease Progression|0|||
49074971|NCT00996892|158107038|FG002|Dose-Escalation Stage 1B|Disease Progression|0|||
49074972|NCT00996892|158107039|FG003|Dose-Escalation Stage 1B|Disease Progression|0|||
49074973|NCT00996892|158107040|FG004|Dose-Escalation Stage 1B|Disease Progression|0|||
49074974|NCT00996892|158107041|FG005|Dose-Escalation Stage 1B|Disease Progression|0|||
49074975|NCT00996892|158107042|FG006|Dose-Escalation Stage 1B|Disease Progression|0|||
49074976|NCT00996892|158107043|FG007|Dose-Escalation Stage 1B|Disease Progression|0|||
49074977|NCT00996892|158107044|FG008|Dose-Escalation Stage 1B|Disease Progression|0|||
49074978|NCT00996892|158107045|FG009|Dose-Escalation Stage 1B|Disease Progression|0|||
49074979|NCT00996892|158107046|FG010|Dose-Escalation Stage 1B|Disease Progression|0|||
49074980|NCT00996892|158107047|FG011|Dose-Escalation Stage 1B|Disease Progression|0|||
49074981|NCT00996892|158107048|FG012|Dose-Escalation Stage 1B|Disease Progression|0|||
49074982|NCT00996892|158107049|FG013|Dose-Escalation Stage 1B|Disease Progression|0|||
49074983|NCT00996892|158107050|FG014|Dose-Escalation Stage 1B|Disease Progression|4|||
49074984|NCT00996892|158107051|FG015|Dose-Escalation Stage 1B|Disease Progression|3|||
49074985|NCT00996892|158107052|FG016|Dose-Escalation Stage 1B|Disease Progression|3|||
49074986|NCT00996892|158107053|FG017|Dose-Escalation Stage 1B|Disease Progression|3|||
49074987|NCT00996892|158107054|FG018|Dose-Escalation Stage 1B|Disease Progression|0|||
49074988|NCT00996892|158107055|FG019|Dose-Escalation Stage 1B|Disease Progression|0|||
49074989|NCT00996892|158107036|FG000|Expansion Stage 2|Adverse Event|0|||
49074990|NCT00996892|158107037|FG001|Expansion Stage 2|Adverse Event|0|||
49074991|NCT00996892|158107038|FG002|Expansion Stage 2|Adverse Event|0|||
49074992|NCT00996892|158107039|FG003|Expansion Stage 2|Adverse Event|0|||
49074993|NCT00996892|158107040|FG004|Expansion Stage 2|Adverse Event|0|||
49074994|NCT00996892|158107041|FG005|Expansion Stage 2|Adverse Event|0|||
49074995|NCT00996892|158107042|FG006|Expansion Stage 2|Adverse Event|0|||
49074996|NCT00996892|158107043|FG007|Expansion Stage 2|Adverse Event|0|||
49074997|NCT00996892|158107044|FG008|Expansion Stage 2|Adverse Event|0|||
49074998|NCT00996892|158107045|FG009|Expansion Stage 2|Adverse Event|0|||
49074999|NCT00996892|158107046|FG010|Expansion Stage 2|Adverse Event|0|||
49075000|NCT00996892|158107047|FG011|Expansion Stage 2|Adverse Event|0|||
49075001|NCT00996892|158107048|FG012|Expansion Stage 2|Adverse Event|0|||
49075002|NCT00996892|158107049|FG013|Expansion Stage 2|Adverse Event|0|||
49075003|NCT00996892|158107050|FG014|Expansion Stage 2|Adverse Event|0|||
49075004|NCT00996892|158107051|FG015|Expansion Stage 2|Adverse Event|0|||
49075005|NCT00996892|158107052|FG016|Expansion Stage 2|Adverse Event|0|||
49075006|NCT00996892|158107053|FG017|Expansion Stage 2|Adverse Event|0|||
49075007|NCT00996892|158107054|FG018|Expansion Stage 2|Adverse Event|3|||
49075008|NCT00996892|158107055|FG019|Expansion Stage 2|Adverse Event|0|||
49075009|NCT00996892|158107036|FG000|Expansion Stage 2|Death|0|||
49075010|NCT00996892|158107037|FG001|Expansion Stage 2|Death|0|||
49075011|NCT00996892|158107038|FG002|Expansion Stage 2|Death|0|||
49075012|NCT00996892|158107039|FG003|Expansion Stage 2|Death|0|||
49075013|NCT00996892|158107040|FG004|Expansion Stage 2|Death|0|||
49075014|NCT00996892|158107041|FG005|Expansion Stage 2|Death|0|||
49075015|NCT00996892|158107042|FG006|Expansion Stage 2|Death|0|||
49075016|NCT00996892|158107043|FG007|Expansion Stage 2|Death|0|||
49075017|NCT00996892|158107044|FG008|Expansion Stage 2|Death|0|||
49075018|NCT00996892|158107045|FG009|Expansion Stage 2|Death|0|||
49075019|NCT00996892|158107046|FG010|Expansion Stage 2|Death|0|||
49075020|NCT00996892|158107047|FG011|Expansion Stage 2|Death|0|||
49075021|NCT00996892|158107048|FG012|Expansion Stage 2|Death|0|||
49075022|NCT00996892|158107049|FG013|Expansion Stage 2|Death|0|||
49075023|NCT00996892|158107050|FG014|Expansion Stage 2|Death|0|||
49075024|NCT00996892|158107051|FG015|Expansion Stage 2|Death|0|||
49075025|NCT00996892|158107052|FG016|Expansion Stage 2|Death|0|||
49075026|NCT00996892|158107053|FG017|Expansion Stage 2|Death|0|||
49075027|NCT00996892|158107054|FG018|Expansion Stage 2|Death|2|||
49075028|NCT00996892|158107055|FG019|Expansion Stage 2|Death|0|||
49075029|NCT00996892|158107036|FG000|Expansion Stage 2|Physician Decision|0|||
49075030|NCT00996892|158107037|FG001|Expansion Stage 2|Physician Decision|0|||
49075031|NCT00996892|158107038|FG002|Expansion Stage 2|Physician Decision|0|||
49075032|NCT00996892|158107039|FG003|Expansion Stage 2|Physician Decision|0|||
49075033|NCT00996892|158107040|FG004|Expansion Stage 2|Physician Decision|0|||
49075034|NCT00996892|158107041|FG005|Expansion Stage 2|Physician Decision|0|||
49075035|NCT00996892|158107042|FG006|Expansion Stage 2|Physician Decision|0|||
49075036|NCT00996892|158107043|FG007|Expansion Stage 2|Physician Decision|0|||
49075037|NCT00996892|158107044|FG008|Expansion Stage 2|Physician Decision|0|||
49075038|NCT00996892|158107045|FG009|Expansion Stage 2|Physician Decision|0|||
49075039|NCT00996892|158107046|FG010|Expansion Stage 2|Physician Decision|0|||
49075040|NCT00996892|158107047|FG011|Expansion Stage 2|Physician Decision|0|||
49075041|NCT00996892|158107048|FG012|Expansion Stage 2|Physician Decision|0|||
49075042|NCT00996892|158107049|FG013|Expansion Stage 2|Physician Decision|0|||
49075043|NCT00996892|158107050|FG014|Expansion Stage 2|Physician Decision|0|||
49075044|NCT00996892|158107051|FG015|Expansion Stage 2|Physician Decision|0|||
49075045|NCT00996892|158107052|FG016|Expansion Stage 2|Physician Decision|0|||
49075046|NCT00996892|158107053|FG017|Expansion Stage 2|Physician Decision|0|||
49075047|NCT00996892|158107054|FG018|Expansion Stage 2|Physician Decision|1|||
49075048|NCT00996892|158107055|FG019|Expansion Stage 2|Physician Decision|0|||
49075049|NCT00996892|158107036|FG000|Expansion Stage 2|Withdrawal by Subject|0|||
49075050|NCT00996892|158107037|FG001|Expansion Stage 2|Withdrawal by Subject|0|||
49075051|NCT00996892|158107038|FG002|Expansion Stage 2|Withdrawal by Subject|0|||
49075052|NCT00996892|158107039|FG003|Expansion Stage 2|Withdrawal by Subject|0|||
49075053|NCT00996892|158107040|FG004|Expansion Stage 2|Withdrawal by Subject|0|||
49075054|NCT00996892|158107041|FG005|Expansion Stage 2|Withdrawal by Subject|0|||
49075055|NCT00996892|158107042|FG006|Expansion Stage 2|Withdrawal by Subject|0|||
49075056|NCT00996892|158107043|FG007|Expansion Stage 2|Withdrawal by Subject|0|||
49075057|NCT00996892|158107044|FG008|Expansion Stage 2|Withdrawal by Subject|0|||
49075058|NCT00996892|158107045|FG009|Expansion Stage 2|Withdrawal by Subject|0|||
49075059|NCT00996892|158107046|FG010|Expansion Stage 2|Withdrawal by Subject|0|||
49075060|NCT00996892|158107047|FG011|Expansion Stage 2|Withdrawal by Subject|0|||
49075061|NCT00996892|158107048|FG012|Expansion Stage 2|Withdrawal by Subject|0|||
49075062|NCT00996892|158107049|FG013|Expansion Stage 2|Withdrawal by Subject|0|||
49075063|NCT00996892|158107050|FG014|Expansion Stage 2|Withdrawal by Subject|0|||
49075064|NCT00996892|158107051|FG015|Expansion Stage 2|Withdrawal by Subject|0|||
49075065|NCT00996892|158107052|FG016|Expansion Stage 2|Withdrawal by Subject|0|||
49075066|NCT00996892|158107053|FG017|Expansion Stage 2|Withdrawal by Subject|0|||
49075067|NCT00996892|158107054|FG018|Expansion Stage 2|Withdrawal by Subject|1|||
49075068|NCT00996892|158107055|FG019|Expansion Stage 2|Withdrawal by Subject|0|||
49075069|NCT00996892|158107036|FG000|Expansion Stage 2|Disease Progression|0|||
49075070|NCT00996892|158107037|FG001|Expansion Stage 2|Disease Progression|0|||
49075071|NCT00996892|158107038|FG002|Expansion Stage 2|Disease Progression|0|||
49075072|NCT00996892|158107039|FG003|Expansion Stage 2|Disease Progression|0|||
49075073|NCT00996892|158107040|FG004|Expansion Stage 2|Disease Progression|0|||
49075074|NCT00996892|158107041|FG005|Expansion Stage 2|Disease Progression|0|||
49075075|NCT00996892|158107042|FG006|Expansion Stage 2|Disease Progression|0|||
49075076|NCT00996892|158107043|FG007|Expansion Stage 2|Disease Progression|0|||
49075077|NCT00996892|158107044|FG008|Expansion Stage 2|Disease Progression|0|||
49075078|NCT00996892|158107045|FG009|Expansion Stage 2|Disease Progression|0|||
49075079|NCT00996892|158107046|FG010|Expansion Stage 2|Disease Progression|0|||
49075080|NCT00996892|158107047|FG011|Expansion Stage 2|Disease Progression|0|||
49075081|NCT00996892|158107048|FG012|Expansion Stage 2|Disease Progression|0|||
49075082|NCT00996892|158107049|FG013|Expansion Stage 2|Disease Progression|0|||
49075083|NCT00996892|158107050|FG014|Expansion Stage 2|Disease Progression|0|||
49075084|NCT00996892|158107051|FG015|Expansion Stage 2|Disease Progression|0|||
49075085|NCT00996892|158107052|FG016|Expansion Stage 2|Disease Progression|0|||
49075086|NCT00996892|158107053|FG017|Expansion Stage 2|Disease Progression|0|||
49075087|NCT00996892|158107054|FG018|Expansion Stage 2|Disease Progression|28|||
49075088|NCT00996892|158107055|FG019|Expansion Stage 2|Disease Progression|0|||
49075089|NCT00996892|158107036|FG000|Expansion Stage 2A|Adverse Event|0|||
49075090|NCT00996892|158107037|FG001|Expansion Stage 2A|Adverse Event|0|||
49075091|NCT00996892|158107038|FG002|Expansion Stage 2A|Adverse Event|0|||
49075092|NCT00996892|158107039|FG003|Expansion Stage 2A|Adverse Event|0|||
49075093|NCT00996892|158107040|FG004|Expansion Stage 2A|Adverse Event|0|||
49075094|NCT00996892|158107041|FG005|Expansion Stage 2A|Adverse Event|0|||
49075095|NCT00996892|158107042|FG006|Expansion Stage 2A|Adverse Event|0|||
49075096|NCT00996892|158107043|FG007|Expansion Stage 2A|Adverse Event|0|||
49075097|NCT00996892|158107044|FG008|Expansion Stage 2A|Adverse Event|0|||
49075098|NCT00996892|158107045|FG009|Expansion Stage 2A|Adverse Event|0|||
49075099|NCT00996892|158107046|FG010|Expansion Stage 2A|Adverse Event|0|||
49075100|NCT00996892|158107047|FG011|Expansion Stage 2A|Adverse Event|0|||
49075101|NCT00996892|158107048|FG012|Expansion Stage 2A|Adverse Event|0|||
49075102|NCT00996892|158107049|FG013|Expansion Stage 2A|Adverse Event|0|||
49075103|NCT00996892|158107050|FG014|Expansion Stage 2A|Adverse Event|0|||
49075104|NCT00996892|158107051|FG015|Expansion Stage 2A|Adverse Event|0|||
49075105|NCT00996892|158107052|FG016|Expansion Stage 2A|Adverse Event|0|||
49075106|NCT00996892|158107053|FG017|Expansion Stage 2A|Adverse Event|0|||
49075107|NCT00996892|158107054|FG018|Expansion Stage 2A|Adverse Event|0|||
49075108|NCT00996892|158107055|FG019|Expansion Stage 2A|Adverse Event|8|||
49075109|NCT00996892|158107036|FG000|Expansion Stage 2A|Physician Decision|0|||
49075110|NCT00996892|158107037|FG001|Expansion Stage 2A|Physician Decision|0|||
49075111|NCT00996892|158107038|FG002|Expansion Stage 2A|Physician Decision|0|||
49075112|NCT00996892|158107039|FG003|Expansion Stage 2A|Physician Decision|0|||
49075113|NCT00996892|158107040|FG004|Expansion Stage 2A|Physician Decision|0|||
49075114|NCT00996892|158107041|FG005|Expansion Stage 2A|Physician Decision|0|||
49075115|NCT00996892|158107042|FG006|Expansion Stage 2A|Physician Decision|0|||
49075116|NCT00996892|158107043|FG007|Expansion Stage 2A|Physician Decision|0|||
49075117|NCT00996892|158107044|FG008|Expansion Stage 2A|Physician Decision|0|||
49075118|NCT00996892|158107045|FG009|Expansion Stage 2A|Physician Decision|0|||
49075119|NCT00996892|158107046|FG010|Expansion Stage 2A|Physician Decision|0|||
49075120|NCT00996892|158107047|FG011|Expansion Stage 2A|Physician Decision|0|||
49075121|NCT00996892|158107048|FG012|Expansion Stage 2A|Physician Decision|0|||
49075122|NCT00996892|158107049|FG013|Expansion Stage 2A|Physician Decision|0|||
49075123|NCT00996892|158107050|FG014|Expansion Stage 2A|Physician Decision|0|||
49075124|NCT00996892|158107051|FG015|Expansion Stage 2A|Physician Decision|0|||
49075125|NCT00996892|158107052|FG016|Expansion Stage 2A|Physician Decision|0|||
49075126|NCT00996892|158107053|FG017|Expansion Stage 2A|Physician Decision|0|||
49075127|NCT00996892|158107054|FG018|Expansion Stage 2A|Physician Decision|0|||
49075128|NCT00996892|158107055|FG019|Expansion Stage 2A|Physician Decision|2|||
49075129|NCT00996892|158107036|FG000|Expansion Stage 2A|Withdrawal by Subject|0|||
49075130|NCT00996892|158107037|FG001|Expansion Stage 2A|Withdrawal by Subject|0|||
49075131|NCT00996892|158107038|FG002|Expansion Stage 2A|Withdrawal by Subject|0|||
49075132|NCT00996892|158107039|FG003|Expansion Stage 2A|Withdrawal by Subject|0|||
49075133|NCT00996892|158107040|FG004|Expansion Stage 2A|Withdrawal by Subject|0|||
49075134|NCT00996892|158107041|FG005|Expansion Stage 2A|Withdrawal by Subject|0|||
49075135|NCT00996892|158107042|FG006|Expansion Stage 2A|Withdrawal by Subject|0|||
49075136|NCT00996892|158107043|FG007|Expansion Stage 2A|Withdrawal by Subject|0|||
49075137|NCT00996892|158107044|FG008|Expansion Stage 2A|Withdrawal by Subject|0|||
49075138|NCT00996892|158107045|FG009|Expansion Stage 2A|Withdrawal by Subject|0|||
49075139|NCT00996892|158107046|FG010|Expansion Stage 2A|Withdrawal by Subject|0|||
49075140|NCT00996892|158107047|FG011|Expansion Stage 2A|Withdrawal by Subject|0|||
49075141|NCT00996892|158107048|FG012|Expansion Stage 2A|Withdrawal by Subject|0|||
49075142|NCT00996892|158107049|FG013|Expansion Stage 2A|Withdrawal by Subject|0|||
49075143|NCT00996892|158107050|FG014|Expansion Stage 2A|Withdrawal by Subject|0|||
49075144|NCT00996892|158107051|FG015|Expansion Stage 2A|Withdrawal by Subject|0|||
49075145|NCT00996892|158107052|FG016|Expansion Stage 2A|Withdrawal by Subject|0|||
49075146|NCT00996892|158107053|FG017|Expansion Stage 2A|Withdrawal by Subject|0|||
49075147|NCT00996892|158107054|FG018|Expansion Stage 2A|Withdrawal by Subject|0|||
49075148|NCT00996892|158107055|FG019|Expansion Stage 2A|Withdrawal by Subject|4|||
49075149|NCT00996892|158107036|FG000|Expansion Stage 2A|Disease Progression|0|||
49075150|NCT00996892|158107037|FG001|Expansion Stage 2A|Disease Progression|0|||
49075151|NCT00996892|158107038|FG002|Expansion Stage 2A|Disease Progression|0|||
49075152|NCT00996892|158107039|FG003|Expansion Stage 2A|Disease Progression|0|||
49075153|NCT00996892|158107040|FG004|Expansion Stage 2A|Disease Progression|0|||
49075154|NCT00996892|158107041|FG005|Expansion Stage 2A|Disease Progression|0|||
49075155|NCT00996892|158107042|FG006|Expansion Stage 2A|Disease Progression|0|||
49075156|NCT00996892|158107043|FG007|Expansion Stage 2A|Disease Progression|0|||
49075157|NCT00996892|158107044|FG008|Expansion Stage 2A|Disease Progression|0|||
49075158|NCT00996892|158107045|FG009|Expansion Stage 2A|Disease Progression|0|||
49075159|NCT00996892|158107046|FG010|Expansion Stage 2A|Disease Progression|0|||
49075160|NCT00996892|158107047|FG011|Expansion Stage 2A|Disease Progression|0|||
49075161|NCT00996892|158107048|FG012|Expansion Stage 2A|Disease Progression|0|||
49075162|NCT00996892|158107049|FG013|Expansion Stage 2A|Disease Progression|0|||
49075163|NCT00996892|158107050|FG014|Expansion Stage 2A|Disease Progression|0|||
49075164|NCT00996892|158107051|FG015|Expansion Stage 2A|Disease Progression|0|||
49075165|NCT00996892|158107052|FG016|Expansion Stage 2A|Disease Progression|0|||
49075166|NCT00996892|158107053|FG017|Expansion Stage 2A|Disease Progression|0|||
49075167|NCT00996892|158107054|FG018|Expansion Stage 2A|Disease Progression|0|||
49075168|NCT00996892|158107055|FG019|Expansion Stage 2A|Disease Progression|31|||
49075169|NCT02198963|158107056|FG000|Overall Study|Adverse Event|1|||
49075170|NCT02198963|158107056|FG000|Overall Study|Withdrawal by Subject|6|||
49075171|NCT00243412|158107059|FG000|Overall Study|Death|0|||
49075172|NCT00243412|158107060|FG001|Overall Study|Death|1|||
49075173|NCT00243412|158107059|FG000|Overall Study|Adverse Event|4|||
49075174|NCT00243412|158107060|FG001|Overall Study|Adverse Event|2|||
49075175|NCT00243412|158107059|FG000|Overall Study|Lost to Follow-up|0|||
49075176|NCT00243412|158107060|FG001|Overall Study|Lost to Follow-up|1|||
49075177|NCT00243412|158107059|FG000|Overall Study|Physician Decision|1|||
49075178|NCT00243412|158107060|FG001|Overall Study|Physician Decision|1|||
49075179|NCT00243412|158107059|FG000|Overall Study|Withdrawal by Subject|4|||
49075180|NCT00243412|158107060|FG001|Overall Study|Withdrawal by Subject|5|||
49075181|NCT00243412|158107059|FG000|Overall Study|Other|1|||
49075182|NCT00243412|158107060|FG001|Overall Study|Other|1|||
49075183|NCT02764151|158107063|FG000|Overall Study|Subject refused further follow-up|0|||
49075184|NCT02764151|158107064|FG001|Overall Study|Subject refused further follow-up|0|||
49075185|NCT02764151|158107065|FG002|Overall Study|Subject refused further follow-up|0|||
49075186|NCT02764151|158107066|FG003|Overall Study|Subject refused further follow-up|1|||
49075187|NCT02764151|158107063|FG000|Overall Study|Other|0|||
49075188|NCT02764151|158107064|FG001|Overall Study|Other|0|||
49075189|NCT02764151|158107065|FG002|Overall Study|Other|0|||
49075190|NCT02764151|158107066|FG003|Overall Study|Other|2|||
49075191|NCT01450683|158107067|FG000|Overall Study|Adverse Event|2|||
49075192|NCT00720382|158107073|FG000|Overall Study|Adverse Event|54|||
49075193|NCT00720382|158107074|FG001|Overall Study|Adverse Event|17|||
49075194|NCT00720382|158107073|FG000|Overall Study|Lack of Efficacy|18|||
49075195|NCT00720382|158107074|FG001|Overall Study|Lack of Efficacy|7|||
49075196|NCT00720382|158107073|FG000|Overall Study|Non-Compliance|15|||
49075197|NCT00720382|158107074|FG001|Overall Study|Non-Compliance|5|||
49075198|NCT00720382|158107073|FG000|Overall Study|Withdrawal by Subject|47|||
49075199|NCT00720382|158107074|FG001|Overall Study|Withdrawal by Subject|11|||
49075200|NCT00720382|158107073|FG000|Overall Study|Lost to Follow-up|28|||
49075201|NCT00720382|158107074|FG001|Overall Study|Lost to Follow-up|14|||
49075202|NCT00720382|158107073|FG000|Overall Study|administrative|14|||
49075203|NCT00720382|158107074|FG001|Overall Study|administrative|5|||
49075204|NCT00708227|158107075|FG000|Overall Study|Physician Decision|0|||
49075205|NCT00708227|158107076|FG001|Overall Study|Physician Decision|3|||
49075206|NCT00708227|158107077|FG002|Overall Study|Physician Decision|1|||
49075207|NCT00708227|158107078|FG003|Overall Study|Physician Decision|2|||
49075208|NCT00708227|158107075|FG000|Overall Study|Withdrawal by Subject|1|||
49075209|NCT00708227|158107076|FG001|Overall Study|Withdrawal by Subject|2|||
49075210|NCT00708227|158107077|FG002|Overall Study|Withdrawal by Subject|0|||
49075211|NCT00708227|158107078|FG003|Overall Study|Withdrawal by Subject|1|||
49075212|NCT02108912|158107080|FG000|Overall Study|Lost to Follow-up|1|||
49075213|NCT02108912|158107081|FG001|Overall Study|Lost to Follow-up|1|||
49075214|NCT02108912|158107080|FG000|Overall Study|lack of transportation|1|||
49075215|NCT02108912|158107081|FG001|Overall Study|lack of transportation|0|||
49075216|NCT02108912|158107080|FG000|Overall Study|high blood pressure|1|||
49075217|NCT02108912|158107081|FG001|Overall Study|high blood pressure|0|||
49075218|NCT03180645|158107082|FG000|Overall Study|Adverse Event|0|||
49075219|NCT03180645|158107083|FG001|Overall Study|Adverse Event|1|||
49075220|NCT03180645|158107084|FG002|Overall Study|Adverse Event|2|||
49075221|NCT01959295|158107085|FG000|Overall Study|Adverse Event|2|||
49075222|NCT01959295|158107086|FG001|Overall Study|Adverse Event|0|||
49075223|NCT01959295|158107085|FG000|Overall Study|Lost to Follow-up|0|||
49075224|NCT01959295|158107086|FG001|Overall Study|Lost to Follow-up|2|||
49075225|NCT01959295|158107085|FG000|Overall Study|Physician Decision|2|||
49075226|NCT01959295|158107086|FG001|Overall Study|Physician Decision|3|||
49075227|NCT01959295|158107085|FG000|Overall Study|Protocol Violation|16|||
49075228|NCT01959295|158107086|FG001|Overall Study|Protocol Violation|5|||
49075229|NCT01959295|158107085|FG000|Overall Study|Withdrawal by Subject|3|||
49075230|NCT01959295|158107086|FG001|Overall Study|Withdrawal by Subject|1|||
49075231|NCT01959295|158107085|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|10|||
49075232|NCT01959295|158107086|FG001|Overall Study|Clinical laboratory value is ineligible on day 1|6|||
49075233|NCT00359801|158108647|FG000|Overall Study|Lost to Follow-up|72|||
49075234|NCT00359801|158108648|FG001|Overall Study|Lost to Follow-up|58|||
49075235|NCT00359801|158108647|FG000|Overall Study|Withdrawal by Subject|143|||
49075236|NCT00359801|158108648|FG001|Overall Study|Withdrawal by Subject|96|||
49075237|NCT00359801|158108647|FG000|Overall Study|Other|66|||
49075238|NCT00359801|158108648|FG001|Overall Study|Other|46|||
49075239|NCT00359801|158108647|FG000|Overall Study|Final Status Unknown: missing data|7|||
49075240|NCT00359801|158108648|FG001|Overall Study|Final Status Unknown: missing data|4|||
49075241|NCT00359801|158108647|FG000|Overall Study|Sponsor Decision|17|||
49075242|NCT00359801|158108648|FG001|Overall Study|Sponsor Decision|16|||
49075243|NCT03765788|158108652|FG000|Overall Study|Subject decision|2|||
49075244|NCT03765788|158108653|FG001|Overall Study|Subject decision|3|||
49075245|NCT03765788|158108652|FG000|Overall Study|Physician Decision|2|||
49075246|NCT03765788|158108653|FG001|Overall Study|Physician Decision|4|||
49075247|NCT03765788|158108652|FG000|Overall Study|Death|0|||
49075248|NCT03765788|158108653|FG001|Overall Study|Death|1|||
49075249|NCT03765788|158108652|FG000|Overall Study|Lost to Follow-up|1|||
49075250|NCT03765788|158108653|FG001|Overall Study|Lost to Follow-up|0|||
49075251|NCT01924754|158108658|FG000|Overall Study|Lost to Follow-up|1|||
49075252|NCT01924754|158108659|FG001|Overall Study|Lost to Follow-up|2|||
49075253|NCT01924754|158108660|FG002|Overall Study|Lost to Follow-up|1|||
49075254|NCT01924754|158108658|FG000|Overall Study|Pregnancy|0|||
49075255|NCT01924754|158108659|FG001|Overall Study|Pregnancy|1|||
49075256|NCT01924754|158108660|FG002|Overall Study|Pregnancy|2|||
49075257|NCT01284361|158108663|FG000|Overall Study|Withdrawal by Subject|1|||
49075258|NCT01284361|158108663|FG000|Overall Study|Protocol Violation|5|||
49075259|NCT01284361|158108663|FG000|Overall Study|Adverse Event|1|||
49075260|NCT01284361|158108663|FG000|Overall Study|Lost to Follow-up|2|||
49075261|NCT02929056|158108664|FG000|Overall Study|Lost to Follow-up|0|||
49075262|NCT02929056|158108665|FG001|Overall Study|Lost to Follow-up|1|||
49075263|NCT00663026|158108666|FG000|Overall Study|Lost to Follow-up|1|||
49075264|NCT00663026|158108667|FG001|Overall Study|Lost to Follow-up|0|||
49075265|NCT00663026|158108668|FG002|Overall Study|Lost to Follow-up|0|||
49075266|NCT00663026|158108666|FG000|Overall Study|Other|1|||
49075267|NCT00663026|158108667|FG001|Overall Study|Other|2|||
49075268|NCT00663026|158108668|FG002|Overall Study|Other|0|||
49075269|NCT00663026|158108666|FG000|Overall Study|Adverse Event|0|||
49075270|NCT00663026|158108667|FG001|Overall Study|Adverse Event|2|||
49075271|NCT00663026|158108668|FG002|Overall Study|Adverse Event|3|||
49075272|NCT00663026|158108666|FG000|Overall Study|Caregiver Request|0|||
49075273|NCT00663026|158108667|FG001|Overall Study|Caregiver Request|2|||
49075274|NCT00663026|158108668|FG002|Overall Study|Caregiver Request|0|||
49075275|NCT00663026|158108666|FG000|Overall Study|Withdrawal by Subject|0|||
49075276|NCT00663026|158108667|FG001|Overall Study|Withdrawal by Subject|0|||
49075277|NCT00663026|158108668|FG002|Overall Study|Withdrawal by Subject|1|||
49075278|NCT02245412|158108672|FG000|Treatment Period|Death|1|||
49075279|NCT02245412|158108673|FG001|Treatment Period|Death|1|||
49075280|NCT02245412|158108674|FG002|Treatment Period|Death|0|||
49075281|NCT02245412|158108672|FG000|Treatment Period|Physician Decision|1|||
49075282|NCT02245412|158108673|FG001|Treatment Period|Physician Decision|1|||
49075283|NCT02245412|158108674|FG002|Treatment Period|Physician Decision|0|||
49075284|NCT02245412|158108672|FG000|Treatment Period|Withdrawal by Subject|2|||
49075285|NCT02245412|158108673|FG001|Treatment Period|Withdrawal by Subject|1|||
49075286|NCT02245412|158108674|FG002|Treatment Period|Withdrawal by Subject|0|||
49075287|NCT02245412|158108672|FG000|Treatment Period|Biopsy did not confirm GI GVHD|1|||
49075288|NCT02245412|158108673|FG001|Treatment Period|Biopsy did not confirm GI GVHD|0|||
49075289|NCT02245412|158108674|FG002|Treatment Period|Biopsy did not confirm GI GVHD|0|||
49075290|NCT02245412|158108672|FG000|Follow-Up Period|Death|4|||
49075291|NCT02245412|158108673|FG001|Follow-Up Period|Death|2|||
49075292|NCT02245412|158108674|FG002|Follow-Up Period|Death|1|||
49075293|NCT02245412|158108672|FG000|Follow-Up Period|Physician Decision|1|||
49075294|NCT02245412|158108673|FG001|Follow-Up Period|Physician Decision|0|||
49075295|NCT02245412|158108674|FG002|Follow-Up Period|Physician Decision|0|||
49075296|NCT02245412|158108672|FG000|Follow-Up Period|Other - Terminated by Sponsor|0|||
49075297|NCT02245412|158108673|FG001|Follow-Up Period|Other - Terminated by Sponsor|0|||
49075298|NCT02245412|158108674|FG002|Follow-Up Period|Other - Terminated by Sponsor|1|||
49075299|NCT01056289|158108675|FG000|Open-label Phase|Adverse Event|29|||
49075300|NCT01056289|158108676|FG001|Open-label Phase|Adverse Event|0|||
49075301|NCT01056289|158108677|FG002|Open-label Phase|Adverse Event|0|||
49075302|NCT01056289|158108678|FG003|Open-label Phase|Adverse Event|0|||
49075303|NCT01056289|158108675|FG000|Open-label Phase|Lost to Follow-up|30|||
49075304|NCT01056289|158108676|FG001|Open-label Phase|Lost to Follow-up|0|||
49075305|NCT01056289|158108677|FG002|Open-label Phase|Lost to Follow-up|0|||
49075306|NCT01056289|158108678|FG003|Open-label Phase|Lost to Follow-up|0|||
49075307|NCT01056289|158108675|FG000|Open-label Phase|Other|9|||
49075308|NCT01056289|158108676|FG001|Open-label Phase|Other|0|||
49075309|NCT01056289|158108677|FG002|Open-label Phase|Other|0|||
49075310|NCT01056289|158108678|FG003|Open-label Phase|Other|0|||
49075311|NCT01056289|158108675|FG000|Open-label Phase|Protocol Violation|6|||
49075312|NCT01056289|158108676|FG001|Open-label Phase|Protocol Violation|0|||
49075313|NCT01056289|158108677|FG002|Open-label Phase|Protocol Violation|0|||
49075314|NCT01056289|158108678|FG003|Open-label Phase|Protocol Violation|0|||
49075315|NCT01056289|158108675|FG000|Open-label Phase|Withdrawal by Subject|26|||
49075316|NCT01056289|158108676|FG001|Open-label Phase|Withdrawal by Subject|0|||
49075317|NCT01056289|158108677|FG002|Open-label Phase|Withdrawal by Subject|0|||
49075318|NCT01056289|158108678|FG003|Open-label Phase|Withdrawal by Subject|0|||
49075319|NCT01056289|158108675|FG000|Open-label Phase|Lack of Efficacy|18|||
49075320|NCT01056289|158108676|FG001|Open-label Phase|Lack of Efficacy|0|||
49075321|NCT01056289|158108677|FG002|Open-label Phase|Lack of Efficacy|0|||
49075322|NCT01056289|158108678|FG003|Open-label Phase|Lack of Efficacy|0|||
49075323|NCT01056289|158108675|FG000|Open-label Phase|Not randomized to Double-blind phase|1|||
49075324|NCT01056289|158108676|FG001|Open-label Phase|Not randomized to Double-blind phase|0|||
49075325|NCT01056289|158108677|FG002|Open-label Phase|Not randomized to Double-blind phase|0|||
49075326|NCT01056289|158108678|FG003|Open-label Phase|Not randomized to Double-blind phase|0|||
49075327|NCT01056289|158108675|FG000|Double-blind Phase|Adverse Event|0|||
49075328|NCT01056289|158108676|FG001|Double-blind Phase|Adverse Event|1|||
49075329|NCT01056289|158108677|FG002|Double-blind Phase|Adverse Event|2|||
49075330|NCT01056289|158108678|FG003|Double-blind Phase|Adverse Event|1|||
49075331|NCT01056289|158108675|FG000|Double-blind Phase|Lost to Follow-up|0|||
49075332|NCT01056289|158108676|FG001|Double-blind Phase|Lost to Follow-up|2|||
49075333|NCT01056289|158108677|FG002|Double-blind Phase|Lost to Follow-up|2|||
49075334|NCT01056289|158108678|FG003|Double-blind Phase|Lost to Follow-up|2|||
49075335|NCT01056289|158108675|FG000|Double-blind Phase|Other|0|||
49075336|NCT01056289|158108676|FG001|Double-blind Phase|Other|0|||
49075337|NCT01056289|158108677|FG002|Double-blind Phase|Other|1|||
49075338|NCT01056289|158108678|FG003|Double-blind Phase|Other|2|||
49075339|NCT01056289|158108675|FG000|Double-blind Phase|Protocol Violation|0|||
49075340|NCT01056289|158108676|FG001|Double-blind Phase|Protocol Violation|0|||
49075341|NCT01056289|158108677|FG002|Double-blind Phase|Protocol Violation|1|||
49075342|NCT01056289|158108678|FG003|Double-blind Phase|Protocol Violation|1|||
49075343|NCT01056289|158108675|FG000|Double-blind Phase|Withdrawal by Subject|0|||
49075344|NCT01056289|158108676|FG001|Double-blind Phase|Withdrawal by Subject|0|||
49075345|NCT01056289|158108677|FG002|Double-blind Phase|Withdrawal by Subject|4|||
49075346|NCT01056289|158108678|FG003|Double-blind Phase|Withdrawal by Subject|2|||
49075347|NCT01056289|158108675|FG000|Double-blind Phase|Discontinuation symptom|0|||
49075348|NCT01056289|158108676|FG001|Double-blind Phase|Discontinuation symptom|1|||
49075349|NCT01056289|158108677|FG002|Double-blind Phase|Discontinuation symptom|2|||
49075350|NCT01056289|158108678|FG003|Double-blind Phase|Discontinuation symptom|2|||
49075351|NCT01056289|158108675|FG000|Double-blind Phase|Physician Decision|0|||
49075352|NCT01056289|158108676|FG001|Double-blind Phase|Physician Decision|0|||
49075353|NCT01056289|158108677|FG002|Double-blind Phase|Physician Decision|1|||
49075354|NCT01056289|158108678|FG003|Double-blind Phase|Physician Decision|0|||
49075355|NCT03907878|158108682|FG000|Treatment Period|Withdrawal by Subject|5|||
49075356|NCT03907878|158108682|FG000|Treatment Period|Adverse Event|4|||
49075357|NCT03907878|158108682|FG000|Treatment Period|Lack of Efficacy|1|||
49075358|NCT03907878|158108682|FG000|Treatment Period|Protocol Violation|1|||
49075359|NCT03907878|158108682|FG000|Follow-up Period|Adverse Event|3|||
49075360|NCT03907878|158108682|FG000|Follow-up Period|Withdrawal by Subject|3|||
49075361|NCT02246114|158108686|FG000|Overall Study|miscarriage|1|||
49075362|NCT02246114|158108687|FG001|Overall Study|miscarriage|0|||
49075363|NCT01141205|158108688|FG000|Overall Study|Physician Decision|1|||
49075364|NCT01141205|158108689|FG001|Overall Study|Physician Decision|1|||
49075365|NCT01141205|158108688|FG000|Overall Study|Lost to Follow-up|1|||
49075366|NCT01141205|158108689|FG001|Overall Study|Lost to Follow-up|0|||
49075367|NCT01141205|158108688|FG000|Overall Study|Withdrawal by Subject|1|||
49075368|NCT01141205|158108689|FG001|Overall Study|Withdrawal by Subject|1|||
49075369|NCT02114385|158108693|FG000|Overall Study|Withdrawal by Subject|3|||
49075370|NCT02114385|158108694|FG001|Overall Study|Withdrawal by Subject|2|||
49075371|NCT02114385|158108693|FG000|Overall Study|Lost to Follow-up|0|||
49075372|NCT02114385|158108694|FG001|Overall Study|Lost to Follow-up|6|||
49075373|NCT01068262|158108697|FG000|Overall Study|Adverse Event|2|||
49075374|NCT01068262|158108698|FG001|Overall Study|Adverse Event|0|||
49075375|NCT01068262|158108699|FG002|Overall Study|Adverse Event|1|||
49075376|NCT01068262|158108700|FG003|Overall Study|Adverse Event|0|||
49075377|NCT01068262|158108697|FG000|Overall Study|Protocol Violation|1|||
49075378|NCT01068262|158108698|FG001|Overall Study|Protocol Violation|0|||
49075379|NCT01068262|158108699|FG002|Overall Study|Protocol Violation|0|||
49075380|NCT01068262|158108700|FG003|Overall Study|Protocol Violation|0|||
49075381|NCT01068262|158108697|FG000|Overall Study|Withdrawal by Subject|0|||
49075382|NCT01068262|158108698|FG001|Overall Study|Withdrawal by Subject|1|||
49075383|NCT01068262|158108699|FG002|Overall Study|Withdrawal by Subject|0|||
49075384|NCT01068262|158108700|FG003|Overall Study|Withdrawal by Subject|0|||
49075385|NCT00195338|158108703|FG000|Overall Study|Lost to Follow-up|2|||
49075386|NCT00195338|158108703|FG000|Overall Study|Adverse Event|5|||
49075387|NCT00195338|158108703|FG000|Overall Study|Lack of Efficacy|1|||
49075388|NCT00195338|158108703|FG000|Overall Study|Early closure of the site|4|||
49075389|NCT01557517|158108704|FG000|Overall Study|Death|1|||
49075390|NCT01557517|158108705|FG001|Overall Study|Death|0|||
49075391|NCT01557517|158108704|FG000|Overall Study|Refused further treatment|0|||
49075392|NCT01557517|158108705|FG001|Overall Study|Refused further treatment|2|||
49075393|NCT01557517|158108704|FG000|Overall Study|Adverse Event|0|||
49075394|NCT01557517|158108705|FG001|Overall Study|Adverse Event|2|||
49075395|NCT01557517|158108704|FG000|Overall Study|Pt declined before treatment started|1|||
49075396|NCT01557517|158108705|FG001|Overall Study|Pt declined before treatment started|0|||
49075397|NCT02252406|158108708|FG000|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2|||
49075398|NCT02252406|158108709|FG001|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3|||
49075399|NCT02252406|158108708|FG000|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1|||
49075400|NCT02252406|158108709|FG001|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0|||
49075401|NCT02252406|158108708|FG000|Starting Dose Ranolazine 500 mg BID|Adverse Event|1|||
49075402|NCT02252406|158108709|FG001|Starting Dose Ranolazine 500 mg BID|Adverse Event|0|||
49075403|NCT02252406|158108708|FG000|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
49075404|NCT02252406|158108709|FG001|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
49075405|NCT02252406|158108708|FG000|Titrated to Ranolazine 1000mg BID|Adverse Event|2|||
49075406|NCT02252406|158108709|FG001|Titrated to Ranolazine 1000mg BID|Adverse Event|0|||
49075407|NCT00447876|158108712|FG000|Overall Study|Withdrawal by Subject|1|||
49075408|NCT00447876|158108713|FG001|Overall Study|Withdrawal by Subject|4|||
49075409|NCT00447876|158108712|FG000|Overall Study|Lost to Follow-up|1|||
49075410|NCT00447876|158108713|FG001|Overall Study|Lost to Follow-up|0|||
49075411|NCT00447876|158108712|FG000|Overall Study|Deterioration of symptomology|1|||
49075412|NCT00447876|158108713|FG001|Overall Study|Deterioration of symptomology|0|||
49075413|NCT02533180|158108714|FG000|Overall Study|Death|0|||
49075414|NCT02533180|158108715|FG001|Overall Study|Death|2|||
49075415|NCT02533180|158108714|FG000|Overall Study|Lost to Follow-up|0|||
49075416|NCT02533180|158108715|FG001|Overall Study|Lost to Follow-up|1|||
49075417|NCT02533180|158108714|FG000|Overall Study|Physician Decision|0|||
49075418|NCT02533180|158108715|FG001|Overall Study|Physician Decision|1|||
49075419|NCT02533180|158108714|FG000|Overall Study|Withdrawal by Subject|2|||
49075420|NCT02533180|158108715|FG001|Overall Study|Withdrawal by Subject|5|||
49075421|NCT02533180|158108714|FG000|Overall Study|Screen Failure|37|||
49075422|NCT02533180|158108715|FG001|Overall Study|Screen Failure|0|||
49075423|NCT02533180|158108714|FG000|Overall Study|Protocol Deviation|0|||
49075424|NCT02533180|158108715|FG001|Overall Study|Protocol Deviation|1|||
49075425|NCT02533180|158108714|FG000|Overall Study|Non-compliance|0|||
49075426|NCT02533180|158108715|FG001|Overall Study|Non-compliance|1|||
49075427|NCT03583086|158108720|FG000|Overall Study|Death|2|||
49075428|NCT03583086|158108721|FG001|Overall Study|Death|6|||
49075429|NCT03583086|158108722|FG002|Overall Study|Death|12|||
49075430|NCT03583086|158108723|FG003|Overall Study|Death|10|||
49075431|NCT03583086|158108724|FG004|Overall Study|Death|14|||
49075432|NCT03583086|158108725|FG005|Overall Study|Death|14|||
49075433|NCT03583086|158108726|FG006|Overall Study|Death|4|||
49075434|NCT03583086|158108720|FG000|Overall Study|Withdrawal by Subject|0|||
49075435|NCT03583086|158108721|FG001|Overall Study|Withdrawal by Subject|0|||
49075436|NCT03583086|158108722|FG002|Overall Study|Withdrawal by Subject|1|||
49075437|NCT03583086|158108723|FG003|Overall Study|Withdrawal by Subject|0|||
49075438|NCT03583086|158108724|FG004|Overall Study|Withdrawal by Subject|0|||
49075439|NCT03583086|158108725|FG005|Overall Study|Withdrawal by Subject|0|||
49075440|NCT03583086|158108726|FG006|Overall Study|Withdrawal by Subject|1|||
49075441|NCT03583086|158108720|FG000|Overall Study|Refused follow-up|0|||
49075442|NCT03583086|158108721|FG001|Overall Study|Refused follow-up|0|||
49075443|NCT03583086|158108722|FG002|Overall Study|Refused follow-up|1|||
49075444|NCT03583086|158108723|FG003|Overall Study|Refused follow-up|0|||
49075445|NCT03583086|158108724|FG004|Overall Study|Refused follow-up|1|||
49075446|NCT03583086|158108725|FG005|Overall Study|Refused follow-up|0|||
49075447|NCT03583086|158108726|FG006|Overall Study|Refused follow-up|0|||
49075448|NCT03583086|158108720|FG000|Overall Study|Declining Performance Status|0|||
49075449|NCT03583086|158108721|FG001|Overall Study|Declining Performance Status|0|||
49075450|NCT03583086|158108722|FG002|Overall Study|Declining Performance Status|1|||
49075451|NCT03583086|158108723|FG003|Overall Study|Declining Performance Status|0|||
49075452|NCT03583086|158108724|FG004|Overall Study|Declining Performance Status|0|||
49075453|NCT03583086|158108725|FG005|Overall Study|Declining Performance Status|0|||
49075454|NCT03583086|158108726|FG006|Overall Study|Declining Performance Status|0|||
49075455|NCT03583086|158108720|FG000|Overall Study|Still on study|0|||
49075456|NCT03583086|158108721|FG001|Overall Study|Still on study|0|||
49075457|NCT03583086|158108722|FG002|Overall Study|Still on study|0|||
49075458|NCT03583086|158108723|FG003|Overall Study|Still on study|1|||
49075459|NCT03583086|158108724|FG004|Overall Study|Still on study|0|||
49075460|NCT03583086|158108725|FG005|Overall Study|Still on study|0|||
49075461|NCT03583086|158108726|FG006|Overall Study|Still on study|1|||
49075462|NCT03583086|158108720|FG000|Overall Study|Disease progression|0|||
49075463|NCT03583086|158108721|FG001|Overall Study|Disease progression|0|||
49075464|NCT03583086|158108722|FG002|Overall Study|Disease progression|0|||
49075465|NCT03583086|158108723|FG003|Overall Study|Disease progression|0|||
49075466|NCT03583086|158108724|FG004|Overall Study|Disease progression|0|||
49075467|NCT03583086|158108725|FG005|Overall Study|Disease progression|0|||
49075468|NCT03583086|158108726|FG006|Overall Study|Disease progression|1|||
49075469|NCT03583086|158108720|FG000|Overall Study|Undergoing radiation therapy|0|||
49075470|NCT03583086|158108721|FG001|Overall Study|Undergoing radiation therapy|0|||
49075471|NCT03583086|158108722|FG002|Overall Study|Undergoing radiation therapy|0|||
49075472|NCT03583086|158108723|FG003|Overall Study|Undergoing radiation therapy|0|||
49075473|NCT03583086|158108724|FG004|Overall Study|Undergoing radiation therapy|0|||
49075474|NCT03583086|158108725|FG005|Overall Study|Undergoing radiation therapy|0|||
49075475|NCT03583086|158108726|FG006|Overall Study|Undergoing radiation therapy|1|||
49075476|NCT03583086|158108720|FG000|Overall Study|Lost to Follow-up|0|||
49075477|NCT03583086|158108721|FG001|Overall Study|Lost to Follow-up|0|||
49075478|NCT03583086|158108722|FG002|Overall Study|Lost to Follow-up|0|||
49075479|NCT03583086|158108723|FG003|Overall Study|Lost to Follow-up|0|||
49075480|NCT03583086|158108724|FG004|Overall Study|Lost to Follow-up|0|||
49075481|NCT03583086|158108725|FG005|Overall Study|Lost to Follow-up|1|||
49075482|NCT03583086|158108726|FG006|Overall Study|Lost to Follow-up|0|||
49075483|NCT03583086|158108720|FG000|Overall Study|Adverse Event|0|||
49075484|NCT03583086|158108721|FG001|Overall Study|Adverse Event|0|||
49075485|NCT03583086|158108722|FG002|Overall Study|Adverse Event|0|||
49075486|NCT03583086|158108723|FG003|Overall Study|Adverse Event|0|||
49075487|NCT03583086|158108724|FG004|Overall Study|Adverse Event|0|||
49075488|NCT03583086|158108725|FG005|Overall Study|Adverse Event|1|||
49075489|NCT03583086|158108726|FG006|Overall Study|Adverse Event|0|||
49075490|NCT01174043|158108727|FG000|Overall Study|Disease progression|5|||
49075491|NCT01174043|158108727|FG000|Overall Study|Adverse Event|3|||
49075492|NCT01174043|158108727|FG000|Overall Study|Death|1|||
49075493|NCT01174043|158108727|FG000|Overall Study|Withdrawal by Subject|2|||
49075494|NCT01085357|158108728|FG000|Overall Study|Adverse Event|1|||
49075495|NCT01085357|158108729|FG001|Overall Study|Adverse Event|1|||
49075496|NCT01085357|158108728|FG000|Overall Study|Subject Decision|4|||
49075497|NCT01085357|158108729|FG001|Overall Study|Subject Decision|3|||
49075498|NCT01085357|158108728|FG000|Overall Study|Investigator Decision|1|||
49075499|NCT01085357|158108729|FG001|Overall Study|Investigator Decision|1|||
49075500|NCT01085357|158108728|FG000|Overall Study|Death|11|||
49075501|NCT01085357|158108729|FG001|Overall Study|Death|1|||
49075502|NCT01085357|158108728|FG000|Overall Study|Lost to Follow-up|2|||
49075503|NCT01085357|158108729|FG001|Overall Study|Lost to Follow-up|0|||
49075504|NCT01611857|158108730|FG000|Overall Study|Withdrawal by Subject|0|||
49075505|NCT01611857|158108731|FG001|Overall Study|Withdrawal by Subject|2|||
49075506|NCT00396812|158108732|FG000|Overall Study|Physician Decision|1|||
49075507|NCT00306995|158108733|FG000|Study Part I|Withdrawal by Subject|0|||
49075508|NCT00306995|158108734|FG001|Study Part I|Withdrawal by Subject|0|||
49075509|NCT00306995|158108735|FG002|Study Part I|Withdrawal by Subject|0|||
49075510|NCT00306995|158108736|FG003|Study Part I|Withdrawal by Subject|0|||
49075511|NCT00306995|158108737|FG004|Study Part I|Withdrawal by Subject|0|||
49075512|NCT00306995|158108738|FG005|Study Part I|Withdrawal by Subject|0|||
49075513|NCT00306995|158108739|FG006|Study Part I|Withdrawal by Subject|1|||
49075514|NCT00306995|158108733|FG000|Study Part II for Subset 2|Serious Adverse Event|0|||
49075515|NCT00306995|158108734|FG001|Study Part II for Subset 2|Serious Adverse Event|1|||
49075516|NCT00306995|158108735|FG002|Study Part II for Subset 2|Serious Adverse Event|0|||
49075517|NCT00306995|158108736|FG003|Study Part II for Subset 2|Serious Adverse Event|0|||
49075518|NCT00306995|158108737|FG004|Study Part II for Subset 2|Serious Adverse Event|0|||
49075519|NCT00306995|158108738|FG005|Study Part II for Subset 2|Serious Adverse Event|0|||
49075520|NCT00306995|158108739|FG006|Study Part II for Subset 2|Serious Adverse Event|0|||
49075521|NCT03280381|158108742|FG000|Overall Study|Physician Decision|0|||
49075522|NCT03280381|158108743|FG001|Overall Study|Physician Decision|2|||
49075523|NCT02536846|158108747|FG000|Overall Study|Withdrawal by Subject|1|||
49075532|NCT04974749|158108751|FG000|Overall Study|Withdrawal by Subject|2|||
49075533|NCT04974749|158108751|FG000|Overall Study|Gestation|1|||
49075534|NCT04868500|158108752|FG000|Overall Study|Participants and Clinical Site Staff terminated early|3|||
49075535|NCT04868500|158108753|FG001|Overall Study|Participants and Clinical Site Staff terminated early|1|||
49075536|NCT04868500|158108752|FG000|Overall Study|Participants and Clinical Site Staff never opened App|1|||
49075537|NCT04868500|158108753|FG001|Overall Study|Participants and Clinical Site Staff never opened App|0|||
49075538|NCT01098487|158108754|FG000|Overall Study|Adverse Event|22|||
49075539|NCT01098487|158108754|FG000|Overall Study|Lack of Efficacy|11|||
49075540|NCT01098487|158108754|FG000|Overall Study|Withdrawal by Subject|7|||
49075541|NCT01098487|158108754|FG000|Overall Study|Lost to Follow-up|3|||
49075542|NCT01098487|158108754|FG000|Overall Study|Physician Decision|1|||
49075543|NCT03519087|158108755|FG000|Clinic Evaluation|Physician Decision|15|||
49075544|NCT03519087|158108756|FG001|Clinic Evaluation|Physician Decision|18|||
49075545|NCT03519087|158108757|FG002|Clinic Evaluation|Physician Decision|0|||
49075546|NCT03519087|158108758|FG003|Clinic Evaluation|Physician Decision|0|||
49075547|NCT03519087|158108759|FG004|Clinic Evaluation|Physician Decision|0|||
49075548|NCT03519087|158108755|FG000|Clinic Evaluation|Protocol Violation|1|||
49075549|NCT03519087|158108756|FG001|Clinic Evaluation|Protocol Violation|0|||
49075550|NCT03519087|158108757|FG002|Clinic Evaluation|Protocol Violation|0|||
49075551|NCT03519087|158108758|FG003|Clinic Evaluation|Protocol Violation|0|||
49075552|NCT03519087|158108759|FG004|Clinic Evaluation|Protocol Violation|0|||
49075553|NCT03519087|158108755|FG000|Re-randomization for Treatment|Withdrawal by Subject|25|||
49075554|NCT03519087|158108756|FG001|Re-randomization for Treatment|Withdrawal by Subject|29|||
49075555|NCT03519087|158108757|FG002|Re-randomization for Treatment|Withdrawal by Subject|0|||
49075556|NCT03519087|158108758|FG003|Re-randomization for Treatment|Withdrawal by Subject|0|||
49075557|NCT03519087|158108759|FG004|Re-randomization for Treatment|Withdrawal by Subject|0|||
49075558|NCT03519087|158108755|FG000|Re-randomization for Treatment|Not appropriate|2|||
49075559|NCT03519087|158108756|FG001|Re-randomization for Treatment|Not appropriate|3|||
49075560|NCT03519087|158108757|FG002|Re-randomization for Treatment|Not appropriate|0|||
49075561|NCT03519087|158108758|FG003|Re-randomization for Treatment|Not appropriate|0|||
49075562|NCT03519087|158108759|FG004|Re-randomization for Treatment|Not appropriate|0|||
49075563|NCT03519087|158108755|FG000|Laboratory Testing|Lost to Follow-up|0|||
49075564|NCT03519087|158108756|FG001|Laboratory Testing|Lost to Follow-up|0|||
49075565|NCT03519087|158108757|FG002|Laboratory Testing|Lost to Follow-up|2|||
49075566|NCT03519087|158108758|FG003|Laboratory Testing|Lost to Follow-up|3|||
49075567|NCT03519087|158108759|FG004|Laboratory Testing|Lost to Follow-up|6|||
49075568|NCT03519087|158108755|FG000|Laboratory Testing|Protocol Violation|0|||
49075569|NCT03519087|158108756|FG001|Laboratory Testing|Protocol Violation|0|||
49075570|NCT03519087|158108757|FG002|Laboratory Testing|Protocol Violation|0|||
49075571|NCT03519087|158108758|FG003|Laboratory Testing|Protocol Violation|1|||
49075572|NCT03519087|158108759|FG004|Laboratory Testing|Protocol Violation|0|||
49075573|NCT02027428|158108760|FG000|Induction|Never treated|7|||
49075574|NCT02027428|158108761|FG001|Induction|Never treated|0|||
49075575|NCT02027428|158108762|FG002|Induction|Never treated|0|||
49075576|NCT02027428|158108760|FG000|Induction|Progressive disease|77|||
49075577|NCT02027428|158108761|FG001|Induction|Progressive disease|0|||
49075578|NCT02027428|158108762|FG002|Induction|Progressive disease|0|||
49075579|NCT02027428|158108760|FG000|Induction|Adverse Event|51|||
49075580|NCT02027428|158108761|FG001|Induction|Adverse Event|0|||
49075581|NCT02027428|158108762|FG002|Induction|Adverse Event|0|||
49075582|NCT02027428|158108760|FG000|Induction|Withdrawal by Subject|22|||
49075583|NCT02027428|158108761|FG001|Induction|Withdrawal by Subject|0|||
49075584|NCT02027428|158108762|FG002|Induction|Withdrawal by Subject|0|||
49075585|NCT02027428|158108760|FG000|Induction|Death|21|||
49075586|NCT02027428|158108761|FG001|Induction|Death|0|||
49075587|NCT02027428|158108762|FG002|Induction|Death|0|||
49075588|NCT02027428|158108760|FG000|Induction|Symptomatic deterioration|16|||
49075589|NCT02027428|158108761|FG001|Induction|Symptomatic deterioration|0|||
49075590|NCT02027428|158108762|FG002|Induction|Symptomatic deterioration|0|||
49075591|NCT02027428|158108760|FG000|Induction|Study terminated by sponsor|12|||
49075592|NCT02027428|158108761|FG001|Induction|Study terminated by sponsor|0|||
49075593|NCT02027428|158108762|FG002|Induction|Study terminated by sponsor|0|||
49075594|NCT02027428|158108760|FG000|Induction|Protocol Violation|1|||
49075595|NCT02027428|158108761|FG001|Induction|Protocol Violation|0|||
49075596|NCT02027428|158108762|FG002|Induction|Protocol Violation|0|||
49075597|NCT02027428|158108760|FG000|Induction|Miscellaneous|14|||
49075598|NCT02027428|158108761|FG001|Induction|Miscellaneous|0|||
49075599|NCT02027428|158108762|FG002|Induction|Miscellaneous|0|||
49075600|NCT02027428|158108760|FG000|Induction|Induction Treatment Ongoing|4|||
49075601|NCT02027428|158108761|FG001|Induction|Induction Treatment Ongoing|0|||
49075602|NCT02027428|158108762|FG002|Induction|Induction Treatment Ongoing|0|||
49075603|NCT02027428|158108760|FG000|Maintenance|Death|0|||
49075604|NCT02027428|158108761|FG001|Maintenance|Death|3|||
49075605|NCT02027428|158108762|FG002|Maintenance|Death|2|||
49075606|NCT02027428|158108760|FG000|Maintenance|Adverse Event|0|||
49075607|NCT02027428|158108761|FG001|Maintenance|Adverse Event|21|||
49075608|NCT02027428|158108762|FG002|Maintenance|Adverse Event|1|||
49075609|NCT02027428|158108760|FG000|Maintenance|Progressive disease|0|||
49075610|NCT02027428|158108761|FG001|Maintenance|Progressive disease|84|||
49075611|NCT02027428|158108762|FG002|Maintenance|Progressive disease|47|||
49075612|NCT02027428|158108760|FG000|Maintenance|Symptomatic deterioration|0|||
49075613|NCT02027428|158108761|FG001|Maintenance|Symptomatic deterioration|4|||
49075614|NCT02027428|158108762|FG002|Maintenance|Symptomatic deterioration|1|||
49075615|NCT02027428|158108760|FG000|Maintenance|Withdrawal by Subject|0|||
49075616|NCT02027428|158108761|FG001|Maintenance|Withdrawal by Subject|6|||
49075617|NCT02027428|158108762|FG002|Maintenance|Withdrawal by Subject|5|||
49075618|NCT02027428|158108760|FG000|Maintenance|Protocol Violation|0|||
49075619|NCT02027428|158108761|FG001|Maintenance|Protocol Violation|0|||
49075620|NCT02027428|158108762|FG002|Maintenance|Protocol Violation|1|||
49075621|NCT02027428|158108760|FG000|Maintenance|Other|0|||
49075622|NCT02027428|158108761|FG001|Maintenance|Other|6|||
49075623|NCT02027428|158108762|FG002|Maintenance|Other|3|||
49075624|NCT02027428|158108760|FG000|Survival Follow-up|Death|0|||
49075625|NCT02027428|158108761|FG001|Survival Follow-up|Death|78|||
49075626|NCT02027428|158108762|FG002|Survival Follow-up|Death|45|||
49075627|NCT02027428|158108760|FG000|Survival Follow-up|Lost to Follow-up|0|||
49075628|NCT02027428|158108761|FG001|Survival Follow-up|Lost to Follow-up|1|||
49075629|NCT02027428|158108762|FG002|Survival Follow-up|Lost to Follow-up|1|||
49075630|NCT02859142|158108763|FG000|Overall Study|Adverse Event|1|||
49075631|NCT02859142|158108764|FG001|Overall Study|Adverse Event|2|||
49075632|NCT02859142|158108763|FG000|Overall Study|Lost to Follow-up|1|||
49075633|NCT02859142|158108764|FG001|Overall Study|Lost to Follow-up|4|||
49075634|NCT02859142|158108763|FG000|Overall Study|Withdrawal by Subject|2|||
49075635|NCT02859142|158108764|FG001|Overall Study|Withdrawal by Subject|0|||
49075636|NCT02859142|158108763|FG000|Overall Study|Scheduling difficulties|0|||
49075637|NCT02859142|158108764|FG001|Overall Study|Scheduling difficulties|3|||
49075638|NCT01128543|158108766|FG000|Overall Study|Withdrawal by Subject|3|||
49075639|NCT01128543|158108766|FG000|Overall Study|Protocol Violation|1|||
49075640|NCT02466685|158108767|FG000|Overall Study|Adverse Event|5|||
49075641|NCT02466685|158108768|FG001|Overall Study|Adverse Event|2|||
49075642|NCT02466685|158108767|FG000|Overall Study|Lost to Follow-up|1|||
49075643|NCT02466685|158108768|FG001|Overall Study|Lost to Follow-up|1|||
49075644|NCT02466685|158108767|FG000|Overall Study|Withdrawal by Subject|1|||
49075645|NCT02466685|158108768|FG001|Overall Study|Withdrawal by Subject|0|||
49075646|NCT02466685|158108767|FG000|Overall Study|Physician Decision|1|||
49075647|NCT02466685|158108768|FG001|Overall Study|Physician Decision|1|||
49075648|NCT01632280|158108769|FG000|Overall Study|Withdrawal by Subject|1|||
49075649|NCT01632280|158108770|FG001|Overall Study|Withdrawal by Subject|0|||
49075650|NCT00995774|158108782|FG000|Training Period 2|Withdrawal by Subject|2|||
49075651|NCT00995774|158108783|FG001|Training Period 2|Withdrawal by Subject|0|||
49075652|NCT00822692|158108784|FG000|Overall Study|Lost to Follow-up|17|||
49075653|NCT00822692|158108785|FG001|Overall Study|Lost to Follow-up|25|||
49075654|NCT04208750|158108787|FG000|Overall Study|Lost to Follow-up|16|||
49075655|NCT04208750|158108788|FG001|Overall Study|Lost to Follow-up|15|||
49075656|NCT01523002|158108789|FG000|Period 1|Withdrawal by Subject|1|||
49075657|NCT01523002|158108790|FG001|Period 1|Withdrawal by Subject|3|||
49075658|NCT01523002|158108789|FG000|Period 1|Lost to Follow-up|1|||
49075659|NCT01523002|158108790|FG001|Period 1|Lost to Follow-up|0|||
49075660|NCT01523002|158108789|FG000|Period 1|Adverse Event|0|||
49075661|NCT01523002|158108790|FG001|Period 1|Adverse Event|8|||
49075662|NCT01523002|158108789|FG000|Period 2|Withdrawal by Subject|4|||
49075663|NCT01523002|158108790|FG001|Period 2|Withdrawal by Subject|1|||
49075664|NCT01523002|158108789|FG000|Period 2|Adverse Event|2|||
49075665|NCT01523002|158108790|FG001|Period 2|Adverse Event|5|||
49075666|NCT01523002|158108789|FG000|Period 3|Withdrawal by Subject|1|||
49075667|NCT01523002|158108790|FG001|Period 3|Withdrawal by Subject|0|||
49075668|NCT01523002|158108789|FG000|Period 3|Adverse Event|3|||
49075669|NCT01523002|158108790|FG001|Period 3|Adverse Event|0|||
49075670|NCT03132155|158110549|FG000|Overall Study|Lack of Efficacy|6|||
49075671|NCT03132155|158110549|FG000|Overall Study|Lost to Follow-up|1|||
49075672|NCT03132155|158110549|FG000|Overall Study|Withdrawal by Subject|1|||
49075673|NCT00794339|158110559|FG000|Overall Study|Withdrawal by Subject|3|||
49075674|NCT00794339|158110559|FG000|Overall Study|Ineligible|4|||
49075675|NCT00794339|158110559|FG000|Overall Study|Tx prior to ATSM|3|||
49075676|NCT00794339|158110559|FG000|Overall Study|ATSM imaging not complete or inadequate|3|||
49075677|NCT00794339|158110559|FG000|Overall Study|Tx not per protocol|1|||
49075678|NCT00582010|158110560|FG000|Overall Study|Death|0|||
49075679|NCT00582010|158110561|FG001|Overall Study|Death|1|||
49075680|NCT01128179|158110563|FG000|Overall Study|Death|1|||
49075681|NCT01128179|158110564|FG001|Overall Study|Death|0|||
49075682|NCT01128179|158110563|FG000|Overall Study|Protocol Violation|1|||
49075683|NCT01128179|158110564|FG001|Overall Study|Protocol Violation|0|||
49075684|NCT00314951|158110568|FG000|Treatment|Didn't meet criteria for mITT population|16|||
49075685|NCT00314951|158110569|FG001|Treatment|Didn't meet criteria for mITT population|11|||
49075686|NCT00314951|158110568|FG000|Follow-up|mITT failure|44|||
49075687|NCT00314951|158110569|FG001|Follow-up|mITT failure|34|||
49075688|NCT03516513|158110570|FG000|Overall Study|Withdrawal by Subject|2|||
49075689|NCT03516513|158110571|FG001|Overall Study|Withdrawal by Subject|2|||
49075690|NCT03516513|158110572|FG002|Overall Study|Withdrawal by Subject|0|||
49075691|NCT03516513|158110573|FG003|Overall Study|Withdrawal by Subject|0|||
49075692|NCT02593110|158110574|FG000|Overall Study|Withdrawal by Subject|0|||
49075693|NCT02593110|158110575|FG001|Overall Study|Withdrawal by Subject|3|||
49075694|NCT02593110|158110576|FG002|Overall Study|Withdrawal by Subject|3|||
49075695|NCT02593110|158110577|FG003|Overall Study|Withdrawal by Subject|2|||
49075696|NCT02593110|158110574|FG000|Overall Study|Death|0|||
49075697|NCT02593110|158110575|FG001|Overall Study|Death|0|||
49075698|NCT02593110|158110576|FG002|Overall Study|Death|1|||
49075699|NCT02593110|158110577|FG003|Overall Study|Death|0|||
49075700|NCT01228019|158110578|FG000|Overall Study|Dose Violation|70|||
49075701|NCT01228019|158110578|FG000|Overall Study|Duplicate enrollment|1|||
49075702|NCT01228019|158110578|FG000|Overall Study|Missing pre-treatment data|72|||
49075703|NCT01228019|158110578|FG000|Overall Study|Triglyceride Entry Criteria Not Met|152|||
49075704|NCT01228019|158110578|FG000|Overall Study|Violation of Entry Criterion|9|||
49075705|NCT01682811|158110594|FG000|Part 2 Dose Level 1|Withdrawal by Subject|0|||
49075706|NCT01682811|158110595|FG001|Part 2 Dose Level 1|Withdrawal by Subject|0|||
49075707|NCT01682811|158110596|FG002|Part 2 Dose Level 1|Withdrawal by Subject|0|||
49075708|NCT01682811|158110597|FG003|Part 2 Dose Level 1|Withdrawal by Subject|0|||
49075709|NCT01682811|158110598|FG004|Part 2 Dose Level 1|Withdrawal by Subject|1|||
49075710|NCT01682811|158110599|FG005|Part 2 Dose Level 1|Withdrawal by Subject|0|||
49075711|NCT01682811|158110600|FG006|Part 2 Dose Level 1|Withdrawal by Subject|0|||
49075712|NCT01682811|158110594|FG000|Part 2 Dose Level 1|Protocol Violation|0|||
49075713|NCT01682811|158110595|FG001|Part 2 Dose Level 1|Protocol Violation|0|||
49075714|NCT01682811|158110596|FG002|Part 2 Dose Level 1|Protocol Violation|0|||
49075715|NCT01682811|158110597|FG003|Part 2 Dose Level 1|Protocol Violation|0|||
49075716|NCT01682811|158110598|FG004|Part 2 Dose Level 1|Protocol Violation|4|||
49075717|NCT01682811|158110599|FG005|Part 2 Dose Level 1|Protocol Violation|0|||
49075718|NCT01682811|158110600|FG006|Part 2 Dose Level 1|Protocol Violation|0|||
49075719|NCT01682811|158110594|FG000|Part 2 Dose Level 1|Lost to Follow-up|0|||
49075720|NCT01682811|158110595|FG001|Part 2 Dose Level 1|Lost to Follow-up|0|||
49075721|NCT01682811|158110596|FG002|Part 2 Dose Level 1|Lost to Follow-up|0|||
49075722|NCT01682811|158110597|FG003|Part 2 Dose Level 1|Lost to Follow-up|0|||
49075723|NCT01682811|158110598|FG004|Part 2 Dose Level 1|Lost to Follow-up|6|||
49075724|NCT01682811|158110599|FG005|Part 2 Dose Level 1|Lost to Follow-up|0|||
49075725|NCT01682811|158110600|FG006|Part 2 Dose Level 1|Lost to Follow-up|0|||
49075726|NCT01682811|158110594|FG000|Part 2 Dose Level 2|Lost to Follow-up|0|||
49075727|NCT01682811|158110595|FG001|Part 2 Dose Level 2|Lost to Follow-up|0|||
49075728|NCT01682811|158110596|FG002|Part 2 Dose Level 2|Lost to Follow-up|0|||
49075729|NCT01682811|158110597|FG003|Part 2 Dose Level 2|Lost to Follow-up|0|||
49075730|NCT01682811|158110598|FG004|Part 2 Dose Level 2|Lost to Follow-up|0|||
49075731|NCT01682811|158110599|FG005|Part 2 Dose Level 2|Lost to Follow-up|3|||
49075732|NCT01682811|158110600|FG006|Part 2 Dose Level 2|Lost to Follow-up|0|||
49075733|NCT03717012|158110603|FG000|Overall Study|Due to trial termination|1|||
49075734|NCT03717012|158110604|FG001|Overall Study|Due to trial termination|2|||
49075735|NCT03717012|158110603|FG000|Overall Study|Protocol Violation|0|||
49075736|NCT03717012|158110604|FG001|Overall Study|Protocol Violation|2|||
49075737|NCT03717012|158110603|FG000|Overall Study|Adverse Event|0|||
49075738|NCT03717012|158110604|FG001|Overall Study|Adverse Event|1|||
49075739|NCT03717012|158110603|FG000|Overall Study|Lung transplant|0|||
49075740|NCT03717012|158110604|FG001|Overall Study|Lung transplant|1|||
49075741|NCT00789035|158110605|FG000|Overall Study|Adverse Event|0|||
49075742|NCT00789035|158110606|FG001|Overall Study|Adverse Event|2|||
49075743|NCT00789035|158110607|FG002|Overall Study|Adverse Event|0|||
49075744|NCT00789035|158110608|FG003|Overall Study|Adverse Event|1|||
49075745|NCT00789035|158110609|FG004|Overall Study|Adverse Event|3|||
49075746|NCT00789035|158110605|FG000|Overall Study|Lack of Efficacy|3|||
49075747|NCT00789035|158110606|FG001|Overall Study|Lack of Efficacy|0|||
49075748|NCT00789035|158110607|FG002|Overall Study|Lack of Efficacy|0|||
49075749|NCT00789035|158110608|FG003|Overall Study|Lack of Efficacy|0|||
49075750|NCT00789035|158110609|FG004|Overall Study|Lack of Efficacy|2|||
49075751|NCT00789035|158110605|FG000|Overall Study|Protocol Violation|1|||
49075752|NCT00789035|158110606|FG001|Overall Study|Protocol Violation|0|||
49075753|NCT00789035|158110607|FG002|Overall Study|Protocol Violation|0|||
49075754|NCT00789035|158110608|FG003|Overall Study|Protocol Violation|0|||
49075755|NCT00789035|158110609|FG004|Overall Study|Protocol Violation|0|||
49075756|NCT00789035|158110605|FG000|Overall Study|Withdrawal by Subject|0|||
49075757|NCT00789035|158110606|FG001|Overall Study|Withdrawal by Subject|2|||
49075758|NCT00789035|158110607|FG002|Overall Study|Withdrawal by Subject|0|||
49075759|NCT00789035|158110608|FG003|Overall Study|Withdrawal by Subject|0|||
49075760|NCT00789035|158110609|FG004|Overall Study|Withdrawal by Subject|0|||
49075761|NCT00789035|158110605|FG000|Overall Study|Other reason not defined above|2|||
49075762|NCT00789035|158110606|FG001|Overall Study|Other reason not defined above|3|||
49075763|NCT00789035|158110607|FG002|Overall Study|Other reason not defined above|1|||
49075764|NCT00789035|158110608|FG003|Overall Study|Other reason not defined above|0|||
49075765|NCT00789035|158110609|FG004|Overall Study|Other reason not defined above|1|||
49075766|NCT04414618|158110610|FG000|Overall Study|Death|3|||
49075767|NCT04414618|158110611|FG001|Overall Study|Death|3|||
49075768|NCT04414618|158110610|FG000|Overall Study|Withdrawal by Subject|2|||
49075769|NCT04414618|158110611|FG001|Overall Study|Withdrawal by Subject|1|||
49075770|NCT04414618|158110610|FG000|Overall Study|Lost to Follow-up|2|||
49075771|NCT04414618|158110611|FG001|Overall Study|Lost to Follow-up|3|||
49075772|NCT04414618|158110610|FG000|Overall Study|Physician Decision|1|||
49075773|NCT04414618|158110611|FG001|Overall Study|Physician Decision|0|||
49075774|NCT00362336|158110612|FG000|Overall Study|Serious Adverse Event|1|||
49075775|NCT00362336|158110613|FG001|Overall Study|Serious Adverse Event|0|||
49075776|NCT00362336|158110614|FG002|Overall Study|Serious Adverse Event|1|||
49075777|NCT00362336|158110612|FG000|Overall Study|Protocol Violation|0|||
49075778|NCT00362336|158110613|FG001|Overall Study|Protocol Violation|0|||
49075779|NCT00362336|158110614|FG002|Overall Study|Protocol Violation|1|||
49075780|NCT00362336|158110612|FG000|Overall Study|Lost to Follow-up|6|||
49075781|NCT00362336|158110613|FG001|Overall Study|Lost to Follow-up|4|||
49075782|NCT00362336|158110614|FG002|Overall Study|Lost to Follow-up|0|||
49075783|NCT00362336|158110612|FG000|Overall Study|Withdrawal by Subject|3|||
49075784|NCT00362336|158110613|FG001|Overall Study|Withdrawal by Subject|3|||
49075785|NCT00362336|158110614|FG002|Overall Study|Withdrawal by Subject|1|||
49075786|NCT00658879|158110617|FG000|Overall Study|Protocol Violation|1|||
49075787|NCT02640690|158110618|FG000|Overall Study|Lost to Follow-up|7|||
49075788|NCT02640690|158110619|FG001|Overall Study|Lost to Follow-up|7|||
49075789|NCT02640690|158110618|FG000|Overall Study|Withdrawal by Subject|16|||
49075790|NCT02640690|158110619|FG001|Overall Study|Withdrawal by Subject|20|||
49075791|NCT02640690|158110618|FG000|Overall Study|Partial completion (insufficient sessions)|2|||
49075792|NCT02640690|158110619|FG001|Overall Study|Partial completion (insufficient sessions)|5|||
49075793|NCT01118975|158110620|FG000|Overall Study|Adverse Event|0|||
49075794|NCT01118975|158110621|FG001|Overall Study|Adverse Event|1|||
49075795|NCT01645787|158110622|FG000|Washout (2 Weeks)|Adverse Event|1|||
49075796|NCT01645787|158110623|FG001|Washout (2 Weeks)|Adverse Event|0|||
49075797|NCT05320887|158110624|FG000|Overall Study|Lost to Follow-up|0|||
49075798|NCT05320887|158110625|FG001|Overall Study|Lost to Follow-up|3|||
49075799|NCT05320887|158110626|FG002|Overall Study|Lost to Follow-up|0|||
49075800|NCT05320887|158110627|FG003|Overall Study|Lost to Follow-up|0|||
49075801|NCT02289456|158110628|FG000|Induction Period|Death|2|||
49075802|NCT02289456|158110628|FG000|Induction Period|Adverse Event|11|||
49075803|NCT02289456|158110628|FG000|Induction Period|Progressive Disease (PD)|4|||
49075804|NCT02289456|158110628|FG000|Induction Period|Symptomatic Deterioration|4|||
49075805|NCT02289456|158110628|FG000|Induction Period|Withdrawal by Subject|2|||
49075806|NCT02289456|158110628|FG000|Induction Period|Miscellaneous|1|||
49075807|NCT02289456|158110628|FG000|Monotherapy Period|Death|1|||
49075808|NCT02289456|158110628|FG000|Monotherapy Period|Adverse Event|1|||
49075809|NCT02289456|158110628|FG000|Monotherapy Period|Progressive Disease (PD)|8|||
49075810|NCT02289456|158110628|FG000|Monotherapy Period|Symptomatic Deterioration|1|||
49075811|NCT02289456|158110628|FG000|Monotherapy Period|Withdrawal by Subject|2|||
49075812|NCT02289456|158110628|FG000|Monotherapy Period|Study Terminated by Sponsor|2|||
49075813|NCT02289456|158110628|FG000|Monotherapy Period|Miscellaneous|1|||
49075814|NCT02910011|158110631|FG000|Overall Study|Physician Decision|2|||
49075815|NCT02463357|158110632|FG000|Overall Study|Withdrawal by Subject|1|||
49075816|NCT02463357|158110633|FG001|Overall Study|Withdrawal by Subject|0|||
49075817|NCT02463357|158110634|FG002|Overall Study|Withdrawal by Subject|0|||
49075818|NCT02463357|158110635|FG003|Overall Study|Withdrawal by Subject|0|||
49075819|NCT02463357|158110636|FG004|Overall Study|Withdrawal by Subject|0|||
49075820|NCT02463357|158110632|FG000|Overall Study|Withdrawal by Subject|0|||
49075821|NCT02463357|158110633|FG001|Overall Study|Withdrawal by Subject|0|||
49075822|NCT02463357|158110634|FG002|Overall Study|Withdrawal by Subject|0|||
49075823|NCT02463357|158110635|FG003|Overall Study|Withdrawal by Subject|0|||
49075824|NCT02463357|158110636|FG004|Overall Study|Withdrawal by Subject|1|||
49075825|NCT02460679|158110643|FG000|Overall Study|Investigator Decision|1|||
49075826|NCT02460679|158110643|FG000|Overall Study|Withdrawal by Subject|4|||
49075827|NCT02620579|158110644|FG000|Overall Study|Physician Decision|0|||
49075828|NCT02620579|158110645|FG001|Overall Study|Physician Decision|0|||
49075829|NCT02620579|158110646|FG002|Overall Study|Physician Decision|0|||
49075830|NCT02620579|158110647|FG003|Overall Study|Physician Decision|1|||
49075831|NCT02620579|158110644|FG000|Overall Study|Withdrawal by Subject|0|||
49075832|NCT02620579|158110645|FG001|Overall Study|Withdrawal by Subject|1|||
49075833|NCT02620579|158110646|FG002|Overall Study|Withdrawal by Subject|1|||
49075834|NCT02620579|158110647|FG003|Overall Study|Withdrawal by Subject|0|||
49075835|NCT00796107|158110655|FG000|Overall Study|Lack of Efficacy|1|||
49075836|NCT00796107|158110655|FG000|Overall Study|Progressive Disease|5|||
49075837|NCT02676765|158110656|FG000|Overall Study|Lost to Follow-up|0|||
49075838|NCT02676765|158110657|FG001|Overall Study|Lost to Follow-up|1|||
49075839|NCT03340974|158110658|FG000|Completion of Study -Long Term Follow up|Death|8|||
49075840|NCT03340974|158110659|FG001|Completion of Study -Long Term Follow up|Death|5|||
49075841|NCT03340974|158110660|FG002|Completion of Study -Long Term Follow up|Death|5|||
49075842|NCT03340974|158110661|FG003|Completion of Study -Long Term Follow up|Death|7|||
49075843|NCT03340974|158110658|FG000|Completion of Study -Long Term Follow up|Withdrawal by Subject|2|||
49075844|NCT03340974|158110659|FG001|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
49075845|NCT03340974|158110660|FG002|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
49075846|NCT03340974|158110661|FG003|Completion of Study -Long Term Follow up|Withdrawal by Subject|1|||
49075847|NCT03340974|158110658|FG000|Completion of Study -Long Term Follow up|Lost to Follow-up|0|||
49075848|NCT03340974|158110659|FG001|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
49075849|NCT03340974|158110660|FG002|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
49075850|NCT03340974|158110661|FG003|Completion of Study -Long Term Follow up|Lost to Follow-up|2|||
49075851|NCT03340974|158110658|FG000|Completion of Study -Long Term Follow up|Last Know Alive|8|||
49075852|NCT03340974|158110659|FG001|Completion of Study -Long Term Follow up|Last Know Alive|0|||
49075853|NCT03340974|158110660|FG002|Completion of Study -Long Term Follow up|Last Know Alive|0|||
49075854|NCT03340974|158110661|FG003|Completion of Study -Long Term Follow up|Last Know Alive|2|||
49075855|NCT02374346|158110668|FG000|Overall Study|operated or discharged during weekend|48|||
49075856|NCT01137071|158110669|FG000|Overall Study|Disease Progression|11|||
49075857|NCT01137071|158110669|FG000|Overall Study|Withdrawal by Subject|2|||
49075858|NCT01137071|158110669|FG000|Overall Study|Wrongly Included|1|||
49075859|NCT02565511|158110670|FG000|Overall Study|Study terminated by Sponsor|35|||
49075860|NCT02565511|158110671|FG001|Overall Study|Study terminated by Sponsor|22|||
49075861|NCT02565511|158110672|FG002|Overall Study|Study terminated by Sponsor|235|||
49075862|NCT02565511|158110673|FG003|Overall Study|Study terminated by Sponsor|156|||
49075863|NCT02565511|158110670|FG000|Overall Study|Withdrawal by Subject|3|||
49075864|NCT02565511|158110671|FG001|Overall Study|Withdrawal by Subject|0|||
49075865|NCT02565511|158110672|FG002|Overall Study|Withdrawal by Subject|12|||
49075866|NCT02565511|158110673|FG003|Overall Study|Withdrawal by Subject|5|||
49075867|NCT02565511|158110670|FG000|Overall Study|Adverse Event|0|||
49075868|NCT02565511|158110671|FG001|Overall Study|Adverse Event|0|||
49075869|NCT02565511|158110672|FG002|Overall Study|Adverse Event|1|||
49075870|NCT02565511|158110673|FG003|Overall Study|Adverse Event|1|||
49075871|NCT02565511|158110670|FG000|Overall Study|Lost to Follow-up|4|||
49075872|NCT02565511|158110671|FG001|Overall Study|Lost to Follow-up|1|||
49075873|NCT02565511|158110672|FG002|Overall Study|Lost to Follow-up|0|||
49075874|NCT02565511|158110673|FG003|Overall Study|Lost to Follow-up|1|||
49075875|NCT02565511|158110670|FG000|Overall Study|Physician Decision|0|||
49075876|NCT02565511|158110671|FG001|Overall Study|Physician Decision|0|||
49075877|NCT02565511|158110672|FG002|Overall Study|Physician Decision|0|||
49075878|NCT02565511|158110673|FG003|Overall Study|Physician Decision|1|||
49075879|NCT02565511|158110670|FG000|Overall Study|Protocol deviation|0|||
49075880|NCT02565511|158110671|FG001|Overall Study|Protocol deviation|0|||
49075881|NCT02565511|158110672|FG002|Overall Study|Protocol deviation|3|||
49075882|NCT02565511|158110673|FG003|Overall Study|Protocol deviation|0|||
49075883|NCT01941498|158110676|FG000|Overall Study|Relocated out of state|1|||
49075884|NCT04807400|158110677|FG000|Overall Study|Adverse Event|2|||
49075885|NCT04807400|158110678|FG001|Overall Study|Adverse Event|3|||
49075886|NCT04807400|158110679|FG002|Overall Study|Adverse Event|3|||
49075887|NCT04807400|158110677|FG000|Overall Study|Death|2|||
49075888|NCT04807400|158110678|FG001|Overall Study|Death|0|||
49075889|NCT04807400|158110679|FG002|Overall Study|Death|0|||
49075890|NCT04807400|158110677|FG000|Overall Study|Lost to Follow-up|8|||
49075891|NCT04807400|158110678|FG001|Overall Study|Lost to Follow-up|6|||
49075892|NCT04807400|158110679|FG002|Overall Study|Lost to Follow-up|6|||
49075893|NCT04807400|158110677|FG000|Overall Study|Non-Compliance With Study Drug|0|||
49075894|NCT04807400|158110678|FG001|Overall Study|Non-Compliance With Study Drug|4|||
49075895|NCT04807400|158110679|FG002|Overall Study|Non-Compliance With Study Drug|1|||
49075896|NCT04807400|158110677|FG000|Overall Study|Participant Decision|20|||
49075897|NCT04807400|158110678|FG001|Overall Study|Participant Decision|19|||
49075898|NCT04807400|158110679|FG002|Overall Study|Participant Decision|26|||
49075899|NCT04807400|158110677|FG000|Overall Study|Physician Decision|0|||
49075900|NCT04807400|158110678|FG001|Overall Study|Physician Decision|1|||
49075901|NCT04807400|158110679|FG002|Overall Study|Physician Decision|0|||
49075902|NCT04807400|158110677|FG000|Overall Study|Protocol Violation|4|||
49075903|NCT04807400|158110678|FG001|Overall Study|Protocol Violation|3|||
49075904|NCT04807400|158110679|FG002|Overall Study|Protocol Violation|7|||
49075905|NCT04807400|158110677|FG000|Overall Study|Withdrawal by Subject|13|||
49075906|NCT04807400|158110678|FG001|Overall Study|Withdrawal by Subject|9|||
49075907|NCT04807400|158110679|FG002|Overall Study|Withdrawal by Subject|20|||
49075908|NCT04807400|158110677|FG000|Overall Study|Mis-randomized|1|||
49075909|NCT04807400|158110678|FG001|Overall Study|Mis-randomized|0|||
49075910|NCT04807400|158110679|FG002|Overall Study|Mis-randomized|0|||
49075911|NCT04194645|158110682|FG000|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
49075912|NCT04194645|158110683|FG001|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
49075913|NCT04194645|158110684|FG002|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
49075914|NCT04194645|158110685|FG003|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
49075915|NCT04194645|158110686|FG004|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
49075916|NCT04194645|158110687|FG005|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
49075917|NCT04194645|158110688|FG006|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
49075918|NCT04194645|158110689|FG007|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
49075919|NCT04194645|158110690|FG008|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
49075920|NCT04194645|158110691|FG009|Wash-out Period 2 (BA Part Only)|Adverse Event|1|||
49075921|NCT04194645|158110692|FG010|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
49075922|NCT04194645|158110693|FG011|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
49075923|NCT04194645|158110694|FG012|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
49075924|NCT04194645|158110695|FG013|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
49075925|NCT04194645|158110696|FG014|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
49075926|NCT00104572|158110700|FG000|Overall Study|Withdrawal by Subject|3|||
49075927|NCT00104572|158110701|FG001|Overall Study|Withdrawal by Subject|3|||
49075928|NCT00104572|158110702|FG002|Overall Study|Withdrawal by Subject|0|||
49075929|NCT00352417|158110703|FG000|Overall Study|Adverse Event|1|||
49075930|NCT00352417|158110704|FG001|Overall Study|Adverse Event|0|||
49075931|NCT00352417|158110703|FG000|Overall Study|Protocol Violation|0|||
49075932|NCT00352417|158110704|FG001|Overall Study|Protocol Violation|2|||
49075933|NCT00352417|158110703|FG000|Overall Study|Withdrawal by Subject|1|||
49075934|NCT00352417|158110704|FG001|Overall Study|Withdrawal by Subject|2|||
49075935|NCT00352417|158110703|FG000|Overall Study|Lost to Follow-up|1|||
49075936|NCT00352417|158110704|FG001|Overall Study|Lost to Follow-up|0|||
49075937|NCT00352417|158110703|FG000|Overall Study|Schedule Change|2|||
49075938|NCT00352417|158110704|FG001|Overall Study|Schedule Change|1|||
49075939|NCT04700137|158110705|FG000|Overall Study|Lost to Follow-up|1|||
49075940|NCT04700137|158110706|FG001|Overall Study|Lost to Follow-up|6|||
49075941|NCT04700137|158110707|FG002|Overall Study|Lost to Follow-up|1|||
49075942|NCT04700137|158110708|FG003|Overall Study|Lost to Follow-up|1|||
49075943|NCT04700137|158110705|FG000|Overall Study|Withdrawal by Subject|0|||
49075944|NCT04700137|158110706|FG001|Overall Study|Withdrawal by Subject|0|||
49075945|NCT04700137|158110707|FG002|Overall Study|Withdrawal by Subject|1|||
49075946|NCT04700137|158110708|FG003|Overall Study|Withdrawal by Subject|0|||
49075947|NCT04700137|158110705|FG000|Overall Study|Death|0|||
49075948|NCT04700137|158110706|FG001|Overall Study|Death|0|||
49075949|NCT04700137|158110707|FG002|Overall Study|Death|1|||
49075950|NCT04700137|158110708|FG003|Overall Study|Death|0|||
49075951|NCT02503787|158110709|FG000|Enrollment|Withdrawal by Subject|6|||
49075952|NCT02503787|158110709|FG000|Enrollment|Inclusion/exclusion criteria not met|4|||
49075953|NCT02503787|158110709|FG000|Enrollment|Physician Decision|2|||
49075954|NCT02503787|158110709|FG000|Enrollment|Insurance issue|2|||
49075955|NCT02503787|158110709|FG000|Enrollment|Lost to Follow-up|1|||
49075956|NCT02503787|158110709|FG000|Enrollment|Study closure|1|||
49075957|NCT02503787|158110709|FG000|Enrollment|Adverse Event|1|||
49075958|NCT02503787|158110709|FG000|Enrollment|Protocol Violation|1|||
49075959|NCT02503787|158110709|FG000|Enrollment|Inability to implant system|1|||
49075960|NCT02503787|158110709|FG000|Enrollment|Unable to be programmed|1|||
49075961|NCT02503787|158110709|FG000|Device Trial (HD Programming Trial)|Lack of Efficacy|6|||
49075962|NCT02503787|158110709|FG000|Device Trial (HD Programming Trial)|Withdrawal by Subject|1|||
49075963|NCT02503787|158110709|FG000|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3|||
49075964|NCT02503787|158110709|FG000|Successful Trial (≥50% Pain Relief)|Physician Decision|2|||
49075965|NCT02503787|158110709|FG000|Implant to 3 Month Endpoint|Adverse Event|2|||
49075966|NCT02503787|158110709|FG000|Implant to 3 Month Endpoint|Withdrawal by Subject|1|||
49075967|NCT02096744|158110710|FG000|Treatment Period 1(7 Days)|Accidental early removal of the patch|0|||
49075968|NCT02096744|158110711|FG001|Treatment Period 1(7 Days)|Accidental early removal of the patch|1|||
49075969|NCT02096744|158110710|FG000|Treatment Period 1(7 Days)|Non compliance with the site rule|1|||
49075970|NCT02096744|158110711|FG001|Treatment Period 1(7 Days)|Non compliance with the site rule|0|||
49075971|NCT02096744|158110710|FG000|Treatment Period 3 (7 Days)|Withdrawal by Subject|0|||
49075972|NCT02096744|158110711|FG001|Treatment Period 3 (7 Days)|Withdrawal by Subject|1|||
49075973|NCT04646005|158110720|FG000|Overall Study|Adverse Event|1|||
49075974|NCT04646005|158110720|FG000|Overall Study|Progressive Disease|60|||
49075975|NCT04646005|158110720|FG000|Overall Study|Death|19|||
49075976|NCT04646005|158110720|FG000|Overall Study|Withdrawal by Subject|9|||
49075977|NCT04646005|158110720|FG000|Overall Study|Study Ongoing|24|||
49075978|NCT00281957|158110723|FG000|Overall Study|Adverse Event|7|||
49075979|NCT00281957|158110724|FG001|Overall Study|Adverse Event|2|||
49075980|NCT00281957|158110723|FG000|Overall Study|Death|1|||
49075981|NCT00281957|158110724|FG001|Overall Study|Death|0|||
49075982|NCT00281957|158110723|FG000|Overall Study|Progression/relapse|47|||
49075983|NCT00281957|158110724|FG001|Overall Study|Progression/relapse|35|||
49075984|NCT00281957|158110723|FG000|Overall Study|Not protocol specified|8|||
49075985|NCT00281957|158110724|FG001|Overall Study|Not protocol specified|1|||
49075986|NCT00281957|158110723|FG000|Overall Study|Not eligible|1|||
49075987|NCT00281957|158110724|FG001|Overall Study|Not eligible|2|||
49075988|NCT00281957|158110723|FG000|Overall Study|Did not start treatment|3|||
49075989|NCT00281957|158110724|FG001|Overall Study|Did not start treatment|1|||
49075990|NCT00281957|158110723|FG000|Overall Study|Refusal unrelated to adverse events|0|||
49075991|NCT00281957|158110724|FG001|Overall Study|Refusal unrelated to adverse events|1|||
49075992|NCT01876446|158110725|FG000|Overall Study|Death|0|||
49075993|NCT01876446|158110726|FG001|Overall Study|Death|1|||
49075994|NCT01876446|158110725|FG000|Overall Study|Withdrawal by Subject|1|||
49075995|NCT01876446|158110726|FG001|Overall Study|Withdrawal by Subject|2|||
49075996|NCT01876446|158110725|FG000|Overall Study|Physician Decision|1|||
49075997|NCT01876446|158110726|FG001|Overall Study|Physician Decision|3|||
49075998|NCT03736031|158110733|FG000|Overall Study|Death|2|||
49075999|NCT03736031|158110734|FG001|Overall Study|Death|4|||
49076000|NCT03736031|158110733|FG000|Overall Study|Lost to Follow-up|21|||
49076001|NCT03736031|158110734|FG001|Overall Study|Lost to Follow-up|2|||
49076002|NCT03736031|158110733|FG000|Overall Study|Withdrawal by Subject|9|||
49076003|NCT03736031|158110734|FG001|Overall Study|Withdrawal by Subject|0|||
49076004|NCT01808573|158110735|FG000|Overall Study|Death|212|||
49076005|NCT01808573|158110736|FG001|Overall Study|Death|240|||
49076006|NCT01808573|158110735|FG000|Overall Study|Withdrawal by Subject|12|||
49076007|NCT01808573|158110736|FG001|Overall Study|Withdrawal by Subject|10|||
49076008|NCT01808573|158110735|FG000|Overall Study|Lost to Follow-up|3|||
49076009|NCT01808573|158110736|FG001|Overall Study|Lost to Follow-up|0|||
49076010|NCT01808573|158110735|FG000|Overall Study|Discontinuation of study by sponsor|79|||
49076011|NCT01808573|158110736|FG001|Overall Study|Discontinuation of study by sponsor|64|||
49076012|NCT01808573|158110735|FG000|Overall Study|Randomized in Error|1|||
49076013|NCT01808573|158110736|FG001|Overall Study|Randomized in Error|0|||
49076014|NCT00625872|158110739|FG000|Overall Study|Withdrawal by Subject|1|||
49076015|NCT00625872|158110740|FG001|Overall Study|Withdrawal by Subject|0|||
49076016|NCT00625872|158110739|FG000|Overall Study|Does not meet inclusion criteria|1|||
49076017|NCT00625872|158110740|FG001|Overall Study|Does not meet inclusion criteria|0|||
49076018|NCT00625872|158110739|FG000|Overall Study|Terminated by sponsor|2|||
49076019|NCT00625872|158110740|FG001|Overall Study|Terminated by sponsor|5|||
49076020|NCT00625872|158110739|FG000|Overall Study|Randomized but not treated|0|||
49076021|NCT00625872|158110740|FG001|Overall Study|Randomized but not treated|1|||
49076022|NCT01256502|158110743|FG000|Overall Study|Had scaffold removed|4|||
49076023|NCT01256502|158110743|FG000|Overall Study|Personal reasons|5|||
49076024|NCT01256502|158110743|FG000|Overall Study|Protocol deviation|1|||
49076025|NCT02201277|158110744|FG000|Overall Study|Death|3|||
49076026|NCT02201277|158110745|FG001|Overall Study|Death|4|||
49076027|NCT02201277|158110744|FG000|Overall Study|Lost to Follow-up|2|||
49076028|NCT02201277|158110745|FG001|Overall Study|Lost to Follow-up|1|||
49076029|NCT02201277|158110744|FG000|Overall Study|Failed retrieval|1|||
49076030|NCT02201277|158110745|FG001|Overall Study|Failed retrieval|0|||
49076031|NCT02201277|158110744|FG000|Overall Study|Physician Decision|1|||
49076032|NCT02201277|158110745|FG001|Overall Study|Physician Decision|0|||
49076033|NCT03281876|158110750|FG000|Overall Study|Adverse Event|4|||
49076034|NCT03281876|158110751|FG001|Overall Study|Adverse Event|15|||
49076035|NCT03281876|158110750|FG000|Overall Study|Lost to Follow-up|1|||
49076036|NCT03281876|158110751|FG001|Overall Study|Lost to Follow-up|4|||
49076037|NCT03281876|158110750|FG000|Overall Study|Withdrawal by Subject|11|||
49076038|NCT03281876|158110751|FG001|Overall Study|Withdrawal by Subject|15|||
49076039|NCT03281876|158110750|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
49076040|NCT03281876|158110751|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
49076041|NCT03281876|158110750|FG000|Overall Study|OTHER|5|||
49076042|NCT03281876|158110751|FG001|Overall Study|OTHER|5|||
49076043|NCT02208089|158110752|FG000|Overall Study|Withdrawal by Subject|1|||
49076044|NCT02208089|158110753|FG001|Overall Study|Withdrawal by Subject|0|||
49076045|NCT02208089|158110752|FG000|Overall Study|Lost to Follow-up|6|||
49076046|NCT02208089|158110753|FG001|Overall Study|Lost to Follow-up|0|||
49076047|NCT02925403|158112541|FG000|Overall Study|Lost to Follow-up|0|||
49076048|NCT02925403|158112542|FG001|Overall Study|Lost to Follow-up|1|||
49076049|NCT01392963|158112543|FG000|Week 0 (First Intervention)|Lost to Follow-up|0|||
49076050|NCT01392963|158112544|FG001|Week 0 (First Intervention)|Lost to Follow-up|1|||
49076051|NCT01392963|158112543|FG000|Week 0 (First Intervention)|Withdrawal by Subject|0|||
49076052|NCT01392963|158112544|FG001|Week 0 (First Intervention)|Withdrawal by Subject|1|||
49076053|NCT01392963|158112543|FG000|Week 24 Follow-up|Lost to Follow-up|2|||
49076054|NCT01392963|158112544|FG001|Week 24 Follow-up|Lost to Follow-up|0|||
49076055|NCT00805675|158112549|FG000|Overall Study|Adverse Event|0|||
49076056|NCT00805675|158112550|FG001|Overall Study|Adverse Event|0|||
49076057|NCT00805675|158112551|FG002|Overall Study|Adverse Event|1|||
49076058|NCT01957397|158112558|FG000|Test Period 1|sudden leakage/small bag|1|||
49076059|NCT01957397|158112559|FG001|Test Period 1|sudden leakage/small bag|1|||
49076060|NCT01957397|158112558|FG000|Test Period 1|Withdrawal by Subject|1|||
49076061|NCT01957397|158112559|FG001|Test Period 1|Withdrawal by Subject|0|||
49076062|NCT01957397|158112558|FG000|Test Period 2|Adverse Event|0|||
49076063|NCT01957397|158112559|FG001|Test Period 2|Adverse Event|1|||
49076064|NCT01957397|158112558|FG000|Test Period 3|Adverse Event|1|||
49076065|NCT01957397|158112559|FG001|Test Period 3|Adverse Event|2|||
49076066|NCT01957397|158112558|FG000|Test Period 3|the adhesive did not work|1|||
49076067|NCT01957397|158112559|FG001|Test Period 3|the adhesive did not work|0|||
49076068|NCT01371539|158112560|FG000|Period One: One Week|Lost to Follow-up|0|||
49076069|NCT01371539|158112561|FG001|Period One: One Week|Lost to Follow-up|1|||
49076070|NCT01371539|158112560|FG000|Period Two: One Week|Lost to Follow-up|0|||
49076071|NCT01371539|158112561|FG001|Period Two: One Week|Lost to Follow-up|1|||
49076072|NCT01371539|158112560|FG000|Period Two: One Week|Unacceptable Objective Visual Acuity|0|||
49076073|NCT01371539|158112561|FG001|Period Two: One Week|Unacceptable Objective Visual Acuity|1|||
49076074|NCT01371539|158112560|FG000|Period Two: One Week|Time/job conflict|0|||
49076075|NCT01371539|158112561|FG001|Period Two: One Week|Time/job conflict|1|||
49076076|NCT01399658|158112564|FG000|Overall Study|Ineligible|1|||
49076077|NCT01399658|158112564|FG000|Overall Study|Machine Technical Issue|3|||
49076078|NCT01399658|158112564|FG000|Overall Study|Alternative therapy|1|||
49076079|NCT01399658|158112564|FG000|Overall Study|No reason given|1|||
49076080|NCT01625988|158112565|FG000|Overall Study|Lost to Follow-up|5|||
49076081|NCT01625988|158112566|FG001|Overall Study|Lost to Follow-up|6|||
49076082|NCT01625988|158112565|FG000|Overall Study|Withdrawal by Subject|8|||
49076083|NCT01625988|158112566|FG001|Overall Study|Withdrawal by Subject|3|||
49076084|NCT01625988|158112565|FG000|Overall Study|Adverse Event|0|||
49076085|NCT01625988|158112566|FG001|Overall Study|Adverse Event|1|||
49076086|NCT01625988|158112565|FG000|Overall Study|Lack of Efficacy|0|||
49076087|NCT01625988|158112566|FG001|Overall Study|Lack of Efficacy|1|||
49076088|NCT01625988|158112565|FG000|Overall Study|Randomized Inappropriately|1|||
49076089|NCT01625988|158112566|FG001|Overall Study|Randomized Inappropriately|0|||
49076090|NCT01625988|158112565|FG000|Overall Study|Protocol Violation|0|||
49076091|NCT01625988|158112566|FG001|Overall Study|Protocol Violation|2|||
49076092|NCT01121562|158112567|FG000|Overall Study|Objective progression or relapse|8|||
49076093|NCT01121562|158112567|FG000|Overall Study|Withdrawal by Subject|1|||
49076094|NCT01121562|158112567|FG000|Overall Study|Adverse Event|1|||
49076095|NCT01121562|158112567|FG000|Overall Study|Sponsor Decision|1|||
49076096|NCT01121562|158112567|FG000|Overall Study|Met study discontinuation criteria|1|||
49076097|NCT01661062|158112568|FG000|Overall Study|Completed Treatment Off Study|3|||
49076098|NCT01661062|158112568|FG000|Overall Study|Withdrawal by Subject|2|||
49076099|NCT04411914|158112569|FG000|CLAV 500mg/Day for Days 1-3|Adverse Event|1|||
49076100|NCT04411914|158112570|FG001|CLAV 500mg/Day for Days 1-3|Adverse Event|0|||
49076101|NCT00616421|158112574|FG000|Overall Study|Withdrawal by Subject|9|||
49076102|NCT00616421|158112575|FG001|Overall Study|Withdrawal by Subject|11|||
49076103|NCT00616421|158112576|FG002|Overall Study|Withdrawal by Subject|8|||
49076104|NCT00616421|158112574|FG000|Overall Study|Lost to Follow-up|12|||
49076105|NCT00616421|158112575|FG001|Overall Study|Lost to Follow-up|26|||
49076106|NCT00616421|158112576|FG002|Overall Study|Lost to Follow-up|30|||
49076107|NCT00616421|158112574|FG000|Overall Study|Inappropriate enrollment|3|||
49076108|NCT00616421|158112575|FG001|Overall Study|Inappropriate enrollment|0|||
49076109|NCT00616421|158112576|FG002|Overall Study|Inappropriate enrollment|1|||
49076110|NCT00616421|158112574|FG000|Overall Study|Administrative reason|1|||
49076111|NCT00616421|158112575|FG001|Overall Study|Administrative reason|0|||
49076112|NCT00616421|158112576|FG002|Overall Study|Administrative reason|0|||
49076113|NCT00616421|158112574|FG000|Overall Study|Protocol Violation|0|||
49076114|NCT00616421|158112575|FG001|Overall Study|Protocol Violation|1|||
49076115|NCT00616421|158112576|FG002|Overall Study|Protocol Violation|2|||
49076116|NCT00616421|158112574|FG000|Overall Study|Unable to classify|1|||
49076117|NCT00616421|158112575|FG001|Overall Study|Unable to classify|0|||
49076118|NCT00616421|158112576|FG002|Overall Study|Unable to classify|0|||
49076119|NCT01495702|158112577|FG000|Randomized Phase|Randomized But Not Treated|1|||
49076120|NCT01495702|158112578|FG001|Randomized Phase|Randomized But Not Treated|4|||
49076121|NCT01495702|158112577|FG000|Randomized Phase|Adverse Event|2|||
49076122|NCT01495702|158112578|FG001|Randomized Phase|Adverse Event|2|||
49076123|NCT01495702|158112577|FG000|Randomized Phase|Death|1|||
49076124|NCT01495702|158112578|FG001|Randomized Phase|Death|0|||
49076125|NCT01495702|158112577|FG000|Randomized Phase|Lack of Efficacy|2|||
49076126|NCT01495702|158112578|FG001|Randomized Phase|Lack of Efficacy|0|||
49076127|NCT01495702|158112577|FG000|Randomized Phase|Investigators Discretion|2|||
49076128|NCT01495702|158112578|FG001|Randomized Phase|Investigators Discretion|0|||
49076129|NCT01495702|158112577|FG000|Randomized Phase|Withdrew Consent|10|||
49076130|NCT01495702|158112578|FG001|Randomized Phase|Withdrew Consent|18|||
49076131|NCT01495702|158112577|FG000|Randomized Phase|Lost to Follow-up|4|||
49076132|NCT01495702|158112578|FG001|Randomized Phase|Lost to Follow-up|3|||
49076133|NCT01495702|158112577|FG000|Randomized Phase|Participant Noncompliance|1|||
49076134|NCT01495702|158112578|FG001|Randomized Phase|Participant Noncompliance|0|||
49076135|NCT01495702|158112577|FG000|Randomized Phase|Protocol Violation|3|||
49076136|NCT01495702|158112578|FG001|Randomized Phase|Protocol Violation|1|||
49076137|NCT04005352|158112579|FG000|Overall Study|Adverse Event|4|||
49076138|NCT04005352|158112580|FG001|Overall Study|Adverse Event|5|||
49076139|NCT04005352|158112579|FG000|Overall Study|Death|4|||
49076140|NCT04005352|158112580|FG001|Overall Study|Death|2|||
49076141|NCT04005352|158112579|FG000|Overall Study|Lost to Follow-up|6|||
49076142|NCT04005352|158112580|FG001|Overall Study|Lost to Follow-up|2|||
49076143|NCT04005352|158112579|FG000|Overall Study|Physician Decision|7|||
49076144|NCT04005352|158112580|FG001|Overall Study|Physician Decision|13|||
49076145|NCT04005352|158112579|FG000|Overall Study|Protocol Violation|0|||
49076146|NCT04005352|158112580|FG001|Overall Study|Protocol Violation|1|||
49076147|NCT04005352|158112579|FG000|Overall Study|Withdrawal by Subject|28|||
49076148|NCT04005352|158112580|FG001|Overall Study|Withdrawal by Subject|38|||
49076149|NCT04315506|158112581|FG000|Overall Study|Lost to Follow-up|74|||
49076150|NCT04315506|158112582|FG001|Overall Study|Lost to Follow-up|82|||
49076151|NCT04315506|158112581|FG000|Overall Study|Withdrawal by Subject|8|||
49076152|NCT04315506|158112582|FG001|Overall Study|Withdrawal by Subject|8|||
49076153|NCT04315506|158112581|FG000|Overall Study|Physician Decision|0|||
49076154|NCT04315506|158112582|FG001|Overall Study|Physician Decision|1|||
49076155|NCT01346293|158112594|FG000|Overall Study|Protocol Violation|30|||
49076156|NCT01346293|158112595|FG001|Overall Study|Protocol Violation|9|||
49076157|NCT01346293|158112594|FG000|Overall Study|Lost to Follow-up|21|||
49076158|NCT01346293|158112595|FG001|Overall Study|Lost to Follow-up|8|||
49076159|NCT01346293|158112594|FG000|Overall Study|Withdrawal by Subject|15|||
49076160|NCT01346293|158112595|FG001|Overall Study|Withdrawal by Subject|4|||
49076161|NCT01346293|158112594|FG000|Overall Study|Other|1|||
49076162|NCT01346293|158112595|FG001|Overall Study|Other|0|||
49076163|NCT00958893|158112603|FG000|Overall Study|Study prematurely terminated|4|||
49076164|NCT03656744|158112604|FG000|Overall Study|Adverse Event|1|||
49076165|NCT03656744|158112605|FG001|Overall Study|Adverse Event|4|||
49076166|NCT03656744|158112606|FG002|Overall Study|Adverse Event|1|||
49076167|NCT03656744|158112604|FG000|Overall Study|Protocol Violation|1|||
49076168|NCT03656744|158112605|FG001|Overall Study|Protocol Violation|0|||
49076169|NCT03656744|158112606|FG002|Overall Study|Protocol Violation|0|||
49076170|NCT03656744|158112604|FG000|Overall Study|Lost to Follow-up|2|||
49076171|NCT03656744|158112605|FG001|Overall Study|Lost to Follow-up|2|||
49076172|NCT03656744|158112606|FG002|Overall Study|Lost to Follow-up|0|||
49076173|NCT03656744|158112604|FG000|Overall Study|Withdrawal by Subject|0|||
49076174|NCT03656744|158112605|FG001|Overall Study|Withdrawal by Subject|1|||
49076175|NCT03656744|158112606|FG002|Overall Study|Withdrawal by Subject|0|||
49076176|NCT03656744|158112604|FG000|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|1|||
49076177|NCT03656744|158112605|FG001|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
49076178|NCT03656744|158112606|FG002|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
49076179|NCT03076775|158112607|FG000|Overall Study|Lost to Follow-up|1|||
49076180|NCT03076775|158112608|FG001|Overall Study|Lost to Follow-up|0|||
49076181|NCT01783886|158112614|FG000|Overall Study|Lost to Follow-up|0|||
49076182|NCT01783886|158112615|FG001|Overall Study|Lost to Follow-up|3|||
49076183|NCT01783886|158112616|FG002|Overall Study|Lost to Follow-up|0|||
49076184|NCT01783886|158112614|FG000|Overall Study|Protocol deviation|0|||
49076185|NCT01783886|158112615|FG001|Overall Study|Protocol deviation|0|||
49076186|NCT01783886|158112616|FG002|Overall Study|Protocol deviation|2|||
49076187|NCT01783886|158112614|FG000|Overall Study|Withdrawal of consent by participant|1|||
49076188|NCT01783886|158112615|FG001|Overall Study|Withdrawal of consent by participant|3|||
49076189|NCT01783886|158112616|FG002|Overall Study|Withdrawal of consent by participant|4|||
49076190|NCT01783886|158112614|FG000|Overall Study|Adverse Event|4|||
49076191|NCT01783886|158112615|FG001|Overall Study|Adverse Event|5|||
49076192|NCT01783886|158112616|FG002|Overall Study|Adverse Event|4|||
49076193|NCT04542057|158112619|FG000|Overall Study|Death|3|||
49076194|NCT04542057|158112620|FG001|Overall Study|Death|1|||
49076195|NCT04542057|158112619|FG000|Overall Study|COPD exacerbation withdrawal criteria|5|||
49076196|NCT04542057|158112620|FG001|Overall Study|COPD exacerbation withdrawal criteria|6|||
49076197|NCT04542057|158112619|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|10|||
49076198|NCT04542057|158112620|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
49076199|NCT04542057|158112619|FG000|Overall Study|Adverse Event|15|||
49076200|NCT04542057|158112620|FG001|Overall Study|Adverse Event|6|||
49076201|NCT04542057|158112619|FG000|Overall Study|COVID-19 adverse event|6|||
49076202|NCT04542057|158112620|FG001|Overall Study|COVID-19 adverse event|4|||
49076203|NCT04542057|158112619|FG000|Overall Study|Lack of Efficacy|2|||
49076204|NCT04542057|158112620|FG001|Overall Study|Lack of Efficacy|5|||
49076205|NCT04542057|158112619|FG000|Overall Study|Study terminated by sponsor|1|||
49076206|NCT04542057|158112620|FG001|Overall Study|Study terminated by sponsor|0|||
49076207|NCT04542057|158112619|FG000|Overall Study|Investigator discretion|2|||
49076208|NCT04542057|158112620|FG001|Overall Study|Investigator discretion|1|||
49076209|NCT04542057|158112619|FG000|Overall Study|Withdrawal by Subject|52|||
49076210|NCT04542057|158112620|FG001|Overall Study|Withdrawal by Subject|30|||
49076211|NCT04542057|158112619|FG000|Overall Study|Lost to Follow-up|8|||
49076212|NCT04542057|158112620|FG001|Overall Study|Lost to Follow-up|11|||
49076213|NCT04542057|158112619|FG000|Overall Study|Other|2|||
49076214|NCT04542057|158112620|FG001|Overall Study|Other|2|||
49076215|NCT01332292|158112621|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
49076216|NCT01332292|158112622|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
49076217|NCT01332292|158112621|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
49076218|NCT01332292|158112622|FG001|Treatment Period 1 (14 Days)|Protocol Violation|1|||
49076219|NCT01332292|158112621|FG000|Treatment Period 2 (14 Days)|Physician Decision|1|||
49076220|NCT01332292|158112622|FG001|Treatment Period 2 (14 Days)|Physician Decision|1|||
49076221|NCT00396565|158112623|FG000|Overall Study|Physician Decision|3|||
49076222|NCT00396565|158112624|FG001|Overall Study|Physician Decision|1|||
49076223|NCT00396565|158112625|FG002|Overall Study|Physician Decision|2|||
49076224|NCT00396565|158112623|FG000|Overall Study|Adverse Event|5|||
49076225|NCT00396565|158112624|FG001|Overall Study|Adverse Event|13|||
49076226|NCT00396565|158112625|FG002|Overall Study|Adverse Event|3|||
49076227|NCT00396565|158112623|FG000|Overall Study|Withdrawal by Subject|8|||
49076228|NCT00396565|158112624|FG001|Overall Study|Withdrawal by Subject|13|||
49076229|NCT00396565|158112625|FG002|Overall Study|Withdrawal by Subject|1|||
49076230|NCT00396565|158112623|FG000|Overall Study|Lack of Efficacy|32|||
49076231|NCT00396565|158112624|FG001|Overall Study|Lack of Efficacy|64|||
49076232|NCT00396565|158112625|FG002|Overall Study|Lack of Efficacy|11|||
49076233|NCT00796757|158112634|FG000|Overall Study|Withdrawal by Subject|14|||
49076234|NCT00796757|158112634|FG000|Overall Study|Death|61|||
49076235|NCT00796757|158112634|FG000|Overall Study|Protocol Violation|1|||
49076236|NCT00796757|158112634|FG000|Overall Study|Participant noncompliance|1|||
49076237|NCT00796757|158112634|FG000|Overall Study|Investigator's decision|2|||
49076238|NCT00796757|158112634|FG000|Overall Study|Other|7|||
49076239|NCT04388553|158112637|FG000|Overall Study|Protocol Violation|1|||
49076240|NCT04388553|158112638|FG001|Overall Study|Protocol Violation|0|||
49076241|NCT00805467|158112639|FG000|Overall Study|Lack of Efficacy|0|||
49076242|NCT00805467|158112640|FG001|Overall Study|Lack of Efficacy|8|||
49076243|NCT00805467|158112641|FG002|Overall Study|Lack of Efficacy|13|||
49076244|NCT00805467|158112642|FG003|Overall Study|Lack of Efficacy|86|||
49076245|NCT00805467|158112639|FG000|Overall Study|Lost to Follow-up|0|||
49076246|NCT00805467|158112640|FG001|Overall Study|Lost to Follow-up|1|||
49076247|NCT00805467|158112641|FG002|Overall Study|Lost to Follow-up|7|||
49076248|NCT00805467|158112642|FG003|Overall Study|Lost to Follow-up|21|||
49076249|NCT00805467|158112639|FG000|Overall Study|Withdrawal by Subject|0|||
49076250|NCT00805467|158112640|FG001|Overall Study|Withdrawal by Subject|6|||
49076251|NCT00805467|158112641|FG002|Overall Study|Withdrawal by Subject|45|||
49076252|NCT00805467|158112642|FG003|Overall Study|Withdrawal by Subject|50|||
49076253|NCT00805467|158112639|FG000|Overall Study|Protocol Violation|0|||
49076254|NCT00805467|158112640|FG001|Overall Study|Protocol Violation|3|||
49076255|NCT00805467|158112641|FG002|Overall Study|Protocol Violation|0|||
49076256|NCT00805467|158112642|FG003|Overall Study|Protocol Violation|5|||
49076257|NCT00805467|158112639|FG000|Overall Study|Adverse Event|0|||
49076258|NCT00805467|158112640|FG001|Overall Study|Adverse Event|13|||
49076259|NCT00805467|158112641|FG002|Overall Study|Adverse Event|26|||
49076260|NCT00805467|158112642|FG003|Overall Study|Adverse Event|57|||
49076261|NCT00805467|158112639|FG000|Overall Study|Death|0|||
49076262|NCT00805467|158112640|FG001|Overall Study|Death|2|||
49076263|NCT00805467|158112641|FG002|Overall Study|Death|7|||
49076264|NCT00805467|158112642|FG003|Overall Study|Death|5|||
49076265|NCT00805467|158112639|FG000|Overall Study|Physician Decision|0|||
49076266|NCT00805467|158112640|FG001|Overall Study|Physician Decision|1|||
49076267|NCT00805467|158112641|FG002|Overall Study|Physician Decision|2|||
49076268|NCT00805467|158112642|FG003|Overall Study|Physician Decision|6|||
49076269|NCT00805467|158112639|FG000|Overall Study|Not reported|0|||
49076270|NCT00805467|158112640|FG001|Overall Study|Not reported|0|||
49076271|NCT00805467|158112641|FG002|Overall Study|Not reported|3|||
49076272|NCT00805467|158112642|FG003|Overall Study|Not reported|7|||
49076273|NCT02443740|158112643|FG000|Intervention Period 1 (3 Days)|Adverse Event|0|||
49076274|NCT02443740|158112644|FG001|Intervention Period 1 (3 Days)|Adverse Event|0|||
49076275|NCT02443740|158112645|FG002|Intervention Period 1 (3 Days)|Adverse Event|0|||
49076276|NCT02443740|158112646|FG003|Intervention Period 1 (3 Days)|Adverse Event|0|||
49076277|NCT02443740|158112647|FG004|Intervention Period 1 (3 Days)|Adverse Event|0|||
49076278|NCT02443740|158112648|FG005|Intervention Period 1 (3 Days)|Adverse Event|1|||
49076279|NCT02443740|158112649|FG006|Intervention Period 1 (3 Days)|Adverse Event|0|||
49076280|NCT02443740|158112650|FG007|Intervention Period 1 (3 Days)|Adverse Event|0|||
49076281|NCT02443740|158112651|FG008|Intervention Period 1 (3 Days)|Adverse Event|0|||
49076282|NCT02443740|158112652|FG009|Intervention Period 1 (3 Days)|Adverse Event|0|||
49076283|NCT02443740|158112653|FG010|Intervention Period 1 (3 Days)|Adverse Event|0|||
49076284|NCT02443740|158112643|FG000|Intervention Period 1 (3 Days)|Protocol Violation|1|||
49076285|NCT02443740|158112644|FG001|Intervention Period 1 (3 Days)|Protocol Violation|0|||
49076286|NCT02443740|158112645|FG002|Intervention Period 1 (3 Days)|Protocol Violation|0|||
49076287|NCT02443740|158112646|FG003|Intervention Period 1 (3 Days)|Protocol Violation|0|||
49076288|NCT02443740|158112647|FG004|Intervention Period 1 (3 Days)|Protocol Violation|0|||
49076289|NCT02443740|158112648|FG005|Intervention Period 1 (3 Days)|Protocol Violation|0|||
49076290|NCT02443740|158112649|FG006|Intervention Period 1 (3 Days)|Protocol Violation|1|||
49076291|NCT02443740|158112650|FG007|Intervention Period 1 (3 Days)|Protocol Violation|0|||
49076292|NCT02443740|158112651|FG008|Intervention Period 1 (3 Days)|Protocol Violation|0|||
49076293|NCT02443740|158112652|FG009|Intervention Period 1 (3 Days)|Protocol Violation|0|||
49076294|NCT02443740|158112653|FG010|Intervention Period 1 (3 Days)|Protocol Violation|0|||
49076295|NCT02443740|158112643|FG000|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
49076296|NCT02443740|158112644|FG001|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
49076297|NCT02443740|158112645|FG002|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
49076298|NCT02443740|158112646|FG003|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
49076299|NCT02443740|158112647|FG004|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
49076300|NCT02443740|158112648|FG005|Intervention Period 1 (3 Days)|Withdrawal by Subject|1|||
49076301|NCT02443740|158112649|FG006|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
49076302|NCT02443740|158112650|FG007|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
49076303|NCT02443740|158112651|FG008|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
49076304|NCT02443740|158112652|FG009|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
49076305|NCT02443740|158112653|FG010|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
49076306|NCT04502212|158112654|FG000|Overall Study|Unevaluable data; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
49076307|NCT04502212|158112654|FG000|Overall Study|Clamp protocol deviation; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
49076308|NCT00489255|158112655|FG000|Screening and Initial Randomization|Discontinued prior to taking study drug|9|||
49076309|NCT00489255|158112656|FG001|Screening and Initial Randomization|Discontinued prior to taking study drug|3|||
49076310|NCT00489255|158112655|FG000|Period 1: Days 1 to 28|Adverse Event|21|||
49076311|NCT00489255|158112656|FG001|Period 1: Days 1 to 28|Adverse Event|8|||
49076312|NCT00489255|158112655|FG000|Period 1: Days 1 to 28|Withdrawal by Subject|5|||
49076313|NCT00489255|158112656|FG001|Period 1: Days 1 to 28|Withdrawal by Subject|0|||
49076314|NCT00489255|158112655|FG000|Period 1: Days 1 to 28|Physician Decision|1|||
49076315|NCT00489255|158112656|FG001|Period 1: Days 1 to 28|Physician Decision|4|||
49076316|NCT00489255|158112655|FG000|Period 1: Days 1 to 28|Noncompliance|2|||
49076317|NCT00489255|158112656|FG001|Period 1: Days 1 to 28|Noncompliance|0|||
49076318|NCT00489255|158112655|FG000|Period 2: Days 29 to 56|Adverse Event|3|||
49076319|NCT00489255|158112656|FG001|Period 2: Days 29 to 56|Adverse Event|1|||
49076320|NCT00489255|158112655|FG000|Period 2: Days 29 to 56|Withdrawal by Subject|0|||
49076321|NCT00489255|158112656|FG001|Period 2: Days 29 to 56|Withdrawal by Subject|3|||
49076322|NCT00489255|158112655|FG000|Period 3: Days 57 to 84|Adverse Event|3|||
49076323|NCT00489255|158112656|FG001|Period 3: Days 57 to 84|Adverse Event|3|||
49076324|NCT00489255|158112655|FG000|Period 3: Days 57 to 84|Withdrawal by Subject|1|||
49076325|NCT00489255|158112656|FG001|Period 3: Days 57 to 84|Withdrawal by Subject|0|||
49076326|NCT00489255|158112655|FG000|Period 3: Days 57 to 84|Lost to Follow-up|0|||
49076327|NCT00489255|158112656|FG001|Period 3: Days 57 to 84|Lost to Follow-up|1|||
49076328|NCT03953612|158112657|FG000|Overall Study|Randomized but did not start|1|||
49076329|NCT03953612|158112658|FG001|Overall Study|Randomized but did not start|1|||
49076330|NCT03953612|158112659|FG002|Overall Study|Randomized but did not start|1|||
49076331|NCT03953612|158112657|FG000|Overall Study|Withdrawal by Subject|2|||
49076332|NCT03953612|158112658|FG001|Overall Study|Withdrawal by Subject|1|||
49076333|NCT03953612|158112659|FG002|Overall Study|Withdrawal by Subject|0|||
49076334|NCT03485352|158112660|FG000|Overall Study|Lost to Follow-up|9|||
49076335|NCT00456300|158112661|FG000|Overall Study|Adverse Event|1|||
49076336|NCT00456300|158112662|FG001|Overall Study|Adverse Event|0|||
49076337|NCT01478373|158112665|FG000|Treatment Phase|Protocol Violation|1|||
49076338|NCT01478373|158112665|FG000|Survival Phase|Adverse Event|8|||
49076339|NCT01478373|158112665|FG000|Survival Phase|Protocol Violation|1|||
49076340|NCT01478373|158112665|FG000|Survival Phase|crossover to another study|2|||
49076341|NCT01478373|158112665|FG000|Survival Phase|Progressive Disease|27|||
49076342|NCT02452476|158112666|FG000|Overall Study|Death|4|||
49076343|NCT02452476|158112667|FG001|Overall Study|Death|7|||
49076344|NCT02452476|158112666|FG000|Overall Study|Lost to Follow-up|1|||
49076345|NCT02452476|158112667|FG001|Overall Study|Lost to Follow-up|1|||
49076346|NCT02452476|158112666|FG000|Overall Study|Physician Decision|1|||
49076347|NCT02452476|158112667|FG001|Overall Study|Physician Decision|1|||
49076348|NCT02452476|158112666|FG000|Overall Study|Not treated|5|||
49076349|NCT02452476|158112667|FG001|Overall Study|Not treated|1|||
49076350|NCT01964976|158112668|FG000|Overall Study|Protocol Violation|31|||
49076351|NCT01512160|158112670|FG000|Overall Study|Lost to Follow-up|1|||
49076352|NCT01512160|158112671|FG001|Overall Study|Lost to Follow-up|0|||
49076353|NCT01512160|158112672|FG002|Overall Study|Lost to Follow-up|0|||
49076354|NCT01512160|158112673|FG003|Overall Study|Lost to Follow-up|0|||
49076355|NCT01512160|158112670|FG000|Overall Study|Withdrawal by Subject|1|||
49076356|NCT01512160|158112671|FG001|Overall Study|Withdrawal by Subject|0|||
49076357|NCT01512160|158112672|FG002|Overall Study|Withdrawal by Subject|0|||
49076358|NCT01512160|158112673|FG003|Overall Study|Withdrawal by Subject|1|||
49076359|NCT02905032|158112693|FG000|Overall Study|Withdrawal by Subject|2|||
49076360|NCT02905032|158112694|FG001|Overall Study|Withdrawal by Subject|0|||
49076361|NCT02905032|158112695|FG002|Overall Study|Withdrawal by Subject|0|||
49076362|NCT02905032|158112693|FG000|Overall Study|Protocol Violation|6|||
49076363|NCT02905032|158112694|FG001|Overall Study|Protocol Violation|12|||
49076364|NCT02905032|158112695|FG002|Overall Study|Protocol Violation|0|||
49076365|NCT00141778|158112696|FG000|Randomization Prior to Study Med|Withdrawal by Subject|5|||
49076366|NCT00141778|158112697|FG001|Randomization Prior to Study Med|Withdrawal by Subject|2|||
49076367|NCT00141778|158112698|FG002|Randomization Prior to Study Med|Withdrawal by Subject|6|||
49076368|NCT00141778|158112696|FG000|Started Study Medication|Met safety criteria for discontinuation|2|||
49076369|NCT00141778|158112697|FG001|Started Study Medication|Met safety criteria for discontinuation|4|||
49076370|NCT00141778|158112698|FG002|Started Study Medication|Met safety criteria for discontinuation|3|||
49076371|NCT00141778|158112696|FG000|Started Study Medication|Withdrawal by Subject|0|||
49076372|NCT00141778|158112697|FG001|Started Study Medication|Withdrawal by Subject|2|||
49076373|NCT00141778|158112698|FG002|Started Study Medication|Withdrawal by Subject|0|||
49076374|NCT00141778|158112696|FG000|Started Study Medication|Difficulty Swallowing|0|||
49076375|NCT00141778|158112697|FG001|Started Study Medication|Difficulty Swallowing|1|||
49076376|NCT00141778|158112698|FG002|Started Study Medication|Difficulty Swallowing|0|||
49076377|NCT00141778|158112696|FG000|Started Study Medication|Chest Discomfort|0|||
49076378|NCT00141778|158112697|FG001|Started Study Medication|Chest Discomfort|0|||
49076379|NCT00141778|158112698|FG002|Started Study Medication|Chest Discomfort|1|||
49076380|NCT00451178|158112699|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
49076381|NCT00451178|158112700|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
49076382|NCT00451178|158112699|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4|||
49076383|NCT00451178|158112700|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3|||
49076384|NCT00451178|158112699|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2|||
49076385|NCT00451178|158112700|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1|||
49076386|NCT00451178|158112699|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1|||
49076387|NCT00451178|158112700|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2|||
49076388|NCT00451178|158112699|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Death|4|||
49076389|NCT00451178|158112700|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Death|3|||
49076390|NCT00451178|158112699|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1|||
49076391|NCT00451178|158112700|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2|||
49076392|NCT00451178|158112699|FG000|Prior to Maintenance Therapy|Physician Decision|2|||
49076393|NCT00451178|158112700|FG001|Prior to Maintenance Therapy|Physician Decision|0|||
49076394|NCT00451178|158112699|FG000|Prior to Maintenance Therapy|PD|2|||
49076395|NCT00451178|158112700|FG001|Prior to Maintenance Therapy|PD|0|||
49076396|NCT00451178|158112699|FG000|Maintenance Therapy (up to 3 Years)|Adverse Event|4|||
49076397|NCT00451178|158112700|FG001|Maintenance Therapy (up to 3 Years)|Adverse Event|0|||
49076398|NCT00451178|158112699|FG000|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5|||
49076399|NCT00451178|158112700|FG001|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0|||
49076400|NCT00451178|158112699|FG000|Maintenance Therapy (up to 3 Years)|Physician Decision|1|||
49076401|NCT00451178|158112700|FG001|Maintenance Therapy (up to 3 Years)|Physician Decision|0|||
49076402|NCT00451178|158112699|FG000|Maintenance Therapy (up to 3 Years)|Death|1|||
49076403|NCT00451178|158112700|FG001|Maintenance Therapy (up to 3 Years)|Death|0|||
49076404|NCT00451178|158112699|FG000|Maintenance Therapy (up to 3 Years)|PD|10|||
49076405|NCT00451178|158112700|FG001|Maintenance Therapy (up to 3 Years)|PD|0|||
49076406|NCT00451178|158112699|FG000|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9|||
49076407|NCT00451178|158112700|FG001|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0|||
49076408|NCT00451178|158112699|FG000|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6|||
49076409|NCT00451178|158112700|FG001|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26|||
49076410|NCT00459043|158114858|FG000|Overall Study|Withdrawal by Subject|1|||
49076411|NCT00459043|158114859|FG001|Overall Study|Withdrawal by Subject|0|||
49076412|NCT01570686|158114860|FG000|Overall Study|Abnormal test procedure result(s)|1|||
49076413|NCT01570686|158114861|FG001|Overall Study|Abnormal test procedure result(s)|1|||
49076414|NCT01570686|158114860|FG000|Overall Study|Administrative problems|0|||
49076415|NCT01570686|158114861|FG001|Overall Study|Administrative problems|1|||
49076416|NCT01570686|158114860|FG000|Overall Study|Adverse Event|8|||
49076417|NCT01570686|158114861|FG001|Overall Study|Adverse Event|6|||
49076418|NCT01570686|158114860|FG000|Overall Study|Lost to Follow-up|4|||
49076419|NCT01570686|158114861|FG001|Overall Study|Lost to Follow-up|3|||
49076420|NCT01570686|158114860|FG000|Overall Study|Protocol Deviation|3|||
49076421|NCT01570686|158114861|FG001|Overall Study|Protocol Deviation|0|||
49076422|NCT01570686|158114860|FG000|Overall Study|Withdrawal by Subject|4|||
49076423|NCT01570686|158114861|FG001|Overall Study|Withdrawal by Subject|4|||
49076424|NCT01570686|158114860|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
49076425|NCT01570686|158114861|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
49076426|NCT00369486|158114862|FG000|4-Week Visit|Missed visit|2|||
49076427|NCT00369486|158114863|FG001|4-Week Visit|Missed visit|2|||
49076428|NCT00369486|158114864|FG002|4-Week Visit|Missed visit|0|||
49076429|NCT00369486|158114865|FG003|4-Week Visit|Missed visit|2|||
49076430|NCT00369486|158114866|FG004|4-Week Visit|Missed visit|1|||
49076431|NCT00369486|158114862|FG000|4-Week Visit|Dropped|0|||
49076432|NCT00369486|158114863|FG001|4-Week Visit|Dropped|0|||
49076433|NCT00369486|158114864|FG002|4-Week Visit|Dropped|1|||
49076434|NCT00369486|158114865|FG003|4-Week Visit|Dropped|0|||
49076435|NCT00369486|158114866|FG004|4-Week Visit|Dropped|0|||
49076436|NCT00369486|158114862|FG000|8-Week Visit|Missed visit|0|||
49076437|NCT00369486|158114863|FG001|8-Week Visit|Missed visit|1|||
49076438|NCT00369486|158114864|FG002|8-Week Visit|Missed visit|0|||
49076439|NCT00369486|158114865|FG003|8-Week Visit|Missed visit|0|||
49076440|NCT00369486|158114866|FG004|8-Week Visit|Missed visit|1|||
49076441|NCT00369486|158114862|FG000|8-Week Visit|Dropped|0|||
49076442|NCT00369486|158114863|FG001|8-Week Visit|Dropped|0|||
49076443|NCT00369486|158114864|FG002|8-Week Visit|Dropped|0|||
49076444|NCT00369486|158114865|FG003|8-Week Visit|Dropped|1|||
49076445|NCT00369486|158114866|FG004|8-Week Visit|Dropped|0|||
49076446|NCT00369486|158114862|FG000|17-Week Visit|Missed visit|0|||
49076447|NCT00369486|158114863|FG001|17-Week Visit|Missed visit|0|||
49076448|NCT00369486|158114864|FG002|17-Week Visit|Missed visit|1|||
49076449|NCT00369486|158114865|FG003|17-Week Visit|Missed visit|1|||
49076450|NCT00369486|158114866|FG004|17-Week Visit|Missed visit|1|||
49076451|NCT00369486|158114862|FG000|34-Week Visit|Dropped|0|||
49076452|NCT00369486|158114863|FG001|34-Week Visit|Dropped|1|||
49076453|NCT00369486|158114864|FG002|34-Week Visit|Dropped|1|||
49076454|NCT00369486|158114865|FG003|34-Week Visit|Dropped|3|||
49076455|NCT00369486|158114866|FG004|34-Week Visit|Dropped|3|||
49076456|NCT00402116|158114867|FG000|Overall Study|Jaw infection after surgery-other|1|||
49076457|NCT00402116|158114868|FG001|Overall Study|Jaw infection after surgery-other|0|||
49076458|NCT00402116|158114869|FG002|Overall Study|Jaw infection after surgery-other|0|||
49076459|NCT00402116|158114867|FG000|Overall Study|Withdrawal by Subject|1|||
49076460|NCT00402116|158114868|FG001|Overall Study|Withdrawal by Subject|0|||
49076461|NCT00402116|158114869|FG002|Overall Study|Withdrawal by Subject|5|||
49076462|NCT00402116|158114867|FG000|Overall Study|Treatment completed per protocol|1|||
49076463|NCT00402116|158114868|FG001|Overall Study|Treatment completed per protocol|1|||
49076464|NCT00402116|158114869|FG002|Overall Study|Treatment completed per protocol|2|||
49076465|NCT00402116|158114867|FG000|Overall Study|other complicating disease|0|||
49076466|NCT00402116|158114868|FG001|Overall Study|other complicating disease|0|||
49076467|NCT00402116|158114869|FG002|Overall Study|other complicating disease|2|||
49076468|NCT00402116|158114867|FG000|Overall Study|Disease Progression|0|||
49076469|NCT00402116|158114868|FG001|Overall Study|Disease Progression|4|||
49076470|NCT00402116|158114869|FG002|Overall Study|Disease Progression|38|||
49076471|NCT00402116|158114867|FG000|Overall Study|mistaken thrombocytopenia|0|||
49076472|NCT00402116|158114868|FG001|Overall Study|mistaken thrombocytopenia|0|||
49076473|NCT00402116|158114869|FG002|Overall Study|mistaken thrombocytopenia|1|||
49076474|NCT00402116|158114867|FG000|Overall Study|decline related hyponatremia/tumor|0|||
49076475|NCT00402116|158114868|FG001|Overall Study|decline related hyponatremia/tumor|0|||
49076476|NCT00402116|158114869|FG002|Overall Study|decline related hyponatremia/tumor|1|||
49076477|NCT00402116|158114867|FG000|Overall Study|Adverse Event|0|||
49076478|NCT00402116|158114868|FG001|Overall Study|Adverse Event|1|||
49076479|NCT00402116|158114869|FG002|Overall Study|Adverse Event|6|||
49076480|NCT04003896|158114870|FG000|Overall Study|Withdrawal by Subject|3|||
49076481|NCT04003896|158114870|FG000|Overall Study|Physician Decision|1|||
49076482|NCT00270855|158114871|FG000|Overall Study|Withdrawal by Subject|8|||
49076483|NCT00270855|158114872|FG001|Overall Study|Withdrawal by Subject|8|||
49076484|NCT00754650|158114873|FG000|Overall Study|Disease Progression|2|||
49076485|NCT02899195|158114874|FG000|Concurrent Durvalumab|Adverse Event|4|||
49076486|NCT02899195|158114874|FG000|Concurrent Durvalumab|Physician Decision|1|||
49076487|NCT02899195|158114874|FG000|Concurrent Durvalumab|Withdrawal by Subject|1|||
49076488|NCT02899195|158114874|FG000|Concurrent Durvalumab|Progressive Disease|5|||
49076489|NCT02899195|158114874|FG000|Maintenance Durvalumab|Adverse Event|1|||
49076490|NCT02899195|158114874|FG000|Maintenance Durvalumab|Physician Decision|1|||
49076491|NCT02899195|158114874|FG000|Maintenance Durvalumab|Withdrawal by Subject|1|||
49076492|NCT02899195|158114874|FG000|Maintenance Durvalumab|Progressive Disease|31|||
49076493|NCT04778904|158114879|FG000|Overall Study|Protocol Violation|1|||
49076494|NCT04778904|158114880|FG001|Overall Study|Protocol Violation|0|||
49076495|NCT04778904|158114881|FG002|Overall Study|Protocol Violation|0|||
49076496|NCT04778904|158114882|FG003|Overall Study|Protocol Violation|0|||
49076497|NCT04778904|158114879|FG000|Overall Study|Withdrawal by Subject|0|||
49076498|NCT04778904|158114880|FG001|Overall Study|Withdrawal by Subject|0|||
49076499|NCT04778904|158114881|FG002|Overall Study|Withdrawal by Subject|1|||
49076500|NCT04778904|158114882|FG003|Overall Study|Withdrawal by Subject|0|||
49076501|NCT03156504|158114883|FG000|Overall Study|Withdrawal by Subject|1|||
49076502|NCT00450801|158114890|FG000|Overall Study|Death|1|||
49076503|NCT02861014|158114895|FG000|Primary Analysis|Adverse Event|7|||
49076504|NCT02861014|158114895|FG000|Primary Analysis|Death|1|||
49076505|NCT02861014|158114895|FG000|Primary Analysis|Lack of Efficacy|3|||
49076506|NCT02861014|158114895|FG000|Primary Analysis|Physician Decision|2|||
49076507|NCT02861014|158114895|FG000|Primary Analysis|Pregnancy|4|||
49076508|NCT02861014|158114895|FG000|Primary Analysis|Protocol Violation|2|||
49076509|NCT02861014|158114895|FG000|Primary Analysis|Study Terminated By Sponsor|3|||
49076510|NCT02861014|158114895|FG000|Primary Analysis|Withdrawal by Subject|14|||
49076511|NCT02861014|158114895|FG000|Primary Analysis|Commercial ocrelizumab|3|||
49076512|NCT02861014|158114895|FG000|Safety Follow-up|Adverse Event|1|||
49076513|NCT02861014|158114895|FG000|Safety Follow-up|Pregnancy|1|||
49076514|NCT02861014|158114895|FG000|Safety Follow-up|Withdrawal by Subject|9|||
49076515|NCT02861014|158114895|FG000|Safety Follow-up|Study terminated by sponsor|1|||
49076516|NCT02861014|158114895|FG000|Safety Follow-up|Physician Decision|1|||
49076517|NCT02861014|158114895|FG000|Safety Follow-up|Roll-over to a long term extension study|1|||
49076518|NCT02861014|158114895|FG000|Safety Follow-up|Commercial ocrelizumab|36|||
49076519|NCT01520870|158114897|FG000|Overall Study|Withdrawal by Subject|2|||
49076520|NCT02681510|158114900|FG000|Overall Study|Withdrawal by Subject|1|||
49076521|NCT02681510|158114900|FG000|Overall Study|Lost to Follow-up|9|||
49076522|NCT04152863|158114901|FG000|Overall Study|Death|13|||
49076523|NCT04152863|158114902|FG001|Overall Study|Death|12|||
49076524|NCT04152863|158114903|FG002|Overall Study|Death|7|||
49076525|NCT04152863|158114901|FG000|Overall Study|Physician Decision|1|||
49076526|NCT04152863|158114902|FG001|Overall Study|Physician Decision|1|||
49076527|NCT04152863|158114903|FG002|Overall Study|Physician Decision|1|||
49076528|NCT04152863|158114901|FG000|Overall Study|Participation in Study Terminated by Sponsor|12|||
49076529|NCT04152863|158114902|FG001|Overall Study|Participation in Study Terminated by Sponsor|14|||
49076530|NCT04152863|158114903|FG002|Overall Study|Participation in Study Terminated by Sponsor|18|||
49076531|NCT04152863|158114901|FG000|Overall Study|Withdrawal by Subject|2|||
49076532|NCT04152863|158114902|FG001|Overall Study|Withdrawal by Subject|1|||
49076533|NCT04152863|158114903|FG002|Overall Study|Withdrawal by Subject|3|||
49076534|NCT01644617|158114905|FG000|Overall Study|Withdrawal by Subject|3|||
49076535|NCT01644617|158114906|FG001|Overall Study|Withdrawal by Subject|4|||
49076536|NCT01644617|158114907|FG002|Overall Study|Withdrawal by Subject|1|||
49076537|NCT01644617|158114905|FG000|Overall Study|Lost to Follow-up|0|||
49076538|NCT01644617|158114906|FG001|Overall Study|Lost to Follow-up|1|||
49076539|NCT01644617|158114907|FG002|Overall Study|Lost to Follow-up|0|||
49076540|NCT01644617|158114905|FG000|Overall Study|Adverse Event|3|||
49076541|NCT01644617|158114906|FG001|Overall Study|Adverse Event|0|||
49076542|NCT01644617|158114907|FG002|Overall Study|Adverse Event|6|||
49076543|NCT02661217|158114908|FG000|Overall Study|Physician Decision|12|||
49076544|NCT02661217|158114909|FG001|Overall Study|Physician Decision|15|||
49076545|NCT02661217|158114908|FG000|Overall Study|Lost to Follow-up|1|||
49076546|NCT02661217|158114909|FG001|Overall Study|Lost to Follow-up|4|||
49076547|NCT02661217|158114908|FG000|Overall Study|Protocol Deviation|0|||
49076548|NCT02661217|158114909|FG001|Overall Study|Protocol Deviation|4|||
49076549|NCT02661217|158114908|FG000|Overall Study|Non-compliance with study treatment|5|||
49076550|NCT02661217|158114909|FG001|Overall Study|Non-compliance with study treatment|5|||
49076551|NCT02661217|158114908|FG000|Overall Study|Death|21|||
49076552|NCT02661217|158114909|FG001|Overall Study|Death|15|||
49076553|NCT02661217|158114908|FG000|Overall Study|Adverse Event|10|||
49076554|NCT02661217|158114909|FG001|Overall Study|Adverse Event|8|||
49076555|NCT02661217|158114908|FG000|Overall Study|Withdrawal by Subject|15|||
49076556|NCT02661217|158114909|FG001|Overall Study|Withdrawal by Subject|19|||
49076557|NCT02661217|158114908|FG000|Overall Study|Did not enter follow-up epoch|7|||
49076558|NCT02661217|158114909|FG001|Overall Study|Did not enter follow-up epoch|10|||
49076559|NCT02661217|158114908|FG000|Overall Study|Death - no study drug received|1|||
49076560|NCT02661217|158114909|FG001|Overall Study|Death - no study drug received|2|||
49076561|NCT02661217|158114908|FG000|Overall Study|Mis-randomized (not in treatment epoch)|3|||
49076562|NCT02661217|158114909|FG001|Overall Study|Mis-randomized (not in treatment epoch)|1|||
49076563|NCT02075515|158114915|FG000|Overall Study|Serious Adverse Event|1|||
49076564|NCT02075515|158114916|FG001|Overall Study|Serious Adverse Event|1|||
49076565|NCT02075515|158114917|FG002|Overall Study|Serious Adverse Event|1|||
49076566|NCT02075515|158114915|FG000|Overall Study|Non-Serious Adverse Event|0|||
49076567|NCT02075515|158114916|FG001|Overall Study|Non-Serious Adverse Event|1|||
49076568|NCT02075515|158114917|FG002|Overall Study|Non-Serious Adverse Event|0|||
49076569|NCT02075515|158114915|FG000|Overall Study|Withdrawal by Subject|2|||
49076570|NCT02075515|158114916|FG001|Overall Study|Withdrawal by Subject|0|||
49076571|NCT02075515|158114917|FG002|Overall Study|Withdrawal by Subject|1|||
49076572|NCT02075515|158114915|FG000|Overall Study|Lost to Follow-up|1|||
49076573|NCT02075515|158114916|FG001|Overall Study|Lost to Follow-up|3|||
49076574|NCT02075515|158114917|FG002|Overall Study|Lost to Follow-up|6|||
49076575|NCT00444587|158114918|FG000|Overall Study|Death|2|||
49076576|NCT00444587|158114919|FG001|Overall Study|Death|1|||
49076577|NCT00444587|158114918|FG000|Overall Study|Progression of the disease|73|||
49076578|NCT00444587|158114919|FG001|Overall Study|Progression of the disease|8|||
49076579|NCT00444587|158114918|FG000|Overall Study|Refused treatment/did not cooperate|4|||
49076580|NCT00444587|158114919|FG001|Overall Study|Refused treatment/did not cooperate|1|||
49076581|NCT00444587|158114918|FG000|Overall Study|Investigator decision|3|||
49076582|NCT00444587|158114919|FG001|Overall Study|Investigator decision|0|||
49076583|NCT00444587|158114918|FG000|Overall Study|Protocol Violation|1|||
49076584|NCT00444587|158114919|FG001|Overall Study|Protocol Violation|0|||
49076585|NCT00444587|158114918|FG000|Overall Study|Missing|0|||
49076586|NCT00444587|158114919|FG001|Overall Study|Missing|5|||
49076587|NCT03593395|158114927|FG000|Overall Study|Lost to Follow-up|48|||
49076588|NCT03593395|158114928|FG001|Overall Study|Lost to Follow-up|3|||
49076589|NCT03593395|158114927|FG000|Overall Study|Withdrawal by Subject|5|||
49076590|NCT03593395|158114928|FG001|Overall Study|Withdrawal by Subject|24|||
49076591|NCT03593395|158114927|FG000|Overall Study|Death|2|||
49076592|NCT03593395|158114928|FG001|Overall Study|Death|3|||
49076593|NCT03593395|158114927|FG000|Overall Study|Physician Decision|0|||
49076594|NCT03593395|158114928|FG001|Overall Study|Physician Decision|6|||
49076595|NCT03593395|158114927|FG000|Overall Study|Participant Relocated|19|||
49076596|NCT03593395|158114928|FG001|Overall Study|Participant Relocated|3|||
49076597|NCT03593395|158114927|FG000|Overall Study|No Information|1|||
49076598|NCT03593395|158114928|FG001|Overall Study|No Information|7|||
49076599|NCT03713632|158114929|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
49076600|NCT03713632|158114930|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
49076601|NCT03713632|158114931|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|8|||
49076602|NCT03713632|158114932|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
49076603|NCT03713632|158114933|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
49076604|NCT03713632|158114929|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
49076605|NCT03713632|158114930|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
49076606|NCT03713632|158114931|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
49076607|NCT03713632|158114932|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
49076608|NCT03713632|158114933|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
49076609|NCT03713632|158114929|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
49076610|NCT03713632|158114930|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
49076611|NCT03713632|158114931|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
49076612|NCT03713632|158114932|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
49076613|NCT03713632|158114933|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
49076614|NCT03713632|158114929|FG000|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
49076615|NCT03713632|158114930|FG001|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
49076616|NCT03713632|158114931|FG002|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
49076617|NCT03713632|158114932|FG003|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
49076618|NCT03713632|158114933|FG004|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
49076619|NCT03713632|158114929|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
49076620|NCT03713632|158114930|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
49076621|NCT03713632|158114931|FG002|Treatment Period 1 (Until Week 16)|Technical problems|1|||
49076622|NCT03713632|158114932|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
49076623|NCT03713632|158114933|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
49076624|NCT03713632|158114929|FG000|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
49076625|NCT03713632|158114930|FG001|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
49076626|NCT03713632|158114931|FG002|Treatment Period 1 (Until Week 16)|Pregnancy|1|||
49076627|NCT03713632|158114932|FG003|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
49076628|NCT03713632|158114933|FG004|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
49076629|NCT03713632|158114929|FG000|Treatment Period 1 (Until Week 16)|Misrandomized Subject|1|||
49076630|NCT03713632|158114930|FG001|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
49076631|NCT03713632|158114931|FG002|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
49076632|NCT03713632|158114932|FG003|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
49076633|NCT03713632|158114933|FG004|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
49076634|NCT03713632|158114929|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
49076635|NCT03713632|158114930|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|18|||
49076636|NCT03713632|158114931|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
49076637|NCT03713632|158114932|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
49076638|NCT03713632|158114933|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|12|||
49076639|NCT03713632|158114929|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
49076640|NCT03713632|158114930|FG001|Treatment Period 2 (After Week 16)|Adverse Event|3|||
49076641|NCT03713632|158114931|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
49076642|NCT03713632|158114932|FG003|Treatment Period 2 (After Week 16)|Adverse Event|2|||
49076643|NCT03713632|158114933|FG004|Treatment Period 2 (After Week 16)|Adverse Event|1|||
49076644|NCT03713632|158114929|FG000|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
49076645|NCT03713632|158114930|FG001|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
49076646|NCT03713632|158114931|FG002|Treatment Period 2 (After Week 16)|Lack of Efficacy|0|||
49076647|NCT03713632|158114932|FG003|Treatment Period 2 (After Week 16)|Lack of Efficacy|1|||
49076648|NCT03713632|158114933|FG004|Treatment Period 2 (After Week 16)|Lack of Efficacy|2|||
49076649|NCT03713632|158114929|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
49076650|NCT03713632|158114930|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|8|||
49076651|NCT03713632|158114931|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
49076652|NCT03713632|158114932|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
49076653|NCT03713632|158114933|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
49076654|NCT03713632|158114929|FG000|Treatment Period 2 (After Week 16)|Physician Decision|1|||
49076655|NCT03713632|158114930|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
49076656|NCT03713632|158114931|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
49076657|NCT03713632|158114932|FG003|Treatment Period 2 (After Week 16)|Physician Decision|0|||
49076658|NCT03713632|158114933|FG004|Treatment Period 2 (After Week 16)|Physician Decision|2|||
49076659|NCT03713632|158114929|FG000|Treatment Period 2 (After Week 16)|Technical Problems|1|||
49076660|NCT03713632|158114930|FG001|Treatment Period 2 (After Week 16)|Technical Problems|0|||
49076661|NCT03713632|158114931|FG002|Treatment Period 2 (After Week 16)|Technical Problems|0|||
49076662|NCT03713632|158114932|FG003|Treatment Period 2 (After Week 16)|Technical Problems|0|||
49076663|NCT03713632|158114933|FG004|Treatment Period 2 (After Week 16)|Technical Problems|0|||
49076664|NCT03713632|158114929|FG000|Treatment Period 2 (After Week 16)|Death|0|||
49076665|NCT03713632|158114930|FG001|Treatment Period 2 (After Week 16)|Death|1|||
49076666|NCT03713632|158114931|FG002|Treatment Period 2 (After Week 16)|Death|0|||
49076667|NCT03713632|158114932|FG003|Treatment Period 2 (After Week 16)|Death|0|||
49076668|NCT03713632|158114933|FG004|Treatment Period 2 (After Week 16)|Death|0|||
49076669|NCT03713632|158114929|FG000|Treatment Period 2 (After Week 16)|Pregnancy|0|||
49076670|NCT03713632|158114930|FG001|Treatment Period 2 (After Week 16)|Pregnancy|1|||
49076671|NCT03713632|158114931|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
49076672|NCT03713632|158114932|FG003|Treatment Period 2 (After Week 16)|Pregnancy|0|||
49076673|NCT03713632|158114933|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
49076674|NCT01524978|158114937|FG000|Overall Study|Other|16|||
49076675|NCT01524978|158114938|FG001|Overall Study|Other|2|||
49076676|NCT01524978|158114939|FG002|Overall Study|Other|1|||
49076677|NCT01524978|158114940|FG003|Overall Study|Other|2|||
49076678|NCT01524978|158114941|FG004|Overall Study|Other|1|||
49076679|NCT01524978|158114942|FG005|Overall Study|Other|3|||
49076680|NCT01524978|158114943|FG006|Overall Study|Other|17|||
49076681|NCT01524978|158114944|FG007|Overall Study|Other|1|||
49076682|NCT01524978|158114945|FG008|Overall Study|Other|2|||
49076683|NCT01524978|158114946|FG009|Overall Study|Other|2|||
49076684|NCT01524978|158114947|FG010|Overall Study|Other|5|||
49076685|NCT01524978|158114937|FG000|Overall Study|Withdrawal by Subject|12|||
49076686|NCT01524978|158114938|FG001|Overall Study|Withdrawal by Subject|0|||
49076687|NCT01524978|158114939|FG002|Overall Study|Withdrawal by Subject|1|||
49076688|NCT01524978|158114940|FG003|Overall Study|Withdrawal by Subject|1|||
49076689|NCT01524978|158114941|FG004|Overall Study|Withdrawal by Subject|3|||
49076690|NCT01524978|158114942|FG005|Overall Study|Withdrawal by Subject|1|||
49076691|NCT01524978|158114943|FG006|Overall Study|Withdrawal by Subject|6|||
49076692|NCT01524978|158114944|FG007|Overall Study|Withdrawal by Subject|2|||
49076693|NCT01524978|158114945|FG008|Overall Study|Withdrawal by Subject|4|||
49076694|NCT01524978|158114946|FG009|Overall Study|Withdrawal by Subject|0|||
49076695|NCT01524978|158114947|FG010|Overall Study|Withdrawal by Subject|5|||
49076696|NCT01524978|158114937|FG000|Overall Study|Lost to Follow-up|0|||
49076697|NCT01524978|158114938|FG001|Overall Study|Lost to Follow-up|0|||
49076698|NCT01524978|158114939|FG002|Overall Study|Lost to Follow-up|3|||
49076699|NCT01524978|158114940|FG003|Overall Study|Lost to Follow-up|0|||
49076700|NCT01524978|158114941|FG004|Overall Study|Lost to Follow-up|1|||
49076701|NCT01524978|158114942|FG005|Overall Study|Lost to Follow-up|1|||
49076702|NCT01524978|158114943|FG006|Overall Study|Lost to Follow-up|2|||
49076703|NCT01524978|158114944|FG007|Overall Study|Lost to Follow-up|0|||
49076704|NCT01524978|158114945|FG008|Overall Study|Lost to Follow-up|1|||
49076705|NCT01524978|158114946|FG009|Overall Study|Lost to Follow-up|1|||
49076706|NCT01524978|158114947|FG010|Overall Study|Lost to Follow-up|1|||
49076707|NCT01524978|158114937|FG000|Overall Study|Death|34|||
49076708|NCT01524978|158114938|FG001|Overall Study|Death|2|||
49076709|NCT01524978|158114939|FG002|Overall Study|Death|5|||
49076710|NCT01524978|158114940|FG003|Overall Study|Death|24|||
49076711|NCT01524978|158114941|FG004|Overall Study|Death|4|||
49076712|NCT01524978|158114942|FG005|Overall Study|Death|4|||
49076713|NCT01524978|158114943|FG006|Overall Study|Death|1|||
49076714|NCT01524978|158114944|FG007|Overall Study|Death|9|||
49076715|NCT01524978|158114945|FG008|Overall Study|Death|5|||
49076716|NCT01524978|158114946|FG009|Overall Study|Death|6|||
49076717|NCT01524978|158114947|FG010|Overall Study|Death|17|||
49076718|NCT02806024|158114948|FG000|Overall Study|Night Delivery|1|||
49076719|NCT02806024|158114949|FG001|Overall Study|Night Delivery|1|||
49076720|NCT02806024|158114948|FG000|Overall Study|DVT during antepartum admission|0|||
49076721|NCT02806024|158114949|FG001|Overall Study|DVT during antepartum admission|1|||
49076722|NCT00940316|158114960|FG000|Reached First Response at 8 Weeks|Adverse Event|2|||
49076723|NCT00940316|158114961|FG001|Reached First Response at 8 Weeks|Adverse Event|1|||
49076724|NCT00940316|158114962|FG002|Reached First Response at 8 Weeks|Adverse Event|0|||
49076725|NCT00940316|158114960|FG000|Reached First Response at 8 Weeks|Progressive disease|1|||
49076726|NCT00940316|158114961|FG001|Reached First Response at 8 Weeks|Progressive disease|3|||
49076727|NCT00940316|158114962|FG002|Reached First Response at 8 Weeks|Progressive disease|0|||
49076728|NCT00940316|158114960|FG000|Moved on to be Treated Cycle 5|Adverse Event|2|||
49076729|NCT00940316|158114961|FG001|Moved on to be Treated Cycle 5|Adverse Event|0|||
49076730|NCT00940316|158114962|FG002|Moved on to be Treated Cycle 5|Adverse Event|0|||
49076731|NCT00940316|158114960|FG000|Treated After Cycle 5|Adverse Event|0|||
49076732|NCT00940316|158114961|FG001|Treated After Cycle 5|Adverse Event|0|||
49076733|NCT00940316|158114962|FG002|Treated After Cycle 5|Adverse Event|1|||
49076734|NCT00940316|158114960|FG000|Treated After Cycle 5|Progressive disease|0|||
49076735|NCT00940316|158114961|FG001|Treated After Cycle 5|Progressive disease|1|||
49076736|NCT00940316|158114962|FG002|Treated After Cycle 5|Progressive disease|0|||
49076737|NCT05299528|158114963|FG000|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
49076738|NCT05299528|158114964|FG001|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|4|||
49076739|NCT05299528|158114965|FG002|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
49076740|NCT05299528|158114966|FG003|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
49076741|NCT05299528|158114967|FG004|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
49076742|NCT05299528|158114968|FG005|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
49076743|NCT05299528|158114969|FG006|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
49076744|NCT05299528|158114963|FG000|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
49076745|NCT05299528|158114964|FG001|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
49076746|NCT05299528|158114965|FG002|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
49076747|NCT05299528|158114966|FG003|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
49076748|NCT05299528|158114967|FG004|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
49076749|NCT05299528|158114968|FG005|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|1|||
49076750|NCT05299528|158114969|FG006|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
49076751|NCT05299528|158114963|FG000|Surgeon Follow-up|Lost to Follow-up|0|||
49076752|NCT05299528|158114964|FG001|Surgeon Follow-up|Lost to Follow-up|0|||
49076753|NCT05299528|158114965|FG002|Surgeon Follow-up|Lost to Follow-up|1|||
49076754|NCT05299528|158114966|FG003|Surgeon Follow-up|Lost to Follow-up|0|||
49076755|NCT05299528|158114967|FG004|Surgeon Follow-up|Lost to Follow-up|0|||
49076756|NCT05299528|158114968|FG005|Surgeon Follow-up|Lost to Follow-up|0|||
49076757|NCT05299528|158114969|FG006|Surgeon Follow-up|Lost to Follow-up|0|||
49076758|NCT01107197|158114970|FG000|Overall Study|Death|12|||
49076759|NCT01107197|158114971|FG001|Overall Study|Death|10|||
49076760|NCT01107197|158114970|FG000|Overall Study|Lost to Follow-up|5|||
49076761|NCT01107197|158114971|FG001|Overall Study|Lost to Follow-up|8|||
49005552|NCT01396278|157857784|FG000|Overall Study|Withdraw due to trial termination|2|||
49005553|NCT01396278|157857785|FG001|Overall Study|Withdraw due to trial termination|1|||
49005554|NCT01396278|157857786|FG002|Overall Study|Withdraw due to trial termination|1|||
49005555|NCT01396278|157857787|FG003|Overall Study|Withdraw due to trial termination|0|||
49005556|NCT01396278|157857788|FG004|Overall Study|Withdraw due to trial termination|2|||
49005557|NCT01766310|157857789|FG000|Overall Study|Lost to Follow-up|1|||
49005558|NCT01766310|157857790|FG001|Overall Study|Lost to Follow-up|3|||
49005559|NCT00478673|157857791|FG000|30-Days Post-Procedure|Death|2|||
49005560|NCT00478673|157857791|FG000|30-Days Post-Procedure|Withdrawal by Subject|1|||
49005561|NCT00478673|157857791|FG000|30-Days Post-Procedure|Missed Visit|7|||
49005562|NCT00478673|157857791|FG000|12-Months Post-Procedure|Death|23|||
49005563|NCT00478673|157857791|FG000|12-Months Post-Procedure|Lost to Follow-up|4|||
49005564|NCT00478673|157857791|FG000|12-Months Post-Procedure|Withdrawal by Subject|6|||
49005565|NCT00478673|157857791|FG000|12-Months Post-Procedure|Missed Visit|25|||
49005566|NCT00478673|157857791|FG000|12-Months Post-Procedure|Visit Not Required by Protocol|6|||
49005567|NCT01749033|157857794|FG000|Overall Study|Did not receive allocated intervention|3|||
49005568|NCT01749033|157857795|FG001|Overall Study|Did not receive allocated intervention|3|||
49005569|NCT01749033|157857796|FG002|Overall Study|Did not receive allocated intervention|0|||
49005570|NCT01749033|157857794|FG000|Overall Study|Lost to Follow-up|0|||
49005571|NCT01749033|157857795|FG001|Overall Study|Lost to Follow-up|2|||
49005572|NCT01749033|157857796|FG002|Overall Study|Lost to Follow-up|1|||
49005573|NCT00481871|157857797|FG000|Overall Study|Progressive Disease - pt withdrew|0|||
49005574|NCT00481871|157857798|FG001|Overall Study|Progressive Disease - pt withdrew|0|||
49005575|NCT00481871|157857799|FG002|Overall Study|Progressive Disease - pt withdrew|1|||
49005576|NCT00481871|157857800|FG003|Overall Study|Progressive Disease - pt withdrew|0|||
49005577|NCT00481871|157857801|FG004|Overall Study|Progressive Disease - pt withdrew|0|||
49005578|NCT03091400|157857803|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
49005579|NCT03091400|157857804|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
49005580|NCT02561000|157857805|FG000|Overall Study|Withdrawal by Subject|2|||
49005581|NCT02561000|157857806|FG001|Overall Study|Withdrawal by Subject|3|||
49005582|NCT02561000|157857807|FG002|Overall Study|Withdrawal by Subject|0|||
49005583|NCT02561000|157857805|FG000|Overall Study|Adverse Event|0|||
49005584|NCT02561000|157857806|FG001|Overall Study|Adverse Event|1|||
49005585|NCT02561000|157857807|FG002|Overall Study|Adverse Event|0|||
49005586|NCT03467971|157857808|FG000|Treatment Period 2|Withdrawal by Subject|0|||
49005587|NCT03467971|157857809|FG001|Treatment Period 2|Withdrawal by Subject|1|||
49005588|NCT00291330|157857835|FG000|Overall Study|Adverse Event|47|||
49005589|NCT00291330|157857836|FG001|Overall Study|Adverse Event|40|||
49005590|NCT00291330|157857835|FG000|Overall Study|Protocol Violation|13|||
49005591|NCT00291330|157857836|FG001|Overall Study|Protocol Violation|20|||
49005592|NCT00291330|157857835|FG000|Overall Study|Lost to Follow-up|16|||
49005593|NCT00291330|157857836|FG001|Overall Study|Lost to Follow-up|11|||
49005594|NCT00291330|157857835|FG000|Overall Study|Withdrawal by Subject|22|||
49005595|NCT00291330|157857836|FG001|Overall Study|Withdrawal by Subject|25|||
49005596|NCT00291330|157857835|FG000|Overall Study|Other|3|||
49005597|NCT00291330|157857836|FG001|Overall Study|Other|1|||
49005598|NCT01829295|157857837|FG000|6-12 Months|Did not want to switch antimetabolites|0|||
49005599|NCT01829295|157857838|FG001|6-12 Months|Did not want to switch antimetabolites|0|||
49005600|NCT01829295|157857839|FG002|6-12 Months|Did not want to switch antimetabolites|9|||
49005601|NCT01829295|157857840|FG003|6-12 Months|Did not want to switch antimetabolites|11|||
49005602|NCT01829295|157857837|FG000|6-12 Months|Adverse Event|0|||
49005603|NCT01829295|157857838|FG001|6-12 Months|Adverse Event|0|||
49005604|NCT01829295|157857839|FG002|6-12 Months|Adverse Event|3|||
49005605|NCT01829295|157857840|FG003|6-12 Months|Adverse Event|2|||
49005606|NCT01829295|157857837|FG000|6-12 Months|Lost to Follow-up|2|||
49005607|NCT01829295|157857838|FG001|6-12 Months|Lost to Follow-up|0|||
49005608|NCT01829295|157857839|FG002|6-12 Months|Lost to Follow-up|0|||
49005609|NCT01829295|157857840|FG003|6-12 Months|Lost to Follow-up|0|||
49005610|NCT01829295|157857837|FG000|6-12 Months|Withdrawal by Subject|2|||
49005611|NCT01829295|157857838|FG001|6-12 Months|Withdrawal by Subject|2|||
49005612|NCT01829295|157857839|FG002|6-12 Months|Withdrawal by Subject|0|||
49005613|NCT01829295|157857840|FG003|6-12 Months|Withdrawal by Subject|0|||
49005614|NCT02865538|157857846|FG000|Overall Study|Withdrawal by Subject|0|||
49005615|NCT02865538|157857847|FG001|Overall Study|Withdrawal by Subject|0|||
49005616|NCT02865538|157857848|FG002|Overall Study|Withdrawal by Subject|1|||
49005617|NCT02865538|157857849|FG003|Overall Study|Withdrawal by Subject|0|||
49005618|NCT02865538|157857850|FG004|Overall Study|Withdrawal by Subject|0|||
49005619|NCT02865538|157857846|FG000|Overall Study|Lost to Follow-up|1|||
49005620|NCT02865538|157857847|FG001|Overall Study|Lost to Follow-up|0|||
49005621|NCT02865538|157857848|FG002|Overall Study|Lost to Follow-up|0|||
49005622|NCT02865538|157857849|FG003|Overall Study|Lost to Follow-up|0|||
49005623|NCT02865538|157857850|FG004|Overall Study|Lost to Follow-up|0|||
49005624|NCT00656019|157857851|FG000|Overall Study|Not Eligible|10|||
49005625|NCT00656019|157857852|FG001|Overall Study|Not Eligible|0|||
49005626|NCT00656019|157857853|FG002|Overall Study|Not Eligible|0|||
49005627|NCT00656019|157857854|FG003|Overall Study|Not Eligible|0|||
49005628|NCT00656019|157857851|FG000|Overall Study|Withdrawal by Subject|2|||
49005629|NCT00656019|157857852|FG001|Overall Study|Withdrawal by Subject|0|||
49005630|NCT00656019|157857853|FG002|Overall Study|Withdrawal by Subject|0|||
49005631|NCT00656019|157857854|FG003|Overall Study|Withdrawal by Subject|0|||
49005632|NCT00656019|157857851|FG000|Overall Study|Lost to Follow-up|2|||
49005633|NCT00656019|157857852|FG001|Overall Study|Lost to Follow-up|1|||
49005634|NCT00656019|157857853|FG002|Overall Study|Lost to Follow-up|0|||
49005635|NCT00656019|157857854|FG003|Overall Study|Lost to Follow-up|0|||
49005636|NCT03125915|157857855|FG000|1 Month Follow up|Lost to Follow-up|3|||
49005637|NCT03125915|157857856|FG001|1 Month Follow up|Lost to Follow-up|3|||
49005638|NCT03125915|157857857|FG002|1 Month Follow up|Lost to Follow-up|2|||
49005639|NCT03125915|157857858|FG003|1 Month Follow up|Lost to Follow-up|3|||
49005640|NCT03125915|157857855|FG000|3 Month Follow-up|Lost to Follow-up|6|||
49005641|NCT03125915|157857856|FG001|3 Month Follow-up|Lost to Follow-up|4|||
49005642|NCT03125915|157857857|FG002|3 Month Follow-up|Lost to Follow-up|4|||
49005643|NCT03125915|157857858|FG003|3 Month Follow-up|Lost to Follow-up|2|||
49005644|NCT03125915|157857855|FG000|6 Month Follow-up|Lost to Follow-up|7|||
49005645|NCT03125915|157857856|FG001|6 Month Follow-up|Lost to Follow-up|3|||
49005646|NCT03125915|157857857|FG002|6 Month Follow-up|Lost to Follow-up|6|||
49005647|NCT03125915|157857858|FG003|6 Month Follow-up|Lost to Follow-up|3|||
49005648|NCT02956005|157857859|FG000|Overall Study|Not eligible|1|||
49005649|NCT02956005|157857859|FG000|Overall Study|Withdrawal by Subject|3|||
49005650|NCT02956005|157857859|FG000|Overall Study|Physician Decision|12|||
49005651|NCT01828112|157857860|FG000|Treatment Phase|Adverse Event|7|||
49005652|NCT01828112|157857861|FG001|Treatment Phase|Adverse Event|8|||
49005653|NCT01828112|157857862|FG002|Treatment Phase|Adverse Event|0|||
49005654|NCT01828112|157857860|FG000|Treatment Phase|Death|9|||
49005655|NCT01828112|157857861|FG001|Treatment Phase|Death|5|||
49005656|NCT01828112|157857862|FG002|Treatment Phase|Death|0|||
49005657|NCT01828112|157857860|FG000|Treatment Phase|No longer required treatment|0|||
49005658|NCT01828112|157857861|FG001|Treatment Phase|No longer required treatment|1|||
49005659|NCT01828112|157857862|FG002|Treatment Phase|No longer required treatment|0|||
49005660|NCT01828112|157857860|FG000|Treatment Phase|Physician Decision|6|||
49005661|NCT01828112|157857861|FG001|Treatment Phase|Physician Decision|7|||
49005662|NCT01828112|157857862|FG002|Treatment Phase|Physician Decision|0|||
49005663|NCT01828112|157857860|FG000|Treatment Phase|Pregnancy|1|||
49005664|NCT01828112|157857861|FG001|Treatment Phase|Pregnancy|0|||
49005665|NCT01828112|157857862|FG002|Treatment Phase|Pregnancy|0|||
49005666|NCT01828112|157857860|FG000|Treatment Phase|Progressive disease|79|||
49005667|NCT01828112|157857861|FG001|Treatment Phase|Progressive disease|87|||
49005668|NCT01828112|157857862|FG002|Treatment Phase|Progressive disease|0|||
49005669|NCT01828112|157857860|FG000|Treatment Phase|Study terminated by sponsor|1|||
49005670|NCT01828112|157857861|FG001|Treatment Phase|Study terminated by sponsor|0|||
49005671|NCT01828112|157857862|FG002|Treatment Phase|Study terminated by sponsor|0|||
49005672|NCT01828112|157857860|FG000|Treatment Phase|Subject/guardian decision|12|||
49005673|NCT01828112|157857861|FG001|Treatment Phase|Subject/guardian decision|8|||
49005674|NCT01828112|157857862|FG002|Treatment Phase|Subject/guardian decision|0|||
49005675|NCT01828112|157857860|FG000|Extension Treatment Phase|Adverse Event|0|||
49005676|NCT01828112|157857861|FG001|Extension Treatment Phase|Adverse Event|0|||
49005677|NCT01828112|157857862|FG002|Extension Treatment Phase|Adverse Event|6|||
49005678|NCT01828112|157857860|FG000|Extension Treatment Phase|Death|0|||
49005679|NCT01828112|157857861|FG001|Extension Treatment Phase|Death|0|||
49005680|NCT01828112|157857862|FG002|Extension Treatment Phase|Death|17|||
49005681|NCT01828112|157857860|FG000|Extension Treatment Phase|Physician Decision|0|||
49005682|NCT01828112|157857861|FG001|Extension Treatment Phase|Physician Decision|0|||
49005683|NCT01828112|157857862|FG002|Extension Treatment Phase|Physician Decision|5|||
49005684|NCT01828112|157857860|FG000|Extension Treatment Phase|Progressive disease|0|||
49005685|NCT01828112|157857861|FG001|Extension Treatment Phase|Progressive disease|0|||
49005686|NCT01828112|157857862|FG002|Extension Treatment Phase|Progressive disease|46|||
49005687|NCT01828112|157857860|FG000|Extension Treatment Phase|Study terminated by sponsor|0|||
49005688|NCT01828112|157857861|FG001|Extension Treatment Phase|Study terminated by sponsor|0|||
49005689|NCT01828112|157857862|FG002|Extension Treatment Phase|Study terminated by sponsor|1|||
49005690|NCT01828112|157857860|FG000|Extension Treatment Phase|Subject/guardian decision|0|||
49005691|NCT01828112|157857861|FG001|Extension Treatment Phase|Subject/guardian decision|0|||
49005692|NCT01828112|157857862|FG002|Extension Treatment Phase|Subject/guardian decision|4|||
49005693|NCT00585039|157857863|FG000|Overall Study|medication spilled|2|||
49005694|NCT00585039|157857864|FG001|Overall Study|medication spilled|0|||
49005695|NCT01010230|157857865|FG000|Overall Study|Withdrawal by Subject|6|||
49005696|NCT01010230|157857866|FG001|Overall Study|Withdrawal by Subject|5|||
49005697|NCT01010230|157857865|FG000|Overall Study|Lost to Follow-up|4|||
49005698|NCT01010230|157857866|FG001|Overall Study|Lost to Follow-up|2|||
49005699|NCT02046369|157857871|FG000|Overall Study|Adverse Event|3|||
49005700|NCT02046369|157857872|FG001|Overall Study|Adverse Event|3|||
49005701|NCT02046369|157857871|FG000|Overall Study|Lack of Efficacy|3|||
49005702|NCT02046369|157857872|FG001|Overall Study|Lack of Efficacy|3|||
49005703|NCT02046369|157857871|FG000|Overall Study|Lost to Follow-up|3|||
49005704|NCT02046369|157857872|FG001|Overall Study|Lost to Follow-up|3|||
49005705|NCT02046369|157857871|FG000|Overall Study|Protocol Violation|1|||
49005706|NCT02046369|157857872|FG001|Overall Study|Protocol Violation|2|||
49005707|NCT02046369|157857871|FG000|Overall Study|Withdrawal by Subject|3|||
49005708|NCT02046369|157857872|FG001|Overall Study|Withdrawal by Subject|6|||
49005709|NCT02046369|157857871|FG000|Overall Study|never received study drug|0|||
49005710|NCT02046369|157857872|FG001|Overall Study|never received study drug|1|||
49005711|NCT02046369|157857871|FG000|Overall Study|non compliance|1|||
49005712|NCT02046369|157857872|FG001|Overall Study|non compliance|0|||
49005713|NCT01529749|157857873|FG000|Overall Study|Lost to Follow-up|0|||
49005714|NCT01529749|157857874|FG001|Overall Study|Lost to Follow-up|1|||
49005715|NCT01529749|157857875|FG002|Overall Study|Lost to Follow-up|1|||
49005716|NCT01529749|157857876|FG003|Overall Study|Lost to Follow-up|0|||
49005717|NCT01529749|157857873|FG000|Overall Study|Physician Decision|0|||
49005718|NCT01529749|157857874|FG001|Overall Study|Physician Decision|0|||
49005719|NCT01529749|157857875|FG002|Overall Study|Physician Decision|0|||
49005720|NCT01529749|157857876|FG003|Overall Study|Physician Decision|1|||
49005721|NCT01529749|157857873|FG000|Overall Study|Withdrawal by Subject|0|||
49005722|NCT01529749|157857874|FG001|Overall Study|Withdrawal by Subject|1|||
49005723|NCT01529749|157857875|FG002|Overall Study|Withdrawal by Subject|1|||
49005724|NCT01529749|157857876|FG003|Overall Study|Withdrawal by Subject|0|||
49005725|NCT01529749|157857873|FG000|Overall Study|Protocol Violation|0|||
49005726|NCT01529749|157857874|FG001|Overall Study|Protocol Violation|0|||
49005727|NCT01529749|157857875|FG002|Overall Study|Protocol Violation|0|||
49005728|NCT01529749|157857876|FG003|Overall Study|Protocol Violation|1|||
49005729|NCT05123027|157857877|FG000|Overall Study|Lost to Follow-up|17|||
49005730|NCT05123027|157857878|FG001|Overall Study|Lost to Follow-up|22|||
49005731|NCT05123027|157857877|FG000|Overall Study|Incarceration|3|||
49005732|NCT05123027|157857878|FG001|Overall Study|Incarceration|4|||
49005733|NCT05123027|157857877|FG000|Overall Study|Death|2|||
49005734|NCT05123027|157857878|FG001|Overall Study|Death|2|||
49005735|NCT05123027|157857877|FG000|Overall Study|Other|2|||
49005736|NCT05123027|157857878|FG001|Overall Study|Other|0|||
49005737|NCT00378482|157857879|FG000|Overall Study|Lost to Follow-up|1|||
49005738|NCT00378482|157857879|FG000|Overall Study|Lack of Efficacy|8|||
49005739|NCT00378482|157857879|FG000|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9|||
49005740|NCT00378482|157857879|FG000|Overall Study|Withdrawal by Subject|4|||
49005741|NCT00378482|157857879|FG000|Overall Study|Adverse Event|9|||
49005742|NCT04317053|157857888|FG000|Overall Study|Withdrawn (screen failure)|4|||
49005743|NCT04317053|157857889|FG001|Overall Study|Withdrawn (screen failure)|2|||
49005744|NCT00915473|157859082|FG000|Screening|Withdrawal by Subject|1|||
49005745|NCT00915473|157859083|FG001|Screening|Withdrawal by Subject|0|||
49005746|NCT00915473|157859082|FG000|4-week Follow Up|Lost to Follow-up|1|||
49005747|NCT00915473|157859083|FG001|4-week Follow Up|Lost to Follow-up|5|||
49005748|NCT01020773|157859084|FG000|Overall Study|Withdrawal by Subject|4|||
49005749|NCT01020773|157859085|FG001|Overall Study|Withdrawal by Subject|3|||
49005750|NCT01389024|157859086|FG000|Overall Study|Withdrawal by Subject|0|||
49005751|NCT01389024|157859087|FG001|Overall Study|Withdrawal by Subject|1|||
49005752|NCT01389024|157859086|FG000|Overall Study|Lost to Follow-up|1|||
49005753|NCT01389024|157859087|FG001|Overall Study|Lost to Follow-up|0|||
49005754|NCT03853213|157859090|FG000|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1|||
49005755|NCT03853213|157859091|FG001|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0|||
49005756|NCT03853213|157859090|FG000|Overall Study|Other (e.g., too busy)|0|||
49005757|NCT03853213|157859091|FG001|Overall Study|Other (e.g., too busy)|2|||
49005758|NCT03302299|157859092|FG000|Overall Study|Protocol Violation|1|||
49005759|NCT02038959|157859097|FG000|Overall Study|Withdrawal by Subject|6|||
49005760|NCT02038959|157859098|FG001|Overall Study|Withdrawal by Subject|8|||
49005761|NCT03515837|157859105|FG000|Overall Study|Death|219|||
49005762|NCT03515837|157859106|FG001|Overall Study|Death|227|||
49005763|NCT03515837|157859105|FG000|Overall Study|Lost to Follow-up|0|||
49005764|NCT03515837|157859106|FG001|Overall Study|Lost to Follow-up|1|||
49005765|NCT03515837|157859105|FG000|Overall Study|Withdrawal by Subject|0|||
49005766|NCT03515837|157859106|FG001|Overall Study|Withdrawal by Subject|4|||
49005767|NCT03515837|157859105|FG000|Overall Study|Participation Was Terminated By Sponsor|26|||
49005768|NCT03515837|157859106|FG001|Overall Study|Participation Was Terminated By Sponsor|15|||
49005769|NCT01964898|157859107|FG000|Overall Study|ineligible post-randomization|1|||
49005770|NCT01964898|157859108|FG001|Overall Study|ineligible post-randomization|1|||
49005771|NCT01964898|157859107|FG000|Overall Study|did not receive the allocated interventi|2|||
49005772|NCT01964898|157859108|FG001|Overall Study|did not receive the allocated interventi|1|||
49005773|NCT01964898|157859107|FG000|Overall Study|Lost to Follow-up|3|||
49005774|NCT01964898|157859108|FG001|Overall Study|Lost to Follow-up|5|||
49005775|NCT01964898|157859107|FG000|Overall Study|Withdrawal by Subject|1|||
49005776|NCT01964898|157859108|FG001|Overall Study|Withdrawal by Subject|0|||
49005777|NCT00267020|157859109|FG000|Overall Study|Adverse Event|22|||
49005778|NCT00267020|157859110|FG001|Overall Study|Adverse Event|5|||
49005779|NCT00267020|157859109|FG000|Overall Study|Death|2|||
49005780|NCT00267020|157859110|FG001|Overall Study|Death|1|||
49005781|NCT00267020|157859109|FG000|Overall Study|Withdrawal by Subject|17|||
49005782|NCT00267020|157859110|FG001|Overall Study|Withdrawal by Subject|7|||
49005783|NCT00267020|157859109|FG000|Overall Study|Physician Decision|3|||
49005784|NCT00267020|157859110|FG001|Overall Study|Physician Decision|2|||
49005785|NCT00267020|157859109|FG000|Overall Study|Disease Progression|39|||
49005786|NCT00267020|157859110|FG001|Overall Study|Disease Progression|25|||
49005787|NCT00267020|157859109|FG000|Overall Study|Unrelated Complication|1|||
49005788|NCT00267020|157859110|FG001|Overall Study|Unrelated Complication|1|||
49005789|NCT00267020|157859109|FG000|Overall Study|Sponsor Request|1|||
49005790|NCT00267020|157859110|FG001|Overall Study|Sponsor Request|0|||
49005791|NCT00267020|157859109|FG000|Overall Study|Other|1|||
49005792|NCT00267020|157859110|FG001|Overall Study|Other|2|||
49005793|NCT01227954|157859120|FG000|Overall Study|Protocol Violation|6|||
49005794|NCT01227954|157859120|FG000|Overall Study|No protocol treatment|7|||
49005795|NCT03174925|157859121|FG000|Overall Study|Elastographic images not retrievable|2|||
49005796|NCT03174925|157859121|FG000|Overall Study|Elastography image not interpretable|1|||
49005797|NCT04388527|157859123|FG000|Overall Study|Death|14|||
49005798|NCT04388527|157859123|FG000|Overall Study|Withdrawal by Subject|2|||
49005799|NCT04388527|157859123|FG000|Overall Study|Lost to Follow-up|1|||
49005800|NCT03333382|157859124|FG000|Overall Study|Lost to Follow-up|1|||
49005801|NCT03333382|157859125|FG001|Overall Study|Lost to Follow-up|0|||
49005802|NCT00520494|157859128|FG000|Overall Study|Withdrawal by Subject|1|||
49005803|NCT04247594|157859129|FG000|Overall Study|Withdrawal by Subject|4|||
49005804|NCT01005680|157859130|FG000|Overall Study|Lost to Follow-up|4|||
49005805|NCT01005680|157859131|FG001|Overall Study|Lost to Follow-up|6|||
49005806|NCT01005680|157859130|FG000|Overall Study|Withdrawal by Subject|1|||
49005807|NCT01005680|157859131|FG001|Overall Study|Withdrawal by Subject|4|||
49005808|NCT01005680|157859130|FG000|Overall Study|Physician Decision|1|||
49005809|NCT01005680|157859131|FG001|Overall Study|Physician Decision|1|||
49005810|NCT00550420|157859132|FG000|Overall Study|Adverse Event|28|||
49005811|NCT00550420|157859132|FG000|Overall Study|Lost to Follow-up|8|||
49005812|NCT00550420|157859132|FG000|Overall Study|Protocol Violation|11|||
49005813|NCT00550420|157859132|FG000|Overall Study|Withdrawal by Subject|30|||
49005814|NCT00550420|157859132|FG000|Overall Study|Still in study at termination|206|||
49005815|NCT00550420|157859132|FG000|Overall Study|Missing|2|||
49005816|NCT00550420|157859132|FG000|Overall Study|Prolonged QT Interval Electrocardiogram|12|||
49005817|NCT00550420|157859132|FG000|Overall Study|Investigators opinion|1|||
49005818|NCT00550420|157859132|FG000|Overall Study|Lack of curative effect|1|||
49005819|NCT00550420|157859132|FG000|Overall Study|Unethical stop of enrollment|2|||
49005820|NCT00550420|157859132|FG000|Overall Study|Caregiver's decision to withdraw|1|||
49005821|NCT00550420|157859132|FG000|Overall Study|Out of Electrocardiogram criteria|1|||
49005822|NCT00550420|157859132|FG000|Overall Study|Exclusion criteria|1|||
49005823|NCT00550420|157859132|FG000|Overall Study|Prohibited medicine|1|||
49005824|NCT03576131|157859133|FG000|Overall Study|Investigator decision|0|||
49005825|NCT03576131|157859134|FG001|Overall Study|Investigator decision|0|||
49005826|NCT03576131|157859135|FG002|Overall Study|Investigator decision|0|||
49005827|NCT03576131|157859136|FG003|Overall Study|Investigator decision|1|||
49005828|NCT03576131|157859137|FG004|Overall Study|Investigator decision|0|||
49005829|NCT03576131|157859138|FG005|Overall Study|Investigator decision|1|||
49005830|NCT03576131|157859139|FG006|Overall Study|Investigator decision|0|||
49005831|NCT03576131|157859140|FG007|Overall Study|Investigator decision|0|||
49005832|NCT03576131|157859133|FG000|Overall Study|Withdrawal by Subject|1|||
49005833|NCT03576131|157859134|FG001|Overall Study|Withdrawal by Subject|1|||
49005834|NCT03576131|157859135|FG002|Overall Study|Withdrawal by Subject|0|||
49005835|NCT03576131|157859136|FG003|Overall Study|Withdrawal by Subject|1|||
49005836|NCT03576131|157859137|FG004|Overall Study|Withdrawal by Subject|2|||
49005837|NCT03576131|157859138|FG005|Overall Study|Withdrawal by Subject|3|||
49005838|NCT03576131|157859139|FG006|Overall Study|Withdrawal by Subject|1|||
49005839|NCT03576131|157859140|FG007|Overall Study|Withdrawal by Subject|0|||
49005840|NCT03576131|157859133|FG000|Overall Study|Death|3|||
49005841|NCT03576131|157859134|FG001|Overall Study|Death|3|||
49005842|NCT03576131|157859135|FG002|Overall Study|Death|1|||
49005843|NCT03576131|157859136|FG003|Overall Study|Death|5|||
49005844|NCT03576131|157859137|FG004|Overall Study|Death|4|||
49005845|NCT03576131|157859138|FG005|Overall Study|Death|1|||
49005846|NCT03576131|157859139|FG006|Overall Study|Death|0|||
49005847|NCT03576131|157859140|FG007|Overall Study|Death|1|||
49005848|NCT03576131|157859133|FG000|Overall Study|New anti-cancer treatment|5|||
49005849|NCT03576131|157859134|FG001|Overall Study|New anti-cancer treatment|1|||
49005850|NCT03576131|157859135|FG002|Overall Study|New anti-cancer treatment|2|||
49005851|NCT03576131|157859136|FG003|Overall Study|New anti-cancer treatment|3|||
49005852|NCT03576131|157859137|FG004|Overall Study|New anti-cancer treatment|0|||
49005853|NCT03576131|157859138|FG005|Overall Study|New anti-cancer treatment|0|||
49005854|NCT03576131|157859139|FG006|Overall Study|New anti-cancer treatment|0|||
49005855|NCT03576131|157859140|FG007|Overall Study|New anti-cancer treatment|0|||
49005856|NCT03576131|157859133|FG000|Overall Study|Unspecified reason|0|||
49005857|NCT03576131|157859134|FG001|Overall Study|Unspecified reason|0|||
49005858|NCT03576131|157859135|FG002|Overall Study|Unspecified reason|1|||
49005859|NCT03576131|157859136|FG003|Overall Study|Unspecified reason|1|||
49005860|NCT03576131|157859137|FG004|Overall Study|Unspecified reason|1|||
49005861|NCT03576131|157859138|FG005|Overall Study|Unspecified reason|1|||
49005862|NCT03576131|157859139|FG006|Overall Study|Unspecified reason|0|||
49005863|NCT03576131|157859140|FG007|Overall Study|Unspecified reason|0|||
49005864|NCT03576131|157859133|FG000|Overall Study|Subject non-compliance|0|||
49005865|NCT03576131|157859134|FG001|Overall Study|Subject non-compliance|0|||
49005866|NCT03576131|157859135|FG002|Overall Study|Subject non-compliance|0|||
49005867|NCT03576131|157859136|FG003|Overall Study|Subject non-compliance|0|||
49005868|NCT03576131|157859137|FG004|Overall Study|Subject non-compliance|0|||
49005869|NCT03576131|157859138|FG005|Overall Study|Subject non-compliance|1|||
49005870|NCT03576131|157859139|FG006|Overall Study|Subject non-compliance|0|||
49005871|NCT03576131|157859140|FG007|Overall Study|Subject non-compliance|0|||
49005872|NCT03471182|157859141|FG000|Overall Study|Withdrawal by Subject|1|||
49005873|NCT03471182|157859142|FG001|Overall Study|Withdrawal by Subject|1|||
49005874|NCT03471182|157859143|FG002|Overall Study|Withdrawal by Subject|0|||
49005875|NCT03471182|157859141|FG000|Overall Study|Technical failure|2|||
49005876|NCT03471182|157859142|FG001|Overall Study|Technical failure|0|||
49005877|NCT03471182|157859143|FG002|Overall Study|Technical failure|0|||
49005878|NCT04440163|157859146|FG000|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|26|||
49005879|NCT04440163|157859147|FG001|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|15|||
49005880|NCT04440163|157859148|FG002|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|42|||
49005881|NCT04440163|157859149|FG003|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|22|||
49005882|NCT04440163|157859150|FG004|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|30|||
49005883|NCT04440163|157859151|FG005|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|3|||
49005884|NCT04440163|157859152|FG006|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|18|||
49005885|NCT04440163|157859153|FG007|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|5|||
49005886|NCT04440163|157859146|FG000|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
49005887|NCT04440163|157859147|FG001|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
49005888|NCT04440163|157859148|FG002|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
49005889|NCT04440163|157859149|FG003|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
49005890|NCT04440163|157859150|FG004|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
49005891|NCT04440163|157859151|FG005|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
49005892|NCT04440163|157859152|FG006|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
49005893|NCT04440163|157859153|FG007|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
49005894|NCT04440163|157859146|FG000|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
49005895|NCT04440163|157859147|FG001|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|1|||
49005896|NCT04440163|157859148|FG002|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
49005897|NCT04440163|157859149|FG003|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
49005898|NCT04440163|157859150|FG004|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
49005899|NCT04440163|157859151|FG005|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|0|||
49005900|NCT04440163|157859152|FG006|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
49005901|NCT04440163|157859153|FG007|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
49005902|NCT04440163|157859146|FG000|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
49005903|NCT04440163|157859147|FG001|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
49005904|NCT04440163|157859148|FG002|Vaccination Phase (Approx. 7 Months)|Pregnancy|2|||
49005905|NCT04440163|157859149|FG003|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
49005906|NCT04440163|157859150|FG004|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
49005907|NCT04440163|157859151|FG005|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
49005908|NCT04440163|157859152|FG006|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
49005909|NCT04440163|157859153|FG007|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
49005910|NCT04440163|157859146|FG000|Vaccination Phase (Approx. 7 Months)|Protocol Violation|1|||
49005911|NCT04440163|157859147|FG001|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
49005912|NCT04440163|157859148|FG002|Vaccination Phase (Approx. 7 Months)|Protocol Violation|5|||
49005913|NCT04440163|157859149|FG003|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
49005914|NCT04440163|157859150|FG004|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
49005915|NCT04440163|157859151|FG005|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
49005916|NCT04440163|157859152|FG006|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
49005917|NCT04440163|157859153|FG007|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
49005918|NCT04440163|157859146|FG000|Vaccination Phase (Approx. 7 Months)|Other|0|||
49005919|NCT04440163|157859147|FG001|Vaccination Phase (Approx. 7 Months)|Other|0|||
49005920|NCT04440163|157859148|FG002|Vaccination Phase (Approx. 7 Months)|Other|3|||
49005921|NCT04440163|157859149|FG003|Vaccination Phase (Approx. 7 Months)|Other|2|||
49005922|NCT04440163|157859150|FG004|Vaccination Phase (Approx. 7 Months)|Other|0|||
49005923|NCT04440163|157859151|FG005|Vaccination Phase (Approx. 7 Months)|Other|1|||
49005924|NCT04440163|157859152|FG006|Vaccination Phase (Approx. 7 Months)|Other|0|||
49005925|NCT04440163|157859153|FG007|Vaccination Phase (Approx. 7 Months)|Other|1|||
49005926|NCT04440163|157859146|FG000|Vaccination Phase (Approx. 7 Months)|Adverse Event|3|||
49005927|NCT04440163|157859147|FG001|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
49005928|NCT04440163|157859148|FG002|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
49005929|NCT04440163|157859149|FG003|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
49005930|NCT04440163|157859150|FG004|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
49005931|NCT04440163|157859151|FG005|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
49005932|NCT04440163|157859152|FG006|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
49005933|NCT04440163|157859153|FG007|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
49005934|NCT04440163|157859146|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|11|||
49005935|NCT04440163|157859147|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
49005936|NCT04440163|157859148|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|18|||
49005937|NCT04440163|157859149|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|14|||
49005938|NCT04440163|157859150|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|10|||
49005939|NCT04440163|157859151|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|3|||
49005940|NCT04440163|157859152|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
49005941|NCT04440163|157859153|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|4|||
49005942|NCT04440163|157859146|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|10|||
49005943|NCT04440163|157859147|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
49005944|NCT04440163|157859148|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|11|||
49005945|NCT04440163|157859149|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|7|||
49005946|NCT04440163|157859150|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|16|||
49005947|NCT04440163|157859151|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
49005948|NCT04440163|157859152|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|3|||
49005949|NCT04440163|157859153|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|2|||
49005950|NCT04440163|157859146|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|5|||
49005951|NCT04440163|157859147|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
49005952|NCT04440163|157859148|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
49005953|NCT04440163|157859149|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
49005954|NCT04440163|157859150|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|7|||
49005955|NCT04440163|157859151|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
49005956|NCT04440163|157859152|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
49005957|NCT04440163|157859153|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
49005958|NCT04440163|157859146|FG000|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|3|||
49005959|NCT04440163|157859147|FG001|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|5|||
49005960|NCT04440163|157859148|FG002|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
49005961|NCT04440163|157859149|FG003|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
49005962|NCT04440163|157859150|FG004|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
49005963|NCT04440163|157859151|FG005|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
49005964|NCT04440163|157859152|FG006|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|2|||
49005965|NCT04440163|157859153|FG007|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
49005966|NCT04440163|157859146|FG000|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
49005967|NCT04440163|157859147|FG001|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
49005968|NCT04440163|157859148|FG002|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
49005969|NCT04440163|157859149|FG003|Follow-up Phase (Approx. 5 Months)|Protocol Violation|1|||
49005970|NCT04440163|157859150|FG004|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
49005971|NCT04440163|157859151|FG005|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
49005972|NCT04440163|157859152|FG006|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
49005973|NCT04440163|157859153|FG007|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
49005974|NCT02748616|157859154|FG000|Overall Study|Lost to Follow-up|1|||
49005975|NCT02748616|157859154|FG000|Overall Study|Withdrawal by Subject|2|||
49005976|NCT02748616|157859154|FG000|Overall Study|Physician Decision|2|||
49005977|NCT02748616|157859154|FG000|Overall Study|Did Not Complete Ursodial Course|2|||
49005978|NCT00782275|157859157|FG000|Overall Study|Adverse Event|11|||
49005979|NCT00782275|157859157|FG000|Overall Study|Withdrawal by Subject|1|||
49005980|NCT00782275|157859157|FG000|Overall Study|Progressive Disease|21|||
49005981|NCT00782275|157859157|FG000|Overall Study|Physician Decision|4|||
49005982|NCT00782275|157859157|FG000|Overall Study|Not started treatment|1|||
49005983|NCT00782275|157859157|FG000|Overall Study|Other|3|||
49005984|NCT01296152|157859158|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
49005985|NCT02018042|157859162|FG000|Overall Study|Withdrawal by Subject|1|||
49005986|NCT00996632|157859171|FG000|Overall Study|Physician Decision|0|||
49005987|NCT00996632|157859172|FG001|Overall Study|Physician Decision|0|||
49005988|NCT01185639|157859175|FG000|Overall Study|Progressed and didn't receive therapy|2|||
49005989|NCT04556838|157859178|FG000|Overall Study|Withdrawal by Subject|3|||
49005990|NCT04556838|157859179|FG001|Overall Study|Withdrawal by Subject|1|||
49005991|NCT04556838|157859180|FG002|Overall Study|Withdrawal by Subject|2|||
49005992|NCT04556838|157859178|FG000|Overall Study|Adverse Event|0|||
49005993|NCT04556838|157859179|FG001|Overall Study|Adverse Event|1|||
49005994|NCT04556838|157859180|FG002|Overall Study|Adverse Event|1|||
49005995|NCT04556838|157859178|FG000|Overall Study|Lost to Follow-up|0|||
49005996|NCT04556838|157859179|FG001|Overall Study|Lost to Follow-up|0|||
49005997|NCT04556838|157859180|FG002|Overall Study|Lost to Follow-up|2|||
49005998|NCT04556838|157859178|FG000|Overall Study|Subject travel|0|||
49005999|NCT04556838|157859179|FG001|Overall Study|Subject travel|1|||
49006000|NCT04556838|157859180|FG002|Overall Study|Subject travel|0|||
49006001|NCT04556838|157859178|FG000|Overall Study|Physician Decision|1|||
49006002|NCT04556838|157859179|FG001|Overall Study|Physician Decision|0|||
49006003|NCT04556838|157859180|FG002|Overall Study|Physician Decision|0|||
49006004|NCT01629693|157859181|FG000|Overall Study|Lost to Follow-up|2|||
49006005|NCT01629693|157859182|FG001|Overall Study|Lost to Follow-up|4|||
49006006|NCT01629693|157859181|FG000|Overall Study|Withdrawal by Subject|2|||
49006007|NCT01629693|157859182|FG001|Overall Study|Withdrawal by Subject|2|||
49006008|NCT01629693|157859181|FG000|Overall Study|Adverse Event|1|||
49006009|NCT01629693|157859182|FG001|Overall Study|Adverse Event|0|||
49006010|NCT01629693|157859181|FG000|Overall Study|Investigator decision|0|||
49006011|NCT01629693|157859182|FG001|Overall Study|Investigator decision|1|||
49006012|NCT01629693|157859181|FG000|Overall Study|Poor comfort of study lenses|0|||
49006013|NCT01629693|157859182|FG001|Overall Study|Poor comfort of study lenses|2|||
49006014|NCT01629693|157859181|FG000|Overall Study|Subject decision unrelated to AE|0|||
49006015|NCT01629693|157859182|FG001|Overall Study|Subject decision unrelated to AE|1|||
49006016|NCT01585831|157859183|FG000|Overall Study|Physician Decision|0|||
49006017|NCT01585831|157859184|FG001|Overall Study|Physician Decision|1|||
49006018|NCT01585831|157859183|FG000|Overall Study|Withdrawal by Subject|2|||
49006019|NCT01585831|157859184|FG001|Overall Study|Withdrawal by Subject|1|||
49006020|NCT02623426|157859185|FG000|Overall Study|Lost to Follow-up|0|||
49006021|NCT02623426|157859186|FG001|Overall Study|Lost to Follow-up|0|||
49006022|NCT02623426|157859187|FG002|Overall Study|Lost to Follow-up|1|||
49006023|NCT02623426|157859185|FG000|Overall Study|Withdrawal by Subject|1|||
49006024|NCT02623426|157859186|FG001|Overall Study|Withdrawal by Subject|2|||
49006025|NCT02623426|157859187|FG002|Overall Study|Withdrawal by Subject|2|||
49006040|NCT03735979|157859190|FG000|Overall Study|Lost to Follow-up|1|||
49006041|NCT03735979|157859191|FG001|Overall Study|Lost to Follow-up|12|||
49006042|NCT03735979|157859192|FG002|Overall Study|Lost to Follow-up|14|||
49006043|NCT03735979|157859190|FG000|Overall Study|Withdrawal by Subject|1|||
49006044|NCT03735979|157859191|FG001|Overall Study|Withdrawal by Subject|5|||
49006045|NCT03735979|157859192|FG002|Overall Study|Withdrawal by Subject|2|||
49006046|NCT03735979|157859190|FG000|Overall Study|Not due to the above reasons|1|||
49006047|NCT03735979|157859191|FG001|Overall Study|Not due to the above reasons|0|||
49006048|NCT03735979|157859192|FG002|Overall Study|Not due to the above reasons|0|||
49006049|NCT04517435|157859193|FG000|Overall Study|Withdrawal by Subject|0|||
49006050|NCT04517435|157859194|FG001|Overall Study|Withdrawal by Subject|0|||
49006051|NCT04517435|157859195|FG002|Overall Study|Withdrawal by Subject|1|||
49006052|NCT04517435|157859193|FG000|Overall Study|Pharmaceutical company discontinued the trial|3|||
49006053|NCT04517435|157859194|FG001|Overall Study|Pharmaceutical company discontinued the trial|6|||
49006054|NCT04517435|157859195|FG002|Overall Study|Pharmaceutical company discontinued the trial|3|||
49006055|NCT00874757|157859196|FG000|Overall Study|Baseline laboratories outside of normal limits (screen fails).|4|||
49006056|NCT04439318|157859197|FG000|Overall Study|Ineligible|1|||
49006057|NCT04439318|157859197|FG000|Overall Study|Never Started Treatment|3|||
49006058|NCT04439318|157859197|FG000|Overall Study|Adverse Event|10|||
49006059|NCT04439318|157859197|FG000|Overall Study|Death|2|||
49006060|NCT04439318|157859197|FG000|Overall Study|Disease Progression|25|||
49006061|NCT04439318|157859197|FG000|Overall Study|Other Complicating Disease|2|||
49006062|NCT04439318|157859197|FG000|Overall Study|Withdrawal by Subject|4|||
49006063|NCT04439318|157859197|FG000|Overall Study|Patient Refusal - Prefers Different Therapy|1|||
49006064|NCT04439318|157859197|FG000|Overall Study|Non-Compliance|1|||
49006065|NCT04439318|157859197|FG000|Overall Study|Still on Treatment|1|||
49006066|NCT04071366|157860762|FG000|Part 1: Open-label (29 Days)|Death|4|||
49006067|NCT04071366|157860763|FG001|Part 1: Open-label (29 Days)|Death|2|||
49006068|NCT04071366|157860764|FG002|Part 1: Open-label (29 Days)|Death|8|||
49006069|NCT04071366|157860765|FG003|Part 1: Open-label (29 Days)|Death|0|||
49006070|NCT04071366|157860766|FG004|Part 1: Open-label (29 Days)|Death|0|||
49006071|NCT04071366|157860762|FG000|Part 1: Open-label (29 Days)|Progressive Disease|0|||
49006072|NCT04071366|157860763|FG001|Part 1: Open-label (29 Days)|Progressive Disease|0|||
49006073|NCT04071366|157860764|FG002|Part 1: Open-label (29 Days)|Progressive Disease|4|||
49006074|NCT04071366|157860765|FG003|Part 1: Open-label (29 Days)|Progressive Disease|0|||
49006075|NCT04071366|157860766|FG004|Part 1: Open-label (29 Days)|Progressive Disease|0|||
49006076|NCT04071366|157860762|FG000|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
49006077|NCT04071366|157860763|FG001|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
49006078|NCT04071366|157860764|FG002|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
49006079|NCT04071366|157860765|FG003|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
49006080|NCT04071366|157860766|FG004|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
49006081|NCT04071366|157860762|FG000|Part 2: Randomized (29 Days)|Death|0|||
49006082|NCT04071366|157860763|FG001|Part 2: Randomized (29 Days)|Death|0|||
49006083|NCT04071366|157860764|FG002|Part 2: Randomized (29 Days)|Death|0|||
49006084|NCT04071366|157860765|FG003|Part 2: Randomized (29 Days)|Death|2|||
49006085|NCT04071366|157860766|FG004|Part 2: Randomized (29 Days)|Death|2|||
49006086|NCT04071366|157860762|FG000|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
49006087|NCT04071366|157860763|FG001|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
49006088|NCT04071366|157860764|FG002|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
49006089|NCT04071366|157860765|FG003|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
49006090|NCT04071366|157860766|FG004|Part 2: Randomized (29 Days)|Lost to Follow-up|1|||
49006091|NCT04071366|157860762|FG000|Part 2: Randomized (29 Days)|Physician Decision|0|||
49006092|NCT04071366|157860763|FG001|Part 2: Randomized (29 Days)|Physician Decision|0|||
49006093|NCT04071366|157860764|FG002|Part 2: Randomized (29 Days)|Physician Decision|0|||
49006094|NCT04071366|157860765|FG003|Part 2: Randomized (29 Days)|Physician Decision|0|||
49006095|NCT04071366|157860766|FG004|Part 2: Randomized (29 Days)|Physician Decision|1|||
49006096|NCT04071366|157860762|FG000|Part 2: Randomized (29 Days)|Progressive Disease|0|||
49006097|NCT04071366|157860763|FG001|Part 2: Randomized (29 Days)|Progressive Disease|0|||
49006098|NCT04071366|157860764|FG002|Part 2: Randomized (29 Days)|Progressive Disease|0|||
49006099|NCT04071366|157860765|FG003|Part 2: Randomized (29 Days)|Progressive Disease|2|||
49006100|NCT04071366|157860766|FG004|Part 2: Randomized (29 Days)|Progressive Disease|4|||
49006101|NCT04071366|157860762|FG000|Part 2: Randomized (29 Days)|Protocol Violation|0|||
49006102|NCT04071366|157860763|FG001|Part 2: Randomized (29 Days)|Protocol Violation|0|||
49006103|NCT04071366|157860764|FG002|Part 2: Randomized (29 Days)|Protocol Violation|0|||
49006104|NCT04071366|157860765|FG003|Part 2: Randomized (29 Days)|Protocol Violation|0|||
49006105|NCT04071366|157860766|FG004|Part 2: Randomized (29 Days)|Protocol Violation|1|||
49006106|NCT04071366|157860762|FG000|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
49006107|NCT04071366|157860763|FG001|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
49006108|NCT04071366|157860764|FG002|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
49006109|NCT04071366|157860765|FG003|Part 2: Randomized (29 Days)|Withdrawal by Subject|1|||
49006110|NCT04071366|157860766|FG004|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
49006111|NCT04071366|157860762|FG000|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
49006112|NCT04071366|157860763|FG001|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
49006113|NCT04071366|157860764|FG002|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
49006114|NCT04071366|157860765|FG003|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|1|||
49006115|NCT04071366|157860766|FG004|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
49006116|NCT02239692|157860767|FG000|Overall Study|Incomplete colonoscopy|1|||
49006117|NCT02239692|157860768|FG001|Overall Study|Incomplete colonoscopy|2|||
49006118|NCT02239692|157860767|FG000|Overall Study|Adverse Event|0|||
49006119|NCT02239692|157860768|FG001|Overall Study|Adverse Event|1|||
49006120|NCT02239692|157860767|FG000|Overall Study|Physician Decision|0|||
49006121|NCT02239692|157860768|FG001|Overall Study|Physician Decision|1|||
49006122|NCT02239692|157860767|FG000|Overall Study|Lost to Follow-up|1|||
49006123|NCT02239692|157860768|FG001|Overall Study|Lost to Follow-up|4|||
49006124|NCT02239692|157860767|FG000|Overall Study|Withdrawal by Subject|3|||
49006125|NCT02239692|157860768|FG001|Overall Study|Withdrawal by Subject|5|||
49006126|NCT02239692|157860767|FG000|Overall Study|Other reason|1|||
49006127|NCT02239692|157860768|FG001|Overall Study|Other reason|0|||
49006128|NCT04318535|157860769|FG000|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
49006129|NCT04318535|157860770|FG001|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1|||
49006130|NCT04318535|157860771|FG002|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
49006131|NCT01678924|157860772|FG000|Overall Study|Adverse Event|1|||
49006132|NCT01678924|157860773|FG001|Overall Study|Adverse Event|1|||
49006133|NCT01678924|157860774|FG002|Overall Study|Adverse Event|0|||
49006134|NCT01678924|157860775|FG003|Overall Study|Adverse Event|1|||
49006135|NCT01678924|157860772|FG000|Overall Study|Lack of Efficacy|7|||
49006136|NCT01678924|157860773|FG001|Overall Study|Lack of Efficacy|2|||
49006137|NCT01678924|157860774|FG002|Overall Study|Lack of Efficacy|0|||
49006138|NCT01678924|157860775|FG003|Overall Study|Lack of Efficacy|5|||
49006139|NCT01678924|157860772|FG000|Overall Study|Lost to Follow-up|0|||
49006140|NCT01678924|157860773|FG001|Overall Study|Lost to Follow-up|4|||
49006141|NCT01678924|157860774|FG002|Overall Study|Lost to Follow-up|0|||
49006142|NCT01678924|157860775|FG003|Overall Study|Lost to Follow-up|2|||
49006143|NCT01678924|157860772|FG000|Overall Study|Personal Reasons|2|||
49006144|NCT01678924|157860773|FG001|Overall Study|Personal Reasons|2|||
49006145|NCT01678924|157860774|FG002|Overall Study|Personal Reasons|2|||
49006146|NCT01678924|157860775|FG003|Overall Study|Personal Reasons|7|||
49006147|NCT01678924|157860772|FG000|Overall Study|Withdrawal by Subject|0|||
49006148|NCT01678924|157860773|FG001|Overall Study|Withdrawal by Subject|3|||
49006149|NCT01678924|157860774|FG002|Overall Study|Withdrawal by Subject|0|||
49006150|NCT01678924|157860775|FG003|Overall Study|Withdrawal by Subject|2|||
49006151|NCT01678924|157860772|FG000|Overall Study|Unable to attend scheduled visits|0|||
49006152|NCT01678924|157860773|FG001|Overall Study|Unable to attend scheduled visits|0|||
49006153|NCT01678924|157860774|FG002|Overall Study|Unable to attend scheduled visits|0|||
49006154|NCT01678924|157860775|FG003|Overall Study|Unable to attend scheduled visits|1|||
49006155|NCT00640614|157860781|FG000|Overall Study|Lost to Follow-up|1|||
49006156|NCT00640614|157860782|FG001|Overall Study|Lost to Follow-up|0|||
49006157|NCT00529802|157860783|FG000|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3|||
49006158|NCT00529802|157860783|FG000|Evaluable for Primary Endpoint|Worsening performance status|2|||
49006159|NCT00529802|157860783|FG000|Evaluable for Primary Endpoint|Adverse Event|2|||
49006160|NCT00529802|157860783|FG000|Evaluable for Primary Endpoint|Death|1|||
49006161|NCT00529802|157860783|FG000|Evaluable for Primary Endpoint|Lack of Efficacy|1|||
49006162|NCT00529802|157860783|FG000|Evaluable for Primary Endpoint|Lost to Follow-up|1|||
49006163|NCT00529802|157860783|FG000|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2|||
49006164|NCT02657356|157860785|FG000|Overall Study|Death|1|||
49006165|NCT02657356|157860786|FG001|Overall Study|Death|0|||
49006166|NCT02657356|157860785|FG000|Overall Study|Withdrawal by Subject|5|||
49006167|NCT02657356|157860786|FG001|Overall Study|Withdrawal by Subject|6|||
49006168|NCT02657356|157860785|FG000|Overall Study|Terminated by Sponsor|8|||
49006169|NCT02657356|157860786|FG001|Overall Study|Terminated by Sponsor|5|||
49006170|NCT02657356|157860785|FG000|Overall Study|Rolled over to EAP study|6|||
49006171|NCT02657356|157860786|FG001|Overall Study|Rolled over to EAP study|4|||
49006172|NCT02209454|157860789|FG000|Second Period|Adverse Event|1|||
49006173|NCT02209454|157860790|FG001|Second Period|Adverse Event|0|||
49006174|NCT00021229|157860791|FG000|Overall Study|Adverse Event|10|||
49006175|NCT00021229|157860792|FG001|Overall Study|Adverse Event|5|||
49006176|NCT00021229|157860793|FG002|Overall Study|Adverse Event|2|||
49006177|NCT00021229|157860791|FG000|Overall Study|Death|0|||
49006178|NCT00021229|157860792|FG001|Overall Study|Death|1|||
49006179|NCT00021229|157860793|FG002|Overall Study|Death|0|||
49006180|NCT00021229|157860791|FG000|Overall Study|Withdrawal by Subject|7|||
49006181|NCT00021229|157860792|FG001|Overall Study|Withdrawal by Subject|7|||
49006182|NCT00021229|157860793|FG002|Overall Study|Withdrawal by Subject|1|||
49006183|NCT00021229|157860791|FG000|Overall Study|Progressive Disease|15|||
49006184|NCT00021229|157860792|FG001|Overall Study|Progressive Disease|19|||
49006185|NCT00021229|157860793|FG002|Overall Study|Progressive Disease|12|||
49006186|NCT00021229|157860791|FG000|Overall Study|Protocol Violation|1|||
49006187|NCT00021229|157860792|FG001|Overall Study|Protocol Violation|1|||
49006188|NCT00021229|157860793|FG002|Overall Study|Protocol Violation|0|||
49006189|NCT00021229|157860791|FG000|Overall Study|Physician Decision|0|||
49006190|NCT00021229|157860792|FG001|Overall Study|Physician Decision|0|||
49006191|NCT00021229|157860793|FG002|Overall Study|Physician Decision|1|||
49006192|NCT00021229|157860791|FG000|Overall Study|Punctate hemmorrhage post RT|2|||
49006193|NCT00021229|157860792|FG001|Overall Study|Punctate hemmorrhage post RT|0|||
49006194|NCT00021229|157860793|FG002|Overall Study|Punctate hemmorrhage post RT|0|||
49006195|NCT02675426|157860794|FG000|Period 1: Week 1 to Week 12|Adverse Event|3|||
49006196|NCT02675426|157860795|FG001|Period 1: Week 1 to Week 12|Adverse Event|3|||
49006197|NCT02675426|157860796|FG002|Period 1: Week 1 to Week 12|Adverse Event|3|||
49006198|NCT02675426|157860797|FG003|Period 1: Week 1 to Week 12|Adverse Event|9|||
49006199|NCT02675426|157860794|FG000|Period 1: Week 1 to Week 12|Withdrawal by Subject|1|||
49006200|NCT02675426|157860795|FG001|Period 1: Week 1 to Week 12|Withdrawal by Subject|2|||
49006201|NCT02675426|157860796|FG002|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
49006202|NCT02675426|157860797|FG003|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
49006203|NCT02675426|157860794|FG000|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
49006204|NCT02675426|157860795|FG001|Period 1: Week 1 to Week 12|Lost to Follow-up|1|||
49006205|NCT02675426|157860796|FG002|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
49006206|NCT02675426|157860797|FG003|Period 1: Week 1 to Week 12|Lost to Follow-up|2|||
49006207|NCT02675426|157860794|FG000|Period 1: Week 1 to Week 12|Other|2|||
49006208|NCT02675426|157860795|FG001|Period 1: Week 1 to Week 12|Other|1|||
49006209|NCT02675426|157860796|FG002|Period 1: Week 1 to Week 12|Other|0|||
49006210|NCT02675426|157860797|FG003|Period 1: Week 1 to Week 12|Other|2|||
49006211|NCT02675426|157860794|FG000|Period 2: Week 12 to Week 260|Adverse Event|13|||
49006212|NCT02675426|157860795|FG001|Period 2: Week 12 to Week 260|Adverse Event|16|||
49006213|NCT02675426|157860796|FG002|Period 2: Week 12 to Week 260|Adverse Event|17|||
49006214|NCT02675426|157860797|FG003|Period 2: Week 12 to Week 260|Adverse Event|30|||
49006215|NCT02675426|157860794|FG000|Period 2: Week 12 to Week 260|Withdrawal by Subject|14|||
49006216|NCT02675426|157860795|FG001|Period 2: Week 12 to Week 260|Withdrawal by Subject|21|||
49006217|NCT02675426|157860796|FG002|Period 2: Week 12 to Week 260|Withdrawal by Subject|31|||
49006218|NCT02675426|157860797|FG003|Period 2: Week 12 to Week 260|Withdrawal by Subject|30|||
49006219|NCT02675426|157860794|FG000|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
49006220|NCT02675426|157860795|FG001|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
49006221|NCT02675426|157860796|FG002|Period 2: Week 12 to Week 260|Lost to Follow-up|10|||
49006222|NCT02675426|157860797|FG003|Period 2: Week 12 to Week 260|Lost to Follow-up|4|||
49006223|NCT02675426|157860794|FG000|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
49006224|NCT02675426|157860795|FG001|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
49006225|NCT02675426|157860796|FG002|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
49006226|NCT02675426|157860797|FG003|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
49006227|NCT02675426|157860794|FG000|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
49006228|NCT02675426|157860795|FG001|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
49006229|NCT02675426|157860796|FG002|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
49006230|NCT02675426|157860797|FG003|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
49006231|NCT02675426|157860794|FG000|Period 2: Week 12 to Week 260|Other|8|||
49006232|NCT02675426|157860795|FG001|Period 2: Week 12 to Week 260|Other|12|||
49006233|NCT02675426|157860796|FG002|Period 2: Week 12 to Week 260|Other|23|||
49006234|NCT02675426|157860797|FG003|Period 2: Week 12 to Week 260|Other|15|||
49006235|NCT02156466|157860802|FG000|Overall Study|Adverse Event|0|||
49006236|NCT02156466|157860803|FG001|Overall Study|Adverse Event|0|||
49006237|NCT02156466|157860804|FG002|Overall Study|Adverse Event|1|||
49006238|NCT02156466|157860805|FG003|Overall Study|Adverse Event|1|||
49006239|NCT02156466|157860806|FG004|Overall Study|Adverse Event|0|||
49006240|NCT02156466|157860802|FG000|Overall Study|Quantiferon Positivity|0|||
49006241|NCT02156466|157860803|FG001|Overall Study|Quantiferon Positivity|0|||
49006242|NCT02156466|157860804|FG002|Overall Study|Quantiferon Positivity|0|||
49006243|NCT02156466|157860805|FG003|Overall Study|Quantiferon Positivity|1|||
49006244|NCT02156466|157860806|FG004|Overall Study|Quantiferon Positivity|0|||
49006245|NCT03543046|157860807|FG000|Overall Study|Adverse Event|1|||
49006246|NCT03543046|157860808|FG001|Overall Study|Adverse Event|1|||
49006247|NCT03543046|157860807|FG000|Overall Study|Physician Decision|1|||
49006248|NCT03543046|157860808|FG001|Overall Study|Physician Decision|1|||
49006249|NCT03543046|157860807|FG000|Overall Study|Protocol Violation|1|||
49006250|NCT03543046|157860808|FG001|Overall Study|Protocol Violation|0|||
49006251|NCT01791127|157860809|FG000|Overall Study|Death|356|||
49006252|NCT01791127|157860809|FG000|Overall Study|Patient has withdrawn from study|293|||
49006253|NCT01791127|157860809|FG000|Overall Study|Lost to Follow-up|42|||
49006254|NCT01791127|157860809|FG000|Overall Study|All Siello leads are explanted|31|||
49006255|NCT01791127|157860809|FG000|Overall Study|Completion of 30 day safety registry|1|||
49006256|NCT01791127|157860809|FG000|Overall Study|Study terminated for EP Passion|749|||
49006257|NCT03231709|157860820|FG000|Treatment Period 1|Reason not Specified|0|||
49006258|NCT03231709|157860821|FG001|Treatment Period 1|Reason not Specified|1|||
49006259|NCT03231709|157860820|FG000|Treatment Period 2|Pretreatment Event/Adverse Event|0|||
49006260|NCT03231709|157860821|FG001|Treatment Period 2|Pretreatment Event/Adverse Event|1|||
49006261|NCT02609178|157860822|FG000|First Crown|Withdrawal by Subject|0|||
49006262|NCT02609178|157860823|FG001|First Crown|Withdrawal by Subject|0|||
49006263|NCT02609178|157860824|FG002|First Crown|Withdrawal by Subject|1|||
49006264|NCT02609178|157860825|FG003|First Crown|Withdrawal by Subject|1|||
49006265|NCT02609178|157860826|FG004|First Crown|Withdrawal by Subject|0|||
49006266|NCT02609178|157860827|FG005|First Crown|Withdrawal by Subject|0|||
49006267|NCT04059354|157860828|FG000|Overall Study|COVID-19 pandemic|3|||
49006268|NCT03451331|157860831|FG000|Overall Study|Withdrawal by Subject|1|||
49006269|NCT03451331|157860832|FG001|Overall Study|Withdrawal by Subject|0|||
49006270|NCT03451331|157860831|FG000|Overall Study|Unable to start treatment.|1|||
49006271|NCT03451331|157860832|FG001|Overall Study|Unable to start treatment.|1|||
49006272|NCT01875991|157860833|FG000|Overall Study|Withdrawal by Subject|6|||
49006273|NCT01875991|157860834|FG001|Overall Study|Withdrawal by Subject|6|||
49006274|NCT01875991|157860833|FG000|Overall Study|Sponsor Decision|1|||
49006275|NCT01875991|157860834|FG001|Overall Study|Sponsor Decision|0|||
49006276|NCT02419469|157860835|FG000|Overall Study|Withdrawal by Subject|1|||
49006277|NCT02773446|157860836|FG000|First Admission|Withdrawal by Subject|0|||
49006278|NCT02773446|157860837|FG001|First Admission|Withdrawal by Subject|0|||
49006279|NCT02773446|157860838|FG002|First Admission|Withdrawal by Subject|0|||
49006280|NCT02773446|157860839|FG003|First Admission|Withdrawal by Subject|1|||
49006281|NCT02773446|157860840|FG004|First Admission|Withdrawal by Subject|0|||
49006282|NCT02773446|157860841|FG005|First Admission|Withdrawal by Subject|0|||
49006283|NCT02773446|157860836|FG000|First Admission|Lost to Follow-up|1|||
49006284|NCT02773446|157860837|FG001|First Admission|Lost to Follow-up|0|||
49006285|NCT02773446|157860838|FG002|First Admission|Lost to Follow-up|0|||
49006286|NCT02773446|157860839|FG003|First Admission|Lost to Follow-up|0|||
49006287|NCT02773446|157860840|FG004|First Admission|Lost to Follow-up|0|||
49006288|NCT02773446|157860841|FG005|First Admission|Lost to Follow-up|0|||
49006289|NCT01682512|157860842|FG000|Overall Study|Adverse Event|6|||
49006290|NCT01682512|157860843|FG001|Overall Study|Adverse Event|5|||
49006291|NCT01682512|157860844|FG002|Overall Study|Adverse Event|2|||
49006292|NCT01682512|157860842|FG000|Overall Study|Withdrawal by Subject|2|||
49006293|NCT01682512|157860843|FG001|Overall Study|Withdrawal by Subject|6|||
49006294|NCT01682512|157860844|FG002|Overall Study|Withdrawal by Subject|3|||
49006295|NCT01682512|157860842|FG000|Overall Study|Physician Decision|0|||
49006296|NCT01682512|157860843|FG001|Overall Study|Physician Decision|2|||
49006297|NCT01682512|157860844|FG002|Overall Study|Physician Decision|0|||
49006298|NCT01682512|157860842|FG000|Overall Study|Study terminated by sponsor|46|||
49006299|NCT01682512|157860843|FG001|Overall Study|Study terminated by sponsor|43|||
49006300|NCT01682512|157860844|FG002|Overall Study|Study terminated by sponsor|0|||
49006301|NCT01682512|157860842|FG000|Overall Study|Lost to Follow-up|3|||
49006302|NCT01682512|157860843|FG001|Overall Study|Lost to Follow-up|0|||
49006303|NCT01682512|157860844|FG002|Overall Study|Lost to Follow-up|2|||
49006304|NCT01682512|157860842|FG000|Overall Study|Protocol Violation|2|||
49006305|NCT01682512|157860843|FG001|Overall Study|Protocol Violation|3|||
49006306|NCT01682512|157860844|FG002|Overall Study|Protocol Violation|2|||
49006307|NCT01682512|157860842|FG000|Overall Study|Primary lack of efficacy|10|||
49006308|NCT01682512|157860843|FG001|Overall Study|Primary lack of efficacy|7|||
49006309|NCT01682512|157860844|FG002|Overall Study|Primary lack of efficacy|7|||
49006310|NCT01682512|157860842|FG000|Overall Study|Secondary lack of efficacy|1|||
49006311|NCT01682512|157860843|FG001|Overall Study|Secondary lack of efficacy|1|||
49006312|NCT01682512|157860844|FG002|Overall Study|Secondary lack of efficacy|0|||
49006313|NCT01682512|157860842|FG000|Overall Study|Other than stated above|2|||
49006314|NCT01682512|157860843|FG001|Overall Study|Other than stated above|4|||
49006315|NCT01682512|157860844|FG002|Overall Study|Other than stated above|2|||
49006316|NCT00289731|157860845|FG000|Overall Study|Adverse Event|1|||
49006317|NCT00289731|157860846|FG001|Overall Study|Adverse Event|2|||
49006318|NCT00289731|157860847|FG002|Overall Study|Adverse Event|2|||
49006319|NCT00289731|157860845|FG000|Overall Study|Other|1|||
49006320|NCT00289731|157860846|FG001|Overall Study|Other|0|||
49006321|NCT00289731|157860847|FG002|Overall Study|Other|0|||
49006322|NCT03876873|157860848|FG000|Overall Study|Physician Decision|0|||
49006323|NCT03876873|157860849|FG001|Overall Study|Physician Decision|1|||
49006324|NCT02030834|157860850|FG000|Overall Study|Death|4|||
49006325|NCT02030834|157860851|FG001|Overall Study|Death|0|||
49006326|NCT02030834|157860852|FG002|Overall Study|Death|0|||
49006327|NCT02030834|157860850|FG000|Overall Study|Manufacturing failure|2|||
49006328|NCT02030834|157860851|FG001|Overall Study|Manufacturing failure|0|||
49006329|NCT02030834|157860852|FG002|Overall Study|Manufacturing failure|1|||
49006330|NCT02030834|157860850|FG000|Overall Study|Disease progression|2|||
49006331|NCT02030834|157860851|FG001|Overall Study|Disease progression|0|||
49006332|NCT02030834|157860852|FG002|Overall Study|Disease progression|2|||
49006333|NCT02030834|157860850|FG000|Overall Study|Lost to Follow-up|1|||
49006334|NCT02030834|157860851|FG001|Overall Study|Lost to Follow-up|0|||
49006335|NCT02030834|157860852|FG002|Overall Study|Lost to Follow-up|0|||
49006336|NCT02030834|157860850|FG000|Overall Study|Withdrawal by Subject|1|||
49006337|NCT02030834|157860851|FG001|Overall Study|Withdrawal by Subject|0|||
49006338|NCT02030834|157860852|FG002|Overall Study|Withdrawal by Subject|0|||
49006339|NCT02030834|157860850|FG000|Overall Study|Lack of funding|1|||
49006340|NCT02030834|157860851|FG001|Overall Study|Lack of funding|0|||
49006341|NCT02030834|157860852|FG002|Overall Study|Lack of funding|0|||
49006342|NCT01453374|157860853|FG000|Overall Study|Adverse Event|7|||
49006343|NCT01453374|157860853|FG000|Overall Study|Lack of Efficacy|1|||
49006344|NCT01453374|157860853|FG000|Overall Study|Lost to Follow-up|3|||
49006345|NCT01453374|157860853|FG000|Overall Study|Withdrawal by Subject|5|||
49006346|NCT01453374|157860853|FG000|Overall Study|Incarcerated|2|||
49006347|NCT00103259|157860854|FG000|Overall Study|Death|3|||
49006348|NCT00103259|157860855|FG001|Overall Study|Death|2|||
49006349|NCT00103259|157860854|FG000|Overall Study|Withdrawal by Subject|2|||
49006350|NCT00103259|157860855|FG001|Overall Study|Withdrawal by Subject|3|||
49006351|NCT00103259|157860854|FG000|Overall Study|alternative therapy|1|||
49006352|NCT00103259|157860855|FG001|Overall Study|alternative therapy|0|||
49006353|NCT00103259|157860854|FG000|Overall Study|other (reasons were not specified)|2|||
49006354|NCT00103259|157860855|FG001|Overall Study|other (reasons were not specified)|1|||
49006355|NCT00103259|157860854|FG000|Overall Study|ineligible/no protocol therapy|4|||
49006356|NCT00103259|157860855|FG001|Overall Study|ineligible/no protocol therapy|6|||
49006357|NCT03506425|157860860|FG000|Overall Study|Adverse Event|1|||
49006358|NCT03506425|157860861|FG001|Overall Study|Adverse Event|3|||
49006359|NCT03506425|157860862|FG002|Overall Study|Adverse Event|0|||
49006360|NCT03506425|157860860|FG000|Overall Study|Death|1|||
49006361|NCT03506425|157860861|FG001|Overall Study|Death|0|||
49006362|NCT03506425|157860862|FG002|Overall Study|Death|0|||
49006363|NCT03506425|157860860|FG000|Overall Study|Withdrawal by Subject|0|||
49006364|NCT03506425|157860861|FG001|Overall Study|Withdrawal by Subject|0|||
49006365|NCT03506425|157860862|FG002|Overall Study|Withdrawal by Subject|1|||
49006366|NCT02643394|157860868|FG000|Overall Study|Protocol Violation|4|||
49006367|NCT02643394|157860869|FG001|Overall Study|Protocol Violation|5|||
49006368|NCT04088734|157860870|FG000|Overall Study|Other, Not Specified|5|||
49006369|NCT00096200|157860872|FG000|Overall Study|Adverse Event|0|||
49006370|NCT00096200|157860873|FG001|Overall Study|Adverse Event|4|||
49006371|NCT00096200|157860874|FG002|Overall Study|Adverse Event|0|||
49006372|NCT00096200|157860872|FG000|Overall Study|Withdrawal by Subject|1|||
49006373|NCT00096200|157860873|FG001|Overall Study|Withdrawal by Subject|2|||
49006374|NCT00096200|157860874|FG002|Overall Study|Withdrawal by Subject|0|||
49006375|NCT00096200|157860872|FG000|Overall Study|Ineligible pathology|0|||
49006376|NCT00096200|157860873|FG001|Overall Study|Ineligible pathology|1|||
49006377|NCT00096200|157860874|FG002|Overall Study|Ineligible pathology|0|||
49006378|NCT00837577|157860875|FG000|Double-blind Period|Clinical Adverse Event|1|||
49006379|NCT00837577|157860876|FG001|Double-blind Period|Clinical Adverse Event|0|||
49006380|NCT00837577|157860875|FG000|Double-blind Period|Withdrawal by Subject|1|||
49006381|NCT00837577|157860876|FG001|Double-blind Period|Withdrawal by Subject|0|||
49006382|NCT00837577|157860875|FG000|Open-label Period|Clinical Adverse Event|2|||
49006383|NCT00837577|157860876|FG001|Open-label Period|Clinical Adverse Event|2|||
49006384|NCT00837577|157860875|FG000|Open-label Period|Laboratory Adverse Event|0|||
49006385|NCT00837577|157860876|FG001|Open-label Period|Laboratory Adverse Event|1|||
49006386|NCT00837577|157860875|FG000|Open-label Period|Lack of Efficacy|4|||
49006387|NCT00837577|157860876|FG001|Open-label Period|Lack of Efficacy|3|||
49006388|NCT00837577|157860875|FG000|Open-label Period|Withdrawal by Subject|1|||
49006389|NCT00837577|157860876|FG001|Open-label Period|Withdrawal by Subject|2|||
49006390|NCT00837577|157860875|FG000|Open-label Period|Other Reason|1|||
49006391|NCT00837577|157860876|FG001|Open-label Period|Other Reason|1|||
49006392|NCT02525562|157860879|FG000|Overall Study|Death|9|||
49006393|NCT02525562|157860880|FG001|Overall Study|Death|0|||
49006394|NCT02525562|157860881|FG002|Overall Study|Death|0|||
49006395|NCT02525562|157860879|FG000|Overall Study|Lost to Follow-up|19|||
49006396|NCT02525562|157860880|FG001|Overall Study|Lost to Follow-up|0|||
49006397|NCT02525562|157860881|FG002|Overall Study|Lost to Follow-up|0|||
49006398|NCT02525562|157860879|FG000|Overall Study|Withdrawal by Subject|37|||
49006399|NCT02525562|157860880|FG001|Overall Study|Withdrawal by Subject|0|||
49006400|NCT02525562|157860881|FG002|Overall Study|Withdrawal by Subject|0|||
49006401|NCT02525562|157860879|FG000|Overall Study|Revision/Removal of Study Device|4|||
49006402|NCT02525562|157860880|FG001|Overall Study|Revision/Removal of Study Device|0|||
49006403|NCT02525562|157860881|FG002|Overall Study|Revision/Removal of Study Device|0|||
49006404|NCT02525562|157860879|FG000|Overall Study|Study Closed by Sponsor|154|||
49006405|NCT02525562|157860880|FG001|Overall Study|Study Closed by Sponsor|0|||
49006406|NCT02525562|157860881|FG002|Overall Study|Study Closed by Sponsor|0|||
49006407|NCT02567266|157860885|FG000|Overall Study|Withdrawal by Subject|10|||
49006408|NCT02567266|157860886|FG001|Overall Study|Withdrawal by Subject|7|||
49006409|NCT02567266|157860887|FG002|Overall Study|Withdrawal by Subject|6|||
49006410|NCT02567266|157860885|FG000|Overall Study|Lost to Follow-up|13|||
49006411|NCT02567266|157860886|FG001|Overall Study|Lost to Follow-up|8|||
49006412|NCT02567266|157860887|FG002|Overall Study|Lost to Follow-up|10|||
49006413|NCT00975884|157860889|FG000|Overall Study|Adverse Event|1|||
49006414|NCT00975884|157860890|FG001|Overall Study|Adverse Event|0|||
49006415|NCT00975884|157860889|FG000|Overall Study|Lost to Follow-up|5|||
49006416|NCT00975884|157860890|FG001|Overall Study|Lost to Follow-up|3|||
49006417|NCT00975884|157860889|FG000|Overall Study|Withdrawal by Subject|9|||
49006418|NCT00975884|157860890|FG001|Overall Study|Withdrawal by Subject|9|||
49006419|NCT00975884|157860889|FG000|Overall Study|Other|1|||
49006420|NCT00975884|157860890|FG001|Overall Study|Other|3|||
49006421|NCT00383019|157860891|FG000|Overall Study|Adverse Event|5|||
49006422|NCT00383019|157860892|FG001|Overall Study|Adverse Event|1|||
49006423|NCT00383019|157860891|FG000|Overall Study|Withdrawal by Subject|0|||
49006424|NCT00383019|157860892|FG001|Overall Study|Withdrawal by Subject|1|||
49006425|NCT00420849|157860893|FG000|Overall Study|Lack of Efficacy|154|||
49006426|NCT00420849|157860893|FG000|Overall Study|Adverse Event|107|||
49006427|NCT00420849|157860893|FG000|Overall Study|Withdrawal by Subject|28|||
49006428|NCT00420849|157860893|FG000|Overall Study|Death|18|||
49006429|NCT00420849|157860893|FG000|Overall Study|Other|14|||
49006430|NCT00420849|157860893|FG000|Overall Study|Transplant|8|||
49006431|NCT00420849|157860893|FG000|Overall Study|Protocol Violation|1|||
49006432|NCT00420849|157860893|FG000|Overall Study|Lost to Follow-up|1|||
49006433|NCT00858234|157862432|FG000|Overall Study|Adverse Event|6|||
49006434|NCT00858234|157862432|FG000|Overall Study|Progressive disease|2|||
49006435|NCT00858234|157862432|FG000|Overall Study|Status unknown|1|||
49006436|NCT01901146|157862438|FG000|Neoadjuvant Phase|Death|1|||
49006437|NCT01901146|157862439|FG001|Neoadjuvant Phase|Death|2|||
49006438|NCT01901146|157862440|FG002|Neoadjuvant Phase|Death|0|||
49006439|NCT01901146|157862441|FG003|Neoadjuvant Phase|Death|0|||
49006440|NCT01901146|157862442|FG004|Neoadjuvant Phase|Death|0|||
49006441|NCT01901146|157862438|FG000|Neoadjuvant Phase|Disease Progression or Recurrence|2|||
49006442|NCT01901146|157862439|FG001|Neoadjuvant Phase|Disease Progression or Recurrence|3|||
49006443|NCT01901146|157862440|FG002|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
49006444|NCT01901146|157862441|FG003|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
49006445|NCT01901146|157862442|FG004|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
49006446|NCT01901146|157862438|FG000|Neoadjuvant Phase|Lost to Follow-up|0|||
49006447|NCT01901146|157862439|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
49006448|NCT01901146|157862440|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
49006449|NCT01901146|157862441|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
49006450|NCT01901146|157862442|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
49006451|NCT01901146|157862438|FG000|Neoadjuvant Phase|Physician Decision|1|||
49006452|NCT01901146|157862439|FG001|Neoadjuvant Phase|Physician Decision|2|||
49006453|NCT01901146|157862440|FG002|Neoadjuvant Phase|Physician Decision|0|||
49006454|NCT01901146|157862441|FG003|Neoadjuvant Phase|Physician Decision|0|||
49006455|NCT01901146|157862442|FG004|Neoadjuvant Phase|Physician Decision|0|||
49006456|NCT01901146|157862438|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
49006457|NCT01901146|157862439|FG001|Neoadjuvant Phase|Withdrawal by Subject|5|||
49006458|NCT01901146|157862440|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
49006459|NCT01901146|157862441|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
49006460|NCT01901146|157862442|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
49006461|NCT01901146|157862438|FG000|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
49006462|NCT01901146|157862439|FG001|Neoadjuvant Phase|Requirement for Alternative Therapy|1|||
49006463|NCT01901146|157862440|FG002|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
49006464|NCT01901146|157862441|FG003|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
49006465|NCT01901146|157862442|FG004|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
49006466|NCT01901146|157862438|FG000|Adjuvant Phase|Other|0|||
49006467|NCT01901146|157862439|FG001|Adjuvant Phase|Other|0|||
49006468|NCT01901146|157862440|FG002|Adjuvant Phase|Other|1|||
49006469|NCT01901146|157862441|FG003|Adjuvant Phase|Other|0|||
49006470|NCT01901146|157862442|FG004|Adjuvant Phase|Other|0|||
49006471|NCT01901146|157862438|FG000|Adjuvant Phase|Death|0|||
49006472|NCT01901146|157862439|FG001|Adjuvant Phase|Death|0|||
49006473|NCT01901146|157862440|FG002|Adjuvant Phase|Death|0|||
49006474|NCT01901146|157862441|FG003|Adjuvant Phase|Death|0|||
49006475|NCT01901146|157862442|FG004|Adjuvant Phase|Death|3|||
49006476|NCT01901146|157862438|FG000|Adjuvant Phase|Disease Progression or Recurrence|0|||
49006477|NCT01901146|157862439|FG001|Adjuvant Phase|Disease Progression or Recurrence|0|||
49006478|NCT01901146|157862440|FG002|Adjuvant Phase|Disease Progression or Recurrence|12|||
49006479|NCT01901146|157862441|FG003|Adjuvant Phase|Disease Progression or Recurrence|4|||
49006480|NCT01901146|157862442|FG004|Adjuvant Phase|Disease Progression or Recurrence|3|||
49006481|NCT01901146|157862438|FG000|Adjuvant Phase|Physician Decision|0|||
49006482|NCT01901146|157862439|FG001|Adjuvant Phase|Physician Decision|0|||
49006483|NCT01901146|157862440|FG002|Adjuvant Phase|Physician Decision|9|||
49006484|NCT01901146|157862441|FG003|Adjuvant Phase|Physician Decision|2|||
49006485|NCT01901146|157862442|FG004|Adjuvant Phase|Physician Decision|4|||
49006486|NCT01901146|157862438|FG000|Adjuvant Phase|Withdrawal by Subject|0|||
49006487|NCT01901146|157862439|FG001|Adjuvant Phase|Withdrawal by Subject|0|||
49006488|NCT01901146|157862440|FG002|Adjuvant Phase|Withdrawal by Subject|4|||
49006489|NCT01901146|157862441|FG003|Adjuvant Phase|Withdrawal by Subject|1|||
49006490|NCT01901146|157862442|FG004|Adjuvant Phase|Withdrawal by Subject|4|||
49006491|NCT00297492|157862443|FG000|Set Quit Date|Lost to Follow-up|7|||
49006492|NCT00297492|157862444|FG001|Set Quit Date|Lost to Follow-up|13|||
49006493|NCT00297492|157862445|FG002|Set Quit Date|Lost to Follow-up|5|||
49006494|NCT00297492|157862443|FG000|6 Month Follow-up|Lost to Follow-up|63|||
49006495|NCT00297492|157862444|FG001|6 Month Follow-up|Lost to Follow-up|49|||
49006496|NCT00297492|157862445|FG002|6 Month Follow-up|Lost to Follow-up|27|||
49006497|NCT02428231|157862446|FG000|Overall Study|Other|10|||
49006498|NCT02428231|157862447|FG001|Overall Study|Other|16|||
49006499|NCT02428231|157862446|FG000|Overall Study|Required Symptomatic Therapy|0|||
49006500|NCT02428231|157862447|FG001|Overall Study|Required Symptomatic Therapy|1|||
49006501|NCT02428231|157862446|FG000|Overall Study|Adverse Event|3|||
49006502|NCT02428231|157862447|FG001|Overall Study|Adverse Event|0|||
49006503|NCT03724968|157862448|FG000|Overall Study|Insurance issues|0|||
49006504|NCT03724968|157862449|FG001|Overall Study|Insurance issues|1|||
49006505|NCT03724968|157862448|FG000|Overall Study|Study closed|0|||
49006506|NCT03724968|157862449|FG001|Overall Study|Study closed|1|||
49006507|NCT01858558|157862452|FG000|Overall Study|Death|1|||
49006508|NCT01858558|157862453|FG001|Overall Study|Death|1|||
49006509|NCT01858558|157862452|FG000|Overall Study|Lost to Follow-up|1|||
49006510|NCT01858558|157862453|FG001|Overall Study|Lost to Follow-up|0|||
49006511|NCT01858558|157862452|FG000|Overall Study|Disease progression|3|||
49006512|NCT01858558|157862453|FG001|Overall Study|Disease progression|1|||
49006513|NCT01858558|157862452|FG000|Overall Study|Product contamination|2|||
49006514|NCT01858558|157862453|FG001|Overall Study|Product contamination|0|||
49006515|NCT01858558|157862452|FG000|Overall Study|Failed expansion of cell product|2|||
49006516|NCT01858558|157862453|FG001|Overall Study|Failed expansion of cell product|0|||
49006517|NCT01784419|157862454|FG000|Overall Study|Adverse Event|3|||
49006518|NCT01336608|157862455|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102|||
49006519|NCT01336608|157862456|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
49006520|NCT01336608|157862457|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
49006521|NCT01336608|157862458|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
49006522|NCT01336608|157862455|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|9|||
49006523|NCT01336608|157862456|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
49006524|NCT01336608|157862457|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
49006525|NCT01336608|157862458|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
49006526|NCT01336608|157862455|FG000|2-week, Single-blind Run-In Period|Adverse Event|1|||
49006527|NCT01336608|157862456|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
49006528|NCT01336608|157862457|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
49006529|NCT01336608|157862458|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
49006530|NCT01336608|157862455|FG000|2-week, Single-blind Run-In Period|Physician Decision|1|||
49006531|NCT01336608|157862456|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
49006532|NCT01336608|157862457|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
49006533|NCT01336608|157862458|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
49006534|NCT01336608|157862455|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|2|||
49006535|NCT01336608|157862456|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
49006536|NCT01336608|157862457|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
49006537|NCT01336608|157862458|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
49006538|NCT01336608|157862455|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
49006539|NCT01336608|157862456|FG001|24-week, Double-blind Treatment Period|Adverse Event|8|||
49006540|NCT01336608|157862457|FG002|24-week, Double-blind Treatment Period|Adverse Event|6|||
49006541|NCT01336608|157862458|FG003|24-week, Double-blind Treatment Period|Adverse Event|7|||
49006542|NCT01336608|157862455|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
49006543|NCT01336608|157862456|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
49006544|NCT01336608|157862457|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
49006545|NCT01336608|157862458|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
49006546|NCT01336608|157862455|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
49006547|NCT01336608|157862456|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
49006548|NCT01336608|157862457|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
49006549|NCT01336608|157862458|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6|||
49006550|NCT01336608|157862455|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
49006551|NCT01336608|157862456|FG001|24-week, Double-blind Treatment Period|Protocol Violation|4|||
49006552|NCT01336608|157862457|FG002|24-week, Double-blind Treatment Period|Protocol Violation|3|||
49006553|NCT01336608|157862458|FG003|24-week, Double-blind Treatment Period|Protocol Violation|3|||
49006554|NCT01336608|157862455|FG000|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
49006555|NCT01336608|157862456|FG001|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
49006556|NCT01336608|157862457|FG002|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3|||
49006557|NCT01336608|157862458|FG003|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6|||
49006558|NCT01336608|157862455|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
49006559|NCT01336608|157862456|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
49006560|NCT01336608|157862457|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
49006561|NCT01336608|157862458|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
49006562|NCT01336608|157862455|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
49006563|NCT01336608|157862456|FG001|24-week, Double-blind Treatment Period|Physician Decision|3|||
49006564|NCT01336608|157862457|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
49006565|NCT01336608|157862458|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
49006566|NCT01336608|157862455|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
49006567|NCT01336608|157862456|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
49006568|NCT01336608|157862457|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
49006569|NCT01336608|157862458|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|1|||
49006570|NCT02237118|157862459|FG000|Overall Study|Protocol Violation|0|||
49006571|NCT02237118|157862460|FG001|Overall Study|Protocol Violation|1|||
49006572|NCT02237118|157862459|FG000|Overall Study|consent withdrawn|1|||
49006573|NCT02237118|157862460|FG001|Overall Study|consent withdrawn|0|||
49006574|NCT00080288|157862461|FG000|Overall Study|Adverse Event|7|||
49006575|NCT00080288|157862462|FG001|Overall Study|Adverse Event|4|||
49006576|NCT00080288|157862461|FG000|Overall Study|Lost to Follow-up|3|||
49006577|NCT00080288|157862462|FG001|Overall Study|Lost to Follow-up|5|||
49006578|NCT00080288|157862461|FG000|Overall Study|Physician Decision|6|||
49006579|NCT00080288|157862462|FG001|Overall Study|Physician Decision|2|||
49006580|NCT00080288|157862461|FG000|Overall Study|Withdrawal by Subject|3|||
49006581|NCT00080288|157862462|FG001|Overall Study|Withdrawal by Subject|16|||
49006582|NCT00080288|157862461|FG000|Overall Study|Miscellaneous|11|||
49006583|NCT00080288|157862462|FG001|Overall Study|Miscellaneous|11|||
49006584|NCT00366678|157862463|FG000|Infant Series|Withdrawal by Subject|8|||
49006585|NCT00366678|157862464|FG001|Infant Series|Withdrawal by Subject|6|||
49006586|NCT00366678|157862465|FG002|Infant Series|Withdrawal by Subject|0|||
49006587|NCT00366678|157862463|FG000|Infant Series|Protocol Violation|4|||
49006588|NCT00366678|157862464|FG001|Infant Series|Protocol Violation|3|||
49006589|NCT00366678|157862465|FG002|Infant Series|Protocol Violation|0|||
49006590|NCT00366678|157862463|FG000|Infant Series|Failed to return|1|||
49006591|NCT00366678|157862464|FG001|Infant Series|Failed to return|1|||
49006592|NCT00366678|157862465|FG002|Infant Series|Failed to return|0|||
49006593|NCT00366678|157862463|FG000|Infant Series|Adverse Event|1|||
49006594|NCT00366678|157862464|FG001|Infant Series|Adverse Event|0|||
49006595|NCT00366678|157862465|FG002|Infant Series|Adverse Event|0|||
49006596|NCT00366678|157862463|FG000|After Infant|Withdrawal by Subject|8|||
49006597|NCT00366678|157862464|FG001|After Infant|Withdrawal by Subject|4|||
49006598|NCT00366678|157862465|FG002|After Infant|Withdrawal by Subject|0|||
49006599|NCT00366678|157862463|FG000|After Infant|Lost to Follow-up|2|||
49006600|NCT00366678|157862464|FG001|After Infant|Lost to Follow-up|1|||
49006601|NCT00366678|157862465|FG002|After Infant|Lost to Follow-up|0|||
49006602|NCT00366678|157862463|FG000|After Infant|Failed to return|5|||
49006603|NCT00366678|157862464|FG001|After Infant|Failed to return|5|||
49006604|NCT00366678|157862465|FG002|After Infant|Failed to return|0|||
49006605|NCT00366678|157862463|FG000|After Infant|Adverse Event|1|||
49006606|NCT00366678|157862464|FG001|After Infant|Adverse Event|0|||
49006607|NCT00366678|157862465|FG002|After Infant|Adverse Event|0|||
49006608|NCT00366678|157862463|FG000|After Infant|Protocol Violation|1|||
49006609|NCT00366678|157862464|FG001|After Infant|Protocol Violation|0|||
49006610|NCT00366678|157862465|FG002|After Infant|Protocol Violation|0|||
49006611|NCT00366678|157862463|FG000|Toddler Dose|Protocol Violation|2|||
49006612|NCT00366678|157862464|FG001|Toddler Dose|Protocol Violation|1|||
49006613|NCT00366678|157862465|FG002|Toddler Dose|Protocol Violation|0|||
49006614|NCT00366678|157862463|FG000|Toddler Dose|Failed to return|1|||
49006615|NCT00366678|157862464|FG001|Toddler Dose|Failed to return|0|||
49006616|NCT00366678|157862465|FG002|Toddler Dose|Failed to return|0|||
49006617|NCT00366678|157862463|FG000|Toddler Dose|Withdrawal by Subject|1|||
49006618|NCT00366678|157862464|FG001|Toddler Dose|Withdrawal by Subject|0|||
49006619|NCT00366678|157862465|FG002|Toddler Dose|Withdrawal by Subject|0|||
49006620|NCT00366678|157862463|FG000|Toddler Dose|protocol deviation|1|||
49006621|NCT00366678|157862464|FG001|Toddler Dose|protocol deviation|0|||
49006622|NCT00366678|157862465|FG002|Toddler Dose|protocol deviation|0|||
49006623|NCT01963676|157862466|FG000|Overall Study|Withdrawal by Subject|1|||
49006624|NCT01963676|157862467|FG001|Overall Study|Withdrawal by Subject|0|||
49006625|NCT02437890|157862472|FG000|Overall Study|Non-compliance to study drug|0|||
49006626|NCT02437890|157862473|FG001|Overall Study|Non-compliance to study drug|1|||
49006627|NCT02437890|157862474|FG002|Overall Study|Non-compliance to study drug|0|||
49006628|NCT02437890|157862475|FG003|Overall Study|Non-compliance to study drug|0|||
49006629|NCT02437890|157862476|FG004|Overall Study|Non-compliance to study drug|1|||
49006630|NCT02437890|157862472|FG000|Overall Study|Sponsor's decision|1|||
49006631|NCT02437890|157862473|FG001|Overall Study|Sponsor's decision|1|||
49006632|NCT02437890|157862474|FG002|Overall Study|Sponsor's decision|4|||
49006633|NCT02437890|157862475|FG003|Overall Study|Sponsor's decision|0|||
49006634|NCT02437890|157862476|FG004|Overall Study|Sponsor's decision|2|||
49006635|NCT02437890|157862472|FG000|Overall Study|Physician Decision|0|||
49006636|NCT02437890|157862473|FG001|Overall Study|Physician Decision|0|||
49006637|NCT02437890|157862474|FG002|Overall Study|Physician Decision|0|||
49006638|NCT02437890|157862475|FG003|Overall Study|Physician Decision|1|||
49006639|NCT02437890|157862476|FG004|Overall Study|Physician Decision|0|||
49006640|NCT02437890|157862472|FG000|Overall Study|Unable to attend visit(s)|1|||
49006641|NCT02437890|157862473|FG001|Overall Study|Unable to attend visit(s)|0|||
49006642|NCT02437890|157862474|FG002|Overall Study|Unable to attend visit(s)|0|||
49006643|NCT02437890|157862475|FG003|Overall Study|Unable to attend visit(s)|0|||
49006644|NCT02437890|157862476|FG004|Overall Study|Unable to attend visit(s)|0|||
49006645|NCT02437890|157862472|FG000|Overall Study|Lack of Efficacy|1|||
49006646|NCT02437890|157862473|FG001|Overall Study|Lack of Efficacy|3|||
49006647|NCT02437890|157862474|FG002|Overall Study|Lack of Efficacy|0|||
49006648|NCT02437890|157862475|FG003|Overall Study|Lack of Efficacy|3|||
49006649|NCT02437890|157862476|FG004|Overall Study|Lack of Efficacy|1|||
49006650|NCT02437890|157862472|FG000|Overall Study|Adverse Event|4|||
49006651|NCT02437890|157862473|FG001|Overall Study|Adverse Event|9|||
49006652|NCT02437890|157862474|FG002|Overall Study|Adverse Event|5|||
49006653|NCT02437890|157862475|FG003|Overall Study|Adverse Event|11|||
49006654|NCT02437890|157862476|FG004|Overall Study|Adverse Event|7|||
49006655|NCT02437890|157862472|FG000|Overall Study|Withdrawal by Subject|1|||
49006656|NCT02437890|157862473|FG001|Overall Study|Withdrawal by Subject|2|||
49006657|NCT02437890|157862474|FG002|Overall Study|Withdrawal by Subject|6|||
49006658|NCT02437890|157862475|FG003|Overall Study|Withdrawal by Subject|5|||
49006659|NCT02437890|157862476|FG004|Overall Study|Withdrawal by Subject|5|||
49006660|NCT02437890|157862472|FG000|Overall Study|Death|0|||
49006661|NCT02437890|157862473|FG001|Overall Study|Death|0|||
49006662|NCT02437890|157862474|FG002|Overall Study|Death|0|||
49006663|NCT02437890|157862475|FG003|Overall Study|Death|2|||
49006664|NCT02437890|157862476|FG004|Overall Study|Death|0|||
49006665|NCT02328547|157862477|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
49006666|NCT02328547|157862478|FG001|First Intervention (12 Weeks)|Lost to Follow-up|0|||
49006667|NCT02328547|157862477|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
49006668|NCT02328547|157862478|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
49006669|NCT00344305|157862479|FG000|Overall Study|Lost to Follow-up|2|||
49006670|NCT00344305|157862480|FG001|Overall Study|Lost to Follow-up|0|||
49006671|NCT00344305|157862479|FG000|Overall Study|Participant was not contacted in window|0|||
49006672|NCT00344305|157862480|FG001|Overall Study|Participant was not contacted in window|1|||
49006673|NCT00078312|157862481|FG000|Overall Study|Adverse Event|43|||
49006674|NCT00078312|157862481|FG000|Overall Study|Lack of Efficacy|15|||
49006675|NCT00078312|157862481|FG000|Overall Study|Lost to Follow-up|41|||
49006676|NCT00078312|157862481|FG000|Overall Study|Physician Decision|9|||
49006677|NCT00078312|157862481|FG000|Overall Study|Protocol Violation|3|||
49006678|NCT00078312|157862481|FG000|Overall Study|Withdrawal by Subject|33|||
49006679|NCT00078312|157862481|FG000|Overall Study|Miscellaneous|33|||
49006680|NCT00331773|157862484|FG000|Overall Study|Withdrawal by Subject|6|||
49006681|NCT00331773|157862485|FG001|Overall Study|Withdrawal by Subject|4|||
49006682|NCT00331773|157862484|FG000|Overall Study|Protocol Violation|10|||
49006683|NCT00331773|157862485|FG001|Overall Study|Protocol Violation|3|||
49006684|NCT01954082|157862486|FG000|Overall Study|Study Suspension|42|||
49006685|NCT01954082|157862487|FG001|Overall Study|Study Suspension|36|||
49006686|NCT01954082|157862486|FG000|Overall Study|Adverse Event|10|||
49006687|NCT01954082|157862487|FG001|Overall Study|Adverse Event|4|||
49006688|NCT01954082|157862486|FG000|Overall Study|Intolerance|0|||
49006689|NCT01954082|157862487|FG001|Overall Study|Intolerance|1|||
49006690|NCT01954082|157862486|FG000|Overall Study|Non-compliance|6|||
49006691|NCT01954082|157862487|FG001|Overall Study|Non-compliance|4|||
49006692|NCT01954082|157862486|FG000|Overall Study|Physician Decision|2|||
49006693|NCT01954082|157862487|FG001|Overall Study|Physician Decision|0|||
49006694|NCT01954082|157862486|FG000|Overall Study|Parent Decision|1|||
49006695|NCT01954082|157862487|FG001|Overall Study|Parent Decision|0|||
49006696|NCT01954082|157862486|FG000|Overall Study|Withdrawal by Subject|0|||
49006697|NCT01954082|157862487|FG001|Overall Study|Withdrawal by Subject|1|||
49006698|NCT01954082|157862486|FG000|Overall Study|Discontinued Early Prior to Transfer|3|||
49006699|NCT01954082|157862487|FG001|Overall Study|Discontinued Early Prior to Transfer|2|||
49006700|NCT01954082|157862486|FG000|Overall Study|Redirection of Care|0|||
49006701|NCT01954082|157862487|FG001|Overall Study|Redirection of Care|2|||
49006702|NCT01954082|157862486|FG000|Overall Study|Miscalculation of Final Dose Day|0|||
49006703|NCT01954082|157862487|FG001|Overall Study|Miscalculation of Final Dose Day|3|||
49006704|NCT01954082|157862486|FG000|Overall Study|Comfort Care|0|||
49006705|NCT01954082|157862487|FG001|Overall Study|Comfort Care|1|||
49006706|NCT01954082|157862486|FG000|Overall Study|Infant Moved|0|||
49006707|NCT01954082|157862487|FG001|Overall Study|Infant Moved|1|||
49006708|NCT01954082|157862486|FG000|Overall Study|Randomized not Treated|4|||
49006709|NCT01954082|157862487|FG001|Overall Study|Randomized not Treated|2|||
49006710|NCT03944707|157862488|FG000|Overall Study|Adverse Event|0|||
49006711|NCT03944707|157862489|FG001|Overall Study|Adverse Event|2|||
49006712|NCT03944707|157862488|FG000|Overall Study|Study terminated by sponsor|12|||
49006713|NCT03944707|157862489|FG001|Overall Study|Study terminated by sponsor|7|||
49006714|NCT03944707|157862488|FG000|Overall Study|Subject decision|0|||
49006715|NCT03944707|157862489|FG001|Overall Study|Subject decision|1|||
49006716|NCT02444182|157862492|FG000|Overall Study|non-compliance|2|||
49006717|NCT02444182|157862493|FG001|Overall Study|non-compliance|1|||
49006718|NCT02444182|157862492|FG000|Overall Study|Lost to Follow-up|0|||
49006719|NCT02444182|157862493|FG001|Overall Study|Lost to Follow-up|4|||
49006720|NCT03216954|157862501|FG000|Overall Study|Adverse Event|0|||
49006721|NCT03216954|157862502|FG001|Overall Study|Adverse Event|0|||
49006722|NCT03216954|157862503|FG002|Overall Study|Adverse Event|1|||
49006723|NCT03216954|157862504|FG003|Overall Study|Adverse Event|0|||
49006724|NCT03216954|157862505|FG004|Overall Study|Adverse Event|1|||
49006725|NCT03216954|157862501|FG000|Overall Study|Withdrawal by Subject|2|||
49006726|NCT03216954|157862502|FG001|Overall Study|Withdrawal by Subject|0|||
49006727|NCT03216954|157862503|FG002|Overall Study|Withdrawal by Subject|0|||
49006728|NCT03216954|157862504|FG003|Overall Study|Withdrawal by Subject|0|||
49006729|NCT03216954|157862505|FG004|Overall Study|Withdrawal by Subject|0|||
49006730|NCT03216954|157862501|FG000|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
49006731|NCT03216954|157862502|FG001|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1|||
49006732|NCT03216954|157862503|FG002|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
49006733|NCT03216954|157862504|FG003|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
49006734|NCT03216954|157862505|FG004|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
49006735|NCT00829439|157862506|FG000|Overall Study|Adverse Event|0|||
49006736|NCT00829439|157862507|FG001|Overall Study|Adverse Event|0|||
49006737|NCT00829439|157862508|FG002|Overall Study|Adverse Event|1|||
49006738|NCT00829439|157862509|FG003|Overall Study|Adverse Event|0|||
49006739|NCT00386100|157862511|FG000|Overall Study|Did not receive study medication|6|||
49006740|NCT00386100|157862512|FG001|Overall Study|Did not receive study medication|4|||
49006741|NCT00386100|157862511|FG000|Overall Study|Adverse Event|15|||
49006742|NCT00386100|157862512|FG001|Overall Study|Adverse Event|25|||
49006743|NCT00386100|157862511|FG000|Overall Study|Death|0|||
49006744|NCT00386100|157862512|FG001|Overall Study|Death|1|||
49006745|NCT00386100|157862511|FG000|Overall Study|Insufficient therapeutic effect|30|||
49006746|NCT00386100|157862512|FG001|Overall Study|Insufficient therapeutic effect|6|||
49006747|NCT00386100|157862511|FG000|Overall Study|Lost to Follow-up|29|||
49006748|NCT00386100|157862512|FG001|Overall Study|Lost to Follow-up|29|||
49006749|NCT00386100|157862511|FG000|Overall Study|Non-compliance|18|||
49006750|NCT00386100|157862512|FG001|Overall Study|Non-compliance|19|||
49006751|NCT00386100|157862511|FG000|Overall Study|Protocol Violation|5|||
49006752|NCT00386100|157862512|FG001|Overall Study|Protocol Violation|3|||
49006753|NCT00386100|157862511|FG000|Overall Study|Withdrawal by Subject|32|||
49006754|NCT00386100|157862512|FG001|Overall Study|Withdrawal by Subject|31|||
49006755|NCT00386100|157862511|FG000|Overall Study|Bone mass density (BMD) loss >6%|4|||
49006756|NCT00386100|157862512|FG001|Overall Study|Bone mass density (BMD) loss >6%|4|||
49006757|NCT00386100|157862511|FG000|Overall Study|BMD <2.5|1|||
49006758|NCT00386100|157862512|FG001|Overall Study|BMD <2.5|0|||
49006759|NCT00386100|157862511|FG000|Overall Study|Consecutive elevated Hba1C|1|||
49006760|NCT00386100|157862512|FG001|Overall Study|Consecutive elevated Hba1C|0|||
49006761|NCT00386100|157862511|FG000|Overall Study|Visit 11 DXA showed excessive bone loss|0|||
49006762|NCT00386100|157862512|FG001|Overall Study|Visit 11 DXA showed excessive bone loss|1|||
49006763|NCT00386100|157862511|FG000|Overall Study|Laboratory findings|1|||
49006764|NCT00386100|157862512|FG001|Overall Study|Laboratory findings|0|||
49006765|NCT00386100|157862511|FG000|Overall Study|Participant's concern due to CPK levels|1|||
49006766|NCT00386100|157862512|FG001|Overall Study|Participant's concern due to CPK levels|0|||
49006767|NCT00386100|157862511|FG000|Overall Study|Participant moving out of state|2|||
49006768|NCT00386100|157862512|FG001|Overall Study|Participant moving out of state|0|||
49006769|NCT00386100|157862511|FG000|Overall Study|Excessive bone loss vs. baseline value|0|||
49006770|NCT00386100|157862512|FG001|Overall Study|Excessive bone loss vs. baseline value|1|||
49006771|NCT00386100|157862511|FG000|Overall Study|Didn't meet entry criteria|1|||
49006772|NCT00386100|157862512|FG001|Overall Study|Didn't meet entry criteria|1|||
49006773|NCT00386100|157862511|FG000|Overall Study|Participant's PCP wanted to stop drug|1|||
49006774|NCT00386100|157862512|FG001|Overall Study|Participant's PCP wanted to stop drug|0|||
49006775|NCT00386100|157862511|FG000|Overall Study|Osteoporosis findings on Visit 2 DXA|0|||
49006776|NCT00386100|157862512|FG001|Overall Study|Osteoporosis findings on Visit 2 DXA|1|||
49006777|NCT00386100|157862511|FG000|Overall Study|Bad metabolic control & patient security|1|||
49006778|NCT00386100|157862512|FG001|Overall Study|Bad metabolic control & patient security|0|||
49006779|NCT00386100|157862511|FG000|Overall Study|Bone loss by DXA bone scan|1|||
49006780|NCT00386100|157862512|FG001|Overall Study|Bone loss by DXA bone scan|0|||
49006781|NCT00386100|157862511|FG000|Overall Study|DBP 93 mmHg at randomization|1|||
49006782|NCT00386100|157862512|FG001|Overall Study|DBP 93 mmHg at randomization|0|||
49006783|NCT00386100|157862511|FG000|Overall Study|7.6% bone loss|1|||
49006784|NCT00386100|157862512|FG001|Overall Study|7.6% bone loss|0|||
49006785|NCT00386100|157862511|FG000|Overall Study|Osteoporosis|0|||
49006786|NCT00386100|157862512|FG001|Overall Study|Osteoporosis|1|||
49006787|NCT00386100|157862511|FG000|Overall Study|Positive pregnancy test|1|||
49006788|NCT00386100|157862512|FG001|Overall Study|Positive pregnancy test|3|||
49006789|NCT00386100|157862511|FG000|Overall Study|Out of country for 5 months|1|||
49006790|NCT00386100|157862512|FG001|Overall Study|Out of country for 5 months|0|||
49006791|NCT00386100|157862511|FG000|Overall Study|Hb1Ac >8%|0|||
49006792|NCT00386100|157862512|FG001|Overall Study|Hb1Ac >8%|1|||
49006793|NCT00386100|157862511|FG000|Overall Study|Participant randomized in error|1|||
49006794|NCT00386100|157862512|FG001|Overall Study|Participant randomized in error|0|||
49006795|NCT00810615|157862513|FG000|Overall Study|Withdrawal by Subject|1|||
49006796|NCT00810615|157862514|FG001|Overall Study|Withdrawal by Subject|1|||
49006797|NCT01238211|157862515|FG000|Overall Study|Continues active treatment|31|||
49006798|NCT01238211|157862515|FG000|Overall Study|Adverse Event|7|||
49006799|NCT01238211|157862515|FG000|Overall Study|Death|4|||
49006800|NCT01238211|157862515|FG000|Overall Study|Relapse/Progression|2|||
49006801|NCT01238211|157862515|FG000|Overall Study|Withdrawal by Subject|7|||
49006802|NCT01238211|157862515|FG000|Overall Study|Non-protocol treatment|4|||
49006803|NCT01238211|157862515|FG000|Overall Study|Investigator/Patient Decision|3|||
49006804|NCT04428502|157862518|FG000|Overall Study|Did not meet entrance criteria|14|||
49006805|NCT01358708|157862519|FG000|Double-Blind Treatment Phase|Lost to Follow-up|2|||
49006806|NCT01358708|157862520|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
49006807|NCT01358708|157862519|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
49006808|NCT01358708|157862520|FG001|Double-Blind Treatment Phase|Protocol Violation|0|||
49006809|NCT01656967|157862521|FG000|Overall Study|faulty monitor|1|||
49006810|NCT01656967|157862522|FG001|Overall Study|faulty monitor|0|||
49006811|NCT01656967|157862521|FG000|Overall Study|unsuccessful ETT insertion|3|||
49006812|NCT01656967|157862522|FG001|Overall Study|unsuccessful ETT insertion|2|||
49006813|NCT00051636|157862523|FG000|Period 1 - Core|Adverse Event|2|||
49006814|NCT00051636|157862524|FG001|Period 1 - Core|Adverse Event|2|||
49006815|NCT00051636|157862523|FG000|Period 1 - Core|Protocol Violation|1|||
49006816|NCT00051636|157862524|FG001|Period 1 - Core|Protocol Violation|0|||
49006817|NCT00051636|157862523|FG000|Period 1 - Core|Withdrawal by Subject|1|||
49006818|NCT00051636|157862524|FG001|Period 1 - Core|Withdrawal by Subject|2|||
49006819|NCT00051636|157862523|FG000|Period 1 - Core|Lost to Follow-up|0|||
49006820|NCT00051636|157862524|FG001|Period 1 - Core|Lost to Follow-up|2|||
49006821|NCT00051636|157862523|FG000|Period 2- Extended Observation Period|Lost to Follow-up|5|||
49006822|NCT00051636|157862524|FG001|Period 2- Extended Observation Period|Lost to Follow-up|4|||
49006823|NCT00051636|157862523|FG000|Period 2- Extended Observation Period|withdrew for nonclinical reason|12|||
49006824|NCT00051636|157862524|FG001|Period 2- Extended Observation Period|withdrew for nonclinical reason|7|||
49006825|NCT00051636|157862523|FG000|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9|||
49006826|NCT00051636|157862524|FG001|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2|||
49006827|NCT00051636|157862523|FG000|Period 2- Extended Observation Period|Death|4|||
49006828|NCT00051636|157862524|FG001|Period 2- Extended Observation Period|Death|5|||
49006829|NCT00051636|157862523|FG000|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40|||
49006830|NCT00051636|157862524|FG001|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12|||
49006831|NCT01174368|157862525|FG000|Overall Study|Withdrawal by Subject|1|||
49006832|NCT00725725|157862526|FG000|Overall Study|Adverse Event|1|||
49006833|NCT00725725|157862527|FG001|Overall Study|Adverse Event|3|||
49006834|NCT00725725|157862528|FG002|Overall Study|Adverse Event|2|||
49006835|NCT00725725|157862526|FG000|Overall Study|Lost to Follow-up|2|||
49006836|NCT00725725|157862527|FG001|Overall Study|Lost to Follow-up|0|||
49006837|NCT00725725|157862528|FG002|Overall Study|Lost to Follow-up|2|||
49006838|NCT00725725|157862526|FG000|Overall Study|Withdrawal by Subject|1|||
49006839|NCT00725725|157862527|FG001|Overall Study|Withdrawal by Subject|0|||
49006840|NCT00725725|157862528|FG002|Overall Study|Withdrawal by Subject|1|||
49006841|NCT00725725|157862526|FG000|Overall Study|Protocol Violation|0|||
49006842|NCT00725725|157862527|FG001|Overall Study|Protocol Violation|1|||
49006843|NCT00725725|157862528|FG002|Overall Study|Protocol Violation|0|||
49006844|NCT00479765|157862534|FG000|Overall Study|study terminated|4|||
49006845|NCT03056001|157862537|FG000|Overall Study|Death|24|||
49006846|NCT01364298|157862538|FG000|Overall Study|Adverse Event|3|||
49006847|NCT01364298|157862539|FG001|Overall Study|Adverse Event|4|||
49006848|NCT01364298|157862538|FG000|Overall Study|Lack of adherence to treatment|1|||
49006849|NCT01364298|157862539|FG001|Overall Study|Lack of adherence to treatment|3|||
49006850|NCT01364298|157862538|FG000|Overall Study|Lack of Efficacy|1|||
49006851|NCT01364298|157862539|FG001|Overall Study|Lack of Efficacy|0|||
49006852|NCT01364298|157862538|FG000|Overall Study|Lost to Follow-up|5|||
49006853|NCT01364298|157862539|FG001|Overall Study|Lost to Follow-up|10|||
49006854|NCT01364298|157862538|FG000|Overall Study|Withdrawal by Subject|3|||
49006855|NCT01364298|157862539|FG001|Overall Study|Withdrawal by Subject|3|||
49006856|NCT01364298|157862538|FG000|Overall Study|Other|1|||
49006857|NCT01364298|157862539|FG001|Overall Study|Other|3|||
49006858|NCT04380701|157862540|FG000|Overall Study|Pregnancy|0|||
49006859|NCT04380701|157862541|FG001|Overall Study|Pregnancy|0|||
49006860|NCT04380701|157862542|FG002|Overall Study|Pregnancy|0|||
49006861|NCT04380701|157862543|FG003|Overall Study|Pregnancy|0|||
49006862|NCT04380701|157862544|FG004|Overall Study|Pregnancy|0|||
49006863|NCT04380701|157862545|FG005|Overall Study|Pregnancy|0|||
49006864|NCT04380701|157862546|FG006|Overall Study|Pregnancy|0|||
49006865|NCT04380701|157862547|FG007|Overall Study|Pregnancy|0|||
49006866|NCT04380701|157862548|FG008|Overall Study|Pregnancy|0|||
49006867|NCT04380701|157862549|FG009|Overall Study|Pregnancy|0|||
49006868|NCT04380701|157862550|FG010|Overall Study|Pregnancy|0|||
49006869|NCT04380701|157862551|FG011|Overall Study|Pregnancy|0|||
49006870|NCT04380701|157862552|FG012|Overall Study|Pregnancy|0|||
49006871|NCT04380701|157862553|FG013|Overall Study|Pregnancy|0|||
49006872|NCT04380701|157862554|FG014|Overall Study|Pregnancy|0|||
49006873|NCT04380701|157862555|FG015|Overall Study|Pregnancy|0|||
49006874|NCT04380701|157862556|FG016|Overall Study|Pregnancy|0|||
49006875|NCT04380701|157862557|FG017|Overall Study|Pregnancy|0|||
49006876|NCT04380701|157862558|FG018|Overall Study|Pregnancy|0|||
49006877|NCT04380701|157862559|FG019|Overall Study|Pregnancy|0|||
49006878|NCT04380701|157862560|FG020|Overall Study|Pregnancy|0|||
49006879|NCT04380701|157862561|FG021|Overall Study|Pregnancy|0|||
49006880|NCT04380701|157862562|FG022|Overall Study|Pregnancy|0|||
49006881|NCT04380701|157862563|FG023|Overall Study|Pregnancy|0|||
49006882|NCT04380701|157862564|FG024|Overall Study|Pregnancy|0|||
49006883|NCT04380701|157862565|FG025|Overall Study|Pregnancy|0|||
49006884|NCT04380701|157862566|FG026|Overall Study|Pregnancy|0|||
49006885|NCT04380701|157862567|FG027|Overall Study|Pregnancy|0|||
49006886|NCT04380701|157862568|FG028|Overall Study|Pregnancy|0|||
49006887|NCT04380701|157862569|FG029|Overall Study|Pregnancy|0|||
49006888|NCT04380701|157862570|FG030|Overall Study|Pregnancy|0|||
49006889|NCT04380701|157862571|FG031|Overall Study|Pregnancy|0|||
49006890|NCT04380701|157862572|FG032|Overall Study|Pregnancy|1|||
49006891|NCT04380701|157862573|FG033|Overall Study|Pregnancy|0|||
49006892|NCT04380701|157862540|FG000|Overall Study|Lost to Follow-up|0|||
49006893|NCT04380701|157862541|FG001|Overall Study|Lost to Follow-up|0|||
49006894|NCT04380701|157862542|FG002|Overall Study|Lost to Follow-up|0|||
49006895|NCT04380701|157862543|FG003|Overall Study|Lost to Follow-up|0|||
49006896|NCT04380701|157862544|FG004|Overall Study|Lost to Follow-up|0|||
49006897|NCT04380701|157862545|FG005|Overall Study|Lost to Follow-up|0|||
49006898|NCT04380701|157862546|FG006|Overall Study|Lost to Follow-up|0|||
49006899|NCT04380701|157862547|FG007|Overall Study|Lost to Follow-up|0|||
49006900|NCT04380701|157862548|FG008|Overall Study|Lost to Follow-up|0|||
49006901|NCT04380701|157862549|FG009|Overall Study|Lost to Follow-up|0|||
49006902|NCT04380701|157862550|FG010|Overall Study|Lost to Follow-up|0|||
49006903|NCT04380701|157862551|FG011|Overall Study|Lost to Follow-up|0|||
49006904|NCT04380701|157862552|FG012|Overall Study|Lost to Follow-up|0|||
49006905|NCT04380701|157862553|FG013|Overall Study|Lost to Follow-up|0|||
49006906|NCT04380701|157862554|FG014|Overall Study|Lost to Follow-up|0|||
49006907|NCT04380701|157862555|FG015|Overall Study|Lost to Follow-up|0|||
49006908|NCT04380701|157862556|FG016|Overall Study|Lost to Follow-up|0|||
49006909|NCT04380701|157862557|FG017|Overall Study|Lost to Follow-up|0|||
49006910|NCT04380701|157862558|FG018|Overall Study|Lost to Follow-up|0|||
49006911|NCT04380701|157862559|FG019|Overall Study|Lost to Follow-up|0|||
49006912|NCT04380701|157862560|FG020|Overall Study|Lost to Follow-up|1|||
49006913|NCT04380701|157862561|FG021|Overall Study|Lost to Follow-up|0|||
49006914|NCT04380701|157862562|FG022|Overall Study|Lost to Follow-up|0|||
49006915|NCT04380701|157862563|FG023|Overall Study|Lost to Follow-up|1|||
49006916|NCT04380701|157862564|FG024|Overall Study|Lost to Follow-up|0|||
49006917|NCT04380701|157862565|FG025|Overall Study|Lost to Follow-up|0|||
49006918|NCT04380701|157862566|FG026|Overall Study|Lost to Follow-up|0|||
49006919|NCT04380701|157862567|FG027|Overall Study|Lost to Follow-up|0|||
49006920|NCT04380701|157862568|FG028|Overall Study|Lost to Follow-up|0|||
49006921|NCT04380701|157862569|FG029|Overall Study|Lost to Follow-up|1|||
49006922|NCT04380701|157862570|FG030|Overall Study|Lost to Follow-up|0|||
49006923|NCT04380701|157862571|FG031|Overall Study|Lost to Follow-up|0|||
49006924|NCT04380701|157862572|FG032|Overall Study|Lost to Follow-up|0|||
49006925|NCT04380701|157862573|FG033|Overall Study|Lost to Follow-up|1|||
49006926|NCT04380701|157862540|FG000|Overall Study|Private reason(s)|0|||
49006927|NCT04380701|157862541|FG001|Overall Study|Private reason(s)|0|||
49006928|NCT04380701|157862542|FG002|Overall Study|Private reason(s)|0|||
49006929|NCT04380701|157862543|FG003|Overall Study|Private reason(s)|0|||
49006930|NCT04380701|157862544|FG004|Overall Study|Private reason(s)|0|||
49006931|NCT04380701|157862545|FG005|Overall Study|Private reason(s)|0|||
49006932|NCT04380701|157862546|FG006|Overall Study|Private reason(s)|1|||
49006933|NCT04380701|157862547|FG007|Overall Study|Private reason(s)|0|||
49006934|NCT04380701|157862548|FG008|Overall Study|Private reason(s)|1|||
49006935|NCT04380701|157862549|FG009|Overall Study|Private reason(s)|1|||
49006936|NCT04380701|157862550|FG010|Overall Study|Private reason(s)|0|||
49006937|NCT04380701|157862551|FG011|Overall Study|Private reason(s)|0|||
49006938|NCT04380701|157862552|FG012|Overall Study|Private reason(s)|0|||
49006939|NCT04380701|157862553|FG013|Overall Study|Private reason(s)|0|||
49006940|NCT04380701|157862554|FG014|Overall Study|Private reason(s)|0|||
49006941|NCT04380701|157862555|FG015|Overall Study|Private reason(s)|0|||
49006942|NCT04380701|157862556|FG016|Overall Study|Private reason(s)|0|||
49006943|NCT04380701|157862557|FG017|Overall Study|Private reason(s)|0|||
49006944|NCT04380701|157862558|FG018|Overall Study|Private reason(s)|0|||
49006945|NCT04380701|157862559|FG019|Overall Study|Private reason(s)|0|||
49006946|NCT04380701|157862560|FG020|Overall Study|Private reason(s)|0|||
49006947|NCT04380701|157862561|FG021|Overall Study|Private reason(s)|0|||
49006948|NCT04380701|157862562|FG022|Overall Study|Private reason(s)|0|||
49006949|NCT04380701|157862563|FG023|Overall Study|Private reason(s)|1|||
49006950|NCT04380701|157862564|FG024|Overall Study|Private reason(s)|0|||
49006951|NCT04380701|157862565|FG025|Overall Study|Private reason(s)|0|||
49006952|NCT04380701|157862566|FG026|Overall Study|Private reason(s)|0|||
49006953|NCT04380701|157862567|FG027|Overall Study|Private reason(s)|0|||
49006954|NCT04380701|157862568|FG028|Overall Study|Private reason(s)|0|||
49006955|NCT04380701|157862569|FG029|Overall Study|Private reason(s)|1|||
49006956|NCT04380701|157862570|FG030|Overall Study|Private reason(s)|0|||
49006957|NCT04380701|157862571|FG031|Overall Study|Private reason(s)|0|||
49006958|NCT04380701|157862572|FG032|Overall Study|Private reason(s)|0|||
49006959|NCT04380701|157862573|FG033|Overall Study|Private reason(s)|0|||
49006960|NCT04380701|157862540|FG000|Overall Study|Withdrawal by Subject|0|||
49006961|NCT04380701|157862541|FG001|Overall Study|Withdrawal by Subject|0|||
49006962|NCT04380701|157862542|FG002|Overall Study|Withdrawal by Subject|0|||
49006963|NCT04380701|157862543|FG003|Overall Study|Withdrawal by Subject|0|||
49006964|NCT04380701|157862544|FG004|Overall Study|Withdrawal by Subject|0|||
49006965|NCT04380701|157862545|FG005|Overall Study|Withdrawal by Subject|0|||
49006966|NCT04380701|157862546|FG006|Overall Study|Withdrawal by Subject|1|||
49006967|NCT04380701|157862547|FG007|Overall Study|Withdrawal by Subject|1|||
49006968|NCT04380701|157862548|FG008|Overall Study|Withdrawal by Subject|0|||
49006969|NCT04380701|157862549|FG009|Overall Study|Withdrawal by Subject|0|||
49006970|NCT04380701|157862550|FG010|Overall Study|Withdrawal by Subject|0|||
49006971|NCT04380701|157862551|FG011|Overall Study|Withdrawal by Subject|1|||
49006972|NCT04380701|157862552|FG012|Overall Study|Withdrawal by Subject|0|||
49006973|NCT04380701|157862553|FG013|Overall Study|Withdrawal by Subject|1|||
49006974|NCT04380701|157862554|FG014|Overall Study|Withdrawal by Subject|0|||
49006975|NCT04380701|157862555|FG015|Overall Study|Withdrawal by Subject|0|||
49006976|NCT04380701|157862556|FG016|Overall Study|Withdrawal by Subject|1|||
49006977|NCT04380701|157862557|FG017|Overall Study|Withdrawal by Subject|0|||
49006978|NCT04380701|157862558|FG018|Overall Study|Withdrawal by Subject|0|||
49006979|NCT04380701|157862559|FG019|Overall Study|Withdrawal by Subject|0|||
49006980|NCT04380701|157862560|FG020|Overall Study|Withdrawal by Subject|0|||
49006981|NCT04380701|157862561|FG021|Overall Study|Withdrawal by Subject|0|||
49006982|NCT04380701|157862562|FG022|Overall Study|Withdrawal by Subject|2|||
49006983|NCT04380701|157862563|FG023|Overall Study|Withdrawal by Subject|2|||
49006984|NCT04380701|157862564|FG024|Overall Study|Withdrawal by Subject|1|||
49006985|NCT04380701|157862565|FG025|Overall Study|Withdrawal by Subject|1|||
49006986|NCT04380701|157862566|FG026|Overall Study|Withdrawal by Subject|0|||
49006987|NCT04380701|157862567|FG027|Overall Study|Withdrawal by Subject|0|||
49006988|NCT04380701|157862568|FG028|Overall Study|Withdrawal by Subject|0|||
49006989|NCT04380701|157862569|FG029|Overall Study|Withdrawal by Subject|0|||
49006990|NCT04380701|157862570|FG030|Overall Study|Withdrawal by Subject|0|||
49006991|NCT04380701|157862571|FG031|Overall Study|Withdrawal by Subject|0|||
49006992|NCT04380701|157862572|FG032|Overall Study|Withdrawal by Subject|0|||
49006993|NCT04380701|157862573|FG033|Overall Study|Withdrawal by Subject|0|||
49006994|NCT04380701|157862540|FG000|Overall Study|Adverse Event|0|||
49006995|NCT04380701|157862541|FG001|Overall Study|Adverse Event|0|||
49006996|NCT04380701|157862542|FG002|Overall Study|Adverse Event|0|||
49006997|NCT04380701|157862543|FG003|Overall Study|Adverse Event|0|||
49006998|NCT04380701|157862544|FG004|Overall Study|Adverse Event|0|||
49006999|NCT04380701|157862545|FG005|Overall Study|Adverse Event|1|||
49007000|NCT04380701|157862546|FG006|Overall Study|Adverse Event|0|||
49007001|NCT04380701|157862547|FG007|Overall Study|Adverse Event|0|||
49007002|NCT04380701|157862548|FG008|Overall Study|Adverse Event|0|||
49007003|NCT04380701|157862549|FG009|Overall Study|Adverse Event|0|||
49007004|NCT04380701|157862550|FG010|Overall Study|Adverse Event|0|||
49007005|NCT04380701|157862551|FG011|Overall Study|Adverse Event|0|||
49007006|NCT04380701|157862552|FG012|Overall Study|Adverse Event|0|||
49007007|NCT04380701|157862553|FG013|Overall Study|Adverse Event|0|||
49007008|NCT04380701|157862554|FG014|Overall Study|Adverse Event|0|||
49007009|NCT04380701|157862555|FG015|Overall Study|Adverse Event|1|||
49007010|NCT04380701|157862556|FG016|Overall Study|Adverse Event|0|||
49007011|NCT04380701|157862557|FG017|Overall Study|Adverse Event|0|||
49007012|NCT04380701|157862558|FG018|Overall Study|Adverse Event|0|||
49007013|NCT04380701|157862559|FG019|Overall Study|Adverse Event|1|||
49007014|NCT04380701|157862560|FG020|Overall Study|Adverse Event|0|||
49007015|NCT04380701|157862561|FG021|Overall Study|Adverse Event|0|||
49007016|NCT04380701|157862562|FG022|Overall Study|Adverse Event|0|||
49007017|NCT04380701|157862563|FG023|Overall Study|Adverse Event|0|||
49007018|NCT04380701|157862564|FG024|Overall Study|Adverse Event|0|||
49007019|NCT04380701|157862565|FG025|Overall Study|Adverse Event|0|||
49007020|NCT04380701|157862566|FG026|Overall Study|Adverse Event|0|||
49007021|NCT04380701|157862567|FG027|Overall Study|Adverse Event|0|||
49007022|NCT04380701|157862568|FG028|Overall Study|Adverse Event|0|||
49007023|NCT04380701|157862569|FG029|Overall Study|Adverse Event|0|||
49007024|NCT04380701|157862570|FG030|Overall Study|Adverse Event|0|||
49007025|NCT04380701|157862571|FG031|Overall Study|Adverse Event|0|||
49007026|NCT04380701|157862572|FG032|Overall Study|Adverse Event|0|||
49007027|NCT04380701|157862573|FG033|Overall Study|Adverse Event|0|||
49007028|NCT04380701|157862540|FG000|Overall Study|Roll-over into trial BNT162-14|0|||
49007029|NCT04380701|157862541|FG001|Overall Study|Roll-over into trial BNT162-14|0|||
49007030|NCT04380701|157862542|FG002|Overall Study|Roll-over into trial BNT162-14|0|||
49007031|NCT04380701|157862543|FG003|Overall Study|Roll-over into trial BNT162-14|0|||
49007032|NCT04380701|157862544|FG004|Overall Study|Roll-over into trial BNT162-14|0|||
49007033|NCT04380701|157862545|FG005|Overall Study|Roll-over into trial BNT162-14|0|||
49007034|NCT04380701|157862546|FG006|Overall Study|Roll-over into trial BNT162-14|0|||
49007035|NCT04380701|157862547|FG007|Overall Study|Roll-over into trial BNT162-14|0|||
49007036|NCT04380701|157862548|FG008|Overall Study|Roll-over into trial BNT162-14|0|||
49007037|NCT04380701|157862549|FG009|Overall Study|Roll-over into trial BNT162-14|0|||
49007038|NCT04380701|157862550|FG010|Overall Study|Roll-over into trial BNT162-14|0|||
49007039|NCT04380701|157862551|FG011|Overall Study|Roll-over into trial BNT162-14|0|||
49007040|NCT04380701|157862552|FG012|Overall Study|Roll-over into trial BNT162-14|0|||
49007041|NCT04380701|157862553|FG013|Overall Study|Roll-over into trial BNT162-14|0|||
49007042|NCT04380701|157862554|FG014|Overall Study|Roll-over into trial BNT162-14|0|||
49007043|NCT04380701|157862555|FG015|Overall Study|Roll-over into trial BNT162-14|0|||
49007044|NCT04380701|157862556|FG016|Overall Study|Roll-over into trial BNT162-14|0|||
49007045|NCT04380701|157862557|FG017|Overall Study|Roll-over into trial BNT162-14|0|||
49007046|NCT04380701|157862558|FG018|Overall Study|Roll-over into trial BNT162-14|0|||
49007047|NCT04380701|157862559|FG019|Overall Study|Roll-over into trial BNT162-14|0|||
49007048|NCT04380701|157862560|FG020|Overall Study|Roll-over into trial BNT162-14|0|||
49007049|NCT04380701|157862561|FG021|Overall Study|Roll-over into trial BNT162-14|11|||
49007050|NCT04380701|157862562|FG022|Overall Study|Roll-over into trial BNT162-14|11|||
49007051|NCT04380701|157862563|FG023|Overall Study|Roll-over into trial BNT162-14|10|||
49007052|NCT04380701|157862564|FG024|Overall Study|Roll-over into trial BNT162-14|31|||
49007053|NCT04380701|157862565|FG025|Overall Study|Roll-over into trial BNT162-14|0|||
49007054|NCT04380701|157862566|FG026|Overall Study|Roll-over into trial BNT162-14|0|||
49007055|NCT04380701|157862567|FG027|Overall Study|Roll-over into trial BNT162-14|0|||
49007056|NCT04380701|157862568|FG028|Overall Study|Roll-over into trial BNT162-14|0|||
49007057|NCT04380701|157862569|FG029|Overall Study|Roll-over into trial BNT162-14|0|||
49007058|NCT04380701|157862570|FG030|Overall Study|Roll-over into trial BNT162-14|0|||
49007059|NCT04380701|157862571|FG031|Overall Study|Roll-over into trial BNT162-14|0|||
49007060|NCT04380701|157862572|FG032|Overall Study|Roll-over into trial BNT162-14|0|||
49007061|NCT04380701|157862573|FG033|Overall Study|Roll-over into trial BNT162-14|0|||
49007062|NCT04380701|157862540|FG000|Overall Study|Physician Decision|0|||
49007063|NCT04380701|157862541|FG001|Overall Study|Physician Decision|0|||
49007064|NCT04380701|157862542|FG002|Overall Study|Physician Decision|0|||
49007065|NCT04380701|157862543|FG003|Overall Study|Physician Decision|0|||
49007066|NCT04380701|157862544|FG004|Overall Study|Physician Decision|0|||
49007067|NCT04380701|157862545|FG005|Overall Study|Physician Decision|0|||
49007068|NCT04380701|157862546|FG006|Overall Study|Physician Decision|0|||
49007069|NCT04380701|157862547|FG007|Overall Study|Physician Decision|0|||
49007070|NCT04380701|157862548|FG008|Overall Study|Physician Decision|0|||
49007071|NCT04380701|157862549|FG009|Overall Study|Physician Decision|0|||
49007072|NCT04380701|157862550|FG010|Overall Study|Physician Decision|0|||
49007073|NCT04380701|157862551|FG011|Overall Study|Physician Decision|0|||
49007074|NCT04380701|157862552|FG012|Overall Study|Physician Decision|0|||
49007075|NCT04380701|157862553|FG013|Overall Study|Physician Decision|0|||
49007076|NCT04380701|157862554|FG014|Overall Study|Physician Decision|0|||
49007077|NCT04380701|157862555|FG015|Overall Study|Physician Decision|0|||
49007078|NCT04380701|157862556|FG016|Overall Study|Physician Decision|0|||
49007079|NCT04380701|157862557|FG017|Overall Study|Physician Decision|0|||
49007080|NCT04380701|157862558|FG018|Overall Study|Physician Decision|0|||
49007081|NCT04380701|157862559|FG019|Overall Study|Physician Decision|0|||
49007082|NCT04380701|157862560|FG020|Overall Study|Physician Decision|0|||
49007083|NCT04380701|157862561|FG021|Overall Study|Physician Decision|0|||
49007084|NCT04380701|157862562|FG022|Overall Study|Physician Decision|0|||
49007085|NCT04380701|157862563|FG023|Overall Study|Physician Decision|0|||
49007086|NCT04380701|157862564|FG024|Overall Study|Physician Decision|2|||
49007087|NCT04380701|157862565|FG025|Overall Study|Physician Decision|0|||
49007088|NCT04380701|157862566|FG026|Overall Study|Physician Decision|0|||
49007089|NCT04380701|157862567|FG027|Overall Study|Physician Decision|0|||
49007090|NCT04380701|157862568|FG028|Overall Study|Physician Decision|0|||
49007091|NCT04380701|157862569|FG029|Overall Study|Physician Decision|0|||
49007092|NCT04380701|157862570|FG030|Overall Study|Physician Decision|0|||
49007093|NCT04380701|157862571|FG031|Overall Study|Physician Decision|0|||
49007094|NCT04380701|157862572|FG032|Overall Study|Physician Decision|0|||
49007095|NCT04380701|157862573|FG033|Overall Study|Physician Decision|0|||
49007096|NCT04380701|157862540|FG000|Overall Study|Death|0|||
49007097|NCT04380701|157862541|FG001|Overall Study|Death|0|||
49007098|NCT04380701|157862542|FG002|Overall Study|Death|0|||
49007099|NCT04380701|157862543|FG003|Overall Study|Death|0|||
49007100|NCT04380701|157862544|FG004|Overall Study|Death|0|||
49007101|NCT04380701|157862545|FG005|Overall Study|Death|0|||
49007102|NCT04380701|157862546|FG006|Overall Study|Death|0|||
49007103|NCT04380701|157862547|FG007|Overall Study|Death|0|||
49007104|NCT04380701|157862548|FG008|Overall Study|Death|0|||
49007105|NCT04380701|157862549|FG009|Overall Study|Death|0|||
49007106|NCT04380701|157862550|FG010|Overall Study|Death|0|||
49007107|NCT04380701|157862551|FG011|Overall Study|Death|0|||
49007108|NCT04380701|157862552|FG012|Overall Study|Death|0|||
49007109|NCT04380701|157862553|FG013|Overall Study|Death|0|||
49007110|NCT04380701|157862554|FG014|Overall Study|Death|0|||
49007111|NCT04380701|157862555|FG015|Overall Study|Death|0|||
49007112|NCT04380701|157862556|FG016|Overall Study|Death|0|||
49007113|NCT04380701|157862557|FG017|Overall Study|Death|0|||
49007114|NCT04380701|157862558|FG018|Overall Study|Death|0|||
49007115|NCT04380701|157862559|FG019|Overall Study|Death|0|||
49007116|NCT04380701|157862560|FG020|Overall Study|Death|0|||
49007117|NCT04380701|157862561|FG021|Overall Study|Death|0|||
49007118|NCT04380701|157862562|FG022|Overall Study|Death|0|||
49007119|NCT04380701|157862563|FG023|Overall Study|Death|0|||
49007120|NCT04380701|157862564|FG024|Overall Study|Death|1|||
49007121|NCT04380701|157862565|FG025|Overall Study|Death|0|||
49007122|NCT04380701|157862566|FG026|Overall Study|Death|0|||
49007123|NCT04380701|157862567|FG027|Overall Study|Death|0|||
49007124|NCT04380701|157862568|FG028|Overall Study|Death|0|||
49007125|NCT04380701|157862569|FG029|Overall Study|Death|0|||
49007126|NCT04380701|157862570|FG030|Overall Study|Death|0|||
49007127|NCT04380701|157862571|FG031|Overall Study|Death|0|||
49007128|NCT04380701|157862572|FG032|Overall Study|Death|0|||
49007129|NCT04380701|157862573|FG033|Overall Study|Death|0|||
49007130|NCT04380701|157862540|FG000|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
49007131|NCT04380701|157862541|FG001|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
49007132|NCT04380701|157862542|FG002|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
49007133|NCT04380701|157862543|FG003|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
49007134|NCT04380701|157862544|FG004|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
49007135|NCT04380701|157862545|FG005|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
49007136|NCT04380701|157862546|FG006|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
49007137|NCT04380701|157862547|FG007|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
49007138|NCT04380701|157862548|FG008|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
49007139|NCT04380701|157862549|FG009|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
49007140|NCT04380701|157862550|FG010|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
49007141|NCT04380701|157862551|FG011|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
49007142|NCT04380701|157862552|FG012|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
49007143|NCT04380701|157862553|FG013|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
49007144|NCT04380701|157862554|FG014|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
49007145|NCT04380701|157862555|FG015|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
49007146|NCT04380701|157862556|FG016|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
49007147|NCT04380701|157862557|FG017|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
49007148|NCT04380701|157862558|FG018|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
49007149|NCT04380701|157862559|FG019|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
49007150|NCT04380701|157862560|FG020|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
49007151|NCT04380701|157862561|FG021|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|4|||
49007152|NCT04380701|157862562|FG022|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|2|||
49007153|NCT04380701|157862563|FG023|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|16|||
49007154|NCT04380701|157862564|FG024|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|55|||
49007155|NCT04380701|157862565|FG025|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
49007156|NCT04380701|157862566|FG026|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
49007157|NCT04380701|157862567|FG027|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
49007158|NCT04380701|157862568|FG028|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
49007159|NCT04380701|157862569|FG029|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
49007160|NCT04380701|157862570|FG030|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
49007161|NCT04380701|157862571|FG031|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
49007162|NCT04380701|157862572|FG032|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
49007163|NCT04380701|157862573|FG033|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
49007164|NCT01488071|157862576|FG000|Overall Study|Adverse Event|15|||
49007165|NCT01488071|157862577|FG001|Overall Study|Adverse Event|23|||
49007166|NCT01488071|157862576|FG000|Overall Study|Lack of Efficacy|11|||
49007167|NCT01488071|157862577|FG001|Overall Study|Lack of Efficacy|17|||
49007168|NCT01488071|157862576|FG000|Overall Study|Non-compliance with study drug|2|||
49007169|NCT01488071|157862577|FG001|Overall Study|Non-compliance with study drug|0|||
49007170|NCT01488071|157862576|FG000|Overall Study|Protocol Violation|5|||
49007171|NCT01488071|157862577|FG001|Overall Study|Protocol Violation|7|||
49007172|NCT01488071|157862576|FG000|Overall Study|Withdrawal of Consent|14|||
49007173|NCT01488071|157862577|FG001|Overall Study|Withdrawal of Consent|12|||
49007174|NCT01488071|157862576|FG000|Overall Study|Lost to Follow-up|1|||
49007175|NCT01488071|157862577|FG001|Overall Study|Lost to Follow-up|0|||
49007176|NCT01488071|157862576|FG000|Overall Study|Administrative or Other Reason(s)|5|||
49007177|NCT01488071|157862577|FG001|Overall Study|Administrative or Other Reason(s)|4|||
49007178|NCT03499249|157862578|FG000|Overall Study|Physician Decision|1|||
49007179|NCT03125629|157862579|FG000|Overall Study|Withdrawal by Subject|2|||
49007180|NCT03125629|157862579|FG000|Overall Study|Equipment malfunction|1|||
49007181|NCT00995930|157862583|FG000|Overall Study|Protocol deviation|2|||
49007182|NCT00995930|157862584|FG001|Overall Study|Protocol deviation|5|||
49007183|NCT00995930|157862583|FG000|Overall Study|Death|0|||
49007184|NCT00995930|157862584|FG001|Overall Study|Death|1|||
49007185|NCT00995930|157862583|FG000|Overall Study|Administrative problems|4|||
49007186|NCT00995930|157862584|FG001|Overall Study|Administrative problems|2|||
49007187|NCT00995930|157862583|FG000|Overall Study|Lost to Follow-up|1|||
49007188|NCT00995930|157862584|FG001|Overall Study|Lost to Follow-up|2|||
49007189|NCT00995930|157862583|FG000|Overall Study|Withdrawal by Subject|3|||
49007190|NCT00995930|157862584|FG001|Overall Study|Withdrawal by Subject|4|||
49007191|NCT00995930|157862583|FG000|Overall Study|Adverse Event|11|||
49007192|NCT00995930|157862584|FG001|Overall Study|Adverse Event|14|||
49007193|NCT00665626|157862585|FG000|Overall Study|Lack of Efficacy|8|||
49007194|NCT00665626|157862586|FG001|Overall Study|Lack of Efficacy|5|||
49007195|NCT00665626|157862585|FG000|Overall Study|Lost to Follow-up|0|||
49007196|NCT00665626|157862586|FG001|Overall Study|Lost to Follow-up|2|||
49007197|NCT00665626|157862585|FG000|Overall Study|Withdrawal by Subject|0|||
49007198|NCT00665626|157862586|FG001|Overall Study|Withdrawal by Subject|1|||
49007199|NCT00665626|157862585|FG000|Overall Study|Protocol Violation|0|||
49007200|NCT00665626|157862586|FG001|Overall Study|Protocol Violation|2|||
49007201|NCT00665626|157862585|FG000|Overall Study|Adverse Event|1|||
49007202|NCT00665626|157862586|FG001|Overall Study|Adverse Event|9|||
49007203|NCT00665626|157862585|FG000|Overall Study|Due to exclusion criteria|0|||
49007204|NCT00665626|157862586|FG001|Overall Study|Due to exclusion criteria|1|||
49007205|NCT00665626|157862585|FG000|Overall Study|Did not fulfil inclusion criteria|0|||
49007206|NCT00665626|157862586|FG001|Overall Study|Did not fulfil inclusion criteria|1|||
49007207|NCT00665626|157862585|FG000|Overall Study|Unably to comply with dosing regimen|0|||
49007208|NCT00665626|157862586|FG001|Overall Study|Unably to comply with dosing regimen|1|||
49007209|NCT00665626|157862585|FG000|Overall Study|Death|1|||
49007210|NCT00665626|157862586|FG001|Overall Study|Death|0|||
49007211|NCT05003167|157862587|FG000|Overall Study|Withdrawal by Subject|1|||
49007212|NCT01142466|157863951|FG000|Overall Study|Adverse Event|2|||
49007213|NCT01142466|157863952|FG001|Overall Study|Adverse Event|1|||
49007214|NCT01142466|157863951|FG000|Overall Study|Withdrawal by Subject|1|||
49007215|NCT01142466|157863952|FG001|Overall Study|Withdrawal by Subject|1|||
49007216|NCT00343642|157863955|FG000|Overall Study|Lost to Follow-up|0|||
49007217|NCT00343642|157863956|FG001|Overall Study|Lost to Follow-up|1|||
49007218|NCT00343642|157863957|FG002|Overall Study|Lost to Follow-up|0|||
49007219|NCT00343642|157863955|FG000|Overall Study|Pregnancy|1|||
49007220|NCT00343642|157863956|FG001|Overall Study|Pregnancy|0|||
49007221|NCT00343642|157863957|FG002|Overall Study|Pregnancy|2|||
49007222|NCT00343642|157863955|FG000|Overall Study|Withdrawal by Subject|2|||
49007223|NCT00343642|157863956|FG001|Overall Study|Withdrawal by Subject|3|||
49007224|NCT00343642|157863957|FG002|Overall Study|Withdrawal by Subject|4|||
49007225|NCT00343642|157863955|FG000|Overall Study|Adverse Event|0|||
49007226|NCT00343642|157863956|FG001|Overall Study|Adverse Event|0|||
49007227|NCT00343642|157863957|FG002|Overall Study|Adverse Event|1|||
49007228|NCT00343642|157863955|FG000|Overall Study|Flare up|6|||
49007229|NCT00343642|157863956|FG001|Overall Study|Flare up|4|||
49007230|NCT00343642|157863957|FG002|Overall Study|Flare up|0|||
49007231|NCT04292171|157863960|FG000|Overall Study|Pharmacy error|2|||
49007232|NCT04292171|157863961|FG001|Overall Study|Pharmacy error|0|||
49007233|NCT04292171|157863960|FG000|Overall Study|Delivered prior to procedure|0|||
49007234|NCT04292171|157863961|FG001|Overall Study|Delivered prior to procedure|1|||
49007235|NCT02253654|157863966|FG000|Overall Study|Withdrawal by Subject|12|||
49007236|NCT02253654|157863967|FG001|Overall Study|Withdrawal by Subject|4|||
49007237|NCT02253654|157863966|FG000|Overall Study|Decision by Sponsor|1|||
49007238|NCT02253654|157863967|FG001|Overall Study|Decision by Sponsor|1|||
49007239|NCT02253654|157863966|FG000|Overall Study|Lost to Follow-up|2|||
49007240|NCT02253654|157863967|FG001|Overall Study|Lost to Follow-up|5|||
49007241|NCT02253654|157863966|FG000|Overall Study|Death|4|||
49007242|NCT02253654|157863967|FG001|Overall Study|Death|7|||
49007243|NCT02253654|157863966|FG000|Overall Study|Did Not Receive Study Treatment|4|||
49007244|NCT02253654|157863967|FG001|Overall Study|Did Not Receive Study Treatment|1|||
49007245|NCT03456726|157863970|FG000|Overall Study|Disease Progression|6|||
49007246|NCT03456726|157863971|FG001|Overall Study|Disease Progression|1|||
49007247|NCT03456726|157863970|FG000|Overall Study|Adverse Event|4|||
49007248|NCT03456726|157863971|FG001|Overall Study|Adverse Event|2|||
49007249|NCT03456726|157863970|FG000|Overall Study|Withdrawal by Subject|1|||
49007250|NCT03456726|157863971|FG001|Overall Study|Withdrawal by Subject|0|||
49007251|NCT03456726|157863970|FG000|Overall Study|Discontinued from study due to switch to commercial tazemetostat|6|||
49007252|NCT03456726|157863971|FG001|Overall Study|Discontinued from study due to switch to commercial tazemetostat|0|||
49007253|NCT01614925|157863976|FG000|Overall Study|Withdrawal by Subject|1|||
49007254|NCT01614925|157863977|FG001|Overall Study|Withdrawal by Subject|0|||
49007255|NCT01614925|157863976|FG000|Overall Study|Protocol Violation|3|||
49007256|NCT01614925|157863977|FG001|Overall Study|Protocol Violation|2|||
49007257|NCT04470622|157863978|FG000|Overall Study|Withdrawal by Subject|0|||
49007258|NCT04470622|157863979|FG001|Overall Study|Withdrawal by Subject|1|||
49007259|NCT04470622|157863978|FG000|Overall Study|Screen Failure|0|||
49007260|NCT04470622|157863979|FG001|Overall Study|Screen Failure|1|||
49007261|NCT04470622|157863978|FG000|Overall Study|Death|0|||
49007262|NCT04470622|157863979|FG001|Overall Study|Death|1|||
49007263|NCT01246973|157863980|FG000|Overall Study|Other|38|||
49007264|NCT01246973|157863981|FG001|Overall Study|Other|25|||
49007265|NCT01246973|157863980|FG000|Overall Study|Adverse Event|16|||
49007266|NCT01246973|157863981|FG001|Overall Study|Adverse Event|9|||
49007267|NCT01246973|157863980|FG000|Overall Study|Withdrawal by Subject|7|||
49007268|NCT01246973|157863981|FG001|Overall Study|Withdrawal by Subject|13|||
49007269|NCT01600014|157863982|FG000|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24|||
49007270|NCT01600014|157863983|FG001|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0|||
49007271|NCT01600014|157863982|FG000|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203|||
49007272|NCT01600014|157863983|FG001|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0|||
49007273|NCT01600014|157863982|FG000|1. Cycle & Observation Period D1 to W52|Adverse Event|6|||
49007274|NCT01600014|157863983|FG001|1. Cycle & Observation Period D1 to W52|Adverse Event|0|||
49007275|NCT01600014|157863982|FG000|1. Cycle & Observation Period D1 to W52|Other|27|||
49007276|NCT01600014|157863983|FG001|1. Cycle & Observation Period D1 to W52|Other|0|||
49007277|NCT01600014|157863982|FG000|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14|||
49007278|NCT01600014|157863983|FG001|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0|||
49007279|NCT01600014|157863982|FG000|1. Cycle & Observation Period D1 to W52|Protocol Violation|6|||
49007280|NCT01600014|157863983|FG001|1. Cycle & Observation Period D1 to W52|Protocol Violation|0|||
49007281|NCT01600014|157863982|FG000|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8|||
49007282|NCT01600014|157863983|FG001|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0|||
49007283|NCT01600014|157863982|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1|||
49007284|NCT01600014|157863983|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2|||
49007285|NCT01600014|157863982|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1|||
49007286|NCT01600014|157863983|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3|||
49007287|NCT01600014|157863982|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2|||
49007288|NCT01600014|157863983|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1|||
49007289|NCT01600014|157863982|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1|||
49007290|NCT01600014|157863983|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0|||
49007291|NCT01600014|157863982|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5|||
49007292|NCT01600014|157863983|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0|||
49007293|NCT01600014|157863982|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
49007294|NCT01600014|157863983|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
49007295|NCT01600014|157863982|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1|||
49007296|NCT01600014|157863983|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3|||
49007297|NCT01600014|157863982|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1|||
49007298|NCT01600014|157863983|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0|||
49007299|NCT01600014|157863982|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1|||
49007300|NCT01600014|157863983|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0|||
49007301|NCT01600014|157863982|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1|||
49007302|NCT01600014|157863983|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0|||
49007303|NCT00399490|157863986|FG000|Overall Study|Adverse Event|19|||
49007304|NCT00399490|157863986|FG000|Overall Study|Lack of Efficacy|31|||
49007305|NCT00399490|157863986|FG000|Overall Study|Lost to Follow-up|5|||
49007306|NCT00399490|157863986|FG000|Overall Study|Withdrawal by Subject|18|||
49007307|NCT00399490|157863986|FG000|Overall Study|Other|25|||
49007308|NCT02414854|157863987|FG000|Overall Study|Adverse Event|9|||
49007309|NCT02414854|157863988|FG001|Overall Study|Adverse Event|7|||
49007310|NCT02414854|157863989|FG002|Overall Study|Adverse Event|1|||
49007311|NCT02414854|157863990|FG003|Overall Study|Adverse Event|12|||
49007312|NCT02414854|157863987|FG000|Overall Study|Poor compliance to protocol|1|||
49007313|NCT02414854|157863988|FG001|Overall Study|Poor compliance to protocol|1|||
49007314|NCT02414854|157863989|FG002|Overall Study|Poor compliance to protocol|2|||
49007315|NCT02414854|157863990|FG003|Overall Study|Poor compliance to protocol|2|||
49007316|NCT02414854|157863987|FG000|Overall Study|Other than specified above|12|||
49007317|NCT02414854|157863988|FG001|Overall Study|Other than specified above|37|||
49007318|NCT02414854|157863989|FG002|Overall Study|Other than specified above|17|||
49007319|NCT02414854|157863990|FG003|Overall Study|Other than specified above|37|||
49007320|NCT02576054|157863991|FG000|Overall Study|Withdrawal by Subject|1|||
49007321|NCT01190098|157863992|FG000|Overall Study|Adverse Event|2|||
49007322|NCT01190098|157863993|FG001|Overall Study|Adverse Event|0|||
49007323|NCT01190098|157863992|FG000|Overall Study|Patient coomorbidity|0|||
49007324|NCT01190098|157863993|FG001|Overall Study|Patient coomorbidity|1|||
49007325|NCT01190098|157863992|FG000|Overall Study|Lack of transportation|1|||
49007326|NCT01190098|157863993|FG001|Overall Study|Lack of transportation|0|||
49007327|NCT01190098|157863992|FG000|Overall Study|Other|0|||
49007328|NCT01190098|157863993|FG001|Overall Study|Other|1|||
49007329|NCT02957682|157863994|FG000|Overall Study|Adverse Event|64|||
49007330|NCT02957682|157863995|FG001|Overall Study|Adverse Event|67|||
49007331|NCT02957682|157863994|FG000|Overall Study|Poor Compliance to Protocol|30|||
49007332|NCT02957682|157863995|FG001|Overall Study|Poor Compliance to Protocol|26|||
49007333|NCT02957682|157863994|FG000|Overall Study|Physician Decision|4|||
49007334|NCT02957682|157863995|FG001|Overall Study|Physician Decision|4|||
49007335|NCT02957682|157863994|FG000|Overall Study|Study Terminated by Sponsor|4|||
49007336|NCT02957682|157863995|FG001|Overall Study|Study Terminated by Sponsor|3|||
49007337|NCT02957682|157863994|FG000|Overall Study|Subject Moved|10|||
49007338|NCT02957682|157863995|FG001|Overall Study|Subject Moved|16|||
49007339|NCT02957682|157863994|FG000|Overall Study|Withdrawal by Subject|64|||
49007340|NCT02957682|157863995|FG001|Overall Study|Withdrawal by Subject|33|||
49007341|NCT02957682|157863994|FG000|Overall Study|Related to IMP Administration|3|||
49007342|NCT02957682|157863995|FG001|Overall Study|Related to IMP Administration|6|||
49007343|NCT02957682|157863994|FG000|Overall Study|Non-disclosed|16|||
49007344|NCT02957682|157863995|FG001|Overall Study|Non-disclosed|12|||
49007345|NCT02957682|157863994|FG000|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3|||
49007346|NCT02957682|157863995|FG001|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2|||
49007347|NCT00566631|157864004|FG000|Part 1: Core Treatment Phase|Lack of Efficacy|18|||
49007348|NCT00566631|157864004|FG000|Part 1: Core Treatment Phase|Physician Decision|1|||
49007349|NCT00566631|157864004|FG000|Part 1: Core Treatment Phase|Adverse Event|9|||
49007350|NCT00566631|157864004|FG000|Part 1: Core Treatment Phase|Lost to Follow-up|4|||
49007351|NCT00566631|157864004|FG000|Part 1: Core Treatment Phase|Withdrawal by Subject|26|||
49007352|NCT00566631|157864004|FG000|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1|||
49007353|NCT00566631|157864004|FG000|Part 1: Core Treatment Phase|Met exclusion criteria|1|||
49007354|NCT00566631|157864004|FG000|Between Treatment and Extension Phase|Participants not willing to participate|95|||
49007355|NCT00566631|157864004|FG000|Part 2: Extension Phase|Lack of Efficacy|25|||
49007356|NCT00566631|157864004|FG000|Part 2: Extension Phase|Withdrawal by Subject|34|||
49007357|NCT00566631|157864004|FG000|Part 2: Extension Phase|Adverse Event|11|||
49007358|NCT00566631|157864004|FG000|Part 2: Extension Phase|Lost to Follow-up|6|||
49007359|NCT00566631|157864004|FG000|Part 2: Extension Phase|Death|1|||
49007360|NCT00566631|157864004|FG000|Part 2: Extension Phase|Other|5|||
49007361|NCT00751998|157864005|FG000|Overall Study|Lost to Follow-up|7|||
49007362|NCT00751998|157864005|FG000|Overall Study|Death|11|||
49007363|NCT00751998|157864005|FG000|Overall Study|Withdrawal by Subject|2|||
49007364|NCT02983227|157864009|FG000|Overall Study|Adverse Event|21|||
49007365|NCT02983227|157864010|FG001|Overall Study|Adverse Event|3|||
49007366|NCT02983227|157864009|FG000|Overall Study|Death|3|||
49007367|NCT02983227|157864010|FG001|Overall Study|Death|0|||
49007368|NCT02983227|157864009|FG000|Overall Study|Lack of Efficacy|8|||
49007369|NCT02983227|157864010|FG001|Overall Study|Lack of Efficacy|1|||
49007370|NCT02983227|157864009|FG000|Overall Study|Lost to Follow-up|3|||
49007371|NCT02983227|157864010|FG001|Overall Study|Lost to Follow-up|0|||
49007372|NCT02983227|157864009|FG000|Overall Study|Multiple Reasons|2|||
49007373|NCT02983227|157864010|FG001|Overall Study|Multiple Reasons|1|||
49007374|NCT02983227|157864009|FG000|Overall Study|Physician Decision|3|||
49007375|NCT02983227|157864010|FG001|Overall Study|Physician Decision|1|||
49007376|NCT02983227|157864009|FG000|Overall Study|Withdrawal by Subject|19|||
49007377|NCT02983227|157864010|FG001|Overall Study|Withdrawal by Subject|8|||
49007378|NCT04476017|157864011|FG000|Part A (28 Days)|Withdrawal by Subject|1|||
49007379|NCT04476017|157864012|FG001|Part A (28 Days)|Withdrawal by Subject|0|||
49007380|NCT02354976|157864013|FG000|Overall Study|Other - reason not specified|1|||
49007381|NCT02354976|157864014|FG001|Overall Study|Other - reason not specified|0|||
49007382|NCT02354976|157864015|FG002|Overall Study|Other - reason not specified|1|||
49007383|NCT02354976|157864013|FG000|Overall Study|Study-specifc withdrawal criteria|0|||
49007384|NCT02354976|157864014|FG001|Overall Study|Study-specifc withdrawal criteria|1|||
49007385|NCT02354976|157864015|FG002|Overall Study|Study-specifc withdrawal criteria|0|||
49007386|NCT02354976|157864013|FG000|Overall Study|Adverse Event|1|||
49007387|NCT02354976|157864014|FG001|Overall Study|Adverse Event|0|||
49007388|NCT02354976|157864015|FG002|Overall Study|Adverse Event|2|||
49007389|NCT00771901|157864016|FG000|Overall Study|Dissat w/# of study medication (40/day)|0|||
49007390|NCT00771901|157864017|FG001|Overall Study|Dissat w/# of study medication (40/day)|0|||
49007391|NCT00771901|157864018|FG002|Overall Study|Dissat w/# of study medication (40/day)|4|||
49007392|NCT00986154|157864021|FG000|Overall Study|Death|136|||
49007393|NCT00986154|157864022|FG001|Overall Study|Death|127|||
49007394|NCT00986154|157864021|FG000|Overall Study|Lost to Follow-up|7|||
49007395|NCT00986154|157864022|FG001|Overall Study|Lost to Follow-up|4|||
49007396|NCT00986154|157864021|FG000|Overall Study|Withdrawal by Subject|32|||
49007397|NCT00986154|157864022|FG001|Overall Study|Withdrawal by Subject|33|||
49007398|NCT00986154|157864021|FG000|Overall Study|investigator/subject decide not continue|6|||
49007399|NCT00986154|157864022|FG001|Overall Study|investigator/subject decide not continue|3|||
49007400|NCT00986154|157864021|FG000|Overall Study|never received study drug|25|||
49007401|NCT00986154|157864022|FG001|Overall Study|never received study drug|27|||
49007402|NCT01706770|157864023|FG000|Overall Study|Lost to Follow-up|1|||
49007403|NCT01706770|157864024|FG001|Overall Study|Lost to Follow-up|0|||
49007404|NCT01706770|157864023|FG000|Overall Study|Physician Decision|1|||
49007405|NCT01706770|157864024|FG001|Overall Study|Physician Decision|0|||
49007406|NCT03726437|157864025|FG000|Overall Study|Lost to Follow-up|85|||
49007407|NCT03726437|157864026|FG001|Overall Study|Lost to Follow-up|76|||
49007408|NCT00068445|157864030|FG000|Randomization|Cancel|1|||
49007409|NCT00068445|157864031|FG001|Randomization|Cancel|3|||
49007410|NCT00068445|157864030|FG000|Randomization|Ineligible|1|||
49007411|NCT00068445|157864031|FG001|Randomization|Ineligible|1|||
49007412|NCT00068445|157864030|FG000|Treatment|Refused Further Treatment|13|||
49007413|NCT00068445|157864031|FG001|Treatment|Refused Further Treatment|10|||
49007414|NCT00068445|157864030|FG000|Treatment|Adverse Event|7|||
49007415|NCT00068445|157864031|FG001|Treatment|Adverse Event|1|||
49007416|NCT00068445|157864030|FG000|Treatment|Other (Specifics not available)|9|||
49007417|NCT00068445|157864031|FG001|Treatment|Other (Specifics not available)|5|||
49007418|NCT01155284|157864032|FG000|Overall Study|Withdrawal by Subject|4|||
49007419|NCT01155284|157864033|FG001|Overall Study|Withdrawal by Subject|3|||
49007420|NCT01155284|157864032|FG000|Overall Study|Lost to Follow-up|1|||
49007421|NCT01155284|157864033|FG001|Overall Study|Lost to Follow-up|2|||
49007422|NCT01155284|157864032|FG000|Overall Study|Physician Decision|1|||
49007423|NCT01155284|157864033|FG001|Overall Study|Physician Decision|0|||
49007424|NCT01155284|157864032|FG000|Overall Study|Adverse Event|1|||
49007425|NCT01155284|157864033|FG001|Overall Study|Adverse Event|0|||
49007426|NCT00123487|157864034|FG000|Randomized|Death prior to starting treatment|0|||
49007427|NCT00123487|157864035|FG001|Randomized|Death prior to starting treatment|1|||
49007428|NCT00123487|157864034|FG000|Randomized|SAE prior to starting treatment|1|||
49007429|NCT00123487|157864035|FG001|Randomized|SAE prior to starting treatment|0|||
49007430|NCT00123487|157864034|FG000|Treated With Study Drug|Adverse Event|23|||
49007431|NCT00123487|157864035|FG001|Treated With Study Drug|Adverse Event|22|||
49007432|NCT00123487|157864034|FG000|Treated With Study Drug|Disease Progression|141|||
49007433|NCT00123487|157864035|FG001|Treated With Study Drug|Disease Progression|122|||
49007434|NCT00123487|157864034|FG000|Treated With Study Drug|Physician Decision|8|||
49007435|NCT00123487|157864035|FG001|Treated With Study Drug|Physician Decision|9|||
49007436|NCT00123487|157864034|FG000|Treated With Study Drug|Other|59|||
49007437|NCT00123487|157864035|FG001|Treated With Study Drug|Other|58|||
49007438|NCT00123487|157864034|FG000|Treated With Study Drug|Study Drug Toxicity|62|||
49007439|NCT00123487|157864035|FG001|Treated With Study Drug|Study Drug Toxicity|80|||
49007440|NCT00123487|157864034|FG000|Treated With Study Drug|Withdrawal by Subject|11|||
49007441|NCT00123487|157864035|FG001|Treated With Study Drug|Withdrawal by Subject|13|||
49007442|NCT00123487|157864034|FG000|Treated With Study Drug|Unknown (case report form lost)|0|||
49007443|NCT00123487|157864035|FG001|Treated With Study Drug|Unknown (case report form lost)|1|||
49007444|NCT00423488|157864037|FG000|Overall Study|No evidence of study drug intake|2|||
49007445|NCT00423488|157864038|FG001|Overall Study|No evidence of study drug intake|1|||
49007446|NCT00423488|157864037|FG000|Overall Study|No post baseline data|3|||
49007447|NCT00423488|157864038|FG001|Overall Study|No post baseline data|0|||
49007448|NCT00811070|157864047|FG000|Overall Study|Death|0|||
49007449|NCT00811070|157864048|FG001|Overall Study|Death|0|||
49007450|NCT00811070|157864049|FG002|Overall Study|Death|0|||
49007451|NCT00811070|157864050|FG003|Overall Study|Death|2|||
49007452|NCT00811070|157864051|FG004|Overall Study|Death|5|||
49007453|NCT00811070|157864052|FG005|Overall Study|Death|0|||
49007454|NCT00811070|157864047|FG000|Overall Study|Other|1|||
49007455|NCT00811070|157864048|FG001|Overall Study|Other|0|||
49007456|NCT00811070|157864049|FG002|Overall Study|Other|0|||
49007457|NCT00811070|157864050|FG003|Overall Study|Other|0|||
49007458|NCT00811070|157864051|FG004|Overall Study|Other|0|||
49007459|NCT00811070|157864052|FG005|Overall Study|Other|0|||
49007460|NCT00811070|157864047|FG000|Overall Study|Withdrawal by Subject|0|||
49007461|NCT00811070|157864048|FG001|Overall Study|Withdrawal by Subject|1|||
49007462|NCT00811070|157864049|FG002|Overall Study|Withdrawal by Subject|0|||
49007463|NCT00811070|157864050|FG003|Overall Study|Withdrawal by Subject|0|||
49007464|NCT00811070|157864051|FG004|Overall Study|Withdrawal by Subject|0|||
49007465|NCT00811070|157864052|FG005|Overall Study|Withdrawal by Subject|0|||
49007466|NCT00811070|157864047|FG000|Overall Study|Physician Decision|0|||
49007467|NCT00811070|157864048|FG001|Overall Study|Physician Decision|0|||
49007468|NCT00811070|157864049|FG002|Overall Study|Physician Decision|0|||
49007469|NCT00811070|157864050|FG003|Overall Study|Physician Decision|0|||
49007470|NCT00811070|157864051|FG004|Overall Study|Physician Decision|0|||
49007471|NCT00811070|157864052|FG005|Overall Study|Physician Decision|1|||
49007472|NCT03550794|157864066|FG000|Overall Study|No longer met inclusion criteria|1|||
49007473|NCT03550794|157864067|FG001|Overall Study|No longer met inclusion criteria|2|||
49007474|NCT03550794|157864066|FG000|Overall Study|Goals of care changed|1|||
49007475|NCT03550794|157864067|FG001|Overall Study|Goals of care changed|0|||
49007476|NCT03550794|157864066|FG000|Overall Study|Withdrawal by Subject|2|||
49007477|NCT03550794|157864067|FG001|Overall Study|Withdrawal by Subject|0|||
49007478|NCT03550794|157864066|FG000|Overall Study|Death|0|||
49007479|NCT03550794|157864067|FG001|Overall Study|Death|1|||
49007480|NCT01864525|157864068|FG000|Overall Study|Adverse Event|1|||
49007481|NCT01864525|157864069|FG001|Overall Study|Adverse Event|0|||
49007482|NCT01890785|157864072|FG000|Third Intervention|Withdrawal by Subject|0|||
49007483|NCT01890785|157864073|FG001|Third Intervention|Withdrawal by Subject|1|||
49007484|NCT01890785|157864074|FG002|Third Intervention|Withdrawal by Subject|0|||
49007485|NCT01890785|157864075|FG003|Third Intervention|Withdrawal by Subject|0|||
49007486|NCT01890785|157864076|FG004|Third Intervention|Withdrawal by Subject|0|||
49007487|NCT01890785|157864077|FG005|Third Intervention|Withdrawal by Subject|0|||
49007488|NCT01715415|157864078|FG000|Double-blind Treatment|Did Not Receive Study Drug|0|||
49007489|NCT01715415|157864079|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
49007490|NCT01715415|157864078|FG000|Double-blind Treatment|Adverse Event|3|||
49007491|NCT01715415|157864079|FG001|Double-blind Treatment|Adverse Event|0|||
49007492|NCT01715415|157864078|FG000|Double-blind Treatment|Withdrawal by Subject|1|||
49007493|NCT01715415|157864079|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
49007494|NCT01715415|157864078|FG000|Double-blind Treatment|Other|1|||
49007495|NCT01715415|157864079|FG001|Double-blind Treatment|Other|0|||
49007496|NCT01715415|157864078|FG000|Open-label Treatment|Adverse Event|0|||
49007497|NCT01715415|157864079|FG001|Open-label Treatment|Adverse Event|1|||
49007498|NCT01715415|157864078|FG000|Open-label Treatment|Subject Noncompliant|0|||
49007499|NCT01715415|157864079|FG001|Open-label Treatment|Subject Noncompliant|1|||
49007500|NCT01964105|157864080|FG000|Overall Study|Lost to Follow-up|2|||
49007501|NCT01964105|157864081|FG001|Overall Study|Lost to Follow-up|13|||
49007502|NCT01964105|157864082|FG002|Overall Study|Lost to Follow-up|0|||
49007503|NCT03940586|157864092|FG000|Overall Study|Death|3|||
49007504|NCT03940586|157864093|FG001|Overall Study|Death|2|||
49007505|NCT03940586|157864094|FG002|Overall Study|Death|0|||
49007506|NCT03940586|157864092|FG000|Overall Study|Physician Decision|1|||
49007507|NCT03940586|157864093|FG001|Overall Study|Physician Decision|0|||
49007508|NCT03940586|157864094|FG002|Overall Study|Physician Decision|1|||
49007509|NCT03940586|157864092|FG000|Overall Study|Withdrawal By Parent/Guardian|3|||
49007510|NCT03940586|157864093|FG001|Overall Study|Withdrawal By Parent/Guardian|4|||
49007511|NCT03940586|157864094|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
49007512|NCT03940586|157864092|FG000|Overall Study|Not Treated|0|||
49007513|NCT03940586|157864093|FG001|Overall Study|Not Treated|2|||
49007514|NCT03940586|157864094|FG002|Overall Study|Not Treated|0|||
49007515|NCT01619085|157864098|FG000|Overall Study|Adverse Event|231|||
49007516|NCT01619085|157864098|FG000|Overall Study|Protocol Violation|4|||
49007517|NCT01619085|157864098|FG000|Overall Study|Lost to Follow-up|3|||
49007518|NCT01619085|157864098|FG000|Overall Study|Withdrawal by Subject|45|||
49007519|NCT01619085|157864098|FG000|Overall Study|Other than specified|96|||
49007520|NCT01619085|157864098|FG000|Overall Study|Not treated|1|||
49007521|NCT01619085|157864098|FG000|Overall Study|Death|145|||
49007522|NCT04288115|157864099|FG000|Overall Study|Withdrawal by Subject|0|||
49007523|NCT04288115|157864100|FG001|Overall Study|Withdrawal by Subject|1|||
49007524|NCT04288115|157864099|FG000|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|3|||
49007525|NCT04288115|157864100|FG001|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|2|||
49076762|NCT01107197|158114970|FG000|Overall Study|Withdrawal by Subject|3|||
49076763|NCT01107197|158114971|FG001|Overall Study|Withdrawal by Subject|5|||
49076764|NCT02123446|158114972|FG000|Washout Period (1 Day)|Physician Decision|1|||
49076765|NCT02123446|158114973|FG001|Washout Period (1 Day)|Physician Decision|0|||
49076766|NCT01301729|158114974|FG000|Overall Study|Withdrawal by Subject|2|||
49076767|NCT01301729|158114974|FG000|Overall Study|Participant did not Return for Treatment|1|||
49076768|NCT01301729|158114974|FG000|Overall Study|Violated Selection Criteria|1|||
49076769|NCT02289729|158114975|FG000|Overall Study|Lack of Efficacy|3|||
49076770|NCT02289729|158114975|FG000|Overall Study|Very Narrow Therapeutic Margin|1|||
49076771|NCT02289729|158114975|FG000|Overall Study|Withdrawal by Subject|1|||
49076772|NCT02289729|158114975|FG000|Overall Study|Death|1|||
49076773|NCT04604795|158114976|FG000|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
49076774|NCT04604795|158114977|FG001|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
49076775|NCT04604795|158114978|FG002|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
49076776|NCT04604795|158114979|FG003|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
49076777|NCT04604795|158114980|FG004|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
49076778|NCT04604795|158114981|FG005|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
49076779|NCT04604795|158114982|FG006|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
49076780|NCT04604795|158114983|FG007|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
49076781|NCT04604795|158114984|FG008|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
49076782|NCT04604795|158114985|FG009|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
49076783|NCT04604795|158114976|FG000|Part B: Up to Day 14|Adverse Event|0|||
49076784|NCT04604795|158114977|FG001|Part B: Up to Day 14|Adverse Event|0|||
49076785|NCT04604795|158114978|FG002|Part B: Up to Day 14|Adverse Event|0|||
49076786|NCT04604795|158114979|FG003|Part B: Up to Day 14|Adverse Event|0|||
49076787|NCT04604795|158114980|FG004|Part B: Up to Day 14|Adverse Event|2|||
49076788|NCT04604795|158114981|FG005|Part B: Up to Day 14|Adverse Event|1|||
49076789|NCT04604795|158114982|FG006|Part B: Up to Day 14|Adverse Event|0|||
49076790|NCT04604795|158114983|FG007|Part B: Up to Day 14|Adverse Event|0|||
49076791|NCT04604795|158114984|FG008|Part B: Up to Day 14|Adverse Event|0|||
49076792|NCT04604795|158114985|FG009|Part B: Up to Day 14|Adverse Event|0|||
49076793|NCT04604795|158114976|FG000|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
49076794|NCT04604795|158114977|FG001|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
49076795|NCT04604795|158114978|FG002|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
49076796|NCT04604795|158114979|FG003|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
49076797|NCT04604795|158114980|FG004|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
49076798|NCT04604795|158114981|FG005|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
49076799|NCT04604795|158114982|FG006|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
49076800|NCT04604795|158114983|FG007|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
49076801|NCT04604795|158114984|FG008|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
49076802|NCT04604795|158114985|FG009|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|1|||
49076803|NCT04604795|158114976|FG000|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
49076804|NCT04604795|158114977|FG001|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
49076805|NCT04604795|158114978|FG002|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
49076806|NCT04604795|158114979|FG003|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
49076807|NCT04604795|158114980|FG004|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
49076808|NCT04604795|158114981|FG005|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
49076809|NCT04604795|158114982|FG006|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
49076810|NCT04604795|158114983|FG007|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
49076811|NCT04604795|158114984|FG008|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|1|||
49076812|NCT04604795|158114985|FG009|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
49076813|NCT04604795|158114976|FG000|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
49076814|NCT04604795|158114977|FG001|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
49076815|NCT04604795|158114978|FG002|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
49076816|NCT04604795|158114979|FG003|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
49076817|NCT04604795|158114980|FG004|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
49076818|NCT04604795|158114981|FG005|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
49076819|NCT04604795|158114982|FG006|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
49076820|NCT04604795|158114983|FG007|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
49076821|NCT04604795|158114984|FG008|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|1|||
49076822|NCT04604795|158114985|FG009|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
49076823|NCT04604795|158114976|FG000|Part C: Period 5 (Day 1)|Adverse Event|0|||
49076824|NCT04604795|158114977|FG001|Part C: Period 5 (Day 1)|Adverse Event|0|||
49076825|NCT04604795|158114978|FG002|Part C: Period 5 (Day 1)|Adverse Event|0|||
49076826|NCT04604795|158114979|FG003|Part C: Period 5 (Day 1)|Adverse Event|0|||
49076827|NCT04604795|158114980|FG004|Part C: Period 5 (Day 1)|Adverse Event|0|||
49076828|NCT04604795|158114981|FG005|Part C: Period 5 (Day 1)|Adverse Event|0|||
49076829|NCT04604795|158114982|FG006|Part C: Period 5 (Day 1)|Adverse Event|0|||
49076830|NCT04604795|158114983|FG007|Part C: Period 5 (Day 1)|Adverse Event|0|||
49076831|NCT04604795|158114984|FG008|Part C: Period 5 (Day 1)|Adverse Event|1|||
49076832|NCT04604795|158114985|FG009|Part C: Period 5 (Day 1)|Adverse Event|0|||
49076833|NCT00683657|158115000|FG000|Overall Study|Adverse Event|0|||
49076834|NCT00683657|158115001|FG001|Overall Study|Adverse Event|1|||
49076835|NCT00683657|158115000|FG000|Overall Study|Subject Withdrew Consent|1|||
49076836|NCT00683657|158115001|FG001|Overall Study|Subject Withdrew Consent|0|||
49076837|NCT01074944|158115003|FG000|Lead-in Period (up to 78 Weeks)|Adverse Event|2|||
49076838|NCT01074944|158115004|FG001|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
49076839|NCT01074944|158115005|FG002|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
49076840|NCT01074944|158115006|FG003|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
49076841|NCT01074944|158115007|FG004|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
49076842|NCT01074944|158115003|FG000|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1|||
49076843|NCT01074944|158115004|FG001|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
49076844|NCT01074944|158115005|FG002|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
49076845|NCT01074944|158115006|FG003|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
49076846|NCT01074944|158115007|FG004|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
49076847|NCT01074944|158115003|FG000|Lead-in Period (up to 78 Weeks)|Pregnancy|4|||
49076848|NCT01074944|158115004|FG001|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
49076849|NCT01074944|158115005|FG002|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
49076850|NCT01074944|158115006|FG003|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
49076851|NCT01074944|158115007|FG004|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
49076852|NCT01074944|158115003|FG000|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6|||
49076853|NCT01074944|158115004|FG001|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
49076854|NCT01074944|158115005|FG002|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
49076855|NCT01074944|158115006|FG003|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
49076856|NCT01074944|158115007|FG004|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
49076857|NCT01074944|158115003|FG000|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
49076858|NCT01074944|158115004|FG001|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2|||
49076859|NCT01074944|158115005|FG002|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3|||
49076860|NCT01074944|158115006|FG003|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
49076861|NCT01074944|158115007|FG004|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
49076862|NCT01074944|158115003|FG000|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
49076863|NCT01074944|158115004|FG001|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6|||
49076864|NCT01074944|158115005|FG002|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1|||
49076865|NCT01074944|158115006|FG003|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
49076866|NCT01074944|158115007|FG004|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
49076867|NCT01074944|158115003|FG000|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
49076868|NCT01074944|158115004|FG001|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
49076869|NCT01074944|158115005|FG002|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
49076870|NCT01074944|158115006|FG003|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
49076871|NCT01074944|158115007|FG004|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
49076872|NCT01074944|158115003|FG000|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
49076873|NCT01074944|158115004|FG001|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1|||
49076874|NCT01074944|158115005|FG002|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
49076875|NCT01074944|158115006|FG003|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
49076876|NCT01074944|158115007|FG004|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
49076877|NCT01074944|158115003|FG000|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
49076878|NCT01074944|158115004|FG001|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
49076879|NCT01074944|158115005|FG002|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
49076880|NCT01074944|158115006|FG003|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
49076881|NCT01074944|158115007|FG004|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
49076882|NCT01074944|158115003|FG000|Long Term Treatment|Adverse Event|0|||
49076883|NCT01074944|158115004|FG001|Long Term Treatment|Adverse Event|0|||
49076884|NCT01074944|158115005|FG002|Long Term Treatment|Adverse Event|0|||
49076885|NCT01074944|158115006|FG003|Long Term Treatment|Adverse Event|3|||
49076886|NCT01074944|158115007|FG004|Long Term Treatment|Adverse Event|0|||
49076887|NCT01074944|158115003|FG000|Long Term Treatment|Lost to Follow-up|0|||
49076888|NCT01074944|158115004|FG001|Long Term Treatment|Lost to Follow-up|0|||
49076889|NCT01074944|158115005|FG002|Long Term Treatment|Lost to Follow-up|0|||
49076890|NCT01074944|158115006|FG003|Long Term Treatment|Lost to Follow-up|2|||
49076891|NCT01074944|158115007|FG004|Long Term Treatment|Lost to Follow-up|0|||
49076892|NCT01074944|158115003|FG000|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
49076893|NCT01074944|158115004|FG001|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
49076894|NCT01074944|158115005|FG002|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
49076895|NCT01074944|158115006|FG003|Long Term Treatment|Transitioned to Commercial Eliglustat|18|||
49076896|NCT01074944|158115007|FG004|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
49076897|NCT01074944|158115003|FG000|Long Term Treatment|Entered in Period, But Not Treated|0|||
49076898|NCT01074944|158115004|FG001|Long Term Treatment|Entered in Period, But Not Treated|0|||
49076899|NCT01074944|158115005|FG002|Long Term Treatment|Entered in Period, But Not Treated|0|||
49076900|NCT01074944|158115006|FG003|Long Term Treatment|Entered in Period, But Not Treated|1|||
49076901|NCT01074944|158115007|FG004|Long Term Treatment|Entered in Period, But Not Treated|0|||
49076902|NCT01074944|158115003|FG000|Long Term Treatment|Withdrawal by Subject|0|||
49076903|NCT01074944|158115004|FG001|Long Term Treatment|Withdrawal by Subject|0|||
49076904|NCT01074944|158115005|FG002|Long Term Treatment|Withdrawal by Subject|0|||
49076905|NCT01074944|158115006|FG003|Long Term Treatment|Withdrawal by Subject|2|||
49076906|NCT01074944|158115007|FG004|Long Term Treatment|Withdrawal by Subject|0|||
49076907|NCT01074944|158115003|FG000|Extended Treatment (up to 42 Months)|Pregnancy|0|||
49076908|NCT01074944|158115004|FG001|Extended Treatment (up to 42 Months)|Pregnancy|0|||
49076909|NCT01074944|158115005|FG002|Extended Treatment (up to 42 Months)|Pregnancy|0|||
49076910|NCT01074944|158115006|FG003|Extended Treatment (up to 42 Months)|Pregnancy|0|||
49076911|NCT01074944|158115007|FG004|Extended Treatment (up to 42 Months)|Pregnancy|2|||
49076912|NCT01074944|158115003|FG000|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
49076913|NCT01074944|158115004|FG001|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
49076914|NCT01074944|158115005|FG002|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
49076915|NCT01074944|158115006|FG003|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
49076916|NCT01074944|158115007|FG004|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3|||
49076917|NCT00852202|158115008|FG000|Overall Study|Adverse Event|2|||
49076918|NCT00852202|158115009|FG001|Overall Study|Adverse Event|3|||
49076919|NCT00852202|158115010|FG002|Overall Study|Adverse Event|7|||
49076920|NCT00852202|158115008|FG000|Overall Study|Lack of Efficacy|4|||
49076921|NCT00852202|158115009|FG001|Overall Study|Lack of Efficacy|1|||
49076922|NCT00852202|158115010|FG002|Overall Study|Lack of Efficacy|2|||
49076923|NCT00852202|158115008|FG000|Overall Study|Protocol Violation|2|||
49076924|NCT00852202|158115009|FG001|Overall Study|Protocol Violation|2|||
49076925|NCT00852202|158115010|FG002|Overall Study|Protocol Violation|7|||
49076926|NCT00852202|158115008|FG000|Overall Study|Withdrawal by Subject|3|||
49076927|NCT00852202|158115009|FG001|Overall Study|Withdrawal by Subject|1|||
49076928|NCT00852202|158115010|FG002|Overall Study|Withdrawal by Subject|2|||
49076929|NCT00852202|158115008|FG000|Overall Study|Lost to Follow-up|5|||
49076930|NCT00852202|158115009|FG001|Overall Study|Lost to Follow-up|5|||
49076931|NCT00852202|158115010|FG002|Overall Study|Lost to Follow-up|6|||
49076932|NCT00852202|158115008|FG000|Overall Study|pregnancy,moving away and surgery|1|||
49076933|NCT00852202|158115009|FG001|Overall Study|pregnancy,moving away and surgery|0|||
49076934|NCT00852202|158115010|FG002|Overall Study|pregnancy,moving away and surgery|2|||
49076935|NCT01408043|158115011|FG000|Overall Study|unable to collect cells|1|||
49076936|NCT03200717|158115018|FG000|Overall Study|Progressive disease|24|||
49076937|NCT03200717|158115019|FG001|Overall Study|Progressive disease|5|||
49076938|NCT03200717|158115018|FG000|Overall Study|Adverse Event|11|||
49076939|NCT03200717|158115019|FG001|Overall Study|Adverse Event|8|||
49076940|NCT03200717|158115018|FG000|Overall Study|Physician Decision|3|||
49076941|NCT03200717|158115019|FG001|Overall Study|Physician Decision|2|||
49076942|NCT03200717|158115018|FG000|Overall Study|Death|2|||
49076943|NCT03200717|158115019|FG001|Overall Study|Death|0|||
49076944|NCT03200717|158115018|FG000|Overall Study|Subject/Guardian Decision|1|||
49076945|NCT03200717|158115019|FG001|Overall Study|Subject/Guardian Decision|0|||
49076946|NCT00972595|158115020|FG000|Period 1|Adverse Event|1|||
49076947|NCT00972595|158115021|FG001|Period 1|Adverse Event|0|||
49076948|NCT02552121|158115022|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2|||
49076949|NCT02552121|158115023|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
49076950|NCT02552121|158115024|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
49076951|NCT02552121|158115025|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
49076952|NCT02552121|158115026|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
49076953|NCT02552121|158115027|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
49076954|NCT02552121|158115028|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
49076955|NCT02552121|158115029|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
49076956|NCT02552121|158115022|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1|||
49076957|NCT02552121|158115023|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
49076958|NCT02552121|158115024|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
49076959|NCT02552121|158115025|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
49076960|NCT02552121|158115026|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
49076961|NCT02552121|158115027|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
49076962|NCT02552121|158115028|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
49076963|NCT02552121|158115029|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
49076964|NCT02552121|158115022|FG000|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
49076965|NCT02552121|158115023|FG001|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1|||
49076966|NCT02552121|158115024|FG002|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
49076967|NCT02552121|158115025|FG003|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
49076968|NCT02552121|158115026|FG004|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
49076969|NCT02552121|158115027|FG005|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
49076970|NCT02552121|158115028|FG006|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
49076971|NCT02552121|158115029|FG007|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
49076972|NCT02552121|158115022|FG000|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
49076973|NCT02552121|158115023|FG001|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2|||
49076974|NCT02552121|158115024|FG002|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
49076975|NCT02552121|158115025|FG003|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
49076976|NCT02552121|158115026|FG004|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
49076977|NCT02552121|158115027|FG005|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
49076978|NCT02552121|158115028|FG006|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
49076979|NCT02552121|158115029|FG007|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
49076980|NCT02552121|158115022|FG000|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
49076981|NCT02552121|158115023|FG001|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2|||
49076982|NCT02552121|158115024|FG002|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
49076983|NCT02552121|158115025|FG003|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
49076984|NCT02552121|158115026|FG004|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
49076985|NCT02552121|158115027|FG005|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
49076986|NCT02552121|158115028|FG006|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
49076987|NCT02552121|158115029|FG007|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
49076988|NCT02552121|158115022|FG000|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
49076989|NCT02552121|158115023|FG001|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1|||
49076990|NCT02552121|158115024|FG002|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
49076991|NCT02552121|158115025|FG003|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
49076992|NCT02552121|158115026|FG004|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
49076993|NCT02552121|158115027|FG005|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
49076994|NCT02552121|158115028|FG006|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
49076995|NCT02552121|158115029|FG007|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
49076996|NCT02552121|158115022|FG000|Part 2: Cohort Expansion|Patient Choice|0|||
49076997|NCT02552121|158115023|FG001|Part 2: Cohort Expansion|Patient Choice|0|||
49076998|NCT02552121|158115024|FG002|Part 2: Cohort Expansion|Patient Choice|1|||
49076999|NCT02552121|158115025|FG003|Part 2: Cohort Expansion|Patient Choice|0|||
49077000|NCT02552121|158115026|FG004|Part 2: Cohort Expansion|Patient Choice|0|||
49077001|NCT02552121|158115027|FG005|Part 2: Cohort Expansion|Patient Choice|0|||
49077002|NCT02552121|158115028|FG006|Part 2: Cohort Expansion|Patient Choice|1|||
49077003|NCT02552121|158115029|FG007|Part 2: Cohort Expansion|Patient Choice|0|||
49077004|NCT02552121|158115022|FG000|Part 2: Cohort Expansion|Disease Progression|0|||
49077005|NCT02552121|158115023|FG001|Part 2: Cohort Expansion|Disease Progression|0|||
49077006|NCT02552121|158115024|FG002|Part 2: Cohort Expansion|Disease Progression|3|||
49077007|NCT02552121|158115025|FG003|Part 2: Cohort Expansion|Disease Progression|2|||
49077008|NCT02552121|158115026|FG004|Part 2: Cohort Expansion|Disease Progression|1|||
49077009|NCT02552121|158115027|FG005|Part 2: Cohort Expansion|Disease Progression|4|||
49077010|NCT02552121|158115028|FG006|Part 2: Cohort Expansion|Disease Progression|0|||
49077011|NCT02552121|158115029|FG007|Part 2: Cohort Expansion|Disease Progression|3|||
49077012|NCT02552121|158115022|FG000|Part 2: Cohort Expansion|Adverse Event|0|||
49077013|NCT02552121|158115023|FG001|Part 2: Cohort Expansion|Adverse Event|0|||
49077014|NCT02552121|158115024|FG002|Part 2: Cohort Expansion|Adverse Event|6|||
49077015|NCT02552121|158115025|FG003|Part 2: Cohort Expansion|Adverse Event|1|||
49077016|NCT02552121|158115026|FG004|Part 2: Cohort Expansion|Adverse Event|0|||
49077017|NCT02552121|158115027|FG005|Part 2: Cohort Expansion|Adverse Event|0|||
49077018|NCT02552121|158115028|FG006|Part 2: Cohort Expansion|Adverse Event|0|||
49077019|NCT02552121|158115029|FG007|Part 2: Cohort Expansion|Adverse Event|0|||
49077020|NCT02552121|158115022|FG000|Part 2: Cohort Expansion|Death|0|||
49077021|NCT02552121|158115023|FG001|Part 2: Cohort Expansion|Death|0|||
49077022|NCT02552121|158115024|FG002|Part 2: Cohort Expansion|Death|1|||
49077023|NCT02552121|158115025|FG003|Part 2: Cohort Expansion|Death|0|||
49077024|NCT02552121|158115026|FG004|Part 2: Cohort Expansion|Death|0|||
49077025|NCT02552121|158115027|FG005|Part 2: Cohort Expansion|Death|0|||
49077026|NCT02552121|158115028|FG006|Part 2: Cohort Expansion|Death|0|||
49077027|NCT02552121|158115029|FG007|Part 2: Cohort Expansion|Death|0|||
49077028|NCT00786409|158115030|FG000|Overall Study|Withdrawal by Subject|2|||
49077029|NCT00786409|158115030|FG000|Overall Study|Adverse Event|2|||
49077030|NCT00786409|158115030|FG000|Overall Study|Pregnancy|2|||
49077031|NCT00786409|158115030|FG000|Overall Study|Lost to Follow-up|1|||
49077032|NCT00699998|158115031|FG000|Overall Study|Withdrawal by Subject|194|||
49077033|NCT00699998|158115032|FG001|Overall Study|Withdrawal by Subject|83|||
49077034|NCT00699998|158115033|FG002|Overall Study|Withdrawal by Subject|202|||
49077035|NCT00699998|158115034|FG003|Overall Study|Withdrawal by Subject|80|||
49077036|NCT00699998|158115031|FG000|Overall Study|Physician Decision|3|||
49077037|NCT00699998|158115032|FG001|Overall Study|Physician Decision|2|||
49077038|NCT00699998|158115033|FG002|Overall Study|Physician Decision|1|||
49077039|NCT00699998|158115034|FG003|Overall Study|Physician Decision|1|||
49077040|NCT00699998|158115031|FG000|Overall Study|Lost to Follow-up|2|||
49077041|NCT00699998|158115032|FG001|Overall Study|Lost to Follow-up|1|||
49077042|NCT00699998|158115033|FG002|Overall Study|Lost to Follow-up|3|||
49077043|NCT00699998|158115034|FG003|Overall Study|Lost to Follow-up|1|||
49077044|NCT05478252|158115035|FG000|Overall Study|Withdrawal by Subject|2|||
49077045|NCT05478252|158115036|FG001|Overall Study|Withdrawal by Subject|3|||
49077046|NCT05478252|158115035|FG000|Overall Study|Lost to Follow-up|4|||
49077047|NCT05478252|158115036|FG001|Overall Study|Lost to Follow-up|2|||
49077048|NCT05478252|158115035|FG000|Overall Study|Physician Decision|1|||
49077049|NCT05478252|158115036|FG001|Overall Study|Physician Decision|1|||
49077050|NCT05478252|158115035|FG000|Overall Study|Death|1|||
49077051|NCT05478252|158115036|FG001|Overall Study|Death|0|||
49077052|NCT03203850|158117502|FG000|Overall Study|Subject/guardian decision|4|||
49077053|NCT03203850|158117503|FG001|Overall Study|Subject/guardian decision|3|||
49077054|NCT03203850|158117502|FG000|Overall Study|Adverse Event|3|||
49077055|NCT03203850|158117503|FG001|Overall Study|Adverse Event|0|||
49077056|NCT03203850|158117502|FG000|Overall Study|Death|1|||
49077057|NCT03203850|158117503|FG001|Overall Study|Death|0|||
49077058|NCT02368314|158117504|FG000|Overall Study|Withdrawal by Subject|2|||
49077059|NCT02368314|158117505|FG001|Overall Study|Withdrawal by Subject|1|||
49077060|NCT02368314|158117504|FG000|Overall Study|Adverse Event|1|||
49077061|NCT02368314|158117505|FG001|Overall Study|Adverse Event|2|||
49077062|NCT03452137|158117506|FG000|Overall Study|Death|67|||
49077063|NCT03452137|158117507|FG001|Overall Study|Death|70|||
49077064|NCT03452137|158117506|FG000|Overall Study|Lost to Follow-up|4|||
49077065|NCT03452137|158117507|FG001|Overall Study|Lost to Follow-up|2|||
49077066|NCT03452137|158117506|FG000|Overall Study|Physician Decision|0|||
49077067|NCT03452137|158117507|FG001|Overall Study|Physician Decision|1|||
49077068|NCT03452137|158117506|FG000|Overall Study|Study Terminated by Sponsor|120|||
49077069|NCT03452137|158117507|FG001|Overall Study|Study Terminated by Sponsor|121|||
49077070|NCT03452137|158117506|FG000|Overall Study|Withdrawal by Subject|12|||
49077071|NCT03452137|158117507|FG001|Overall Study|Withdrawal by Subject|9|||
49077072|NCT01721317|158117515|FG000|Overall Study|Study Closed / Terminated|2|||
49077073|NCT01721317|158117516|FG001|Overall Study|Study Closed / Terminated|2|||
49077074|NCT01721317|158117515|FG000|Overall Study|Physician Decision|0|||
49077075|NCT01721317|158117516|FG001|Overall Study|Physician Decision|1|||
49077076|NCT01721317|158117515|FG000|Overall Study|Withdrawal by Subject|0|||
49077077|NCT01721317|158117516|FG001|Overall Study|Withdrawal by Subject|1|||
49077078|NCT02892149|158117529|FG000|Overall Study|Death|262|||
49077079|NCT02892149|158117530|FG001|Overall Study|Death|278|||
49077080|NCT02892149|158117529|FG000|Overall Study|Withdrawal by Subject|53|||
49077081|NCT02892149|158117530|FG001|Overall Study|Withdrawal by Subject|47|||
49077082|NCT02892149|158117529|FG000|Overall Study|Lost to Follow-up|37|||
49077083|NCT02892149|158117530|FG001|Overall Study|Lost to Follow-up|31|||
49077084|NCT01098474|158117535|FG000|Active Phase|Other|0|||
49077085|NCT01098474|158117536|FG001|Active Phase|Other|0|||
49077086|NCT01098474|158117537|FG002|Active Phase|Other|3|||
49077087|NCT01098474|158117538|FG003|Active Phase|Other|0|||
49077088|NCT01098474|158117539|FG004|Active Phase|Other|0|||
49077089|NCT01098474|158117540|FG005|Active Phase|Other|0|||
49077090|NCT01098474|158117535|FG000|Active Phase|Withdrawal by Subject|1|||
49077091|NCT01098474|158117536|FG001|Active Phase|Withdrawal by Subject|1|||
49077092|NCT01098474|158117537|FG002|Active Phase|Withdrawal by Subject|2|||
49077093|NCT01098474|158117538|FG003|Active Phase|Withdrawal by Subject|0|||
49077094|NCT01098474|158117539|FG004|Active Phase|Withdrawal by Subject|0|||
49077095|NCT01098474|158117540|FG005|Active Phase|Withdrawal by Subject|0|||
49077096|NCT01098474|158117535|FG000|Active Phase|Lost to Follow-up|1|||
49077097|NCT01098474|158117536|FG001|Active Phase|Lost to Follow-up|0|||
49077098|NCT01098474|158117537|FG002|Active Phase|Lost to Follow-up|0|||
49077099|NCT01098474|158117538|FG003|Active Phase|Lost to Follow-up|0|||
49077100|NCT01098474|158117539|FG004|Active Phase|Lost to Follow-up|0|||
49077101|NCT01098474|158117540|FG005|Active Phase|Lost to Follow-up|0|||
49077102|NCT01098474|158117535|FG000|Follow Up Phase|Travelled out of study area|0|||
49077103|NCT01098474|158117536|FG001|Follow Up Phase|Travelled out of study area|0|||
49077104|NCT01098474|158117537|FG002|Follow Up Phase|Travelled out of study area|0|||
49077105|NCT01098474|158117538|FG003|Follow Up Phase|Travelled out of study area|0|||
49077106|NCT01098474|158117539|FG004|Follow Up Phase|Travelled out of study area|1|||
49077107|NCT01098474|158117540|FG005|Follow Up Phase|Travelled out of study area|0|||
49077108|NCT01098474|158117535|FG000|Follow Up Phase|Other|0|||
49077109|NCT01098474|158117536|FG001|Follow Up Phase|Other|0|||
49077110|NCT01098474|158117537|FG002|Follow Up Phase|Other|0|||
49077111|NCT01098474|158117538|FG003|Follow Up Phase|Other|0|||
49077112|NCT01098474|158117539|FG004|Follow Up Phase|Other|0|||
49077113|NCT01098474|158117540|FG005|Follow Up Phase|Other|4|||
49077114|NCT01098474|158117535|FG000|Follow Up Phase|Withdrawal by Subject|0|||
49077115|NCT01098474|158117536|FG001|Follow Up Phase|Withdrawal by Subject|0|||
49077116|NCT01098474|158117537|FG002|Follow Up Phase|Withdrawal by Subject|0|||
49077117|NCT01098474|158117538|FG003|Follow Up Phase|Withdrawal by Subject|2|||
49077118|NCT01098474|158117539|FG004|Follow Up Phase|Withdrawal by Subject|0|||
49077119|NCT01098474|158117540|FG005|Follow Up Phase|Withdrawal by Subject|1|||
49077120|NCT01098474|158117535|FG000|Follow Up Phase|Lost to Follow-up|0|||
49077121|NCT01098474|158117536|FG001|Follow Up Phase|Lost to Follow-up|0|||
49077122|NCT01098474|158117537|FG002|Follow Up Phase|Lost to Follow-up|0|||
49077123|NCT01098474|158117538|FG003|Follow Up Phase|Lost to Follow-up|0|||
49077124|NCT01098474|158117539|FG004|Follow Up Phase|Lost to Follow-up|1|||
49077125|NCT01098474|158117540|FG005|Follow Up Phase|Lost to Follow-up|0|||
49077126|NCT00595309|158117546|FG000|Overall Study|Lost to Follow-up|1|||
49077127|NCT00595309|158117546|FG000|Overall Study|planned vaccination against yellow fever|1|||
49077128|NCT00595309|158117546|FG000|Overall Study|acute infection after V0|1|||
49077129|NCT00595309|158117546|FG000|Overall Study|personal reason|1|||
49077130|NCT02797171|158117547|FG000|Overall Study|Lost to Follow-up|2|||
49077131|NCT02797171|158117548|FG001|Overall Study|Lost to Follow-up|0|||
49077132|NCT02797171|158117549|FG002|Overall Study|Lost to Follow-up|2|||
49077133|NCT02797171|158117550|FG003|Overall Study|Lost to Follow-up|1|||
49077134|NCT02797171|158117551|FG004|Overall Study|Lost to Follow-up|2|||
49077135|NCT02797171|158117552|FG005|Overall Study|Lost to Follow-up|0|||
49077136|NCT02797171|158117547|FG000|Overall Study|Withdrawal by Subject|1|||
49077137|NCT02797171|158117548|FG001|Overall Study|Withdrawal by Subject|1|||
49077138|NCT02797171|158117549|FG002|Overall Study|Withdrawal by Subject|0|||
49077139|NCT02797171|158117550|FG003|Overall Study|Withdrawal by Subject|0|||
49077140|NCT02797171|158117551|FG004|Overall Study|Withdrawal by Subject|0|||
49077141|NCT02797171|158117552|FG005|Overall Study|Withdrawal by Subject|0|||
49077142|NCT02797171|158117547|FG000|Overall Study|Protocol Violation|1|||
49077143|NCT02797171|158117548|FG001|Overall Study|Protocol Violation|0|||
49077144|NCT02797171|158117549|FG002|Overall Study|Protocol Violation|0|||
49077145|NCT02797171|158117550|FG003|Overall Study|Protocol Violation|0|||
49077146|NCT02797171|158117551|FG004|Overall Study|Protocol Violation|0|||
49077147|NCT02797171|158117552|FG005|Overall Study|Protocol Violation|0|||
49077148|NCT02797171|158117547|FG000|Overall Study|Participant unable to adhere|0|||
49077149|NCT02797171|158117548|FG001|Overall Study|Participant unable to adhere|1|||
49077150|NCT02797171|158117549|FG002|Overall Study|Participant unable to adhere|0|||
49077151|NCT02797171|158117550|FG003|Overall Study|Participant unable to adhere|0|||
49077152|NCT02797171|158117551|FG004|Overall Study|Participant unable to adhere|0|||
49077153|NCT02797171|158117552|FG005|Overall Study|Participant unable to adhere|0|||
49077154|NCT02797171|158117547|FG000|Overall Study|Not Randomized|0|||
49077155|NCT02797171|158117548|FG001|Overall Study|Not Randomized|0|||
49077156|NCT02797171|158117549|FG002|Overall Study|Not Randomized|0|||
49077157|NCT02797171|158117550|FG003|Overall Study|Not Randomized|0|||
49077158|NCT02797171|158117551|FG004|Overall Study|Not Randomized|0|||
49077159|NCT02797171|158117552|FG005|Overall Study|Not Randomized|1|||
49077160|NCT02540083|158117555|FG000|Overall Study|Withdrawal by Subject|16|||
49077161|NCT00101283|158117556|FG000|Overall Study|Withdrawal by Subject|0|||
49077162|NCT00101283|158117557|FG001|Overall Study|Withdrawal by Subject|1|||
49077163|NCT00101283|158117556|FG000|Overall Study|Insurance Refusal|0|||
49077164|NCT00101283|158117557|FG001|Overall Study|Insurance Refusal|1|||
49077165|NCT00101283|158117556|FG000|Overall Study|Prostate Cancer Recurrence|0|||
49077166|NCT00101283|158117557|FG001|Overall Study|Prostate Cancer Recurrence|1|||
49077167|NCT00626561|158117558|FG000|Overall Study|Withdrawal by Subject|2|||
49077168|NCT00626561|158117558|FG000|Overall Study|Disease Progression|2|||
49077169|NCT01720225|158117567|FG000|Overall Study|Withdrawal by Subject|0|||
49077170|NCT01720225|158117568|FG001|Overall Study|Withdrawal by Subject|1|||
49077171|NCT01720225|158117567|FG000|Overall Study|Did not complete 2 cycles of therapy|3|||
49077172|NCT01720225|158117568|FG001|Overall Study|Did not complete 2 cycles of therapy|0|||
49077173|NCT01372748|158117569|FG000|Overall Study|Lost to Follow-up|16|||
49077174|NCT01372748|158117570|FG001|Overall Study|Lost to Follow-up|34|||
49077175|NCT01372748|158117569|FG000|Overall Study|Withdrawal by Subject|7|||
49077176|NCT01372748|158117570|FG001|Overall Study|Withdrawal by Subject|5|||
49077177|NCT01473407|158117571|FG000|Overall Study|Physician Decision|1|||
49077178|NCT01473407|158117572|FG001|Overall Study|Physician Decision|4|||
49077179|NCT01473407|158117571|FG000|Overall Study|Lost to Follow-up|10|||
49077180|NCT01473407|158117572|FG001|Overall Study|Lost to Follow-up|4|||
49077181|NCT01473407|158117571|FG000|Overall Study|Adverse Event|8|||
49077182|NCT01473407|158117572|FG001|Overall Study|Adverse Event|8|||
49077183|NCT01473407|158117571|FG000|Overall Study|Randomization Error|3|||
49077184|NCT01473407|158117572|FG001|Overall Study|Randomization Error|1|||
49077185|NCT01473407|158117571|FG000|Overall Study|Withdrawal by Subject|4|||
49077186|NCT01473407|158117572|FG001|Overall Study|Withdrawal by Subject|7|||
49077187|NCT01473407|158117571|FG000|Overall Study|Kidney Transplant|7|||
49077188|NCT01473407|158117572|FG001|Overall Study|Kidney Transplant|6|||
49077189|NCT01473407|158117571|FG000|Overall Study|Vacation/Travel|1|||
49077190|NCT01473407|158117572|FG001|Overall Study|Vacation/Travel|1|||
49077191|NCT01473407|158117571|FG000|Overall Study|Elevated Hemoglobin|1|||
49077192|NCT01473407|158117572|FG001|Overall Study|Elevated Hemoglobin|0|||
49077193|NCT01473407|158117571|FG000|Overall Study|Patient Received Aranesp|1|||
49077194|NCT01473407|158117572|FG001|Overall Study|Patient Received Aranesp|0|||
49077195|NCT01473407|158117571|FG000|Overall Study|Patient Lost Green Card Status|1|||
49077196|NCT01473407|158117572|FG001|Overall Study|Patient Lost Green Card Status|0|||
49077197|NCT01473407|158117571|FG000|Overall Study|Temperature Excursion|2|||
49077198|NCT01473407|158117572|FG001|Overall Study|Temperature Excursion|3|||
49077199|NCT01473407|158117571|FG000|Overall Study|Transfer to Another Facility/Unit|4|||
49077200|NCT01473407|158117572|FG001|Overall Study|Transfer to Another Facility/Unit|3|||
49077201|NCT01473407|158117571|FG000|Overall Study|Sponsor's Decision|10|||
49077202|NCT01473407|158117572|FG001|Overall Study|Sponsor's Decision|10|||
49077203|NCT01473407|158117571|FG000|Overall Study|Site Closure|1|||
49077204|NCT01473407|158117572|FG001|Overall Study|Site Closure|0|||
49077205|NCT02422797|158117573|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|11|||
49077206|NCT02422797|158117574|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|1|||
49077207|NCT02422797|158117573|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
49077208|NCT02422797|158117574|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|1|||
49077209|NCT02422797|158117573|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
49077210|NCT02422797|158117574|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
49077211|NCT02422797|158117573|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
49077212|NCT02422797|158117574|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
49077213|NCT02422797|158117573|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|0|||
49077214|NCT02422797|158117574|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|3|||
49077215|NCT02422797|158117573|FG000|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
49077216|NCT02422797|158117574|FG001|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
49077217|NCT02422797|158117573|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2|||
49077218|NCT02422797|158117574|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
49077219|NCT02422797|158117573|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
49077220|NCT02422797|158117574|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1|||
49077221|NCT02422797|158117573|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10|||
49077222|NCT02422797|158117574|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6|||
49077223|NCT02422797|158117573|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5|||
49077224|NCT02422797|158117574|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
49077225|NCT02422797|158117573|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
49077226|NCT02422797|158117574|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
49077227|NCT02422797|158117573|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2|||
49077228|NCT02422797|158117574|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6|||
49077229|NCT02422797|158117573|FG000|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1|||
49077230|NCT02422797|158117574|FG001|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0|||
49077231|NCT02422797|158117573|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
49077232|NCT02422797|158117574|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0|||
49077233|NCT02422797|158117573|FG000|Continuation Phase(Week 148 to Week 410)|Investigator discretion|1|||
49077234|NCT02422797|158117574|FG001|Continuation Phase(Week 148 to Week 410)|Investigator discretion|2|||
49077235|NCT02422797|158117573|FG000|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|0|||
49077236|NCT02422797|158117574|FG001|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|3|||
49077237|NCT02422797|158117573|FG000|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|1|||
49077238|NCT02422797|158117574|FG001|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|0|||
49077239|NCT02422797|158117573|FG000|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|4|||
49077240|NCT02422797|158117574|FG001|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|1|||
49077241|NCT02422797|158117573|FG000|Continuation Phase(Week 148 to Week 410)|Protocol Violation|0|||
49077242|NCT02422797|158117574|FG001|Continuation Phase(Week 148 to Week 410)|Protocol Violation|1|||
49077243|NCT02422797|158117573|FG000|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
49077244|NCT02422797|158117574|FG001|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
49077245|NCT02422797|158117573|FG000|Continuation Phase(Week 148 to Week 410)|Adverse Event|0|||
49077246|NCT02422797|158117574|FG001|Continuation Phase(Week 148 to Week 410)|Adverse Event|2|||
49077247|NCT04071405|158117575|FG000|Overall Study|Protocol Violation|3|||
49077248|NCT00134901|158117576|FG000|Overall Study|Lost to Follow-up|5|||
49077249|NCT00134901|158117577|FG001|Overall Study|Lost to Follow-up|5|||
49077250|NCT00134901|158117576|FG000|Overall Study|discontinued intervention|12|||
49077251|NCT00134901|158117577|FG001|Overall Study|discontinued intervention|10|||
49077252|NCT00369941|158117578|FG000|Overall Study|Never Treated|1|||
49077253|NCT00369941|158117579|FG001|Overall Study|Never Treated|2|||
49077254|NCT00369941|158117578|FG000|Overall Study|Adverse Event|14|||
49077255|NCT00369941|158117579|FG001|Overall Study|Adverse Event|28|||
49077256|NCT00369941|158117578|FG000|Overall Study|Lack of Efficacy|6|||
49077257|NCT00369941|158117579|FG001|Overall Study|Lack of Efficacy|10|||
49077258|NCT00369941|158117578|FG000|Overall Study|Lost to Follow-up|12|||
49077259|NCT00369941|158117579|FG001|Overall Study|Lost to Follow-up|22|||
49077260|NCT00369941|158117578|FG000|Overall Study|Protocol Violation|5|||
49077261|NCT00369941|158117579|FG001|Overall Study|Protocol Violation|3|||
49077262|NCT00369941|158117578|FG000|Overall Study|Withdrawal by Subject|5|||
49077263|NCT00369941|158117579|FG001|Overall Study|Withdrawal by Subject|18|||
49077264|NCT00369941|158117578|FG000|Overall Study|Pregnancy|4|||
49077265|NCT00369941|158117579|FG001|Overall Study|Pregnancy|2|||
49077266|NCT00369941|158117578|FG000|Overall Study|Completed, Did Not Enter Extension|5|||
49077267|NCT00369941|158117579|FG001|Overall Study|Completed, Did Not Enter Extension|6|||
49077268|NCT00369941|158117578|FG000|Overall Study|Moved|11|||
49077269|NCT00369941|158117579|FG001|Overall Study|Moved|5|||
49077270|NCT00369941|158117578|FG000|Overall Study|Treatment with Prohibited Medication|3|||
49077271|NCT00369941|158117579|FG001|Overall Study|Treatment with Prohibited Medication|1|||
49077272|NCT00369941|158117578|FG000|Overall Study|Employment Interfered with Study Visits|1|||
49077273|NCT00369941|158117579|FG001|Overall Study|Employment Interfered with Study Visits|0|||
49077274|NCT00369941|158117578|FG000|Overall Study|Study Site Terminated|2|||
49077275|NCT00369941|158117579|FG001|Overall Study|Study Site Terminated|0|||
49077276|NCT00369941|158117578|FG000|Overall Study|Miscellaneous|3|||
49077277|NCT00369941|158117579|FG001|Overall Study|Miscellaneous|3|||
49077278|NCT02301390|158117580|FG000|Overall Study|Withdrawal by Subject|3|||
49077279|NCT02301390|158117581|FG001|Overall Study|Withdrawal by Subject|5|||
49077280|NCT02301390|158117580|FG000|Overall Study|Protocol Violation|1|||
49077281|NCT02301390|158117581|FG001|Overall Study|Protocol Violation|0|||
49077282|NCT02301390|158117580|FG000|Overall Study|Physician Decision|1|||
49077283|NCT02301390|158117581|FG001|Overall Study|Physician Decision|0|||
49077284|NCT02301390|158117580|FG000|Overall Study|Lost to Follow-up|0|||
49077285|NCT02301390|158117581|FG001|Overall Study|Lost to Follow-up|1|||
49077286|NCT02301390|158117580|FG000|Overall Study|Death|2|||
49077287|NCT02301390|158117581|FG001|Overall Study|Death|2|||
49077288|NCT02301390|158117580|FG000|Overall Study|Procedure not completed|0|||
49077289|NCT02301390|158117581|FG001|Overall Study|Procedure not completed|4|||
49077290|NCT02301390|158117580|FG000|Overall Study|Missed multiple visits|1|||
49077291|NCT02301390|158117581|FG001|Overall Study|Missed multiple visits|1|||
49077292|NCT02301390|158117580|FG000|Overall Study|study terminated|2|||
49077293|NCT02301390|158117581|FG001|Overall Study|study terminated|0|||
49077294|NCT03071276|158117582|FG000|Overall Study|Adverse Event|1|||
49077295|NCT03071276|158117582|FG000|Overall Study|Lack of Efficacy|14|||
49077296|NCT00398866|158117593|FG000|Overall Study|Adverse Event|1|||
49077297|NCT00398866|158117594|FG001|Overall Study|Adverse Event|0|||
49077298|NCT00398866|158117595|FG002|Overall Study|Adverse Event|0|||
49077299|NCT00398866|158117593|FG000|Overall Study|Lack of Efficacy|0|||
49077300|NCT00398866|158117594|FG001|Overall Study|Lack of Efficacy|0|||
49077301|NCT00398866|158117595|FG002|Overall Study|Lack of Efficacy|1|||
49077302|NCT00398866|158117593|FG000|Overall Study|Lost to Follow-up|7|||
49077303|NCT00398866|158117594|FG001|Overall Study|Lost to Follow-up|6|||
49077304|NCT00398866|158117595|FG002|Overall Study|Lost to Follow-up|4|||
49077305|NCT00398866|158117593|FG000|Overall Study|Withdrawal by Subject|5|||
49077306|NCT00398866|158117594|FG001|Overall Study|Withdrawal by Subject|1|||
49077307|NCT00398866|158117595|FG002|Overall Study|Withdrawal by Subject|2|||
49077308|NCT00398866|158117593|FG000|Overall Study|Unable to complete requirements of study|1|||
49077309|NCT00398866|158117594|FG001|Overall Study|Unable to complete requirements of study|1|||
49077310|NCT00398866|158117595|FG002|Overall Study|Unable to complete requirements of study|1|||
49077311|NCT02224157|158117596|FG000|Overall Study|Severe non-compliance to protocol|2|||
49077312|NCT02224157|158117597|FG001|Overall Study|Severe non-compliance to protocol|2|||
49077313|NCT02224157|158117596|FG000|Overall Study|Other|13|||
49077314|NCT02224157|158117597|FG001|Overall Study|Other|10|||
49077315|NCT02224157|158117596|FG000|Overall Study|Subject decision|58|||
49077316|NCT02224157|158117597|FG001|Overall Study|Subject decision|50|||
49077317|NCT02224157|158117596|FG000|Overall Study|Prematurely closed site|4|||
49077318|NCT02224157|158117597|FG001|Overall Study|Prematurely closed site|2|||
49077319|NCT02224157|158117596|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
49077320|NCT02224157|158117597|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
49077321|NCT02224157|158117596|FG000|Overall Study|Lost to Follow-up|27|||
49077322|NCT02224157|158117597|FG001|Overall Study|Lost to Follow-up|35|||
49077323|NCT02224157|158117596|FG000|Overall Study|Death|1|||
49077324|NCT02224157|158117597|FG001|Overall Study|Death|1|||
49077325|NCT02224157|158117596|FG000|Overall Study|Adverse Event|1|||
49077326|NCT02224157|158117597|FG001|Overall Study|Adverse Event|3|||
49077327|NCT04324021|158117599|FG000|Overall Study|Adverse Event|1|||
49077328|NCT04324021|158117600|FG001|Overall Study|Adverse Event|0|||
49077329|NCT04324021|158117601|FG002|Overall Study|Adverse Event|0|||
49077330|NCT04324021|158117599|FG000|Overall Study|Lack of Efficacy|0|||
49077331|NCT04324021|158117600|FG001|Overall Study|Lack of Efficacy|0|||
49077332|NCT04324021|158117601|FG002|Overall Study|Lack of Efficacy|1|||
49077333|NCT04324021|158117599|FG000|Overall Study|Death|1|||
49077334|NCT04324021|158117600|FG001|Overall Study|Death|1|||
49077335|NCT04324021|158117601|FG002|Overall Study|Death|0|||
49077336|NCT03910673|158117602|FG000|Overall Study|Adverse Event|0|||
49077337|NCT03910673|158117603|FG001|Overall Study|Adverse Event|0|||
49077338|NCT03910673|158117604|FG002|Overall Study|Adverse Event|0|||
49077339|NCT03910673|158117605|FG003|Overall Study|Adverse Event|2|||
49077340|NCT03910673|158117606|FG004|Overall Study|Adverse Event|0|||
49077341|NCT00098774|158117607|FG000|Overall Study|Adverse Event|2|||
49077342|NCT00098774|158117607|FG000|Overall Study|Disease Progression|9|||
49077343|NCT00098774|158117607|FG000|Overall Study|Withdrawal by Subject|1|||
49077344|NCT00098774|158117607|FG000|Overall Study|Failed (to respond) during induction|4|||
49077345|NCT00098774|158117607|FG000|Overall Study|Physician Decision|2|||
49077346|NCT03097991|158117608|FG000|Overall Study|Didn't meet study criteria|8|||
49077347|NCT03097991|158117609|FG001|Overall Study|Didn't meet study criteria|0|||
49077348|NCT03097991|158117608|FG000|Overall Study|Withdrawal by Subject|12|||
49077349|NCT03097991|158117609|FG001|Overall Study|Withdrawal by Subject|6|||
49077350|NCT03097991|158117608|FG000|Overall Study|Death of Baby|3|||
49077351|NCT03097991|158117609|FG001|Overall Study|Death of Baby|1|||
49077352|NCT03097991|158117608|FG000|Overall Study|Lost to Follow-up|24|||
49077353|NCT03097991|158117609|FG001|Overall Study|Lost to Follow-up|38|||
49077354|NCT03097991|158117608|FG000|Overall Study|Adverse Event|3|||
49077355|NCT03097991|158117609|FG001|Overall Study|Adverse Event|5|||
49077356|NCT03404674|158117610|FG000|Overall Study|Inability to Attend Future Visits|0|||
49077357|NCT03404674|158117611|FG001|Overall Study|Inability to Attend Future Visits|1|||
49077358|NCT03404674|158117612|FG002|Overall Study|Inability to Attend Future Visits|1|||
49077359|NCT03404674|158117613|FG003|Overall Study|Inability to Attend Future Visits|0|||
49077360|NCT03404674|158117614|FG004|Overall Study|Inability to Attend Future Visits|0|||
49077361|NCT03404674|158117615|FG005|Overall Study|Inability to Attend Future Visits|0|||
49077362|NCT03404674|158117610|FG000|Overall Study|Behavioral Problems|0|||
49077363|NCT03404674|158117611|FG001|Overall Study|Behavioral Problems|0|||
49077364|NCT03404674|158117612|FG002|Overall Study|Behavioral Problems|1|||
49077365|NCT03404674|158117613|FG003|Overall Study|Behavioral Problems|0|||
49077366|NCT03404674|158117614|FG004|Overall Study|Behavioral Problems|0|||
49077367|NCT03404674|158117615|FG005|Overall Study|Behavioral Problems|0|||
49077368|NCT03404674|158117610|FG000|Overall Study|Started a Medication that Precluded Eligibility|0|||
49077369|NCT03404674|158117611|FG001|Overall Study|Started a Medication that Precluded Eligibility|0|||
49077370|NCT03404674|158117612|FG002|Overall Study|Started a Medication that Precluded Eligibility|0|||
49077371|NCT03404674|158117613|FG003|Overall Study|Started a Medication that Precluded Eligibility|1|||
49077372|NCT03404674|158117614|FG004|Overall Study|Started a Medication that Precluded Eligibility|0|||
49077373|NCT03404674|158117615|FG005|Overall Study|Started a Medication that Precluded Eligibility|1|||
49077374|NCT02348112|158117618|FG000|Overall Study|Withdrawal by Subject|32|||
49077375|NCT02348112|158117619|FG001|Overall Study|Withdrawal by Subject|29|||
49077376|NCT02348112|158117618|FG000|Overall Study|Lost to Follow-up|24|||
49077377|NCT02348112|158117619|FG001|Overall Study|Lost to Follow-up|20|||
49077378|NCT02348112|158117618|FG000|Overall Study|Physician Decision|17|||
49077379|NCT02348112|158117619|FG001|Overall Study|Physician Decision|15|||
49077380|NCT02348112|158117618|FG000|Overall Study|Site closed due to PI leaving|0|||
49077381|NCT02348112|158117619|FG001|Overall Study|Site closed due to PI leaving|30|||
49077382|NCT02348112|158117618|FG000|Overall Study|Sponsor withdrawal|0|||
49077383|NCT02348112|158117619|FG001|Overall Study|Sponsor withdrawal|7|||
49077384|NCT02348112|158117618|FG000|Overall Study|Death|0|||
49077385|NCT02348112|158117619|FG001|Overall Study|Death|1|||
49077386|NCT05022212|158117625|FG000|Overall Study|Lost to Follow-up|0|||
49077387|NCT05022212|158117626|FG001|Overall Study|Lost to Follow-up|2|||
49077388|NCT01998841|158117627|FG000|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
49077389|NCT01998841|158117628|FG001|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
49077390|NCT01998841|158117629|FG002|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|3|||
49077391|NCT01998841|158117630|FG003|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
49077392|NCT01998841|158117631|FG004|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
49077393|NCT01998841|158117627|FG000|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
49077394|NCT01998841|158117628|FG001|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
49077395|NCT01998841|158117629|FG002|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
49077396|NCT01998841|158117630|FG003|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|7|||
49077397|NCT01998841|158117631|FG004|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|2|||
49077398|NCT02586155|158117632|FG000|Overall Study|Adverse Event|2|||
49077399|NCT02586155|158117633|FG001|Overall Study|Adverse Event|3|||
49077400|NCT02586155|158117632|FG000|Overall Study|Withdrawal by Subject|31|||
49077401|NCT02586155|158117633|FG001|Overall Study|Withdrawal by Subject|24|||
49077402|NCT02586155|158117632|FG000|Overall Study|Lost to Follow-up|7|||
49077403|NCT02586155|158117633|FG001|Overall Study|Lost to Follow-up|13|||
49077404|NCT02586155|158117632|FG000|Overall Study|Death|61|||
49077405|NCT02586155|158117633|FG001|Overall Study|Death|72|||
49077406|NCT02586155|158117632|FG000|Overall Study|Other reasons|26|||
49077407|NCT02586155|158117633|FG001|Overall Study|Other reasons|15|||
49077408|NCT03629184|158117634|FG000|Overall Study|Withdrawal by Subject|2|||
49077409|NCT03629184|158117635|FG001|Overall Study|Withdrawal by Subject|1|||
49077410|NCT03629184|158117634|FG000|Overall Study|Physician Decision|1|||
49077411|NCT03629184|158117635|FG001|Overall Study|Physician Decision|0|||
49077412|NCT01461538|158117637|FG000|Overall Study|Death|15|||
49077413|NCT01461538|158117638|FG001|Overall Study|Death|6|||
49077414|NCT01461538|158117639|FG002|Overall Study|Death|2|||
49077415|NCT01461538|158117637|FG000|Overall Study|Study Stopped by Sponsor|2|||
49077416|NCT01461538|158117638|FG001|Overall Study|Study Stopped by Sponsor|1|||
49077417|NCT01461538|158117639|FG002|Overall Study|Study Stopped by Sponsor|0|||
49077418|NCT01461538|158117637|FG000|Overall Study|Withdrawal by Subject|1|||
49077419|NCT01461538|158117638|FG001|Overall Study|Withdrawal by Subject|1|||
49077420|NCT01461538|158117639|FG002|Overall Study|Withdrawal by Subject|0|||
49077421|NCT02729909|158117640|FG000|Overall Study|Lost to Follow-up|0|||
49077422|NCT02729909|158117641|FG001|Overall Study|Lost to Follow-up|1|||
49077423|NCT02729909|158117640|FG000|Overall Study|Lack of Efficacy|0|||
49077424|NCT02729909|158117641|FG001|Overall Study|Lack of Efficacy|2|||
49077425|NCT02729909|158117640|FG000|Overall Study|Significant Protocol Deviation|0|||
49077426|NCT02729909|158117641|FG001|Overall Study|Significant Protocol Deviation|2|||
49077427|NCT02729909|158117640|FG000|Overall Study|Voluntary Withdrawal|1|||
49077428|NCT02729909|158117641|FG001|Overall Study|Voluntary Withdrawal|0|||
49077429|NCT02215967|158117648|FG000|Overall Study|Patient became ineligible for treatment|0|||
49077430|NCT02215967|158117649|FG001|Overall Study|Patient became ineligible for treatment|0|||
49077431|NCT02215967|158117650|FG002|Overall Study|Patient became ineligible for treatment|0|||
49077432|NCT02215967|158117651|FG003|Overall Study|Patient became ineligible for treatment|3|||
49077433|NCT02215967|158117648|FG000|Overall Study|Patient did not get CAR T-Cells|0|||
49077434|NCT02215967|158117649|FG001|Overall Study|Patient did not get CAR T-Cells|0|||
49077435|NCT02215967|158117650|FG002|Overall Study|Patient did not get CAR T-Cells|1|||
49077436|NCT02215967|158117651|FG003|Overall Study|Patient did not get CAR T-Cells|0|||
49077437|NCT04779879|158117653|FG000|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
49077438|NCT04779879|158117654|FG001|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
49077439|NCT04779879|158117655|FG002|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
49077440|NCT04779879|158117656|FG003|Part B: Up to Week 36|Randomized, but did not receive treatment|1|||
49077441|NCT04779879|158117657|FG004|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
49077442|NCT04779879|158117658|FG005|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
49077443|NCT04779879|158117653|FG000|Part B: Up to Week 36|Withdrawal by Subject|0|||
49077444|NCT04779879|158117654|FG001|Part B: Up to Week 36|Withdrawal by Subject|0|||
49077445|NCT04779879|158117655|FG002|Part B: Up to Week 36|Withdrawal by Subject|0|||
49077446|NCT04779879|158117656|FG003|Part B: Up to Week 36|Withdrawal by Subject|1|||
49077447|NCT04779879|158117657|FG004|Part B: Up to Week 36|Withdrawal by Subject|0|||
49077448|NCT04779879|158117658|FG005|Part B: Up to Week 36|Withdrawal by Subject|0|||
49077449|NCT04779879|158117653|FG000|Part C: Up to Week 36|Death|0|||
49077450|NCT04779879|158117654|FG001|Part C: Up to Week 36|Death|0|||
49077451|NCT04779879|158117655|FG002|Part C: Up to Week 36|Death|0|||
49077452|NCT04779879|158117656|FG003|Part C: Up to Week 36|Death|0|||
49077453|NCT04779879|158117657|FG004|Part C: Up to Week 36|Death|0|||
49077454|NCT04779879|158117658|FG005|Part C: Up to Week 36|Death|1|||
49077455|NCT04779879|158117653|FG000|Part C: Up to Week 36|Withdrawal by Subject|0|||
49077456|NCT04779879|158117654|FG001|Part C: Up to Week 36|Withdrawal by Subject|0|||
49077457|NCT04779879|158117655|FG002|Part C: Up to Week 36|Withdrawal by Subject|0|||
49077458|NCT04779879|158117656|FG003|Part C: Up to Week 36|Withdrawal by Subject|0|||
49077459|NCT04779879|158117657|FG004|Part C: Up to Week 36|Withdrawal by Subject|4|||
49077460|NCT04779879|158117658|FG005|Part C: Up to Week 36|Withdrawal by Subject|2|||
49077461|NCT03447743|158117659|FG000|Overall Study|Withdrawal by Subject|2|||
49077462|NCT03447743|158117659|FG000|Overall Study|Lost to Follow-up|3|||
49077463|NCT03447743|158117659|FG000|Overall Study|Adverse Event|1|||
49077464|NCT03447743|158117659|FG000|Overall Study|Did not meet criteria to continue|1|||
49077465|NCT02046603|158117660|FG000|Overall Study|Other|11|||
49077466|NCT02046603|158117661|FG001|Overall Study|Other|66|||
49077467|NCT02046603|158117660|FG000|Overall Study|Protocol Violation|0|||
49077468|NCT02046603|158117661|FG001|Overall Study|Protocol Violation|1|||
49077469|NCT02046603|158117660|FG000|Overall Study|Participant/legal guardian decision|1|||
49077470|NCT02046603|158117661|FG001|Overall Study|Participant/legal guardian decision|3|||
49077471|NCT02046603|158117660|FG000|Overall Study|Physician Decision|2|||
49077472|NCT02046603|158117661|FG001|Overall Study|Physician Decision|1|||
49077473|NCT02046603|158117660|FG000|Overall Study|Lost to Follow-up|1|||
49077474|NCT02046603|158117661|FG001|Overall Study|Lost to Follow-up|2|||
49077475|NCT02046603|158117660|FG000|Overall Study|Death|0|||
49077476|NCT02046603|158117661|FG001|Overall Study|Death|1|||
49077477|NCT02046603|158117660|FG000|Overall Study|Adverse Event|0|||
49077478|NCT02046603|158117661|FG001|Overall Study|Adverse Event|1|||
49077479|NCT00640315|158117663|FG000|Overall Study|Withdrawal by Subject|0|||
49077480|NCT00640315|158117664|FG001|Overall Study|Withdrawal by Subject|1|||
49077481|NCT05048329|158119350|FG000|Overall Study|Withdrawal by Subject|1|||
49077482|NCT05048329|158119350|FG000|Overall Study|Screenfail|1|||
49077483|NCT02864992|158119351|FG000|Overall Study|still on treatment|15|||
49077484|NCT02864992|158119352|FG001|Overall Study|still on treatment|1|||
49077485|NCT02864992|158119353|FG002|Overall Study|still on treatment|33|||
49077486|NCT03772717|158119354|FG000|Overall Study|Withdrawal by Subject|2|||
49077487|NCT04138043|158119355|FG000|Overall Study|Withdrawal by Subject|0|||
49077488|NCT04138043|158119356|FG001|Overall Study|Withdrawal by Subject|1|||
49077489|NCT02856802|158119357|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
49077490|NCT02856802|158119358|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|2|||
49077491|NCT02856802|158119357|FG000|Double-Blind Treatment Period 1|Lost to Follow-up|1|||
49077492|NCT02856802|158119358|FG001|Double-Blind Treatment Period 1|Lost to Follow-up|0|||
49077493|NCT02856802|158119357|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
49077494|NCT02856802|158119358|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
49077495|NCT02856802|158119357|FG000|Double-Blind Treatment Period 1|Sponsor terminated|1|||
49077496|NCT02856802|158119358|FG001|Double-Blind Treatment Period 1|Sponsor terminated|0|||
49077497|NCT02856802|158119357|FG000|Double-Blind Treatment Period 1|Lack of diary compliance|0|||
49077498|NCT02856802|158119358|FG001|Double-Blind Treatment Period 1|Lack of diary compliance|2|||
49077499|NCT02856802|158119357|FG000|Double-Blind Treatment Period 2|Lost to Follow-up|1|||
49077500|NCT02856802|158119358|FG001|Double-Blind Treatment Period 2|Lost to Follow-up|0|||
49077501|NCT01810302|158119359|FG000|Overall Study|Death|1|||
49077502|NCT01810302|158119360|FG001|Overall Study|Death|0|||
49077503|NCT01810302|158119359|FG000|Overall Study|Physician Decision|0|||
49077504|NCT01810302|158119360|FG001|Overall Study|Physician Decision|1|||
49077505|NCT00587860|158119361|FG000|Overall Study|Lost to Follow-up|2|||
49077506|NCT00587860|158119362|FG001|Overall Study|Lost to Follow-up|2|||
49077507|NCT00587860|158119361|FG000|Overall Study|Withdrawal by Subject|3|||
49077508|NCT00587860|158119362|FG001|Overall Study|Withdrawal by Subject|3|||
49077509|NCT01659125|158119366|FG000|Overall Study|Withdrawal by Subject|2|||
49077510|NCT01659125|158119366|FG000|Overall Study|Lost to Follow-up|7|||
49077511|NCT01659125|158119366|FG000|Overall Study|Technical Problem|1|||
49077512|NCT01659125|158119366|FG000|Overall Study|Time Constraints|2|||
49077513|NCT01659125|158119366|FG000|Overall Study|Failed to Start Treatment|2|||
49077514|NCT01396512|158119367|FG000|Overall Study|Withdrawal by Subject|0|||
49077515|NCT01396512|158119368|FG001|Overall Study|Withdrawal by Subject|1|||
49077516|NCT00261443|158119369|FG000|1: Confirmation of Partial Nonresponse|Adverse Event|33|||
49077517|NCT00261443|158119370|FG001|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
49077518|NCT00261443|158119371|FG002|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
49077519|NCT00261443|158119369|FG000|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93|||
49077520|NCT00261443|158119370|FG001|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
49077521|NCT00261443|158119371|FG002|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
49077522|NCT00261443|158119369|FG000|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111|||
49077523|NCT00261443|158119370|FG001|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
49077524|NCT00261443|158119371|FG002|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
49077525|NCT00261443|158119369|FG000|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23|||
49077526|NCT00261443|158119370|FG001|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
49077527|NCT00261443|158119371|FG002|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
49077528|NCT00261443|158119369|FG000|1: Confirmation of Partial Nonresponse|Pregnancy|1|||
49077529|NCT00261443|158119370|FG001|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
49077530|NCT00261443|158119371|FG002|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
49077531|NCT00261443|158119369|FG000|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307|||
49077532|NCT00261443|158119370|FG001|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
49077533|NCT00261443|158119371|FG002|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
49077534|NCT00261443|158119369|FG000|1: Confirmation of Partial Nonresponse|Other Reasons|16|||
49077535|NCT00261443|158119370|FG001|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
49077536|NCT00261443|158119371|FG002|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
49077537|NCT00261443|158119369|FG000|2: Stability & Maintenance of Stability|Lack of Efficacy|43|||
49077538|NCT00261443|158119370|FG001|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
49077539|NCT00261443|158119371|FG002|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
49077540|NCT00261443|158119369|FG000|2: Stability & Maintenance of Stability|Adverse Event|93|||
49077541|NCT00261443|158119370|FG001|2: Stability & Maintenance of Stability|Adverse Event|0|||
49077542|NCT00261443|158119371|FG002|2: Stability & Maintenance of Stability|Adverse Event|0|||
49077543|NCT00261443|158119369|FG000|2: Stability & Maintenance of Stability|Withdrawal by Subject|65|||
49077544|NCT00261443|158119370|FG001|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
49077545|NCT00261443|158119371|FG002|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
49077546|NCT00261443|158119369|FG000|2: Stability & Maintenance of Stability|Lost to Follow-up|59|||
49077547|NCT00261443|158119370|FG001|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
49077548|NCT00261443|158119371|FG002|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
49077549|NCT00261443|158119369|FG000|2: Stability & Maintenance of Stability|Poor/Noncompliance|33|||
49077550|NCT00261443|158119370|FG001|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
49077551|NCT00261443|158119371|FG002|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
49077552|NCT00261443|158119369|FG000|2: Stability & Maintenance of Stability|Pregnancy|1|||
49077553|NCT00261443|158119370|FG001|2: Stability & Maintenance of Stability|Pregnancy|0|||
49077554|NCT00261443|158119371|FG002|2: Stability & Maintenance of Stability|Pregnancy|0|||
49077555|NCT00261443|158119369|FG000|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32|||
49077556|NCT00261443|158119370|FG001|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
49077557|NCT00261443|158119371|FG002|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
49077558|NCT00261443|158119369|FG000|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1|||
49077559|NCT00261443|158119370|FG001|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
49077560|NCT00261443|158119371|FG002|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
49077561|NCT00261443|158119369|FG000|2: Stability & Maintenance of Stability|Other Reasons|13|||
49077562|NCT00261443|158119370|FG001|2: Stability & Maintenance of Stability|Other Reasons|0|||
49077563|NCT00261443|158119371|FG002|2: Stability & Maintenance of Stability|Other Reasons|0|||
49077564|NCT00261443|158119369|FG000|3: Assessment of Relapse|Lack of Efficacy|0|||
49077565|NCT00261443|158119370|FG001|3: Assessment of Relapse|Lack of Efficacy|31|||
49077566|NCT00261443|158119371|FG002|3: Assessment of Relapse|Lack of Efficacy|14|||
49077567|NCT00261443|158119369|FG000|3: Assessment of Relapse|Adverse Event|0|||
49077568|NCT00261443|158119370|FG001|3: Assessment of Relapse|Adverse Event|15|||
49077569|NCT00261443|158119371|FG002|3: Assessment of Relapse|Adverse Event|19|||
49077570|NCT00261443|158119369|FG000|3: Assessment of Relapse|Withdrawal by Subject|0|||
49077571|NCT00261443|158119370|FG001|3: Assessment of Relapse|Withdrawal by Subject|14|||
49077572|NCT00261443|158119371|FG002|3: Assessment of Relapse|Withdrawal by Subject|15|||
49077573|NCT00261443|158119369|FG000|3: Assessment of Relapse|Death|0|||
49077574|NCT00261443|158119370|FG001|3: Assessment of Relapse|Death|0|||
49077575|NCT00261443|158119371|FG002|3: Assessment of Relapse|Death|1|||
49077576|NCT00261443|158119369|FG000|3: Assessment of Relapse|Lost to Follow-up|0|||
49077577|NCT00261443|158119370|FG001|3: Assessment of Relapse|Lost to Follow-up|7|||
49077578|NCT00261443|158119371|FG002|3: Assessment of Relapse|Lost to Follow-up|6|||
49077579|NCT00261443|158119369|FG000|3: Assessment of Relapse|Poor/Noncompliance|0|||
49077580|NCT00261443|158119370|FG001|3: Assessment of Relapse|Poor/Noncompliance|5|||
49077581|NCT00261443|158119371|FG002|3: Assessment of Relapse|Poor/Noncompliance|3|||
49077582|NCT00261443|158119369|FG000|3: Assessment of Relapse|Pregnancy|0|||
49077583|NCT00261443|158119370|FG001|3: Assessment of Relapse|Pregnancy|2|||
49077584|NCT00261443|158119371|FG002|3: Assessment of Relapse|Pregnancy|1|||
49077585|NCT00261443|158119369|FG000|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0|||
49077586|NCT00261443|158119370|FG001|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2|||
49077587|NCT00261443|158119371|FG002|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1|||
49077588|NCT00261443|158119369|FG000|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
49077589|NCT00261443|158119370|FG001|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
49077590|NCT00261443|158119371|FG002|3: Assessment of Relapse|Administrative Reason By Sponsor|2|||
49077591|NCT00261443|158119369|FG000|3: Assessment of Relapse|Other Reasons|0|||
49077592|NCT00261443|158119370|FG001|3: Assessment of Relapse|Other Reasons|4|||
49077593|NCT00261443|158119371|FG002|3: Assessment of Relapse|Other Reasons|3|||
49077594|NCT00261443|158119369|FG000|4: Extension Phase|Adverse Event|0|||
49077595|NCT00261443|158119370|FG001|4: Extension Phase|Adverse Event|1|||
49077596|NCT00261443|158119371|FG002|4: Extension Phase|Adverse Event|0|||
49077597|NCT00261443|158119369|FG000|4: Extension Phase|Withdrawal by Subject|0|||
49077598|NCT00261443|158119370|FG001|4: Extension Phase|Withdrawal by Subject|1|||
49077599|NCT00261443|158119371|FG002|4: Extension Phase|Withdrawal by Subject|2|||
49077600|NCT00261443|158119369|FG000|4: Extension Phase|Lost to Follow-up|0|||
49077601|NCT00261443|158119370|FG001|4: Extension Phase|Lost to Follow-up|1|||
49077602|NCT00261443|158119371|FG002|4: Extension Phase|Lost to Follow-up|0|||
49077603|NCT01286753|158119374|FG000|Overall Study|Adverse Event|7|||
49077604|NCT01286753|158119375|FG001|Overall Study|Adverse Event|6|||
49077605|NCT01286753|158119374|FG000|Overall Study|Progression|11|||
49077606|NCT01286753|158119375|FG001|Overall Study|Progression|13|||
49077607|NCT01286753|158119374|FG000|Overall Study|Refused Treatment|1|||
49077608|NCT01286753|158119375|FG001|Overall Study|Refused Treatment|0|||
49077609|NCT01286753|158119374|FG000|Overall Study|Withdrawal of Consent|0|||
49077610|NCT01286753|158119375|FG001|Overall Study|Withdrawal of Consent|2|||
49077611|NCT01286753|158119374|FG000|Overall Study|Discontinued to Join Extension Study|6|||
49077612|NCT01286753|158119375|FG001|Overall Study|Discontinued to Join Extension Study|4|||
49077613|NCT01286753|158119374|FG000|Overall Study|Participant to Receive Radiotherapy|1|||
49077614|NCT01286753|158119375|FG001|Overall Study|Participant to Receive Radiotherapy|0|||
49077615|NCT02618759|158119379|FG000|Overall Study|Lost to Follow-up|0|||
49077616|NCT02618759|158119380|FG001|Overall Study|Lost to Follow-up|1|||
49077617|NCT02618759|158119379|FG000|Overall Study|Withdrawal by Subject|1|||
49077618|NCT02618759|158119380|FG001|Overall Study|Withdrawal by Subject|0|||
49077619|NCT02618759|158119379|FG000|Overall Study|Other Reasons|1|||
49077620|NCT02618759|158119380|FG001|Overall Study|Other Reasons|4|||
49077621|NCT02500043|158119383|FG000|Overall Study|Randomized, but not Treated|2|||
49077622|NCT02500043|158119384|FG001|Overall Study|Randomized, but not Treated|2|||
49077623|NCT02500043|158119383|FG000|Overall Study|Ongoing at Date of Cut-Off|19|||
49077624|NCT02500043|158119384|FG001|Overall Study|Ongoing at Date of Cut-Off|3|||
49077625|NCT02500043|158119383|FG000|Overall Study|Adverse Event|33|||
49077626|NCT02500043|158119384|FG001|Overall Study|Adverse Event|11|||
49077627|NCT02500043|158119383|FG000|Overall Study|Clinical Progression|54|||
49077628|NCT02500043|158119384|FG001|Overall Study|Clinical Progression|35|||
49077629|NCT02500043|158119383|FG000|Overall Study|Radiological Progression|192|||
49077630|NCT02500043|158119384|FG001|Overall Study|Radiological Progression|110|||
49077631|NCT02500043|158119383|FG000|Overall Study|Physician's Decision|11|||
49077632|NCT02500043|158119384|FG001|Overall Study|Physician's Decision|3|||
49077633|NCT02500043|158119383|FG000|Overall Study|Withdrawal by Subject|14|||
49077634|NCT02500043|158119384|FG001|Overall Study|Withdrawal by Subject|4|||
49077635|NCT02500043|158119383|FG000|Overall Study|Death|11|||
49077636|NCT02500043|158119384|FG001|Overall Study|Death|2|||
49077637|NCT02500043|158119383|FG000|Overall Study|Protocol Deviation|1|||
49077638|NCT02500043|158119384|FG001|Overall Study|Protocol Deviation|0|||
49077639|NCT01371747|158119385|FG000|Overall Study|Adverse Event|4|||
49077640|NCT01371747|158119386|FG001|Overall Study|Adverse Event|2|||
49077641|NCT01371747|158119387|FG002|Overall Study|Adverse Event|7|||
49077642|NCT01371747|158119388|FG003|Overall Study|Adverse Event|2|||
49077643|NCT01371747|158119389|FG004|Overall Study|Adverse Event|2|||
49077644|NCT01371747|158119390|FG005|Overall Study|Adverse Event|2|||
49077645|NCT01371747|158119385|FG000|Overall Study|Death|1|||
49077646|NCT01371747|158119386|FG001|Overall Study|Death|0|||
49077647|NCT01371747|158119387|FG002|Overall Study|Death|4|||
49077648|NCT01371747|158119388|FG003|Overall Study|Death|1|||
49077649|NCT01371747|158119389|FG004|Overall Study|Death|2|||
49077650|NCT01371747|158119390|FG005|Overall Study|Death|0|||
49077651|NCT01371747|158119385|FG000|Overall Study|Abnormal Renal Function|0|||
49077652|NCT01371747|158119386|FG001|Overall Study|Abnormal Renal Function|2|||
49077653|NCT01371747|158119387|FG002|Overall Study|Abnormal Renal Function|0|||
49077654|NCT01371747|158119388|FG003|Overall Study|Abnormal Renal Function|1|||
49077655|NCT01371747|158119389|FG004|Overall Study|Abnormal Renal Function|0|||
49077656|NCT01371747|158119390|FG005|Overall Study|Abnormal Renal Function|1|||
49077657|NCT01371747|158119385|FG000|Overall Study|High Serum Potassium Results|1|||
49077658|NCT01371747|158119386|FG001|Overall Study|High Serum Potassium Results|1|||
49077659|NCT01371747|158119387|FG002|Overall Study|High Serum Potassium Results|1|||
49077660|NCT01371747|158119388|FG003|Overall Study|High Serum Potassium Results|2|||
49077661|NCT01371747|158119389|FG004|Overall Study|High Serum Potassium Results|0|||
49077662|NCT01371747|158119390|FG005|Overall Study|High Serum Potassium Results|2|||
49077663|NCT01371747|158119385|FG000|Overall Study|Low Serum Potassium Results|1|||
49077664|NCT01371747|158119386|FG001|Overall Study|Low Serum Potassium Results|1|||
49077665|NCT01371747|158119387|FG002|Overall Study|Low Serum Potassium Results|1|||
49077666|NCT01371747|158119388|FG003|Overall Study|Low Serum Potassium Results|1|||
49077667|NCT01371747|158119389|FG004|Overall Study|Low Serum Potassium Results|0|||
49077668|NCT01371747|158119390|FG005|Overall Study|Low Serum Potassium Results|3|||
49077669|NCT01371747|158119385|FG000|Overall Study|Protocol Violation|0|||
49077670|NCT01371747|158119386|FG001|Overall Study|Protocol Violation|0|||
49077671|NCT01371747|158119387|FG002|Overall Study|Protocol Violation|1|||
49077672|NCT01371747|158119388|FG003|Overall Study|Protocol Violation|0|||
49077673|NCT01371747|158119389|FG004|Overall Study|Protocol Violation|0|||
49077674|NCT01371747|158119390|FG005|Overall Study|Protocol Violation|0|||
49077675|NCT01371747|158119385|FG000|Overall Study|Non-Compliance|3|||
49077676|NCT01371747|158119386|FG001|Overall Study|Non-Compliance|4|||
49077677|NCT01371747|158119387|FG002|Overall Study|Non-Compliance|3|||
49077678|NCT01371747|158119388|FG003|Overall Study|Non-Compliance|0|||
49077679|NCT01371747|158119389|FG004|Overall Study|Non-Compliance|0|||
49077680|NCT01371747|158119390|FG005|Overall Study|Non-Compliance|1|||
49077681|NCT01371747|158119385|FG000|Overall Study|Physician Decision|0|||
49077682|NCT01371747|158119386|FG001|Overall Study|Physician Decision|0|||
49077683|NCT01371747|158119387|FG002|Overall Study|Physician Decision|0|||
49077684|NCT01371747|158119388|FG003|Overall Study|Physician Decision|0|||
49077685|NCT01371747|158119389|FG004|Overall Study|Physician Decision|1|||
49077686|NCT01371747|158119390|FG005|Overall Study|Physician Decision|0|||
49077687|NCT01371747|158119385|FG000|Overall Study|Withdrawal by Subject|6|||
49077688|NCT01371747|158119386|FG001|Overall Study|Withdrawal by Subject|12|||
49077689|NCT01371747|158119387|FG002|Overall Study|Withdrawal by Subject|5|||
49077690|NCT01371747|158119388|FG003|Overall Study|Withdrawal by Subject|2|||
49077691|NCT01371747|158119389|FG004|Overall Study|Withdrawal by Subject|2|||
49077692|NCT01371747|158119390|FG005|Overall Study|Withdrawal by Subject|4|||
49077693|NCT01371747|158119385|FG000|Overall Study|Other Reasons|2|||
49077694|NCT01371747|158119386|FG001|Overall Study|Other Reasons|1|||
49077695|NCT01371747|158119387|FG002|Overall Study|Other Reasons|2|||
49077696|NCT01371747|158119388|FG003|Overall Study|Other Reasons|0|||
49077697|NCT01371747|158119389|FG004|Overall Study|Other Reasons|0|||
49077698|NCT01371747|158119390|FG005|Overall Study|Other Reasons|1|||
49077699|NCT00580788|158119392|FG000|Overall Study|Adverse Event|0|||
49077700|NCT00580788|158119393|FG001|Overall Study|Adverse Event|0|||
49077701|NCT00580788|158119394|FG002|Overall Study|Adverse Event|0|||
49077702|NCT00580788|158119395|FG003|Overall Study|Adverse Event|1|||
49077703|NCT02129608|158119396|FG000|Overall Study|Lost to Follow-up|0|||
49077704|NCT02129608|158119397|FG001|Overall Study|Lost to Follow-up|1|||
49077705|NCT02129608|158119398|FG002|Overall Study|Lost to Follow-up|1|||
49077706|NCT02129608|158119396|FG000|Overall Study|Withdrawal by Subject|0|||
49077707|NCT02129608|158119397|FG001|Overall Study|Withdrawal by Subject|0|||
49077708|NCT02129608|158119398|FG002|Overall Study|Withdrawal by Subject|2|||
49077709|NCT00696787|158119400|FG000|Overall Study|Adverse Event|1|||
49077710|NCT00696787|158119401|FG001|Overall Study|Adverse Event|0|||
49077711|NCT00696787|158119402|FG002|Overall Study|Adverse Event|6|||
49077712|NCT00696787|158119400|FG000|Overall Study|Discontinuation by Sponsor|9|||
49077713|NCT00696787|158119401|FG001|Overall Study|Discontinuation by Sponsor|13|||
49077714|NCT00696787|158119402|FG002|Overall Study|Discontinuation by Sponsor|14|||
49077715|NCT00696787|158119400|FG000|Overall Study|Lack of Efficacy|0|||
49077716|NCT00696787|158119401|FG001|Overall Study|Lack of Efficacy|1|||
49077717|NCT00696787|158119402|FG002|Overall Study|Lack of Efficacy|0|||
49077718|NCT00696787|158119400|FG000|Overall Study|Lost to Follow-up|4|||
49077719|NCT00696787|158119401|FG001|Overall Study|Lost to Follow-up|0|||
49077720|NCT00696787|158119402|FG002|Overall Study|Lost to Follow-up|3|||
49077721|NCT00696787|158119400|FG000|Overall Study|Withdrawal by Subject|0|||
49077722|NCT00696787|158119401|FG001|Overall Study|Withdrawal by Subject|3|||
49077723|NCT00696787|158119402|FG002|Overall Study|Withdrawal by Subject|2|||
49077724|NCT00696787|158119400|FG000|Overall Study|Failed to return|1|||
49077725|NCT00696787|158119401|FG001|Overall Study|Failed to return|3|||
49077726|NCT00696787|158119402|FG002|Overall Study|Failed to return|1|||
49077727|NCT00417170|158119403|FG000|Overall Study|Adverse Event|1|||
49077728|NCT00417170|158119404|FG001|Overall Study|Adverse Event|1|||
49077729|NCT00417170|158119403|FG000|Overall Study|Withdrawal by Subject|1|||
49077730|NCT00417170|158119404|FG001|Overall Study|Withdrawal by Subject|1|||
49077731|NCT00417170|158119403|FG000|Overall Study|Lost to Follow-up|0|||
49077732|NCT00417170|158119404|FG001|Overall Study|Lost to Follow-up|1|||
49077733|NCT00378573|158119406|FG000|Treatment Period|Adverse Event|9|||
49077734|NCT00378573|158119406|FG000|Treatment Period|Physician Decision|1|||
49077735|NCT00378573|158119406|FG000|Treatment Period|Withdrawal by Subject|2|||
49077736|NCT00378573|158119406|FG000|Treatment Period|Disease Progression|4|||
49077737|NCT00378573|158119406|FG000|Treatment Period|Sponsor decision to close study|1|||
49077738|NCT00378573|158119406|FG000|Follow-up|Death|12|||
49077739|NCT00378573|158119406|FG000|Follow-up|Lost to Follow-up|1|||
49077740|NCT00378573|158119406|FG000|Follow-up|Withdrawal by Subject|1|||
49077741|NCT00196326|158119408|FG000|Overall Study|Did not meet protocol requirements|64|||
49077742|NCT00196326|158119408|FG000|Overall Study|Non-compliance with the protocol|81|||
49077743|NCT00196326|158119408|FG000|Overall Study|Physician Decision|3|||
49077744|NCT00196326|158119408|FG000|Overall Study|Withdrawal by Subject|225|||
49077745|NCT00196326|158119408|FG000|Overall Study|Adverse Event|253|||
49077746|NCT00196326|158119408|FG000|Overall Study|Pregnancy|34|||
49077747|NCT00196326|158119408|FG000|Overall Study|Lost to Follow-up|304|||
49077748|NCT00196326|158119408|FG000|Overall Study|Other|22|||
49077749|NCT00741338|158119409|FG000|Overall Study|Adverse Event|0|||
49077750|NCT00741338|158119410|FG001|Overall Study|Adverse Event|1|||
49077751|NCT02165735|158119419|FG000|Overall Study|Lost to Follow-up|12|||
49077752|NCT02165735|158119420|FG001|Overall Study|Lost to Follow-up|10|||
49077753|NCT02165735|158119419|FG000|Overall Study|Withdrawal by Subject|3|||
49077754|NCT02165735|158119420|FG001|Overall Study|Withdrawal by Subject|0|||
49077755|NCT02165735|158119419|FG000|Overall Study|Participant indicated lack of time|1|||
49077756|NCT02165735|158119420|FG001|Overall Study|Participant indicated lack of time|3|||
49077757|NCT02165735|158119419|FG000|Overall Study|Protocol Violation|0|||
49077758|NCT02165735|158119420|FG001|Overall Study|Protocol Violation|1|||
49077759|NCT03066258|158119421|FG000|Overall Study|Death|1|||
49077760|NCT03066258|158119422|FG001|Overall Study|Death|0|||
49077761|NCT03066258|158119423|FG002|Overall Study|Death|0|||
49077762|NCT03066258|158119424|FG003|Overall Study|Death|0|||
49077763|NCT03066258|158119425|FG004|Overall Study|Death|1|||
49077764|NCT01427608|158119426|FG000|Overall Study|Death|1|||
49077765|NCT01427608|158119427|FG001|Overall Study|Death|0|||
49077766|NCT01427608|158119426|FG000|Overall Study|Withdrawal by Subject|7|||
49077767|NCT01427608|158119427|FG001|Overall Study|Withdrawal by Subject|3|||
49077768|NCT01427608|158119426|FG000|Overall Study|Relapsed-all cause|13|||
49077769|NCT01427608|158119427|FG001|Overall Study|Relapsed-all cause|34|||
49077770|NCT01427608|158119426|FG000|Overall Study|Events not attributed to study meds|0|||
49077771|NCT01427608|158119427|FG001|Overall Study|Events not attributed to study meds|1|||
49077772|NCT03993379|158119428|FG000|Overall Study|The study was terminated early due to business decision.|0|||
49077773|NCT03993379|158119429|FG001|Overall Study|The study was terminated early due to business decision.|2|||
49077774|NCT03993379|158119430|FG002|Overall Study|The study was terminated early due to business decision.|0|||
49077775|NCT03993379|158119431|FG003|Overall Study|The study was terminated early due to business decision.|0|||
49077776|NCT03993379|158119428|FG000|Overall Study|Withdrawal by Subject|0|||
49077777|NCT03993379|158119429|FG001|Overall Study|Withdrawal by Subject|1|||
49077778|NCT03993379|158119430|FG002|Overall Study|Withdrawal by Subject|0|||
49077779|NCT03993379|158119431|FG003|Overall Study|Withdrawal by Subject|0|||
49077780|NCT00853099|158119432|FG000|Double-blind Period|Adverse Event|7|||
49077781|NCT00853099|158119433|FG001|Double-blind Period|Adverse Event|9|||
49077782|NCT00853099|158119434|FG002|Double-blind Period|Adverse Event|13|||
49077783|NCT00853099|158119435|FG003|Double-blind Period|Adverse Event|0|||
49077784|NCT00853099|158119432|FG000|Double-blind Period|Withdrawal by Subject|2|||
49077785|NCT00853099|158119433|FG001|Double-blind Period|Withdrawal by Subject|3|||
49077786|NCT00853099|158119434|FG002|Double-blind Period|Withdrawal by Subject|0|||
49077787|NCT00853099|158119435|FG003|Double-blind Period|Withdrawal by Subject|0|||
49077788|NCT00853099|158119432|FG000|Double-blind Period|Lack of Efficacy|14|||
49077789|NCT00853099|158119433|FG001|Double-blind Period|Lack of Efficacy|17|||
49077790|NCT00853099|158119434|FG002|Double-blind Period|Lack of Efficacy|16|||
49077791|NCT00853099|158119435|FG003|Double-blind Period|Lack of Efficacy|0|||
49077792|NCT00853099|158119432|FG000|Double-blind Period|Other|0|||
49077793|NCT00853099|158119433|FG001|Double-blind Period|Other|0|||
49077794|NCT00853099|158119434|FG002|Double-blind Period|Other|1|||
49077795|NCT00853099|158119435|FG003|Double-blind Period|Other|0|||
49077796|NCT00853099|158119432|FG000|Double-blind Period|Mistreated with rescue study drug|0|||
49077797|NCT00853099|158119433|FG001|Double-blind Period|Mistreated with rescue study drug|0|||
49077798|NCT00853099|158119434|FG002|Double-blind Period|Mistreated with rescue study drug|1|||
49077799|NCT00853099|158119435|FG003|Double-blind Period|Mistreated with rescue study drug|0|||
49077800|NCT00853099|158119432|FG000|Double-blind + Open-label Periods|Lack of Efficacy|0|||
49077801|NCT00853099|158119433|FG001|Double-blind + Open-label Periods|Lack of Efficacy|0|||
49077802|NCT00853099|158119434|FG002|Double-blind + Open-label Periods|Lack of Efficacy|0|||
49077803|NCT00853099|158119435|FG003|Double-blind + Open-label Periods|Lack of Efficacy|74|||
49077804|NCT00853099|158119432|FG000|Double-blind + Open-label Periods|Adverse Event|0|||
49077805|NCT00853099|158119433|FG001|Double-blind + Open-label Periods|Adverse Event|0|||
49077806|NCT00853099|158119434|FG002|Double-blind + Open-label Periods|Adverse Event|0|||
49077807|NCT00853099|158119435|FG003|Double-blind + Open-label Periods|Adverse Event|47|||
49077808|NCT00853099|158119432|FG000|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
49077809|NCT00853099|158119433|FG001|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
49077810|NCT00853099|158119434|FG002|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
49077811|NCT00853099|158119435|FG003|Double-blind + Open-label Periods|Withdrawal by Subject|20|||
49077812|NCT00853099|158119432|FG000|Double-blind + Open-label Periods|Other|0|||
49077813|NCT00853099|158119433|FG001|Double-blind + Open-label Periods|Other|0|||
49077814|NCT00853099|158119434|FG002|Double-blind + Open-label Periods|Other|0|||
49077815|NCT00853099|158119435|FG003|Double-blind + Open-label Periods|Other|6|||
49077816|NCT01027702|158119440|FG000|Overall Study|Received subsequent therapy|1|||
49077817|NCT01027702|158119441|FG001|Overall Study|Received subsequent therapy|2|||
49077818|NCT01027702|158119442|FG002|Overall Study|Received subsequent therapy|0|||
49077819|NCT01027702|158119443|FG003|Overall Study|Received subsequent therapy|4|||
49077820|NCT01027702|158119444|FG004|Overall Study|Received subsequent therapy|1|||
49077821|NCT01027702|158119445|FG005|Overall Study|Received subsequent therapy|0|||
49077822|NCT01027702|158119446|FG006|Overall Study|Received subsequent therapy|1|||
49077823|NCT01027702|158119440|FG000|Overall Study|Death|0|||
49077824|NCT01027702|158119441|FG001|Overall Study|Death|0|||
49077825|NCT01027702|158119442|FG002|Overall Study|Death|1|||
49077826|NCT01027702|158119443|FG003|Overall Study|Death|0|||
49077827|NCT01027702|158119444|FG004|Overall Study|Death|0|||
49077828|NCT01027702|158119445|FG005|Overall Study|Death|0|||
49077829|NCT01027702|158119446|FG006|Overall Study|Death|0|||
49077830|NCT00403585|158119450|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
49077831|NCT00403585|158119450|FG000|Open-Label Phase; Extension Study|Withdrawal by Subject|2|||
49077832|NCT00403585|158119450|FG000|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4|||
49077833|NCT00185588|158119451|FG000|Overall Study|Adverse Event|3|||
49077834|NCT00185588|158119452|FG001|Overall Study|Adverse Event|1|||
49077835|NCT00185588|158119453|FG002|Overall Study|Adverse Event|4|||
49077836|NCT00185588|158119454|FG003|Overall Study|Adverse Event|2|||
49077837|NCT00185588|158119451|FG000|Overall Study|Lost to Follow-up|0|||
49077838|NCT00185588|158119452|FG001|Overall Study|Lost to Follow-up|0|||
49077839|NCT00185588|158119453|FG002|Overall Study|Lost to Follow-up|1|||
49077840|NCT00185588|158119454|FG003|Overall Study|Lost to Follow-up|2|||
49077841|NCT00185588|158119451|FG000|Overall Study|Withdrawal by Subject|0|||
49077842|NCT00185588|158119452|FG001|Overall Study|Withdrawal by Subject|1|||
49077843|NCT00185588|158119453|FG002|Overall Study|Withdrawal by Subject|0|||
49077844|NCT00185588|158119454|FG003|Overall Study|Withdrawal by Subject|0|||
49077845|NCT00185588|158119451|FG000|Overall Study|Physician Decision|0|||
49077846|NCT00185588|158119452|FG001|Overall Study|Physician Decision|0|||
49077847|NCT00185588|158119453|FG002|Overall Study|Physician Decision|1|||
49077848|NCT00185588|158119454|FG003|Overall Study|Physician Decision|0|||
49077849|NCT02604407|158119458|FG000|Overall Study|Adverse Event|0|||
49077850|NCT02604407|158119459|FG001|Overall Study|Adverse Event|7|||
49077851|NCT02604407|158119460|FG002|Overall Study|Adverse Event|5|||
49077852|NCT02604407|158119458|FG000|Overall Study|Protocol Violation|2|||
49077853|NCT02604407|158119459|FG001|Overall Study|Protocol Violation|0|||
49077854|NCT02604407|158119460|FG002|Overall Study|Protocol Violation|0|||
49077855|NCT02604407|158119458|FG000|Overall Study|Withdrawal by Subject|3|||
49077856|NCT02604407|158119459|FG001|Overall Study|Withdrawal by Subject|3|||
49077857|NCT02604407|158119460|FG002|Overall Study|Withdrawal by Subject|5|||
49077858|NCT02604407|158119458|FG000|Overall Study|Lost to Follow-up|2|||
49077859|NCT02604407|158119459|FG001|Overall Study|Lost to Follow-up|1|||
49077860|NCT02604407|158119460|FG002|Overall Study|Lost to Follow-up|2|||
49077861|NCT02604407|158119458|FG000|Overall Study|Lack of Efficacy|1|||
49077862|NCT02604407|158119459|FG001|Overall Study|Lack of Efficacy|0|||
49077863|NCT02604407|158119460|FG002|Overall Study|Lack of Efficacy|0|||
49077864|NCT02604407|158119458|FG000|Overall Study|Other|3|||
49077865|NCT02604407|158119459|FG001|Overall Study|Other|1|||
49077866|NCT02604407|158119460|FG002|Overall Study|Other|4|||
49077867|NCT00661193|158119461|FG000|Overall Study|Adverse Event|2|||
49077868|NCT00661193|158119462|FG001|Overall Study|Adverse Event|1|||
49077869|NCT00661193|158119461|FG000|Overall Study|Withdrawal by Subject|3|||
49077870|NCT00661193|158119462|FG001|Overall Study|Withdrawal by Subject|1|||
49077871|NCT00661193|158119461|FG000|Overall Study|Progression|27|||
49077872|NCT00661193|158119462|FG001|Overall Study|Progression|24|||
49077873|NCT00661193|158119461|FG000|Overall Study|Not protocol specified|1|||
49077874|NCT00661193|158119462|FG001|Overall Study|Not protocol specified|0|||
49077875|NCT01994850|158119465|FG000|Overall Study|Physician Decision|1|||
49077876|NCT01994850|158119465|FG000|Overall Study|Withdrawal by Subject|1|||
49077877|NCT00606632|158119466|FG000|Overall Study|Withdrawal by Subject|13|||
49077878|NCT00606632|158119466|FG000|Overall Study|Miscellaneous reasons|9|||
49077879|NCT04877457|158119471|FG000|Overall Study|Early termination of study due to low enrollment|2|||
49077880|NCT04877457|158119472|FG001|Overall Study|Early termination of study due to low enrollment|1|||
49077881|NCT02324582|158119473|FG000|Overall Study|Screen Failures|0|||
49077882|NCT02324582|158119474|FG001|Overall Study|Screen Failures|5|||
49077883|NCT00246324|158119475|FG000|Overall Study|Withdrawal by Subject|1|||
49077884|NCT02006732|158119476|FG000|Overall Study|Adverse Event|10|||
49077885|NCT02006732|158119477|FG001|Overall Study|Adverse Event|7|||
49077886|NCT02006732|158119478|FG002|Overall Study|Adverse Event|4|||
49077887|NCT02006732|158119479|FG003|Overall Study|Adverse Event|2|||
49077888|NCT02006732|158119476|FG000|Overall Study|Lack of Efficacy|6|||
49077889|NCT02006732|158119477|FG001|Overall Study|Lack of Efficacy|3|||
49077890|NCT02006732|158119478|FG002|Overall Study|Lack of Efficacy|1|||
49077891|NCT02006732|158119479|FG003|Overall Study|Lack of Efficacy|1|||
49077892|NCT02006732|158119476|FG000|Overall Study|Protocol Violation|1|||
49077893|NCT02006732|158119477|FG001|Overall Study|Protocol Violation|1|||
49077894|NCT02006732|158119478|FG002|Overall Study|Protocol Violation|0|||
49077895|NCT02006732|158119479|FG003|Overall Study|Protocol Violation|0|||
49077896|NCT02006732|158119476|FG000|Overall Study|Lost to Follow-up|0|||
49077897|NCT02006732|158119477|FG001|Overall Study|Lost to Follow-up|1|||
49077898|NCT02006732|158119478|FG002|Overall Study|Lost to Follow-up|0|||
49077899|NCT02006732|158119479|FG003|Overall Study|Lost to Follow-up|0|||
49077900|NCT02006732|158119476|FG000|Overall Study|Withdrawal by Subject|3|||
49077901|NCT02006732|158119477|FG001|Overall Study|Withdrawal by Subject|0|||
49077902|NCT02006732|158119478|FG002|Overall Study|Withdrawal by Subject|4|||
49077903|NCT02006732|158119479|FG003|Overall Study|Withdrawal by Subject|1|||
49077904|NCT00299130|158119481|FG000|Treatment Period (up to 5 Years)|Adverse Event|13|||
49077905|NCT00299130|158119482|FG001|Treatment Period (up to 5 Years)|Adverse Event|8|||
49077906|NCT00299130|158119483|FG002|Treatment Period (up to 5 Years)|Adverse Event|13|||
49077907|NCT00299130|158119481|FG000|Treatment Period (up to 5 Years)|Death|1|||
49077908|NCT00299130|158119482|FG001|Treatment Period (up to 5 Years)|Death|3|||
49077909|NCT00299130|158119483|FG002|Treatment Period (up to 5 Years)|Death|1|||
49077910|NCT00299130|158119481|FG000|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19|||
49077911|NCT00299130|158119482|FG001|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
49077912|NCT00299130|158119483|FG002|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
49077913|NCT00299130|158119481|FG000|Treatment Period (up to 5 Years)|Protocol Violation|0|||
49077914|NCT00299130|158119482|FG001|Treatment Period (up to 5 Years)|Protocol Violation|1|||
49077915|NCT00299130|158119483|FG002|Treatment Period (up to 5 Years)|Protocol Violation|0|||
49077916|NCT00299130|158119481|FG000|Treatment Period (up to 5 Years)|Refused Treatment|12|||
49077917|NCT00299130|158119482|FG001|Treatment Period (up to 5 Years)|Refused Treatment|12|||
49077918|NCT00299130|158119483|FG002|Treatment Period (up to 5 Years)|Refused Treatment|19|||
49077919|NCT00299130|158119481|FG000|Treatment Period (up to 5 Years)|Failure to Return|4|||
49077920|NCT00299130|158119482|FG001|Treatment Period (up to 5 Years)|Failure to Return|6|||
49077921|NCT00299130|158119483|FG002|Treatment Period (up to 5 Years)|Failure to Return|6|||
49077922|NCT00299130|158119481|FG000|Treatment Period (up to 5 Years)|Reason not Specified|4|||
49077923|NCT00299130|158119482|FG001|Treatment Period (up to 5 Years)|Reason not Specified|6|||
49077924|NCT00299130|158119483|FG002|Treatment Period (up to 5 Years)|Reason not Specified|4|||
49077925|NCT00299130|158119481|FG000|Treatment Period (up to 5 Years)|Withdrawal by Subject|0|||
49077926|NCT00299130|158119482|FG001|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
49077927|NCT00299130|158119483|FG002|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
49077928|NCT00299130|158119481|FG000|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
49077929|NCT00299130|158119482|FG001|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9|||
49077930|NCT00299130|158119483|FG002|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
49077931|NCT00299130|158119481|FG000|Safety Follow-up (SFU) (48 Weeks)|Death|4|||
49077932|NCT00299130|158119482|FG001|Safety Follow-up (SFU) (48 Weeks)|Death|5|||
49077933|NCT00299130|158119483|FG002|Safety Follow-up (SFU) (48 Weeks)|Death|3|||
49077934|NCT00299130|158119481|FG000|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
49077935|NCT00299130|158119482|FG001|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
49077936|NCT00299130|158119483|FG002|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2|||
49077937|NCT00299130|158119481|FG000|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14|||
49077938|NCT00299130|158119482|FG001|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7|||
49077939|NCT00299130|158119483|FG002|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15|||
49077940|NCT00299130|158119481|FG000|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
49077941|NCT00299130|158119482|FG001|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1|||
49077942|NCT00299130|158119483|FG002|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
49077943|NCT00299130|158119481|FG000|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
49077944|NCT00299130|158119482|FG001|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
49077945|NCT00299130|158119483|FG002|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21|||
49077946|NCT00299130|158119481|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
49077947|NCT00299130|158119482|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Death|3|||
49077948|NCT00299130|158119483|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
49077949|NCT00299130|158119481|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0|||
49077950|NCT00299130|158119482|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
49077951|NCT00299130|158119483|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
49077952|NCT00299130|158119481|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0|||
49077953|NCT00299130|158119482|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3|||
49077954|NCT00299130|158119483|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4|||
49077955|NCT00948155|158119484|FG000|First Intervention 21 Days|Lost to Follow-up|2|||
49077956|NCT00948155|158119485|FG001|First Intervention 21 Days|Lost to Follow-up|2|||
49077957|NCT00948155|158119484|FG000|Washout 14 Days|Lost to Follow-up|1|||
49077958|NCT00948155|158119485|FG001|Washout 14 Days|Lost to Follow-up|2|||
49077959|NCT02211417|158119486|FG000|Overall Study|Withdrawal by Subject|11|||
49077960|NCT02211417|158119487|FG001|Overall Study|Withdrawal by Subject|8|||
49077961|NCT02211417|158119486|FG000|Overall Study|Protocol Violation|1|||
49077962|NCT02211417|158119487|FG001|Overall Study|Protocol Violation|0|||
49077963|NCT02211417|158119486|FG000|Overall Study|Pregnancy|0|||
49077964|NCT02211417|158119487|FG001|Overall Study|Pregnancy|1|||
49077965|NCT02211417|158119486|FG000|Overall Study|Lost to Follow-up|2|||
49077966|NCT02211417|158119487|FG001|Overall Study|Lost to Follow-up|3|||
49077967|NCT02211417|158119486|FG000|Overall Study|Adverse Event|1|||
49077968|NCT02211417|158119487|FG001|Overall Study|Adverse Event|4|||
49077969|NCT02766335|158119488|FG000|Initial Registration|Adverse Event|6|||
49077970|NCT02766335|158119489|FG001|Initial Registration|Adverse Event|3|||
49077971|NCT02766335|158119490|FG002|Initial Registration|Adverse Event|0|||
49077972|NCT02766335|158119488|FG000|Initial Registration|Refusal unrelated to adverse event|1|||
49077973|NCT02766335|158119489|FG001|Initial Registration|Refusal unrelated to adverse event|0|||
49077974|NCT02766335|158119490|FG002|Initial Registration|Refusal unrelated to adverse event|0|||
49077975|NCT02766335|158119488|FG000|Initial Registration|Progression/relapse|49|||
49077976|NCT02766335|158119489|FG001|Initial Registration|Progression/relapse|15|||
49077977|NCT02766335|158119490|FG002|Initial Registration|Progression/relapse|0|||
49077978|NCT02766335|158119488|FG000|Initial Registration|Death|1|||
49077979|NCT02766335|158119489|FG001|Initial Registration|Death|3|||
49077980|NCT02766335|158119490|FG002|Initial Registration|Death|0|||
49077981|NCT02766335|158119488|FG000|Initial Registration|not protocol specified|1|||
49077982|NCT02766335|158119489|FG001|Initial Registration|not protocol specified|9|||
49077983|NCT02766335|158119490|FG002|Initial Registration|not protocol specified|0|||
49077984|NCT02766335|158119488|FG000|Re-registration of Arm I to MEDI4738|Death|0|||
49077985|NCT02766335|158119489|FG001|Re-registration of Arm I to MEDI4738|Death|0|||
49077986|NCT02766335|158119490|FG002|Re-registration of Arm I to MEDI4738|Death|1|||
49077987|NCT02766335|158119488|FG000|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
49077988|NCT02766335|158119489|FG001|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
49077989|NCT02766335|158119490|FG002|Re-registration of Arm I to MEDI4738|Progression/relapse|1|||
49077990|NCT01198132|158119493|FG000|Overall Study|Withdrawal by Subject|4|||
49077991|NCT01198132|158119494|FG001|Overall Study|Withdrawal by Subject|5|||
49077992|NCT01198132|158119493|FG000|Overall Study|Physician Decision|5|||
49077993|NCT01198132|158119494|FG001|Overall Study|Physician Decision|4|||
49077994|NCT01198132|158119493|FG000|Overall Study|Other Unspecified|3|||
49077995|NCT01198132|158119494|FG001|Overall Study|Other Unspecified|6|||
49077996|NCT01198132|158119493|FG000|Overall Study|Lack of Efficacy|2|||
49077997|NCT01198132|158119494|FG001|Overall Study|Lack of Efficacy|3|||
49077998|NCT01198132|158119493|FG000|Overall Study|Sign/symptoms of underlying disease|2|||
49077999|NCT01198132|158119494|FG001|Overall Study|Sign/symptoms of underlying disease|1|||
49078000|NCT01198132|158119493|FG000|Overall Study|Abnormal/clinically significant biologic|1|||
49078001|NCT01198132|158119494|FG001|Overall Study|Abnormal/clinically significant biologic|1|||
49078002|NCT01198132|158119493|FG000|Overall Study|Adverse Event|0|||
49078003|NCT01198132|158119494|FG001|Overall Study|Adverse Event|1|||
49078004|NCT01198132|158119493|FG000|Overall Study|Protocol Violation|1|||
49078005|NCT01198132|158119494|FG001|Overall Study|Protocol Violation|0|||
49078006|NCT04052620|158119499|FG000|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|1|||
49078007|NCT04052620|158119500|FG001|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|0|||
49078008|NCT04052620|158119499|FG000|Overall Study|Withdrawal by Subject|1|||
49078009|NCT04052620|158119500|FG001|Overall Study|Withdrawal by Subject|0|||
49078010|NCT04052620|158119499|FG000|Overall Study|Lost to Follow-up|1|||
49078011|NCT04052620|158119500|FG001|Overall Study|Lost to Follow-up|1|||
49078012|NCT04052620|158119499|FG000|Overall Study|Adverse Event|1|||
49078013|NCT04052620|158119500|FG001|Overall Study|Adverse Event|0|||
49078014|NCT04052620|158119499|FG000|Overall Study|Subject did not meet study Criteria|0|||
49078015|NCT04052620|158119500|FG001|Overall Study|Subject did not meet study Criteria|1|||
49078016|NCT04052620|158119499|FG000|Overall Study|Screened failure, randomized by mistake|0|||
49078017|NCT04052620|158119500|FG001|Overall Study|Screened failure, randomized by mistake|1|||
49078018|NCT04052620|158119499|FG000|Overall Study|Personal reasons|2|||
49078019|NCT04052620|158119500|FG001|Overall Study|Personal reasons|4|||
49078020|NCT04052620|158119499|FG000|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|1|||
49078021|NCT04052620|158119500|FG001|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|0|||
49078022|NCT00345631|158119501|FG000|Overall Study|Withdrawal by Subject|1|||
49078023|NCT00345631|158119502|FG001|Overall Study|Withdrawal by Subject|0|||
49078024|NCT00345631|158119503|FG002|Overall Study|Withdrawal by Subject|1|||
49078025|NCT00345631|158119501|FG000|Overall Study|Adverse Event|0|||
49078026|NCT00345631|158119502|FG001|Overall Study|Adverse Event|1|||
49078027|NCT00345631|158119503|FG002|Overall Study|Adverse Event|0|||
49078028|NCT00345631|158119501|FG000|Overall Study|Lost to Follow-up|3|||
49078029|NCT00345631|158119502|FG001|Overall Study|Lost to Follow-up|7|||
49078030|NCT00345631|158119503|FG002|Overall Study|Lost to Follow-up|4|||
49078031|NCT00345631|158119501|FG000|Overall Study|Other reasons|0|||
49078032|NCT00345631|158119502|FG001|Overall Study|Other reasons|0|||
49078033|NCT00345631|158119503|FG002|Overall Study|Other reasons|1|||
49078034|NCT01406574|158119504|FG000|Overall Study|Adverse Event|0|||
49078035|NCT01406574|158119505|FG001|Overall Study|Adverse Event|0|||
49078036|NCT01406574|158119506|FG002|Overall Study|Adverse Event|1|||
49078037|NCT01406574|158119507|FG003|Overall Study|Adverse Event|3|||
49078038|NCT01406574|158119504|FG000|Overall Study|Physician Decision|0|||
49078039|NCT01406574|158119505|FG001|Overall Study|Physician Decision|0|||
49078040|NCT01406574|158119506|FG002|Overall Study|Physician Decision|0|||
49078041|NCT01406574|158119507|FG003|Overall Study|Physician Decision|1|||
49078042|NCT01406574|158119504|FG000|Overall Study|Withdrawal by Subject|0|||
49078043|NCT01406574|158119505|FG001|Overall Study|Withdrawal by Subject|1|||
49078044|NCT01406574|158119506|FG002|Overall Study|Withdrawal by Subject|0|||
49078045|NCT01406574|158119507|FG003|Overall Study|Withdrawal by Subject|0|||
49078046|NCT01406574|158119504|FG000|Overall Study|Definite progression of primary disease|1|||
49078047|NCT01406574|158119505|FG001|Overall Study|Definite progression of primary disease|0|||
49078048|NCT01406574|158119506|FG002|Overall Study|Definite progression of primary disease|0|||
49078049|NCT01406574|158119507|FG003|Overall Study|Definite progression of primary disease|0|||
49078050|NCT01256879|158119508|FG000|Overall Study|Withdrawal by Subject|1|||
49078051|NCT01911273|158119510|FG000|Overall Study|Progression of Disease|1|||
49078052|NCT01911273|158119511|FG001|Overall Study|Progression of Disease|0|||
49078053|NCT01911273|158119510|FG000|Overall Study|Withdrawal by Subject|0|||
49078054|NCT01911273|158119511|FG001|Overall Study|Withdrawal by Subject|2|||
49078055|NCT03552380|158119512|FG000|Study Treatment|Disease Progression|3|||
49078056|NCT03552380|158119513|FG001|Study Treatment|Disease Progression|4|||
49078057|NCT03552380|158119512|FG000|Study Treatment|Adverse Event|2|||
49078058|NCT03552380|158119513|FG001|Study Treatment|Adverse Event|2|||
49078059|NCT03552380|158119512|FG000|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
49078060|NCT03552380|158119513|FG001|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
49078061|NCT03552380|158119512|FG000|Follow up|Death|3|||
49078062|NCT03552380|158119513|FG001|Follow up|Death|4|||
49078063|NCT03552380|158119512|FG000|Follow up|Site IRB terminated|0|||
49078064|NCT03552380|158119513|FG001|Follow up|Site IRB terminated|1|||
49078065|NCT01308424|158119518|FG000|Baseline Eligibility|Screen Failures|71|||
49078066|NCT01308424|158119519|FG001|Baseline Eligibility|Screen Failures|0|||
49078067|NCT01308424|158119520|FG002|Baseline Eligibility|Screen Failures|0|||
49078068|NCT01308424|158119518|FG000|Randomization|Adverse Event|0|||
49078069|NCT01308424|158119519|FG001|Randomization|Adverse Event|1|||
49078070|NCT01308424|158119520|FG002|Randomization|Adverse Event|1|||
49078071|NCT01308424|158119518|FG000|Randomization|Lost to Follow-up|0|||
49078072|NCT01308424|158119519|FG001|Randomization|Lost to Follow-up|1|||
49078073|NCT01308424|158119520|FG002|Randomization|Lost to Follow-up|0|||
49078074|NCT01308424|158119518|FG000|Randomization|Physician Decision|0|||
49078075|NCT01308424|158119519|FG001|Randomization|Physician Decision|1|||
49078076|NCT01308424|158119520|FG002|Randomization|Physician Decision|1|||
49078077|NCT02308124|158119521|FG000|Overall Study|Lost to Follow-up|6|||
49078078|NCT02308124|158119522|FG001|Overall Study|Lost to Follow-up|6|||
49078079|NCT02308124|158119523|FG002|Overall Study|Lost to Follow-up|6|||
49078080|NCT02308124|158119521|FG000|Overall Study|Adverse Event|0|||
49078081|NCT02308124|158119522|FG001|Overall Study|Adverse Event|2|||
49078082|NCT02308124|158119523|FG002|Overall Study|Adverse Event|2|||
49078083|NCT00739063|158119524|FG000|Overall Study|Screen failures|8|||
49078084|NCT02201784|158119525|FG000|Overall Study|Failure to achieve adequate block|2|||
49078085|NCT02201784|158119526|FG001|Overall Study|Failure to achieve adequate block|0|||
49078086|NCT05101343|158119527|FG000|Overall Study|Withdrawal by Subject|2|||
49078087|NCT05101343|158119528|FG001|Overall Study|Withdrawal by Subject|1|||
49078088|NCT00461253|158121061|FG000|Overall Study|Death|985|||
49078089|NCT00461253|158121062|FG001|Overall Study|Death|0|||
49078090|NCT00461253|158121061|FG000|Overall Study|Protocol Violation|613|||
49078091|NCT00461253|158121062|FG001|Overall Study|Protocol Violation|236|||
49078092|NCT00461253|158121061|FG000|Overall Study|no response|2609|||
49078093|NCT00461253|158121062|FG001|Overall Study|no response|11789|||
49078094|NCT00461253|158121061|FG000|Overall Study|administrative|773|||
49078095|NCT00461253|158121062|FG001|Overall Study|administrative|7773|||
49078096|NCT02755649|158121063|FG000|Overall Study|Transitioned into OLE study|99|||
49078097|NCT02755649|158121064|FG001|Overall Study|Transitioned into OLE study|98|||
49078098|NCT02755649|158121065|FG002|Overall Study|Transitioned into OLE study|100|||
49078099|NCT02755649|158121063|FG000|Overall Study|Did Not Complete Follow-up Visits|1|||
49078100|NCT02755649|158121064|FG001|Overall Study|Did Not Complete Follow-up Visits|0|||
49078101|NCT02755649|158121065|FG002|Overall Study|Did Not Complete Follow-up Visits|0|||
49078102|NCT02755649|158121063|FG000|Overall Study|Physician Decision|0|||
49078103|NCT02755649|158121064|FG001|Overall Study|Physician Decision|0|||
49078104|NCT02755649|158121065|FG002|Overall Study|Physician Decision|2|||
49078105|NCT02755649|158121063|FG000|Overall Study|Withdrawal by Subject|0|||
49078106|NCT02755649|158121064|FG001|Overall Study|Withdrawal by Subject|1|||
49078107|NCT02755649|158121065|FG002|Overall Study|Withdrawal by Subject|0|||
49078108|NCT02755649|158121063|FG000|Overall Study|Undecided|1|||
49078109|NCT02755649|158121064|FG001|Overall Study|Undecided|0|||
49078110|NCT02755649|158121065|FG002|Overall Study|Undecided|0|||
49078111|NCT02126826|158121066|FG000|Overall Study|Withdrawal by Subject|0|||
49078112|NCT02126826|158121067|FG001|Overall Study|Withdrawal by Subject|0|||
49078113|NCT02126826|158121068|FG002|Overall Study|Withdrawal by Subject|0|||
49078114|NCT02126826|158121069|FG003|Overall Study|Withdrawal by Subject|1|||
49078115|NCT02126826|158121070|FG004|Overall Study|Withdrawal by Subject|0|||
49078116|NCT02126826|158121071|FG005|Overall Study|Withdrawal by Subject|0|||
49078117|NCT02126826|158121072|FG006|Overall Study|Withdrawal by Subject|0|||
49078118|NCT02152605|158121073|FG000|Overall Study|Adverse Event|6|||
49078119|NCT02152605|158121074|FG001|Overall Study|Adverse Event|8|||
49078120|NCT02152605|158121073|FG000|Overall Study|Lack of Efficacy|7|||
49078121|NCT02152605|158121074|FG001|Overall Study|Lack of Efficacy|4|||
49078122|NCT02152605|158121073|FG000|Overall Study|Protocol deviation|1|||
49078123|NCT02152605|158121074|FG001|Overall Study|Protocol deviation|4|||
49078124|NCT02152605|158121073|FG000|Overall Study|Lost to Follow-up|1|||
49078125|NCT02152605|158121074|FG001|Overall Study|Lost to Follow-up|0|||
49078126|NCT02152605|158121073|FG000|Overall Study|Withdrew consent|4|||
49078127|NCT02152605|158121074|FG001|Overall Study|Withdrew consent|2|||
49078128|NCT04971187|158121083|FG000|Overall Study|Screen failures|2|||
49078129|NCT03301649|158121088|FG000|Overall Study|Need alternate therapy due to live lice|17|||
49078130|NCT03301649|158121089|FG001|Overall Study|Need alternate therapy due to live lice|25|||
49078131|NCT03301649|158121090|FG002|Overall Study|Need alternate therapy due to live lice|81|||
49078132|NCT03301649|158121088|FG000|Overall Study|Lost to Follow-up|11|||
49078133|NCT03301649|158121089|FG001|Overall Study|Lost to Follow-up|11|||
49078134|NCT03301649|158121090|FG002|Overall Study|Lost to Follow-up|3|||
49078135|NCT03301649|158121088|FG000|Overall Study|Protocol Violation|0|||
49078136|NCT03301649|158121089|FG001|Overall Study|Protocol Violation|1|||
49078137|NCT03301649|158121090|FG002|Overall Study|Protocol Violation|1|||
49078138|NCT03301649|158121088|FG000|Overall Study|Withdrawal by Subject|10|||
49078139|NCT03301649|158121089|FG001|Overall Study|Withdrawal by Subject|4|||
49078140|NCT03301649|158121090|FG002|Overall Study|Withdrawal by Subject|0|||
49078141|NCT03301649|158121088|FG000|Overall Study|Other than specified|5|||
49078142|NCT03301649|158121089|FG001|Overall Study|Other than specified|3|||
49078143|NCT03301649|158121090|FG002|Overall Study|Other than specified|0|||
49078144|NCT02685735|158121091|FG000|Overall Study|Missing construct or pain data|23|||
49078145|NCT02685735|158121092|FG001|Overall Study|Missing construct or pain data|22|||
49078146|NCT02964312|158121093|FG000|Overall Study|Lost to Follow-up|28|||
49078147|NCT02964312|158121093|FG000|Overall Study|Withdrawal by Subject|11|||
49078148|NCT02964312|158121093|FG000|Overall Study|Lack of Efficacy|10|||
49078149|NCT02964312|158121093|FG000|Overall Study|Did not consent to long-term FU|14|||
49078150|NCT02964312|158121093|FG000|Overall Study|Death|1|||
49078151|NCT02481869|158121096|FG000|Overall Study|Lost to Follow-up|3|||
49078152|NCT02481869|158121097|FG001|Overall Study|Lost to Follow-up|4|||
49078153|NCT02481869|158121096|FG000|Overall Study|Withdrawal by Subject|2|||
49078154|NCT02481869|158121097|FG001|Overall Study|Withdrawal by Subject|0|||
49078155|NCT00191191|158121105|FG000|Overall Study|Entry Criteria Exclusion|2|||
49078156|NCT00191191|158121106|FG001|Overall Study|Entry Criteria Exclusion|0|||
49078157|NCT00191191|158121105|FG000|Overall Study|Treated with Another Systemic Agent|1|||
49078158|NCT00191191|158121106|FG001|Overall Study|Treated with Another Systemic Agent|1|||
49078159|NCT00191191|158121105|FG000|Overall Study|Adverse Event|11|||
49078160|NCT00191191|158121106|FG001|Overall Study|Adverse Event|21|||
49078161|NCT00191191|158121105|FG000|Overall Study|Progressive Disease|84|||
49078162|NCT00191191|158121106|FG001|Overall Study|Progressive Disease|72|||
49078163|NCT00191191|158121105|FG000|Overall Study|Toxicity After Dose Reduction|7|||
49078164|NCT00191191|158121106|FG001|Overall Study|Toxicity After Dose Reduction|8|||
49078165|NCT00191191|158121105|FG000|Overall Study|Family/Caregiver Decision|5|||
49078166|NCT00191191|158121106|FG001|Overall Study|Family/Caregiver Decision|7|||
49078167|NCT00191191|158121105|FG000|Overall Study|Lost to Follow-up|1|||
49078168|NCT00191191|158121106|FG001|Overall Study|Lost to Follow-up|0|||
49078169|NCT00191191|158121105|FG000|Overall Study|Physician Decision|3|||
49078170|NCT00191191|158121106|FG001|Overall Study|Physician Decision|2|||
49078171|NCT00191191|158121105|FG000|Overall Study|Good Clinical Practice Violation|0|||
49078172|NCT00191191|158121106|FG001|Overall Study|Good Clinical Practice Violation|1|||
49078173|NCT03348163|158121107|FG000|Overall Study|Withdrawal by Subject|2|||
49078174|NCT03348163|158121108|FG001|Overall Study|Withdrawal by Subject|0|||
49078175|NCT02756208|158121112|FG000|Overall Study|Withdrawal by Subject|1|||
49078176|NCT02756208|158121113|FG001|Overall Study|Withdrawal by Subject|0|||
49078177|NCT02756208|158121114|FG002|Overall Study|Withdrawal by Subject|1|||
49078178|NCT02756208|158121115|FG003|Overall Study|Withdrawal by Subject|3|||
49078179|NCT02756208|158121112|FG000|Overall Study|Lost to Follow-up|3|||
49078180|NCT02756208|158121113|FG001|Overall Study|Lost to Follow-up|1|||
49078181|NCT02756208|158121114|FG002|Overall Study|Lost to Follow-up|1|||
49078182|NCT02756208|158121115|FG003|Overall Study|Lost to Follow-up|1|||
49078183|NCT02756208|158121112|FG000|Overall Study|Physician Decision|1|||
49078184|NCT02756208|158121113|FG001|Overall Study|Physician Decision|0|||
49078185|NCT02756208|158121114|FG002|Overall Study|Physician Decision|0|||
49078186|NCT02756208|158121115|FG003|Overall Study|Physician Decision|0|||
49078187|NCT02756208|158121112|FG000|Overall Study|Protocol Violation|0|||
49078188|NCT02756208|158121113|FG001|Overall Study|Protocol Violation|1|||
49078189|NCT02756208|158121114|FG002|Overall Study|Protocol Violation|0|||
49078190|NCT02756208|158121115|FG003|Overall Study|Protocol Violation|0|||
49078191|NCT02276807|158121116|FG000|Overall Study|Withdrawal by Subject|8|||
49078192|NCT02276807|158121117|FG001|Overall Study|Withdrawal by Subject|7|||
49078193|NCT02276807|158121116|FG000|Overall Study|Lost to Follow-up|10|||
49078194|NCT02276807|158121117|FG001|Overall Study|Lost to Follow-up|10|||
49078195|NCT04841577|158121119|FG000|Overall Study|Adverse Event|5|||
49078196|NCT04841577|158121120|FG001|Overall Study|Adverse Event|10|||
49078197|NCT04841577|158121119|FG000|Overall Study|Lost to Follow-up|8|||
49078198|NCT04841577|158121120|FG001|Overall Study|Lost to Follow-up|7|||
49078199|NCT04841577|158121119|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
49078200|NCT04841577|158121120|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|8|||
49078201|NCT04841577|158121119|FG000|Overall Study|Other|0|||
49078202|NCT04841577|158121120|FG001|Overall Study|Other|1|||
49078203|NCT00261950|158121127|FG000|Overall Study|Lost to Follow-up|2|||
49078204|NCT00261950|158121127|FG000|Overall Study|Death|6|||
49078205|NCT00261950|158121127|FG000|Overall Study|Withdrawal by Subject|5|||
49078206|NCT00261950|158121127|FG000|Overall Study|Other|1|||
49078207|NCT00261950|158121127|FG000|Overall Study|Physician Decision|1|||
49078208|NCT00261950|158121127|FG000|Overall Study|Protocol specified Criteria|11|||
49078209|NCT03280264|158121128|FG000|Overall Study|Adverse Event|1|||
49078210|NCT03280264|158121128|FG000|Overall Study|Physician Decision|1|||
49078211|NCT03280264|158121128|FG000|Overall Study|Withdrawal by Subject|1|||
49078212|NCT02370238|158121129|FG000|Overall Study|Death|42|||
49078213|NCT02370238|158121130|FG001|Overall Study|Death|35|||
49078214|NCT02370238|158121129|FG000|Overall Study|Lost to Follow-up|1|||
49078215|NCT02370238|158121130|FG001|Overall Study|Lost to Follow-up|3|||
49078216|NCT02370238|158121129|FG000|Overall Study|Withdrawal by Subject|2|||
49078217|NCT02370238|158121130|FG001|Overall Study|Withdrawal by Subject|6|||
49078218|NCT02370238|158121129|FG000|Overall Study|Other|2|||
49078219|NCT02370238|158121130|FG001|Overall Study|Other|1|||
49078220|NCT00445432|158121136|FG000|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1|||
49078221|NCT00445432|158121137|FG001|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2|||
49078222|NCT00445432|158121138|FG002|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7|||
49078223|NCT00445432|158121139|FG003|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0|||
49078224|NCT00445432|158121136|FG000|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
49078225|NCT00445432|158121137|FG001|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
49078226|NCT00445432|158121138|FG002|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2|||
49078227|NCT00445432|158121139|FG003|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
49078228|NCT00445432|158121136|FG000|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14|||
49078229|NCT00445432|158121137|FG001|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20|||
49078230|NCT00445432|158121138|FG002|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
49078231|NCT00445432|158121139|FG003|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
49078232|NCT00445432|158121136|FG000|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
49078233|NCT00445432|158121137|FG001|Through Week 52 of NCT00445432 (M06-837)|Other|1|||
49078234|NCT00445432|158121138|FG002|Through Week 52 of NCT00445432 (M06-837)|Other|2|||
49078235|NCT00445432|158121139|FG003|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
49078236|NCT00445432|158121136|FG000|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
49078237|NCT00445432|158121137|FG001|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
49078238|NCT00445432|158121138|FG002|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
49078239|NCT00445432|158121139|FG003|148 Weeks of Adalimumab Treatment|Adverse Event|32|||
49078240|NCT00445432|158121136|FG000|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
49078241|NCT00445432|158121137|FG001|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
49078242|NCT00445432|158121138|FG002|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
49078243|NCT00445432|158121139|FG003|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3|||
49078244|NCT00445432|158121136|FG000|148 Weeks of Adalimumab Treatment|Other|0|||
49078245|NCT00445432|158121137|FG001|148 Weeks of Adalimumab Treatment|Other|0|||
49078246|NCT00445432|158121138|FG002|148 Weeks of Adalimumab Treatment|Other|0|||
49078247|NCT00445432|158121139|FG003|148 Weeks of Adalimumab Treatment|Other|9|||
49078248|NCT02290405|158121142|FG000|Overall Study|Withdrawal by Subject|1|||
49078249|NCT02290405|158121143|FG001|Overall Study|Withdrawal by Subject|0|||
49078250|NCT03645863|158121144|FG000|Overall Study|Withdrawal by Subject|1|||
49078251|NCT03645863|158121145|FG001|Overall Study|Withdrawal by Subject|0|||
49078252|NCT03645863|158121146|FG002|Overall Study|Withdrawal by Subject|0|||
49078253|NCT02016183|158121148|FG000|Overall Study|Case Report Forms Uncollected|13|||
49078254|NCT02016183|158121148|FG000|Overall Study|Protocol Violation|52|||
49078255|NCT00996489|158121149|FG000|Overall Study|Device failure|45|||
49078256|NCT00996489|158121149|FG000|Overall Study|Discontinued|116|||
49078257|NCT01070953|158121150|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|612|||
49078258|NCT01070953|158121150|FG000|Participants for Safety Evaluation|Off-label use|283|||
49078259|NCT01070953|158121150|FG000|Participants for Safety Evaluation|Duplicated participants|22|||
49078260|NCT01070953|158121150|FG000|Participants for Safety Evaluation|Treatment prior to date of contract|8|||
49078261|NCT01070953|158121150|FG000|Participants for Safety Evaluation|Uncontracted participants|4|||
49078262|NCT01070953|158121150|FG000|Participants for Safety Evaluation|Violation of inclusions & off label use|1|||
49078263|NCT01070953|158121150|FG000|Participants for Safety Evaluation|Duplicated participants & off-label use|1|||
49078264|NCT01070953|158121150|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|119|||
49078265|NCT01070953|158121150|FG000|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106|||
49078266|NCT01070953|158121150|FG000|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2|||
49078267|NCT01755091|158121151|FG000|Overall Study|Withdrawal by Subject|6|||
49078268|NCT01755091|158121152|FG001|Overall Study|Withdrawal by Subject|1|||
49078269|NCT01755091|158121153|FG002|Overall Study|Withdrawal by Subject|3|||
49078270|NCT01755091|158121151|FG000|Overall Study|Adverse Event|1|||
49078271|NCT01755091|158121152|FG001|Overall Study|Adverse Event|1|||
49078272|NCT01755091|158121153|FG002|Overall Study|Adverse Event|1|||
49078273|NCT01755091|158121151|FG000|Overall Study|Lost to Follow-up|1|||
49078274|NCT01755091|158121152|FG001|Overall Study|Lost to Follow-up|0|||
49078275|NCT01755091|158121153|FG002|Overall Study|Lost to Follow-up|1|||
49078276|NCT01755091|158121151|FG000|Overall Study|Physician Decision|1|||
49078277|NCT01755091|158121152|FG001|Overall Study|Physician Decision|1|||
49078278|NCT01755091|158121153|FG002|Overall Study|Physician Decision|2|||
49078279|NCT03142191|158121154|FG000|Placebo Controlled Period|Death|0|||
49078280|NCT03142191|158121155|FG001|Placebo Controlled Period|Death|1|||
49078281|NCT03142191|158121156|FG002|Placebo Controlled Period|Death|1|||
49078282|NCT03142191|158121157|FG003|Placebo Controlled Period|Death|0|||
49078283|NCT03142191|158121158|FG004|Placebo Controlled Period|Death|0|||
49078284|NCT03142191|158121154|FG000|Placebo Controlled Period|Adverse Event|4|||
49078285|NCT03142191|158121155|FG001|Placebo Controlled Period|Adverse Event|5|||
49078286|NCT03142191|158121156|FG002|Placebo Controlled Period|Adverse Event|1|||
49078287|NCT03142191|158121157|FG003|Placebo Controlled Period|Adverse Event|0|||
49078288|NCT03142191|158121158|FG004|Placebo Controlled Period|Adverse Event|0|||
49078289|NCT03142191|158121154|FG000|Placebo Controlled Period|Progressive Disease|1|||
49078290|NCT03142191|158121155|FG001|Placebo Controlled Period|Progressive Disease|0|||
49078291|NCT03142191|158121156|FG002|Placebo Controlled Period|Progressive Disease|1|||
49078292|NCT03142191|158121157|FG003|Placebo Controlled Period|Progressive Disease|0|||
49078293|NCT03142191|158121158|FG004|Placebo Controlled Period|Progressive Disease|0|||
49078294|NCT03142191|158121154|FG000|Placebo Controlled Period|Withdrawal by participant|1|||
49078295|NCT03142191|158121155|FG001|Placebo Controlled Period|Withdrawal by participant|3|||
49078296|NCT03142191|158121156|FG002|Placebo Controlled Period|Withdrawal by participant|2|||
49078297|NCT03142191|158121157|FG003|Placebo Controlled Period|Withdrawal by participant|0|||
49078298|NCT03142191|158121158|FG004|Placebo Controlled Period|Withdrawal by participant|1|||
49078299|NCT03142191|158121154|FG000|Placebo Controlled Period|Other Reasons|1|||
49078300|NCT03142191|158121155|FG001|Placebo Controlled Period|Other Reasons|0|||
49078301|NCT03142191|158121156|FG002|Placebo Controlled Period|Other Reasons|0|||
49078302|NCT03142191|158121157|FG003|Placebo Controlled Period|Other Reasons|0|||
49078303|NCT03142191|158121158|FG004|Placebo Controlled Period|Other Reasons|0|||
49078304|NCT03142191|158121154|FG000|Active Treatment Extension Period|Death|2|||
49078305|NCT03142191|158121155|FG001|Active Treatment Extension Period|Death|1|||
49078306|NCT03142191|158121156|FG002|Active Treatment Extension Period|Death|1|||
49078307|NCT03142191|158121157|FG003|Active Treatment Extension Period|Death|1|||
49078308|NCT03142191|158121158|FG004|Active Treatment Extension Period|Death|0|||
49078309|NCT03142191|158121154|FG000|Active Treatment Extension Period|Adverse Event|6|||
49078310|NCT03142191|158121155|FG001|Active Treatment Extension Period|Adverse Event|5|||
49078311|NCT03142191|158121156|FG002|Active Treatment Extension Period|Adverse Event|4|||
49078312|NCT03142191|158121157|FG003|Active Treatment Extension Period|Adverse Event|1|||
49078313|NCT03142191|158121158|FG004|Active Treatment Extension Period|Adverse Event|0|||
49078314|NCT03142191|158121154|FG000|Active Treatment Extension Period|Progressive Disease|10|||
49078315|NCT03142191|158121155|FG001|Active Treatment Extension Period|Progressive Disease|5|||
49078316|NCT03142191|158121156|FG002|Active Treatment Extension Period|Progressive Disease|4|||
49078317|NCT03142191|158121157|FG003|Active Treatment Extension Period|Progressive Disease|1|||
49078318|NCT03142191|158121158|FG004|Active Treatment Extension Period|Progressive Disease|2|||
49078319|NCT03142191|158121154|FG000|Active Treatment Extension Period|Withdrawal by participant|2|||
49078320|NCT03142191|158121155|FG001|Active Treatment Extension Period|Withdrawal by participant|0|||
49078321|NCT03142191|158121156|FG002|Active Treatment Extension Period|Withdrawal by participant|3|||
49078322|NCT03142191|158121157|FG003|Active Treatment Extension Period|Withdrawal by participant|1|||
49078323|NCT03142191|158121158|FG004|Active Treatment Extension Period|Withdrawal by participant|1|||
49078324|NCT03142191|158121154|FG000|Active Treatment Extension Period|Physician Decision|2|||
49078325|NCT03142191|158121155|FG001|Active Treatment Extension Period|Physician Decision|0|||
49078326|NCT03142191|158121156|FG002|Active Treatment Extension Period|Physician Decision|0|||
49078327|NCT03142191|158121157|FG003|Active Treatment Extension Period|Physician Decision|0|||
49078328|NCT03142191|158121158|FG004|Active Treatment Extension Period|Physician Decision|0|||
49078329|NCT03142191|158121154|FG000|Active Treatment Extension Period|Other Reasons|3|||
49078330|NCT03142191|158121155|FG001|Active Treatment Extension Period|Other Reasons|3|||
49078331|NCT03142191|158121156|FG002|Active Treatment Extension Period|Other Reasons|3|||
49078332|NCT03142191|158121157|FG003|Active Treatment Extension Period|Other Reasons|8|||
49078333|NCT03142191|158121158|FG004|Active Treatment Extension Period|Other Reasons|3|||
49078334|NCT03142191|158121154|FG000|Active Treatment Extension Period|Unknown, participant missing|1|||
49078335|NCT03142191|158121155|FG001|Active Treatment Extension Period|Unknown, participant missing|0|||
49078336|NCT03142191|158121156|FG002|Active Treatment Extension Period|Unknown, participant missing|0|||
49078337|NCT03142191|158121157|FG003|Active Treatment Extension Period|Unknown, participant missing|0|||
49078338|NCT03142191|158121158|FG004|Active Treatment Extension Period|Unknown, participant missing|0|||
49078339|NCT01320293|158121159|FG000|Overall Study|Lack of Efficacy|1|||
49078340|NCT01320293|158121159|FG000|Overall Study|Adverse Event|1|||
49078341|NCT00397514|158121163|FG000|Overall Study|Withdrawal by Subject|1|||
49078342|NCT00397514|158121163|FG000|Overall Study|Pacing wire malfunction|1|||
49078343|NCT00397514|158121163|FG000|Overall Study|Not able to capture & pace LV intraoper.|4|||
49078344|NCT00397514|158121163|FG000|Overall Study|early extubation|2|||
49078345|NCT00397514|158121163|FG000|Overall Study|poor echocardiographic windows|1|||
49078346|NCT00445146|158121164|FG000|Overall Study|Withdrew Consent|29|||
49078347|NCT00445146|158121164|FG000|Overall Study|Lack of Efficacy|28|||
49078348|NCT00445146|158121164|FG000|Overall Study|Investigator's Discretion|22|||
49078349|NCT00445146|158121164|FG000|Overall Study|Adverse Event|13|||
49078350|NCT00445146|158121164|FG000|Overall Study|Lost to Follow-up|13|||
49078351|NCT00445146|158121164|FG000|Overall Study|Death|9|||
49078352|NCT00445146|158121164|FG000|Overall Study|Protocol Violation|4|||
49078353|NCT00445146|158121164|FG000|Overall Study|Pregnancy|1|||
49078354|NCT00193050|158121165|FG000|Neoadjuvant Treatment|Lack of Efficacy|2|||
49078355|NCT00193050|158121165|FG000|Neoadjuvant Treatment|Intercurrent Illness|3|||
49078356|NCT00193050|158121165|FG000|Neoadjuvant Treatment|Physician Decision|2|||
49078357|NCT00193050|158121165|FG000|Neoadjuvant Treatment|Adverse Event|2|||
49078358|NCT00193050|158121165|FG000|Adjuvant|Physician Decision|5|||
49078359|NCT00193050|158121165|FG000|Adjuvant|Intercurrent Hospitalization|3|||
49078360|NCT00193050|158121165|FG000|Adjuvant|Lack of Efficacy|2|||
49078361|NCT02431364|158121166|FG000|Overall Study|Adverse Event|0|||
49078362|NCT02431364|158121167|FG001|Overall Study|Adverse Event|1|||
49078363|NCT02431364|158121168|FG002|Overall Study|Adverse Event|0|||
49078364|NCT02431364|158121169|FG003|Overall Study|Adverse Event|0|||
49078365|NCT02431364|158121170|FG004|Overall Study|Adverse Event|0|||
49078366|NCT02431364|158121166|FG000|Overall Study|Randomized but never treated|0|||
49078367|NCT02431364|158121167|FG001|Overall Study|Randomized but never treated|0|||
49078368|NCT02431364|158121168|FG002|Overall Study|Randomized but never treated|0|||
49078369|NCT02431364|158121169|FG003|Overall Study|Randomized but never treated|1|||
49078370|NCT02431364|158121170|FG004|Overall Study|Randomized but never treated|0|||
49078371|NCT00061932|158121171|FG000|Overall Study|Withdrawal by Subject|13|||
49078372|NCT00061932|158121172|FG001|Overall Study|Withdrawal by Subject|4|||
49078373|NCT00916383|158121173|FG000|Overall Study|Adverse Event|1|||
49078374|NCT00916383|158121173|FG000|Overall Study|Death|1|||
49078375|NCT00916383|158121173|FG000|Overall Study|Protocol Violation|1|||
49078376|NCT00258960|158121174|FG000|Overall Study|Death|2|||
49078377|NCT00258960|158121174|FG000|Overall Study|Disease Progression|7|||
49078378|NCT00258960|158121174|FG000|Overall Study|Adverse Event|4|||
49078379|NCT00258960|158121174|FG000|Overall Study|Physician Decision|1|||
49078380|NCT00258960|158121174|FG000|Overall Study|Withdrawal by Subject|1|||
49078381|NCT00258960|158121174|FG000|Overall Study|Mistake|2|||
49078382|NCT02899962|158121175|FG000|Open-label Phase|Adverse Event|2|||
49078383|NCT02899962|158121176|FG001|Open-label Phase|Adverse Event|0|||
49078384|NCT02899962|158121177|FG002|Open-label Phase|Adverse Event|0|||
49078385|NCT02899962|158121175|FG000|Open-label Phase|Lost to Follow-up|9|||
49078386|NCT02899962|158121176|FG001|Open-label Phase|Lost to Follow-up|0|||
49078387|NCT02899962|158121177|FG002|Open-label Phase|Lost to Follow-up|0|||
49078388|NCT02899962|158121175|FG000|Open-label Phase|Other reasons|9|||
49078389|NCT02899962|158121176|FG001|Open-label Phase|Other reasons|0|||
49078390|NCT02899962|158121177|FG002|Open-label Phase|Other reasons|0|||
49078391|NCT02899962|158121175|FG000|Open-label Phase|Withdrawal by Subject|7|||
49078392|NCT02899962|158121176|FG001|Open-label Phase|Withdrawal by Subject|0|||
49078393|NCT02899962|158121177|FG002|Open-label Phase|Withdrawal by Subject|0|||
49078394|NCT02899962|158121175|FG000|Maintenance Phase|Adverse Event|0|||
49078395|NCT02899962|158121176|FG001|Maintenance Phase|Adverse Event|2|||
49078396|NCT02899962|158121177|FG002|Maintenance Phase|Adverse Event|1|||
49078397|NCT02899962|158121175|FG000|Maintenance Phase|Death|0|||
49078398|NCT02899962|158121176|FG001|Maintenance Phase|Death|0|||
49078399|NCT02899962|158121177|FG002|Maintenance Phase|Death|1|||
49078400|NCT02899962|158121175|FG000|Maintenance Phase|Lack of Efficacy|0|||
49078401|NCT02899962|158121176|FG001|Maintenance Phase|Lack of Efficacy|20|||
49078402|NCT02899962|158121177|FG002|Maintenance Phase|Lack of Efficacy|16|||
49078403|NCT02899962|158121175|FG000|Maintenance Phase|Lost to Follow-up|0|||
49078404|NCT02899962|158121176|FG001|Maintenance Phase|Lost to Follow-up|12|||
49078405|NCT02899962|158121177|FG002|Maintenance Phase|Lost to Follow-up|14|||
49078406|NCT02899962|158121175|FG000|Maintenance Phase|Other reasons|0|||
49078407|NCT02899962|158121176|FG001|Maintenance Phase|Other reasons|9|||
49078408|NCT02899962|158121177|FG002|Maintenance Phase|Other reasons|13|||
49078409|NCT02899962|158121175|FG000|Maintenance Phase|Not achieve treatment success after Wk 4|0|||
49078410|NCT02899962|158121176|FG001|Maintenance Phase|Not achieve treatment success after Wk 4|3|||
49078411|NCT02899962|158121177|FG002|Maintenance Phase|Not achieve treatment success after Wk 4|2|||
49078412|NCT02899962|158121175|FG000|Maintenance Phase|Not clear/almost clear after rescue med|0|||
49078413|NCT02899962|158121176|FG001|Maintenance Phase|Not clear/almost clear after rescue med|65|||
49078414|NCT02899962|158121177|FG002|Maintenance Phase|Not clear/almost clear after rescue med|70|||
49078415|NCT02899962|158121175|FG000|Maintenance Phase|Withdrawal by Subject|0|||
49078416|NCT02899962|158121176|FG001|Maintenance Phase|Withdrawal by Subject|30|||
49078417|NCT02899962|158121177|FG002|Maintenance Phase|Withdrawal by Subject|36|||
49078418|NCT02492867|158121178|FG000|Overall Study|Alternate therapy|1|||
49078419|NCT02492867|158121178|FG000|Overall Study|Withdrawal by Subject|2|||
49078420|NCT02492867|158121178|FG000|Overall Study|Disease progression after treatment started|1|||
49078421|NCT02492867|158121178|FG000|Overall Study|Death|1|||
49078422|NCT00473590|158121179|FG000|Overall Study|Adverse Event|3|||
49078423|NCT00473590|158121180|FG001|Overall Study|Adverse Event|3|||
49078424|NCT00473590|158121179|FG000|Overall Study|Death|4|||
49078425|NCT00473590|158121180|FG001|Overall Study|Death|2|||
49078426|NCT00473590|158121179|FG000|Overall Study|Progression not resulting in death|24|||
49078427|NCT00473590|158121180|FG001|Overall Study|Progression not resulting in death|20|||
49078428|NCT00473590|158121179|FG000|Overall Study|Non-protocol-specified therapy|7|||
49078429|NCT00473590|158121180|FG001|Overall Study|Non-protocol-specified therapy|5|||
49078430|NCT00473590|158121179|FG000|Overall Study|Physician Decision|2|||
49078431|NCT00473590|158121180|FG001|Overall Study|Physician Decision|4|||
49078432|NCT00473590|158121179|FG000|Overall Study|Withdrawal by Subject|5|||
49078433|NCT00473590|158121180|FG001|Overall Study|Withdrawal by Subject|3|||
49078434|NCT00473590|158121179|FG000|Overall Study|Other|0|||
49078435|NCT00473590|158121180|FG001|Overall Study|Other|1|||
49078436|NCT01112059|158121181|FG000|Overall Study|Withdrawal by Subject|1|||
49078437|NCT01112059|158121182|FG001|Overall Study|Withdrawal by Subject|0|||
49078438|NCT01245283|158121185|FG000|Overall Study|Lost to Follow-up|14|||
49078439|NCT01245283|158121186|FG001|Overall Study|Lost to Follow-up|11|||
49078440|NCT01245283|158121187|FG002|Overall Study|Lost to Follow-up|11|||
49078441|NCT01982955|158121198|FG000|Overall Study|Randomized but not treated|0|||
49078442|NCT01982955|158121199|FG001|Overall Study|Randomized but not treated|0|||
49078443|NCT01982955|158121200|FG002|Overall Study|Randomized but not treated|0|||
49078444|NCT01982955|158121201|FG003|Overall Study|Randomized but not treated|1|||
49078445|NCT01982955|158121202|FG004|Overall Study|Randomized but not treated|0|||
49078446|NCT01821807|158121203|FG000|Overall Study|Lost to Follow-up|3|||
49078447|NCT01821807|158121204|FG001|Overall Study|Lost to Follow-up|1|||
49078448|NCT02017015|158122849|FG000|Overall Study|Adverse Event|9|||
49078449|NCT02017015|158122849|FG000|Overall Study|Withdrawal by Subject|21|||
49078450|NCT02017015|158122849|FG000|Overall Study|Death|4|||
49078451|NCT02017015|158122849|FG000|Overall Study|Progressive Disease|31|||
49078452|NCT02017015|158122849|FG000|Overall Study|Non-compliance with study drug|2|||
49078453|NCT02017015|158122849|FG000|Overall Study|Physician Decision|2|||
49078454|NCT03092219|158122850|FG000|Overall Study|Protocol Violation|7|||
49078455|NCT03092219|158122851|FG001|Overall Study|Protocol Violation|4|||
49078456|NCT03888066|158122852|FG000|Run-in Phase|Randomization Criterion #1|24|||
49078457|NCT03888066|158122853|FG001|Run-in Phase|Randomization Criterion #1|0|||
49078458|NCT03888066|158122852|FG000|Run-in Phase|Randomization Criteria #1, #2|5|||
49078459|NCT03888066|158122853|FG001|Run-in Phase|Randomization Criteria #1, #2|0|||
49078460|NCT03888066|158122852|FG000|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
49078461|NCT03888066|158122853|FG001|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
49078462|NCT03888066|158122852|FG000|Run-in Phase|Randomization Criteria #1, #3|1|||
49078463|NCT03888066|158122853|FG001|Run-in Phase|Randomization Criteria #1, #3|0|||
49078464|NCT03888066|158122852|FG000|Run-in Phase|Randomization Criteria #1, #4|1|||
49078465|NCT03888066|158122853|FG001|Run-in Phase|Randomization Criteria #1, #4|0|||
49078466|NCT03888066|158122852|FG000|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
49078467|NCT03888066|158122853|FG001|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
49078468|NCT03888066|158122852|FG000|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
49078469|NCT03888066|158122853|FG001|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
49078470|NCT03888066|158122852|FG000|Run-in Phase|Randomization Criterion #1; AE|4|||
49078471|NCT03888066|158122853|FG001|Run-in Phase|Randomization Criterion #1; AE|0|||
49078472|NCT03888066|158122852|FG000|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
49078473|NCT03888066|158122853|FG001|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
49078474|NCT03888066|158122852|FG000|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
49078475|NCT03888066|158122853|FG001|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
49078476|NCT03888066|158122852|FG000|Run-in Phase|Randomization Criterion #2|5|||
49078477|NCT03888066|158122853|FG001|Run-in Phase|Randomization Criterion #2|0|||
49078478|NCT03888066|158122852|FG000|Run-in Phase|Randomization Criteria #2, #3|1|||
49078479|NCT03888066|158122853|FG001|Run-in Phase|Randomization Criteria #2, #3|0|||
49078480|NCT03888066|158122852|FG000|Run-in Phase|Randomization Criteria #2, #3, #4|1|||
49078481|NCT03888066|158122853|FG001|Run-in Phase|Randomization Criteria #2, #3, #4|0|||
49078482|NCT03888066|158122852|FG000|Run-in Phase|Randomization Criteria #2, #4|4|||
49078483|NCT03888066|158122853|FG001|Run-in Phase|Randomization Criteria #2, #4|0|||
49078484|NCT03888066|158122852|FG000|Run-in Phase|Randomization Criterion #3|11|||
49078485|NCT03888066|158122853|FG001|Run-in Phase|Randomization Criterion #3|0|||
49078486|NCT03888066|158122852|FG000|Run-in Phase|Randomization Criteria #3, #4|1|||
49078487|NCT03888066|158122853|FG001|Run-in Phase|Randomization Criteria #3, #4|0|||
49078488|NCT03888066|158122852|FG000|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
49078489|NCT03888066|158122853|FG001|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
49078490|NCT03888066|158122852|FG000|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
49078491|NCT03888066|158122853|FG001|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
49078492|NCT03888066|158122852|FG000|Run-in Phase|Randomization Criterion #4|3|||
49078493|NCT03888066|158122853|FG001|Run-in Phase|Randomization Criterion #4|0|||
49078494|NCT03888066|158122852|FG000|Run-in Phase|Randomization Criterion #3; Physician Decision|1|||
49078495|NCT03888066|158122853|FG001|Run-in Phase|Randomization Criterion #3; Physician Decision|0|||
49078496|NCT03888066|158122852|FG000|Run-in Phase|Randomization Criterion #4; AE|4|||
49078497|NCT03888066|158122853|FG001|Run-in Phase|Randomization Criterion #4; AE|0|||
49078498|NCT03888066|158122852|FG000|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
49078499|NCT03888066|158122853|FG001|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
49078500|NCT03888066|158122852|FG000|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|1|||
49078501|NCT03888066|158122853|FG001|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|0|||
49078502|NCT03888066|158122852|FG000|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
49078503|NCT03888066|158122853|FG001|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
49078504|NCT03888066|158122852|FG000|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
49078505|NCT03888066|158122853|FG001|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
49078506|NCT03888066|158122852|FG000|Run-in Phase|AE (Adverse Event)|17|||
49078507|NCT03888066|158122853|FG001|Run-in Phase|AE (Adverse Event)|0|||
49078508|NCT03888066|158122852|FG000|Run-in Phase|AE; Withdrawal By Subject|3|||
49078509|NCT03888066|158122853|FG001|Run-in Phase|AE; Withdrawal By Subject|0|||
49078510|NCT03888066|158122852|FG000|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
49078511|NCT03888066|158122853|FG001|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
49078512|NCT03888066|158122852|FG000|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
49078513|NCT03888066|158122853|FG001|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
49078514|NCT03888066|158122852|FG000|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
49078515|NCT03888066|158122853|FG001|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
49078516|NCT03888066|158122852|FG000|Run-in Phase|Withdrawal by Subject|43|||
49078517|NCT03888066|158122853|FG001|Run-in Phase|Withdrawal by Subject|0|||
49078518|NCT03888066|158122852|FG000|Run-in Phase|AE; Physician Decision|1|||
49078519|NCT03888066|158122853|FG001|Run-in Phase|AE; Physician Decision|0|||
49078520|NCT03888066|158122852|FG000|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|10|||
49078521|NCT03888066|158122853|FG001|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
49078522|NCT03888066|158122852|FG000|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|1|||
49078523|NCT03888066|158122853|FG001|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|0|||
49078524|NCT03888066|158122852|FG000|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|6|||
49078525|NCT03888066|158122853|FG001|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
49078526|NCT03888066|158122852|FG000|Run-in Phase|Death|1|||
49078527|NCT03888066|158122853|FG001|Run-in Phase|Death|0|||
49078528|NCT03888066|158122852|FG000|Run-in Phase|Non-Compliance With Study Drug|2|||
49078529|NCT03888066|158122853|FG001|Run-in Phase|Non-Compliance With Study Drug|0|||
49078530|NCT03888066|158122852|FG000|Run-in Phase|Physician Decision|1|||
49078531|NCT03888066|158122853|FG001|Run-in Phase|Physician Decision|0|||
49078532|NCT03888066|158122852|FG000|Run-in Phase|Protocol Violation|13|||
49078533|NCT03888066|158122853|FG001|Run-in Phase|Protocol Violation|0|||
49078534|NCT03888066|158122852|FG000|Run-in Phase|Sponsor Request|34|||
49078535|NCT03888066|158122853|FG001|Run-in Phase|Sponsor Request|0|||
49078536|NCT03888066|158122852|FG000|Run-in Phase|Study Terminated By Sponsor|71|||
49078537|NCT03888066|158122853|FG001|Run-in Phase|Study Terminated By Sponsor|0|||
49078538|NCT03888066|158122852|FG000|Run-in Phase|Withdrawal Of Consent|1|||
49078539|NCT03888066|158122853|FG001|Run-in Phase|Withdrawal Of Consent|0|||
49078540|NCT03888066|158122852|FG000|Run-in Phase|Exceeded 12 Weeks Of Run In|2|||
49078541|NCT03888066|158122853|FG001|Run-in Phase|Exceeded 12 Weeks Of Run In|0|||
49078542|NCT03888066|158122852|FG000|Run-in Phase|Not treated with Patiromer during Run-in|27|||
49078543|NCT03888066|158122853|FG001|Run-in Phase|Not treated with Patiromer during Run-in|0|||
49078544|NCT03888066|158122852|FG000|Treatment Phase (Overall Study)|Protocol Violation|0|||
49078545|NCT03888066|158122853|FG001|Treatment Phase (Overall Study)|Protocol Violation|1|||
49078546|NCT03888066|158122852|FG000|Treatment Phase (Overall Study)|Physician Decision|20|||
49078547|NCT03888066|158122853|FG001|Treatment Phase (Overall Study)|Physician Decision|13|||
49078548|NCT03888066|158122852|FG000|Treatment Phase (Overall Study)|Adverse Event|27|||
49078549|NCT03888066|158122853|FG001|Treatment Phase (Overall Study)|Adverse Event|21|||
49078550|NCT03888066|158122852|FG000|Treatment Phase (Overall Study)|Lost to Follow-up|1|||
49078551|NCT03888066|158122853|FG001|Treatment Phase (Overall Study)|Lost to Follow-up|0|||
49078552|NCT03888066|158122852|FG000|Treatment Phase (Overall Study)|Consent withdrawn by subject|21|||
49078553|NCT03888066|158122853|FG001|Treatment Phase (Overall Study)|Consent withdrawn by subject|25|||
49078554|NCT03888066|158122852|FG000|Treatment Phase (Overall Study)|End of study visit not completed/delayed|1|||
49078555|NCT03888066|158122853|FG001|Treatment Phase (Overall Study)|End of study visit not completed/delayed|3|||
49078556|NCT03888066|158122852|FG000|Treatment Phase (Overall Study)|Early study termination|0|||
49078557|NCT03888066|158122853|FG001|Treatment Phase (Overall Study)|Early study termination|1|||
49078558|NCT03888066|158122852|FG000|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
49078559|NCT03888066|158122853|FG001|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
49078560|NCT03888066|158122852|FG000|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
49078561|NCT03888066|158122853|FG001|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
49078562|NCT03888066|158122852|FG000|Treatment Phase (Overall Study)|Sponsor's decision|1|||
49078563|NCT03888066|158122853|FG001|Treatment Phase (Overall Study)|Sponsor's decision|0|||
49078564|NCT03333941|158122855|FG000|Overall Study|Lost to Follow-up|10|||
49078565|NCT03333941|158122855|FG000|Overall Study|Death|2|||
49078566|NCT03333941|158122855|FG000|Overall Study|Adverse Event|1|||
49078567|NCT01443728|158122861|FG000|Overall Study|Lost to Follow-up|2|||
49078568|NCT01443728|158122862|FG001|Overall Study|Lost to Follow-up|0|||
49078569|NCT01443728|158122861|FG000|Overall Study|Withdrawal by Subject|1|||
49078570|NCT01443728|158122862|FG001|Overall Study|Withdrawal by Subject|1|||
49078571|NCT01443728|158122861|FG000|Overall Study|Adverse Event|0|||
49078572|NCT01443728|158122862|FG001|Overall Study|Adverse Event|2|||
49078573|NCT00233948|158122863|FG000|Overall Study|Adverse Event|1|||
49078574|NCT00233948|158122864|FG001|Overall Study|Adverse Event|0|||
49078575|NCT00233948|158122865|FG002|Overall Study|Adverse Event|0|||
49078576|NCT00233948|158122866|FG003|Overall Study|Adverse Event|0|||
49078577|NCT00233948|158122867|FG004|Overall Study|Adverse Event|0|||
49078578|NCT00233948|158122868|FG005|Overall Study|Adverse Event|0|||
49078579|NCT00711880|158122871|FG000|Overall Study|Adverse Event|11|||
49078580|NCT00711880|158122872|FG001|Overall Study|Adverse Event|2|||
49078581|NCT00711880|158122871|FG000|Overall Study|Patient non-compliance|1|||
49078582|NCT00711880|158122872|FG001|Overall Study|Patient non-compliance|0|||
49078583|NCT00711880|158122871|FG000|Overall Study|Lack of Efficacy|1|||
49078584|NCT00711880|158122872|FG001|Overall Study|Lack of Efficacy|5|||
49078585|NCT02862730|158122873|FG000|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
49078586|NCT02862730|158122874|FG001|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
49078587|NCT02862730|158122875|FG002|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1|||
49078588|NCT02862730|158122876|FG003|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
49078589|NCT02862730|158122877|FG004|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
49078590|NCT02862730|158122878|FG005|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
49078591|NCT02862730|158122879|FG006|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
49078592|NCT02862730|158122873|FG000|Second Intervention (84 Hours)|Withdrawal by Subject|1|||
49078593|NCT02862730|158122874|FG001|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
49078594|NCT02862730|158122875|FG002|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
49078595|NCT02862730|158122876|FG003|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
49078596|NCT02862730|158122877|FG004|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
49078597|NCT02862730|158122878|FG005|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
49078598|NCT02862730|158122879|FG006|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
49078599|NCT02862730|158122873|FG000|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
49078600|NCT02862730|158122874|FG001|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
49078601|NCT02862730|158122875|FG002|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
49078602|NCT02862730|158122876|FG003|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
49078603|NCT02862730|158122877|FG004|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
49078604|NCT02862730|158122878|FG005|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
49078605|NCT02862730|158122879|FG006|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
49078606|NCT02862730|158122873|FG000|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
49078607|NCT02862730|158122874|FG001|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
49078608|NCT02862730|158122875|FG002|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
49078609|NCT02862730|158122876|FG003|Third Intervention (84 Hours)|diagnosis of gastroparesis|1|||
49078610|NCT02862730|158122877|FG004|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
49078611|NCT02862730|158122878|FG005|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
49078612|NCT02862730|158122879|FG006|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
49078613|NCT03908437|158122884|FG000|Overall Study|Death|0|||
49078614|NCT03908437|158122885|FG001|Overall Study|Death|1|||
49078615|NCT03908437|158122884|FG000|Overall Study|Lost to Follow-up|31|||
49078616|NCT03908437|158122885|FG001|Overall Study|Lost to Follow-up|24|||
49078617|NCT00704132|158122886|FG000|Overall Study|Clinical Adverse Experience|1|||
49078618|NCT00704132|158122887|FG001|Overall Study|Clinical Adverse Experience|0|||
49078619|NCT00704132|158122886|FG000|Overall Study|Lack of Efficacy|0|||
49078620|NCT00704132|158122887|FG001|Overall Study|Lack of Efficacy|1|||
49078621|NCT00704132|158122886|FG000|Overall Study|Withdrawal by Subject|0|||
49078622|NCT00704132|158122887|FG001|Overall Study|Withdrawal by Subject|1|||
49078623|NCT05445492|158122888|FG000|Overall Study|Physician Decision|1|||
49078624|NCT00442962|158122889|FG000|Overall Study|Pregnancy|1|||
49078625|NCT00442962|158122889|FG000|Overall Study|Lost to Follow-up|7|||
49078626|NCT03685344|158122890|FG000|Overall Study|Withdrawal by Subject|1|||
49078627|NCT03685344|158122891|FG001|Overall Study|Withdrawal by Subject|1|||
49078628|NCT03685344|158122892|FG002|Overall Study|Withdrawal by Subject|2|||
49078629|NCT03685344|158122893|FG003|Overall Study|Withdrawal by Subject|0|||
49078630|NCT03685344|158122890|FG000|Overall Study|Physician Decision|1|||
49078631|NCT03685344|158122891|FG001|Overall Study|Physician Decision|1|||
49078632|NCT03685344|158122892|FG002|Overall Study|Physician Decision|5|||
49078633|NCT03685344|158122893|FG003|Overall Study|Physician Decision|0|||
49078634|NCT03685344|158122890|FG000|Overall Study|Death|1|||
49078635|NCT03685344|158122891|FG001|Overall Study|Death|1|||
49078636|NCT03685344|158122892|FG002|Overall Study|Death|0|||
49078637|NCT03685344|158122893|FG003|Overall Study|Death|0|||
49078638|NCT04238650|158122895|FG000|Overall Study|Withdrawal by Subject|0|||
49078639|NCT04238650|158122896|FG001|Overall Study|Withdrawal by Subject|1|||
49078640|NCT04289363|158122897|FG000|Overall Study|Lost to Follow-up|14|||
49078641|NCT04289363|158122898|FG001|Overall Study|Lost to Follow-up|0|||
49078642|NCT03633825|158122900|FG000|Enrollment|Did not post on network|5066|||
49078643|NCT03633825|158122901|FG001|Enrollment|Did not post on network|5080|||
49078644|NCT03633825|158122900|FG000|Enrollment|Post not classified as crisis|13967|||
49078645|NCT03633825|158122901|FG001|Enrollment|Post not classified as crisis|13757|||
49078646|NCT03633825|158122900|FG000|Follow up|Lost to Follow-up|478|||
49078647|NCT03633825|158122901|FG001|Follow up|Lost to Follow-up|450|||
49078648|NCT03126435|158122905|FG000|Overall Study|Death|90|||
49078649|NCT03126435|158122906|FG001|Overall Study|Death|84|||
49078650|NCT03126435|158122905|FG000|Overall Study|Lost to Follow-up|4|||
49078651|NCT03126435|158122906|FG001|Overall Study|Lost to Follow-up|3|||
49078652|NCT03126435|158122905|FG000|Overall Study|Physician Decision|0|||
49078653|NCT03126435|158122906|FG001|Overall Study|Physician Decision|1|||
49078654|NCT03126435|158122905|FG000|Overall Study|Withdrawal by Subject|6|||
49078655|NCT03126435|158122906|FG001|Overall Study|Withdrawal by Subject|12|||
49078656|NCT03126435|158122905|FG000|Overall Study|e.g. Sponsor Decision, General Deterioration...|6|||
49078657|NCT03126435|158122906|FG001|Overall Study|e.g. Sponsor Decision, General Deterioration...|4|||
49078658|NCT02445963|158122907|FG000|Overall Study|Lost to Follow-up|1|||
49078659|NCT02445963|158122908|FG001|Overall Study|Lost to Follow-up|0|||
49078660|NCT02445963|158122909|FG002|Overall Study|Lost to Follow-up|0|||
49078661|NCT02445963|158122910|FG003|Overall Study|Lost to Follow-up|0|||
49078662|NCT02445963|158122907|FG000|Overall Study|Change in employment|1|||
49078663|NCT02445963|158122908|FG001|Overall Study|Change in employment|0|||
49078664|NCT02445963|158122909|FG002|Overall Study|Change in employment|0|||
49078665|NCT02445963|158122910|FG003|Overall Study|Change in employment|0|||
49078666|NCT02445963|158122907|FG000|Overall Study|Symptoms post-vaccination|0|||
49078667|NCT02445963|158122908|FG001|Overall Study|Symptoms post-vaccination|0|||
49078668|NCT02445963|158122909|FG002|Overall Study|Symptoms post-vaccination|1|||
49078669|NCT02445963|158122910|FG003|Overall Study|Symptoms post-vaccination|0|||
49078670|NCT02121652|158122915|FG000|Overall Study|Lost to Follow-up|2|||
49078671|NCT02121652|158122916|FG001|Overall Study|Lost to Follow-up|1|||
49078672|NCT02121652|158122915|FG000|Overall Study|Death|1|||
49078673|NCT02121652|158122916|FG001|Overall Study|Death|0|||
49078674|NCT02121652|158122915|FG000|Overall Study|Withdrawal by Subject|3|||
49078675|NCT02121652|158122916|FG001|Overall Study|Withdrawal by Subject|3|||
49078676|NCT02585778|158122917|FG000|Overall Study|Adverse Event|17|||
49078677|NCT02585778|158122918|FG001|Overall Study|Adverse Event|4|||
49078678|NCT02585778|158122917|FG000|Overall Study|Participant did not wish to continue|9|||
49078679|NCT02585778|158122918|FG001|Overall Study|Participant did not wish to continue|4|||
49078680|NCT02585778|158122917|FG000|Overall Study|Poor compliance to study protocol|0|||
49078681|NCT02585778|158122918|FG001|Overall Study|Poor compliance to study protocol|2|||
49078682|NCT02585778|158122917|FG000|Overall Study|Death|0|||
49078683|NCT02585778|158122918|FG001|Overall Study|Death|1|||
49078684|NCT02585778|158122917|FG000|Overall Study|Randomized but not treated|1|||
49078685|NCT02585778|158122918|FG001|Overall Study|Randomized but not treated|2|||
49078686|NCT02585778|158122917|FG000|Overall Study|Other than specified above|6|||
49078687|NCT02585778|158122918|FG001|Overall Study|Other than specified above|2|||
49078688|NCT00182325|158122923|FG000|Overall Study|Lost to Follow-up|7|||
49078689|NCT00182325|158122924|FG001|Overall Study|Lost to Follow-up|7|||
49078690|NCT00182325|158122923|FG000|Overall Study|Miscarriage|5|||
49078691|NCT00182325|158122924|FG001|Overall Study|Miscarriage|3|||
49078692|NCT00182325|158122923|FG000|Overall Study|Did not complete survey|22|||
49078693|NCT00182325|158122924|FG001|Overall Study|Did not complete survey|43|||
49078694|NCT00799058|158122925|FG000|Overall Study|Withdrawal by Subject|2|||
49078695|NCT00799058|158122926|FG001|Overall Study|Withdrawal by Subject|2|||
49078696|NCT00799058|158122927|FG002|Overall Study|Withdrawal by Subject|2|||
49078697|NCT00799058|158122925|FG000|Overall Study|Lost to Follow-up|1|||
49078698|NCT00799058|158122926|FG001|Overall Study|Lost to Follow-up|2|||
49078699|NCT00799058|158122927|FG002|Overall Study|Lost to Follow-up|1|||
49078700|NCT00799058|158122925|FG000|Overall Study|Adverse Event|0|||
49078701|NCT00799058|158122926|FG001|Overall Study|Adverse Event|2|||
49078702|NCT00799058|158122927|FG002|Overall Study|Adverse Event|0|||
49078703|NCT00799058|158122925|FG000|Overall Study|Pregnancy|1|||
49078704|NCT00799058|158122926|FG001|Overall Study|Pregnancy|0|||
49078705|NCT00799058|158122927|FG002|Overall Study|Pregnancy|0|||
49078706|NCT00799058|158122925|FG000|Overall Study|Not adherent|3|||
49078707|NCT00799058|158122926|FG001|Overall Study|Not adherent|2|||
49078708|NCT00799058|158122927|FG002|Overall Study|Not adherent|1|||
49078709|NCT00799058|158122925|FG000|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
49078710|NCT00799058|158122926|FG001|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
49078711|NCT00799058|158122927|FG002|Overall Study|discontinued use of IP due to AE, but completed visits|1|||
49078712|NCT00799058|158122925|FG000|Overall Study|IP dispensing error|1|||
49078713|NCT00799058|158122926|FG001|Overall Study|IP dispensing error|0|||
49078714|NCT00799058|158122927|FG002|Overall Study|IP dispensing error|0|||
49078715|NCT00799058|158122925|FG000|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
49078716|NCT00799058|158122926|FG001|Overall Study|not enough IP to complete trial due to IP dispending error|1|||
49078717|NCT00799058|158122927|FG002|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
49078718|NCT00799058|158122925|FG000|Overall Study|IP discontinued too long during BV treatment|1|||
49078719|NCT00799058|158122926|FG001|Overall Study|IP discontinued too long during BV treatment|0|||
49078720|NCT00799058|158122927|FG002|Overall Study|IP discontinued too long during BV treatment|0|||
49078721|NCT00799058|158122925|FG000|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
49078722|NCT00799058|158122926|FG001|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
49078723|NCT00799058|158122927|FG002|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|1|||
49078724|NCT00799058|158122925|FG000|Overall Study|participant did not attend clinic visit 6 (final visit)|1|||
49078725|NCT00799058|158122926|FG001|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
49078726|NCT00799058|158122927|FG002|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
49078727|NCT01277211|158122935|FG000|Overall Study|Adverse Event|60|||
49078728|NCT01277211|158122936|FG001|Overall Study|Adverse Event|22|||
49078729|NCT01277211|158122935|FG000|Overall Study|Pregnancy|9|||
49078730|NCT01277211|158122936|FG001|Overall Study|Pregnancy|4|||
49078731|NCT01277211|158122935|FG000|Overall Study|Lost to Follow-up|14|||
49078732|NCT01277211|158122936|FG001|Overall Study|Lost to Follow-up|9|||
49078733|NCT01277211|158122935|FG000|Overall Study|Did not wish to continue|17|||
49078734|NCT01277211|158122936|FG001|Overall Study|Did not wish to continue|0|||
49078735|NCT01277211|158122935|FG000|Overall Study|Withdrew Consent|9|||
49078736|NCT01277211|158122936|FG001|Overall Study|Withdrew Consent|9|||
49078737|NCT01277211|158122935|FG000|Overall Study|Non-compliance with protocol|13|||
49078738|NCT01277211|158122936|FG001|Overall Study|Non-compliance with protocol|4|||
49078739|NCT01277211|158122935|FG000|Overall Study|Did not meet protocol eligibility|1|||
49078740|NCT01277211|158122936|FG001|Overall Study|Did not meet protocol eligibility|0|||
49078741|NCT01277211|158122935|FG000|Overall Study|Administrative|3|||
49078742|NCT01277211|158122936|FG001|Overall Study|Administrative|0|||
49078743|NCT01277211|158122935|FG000|Overall Study|Pregnancy wish|0|||
49078744|NCT01277211|158122936|FG001|Overall Study|Pregnancy wish|2|||
49078745|NCT01277211|158122935|FG000|Overall Study|Discontinued prior to treatment|24|||
49078746|NCT01277211|158122936|FG001|Overall Study|Discontinued prior to treatment|13|||
49078747|NCT00129545|158122937|FG000|Overall Study|Death|5|||
49078748|NCT00129545|158122938|FG001|Overall Study|Death|60|||
49078749|NCT00129545|158122939|FG002|Overall Study|Death|44|||
49078750|NCT00129545|158122937|FG000|Overall Study|Withdrawal by Subject|3|||
49078751|NCT00129545|158122938|FG001|Overall Study|Withdrawal by Subject|18|||
49078752|NCT00129545|158122939|FG002|Overall Study|Withdrawal by Subject|44|||
49078753|NCT00129545|158122937|FG000|Overall Study|Lost to Follow-up|2|||
49078754|NCT00129545|158122938|FG001|Overall Study|Lost to Follow-up|22|||
49078755|NCT00129545|158122939|FG002|Overall Study|Lost to Follow-up|13|||
49078756|NCT00129545|158122937|FG000|Overall Study|Physician Decision|0|||
49078757|NCT00129545|158122938|FG001|Overall Study|Physician Decision|3|||
49078758|NCT00129545|158122939|FG002|Overall Study|Physician Decision|10|||
49078759|NCT00129545|158122937|FG000|Overall Study|Device not implanted|16|||
49078760|NCT00129545|158122938|FG001|Overall Study|Device not implanted|61|||
49078761|NCT00129545|158122939|FG002|Overall Study|Device not implanted|0|||
49078762|NCT00770328|158122940|FG000|Overall Study|Adverse Event|11|||
49078763|NCT00770328|158122941|FG001|Overall Study|Adverse Event|2|||
49078764|NCT00770328|158122940|FG000|Overall Study|Lost to Follow-up|2|||
49078765|NCT00770328|158122941|FG001|Overall Study|Lost to Follow-up|2|||
49078766|NCT04660331|158122946|FG000|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
49078767|NCT04660331|158122947|FG001|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
49078768|NCT04660331|158122948|FG002|PROMOTE Intervention (Aim 2)|Lost to Follow-up|5|||
49078769|NCT03452943|158122949|FG000|Titration Period (7 Weeks)|Adverse Event|1|||
49078770|NCT03452943|158122950|FG001|Titration Period (7 Weeks)|Adverse Event|1|||
49078771|NCT03452943|158122949|FG000|Titration Period (7 Weeks)|Protocol Violation|0|||
49078772|NCT03452943|158122950|FG001|Titration Period (7 Weeks)|Protocol Violation|1|||
49078773|NCT03452943|158122949|FG000|Titration Period (7 Weeks)|Withdrawal by Subject|3|||
49078774|NCT03452943|158122950|FG001|Titration Period (7 Weeks)|Withdrawal by Subject|2|||
49078775|NCT03452943|158122949|FG000|Titration Period (7 Weeks)|Lost to Follow-up|1|||
49078776|NCT03452943|158122950|FG001|Titration Period (7 Weeks)|Lost to Follow-up|0|||
49078777|NCT03452943|158122949|FG000|Maintenance Period (5 Weeks)|Adverse Event|1|||
49078778|NCT03452943|158122950|FG001|Maintenance Period (5 Weeks)|Adverse Event|0|||
49078779|NCT03452943|158122949|FG000|Maintenance Period (5 Weeks)|Withdrawal by Subject|2|||
49078780|NCT03452943|158122950|FG001|Maintenance Period (5 Weeks)|Withdrawal by Subject|0|||
49078781|NCT01130493|158122951|FG000|Open-label Dose Conversion to IPX066|Adverse Event|1|||
49078782|NCT01130493|158122952|FG001|Open-label Dose Conversion to IPX066|Adverse Event|0|||
49078783|NCT01130493|158122953|FG002|Open-label Dose Conversion to IPX066|Adverse Event|0|||
49078784|NCT01130493|158122951|FG000|Open-label Dose Conversion to IPX066|Protocol Violation|3|||
49078785|NCT01130493|158122952|FG001|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
49078786|NCT01130493|158122953|FG002|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
49078787|NCT01130493|158122951|FG000|Open-label Dose Conversion to IPX066|Lack of Efficacy|7|||
49078788|NCT01130493|158122952|FG001|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
49078789|NCT01130493|158122953|FG002|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
49078790|NCT01130493|158122951|FG000|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7|||
49078791|NCT01130493|158122952|FG001|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
49078792|NCT01130493|158122953|FG002|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
49078793|NCT01130493|158122951|FG000|Open-label Dose Conversion to IPX066|Diary imcomplete|1|||
49078794|NCT01130493|158122952|FG001|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
49078795|NCT01130493|158122953|FG002|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
49078796|NCT01130493|158122951|FG000|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
49078797|NCT01130493|158122952|FG001|Part 1: Double-blind Treatment Period 1|Protocol Violation|1|||
49078798|NCT01130493|158122953|FG002|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
49078799|NCT01130493|158122951|FG000|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
49078800|NCT01130493|158122952|FG001|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1|||
49078801|NCT01130493|158122953|FG002|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
49078802|NCT01130493|158122951|FG000|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
49078803|NCT01130493|158122952|FG001|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1|||
49078804|NCT01130493|158122953|FG002|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
49078805|NCT01130493|158122951|FG000|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
49078806|NCT01130493|158122952|FG001|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
49078807|NCT01130493|158122953|FG002|Part 1: Open-Label IPX066 Washout|Adverse Event|1|||
49078808|NCT01130493|158122951|FG000|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
49078809|NCT01130493|158122952|FG001|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
49078810|NCT01130493|158122953|FG002|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1|||
49078811|NCT01130493|158122951|FG000|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
49078812|NCT01130493|158122952|FG001|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
49078813|NCT01130493|158122953|FG002|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1|||
49078814|NCT01130493|158122951|FG000|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
49078815|NCT01130493|158122952|FG001|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
49078816|NCT01130493|158122953|FG002|Part 1: Double-blind Treatment Period 2|Noncompliance|1|||
49078817|NCT01130493|158122951|FG000|Part 2: OLE|Adverse Event|0|||
49078818|NCT01130493|158122952|FG001|Part 2: OLE|Adverse Event|2|||
49078819|NCT01130493|158122953|FG002|Part 2: OLE|Adverse Event|1|||
49078820|NCT01130493|158122951|FG000|Part 2: OLE|Withdrawal by Subject|0|||
49078821|NCT01130493|158122952|FG001|Part 2: OLE|Withdrawal by Subject|1|||
49078822|NCT01130493|158122953|FG002|Part 2: OLE|Withdrawal by Subject|4|||
49078823|NCT03125798|158122955|FG000|Overall Study|Lack of electrosurgical device in the operating room|2|||
49078824|NCT03125798|158122956|FG001|Overall Study|Lack of electrosurgical device in the operating room|0|||
49078825|NCT03125798|158122955|FG000|Overall Study|Conversion to thoracotomy|7|||
49078826|NCT03125798|158122956|FG001|Overall Study|Conversion to thoracotomy|7|||
49078827|NCT02461160|158122958|FG000|Overall Study|Lost to Follow-up|0|||
49078828|NCT02461160|158122959|FG001|Overall Study|Lost to Follow-up|0|||
49078829|NCT02461160|158122960|FG002|Overall Study|Lost to Follow-up|0|||
49078830|NCT02461160|158122961|FG003|Overall Study|Lost to Follow-up|0|||
49078831|NCT02461160|158122962|FG004|Overall Study|Lost to Follow-up|0|||
49078832|NCT02461160|158122963|FG005|Overall Study|Lost to Follow-up|0|||
49078833|NCT02461160|158122964|FG006|Overall Study|Lost to Follow-up|0|||
49078834|NCT02461160|158122965|FG007|Overall Study|Lost to Follow-up|1|||
49078835|NCT02461160|158122966|FG008|Overall Study|Lost to Follow-up|0|||
49078836|NCT02461160|158122967|FG009|Overall Study|Lost to Follow-up|0|||
49078837|NCT02461160|158122968|FG010|Overall Study|Lost to Follow-up|0|||
49078838|NCT02461160|158122969|FG011|Overall Study|Lost to Follow-up|0|||
49078839|NCT02461160|158122970|FG012|Overall Study|Lost to Follow-up|0|||
49078840|NCT02430480|158122971|FG000|Overall Study|Death|1|||
49078841|NCT02430480|158122971|FG000|Overall Study|Anesthesia concerns|1|||
49078842|NCT02430480|158122971|FG000|Overall Study|Progressed on treatment|1|||
49078843|NCT02854527|158122972|FG000|Overall Study|Adverse Event|0|||
49078844|NCT02854527|158122973|FG001|Overall Study|Adverse Event|0|||
49078845|NCT02854527|158122974|FG002|Overall Study|Adverse Event|0|||
49078846|NCT02854527|158122975|FG003|Overall Study|Adverse Event|0|||
49078847|NCT02854527|158122976|FG004|Overall Study|Adverse Event|1|||
49078848|NCT02854527|158122977|FG005|Overall Study|Adverse Event|0|||
49078849|NCT02854527|158122978|FG006|Overall Study|Adverse Event|0|||
49078850|NCT02854527|158122979|FG007|Overall Study|Adverse Event|0|||
49078851|NCT02854527|158122980|FG008|Overall Study|Adverse Event|0|||
49078852|NCT02854527|158122981|FG009|Overall Study|Adverse Event|0|||
49078853|NCT02854527|158122972|FG000|Overall Study|Lost to Follow-up|0|||
49078854|NCT02854527|158122973|FG001|Overall Study|Lost to Follow-up|0|||
49078855|NCT02854527|158122974|FG002|Overall Study|Lost to Follow-up|0|||
49078856|NCT02854527|158122975|FG003|Overall Study|Lost to Follow-up|1|||
49078857|NCT02854527|158122976|FG004|Overall Study|Lost to Follow-up|0|||
49078858|NCT02854527|158122977|FG005|Overall Study|Lost to Follow-up|0|||
49078859|NCT02854527|158122978|FG006|Overall Study|Lost to Follow-up|0|||
49078860|NCT02854527|158122979|FG007|Overall Study|Lost to Follow-up|0|||
49078861|NCT02854527|158122980|FG008|Overall Study|Lost to Follow-up|0|||
49078862|NCT02854527|158122981|FG009|Overall Study|Lost to Follow-up|0|||
49078863|NCT02072980|158122982|FG000|Period 2, Second Wear|Adverse Event|0|||
49078864|NCT02072980|158122983|FG001|Period 2, Second Wear|Adverse Event|1|||
49078865|NCT00946920|158122984|FG000|Overall Study|Withdrawal by Subject|28|||
49078866|NCT00946920|158122985|FG001|Overall Study|Withdrawal by Subject|15|||
49078867|NCT00946920|158122984|FG000|Overall Study|Lost to Follow-up|2|||
49078868|NCT00946920|158122985|FG001|Overall Study|Lost to Follow-up|2|||
49078869|NCT00946920|158122984|FG000|Overall Study|Physician Decision|5|||
49078870|NCT00946920|158122985|FG001|Overall Study|Physician Decision|2|||
49078871|NCT00946920|158122984|FG000|Overall Study|Adverse Event|41|||
49078872|NCT00946920|158122985|FG001|Overall Study|Adverse Event|14|||
49078873|NCT00946920|158122984|FG000|Overall Study|Protocol Violation|16|||
49078874|NCT00946920|158122985|FG001|Overall Study|Protocol Violation|8|||
49078875|NCT00946920|158122984|FG000|Overall Study|Miscellaneous reasons|18|||
49078876|NCT00946920|158122985|FG001|Overall Study|Miscellaneous reasons|3|||
49078877|NCT05093829|158122988|FG000|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
49078878|NCT05093829|158122989|FG001|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
49078879|NCT05093829|158122990|FG002|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|123|||
49078880|NCT05093829|158122991|FG003|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
49078881|NCT05093829|158122992|FG004|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
49078882|NCT00625820|158122997|FG000|Overall Study|Withdrawal by Subject|1|||
49078883|NCT04146012|158123002|FG000|Overall Study|Study Terminated|30|||
49078884|NCT04146012|158123003|FG001|Overall Study|Study Terminated|15|||
49078885|NCT00866359|158123006|FG000|Treatment Phase (Days 1 to 85)|Adverse Event|5|||
49078886|NCT00866359|158123007|FG001|Treatment Phase (Days 1 to 85)|Adverse Event|4|||
49078887|NCT00866359|158123008|FG002|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
49078888|NCT00866359|158123009|FG003|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
49078889|NCT00866359|158123006|FG000|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3|||
49078890|NCT00866359|158123007|FG001|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
49078891|NCT00866359|158123008|FG002|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
49078892|NCT00866359|158123009|FG003|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
49078893|NCT00866359|158123006|FG000|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1|||
49078894|NCT00866359|158123007|FG001|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
49078895|NCT00866359|158123008|FG002|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
49078896|NCT00866359|158123009|FG003|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
49078897|NCT00866359|158123006|FG000|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
49078898|NCT00866359|158123007|FG001|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
49078899|NCT00866359|158123008|FG002|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
49078900|NCT00866359|158123009|FG003|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
49078901|NCT00866359|158123006|FG000|Treatment Phase (Days 1 to 85)|Other|1|||
49078902|NCT00866359|158123007|FG001|Treatment Phase (Days 1 to 85)|Other|0|||
49078903|NCT00866359|158123008|FG002|Treatment Phase (Days 1 to 85)|Other|0|||
49078904|NCT00866359|158123009|FG003|Treatment Phase (Days 1 to 85)|Other|0|||
49078905|NCT00866359|158123006|FG000|Extension Phase (Day 86 to 169)|Adverse Event|0|||
49078906|NCT00866359|158123007|FG001|Extension Phase (Day 86 to 169)|Adverse Event|0|||
49078907|NCT00866359|158123008|FG002|Extension Phase (Day 86 to 169)|Adverse Event|1|||
49078908|NCT00866359|158123009|FG003|Extension Phase (Day 86 to 169)|Adverse Event|3|||
49078909|NCT02633787|158123012|FG000|Overall Study|Withdrawal by Subject|1|||
49078910|NCT00584454|158123013|FG000|Overall Study|Adverse Event|1|||
49078911|NCT00584454|158123013|FG000|Overall Study|Relocation|1|||
49078912|NCT00584454|158123013|FG000|Overall Study|Clinical Hold|2|||
49078913|NCT02404805|158123014|FG000|Overall Study|Withdrawal by Subject|1|||
49078914|NCT02404805|158123015|FG001|Overall Study|Withdrawal by Subject|0|||
49078915|NCT02404805|158123016|FG002|Overall Study|Withdrawal by Subject|0|||
49078916|NCT02404805|158123017|FG003|Overall Study|Withdrawal by Subject|0|||
49078917|NCT02404805|158123018|FG004|Overall Study|Withdrawal by Subject|0|||
49078918|NCT02404805|158123019|FG005|Overall Study|Withdrawal by Subject|0|||
49078919|NCT02163057|158123020|FG000|Overall Study|Participant Refusal to Continue|2|||
49078920|NCT02163057|158123021|FG001|Overall Study|Participant Refusal to Continue|2|||
49078921|NCT02163057|158123020|FG000|Overall Study|Participant Significant Noncompliance|0|||
49078922|NCT02163057|158123021|FG001|Overall Study|Participant Significant Noncompliance|1|||
49078923|NCT02163057|158123020|FG000|Overall Study|Progression of Disease|1|||
49078924|NCT02163057|158123021|FG001|Overall Study|Progression of Disease|2|||
49078925|NCT01625091|158123022|FG000|Intervention|Death|1|||
49078926|NCT01625091|158123023|FG001|Intervention|Death|1|||
49078927|NCT01625091|158123022|FG000|Intervention|Withdrawal by Subject|4|||
49078928|NCT01625091|158123023|FG001|Intervention|Withdrawal by Subject|1|||
49078929|NCT01625091|158123022|FG000|Intervention|Adverse Event|0|||
49078930|NCT01625091|158123023|FG001|Intervention|Adverse Event|2|||
49078931|NCT01625091|158123022|FG000|Intervention|Lost to Follow-up|4|||
49078932|NCT01625091|158123023|FG001|Intervention|Lost to Follow-up|4|||
49078933|NCT01625091|158123022|FG000|Intervention|Study termination|2|||
49078934|NCT01625091|158123023|FG001|Intervention|Study termination|3|||
49078935|NCT01625091|158123022|FG000|Post-intervention|Death|0|||
49078936|NCT01625091|158123023|FG001|Post-intervention|Death|1|||
49078937|NCT01625091|158123022|FG000|Post-intervention|Lost to Follow-up|2|||
49078938|NCT01625091|158123023|FG001|Post-intervention|Lost to Follow-up|0|||
49078939|NCT01625091|158123022|FG000|Post-intervention|Study termination|2|||
49078940|NCT01625091|158123023|FG001|Post-intervention|Study termination|1|||
49078941|NCT00858273|158123024|FG000|Overall Study|Protocol Violation|3|||
49078942|NCT00858273|158123025|FG001|Overall Study|Protocol Violation|5|||
49078943|NCT03278626|158124563|FG000|Overall Study|Death|2|||
49078944|NCT03278626|158124563|FG000|Overall Study|Toxicity|1|||
49078945|NCT03278626|158124563|FG000|Overall Study|Disease Progression|2|||
49078946|NCT01433055|158124565|FG000|Overall Study|Diagnosed with cancer unrelated to study|1|||
49078947|NCT01433055|158124566|FG001|Overall Study|Diagnosed with cancer unrelated to study|0|||
49078948|NCT01433055|158124565|FG000|Overall Study|Severely elevated triglycerides at entry|1|||
49078949|NCT01433055|158124566|FG001|Overall Study|Severely elevated triglycerides at entry|0|||
49078950|NCT02856555|158124570|FG000|Overall Study|Adverse Event|1|||
49078951|NCT02856555|158124571|FG001|Overall Study|Adverse Event|0|||
49078952|NCT02856555|158124572|FG002|Overall Study|Adverse Event|0|||
49078953|NCT02856555|158124570|FG000|Overall Study|Lost to Follow-up|1|||
49078954|NCT02856555|158124571|FG001|Overall Study|Lost to Follow-up|3|||
49078955|NCT02856555|158124572|FG002|Overall Study|Lost to Follow-up|0|||
49078956|NCT02856555|158124570|FG000|Overall Study|Withdrawal by Subject|3|||
49078957|NCT02856555|158124571|FG001|Overall Study|Withdrawal by Subject|0|||
49078958|NCT02856555|158124572|FG002|Overall Study|Withdrawal by Subject|0|||
49078959|NCT02856555|158124570|FG000|Overall Study|Randomized but Never Treated|0|||
49078960|NCT02856555|158124571|FG001|Overall Study|Randomized but Never Treated|1|||
49078961|NCT02856555|158124572|FG002|Overall Study|Randomized but Never Treated|0|||
49078962|NCT02717455|158124573|FG000|Overall Study|Adverse Event|1|||
49078963|NCT02717455|158124574|FG001|Overall Study|Adverse Event|0|||
49078964|NCT02717455|158124575|FG002|Overall Study|Adverse Event|0|||
49078965|NCT02717455|158124576|FG003|Overall Study|Adverse Event|2|||
49078966|NCT02717455|158124577|FG004|Overall Study|Adverse Event|2|||
49078967|NCT02717455|158124578|FG005|Overall Study|Adverse Event|2|||
49078968|NCT02717455|158124573|FG000|Overall Study|Withdrawal by Subject|1|||
49078969|NCT02717455|158124574|FG001|Overall Study|Withdrawal by Subject|1|||
49078970|NCT02717455|158124575|FG002|Overall Study|Withdrawal by Subject|0|||
49078971|NCT02717455|158124576|FG003|Overall Study|Withdrawal by Subject|2|||
49078972|NCT02717455|158124577|FG004|Overall Study|Withdrawal by Subject|2|||
49078973|NCT02717455|158124578|FG005|Overall Study|Withdrawal by Subject|1|||
49078974|NCT02717455|158124573|FG000|Overall Study|Death|1|||
49078975|NCT02717455|158124574|FG001|Overall Study|Death|0|||
49078976|NCT02717455|158124575|FG002|Overall Study|Death|0|||
49078977|NCT02717455|158124576|FG003|Overall Study|Death|0|||
49078978|NCT02717455|158124577|FG004|Overall Study|Death|1|||
49078979|NCT02717455|158124578|FG005|Overall Study|Death|0|||
49078980|NCT02717455|158124573|FG000|Overall Study|Did not receive study drug|0|||
49078981|NCT02717455|158124574|FG001|Overall Study|Did not receive study drug|0|||
49078982|NCT02717455|158124575|FG002|Overall Study|Did not receive study drug|0|||
49078983|NCT02717455|158124576|FG003|Overall Study|Did not receive study drug|1|||
49078984|NCT02717455|158124577|FG004|Overall Study|Did not receive study drug|0|||
49078985|NCT02717455|158124578|FG005|Overall Study|Did not receive study drug|1|||
49078986|NCT02717455|158124573|FG000|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
49078987|NCT02717455|158124574|FG001|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
49078988|NCT02717455|158124575|FG002|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
49078989|NCT02717455|158124576|FG003|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
49078990|NCT02717455|158124577|FG004|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
49078991|NCT02717455|158124578|FG005|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|1|||
49078992|NCT02717455|158124573|FG000|Overall Study|Patient off-treatment for other complicating disease|0|||
49078993|NCT02717455|158124574|FG001|Overall Study|Patient off-treatment for other complicating disease|0|||
49078994|NCT02717455|158124575|FG002|Overall Study|Patient off-treatment for other complicating disease|0|||
49078995|NCT02717455|158124576|FG003|Overall Study|Patient off-treatment for other complicating disease|1|||
49078996|NCT02717455|158124577|FG004|Overall Study|Patient off-treatment for other complicating disease|0|||
49078997|NCT02717455|158124578|FG005|Overall Study|Patient off-treatment for other complicating disease|0|||
49078998|NCT05013008|158124579|FG000|Overall Study|Exclusion from mBFAS|5|||
49078999|NCT05013008|158124580|FG001|Overall Study|Exclusion from mBFAS|25|||
49079000|NCT02094417|158124581|FG000|Overall Study|Adverse Event|0|||
49079001|NCT02094417|158124582|FG001|Overall Study|Adverse Event|0|||
49079002|NCT02094417|158124583|FG002|Overall Study|Adverse Event|0|||
49079003|NCT02094417|158124584|FG003|Overall Study|Adverse Event|1|||
49079004|NCT02094417|158124581|FG000|Overall Study|Eligibility criteria|0|||
49079005|NCT02094417|158124582|FG001|Overall Study|Eligibility criteria|1|||
49079006|NCT02094417|158124583|FG002|Overall Study|Eligibility criteria|0|||
49079007|NCT02094417|158124584|FG003|Overall Study|Eligibility criteria|0|||
49079008|NCT02094417|158124581|FG000|Overall Study|No responder|4|||
49079009|NCT02094417|158124582|FG001|Overall Study|No responder|4|||
49079010|NCT02094417|158124583|FG002|Overall Study|No responder|4|||
49079011|NCT02094417|158124584|FG003|Overall Study|No responder|3|||
49079012|NCT02094417|158124581|FG000|Overall Study|Unable to conduct observations or assess|0|||
49079013|NCT02094417|158124582|FG001|Overall Study|Unable to conduct observations or assess|1|||
49079014|NCT02094417|158124583|FG002|Overall Study|Unable to conduct observations or assess|0|||
49079015|NCT02094417|158124584|FG003|Overall Study|Unable to conduct observations or assess|0|||
49079016|NCT02094417|158124581|FG000|Overall Study|Withdrawal by Subject|1|||
49079017|NCT02094417|158124582|FG001|Overall Study|Withdrawal by Subject|2|||
49079018|NCT02094417|158124583|FG002|Overall Study|Withdrawal by Subject|1|||
49079019|NCT02094417|158124584|FG003|Overall Study|Withdrawal by Subject|3|||
49079020|NCT03573830|158124585|FG000|Overall Study|Dropped without completing treatment|0|||
49079021|NCT03573830|158124586|FG001|Overall Study|Dropped without completing treatment|7|||
49079022|NCT03573830|158124585|FG000|Overall Study|Lost to Follow-up|4|||
49079023|NCT03573830|158124586|FG001|Overall Study|Lost to Follow-up|0|||
49079024|NCT00733005|158124587|FG000|Overall Study|Adverse Event|0|||
49079025|NCT00733005|158124588|FG001|Overall Study|Adverse Event|1|||
49079026|NCT00733005|158124587|FG000|Overall Study|Treatment Failure|0|||
49079027|NCT00733005|158124588|FG001|Overall Study|Treatment Failure|1|||
49079028|NCT00733005|158124587|FG000|Overall Study|Withdrawal by Subject|0|||
49079029|NCT00733005|158124588|FG001|Overall Study|Withdrawal by Subject|1|||
49079030|NCT00733005|158124587|FG000|Overall Study|Protocol Violation|2|||
49079031|NCT00733005|158124588|FG001|Overall Study|Protocol Violation|0|||
49079032|NCT01769456|158124589|FG000|Overall Study|Lost to Follow-up|19|||
49079033|NCT01769456|158124589|FG000|Overall Study|Withdrawal by Subject|3|||
49079034|NCT01769456|158124589|FG000|Overall Study|Did not receive PCC intervention|6|||
49079035|NCT01769456|158124589|FG000|Overall Study|Moved out of the area|3|||
49079036|NCT01769456|158124589|FG000|Overall Study|No wk 0 visit w/in 30 days of screening|5|||
49079037|NCT01769456|158124589|FG000|Overall Study|Parental request to youth to withdraw|1|||
49079038|NCT01403051|158124590|FG000|Overall Study|Protocol Violation|2|||
49079039|NCT01403051|158124591|FG001|Overall Study|Protocol Violation|0|||
49079040|NCT01403051|158124590|FG000|Overall Study|Death|1|||
49079041|NCT01403051|158124591|FG001|Overall Study|Death|0|||
49079042|NCT01403051|158124590|FG000|Overall Study|Withdrawal by Subject|2|||
49079043|NCT01403051|158124591|FG001|Overall Study|Withdrawal by Subject|1|||
49079044|NCT01403051|158124590|FG000|Overall Study|Lost to Follow-up|5|||
49079045|NCT01403051|158124591|FG001|Overall Study|Lost to Follow-up|5|||
49079046|NCT03971474|158124597|FG000|Overall Study|Adverse Event|11|||
49079047|NCT03971474|158124598|FG001|Overall Study|Adverse Event|7|||
49079048|NCT03971474|158124597|FG000|Overall Study|Refusal unrelated to adverse event|5|||
49079049|NCT03971474|158124598|FG001|Overall Study|Refusal unrelated to adverse event|1|||
49079050|NCT03971474|158124597|FG000|Overall Study|Progression/relapse|40|||
49079051|NCT03971474|158124598|FG001|Overall Study|Progression/relapse|47|||
49079052|NCT03971474|158124597|FG000|Overall Study|Death|6|||
49079053|NCT03971474|158124598|FG001|Overall Study|Death|3|||
49079054|NCT03971474|158124597|FG000|Overall Study|Other - not protocol specified|5|||
49079055|NCT03971474|158124598|FG001|Overall Study|Other - not protocol specified|4|||
49079056|NCT03971474|158124597|FG000|Overall Study|On treatment|0|||
49079057|NCT03971474|158124598|FG001|Overall Study|On treatment|7|||
49079058|NCT01811472|158124600|FG000|Overall Study|Adverse Event|1|||
49079059|NCT01811472|158124601|FG001|Overall Study|Adverse Event|0|||
49079060|NCT01811472|158124602|FG002|Overall Study|Adverse Event|4|||
49079061|NCT01811472|158124600|FG000|Overall Study|Lost to Follow-up|0|||
49079062|NCT01811472|158124601|FG001|Overall Study|Lost to Follow-up|0|||
49079063|NCT01811472|158124602|FG002|Overall Study|Lost to Follow-up|1|||
49079064|NCT01811472|158124600|FG000|Overall Study|Subject/guardian decision|1|||
49079065|NCT01811472|158124601|FG001|Overall Study|Subject/guardian decision|0|||
49079066|NCT01811472|158124602|FG002|Overall Study|Subject/guardian decision|0|||
49079067|NCT03288714|158124605|FG000|Overall Study|Lost to Follow-up|2|||
49079068|NCT03288714|158124606|FG001|Overall Study|Lost to Follow-up|1|||
49079069|NCT03288714|158124605|FG000|Overall Study|Non-compliance with study schedule|2|||
49079070|NCT03288714|158124606|FG001|Overall Study|Non-compliance with study schedule|0|||
49079071|NCT03288714|158124605|FG000|Overall Study|Withdrawal by Subject|3|||
49079072|NCT03288714|158124606|FG001|Overall Study|Withdrawal by Subject|1|||
49079073|NCT03288714|158124605|FG000|Overall Study|Clinical Worsening|2|||
49079074|NCT03288714|158124606|FG001|Overall Study|Clinical Worsening|1|||
49079075|NCT03288714|158124605|FG000|Overall Study|Adverse Event|1|||
49079076|NCT03288714|158124606|FG001|Overall Study|Adverse Event|0|||
49079077|NCT01023035|158124607|FG000|Treatment Period|Adverse Event|27|||
49079078|NCT01023035|158124608|FG001|Treatment Period|Adverse Event|32|||
49079079|NCT01023035|158124609|FG002|Treatment Period|Adverse Event|50|||
49079080|NCT01023035|158124607|FG000|Treatment Period|Non-Medical Reasons|19|||
49079081|NCT01023035|158124608|FG001|Treatment Period|Non-Medical Reasons|22|||
49079082|NCT01023035|158124609|FG002|Treatment Period|Non-Medical Reasons|44|||
49079083|NCT01023035|158124607|FG000|Treatment Period|Treatment Failure|26|||
49079084|NCT01023035|158124608|FG001|Treatment Period|Treatment Failure|31|||
49079085|NCT01023035|158124609|FG002|Treatment Period|Treatment Failure|24|||
49079086|NCT01023035|158124607|FG000|Follow-up Period (up to Week 72)|Adverse Event|2|||
49079087|NCT01023035|158124608|FG001|Follow-up Period (up to Week 72)|Adverse Event|0|||
49079088|NCT01023035|158124609|FG002|Follow-up Period (up to Week 72)|Adverse Event|1|||
49079089|NCT01023035|158124607|FG000|Follow-up Period (up to Week 72)|Non-medical Reason|26|||
49079090|NCT01023035|158124608|FG001|Follow-up Period (up to Week 72)|Non-medical Reason|28|||
49079091|NCT01023035|158124609|FG002|Follow-up Period (up to Week 72)|Non-medical Reason|38|||
49079092|NCT01807065|158124610|FG000|Overall Study|Receive no sip-T due to IV access|1|||
49079093|NCT01807065|158124611|FG001|Overall Study|Receive no sip-T due to IV access|1|||
49079094|NCT01153425|158124614|FG000|Overall Study|Withdrawal by Subject|3|||
49079095|NCT01153425|158124615|FG001|Overall Study|Withdrawal by Subject|3|||
49079096|NCT02789137|158124618|FG000|Overall Study|Dropped out/Died|58|||
49079097|NCT01937871|158124619|FG000|Overall Study|Adverse Event|6|||
49079098|NCT01937871|158124620|FG001|Overall Study|Adverse Event|6|||
49079099|NCT01937871|158124621|FG002|Overall Study|Adverse Event|2|||
49079100|NCT01937871|158124619|FG000|Overall Study|Lost to Follow-up|8|||
49079101|NCT01937871|158124620|FG001|Overall Study|Lost to Follow-up|2|||
49079102|NCT01937871|158124621|FG002|Overall Study|Lost to Follow-up|4|||
49079103|NCT01937871|158124619|FG000|Overall Study|Withdrawal by Subject|9|||
49079104|NCT01937871|158124620|FG001|Overall Study|Withdrawal by Subject|6|||
49079105|NCT01937871|158124621|FG002|Overall Study|Withdrawal by Subject|4|||
49079106|NCT01937871|158124619|FG000|Overall Study|Physician Decision|0|||
49079107|NCT01937871|158124620|FG001|Overall Study|Physician Decision|1|||
49079108|NCT01937871|158124621|FG002|Overall Study|Physician Decision|0|||
49079109|NCT01937871|158124619|FG000|Overall Study|Entry Criteria Not Met|1|||
49079110|NCT01937871|158124620|FG001|Overall Study|Entry Criteria Not Met|2|||
49079111|NCT01937871|158124621|FG002|Overall Study|Entry Criteria Not Met|1|||
49079112|NCT00970593|158124630|FG000|Overall Study|Adverse Event|1|||
49079113|NCT00970593|158124631|FG001|Overall Study|Adverse Event|1|||
49079114|NCT00970593|158124632|FG002|Overall Study|Adverse Event|0|||
49079115|NCT00970593|158124633|FG003|Overall Study|Adverse Event|0|||
49079116|NCT00970593|158124634|FG004|Overall Study|Adverse Event|0|||
49079117|NCT00970593|158124635|FG005|Overall Study|Adverse Event|0|||
49079118|NCT00970593|158124636|FG006|Overall Study|Adverse Event|0|||
49079119|NCT00970593|158124630|FG000|Overall Study|Discontinuation of study by sponsor|0|||
49079120|NCT00970593|158124631|FG001|Overall Study|Discontinuation of study by sponsor|0|||
49079121|NCT00970593|158124632|FG002|Overall Study|Discontinuation of study by sponsor|5|||
49079122|NCT00970593|158124633|FG003|Overall Study|Discontinuation of study by sponsor|0|||
49079123|NCT00970593|158124634|FG004|Overall Study|Discontinuation of study by sponsor|0|||
49079124|NCT00970593|158124635|FG005|Overall Study|Discontinuation of study by sponsor|0|||
49079125|NCT00970593|158124636|FG006|Overall Study|Discontinuation of study by sponsor|2|||
49079126|NCT00970593|158124630|FG000|Overall Study|Withdrawal by Subject|0|||
49079127|NCT00970593|158124631|FG001|Overall Study|Withdrawal by Subject|0|||
49079128|NCT00970593|158124632|FG002|Overall Study|Withdrawal by Subject|1|||
49079129|NCT00970593|158124633|FG003|Overall Study|Withdrawal by Subject|0|||
49079130|NCT00970593|158124634|FG004|Overall Study|Withdrawal by Subject|0|||
49079131|NCT00970593|158124635|FG005|Overall Study|Withdrawal by Subject|0|||
49079132|NCT00970593|158124636|FG006|Overall Study|Withdrawal by Subject|0|||
49079133|NCT00524420|158124637|FG000|Overall Study|Lack of Efficacy|1|||
49079134|NCT00524420|158124638|FG001|Overall Study|Lack of Efficacy|0|||
49079135|NCT00577863|158124639|FG000|Overall Study|Adverse Event|4|||
49079136|NCT00577863|158124640|FG001|Overall Study|Adverse Event|2|||
49079137|NCT00577863|158124639|FG000|Overall Study|Death|1|||
49079138|NCT00577863|158124640|FG001|Overall Study|Death|0|||
49079139|NCT00577863|158124639|FG000|Overall Study|Lost to Follow-up|2|||
49079140|NCT00577863|158124640|FG001|Overall Study|Lost to Follow-up|2|||
49079141|NCT00577863|158124639|FG000|Overall Study|Entry Criteria Exclusion|1|||
49079142|NCT00577863|158124640|FG001|Overall Study|Entry Criteria Exclusion|0|||
49079143|NCT00577863|158124639|FG000|Overall Study|Withdrawal by Subject|0|||
49079144|NCT00577863|158124640|FG001|Overall Study|Withdrawal by Subject|2|||
49079145|NCT00577863|158124639|FG000|Overall Study|Sponsor Decision|2|||
49079146|NCT00577863|158124640|FG001|Overall Study|Sponsor Decision|7|||
49079147|NCT00577863|158124639|FG000|Overall Study|Did Not Receive at Least One Injection|0|||
49079148|NCT00577863|158124640|FG001|Overall Study|Did Not Receive at Least One Injection|1|||
49079149|NCT01482312|158124644|FG000|Period 1, 90 Minutes of Wear|Other|1|||
49079150|NCT01482312|158124645|FG001|Period 1, 90 Minutes of Wear|Other|0|||
49079151|NCT01482312|158124646|FG002|Period 1, 90 Minutes of Wear|Other|0|||
49079152|NCT01482312|158124644|FG000|Period 2, 90 Minutes of Wear|Other|1|||
49079153|NCT01482312|158124645|FG001|Period 2, 90 Minutes of Wear|Other|0|||
49079154|NCT01482312|158124646|FG002|Period 2, 90 Minutes of Wear|Other|0|||
49079155|NCT02738138|158124652|FG000|Overall Study|Adverse Event|0|||
49079156|NCT02738138|158124653|FG001|Overall Study|Adverse Event|1|||
49079157|NCT02738138|158124652|FG000|Overall Study|Lost to Follow-up|2|||
49079158|NCT02738138|158124653|FG001|Overall Study|Lost to Follow-up|0|||
49079159|NCT02738138|158124652|FG000|Overall Study|Other - not further specified|1|||
49079160|NCT02738138|158124653|FG001|Overall Study|Other - not further specified|0|||
49079161|NCT00613171|158124656|FG000|Overall Study|Adverse Event|7|||
49079162|NCT00613171|158124656|FG000|Overall Study|Withdrawal by Subject|3|||
49079163|NCT00613171|158124656|FG000|Overall Study|Reason not Specified|4|||
49079164|NCT03154125|158124657|FG000|Overall Study|Lost to Follow-up|11|||
49079165|NCT03154125|158124658|FG001|Overall Study|Lost to Follow-up|11|||
49079166|NCT03154125|158124659|FG002|Overall Study|Lost to Follow-up|0|||
49079167|NCT03154125|158124657|FG000|Overall Study|Withdrawal by Subject|49|||
49079168|NCT03154125|158124658|FG001|Overall Study|Withdrawal by Subject|55|||
49079169|NCT03154125|158124659|FG002|Overall Study|Withdrawal by Subject|8|||
49079170|NCT03154125|158124657|FG000|Overall Study|Physician Decision|13|||
49079171|NCT03154125|158124658|FG001|Overall Study|Physician Decision|6|||
49079172|NCT03154125|158124659|FG002|Overall Study|Physician Decision|0|||
49079173|NCT03154125|158124657|FG000|Overall Study|Protocol Violation|3|||
49079174|NCT03154125|158124658|FG001|Overall Study|Protocol Violation|5|||
49079175|NCT03154125|158124659|FG002|Overall Study|Protocol Violation|0|||
49079176|NCT03639779|158124665|FG000|Overall Study|Lost to Follow-up|1|||
49079177|NCT02189837|158124666|FG000|Overall Study|Withdrawal by Subject|2|||
49079178|NCT02189837|158124667|FG001|Overall Study|Withdrawal by Subject|1|||
49079179|NCT02189837|158124668|FG002|Overall Study|Withdrawal by Subject|3|||
49079180|NCT02189837|158124669|FG003|Overall Study|Withdrawal by Subject|1|||
49079181|NCT02189837|158124666|FG000|Overall Study|Sponsor Decision|0|||
49079182|NCT02189837|158124667|FG001|Overall Study|Sponsor Decision|0|||
49079183|NCT02189837|158124668|FG002|Overall Study|Sponsor Decision|0|||
49079184|NCT02189837|158124669|FG003|Overall Study|Sponsor Decision|1|||
49079185|NCT00810511|158124672|FG000|Overall Study|Protocol Violation|0|||
49079186|NCT00810511|158124673|FG001|Overall Study|Protocol Violation|1|||
49079187|NCT00810511|158124672|FG000|Overall Study|Lack of Efficacy|9|||
49079188|NCT00810511|158124673|FG001|Overall Study|Lack of Efficacy|1|||
49079189|NCT00810511|158124672|FG000|Overall Study|death in the family|0|||
49079190|NCT00810511|158124673|FG001|Overall Study|death in the family|1|||
49079191|NCT00810511|158124672|FG000|Overall Study|Lost to Follow-up|1|||
49079192|NCT00810511|158124673|FG001|Overall Study|Lost to Follow-up|0|||
49079193|NCT00810511|158124672|FG000|Overall Study|deposits on contact lens|0|||
49079194|NCT00810511|158124673|FG001|Overall Study|deposits on contact lens|1|||
49079195|NCT02088697|158124674|FG000|Period I|Physician Decision|1|||
49079196|NCT02088697|158124675|FG001|Period I|Physician Decision|4|||
49079197|NCT02088697|158124674|FG000|Wash-out Period (at Least 10 Days)|Adverse Event|1|||
49079198|NCT02088697|158124675|FG001|Wash-out Period (at Least 10 Days)|Adverse Event|0|||
49079199|NCT04123405|158124678|FG000|Overall Study|Adverse Event|1|||
49079200|NCT04123405|158124679|FG001|Overall Study|Adverse Event|2|||
49079201|NCT04123405|158124680|FG002|Overall Study|Adverse Event|3|||
49079202|NCT04123405|158124681|FG003|Overall Study|Adverse Event|3|||
49079203|NCT04123405|158124678|FG000|Overall Study|Exclusion criteria met|1|||
49079204|NCT04123405|158124679|FG001|Overall Study|Exclusion criteria met|2|||
49079205|NCT04123405|158124680|FG002|Overall Study|Exclusion criteria met|0|||
49079206|NCT04123405|158124681|FG003|Overall Study|Exclusion criteria met|2|||
49079207|NCT04123405|158124678|FG000|Overall Study|Withdrawal by Subject|1|||
49079208|NCT04123405|158124679|FG001|Overall Study|Withdrawal by Subject|3|||
49079209|NCT04123405|158124680|FG002|Overall Study|Withdrawal by Subject|0|||
49079210|NCT04123405|158124681|FG003|Overall Study|Withdrawal by Subject|2|||
49079211|NCT04123405|158124678|FG000|Overall Study|Contact to subject lost|0|||
49079212|NCT04123405|158124679|FG001|Overall Study|Contact to subject lost|0|||
49079213|NCT04123405|158124680|FG002|Overall Study|Contact to subject lost|0|||
49079214|NCT04123405|158124681|FG003|Overall Study|Contact to subject lost|1|||
49079215|NCT04123405|158124678|FG000|Overall Study|screening failure|1|||
49079216|NCT04123405|158124679|FG001|Overall Study|screening failure|0|||
49079217|NCT04123405|158124680|FG002|Overall Study|screening failure|0|||
49079218|NCT04123405|158124681|FG003|Overall Study|screening failure|0|||
49079219|NCT04578535|158124682|FG000|Overall Study|Lost to Follow-up|1|||
49079220|NCT04578535|158124683|FG001|Overall Study|Lost to Follow-up|0|||
49079221|NCT04578535|158124684|FG002|Overall Study|Lost to Follow-up|0|||
49079222|NCT04578535|158124685|FG003|Overall Study|Lost to Follow-up|1|||
49079223|NCT04578535|158124686|FG004|Overall Study|Lost to Follow-up|0|||
49079224|NCT04578535|158124687|FG005|Overall Study|Lost to Follow-up|2|||
49079225|NCT04578535|158124682|FG000|Overall Study|Pregnancy|1|||
49079226|NCT04578535|158124683|FG001|Overall Study|Pregnancy|0|||
49079227|NCT04578535|158124684|FG002|Overall Study|Pregnancy|0|||
49079228|NCT04578535|158124685|FG003|Overall Study|Pregnancy|0|||
49079229|NCT04578535|158124686|FG004|Overall Study|Pregnancy|0|||
49079230|NCT04578535|158124687|FG005|Overall Study|Pregnancy|0|||
49079231|NCT04578535|158124682|FG000|Overall Study|Withdrawal by Subject|0|||
49079232|NCT04578535|158124683|FG001|Overall Study|Withdrawal by Subject|0|||
49079233|NCT04578535|158124684|FG002|Overall Study|Withdrawal by Subject|0|||
49079234|NCT04578535|158124685|FG003|Overall Study|Withdrawal by Subject|1|||
49079235|NCT04578535|158124686|FG004|Overall Study|Withdrawal by Subject|1|||
49079236|NCT04578535|158124687|FG005|Overall Study|Withdrawal by Subject|5|||
49079237|NCT04578535|158124682|FG000|Overall Study|Non-Compliance with Study Procedures|0|||
49079238|NCT04578535|158124683|FG001|Overall Study|Non-Compliance with Study Procedures|0|||
49079239|NCT04578535|158124684|FG002|Overall Study|Non-Compliance with Study Procedures|0|||
49079240|NCT04578535|158124685|FG003|Overall Study|Non-Compliance with Study Procedures|0|||
49079241|NCT04578535|158124686|FG004|Overall Study|Non-Compliance with Study Procedures|1|||
49079242|NCT04578535|158124687|FG005|Overall Study|Non-Compliance with Study Procedures|0|||
49079243|NCT00490841|158124703|FG000|Overall Study|Death|5|||
49079244|NCT00490841|158124703|FG000|Overall Study|Withdrawal by Subject|4|||
49079245|NCT00490841|158124703|FG000|Overall Study|Lost to Follow-up|1|||
49079246|NCT00490841|158124703|FG000|Overall Study|30 day f/u, only non-study stent used|3|||
49079247|NCT03624192|158124704|FG000|Overall Study|Lost to Follow-up|1|||
49079248|NCT03624192|158124705|FG001|Overall Study|Lost to Follow-up|1|||
49079249|NCT03323398|158124712|FG000|Overall Study|Other than Specified|0|||
49079250|NCT03323398|158124713|FG001|Overall Study|Other than Specified|1|||
49079251|NCT03323398|158124714|FG002|Overall Study|Other than Specified|2|||
49079252|NCT03323398|158124715|FG003|Overall Study|Other than Specified|0|||
49079253|NCT03323398|158124716|FG004|Overall Study|Other than Specified|0|||
49079254|NCT03323398|158124717|FG005|Overall Study|Other than Specified|0|||
49079255|NCT03323398|158124718|FG006|Overall Study|Other than Specified|1|||
49079256|NCT03323398|158124719|FG007|Overall Study|Other than Specified|0|||
49079257|NCT03323398|158124720|FG008|Overall Study|Other than Specified|2|||
49079258|NCT03323398|158124712|FG000|Overall Study|Lost to Follow-up|1|||
49079259|NCT03323398|158124713|FG001|Overall Study|Lost to Follow-up|2|||
49079260|NCT03323398|158124714|FG002|Overall Study|Lost to Follow-up|1|||
49079261|NCT03323398|158124715|FG003|Overall Study|Lost to Follow-up|0|||
49079262|NCT03323398|158124716|FG004|Overall Study|Lost to Follow-up|0|||
49079263|NCT03323398|158124717|FG005|Overall Study|Lost to Follow-up|0|||
49079264|NCT03323398|158124718|FG006|Overall Study|Lost to Follow-up|0|||
49079265|NCT03323398|158124719|FG007|Overall Study|Lost to Follow-up|0|||
49079266|NCT03323398|158124720|FG008|Overall Study|Lost to Follow-up|0|||
49079267|NCT03323398|158124712|FG000|Overall Study|Death|4|||
49079268|NCT03323398|158124713|FG001|Overall Study|Death|6|||
49079269|NCT03323398|158124714|FG002|Overall Study|Death|2|||
49079270|NCT03323398|158124715|FG003|Overall Study|Death|2|||
49079271|NCT03323398|158124716|FG004|Overall Study|Death|1|||
49079272|NCT03323398|158124717|FG005|Overall Study|Death|2|||
49079273|NCT03323398|158124718|FG006|Overall Study|Death|0|||
49079274|NCT03323398|158124719|FG007|Overall Study|Death|0|||
49079275|NCT03323398|158124720|FG008|Overall Study|Death|6|||
49079276|NCT03323398|158124712|FG000|Overall Study|Received Alternative Anticancer Therapy|2|||
49079277|NCT03323398|158124713|FG001|Overall Study|Received Alternative Anticancer Therapy|1|||
49079278|NCT03323398|158124714|FG002|Overall Study|Received Alternative Anticancer Therapy|2|||
49079279|NCT03323398|158124715|FG003|Overall Study|Received Alternative Anticancer Therapy|0|||
49079280|NCT03323398|158124716|FG004|Overall Study|Received Alternative Anticancer Therapy|0|||
49079281|NCT03323398|158124717|FG005|Overall Study|Received Alternative Anticancer Therapy|0|||
49079282|NCT03323398|158124718|FG006|Overall Study|Received Alternative Anticancer Therapy|0|||
49079283|NCT03323398|158124719|FG007|Overall Study|Received Alternative Anticancer Therapy|0|||
49079284|NCT03323398|158124720|FG008|Overall Study|Received Alternative Anticancer Therapy|0|||
49079285|NCT03323398|158124712|FG000|Overall Study|Withdrawal by Subject|2|||
49079286|NCT03323398|158124713|FG001|Overall Study|Withdrawal by Subject|1|||
49079287|NCT03323398|158124714|FG002|Overall Study|Withdrawal by Subject|3|||
49079288|NCT03323398|158124715|FG003|Overall Study|Withdrawal by Subject|0|||
49079289|NCT03323398|158124716|FG004|Overall Study|Withdrawal by Subject|0|||
49079290|NCT03323398|158124717|FG005|Overall Study|Withdrawal by Subject|1|||
49079291|NCT03323398|158124718|FG006|Overall Study|Withdrawal by Subject|0|||
49079292|NCT03323398|158124719|FG007|Overall Study|Withdrawal by Subject|0|||
49079293|NCT03323398|158124720|FG008|Overall Study|Withdrawal by Subject|0|||
49079294|NCT03323398|158124712|FG000|Overall Study|Participant was Put on Hospice|0|||
49079295|NCT03323398|158124713|FG001|Overall Study|Participant was Put on Hospice|0|||
49079296|NCT03323398|158124714|FG002|Overall Study|Participant was Put on Hospice|0|||
49079297|NCT03323398|158124715|FG003|Overall Study|Participant was Put on Hospice|0|||
49079298|NCT03323398|158124716|FG004|Overall Study|Participant was Put on Hospice|0|||
49079299|NCT03323398|158124717|FG005|Overall Study|Participant was Put on Hospice|0|||
49079300|NCT03323398|158124718|FG006|Overall Study|Participant was Put on Hospice|1|||
49079301|NCT03323398|158124719|FG007|Overall Study|Participant was Put on Hospice|0|||
49079302|NCT03323398|158124720|FG008|Overall Study|Participant was Put on Hospice|0|||
49079303|NCT03323398|158124712|FG000|Overall Study|Discontinued Following Discussion with Physician|0|||
49079304|NCT03323398|158124713|FG001|Overall Study|Discontinued Following Discussion with Physician|0|||
49079305|NCT03323398|158124714|FG002|Overall Study|Discontinued Following Discussion with Physician|0|||
49079306|NCT03323398|158124715|FG003|Overall Study|Discontinued Following Discussion with Physician|0|||
49079307|NCT03323398|158124716|FG004|Overall Study|Discontinued Following Discussion with Physician|0|||
49079308|NCT03323398|158124717|FG005|Overall Study|Discontinued Following Discussion with Physician|0|||
49079309|NCT03323398|158124718|FG006|Overall Study|Discontinued Following Discussion with Physician|0|||
49079310|NCT03323398|158124719|FG007|Overall Study|Discontinued Following Discussion with Physician|1|||
49079311|NCT03323398|158124720|FG008|Overall Study|Discontinued Following Discussion with Physician|0|||
49079312|NCT03567980|158124725|FG000|Overall Study|Adverse Event|1|||
49079313|NCT03296527|158124726|FG000|Overall Study|Adverse Event|15|||
49079314|NCT03296527|158124727|FG001|Overall Study|Adverse Event|33|||
49079315|NCT03296527|158124726|FG000|Overall Study|Protocol Deviation|4|||
49079316|NCT03296527|158124727|FG001|Overall Study|Protocol Deviation|0|||
49079317|NCT03296527|158124726|FG000|Overall Study|Participant withdrew consent|3|||
49079318|NCT03296527|158124727|FG001|Overall Study|Participant withdrew consent|1|||
49079319|NCT03296527|158124726|FG000|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9|||
49079320|NCT03296527|158124727|FG001|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14|||
49079321|NCT03296527|158124726|FG000|Overall Study|Discontinuations due to withdrawal from trial|2|||
49079322|NCT03296527|158124727|FG001|Overall Study|Discontinuations due to withdrawal from trial|3|||
49079323|NCT03296527|158124726|FG000|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0|||
49079324|NCT03296527|158124727|FG001|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2|||
49079325|NCT03296527|158124726|FG000|Overall Study|Discontinuation due to liquid in uterus|1|||
49079326|NCT03296527|158124727|FG001|Overall Study|Discontinuation due to liquid in uterus|0|||
49079327|NCT03296527|158124726|FG000|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1|||
49079328|NCT03296527|158124727|FG001|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0|||
49079329|NCT01610492|158124728|FG000|Overall Study|Adverse Event|1|||
49079330|NCT01610492|158124728|FG000|Overall Study|Lack of Efficacy|3|||
49079331|NCT01610492|158124728|FG000|Overall Study|Other: Reached stopping criteria|1|||
49079332|NCT01610492|158124728|FG000|Overall Study|Other:Treatment stopped due to remission|1|||
49079333|NCT01757275|158124732|FG000|Overall Study|Lost to Follow-up|1|||
49079334|NCT01757275|158124733|FG001|Overall Study|Lost to Follow-up|2|||
49079335|NCT01757275|158124732|FG000|Overall Study|Adverse Event|3|||
49079336|NCT01757275|158124733|FG001|Overall Study|Adverse Event|3|||
49079337|NCT01757275|158124732|FG000|Overall Study|Withdrawal by Subject|2|||
49079338|NCT01757275|158124733|FG001|Overall Study|Withdrawal by Subject|4|||
49079339|NCT01757275|158124732|FG000|Overall Study|Not treated|3|||
49079340|NCT01757275|158124733|FG001|Overall Study|Not treated|4|||
49079341|NCT03093259|158124734|FG000|Overall Study|Adverse Event|1|||
49079342|NCT03093259|158124735|FG001|Overall Study|Adverse Event|0|||
49079343|NCT03093259|158124734|FG000|Overall Study|Withdrawal by Subject|1|||
49079344|NCT03093259|158124735|FG001|Overall Study|Withdrawal by Subject|0|||
49079345|NCT02575833|158124736|FG000|Overall Study|Withdrawal by Subject|0|||
49079346|NCT02575833|158124737|FG001|Overall Study|Withdrawal by Subject|1|||
49079347|NCT02575833|158124736|FG000|Overall Study|Lost to Follow-up|1|||
49079348|NCT02575833|158124737|FG001|Overall Study|Lost to Follow-up|0|||
49079349|NCT04782076|158124740|FG000|Overall Study|Family Emergency|1|||
49079350|NCT01154231|158124741|FG000|Overall Study|Safety Unassessable, No Drug Admin.|1|||
49079351|NCT01154231|158124741|FG000|Overall Study|No Info. After 1st Day, No Drug Admin.|1|||
49079352|NCT01200069|158126433|FG000|Overall Study|Withdrawal by Subject|0|||
49079353|NCT01200069|158126434|FG001|Overall Study|Withdrawal by Subject|1|||
49079354|NCT01042093|158126435|FG000|Overall Study|Protocol Violation|2|||
49079355|NCT01042093|158126436|FG001|Overall Study|Protocol Violation|2|||
49079356|NCT01042093|158126437|FG002|Overall Study|Protocol Violation|2|||
49079357|NCT01042093|158126438|FG003|Overall Study|Protocol Violation|3|||
49079358|NCT01042093|158126435|FG000|Overall Study|Withdrawal by Subject|0|||
49079359|NCT01042093|158126436|FG001|Overall Study|Withdrawal by Subject|0|||
49079360|NCT01042093|158126437|FG002|Overall Study|Withdrawal by Subject|0|||
49079361|NCT01042093|158126438|FG003|Overall Study|Withdrawal by Subject|1|||
49079362|NCT00266630|158126447|FG000|Overall Study|Adverse Event|8|||
49079363|NCT00266630|158126448|FG001|Overall Study|Adverse Event|6|||
49079364|NCT00266630|158126447|FG000|Overall Study|Lack of Efficacy|1|||
49079365|NCT00266630|158126448|FG001|Overall Study|Lack of Efficacy|4|||
49079366|NCT00266630|158126447|FG000|Overall Study|Entry Criteria not met|1|||
49079367|NCT00266630|158126448|FG001|Overall Study|Entry Criteria not met|0|||
49079368|NCT00266630|158126447|FG000|Overall Study|Protocol Violation|1|||
49079369|NCT00266630|158126448|FG001|Overall Study|Protocol Violation|3|||
49079370|NCT00266630|158126447|FG000|Overall Study|Physician Decision|1|||
49079371|NCT00266630|158126448|FG001|Overall Study|Physician Decision|2|||
49079372|NCT00266630|158126447|FG000|Overall Study|Withdrawal by Subject|10|||
49079373|NCT00266630|158126448|FG001|Overall Study|Withdrawal by Subject|2|||
49079374|NCT00266630|158126447|FG000|Overall Study|Lost to Follow-up|1|||
49079375|NCT00266630|158126448|FG001|Overall Study|Lost to Follow-up|0|||
49079376|NCT00266630|158126447|FG000|Overall Study|Other|19|||
49079377|NCT00266630|158126448|FG001|Overall Study|Other|11|||
49079378|NCT03410056|158126449|FG000|Overall Study|Decision by Sponsor|0|||
49079379|NCT03410056|158126450|FG001|Overall Study|Decision by Sponsor|0|||
49079380|NCT03410056|158126451|FG002|Overall Study|Decision by Sponsor|3|||
49079381|NCT03410056|158126452|FG003|Overall Study|Decision by Sponsor|0|||
49079382|NCT03410056|158126453|FG004|Overall Study|Decision by Sponsor|0|||
49079383|NCT03410056|158126454|FG005|Overall Study|Decision by Sponsor|0|||
49079384|NCT03410056|158126455|FG006|Overall Study|Decision by Sponsor|0|||
49079385|NCT03410056|158126449|FG000|Overall Study|Withdrawal by Subject|0|||
49079386|NCT03410056|158126450|FG001|Overall Study|Withdrawal by Subject|2|||
49079387|NCT03410056|158126451|FG002|Overall Study|Withdrawal by Subject|5|||
49079388|NCT03410056|158126452|FG003|Overall Study|Withdrawal by Subject|5|||
49079389|NCT03410056|158126453|FG004|Overall Study|Withdrawal by Subject|0|||
49079390|NCT03410056|158126454|FG005|Overall Study|Withdrawal by Subject|0|||
49079391|NCT03410056|158126455|FG006|Overall Study|Withdrawal by Subject|0|||
49079392|NCT01699815|158126469|FG000|Overall Study|Protocol Violation|4|||
49079393|NCT01699815|158126470|FG001|Overall Study|Protocol Violation|7|||
49079394|NCT01699815|158126469|FG000|Overall Study|record could not be located|1|||
49079395|NCT01699815|158126470|FG001|Overall Study|record could not be located|0|||
49079396|NCT01699815|158126469|FG000|Overall Study|Adverse Event|0|||
49079397|NCT01699815|158126470|FG001|Overall Study|Adverse Event|1|||
49079398|NCT02501928|158126471|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
49079399|NCT02501928|158126472|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
49079400|NCT02501928|158126473|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
49079401|NCT02501928|158126474|FG003|Overall Study|Withdrawal By Parent/Guardian|0|||
49079402|NCT02501928|158126475|FG004|Overall Study|Withdrawal By Parent/Guardian|1|||
49079403|NCT02501928|158126476|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
49079404|NCT00344448|158126479|FG000|Screening|Withdrawal by Subject|0|||
49079405|NCT00344448|158126480|FG001|Screening|Withdrawal by Subject|1|||
49079406|NCT00344448|158126479|FG000|Double Blind, Placebo Controlled|Withdrawal by Subject|1|||
49079407|NCT00344448|158126480|FG001|Double Blind, Placebo Controlled|Withdrawal by Subject|0|||
49079408|NCT00344448|158126479|FG000|Double Blind, Placebo Controlled|Study terminated|1|||
49079409|NCT00344448|158126480|FG001|Double Blind, Placebo Controlled|Study terminated|0|||
49079410|NCT00344448|158126479|FG000|Open Label|Withdrawal by Subject|1|||
49079411|NCT00344448|158126480|FG001|Open Label|Withdrawal by Subject|1|||
49079412|NCT00344448|158126479|FG000|Open Label|Study terminated|1|||
49079413|NCT00344448|158126480|FG001|Open Label|Study terminated|0|||
49079414|NCT03305848|158126485|FG000|Overall Study|Symptom resolution after consent, but before study drug administration|1|||
49079415|NCT03305848|158126485|FG000|Overall Study|Physician Decision|2|||
49079416|NCT02203357|158126486|FG000|Overall Study|Lost to Follow-up|58|||
49079417|NCT02203357|158126487|FG001|Overall Study|Lost to Follow-up|66|||
49079418|NCT02203357|158126488|FG002|Overall Study|Lost to Follow-up|70|||
49079419|NCT00356525|158126490|FG000|Overall Study|Progressive Disease|8|||
49079420|NCT00356525|158126491|FG001|Overall Study|Progressive Disease|5|||
49079421|NCT00356525|158126492|FG002|Overall Study|Progressive Disease|4|||
49079422|NCT00356525|158126493|FG003|Overall Study|Progressive Disease|2|||
49079423|NCT00356525|158126490|FG000|Overall Study|Adverse Event|1|||
49079424|NCT00356525|158126491|FG001|Overall Study|Adverse Event|3|||
49079425|NCT00356525|158126492|FG002|Overall Study|Adverse Event|1|||
49079426|NCT00356525|158126493|FG003|Overall Study|Adverse Event|1|||
49079427|NCT00356525|158126490|FG000|Overall Study|Lost to Follow-up|1|||
49079428|NCT00356525|158126491|FG001|Overall Study|Lost to Follow-up|0|||
49079429|NCT00356525|158126492|FG002|Overall Study|Lost to Follow-up|0|||
49079430|NCT00356525|158126493|FG003|Overall Study|Lost to Follow-up|0|||
49079431|NCT00356525|158126490|FG000|Overall Study|Physician Decision|2|||
49079432|NCT00356525|158126491|FG001|Overall Study|Physician Decision|2|||
49079433|NCT00356525|158126492|FG002|Overall Study|Physician Decision|2|||
49079434|NCT00356525|158126493|FG003|Overall Study|Physician Decision|1|||
49079435|NCT00356525|158126490|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
49079436|NCT00356525|158126491|FG001|Overall Study|Protocol Entry Criteria Not Met|0|||
49079437|NCT00356525|158126492|FG002|Overall Study|Protocol Entry Criteria Not Met|0|||
49079438|NCT00356525|158126493|FG003|Overall Study|Protocol Entry Criteria Not Met|0|||
49079439|NCT00356525|158126490|FG000|Overall Study|Withdrawal by Subject|1|||
49079440|NCT00356525|158126491|FG001|Overall Study|Withdrawal by Subject|1|||
49079441|NCT00356525|158126492|FG002|Overall Study|Withdrawal by Subject|0|||
49079442|NCT00356525|158126493|FG003|Overall Study|Withdrawal by Subject|3|||
49079443|NCT00356525|158126490|FG000|Overall Study|Death|0|||
49079444|NCT00356525|158126491|FG001|Overall Study|Death|0|||
49079445|NCT00356525|158126492|FG002|Overall Study|Death|0|||
49079446|NCT00356525|158126493|FG003|Overall Study|Death|1|||
49079447|NCT00356525|158126490|FG000|Overall Study|Sponsor Decision|0|||
49079448|NCT00356525|158126491|FG001|Overall Study|Sponsor Decision|0|||
49079449|NCT00356525|158126492|FG002|Overall Study|Sponsor Decision|0|||
49079450|NCT00356525|158126493|FG003|Overall Study|Sponsor Decision|1|||
49079451|NCT01597778|158126510|FG000|Overall Study|Death|7|||
49079452|NCT01597778|158126511|FG001|Overall Study|Death|10|||
49079453|NCT01597778|158126510|FG000|Overall Study|Withdrawal by Subject|3|||
49079454|NCT01597778|158126511|FG001|Overall Study|Withdrawal by Subject|4|||
49079455|NCT01597778|158126510|FG000|Overall Study|Adverse Event|1|||
49079456|NCT01597778|158126511|FG001|Overall Study|Adverse Event|1|||
49079457|NCT01597778|158126510|FG000|Overall Study|Protocol Violation|1|||
49079458|NCT01597778|158126511|FG001|Overall Study|Protocol Violation|11|||
49079459|NCT01597778|158126510|FG000|Overall Study|Transplanted off protocol|2|||
49079460|NCT01597778|158126511|FG001|Overall Study|Transplanted off protocol|3|||
49079461|NCT02413229|158126517|FG000|Overall Study|Adverse Event|0|||
49079462|NCT02413229|158126518|FG001|Overall Study|Adverse Event|0|||
49079463|NCT02413229|158126519|FG002|Overall Study|Adverse Event|0|||
49079464|NCT02413229|158126520|FG003|Overall Study|Adverse Event|1|||
49079465|NCT02413229|158126521|FG004|Overall Study|Adverse Event|0|||
49079466|NCT02413229|158126522|FG005|Overall Study|Adverse Event|0|||
49079467|NCT02413229|158126523|FG006|Overall Study|Adverse Event|0|||
49079468|NCT02413229|158126524|FG007|Overall Study|Adverse Event|1|||
49079469|NCT02413229|158126517|FG000|Overall Study|Lost to Follow-up|0|||
49079470|NCT02413229|158126518|FG001|Overall Study|Lost to Follow-up|0|||
49079471|NCT02413229|158126519|FG002|Overall Study|Lost to Follow-up|1|||
49079472|NCT02413229|158126520|FG003|Overall Study|Lost to Follow-up|0|||
49079473|NCT02413229|158126521|FG004|Overall Study|Lost to Follow-up|2|||
49079474|NCT02413229|158126522|FG005|Overall Study|Lost to Follow-up|0|||
49079475|NCT02413229|158126523|FG006|Overall Study|Lost to Follow-up|0|||
49079476|NCT02413229|158126524|FG007|Overall Study|Lost to Follow-up|0|||
49079477|NCT02413229|158126517|FG000|Overall Study|Withdrawal by Subject|1|||
49079478|NCT02413229|158126518|FG001|Overall Study|Withdrawal by Subject|1|||
49079479|NCT02413229|158126519|FG002|Overall Study|Withdrawal by Subject|0|||
49079480|NCT02413229|158126520|FG003|Overall Study|Withdrawal by Subject|0|||
49079481|NCT02413229|158126521|FG004|Overall Study|Withdrawal by Subject|1|||
49079482|NCT02413229|158126522|FG005|Overall Study|Withdrawal by Subject|0|||
49079483|NCT02413229|158126523|FG006|Overall Study|Withdrawal by Subject|0|||
49079484|NCT02413229|158126524|FG007|Overall Study|Withdrawal by Subject|2|||
49079485|NCT02413229|158126517|FG000|Overall Study|Progressive Disease|0|||
49079486|NCT02413229|158126518|FG001|Overall Study|Progressive Disease|0|||
49079487|NCT02413229|158126519|FG002|Overall Study|Progressive Disease|0|||
49079488|NCT02413229|158126520|FG003|Overall Study|Progressive Disease|0|||
49079489|NCT02413229|158126521|FG004|Overall Study|Progressive Disease|0|||
49079490|NCT02413229|158126522|FG005|Overall Study|Progressive Disease|0|||
49079491|NCT02413229|158126523|FG006|Overall Study|Progressive Disease|0|||
49079492|NCT02413229|158126524|FG007|Overall Study|Progressive Disease|1|||
49079493|NCT02932462|158126525|FG000|Overall Study|Adverse Event|1|||
49079494|NCT02932462|158126526|FG001|Overall Study|Adverse Event|2|||
49079495|NCT02932462|158126525|FG000|Overall Study|Lost to Follow-up|4|||
49079496|NCT02932462|158126526|FG001|Overall Study|Lost to Follow-up|1|||
49079497|NCT02932462|158126525|FG000|Overall Study|Protocol Violation|0|||
49079498|NCT02932462|158126526|FG001|Overall Study|Protocol Violation|5|||
49079499|NCT02932462|158126525|FG000|Overall Study|Withdrawal by Subject|1|||
49079500|NCT02932462|158126526|FG001|Overall Study|Withdrawal by Subject|4|||
49079501|NCT02932462|158126525|FG000|Overall Study|Non-Compliance With Study Drug|0|||
49079502|NCT02932462|158126526|FG001|Overall Study|Non-Compliance With Study Drug|1|||
49079503|NCT02932462|158126525|FG000|Overall Study|Progressive Disease|1|||
49079504|NCT02932462|158126526|FG001|Overall Study|Progressive Disease|0|||
49079505|NCT00470535|158126527|FG000|Overall Study|Disease Progression|13|||
49079506|NCT00470535|158126527|FG000|Overall Study|Withdrawal by Subject|1|||
49079507|NCT00470535|158126527|FG000|Overall Study|Adverse Event|1|||
49079508|NCT00470535|158126527|FG000|Overall Study|Death|1|||
49079509|NCT00470535|158126527|FG000|Overall Study|Other|2|||
49079510|NCT05024747|158126533|FG000|Period 1 (Day 1 to 2)|Protocol Violation|1|||
49079511|NCT05024747|158126534|FG001|Period 1 (Day 1 to 2)|Protocol Violation|3|||
49079512|NCT05024747|158126533|FG000|Period 1 (Day 1 to 2)|Adverse Event|0|||
49079513|NCT05024747|158126534|FG001|Period 1 (Day 1 to 2)|Adverse Event|1|||
49079514|NCT05024747|158126533|FG000|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|0|||
49079515|NCT05024747|158126534|FG001|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|1|||
49079516|NCT03594071|158126535|FG000|Overall Study|Re-operation|3|||
49079517|NCT03594071|158126535|FG000|Overall Study|Missed visit|2|||
49079518|NCT01750190|158126536|FG000|Overall Study|Adverse Event|47|||
49079519|NCT01750190|158126537|FG001|Overall Study|Adverse Event|19|||
49079520|NCT01750190|158126536|FG000|Overall Study|Death|38|||
49079521|NCT01750190|158126537|FG001|Overall Study|Death|11|||
49079522|NCT01750190|158126536|FG000|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2|||
49079523|NCT01750190|158126537|FG001|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43|||
49079524|NCT01750190|158126536|FG000|Overall Study|Lost to Follow-up|28|||
49079525|NCT01750190|158126537|FG001|Overall Study|Lost to Follow-up|7|||
49079526|NCT01750190|158126536|FG000|Overall Study|Physician Decision|16|||
49079527|NCT01750190|158126537|FG001|Overall Study|Physician Decision|17|||
49079528|NCT01750190|158126536|FG000|Overall Study|Protocol Violation|6|||
49079529|NCT01750190|158126537|FG001|Overall Study|Protocol Violation|5|||
49079530|NCT01750190|158126536|FG000|Overall Study|Study/Site Terminated by Sponsor|4|||
49079531|NCT01750190|158126537|FG001|Overall Study|Study/Site Terminated by Sponsor|1|||
49079532|NCT01750190|158126536|FG000|Overall Study|Withdrawal by Subject|83|||
49079533|NCT01750190|158126537|FG001|Overall Study|Withdrawal by Subject|89|||
49079534|NCT01750190|158126536|FG000|Overall Study|Kidney Transplant|8|||
49079535|NCT01750190|158126537|FG001|Overall Study|Kidney Transplant|4|||
49079536|NCT01750190|158126536|FG000|Overall Study|Dialysis|22|||
49079537|NCT01750190|158126537|FG001|Overall Study|Dialysis|8|||
49079538|NCT01750190|158126536|FG000|Overall Study|Other than Specified|13|||
49079539|NCT01750190|158126537|FG001|Overall Study|Other than Specified|4|||
49079540|NCT02009722|158126538|FG000|Overall Study|Protocol Violation|1|||
49079541|NCT02009722|158126539|FG001|Overall Study|Protocol Violation|2|||
49079542|NCT02009722|158126538|FG000|Overall Study|Did not receive intervention|0|||
49079543|NCT02009722|158126539|FG001|Overall Study|Did not receive intervention|1|||
49079544|NCT02955212|158126540|FG000|Period 1: Double-blind Treatment Period|Adverse Event|4|||
49079545|NCT02955212|158126541|FG001|Period 1: Double-blind Treatment Period|Adverse Event|7|||
49079546|NCT02955212|158126540|FG000|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8|||
49079547|NCT02955212|158126541|FG001|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3|||
49079548|NCT02955212|158126540|FG000|Period 1: Double-blind Treatment Period|Lost to Follow-up|1|||
49079549|NCT02955212|158126541|FG001|Period 1: Double-blind Treatment Period|Lost to Follow-up|0|||
49079550|NCT02955212|158126540|FG000|Period 1: Double-blind Treatment Period|Other|3|||
49079551|NCT02955212|158126541|FG001|Period 1: Double-blind Treatment Period|Other|2|||
49079552|NCT02955212|158126540|FG000|Period 2: Open-label Extension|Adverse Event|11|||
49079553|NCT02955212|158126541|FG001|Period 2: Open-label Extension|Adverse Event|7|||
49079554|NCT02955212|158126540|FG000|Period 2: Open-label Extension|Withdrawal by Subject|1|||
49079555|NCT02955212|158126541|FG001|Period 2: Open-label Extension|Withdrawal by Subject|4|||
49079556|NCT02955212|158126540|FG000|Period 2: Open-label Extension|Lack of Efficacy|3|||
49079557|NCT02955212|158126541|FG001|Period 2: Open-label Extension|Lack of Efficacy|2|||
49079558|NCT02955212|158126540|FG000|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0|||
49079559|NCT02955212|158126541|FG001|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1|||
49079560|NCT02955212|158126540|FG000|Period 2: Open-label Extension|Other|2|||
49079561|NCT02955212|158126541|FG001|Period 2: Open-label Extension|Other|4|||
49079562|NCT02287922|158126542|FG000|Overall Study|Adverse Event|1|||
49079563|NCT02287922|158126543|FG001|Overall Study|Adverse Event|1|||
49079564|NCT02287922|158126544|FG002|Overall Study|Adverse Event|3|||
49079565|NCT02287922|158126545|FG003|Overall Study|Adverse Event|4|||
49079566|NCT02287922|158126542|FG000|Overall Study|Withdrawal by Subject|1|||
49079567|NCT02287922|158126543|FG001|Overall Study|Withdrawal by Subject|1|||
49079568|NCT02287922|158126544|FG002|Overall Study|Withdrawal by Subject|1|||
49079569|NCT02287922|158126545|FG003|Overall Study|Withdrawal by Subject|2|||
49079570|NCT02287922|158126542|FG000|Overall Study|Lost to Follow-up|0|||
49079571|NCT02287922|158126543|FG001|Overall Study|Lost to Follow-up|0|||
49079572|NCT02287922|158126544|FG002|Overall Study|Lost to Follow-up|1|||
49079573|NCT02287922|158126545|FG003|Overall Study|Lost to Follow-up|0|||
49079574|NCT02287922|158126542|FG000|Overall Study|Sponsor's decision|0|||
49079575|NCT02287922|158126543|FG001|Overall Study|Sponsor's decision|0|||
49079576|NCT02287922|158126544|FG002|Overall Study|Sponsor's decision|0|||
49079577|NCT02287922|158126545|FG003|Overall Study|Sponsor's decision|1|||
49079578|NCT02287922|158126542|FG000|Overall Study|Other|1|||
49079579|NCT02287922|158126543|FG001|Overall Study|Other|0|||
49079580|NCT02287922|158126544|FG002|Overall Study|Other|2|||
49079581|NCT02287922|158126545|FG003|Overall Study|Other|0|||
49079582|NCT01108718|158126546|FG000|Received Second Intervention (2 Months)|Withdrawal by Subject|1|||
49079583|NCT01108718|158126547|FG001|Received Second Intervention (2 Months)|Withdrawal by Subject|0|||
49079584|NCT01841593|158126548|FG000|First Intervention (Days 1 to 7)|Protocol Violation|0|||
49079585|NCT01841593|158126549|FG001|First Intervention (Days 1 to 7)|Protocol Violation|1|||
49079586|NCT01841593|158126548|FG000|Second Intervention (Days 8 to 14)|Adverse Event|1|||
49079587|NCT01841593|158126549|FG001|Second Intervention (Days 8 to 14)|Adverse Event|0|||
49079588|NCT02756611|158126550|FG000|Overall Study|Death|70|||
49079589|NCT02756611|158126550|FG000|Overall Study|Withdrawal by Subject|2|||
49079590|NCT02756611|158126550|FG000|Overall Study|Lost to Follow-up|3|||
49079591|NCT02756611|158126550|FG000|Overall Study|Transitioned to Long-term Extension Study M19-388 (NCT03844048)|49|||
49079592|NCT02756611|158126550|FG000|Overall Study|Other|10|||
49079593|NCT00550459|158126574|FG000|Overall Study|Adverse Event|0|||
49079594|NCT00550459|158126575|FG001|Overall Study|Adverse Event|2|||
49079595|NCT00550459|158126574|FG000|Overall Study|Withdrawal by Subject|1|||
49079596|NCT00550459|158126575|FG001|Overall Study|Withdrawal by Subject|1|||
49079597|NCT01401452|158126576|FG000|Overall Study|Adverse reaction|9|||
49079598|NCT01401452|158126576|FG000|Overall Study|Lost to Follow-up|12|||
49079599|NCT01401452|158126576|FG000|Overall Study|Lack of Efficacy|30|||
49079600|NCT01401452|158126576|FG000|Overall Study|Participant developed breast cancer|1|||
49079601|NCT01401452|158126576|FG000|Overall Study|Tx stopped due to financial reasons|1|||
49079602|NCT01401452|158126576|FG000|Overall Study|Tx stopped by psychiatrist|1|||
49079603|NCT01401452|158126576|FG000|Overall Study|No more visits within the 36 wk followup|4|||
49079604|NCT01401452|158126576|FG000|Overall Study|Subject did not come to follow up visits|2|||
49079605|NCT01401452|158126576|FG000|Overall Study|Subject didn't return for routine visits|1|||
49079606|NCT01401452|158126576|FG000|Overall Study|Subject moved to another city|1|||
49079607|NCT01401452|158126576|FG000|Overall Study|Subject's wife wants to get pregnant|1|||
49079608|NCT01401452|158126576|FG000|Overall Study|Psoriatic arthritis|1|||
49079609|NCT01401452|158126576|FG000|Overall Study|Participant stopped Tx|2|||
49079610|NCT01401452|158126576|FG000|Overall Study|Discontinuation for personal reasons|1|||
49079611|NCT01401452|158126576|FG000|Overall Study|Treatment failure|1|||
49079612|NCT01401452|158126576|FG000|Overall Study|Unsatisfactory output|1|||
49079613|NCT01401452|158126576|FG000|Overall Study|Subject withdrew because of Tx success|1|||
49079614|NCT01401452|158126576|FG000|Overall Study|Subject chose to discontinue treatment|1|||
49079615|NCT01401452|158126576|FG000|Overall Study|Participant withdrew consent|1|||
49079616|NCT01742897|158126577|FG000|Overall Study|Adverse Event|3|||
49079617|NCT01742897|158126577|FG000|Overall Study|Withdrawal by Subject|1|||
49079618|NCT01742897|158126577|FG000|Overall Study|Other|1|||
49079619|NCT01597973|158126578|FG000|Overall Study|Found ineligible before study medication started|4|||
49079620|NCT01597973|158126579|FG001|Overall Study|Found ineligible before study medication started|2|||
49079621|NCT01597973|158126578|FG000|Overall Study|Eligible pathogen not confirmed|14|||
49079622|NCT01597973|158126579|FG001|Overall Study|Eligible pathogen not confirmed|15|||
49079623|NCT01597973|158126578|FG000|Overall Study|LAR not authorized to consent|0|||
49079624|NCT01597973|158126579|FG001|Overall Study|LAR not authorized to consent|1|||
49079625|NCT01597973|158126578|FG000|Overall Study|Ineligible due to early seizures|1|||
49079626|NCT01597973|158126579|FG001|Overall Study|Ineligible due to early seizures|0|||
49079627|NCT01597973|158126578|FG000|Overall Study|Ineligible due to non-target infection|1|||
49079628|NCT01597973|158126579|FG001|Overall Study|Ineligible due to non-target infection|1|||
49079629|NCT01565889|158126580|FG000|Part A|Withdrawal by Subject|1|||
49079630|NCT01565889|158126581|FG001|Part A|Withdrawal by Subject|0|||
49079631|NCT01565889|158126582|FG002|Part A|Withdrawal by Subject|0|||
49079632|NCT01565889|158126583|FG003|Part A|Withdrawal by Subject|0|||
49079633|NCT01565889|158126584|FG004|Part A|Withdrawal by Subject|0|||
49079634|NCT01565889|158126585|FG005|Part A|Withdrawal by Subject|0|||
49079635|NCT01565889|158126580|FG000|Part B|Withdrawal by Subject|0|||
49079636|NCT01565889|158126581|FG001|Part B|Withdrawal by Subject|0|||
49079637|NCT01565889|158126582|FG002|Part B|Withdrawal by Subject|0|||
49079638|NCT01565889|158126583|FG003|Part B|Withdrawal by Subject|0|||
49079639|NCT01565889|158126584|FG004|Part B|Withdrawal by Subject|0|||
49079640|NCT01565889|158126585|FG005|Part B|Withdrawal by Subject|1|||
49079641|NCT01565889|158126580|FG000|Part B|Lack of Efficacy|0|||
49079642|NCT01565889|158126581|FG001|Part B|Lack of Efficacy|0|||
49079643|NCT01565889|158126582|FG002|Part B|Lack of Efficacy|0|||
49079644|NCT01565889|158126583|FG003|Part B|Lack of Efficacy|0|||
49079645|NCT01565889|158126584|FG004|Part B|Lack of Efficacy|0|||
49079646|NCT01565889|158126585|FG005|Part B|Lack of Efficacy|2|||
49079647|NCT01565889|158126580|FG000|Part B|Lost to Follow-up|0|||
49079648|NCT01565889|158126581|FG001|Part B|Lost to Follow-up|0|||
49079649|NCT01565889|158126582|FG002|Part B|Lost to Follow-up|0|||
49079650|NCT01565889|158126583|FG003|Part B|Lost to Follow-up|0|||
49079651|NCT01565889|158126584|FG004|Part B|Lost to Follow-up|0|||
49079652|NCT01565889|158126585|FG005|Part B|Lost to Follow-up|1|||
49079653|NCT00768248|158126589|FG000|Overall Study|Research coordinator didn't collect data|1|||
49079654|NCT00768248|158126590|FG001|Overall Study|Research coordinator didn't collect data|1|||
49079655|NCT02553772|158126592|FG000|Overall Study|Adverse Event|2|||
49079656|NCT02553772|158126593|FG001|Overall Study|Adverse Event|3|||
49079657|NCT02553772|158126592|FG000|Overall Study|Lost to Follow-up|2|||
49079658|NCT02553772|158126593|FG001|Overall Study|Lost to Follow-up|1|||
49079659|NCT02553772|158126592|FG000|Overall Study|Withdrawal of Consent|1|||
49079660|NCT02553772|158126593|FG001|Overall Study|Withdrawal of Consent|1|||
49079661|NCT02553772|158126592|FG000|Overall Study|Lack of Efficacy|1|||
49079662|NCT02553772|158126593|FG001|Overall Study|Lack of Efficacy|0|||
49079663|NCT02553772|158126592|FG000|Overall Study|Other Miscellaneous Reasons|0|||
49079664|NCT02553772|158126593|FG001|Overall Study|Other Miscellaneous Reasons|1|||
49079665|NCT02723344|158126596|FG000|Overall Study|Lost to Follow-up|0|||
49079666|NCT02723344|158126597|FG001|Overall Study|Lost to Follow-up|4|||
49079667|NCT01547390|158126601|FG000|Overall Study|Withdrawal by Subject|10|||
49079668|NCT01547390|158126602|FG001|Overall Study|Withdrawal by Subject|7|||
49079669|NCT01547390|158126601|FG000|Overall Study|termination of pregnancy|0|||
49079670|NCT01547390|158126602|FG001|Overall Study|termination of pregnancy|1|||
49079671|NCT01547390|158126601|FG000|Overall Study|Lost to Follow-up|0|||
49079672|NCT01547390|158126602|FG001|Overall Study|Lost to Follow-up|2|||
49079673|NCT01547390|158126601|FG000|Overall Study|Adverse Event|3|||
49079674|NCT01547390|158126602|FG001|Overall Study|Adverse Event|0|||
49079675|NCT02524847|158126603|FG000|Overall Study|Adverse Event|4|||
49079676|NCT02524847|158126603|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
49079677|NCT02524847|158126603|FG000|Overall Study|Condition no Longer Requires Treatment|4|||
49079678|NCT02524847|158126603|FG000|Overall Study|Death|1|||
49079679|NCT02524847|158126603|FG000|Overall Study|Reason not Specified|1|||
49079680|NCT01326845|158126604|FG000|Overall Study|Administrative Problems|5|||
49079681|NCT01326845|158126605|FG001|Overall Study|Administrative Problems|2|||
49079682|NCT01326845|158126604|FG000|Overall Study|Adverse Event|1|||
49079683|NCT01326845|158126605|FG001|Overall Study|Adverse Event|0|||
49079684|NCT01326845|158126604|FG000|Overall Study|Misisng|1|||
49079685|NCT01326845|158126605|FG001|Overall Study|Misisng|3|||
49079686|NCT01459783|158126606|FG000|Baseline to 6 Months|Death|1|||
49079687|NCT01459783|158126607|FG001|Baseline to 6 Months|Death|0|||
49079688|NCT01459783|158126606|FG000|Baseline to 6 Months|Withdrawal by Subject|12|||
49079689|NCT01459783|158126607|FG001|Baseline to 6 Months|Withdrawal by Subject|6|||
49079690|NCT01459783|158126606|FG000|Baseline to 6 Months|Lost to Follow-up|19|||
49079691|NCT01459783|158126607|FG001|Baseline to 6 Months|Lost to Follow-up|14|||
49079692|NCT01459783|158126606|FG000|6 Months to 12 Months|Death|0|||
49079693|NCT01459783|158126607|FG001|6 Months to 12 Months|Death|1|||
49079694|NCT01459783|158126606|FG000|6 Months to 12 Months|Withdrawal by Subject|6|||
49079695|NCT01459783|158126607|FG001|6 Months to 12 Months|Withdrawal by Subject|5|||
49079696|NCT01459783|158126606|FG000|6 Months to 12 Months|Lost to Follow-up|2|||
49079697|NCT01459783|158126607|FG001|6 Months to 12 Months|Lost to Follow-up|7|||
49079698|NCT01459783|158126606|FG000|6 Months to 12 Months|Study ended before 12-month follow-up|11|||
49079699|NCT01459783|158126607|FG001|6 Months to 12 Months|Study ended before 12-month follow-up|17|||
49079700|NCT04981717|158128639|FG000|Overall Study|Protocol Violation|0|||
49079701|NCT04981717|158128640|FG001|Overall Study|Protocol Violation|3|||
49079702|NCT04981717|158128639|FG000|Overall Study|Adverse Event|1|||
49079703|NCT04981717|158128640|FG001|Overall Study|Adverse Event|3|||
49079704|NCT04981717|158128639|FG000|Overall Study|Pregnancy|1|||
49079705|NCT04981717|158128640|FG001|Overall Study|Pregnancy|0|||
49079706|NCT04981717|158128639|FG000|Overall Study|Physician Decision|1|||
49079707|NCT04981717|158128640|FG001|Overall Study|Physician Decision|0|||
49079708|NCT04981717|158128639|FG000|Overall Study|Sponsor Request|157|||
49079709|NCT04981717|158128640|FG001|Overall Study|Sponsor Request|172|||
49079710|NCT04981717|158128639|FG000|Overall Study|Lost to Follow-up|4|||
49079711|NCT04981717|158128640|FG001|Overall Study|Lost to Follow-up|5|||
49079712|NCT04981717|158128639|FG000|Overall Study|Withdrawal by Subject|50|||
49079713|NCT04981717|158128640|FG001|Overall Study|Withdrawal by Subject|37|||
49079714|NCT03284723|158128644|FG000|Overall Study|Death|0|||
49079715|NCT03284723|158128645|FG001|Overall Study|Death|0|||
49079716|NCT03284723|158128646|FG002|Overall Study|Death|0|||
49079717|NCT03284723|158128647|FG003|Overall Study|Death|1|||
49079718|NCT03284723|158128648|FG004|Overall Study|Death|0|||
49079719|NCT03284723|158128649|FG005|Overall Study|Death|0|||
49079720|NCT03284723|158128650|FG006|Overall Study|Death|1|||
49079721|NCT03284723|158128651|FG007|Overall Study|Death|0|||
49079722|NCT03284723|158128652|FG008|Overall Study|Death|0|||
49079723|NCT03284723|158128653|FG009|Overall Study|Death|2|||
49079724|NCT03284723|158128654|FG010|Overall Study|Death|1|||
49079725|NCT03284723|158128655|FG011|Overall Study|Death|0|||
49079726|NCT03284723|158128644|FG000|Overall Study|Lost to Follow-up|0|||
49079727|NCT03284723|158128645|FG001|Overall Study|Lost to Follow-up|0|||
49079728|NCT03284723|158128646|FG002|Overall Study|Lost to Follow-up|0|||
49079729|NCT03284723|158128647|FG003|Overall Study|Lost to Follow-up|0|||
49079730|NCT03284723|158128648|FG004|Overall Study|Lost to Follow-up|0|||
49079731|NCT03284723|158128649|FG005|Overall Study|Lost to Follow-up|2|||
49079732|NCT03284723|158128650|FG006|Overall Study|Lost to Follow-up|1|||
49079733|NCT03284723|158128651|FG007|Overall Study|Lost to Follow-up|0|||
49079734|NCT03284723|158128652|FG008|Overall Study|Lost to Follow-up|0|||
49079735|NCT03284723|158128653|FG009|Overall Study|Lost to Follow-up|2|||
49079736|NCT03284723|158128654|FG010|Overall Study|Lost to Follow-up|0|||
49079737|NCT03284723|158128655|FG011|Overall Study|Lost to Follow-up|0|||
49079738|NCT03284723|158128644|FG000|Overall Study|Study Terminated By Sponsor|0|||
49079739|NCT03284723|158128645|FG001|Overall Study|Study Terminated By Sponsor|0|||
49079740|NCT03284723|158128646|FG002|Overall Study|Study Terminated By Sponsor|0|||
49079741|NCT03284723|158128647|FG003|Overall Study|Study Terminated By Sponsor|0|||
49079742|NCT03284723|158128648|FG004|Overall Study|Study Terminated By Sponsor|1|||
49079743|NCT03284723|158128649|FG005|Overall Study|Study Terminated By Sponsor|0|||
49079744|NCT03284723|158128650|FG006|Overall Study|Study Terminated By Sponsor|0|||
49079745|NCT03284723|158128651|FG007|Overall Study|Study Terminated By Sponsor|0|||
49079746|NCT03284723|158128652|FG008|Overall Study|Study Terminated By Sponsor|1|||
49079747|NCT03284723|158128653|FG009|Overall Study|Study Terminated By Sponsor|1|||
49079748|NCT03284723|158128654|FG010|Overall Study|Study Terminated By Sponsor|1|||
49079749|NCT03284723|158128655|FG011|Overall Study|Study Terminated By Sponsor|1|||
49079750|NCT03284723|158128644|FG000|Overall Study|Withdrawal by Subject|0|||
49079751|NCT03284723|158128645|FG001|Overall Study|Withdrawal by Subject|0|||
49079752|NCT03284723|158128646|FG002|Overall Study|Withdrawal by Subject|0|||
49079753|NCT03284723|158128647|FG003|Overall Study|Withdrawal by Subject|0|||
49079754|NCT03284723|158128648|FG004|Overall Study|Withdrawal by Subject|5|||
49079755|NCT03284723|158128649|FG005|Overall Study|Withdrawal by Subject|3|||
49079756|NCT03284723|158128650|FG006|Overall Study|Withdrawal by Subject|1|||
49079757|NCT03284723|158128651|FG007|Overall Study|Withdrawal by Subject|0|||
49079758|NCT03284723|158128652|FG008|Overall Study|Withdrawal by Subject|6|||
49079759|NCT03284723|158128653|FG009|Overall Study|Withdrawal by Subject|0|||
49079760|NCT03284723|158128654|FG010|Overall Study|Withdrawal by Subject|3|||
49079761|NCT03284723|158128655|FG011|Overall Study|Withdrawal by Subject|1|||
49079762|NCT03284723|158128644|FG000|Overall Study|Other|1|||
49079763|NCT03284723|158128645|FG001|Overall Study|Other|0|||
49079764|NCT03284723|158128646|FG002|Overall Study|Other|1|||
49079765|NCT03284723|158128647|FG003|Overall Study|Other|0|||
49079766|NCT03284723|158128648|FG004|Overall Study|Other|1|||
49079767|NCT03284723|158128649|FG005|Overall Study|Other|0|||
49079768|NCT03284723|158128650|FG006|Overall Study|Other|0|||
49079769|NCT03284723|158128651|FG007|Overall Study|Other|0|||
49079770|NCT03284723|158128652|FG008|Overall Study|Other|0|||
49079771|NCT03284723|158128653|FG009|Overall Study|Other|0|||
49079772|NCT03284723|158128654|FG010|Overall Study|Other|1|||
49079773|NCT03284723|158128655|FG011|Overall Study|Other|0|||
49079774|NCT03284723|158128644|FG000|Overall Study|Adverse Event|0|||
49079775|NCT03284723|158128645|FG001|Overall Study|Adverse Event|0|||
49079776|NCT03284723|158128646|FG002|Overall Study|Adverse Event|0|||
49079777|NCT03284723|158128647|FG003|Overall Study|Adverse Event|0|||
49079778|NCT03284723|158128648|FG004|Overall Study|Adverse Event|0|||
49079779|NCT03284723|158128649|FG005|Overall Study|Adverse Event|0|||
49079780|NCT03284723|158128650|FG006|Overall Study|Adverse Event|0|||
49079781|NCT03284723|158128651|FG007|Overall Study|Adverse Event|0|||
49079782|NCT03284723|158128652|FG008|Overall Study|Adverse Event|1|||
49079783|NCT03284723|158128653|FG009|Overall Study|Adverse Event|0|||
49079784|NCT03284723|158128654|FG010|Overall Study|Adverse Event|0|||
49079785|NCT03284723|158128655|FG011|Overall Study|Adverse Event|0|||
49079786|NCT00678210|158128656|FG000|Overall Study|Adverse Event|1|||
49079787|NCT00678210|158128657|FG001|Overall Study|Adverse Event|2|||
49079788|NCT00678210|158128658|FG002|Overall Study|Adverse Event|3|||
49079789|NCT00678210|158128659|FG003|Overall Study|Adverse Event|3|||
49079790|NCT00678210|158128656|FG000|Overall Study|Lack of Efficacy|2|||
49079791|NCT00678210|158128657|FG001|Overall Study|Lack of Efficacy|3|||
49079792|NCT00678210|158128658|FG002|Overall Study|Lack of Efficacy|1|||
49079793|NCT00678210|158128659|FG003|Overall Study|Lack of Efficacy|9|||
49079794|NCT00678210|158128656|FG000|Overall Study|Lost to Follow-up|4|||
49079795|NCT00678210|158128657|FG001|Overall Study|Lost to Follow-up|2|||
49079796|NCT00678210|158128658|FG002|Overall Study|Lost to Follow-up|0|||
49079797|NCT00678210|158128659|FG003|Overall Study|Lost to Follow-up|1|||
49079798|NCT00678210|158128656|FG000|Overall Study|Withdrawal by Subject|3|||
49079799|NCT00678210|158128657|FG001|Overall Study|Withdrawal by Subject|4|||
49079800|NCT00678210|158128658|FG002|Overall Study|Withdrawal by Subject|1|||
49079801|NCT00678210|158128659|FG003|Overall Study|Withdrawal by Subject|7|||
49079802|NCT00678210|158128656|FG000|Overall Study|Other|1|||
49079803|NCT00678210|158128657|FG001|Overall Study|Other|0|||
49079804|NCT00678210|158128658|FG002|Overall Study|Other|1|||
49079805|NCT00678210|158128659|FG003|Overall Study|Other|0|||
49079806|NCT02207634|158128660|FG000|Overall Study|Withdrawal by Subject|21|||
49079807|NCT02207634|158128661|FG001|Overall Study|Withdrawal by Subject|31|||
49079808|NCT02207634|158128660|FG000|Overall Study|Lost to Follow-up|1|||
49079809|NCT02207634|158128661|FG001|Overall Study|Lost to Follow-up|0|||
49079810|NCT04825912|158128662|FG000|Overall Study|Death|3|||
49079811|NCT04825912|158128662|FG000|Overall Study|Withdrawal by Subject|1|||
49079812|NCT00615199|158128663|FG000|Overall Study|Adverse Event|3|||
49079813|NCT00615199|158128664|FG001|Overall Study|Adverse Event|1|||
49079814|NCT00615199|158128665|FG002|Overall Study|Adverse Event|1|||
49079815|NCT00615199|158128666|FG003|Overall Study|Adverse Event|0|||
49079816|NCT00615199|158128663|FG000|Overall Study|Lack of Efficacy|2|||
49079817|NCT00615199|158128664|FG001|Overall Study|Lack of Efficacy|0|||
49079818|NCT00615199|158128665|FG002|Overall Study|Lack of Efficacy|0|||
49079819|NCT00615199|158128666|FG003|Overall Study|Lack of Efficacy|1|||
49079820|NCT00615199|158128663|FG000|Overall Study|Lost to Follow-up|1|||
49079821|NCT00615199|158128664|FG001|Overall Study|Lost to Follow-up|0|||
49079822|NCT00615199|158128665|FG002|Overall Study|Lost to Follow-up|0|||
49079823|NCT00615199|158128666|FG003|Overall Study|Lost to Follow-up|0|||
49079824|NCT00615199|158128663|FG000|Overall Study|Other|0|||
49079825|NCT00615199|158128664|FG001|Overall Study|Other|0|||
49079826|NCT00615199|158128665|FG002|Overall Study|Other|0|||
49079827|NCT00615199|158128666|FG003|Overall Study|Other|1|||
49079828|NCT00615199|158128663|FG000|Overall Study|Withdrawal by Subject|2|||
49079829|NCT00615199|158128664|FG001|Overall Study|Withdrawal by Subject|1|||
49079830|NCT00615199|158128665|FG002|Overall Study|Withdrawal by Subject|0|||
49079831|NCT00615199|158128666|FG003|Overall Study|Withdrawal by Subject|0|||
49079832|NCT01090414|158128669|FG000|Study 101-99|Progressive Disease|28|||
49079833|NCT01090414|158128670|FG001|Study 101-99|Progressive Disease|48|||
49079834|NCT01090414|158128671|FG002|Study 101-99|Progressive Disease|10|||
49079835|NCT01090414|158128672|FG003|Study 101-99|Progressive Disease|4|||
49079836|NCT01090414|158128669|FG000|Study 101-99|Adverse Event|10|||
49079837|NCT01090414|158128670|FG001|Study 101-99|Adverse Event|28|||
49079838|NCT01090414|158128671|FG002|Study 101-99|Adverse Event|18|||
49079839|NCT01090414|158128672|FG003|Study 101-99|Adverse Event|0|||
49079840|NCT01090414|158128669|FG000|Study 101-99|Investigator Request|1|||
49079841|NCT01090414|158128670|FG001|Study 101-99|Investigator Request|11|||
49079842|NCT01090414|158128671|FG002|Study 101-99|Investigator Request|4|||
49079843|NCT01090414|158128672|FG003|Study 101-99|Investigator Request|0|||
49079844|NCT01090414|158128669|FG000|Study 101-99|Death|3|||
49079845|NCT01090414|158128670|FG001|Study 101-99|Death|8|||
49079846|NCT01090414|158128671|FG002|Study 101-99|Death|1|||
49079847|NCT01090414|158128672|FG003|Study 101-99|Death|0|||
49079848|NCT01090414|158128669|FG000|Study 101-99|Sponsor Discontinued Study|0|||
49079849|NCT01090414|158128670|FG001|Study 101-99|Sponsor Discontinued Study|7|||
49079850|NCT01090414|158128671|FG002|Study 101-99|Sponsor Discontinued Study|5|||
49079851|NCT01090414|158128672|FG003|Study 101-99|Sponsor Discontinued Study|0|||
49079852|NCT01090414|158128669|FG000|Study 101-99|Other (Unknown Reasons)|3|||
49079853|NCT01090414|158128670|FG001|Study 101-99|Other (Unknown Reasons)|3|||
49079854|NCT01090414|158128671|FG002|Study 101-99|Other (Unknown Reasons)|0|||
49079855|NCT01090414|158128672|FG003|Study 101-99|Other (Unknown Reasons)|0|||
49079856|NCT01090414|158128669|FG000|Study 101-99|Withdrew Consent|0|||
49079857|NCT01090414|158128670|FG001|Study 101-99|Withdrew Consent|2|||
49079858|NCT01090414|158128671|FG002|Study 101-99|Withdrew Consent|3|||
49079859|NCT01090414|158128672|FG003|Study 101-99|Withdrew Consent|1|||
49079860|NCT01090414|158128669|FG000|Study 101-99|Participant Request|3|||
49079861|NCT01090414|158128670|FG001|Study 101-99|Participant Request|1|||
49079862|NCT01090414|158128671|FG002|Study 101-99|Participant Request|0|||
49079863|NCT01090414|158128672|FG003|Study 101-99|Participant Request|0|||
49079864|NCT02719184|158128675|FG000|Overall Study|Other than listed|1|||
49079865|NCT02719184|158128676|FG001|Overall Study|Other than listed|12|||
49079866|NCT02719184|158128677|FG002|Overall Study|Other than listed|13|||
49079867|NCT02719184|158128678|FG003|Overall Study|Other than listed|22|||
49079868|NCT02719184|158128679|FG004|Overall Study|Other than listed|9|||
49079869|NCT02719184|158128675|FG000|Overall Study|Withdrawal by Subject|5|||
49079870|NCT02719184|158128676|FG001|Overall Study|Withdrawal by Subject|3|||
49079871|NCT02719184|158128677|FG002|Overall Study|Withdrawal by Subject|6|||
49079872|NCT02719184|158128678|FG003|Overall Study|Withdrawal by Subject|6|||
49079873|NCT02719184|158128679|FG004|Overall Study|Withdrawal by Subject|0|||
49079874|NCT02719184|158128675|FG000|Overall Study|Lost to Follow-up|0|||
49079875|NCT02719184|158128676|FG001|Overall Study|Lost to Follow-up|4|||
49079876|NCT02719184|158128677|FG002|Overall Study|Lost to Follow-up|1|||
49079877|NCT02719184|158128678|FG003|Overall Study|Lost to Follow-up|3|||
49079878|NCT02719184|158128679|FG004|Overall Study|Lost to Follow-up|0|||
49079879|NCT02719184|158128675|FG000|Overall Study|Protocol Violation|0|||
49079880|NCT02719184|158128676|FG001|Overall Study|Protocol Violation|3|||
49079881|NCT02719184|158128677|FG002|Overall Study|Protocol Violation|0|||
49079882|NCT02719184|158128678|FG003|Overall Study|Protocol Violation|2|||
49079883|NCT02719184|158128679|FG004|Overall Study|Protocol Violation|0|||
49079884|NCT02719184|158128675|FG000|Overall Study|Adverse Event|0|||
49079885|NCT02719184|158128676|FG001|Overall Study|Adverse Event|0|||
49079886|NCT02719184|158128677|FG002|Overall Study|Adverse Event|0|||
49079887|NCT02719184|158128678|FG003|Overall Study|Adverse Event|3|||
49079888|NCT02719184|158128679|FG004|Overall Study|Adverse Event|0|||
49079889|NCT01295320|158128680|FG000|Overall Study|Adverse Event|2|||
49079890|NCT01295320|158128680|FG000|Overall Study|Lost to Follow-up|4|||
49079891|NCT01295320|158128680|FG000|Overall Study|Withdrawal by Subject|2|||
49079892|NCT01295320|158128680|FG000|Overall Study|Subject was bedridden|1|||
49079893|NCT01295320|158128680|FG000|Overall Study|Unable to travel|1|||
49079894|NCT00462904|158128681|FG000|Overall Study|Lost to Follow-up|1|||
49079895|NCT00652340|158128682|FG000|Overall Study|Had not progressed.|4|||
49079896|NCT00652340|158128683|FG001|Overall Study|Had not progressed.|3|||
49079897|NCT01995513|158128684|FG000|Period 1: First Open Label Treatment|Other|34|||
49079898|NCT01995513|158128685|FG001|Period 1: First Open Label Treatment|Other|0|||
49079899|NCT01995513|158128686|FG002|Period 1: First Open Label Treatment|Other|0|||
49079900|NCT01995513|158128687|FG003|Period 1: First Open Label Treatment|Other|0|||
49079901|NCT01995513|158128684|FG000|Period 1: First Open Label Treatment|Death|14|||
49079902|NCT01995513|158128685|FG001|Period 1: First Open Label Treatment|Death|0|||
49079903|NCT01995513|158128686|FG002|Period 1: First Open Label Treatment|Death|0|||
49079904|NCT01995513|158128687|FG003|Period 1: First Open Label Treatment|Death|0|||
49079905|NCT01995513|158128684|FG000|Period 1: First Open Label Treatment|Adverse Event|40|||
49079906|NCT01995513|158128685|FG001|Period 1: First Open Label Treatment|Adverse Event|0|||
49079907|NCT01995513|158128686|FG002|Period 1: First Open Label Treatment|Adverse Event|0|||
49079908|NCT01995513|158128687|FG003|Period 1: First Open Label Treatment|Adverse Event|0|||
49079909|NCT01995513|158128684|FG000|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|43|||
49079910|NCT01995513|158128685|FG001|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
49079911|NCT01995513|158128686|FG002|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
49079912|NCT01995513|158128687|FG003|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
49079913|NCT01995513|158128684|FG000|Period 1: First Open Label Treatment|Disease Progression|92|||
49079914|NCT01995513|158128685|FG001|Period 1: First Open Label Treatment|Disease Progression|0|||
49079915|NCT01995513|158128686|FG002|Period 1: First Open Label Treatment|Disease Progression|0|||
49079916|NCT01995513|158128687|FG003|Period 1: First Open Label Treatment|Disease Progression|0|||
49079917|NCT01995513|158128684|FG000|Period 1: First Open Label Treatment|Protocol Non-Compliance|2|||
49079918|NCT01995513|158128685|FG001|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
49079919|NCT01995513|158128686|FG002|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
49079920|NCT01995513|158128687|FG003|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
49079921|NCT01995513|158128684|FG000|Period 1: First Open Label Treatment|Withdrawal by Subject|20|||
49079922|NCT01995513|158128685|FG001|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
49079923|NCT01995513|158128686|FG002|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
49079924|NCT01995513|158128687|FG003|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
49079925|NCT01995513|158128684|FG000|Period 1: Second Open Label Treatment|Other|0|||
49079926|NCT01995513|158128685|FG001|Period 1: Second Open Label Treatment|Other|2|||
49079927|NCT01995513|158128686|FG002|Period 1: Second Open Label Treatment|Other|0|||
49079928|NCT01995513|158128687|FG003|Period 1: Second Open Label Treatment|Other|0|||
49079929|NCT01995513|158128684|FG000|Period 1: Second Open Label Treatment|Disease Progression|0|||
49079930|NCT01995513|158128685|FG001|Period 1: Second Open Label Treatment|Disease Progression|11|||
49079931|NCT01995513|158128686|FG002|Period 1: Second Open Label Treatment|Disease Progression|0|||
49079932|NCT01995513|158128687|FG003|Period 1: Second Open Label Treatment|Disease Progression|0|||
49079933|NCT01995513|158128684|FG000|Period 2: Double Blind Treatment|Death|0|||
49079934|NCT01995513|158128685|FG001|Period 2: Double Blind Treatment|Death|0|||
49079935|NCT01995513|158128686|FG002|Period 2: Double Blind Treatment|Death|0|||
49079936|NCT01995513|158128687|FG003|Period 2: Double Blind Treatment|Death|1|||
49079937|NCT01995513|158128684|FG000|Period 2: Double Blind Treatment|Other|0|||
49079938|NCT01995513|158128685|FG001|Period 2: Double Blind Treatment|Other|0|||
49079939|NCT01995513|158128686|FG002|Period 2: Double Blind Treatment|Other|3|||
49079940|NCT01995513|158128687|FG003|Period 2: Double Blind Treatment|Other|3|||
49079941|NCT01995513|158128684|FG000|Period 2: Double Blind Treatment|Disease Progression|0|||
49079942|NCT01995513|158128685|FG001|Period 2: Double Blind Treatment|Disease Progression|0|||
49079943|NCT01995513|158128686|FG002|Period 2: Double Blind Treatment|Disease Progression|104|||
49079944|NCT01995513|158128687|FG003|Period 2: Double Blind Treatment|Disease Progression|107|||
49079945|NCT01995513|158128684|FG000|Period 2: Double Blind Treatment|Adverse Event|0|||
49079946|NCT01995513|158128685|FG001|Period 2: Double Blind Treatment|Adverse Event|0|||
49079947|NCT01995513|158128686|FG002|Period 2: Double Blind Treatment|Adverse Event|14|||
49079948|NCT01995513|158128687|FG003|Period 2: Double Blind Treatment|Adverse Event|5|||
49079949|NCT01995513|158128684|FG000|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
49079950|NCT01995513|158128685|FG001|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
49079951|NCT01995513|158128686|FG002|Period 2: Double Blind Treatment|Withdrawal by Subject|5|||
49079952|NCT01995513|158128687|FG003|Period 2: Double Blind Treatment|Withdrawal by Subject|8|||
49079953|NCT01995513|158128684|FG000|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
49079954|NCT01995513|158128685|FG001|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
49079955|NCT01995513|158128686|FG002|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
49079956|NCT01995513|158128687|FG003|Period 2: Double Blind Treatment|Protocol Non-Compliance|1|||
49079957|NCT02439216|158128688|FG000|PartA(7 Day Open-Label Treatment Period)|Screen failure|1|||
49079958|NCT02439216|158128689|FG001|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
49079959|NCT02439216|158128690|FG002|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
49079960|NCT02439216|158128691|FG003|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
49079961|NCT02439216|158128692|FG004|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
49079962|NCT02439216|158128693|FG005|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
49079963|NCT02439216|158128694|FG006|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
49079964|NCT02439216|158128695|FG007|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
49079965|NCT02439216|158128696|FG008|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
49079966|NCT02439216|158128688|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
49079967|NCT02439216|158128689|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
49079968|NCT02439216|158128690|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
49079969|NCT02439216|158128691|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
49079970|NCT02439216|158128692|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
49079971|NCT02439216|158128693|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
49079972|NCT02439216|158128694|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
49079973|NCT02439216|158128695|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|1|||
49079974|NCT02439216|158128696|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
49079975|NCT02439216|158128688|FG000|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
49079976|NCT02439216|158128689|FG001|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
49079977|NCT02439216|158128690|FG002|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
49079978|NCT02439216|158128691|FG003|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
49079979|NCT02439216|158128692|FG004|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
49079980|NCT02439216|158128693|FG005|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
49079981|NCT02439216|158128694|FG006|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
49079982|NCT02439216|158128695|FG007|Part C (138-week, Open-label Treatment)|Lost to Follow-up|1|||
49079983|NCT02439216|158128696|FG008|Part C (138-week, Open-label Treatment)|Lost to Follow-up|2|||
49079984|NCT02439216|158128688|FG000|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
49079985|NCT02439216|158128689|FG001|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
49079986|NCT02439216|158128690|FG002|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
49079987|NCT02439216|158128691|FG003|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
49079988|NCT02439216|158128692|FG004|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
49079989|NCT02439216|158128693|FG005|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
49079990|NCT02439216|158128694|FG006|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
49079991|NCT02439216|158128695|FG007|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
49079992|NCT02439216|158128696|FG008|Part C (138-week, Open-label Treatment)|Progressive disease|3|||
49079993|NCT02439216|158128688|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
49079994|NCT02439216|158128689|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
49079995|NCT02439216|158128690|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
49079996|NCT02439216|158128691|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
49079997|NCT02439216|158128692|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
49079998|NCT02439216|158128693|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
49079999|NCT02439216|158128694|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
49080000|NCT02439216|158128695|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|5|||
49080001|NCT02439216|158128696|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|6|||
49080002|NCT02652949|158128697|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
49080003|NCT02652949|158128697|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
49080004|NCT02652949|158128697|FG000|6-Month Follow-up Secondary Endpoint|Death|5|||
49080005|NCT02652949|158128697|FG000|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
49080006|NCT02652949|158128697|FG000|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
49080007|NCT02652949|158128697|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
49080008|NCT02652949|158128697|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
49080009|NCT02652949|158128697|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
49080010|NCT02652949|158128697|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
49080011|NCT02652949|158128697|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
49080012|NCT02652949|158128697|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
49080013|NCT02652949|158128697|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
49080014|NCT02652949|158128697|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
49080015|NCT02652949|158128697|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
49080016|NCT02652949|158128697|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
49080017|NCT02652949|158128697|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
49080018|NCT02652949|158128697|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
49080019|NCT01439802|158128701|FG000|6 Weeks Postpartum Status|Lost to Follow-up|36|||
49080020|NCT01439802|158128701|FG000|6 Months Postpartum Status|Lost to Follow-up|12|||
49080021|NCT02094300|158128702|FG000|Overall Study|Death|7|||
49080022|NCT02094300|158128702|FG000|Overall Study|Lost to Follow-up|10|||
49080023|NCT02094300|158128702|FG000|Overall Study|Still be eligible for follow-up|3|||
49080024|NCT01232452|158128703|FG000|Overall Study|Adverse Event|17|||
49080025|NCT01232452|158128704|FG001|Overall Study|Adverse Event|15|||
49080026|NCT01232452|158128703|FG000|Overall Study|Withdrawal by Subject|11|||
49080027|NCT01232452|158128704|FG001|Overall Study|Withdrawal by Subject|8|||
49080028|NCT01232452|158128703|FG000|Overall Study|Physician Decision|8|||
49080029|NCT01232452|158128704|FG001|Overall Study|Physician Decision|12|||
49080030|NCT01232452|158128703|FG000|Overall Study|Protocol entry criterion not met|0|||
49080031|NCT01232452|158128704|FG001|Overall Study|Protocol entry criterion not met|2|||
49080032|NCT01232452|158128703|FG000|Overall Study|Sponsor Decision|3|||
49080033|NCT01232452|158128704|FG001|Overall Study|Sponsor Decision|1|||
49080034|NCT01232452|158128703|FG000|Overall Study|Protocol Violation|0|||
49080035|NCT01232452|158128704|FG001|Overall Study|Protocol Violation|1|||
49080036|NCT04108299|158128709|FG000|Overall Study|Not interested in participating|2|||
49080037|NCT04108299|158128710|FG001|Overall Study|Not interested in participating|1|||
49080038|NCT04108299|158128711|FG002|Overall Study|Not interested in participating|2|||
49080039|NCT04108299|158128712|FG003|Overall Study|Not interested in participating|1|||
49080040|NCT03682107|158128716|FG000|Overall Study|Withdrawal by Subject|0|||
49080041|NCT03682107|158128717|FG001|Overall Study|Withdrawal by Subject|1|||
49080042|NCT03682107|158128718|FG002|Overall Study|Withdrawal by Subject|0|||
49080043|NCT03682107|158128719|FG003|Overall Study|Withdrawal by Subject|0|||
49080044|NCT03682107|158128720|FG004|Overall Study|Withdrawal by Subject|0|||
49080045|NCT00247676|158128721|FG000|Overall Study|Death|5|||
49080046|NCT00247676|158128721|FG000|Overall Study|Adverse Event|11|||
49080047|NCT00247676|158128721|FG000|Overall Study|Lack of Efficacy|15|||
49080048|NCT00247676|158128721|FG000|Overall Study|Other|3|||
49080049|NCT00247676|158128721|FG000|Overall Study|Withdrawal by Subject|2|||
49080050|NCT00662649|158128722|FG000|Core Study (24 Months)|Withdrawal by Subject|31|||
49080051|NCT00662649|158128723|FG001|Core Study (24 Months)|Withdrawal by Subject|17|||
49080052|NCT00662649|158128724|FG002|Core Study (24 Months)|Withdrawal by Subject|28|||
49080053|NCT00662649|158128725|FG003|Core Study (24 Months)|Withdrawal by Subject|0|||
49080054|NCT00662649|158128726|FG004|Core Study (24 Months)|Withdrawal by Subject|0|||
49080055|NCT00662649|158128722|FG000|Core Study (24 Months)|Adverse Event|22|||
49080056|NCT00662649|158128723|FG001|Core Study (24 Months)|Adverse Event|13|||
49080057|NCT00662649|158128724|FG002|Core Study (24 Months)|Adverse Event|18|||
49080058|NCT00662649|158128725|FG003|Core Study (24 Months)|Adverse Event|0|||
49080059|NCT00662649|158128726|FG004|Core Study (24 Months)|Adverse Event|0|||
49080060|NCT00662649|158128722|FG000|Core Study (24 Months)|Unsatisfactory therapeutic effect|13|||
49080061|NCT00662649|158128723|FG001|Core Study (24 Months)|Unsatisfactory therapeutic effect|6|||
49080062|NCT00662649|158128724|FG002|Core Study (24 Months)|Unsatisfactory therapeutic effect|25|||
49080063|NCT00662649|158128725|FG003|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
49080064|NCT00662649|158128726|FG004|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
49080065|NCT00662649|158128722|FG000|Core Study (24 Months)|Abnormal laboratory value(s)|20|||
49080066|NCT00662649|158128723|FG001|Core Study (24 Months)|Abnormal laboratory value(s)|9|||
49080067|NCT00662649|158128724|FG002|Core Study (24 Months)|Abnormal laboratory value(s)|1|||
49080068|NCT00662649|158128725|FG003|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
49080069|NCT00662649|158128726|FG004|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
49080070|NCT00662649|158128722|FG000|Core Study (24 Months)|Lost to Follow-up|3|||
49080071|NCT00662649|158128723|FG001|Core Study (24 Months)|Lost to Follow-up|5|||
49080072|NCT00662649|158128724|FG002|Core Study (24 Months)|Lost to Follow-up|7|||
49080073|NCT00662649|158128725|FG003|Core Study (24 Months)|Lost to Follow-up|0|||
49080074|NCT00662649|158128726|FG004|Core Study (24 Months)|Lost to Follow-up|0|||
49080075|NCT00662649|158128722|FG000|Core Study (24 Months)|Protocol Violation|5|||
49080076|NCT00662649|158128723|FG001|Core Study (24 Months)|Protocol Violation|5|||
49080077|NCT00662649|158128724|FG002|Core Study (24 Months)|Protocol Violation|4|||
49080078|NCT00662649|158128725|FG003|Core Study (24 Months)|Protocol Violation|0|||
49080079|NCT00662649|158128726|FG004|Core Study (24 Months)|Protocol Violation|0|||
49080080|NCT00662649|158128722|FG000|Core Study (24 Months)|Abnormal test procedure result(s)|2|||
49080081|NCT00662649|158128723|FG001|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
49080082|NCT00662649|158128724|FG002|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
49080083|NCT00662649|158128725|FG003|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
49080084|NCT00662649|158128726|FG004|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
49080085|NCT00662649|158128722|FG000|Core Study (24 Months)|Death|1|||
49080086|NCT00662649|158128723|FG001|Core Study (24 Months)|Death|0|||
49080087|NCT00662649|158128724|FG002|Core Study (24 Months)|Death|2|||
49080088|NCT00662649|158128725|FG003|Core Study (24 Months)|Death|0|||
49080089|NCT00662649|158128726|FG004|Core Study (24 Months)|Death|0|||
49080090|NCT00662649|158128722|FG000|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10|||
49080091|NCT00662649|158128723|FG001|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5|||
49080092|NCT00662649|158128724|FG002|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0|||
49080093|NCT00662649|158128725|FG003|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8|||
49080094|NCT00662649|158128726|FG004|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3|||
49080095|NCT00662649|158128722|FG000|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
49080096|NCT00662649|158128723|FG001|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
49080097|NCT00662649|158128724|FG002|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0|||
49080098|NCT00662649|158128725|FG003|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
49080099|NCT00662649|158128726|FG004|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
49080100|NCT00662649|158128722|FG000|Extension Study (Month 24 to 60)|Administrative problems|0|||
49080101|NCT00662649|158128723|FG001|Extension Study (Month 24 to 60)|Administrative problems|0|||
49080102|NCT00662649|158128724|FG002|Extension Study (Month 24 to 60)|Administrative problems|0|||
49080103|NCT00662649|158128725|FG003|Extension Study (Month 24 to 60)|Administrative problems|1|||
49080104|NCT00662649|158128726|FG004|Extension Study (Month 24 to 60)|Administrative problems|0|||
49080105|NCT00662649|158128722|FG000|Extension Study (Month 24 to 60)|Adverse Event|6|||
49080106|NCT00662649|158128723|FG001|Extension Study (Month 24 to 60)|Adverse Event|9|||
49080107|NCT00662649|158128724|FG002|Extension Study (Month 24 to 60)|Adverse Event|0|||
49080108|NCT00662649|158128725|FG003|Extension Study (Month 24 to 60)|Adverse Event|6|||
49080109|NCT00662649|158128726|FG004|Extension Study (Month 24 to 60)|Adverse Event|10|||
49080110|NCT00662649|158128722|FG000|Extension Study (Month 24 to 60)|Lost to Follow-up|2|||
49080111|NCT00662649|158128723|FG001|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
49080112|NCT00662649|158128724|FG002|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
49080113|NCT00662649|158128725|FG003|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
49080114|NCT00662649|158128726|FG004|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
49080115|NCT00662649|158128722|FG000|Extension Study (Month 24 to 60)|Protocol Violation|1|||
49080116|NCT00662649|158128723|FG001|Extension Study (Month 24 to 60)|Protocol Violation|1|||
49080117|NCT00662649|158128724|FG002|Extension Study (Month 24 to 60)|Protocol Violation|0|||
49080118|NCT00662649|158128725|FG003|Extension Study (Month 24 to 60)|Protocol Violation|0|||
49080119|NCT00662649|158128726|FG004|Extension Study (Month 24 to 60)|Protocol Violation|0|||
49080120|NCT00662649|158128722|FG000|Extension Study (Month 24 to 60)|Subject withdrew consent|19|||
49080121|NCT00662649|158128723|FG001|Extension Study (Month 24 to 60)|Subject withdrew consent|23|||
49080122|NCT00662649|158128724|FG002|Extension Study (Month 24 to 60)|Subject withdrew consent|0|||
49080123|NCT00662649|158128725|FG003|Extension Study (Month 24 to 60)|Subject withdrew consent|15|||
49080124|NCT00662649|158128726|FG004|Extension Study (Month 24 to 60)|Subject withdrew consent|9|||
49080125|NCT00662649|158128722|FG000|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
49080126|NCT00662649|158128723|FG001|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1|||
49080127|NCT00662649|158128724|FG002|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
49080128|NCT00662649|158128725|FG003|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
49080129|NCT00662649|158128726|FG004|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
49080130|NCT00662649|158128722|FG000|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
49080131|NCT00662649|158128723|FG001|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
49080132|NCT00662649|158128724|FG002|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0|||
49080133|NCT00662649|158128725|FG003|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
49080134|NCT00662649|158128726|FG004|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
49080135|NCT02288312|158128728|FG000|Overall Study|Pregnancy|1|||
49080136|NCT02288312|158128729|FG001|Overall Study|Pregnancy|0|||
49080137|NCT02288312|158128730|FG002|Overall Study|Pregnancy|0|||
49080138|NCT04342819|158128733|FG000|Overall Study|Declined|4|||
49080139|NCT04342819|158128733|FG000|Overall Study|Not meeeting selection criteria|1|||
49080140|NCT00911300|158128734|FG000|Overall Study|Primary Endpoint Component Occurred|1|||
49080141|NCT00911300|158128735|FG001|Overall Study|Primary Endpoint Component Occurred|2|||
49080142|NCT00911300|158128734|FG000|Overall Study|Death|1|||
49080143|NCT00911300|158128735|FG001|Overall Study|Death|0|||
49080144|NCT00911300|158128734|FG000|Overall Study|Thrombus Persistant in Second TEE|3|||
49080145|NCT00911300|158128735|FG001|Overall Study|Thrombus Persistant in Second TEE|7|||
49080146|NCT00911300|158128734|FG000|Overall Study|Adverse Event|14|||
49080147|NCT00911300|158128735|FG001|Overall Study|Adverse Event|6|||
49080148|NCT00911300|158128734|FG000|Overall Study|Protocol Violation|3|||
49080149|NCT00911300|158128735|FG001|Overall Study|Protocol Violation|2|||
49080150|NCT00911300|158128734|FG000|Overall Study|Consent Withdrawn|4|||
49080151|NCT00911300|158128735|FG001|Overall Study|Consent Withdrawn|12|||
49080152|NCT00911300|158128734|FG000|Overall Study|Coronary Angiography Performed|1|||
49080153|NCT00911300|158128735|FG001|Overall Study|Coronary Angiography Performed|0|||
49080154|NCT00911300|158128734|FG000|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
49080155|NCT00911300|158128735|FG001|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
49080156|NCT00911300|158128734|FG000|Overall Study|Received Commercial Treatment|1|||
49080157|NCT00911300|158128735|FG001|Overall Study|Received Commercial Treatment|0|||
49080158|NCT00911300|158128734|FG000|Overall Study|Recurrent Tachyarrhythmia|1|||
49080159|NCT00911300|158128735|FG001|Overall Study|Recurrent Tachyarrhythmia|1|||
49080160|NCT00911300|158128734|FG000|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
49080161|NCT00911300|158128735|FG001|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
49080162|NCT00911300|158128734|FG000|Overall Study|Nurse Unavailable in Participant's City|1|||
49080163|NCT00911300|158128735|FG001|Overall Study|Nurse Unavailable in Participant's City|0|||
49080164|NCT00911300|158128734|FG000|Overall Study|CV Unsuccessful; Phenprocoumon Received|1|||
49080165|NCT00911300|158128735|FG001|Overall Study|CV Unsuccessful; Phenprocoumon Received|0|||
49080166|NCT00911300|158128734|FG000|Overall Study|Participant Could Not Stay in Hospital|0|||
49080167|NCT00911300|158128735|FG001|Overall Study|Participant Could Not Stay in Hospital|1|||
49080168|NCT00911300|158128734|FG000|Overall Study|Investigator's Decision; New AF Episode|0|||
49080169|NCT00911300|158128735|FG001|Overall Study|Investigator's Decision; New AF Episode|1|||
49080170|NCT00911300|158128734|FG000|Overall Study|International Normalized Ratio Too High|0|||
49080171|NCT00911300|158128735|FG001|Overall Study|International Normalized Ratio Too High|1|||
49080172|NCT00911300|158128734|FG000|Overall Study|Participant Refused Hospital Consulation|0|||
49080173|NCT00911300|158128735|FG001|Overall Study|Participant Refused Hospital Consulation|1|||
49080174|NCT00911300|158128734|FG000|Overall Study|Underlying Disease (Myocarditis)|0|||
49080175|NCT00911300|158128735|FG001|Overall Study|Underlying Disease (Myocarditis)|1|||
49080176|NCT00911300|158128734|FG000|Overall Study|Physician Decision|0|||
49080177|NCT00911300|158128735|FG001|Overall Study|Physician Decision|1|||
49080178|NCT00911300|158128734|FG000|Overall Study|Treatment Stopped by Mistake|0|||
49080179|NCT00911300|158128735|FG001|Overall Study|Treatment Stopped by Mistake|1|||
49080180|NCT00911300|158128734|FG000|Overall Study|Randomized; No Study Medication Received|0|||
49080181|NCT00911300|158128735|FG001|Overall Study|Randomized; No Study Medication Received|2|||
49080182|NCT00742209|158128737|FG000|Overall Study|Adverse Event|11|||
49080183|NCT00742209|158128738|FG001|Overall Study|Adverse Event|4|||
49080184|NCT00742209|158128739|FG002|Overall Study|Adverse Event|17|||
49080185|NCT00742209|158128740|FG003|Overall Study|Adverse Event|16|||
49080186|NCT00742209|158128741|FG004|Overall Study|Adverse Event|13|||
49080187|NCT00742209|158128737|FG000|Overall Study|Participant Withdrew Consent|8|||
49080188|NCT00742209|158128738|FG001|Overall Study|Participant Withdrew Consent|4|||
49080189|NCT00742209|158128739|FG002|Overall Study|Participant Withdrew Consent|14|||
49080190|NCT00742209|158128740|FG003|Overall Study|Participant Withdrew Consent|7|||
49080191|NCT00742209|158128741|FG004|Overall Study|Participant Withdrew Consent|4|||
49080192|NCT00742209|158128737|FG000|Overall Study|Protocol Violation|6|||
49080193|NCT00742209|158128738|FG001|Overall Study|Protocol Violation|5|||
49080194|NCT00742209|158128739|FG002|Overall Study|Protocol Violation|4|||
49080195|NCT00742209|158128740|FG003|Overall Study|Protocol Violation|5|||
49080196|NCT00742209|158128741|FG004|Overall Study|Protocol Violation|3|||
49080197|NCT00742209|158128737|FG000|Overall Study|Lost to Follow-up|3|||
49080198|NCT00742209|158128738|FG001|Overall Study|Lost to Follow-up|4|||
49080199|NCT00742209|158128739|FG002|Overall Study|Lost to Follow-up|5|||
49080200|NCT00742209|158128740|FG003|Overall Study|Lost to Follow-up|5|||
49080201|NCT00742209|158128741|FG004|Overall Study|Lost to Follow-up|3|||
49080202|NCT00742209|158128737|FG000|Overall Study|Lack of Efficacy|6|||
49080203|NCT00742209|158128738|FG001|Overall Study|Lack of Efficacy|1|||
49080204|NCT00742209|158128739|FG002|Overall Study|Lack of Efficacy|1|||
49080205|NCT00742209|158128740|FG003|Overall Study|Lack of Efficacy|3|||
49080206|NCT00742209|158128741|FG004|Overall Study|Lack of Efficacy|1|||
49080207|NCT00742209|158128737|FG000|Overall Study|Investigator Discretion|0|||
49080208|NCT00742209|158128738|FG001|Overall Study|Investigator Discretion|0|||
49080209|NCT00742209|158128739|FG002|Overall Study|Investigator Discretion|5|||
49080210|NCT00742209|158128740|FG003|Overall Study|Investigator Discretion|1|||
49080211|NCT00742209|158128741|FG004|Overall Study|Investigator Discretion|1|||
49080212|NCT03022370|158128742|FG000|Overall Study|Death|6|||
49080213|NCT03022370|158128743|FG001|Overall Study|Death|12|||
49080214|NCT03022370|158128742|FG000|Overall Study|Lost to Follow-up|174|||
49080215|NCT03022370|158128743|FG001|Overall Study|Lost to Follow-up|109|||
49080216|NCT00129389|158128744|FG000|Overall Study|Adverse Event|19|||
49080217|NCT00129389|158128745|FG001|Overall Study|Adverse Event|87|||
49080218|NCT00129389|158128744|FG000|Overall Study|Death|0|||
49080219|NCT00129389|158128745|FG001|Overall Study|Death|1|||
49080220|NCT00129389|158128744|FG000|Overall Study|Lost to Follow-up|2|||
49080221|NCT00129389|158128745|FG001|Overall Study|Lost to Follow-up|1|||
49080222|NCT00129389|158128744|FG000|Overall Study|Physician Decision|0|||
49080223|NCT00129389|158128745|FG001|Overall Study|Physician Decision|4|||
49080224|NCT00129389|158128744|FG000|Overall Study|Protocol Violation|0|||
49080225|NCT00129389|158128745|FG001|Overall Study|Protocol Violation|6|||
49080226|NCT00129389|158128744|FG000|Overall Study|Withdrawal by Subject|9|||
49080227|NCT00129389|158128745|FG001|Overall Study|Withdrawal by Subject|23|||
49080228|NCT00129389|158128744|FG000|Overall Study|Relapse|1|||
49080229|NCT00129389|158128745|FG001|Overall Study|Relapse|0|||
49080230|NCT00129389|158128744|FG000|Overall Study|Not eligible|1|||
49080231|NCT00129389|158128745|FG001|Overall Study|Not eligible|2|||
49080232|NCT00129389|158128744|FG000|Overall Study|Crossed to the other arm|1|||
49080233|NCT00129389|158128745|FG001|Overall Study|Crossed to the other arm|16|||
49080234|NCT00725491|158128748|FG000|Overall Study|Adverse Event|3|||
49080235|NCT00725491|158128749|FG001|Overall Study|Adverse Event|2|||
49080236|NCT00725491|158128748|FG000|Overall Study|Pregnancy|0|||
49080237|NCT00725491|158128749|FG001|Overall Study|Pregnancy|3|||
49080238|NCT00725491|158128748|FG000|Overall Study|Risk for hyperstimulation|2|||
49080239|NCT00725491|158128749|FG001|Overall Study|Risk for hyperstimulation|9|||
49080240|NCT00725491|158128748|FG000|Overall Study|No/too few oocytes/bad quality oocytes|1|||
49080241|NCT00725491|158128749|FG001|Overall Study|No/too few oocytes/bad quality oocytes|1|||
49080242|NCT00725491|158128748|FG000|Overall Study|Fertilization failure|0|||
49080243|NCT00725491|158128749|FG001|Overall Study|Fertilization failure|1|||
49080244|NCT00725491|158128748|FG000|Overall Study|No/too few embryos/ bad quality embryos|3|||
49080245|NCT00725491|158128749|FG001|Overall Study|No/too few embryos/ bad quality embryos|2|||
49080246|NCT00668317|158128752|FG000|Overall Study|Adverse Event|2|||
49080247|NCT00307086|158128761|FG000|Overall Study|ineligible|5|||
49080248|NCT03541317|158128762|FG000|Stage 2 of the Implementation|Withdrawal by Subject|1|||
49080249|NCT03541317|158128763|FG001|Stage 2 of the Implementation|Withdrawal by Subject|0|||
49080250|NCT03541317|158128764|FG002|Stage 2 of the Implementation|Withdrawal by Subject|0|||
49080251|NCT03541317|158128765|FG003|Stage 2 of the Implementation|Withdrawal by Subject|0|||
49080252|NCT03541317|158128766|FG004|Stage 2 of the Implementation|Withdrawal by Subject|0|||
49080253|NCT03541317|158128767|FG005|Stage 2 of the Implementation|Withdrawal by Subject|0|||
49080254|NCT00879086|158128770|FG000|Overall Study|Adverse Event|3|||
49080255|NCT00879086|158128771|FG001|Overall Study|Adverse Event|15|||
49080256|NCT00879086|158128770|FG000|Overall Study|Participant choice|2|||
49080257|NCT00879086|158128771|FG001|Overall Study|Participant choice|2|||
49080258|NCT00879086|158128770|FG000|Overall Study|Progression of disease|40|||
49080259|NCT00879086|158128771|FG001|Overall Study|Progression of disease|26|||
49080260|NCT00879086|158128770|FG000|Overall Study|Withdrawal of consent|2|||
49080261|NCT00879086|158128771|FG001|Overall Study|Withdrawal of consent|1|||
49080262|NCT00879086|158128770|FG000|Overall Study|Other|4|||
49080263|NCT00879086|158128771|FG001|Overall Study|Other|6|||
49080264|NCT00879086|158128770|FG000|Overall Study|Death|1|||
49080265|NCT00879086|158128771|FG001|Overall Study|Death|2|||
49080266|NCT02969044|158128772|FG000|Overall Study|Withdrawal by Subject|2|||
49080267|NCT02969044|158128773|FG001|Overall Study|Withdrawal by Subject|6|||
49080268|NCT02969044|158128772|FG000|Overall Study|Adverse Event|3|||
49080269|NCT02969044|158128773|FG001|Overall Study|Adverse Event|0|||
49080270|NCT01487525|158128774|FG000|Overall Study|Withdrawal by Subject|0|||
49080271|NCT01487525|158128775|FG001|Overall Study|Withdrawal by Subject|1|||
49080272|NCT01149863|158128777|FG000|Overall Study|Missing data or Not receiveing studydrug|3|||
49080273|NCT00111241|158128780|FG000|Overall Study|Lost to Follow-up|1|||
49080274|NCT00111241|158128781|FG001|Overall Study|Lost to Follow-up|0|||
49080275|NCT00111241|158128780|FG000|Overall Study|Withdrawal by Subject|4|||
49080276|NCT00111241|158128781|FG001|Overall Study|Withdrawal by Subject|0|||
49080277|NCT00111241|158128780|FG000|Overall Study|Protocol Violation|9|||
49080278|NCT00111241|158128781|FG001|Overall Study|Protocol Violation|8|||
49080279|NCT00111241|158128780|FG000|Overall Study|Adverse Event|1|||
49080280|NCT00111241|158128781|FG001|Overall Study|Adverse Event|0|||
49080281|NCT04728802|158128782|FG000|Overall Study|Withdrawal by Subject|4|||
49080282|NCT04728802|158128783|FG001|Overall Study|Withdrawal by Subject|20|||
49080283|NCT04728802|158128782|FG000|Overall Study|Physician Decision|7|||
49080284|NCT04728802|158128783|FG001|Overall Study|Physician Decision|7|||
49080285|NCT04728802|158128782|FG000|Overall Study|Protocol Violation|10|||
49080286|NCT04728802|158128783|FG001|Overall Study|Protocol Violation|4|||
49080287|NCT04728802|158128782|FG000|Overall Study|Transfer|1|||
49080288|NCT04728802|158128783|FG001|Overall Study|Transfer|0|||
49080289|NCT04728802|158128782|FG000|Overall Study|Death|4|||
49080290|NCT04728802|158128783|FG001|Overall Study|Death|5|||
49080291|NCT04728802|158128782|FG000|Overall Study|Other|3|||
49080292|NCT04728802|158128783|FG001|Overall Study|Other|0|||
49080293|NCT01640249|158128785|FG000|Period 1|Withdrawal by Subject|1|||
49080294|NCT01640249|158128786|FG001|Period 1|Withdrawal by Subject|0|||
49080295|NCT01640249|158128787|FG002|Period 1|Withdrawal by Subject|0|||
49080296|NCT01640249|158128788|FG003|Period 1|Withdrawal by Subject|0|||
49080297|NCT01640249|158128789|FG004|Period 1|Withdrawal by Subject|0|||
49080298|NCT01640249|158128790|FG005|Period 1|Withdrawal by Subject|1|||
49080299|NCT01640249|158128791|FG006|Period 1|Withdrawal by Subject|0|||
49080300|NCT04650204|158128803|FG000|Overall Study|Study was Terminated|2|||
49080301|NCT04650204|158128804|FG001|Overall Study|Study was Terminated|1|||
49080302|NCT01169350|158128807|FG000|Overall Study|Physician Decision|3|||
49080303|NCT01169350|158128807|FG000|Overall Study|Lost to Follow-up|2|||
49080304|NCT03367819|158128808|FG000|Overall Study|Adverse Event|4|||
49080305|NCT03367819|158128809|FG001|Overall Study|Adverse Event|4|||
49080306|NCT03367819|158128808|FG000|Overall Study|Progressive Disease|15|||
49080307|NCT03367819|158128809|FG001|Overall Study|Progressive Disease|13|||
49080308|NCT03367819|158128808|FG000|Overall Study|Withdrawal by Subject|1|||
49080309|NCT03367819|158128809|FG001|Overall Study|Withdrawal by Subject|0|||
49080310|NCT03367819|158128808|FG000|Overall Study|Other|4|||
49080311|NCT03367819|158128809|FG001|Overall Study|Other|2|||
49080312|NCT02601014|158128810|FG000|Overall Study|Adverse Event|3|||
49080313|NCT02601014|158128811|FG001|Overall Study|Adverse Event|3|||
49080314|NCT02601014|158128810|FG000|Overall Study|Death|3|||
49080315|NCT02601014|158128811|FG001|Overall Study|Death|1|||
49080316|NCT02601014|158128810|FG000|Overall Study|Disease progression|4|||
49080317|NCT02601014|158128811|FG001|Overall Study|Disease progression|8|||
49080318|NCT04352101|158128812|FG000|Overall Study|Physician Decision|2|||
49080319|NCT04352101|158128813|FG001|Overall Study|Physician Decision|1|||
49080320|NCT04211831|158128814|FG000|Overall Study|Withdrawal by Subject|4|||
49080321|NCT04211831|158128815|FG001|Overall Study|Withdrawal by Subject|1|||
49080322|NCT04211831|158128816|FG002|Overall Study|Withdrawal by Subject|1|||
49080323|NCT04211831|158128814|FG000|Overall Study|Protocol Violation|0|||
49080324|NCT04211831|158128815|FG001|Overall Study|Protocol Violation|0|||
49080325|NCT04211831|158128816|FG002|Overall Study|Protocol Violation|1|||
49080326|NCT04211831|158128814|FG000|Overall Study|Adverse Event|0|||
49080327|NCT04211831|158128815|FG001|Overall Study|Adverse Event|1|||
49080328|NCT04211831|158128816|FG002|Overall Study|Adverse Event|0|||
49080329|NCT04211831|158128814|FG000|Overall Study|Lack of Efficacy|0|||
49080330|NCT04211831|158128815|FG001|Overall Study|Lack of Efficacy|0|||
49080331|NCT04211831|158128816|FG002|Overall Study|Lack of Efficacy|1|||
49080332|NCT04211831|158128814|FG000|Overall Study|Lost to Follow-up|0|||
49080333|NCT04211831|158128815|FG001|Overall Study|Lost to Follow-up|0|||
49080334|NCT04211831|158128816|FG002|Overall Study|Lost to Follow-up|2|||
49080335|NCT04211831|158128814|FG000|Overall Study|Unable to Complete the Procedures Successfully|0|||
49080336|NCT04211831|158128815|FG001|Overall Study|Unable to Complete the Procedures Successfully|1|||
49080337|NCT04211831|158128816|FG002|Overall Study|Unable to Complete the Procedures Successfully|0|||
49080338|NCT04211831|158128814|FG000|Overall Study|Other|0|||
49080339|NCT04211831|158128815|FG001|Overall Study|Other|1|||
49080340|NCT04211831|158128816|FG002|Overall Study|Other|0|||
49080341|NCT01168427|158128817|FG000|Overall Study|Patient exited prior to implant|1|||
49080342|NCT00982657|158128818|FG000|Overall Study|Death|1|||
49080343|NCT00982657|158128819|FG001|Overall Study|Death|0|||
49080344|NCT00982657|158128820|FG002|Overall Study|Death|1|||
49080345|NCT00982657|158128821|FG003|Overall Study|Death|1|||
49080346|NCT00982657|158128818|FG000|Overall Study|Withdrawal by Subject|0|||
49080347|NCT00982657|158128819|FG001|Overall Study|Withdrawal by Subject|0|||
49080348|NCT00982657|158128820|FG002|Overall Study|Withdrawal by Subject|1|||
49080349|NCT00982657|158128821|FG003|Overall Study|Withdrawal by Subject|3|||
49080350|NCT00982657|158128818|FG000|Overall Study|Other|0|||
49080351|NCT00982657|158128819|FG001|Overall Study|Other|0|||
49080352|NCT00982657|158128820|FG002|Overall Study|Other|0|||
49080353|NCT00982657|158128821|FG003|Overall Study|Other|4|||
49080354|NCT00982657|158128818|FG000|Overall Study|On going at date of cut-off|0|||
49080355|NCT00982657|158128819|FG001|Overall Study|On going at date of cut-off|0|||
49080356|NCT00982657|158128820|FG002|Overall Study|On going at date of cut-off|0|||
49080357|NCT00982657|158128821|FG003|Overall Study|On going at date of cut-off|1|||
49080358|NCT01891864|158128823|FG000|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
49080359|NCT01891864|158128824|FG001|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
49080360|NCT01891864|158128825|FG002|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
49080361|NCT01891864|158128826|FG003|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
49080362|NCT01891864|158128827|FG004|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
49080363|NCT01891864|158128828|FG005|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
49080364|NCT01891864|158128823|FG000|Treatment Period 1|Physician Decision|0|||
49080365|NCT01891864|158128824|FG001|Treatment Period 1|Physician Decision|1|||
49080366|NCT01891864|158128825|FG002|Treatment Period 1|Physician Decision|0|||
49080367|NCT01891864|158128826|FG003|Treatment Period 1|Physician Decision|0|||
49080368|NCT01891864|158128827|FG004|Treatment Period 1|Physician Decision|0|||
49080369|NCT01891864|158128828|FG005|Treatment Period 1|Physician Decision|0|||
49080370|NCT01891864|158128823|FG000|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
49080371|NCT01891864|158128824|FG001|Treatment Period 1|Adverse Event, Serious, Fatal|1|||
49080372|NCT01891864|158128825|FG002|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
49080373|NCT01891864|158128826|FG003|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
49080374|NCT01891864|158128827|FG004|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
49080375|NCT01891864|158128828|FG005|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
49080376|NCT01891864|158128823|FG000|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
49080377|NCT01891864|158128824|FG001|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
49080378|NCT01891864|158128825|FG002|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
49080379|NCT01891864|158128826|FG003|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
49080380|NCT01891864|158128827|FG004|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
49080381|NCT01891864|158128828|FG005|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
49080382|NCT01891864|158128823|FG000|Treatment Period 1|Withdrawal by Subject|2|||
49080383|NCT01891864|158128824|FG001|Treatment Period 1|Withdrawal by Subject|5|||
49080384|NCT01891864|158128825|FG002|Treatment Period 1|Withdrawal by Subject|0|||
49080385|NCT01891864|158128826|FG003|Treatment Period 1|Withdrawal by Subject|0|||
49080386|NCT01891864|158128827|FG004|Treatment Period 1|Withdrawal by Subject|0|||
49080387|NCT01891864|158128828|FG005|Treatment Period 1|Withdrawal by Subject|0|||
49080388|NCT01891864|158128823|FG000|Treatment Period 1|Lost to Follow-up|1|||
49080389|NCT01891864|158128824|FG001|Treatment Period 1|Lost to Follow-up|0|||
49080390|NCT01891864|158128825|FG002|Treatment Period 1|Lost to Follow-up|0|||
49080391|NCT01891864|158128826|FG003|Treatment Period 1|Lost to Follow-up|0|||
49080392|NCT01891864|158128827|FG004|Treatment Period 1|Lost to Follow-up|0|||
49080393|NCT01891864|158128828|FG005|Treatment Period 1|Lost to Follow-up|0|||
49080394|NCT01891864|158128823|FG000|Treatment Period 2|Protocol Violation|0|||
49080395|NCT01891864|158128824|FG001|Treatment Period 2|Protocol Violation|0|||
49080396|NCT01891864|158128825|FG002|Treatment Period 2|Protocol Violation|0|||
49080397|NCT01891864|158128826|FG003|Treatment Period 2|Protocol Violation|1|||
49080398|NCT01891864|158128827|FG004|Treatment Period 2|Protocol Violation|0|||
49080399|NCT01891864|158128828|FG005|Treatment Period 2|Protocol Violation|0|||
49080400|NCT01891864|158128823|FG000|Treatment Period 2|Physician Decision|0|||
49080401|NCT01891864|158128824|FG001|Treatment Period 2|Physician Decision|0|||
49080402|NCT01891864|158128825|FG002|Treatment Period 2|Physician Decision|1|||
49080403|NCT01891864|158128826|FG003|Treatment Period 2|Physician Decision|0|||
49080404|NCT01891864|158128827|FG004|Treatment Period 2|Physician Decision|0|||
49080405|NCT01891864|158128828|FG005|Treatment Period 2|Physician Decision|0|||
49080406|NCT01891864|158128823|FG000|Treatment Period 2|Site Termination|0|||
49080407|NCT01891864|158128824|FG001|Treatment Period 2|Site Termination|0|||
49080408|NCT01891864|158128825|FG002|Treatment Period 2|Site Termination|1|||
49080409|NCT01891864|158128826|FG003|Treatment Period 2|Site Termination|2|||
49080410|NCT01891864|158128827|FG004|Treatment Period 2|Site Termination|0|||
49080411|NCT01891864|158128828|FG005|Treatment Period 2|Site Termination|0|||
49080412|NCT01891864|158128823|FG000|Treatment Period 2|Lack of Efficacy|0|||
49080413|NCT01891864|158128824|FG001|Treatment Period 2|Lack of Efficacy|0|||
49080414|NCT01891864|158128825|FG002|Treatment Period 2|Lack of Efficacy|1|||
49080415|NCT01891864|158128826|FG003|Treatment Period 2|Lack of Efficacy|0|||
49080416|NCT01891864|158128827|FG004|Treatment Period 2|Lack of Efficacy|1|||
49080417|NCT01891864|158128828|FG005|Treatment Period 2|Lack of Efficacy|0|||
49080418|NCT01891864|158128823|FG000|Treatment Period 2|Adverse Event|0|||
49080419|NCT01891864|158128824|FG001|Treatment Period 2|Adverse Event|0|||
49080420|NCT01891864|158128825|FG002|Treatment Period 2|Adverse Event|1|||
49080421|NCT01891864|158128826|FG003|Treatment Period 2|Adverse Event|2|||
49080422|NCT01891864|158128827|FG004|Treatment Period 2|Adverse Event|0|||
49080423|NCT01891864|158128828|FG005|Treatment Period 2|Adverse Event|4|||
49080424|NCT01891864|158128823|FG000|Treatment Period 2|Termination of Site|0|||
49080425|NCT01891864|158128824|FG001|Treatment Period 2|Termination of Site|0|||
49080426|NCT01891864|158128825|FG002|Treatment Period 2|Termination of Site|0|||
49080427|NCT01891864|158128826|FG003|Treatment Period 2|Termination of Site|0|||
49080428|NCT01891864|158128827|FG004|Treatment Period 2|Termination of Site|2|||
49080429|NCT01891864|158128828|FG005|Treatment Period 2|Termination of Site|0|||
49080430|NCT01891864|158128823|FG000|Treatment Period 2|Withdrawal by Subject|0|||
49080431|NCT01891864|158128824|FG001|Treatment Period 2|Withdrawal by Subject|0|||
49080432|NCT01891864|158128825|FG002|Treatment Period 2|Withdrawal by Subject|3|||
49080433|NCT01891864|158128826|FG003|Treatment Period 2|Withdrawal by Subject|4|||
49080434|NCT01891864|158128827|FG004|Treatment Period 2|Withdrawal by Subject|1|||
49080435|NCT01891864|158128828|FG005|Treatment Period 2|Withdrawal by Subject|1|||
49080436|NCT01891864|158128823|FG000|Extension Period|Lack of Efficacy|0|||
49080437|NCT01891864|158128824|FG001|Extension Period|Lack of Efficacy|0|||
49080438|NCT01891864|158128825|FG002|Extension Period|Lack of Efficacy|0|||
49080439|NCT01891864|158128826|FG003|Extension Period|Lack of Efficacy|1|||
49080440|NCT01891864|158128827|FG004|Extension Period|Lack of Efficacy|1|||
49080441|NCT01891864|158128828|FG005|Extension Period|Lack of Efficacy|0|||
49080442|NCT01891864|158128823|FG000|Extension Period|Pregnancy|0|||
49080443|NCT01891864|158128824|FG001|Extension Period|Pregnancy|0|||
49080444|NCT01891864|158128825|FG002|Extension Period|Pregnancy|1|||
49080445|NCT01891864|158128826|FG003|Extension Period|Pregnancy|0|||
49080446|NCT01891864|158128827|FG004|Extension Period|Pregnancy|0|||
49080447|NCT01891864|158128828|FG005|Extension Period|Pregnancy|0|||
49080448|NCT01891864|158128823|FG000|Extension Period|Adverse Event|0|||
49080449|NCT01891864|158128824|FG001|Extension Period|Adverse Event|0|||
49080450|NCT01891864|158128825|FG002|Extension Period|Adverse Event|4|||
49080451|NCT01891864|158128826|FG003|Extension Period|Adverse Event|2|||
49080452|NCT01891864|158128827|FG004|Extension Period|Adverse Event|2|||
49080453|NCT01891864|158128828|FG005|Extension Period|Adverse Event|0|||
49080454|NCT01891864|158128823|FG000|Extension Period|Withdrawal by Subject|0|||
49080455|NCT01891864|158128824|FG001|Extension Period|Withdrawal by Subject|0|||
49080456|NCT01891864|158128825|FG002|Extension Period|Withdrawal by Subject|1|||
49080457|NCT01891864|158128826|FG003|Extension Period|Withdrawal by Subject|2|||
49080458|NCT01891864|158128827|FG004|Extension Period|Withdrawal by Subject|4|||
49080459|NCT01891864|158128828|FG005|Extension Period|Withdrawal by Subject|0|||
49080460|NCT01891864|158128823|FG000|Extension Period|Lost to Follow-up|0|||
49080461|NCT01891864|158128824|FG001|Extension Period|Lost to Follow-up|0|||
49080462|NCT01891864|158128825|FG002|Extension Period|Lost to Follow-up|2|||
49080463|NCT01891864|158128826|FG003|Extension Period|Lost to Follow-up|0|||
49080464|NCT01891864|158128827|FG004|Extension Period|Lost to Follow-up|0|||
49080465|NCT01891864|158128828|FG005|Extension Period|Lost to Follow-up|0|||
49080466|NCT05244122|158130328|FG000|Overall Study|Withdrawal by Subject|318|||
49080467|NCT01564537|158130329|FG000|Overall Study|Site Terminated by Sponsor|1|||
49080468|NCT01564537|158130330|FG001|Overall Study|Site Terminated by Sponsor|0|||
49080469|NCT01564537|158130329|FG000|Overall Study|Withdrawal by Subject|12|||
49080470|NCT01564537|158130330|FG001|Overall Study|Withdrawal by Subject|14|||
49080471|NCT01564537|158130329|FG000|Overall Study|Lost to Follow-up|7|||
49080472|NCT01564537|158130330|FG001|Overall Study|Lost to Follow-up|3|||
49080473|NCT01564537|158130329|FG000|Overall Study|Reason not specified|81|||
49080474|NCT01564537|158130330|FG001|Overall Study|Reason not specified|82|||
49080475|NCT00887289|158130332|FG000|Overall Study|Lack of Efficacy|14|||
49080476|NCT00887289|158130332|FG000|Overall Study|Adverse Event|27|||
49080477|NCT00887289|158130332|FG000|Overall Study|Withdrawal by Subject|26|||
49080478|NCT00887289|158130332|FG000|Overall Study|Lost to Follow-up|8|||
49080479|NCT00887289|158130332|FG000|Overall Study|Other|20|||
49080480|NCT02077140|158130333|FG000|Overall Study|Lost to Follow-up|4|||
49080481|NCT02077140|158130334|FG001|Overall Study|Lost to Follow-up|1|||
49080482|NCT02077140|158130335|FG002|Overall Study|Lost to Follow-up|2|||
49080483|NCT02077140|158130336|FG003|Overall Study|Lost to Follow-up|2|||
49080484|NCT02077140|158130337|FG004|Overall Study|Lost to Follow-up|3|||
49080485|NCT02077140|158130333|FG000|Overall Study|Withdrawal by Subject|0|||
49080486|NCT02077140|158130334|FG001|Overall Study|Withdrawal by Subject|1|||
49080487|NCT02077140|158130335|FG002|Overall Study|Withdrawal by Subject|0|||
49080488|NCT02077140|158130336|FG003|Overall Study|Withdrawal by Subject|2|||
49080489|NCT02077140|158130337|FG004|Overall Study|Withdrawal by Subject|2|||
49080490|NCT00591773|158130340|FG000|Overall Study|Adverse Event|9|||
49080491|NCT00591773|158130341|FG001|Overall Study|Adverse Event|9|||
49080492|NCT00591773|158130342|FG002|Overall Study|Adverse Event|6|||
49080493|NCT00591773|158130340|FG000|Overall Study|Protocol Violation|2|||
49080494|NCT00591773|158130341|FG001|Overall Study|Protocol Violation|3|||
49080495|NCT00591773|158130342|FG002|Overall Study|Protocol Violation|0|||
49080496|NCT00591773|158130340|FG000|Overall Study|Lost to Follow-up|1|||
49080497|NCT00591773|158130341|FG001|Overall Study|Lost to Follow-up|4|||
49080498|NCT00591773|158130342|FG002|Overall Study|Lost to Follow-up|1|||
49080499|NCT00591773|158130340|FG000|Overall Study|Withdrawal by Subject|2|||
49080500|NCT00591773|158130341|FG001|Overall Study|Withdrawal by Subject|5|||
49080501|NCT00591773|158130342|FG002|Overall Study|Withdrawal by Subject|3|||
49080502|NCT00591773|158130340|FG000|Overall Study|Lack of Efficacy|1|||
49080503|NCT00591773|158130341|FG001|Overall Study|Lack of Efficacy|2|||
49080504|NCT00591773|158130342|FG002|Overall Study|Lack of Efficacy|2|||
49080505|NCT00591773|158130340|FG000|Overall Study|Other|1|||
49080506|NCT00591773|158130341|FG001|Overall Study|Other|1|||
49080507|NCT00591773|158130342|FG002|Overall Study|Other|4|||
49080508|NCT00459355|158130343|FG000|Overall Study|Subject no longer met inc criteria|20|||
49080509|NCT00459355|158130344|FG001|Overall Study|Subject no longer met inc criteria|18|||
49080510|NCT03022084|158130355|FG000|Overall Study|Lost to Follow-up|2|||
49080511|NCT03022084|158130356|FG001|Overall Study|Lost to Follow-up|3|||
49080512|NCT01026194|158130357|FG000|Period 1：Double Blind Period|Adverse Event|2|||
49080513|NCT01026194|158130358|FG001|Period 1：Double Blind Period|Adverse Event|1|||
49080514|NCT01026194|158130357|FG000|Period 1：Double Blind Period|Lack of Efficacy|1|||
49080515|NCT01026194|158130358|FG001|Period 1：Double Blind Period|Lack of Efficacy|0|||
49080516|NCT01026194|158130357|FG000|Period 1：Double Blind Period|Physician Decision|0|||
49080517|NCT01026194|158130358|FG001|Period 1：Double Blind Period|Physician Decision|4|||
49080518|NCT01026194|158130357|FG000|Period 2：Open-label Period|Adverse Event|4|||
49080519|NCT01026194|158130358|FG001|Period 2：Open-label Period|Adverse Event|5|||
49080520|NCT01026194|158130357|FG000|Period 2：Open-label Period|Physician Decision|3|||
49080521|NCT01026194|158130358|FG001|Period 2：Open-label Period|Physician Decision|1|||
49080522|NCT01026194|158130357|FG000|Period 2：Open-label Period|Withdrawal by Subject|0|||
49080523|NCT01026194|158130358|FG001|Period 2：Open-label Period|Withdrawal by Subject|4|||
49080524|NCT01866826|158130359|FG000|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1|||
49080525|NCT01866826|158130360|FG001|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0|||
49080526|NCT01866826|158130359|FG000|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0|||
49080527|NCT01866826|158130360|FG001|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2|||
49080528|NCT01866826|158130359|FG000|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0|||
49080529|NCT01866826|158130360|FG001|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1|||
49080530|NCT02493660|158130361|FG000|Overall Study|Physician Decision|0|||
49080531|NCT02493660|158130362|FG001|Overall Study|Physician Decision|1|||
49080532|NCT02493660|158130361|FG000|Overall Study|Adverse Event|4|||
49080533|NCT02493660|158130362|FG001|Overall Study|Adverse Event|2|||
49080534|NCT02493660|158130361|FG000|Overall Study|Withdrawal by Subject|2|||
49080535|NCT02493660|158130362|FG001|Overall Study|Withdrawal by Subject|3|||
49080536|NCT02493660|158130361|FG000|Overall Study|Subject unable to return for follow-up visits|2|||
49080537|NCT02493660|158130362|FG001|Overall Study|Subject unable to return for follow-up visits|0|||
49080538|NCT02493660|158130361|FG000|Overall Study|Protocol Violation|0|||
49080539|NCT02493660|158130362|FG001|Overall Study|Protocol Violation|1|||
49080540|NCT02493660|158130361|FG000|Overall Study|Death|0|||
49080541|NCT02493660|158130362|FG001|Overall Study|Death|1|||
49080542|NCT02493660|158130361|FG000|Overall Study|Lost to Follow-up|2|||
49080543|NCT02493660|158130362|FG001|Overall Study|Lost to Follow-up|4|||
49080544|NCT00709995|158130366|FG000|Overall Study|Adverse Event|4|||
49080545|NCT00709995|158130367|FG001|Overall Study|Adverse Event|2|||
49080546|NCT00709995|158130366|FG000|Overall Study|Withdrawal by Subject|1|||
49080547|NCT00709995|158130367|FG001|Overall Study|Withdrawal by Subject|3|||
49080548|NCT01276041|158130368|FG000|Overall Study|Adverse Event|2|||
49080549|NCT01276041|158130368|FG000|Overall Study|Protocol Violation|1|||
49080550|NCT04428034|158130378|FG000|Enrollment to Intervention Completion|Protocol Violation|6|||
49080551|NCT00699816|158130381|FG000|Overall Study|Protocol Violation|1|||
49080552|NCT00699816|158130382|FG001|Overall Study|Protocol Violation|3|||
49080553|NCT02454933|158130387|FG000|Overall Study|Progressive disease|10|||
49080554|NCT02454933|158130388|FG001|Overall Study|Progressive disease|7|||
49080555|NCT02454933|158130387|FG000|Overall Study|Adverse Event|1|||
49080556|NCT02454933|158130388|FG001|Overall Study|Adverse Event|1|||
49080557|NCT02454933|158130387|FG000|Overall Study|Withdrawal by Subject|0|||
49080558|NCT02454933|158130388|FG001|Overall Study|Withdrawal by Subject|3|||
49080559|NCT02454933|158130387|FG000|Overall Study|Lost to Follow-up|1|||
49080560|NCT02454933|158130388|FG001|Overall Study|Lost to Follow-up|0|||
49080561|NCT00560391|158130390|FG000|Overall Study|Still on treatment|0|||
49080562|NCT00560391|158130391|FG001|Overall Study|Still on treatment|0|||
49080563|NCT00560391|158130392|FG002|Overall Study|Still on treatment|0|||
49080564|NCT00560391|158130393|FG003|Overall Study|Still on treatment|1|||
49080565|NCT00560391|158130394|FG004|Overall Study|Still on treatment|2|||
49080566|NCT00955617|158130395|FG000|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2|||
49080567|NCT00955617|158130396|FG001|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1|||
49080568|NCT00955617|158130395|FG000|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0|||
49080569|NCT00955617|158130396|FG001|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1|||
49080570|NCT00955617|158130395|FG000|Second MRA (Between Day 1 and Day 51)|technical incident|0|||
49080571|NCT00955617|158130396|FG001|Second MRA (Between Day 1 and Day 51)|technical incident|1|||
49080572|NCT00955617|158130395|FG000|Second MRA (Between Day 1 and Day 51)|conventional angiography|1|||
49080573|NCT00955617|158130396|FG001|Second MRA (Between Day 1 and Day 51)|conventional angiography|0|||
49080574|NCT04176250|158130397|FG000|Overall Study|Adverse Event|0|||
49080575|NCT04176250|158130398|FG001|Overall Study|Adverse Event|1|||
49080576|NCT04176250|158130399|FG002|Overall Study|Adverse Event|0|||
49080577|NCT04176250|158130400|FG003|Overall Study|Adverse Event|1|||
49080578|NCT04176250|158130401|FG004|Overall Study|Adverse Event|0|||
49080579|NCT04176250|158130402|FG005|Overall Study|Adverse Event|1|||
49080580|NCT04176250|158130397|FG000|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
49080581|NCT04176250|158130398|FG001|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
49080582|NCT04176250|158130399|FG002|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
49080583|NCT04176250|158130400|FG003|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
49080584|NCT04176250|158130401|FG004|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
49080585|NCT04176250|158130402|FG005|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
49080586|NCT04176250|158130397|FG000|Overall Study|Withdrawal by Subject|0|||
49080587|NCT04176250|158130398|FG001|Overall Study|Withdrawal by Subject|0|||
49080588|NCT04176250|158130399|FG002|Overall Study|Withdrawal by Subject|0|||
49080589|NCT04176250|158130400|FG003|Overall Study|Withdrawal by Subject|0|||
49080590|NCT04176250|158130401|FG004|Overall Study|Withdrawal by Subject|0|||
49080591|NCT04176250|158130402|FG005|Overall Study|Withdrawal by Subject|1|||
49080592|NCT04176250|158130397|FG000|Overall Study|Randomized in error|0|||
49080593|NCT04176250|158130398|FG001|Overall Study|Randomized in error|0|||
49080594|NCT04176250|158130399|FG002|Overall Study|Randomized in error|0|||
49080595|NCT04176250|158130400|FG003|Overall Study|Randomized in error|0|||
49080596|NCT04176250|158130401|FG004|Overall Study|Randomized in error|1|||
49080597|NCT04176250|158130402|FG005|Overall Study|Randomized in error|0|||
49080598|NCT01895777|158130403|FG000|Overall Study|Adverse Event|1|||
49080599|NCT01895777|158130404|FG001|Overall Study|Adverse Event|2|||
49080600|NCT01895777|158130403|FG000|Overall Study|Lost to Follow-up|2|||
49080601|NCT01895777|158130404|FG001|Overall Study|Lost to Follow-up|0|||
49080602|NCT01895777|158130403|FG000|Overall Study|Not treated|1|||
49080603|NCT01895777|158130404|FG001|Overall Study|Not treated|0|||
49080604|NCT01895777|158130403|FG000|Overall Study|Other reasons|3|||
49080605|NCT01895777|158130404|FG001|Overall Study|Other reasons|2|||
49080606|NCT01895777|158130403|FG000|Overall Study|Non-compliance with the CTP|2|||
49080607|NCT01895777|158130404|FG001|Overall Study|Non-compliance with the CTP|1|||
49080608|NCT02635984|158130405|FG000|Overall Study|Lost to Follow-up|2|||
49080609|NCT02635984|158130406|FG001|Overall Study|Lost to Follow-up|4|||
49080610|NCT02635984|158130405|FG000|Overall Study|Study Arm Closed|1|||
49080611|NCT02635984|158130406|FG001|Overall Study|Study Arm Closed|0|||
49080612|NCT01870778|158130408|FG000|Overall Study|Withdrawal by Subject|8|||
49080613|NCT01870778|158130409|FG001|Overall Study|Withdrawal by Subject|7|||
49080614|NCT01870778|158130408|FG000|Overall Study|Lost to Follow-up|0|||
49080615|NCT01870778|158130409|FG001|Overall Study|Lost to Follow-up|2|||
49080616|NCT00065156|158130410|FG000|Overall Study|Adverse Event|37|||
49080617|NCT00065156|158130410|FG000|Overall Study|Lack of Efficacy|52|||
49080618|NCT00065156|158130410|FG000|Overall Study|Withdrawal by Subject|8|||
49080619|NCT00065156|158130410|FG000|Overall Study|Lost to Follow-up|1|||
49080620|NCT00065156|158130410|FG000|Overall Study|Death|11|||
49080621|NCT00065156|158130410|FG000|Overall Study|Study Closed by Sponsor|2|||
49080622|NCT00065156|158130410|FG000|Overall Study|Disease Progression|7|||
49080623|NCT00065156|158130410|FG000|Overall Study|Investigator Decision|2|||
49080624|NCT00065156|158130410|FG000|Overall Study|Non-Compliance|2|||
49080625|NCT00065156|158130410|FG000|Overall Study|Loss of Response|1|||
49080626|NCT00065156|158130410|FG000|Overall Study|Secondary Malign Disease|1|||
49080627|NCT05317312|158130411|FG000|Overall Study|Withdrawal by Subject|0|||
49080628|NCT05317312|158130412|FG001|Overall Study|Withdrawal by Subject|1|||
49080629|NCT05317312|158130413|FG002|Overall Study|Withdrawal by Subject|0|||
49080630|NCT05317312|158130414|FG003|Overall Study|Withdrawal by Subject|0|||
49080631|NCT05317312|158130411|FG000|Overall Study|Lost to Follow-up|0|||
49080632|NCT05317312|158130412|FG001|Overall Study|Lost to Follow-up|0|||
49080633|NCT05317312|158130413|FG002|Overall Study|Lost to Follow-up|0|||
49080634|NCT05317312|158130414|FG003|Overall Study|Lost to Follow-up|1|||
49080635|NCT05317312|158130411|FG000|Overall Study|Excluded as exclusion criteria was met.|0|||
49080636|NCT05317312|158130412|FG001|Overall Study|Excluded as exclusion criteria was met.|0|||
49080637|NCT05317312|158130413|FG002|Overall Study|Excluded as exclusion criteria was met.|1|||
49080638|NCT05317312|158130414|FG003|Overall Study|Excluded as exclusion criteria was met.|0|||
49080639|NCT00312338|158130415|FG000|Overall Study|Adverse Event|7|||
49080640|NCT00312338|158130416|FG001|Overall Study|Adverse Event|2|||
49080641|NCT00312338|158130415|FG000|Overall Study|Lost to Follow-up|9|||
49080642|NCT00312338|158130416|FG001|Overall Study|Lost to Follow-up|1|||
49080643|NCT00312338|158130415|FG000|Overall Study|Withdrawal by Subject|4|||
49080644|NCT00312338|158130416|FG001|Overall Study|Withdrawal by Subject|0|||
49080645|NCT00312338|158130415|FG000|Overall Study|Subsequent infection|2|||
49080646|NCT00312338|158130416|FG001|Overall Study|Subsequent infection|0|||
49080647|NCT01330303|158130417|FG000|Period 1|Adverse Event|1|||
49080648|NCT01330303|158130418|FG001|Period 1|Adverse Event|0|||
49080649|NCT01330303|158130417|FG000|Period 1|Protocol Violation|0|||
49080650|NCT01330303|158130418|FG001|Period 1|Protocol Violation|1|||
49080651|NCT01330303|158130417|FG000|Period 1|Withdrawal by Subject|0|||
49080652|NCT01330303|158130418|FG001|Period 1|Withdrawal by Subject|1|||
49080653|NCT00262028|158130419|FG000|Overall Study|Withdrawal by Subject|6|||
49080654|NCT00262028|158130420|FG001|Overall Study|Withdrawal by Subject|3|||
49080655|NCT00262028|158130421|FG002|Overall Study|Withdrawal by Subject|6|||
49080656|NCT00262028|158130422|FG003|Overall Study|Withdrawal by Subject|5|||
49080657|NCT00262028|158130423|FG004|Overall Study|Withdrawal by Subject|2|||
49080658|NCT00262028|158130424|FG005|Overall Study|Withdrawal by Subject|3|||
49080659|NCT00262028|158130425|FG006|Overall Study|Withdrawal by Subject|5|||
49080660|NCT00262028|158130426|FG007|Overall Study|Withdrawal by Subject|7|||
49080661|NCT00262028|158130427|FG008|Overall Study|Withdrawal by Subject|2|||
49080662|NCT00262028|158130419|FG000|Overall Study|Lost to Follow-up|7|||
49080663|NCT00262028|158130420|FG001|Overall Study|Lost to Follow-up|7|||
49080664|NCT00262028|158130421|FG002|Overall Study|Lost to Follow-up|5|||
49080665|NCT00262028|158130422|FG003|Overall Study|Lost to Follow-up|5|||
49080666|NCT00262028|158130423|FG004|Overall Study|Lost to Follow-up|4|||
49080667|NCT00262028|158130424|FG005|Overall Study|Lost to Follow-up|3|||
49080668|NCT00262028|158130425|FG006|Overall Study|Lost to Follow-up|3|||
49080669|NCT00262028|158130426|FG007|Overall Study|Lost to Follow-up|5|||
49080670|NCT00262028|158130427|FG008|Overall Study|Lost to Follow-up|6|||
49080671|NCT00262028|158130419|FG000|Overall Study|Administrative Reason|11|||
49080672|NCT00262028|158130420|FG001|Overall Study|Administrative Reason|14|||
49080673|NCT00262028|158130421|FG002|Overall Study|Administrative Reason|9|||
49080674|NCT00262028|158130422|FG003|Overall Study|Administrative Reason|12|||
49080675|NCT00262028|158130423|FG004|Overall Study|Administrative Reason|6|||
49080676|NCT00262028|158130424|FG005|Overall Study|Administrative Reason|7|||
49080677|NCT00262028|158130425|FG006|Overall Study|Administrative Reason|4|||
49080678|NCT00262028|158130426|FG007|Overall Study|Administrative Reason|6|||
49080679|NCT00262028|158130427|FG008|Overall Study|Administrative Reason|10|||
49080680|NCT00262028|158130419|FG000|Overall Study|Protocol Violation|0|||
49080681|NCT00262028|158130420|FG001|Overall Study|Protocol Violation|0|||
49080682|NCT00262028|158130421|FG002|Overall Study|Protocol Violation|0|||
49080683|NCT00262028|158130422|FG003|Overall Study|Protocol Violation|1|||
49080684|NCT00262028|158130423|FG004|Overall Study|Protocol Violation|0|||
49080685|NCT00262028|158130424|FG005|Overall Study|Protocol Violation|0|||
49080686|NCT00262028|158130425|FG006|Overall Study|Protocol Violation|0|||
49080687|NCT00262028|158130426|FG007|Overall Study|Protocol Violation|0|||
49080688|NCT00262028|158130427|FG008|Overall Study|Protocol Violation|0|||
49080689|NCT00262028|158130419|FG000|Overall Study|Unable to classify|0|||
49080690|NCT00262028|158130420|FG001|Overall Study|Unable to classify|3|||
49080691|NCT00262028|158130421|FG002|Overall Study|Unable to classify|0|||
49080692|NCT00262028|158130422|FG003|Overall Study|Unable to classify|0|||
49080693|NCT00262028|158130423|FG004|Overall Study|Unable to classify|0|||
49080694|NCT00262028|158130424|FG005|Overall Study|Unable to classify|0|||
49080695|NCT00262028|158130425|FG006|Overall Study|Unable to classify|0|||
49080696|NCT00262028|158130426|FG007|Overall Study|Unable to classify|0|||
49080697|NCT00262028|158130427|FG008|Overall Study|Unable to classify|1|||
49080698|NCT00100828|158130428|FG000|Overall Study|Physician Decision|6|||
49080699|NCT03817190|158130429|FG000|Overall Study|Early Termination|13|||
49080700|NCT03817190|158130430|FG001|Overall Study|Early Termination|20|||
49080701|NCT03817190|158130429|FG000|Overall Study|Adverse Event|10|||
49080702|NCT03817190|158130430|FG001|Overall Study|Adverse Event|17|||
49080703|NCT03817190|158130429|FG000|Overall Study|Withdrawal by Subject|12|||
49080704|NCT03817190|158130430|FG001|Overall Study|Withdrawal by Subject|8|||
49080705|NCT03817190|158130429|FG000|Overall Study|Lost to Follow-up|11|||
49080706|NCT03817190|158130430|FG001|Overall Study|Lost to Follow-up|7|||
49080707|NCT03817190|158130429|FG000|Overall Study|Lack of Efficacy|7|||
49080708|NCT03817190|158130430|FG001|Overall Study|Lack of Efficacy|5|||
49080709|NCT03817190|158130429|FG000|Overall Study|Investigator Decision|5|||
49080710|NCT03817190|158130430|FG001|Overall Study|Investigator Decision|1|||
49080711|NCT03817190|158130429|FG000|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|0|||
49080712|NCT03817190|158130430|FG001|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|1|||
49080713|NCT03817190|158130429|FG000|Overall Study|Lack of Contact|1|||
49080714|NCT03817190|158130430|FG001|Overall Study|Lack of Contact|0|||
49080715|NCT03817190|158130429|FG000|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|1|||
49080716|NCT03817190|158130430|FG001|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|0|||
49080717|NCT01197911|158130431|FG000|Overall Study|Adverse Event|0|||
49080718|NCT01197911|158130432|FG001|Overall Study|Adverse Event|0|||
49080719|NCT01197911|158130433|FG002|Overall Study|Adverse Event|1|||
49080720|NCT01306305|158130434|FG000|Overall Study|Lost to Follow-up|1|||
49080721|NCT01306305|158130435|FG001|Overall Study|Lost to Follow-up|0|||
49080722|NCT01306305|158130434|FG000|Overall Study|Withdrew consent|1|||
49080723|NCT01306305|158130435|FG001|Overall Study|Withdrew consent|0|||
49080724|NCT02235454|158130436|FG000|Overall Study|Withdrawal by Subject|2|||
49080725|NCT00931411|158130437|FG000|First Intervention - 42 Days|Adverse Event|2|||
49080726|NCT00931411|158130438|FG001|First Intervention - 42 Days|Adverse Event|3|||
49080727|NCT00931411|158130437|FG000|First Intervention - 42 Days|Lost to Follow-up|2|||
49080728|NCT00931411|158130438|FG001|First Intervention - 42 Days|Lost to Follow-up|0|||
49080729|NCT00931411|158130437|FG000|After Crossover - 14 Days (up to Day 56)|Adverse Event|0|||
49080730|NCT00931411|158130438|FG001|After Crossover - 14 Days (up to Day 56)|Adverse Event|1|||
49080731|NCT00610129|158130439|FG000|Overall Study|Not treated since patients ineligible|3|||
49080732|NCT02964247|158130440|FG000|Overall Study|Lost to Follow-up|2|||
49080733|NCT02964247|158130441|FG001|Overall Study|Lost to Follow-up|0|||
49080734|NCT02964247|158130440|FG000|Overall Study|Withdrawal by Subject|1|||
49080735|NCT02964247|158130441|FG001|Overall Study|Withdrawal by Subject|2|||
49080736|NCT03759392|158130443|FG000|Overall Study|Adverse Event|12|||
49080737|NCT03759392|158130444|FG001|Overall Study|Adverse Event|4|||
49080738|NCT03759392|158130443|FG000|Overall Study|Death|2|||
49080739|NCT03759392|158130444|FG001|Overall Study|Death|1|||
49080740|NCT03759392|158130443|FG000|Overall Study|Withdrawal by Subject|2|||
49080741|NCT03759392|158130444|FG001|Overall Study|Withdrawal by Subject|0|||
49080742|NCT03759392|158130443|FG000|Overall Study|Protocol Violation|2|||
49080743|NCT03759392|158130444|FG001|Overall Study|Protocol Violation|0|||
49080744|NCT03759392|158130443|FG000|Overall Study|Physician Decision|0|||
49080745|NCT03759392|158130444|FG001|Overall Study|Physician Decision|1|||
49080746|NCT03759392|158130443|FG000|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|1|||
49080747|NCT03759392|158130444|FG001|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|0|||
49080748|NCT03759392|158130443|FG000|Overall Study|No longer able to take medicines|1|||
49080749|NCT03759392|158130444|FG001|Overall Study|No longer able to take medicines|0|||
49080750|NCT03759392|158130443|FG000|Overall Study|Stopped taking study drug|1|||
49080751|NCT03759392|158130444|FG001|Overall Study|Stopped taking study drug|0|||
49080752|NCT02623725|158130445|FG000|Overall Study|Non compliance with protocol|9|||
49080753|NCT02623725|158130446|FG001|Overall Study|Non compliance with protocol|3|||
49080754|NCT02623725|158130445|FG000|Overall Study|Serious adverse event|0|||
49080755|NCT02623725|158130446|FG001|Overall Study|Serious adverse event|2|||
49080756|NCT02623725|158130445|FG000|Overall Study|Withdrawal by Subject|7|||
49080757|NCT02623725|158130446|FG001|Overall Study|Withdrawal by Subject|1|||
49080758|NCT04720105|158130450|FG000|Overall Study|Lack of Efficacy|1|||
49080759|NCT04720105|158130450|FG000|Overall Study|Lost to Follow-up|1|||
49080760|NCT04720105|158130450|FG000|Overall Study|Withdrawal by Subject|3|||
49080761|NCT02040805|158130451|FG000|Overall Study|Lost to Follow-up|14|||
49080762|NCT02040805|158130452|FG001|Overall Study|Lost to Follow-up|9|||
49080763|NCT02040805|158130451|FG000|Overall Study|Withdrawal by Subject|28|||
49080764|NCT02040805|158130452|FG001|Overall Study|Withdrawal by Subject|41|||
49080765|NCT01009814|158132469|FG000|Overall Study|No longer met study criteria|1|||
49080766|NCT01009814|158132470|FG001|Overall Study|No longer met study criteria|1|||
49080767|NCT01009814|158132471|FG002|Overall Study|No longer met study criteria|0|||
49080768|NCT01009814|158132472|FG003|Overall Study|No longer met study criteria|0|||
49080769|NCT01009814|158132473|FG004|Overall Study|No longer met study criteria|0|||
49080770|NCT00618371|158132474|FG000|Overall Study|Withdrawal by Subject|2|||
49080771|NCT02115607|158132477|FG000|Overall Study|Withdrawal by Subject|1|||
49080772|NCT01050530|158132481|FG000|Overall Study|Adverse Event|6|||
49080773|NCT01050530|158132482|FG001|Overall Study|Adverse Event|3|||
49080774|NCT01050530|158132481|FG000|Overall Study|Lack of Efficacy|1|||
49080775|NCT01050530|158132482|FG001|Overall Study|Lack of Efficacy|4|||
49080776|NCT01050530|158132481|FG000|Overall Study|Withdrawal by Subject|0|||
49080777|NCT01050530|158132482|FG001|Overall Study|Withdrawal by Subject|3|||
49080778|NCT01050530|158132481|FG000|Overall Study|Protocol Violation|1|||
49080779|NCT01050530|158132482|FG001|Overall Study|Protocol Violation|0|||
49080780|NCT00638508|158132490|FG000|Overall Study|Physician Decision|5|||
49080781|NCT00638508|158132491|FG001|Overall Study|Physician Decision|2|||
49080782|NCT01495000|158132494|FG000|Overall Study|Lost to Follow-up|2|||
49080783|NCT01495000|158132495|FG001|Overall Study|Lost to Follow-up|2|||
49080784|NCT01495000|158132494|FG000|Overall Study|Protocol Violation|1|||
49080785|NCT01495000|158132495|FG001|Overall Study|Protocol Violation|0|||
49080786|NCT01495000|158132494|FG000|Overall Study|Withdrawal by Subject|10|||
49080787|NCT01495000|158132495|FG001|Overall Study|Withdrawal by Subject|10|||
49080788|NCT00370552|158132498|FG000|Overall Study|Adverse Event|2|||
49080789|NCT00370552|158132499|FG001|Overall Study|Adverse Event|2|||
49080790|NCT00370552|158132500|FG002|Overall Study|Adverse Event|2|||
49080791|NCT00370552|158132498|FG000|Overall Study|Disease progression|23|||
49080792|NCT00370552|158132499|FG001|Overall Study|Disease progression|23|||
49080793|NCT00370552|158132500|FG002|Overall Study|Disease progression|15|||
49080794|NCT00370552|158132498|FG000|Overall Study|Maximum clinical benefit|3|||
49080795|NCT00370552|158132499|FG001|Overall Study|Maximum clinical benefit|5|||
49080796|NCT00370552|158132500|FG002|Overall Study|Maximum clinical benefit|5|||
49080797|NCT00370552|158132498|FG000|Overall Study|Poor or noncompliance|0|||
49080798|NCT00370552|158132499|FG001|Overall Study|Poor or noncompliance|0|||
49080799|NCT00370552|158132500|FG002|Overall Study|Poor or noncompliance|1|||
49080800|NCT00370552|158132498|FG000|Overall Study|Study drug toxicity|11|||
49080801|NCT00370552|158132499|FG001|Overall Study|Study drug toxicity|8|||
49080802|NCT00370552|158132500|FG002|Overall Study|Study drug toxicity|6|||
49080803|NCT00370552|158132498|FG000|Overall Study|Withdrawal by Subject|2|||
49080804|NCT00370552|158132499|FG001|Overall Study|Withdrawal by Subject|0|||
49080805|NCT00370552|158132500|FG002|Overall Study|Withdrawal by Subject|1|||
49080806|NCT00370552|158132498|FG000|Overall Study|Still on treatment|1|||
49080807|NCT00370552|158132499|FG001|Overall Study|Still on treatment|3|||
49080808|NCT00370552|158132500|FG002|Overall Study|Still on treatment|2|||
49080809|NCT00370552|158132498|FG000|Overall Study|Never treated|1|||
49080810|NCT00370552|158132499|FG001|Overall Study|Never treated|0|||
49080811|NCT00370552|158132500|FG002|Overall Study|Never treated|0|||
49080812|NCT00370552|158132498|FG000|Overall Study|Physician Decision|1|||
49080813|NCT00370552|158132499|FG001|Overall Study|Physician Decision|1|||
49080814|NCT00370552|158132500|FG002|Overall Study|Physician Decision|0|||
49080815|NCT00370552|158132498|FG000|Overall Study|Investigator decision|2|||
49080816|NCT00370552|158132499|FG001|Overall Study|Investigator decision|1|||
49080817|NCT00370552|158132500|FG002|Overall Study|Investigator decision|0|||
49080818|NCT00370552|158132498|FG000|Overall Study|High risk of allergic reaction|0|||
49080819|NCT00370552|158132499|FG001|Overall Study|High risk of allergic reaction|1|||
49080820|NCT00370552|158132500|FG002|Overall Study|High risk of allergic reaction|0|||
49080821|NCT00370552|158132498|FG000|Overall Study|Planned radiation for palliation|0|||
49080822|NCT00370552|158132499|FG001|Overall Study|Planned radiation for palliation|1|||
49080823|NCT00370552|158132500|FG002|Overall Study|Planned radiation for palliation|0|||
49080824|NCT02070965|158132503|FG000|Overall Study|Lost to Follow-up|0|||
49080825|NCT02070965|158132504|FG001|Overall Study|Lost to Follow-up|1|||
49080826|NCT02070965|158132505|FG002|Overall Study|Lost to Follow-up|0|||
49080827|NCT02070965|158132503|FG000|Overall Study|Withdrawal by Subject|1|||
49080828|NCT02070965|158132504|FG001|Overall Study|Withdrawal by Subject|1|||
49080829|NCT02070965|158132505|FG002|Overall Study|Withdrawal by Subject|1|||
49080830|NCT02070965|158132503|FG000|Overall Study|Subject moved|1|||
49080831|NCT02070965|158132504|FG001|Overall Study|Subject moved|0|||
49080832|NCT02070965|158132505|FG002|Overall Study|Subject moved|0|||
49080833|NCT04447040|158132506|FG000|Overall Study|Lost to Follow-up|2|||
49080834|NCT04447040|158132507|FG001|Overall Study|Lost to Follow-up|1|||
49080835|NCT04447040|158132508|FG002|Overall Study|Lost to Follow-up|3|||
49080836|NCT04447040|158132509|FG003|Overall Study|Lost to Follow-up|3|||
49080837|NCT04447040|158132510|FG004|Overall Study|Lost to Follow-up|1|||
49080838|NCT04447040|158132511|FG005|Overall Study|Lost to Follow-up|3|||
49080839|NCT04447040|158132506|FG000|Overall Study|Withdrawal by Subject|0|||
49080840|NCT04447040|158132507|FG001|Overall Study|Withdrawal by Subject|1|||
49080841|NCT04447040|158132508|FG002|Overall Study|Withdrawal by Subject|1|||
49080842|NCT04447040|158132509|FG003|Overall Study|Withdrawal by Subject|1|||
49080843|NCT04447040|158132510|FG004|Overall Study|Withdrawal by Subject|0|||
49080844|NCT04447040|158132511|FG005|Overall Study|Withdrawal by Subject|0|||
49080845|NCT02556801|158132512|FG000|Overall Study|Lost to Follow-up|1|||
49080846|NCT02556801|158132513|FG001|Overall Study|Lost to Follow-up|0|||
49080847|NCT02556801|158132514|FG002|Overall Study|Lost to Follow-up|2|||
49080848|NCT02556801|158132515|FG003|Overall Study|Lost to Follow-up|0|||
49080849|NCT02556801|158132512|FG000|Overall Study|Withdrawal by Subject|1|||
49080850|NCT02556801|158132513|FG001|Overall Study|Withdrawal by Subject|1|||
49080851|NCT02556801|158132514|FG002|Overall Study|Withdrawal by Subject|1|||
49080852|NCT02556801|158132515|FG003|Overall Study|Withdrawal by Subject|0|||
49080853|NCT02556801|158132512|FG000|Overall Study|Protocol Violation|0|||
49080854|NCT02556801|158132513|FG001|Overall Study|Protocol Violation|3|||
49080855|NCT02556801|158132514|FG002|Overall Study|Protocol Violation|1|||
49080856|NCT02556801|158132515|FG003|Overall Study|Protocol Violation|1|||
49080857|NCT02556801|158132512|FG000|Overall Study|Adverse Event|0|||
49080858|NCT02556801|158132513|FG001|Overall Study|Adverse Event|2|||
49080859|NCT02556801|158132514|FG002|Overall Study|Adverse Event|0|||
49080860|NCT02556801|158132515|FG003|Overall Study|Adverse Event|3|||
49080861|NCT02556801|158132512|FG000|Overall Study|Pregnancy|0|||
49080862|NCT02556801|158132513|FG001|Overall Study|Pregnancy|1|||
49080863|NCT02556801|158132514|FG002|Overall Study|Pregnancy|0|||
49080864|NCT02556801|158132515|FG003|Overall Study|Pregnancy|0|||
49080865|NCT02556801|158132512|FG000|Overall Study|Personal reasons patient|0|||
49080866|NCT02556801|158132513|FG001|Overall Study|Personal reasons patient|0|||
49080867|NCT02556801|158132514|FG002|Overall Study|Personal reasons patient|0|||
49080868|NCT02556801|158132515|FG003|Overall Study|Personal reasons patient|1|||
49080869|NCT01526057|158132516|FG000|Overall Study|Withdrawal by Subject|3|||
49080870|NCT01526057|158132517|FG001|Overall Study|Withdrawal by Subject|2|||
49080871|NCT01526057|158132518|FG002|Overall Study|Withdrawal by Subject|2|||
49080872|NCT01526057|158132516|FG000|Overall Study|Adverse Event|3|||
49080873|NCT01526057|158132517|FG001|Overall Study|Adverse Event|1|||
49080874|NCT01526057|158132518|FG002|Overall Study|Adverse Event|1|||
49080875|NCT01526057|158132516|FG000|Overall Study|Death|1|||
49080876|NCT01526057|158132517|FG001|Overall Study|Death|0|||
49080877|NCT01526057|158132518|FG002|Overall Study|Death|0|||
49080878|NCT01526057|158132516|FG000|Overall Study|Lost to Follow-up|1|||
49080879|NCT01526057|158132517|FG001|Overall Study|Lost to Follow-up|0|||
49080880|NCT01526057|158132518|FG002|Overall Study|Lost to Follow-up|1|||
49080881|NCT01526057|158132516|FG000|Overall Study|Other|1|||
49080882|NCT01526057|158132517|FG001|Overall Study|Other|0|||
49080883|NCT01526057|158132518|FG002|Overall Study|Other|1|||
49080884|NCT01526057|158132516|FG000|Overall Study|Protocol Violation|0|||
49080885|NCT01526057|158132517|FG001|Overall Study|Protocol Violation|0|||
49080886|NCT01526057|158132518|FG002|Overall Study|Protocol Violation|1|||
49080887|NCT00838526|158132523|FG000|Overall Study|Adverse Event|3|||
49080888|NCT00838526|158132524|FG001|Overall Study|Adverse Event|12|||
49080889|NCT00838526|158132523|FG000|Overall Study|Lost to Follow-up|4|||
49080890|NCT00838526|158132524|FG001|Overall Study|Lost to Follow-up|12|||
49080891|NCT00838526|158132523|FG000|Overall Study|Withdrawal by Subject|4|||
49080892|NCT00838526|158132524|FG001|Overall Study|Withdrawal by Subject|5|||
49080893|NCT00838526|158132523|FG000|Overall Study|Lack of Efficacy|2|||
49080894|NCT00838526|158132524|FG001|Overall Study|Lack of Efficacy|3|||
49080895|NCT00838526|158132523|FG000|Overall Study|Other|11|||
49080896|NCT00838526|158132524|FG001|Overall Study|Other|7|||
49080897|NCT00485264|158132525|FG000|Overall Study|Enrolled But Not Given Treatment|0|||
49080898|NCT00485264|158132526|FG001|Overall Study|Enrolled But Not Given Treatment|0|||
49080899|NCT00485264|158132527|FG002|Overall Study|Enrolled But Not Given Treatment|0|||
49080900|NCT00485264|158132528|FG003|Overall Study|Enrolled But Not Given Treatment|0|||
49080901|NCT00485264|158132529|FG004|Overall Study|Enrolled But Not Given Treatment|1|||
49080902|NCT00485264|158132530|FG005|Overall Study|Enrolled But Not Given Treatment|0|||
49080903|NCT00485264|158132525|FG000|Overall Study|Death|1|||
49080904|NCT00485264|158132526|FG001|Overall Study|Death|0|||
49080905|NCT00485264|158132527|FG002|Overall Study|Death|0|||
49080906|NCT00485264|158132528|FG003|Overall Study|Death|0|||
49080907|NCT00485264|158132529|FG004|Overall Study|Death|1|||
49080908|NCT00485264|158132530|FG005|Overall Study|Death|0|||
49080909|NCT00485264|158132525|FG000|Overall Study|Adverse Event|1|||
49080910|NCT00485264|158132526|FG001|Overall Study|Adverse Event|0|||
49080911|NCT00485264|158132527|FG002|Overall Study|Adverse Event|2|||
49080912|NCT00485264|158132528|FG003|Overall Study|Adverse Event|3|||
49080913|NCT00485264|158132529|FG004|Overall Study|Adverse Event|1|||
49080914|NCT00485264|158132530|FG005|Overall Study|Adverse Event|3|||
49080915|NCT00485264|158132525|FG000|Overall Study|Pregnancy|4|||
49080916|NCT00485264|158132526|FG001|Overall Study|Pregnancy|0|||
49080917|NCT00485264|158132527|FG002|Overall Study|Pregnancy|0|||
49080918|NCT00485264|158132528|FG003|Overall Study|Pregnancy|0|||
49080919|NCT00485264|158132529|FG004|Overall Study|Pregnancy|0|||
49080920|NCT00485264|158132530|FG005|Overall Study|Pregnancy|0|||
49080921|NCT00485264|158132525|FG000|Overall Study|Disallowed Medication|0|||
49080922|NCT00485264|158132526|FG001|Overall Study|Disallowed Medication|0|||
49080923|NCT00485264|158132527|FG002|Overall Study|Disallowed Medication|0|||
49080924|NCT00485264|158132528|FG003|Overall Study|Disallowed Medication|0|||
49080925|NCT00485264|158132529|FG004|Overall Study|Disallowed Medication|0|||
49080926|NCT00485264|158132530|FG005|Overall Study|Disallowed Medication|1|||
49080927|NCT00485264|158132525|FG000|Overall Study|Number/Volume/Timing of Study Meds|2|||
49080928|NCT00485264|158132526|FG001|Overall Study|Number/Volume/Timing of Study Meds|1|||
49080929|NCT00485264|158132527|FG002|Overall Study|Number/Volume/Timing of Study Meds|1|||
49080930|NCT00485264|158132528|FG003|Overall Study|Number/Volume/Timing of Study Meds|0|||
49080931|NCT00485264|158132529|FG004|Overall Study|Number/Volume/Timing of Study Meds|0|||
49080932|NCT00485264|158132530|FG005|Overall Study|Number/Volume/Timing of Study Meds|0|||
49080933|NCT00485264|158132525|FG000|Overall Study|Lack of Efficacy|0|||
49080934|NCT00485264|158132526|FG001|Overall Study|Lack of Efficacy|1|||
49080935|NCT00485264|158132527|FG002|Overall Study|Lack of Efficacy|0|||
49080936|NCT00485264|158132528|FG003|Overall Study|Lack of Efficacy|0|||
49080937|NCT00485264|158132529|FG004|Overall Study|Lack of Efficacy|0|||
49080938|NCT00485264|158132530|FG005|Overall Study|Lack of Efficacy|0|||
49080939|NCT00485264|158132525|FG000|Overall Study|Guardian Consent Withdrawn|1|||
49080940|NCT00485264|158132526|FG001|Overall Study|Guardian Consent Withdrawn|0|||
49080941|NCT00485264|158132527|FG002|Overall Study|Guardian Consent Withdrawn|0|||
49080942|NCT00485264|158132528|FG003|Overall Study|Guardian Consent Withdrawn|0|||
49080943|NCT00485264|158132529|FG004|Overall Study|Guardian Consent Withdrawn|1|||
49080944|NCT00485264|158132530|FG005|Overall Study|Guardian Consent Withdrawn|0|||
49080945|NCT00485264|158132525|FG000|Overall Study|Physician Decision|0|||
49080946|NCT00485264|158132526|FG001|Overall Study|Physician Decision|2|||
49080947|NCT00485264|158132527|FG002|Overall Study|Physician Decision|0|||
49080948|NCT00485264|158132528|FG003|Overall Study|Physician Decision|0|||
49080949|NCT00485264|158132529|FG004|Overall Study|Physician Decision|0|||
49080950|NCT00485264|158132530|FG005|Overall Study|Physician Decision|0|||
49080951|NCT00485264|158132525|FG000|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
49080952|NCT00485264|158132526|FG001|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
49080953|NCT00485264|158132527|FG002|Overall Study|Intolerance/Unable to Tolerate Dose|1|||
49080954|NCT00485264|158132528|FG003|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
49080955|NCT00485264|158132529|FG004|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
49080956|NCT00485264|158132530|FG005|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
49080957|NCT00485264|158132525|FG000|Overall Study|Not Able to Attend Clinic|5|||
49080958|NCT00485264|158132526|FG001|Overall Study|Not Able to Attend Clinic|0|||
49080959|NCT00485264|158132527|FG002|Overall Study|Not Able to Attend Clinic|0|||
49080960|NCT00485264|158132528|FG003|Overall Study|Not Able to Attend Clinic|1|||
49080961|NCT00485264|158132529|FG004|Overall Study|Not Able to Attend Clinic|1|||
49080962|NCT00485264|158132530|FG005|Overall Study|Not Able to Attend Clinic|2|||
49080963|NCT00485264|158132525|FG000|Overall Study|Non-Compliant|17|||
49080964|NCT00485264|158132526|FG001|Overall Study|Non-Compliant|2|||
49080965|NCT00485264|158132527|FG002|Overall Study|Non-Compliant|1|||
49080966|NCT00485264|158132528|FG003|Overall Study|Non-Compliant|0|||
49080967|NCT00485264|158132529|FG004|Overall Study|Non-Compliant|1|||
49080968|NCT00485264|158132530|FG005|Overall Study|Non-Compliant|0|||
49080969|NCT00485264|158132525|FG000|Overall Study|Lost to Follow-up|2|||
49080970|NCT00485264|158132526|FG001|Overall Study|Lost to Follow-up|1|||
49080971|NCT00485264|158132527|FG002|Overall Study|Lost to Follow-up|1|||
49080972|NCT00485264|158132528|FG003|Overall Study|Lost to Follow-up|0|||
49080973|NCT00485264|158132529|FG004|Overall Study|Lost to Follow-up|0|||
49080974|NCT00485264|158132530|FG005|Overall Study|Lost to Follow-up|1|||
49080975|NCT00485264|158132525|FG000|Overall Study|Other Reason|3|||
49080976|NCT00485264|158132526|FG001|Overall Study|Other Reason|0|||
49080977|NCT00485264|158132527|FG002|Overall Study|Other Reason|0|||
49080978|NCT00485264|158132528|FG003|Overall Study|Other Reason|0|||
49080979|NCT00485264|158132529|FG004|Overall Study|Other Reason|0|||
49080980|NCT00485264|158132530|FG005|Overall Study|Other Reason|0|||
49080981|NCT03668808|158132531|FG000|First Intervention|Withdrawal by Subject|2|||
49080982|NCT03668808|158132532|FG001|First Intervention|Withdrawal by Subject|2|||
49080983|NCT02273388|158132533|FG000|Overall Study|Adverse Event|0|||
49080984|NCT02273388|158132534|FG001|Overall Study|Adverse Event|0|||
49080985|NCT02273388|158132535|FG002|Overall Study|Adverse Event|0|||
49080986|NCT02273388|158132536|FG003|Overall Study|Adverse Event|0|||
49080987|NCT02273388|158132537|FG004|Overall Study|Adverse Event|0|||
49080988|NCT02273388|158132538|FG005|Overall Study|Adverse Event|0|||
49080989|NCT02273388|158132539|FG006|Overall Study|Adverse Event|1|||
49080990|NCT02273388|158132540|FG007|Overall Study|Adverse Event|2|||
49080991|NCT02273388|158132541|FG008|Overall Study|Adverse Event|0|||
49080992|NCT02273388|158132542|FG009|Overall Study|Adverse Event|0|||
49080993|NCT02273388|158132543|FG010|Overall Study|Adverse Event|0|||
49080994|NCT02273388|158132544|FG011|Overall Study|Adverse Event|0|||
49080995|NCT02273388|158132533|FG000|Overall Study|Adverse Event study disease worse|4|||
49080996|NCT02273388|158132534|FG001|Overall Study|Adverse Event study disease worse|3|||
49080997|NCT02273388|158132535|FG002|Overall Study|Adverse Event study disease worse|3|||
49080998|NCT02273388|158132536|FG003|Overall Study|Adverse Event study disease worse|2|||
49080999|NCT02273388|158132537|FG004|Overall Study|Adverse Event study disease worse|4|||
49081000|NCT02273388|158132538|FG005|Overall Study|Adverse Event study disease worse|3|||
49081001|NCT02273388|158132539|FG006|Overall Study|Adverse Event study disease worse|14|||
49081002|NCT02273388|158132540|FG007|Overall Study|Adverse Event study disease worse|6|||
49081003|NCT02273388|158132541|FG008|Overall Study|Adverse Event study disease worse|6|||
49081004|NCT02273388|158132542|FG009|Overall Study|Adverse Event study disease worse|5|||
49081005|NCT02273388|158132543|FG010|Overall Study|Adverse Event study disease worse|10|||
49081006|NCT02273388|158132544|FG011|Overall Study|Adverse Event study disease worse|1|||
49081007|NCT02273388|158132533|FG000|Overall Study|Sponsor decision|0|||
49081008|NCT02273388|158132534|FG001|Overall Study|Sponsor decision|0|||
49081009|NCT02273388|158132535|FG002|Overall Study|Sponsor decision|0|||
49081010|NCT02273388|158132536|FG003|Overall Study|Sponsor decision|0|||
49081011|NCT02273388|158132537|FG004|Overall Study|Sponsor decision|0|||
49081012|NCT02273388|158132538|FG005|Overall Study|Sponsor decision|0|||
49081013|NCT02273388|158132539|FG006|Overall Study|Sponsor decision|0|||
49081014|NCT02273388|158132540|FG007|Overall Study|Sponsor decision|0|||
49081015|NCT02273388|158132541|FG008|Overall Study|Sponsor decision|0|||
49081016|NCT02273388|158132542|FG009|Overall Study|Sponsor decision|0|||
49081017|NCT02273388|158132543|FG010|Overall Study|Sponsor decision|0|||
49081018|NCT02273388|158132544|FG011|Overall Study|Sponsor decision|1|||
49081019|NCT01289678|158132545|FG000|Overall Study|Physician Decision|6|||
49081020|NCT00214383|158132546|FG000|Overall Study|Lost to Follow-up|16|||
49081021|NCT00214383|158132547|FG001|Overall Study|Lost to Follow-up|26|||
49081022|NCT03500198|158132555|FG000|Overall Study|Lost to Follow-up|0|||
49081023|NCT03500198|158132556|FG001|Overall Study|Lost to Follow-up|1|||
49081024|NCT03267212|158132557|FG000|First Intervention|Lost to Follow-up|0|||
49081025|NCT03267212|158132558|FG001|First Intervention|Lost to Follow-up|2|||
49081026|NCT03267212|158132557|FG000|First Intervention|Withdrawal by Subject|1|||
49081027|NCT03267212|158132558|FG001|First Intervention|Withdrawal by Subject|1|||
49081028|NCT03267212|158132557|FG000|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1|||
49081029|NCT03267212|158132558|FG001|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0|||
49081030|NCT00322712|158132559|FG000|Overall Study|treated with bevacizumab not cetuximab|1|||
49081031|NCT02071225|158132560|FG000|Overall Study|Withdrawal of Consent|2|||
49081032|NCT02071225|158132560|FG000|Overall Study|Protocol Deviation|1|||
49081033|NCT02071225|158132560|FG000|Overall Study|Lost to Follow-up|2|||
49081034|NCT02071225|158132560|FG000|Overall Study|Death|25|||
49081035|NCT01526655|158132561|FG000|Overall Study|Withdrawal by Subject|0|||
49081036|NCT01526655|158132562|FG001|Overall Study|Withdrawal by Subject|1|||
49081037|NCT01514461|158132565|FG000|Overall Study|Adverse Event|2|||
49081038|NCT01514461|158132566|FG001|Overall Study|Adverse Event|1|||
49081039|NCT01514461|158132567|FG002|Overall Study|Adverse Event|3|||
49081040|NCT01514461|158132565|FG000|Overall Study|Physician Decision|1|||
49081041|NCT01514461|158132566|FG001|Overall Study|Physician Decision|1|||
49081042|NCT01514461|158132567|FG002|Overall Study|Physician Decision|0|||
49081043|NCT01514461|158132565|FG000|Overall Study|Patient/guardian decision|1|||
49081044|NCT01514461|158132566|FG001|Overall Study|Patient/guardian decision|1|||
49081045|NCT01514461|158132567|FG002|Overall Study|Patient/guardian decision|1|||
49081046|NCT01514461|158132565|FG000|Overall Study|Death|1|||
49081047|NCT01514461|158132566|FG001|Overall Study|Death|0|||
49081048|NCT01514461|158132567|FG002|Overall Study|Death|0|||
49081049|NCT01569295|158132568|FG000|Overall Study|Progressive Disease|75|||
49081050|NCT01569295|158132569|FG001|Overall Study|Progressive Disease|139|||
49081051|NCT01569295|158132568|FG000|Overall Study|Adverse Event|39|||
49081052|NCT01569295|158132569|FG001|Overall Study|Adverse Event|14|||
49081053|NCT01569295|158132568|FG000|Overall Study|Withdrawal by Subject|25|||
49081054|NCT01569295|158132569|FG001|Overall Study|Withdrawal by Subject|12|||
49081055|NCT01569295|158132568|FG000|Overall Study|Death|19|||
49081056|NCT01569295|158132569|FG001|Overall Study|Death|15|||
49081057|NCT01569295|158132568|FG000|Overall Study|Physician Decision|13|||
49081058|NCT01569295|158132569|FG001|Overall Study|Physician Decision|18|||
49081059|NCT01569295|158132568|FG000|Overall Study|Study Terminated by Sponsor|24|||
49081060|NCT01569295|158132569|FG001|Overall Study|Study Terminated by Sponsor|2|||
49081061|NCT01569295|158132568|FG000|Overall Study|Other Reason not Specified|3|||
49081062|NCT01569295|158132569|FG001|Overall Study|Other Reason not Specified|5|||
49081063|NCT01569295|158132568|FG000|Overall Study|Non-Compliance with Study Drug|6|||
49081064|NCT01569295|158132569|FG001|Overall Study|Non-Compliance with Study Drug|1|||
49081065|NCT01569295|158132568|FG000|Overall Study|Other Anticancer/Experimental Therapy|2|||
49081066|NCT01569295|158132569|FG001|Overall Study|Other Anticancer/Experimental Therapy|2|||
49081067|NCT01569295|158132568|FG000|Overall Study|Lost to Follow-up|1|||
49081068|NCT01569295|158132569|FG001|Overall Study|Lost to Follow-up|1|||
49081069|NCT03889886|158132570|FG000|Overall Study|Other|0|||
49081070|NCT03889886|158132571|FG001|Overall Study|Other|1|||
49081071|NCT03889886|158132572|FG002|Overall Study|Other|0|||
49081072|NCT03889886|158132573|FG003|Overall Study|Other|1|||
49081073|NCT03889886|158132570|FG000|Overall Study|Withdrawal by Subject|0|||
49081074|NCT03889886|158132571|FG001|Overall Study|Withdrawal by Subject|0|||
49081075|NCT03889886|158132572|FG002|Overall Study|Withdrawal by Subject|1|||
49081076|NCT03889886|158132573|FG003|Overall Study|Withdrawal by Subject|0|||
49081077|NCT03889886|158132570|FG000|Overall Study|Adverse Event|0|||
49081078|NCT03889886|158132571|FG001|Overall Study|Adverse Event|0|||
49081079|NCT03889886|158132572|FG002|Overall Study|Adverse Event|0|||
49081080|NCT03889886|158132573|FG003|Overall Study|Adverse Event|6|||
49081081|NCT00654095|158132575|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
49081082|NCT00654095|158132575|FG000|Overall Study|Elevated triglyceride level (2)|1|||
49081083|NCT00654095|158132575|FG000|Overall Study|Elevated alanine aminotransferase (3)|1|||
49081084|NCT00654095|158132575|FG000|Overall Study|Adverse Event|11|||
49081085|NCT00654095|158132575|FG000|Overall Study|Withdrawal by Subject|5|||
49081086|NCT00654095|158132575|FG000|Overall Study|Elevated alanine aminotransferase (4)|7|||
49081087|NCT00654095|158132575|FG000|Overall Study|Adverse reaction did not improve (5)|4|||
49081088|NCT00654095|158132575|FG000|Overall Study|Did not meet inclusion criteria|1|||
49081089|NCT00758524|158132576|FG000|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
49081090|NCT00758524|158132577|FG001|Core Period (Week 0 to Week 8)|Lack of Efficacy|2|||
49081091|NCT00758524|158132578|FG002|Core Period (Week 0 to Week 8)|Lack of Efficacy|4|||
49081092|NCT00758524|158132579|FG003|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
49081093|NCT00758524|158132580|FG004|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
49081094|NCT00758524|158132581|FG005|Core Period (Week 0 to Week 8)|Lack of Efficacy|5|||
49081095|NCT00758524|158132582|FG006|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
49081096|NCT00758524|158132583|FG007|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
49081097|NCT00758524|158132584|FG008|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
49081098|NCT00758524|158132585|FG009|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
49081099|NCT00758524|158132586|FG010|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
49081100|NCT00758524|158132587|FG011|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
49081101|NCT00758524|158132588|FG012|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
49081102|NCT00758524|158132589|FG013|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
49081103|NCT00758524|158132590|FG014|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
49081104|NCT00758524|158132591|FG015|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
49081105|NCT00758524|158132592|FG016|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
49081106|NCT00758524|158132576|FG000|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
49081107|NCT00758524|158132577|FG001|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
49081108|NCT00758524|158132578|FG002|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2|||
49081109|NCT00758524|158132579|FG003|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
49081110|NCT00758524|158132580|FG004|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1|||
49081111|NCT00758524|158132581|FG005|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
49081112|NCT00758524|158132582|FG006|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
49081113|NCT00758524|158132583|FG007|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
49081114|NCT00758524|158132584|FG008|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
49081115|NCT00758524|158132585|FG009|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
49081116|NCT00758524|158132586|FG010|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
49081117|NCT00758524|158132587|FG011|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
49081118|NCT00758524|158132588|FG012|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
49081119|NCT00758524|158132589|FG013|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
49081120|NCT00758524|158132590|FG014|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
49081121|NCT00758524|158132591|FG015|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
49081122|NCT00758524|158132592|FG016|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
49081123|NCT00758524|158132576|FG000|Core Period (Week 0 to Week 8)|Adverse Event|2|||
49081124|NCT00758524|158132577|FG001|Core Period (Week 0 to Week 8)|Adverse Event|1|||
49081125|NCT00758524|158132578|FG002|Core Period (Week 0 to Week 8)|Adverse Event|1|||
49081126|NCT00758524|158132579|FG003|Core Period (Week 0 to Week 8)|Adverse Event|3|||
49081127|NCT00758524|158132580|FG004|Core Period (Week 0 to Week 8)|Adverse Event|2|||
49081128|NCT00758524|158132581|FG005|Core Period (Week 0 to Week 8)|Adverse Event|1|||
49081129|NCT00758524|158132582|FG006|Core Period (Week 0 to Week 8)|Adverse Event|0|||
49081130|NCT00758524|158132583|FG007|Core Period (Week 0 to Week 8)|Adverse Event|0|||
49081131|NCT00758524|158132584|FG008|Core Period (Week 0 to Week 8)|Adverse Event|0|||
49081132|NCT00758524|158132585|FG009|Core Period (Week 0 to Week 8)|Adverse Event|0|||
49081133|NCT00758524|158132586|FG010|Core Period (Week 0 to Week 8)|Adverse Event|0|||
49081134|NCT00758524|158132587|FG011|Core Period (Week 0 to Week 8)|Adverse Event|0|||
49081135|NCT00758524|158132588|FG012|Core Period (Week 0 to Week 8)|Adverse Event|0|||
49081136|NCT00758524|158132589|FG013|Core Period (Week 0 to Week 8)|Adverse Event|0|||
49081137|NCT00758524|158132590|FG014|Core Period (Week 0 to Week 8)|Adverse Event|0|||
49081138|NCT00758524|158132591|FG015|Core Period (Week 0 to Week 8)|Adverse Event|0|||
49081139|NCT00758524|158132592|FG016|Core Period (Week 0 to Week 8)|Adverse Event|0|||
49081140|NCT00758524|158132576|FG000|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
49081141|NCT00758524|158132577|FG001|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
49081142|NCT00758524|158132578|FG002|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
49081143|NCT00758524|158132579|FG003|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
49081144|NCT00758524|158132580|FG004|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
49081145|NCT00758524|158132581|FG005|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
49081146|NCT00758524|158132582|FG006|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
49081147|NCT00758524|158132583|FG007|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
49081148|NCT00758524|158132584|FG008|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
49081149|NCT00758524|158132585|FG009|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
49081150|NCT00758524|158132586|FG010|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
49081151|NCT00758524|158132587|FG011|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
49081152|NCT00758524|158132588|FG012|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
49081153|NCT00758524|158132589|FG013|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
49081154|NCT00758524|158132590|FG014|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
49081155|NCT00758524|158132591|FG015|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
49081156|NCT00758524|158132592|FG016|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
49081157|NCT00758524|158132576|FG000|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
49081158|NCT00758524|158132577|FG001|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
49081159|NCT00758524|158132578|FG002|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
49081160|NCT00758524|158132579|FG003|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
49081161|NCT00758524|158132580|FG004|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
49081162|NCT00758524|158132581|FG005|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
49081163|NCT00758524|158132582|FG006|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
49081164|NCT00758524|158132583|FG007|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
49081165|NCT00758524|158132584|FG008|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
49081166|NCT00758524|158132585|FG009|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
49081167|NCT00758524|158132586|FG010|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
49081168|NCT00758524|158132587|FG011|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
49081169|NCT00758524|158132588|FG012|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
49081170|NCT00758524|158132589|FG013|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
49081171|NCT00758524|158132590|FG014|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
49081172|NCT00758524|158132591|FG015|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
49081173|NCT00758524|158132592|FG016|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
49081174|NCT00758524|158132576|FG000|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
49081175|NCT00758524|158132577|FG001|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
49081176|NCT00758524|158132578|FG002|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
49081177|NCT00758524|158132579|FG003|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
49081178|NCT00758524|158132580|FG004|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1|||
49081179|NCT00758524|158132581|FG005|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
49081180|NCT00758524|158132582|FG006|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
49081181|NCT00758524|158132583|FG007|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
49081182|NCT00758524|158132584|FG008|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
49081183|NCT00758524|158132585|FG009|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
49081184|NCT00758524|158132586|FG010|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
49081185|NCT00758524|158132587|FG011|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
49081186|NCT00758524|158132588|FG012|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
49081187|NCT00758524|158132589|FG013|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
49081188|NCT00758524|158132590|FG014|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
49081189|NCT00758524|158132591|FG015|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
49081190|NCT00758524|158132592|FG016|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
49081191|NCT00758524|158132576|FG000|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
49081192|NCT00758524|158132577|FG001|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1|||
49081193|NCT00758524|158132578|FG002|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
49081194|NCT00758524|158132579|FG003|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
49081195|NCT00758524|158132580|FG004|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
49081196|NCT00758524|158132581|FG005|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
49081197|NCT00758524|158132582|FG006|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
49081198|NCT00758524|158132583|FG007|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
49081199|NCT00758524|158132584|FG008|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
49081200|NCT00758524|158132585|FG009|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
49081201|NCT00758524|158132586|FG010|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
49081202|NCT00758524|158132587|FG011|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
49081203|NCT00758524|158132588|FG012|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
49081204|NCT00758524|158132589|FG013|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
49081205|NCT00758524|158132590|FG014|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
49081206|NCT00758524|158132591|FG015|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
49081207|NCT00758524|158132592|FG016|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
49081208|NCT00758524|158132576|FG000|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
49081209|NCT00758524|158132577|FG001|Core Period (Week 0 to Week 8)|Reason not Specified|1|||
49081210|NCT00758524|158132578|FG002|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
49081211|NCT00758524|158132579|FG003|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
49081212|NCT00758524|158132580|FG004|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
49081213|NCT00758524|158132581|FG005|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
49081214|NCT00758524|158132582|FG006|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
49081215|NCT00758524|158132583|FG007|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
49081216|NCT00758524|158132584|FG008|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
49081217|NCT00758524|158132585|FG009|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
49081218|NCT00758524|158132586|FG010|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
49081219|NCT00758524|158132587|FG011|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
49081220|NCT00758524|158132588|FG012|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
49081221|NCT00758524|158132589|FG013|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
49081222|NCT00758524|158132590|FG014|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
49081223|NCT00758524|158132591|FG015|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
49081224|NCT00758524|158132592|FG016|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
49081225|NCT00758524|158132576|FG000|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
49081226|NCT00758524|158132577|FG001|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
49081227|NCT00758524|158132578|FG002|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
49081228|NCT00758524|158132579|FG003|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
49081229|NCT00758524|158132580|FG004|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
49081230|NCT00758524|158132581|FG005|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
49081231|NCT00758524|158132582|FG006|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
49081232|NCT00758524|158132583|FG007|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
49081233|NCT00758524|158132584|FG008|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2|||
49081234|NCT00758524|158132585|FG009|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
49081235|NCT00758524|158132586|FG010|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
49081236|NCT00758524|158132587|FG011|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
49081237|NCT00758524|158132588|FG012|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
49081238|NCT00758524|158132589|FG013|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
49081239|NCT00758524|158132590|FG014|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
49081240|NCT00758524|158132591|FG015|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
49081241|NCT00758524|158132592|FG016|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
49081242|NCT00758524|158132576|FG000|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
49081243|NCT00758524|158132577|FG001|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
49081244|NCT00758524|158132578|FG002|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
49081245|NCT00758524|158132579|FG003|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
49081246|NCT00758524|158132580|FG004|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
49081247|NCT00758524|158132581|FG005|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
49081248|NCT00758524|158132582|FG006|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1|||
49081249|NCT00758524|158132583|FG007|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
49081250|NCT00758524|158132584|FG008|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
49081251|NCT00758524|158132585|FG009|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
49081252|NCT00758524|158132586|FG010|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
49081253|NCT00758524|158132587|FG011|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
49081254|NCT00758524|158132588|FG012|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
49081255|NCT00758524|158132589|FG013|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
49081256|NCT00758524|158132590|FG014|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
49081257|NCT00758524|158132591|FG015|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
49081258|NCT00758524|158132592|FG016|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
49081259|NCT02058069|158132593|FG000|Overall Study|Exclusion due to implant size|5|||
49081260|NCT02058069|158132593|FG000|Overall Study|Withdrawal by Subject|6|||
49081261|NCT01254643|158132601|FG000|Overall Study|Withdrawal by Subject|1|||
49081262|NCT01626690|158132605|FG000|Overall Study|Protocol Violation|1|||
49081263|NCT01626690|158132606|FG001|Overall Study|Protocol Violation|0|||
49081264|NCT01626690|158132605|FG000|Overall Study|Adverse Event|1|||
49081265|NCT01626690|158132606|FG001|Overall Study|Adverse Event|0|||
49081266|NCT02286843|158132607|FG000|Overall Study|Not Treated|4|||
49081267|NCT02286843|158132607|FG000|Overall Study|Protocol Violation|1|||
49081268|NCT02286843|158132607|FG000|Overall Study|Withdrawal by Subject|1|||
49081269|NCT00235755|158132608|FG000|4-Week Titration Phase|Adverse Event|6|||
49081270|NCT00235755|158132609|FG001|4-Week Titration Phase|Adverse Event|14|||
49081271|NCT00235755|158132610|FG002|4-Week Titration Phase|Adverse Event|20|||
49081272|NCT00235755|158132608|FG000|4-Week Titration Phase|Lost to Follow-up|0|||
49081273|NCT00235755|158132609|FG001|4-Week Titration Phase|Lost to Follow-up|1|||
49081274|NCT00235755|158132610|FG002|4-Week Titration Phase|Lost to Follow-up|1|||
49081275|NCT00235755|158132608|FG000|4-Week Titration Phase|Protocol Violation|2|||
49081276|NCT00235755|158132609|FG001|4-Week Titration Phase|Protocol Violation|2|||
49081277|NCT00235755|158132610|FG002|4-Week Titration Phase|Protocol Violation|1|||
49081278|NCT00235755|158132608|FG000|4-Week Titration Phase|Withdrawal by Subject|1|||
49081279|NCT00235755|158132609|FG001|4-Week Titration Phase|Withdrawal by Subject|2|||
49081280|NCT00235755|158132610|FG002|4-Week Titration Phase|Withdrawal by Subject|3|||
49081281|NCT00235755|158132608|FG000|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
49081282|NCT00235755|158132609|FG001|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
49081283|NCT00235755|158132610|FG002|4-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
49081284|NCT00235755|158132608|FG000|4-Week Titration Phase|Randomization Occurred in Error|1|||
49081285|NCT00235755|158132609|FG001|4-Week Titration Phase|Randomization Occurred in Error|0|||
49081286|NCT00235755|158132610|FG002|4-Week Titration Phase|Randomization Occurred in Error|0|||
49081287|NCT00235755|158132608|FG000|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1|||
49081288|NCT00235755|158132609|FG001|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
49081289|NCT00235755|158132610|FG002|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
49081290|NCT00235755|158132608|FG000|12-Week Maintenance Phase|Adverse Event|8|||
49081291|NCT00235755|158132609|FG001|12-Week Maintenance Phase|Adverse Event|12|||
49081292|NCT00235755|158132610|FG002|12-Week Maintenance Phase|Adverse Event|26|||
49081293|NCT00235755|158132608|FG000|12-Week Maintenance Phase|Lost to Follow-up|2|||
49081294|NCT00235755|158132609|FG001|12-Week Maintenance Phase|Lost to Follow-up|3|||
49081295|NCT00235755|158132610|FG002|12-Week Maintenance Phase|Lost to Follow-up|0|||
49081296|NCT00235755|158132608|FG000|12-Week Maintenance Phase|Lack of Efficacy|5|||
49081297|NCT00235755|158132609|FG001|12-Week Maintenance Phase|Lack of Efficacy|0|||
49081298|NCT00235755|158132610|FG002|12-Week Maintenance Phase|Lack of Efficacy|0|||
49081299|NCT00235755|158132608|FG000|12-Week Maintenance Phase|Protocol Violation|0|||
49081300|NCT00235755|158132609|FG001|12-Week Maintenance Phase|Protocol Violation|4|||
49081301|NCT00235755|158132610|FG002|12-Week Maintenance Phase|Protocol Violation|2|||
49081302|NCT00235755|158132608|FG000|12-Week Maintenance Phase|Withdrawal by Subject|0|||
49081303|NCT00235755|158132609|FG001|12-Week Maintenance Phase|Withdrawal by Subject|8|||
49081304|NCT00235755|158132610|FG002|12-Week Maintenance Phase|Withdrawal by Subject|3|||
49081305|NCT00235755|158132608|FG000|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1|||
49081306|NCT00235755|158132609|FG001|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
49081307|NCT00235755|158132610|FG002|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
49081308|NCT03518008|158132611|FG000|Period 2, Second Week of Wear|Family emergency|0|||
49081309|NCT03518008|158132612|FG001|Period 2, Second Week of Wear|Family emergency|1|||
49081310|NCT01147068|158132614|FG000|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
49081311|NCT01147068|158132615|FG001|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
49081312|NCT01147068|158132616|FG002|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
49081313|NCT01147068|158132617|FG003|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
49081314|NCT01147068|158132618|FG004|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
49081315|NCT01147068|158132619|FG005|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
49081316|NCT01147068|158132620|FG006|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
49081317|NCT01147068|158132614|FG000|Subjects That Received 2nd Dose|Ineligible|0|||
49081318|NCT01147068|158132615|FG001|Subjects That Received 2nd Dose|Ineligible|1|||
49081319|NCT01147068|158132616|FG002|Subjects That Received 2nd Dose|Ineligible|0|||
49081320|NCT01147068|158132617|FG003|Subjects That Received 2nd Dose|Ineligible|0|||
49081321|NCT01147068|158132618|FG004|Subjects That Received 2nd Dose|Ineligible|0|||
49081322|NCT01147068|158132619|FG005|Subjects That Received 2nd Dose|Ineligible|0|||
49081323|NCT01147068|158132620|FG006|Subjects That Received 2nd Dose|Ineligible|0|||
49081324|NCT01147068|158132614|FG000|Subjects That Received 2nd Dose|Did not complete the study|0|||
49081325|NCT01147068|158132615|FG001|Subjects That Received 2nd Dose|Did not complete the study|1|||
49081326|NCT01147068|158132616|FG002|Subjects That Received 2nd Dose|Did not complete the study|0|||
49081327|NCT01147068|158132617|FG003|Subjects That Received 2nd Dose|Did not complete the study|0|||
49081328|NCT01147068|158132618|FG004|Subjects That Received 2nd Dose|Did not complete the study|0|||
49081329|NCT01147068|158132619|FG005|Subjects That Received 2nd Dose|Did not complete the study|1|||
49081330|NCT01147068|158132620|FG006|Subjects That Received 2nd Dose|Did not complete the study|0|||
49081331|NCT01147068|158132614|FG000|Subjects That Received 2nd Dose|Other|0|||
49081332|NCT01147068|158132615|FG001|Subjects That Received 2nd Dose|Other|3|||
49081333|NCT01147068|158132616|FG002|Subjects That Received 2nd Dose|Other|3|||
49081334|NCT01147068|158132617|FG003|Subjects That Received 2nd Dose|Other|0|||
49081335|NCT01147068|158132618|FG004|Subjects That Received 2nd Dose|Other|1|||
49081336|NCT01147068|158132619|FG005|Subjects That Received 2nd Dose|Other|0|||
49081337|NCT01147068|158132620|FG006|Subjects That Received 2nd Dose|Other|0|||
49081338|NCT01147068|158132614|FG000|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
49081339|NCT01147068|158132615|FG001|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
49081340|NCT01147068|158132616|FG002|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
49081341|NCT01147068|158132617|FG003|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
49081342|NCT01147068|158132618|FG004|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
49081343|NCT01147068|158132619|FG005|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
49081344|NCT01147068|158132620|FG006|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
49081345|NCT01147068|158132614|FG000|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
49081346|NCT01147068|158132615|FG001|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
49081347|NCT01147068|158132616|FG002|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
49081348|NCT01147068|158132617|FG003|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2|||
49081349|NCT01147068|158132618|FG004|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
49081350|NCT01147068|158132619|FG005|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
49081351|NCT01147068|158132620|FG006|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
49081352|NCT01147068|158132614|FG000|Subjects That Completed Safety Follow-up|Ineligible|0|||
49081353|NCT01147068|158132615|FG001|Subjects That Completed Safety Follow-up|Ineligible|1|||
49081354|NCT01147068|158132616|FG002|Subjects That Completed Safety Follow-up|Ineligible|0|||
49081355|NCT01147068|158132617|FG003|Subjects That Completed Safety Follow-up|Ineligible|0|||
49081356|NCT01147068|158132618|FG004|Subjects That Completed Safety Follow-up|Ineligible|0|||
49081357|NCT01147068|158132619|FG005|Subjects That Completed Safety Follow-up|Ineligible|0|||
49081358|NCT01147068|158132620|FG006|Subjects That Completed Safety Follow-up|Ineligible|0|||
49081359|NCT00122382|158132626|FG000|Double-Blind Study|Adverse Event|9|||
49081360|NCT00122382|158132627|FG001|Double-Blind Study|Adverse Event|11|||
49081361|NCT00122382|158132628|FG002|Double-Blind Study|Adverse Event|0|||
49081362|NCT00122382|158132626|FG000|Double-Blind Study|Death|2|||
49081363|NCT00122382|158132627|FG001|Double-Blind Study|Death|2|||
49081364|NCT00122382|158132628|FG002|Double-Blind Study|Death|0|||
49081365|NCT00122382|158132626|FG000|Double-Blind Study|Lack of Efficacy|0|||
49081366|NCT00122382|158132627|FG001|Double-Blind Study|Lack of Efficacy|8|||
49081367|NCT00122382|158132628|FG002|Double-Blind Study|Lack of Efficacy|0|||
49081368|NCT00122382|158132626|FG000|Double-Blind Study|Lost to Follow-up|2|||
49081369|NCT00122382|158132627|FG001|Double-Blind Study|Lost to Follow-up|1|||
49081370|NCT00122382|158132628|FG002|Double-Blind Study|Lost to Follow-up|0|||
49081371|NCT00122382|158132626|FG000|Double-Blind Study|Pregnancy|2|||
49081372|NCT00122382|158132627|FG001|Double-Blind Study|Pregnancy|0|||
49081373|NCT00122382|158132628|FG002|Double-Blind Study|Pregnancy|0|||
49081374|NCT00122382|158132626|FG000|Double-Blind Study|Subject No Longer Meets Study Criteria|1|||
49081375|NCT00122382|158132627|FG001|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
49081376|NCT00122382|158132628|FG002|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
49081377|NCT00122382|158132626|FG000|Double-Blind Study|Withdrawal of Consent|7|||
49081378|NCT00122382|158132627|FG001|Double-Blind Study|Withdrawal of Consent|3|||
49081379|NCT00122382|158132628|FG002|Double-Blind Study|Withdrawal of Consent|0|||
49081380|NCT00122382|158132626|FG000|Double-Blind Study|Protocol Violation|1|||
49081381|NCT00122382|158132627|FG001|Double-Blind Study|Protocol Violation|0|||
49081382|NCT00122382|158132628|FG002|Double-Blind Study|Protocol Violation|0|||
49081383|NCT00122382|158132626|FG000|Double-Blind Study|Methotrexate Discontinued|0|||
49081384|NCT00122382|158132627|FG001|Double-Blind Study|Methotrexate Discontinued|1|||
49081385|NCT00122382|158132628|FG002|Double-Blind Study|Methotrexate Discontinued|0|||
49081386|NCT00122382|158132626|FG000|Double-Blind Study|Randomized but not treated|0|||
49081387|NCT00122382|158132627|FG001|Double-Blind Study|Randomized but not treated|2|||
49081388|NCT00122382|158132628|FG002|Double-Blind Study|Randomized but not treated|0|||
49081389|NCT00122382|158132626|FG000|Open-Label Study|Adverse Event|0|||
49081390|NCT00122382|158132627|FG001|Open-Label Study|Adverse Event|0|||
49081391|NCT00122382|158132628|FG002|Open-Label Study|Adverse Event|11|||
49081392|NCT00122382|158132626|FG000|Open-Label Study|Death|0|||
49081393|NCT00122382|158132627|FG001|Open-Label Study|Death|0|||
49081394|NCT00122382|158132628|FG002|Open-Label Study|Death|2|||
49081395|NCT00122382|158132626|FG000|Open-Label Study|Lack of Efficacy|0|||
49081396|NCT00122382|158132627|FG001|Open-Label Study|Lack of Efficacy|0|||
49081397|NCT00122382|158132628|FG002|Open-Label Study|Lack of Efficacy|3|||
49081398|NCT00122382|158132626|FG000|Open-Label Study|Lost to Follow-up|0|||
49081399|NCT00122382|158132627|FG001|Open-Label Study|Lost to Follow-up|0|||
49081400|NCT00122382|158132628|FG002|Open-Label Study|Lost to Follow-up|3|||
49081401|NCT00122382|158132626|FG000|Open-Label Study|Pregnancy|0|||
49081402|NCT00122382|158132627|FG001|Open-Label Study|Pregnancy|0|||
49081403|NCT00122382|158132628|FG002|Open-Label Study|Pregnancy|2|||
49081404|NCT00122382|158132626|FG000|Open-Label Study|Poor/Non-Compliance|0|||
49081405|NCT00122382|158132627|FG001|Open-Label Study|Poor/Non-Compliance|0|||
49081406|NCT00122382|158132628|FG002|Open-Label Study|Poor/Non-Compliance|1|||
49081407|NCT00122382|158132626|FG000|Open-Label Study|Withdrawal of Consent|0|||
49081408|NCT00122382|158132627|FG001|Open-Label Study|Withdrawal of Consent|0|||
49081409|NCT00122382|158132628|FG002|Open-Label Study|Withdrawal of Consent|4|||
49081410|NCT00725920|158132629|FG000|Overall Study|Lack of Efficacy|3|||
49081411|NCT00725920|158132630|FG001|Overall Study|Lack of Efficacy|6|||
49081412|NCT03918629|158132634|FG000|Overall Study|Adverse Event|19|||
49081413|NCT03918629|158132635|FG001|Overall Study|Adverse Event|20|||
49081414|NCT03918629|158132634|FG000|Overall Study|Death|14|||
49081415|NCT03918629|158132635|FG001|Overall Study|Death|7|||
49081416|NCT03918629|158132634|FG000|Overall Study|Lost to Follow-up|36|||
49081417|NCT03918629|158132635|FG001|Overall Study|Lost to Follow-up|28|||
49081418|NCT03918629|158132634|FG000|Overall Study|Physician Decision|1|||
49081419|NCT03918629|158132635|FG001|Overall Study|Physician Decision|0|||
49081420|NCT03918629|158132634|FG000|Overall Study|Protocol Violation|7|||
49081421|NCT03918629|158132635|FG001|Overall Study|Protocol Violation|4|||
49081422|NCT03918629|158132634|FG000|Overall Study|Withdrawal by Subject|47|||
49081423|NCT03918629|158132635|FG001|Overall Study|Withdrawal by Subject|47|||
49081424|NCT03918629|158132634|FG000|Overall Study|Other|7|||
49081425|NCT03918629|158132635|FG001|Overall Study|Other|11|||
49081426|NCT03918629|158132634|FG000|Overall Study|Randomized but not vaccinated|2|||
49081427|NCT03918629|158132635|FG001|Overall Study|Randomized but not vaccinated|1|||
49081428|NCT00967330|158132636|FG000|Overall Study|Protocol Violation|3|||
49081429|NCT00967330|158132637|FG001|Overall Study|Protocol Violation|4|||
49081430|NCT00967330|158132636|FG000|Overall Study|Regular|10|||
49081431|NCT00967330|158132637|FG001|Overall Study|Regular|3|||
49081432|NCT00967330|158132636|FG000|Overall Study|Withdrawal by Subject|6|||
49081433|NCT00967330|158132637|FG001|Overall Study|Withdrawal by Subject|0|||
49081434|NCT00967330|158132636|FG000|Overall Study|Lost to Follow-up|1|||
49081435|NCT00967330|158132637|FG001|Overall Study|Lost to Follow-up|1|||
49081436|NCT00967330|158132636|FG000|Overall Study|Death|102|||
49081437|NCT00967330|158132637|FG001|Overall Study|Death|51|||
49081438|NCT00967330|158132636|FG000|Overall Study|Severe protocol deviation|0|||
49081439|NCT00967330|158132637|FG001|Overall Study|Severe protocol deviation|1|||
49081440|NCT02456740|158132638|FG000|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
49081441|NCT02456740|158132639|FG001|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
49081442|NCT02456740|158132640|FG002|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
49081443|NCT02456740|158132641|FG003|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
49081444|NCT02456740|158132642|FG004|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
49081445|NCT02456740|158132643|FG005|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
49081446|NCT02456740|158132644|FG006|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
49081447|NCT02456740|158132645|FG007|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
49081448|NCT02456740|158132646|FG008|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
49081449|NCT02456740|158132638|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27|||
49081450|NCT02456740|158132639|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28|||
49081451|NCT02456740|158132640|FG002|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21|||
49081452|NCT02456740|158132641|FG003|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
49081453|NCT02456740|158132642|FG004|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
49081454|NCT02456740|158132643|FG005|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
49081455|NCT02456740|158132644|FG006|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
49081456|NCT02456740|158132645|FG007|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
49081457|NCT02456740|158132646|FG008|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
49081458|NCT02456740|158132638|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9|||
49081459|NCT02456740|158132639|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4|||
49081460|NCT02456740|158132640|FG002|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5|||
49081461|NCT02456740|158132641|FG003|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
49081462|NCT02456740|158132642|FG004|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
49081463|NCT02456740|158132643|FG005|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
49081464|NCT02456740|158132644|FG006|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
49081465|NCT02456740|158132645|FG007|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
49081466|NCT02456740|158132646|FG008|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
49081467|NCT02456740|158132638|FG000|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
49081468|NCT02456740|158132639|FG001|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
49081469|NCT02456740|158132640|FG002|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
49081470|NCT02456740|158132641|FG003|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1|||
49081471|NCT02456740|158132642|FG004|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4|||
49081472|NCT02456740|158132643|FG005|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
49081473|NCT02456740|158132644|FG006|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
49081474|NCT02456740|158132645|FG007|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
49081475|NCT02456740|158132646|FG008|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5|||
49081476|NCT02456740|158132638|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
49081477|NCT02456740|158132639|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
49081478|NCT02456740|158132640|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
49081479|NCT02456740|158132641|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10|||
49081480|NCT02456740|158132642|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11|||
49081481|NCT02456740|158132643|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
49081482|NCT02456740|158132644|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
49081483|NCT02456740|158132645|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
49081484|NCT02456740|158132646|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
49081485|NCT02456740|158132638|FG000|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
49081486|NCT02456740|158132639|FG001|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
49081487|NCT02456740|158132640|FG002|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
49081488|NCT02456740|158132641|FG003|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
49081489|NCT02456740|158132642|FG004|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
49081490|NCT02456740|158132643|FG005|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
49081491|NCT02456740|158132644|FG006|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
49081492|NCT02456740|158132645|FG007|Active Treatment Phase (Weeks 24 - 52)|Death|1|||
49081493|NCT02456740|158132646|FG008|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
49081494|NCT02456740|158132638|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
49081495|NCT02456740|158132639|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
49081496|NCT02456740|158132640|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
49081497|NCT02456740|158132641|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
49081498|NCT02456740|158132642|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2|||
49081499|NCT02456740|158132643|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
49081500|NCT02456740|158132644|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
49081501|NCT02456740|158132645|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
49081502|NCT02456740|158132646|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
49081503|NCT01288079|158132647|FG000|Overall Study|Withdrawal by Subject|2|||
49081504|NCT01288079|158132648|FG001|Overall Study|Withdrawal by Subject|4|||
49081505|NCT01288079|158132649|FG002|Overall Study|Withdrawal by Subject|1|||
49081506|NCT01288079|158132650|FG003|Overall Study|Withdrawal by Subject|0|||
49081507|NCT01288079|158132647|FG000|Overall Study|Adverse Event|2|||
49081508|NCT01288079|158132648|FG001|Overall Study|Adverse Event|1|||
49081509|NCT01288079|158132649|FG002|Overall Study|Adverse Event|2|||
49081510|NCT01288079|158132650|FG003|Overall Study|Adverse Event|3|||
49081511|NCT01288079|158132647|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
49081512|NCT01288079|158132648|FG001|Overall Study|Severe Non-Compliance to Protocol|3|||
49081513|NCT01288079|158132649|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
49081514|NCT01288079|158132650|FG003|Overall Study|Severe Non-Compliance to Protocol|3|||
49081515|NCT01288079|158132647|FG000|Overall Study|Condition under Investigation Worsened|0|||
49081516|NCT01288079|158132648|FG001|Overall Study|Condition under Investigation Worsened|0|||
49081517|NCT01288079|158132649|FG002|Overall Study|Condition under Investigation Worsened|0|||
49081518|NCT01288079|158132650|FG003|Overall Study|Condition under Investigation Worsened|1|||
49081519|NCT01288079|158132647|FG000|Overall Study|Lack of Efficacy|2|||
49081520|NCT01288079|158132648|FG001|Overall Study|Lack of Efficacy|2|||
49081521|NCT01288079|158132649|FG002|Overall Study|Lack of Efficacy|0|||
49081522|NCT01288079|158132650|FG003|Overall Study|Lack of Efficacy|2|||
49081523|NCT01288079|158132647|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
49081524|NCT01288079|158132648|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
49081525|NCT01288079|158132649|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
49081526|NCT01288079|158132650|FG003|Overall Study|Study-Specific Withdrawal Criteria|0|||
49081527|NCT01288079|158132647|FG000|Overall Study|Lost to Follow-up|1|||
49081528|NCT01288079|158132648|FG001|Overall Study|Lost to Follow-up|1|||
49081529|NCT01288079|158132649|FG002|Overall Study|Lost to Follow-up|1|||
49081530|NCT01288079|158132650|FG003|Overall Study|Lost to Follow-up|0|||
49081531|NCT01288079|158132647|FG000|Overall Study|Other or Study Termination|11|||
49081532|NCT01288079|158132648|FG001|Overall Study|Other or Study Termination|15|||
49081533|NCT01288079|158132649|FG002|Overall Study|Other or Study Termination|14|||
49081534|NCT01288079|158132650|FG003|Overall Study|Other or Study Termination|8|||
49081535|NCT01530464|158132652|FG000|Washout (24h)|Withdrawal by Subject|1|||
49081536|NCT01530464|158132653|FG001|Washout (24h)|Withdrawal by Subject|0|||
49081537|NCT01530464|158132652|FG000|Washout (24h)|Withdrawal by Subject|0|||
49081538|NCT01530464|158132653|FG001|Washout (24h)|Withdrawal by Subject|1|||
49081539|NCT02698163|158132655|FG000|Overall Study|Lost to Follow-up|0|||
49081540|NCT02698163|158132656|FG001|Overall Study|Lost to Follow-up|1|||
49081541|NCT01213966|158132657|FG000|Overall Study|Protocol Violation|1|||
49081542|NCT01213966|158132658|FG001|Overall Study|Protocol Violation|0|||
49081543|NCT01213966|158132659|FG002|Overall Study|Protocol Violation|3|||
49081544|NCT01213966|158132660|FG003|Overall Study|Protocol Violation|1|||
49081545|NCT05373108|158132661|FG000|Overall Study|Withdrawal by Subject|2|||
49081546|NCT02892331|158132665|FG000|Overall Study|Withdrawal by Subject|0|||
49081547|NCT02892331|158132666|FG001|Overall Study|Withdrawal by Subject|1|||
49081548|NCT02892331|158132667|FG002|Overall Study|Withdrawal by Subject|1|||
49081549|NCT02892331|158132665|FG000|Overall Study|Sick family member|0|||
49081550|NCT02892331|158132666|FG001|Overall Study|Sick family member|0|||
49081551|NCT02892331|158132667|FG002|Overall Study|Sick family member|1|||
49081552|NCT02892331|158132665|FG000|Overall Study|Corona virus pandemic|1|||
49081553|NCT02892331|158132666|FG001|Overall Study|Corona virus pandemic|0|||
49081554|NCT02892331|158132667|FG002|Overall Study|Corona virus pandemic|1|||
49081555|NCT02892331|158132665|FG000|Overall Study|Lost to Follow-up|1|||
49081556|NCT02892331|158132666|FG001|Overall Study|Lost to Follow-up|0|||
49081557|NCT02892331|158132667|FG002|Overall Study|Lost to Follow-up|1|||
49081558|NCT02892331|158132665|FG000|Overall Study|Blood pressure was too elevated|0|||
49081559|NCT02892331|158132666|FG001|Overall Study|Blood pressure was too elevated|1|||
49081560|NCT02892331|158132667|FG002|Overall Study|Blood pressure was too elevated|0|||
49081561|NCT02892331|158132665|FG000|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
49081562|NCT02892331|158132666|FG001|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|1|||
49081563|NCT02892331|158132667|FG002|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
49081564|NCT01133067|158132671|FG000|Overall Study|Death|136|||
49081565|NCT01133067|158132671|FG000|Overall Study|Lost to Follow-up|3|||
49081566|NCT03539302|158132672|FG000|Overall Study|Spontaneous cardio version|0|||
49081567|NCT03539302|158132673|FG001|Overall Study|Spontaneous cardio version|0|||
49081568|NCT03539302|158132674|FG002|Overall Study|Spontaneous cardio version|0|||
49081569|NCT03539302|158132675|FG003|Overall Study|Spontaneous cardio version|0|||
49081570|NCT03539302|158132676|FG004|Overall Study|Spontaneous cardio version|0|||
49081571|NCT03539302|158132677|FG005|Overall Study|Spontaneous cardio version|1|||
49081572|NCT03539302|158132678|FG006|Overall Study|Spontaneous cardio version|1|||
49081573|NCT00740636|158132679|FG000|Overall Study|Adverse Event|0|||
49081574|NCT00740636|158132680|FG001|Overall Study|Adverse Event|2|||
49081575|NCT00740636|158132679|FG000|Overall Study|Patient Ineligible|0|||
49081576|NCT00740636|158132680|FG001|Overall Study|Patient Ineligible|1|||
49081577|NCT00740636|158132679|FG000|Overall Study|Patient Not Treated|0|||
49081578|NCT00740636|158132680|FG001|Overall Study|Patient Not Treated|1|||
49081579|NCT00740636|158132679|FG000|Overall Study|Progressive Disease|1|||
49081580|NCT00740636|158132680|FG001|Overall Study|Progressive Disease|0|||
49081581|NCT00740636|158132679|FG000|Overall Study|Death|1|||
49081582|NCT00740636|158132680|FG001|Overall Study|Death|0|||
49081583|NCT01982682|158135012|FG000|Overall Study|Physician Decision|1|||
49081584|NCT00974922|158135013|FG000|Overall Study|study terminated|24|||
49081585|NCT00287586|158135014|FG000|Overall Study|Withdrew Consent|19|||
49081586|NCT00287586|158135015|FG001|Overall Study|Withdrew Consent|30|||
49081587|NCT00287586|158135014|FG000|Overall Study|Lost to Follow-up|5|||
49081588|NCT00287586|158135015|FG001|Overall Study|Lost to Follow-up|4|||
49081589|NCT00287586|158135014|FG000|Overall Study|Death|2|||
49081590|NCT00287586|158135015|FG001|Overall Study|Death|3|||
49081591|NCT00287586|158135014|FG000|Overall Study|Elevated Hematocrit|3|||
49081592|NCT00287586|158135015|FG001|Overall Study|Elevated Hematocrit|0|||
49081593|NCT00287586|158135014|FG000|Overall Study|Rash|3|||
49081594|NCT00287586|158135015|FG001|Overall Study|Rash|0|||
49081595|NCT00287586|158135014|FG000|Overall Study|Elevated Prostate Specific Antigen|2|||
49081596|NCT00287586|158135015|FG001|Overall Study|Elevated Prostate Specific Antigen|0|||
49081597|NCT00287586|158135014|FG000|Overall Study|Stroke|2|||
49081598|NCT00287586|158135015|FG001|Overall Study|Stroke|0|||
49081599|NCT00287586|158135014|FG000|Overall Study|Myocardial Infarction|1|||
49081600|NCT00287586|158135015|FG001|Overall Study|Myocardial Infarction|0|||
49081601|NCT00287586|158135014|FG000|Overall Study|Lower Urinary Tract Symptoms|1|||
49081602|NCT00287586|158135015|FG001|Overall Study|Lower Urinary Tract Symptoms|0|||
49081603|NCT00287586|158135014|FG000|Overall Study|Cognitive Impairment|1|||
49081604|NCT00287586|158135015|FG001|Overall Study|Cognitive Impairment|0|||
49081605|NCT00287586|158135014|FG000|Overall Study|Pancreatic Cancer|1|||
49081606|NCT00287586|158135015|FG001|Overall Study|Pancreatic Cancer|3|||
49081607|NCT00287586|158135014|FG000|Overall Study|Sleep Apnea|1|||
49081608|NCT00287586|158135015|FG001|Overall Study|Sleep Apnea|0|||
49081609|NCT00287586|158135014|FG000|Overall Study|Shoulder Pain|1|||
49081610|NCT00287586|158135015|FG001|Overall Study|Shoulder Pain|0|||
49081611|NCT00287586|158135014|FG000|Overall Study|Inappropriate Behaviour with Staff|1|||
49081612|NCT00287586|158135015|FG001|Overall Study|Inappropriate Behaviour with Staff|0|||
49081613|NCT00287586|158135014|FG000|Overall Study|Nonadherence|1|||
49081614|NCT00287586|158135015|FG001|Overall Study|Nonadherence|1|||
49081615|NCT00287586|158135014|FG000|Overall Study|Enrolled in Another Study|1|||
49081616|NCT00287586|158135015|FG001|Overall Study|Enrolled in Another Study|0|||
49081617|NCT00287586|158135014|FG000|Overall Study|Major Depression|0|||
49081618|NCT00287586|158135015|FG001|Overall Study|Major Depression|2|||
49081619|NCT00287586|158135014|FG000|Overall Study|Lung Cancer|0|||
49081620|NCT00287586|158135015|FG001|Overall Study|Lung Cancer|2|||
49081621|NCT00287586|158135014|FG000|Overall Study|Elevated IPSS Score|0|||
49081622|NCT00287586|158135015|FG001|Overall Study|Elevated IPSS Score|1|||
49081623|NCT00287586|158135014|FG000|Overall Study|Retroperitoneal Cancer|0|||
49081624|NCT00287586|158135015|FG001|Overall Study|Retroperitoneal Cancer|1|||
49081625|NCT00287586|158135014|FG000|Overall Study|Mastodynia and Gynecomastia|0|||
49081626|NCT00287586|158135015|FG001|Overall Study|Mastodynia and Gynecomastia|1|||
49081627|NCT00287586|158135014|FG000|Overall Study|Mood Swings and Irritability|0|||
49081628|NCT00287586|158135015|FG001|Overall Study|Mood Swings and Irritability|1|||
49081629|NCT00287586|158135014|FG000|Overall Study|Bradycardia|0|||
49081630|NCT00287586|158135015|FG001|Overall Study|Bradycardia|1|||
49081631|NCT00287586|158135014|FG000|Overall Study|Itchy Swollen Eyes|0|||
49081632|NCT00287586|158135015|FG001|Overall Study|Itchy Swollen Eyes|1|||
49081633|NCT00287586|158135014|FG000|Overall Study|Recurrent Melanoma|0|||
49081634|NCT00287586|158135015|FG001|Overall Study|Recurrent Melanoma|1|||
49081635|NCT02135614|158135018|FG000|Overall Study|Randomized but Not Treated|2|||
49081636|NCT02135614|158135019|FG001|Overall Study|Randomized but Not Treated|1|||
49081637|NCT02135614|158135018|FG000|Overall Study|Adverse Event|0|||
49081638|NCT02135614|158135019|FG001|Overall Study|Adverse Event|1|||
49081639|NCT02135614|158135018|FG000|Overall Study|Death|1|||
49081640|NCT02135614|158135019|FG001|Overall Study|Death|0|||
49081641|NCT02135614|158135018|FG000|Overall Study|Investigator's Discretion|0|||
49081642|NCT02135614|158135019|FG001|Overall Study|Investigator's Discretion|1|||
49081643|NCT02135614|158135018|FG000|Overall Study|Withdrew Consent|2|||
49081644|NCT02135614|158135019|FG001|Overall Study|Withdrew Consent|2|||
49081645|NCT02135614|158135018|FG000|Overall Study|Lost to Follow-up|3|||
49081646|NCT02135614|158135019|FG001|Overall Study|Lost to Follow-up|0|||
49081647|NCT02653625|158135021|FG000|Overall Study|Adverse Event|1|||
49081648|NCT02653625|158135021|FG000|Overall Study|Non-compliance with Study Drug|1|||
49081649|NCT02653625|158135021|FG000|Overall Study|Protocol Violation|1|||
49081650|NCT02653625|158135021|FG000|Overall Study|Suspected Drug Induced Liver Injury|1|||
49081651|NCT01762800|158135022|FG000|Overall Study|Adverse Event|8|||
49081652|NCT01762800|158135023|FG001|Overall Study|Adverse Event|13|||
49081653|NCT01762800|158135022|FG000|Overall Study|Lack of Efficacy|3|||
49081654|NCT01762800|158135023|FG001|Overall Study|Lack of Efficacy|2|||
49081655|NCT01762800|158135022|FG000|Overall Study|Study Closed/Terminated|0|||
49081656|NCT01762800|158135023|FG001|Overall Study|Study Closed/Terminated|1|||
49081657|NCT01762800|158135022|FG000|Overall Study|Physician Decision|1|||
49081658|NCT01762800|158135023|FG001|Overall Study|Physician Decision|1|||
49081659|NCT01762800|158135022|FG000|Overall Study|Withdrawal by Subject|7|||
49081660|NCT01762800|158135023|FG001|Overall Study|Withdrawal by Subject|4|||
49081661|NCT05377749|158135024|FG000|3 Weeks|Lost to Follow-up|2|||
49081662|NCT05377749|158135025|FG001|3 Weeks|Lost to Follow-up|4|||
49081663|NCT05377749|158135024|FG000|3 Weeks|Withdrawal by Subject|1|||
49081664|NCT05377749|158135025|FG001|3 Weeks|Withdrawal by Subject|1|||
49081665|NCT00064987|158135026|FG000|Overall Study|Physician Decision|3|||
49081666|NCT00064987|158135027|FG001|Overall Study|Physician Decision|0|||
49081667|NCT00451204|158135030|FG000|Overall Study|Adverse Event|4|||
49081668|NCT00451204|158135031|FG001|Overall Study|Adverse Event|6|||
49081669|NCT00451204|158135030|FG000|Overall Study|Lack of Efficacy|4|||
49081670|NCT00451204|158135031|FG001|Overall Study|Lack of Efficacy|4|||
49081671|NCT00451204|158135030|FG000|Overall Study|Lost to Follow-up|4|||
49081672|NCT00451204|158135031|FG001|Overall Study|Lost to Follow-up|4|||
49081673|NCT00451204|158135030|FG000|Overall Study|Protocol Violation|1|||
49081674|NCT00451204|158135031|FG001|Overall Study|Protocol Violation|0|||
49081675|NCT00451204|158135030|FG000|Overall Study|Patient refusal|8|||
49081676|NCT00451204|158135031|FG001|Overall Study|Patient refusal|4|||
49081677|NCT00451204|158135030|FG000|Overall Study|Other|1|||
49081678|NCT00451204|158135031|FG001|Overall Study|Other|2|||
49081679|NCT02548156|158135032|FG000|Washout Period 1|Lost to Follow-up|0|||
49081680|NCT02548156|158135033|FG001|Washout Period 1|Lost to Follow-up|0|||
49081681|NCT02548156|158135034|FG002|Washout Period 1|Lost to Follow-up|0|||
49081682|NCT02548156|158135035|FG003|Washout Period 1|Lost to Follow-up|0|||
49081683|NCT02548156|158135036|FG004|Washout Period 1|Lost to Follow-up|1|||
49081684|NCT02548156|158135037|FG005|Washout Period 1|Lost to Follow-up|0|||
49081685|NCT04515147|158135038|FG000|Overall Study|Withdrawal by Subject|1|||
49081686|NCT04515147|158135039|FG001|Overall Study|Withdrawal by Subject|0|||
49081687|NCT04515147|158135040|FG002|Overall Study|Withdrawal by Subject|10|||
49081688|NCT04515147|158135041|FG003|Overall Study|Withdrawal by Subject|18|||
49081689|NCT04515147|158135042|FG004|Overall Study|Withdrawal by Subject|1|||
49081690|NCT04515147|158135043|FG005|Overall Study|Withdrawal by Subject|8|||
49081691|NCT04515147|158135038|FG000|Overall Study|Lost to Follow-up|0|||
49081692|NCT04515147|158135039|FG001|Overall Study|Lost to Follow-up|1|||
49081693|NCT04515147|158135040|FG002|Overall Study|Lost to Follow-up|5|||
49081694|NCT04515147|158135041|FG003|Overall Study|Lost to Follow-up|6|||
49081695|NCT04515147|158135042|FG004|Overall Study|Lost to Follow-up|2|||
49081696|NCT04515147|158135043|FG005|Overall Study|Lost to Follow-up|1|||
49081697|NCT04515147|158135038|FG000|Overall Study|Adverse Event|0|||
49081698|NCT04515147|158135039|FG001|Overall Study|Adverse Event|0|||
49081699|NCT04515147|158135040|FG002|Overall Study|Adverse Event|0|||
49081700|NCT04515147|158135041|FG003|Overall Study|Adverse Event|2|||
49081701|NCT04515147|158135042|FG004|Overall Study|Adverse Event|0|||
49081702|NCT04515147|158135043|FG005|Overall Study|Adverse Event|0|||
49081703|NCT04515147|158135038|FG000|Overall Study|Miscellaneous|0|||
49081704|NCT04515147|158135039|FG001|Overall Study|Miscellaneous|0|||
49081705|NCT04515147|158135040|FG002|Overall Study|Miscellaneous|0|||
49081706|NCT04515147|158135041|FG003|Overall Study|Miscellaneous|1|||
49081707|NCT04515147|158135042|FG004|Overall Study|Miscellaneous|0|||
49081708|NCT04515147|158135043|FG005|Overall Study|Miscellaneous|1|||
49081709|NCT05219448|158135046|FG000|Overall Study|Lost to Follow-up|9|||
49081710|NCT05219448|158135047|FG001|Overall Study|Lost to Follow-up|0|||
49081711|NCT00545714|158135048|FG000|Induction Phase (6 Months)|Physician Decision|3|||
49081712|NCT00545714|158135048|FG000|Induction Phase (6 Months)|Unacceptable Toxicity|6|||
49081713|NCT00545714|158135048|FG000|Induction Phase (6 Months)|Disease Progression|1|||
49081714|NCT00545714|158135048|FG000|Induction Phase (6 Months)|Eligibility Criteria Violation|2|||
49081715|NCT00545714|158135048|FG000|Maintenance Phase (36 Months)|Unacceptable Toxicity|16|||
49081716|NCT00545714|158135048|FG000|Maintenance Phase (36 Months)|Disease Progression|9|||
49081717|NCT00545714|158135048|FG000|Maintenance Phase (36 Months)|Physician Decision|1|||
49081718|NCT00545714|158135048|FG000|Maintenance Phase (36 Months)|Protocol Violation|1|||
49081719|NCT00545714|158135048|FG000|Maintenance Phase (36 Months)|Withdrawal by Subject|3|||
49081720|NCT00545714|158135048|FG000|Maintenance Phase (36 Months)|Death|2|||
49081721|NCT02515331|158135049|FG000|Overall Study|Withdrawal by Subject|0|||
49081722|NCT02515331|158135050|FG001|Overall Study|Withdrawal by Subject|0|||
49081723|NCT02515331|158135051|FG002|Overall Study|Withdrawal by Subject|1|||
49081724|NCT02515331|158135049|FG000|Overall Study|Protocol deviation|0|||
49081725|NCT02515331|158135050|FG001|Overall Study|Protocol deviation|0|||
49081726|NCT02515331|158135051|FG002|Overall Study|Protocol deviation|3|||
49081727|NCT02515331|158135049|FG000|Overall Study|Adverse Event|2|||
49081728|NCT02515331|158135050|FG001|Overall Study|Adverse Event|0|||
49081729|NCT02515331|158135051|FG002|Overall Study|Adverse Event|0|||
49081730|NCT00124748|158135052|FG000|Overall Study|Adverse Event|8|||
49081731|NCT00124748|158135053|FG001|Overall Study|Adverse Event|39|||
49081732|NCT00124748|158135052|FG000|Overall Study|Abnormal laboratory Value|2|||
49081733|NCT00124748|158135053|FG001|Overall Study|Abnormal laboratory Value|2|||
49081734|NCT00124748|158135052|FG000|Overall Study|Abnormal Procedure|0|||
49081735|NCT00124748|158135053|FG001|Overall Study|Abnormal Procedure|1|||
49081736|NCT00124748|158135052|FG000|Overall Study|Lack of Efficacy|20|||
49081737|NCT00124748|158135053|FG001|Overall Study|Lack of Efficacy|41|||
49081738|NCT00124748|158135052|FG000|Overall Study|No longer requires study drug|1|||
49081739|NCT00124748|158135053|FG001|Overall Study|No longer requires study drug|1|||
49081740|NCT00124748|158135052|FG000|Overall Study|Protocol Violation|3|||
49081741|NCT00124748|158135053|FG001|Overall Study|Protocol Violation|1|||
49081742|NCT00124748|158135052|FG000|Overall Study|Withdrawal by Subject|5|||
49081743|NCT00124748|158135053|FG001|Overall Study|Withdrawal by Subject|15|||
49081744|NCT00124748|158135052|FG000|Overall Study|Lost to Follow-up|2|||
49081745|NCT00124748|158135053|FG001|Overall Study|Lost to Follow-up|7|||
49081746|NCT00124748|158135052|FG000|Overall Study|Administrative Problem(Study Terminated)|101|||
49081747|NCT00124748|158135053|FG001|Overall Study|Administrative Problem(Study Terminated)|174|||
49081748|NCT00124748|158135052|FG000|Overall Study|Death|1|||
49081749|NCT00124748|158135053|FG001|Overall Study|Death|3|||
49081750|NCT03499067|158135056|FG000|First Intervention|Physician Decision|2|||
49081751|NCT03499067|158135057|FG001|First Intervention|Physician Decision|1|||
49081752|NCT03499067|158135056|FG000|First Intervention|Withdrawal by Subject|3|||
49081753|NCT03499067|158135057|FG001|First Intervention|Withdrawal by Subject|6|||
49081754|NCT00276484|158135060|FG000|Overall Study|Adverse Event|4|||
49081755|NCT00276484|158135061|FG001|Overall Study|Adverse Event|7|||
49081756|NCT00276484|158135060|FG000|Overall Study|Lost to Follow-up|1|||
49081757|NCT00276484|158135061|FG001|Overall Study|Lost to Follow-up|1|||
49081758|NCT00276484|158135060|FG000|Overall Study|Protocol Violation|0|||
49081759|NCT00276484|158135061|FG001|Overall Study|Protocol Violation|1|||
49081760|NCT00276484|158135060|FG000|Overall Study|Withdrawal by Subject|4|||
49081761|NCT00276484|158135061|FG001|Overall Study|Withdrawal by Subject|3|||
49081762|NCT00276484|158135060|FG000|Overall Study|Could not take time off work|0|||
49081763|NCT00276484|158135061|FG001|Overall Study|Could not take time off work|1|||
49081764|NCT02440464|158135063|FG000|Overall Study|Withdrawal by Subject|3|||
49081765|NCT02440464|158135064|FG001|Overall Study|Withdrawal by Subject|2|||
49081766|NCT02001987|158135067|FG000|Core Study Period (24 Weeks)|Adverse Event|9|||
49081767|NCT02001987|158135067|FG000|Core Study Period (24 Weeks)|Death|1|||
49081768|NCT02001987|158135067|FG000|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2|||
49081769|NCT02001987|158135067|FG000|Core Study Period (24 Weeks)|Physician Decision|1|||
49081770|NCT02001987|158135067|FG000|Core Study Period (24 Weeks)|Withdrawal by Subject|4|||
49081771|NCT02001987|158135067|FG000|Core Study Period (24 Weeks)|Protocol Violation|3|||
49081772|NCT02001987|158135067|FG000|Core Study Period (24 Weeks)|Lack of Efficacy|3|||
49081773|NCT02001987|158135067|FG000|LTE Period (52 Weeks)|Lost to Follow-up|2|||
49081774|NCT02001987|158135067|FG000|LTE Period (52 Weeks)|Physician Decision|2|||
49081775|NCT02001987|158135067|FG000|LTE Period (52 Weeks)|Withdrawal by Subject|1|||
49081776|NCT02001987|158135067|FG000|LTE Period (52 Weeks)|Lack of Efficacy|1|||
49081777|NCT02001987|158135067|FG000|LTE Period (52 Weeks)|Other|3|||
49081778|NCT02064296|158135082|FG000|Eligibility to Baseline Data Collection|Withdrawal by Subject|1|||
49081779|NCT02064296|158135083|FG001|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
49081780|NCT02064296|158135084|FG002|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
49081781|NCT02064296|158135082|FG000|Intervention|Withdrawal by Subject|0|||
49081782|NCT02064296|158135083|FG001|Intervention|Withdrawal by Subject|1|||
49081783|NCT02064296|158135084|FG002|Intervention|Withdrawal by Subject|2|||
49081784|NCT02392481|158135085|FG000|Overall Study|Adverse Event|0|||
49081785|NCT02392481|158135086|FG001|Overall Study|Adverse Event|0|||
49081786|NCT02392481|158135087|FG002|Overall Study|Adverse Event|1|||
49081787|NCT02392481|158135088|FG003|Overall Study|Adverse Event|2|||
49081788|NCT02392481|158135085|FG000|Overall Study|Withdrawal by Subject|0|||
49081789|NCT02392481|158135086|FG001|Overall Study|Withdrawal by Subject|0|||
49081790|NCT02392481|158135087|FG002|Overall Study|Withdrawal by Subject|1|||
49081791|NCT02392481|158135088|FG003|Overall Study|Withdrawal by Subject|0|||
49081792|NCT03334435|158135089|FG000|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|70|||
49081793|NCT03334435|158135090|FG001|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|32|||
49081794|NCT03334435|158135091|FG002|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|379|||
49081795|NCT03334435|158135092|FG003|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|519|||
49081796|NCT03334435|158135093|FG004|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|146|||
49081797|NCT03334435|158135094|FG005|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
49081798|NCT03334435|158135095|FG006|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
49081799|NCT03334435|158135096|FG007|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
49081800|NCT03334435|158135097|FG008|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
49081801|NCT03334435|158135098|FG009|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
49081802|NCT03334435|158135099|FG010|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
49081803|NCT03334435|158135100|FG011|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
49081804|NCT03334435|158135101|FG012|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
49081805|NCT03334435|158135102|FG013|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
49081806|NCT03334435|158135103|FG014|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
49081807|NCT03334435|158135089|FG000|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|3|||
49081808|NCT03334435|158135090|FG001|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|5|||
49081809|NCT03334435|158135091|FG002|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|76|||
49081810|NCT03334435|158135092|FG003|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|140|||
49081811|NCT03334435|158135093|FG004|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|61|||
49081812|NCT03334435|158135094|FG005|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
49081813|NCT03334435|158135095|FG006|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
49081814|NCT03334435|158135096|FG007|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
49081815|NCT03334435|158135097|FG008|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
49081816|NCT03334435|158135098|FG009|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
49081817|NCT03334435|158135099|FG010|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
49081818|NCT03334435|158135100|FG011|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
49081819|NCT03334435|158135101|FG012|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
49081820|NCT03334435|158135102|FG013|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
49081821|NCT03334435|158135103|FG014|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
49081822|NCT03334435|158135089|FG000|Treatment Period 1: Week 0 to Week 52|Adverse Event|2|||
49081823|NCT03334435|158135090|FG001|Treatment Period 1: Week 0 to Week 52|Adverse Event|1|||
49081824|NCT03334435|158135091|FG002|Treatment Period 1: Week 0 to Week 52|Adverse Event|9|||
49081825|NCT03334435|158135092|FG003|Treatment Period 1: Week 0 to Week 52|Adverse Event|23|||
49081826|NCT03334435|158135093|FG004|Treatment Period 1: Week 0 to Week 52|Adverse Event|13|||
49081827|NCT03334435|158135094|FG005|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
49081828|NCT03334435|158135095|FG006|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
49081829|NCT03334435|158135096|FG007|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
49081830|NCT03334435|158135097|FG008|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
49081831|NCT03334435|158135098|FG009|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
49081832|NCT03334435|158135099|FG010|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
49081833|NCT03334435|158135100|FG011|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
49081834|NCT03334435|158135101|FG012|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
49081835|NCT03334435|158135102|FG013|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
49081836|NCT03334435|158135103|FG014|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
49081837|NCT03334435|158135089|FG000|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|11|||
49081838|NCT03334435|158135090|FG001|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|4|||
49081839|NCT03334435|158135091|FG002|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|38|||
49081840|NCT03334435|158135092|FG003|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|42|||
49081841|NCT03334435|158135093|FG004|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|20|||
49081842|NCT03334435|158135094|FG005|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
49081843|NCT03334435|158135095|FG006|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
49081844|NCT03334435|158135096|FG007|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
49081845|NCT03334435|158135097|FG008|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
49081846|NCT03334435|158135098|FG009|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
49081847|NCT03334435|158135099|FG010|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
49081848|NCT03334435|158135100|FG011|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
49081849|NCT03334435|158135101|FG012|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
49081850|NCT03334435|158135102|FG013|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
49081851|NCT03334435|158135103|FG014|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
49081852|NCT03334435|158135089|FG000|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|3|||
49081853|NCT03334435|158135090|FG001|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
49081854|NCT03334435|158135091|FG002|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|2|||
49081855|NCT03334435|158135092|FG003|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
49081856|NCT03334435|158135093|FG004|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
49081857|NCT03334435|158135094|FG005|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
49081858|NCT03334435|158135095|FG006|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
49081859|NCT03334435|158135096|FG007|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
49081860|NCT03334435|158135097|FG008|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
49081861|NCT03334435|158135098|FG009|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
49081862|NCT03334435|158135099|FG010|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
49081863|NCT03334435|158135100|FG011|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
49081864|NCT03334435|158135101|FG012|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
49081865|NCT03334435|158135102|FG013|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
49081866|NCT03334435|158135103|FG014|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
49081867|NCT03334435|158135089|FG000|Treatment Period 1: Week 0 to Week 52|Death|0|||
49081868|NCT03334435|158135090|FG001|Treatment Period 1: Week 0 to Week 52|Death|0|||
49081869|NCT03334435|158135091|FG002|Treatment Period 1: Week 0 to Week 52|Death|0|||
49081870|NCT03334435|158135092|FG003|Treatment Period 1: Week 0 to Week 52|Death|1|||
49081871|NCT03334435|158135093|FG004|Treatment Period 1: Week 0 to Week 52|Death|0|||
49081872|NCT03334435|158135094|FG005|Treatment Period 1: Week 0 to Week 52|Death|0|||
49081873|NCT03334435|158135095|FG006|Treatment Period 1: Week 0 to Week 52|Death|0|||
49081874|NCT03334435|158135096|FG007|Treatment Period 1: Week 0 to Week 52|Death|0|||
49081875|NCT03334435|158135097|FG008|Treatment Period 1: Week 0 to Week 52|Death|0|||
49081876|NCT03334435|158135098|FG009|Treatment Period 1: Week 0 to Week 52|Death|0|||
49081877|NCT03334435|158135099|FG010|Treatment Period 1: Week 0 to Week 52|Death|0|||
49081878|NCT03334435|158135100|FG011|Treatment Period 1: Week 0 to Week 52|Death|0|||
49081879|NCT03334435|158135101|FG012|Treatment Period 1: Week 0 to Week 52|Death|0|||
49081880|NCT03334435|158135102|FG013|Treatment Period 1: Week 0 to Week 52|Death|0|||
49081881|NCT03334435|158135103|FG014|Treatment Period 1: Week 0 to Week 52|Death|0|||
49081882|NCT03334435|158135089|FG000|Treatment Period 1: Week 0 to Week 52|Other|0|||
49081883|NCT03334435|158135090|FG001|Treatment Period 1: Week 0 to Week 52|Other|1|||
49081884|NCT03334435|158135091|FG002|Treatment Period 1: Week 0 to Week 52|Other|3|||
49081885|NCT03334435|158135092|FG003|Treatment Period 1: Week 0 to Week 52|Other|2|||
49081886|NCT03334435|158135093|FG004|Treatment Period 1: Week 0 to Week 52|Other|1|||
49081887|NCT03334435|158135094|FG005|Treatment Period 1: Week 0 to Week 52|Other|0|||
49081888|NCT03334435|158135095|FG006|Treatment Period 1: Week 0 to Week 52|Other|0|||
49081889|NCT03334435|158135096|FG007|Treatment Period 1: Week 0 to Week 52|Other|0|||
49081890|NCT03334435|158135097|FG008|Treatment Period 1: Week 0 to Week 52|Other|0|||
49081891|NCT03334435|158135098|FG009|Treatment Period 1: Week 0 to Week 52|Other|0|||
49081892|NCT03334435|158135099|FG010|Treatment Period 1: Week 0 to Week 52|Other|0|||
49081893|NCT03334435|158135100|FG011|Treatment Period 1: Week 0 to Week 52|Other|0|||
49081894|NCT03334435|158135101|FG012|Treatment Period 1: Week 0 to Week 52|Other|0|||
49081895|NCT03334435|158135102|FG013|Treatment Period 1: Week 0 to Week 52|Other|0|||
49081896|NCT03334435|158135103|FG014|Treatment Period 1: Week 0 to Week 52|Other|0|||
49081897|NCT03334435|158135089|FG000|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
49081898|NCT03334435|158135090|FG001|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
49081899|NCT03334435|158135091|FG002|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
49081900|NCT03334435|158135092|FG003|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
49081901|NCT03334435|158135093|FG004|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
49081902|NCT03334435|158135094|FG005|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
49081903|NCT03334435|158135095|FG006|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|21|||
49081904|NCT03334435|158135096|FG007|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
49081905|NCT03334435|158135097|FG008|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|19|||
49081906|NCT03334435|158135098|FG009|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|15|||
49081907|NCT03334435|158135099|FG010|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
49081908|NCT03334435|158135100|FG011|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|16|||
49081909|NCT03334435|158135101|FG012|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|3|||
49081910|NCT03334435|158135102|FG013|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|66|||
49081911|NCT03334435|158135103|FG014|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|70|||
49081912|NCT03334435|158135089|FG000|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
49081913|NCT03334435|158135090|FG001|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
49081914|NCT03334435|158135091|FG002|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
49081915|NCT03334435|158135092|FG003|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
49081916|NCT03334435|158135093|FG004|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
49081917|NCT03334435|158135094|FG005|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|13|||
49081918|NCT03334435|158135095|FG006|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|10|||
49081919|NCT03334435|158135096|FG007|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|11|||
49081920|NCT03334435|158135097|FG008|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
49081921|NCT03334435|158135098|FG009|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|12|||
49081922|NCT03334435|158135099|FG010|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|8|||
49081923|NCT03334435|158135100|FG011|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
49081924|NCT03334435|158135101|FG012|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|2|||
49081925|NCT03334435|158135102|FG013|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|63|||
49081926|NCT03334435|158135103|FG014|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|72|||
49081927|NCT03334435|158135089|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
49081928|NCT03334435|158135090|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
49081929|NCT03334435|158135091|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
49081930|NCT03334435|158135092|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
49081931|NCT03334435|158135093|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
49081932|NCT03334435|158135094|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|23|||
49081933|NCT03334435|158135095|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|15|||
49081934|NCT03334435|158135096|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|20|||
49081935|NCT03334435|158135097|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|17|||
49081936|NCT03334435|158135098|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|10|||
49081937|NCT03334435|158135099|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|11|||
49081938|NCT03334435|158135100|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|8|||
49081939|NCT03334435|158135101|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
49081940|NCT03334435|158135102|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|41|||
49081941|NCT03334435|158135103|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|32|||
49081942|NCT03334435|158135089|FG000|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
49081943|NCT03334435|158135090|FG001|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
49081944|NCT03334435|158135091|FG002|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
49081945|NCT03334435|158135092|FG003|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
49081946|NCT03334435|158135093|FG004|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
49081947|NCT03334435|158135094|FG005|Treatment Period 2: Week 52 to Week 200|Adverse Event|6|||
49081948|NCT03334435|158135095|FG006|Treatment Period 2: Week 52 to Week 200|Adverse Event|1|||
49081949|NCT03334435|158135096|FG007|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
49081950|NCT03334435|158135097|FG008|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
49081951|NCT03334435|158135098|FG009|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
49081952|NCT03334435|158135099|FG010|Treatment Period 2: Week 52 to Week 200|Adverse Event|9|||
49081953|NCT03334435|158135100|FG011|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
49081954|NCT03334435|158135101|FG012|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
49081955|NCT03334435|158135102|FG013|Treatment Period 2: Week 52 to Week 200|Adverse Event|11|||
49081956|NCT03334435|158135103|FG014|Treatment Period 2: Week 52 to Week 200|Adverse Event|13|||
49081957|NCT03334435|158135089|FG000|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
49081958|NCT03334435|158135090|FG001|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
49081959|NCT03334435|158135091|FG002|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
49081960|NCT03334435|158135092|FG003|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
49081961|NCT03334435|158135093|FG004|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
49081962|NCT03334435|158135094|FG005|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
49081963|NCT03334435|158135095|FG006|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
49081964|NCT03334435|158135096|FG007|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
49081965|NCT03334435|158135097|FG008|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|3|||
49081966|NCT03334435|158135098|FG009|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
49081967|NCT03334435|158135099|FG010|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
49081968|NCT03334435|158135100|FG011|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
49081969|NCT03334435|158135101|FG012|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
49081970|NCT03334435|158135102|FG013|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
49081971|NCT03334435|158135103|FG014|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
49081972|NCT03334435|158135089|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
49081973|NCT03334435|158135090|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
49081974|NCT03334435|158135091|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
49081975|NCT03334435|158135092|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
49081976|NCT03334435|158135093|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
49081977|NCT03334435|158135094|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
49081978|NCT03334435|158135095|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
49081979|NCT03334435|158135096|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
49081980|NCT03334435|158135097|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
49081981|NCT03334435|158135098|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
49081982|NCT03334435|158135099|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
49081983|NCT03334435|158135100|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
49081984|NCT03334435|158135101|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
49081985|NCT03334435|158135102|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
49081986|NCT03334435|158135103|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
49081987|NCT03334435|158135089|FG000|Treatment Period 2: Week 52 to Week 200|Death|0|||
49081988|NCT03334435|158135090|FG001|Treatment Period 2: Week 52 to Week 200|Death|0|||
49081989|NCT03334435|158135091|FG002|Treatment Period 2: Week 52 to Week 200|Death|0|||
49081990|NCT03334435|158135092|FG003|Treatment Period 2: Week 52 to Week 200|Death|0|||
49081991|NCT03334435|158135093|FG004|Treatment Period 2: Week 52 to Week 200|Death|0|||
49081992|NCT03334435|158135094|FG005|Treatment Period 2: Week 52 to Week 200|Death|1|||
49081993|NCT03334435|158135095|FG006|Treatment Period 2: Week 52 to Week 200|Death|0|||
49081994|NCT03334435|158135096|FG007|Treatment Period 2: Week 52 to Week 200|Death|0|||
49081995|NCT03334435|158135097|FG008|Treatment Period 2: Week 52 to Week 200|Death|0|||
49081996|NCT03334435|158135098|FG009|Treatment Period 2: Week 52 to Week 200|Death|0|||
49081997|NCT03334435|158135099|FG010|Treatment Period 2: Week 52 to Week 200|Death|0|||
49081998|NCT03334435|158135100|FG011|Treatment Period 2: Week 52 to Week 200|Death|0|||
49081999|NCT03334435|158135101|FG012|Treatment Period 2: Week 52 to Week 200|Death|0|||
49082000|NCT03334435|158135102|FG013|Treatment Period 2: Week 52 to Week 200|Death|0|||
49082001|NCT03334435|158135103|FG014|Treatment Period 2: Week 52 to Week 200|Death|1|||
49082002|NCT03334435|158135089|FG000|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
49082003|NCT03334435|158135090|FG001|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
49082004|NCT03334435|158135091|FG002|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
49082005|NCT03334435|158135092|FG003|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
49082006|NCT03334435|158135093|FG004|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
49082007|NCT03334435|158135094|FG005|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
49082008|NCT03334435|158135095|FG006|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
49082009|NCT03334435|158135096|FG007|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
49082010|NCT03334435|158135097|FG008|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
49082011|NCT03334435|158135098|FG009|Treatment Period 2: Week 52 to Week 200|Physician is retiring|3|||
49082012|NCT03334435|158135099|FG010|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
49082013|NCT03334435|158135100|FG011|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
49082014|NCT03334435|158135101|FG012|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
49082015|NCT03334435|158135102|FG013|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
49082016|NCT03334435|158135103|FG014|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
49082017|NCT03334435|158135089|FG000|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
49082018|NCT03334435|158135090|FG001|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
49082019|NCT03334435|158135091|FG002|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
49082020|NCT03334435|158135092|FG003|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
49082021|NCT03334435|158135093|FG004|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
49082022|NCT03334435|158135094|FG005|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
49082023|NCT03334435|158135095|FG006|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
49082024|NCT03334435|158135096|FG007|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
49082025|NCT03334435|158135097|FG008|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
49082026|NCT03334435|158135098|FG009|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
49082027|NCT03334435|158135099|FG010|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
49082028|NCT03334435|158135100|FG011|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
49082029|NCT03334435|158135101|FG012|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
49082030|NCT03334435|158135102|FG013|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
49082031|NCT03334435|158135103|FG014|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
49082032|NCT03334435|158135089|FG000|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
49082033|NCT03334435|158135090|FG001|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
49082034|NCT03334435|158135091|FG002|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
49082035|NCT03334435|158135092|FG003|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
49082036|NCT03334435|158135093|FG004|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
49082037|NCT03334435|158135094|FG005|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
49082038|NCT03334435|158135095|FG006|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
49082039|NCT03334435|158135096|FG007|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
49082040|NCT03334435|158135097|FG008|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
49082041|NCT03334435|158135098|FG009|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
49082042|NCT03334435|158135099|FG010|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
49082043|NCT03334435|158135100|FG011|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
49082044|NCT03334435|158135101|FG012|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
49082045|NCT03334435|158135102|FG013|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
49082046|NCT03334435|158135103|FG014|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
49082047|NCT03334435|158135089|FG000|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
49082048|NCT03334435|158135090|FG001|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
49082049|NCT03334435|158135091|FG002|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
49082050|NCT03334435|158135092|FG003|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
49082051|NCT03334435|158135093|FG004|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
49082052|NCT03334435|158135094|FG005|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
49082053|NCT03334435|158135095|FG006|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
49082054|NCT03334435|158135096|FG007|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
49082055|NCT03334435|158135097|FG008|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
49082056|NCT03334435|158135098|FG009|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
49082057|NCT03334435|158135099|FG010|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
49082058|NCT03334435|158135100|FG011|Treatment Period 2: Week 52 to Week 200|Sponsor decision|3|||
49082059|NCT03334435|158135101|FG012|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
49082060|NCT03334435|158135102|FG013|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
49082061|NCT03334435|158135103|FG014|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
49082062|NCT03334435|158135089|FG000|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
49082063|NCT03334435|158135090|FG001|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
49082064|NCT03334435|158135091|FG002|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
49082065|NCT03334435|158135092|FG003|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
49082066|NCT03334435|158135093|FG004|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
49082067|NCT03334435|158135094|FG005|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
49082068|NCT03334435|158135095|FG006|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
49082069|NCT03334435|158135096|FG007|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
49082070|NCT03334435|158135097|FG008|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
49082071|NCT03334435|158135098|FG009|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
49082072|NCT03334435|158135099|FG010|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
49082073|NCT03334435|158135100|FG011|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
49082074|NCT03334435|158135101|FG012|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
49082075|NCT03334435|158135102|FG013|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
49082076|NCT03334435|158135103|FG014|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
49082077|NCT02502149|158135105|FG000|Intermediate|Discontinued prematurely|1|||
49082078|NCT02502149|158135106|FG001|Intermediate|Discontinued prematurely|0|||
49082079|NCT02502149|158135107|FG002|Intermediate|Discontinued prematurely|0|||
49082080|NCT02502149|158135108|FG003|Intermediate|Discontinued prematurely|0|||
49082081|NCT02502149|158135109|FG004|Intermediate|Discontinued prematurely|0|||
49082082|NCT03922321|158135110|FG000|Overall Study|Participant Moved|1|||
49082083|NCT03922321|158135110|FG000|Overall Study|Unable to Come to Site Due to COVID 19|1|||
49082084|NCT01431079|158135111|FG000|Overall Study|Lost to Follow-up|35|||
49082085|NCT01431079|158135112|FG001|Overall Study|Lost to Follow-up|39|||
49082086|NCT04747470|158135113|FG000|Overall Study|Death|0|||
49082087|NCT04747470|158135114|FG001|Overall Study|Death|3|||
49082088|NCT04747470|158135115|FG002|Overall Study|Death|2|||
49082089|NCT04747470|158135116|FG003|Overall Study|Death|2|||
49082090|NCT04747470|158135117|FG004|Overall Study|Death|2|||
49082091|NCT04747470|158135118|FG005|Overall Study|Death|0|||
49082092|NCT04747470|158135119|FG006|Overall Study|Death|0|||
49082093|NCT04747470|158135120|FG007|Overall Study|Death|0|||
49082094|NCT04747470|158135121|FG008|Overall Study|Death|0|||
49082095|NCT04747470|158135122|FG009|Overall Study|Death|0|||
49082096|NCT04747470|158135123|FG010|Overall Study|Death|0|||
49082097|NCT04747470|158135113|FG000|Overall Study|Withdrew Consent|0|||
49082098|NCT04747470|158135114|FG001|Overall Study|Withdrew Consent|0|||
49082099|NCT04747470|158135115|FG002|Overall Study|Withdrew Consent|0|||
49082100|NCT04747470|158135116|FG003|Overall Study|Withdrew Consent|1|||
49082101|NCT04747470|158135117|FG004|Overall Study|Withdrew Consent|0|||
49082102|NCT04747470|158135118|FG005|Overall Study|Withdrew Consent|0|||
49082103|NCT04747470|158135119|FG006|Overall Study|Withdrew Consent|0|||
49082104|NCT04747470|158135120|FG007|Overall Study|Withdrew Consent|0|||
49082105|NCT04747470|158135121|FG008|Overall Study|Withdrew Consent|0|||
49082106|NCT04747470|158135122|FG009|Overall Study|Withdrew Consent|0|||
49082107|NCT04747470|158135123|FG010|Overall Study|Withdrew Consent|0|||
49082108|NCT04747470|158135113|FG000|Overall Study|Study Terminated by Sponsor|0|||
49082109|NCT04747470|158135114|FG001|Overall Study|Study Terminated by Sponsor|0|||
49082110|NCT04747470|158135115|FG002|Overall Study|Study Terminated by Sponsor|1|||
49082111|NCT04747470|158135116|FG003|Overall Study|Study Terminated by Sponsor|0|||
49082112|NCT04747470|158135117|FG004|Overall Study|Study Terminated by Sponsor|2|||
49082113|NCT04747470|158135118|FG005|Overall Study|Study Terminated by Sponsor|0|||
49082114|NCT04747470|158135119|FG006|Overall Study|Study Terminated by Sponsor|0|||
49082115|NCT04747470|158135120|FG007|Overall Study|Study Terminated by Sponsor|0|||
49082116|NCT04747470|158135121|FG008|Overall Study|Study Terminated by Sponsor|0|||
49082117|NCT04747470|158135122|FG009|Overall Study|Study Terminated by Sponsor|0|||
49082118|NCT04747470|158135123|FG010|Overall Study|Study Terminated by Sponsor|0|||
49082119|NCT02790437|158135124|FG000|Overall Study|Patient graft failure - nephrectomy|1|||
49082120|NCT02790437|158135125|FG001|Overall Study|Patient graft failure - nephrectomy|0|||
49082121|NCT02790437|158135124|FG000|Overall Study|Adverse Event|1|||
49082122|NCT02790437|158135125|FG001|Overall Study|Adverse Event|0|||
49082123|NCT02790437|158135124|FG000|Overall Study|Withdrawal by Subject|1|||
49082124|NCT02790437|158135125|FG001|Overall Study|Withdrawal by Subject|0|||
49082125|NCT01202175|158135129|FG000|Overall Study|Lost to Follow-up|2|||
49082126|NCT01202175|158135129|FG000|Overall Study|Withdrawal by Subject|1|||
49082127|NCT01202175|158135129|FG000|Overall Study|Adverse Event|2|||
49082128|NCT02548832|158135130|FG000|Overall Study|Lost to Follow-up|2|||
49082129|NCT02548832|158135131|FG001|Overall Study|Lost to Follow-up|2|||
49082130|NCT02548832|158135132|FG002|Overall Study|Lost to Follow-up|2|||
49082131|NCT03565900|158135133|FG000|Overall Study|Disposition Unknown|4|||
49082132|NCT03565900|158135134|FG001|Overall Study|Disposition Unknown|1|||
49082133|NCT03565900|158135133|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
49082134|NCT03565900|158135134|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
49082135|NCT03565900|158135133|FG000|Overall Study|Withdrawal by Subject|4|||
49082136|NCT03565900|158135134|FG001|Overall Study|Withdrawal by Subject|5|||
49082137|NCT03565900|158135133|FG000|Overall Study|Randomized By Mistake|0|||
49082138|NCT03565900|158135134|FG001|Overall Study|Randomized By Mistake|2|||
49082139|NCT03565900|158135133|FG000|Overall Study|Physician Decision|7|||
49082140|NCT03565900|158135134|FG001|Overall Study|Physician Decision|11|||
49082141|NCT03565900|158135133|FG000|Overall Study|Death|9|||
49082142|NCT03565900|158135134|FG001|Overall Study|Death|7|||
49082143|NCT02968576|158135135|FG000|Overall Study|Pregnancy|0|||
49082144|NCT02968576|158135136|FG001|Overall Study|Pregnancy|1|||
49082145|NCT04688671|158135137|FG000|Overall Study|Adverse Event|3|||
49082146|NCT04688671|158135138|FG001|Overall Study|Adverse Event|1|||
49082147|NCT04688671|158135137|FG000|Overall Study|Withdrawal by Subject|3|||
49082148|NCT04688671|158135138|FG001|Overall Study|Withdrawal by Subject|1|||
49082149|NCT04688671|158135137|FG000|Overall Study|Lack of Efficacy|1|||
49082150|NCT04688671|158135138|FG001|Overall Study|Lack of Efficacy|1|||
49082151|NCT04688671|158135137|FG000|Overall Study|Protocol Violation|1|||
49082152|NCT04688671|158135138|FG001|Overall Study|Protocol Violation|0|||
49082153|NCT04688671|158135137|FG000|Overall Study|Lost to Follow-up|0|||
49082154|NCT04688671|158135138|FG001|Overall Study|Lost to Follow-up|1|||
49082155|NCT04583735|158135139|FG000|Double-masked Treatment Period|Adverse Event|0|||
49082156|NCT04583735|158135140|FG001|Double-masked Treatment Period|Adverse Event|1|||
49082157|NCT04583735|158135139|FG000|Double-masked Treatment Period|Lost to Follow-up|2|||
49082158|NCT04583735|158135140|FG001|Double-masked Treatment Period|Lost to Follow-up|0|||
49082159|NCT04583735|158135139|FG000|Double-masked Treatment Period|Withdrawal by Subject|1|||
49082160|NCT04583735|158135140|FG001|Double-masked Treatment Period|Withdrawal by Subject|0|||
49082161|NCT04583735|158135139|FG000|Open-label Treatment Period|Adverse Event|1|||
49082162|NCT04583735|158135140|FG001|Open-label Treatment Period|Adverse Event|1|||
49082163|NCT04583735|158135139|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
49082164|NCT04583735|158135140|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
49082165|NCT04583735|158135139|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
49082166|NCT04583735|158135140|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
49082167|NCT00124917|158135141|FG000|Overall Study|Physician Decision|3|||
49082168|NCT05271175|158135142|FG000|One Week Follow up|Lost to Follow-up|10|||
49082169|NCT05271175|158135143|FG001|One Week Follow up|Lost to Follow-up|7|||
49082170|NCT05271175|158135144|FG002|One Week Follow up|Lost to Follow-up|5|||
49082171|NCT05271175|158135142|FG000|One Month Follow up|Lost to Follow-up|12|||
49082172|NCT05271175|158135143|FG001|One Month Follow up|Lost to Follow-up|7|||
49082173|NCT05271175|158135144|FG002|One Month Follow up|Lost to Follow-up|9|||
49082174|NCT05271175|158135142|FG000|Six Months Follow up|Lost to Follow-up|8|||
49082175|NCT05271175|158135143|FG001|Six Months Follow up|Lost to Follow-up|2|||
49082176|NCT05271175|158135144|FG002|Six Months Follow up|Lost to Follow-up|2|||
49082177|NCT02105987|158135145|FG000|Early Switch Phase (24 Weeks)|Adverse Event|10|||
49082178|NCT02105987|158135146|FG001|Early Switch Phase (24 Weeks)|Adverse Event|0|||
49082179|NCT02105987|158135147|FG002|Early Switch Phase (24 Weeks)|Adverse Event|0|||
49082180|NCT02105987|158135148|FG003|Early Switch Phase (24 Weeks)|Adverse Event|0|||
49082181|NCT02105987|158135149|FG004|Early Switch Phase (24 Weeks)|Adverse Event|0|||
49082182|NCT02105987|158135150|FG005|Early Switch Phase (24 Weeks)|Adverse Event|0|||
49082183|NCT02105987|158135145|FG000|Early Switch Phase (24 Weeks)|Protocol Violation|15|||
49082184|NCT02105987|158135146|FG001|Early Switch Phase (24 Weeks)|Protocol Violation|17|||
49082185|NCT02105987|158135147|FG002|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
49082186|NCT02105987|158135148|FG003|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
49082187|NCT02105987|158135149|FG004|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
49082188|NCT02105987|158135150|FG005|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
49082189|NCT02105987|158135145|FG000|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4|||
49082190|NCT02105987|158135146|FG001|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10|||
49082191|NCT02105987|158135147|FG002|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
49082192|NCT02105987|158135148|FG003|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
49082193|NCT02105987|158135149|FG004|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
49082194|NCT02105987|158135150|FG005|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
49082195|NCT02105987|158135145|FG000|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
49082196|NCT02105987|158135146|FG001|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
49082197|NCT02105987|158135147|FG002|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
49082198|NCT02105987|158135148|FG003|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
49082199|NCT02105987|158135149|FG004|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
49082200|NCT02105987|158135150|FG005|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
49082201|NCT02105987|158135145|FG000|Early Switch Phase (24 Weeks)|Physician Decision|4|||
49082202|NCT02105987|158135146|FG001|Early Switch Phase (24 Weeks)|Physician Decision|3|||
49082203|NCT02105987|158135147|FG002|Early Switch Phase (24 Weeks)|Physician Decision|0|||
49082204|NCT02105987|158135148|FG003|Early Switch Phase (24 Weeks)|Physician Decision|0|||
49082205|NCT02105987|158135149|FG004|Early Switch Phase (24 Weeks)|Physician Decision|0|||
49082206|NCT02105987|158135150|FG005|Early Switch Phase (24 Weeks)|Physician Decision|0|||
49082207|NCT02105987|158135145|FG000|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
49082208|NCT02105987|158135146|FG001|Early Switch Phase (24 Weeks)|Missing Disposition Data|1|||
49082209|NCT02105987|158135147|FG002|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
49082210|NCT02105987|158135148|FG003|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
49082211|NCT02105987|158135149|FG004|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
49082212|NCT02105987|158135150|FG005|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
49082213|NCT02105987|158135145|FG000|Late Switch Phase (24 Weeks)|Adverse Event|0|||
49082214|NCT02105987|158135146|FG001|Late Switch Phase (24 Weeks)|Adverse Event|0|||
49082215|NCT02105987|158135147|FG002|Late Switch Phase (24 Weeks)|Adverse Event|10|||
49082216|NCT02105987|158135148|FG003|Late Switch Phase (24 Weeks)|Adverse Event|4|||
49082217|NCT02105987|158135149|FG004|Late Switch Phase (24 Weeks)|Adverse Event|0|||
49082218|NCT02105987|158135150|FG005|Late Switch Phase (24 Weeks)|Adverse Event|0|||
49082219|NCT02105987|158135145|FG000|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
49082220|NCT02105987|158135146|FG001|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
49082221|NCT02105987|158135147|FG002|Late Switch Phase (24 Weeks)|Protocol Violation|15|||
49082222|NCT02105987|158135148|FG003|Late Switch Phase (24 Weeks)|Protocol Violation|1|||
49082223|NCT02105987|158135149|FG004|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
49082224|NCT02105987|158135150|FG005|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
49082225|NCT02105987|158135145|FG000|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
49082226|NCT02105987|158135146|FG001|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
49082227|NCT02105987|158135147|FG002|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6|||
49082228|NCT02105987|158135148|FG003|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5|||
49082229|NCT02105987|158135149|FG004|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
49082230|NCT02105987|158135150|FG005|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
49082231|NCT02105987|158135145|FG000|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
49082232|NCT02105987|158135146|FG001|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
49082233|NCT02105987|158135147|FG002|Late Switch Phase (24 Weeks)|Lost to Follow-up|8|||
49082234|NCT02105987|158135148|FG003|Late Switch Phase (24 Weeks)|Lost to Follow-up|3|||
49082235|NCT02105987|158135149|FG004|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
49082236|NCT02105987|158135150|FG005|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
49082237|NCT02105987|158135145|FG000|Late Switch Phase (24 Weeks)|Physician Decision|0|||
49082238|NCT02105987|158135146|FG001|Late Switch Phase (24 Weeks)|Physician Decision|0|||
49082239|NCT02105987|158135147|FG002|Late Switch Phase (24 Weeks)|Physician Decision|5|||
49082240|NCT02105987|158135148|FG003|Late Switch Phase (24 Weeks)|Physician Decision|0|||
49082241|NCT02105987|158135149|FG004|Late Switch Phase (24 Weeks)|Physician Decision|0|||
49082242|NCT02105987|158135150|FG005|Late Switch Phase (24 Weeks)|Physician Decision|0|||
49082243|NCT02105987|158135145|FG000|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
49082244|NCT02105987|158135146|FG001|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
49082245|NCT02105987|158135147|FG002|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
49082246|NCT02105987|158135148|FG003|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1|||
49082247|NCT02105987|158135149|FG004|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
49082248|NCT02105987|158135150|FG005|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
49082249|NCT02105987|158135145|FG000|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
49082250|NCT02105987|158135146|FG001|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
49082251|NCT02105987|158135147|FG002|Late Switch Phase (24 Weeks)|Per sponsor request|1|||
49082252|NCT02105987|158135148|FG003|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
49082253|NCT02105987|158135149|FG004|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
49082254|NCT02105987|158135150|FG005|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
49082255|NCT02105987|158135145|FG000|Continuation Phase|Protocol Violation|0|||
49082256|NCT02105987|158135146|FG001|Continuation Phase|Protocol Violation|0|||
49082257|NCT02105987|158135147|FG002|Continuation Phase|Protocol Violation|0|||
49082258|NCT02105987|158135148|FG003|Continuation Phase|Protocol Violation|0|||
49082259|NCT02105987|158135149|FG004|Continuation Phase|Protocol Violation|1|||
49082260|NCT02105987|158135150|FG005|Continuation Phase|Protocol Violation|0|||
49082261|NCT01709500|158135151|FG000|Overall Study|Randomized but not treated|0|||
49082262|NCT01709500|158135152|FG001|Overall Study|Randomized but not treated|1|||
49082263|NCT01709500|158135151|FG000|Overall Study|Adverse Event|5|||
49082264|NCT01709500|158135152|FG001|Overall Study|Adverse Event|1|||
49082265|NCT01709500|158135151|FG000|Overall Study|Poor compliance to protocol|2|||
49082266|NCT01709500|158135152|FG001|Overall Study|Poor compliance to protocol|1|||
49082267|NCT01709500|158135151|FG000|Overall Study|Other|3|||
49082268|NCT01709500|158135152|FG001|Overall Study|Other|1|||
49082269|NCT01709500|158135151|FG000|Overall Study|Related to IMP administration|1|||
49082270|NCT01709500|158135152|FG001|Overall Study|Related to IMP administration|0|||
49082271|NCT01709500|158135151|FG000|Overall Study|Treatment ongoing|156|||
49082272|NCT01709500|158135152|FG001|Overall Study|Treatment ongoing|78|||
49082273|NCT03170544|158135154|FG000|Part 1|Lost to Follow-up|1|||
49082274|NCT03170544|158135155|FG001|Part 1|Lost to Follow-up|0|||
49082275|NCT03170544|158135156|FG002|Part 1|Lost to Follow-up|0|||
49082276|NCT03170544|158135157|FG003|Part 1|Lost to Follow-up|0|||
49082277|NCT03170544|158135158|FG004|Part 1|Lost to Follow-up|0|||
49082278|NCT03170544|158135159|FG005|Part 1|Lost to Follow-up|0|||
49082279|NCT03170544|158135160|FG006|Part 1|Lost to Follow-up|0|||
49082280|NCT03170544|158135161|FG007|Part 1|Lost to Follow-up|0|||
49082281|NCT03170544|158135162|FG008|Part 1|Lost to Follow-up|0|||
49082282|NCT03170544|158135163|FG009|Part 1|Lost to Follow-up|0|||
49082283|NCT03170544|158135164|FG010|Part 1|Lost to Follow-up|0|||
49082284|NCT03170544|158135165|FG011|Part 1|Lost to Follow-up|0|||
49082285|NCT03170544|158135154|FG000|Part 1|Not treated|0|||
49082286|NCT03170544|158135155|FG001|Part 1|Not treated|0|||
49082287|NCT03170544|158135156|FG002|Part 1|Not treated|0|||
49082288|NCT03170544|158135157|FG003|Part 1|Not treated|1|||
49082289|NCT03170544|158135158|FG004|Part 1|Not treated|0|||
49082290|NCT03170544|158135159|FG005|Part 1|Not treated|0|||
49082291|NCT03170544|158135160|FG006|Part 1|Not treated|0|||
49082292|NCT03170544|158135161|FG007|Part 1|Not treated|0|||
49082293|NCT03170544|158135162|FG008|Part 1|Not treated|0|||
49082294|NCT03170544|158135163|FG009|Part 1|Not treated|0|||
49082295|NCT03170544|158135164|FG010|Part 1|Not treated|0|||
49082296|NCT03170544|158135165|FG011|Part 1|Not treated|0|||
49082297|NCT00908544|158135166|FG000|Overall Study|Withdrawal by Subject|2|||
49082298|NCT00908544|158135167|FG001|Overall Study|Withdrawal by Subject|4|||
49082299|NCT00908544|158135166|FG000|Overall Study|Lack of Efficacy|0|||
49082300|NCT00908544|158135167|FG001|Overall Study|Lack of Efficacy|1|||
49082301|NCT00908544|158135166|FG000|Overall Study|Pregnancy|1|||
49082302|NCT00908544|158135167|FG001|Overall Study|Pregnancy|0|||
49082303|NCT00908544|158135166|FG000|Overall Study|Relocation abroad|1|||
49082304|NCT00908544|158135167|FG001|Overall Study|Relocation abroad|1|||
49082305|NCT00908544|158135166|FG000|Overall Study|Unable to visit sutdy center|1|||
49082306|NCT00908544|158135167|FG001|Overall Study|Unable to visit sutdy center|0|||
49082307|NCT02387840|158135168|FG000|Overall Study|Death|0|||
49082308|NCT02387840|158135169|FG001|Overall Study|Death|0|||
49082309|NCT02387840|158135170|FG002|Overall Study|Death|0|||
49082310|NCT02387840|158135171|FG003|Overall Study|Death|0|||
49082311|NCT02387840|158135172|FG004|Overall Study|Death|0|||
49082312|NCT02387840|158135173|FG005|Overall Study|Death|1|||
49082313|NCT00752128|158135181|FG000|Overall Study|Withdrawal by Subject|4|||
49082314|NCT03591874|158135184|FG000|Overall Study|Adverse Event|4|||
49082315|NCT03591874|158135185|FG001|Overall Study|Adverse Event|0|||
49082316|NCT03591874|158135184|FG000|Overall Study|Withdrawal by Subject|2|||
49082317|NCT03591874|158135185|FG001|Overall Study|Withdrawal by Subject|1|||
49082318|NCT03591874|158135184|FG000|Overall Study|Investigator Withdrawal of Subject|1|||
49082319|NCT03591874|158135185|FG001|Overall Study|Investigator Withdrawal of Subject|0|||
49082320|NCT03591874|158135184|FG000|Overall Study|On Study at Time of Study Termination|12|||
49082321|NCT03591874|158135185|FG001|Overall Study|On Study at Time of Study Termination|6|||
49082322|NCT00570063|158135186|FG000|Overall Study|Adverse Event|4|||
49082323|NCT00570063|158135187|FG001|Overall Study|Adverse Event|1|||
49082324|NCT00570063|158135186|FG000|Overall Study|Lack of Efficacy|0|||
49082325|NCT00570063|158135187|FG001|Overall Study|Lack of Efficacy|1|||
49082326|NCT00570063|158135186|FG000|Overall Study|Withdrawal by Subject|4|||
49082327|NCT00570063|158135187|FG001|Overall Study|Withdrawal by Subject|3|||
49082328|NCT00570063|158135186|FG000|Overall Study|Sponsor's Decision|7|||
49082329|NCT00570063|158135187|FG001|Overall Study|Sponsor's Decision|3|||
49082330|NCT04564092|158135188|FG000|Overall Study|Withdrawal by Subject|1|||
49082331|NCT00071110|158135192|FG000|Overall Study|Protocol Violation|0|||
49082332|NCT00071110|158135193|FG001|Overall Study|Protocol Violation|4|||
49082333|NCT03408639|158137605|FG000|Overall Study|Death|5|||
49082334|NCT03408639|158137606|FG001|Overall Study|Death|5|||
49082335|NCT03408639|158137605|FG000|Overall Study|Lost to Follow-up|1|||
49082336|NCT03408639|158137606|FG001|Overall Study|Lost to Follow-up|4|||
49082337|NCT03408639|158137605|FG000|Overall Study|Withdrawal by Subject|2|||
49082338|NCT03408639|158137606|FG001|Overall Study|Withdrawal by Subject|7|||
49082339|NCT03408639|158137605|FG000|Overall Study|Physician Decision|3|||
49082340|NCT03408639|158137606|FG001|Overall Study|Physician Decision|6|||
49082341|NCT02969382|158137614|FG000|Overall Study|Adverse Event|8|||
49082342|NCT02969382|158137615|FG001|Overall Study|Adverse Event|10|||
49082343|NCT02969382|158137614|FG000|Overall Study|Lack of Efficacy|4|||
49082344|NCT02969382|158137615|FG001|Overall Study|Lack of Efficacy|5|||
49082345|NCT02969382|158137614|FG000|Overall Study|Death|0|||
49082346|NCT02969382|158137615|FG001|Overall Study|Death|1|||
49082347|NCT02969382|158137614|FG000|Overall Study|PROTOCOL DEVIATION|0|||
49082348|NCT02969382|158137615|FG001|Overall Study|PROTOCOL DEVIATION|1|||
49082349|NCT02969382|158137614|FG000|Overall Study|Withdrawal by Subject|14|||
49082350|NCT02969382|158137615|FG001|Overall Study|Withdrawal by Subject|9|||
49082351|NCT02640482|158137616|FG000|Overall Study|Lost to Follow-up|3|||
49082352|NCT02640482|158137617|FG001|Overall Study|Lost to Follow-up|0|||
49082353|NCT01173120|158137621|FG000|Overall Study|Lack of Efficacy|2|||
49082354|NCT01173120|158137621|FG000|Overall Study|Lost to Follow-up|1|||
49082355|NCT01173120|158137621|FG000|Overall Study|Participant Decision|2|||
49082356|NCT01173120|158137621|FG000|Overall Study|Switch-Administrative Reason By Sponsor|33|||
49082357|NCT01173120|158137621|FG000|Overall Study|Switch-Participant Decision|12|||
49082358|NCT01173120|158137621|FG000|Overall Study|Switch-Difficulty With Device|12|||
49082359|NCT02090725|158137622|FG000|Overall Study|Withdrawal by Subject|1|||
49082360|NCT02090725|158137622|FG000|Overall Study|participants moved from area|3|||
49082361|NCT01499095|158137623|FG000|Overall Study|Randomized But Not Treated|1|||
49082362|NCT01499095|158137624|FG001|Overall Study|Randomized But Not Treated|1|||
49082363|NCT01499095|158137623|FG000|Overall Study|Adverse Event|12|||
49082364|NCT01499095|158137624|FG001|Overall Study|Adverse Event|7|||
49082365|NCT01499095|158137623|FG000|Overall Study|Lack of Efficacy|2|||
49082366|NCT01499095|158137624|FG001|Overall Study|Lack of Efficacy|1|||
49082367|NCT01499095|158137623|FG000|Overall Study|Protocol Violation|6|||
49082368|NCT01499095|158137624|FG001|Overall Study|Protocol Violation|7|||
49082369|NCT01499095|158137623|FG000|Overall Study|Received Rescue Therapy|32|||
49082370|NCT01499095|158137624|FG001|Overall Study|Received Rescue Therapy|40|||
49082371|NCT01499095|158137623|FG000|Overall Study|Diverse Reasons|22|||
49082372|NCT01499095|158137624|FG001|Overall Study|Diverse Reasons|25|||
49082373|NCT01499095|158137623|FG000|Overall Study|Lost to Follow-up|6|||
49082374|NCT01499095|158137624|FG001|Overall Study|Lost to Follow-up|4|||
49082375|NCT01499095|158137623|FG000|Overall Study|Insulin Dropped Below Authorized Dose|0|||
49082376|NCT01499095|158137624|FG001|Overall Study|Insulin Dropped Below Authorized Dose|5|||
49082377|NCT01499095|158137623|FG000|Overall Study|Hypoglycemia|3|||
49082378|NCT01499095|158137624|FG001|Overall Study|Hypoglycemia|1|||
49082379|NCT01499095|158137623|FG000|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2|||
49082380|NCT01499095|158137624|FG001|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1|||
49082381|NCT01499095|158137623|FG000|Overall Study|Change in Injection Schedule|2|||
49082382|NCT01499095|158137624|FG001|Overall Study|Change in Injection Schedule|0|||
49082383|NCT01499095|158137623|FG000|Overall Study|Perceived Lack of Efficacy|1|||
49082384|NCT01499095|158137624|FG001|Overall Study|Perceived Lack of Efficacy|1|||
49082385|NCT01214655|158137625|FG000|Part A|Progressive Disease|7|||
49082386|NCT01214655|158137626|FG001|Part A|Progressive Disease|0|||
49082387|NCT01214655|158137627|FG002|Part A|Progressive Disease|0|||
49082388|NCT01214655|158137625|FG000|Part A|Physician Decision|1|||
49082389|NCT01214655|158137626|FG001|Part A|Physician Decision|0|||
49082390|NCT01214655|158137627|FG002|Part A|Physician Decision|0|||
49082391|NCT01214655|158137625|FG000|Part B|Progressive disease|0|||
49082392|NCT01214655|158137626|FG001|Part B|Progressive disease|10|||
49082393|NCT01214655|158137627|FG002|Part B|Progressive disease|0|||
49082394|NCT01214655|158137625|FG000|Part B|Death|0|||
49082395|NCT01214655|158137626|FG001|Part B|Death|1|||
49082396|NCT01214655|158137627|FG002|Part B|Death|0|||
49082397|NCT01214655|158137625|FG000|Part B|Withdrawal by Subject|0|||
49082398|NCT01214655|158137626|FG001|Part B|Withdrawal by Subject|2|||
49082399|NCT01214655|158137627|FG002|Part B|Withdrawal by Subject|0|||
49082400|NCT01214655|158137625|FG000|Part C|Progressive Disease|0|||
49082401|NCT01214655|158137626|FG001|Part C|Progressive Disease|0|||
49082402|NCT01214655|158137627|FG002|Part C|Progressive Disease|5|||
49082403|NCT01214655|158137625|FG000|Part C|Death|0|||
49082404|NCT01214655|158137626|FG001|Part C|Death|0|||
49082405|NCT01214655|158137627|FG002|Part C|Death|1|||
49082406|NCT01214655|158137625|FG000|Part C|Physician Decision|0|||
49082407|NCT01214655|158137626|FG001|Part C|Physician Decision|0|||
49082408|NCT01214655|158137627|FG002|Part C|Physician Decision|1|||
49082409|NCT00764881|158137631|FG000|Overall Study|Adverse Event|5|||
49082410|NCT00764881|158137632|FG001|Overall Study|Adverse Event|1|||
49082411|NCT00764881|158137631|FG000|Overall Study|Withdrawal by Subject|1|||
49082412|NCT00764881|158137632|FG001|Overall Study|Withdrawal by Subject|3|||
49082413|NCT00764881|158137631|FG000|Overall Study|Protocol Violation|2|||
49082414|NCT00764881|158137632|FG001|Overall Study|Protocol Violation|2|||
49082415|NCT00764881|158137631|FG000|Overall Study|Lost to Follow-up|2|||
49082416|NCT00764881|158137632|FG001|Overall Study|Lost to Follow-up|0|||
49082417|NCT00764881|158137631|FG000|Overall Study|Noncompliant|1|||
49082418|NCT00764881|158137632|FG001|Overall Study|Noncompliant|0|||
49082419|NCT00764881|158137631|FG000|Overall Study|Accidentally discontinued study drug|1|||
49082420|NCT00764881|158137632|FG001|Overall Study|Accidentally discontinued study drug|0|||
49082421|NCT00764881|158137631|FG000|Overall Study|Wished to become pregnant|1|||
49082422|NCT00764881|158137632|FG001|Overall Study|Wished to become pregnant|0|||
49082423|NCT00764881|158137631|FG000|Overall Study|Carcinoma detected|1|||
49082424|NCT00764881|158137632|FG001|Overall Study|Carcinoma detected|0|||
49082425|NCT00764881|158137631|FG000|Overall Study|Possibly noncompliant (study drug)|0|||
49082426|NCT00764881|158137632|FG001|Overall Study|Possibly noncompliant (study drug)|2|||
49082427|NCT00764881|158137631|FG000|Overall Study|no treatment or no observation|2|||
49082428|NCT00764881|158137632|FG001|Overall Study|no treatment or no observation|2|||
49082429|NCT00113763|158137633|FG000|Overall Study|Adverse Event|5|||
49082430|NCT00113763|158137634|FG001|Overall Study|Adverse Event|2|||
49082431|NCT00113763|158137633|FG000|Overall Study|Disease Progression|28|||
49082432|NCT00113763|158137634|FG001|Overall Study|Disease Progression|14|||
49082433|NCT00113763|158137633|FG000|Overall Study|Lost to Follow-up|10|||
49082434|NCT00113763|158137634|FG001|Overall Study|Lost to Follow-up|0|||
49082435|NCT00113763|158137633|FG000|Overall Study|Withdrawal by Subject|1|||
49082436|NCT00113763|158137634|FG001|Overall Study|Withdrawal by Subject|4|||
49082437|NCT00113763|158137633|FG000|Overall Study|Other|27|||
49082438|NCT00113763|158137634|FG001|Overall Study|Other|6|||
49082439|NCT00113763|158137633|FG000|Overall Study|Non-compliance|1|||
49082440|NCT00113763|158137634|FG001|Overall Study|Non-compliance|0|||
49082441|NCT00113763|158137633|FG000|Overall Study|Ongoing|1|||
49082442|NCT00113763|158137634|FG001|Overall Study|Ongoing|0|||
49082443|NCT00517881|158137635|FG000|Overall Study|Protocol Violation|2|||
49082444|NCT00517881|158137635|FG000|Overall Study|Adverse Event|1|||
49082445|NCT00517881|158137635|FG000|Overall Study|Renal transplantation|2|||
49082446|NCT01207583|158137638|FG000|Overall Study|Withdrawal by Subject|0|||
49082447|NCT01207583|158137639|FG001|Overall Study|Withdrawal by Subject|3|||
49082448|NCT01207583|158137640|FG002|Overall Study|Withdrawal by Subject|1|||
49082449|NCT01207583|158137638|FG000|Overall Study|Participant failed to return|1|||
49082450|NCT01207583|158137639|FG001|Overall Study|Participant failed to return|0|||
49082451|NCT01207583|158137640|FG002|Overall Study|Participant failed to return|0|||
49082452|NCT01207583|158137638|FG000|Overall Study|Lost to Follow-up|0|||
49082453|NCT01207583|158137639|FG001|Overall Study|Lost to Follow-up|2|||
49082454|NCT01207583|158137640|FG002|Overall Study|Lost to Follow-up|0|||
49082455|NCT03055624|158137644|FG000|Overall Study|Study closed|9|||
49082456|NCT00280735|158137645|FG000|Overall Study|Adverse Event|5|||
49082457|NCT00280735|158137645|FG000|Overall Study|Lack of Efficacy|3|||
49082458|NCT00280735|158137645|FG000|Overall Study|Withdrawal by Subject|8|||
49082459|NCT00280735|158137645|FG000|Overall Study|Intercurrent Illness|2|||
49082460|NCT04753216|158137651|FG000|Screening - 1st Response Assessment|Adverse Event|1|||
49082461|NCT04753216|158137651|FG000|Cycle 3 - 2nd Response Assessment|Disease Progression|1|||
49082462|NCT04753216|158137651|FG000|Cycle 5 - 3rd Response Assessment|Withdrawal by Subject|1|||
49082463|NCT00595621|158137652|FG000|Open Label Run in|Adverse Event|1|||
49082464|NCT00595621|158137653|FG001|Open Label Run in|Adverse Event|0|||
49082465|NCT00595621|158137652|FG000|Open Label Run in|Physician Decision|1|||
49082466|NCT00595621|158137653|FG001|Open Label Run in|Physician Decision|0|||
49082467|NCT00595621|158137652|FG000|Open Label Run in|Withdrawal by Subject|1|||
49082468|NCT00595621|158137653|FG001|Open Label Run in|Withdrawal by Subject|0|||
49082469|NCT00595621|158137652|FG000|Randomization and Study|Adverse Event|2|||
49082470|NCT00595621|158137653|FG001|Randomization and Study|Adverse Event|0|||
49082471|NCT00595621|158137652|FG000|Randomization and Study|Withdrawal by Subject|0|||
49082472|NCT00595621|158137653|FG001|Randomization and Study|Withdrawal by Subject|1|||
49082473|NCT00324987|158137654|FG000|Overall Study|Adverse Event|2|||
49082474|NCT00324987|158137655|FG001|Overall Study|Adverse Event|1|||
49082475|NCT00324987|158137654|FG000|Overall Study|Withdrawal by Subject|1|||
49082476|NCT00324987|158137655|FG001|Overall Study|Withdrawal by Subject|1|||
49082477|NCT00324987|158137654|FG000|Overall Study|Progression|1|||
49082478|NCT00324987|158137655|FG001|Overall Study|Progression|1|||
49082479|NCT00324987|158137654|FG000|Overall Study|symptomatic deterioration, toxicity, etc|2|||
49082480|NCT00324987|158137655|FG001|Overall Study|symptomatic deterioration, toxicity, etc|3|||
49082481|NCT01965860|158137656|FG000|Overall Study|Pregnancy|1|||
49082482|NCT01965860|158137657|FG001|Overall Study|Pregnancy|0|||
49082483|NCT01965860|158137658|FG002|Overall Study|Pregnancy|1|||
49082484|NCT01965860|158137656|FG000|Overall Study|Logistics|1|||
49082485|NCT01965860|158137657|FG001|Overall Study|Logistics|0|||
49082486|NCT01965860|158137658|FG002|Overall Study|Logistics|0|||
49082487|NCT01342081|158137659|FG000|Overall Study|Did not receive allocated intervention|0|||
49082488|NCT01342081|158137660|FG001|Overall Study|Did not receive allocated intervention|0|||
49082489|NCT01342081|158137661|FG002|Overall Study|Did not receive allocated intervention|1|||
49082490|NCT01342081|158137659|FG000|Overall Study|Adverse Event|1|||
49082491|NCT01342081|158137660|FG001|Overall Study|Adverse Event|0|||
49082492|NCT01342081|158137661|FG002|Overall Study|Adverse Event|0|||
49082493|NCT01342081|158137659|FG000|Overall Study|Physician Decision|0|||
49082494|NCT01342081|158137660|FG001|Overall Study|Physician Decision|1|||
49082495|NCT01342081|158137661|FG002|Overall Study|Physician Decision|0|||
49082496|NCT01342081|158137659|FG000|Overall Study|Withdrawal by Subject|1|||
49082497|NCT01342081|158137660|FG001|Overall Study|Withdrawal by Subject|1|||
49082498|NCT01342081|158137661|FG002|Overall Study|Withdrawal by Subject|0|||
49082499|NCT03345420|158137666|FG000|Overall Study|Withdrawal by Subject|1|||
49082500|NCT02222922|158137667|FG000|Overall Study|Death|0|||
49082501|NCT02222922|158137668|FG001|Overall Study|Death|0|||
49082502|NCT02222922|158137669|FG002|Overall Study|Death|0|||
49082503|NCT02222922|158137670|FG003|Overall Study|Death|0|||
49082504|NCT02222922|158137671|FG004|Overall Study|Death|13|||
49082505|NCT02222922|158137672|FG005|Overall Study|Death|0|||
49082506|NCT02222922|158137673|FG006|Overall Study|Death|0|||
49082507|NCT02222922|158137674|FG007|Overall Study|Death|0|||
49082508|NCT02222922|158137675|FG008|Overall Study|Death|2|||
49082509|NCT02222922|158137667|FG000|Overall Study|Lost to Follow-up|0|||
49082510|NCT02222922|158137668|FG001|Overall Study|Lost to Follow-up|0|||
49082511|NCT02222922|158137669|FG002|Overall Study|Lost to Follow-up|1|||
49082512|NCT02222922|158137670|FG003|Overall Study|Lost to Follow-up|0|||
49082513|NCT02222922|158137671|FG004|Overall Study|Lost to Follow-up|9|||
49082514|NCT02222922|158137672|FG005|Overall Study|Lost to Follow-up|1|||
49082515|NCT02222922|158137673|FG006|Overall Study|Lost to Follow-up|0|||
49082516|NCT02222922|158137674|FG007|Overall Study|Lost to Follow-up|0|||
49082517|NCT02222922|158137675|FG008|Overall Study|Lost to Follow-up|0|||
49082518|NCT02222922|158137667|FG000|Overall Study|Other|0|||
49082519|NCT02222922|158137668|FG001|Overall Study|Other|0|||
49082520|NCT02222922|158137669|FG002|Overall Study|Other|0|||
49082521|NCT02222922|158137670|FG003|Overall Study|Other|2|||
49082522|NCT02222922|158137671|FG004|Overall Study|Other|10|||
49082523|NCT02222922|158137672|FG005|Overall Study|Other|2|||
49082524|NCT02222922|158137673|FG006|Overall Study|Other|2|||
49082525|NCT02222922|158137674|FG007|Overall Study|Other|4|||
49082526|NCT02222922|158137675|FG008|Overall Study|Other|1|||
49082527|NCT02222922|158137667|FG000|Overall Study|Participant refused further follow-up|1|||
49082528|NCT02222922|158137668|FG001|Overall Study|Participant refused further follow-up|0|||
49082529|NCT02222922|158137669|FG002|Overall Study|Participant refused further follow-up|0|||
49082530|NCT02222922|158137670|FG003|Overall Study|Participant refused further follow-up|1|||
49082531|NCT02222922|158137671|FG004|Overall Study|Participant refused further follow-up|6|||
49082532|NCT02222922|158137672|FG005|Overall Study|Participant refused further follow-up|0|||
49082533|NCT02222922|158137673|FG006|Overall Study|Participant refused further follow-up|0|||
49082534|NCT02222922|158137674|FG007|Overall Study|Participant refused further follow-up|0|||
49082535|NCT02222922|158137675|FG008|Overall Study|Participant refused further follow-up|3|||
49082536|NCT03832686|158137678|FG000|Overall Study|Lost to Follow-up|6|||
49082537|NCT03832686|158137679|FG001|Overall Study|Lost to Follow-up|9|||
49082538|NCT03832686|158137678|FG000|Overall Study|Discontinued Intervention|5|||
49082539|NCT03832686|158137679|FG001|Overall Study|Discontinued Intervention|4|||
49082540|NCT03359850|158137687|FG000|PK Phase (Up to Day 8)|Physician Decision|0|||
49082541|NCT03359850|158137688|FG001|PK Phase (Up to Day 8)|Physician Decision|1|||
49082542|NCT03359850|158137687|FG000|PK Phase (Up to Day 8)|Adverse Event|1|||
49082543|NCT03359850|158137688|FG001|PK Phase (Up to Day 8)|Adverse Event|0|||
49082544|NCT03359850|158137687|FG000|Extension Phase (Up to 28 Months)|Death|2|||
49082545|NCT03359850|158137688|FG001|Extension Phase (Up to 28 Months)|Death|4|||
49082546|NCT03359850|158137687|FG000|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1|||
49082547|NCT03359850|158137688|FG001|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2|||
49082548|NCT03359850|158137687|FG000|Extension Phase (Up to 28 Months)|Disease Progression|5|||
49082549|NCT03359850|158137688|FG001|Extension Phase (Up to 28 Months)|Disease Progression|0|||
49082550|NCT04067050|158137689|FG000|One Month|Lost to Follow-up|4|||
49082551|NCT04067050|158137690|FG001|One Month|Lost to Follow-up|0|||
49082552|NCT04067050|158137689|FG000|Two Month|Lost to Follow-up|1|||
49082553|NCT04067050|158137690|FG001|Two Month|Lost to Follow-up|0|||
49082554|NCT04067050|158137689|FG000|Two Month|Adverse Event|1|||
49082555|NCT04067050|158137690|FG001|Two Month|Adverse Event|0|||
49082556|NCT00942084|158137693|FG000|Overall Study|Death|2|||
49082557|NCT01350271|158137697|FG000|Overall Study|Lost to Follow-up|21|||
49082558|NCT01350271|158137698|FG001|Overall Study|Lost to Follow-up|17|||
49082559|NCT01350271|158137699|FG002|Overall Study|Lost to Follow-up|26|||
49082560|NCT02906670|158137700|FG000|Cohort 1, QW|Radiological Progression|1|||
49082561|NCT02906670|158137701|FG001|Cohort 1, QW|Radiological Progression|0|||
49082562|NCT02906670|158137702|FG002|Cohort 1, QW|Radiological Progression|0|||
49082563|NCT02906670|158137703|FG003|Cohort 1, QW|Radiological Progression|0|||
49082564|NCT02906670|158137704|FG004|Cohort 1, QW|Radiological Progression|0|||
49082565|NCT02906670|158137705|FG005|Cohort 1, QW|Radiological Progression|0|||
49082566|NCT02906670|158137706|FG006|Cohort 1, QW|Radiological Progression|0|||
49082567|NCT02906670|158137707|FG007|Cohort 1, QW|Radiological Progression|0|||
49082568|NCT02906670|158137708|FG008|Cohort 1, QW|Radiological Progression|0|||
49082569|NCT02906670|158137709|FG009|Cohort 1, QW|Radiological Progression|0|||
49082570|NCT02906670|158137700|FG000|Cohort 2, QW|Radiological Progression|0|||
49082571|NCT02906670|158137701|FG001|Cohort 2, QW|Radiological Progression|1|||
49082572|NCT02906670|158137702|FG002|Cohort 2, QW|Radiological Progression|0|||
49082573|NCT02906670|158137703|FG003|Cohort 2, QW|Radiological Progression|0|||
49082574|NCT02906670|158137704|FG004|Cohort 2, QW|Radiological Progression|0|||
49082575|NCT02906670|158137705|FG005|Cohort 2, QW|Radiological Progression|0|||
49082576|NCT02906670|158137706|FG006|Cohort 2, QW|Radiological Progression|0|||
49082577|NCT02906670|158137707|FG007|Cohort 2, QW|Radiological Progression|0|||
49082578|NCT02906670|158137708|FG008|Cohort 2, QW|Radiological Progression|0|||
49082579|NCT02906670|158137709|FG009|Cohort 2, QW|Radiological Progression|0|||
49082580|NCT02906670|158137700|FG000|Cohort 3, QW|Radiological Progression|0|||
49082581|NCT02906670|158137701|FG001|Cohort 3, QW|Radiological Progression|0|||
49082582|NCT02906670|158137702|FG002|Cohort 3, QW|Radiological Progression|2|||
49082583|NCT02906670|158137703|FG003|Cohort 3, QW|Radiological Progression|0|||
49082584|NCT02906670|158137704|FG004|Cohort 3, QW|Radiological Progression|0|||
49082585|NCT02906670|158137705|FG005|Cohort 3, QW|Radiological Progression|0|||
49082586|NCT02906670|158137706|FG006|Cohort 3, QW|Radiological Progression|0|||
49082587|NCT02906670|158137707|FG007|Cohort 3, QW|Radiological Progression|0|||
49082588|NCT02906670|158137708|FG008|Cohort 3, QW|Radiological Progression|0|||
49082589|NCT02906670|158137709|FG009|Cohort 3, QW|Radiological Progression|0|||
49082590|NCT02906670|158137700|FG000|Cohort 3, QW|Lack of Clinical Benefit|0|||
49082591|NCT02906670|158137701|FG001|Cohort 3, QW|Lack of Clinical Benefit|0|||
49082592|NCT02906670|158137702|FG002|Cohort 3, QW|Lack of Clinical Benefit|2|||
49082593|NCT02906670|158137703|FG003|Cohort 3, QW|Lack of Clinical Benefit|0|||
49082594|NCT02906670|158137704|FG004|Cohort 3, QW|Lack of Clinical Benefit|0|||
49082595|NCT02906670|158137705|FG005|Cohort 3, QW|Lack of Clinical Benefit|0|||
49082596|NCT02906670|158137706|FG006|Cohort 3, QW|Lack of Clinical Benefit|0|||
49082597|NCT02906670|158137707|FG007|Cohort 3, QW|Lack of Clinical Benefit|0|||
49082598|NCT02906670|158137708|FG008|Cohort 3, QW|Lack of Clinical Benefit|0|||
49082599|NCT02906670|158137709|FG009|Cohort 3, QW|Lack of Clinical Benefit|0|||
49082600|NCT02906670|158137700|FG000|Cohort 4, Q2W|Radiological Progression|0|||
49082601|NCT02906670|158137701|FG001|Cohort 4, Q2W|Radiological Progression|0|||
49082602|NCT02906670|158137702|FG002|Cohort 4, Q2W|Radiological Progression|0|||
49082603|NCT02906670|158137703|FG003|Cohort 4, Q2W|Radiological Progression|0|||
49082604|NCT02906670|158137704|FG004|Cohort 4, Q2W|Radiological Progression|0|||
49082605|NCT02906670|158137705|FG005|Cohort 4, Q2W|Radiological Progression|1|||
49082606|NCT02906670|158137706|FG006|Cohort 4, Q2W|Radiological Progression|0|||
49082607|NCT02906670|158137707|FG007|Cohort 4, Q2W|Radiological Progression|0|||
49082608|NCT02906670|158137708|FG008|Cohort 4, Q2W|Radiological Progression|0|||
49082609|NCT02906670|158137709|FG009|Cohort 4, Q2W|Radiological Progression|0|||
49082610|NCT02906670|158137700|FG000|Cohort 4, Q2W|Clinical Progression|0|||
49082611|NCT02906670|158137701|FG001|Cohort 4, Q2W|Clinical Progression|0|||
49082612|NCT02906670|158137702|FG002|Cohort 4, Q2W|Clinical Progression|0|||
49082613|NCT02906670|158137703|FG003|Cohort 4, Q2W|Clinical Progression|0|||
49082614|NCT02906670|158137704|FG004|Cohort 4, Q2W|Clinical Progression|0|||
49082615|NCT02906670|158137705|FG005|Cohort 4, Q2W|Clinical Progression|2|||
49082616|NCT02906670|158137706|FG006|Cohort 4, Q2W|Clinical Progression|0|||
49082617|NCT02906670|158137707|FG007|Cohort 4, Q2W|Clinical Progression|0|||
49082618|NCT02906670|158137708|FG008|Cohort 4, Q2W|Clinical Progression|0|||
49082619|NCT02906670|158137709|FG009|Cohort 4, Q2W|Clinical Progression|0|||
49082620|NCT02906670|158137700|FG000|Cohort 5, Q2W|Radiological Progression|0|||
49082621|NCT02906670|158137701|FG001|Cohort 5, Q2W|Radiological Progression|0|||
49082622|NCT02906670|158137702|FG002|Cohort 5, Q2W|Radiological Progression|0|||
49082623|NCT02906670|158137703|FG003|Cohort 5, Q2W|Radiological Progression|0|||
49082624|NCT02906670|158137704|FG004|Cohort 5, Q2W|Radiological Progression|0|||
49082625|NCT02906670|158137705|FG005|Cohort 5, Q2W|Radiological Progression|0|||
49082626|NCT02906670|158137706|FG006|Cohort 5, Q2W|Radiological Progression|4|||
49082627|NCT02906670|158137707|FG007|Cohort 5, Q2W|Radiological Progression|0|||
49082628|NCT02906670|158137708|FG008|Cohort 5, Q2W|Radiological Progression|0|||
49082629|NCT02906670|158137709|FG009|Cohort 5, Q2W|Radiological Progression|0|||
49082630|NCT02906670|158137700|FG000|Cohort 5, Q2W|Clinical Progression|0|||
49082631|NCT02906670|158137701|FG001|Cohort 5, Q2W|Clinical Progression|0|||
49082632|NCT02906670|158137702|FG002|Cohort 5, Q2W|Clinical Progression|0|||
49082633|NCT02906670|158137703|FG003|Cohort 5, Q2W|Clinical Progression|0|||
49082634|NCT02906670|158137704|FG004|Cohort 5, Q2W|Clinical Progression|0|||
49082635|NCT02906670|158137705|FG005|Cohort 5, Q2W|Clinical Progression|0|||
49082636|NCT02906670|158137706|FG006|Cohort 5, Q2W|Clinical Progression|1|||
49082637|NCT02906670|158137707|FG007|Cohort 5, Q2W|Clinical Progression|0|||
49082638|NCT02906670|158137708|FG008|Cohort 5, Q2W|Clinical Progression|0|||
49082639|NCT02906670|158137709|FG009|Cohort 5, Q2W|Clinical Progression|0|||
49082640|NCT02906670|158137700|FG000|Cohort 5, Q2W|Adverse Event|0|||
49082641|NCT02906670|158137701|FG001|Cohort 5, Q2W|Adverse Event|0|||
49082642|NCT02906670|158137702|FG002|Cohort 5, Q2W|Adverse Event|0|||
49082643|NCT02906670|158137703|FG003|Cohort 5, Q2W|Adverse Event|0|||
49082644|NCT02906670|158137704|FG004|Cohort 5, Q2W|Adverse Event|0|||
49082645|NCT02906670|158137705|FG005|Cohort 5, Q2W|Adverse Event|0|||
49082646|NCT02906670|158137706|FG006|Cohort 5, Q2W|Adverse Event|1|||
49082647|NCT02906670|158137707|FG007|Cohort 5, Q2W|Adverse Event|0|||
49082648|NCT02906670|158137708|FG008|Cohort 5, Q2W|Adverse Event|0|||
49082649|NCT02906670|158137709|FG009|Cohort 5, Q2W|Adverse Event|0|||
49082650|NCT02906670|158137700|FG000|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
49082651|NCT02906670|158137701|FG001|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
49082652|NCT02906670|158137702|FG002|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
49082653|NCT02906670|158137703|FG003|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
49082654|NCT02906670|158137704|FG004|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
49082655|NCT02906670|158137705|FG005|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
49082656|NCT02906670|158137706|FG006|Cohort 5, Q2W|Lack of Clinical Benefit|1|||
49082657|NCT02906670|158137707|FG007|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
49082658|NCT02906670|158137708|FG008|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
49082659|NCT02906670|158137709|FG009|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
49082660|NCT02906670|158137700|FG000|Cohort 5P, Q2W|Radiological Progression|0|||
49082661|NCT02906670|158137701|FG001|Cohort 5P, Q2W|Radiological Progression|0|||
49082662|NCT02906670|158137702|FG002|Cohort 5P, Q2W|Radiological Progression|0|||
49082663|NCT02906670|158137703|FG003|Cohort 5P, Q2W|Radiological Progression|0|||
49082664|NCT02906670|158137704|FG004|Cohort 5P, Q2W|Radiological Progression|0|||
49082665|NCT02906670|158137705|FG005|Cohort 5P, Q2W|Radiological Progression|0|||
49082666|NCT02906670|158137706|FG006|Cohort 5P, Q2W|Radiological Progression|0|||
49082667|NCT02906670|158137707|FG007|Cohort 5P, Q2W|Radiological Progression|2|||
49082668|NCT02906670|158137708|FG008|Cohort 5P, Q2W|Radiological Progression|0|||
49082669|NCT02906670|158137709|FG009|Cohort 5P, Q2W|Radiological Progression|0|||
49082670|NCT02906670|158137700|FG000|Cohort 5P, Q2W|Adverse Event|0|||
49082671|NCT02906670|158137701|FG001|Cohort 5P, Q2W|Adverse Event|0|||
49082672|NCT02906670|158137702|FG002|Cohort 5P, Q2W|Adverse Event|0|||
49082673|NCT02906670|158137703|FG003|Cohort 5P, Q2W|Adverse Event|0|||
49082674|NCT02906670|158137704|FG004|Cohort 5P, Q2W|Adverse Event|0|||
49082675|NCT02906670|158137705|FG005|Cohort 5P, Q2W|Adverse Event|0|||
49082676|NCT02906670|158137706|FG006|Cohort 5P, Q2W|Adverse Event|0|||
49082677|NCT02906670|158137707|FG007|Cohort 5P, Q2W|Adverse Event|1|||
49082678|NCT02906670|158137708|FG008|Cohort 5P, Q2W|Adverse Event|0|||
49082679|NCT02906670|158137709|FG009|Cohort 5P, Q2W|Adverse Event|0|||
49082680|NCT02906670|158137700|FG000|Cohort 6P, Q2W|Radiological Progression|0|||
49082681|NCT02906670|158137701|FG001|Cohort 6P, Q2W|Radiological Progression|0|||
49082682|NCT02906670|158137702|FG002|Cohort 6P, Q2W|Radiological Progression|0|||
49082683|NCT02906670|158137703|FG003|Cohort 6P, Q2W|Radiological Progression|0|||
49082684|NCT02906670|158137704|FG004|Cohort 6P, Q2W|Radiological Progression|0|||
49082685|NCT02906670|158137705|FG005|Cohort 6P, Q2W|Radiological Progression|0|||
49082686|NCT02906670|158137706|FG006|Cohort 6P, Q2W|Radiological Progression|0|||
49082687|NCT02906670|158137707|FG007|Cohort 6P, Q2W|Radiological Progression|0|||
49082688|NCT02906670|158137708|FG008|Cohort 6P, Q2W|Radiological Progression|1|||
49082689|NCT02906670|158137709|FG009|Cohort 6P, Q2W|Radiological Progression|0|||
49082690|NCT02906670|158137700|FG000|Cohort 6P, Q2W|Clinical Progression|0|||
49082691|NCT02906670|158137701|FG001|Cohort 6P, Q2W|Clinical Progression|0|||
49082692|NCT02906670|158137702|FG002|Cohort 6P, Q2W|Clinical Progression|0|||
49082693|NCT02906670|158137703|FG003|Cohort 6P, Q2W|Clinical Progression|0|||
49082694|NCT02906670|158137704|FG004|Cohort 6P, Q2W|Clinical Progression|0|||
49082695|NCT02906670|158137705|FG005|Cohort 6P, Q2W|Clinical Progression|0|||
49082696|NCT02906670|158137706|FG006|Cohort 6P, Q2W|Clinical Progression|0|||
49082697|NCT02906670|158137707|FG007|Cohort 6P, Q2W|Clinical Progression|0|||
49082698|NCT02906670|158137708|FG008|Cohort 6P, Q2W|Clinical Progression|3|||
49082699|NCT02906670|158137709|FG009|Cohort 6P, Q2W|Clinical Progression|0|||
49082700|NCT02906670|158137700|FG000|Cohort 4P, QW|Radiological Progression|0|||
49082701|NCT02906670|158137701|FG001|Cohort 4P, QW|Radiological Progression|0|||
49082702|NCT02906670|158137702|FG002|Cohort 4P, QW|Radiological Progression|0|||
49082703|NCT02906670|158137703|FG003|Cohort 4P, QW|Radiological Progression|3|||
49082704|NCT02906670|158137704|FG004|Cohort 4P, QW|Radiological Progression|0|||
49082705|NCT02906670|158137705|FG005|Cohort 4P, QW|Radiological Progression|0|||
49082706|NCT02906670|158137706|FG006|Cohort 4P, QW|Radiological Progression|0|||
49082707|NCT02906670|158137707|FG007|Cohort 4P, QW|Radiological Progression|0|||
49082708|NCT02906670|158137708|FG008|Cohort 4P, QW|Radiological Progression|0|||
49082709|NCT02906670|158137709|FG009|Cohort 4P, QW|Radiological Progression|0|||
49082710|NCT02906670|158137700|FG000|Cohort 7P, Q2W|Adverse Event|0|||
49082711|NCT02906670|158137701|FG001|Cohort 7P, Q2W|Adverse Event|0|||
49082712|NCT02906670|158137702|FG002|Cohort 7P, Q2W|Adverse Event|0|||
49082713|NCT02906670|158137703|FG003|Cohort 7P, Q2W|Adverse Event|0|||
49082714|NCT02906670|158137704|FG004|Cohort 7P, Q2W|Adverse Event|0|||
49082715|NCT02906670|158137705|FG005|Cohort 7P, Q2W|Adverse Event|0|||
49082716|NCT02906670|158137706|FG006|Cohort 7P, Q2W|Adverse Event|0|||
49082717|NCT02906670|158137707|FG007|Cohort 7P, Q2W|Adverse Event|0|||
49082718|NCT02906670|158137708|FG008|Cohort 7P, Q2W|Adverse Event|0|||
49082719|NCT02906670|158137709|FG009|Cohort 7P, Q2W|Adverse Event|1|||
49082720|NCT02906670|158137700|FG000|Cohort 7P, Q2W|Physician Decision|0|||
49082721|NCT02906670|158137701|FG001|Cohort 7P, Q2W|Physician Decision|0|||
49082722|NCT02906670|158137702|FG002|Cohort 7P, Q2W|Physician Decision|0|||
49082723|NCT02906670|158137703|FG003|Cohort 7P, Q2W|Physician Decision|0|||
49082724|NCT02906670|158137704|FG004|Cohort 7P, Q2W|Physician Decision|0|||
49082725|NCT02906670|158137705|FG005|Cohort 7P, Q2W|Physician Decision|0|||
49082726|NCT02906670|158137706|FG006|Cohort 7P, Q2W|Physician Decision|0|||
49082727|NCT02906670|158137707|FG007|Cohort 7P, Q2W|Physician Decision|0|||
49082728|NCT02906670|158137708|FG008|Cohort 7P, Q2W|Physician Decision|0|||
49082729|NCT02906670|158137709|FG009|Cohort 7P, Q2W|Physician Decision|1|||
49082730|NCT02906670|158137700|FG000|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
49082731|NCT02906670|158137701|FG001|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
49082732|NCT02906670|158137702|FG002|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
49082733|NCT02906670|158137703|FG003|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
49082734|NCT02906670|158137704|FG004|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
49082735|NCT02906670|158137705|FG005|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
49082736|NCT02906670|158137706|FG006|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
49082737|NCT02906670|158137707|FG007|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
49082738|NCT02906670|158137708|FG008|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
49082739|NCT02906670|158137709|FG009|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1|||
49082740|NCT02906670|158137700|FG000|Cohort 5P, QW|Radiological Progression|0|||
49082741|NCT02906670|158137701|FG001|Cohort 5P, QW|Radiological Progression|0|||
49082742|NCT02906670|158137702|FG002|Cohort 5P, QW|Radiological Progression|0|||
49082743|NCT02906670|158137703|FG003|Cohort 5P, QW|Radiological Progression|0|||
49082744|NCT02906670|158137704|FG004|Cohort 5P, QW|Radiological Progression|3|||
49082745|NCT02906670|158137705|FG005|Cohort 5P, QW|Radiological Progression|0|||
49082746|NCT02906670|158137706|FG006|Cohort 5P, QW|Radiological Progression|0|||
49082747|NCT02906670|158137707|FG007|Cohort 5P, QW|Radiological Progression|0|||
49082748|NCT02906670|158137708|FG008|Cohort 5P, QW|Radiological Progression|0|||
49082749|NCT02906670|158137709|FG009|Cohort 5P, QW|Radiological Progression|0|||
49082750|NCT01349192|158137710|FG000|Overall Study|Protocol Violation|0|||
49082751|NCT01349192|158137711|FG001|Overall Study|Protocol Violation|1|||
49082752|NCT01349192|158137710|FG000|Overall Study|Withdrawal by Subject|0|||
49082753|NCT01349192|158137711|FG001|Overall Study|Withdrawal by Subject|2|||
49082754|NCT01349192|158137710|FG000|Overall Study|Lost to Follow-up|1|||
49082755|NCT01349192|158137711|FG001|Overall Study|Lost to Follow-up|3|||
49082756|NCT01349192|158137710|FG000|Overall Study|Failure to adhere to Protocol|2|||
49082757|NCT01349192|158137711|FG001|Overall Study|Failure to adhere to Protocol|0|||
49082758|NCT01176513|158137712|FG000|Overall Study|Withdrew subjects prior to dosing|3|||
49082759|NCT01060072|158137713|FG000|Overall Study|Adverse Event|1|||
49082760|NCT01060072|158137714|FG001|Overall Study|Adverse Event|1|||
49082761|NCT01060072|158137713|FG000|Overall Study|Physician Decision|0|||
49082762|NCT01060072|158137714|FG001|Overall Study|Physician Decision|2|||
49082763|NCT01060072|158137713|FG000|Overall Study|Protocol Violation|0|||
49082764|NCT01060072|158137714|FG001|Overall Study|Protocol Violation|1|||
49082765|NCT01060072|158137713|FG000|Overall Study|Acute cholecystitis|1|||
49082766|NCT01060072|158137714|FG001|Overall Study|Acute cholecystitis|0|||
49082767|NCT01060072|158137713|FG000|Overall Study|Excluded Medications|0|||
49082768|NCT01060072|158137714|FG001|Overall Study|Excluded Medications|1|||
49082769|NCT00837148|158137715|FG000|Overall Study|Adverse Event|1|||
49082770|NCT00837148|158137715|FG000|Overall Study|Death|1|||
49082771|NCT01262872|158137716|FG000|Step 2|Death|0|||
49082772|NCT01262872|158137717|FG001|Step 2|Death|0|||
49082773|NCT01262872|158137718|FG002|Step 2|Death|0|||
49082774|NCT01262872|158137719|FG003|Step 2|Death|1|||
49082775|NCT01262872|158137720|FG004|Step 2|Death|0|||
49082776|NCT01262872|158137721|FG005|Step 2|Death|2|||
49082777|NCT01262872|158137722|FG006|Step 2|Death|2|||
49082778|NCT01262872|158137723|FG007|Step 2|Death|1|||
49082779|NCT01262872|158137716|FG000|Step 2|Protocol Violation|0|||
49082780|NCT01262872|158137717|FG001|Step 2|Protocol Violation|0|||
49082781|NCT01262872|158137718|FG002|Step 2|Protocol Violation|1|||
49082782|NCT01262872|158137719|FG003|Step 2|Protocol Violation|0|||
49082783|NCT01262872|158137720|FG004|Step 2|Protocol Violation|0|||
49082784|NCT01262872|158137721|FG005|Step 2|Protocol Violation|0|||
49082785|NCT01262872|158137722|FG006|Step 2|Protocol Violation|3|||
49082786|NCT01262872|158137723|FG007|Step 2|Protocol Violation|1|||
49082787|NCT01262872|158137716|FG000|Step 2|Withdrawal by Subject|0|||
49082788|NCT01262872|158137717|FG001|Step 2|Withdrawal by Subject|0|||
49082789|NCT01262872|158137718|FG002|Step 2|Withdrawal by Subject|4|||
49082790|NCT01262872|158137719|FG003|Step 2|Withdrawal by Subject|6|||
49082791|NCT01262872|158137720|FG004|Step 2|Withdrawal by Subject|3|||
49082792|NCT01262872|158137721|FG005|Step 2|Withdrawal by Subject|1|||
49082793|NCT01262872|158137722|FG006|Step 2|Withdrawal by Subject|2|||
49082794|NCT01262872|158137723|FG007|Step 2|Withdrawal by Subject|1|||
49082795|NCT01262872|158137716|FG000|Step 2|Migrated/moved from study area|0|||
49082796|NCT01262872|158137717|FG001|Step 2|Migrated/moved from study area|0|||
49082797|NCT01262872|158137718|FG002|Step 2|Migrated/moved from study area|4|||
49082798|NCT01262872|158137719|FG003|Step 2|Migrated/moved from study area|3|||
49082799|NCT01262872|158137720|FG004|Step 2|Migrated/moved from study area|2|||
49082800|NCT01262872|158137721|FG005|Step 2|Migrated/moved from study area|6|||
49082801|NCT01262872|158137722|FG006|Step 2|Migrated/moved from study area|2|||
49082802|NCT01262872|158137723|FG007|Step 2|Migrated/moved from study area|3|||
49082803|NCT01383174|158137724|FG000|3 Month Assessment|Death|0|||
49082804|NCT01383174|158137725|FG001|3 Month Assessment|Death|1|||
49082805|NCT01383174|158137724|FG000|3 Month Assessment|Lost to Follow-up|2|||
49082806|NCT01383174|158137725|FG001|3 Month Assessment|Lost to Follow-up|0|||
49082807|NCT01383174|158137724|FG000|3 Month Assessment|Refused to complete|4|||
49082808|NCT01383174|158137725|FG001|3 Month Assessment|Refused to complete|0|||
49082809|NCT01383174|158137724|FG000|6 Month Assessment|Lost to Follow-up|1|||
49082810|NCT01383174|158137725|FG001|6 Month Assessment|Lost to Follow-up|1|||
49082811|NCT01383174|158137724|FG000|6 Month Assessment|Refused to complete|4|||
49082812|NCT01383174|158137725|FG001|6 Month Assessment|Refused to complete|0|||
49082813|NCT00153179|158137731|FG000|Study Visit Day 2|Withdrawal by Subject|1|||
49082814|NCT00153179|158137732|FG001|Study Visit Day 2|Withdrawal by Subject|0|||
49082815|NCT00153179|158137733|FG002|Study Visit Day 2|Withdrawal by Subject|2|||
49082816|NCT00153179|158137734|FG003|Study Visit Day 2|Withdrawal by Subject|2|||
49082817|NCT04135937|158137736|FG000|Overall Study|Lost to Follow-up|2|||
49082818|NCT04135937|158137736|FG000|Overall Study|Withdrawal by Subject|1|||
49082819|NCT02291237|158137737|FG000|Overall Study|Study Terminated by Sponsor|72|||
49082820|NCT02291237|158137738|FG001|Overall Study|Study Terminated by Sponsor|67|||
49082821|NCT02291237|158137737|FG000|Overall Study|Adverse Event|1|||
49082822|NCT02291237|158137738|FG001|Overall Study|Adverse Event|3|||
49082823|NCT02291237|158137737|FG000|Overall Study|Investigator's Discretion|0|||
49082824|NCT02291237|158137738|FG001|Overall Study|Investigator's Discretion|3|||
49082825|NCT02291237|158137737|FG000|Overall Study|Withdrew Consent|11|||
49082826|NCT02291237|158137738|FG001|Overall Study|Withdrew Consent|11|||
49082827|NCT02291237|158137737|FG000|Overall Study|Lost to Follow-up|0|||
49082828|NCT02291237|158137738|FG001|Overall Study|Lost to Follow-up|2|||
49082829|NCT02291237|158137737|FG000|Overall Study|Subject Required Prohibited Medication|2|||
49082830|NCT02291237|158137738|FG001|Overall Study|Subject Required Prohibited Medication|0|||
49082831|NCT02166333|158137739|FG000|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4|||
49082832|NCT02166333|158137740|FG001|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
49082833|NCT02166333|158137741|FG002|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
49082834|NCT02166333|158137742|FG003|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
49082835|NCT02166333|158137743|FG004|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3|||
49082836|NCT02166333|158137744|FG005|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1|||
49082837|NCT02166333|158137739|FG000|Stage 1|Death|4|||
49082838|NCT02166333|158137740|FG001|Stage 1|Death|0|||
49082839|NCT02166333|158137741|FG002|Stage 1|Death|2|||
49082840|NCT02166333|158137742|FG003|Stage 1|Death|0|||
49082841|NCT02166333|158137743|FG004|Stage 1|Death|3|||
49082842|NCT02166333|158137744|FG005|Stage 1|Death|2|||
49082843|NCT02166333|158137739|FG000|Stage 1|Lost to Follow-up|12|||
49082844|NCT02166333|158137740|FG001|Stage 1|Lost to Follow-up|0|||
49082845|NCT02166333|158137741|FG002|Stage 1|Lost to Follow-up|6|||
49082846|NCT02166333|158137742|FG003|Stage 1|Lost to Follow-up|0|||
49082847|NCT02166333|158137743|FG004|Stage 1|Lost to Follow-up|3|||
49082848|NCT02166333|158137744|FG005|Stage 1|Lost to Follow-up|3|||
49082849|NCT02166333|158137739|FG000|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180|||
49082850|NCT02166333|158137740|FG001|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
49082851|NCT02166333|158137741|FG002|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63|||
49082852|NCT02166333|158137742|FG003|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
49082853|NCT02166333|158137743|FG004|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54|||
49082854|NCT02166333|158137744|FG005|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52|||
49082855|NCT02166333|158137739|FG000|Stage 2|Death|4|||
49082856|NCT02166333|158137740|FG001|Stage 2|Death|2|||
49082857|NCT02166333|158137741|FG002|Stage 2|Death|1|||
49082858|NCT02166333|158137742|FG003|Stage 2|Death|0|||
49082859|NCT02166333|158137743|FG004|Stage 2|Death|0|||
49082860|NCT02166333|158137744|FG005|Stage 2|Death|1|||
49082861|NCT02166333|158137739|FG000|Stage 2|Lost to Follow-up|23|||
49082862|NCT02166333|158137740|FG001|Stage 2|Lost to Follow-up|4|||
49082863|NCT02166333|158137741|FG002|Stage 2|Lost to Follow-up|11|||
49082864|NCT02166333|158137742|FG003|Stage 2|Lost to Follow-up|9|||
49082865|NCT02166333|158137743|FG004|Stage 2|Lost to Follow-up|3|||
49082866|NCT02166333|158137744|FG005|Stage 2|Lost to Follow-up|6|||
49082867|NCT00503698|158137748|FG000|Overall Study|Protocol Violation|5|||
49082868|NCT00503698|158137749|FG001|Overall Study|Protocol Violation|6|||
49082869|NCT00503698|158137748|FG000|Overall Study|Adverse Event|52|||
49082870|NCT00503698|158137749|FG001|Overall Study|Adverse Event|41|||
49082871|NCT00503698|158137748|FG000|Overall Study|Death|1|||
49082872|NCT00503698|158137749|FG001|Overall Study|Death|0|||
49082873|NCT00503698|158137748|FG000|Overall Study|Lack of Efficacy|3|||
49082874|NCT00503698|158137749|FG001|Overall Study|Lack of Efficacy|4|||
49082875|NCT00503698|158137748|FG000|Overall Study|Trial terminated|216|||
49082876|NCT00503698|158137749|FG001|Overall Study|Trial terminated|253|||
49082877|NCT00503698|158137748|FG000|Overall Study|End hemodialysis due to renal transplant|10|||
49082878|NCT00503698|158137749|FG001|Overall Study|End hemodialysis due to renal transplant|4|||
49082879|NCT00503698|158137748|FG000|Overall Study|Pregnancy/intention to become pregnant|1|||
49082880|NCT00503698|158137749|FG001|Overall Study|Pregnancy/intention to become pregnant|0|||
49082881|NCT00503698|158137748|FG000|Overall Study|Any condition in exclusion criteria|4|||
49082882|NCT00503698|158137749|FG001|Overall Study|Any condition in exclusion criteria|6|||
49082883|NCT00503698|158137748|FG000|Overall Study|Switch to peritoneal or home dialysis|2|||
49082884|NCT00503698|158137749|FG001|Overall Study|Switch to peritoneal or home dialysis|2|||
49082885|NCT00503698|158137748|FG000|Overall Study|Move to nonparticipating dialysis center|2|||
49082886|NCT00503698|158137749|FG001|Overall Study|Move to nonparticipating dialysis center|1|||
49082887|NCT00503698|158137748|FG000|Overall Study|Critically ill|2|||
49082888|NCT00503698|158137749|FG001|Overall Study|Critically ill|0|||
49082889|NCT00503698|158137748|FG000|Overall Study|Unclassified|48|||
49082890|NCT00503698|158137749|FG001|Overall Study|Unclassified|32|||
49082891|NCT00503698|158137748|FG000|Overall Study|Not exposed to trial drug|11|||
49082892|NCT00503698|158137749|FG001|Overall Study|Not exposed to trial drug|6|||
49082893|NCT02269098|158137750|FG000|Overall Study|Lost to Follow-up|14|||
49082894|NCT02269098|158137751|FG001|Overall Study|Lost to Follow-up|9|||
49082895|NCT03411863|158137756|FG000|Overall Study|Withdrawal by Subject|3|||
49082896|NCT03411863|158137757|FG001|Overall Study|Withdrawal by Subject|1|||
49082897|NCT03411863|158137756|FG000|Overall Study|Physician Decision|0|||
49082898|NCT03411863|158137757|FG001|Overall Study|Physician Decision|1|||
49082899|NCT01197534|158137758|FG000|Overall Study|Not reported|16|||
49082900|NCT01197534|158137759|FG001|Overall Study|Not reported|10|||
49082901|NCT01197534|158137760|FG002|Overall Study|Not reported|16|||
49082902|NCT01197534|158137758|FG000|Overall Study|Enrolment in long term extension|57|||
49082903|NCT01197534|158137759|FG001|Overall Study|Enrolment in long term extension|66|||
49082904|NCT01197534|158137760|FG002|Overall Study|Enrolment in long term extension|119|||
49082905|NCT01197534|158137758|FG000|Overall Study|Severe non-compliance to protocol|3|||
49082906|NCT01197534|158137759|FG001|Overall Study|Severe non-compliance to protocol|4|||
49082907|NCT01197534|158137760|FG002|Overall Study|Severe non-compliance to protocol|1|||
49082908|NCT01197534|158137758|FG000|Overall Study|Lack of therapeutic response|9|||
49082909|NCT01197534|158137759|FG001|Overall Study|Lack of therapeutic response|4|||
49082910|NCT01197534|158137760|FG002|Overall Study|Lack of therapeutic response|9|||
49082911|NCT01197534|158137758|FG000|Overall Study|Dev. of study specific discont. criteria|13|||
49082912|NCT01197534|158137759|FG001|Overall Study|Dev. of study specific discont. criteria|6|||
49082913|NCT01197534|158137760|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
49082914|NCT01197534|158137758|FG000|Overall Study|Lost to Follow-up|1|||
49082915|NCT01197534|158137759|FG001|Overall Study|Lost to Follow-up|4|||
49082916|NCT01197534|158137760|FG002|Overall Study|Lost to Follow-up|2|||
49082917|NCT01197534|158137758|FG000|Overall Study|Adverse Event|35|||
49082918|NCT01197534|158137759|FG001|Overall Study|Adverse Event|36|||
49082919|NCT01197534|158137760|FG002|Overall Study|Adverse Event|24|||
49082920|NCT00682786|158137762|FG000|Overall Study|Withdrawal by Subject|2|||
49082921|NCT00682786|158137763|FG001|Overall Study|Withdrawal by Subject|2|||
49082922|NCT00682786|158137762|FG000|Overall Study|Did not receive irinotecan|0|||
49082923|NCT00682786|158137763|FG001|Overall Study|Did not receive irinotecan|1|||
49082924|NCT02286713|158137764|FG000|One Week Follow-Up|Death|1|||
49082925|NCT02286713|158137765|FG001|One Week Follow-Up|Death|0|||
49082926|NCT02286713|158137764|FG000|One Week Follow-Up|Lost to Follow-up|17|||
49082927|NCT02286713|158137765|FG001|One Week Follow-Up|Lost to Follow-up|21|||
49082928|NCT02286713|158137764|FG000|One Week Follow-Up|Withdrawal by Subject|6|||
49082929|NCT02286713|158137765|FG001|One Week Follow-Up|Withdrawal by Subject|3|||
49082930|NCT02286713|158137764|FG000|Three Month Follow-Up|Death|1|||
49082931|NCT02286713|158137765|FG001|Three Month Follow-Up|Death|1|||
49082932|NCT02286713|158137764|FG000|Three Month Follow-Up|Lost to Follow-up|26|||
49082933|NCT02286713|158137765|FG001|Three Month Follow-Up|Lost to Follow-up|24|||
49082934|NCT02286713|158137764|FG000|Three Month Follow-Up|Withdrawal by Subject|1|||
49082935|NCT02286713|158137765|FG001|Three Month Follow-Up|Withdrawal by Subject|1|||
49082936|NCT02286713|158137764|FG000|Six Month Follow-Up|Death|2|||
49082937|NCT02286713|158137765|FG001|Six Month Follow-Up|Death|0|||
49082938|NCT02286713|158137764|FG000|Six Month Follow-Up|Lost to Follow-up|30|||
49082939|NCT02286713|158137765|FG001|Six Month Follow-Up|Lost to Follow-up|27|||
49082940|NCT03644342|158137766|FG000|Overall Study|Adverse Event|2|||
49082941|NCT03644342|158137767|FG001|Overall Study|Adverse Event|0|||
49082942|NCT03644342|158137766|FG000|Overall Study|Protocol Violation|0|||
49082943|NCT03644342|158137767|FG001|Overall Study|Protocol Violation|1|||
49082944|NCT04314037|158137768|FG000|Treatment Period 2|Adverse Event|1|||
49082945|NCT04314037|158137769|FG001|Treatment Period 2|Adverse Event|0|||
49082946|NCT04314037|158137768|FG000|Treatment Period 3|Protocol Violation|1|||
49082947|NCT04314037|158137769|FG001|Treatment Period 3|Protocol Violation|0|||
49082948|NCT04314037|158137768|FG000|Treatment Period 3|Adverse Event|0|||
49082949|NCT04314037|158137769|FG001|Treatment Period 3|Adverse Event|1|||
49082950|NCT03657797|158139453|FG000|Overall Study|Lost to Follow-up|0|||
49082951|NCT03657797|158139454|FG001|Overall Study|Lost to Follow-up|1|||
49082952|NCT03657797|158139455|FG002|Overall Study|Lost to Follow-up|1|||
49082953|NCT03657797|158139456|FG003|Overall Study|Lost to Follow-up|0|||
49082954|NCT03657797|158139453|FG000|Overall Study|Physician Decision|0|||
49082955|NCT03657797|158139454|FG001|Overall Study|Physician Decision|1|||
49082956|NCT03657797|158139455|FG002|Overall Study|Physician Decision|0|||
49082957|NCT03657797|158139456|FG003|Overall Study|Physician Decision|0|||
49082958|NCT03657797|158139453|FG000|Overall Study|Withdrawal by Subject|0|||
49082959|NCT03657797|158139454|FG001|Overall Study|Withdrawal by Subject|1|||
49082960|NCT03657797|158139455|FG002|Overall Study|Withdrawal by Subject|2|||
49082961|NCT03657797|158139456|FG003|Overall Study|Withdrawal by Subject|0|||
49082962|NCT03657797|158139453|FG000|Overall Study|Adverse Event|0|||
49082963|NCT03657797|158139454|FG001|Overall Study|Adverse Event|0|||
49082964|NCT03657797|158139455|FG002|Overall Study|Adverse Event|2|||
49082965|NCT03657797|158139456|FG003|Overall Study|Adverse Event|0|||
49082966|NCT00725283|158139457|FG000|Overall Study|Missing Code|3|||
49082967|NCT00725283|158139457|FG000|Overall Study|Death|5|||
49082968|NCT00725283|158139457|FG000|Overall Study|Other|6|||
49082969|NCT00725283|158139457|FG000|Overall Study|Withdrawal by Subject|10|||
49082970|NCT01368497|158139458|FG000|Overall Study|Lost to Follow-up|2|||
49082971|NCT03103087|158139459|FG000|Overall Study|Did not receive any study drug|1|||
49082972|NCT03103087|158139460|FG001|Overall Study|Did not receive any study drug|0|||
49082973|NCT03103087|158139461|FG002|Overall Study|Did not receive any study drug|0|||
49082974|NCT03103087|158139459|FG000|Overall Study|Protocol Violation|1|||
49082975|NCT03103087|158139460|FG001|Overall Study|Protocol Violation|2|||
49082976|NCT03103087|158139461|FG002|Overall Study|Protocol Violation|1|||
49082977|NCT03103087|158139459|FG000|Overall Study|Lack of Efficacy|2|||
49082978|NCT03103087|158139460|FG001|Overall Study|Lack of Efficacy|1|||
49082979|NCT03103087|158139461|FG002|Overall Study|Lack of Efficacy|1|||
49082980|NCT03103087|158139459|FG000|Overall Study|Pregnancy|0|||
49082981|NCT03103087|158139460|FG001|Overall Study|Pregnancy|0|||
49082982|NCT03103087|158139461|FG002|Overall Study|Pregnancy|1|||
49082983|NCT03103087|158139459|FG000|Overall Study|Adverse Event|2|||
49082984|NCT03103087|158139460|FG001|Overall Study|Adverse Event|15|||
49082985|NCT03103087|158139461|FG002|Overall Study|Adverse Event|6|||
49082986|NCT03103087|158139459|FG000|Overall Study|Withdrawal by Subject|13|||
49082987|NCT03103087|158139460|FG001|Overall Study|Withdrawal by Subject|6|||
49082988|NCT03103087|158139461|FG002|Overall Study|Withdrawal by Subject|6|||
49082989|NCT03103087|158139459|FG000|Overall Study|Lost to Follow-up|4|||
49082990|NCT03103087|158139460|FG001|Overall Study|Lost to Follow-up|2|||
49082991|NCT03103087|158139461|FG002|Overall Study|Lost to Follow-up|7|||
49082992|NCT03103087|158139459|FG000|Overall Study|Other reason not reported|1|||
49082993|NCT03103087|158139460|FG001|Overall Study|Other reason not reported|3|||
49082994|NCT03103087|158139461|FG002|Overall Study|Other reason not reported|5|||
49082995|NCT03743415|158139462|FG000|Overall Study|Death|5|||
49082996|NCT03743415|158139463|FG001|Overall Study|Death|3|||
49082997|NCT03743415|158139464|FG002|Overall Study|Death|1|||
49082998|NCT03743415|158139465|FG003|Overall Study|Death|4|||
49082999|NCT03743415|158139466|FG004|Overall Study|Death|0|||
49083000|NCT03743415|158139467|FG005|Overall Study|Death|0|||
49083001|NCT03743415|158139468|FG006|Overall Study|Death|0|||
49083002|NCT03743415|158139469|FG007|Overall Study|Death|0|||
49083003|NCT03743415|158139470|FG008|Overall Study|Death|1|||
49083004|NCT03743415|158139471|FG009|Overall Study|Death|0|||
49083005|NCT03743415|158139462|FG000|Overall Study|Withdrawal by Subject|1|||
49083006|NCT03743415|158139463|FG001|Overall Study|Withdrawal by Subject|0|||
49083007|NCT03743415|158139464|FG002|Overall Study|Withdrawal by Subject|4|||
49083008|NCT03743415|158139465|FG003|Overall Study|Withdrawal by Subject|5|||
49083009|NCT03743415|158139466|FG004|Overall Study|Withdrawal by Subject|5|||
49083010|NCT03743415|158139467|FG005|Overall Study|Withdrawal by Subject|2|||
49083011|NCT03743415|158139468|FG006|Overall Study|Withdrawal by Subject|2|||
49083012|NCT03743415|158139469|FG007|Overall Study|Withdrawal by Subject|5|||
49083013|NCT03743415|158139470|FG008|Overall Study|Withdrawal by Subject|9|||
49083014|NCT03743415|158139471|FG009|Overall Study|Withdrawal by Subject|10|||
49083015|NCT03743415|158139462|FG000|Overall Study|Lost to Follow-up|2|||
49083016|NCT03743415|158139463|FG001|Overall Study|Lost to Follow-up|0|||
49083017|NCT03743415|158139464|FG002|Overall Study|Lost to Follow-up|2|||
49083018|NCT03743415|158139465|FG003|Overall Study|Lost to Follow-up|1|||
49083019|NCT03743415|158139466|FG004|Overall Study|Lost to Follow-up|1|||
49083020|NCT03743415|158139467|FG005|Overall Study|Lost to Follow-up|0|||
49083021|NCT03743415|158139468|FG006|Overall Study|Lost to Follow-up|1|||
49083022|NCT03743415|158139469|FG007|Overall Study|Lost to Follow-up|4|||
49083023|NCT03743415|158139470|FG008|Overall Study|Lost to Follow-up|13|||
49083024|NCT03743415|158139471|FG009|Overall Study|Lost to Follow-up|13|||
49083025|NCT02762929|158139472|FG000|Overall Study|Adverse Event|0|||
49083026|NCT02762929|158139473|FG001|Overall Study|Adverse Event|0|||
49083027|NCT02762929|158139474|FG002|Overall Study|Adverse Event|0|||
49083028|NCT02762929|158139475|FG003|Overall Study|Adverse Event|1|||
49083029|NCT02762929|158139476|FG004|Overall Study|Adverse Event|0|||
49083030|NCT02762929|158139477|FG005|Overall Study|Adverse Event|0|||
49083031|NCT02762929|158139472|FG000|Overall Study|Lost to Follow-up|1|||
49083032|NCT02762929|158139473|FG001|Overall Study|Lost to Follow-up|2|||
49083033|NCT02762929|158139474|FG002|Overall Study|Lost to Follow-up|0|||
49083034|NCT02762929|158139475|FG003|Overall Study|Lost to Follow-up|1|||
49083035|NCT02762929|158139476|FG004|Overall Study|Lost to Follow-up|0|||
49083036|NCT02762929|158139477|FG005|Overall Study|Lost to Follow-up|0|||
49083037|NCT02762929|158139472|FG000|Overall Study|Withdrawal by Subject|0|||
49083038|NCT02762929|158139473|FG001|Overall Study|Withdrawal by Subject|1|||
49083039|NCT02762929|158139474|FG002|Overall Study|Withdrawal by Subject|0|||
49083040|NCT02762929|158139475|FG003|Overall Study|Withdrawal by Subject|0|||
49083041|NCT02762929|158139476|FG004|Overall Study|Withdrawal by Subject|0|||
49083042|NCT02762929|158139477|FG005|Overall Study|Withdrawal by Subject|0|||
49083043|NCT02762929|158139472|FG000|Overall Study|exclusionary medication disclosed late|0|||
49083044|NCT02762929|158139473|FG001|Overall Study|exclusionary medication disclosed late|0|||
49083045|NCT02762929|158139474|FG002|Overall Study|exclusionary medication disclosed late|0|||
49083046|NCT02762929|158139475|FG003|Overall Study|exclusionary medication disclosed late|1|||
49083047|NCT02762929|158139476|FG004|Overall Study|exclusionary medication disclosed late|0|||
49083048|NCT02762929|158139477|FG005|Overall Study|exclusionary medication disclosed late|0|||
49083049|NCT01567462|158139478|FG000|Overall Study|Withdrawal by Subject|4|||
49083050|NCT01567462|158139479|FG001|Overall Study|Withdrawal by Subject|7|||
49083051|NCT02656303|158139480|FG000|Overall Study|Adverse Event|3|||
49083052|NCT02656303|158139481|FG001|Overall Study|Adverse Event|2|||
49083053|NCT02656303|158139482|FG002|Overall Study|Adverse Event|0|||
49083054|NCT02656303|158139480|FG000|Overall Study|Death|12|||
49083055|NCT02656303|158139481|FG001|Overall Study|Death|4|||
49083056|NCT02656303|158139482|FG002|Overall Study|Death|1|||
49083057|NCT02656303|158139480|FG000|Overall Study|Lack of Efficacy|1|||
49083058|NCT02656303|158139481|FG001|Overall Study|Lack of Efficacy|0|||
49083059|NCT02656303|158139482|FG002|Overall Study|Lack of Efficacy|0|||
49083060|NCT02656303|158139480|FG000|Overall Study|Non-Compliance with Study|1|||
49083061|NCT02656303|158139481|FG001|Overall Study|Non-Compliance with Study|1|||
49083062|NCT02656303|158139482|FG002|Overall Study|Non-Compliance with Study|0|||
49083063|NCT02656303|158139480|FG000|Overall Study|Investigator Decision|2|||
49083064|NCT02656303|158139481|FG001|Overall Study|Investigator Decision|1|||
49083065|NCT02656303|158139482|FG002|Overall Study|Investigator Decision|0|||
49083066|NCT02656303|158139480|FG000|Overall Study|Progressive Disease|25|||
49083067|NCT02656303|158139481|FG001|Overall Study|Progressive Disease|14|||
49083068|NCT02656303|158139482|FG002|Overall Study|Progressive Disease|10|||
49083069|NCT02656303|158139480|FG000|Overall Study|Study Terminated by Sponsor|20|||
49083070|NCT02656303|158139481|FG001|Overall Study|Study Terminated by Sponsor|7|||
49083071|NCT02656303|158139482|FG002|Overall Study|Study Terminated by Sponsor|5|||
49083072|NCT02656303|158139480|FG000|Overall Study|Withdrawal of Consent by Participants|1|||
49083073|NCT02656303|158139481|FG001|Overall Study|Withdrawal of Consent by Participants|1|||
49083074|NCT02656303|158139482|FG002|Overall Study|Withdrawal of Consent by Participants|0|||
49083075|NCT02656303|158139480|FG000|Overall Study|Initiation of Non-protocol Intervention|1|||
49083076|NCT02656303|158139481|FG001|Overall Study|Initiation of Non-protocol Intervention|0|||
49083077|NCT02656303|158139482|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
49083078|NCT02656303|158139480|FG000|Overall Study|Reason not Specified|1|||
49083079|NCT02656303|158139481|FG001|Overall Study|Reason not Specified|1|||
49083080|NCT02656303|158139482|FG002|Overall Study|Reason not Specified|2|||
49083081|NCT00413699|158139483|FG000|Initial Period|Death|25|||
49083082|NCT00413699|158139484|FG001|Initial Period|Death|30|||
49083083|NCT00413699|158139485|FG002|Initial Period|Death|0|||
49083084|NCT00413699|158139483|FG000|Initial Period|Lack of Efficacy|59|||
49083085|NCT00413699|158139484|FG001|Initial Period|Lack of Efficacy|115|||
49083086|NCT00413699|158139485|FG002|Initial Period|Lack of Efficacy|0|||
49083087|NCT00413699|158139483|FG000|Initial Period|Lost to Follow-up|31|||
49083088|NCT00413699|158139484|FG001|Initial Period|Lost to Follow-up|101|||
49083089|NCT00413699|158139485|FG002|Initial Period|Lost to Follow-up|0|||
49083090|NCT00413699|158139483|FG000|Initial Period|Protocol Violation|38|||
49083091|NCT00413699|158139484|FG001|Initial Period|Protocol Violation|89|||
49083092|NCT00413699|158139485|FG002|Initial Period|Protocol Violation|0|||
49083093|NCT00413699|158139483|FG000|Initial Period|Pregnancy|10|||
49083094|NCT00413699|158139484|FG001|Initial Period|Pregnancy|8|||
49083095|NCT00413699|158139485|FG002|Initial Period|Pregnancy|0|||
49083096|NCT00413699|158139483|FG000|Initial Period|Did not meet entrance criteria|2|||
49083097|NCT00413699|158139484|FG001|Initial Period|Did not meet entrance criteria|2|||
49083098|NCT00413699|158139485|FG002|Initial Period|Did not meet entrance criteria|0|||
49083099|NCT00413699|158139483|FG000|Initial Period|Medication error without adverse event|0|||
49083100|NCT00413699|158139484|FG001|Initial Period|Medication error without adverse event|1|||
49083101|NCT00413699|158139485|FG002|Initial Period|Medication error without adverse event|0|||
49083102|NCT00413699|158139483|FG000|Initial Period|Study terminated by Sponsor|0|||
49083103|NCT00413699|158139484|FG001|Initial Period|Study terminated by Sponsor|1|||
49083104|NCT00413699|158139485|FG002|Initial Period|Study terminated by Sponsor|0|||
49083105|NCT00413699|158139483|FG000|Initial Period|Other|67|||
49083106|NCT00413699|158139484|FG001|Initial Period|Other|211|||
49083107|NCT00413699|158139485|FG002|Initial Period|Other|0|||
49083108|NCT00413699|158139483|FG000|Initial Period|Adverse event related to study drug|178|||
49083109|NCT00413699|158139484|FG001|Initial Period|Adverse event related to study drug|527|||
49083110|NCT00413699|158139485|FG002|Initial Period|Adverse event related to study drug|0|||
49083111|NCT00413699|158139483|FG000|Initial Period|Adverse event not related to study drug|113|||
49083112|NCT00413699|158139484|FG001|Initial Period|Adverse event not related to study drug|248|||
49083113|NCT00413699|158139485|FG002|Initial Period|Adverse event not related to study drug|0|||
49083114|NCT00413699|158139483|FG000|Initial Period|Missing end of study page|0|||
49083115|NCT00413699|158139484|FG001|Initial Period|Missing end of study page|4|||
49083116|NCT00413699|158139485|FG002|Initial Period|Missing end of study page|0|||
49083117|NCT00413699|158139483|FG000|Initial Period|No longer willing to participate|116|||
49083118|NCT00413699|158139484|FG001|Initial Period|No longer willing to participate|368|||
49083119|NCT00413699|158139485|FG002|Initial Period|No longer willing to participate|0|||
49083120|NCT00413699|158139483|FG000|Extension Period|No Longer Willing to Participate|0|||
49083121|NCT00413699|158139484|FG001|Extension Period|No Longer Willing to Participate|0|||
49083122|NCT00413699|158139485|FG002|Extension Period|No Longer Willing to Participate|2|||
49083123|NCT00413699|158139483|FG000|Extension Period|Protocol Violation|0|||
49083124|NCT00413699|158139484|FG001|Extension Period|Protocol Violation|0|||
49083125|NCT00413699|158139485|FG002|Extension Period|Protocol Violation|1|||
49083126|NCT00413699|158139483|FG000|Extension Period|Adverse Event|0|||
49083127|NCT00413699|158139484|FG001|Extension Period|Adverse Event|0|||
49083128|NCT00413699|158139485|FG002|Extension Period|Adverse Event|2|||
49083129|NCT01383707|158139488|FG000|Overall Study|Consent withdrawal|6|||
49083130|NCT01383707|158139488|FG000|Overall Study|Death|19|||
49083131|NCT01383707|158139488|FG000|Overall Study|Other|8|||
49083132|NCT01383707|158139488|FG000|Overall Study|Sponsor's decision|2|||
49083133|NCT01383707|158139488|FG000|Overall Study|Adverse Event|14|||
49083134|NCT01383707|158139488|FG000|Overall Study|Progressive disease|23|||
49083135|NCT01609790|158139497|FG000|Overall Study|Protocol Violation|1|||
49083136|NCT01609790|158139498|FG001|Overall Study|Protocol Violation|7|||
49083137|NCT01609790|158139499|FG002|Overall Study|Protocol Violation|8|||
49083138|NCT03052751|158139502|FG000|Dosing Period 1|Adverse Event|0|||
49083139|NCT03052751|158139503|FG001|Dosing Period 1|Adverse Event|1|||
49083140|NCT03052751|158139504|FG002|Dosing Period 1|Adverse Event|0|||
49083141|NCT03052751|158139505|FG003|Dosing Period 1|Adverse Event|0|||
49083142|NCT03052751|158139506|FG004|Dosing Period 1|Adverse Event|0|||
49083143|NCT03052751|158139507|FG005|Dosing Period 1|Adverse Event|0|||
49083144|NCT03052751|158139502|FG000|Dosing Period 2|Adverse Event|0|||
49083145|NCT03052751|158139503|FG001|Dosing Period 2|Adverse Event|0|||
49083146|NCT03052751|158139504|FG002|Dosing Period 2|Adverse Event|3|||
49083147|NCT03052751|158139505|FG003|Dosing Period 2|Adverse Event|0|||
49083148|NCT03052751|158139506|FG004|Dosing Period 2|Adverse Event|0|||
49083149|NCT03052751|158139507|FG005|Dosing Period 2|Adverse Event|0|||
49083150|NCT03052751|158139502|FG000|Observation Period|Adverse Event|0|||
49083151|NCT03052751|158139503|FG001|Observation Period|Adverse Event|0|||
49083152|NCT03052751|158139504|FG002|Observation Period|Adverse Event|0|||
49083153|NCT03052751|158139505|FG003|Observation Period|Adverse Event|0|||
49083154|NCT03052751|158139506|FG004|Observation Period|Adverse Event|1|||
49083155|NCT03052751|158139507|FG005|Observation Period|Adverse Event|0|||
49083156|NCT03597295|158139522|FG000|Overall Study|Death|70|||
49083157|NCT03597295|158139522|FG000|Overall Study|Lost to Follow-up|7|||
49083158|NCT04720053|158139543|FG000|Overall Study|Lost to Follow-up|12|||
49083159|NCT00942357|158139549|FG000|Overall Study|Ineligible|37|||
49083160|NCT00942357|158139550|FG001|Overall Study|Ineligible|40|||
49083161|NCT01960257|158139559|FG000|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12|||
49083162|NCT01960257|158139560|FG001|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
49083163|NCT01960257|158139561|FG002|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
49083164|NCT01960257|158139559|FG000|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3|||
49083165|NCT01960257|158139560|FG001|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
49083166|NCT01960257|158139561|FG002|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
49083167|NCT01960257|158139559|FG000|Stage 1 (1-3 Weeks)|Adverse Event|1|||
49083168|NCT01960257|158139560|FG001|Stage 1 (1-3 Weeks)|Adverse Event|0|||
49083169|NCT01960257|158139561|FG002|Stage 1 (1-3 Weeks)|Adverse Event|0|||
49083170|NCT03817125|158139562|FG000|Overall Study|Adverse Event|1|||
49083171|NCT03817125|158139563|FG001|Overall Study|Adverse Event|0|||
49083172|NCT03817125|158139562|FG000|Overall Study|Physician Decision|0|||
49083173|NCT03817125|158139563|FG001|Overall Study|Physician Decision|1|||
49083174|NCT03817125|158139562|FG000|Overall Study|Lack of Efficacy|1|||
49083175|NCT03817125|158139563|FG001|Overall Study|Lack of Efficacy|5|||
49083176|NCT02002221|158139564|FG000|Overall Study|Adverse Event|2|||
49083177|NCT02002221|158139565|FG001|Overall Study|Adverse Event|1|||
49083178|NCT02002221|158139564|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
49083179|NCT02002221|158139565|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
49083180|NCT02002221|158139564|FG000|Overall Study|Patient withdrew consent|0|||
49083181|NCT02002221|158139565|FG001|Overall Study|Patient withdrew consent|1|||
49083182|NCT01942993|158139566|FG000|Overall Study|Lost to Follow-up|1|||
49083183|NCT01942993|158139566|FG000|Overall Study|Physician Decision|1|||
49083184|NCT04421131|158139567|FG000|Overall Study|Lost to Follow-up|1|||
49083185|NCT04421131|158139567|FG000|Overall Study|Protocol Violation|2|||
49083186|NCT04421131|158139567|FG000|Overall Study|App crashed|5|||
49083187|NCT03749330|158139568|FG000|Overall Study|Clinicians left work in the CICU|0|||
49083188|NCT03749330|158139569|FG001|Overall Study|Clinicians left work in the CICU|2|||
49083189|NCT03749330|158139570|FG002|Overall Study|Clinicians left work in the CICU|0|||
49083190|NCT03749330|158139571|FG003|Overall Study|Clinicians left work in the CICU|0|||
49083191|NCT03749330|158139572|FG004|Overall Study|Clinicians left work in the CICU|0|||
49083192|NCT03749330|158139573|FG005|Overall Study|Clinicians left work in the CICU|0|||
49083193|NCT02342678|158139574|FG000|Overall Study|Lost to Follow-up|0|||
49083194|NCT02342678|158139575|FG001|Overall Study|Lost to Follow-up|1|||
49083195|NCT02342678|158139574|FG000|Overall Study|Too busy to complete study|0|||
49083196|NCT02342678|158139575|FG001|Overall Study|Too busy to complete study|2|||
49083197|NCT02342678|158139574|FG000|Overall Study|Family illness/emergency|0|||
49083198|NCT02342678|158139575|FG001|Overall Study|Family illness/emergency|1|||
49083199|NCT02342678|158139574|FG000|Overall Study|Illness/medical reason|1|||
49083200|NCT02342678|158139575|FG001|Overall Study|Illness/medical reason|1|||
49083201|NCT02860546|158139579|FG000|Overall Study|Clinical Progression|6|||
49083202|NCT02860546|158139579|FG000|Overall Study|Radiological Progression|12|||
49083203|NCT01651117|158139581|FG000|Overall Study|Death|2|||
49083204|NCT01651117|158139582|FG001|Overall Study|Death|3|||
49083205|NCT01651117|158139583|FG002|Overall Study|Death|2|||
49083206|NCT01651117|158139584|FG003|Overall Study|Death|2|||
49083207|NCT02942017|158139585|FG000|Overall Study|Adverse Event|0|||
49083208|NCT02942017|158139586|FG001|Overall Study|Adverse Event|1|||
49083209|NCT02942017|158139585|FG000|Overall Study|Withdrawal by Subject|0|||
49083210|NCT02942017|158139586|FG001|Overall Study|Withdrawal by Subject|1|||
49083211|NCT02942017|158139585|FG000|Overall Study|Lost to Follow-up|1|||
49083212|NCT02942017|158139586|FG001|Overall Study|Lost to Follow-up|1|||
49083213|NCT02942017|158139585|FG000|Overall Study|Randomized but not dosed|1|||
49083214|NCT02942017|158139586|FG001|Overall Study|Randomized but not dosed|3|||
49083215|NCT02714218|158139587|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
49083216|NCT02714218|158139588|FG001|Pre-Treatment Period|Participant no longer meets study criteria|1|||
49083217|NCT02714218|158139589|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
49083218|NCT02714218|158139587|FG000|Pre-Treatment Period|Other reasons|0|||
49083219|NCT02714218|158139588|FG001|Pre-Treatment Period|Other reasons|1|||
49083220|NCT02714218|158139589|FG002|Pre-Treatment Period|Other reasons|0|||
49083221|NCT02714218|158139587|FG000|Treatment Period|Disease Progression|55|||
49083222|NCT02714218|158139588|FG001|Treatment Period|Disease Progression|52|||
49083223|NCT02714218|158139589|FG002|Treatment Period|Disease Progression|14|||
49083224|NCT02714218|158139587|FG000|Treatment Period|Study drug toxicity|46|||
49083225|NCT02714218|158139588|FG001|Treatment Period|Study drug toxicity|70|||
49083226|NCT02714218|158139589|FG002|Treatment Period|Study drug toxicity|6|||
49083227|NCT02714218|158139587|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
49083228|NCT02714218|158139588|FG001|Treatment Period|Adverse event unrelated to study drug|6|||
49083229|NCT02714218|158139589|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
49083230|NCT02714218|158139587|FG000|Treatment Period|Request to discontinue treatment|1|||
49083231|NCT02714218|158139588|FG001|Treatment Period|Request to discontinue treatment|4|||
49083232|NCT02714218|158139589|FG002|Treatment Period|Request to discontinue treatment|1|||
49083233|NCT02714218|158139587|FG000|Treatment Period|Participant withdrew consent|2|||
49083234|NCT02714218|158139588|FG001|Treatment Period|Participant withdrew consent|2|||
49083235|NCT02714218|158139589|FG002|Treatment Period|Participant withdrew consent|0|||
49083236|NCT02714218|158139587|FG000|Treatment Period|Maximum clinical benefit|4|||
49083237|NCT02714218|158139588|FG001|Treatment Period|Maximum clinical benefit|2|||
49083238|NCT02714218|158139589|FG002|Treatment Period|Maximum clinical benefit|0|||
49083239|NCT02714218|158139587|FG000|Treatment Period|Administrative reason by sponsor|2|||
49083240|NCT02714218|158139588|FG001|Treatment Period|Administrative reason by sponsor|1|||
49083241|NCT02714218|158139589|FG002|Treatment Period|Administrative reason by sponsor|0|||
49083242|NCT02714218|158139587|FG000|Treatment Period|Other reasons|6|||
49083243|NCT02714218|158139588|FG001|Treatment Period|Other reasons|6|||
49083244|NCT02714218|158139589|FG002|Treatment Period|Other reasons|0|||
49083245|NCT02714218|158139587|FG000|Treatment Period|Completed treatment as per protocol|36|||
49083246|NCT02714218|158139588|FG001|Treatment Period|Completed treatment as per protocol|27|||
49083247|NCT02714218|158139589|FG002|Treatment Period|Completed treatment as per protocol|3|||
49083248|NCT02714218|158139587|FG000|Treatment Period|Not reported|9|||
49083249|NCT02714218|158139588|FG001|Treatment Period|Not reported|6|||
49083250|NCT02714218|158139589|FG002|Treatment Period|Not reported|0|||
49083251|NCT01622673|158139590|FG000|Treatment Period 1|Withdrawal by Subject|0|||
49083252|NCT01622673|158139591|FG001|Treatment Period 1|Withdrawal by Subject|0|||
49083253|NCT01622673|158139592|FG002|Treatment Period 1|Withdrawal by Subject|0|||
49083254|NCT01622673|158139593|FG003|Treatment Period 1|Withdrawal by Subject|1|||
49083255|NCT01622673|158139594|FG004|Treatment Period 1|Withdrawal by Subject|0|||
49083256|NCT01622673|158139595|FG005|Treatment Period 1|Withdrawal by Subject|0|||
49083257|NCT01622673|158139590|FG000|Treatment Period 1|Protocol Violation|0|||
49083258|NCT01622673|158139591|FG001|Treatment Period 1|Protocol Violation|1|||
49083259|NCT01622673|158139592|FG002|Treatment Period 1|Protocol Violation|0|||
49083260|NCT01622673|158139593|FG003|Treatment Period 1|Protocol Violation|0|||
49083261|NCT01622673|158139594|FG004|Treatment Period 1|Protocol Violation|0|||
49083262|NCT01622673|158139595|FG005|Treatment Period 1|Protocol Violation|0|||
49083263|NCT01622673|158139590|FG000|Treatment Period 2|Withdrawal by Subject|0|||
49083264|NCT01622673|158139591|FG001|Treatment Period 2|Withdrawal by Subject|0|||
49083265|NCT01622673|158139592|FG002|Treatment Period 2|Withdrawal by Subject|0|||
49083266|NCT01622673|158139593|FG003|Treatment Period 2|Withdrawal by Subject|1|||
49083267|NCT01622673|158139594|FG004|Treatment Period 2|Withdrawal by Subject|0|||
49083268|NCT01622673|158139595|FG005|Treatment Period 2|Withdrawal by Subject|0|||
49083269|NCT01622673|158139590|FG000|Treatment Period 3|Protocol Violation|0|||
49083270|NCT01622673|158139591|FG001|Treatment Period 3|Protocol Violation|1|||
49083271|NCT01622673|158139592|FG002|Treatment Period 3|Protocol Violation|0|||
49083272|NCT01622673|158139593|FG003|Treatment Period 3|Protocol Violation|0|||
49083273|NCT01622673|158139594|FG004|Treatment Period 3|Protocol Violation|0|||
49083274|NCT01622673|158139595|FG005|Treatment Period 3|Protocol Violation|0|||
49083275|NCT01753570|158139598|FG000|Overall Study|Adverse Event|1|||
49083276|NCT01753570|158139599|FG001|Overall Study|Adverse Event|0|||
49083277|NCT01753570|158139600|FG002|Overall Study|Adverse Event|1|||
49083278|NCT01753570|158139598|FG000|Overall Study|Physician Decision|0|||
49083279|NCT01753570|158139599|FG001|Overall Study|Physician Decision|1|||
49083280|NCT01753570|158139600|FG002|Overall Study|Physician Decision|0|||
49083281|NCT01753570|158139598|FG000|Overall Study|Withdrawal by Subject|1|||
49083282|NCT01753570|158139599|FG001|Overall Study|Withdrawal by Subject|4|||
49083283|NCT01753570|158139600|FG002|Overall Study|Withdrawal by Subject|0|||
49083284|NCT02301169|158139601|FG000|Overall Study|Adverse Event|1|||
49083285|NCT02301169|158139602|FG001|Overall Study|Adverse Event|0|||
49083286|NCT00380874|158139603|FG000|Overall Study|Adverse Event|7|||
49083287|NCT00380874|158139604|FG001|Overall Study|Adverse Event|7|||
49083288|NCT00380874|158139603|FG000|Overall Study|Death|1|||
49083289|NCT00380874|158139604|FG001|Overall Study|Death|0|||
49083290|NCT00380874|158139603|FG000|Overall Study|Withdrawal by Subject|2|||
49083291|NCT00380874|158139604|FG001|Overall Study|Withdrawal by Subject|1|||
49083292|NCT00380874|158139603|FG000|Overall Study|Not related to study drug|3|||
49083293|NCT00380874|158139604|FG001|Overall Study|Not related to study drug|2|||
49083294|NCT03839628|158139605|FG000|Overall Study|Withdrawal by Subject|1|||
49083295|NCT00720213|158139608|FG000|Screening Phase With Diagnostic PSG|Screen Failure|7|||
49083296|NCT00720213|158139609|FG001|Screening Phase With Diagnostic PSG|Screen Failure|0|||
49083297|NCT00720213|158139610|FG002|Screening Phase With Diagnostic PSG|Screen Failure|0|||
49083298|NCT01198470|158139611|FG000|Overall Study|Adverse Event|2|||
49083299|NCT00470470|158139614|FG000|Overall Study|Adverse Event|2|||
49083300|NCT00470470|158139614|FG000|Overall Study|Death|2|||
49083301|NCT00470470|158139614|FG000|Overall Study|Not treated|1|||
49083302|NCT01787292|158139615|FG000|Crossover Exercise Interventions|Withdrawal by Subject|2|||
49083303|NCT01787292|158139616|FG001|Crossover Exercise Interventions|Withdrawal by Subject|2|||
49083304|NCT01787292|158139615|FG000|Home Based Exercise Program|Withdrawal by Subject|3|||
49083305|NCT01787292|158139616|FG001|Home Based Exercise Program|Withdrawal by Subject|1|||
49083306|NCT01522456|158139617|FG000|Overall Study|Adverse Event|2|||
49083307|NCT01522456|158139617|FG000|Overall Study|Lost to Follow-up|2|||
49083308|NCT01522456|158139617|FG000|Overall Study|Withdrawal by Subject|2|||
49083309|NCT01522456|158139617|FG000|Overall Study|Pregnancy|1|||
49083310|NCT01522456|158139617|FG000|Overall Study|Tolerability Assessment|1|||
49083311|NCT01153815|158139618|FG000|Overall Study|Adverse Event|3|||
49083312|NCT01153815|158139619|FG001|Overall Study|Adverse Event|1|||
49083313|NCT01153815|158139618|FG000|Overall Study|Withdrawal by Subject|6|||
49083314|NCT01153815|158139619|FG001|Overall Study|Withdrawal by Subject|4|||
49083315|NCT03181633|158139620|FG000|Overall Study|Withdrawal by Subject|1|||
49083316|NCT03181633|158139620|FG000|Overall Study|Missing follow-up visit|1|||
49083317|NCT00349973|158139621|FG000|Overall Study|Adverse Event|3|||
49083318|NCT00349973|158139622|FG001|Overall Study|Adverse Event|3|||
49083319|NCT00349973|158139621|FG000|Overall Study|Withdrawal by Subject|1|||
49083320|NCT00349973|158139622|FG001|Overall Study|Withdrawal by Subject|0|||
49083321|NCT02107131|158139629|FG000|Overall Study|Lost to Follow-up|4|||
49083322|NCT02107131|158139630|FG001|Overall Study|Lost to Follow-up|4|||
49083323|NCT02107131|158139629|FG000|Overall Study|Physician Decision|1|||
49083324|NCT02107131|158139630|FG001|Overall Study|Physician Decision|0|||
49083325|NCT02107131|158139629|FG000|Overall Study|Withdrawal by Subject|2|||
49083326|NCT02107131|158139630|FG001|Overall Study|Withdrawal by Subject|0|||
49083327|NCT02107131|158139629|FG000|Overall Study|mental instability|1|||
49083328|NCT02107131|158139630|FG001|Overall Study|mental instability|0|||
49083329|NCT02107131|158139629|FG000|Overall Study|Death|0|||
49083330|NCT02107131|158139630|FG001|Overall Study|Death|1|||
49083331|NCT02107131|158139629|FG000|Overall Study|Protocol Violation|0|||
49083332|NCT02107131|158139630|FG001|Overall Study|Protocol Violation|4|||
49083333|NCT02548143|158139632|FG000|Overall Study|Adverse Event|1|||
49083334|NCT02548143|158139633|FG001|Overall Study|Adverse Event|0|||
49083335|NCT02548143|158139632|FG000|Overall Study|Withdrawal by Subject|0|||
49083336|NCT02548143|158139633|FG001|Overall Study|Withdrawal by Subject|1|||
49083337|NCT00697463|158139634|FG000|Overall Study|Withdrawal by Subject|1|||
49083338|NCT02747108|158139638|FG000|Overall Study|Death|2|||
49083339|NCT02747108|158139639|FG001|Overall Study|Death|2|||
49083340|NCT02747108|158139638|FG000|Overall Study|Withdrawal by Subject|1|||
49083341|NCT02747108|158139639|FG001|Overall Study|Withdrawal by Subject|0|||
49083342|NCT02747108|158139638|FG000|Overall Study|Protocol Violation|2|||
49083343|NCT02747108|158139639|FG001|Overall Study|Protocol Violation|0|||
49083344|NCT03564119|158139640|FG000|Overall Study|Adverse Event|4|||
49083345|NCT03564119|158139641|FG001|Overall Study|Adverse Event|0|||
49083346|NCT03564119|158139640|FG000|Overall Study|Lost to Follow-up|1|||
49083347|NCT03564119|158139641|FG001|Overall Study|Lost to Follow-up|4|||
49083348|NCT03564119|158139640|FG000|Overall Study|Protocol Violation|1|||
49083349|NCT03564119|158139641|FG001|Overall Study|Protocol Violation|0|||
49083350|NCT03564119|158139640|FG000|Overall Study|Withdrawal by Subject|9|||
49083351|NCT03564119|158139641|FG001|Overall Study|Withdrawal by Subject|4|||
49083352|NCT03564119|158139640|FG000|Overall Study|Other Than Specified|0|||
49083353|NCT03564119|158139641|FG001|Overall Study|Other Than Specified|1|||
49083354|NCT02157376|158139645|FG000|Overall Study|Death|10|||
49083355|NCT02157376|158139646|FG001|Overall Study|Death|4|||
49083356|NCT02157376|158139645|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
49083357|NCT02157376|158139646|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
49083358|NCT02157376|158139645|FG000|Overall Study|Withdrawal by Subject|3|||
49083359|NCT02157376|158139646|FG001|Overall Study|Withdrawal by Subject|8|||
49083360|NCT02157376|158139645|FG000|Overall Study|Not treated|8|||
49083361|NCT02157376|158139646|FG001|Overall Study|Not treated|3|||
49083362|NCT02157376|158139645|FG000|Overall Study|Investigator's misjudgement|1|||
49083363|NCT02157376|158139646|FG001|Overall Study|Investigator's misjudgement|2|||
49083364|NCT05966584|158139647|FG000|Overall Study|Lost to Follow-up|1|||
49083365|NCT04358081|158141235|FG000|Treatment Phase of Study|Withdrawal by Subject|0|||
49083366|NCT04358081|158141236|FG001|Treatment Phase of Study|Withdrawal by Subject|1|||
49083367|NCT04358081|158141237|FG002|Treatment Phase of Study|Withdrawal by Subject|1|||
49083368|NCT04358081|158141235|FG000|Treatment Phase of Study|Adverse Event|1|||
49083369|NCT04358081|158141236|FG001|Treatment Phase of Study|Adverse Event|0|||
49083370|NCT04358081|158141237|FG002|Treatment Phase of Study|Adverse Event|1|||
49083371|NCT04358081|158141235|FG000|Treatment Phase of Study|Physician Decision|2|||
49083372|NCT04358081|158141236|FG001|Treatment Phase of Study|Physician Decision|0|||
49083373|NCT04358081|158141237|FG002|Treatment Phase of Study|Physician Decision|1|||
49083374|NCT04358081|158141235|FG000|Treatment Phase of Study|Protocol Violation|1|||
49083375|NCT04358081|158141236|FG001|Treatment Phase of Study|Protocol Violation|0|||
49083376|NCT04358081|158141237|FG002|Treatment Phase of Study|Protocol Violation|0|||
49083377|NCT04358081|158141235|FG000|Study Completion Phase|Death|0|||
49083378|NCT04358081|158141236|FG001|Study Completion Phase|Death|0|||
49083379|NCT04358081|158141237|FG002|Study Completion Phase|Death|1|||
49083380|NCT04358081|158141235|FG000|Study Completion Phase|Lost to Follow-up|1|||
49083381|NCT04358081|158141236|FG001|Study Completion Phase|Lost to Follow-up|0|||
49083382|NCT04358081|158141237|FG002|Study Completion Phase|Lost to Follow-up|1|||
49083383|NCT01130532|158141238|FG000|Period III (Weeks 0-12)|Adverse Event|3|||
49083384|NCT01130532|158141239|FG001|Period III (Weeks 0-12)|Adverse Event|3|||
49083385|NCT01130532|158141240|FG002|Period III (Weeks 0-12)|Adverse Event|2|||
49083386|NCT01130532|158141241|FG003|Period III (Weeks 0-12)|Adverse Event|0|||
49083387|NCT01130532|158141238|FG000|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
49083388|NCT01130532|158141239|FG001|Period III (Weeks 0-12)|Entry Criteria Not Met|2|||
49083389|NCT01130532|158141240|FG002|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
49083390|NCT01130532|158141241|FG003|Period III (Weeks 0-12)|Entry Criteria Not Met|0|||
49083391|NCT01130532|158141238|FG000|Period III (Weeks 0-12)|Lack of Efficacy|2|||
49083392|NCT01130532|158141239|FG001|Period III (Weeks 0-12)|Lack of Efficacy|0|||
49083393|NCT01130532|158141240|FG002|Period III (Weeks 0-12)|Lack of Efficacy|1|||
49083394|NCT01130532|158141241|FG003|Period III (Weeks 0-12)|Lack of Efficacy|0|||
49083395|NCT01130532|158141238|FG000|Period III (Weeks 0-12)|Lost to Follow-up|2|||
49083396|NCT01130532|158141239|FG001|Period III (Weeks 0-12)|Lost to Follow-up|2|||
49083397|NCT01130532|158141240|FG002|Period III (Weeks 0-12)|Lost to Follow-up|3|||
49083398|NCT01130532|158141241|FG003|Period III (Weeks 0-12)|Lost to Follow-up|0|||
49083399|NCT01130532|158141238|FG000|Period III (Weeks 0-12)|Protocol Violation|0|||
49083400|NCT01130532|158141239|FG001|Period III (Weeks 0-12)|Protocol Violation|0|||
49083401|NCT01130532|158141240|FG002|Period III (Weeks 0-12)|Protocol Violation|1|||
49083402|NCT01130532|158141241|FG003|Period III (Weeks 0-12)|Protocol Violation|0|||
49083403|NCT01130532|158141238|FG000|Period III (Weeks 0-12)|Sponsor Decision|3|||
49083404|NCT01130532|158141239|FG001|Period III (Weeks 0-12)|Sponsor Decision|4|||
49083405|NCT01130532|158141240|FG002|Period III (Weeks 0-12)|Sponsor Decision|2|||
49083406|NCT01130532|158141241|FG003|Period III (Weeks 0-12)|Sponsor Decision|0|||
49083407|NCT01130532|158141238|FG000|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
49083408|NCT01130532|158141239|FG001|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
49083409|NCT01130532|158141240|FG002|Period III (Weeks 0-12)|Withdrawal by Subject|6|||
49083410|NCT01130532|158141241|FG003|Period III (Weeks 0-12)|Withdrawal by Subject|0|||
49083411|NCT01130532|158141238|FG000|Period IV (Weeks 13-16)|Adverse Event|0|||
49083412|NCT01130532|158141239|FG001|Period IV (Weeks 13-16)|Adverse Event|0|||
49083413|NCT01130532|158141240|FG002|Period IV (Weeks 13-16)|Adverse Event|0|||
49083414|NCT01130532|158141241|FG003|Period IV (Weeks 13-16)|Adverse Event|1|||
49083415|NCT01130532|158141238|FG000|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
49083416|NCT01130532|158141239|FG001|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
49083417|NCT01130532|158141240|FG002|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
49083418|NCT01130532|158141241|FG003|Period IV (Weeks 13-16)|Entry Criteria Not Met|1|||
49083419|NCT01130532|158141238|FG000|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
49083420|NCT01130532|158141239|FG001|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
49083421|NCT01130532|158141240|FG002|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
49083422|NCT01130532|158141241|FG003|Period IV (Weeks 13-16)|Lost to Follow-up|5|||
49083423|NCT01130532|158141238|FG000|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
49083424|NCT01130532|158141239|FG001|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
49083425|NCT01130532|158141240|FG002|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
49083426|NCT01130532|158141241|FG003|Period IV (Weeks 13-16)|Withdrawal by Subject|3|||
49083427|NCT02847260|158141242|FG000|Overall Study|Adverse Event|3|||
49083428|NCT02847260|158141242|FG000|Overall Study|Withdrawal by Subject|2|||
49083429|NCT02847260|158141242|FG000|Overall Study|Clinical Deterioration|1|||
49083430|NCT02847260|158141242|FG000|Overall Study|Physician Decision|1|||
49083431|NCT00118157|158141250|FG000|Overall Study|Adverse Event|2|||
49083432|NCT00118157|158141250|FG000|Overall Study|Death|8|||
49083433|NCT00118157|158141250|FG000|Overall Study|Withdrawal by Subject|2|||
49083434|NCT01062425|158141251|FG000|Overall Study|Protocol Violation|3|||
49083435|NCT01062425|158141252|FG001|Overall Study|Protocol Violation|6|||
49083436|NCT01973439|158141253|FG000|Overall Study|Lost samples from one PK Day|2|||
49083437|NCT01973439|158141253|FG000|Overall Study|Vomiting after commencing once daily|1|||
49083438|NCT01973439|158141253|FG000|Overall Study|PK curve incomplete|2|||
49083439|NCT03347110|158141254|FG000|Overall Study|Other (Participant is incarcerated)|1|||
49083440|NCT03347110|158141254|FG000|Overall Study|Withdrawal by Subject|9|||
49083441|NCT03347110|158141254|FG000|Overall Study|Lost to Follow-up|1|||
49083442|NCT03347110|158141254|FG000|Overall Study|Lack of Efficacy|2|||
49083443|NCT03347110|158141254|FG000|Overall Study|Adverse Event, non-fatal|9|||
49083444|NCT02038010|158141255|FG000|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
49083445|NCT02038010|158141256|FG001|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1|||
49083446|NCT02038010|158141257|FG002|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
49083447|NCT02038010|158141258|FG003|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
49083448|NCT02038010|158141255|FG000|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1|||
49083449|NCT02038010|158141256|FG001|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
49083450|NCT02038010|158141257|FG002|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
49083451|NCT02038010|158141258|FG003|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
49083452|NCT02038010|158141255|FG000|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
49083453|NCT02038010|158141256|FG001|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1|||
49083454|NCT02038010|158141257|FG002|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
49083455|NCT02038010|158141258|FG003|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
49083456|NCT02038010|158141255|FG000|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
49083457|NCT02038010|158141256|FG001|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
49083458|NCT02038010|158141257|FG002|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
49083459|NCT02038010|158141258|FG003|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
49083460|NCT02038010|158141255|FG000|Follow Up|Death|4|||
49083461|NCT02038010|158141256|FG001|Follow Up|Death|3|||
49083462|NCT02038010|158141257|FG002|Follow Up|Death|0|||
49083463|NCT02038010|158141258|FG003|Follow Up|Death|0|||
49083464|NCT02038010|158141255|FG000|Follow Up|Other|3|||
49083465|NCT02038010|158141256|FG001|Follow Up|Other|0|||
49083466|NCT02038010|158141257|FG002|Follow Up|Other|0|||
49083467|NCT02038010|158141258|FG003|Follow Up|Other|0|||
49083468|NCT01998919|158141266|FG000|Overall Study|Death|2|||
49083469|NCT01998919|158141267|FG001|Overall Study|Death|2|||
49083470|NCT01998919|158141266|FG000|Overall Study|Adverse Event|0|||
49083471|NCT01998919|158141267|FG001|Overall Study|Adverse Event|5|||
49083472|NCT01998919|158141266|FG000|Overall Study|Disease progression|31|||
49083473|NCT01998919|158141267|FG001|Overall Study|Disease progression|22|||
49083474|NCT01998919|158141266|FG000|Overall Study|Withdrawal by Subject|2|||
49083475|NCT01998919|158141267|FG001|Overall Study|Withdrawal by Subject|4|||
49083476|NCT01998919|158141266|FG000|Overall Study|Lost to Follow-up|2|||
49083477|NCT01998919|158141267|FG001|Overall Study|Lost to Follow-up|0|||
49083478|NCT01998919|158141266|FG000|Overall Study|Other|5|||
49083479|NCT01998919|158141267|FG001|Overall Study|Other|2|||
49083480|NCT00116779|158141268|FG000|Overall Study|Adverse Event|4|||
49083481|NCT00116779|158141269|FG001|Overall Study|Adverse Event|2|||
49083482|NCT00116779|158141268|FG000|Overall Study|Protocol Violation|1|||
49083483|NCT00116779|158141269|FG001|Overall Study|Protocol Violation|4|||
49083484|NCT00116779|158141268|FG000|Overall Study|Withdrawal by Subject|4|||
49083485|NCT00116779|158141269|FG001|Overall Study|Withdrawal by Subject|1|||
49083486|NCT00116779|158141268|FG000|Overall Study|Inadequate testosterone suppression|7|||
49083487|NCT00116779|158141269|FG001|Overall Study|Inadequate testosterone suppression|9|||
49083488|NCT00116779|158141268|FG000|Overall Study|Physician Decision|3|||
49083489|NCT00116779|158141269|FG001|Overall Study|Physician Decision|1|||
49083490|NCT00116779|158141268|FG000|Overall Study|Elevated PSA levels|2|||
49083491|NCT00116779|158141269|FG001|Overall Study|Elevated PSA levels|2|||
49083492|NCT02105467|158141272|FG000|Period 1|Lost to Follow-up|1|||
49083493|NCT02105467|158141273|FG001|Period 1|Lost to Follow-up|0|||
49083494|NCT02105467|158141272|FG000|Period 1|Death|1|||
49083495|NCT02105467|158141273|FG001|Period 1|Death|0|||
49083496|NCT02105467|158141272|FG000|Period 2|Lost to Follow-up|1|||
49083497|NCT02105467|158141273|FG001|Period 2|Lost to Follow-up|0|||
49083498|NCT02105467|158141272|FG000|Period 2|Death|1|||
49083499|NCT02105467|158141273|FG001|Period 2|Death|0|||
49083500|NCT02105467|158141272|FG000|Period 2|Withdrawal by Subject|0|||
49083501|NCT02105467|158141273|FG001|Period 2|Withdrawal by Subject|2|||
49083502|NCT02105467|158141272|FG000|Period 3|Lost to Follow-up|0|||
49083503|NCT02105467|158141273|FG001|Period 3|Lost to Follow-up|1|||
49083504|NCT03270657|158141274|FG000|Overall Study|Withdrawal by Subject|1|||
49083505|NCT02383017|158141279|FG000|Overall Study|Injury Sustained Outside Study|1|||
49083506|NCT02383017|158141280|FG001|Overall Study|Injury Sustained Outside Study|0|||
49083507|NCT02383017|158141279|FG000|Overall Study|Compliance|3|||
49083508|NCT02383017|158141280|FG001|Overall Study|Compliance|2|||
49083509|NCT02383017|158141279|FG000|Overall Study|Found to be Hypogonadal|1|||
49083510|NCT02383017|158141280|FG001|Overall Study|Found to be Hypogonadal|0|||
49083511|NCT01037218|158141281|FG000|Overall Study|Adverse Event|4|||
49083512|NCT01037218|158141282|FG001|Overall Study|Adverse Event|2|||
49083513|NCT01037218|158141283|FG002|Overall Study|Adverse Event|2|||
49083514|NCT01037218|158141284|FG003|Overall Study|Adverse Event|1|||
49083515|NCT01037218|158141281|FG000|Overall Study|Lack of Efficacy|0|||
49083516|NCT01037218|158141282|FG001|Overall Study|Lack of Efficacy|2|||
49083517|NCT01037218|158141283|FG002|Overall Study|Lack of Efficacy|1|||
49083518|NCT01037218|158141284|FG003|Overall Study|Lack of Efficacy|5|||
49083519|NCT01037218|158141281|FG000|Overall Study|Lost to Follow-up|3|||
49083520|NCT01037218|158141282|FG001|Overall Study|Lost to Follow-up|5|||
49083521|NCT01037218|158141283|FG002|Overall Study|Lost to Follow-up|4|||
49083522|NCT01037218|158141284|FG003|Overall Study|Lost to Follow-up|2|||
49083523|NCT01037218|158141281|FG000|Overall Study|Withdrawal by Subject|6|||
49083524|NCT01037218|158141282|FG001|Overall Study|Withdrawal by Subject|7|||
49083525|NCT01037218|158141283|FG002|Overall Study|Withdrawal by Subject|7|||
49083526|NCT01037218|158141284|FG003|Overall Study|Withdrawal by Subject|4|||
49083527|NCT01037218|158141281|FG000|Overall Study|Partner Withdrew Consent|0|||
49083528|NCT01037218|158141282|FG001|Overall Study|Partner Withdrew Consent|3|||
49083529|NCT01037218|158141283|FG002|Overall Study|Partner Withdrew Consent|2|||
49083530|NCT01037218|158141284|FG003|Overall Study|Partner Withdrew Consent|1|||
49083531|NCT01037218|158141281|FG000|Overall Study|Protocol Violation|0|||
49083532|NCT01037218|158141282|FG001|Overall Study|Protocol Violation|0|||
49083533|NCT01037218|158141283|FG002|Overall Study|Protocol Violation|2|||
49083534|NCT01037218|158141284|FG003|Overall Study|Protocol Violation|2|||
49083535|NCT01037218|158141281|FG000|Overall Study|Various|3|||
49083536|NCT01037218|158141282|FG001|Overall Study|Various|2|||
49083537|NCT01037218|158141283|FG002|Overall Study|Various|3|||
49083538|NCT01037218|158141284|FG003|Overall Study|Various|1|||
49083539|NCT01321879|158141289|FG000|Overall Study|Lack of Efficacy|5|||
49083540|NCT01321879|158141289|FG000|Overall Study|Adverse Event|5|||
49083541|NCT01321879|158141289|FG000|Overall Study|Death|3|||
49083542|NCT01321879|158141289|FG000|Overall Study|Withdrawal by Subject|1|||
49083543|NCT00897715|158141290|FG000|Overall Study|Lost to Follow-up|0|||
49083544|NCT00897715|158141291|FG001|Overall Study|Lost to Follow-up|1|||
49083545|NCT00897715|158141290|FG000|Overall Study|Physician Decision|1|||
49083546|NCT00897715|158141291|FG001|Overall Study|Physician Decision|0|||
49083547|NCT00897715|158141290|FG000|Overall Study|increased risk of infection|1|||
49083548|NCT00897715|158141291|FG001|Overall Study|increased risk of infection|0|||
49083549|NCT00958828|158141292|FG000|Period 1, 1 Week of Wear|Randomization break|0|||
49083550|NCT00958828|158141293|FG001|Period 1, 1 Week of Wear|Randomization break|1|||
49083551|NCT00958828|158141292|FG000|Period 2, 1 Week of Wear|Unacceptable lens fit|0|||
49083552|NCT00958828|158141293|FG001|Period 2, 1 Week of Wear|Unacceptable lens fit|1|||
49083553|NCT00468819|158141297|FG000|Overall Study|Withdrawal by Subject|4|||
49083554|NCT00468819|158141298|FG001|Overall Study|Withdrawal by Subject|0|||
49083555|NCT00468819|158141299|FG002|Overall Study|Withdrawal by Subject|1|||
49083556|NCT00468819|158141297|FG000|Overall Study|Lost to Follow-up|0|||
49083557|NCT00468819|158141298|FG001|Overall Study|Lost to Follow-up|0|||
49083558|NCT00468819|158141299|FG002|Overall Study|Lost to Follow-up|1|||
49083559|NCT00468819|158141297|FG000|Overall Study|Drop-outs (Treatment never received)|2|||
49083560|NCT00468819|158141298|FG001|Overall Study|Drop-outs (Treatment never received)|0|||
49083561|NCT00468819|158141299|FG002|Overall Study|Drop-outs (Treatment never received)|0|||
49083562|NCT03472014|158141300|FG000|Overall Study|Lost to Follow-up|4|||
49083563|NCT02075203|158141303|FG000|Overall Study|Withdrawal by Subject|1|||
49083564|NCT02075203|158141304|FG001|Overall Study|Withdrawal by Subject|0|||
49083565|NCT02075203|158141305|FG002|Overall Study|Withdrawal by Subject|1|||
49083566|NCT02075203|158141303|FG000|Overall Study|Adverse Event|1|||
49083567|NCT02075203|158141304|FG001|Overall Study|Adverse Event|0|||
49083568|NCT02075203|158141305|FG002|Overall Study|Adverse Event|0|||
49083569|NCT02075203|158141303|FG000|Overall Study|participant refused to use contraception|1|||
49083570|NCT02075203|158141304|FG001|Overall Study|participant refused to use contraception|0|||
49083571|NCT02075203|158141305|FG002|Overall Study|participant refused to use contraception|0|||
49083572|NCT03620708|158141308|FG000|Overall Study|Lost to Follow-up|1|||
49083573|NCT03620708|158141309|FG001|Overall Study|Lost to Follow-up|1|||
49083574|NCT03620708|158141310|FG002|Overall Study|Lost to Follow-up|2|||
49083575|NCT03620708|158141308|FG000|Overall Study|Withdrawal by Subject|0|||
49083576|NCT03620708|158141309|FG001|Overall Study|Withdrawal by Subject|0|||
49083577|NCT03620708|158141310|FG002|Overall Study|Withdrawal by Subject|1|||
49083578|NCT01269918|158141311|FG000|Overall Study|Did not receive study drug|0|||
49083579|NCT01269918|158141312|FG001|Overall Study|Did not receive study drug|3|||
49083580|NCT00666328|158141316|FG000|Overall Study|Death|2|||
49083581|NCT00666328|158141316|FG000|Overall Study|Lost to Follow-up|2|||
49083582|NCT00666328|158141316|FG000|Overall Study|No longer met eligibility criteria|1|||
49083583|NCT03866577|158141317|FG000|Overall Study|Protocol Violation|0|||
49083584|NCT03866577|158141318|FG001|Overall Study|Protocol Violation|0|||
49083585|NCT03866577|158141319|FG002|Overall Study|Protocol Violation|0|||
49083586|NCT03866577|158141320|FG003|Overall Study|Protocol Violation|0|||
49083587|NCT03866577|158141321|FG004|Overall Study|Protocol Violation|0|||
49083588|NCT03866577|158141322|FG005|Overall Study|Protocol Violation|0|||
49083589|NCT03866577|158141323|FG006|Overall Study|Protocol Violation|0|||
49083590|NCT03866577|158141324|FG007|Overall Study|Protocol Violation|0|||
49083591|NCT03866577|158141325|FG008|Overall Study|Protocol Violation|0|||
49083592|NCT03866577|158141326|FG009|Overall Study|Protocol Violation|0|||
49083593|NCT03866577|158141327|FG010|Overall Study|Protocol Violation|0|||
49083594|NCT03866577|158141328|FG011|Overall Study|Protocol Violation|1|||
49083595|NCT03866577|158141329|FG012|Overall Study|Protocol Violation|0|||
49083596|NCT03866577|158141317|FG000|Overall Study|Withdrawal by Subject|0|||
49083597|NCT03866577|158141318|FG001|Overall Study|Withdrawal by Subject|0|||
49083598|NCT03866577|158141319|FG002|Overall Study|Withdrawal by Subject|0|||
49083599|NCT03866577|158141320|FG003|Overall Study|Withdrawal by Subject|0|||
49083600|NCT03866577|158141321|FG004|Overall Study|Withdrawal by Subject|0|||
49083601|NCT03866577|158141322|FG005|Overall Study|Withdrawal by Subject|0|||
49083602|NCT03866577|158141323|FG006|Overall Study|Withdrawal by Subject|0|||
49083603|NCT03866577|158141324|FG007|Overall Study|Withdrawal by Subject|0|||
49083604|NCT03866577|158141325|FG008|Overall Study|Withdrawal by Subject|1|||
49083605|NCT03866577|158141326|FG009|Overall Study|Withdrawal by Subject|1|||
49083606|NCT03866577|158141327|FG010|Overall Study|Withdrawal by Subject|0|||
49083607|NCT03866577|158141328|FG011|Overall Study|Withdrawal by Subject|0|||
49083608|NCT03866577|158141329|FG012|Overall Study|Withdrawal by Subject|0|||
49083609|NCT03866577|158141317|FG000|Overall Study|Not qualified for IVIg infusion|0|||
49083610|NCT03866577|158141318|FG001|Overall Study|Not qualified for IVIg infusion|0|||
49083611|NCT03866577|158141319|FG002|Overall Study|Not qualified for IVIg infusion|0|||
49083612|NCT03866577|158141320|FG003|Overall Study|Not qualified for IVIg infusion|0|||
49083613|NCT03866577|158141321|FG004|Overall Study|Not qualified for IVIg infusion|0|||
49083614|NCT03866577|158141322|FG005|Overall Study|Not qualified for IVIg infusion|0|||
49083615|NCT03866577|158141323|FG006|Overall Study|Not qualified for IVIg infusion|0|||
49083616|NCT03866577|158141324|FG007|Overall Study|Not qualified for IVIg infusion|0|||
49083617|NCT03866577|158141325|FG008|Overall Study|Not qualified for IVIg infusion|0|||
49083618|NCT03866577|158141326|FG009|Overall Study|Not qualified for IVIg infusion|1|||
49083619|NCT03866577|158141327|FG010|Overall Study|Not qualified for IVIg infusion|0|||
49083620|NCT03866577|158141328|FG011|Overall Study|Not qualified for IVIg infusion|0|||
49083621|NCT03866577|158141329|FG012|Overall Study|Not qualified for IVIg infusion|0|||
49083622|NCT03380429|158141331|FG000|Overall Study|Physician Decision|0|||
49083623|NCT03380429|158141332|FG001|Overall Study|Physician Decision|1|||
49083624|NCT03380429|158141333|FG002|Overall Study|Physician Decision|0|||
49083625|NCT03380429|158141334|FG003|Overall Study|Physician Decision|1|||
49083626|NCT03380429|158141335|FG004|Overall Study|Physician Decision|1|||
49083627|NCT03380429|158141331|FG000|Overall Study|Withdrawal by Subject|3|||
49083628|NCT03380429|158141332|FG001|Overall Study|Withdrawal by Subject|3|||
49083629|NCT03380429|158141333|FG002|Overall Study|Withdrawal by Subject|5|||
49083630|NCT03380429|158141334|FG003|Overall Study|Withdrawal by Subject|2|||
49083631|NCT03380429|158141335|FG004|Overall Study|Withdrawal by Subject|1|||
49083632|NCT03380429|158141331|FG000|Overall Study|Lost to Follow-up|0|||
49083633|NCT03380429|158141332|FG001|Overall Study|Lost to Follow-up|2|||
49083634|NCT03380429|158141333|FG002|Overall Study|Lost to Follow-up|4|||
49083635|NCT03380429|158141334|FG003|Overall Study|Lost to Follow-up|3|||
49083636|NCT03380429|158141335|FG004|Overall Study|Lost to Follow-up|1|||
49083637|NCT03380429|158141331|FG000|Overall Study|Protocol Violation|1|||
49083638|NCT03380429|158141332|FG001|Overall Study|Protocol Violation|0|||
49083639|NCT03380429|158141333|FG002|Overall Study|Protocol Violation|1|||
49083640|NCT03380429|158141334|FG003|Overall Study|Protocol Violation|0|||
49083641|NCT03380429|158141335|FG004|Overall Study|Protocol Violation|1|||
49083642|NCT03380429|158141331|FG000|Overall Study|Lack of Efficacy|0|||
49083643|NCT03380429|158141332|FG001|Overall Study|Lack of Efficacy|0|||
49083644|NCT03380429|158141333|FG002|Overall Study|Lack of Efficacy|0|||
49083645|NCT03380429|158141334|FG003|Overall Study|Lack of Efficacy|2|||
49083646|NCT03380429|158141335|FG004|Overall Study|Lack of Efficacy|1|||
49083647|NCT03380429|158141331|FG000|Overall Study|Adverse Event|1|||
49083648|NCT03380429|158141332|FG001|Overall Study|Adverse Event|1|||
49083649|NCT03380429|158141333|FG002|Overall Study|Adverse Event|1|||
49083650|NCT03380429|158141334|FG003|Overall Study|Adverse Event|2|||
49083651|NCT03380429|158141335|FG004|Overall Study|Adverse Event|0|||
49083652|NCT01000155|158141338|FG000|Overall Study|Withdrawal by Subject|1|||
49083653|NCT01000155|158141338|FG000|Overall Study|Adverse Event|1|||
49083654|NCT01215136|158141339|FG000|Overall Study|Adverse Event|2|||
49083655|NCT01215136|158141340|FG001|Overall Study|Adverse Event|9|||
49083656|NCT01215136|158141339|FG000|Overall Study|Disease Progression|3|||
49083657|NCT01215136|158141340|FG001|Overall Study|Disease Progression|14|||
49083658|NCT01215136|158141339|FG000|Overall Study|Symptomatic Deterioration|1|||
49083659|NCT01215136|158141340|FG001|Overall Study|Symptomatic Deterioration|1|||
49083660|NCT01215136|158141339|FG000|Overall Study|Death|0|||
49083661|NCT01215136|158141340|FG001|Overall Study|Death|2|||
49083662|NCT01215136|158141339|FG000|Overall Study|Withdrawal by Subject|0|||
49083663|NCT01215136|158141340|FG001|Overall Study|Withdrawal by Subject|1|||
49083664|NCT03164551|158141345|FG000|Overall Study|Imaging discontinued prior completion|8|||
49083665|NCT03164551|158141346|FG001|Overall Study|Imaging discontinued prior completion|0|||
49083666|NCT03164551|158141345|FG000|Overall Study|Participant was non-compliant|1|||
49083667|NCT03164551|158141346|FG001|Overall Study|Participant was non-compliant|0|||
49083668|NCT03164551|158141345|FG000|Overall Study|Cancellation of Fresh Embryo Transfer|12|||
49083669|NCT03164551|158141346|FG001|Overall Study|Cancellation of Fresh Embryo Transfer|14|||
49083670|NCT03164551|158141345|FG000|Overall Study|Other|8|||
49083671|NCT03164551|158141346|FG001|Overall Study|Other|2|||
49083672|NCT01515423|158141347|FG000|Open Label Phase|Adverse Event|57|||
49083673|NCT01515423|158141348|FG001|Open Label Phase|Adverse Event|0|||
49083674|NCT01515423|158141349|FG002|Open Label Phase|Adverse Event|0|||
49083675|NCT01515423|158141347|FG000|Open Label Phase|Death|2|||
49083676|NCT01515423|158141348|FG001|Open Label Phase|Death|0|||
49083677|NCT01515423|158141349|FG002|Open Label Phase|Death|0|||
49083678|NCT01515423|158141347|FG000|Open Label Phase|Lack of Efficacy|117|||
49083679|NCT01515423|158141348|FG001|Open Label Phase|Lack of Efficacy|0|||
49083680|NCT01515423|158141349|FG002|Open Label Phase|Lack of Efficacy|0|||
49083681|NCT01515423|158141347|FG000|Open Label Phase|Lost to Follow-up|21|||
49083682|NCT01515423|158141348|FG001|Open Label Phase|Lost to Follow-up|0|||
49083683|NCT01515423|158141349|FG002|Open Label Phase|Lost to Follow-up|0|||
49083684|NCT01515423|158141347|FG000|Open Label Phase|Withdrawal by Subject|118|||
49083685|NCT01515423|158141348|FG001|Open Label Phase|Withdrawal by Subject|0|||
49083686|NCT01515423|158141349|FG002|Open Label Phase|Withdrawal by Subject|0|||
49083687|NCT01515423|158141347|FG000|Open Label Phase|excluded from DB Phase|70|||
49083688|NCT01515423|158141348|FG001|Open Label Phase|excluded from DB Phase|0|||
49083689|NCT01515423|158141349|FG002|Open Label Phase|excluded from DB Phase|0|||
49083690|NCT01515423|158141347|FG000|Open Label Phase|Other|28|||
49083691|NCT01515423|158141348|FG001|Open Label Phase|Other|0|||
49083692|NCT01515423|158141349|FG002|Open Label Phase|Other|0|||
49083693|NCT01515423|158141347|FG000|DOUBLE BLIND|Adverse Event|0|||
49083694|NCT01515423|158141348|FG001|DOUBLE BLIND|Adverse Event|15|||
49083695|NCT01515423|158141349|FG002|DOUBLE BLIND|Adverse Event|13|||
49083696|NCT01515423|158141347|FG000|DOUBLE BLIND|Death|0|||
49083697|NCT01515423|158141348|FG001|DOUBLE BLIND|Death|1|||
49083698|NCT01515423|158141349|FG002|DOUBLE BLIND|Death|2|||
49083699|NCT01515423|158141347|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
49083700|NCT01515423|158141348|FG001|DOUBLE BLIND|Lost to Follow-up|7|||
49083701|NCT01515423|158141349|FG002|DOUBLE BLIND|Lost to Follow-up|12|||
49083702|NCT01515423|158141347|FG000|DOUBLE BLIND|Pregnancy|0|||
49083703|NCT01515423|158141348|FG001|DOUBLE BLIND|Pregnancy|2|||
49083704|NCT01515423|158141349|FG002|DOUBLE BLIND|Pregnancy|0|||
49083705|NCT01515423|158141347|FG000|DOUBLE BLIND|Withdrawal by Subject|0|||
49083706|NCT01515423|158141348|FG001|DOUBLE BLIND|Withdrawal by Subject|50|||
49083707|NCT01515423|158141349|FG002|DOUBLE BLIND|Withdrawal by Subject|53|||
49083708|NCT01515423|158141347|FG000|DOUBLE BLIND|Other|0|||
49083709|NCT01515423|158141348|FG001|DOUBLE BLIND|Other|6|||
49083710|NCT01515423|158141349|FG002|DOUBLE BLIND|Other|12|||
49083711|NCT01515423|158141347|FG000|DOUBLE BLIND|Blind broken by investigator|0|||
49083712|NCT01515423|158141348|FG001|DOUBLE BLIND|Blind broken by investigator|1|||
49083713|NCT01515423|158141349|FG002|DOUBLE BLIND|Blind broken by investigator|0|||
49083714|NCT01707290|158141360|FG000|Overall Study|Adverse event (AE)|1|||
49083715|NCT01707290|158141361|FG001|Overall Study|Adverse event (AE)|0|||
49083716|NCT01707290|158141360|FG000|Overall Study|Physician Decision|1|||
49083717|NCT01707290|158141361|FG001|Overall Study|Physician Decision|0|||
49083718|NCT01707290|158141360|FG000|Overall Study|Lost to Follow-up|3|||
49083719|NCT01707290|158141361|FG001|Overall Study|Lost to Follow-up|0|||
49083720|NCT01707290|158141360|FG000|Overall Study|Withdrawal of Consent (Not Due to AE)|4|||
49083721|NCT01707290|158141361|FG001|Overall Study|Withdrawal of Consent (Not Due to AE)|0|||
49083722|NCT01707290|158141360|FG000|Overall Study|Commercial drug available|60|||
49083723|NCT01707290|158141361|FG001|Overall Study|Commercial drug available|1|||
49083724|NCT01707290|158141360|FG000|Overall Study|Other unspecified|17|||
49083725|NCT01707290|158141361|FG001|Overall Study|Other unspecified|0|||
49083726|NCT02174627|158141368|FG000|Overall Study|Missing|0|||
49083727|NCT02174627|158141369|FG001|Overall Study|Missing|1|||
49083728|NCT02174627|158141368|FG000|Overall Study|Incorrect enrolment before randomization|0|||
49083729|NCT02174627|158141369|FG001|Overall Study|Incorrect enrolment before randomization|1|||
49083730|NCT02174627|158141368|FG000|Overall Study|Participant decision|84|||
49083731|NCT02174627|158141369|FG001|Overall Study|Participant decision|128|||
49083732|NCT01924689|158141370|FG000|Overall Study|Death|0|||
49083733|NCT01924689|158141371|FG001|Overall Study|Death|1|||
49083734|NCT01924689|158141372|FG002|Overall Study|Death|0|||
49083735|NCT01924689|158141373|FG003|Overall Study|Death|1|||
49083736|NCT01924689|158141374|FG004|Overall Study|Death|0|||
49083737|NCT01924689|158141375|FG005|Overall Study|Death|0|||
49083738|NCT01924689|158141370|FG000|Overall Study|Disease progression|0|||
49083739|NCT01924689|158141371|FG001|Overall Study|Disease progression|0|||
49083740|NCT01924689|158141372|FG002|Overall Study|Disease progression|2|||
49083741|NCT01924689|158141373|FG003|Overall Study|Disease progression|0|||
49083742|NCT01924689|158141374|FG004|Overall Study|Disease progression|3|||
49083743|NCT01924689|158141375|FG005|Overall Study|Disease progression|2|||
49083744|NCT01924689|158141370|FG000|Overall Study|New therapy or study|3|||
49083745|NCT01924689|158141371|FG001|Overall Study|New therapy or study|2|||
49083746|NCT01924689|158141372|FG002|Overall Study|New therapy or study|1|||
49083747|NCT01924689|158141373|FG003|Overall Study|New therapy or study|4|||
49083748|NCT01924689|158141374|FG004|Overall Study|New therapy or study|2|||
49083749|NCT01924689|158141375|FG005|Overall Study|New therapy or study|0|||
49083750|NCT01924689|158141370|FG000|Overall Study|Withdrawal of consent|0|||
49083751|NCT01924689|158141371|FG001|Overall Study|Withdrawal of consent|0|||
49083752|NCT01924689|158141372|FG002|Overall Study|Withdrawal of consent|1|||
49083753|NCT01924689|158141373|FG003|Overall Study|Withdrawal of consent|1|||
49083754|NCT01924689|158141374|FG004|Overall Study|Withdrawal of consent|0|||
49083755|NCT01924689|158141375|FG005|Overall Study|Withdrawal of consent|0|||
49083756|NCT01924689|158141370|FG000|Overall Study|Other|0|||
49083757|NCT01924689|158141371|FG001|Overall Study|Other|0|||
49083758|NCT01924689|158141372|FG002|Overall Study|Other|0|||
49083759|NCT01924689|158141373|FG003|Overall Study|Other|0|||
49083760|NCT01924689|158141374|FG004|Overall Study|Other|1|||
49083761|NCT01924689|158141375|FG005|Overall Study|Other|0|||
49083762|NCT04495829|158141379|FG000|Overall Study|Lost to Follow-up|2|||
49083763|NCT04495829|158141379|FG000|Overall Study|Inclusion criterion not met|3|||
49083764|NCT02654054|158141383|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
49083765|NCT02654054|158141384|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
49083766|NCT02654054|158141385|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
49083767|NCT02654054|158141383|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
49083768|NCT02654054|158141384|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
49083769|NCT02654054|158141385|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
49083770|NCT02654054|158141383|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
49083771|NCT02654054|158141384|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
49083772|NCT02654054|158141385|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
49083773|NCT02654054|158141383|FG000|Post-Treatment Follow-Up Period|Other|1|||
49083774|NCT02654054|158141384|FG001|Post-Treatment Follow-Up Period|Other|0|||
49083775|NCT02654054|158141385|FG002|Post-Treatment Follow-Up Period|Other|4|||
49083776|NCT02654054|158141383|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
49083777|NCT02654054|158141384|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
49083778|NCT02654054|158141385|FG002|Post-Treatment Follow-Up Period|Non-Compliance|4|||
49083779|NCT01777282|158141386|FG000|Overall Study|Persistent Hyperglycemia|0|||
49083780|NCT01777282|158141387|FG001|Overall Study|Persistent Hyperglycemia|0|||
49083781|NCT01777282|158141388|FG002|Overall Study|Persistent Hyperglycemia|1|||
49083782|NCT01777282|158141389|FG003|Overall Study|Persistent Hyperglycemia|0|||
49083783|NCT01777282|158141390|FG004|Overall Study|Persistent Hyperglycemia|0|||
49083784|NCT01777282|158141386|FG000|Overall Study|New Antidiabetic Medication|0|||
49083785|NCT01777282|158141387|FG001|Overall Study|New Antidiabetic Medication|0|||
49083786|NCT01777282|158141388|FG002|Overall Study|New Antidiabetic Medication|1|||
49083787|NCT01777282|158141389|FG003|Overall Study|New Antidiabetic Medication|0|||
49083788|NCT01777282|158141390|FG004|Overall Study|New Antidiabetic Medication|0|||
49083789|NCT01777282|158141386|FG000|Overall Study|Adverse Event|4|||
49083790|NCT01777282|158141387|FG001|Overall Study|Adverse Event|4|||
49083791|NCT01777282|158141388|FG002|Overall Study|Adverse Event|2|||
49083792|NCT01777282|158141389|FG003|Overall Study|Adverse Event|1|||
49083793|NCT01777282|158141390|FG004|Overall Study|Adverse Event|3|||
49083794|NCT01777282|158141386|FG000|Overall Study|Withdrawal by Subject|4|||
49083795|NCT01777282|158141387|FG001|Overall Study|Withdrawal by Subject|0|||
49083796|NCT01777282|158141388|FG002|Overall Study|Withdrawal by Subject|0|||
49083797|NCT01777282|158141389|FG003|Overall Study|Withdrawal by Subject|1|||
49083798|NCT01777282|158141390|FG004|Overall Study|Withdrawal by Subject|2|||
49083799|NCT01777282|158141386|FG000|Overall Study|Protocol Violation|2|||
49083800|NCT01777282|158141387|FG001|Overall Study|Protocol Violation|0|||
49083801|NCT01777282|158141388|FG002|Overall Study|Protocol Violation|1|||
49083802|NCT01777282|158141389|FG003|Overall Study|Protocol Violation|0|||
49083803|NCT01777282|158141390|FG004|Overall Study|Protocol Violation|2|||
49083804|NCT01777282|158141386|FG000|Overall Study|Moved, transfer abroad, did not enter FU|1|||
49083805|NCT01777282|158141387|FG001|Overall Study|Moved, transfer abroad, did not enter FU|0|||
49083806|NCT01777282|158141388|FG002|Overall Study|Moved, transfer abroad, did not enter FU|1|||
49083807|NCT01777282|158141389|FG003|Overall Study|Moved, transfer abroad, did not enter FU|0|||
49083808|NCT01777282|158141390|FG004|Overall Study|Moved, transfer abroad, did not enter FU|0|||
49083809|NCT00359424|158141391|FG000|Overall Study|Death|99|||
49083810|NCT00359424|158141392|FG001|Overall Study|Death|58|||
49083811|NCT00359424|158141391|FG000|Overall Study|Lost to Follow-up|19|||
49083812|NCT00359424|158141392|FG001|Overall Study|Lost to Follow-up|7|||
49083813|NCT00359424|158141391|FG000|Overall Study|Withdrawal by Subject|10|||
49083814|NCT00359424|158141392|FG001|Overall Study|Withdrawal by Subject|2|||
49083815|NCT00359424|158141391|FG000|Overall Study|follow up not conducted|2|||
49083816|NCT00359424|158141392|FG001|Overall Study|follow up not conducted|0|||
49083817|NCT02568189|158141397|FG000|Overall Study|Protocol Violation|0|||
49083818|NCT02568189|158141398|FG001|Overall Study|Protocol Violation|0|||
49083819|NCT02568189|158141399|FG002|Overall Study|Protocol Violation|19|||
49083820|NCT02568189|158141400|FG003|Overall Study|Protocol Violation|18|||
49083821|NCT03631706|158141401|FG000|Overall Study|Randomized, not treated|1|||
49083822|NCT03631706|158141402|FG001|Overall Study|Randomized, not treated|0|||
49083823|NCT03631706|158141401|FG000|Overall Study|Treatment ongoing|26|||
49083824|NCT03631706|158141402|FG001|Overall Study|Treatment ongoing|57|||
49083825|NCT03631706|158141401|FG000|Overall Study|Off treatment (Treatment completed and discontinued) and in follow up)|65|||
49083826|NCT03631706|158141402|FG001|Overall Study|Off treatment (Treatment completed and discontinued) and in follow up)|41|||
49083827|NCT02115269|158143739|FG000|Overall Study|Lost to Follow-up|43|||
49083828|NCT02115269|158143739|FG000|Overall Study|Did not complete patient diary|3|||
49083829|NCT02115269|158143739|FG000|Overall Study|Moved to another city|7|||
49083830|NCT02115269|158143739|FG000|Overall Study|Withdrawal by Subject|2|||
49083831|NCT02115269|158143739|FG000|Overall Study|Didn't take study drug|2|||
49083832|NCT00711243|158143740|FG000|Registed and Started Treatment|Withdrawal by Subject|0|||
49083833|NCT00711243|158143741|FG001|Registed and Started Treatment|Withdrawal by Subject|0|||
49083834|NCT00711243|158143742|FG002|Registed and Started Treatment|Withdrawal by Subject|0|||
49083835|NCT00711243|158143743|FG003|Registed and Started Treatment|Withdrawal by Subject|0|||
49083836|NCT00711243|158143744|FG004|Registed and Started Treatment|Withdrawal by Subject|0|||
49083837|NCT00711243|158143745|FG005|Registed and Started Treatment|Withdrawal by Subject|1|||
49083838|NCT00711243|158143740|FG000|Reached First Response/4 Cycles|Death|0|||
49083839|NCT00711243|158143741|FG001|Reached First Response/4 Cycles|Death|0|||
49083840|NCT00711243|158143742|FG002|Reached First Response/4 Cycles|Death|0|||
49083841|NCT00711243|158143743|FG003|Reached First Response/4 Cycles|Death|0|||
49083842|NCT00711243|158143744|FG004|Reached First Response/4 Cycles|Death|0|||
49083843|NCT00711243|158143745|FG005|Reached First Response/4 Cycles|Death|2|||
49083844|NCT00711243|158143740|FG000|Reached First Response/4 Cycles|Progressive disease|0|||
49083845|NCT00711243|158143741|FG001|Reached First Response/4 Cycles|Progressive disease|0|||
49083846|NCT00711243|158143742|FG002|Reached First Response/4 Cycles|Progressive disease|0|||
49083847|NCT00711243|158143743|FG003|Reached First Response/4 Cycles|Progressive disease|1|||
49083848|NCT00711243|158143744|FG004|Reached First Response/4 Cycles|Progressive disease|0|||
49083849|NCT00711243|158143745|FG005|Reached First Response/4 Cycles|Progressive disease|0|||
49083850|NCT00711243|158143740|FG000|Treated Cycle 5 After First Response|Progressive disease|1|||
49083851|NCT00711243|158143741|FG001|Treated Cycle 5 After First Response|Progressive disease|2|||
49083852|NCT00711243|158143742|FG002|Treated Cycle 5 After First Response|Progressive disease|0|||
49083853|NCT00711243|158143743|FG003|Treated Cycle 5 After First Response|Progressive disease|0|||
49083854|NCT00711243|158143744|FG004|Treated Cycle 5 After First Response|Progressive disease|1|||
49083855|NCT00711243|158143745|FG005|Treated Cycle 5 After First Response|Progressive disease|1|||
49083856|NCT00711243|158143740|FG000|Treated Cycle 5 After First Response|Death|0|||
49083857|NCT00711243|158143741|FG001|Treated Cycle 5 After First Response|Death|0|||
49083858|NCT00711243|158143742|FG002|Treated Cycle 5 After First Response|Death|0|||
49083859|NCT00711243|158143743|FG003|Treated Cycle 5 After First Response|Death|0|||
49083860|NCT00711243|158143744|FG004|Treated Cycle 5 After First Response|Death|0|||
49083861|NCT00711243|158143745|FG005|Treated Cycle 5 After First Response|Death|2|||
49083862|NCT00711243|158143740|FG000|Treated Cycle 5 After First Response|Decline in performance status|0|||
49083863|NCT00711243|158143741|FG001|Treated Cycle 5 After First Response|Decline in performance status|0|||
49083864|NCT00711243|158143742|FG002|Treated Cycle 5 After First Response|Decline in performance status|0|||
49083865|NCT00711243|158143743|FG003|Treated Cycle 5 After First Response|Decline in performance status|0|||
49083866|NCT00711243|158143744|FG004|Treated Cycle 5 After First Response|Decline in performance status|0|||
49083867|NCT00711243|158143745|FG005|Treated Cycle 5 After First Response|Decline in performance status|1|||
49083868|NCT00711243|158143740|FG000|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
49083869|NCT00711243|158143741|FG001|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
49083870|NCT00711243|158143742|FG002|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
49083871|NCT00711243|158143743|FG003|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
49083872|NCT00711243|158143744|FG004|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
49083873|NCT00711243|158143745|FG005|Follow up Every 3 Months Until Death|Lost to Follow-up|2|||
49083874|NCT00886015|158143747|FG000|Overall Study|Death|0|||
49083875|NCT00886015|158143748|FG001|Overall Study|Death|2|||
49083876|NCT00075816|158143749|FG000|Overall Study|Did not undergo transplantation|14|||
49083877|NCT00075816|158143750|FG001|Overall Study|Did not undergo transplantation|11|||
49083878|NCT00696423|158143751|FG000|Overall Study|Lost to Follow-up|0|||
49083879|NCT00696423|158143752|FG001|Overall Study|Lost to Follow-up|5|||
49083880|NCT03511105|158143753|FG000|Overall Study|Adverse Event|1|||
49083881|NCT03511105|158143754|FG001|Overall Study|Adverse Event|0|||
49083882|NCT03511105|158143753|FG000|Overall Study|Withdrew consent|1|||
49083883|NCT03511105|158143754|FG001|Overall Study|Withdrew consent|0|||
49083884|NCT01823328|158143755|FG000|Overall Study|Withdrawal by Subject|8|||
49083885|NCT01823328|158143756|FG001|Overall Study|Withdrawal by Subject|6|||
49083886|NCT02013817|158143757|FG000|Overall Study|Adverse Event|12|||
49083887|NCT02013817|158143757|FG000|Overall Study|Withdrawal by Subject|4|||
49083888|NCT02013817|158143757|FG000|Overall Study|Death|2|||
49083889|NCT02013817|158143757|FG000|Overall Study|Other|9|||
49083890|NCT01977417|158143758|FG000|Overall Study|Adverse Event|1|||
49083891|NCT01977417|158143759|FG001|Overall Study|Adverse Event|0|||
49083892|NCT01977417|158143758|FG000|Overall Study|Withdrawal by Subject|2|||
49083893|NCT01977417|158143759|FG001|Overall Study|Withdrawal by Subject|4|||
49083894|NCT01977417|158143758|FG000|Overall Study|Female enrollment goal met|0|||
49083895|NCT01977417|158143759|FG001|Overall Study|Female enrollment goal met|2|||
49083896|NCT02676882|158143761|FG000|Overall Study|Adverse Event|1|||
49083897|NCT02676882|158143762|FG001|Overall Study|Adverse Event|0|||
49083898|NCT02676882|158143761|FG000|Overall Study|Lost to Follow-up|1|||
49083899|NCT02676882|158143762|FG001|Overall Study|Lost to Follow-up|0|||
49083900|NCT02676882|158143761|FG000|Overall Study|Withdrawal by Subject|1|||
49083901|NCT02676882|158143762|FG001|Overall Study|Withdrawal by Subject|2|||
49083902|NCT01068860|158143766|FG000|Overall Study|Withdrawal by Subject|0|||
49083903|NCT01068860|158143767|FG001|Overall Study|Withdrawal by Subject|0|||
49083904|NCT01068860|158143768|FG002|Overall Study|Withdrawal by Subject|0|||
49083905|NCT01068860|158143769|FG003|Overall Study|Withdrawal by Subject|0|||
49083906|NCT01068860|158143770|FG004|Overall Study|Withdrawal by Subject|0|||
49083907|NCT01068860|158143771|FG005|Overall Study|Withdrawal by Subject|2|||
49083908|NCT01068860|158143772|FG006|Overall Study|Withdrawal by Subject|0|||
49083909|NCT01068860|158143773|FG007|Overall Study|Withdrawal by Subject|0|||
49083910|NCT01068860|158143774|FG008|Overall Study|Withdrawal by Subject|0|||
49083911|NCT01068860|158143775|FG009|Overall Study|Withdrawal by Subject|3|||
49083912|NCT01068860|158143766|FG000|Overall Study|Administrative problems; misrandomized|0|||
49083913|NCT01068860|158143767|FG001|Overall Study|Administrative problems; misrandomized|0|||
49083914|NCT01068860|158143768|FG002|Overall Study|Administrative problems; misrandomized|0|||
49083915|NCT01068860|158143769|FG003|Overall Study|Administrative problems; misrandomized|1|||
49083916|NCT01068860|158143770|FG004|Overall Study|Administrative problems; misrandomized|0|||
49083917|NCT01068860|158143771|FG005|Overall Study|Administrative problems; misrandomized|0|||
49083918|NCT01068860|158143772|FG006|Overall Study|Administrative problems; misrandomized|0|||
49083919|NCT01068860|158143773|FG007|Overall Study|Administrative problems; misrandomized|0|||
49083920|NCT01068860|158143774|FG008|Overall Study|Administrative problems; misrandomized|0|||
49083921|NCT01068860|158143775|FG009|Overall Study|Administrative problems; misrandomized|1|||
49083922|NCT01068860|158143766|FG000|Overall Study|Lost to Follow-up|0|||
49083923|NCT01068860|158143767|FG001|Overall Study|Lost to Follow-up|1|||
49083924|NCT01068860|158143768|FG002|Overall Study|Lost to Follow-up|0|||
49083925|NCT01068860|158143769|FG003|Overall Study|Lost to Follow-up|0|||
49083926|NCT01068860|158143770|FG004|Overall Study|Lost to Follow-up|0|||
49083927|NCT01068860|158143771|FG005|Overall Study|Lost to Follow-up|0|||
49083928|NCT01068860|158143772|FG006|Overall Study|Lost to Follow-up|0|||
49083929|NCT01068860|158143773|FG007|Overall Study|Lost to Follow-up|0|||
49083930|NCT01068860|158143774|FG008|Overall Study|Lost to Follow-up|0|||
49083931|NCT01068860|158143775|FG009|Overall Study|Lost to Follow-up|0|||
49083932|NCT02568072|158143776|FG000|Overall Study|Unavailable for appointment|23|||
49083933|NCT02568072|158143776|FG000|Overall Study|Unable to contact|3|||
49083934|NCT02568072|158143776|FG000|Overall Study|Diagnosis of Long QT Syndrome|1|||
49083935|NCT02568072|158143776|FG000|Overall Study|Withdrawal by Subject|1|||
49083936|NCT02568072|158143776|FG000|Overall Study|Sustained injury, marathon not run|24|||
49083937|NCT00460603|158143780|FG000|Phase 1|Death|1|||
49083938|NCT00460603|158143781|FG001|Phase 1|Death|0|||
49083939|NCT00460603|158143782|FG002|Phase 1|Death|0|||
49083940|NCT00460603|158143783|FG003|Phase 1|Death|2|||
49083941|NCT00460603|158143784|FG004|Phase 1|Death|0|||
49083942|NCT00460603|158143785|FG005|Phase 1|Death|0|||
49083943|NCT00460603|158143786|FG006|Phase 1|Death|0|||
49083944|NCT00460603|158143787|FG007|Phase 1|Death|0|||
49083945|NCT00460603|158143788|FG008|Phase 1|Death|1|||
49083946|NCT00460603|158143789|FG009|Phase 1|Death|0|||
49083947|NCT00460603|158143790|FG010|Phase 1|Death|0|||
49083948|NCT00460603|158143791|FG011|Phase 1|Death|0|||
49083949|NCT00460603|158143780|FG000|Phase 1|Adverse Event|3|||
49083950|NCT00460603|158143781|FG001|Phase 1|Adverse Event|1|||
49083951|NCT00460603|158143782|FG002|Phase 1|Adverse Event|1|||
49083952|NCT00460603|158143783|FG003|Phase 1|Adverse Event|2|||
49083953|NCT00460603|158143784|FG004|Phase 1|Adverse Event|0|||
49083954|NCT00460603|158143785|FG005|Phase 1|Adverse Event|0|||
49083955|NCT00460603|158143786|FG006|Phase 1|Adverse Event|3|||
49083956|NCT00460603|158143787|FG007|Phase 1|Adverse Event|0|||
49083957|NCT00460603|158143788|FG008|Phase 1|Adverse Event|4|||
49083958|NCT00460603|158143789|FG009|Phase 1|Adverse Event|0|||
49083959|NCT00460603|158143790|FG010|Phase 1|Adverse Event|0|||
49083960|NCT00460603|158143791|FG011|Phase 1|Adverse Event|0|||
49083961|NCT00460603|158143780|FG000|Phase 1|Lack of Efficacy|1|||
49083962|NCT00460603|158143781|FG001|Phase 1|Lack of Efficacy|0|||
49083963|NCT00460603|158143782|FG002|Phase 1|Lack of Efficacy|1|||
49083964|NCT00460603|158143783|FG003|Phase 1|Lack of Efficacy|2|||
49083965|NCT00460603|158143784|FG004|Phase 1|Lack of Efficacy|2|||
49083966|NCT00460603|158143785|FG005|Phase 1|Lack of Efficacy|2|||
49083967|NCT00460603|158143786|FG006|Phase 1|Lack of Efficacy|2|||
49083968|NCT00460603|158143787|FG007|Phase 1|Lack of Efficacy|2|||
49083969|NCT00460603|158143788|FG008|Phase 1|Lack of Efficacy|11|||
49083970|NCT00460603|158143789|FG009|Phase 1|Lack of Efficacy|0|||
49083971|NCT00460603|158143790|FG010|Phase 1|Lack of Efficacy|0|||
49083972|NCT00460603|158143791|FG011|Phase 1|Lack of Efficacy|0|||
49083973|NCT00460603|158143780|FG000|Phase 1|Withdrawal by Subject|1|||
49083974|NCT00460603|158143781|FG001|Phase 1|Withdrawal by Subject|2|||
49083975|NCT00460603|158143782|FG002|Phase 1|Withdrawal by Subject|1|||
49083976|NCT00460603|158143783|FG003|Phase 1|Withdrawal by Subject|1|||
49083977|NCT00460603|158143784|FG004|Phase 1|Withdrawal by Subject|3|||
49083978|NCT00460603|158143785|FG005|Phase 1|Withdrawal by Subject|0|||
49083979|NCT00460603|158143786|FG006|Phase 1|Withdrawal by Subject|1|||
49083980|NCT00460603|158143787|FG007|Phase 1|Withdrawal by Subject|0|||
49083981|NCT00460603|158143788|FG008|Phase 1|Withdrawal by Subject|2|||
49083982|NCT00460603|158143789|FG009|Phase 1|Withdrawal by Subject|0|||
49083983|NCT00460603|158143790|FG010|Phase 1|Withdrawal by Subject|0|||
49083984|NCT00460603|158143791|FG011|Phase 1|Withdrawal by Subject|0|||
49083985|NCT00460603|158143780|FG000|Phase 1|Other|0|||
49083986|NCT00460603|158143781|FG001|Phase 1|Other|3|||
49083987|NCT00460603|158143782|FG002|Phase 1|Other|1|||
49083988|NCT00460603|158143783|FG003|Phase 1|Other|1|||
49083989|NCT00460603|158143784|FG004|Phase 1|Other|1|||
49083990|NCT00460603|158143785|FG005|Phase 1|Other|2|||
49083991|NCT00460603|158143786|FG006|Phase 1|Other|0|||
49083992|NCT00460603|158143787|FG007|Phase 1|Other|1|||
49083993|NCT00460603|158143788|FG008|Phase 1|Other|0|||
49083994|NCT00460603|158143789|FG009|Phase 1|Other|0|||
49083995|NCT00460603|158143790|FG010|Phase 1|Other|0|||
49083996|NCT00460603|158143791|FG011|Phase 1|Other|0|||
49083997|NCT00460603|158143780|FG000|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
49083998|NCT00460603|158143781|FG001|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
49083999|NCT00460603|158143782|FG002|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
49084000|NCT00460603|158143783|FG003|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
49084001|NCT00460603|158143784|FG004|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
49084002|NCT00460603|158143785|FG005|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
49084003|NCT00460603|158143786|FG006|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
49084004|NCT00460603|158143787|FG007|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
49084005|NCT00460603|158143788|FG008|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
49084006|NCT00460603|158143789|FG009|Phase 2|Ongoing in study A4061008 (NCT00828919)|1|||
49084007|NCT00460603|158143790|FG010|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
49084008|NCT00460603|158143791|FG011|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
49084009|NCT00460603|158143780|FG000|Phase 2|Adverse Event|0|||
49084010|NCT00460603|158143781|FG001|Phase 2|Adverse Event|0|||
49084011|NCT00460603|158143782|FG002|Phase 2|Adverse Event|0|||
49084012|NCT00460603|158143783|FG003|Phase 2|Adverse Event|0|||
49084013|NCT00460603|158143784|FG004|Phase 2|Adverse Event|0|||
49084014|NCT00460603|158143785|FG005|Phase 2|Adverse Event|0|||
49084015|NCT00460603|158143786|FG006|Phase 2|Adverse Event|0|||
49084016|NCT00460603|158143787|FG007|Phase 2|Adverse Event|0|||
49084017|NCT00460603|158143788|FG008|Phase 2|Adverse Event|0|||
49084018|NCT00460603|158143789|FG009|Phase 2|Adverse Event|12|||
49084019|NCT00460603|158143790|FG010|Phase 2|Adverse Event|9|||
49084020|NCT00460603|158143791|FG011|Phase 2|Adverse Event|10|||
49084021|NCT00460603|158143780|FG000|Phase 2|Death|0|||
49084022|NCT00460603|158143781|FG001|Phase 2|Death|0|||
49084023|NCT00460603|158143782|FG002|Phase 2|Death|0|||
49084024|NCT00460603|158143783|FG003|Phase 2|Death|0|||
49084025|NCT00460603|158143784|FG004|Phase 2|Death|0|||
49084026|NCT00460603|158143785|FG005|Phase 2|Death|0|||
49084027|NCT00460603|158143786|FG006|Phase 2|Death|0|||
49084028|NCT00460603|158143787|FG007|Phase 2|Death|0|||
49084029|NCT00460603|158143788|FG008|Phase 2|Death|0|||
49084030|NCT00460603|158143789|FG009|Phase 2|Death|4|||
49084031|NCT00460603|158143790|FG010|Phase 2|Death|2|||
49084032|NCT00460603|158143791|FG011|Phase 2|Death|2|||
49084033|NCT00460603|158143780|FG000|Phase 2|Protocol Violation|0|||
49084034|NCT00460603|158143781|FG001|Phase 2|Protocol Violation|0|||
49084035|NCT00460603|158143782|FG002|Phase 2|Protocol Violation|0|||
49084036|NCT00460603|158143783|FG003|Phase 2|Protocol Violation|0|||
49084037|NCT00460603|158143784|FG004|Phase 2|Protocol Violation|0|||
49084038|NCT00460603|158143785|FG005|Phase 2|Protocol Violation|0|||
49084039|NCT00460603|158143786|FG006|Phase 2|Protocol Violation|0|||
49084040|NCT00460603|158143787|FG007|Phase 2|Protocol Violation|0|||
49084041|NCT00460603|158143788|FG008|Phase 2|Protocol Violation|0|||
49084042|NCT00460603|158143789|FG009|Phase 2|Protocol Violation|1|||
49084043|NCT00460603|158143790|FG010|Phase 2|Protocol Violation|1|||
49084044|NCT00460603|158143791|FG011|Phase 2|Protocol Violation|0|||
49084045|NCT00460603|158143780|FG000|Phase 2|Lost to Follow-up|0|||
49084046|NCT00460603|158143781|FG001|Phase 2|Lost to Follow-up|0|||
49084047|NCT00460603|158143782|FG002|Phase 2|Lost to Follow-up|0|||
49084048|NCT00460603|158143783|FG003|Phase 2|Lost to Follow-up|0|||
49084049|NCT00460603|158143784|FG004|Phase 2|Lost to Follow-up|0|||
49084050|NCT00460603|158143785|FG005|Phase 2|Lost to Follow-up|0|||
49084051|NCT00460603|158143786|FG006|Phase 2|Lost to Follow-up|0|||
49084052|NCT00460603|158143787|FG007|Phase 2|Lost to Follow-up|0|||
49084053|NCT00460603|158143788|FG008|Phase 2|Lost to Follow-up|0|||
49084054|NCT00460603|158143789|FG009|Phase 2|Lost to Follow-up|1|||
49084055|NCT00460603|158143790|FG010|Phase 2|Lost to Follow-up|0|||
49084056|NCT00460603|158143791|FG011|Phase 2|Lost to Follow-up|0|||
49084057|NCT00460603|158143780|FG000|Phase 2|Other|0|||
49084058|NCT00460603|158143781|FG001|Phase 2|Other|0|||
49084059|NCT00460603|158143782|FG002|Phase 2|Other|0|||
49084060|NCT00460603|158143783|FG003|Phase 2|Other|0|||
49084061|NCT00460603|158143784|FG004|Phase 2|Other|0|||
49084062|NCT00460603|158143785|FG005|Phase 2|Other|0|||
49084063|NCT00460603|158143786|FG006|Phase 2|Other|0|||
49084064|NCT00460603|158143787|FG007|Phase 2|Other|0|||
49084065|NCT00460603|158143788|FG008|Phase 2|Other|0|||
49084066|NCT00460603|158143789|FG009|Phase 2|Other|6|||
49084067|NCT00460603|158143790|FG010|Phase 2|Other|16|||
49084068|NCT00460603|158143791|FG011|Phase 2|Other|7|||
49084069|NCT00460603|158143780|FG000|Phase 2|Objective Progression or Relapse|0|||
49084070|NCT00460603|158143781|FG001|Phase 2|Objective Progression or Relapse|0|||
49084071|NCT00460603|158143782|FG002|Phase 2|Objective Progression or Relapse|0|||
49084072|NCT00460603|158143783|FG003|Phase 2|Objective Progression or Relapse|0|||
49084073|NCT00460603|158143784|FG004|Phase 2|Objective Progression or Relapse|0|||
49084074|NCT00460603|158143785|FG005|Phase 2|Objective Progression or Relapse|0|||
49084075|NCT00460603|158143786|FG006|Phase 2|Objective Progression or Relapse|0|||
49084076|NCT00460603|158143787|FG007|Phase 2|Objective Progression or Relapse|0|||
49084077|NCT00460603|158143788|FG008|Phase 2|Objective Progression or Relapse|0|||
49084078|NCT00460603|158143789|FG009|Phase 2|Objective Progression or Relapse|9|||
49084079|NCT00460603|158143790|FG010|Phase 2|Objective Progression or Relapse|10|||
49084080|NCT00460603|158143791|FG011|Phase 2|Objective Progression or Relapse|17|||
49084081|NCT00460603|158143780|FG000|Phase 2|Global Deterioration of Health Status|0|||
49084082|NCT00460603|158143781|FG001|Phase 2|Global Deterioration of Health Status|0|||
49084083|NCT00460603|158143782|FG002|Phase 2|Global Deterioration of Health Status|0|||
49084084|NCT00460603|158143783|FG003|Phase 2|Global Deterioration of Health Status|0|||
49084085|NCT00460603|158143784|FG004|Phase 2|Global Deterioration of Health Status|0|||
49084086|NCT00460603|158143785|FG005|Phase 2|Global Deterioration of Health Status|0|||
49084087|NCT00460603|158143786|FG006|Phase 2|Global Deterioration of Health Status|0|||
49084088|NCT00460603|158143787|FG007|Phase 2|Global Deterioration of Health Status|0|||
49084089|NCT00460603|158143788|FG008|Phase 2|Global Deterioration of Health Status|0|||
49084090|NCT00460603|158143789|FG009|Phase 2|Global Deterioration of Health Status|0|||
49084091|NCT00460603|158143790|FG010|Phase 2|Global Deterioration of Health Status|1|||
49084092|NCT00460603|158143791|FG011|Phase 2|Global Deterioration of Health Status|0|||
49084093|NCT00460603|158143780|FG000|Phase 2|Withdrawal by Subject|0|||
49084094|NCT00460603|158143781|FG001|Phase 2|Withdrawal by Subject|0|||
49084095|NCT00460603|158143782|FG002|Phase 2|Withdrawal by Subject|0|||
49084096|NCT00460603|158143783|FG003|Phase 2|Withdrawal by Subject|0|||
49084097|NCT00460603|158143784|FG004|Phase 2|Withdrawal by Subject|0|||
49084098|NCT00460603|158143785|FG005|Phase 2|Withdrawal by Subject|0|||
49084099|NCT00460603|158143786|FG006|Phase 2|Withdrawal by Subject|0|||
49084100|NCT00460603|158143787|FG007|Phase 2|Withdrawal by Subject|0|||
49084101|NCT00460603|158143788|FG008|Phase 2|Withdrawal by Subject|0|||
49084102|NCT00460603|158143789|FG009|Phase 2|Withdrawal by Subject|5|||
49084103|NCT00460603|158143790|FG010|Phase 2|Withdrawal by Subject|4|||
49084104|NCT00460603|158143791|FG011|Phase 2|Withdrawal by Subject|5|||
49084105|NCT00460603|158143780|FG000|Phase 2|Randomized, but not treated|0|||
49084106|NCT00460603|158143781|FG001|Phase 2|Randomized, but not treated|0|||
49084107|NCT00460603|158143782|FG002|Phase 2|Randomized, but not treated|0|||
49084108|NCT00460603|158143783|FG003|Phase 2|Randomized, but not treated|0|||
49084109|NCT00460603|158143784|FG004|Phase 2|Randomized, but not treated|0|||
49084110|NCT00460603|158143785|FG005|Phase 2|Randomized, but not treated|0|||
49084111|NCT00460603|158143786|FG006|Phase 2|Randomized, but not treated|0|||
49084112|NCT00460603|158143787|FG007|Phase 2|Randomized, but not treated|0|||
49084113|NCT00460603|158143788|FG008|Phase 2|Randomized, but not treated|0|||
49084114|NCT00460603|158143789|FG009|Phase 2|Randomized, but not treated|3|||
49084115|NCT00460603|158143790|FG010|Phase 2|Randomized, but not treated|0|||
49084116|NCT00460603|158143791|FG011|Phase 2|Randomized, but not treated|0|||
49084117|NCT01071915|158143792|FG000|Overall Study|Adverse Event|3|||
49084118|NCT01071915|158143792|FG000|Overall Study|Physician Decision|2|||
49084119|NCT01071915|158143792|FG000|Overall Study|Withdrawal by Subject|2|||
49084120|NCT01071915|158143792|FG000|Overall Study|Miscellaneous Reasons|2|||
49084121|NCT02687451|158143800|FG000|Overall Study|Withdrawal by Subject|1|||
49084122|NCT02687451|158143801|FG001|Overall Study|Withdrawal by Subject|0|||
49084123|NCT02687451|158143802|FG002|Overall Study|Withdrawal by Subject|0|||
49084124|NCT02687451|158143803|FG003|Overall Study|Withdrawal by Subject|0|||
49084125|NCT02687451|158143804|FG004|Overall Study|Withdrawal by Subject|0|||
49084126|NCT02687451|158143805|FG005|Overall Study|Withdrawal by Subject|1|||
49084127|NCT00927589|158143806|FG000|Overall Study|Death|1|||
49084128|NCT00927589|158143806|FG000|Overall Study|Physician Decision|1|||
49084129|NCT00927589|158143806|FG000|Overall Study|Withdrawal by Subject|3|||
49084130|NCT00927589|158143806|FG000|Overall Study|Adverse Event|2|||
49084131|NCT00927589|158143806|FG000|Overall Study|Disease Progression|8|||
49084132|NCT00927589|158143806|FG000|Overall Study|Non-compliance|1|||
49084133|NCT00513240|158143808|FG000|Overall Study|Did not have intended surgery|3|||
49084134|NCT00513240|158143809|FG001|Overall Study|Did not have intended surgery|0|||
49084135|NCT00513240|158143808|FG000|Overall Study|Death|3|||
49084136|NCT00513240|158143809|FG001|Overall Study|Death|3|||
49084137|NCT00513240|158143808|FG000|Overall Study|Withdrawal by Subject|7|||
49084138|NCT00513240|158143809|FG001|Overall Study|Withdrawal by Subject|4|||
49084139|NCT00114140|158143810|FG000|Overall Study|Protocol Violation|7|||
49084140|NCT01518322|158143811|FG000|Overall Study|FeNO measurement was missing|13|||
49084141|NCT02088177|158143816|FG000|Overall Study|Lost to Follow-up|3|||
49084142|NCT01103180|158143817|FG000|Overall Study|Withdrawal by Subject|8|||
49084143|NCT01103180|158143818|FG001|Overall Study|Withdrawal by Subject|13|||
49084144|NCT01103180|158143817|FG000|Overall Study|Lost to Follow-up|13|||
49084145|NCT01103180|158143818|FG001|Overall Study|Lost to Follow-up|7|||
49084146|NCT01103180|158143817|FG000|Overall Study|Physician Decision|1|||
49084147|NCT01103180|158143818|FG001|Overall Study|Physician Decision|0|||
49084148|NCT01103180|158143817|FG000|Overall Study|Protocol Violation|0|||
49084149|NCT01103180|158143818|FG001|Overall Study|Protocol Violation|1|||
49084150|NCT01778530|158143820|FG000|Overall Study|Progression on study|1|||
49084151|NCT01778530|158143820|FG000|Overall Study|Adverse event/side effect|1|||
49084152|NCT02505217|158143821|FG000|Overall Study|Withdrawal by Subject|1|||
49084153|NCT02505217|158143822|FG001|Overall Study|Withdrawal by Subject|2|||
49084154|NCT03871543|158143823|FG000|Period 1|Unsatisfactory Lens Fitting due Test Article|10|||
49084155|NCT03871543|158143823|FG000|Period 1|Investigator Error|1|||
49084156|NCT03871543|158143823|FG000|Period 1|Protocol Violation|2|||
49084157|NCT03871543|158143823|FG000|Period 1|COVID-19 Related|1|||
49084158|NCT03871543|158143823|FG000|Period 1|Subject No Longer meets Eligibility Criteria|112|||
49084159|NCT03871543|158143823|FG000|Period 1|Withdrawal by Subject|10|||
49084160|NCT03871543|158143823|FG000|Period 2|Adverse Event|1|||
49084161|NCT03871543|158143823|FG000|Period 2|Withdrawal by Subject|1|||
49084162|NCT00110396|158143829|FG000|Overall Study|Adverse Event|15|||
49084163|NCT00110396|158143829|FG000|Overall Study|Lost to Follow-up|1|||
49084164|NCT00110396|158143829|FG000|Overall Study|Administration of plasmapheresis|1|||
49084165|NCT00110396|158143829|FG000|Overall Study|Initiated mitoxantrone therapy|1|||
49084166|NCT00110396|158143829|FG000|Overall Study|Lack of Efficacy|1|||
49084167|NCT00110396|158143829|FG000|Overall Study|Decided not to continue treatment|1|||
49084168|NCT00110396|158143829|FG000|Overall Study|Patient non-compliance|1|||
49084169|NCT00110396|158143829|FG000|Overall Study|Patient refused to continue|1|||
49084170|NCT00110396|158143829|FG000|Overall Study|Patient refused to participate|1|||
49084171|NCT00110396|158143829|FG000|Overall Study|Patient will|1|||
49084172|NCT00110396|158143829|FG000|Overall Study|Patient's decision|1|||
49084173|NCT00110396|158143829|FG000|Overall Study|Participation in MS vaccine study|1|||
49084174|NCT00110396|158143829|FG000|Overall Study|Pregnancy|1|||
49084175|NCT00110396|158143829|FG000|Overall Study|Pregnancy (Protocol violation)|2|||
49084176|NCT00110396|158143829|FG000|Overall Study|Protocol Violation|2|||
49084177|NCT00110396|158143829|FG000|Overall Study|Patient refused to come back|1|||
49084178|NCT00110396|158143829|FG000|Overall Study|The patient has refused|2|||
49084179|NCT00110396|158143829|FG000|Overall Study|The patient has refused to visit site|1|||
49084180|NCT00110396|158143829|FG000|Overall Study|Patient is to be administered copaxone|1|||
49084181|NCT02792517|158143830|FG000|Overall Study|Withdrawal by Subject|10|||
49084182|NCT02792517|158143830|FG000|Overall Study|Decision by Sponsor|7|||
49084183|NCT02792517|158143830|FG000|Overall Study|Lost to Follow-up|3|||
49084184|NCT01894919|158143831|FG000|Overall Study|Withdrawal by Subject|1|||
49084185|NCT01894919|158143832|FG001|Overall Study|Withdrawal by Subject|0|||
49084186|NCT01894919|158143833|FG002|Overall Study|Withdrawal by Subject|0|||
49084187|NCT01894919|158143834|FG003|Overall Study|Withdrawal by Subject|0|||
49084188|NCT01894919|158143835|FG004|Overall Study|Withdrawal by Subject|1|||
49084189|NCT01894919|158143836|FG005|Overall Study|Withdrawal by Subject|0|||
49084190|NCT01894919|158143837|FG006|Overall Study|Withdrawal by Subject|0|||
49084191|NCT01894919|158143838|FG007|Overall Study|Withdrawal by Subject|0|||
49084192|NCT01894919|158143839|FG008|Overall Study|Withdrawal by Subject|0|||
49084193|NCT01894919|158143840|FG009|Overall Study|Withdrawal by Subject|1|||
49084194|NCT01894919|158143841|FG010|Overall Study|Withdrawal by Subject|1|||
49084195|NCT01894919|158143842|FG011|Overall Study|Withdrawal by Subject|0|||
49084196|NCT01894919|158143843|FG012|Overall Study|Withdrawal by Subject|0|||
49084197|NCT01894919|158143831|FG000|Overall Study|Adverse Event|0|||
49084198|NCT01894919|158143832|FG001|Overall Study|Adverse Event|0|||
49084199|NCT01894919|158143833|FG002|Overall Study|Adverse Event|0|||
49084200|NCT01894919|158143834|FG003|Overall Study|Adverse Event|0|||
49084201|NCT01894919|158143835|FG004|Overall Study|Adverse Event|0|||
49084202|NCT01894919|158143836|FG005|Overall Study|Adverse Event|0|||
49084203|NCT01894919|158143837|FG006|Overall Study|Adverse Event|0|||
49084204|NCT01894919|158143838|FG007|Overall Study|Adverse Event|0|||
49084205|NCT01894919|158143839|FG008|Overall Study|Adverse Event|0|||
49084206|NCT01894919|158143840|FG009|Overall Study|Adverse Event|0|||
49084207|NCT01894919|158143841|FG010|Overall Study|Adverse Event|1|||
49084208|NCT01894919|158143842|FG011|Overall Study|Adverse Event|0|||
49084209|NCT01894919|158143843|FG012|Overall Study|Adverse Event|0|||
49084210|NCT01894919|158143831|FG000|Overall Study|Other-Unspecified|1|||
49084211|NCT01894919|158143832|FG001|Overall Study|Other-Unspecified|0|||
49084212|NCT01894919|158143833|FG002|Overall Study|Other-Unspecified|0|||
49084213|NCT01894919|158143834|FG003|Overall Study|Other-Unspecified|0|||
49084214|NCT01894919|158143835|FG004|Overall Study|Other-Unspecified|0|||
49084215|NCT01894919|158143836|FG005|Overall Study|Other-Unspecified|0|||
49084216|NCT01894919|158143837|FG006|Overall Study|Other-Unspecified|0|||
49084217|NCT01894919|158143838|FG007|Overall Study|Other-Unspecified|0|||
49084218|NCT01894919|158143839|FG008|Overall Study|Other-Unspecified|0|||
49084219|NCT01894919|158143840|FG009|Overall Study|Other-Unspecified|0|||
49084220|NCT01894919|158143841|FG010|Overall Study|Other-Unspecified|0|||
49084221|NCT01894919|158143842|FG011|Overall Study|Other-Unspecified|0|||
49084222|NCT01894919|158143843|FG012|Overall Study|Other-Unspecified|0|||
49084223|NCT01894919|158143831|FG000|Overall Study|Lost to Follow-up|0|||
49084224|NCT01894919|158143832|FG001|Overall Study|Lost to Follow-up|0|||
49084225|NCT01894919|158143833|FG002|Overall Study|Lost to Follow-up|0|||
49084226|NCT01894919|158143834|FG003|Overall Study|Lost to Follow-up|0|||
49084227|NCT01894919|158143835|FG004|Overall Study|Lost to Follow-up|2|||
49084228|NCT01894919|158143836|FG005|Overall Study|Lost to Follow-up|0|||
49084229|NCT01894919|158143837|FG006|Overall Study|Lost to Follow-up|0|||
49084230|NCT01894919|158143838|FG007|Overall Study|Lost to Follow-up|0|||
49084231|NCT01894919|158143839|FG008|Overall Study|Lost to Follow-up|0|||
49084232|NCT01894919|158143840|FG009|Overall Study|Lost to Follow-up|0|||
49084233|NCT01894919|158143841|FG010|Overall Study|Lost to Follow-up|0|||
49084234|NCT01894919|158143842|FG011|Overall Study|Lost to Follow-up|0|||
49084235|NCT01894919|158143843|FG012|Overall Study|Lost to Follow-up|0|||
49084236|NCT00882518|158143846|FG000|Overall Study|Adverse Event|9|||
49084237|NCT00882518|158143847|FG001|Overall Study|Adverse Event|18|||
49084238|NCT00882518|158143846|FG000|Overall Study|Withdrawal by Subject|9|||
49084239|NCT00882518|158143847|FG001|Overall Study|Withdrawal by Subject|13|||
49084240|NCT00882518|158143846|FG000|Overall Study|Lack of Efficacy|12|||
49084241|NCT00882518|158143847|FG001|Overall Study|Lack of Efficacy|9|||
49084242|NCT00882518|158143846|FG000|Overall Study|Severe non-compliance to protocol|3|||
49084243|NCT00882518|158143847|FG001|Overall Study|Severe non-compliance to protocol|1|||
49084244|NCT00882518|158143846|FG000|Overall Study|Incorrect enrolment|4|||
49084245|NCT00882518|158143847|FG001|Overall Study|Incorrect enrolment|2|||
49084246|NCT00882518|158143846|FG000|Overall Study|Central lab closure for National day|1|||
49084247|NCT00882518|158143847|FG001|Overall Study|Central lab closure for National day|0|||
49084248|NCT00882518|158143846|FG000|Overall Study|Allocating random number by mistake|0|||
49084249|NCT00882518|158143847|FG001|Overall Study|Allocating random number by mistake|1|||
49084250|NCT02414958|158143848|FG000|Overall Study|Adverse Event|6|||
49084251|NCT02414958|158143849|FG001|Overall Study|Adverse Event|6|||
49084252|NCT02414958|158143850|FG002|Overall Study|Adverse Event|3|||
49084253|NCT02414958|158143848|FG000|Overall Study|Protocol Violation|10|||
49084254|NCT02414958|158143849|FG001|Overall Study|Protocol Violation|3|||
49084255|NCT02414958|158143850|FG002|Overall Study|Protocol Violation|1|||
49084256|NCT02414958|158143848|FG000|Overall Study|Lost to Follow-up|7|||
49084257|NCT02414958|158143849|FG001|Overall Study|Lost to Follow-up|4|||
49084258|NCT02414958|158143850|FG002|Overall Study|Lost to Follow-up|0|||
49084259|NCT02414958|158143848|FG000|Overall Study|Withdrawal by Subject|5|||
49084260|NCT02414958|158143849|FG001|Overall Study|Withdrawal by Subject|3|||
49084261|NCT02414958|158143850|FG002|Overall Study|Withdrawal by Subject|5|||
49084262|NCT02414958|158143848|FG000|Overall Study|Other than specified|4|||
49084263|NCT02414958|158143849|FG001|Overall Study|Other than specified|4|||
49084264|NCT02414958|158143850|FG002|Overall Study|Other than specified|5|||
49084265|NCT00455403|158143851|FG000|Overall Study|Lost to Follow-up|2|||
49084266|NCT00455403|158143852|FG001|Overall Study|Lost to Follow-up|1|||
49084267|NCT00455403|158143851|FG000|Overall Study|Withdrawal by Subject|1|||
49084268|NCT00455403|158143852|FG001|Overall Study|Withdrawal by Subject|3|||
49084269|NCT00455403|158143851|FG000|Overall Study|Protocol Violation|0|||
49084270|NCT00455403|158143852|FG001|Overall Study|Protocol Violation|2|||
49084271|NCT00350207|158143853|FG000|Overall Study|Adverse Event|5|||
49084272|NCT00350207|158143854|FG001|Overall Study|Adverse Event|2|||
49084273|NCT00350207|158143855|FG002|Overall Study|Adverse Event|2|||
49084274|NCT00350207|158143853|FG000|Overall Study|Lack of Efficacy|1|||
49084275|NCT00350207|158143854|FG001|Overall Study|Lack of Efficacy|0|||
49084276|NCT00350207|158143855|FG002|Overall Study|Lack of Efficacy|2|||
49084277|NCT00350207|158143853|FG000|Overall Study|Lost to Follow-up|1|||
49084278|NCT00350207|158143854|FG001|Overall Study|Lost to Follow-up|0|||
49084279|NCT00350207|158143855|FG002|Overall Study|Lost to Follow-up|1|||
49084280|NCT00350207|158143853|FG000|Overall Study|Withdrawal by Subject|0|||
49084281|NCT00350207|158143854|FG001|Overall Study|Withdrawal by Subject|1|||
49084282|NCT00350207|158143855|FG002|Overall Study|Withdrawal by Subject|1|||
49084283|NCT00350207|158143853|FG000|Overall Study|Other|1|||
49084284|NCT00350207|158143854|FG001|Overall Study|Other|3|||
49084285|NCT00350207|158143855|FG002|Overall Study|Other|1|||
49084286|NCT03711188|158143856|FG000|Overall Study|Disease progression|11|||
49084287|NCT03711188|158143856|FG000|Overall Study|Adverse Event|1|||
49084288|NCT01433471|158143857|FG000|Overall Study|Withdrawal by Subject|0|||
49084289|NCT01433471|158143858|FG001|Overall Study|Withdrawal by Subject|1|||
49084290|NCT03238651|158143861|FG000|Overall Study|Other|0|||
49084291|NCT03238651|158143862|FG001|Overall Study|Other|0|||
49084292|NCT03238651|158143863|FG002|Overall Study|Other|0|||
49084293|NCT03238651|158143864|FG003|Overall Study|Other|0|||
49084294|NCT03238651|158143865|FG004|Overall Study|Other|1|||
49084295|NCT03238651|158143861|FG000|Overall Study|Progressive Disease|2|||
49084296|NCT03238651|158143862|FG001|Overall Study|Progressive Disease|2|||
49084297|NCT03238651|158143863|FG002|Overall Study|Progressive Disease|2|||
49084298|NCT03238651|158143864|FG003|Overall Study|Progressive Disease|2|||
49084299|NCT03238651|158143865|FG004|Overall Study|Progressive Disease|0|||
49084300|NCT03238651|158143861|FG000|Overall Study|Withdrawal by Subject|0|||
49084301|NCT03238651|158143862|FG001|Overall Study|Withdrawal by Subject|1|||
49084302|NCT03238651|158143863|FG002|Overall Study|Withdrawal by Subject|0|||
49084303|NCT03238651|158143864|FG003|Overall Study|Withdrawal by Subject|1|||
49084304|NCT03238651|158143865|FG004|Overall Study|Withdrawal by Subject|0|||
49084305|NCT03238651|158143861|FG000|Overall Study|Adverse Event|1|||
49084306|NCT03238651|158143862|FG001|Overall Study|Adverse Event|3|||
49084307|NCT03238651|158143863|FG002|Overall Study|Adverse Event|2|||
49084308|NCT03238651|158143864|FG003|Overall Study|Adverse Event|0|||
49084309|NCT03238651|158143865|FG004|Overall Study|Adverse Event|0|||
49084310|NCT00568451|158143866|FG000|Overall Study|Disease Progression|0|||
49084311|NCT00568451|158143867|FG001|Overall Study|Disease Progression|0|||
49084312|NCT00568451|158143868|FG002|Overall Study|Disease Progression|2|||
49084313|NCT00568451|158143869|FG003|Overall Study|Disease Progression|7|||
49084314|NCT00495391|158143870|FG000|Overall Study|Lack of Efficacy|34|||
49084315|NCT00495391|158143871|FG001|Overall Study|Lack of Efficacy|18|||
49084316|NCT00495391|158143870|FG000|Overall Study|Withdrawal by Subject|2|||
49084317|NCT00495391|158143871|FG001|Overall Study|Withdrawal by Subject|3|||
49084318|NCT03875508|158143872|FG000|Overall Study|Adverse Event|1|||
49084319|NCT03875508|158143872|FG000|Overall Study|Lost to Follow-up|8|||
49084320|NCT03875508|158143872|FG000|Overall Study|Lack of Efficacy|1|||
49084321|NCT03875508|158143872|FG000|Overall Study|Other, not specified|2|||
49084322|NCT03214224|158143873|FG000|Overall Study|Protocol Violation|1|||
49084323|NCT03214224|158143873|FG000|Overall Study|Withdrawal by Subject|2|||
49084324|NCT03214224|158143873|FG000|Overall Study|Practice controls or therapists|6|||
49084325|NCT03571828|158143876|FG000|Overall Study|Withdrawal by Subject|1|||
49084326|NCT03571828|158143877|FG001|Overall Study|Withdrawal by Subject|0|||
49084327|NCT03571828|158143876|FG000|Overall Study|Decision by sponsor|5|||
49084328|NCT03571828|158143877|FG001|Overall Study|Decision by sponsor|1|||
49084329|NCT03571828|158143876|FG000|Overall Study|Death|2|||
49084330|NCT03571828|158143877|FG001|Overall Study|Death|0|||
49084331|NCT03743051|158143878|FG000|Overall Study|Adverse Event|5|||
49084332|NCT03743051|158143879|FG001|Overall Study|Adverse Event|9|||
49084333|NCT03743051|158143878|FG000|Overall Study|Death|27|||
49084334|NCT03743051|158143879|FG001|Overall Study|Death|26|||
49084335|NCT03743051|158143878|FG000|Overall Study|Lost to Follow-up|4|||
49084336|NCT03743051|158143879|FG001|Overall Study|Lost to Follow-up|8|||
49084337|NCT03743051|158143878|FG000|Overall Study|Withdrawal by Subject|32|||
49084338|NCT03743051|158143879|FG001|Overall Study|Withdrawal by Subject|19|||
49084339|NCT03743051|158143878|FG000|Overall Study|Physician Decision|10|||
49084340|NCT03743051|158143879|FG001|Overall Study|Physician Decision|15|||
49084341|NCT03743051|158143878|FG000|Overall Study|"Reported as Other in Clinical Study Report"|3|||
49084342|NCT03743051|158143879|FG001|Overall Study|"Reported as Other in Clinical Study Report"|6|||
49084343|NCT01808066|158143884|FG000|Overall Study|Withdrawal by Subject|15|||
49084344|NCT02314026|158143885|FG000|Overall Study|Protocol Violation|28|||
49084345|NCT01127256|158143889|FG000|Overall Study|Adverse Event|13|||
49084346|NCT01127256|158143890|FG001|Overall Study|Adverse Event|13|||
49084347|NCT01127256|158143889|FG000|Overall Study|Lack of Efficacy|4|||
49084348|NCT01127256|158143890|FG001|Overall Study|Lack of Efficacy|0|||
49084349|NCT01127256|158143889|FG000|Overall Study|Lost to Follow-up|16|||
49084350|NCT01127256|158143890|FG001|Overall Study|Lost to Follow-up|17|||
49084351|NCT01127256|158143889|FG000|Overall Study|Withdrawal by Subject|5|||
49084352|NCT01127256|158143890|FG001|Overall Study|Withdrawal by Subject|9|||
49084353|NCT01127256|158143889|FG000|Overall Study|Protocol Violation|1|||
49084354|NCT01127256|158143890|FG001|Overall Study|Protocol Violation|0|||
49084355|NCT01532934|158143895|FG000|Overall Study|Lost to Follow-up|11|||
49084356|NCT01532934|158143896|FG001|Overall Study|Lost to Follow-up|11|||
49084357|NCT01532934|158143895|FG000|Overall Study|In controlled environment|3|||
49084358|NCT01532934|158143896|FG001|Overall Study|In controlled environment|2|||
49084359|NCT00729937|158143897|FG000|Overall Study|Lost to Follow-up|49|||
49084360|NCT00729937|158143898|FG001|Overall Study|Lost to Follow-up|58|||
49084361|NCT00729937|158143899|FG002|Overall Study|Lost to Follow-up|18|||
49084362|NCT00729937|158143900|FG003|Overall Study|Lost to Follow-up|33|||
49084363|NCT00729937|158143901|FG004|Overall Study|Lost to Follow-up|18|||
49084364|NCT00729937|158143902|FG005|Overall Study|Lost to Follow-up|23|||
49084365|NCT00729937|158143897|FG000|Overall Study|Physician Decision|7|||
49084366|NCT00729937|158143898|FG001|Overall Study|Physician Decision|16|||
49084367|NCT00729937|158143899|FG002|Overall Study|Physician Decision|2|||
49084368|NCT00729937|158143900|FG003|Overall Study|Physician Decision|0|||
49084369|NCT00729937|158143901|FG004|Overall Study|Physician Decision|5|||
49084370|NCT00729937|158143902|FG005|Overall Study|Physician Decision|8|||
49084371|NCT00729937|158143897|FG000|Overall Study|Death|1|||
49084372|NCT00729937|158143898|FG001|Overall Study|Death|0|||
49084373|NCT00729937|158143899|FG002|Overall Study|Death|1|||
49084374|NCT00729937|158143900|FG003|Overall Study|Death|0|||
49084375|NCT00729937|158143901|FG004|Overall Study|Death|0|||
49084376|NCT00729937|158143902|FG005|Overall Study|Death|1|||
49084377|NCT00729937|158143897|FG000|Overall Study|Withdrawal by Subject|3|||
49084378|NCT00729937|158143898|FG001|Overall Study|Withdrawal by Subject|5|||
49084379|NCT00729937|158143899|FG002|Overall Study|Withdrawal by Subject|6|||
49084380|NCT00729937|158143900|FG003|Overall Study|Withdrawal by Subject|0|||
49084381|NCT00729937|158143901|FG004|Overall Study|Withdrawal by Subject|4|||
49084382|NCT00729937|158143902|FG005|Overall Study|Withdrawal by Subject|2|||
49084383|NCT00729937|158143897|FG000|Overall Study|Randomized but not treated|12|||
49084384|NCT00729937|158143898|FG001|Overall Study|Randomized but not treated|6|||
49084385|NCT00729937|158143899|FG002|Overall Study|Randomized but not treated|1|||
49084386|NCT00729937|158143900|FG003|Overall Study|Randomized but not treated|0|||
49084387|NCT00729937|158143901|FG004|Overall Study|Randomized but not treated|1|||
49084388|NCT00729937|158143902|FG005|Overall Study|Randomized but not treated|3|||
49084389|NCT00729937|158143897|FG000|Overall Study|Did not meet eligibility criteria|2|||
49084390|NCT00729937|158143898|FG001|Overall Study|Did not meet eligibility criteria|1|||
49084391|NCT00729937|158143899|FG002|Overall Study|Did not meet eligibility criteria|0|||
49084392|NCT00729937|158143900|FG003|Overall Study|Did not meet eligibility criteria|0|||
49084393|NCT00729937|158143901|FG004|Overall Study|Did not meet eligibility criteria|0|||
49084394|NCT00729937|158143902|FG005|Overall Study|Did not meet eligibility criteria|0|||
49084395|NCT00729937|158143897|FG000|Overall Study|Incarcerated|0|||
49084396|NCT00729937|158143898|FG001|Overall Study|Incarcerated|2|||
49084397|NCT00729937|158143899|FG002|Overall Study|Incarcerated|1|||
49084398|NCT00729937|158143900|FG003|Overall Study|Incarcerated|1|||
49084399|NCT00729937|158143901|FG004|Overall Study|Incarcerated|0|||
49084400|NCT00729937|158143902|FG005|Overall Study|Incarcerated|0|||
49084401|NCT00420420|158143903|FG000|Overall Study|Adverse Event|5|||
49084402|NCT00420420|158143904|FG001|Overall Study|Adverse Event|3|||
49084403|NCT00420420|158143903|FG000|Overall Study|Protocol Violation|1|||
49084404|NCT00420420|158143904|FG001|Overall Study|Protocol Violation|1|||
49084405|NCT00420420|158143903|FG000|Overall Study|Withdrawal by Subject|1|||
49084406|NCT00420420|158143904|FG001|Overall Study|Withdrawal by Subject|0|||
49084407|NCT00420420|158143903|FG000|Overall Study|sponsor decision (abnormal ECG @ screen)|1|||
49084408|NCT00420420|158143904|FG001|Overall Study|sponsor decision (abnormal ECG @ screen)|0|||
49084409|NCT00273182|158143905|FG000|Overall Study|Death|450|||
49084410|NCT00273182|158143905|FG000|Overall Study|Lost to Follow-up|88|||
49084411|NCT00273182|158143905|FG000|Overall Study|Withdrawal by Subject|257|||
49084412|NCT00273182|158143905|FG000|Overall Study|Device/System Explant|154|||
49084413|NCT00273182|158143905|FG000|Overall Study|Site exit, system change, 36 m FU missed|36|||
49084414|NCT04871776|158143909|FG000|Overall Study|Death after randomization but before intervention could have been administered|0|||
49084415|NCT04871776|158143910|FG001|Overall Study|Death after randomization but before intervention could have been administered|2|||
49084416|NCT04871776|158143911|FG002|Overall Study|Death after randomization but before intervention could have been administered|1|||
49084417|NCT04871776|158143909|FG000|Overall Study|Did not meet eligibility criteria|1|||
49084418|NCT04871776|158143910|FG001|Overall Study|Did not meet eligibility criteria|1|||
49084419|NCT04871776|158143911|FG002|Overall Study|Did not meet eligibility criteria|1|||
49084420|NCT01131455|158143916|FG000|Overall Study|Death of PI|6|||
49084421|NCT01131455|158143917|FG001|Overall Study|Death of PI|4|||
49084422|NCT01131455|158143918|FG002|Overall Study|Death of PI|0|||
49084423|NCT02259010|158143921|FG000|Overall Study|Didn't Completed Dosing; PK Assessment|5|||
49084424|NCT02462603|158143924|FG000|Overall Study|Investigator Decision|1|||
49084425|NCT02462603|158143924|FG000|Overall Study|Non-Compliance|1|||
49084426|NCT02462603|158143924|FG000|Overall Study|Withdrawal by Subject|2|||
49084427|NCT03194542|158143925|FG000|Overall Study|Participant to Receive Bone Marrow Transplant|1|||
49084428|NCT03194542|158143926|FG001|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
49084429|NCT03194542|158143927|FG002|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
49084430|NCT03194542|158143928|FG003|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
49084431|NCT03194542|158143925|FG000|Overall Study|Rollover to Long-term follow-up Protocol|1|||
49084432|NCT03194542|158143926|FG001|Overall Study|Rollover to Long-term follow-up Protocol|1|||
49084433|NCT03194542|158143927|FG002|Overall Study|Rollover to Long-term follow-up Protocol|0|||
49084434|NCT03194542|158143928|FG003|Overall Study|Rollover to Long-term follow-up Protocol|5|||
49084435|NCT03194542|158143925|FG000|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
49084436|NCT03194542|158143926|FG001|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
49084437|NCT03194542|158143927|FG002|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
49084438|NCT03194542|158143928|FG003|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
49084439|NCT03194542|158143925|FG000|Overall Study|Loss of Response|4|||
49084440|NCT03194542|158143926|FG001|Overall Study|Loss of Response|2|||
49084441|NCT03194542|158143927|FG002|Overall Study|Loss of Response|3|||
49084442|NCT03194542|158143928|FG003|Overall Study|Loss of Response|4|||
49084443|NCT03194542|158143925|FG000|Overall Study|Physician Decision|0|||
49084444|NCT03194542|158143926|FG001|Overall Study|Physician Decision|1|||
49084445|NCT03194542|158143927|FG002|Overall Study|Physician Decision|0|||
49084446|NCT03194542|158143928|FG003|Overall Study|Physician Decision|0|||
49084447|NCT03194542|158143925|FG000|Overall Study|Lack of Efficacy|2|||
49084448|NCT03194542|158143926|FG001|Overall Study|Lack of Efficacy|2|||
49084449|NCT03194542|158143927|FG002|Overall Study|Lack of Efficacy|2|||
49084450|NCT03194542|158143928|FG003|Overall Study|Lack of Efficacy|6|||
49084451|NCT03194542|158143925|FG000|Overall Study|Withdrawal by Subject|2|||
49084452|NCT03194542|158143926|FG001|Overall Study|Withdrawal by Subject|1|||
49084453|NCT03194542|158143927|FG002|Overall Study|Withdrawal by Subject|5|||
49084454|NCT03194542|158143928|FG003|Overall Study|Withdrawal by Subject|4|||
49084455|NCT03194542|158143925|FG000|Overall Study|Progressive Disease|1|||
49084456|NCT03194542|158143926|FG001|Overall Study|Progressive Disease|0|||
49084457|NCT03194542|158143927|FG002|Overall Study|Progressive Disease|1|||
49084458|NCT03194542|158143928|FG003|Overall Study|Progressive Disease|1|||
49084459|NCT03194542|158143925|FG000|Overall Study|Adverse Event|1|||
49084460|NCT03194542|158143926|FG001|Overall Study|Adverse Event|2|||
49084461|NCT03194542|158143927|FG002|Overall Study|Adverse Event|0|||
49084462|NCT03194542|158143928|FG003|Overall Study|Adverse Event|5|||
49084463|NCT03194542|158143925|FG000|Overall Study|Death|1|||
49084464|NCT03194542|158143926|FG001|Overall Study|Death|2|||
49084465|NCT03194542|158143927|FG002|Overall Study|Death|0|||
49084466|NCT03194542|158143928|FG003|Overall Study|Death|5|||
49084467|NCT03194542|158143925|FG000|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
49084468|NCT03194542|158143926|FG001|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|10|||
49084469|NCT03194542|158143927|FG002|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|2|||
49084470|NCT03194542|158143928|FG003|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
49084471|NCT00634036|158143929|FG000|Overall Study|Lost to Follow-up|1|||
49084472|NCT00634036|158143930|FG001|Overall Study|Lost to Follow-up|1|||
49084473|NCT00634036|158143929|FG000|Overall Study|Withdrawal by Subject|1|||
49084474|NCT00634036|158143930|FG001|Overall Study|Withdrawal by Subject|1|||
49084475|NCT04762160|158143933|FG000|Overall Study|Study terminated early due to business reasons|5|||
49084476|NCT03859427|158143934|FG000|Overall Study|Withdrawal by Subject|4|||
49084477|NCT03859427|158143935|FG001|Overall Study|Withdrawal by Subject|7|||
49084478|NCT03859427|158143934|FG000|Overall Study|Decision by sponsor|0|||
49084479|NCT03859427|158143935|FG001|Overall Study|Decision by sponsor|3|||
49084480|NCT03859427|158143934|FG000|Overall Study|Lost to Follow-up|3|||
49084481|NCT03859427|158143935|FG001|Overall Study|Lost to Follow-up|2|||
49084482|NCT03859427|158143934|FG000|Overall Study|Death|22|||
49084483|NCT03859427|158143935|FG001|Overall Study|Death|25|||
49084484|NCT00529373|158143936|FG000|Base Study|Adverse Event|525|||
49084485|NCT00529373|158143937|FG001|Base Study|Adverse Event|470|||
49084486|NCT00529373|158143936|FG000|Base Study|Lack of Efficacy|16|||
49084487|NCT00529373|158143937|FG001|Base Study|Lack of Efficacy|75|||
49084488|NCT00529373|158143936|FG000|Base Study|Lost to Follow-up|221|||
49084489|NCT00529373|158143937|FG001|Base Study|Lost to Follow-up|208|||
49084490|NCT00529373|158143936|FG000|Base Study|Other Protocol Specified Criteria|19|||
49084491|NCT00529373|158143937|FG001|Base Study|Other Protocol Specified Criteria|20|||
49084492|NCT00529373|158143936|FG000|Base Study|Physician Decision|60|||
49084493|NCT00529373|158143937|FG001|Base Study|Physician Decision|52|||
49084494|NCT00529373|158143936|FG000|Base Study|Protocol Violation|48|||
49084495|NCT00529373|158143937|FG001|Base Study|Protocol Violation|38|||
49084496|NCT00529373|158143936|FG000|Base Study|Withdrawal by Subject|1062|||
49084497|NCT00529373|158143937|FG001|Base Study|Withdrawal by Subject|967|||
49084498|NCT00529373|158143936|FG000|Base Study|Did not continue into Extension|1795|||
49084499|NCT00529373|158143937|FG001|Base Study|Did not continue into Extension|2238|||
49084500|NCT00529373|158143936|FG000|First Extension Study|Adverse Event|162|||
49084501|NCT00529373|158143937|FG001|First Extension Study|Adverse Event|142|||
49084502|NCT00529373|158143936|FG000|First Extension Study|Lack of Efficacy|65|||
49084503|NCT00529373|158143937|FG001|First Extension Study|Lack of Efficacy|427|||
49084504|NCT00529373|158143936|FG000|First Extension Study|Lost to Follow-up|41|||
49084505|NCT00529373|158143937|FG001|First Extension Study|Lost to Follow-up|37|||
49084506|NCT00529373|158143936|FG000|First Extension Study|Other|27|||
49084507|NCT00529373|158143937|FG001|First Extension Study|Other|47|||
49084508|NCT00529373|158143936|FG000|First Extension Study|Physician Decision|50|||
49084509|NCT00529373|158143937|FG001|First Extension Study|Physician Decision|45|||
49084510|NCT00529373|158143936|FG000|First Extension Study|Protocol Violation|16|||
49084511|NCT00529373|158143937|FG001|First Extension Study|Protocol Violation|13|||
49084512|NCT00529373|158143936|FG000|First Extension Study|Withdrawal by Subject|296|||
49084513|NCT00529373|158143937|FG001|First Extension Study|Withdrawal by Subject|287|||
49084514|NCT00529373|158143936|FG000|First Extension Study|Disposition record non-existing|0|||
49084515|NCT00529373|158143937|FG001|First Extension Study|Disposition record non-existing|1|||
49084516|NCT00529373|158143936|FG000|First Extension Study|Discontinued after 5 years completion|208|||
49084517|NCT00529373|158143937|FG001|First Extension Study|Discontinued after 5 years completion|346|||
49084518|NCT00529373|158143936|FG000|First Extension Study|Did not cont. into 2nd Ext (verified)|256|||
49084519|NCT00529373|158143937|FG001|First Extension Study|Did not cont. into 2nd Ext (verified)|281|||
49084520|NCT00529373|158143936|FG000|First Extension Study|Did not cont. into 2nd Ext (unknown)|32|||
49084521|NCT00529373|158143937|FG001|First Extension Study|Did not cont. into 2nd Ext (unknown)|25|||
49084522|NCT00529373|158143936|FG000|Second Extension Study|Adverse Event|101|||
49084523|NCT00529373|158143937|FG001|Second Extension Study|Adverse Event|51|||
49084524|NCT00529373|158143936|FG000|Second Extension Study|Lack of Efficacy|7|||
49084525|NCT00529373|158143937|FG001|Second Extension Study|Lack of Efficacy|15|||
49084526|NCT00529373|158143936|FG000|Second Extension Study|Lost to Follow-up|18|||
49084527|NCT00529373|158143937|FG001|Second Extension Study|Lost to Follow-up|12|||
49084528|NCT00529373|158143936|FG000|Second Extension Study|Other|7|||
49084529|NCT00529373|158143937|FG001|Second Extension Study|Other|12|||
49084530|NCT00529373|158143936|FG000|Second Extension Study|Physician Decision|63|||
49084531|NCT00529373|158143937|FG001|Second Extension Study|Physician Decision|26|||
49084532|NCT00529373|158143936|FG000|Second Extension Study|Protocol Violation|2|||
49084533|NCT00529373|158143937|FG001|Second Extension Study|Protocol Violation|1|||
49084534|NCT00529373|158143936|FG000|Second Extension Study|Withdrawal by Subject|97|||
49084535|NCT00529373|158143937|FG001|Second Extension Study|Withdrawal by Subject|75|||
49084536|NCT00529373|158143936|FG000|Second Extension Study|Status Missing|5|||
49084537|NCT00529373|158143937|FG001|Second Extension Study|Status Missing|5|||
49084538|NCT03655405|158143946|FG000|Overall Study|Death after initial data collection|4|||
49084539|NCT03655405|158143947|FG001|Overall Study|Death after initial data collection|2|||
49084540|NCT03655405|158143946|FG000|Overall Study|Died before initial data collection|1|||
49084541|NCT03655405|158143947|FG001|Overall Study|Died before initial data collection|2|||
49084542|NCT03655405|158143946|FG000|Overall Study|Protocol Violation|0|||
49084543|NCT03655405|158143947|FG001|Overall Study|Protocol Violation|1|||
49084544|NCT00979654|158143948|FG000|Overall Study|Lost to Follow-up|1|||
49084545|NCT00979654|158143948|FG000|Overall Study|Withdrawal by Subject|22|||
49084546|NCT00979654|158143948|FG000|Overall Study|Death|1|||
49084547|NCT00979654|158143948|FG000|Overall Study|Lack of Efficacy|6|||
49084548|NCT00979654|158143948|FG000|Overall Study|Adverse Event|1|||
49084549|NCT00979654|158143948|FG000|Overall Study|Adverse Event of Diverticulitis|1|||
49084550|NCT00979654|158143948|FG000|Overall Study|Per Principal Investigator's Discretion|1|||
49084551|NCT00979654|158143948|FG000|Overall Study|Patient Wanted to Pursue Other Treatment|1|||
49084552|NCT00979654|158143948|FG000|Overall Study|Serious Adverse Event|1|||
49084553|NCT00979654|158143948|FG000|Overall Study|Unfavorable Risk-Benefit Analysis|1|||
49084554|NCT01408303|158143949|FG000|Overall Study|Adverse Event|3|||
49084555|NCT01408303|158143950|FG001|Overall Study|Adverse Event|7|||
49084556|NCT01408303|158143951|FG002|Overall Study|Adverse Event|2|||
49084557|NCT01408303|158143949|FG000|Overall Study|Lost to Follow-up|0|||
49084558|NCT01408303|158143950|FG001|Overall Study|Lost to Follow-up|1|||
49084559|NCT01408303|158143951|FG002|Overall Study|Lost to Follow-up|2|||
49084560|NCT01408303|158143949|FG000|Overall Study|Withdrawal by Subject|2|||
49084561|NCT01408303|158143950|FG001|Overall Study|Withdrawal by Subject|3|||
49084562|NCT01408303|158143951|FG002|Overall Study|Withdrawal by Subject|1|||
49084563|NCT01408303|158143949|FG000|Overall Study|Protocol Violation|0|||
49084564|NCT01408303|158143950|FG001|Overall Study|Protocol Violation|1|||
49084565|NCT01408303|158143951|FG002|Overall Study|Protocol Violation|0|||
49084566|NCT01408303|158143949|FG000|Overall Study|Noncompliance|1|||
49084567|NCT01408303|158143950|FG001|Overall Study|Noncompliance|0|||
49084568|NCT01408303|158143951|FG002|Overall Study|Noncompliance|1|||
49084569|NCT00443729|158145462|FG000|Overall Study|Never Treated|0|||
49084570|NCT00443729|158145463|FG001|Overall Study|Never Treated|1|||
49084571|NCT00443729|158145462|FG000|Overall Study|Lack of Efficacy|4|||
49084572|NCT00443729|158145463|FG001|Overall Study|Lack of Efficacy|2|||
49084573|NCT00443729|158145462|FG000|Overall Study|Lost to Follow-up|0|||
49084574|NCT00443729|158145463|FG001|Overall Study|Lost to Follow-up|1|||
49084575|NCT00443729|158145462|FG000|Overall Study|Physician Decision|2|||
49084576|NCT00443729|158145463|FG001|Overall Study|Physician Decision|1|||
49084577|NCT00443729|158145462|FG000|Overall Study|Protocol Violation|1|||
49084578|NCT00443729|158145463|FG001|Overall Study|Protocol Violation|1|||
49084579|NCT00443729|158145462|FG000|Overall Study|Withdrawal by Subject|3|||
49084580|NCT00443729|158145463|FG001|Overall Study|Withdrawal by Subject|1|||
49084581|NCT04173507|158145464|FG000|Overall Study|On Treatment|3|||
49084582|NCT04173507|158145464|FG000|Overall Study|Adverse Event|3|||
49084583|NCT04173507|158145464|FG000|Overall Study|Progression/Relapse|34|||
49084584|NCT04173507|158145464|FG000|Overall Study|Death|2|||
49084585|NCT00707239|158145465|FG000|Overall Study|Adverse Event|5|||
49084586|NCT00707239|158145466|FG001|Overall Study|Adverse Event|3|||
49084587|NCT00707239|158145467|FG002|Overall Study|Adverse Event|2|||
49084588|NCT00707239|158145465|FG000|Overall Study|Death|3|||
49084589|NCT00707239|158145466|FG001|Overall Study|Death|1|||
49084590|NCT00707239|158145467|FG002|Overall Study|Death|3|||
49084591|NCT00707239|158145465|FG000|Overall Study|Physician Decision|1|||
49084592|NCT00707239|158145466|FG001|Overall Study|Physician Decision|1|||
49084593|NCT00707239|158145467|FG002|Overall Study|Physician Decision|2|||
49084594|NCT00707239|158145465|FG000|Overall Study|Protocol Violation|0|||
49084595|NCT00707239|158145466|FG001|Overall Study|Protocol Violation|0|||
49084596|NCT00707239|158145467|FG002|Overall Study|Protocol Violation|1|||
49084597|NCT00707239|158145465|FG000|Overall Study|Lack of Efficacy|1|||
49084598|NCT00707239|158145466|FG001|Overall Study|Lack of Efficacy|2|||
49084599|NCT00707239|158145467|FG002|Overall Study|Lack of Efficacy|0|||
49084600|NCT00707239|158145465|FG000|Overall Study|Randomized, but not treated|1|||
49084601|NCT00707239|158145466|FG001|Overall Study|Randomized, but not treated|1|||
49084602|NCT00707239|158145467|FG002|Overall Study|Randomized, but not treated|1|||
49084603|NCT00707239|158145465|FG000|Overall Study|Other|8|||
49084604|NCT00707239|158145466|FG001|Overall Study|Other|3|||
49084605|NCT00707239|158145467|FG002|Overall Study|Other|5|||
49084606|NCT01641640|158145469|FG000|Overall Study|Enrolled but not treated|1|||
49084607|NCT01641640|158145469|FG000|Overall Study|Efficacy failure|29|||
49084608|NCT01641640|158145469|FG000|Overall Study|Lost to Follow-up|3|||
49084609|NCT01641640|158145469|FG000|Overall Study|Withdrawal by Subject|2|||
49084610|NCT01641640|158145469|FG000|Overall Study|Adverse Event|1|||
49084611|NCT00289848|158145475|FG000|Overall Study|Adverse Event|6|||
49084612|NCT00289848|158145476|FG001|Overall Study|Adverse Event|4|||
49084613|NCT00289848|158145475|FG000|Overall Study|Death|1|||
49084614|NCT00289848|158145476|FG001|Overall Study|Death|0|||
49084615|NCT00289848|158145475|FG000|Overall Study|Lack of Efficacy|20|||
49084616|NCT00289848|158145476|FG001|Overall Study|Lack of Efficacy|24|||
49084617|NCT00289848|158145475|FG000|Overall Study|Lost to Follow-up|3|||
49084618|NCT00289848|158145476|FG001|Overall Study|Lost to Follow-up|1|||
49084619|NCT00289848|158145475|FG000|Overall Study|Protocol Violation|5|||
49084620|NCT00289848|158145476|FG001|Overall Study|Protocol Violation|2|||
49084621|NCT00289848|158145475|FG000|Overall Study|Withdrawal by Subject|5|||
49084622|NCT00289848|158145476|FG001|Overall Study|Withdrawal by Subject|11|||
49084623|NCT00289848|158145475|FG000|Overall Study|Patient Moved|6|||
49084624|NCT00289848|158145476|FG001|Overall Study|Patient Moved|2|||
49084625|NCT00289848|158145475|FG000|Overall Study|Open-Label AHA Treatment Requested|0|||
49084626|NCT00289848|158145476|FG001|Overall Study|Open-Label AHA Treatment Requested|1|||
49084627|NCT00162981|158145477|FG000|Overall Study|Adverse Event|2|||
49084628|NCT00162981|158145478|FG001|Overall Study|Adverse Event|5|||
49084629|NCT00162981|158145477|FG000|Overall Study|Withdrawal by Subject|1|||
49084630|NCT00162981|158145478|FG001|Overall Study|Withdrawal by Subject|1|||
49084631|NCT00162981|158145477|FG000|Overall Study|Physician Decision|1|||
49084632|NCT00162981|158145478|FG001|Overall Study|Physician Decision|0|||
49084633|NCT00991887|158145487|FG000|Overall Study|Lost to Follow-up|2|||
49084634|NCT00991887|158145488|FG001|Overall Study|Lost to Follow-up|1|||
49084635|NCT04030299|158145490|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
49084636|NCT04030299|158145490|FG000|Overall Study|Withdrawal by Subject|3|||
49084637|NCT02137252|158145491|FG000|Overall Study|trial terminated early|2|||
49084638|NCT02137252|158145492|FG001|Overall Study|trial terminated early|1|||
49084639|NCT00711087|158145493|FG000|Overall Study|Lost to Follow-up|1|||
49084640|NCT00711087|158145494|FG001|Overall Study|Lost to Follow-up|0|||
49084641|NCT01753999|158145495|FG000|Period 1 - Initial Assignment|Physician Decision|2|||
49084642|NCT01753999|158145496|FG001|Period 1 - Initial Assignment|Physician Decision|3|||
49084643|NCT01753999|158145495|FG000|Period 1 - Initial Assignment|Withdrawal by Subject|19|||
49084644|NCT01753999|158145496|FG001|Period 1 - Initial Assignment|Withdrawal by Subject|20|||
49084645|NCT01753999|158145495|FG000|Period 1 - Initial Assignment|Lost to Follow-up|18|||
49084646|NCT01753999|158145496|FG001|Period 1 - Initial Assignment|Lost to Follow-up|27|||
49084647|NCT01753999|158145495|FG000|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13|||
49084648|NCT01753999|158145496|FG001|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17|||
49084649|NCT01753999|158145495|FG000|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3|||
49084650|NCT01753999|158145496|FG001|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5|||
49084651|NCT01753999|158145495|FG000|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
49084652|NCT01753999|158145496|FG001|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
49084653|NCT00793871|158145499|FG000|Overall Study|Death|50|||
49084654|NCT00793871|158145499|FG000|Overall Study|Lost to Follow-up|3|||
49084655|NCT00793871|158145499|FG000|Overall Study|Study terminated by the Sponsor|7|||
49084656|NCT04509076|158145501|FG000|Overall Study|Withdrawal by Subject|1|||
49084657|NCT04509076|158145502|FG001|Overall Study|Withdrawal by Subject|2|||
49084658|NCT04509076|158145501|FG000|Overall Study|Lost to Follow-up|1|||
49084659|NCT04509076|158145502|FG001|Overall Study|Lost to Follow-up|2|||
49084660|NCT02500589|158145503|FG000|Overall Study|Withdrawal by Subject|11|||
49084661|NCT02500589|158145504|FG001|Overall Study|Withdrawal by Subject|14|||
49084662|NCT02500589|158145503|FG000|Overall Study|Lost to Follow-up|10|||
49084663|NCT02500589|158145504|FG001|Overall Study|Lost to Follow-up|12|||
49084664|NCT02500589|158145503|FG000|Overall Study|Excluded post rand: cognitive impairment|0|||
49084665|NCT02500589|158145504|FG001|Overall Study|Excluded post rand: cognitive impairment|1|||
49084666|NCT02500589|158145503|FG000|Overall Study|Death|7|||
49084667|NCT02500589|158145504|FG001|Overall Study|Death|5|||
49084668|NCT02712320|158145505|FG000|Overall Study|Lost to Follow-up|1|||
49084669|NCT02712320|158145505|FG000|Overall Study|Withdrawal by Subject|1|||
49084670|NCT02712320|158145505|FG000|Overall Study|Transferred to another facility|1|||
49084671|NCT02712320|158145505|FG000|Overall Study|Treating with the prohibited medications|2|||
49084672|NCT00245466|158145508|FG000|Overall Study|Adverse Event|2|||
49084673|NCT00245466|158145509|FG001|Overall Study|Adverse Event|8|||
49084674|NCT00245466|158145510|FG002|Overall Study|Adverse Event|4|||
49084675|NCT00245466|158145508|FG000|Overall Study|Low prostate specific antigen suppr|16|||
49084676|NCT00245466|158145509|FG001|Overall Study|Low prostate specific antigen suppr|14|||
49084677|NCT00245466|158145510|FG002|Overall Study|Low prostate specific antigen suppr|5|||
49084678|NCT00245466|158145508|FG000|Overall Study|Insufficient testosterone suppr|12|||
49084679|NCT00245466|158145509|FG001|Overall Study|Insufficient testosterone suppr|12|||
49084680|NCT00245466|158145510|FG002|Overall Study|Insufficient testosterone suppr|21|||
49084681|NCT00245466|158145508|FG000|Overall Study|Insufficient PSA and testosterone suppr|0|||
49084682|NCT00245466|158145509|FG001|Overall Study|Insufficient PSA and testosterone suppr|0|||
49084683|NCT00245466|158145510|FG002|Overall Study|Insufficient PSA and testosterone suppr|3|||
49084684|NCT00245466|158145508|FG000|Overall Study|Withdrawal by Subject|2|||
49084685|NCT00245466|158145509|FG001|Overall Study|Withdrawal by Subject|2|||
49084686|NCT00245466|158145510|FG002|Overall Study|Withdrawal by Subject|1|||
49084687|NCT00245466|158145508|FG000|Overall Study|Lost to Follow-up|3|||
49084688|NCT00245466|158145509|FG001|Overall Study|Lost to Follow-up|0|||
49084689|NCT00245466|158145510|FG002|Overall Study|Lost to Follow-up|0|||
49084690|NCT00245466|158145508|FG000|Overall Study|Disease progression|0|||
49084691|NCT00245466|158145509|FG001|Overall Study|Disease progression|3|||
49084692|NCT00245466|158145510|FG002|Overall Study|Disease progression|1|||
49084693|NCT00245466|158145508|FG000|Overall Study|Protocol Violation|1|||
49084694|NCT00245466|158145509|FG001|Overall Study|Protocol Violation|2|||
49084695|NCT00245466|158145510|FG002|Overall Study|Protocol Violation|2|||
49084696|NCT00245466|158145508|FG000|Overall Study|Death|0|||
49084697|NCT00245466|158145509|FG001|Overall Study|Death|2|||
49084698|NCT00245466|158145510|FG002|Overall Study|Death|0|||
49084699|NCT00245466|158145508|FG000|Overall Study|Administrative reasons|0|||
49084700|NCT00245466|158145509|FG001|Overall Study|Administrative reasons|1|||
49084701|NCT00245466|158145510|FG002|Overall Study|Administrative reasons|0|||
49084702|NCT02288325|158145511|FG000|Run-in Period|Adverse Event|48|||
49084703|NCT02288325|158145512|FG001|Run-in Period|Adverse Event|0|||
49084704|NCT02288325|158145513|FG002|Run-in Period|Adverse Event|0|||
49084705|NCT02288325|158145511|FG000|Run-in Period|Lack of Efficacy|16|||
49084706|NCT02288325|158145512|FG001|Run-in Period|Lack of Efficacy|0|||
49084707|NCT02288325|158145513|FG002|Run-in Period|Lack of Efficacy|0|||
49084708|NCT02288325|158145511|FG000|Run-in Period|Withdrawal of Consent|28|||
49084709|NCT02288325|158145512|FG001|Run-in Period|Withdrawal of Consent|0|||
49084710|NCT02288325|158145513|FG002|Run-in Period|Withdrawal of Consent|0|||
49084711|NCT02288325|158145511|FG000|Run-in Period|Lost to Follow-up|25|||
49084712|NCT02288325|158145512|FG001|Run-in Period|Lost to Follow-up|0|||
49084713|NCT02288325|158145513|FG002|Run-in Period|Lost to Follow-up|0|||
49084714|NCT02288325|158145511|FG000|Run-in Period|Protocol Violation|17|||
49084715|NCT02288325|158145512|FG001|Run-in Period|Protocol Violation|0|||
49084716|NCT02288325|158145513|FG002|Run-in Period|Protocol Violation|0|||
49084717|NCT02288325|158145511|FG000|Run-in Period|Non-Compliance With Study Drug|3|||
49084718|NCT02288325|158145512|FG001|Run-in Period|Non-Compliance With Study Drug|0|||
49084719|NCT02288325|158145513|FG002|Run-in Period|Non-Compliance With Study Drug|0|||
49084720|NCT02288325|158145511|FG000|Run-in Period|Reason not Specified|8|||
49084721|NCT02288325|158145512|FG001|Run-in Period|Reason not Specified|0|||
49084722|NCT02288325|158145513|FG002|Run-in Period|Reason not Specified|0|||
49084723|NCT02288325|158145511|FG000|Stabilization Period|Adverse Event|13|||
49084724|NCT02288325|158145512|FG001|Stabilization Period|Adverse Event|0|||
49084725|NCT02288325|158145513|FG002|Stabilization Period|Adverse Event|0|||
49084726|NCT02288325|158145511|FG000|Stabilization Period|Lack of Efficacy|22|||
49084727|NCT02288325|158145512|FG001|Stabilization Period|Lack of Efficacy|0|||
49084728|NCT02288325|158145513|FG002|Stabilization Period|Lack of Efficacy|0|||
49084729|NCT02288325|158145511|FG000|Stabilization Period|Withdrawal of Consent|23|||
49084730|NCT02288325|158145512|FG001|Stabilization Period|Withdrawal of Consent|0|||
49084731|NCT02288325|158145513|FG002|Stabilization Period|Withdrawal of Consent|0|||
49084732|NCT02288325|158145511|FG000|Stabilization Period|Lost to Follow-up|12|||
49084733|NCT02288325|158145512|FG001|Stabilization Period|Lost to Follow-up|0|||
49084734|NCT02288325|158145513|FG002|Stabilization Period|Lost to Follow-up|0|||
49084735|NCT02288325|158145511|FG000|Stabilization Period|Protocol Violation|8|||
49084736|NCT02288325|158145512|FG001|Stabilization Period|Protocol Violation|0|||
49084737|NCT02288325|158145513|FG002|Stabilization Period|Protocol Violation|0|||
49084738|NCT02288325|158145511|FG000|Stabilization Period|Non-Compliance With Study Drug|5|||
49084739|NCT02288325|158145512|FG001|Stabilization Period|Non-Compliance With Study Drug|0|||
49084740|NCT02288325|158145513|FG002|Stabilization Period|Non-Compliance With Study Drug|0|||
49084741|NCT02288325|158145511|FG000|Stabilization Period|Reason not Specified|15|||
49084742|NCT02288325|158145512|FG001|Stabilization Period|Reason not Specified|0|||
49084743|NCT02288325|158145513|FG002|Stabilization Period|Reason not Specified|0|||
49084744|NCT02288325|158145511|FG000|Double-blind Treatment Period|Adverse Event|0|||
49084745|NCT02288325|158145512|FG001|Double-blind Treatment Period|Adverse Event|2|||
49084746|NCT02288325|158145513|FG002|Double-blind Treatment Period|Adverse Event|5|||
49084747|NCT02288325|158145511|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
49084748|NCT02288325|158145512|FG001|Double-blind Treatment Period|Withdrawal of Consent|8|||
49084749|NCT02288325|158145513|FG002|Double-blind Treatment Period|Withdrawal of Consent|8|||
49084750|NCT02288325|158145511|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
49084751|NCT02288325|158145512|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
49084752|NCT02288325|158145513|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
49084753|NCT02288325|158145511|FG000|Double-blind Treatment Period|Protocol Violation|0|||
49084754|NCT02288325|158145512|FG001|Double-blind Treatment Period|Protocol Violation|1|||
49084755|NCT02288325|158145513|FG002|Double-blind Treatment Period|Protocol Violation|2|||
49084756|NCT02288325|158145511|FG000|Double-blind Treatment Period|Non-Compliance With Study Drug|0|||
49084757|NCT02288325|158145512|FG001|Double-blind Treatment Period|Non-Compliance With Study Drug|1|||
49084758|NCT02288325|158145513|FG002|Double-blind Treatment Period|Non-Compliance With Study Drug|4|||
49084759|NCT02288325|158145511|FG000|Double-blind Treatment Period|Multiple Reasons|0|||
49084760|NCT02288325|158145512|FG001|Double-blind Treatment Period|Multiple Reasons|8|||
49084761|NCT02288325|158145513|FG002|Double-blind Treatment Period|Multiple Reasons|2|||
49084762|NCT03802825|158145514|FG000|Overall Study|Lost to follow-up for intervention|12|||
49084763|NCT03802825|158145515|FG001|Overall Study|Lost to follow-up for intervention|3|||
49084764|NCT03802825|158145514|FG000|Overall Study|Received only 1 component of intervention|0|||
49084765|NCT03802825|158145515|FG001|Overall Study|Received only 1 component of intervention|13|||
49084766|NCT03885661|158145516|FG000|Overall Study|Withdrawal by Subject|0|||
49084767|NCT03885661|158145517|FG001|Overall Study|Withdrawal by Subject|1|||
49084768|NCT03885661|158145516|FG000|Overall Study|Unwilling to undergo required study procedure|1|||
49084769|NCT03885661|158145517|FG001|Overall Study|Unwilling to undergo required study procedure|0|||
49084770|NCT05266053|158145520|FG000|Overall Study|Withdrawal by Subject|8|||
49084771|NCT05266053|158145521|FG001|Overall Study|Withdrawal by Subject|4|||
49084772|NCT03652051|158145522|FG000|Stage 1|Adverse Event|0|||
49084773|NCT03652051|158145523|FG001|Stage 1|Adverse Event|5|||
49084774|NCT03652051|158145524|FG002|Stage 1|Adverse Event|7|||
49084775|NCT03652051|158145525|FG003|Stage 1|Adverse Event|1|||
49084776|NCT03652051|158145522|FG000|Stage 1|Withdrawal by Subject|0|||
49084777|NCT03652051|158145523|FG001|Stage 1|Withdrawal by Subject|0|||
49084778|NCT03652051|158145524|FG002|Stage 1|Withdrawal by Subject|1|||
49084779|NCT03652051|158145525|FG003|Stage 1|Withdrawal by Subject|0|||
49084780|NCT03652051|158145522|FG000|Stage 2|Adverse Event|0|||
49084781|NCT03652051|158145523|FG001|Stage 2|Adverse Event|2|||
49084782|NCT03652051|158145524|FG002|Stage 2|Adverse Event|1|||
49084783|NCT03652051|158145525|FG003|Stage 2|Adverse Event|0|||
49084784|NCT03652051|158145522|FG000|Stage 2|Protocol Violation|0|||
49084785|NCT03652051|158145523|FG001|Stage 2|Protocol Violation|1|||
49084786|NCT03652051|158145524|FG002|Stage 2|Protocol Violation|6|||
49084787|NCT03652051|158145525|FG003|Stage 2|Protocol Violation|0|||
49084788|NCT03652051|158145522|FG000|Stage 2|Lost to Follow-up|0|||
49084789|NCT03652051|158145523|FG001|Stage 2|Lost to Follow-up|2|||
49084790|NCT03652051|158145524|FG002|Stage 2|Lost to Follow-up|0|||
49084791|NCT03652051|158145525|FG003|Stage 2|Lost to Follow-up|3|||
49084792|NCT03652051|158145522|FG000|Stage 2|Withdrawal by Subject|0|||
49084793|NCT03652051|158145523|FG001|Stage 2|Withdrawal by Subject|11|||
49084794|NCT03652051|158145524|FG002|Stage 2|Withdrawal by Subject|9|||
49084795|NCT03652051|158145525|FG003|Stage 2|Withdrawal by Subject|3|||
49084796|NCT02232984|158145529|FG000|Overall Study|Withdrawal by Subject|5|||
49084797|NCT02232984|158145529|FG000|Overall Study|Death|1|||
49084798|NCT02232984|158145529|FG000|Overall Study|Investigator withdrawal|10|||
49084799|NCT02232984|158145529|FG000|Overall Study|Device implant unsuccessful|53|||
49084800|NCT02232984|158145529|FG000|Overall Study|not disclosed by site|7|||
49084801|NCT02232984|158145529|FG000|Overall Study|Protocol Violation|1|||
49084802|NCT01343043|158145533|FG000|Overall Study|Disease progression before treatment|1|||
49084803|NCT01343043|158145534|FG001|Overall Study|Disease progression before treatment|0|||
49084804|NCT01343043|158145535|FG002|Overall Study|Disease progression before treatment|0|||
49084805|NCT01343043|158145536|FG003|Overall Study|Disease progression before treatment|0|||
49084806|NCT01343043|158145533|FG000|Overall Study|Withdrawal by Subject|1|||
49084807|NCT01343043|158145534|FG001|Overall Study|Withdrawal by Subject|0|||
49084808|NCT01343043|158145535|FG002|Overall Study|Withdrawal by Subject|0|||
49084809|NCT01343043|158145536|FG003|Overall Study|Withdrawal by Subject|0|||
49084810|NCT01343043|158145533|FG000|Overall Study|Death|1|||
49084811|NCT01343043|158145534|FG001|Overall Study|Death|1|||
49084812|NCT01343043|158145535|FG002|Overall Study|Death|0|||
49084813|NCT01343043|158145536|FG003|Overall Study|Death|1|||
49084814|NCT02394600|158145537|FG000|Overall Study|Adverse Event|3|||
49084815|NCT02394600|158145538|FG001|Overall Study|Adverse Event|0|||
49084816|NCT02394600|158145537|FG000|Overall Study|Lost to Follow-up|0|||
49084817|NCT02394600|158145538|FG001|Overall Study|Lost to Follow-up|1|||
49084818|NCT02394600|158145537|FG000|Overall Study|Withdrawal by Subject|0|||
49084819|NCT02394600|158145538|FG001|Overall Study|Withdrawal by Subject|1|||
49084820|NCT02394600|158145537|FG000|Overall Study|Protocol Violation|1|||
49084821|NCT02394600|158145538|FG001|Overall Study|Protocol Violation|0|||
49084822|NCT01791894|158145539|FG000|Overall Study|Adverse Event|1|||
49084823|NCT02949973|158145542|FG000|Overall Study|Physician Decision|1|||
49084824|NCT01125917|158145543|FG000|Overall Study|Adverse Event|43|||
49084825|NCT01125917|158145543|FG000|Overall Study|Lost to Follow-up|23|||
49084826|NCT01125917|158145543|FG000|Overall Study|Withdrawal by Subject|31|||
49084827|NCT01125917|158145543|FG000|Overall Study|Administrative|223|||
49084828|NCT01125917|158145543|FG000|Overall Study|Lack of Efficacy|19|||
49084829|NCT01786993|158145544|FG000|Overall Study|Death|6|||
49084830|NCT01786993|158145545|FG001|Overall Study|Death|7|||
49084831|NCT01786993|158145544|FG000|Overall Study|Withdrawal by Subject|3|||
49084832|NCT01786993|158145545|FG001|Overall Study|Withdrawal by Subject|2|||
49084833|NCT01786993|158145544|FG000|Overall Study|Lost to Follow-up|0|||
49084834|NCT01786993|158145545|FG001|Overall Study|Lost to Follow-up|1|||
49084835|NCT01786993|158145544|FG000|Overall Study|Subject Non-Compliance|1|||
49084836|NCT01786993|158145545|FG001|Overall Study|Subject Non-Compliance|0|||
49084837|NCT01786993|158145544|FG000|Overall Study|System Explant|1|||
49084838|NCT01786993|158145545|FG001|Overall Study|System Explant|0|||
49084839|NCT01786993|158145544|FG000|Overall Study|Hospice Admission|1|||
49084840|NCT01786993|158145545|FG001|Overall Study|Hospice Admission|0|||
49084841|NCT03307252|158145546|FG000|Part 2, Period 1|Treatment not received|0|||
49084842|NCT03307252|158145547|FG001|Part 2, Period 1|Treatment not received|0|||
49084843|NCT03307252|158145548|FG002|Part 2, Period 1|Treatment not received|0|||
49084844|NCT03307252|158145549|FG003|Part 2, Period 1|Treatment not received|0|||
49084845|NCT03307252|158145550|FG004|Part 2, Period 1|Treatment not received|0|||
49084846|NCT03307252|158145551|FG005|Part 2, Period 1|Treatment not received|1|||
49084847|NCT03307252|158145552|FG006|Part 2, Period 1|Treatment not received|0|||
49084848|NCT03307252|158145553|FG007|Part 2, Period 1|Treatment not received|0|||
49084849|NCT03307252|158145554|FG008|Part 2, Period 1|Treatment not received|0|||
49084850|NCT03307252|158145555|FG009|Part 2, Period 1|Treatment not received|0|||
49084851|NCT03307252|158145556|FG010|Part 2, Period 1|Treatment not received|0|||
49084852|NCT03307252|158145546|FG000|Part 2, Period 3|Other than listed|0|||
49084853|NCT03307252|158145547|FG001|Part 2, Period 3|Other than listed|0|||
49084854|NCT03307252|158145548|FG002|Part 2, Period 3|Other than listed|0|||
49084855|NCT03307252|158145549|FG003|Part 2, Period 3|Other than listed|0|||
49084856|NCT03307252|158145550|FG004|Part 2, Period 3|Other than listed|1|||
49084857|NCT03307252|158145551|FG005|Part 2, Period 3|Other than listed|0|||
49084858|NCT03307252|158145552|FG006|Part 2, Period 3|Other than listed|0|||
49084859|NCT03307252|158145553|FG007|Part 2, Period 3|Other than listed|0|||
49084860|NCT03307252|158145554|FG008|Part 2, Period 3|Other than listed|0|||
49084861|NCT03307252|158145555|FG009|Part 2, Period 3|Other than listed|0|||
49084862|NCT03307252|158145556|FG010|Part 2, Period 3|Other than listed|0|||
49084863|NCT03307252|158145546|FG000|Part 2, Period 4|Other than listed|0|||
49084864|NCT03307252|158145547|FG001|Part 2, Period 4|Other than listed|0|||
49084865|NCT03307252|158145548|FG002|Part 2, Period 4|Other than listed|0|||
49084866|NCT03307252|158145549|FG003|Part 2, Period 4|Other than listed|0|||
49084867|NCT03307252|158145550|FG004|Part 2, Period 4|Other than listed|0|||
49084868|NCT03307252|158145551|FG005|Part 2, Period 4|Other than listed|0|||
49084869|NCT03307252|158145552|FG006|Part 2, Period 4|Other than listed|1|||
49084870|NCT03307252|158145553|FG007|Part 2, Period 4|Other than listed|0|||
49084871|NCT03307252|158145554|FG008|Part 2, Period 4|Other than listed|0|||
49084872|NCT03307252|158145555|FG009|Part 2, Period 4|Other than listed|0|||
49084873|NCT03307252|158145556|FG010|Part 2, Period 4|Other than listed|0|||
49084874|NCT03307252|158145546|FG000|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
49084875|NCT03307252|158145547|FG001|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
49084876|NCT03307252|158145548|FG002|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
49084877|NCT03307252|158145549|FG003|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
49084878|NCT03307252|158145550|FG004|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
49084879|NCT03307252|158145551|FG005|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
49084880|NCT03307252|158145552|FG006|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
49084881|NCT03307252|158145553|FG007|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
49084882|NCT03307252|158145554|FG008|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
49084883|NCT03307252|158145555|FG009|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
49084884|NCT03307252|158145556|FG010|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1|||
49084885|NCT03517540|158145558|FG000|Overall Study|Protocol Violation|2|||
49084886|NCT03517540|158145559|FG001|Overall Study|Protocol Violation|0|||
49084887|NCT03517540|158145560|FG002|Overall Study|Protocol Violation|0|||
49084888|NCT03517540|158145561|FG003|Overall Study|Protocol Violation|1|||
49084889|NCT03517540|158145558|FG000|Overall Study|Adverse Event|9|||
49084890|NCT03517540|158145559|FG001|Overall Study|Adverse Event|3|||
49084891|NCT03517540|158145560|FG002|Overall Study|Adverse Event|8|||
49084892|NCT03517540|158145561|FG003|Overall Study|Adverse Event|1|||
49084893|NCT03517540|158145558|FG000|Overall Study|Withdrawal by Subject|3|||
49084894|NCT03517540|158145559|FG001|Overall Study|Withdrawal by Subject|4|||
49084895|NCT03517540|158145560|FG002|Overall Study|Withdrawal by Subject|1|||
49084896|NCT03517540|158145561|FG003|Overall Study|Withdrawal by Subject|3|||
49084897|NCT03896022|158145567|FG000|Overall Study|Withdrawal by Subject|1|||
49084898|NCT03896022|158145568|FG001|Overall Study|Withdrawal by Subject|0|||
49084899|NCT03896022|158145569|FG002|Overall Study|Withdrawal by Subject|0|||
49084900|NCT03896022|158145567|FG000|Overall Study|Did not have procedure|3|||
49084901|NCT03896022|158145568|FG001|Overall Study|Did not have procedure|0|||
49084902|NCT03896022|158145569|FG002|Overall Study|Did not have procedure|0|||
49084903|NCT00226499|158145576|FG000|Overall Study|Adverse Event|10|||
49084904|NCT00226499|158145577|FG001|Overall Study|Adverse Event|6|||
49084905|NCT00226499|158145578|FG002|Overall Study|Adverse Event|3|||
49084906|NCT00226499|158145576|FG000|Overall Study|Others|1064|||
49084907|NCT00226499|158145577|FG001|Overall Study|Others|1066|||
49084908|NCT00226499|158145578|FG002|Overall Study|Others|356|||
49084909|NCT02712554|158145580|FG000|Part B: Qualification Phase|Drug Discrimination Failure|0|||
49084910|NCT02712554|158145581|FG001|Part B: Qualification Phase|Drug Discrimination Failure|13|||
49084911|NCT02712554|158145580|FG000|Part B: Qualification Phase|Sponsor Decision|0|||
49084912|NCT02712554|158145581|FG001|Part B: Qualification Phase|Sponsor Decision|4|||
49084913|NCT02712554|158145580|FG000|Part B: Qualification Phase|Withdrawal by Subject|0|||
49084914|NCT02712554|158145581|FG001|Part B: Qualification Phase|Withdrawal by Subject|3|||
49084915|NCT02712554|158145580|FG000|Part B: Qualification Phase|Adverse Event|0|||
49084916|NCT02712554|158145581|FG001|Part B: Qualification Phase|Adverse Event|1|||
49084917|NCT02712554|158145580|FG000|Part B: Treatment Phase|Adverse Event|0|||
49084918|NCT02712554|158145581|FG001|Part B: Treatment Phase|Adverse Event|1|||
49084919|NCT02712554|158145580|FG000|Part B: Treatment Phase|Withdrawal by Subject|0|||
49084920|NCT02712554|158145581|FG001|Part B: Treatment Phase|Withdrawal by Subject|1|||
49084921|NCT02712554|158145580|FG000|Part B: Treatment Phase|Other|0|||
49084922|NCT02712554|158145581|FG001|Part B: Treatment Phase|Other|1|||
49084923|NCT01554527|158145582|FG000|Overall Study|Withdrawal by Subject|1|||
49084924|NCT01554527|158145583|FG001|Overall Study|Withdrawal by Subject|0|||
49084925|NCT01554527|158145584|FG002|Overall Study|Withdrawal by Subject|3|||
49084926|NCT01554527|158145582|FG000|Overall Study|Lost to Follow-up|0|||
49084927|NCT01554527|158145583|FG001|Overall Study|Lost to Follow-up|0|||
49084928|NCT01554527|158145584|FG002|Overall Study|Lost to Follow-up|4|||
49084929|NCT01554527|158145582|FG000|Overall Study|Physician Decision|0|||
49084930|NCT01554527|158145583|FG001|Overall Study|Physician Decision|0|||
49084931|NCT01554527|158145584|FG002|Overall Study|Physician Decision|1|||
49084932|NCT00856492|158145587|FG000|Overall Study|Ineligible or withdrew consent|1|||
49084933|NCT00856492|158145588|FG001|Overall Study|Ineligible or withdrew consent|1|||
49084934|NCT00856492|158145589|FG002|Overall Study|Ineligible or withdrew consent|2|||
49084935|NCT01074268|158145590|FG000|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3|||
49084936|NCT01074268|158145591|FG001|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1|||
49084937|NCT01074268|158145590|FG000|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0|||
49084938|NCT01074268|158145591|FG001|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2|||
49084939|NCT01074268|158145590|FG000|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3|||
49084940|NCT01074268|158145591|FG001|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4|||
49084941|NCT01074268|158145590|FG000|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6|||
49084942|NCT01074268|158145591|FG001|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3|||
49084943|NCT01074268|158145590|FG000|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8|||
49084944|NCT01074268|158145591|FG001|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5|||
49084945|NCT01074268|158145590|FG000|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
49084946|NCT01074268|158145591|FG001|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
49084947|NCT01074268|158145590|FG000|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0|||
49084948|NCT01074268|158145591|FG001|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2|||
49084949|NCT01074268|158145590|FG000|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
49084950|NCT01074268|158145591|FG001|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
49084951|NCT01074268|158145590|FG000|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3|||
49084952|NCT01074268|158145591|FG001|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2|||
49084953|NCT01863667|158145594|FG000|Overall Study|Adverse Event|1|||
49084954|NCT01863667|158145595|FG001|Overall Study|Adverse Event|0|||
49084955|NCT01863667|158145594|FG000|Overall Study|Study terminated by Sponsor|30|||
49084956|NCT01863667|158145595|FG001|Overall Study|Study terminated by Sponsor|30|||
49084957|NCT01863667|158145594|FG000|Overall Study|Withdrawal by Subject|2|||
49084958|NCT01863667|158145595|FG001|Overall Study|Withdrawal by Subject|2|||
49084959|NCT02503540|158145596|FG000|Overall Study|Death|2|||
49084960|NCT02503540|158145596|FG000|Overall Study|Withdrawal by Subject|1|||
49084961|NCT01662492|158145597|FG000|Overall Study|Other miscellaneous reasons.|1|||
49084962|NCT01662492|158145598|FG001|Overall Study|Other miscellaneous reasons.|0|||
49084963|NCT01662492|158145599|FG002|Overall Study|Other miscellaneous reasons.|1|||
49084964|NCT01662492|158145597|FG000|Overall Study|Withdrawal by Subject|0|||
49084965|NCT01662492|158145598|FG001|Overall Study|Withdrawal by Subject|0|||
49084966|NCT01662492|158145599|FG002|Overall Study|Withdrawal by Subject|1|||
49084967|NCT01662492|158145597|FG000|Overall Study|Protocol Violation|1|||
49084968|NCT01662492|158145598|FG001|Overall Study|Protocol Violation|0|||
49084969|NCT01662492|158145599|FG002|Overall Study|Protocol Violation|0|||
49084970|NCT01662492|158145597|FG000|Overall Study|Lost to Follow-up|0|||
49084971|NCT01662492|158145598|FG001|Overall Study|Lost to Follow-up|0|||
49084972|NCT01662492|158145599|FG002|Overall Study|Lost to Follow-up|2|||
49084973|NCT01662492|158145597|FG000|Overall Study|Lack of Efficacy|1|||
49084974|NCT01662492|158145598|FG001|Overall Study|Lack of Efficacy|1|||
49084975|NCT01662492|158145599|FG002|Overall Study|Lack of Efficacy|2|||
49084976|NCT01591096|158145602|FG000|Overall Study|Adverse Event|1|||
49084977|NCT01831635|158145603|FG000|Overall Study|Withdrawal by Subject|0|||
49084978|NCT01831635|158145604|FG001|Overall Study|Withdrawal by Subject|2|||
49084979|NCT01831635|158145605|FG002|Overall Study|Withdrawal by Subject|0|||
49084980|NCT00315458|158145611|FG000|Overall Study|Administrative|0|||
49084981|NCT00315458|158145612|FG001|Overall Study|Administrative|3|||
49084982|NCT00315458|158145613|FG002|Overall Study|Administrative|8|||
49084983|NCT00315458|158145614|FG003|Overall Study|Administrative|21|||
49084984|NCT00315458|158145611|FG000|Overall Study|Adverse Event|2|||
49084985|NCT00315458|158145612|FG001|Overall Study|Adverse Event|4|||
49084986|NCT00315458|158145613|FG002|Overall Study|Adverse Event|23|||
49084987|NCT00315458|158145614|FG003|Overall Study|Adverse Event|3|||
49084988|NCT00315458|158145611|FG000|Overall Study|Lost to Follow-up|1|||
49084989|NCT00315458|158145612|FG001|Overall Study|Lost to Follow-up|2|||
49084990|NCT00315458|158145613|FG002|Overall Study|Lost to Follow-up|0|||
49084991|NCT00315458|158145614|FG003|Overall Study|Lost to Follow-up|2|||
49084992|NCT00315458|158145611|FG000|Overall Study|Withdrawal by Subject|0|||
49084993|NCT00315458|158145612|FG001|Overall Study|Withdrawal by Subject|3|||
49084994|NCT00315458|158145613|FG002|Overall Study|Withdrawal by Subject|0|||
49084995|NCT00315458|158145614|FG003|Overall Study|Withdrawal by Subject|2|||
49084996|NCT00315458|158145611|FG000|Overall Study|Lack of Efficacy|0|||
49084997|NCT00315458|158145612|FG001|Overall Study|Lack of Efficacy|0|||
49084998|NCT00315458|158145613|FG002|Overall Study|Lack of Efficacy|20|||
49084999|NCT00315458|158145614|FG003|Overall Study|Lack of Efficacy|1|||
49085000|NCT00315458|158145611|FG000|Overall Study|Did not qualify|0|||
49085001|NCT00315458|158145612|FG001|Overall Study|Did not qualify|0|||
49085002|NCT00315458|158145613|FG002|Overall Study|Did not qualify|1|||
49085003|NCT00315458|158145614|FG003|Overall Study|Did not qualify|0|||
49085004|NCT01207687|158145615|FG000|Overall Study|Adverse Event|1|||
49085005|NCT01207687|158145615|FG000|Overall Study|Withdrawal by Subject|1|||
49085006|NCT02907177|158147412|FG000|Overall Study|Death|0|||
49085007|NCT02907177|158147413|FG001|Overall Study|Death|1|||
49085008|NCT02907177|158147412|FG000|Overall Study|Physician Decision|3|||
49085009|NCT02907177|158147413|FG001|Overall Study|Physician Decision|3|||
49085010|NCT02907177|158147412|FG000|Overall Study|Withdrawal by Subject|15|||
49085011|NCT02907177|158147413|FG001|Overall Study|Withdrawal by Subject|7|||
49085012|NCT02907177|158147412|FG000|Overall Study|Sponsor's Decision|50|||
49085013|NCT02907177|158147413|FG001|Overall Study|Sponsor's Decision|57|||
49085014|NCT02630251|158147414|FG000|Overall Study|Physician Decision|0|||
49085015|NCT02630251|158147415|FG001|Overall Study|Physician Decision|0|||
49085016|NCT02630251|158147416|FG002|Overall Study|Physician Decision|1|||
49085017|NCT02630251|158147417|FG003|Overall Study|Physician Decision|0|||
49085018|NCT02810457|158147418|FG000|Overall Study|Randomised but no treatment received|2|||
49085019|NCT02810457|158147419|FG001|Overall Study|Randomised but no treatment received|1|||
49085020|NCT02810457|158147418|FG000|Overall Study|Objective PD assessed by RECIST v1.1|191|||
49085021|NCT02810457|158147419|FG001|Overall Study|Objective PD assessed by RECIST v1.1|199|||
49085022|NCT02810457|158147418|FG000|Overall Study|Adverse Event|37|||
49085023|NCT02810457|158147419|FG001|Overall Study|Adverse Event|43|||
49085024|NCT02810457|158147418|FG000|Overall Study|Patient decision|31|||
49085025|NCT02810457|158147419|FG001|Overall Study|Patient decision|35|||
49085026|NCT02810457|158147418|FG000|Overall Study|Patient lost to follow-up|2|||
49085027|NCT02810457|158147419|FG001|Overall Study|Patient lost to follow-up|2|||
49085028|NCT02810457|158147418|FG000|Overall Study|Death|39|||
49085029|NCT02810457|158147419|FG001|Overall Study|Death|28|||
49085030|NCT02810457|158147418|FG000|Overall Study|Ongoing at data cutoff and discontinued|3|||
49085031|NCT02810457|158147419|FG001|Overall Study|Ongoing at data cutoff and discontinued|2|||
49085032|NCT02810457|158147418|FG000|Overall Study|Clinical progression|15|||
49085033|NCT02810457|158147419|FG001|Overall Study|Clinical progression|16|||
49085034|NCT02810457|158147418|FG000|Overall Study|Investigator decision|3|||
49085035|NCT02810457|158147419|FG001|Overall Study|Investigator decision|2|||
49085036|NCT02810457|158147418|FG000|Overall Study|Patient ineligibility|3|||
49085037|NCT02810457|158147419|FG001|Overall Study|Patient ineligibility|0|||
49085038|NCT02810457|158147418|FG000|Overall Study|Miscalculated PD|1|||
49085039|NCT02810457|158147419|FG001|Overall Study|Miscalculated PD|0|||
49085040|NCT02810457|158147418|FG000|Overall Study|Physician Decision|0|||
49085041|NCT02810457|158147419|FG001|Overall Study|Physician Decision|1|||
49085042|NCT01842438|158147420|FG000|T1: Immediately After the Intervention|Withdrawal by Subject|6|||
49085043|NCT01842438|158147421|FG001|T1: Immediately After the Intervention|Withdrawal by Subject|8|||
49085044|NCT01842438|158147420|FG000|T2: 6month Follow-up|Withdrawal by Subject|4|||
49085045|NCT01842438|158147421|FG001|T2: 6month Follow-up|Withdrawal by Subject|3|||
49085046|NCT01842438|158147420|FG000|T2: 6month Follow-up|Death|0|||
49085047|NCT01842438|158147421|FG001|T2: 6month Follow-up|Death|1|||
49085048|NCT00782626|158147425|FG000|Overall Study|Adverse Event|1|||
49085049|NCT00782626|158147425|FG000|Overall Study|Progressive Disease|5|||
49085050|NCT00782626|158147425|FG000|Overall Study|Other Complicating Disease|1|||
49085051|NCT01692626|158147426|FG000|Overall Study|Death|0|||
49085052|NCT01692626|158147427|FG001|Overall Study|Death|1|||
49085053|NCT01692626|158147426|FG000|Overall Study|Adverse Event|2|||
49085054|NCT01692626|158147427|FG001|Overall Study|Adverse Event|3|||
49085055|NCT01692626|158147426|FG000|Overall Study|Protocol Violation|1|||
49085056|NCT01692626|158147427|FG001|Overall Study|Protocol Violation|2|||
49085057|NCT01692626|158147426|FG000|Overall Study|Withdrawal by Subject|1|||
49085058|NCT01692626|158147427|FG001|Overall Study|Withdrawal by Subject|0|||
49085059|NCT03989102|158147428|FG000|Year 1|Withdrawal by Subject|6|||
49085060|NCT03989102|158147429|FG001|Year 1|Withdrawal by Subject|2|||
49085061|NCT03989102|158147430|FG002|Year 1|Withdrawal by Subject|7|||
49085062|NCT03989102|158147428|FG000|Year 1|Lost to Follow-up|5|||
49085063|NCT03989102|158147429|FG001|Year 1|Lost to Follow-up|2|||
49085064|NCT03989102|158147430|FG002|Year 1|Lost to Follow-up|5|||
49085065|NCT03989102|158147428|FG000|Year 1|Subject met withdrawal criteria|1|||
49085066|NCT03989102|158147429|FG001|Year 1|Subject met withdrawal criteria|0|||
49085067|NCT03989102|158147430|FG002|Year 1|Subject met withdrawal criteria|1|||
49085068|NCT03989102|158147428|FG000|Year 2|Lost to Follow-up|7|||
49085069|NCT03989102|158147429|FG001|Year 2|Lost to Follow-up|3|||
49085070|NCT03989102|158147430|FG002|Year 2|Lost to Follow-up|4|||
49085071|NCT03989102|158147428|FG000|Year 2|Withdrawal by Subject|3|||
49085072|NCT03989102|158147429|FG001|Year 2|Withdrawal by Subject|1|||
49085073|NCT03989102|158147430|FG002|Year 2|Withdrawal by Subject|2|||
49085074|NCT03989102|158147428|FG000|Year 2|Subject non-compliant|3|||
49085075|NCT03989102|158147429|FG001|Year 2|Subject non-compliant|2|||
49085076|NCT03989102|158147430|FG002|Year 2|Subject non-compliant|0|||
49085077|NCT03989102|158147428|FG000|Year 2|Travel|1|||
49085078|NCT03989102|158147429|FG001|Year 2|Travel|0|||
49085079|NCT03989102|158147430|FG002|Year 2|Travel|1|||
49085080|NCT03989102|158147428|FG000|Year 2|P16 missing|4|||
49085081|NCT03989102|158147429|FG001|Year 2|P16 missing|2|||
49085082|NCT03989102|158147430|FG002|Year 2|P16 missing|1|||
49085083|NCT03989102|158147428|FG000|Year 2|P11 missing|1|||
49085084|NCT03989102|158147429|FG001|Year 2|P11 missing|3|||
49085085|NCT03989102|158147430|FG002|Year 2|P11 missing|7|||
49085086|NCT03989102|158147428|FG000|Year 2|Definitive displacement outside the study site|0|||
49085087|NCT03989102|158147429|FG001|Year 2|Definitive displacement outside the study site|1|||
49085088|NCT03989102|158147430|FG002|Year 2|Definitive displacement outside the study site|0|||
49085089|NCT03989102|158147428|FG000|Year 2|Subject missed last study visit|0|||
49085090|NCT03989102|158147429|FG001|Year 2|Subject missed last study visit|1|||
49085091|NCT03989102|158147430|FG002|Year 2|Subject missed last study visit|0|||
49085092|NCT03989102|158147428|FG000|Year 2|Death|0|||
49085093|NCT03989102|158147429|FG001|Year 2|Death|1|||
49085094|NCT03989102|158147430|FG002|Year 2|Death|0|||
49085095|NCT03989102|158147428|FG000|Year 2|Subject not reachable|0|||
49085096|NCT03989102|158147429|FG001|Year 2|Subject not reachable|0|||
49085097|NCT03989102|158147430|FG002|Year 2|Subject not reachable|1|||
49085098|NCT03989102|158147428|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|1|||
49085099|NCT03989102|158147429|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
49085100|NCT03989102|158147430|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
49085101|NCT03989102|158147428|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
49085102|NCT03989102|158147429|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
49085103|NCT03989102|158147430|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
49085104|NCT03989102|158147428|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|1|||
49085105|NCT03989102|158147429|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
49085106|NCT03989102|158147430|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
49085107|NCT03989102|158147428|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|2|||
49085108|NCT03989102|158147429|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|1|||
49085109|NCT03989102|158147430|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|0|||
49085110|NCT03989102|158147428|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
49085111|NCT03989102|158147429|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Travel|3|||
49085112|NCT03989102|158147430|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
49085113|NCT03989102|158147428|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
49085114|NCT03989102|158147429|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
49085115|NCT03989102|158147430|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|1|||
49085116|NCT01402570|158147433|FG000|Overall Study|Adverse Event|1|||
49085117|NCT01467713|158147434|FG000|Overall Study|Pretreatment Event or Adverse Event|9|||
49085118|NCT01467713|158147435|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
49085119|NCT01467713|158147436|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
49085120|NCT01467713|158147437|FG003|Overall Study|Pretreatment Event or Adverse Event|5|||
49085121|NCT01467713|158147434|FG000|Overall Study|Major Protocol Deviation|2|||
49085122|NCT01467713|158147435|FG001|Overall Study|Major Protocol Deviation|4|||
49085123|NCT01467713|158147436|FG002|Overall Study|Major Protocol Deviation|4|||
49085124|NCT01467713|158147437|FG003|Overall Study|Major Protocol Deviation|1|||
49085125|NCT01467713|158147434|FG000|Overall Study|Lost to Follow-up|9|||
49085126|NCT01467713|158147435|FG001|Overall Study|Lost to Follow-up|12|||
49085127|NCT01467713|158147436|FG002|Overall Study|Lost to Follow-up|6|||
49085128|NCT01467713|158147437|FG003|Overall Study|Lost to Follow-up|9|||
49085129|NCT01467713|158147434|FG000|Overall Study|Voluntary Withdrawal|18|||
49085130|NCT01467713|158147435|FG001|Overall Study|Voluntary Withdrawal|14|||
49085131|NCT01467713|158147436|FG002|Overall Study|Voluntary Withdrawal|21|||
49085132|NCT01467713|158147437|FG003|Overall Study|Voluntary Withdrawal|20|||
49085133|NCT01467713|158147434|FG000|Overall Study|Study Termination|23|||
49085134|NCT01467713|158147435|FG001|Overall Study|Study Termination|33|||
49085135|NCT01467713|158147436|FG002|Overall Study|Study Termination|28|||
49085136|NCT01467713|158147437|FG003|Overall Study|Study Termination|29|||
49085137|NCT01467713|158147434|FG000|Overall Study|Pregnancy|0|||
49085138|NCT01467713|158147435|FG001|Overall Study|Pregnancy|1|||
49085139|NCT01467713|158147436|FG002|Overall Study|Pregnancy|1|||
49085140|NCT01467713|158147437|FG003|Overall Study|Pregnancy|3|||
49085141|NCT01467713|158147434|FG000|Overall Study|Relapse|35|||
49085142|NCT01467713|158147435|FG001|Overall Study|Relapse|25|||
49085143|NCT01467713|158147436|FG002|Overall Study|Relapse|28|||
49085144|NCT01467713|158147437|FG003|Overall Study|Relapse|35|||
49085145|NCT01467713|158147434|FG000|Overall Study|Reason not Specified|6|||
49085146|NCT01467713|158147435|FG001|Overall Study|Reason not Specified|11|||
49085147|NCT01467713|158147436|FG002|Overall Study|Reason not Specified|8|||
49085148|NCT01467713|158147437|FG003|Overall Study|Reason not Specified|7|||
49085149|NCT04909853|158147438|FG000|Part 1|Assigned but not treated|0|||
49085150|NCT04909853|158147439|FG001|Part 1|Assigned but not treated|0|||
49085151|NCT04909853|158147440|FG002|Part 1|Assigned but not treated|1|||
49085152|NCT04909853|158147441|FG003|Part 1|Assigned but not treated|0|||
49085153|NCT04909853|158147438|FG000|Part 2|Adverse Event|0|||
49085154|NCT04909853|158147439|FG001|Part 2|Adverse Event|0|||
49085155|NCT04909853|158147440|FG002|Part 2|Adverse Event|0|||
49085156|NCT04909853|158147441|FG003|Part 2|Adverse Event|1|||
49085157|NCT03642262|158147442|FG000|Period 1|Withdrawal by Subject|1|||
49085158|NCT03642262|158147443|FG001|Period 1|Withdrawal by Subject|1|||
49085159|NCT03642262|158147442|FG000|Period 1|Adverse Event|0|||
49085160|NCT03642262|158147443|FG001|Period 1|Adverse Event|1|||
49085161|NCT01125189|158147444|FG000|Treatment Period|Lack of Efficacy|15|||
49085162|NCT01125189|158147445|FG001|Treatment Period|Lack of Efficacy|18|||
49085163|NCT01125189|158147446|FG002|Treatment Period|Lack of Efficacy|25|||
49085164|NCT01125189|158147444|FG000|Treatment Period|Adverse Event|7|||
49085165|NCT01125189|158147445|FG001|Treatment Period|Adverse Event|8|||
49085166|NCT01125189|158147446|FG002|Treatment Period|Adverse Event|8|||
49085167|NCT01125189|158147444|FG000|Treatment Period|Withdrawal by Subject|3|||
49085168|NCT01125189|158147445|FG001|Treatment Period|Withdrawal by Subject|1|||
49085169|NCT01125189|158147446|FG002|Treatment Period|Withdrawal by Subject|1|||
49085170|NCT01125189|158147444|FG000|Treatment Period|Death|1|||
49085171|NCT01125189|158147445|FG001|Treatment Period|Death|0|||
49085172|NCT01125189|158147446|FG002|Treatment Period|Death|0|||
49085173|NCT01125189|158147444|FG000|Treatment Period|Lost to Follow-up|1|||
49085174|NCT01125189|158147445|FG001|Treatment Period|Lost to Follow-up|2|||
49085175|NCT01125189|158147446|FG002|Treatment Period|Lost to Follow-up|1|||
49085176|NCT01125189|158147444|FG000|Treatment Period|Poor compliance/noncompliance|0|||
49085177|NCT01125189|158147445|FG001|Treatment Period|Poor compliance/noncompliance|1|||
49085178|NCT01125189|158147446|FG002|Treatment Period|Poor compliance/noncompliance|0|||
49085179|NCT01125189|158147444|FG000|Treatment Period|Participants requested to discontinue|1|||
49085180|NCT01125189|158147445|FG001|Treatment Period|Participants requested to discontinue|3|||
49085181|NCT01125189|158147446|FG002|Treatment Period|Participants requested to discontinue|4|||
49085182|NCT01125189|158147444|FG000|Treatment Period|Other reasons|1|||
49085183|NCT01125189|158147445|FG001|Treatment Period|Other reasons|1|||
49085184|NCT01125189|158147446|FG002|Treatment Period|Other reasons|0|||
49085185|NCT01125189|158147444|FG000|Treatment Period|Completed 24 week treatment period only|2|||
49085186|NCT01125189|158147445|FG001|Treatment Period|Completed 24 week treatment period only|1|||
49085187|NCT01125189|158147446|FG002|Treatment Period|Completed 24 week treatment period only|2|||
49085188|NCT01125189|158147444|FG000|Follow up Period|Withdrawal by Subject|3|||
49085189|NCT01125189|158147445|FG001|Follow up Period|Withdrawal by Subject|2|||
49085190|NCT01125189|158147446|FG002|Follow up Period|Withdrawal by Subject|5|||
49085191|NCT01125189|158147444|FG000|Follow up Period|Death|1|||
49085192|NCT01125189|158147445|FG001|Follow up Period|Death|0|||
49085193|NCT01125189|158147446|FG002|Follow up Period|Death|0|||
49085194|NCT01125189|158147444|FG000|Follow up Period|Lost to Follow-up|12|||
49085195|NCT01125189|158147445|FG001|Follow up Period|Lost to Follow-up|9|||
49085196|NCT01125189|158147446|FG002|Follow up Period|Lost to Follow-up|6|||
49085197|NCT01125189|158147444|FG000|Follow up Period|Other reasons|4|||
49085198|NCT01125189|158147445|FG001|Follow up Period|Other reasons|4|||
49085199|NCT01125189|158147446|FG002|Follow up Period|Other reasons|5|||
49085200|NCT01234350|158147447|FG000|Overall Study|Adverse Event|277|||
49085201|NCT01234350|158147448|FG001|Overall Study|Adverse Event|92|||
49085202|NCT01234350|158147447|FG000|Overall Study|Withdrawal by Subject|61|||
49085203|NCT01234350|158147448|FG001|Overall Study|Withdrawal by Subject|36|||
49085204|NCT01234350|158147447|FG000|Overall Study|Lost to Follow-up|115|||
49085205|NCT01234350|158147448|FG001|Overall Study|Lost to Follow-up|47|||
49085206|NCT01234350|158147447|FG000|Overall Study|Covers a diverse set of reasons|234|||
49085207|NCT01234350|158147448|FG001|Overall Study|Covers a diverse set of reasons|92|||
49085208|NCT01199939|158147451|FG000|Overall Study|Adverse Event|4|||
49085209|NCT01199939|158147451|FG000|Overall Study|Protocol Violation|3|||
49085210|NCT01199939|158147451|FG000|Overall Study|Lost to Follow-up|2|||
49085211|NCT01199939|158147451|FG000|Overall Study|Reached a virologic endpoint|4|||
49085212|NCT04620746|158147454|FG000|Overall Study|Adverse Event|2|||
49085213|NCT04620746|158147455|FG001|Overall Study|Adverse Event|0|||
49085214|NCT04620746|158147454|FG000|Overall Study|Uniterpretable skin test|1|||
49085215|NCT04620746|158147455|FG001|Overall Study|Uniterpretable skin test|0|||
49085216|NCT04620746|158147454|FG000|Overall Study|Withdrawal by Subject|0|||
49085217|NCT04620746|158147455|FG001|Overall Study|Withdrawal by Subject|1|||
49085218|NCT00811733|158147464|FG000|Overall Study|Investigator Discretion|10|||
49085219|NCT00811733|158147465|FG001|Overall Study|Investigator Discretion|8|||
49085220|NCT00811733|158147464|FG000|Overall Study|Withdrawal by Subject|1|||
49085221|NCT00811733|158147465|FG001|Overall Study|Withdrawal by Subject|2|||
49085222|NCT00856193|158147466|FG000|Period 2|Abnormal test procedure results|0|||
49085223|NCT00856193|158147467|FG001|Period 2|Abnormal test procedure results|1|||
49085224|NCT00856193|158147466|FG000|Period 2|Lost to Follow-up|0|||
49085225|NCT00856193|158147467|FG001|Period 2|Lost to Follow-up|1|||
49085226|NCT05064397|158147468|FG000|Overall Study|Adverse Event|4|||
49085227|NCT05064397|158147468|FG000|Overall Study|Lack of Efficacy|12|||
49085228|NCT05064397|158147468|FG000|Overall Study|Withdrawal by Subject|3|||
49085229|NCT05064397|158147468|FG000|Overall Study|Lost to Follow-up|1|||
49085230|NCT05064397|158147468|FG000|Overall Study|Other reasons|3|||
49085231|NCT00063934|158147470|FG000|Overall Study|Ineligible|1|||
49085232|NCT04341363|158147471|FG000|Overall Study|Adverse Event|1|||
49085233|NCT04341363|158147471|FG000|Overall Study|Withdrawal by Subject|1|||
49085234|NCT03351608|158147472|FG000|Overall Study|Lost to Follow-up|0|||
49085235|NCT03351608|158147473|FG001|Overall Study|Lost to Follow-up|1|||
49085236|NCT03351608|158147474|FG002|Overall Study|Lost to Follow-up|1|||
49085237|NCT03351608|158147475|FG003|Overall Study|Lost to Follow-up|1|||
49085238|NCT03351608|158147476|FG004|Overall Study|Lost to Follow-up|1|||
49085239|NCT03351608|158147472|FG000|Overall Study|Physician Decision|1|||
49085240|NCT03351608|158147473|FG001|Overall Study|Physician Decision|0|||
49085241|NCT03351608|158147474|FG002|Overall Study|Physician Decision|0|||
49085242|NCT03351608|158147475|FG003|Overall Study|Physician Decision|2|||
49085243|NCT03351608|158147476|FG004|Overall Study|Physician Decision|1|||
49085244|NCT03351608|158147472|FG000|Overall Study|Randomized by mistake, no treatment given|0|||
49085245|NCT03351608|158147473|FG001|Overall Study|Randomized by mistake, no treatment given|0|||
49085246|NCT03351608|158147474|FG002|Overall Study|Randomized by mistake, no treatment given|0|||
49085247|NCT03351608|158147475|FG003|Overall Study|Randomized by mistake, no treatment given|1|||
49085248|NCT03351608|158147476|FG004|Overall Study|Randomized by mistake, no treatment given|0|||
49085249|NCT03351608|158147472|FG000|Overall Study|Withdrawal by parent/guardian|0|||
49085250|NCT03351608|158147473|FG001|Overall Study|Withdrawal by parent/guardian|0|||
49085251|NCT03351608|158147474|FG002|Overall Study|Withdrawal by parent/guardian|1|||
49085252|NCT03351608|158147475|FG003|Overall Study|Withdrawal by parent/guardian|1|||
49085253|NCT03351608|158147476|FG004|Overall Study|Withdrawal by parent/guardian|0|||
49085254|NCT03351608|158147472|FG000|Overall Study|Other|0|||
49085255|NCT03351608|158147473|FG001|Overall Study|Other|1|||
49085256|NCT03351608|158147474|FG002|Overall Study|Other|1|||
49085257|NCT03351608|158147475|FG003|Overall Study|Other|3|||
49085258|NCT03351608|158147476|FG004|Overall Study|Other|0|||
49085259|NCT02550561|158147484|FG000|Overall Study|Lost to Follow-up|5|||
49085260|NCT02550561|158147484|FG000|Overall Study|Withdrawal by Subject|1|||
49085261|NCT01958437|158147485|FG000|Overall Study|Incidental MRI findings|0|||
49085262|NCT01958437|158147486|FG001|Overall Study|Incidental MRI findings|0|||
49085263|NCT01958437|158147487|FG002|Overall Study|Incidental MRI findings|1|||
49085264|NCT01958437|158147488|FG003|Overall Study|Incidental MRI findings|1|||
49085265|NCT01113892|158147492|FG000|Overall Study|Lost to Follow-up|2|||
49085266|NCT01113892|158147493|FG001|Overall Study|Lost to Follow-up|2|||
49085267|NCT01113892|158147492|FG000|Overall Study|Withdrawal by Subject|1|||
49085268|NCT01113892|158147493|FG001|Overall Study|Withdrawal by Subject|1|||
49085269|NCT01113892|158147492|FG000|Overall Study|Death|2|||
49085270|NCT01113892|158147493|FG001|Overall Study|Death|4|||
49085271|NCT01113892|158147492|FG000|Overall Study|Graft no longer evaluable|9|||
49085272|NCT01113892|158147493|FG001|Overall Study|Graft no longer evaluable|9|||
49085273|NCT03534687|158147496|FG000|Overall Study|Lost to Follow-up|7|||
49085274|NCT03534687|158147497|FG001|Overall Study|Lost to Follow-up|2|||
49085275|NCT03428152|158147498|FG000|Overall Study|Physician Decision|4|||
49085276|NCT03428152|158147499|FG001|Overall Study|Physician Decision|2|||
49085277|NCT03428152|158147498|FG000|Overall Study|Protocol Violation|3|||
49085278|NCT03428152|158147499|FG001|Overall Study|Protocol Violation|5|||
49085279|NCT03428152|158147498|FG000|Overall Study|Lack of Efficacy|0|||
49085280|NCT03428152|158147499|FG001|Overall Study|Lack of Efficacy|4|||
49085281|NCT00712712|158147506|FG000|Overall Study|Protocol Violation|11|||
49085282|NCT00712712|158147506|FG000|Overall Study|Radiofrequency not done|3|||
49085283|NCT00712712|158147506|FG000|Overall Study|Death|8|||
49085284|NCT00712712|158147506|FG000|Overall Study|Withdrawal by Subject|1|||
49085285|NCT02996968|158147507|FG000|Overall Study|Withdrawal by Subject|1|||
49085286|NCT02996968|158147508|FG001|Overall Study|Withdrawal by Subject|0|||
49085287|NCT01420068|158147516|FG000|Overall Study|Administrative problems|1|||
49085288|NCT01420068|158147517|FG001|Overall Study|Administrative problems|3|||
49085289|NCT01420068|158147516|FG000|Overall Study|Withdrawal by Subject|1|||
49085290|NCT01420068|158147517|FG001|Overall Study|Withdrawal by Subject|2|||
49085291|NCT01252095|158147518|FG000|Overall Study|Disease progression|1|||
49085292|NCT01252095|158147519|FG001|Overall Study|Disease progression|0|||
49085293|NCT02418949|158147526|FG000|Overall Study|Withdrawal by Subject|1|||
49085294|NCT02418949|158147527|FG001|Overall Study|Withdrawal by Subject|0|||
49085295|NCT02418949|158147528|FG002|Overall Study|Withdrawal by Subject|1|||
49085296|NCT02418949|158147529|FG003|Overall Study|Withdrawal by Subject|1|||
49085297|NCT02418949|158147526|FG000|Overall Study|Lost to Follow-up|1|||
49085298|NCT02418949|158147527|FG001|Overall Study|Lost to Follow-up|0|||
49085299|NCT02418949|158147528|FG002|Overall Study|Lost to Follow-up|1|||
49085300|NCT02418949|158147529|FG003|Overall Study|Lost to Follow-up|0|||
49085301|NCT02418949|158147526|FG000|Overall Study|Physician Decision|1|||
49085302|NCT02418949|158147527|FG001|Overall Study|Physician Decision|1|||
49085303|NCT02418949|158147528|FG002|Overall Study|Physician Decision|1|||
49085304|NCT02418949|158147529|FG003|Overall Study|Physician Decision|0|||
49085305|NCT03926117|158147533|FG000|Overall Study|Unclassified|1|||
49085306|NCT03926117|158147534|FG001|Overall Study|Unclassified|4|||
49085307|NCT03926117|158147535|FG002|Overall Study|Unclassified|1|||
49085308|NCT03926117|158147536|FG003|Overall Study|Unclassified|4|||
49085309|NCT03926117|158147533|FG000|Overall Study|Withdrawal by Subject|3|||
49085310|NCT03926117|158147534|FG001|Overall Study|Withdrawal by Subject|0|||
49085311|NCT03926117|158147535|FG002|Overall Study|Withdrawal by Subject|1|||
49085312|NCT03926117|158147536|FG003|Overall Study|Withdrawal by Subject|1|||
49085313|NCT03926117|158147533|FG000|Overall Study|Lost to Follow-up|0|||
49085314|NCT03926117|158147534|FG001|Overall Study|Lost to Follow-up|2|||
49085315|NCT03926117|158147535|FG002|Overall Study|Lost to Follow-up|1|||
49085316|NCT03926117|158147536|FG003|Overall Study|Lost to Follow-up|0|||
49085317|NCT03926117|158147533|FG000|Overall Study|Adverse Event|1|||
49085318|NCT03926117|158147534|FG001|Overall Study|Adverse Event|2|||
49085319|NCT03926117|158147535|FG002|Overall Study|Adverse Event|3|||
49085320|NCT03926117|158147536|FG003|Overall Study|Adverse Event|1|||
49085321|NCT03926117|158147533|FG000|Overall Study|Randomized but not treated|1|||
49085322|NCT03926117|158147534|FG001|Overall Study|Randomized but not treated|1|||
49085323|NCT03926117|158147535|FG002|Overall Study|Randomized but not treated|0|||
49085324|NCT03926117|158147536|FG003|Overall Study|Randomized but not treated|1|||
49085325|NCT01422213|158147539|FG000|Overall Study|Adverse Event|8|||
49085326|NCT01422213|158147540|FG001|Overall Study|Adverse Event|7|||
49085327|NCT01422213|158147541|FG002|Overall Study|Adverse Event|11|||
49085328|NCT01422213|158147539|FG000|Overall Study|Lack of Efficacy|10|||
49085329|NCT01422213|158147540|FG001|Overall Study|Lack of Efficacy|2|||
49085330|NCT01422213|158147541|FG002|Overall Study|Lack of Efficacy|2|||
49085331|NCT01422213|158147539|FG000|Overall Study|Non-compliance with study drug|0|||
49085332|NCT01422213|158147540|FG001|Overall Study|Non-compliance with study drug|1|||
49085333|NCT01422213|158147541|FG002|Overall Study|Non-compliance with study drug|0|||
49085334|NCT01422213|158147539|FG000|Overall Study|Protocol Violation|0|||
49085335|NCT01422213|158147540|FG001|Overall Study|Protocol Violation|2|||
49085336|NCT01422213|158147541|FG002|Overall Study|Protocol Violation|4|||
49085337|NCT01422213|158147539|FG000|Overall Study|Withdrawal of Consent|7|||
49085338|NCT01422213|158147540|FG001|Overall Study|Withdrawal of Consent|3|||
49085339|NCT01422213|158147541|FG002|Overall Study|Withdrawal of Consent|5|||
49085340|NCT01422213|158147539|FG000|Overall Study|Lost to Follow-up|3|||
49085341|NCT01422213|158147540|FG001|Overall Study|Lost to Follow-up|3|||
49085342|NCT01422213|158147541|FG002|Overall Study|Lost to Follow-up|5|||
49085343|NCT01422213|158147539|FG000|Overall Study|Administrative or Other Reason(s)|5|||
49085344|NCT01422213|158147540|FG001|Overall Study|Administrative or Other Reason(s)|4|||
49085345|NCT01422213|158147541|FG002|Overall Study|Administrative or Other Reason(s)|2|||
49085346|NCT01827111|158147547|FG000|Overall Study|Disease Progression|1|||
49085347|NCT01052480|158147551|FG000|Overall Study|Lost to Follow-up|3|||
49085348|NCT01052480|158147552|FG001|Overall Study|Lost to Follow-up|3|||
49085349|NCT01052480|158147551|FG000|Overall Study|Protocol Violation|1|||
49085350|NCT01052480|158147552|FG001|Overall Study|Protocol Violation|0|||
49085351|NCT01052480|158147551|FG000|Overall Study|Withdrawal by Subject|3|||
49085352|NCT01052480|158147552|FG001|Overall Study|Withdrawal by Subject|7|||
49085353|NCT01052480|158147551|FG000|Overall Study|Physician Decision|0|||
49085354|NCT01052480|158147552|FG001|Overall Study|Physician Decision|2|||
49085355|NCT01052480|158147551|FG000|Overall Study|Death|1|||
49085356|NCT01052480|158147552|FG001|Overall Study|Death|5|||
49085357|NCT01956773|158147553|FG000|Overall Study|Lost to Follow-up|628|||
49085358|NCT01956773|158147554|FG001|Overall Study|Lost to Follow-up|1|||
49085359|NCT03627546|158147563|FG000|Overall Study|Deemed ineligible after ransdomization|1|||
49085360|NCT03627546|158147564|FG001|Overall Study|Deemed ineligible after ransdomization|0|||
49085361|NCT03627546|158147565|FG002|Overall Study|Deemed ineligible after ransdomization|0|||
49085362|NCT03627546|158147563|FG000|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
49085363|NCT03627546|158147564|FG001|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
49085364|NCT03627546|158147565|FG002|Overall Study|HCV RNA Negative (protocol pre-specified)|13|||
49085365|NCT01578239|158147566|FG000|Treatment Period|Progressive Disease|19|||
49085366|NCT01578239|158147567|FG001|Treatment Period|Progressive Disease|64|||
49085367|NCT01578239|158147566|FG000|Treatment Period|Physician Decision|17|||
49085368|NCT01578239|158147567|FG001|Treatment Period|Physician Decision|17|||
49085369|NCT01578239|158147566|FG000|Treatment Period|Adverse Event|13|||
49085370|NCT01578239|158147567|FG001|Treatment Period|Adverse Event|10|||
49085371|NCT01578239|158147566|FG000|Treatment Period|Non-compliance|2|||
49085372|NCT01578239|158147567|FG001|Treatment Period|Non-compliance|0|||
49085373|NCT01578239|158147566|FG000|Treatment Period|Withdrawal by Subject|10|||
49085374|NCT01578239|158147567|FG001|Treatment Period|Withdrawal by Subject|9|||
49085375|NCT01578239|158147566|FG000|Treatment Period|Other|6|||
49085376|NCT01578239|158147567|FG001|Treatment Period|Other|1|||
49085377|NCT01578239|158147566|FG000|Long-term Follow-Up Period|Death|69|||
49085378|NCT01578239|158147567|FG001|Long-term Follow-Up Period|Death|64|||
49085379|NCT01578239|158147566|FG000|Long-term Follow-Up Period|Consent withdrawal|4|||
49085380|NCT01578239|158147567|FG001|Long-term Follow-Up Period|Consent withdrawal|10|||
49085381|NCT01578239|158147566|FG000|Long-term Follow-Up Period|Lost to Follow-up|2|||
49085382|NCT01578239|158147567|FG001|Long-term Follow-Up Period|Lost to Follow-up|4|||
49085383|NCT01578239|158147566|FG000|Long-term Follow-Up Period|Other|2|||
49085384|NCT01578239|158147567|FG001|Long-term Follow-Up Period|Other|2|||
49085385|NCT00615550|158147569|FG000|Overall Study|Lost to Follow-up|6|||
49085386|NCT00615550|158147570|FG001|Overall Study|Lost to Follow-up|1|||
49085387|NCT02220764|158147571|FG000|Overall Study|Lost to Follow-up|3|||
49085388|NCT02220764|158147572|FG001|Overall Study|Lost to Follow-up|1|||
49085389|NCT02220764|158147571|FG000|Overall Study|Death|1|||
49085390|NCT02220764|158147572|FG001|Overall Study|Death|0|||
49085391|NCT00564850|158147573|FG000|Overall Study|Protocol Violation|2|||
49085392|NCT02347813|158147574|FG000|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
49085393|NCT02347813|158147575|FG001|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
49085394|NCT02347813|158147574|FG000|First Intervention, 24 Weeks|Adverse Event|1|||
49085395|NCT02347813|158147575|FG001|First Intervention, 24 Weeks|Adverse Event|1|||
49085396|NCT02640664|158147576|FG000|Epoch 1|Withdrawal of informed consent|1|||
49085397|NCT02640664|158147577|FG001|Epoch 1|Withdrawal of informed consent|0|||
49085398|NCT02640664|158147578|FG002|Epoch 1|Withdrawal of informed consent|0|||
49085399|NCT02640664|158147576|FG000|Epoch 1|Death|0|||
49085400|NCT02640664|158147577|FG001|Epoch 1|Death|0|||
49085401|NCT02640664|158147578|FG002|Epoch 1|Death|1|||
49085402|NCT02640664|158147576|FG000|Epoch 2|Withdrawal of informed consent|3|||
49085403|NCT02640664|158147577|FG001|Epoch 2|Withdrawal of informed consent|4|||
49085404|NCT02640664|158147578|FG002|Epoch 2|Withdrawal of informed consent|2|||
49085405|NCT02640664|158147576|FG000|Epoch 2|Subject/guardian decision|0|||
49085406|NCT02640664|158147577|FG001|Epoch 2|Subject/guardian decision|2|||
49085407|NCT02640664|158147578|FG002|Epoch 2|Subject/guardian decision|2|||
49085408|NCT02640664|158147576|FG000|Epoch 2|Lost to Follow-up|3|||
49085409|NCT02640664|158147577|FG001|Epoch 2|Lost to Follow-up|4|||
49085410|NCT02640664|158147578|FG002|Epoch 2|Lost to Follow-up|1|||
49085411|NCT02640664|158147576|FG000|Epoch 2|Death|0|||
49085412|NCT02640664|158147577|FG001|Epoch 2|Death|0|||
49085413|NCT02640664|158147578|FG002|Epoch 2|Death|1|||
49085414|NCT01537042|158147581|FG000|Overall Study|Adverse Event|0|||
49085415|NCT01537042|158147582|FG001|Overall Study|Adverse Event|2|||
49085416|NCT01537042|158147581|FG000|Overall Study|Lack of Efficacy|0|||
49085417|NCT01537042|158147582|FG001|Overall Study|Lack of Efficacy|1|||
49085418|NCT01537042|158147581|FG000|Overall Study|Protocol Violation|0|||
49085419|NCT01537042|158147582|FG001|Overall Study|Protocol Violation|1|||
49085420|NCT01537042|158147581|FG000|Overall Study|Other|0|||
49085421|NCT01537042|158147582|FG001|Overall Study|Other|1|||
49085422|NCT01991743|158147586|FG000|Overall Study|external cephalic version not performed|0|||
49085423|NCT01991743|158147587|FG001|Overall Study|external cephalic version not performed|0|||
49085424|NCT01991743|158147588|FG002|Overall Study|external cephalic version not performed|1|||
49085425|NCT01991743|158147589|FG003|Overall Study|external cephalic version not performed|0|||
49085426|NCT01119859|158147590|FG000|Overall Study|Adverse Event|9|||
49085427|NCT01119859|158147591|FG001|Overall Study|Adverse Event|10|||
49085428|NCT01119859|158147590|FG000|Overall Study|Death|2|||
49085429|NCT01119859|158147591|FG001|Overall Study|Death|0|||
49085430|NCT01119859|158147590|FG000|Overall Study|Insufficient therapeutic response|7|||
49085431|NCT01119859|158147591|FG001|Overall Study|Insufficient therapeutic response|14|||
49085432|NCT01119859|158147590|FG000|Overall Study|Refused treatment|3|||
49085433|NCT01119859|158147591|FG001|Overall Study|Refused treatment|6|||
49085434|NCT01119859|158147590|FG000|Overall Study|Failure to return|3|||
49085435|NCT01119859|158147591|FG001|Overall Study|Failure to return|0|||
49085436|NCT01167140|158147592|FG000|Overall Study|Withdrawal by Subject|1|||
49085437|NCT03805412|158147593|FG000|Overall Study|Lost to Follow-up|0|||
49085438|NCT03805412|158147594|FG001|Overall Study|Lost to Follow-up|1|||
49085439|NCT01277601|158149371|FG000|Overall Study|Adverse Event|5|||
49085440|NCT01277601|158149372|FG001|Overall Study|Adverse Event|3|||
49085441|NCT01277601|158149373|FG002|Overall Study|Adverse Event|0|||
49085442|NCT01277601|158149374|FG003|Overall Study|Adverse Event|7|||
49085443|NCT01277601|158149371|FG000|Overall Study|Withdrawal by Subject|18|||
49085444|NCT01277601|158149372|FG001|Overall Study|Withdrawal by Subject|21|||
49085445|NCT01277601|158149373|FG002|Overall Study|Withdrawal by Subject|8|||
49085446|NCT01277601|158149374|FG003|Overall Study|Withdrawal by Subject|17|||
49085447|NCT01277601|158149371|FG000|Overall Study|Lost to Follow-up|7|||
49085448|NCT01277601|158149372|FG001|Overall Study|Lost to Follow-up|9|||
49085449|NCT01277601|158149373|FG002|Overall Study|Lost to Follow-up|4|||
49085450|NCT01277601|158149374|FG003|Overall Study|Lost to Follow-up|2|||
49085451|NCT01277601|158149371|FG000|Overall Study|Physician Decision|3|||
49085452|NCT01277601|158149372|FG001|Overall Study|Physician Decision|5|||
49085453|NCT01277601|158149373|FG002|Overall Study|Physician Decision|1|||
49085454|NCT01277601|158149374|FG003|Overall Study|Physician Decision|6|||
49085455|NCT01277601|158149371|FG000|Overall Study|Pregnancy|2|||
49085456|NCT01277601|158149372|FG001|Overall Study|Pregnancy|2|||
49085457|NCT01277601|158149373|FG002|Overall Study|Pregnancy|4|||
49085458|NCT01277601|158149374|FG003|Overall Study|Pregnancy|1|||
49085459|NCT01277601|158149371|FG000|Overall Study|Noncompliance with Study Drug|1|||
49085460|NCT01277601|158149372|FG001|Overall Study|Noncompliance with Study Drug|3|||
49085461|NCT01277601|158149373|FG002|Overall Study|Noncompliance with Study Drug|2|||
49085462|NCT01277601|158149374|FG003|Overall Study|Noncompliance with Study Drug|0|||
49085463|NCT01277601|158149371|FG000|Overall Study|Subject Never Dosed with Study Drug|1|||
49085464|NCT01277601|158149372|FG001|Overall Study|Subject Never Dosed with Study Drug|2|||
49085465|NCT01277601|158149373|FG002|Overall Study|Subject Never Dosed with Study Drug|3|||
49085466|NCT01277601|158149374|FG003|Overall Study|Subject Never Dosed with Study Drug|1|||
49085467|NCT01277601|158149371|FG000|Overall Study|Protocol Violation|0|||
49085468|NCT01277601|158149372|FG001|Overall Study|Protocol Violation|2|||
49085469|NCT01277601|158149373|FG002|Overall Study|Protocol Violation|5|||
49085470|NCT01277601|158149374|FG003|Overall Study|Protocol Violation|0|||
49085471|NCT01277601|158149371|FG000|Overall Study|Subject Terminated from Study by Sponsor|0|||
49085472|NCT01277601|158149372|FG001|Overall Study|Subject Terminated from Study by Sponsor|1|||
49085473|NCT01277601|158149373|FG002|Overall Study|Subject Terminated from Study by Sponsor|0|||
49085474|NCT01277601|158149374|FG003|Overall Study|Subject Terminated from Study by Sponsor|2|||
49085475|NCT04846569|158149378|FG000|Overall Study|Withdrawal by Subject|3|||
49085476|NCT04846569|158149379|FG001|Overall Study|Withdrawal by Subject|1|||
49085477|NCT02832687|158149382|FG000|Overall Study|Adverse Event|0|||
49085478|NCT02832687|158149383|FG001|Overall Study|Adverse Event|2|||
49085479|NCT04054765|158149388|FG000|Baseline|Withdrawal by Subject|5|||
49085480|NCT04054765|158149389|FG001|Baseline|Withdrawal by Subject|3|||
49085481|NCT04054765|158149388|FG000|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8|||
49085482|NCT04054765|158149389|FG001|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3|||
49085483|NCT04054765|158149388|FG000|3-month Follow up|Withdrawal by Subject|0|||
49085484|NCT04054765|158149389|FG001|3-month Follow up|Withdrawal by Subject|3|||
49085485|NCT04054765|158149388|FG000|6-month Follow up|Lost to Follow-up|32|||
49085486|NCT04054765|158149389|FG001|6-month Follow up|Lost to Follow-up|32|||
49085487|NCT01962103|158149390|FG000|Phase 1|Adverse Event|4|||
49085488|NCT01962103|158149391|FG001|Phase 1|Adverse Event|0|||
49085489|NCT01962103|158149392|FG002|Phase 1|Adverse Event|2|||
49085490|NCT01962103|158149393|FG003|Phase 1|Adverse Event|1|||
49085491|NCT01962103|158149394|FG004|Phase 1|Adverse Event|2|||
49085492|NCT01962103|158149395|FG005|Phase 1|Adverse Event|2|||
49085493|NCT01962103|158149396|FG006|Phase 1|Adverse Event|0|||
49085494|NCT01962103|158149397|FG007|Phase 1|Adverse Event|0|||
49085495|NCT01962103|158149398|FG008|Phase 1|Adverse Event|0|||
49085496|NCT01962103|158149390|FG000|Phase 1|Progressive Disease|8|||
49085497|NCT01962103|158149391|FG001|Phase 1|Progressive Disease|6|||
49085498|NCT01962103|158149392|FG002|Phase 1|Progressive Disease|8|||
49085499|NCT01962103|158149393|FG003|Phase 1|Progressive Disease|4|||
49085500|NCT01962103|158149394|FG004|Phase 1|Progressive Disease|5|||
49085501|NCT01962103|158149395|FG005|Phase 1|Progressive Disease|4|||
49085502|NCT01962103|158149396|FG006|Phase 1|Progressive Disease|0|||
49085503|NCT01962103|158149397|FG007|Phase 1|Progressive Disease|0|||
49085504|NCT01962103|158149398|FG008|Phase 1|Progressive Disease|0|||
49085505|NCT01962103|158149390|FG000|Phase 1|Withdrawal by Subject|0|||
49085506|NCT01962103|158149391|FG001|Phase 1|Withdrawal by Subject|0|||
49085507|NCT01962103|158149392|FG002|Phase 1|Withdrawal by Subject|0|||
49085508|NCT01962103|158149393|FG003|Phase 1|Withdrawal by Subject|2|||
49085509|NCT01962103|158149394|FG004|Phase 1|Withdrawal by Subject|0|||
49085510|NCT01962103|158149395|FG005|Phase 1|Withdrawal by Subject|0|||
49085511|NCT01962103|158149396|FG006|Phase 1|Withdrawal by Subject|0|||
49085512|NCT01962103|158149397|FG007|Phase 1|Withdrawal by Subject|0|||
49085513|NCT01962103|158149398|FG008|Phase 1|Withdrawal by Subject|0|||
49085514|NCT01962103|158149390|FG000|Phase 1|Withdrawal by Parent/Guardian|0|||
49085515|NCT01962103|158149391|FG001|Phase 1|Withdrawal by Parent/Guardian|0|||
49085516|NCT01962103|158149392|FG002|Phase 1|Withdrawal by Parent/Guardian|2|||
49085517|NCT01962103|158149393|FG003|Phase 1|Withdrawal by Parent/Guardian|1|||
49085518|NCT01962103|158149394|FG004|Phase 1|Withdrawal by Parent/Guardian|0|||
49085519|NCT01962103|158149395|FG005|Phase 1|Withdrawal by Parent/Guardian|0|||
49085520|NCT01962103|158149396|FG006|Phase 1|Withdrawal by Parent/Guardian|0|||
49085521|NCT01962103|158149397|FG007|Phase 1|Withdrawal by Parent/Guardian|0|||
49085522|NCT01962103|158149398|FG008|Phase 1|Withdrawal by Parent/Guardian|0|||
49085523|NCT01962103|158149390|FG000|Phase 1|Physician Decision|0|||
49085524|NCT01962103|158149391|FG001|Phase 1|Physician Decision|0|||
49085525|NCT01962103|158149392|FG002|Phase 1|Physician Decision|0|||
49085526|NCT01962103|158149393|FG003|Phase 1|Physician Decision|1|||
49085527|NCT01962103|158149394|FG004|Phase 1|Physician Decision|0|||
49085528|NCT01962103|158149395|FG005|Phase 1|Physician Decision|0|||
49085529|NCT01962103|158149396|FG006|Phase 1|Physician Decision|0|||
49085530|NCT01962103|158149397|FG007|Phase 1|Physician Decision|0|||
49085531|NCT01962103|158149398|FG008|Phase 1|Physician Decision|0|||
49085532|NCT01962103|158149390|FG000|Phase 1|Symptomatic Deterioration|3|||
49085533|NCT01962103|158149391|FG001|Phase 1|Symptomatic Deterioration|2|||
49085534|NCT01962103|158149392|FG002|Phase 1|Symptomatic Deterioration|2|||
49085535|NCT01962103|158149393|FG003|Phase 1|Symptomatic Deterioration|2|||
49085536|NCT01962103|158149394|FG004|Phase 1|Symptomatic Deterioration|1|||
49085537|NCT01962103|158149395|FG005|Phase 1|Symptomatic Deterioration|1|||
49085538|NCT01962103|158149396|FG006|Phase 1|Symptomatic Deterioration|0|||
49085539|NCT01962103|158149397|FG007|Phase 1|Symptomatic Deterioration|0|||
49085540|NCT01962103|158149398|FG008|Phase 1|Symptomatic Deterioration|0|||
49085541|NCT01962103|158149390|FG000|Phase 1|Miscellaneous|1|||
49085542|NCT01962103|158149391|FG001|Phase 1|Miscellaneous|0|||
49085543|NCT01962103|158149392|FG002|Phase 1|Miscellaneous|0|||
49085544|NCT01962103|158149393|FG003|Phase 1|Miscellaneous|0|||
49085545|NCT01962103|158149394|FG004|Phase 1|Miscellaneous|0|||
49085546|NCT01962103|158149395|FG005|Phase 1|Miscellaneous|0|||
49085547|NCT01962103|158149396|FG006|Phase 1|Miscellaneous|0|||
49085548|NCT01962103|158149397|FG007|Phase 1|Miscellaneous|0|||
49085549|NCT01962103|158149398|FG008|Phase 1|Miscellaneous|0|||
49085550|NCT01962103|158149390|FG000|Phase 2|Adverse Event|0|||
49085551|NCT01962103|158149391|FG001|Phase 2|Adverse Event|0|||
49085552|NCT01962103|158149392|FG002|Phase 2|Adverse Event|0|||
49085553|NCT01962103|158149393|FG003|Phase 2|Adverse Event|0|||
49085554|NCT01962103|158149394|FG004|Phase 2|Adverse Event|0|||
49085555|NCT01962103|158149395|FG005|Phase 2|Adverse Event|0|||
49085556|NCT01962103|158149396|FG006|Phase 2|Adverse Event|1|||
49085557|NCT01962103|158149397|FG007|Phase 2|Adverse Event|0|||
49085558|NCT01962103|158149398|FG008|Phase 2|Adverse Event|3|||
49085559|NCT01962103|158149390|FG000|Phase 2|Progressive Disease|0|||
49085560|NCT01962103|158149391|FG001|Phase 2|Progressive Disease|0|||
49085561|NCT01962103|158149392|FG002|Phase 2|Progressive Disease|0|||
49085562|NCT01962103|158149393|FG003|Phase 2|Progressive Disease|0|||
49085563|NCT01962103|158149394|FG004|Phase 2|Progressive Disease|0|||
49085564|NCT01962103|158149395|FG005|Phase 2|Progressive Disease|0|||
49085565|NCT01962103|158149396|FG006|Phase 2|Progressive Disease|11|||
49085566|NCT01962103|158149397|FG007|Phase 2|Progressive Disease|12|||
49085567|NCT01962103|158149398|FG008|Phase 2|Progressive Disease|11|||
49085568|NCT01962103|158149390|FG000|Phase 2|Symptomatic Deterioration|0|||
49085569|NCT01962103|158149391|FG001|Phase 2|Symptomatic Deterioration|0|||
49085570|NCT01962103|158149392|FG002|Phase 2|Symptomatic Deterioration|0|||
49085571|NCT01962103|158149393|FG003|Phase 2|Symptomatic Deterioration|0|||
49085572|NCT01962103|158149394|FG004|Phase 2|Symptomatic Deterioration|0|||
49085573|NCT01962103|158149395|FG005|Phase 2|Symptomatic Deterioration|0|||
49085574|NCT01962103|158149396|FG006|Phase 2|Symptomatic Deterioration|2|||
49085575|NCT01962103|158149397|FG007|Phase 2|Symptomatic Deterioration|2|||
49085576|NCT01962103|158149398|FG008|Phase 2|Symptomatic Deterioration|0|||
49085577|NCT05344560|158149401|FG000|Period 1|Subject out of visit window|1|||
49085578|NCT05344560|158149402|FG001|Period 1|Subject out of visit window|1|||
49085579|NCT05344560|158149401|FG000|Period 2|Covid-19 Related|1|||
49085580|NCT05344560|158149402|FG001|Period 2|Covid-19 Related|0|||
49085581|NCT05344560|158149401|FG000|Period 2|Adverse Event|1|||
49085582|NCT05344560|158149402|FG001|Period 2|Adverse Event|0|||
49085583|NCT05344560|158149401|FG000|Period 2|Subject out of visit window|1|||
49085584|NCT05344560|158149402|FG001|Period 2|Subject out of visit window|1|||
49085585|NCT05344560|158149401|FG000|Period 3|Subject out of visit window|1|||
49085586|NCT05344560|158149402|FG001|Period 3|Subject out of visit window|0|||
49085587|NCT01930162|158149403|FG000|Overall Study|Abnormal test procedure result(s)|4|||
49085588|NCT01930162|158149403|FG000|Overall Study|Death|1|||
49085589|NCT02877004|158149404|FG000|Overall Study|Pregnancy|0|||
49085590|NCT02877004|158149405|FG001|Overall Study|Pregnancy|0|||
49085591|NCT02877004|158149406|FG002|Overall Study|Pregnancy|1|||
49085592|NCT02727478|158149407|FG000|Overall Study|Withdrawal by Subject|8|||
49085593|NCT02727478|158149408|FG001|Overall Study|Withdrawal by Subject|10|||
49085594|NCT02962648|158149413|FG000|Overall Study|Withdrawal by Subject|3|||
49085595|NCT02962648|158149413|FG000|Overall Study|Lost to Follow-up|3|||
49085596|NCT02962648|158149413|FG000|Overall Study|Physician Decision|1|||
49085597|NCT02962648|158149413|FG000|Overall Study|Subject had problems with transportation|2|||
49085598|NCT01051960|158149414|FG000|Overall Study|Adverse Event|1|||
49085599|NCT00395629|158149415|FG000|Core Study|Adverse Event|0|||
49085600|NCT00395629|158149416|FG001|Core Study|Adverse Event|3|||
49085601|NCT00395629|158149417|FG002|Core Study|Adverse Event|4|||
49085602|NCT00395629|158149415|FG000|Core Study|Abnormal laboratory value(s)|0|||
49085603|NCT00395629|158149416|FG001|Core Study|Abnormal laboratory value(s)|0|||
49085604|NCT00395629|158149417|FG002|Core Study|Abnormal laboratory value(s)|1|||
49085605|NCT00395629|158149415|FG000|Core Study|Protocol Violation|1|||
49085606|NCT00395629|158149416|FG001|Core Study|Protocol Violation|0|||
49085607|NCT00395629|158149417|FG002|Core Study|Protocol Violation|0|||
49085608|NCT00395629|158149415|FG000|Core Study|Withdrawal by Subject|0|||
49085609|NCT00395629|158149416|FG001|Core Study|Withdrawal by Subject|1|||
49085610|NCT00395629|158149417|FG002|Core Study|Withdrawal by Subject|1|||
49085611|NCT00395629|158149415|FG000|Core Study|Lost to Follow-up|0|||
49085612|NCT00395629|158149416|FG001|Core Study|Lost to Follow-up|0|||
49085613|NCT00395629|158149417|FG002|Core Study|Lost to Follow-up|1|||
49085614|NCT00395629|158149415|FG000|Extension Study|Adverse Event|0|||
49085615|NCT00395629|158149416|FG001|Extension Study|Adverse Event|0|||
49085616|NCT00395629|158149417|FG002|Extension Study|Adverse Event|2|||
49085617|NCT00395629|158149415|FG000|Extension Study|Administrative problems|0|||
49085618|NCT00395629|158149416|FG001|Extension Study|Administrative problems|0|||
49085619|NCT00395629|158149417|FG002|Extension Study|Administrative problems|1|||
49085620|NCT01686373|158149418|FG000|Overall Study|Lost to Follow-up|3|||
49085621|NCT01686373|158149419|FG001|Overall Study|Lost to Follow-up|0|||
49085622|NCT01686373|158149418|FG000|Overall Study|Withdrawal by Subject|0|||
49085623|NCT01686373|158149419|FG001|Overall Study|Withdrawal by Subject|1|||
49085624|NCT01686373|158149418|FG000|Overall Study|Adverse Event|0|||
49085625|NCT01686373|158149419|FG001|Overall Study|Adverse Event|1|||
49085626|NCT00360282|158149420|FG000|Washout 1-3 Weeks|Lost to Follow-up|0|||
49085627|NCT00360282|158149421|FG001|Washout 1-3 Weeks|Lost to Follow-up|0|||
49085628|NCT00360282|158149422|FG002|Washout 1-3 Weeks|Lost to Follow-up|1|||
49085629|NCT00360282|158149423|FG003|Washout 1-3 Weeks|Lost to Follow-up|0|||
49085630|NCT00360282|158149420|FG000|Second Intervention|Adverse Event|0|||
49085631|NCT00360282|158149421|FG001|Second Intervention|Adverse Event|1|||
49085632|NCT00360282|158149422|FG002|Second Intervention|Adverse Event|0|||
49085633|NCT00360282|158149423|FG003|Second Intervention|Adverse Event|0|||
49085634|NCT00808210|158149426|FG000|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3|||
49085635|NCT00808210|158149427|FG001|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7|||
49085636|NCT00808210|158149426|FG000|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6|||
49085637|NCT00808210|158149427|FG001|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2|||
49085638|NCT00808210|158149426|FG000|Double-Blind TX Period|Adverse Event|0|||
49085639|NCT00808210|158149427|FG001|Double-Blind TX Period|Adverse Event|1|||
49085640|NCT00808210|158149426|FG000|Double-Blind TX Period|Sponsor decision to terminate study|1|||
49085641|NCT00808210|158149427|FG001|Double-Blind TX Period|Sponsor decision to terminate study|1|||
49085642|NCT00808210|158149426|FG000|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
49085643|NCT00808210|158149427|FG001|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
49085644|NCT00808210|158149426|FG000|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9|||
49085645|NCT00808210|158149427|FG001|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4|||
49085646|NCT02044302|158149433|FG000|Overall Study|study terminated|2|||
49085647|NCT02044302|158149434|FG001|Overall Study|study terminated|0|||
49085648|NCT00502242|158149438|FG000|Overall Study|Lack of Efficacy|1|||
49085649|NCT00502242|158149439|FG001|Overall Study|Lack of Efficacy|11|||
49085650|NCT00502242|158149438|FG000|Overall Study|Adverse Event|31|||
49085651|NCT00502242|158149439|FG001|Overall Study|Adverse Event|20|||
49085652|NCT00502242|158149438|FG000|Overall Study|Physician Decision|2|||
49085653|NCT00502242|158149439|FG001|Overall Study|Physician Decision|3|||
49085654|NCT00502242|158149438|FG000|Overall Study|Other - Unspecified|8|||
49085655|NCT00502242|158149439|FG001|Overall Study|Other - Unspecified|14|||
49085656|NCT00502242|158149438|FG000|Overall Study|Protocol Violation|3|||
49085657|NCT00502242|158149439|FG001|Overall Study|Protocol Violation|1|||
49085658|NCT00502242|158149438|FG000|Overall Study|Withdrawal by Subject|6|||
49085659|NCT00502242|158149439|FG001|Overall Study|Withdrawal by Subject|7|||
49085660|NCT04537078|158149440|FG000|Overall Study|Protocol Violation|3|||
49085661|NCT04537078|158149441|FG001|Overall Study|Protocol Violation|2|||
49085662|NCT04537078|158149440|FG000|Overall Study|Lost to Follow-up|1|||
49085663|NCT04537078|158149441|FG001|Overall Study|Lost to Follow-up|0|||
49085664|NCT04537078|158149440|FG000|Overall Study|Withdrawal by Subject|0|||
49085665|NCT04537078|158149441|FG001|Overall Study|Withdrawal by Subject|1|||
49085666|NCT01671007|158149442|FG000|Overall Study|Other reasons than listed|166|||
49085667|NCT01671007|158149443|FG001|Overall Study|Other reasons than listed|373|||
49085668|NCT01671007|158149444|FG002|Overall Study|Other reasons than listed|197|||
49085669|NCT01671007|158149445|FG003|Overall Study|Other reasons than listed|228|||
49085670|NCT01671007|158149446|FG004|Overall Study|Other reasons than listed|14|||
49085671|NCT01671007|158149447|FG005|Overall Study|Other reasons than listed|71|||
49085672|NCT01671007|158149448|FG006|Overall Study|Other reasons than listed|17|||
49085673|NCT01671007|158149449|FG007|Overall Study|Other reasons than listed|66|||
49085674|NCT01671007|158149450|FG008|Overall Study|Other reasons than listed|0|||
49085675|NCT01671007|158149442|FG000|Overall Study|Withdrawal by Subject|36|||
49085676|NCT01671007|158149443|FG001|Overall Study|Withdrawal by Subject|59|||
49085677|NCT01671007|158149444|FG002|Overall Study|Withdrawal by Subject|53|||
49085678|NCT01671007|158149445|FG003|Overall Study|Withdrawal by Subject|58|||
49085679|NCT01671007|158149446|FG004|Overall Study|Withdrawal by Subject|4|||
49085680|NCT01671007|158149447|FG005|Overall Study|Withdrawal by Subject|15|||
49085681|NCT01671007|158149448|FG006|Overall Study|Withdrawal by Subject|1|||
49085682|NCT01671007|158149449|FG007|Overall Study|Withdrawal by Subject|19|||
49085683|NCT01671007|158149450|FG008|Overall Study|Withdrawal by Subject|0|||
49085684|NCT01671007|158149442|FG000|Overall Study|Lost to Follow-up|93|||
49085685|NCT01671007|158149443|FG001|Overall Study|Lost to Follow-up|142|||
49085686|NCT01671007|158149444|FG002|Overall Study|Lost to Follow-up|91|||
49085687|NCT01671007|158149445|FG003|Overall Study|Lost to Follow-up|63|||
49085688|NCT01671007|158149446|FG004|Overall Study|Lost to Follow-up|7|||
49085689|NCT01671007|158149447|FG005|Overall Study|Lost to Follow-up|20|||
49085690|NCT01671007|158149448|FG006|Overall Study|Lost to Follow-up|2|||
49085691|NCT01671007|158149449|FG007|Overall Study|Lost to Follow-up|28|||
49085692|NCT01671007|158149450|FG008|Overall Study|Lost to Follow-up|0|||
49085693|NCT01671007|158149442|FG000|Overall Study|No end of study case report form|3|||
49085694|NCT01671007|158149443|FG001|Overall Study|No end of study case report form|1|||
49085695|NCT01671007|158149444|FG002|Overall Study|No end of study case report form|0|||
49085696|NCT01671007|158149445|FG003|Overall Study|No end of study case report form|2|||
49085697|NCT01671007|158149446|FG004|Overall Study|No end of study case report form|0|||
49085698|NCT01671007|158149447|FG005|Overall Study|No end of study case report form|0|||
49085699|NCT01671007|158149448|FG006|Overall Study|No end of study case report form|0|||
49085700|NCT01671007|158149449|FG007|Overall Study|No end of study case report form|0|||
49085701|NCT01671007|158149450|FG008|Overall Study|No end of study case report form|0|||
49085702|NCT01671007|158149442|FG000|Overall Study|Not eligible|23|||
49085703|NCT01671007|158149443|FG001|Overall Study|Not eligible|76|||
49085704|NCT01671007|158149444|FG002|Overall Study|Not eligible|25|||
49085705|NCT01671007|158149445|FG003|Overall Study|Not eligible|17|||
49085706|NCT01671007|158149446|FG004|Overall Study|Not eligible|0|||
49085707|NCT01671007|158149447|FG005|Overall Study|Not eligible|6|||
49085708|NCT01671007|158149448|FG006|Overall Study|Not eligible|1|||
49085709|NCT01671007|158149449|FG007|Overall Study|Not eligible|19|||
49085710|NCT01671007|158149450|FG008|Overall Study|Not eligible|0|||
49085711|NCT03817853|158149451|FG000|Induction Phase|Adverse Event|5|||
49085712|NCT03817853|158149452|FG001|Induction Phase|Adverse Event|0|||
49085713|NCT03817853|158149453|FG002|Induction Phase|Adverse Event|0|||
49085714|NCT03817853|158149451|FG000|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3|||
49085715|NCT03817853|158149452|FG001|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
49085716|NCT03817853|158149453|FG002|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
49085717|NCT03817853|158149451|FG000|Induction Phase|Physician Decision|2|||
49085718|NCT03817853|158149452|FG001|Induction Phase|Physician Decision|0|||
49085719|NCT03817853|158149453|FG002|Induction Phase|Physician Decision|0|||
49085720|NCT03817853|158149451|FG000|Induction Phase|Progressive Disease|6|||
49085721|NCT03817853|158149452|FG001|Induction Phase|Progressive Disease|0|||
49085722|NCT03817853|158149453|FG002|Induction Phase|Progressive Disease|0|||
49085723|NCT03817853|158149451|FG000|Induction Phase|Withdrawal by Subject|4|||
49085724|NCT03817853|158149452|FG001|Induction Phase|Withdrawal by Subject|0|||
49085725|NCT03817853|158149453|FG002|Induction Phase|Withdrawal by Subject|0|||
49085726|NCT03817853|158149451|FG000|Maintenance Phase|Adverse Event|0|||
49085727|NCT03817853|158149452|FG001|Maintenance Phase|Adverse Event|8|||
49085728|NCT03817853|158149453|FG002|Maintenance Phase|Adverse Event|0|||
49085729|NCT03817853|158149451|FG000|Maintenance Phase|Death|0|||
49085730|NCT03817853|158149452|FG001|Maintenance Phase|Death|5|||
49085731|NCT03817853|158149453|FG002|Maintenance Phase|Death|0|||
49085732|NCT03817853|158149451|FG000|Maintenance Phase|Progressive Disease|0|||
49085733|NCT03817853|158149452|FG001|Maintenance Phase|Progressive Disease|7|||
49085734|NCT03817853|158149453|FG002|Maintenance Phase|Progressive Disease|0|||
49085735|NCT03817853|158149451|FG000|Maintenance Phase|Withdrawal by Subject|0|||
49085736|NCT03817853|158149452|FG001|Maintenance Phase|Withdrawal by Subject|2|||
49085737|NCT03817853|158149453|FG002|Maintenance Phase|Withdrawal by Subject|0|||
49085738|NCT03817853|158149451|FG000|Maintenance Phase|Physician Decision|0|||
49085739|NCT03817853|158149452|FG001|Maintenance Phase|Physician Decision|1|||
49085740|NCT03817853|158149453|FG002|Maintenance Phase|Physician Decision|0|||
49085741|NCT03817853|158149451|FG000|Maintenance Phase|Various reasons|0|||
49085742|NCT03817853|158149452|FG001|Maintenance Phase|Various reasons|4|||
49085743|NCT03817853|158149453|FG002|Maintenance Phase|Various reasons|0|||
49085744|NCT03817853|158149451|FG000|Maintenance Phase|Protocol Deviation|0|||
49085745|NCT03817853|158149452|FG001|Maintenance Phase|Protocol Deviation|1|||
49085746|NCT03817853|158149453|FG002|Maintenance Phase|Protocol Deviation|0|||
49085747|NCT03817853|158149451|FG000|Follow-up Phase|Adverse Event|0|||
49085748|NCT03817853|158149452|FG001|Follow-up Phase|Adverse Event|0|||
49085749|NCT03817853|158149453|FG002|Follow-up Phase|Adverse Event|2|||
49085750|NCT03817853|158149451|FG000|Follow-up Phase|Death|0|||
49085751|NCT03817853|158149452|FG001|Follow-up Phase|Death|0|||
49085752|NCT03817853|158149453|FG002|Follow-up Phase|Death|1|||
49085753|NCT03817853|158149451|FG000|Follow-up Phase|Progressive Disease|0|||
49085754|NCT03817853|158149452|FG001|Follow-up Phase|Progressive Disease|0|||
49085755|NCT03817853|158149453|FG002|Follow-up Phase|Progressive Disease|3|||
49085756|NCT03817853|158149451|FG000|Follow-up Phase|Withdrawal by Subject|0|||
49085757|NCT03817853|158149452|FG001|Follow-up Phase|Withdrawal by Subject|0|||
49085758|NCT03817853|158149453|FG002|Follow-up Phase|Withdrawal by Subject|1|||
49085759|NCT01836471|158149454|FG000|Overall Study|Pregnancy|1|||
49085760|NCT01836471|158149455|FG001|Overall Study|Pregnancy|0|||
49085761|NCT01836471|158149456|FG002|Overall Study|Pregnancy|0|||
49085762|NCT01836471|158149457|FG003|Overall Study|Pregnancy|0|||
49085763|NCT01836471|158149458|FG004|Overall Study|Pregnancy|0|||
49085764|NCT01836471|158149454|FG000|Overall Study|Withdrawal by Subject|3|||
49085765|NCT01836471|158149455|FG001|Overall Study|Withdrawal by Subject|4|||
49085766|NCT01836471|158149456|FG002|Overall Study|Withdrawal by Subject|1|||
49085767|NCT01836471|158149457|FG003|Overall Study|Withdrawal by Subject|0|||
49085768|NCT01836471|158149458|FG004|Overall Study|Withdrawal by Subject|2|||
49085769|NCT01836471|158149454|FG000|Overall Study|Physician Decision|0|||
49085770|NCT01836471|158149455|FG001|Overall Study|Physician Decision|1|||
49085771|NCT01836471|158149456|FG002|Overall Study|Physician Decision|0|||
49085772|NCT01836471|158149457|FG003|Overall Study|Physician Decision|0|||
49085773|NCT01836471|158149458|FG004|Overall Study|Physician Decision|0|||
49085774|NCT01836471|158149454|FG000|Overall Study|Lost to Follow-up|0|||
49085775|NCT01836471|158149455|FG001|Overall Study|Lost to Follow-up|0|||
49085776|NCT01836471|158149456|FG002|Overall Study|Lost to Follow-up|0|||
49085777|NCT01836471|158149457|FG003|Overall Study|Lost to Follow-up|1|||
49085778|NCT01836471|158149458|FG004|Overall Study|Lost to Follow-up|1|||
49085779|NCT01836471|158149454|FG000|Overall Study|Adverse Event|6|||
49085780|NCT01836471|158149455|FG001|Overall Study|Adverse Event|3|||
49085781|NCT01836471|158149456|FG002|Overall Study|Adverse Event|1|||
49085782|NCT01836471|158149457|FG003|Overall Study|Adverse Event|1|||
49085783|NCT01836471|158149458|FG004|Overall Study|Adverse Event|2|||
49085784|NCT01836471|158149454|FG000|Overall Study|Non compliance with tx|1|||
49085785|NCT01836471|158149455|FG001|Overall Study|Non compliance with tx|1|||
49085786|NCT01836471|158149456|FG002|Overall Study|Non compliance with tx|0|||
49085787|NCT01836471|158149457|FG003|Overall Study|Non compliance with tx|0|||
49085788|NCT01836471|158149458|FG004|Overall Study|Non compliance with tx|0|||
49085789|NCT01283464|158149464|FG000|Overall Study|Lost to Follow-up|0|||
49085790|NCT01283464|158149465|FG001|Overall Study|Lost to Follow-up|1|||
49085791|NCT01283464|158149464|FG000|Overall Study|Withdrawal by Subject|1|||
49085792|NCT01283464|158149465|FG001|Overall Study|Withdrawal by Subject|0|||
49085793|NCT01283464|158149464|FG000|Overall Study|Physician Decision|1|||
49085794|NCT01283464|158149465|FG001|Overall Study|Physician Decision|0|||
49085795|NCT02268916|158149466|FG000|Overall Study|Lost to Follow-up|1|||
49085796|NCT02268916|158149467|FG001|Overall Study|Lost to Follow-up|1|||
49085797|NCT02268916|158149466|FG000|Overall Study|Withdrawal by Subject|6|||
49085798|NCT02268916|158149467|FG001|Overall Study|Withdrawal by Subject|5|||
49085799|NCT02268916|158149466|FG000|Overall Study|Participant did not have diabetes|1|||
49085800|NCT02268916|158149467|FG001|Overall Study|Participant did not have diabetes|0|||
49085801|NCT02268916|158149466|FG000|Overall Study|Did not complete home monitoring activities after baseline visit|9|||
49085802|NCT02268916|158149467|FG001|Overall Study|Did not complete home monitoring activities after baseline visit|4|||
49085803|NCT01139775|158149468|FG000|Overall Study|Adverse Event|0|||
49085804|NCT01139775|158149469|FG001|Overall Study|Adverse Event|6|||
49085805|NCT01139775|158149470|FG002|Overall Study|Adverse Event|2|||
49085806|NCT01139775|158149468|FG000|Overall Study|Protocol Violation|0|||
49085807|NCT01139775|158149469|FG001|Overall Study|Protocol Violation|5|||
49085808|NCT01139775|158149470|FG002|Overall Study|Protocol Violation|0|||
49085809|NCT01139775|158149468|FG000|Overall Study|Withdrawal by Subject|1|||
49085810|NCT01139775|158149469|FG001|Overall Study|Withdrawal by Subject|0|||
49085811|NCT01139775|158149470|FG002|Overall Study|Withdrawal by Subject|2|||
49085812|NCT01139775|158149468|FG000|Overall Study|Physician Decision|0|||
49085813|NCT01139775|158149469|FG001|Overall Study|Physician Decision|2|||
49085814|NCT01139775|158149470|FG002|Overall Study|Physician Decision|2|||
49085815|NCT00365794|158149471|FG000|Overall Study|Withdrawal by Subject|2|||
49085816|NCT00586703|158149472|FG000|Overall Study|Death|12|||
49085817|NCT00745901|158149478|FG000|Overall Study|Adverse Event|3|||
49085818|NCT00745901|158149479|FG001|Overall Study|Adverse Event|4|||
49085819|NCT00745901|158149478|FG000|Overall Study|Protocol Violation|0|||
49085820|NCT00745901|158149479|FG001|Overall Study|Protocol Violation|1|||
49085821|NCT00745901|158149478|FG000|Overall Study|Withdrawal by Subject|1|||
49085822|NCT00745901|158149479|FG001|Overall Study|Withdrawal by Subject|0|||
49085823|NCT00745901|158149478|FG000|Overall Study|Lost to Follow-up|7|||
49085824|NCT00745901|158149479|FG001|Overall Study|Lost to Follow-up|4|||
49085825|NCT00745901|158149478|FG000|Overall Study|Pregnancy|2|||
49085826|NCT00745901|158149479|FG001|Overall Study|Pregnancy|4|||
49085827|NCT00745901|158149478|FG000|Overall Study|Lack of compliance|2|||
49085828|NCT00745901|158149479|FG001|Overall Study|Lack of compliance|2|||
49085829|NCT00745901|158149478|FG000|Overall Study|Patient's next menses did not start with|1|||
49085830|NCT00745901|158149479|FG001|Overall Study|Patient's next menses did not start with|0|||
49085831|NCT00745901|158149478|FG000|Overall Study|Results of Pap smear at Vis 1 malignant|0|||
49085832|NCT00745901|158149479|FG001|Overall Study|Results of Pap smear at Vis 1 malignant|2|||
49085833|NCT00745901|158149478|FG000|Overall Study|Chlamydia test at Visit 1 was positive|1|||
49085834|NCT00745901|158149479|FG001|Overall Study|Chlamydia test at Visit 1 was positive|1|||
49085835|NCT00745901|158149478|FG000|Overall Study|Patient didn't take any study medication|7|||
49085836|NCT00745901|158149479|FG001|Overall Study|Patient didn't take any study medication|3|||
49085837|NCT02554682|158149480|FG000|Overall Study|Lost to Follow-up|11|||
49085838|NCT02554682|158149481|FG001|Overall Study|Lost to Follow-up|9|||
49085839|NCT02554682|158149482|FG002|Overall Study|Lost to Follow-up|4|||
49085840|NCT02554682|158149483|FG003|Overall Study|Lost to Follow-up|3|||
49085841|NCT02554682|158149484|FG004|Overall Study|Lost to Follow-up|2|||
49085842|NCT02554682|158149485|FG005|Overall Study|Lost to Follow-up|1|||
49085843|NCT02554682|158149486|FG006|Overall Study|Lost to Follow-up|6|||
49085844|NCT02554682|158149487|FG007|Overall Study|Lost to Follow-up|6|||
49085845|NCT02554682|158149488|FG008|Overall Study|Lost to Follow-up|2|||
49085846|NCT02554682|158149489|FG009|Overall Study|Lost to Follow-up|2|||
49085847|NCT02554682|158149480|FG000|Overall Study|Withdrawal by Subject|2|||
49085848|NCT02554682|158149481|FG001|Overall Study|Withdrawal by Subject|1|||
49085849|NCT02554682|158149482|FG002|Overall Study|Withdrawal by Subject|0|||
49085850|NCT02554682|158149483|FG003|Overall Study|Withdrawal by Subject|0|||
49085851|NCT02554682|158149484|FG004|Overall Study|Withdrawal by Subject|0|||
49085852|NCT02554682|158149485|FG005|Overall Study|Withdrawal by Subject|0|||
49085853|NCT02554682|158149486|FG006|Overall Study|Withdrawal by Subject|0|||
49085854|NCT02554682|158149487|FG007|Overall Study|Withdrawal by Subject|0|||
49085855|NCT02554682|158149488|FG008|Overall Study|Withdrawal by Subject|0|||
49085856|NCT02554682|158149489|FG009|Overall Study|Withdrawal by Subject|0|||
49085857|NCT02554682|158149480|FG000|Overall Study|Physician Decision|2|||
49085858|NCT02554682|158149481|FG001|Overall Study|Physician Decision|2|||
49085859|NCT02554682|158149482|FG002|Overall Study|Physician Decision|0|||
49085860|NCT02554682|158149483|FG003|Overall Study|Physician Decision|0|||
49085861|NCT02554682|158149484|FG004|Overall Study|Physician Decision|0|||
49085862|NCT02554682|158149485|FG005|Overall Study|Physician Decision|0|||
49085863|NCT02554682|158149486|FG006|Overall Study|Physician Decision|0|||
49085864|NCT02554682|158149487|FG007|Overall Study|Physician Decision|0|||
49085865|NCT02554682|158149488|FG008|Overall Study|Physician Decision|0|||
49085866|NCT02554682|158149489|FG009|Overall Study|Physician Decision|0|||
49085867|NCT00806403|158149490|FG000|Overall Study|Death|4|||
49085868|NCT00806403|158149491|FG001|Overall Study|Death|3|||
49085869|NCT00014495|158149492|FG000|Overall Study|Death|0|||
49085870|NCT00014495|158149493|FG001|Overall Study|Death|0|||
49085871|NCT00014495|158149494|FG002|Overall Study|Death|1|||
49085872|NCT00014495|158149495|FG003|Overall Study|Death|0|||
49085873|NCT00014495|158149492|FG000|Overall Study|Clinical deterioration|0|||
49085874|NCT00014495|158149493|FG001|Overall Study|Clinical deterioration|0|||
49085875|NCT00014495|158149494|FG002|Overall Study|Clinical deterioration|0|||
49085876|NCT00014495|158149495|FG003|Overall Study|Clinical deterioration|1|||
49085877|NCT01890122|158149500|FG000|Overall Study|Adverse Event|1|||
49085878|NCT01890122|158149501|FG001|Overall Study|Adverse Event|1|||
49085879|NCT01890122|158149502|FG002|Overall Study|Adverse Event|1|||
49085880|NCT01890122|158149503|FG003|Overall Study|Adverse Event|2|||
49085881|NCT01890122|158149500|FG000|Overall Study|Major Protocol Deviation|3|||
49085882|NCT01890122|158149501|FG001|Overall Study|Major Protocol Deviation|1|||
49085883|NCT01890122|158149502|FG002|Overall Study|Major Protocol Deviation|0|||
49085884|NCT01890122|158149503|FG003|Overall Study|Major Protocol Deviation|1|||
49085885|NCT01890122|158149500|FG000|Overall Study|Lost to Follow-up|0|||
49085886|NCT01890122|158149501|FG001|Overall Study|Lost to Follow-up|1|||
49085887|NCT01890122|158149502|FG002|Overall Study|Lost to Follow-up|2|||
49085888|NCT01890122|158149503|FG003|Overall Study|Lost to Follow-up|2|||
49085889|NCT01890122|158149500|FG000|Overall Study|Voluntary Withdrawal|8|||
49085890|NCT01890122|158149501|FG001|Overall Study|Voluntary Withdrawal|8|||
49085891|NCT01890122|158149502|FG002|Overall Study|Voluntary Withdrawal|2|||
49085892|NCT01890122|158149503|FG003|Overall Study|Voluntary Withdrawal|11|||
49085893|NCT01890122|158149500|FG000|Overall Study|Lack of Efficacy|14|||
49085894|NCT01890122|158149501|FG001|Overall Study|Lack of Efficacy|24|||
49085895|NCT01890122|158149502|FG002|Overall Study|Lack of Efficacy|7|||
49085896|NCT01890122|158149503|FG003|Overall Study|Lack of Efficacy|41|||
49085897|NCT01890122|158149500|FG000|Overall Study|Reason not Specified|0|||
49085898|NCT01890122|158149501|FG001|Overall Study|Reason not Specified|1|||
49085899|NCT01890122|158149502|FG002|Overall Study|Reason not Specified|1|||
49085900|NCT01890122|158149503|FG003|Overall Study|Reason not Specified|2|||
49085901|NCT01890122|158149500|FG000|Overall Study|Randomized but not Treated|1|||
49085902|NCT01890122|158149501|FG001|Overall Study|Randomized but not Treated|1|||
49085903|NCT01890122|158149502|FG002|Overall Study|Randomized but not Treated|0|||
49085904|NCT01890122|158149503|FG003|Overall Study|Randomized but not Treated|0|||
49085905|NCT00314327|158149507|FG000|Overall Study|Withdrawal by Subject|1|||
49085906|NCT02741076|158149508|FG000|Overall Study|Adverse Event|0|||
49085907|NCT02741076|158149509|FG001|Overall Study|Adverse Event|1|||
49085908|NCT02741076|158149510|FG002|Overall Study|Adverse Event|1|||
49085909|NCT02741076|158149511|FG003|Overall Study|Adverse Event|0|||
49085910|NCT02741076|158149508|FG000|Overall Study|Lack of Efficacy|1|||
49085911|NCT02741076|158149509|FG001|Overall Study|Lack of Efficacy|0|||
49085912|NCT02741076|158149510|FG002|Overall Study|Lack of Efficacy|0|||
49085913|NCT02741076|158149511|FG003|Overall Study|Lack of Efficacy|0|||
49085914|NCT02741076|158149508|FG000|Overall Study|Withdrawal by Subject|0|||
49085915|NCT02741076|158149509|FG001|Overall Study|Withdrawal by Subject|1|||
49085916|NCT02741076|158149510|FG002|Overall Study|Withdrawal by Subject|0|||
49085917|NCT02741076|158149511|FG003|Overall Study|Withdrawal by Subject|0|||
49085918|NCT02741076|158149508|FG000|Overall Study|Sponsor Request|2|||
49085919|NCT02741076|158149509|FG001|Overall Study|Sponsor Request|3|||
49085920|NCT02741076|158149510|FG002|Overall Study|Sponsor Request|0|||
49085921|NCT02741076|158149511|FG003|Overall Study|Sponsor Request|1|||
49085922|NCT02741076|158149508|FG000|Overall Study|No additional information available|0|||
49085923|NCT02741076|158149509|FG001|Overall Study|No additional information available|0|||
49085924|NCT02741076|158149510|FG002|Overall Study|No additional information available|1|||
49085925|NCT02741076|158149511|FG003|Overall Study|No additional information available|1|||
49085926|NCT02837731|158149512|FG000|Allocation|Admitted to General Floor|3|||
49085927|NCT02837731|158149513|FG001|Allocation|Admitted to General Floor|4|||
49085928|NCT02837731|158149512|FG000|Allocation|Immediate surgery/withdrew|2|||
49085929|NCT02837731|158149513|FG001|Allocation|Immediate surgery/withdrew|0|||
49085930|NCT02837731|158149512|FG000|Allocation|Diabetic Ketoacidosis/withdrew|1|||
49085931|NCT02837731|158149513|FG001|Allocation|Diabetic Ketoacidosis/withdrew|0|||
49085932|NCT02837731|158149512|FG000|Allocation|Withdrawal by Subject|2|||
49085933|NCT02837731|158149513|FG001|Allocation|Withdrawal by Subject|0|||
49085934|NCT02837731|158149512|FG000|Allocation|Device not available|1|||
49085935|NCT02837731|158149513|FG001|Allocation|Device not available|0|||
49085936|NCT02837731|158149512|FG000|Allocation|Protocol not implemented|7|||
49085937|NCT02837731|158149513|FG001|Allocation|Protocol not implemented|0|||
49085938|NCT02837731|158149512|FG000|Allocation|Moribund/Do not resuscitate|2|||
49085939|NCT02837731|158149513|FG001|Allocation|Moribund/Do not resuscitate|0|||
49085940|NCT02837731|158149512|FG000|Allocation|Did not meet sepsis criteria|1|||
49085941|NCT02837731|158149513|FG001|Allocation|Did not meet sepsis criteria|2|||
49085942|NCT02837731|158149512|FG000|Allocation|Known aortic abnormalities|0|||
49085943|NCT02837731|158149513|FG001|Allocation|Known aortic abnormalities|1|||
49085944|NCT02965573|158149515|FG000|Overall Study|Lack of Efficacy|1|||
49085945|NCT02965573|158149516|FG001|Overall Study|Lack of Efficacy|0|||
49085946|NCT01779440|158149519|FG000|Overall Study|Withdrawal by Subject|3|||
49085947|NCT01779440|158149520|FG001|Overall Study|Withdrawal by Subject|5|||
49085948|NCT01205269|158149521|FG000|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
49085949|NCT01205269|158149522|FG001|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
49085950|NCT01205269|158149523|FG002|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
49085951|NCT01205269|158149524|FG003|Period 4 - Washout|Eligibility criteria not fulfilled|1|||
49085952|NCT01205269|158149525|FG004|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
49085953|NCT01205269|158149526|FG005|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
49085954|NCT01804946|158149527|FG000|Overall Study|Protocol Violation|1|||
49085955|NCT01804946|158149528|FG001|Overall Study|Protocol Violation|0|||
49085956|NCT01804946|158149527|FG000|Overall Study|Adverse Event|0|||
49085957|NCT01804946|158149528|FG001|Overall Study|Adverse Event|1|||
49085958|NCT01804946|158149527|FG000|Overall Study|Insufficient data available|0|||
49085959|NCT01804946|158149528|FG001|Overall Study|Insufficient data available|1|||
49085960|NCT01804946|158149527|FG000|Overall Study|Do not meet inclusion criteria|1|||
49085961|NCT01804946|158149528|FG001|Overall Study|Do not meet inclusion criteria|2|||
49085962|NCT03830333|158149529|FG000|Overall Study|Death|0|||
49085963|NCT03830333|158149530|FG001|Overall Study|Death|1|||
49085964|NCT03830333|158149529|FG000|Overall Study|Withdrawal by Subject|5|||
49085965|NCT03830333|158149530|FG001|Overall Study|Withdrawal by Subject|1|||
49085966|NCT03830333|158149529|FG000|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3|||
49085967|NCT03830333|158149530|FG001|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2|||
49085968|NCT00987337|158149531|FG000|Overall Study|Adverse Event|10|||
49085969|NCT00987337|158149532|FG001|Overall Study|Adverse Event|9|||
49085970|NCT00987337|158149533|FG002|Overall Study|Adverse Event|8|||
49085971|NCT00987337|158149531|FG000|Overall Study|Insufficient Virologic Response|10|||
49085972|NCT00987337|158149532|FG001|Overall Study|Insufficient Virologic Response|7|||
49085973|NCT00987337|158149533|FG002|Overall Study|Insufficient Virologic Response|12|||
49085974|NCT00987337|158149531|FG000|Overall Study|Virologic Breakthrough|2|||
49085975|NCT00987337|158149532|FG001|Overall Study|Virologic Breakthrough|2|||
49085976|NCT00987337|158149533|FG002|Overall Study|Virologic Breakthrough|8|||
49085977|NCT00987337|158149531|FG000|Overall Study|Lost to Follow-up|10|||
49085978|NCT00987337|158149532|FG001|Overall Study|Lost to Follow-up|6|||
49085979|NCT00987337|158149533|FG002|Overall Study|Lost to Follow-up|2|||
49085980|NCT00987337|158149531|FG000|Overall Study|Withdrawal by Subject|6|||
49085981|NCT00987337|158149532|FG001|Overall Study|Withdrawal by Subject|9|||
49085982|NCT00987337|158149533|FG002|Overall Study|Withdrawal by Subject|9|||
49085983|NCT00987337|158149531|FG000|Overall Study|Other|0|||
49085984|NCT00987337|158149532|FG001|Overall Study|Other|2|||
49085985|NCT00987337|158149533|FG002|Overall Study|Other|5|||
49085986|NCT00987337|158149531|FG000|Overall Study|Protocol Violation|1|||
49085987|NCT00987337|158149532|FG001|Overall Study|Protocol Violation|0|||
49085988|NCT00987337|158149533|FG002|Overall Study|Protocol Violation|2|||
49085989|NCT00987337|158149531|FG000|Overall Study|Participant Relapsed|18|||
49085990|NCT00987337|158149532|FG001|Overall Study|Participant Relapsed|20|||
49085991|NCT00987337|158149533|FG002|Overall Study|Participant Relapsed|5|||
49085992|NCT02859337|158149534|FG000|Overall Study|Study drug not dosed (no dominant follicle)|2|||
49085993|NCT02859337|158149535|FG001|Overall Study|Study drug not dosed (no dominant follicle)|2|||
49085994|NCT02859337|158149536|FG002|Overall Study|Study drug not dosed (no dominant follicle)|0|||
49085995|NCT02859337|158149534|FG000|Overall Study|Withdrawal by Subject|3|||
49085996|NCT02859337|158149535|FG001|Overall Study|Withdrawal by Subject|1|||
49085997|NCT02859337|158149536|FG002|Overall Study|Withdrawal by Subject|0|||
49085998|NCT02859337|158149534|FG000|Overall Study|Lost to Follow-up|1|||
49085999|NCT02859337|158149535|FG001|Overall Study|Lost to Follow-up|0|||
49086000|NCT02859337|158149536|FG002|Overall Study|Lost to Follow-up|0|||
49086001|NCT00722137|158149537|FG000|Overall Study|Overt Disease Progression|5|||
49086002|NCT00722137|158149538|FG001|Overall Study|Overt Disease Progression|4|||
49086003|NCT00722137|158149537|FG000|Overall Study|Adverse Event|17|||
49086004|NCT00722137|158149538|FG001|Overall Study|Adverse Event|21|||
49086005|NCT00722137|158149537|FG000|Overall Study|Death|12|||
49086006|NCT00722137|158149538|FG001|Overall Study|Death|7|||
49086007|NCT00722137|158149537|FG000|Overall Study|Withdrawal by Subject|6|||
49086008|NCT00722137|158149538|FG001|Overall Study|Withdrawal by Subject|9|||
49086009|NCT00722137|158149537|FG000|Overall Study|Other Reason Unknown|3|||
49086010|NCT00722137|158149538|FG001|Overall Study|Other Reason Unknown|4|||
49086011|NCT00722137|158149537|FG000|Overall Study|Randomized But Not Treated|2|||
49086012|NCT00722137|158149538|FG001|Overall Study|Randomized But Not Treated|3|||
49086013|NCT00523848|158149539|FG000|Overall Study|Adverse Event|11|||
49086014|NCT00523848|158149539|FG000|Overall Study|Withdrawal by Subject|2|||
49086015|NCT00523848|158149539|FG000|Overall Study|NOT TREATED (Became ineligible)|2|||
49086016|NCT00523848|158149539|FG000|Overall Study|Disease Progression|5|||
49086017|NCT00523848|158149539|FG000|Overall Study|Other, unspecified|4|||
49086018|NCT02729025|158149540|FG000|Overall Study|Sponsor Decision|0|||
49086019|NCT02729025|158149541|FG001|Overall Study|Sponsor Decision|1|||
49086020|NCT01445730|158149542|FG000|Overall Study|Adverse Event|1|||
49086021|NCT01445730|158149542|FG000|Overall Study|For the advice of a dentist|1|||
49086022|NCT01445730|158149542|FG000|Overall Study|The data from magnetic resonance examinations were not sufficient|9|||
49086023|NCT00603473|158149545|FG000|Overall Study|Adverse Event|4|||
49086024|NCT00603473|158149545|FG000|Overall Study|Lack of Efficacy|4|||
49086025|NCT00603473|158149545|FG000|Overall Study|Protocol Violation|1|||
49086026|NCT01367886|158149548|FG000|Overall Study|Lost to Follow-up|4|||
49086027|NCT01367886|158149548|FG000|Overall Study|Lack of Efficacy|2|||
49086028|NCT01367886|158149548|FG000|Overall Study|Death|1|||
49086029|NCT02389829|158149564|FG000|Overall Study|Lost to Follow-up|0|||
49086030|NCT02389829|158149565|FG001|Overall Study|Lost to Follow-up|1|||
49086031|NCT04982575|158151503|FG000|Overall Study|Withdrawal by Subject|2|||
49086032|NCT04982575|158151504|FG001|Overall Study|Withdrawal by Subject|0|||
49086033|NCT04982575|158151505|FG002|Overall Study|Withdrawal by Subject|2|||
49086034|NCT00855894|158151506|FG000|Overall Study|Death|31|||
49086035|NCT00855894|158151506|FG000|Overall Study|Patient's decision|1|||
49086036|NCT00855894|158151506|FG000|Overall Study|Disease progression|1|||
49086037|NCT01557504|158151507|FG000|Overall Study|Physician Decision|1|||
49086038|NCT01557504|158151508|FG001|Overall Study|Physician Decision|0|||
49086039|NCT04231825|158151509|FG000|Overall Study|Protocol Violation|3|||
49086040|NCT04231825|158151510|FG001|Overall Study|Protocol Violation|3|||
49086041|NCT04231825|158151509|FG000|Overall Study|Lost to Follow-up|0|||
49086042|NCT04231825|158151510|FG001|Overall Study|Lost to Follow-up|1|||
49086043|NCT01321749|158151518|FG000|Overall Study|Lost to Follow-up|4|||
49086044|NCT01321749|158151519|FG001|Overall Study|Lost to Follow-up|11|||
49086045|NCT01321749|158151518|FG000|Overall Study|Protocol Violation|4|||
49086046|NCT01321749|158151519|FG001|Overall Study|Protocol Violation|7|||
49086047|NCT01321749|158151518|FG000|Overall Study|Withdrawal by Subject|5|||
49086048|NCT01321749|158151519|FG001|Overall Study|Withdrawal by Subject|4|||
49086049|NCT00077207|158151523|FG000|Overall Study|Adverse Event|5|||
49086050|NCT00077207|158151523|FG000|Overall Study|Lack of Efficacy|12|||
49086051|NCT00077207|158151523|FG000|Overall Study|Physician Decision|6|||
49086052|NCT00077207|158151523|FG000|Overall Study|Withdrawal by Subject|6|||
49086053|NCT00077207|158151523|FG000|Overall Study|Ineligible|1|||
49086054|NCT02572570|158151524|FG000|Overall Study|Study Terminated|27|||
49086055|NCT01290068|158151525|FG000|Overall Study|Adverse Event|1|||
49086056|NCT01290068|158151526|FG001|Overall Study|Adverse Event|3|||
49086057|NCT01290068|158151525|FG000|Overall Study|Lost to Follow-up|3|||
49086058|NCT01290068|158151526|FG001|Overall Study|Lost to Follow-up|0|||
49086059|NCT01290068|158151525|FG000|Overall Study|Withdrawal by subject prior to implant|0|||
49086060|NCT01290068|158151526|FG001|Overall Study|Withdrawal by subject prior to implant|2|||
49086061|NCT01290068|158151525|FG000|Overall Study|Other|3|||
49086062|NCT01290068|158151526|FG001|Overall Study|Other|1|||
49086063|NCT01173523|158151529|FG000|Overall Study|Clinical Progression|1|||
49086064|NCT01173523|158151530|FG001|Overall Study|Clinical Progression|1|||
49086065|NCT01173523|158151529|FG000|Overall Study|Progressive Disease|10|||
49086066|NCT01173523|158151530|FG001|Overall Study|Progressive Disease|8|||
49086067|NCT01173523|158151529|FG000|Overall Study|Other|2|||
49086068|NCT01173523|158151530|FG001|Overall Study|Other|3|||
49086069|NCT00840749|158151531|FG000|Overall Study|Death|1|||
49086070|NCT00840749|158151532|FG001|Overall Study|Death|2|||
49086071|NCT00840749|158151531|FG000|Overall Study|not treated on study arm|11|||
49086072|NCT00840749|158151532|FG001|Overall Study|not treated on study arm|11|||
49086073|NCT00840749|158151531|FG000|Overall Study|study closed|19|||
49086074|NCT00840749|158151532|FG001|Overall Study|study closed|14|||
49086075|NCT02633293|158151533|FG000|Overall Study|Death|56|||
49086076|NCT02633293|158151533|FG000|Overall Study|Progressive Disease|12|||
49086077|NCT02633293|158151533|FG000|Overall Study|Adverse Event|29|||
49086078|NCT02633293|158151533|FG000|Overall Study|Withdrawal by Subject|41|||
49086079|NCT02633293|158151533|FG000|Overall Study|Protocol Violation|1|||
49086080|NCT02633293|158151533|FG000|Overall Study|Lost to Follow-up|1|||
49086081|NCT02633293|158151533|FG000|Overall Study|Study Terminated by Sponsor|24|||
49086082|NCT02633293|158151533|FG000|Overall Study|Withdrawal by Sponsor Prior to Dose Administration|1|||
49086083|NCT02633293|158151533|FG000|Overall Study|Lung Transplant|5|||
49086084|NCT02633293|158151533|FG000|Overall Study|Lack of Efficacy|2|||
49086085|NCT02633293|158151533|FG000|Overall Study|Principal Investigator Terminated Study Site|1|||
49086086|NCT01017874|158151534|FG000|Overall Study|Withdrawal by Subject|23|||
49086087|NCT01017874|158151535|FG001|Overall Study|Withdrawal by Subject|20|||
49086088|NCT01017874|158151534|FG000|Overall Study|Sponsor decision|3|||
49086089|NCT01017874|158151535|FG001|Overall Study|Sponsor decision|1|||
49086090|NCT01017874|158151534|FG000|Overall Study|Lost to Follow-up|3|||
49086091|NCT01017874|158151535|FG001|Overall Study|Lost to Follow-up|2|||
49086092|NCT01017874|158151534|FG000|Overall Study|Physician Decision|1|||
49086093|NCT01017874|158151535|FG001|Overall Study|Physician Decision|3|||
49086094|NCT00925704|158151536|FG000|First Intervention|Withdrew consent|0|||
49086095|NCT00925704|158151537|FG001|First Intervention|Withdrew consent|0|||
49086096|NCT00925704|158151538|FG002|First Intervention|Withdrew consent|0|||
49086097|NCT00925704|158151539|FG003|First Intervention|Withdrew consent|1|||
49086098|NCT00925704|158151540|FG004|First Intervention|Withdrew consent|1|||
49086099|NCT00925704|158151541|FG005|First Intervention|Withdrew consent|0|||
49086100|NCT00925704|158151536|FG000|Second Intervention|Withdrawal by Subject|1|||
49086101|NCT00925704|158151537|FG001|Second Intervention|Withdrawal by Subject|0|||
49086102|NCT00925704|158151538|FG002|Second Intervention|Withdrawal by Subject|0|||
49086103|NCT00925704|158151539|FG003|Second Intervention|Withdrawal by Subject|0|||
49086104|NCT00925704|158151540|FG004|Second Intervention|Withdrawal by Subject|1|||
49086105|NCT00925704|158151541|FG005|Second Intervention|Withdrawal by Subject|0|||
49086106|NCT00925704|158151536|FG000|Third Intervention|Withdrew consent|0|||
49086107|NCT00925704|158151537|FG001|Third Intervention|Withdrew consent|0|||
49086108|NCT00925704|158151538|FG002|Third Intervention|Withdrew consent|0|||
49086109|NCT00925704|158151539|FG003|Third Intervention|Withdrew consent|0|||
49086110|NCT00925704|158151540|FG004|Third Intervention|Withdrew consent|0|||
49086111|NCT00925704|158151541|FG005|Third Intervention|Withdrew consent|1|||
49086112|NCT03207815|158151542|FG000|Overall Study|Protocol Violation|3|||
49086113|NCT03207815|158151543|FG001|Overall Study|Protocol Violation|1|||
49086114|NCT03207815|158151542|FG000|Overall Study|Adverse Event|1|||
49086115|NCT03207815|158151543|FG001|Overall Study|Adverse Event|2|||
49086116|NCT03207815|158151542|FG000|Overall Study|Lost to Follow-up|1|||
49086117|NCT03207815|158151543|FG001|Overall Study|Lost to Follow-up|2|||
49086118|NCT03207815|158151542|FG000|Overall Study|Investigator's Discretion|1|||
49086119|NCT03207815|158151543|FG001|Overall Study|Investigator's Discretion|1|||
49086120|NCT03207815|158151542|FG000|Overall Study|Lack of Efficacy|0|||
49086121|NCT03207815|158151543|FG001|Overall Study|Lack of Efficacy|1|||
49086122|NCT03207815|158151542|FG000|Overall Study|Pregnancy/Partner Pregnancy|1|||
49086123|NCT03207815|158151543|FG001|Overall Study|Pregnancy/Partner Pregnancy|0|||
49086124|NCT03207815|158151542|FG000|Overall Study|Withdrew Consent|1|||
49086125|NCT03207815|158151543|FG001|Overall Study|Withdrew Consent|0|||
49086126|NCT05370040|158151547|FG000|Overall Study|Lost to Follow-up|0|||
49086127|NCT05370040|158151548|FG001|Overall Study|Lost to Follow-up|0|||
49086128|NCT05370040|158151549|FG002|Overall Study|Lost to Follow-up|1|||
49086129|NCT05370040|158151550|FG003|Overall Study|Lost to Follow-up|0|||
49086130|NCT05370040|158151551|FG004|Overall Study|Lost to Follow-up|1|||
49086131|NCT05370040|158151552|FG005|Overall Study|Lost to Follow-up|0|||
49086132|NCT00428246|158151553|FG000|Overall Study|Withdrawal by Subject|0|||
49086133|NCT00428246|158151554|FG001|Overall Study|Withdrawal by Subject|0|||
49086134|NCT00428246|158151555|FG002|Overall Study|Withdrawal by Subject|1|||
49086135|NCT00428246|158151553|FG000|Overall Study|Adverse Event|1|||
49086136|NCT00428246|158151554|FG001|Overall Study|Adverse Event|0|||
49086137|NCT00428246|158151555|FG002|Overall Study|Adverse Event|0|||
49086138|NCT00391768|158151556|FG000|Overall Study|Withdrawal by Subject|0|||
49086139|NCT00391768|158151557|FG001|Overall Study|Withdrawal by Subject|0|||
49086140|NCT00391768|158151558|FG002|Overall Study|Withdrawal by Subject|1|||
49086141|NCT00391768|158151559|FG003|Overall Study|Withdrawal by Subject|0|||
49086142|NCT00391768|158151560|FG004|Overall Study|Withdrawal by Subject|0|||
49086143|NCT00391768|158151561|FG005|Overall Study|Withdrawal by Subject|1|||
49086144|NCT00391768|158151562|FG006|Overall Study|Withdrawal by Subject|1|||
49086145|NCT00391768|158151556|FG000|Overall Study|Lost to Follow-up|0|||
49086146|NCT00391768|158151557|FG001|Overall Study|Lost to Follow-up|0|||
49086147|NCT00391768|158151558|FG002|Overall Study|Lost to Follow-up|0|||
49086148|NCT00391768|158151559|FG003|Overall Study|Lost to Follow-up|1|||
49086149|NCT00391768|158151560|FG004|Overall Study|Lost to Follow-up|2|||
49086150|NCT00391768|158151561|FG005|Overall Study|Lost to Follow-up|2|||
49086151|NCT00391768|158151562|FG006|Overall Study|Lost to Follow-up|3|||
49086152|NCT02569801|158151563|FG000|Overall Study|Withdrawal by Subject|9|||
49086153|NCT02569801|158151564|FG001|Overall Study|Withdrawal by Subject|9|||
49086154|NCT02569801|158151563|FG000|Overall Study|Sponsor Decision|13|||
49086155|NCT02569801|158151564|FG001|Overall Study|Sponsor Decision|14|||
49086156|NCT02569801|158151563|FG000|Overall Study|Progressive Disease|2|||
49086157|NCT02569801|158151564|FG001|Overall Study|Progressive Disease|7|||
49086158|NCT02569801|158151563|FG000|Overall Study|Lost to Follow-up|0|||
49086159|NCT02569801|158151564|FG001|Overall Study|Lost to Follow-up|1|||
49086160|NCT02569801|158151563|FG000|Overall Study|Death|12|||
49086161|NCT02569801|158151564|FG001|Overall Study|Death|4|||
49086162|NCT01293695|158151565|FG000|Overall Study|Withdrawal by Subject|7|||
49086163|NCT01293695|158151566|FG001|Overall Study|Withdrawal by Subject|1|||
49086164|NCT01293695|158151565|FG000|Overall Study|Lost to Follow-up|8|||
49086165|NCT01293695|158151566|FG001|Overall Study|Lost to Follow-up|6|||
49086166|NCT01960413|158151569|FG000|Overall Study|Withdrawal by Subject|1|||
49086167|NCT01960413|158151570|FG001|Overall Study|Withdrawal by Subject|1|||
49086168|NCT01960413|158151569|FG000|Overall Study|Physician Decision|1|||
49086169|NCT01960413|158151570|FG001|Overall Study|Physician Decision|0|||
49086170|NCT01960413|158151569|FG000|Overall Study|Lost to Follow-up|2|||
49086171|NCT01960413|158151570|FG001|Overall Study|Lost to Follow-up|0|||
49086172|NCT00778817|158151583|FG000|Overall Study|Adverse Event|2|||
49086173|NCT00778817|158151583|FG000|Overall Study|Withdrawal by Subject|2|||
49086174|NCT01620138|158151584|FG000|Overall Study|Withdrawal by Subject|3|||
49086175|NCT01620138|158151585|FG001|Overall Study|Withdrawal by Subject|0|||
49086176|NCT01620138|158151584|FG000|Overall Study|Lack of Efficacy|1|||
49086177|NCT01620138|158151585|FG001|Overall Study|Lack of Efficacy|0|||
49086178|NCT01620138|158151584|FG000|Overall Study|Adverse Event|2|||
49086179|NCT01620138|158151585|FG001|Overall Study|Adverse Event|0|||
49086180|NCT01082328|158151588|FG000|Overall Study|Adverse Event|1|||
49086181|NCT02285361|158151591|FG000|Overall Study|Protocol Violation|43|||
49086182|NCT02285361|158151591|FG000|Overall Study|Lost to Follow-up|5|||
49086183|NCT02285361|158151591|FG000|Overall Study|Not taken GIOTRIF|2|||
49086184|NCT02285361|158151591|FG000|Overall Study|Consented prior to the contract date|1|||
49086185|NCT00957801|158151592|FG000|Overall Study|Withdrawal by Subject|0|||
49086186|NCT00957801|158151593|FG001|Overall Study|Withdrawal by Subject|0|||
49086187|NCT00957801|158151594|FG002|Overall Study|Withdrawal by Subject|0|||
49086188|NCT00957801|158151595|FG003|Overall Study|Withdrawal by Subject|1|||
49086189|NCT00031590|158151596|FG000|Overall Study|Adverse Event|1|||
49086190|NCT00031590|158151596|FG000|Overall Study|Withdrawal by parents|2|||
49086191|NCT02059135|158151601|FG000|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3|||
49086192|NCT02059135|158151602|FG001|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2|||
49086193|NCT02059135|158151601|FG000|Maternal Follow-up (ITT Population)|Lost to Follow-up|0|||
49086194|NCT02059135|158151602|FG001|Maternal Follow-up (ITT Population)|Lost to Follow-up|3|||
49086195|NCT02059135|158151601|FG000|Maternal Follow-up (ITT Population)|declined to see site staff|0|||
49086196|NCT02059135|158151602|FG001|Maternal Follow-up (ITT Population)|declined to see site staff|1|||
49086197|NCT02059135|158151601|FG000|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0|||
49086198|NCT02059135|158151602|FG001|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1|||
49086199|NCT02059135|158151601|FG000|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1|||
49086200|NCT02059135|158151602|FG001|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0|||
49086201|NCT02059135|158151601|FG000|Neonatal Follow-up (Safety Population)|Death|3|||
49086202|NCT02059135|158151602|FG001|Neonatal Follow-up (Safety Population)|Death|2|||
49086203|NCT02059135|158151601|FG000|Neonatal Follow-up (Safety Population)|delivered at another hospital|0|||
49086204|NCT02059135|158151602|FG001|Neonatal Follow-up (Safety Population)|delivered at another hospital|1|||
49086205|NCT02059135|158151601|FG000|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0|||
49086206|NCT02059135|158151602|FG001|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1|||
49086207|NCT02356588|158151603|FG000|Overall Study|Lack of Efficacy|4|||
49086208|NCT02356588|158151604|FG001|Overall Study|Lack of Efficacy|10|||
49086209|NCT02356588|158151603|FG000|Overall Study|Adverse Event|0|||
49086210|NCT02356588|158151604|FG001|Overall Study|Adverse Event|2|||
49086211|NCT02356588|158151603|FG000|Overall Study|Withdrawal by Subject|1|||
49086212|NCT02356588|158151604|FG001|Overall Study|Withdrawal by Subject|0|||
49086213|NCT02356588|158151603|FG000|Overall Study|Protocol Violation|0|||
49086214|NCT02356588|158151604|FG001|Overall Study|Protocol Violation|1|||
49086215|NCT03762265|158151605|FG000|BT Period: Weeks 1 to 37|Adverse Event|7|||
49086216|NCT03762265|158151606|FG001|BT Period: Weeks 1 to 37|Adverse Event|2|||
49086217|NCT03762265|158151605|FG000|BT Period: Weeks 1 to 37|Lack of Efficacy|1|||
49086218|NCT03762265|158151606|FG001|BT Period: Weeks 1 to 37|Lack of Efficacy|0|||
49086219|NCT03762265|158151605|FG000|BT Period: Weeks 1 to 37|Physician Decision|1|||
49086220|NCT03762265|158151606|FG001|BT Period: Weeks 1 to 37|Physician Decision|0|||
49086221|NCT03762265|158151605|FG000|BT Period: Weeks 1 to 37|Required prohibited medication|2|||
49086222|NCT03762265|158151606|FG001|BT Period: Weeks 1 to 37|Required prohibited medication|0|||
49086223|NCT03762265|158151605|FG000|BT Period: Weeks 1 to 37|Withdrawal by Subject|4|||
49086224|NCT03762265|158151606|FG001|BT Period: Weeks 1 to 37|Withdrawal by Subject|0|||
49086225|NCT03762265|158151605|FG000|BT Period: Weeks 1 to 37|Other|0|||
49086226|NCT03762265|158151606|FG001|BT Period: Weeks 1 to 37|Other|1|||
49086227|NCT03762265|158151605|FG000|OLE Period: Weeks 37 to 61|Adverse Event|1|||
49086228|NCT03762265|158151606|FG001|OLE Period: Weeks 37 to 61|Adverse Event|2|||
49086229|NCT03762265|158151605|FG000|OLE Period: Weeks 37 to 61|Lack of Efficacy|3|||
49086230|NCT03762265|158151606|FG001|OLE Period: Weeks 37 to 61|Lack of Efficacy|2|||
49086231|NCT03762265|158151605|FG000|OLE Period: Weeks 37 to 61|Non-compliance with study drug|1|||
49086232|NCT03762265|158151606|FG001|OLE Period: Weeks 37 to 61|Non-compliance with study drug|0|||
49086233|NCT03762265|158151605|FG000|OLE Period: Weeks 37 to 61|Study terminated by sponsor|8|||
49086234|NCT03762265|158151606|FG001|OLE Period: Weeks 37 to 61|Study terminated by sponsor|10|||
49086235|NCT03762265|158151605|FG000|OLE Period: Weeks 37 to 61|Withdrawal by Subject|3|||
49086236|NCT03762265|158151606|FG001|OLE Period: Weeks 37 to 61|Withdrawal by Subject|2|||
49086237|NCT03762265|158151605|FG000|LTE Period: Weeks 61 to 109|Lack of Efficacy|0|||
49086238|NCT03762265|158151606|FG001|LTE Period: Weeks 61 to 109|Lack of Efficacy|1|||
49086239|NCT03762265|158151605|FG000|LTE Period: Weeks 61 to 109|Study terminated by sponsor|28|||
49086240|NCT03762265|158151606|FG001|LTE Period: Weeks 61 to 109|Study terminated by sponsor|25|||
49086241|NCT03762265|158151605|FG000|LTE Period: Weeks 61 to 109|Withdrawal by Subject|0|||
49086242|NCT03762265|158151606|FG001|LTE Period: Weeks 61 to 109|Withdrawal by Subject|2|||
49086243|NCT03762265|158151605|FG000|LTE Period: Weeks 61 to 109|Other|1|||
49086244|NCT03762265|158151606|FG001|LTE Period: Weeks 61 to 109|Other|0|||
49086245|NCT00884117|158151609|FG000|Overall Study|Adverse Event|2|||
49086246|NCT00884117|158151609|FG000|Overall Study|Withdrawal by Subject|89|||
49086247|NCT00884117|158151609|FG000|Overall Study|Death|3|||
49086248|NCT00884117|158151609|FG000|Overall Study|Lost to Follow-up|143|||
49086249|NCT00884117|158151609|FG000|Overall Study|Other|12|||
49086250|NCT01882985|158151614|FG000|Overall Study|Lost to Follow-up|1|||
49086251|NCT01882985|158151614|FG000|Overall Study|Withdrawal by Subject|1|||
49086252|NCT04526288|158151615|FG000|Overall Study|Disease Progression|1|||
49086253|NCT04526288|158151616|FG001|Overall Study|Disease Progression|0|||
49086254|NCT00984542|158151617|FG000|Overall Study|disease progression|19|||
49086255|NCT00984542|158151617|FG000|Overall Study|toxicity|7|||
49086256|NCT00984542|158151617|FG000|Overall Study|Death|7|||
49086257|NCT00984542|158151617|FG000|Overall Study|complicating disease|3|||
49086258|NCT00984542|158151617|FG000|Overall Study|Withdrawal by Subject|3|||
49086259|NCT00984542|158151617|FG000|Overall Study|clinical deterioration|2|||
49086260|NCT00828568|158151624|FG000|Randomized|Withdrawal by Subject|1|||
49086261|NCT00828568|158151625|FG001|Randomized|Withdrawal by Subject|0|||
49086262|NCT00828568|158151626|FG002|Randomized|Withdrawal by Subject|2|||
49086263|NCT00828568|158151624|FG000|Treated - Received at Least One Dose|Adverse Event|11|||
49086264|NCT00828568|158151625|FG001|Treated - Received at Least One Dose|Adverse Event|8|||
49086265|NCT00828568|158151626|FG002|Treated - Received at Least One Dose|Adverse Event|1|||
49086266|NCT00828568|158151624|FG000|Treated - Received at Least One Dose|Withdrawal by Subject|9|||
49086267|NCT00828568|158151625|FG001|Treated - Received at Least One Dose|Withdrawal by Subject|11|||
49086268|NCT00828568|158151626|FG002|Treated - Received at Least One Dose|Withdrawal by Subject|0|||
49086269|NCT00828568|158151624|FG000|Treated - Received at Least One Dose|Lost to Follow-up|1|||
49086270|NCT00828568|158151625|FG001|Treated - Received at Least One Dose|Lost to Follow-up|5|||
49086271|NCT00828568|158151626|FG002|Treated - Received at Least One Dose|Lost to Follow-up|1|||
49086272|NCT00828568|158151624|FG000|Treated - Received at Least One Dose|Protocol Violation|9|||
49086273|NCT00828568|158151625|FG001|Treated - Received at Least One Dose|Protocol Violation|5|||
49086274|NCT00828568|158151626|FG002|Treated - Received at Least One Dose|Protocol Violation|3|||
49086275|NCT00450437|158151661|FG000|Overall Study|Withdrawal by Subject|10|||
49086276|NCT00450437|158151662|FG001|Overall Study|Withdrawal by Subject|2|||
49086277|NCT00450437|158151663|FG002|Overall Study|Withdrawal by Subject|0|||
49086278|NCT00450437|158151664|FG003|Overall Study|Withdrawal by Subject|1|||
49086279|NCT00450437|158151661|FG000|Overall Study|Lost to Follow-up|31|||
49086280|NCT00450437|158151662|FG001|Overall Study|Lost to Follow-up|12|||
49086281|NCT00450437|158151663|FG002|Overall Study|Lost to Follow-up|19|||
49086282|NCT00450437|158151664|FG003|Overall Study|Lost to Follow-up|9|||
49086283|NCT00450437|158151661|FG000|Overall Study|Protocol Violation|0|||
49086284|NCT00450437|158151662|FG001|Overall Study|Protocol Violation|1|||
49086285|NCT00450437|158151663|FG002|Overall Study|Protocol Violation|0|||
49086286|NCT00450437|158151664|FG003|Overall Study|Protocol Violation|1|||
49086287|NCT00450437|158151661|FG000|Overall Study|Inappropriate enrollment|4|||
49086288|NCT00450437|158151662|FG001|Overall Study|Inappropriate enrollment|1|||
49086289|NCT00450437|158151663|FG002|Overall Study|Inappropriate enrollment|3|||
49086290|NCT00450437|158151664|FG003|Overall Study|Inappropriate enrollment|0|||
49086291|NCT00450437|158151661|FG000|Overall Study|Administrative reason|0|||
49086292|NCT00450437|158151662|FG001|Overall Study|Administrative reason|0|||
49086293|NCT00450437|158151663|FG002|Overall Study|Administrative reason|1|||
49086294|NCT00450437|158151664|FG003|Overall Study|Administrative reason|0|||
49086295|NCT00450437|158151661|FG000|Overall Study|Unable to Classify|1|||
49086296|NCT00450437|158151662|FG001|Overall Study|Unable to Classify|0|||
49086297|NCT00450437|158151663|FG002|Overall Study|Unable to Classify|1|||
49086298|NCT00450437|158151664|FG003|Overall Study|Unable to Classify|0|||
49086299|NCT02522884|158151665|FG000|Overall Study|Withdrawal by Subject|6|||
49086300|NCT02522884|158151665|FG000|Overall Study|Death|3|||
49086301|NCT02522884|158151665|FG000|Overall Study|Missed 12-month Follow-up|9|||
49086302|NCT01129557|158151669|FG000|Overall Study|Adverse Event|1|||
49086303|NCT01129557|158151670|FG001|Overall Study|Adverse Event|2|||
49086304|NCT01129557|158151671|FG002|Overall Study|Adverse Event|2|||
49086305|NCT01129557|158151669|FG000|Overall Study|Novartis terminated study early|3|||
49086306|NCT01129557|158151670|FG001|Overall Study|Novartis terminated study early|3|||
49086307|NCT01129557|158151671|FG002|Overall Study|Novartis terminated study early|2|||
49086308|NCT04577404|158151672|FG000|Overall Study|Adverse Event|31|||
49086309|NCT04577404|158151672|FG000|Overall Study|Death|1|||
49086310|NCT04577404|158151672|FG000|Overall Study|Lack of Efficacy|3|||
49086311|NCT04577404|158151672|FG000|Overall Study|Physician Decision|7|||
49086312|NCT04577404|158151672|FG000|Overall Study|Withdrawal by Subject|21|||
49086313|NCT04577404|158151672|FG000|Overall Study|Switched to commercial oral Edaravon etc.|12|||
49086314|NCT00985504|158151673|FG000|Acute Treatment Period|Adverse Event|3|||
49086315|NCT00985504|158151674|FG001|Acute Treatment Period|Adverse Event|4|||
49086316|NCT00985504|158151673|FG000|Acute Treatment Period|Entry Criteria Not Met|1|||
49086317|NCT00985504|158151674|FG001|Acute Treatment Period|Entry Criteria Not Met|2|||
49086318|NCT00985504|158151673|FG000|Acute Treatment Period|Protocol Violation|2|||
49086319|NCT00985504|158151674|FG001|Acute Treatment Period|Protocol Violation|0|||
49086320|NCT00985504|158151673|FG000|Acute Treatment Period|Sponsor Decision|0|||
49086321|NCT00985504|158151674|FG001|Acute Treatment Period|Sponsor Decision|1|||
49086322|NCT00985504|158151673|FG000|Acute Treatment Period|Withdrawal by Subject|9|||
49086323|NCT00985504|158151674|FG001|Acute Treatment Period|Withdrawal by Subject|5|||
49086324|NCT00985504|158151673|FG000|Optimization Period|Adverse Event|7|||
49086325|NCT00985504|158151674|FG001|Optimization Period|Adverse Event|9|||
49086326|NCT00985504|158151673|FG000|Optimization Period|Death|0|||
49086327|NCT00985504|158151674|FG001|Optimization Period|Death|1|||
49086328|NCT00985504|158151673|FG000|Optimization Period|Lack of Efficacy|5|||
49086329|NCT00985504|158151674|FG001|Optimization Period|Lack of Efficacy|3|||
49086330|NCT00985504|158151673|FG000|Optimization Period|Lost to Follow-up|0|||
49086331|NCT00985504|158151674|FG001|Optimization Period|Lost to Follow-up|1|||
49086332|NCT00985504|158151673|FG000|Optimization Period|Physician Decision|1|||
49086333|NCT00985504|158151674|FG001|Optimization Period|Physician Decision|0|||
49086334|NCT00985504|158151673|FG000|Optimization Period|Protocol Violation|3|||
49086335|NCT00985504|158151674|FG001|Optimization Period|Protocol Violation|1|||
49086336|NCT00985504|158151673|FG000|Optimization Period|Withdrawal by Subject|10|||
49086337|NCT00985504|158151674|FG001|Optimization Period|Withdrawal by Subject|8|||
49086338|NCT00669669|158151680|FG000|Overall Study|To late to start treatment|1|||
49086339|NCT00086619|158151681|FG000|Overall Study|Withdrawal by Subject|6|||
49086340|NCT00086619|158151682|FG001|Overall Study|Withdrawal by Subject|6|||
49086341|NCT00086619|158151681|FG000|Overall Study|Adverse Event|8|||
49086342|NCT00086619|158151682|FG001|Overall Study|Adverse Event|10|||
49086343|NCT00086619|158151681|FG000|Overall Study|Protocol Violation|1|||
49086344|NCT00086619|158151682|FG001|Overall Study|Protocol Violation|1|||
49086345|NCT02872714|158151683|FG000|Overall Study|Progressive Disease|1|||
49086346|NCT02872714|158151684|FG001|Overall Study|Progressive Disease|2|||
49086347|NCT02872714|158151685|FG002|Overall Study|Progressive Disease|0|||
49086348|NCT02872714|158151686|FG003|Overall Study|Progressive Disease|0|||
49086349|NCT02872714|158151687|FG004|Overall Study|Progressive Disease|0|||
49086350|NCT02872714|158151683|FG000|Overall Study|Death|87|||
49086351|NCT02872714|158151684|FG001|Overall Study|Death|36|||
49086352|NCT02872714|158151685|FG002|Overall Study|Death|8|||
49086353|NCT02872714|158151686|FG003|Overall Study|Death|81|||
49086354|NCT02872714|158151687|FG004|Overall Study|Death|2|||
49086355|NCT02872714|158151683|FG000|Overall Study|Lost to Follow-up|2|||
49086356|NCT02872714|158151684|FG001|Overall Study|Lost to Follow-up|1|||
49086357|NCT02872714|158151685|FG002|Overall Study|Lost to Follow-up|0|||
49086358|NCT02872714|158151686|FG003|Overall Study|Lost to Follow-up|3|||
49086359|NCT02872714|158151687|FG004|Overall Study|Lost to Follow-up|0|||
49086360|NCT02872714|158151683|FG000|Overall Study|Physician Decision|0|||
49086361|NCT02872714|158151684|FG001|Overall Study|Physician Decision|0|||
49086362|NCT02872714|158151685|FG002|Overall Study|Physician Decision|0|||
49086363|NCT02872714|158151686|FG003|Overall Study|Physician Decision|1|||
49086364|NCT02872714|158151687|FG004|Overall Study|Physician Decision|0|||
49086365|NCT02872714|158151683|FG000|Overall Study|Withdrawal by Subject|1|||
49086366|NCT02872714|158151684|FG001|Overall Study|Withdrawal by Subject|3|||
49086367|NCT02872714|158151685|FG002|Overall Study|Withdrawal by Subject|0|||
49086368|NCT02872714|158151686|FG003|Overall Study|Withdrawal by Subject|2|||
49086369|NCT02872714|158151687|FG004|Overall Study|Withdrawal by Subject|0|||
49086370|NCT02872714|158151683|FG000|Overall Study|Captured as Other|2|||
49086371|NCT02872714|158151684|FG001|Overall Study|Captured as Other|0|||
49086372|NCT02872714|158151685|FG002|Overall Study|Captured as Other|0|||
49086373|NCT02872714|158151686|FG003|Overall Study|Captured as Other|1|||
49086374|NCT02872714|158151687|FG004|Overall Study|Captured as Other|0|||
49086375|NCT04390113|158151688|FG000|Overall Study|Not Treated|0|||
49086376|NCT04390113|158151689|FG001|Overall Study|Not Treated|1|||
49086377|NCT04390113|158151688|FG000|Overall Study|Adverse Event|1|||
49086378|NCT04390113|158151689|FG001|Overall Study|Adverse Event|0|||
49086379|NCT04390113|158151688|FG000|Overall Study|Death|2|||
49086380|NCT04390113|158151689|FG001|Overall Study|Death|1|||
49086381|NCT04390113|158151688|FG000|Overall Study|Physician Decision|1|||
49086382|NCT04390113|158151689|FG001|Overall Study|Physician Decision|3|||
49086383|NCT04390113|158151688|FG000|Overall Study|Study Terminated by Sponsor|5|||
49086384|NCT04390113|158151689|FG001|Overall Study|Study Terminated by Sponsor|3|||
49086385|NCT04390113|158151688|FG000|Overall Study|Withdrawal by Subject|10|||
49086386|NCT04390113|158151689|FG001|Overall Study|Withdrawal by Subject|5|||
49086387|NCT04390113|158151688|FG000|Overall Study|Other|1|||
49086388|NCT04390113|158151689|FG001|Overall Study|Other|0|||
49086389|NCT04390113|158151688|FG000|Overall Study|Missing|0|||
49086390|NCT04390113|158151689|FG001|Overall Study|Missing|1|||
49086391|NCT00848718|158151690|FG000|Overall Study|Adverse Event|2|||
49086392|NCT00848718|158151691|FG001|Overall Study|Adverse Event|2|||
49086393|NCT00848718|158151692|FG002|Overall Study|Adverse Event|1|||
49086394|NCT00848718|158151693|FG003|Overall Study|Adverse Event|1|||
49086395|NCT00848718|158151694|FG004|Overall Study|Adverse Event|1|||
49086396|NCT00848718|158151695|FG005|Overall Study|Adverse Event|0|||
49086397|NCT00848718|158151696|FG006|Overall Study|Adverse Event|0|||
49086398|NCT00848718|158151697|FG007|Overall Study|Adverse Event|1|||
49086399|NCT00848718|158151698|FG008|Overall Study|Adverse Event|1|||
49086400|NCT00848718|158151699|FG009|Overall Study|Adverse Event|0|||
49086401|NCT00848718|158151700|FG010|Overall Study|Adverse Event|0|||
49086402|NCT00848718|158151701|FG011|Overall Study|Adverse Event|0|||
49086403|NCT00848718|158151702|FG012|Overall Study|Adverse Event|2|||
49086404|NCT00848718|158151690|FG000|Overall Study|Lack of Efficacy|0|||
49086405|NCT00848718|158151691|FG001|Overall Study|Lack of Efficacy|0|||
49086406|NCT00848718|158151692|FG002|Overall Study|Lack of Efficacy|1|||
49086407|NCT00848718|158151693|FG003|Overall Study|Lack of Efficacy|0|||
49086408|NCT00848718|158151694|FG004|Overall Study|Lack of Efficacy|0|||
49086409|NCT00848718|158151695|FG005|Overall Study|Lack of Efficacy|0|||
49086410|NCT00848718|158151696|FG006|Overall Study|Lack of Efficacy|1|||
49086411|NCT00848718|158151697|FG007|Overall Study|Lack of Efficacy|0|||
49086412|NCT00848718|158151698|FG008|Overall Study|Lack of Efficacy|0|||
49086413|NCT00848718|158151699|FG009|Overall Study|Lack of Efficacy|0|||
49086414|NCT00848718|158151700|FG010|Overall Study|Lack of Efficacy|0|||
49086415|NCT00848718|158151701|FG011|Overall Study|Lack of Efficacy|0|||
49086416|NCT00848718|158151702|FG012|Overall Study|Lack of Efficacy|0|||
49086417|NCT00848718|158151690|FG000|Overall Study|Physician Decision|0|||
49086418|NCT00848718|158151691|FG001|Overall Study|Physician Decision|1|||
49086419|NCT00848718|158151692|FG002|Overall Study|Physician Decision|0|||
49086420|NCT00848718|158151693|FG003|Overall Study|Physician Decision|0|||
49086421|NCT00848718|158151694|FG004|Overall Study|Physician Decision|1|||
49086422|NCT00848718|158151695|FG005|Overall Study|Physician Decision|1|||
49086423|NCT00848718|158151696|FG006|Overall Study|Physician Decision|0|||
49086424|NCT00848718|158151697|FG007|Overall Study|Physician Decision|0|||
49086425|NCT00848718|158151698|FG008|Overall Study|Physician Decision|1|||
49086426|NCT00848718|158151699|FG009|Overall Study|Physician Decision|2|||
49086427|NCT00848718|158151700|FG010|Overall Study|Physician Decision|0|||
49086428|NCT00848718|158151701|FG011|Overall Study|Physician Decision|0|||
49086429|NCT00848718|158151702|FG012|Overall Study|Physician Decision|1|||
49086430|NCT00848718|158151690|FG000|Overall Study|Progressive disease before treatment|1|||
49086431|NCT00848718|158151691|FG001|Overall Study|Progressive disease before treatment|5|||
49086432|NCT00848718|158151692|FG002|Overall Study|Progressive disease before treatment|1|||
49086433|NCT00848718|158151693|FG003|Overall Study|Progressive disease before treatment|3|||
49086434|NCT00848718|158151694|FG004|Overall Study|Progressive disease before treatment|4|||
49086435|NCT00848718|158151695|FG005|Overall Study|Progressive disease before treatment|4|||
49086436|NCT00848718|158151696|FG006|Overall Study|Progressive disease before treatment|2|||
49086437|NCT00848718|158151697|FG007|Overall Study|Progressive disease before treatment|1|||
49086438|NCT00848718|158151698|FG008|Overall Study|Progressive disease before treatment|2|||
49086439|NCT00848718|158151699|FG009|Overall Study|Progressive disease before treatment|7|||
49086440|NCT00848718|158151700|FG010|Overall Study|Progressive disease before treatment|3|||
49086441|NCT00848718|158151701|FG011|Overall Study|Progressive disease before treatment|6|||
49086442|NCT00848718|158151702|FG012|Overall Study|Progressive disease before treatment|2|||
49086443|NCT00848718|158151690|FG000|Overall Study|Protocol Violation|0|||
49086444|NCT00848718|158151691|FG001|Overall Study|Protocol Violation|1|||
49086445|NCT00848718|158151692|FG002|Overall Study|Protocol Violation|0|||
49086446|NCT00848718|158151693|FG003|Overall Study|Protocol Violation|0|||
49086447|NCT00848718|158151694|FG004|Overall Study|Protocol Violation|0|||
49086448|NCT00848718|158151695|FG005|Overall Study|Protocol Violation|0|||
49086449|NCT00848718|158151696|FG006|Overall Study|Protocol Violation|0|||
49086450|NCT00848718|158151697|FG007|Overall Study|Protocol Violation|1|||
49086451|NCT00848718|158151698|FG008|Overall Study|Protocol Violation|0|||
49086452|NCT00848718|158151699|FG009|Overall Study|Protocol Violation|0|||
49086453|NCT00848718|158151700|FG010|Overall Study|Protocol Violation|0|||
49086454|NCT00848718|158151701|FG011|Overall Study|Protocol Violation|0|||
49086455|NCT00848718|158151702|FG012|Overall Study|Protocol Violation|1|||
49086456|NCT00848718|158151690|FG000|Overall Study|Withdrawal by Subject|1|||
49086457|NCT00848718|158151691|FG001|Overall Study|Withdrawal by Subject|0|||
49086458|NCT00848718|158151692|FG002|Overall Study|Withdrawal by Subject|0|||
49086459|NCT00848718|158151693|FG003|Overall Study|Withdrawal by Subject|1|||
49086460|NCT00848718|158151694|FG004|Overall Study|Withdrawal by Subject|0|||
49086461|NCT00848718|158151695|FG005|Overall Study|Withdrawal by Subject|0|||
49086462|NCT00848718|158151696|FG006|Overall Study|Withdrawal by Subject|0|||
49086463|NCT00848718|158151697|FG007|Overall Study|Withdrawal by Subject|0|||
49086464|NCT00848718|158151698|FG008|Overall Study|Withdrawal by Subject|0|||
49086465|NCT00848718|158151699|FG009|Overall Study|Withdrawal by Subject|0|||
49086466|NCT00848718|158151700|FG010|Overall Study|Withdrawal by Subject|1|||
49086467|NCT00848718|158151701|FG011|Overall Study|Withdrawal by Subject|0|||
49086468|NCT00848718|158151702|FG012|Overall Study|Withdrawal by Subject|0|||
49086469|NCT00848718|158151690|FG000|Overall Study|Progressive disease during treatment|3|||
49086470|NCT00848718|158151691|FG001|Overall Study|Progressive disease during treatment|0|||
49086471|NCT00848718|158151692|FG002|Overall Study|Progressive disease during treatment|3|||
49086472|NCT00848718|158151693|FG003|Overall Study|Progressive disease during treatment|0|||
49086473|NCT00848718|158151694|FG004|Overall Study|Progressive disease during treatment|0|||
49086474|NCT00848718|158151695|FG005|Overall Study|Progressive disease during treatment|0|||
49086475|NCT00848718|158151696|FG006|Overall Study|Progressive disease during treatment|0|||
49086476|NCT00848718|158151697|FG007|Overall Study|Progressive disease during treatment|2|||
49086477|NCT00848718|158151698|FG008|Overall Study|Progressive disease during treatment|0|||
49086478|NCT00848718|158151699|FG009|Overall Study|Progressive disease during treatment|0|||
49086479|NCT00848718|158151700|FG010|Overall Study|Progressive disease during treatment|0|||
49086480|NCT00848718|158151701|FG011|Overall Study|Progressive disease during treatment|0|||
49086481|NCT00848718|158151702|FG012|Overall Study|Progressive disease during treatment|2|||
49086482|NCT00489918|158151703|FG000|Overall Study|Withdrawal by Subject|2|||
49086483|NCT00489918|158151704|FG001|Overall Study|Withdrawal by Subject|1|||
49086484|NCT00489918|158151705|FG002|Overall Study|Withdrawal by Subject|1|||
49086485|NCT00489918|158151706|FG003|Overall Study|Withdrawal by Subject|0|||
49086486|NCT00489918|158151707|FG004|Overall Study|Withdrawal by Subject|1|||
49086487|NCT00489918|158151703|FG000|Overall Study|Adverse Event|0|||
49086488|NCT00489918|158151704|FG001|Overall Study|Adverse Event|1|||
49086489|NCT00489918|158151705|FG002|Overall Study|Adverse Event|1|||
49086490|NCT00489918|158151706|FG003|Overall Study|Adverse Event|0|||
49086491|NCT00489918|158151707|FG004|Overall Study|Adverse Event|0|||
49086492|NCT00489918|158151703|FG000|Overall Study|Lost to Follow-up|0|||
49086493|NCT00489918|158151704|FG001|Overall Study|Lost to Follow-up|0|||
49086494|NCT00489918|158151705|FG002|Overall Study|Lost to Follow-up|1|||
49086495|NCT00489918|158151706|FG003|Overall Study|Lost to Follow-up|1|||
49086496|NCT00489918|158151707|FG004|Overall Study|Lost to Follow-up|0|||
49086497|NCT00489918|158151703|FG000|Overall Study|Physician Decision|0|||
49086498|NCT00489918|158151704|FG001|Overall Study|Physician Decision|0|||
49086499|NCT00489918|158151705|FG002|Overall Study|Physician Decision|1|||
49086500|NCT00489918|158151706|FG003|Overall Study|Physician Decision|0|||
49086501|NCT00489918|158151707|FG004|Overall Study|Physician Decision|0|||
49086502|NCT02748213|158151708|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
49086503|NCT02748213|158151709|FG001|Overall Study|Withdrawal Prior to Treatment|2|||
49086504|NCT02748213|158151708|FG000|Overall Study|Abnormal Laboratory Test|1|||
49086505|NCT02748213|158151709|FG001|Overall Study|Abnormal Laboratory Test|0|||
49086506|NCT02748213|158151708|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
49086507|NCT02748213|158151709|FG001|Overall Study|Adverse Event or Intercurrent Illness|11|||
49086508|NCT02748213|158151708|FG000|Overall Study|Death|5|||
49086509|NCT02748213|158151709|FG001|Overall Study|Death|3|||
49086510|NCT02748213|158151708|FG000|Overall Study|Insufficient Therapeutic Response|56|||
49086511|NCT02748213|158151709|FG001|Overall Study|Insufficient Therapeutic Response|57|||
49086512|NCT02748213|158151708|FG000|Overall Study|Violation of Selection Criteria|2|||
49086513|NCT02748213|158151709|FG001|Overall Study|Violation of Selection Criteria|0|||
49086514|NCT02748213|158151708|FG000|Overall Study|Protocol Violation|6|||
49086515|NCT02748213|158151709|FG001|Overall Study|Protocol Violation|4|||
49086516|NCT02748213|158151708|FG000|Overall Study|Refused Treatment*|6|||
49086517|NCT02748213|158151709|FG001|Overall Study|Refused Treatment*|6|||
49086518|NCT02748213|158151708|FG000|Overall Study|Failure to Return|1|||
49086519|NCT02748213|158151709|FG001|Overall Study|Failure to Return|0|||
49086520|NCT02748213|158151708|FG000|Overall Study|Other|30|||
49086521|NCT02748213|158151709|FG001|Overall Study|Other|29|||
49086522|NCT01611883|158151712|FG000|Overall Study|Adverse Event|1|||
49086523|NCT01611883|158151713|FG001|Overall Study|Adverse Event|1|||
49086524|NCT04200651|158151714|FG000|Overall Study|Moved to another country during follow-up|2|||
49086525|NCT04200651|158151715|FG001|Overall Study|Moved to another country during follow-up|2|||
49086526|NCT04200651|158151714|FG000|Overall Study|Lost to Follow-up|1|||
49086527|NCT04200651|158151715|FG001|Overall Study|Lost to Follow-up|3|||
49086528|NCT00708461|158151716|FG000|Overall Study|Lost to Follow-up|18|||
49086529|NCT00708461|158151717|FG001|Overall Study|Lost to Follow-up|11|||
49086530|NCT00708461|158151716|FG000|Overall Study|Withdrawal by Subject|8|||
49086531|NCT00708461|158151717|FG001|Overall Study|Withdrawal by Subject|9|||
49086532|NCT00708461|158151716|FG000|Overall Study|left workforce|115|||
49086533|NCT00708461|158151717|FG001|Overall Study|left workforce|180|||
49086534|NCT03379727|158151722|FG000|Overall Study|Lack of Efficacy|73|||
49086535|NCT03379727|158151722|FG000|Overall Study|Adverse Event|32|||
49086536|NCT03379727|158151722|FG000|Overall Study|Death|18|||
49086537|NCT03379727|158151722|FG000|Overall Study|Patient/guardian decision|17|||
49086538|NCT03379727|158151722|FG000|Overall Study|Physician Decision|104|||
49086539|NCT03379727|158151722|FG000|Overall Study|Protocol Violation|4|||
49086540|NCT03379727|158151722|FG000|Overall Study|Lost to Follow-up|1|||
49086541|NCT00030901|158151725|FG000|Initial Registration|Ineligible|167|||
49086542|NCT00030901|158151726|FG001|Initial Registration|Ineligible|0|||
49086543|NCT00030901|158151727|FG002|Initial Registration|Ineligible|0|||
49086544|NCT00030901|158151725|FG000|Randomization|Adverse Event|0|||
49086545|NCT00030901|158151726|FG001|Randomization|Adverse Event|11|||
49086546|NCT00030901|158151727|FG002|Randomization|Adverse Event|7|||
49086547|NCT00030901|158151725|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
49086548|NCT00030901|158151726|FG001|Randomization|Refusal Unrelated to Adverse Event|16|||
49086549|NCT00030901|158151727|FG002|Randomization|Refusal Unrelated to Adverse Event|10|||
49086550|NCT00030901|158151725|FG000|Randomization|Progression/Relapse|0|||
49086551|NCT00030901|158151726|FG001|Randomization|Progression/Relapse|22|||
49086552|NCT00030901|158151727|FG002|Randomization|Progression/Relapse|21|||
49086553|NCT00030901|158151725|FG000|Randomization|Death|0|||
49086554|NCT00030901|158151726|FG001|Randomization|Death|1|||
49086555|NCT00030901|158151727|FG002|Randomization|Death|3|||
49086556|NCT00030901|158151725|FG000|Randomization|Other|0|||
49086557|NCT00030901|158151726|FG001|Randomization|Other|36|||
49086558|NCT00030901|158151727|FG002|Randomization|Other|33|||
49086559|NCT00030901|158151725|FG000|Randomization|Ineligible|0|||
49086560|NCT00030901|158151726|FG001|Randomization|Ineligible|15|||
49086561|NCT00030901|158151727|FG002|Randomization|Ineligible|14|||
49086562|NCT01134939|158151728|FG000|Overall Study|Adverse Event|9|||
49086563|NCT01134939|158151729|FG001|Overall Study|Adverse Event|3|||
49086564|NCT01134939|158151730|FG002|Overall Study|Adverse Event|4|||
49086565|NCT01134939|158151731|FG003|Overall Study|Adverse Event|5|||
49086566|NCT01134939|158151732|FG004|Overall Study|Adverse Event|5|||
49086567|NCT01134939|158151733|FG005|Overall Study|Adverse Event|5|||
49086568|NCT01134939|158151734|FG006|Overall Study|Adverse Event|1|||
49086569|NCT01134939|158151735|FG007|Overall Study|Adverse Event|0|||
49086570|NCT01134939|158151728|FG000|Overall Study|Lack of Efficacy|2|||
49086571|NCT01134939|158151729|FG001|Overall Study|Lack of Efficacy|5|||
49086572|NCT01134939|158151730|FG002|Overall Study|Lack of Efficacy|1|||
49086573|NCT01134939|158151731|FG003|Overall Study|Lack of Efficacy|0|||
49086574|NCT01134939|158151732|FG004|Overall Study|Lack of Efficacy|3|||
49086575|NCT01134939|158151733|FG005|Overall Study|Lack of Efficacy|0|||
49086576|NCT01134939|158151734|FG006|Overall Study|Lack of Efficacy|1|||
49086577|NCT01134939|158151735|FG007|Overall Study|Lack of Efficacy|0|||
49086578|NCT01134939|158151728|FG000|Overall Study|Lost to Follow-up|2|||
49086579|NCT01134939|158151729|FG001|Overall Study|Lost to Follow-up|3|||
49086580|NCT01134939|158151730|FG002|Overall Study|Lost to Follow-up|0|||
49086581|NCT01134939|158151731|FG003|Overall Study|Lost to Follow-up|1|||
49086582|NCT01134939|158151732|FG004|Overall Study|Lost to Follow-up|2|||
49086583|NCT01134939|158151733|FG005|Overall Study|Lost to Follow-up|1|||
49086584|NCT01134939|158151734|FG006|Overall Study|Lost to Follow-up|0|||
49086585|NCT01134939|158151735|FG007|Overall Study|Lost to Follow-up|0|||
49086586|NCT01134939|158151728|FG000|Overall Study|Death|0|||
49086587|NCT01134939|158151729|FG001|Overall Study|Death|1|||
49086588|NCT01134939|158151730|FG002|Overall Study|Death|0|||
49086589|NCT01134939|158151731|FG003|Overall Study|Death|0|||
49086590|NCT01134939|158151732|FG004|Overall Study|Death|0|||
49086591|NCT01134939|158151733|FG005|Overall Study|Death|0|||
49086592|NCT01134939|158151734|FG006|Overall Study|Death|0|||
49086593|NCT01134939|158151735|FG007|Overall Study|Death|0|||
49086594|NCT01134939|158151728|FG000|Overall Study|Termination page not available|4|||
49086595|NCT01134939|158151729|FG001|Overall Study|Termination page not available|6|||
49086596|NCT01134939|158151730|FG002|Overall Study|Termination page not available|5|||
49086597|NCT01134939|158151731|FG003|Overall Study|Termination page not available|8|||
49086598|NCT01134939|158151732|FG004|Overall Study|Termination page not available|0|||
49086599|NCT01134939|158151733|FG005|Overall Study|Termination page not available|3|||
49086600|NCT01134939|158151734|FG006|Overall Study|Termination page not available|7|||
49086601|NCT01134939|158151735|FG007|Overall Study|Termination page not available|0|||
49086602|NCT00733421|158151736|FG000|Overall Study|Withdrawal by Subject|1|||
49086603|NCT00733421|158151737|FG001|Overall Study|Withdrawal by Subject|1|||
49086604|NCT00739882|158154037|FG000|Double-blind Period|Adverse Event|1|||
49086605|NCT00739882|158154038|FG001|Double-blind Period|Adverse Event|2|||
49086606|NCT00739882|158154037|FG000|Double-blind Period|Protocol Violation|1|||
49086607|NCT00739882|158154038|FG001|Double-blind Period|Protocol Violation|0|||
49086608|NCT00739882|158154037|FG000|Double-blind Period|Lack of Efficacy|1|||
49086609|NCT00739882|158154038|FG001|Double-blind Period|Lack of Efficacy|1|||
49086610|NCT00739882|158154037|FG000|Double-blind Period|Other|16|||
49086611|NCT00739882|158154038|FG001|Double-blind Period|Other|8|||
49086612|NCT00739882|158154037|FG000|Open-label Period|Adverse Event|1|||
49086613|NCT00739882|158154038|FG001|Open-label Period|Adverse Event|0|||
49086614|NCT00739882|158154037|FG000|Open-label Period|Other|9|||
49086615|NCT00739882|158154038|FG001|Open-label Period|Other|5|||
49086616|NCT04179838|158154039|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
49086617|NCT04179838|158154040|FG001|First Intervention (1 Day)|Withdrawal by Subject|3|||
49086618|NCT04179838|158154039|FG000|Second Intervention (1 Day)|Protocol Violation|0|||
49086619|NCT04179838|158154040|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
49086620|NCT02366689|158154049|FG000|Overall Study|Withdrawal by Subject|1|||
49086621|NCT02366689|158154050|FG001|Overall Study|Withdrawal by Subject|0|||
49086622|NCT02366689|158154051|FG002|Overall Study|Withdrawal by Subject|1|||
49086623|NCT02366689|158154049|FG000|Overall Study|Lost to Follow-up|3|||
49086624|NCT02366689|158154050|FG001|Overall Study|Lost to Follow-up|2|||
49086625|NCT02366689|158154051|FG002|Overall Study|Lost to Follow-up|0|||
49086626|NCT02366689|158154049|FG000|Overall Study|Pregnancy|0|||
49086627|NCT02366689|158154050|FG001|Overall Study|Pregnancy|1|||
49086628|NCT02366689|158154051|FG002|Overall Study|Pregnancy|1|||
49086629|NCT01662635|158154052|FG000|Overall Study|scarce samples for evaluation|30|||
49086630|NCT02019472|158154053|FG000|Overall Study|Adverse Event|14|||
49086631|NCT02019472|158154054|FG001|Overall Study|Adverse Event|23|||
49086632|NCT02019472|158154055|FG002|Overall Study|Adverse Event|17|||
49086633|NCT02019472|158154053|FG000|Overall Study|Death|0|||
49086634|NCT02019472|158154054|FG001|Overall Study|Death|1|||
49086635|NCT02019472|158154055|FG002|Overall Study|Death|1|||
49086636|NCT02019472|158154053|FG000|Overall Study|Lack of Efficacy|7|||
49086637|NCT02019472|158154054|FG001|Overall Study|Lack of Efficacy|4|||
49086638|NCT02019472|158154055|FG002|Overall Study|Lack of Efficacy|4|||
49086639|NCT02019472|158154053|FG000|Overall Study|Lost to Follow-up|0|||
49086640|NCT02019472|158154054|FG001|Overall Study|Lost to Follow-up|2|||
49086641|NCT02019472|158154055|FG002|Overall Study|Lost to Follow-up|1|||
49086642|NCT02019472|158154053|FG000|Overall Study|Physician Decision|1|||
49086643|NCT02019472|158154054|FG001|Overall Study|Physician Decision|2|||
49086644|NCT02019472|158154055|FG002|Overall Study|Physician Decision|0|||
49086645|NCT02019472|158154053|FG000|Overall Study|Pregnancy|1|||
49086646|NCT02019472|158154054|FG001|Overall Study|Pregnancy|2|||
49086647|NCT02019472|158154055|FG002|Overall Study|Pregnancy|2|||
49086648|NCT02019472|158154053|FG000|Overall Study|Withdrawal by Subject|11|||
49086649|NCT02019472|158154054|FG001|Overall Study|Withdrawal by Subject|10|||
49086650|NCT02019472|158154055|FG002|Overall Study|Withdrawal by Subject|11|||
49086651|NCT02019472|158154053|FG000|Overall Study|Other|3|||
49086652|NCT02019472|158154054|FG001|Overall Study|Other|8|||
49086653|NCT02019472|158154055|FG002|Overall Study|Other|6|||
49086654|NCT02763046|158154056|FG000|Overall Study|Adverse Event|5|||
49086655|NCT02763046|158154057|FG001|Overall Study|Adverse Event|4|||
49086656|NCT02763046|158154058|FG002|Overall Study|Adverse Event|0|||
49086657|NCT02763046|158154056|FG000|Overall Study|Lack of Efficacy|1|||
49086658|NCT02763046|158154057|FG001|Overall Study|Lack of Efficacy|1|||
49086659|NCT02763046|158154058|FG002|Overall Study|Lack of Efficacy|3|||
49086660|NCT02763046|158154056|FG000|Overall Study|Physician Decision|1|||
49086661|NCT02763046|158154057|FG001|Overall Study|Physician Decision|0|||
49086662|NCT02763046|158154058|FG002|Overall Study|Physician Decision|1|||
49086663|NCT02763046|158154056|FG000|Overall Study|Subject/guardian decision|2|||
49086664|NCT02763046|158154057|FG001|Overall Study|Subject/guardian decision|0|||
49086665|NCT02763046|158154058|FG002|Overall Study|Subject/guardian decision|4|||
49086666|NCT00513695|158154061|FG000|Overall Study|Discontinued therapy|2|||
49086667|NCT00513695|158154061|FG000|Overall Study|Progression prior to surgery|3|||
49086668|NCT01217112|158154062|FG000|Overall Study|Adverse Event|0|||
49086669|NCT01217112|158154063|FG001|Overall Study|Adverse Event|2|||
49086670|NCT01217112|158154064|FG002|Overall Study|Adverse Event|0|||
49086671|NCT01217112|158154065|FG003|Overall Study|Adverse Event|2|||
49086672|NCT01217112|158154066|FG004|Overall Study|Adverse Event|0|||
49086673|NCT01217112|158154062|FG000|Overall Study|Withdrawal by Subject|0|||
49086674|NCT01217112|158154063|FG001|Overall Study|Withdrawal by Subject|0|||
49086675|NCT01217112|158154064|FG002|Overall Study|Withdrawal by Subject|1|||
49086676|NCT01217112|158154065|FG003|Overall Study|Withdrawal by Subject|0|||
49086677|NCT01217112|158154066|FG004|Overall Study|Withdrawal by Subject|0|||
49086678|NCT01217112|158154062|FG000|Overall Study|Physician Decision|0|||
49086679|NCT01217112|158154063|FG001|Overall Study|Physician Decision|0|||
49086680|NCT01217112|158154064|FG002|Overall Study|Physician Decision|0|||
49086681|NCT01217112|158154065|FG003|Overall Study|Physician Decision|0|||
49086682|NCT01217112|158154066|FG004|Overall Study|Physician Decision|1|||
49086683|NCT02861807|158154067|FG000|Overall Study|Lost to Follow-up|7|||
49086684|NCT02861807|158154068|FG001|Overall Study|Lost to Follow-up|6|||
49086685|NCT02861807|158154067|FG000|Overall Study|Withdrawal by Subject|5|||
49086686|NCT02861807|158154068|FG001|Overall Study|Withdrawal by Subject|8|||
49086687|NCT02570308|158154070|FG000|Overall Study|Death|1|||
49086688|NCT02570308|158154071|FG001|Overall Study|Death|5|||
49086689|NCT02570308|158154072|FG002|Overall Study|Death|4|||
49086690|NCT02570308|158154073|FG003|Overall Study|Death|4|||
49086691|NCT02570308|158154074|FG004|Overall Study|Death|69|||
49086692|NCT02570308|158154070|FG000|Overall Study|Lost to Follow-up|0|||
49086693|NCT02570308|158154071|FG001|Overall Study|Lost to Follow-up|0|||
49086694|NCT02570308|158154072|FG002|Overall Study|Lost to Follow-up|0|||
49086695|NCT02570308|158154073|FG003|Overall Study|Lost to Follow-up|0|||
49086696|NCT02570308|158154074|FG004|Overall Study|Lost to Follow-up|2|||
49086697|NCT02570308|158154070|FG000|Overall Study|Withdrawal by Subject|0|||
49086698|NCT02570308|158154071|FG001|Overall Study|Withdrawal by Subject|0|||
49086699|NCT02570308|158154072|FG002|Overall Study|Withdrawal by Subject|0|||
49086700|NCT02570308|158154073|FG003|Overall Study|Withdrawal by Subject|0|||
49086701|NCT02570308|158154074|FG004|Overall Study|Withdrawal by Subject|1|||
49086702|NCT02570308|158154070|FG000|Overall Study|Other|0|||
49086703|NCT02570308|158154071|FG001|Overall Study|Other|0|||
49086704|NCT02570308|158154072|FG002|Overall Study|Other|0|||
49086705|NCT02570308|158154073|FG003|Overall Study|Other|0|||
49086706|NCT02570308|158154074|FG004|Overall Study|Other|2|||
49086707|NCT03877068|158154077|FG000|Overall Study|Physician Decision|9|||
49086708|NCT03877068|158154078|FG001|Overall Study|Physician Decision|3|||
49086709|NCT00314340|158154079|FG000|Overall Study|lost interest|1|||
49086710|NCT02069015|158154080|FG000|Overall Study|Lost to Follow-up|39|||
49086711|NCT02069015|158154081|FG001|Overall Study|Lost to Follow-up|32|||
49086712|NCT02069015|158154080|FG000|Overall Study|Withdrawal by Subject|1|||
49086713|NCT02069015|158154081|FG001|Overall Study|Withdrawal by Subject|1|||
49086714|NCT02509507|158154082|FG000|Overall Study|Death|21|||
49086715|NCT02509507|158154083|FG001|Overall Study|Death|3|||
49086716|NCT02509507|158154084|FG002|Overall Study|Death|22|||
49086717|NCT02509507|158154085|FG003|Overall Study|Death|14|||
49086718|NCT02509507|158154086|FG004|Overall Study|Death|8|||
49086719|NCT02509507|158154087|FG005|Overall Study|Death|12|||
49086720|NCT02509507|158154088|FG006|Overall Study|Death|5|||
49086721|NCT02509507|158154089|FG007|Overall Study|Death|4|||
49086722|NCT02509507|158154090|FG008|Overall Study|Death|8|||
49086723|NCT02509507|158154082|FG000|Overall Study|Lost to Follow-up|0|||
49086724|NCT02509507|158154083|FG001|Overall Study|Lost to Follow-up|1|||
49086725|NCT02509507|158154084|FG002|Overall Study|Lost to Follow-up|0|||
49086726|NCT02509507|158154085|FG003|Overall Study|Lost to Follow-up|0|||
49086727|NCT02509507|158154086|FG004|Overall Study|Lost to Follow-up|0|||
49086728|NCT02509507|158154087|FG005|Overall Study|Lost to Follow-up|2|||
49086729|NCT02509507|158154088|FG006|Overall Study|Lost to Follow-up|0|||
49086730|NCT02509507|158154089|FG007|Overall Study|Lost to Follow-up|0|||
49086731|NCT02509507|158154090|FG008|Overall Study|Lost to Follow-up|0|||
49086732|NCT02509507|158154082|FG000|Overall Study|Withdrawal by Subject|2|||
49086733|NCT02509507|158154083|FG001|Overall Study|Withdrawal by Subject|0|||
49086734|NCT02509507|158154084|FG002|Overall Study|Withdrawal by Subject|1|||
49086735|NCT02509507|158154085|FG003|Overall Study|Withdrawal by Subject|4|||
49086736|NCT02509507|158154086|FG004|Overall Study|Withdrawal by Subject|1|||
49086737|NCT02509507|158154087|FG005|Overall Study|Withdrawal by Subject|3|||
49086738|NCT02509507|158154088|FG006|Overall Study|Withdrawal by Subject|4|||
49086739|NCT02509507|158154089|FG007|Overall Study|Withdrawal by Subject|0|||
49086740|NCT02509507|158154090|FG008|Overall Study|Withdrawal by Subject|1|||
49086741|NCT00791778|158154091|FG000|Double-blind Treatment|Adverse Event|49|||
49086742|NCT00791778|158154092|FG001|Double-blind Treatment|Adverse Event|9|||
49086743|NCT00791778|158154091|FG000|Double-blind Treatment|Physician Decision|6|||
49086744|NCT00791778|158154092|FG001|Double-blind Treatment|Physician Decision|26|||
49086745|NCT00791778|158154091|FG000|Double-blind Treatment|Protocol Violation|0|||
49086746|NCT00791778|158154092|FG001|Double-blind Treatment|Protocol Violation|4|||
49086747|NCT00791778|158154091|FG000|Double-blind Treatment|Withdrawal by Subject|20|||
49086748|NCT00791778|158154092|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
49086749|NCT00791778|158154091|FG000|Double-blind Treatment|Non-compliant with study medication|2|||
49086750|NCT00791778|158154092|FG001|Double-blind Treatment|Non-compliant with study medication|0|||
49086751|NCT00791778|158154091|FG000|Follow-up|Withdrawal by Subject|3|||
49086752|NCT00791778|158154092|FG001|Follow-up|Withdrawal by Subject|0|||
49086753|NCT00791778|158154091|FG000|Follow-up|Lost to Follow-up|2|||
49086754|NCT00791778|158154092|FG001|Follow-up|Lost to Follow-up|1|||
49086755|NCT03051100|158154093|FG000|Overall Study|Withdrawal by Subject|1|||
49086756|NCT03051100|158154094|FG001|Overall Study|Withdrawal by Subject|0|||
49086757|NCT00444535|158154096|FG000|Overall Study|Withdrawal by Subject|5|||
49086758|NCT00444535|158154096|FG000|Overall Study|Physician Decision|5|||
49086759|NCT00444535|158154096|FG000|Overall Study|progressive disease|1|||
49086760|NCT00444535|158154096|FG000|Overall Study|Adverse Event|2|||
49086761|NCT01418378|158154099|FG000|Overall Study|Death|1|||
49086762|NCT01418378|158154100|FG001|Overall Study|Death|2|||
49086763|NCT01418378|158154099|FG000|Overall Study|Physician Decision|0|||
49086764|NCT01418378|158154100|FG001|Overall Study|Physician Decision|1|||
49086765|NCT01418378|158154099|FG000|Overall Study|ligament imbalance|0|||
49086766|NCT01418378|158154100|FG001|Overall Study|ligament imbalance|1|||
49086767|NCT01418378|158154099|FG000|Overall Study|developed chronic myopathy|0|||
49086768|NCT01418378|158154100|FG001|Overall Study|developed chronic myopathy|1|||
49086769|NCT00191477|158154102|FG000|Overall Study|Tumor Recurrence|49|||
49086770|NCT00191477|158154103|FG001|Overall Study|Tumor Recurrence|48|||
49086771|NCT00191477|158154102|FG000|Overall Study|Death, Study Disease|1|||
49086772|NCT00191477|158154103|FG001|Overall Study|Death, Study Disease|1|||
49086773|NCT00191477|158154102|FG000|Overall Study|Death, Other Cause|3|||
49086774|NCT00191477|158154103|FG001|Overall Study|Death, Other Cause|6|||
49086775|NCT00191477|158154102|FG000|Overall Study|Lost to Follow-up|23|||
49086776|NCT00191477|158154103|FG001|Overall Study|Lost to Follow-up|21|||
49086777|NCT00191477|158154102|FG000|Overall Study|Protocol Violation|1|||
49086778|NCT00191477|158154103|FG001|Overall Study|Protocol Violation|1|||
49086779|NCT00191477|158154102|FG000|Overall Study|Treatment Change|2|||
49086780|NCT00191477|158154103|FG001|Overall Study|Treatment Change|0|||
49086781|NCT00191477|158154102|FG000|Overall Study|Withdrawal by Subject|2|||
49086782|NCT00191477|158154103|FG001|Overall Study|Withdrawal by Subject|0|||
49086783|NCT00191477|158154102|FG000|Overall Study|Other|2|||
49086784|NCT00191477|158154103|FG001|Overall Study|Other|0|||
49086785|NCT00191477|158154102|FG000|Overall Study|Not Eligible|41|||
49086786|NCT00191477|158154103|FG001|Overall Study|Not Eligible|38|||
49086787|NCT00191477|158154102|FG000|Overall Study|Pathological Specimen Lost|1|||
49086788|NCT00191477|158154103|FG001|Overall Study|Pathological Specimen Lost|0|||
49086789|NCT00191477|158154102|FG000|Overall Study|Discontinued Prior to Instillation|13|||
49086790|NCT00191477|158154103|FG001|Overall Study|Discontinued Prior to Instillation|14|||
49086791|NCT05000164|158154104|FG000|Overall Study|Adverse Event|1|||
49086792|NCT05000164|158154104|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
49086793|NCT05000164|158154104|FG000|Overall Study|Lens Discomfort|3|||
49086794|NCT05000164|158154104|FG000|Overall Study|Withdrew Consent during Study|2|||
49086795|NCT05000164|158154104|FG000|Overall Study|Subject Withdrawn by PI|2|||
49086796|NCT05000164|158154104|FG000|Overall Study|Other Fractured Test Article|1|||
49086797|NCT01568892|158154107|FG000|Open-label Phase|Adverse Event|2|||
49086798|NCT01568892|158154108|FG001|Open-label Phase|Adverse Event|0|||
49086799|NCT01568892|158154107|FG000|Open-label Phase|Lack of Efficacy|4|||
49086800|NCT01568892|158154108|FG001|Open-label Phase|Lack of Efficacy|2|||
49086801|NCT01568892|158154107|FG000|Open-label Phase|Lost to Follow-up|0|||
49086802|NCT01568892|158154108|FG001|Open-label Phase|Lost to Follow-up|1|||
49086803|NCT01415518|158154122|FG000|Overall Study|Withdrawal by Subject|2|||
49086804|NCT01415518|158154123|FG001|Overall Study|Withdrawal by Subject|12|||
49086805|NCT01415518|158154122|FG000|Overall Study|Protocol Violation|6|||
49086806|NCT01415518|158154123|FG001|Overall Study|Protocol Violation|8|||
49086807|NCT01415518|158154122|FG000|Overall Study|Lost to Follow-up|3|||
49086808|NCT01415518|158154123|FG001|Overall Study|Lost to Follow-up|5|||
49086809|NCT01415518|158154122|FG000|Overall Study|Adverse Event|3|||
49086810|NCT01415518|158154123|FG001|Overall Study|Adverse Event|4|||
49086811|NCT01415518|158154122|FG000|Overall Study|Death|1|||
49086812|NCT01415518|158154123|FG001|Overall Study|Death|1|||
49086813|NCT01415518|158154122|FG000|Overall Study|Condition under Investigation Worsened|1|||
49086814|NCT01415518|158154123|FG001|Overall Study|Condition under Investigation Worsened|1|||
49086815|NCT02857816|158154124|FG000|Overall Study|Screen Failure|33|||
49086816|NCT02857816|158154124|FG000|Overall Study|Withdrawal by Subject|4|||
49086817|NCT02857816|158154124|FG000|Overall Study|Lost to Follow-up|1|||
49086818|NCT00765102|158154125|FG000|Overall Study|Progressive disease|18|||
49086819|NCT00765102|158154125|FG000|Overall Study|Adverse Event|6|||
49086820|NCT00765102|158154125|FG000|Overall Study|Physician Decision|4|||
49086821|NCT00765102|158154125|FG000|Overall Study|Withdrawal by Subject|2|||
49086822|NCT00765102|158154125|FG000|Overall Study|Protocol Violation|1|||
49086823|NCT02291510|158154126|FG000|Overall Study|Adverse Event|0|||
49086824|NCT02291510|158154127|FG001|Overall Study|Adverse Event|0|||
49086825|NCT02291510|158154128|FG002|Overall Study|Adverse Event|0|||
49086826|NCT02291510|158154129|FG003|Overall Study|Adverse Event|1|||
49086827|NCT02062450|158154132|FG000|Overall Study|No follow-up visit|124|||
49086828|NCT01486446|158154141|FG000|Overall Study|Adverse Event|1|||
49086829|NCT01486446|158154142|FG001|Overall Study|Adverse Event|0|||
49086830|NCT01801865|158154143|FG000|Overall Study|Patients scanned on another MRI scanner|35|||
49086831|NCT01801865|158154143|FG000|Overall Study|Physician Decision|7|||
49086832|NCT03711786|158154145|FG000|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|13|||
49086833|NCT03711786|158154146|FG001|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|4|||
49086834|NCT03711786|158154145|FG000|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|0|||
49086835|NCT03711786|158154146|FG001|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|1|||
49086836|NCT03711786|158154145|FG000|Period 1: Recruited in Study Months 1-5|Death|7|||
49086837|NCT03711786|158154146|FG001|Period 1: Recruited in Study Months 1-5|Death|1|||
49086838|NCT03711786|158154145|FG000|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|17|||
49086839|NCT03711786|158154146|FG001|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|21|||
49086840|NCT03711786|158154145|FG000|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|0|||
49086841|NCT03711786|158154146|FG001|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|5|||
49086842|NCT03711786|158154145|FG000|Period 1: Recruited in Study Months 6-32|Death|5|||
49086843|NCT03711786|158154146|FG001|Period 1: Recruited in Study Months 6-32|Death|4|||
49086844|NCT00789854|158154153|FG000|Overall Study|Adverse Event|28|||
49086845|NCT00789854|158154154|FG001|Overall Study|Adverse Event|23|||
49086846|NCT00789854|158154155|FG002|Overall Study|Adverse Event|18|||
49086847|NCT00789854|158154153|FG000|Overall Study|Lost to Follow-up|1|||
49086848|NCT00789854|158154154|FG001|Overall Study|Lost to Follow-up|1|||
49086849|NCT00789854|158154155|FG002|Overall Study|Lost to Follow-up|4|||
49086850|NCT00789854|158154153|FG000|Overall Study|Withdrawal by Subject|9|||
49086851|NCT00789854|158154154|FG001|Overall Study|Withdrawal by Subject|6|||
49086852|NCT00789854|158154155|FG002|Overall Study|Withdrawal by Subject|17|||
49086853|NCT00789854|158154153|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
49086854|NCT00789854|158154154|FG001|Overall Study|Eligibility criteria not fulfilled|5|||
49086855|NCT00789854|158154155|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
49086856|NCT00789854|158154153|FG000|Overall Study|Severe non-compliance to the protocol|3|||
49086857|NCT00789854|158154154|FG001|Overall Study|Severe non-compliance to the protocol|0|||
49086858|NCT00789854|158154155|FG002|Overall Study|Severe non-compliance to the protocol|0|||
49086859|NCT00789854|158154153|FG000|Overall Study|Safety reasons|0|||
49086860|NCT00789854|158154154|FG001|Overall Study|Safety reasons|0|||
49086861|NCT00789854|158154155|FG002|Overall Study|Safety reasons|2|||
49086862|NCT00789854|158154153|FG000|Overall Study|Other|6|||
49086863|NCT00789854|158154154|FG001|Overall Study|Other|0|||
49086864|NCT00789854|158154155|FG002|Overall Study|Other|5|||
49086865|NCT03850483|158154158|FG000|Treatment for Stage 1|Adverse Event|1|||
49086866|NCT03850483|158154159|FG001|Treatment for Stage 1|Adverse Event|1|||
49086867|NCT03850483|158154160|FG002|Treatment for Stage 1|Adverse Event|3|||
49086868|NCT03850483|158154161|FG003|Treatment for Stage 1|Adverse Event|0|||
49086869|NCT03850483|158154162|FG004|Treatment for Stage 1|Adverse Event|2|||
49086870|NCT03850483|158154163|FG005|Treatment for Stage 1|Adverse Event|0|||
49086871|NCT03850483|158154164|FG006|Treatment for Stage 1|Adverse Event|2|||
49086872|NCT03850483|158154165|FG007|Treatment for Stage 1|Adverse Event|2|||
49086873|NCT03850483|158154166|FG008|Treatment for Stage 1|Adverse Event|0|||
49086874|NCT03850483|158154167|FG009|Treatment for Stage 1|Adverse Event|0|||
49086875|NCT03850483|158154158|FG000|Treatment for Stage 1|Withdrawal by Subject|4|||
49086876|NCT03850483|158154159|FG001|Treatment for Stage 1|Withdrawal by Subject|4|||
49086877|NCT03850483|158154160|FG002|Treatment for Stage 1|Withdrawal by Subject|2|||
49086878|NCT03850483|158154161|FG003|Treatment for Stage 1|Withdrawal by Subject|2|||
49086879|NCT03850483|158154162|FG004|Treatment for Stage 1|Withdrawal by Subject|2|||
49086880|NCT03850483|158154163|FG005|Treatment for Stage 1|Withdrawal by Subject|1|||
49086881|NCT03850483|158154164|FG006|Treatment for Stage 1|Withdrawal by Subject|2|||
49086882|NCT03850483|158154165|FG007|Treatment for Stage 1|Withdrawal by Subject|3|||
49086883|NCT03850483|158154166|FG008|Treatment for Stage 1|Withdrawal by Subject|0|||
49086884|NCT03850483|158154167|FG009|Treatment for Stage 1|Withdrawal by Subject|0|||
49086885|NCT03850483|158154158|FG000|Treatment for Stage 1|Protocol Violation|1|||
49086886|NCT03850483|158154159|FG001|Treatment for Stage 1|Protocol Violation|0|||
49086887|NCT03850483|158154160|FG002|Treatment for Stage 1|Protocol Violation|0|||
49086888|NCT03850483|158154161|FG003|Treatment for Stage 1|Protocol Violation|0|||
49086889|NCT03850483|158154162|FG004|Treatment for Stage 1|Protocol Violation|0|||
49086890|NCT03850483|158154163|FG005|Treatment for Stage 1|Protocol Violation|0|||
49086891|NCT03850483|158154164|FG006|Treatment for Stage 1|Protocol Violation|1|||
49086892|NCT03850483|158154165|FG007|Treatment for Stage 1|Protocol Violation|0|||
49086893|NCT03850483|158154166|FG008|Treatment for Stage 1|Protocol Violation|0|||
49086894|NCT03850483|158154167|FG009|Treatment for Stage 1|Protocol Violation|0|||
49086895|NCT03850483|158154158|FG000|Treatment for Stage 1|Physician Decision|0|||
49086896|NCT03850483|158154159|FG001|Treatment for Stage 1|Physician Decision|0|||
49086897|NCT03850483|158154160|FG002|Treatment for Stage 1|Physician Decision|0|||
49086898|NCT03850483|158154161|FG003|Treatment for Stage 1|Physician Decision|0|||
49086899|NCT03850483|158154162|FG004|Treatment for Stage 1|Physician Decision|0|||
49086900|NCT03850483|158154163|FG005|Treatment for Stage 1|Physician Decision|1|||
49086901|NCT03850483|158154164|FG006|Treatment for Stage 1|Physician Decision|0|||
49086902|NCT03850483|158154165|FG007|Treatment for Stage 1|Physician Decision|0|||
49086903|NCT03850483|158154166|FG008|Treatment for Stage 1|Physician Decision|0|||
49086904|NCT03850483|158154167|FG009|Treatment for Stage 1|Physician Decision|0|||
49086905|NCT03850483|158154158|FG000|Treatment for Stage 1|Other|0|||
49086906|NCT03850483|158154159|FG001|Treatment for Stage 1|Other|0|||
49086907|NCT03850483|158154160|FG002|Treatment for Stage 1|Other|0|||
49086908|NCT03850483|158154161|FG003|Treatment for Stage 1|Other|0|||
49086909|NCT03850483|158154162|FG004|Treatment for Stage 1|Other|2|||
49086910|NCT03850483|158154163|FG005|Treatment for Stage 1|Other|1|||
49086911|NCT03850483|158154164|FG006|Treatment for Stage 1|Other|0|||
49086912|NCT03850483|158154165|FG007|Treatment for Stage 1|Other|0|||
49086913|NCT03850483|158154166|FG008|Treatment for Stage 1|Other|0|||
49086914|NCT03850483|158154167|FG009|Treatment for Stage 1|Other|0|||
49086915|NCT03850483|158154158|FG000|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
49086916|NCT03850483|158154159|FG001|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
49086917|NCT03850483|158154160|FG002|Treatment for Stage 1|Non-Compliance With Study Drug|1|||
49086918|NCT03850483|158154161|FG003|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
49086919|NCT03850483|158154162|FG004|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
49086920|NCT03850483|158154163|FG005|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
49086921|NCT03850483|158154164|FG006|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
49086922|NCT03850483|158154165|FG007|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
49086923|NCT03850483|158154166|FG008|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
49086924|NCT03850483|158154167|FG009|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
49086925|NCT03850483|158154158|FG000|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
49086926|NCT03850483|158154159|FG001|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
49086927|NCT03850483|158154160|FG002|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
49086928|NCT03850483|158154161|FG003|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
49086929|NCT03850483|158154162|FG004|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
49086930|NCT03850483|158154163|FG005|Treatment for Stage 1|No Longer Met Eligibility Criteria|1|||
49086931|NCT03850483|158154164|FG006|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
49086932|NCT03850483|158154165|FG007|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
49086933|NCT03850483|158154166|FG008|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
49086934|NCT03850483|158154167|FG009|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
49086935|NCT03850483|158154158|FG000|Treatment for Stage 1|Lost to Follow-up|0|||
49086936|NCT03850483|158154159|FG001|Treatment for Stage 1|Lost to Follow-up|1|||
49086937|NCT03850483|158154160|FG002|Treatment for Stage 1|Lost to Follow-up|1|||
49086938|NCT03850483|158154161|FG003|Treatment for Stage 1|Lost to Follow-up|1|||
49086939|NCT03850483|158154162|FG004|Treatment for Stage 1|Lost to Follow-up|0|||
49086940|NCT03850483|158154163|FG005|Treatment for Stage 1|Lost to Follow-up|1|||
49086941|NCT03850483|158154164|FG006|Treatment for Stage 1|Lost to Follow-up|2|||
49086942|NCT03850483|158154165|FG007|Treatment for Stage 1|Lost to Follow-up|0|||
49086943|NCT03850483|158154166|FG008|Treatment for Stage 1|Lost to Follow-up|0|||
49086944|NCT03850483|158154167|FG009|Treatment for Stage 1|Lost to Follow-up|0|||
49086945|NCT03850483|158154158|FG000|Treatment for Stage 1|Lack of Efficacy|1|||
49086946|NCT03850483|158154159|FG001|Treatment for Stage 1|Lack of Efficacy|2|||
49086947|NCT03850483|158154160|FG002|Treatment for Stage 1|Lack of Efficacy|2|||
49086948|NCT03850483|158154161|FG003|Treatment for Stage 1|Lack of Efficacy|3|||
49086949|NCT03850483|158154162|FG004|Treatment for Stage 1|Lack of Efficacy|2|||
49086950|NCT03850483|158154163|FG005|Treatment for Stage 1|Lack of Efficacy|4|||
49086951|NCT03850483|158154164|FG006|Treatment for Stage 1|Lack of Efficacy|3|||
49086952|NCT03850483|158154165|FG007|Treatment for Stage 1|Lack of Efficacy|1|||
49086953|NCT03850483|158154166|FG008|Treatment for Stage 1|Lack of Efficacy|0|||
49086954|NCT03850483|158154167|FG009|Treatment for Stage 1|Lack of Efficacy|0|||
49086955|NCT03850483|158154158|FG000|Treatment for Stage 1|Death|0|||
49086956|NCT03850483|158154159|FG001|Treatment for Stage 1|Death|0|||
49086957|NCT03850483|158154160|FG002|Treatment for Stage 1|Death|0|||
49086958|NCT03850483|158154161|FG003|Treatment for Stage 1|Death|0|||
49086959|NCT03850483|158154162|FG004|Treatment for Stage 1|Death|0|||
49086960|NCT03850483|158154163|FG005|Treatment for Stage 1|Death|1|||
49086961|NCT03850483|158154164|FG006|Treatment for Stage 1|Death|0|||
49086962|NCT03850483|158154165|FG007|Treatment for Stage 1|Death|0|||
49086963|NCT03850483|158154166|FG008|Treatment for Stage 1|Death|0|||
49086964|NCT03850483|158154167|FG009|Treatment for Stage 1|Death|0|||
49086965|NCT03850483|158154158|FG000|Treatment for Stage 1|Refused Further Treatment|1|||
49086966|NCT03850483|158154159|FG001|Treatment for Stage 1|Refused Further Treatment|0|||
49086967|NCT03850483|158154160|FG002|Treatment for Stage 1|Refused Further Treatment|2|||
49086968|NCT03850483|158154161|FG003|Treatment for Stage 1|Refused Further Treatment|0|||
49086969|NCT03850483|158154162|FG004|Treatment for Stage 1|Refused Further Treatment|1|||
49086970|NCT03850483|158154163|FG005|Treatment for Stage 1|Refused Further Treatment|0|||
49086971|NCT03850483|158154164|FG006|Treatment for Stage 1|Refused Further Treatment|1|||
49086972|NCT03850483|158154165|FG007|Treatment for Stage 1|Refused Further Treatment|0|||
49086973|NCT03850483|158154166|FG008|Treatment for Stage 1|Refused Further Treatment|0|||
49086974|NCT03850483|158154167|FG009|Treatment for Stage 1|Refused Further Treatment|0|||
49086975|NCT03850483|158154158|FG000|Treatment for Stage 1|Randomized but not Treated|0|||
49086976|NCT03850483|158154159|FG001|Treatment for Stage 1|Randomized but not Treated|0|||
49086977|NCT03850483|158154160|FG002|Treatment for Stage 1|Randomized but not Treated|0|||
49086978|NCT03850483|158154161|FG003|Treatment for Stage 1|Randomized but not Treated|0|||
49086979|NCT03850483|158154162|FG004|Treatment for Stage 1|Randomized but not Treated|0|||
49086980|NCT03850483|158154163|FG005|Treatment for Stage 1|Randomized but not Treated|1|||
49086981|NCT03850483|158154164|FG006|Treatment for Stage 1|Randomized but not Treated|0|||
49086982|NCT03850483|158154165|FG007|Treatment for Stage 1|Randomized but not Treated|0|||
49086983|NCT03850483|158154166|FG008|Treatment for Stage 1|Randomized but not Treated|0|||
49086984|NCT03850483|158154167|FG009|Treatment for Stage 1|Randomized but not Treated|0|||
49086985|NCT03850483|158154158|FG000|Follow-up for Stage 1|Withdrawal by Subject|0|||
49086986|NCT03850483|158154159|FG001|Follow-up for Stage 1|Withdrawal by Subject|0|||
49086987|NCT03850483|158154160|FG002|Follow-up for Stage 1|Withdrawal by Subject|0|||
49086988|NCT03850483|158154161|FG003|Follow-up for Stage 1|Withdrawal by Subject|0|||
49086989|NCT03850483|158154162|FG004|Follow-up for Stage 1|Withdrawal by Subject|0|||
49086990|NCT03850483|158154163|FG005|Follow-up for Stage 1|Withdrawal by Subject|0|||
49086991|NCT03850483|158154164|FG006|Follow-up for Stage 1|Withdrawal by Subject|1|||
49086992|NCT03850483|158154165|FG007|Follow-up for Stage 1|Withdrawal by Subject|2|||
49086993|NCT03850483|158154166|FG008|Follow-up for Stage 1|Withdrawal by Subject|0|||
49086994|NCT03850483|158154167|FG009|Follow-up for Stage 1|Withdrawal by Subject|0|||
49086995|NCT03850483|158154158|FG000|Follow-up for Stage 1|Physician Decision|0|||
49086996|NCT03850483|158154159|FG001|Follow-up for Stage 1|Physician Decision|0|||
49086997|NCT03850483|158154160|FG002|Follow-up for Stage 1|Physician Decision|0|||
49086998|NCT03850483|158154161|FG003|Follow-up for Stage 1|Physician Decision|0|||
49086999|NCT03850483|158154162|FG004|Follow-up for Stage 1|Physician Decision|1|||
49087000|NCT03850483|158154163|FG005|Follow-up for Stage 1|Physician Decision|0|||
49087001|NCT03850483|158154164|FG006|Follow-up for Stage 1|Physician Decision|1|||
49087002|NCT03850483|158154165|FG007|Follow-up for Stage 1|Physician Decision|0|||
49087003|NCT03850483|158154166|FG008|Follow-up for Stage 1|Physician Decision|0|||
49087004|NCT03850483|158154167|FG009|Follow-up for Stage 1|Physician Decision|0|||
49087005|NCT03850483|158154158|FG000|Follow-up for Stage 1|Lack of Efficacy|0|||
49087006|NCT03850483|158154159|FG001|Follow-up for Stage 1|Lack of Efficacy|0|||
49087007|NCT03850483|158154160|FG002|Follow-up for Stage 1|Lack of Efficacy|1|||
49087008|NCT03850483|158154161|FG003|Follow-up for Stage 1|Lack of Efficacy|0|||
49087009|NCT03850483|158154162|FG004|Follow-up for Stage 1|Lack of Efficacy|0|||
49087010|NCT03850483|158154163|FG005|Follow-up for Stage 1|Lack of Efficacy|0|||
49087011|NCT03850483|158154164|FG006|Follow-up for Stage 1|Lack of Efficacy|0|||
49087012|NCT03850483|158154165|FG007|Follow-up for Stage 1|Lack of Efficacy|1|||
49087013|NCT03850483|158154166|FG008|Follow-up for Stage 1|Lack of Efficacy|0|||
49087014|NCT03850483|158154167|FG009|Follow-up for Stage 1|Lack of Efficacy|0|||
49087015|NCT03850483|158154158|FG000|Follow-up for Stage 1|Adverse Event|0|||
49087016|NCT03850483|158154159|FG001|Follow-up for Stage 1|Adverse Event|0|||
49087017|NCT03850483|158154160|FG002|Follow-up for Stage 1|Adverse Event|1|||
49087018|NCT03850483|158154161|FG003|Follow-up for Stage 1|Adverse Event|0|||
49087019|NCT03850483|158154162|FG004|Follow-up for Stage 1|Adverse Event|0|||
49087020|NCT03850483|158154163|FG005|Follow-up for Stage 1|Adverse Event|1|||
49087021|NCT03850483|158154164|FG006|Follow-up for Stage 1|Adverse Event|0|||
49087022|NCT03850483|158154165|FG007|Follow-up for Stage 1|Adverse Event|0|||
49087023|NCT03850483|158154166|FG008|Follow-up for Stage 1|Adverse Event|0|||
49087024|NCT03850483|158154167|FG009|Follow-up for Stage 1|Adverse Event|0|||
49087025|NCT03850483|158154158|FG000|Follow-up for Stage 1|Refused Further Study Procedures|0|||
49087026|NCT03850483|158154159|FG001|Follow-up for Stage 1|Refused Further Study Procedures|1|||
49087027|NCT03850483|158154160|FG002|Follow-up for Stage 1|Refused Further Study Procedures|0|||
49087028|NCT03850483|158154161|FG003|Follow-up for Stage 1|Refused Further Study Procedures|0|||
49087029|NCT03850483|158154162|FG004|Follow-up for Stage 1|Refused Further Study Procedures|2|||
49087030|NCT03850483|158154163|FG005|Follow-up for Stage 1|Refused Further Study Procedures|2|||
49087031|NCT03850483|158154164|FG006|Follow-up for Stage 1|Refused Further Study Procedures|0|||
49087032|NCT03850483|158154165|FG007|Follow-up for Stage 1|Refused Further Study Procedures|0|||
49087033|NCT03850483|158154166|FG008|Follow-up for Stage 1|Refused Further Study Procedures|0|||
49087034|NCT03850483|158154167|FG009|Follow-up for Stage 1|Refused Further Study Procedures|0|||
49087035|NCT03850483|158154158|FG000|Follow-up for Stage 1|Other|0|||
49087036|NCT03850483|158154159|FG001|Follow-up for Stage 1|Other|2|||
49087037|NCT03850483|158154160|FG002|Follow-up for Stage 1|Other|0|||
49087038|NCT03850483|158154161|FG003|Follow-up for Stage 1|Other|2|||
49087039|NCT03850483|158154162|FG004|Follow-up for Stage 1|Other|0|||
49087040|NCT03850483|158154163|FG005|Follow-up for Stage 1|Other|1|||
49087041|NCT03850483|158154164|FG006|Follow-up for Stage 1|Other|0|||
49087042|NCT03850483|158154165|FG007|Follow-up for Stage 1|Other|0|||
49087043|NCT03850483|158154166|FG008|Follow-up for Stage 1|Other|0|||
49087044|NCT03850483|158154167|FG009|Follow-up for Stage 1|Other|0|||
49087045|NCT03850483|158154158|FG000|Treatment for Stage 2|Adverse Event|0|||
49087046|NCT03850483|158154159|FG001|Treatment for Stage 2|Adverse Event|0|||
49087047|NCT03850483|158154160|FG002|Treatment for Stage 2|Adverse Event|0|||
49087048|NCT03850483|158154161|FG003|Treatment for Stage 2|Adverse Event|0|||
49087049|NCT03850483|158154162|FG004|Treatment for Stage 2|Adverse Event|0|||
49087050|NCT03850483|158154163|FG005|Treatment for Stage 2|Adverse Event|0|||
49087051|NCT03850483|158154164|FG006|Treatment for Stage 2|Adverse Event|0|||
49087052|NCT03850483|158154165|FG007|Treatment for Stage 2|Adverse Event|0|||
49087053|NCT03850483|158154166|FG008|Treatment for Stage 2|Adverse Event|0|||
49087054|NCT03850483|158154167|FG009|Treatment for Stage 2|Adverse Event|1|||
49087055|NCT03850483|158154158|FG000|Treatment for Stage 2|Lack of Efficacy|0|||
49087056|NCT03850483|158154159|FG001|Treatment for Stage 2|Lack of Efficacy|0|||
49087057|NCT03850483|158154160|FG002|Treatment for Stage 2|Lack of Efficacy|0|||
49087058|NCT03850483|158154161|FG003|Treatment for Stage 2|Lack of Efficacy|0|||
49087059|NCT03850483|158154162|FG004|Treatment for Stage 2|Lack of Efficacy|0|||
49087060|NCT03850483|158154163|FG005|Treatment for Stage 2|Lack of Efficacy|0|||
49087061|NCT03850483|158154164|FG006|Treatment for Stage 2|Lack of Efficacy|0|||
49087062|NCT03850483|158154165|FG007|Treatment for Stage 2|Lack of Efficacy|0|||
49087063|NCT03850483|158154166|FG008|Treatment for Stage 2|Lack of Efficacy|1|||
49087064|NCT03850483|158154167|FG009|Treatment for Stage 2|Lack of Efficacy|0|||
49087065|NCT03850483|158154158|FG000|Treatment for Stage 2|Lost to Follow-up|0|||
49087066|NCT03850483|158154159|FG001|Treatment for Stage 2|Lost to Follow-up|0|||
49087067|NCT03850483|158154160|FG002|Treatment for Stage 2|Lost to Follow-up|0|||
49087068|NCT03850483|158154161|FG003|Treatment for Stage 2|Lost to Follow-up|0|||
49087069|NCT03850483|158154162|FG004|Treatment for Stage 2|Lost to Follow-up|0|||
49087070|NCT03850483|158154163|FG005|Treatment for Stage 2|Lost to Follow-up|0|||
49087071|NCT03850483|158154164|FG006|Treatment for Stage 2|Lost to Follow-up|0|||
49087072|NCT03850483|158154165|FG007|Treatment for Stage 2|Lost to Follow-up|0|||
49087073|NCT03850483|158154166|FG008|Treatment for Stage 2|Lost to Follow-up|0|||
49087074|NCT03850483|158154167|FG009|Treatment for Stage 2|Lost to Follow-up|3|||
49087075|NCT03850483|158154158|FG000|Treatment for Stage 2|Physician Decision|0|||
49087076|NCT03850483|158154159|FG001|Treatment for Stage 2|Physician Decision|0|||
49087077|NCT03850483|158154160|FG002|Treatment for Stage 2|Physician Decision|0|||
49087078|NCT03850483|158154161|FG003|Treatment for Stage 2|Physician Decision|0|||
49087079|NCT03850483|158154162|FG004|Treatment for Stage 2|Physician Decision|0|||
49087080|NCT03850483|158154163|FG005|Treatment for Stage 2|Physician Decision|0|||
49087081|NCT03850483|158154164|FG006|Treatment for Stage 2|Physician Decision|0|||
49087082|NCT03850483|158154165|FG007|Treatment for Stage 2|Physician Decision|0|||
49087083|NCT03850483|158154166|FG008|Treatment for Stage 2|Physician Decision|0|||
49087084|NCT03850483|158154167|FG009|Treatment for Stage 2|Physician Decision|1|||
49087085|NCT03850483|158154158|FG000|Treatment for Stage 2|Protocol Violation|0|||
49087086|NCT03850483|158154159|FG001|Treatment for Stage 2|Protocol Violation|0|||
49087087|NCT03850483|158154160|FG002|Treatment for Stage 2|Protocol Violation|0|||
49087088|NCT03850483|158154161|FG003|Treatment for Stage 2|Protocol Violation|0|||
49087089|NCT03850483|158154162|FG004|Treatment for Stage 2|Protocol Violation|0|||
49087090|NCT03850483|158154163|FG005|Treatment for Stage 2|Protocol Violation|0|||
49087091|NCT03850483|158154164|FG006|Treatment for Stage 2|Protocol Violation|0|||
49087092|NCT03850483|158154165|FG007|Treatment for Stage 2|Protocol Violation|0|||
49087093|NCT03850483|158154166|FG008|Treatment for Stage 2|Protocol Violation|1|||
49087094|NCT03850483|158154167|FG009|Treatment for Stage 2|Protocol Violation|0|||
49087095|NCT03850483|158154158|FG000|Treatment for Stage 2|Withdrawal by Subject|0|||
49087096|NCT03850483|158154159|FG001|Treatment for Stage 2|Withdrawal by Subject|0|||
49087097|NCT03850483|158154160|FG002|Treatment for Stage 2|Withdrawal by Subject|0|||
49087098|NCT03850483|158154161|FG003|Treatment for Stage 2|Withdrawal by Subject|0|||
49087099|NCT03850483|158154162|FG004|Treatment for Stage 2|Withdrawal by Subject|0|||
49087100|NCT03850483|158154163|FG005|Treatment for Stage 2|Withdrawal by Subject|0|||
49087101|NCT03850483|158154164|FG006|Treatment for Stage 2|Withdrawal by Subject|0|||
49087102|NCT03850483|158154165|FG007|Treatment for Stage 2|Withdrawal by Subject|0|||
49087103|NCT03850483|158154166|FG008|Treatment for Stage 2|Withdrawal by Subject|2|||
49087104|NCT03850483|158154167|FG009|Treatment for Stage 2|Withdrawal by Subject|5|||
49087105|NCT03850483|158154158|FG000|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
49087106|NCT03850483|158154159|FG001|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
49087107|NCT03850483|158154160|FG002|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
49087108|NCT03850483|158154161|FG003|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
49087109|NCT03850483|158154162|FG004|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
49087110|NCT03850483|158154163|FG005|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
49087111|NCT03850483|158154164|FG006|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
49087112|NCT03850483|158154165|FG007|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
49087113|NCT03850483|158154166|FG008|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
49087114|NCT03850483|158154167|FG009|Treatment for Stage 2|No Longer Meets Eligibility Criteria|1|||
49087115|NCT03850483|158154158|FG000|Treatment for Stage 2|Refused Further Treatment|0|||
49087116|NCT03850483|158154159|FG001|Treatment for Stage 2|Refused Further Treatment|0|||
49087117|NCT03850483|158154160|FG002|Treatment for Stage 2|Refused Further Treatment|0|||
49087118|NCT03850483|158154161|FG003|Treatment for Stage 2|Refused Further Treatment|0|||
49087119|NCT03850483|158154162|FG004|Treatment for Stage 2|Refused Further Treatment|0|||
49087120|NCT03850483|158154163|FG005|Treatment for Stage 2|Refused Further Treatment|0|||
49087121|NCT03850483|158154164|FG006|Treatment for Stage 2|Refused Further Treatment|0|||
49087122|NCT03850483|158154165|FG007|Treatment for Stage 2|Refused Further Treatment|0|||
49087123|NCT03850483|158154166|FG008|Treatment for Stage 2|Refused Further Treatment|1|||
49087124|NCT03850483|158154167|FG009|Treatment for Stage 2|Refused Further Treatment|0|||
49087125|NCT03850483|158154158|FG000|Follow-up For Stage 2|Lost to Follow-up|0|||
49087126|NCT03850483|158154159|FG001|Follow-up For Stage 2|Lost to Follow-up|0|||
49087127|NCT03850483|158154160|FG002|Follow-up For Stage 2|Lost to Follow-up|0|||
49087128|NCT03850483|158154161|FG003|Follow-up For Stage 2|Lost to Follow-up|0|||
49087129|NCT03850483|158154162|FG004|Follow-up For Stage 2|Lost to Follow-up|0|||
49087130|NCT03850483|158154163|FG005|Follow-up For Stage 2|Lost to Follow-up|0|||
49087131|NCT03850483|158154164|FG006|Follow-up For Stage 2|Lost to Follow-up|0|||
49087132|NCT03850483|158154165|FG007|Follow-up For Stage 2|Lost to Follow-up|0|||
49087133|NCT03850483|158154166|FG008|Follow-up For Stage 2|Lost to Follow-up|0|||
49087134|NCT03850483|158154167|FG009|Follow-up For Stage 2|Lost to Follow-up|1|||
49087135|NCT03850483|158154158|FG000|Follow-up For Stage 2|Other|0|||
49087136|NCT03850483|158154159|FG001|Follow-up For Stage 2|Other|0|||
49087137|NCT03850483|158154160|FG002|Follow-up For Stage 2|Other|0|||
49087138|NCT03850483|158154161|FG003|Follow-up For Stage 2|Other|0|||
49087139|NCT03850483|158154162|FG004|Follow-up For Stage 2|Other|0|||
49087140|NCT03850483|158154163|FG005|Follow-up For Stage 2|Other|0|||
49087141|NCT03850483|158154164|FG006|Follow-up For Stage 2|Other|0|||
49087142|NCT03850483|158154165|FG007|Follow-up For Stage 2|Other|0|||
49087143|NCT03850483|158154166|FG008|Follow-up For Stage 2|Other|0|||
49087144|NCT03850483|158154167|FG009|Follow-up For Stage 2|Other|1|||
49087145|NCT02576847|158154168|FG000|Overall Study|Adverse Event|27|||
49087146|NCT02576847|158154168|FG000|Overall Study|Lost to Follow-up|22|||
49087147|NCT02576847|158154168|FG000|Overall Study|Physician Decision|1|||
49087148|NCT02576847|158154168|FG000|Overall Study|Pregnancy|1|||
49087149|NCT02576847|158154168|FG000|Overall Study|Protocol Violation|3|||
49087150|NCT02576847|158154168|FG000|Overall Study|Withdrawal by Subject|78|||
49087151|NCT02576847|158154168|FG000|Overall Study|Other|5|||
49087152|NCT01806051|158154169|FG000|Overall Study|Withdrawal by Subject|6|||
49087153|NCT02418182|158154170|FG000|Overall Study|Unable to re-consent|18|||
49087154|NCT02418182|158154171|FG001|Overall Study|Unable to re-consent|15|||
49087155|NCT02418182|158154170|FG000|Overall Study|Lost to Follow-up|0|||
49087156|NCT02418182|158154171|FG001|Overall Study|Lost to Follow-up|2|||
49087157|NCT04305327|158154172|FG000|Overall Study|Study early termination|2|||
49087158|NCT04305327|158154173|FG001|Overall Study|Study early termination|5|||
49087159|NCT04305327|158154174|FG002|Overall Study|Study early termination|2|||
49087160|NCT04305327|158154175|FG003|Overall Study|Study early termination|2|||
49087161|NCT04305327|158154172|FG000|Overall Study|Withdrawal by Subject|0|||
49087162|NCT04305327|158154173|FG001|Overall Study|Withdrawal by Subject|1|||
49087163|NCT04305327|158154174|FG002|Overall Study|Withdrawal by Subject|0|||
49087164|NCT04305327|158154175|FG003|Overall Study|Withdrawal by Subject|0|||
49087165|NCT01205776|158154176|FG000|Overall Study|Lost to Follow-up|53|||
49087166|NCT01205776|158154177|FG001|Overall Study|Lost to Follow-up|61|||
49087167|NCT01205776|158154176|FG000|Overall Study|Withdrawal by Subject|11|||
49087168|NCT01205776|158154177|FG001|Overall Study|Withdrawal by Subject|34|||
49087169|NCT03170362|158154178|FG000|Overall Study|Death|2|||
49087170|NCT03170362|158154179|FG001|Overall Study|Death|2|||
49087171|NCT03170362|158154178|FG000|Overall Study|Withdrawal by Subject|23|||
49087172|NCT03170362|158154179|FG001|Overall Study|Withdrawal by Subject|22|||
49087173|NCT03170362|158154178|FG000|Overall Study|Lost to Follow-up|187|||
49087174|NCT03170362|158154179|FG001|Overall Study|Lost to Follow-up|167|||
49087175|NCT01796392|158154180|FG000|Overall Study|Withdrawal by Subject|2|||
49087176|NCT01796392|158154181|FG001|Overall Study|Withdrawal by Subject|0|||
49087177|NCT01796392|158154180|FG000|Overall Study|Death|5|||
49087178|NCT01796392|158154181|FG001|Overall Study|Death|1|||
49087179|NCT01796392|158154180|FG000|Overall Study|Excluded for medical reasons|1|||
49087180|NCT01796392|158154181|FG001|Overall Study|Excluded for medical reasons|2|||
49087181|NCT01796392|158154180|FG000|Overall Study|Lost to Follow-up|1|||
49087182|NCT01796392|158154181|FG001|Overall Study|Lost to Follow-up|0|||
49087183|NCT00734994|158154182|FG000|Overall Study|Withdrawal by Subject|1|||
49087184|NCT02362360|158154183|FG000|Period 1|Lack of Efficacy|1|||
49087185|NCT02362360|158154184|FG001|Period 1|Lack of Efficacy|0|||
49087186|NCT02362360|158154183|FG000|Period 1|Withdrawal by Subject|2|||
49087187|NCT02362360|158154184|FG001|Period 1|Withdrawal by Subject|1|||
49087188|NCT03225105|158154187|FG000|Overall Study|Withdrawal by Subject|1|||
49087189|NCT03225105|158154188|FG001|Overall Study|Withdrawal by Subject|0|||
49087190|NCT03225105|158154189|FG002|Overall Study|Withdrawal by Subject|0|||
49087191|NCT03225105|158154190|FG003|Overall Study|Withdrawal by Subject|0|||
49087192|NCT03225105|158154187|FG000|Overall Study|Death|0|||
49087193|NCT03225105|158154188|FG001|Overall Study|Death|4|||
49087194|NCT03225105|158154189|FG002|Overall Study|Death|2|||
49087195|NCT03225105|158154190|FG003|Overall Study|Death|0|||
49087196|NCT03225105|158154187|FG000|Overall Study|Study termination per Sponsor Decision|2|||
49087197|NCT03225105|158154188|FG001|Overall Study|Study termination per Sponsor Decision|0|||
49087198|NCT03225105|158154189|FG002|Overall Study|Study termination per Sponsor Decision|3|||
49087199|NCT03225105|158154190|FG003|Overall Study|Study termination per Sponsor Decision|3|||
49099009|NCT02419612|158197015|FG000|Short-term Treatment Period|Worsening of liver function|0|||
49099010|NCT02419612|158197016|FG001|Short-term Treatment Period|Worsening of liver function|1|||
49099011|NCT02419612|158197015|FG000|Short-term Treatment Period|Subject moved out of state|0|||
49099012|NCT02419612|158197016|FG001|Short-term Treatment Period|Subject moved out of state|1|||
49099013|NCT02419612|158197015|FG000|Long-term Treatment Period|Non-compliance with Study Drug|1|||
49099014|NCT02419612|158197016|FG001|Long-term Treatment Period|Non-compliance with Study Drug|1|||
49099015|NCT02419612|158197015|FG000|Long-term Treatment Period|Lost to Follow-up|6|||
49099016|NCT02419612|158197016|FG001|Long-term Treatment Period|Lost to Follow-up|4|||
49099017|NCT02419612|158197015|FG000|Long-term Treatment Period|Lack of Efficacy|1|||
49099018|NCT02419612|158197016|FG001|Long-term Treatment Period|Lack of Efficacy|1|||
49099019|NCT02419612|158197015|FG000|Long-term Treatment Period|Death|0|||
49099020|NCT02419612|158197016|FG001|Long-term Treatment Period|Death|1|||
49099021|NCT02419612|158197015|FG000|Long-term Treatment Period|Adverse Event|0|||
49099022|NCT02419612|158197016|FG001|Long-term Treatment Period|Adverse Event|5|||
49099023|NCT02419612|158197015|FG000|Long-term Treatment Period|Other|4|||
49099024|NCT02419612|158197016|FG001|Long-term Treatment Period|Other|4|||
49099025|NCT02419612|158197015|FG000|Long-term Treatment Period|Subject Decision|2|||
49099026|NCT02419612|158197016|FG001|Long-term Treatment Period|Subject Decision|4|||
49099027|NCT02419612|158197015|FG000|Long-term Treatment Period|Withdrawal by Subject|8|||
49099028|NCT02419612|158197016|FG001|Long-term Treatment Period|Withdrawal by Subject|2|||
49099029|NCT00533702|158197019|FG000|Overall Study|Withdrawal by Subject|3|||
49099030|NCT00533702|158197020|FG001|Overall Study|Withdrawal by Subject|1|||
49099031|NCT00533702|158197019|FG000|Overall Study|Found ineligible after randomization|2|||
49099032|NCT00533702|158197020|FG001|Overall Study|Found ineligible after randomization|1|||
49099033|NCT02009397|158197023|FG000|Overall Study|Protocol Violation|6|||
49099034|NCT02009397|158197023|FG000|Overall Study|Death|8|||
49099035|NCT02009397|158197023|FG000|Overall Study|Lost to Follow-up|6|||
49099036|NCT01953601|158198740|FG000|Part 1 (Base Study)|Adverse Event|24|||
49099037|NCT01953601|158198741|FG001|Part 1 (Base Study)|Adverse Event|37|||
49099038|NCT01953601|158198742|FG002|Part 1 (Base Study)|Adverse Event|15|||
49099039|NCT01953601|158198740|FG000|Part 1 (Base Study)|Death|2|||
49099040|NCT01953601|158198741|FG001|Part 1 (Base Study)|Death|0|||
49099041|NCT01953601|158198742|FG002|Part 1 (Base Study)|Death|3|||
49099042|NCT01953601|158198740|FG000|Part 1 (Base Study)|Lack of Efficacy|3|||
49099043|NCT01953601|158198741|FG001|Part 1 (Base Study)|Lack of Efficacy|1|||
49099044|NCT01953601|158198742|FG002|Part 1 (Base Study)|Lack of Efficacy|4|||
49099045|NCT01953601|158198740|FG000|Part 1 (Base Study)|Lost to Follow-up|1|||
49099046|NCT01953601|158198741|FG001|Part 1 (Base Study)|Lost to Follow-up|3|||
49099047|NCT01953601|158198742|FG002|Part 1 (Base Study)|Lost to Follow-up|6|||
49099048|NCT01953601|158198740|FG000|Part 1 (Base Study)|Non-compliance with study drug|0|||
49099049|NCT01953601|158198741|FG001|Part 1 (Base Study)|Non-compliance with study drug|3|||
49099050|NCT01953601|158198742|FG002|Part 1 (Base Study)|Non-compliance with study drug|1|||
49099051|NCT01953601|158198740|FG000|Part 1 (Base Study)|Physician Decision|3|||
49099052|NCT01953601|158198741|FG001|Part 1 (Base Study)|Physician Decision|7|||
49099053|NCT01953601|158198742|FG002|Part 1 (Base Study)|Physician Decision|4|||
49099054|NCT01953601|158198740|FG000|Part 1 (Base Study)|Screen failure|1|||
49099055|NCT01953601|158198741|FG001|Part 1 (Base Study)|Screen failure|0|||
49099056|NCT01953601|158198742|FG002|Part 1 (Base Study)|Screen failure|1|||
49099057|NCT01953601|158198740|FG000|Part 1 (Base Study)|Site discontinued study participation|2|||
49099058|NCT01953601|158198741|FG001|Part 1 (Base Study)|Site discontinued study participation|0|||
49099059|NCT01953601|158198742|FG002|Part 1 (Base Study)|Site discontinued study participation|0|||
49099060|NCT01953601|158198740|FG000|Part 1 (Base Study)|Study terminated by sponsor|174|||
49099061|NCT01953601|158198741|FG001|Part 1 (Base Study)|Study terminated by sponsor|169|||
49099062|NCT01953601|158198742|FG002|Part 1 (Base Study)|Study terminated by sponsor|179|||
49099063|NCT01953601|158198740|FG000|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7|||
49099064|NCT01953601|158198741|FG001|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8|||
49099065|NCT01953601|158198742|FG002|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10|||
49099066|NCT01953601|158198740|FG000|Part 1 (Base Study)|Subject moved|2|||
49099067|NCT01953601|158198741|FG001|Part 1 (Base Study)|Subject moved|2|||
49099068|NCT01953601|158198742|FG002|Part 1 (Base Study)|Subject moved|1|||
49099069|NCT01953601|158198740|FG000|Part 1 (Base Study)|Withdrawal by Subject|32|||
49099070|NCT01953601|158198741|FG001|Part 1 (Base Study)|Withdrawal by Subject|23|||
49099071|NCT01953601|158198742|FG002|Part 1 (Base Study)|Withdrawal by Subject|22|||
49087200|NCT02513160|158155767|FG000|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33|||
49087201|NCT02513160|158155768|FG001|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
49087202|NCT02513160|158155769|FG002|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
49087203|NCT02513160|158155770|FG003|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
49087204|NCT02513160|158155767|FG000|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214|||
49087205|NCT02513160|158155768|FG001|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
49087206|NCT02513160|158155769|FG002|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
49087207|NCT02513160|158155770|FG003|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
49087208|NCT02513160|158155767|FG000|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6|||
49087209|NCT02513160|158155768|FG001|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
49087210|NCT02513160|158155769|FG002|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
49087211|NCT02513160|158155770|FG003|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
49087212|NCT02513160|158155767|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|4|||
49087213|NCT02513160|158155768|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
49087214|NCT02513160|158155769|FG002|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
49087215|NCT02513160|158155770|FG003|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
49087216|NCT02513160|158155767|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20|||
49087217|NCT02513160|158155768|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
49087218|NCT02513160|158155769|FG002|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
49087219|NCT02513160|158155770|FG003|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
49087220|NCT02513160|158155767|FG000|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1|||
49087221|NCT02513160|158155768|FG001|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
49087222|NCT02513160|158155769|FG002|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
49087223|NCT02513160|158155770|FG003|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
49087224|NCT02513160|158155767|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10|||
49087225|NCT02513160|158155768|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
49087226|NCT02513160|158155769|FG002|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
49087227|NCT02513160|158155770|FG003|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
49087228|NCT02513160|158155767|FG000|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
49087229|NCT02513160|158155768|FG001|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
49087230|NCT02513160|158155769|FG002|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0|||
49087231|NCT02513160|158155770|FG003|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1|||
49087232|NCT02513160|158155767|FG000|Treatment Period (Day 0 to Week 6)|Noncompliance|1|||
49087233|NCT02513160|158155768|FG001|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
49087234|NCT02513160|158155769|FG002|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
49087235|NCT02513160|158155770|FG003|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
49087236|NCT02513160|158155767|FG000|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2|||
49087237|NCT02513160|158155768|FG001|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
49087238|NCT02513160|158155769|FG002|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
49087239|NCT02513160|158155770|FG003|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
49087240|NCT02513160|158155767|FG000|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1|||
49087241|NCT02513160|158155768|FG001|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
49087242|NCT02513160|158155769|FG002|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
49087243|NCT02513160|158155770|FG003|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
49087244|NCT02513160|158155767|FG000|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
49087245|NCT02513160|158155768|FG001|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1|||
49087246|NCT02513160|158155769|FG002|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
49087247|NCT02513160|158155770|FG003|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
49087248|NCT01168232|158155771|FG000|Overall Study|Ineligible-Second primary cancer site|1|||
49087249|NCT01168232|158155771|FG000|Overall Study|Ineligible- Wrong cell type|6|||
49087250|NCT01168232|158155771|FG000|Overall Study|Ineligible-Inadequate pathology|1|||
49087251|NCT02750618|158155772|FG000|Overall Study|Withdrawal by Subject|1|||
49087252|NCT02445248|158155778|FG000|Overall Study|Death|45|||
49087253|NCT02445248|158155779|FG001|Overall Study|Death|12|||
49087254|NCT02445248|158155778|FG000|Overall Study|Progressive disease|13|||
49087255|NCT02445248|158155779|FG001|Overall Study|Progressive disease|1|||
49087256|NCT02445248|158155778|FG000|Overall Study|Subject decision|8|||
49087257|NCT02445248|158155779|FG001|Overall Study|Subject decision|0|||
49087258|NCT02445248|158155778|FG000|Overall Study|Physician Decision|5|||
49087259|NCT02445248|158155779|FG001|Overall Study|Physician Decision|0|||
49087260|NCT02445248|158155778|FG000|Overall Study|Adverse Event|1|||
49087261|NCT02445248|158155779|FG001|Overall Study|Adverse Event|0|||
49087262|NCT02445248|158155778|FG000|Overall Study|Lost to Follow-up|1|||
49087263|NCT02445248|158155779|FG001|Overall Study|Lost to Follow-up|0|||
49087264|NCT01922037|158155780|FG000|Overall Study|Withdrawal by Subject|2|||
49087265|NCT01922037|158155781|FG001|Overall Study|Withdrawal by Subject|44|||
49087266|NCT01922037|158155780|FG000|Overall Study|Adverse Event|1|||
49087267|NCT01922037|158155781|FG001|Overall Study|Adverse Event|7|||
49087268|NCT01922037|158155780|FG000|Overall Study|Death|0|||
49087269|NCT01922037|158155781|FG001|Overall Study|Death|5|||
49087270|NCT01922037|158155780|FG000|Overall Study|Pregnancy|0|||
49087271|NCT01922037|158155781|FG001|Overall Study|Pregnancy|2|||
49087272|NCT01922037|158155780|FG000|Overall Study|Participant non-compliance|4|||
49087273|NCT01922037|158155781|FG001|Overall Study|Participant non-compliance|46|||
49087274|NCT01922037|158155780|FG000|Overall Study|Investigator/Sponsor decision|1|||
49087275|NCT01922037|158155781|FG001|Overall Study|Investigator/Sponsor decision|4|||
49087276|NCT01922037|158155780|FG000|Overall Study|Other unspecified|2|||
49087277|NCT01922037|158155781|FG001|Overall Study|Other unspecified|66|||
49087278|NCT03493854|158155782|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3|||
49087279|NCT03493854|158155783|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5|||
49087280|NCT03493854|158155782|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
49087281|NCT03493854|158155783|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
49087282|NCT03493854|158155782|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0|||
49087283|NCT03493854|158155783|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1|||
49087284|NCT03493854|158155782|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1|||
49087285|NCT03493854|158155783|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2|||
49087286|NCT03493854|158155782|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
49087287|NCT03493854|158155783|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
49087288|NCT03493854|158155782|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
49087289|NCT03493854|158155783|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|2|||
49087290|NCT03493854|158155782|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
49087291|NCT03493854|158155783|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|0|||
49087292|NCT03493854|158155782|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|12|||
49087293|NCT03493854|158155783|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|7|||
49087294|NCT03493854|158155782|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0|||
49087295|NCT03493854|158155783|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|2|||
49087296|NCT03493854|158155782|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|4|||
49087297|NCT03493854|158155783|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0|||
49087298|NCT03493854|158155782|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
49087299|NCT03493854|158155783|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
49087300|NCT03493854|158155782|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Other|7|||
49087301|NCT03493854|158155783|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Other|2|||
49087302|NCT03493854|158155782|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
49087303|NCT03493854|158155783|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
49087304|NCT03493854|158155782|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|3|||
49087305|NCT03493854|158155783|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|2|||
49087306|NCT03493854|158155782|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|4|||
49087307|NCT03493854|158155783|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|1|||
49087308|NCT03493854|158155782|FG000|Treatment-Free Follow-Up (up to 3 Years)|Death|10|||
49087309|NCT03493854|158155783|FG001|Treatment-Free Follow-Up (up to 3 Years)|Death|11|||
49087310|NCT03493854|158155782|FG000|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
49087311|NCT03493854|158155783|FG001|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
49087312|NCT03493854|158155782|FG000|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|4|||
49087313|NCT03493854|158155783|FG001|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|1|||
49087314|NCT02157935|158155790|FG000|Overall Study|Withdrawal by Subject|25|||
49087315|NCT02157935|158155791|FG001|Overall Study|Withdrawal by Subject|39|||
49087316|NCT02157935|158155790|FG000|Overall Study|Screen failure|1|||
49087317|NCT02157935|158155791|FG001|Overall Study|Screen failure|2|||
49087318|NCT02157935|158155790|FG000|Overall Study|Protocol Violation|1|||
49087319|NCT02157935|158155791|FG001|Overall Study|Protocol Violation|0|||
49087320|NCT02157935|158155790|FG000|Overall Study|Progressive disease|0|||
49087321|NCT02157935|158155791|FG001|Overall Study|Progressive disease|2|||
49087322|NCT02157935|158155790|FG000|Overall Study|Other|5|||
49087323|NCT02157935|158155791|FG001|Overall Study|Other|12|||
49087324|NCT02157935|158155790|FG000|Overall Study|Lack of Efficacy|0|||
49087325|NCT02157935|158155791|FG001|Overall Study|Lack of Efficacy|1|||
49087326|NCT02157935|158155790|FG000|Overall Study|Death|4|||
49087327|NCT02157935|158155791|FG001|Overall Study|Death|4|||
49087328|NCT02157935|158155790|FG000|Overall Study|Adverse Event|3|||
49087329|NCT02157935|158155791|FG001|Overall Study|Adverse Event|5|||
49087330|NCT04565145|158155792|FG000|Overall Study|Withdrawal by Subject|1|||
49087331|NCT04565145|158155793|FG001|Overall Study|Withdrawal by Subject|1|||
49087332|NCT00536939|158155794|FG000|Overall Study|Withdrawal by Subject|1|||
49087333|NCT00536939|158155795|FG001|Overall Study|Withdrawal by Subject|0|||
49087334|NCT00536939|158155794|FG000|Overall Study|Other Complicating Disease|1|||
49087335|NCT00536939|158155795|FG001|Overall Study|Other Complicating Disease|0|||
49087336|NCT01067105|158155796|FG000|Overall Study|Adverse Event|14|||
49087337|NCT01067105|158155796|FG000|Overall Study|Protocol Violation|48|||
49087338|NCT01067105|158155796|FG000|Overall Study|Withdrawal by Subject|36|||
49087339|NCT01067105|158155796|FG000|Overall Study|Lost to Follow-up|6|||
49087340|NCT01067105|158155796|FG000|Overall Study|Physician Decision|6|||
49087341|NCT01067105|158155796|FG000|Overall Study|Other|31|||
49087342|NCT05506046|158155797|FG000|Overall Study|Lost to Follow-up|89|||
49087343|NCT05506046|158155798|FG001|Overall Study|Lost to Follow-up|101|||
49087344|NCT05506046|158155799|FG002|Overall Study|Lost to Follow-up|102|||
49087345|NCT05506046|158155800|FG003|Overall Study|Lost to Follow-up|99|||
49087346|NCT03442751|158155803|FG000|Overall Study|Withdrawal by Subject|3|||
49087347|NCT03442751|158155804|FG001|Overall Study|Withdrawal by Subject|1|||
49087348|NCT03442751|158155803|FG000|Overall Study|Lost to Follow-up|3|||
49087349|NCT03442751|158155804|FG001|Overall Study|Lost to Follow-up|0|||
49087350|NCT05061693|158155805|FG000|Overall Study|Adverse Event|1|||
49087351|NCT05061693|158155806|FG001|Overall Study|Adverse Event|1|||
49087352|NCT05061693|158155807|FG002|Overall Study|Adverse Event|1|||
49087353|NCT05061693|158155808|FG003|Overall Study|Adverse Event|0|||
49087354|NCT05061693|158155805|FG000|Overall Study|Death|0|||
49087355|NCT05061693|158155806|FG001|Overall Study|Death|1|||
49087356|NCT05061693|158155807|FG002|Overall Study|Death|0|||
49087357|NCT05061693|158155808|FG003|Overall Study|Death|0|||
49087358|NCT05061693|158155805|FG000|Overall Study|Lack of Efficacy|1|||
49087359|NCT05061693|158155806|FG001|Overall Study|Lack of Efficacy|0|||
49087360|NCT05061693|158155807|FG002|Overall Study|Lack of Efficacy|0|||
49087361|NCT05061693|158155808|FG003|Overall Study|Lack of Efficacy|0|||
49087362|NCT05061693|158155805|FG000|Overall Study|Lost to Follow-up|0|||
49087363|NCT05061693|158155806|FG001|Overall Study|Lost to Follow-up|0|||
49087364|NCT05061693|158155807|FG002|Overall Study|Lost to Follow-up|1|||
49087365|NCT05061693|158155808|FG003|Overall Study|Lost to Follow-up|0|||
49087366|NCT05061693|158155805|FG000|Overall Study|Protocol Violation|1|||
49087367|NCT05061693|158155806|FG001|Overall Study|Protocol Violation|1|||
49087368|NCT05061693|158155807|FG002|Overall Study|Protocol Violation|1|||
49087369|NCT05061693|158155808|FG003|Overall Study|Protocol Violation|2|||
49087370|NCT05061693|158155805|FG000|Overall Study|Withdrawal by Subject|2|||
49087371|NCT05061693|158155806|FG001|Overall Study|Withdrawal by Subject|4|||
49087372|NCT05061693|158155807|FG002|Overall Study|Withdrawal by Subject|2|||
49087373|NCT05061693|158155808|FG003|Overall Study|Withdrawal by Subject|2|||
49087374|NCT00449865|158155809|FG000|Overall Study|Withdrawal by Subject|110|||
49087375|NCT00449865|158155810|FG001|Overall Study|Withdrawal by Subject|110|||
49087376|NCT00449865|158155809|FG000|Overall Study|Lost to Follow-up|36|||
49087377|NCT00449865|158155810|FG001|Overall Study|Lost to Follow-up|37|||
49087378|NCT00449865|158155809|FG000|Overall Study|Physician Decision|13|||
49087379|NCT00449865|158155810|FG001|Overall Study|Physician Decision|12|||
49087380|NCT00449865|158155809|FG000|Overall Study|Death|31|||
49087381|NCT00449865|158155810|FG001|Overall Study|Death|40|||
49087382|NCT00449865|158155809|FG000|Overall Study|Protocol Violation|8|||
49087383|NCT00449865|158155810|FG001|Overall Study|Protocol Violation|7|||
49087384|NCT00449865|158155809|FG000|Overall Study|Study was stopped|324|||
49087385|NCT00449865|158155810|FG001|Overall Study|Study was stopped|328|||
49087386|NCT02626026|158155811|FG000|Overall Study|Randomized but Never Treated|0|||
49087387|NCT02626026|158155812|FG001|Overall Study|Randomized but Never Treated|0|||
49087388|NCT02626026|158155813|FG002|Overall Study|Randomized but Never Treated|0|||
49087389|NCT02626026|158155814|FG003|Overall Study|Randomized but Never Treated|0|||
49087390|NCT02626026|158155815|FG004|Overall Study|Randomized but Never Treated|1|||
49087391|NCT02626026|158155816|FG005|Overall Study|Randomized but Never Treated|0|||
49087392|NCT01778855|158155817|FG000|Overall Study|Death|0|||
49087393|NCT01778855|158155818|FG001|Overall Study|Death|1|||
49087394|NCT00406367|158155819|FG000|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4|||
49087395|NCT00406367|158155820|FG001|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0|||
49087396|NCT00406367|158155819|FG000|Main Period - 6 to 20 Weeks|Consent Withdrawn|1|||
49087397|NCT00406367|158155820|FG001|Main Period - 6 to 20 Weeks|Consent Withdrawn|0|||
49087398|NCT00406367|158155819|FG000|Main Period - 6 to 20 Weeks|Lost to Follow-up|0|||
49087399|NCT00406367|158155820|FG001|Main Period - 6 to 20 Weeks|Lost to Follow-up|1|||
49087400|NCT00406367|158155819|FG000|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0|||
49087401|NCT00406367|158155820|FG001|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1|||
49087402|NCT00406367|158155819|FG000|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2|||
49087403|NCT00406367|158155820|FG001|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0|||
49087404|NCT00406367|158155819|FG000|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6|||
49087405|NCT00406367|158155820|FG001|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0|||
49087406|NCT00406367|158155819|FG000|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
49087407|NCT00406367|158155820|FG001|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
49087408|NCT00406367|158155819|FG000|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4|||
49087409|NCT00406367|158155820|FG001|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0|||
49087410|NCT00406367|158155819|FG000|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1|||
49087411|NCT00406367|158155820|FG001|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0|||
49087412|NCT00406367|158155819|FG000|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1|||
49087413|NCT00406367|158155820|FG001|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0|||
49087414|NCT00406367|158155819|FG000|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1|||
49087415|NCT00406367|158155820|FG001|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0|||
49087416|NCT00406367|158155819|FG000|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1|||
49087417|NCT00406367|158155820|FG001|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0|||
49087418|NCT00171210|158155822|FG000|Overall Study|Adverse Event|16|||
49087419|NCT00171210|158155823|FG001|Overall Study|Adverse Event|27|||
49087420|NCT00171210|158155822|FG000|Overall Study|Abnormal laboratory value(s)|6|||
49087421|NCT00171210|158155823|FG001|Overall Study|Abnormal laboratory value(s)|3|||
49087422|NCT00171210|158155822|FG000|Overall Study|Abnormal test procedure result(s)|0|||
49087423|NCT00171210|158155823|FG001|Overall Study|Abnormal test procedure result(s)|1|||
49087424|NCT00171210|158155822|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
49087425|NCT00171210|158155823|FG001|Overall Study|Unsatisfactory therapeutic effect|15|||
49087426|NCT00171210|158155822|FG000|Overall Study|Protocol Violation|0|||
49087427|NCT00171210|158155823|FG001|Overall Study|Protocol Violation|2|||
49087428|NCT00171210|158155822|FG000|Overall Study|Withdrawal by Subject|32|||
49087429|NCT00171210|158155823|FG001|Overall Study|Withdrawal by Subject|30|||
49087430|NCT00171210|158155822|FG000|Overall Study|Lost to Follow-up|1|||
49087431|NCT00171210|158155823|FG001|Overall Study|Lost to Follow-up|0|||
49087432|NCT00171210|158155822|FG000|Overall Study|Administrative problems|1|||
49087433|NCT00171210|158155823|FG001|Overall Study|Administrative problems|1|||
49087434|NCT00171210|158155822|FG000|Overall Study|Death|2|||
49087435|NCT00171210|158155823|FG001|Overall Study|Death|3|||
49087436|NCT00171210|158155822|FG000|Overall Study|Stopped at end of core|0|||
49087437|NCT00171210|158155823|FG001|Overall Study|Stopped at end of core|32|||
49087438|NCT00171210|158155822|FG000|Overall Study|Stopped at end of extension 1|0|||
49087439|NCT00171210|158155823|FG001|Overall Study|Stopped at end of extension 1|1|||
49087440|NCT03150719|158155824|FG000|Overall Study|Adverse Event|0|||
49087441|NCT03150719|158155825|FG001|Overall Study|Adverse Event|1|||
49087442|NCT03150719|158155824|FG000|Overall Study|Death|0|||
49087443|NCT03150719|158155825|FG001|Overall Study|Death|1|||
49087444|NCT03150719|158155824|FG000|Overall Study|Other|1|||
49087445|NCT03150719|158155825|FG001|Overall Study|Other|0|||
49087446|NCT03776357|158155828|FG000|Overall Study|Lost to Follow-up|3|||
49087447|NCT01006122|158155831|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
49087448|NCT01006122|158155832|FG001|First Double-blind Intervention Period|Lost to Follow-up|2|||
49087449|NCT01006122|158155831|FG000|First Double-blind Intervention Period|Protocol Violation|1|||
49087450|NCT01006122|158155832|FG001|First Double-blind Intervention Period|Protocol Violation|1|||
49087451|NCT01006122|158155831|FG000|First Double-blind Intervention Period|Pregnancy|0|||
49087452|NCT01006122|158155832|FG001|First Double-blind Intervention Period|Pregnancy|1|||
49087453|NCT01006122|158155831|FG000|First Double-blind Intervention Period|Withdrawal by Subject|9|||
49087454|NCT01006122|158155832|FG001|First Double-blind Intervention Period|Withdrawal by Subject|8|||
49087455|NCT01006122|158155831|FG000|First Double-blind Intervention Period|Does not meet entrance criteria|1|||
49087456|NCT01006122|158155832|FG001|First Double-blind Intervention Period|Does not meet entrance criteria|0|||
49087457|NCT01006122|158155831|FG000|First Double-blind Intervention Period|Lack of Efficacy|2|||
49087458|NCT01006122|158155832|FG001|First Double-blind Intervention Period|Lack of Efficacy|1|||
49087459|NCT01006122|158155831|FG000|First Double-blind Intervention Period|Other|3|||
49087460|NCT01006122|158155832|FG001|First Double-blind Intervention Period|Other|0|||
49087461|NCT01006122|158155831|FG000|First Double-blind Intervention Period|Adverse Event|0|||
49087462|NCT01006122|158155832|FG001|First Double-blind Intervention Period|Adverse Event|4|||
49087463|NCT01006122|158155831|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
49087464|NCT01006122|158155832|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
49087465|NCT01006122|158155831|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
49087466|NCT01006122|158155832|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
49087467|NCT01006122|158155831|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
49087468|NCT01006122|158155832|FG001|Second Double-blind Intervention Period|Lost to Follow-up|3|||
49087469|NCT01006122|158155831|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
49087470|NCT01006122|158155832|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|2|||
49087471|NCT01006122|158155831|FG000|Second Double-blind Intervention Period|Death|0|||
49087472|NCT01006122|158155832|FG001|Second Double-blind Intervention Period|Death|1|||
49087473|NCT03660930|158155833|FG000|Overall Study|Adverse Event|0|||
49087474|NCT03660930|158155834|FG001|Overall Study|Adverse Event|0|||
49087475|NCT03660930|158155835|FG002|Overall Study|Adverse Event|0|||
49087476|NCT03660930|158155836|FG003|Overall Study|Adverse Event|2|||
49087477|NCT03660930|158155837|FG004|Overall Study|Adverse Event|0|||
49087478|NCT03660930|158155838|FG005|Overall Study|Adverse Event|1|||
49087479|NCT03660930|158155839|FG006|Overall Study|Adverse Event|0|||
49087480|NCT03660930|158155840|FG007|Overall Study|Adverse Event|0|||
49087481|NCT03660930|158155833|FG000|Overall Study|Withdrawal by Subject|0|||
49087482|NCT03660930|158155834|FG001|Overall Study|Withdrawal by Subject|0|||
49087483|NCT03660930|158155835|FG002|Overall Study|Withdrawal by Subject|0|||
49087484|NCT03660930|158155836|FG003|Overall Study|Withdrawal by Subject|0|||
49087485|NCT03660930|158155837|FG004|Overall Study|Withdrawal by Subject|0|||
49087486|NCT03660930|158155838|FG005|Overall Study|Withdrawal by Subject|1|||
49087487|NCT03660930|158155839|FG006|Overall Study|Withdrawal by Subject|0|||
49087488|NCT03660930|158155840|FG007|Overall Study|Withdrawal by Subject|0|||
49087489|NCT03660930|158155833|FG000|Overall Study|On Treatment|0|||
49087490|NCT03660930|158155834|FG001|Overall Study|On Treatment|0|||
49087491|NCT03660930|158155835|FG002|Overall Study|On Treatment|0|||
49087492|NCT03660930|158155836|FG003|Overall Study|On Treatment|0|||
49087493|NCT03660930|158155837|FG004|Overall Study|On Treatment|0|||
49087494|NCT03660930|158155838|FG005|Overall Study|On Treatment|0|||
49087495|NCT03660930|158155839|FG006|Overall Study|On Treatment|0|||
49087496|NCT03660930|158155840|FG007|Overall Study|On Treatment|1|||
49087497|NCT03660930|158155833|FG000|Overall Study|In Follow-up|0|||
49087498|NCT03660930|158155834|FG001|Overall Study|In Follow-up|0|||
49087499|NCT03660930|158155835|FG002|Overall Study|In Follow-up|0|||
49087500|NCT03660930|158155836|FG003|Overall Study|In Follow-up|0|||
49087501|NCT03660930|158155837|FG004|Overall Study|In Follow-up|0|||
49087502|NCT03660930|158155838|FG005|Overall Study|In Follow-up|0|||
49087503|NCT03660930|158155839|FG006|Overall Study|In Follow-up|1|||
49087504|NCT03660930|158155840|FG007|Overall Study|In Follow-up|2|||
49087505|NCT02454608|158155841|FG000|Double-Blind Period|Lack of Efficacy|0|||
49087506|NCT02454608|158155842|FG001|Double-Blind Period|Lack of Efficacy|2|||
49087507|NCT02454608|158155843|FG002|Double-Blind Period|Lack of Efficacy|0|||
49087508|NCT02454608|158155841|FG000|Open Label Period|Lost to Follow-up|0|||
49087509|NCT02454608|158155842|FG001|Open Label Period|Lost to Follow-up|0|||
49087510|NCT02454608|158155843|FG002|Open Label Period|Lost to Follow-up|11|||
49087511|NCT02454608|158155841|FG000|Open Label Period|Withdrawal by Subject|0|||
49087512|NCT02454608|158155842|FG001|Open Label Period|Withdrawal by Subject|0|||
49087513|NCT02454608|158155843|FG002|Open Label Period|Withdrawal by Subject|8|||
49087514|NCT03473925|158155844|FG000|Overall Study|Death|48|||
49087515|NCT03473925|158155845|FG001|Overall Study|Death|44|||
49087516|NCT03473925|158155844|FG000|Overall Study|Sponsor Decision|2|||
49087517|NCT03473925|158155845|FG001|Overall Study|Sponsor Decision|7|||
49087518|NCT03473925|158155844|FG000|Overall Study|Withdrawal by Subject|1|||
49087519|NCT03473925|158155845|FG001|Overall Study|Withdrawal by Subject|3|||
49087520|NCT03473925|158155844|FG000|Overall Study|Not Treated|1|||
49087521|NCT03473925|158155845|FG001|Overall Study|Not Treated|1|||
49087522|NCT01431716|158155846|FG000|Overall Study|Withdrawal of consent|1|||
49087523|NCT03922308|158155847|FG000|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
49087524|NCT03922308|158155848|FG001|Overall Study|Not Meeting Confirmatory Inclusion Criteria|1|||
49087525|NCT03922308|158155849|FG002|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
49087526|NCT03922308|158155847|FG000|Overall Study|Lost to Follow-up|1|||
49087527|NCT03922308|158155848|FG001|Overall Study|Lost to Follow-up|0|||
49087528|NCT03922308|158155849|FG002|Overall Study|Lost to Follow-up|0|||
49087529|NCT03922308|158155847|FG000|Overall Study|Reason not Specified|0|||
49087530|NCT03922308|158155848|FG001|Overall Study|Reason not Specified|2|||
49087531|NCT03922308|158155849|FG002|Overall Study|Reason not Specified|1|||
49087532|NCT05005507|158155852|FG000|Overall Study|Premature termination of study|1|||
49087533|NCT01812109|158155853|FG000|Overall Study|research personnel delay|16|||
49087534|NCT01812109|158155853|FG000|Overall Study|NIRS Unattainable|17|||
49087535|NCT01286467|158155858|FG000|Overall Study|Death|1|||
49087536|NCT01286467|158155859|FG001|Overall Study|Death|1|||
49087537|NCT01286467|158155860|FG002|Overall Study|Death|1|||
49087538|NCT01286467|158155861|FG003|Overall Study|Death|0|||
49087539|NCT01286467|158155858|FG000|Overall Study|Lost to Follow-up|0|||
49087540|NCT01286467|158155859|FG001|Overall Study|Lost to Follow-up|0|||
49087541|NCT01286467|158155860|FG002|Overall Study|Lost to Follow-up|0|||
49087542|NCT01286467|158155861|FG003|Overall Study|Lost to Follow-up|1|||
49087543|NCT01286467|158155858|FG000|Overall Study|Withdrawal by Subject|0|||
49087544|NCT01286467|158155859|FG001|Overall Study|Withdrawal by Subject|0|||
49087545|NCT01286467|158155860|FG002|Overall Study|Withdrawal by Subject|1|||
49087546|NCT01286467|158155861|FG003|Overall Study|Withdrawal by Subject|0|||
49087547|NCT01286467|158155858|FG000|Overall Study|Physician Decision|0|||
49087548|NCT01286467|158155859|FG001|Overall Study|Physician Decision|0|||
49087549|NCT01286467|158155860|FG002|Overall Study|Physician Decision|0|||
49087550|NCT01286467|158155861|FG003|Overall Study|Physician Decision|1|||
49087551|NCT01286467|158155858|FG000|Overall Study|Disease progression|3|||
49087552|NCT01286467|158155859|FG001|Overall Study|Disease progression|2|||
49087553|NCT01286467|158155860|FG002|Overall Study|Disease progression|2|||
49087554|NCT01286467|158155861|FG003|Overall Study|Disease progression|3|||
49087555|NCT01286467|158155858|FG000|Overall Study|Adverse Event|0|||
49087556|NCT01286467|158155859|FG001|Overall Study|Adverse Event|1|||
49087557|NCT01286467|158155860|FG002|Overall Study|Adverse Event|2|||
49087558|NCT01286467|158155861|FG003|Overall Study|Adverse Event|3|||
49087559|NCT01286467|158155858|FG000|Overall Study|Study drug stop longer than 14 days|0|||
49087560|NCT01286467|158155859|FG001|Overall Study|Study drug stop longer than 14 days|0|||
49087561|NCT01286467|158155860|FG002|Overall Study|Study drug stop longer than 14 days|1|||
49087562|NCT01286467|158155861|FG003|Overall Study|Study drug stop longer than 14 days|0|||
49087563|NCT03020992|158155862|FG000|Overall Study|Adverse Event|5|||
49087564|NCT03020992|158155862|FG000|Overall Study|Withdrawal by Subject|1|||
49087565|NCT01697748|158155865|FG000|Overall Study|ineligible skin incision|1|||
49087566|NCT01697748|158155866|FG001|Overall Study|ineligible skin incision|2|||
49087567|NCT01697748|158155865|FG000|Overall Study|ineligible uterine incision|4|||
49087568|NCT01697748|158155866|FG001|Overall Study|ineligible uterine incision|1|||
49087569|NCT01697748|158155865|FG000|Overall Study|Lost to Follow-up|53|||
49087570|NCT01697748|158155866|FG001|Overall Study|Lost to Follow-up|65|||
49087571|NCT01928472|158155869|FG000|Overall Study|Death|0|||
49087572|NCT01928472|158155870|FG001|Overall Study|Death|0|||
49087573|NCT01928472|158155871|FG002|Overall Study|Death|1|||
49087574|NCT01928472|158155872|FG003|Overall Study|Death|0|||
49087575|NCT01928472|158155869|FG000|Overall Study|Withdrawal by Subject|4|||
49087576|NCT01928472|158155870|FG001|Overall Study|Withdrawal by Subject|4|||
49087577|NCT01928472|158155871|FG002|Overall Study|Withdrawal by Subject|1|||
49087578|NCT01928472|158155872|FG003|Overall Study|Withdrawal by Subject|2|||
49087579|NCT01928472|158155869|FG000|Overall Study|Lost to Follow-up|2|||
49087580|NCT01928472|158155870|FG001|Overall Study|Lost to Follow-up|3|||
49087581|NCT01928472|158155871|FG002|Overall Study|Lost to Follow-up|4|||
49087582|NCT01928472|158155872|FG003|Overall Study|Lost to Follow-up|0|||
49087583|NCT01928472|158155869|FG000|Overall Study|Administrative Reason|2|||
49087584|NCT01928472|158155870|FG001|Overall Study|Administrative Reason|1|||
49087585|NCT01928472|158155871|FG002|Overall Study|Administrative Reason|0|||
49087586|NCT01928472|158155872|FG003|Overall Study|Administrative Reason|0|||
49087587|NCT01928472|158155869|FG000|Overall Study|Unclassified|0|||
49087588|NCT01928472|158155870|FG001|Overall Study|Unclassified|0|||
49087589|NCT01928472|158155871|FG002|Overall Study|Unclassified|1|||
49087590|NCT01928472|158155872|FG003|Overall Study|Unclassified|0|||
49087591|NCT04335123|158155873|FG000|Overall Study|Withdrawal by Subject|2|||
49087592|NCT04335123|158155874|FG001|Overall Study|Withdrawal by Subject|0|||
49087593|NCT04335123|158155873|FG000|Overall Study|Physician Decision|2|||
49087594|NCT04335123|158155874|FG001|Overall Study|Physician Decision|0|||
49087595|NCT01757535|158155875|FG000|Overall Study|Disease Relapse|143|||
49087596|NCT01757535|158155876|FG001|Overall Study|Disease Relapse|180|||
49087597|NCT01757535|158155875|FG000|Overall Study|Adverse Event|29|||
49087598|NCT01757535|158155876|FG001|Overall Study|Adverse Event|11|||
49087599|NCT01757535|158155875|FG000|Overall Study|Withdrawal by Subject|9|||
49087600|NCT01757535|158155876|FG001|Overall Study|Withdrawal by Subject|13|||
49087601|NCT01757535|158155875|FG000|Overall Study|Miscellaneous|5|||
49087602|NCT01757535|158155876|FG001|Overall Study|Miscellaneous|2|||
49087603|NCT01757535|158155875|FG000|Overall Study|Physician Decision|6|||
49087604|NCT01757535|158155876|FG001|Overall Study|Physician Decision|0|||
49087605|NCT01757535|158155875|FG000|Overall Study|Death|1|||
49087606|NCT01757535|158155876|FG001|Overall Study|Death|2|||
49087607|NCT02946463|158155877|FG000|Primary Evaluation Period|Physician Decision|0|||
49087608|NCT02946463|158155878|FG001|Primary Evaluation Period|Physician Decision|1|||
49087609|NCT02946463|158155879|FG002|Primary Evaluation Period|Physician Decision|0|||
49087610|NCT02946463|158155880|FG003|Primary Evaluation Period|Physician Decision|0|||
49087611|NCT02946463|158155877|FG000|Primary Evaluation Period|Withdrawal by Subject|0|||
49087612|NCT02946463|158155878|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
49087613|NCT02946463|158155879|FG002|Primary Evaluation Period|Withdrawal by Subject|0|||
49087614|NCT02946463|158155880|FG003|Primary Evaluation Period|Withdrawal by Subject|0|||
49087615|NCT02946463|158155877|FG000|Extension Period|Death|4|||
49087616|NCT02946463|158155878|FG001|Extension Period|Death|4|||
49087617|NCT02946463|158155879|FG002|Extension Period|Death|0|||
49087618|NCT02946463|158155880|FG003|Extension Period|Death|0|||
49087619|NCT02946463|158155877|FG000|Extension Period|Withdrawal by Subject|4|||
49087620|NCT02946463|158155878|FG001|Extension Period|Withdrawal by Subject|3|||
49087621|NCT02946463|158155879|FG002|Extension Period|Withdrawal by Subject|0|||
49087622|NCT02946463|158155880|FG003|Extension Period|Withdrawal by Subject|0|||
49087623|NCT02946463|158155877|FG000|Extension Period|Other than specified|2|||
49087624|NCT02946463|158155878|FG001|Extension Period|Other than specified|3|||
49087625|NCT02946463|158155879|FG002|Extension Period|Other than specified|2|||
49087626|NCT02946463|158155880|FG003|Extension Period|Other than specified|0|||
49087627|NCT02946463|158155877|FG000|Extension Period|Physician Decision|1|||
49087628|NCT02946463|158155878|FG001|Extension Period|Physician Decision|4|||
49087629|NCT02946463|158155879|FG002|Extension Period|Physician Decision|0|||
49087630|NCT02946463|158155880|FG003|Extension Period|Physician Decision|0|||
49087631|NCT02946463|158155877|FG000|Extension Period|Pregnancy|3|||
49087632|NCT02946463|158155878|FG001|Extension Period|Pregnancy|1|||
49087633|NCT02946463|158155879|FG002|Extension Period|Pregnancy|0|||
49087634|NCT02946463|158155880|FG003|Extension Period|Pregnancy|0|||
49087635|NCT02946463|158155877|FG000|Extension Period|Adverse Event|1|||
49087636|NCT02946463|158155878|FG001|Extension Period|Adverse Event|2|||
49087637|NCT02946463|158155879|FG002|Extension Period|Adverse Event|0|||
49087638|NCT02946463|158155880|FG003|Extension Period|Adverse Event|0|||
49087639|NCT02946463|158155877|FG000|Extension Period|Lost to Follow-up|1|||
49087640|NCT02946463|158155878|FG001|Extension Period|Lost to Follow-up|0|||
49087641|NCT02946463|158155879|FG002|Extension Period|Lost to Follow-up|0|||
49087642|NCT02946463|158155880|FG003|Extension Period|Lost to Follow-up|0|||
49087643|NCT01753310|158155881|FG000|Overall Study|Entered into open label extension study|25|||
49087644|NCT01753310|158155882|FG001|Overall Study|Entered into open label extension study|22|||
49087645|NCT01753310|158155881|FG000|Overall Study|Adverse Event|1|||
49087646|NCT01753310|158155882|FG001|Overall Study|Adverse Event|0|||
49087647|NCT01753310|158155881|FG000|Overall Study|Lost to Follow-up|2|||
49087648|NCT01753310|158155882|FG001|Overall Study|Lost to Follow-up|0|||
49087649|NCT01753310|158155881|FG000|Overall Study|Subject decision|2|||
49087650|NCT01753310|158155882|FG001|Overall Study|Subject decision|2|||
49087651|NCT01753310|158155881|FG000|Overall Study|Sponsor decision|1|||
49087652|NCT01753310|158155882|FG001|Overall Study|Sponsor decision|0|||
49087653|NCT01753310|158155881|FG000|Overall Study|Withdrawal by Subject|1|||
49087654|NCT01753310|158155882|FG001|Overall Study|Withdrawal by Subject|0|||
49087655|NCT02169271|158155883|FG000|Overall Study|Protocol Violation|1|||
49087656|NCT02169271|158155884|FG001|Overall Study|Protocol Violation|2|||
49087657|NCT02644668|158155886|FG000|Overall Study|Adverse Event|2|||
49087658|NCT02644668|158155887|FG001|Overall Study|Adverse Event|0|||
49087659|NCT02644668|158155888|FG002|Overall Study|Adverse Event|1|||
49087660|NCT02644668|158155886|FG000|Overall Study|Protocol Violation|0|||
49087661|NCT02644668|158155887|FG001|Overall Study|Protocol Violation|0|||
49087662|NCT02644668|158155888|FG002|Overall Study|Protocol Violation|1|||
49087663|NCT02644668|158155886|FG000|Overall Study|Withdrawal by Subject|0|||
49087664|NCT02644668|158155887|FG001|Overall Study|Withdrawal by Subject|0|||
49087665|NCT02644668|158155888|FG002|Overall Study|Withdrawal by Subject|1|||
49087666|NCT02547220|158155895|FG000|Overall Study|Withdrawal by Subject|1|||
49087667|NCT02547220|158155896|FG001|Overall Study|Withdrawal by Subject|0|||
49087668|NCT02547220|158155895|FG000|Overall Study|Study terminated by sponsor|18|||
49087669|NCT02547220|158155896|FG001|Overall Study|Study terminated by sponsor|20|||
49087670|NCT01120184|158157706|FG000|Overall Study|Adverse Event|0|||
49087671|NCT01120184|158157707|FG001|Overall Study|Adverse Event|1|||
49087672|NCT01120184|158157708|FG002|Overall Study|Adverse Event|0|||
49087673|NCT01120184|158157706|FG000|Overall Study|Lost to Follow-up|13|||
49087674|NCT01120184|158157707|FG001|Overall Study|Lost to Follow-up|13|||
49087675|NCT01120184|158157708|FG002|Overall Study|Lost to Follow-up|11|||
49087676|NCT01120184|158157706|FG000|Overall Study|Physician Decision|9|||
49087677|NCT01120184|158157707|FG001|Overall Study|Physician Decision|1|||
49087678|NCT01120184|158157708|FG002|Overall Study|Physician Decision|3|||
49087679|NCT01120184|158157706|FG000|Overall Study|Reason not Specified|8|||
49087680|NCT01120184|158157707|FG001|Overall Study|Reason not Specified|3|||
49087681|NCT01120184|158157708|FG002|Overall Study|Reason not Specified|12|||
49087682|NCT01120184|158157706|FG000|Overall Study|Sponsor Decision to Terminate Study|133|||
49087683|NCT01120184|158157707|FG001|Overall Study|Sponsor Decision to Terminate Study|144|||
49087684|NCT01120184|158157708|FG002|Overall Study|Sponsor Decision to Terminate Study|143|||
49087685|NCT01120184|158157706|FG000|Overall Study|Subject/ Guardian Decision to Withdraw|32|||
49087686|NCT01120184|158157707|FG001|Overall Study|Subject/ Guardian Decision to Withdraw|29|||
49087687|NCT01120184|158157708|FG002|Overall Study|Subject/ Guardian Decision to Withdraw|25|||
49087688|NCT01120184|158157706|FG000|Overall Study|Death|170|||
49087689|NCT01120184|158157707|FG001|Overall Study|Death|176|||
49087690|NCT01120184|158157708|FG002|Overall Study|Death|169|||
49087691|NCT01417156|158157709|FG000|Overall Study|Adverse Event|12|||
49087692|NCT01417156|158157709|FG000|Overall Study|Protocol Violation|2|||
49087693|NCT02596971|158157710|FG000|Overall Study|Death|5|||
49087694|NCT02596971|158157711|FG001|Overall Study|Death|1|||
49087695|NCT02596971|158157712|FG002|Overall Study|Death|5|||
49087696|NCT02596971|158157710|FG000|Overall Study|Withdrawal by Subject|5|||
49087697|NCT02596971|158157711|FG001|Overall Study|Withdrawal by Subject|1|||
49087698|NCT02596971|158157712|FG002|Overall Study|Withdrawal by Subject|4|||
49087699|NCT03192488|158157713|FG000|First Washout (>6d)|Withdrawal by Subject|0|||
49087700|NCT03192488|158157714|FG001|First Washout (>6d)|Withdrawal by Subject|0|||
49087701|NCT03192488|158157715|FG002|First Washout (>6d)|Withdrawal by Subject|1|||
49087702|NCT03192488|158157716|FG003|First Washout (>6d)|Withdrawal by Subject|0|||
49087703|NCT03192488|158157717|FG004|First Washout (>6d)|Withdrawal by Subject|0|||
49087704|NCT03192488|158157718|FG005|First Washout (>6d)|Withdrawal by Subject|1|||
49087705|NCT03192488|158157713|FG000|Third Intervention (d1)|Adverse Event|0|||
49087706|NCT03192488|158157714|FG001|Third Intervention (d1)|Adverse Event|0|||
49087707|NCT03192488|158157715|FG002|Third Intervention (d1)|Adverse Event|0|||
49087708|NCT03192488|158157716|FG003|Third Intervention (d1)|Adverse Event|0|||
49087709|NCT03192488|158157717|FG004|Third Intervention (d1)|Adverse Event|1|||
49087710|NCT03192488|158157718|FG005|Third Intervention (d1)|Adverse Event|0|||
49087711|NCT03283566|158157725|FG000|Overall Study|Lost to Follow-up|1|||
49087712|NCT03283566|158157726|FG001|Overall Study|Lost to Follow-up|2|||
49087713|NCT00595920|158157727|FG000|Overall Study|The OLTERMS study was discontinued by th|116|||
49087714|NCT00351468|158157729|FG000|Overall Study|Adverse Event|42|||
49087715|NCT00351468|158157729|FG000|Overall Study|Withdrawal by Subject|39|||
49087716|NCT00351468|158157729|FG000|Overall Study|Various -follow up w clinical team|39|||
49087717|NCT00351468|158157729|FG000|Overall Study|Lack of Efficacy|32|||
49087718|NCT00351468|158157729|FG000|Overall Study|Non-compliance|8|||
49087719|NCT00351468|158157729|FG000|Overall Study|Lost to Follow-up|4|||
49087720|NCT00351468|158157729|FG000|Overall Study|Protocol Violation|3|||
49087721|NCT03048747|158157730|FG000|Overall Study|Adverse Event|2|||
49087722|NCT03048747|158157730|FG000|Overall Study|Participant Met Withdrawal Criteria|2|||
49087723|NCT03048747|158157730|FG000|Overall Study|Physician Decision|1|||
49087724|NCT00824772|158157731|FG000|Overall Study|Withdrawal by Subject|8|||
49087725|NCT03588910|158157732|FG000|Overall Study|Withdrawal by Subject|1|||
49087726|NCT03588910|158157733|FG001|Overall Study|Withdrawal by Subject|0|||
49087727|NCT03588910|158157732|FG000|Overall Study|Allergy|2|||
49087728|NCT03588910|158157733|FG001|Overall Study|Allergy|0|||
49087729|NCT03588910|158157732|FG000|Overall Study|Protocol Violation|0|||
49087730|NCT03588910|158157733|FG001|Overall Study|Protocol Violation|3|||
49087731|NCT03588910|158157732|FG000|Overall Study|Did not complete Day 1 Survey|5|||
49087732|NCT03588910|158157733|FG001|Overall Study|Did not complete Day 1 Survey|10|||
49087733|NCT03588910|158157732|FG000|Overall Study|Did not complete Day 7 Survey|5|||
49087734|NCT03588910|158157733|FG001|Overall Study|Did not complete Day 7 Survey|2|||
49087735|NCT00838903|158157734|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
49087736|NCT00838903|158157735|FG001|Treatment Period (156 Weeks)|Adverse Event|13|||
49087737|NCT00838903|158157736|FG002|Treatment Period (156 Weeks)|Adverse Event|17|||
49087738|NCT00838903|158157737|FG003|Treatment Period (156 Weeks)|Adverse Event|25|||
49087739|NCT00838903|158157734|FG000|Treatment Period (156 Weeks)|Protocol Violation|1|||
49087740|NCT00838903|158157735|FG001|Treatment Period (156 Weeks)|Protocol Violation|6|||
49087741|NCT00838903|158157736|FG002|Treatment Period (156 Weeks)|Protocol Violation|6|||
49087742|NCT00838903|158157737|FG003|Treatment Period (156 Weeks)|Protocol Violation|5|||
49087743|NCT00838903|158157734|FG000|Treatment Period (156 Weeks)|Noncompliance|9|||
49087744|NCT00838903|158157735|FG001|Treatment Period (156 Weeks)|Noncompliance|13|||
49087745|NCT00838903|158157736|FG002|Treatment Period (156 Weeks)|Noncompliance|12|||
49087746|NCT00838903|158157737|FG003|Treatment Period (156 Weeks)|Noncompliance|6|||
49087747|NCT00838903|158157734|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
49087748|NCT00838903|158157735|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
49087749|NCT00838903|158157736|FG002|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
49087750|NCT00838903|158157737|FG003|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
49087751|NCT00838903|158157734|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|4|||
49087752|NCT00838903|158157735|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|16|||
49087753|NCT00838903|158157736|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|15|||
49087754|NCT00838903|158157737|FG003|Treatment Period (156 Weeks)|Lost to Follow-up|13|||
49087755|NCT00838903|158157734|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|20|||
49087756|NCT00838903|158157735|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|55|||
49087757|NCT00838903|158157736|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|56|||
49087758|NCT00838903|158157737|FG003|Treatment Period (156 Weeks)|Withdrawal by Subject|53|||
49087759|NCT00838903|158157734|FG000|Treatment Period (156 Weeks)|Physician Decision|1|||
49087760|NCT00838903|158157735|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
49087761|NCT00838903|158157736|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
49087762|NCT00838903|158157737|FG003|Treatment Period (156 Weeks)|Physician Decision|2|||
49087763|NCT00838903|158157734|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3|||
49087764|NCT00838903|158157735|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
49087765|NCT00838903|158157736|FG002|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
49087766|NCT00838903|158157737|FG003|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4|||
49087767|NCT00838903|158157734|FG000|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
49087768|NCT00838903|158157735|FG001|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1|||
49087769|NCT00838903|158157736|FG002|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
49087770|NCT00838903|158157737|FG003|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
49087771|NCT00838903|158157734|FG000|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
49087772|NCT00838903|158157735|FG001|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
49087773|NCT00838903|158157736|FG002|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
49087774|NCT00838903|158157737|FG003|Treatment Period (156 Weeks)|Poor Glycemic Control|1|||
49087775|NCT00838903|158157734|FG000|Treatment Period (156 Weeks)|Poor Therapeutic Response|1|||
49087776|NCT00838903|158157735|FG001|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
49087777|NCT00838903|158157736|FG002|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
49087778|NCT00838903|158157737|FG003|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
49087779|NCT00838903|158157734|FG000|Treatment Period (156 Weeks)|Pregnancy|0|||
49087780|NCT00838903|158157735|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
49087781|NCT00838903|158157736|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
49087782|NCT00838903|158157737|FG003|Treatment Period (156 Weeks)|Pregnancy|0|||
49087783|NCT00838903|158157734|FG000|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
49087784|NCT00838903|158157735|FG001|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
49087785|NCT00838903|158157736|FG002|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1|||
49087786|NCT00838903|158157737|FG003|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
49087787|NCT00838903|158157734|FG000|Treatment Period (156 Weeks)|Site closed|0|||
49087788|NCT00838903|158157735|FG001|Treatment Period (156 Weeks)|Site closed|0|||
49087789|NCT00838903|158157736|FG002|Treatment Period (156 Weeks)|Site closed|1|||
49087790|NCT00838903|158157737|FG003|Treatment Period (156 Weeks)|Site closed|0|||
49087791|NCT00838903|158157734|FG000|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1|||
49087792|NCT00838903|158157735|FG001|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
49087793|NCT00838903|158157736|FG002|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
49087794|NCT00838903|158157737|FG003|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
49087795|NCT00838903|158157734|FG000|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
49087796|NCT00838903|158157735|FG001|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
49087797|NCT00838903|158157736|FG002|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
49087798|NCT00838903|158157737|FG003|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
49087799|NCT00838903|158157734|FG000|Treatment Period (156 Weeks)|Missing Active Treatment Status|1|||
49087800|NCT00838903|158157735|FG001|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
49087801|NCT00838903|158157736|FG002|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
49087802|NCT00838903|158157737|FG003|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
49087803|NCT00838903|158157734|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
49087804|NCT00838903|158157735|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
49087805|NCT00838903|158157736|FG002|Follow-up Period (8 Weeks)|Adverse Event|3|||
49087806|NCT00838903|158157737|FG003|Follow-up Period (8 Weeks)|Adverse Event|1|||
49087807|NCT00838903|158157734|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
49087808|NCT00838903|158157735|FG001|Follow-up Period (8 Weeks)|Noncompliance|8|||
49087809|NCT00838903|158157736|FG002|Follow-up Period (8 Weeks)|Noncompliance|5|||
49087810|NCT00838903|158157737|FG003|Follow-up Period (8 Weeks)|Noncompliance|5|||
49087811|NCT00838903|158157734|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|6|||
49087812|NCT00838903|158157735|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|28|||
49087813|NCT00838903|158157736|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
49087814|NCT00838903|158157737|FG003|Follow-up Period (8 Weeks)|Lost to Follow-up|24|||
49087815|NCT00838903|158157734|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5|||
49087816|NCT00838903|158157735|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
49087817|NCT00838903|158157736|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12|||
49087818|NCT00838903|158157737|FG003|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
49087819|NCT00838903|158157734|FG000|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8|||
49087820|NCT00838903|158157735|FG001|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13|||
49087821|NCT00838903|158157736|FG002|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
49087822|NCT00838903|158157737|FG003|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
49087823|NCT00838903|158157734|FG000|Follow-up Period (8 Weeks)|Physician Decision|1|||
49087824|NCT00838903|158157735|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
49087825|NCT00838903|158157736|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
49087826|NCT00838903|158157737|FG003|Follow-up Period (8 Weeks)|Physician Decision|1|||
49087827|NCT00838903|158157734|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3|||
49087828|NCT00838903|158157735|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
49087829|NCT00838903|158157736|FG002|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6|||
49087830|NCT00838903|158157737|FG003|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
49087831|NCT00838903|158157734|FG000|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
49087832|NCT00838903|158157735|FG001|Follow-up Period (8 Weeks)|ICF Withdrawn|1|||
49087833|NCT00838903|158157736|FG002|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
49087834|NCT00838903|158157737|FG003|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
49087835|NCT00838903|158157734|FG000|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
49087836|NCT00838903|158157735|FG001|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1|||
49087837|NCT00838903|158157736|FG002|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
49087838|NCT00838903|158157737|FG003|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
49087839|NCT00838903|158157734|FG000|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
49087840|NCT00838903|158157735|FG001|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
49087841|NCT00838903|158157736|FG002|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
49087842|NCT00838903|158157737|FG003|Follow-up Period (8 Weeks)|Subject Moved out of Town|1|||
49087843|NCT00838903|158157734|FG000|Follow-up Period (8 Weeks)|Missing|1|||
49087844|NCT00838903|158157735|FG001|Follow-up Period (8 Weeks)|Missing|2|||
49087845|NCT00838903|158157736|FG002|Follow-up Period (8 Weeks)|Missing|1|||
49087846|NCT00838903|158157737|FG003|Follow-up Period (8 Weeks)|Missing|1|||
49087847|NCT00818766|158157738|FG000|Overall Study|Could not be Contacted on Day 28|11|||
49087848|NCT00818766|158157739|FG001|Overall Study|Could not be Contacted on Day 28|10|||
49087849|NCT00818766|158157738|FG000|Overall Study|Death|1|||
49087850|NCT00818766|158157739|FG001|Overall Study|Death|0|||
49087851|NCT00818766|158157738|FG000|Overall Study|Did not Receive Allocated Intervention|3|||
49087852|NCT00818766|158157739|FG001|Overall Study|Did not Receive Allocated Intervention|0|||
49087853|NCT03096314|158157740|FG000|Screened Vitamin D Deficient|Lost to Follow-up|9|||
49087854|NCT03096314|158157741|FG001|Screened Vitamin D Deficient|Lost to Follow-up|12|||
49087855|NCT02512302|158157744|FG000|Period 1|Adverse Event|0|||
49087856|NCT02512302|158157745|FG001|Period 1|Adverse Event|1|||
49087857|NCT02512302|158157746|FG002|Period 1|Adverse Event|0|||
49087858|NCT02512302|158157747|FG003|Period 1|Adverse Event|0|||
49087859|NCT02512302|158157748|FG004|Period 1|Adverse Event|0|||
49087860|NCT02512302|158157749|FG005|Period 1|Adverse Event|0|||
49087861|NCT02512302|158157750|FG006|Period 1|Adverse Event|0|||
49087862|NCT02512302|158157751|FG007|Period 1|Adverse Event|0|||
49087863|NCT02512302|158157752|FG008|Period 1|Adverse Event|0|||
49087864|NCT02512302|158157753|FG009|Period 1|Adverse Event|0|||
49087865|NCT02512302|158157744|FG000|Period 2|Adverse Event|0|||
49087866|NCT02512302|158157745|FG001|Period 2|Adverse Event|0|||
49087867|NCT02512302|158157746|FG002|Period 2|Adverse Event|0|||
49087868|NCT02512302|158157747|FG003|Period 2|Adverse Event|0|||
49087869|NCT02512302|158157748|FG004|Period 2|Adverse Event|0|||
49087870|NCT02512302|158157749|FG005|Period 2|Adverse Event|0|||
49087871|NCT02512302|158157750|FG006|Period 2|Adverse Event|0|||
49087872|NCT02512302|158157751|FG007|Period 2|Adverse Event|0|||
49087873|NCT02512302|158157752|FG008|Period 2|Adverse Event|0|||
49087874|NCT02512302|158157753|FG009|Period 2|Adverse Event|1|||
49087875|NCT02512302|158157744|FG000|Period 3|Lost to Follow-up|0|||
49087876|NCT02512302|158157745|FG001|Period 3|Lost to Follow-up|0|||
49087877|NCT02512302|158157746|FG002|Period 3|Lost to Follow-up|1|||
49087878|NCT02512302|158157747|FG003|Period 3|Lost to Follow-up|0|||
49087879|NCT02512302|158157748|FG004|Period 3|Lost to Follow-up|0|||
49087880|NCT02512302|158157749|FG005|Period 3|Lost to Follow-up|0|||
49087881|NCT02512302|158157750|FG006|Period 3|Lost to Follow-up|0|||
49087882|NCT02512302|158157751|FG007|Period 3|Lost to Follow-up|0|||
49087883|NCT02512302|158157752|FG008|Period 3|Lost to Follow-up|0|||
49087884|NCT02512302|158157753|FG009|Period 3|Lost to Follow-up|0|||
49087885|NCT02512302|158157744|FG000|Period 4|Adverse Event|0|||
49087886|NCT02512302|158157745|FG001|Period 4|Adverse Event|0|||
49087887|NCT02512302|158157746|FG002|Period 4|Adverse Event|0|||
49087888|NCT02512302|158157747|FG003|Period 4|Adverse Event|0|||
49087889|NCT02512302|158157748|FG004|Period 4|Adverse Event|0|||
49087890|NCT02512302|158157749|FG005|Period 4|Adverse Event|0|||
49087891|NCT02512302|158157750|FG006|Period 4|Adverse Event|1|||
49087892|NCT02512302|158157751|FG007|Period 4|Adverse Event|0|||
49087893|NCT02512302|158157752|FG008|Period 4|Adverse Event|0|||
49087894|NCT02512302|158157753|FG009|Period 4|Adverse Event|0|||
49087895|NCT04570670|158157761|FG000|Overall Study|Withdrawal by Subject|1|||
49087896|NCT04570670|158157762|FG001|Overall Study|Withdrawal by Subject|0|||
49087897|NCT01790984|158157770|FG000|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
49087898|NCT01790984|158157771|FG001|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
49087899|NCT01790984|158157772|FG002|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
49087900|NCT01790984|158157773|FG003|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
49087901|NCT03187301|158157774|FG000|Titration Period|Adverse Event|0|||
49087902|NCT03187301|158157775|FG001|Titration Period|Adverse Event|0|||
49087903|NCT03187301|158157776|FG002|Titration Period|Adverse Event|0|||
49087904|NCT03187301|158157777|FG003|Titration Period|Adverse Event|0|||
49087905|NCT03187301|158157778|FG004|Titration Period|Adverse Event|0|||
49087906|NCT03187301|158157779|FG005|Titration Period|Adverse Event|0|||
49087907|NCT03187301|158157780|FG006|Titration Period|Adverse Event|5|||
49087908|NCT03187301|158157774|FG000|Titration Period|Withdrawal by Subject|0|||
49087909|NCT03187301|158157775|FG001|Titration Period|Withdrawal by Subject|0|||
49087910|NCT03187301|158157776|FG002|Titration Period|Withdrawal by Subject|0|||
49087911|NCT03187301|158157777|FG003|Titration Period|Withdrawal by Subject|0|||
49087912|NCT03187301|158157778|FG004|Titration Period|Withdrawal by Subject|0|||
49087913|NCT03187301|158157779|FG005|Titration Period|Withdrawal by Subject|0|||
49087914|NCT03187301|158157780|FG006|Titration Period|Withdrawal by Subject|1|||
49087915|NCT03187301|158157774|FG000|Titration Period|Exclusion Criteria Met|0|||
49087916|NCT03187301|158157775|FG001|Titration Period|Exclusion Criteria Met|0|||
49087917|NCT03187301|158157776|FG002|Titration Period|Exclusion Criteria Met|0|||
49087918|NCT03187301|158157777|FG003|Titration Period|Exclusion Criteria Met|0|||
49087919|NCT03187301|158157778|FG004|Titration Period|Exclusion Criteria Met|0|||
49087920|NCT03187301|158157779|FG005|Titration Period|Exclusion Criteria Met|0|||
49087921|NCT03187301|158157780|FG006|Titration Period|Exclusion Criteria Met|1|||
49087922|NCT03187301|158157774|FG000|Pre-Intervention|Withdrawal by Subject|1|||
49087923|NCT03187301|158157775|FG001|Pre-Intervention|Withdrawal by Subject|0|||
49087924|NCT03187301|158157776|FG002|Pre-Intervention|Withdrawal by Subject|0|||
49087925|NCT03187301|158157777|FG003|Pre-Intervention|Withdrawal by Subject|0|||
49087926|NCT03187301|158157778|FG004|Pre-Intervention|Withdrawal by Subject|0|||
49087927|NCT03187301|158157779|FG005|Pre-Intervention|Withdrawal by Subject|0|||
49087928|NCT03187301|158157780|FG006|Pre-Intervention|Withdrawal by Subject|0|||
49087929|NCT03313180|158157788|FG000|Overall Study|Adverse Event|120|||
49087930|NCT03313180|158157788|FG000|Overall Study|Lost to Follow-up|3|||
49087931|NCT03313180|158157788|FG000|Overall Study|Withdrawal by Subject|39|||
49087932|NCT03313180|158157788|FG000|Overall Study|Other than listed above|15|||
49087933|NCT03313180|158157788|FG000|Overall Study|Covid-19 related|2|||
49087934|NCT01966120|158157789|FG000|Overall Study|Withdrawal by Subject|0|||
49087935|NCT01966120|158157790|FG001|Overall Study|Withdrawal by Subject|5|||
49087936|NCT01966120|158157789|FG000|Overall Study|Lost to Follow-up|1|||
49087937|NCT01966120|158157790|FG001|Overall Study|Lost to Follow-up|1|||
49087938|NCT03335475|158157792|FG000|Overall Study|Did not wear accelerometer|4|||
49087939|NCT03335475|158157793|FG001|Overall Study|Did not wear accelerometer|0|||
49087940|NCT03335475|158157792|FG000|Overall Study|Withdrawal by Subject|0|||
49087941|NCT03335475|158157793|FG001|Overall Study|Withdrawal by Subject|1|||
49087942|NCT01058642|158157794|FG000|Treatment Period 1|Adverse Event|0|||
49087943|NCT01058642|158157795|FG001|Treatment Period 1|Adverse Event|1|||
49087944|NCT01058642|158157796|FG002|Treatment Period 1|Adverse Event|1|||
49087945|NCT01058642|158157797|FG003|Treatment Period 1|Adverse Event|0|||
49087946|NCT01058642|158157794|FG000|Treatment Period 1|Physician Decision|0|||
49087947|NCT01058642|158157795|FG001|Treatment Period 1|Physician Decision|0|||
49087948|NCT01058642|158157796|FG002|Treatment Period 1|Physician Decision|1|||
49087949|NCT01058642|158157797|FG003|Treatment Period 1|Physician Decision|0|||
49087950|NCT01058642|158157794|FG000|Treatment Period 1|Withdrawal by Subject|1|||
49087951|NCT01058642|158157795|FG001|Treatment Period 1|Withdrawal by Subject|0|||
49087952|NCT01058642|158157796|FG002|Treatment Period 1|Withdrawal by Subject|0|||
49087953|NCT01058642|158157797|FG003|Treatment Period 1|Withdrawal by Subject|0|||
49087954|NCT01058642|158157794|FG000|Treatment Period 1|Lack of Efficacy|0|||
49087955|NCT01058642|158157795|FG001|Treatment Period 1|Lack of Efficacy|0|||
49087956|NCT01058642|158157796|FG002|Treatment Period 1|Lack of Efficacy|0|||
49087957|NCT01058642|158157797|FG003|Treatment Period 1|Lack of Efficacy|1|||
49087958|NCT01058642|158157794|FG000|Treatment Period 1|Protocol Violation|0|||
49087959|NCT01058642|158157795|FG001|Treatment Period 1|Protocol Violation|0|||
49087960|NCT01058642|158157796|FG002|Treatment Period 1|Protocol Violation|0|||
49087961|NCT01058642|158157797|FG003|Treatment Period 1|Protocol Violation|1|||
49087962|NCT01058642|158157794|FG000|Treatment Period 1|Lack of Compliance with Study Drug|1|||
49087963|NCT01058642|158157795|FG001|Treatment Period 1|Lack of Compliance with Study Drug|0|||
49087964|NCT01058642|158157796|FG002|Treatment Period 1|Lack of Compliance with Study Drug|0|||
49087965|NCT01058642|158157797|FG003|Treatment Period 1|Lack of Compliance with Study Drug|0|||
49087966|NCT04498182|158157800|FG000|Overall Study|Adverse Event|2|||
49087967|NCT04498182|158157801|FG001|Overall Study|Adverse Event|3|||
49087968|NCT04498182|158157802|FG002|Overall Study|Adverse Event|2|||
49087969|NCT04498182|158157800|FG000|Overall Study|Withdrawal of Consent|3|||
49087970|NCT04498182|158157801|FG001|Overall Study|Withdrawal of Consent|4|||
49087971|NCT04498182|158157802|FG002|Overall Study|Withdrawal of Consent|3|||
49087972|NCT04498182|158157800|FG000|Overall Study|Non-Compliant|1|||
49087973|NCT04498182|158157801|FG001|Overall Study|Non-Compliant|0|||
49087974|NCT04498182|158157802|FG002|Overall Study|Non-Compliant|1|||
49087975|NCT04498182|158157800|FG000|Overall Study|Lost to Follow-up|0|||
49087976|NCT04498182|158157801|FG001|Overall Study|Lost to Follow-up|0|||
49087977|NCT04498182|158157802|FG002|Overall Study|Lost to Follow-up|1|||
49087978|NCT04498182|158157800|FG000|Overall Study|Investigator Decision|0|||
49087979|NCT04498182|158157801|FG001|Overall Study|Investigator Decision|0|||
49087980|NCT04498182|158157802|FG002|Overall Study|Investigator Decision|1|||
49087981|NCT04498182|158157800|FG000|Overall Study|Protocol Violation|1|||
49087982|NCT04498182|158157801|FG001|Overall Study|Protocol Violation|0|||
49087983|NCT04498182|158157802|FG002|Overall Study|Protocol Violation|2|||
49087984|NCT01704495|158157803|FG000|Subjects Randomized|Other Reason|3|||
49087985|NCT01704495|158157804|FG001|Subjects Randomized|Other Reason|2|||
49087986|NCT01704495|158157805|FG002|Subjects Randomized|Other Reason|3|||
49087987|NCT01704495|158157806|FG003|Subjects Randomized|Other Reason|2|||
49087988|NCT01704495|158157803|FG000|Subjects Randomized|Discontinuation criteria met|4|||
49087989|NCT01704495|158157804|FG001|Subjects Randomized|Discontinuation criteria met|2|||
49087990|NCT01704495|158157805|FG002|Subjects Randomized|Discontinuation criteria met|2|||
49087991|NCT01704495|158157806|FG003|Subjects Randomized|Discontinuation criteria met|0|||
49087992|NCT01704495|158157803|FG000|Subjects Randomized|Adverse Event|8|||
49087993|NCT01704495|158157804|FG001|Subjects Randomized|Adverse Event|2|||
49087994|NCT01704495|158157805|FG002|Subjects Randomized|Adverse Event|0|||
49087995|NCT01704495|158157806|FG003|Subjects Randomized|Adverse Event|7|||
49087996|NCT01704495|158157803|FG000|Subjects Randomized|Withdrawal by Subject|5|||
49087997|NCT01704495|158157804|FG001|Subjects Randomized|Withdrawal by Subject|5|||
49087998|NCT01704495|158157805|FG002|Subjects Randomized|Withdrawal by Subject|5|||
49087999|NCT01704495|158157806|FG003|Subjects Randomized|Withdrawal by Subject|5|||
49088000|NCT01704495|158157803|FG000|Subjects Randomized|Protocol Violation|1|||
49088001|NCT01704495|158157804|FG001|Subjects Randomized|Protocol Violation|1|||
49088002|NCT01704495|158157805|FG002|Subjects Randomized|Protocol Violation|2|||
49088003|NCT01704495|158157806|FG003|Subjects Randomized|Protocol Violation|0|||
49088004|NCT01704495|158157803|FG000|Subjects Randomized|Eligibility criteria not fulfilled|1|||
49088005|NCT01704495|158157804|FG001|Subjects Randomized|Eligibility criteria not fulfilled|3|||
49088006|NCT01704495|158157805|FG002|Subjects Randomized|Eligibility criteria not fulfilled|4|||
49088007|NCT01704495|158157806|FG003|Subjects Randomized|Eligibility criteria not fulfilled|3|||
49088008|NCT01704495|158157803|FG000|Optional Safety Extension|Adverse Event|0|||
49088009|NCT01704495|158157804|FG001|Optional Safety Extension|Adverse Event|4|||
49088010|NCT01704495|158157805|FG002|Optional Safety Extension|Adverse Event|0|||
49088011|NCT01704495|158157806|FG003|Optional Safety Extension|Adverse Event|1|||
49088012|NCT01704495|158157803|FG000|Optional Safety Extension|Other reason|27|||
49088013|NCT01704495|158157804|FG001|Optional Safety Extension|Other reason|29|||
49088014|NCT01704495|158157805|FG002|Optional Safety Extension|Other reason|30|||
49088015|NCT01704495|158157806|FG003|Optional Safety Extension|Other reason|28|||
49088016|NCT01704495|158157803|FG000|Optional Safety Extension|Withdrawal by Subject|2|||
49088017|NCT01704495|158157804|FG001|Optional Safety Extension|Withdrawal by Subject|0|||
49088018|NCT01704495|158157805|FG002|Optional Safety Extension|Withdrawal by Subject|1|||
49088019|NCT01704495|158157806|FG003|Optional Safety Extension|Withdrawal by Subject|2|||
49088020|NCT01256450|158157807|FG000|Open-label Titration|Adverse Event|39|||
49088021|NCT01256450|158157808|FG001|Open-label Titration|Adverse Event|0|||
49088022|NCT01256450|158157809|FG002|Open-label Titration|Adverse Event|0|||
49088023|NCT01256450|158157807|FG000|Open-label Titration|Lost to Follow-up|7|||
49088024|NCT01256450|158157808|FG001|Open-label Titration|Lost to Follow-up|0|||
49088025|NCT01256450|158157809|FG002|Open-label Titration|Lost to Follow-up|0|||
49088026|NCT01256450|158157807|FG000|Open-label Titration|Lack of analgesic effect|30|||
49088027|NCT01256450|158157808|FG001|Open-label Titration|Lack of analgesic effect|0|||
49088028|NCT01256450|158157809|FG002|Open-label Titration|Lack of analgesic effect|0|||
49088029|NCT01256450|158157807|FG000|Open-label Titration|Non-compliance|9|||
49088030|NCT01256450|158157808|FG001|Open-label Titration|Non-compliance|0|||
49088031|NCT01256450|158157809|FG002|Open-label Titration|Non-compliance|0|||
49088032|NCT01256450|158157807|FG000|Open-label Titration|Screen failure|1|||
49088033|NCT01256450|158157808|FG001|Open-label Titration|Screen failure|0|||
49088034|NCT01256450|158157809|FG002|Open-label Titration|Screen failure|0|||
49088035|NCT01256450|158157807|FG000|Open-label Titration|Other|13|||
49088036|NCT01256450|158157808|FG001|Open-label Titration|Other|0|||
49088037|NCT01256450|158157809|FG002|Open-label Titration|Other|0|||
49088038|NCT01256450|158157807|FG000|Double-blind Treatment|Adverse Event|0|||
49088039|NCT01256450|158157808|FG001|Double-blind Treatment|Adverse Event|8|||
49088040|NCT01256450|158157809|FG002|Double-blind Treatment|Adverse Event|6|||
49088041|NCT01256450|158157807|FG000|Double-blind Treatment|Lost to Follow-up|0|||
49088042|NCT01256450|158157808|FG001|Double-blind Treatment|Lost to Follow-up|1|||
49088043|NCT01256450|158157809|FG002|Double-blind Treatment|Lost to Follow-up|7|||
49088044|NCT01256450|158157807|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
49088045|NCT01256450|158157808|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
49088046|NCT01256450|158157809|FG002|Double-blind Treatment|Withdrawal by Subject|1|||
49088047|NCT01256450|158157807|FG000|Double-blind Treatment|Lack of analgesic effect|0|||
49088048|NCT01256450|158157808|FG001|Double-blind Treatment|Lack of analgesic effect|5|||
49088049|NCT01256450|158157809|FG002|Double-blind Treatment|Lack of analgesic effect|6|||
49088050|NCT01256450|158157807|FG000|Double-blind Treatment|Non-compliance|0|||
49088051|NCT01256450|158157808|FG001|Double-blind Treatment|Non-compliance|5|||
49088052|NCT01256450|158157809|FG002|Double-blind Treatment|Non-compliance|4|||
49088053|NCT01256450|158157807|FG000|Double-blind Treatment|Opioid withdrawal symptoms|0|||
49088054|NCT01256450|158157808|FG001|Double-blind Treatment|Opioid withdrawal symptoms|0|||
49088055|NCT01256450|158157809|FG002|Double-blind Treatment|Opioid withdrawal symptoms|1|||
49088056|NCT01256450|158157807|FG000|Double-blind Treatment|Other|0|||
49088057|NCT01256450|158157808|FG001|Double-blind Treatment|Other|9|||
49088058|NCT01256450|158157809|FG002|Double-blind Treatment|Other|12|||
49088059|NCT02510664|158157811|FG000|Overall Study|Transferred Care|9|||
49088060|NCT02510664|158157812|FG001|Overall Study|Transferred Care|9|||
49088061|NCT02510664|158157813|FG002|Overall Study|Transferred Care|0|||
49088062|NCT02510664|158157811|FG000|Overall Study|Provider Retired/No Time to Reschedule|10|||
49088063|NCT02510664|158157812|FG001|Overall Study|Provider Retired/No Time to Reschedule|10|||
49088064|NCT02510664|158157813|FG002|Overall Study|Provider Retired/No Time to Reschedule|0|||
49088065|NCT02510664|158157811|FG000|Overall Study|Time Constraints|1|||
49088066|NCT02510664|158157812|FG001|Overall Study|Time Constraints|1|||
49088067|NCT02510664|158157813|FG002|Overall Study|Time Constraints|0|||
49088068|NCT02375971|158157814|FG000|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
49088069|NCT02375971|158157815|FG001|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
49088070|NCT02375971|158157816|FG002|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2|||
49088071|NCT02375971|158157814|FG000|Treatment (Day 1 - Baseline)|Physician Decision|1|||
49088072|NCT02375971|158157815|FG001|Treatment (Day 1 - Baseline)|Physician Decision|1|||
49088073|NCT02375971|158157816|FG002|Treatment (Day 1 - Baseline)|Physician Decision|1|||
49088074|NCT02375971|158157814|FG000|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
49088075|NCT02375971|158157815|FG001|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
49088076|NCT02375971|158157816|FG002|Treatment (Day 1 - Baseline)|Lost to Follow-up|1|||
49088077|NCT02375971|158157814|FG000|Treatment (Day 1 - Baseline)|Adverse Event|0|||
49088078|NCT02375971|158157815|FG001|Treatment (Day 1 - Baseline)|Adverse Event|0|||
49088079|NCT02375971|158157816|FG002|Treatment (Day 1 - Baseline)|Adverse Event|1|||
49088080|NCT02375971|158157814|FG000|Follow-Up Phase (up to Day 169)|Adverse Event|1|||
49088081|NCT02375971|158157815|FG001|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
49088082|NCT02375971|158157816|FG002|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
49088083|NCT02375971|158157814|FG000|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
49088084|NCT02375971|158157815|FG001|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0|||
49088085|NCT02375971|158157816|FG002|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
49088086|NCT02375971|158157814|FG000|Follow-Up Phase (up to Day 169)|Death|4|||
49088087|NCT02375971|158157815|FG001|Follow-Up Phase (up to Day 169)|Death|4|||
49088088|NCT02375971|158157816|FG002|Follow-Up Phase (up to Day 169)|Death|4|||
49088089|NCT02375971|158157814|FG000|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
49088090|NCT02375971|158157815|FG001|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
49088091|NCT02375971|158157816|FG002|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0|||
49088092|NCT00679211|158157817|FG000|Overall Study|Progressive disease|82|||
49088093|NCT00679211|158157817|FG000|Overall Study|Adverse Event|7|||
49088094|NCT00679211|158157817|FG000|Overall Study|Withdrawal by Subject|2|||
49088095|NCT00679211|158157817|FG000|Overall Study|Physician Decision|5|||
49088096|NCT00679211|158157817|FG000|Overall Study|Refused to undergo protocol procedures|1|||
49088097|NCT00679211|158157817|FG000|Overall Study|Transferred to extension study TDM4529g|12|||
49088098|NCT00679211|158157817|FG000|Overall Study|Other|1|||
49088099|NCT01051791|158157829|FG000|Overall Study|Failed screening|3|||
49088100|NCT01051791|158157829|FG000|Overall Study|Withdrawal by Subject|1|||
49088101|NCT02841995|158157836|FG000|Overall Study|Disease progression|5|||
49088102|NCT02841995|158157837|FG001|Overall Study|Disease progression|11|||
49088103|NCT02841995|158157838|FG002|Overall Study|Disease progression|8|||
49088104|NCT02841995|158157836|FG000|Overall Study|Withdrawal by Subject|2|||
49088105|NCT02841995|158157837|FG001|Overall Study|Withdrawal by Subject|4|||
49088106|NCT02841995|158157838|FG002|Overall Study|Withdrawal by Subject|4|||
49088107|NCT02841995|158157836|FG000|Overall Study|Adverse Event|2|||
49088108|NCT02841995|158157837|FG001|Overall Study|Adverse Event|0|||
49088109|NCT02841995|158157838|FG002|Overall Study|Adverse Event|1|||
49088110|NCT02841995|158157836|FG000|Overall Study|Investigator decision|2|||
49088111|NCT02841995|158157837|FG001|Overall Study|Investigator decision|0|||
49088112|NCT02841995|158157838|FG002|Overall Study|Investigator decision|1|||
49088113|NCT02841995|158157836|FG000|Overall Study|Death|0|||
49088114|NCT02841995|158157837|FG001|Overall Study|Death|0|||
49088115|NCT02841995|158157838|FG002|Overall Study|Death|2|||
49088116|NCT02841995|158157836|FG000|Overall Study|Noncompliance to protocol|1|||
49088117|NCT02841995|158157837|FG001|Overall Study|Noncompliance to protocol|0|||
49088118|NCT02841995|158157838|FG002|Overall Study|Noncompliance to protocol|0|||
49088119|NCT02841995|158157836|FG000|Overall Study|Sponsor decision|1|||
49088120|NCT02841995|158157837|FG001|Overall Study|Sponsor decision|0|||
49088121|NCT02841995|158157838|FG002|Overall Study|Sponsor decision|0|||
49088122|NCT02841995|158157836|FG000|Overall Study|Other|4|||
49088123|NCT02841995|158157837|FG001|Overall Study|Other|1|||
49088124|NCT02841995|158157838|FG002|Overall Study|Other|5|||
49088125|NCT04387435|158157843|FG000|Overall Study|Physician Decision|1|||
49088126|NCT00594165|158157844|FG000|Overall Study|Major protocol violation|1|||
49088127|NCT00594165|158157844|FG000|Overall Study|Lack of Efficacy|12|||
49088128|NCT00594165|158157844|FG000|Overall Study|Adverse Event|52|||
49088129|NCT00594165|158157844|FG000|Overall Study|Unsatisfactory compliance of subject|6|||
49088130|NCT00594165|158157844|FG000|Overall Study|Subject withdrew consent|27|||
49088131|NCT00594165|158157844|FG000|Overall Study|Study ended per sponsor|102|||
49088132|NCT00594165|158157844|FG000|Overall Study|Lost to Follow-up|4|||
49088133|NCT00594165|158157844|FG000|Overall Study|Other: PI discretion|5|||
49088134|NCT00594165|158157844|FG000|Overall Study|Other: Subject moving|3|||
49088135|NCT00594165|158157844|FG000|Overall Study|Other: Brain surgery controlled symptoms|1|||
49088136|NCT00594165|158157844|FG000|Overall Study|Other: House bound; can't get to clinic|1|||
49088137|NCT00594165|158157844|FG000|Overall Study|Other: Subject enrolled in other trial|1|||
49088138|NCT00594165|158157844|FG000|Overall Study|Other: Site terminated participation|2|||
49088139|NCT04830969|158157845|FG000|Overall Study|Withdrawal by Subject|6|||
49088140|NCT04830969|158157846|FG001|Overall Study|Withdrawal by Subject|2|||
49088141|NCT04830969|158157845|FG000|Overall Study|Protocol Violation|3|||
49088142|NCT04830969|158157846|FG001|Overall Study|Protocol Violation|9|||
49088143|NCT04830969|158157845|FG000|Overall Study|Lost to Follow-up|4|||
49088144|NCT04830969|158157846|FG001|Overall Study|Lost to Follow-up|4|||
49088145|NCT00403481|158157849|FG000|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1|||
49088146|NCT00403481|158157849|FG000|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1|||
49088147|NCT00403481|158157849|FG000|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3|||
49088148|NCT00403481|158157849|FG000|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1|||
49088149|NCT00403481|158157849|FG000|Olm 40 mg|Adverse Event|2|||
49088150|NCT00403481|158157849|FG000|Olm 40 mg|Protocol Violation|1|||
49088151|NCT00403481|158157849|FG000|Olm 40 mg|Withdrawal by Subject|1|||
49088152|NCT00403481|158157849|FG000|Olm 40 mg|Other|1|||
49088153|NCT00403481|158157849|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2|||
49088154|NCT00403481|158157849|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1|||
49088155|NCT00403481|158157849|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1|||
49088156|NCT00403481|158157849|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1|||
49088157|NCT00403481|158157849|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1|||
49088158|NCT00403481|158157849|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
49088159|NCT00634803|158157853|FG000|Overall Study|Lost to Follow-up|6|||
49088160|NCT00634803|158157854|FG001|Overall Study|Lost to Follow-up|7|||
49088161|NCT00634803|158157855|FG002|Overall Study|Lost to Follow-up|7|||
49088162|NCT00931528|158157856|FG000|Overall Study|Protocol Violation|9|||
49088163|NCT00931528|158157857|FG001|Overall Study|Protocol Violation|12|||
49088164|NCT00931528|158157856|FG000|Overall Study|Withdrawal by Subject|4|||
49088165|NCT00931528|158157857|FG001|Overall Study|Withdrawal by Subject|12|||
49088166|NCT00931528|158157856|FG000|Overall Study|Lost to Follow-up|6|||
49088167|NCT00931528|158157857|FG001|Overall Study|Lost to Follow-up|13|||
49088168|NCT00931528|158157856|FG000|Overall Study|Assessment outside of Time Frame|22|||
49088169|NCT00931528|158157857|FG001|Overall Study|Assessment outside of Time Frame|23|||
49088170|NCT00396656|158157859|FG000|First Treatment Period|Withdrawal by Subject|0|||
49088171|NCT00396656|158157860|FG001|First Treatment Period|Withdrawal by Subject|2|||
49088172|NCT00396656|158157859|FG000|Second Treatment Period|Adverse Event|0|||
49088173|NCT00396656|158157860|FG001|Second Treatment Period|Adverse Event|1|||
49088174|NCT02091089|158157861|FG000|Overall Study|Lost to Follow-up|2|||
49088175|NCT02929589|158157862|FG000|Overall Study|Withdrawal by Subject|1|||
49088176|NCT02929589|158157863|FG001|Overall Study|Withdrawal by Subject|0|||
49088177|NCT02929589|158157864|FG002|Overall Study|Withdrawal by Subject|0|||
49088178|NCT02929589|158157865|FG003|Overall Study|Withdrawal by Subject|0|||
49088179|NCT02929589|158157862|FG000|Overall Study|Physician Decision|2|||
49088180|NCT02929589|158157863|FG001|Overall Study|Physician Decision|0|||
49088181|NCT02929589|158157864|FG002|Overall Study|Physician Decision|0|||
49088182|NCT02929589|158157865|FG003|Overall Study|Physician Decision|0|||
49088183|NCT01422889|158157866|FG000|Overall Study|No Data Entered for Study Stent|9|||
49088184|NCT03193853|158157867|FG000|Overall Study|Death|6|||
49088185|NCT01749826|158157868|FG000|Overall Study|Study Terminated|20|||
49088186|NCT01749826|158157869|FG001|Overall Study|Study Terminated|0|||
49088187|NCT00764660|158157870|FG000|Overall Study|Adverse Event|6|||
49088188|NCT00764660|158157871|FG001|Overall Study|Adverse Event|3|||
49088189|NCT00764660|158157870|FG000|Overall Study|Lost to Follow-up|3|||
49088190|NCT00764660|158157871|FG001|Overall Study|Lost to Follow-up|4|||
49088191|NCT00764660|158157870|FG000|Overall Study|Withdrawal by Subject|7|||
49088192|NCT00764660|158157871|FG001|Overall Study|Withdrawal by Subject|3|||
49088193|NCT00764660|158157870|FG000|Overall Study|Noncompliance With Protocol|5|||
49088194|NCT00764660|158157871|FG001|Overall Study|Noncompliance With Protocol|1|||
49088195|NCT00764660|158157870|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
49088196|NCT00764660|158157871|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
49088197|NCT04031846|158157874|FG000|Overall Study|Lost to Follow-up|4|||
49088198|NCT04031846|158157875|FG001|Overall Study|Lost to Follow-up|4|||
49088199|NCT04031846|158157874|FG000|Overall Study|Physician Decision|0|||
49088200|NCT04031846|158157875|FG001|Overall Study|Physician Decision|1|||
49088201|NCT04031846|158157874|FG000|Overall Study|Protocol Violation|1|||
49088202|NCT04031846|158157875|FG001|Overall Study|Protocol Violation|1|||
49088203|NCT04031846|158157874|FG000|Overall Study|Withdrawal By Parent/Guardian|17|||
49088204|NCT04031846|158157875|FG001|Overall Study|Withdrawal By Parent/Guardian|17|||
49088205|NCT00550043|158157876|FG000|Overall Study|Adverse Event|0|||
49088206|NCT00550043|158157877|FG001|Overall Study|Adverse Event|0|||
49088207|NCT00550043|158157878|FG002|Overall Study|Adverse Event|0|||
49088208|NCT00550043|158157879|FG003|Overall Study|Adverse Event|1|||
49088209|NCT00550043|158157880|FG004|Overall Study|Adverse Event|1|||
49088210|NCT00550043|158157876|FG000|Overall Study|Subject Withdrew Consent|0|||
49088211|NCT00550043|158157877|FG001|Overall Study|Subject Withdrew Consent|2|||
49088212|NCT00550043|158157878|FG002|Overall Study|Subject Withdrew Consent|1|||
49088213|NCT00550043|158157879|FG003|Overall Study|Subject Withdrew Consent|0|||
49088214|NCT00550043|158157880|FG004|Overall Study|Subject Withdrew Consent|0|||
49088215|NCT00550043|158157876|FG000|Overall Study|Other Reasons- Unspecified|0|||
49088216|NCT00550043|158157877|FG001|Overall Study|Other Reasons- Unspecified|1|||
49088217|NCT00550043|158157878|FG002|Overall Study|Other Reasons- Unspecified|0|||
49088218|NCT00550043|158157879|FG003|Overall Study|Other Reasons- Unspecified|1|||
49088219|NCT00550043|158157880|FG004|Overall Study|Other Reasons- Unspecified|0|||
49088220|NCT04021914|158159240|FG000|Overall Study|Did not meet inclusion criteria on confirmatory testing|1|||
49088221|NCT02525783|158159241|FG000|Overall Study|Lost to Follow-up|10|||
49088222|NCT01401361|158159242|FG000|Overall Study|Withdrawal by Subject|16|||
49088223|NCT01401361|158159242|FG000|Overall Study|Lack of Efficacy|6|||
49088224|NCT01401361|158159242|FG000|Overall Study|Physician Decision|1|||
49088225|NCT01401361|158159242|FG000|Overall Study|Lost to Follow-up|3|||
49088226|NCT01401361|158159242|FG000|Overall Study|Subject/family decision post procedure|2|||
49088227|NCT00611923|158159245|FG000|Overall Study|Withdrawal by Subject|2|||
49088228|NCT00611923|158159246|FG001|Overall Study|Withdrawal by Subject|2|||
49088229|NCT00866281|158159247|FG000|Overall Study|Adverse Event|1|||
49088230|NCT00866281|158159248|FG001|Overall Study|Adverse Event|0|||
49088231|NCT00866281|158159247|FG000|Overall Study|Withdrawal by participants|3|||
49088232|NCT00866281|158159248|FG001|Overall Study|Withdrawal by participants|0|||
49088233|NCT00866281|158159247|FG000|Overall Study|Disease progression|3|||
49088234|NCT00866281|158159248|FG001|Overall Study|Disease progression|11|||
49088235|NCT00866281|158159247|FG000|Overall Study|New cancer therapy|0|||
49088236|NCT00866281|158159248|FG001|Overall Study|New cancer therapy|4|||
49088237|NCT01894841|158159249|FG000|Overall Study|Withdrawal by Subject|9|||
49088238|NCT01894841|158159250|FG001|Overall Study|Withdrawal by Subject|4|||
49088239|NCT01894841|158159249|FG000|Overall Study|Withdrawn by investigator|2|||
49088240|NCT01894841|158159250|FG001|Overall Study|Withdrawn by investigator|2|||
49088241|NCT01894841|158159249|FG000|Overall Study|Lost to Follow-up|7|||
49088242|NCT01894841|158159250|FG001|Overall Study|Lost to Follow-up|3|||
49088243|NCT01100086|158159251|FG000|Period 1|Withdrawal by Subject|1|||
49088244|NCT01100086|158159252|FG001|Period 1|Withdrawal by Subject|0|||
49088245|NCT00471822|158159253|FG000|Overall Study|Protocol Violation|2|||
49088246|NCT00529087|158159254|FG000|Overall Study|Adverse Event|10|||
49088247|NCT00529087|158159255|FG001|Overall Study|Adverse Event|13|||
49088248|NCT00529087|158159256|FG002|Overall Study|Adverse Event|4|||
49088249|NCT00529087|158159254|FG000|Overall Study|Lost to Follow-up|6|||
49088250|NCT00529087|158159255|FG001|Overall Study|Lost to Follow-up|4|||
49088251|NCT00529087|158159256|FG002|Overall Study|Lost to Follow-up|1|||
49088252|NCT00529087|158159254|FG000|Overall Study|Protocol Violation|8|||
49088253|NCT00529087|158159255|FG001|Overall Study|Protocol Violation|7|||
49088254|NCT00529087|158159256|FG002|Overall Study|Protocol Violation|6|||
49088255|NCT00529087|158159254|FG000|Overall Study|Withdrawal by Subject|3|||
49088256|NCT00529087|158159255|FG001|Overall Study|Withdrawal by Subject|3|||
49088257|NCT00529087|158159256|FG002|Overall Study|Withdrawal by Subject|3|||
49088258|NCT00529087|158159254|FG000|Overall Study|Protocol deviation|1|||
49088259|NCT00529087|158159255|FG001|Overall Study|Protocol deviation|1|||
49088260|NCT00529087|158159256|FG002|Overall Study|Protocol deviation|2|||
49088261|NCT02172664|158159259|FG000|Overall Study|Lost to Follow-up|4|||
49088262|NCT02172664|158159260|FG001|Overall Study|Lost to Follow-up|4|||
49088263|NCT02172664|158159259|FG000|Overall Study|Death|1|||
49088264|NCT02172664|158159260|FG001|Overall Study|Death|1|||
49088265|NCT02172664|158159259|FG000|Overall Study|Moved out of area|1|||
49088266|NCT02172664|158159260|FG001|Overall Study|Moved out of area|1|||
49088267|NCT00739661|158159261|FG000|Overall Study|Adverse Event|2|||
49088268|NCT00739661|158159262|FG001|Overall Study|Adverse Event|0|||
49088269|NCT00739661|158159261|FG000|Overall Study|Physician decision to withdraw patient|1|||
49088270|NCT00739661|158159262|FG001|Overall Study|Physician decision to withdraw patient|0|||
49088271|NCT00739661|158159261|FG000|Overall Study|Patient decision to withdraw|9|||
49088272|NCT00739661|158159262|FG001|Overall Study|Patient decision to withdraw|4|||
49088273|NCT00739661|158159261|FG000|Overall Study|Disease progression, radiographic|33|||
49088274|NCT00739661|158159262|FG001|Overall Study|Disease progression, radiographic|37|||
49088275|NCT00739661|158159261|FG000|Overall Study|Reason for discontinuation not available|1|||
49088276|NCT00739661|158159262|FG001|Overall Study|Reason for discontinuation not available|1|||
49088277|NCT01346696|158159263|FG000|Overall Study|Death|1|||
49088278|NCT04630002|158159265|FG000|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
49088279|NCT04630002|158159266|FG001|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
49088280|NCT04630002|158159267|FG002|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
49088281|NCT04630002|158159265|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|1|||
49088282|NCT04630002|158159266|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
49088283|NCT04630002|158159267|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
49088284|NCT04630002|158159265|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
49088285|NCT04630002|158159266|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
49088286|NCT04630002|158159267|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
49088287|NCT04630002|158159265|FG000|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
49088288|NCT04630002|158159266|FG001|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
49088289|NCT04630002|158159267|FG002|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
49088290|NCT04630002|158159265|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
49088291|NCT04630002|158159266|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|2|||
49088292|NCT04630002|158159267|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
49088293|NCT04630002|158159265|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
49088294|NCT04630002|158159266|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
49088295|NCT04630002|158159267|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
49088296|NCT04630002|158159265|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
49088297|NCT04630002|158159266|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
49088298|NCT04630002|158159267|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|1|||
49088299|NCT04630002|158159265|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
49088300|NCT04630002|158159266|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
49088301|NCT04630002|158159267|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|1|||
49088302|NCT00839800|158159268|FG000|Overall Study|Adverse Event|8|||
49088303|NCT00839800|158159269|FG001|Overall Study|Adverse Event|12|||
49088304|NCT00839800|158159268|FG000|Overall Study|Lost to Follow-up|31|||
49088305|NCT00839800|158159269|FG001|Overall Study|Lost to Follow-up|26|||
49088306|NCT00839800|158159268|FG000|Overall Study|Withdrawal by Subject|28|||
49088307|NCT00839800|158159269|FG001|Overall Study|Withdrawal by Subject|34|||
49088308|NCT00839800|158159268|FG000|Overall Study|Incorrect Enrolment|3|||
49088309|NCT00839800|158159269|FG001|Overall Study|Incorrect Enrolment|3|||
49088310|NCT00839800|158159268|FG000|Overall Study|Study-Specific Discontinuation Criteria|6|||
49088311|NCT00839800|158159269|FG001|Overall Study|Study-Specific Discontinuation Criteria|13|||
49088312|NCT00839800|158159268|FG000|Overall Study|Safety Reasons|2|||
49088313|NCT00839800|158159269|FG001|Overall Study|Safety Reasons|1|||
49088314|NCT00839800|158159268|FG000|Overall Study|Other|8|||
49088315|NCT00839800|158159269|FG001|Overall Study|Other|14|||
49088316|NCT00839800|158159268|FG000|Overall Study|Severe Non-Compliance to Protocol|7|||
49088317|NCT00839800|158159269|FG001|Overall Study|Severe Non-Compliance to Protocol|7|||
49088318|NCT02182843|158159278|FG000|Overall Study|Withdrawal by Subject|7|||
49088319|NCT02182843|158159278|FG000|Overall Study|Lost to Follow-up|2|||
49088320|NCT02182843|158159278|FG000|Overall Study|Adverse Event|1|||
49088321|NCT00288626|158159281|FG000|Overall Study|Death|3|||
49088322|NCT00288626|158159281|FG000|Overall Study|Withdrawal by Subject|4|||
49088323|NCT04578457|158159286|FG000|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2|||
49088324|NCT04578457|158159286|FG000|Hearing Aid With NR (1)|Withdrawal by Subject|2|||
49088325|NCT04578457|158159286|FG000|Hearing Aid With NR (2)|Withdrawal by Subject|2|||
49088326|NCT04578457|158159286|FG000|Hearing Aid With NR (4)|Withdrawal by Subject|2|||
49088327|NCT00832455|158159287|FG000|Overall Study|Adverse Event|13|||
49088328|NCT00832455|158159287|FG000|Overall Study|Lost to Follow-up|26|||
49088329|NCT00832455|158159287|FG000|Overall Study|Protocol Violation|4|||
49088330|NCT00832455|158159287|FG000|Overall Study|Withdrawal by Subject|17|||
49088331|NCT00832455|158159287|FG000|Overall Study|Screening Failure|2|||
49088332|NCT00832455|158159287|FG000|Overall Study|Stopped Medication|4|||
49088333|NCT00832455|158159287|FG000|Overall Study|Parent misunderstood study|1|||
49088334|NCT00832455|158159287|FG000|Overall Study|Parent dissatisfied|1|||
49088335|NCT00832455|158159287|FG000|Overall Study|No improvement|3|||
49088336|NCT00832455|158159287|FG000|Overall Study|Patient moved|1|||
49088337|NCT04013672|158159289|FG000|Overall Study|Withdrawal by Subject|3|||
49088338|NCT04013672|158159290|FG001|Overall Study|Withdrawal by Subject|0|||
49088339|NCT04013672|158159289|FG000|Overall Study|Death|1|||
49088340|NCT04013672|158159290|FG001|Overall Study|Death|0|||
49088341|NCT04013672|158159289|FG000|Overall Study|Physician Decision|5|||
49088342|NCT04013672|158159290|FG001|Overall Study|Physician Decision|0|||
49088343|NCT03809663|158159291|FG000|Overall Study|Decision by sponsor|24|||
49088344|NCT03809663|158159292|FG001|Overall Study|Decision by sponsor|18|||
49088345|NCT03809663|158159293|FG002|Overall Study|Decision by sponsor|20|||
49088346|NCT03809663|158159294|FG003|Overall Study|Decision by sponsor|20|||
49088347|NCT03809663|158159295|FG004|Overall Study|Decision by sponsor|0|||
49088348|NCT03809663|158159296|FG005|Overall Study|Decision by sponsor|0|||
49088349|NCT03809663|158159291|FG000|Overall Study|Withdrawal by Subject|26|||
49088350|NCT03809663|158159292|FG001|Overall Study|Withdrawal by Subject|22|||
49088351|NCT03809663|158159293|FG002|Overall Study|Withdrawal by Subject|27|||
49088352|NCT03809663|158159294|FG003|Overall Study|Withdrawal by Subject|26|||
49088353|NCT03809663|158159295|FG004|Overall Study|Withdrawal by Subject|0|||
49088354|NCT03809663|158159296|FG005|Overall Study|Withdrawal by Subject|0|||
49088355|NCT03809663|158159291|FG000|Overall Study|Lost to Follow-up|1|||
49088356|NCT03809663|158159292|FG001|Overall Study|Lost to Follow-up|4|||
49088357|NCT03809663|158159293|FG002|Overall Study|Lost to Follow-up|1|||
49088358|NCT03809663|158159294|FG003|Overall Study|Lost to Follow-up|1|||
49088359|NCT03809663|158159295|FG004|Overall Study|Lost to Follow-up|0|||
49088360|NCT03809663|158159296|FG005|Overall Study|Lost to Follow-up|0|||
49088361|NCT02755103|158159303|FG000|Overall Study|Lost to Follow-up|17|||
49088362|NCT02755103|158159304|FG001|Overall Study|Lost to Follow-up|15|||
49088363|NCT02755103|158159303|FG000|Overall Study|Death|0|||
49088364|NCT02755103|158159304|FG001|Overall Study|Death|1|||
49088365|NCT02755103|158159303|FG000|Overall Study|Physician Decision|0|||
49088366|NCT02755103|158159304|FG001|Overall Study|Physician Decision|1|||
49088367|NCT02755103|158159303|FG000|Overall Study|Pregnancy|0|||
49088368|NCT02755103|158159304|FG001|Overall Study|Pregnancy|1|||
49088369|NCT02755103|158159303|FG000|Overall Study|Withdrawal by Subject|3|||
49088370|NCT02755103|158159304|FG001|Overall Study|Withdrawal by Subject|0|||
49088371|NCT02275819|158159309|FG000|Overall Study|Adverse Event|0|||
49088372|NCT02275819|158159310|FG001|Overall Study|Adverse Event|1|||
49088373|NCT01730053|158159314|FG000|Overall Study|Participant moved|0|||
49088374|NCT01730053|158159315|FG001|Overall Study|Participant moved|0|||
49088375|NCT01730053|158159316|FG002|Overall Study|Participant moved|1|||
49088376|NCT01730053|158159317|FG003|Overall Study|Participant moved|0|||
49088377|NCT01730053|158159318|FG004|Overall Study|Participant moved|0|||
49088378|NCT01730053|158159319|FG005|Overall Study|Participant moved|0|||
49088379|NCT01730053|158159314|FG000|Overall Study|Physician Decision|0|||
49088380|NCT01730053|158159315|FG001|Overall Study|Physician Decision|0|||
49088381|NCT01730053|158159316|FG002|Overall Study|Physician Decision|0|||
49088382|NCT01730053|158159317|FG003|Overall Study|Physician Decision|1|||
49088383|NCT01730053|158159318|FG004|Overall Study|Physician Decision|0|||
49088384|NCT01730053|158159319|FG005|Overall Study|Physician Decision|0|||
49088385|NCT01730053|158159314|FG000|Overall Study|Adverse Event|2|||
49088386|NCT01730053|158159315|FG001|Overall Study|Adverse Event|6|||
49088387|NCT01730053|158159316|FG002|Overall Study|Adverse Event|3|||
49088388|NCT01730053|158159317|FG003|Overall Study|Adverse Event|3|||
49088389|NCT01730053|158159318|FG004|Overall Study|Adverse Event|2|||
49088390|NCT01730053|158159319|FG005|Overall Study|Adverse Event|2|||
49088391|NCT01730053|158159314|FG000|Overall Study|Poor compliance to protocol|1|||
49088392|NCT01730053|158159315|FG001|Overall Study|Poor compliance to protocol|2|||
49088393|NCT01730053|158159316|FG002|Overall Study|Poor compliance to protocol|2|||
49088394|NCT01730053|158159317|FG003|Overall Study|Poor compliance to protocol|0|||
49088395|NCT01730053|158159318|FG004|Overall Study|Poor compliance to protocol|0|||
49088396|NCT01730053|158159319|FG005|Overall Study|Poor compliance to protocol|2|||
49088397|NCT01730053|158159314|FG000|Overall Study|Other than specified|2|||
49088398|NCT01730053|158159315|FG001|Overall Study|Other than specified|6|||
49088399|NCT01730053|158159316|FG002|Overall Study|Other than specified|5|||
49088400|NCT01730053|158159317|FG003|Overall Study|Other than specified|4|||
49088401|NCT01730053|158159318|FG004|Overall Study|Other than specified|7|||
49088402|NCT01730053|158159319|FG005|Overall Study|Other than specified|9|||
49088403|NCT02343939|158159320|FG000|Overall Study|Death|0|||
49088404|NCT02343939|158159321|FG001|Overall Study|Death|15|||
49088405|NCT02343939|158159322|FG002|Overall Study|Death|4|||
49088406|NCT02343939|158159323|FG003|Overall Study|Death|2|||
49088407|NCT02343939|158159324|FG004|Overall Study|Death|5|||
49088408|NCT02343939|158159325|FG005|Overall Study|Death|11|||
49088409|NCT02343939|158159326|FG006|Overall Study|Death|8|||
49088410|NCT02343939|158159327|FG007|Overall Study|Death|22|||
49088411|NCT02343939|158159328|FG008|Overall Study|Death|1|||
49088412|NCT02343939|158159320|FG000|Overall Study|Study terminated by sponsor|0|||
49088413|NCT02343939|158159321|FG001|Overall Study|Study terminated by sponsor|27|||
49088414|NCT02343939|158159322|FG002|Overall Study|Study terminated by sponsor|0|||
49088415|NCT02343939|158159323|FG003|Overall Study|Study terminated by sponsor|1|||
49088416|NCT02343939|158159324|FG004|Overall Study|Study terminated by sponsor|1|||
49088417|NCT02343939|158159325|FG005|Overall Study|Study terminated by sponsor|5|||
49088418|NCT02343939|158159326|FG006|Overall Study|Study terminated by sponsor|3|||
49088419|NCT02343939|158159327|FG007|Overall Study|Study terminated by sponsor|4|||
49088420|NCT02343939|158159328|FG008|Overall Study|Study terminated by sponsor|0|||
49088421|NCT02343939|158159320|FG000|Overall Study|Withdrew consent|3|||
49088422|NCT02343939|158159321|FG001|Overall Study|Withdrew consent|6|||
49088423|NCT02343939|158159322|FG002|Overall Study|Withdrew consent|1|||
49088424|NCT02343939|158159323|FG003|Overall Study|Withdrew consent|2|||
49088425|NCT02343939|158159324|FG004|Overall Study|Withdrew consent|2|||
49088426|NCT02343939|158159325|FG005|Overall Study|Withdrew consent|0|||
49088427|NCT02343939|158159326|FG006|Overall Study|Withdrew consent|0|||
49088428|NCT02343939|158159327|FG007|Overall Study|Withdrew consent|8|||
49088429|NCT02343939|158159328|FG008|Overall Study|Withdrew consent|6|||
49088430|NCT02343939|158159320|FG000|Overall Study|Treatment failure|0|||
49088431|NCT02343939|158159321|FG001|Overall Study|Treatment failure|0|||
49088432|NCT02343939|158159322|FG002|Overall Study|Treatment failure|0|||
49088433|NCT02343939|158159323|FG003|Overall Study|Treatment failure|0|||
49088434|NCT02343939|158159324|FG004|Overall Study|Treatment failure|0|||
49088435|NCT02343939|158159325|FG005|Overall Study|Treatment failure|0|||
49088436|NCT02343939|158159326|FG006|Overall Study|Treatment failure|2|||
49088437|NCT02343939|158159327|FG007|Overall Study|Treatment failure|1|||
49088438|NCT02343939|158159328|FG008|Overall Study|Treatment failure|0|||
49088439|NCT02343939|158159320|FG000|Overall Study|Investigator's discretion|0|||
49088440|NCT02343939|158159321|FG001|Overall Study|Investigator's discretion|0|||
49088441|NCT02343939|158159322|FG002|Overall Study|Investigator's discretion|0|||
49088442|NCT02343939|158159323|FG003|Overall Study|Investigator's discretion|1|||
49088443|NCT02343939|158159324|FG004|Overall Study|Investigator's discretion|0|||
49088444|NCT02343939|158159325|FG005|Overall Study|Investigator's discretion|0|||
49088445|NCT02343939|158159326|FG006|Overall Study|Investigator's discretion|1|||
49088446|NCT02343939|158159327|FG007|Overall Study|Investigator's discretion|0|||
49088447|NCT02343939|158159328|FG008|Overall Study|Investigator's discretion|0|||
49088448|NCT02343939|158159320|FG000|Overall Study|Adverse Event|0|||
49088449|NCT02343939|158159321|FG001|Overall Study|Adverse Event|0|||
49088450|NCT02343939|158159322|FG002|Overall Study|Adverse Event|0|||
49088451|NCT02343939|158159323|FG003|Overall Study|Adverse Event|0|||
49088452|NCT02343939|158159324|FG004|Overall Study|Adverse Event|0|||
49088453|NCT02343939|158159325|FG005|Overall Study|Adverse Event|1|||
49088454|NCT02343939|158159326|FG006|Overall Study|Adverse Event|0|||
49088455|NCT02343939|158159327|FG007|Overall Study|Adverse Event|0|||
49088456|NCT02343939|158159328|FG008|Overall Study|Adverse Event|0|||
49088457|NCT02343939|158159320|FG000|Overall Study|Never Treated With ENTO|0|||
49088458|NCT02343939|158159321|FG001|Overall Study|Never Treated With ENTO|0|||
49088459|NCT02343939|158159322|FG002|Overall Study|Never Treated With ENTO|0|||
49088460|NCT02343939|158159323|FG003|Overall Study|Never Treated With ENTO|0|||
49088461|NCT02343939|158159324|FG004|Overall Study|Never Treated With ENTO|0|||
49088462|NCT02343939|158159325|FG005|Overall Study|Never Treated With ENTO|0|||
49088463|NCT02343939|158159326|FG006|Overall Study|Never Treated With ENTO|1|||
49088464|NCT02343939|158159327|FG007|Overall Study|Never Treated With ENTO|2|||
49088465|NCT02343939|158159328|FG008|Overall Study|Never Treated With ENTO|0|||
49088466|NCT01441765|158159334|FG000|Overall Study|Death|1|||
49088467|NCT01441765|158159335|FG001|Overall Study|Death|0|||
49088468|NCT00454363|158159336|FG000|Overall Study|Adverse Event|1|||
49088469|NCT00454363|158159337|FG001|Overall Study|Adverse Event|2|||
49088470|NCT00454363|158159336|FG000|Overall Study|Withdrawal prior to 12 weeks treatment|4|||
49088471|NCT00454363|158159337|FG001|Overall Study|Withdrawal prior to 12 weeks treatment|0|||
49088472|NCT00552396|158159346|FG000|Overall Study|protocol withdrawal criteria|3|||
49088473|NCT00552396|158159347|FG001|Overall Study|protocol withdrawal criteria|3|||
49088474|NCT00552396|158159348|FG002|Overall Study|protocol withdrawal criteria|3|||
49088475|NCT00552396|158159349|FG003|Overall Study|protocol withdrawal criteria|6|||
49088476|NCT00552396|158159350|FG004|Overall Study|protocol withdrawal criteria|3|||
49088477|NCT00552396|158159351|FG005|Overall Study|protocol withdrawal criteria|3|||
49088478|NCT00552396|158159352|FG006|Overall Study|protocol withdrawal criteria|9|||
49088479|NCT04185220|158159353|FG000|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|0|||
49088480|NCT04185220|158159354|FG001|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|1|||
49088481|NCT04185220|158159353|FG000|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|0|||
49088482|NCT04185220|158159354|FG001|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|1|||
49088483|NCT02431676|158159356|FG000|Overall Study|no lab obtained|0|||
49088484|NCT02431676|158159357|FG001|Overall Study|no lab obtained|1|||
49088485|NCT02431676|158159358|FG002|Overall Study|no lab obtained|2|||
49088486|NCT00571727|158159359|FG000|Overall Study|Did not enter in this study|1|||
49088487|NCT00571727|158159359|FG000|Overall Study|Non-compliance|4|||
49088488|NCT00571727|158159359|FG000|Overall Study|Lost to Follow-up|30|||
49088489|NCT00571727|158159359|FG000|Overall Study|Poor growth|1|||
49088490|NCT00571727|158159359|FG000|Overall Study|Parent/patient decision|2|||
49088491|NCT00571727|158159359|FG000|Overall Study|Participant transferred to commercial drug|14|||
49088492|NCT00571727|158159359|FG000|Overall Study|Unable to provide study drug|6|||
49088493|NCT00571727|158159359|FG000|Overall Study|On-treatment at end of study|8|||
49088494|NCT03526861|158160734|FG000|Initial Treatment Period|Not dosed|1|||
49088495|NCT03526861|158160735|FG001|Initial Treatment Period|Not dosed|1|||
49088496|NCT03526861|158160736|FG002|Initial Treatment Period|Not dosed|1|||
49088497|NCT03526861|158160737|FG003|Initial Treatment Period|Not dosed|0|||
49088498|NCT03526861|158160738|FG004|Initial Treatment Period|Not dosed|0|||
49088499|NCT03526861|158160739|FG005|Initial Treatment Period|Not dosed|0|||
49088500|NCT03526861|158160740|FG006|Initial Treatment Period|Not dosed|0|||
49088501|NCT03526861|158160741|FG007|Initial Treatment Period|Not dosed|0|||
49088502|NCT03526861|158160742|FG008|Initial Treatment Period|Not dosed|0|||
49088503|NCT03526861|158160734|FG000|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3|||
49088504|NCT03526861|158160735|FG001|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
49088505|NCT03526861|158160736|FG002|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5|||
49088506|NCT03526861|158160737|FG003|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
49088507|NCT03526861|158160738|FG004|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
49088508|NCT03526861|158160739|FG005|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
49088509|NCT03526861|158160740|FG006|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
49088510|NCT03526861|158160741|FG007|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
49088511|NCT03526861|158160742|FG008|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
49088512|NCT03526861|158160734|FG000|Initial Treatment Period|Subject discontinued IMP before Week 16|3|||
49088513|NCT03526861|158160735|FG001|Initial Treatment Period|Subject discontinued IMP before Week 16|5|||
49088514|NCT03526861|158160736|FG002|Initial Treatment Period|Subject discontinued IMP before Week 16|8|||
49088515|NCT03526861|158160737|FG003|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
49088516|NCT03526861|158160738|FG004|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
49088517|NCT03526861|158160739|FG005|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
49088518|NCT03526861|158160740|FG006|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
49088519|NCT03526861|158160741|FG007|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
49088520|NCT03526861|158160742|FG008|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
49088521|NCT03526861|158160734|FG000|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
49088522|NCT03526861|158160735|FG001|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
49088523|NCT03526861|158160736|FG002|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
49088524|NCT03526861|158160737|FG003|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
49088525|NCT03526861|158160738|FG004|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
49088526|NCT03526861|158160739|FG005|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
49088527|NCT03526861|158160740|FG006|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
49088528|NCT03526861|158160741|FG007|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
49088529|NCT03526861|158160742|FG008|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
49088530|NCT03526861|158160734|FG000|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
49088531|NCT03526861|158160735|FG001|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
49088532|NCT03526861|158160736|FG002|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
49088533|NCT03526861|158160737|FG003|Maintenance Treatment Period|Subject transferred to open-label treatment|6|||
49088534|NCT03526861|158160738|FG004|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
49088535|NCT03526861|158160739|FG005|Maintenance Treatment Period|Subject transferred to open-label treatment|4|||
49088536|NCT03526861|158160740|FG006|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
49088537|NCT03526861|158160741|FG007|Maintenance Treatment Period|Subject transferred to open-label treatment|2|||
49088538|NCT03526861|158160742|FG008|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
49088539|NCT03526861|158160734|FG000|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
49088540|NCT03526861|158160735|FG001|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
49088541|NCT03526861|158160736|FG002|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
49088542|NCT03526861|158160737|FG003|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
49088543|NCT03526861|158160738|FG004|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
49088544|NCT03526861|158160739|FG005|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
49088545|NCT03526861|158160740|FG006|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
49088546|NCT03526861|158160741|FG007|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
49088547|NCT03526861|158160742|FG008|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
49088548|NCT03526861|158160734|FG000|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
49088549|NCT03526861|158160735|FG001|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
49088550|NCT03526861|158160736|FG002|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
49088551|NCT03526861|158160737|FG003|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
49088552|NCT03526861|158160738|FG004|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
49088553|NCT03526861|158160739|FG005|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
49088554|NCT03526861|158160740|FG006|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
49088555|NCT03526861|158160741|FG007|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
49088556|NCT03526861|158160742|FG008|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19|||
49088557|NCT03526861|158160734|FG000|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
49088558|NCT03526861|158160735|FG001|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
49088559|NCT03526861|158160736|FG002|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
49088560|NCT03526861|158160737|FG003|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
49088561|NCT03526861|158160738|FG004|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
49088562|NCT03526861|158160739|FG005|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
49088563|NCT03526861|158160740|FG006|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
49088564|NCT03526861|158160741|FG007|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
49088565|NCT03526861|158160742|FG008|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1|||
49088566|NCT03526861|158160734|FG000|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
49088567|NCT03526861|158160735|FG001|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
49088568|NCT03526861|158160736|FG002|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
49088569|NCT03526861|158160737|FG003|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
49088570|NCT03526861|158160738|FG004|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
49088571|NCT03526861|158160739|FG005|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
49088572|NCT03526861|158160740|FG006|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
49088573|NCT03526861|158160741|FG007|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
49099072|NCT01953601|158198740|FG000|Part 2 (Extension Study)|Adverse Event|1|||
49088574|NCT03526861|158160742|FG008|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8|||
49088575|NCT00683618|158160743|FG000|Randomised Treatment Period|Withdrawal by Subject|4|||
49088576|NCT00683618|158160744|FG001|Randomised Treatment Period|Withdrawal by Subject|1|||
49088577|NCT00683618|158160745|FG002|Randomised Treatment Period|Withdrawal by Subject|2|||
49088578|NCT00683618|158160743|FG000|Randomised Treatment Period|Protocol Violation|0|||
49088579|NCT00683618|158160744|FG001|Randomised Treatment Period|Protocol Violation|1|||
49088580|NCT00683618|158160745|FG002|Randomised Treatment Period|Protocol Violation|0|||
49088581|NCT00683618|158160743|FG000|Randomised Treatment Period|Adverse Event|2|||
49088582|NCT00683618|158160744|FG001|Randomised Treatment Period|Adverse Event|0|||
49088583|NCT00683618|158160745|FG002|Randomised Treatment Period|Adverse Event|2|||
49088584|NCT00683618|158160743|FG000|Randomised Treatment Period|Reason not provided|0|||
49088585|NCT00683618|158160744|FG001|Randomised Treatment Period|Reason not provided|0|||
49088586|NCT00683618|158160745|FG002|Randomised Treatment Period|Reason not provided|2|||
49088587|NCT00683618|158160743|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
49088588|NCT00683618|158160744|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
49088589|NCT00683618|158160745|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
49088590|NCT00683618|158160743|FG000|Extension Treatment Period|Adverse Event|1|||
49088591|NCT00683618|158160744|FG001|Extension Treatment Period|Adverse Event|0|||
49088592|NCT00683618|158160745|FG002|Extension Treatment Period|Adverse Event|0|||
49088593|NCT00683618|158160743|FG000|Extension Treatment Period|Protocol Violation|1|||
49088594|NCT00683618|158160744|FG001|Extension Treatment Period|Protocol Violation|0|||
49088595|NCT00683618|158160745|FG002|Extension Treatment Period|Protocol Violation|0|||
49088596|NCT01002989|158160747|FG000|Overall Study|exclusion criteria, no consent|5|||
49088597|NCT02764762|158160748|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
49088598|NCT02764762|158160748|FG000|Overall Study|Lost to Follow-up|4|||
49088599|NCT02764762|158160748|FG000|Overall Study|Voluntary Withdrawal|8|||
49088600|NCT02764762|158160748|FG000|Overall Study|Site Termination|1|||
49088601|NCT02764762|158160748|FG000|Overall Study|Lack of Efficacy|16|||
49088602|NCT02764762|158160748|FG000|Overall Study|Reason not Specified|1|||
49088603|NCT02954601|158160749|FG000|First Intervention (Five Days)|Withdrawal by Subject|0|||
49088604|NCT02954601|158160750|FG001|First Intervention (Five Days)|Withdrawal by Subject|0|||
49088605|NCT02954601|158160751|FG002|First Intervention (Five Days)|Withdrawal by Subject|1|||
49088606|NCT02954601|158160752|FG003|First Intervention (Five Days)|Withdrawal by Subject|0|||
49088607|NCT03852472|158160753|FG000|Period 1 - 12 Weeks|Withdrawal by Subject|8|||
49088608|NCT03852472|158160754|FG001|Period 1 - 12 Weeks|Withdrawal by Subject|10|||
49088609|NCT03852472|158160755|FG002|Period 1 - 12 Weeks|Withdrawal by Subject|7|||
49088610|NCT03852472|158160756|FG003|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
49088611|NCT03852472|158160757|FG004|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
49088612|NCT03852472|158160753|FG000|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
49088613|NCT03852472|158160754|FG001|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|1|||
49088614|NCT03852472|158160755|FG002|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|3|||
49088615|NCT03852472|158160756|FG003|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
49088616|NCT03852472|158160757|FG004|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
49088617|NCT03852472|158160753|FG000|Period 1 - 12 Weeks|Lost to Follow-up|5|||
49088618|NCT03852472|158160754|FG001|Period 1 - 12 Weeks|Lost to Follow-up|5|||
49088619|NCT03852472|158160755|FG002|Period 1 - 12 Weeks|Lost to Follow-up|7|||
49088620|NCT03852472|158160756|FG003|Period 1 - 12 Weeks|Lost to Follow-up|0|||
49088621|NCT03852472|158160757|FG004|Period 1 - 12 Weeks|Lost to Follow-up|0|||
49088622|NCT03852472|158160753|FG000|Period 1 - 12 Weeks|Noncompliance with the protocol|2|||
49088623|NCT03852472|158160754|FG001|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
49088624|NCT03852472|158160755|FG002|Period 1 - 12 Weeks|Noncompliance with the protocol|4|||
49088625|NCT03852472|158160756|FG003|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
49088626|NCT03852472|158160757|FG004|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
49088627|NCT03852472|158160753|FG000|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
49088628|NCT03852472|158160754|FG001|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|3|||
49088629|NCT03852472|158160755|FG002|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
49088630|NCT03852472|158160756|FG003|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
49088631|NCT03852472|158160757|FG004|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
49088632|NCT03852472|158160753|FG000|Period 1 - 12 Weeks|Adverse Event|4|||
49088633|NCT03852472|158160754|FG001|Period 1 - 12 Weeks|Adverse Event|6|||
49088634|NCT03852472|158160755|FG002|Period 1 - 12 Weeks|Adverse Event|4|||
49088635|NCT03852472|158160756|FG003|Period 1 - 12 Weeks|Adverse Event|0|||
49088636|NCT03852472|158160757|FG004|Period 1 - 12 Weeks|Adverse Event|0|||
49088637|NCT03852472|158160753|FG000|Period 1 - 12 Weeks|Reason not stated|2|||
49088638|NCT03852472|158160754|FG001|Period 1 - 12 Weeks|Reason not stated|1|||
49088639|NCT03852472|158160755|FG002|Period 1 - 12 Weeks|Reason not stated|0|||
49088640|NCT03852472|158160756|FG003|Period 1 - 12 Weeks|Reason not stated|0|||
49088641|NCT03852472|158160757|FG004|Period 1 - 12 Weeks|Reason not stated|0|||
49088642|NCT03852472|158160753|FG000|Period 2 - Week 44|Withdrawal by Subject|0|||
49088643|NCT03852472|158160754|FG001|Period 2 - Week 44|Withdrawal by Subject|22|||
49088644|NCT03852472|158160755|FG002|Period 2 - Week 44|Withdrawal by Subject|15|||
49088645|NCT03852472|158160756|FG003|Period 2 - Week 44|Withdrawal by Subject|10|||
49088646|NCT03852472|158160757|FG004|Period 2 - Week 44|Withdrawal by Subject|10|||
49088647|NCT03852472|158160753|FG000|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
49088648|NCT03852472|158160754|FG001|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|2|||
49088649|NCT03852472|158160755|FG002|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
49088650|NCT03852472|158160756|FG003|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
49088651|NCT03852472|158160757|FG004|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
49088652|NCT03852472|158160753|FG000|Period 2 - Week 44|Lost to Follow-up|0|||
49088653|NCT03852472|158160754|FG001|Period 2 - Week 44|Lost to Follow-up|8|||
49088654|NCT03852472|158160755|FG002|Period 2 - Week 44|Lost to Follow-up|12|||
49088655|NCT03852472|158160756|FG003|Period 2 - Week 44|Lost to Follow-up|1|||
49088656|NCT03852472|158160757|FG004|Period 2 - Week 44|Lost to Follow-up|2|||
49088657|NCT03852472|158160753|FG000|Period 2 - Week 44|Noncompliance with the protocol|0|||
49088658|NCT03852472|158160754|FG001|Period 2 - Week 44|Noncompliance with the protocol|2|||
49088659|NCT03852472|158160755|FG002|Period 2 - Week 44|Noncompliance with the protocol|1|||
49088660|NCT03852472|158160756|FG003|Period 2 - Week 44|Noncompliance with the protocol|0|||
49088661|NCT03852472|158160757|FG004|Period 2 - Week 44|Noncompliance with the protocol|0|||
49088662|NCT03852472|158160753|FG000|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|0|||
49088663|NCT03852472|158160754|FG001|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|1|||
49088664|NCT03852472|158160755|FG002|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
49088665|NCT03852472|158160756|FG003|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|2|||
49088666|NCT03852472|158160757|FG004|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
49088667|NCT03852472|158160753|FG000|Period 2 - Week 44|Adverse Event|0|||
49088668|NCT03852472|158160754|FG001|Period 2 - Week 44|Adverse Event|3|||
49088669|NCT03852472|158160755|FG002|Period 2 - Week 44|Adverse Event|1|||
49088670|NCT03852472|158160756|FG003|Period 2 - Week 44|Adverse Event|2|||
49088671|NCT03852472|158160757|FG004|Period 2 - Week 44|Adverse Event|2|||
49088672|NCT03852472|158160753|FG000|Period 2 - Week 44|COVID-19 Related|0|||
49088673|NCT03852472|158160754|FG001|Period 2 - Week 44|COVID-19 Related|0|||
49088674|NCT03852472|158160755|FG002|Period 2 - Week 44|COVID-19 Related|0|||
49088675|NCT03852472|158160756|FG003|Period 2 - Week 44|COVID-19 Related|1|||
49088676|NCT03852472|158160757|FG004|Period 2 - Week 44|COVID-19 Related|0|||
49088677|NCT03852472|158160753|FG000|Period 2 - Week 44|Reason not stated|0|||
49088678|NCT03852472|158160754|FG001|Period 2 - Week 44|Reason not stated|0|||
49088679|NCT03852472|158160755|FG002|Period 2 - Week 44|Reason not stated|0|||
49088680|NCT03852472|158160756|FG003|Period 2 - Week 44|Reason not stated|0|||
49088681|NCT03852472|158160757|FG004|Period 2 - Week 44|Reason not stated|1|||
49088682|NCT02760004|158160758|FG000|Overall Study|Lost to Follow-up|13|||
49088683|NCT02760004|158160759|FG001|Overall Study|Lost to Follow-up|22|||
49088684|NCT00461630|158160760|FG000|Overall Study|Death|798|||
49088685|NCT00461630|158160761|FG001|Overall Study|Death|732|||
49088686|NCT00461630|158160760|FG000|Overall Study|Lost to Follow-up|108|||
49088687|NCT00461630|158160761|FG001|Overall Study|Lost to Follow-up|95|||
49088688|NCT00442897|158160763|FG000|Base Study (12 Week Follow-up)|Adverse Event|1|||
49088689|NCT00442897|158160764|FG001|Base Study (12 Week Follow-up)|Adverse Event|0|||
49088690|NCT00442897|158160763|FG000|Base Study (12 Week Follow-up)|Death|0|||
49088691|NCT00442897|158160764|FG001|Base Study (12 Week Follow-up)|Death|1|||
49088692|NCT00442897|158160763|FG000|Base Study (12 Week Follow-up)|Protocol Violation|7|||
49088693|NCT00442897|158160764|FG001|Base Study (12 Week Follow-up)|Protocol Violation|3|||
49088694|NCT00442897|158160763|FG000|Base Study (12 Week Follow-up)|Withdrawal by Subject|9|||
49088695|NCT00442897|158160764|FG001|Base Study (12 Week Follow-up)|Withdrawal by Subject|8|||
49088696|NCT00442897|158160763|FG000|24 Weeks Follow-up (3 Centers)|Adverse Event|1|||
49088697|NCT00442897|158160764|FG001|24 Weeks Follow-up (3 Centers)|Adverse Event|0|||
49088698|NCT00442897|158160763|FG000|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
49088699|NCT00442897|158160764|FG001|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
49088700|NCT00442897|158160763|FG000|24 Weeks Follow-up (3 Centers)|Protocol Violation|2|||
49088701|NCT00442897|158160764|FG001|24 Weeks Follow-up (3 Centers)|Protocol Violation|1|||
49088702|NCT00442897|158160763|FG000|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1|||
49088703|NCT00442897|158160764|FG001|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3|||
49088704|NCT00891020|158160768|FG000|24 Week Treatment Period|Adverse event or intercurrent illness|11|||
49088705|NCT00891020|158160769|FG001|24 Week Treatment Period|Adverse event or intercurrent illness|32|||
49088706|NCT00891020|158160770|FG002|24 Week Treatment Period|Adverse event or intercurrent illness|17|||
49088707|NCT00891020|158160768|FG000|24 Week Treatment Period|Death|0|||
49088708|NCT00891020|158160769|FG001|24 Week Treatment Period|Death|2|||
49088709|NCT00891020|158160770|FG002|24 Week Treatment Period|Death|0|||
49088710|NCT00891020|158160768|FG000|24 Week Treatment Period|Insufficient therapeutic response|6|||
49088711|NCT00891020|158160769|FG001|24 Week Treatment Period|Insufficient therapeutic response|9|||
49088712|NCT00891020|158160770|FG002|24 Week Treatment Period|Insufficient therapeutic response|15|||
49088713|NCT00891020|158160768|FG000|24 Week Treatment Period|Failure to return|4|||
49088714|NCT00891020|158160769|FG001|24 Week Treatment Period|Failure to return|5|||
49088715|NCT00891020|158160770|FG002|24 Week Treatment Period|Failure to return|5|||
49088716|NCT00891020|158160768|FG000|24 Week Treatment Period|Violation of selection criteria at entry|1|||
49088717|NCT00891020|158160769|FG001|24 Week Treatment Period|Violation of selection criteria at entry|0|||
49088718|NCT00891020|158160770|FG002|24 Week Treatment Period|Violation of selection criteria at entry|2|||
49088719|NCT00891020|158160768|FG000|24 Week Treatment Period|Other protocol violation|1|||
49088720|NCT00891020|158160769|FG001|24 Week Treatment Period|Other protocol violation|1|||
49088721|NCT00891020|158160770|FG002|24 Week Treatment Period|Other protocol violation|2|||
49088722|NCT00891020|158160768|FG000|24 Week Treatment Period|Refused treatment/did not cooperate|3|||
49088723|NCT00891020|158160769|FG001|24 Week Treatment Period|Refused treatment/did not cooperate|2|||
49088724|NCT00891020|158160770|FG002|24 Week Treatment Period|Refused treatment/did not cooperate|1|||
49088725|NCT00891020|158160768|FG000|24 Week Treatment Period|Withdrew consent|6|||
49088726|NCT00891020|158160769|FG001|24 Week Treatment Period|Withdrew consent|3|||
49088727|NCT00891020|158160770|FG002|24 Week Treatment Period|Withdrew consent|15|||
49088728|NCT00891020|158160768|FG000|24 Week Treatment Period|Administrative/Other|5|||
49088729|NCT00891020|158160769|FG001|24 Week Treatment Period|Administrative/Other|6|||
49088730|NCT00891020|158160770|FG002|24 Week Treatment Period|Administrative/Other|1|||
49088731|NCT00891020|158160768|FG000|Long-term Extension Period|Adverse Event|1|||
49088732|NCT00891020|158160769|FG001|Long-term Extension Period|Adverse Event|11|||
49088733|NCT00891020|158160770|FG002|Long-term Extension Period|Adverse Event|10|||
49088734|NCT00891020|158160768|FG000|Long-term Extension Period|Death|0|||
49088735|NCT00891020|158160769|FG001|Long-term Extension Period|Death|0|||
49088736|NCT00891020|158160770|FG002|Long-term Extension Period|Death|1|||
49088737|NCT00891020|158160768|FG000|Long-term Extension Period|Insufficient therapeutic response|3|||
49088738|NCT00891020|158160769|FG001|Long-term Extension Period|Insufficient therapeutic response|2|||
49088739|NCT00891020|158160770|FG002|Long-term Extension Period|Insufficient therapeutic response|2|||
49088740|NCT00891020|158160768|FG000|Long-term Extension Period|Protocol Violation|0|||
49088741|NCT00891020|158160769|FG001|Long-term Extension Period|Protocol Violation|1|||
49088742|NCT00891020|158160770|FG002|Long-term Extension Period|Protocol Violation|1|||
49088743|NCT00891020|158160768|FG000|Long-term Extension Period|Refused treatment/did not cooperate|1|||
49088744|NCT00891020|158160769|FG001|Long-term Extension Period|Refused treatment/did not cooperate|6|||
49088745|NCT00891020|158160770|FG002|Long-term Extension Period|Refused treatment/did not cooperate|4|||
49088746|NCT00891020|158160768|FG000|Long-term Extension Period|Failure to return|0|||
49088747|NCT00891020|158160769|FG001|Long-term Extension Period|Failure to return|2|||
49088748|NCT00891020|158160770|FG002|Long-term Extension Period|Failure to return|3|||
49088749|NCT00891020|158160768|FG000|Long-term Extension Period|Administrative|1|||
49088750|NCT00891020|158160769|FG001|Long-term Extension Period|Administrative|2|||
49088751|NCT00891020|158160770|FG002|Long-term Extension Period|Administrative|2|||
49088752|NCT02588612|158160771|FG000|Overall Study|Physician Decision|1|||
49088753|NCT02588612|158160771|FG000|Overall Study|Leukapheresis did not yield enough cells|1|||
49088754|NCT02588612|158160771|FG000|Overall Study|Failed eligibility prior to chemotherapy|2|||
49088755|NCT02588612|158160771|FG000|Overall Study|Death prior to T-cell infusion|1|||
49088756|NCT00320710|158160772|FG000|Overall Study|Disease progression|24|||
49088757|NCT00320710|158160773|FG001|Overall Study|Disease progression|19|||
49088758|NCT00320710|158160774|FG002|Overall Study|Disease progression|2|||
49088759|NCT00320710|158160772|FG000|Overall Study|Death|10|||
49088760|NCT00320710|158160773|FG001|Overall Study|Death|7|||
49088761|NCT00320710|158160774|FG002|Overall Study|Death|1|||
49088762|NCT00320710|158160772|FG000|Overall Study|Administrative problems|1|||
49088763|NCT00320710|158160773|FG001|Overall Study|Administrative problems|2|||
49088764|NCT00320710|158160774|FG002|Overall Study|Administrative problems|0|||
49088765|NCT00320710|158160772|FG000|Overall Study|Withdrawal by Subject|20|||
49088766|NCT00320710|158160773|FG001|Overall Study|Withdrawal by Subject|26|||
49088767|NCT00320710|158160774|FG002|Overall Study|Withdrawal by Subject|1|||
49088768|NCT00320710|158160772|FG000|Overall Study|Protocol Violation|6|||
49088769|NCT00320710|158160773|FG001|Overall Study|Protocol Violation|5|||
49088770|NCT00320710|158160774|FG002|Overall Study|Protocol Violation|0|||
49088771|NCT00320710|158160772|FG000|Overall Study|Abnormal test procedure result(s)|2|||
49088772|NCT00320710|158160773|FG001|Overall Study|Abnormal test procedure result(s)|0|||
49088773|NCT00320710|158160774|FG002|Overall Study|Abnormal test procedure result(s)|0|||
49088774|NCT00320710|158160772|FG000|Overall Study|Abnormal laboratory value(s)|12|||
49088775|NCT00320710|158160773|FG001|Overall Study|Abnormal laboratory value(s)|3|||
49088776|NCT00320710|158160774|FG002|Overall Study|Abnormal laboratory value(s)|0|||
49088777|NCT00320710|158160772|FG000|Overall Study|Adverse Event|18|||
49088778|NCT00320710|158160773|FG001|Overall Study|Adverse Event|14|||
49088779|NCT00320710|158160774|FG002|Overall Study|Adverse Event|1|||
49088780|NCT00320710|158160772|FG000|Overall Study|Lost to Follow-up|1|||
49088781|NCT00320710|158160773|FG001|Overall Study|Lost to Follow-up|0|||
49088782|NCT00320710|158160774|FG002|Overall Study|Lost to Follow-up|0|||
49088783|NCT03866512|158160775|FG000|Overall Study|Lost to Follow-up|1|||
49088784|NCT03866512|158160776|FG001|Overall Study|Lost to Follow-up|2|||
49088785|NCT03866512|158160777|FG002|Overall Study|Lost to Follow-up|1|||
49088786|NCT03866512|158160775|FG000|Overall Study|Cannulation issues|0|||
49088787|NCT03866512|158160776|FG001|Overall Study|Cannulation issues|1|||
49088788|NCT03866512|158160777|FG002|Overall Study|Cannulation issues|2|||
49088789|NCT02801617|158160778|FG000|Overall Study|Protocol Violation|2|||
49088790|NCT02801617|158160779|FG001|Overall Study|Protocol Violation|6|||
49088791|NCT01372618|158160780|FG000|Overall Study|PI Died. Study Terminated|9|||
49088792|NCT03448419|158160781|FG000|Overall Study|Adverse Event|10|||
49088793|NCT03448419|158160782|FG001|Overall Study|Adverse Event|9|||
49088794|NCT03448419|158160781|FG000|Overall Study|Lost to Follow-up|0|||
49088795|NCT03448419|158160782|FG001|Overall Study|Lost to Follow-up|2|||
49088796|NCT03448419|158160781|FG000|Overall Study|Withdrawal by Subject|3|||
49088797|NCT03448419|158160782|FG001|Overall Study|Withdrawal by Subject|1|||
49088798|NCT03448419|158160781|FG000|Overall Study|Not treated|0|||
49088799|NCT03448419|158160782|FG001|Overall Study|Not treated|1|||
49088800|NCT03448419|158160781|FG000|Overall Study|Patient did not attend all visits|0|||
49088801|NCT03448419|158160782|FG001|Overall Study|Patient did not attend all visits|2|||
49088802|NCT03448419|158160781|FG000|Overall Study|Withdrawn by Sponsor|0|||
49088803|NCT03448419|158160782|FG001|Overall Study|Withdrawn by Sponsor|1|||
49088804|NCT01954056|158160793|FG000|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1|||
49088805|NCT01954056|158160794|FG001|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0|||
49088806|NCT00506415|158160795|FG000|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272|||
49088807|NCT00506415|158160796|FG001|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
49088808|NCT00506415|158160797|FG002|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
49088809|NCT00506415|158160798|FG003|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
49088810|NCT00506415|158160795|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1|||
49088811|NCT00506415|158160796|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
49088812|NCT00506415|158160797|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
49088813|NCT00506415|158160798|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
49088814|NCT00506415|158160795|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1|||
49088815|NCT00506415|158160796|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
49088816|NCT00506415|158160797|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
49088817|NCT00506415|158160798|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
49088818|NCT00506415|158160795|FG000|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58|||
49088819|NCT00506415|158160796|FG001|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
49088820|NCT00506415|158160797|FG002|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
49088821|NCT00506415|158160798|FG003|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
49088822|NCT00506415|158160795|FG000|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88|||
49088823|NCT00506415|158160796|FG001|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
49088824|NCT00506415|158160797|FG002|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
49088825|NCT00506415|158160798|FG003|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
49088826|NCT00506415|158160795|FG000|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22|||
49088827|NCT00506415|158160796|FG001|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
49088828|NCT00506415|158160797|FG002|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
49088829|NCT00506415|158160798|FG003|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
49088830|NCT00506415|158160795|FG000|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7|||
49088831|NCT00506415|158160796|FG001|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
49088832|NCT00506415|158160797|FG002|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
49088833|NCT00506415|158160798|FG003|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
49088834|NCT00506415|158160795|FG000|Initial Open Label (Maximum 48 Weeks)|Death|22|||
49088835|NCT00506415|158160796|FG001|Initial Open Label (Maximum 48 Weeks)|Death|0|||
49088836|NCT00506415|158160797|FG002|Initial Open Label (Maximum 48 Weeks)|Death|0|||
49088837|NCT00506415|158160798|FG003|Initial Open Label (Maximum 48 Weeks)|Death|0|||
49088838|NCT00506415|158160795|FG000|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28|||
49088839|NCT00506415|158160796|FG001|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
49088840|NCT00506415|158160797|FG002|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
49088841|NCT00506415|158160798|FG003|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
49088842|NCT00506415|158160795|FG000|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
49088843|NCT00506415|158160796|FG001|Double Blind (Maximum 48 Weeks )|Adverse Event|33|||
49088844|NCT00506415|158160797|FG002|Double Blind (Maximum 48 Weeks )|Adverse Event|28|||
49088845|NCT00506415|158160798|FG003|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
49088846|NCT00506415|158160795|FG000|Double Blind (Maximum 48 Weeks )|Death|0|||
49088847|NCT00506415|158160796|FG001|Double Blind (Maximum 48 Weeks )|Death|5|||
49088848|NCT00506415|158160797|FG002|Double Blind (Maximum 48 Weeks )|Death|3|||
49088849|NCT00506415|158160798|FG003|Double Blind (Maximum 48 Weeks )|Death|0|||
49088850|NCT00506415|158160795|FG000|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
49088851|NCT00506415|158160796|FG001|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
49088852|NCT00506415|158160797|FG002|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
49088853|NCT00506415|158160798|FG003|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
49088854|NCT00506415|158160795|FG000|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
49088855|NCT00506415|158160796|FG001|Double Blind (Maximum 48 Weeks )|Protocol Violation|5|||
49088856|NCT00506415|158160797|FG002|Double Blind (Maximum 48 Weeks )|Protocol Violation|3|||
49088857|NCT00506415|158160798|FG003|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
49088858|NCT00506415|158160795|FG000|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
49088859|NCT00506415|158160796|FG001|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4|||
49088860|NCT00506415|158160797|FG002|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6|||
49088861|NCT00506415|158160798|FG003|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
49088862|NCT00506415|158160795|FG000|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
49088863|NCT00506415|158160796|FG001|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20|||
49088864|NCT00506415|158160797|FG002|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17|||
49088865|NCT00506415|158160798|FG003|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
49088866|NCT00506415|158160795|FG000|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
49088867|NCT00506415|158160796|FG001|Double Blind (Maximum 48 Weeks )|Administrative problems|3|||
49088868|NCT00506415|158160797|FG002|Double Blind (Maximum 48 Weeks )|Administrative problems|2|||
49088869|NCT00506415|158160798|FG003|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
49088870|NCT00506415|158160795|FG000|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
49088871|NCT00506415|158160796|FG001|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
49088872|NCT00506415|158160797|FG002|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1|||
49088873|NCT00506415|158160798|FG003|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
49088874|NCT00506415|158160795|FG000|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
49088875|NCT00506415|158160796|FG001|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
49088876|NCT00506415|158160797|FG002|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
49088877|NCT00506415|158160798|FG003|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4|||
49088878|NCT00506415|158160795|FG000|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
49088879|NCT00506415|158160796|FG001|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
49088880|NCT00506415|158160797|FG002|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
49088881|NCT00506415|158160798|FG003|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18|||
49088882|NCT00506415|158160795|FG000|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
49088883|NCT00506415|158160796|FG001|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
49088884|NCT00506415|158160797|FG002|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
49088885|NCT00506415|158160798|FG003|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8|||
49088886|NCT00506415|158160795|FG000|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
49088887|NCT00506415|158160796|FG001|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
49088888|NCT00506415|158160797|FG002|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
49088889|NCT00506415|158160798|FG003|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14|||
49088890|NCT00506415|158160795|FG000|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
49088891|NCT00506415|158160796|FG001|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
49088892|NCT00506415|158160797|FG002|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
49088893|NCT00506415|158160798|FG003|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5|||
49088894|NCT00506415|158160795|FG000|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
49088895|NCT00506415|158160796|FG001|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
49088896|NCT00506415|158160797|FG002|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
49088897|NCT00506415|158160798|FG003|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6|||
49088898|NCT00506415|158160795|FG000|Extended Open Label (Maximum 48 Weeks)|Death|0|||
49088899|NCT00506415|158160796|FG001|Extended Open Label (Maximum 48 Weeks)|Death|0|||
49088900|NCT00506415|158160797|FG002|Extended Open Label (Maximum 48 Weeks)|Death|0|||
49088901|NCT00506415|158160798|FG003|Extended Open Label (Maximum 48 Weeks)|Death|7|||
49088902|NCT03751098|158160803|FG000|Overall Study|Withdrawal by Subject|0|||
49088903|NCT03751098|158160804|FG001|Overall Study|Withdrawal by Subject|1|||
49088904|NCT00997373|158160805|FG000|Overall Study|Withdrawal by Subject|5|||
49088905|NCT00997373|158160806|FG001|Overall Study|Withdrawal by Subject|0|||
49088906|NCT00997373|158160805|FG000|Overall Study|wrong tumor type|4|||
49088907|NCT00997373|158160806|FG001|Overall Study|wrong tumor type|0|||
49088908|NCT00997373|158160805|FG000|Overall Study|could not have hysterectomy|6|||
49088909|NCT00997373|158160806|FG001|Overall Study|could not have hysterectomy|0|||
49088910|NCT03376789|158160808|FG000|Overall Study|Withdrawal by Subject|3|||
49088911|NCT03376789|158160809|FG001|Overall Study|Withdrawal by Subject|5|||
49088912|NCT03376789|158160808|FG000|Overall Study|Protocol Violation|0|||
49088913|NCT03376789|158160809|FG001|Overall Study|Protocol Violation|1|||
49088914|NCT03376789|158160808|FG000|Overall Study|Adverse Event|0|||
49088915|NCT03376789|158160809|FG001|Overall Study|Adverse Event|1|||
49088916|NCT03376789|158160808|FG000|Overall Study|Lost to Follow-up|1|||
49088917|NCT03376789|158160809|FG001|Overall Study|Lost to Follow-up|1|||
49088918|NCT03376789|158160808|FG000|Overall Study|Per sponsor due to noncompliance|1|||
49088919|NCT03376789|158160809|FG001|Overall Study|Per sponsor due to noncompliance|0|||
49088920|NCT03376789|158160808|FG000|Overall Study|Subject off study medication|0|||
49088921|NCT03376789|158160809|FG001|Overall Study|Subject off study medication|1|||
49088922|NCT04090060|158160810|FG000|Overall Study|Lost to Follow-up|76|||
49088923|NCT04090060|158160811|FG001|Overall Study|Lost to Follow-up|77|||
49088924|NCT04615403|158160814|FG000|Overall Study|Death|1|||
49088925|NCT03337113|158160815|FG000|Overall Study|Adverse Event|1|||
49088926|NCT03337113|158160816|FG001|Overall Study|Adverse Event|1|||
49088927|NCT03337113|158160817|FG002|Overall Study|Adverse Event|0|||
49088928|NCT03337113|158160818|FG003|Overall Study|Adverse Event|1|||
49088929|NCT03337113|158160815|FG000|Overall Study|Physician Decision|0|||
49088930|NCT03337113|158160816|FG001|Overall Study|Physician Decision|2|||
49088931|NCT03337113|158160817|FG002|Overall Study|Physician Decision|0|||
49088932|NCT03337113|158160818|FG003|Overall Study|Physician Decision|1|||
49088933|NCT03337113|158160815|FG000|Overall Study|Withdrawal by Subject|0|||
49088934|NCT03337113|158160816|FG001|Overall Study|Withdrawal by Subject|0|||
49088935|NCT03337113|158160817|FG002|Overall Study|Withdrawal by Subject|1|||
49088936|NCT03337113|158160818|FG003|Overall Study|Withdrawal by Subject|0|||
49088937|NCT03168711|158160826|FG000|Overall Study|Adverse Event|2|||
49088938|NCT03168711|158160827|FG001|Overall Study|Adverse Event|0|||
49088939|NCT03168711|158160826|FG000|Overall Study|Withdrawal by Subject|0|||
49088940|NCT03168711|158160827|FG001|Overall Study|Withdrawal by Subject|1|||
49088941|NCT03168711|158160826|FG000|Overall Study|Death|0|||
49088942|NCT03168711|158160827|FG001|Overall Study|Death|1|||
49088943|NCT04548193|158160828|FG000|Overall Study|Lost to Follow-up|0|||
49088944|NCT04548193|158160829|FG001|Overall Study|Lost to Follow-up|1|||
49088945|NCT04548193|158160828|FG000|Overall Study|Death|0|||
49088946|NCT04548193|158160829|FG001|Overall Study|Death|1|||
49088947|NCT04548193|158160828|FG000|Overall Study|Not eligible. Participant underwent cystectomy in August|1|||
49088948|NCT04548193|158160829|FG001|Overall Study|Not eligible. Participant underwent cystectomy in August|0|||
49088949|NCT04548193|158160828|FG000|Overall Study|Withdrawal by Subject|2|||
49088950|NCT04548193|158160829|FG001|Overall Study|Withdrawal by Subject|2|||
49088951|NCT04177095|158160834|FG000|Overall Study|Withdrawal by Subject|3|||
49088952|NCT04177095|158160834|FG000|Overall Study|Screen Failure|3|||
49088953|NCT04177095|158160834|FG000|Overall Study|Problems with the Trugraf assay|1|||
49088954|NCT02792062|158160842|FG000|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1|||
49088955|NCT02792062|158160843|FG001|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
49088956|NCT02792062|158160844|FG002|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
49088957|NCT02792062|158160845|FG003|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
49088958|NCT02792062|158160846|FG004|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
49088959|NCT02792062|158160847|FG005|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
49088960|NCT01081769|158160848|FG000|Whole Intent-to-Treat|Missing Responder Assessment|10|||
49088961|NCT01081769|158160849|FG001|Whole Intent-to-Treat|Missing Responder Assessment|12|||
49088962|NCT01081769|158160848|FG000|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
49088963|NCT01081769|158160849|FG001|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
49088964|NCT01081769|158160848|FG000|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6|||
49088965|NCT01081769|158160849|FG001|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7|||
49088966|NCT01081769|158160848|FG000|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2|||
49088967|NCT01081769|158160849|FG001|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0|||
49088968|NCT01081769|158160848|FG000|CORE Intent-To-Treat|Adverse Event|14|||
49088969|NCT01081769|158160849|FG001|CORE Intent-To-Treat|Adverse Event|11|||
49088970|NCT01081769|158160848|FG000|CORE Intent-To-Treat|Death|1|||
49088971|NCT01081769|158160849|FG001|CORE Intent-To-Treat|Death|1|||
49088972|NCT01081769|158160848|FG000|CORE Intent-To-Treat|Lack of Efficacy|2|||
49088973|NCT01081769|158160849|FG001|CORE Intent-To-Treat|Lack of Efficacy|6|||
49088974|NCT01081769|158160848|FG000|CORE Intent-To-Treat|Lost to Follow-up|4|||
49088975|NCT01081769|158160849|FG001|CORE Intent-To-Treat|Lost to Follow-up|5|||
49088976|NCT01081769|158160848|FG000|CORE Intent-To-Treat|Pregnancy|1|||
49088977|NCT01081769|158160849|FG001|CORE Intent-To-Treat|Pregnancy|0|||
49088978|NCT01081769|158160848|FG000|CORE Intent-To-Treat|Withdrawal by Subject|52|||
49088979|NCT01081769|158160849|FG001|CORE Intent-To-Treat|Withdrawal by Subject|60|||
49088980|NCT01081769|158160848|FG000|CORE Intent-To-Treat|Noncompliance With Study Drug|0|||
49088981|NCT01081769|158160849|FG001|CORE Intent-To-Treat|Noncompliance With Study Drug|5|||
49088982|NCT01081769|158160848|FG000|CORE Intent-To-Treat|Other|0|||
49088983|NCT01081769|158160849|FG001|CORE Intent-To-Treat|Other|1|||
49088984|NCT01081769|158160848|FG000|CORE Intent-To-Treat|Ineligibility|3|||
49088985|NCT01081769|158160849|FG001|CORE Intent-To-Treat|Ineligibility|4|||
49088986|NCT01081769|158160848|FG000|CORE Intent-To-Treat|Visit Schedule Issues|1|||
49088987|NCT01081769|158160849|FG001|CORE Intent-To-Treat|Visit Schedule Issues|2|||
49088988|NCT01081769|158160848|FG000|CORE Intent-To-Treat|Patient Moved|2|||
49088989|NCT01081769|158160849|FG001|CORE Intent-To-Treat|Patient Moved|2|||
49088990|NCT00558467|158160853|FG000|Overall Study|Adverse Event|1|||
49088991|NCT00558467|158160854|FG001|Overall Study|Adverse Event|2|||
49088992|NCT00558467|158160853|FG000|Overall Study|Lack of Efficacy|0|||
49088993|NCT00558467|158160854|FG001|Overall Study|Lack of Efficacy|1|||
49088994|NCT00558467|158160853|FG000|Overall Study|Patient moving out of state|0|||
49088995|NCT00558467|158160854|FG001|Overall Study|Patient moving out of state|1|||
49088996|NCT02176655|158160857|FG000|Overall Study|Subjects did not treat|6|||
49088997|NCT00558701|158160875|FG000|Overall Study|Protocol Deviations|1|||
49088998|NCT00558701|158160876|FG001|Overall Study|Protocol Deviations|4|||
49088999|NCT01139125|158160878|FG000|Overall Study|Withdrawal by Subject|1|||
49089000|NCT00765336|158160879|FG000|Overall Study|Protocol Violation|4|||
49089001|NCT00765336|158160880|FG001|Overall Study|Protocol Violation|2|||
49089002|NCT00765336|158160879|FG000|Overall Study|Withdrawal by Subject|6|||
49089003|NCT00765336|158160880|FG001|Overall Study|Withdrawal by Subject|4|||
49089004|NCT00765336|158160879|FG000|Overall Study|Lost to Follow-up|7|||
49089005|NCT00765336|158160880|FG001|Overall Study|Lost to Follow-up|9|||
49089006|NCT00765336|158160879|FG000|Overall Study|Adverse Event|2|||
49089007|NCT00765336|158160880|FG001|Overall Study|Adverse Event|1|||
49089008|NCT01303172|158160881|FG000|Overall Study|Physician Decision|9|||
49089009|NCT01303172|158160882|FG001|Overall Study|Physician Decision|6|||
49089010|NCT01303172|158160881|FG000|Overall Study|Adverse Event|5|||
49089011|NCT01303172|158160882|FG001|Overall Study|Adverse Event|2|||
49089012|NCT01303172|158160881|FG000|Overall Study|Withdrawal by Subject|4|||
49089013|NCT01303172|158160882|FG001|Overall Study|Withdrawal by Subject|2|||
49089014|NCT01303172|158160881|FG000|Overall Study|Death|20|||
49089015|NCT01303172|158160882|FG001|Overall Study|Death|7|||
49089016|NCT01303172|158160881|FG000|Overall Study|Lack of Efficacy|25|||
49089017|NCT01303172|158160882|FG001|Overall Study|Lack of Efficacy|17|||
49089018|NCT02589639|158160885|FG000|Overall Study|Lost to Follow-up|1|||
49089019|NCT02589639|158160886|FG001|Overall Study|Lost to Follow-up|0|||
49089020|NCT02589639|158160887|FG002|Overall Study|Lost to Follow-up|0|||
49089021|NCT02589639|158160885|FG000|Overall Study|Protocol Violation|1|||
49089022|NCT02589639|158160886|FG001|Overall Study|Protocol Violation|0|||
49089023|NCT02589639|158160887|FG002|Overall Study|Protocol Violation|0|||
49089024|NCT02589639|158160885|FG000|Overall Study|Patient withdrawal, not due to AE|3|||
49089025|NCT02589639|158160886|FG001|Overall Study|Patient withdrawal, not due to AE|0|||
49089026|NCT02589639|158160887|FG002|Overall Study|Patient withdrawal, not due to AE|0|||
49089027|NCT02589639|158160885|FG000|Overall Study|Adverse Event|4|||
49089028|NCT02589639|158160886|FG001|Overall Study|Adverse Event|5|||
49089029|NCT02589639|158160887|FG002|Overall Study|Adverse Event|3|||
49089030|NCT02589639|158160885|FG000|Overall Study|Other reason than specified above|1|||
49089031|NCT02589639|158160886|FG001|Overall Study|Other reason than specified above|2|||
49089032|NCT02589639|158160887|FG002|Overall Study|Other reason than specified above|1|||
49089033|NCT02589639|158160885|FG000|Overall Study|Not Treated|0|||
49089034|NCT02589639|158160886|FG001|Overall Study|Not Treated|3|||
49089035|NCT02589639|158160887|FG002|Overall Study|Not Treated|0|||
49089036|NCT01276756|158160890|FG000|Overall Study|Lost to Follow-up|2|||
49089037|NCT01276756|158160891|FG001|Overall Study|Lost to Follow-up|0|||
49089038|NCT01276756|158160890|FG000|Overall Study|Adverse Event|3|||
49089039|NCT01276756|158160891|FG001|Overall Study|Adverse Event|2|||
49089040|NCT01209520|158160892|FG000|Overall Study|Withdrawal by Subject|3|||
49089041|NCT02887183|158160896|FG000|Overall Study|Adverse Event|44|||
49089042|NCT02887183|158160896|FG000|Overall Study|Death|30|||
49089043|NCT02887183|158160896|FG000|Overall Study|Pregnancy|1|||
49089044|NCT02887183|158160896|FG000|Overall Study|Protocol Violation|6|||
49089045|NCT02887183|158160896|FG000|Overall Study|Technical Problems|2|||
49089046|NCT02887183|158160896|FG000|Overall Study|Lost to Follow-up|13|||
49089047|NCT02887183|158160896|FG000|Overall Study|Physician Decision|10|||
49089048|NCT02887183|158160896|FG000|Overall Study|Withdrawal by Subject|35|||
49089049|NCT01031680|158160897|FG000|Overall Study|Adverse Event|8|||
49089050|NCT01031680|158160898|FG001|Overall Study|Adverse Event|3|||
49089051|NCT01031680|158160897|FG000|Overall Study|Lost to Follow-up|2|||
49089052|NCT01031680|158160898|FG001|Overall Study|Lost to Follow-up|10|||
49089053|NCT01031680|158160897|FG000|Overall Study|Withdrawal by Subject|12|||
49089054|NCT01031680|158160898|FG001|Overall Study|Withdrawal by Subject|16|||
49089055|NCT01031680|158160897|FG000|Overall Study|Death|2|||
49089056|NCT01031680|158160898|FG001|Overall Study|Death|1|||
49089057|NCT01031680|158160897|FG000|Overall Study|Subject No Longer Meets Study Criteria|26|||
49089058|NCT01031680|158160898|FG001|Overall Study|Subject No Longer Meets Study Criteria|17|||
49089059|NCT01031680|158160897|FG000|Overall Study|Poor/Non-compliance|5|||
49089060|NCT01031680|158160898|FG001|Overall Study|Poor/Non-compliance|6|||
49089061|NCT01031680|158160897|FG000|Overall Study|Safety|1|||
49089062|NCT01031680|158160898|FG001|Overall Study|Safety|0|||
49089063|NCT01031680|158160897|FG000|Overall Study|Incorrect Enrolment|1|||
49089064|NCT01031680|158160898|FG001|Overall Study|Incorrect Enrolment|2|||
49089065|NCT01031680|158160897|FG000|Overall Study|Administrative Reason by Sponsor|0|||
49089066|NCT01031680|158160898|FG001|Overall Study|Administrative Reason by Sponsor|1|||
49089067|NCT01031680|158160897|FG000|Overall Study|Various|0|||
49089068|NCT01031680|158160898|FG001|Overall Study|Various|2|||
49089069|NCT00318474|158162227|FG000|Overall Study|Adverse Event|1|||
49089070|NCT00318474|158162228|FG001|Overall Study|Adverse Event|1|||
49089071|NCT00318474|158162227|FG000|Overall Study|Lost to Follow-up|0|||
49089072|NCT00318474|158162228|FG001|Overall Study|Lost to Follow-up|1|||
49089073|NCT00318474|158162227|FG000|Overall Study|Pregnancy|0|||
49089074|NCT00318474|158162228|FG001|Overall Study|Pregnancy|2|||
49089075|NCT00318474|158162227|FG000|Overall Study|Protocol Violation|1|||
49089076|NCT00318474|158162228|FG001|Overall Study|Protocol Violation|0|||
49089077|NCT00318474|158162227|FG000|Overall Study|Withdrawal by Subject|3|||
49089078|NCT00318474|158162228|FG001|Overall Study|Withdrawal by Subject|2|||
49089079|NCT00318474|158162227|FG000|Overall Study|Fall in GFR|3|||
49089080|NCT00318474|158162228|FG001|Overall Study|Fall in GFR|3|||
49089081|NCT00318474|158162227|FG000|Overall Study|Post-therapy hyperflycemia|0|||
49089082|NCT00318474|158162228|FG001|Overall Study|Post-therapy hyperflycemia|1|||
49089083|NCT00318474|158162227|FG000|Overall Study|Trial terminated|10|||
49089084|NCT00318474|158162228|FG001|Overall Study|Trial terminated|7|||
49089085|NCT00298272|158162229|FG000|Double-blind Phase|Adverse Event|2|||
49089086|NCT00298272|158162230|FG001|Double-blind Phase|Adverse Event|0|||
49089087|NCT00298272|158162229|FG000|Double-blind Phase|Failure to Return|2|||
49089088|NCT00298272|158162230|FG001|Double-blind Phase|Failure to Return|0|||
49089089|NCT00298272|158162229|FG000|Double-blind Phase|Protocol Violation|2|||
49089090|NCT00298272|158162230|FG001|Double-blind Phase|Protocol Violation|0|||
49089091|NCT00298272|158162229|FG000|Double-blind Phase|Withdrawal by Subject|2|||
49089092|NCT00298272|158162230|FG001|Double-blind Phase|Withdrawal by Subject|0|||
49089093|NCT00298272|158162229|FG000|Open Label Retreatment Phase|Adverse Event|1|||
49089094|NCT00298272|158162230|FG001|Open Label Retreatment Phase|Adverse Event|2|||
49089095|NCT00298272|158162229|FG000|Open Label Retreatment Phase|Insufficient Therapeutic Response|2|||
49089096|NCT00298272|158162230|FG001|Open Label Retreatment Phase|Insufficient Therapeutic Response|1|||
49089097|NCT00298272|158162229|FG000|Open Label Retreatment Phase|Failure to Return|1|||
49089098|NCT00298272|158162230|FG001|Open Label Retreatment Phase|Failure to Return|0|||
49089099|NCT00298272|158162229|FG000|Open Label Retreatment Phase|Protocol Violation|2|||
49089100|NCT00298272|158162230|FG001|Open Label Retreatment Phase|Protocol Violation|1|||
49089101|NCT00298272|158162229|FG000|Open Label Retreatment Phase|Withdrawal by Subject|1|||
49089102|NCT00298272|158162230|FG001|Open Label Retreatment Phase|Withdrawal by Subject|0|||
49089103|NCT00298272|158162229|FG000|Open Label Retreatment Phase|Administrative/Other Reason|2|||
49089104|NCT00298272|158162230|FG001|Open Label Retreatment Phase|Administrative/Other Reason|0|||
49089105|NCT00298272|158162229|FG000|Safety Follow-up Phase|Failure to Return|1|||
49089106|NCT00298272|158162230|FG001|Safety Follow-up Phase|Failure to Return|1|||
49089107|NCT00298272|158162229|FG000|Safety Follow-up Phase|Withdrawal by Subject|2|||
49089108|NCT00298272|158162230|FG001|Safety Follow-up Phase|Withdrawal by Subject|2|||
49089109|NCT00298272|158162229|FG000|Safety Follow-up Phase|Administrative/Other Reason|1|||
49089110|NCT00298272|158162230|FG001|Safety Follow-up Phase|Administrative/Other Reason|1|||
49089111|NCT02151851|158162233|FG000|Overall Study|Lack of Efficacy|67|||
49089112|NCT02151851|158162234|FG001|Overall Study|Lack of Efficacy|94|||
49089113|NCT02151851|158162233|FG000|Overall Study|Protocol Violation|0|||
49089114|NCT02151851|158162234|FG001|Overall Study|Protocol Violation|1|||
49089115|NCT02151851|158162233|FG000|Overall Study|Withdrawal by Subject|2|||
49089116|NCT02151851|158162234|FG001|Overall Study|Withdrawal by Subject|5|||
49089117|NCT02151851|158162233|FG000|Overall Study|Medical impairment|1|||
49089118|NCT02151851|158162234|FG001|Overall Study|Medical impairment|0|||
49089119|NCT02151851|158162233|FG000|Overall Study|Low compliance to study visits|0|||
49089120|NCT02151851|158162234|FG001|Overall Study|Low compliance to study visits|1|||
49089121|NCT02151851|158162233|FG000|Overall Study|Subject entered into study in error|0|||
49089122|NCT02151851|158162234|FG001|Overall Study|Subject entered into study in error|1|||
49089123|NCT02151851|158162233|FG000|Overall Study|Adverse Event|6|||
49089124|NCT02151851|158162234|FG001|Overall Study|Adverse Event|28|||
49089125|NCT01703260|158162235|FG000|Overall Study|Adverse Event|1|||
49089126|NCT01703260|158162236|FG001|Overall Study|Adverse Event|2|||
49089127|NCT01703260|158162237|FG002|Overall Study|Adverse Event|2|||
49089128|NCT01703260|158162235|FG000|Overall Study|Lost to Follow-up|1|||
49089129|NCT01703260|158162236|FG001|Overall Study|Lost to Follow-up|0|||
49089130|NCT01703260|158162237|FG002|Overall Study|Lost to Follow-up|0|||
49089131|NCT01703260|158162235|FG000|Overall Study|Withdrawal by Subject|0|||
49089132|NCT01703260|158162236|FG001|Overall Study|Withdrawal by Subject|0|||
49089133|NCT01703260|158162237|FG002|Overall Study|Withdrawal by Subject|1|||
49089134|NCT01703260|158162235|FG000|Overall Study|Study Termination|1|||
49089135|NCT01703260|158162236|FG001|Overall Study|Study Termination|2|||
49089136|NCT01703260|158162237|FG002|Overall Study|Study Termination|0|||
49089137|NCT01164579|158162244|FG000|Overall Study|Lack of Efficacy|0|||
49089138|NCT01164579|158162245|FG001|Overall Study|Lack of Efficacy|0|||
49089139|NCT01164579|158162246|FG002|Overall Study|Lack of Efficacy|6|||
49089140|NCT01164579|158162244|FG000|Overall Study|Lost to Follow-up|1|||
49089141|NCT01164579|158162245|FG001|Overall Study|Lost to Follow-up|1|||
49089142|NCT01164579|158162246|FG002|Overall Study|Lost to Follow-up|0|||
49089143|NCT01164579|158162244|FG000|Overall Study|Withdrawal by Subject|2|||
49089144|NCT01164579|158162245|FG001|Overall Study|Withdrawal by Subject|5|||
49089145|NCT01164579|158162246|FG002|Overall Study|Withdrawal by Subject|3|||
49089146|NCT01164579|158162244|FG000|Overall Study|Protocol Violation|0|||
49089147|NCT01164579|158162245|FG001|Overall Study|Protocol Violation|1|||
49089148|NCT01164579|158162246|FG002|Overall Study|Protocol Violation|2|||
49089149|NCT01164579|158162244|FG000|Overall Study|Adverse Event|4|||
49089150|NCT01164579|158162245|FG001|Overall Study|Adverse Event|2|||
49089151|NCT01164579|158162246|FG002|Overall Study|Adverse Event|5|||
49089152|NCT01164579|158162244|FG000|Overall Study|Reason not specified|1|||
49089153|NCT01164579|158162245|FG001|Overall Study|Reason not specified|0|||
49089154|NCT01164579|158162246|FG002|Overall Study|Reason not specified|0|||
49089155|NCT00630825|158162249|FG000|Overall Study|Adverse Event|4|||
49089156|NCT00630825|158162250|FG001|Overall Study|Adverse Event|4|||
49089157|NCT00630825|158162251|FG002|Overall Study|Adverse Event|3|||
49089158|NCT00630825|158162252|FG003|Overall Study|Adverse Event|1|||
49089159|NCT00630825|158162249|FG000|Overall Study|Entry Criteria Not Met|1|||
49089160|NCT00630825|158162250|FG001|Overall Study|Entry Criteria Not Met|0|||
49089161|NCT00630825|158162251|FG002|Overall Study|Entry Criteria Not Met|2|||
49089162|NCT00630825|158162252|FG003|Overall Study|Entry Criteria Not Met|1|||
49089163|NCT00630825|158162249|FG000|Overall Study|Lost to Follow-up|1|||
49089164|NCT00630825|158162250|FG001|Overall Study|Lost to Follow-up|1|||
49089165|NCT00630825|158162251|FG002|Overall Study|Lost to Follow-up|1|||
49089166|NCT00630825|158162252|FG003|Overall Study|Lost to Follow-up|1|||
49089167|NCT00630825|158162249|FG000|Overall Study|Physician Decision|1|||
49089168|NCT00630825|158162250|FG001|Overall Study|Physician Decision|0|||
49089169|NCT00630825|158162251|FG002|Overall Study|Physician Decision|0|||
49089170|NCT00630825|158162252|FG003|Overall Study|Physician Decision|0|||
49089171|NCT00630825|158162249|FG000|Overall Study|Withdrawal by Subject|2|||
49089172|NCT00630825|158162250|FG001|Overall Study|Withdrawal by Subject|2|||
49089173|NCT00630825|158162251|FG002|Overall Study|Withdrawal by Subject|2|||
49089174|NCT00630825|158162252|FG003|Overall Study|Withdrawal by Subject|3|||
49089175|NCT02042014|158162253|FG000|Overall Study|Adverse Event|1|||
49089176|NCT02042014|158162253|FG000|Overall Study|Physician Decision|7|||
49089177|NCT02198664|158162257|FG000|Overall Study|Adverse Event|2|||
49089178|NCT02198664|158162258|FG001|Overall Study|Adverse Event|0|||
49089179|NCT02198664|158162257|FG000|Overall Study|Withdrawal by Subject|11|||
49089180|NCT02198664|158162258|FG001|Overall Study|Withdrawal by Subject|8|||
49089181|NCT02198664|158162257|FG000|Overall Study|Failure to tolerate|2|||
49089182|NCT02198664|158162258|FG001|Overall Study|Failure to tolerate|0|||
49089183|NCT02198664|158162257|FG000|Overall Study|Not stated|1|||
49089184|NCT02198664|158162258|FG001|Overall Study|Not stated|0|||
49089185|NCT00777296|158162261|FG000|Overall Study|Adverse Event|0|||
49089186|NCT00777296|158162262|FG001|Overall Study|Adverse Event|1|||
49089187|NCT00777296|158162263|FG002|Overall Study|Adverse Event|0|||
49089188|NCT00777296|158162264|FG003|Overall Study|Adverse Event|1|||
49089189|NCT00777296|158162261|FG000|Overall Study|Withdrawal by Subject|1|||
49089190|NCT00777296|158162262|FG001|Overall Study|Withdrawal by Subject|0|||
49089191|NCT00777296|158162263|FG002|Overall Study|Withdrawal by Subject|0|||
49089192|NCT00777296|158162264|FG003|Overall Study|Withdrawal by Subject|0|||
49089193|NCT00777296|158162261|FG000|Overall Study|CRF form not completed|0|||
49089194|NCT00777296|158162262|FG001|Overall Study|CRF form not completed|0|||
49089195|NCT00777296|158162263|FG002|Overall Study|CRF form not completed|2|||
49089196|NCT00777296|158162264|FG003|Overall Study|CRF form not completed|0|||
49089197|NCT02211209|158162265|FG000|Overall Study|Investigator judgment|0|||
49089198|NCT02211209|158162266|FG001|Overall Study|Investigator judgment|1|||
49089199|NCT02211209|158162265|FG000|Overall Study|Voluntary withdrawal|1|||
49089200|NCT02211209|158162266|FG001|Overall Study|Voluntary withdrawal|4|||
49089201|NCT02211209|158162265|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
49089202|NCT02211209|158162266|FG001|Overall Study|Adverse Event or Serious Adverse Event|9|||
49089203|NCT02211209|158162265|FG000|Overall Study|Reason Not Specified|1|||
49089204|NCT02211209|158162266|FG001|Overall Study|Reason Not Specified|0|||
49089205|NCT00507455|158162269|FG000|Overall Study|Adverse Event|3|||
49089206|NCT00507455|158162270|FG001|Overall Study|Adverse Event|3|||
49089207|NCT00507455|158162271|FG002|Overall Study|Adverse Event|6|||
49089208|NCT00507455|158162269|FG000|Overall Study|Withdrawal by Subject|2|||
49089209|NCT00507455|158162270|FG001|Overall Study|Withdrawal by Subject|1|||
49089210|NCT00507455|158162271|FG002|Overall Study|Withdrawal by Subject|2|||
49089211|NCT00507455|158162269|FG000|Overall Study|Protocol Violation|4|||
49089212|NCT00507455|158162270|FG001|Overall Study|Protocol Violation|1|||
49089213|NCT00507455|158162271|FG002|Overall Study|Protocol Violation|1|||
49089214|NCT00507455|158162269|FG000|Overall Study|Lost to Follow-up|2|||
49089215|NCT00507455|158162270|FG001|Overall Study|Lost to Follow-up|0|||
49089216|NCT00507455|158162271|FG002|Overall Study|Lost to Follow-up|2|||
49089217|NCT00507455|158162269|FG000|Overall Study|Lack of Efficacy|0|||
49089218|NCT00507455|158162270|FG001|Overall Study|Lack of Efficacy|1|||
49089219|NCT00507455|158162271|FG002|Overall Study|Lack of Efficacy|0|||
49089220|NCT00507455|158162269|FG000|Overall Study|Other - miscellaneous reason|1|||
49089221|NCT00507455|158162270|FG001|Overall Study|Other - miscellaneous reason|0|||
49089222|NCT00507455|158162271|FG002|Overall Study|Other - miscellaneous reason|1|||
49089223|NCT03876743|158162272|FG000|Overall Study|Lost to Follow-up|6|||
49089224|NCT03876743|158162273|FG001|Overall Study|Lost to Follow-up|4|||
49089225|NCT03876743|158162274|FG002|Overall Study|Lost to Follow-up|4|||
49089226|NCT03876743|158162275|FG003|Overall Study|Lost to Follow-up|7|||
49089227|NCT03889418|158162276|FG000|April-June 2019 (Months 0-3)|Protocol Violation|1|||
49089228|NCT03889418|158162277|FG001|April-June 2019 (Months 0-3)|Protocol Violation|0|||
49089229|NCT03889418|158162278|FG002|April-June 2019 (Months 0-3)|Protocol Violation|0|||
49089230|NCT03889418|158162279|FG003|April-June 2019 (Months 0-3)|Protocol Violation|0|||
49089231|NCT03889418|158162280|FG004|April-June 2019 (Months 0-3)|Protocol Violation|0|||
49089232|NCT03889418|158162281|FG005|April-June 2019 (Months 0-3)|Protocol Violation|0|||
49089233|NCT03889418|158162282|FG006|April-June 2019 (Months 0-3)|Protocol Violation|0|||
49089234|NCT03889418|158162283|FG007|April-June 2019 (Months 0-3)|Protocol Violation|0|||
49089235|NCT03889418|158162284|FG008|April-June 2019 (Months 0-3)|Protocol Violation|0|||
49089236|NCT03889418|158162285|FG009|April-June 2019 (Months 0-3)|Protocol Violation|0|||
49089237|NCT03889418|158162276|FG000|July-September 2019 (Months 4-6)|Protocol Violation|0|||
49089238|NCT03889418|158162277|FG001|July-September 2019 (Months 4-6)|Protocol Violation|1|||
49089239|NCT03889418|158162278|FG002|July-September 2019 (Months 4-6)|Protocol Violation|1|||
49089240|NCT03889418|158162279|FG003|July-September 2019 (Months 4-6)|Protocol Violation|0|||
49089241|NCT03889418|158162280|FG004|July-September 2019 (Months 4-6)|Protocol Violation|0|||
49089242|NCT03889418|158162281|FG005|July-September 2019 (Months 4-6)|Protocol Violation|0|||
49089243|NCT03889418|158162282|FG006|July-September 2019 (Months 4-6)|Protocol Violation|0|||
49089244|NCT03889418|158162283|FG007|July-September 2019 (Months 4-6)|Protocol Violation|0|||
49089245|NCT03889418|158162284|FG008|July-September 2019 (Months 4-6)|Protocol Violation|0|||
49089246|NCT03889418|158162285|FG009|July-September 2019 (Months 4-6)|Protocol Violation|0|||
49089247|NCT03889418|158162276|FG000|October-December 2019 (Month 7-9)|Death|0|||
49089248|NCT03889418|158162277|FG001|October-December 2019 (Month 7-9)|Death|0|||
49089249|NCT03889418|158162278|FG002|October-December 2019 (Month 7-9)|Death|0|||
49089250|NCT03889418|158162279|FG003|October-December 2019 (Month 7-9)|Death|0|||
49089251|NCT03889418|158162280|FG004|October-December 2019 (Month 7-9)|Death|0|||
49089252|NCT03889418|158162281|FG005|October-December 2019 (Month 7-9)|Death|0|||
49089253|NCT03889418|158162282|FG006|October-December 2019 (Month 7-9)|Death|0|||
49089254|NCT03889418|158162283|FG007|October-December 2019 (Month 7-9)|Death|0|||
49089255|NCT03889418|158162284|FG008|October-December 2019 (Month 7-9)|Death|1|||
49089256|NCT03889418|158162285|FG009|October-December 2019 (Month 7-9)|Death|0|||
49089257|NCT03889418|158162276|FG000|January - March 2020 (Month 10-12)|Protocol Violation|0|||
49089258|NCT03889418|158162277|FG001|January - March 2020 (Month 10-12)|Protocol Violation|0|||
49089259|NCT03889418|158162278|FG002|January - March 2020 (Month 10-12)|Protocol Violation|0|||
49089260|NCT03889418|158162279|FG003|January - March 2020 (Month 10-12)|Protocol Violation|1|||
49089261|NCT03889418|158162280|FG004|January - March 2020 (Month 10-12)|Protocol Violation|0|||
49089262|NCT03889418|158162281|FG005|January - March 2020 (Month 10-12)|Protocol Violation|0|||
49089263|NCT03889418|158162282|FG006|January - March 2020 (Month 10-12)|Protocol Violation|0|||
49089264|NCT03889418|158162283|FG007|January - March 2020 (Month 10-12)|Protocol Violation|2|||
49089265|NCT03889418|158162284|FG008|January - March 2020 (Month 10-12)|Protocol Violation|0|||
49089266|NCT03889418|158162285|FG009|January - March 2020 (Month 10-12)|Protocol Violation|0|||
49089267|NCT03889418|158162276|FG000|April - June 2020 (Month 13-15)|Death|0|||
49089268|NCT03889418|158162277|FG001|April - June 2020 (Month 13-15)|Death|1|||
49089269|NCT03889418|158162278|FG002|April - June 2020 (Month 13-15)|Death|0|||
49089270|NCT03889418|158162279|FG003|April - June 2020 (Month 13-15)|Death|0|||
49089271|NCT03889418|158162280|FG004|April - June 2020 (Month 13-15)|Death|0|||
49089272|NCT03889418|158162281|FG005|April - June 2020 (Month 13-15)|Death|0|||
49089273|NCT03889418|158162282|FG006|April - June 2020 (Month 13-15)|Death|0|||
49089274|NCT03889418|158162283|FG007|April - June 2020 (Month 13-15)|Death|0|||
49089275|NCT03889418|158162284|FG008|April - June 2020 (Month 13-15)|Death|0|||
49089276|NCT03889418|158162285|FG009|April - June 2020 (Month 13-15)|Death|0|||
49089277|NCT03889418|158162276|FG000|April - June 2020 (Month 13-15)|Protocol Violation|0|||
49089278|NCT03889418|158162277|FG001|April - June 2020 (Month 13-15)|Protocol Violation|0|||
49089279|NCT03889418|158162278|FG002|April - June 2020 (Month 13-15)|Protocol Violation|0|||
49089280|NCT03889418|158162279|FG003|April - June 2020 (Month 13-15)|Protocol Violation|1|||
49089281|NCT03889418|158162280|FG004|April - June 2020 (Month 13-15)|Protocol Violation|0|||
49089282|NCT03889418|158162281|FG005|April - June 2020 (Month 13-15)|Protocol Violation|0|||
49089283|NCT03889418|158162282|FG006|April - June 2020 (Month 13-15)|Protocol Violation|0|||
49089284|NCT03889418|158162283|FG007|April - June 2020 (Month 13-15)|Protocol Violation|0|||
49089285|NCT03889418|158162284|FG008|April - June 2020 (Month 13-15)|Protocol Violation|0|||
49089286|NCT03889418|158162285|FG009|April - June 2020 (Month 13-15)|Protocol Violation|0|||
49089287|NCT03889418|158162276|FG000|July 2020 - January 2022 (Month 16-28)|Death|1|||
49089288|NCT03889418|158162277|FG001|July 2020 - January 2022 (Month 16-28)|Death|0|||
49089289|NCT03889418|158162278|FG002|July 2020 - January 2022 (Month 16-28)|Death|2|||
49089290|NCT03889418|158162279|FG003|July 2020 - January 2022 (Month 16-28)|Death|1|||
49089291|NCT03889418|158162280|FG004|July 2020 - January 2022 (Month 16-28)|Death|0|||
49089292|NCT03889418|158162281|FG005|July 2020 - January 2022 (Month 16-28)|Death|0|||
49089293|NCT03889418|158162282|FG006|July 2020 - January 2022 (Month 16-28)|Death|0|||
49089294|NCT03889418|158162283|FG007|July 2020 - January 2022 (Month 16-28)|Death|1|||
49089295|NCT03889418|158162284|FG008|July 2020 - January 2022 (Month 16-28)|Death|0|||
49089296|NCT03889418|158162285|FG009|July 2020 - January 2022 (Month 16-28)|Death|0|||
49089297|NCT03889418|158162276|FG000|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
49089298|NCT03889418|158162277|FG001|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
49089299|NCT03889418|158162278|FG002|July 2020 - January 2022 (Month 16-28)|Protocol Violation|2|||
49089300|NCT03889418|158162279|FG003|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
49089301|NCT03889418|158162280|FG004|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
49089302|NCT03889418|158162281|FG005|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
49089303|NCT03889418|158162282|FG006|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
49089304|NCT03889418|158162283|FG007|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
49089305|NCT03889418|158162284|FG008|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
49089306|NCT03889418|158162285|FG009|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
49089307|NCT02019264|158162286|FG000|Overall Study|Not treated|6|||
49089308|NCT02019264|158162287|FG001|Overall Study|Not treated|4|||
49089309|NCT02019264|158162286|FG000|Overall Study|Lost to Follow-up|50|||
49089310|NCT02019264|158162287|FG001|Overall Study|Lost to Follow-up|47|||
49089311|NCT02019264|158162286|FG000|Overall Study|Withdrawal by Subject|142|||
49089312|NCT02019264|158162287|FG001|Overall Study|Withdrawal by Subject|117|||
49089313|NCT02019264|158162286|FG000|Overall Study|Administrative reason|36|||
49089314|NCT02019264|158162287|FG001|Overall Study|Administrative reason|28|||
49089315|NCT02019264|158162286|FG000|Overall Study|Missing|14|||
49089316|NCT02019264|158162287|FG001|Overall Study|Missing|11|||
49089317|NCT06110494|158162290|FG000|Overall Study|Protocol Violation|2|||
49089318|NCT06110494|158162291|FG001|Overall Study|Protocol Violation|0|||
49089319|NCT06110494|158162292|FG002|Overall Study|Protocol Violation|1|||
49089320|NCT06110494|158162290|FG000|Overall Study|Dixon's test for outlier analysis|1|||
49089321|NCT06110494|158162291|FG001|Overall Study|Dixon's test for outlier analysis|1|||
49089322|NCT06110494|158162292|FG002|Overall Study|Dixon's test for outlier analysis|0|||
49089323|NCT00427648|158162294|FG000|Overall Study|Protocol Violation|1|||
49089324|NCT00427648|158162295|FG001|Overall Study|Protocol Violation|2|||
49089325|NCT00427648|158162294|FG000|Overall Study|Adverse Event|0|||
49089326|NCT00427648|158162295|FG001|Overall Study|Adverse Event|1|||
49089327|NCT03570619|158162298|FG000|Overall Study|Adverse Event|2|||
49089328|NCT03570619|158162299|FG001|Overall Study|Adverse Event|0|||
49089329|NCT03570619|158162300|FG002|Overall Study|Adverse Event|1|||
49089330|NCT03570619|158162298|FG000|Overall Study|new diagnosis of new malignancy|1|||
49089331|NCT03570619|158162299|FG001|Overall Study|new diagnosis of new malignancy|0|||
49089332|NCT03570619|158162300|FG002|Overall Study|new diagnosis of new malignancy|0|||
49089333|NCT03570619|158162298|FG000|Overall Study|Physician Decision|1|||
49089334|NCT03570619|158162299|FG001|Overall Study|Physician Decision|1|||
49089335|NCT03570619|158162300|FG002|Overall Study|Physician Decision|0|||
49089336|NCT03570619|158162298|FG000|Overall Study|Withdrawal by Subject|0|||
49089337|NCT03570619|158162299|FG001|Overall Study|Withdrawal by Subject|2|||
49089338|NCT03570619|158162300|FG002|Overall Study|Withdrawal by Subject|0|||
49089339|NCT00954941|158162301|FG000|Overall Study|Received treatment at home|1|||
49089340|NCT00954941|158162302|FG001|Overall Study|Received treatment at home|0|||
49089341|NCT00954941|158162301|FG000|Overall Study|Withdrawal by Subject|1|||
49089342|NCT00954941|158162302|FG001|Overall Study|Withdrawal by Subject|0|||
49089343|NCT00954941|158162301|FG000|Overall Study|Insurance Denial|2|||
49089344|NCT00954941|158162302|FG001|Overall Study|Insurance Denial|2|||
49089345|NCT00954941|158162301|FG000|Overall Study|Physician Decision|2|||
49089346|NCT00954941|158162302|FG001|Overall Study|Physician Decision|2|||
49089347|NCT00954941|158162301|FG000|Overall Study|Ineligible|2|||
49089348|NCT00954941|158162302|FG001|Overall Study|Ineligible|2|||
49089349|NCT00954941|158162301|FG000|Overall Study|Adverse Event|0|||
49089350|NCT00954941|158162302|FG001|Overall Study|Adverse Event|1|||
49089351|NCT01297517|158162303|FG000|Overall Study|Adverse Event|21|||
49089352|NCT01297517|158162304|FG001|Overall Study|Adverse Event|7|||
49089353|NCT01297517|158162305|FG002|Overall Study|Adverse Event|16|||
49089354|NCT01297517|158162303|FG000|Overall Study|Lost to Follow-up|1|||
49089355|NCT01297517|158162304|FG001|Overall Study|Lost to Follow-up|0|||
49089356|NCT01297517|158162305|FG002|Overall Study|Lost to Follow-up|1|||
49089357|NCT01297517|158162303|FG000|Overall Study|Patient Decision Unrelated to AE|2|||
49089358|NCT01297517|158162304|FG001|Overall Study|Patient Decision Unrelated to AE|3|||
49089359|NCT01297517|158162305|FG002|Overall Study|Patient Decision Unrelated to AE|7|||
49089360|NCT01297517|158162303|FG000|Overall Study|Noncompliance|1|||
49089361|NCT01297517|158162304|FG001|Overall Study|Noncompliance|0|||
49089362|NCT01297517|158162305|FG002|Overall Study|Noncompliance|0|||
49089363|NCT01297517|158162303|FG000|Overall Study|Protocol Violation|1|||
49089364|NCT01297517|158162304|FG001|Overall Study|Protocol Violation|1|||
49089365|NCT01297517|158162305|FG002|Overall Study|Protocol Violation|1|||
49089366|NCT01297517|158162303|FG000|Overall Study|Inadequate Control of IOP|1|||
49089367|NCT01297517|158162304|FG001|Overall Study|Inadequate Control of IOP|1|||
49089368|NCT01297517|158162305|FG002|Overall Study|Inadequate Control of IOP|2|||
49089369|NCT00410813|158162306|FG000|Overall Study|Adverse Event|6|||
49089370|NCT00410813|158162307|FG001|Overall Study|Adverse Event|11|||
49089371|NCT00410813|158162306|FG000|Overall Study|Progression|32|||
49089372|NCT00410813|158162307|FG001|Overall Study|Progression|21|||
49089373|NCT00410813|158162306|FG000|Overall Study|Not protocol specified|3|||
49089374|NCT00410813|158162307|FG001|Overall Study|Not protocol specified|4|||
49089375|NCT00410813|158162306|FG000|Overall Study|Ineligible|2|||
49089376|NCT00410813|158162307|FG001|Overall Study|Ineligible|4|||
49089377|NCT00410813|158162306|FG000|Overall Study|Death|0|||
49089378|NCT00410813|158162307|FG001|Overall Study|Death|2|||
49089379|NCT01609296|158162308|FG000|Overall Study|Death|253|||
49089380|NCT01609296|158162308|FG000|Overall Study|Withdrawal by Subject|151|||
49089381|NCT01609296|158162308|FG000|Overall Study|Lost to Follow-up|21|||
49089382|NCT01609296|158162308|FG000|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35|||
49089383|NCT01609296|158162308|FG000|Overall Study|missed visit but known to be alive|28|||
49089384|NCT01288937|158162309|FG000|Overall Study|Adverse Event|1|||
49089385|NCT01288937|158162310|FG001|Overall Study|Adverse Event|0|||
49089386|NCT02684097|158162311|FG000|Overall Study|Lack of Efficacy|13|||
49089387|NCT02684097|158162312|FG001|Overall Study|Lack of Efficacy|6|||
49089388|NCT01580670|158162313|FG000|Maintenance Period (Week 14 to 54)|Adverse Event|1|||
49089389|NCT01580670|158162313|FG000|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1|||
49089390|NCT00462709|158162314|FG000|Overall Study|Transitioned to commercial C1INH-nf|40|||
49089391|NCT00462709|158162314|FG000|Overall Study|Lost to Follow-up|10|||
49089392|NCT00462709|158162314|FG000|Overall Study|Withdrawal by Subject|8|||
49089393|NCT00462709|158162314|FG000|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3|||
49089394|NCT00462709|158162314|FG000|Overall Study|Death|2|||
49089395|NCT00462709|158162314|FG000|Overall Study|Logistical reasons|2|||
49089396|NCT00462709|158162314|FG000|Overall Study|Physician Decision|1|||
49089397|NCT00462709|158162314|FG000|Overall Study|Withdrew to start treatment with Cetor|1|||
49089398|NCT00460811|158162315|FG000|Overall Study|Adverse Event|4|||
49089399|NCT00460811|158162316|FG001|Overall Study|Adverse Event|6|||
49089400|NCT00460811|158162317|FG002|Overall Study|Adverse Event|3|||
49089401|NCT00460811|158162318|FG003|Overall Study|Adverse Event|10|||
49089402|NCT00460811|158162319|FG004|Overall Study|Adverse Event|2|||
49089403|NCT00460811|158162315|FG000|Overall Study|Noncompliance|1|||
49089404|NCT00460811|158162316|FG001|Overall Study|Noncompliance|0|||
49089405|NCT00460811|158162317|FG002|Overall Study|Noncompliance|0|||
49089406|NCT00460811|158162318|FG003|Overall Study|Noncompliance|2|||
49089407|NCT00460811|158162319|FG004|Overall Study|Noncompliance|1|||
49089408|NCT00460811|158162315|FG000|Overall Study|Withdrawal by Subject|7|||
49089409|NCT00460811|158162316|FG001|Overall Study|Withdrawal by Subject|7|||
49089410|NCT00460811|158162317|FG002|Overall Study|Withdrawal by Subject|6|||
49089411|NCT00460811|158162318|FG003|Overall Study|Withdrawal by Subject|3|||
49089412|NCT00460811|158162319|FG004|Overall Study|Withdrawal by Subject|11|||
49089413|NCT00460811|158162315|FG000|Overall Study|Physician Decision|1|||
49089414|NCT00460811|158162316|FG001|Overall Study|Physician Decision|0|||
49089415|NCT00460811|158162317|FG002|Overall Study|Physician Decision|0|||
49089416|NCT00460811|158162318|FG003|Overall Study|Physician Decision|0|||
49089417|NCT00460811|158162319|FG004|Overall Study|Physician Decision|0|||
49089418|NCT00460811|158162315|FG000|Overall Study|Lost to Follow-up|3|||
49089419|NCT00460811|158162316|FG001|Overall Study|Lost to Follow-up|2|||
49089420|NCT00460811|158162317|FG002|Overall Study|Lost to Follow-up|5|||
49089421|NCT00460811|158162318|FG003|Overall Study|Lost to Follow-up|3|||
49089422|NCT00460811|158162319|FG004|Overall Study|Lost to Follow-up|6|||
49089423|NCT02097745|158162320|FG000|Overall Study|Adverse Event|25|||
49089424|NCT02097745|158162320|FG000|Overall Study|Death|16|||
49089425|NCT02097745|158162320|FG000|Overall Study|Failure to Return|14|||
49089426|NCT02097745|158162320|FG000|Overall Study|Administrative/Other|27|||
49089427|NCT02097745|158162320|FG000|Overall Study|Reason Not Specified|96|||
49089428|NCT02159053|158162321|FG000|Overall Study|Death|2|||
49089429|NCT02159053|158162322|FG001|Overall Study|Death|0|||
49089430|NCT02159053|158162323|FG002|Overall Study|Death|1|||
49089431|NCT02159053|158162321|FG000|Overall Study|Physician Decision|0|||
49089432|NCT02159053|158162322|FG001|Overall Study|Physician Decision|1|||
49089433|NCT02159053|158162323|FG002|Overall Study|Physician Decision|1|||
49089434|NCT02159053|158162321|FG000|Overall Study|Lack of Efficacy|3|||
49089435|NCT02159053|158162322|FG001|Overall Study|Lack of Efficacy|4|||
49089436|NCT02159053|158162323|FG002|Overall Study|Lack of Efficacy|7|||
49089437|NCT02159053|158162321|FG000|Overall Study|Adverse Event|7|||
49089438|NCT02159053|158162322|FG001|Overall Study|Adverse Event|6|||
49089439|NCT02159053|158162323|FG002|Overall Study|Adverse Event|5|||
49089440|NCT02159053|158162321|FG000|Overall Study|Participants/guardian decision|8|||
49089441|NCT02159053|158162322|FG001|Overall Study|Participants/guardian decision|10|||
49089442|NCT02159053|158162323|FG002|Overall Study|Participants/guardian decision|6|||
49089443|NCT02821754|158162324|FG000|Overall Study|Procedure not required prior to amendment change|13|||
49089444|NCT02821754|158162325|FG001|Overall Study|Procedure not required prior to amendment change|11|||
49089445|NCT02821754|158162326|FG002|Overall Study|Procedure not required prior to amendment change|0|||
49089446|NCT02821754|158162324|FG000|Overall Study|Participant's Clinical status|2|||
49089447|NCT02821754|158162325|FG001|Overall Study|Participant's Clinical status|0|||
49089448|NCT02821754|158162326|FG002|Overall Study|Participant's Clinical status|0|||
49089449|NCT02821754|158162324|FG000|Overall Study|Participant removed for noncompliance|1|||
49089450|NCT02821754|158162325|FG001|Overall Study|Participant removed for noncompliance|0|||
49089451|NCT02821754|158162326|FG002|Overall Study|Participant removed for noncompliance|0|||
49089452|NCT02821754|158162324|FG000|Overall Study|Drug not available.|0|||
49089453|NCT02821754|158162325|FG001|Overall Study|Drug not available.|0|||
49089454|NCT02821754|158162326|FG002|Overall Study|Drug not available.|1|||
49089455|NCT02821754|158162324|FG000|Overall Study|Participant declined to participate (before treatment started.)|0|||
49089456|NCT02821754|158162325|FG001|Overall Study|Participant declined to participate (before treatment started.)|1|||
49089457|NCT02821754|158162326|FG002|Overall Study|Participant declined to participate (before treatment started.)|1|||
49089458|NCT02203721|158162330|FG000|Overall Study|Lost to Follow-up|1|||
49089459|NCT02203721|158162331|FG001|Overall Study|Lost to Follow-up|0|||
49089460|NCT02203721|158162330|FG000|Overall Study|Death|0|||
49089461|NCT02203721|158162331|FG001|Overall Study|Death|2|||
49089462|NCT02203721|158162330|FG000|Overall Study|Illness|0|||
49089463|NCT02203721|158162331|FG001|Overall Study|Illness|1|||
49089464|NCT02593097|158162339|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
49089465|NCT02593097|158162340|FG001|First Intervention (12 Weeks)|Lost to Follow-up|2|||
49089466|NCT02593097|158162339|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
49089467|NCT02593097|158162340|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
49089468|NCT02593097|158162339|FG000|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
49089469|NCT02593097|158162340|FG001|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
49089470|NCT02593097|158162339|FG000|Second Intervention (12 Weeks)|Lack of Efficacy|1|||
49089471|NCT02593097|158162340|FG001|Second Intervention (12 Weeks)|Lack of Efficacy|0|||
49089472|NCT02593097|158162339|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
49089473|NCT02593097|158162340|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
49089474|NCT01896128|158162341|FG000|Overall Study|Withdrawal by Subject|3|||
49089475|NCT01896128|158162342|FG001|Overall Study|Withdrawal by Subject|3|||
49089476|NCT03682848|158162343|FG000|Overall Study|Withdrawal by Subject|2|||
49089477|NCT03682848|158162343|FG000|Overall Study|Site closed|5|||
49089478|NCT03682848|158162343|FG000|Overall Study|Protocol Deviation|1|||
49089479|NCT03682848|158162343|FG000|Overall Study|Adverse Event|1|||
49089480|NCT00961350|158162344|FG000|Overall Study|Adverse Event|18|||
49089481|NCT00961350|158162345|FG001|Overall Study|Adverse Event|33|||
49089482|NCT00961350|158162344|FG000|Overall Study|Withdrawal by Subject|10|||
49089483|NCT00961350|158162345|FG001|Overall Study|Withdrawal by Subject|10|||
49089484|NCT00961350|158162344|FG000|Overall Study|Lost to Follow-up|3|||
49089485|NCT00961350|158162345|FG001|Overall Study|Lost to Follow-up|3|||
49089486|NCT00961350|158162344|FG000|Overall Study|Misc|16|||
49089487|NCT00961350|158162345|FG001|Overall Study|Misc|21|||
49089488|NCT03478644|158162346|FG000|Phase 2|Withdrawal by Subject|2|||
49089489|NCT03478644|158162347|FG001|Phase 2|Withdrawal by Subject|1|||
49089490|NCT03478644|158162346|FG000|Phase 2|Lost to Follow-up|1|||
49089491|NCT03478644|158162347|FG001|Phase 2|Lost to Follow-up|0|||
49089492|NCT01029782|158162351|FG000|Overall Study|Lost to Follow-up|2|||
49089493|NCT01029782|158162352|FG001|Overall Study|Lost to Follow-up|2|||
49089494|NCT01029782|158162351|FG000|Overall Study|Diagnosis changed|1|||
49089495|NCT01029782|158162352|FG001|Overall Study|Diagnosis changed|1|||
49089496|NCT01029782|158162351|FG000|Overall Study|Adverse Event|0|||
49089497|NCT01029782|158162352|FG001|Overall Study|Adverse Event|1|||
49089498|NCT01029782|158162351|FG000|Overall Study|Physician Decision|0|||
49089499|NCT01029782|158162352|FG001|Overall Study|Physician Decision|1|||
49089500|NCT01029782|158162351|FG000|Overall Study|Protocol Violation|0|||
49089501|NCT01029782|158162352|FG001|Overall Study|Protocol Violation|2|||
49089502|NCT01029782|158162351|FG000|Overall Study|Withdrawal by Subject|0|||
49089503|NCT01029782|158162352|FG001|Overall Study|Withdrawal by Subject|1|||
49089504|NCT02844543|158164029|FG000|Overall Study|Withdrawal by Subject|4|||
49089505|NCT02844543|158164029|FG000|Overall Study|Did not meet eligibility criteria|1|||
49089506|NCT03349060|158164030|FG000|Overall Study|Adverse Event|9|||
49089507|NCT03349060|158164031|FG001|Overall Study|Adverse Event|9|||
49089508|NCT03349060|158164032|FG002|Overall Study|Adverse Event|7|||
49089509|NCT03349060|158164030|FG000|Overall Study|Lack of Efficacy|1|||
49089510|NCT03349060|158164031|FG001|Overall Study|Lack of Efficacy|0|||
49089511|NCT03349060|158164032|FG002|Overall Study|Lack of Efficacy|2|||
49089512|NCT03349060|158164030|FG000|Overall Study|Lost to Follow-up|2|||
49089513|NCT03349060|158164031|FG001|Overall Study|Lost to Follow-up|1|||
49089514|NCT03349060|158164032|FG002|Overall Study|Lost to Follow-up|1|||
49089515|NCT03349060|158164030|FG000|Overall Study|Protocol Violation|2|||
49089516|NCT03349060|158164031|FG001|Overall Study|Protocol Violation|2|||
49089517|NCT03349060|158164032|FG002|Overall Study|Protocol Violation|1|||
49089518|NCT03349060|158164030|FG000|Overall Study|Withdrawal by Subject|5|||
49089519|NCT03349060|158164031|FG001|Overall Study|Withdrawal by Subject|3|||
49089520|NCT03349060|158164032|FG002|Overall Study|Withdrawal by Subject|4|||
49089521|NCT03349060|158164030|FG000|Overall Study|Medication error,no linked adverse event|0|||
49089522|NCT03349060|158164031|FG001|Overall Study|Medication error,no linked adverse event|0|||
49089523|NCT03349060|158164032|FG002|Overall Study|Medication error,no linked adverse event|1|||
49089524|NCT03349060|158164030|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
49089525|NCT03349060|158164031|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
49089526|NCT03349060|158164032|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
49089527|NCT03349060|158164030|FG000|Overall Study|Other|2|||
49089528|NCT03349060|158164031|FG001|Overall Study|Other|1|||
49089529|NCT03349060|158164032|FG002|Overall Study|Other|0|||
49089530|NCT01996241|158164037|FG000|Overall Study|Lost to Follow-up|252|||
49089531|NCT01996241|158164038|FG001|Overall Study|Lost to Follow-up|235|||
49089532|NCT00086684|158164046|FG000|Overall Study|Adverse Event|12|||
49089533|NCT00086684|158164047|FG001|Overall Study|Adverse Event|17|||
49089534|NCT00086684|158164048|FG002|Overall Study|Adverse Event|14|||
49089535|NCT00086684|158164046|FG000|Overall Study|Lack of Efficacy|6|||
49089536|NCT00086684|158164047|FG001|Overall Study|Lack of Efficacy|6|||
49089537|NCT00086684|158164048|FG002|Overall Study|Lack of Efficacy|5|||
49089538|NCT00086684|158164046|FG000|Overall Study|Lost to Follow-up|15|||
49089539|NCT00086684|158164047|FG001|Overall Study|Lost to Follow-up|8|||
49089540|NCT00086684|158164048|FG002|Overall Study|Lost to Follow-up|10|||
49089541|NCT00086684|158164046|FG000|Overall Study|Protocol Violation|8|||
49089542|NCT00086684|158164047|FG001|Overall Study|Protocol Violation|3|||
49089543|NCT00086684|158164048|FG002|Overall Study|Protocol Violation|0|||
49089544|NCT00086684|158164046|FG000|Overall Study|Withdrawal by Subject|0|||
49089545|NCT00086684|158164047|FG001|Overall Study|Withdrawal by Subject|4|||
49089546|NCT00086684|158164048|FG002|Overall Study|Withdrawal by Subject|10|||
49089547|NCT00086684|158164046|FG000|Overall Study|NONCOMPLIANCE|5|||
49089548|NCT00086684|158164047|FG001|Overall Study|NONCOMPLIANCE|7|||
49089549|NCT00086684|158164048|FG002|Overall Study|NONCOMPLIANCE|6|||
49089550|NCT00086684|158164046|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
49089551|NCT00086684|158164047|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
49089552|NCT00086684|158164048|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
49089553|NCT00086684|158164046|FG000|Overall Study|WITHDRAWAL OF CONSENT|5|||
49089554|NCT00086684|158164047|FG001|Overall Study|WITHDRAWAL OF CONSENT|7|||
49089555|NCT00086684|158164048|FG002|Overall Study|WITHDRAWAL OF CONSENT|5|||
49089556|NCT00086684|158164046|FG000|Overall Study|Other|4|||
49089557|NCT00086684|158164047|FG001|Overall Study|Other|2|||
49089558|NCT00086684|158164048|FG002|Overall Study|Other|3|||
49089559|NCT00915018|158164049|FG000|Overall Study|Death|75|||
49089560|NCT00915018|158164050|FG001|Overall Study|Death|70|||
49089561|NCT00915018|158164049|FG000|Overall Study|Lost to Follow-up|10|||
49089562|NCT00915018|158164050|FG001|Overall Study|Lost to Follow-up|5|||
49089563|NCT00915018|158164049|FG000|Overall Study|Withdrawal by Subject|38|||
49089564|NCT00915018|158164050|FG001|Overall Study|Withdrawal by Subject|27|||
49089565|NCT00915018|158164049|FG000|Overall Study|By Sponsor due to Protocol Amendment|92|||
49089566|NCT00915018|158164050|FG001|Overall Study|By Sponsor due to Protocol Amendment|105|||
49089567|NCT01611935|158164055|FG000|Overall Study|Family Declined Participation|1|||
49089568|NCT01611935|158164056|FG001|Overall Study|Family Declined Participation|0|||
49089569|NCT00457002|158164057|FG000|Overall Study|Death|40|||
49089570|NCT00457002|158164058|FG001|Overall Study|Death|47|||
49089571|NCT00457002|158164057|FG000|Overall Study|Adverse Event|284|||
49089572|NCT00457002|158164058|FG001|Overall Study|Adverse Event|260|||
49089573|NCT00457002|158164057|FG000|Overall Study|Withdrawal by Subject|299|||
49089574|NCT00457002|158164058|FG001|Overall Study|Withdrawal by Subject|271|||
49089575|NCT00457002|158164057|FG000|Overall Study|Lost to Follow-up|72|||
49089576|NCT00457002|158164058|FG001|Overall Study|Lost to Follow-up|71|||
49089577|NCT00457002|158164057|FG000|Overall Study|Poor/Non-compliance|46|||
49089578|NCT00457002|158164058|FG001|Overall Study|Poor/Non-compliance|33|||
49089579|NCT00457002|158164057|FG000|Overall Study|No longer met criteria|41|||
49089580|NCT00457002|158164058|FG001|Overall Study|No longer met criteria|37|||
49089581|NCT00457002|158164057|FG000|Overall Study|Administrative reason by Sponsor|1|||
49089582|NCT00457002|158164058|FG001|Overall Study|Administrative reason by Sponsor|0|||
49089583|NCT00457002|158164057|FG000|Overall Study|non-specified|29|||
49089584|NCT00457002|158164058|FG001|Overall Study|non-specified|38|||
49089585|NCT00457002|158164057|FG000|Overall Study|treated for 1 day; missing status/reason|1|||
49089586|NCT00457002|158164058|FG001|Overall Study|treated for 1 day; missing status/reason|0|||
49089587|NCT02547428|158164066|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|8|||
49089588|NCT02547428|158164067|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|1|||
49089589|NCT02547428|158164066|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
49089590|NCT02547428|158164067|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
49089591|NCT02547428|158164066|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
49089592|NCT02547428|158164067|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
49089593|NCT02547428|158164066|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|1|||
49089594|NCT02547428|158164067|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|3|||
49089595|NCT02547428|158164066|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|0|||
49089596|NCT02547428|158164067|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|3|||
49089597|NCT02547428|158164066|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|0|||
49089598|NCT02547428|158164067|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|3|||
49089599|NCT02547428|158164066|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|0|||
49089600|NCT02547428|158164067|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|1|||
49089601|NCT02547428|158164066|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|1|||
49089602|NCT02547428|158164067|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|0|||
49089603|NCT03318861|158164068|FG000|Overall Study|Death|2|||
49089604|NCT03318861|158164069|FG001|Overall Study|Death|3|||
49089605|NCT03318861|158164070|FG002|Overall Study|Death|3|||
49089606|NCT03318861|158164071|FG003|Overall Study|Death|2|||
49089607|NCT03318861|158164072|FG004|Overall Study|Death|2|||
49089608|NCT03318861|158164068|FG000|Overall Study|Enrolled But Never Treated|0|||
49089609|NCT03318861|158164069|FG001|Overall Study|Enrolled But Never Treated|1|||
49089610|NCT03318861|158164070|FG002|Overall Study|Enrolled But Never Treated|0|||
49089611|NCT03318861|158164071|FG003|Overall Study|Enrolled But Never Treated|1|||
49089612|NCT03318861|158164072|FG004|Overall Study|Enrolled But Never Treated|1|||
49089613|NCT03318861|158164068|FG000|Overall Study|Informed Consent Withdraw|0|||
49089614|NCT03318861|158164069|FG001|Overall Study|Informed Consent Withdraw|0|||
49089615|NCT03318861|158164070|FG002|Overall Study|Informed Consent Withdraw|0|||
49089616|NCT03318861|158164071|FG003|Overall Study|Informed Consent Withdraw|1|||
49089617|NCT03318861|158164072|FG004|Overall Study|Informed Consent Withdraw|0|||
49089618|NCT03318861|158164068|FG000|Overall Study|Withdrawal of Consent From Further Follow-up|1|||
49089619|NCT03318861|158164069|FG001|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
49089620|NCT03318861|158164070|FG002|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
49089621|NCT03318861|158164071|FG003|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
49089622|NCT03318861|158164072|FG004|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
49089623|NCT00917852|158164074|FG000|Overall Study|Death|6|||
49089624|NCT01609010|158164077|FG000|Overall Study|Stable disease (SD)|22|||
49089625|NCT01609010|158164078|FG001|Overall Study|Stable disease (SD)|16|||
49089626|NCT01609010|158164077|FG000|Overall Study|Progressive disease (PD)|8|||
49089627|NCT01609010|158164078|FG001|Overall Study|Progressive disease (PD)|10|||
49089628|NCT01609010|158164077|FG000|Overall Study|Adverse Event|3|||
49089629|NCT01609010|158164078|FG001|Overall Study|Adverse Event|6|||
49089630|NCT01609010|158164077|FG000|Overall Study|Withdrawal by Subject|2|||
49089631|NCT01609010|158164078|FG001|Overall Study|Withdrawal by Subject|2|||
49089632|NCT01609010|158164077|FG000|Overall Study|Other|2|||
49089633|NCT01609010|158164078|FG001|Overall Study|Other|0|||
49089634|NCT01609010|158164077|FG000|Overall Study|Other malignancy|1|||
49089635|NCT01609010|158164078|FG001|Overall Study|Other malignancy|0|||
49089636|NCT01609010|158164077|FG000|Overall Study|Pathology review|2|||
49089637|NCT01609010|158164078|FG001|Overall Study|Pathology review|1|||
49089638|NCT01609010|158164077|FG000|Overall Study|Protocol Violation|1|||
49089639|NCT01609010|158164078|FG001|Overall Study|Protocol Violation|1|||
49089640|NCT01609010|158164077|FG000|Overall Study|New cancer|1|||
49089641|NCT01609010|158164078|FG001|Overall Study|New cancer|0|||
49089642|NCT01609010|158164077|FG000|Overall Study|Lost to Follow-up|1|||
49089643|NCT01609010|158164078|FG001|Overall Study|Lost to Follow-up|1|||
49089644|NCT03340454|158164080|FG000|Overall Study|Lost to Follow-up|0|||
49089645|NCT03340454|158164081|FG001|Overall Study|Lost to Follow-up|4|||
49089646|NCT02556775|158164085|FG000|Overall Study|Withdrawal by Subject|1|||
49089647|NCT02556775|158164086|FG001|Overall Study|Withdrawal by Subject|0|||
49089648|NCT02556775|158164087|FG002|Overall Study|Withdrawal by Subject|1|||
49089649|NCT02556775|158164088|FG003|Overall Study|Withdrawal by Subject|0|||
49089650|NCT02556775|158164085|FG000|Overall Study|Lost to Follow-up|1|||
49089651|NCT02556775|158164086|FG001|Overall Study|Lost to Follow-up|0|||
49089652|NCT02556775|158164087|FG002|Overall Study|Lost to Follow-up|0|||
49089653|NCT02556775|158164088|FG003|Overall Study|Lost to Follow-up|0|||
49089654|NCT01346059|158164089|FG000|Overall Study|Withdrawal by Subject|1|||
49089655|NCT01346059|158164090|FG001|Overall Study|Withdrawal by Subject|0|||
49089656|NCT03103152|158164098|FG000|Overall Study|Physician Decision|5|||
49089657|NCT03103152|158164099|FG001|Overall Study|Physician Decision|2|||
49089658|NCT03103152|158164100|FG002|Overall Study|Physician Decision|6|||
49089659|NCT03103152|158164101|FG003|Overall Study|Physician Decision|3|||
49089660|NCT03103152|158164102|FG004|Overall Study|Physician Decision|3|||
49089661|NCT03103152|158164103|FG005|Overall Study|Physician Decision|1|||
49089662|NCT03103152|158164098|FG000|Overall Study|Protocol Violation|2|||
49089663|NCT03103152|158164099|FG001|Overall Study|Protocol Violation|2|||
49089664|NCT03103152|158164100|FG002|Overall Study|Protocol Violation|1|||
49089665|NCT03103152|158164101|FG003|Overall Study|Protocol Violation|2|||
49089666|NCT03103152|158164102|FG004|Overall Study|Protocol Violation|1|||
49089667|NCT03103152|158164103|FG005|Overall Study|Protocol Violation|1|||
49089668|NCT03103152|158164098|FG000|Overall Study|Inter-current illness|0|||
49089669|NCT03103152|158164099|FG001|Overall Study|Inter-current illness|0|||
49089670|NCT03103152|158164100|FG002|Overall Study|Inter-current illness|1|||
49089671|NCT03103152|158164101|FG003|Overall Study|Inter-current illness|0|||
49089672|NCT03103152|158164102|FG004|Overall Study|Inter-current illness|0|||
49089673|NCT03103152|158164103|FG005|Overall Study|Inter-current illness|0|||
49089674|NCT03103152|158164098|FG000|Overall Study|Death|0|||
49089675|NCT03103152|158164099|FG001|Overall Study|Death|1|||
49089676|NCT03103152|158164100|FG002|Overall Study|Death|0|||
49089677|NCT03103152|158164101|FG003|Overall Study|Death|0|||
49089678|NCT03103152|158164102|FG004|Overall Study|Death|0|||
49089679|NCT03103152|158164103|FG005|Overall Study|Death|0|||
49089680|NCT03103152|158164098|FG000|Overall Study|Adverse Event|0|||
49089681|NCT03103152|158164099|FG001|Overall Study|Adverse Event|0|||
49089682|NCT03103152|158164100|FG002|Overall Study|Adverse Event|1|||
49089683|NCT03103152|158164101|FG003|Overall Study|Adverse Event|0|||
49089684|NCT03103152|158164102|FG004|Overall Study|Adverse Event|0|||
49089685|NCT03103152|158164103|FG005|Overall Study|Adverse Event|1|||
49089686|NCT03103152|158164098|FG000|Overall Study|Withdrawal by Subject|1|||
49089687|NCT03103152|158164099|FG001|Overall Study|Withdrawal by Subject|0|||
49089688|NCT03103152|158164100|FG002|Overall Study|Withdrawal by Subject|1|||
49089689|NCT03103152|158164101|FG003|Overall Study|Withdrawal by Subject|1|||
49089690|NCT03103152|158164102|FG004|Overall Study|Withdrawal by Subject|1|||
49089691|NCT03103152|158164103|FG005|Overall Study|Withdrawal by Subject|1|||
49089692|NCT03103152|158164098|FG000|Overall Study|Patient wishes to come off active surveillance|2|||
49089693|NCT03103152|158164099|FG001|Overall Study|Patient wishes to come off active surveillance|0|||
49089694|NCT03103152|158164100|FG002|Overall Study|Patient wishes to come off active surveillance|1|||
49089695|NCT03103152|158164101|FG003|Overall Study|Patient wishes to come off active surveillance|1|||
49089696|NCT03103152|158164102|FG004|Overall Study|Patient wishes to come off active surveillance|1|||
49089697|NCT03103152|158164103|FG005|Overall Study|Patient wishes to come off active surveillance|3|||
49089698|NCT03103152|158164098|FG000|Overall Study|Unacceptable side effects|0|||
49089699|NCT03103152|158164099|FG001|Overall Study|Unacceptable side effects|0|||
49089700|NCT03103152|158164100|FG002|Overall Study|Unacceptable side effects|0|||
49089701|NCT03103152|158164101|FG003|Overall Study|Unacceptable side effects|0|||
49089702|NCT03103152|158164102|FG004|Overall Study|Unacceptable side effects|0|||
49089703|NCT03103152|158164103|FG005|Overall Study|Unacceptable side effects|1|||
49089704|NCT03103152|158164098|FG000|Overall Study|Lost to Follow-up|0|||
49089705|NCT03103152|158164099|FG001|Overall Study|Lost to Follow-up|1|||
49089706|NCT03103152|158164100|FG002|Overall Study|Lost to Follow-up|0|||
49089707|NCT03103152|158164101|FG003|Overall Study|Lost to Follow-up|1|||
49089708|NCT03103152|158164102|FG004|Overall Study|Lost to Follow-up|0|||
49089709|NCT03103152|158164103|FG005|Overall Study|Lost to Follow-up|1|||
49089710|NCT03103152|158164098|FG000|Overall Study|Testicular pain|0|||
49089711|NCT03103152|158164099|FG001|Overall Study|Testicular pain|0|||
49089712|NCT03103152|158164100|FG002|Overall Study|Testicular pain|0|||
49089713|NCT03103152|158164101|FG003|Overall Study|Testicular pain|1|||
49089714|NCT03103152|158164102|FG004|Overall Study|Testicular pain|0|||
49089715|NCT03103152|158164103|FG005|Overall Study|Testicular pain|0|||
49089716|NCT00092118|158164104|FG000|Overall Study|Adverse Event|35|||
49089717|NCT00092118|158164105|FG001|Overall Study|Adverse Event|32|||
49089718|NCT00092118|158164104|FG000|Overall Study|Lack of Efficacy|12|||
49089719|NCT00092118|158164105|FG001|Overall Study|Lack of Efficacy|14|||
49089720|NCT00092118|158164104|FG000|Overall Study|Lost to Follow-up|4|||
49089721|NCT00092118|158164105|FG001|Overall Study|Lost to Follow-up|3|||
49089722|NCT00092118|158164104|FG000|Overall Study|Protocol Violation|23|||
49089723|NCT00092118|158164105|FG001|Overall Study|Protocol Violation|25|||
49089724|NCT00092118|158164104|FG000|Overall Study|Withdrawal by Subject|4|||
49089725|NCT00092118|158164105|FG001|Overall Study|Withdrawal by Subject|10|||
49089726|NCT00092118|158164104|FG000|Overall Study|Other|6|||
49089727|NCT00092118|158164105|FG001|Overall Study|Other|5|||
49089728|NCT03123393|158164106|FG000|Overall Study|Study Terminated by Sponsor|6|||
49089729|NCT03123393|158164107|FG001|Overall Study|Study Terminated by Sponsor|9|||
49089730|NCT03123393|158164106|FG000|Overall Study|Withdrawal by Subject|2|||
49089731|NCT03123393|158164107|FG001|Overall Study|Withdrawal by Subject|1|||
49089732|NCT03123393|158164106|FG000|Overall Study|Reason not Specified|13|||
49089733|NCT03123393|158164107|FG001|Overall Study|Reason not Specified|13|||
49089734|NCT05027451|158164108|FG000|Overall Study|Lost to Follow-up|1|||
49089735|NCT05027451|158164109|FG001|Overall Study|Lost to Follow-up|1|||
49089736|NCT00105079|158164112|FG000|Overall Study|Adverse Event|5|||
49089737|NCT00105079|158164113|FG001|Overall Study|Adverse Event|12|||
49089738|NCT00105079|158164112|FG000|Overall Study|Death|3|||
49089739|NCT00105079|158164113|FG001|Overall Study|Death|1|||
49089740|NCT00105079|158164112|FG000|Overall Study|Lost to Follow-up|12|||
49089741|NCT00105079|158164113|FG001|Overall Study|Lost to Follow-up|12|||
49089742|NCT00105079|158164112|FG000|Overall Study|Lack of Efficacy|9|||
49089743|NCT00105079|158164113|FG001|Overall Study|Lack of Efficacy|3|||
49089744|NCT00105079|158164112|FG000|Overall Study|Refused treatment|6|||
49089745|NCT00105079|158164113|FG001|Overall Study|Refused treatment|4|||
49089746|NCT00105079|158164112|FG000|Overall Study|Violation of selection criteria at entry|0|||
49089747|NCT00105079|158164113|FG001|Overall Study|Violation of selection criteria at entry|2|||
49089748|NCT00105079|158164112|FG000|Overall Study|Protocol Violation|1|||
49089749|NCT00105079|158164113|FG001|Overall Study|Protocol Violation|0|||
49089750|NCT00105079|158164112|FG000|Overall Study|Other|3|||
49089751|NCT00105079|158164113|FG001|Overall Study|Other|1|||
49089752|NCT01866111|158164114|FG000|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|14|||
49089753|NCT01866111|158164115|FG001|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|13|||
49089754|NCT01866111|158164116|FG002|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|20|||
49089755|NCT01866111|158164117|FG003|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|30|||
49089756|NCT01866111|158164114|FG000|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|65|||
49089757|NCT01866111|158164115|FG001|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|67|||
49089758|NCT01866111|158164116|FG002|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|63|||
49089759|NCT01866111|158164117|FG003|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|52|||
49089760|NCT01464593|158164120|FG000|Overall Study|Study terminated early due to lack of enrollment|1|||
49089761|NCT00302328|158164121|FG000|Overall Study|Physician Decision|0|||
49089762|NCT00302328|158164122|FG001|Overall Study|Physician Decision|1|||
49089763|NCT00302328|158164123|FG002|Overall Study|Physician Decision|0|||
49089764|NCT04411810|158164124|FG000|Overall Study|Screen failure|1|||
49089765|NCT04411810|158164124|FG000|Overall Study|Withdrawal by Subject|1|||
49089766|NCT01920958|158164127|FG000|Overall Study|Did Not Fulfill Inclusion Criteria|5|||
49089767|NCT02490371|158164130|FG000|Overall Study|Lost to Follow-up|1|||
49089768|NCT02490371|158164131|FG001|Overall Study|Lost to Follow-up|1|||
49089769|NCT01718535|158164133|FG000|Overall Study|Bidirectional Sequencing not possible|1|||
49089770|NCT01718535|158164134|FG001|Overall Study|Bidirectional Sequencing not possible|0|||
49089771|NCT01718535|158164135|FG002|Overall Study|Bidirectional Sequencing not possible|0|||
49089772|NCT01718535|158164136|FG003|Overall Study|Bidirectional Sequencing not possible|1|||
49089773|NCT01718535|158164137|FG004|Overall Study|Bidirectional Sequencing not possible|0|||
49089774|NCT01718535|158164138|FG005|Overall Study|Bidirectional Sequencing not possible|0|||
49089775|NCT01718535|158164139|FG006|Overall Study|Bidirectional Sequencing not possible|0|||
49089776|NCT01718535|158164140|FG007|Overall Study|Bidirectional Sequencing not possible|0|||
49089777|NCT01718535|158164141|FG008|Overall Study|Bidirectional Sequencing not possible|0|||
49089778|NCT01718535|158164142|FG009|Overall Study|Bidirectional Sequencing not possible|0|||
49089779|NCT02914613|158164143|FG000|Overall Study|Withdrawal by Subject|1|||
49089780|NCT02914613|158164144|FG001|Overall Study|Withdrawal by Subject|2|||
49089781|NCT02914613|158164143|FG000|Overall Study|Adverse Event|1|||
49089782|NCT02914613|158164144|FG001|Overall Study|Adverse Event|0|||
49089783|NCT01163851|158164147|FG000|Overall Study|Site Closure|0|||
49089784|NCT01163851|158164148|FG001|Overall Study|Site Closure|1|||
49089785|NCT01163851|158164147|FG000|Overall Study|Enrolled but not treated|1|||
49089786|NCT01163851|158164148|FG001|Overall Study|Enrolled but not treated|0|||
49089787|NCT00026494|158164149|FG000|Overall Study|Withdrawal by Subject|1|||
49089788|NCT00026494|158164150|FG001|Overall Study|Withdrawal by Subject|0|||
49089789|NCT00026494|158164151|FG002|Overall Study|Withdrawal by Subject|1|||
49089790|NCT00026494|158164152|FG003|Overall Study|Withdrawal by Subject|0|||
49089791|NCT00026494|158164149|FG000|Overall Study|Patient non-compliance|1|||
49089792|NCT00026494|158164150|FG001|Overall Study|Patient non-compliance|0|||
49089793|NCT00026494|158164151|FG002|Overall Study|Patient non-compliance|0|||
49089794|NCT00026494|158164152|FG003|Overall Study|Patient non-compliance|0|||
49089795|NCT00026494|158164149|FG000|Overall Study|Patient not treated|0|||
49089796|NCT00026494|158164150|FG001|Overall Study|Patient not treated|0|||
49089797|NCT00026494|158164151|FG002|Overall Study|Patient not treated|2|||
49089798|NCT00026494|158164152|FG003|Overall Study|Patient not treated|0|||
49089799|NCT00026494|158164149|FG000|Overall Study|Clinical progression|0|||
49089800|NCT00026494|158164150|FG001|Overall Study|Clinical progression|0|||
49089801|NCT00026494|158164151|FG002|Overall Study|Clinical progression|3|||
49089802|NCT00026494|158164152|FG003|Overall Study|Clinical progression|0|||
49089803|NCT02748356|158164153|FG000|Overall Study|Withdrawal by Subject|1|||
49089804|NCT00478777|158164157|FG000|Overall Study|Adverse Event|29|||
49089805|NCT00478777|158164157|FG000|Overall Study|Lack of Efficacy|23|||
49089806|NCT00478777|158164157|FG000|Overall Study|Withdrawal by Subject|4|||
49089807|NCT00478777|158164157|FG000|Overall Study|Death|3|||
49089808|NCT00478777|158164157|FG000|Overall Study|Protocol Violation|3|||
49089809|NCT00478777|158164157|FG000|Overall Study|Lost to Follow-up|3|||
49089810|NCT00478777|158164157|FG000|Overall Study|Physician Decision|1|||
49089811|NCT00478777|158164157|FG000|Overall Study|Intolerance of therapy|1|||
49089812|NCT00478777|158164157|FG000|Overall Study|Lack of compliance|1|||
49089813|NCT00478777|158164157|FG000|Overall Study|Lymphocytes infusion|1|||
49089814|NCT00478777|158164157|FG000|Overall Study|End of therapy|2|||
49089815|NCT00478777|158164157|FG000|Overall Study|Not treated with lenalidomide|6|||
49089816|NCT00425750|158164158|FG000|Overall Study|Death|1|||
49089817|NCT00425750|158164158|FG000|Overall Study|Withdrawal by Subject|3|||
49089818|NCT00425750|158164158|FG000|Overall Study|Adverse Event|3|||
49089819|NCT00425750|158164158|FG000|Overall Study|Progression of disease|18|||
49089820|NCT00364923|158164159|FG000|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4|||
49089821|NCT00364923|158164159|FG000|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24|||
49089822|NCT02099110|158164162|FG000|Overall Study|Protocol Violation|2|||
49089823|NCT02099110|158164163|FG001|Overall Study|Protocol Violation|1|||
49089824|NCT02099110|158164164|FG002|Overall Study|Protocol Violation|0|||
49089825|NCT02099110|158164165|FG003|Overall Study|Protocol Violation|3|||
49089826|NCT02099110|158164166|FG004|Overall Study|Protocol Violation|1|||
49089827|NCT02099110|158164162|FG000|Overall Study|Participant moved|1|||
49089828|NCT02099110|158164163|FG001|Overall Study|Participant moved|1|||
49089829|NCT02099110|158164164|FG002|Overall Study|Participant moved|1|||
49089830|NCT02099110|158164165|FG003|Overall Study|Participant moved|0|||
49089831|NCT02099110|158164166|FG004|Overall Study|Participant moved|2|||
49089832|NCT02099110|158164162|FG000|Overall Study|Withdrawal by Subject|7|||
49089833|NCT02099110|158164163|FG001|Overall Study|Withdrawal by Subject|11|||
49089834|NCT02099110|158164164|FG002|Overall Study|Withdrawal by Subject|13|||
49089835|NCT02099110|158164165|FG003|Overall Study|Withdrawal by Subject|9|||
49089836|NCT02099110|158164166|FG004|Overall Study|Withdrawal by Subject|13|||
49089837|NCT02099110|158164162|FG000|Overall Study|Adverse Event|3|||
49089838|NCT02099110|158164163|FG001|Overall Study|Adverse Event|5|||
49089839|NCT02099110|158164164|FG002|Overall Study|Adverse Event|2|||
49089840|NCT02099110|158164165|FG003|Overall Study|Adverse Event|3|||
49089841|NCT02099110|158164166|FG004|Overall Study|Adverse Event|2|||
49089842|NCT02099110|158164162|FG000|Overall Study|Lost to Follow-up|6|||
49089843|NCT02099110|158164163|FG001|Overall Study|Lost to Follow-up|12|||
49089844|NCT02099110|158164164|FG002|Overall Study|Lost to Follow-up|11|||
49089845|NCT02099110|158164165|FG003|Overall Study|Lost to Follow-up|5|||
49089846|NCT02099110|158164166|FG004|Overall Study|Lost to Follow-up|6|||
49089847|NCT02099110|158164162|FG000|Overall Study|Death|0|||
49089848|NCT02099110|158164163|FG001|Overall Study|Death|1|||
49089849|NCT02099110|158164164|FG002|Overall Study|Death|0|||
49089850|NCT02099110|158164165|FG003|Overall Study|Death|0|||
49089851|NCT02099110|158164166|FG004|Overall Study|Death|0|||
49089852|NCT02099110|158164162|FG000|Overall Study|Screen failure|0|||
49089853|NCT02099110|158164163|FG001|Overall Study|Screen failure|0|||
49089854|NCT02099110|158164164|FG002|Overall Study|Screen failure|0|||
49089855|NCT02099110|158164165|FG003|Overall Study|Screen failure|0|||
49089856|NCT02099110|158164166|FG004|Overall Study|Screen failure|1|||
49089857|NCT02099110|158164162|FG000|Overall Study|Non-compliance with study drug|2|||
49089858|NCT02099110|158164163|FG001|Overall Study|Non-compliance with study drug|0|||
49089859|NCT02099110|158164164|FG002|Overall Study|Non-compliance with study drug|0|||
49089860|NCT02099110|158164165|FG003|Overall Study|Non-compliance with study drug|0|||
49089861|NCT02099110|158164166|FG004|Overall Study|Non-compliance with study drug|1|||
49089862|NCT02099110|158164162|FG000|Overall Study|Physician Decision|3|||
49089863|NCT02099110|158164163|FG001|Overall Study|Physician Decision|0|||
49089864|NCT02099110|158164164|FG002|Overall Study|Physician Decision|1|||
49089865|NCT02099110|158164165|FG003|Overall Study|Physician Decision|2|||
49089866|NCT02099110|158164166|FG004|Overall Study|Physician Decision|1|||
49089867|NCT01435460|158164167|FG000|Overall Study|Adverse Event|2|||
49089868|NCT01435460|158164168|FG001|Overall Study|Adverse Event|1|||
49089869|NCT01435460|158164167|FG000|Overall Study|Lost to Follow-up|6|||
49089870|NCT01435460|158164168|FG001|Overall Study|Lost to Follow-up|1|||
49089871|NCT01435460|158164167|FG000|Overall Study|Withdrawal by Subject|1|||
49089872|NCT01435460|158164168|FG001|Overall Study|Withdrawal by Subject|3|||
49089873|NCT01435460|158164167|FG000|Overall Study|Protocol Violation|0|||
49089874|NCT01435460|158164168|FG001|Overall Study|Protocol Violation|1|||
49089875|NCT01435460|158164167|FG000|Overall Study|Did not meet eligibility criteria|2|||
49089876|NCT01435460|158164168|FG001|Overall Study|Did not meet eligibility criteria|0|||
49089877|NCT04152837|158164175|FG000|Baseline Period (No Treatment)|Baseline Failure|1|||
49089878|NCT04152837|158164175|FG000|Maintenance Period|Adverse Event|1|||
49089879|NCT04152837|158164175|FG000|Maintenance Period|Withdrawal by Subject|1|||
49089880|NCT04152837|158164175|FG000|Maintenance Period|Sponsor Termination of Study|2|||
49089881|NCT00586820|158164179|FG000|Overall Study|Unsuccessful PCI|1|||
49089882|NCT00586820|158164180|FG001|Overall Study|Unsuccessful PCI|0|||
49089883|NCT03319732|158164184|FG000|Overall Study|Adverse Event|40|||
49089884|NCT03319732|158164184|FG000|Overall Study|Withdrawal by Subject|50|||
49089885|NCT03319732|158164184|FG000|Overall Study|MS relapse|10|||
49089886|NCT03319732|158164184|FG000|Overall Study|reason not specified|5|||
49089887|NCT00757042|158164185|FG000|Overall Study|Lost to Follow-up|0|||
49089888|NCT00757042|158164186|FG001|Overall Study|Lost to Follow-up|0|||
49089889|NCT00757042|158164187|FG002|Overall Study|Lost to Follow-up|0|||
49089890|NCT00757042|158164188|FG003|Overall Study|Lost to Follow-up|0|||
49089891|NCT00757042|158164189|FG004|Overall Study|Lost to Follow-up|0|||
49089892|NCT00757042|158164190|FG005|Overall Study|Lost to Follow-up|0|||
49089893|NCT00757042|158164191|FG006|Overall Study|Lost to Follow-up|0|||
49089894|NCT00757042|158164192|FG007|Overall Study|Lost to Follow-up|0|||
49089895|NCT00757042|158164193|FG008|Overall Study|Lost to Follow-up|1|||
49089896|NCT00757042|158164194|FG009|Overall Study|Lost to Follow-up|0|||
49089897|NCT00757042|158164195|FG010|Overall Study|Lost to Follow-up|0|||
49089898|NCT00757042|158164185|FG000|Overall Study|Ineligibility Determined|0|||
49089899|NCT00757042|158164186|FG001|Overall Study|Ineligibility Determined|0|||
49089900|NCT00757042|158164187|FG002|Overall Study|Ineligibility Determined|0|||
49089901|NCT00757042|158164188|FG003|Overall Study|Ineligibility Determined|0|||
49089902|NCT00757042|158164189|FG004|Overall Study|Ineligibility Determined|0|||
49089903|NCT00757042|158164190|FG005|Overall Study|Ineligibility Determined|0|||
49089904|NCT00757042|158164191|FG006|Overall Study|Ineligibility Determined|0|||
49089905|NCT00757042|158164192|FG007|Overall Study|Ineligibility Determined|0|||
49089906|NCT00757042|158164193|FG008|Overall Study|Ineligibility Determined|0|||
49089907|NCT00757042|158164194|FG009|Overall Study|Ineligibility Determined|0|||
49089908|NCT00757042|158164195|FG010|Overall Study|Ineligibility Determined|1|||
49089909|NCT00757042|158164185|FG000|Overall Study|Withdrawal by Subject|0|||
49089910|NCT00757042|158164186|FG001|Overall Study|Withdrawal by Subject|0|||
49089911|NCT00757042|158164187|FG002|Overall Study|Withdrawal by Subject|0|||
49089912|NCT00757042|158164188|FG003|Overall Study|Withdrawal by Subject|0|||
49089913|NCT00757042|158164189|FG004|Overall Study|Withdrawal by Subject|0|||
49089914|NCT00757042|158164190|FG005|Overall Study|Withdrawal by Subject|0|||
49089915|NCT00757042|158164191|FG006|Overall Study|Withdrawal by Subject|0|||
49089916|NCT00757042|158164192|FG007|Overall Study|Withdrawal by Subject|0|||
49089917|NCT00757042|158164193|FG008|Overall Study|Withdrawal by Subject|0|||
49089918|NCT00757042|158164194|FG009|Overall Study|Withdrawal by Subject|1|||
49089919|NCT00757042|158164195|FG010|Overall Study|Withdrawal by Subject|0|||
49089920|NCT03887442|158164196|FG000|Overall Study|Adverse Event|1|||
49089921|NCT03887442|158164197|FG001|Overall Study|Adverse Event|0|||
49089922|NCT00556933|158164203|FG000|Single vs. Divided-dose rATG Induction|Protocol Violation|2|||
49089923|NCT00556933|158164204|FG001|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
49089924|NCT00556933|158164205|FG002|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
49089925|NCT00556933|158164206|FG003|Single vs. Divided-dose rATG Induction|Protocol Violation|0|||
49089926|NCT00556933|158164203|FG000|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
49089927|NCT00556933|158164204|FG001|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
49089928|NCT00556933|158164205|FG002|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1|||
49089929|NCT00556933|158164206|FG003|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
49089930|NCT00556933|158164203|FG000|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0|||
49089931|NCT00556933|158164204|FG001|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
49089932|NCT00556933|158164205|FG002|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
49089933|NCT00556933|158164206|FG003|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
49089934|NCT00556933|158164203|FG000|Single vs. Divided-dose rATG Induction|Death|0|||
49089935|NCT00556933|158164204|FG001|Single vs. Divided-dose rATG Induction|Death|1|||
49089936|NCT00556933|158164205|FG002|Single vs. Divided-dose rATG Induction|Death|0|||
49089937|NCT00556933|158164206|FG003|Single vs. Divided-dose rATG Induction|Death|0|||
49089938|NCT00556933|158164203|FG000|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
49089939|NCT00556933|158164204|FG001|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1|||
49089940|NCT00556933|158164205|FG002|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
49089941|NCT00556933|158164206|FG003|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
49089942|NCT00556933|158164203|FG000|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
49089943|NCT00556933|158164204|FG001|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1|||
49089944|NCT00556933|158164205|FG002|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
49089945|NCT00556933|158164206|FG003|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
49089946|NCT00556933|158164203|FG000|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
49089947|NCT00556933|158164204|FG001|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
49089948|NCT00556933|158164205|FG002|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
49089949|NCT00556933|158164206|FG003|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
49089950|NCT00556933|158164203|FG000|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
49089951|NCT00556933|158164204|FG001|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
49089952|NCT00556933|158164205|FG002|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
49089953|NCT00556933|158164206|FG003|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
49089954|NCT00556933|158164203|FG000|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
49089955|NCT00556933|158164204|FG001|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
49089956|NCT00556933|158164205|FG002|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
49089957|NCT00556933|158164206|FG003|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
49089958|NCT00556933|158164203|FG000|CNI Withdrawal vs. Minimization|Graft loss|0|||
49089959|NCT00556933|158164204|FG001|CNI Withdrawal vs. Minimization|Graft loss|1|||
49089960|NCT00556933|158164205|FG002|CNI Withdrawal vs. Minimization|Graft loss|2|||
49089961|NCT00556933|158164206|FG003|CNI Withdrawal vs. Minimization|Graft loss|0|||
49089962|NCT00556933|158164203|FG000|CNI Withdrawal vs. Minimization|Death|0|||
49089963|NCT00556933|158164204|FG001|CNI Withdrawal vs. Minimization|Death|0|||
49089964|NCT00556933|158164205|FG002|CNI Withdrawal vs. Minimization|Death|0|||
49089965|NCT00556933|158164206|FG003|CNI Withdrawal vs. Minimization|Death|1|||
49089966|NCT02654977|158164210|FG000|Overall Study|Death|1|||
49089967|NCT02654977|158164210|FG000|Overall Study|Lost to Follow-up|1|||
49089968|NCT02654977|158164210|FG000|Overall Study|Adverse Event|1|||
49089969|NCT02654977|158164210|FG000|Overall Study|Withdrawal by Subject|1|||
49089970|NCT02654977|158164210|FG000|Overall Study|Lack of Efficacy|3|||
49089971|NCT00430573|158164211|FG000|Overall Study|Withdrawal by Subject|5|||
49089972|NCT01921101|158164212|FG000|Overall Study|Death|16|||
49089973|NCT01921101|158164213|FG001|Overall Study|Death|6|||
49089974|NCT00767455|158164214|FG000|Overall Study|Investigator error|19|||
49089975|NCT01068678|158165734|FG000|Overall Study|Lack of Efficacy|3|||
49089976|NCT01068678|158165735|FG001|Overall Study|Lack of Efficacy|2|||
49089977|NCT01068678|158165734|FG000|Overall Study|Protocol Violation|5|||
49089978|NCT01068678|158165735|FG001|Overall Study|Protocol Violation|1|||
49089979|NCT01068678|158165734|FG000|Overall Study|Withdrawal criteria|12|||
49089980|NCT01068678|158165735|FG001|Overall Study|Withdrawal criteria|6|||
49089981|NCT01068678|158165734|FG000|Overall Study|Unclassified|18|||
49089982|NCT01068678|158165735|FG001|Overall Study|Unclassified|15|||
49089983|NCT00347958|158165736|FG000|Overall Study|Adverse Event|1|||
49089984|NCT00347958|158165736|FG000|Overall Study|Protocol Violation|2|||
49089985|NCT00347958|158165736|FG000|Overall Study|Withdrawal by Subject|1|||
49089986|NCT01623310|158165737|FG000|Overall Study|Adverse Event|21|||
49089987|NCT01623310|158165737|FG000|Overall Study|Lost to Follow-up|18|||
49089988|NCT01623310|158165737|FG000|Overall Study|Lack of Efficacy|6|||
49089989|NCT01623310|158165737|FG000|Overall Study|Protocol Violation|6|||
49089990|NCT01623310|158165737|FG000|Overall Study|Withdrawal by Subject|25|||
49089991|NCT01623310|158165737|FG000|Overall Study|Became potentially child-bearing|1|||
49089992|NCT01623310|158165737|FG000|Overall Study|Diagnoses of bilateral cateracts|1|||
49089993|NCT01623310|158165737|FG000|Overall Study|Investigators Discretion-Noncompliant|1|||
49089994|NCT03056638|158165738|FG000|Overall Study|Death|1|||
49089995|NCT03056638|158165739|FG001|Overall Study|Death|0|||
49089996|NCT04168112|158165740|FG000|Overall Study|Lost to Follow-up|1|||
49089997|NCT04168112|158165741|FG001|Overall Study|Lost to Follow-up|0|||
49089998|NCT04168112|158165740|FG000|Overall Study|Withdrawal by Subject|1|||
49089999|NCT04168112|158165741|FG001|Overall Study|Withdrawal by Subject|0|||
49090000|NCT01735916|158165742|FG000|Overall Study|Subject not eligible to be randomized|11|||
49090001|NCT01735916|158165743|FG001|Overall Study|Subject not eligible to be randomized|0|||
49090002|NCT01735916|158165744|FG002|Overall Study|Subject not eligible to be randomized|0|||
49090003|NCT01735916|158165742|FG000|Overall Study|Early termination of study by sponsor|4|||
49090004|NCT01735916|158165743|FG001|Overall Study|Early termination of study by sponsor|19|||
49090005|NCT01735916|158165744|FG002|Overall Study|Early termination of study by sponsor|7|||
49090006|NCT01735916|158165742|FG000|Overall Study|Withdrawal by Subject|3|||
49090007|NCT01735916|158165743|FG001|Overall Study|Withdrawal by Subject|0|||
49090008|NCT01735916|158165744|FG002|Overall Study|Withdrawal by Subject|0|||
49090009|NCT00471081|158165745|FG000|Active Phase|Protocol Violation|1|||
49090010|NCT00471081|158165746|FG001|Active Phase|Protocol Violation|1|||
49090011|NCT00471081|158165745|FG000|Active Phase|Withdrawal by Subject|0|||
49090012|NCT00471081|158165746|FG001|Active Phase|Withdrawal by Subject|3|||
49090013|NCT00471081|158165745|FG000|Active Phase|Lost to Follow-up|0|||
49090014|NCT00471081|158165746|FG001|Active Phase|Lost to Follow-up|1|||
49090015|NCT00471081|158165745|FG000|Active Phase|Lost health plan/insurance|1|||
49090016|NCT00471081|158165746|FG001|Active Phase|Lost health plan/insurance|8|||
49090017|NCT00471081|158165745|FG000|Extended Safety Follow-Up|Withdrawal by Subject|1|||
49090018|NCT00471081|158165746|FG001|Extended Safety Follow-Up|Withdrawal by Subject|4|||
49090019|NCT00471081|158165745|FG000|Extended Safety Follow-Up|Lost to Follow-up|1|||
49090020|NCT00471081|158165746|FG001|Extended Safety Follow-Up|Lost to Follow-up|8|||
49090021|NCT00471081|158165745|FG000|Extended Safety Follow-Up|Missing confirmed|0|||
49090022|NCT00471081|158165746|FG001|Extended Safety Follow-Up|Missing confirmed|1|||
49090023|NCT02844933|158165749|FG000|Overall Study|Discontinued due to premature termination of study|3|||
49090024|NCT02844933|158165750|FG001|Overall Study|Discontinued due to premature termination of study|2|||
49090025|NCT01479465|158165751|FG000|Overall Study|Disease Progression|9|||
49090026|NCT01479465|158165752|FG001|Overall Study|Disease Progression|61|||
49090027|NCT01479465|158165753|FG002|Overall Study|Disease Progression|65|||
49090028|NCT01479465|158165754|FG003|Overall Study|Disease Progression|70|||
49090029|NCT01479465|158165751|FG000|Overall Study|Study Discontinued by Sponsor|0|||
49090030|NCT01479465|158165752|FG001|Overall Study|Study Discontinued by Sponsor|7|||
49090031|NCT01479465|158165753|FG002|Overall Study|Study Discontinued by Sponsor|5|||
49090032|NCT01479465|158165754|FG003|Overall Study|Study Discontinued by Sponsor|3|||
49090033|NCT01479465|158165751|FG000|Overall Study|Adverse Event|0|||
49090034|NCT01479465|158165752|FG001|Overall Study|Adverse Event|3|||
49090035|NCT01479465|158165753|FG002|Overall Study|Adverse Event|6|||
49090036|NCT01479465|158165754|FG003|Overall Study|Adverse Event|4|||
49090037|NCT01479465|158165751|FG000|Overall Study|Investigator Discretion|1|||
49090038|NCT01479465|158165752|FG001|Overall Study|Investigator Discretion|4|||
49090039|NCT01479465|158165753|FG002|Overall Study|Investigator Discretion|2|||
49090040|NCT01479465|158165754|FG003|Overall Study|Investigator Discretion|4|||
49090041|NCT01479465|158165751|FG000|Overall Study|Subject Request|1|||
49090042|NCT01479465|158165752|FG001|Overall Study|Subject Request|3|||
49090043|NCT01479465|158165753|FG002|Overall Study|Subject Request|4|||
49090044|NCT01479465|158165754|FG003|Overall Study|Subject Request|2|||
49090045|NCT01479465|158165751|FG000|Overall Study|Subject Withdrew Consent|0|||
49090046|NCT01479465|158165752|FG001|Overall Study|Subject Withdrew Consent|5|||
49090047|NCT01479465|158165753|FG002|Overall Study|Subject Withdrew Consent|2|||
49090048|NCT01479465|158165754|FG003|Overall Study|Subject Withdrew Consent|1|||
49090049|NCT01479465|158165751|FG000|Overall Study|Protocol Violation|0|||
49090050|NCT01479465|158165752|FG001|Overall Study|Protocol Violation|1|||
49090051|NCT01479465|158165753|FG002|Overall Study|Protocol Violation|1|||
49090052|NCT01479465|158165754|FG003|Overall Study|Protocol Violation|0|||
49090053|NCT01479465|158165751|FG000|Overall Study|Death|0|||
49090054|NCT01479465|158165752|FG001|Overall Study|Death|0|||
49090055|NCT01479465|158165753|FG002|Overall Study|Death|0|||
49090056|NCT01479465|158165754|FG003|Overall Study|Death|1|||
49090057|NCT01479465|158165751|FG000|Overall Study|Lost to Follow-up|0|||
49090058|NCT01479465|158165752|FG001|Overall Study|Lost to Follow-up|0|||
49090059|NCT01479465|158165753|FG002|Overall Study|Lost to Follow-up|1|||
49090060|NCT01479465|158165754|FG003|Overall Study|Lost to Follow-up|0|||
49090061|NCT02275546|158165768|FG000|Treatment Period 2|Withdrawal by Subject|2|||
49090062|NCT02275546|158165769|FG001|Treatment Period 2|Withdrawal by Subject|1|||
49090063|NCT02275546|158165768|FG000|Treatment Period 2|Protocol Violation|0|||
49090064|NCT02275546|158165769|FG001|Treatment Period 2|Protocol Violation|1|||
49090065|NCT02955355|158165773|FG000|Overall Study|Adverse Event|4|||
49090066|NCT02955355|158165773|FG000|Overall Study|Death|1|||
49090067|NCT02955355|158165773|FG000|Overall Study|Physician Decision|21|||
49090068|NCT02955355|158165773|FG000|Overall Study|Site Terminated by Sponsor|35|||
49090069|NCT02955355|158165773|FG000|Overall Study|Withdrawal by Subject|19|||
49090070|NCT02955355|158165773|FG000|Overall Study|Reason Not Specified|5|||
49090071|NCT02612623|158165774|FG000|Overall Study|Withdrawal by Subject|0|||
49090072|NCT02612623|158165775|FG001|Overall Study|Withdrawal by Subject|1|||
49090073|NCT02612623|158165776|FG002|Overall Study|Withdrawal by Subject|0|||
49090074|NCT02612623|158165777|FG003|Overall Study|Withdrawal by Subject|0|||
49090075|NCT02612623|158165774|FG000|Overall Study|Adverse Event|1|||
49090076|NCT02612623|158165775|FG001|Overall Study|Adverse Event|0|||
49090077|NCT02612623|158165776|FG002|Overall Study|Adverse Event|1|||
49090078|NCT02612623|158165777|FG003|Overall Study|Adverse Event|0|||
49090079|NCT04227197|158165778|FG000|Randomization|Protocol Violation|1|||
49090080|NCT04227197|158165779|FG001|Randomization|Protocol Violation|0|||
49090081|NCT04227197|158165778|FG000|Randomization|Discontinued participation because uncomfortable sharing information|1|||
49090082|NCT04227197|158165779|FG001|Randomization|Discontinued participation because uncomfortable sharing information|0|||
49090083|NCT04227197|158165778|FG000|Primary Care Provider (PCP) Visit|Did not complete PCP visit|2|||
49090084|NCT04227197|158165779|FG001|Primary Care Provider (PCP) Visit|Did not complete PCP visit|0|||
49090085|NCT04227197|158165778|FG000|2-week Follow-up Survey for Caregivers|Not responsive|7|||
49090086|NCT04227197|158165779|FG001|2-week Follow-up Survey for Caregivers|Not responsive|5|||
49090087|NCT04227197|158165778|FG000|2-week Follow-up Survey for Caregivers|Lost to Follow-up|5|||
49090088|NCT04227197|158165779|FG001|2-week Follow-up Survey for Caregivers|Lost to Follow-up|0|||
49090089|NCT04227197|158165778|FG000|2-week Follow-up Survey for PCP's|Not responsive|20|||
49090090|NCT04227197|158165779|FG001|2-week Follow-up Survey for PCP's|Not responsive|25|||
49090091|NCT04227197|158165778|FG000|7-month Follow-up Survey for Caregivers|Lost to Follow-up|11|||
49090092|NCT04227197|158165779|FG001|7-month Follow-up Survey for Caregivers|Lost to Follow-up|3|||
49090093|NCT00833105|158165780|FG000|Overall Study|Withdrawal by Subject|1|||
49090094|NCT00833105|158165780|FG000|Overall Study|Adverse Event|2|||
49090095|NCT00570141|158165781|FG000|Overall Study|Adverse Event|1|||
49090096|NCT00570141|158165781|FG000|Overall Study|Missed visits|1|||
49090097|NCT00570141|158165781|FG000|Overall Study|Lost to Follow-up|1|||
49090098|NCT04390503|158165782|FG000|Overall Study|Physician Decision|2|||
49090099|NCT04390503|158165783|FG001|Overall Study|Physician Decision|1|||
49090100|NCT04390503|158165782|FG000|Overall Study|Adverse Event|1|||
49090101|NCT04390503|158165783|FG001|Overall Study|Adverse Event|0|||
49090102|NCT00356603|158165784|FG000|Overall Study|Other|6|||
49090103|NCT00356603|158165785|FG001|Overall Study|Other|3|||
49090104|NCT03309943|158165786|FG000|Overall Study|Withdrawal by Subject|0|||
49090105|NCT03309943|158165787|FG001|Overall Study|Withdrawal by Subject|1|||
49090106|NCT03309943|158165786|FG000|Overall Study|Inappropriate behavior towards staff|0|||
49090107|NCT03309943|158165787|FG001|Overall Study|Inappropriate behavior towards staff|1|||
49090108|NCT00931255|158165788|FG000|Overall Study|Follow up biopsy not done|2|||
49090109|NCT00931255|158165789|FG001|Overall Study|Follow up biopsy not done|3|||
49090110|NCT00658723|158165790|FG000|Overall Study|Lost to Follow-up|0|||
49090111|NCT00658723|158165791|FG001|Overall Study|Lost to Follow-up|2|||
49090112|NCT00658723|158165792|FG002|Overall Study|Lost to Follow-up|2|||
49090113|NCT00658723|158165790|FG000|Overall Study|Death|2|||
49090114|NCT00658723|158165791|FG001|Overall Study|Death|1|||
49090115|NCT00658723|158165792|FG002|Overall Study|Death|4|||
49090116|NCT00658723|158165790|FG000|Overall Study|Scheduling Issue|1|||
49090117|NCT00658723|158165791|FG001|Overall Study|Scheduling Issue|1|||
49090118|NCT00658723|158165792|FG002|Overall Study|Scheduling Issue|0|||
49090119|NCT00658723|158165790|FG000|Overall Study|Withdrawal by Subject|1|||
49090120|NCT00658723|158165791|FG001|Overall Study|Withdrawal by Subject|0|||
49090121|NCT00658723|158165792|FG002|Overall Study|Withdrawal by Subject|1|||
49090122|NCT01372995|158165793|FG000|Overall Study|Spouse withdrew participant from study|0|||
49090123|NCT01372995|158165794|FG001|Overall Study|Spouse withdrew participant from study|1|||
49090124|NCT01372995|158165795|FG002|Overall Study|Spouse withdrew participant from study|0|||
49090125|NCT01372995|158165793|FG000|Overall Study|Physician Decision|0|||
49090126|NCT01372995|158165794|FG001|Overall Study|Physician Decision|0|||
49090127|NCT01372995|158165795|FG002|Overall Study|Physician Decision|1|||
49090128|NCT00386360|158165807|FG000|Overall Study|Adverse Event|4|||
49090129|NCT00386360|158165808|FG001|Overall Study|Adverse Event|2|||
49090130|NCT00386360|158165807|FG000|Overall Study|Physician Decision|2|||
49090131|NCT00386360|158165808|FG001|Overall Study|Physician Decision|2|||
49090132|NCT00386360|158165807|FG000|Overall Study|Lost to Follow-up|0|||
49090133|NCT00386360|158165808|FG001|Overall Study|Lost to Follow-up|2|||
49090134|NCT00386360|158165807|FG000|Overall Study|Protocol Violation|0|||
49090135|NCT00386360|158165808|FG001|Overall Study|Protocol Violation|3|||
49090136|NCT00386360|158165807|FG000|Overall Study|Withdrawal by Subject|3|||
49090137|NCT00386360|158165808|FG001|Overall Study|Withdrawal by Subject|6|||
49090138|NCT00386360|158165807|FG000|Overall Study|Did not take any study medication|0|||
49090139|NCT00386360|158165808|FG001|Overall Study|Did not take any study medication|2|||
49090140|NCT01314872|158165809|FG000|Treatment Period 1|Protocol Violation|2|||
49090141|NCT01314872|158165810|FG001|Treatment Period 1|Protocol Violation|1|||
49090142|NCT01314872|158165811|FG002|Treatment Period 1|Protocol Violation|1|||
49090143|NCT01314872|158165812|FG003|Treatment Period 1|Protocol Violation|0|||
49090144|NCT01314872|158165813|FG004|Treatment Period 1|Protocol Violation|1|||
49090145|NCT01314872|158165814|FG005|Treatment Period 1|Protocol Violation|0|||
49090146|NCT01314872|158165815|FG006|Treatment Period 1|Protocol Violation|0|||
49090147|NCT01314872|158165816|FG007|Treatment Period 1|Protocol Violation|0|||
49090148|NCT01314872|158165817|FG008|Treatment Period 1|Protocol Violation|0|||
49090149|NCT01314872|158165818|FG009|Treatment Period 1|Protocol Violation|1|||
49090150|NCT01314872|158165819|FG010|Treatment Period 1|Protocol Violation|1|||
49090151|NCT01314872|158165820|FG011|Treatment Period 1|Protocol Violation|0|||
49090152|NCT01314872|158165821|FG012|Treatment Period 1|Protocol Violation|0|||
49090153|NCT01314872|158165822|FG013|Treatment Period 1|Protocol Violation|0|||
49090154|NCT01314872|158165823|FG014|Treatment Period 1|Protocol Violation|0|||
49090155|NCT01314872|158165809|FG000|Treatment Period 1|Physician Decision|0|||
49090156|NCT01314872|158165810|FG001|Treatment Period 1|Physician Decision|1|||
49090157|NCT01314872|158165811|FG002|Treatment Period 1|Physician Decision|0|||
49090158|NCT01314872|158165812|FG003|Treatment Period 1|Physician Decision|1|||
49090159|NCT01314872|158165813|FG004|Treatment Period 1|Physician Decision|0|||
49090160|NCT01314872|158165814|FG005|Treatment Period 1|Physician Decision|0|||
49090161|NCT01314872|158165815|FG006|Treatment Period 1|Physician Decision|0|||
49090162|NCT01314872|158165816|FG007|Treatment Period 1|Physician Decision|0|||
49090163|NCT01314872|158165817|FG008|Treatment Period 1|Physician Decision|0|||
49090164|NCT01314872|158165818|FG009|Treatment Period 1|Physician Decision|1|||
49090165|NCT01314872|158165819|FG010|Treatment Period 1|Physician Decision|0|||
49090166|NCT01314872|158165820|FG011|Treatment Period 1|Physician Decision|0|||
49090167|NCT01314872|158165821|FG012|Treatment Period 1|Physician Decision|0|||
49090168|NCT01314872|158165822|FG013|Treatment Period 1|Physician Decision|0|||
49090169|NCT01314872|158165823|FG014|Treatment Period 1|Physician Decision|0|||
49090170|NCT01314872|158165809|FG000|Treatment Period 1|Lack of Efficacy|1|||
49090171|NCT01314872|158165810|FG001|Treatment Period 1|Lack of Efficacy|0|||
49090172|NCT01314872|158165811|FG002|Treatment Period 1|Lack of Efficacy|0|||
49090173|NCT01314872|158165812|FG003|Treatment Period 1|Lack of Efficacy|0|||
49090174|NCT01314872|158165813|FG004|Treatment Period 1|Lack of Efficacy|0|||
49090175|NCT01314872|158165814|FG005|Treatment Period 1|Lack of Efficacy|1|||
49090176|NCT01314872|158165815|FG006|Treatment Period 1|Lack of Efficacy|0|||
49090177|NCT01314872|158165816|FG007|Treatment Period 1|Lack of Efficacy|2|||
49090178|NCT01314872|158165817|FG008|Treatment Period 1|Lack of Efficacy|0|||
49090179|NCT01314872|158165818|FG009|Treatment Period 1|Lack of Efficacy|0|||
49090180|NCT01314872|158165819|FG010|Treatment Period 1|Lack of Efficacy|0|||
49090181|NCT01314872|158165820|FG011|Treatment Period 1|Lack of Efficacy|0|||
49090182|NCT01314872|158165821|FG012|Treatment Period 1|Lack of Efficacy|0|||
49090183|NCT01314872|158165822|FG013|Treatment Period 1|Lack of Efficacy|0|||
49090184|NCT01314872|158165823|FG014|Treatment Period 1|Lack of Efficacy|0|||
49090185|NCT01314872|158165809|FG000|Treatment Period 1|Adverse event, non-fatal|4|||
49090186|NCT01314872|158165810|FG001|Treatment Period 1|Adverse event, non-fatal|2|||
49090187|NCT01314872|158165811|FG002|Treatment Period 1|Adverse event, non-fatal|3|||
49090188|NCT01314872|158165812|FG003|Treatment Period 1|Adverse event, non-fatal|2|||
49090189|NCT01314872|158165813|FG004|Treatment Period 1|Adverse event, non-fatal|2|||
49090190|NCT01314872|158165814|FG005|Treatment Period 1|Adverse event, non-fatal|4|||
49090191|NCT01314872|158165815|FG006|Treatment Period 1|Adverse event, non-fatal|4|||
49090192|NCT01314872|158165816|FG007|Treatment Period 1|Adverse event, non-fatal|2|||
49090193|NCT01314872|158165817|FG008|Treatment Period 1|Adverse event, non-fatal|3|||
49090194|NCT01314872|158165818|FG009|Treatment Period 1|Adverse event, non-fatal|0|||
49090195|NCT01314872|158165819|FG010|Treatment Period 1|Adverse event, non-fatal|1|||
49090196|NCT01314872|158165820|FG011|Treatment Period 1|Adverse event, non-fatal|0|||
49090197|NCT01314872|158165821|FG012|Treatment Period 1|Adverse event, non-fatal|0|||
49090198|NCT01314872|158165822|FG013|Treatment Period 1|Adverse event, non-fatal|0|||
49090199|NCT01314872|158165823|FG014|Treatment Period 1|Adverse event, non-fatal|0|||
49090200|NCT01314872|158165809|FG000|Treatment Period 1|Withdrawal by Subject|3|||
49090201|NCT01314872|158165810|FG001|Treatment Period 1|Withdrawal by Subject|1|||
49090202|NCT01314872|158165811|FG002|Treatment Period 1|Withdrawal by Subject|0|||
49090203|NCT01314872|158165812|FG003|Treatment Period 1|Withdrawal by Subject|2|||
49090204|NCT01314872|158165813|FG004|Treatment Period 1|Withdrawal by Subject|3|||
49090205|NCT01314872|158165814|FG005|Treatment Period 1|Withdrawal by Subject|1|||
49090206|NCT01314872|158165815|FG006|Treatment Period 1|Withdrawal by Subject|3|||
49090207|NCT01314872|158165816|FG007|Treatment Period 1|Withdrawal by Subject|2|||
49090208|NCT01314872|158165817|FG008|Treatment Period 1|Withdrawal by Subject|2|||
49090209|NCT01314872|158165818|FG009|Treatment Period 1|Withdrawal by Subject|2|||
49090210|NCT01314872|158165819|FG010|Treatment Period 1|Withdrawal by Subject|1|||
49090211|NCT01314872|158165820|FG011|Treatment Period 1|Withdrawal by Subject|0|||
49090212|NCT01314872|158165821|FG012|Treatment Period 1|Withdrawal by Subject|0|||
49090213|NCT01314872|158165822|FG013|Treatment Period 1|Withdrawal by Subject|0|||
49090214|NCT01314872|158165823|FG014|Treatment Period 1|Withdrawal by Subject|0|||
49090215|NCT01314872|158165809|FG000|Treatment Period 1|Lost to Follow-up|0|||
49090216|NCT01314872|158165810|FG001|Treatment Period 1|Lost to Follow-up|1|||
49090217|NCT01314872|158165811|FG002|Treatment Period 1|Lost to Follow-up|2|||
49090218|NCT01314872|158165812|FG003|Treatment Period 1|Lost to Follow-up|2|||
49090219|NCT01314872|158165813|FG004|Treatment Period 1|Lost to Follow-up|1|||
49090220|NCT01314872|158165814|FG005|Treatment Period 1|Lost to Follow-up|1|||
49090221|NCT01314872|158165815|FG006|Treatment Period 1|Lost to Follow-up|1|||
49090222|NCT01314872|158165816|FG007|Treatment Period 1|Lost to Follow-up|1|||
49090223|NCT01314872|158165817|FG008|Treatment Period 1|Lost to Follow-up|1|||
49090224|NCT01314872|158165818|FG009|Treatment Period 1|Lost to Follow-up|0|||
49090225|NCT01314872|158165819|FG010|Treatment Period 1|Lost to Follow-up|0|||
49090226|NCT01314872|158165820|FG011|Treatment Period 1|Lost to Follow-up|0|||
49090227|NCT01314872|158165821|FG012|Treatment Period 1|Lost to Follow-up|0|||
49090228|NCT01314872|158165822|FG013|Treatment Period 1|Lost to Follow-up|0|||
49090229|NCT01314872|158165823|FG014|Treatment Period 1|Lost to Follow-up|0|||
49090230|NCT01314872|158165809|FG000|Period 2|Protocol Violation|0|||
49090231|NCT01314872|158165810|FG001|Period 2|Protocol Violation|0|||
49090232|NCT01314872|158165811|FG002|Period 2|Protocol Violation|0|||
49090233|NCT01314872|158165812|FG003|Period 2|Protocol Violation|0|||
49090234|NCT01314872|158165813|FG004|Period 2|Protocol Violation|0|||
49090235|NCT01314872|158165814|FG005|Period 2|Protocol Violation|0|||
49090236|NCT01314872|158165815|FG006|Period 2|Protocol Violation|0|||
49090237|NCT01314872|158165816|FG007|Period 2|Protocol Violation|0|||
49090238|NCT01314872|158165817|FG008|Period 2|Protocol Violation|0|||
49090239|NCT01314872|158165818|FG009|Period 2|Protocol Violation|0|||
49090240|NCT01314872|158165819|FG010|Period 2|Protocol Violation|0|||
49090241|NCT01314872|158165820|FG011|Period 2|Protocol Violation|3|||
49090242|NCT01314872|158165821|FG012|Period 2|Protocol Violation|3|||
49090243|NCT01314872|158165822|FG013|Period 2|Protocol Violation|2|||
49090244|NCT01314872|158165823|FG014|Period 2|Protocol Violation|0|||
49090245|NCT01314872|158165809|FG000|Period 2|Non-compliance with study drug|0|||
49090246|NCT01314872|158165810|FG001|Period 2|Non-compliance with study drug|0|||
49090247|NCT01314872|158165811|FG002|Period 2|Non-compliance with study drug|0|||
49090248|NCT01314872|158165812|FG003|Period 2|Non-compliance with study drug|0|||
49090249|NCT01314872|158165813|FG004|Period 2|Non-compliance with study drug|0|||
49090250|NCT01314872|158165814|FG005|Period 2|Non-compliance with study drug|0|||
49090251|NCT01314872|158165815|FG006|Period 2|Non-compliance with study drug|0|||
49090252|NCT01314872|158165816|FG007|Period 2|Non-compliance with study drug|0|||
49090253|NCT01314872|158165817|FG008|Period 2|Non-compliance with study drug|0|||
49090254|NCT01314872|158165818|FG009|Period 2|Non-compliance with study drug|0|||
49090255|NCT01314872|158165819|FG010|Period 2|Non-compliance with study drug|0|||
49090256|NCT01314872|158165820|FG011|Period 2|Non-compliance with study drug|3|||
49090257|NCT01314872|158165821|FG012|Period 2|Non-compliance with study drug|3|||
49090258|NCT01314872|158165822|FG013|Period 2|Non-compliance with study drug|1|||
49090259|NCT01314872|158165823|FG014|Period 2|Non-compliance with study drug|2|||
49090260|NCT01314872|158165809|FG000|Period 2|Lack of Efficacy|0|||
49090261|NCT01314872|158165810|FG001|Period 2|Lack of Efficacy|0|||
49090262|NCT01314872|158165811|FG002|Period 2|Lack of Efficacy|0|||
49090263|NCT01314872|158165812|FG003|Period 2|Lack of Efficacy|0|||
49090264|NCT01314872|158165813|FG004|Period 2|Lack of Efficacy|0|||
49090265|NCT01314872|158165814|FG005|Period 2|Lack of Efficacy|0|||
49090266|NCT01314872|158165815|FG006|Period 2|Lack of Efficacy|0|||
49090267|NCT01314872|158165816|FG007|Period 2|Lack of Efficacy|0|||
49090268|NCT01314872|158165817|FG008|Period 2|Lack of Efficacy|0|||
49090269|NCT01314872|158165818|FG009|Period 2|Lack of Efficacy|0|||
49090270|NCT01314872|158165819|FG010|Period 2|Lack of Efficacy|0|||
49090271|NCT01314872|158165820|FG011|Period 2|Lack of Efficacy|7|||
49090272|NCT01314872|158165821|FG012|Period 2|Lack of Efficacy|12|||
49090273|NCT01314872|158165822|FG013|Period 2|Lack of Efficacy|9|||
49090274|NCT01314872|158165823|FG014|Period 2|Lack of Efficacy|2|||
49090275|NCT01314872|158165809|FG000|Period 2|Pregnancy|0|||
49090276|NCT01314872|158165810|FG001|Period 2|Pregnancy|0|||
49090277|NCT01314872|158165811|FG002|Period 2|Pregnancy|0|||
49090278|NCT01314872|158165812|FG003|Period 2|Pregnancy|0|||
49090279|NCT01314872|158165813|FG004|Period 2|Pregnancy|0|||
49090280|NCT01314872|158165814|FG005|Period 2|Pregnancy|0|||
49090281|NCT01314872|158165815|FG006|Period 2|Pregnancy|0|||
49090282|NCT01314872|158165816|FG007|Period 2|Pregnancy|0|||
49090283|NCT01314872|158165817|FG008|Period 2|Pregnancy|0|||
49090284|NCT01314872|158165818|FG009|Period 2|Pregnancy|0|||
49090285|NCT01314872|158165819|FG010|Period 2|Pregnancy|0|||
49090286|NCT01314872|158165820|FG011|Period 2|Pregnancy|0|||
49090287|NCT01314872|158165821|FG012|Period 2|Pregnancy|0|||
49090288|NCT01314872|158165822|FG013|Period 2|Pregnancy|0|||
49090289|NCT01314872|158165823|FG014|Period 2|Pregnancy|1|||
49090290|NCT01314872|158165809|FG000|Period 2|Study terminated by Sponsor|0|||
49090291|NCT01314872|158165810|FG001|Period 2|Study terminated by Sponsor|0|||
49090292|NCT01314872|158165811|FG002|Period 2|Study terminated by Sponsor|0|||
49090293|NCT01314872|158165812|FG003|Period 2|Study terminated by Sponsor|0|||
49090294|NCT01314872|158165813|FG004|Period 2|Study terminated by Sponsor|0|||
49090295|NCT01314872|158165814|FG005|Period 2|Study terminated by Sponsor|0|||
49090296|NCT01314872|158165815|FG006|Period 2|Study terminated by Sponsor|0|||
49090297|NCT01314872|158165816|FG007|Period 2|Study terminated by Sponsor|0|||
49090298|NCT01314872|158165817|FG008|Period 2|Study terminated by Sponsor|0|||
49090299|NCT01314872|158165818|FG009|Period 2|Study terminated by Sponsor|0|||
49090300|NCT01314872|158165819|FG010|Period 2|Study terminated by Sponsor|0|||
49090301|NCT01314872|158165820|FG011|Period 2|Study terminated by Sponsor|2|||
49090302|NCT01314872|158165821|FG012|Period 2|Study terminated by Sponsor|2|||
49090303|NCT01314872|158165822|FG013|Period 2|Study terminated by Sponsor|3|||
49090304|NCT01314872|158165823|FG014|Period 2|Study terminated by Sponsor|0|||
49090305|NCT01314872|158165809|FG000|Period 2|Adverse event, non-fatal|0|||
49090306|NCT01314872|158165810|FG001|Period 2|Adverse event, non-fatal|0|||
49090307|NCT01314872|158165811|FG002|Period 2|Adverse event, non-fatal|0|||
49090308|NCT01314872|158165812|FG003|Period 2|Adverse event, non-fatal|0|||
49090309|NCT01314872|158165813|FG004|Period 2|Adverse event, non-fatal|0|||
49090310|NCT01314872|158165814|FG005|Period 2|Adverse event, non-fatal|0|||
49090311|NCT01314872|158165815|FG006|Period 2|Adverse event, non-fatal|0|||
49090312|NCT01314872|158165816|FG007|Period 2|Adverse event, non-fatal|0|||
49090313|NCT01314872|158165817|FG008|Period 2|Adverse event, non-fatal|0|||
49090314|NCT01314872|158165818|FG009|Period 2|Adverse event, non-fatal|0|||
49090315|NCT01314872|158165819|FG010|Period 2|Adverse event, non-fatal|0|||
49090316|NCT01314872|158165820|FG011|Period 2|Adverse event, non-fatal|13|||
49090317|NCT01314872|158165821|FG012|Period 2|Adverse event, non-fatal|16|||
49090318|NCT01314872|158165822|FG013|Period 2|Adverse event, non-fatal|24|||
49090319|NCT01314872|158165823|FG014|Period 2|Adverse event, non-fatal|9|||
49090320|NCT01314872|158165809|FG000|Period 2|Withdrawal by Subject|0|||
49090321|NCT01314872|158165810|FG001|Period 2|Withdrawal by Subject|0|||
49090322|NCT01314872|158165811|FG002|Period 2|Withdrawal by Subject|0|||
49090323|NCT01314872|158165812|FG003|Period 2|Withdrawal by Subject|0|||
49090324|NCT01314872|158165813|FG004|Period 2|Withdrawal by Subject|0|||
49090325|NCT01314872|158165814|FG005|Period 2|Withdrawal by Subject|0|||
49090326|NCT01314872|158165815|FG006|Period 2|Withdrawal by Subject|0|||
49090327|NCT01314872|158165816|FG007|Period 2|Withdrawal by Subject|0|||
49090328|NCT01314872|158165817|FG008|Period 2|Withdrawal by Subject|0|||
49090329|NCT01314872|158165818|FG009|Period 2|Withdrawal by Subject|0|||
49090330|NCT01314872|158165819|FG010|Period 2|Withdrawal by Subject|0|||
49090331|NCT01314872|158165820|FG011|Period 2|Withdrawal by Subject|14|||
49090332|NCT01314872|158165821|FG012|Period 2|Withdrawal by Subject|17|||
49090333|NCT01314872|158165822|FG013|Period 2|Withdrawal by Subject|12|||
49090334|NCT01314872|158165823|FG014|Period 2|Withdrawal by Subject|4|||
49090335|NCT01314872|158165809|FG000|Period 2|Lost to Follow-up|0|||
49090336|NCT01314872|158165810|FG001|Period 2|Lost to Follow-up|0|||
49090337|NCT01314872|158165811|FG002|Period 2|Lost to Follow-up|0|||
49090338|NCT01314872|158165812|FG003|Period 2|Lost to Follow-up|0|||
49090339|NCT01314872|158165813|FG004|Period 2|Lost to Follow-up|0|||
49090340|NCT01314872|158165814|FG005|Period 2|Lost to Follow-up|0|||
49090341|NCT01314872|158165815|FG006|Period 2|Lost to Follow-up|0|||
49090342|NCT01314872|158165816|FG007|Period 2|Lost to Follow-up|0|||
49090343|NCT01314872|158165817|FG008|Period 2|Lost to Follow-up|0|||
49090344|NCT01314872|158165818|FG009|Period 2|Lost to Follow-up|0|||
49090345|NCT01314872|158165819|FG010|Period 2|Lost to Follow-up|0|||
49090346|NCT01314872|158165820|FG011|Period 2|Lost to Follow-up|6|||
49090347|NCT01314872|158165821|FG012|Period 2|Lost to Follow-up|7|||
49090348|NCT01314872|158165822|FG013|Period 2|Lost to Follow-up|2|||
49090349|NCT01314872|158165823|FG014|Period 2|Lost to Follow-up|6|||
49090350|NCT04537234|158165824|FG000|Overall Study|Withdrawal by Subject|2|||
49090351|NCT04537234|158165825|FG001|Overall Study|Withdrawal by Subject|0|||
49090352|NCT01464424|158165826|FG000|Period 1, First 6 Weeks|Adverse Event|0|||
49090353|NCT01464424|158165827|FG001|Period 1, First 6 Weeks|Adverse Event|1|||
49090354|NCT01560234|158165828|FG000|Overall Study|Lost to Follow-up|3|||
49090355|NCT01560234|158165829|FG001|Overall Study|Lost to Follow-up|0|||
49090356|NCT01560234|158165830|FG002|Overall Study|Lost to Follow-up|1|||
49090357|NCT01560234|158165831|FG003|Overall Study|Lost to Follow-up|0|||
49090358|NCT01560234|158165832|FG004|Overall Study|Lost to Follow-up|0|||
49090359|NCT01560234|158165833|FG005|Overall Study|Lost to Follow-up|2|||
49090360|NCT01560234|158165834|FG006|Overall Study|Lost to Follow-up|0|||
49090361|NCT01560234|158165835|FG007|Overall Study|Lost to Follow-up|2|||
49090362|NCT01464333|158165842|FG000|Overall Study|Adverse Event|34|||
49090363|NCT01464333|158165842|FG000|Overall Study|Lack of Efficacy|72|||
49090364|NCT01464333|158165842|FG000|Overall Study|Withdrawal by Subject|11|||
49090365|NCT01464333|158165842|FG000|Overall Study|Other|4|||
49090366|NCT01464333|158165842|FG000|Overall Study|No Hospital Visit|42|||
49090367|NCT03482453|158165843|FG000|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
49090368|NCT03482453|158165844|FG001|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
49090369|NCT03482453|158165845|FG002|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
49090370|NCT03482453|158165846|FG003|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
49090371|NCT03482453|158165847|FG004|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
49090372|NCT03482453|158165848|FG005|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
49090373|NCT03482453|158165849|FG006|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
49090374|NCT03482453|158165850|FG007|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
49090375|NCT03482453|158165851|FG008|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
49090376|NCT03482453|158165852|FG009|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
49090377|NCT03482453|158165853|FG010|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1|||
49090378|NCT03482453|158165854|FG011|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
49090379|NCT01726270|158165855|FG000|Part 1, Self-Selection Phase|Withdrawal by Subject|10|||
49090380|NCT01726270|158165855|FG000|Eligibility for Part 2|Eligible but did not enter Part 2|20|||
49090381|NCT01726270|158165855|FG000|Part 2, Actual-Use Phase|Withdrawal by Subject|21|||
49090382|NCT01726270|158165855|FG000|Part 2, Actual-Use Phase|Adverse Event|6|||
49090383|NCT01726270|158165855|FG000|Part 2, Actual-Use Phase|Lost to Follow-up|5|||
49090384|NCT01726270|158165855|FG000|Part 2, Actual-Use Phase|Other than reason specified above|7|||
49090385|NCT00546377|158165857|FG000|Overall Study|Deemed ineligible|1|||
49090386|NCT00546377|158165857|FG000|Overall Study|Adverse Event|6|||
49090387|NCT02068508|158165858|FG000|Overall Study|Case report forms uncollected|27|||
49090388|NCT02068508|158165858|FG000|Overall Study|Patient did not visit the study site|1|||
49090389|NCT02068508|158165858|FG000|Overall Study|Protocol Violation|4|||
49090390|NCT02064816|158165859|FG000|Overall Study|Adverse Event|3|||
49090391|NCT02064816|158165860|FG001|Overall Study|Adverse Event|2|||
49090392|NCT02064816|158165859|FG000|Overall Study|Withdrawal by Subject|2|||
49090393|NCT02064816|158165860|FG001|Overall Study|Withdrawal by Subject|1|||
49090394|NCT02064816|158165859|FG000|Overall Study|Lost to Follow-up|2|||
49090395|NCT02064816|158165860|FG001|Overall Study|Lost to Follow-up|1|||
49090396|NCT02064816|158165859|FG000|Overall Study|Therapeutic failure|0|||
49090397|NCT02064816|158165860|FG001|Overall Study|Therapeutic failure|1|||
49090398|NCT02064816|158165859|FG000|Overall Study|Other|1|||
49090399|NCT02064816|158165860|FG001|Overall Study|Other|3|||
49090400|NCT03278613|158165861|FG000|Overall Study|Lost to Follow-up|3|||
49090401|NCT03278613|158165862|FG001|Overall Study|Lost to Follow-up|1|||
49090402|NCT01218087|158165867|FG000|Overall Study|Death|2|||
49090403|NCT01218087|158165868|FG001|Overall Study|Death|1|||
49090404|NCT01218087|158165867|FG000|Overall Study|Withdrawal by Subject|5|||
49090405|NCT01218087|158165868|FG001|Overall Study|Withdrawal by Subject|0|||
49090406|NCT01218087|158165867|FG000|Overall Study|Transferred|8|||
49090407|NCT01218087|158165868|FG001|Overall Study|Transferred|5|||
49090408|NCT02195869|158165869|FG000|Overall Study|cGVHD Progression|5|||
49090409|NCT02195869|158165869|FG000|Overall Study|Malignancy Progression/relapse|2|||
49090410|NCT02195869|158165869|FG000|Overall Study|Adverse Event|15|||
49090411|NCT02195869|158165869|FG000|Overall Study|Withdrawal by Subject|7|||
49090412|NCT02195869|158165869|FG000|Overall Study|Physician Decision|4|||
49090413|NCT02195869|158165869|FG000|Overall Study|Study Terminated by Sponsor|7|||
49090414|NCT02195869|158165869|FG000|Overall Study|Noncompliance with study drug|2|||
49090415|NCT02073929|158165870|FG000|Overall Study|Lost to Follow-up|2|||
49090416|NCT02073929|158165871|FG001|Overall Study|Lost to Follow-up|1|||
49090417|NCT02073929|158165870|FG000|Overall Study|Adverse Event|2|||
49090418|NCT02073929|158165871|FG001|Overall Study|Adverse Event|1|||
49090419|NCT02073929|158165870|FG000|Overall Study|Withdrawal by Subject|0|||
49090420|NCT02073929|158165871|FG001|Overall Study|Withdrawal by Subject|1|||
49090421|NCT00789698|158165872|FG000|Overall Study|Lack of Efficacy|10|||
49090422|NCT00789698|158165873|FG001|Overall Study|Lack of Efficacy|4|||
49090423|NCT00789698|158165874|FG002|Overall Study|Lack of Efficacy|5|||
49090424|NCT00789698|158165875|FG003|Overall Study|Lack of Efficacy|18|||
49090425|NCT00789698|158165872|FG000|Overall Study|Adverse Event|5|||
49090426|NCT00789698|158165873|FG001|Overall Study|Adverse Event|5|||
49090427|NCT00789698|158165874|FG002|Overall Study|Adverse Event|3|||
49090428|NCT00789698|158165875|FG003|Overall Study|Adverse Event|4|||
49090429|NCT00789698|158165872|FG000|Overall Study|Lost to Follow-up|5|||
49090430|NCT00789698|158165873|FG001|Overall Study|Lost to Follow-up|5|||
49090431|NCT00789698|158165874|FG002|Overall Study|Lost to Follow-up|2|||
49090432|NCT00789698|158165875|FG003|Overall Study|Lost to Follow-up|9|||
49090433|NCT00789698|158165872|FG000|Overall Study|Protocol Violation|6|||
49090434|NCT00789698|158165873|FG001|Overall Study|Protocol Violation|1|||
49090435|NCT00789698|158165874|FG002|Overall Study|Protocol Violation|2|||
49090436|NCT00789698|158165875|FG003|Overall Study|Protocol Violation|1|||
49090437|NCT00789698|158165872|FG000|Overall Study|Withdrawal by Subject|14|||
49090438|NCT00789698|158165873|FG001|Overall Study|Withdrawal by Subject|15|||
49090439|NCT00789698|158165874|FG002|Overall Study|Withdrawal by Subject|12|||
49090440|NCT00789698|158165875|FG003|Overall Study|Withdrawal by Subject|19|||
49090441|NCT00789698|158165872|FG000|Overall Study|Administrative|0|||
49090442|NCT00789698|158165873|FG001|Overall Study|Administrative|3|||
49090443|NCT00789698|158165874|FG002|Overall Study|Administrative|3|||
49090444|NCT00789698|158165875|FG003|Overall Study|Administrative|1|||
49090445|NCT01208974|158165877|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|1|||
49090446|NCT01208974|158165878|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
49090447|NCT01208974|158165879|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
49090448|NCT01208974|158165880|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
49090449|NCT01208974|158165877|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|1|||
49090450|NCT01208974|158165878|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
49090451|NCT01208974|158165879|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
49090452|NCT01208974|158165880|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
49090453|NCT01208974|158165877|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|1|||
49090454|NCT01208974|158165878|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
49090455|NCT01208974|158165879|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
49090456|NCT01208974|158165880|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
49090457|NCT01500382|158165881|FG000|Washout Period|Study site went out of business|0|||
49090458|NCT01500382|158165882|FG001|Washout Period|Study site went out of business|0|||
49090459|NCT01500382|158165883|FG002|Washout Period|Study site went out of business|1|||
49090460|NCT01500382|158165884|FG003|Washout Period|Study site went out of business|0|||
49090461|NCT02861586|158167616|FG000|Overall Study|Withdrawal by Subject|1|||
49090462|NCT02861586|158167617|FG001|Overall Study|Withdrawal by Subject|2|||
49090463|NCT02861586|158167618|FG002|Overall Study|Withdrawal by Subject|0|||
49090464|NCT02861586|158167619|FG003|Overall Study|Withdrawal by Subject|0|||
49090465|NCT02861586|158167620|FG004|Overall Study|Withdrawal by Subject|0|||
49090466|NCT02861586|158167621|FG005|Overall Study|Withdrawal by Subject|1|||
49090467|NCT02861586|158167622|FG006|Overall Study|Withdrawal by Subject|1|||
49090468|NCT02861586|158167623|FG007|Overall Study|Withdrawal by Subject|0|||
49090469|NCT02861586|158167616|FG000|Overall Study|Lost to Follow-up|3|||
49090470|NCT02861586|158167617|FG001|Overall Study|Lost to Follow-up|1|||
49090471|NCT02861586|158167618|FG002|Overall Study|Lost to Follow-up|1|||
49090472|NCT02861586|158167619|FG003|Overall Study|Lost to Follow-up|0|||
49090473|NCT02861586|158167620|FG004|Overall Study|Lost to Follow-up|0|||
49090474|NCT02861586|158167621|FG005|Overall Study|Lost to Follow-up|3|||
49090475|NCT02861586|158167622|FG006|Overall Study|Lost to Follow-up|0|||
49090476|NCT02861586|158167623|FG007|Overall Study|Lost to Follow-up|0|||
49090477|NCT02861586|158167616|FG000|Overall Study|Adverse Event|0|||
49090478|NCT02861586|158167617|FG001|Overall Study|Adverse Event|0|||
49090479|NCT02861586|158167618|FG002|Overall Study|Adverse Event|0|||
49090480|NCT02861586|158167619|FG003|Overall Study|Adverse Event|0|||
49090481|NCT02861586|158167620|FG004|Overall Study|Adverse Event|0|||
49090482|NCT02861586|158167621|FG005|Overall Study|Adverse Event|1|||
49090483|NCT02861586|158167622|FG006|Overall Study|Adverse Event|0|||
49090484|NCT02861586|158167623|FG007|Overall Study|Adverse Event|0|||
49090485|NCT00754234|158167624|FG000|Overall Study|Withdrawal by Subject|3|||
49090486|NCT02283268|158167630|FG000|Overall Study|Withdrawal by Subject|1|||
49090487|NCT00454246|158167631|FG000|Overall Study|Adverse Event|2|||
49090488|NCT00454246|158167632|FG001|Overall Study|Adverse Event|2|||
49090489|NCT00454246|158167633|FG002|Overall Study|Adverse Event|0|||
49090490|NCT00454246|158167631|FG000|Overall Study|Violation of selection criteria at entry|6|||
49090491|NCT00454246|158167632|FG001|Overall Study|Violation of selection criteria at entry|0|||
49090492|NCT00454246|158167633|FG002|Overall Study|Violation of selection criteria at entry|0|||
49090493|NCT00454246|158167631|FG000|Overall Study|Protocol Violation|1|||
49090494|NCT00454246|158167632|FG001|Overall Study|Protocol Violation|0|||
49090495|NCT00454246|158167633|FG002|Overall Study|Protocol Violation|0|||
49090496|NCT00454246|158167631|FG000|Overall Study|Refused Treatment|1|||
49090497|NCT00454246|158167632|FG001|Overall Study|Refused Treatment|1|||
49090498|NCT00454246|158167633|FG002|Overall Study|Refused Treatment|0|||
49090499|NCT00454246|158167631|FG000|Overall Study|Failure to return|1|||
49090500|NCT00454246|158167632|FG001|Overall Study|Failure to return|0|||
49090501|NCT00454246|158167633|FG002|Overall Study|Failure to return|0|||
49090502|NCT00454246|158167631|FG000|Overall Study|Early termination of study|62|||
49090503|NCT00454246|158167632|FG001|Overall Study|Early termination of study|26|||
49090504|NCT00454246|158167633|FG002|Overall Study|Early termination of study|9|||
49090505|NCT02530125|158167639|FG000|Completed Treatment|Early termination of study|1|||
49090506|NCT02530125|158167639|FG000|Followed for Survival for 2 Years|Early termination of study|3|||
49090507|NCT03656068|158167640|FG000|Overall Study|Withdrawal by Subject|4|||
49090508|NCT03656068|158167640|FG000|Overall Study|Adverse Event|1|||
49090509|NCT00651261|158167642|FG000|Overall Study|Adverse Event|32|||
49090510|NCT00651261|158167643|FG001|Overall Study|Adverse Event|22|||
49090511|NCT00651261|158167642|FG000|Overall Study|Death|18|||
49090512|NCT00651261|158167643|FG001|Overall Study|Death|18|||
49090513|NCT00651261|158167642|FG000|Overall Study|Withdrawal by Subject|22|||
49090514|NCT00651261|158167643|FG001|Overall Study|Withdrawal by Subject|40|||
49090515|NCT00651261|158167642|FG000|Overall Study|Induction failure|24|||
49090516|NCT00651261|158167643|FG001|Overall Study|Induction failure|35|||
49090517|NCT00651261|158167642|FG000|Overall Study|Disease progression|58|||
49090518|NCT00651261|158167643|FG001|Overall Study|Disease progression|58|||
49090519|NCT00651261|158167642|FG000|Overall Study|Alternative therapy|109|||
49090520|NCT00651261|158167643|FG001|Overall Study|Alternative therapy|107|||
49090521|NCT00651261|158167642|FG000|Overall Study|Other disease or participant decisions|23|||
49090522|NCT00651261|158167643|FG001|Overall Study|Other disease or participant decisions|23|||
49090523|NCT00651261|158167642|FG000|Overall Study|Never treated|5|||
49090524|NCT00651261|158167643|FG001|Overall Study|Never treated|3|||
49090525|NCT02230904|158167644|FG000|Overall Study|Safety follow up could not take place|0|||
49090526|NCT02230904|158167645|FG001|Overall Study|Safety follow up could not take place|1|||
49090527|NCT00628212|158167646|FG000|Overall Study|Adverse Event|2|||
49090528|NCT00628212|158167647|FG001|Overall Study|Adverse Event|0|||
49090529|NCT00628212|158167648|FG002|Overall Study|Adverse Event|1|||
49090530|NCT00628212|158167649|FG003|Overall Study|Adverse Event|2|||
49090531|NCT00628212|158167646|FG000|Overall Study|Physician Decision|1|||
49090532|NCT00628212|158167647|FG001|Overall Study|Physician Decision|1|||
49090533|NCT00628212|158167648|FG002|Overall Study|Physician Decision|2|||
49090534|NCT00628212|158167649|FG003|Overall Study|Physician Decision|3|||
49090535|NCT01592786|158167650|FG000|Overall Study|Adverse Event|60|||
49090536|NCT01592786|158167650|FG000|Overall Study|Lack of Efficacy|19|||
49090537|NCT01592786|158167650|FG000|Overall Study|Protocol Violation|14|||
49090538|NCT01592786|158167650|FG000|Overall Study|Withdrawal by Subject|23|||
49090539|NCT01592786|158167650|FG000|Overall Study|Lost to Follow-up|19|||
49090540|NCT01592786|158167650|FG000|Overall Study|Other|3|||
49090541|NCT02025725|158167651|FG000|Overall Study|Adverse Event|5|||
49090542|NCT02025725|158167652|FG001|Overall Study|Adverse Event|0|||
49090543|NCT02025725|158167651|FG000|Overall Study|Lost to Follow-up|2|||
49090544|NCT02025725|158167652|FG001|Overall Study|Lost to Follow-up|0|||
49090545|NCT02025725|158167651|FG000|Overall Study|Protocol Violation|1|||
49090546|NCT02025725|158167652|FG001|Overall Study|Protocol Violation|1|||
49090547|NCT02025725|158167651|FG000|Overall Study|Withdrawal by Subject|3|||
49090548|NCT02025725|158167652|FG001|Overall Study|Withdrawal by Subject|2|||
49090549|NCT02025725|158167651|FG000|Overall Study|Post-dose QTcB > 270 msec|0|||
49090550|NCT02025725|158167652|FG001|Overall Study|Post-dose QTcB > 270 msec|1|||
49090551|NCT01681212|158167653|FG000|Overall Study|No longer met study criteria|5|||
49090552|NCT01681212|158167653|FG000|Overall Study|Administrative reason by sponsor|1|||
49090553|NCT00610155|158167654|FG000|Period 1|Withdrawal by Subject|0|||
49090554|NCT00610155|158167655|FG001|Period 1|Withdrawal by Subject|0|||
49090555|NCT00610155|158167656|FG002|Period 1|Withdrawal by Subject|1|||
49090556|NCT00610155|158167657|FG003|Period 1|Withdrawal by Subject|0|||
49090557|NCT00610155|158167658|FG004|Period 1|Withdrawal by Subject|0|||
49090558|NCT00610155|158167659|FG005|Period 1|Withdrawal by Subject|0|||
49090559|NCT00610155|158167654|FG000|Period 3|Adverse Event|1|||
49090560|NCT00610155|158167655|FG001|Period 3|Adverse Event|0|||
49090561|NCT00610155|158167656|FG002|Period 3|Adverse Event|0|||
49090562|NCT00610155|158167657|FG003|Period 3|Adverse Event|0|||
49090563|NCT00610155|158167658|FG004|Period 3|Adverse Event|0|||
49090564|NCT00610155|158167659|FG005|Period 3|Adverse Event|0|||
49090565|NCT00789373|158167660|FG000|Induction|Adverse Event|64|||
49090566|NCT00789373|158167661|FG001|Induction|Adverse Event|0|||
49090567|NCT00789373|158167662|FG002|Induction|Adverse Event|0|||
49090568|NCT00789373|158167660|FG000|Induction|Death Due to study disease|24|||
49090569|NCT00789373|158167661|FG001|Induction|Death Due to study disease|0|||
49090570|NCT00789373|158167662|FG002|Induction|Death Due to study disease|0|||
49090571|NCT00789373|158167660|FG000|Induction|Death due to adverse event|19|||
49090572|NCT00789373|158167661|FG001|Induction|Death due to adverse event|0|||
49090573|NCT00789373|158167662|FG002|Induction|Death due to adverse event|0|||
49090574|NCT00789373|158167660|FG000|Induction|Death due to toxicity|11|||
49090575|NCT00789373|158167661|FG001|Induction|Death due to toxicity|0|||
49090576|NCT00789373|158167662|FG002|Induction|Death due to toxicity|0|||
49090577|NCT00789373|158167660|FG000|Induction|Death due to procedure|1|||
49090578|NCT00789373|158167661|FG001|Induction|Death due to procedure|0|||
49090579|NCT00789373|158167662|FG002|Induction|Death due to procedure|0|||
49090580|NCT00789373|158167660|FG000|Induction|Investigator decision|7|||
49090581|NCT00789373|158167661|FG001|Induction|Investigator decision|0|||
49090582|NCT00789373|158167662|FG002|Induction|Investigator decision|0|||
49090583|NCT00789373|158167660|FG000|Induction|Protocol entry criteria not met|9|||
49090584|NCT00789373|158167661|FG001|Induction|Protocol entry criteria not met|0|||
49090585|NCT00789373|158167662|FG002|Induction|Protocol entry criteria not met|0|||
49090586|NCT00789373|158167660|FG000|Induction|Lost to Follow-up|6|||
49090587|NCT00789373|158167661|FG001|Induction|Lost to Follow-up|0|||
49090588|NCT00789373|158167662|FG002|Induction|Lost to Follow-up|0|||
49090589|NCT00789373|158167660|FG000|Induction|Protocol Violation|1|||
49090590|NCT00789373|158167661|FG001|Induction|Protocol Violation|0|||
49090591|NCT00789373|158167662|FG002|Induction|Protocol Violation|0|||
49090592|NCT00789373|158167660|FG000|Induction|Progressive Disease|220|||
49090593|NCT00789373|158167661|FG001|Induction|Progressive Disease|0|||
49090594|NCT00789373|158167662|FG002|Induction|Progressive Disease|0|||
49090595|NCT00789373|158167660|FG000|Induction|Withdrawal by Subject|37|||
49090596|NCT00789373|158167661|FG001|Induction|Withdrawal by Subject|0|||
49090597|NCT00789373|158167662|FG002|Induction|Withdrawal by Subject|0|||
49090598|NCT00789373|158167660|FG000|Maintenance|Adverse Event|0|||
49090599|NCT00789373|158167661|FG001|Maintenance|Adverse Event|65|||
49090600|NCT00789373|158167662|FG002|Maintenance|Adverse Event|12|||
49090601|NCT00789373|158167660|FG000|Maintenance|Death due to study disease|0|||
49090602|NCT00789373|158167661|FG001|Maintenance|Death due to study disease|3|||
49090603|NCT00789373|158167662|FG002|Maintenance|Death due to study disease|1|||
49090604|NCT00789373|158167660|FG000|Maintenance|Death due to adverse event|0|||
49090605|NCT00789373|158167661|FG001|Maintenance|Death due to adverse event|4|||
49090606|NCT00789373|158167662|FG002|Maintenance|Death due to adverse event|1|||
49090607|NCT00789373|158167660|FG000|Maintenance|Death due to toxicity|0|||
49090608|NCT00789373|158167661|FG001|Maintenance|Death due to toxicity|1|||
49090609|NCT00789373|158167662|FG002|Maintenance|Death due to toxicity|2|||
49090610|NCT00789373|158167660|FG000|Maintenance|Investigator Decision|0|||
49090611|NCT00789373|158167661|FG001|Maintenance|Investigator Decision|4|||
49090612|NCT00789373|158167662|FG002|Maintenance|Investigator Decision|2|||
49090613|NCT00789373|158167660|FG000|Maintenance|Protocol entry criteria not met|0|||
49090614|NCT00789373|158167661|FG001|Maintenance|Protocol entry criteria not met|2|||
49090615|NCT00789373|158167662|FG002|Maintenance|Protocol entry criteria not met|0|||
49090616|NCT00789373|158167660|FG000|Maintenance|Lost to Follow-up|0|||
49090617|NCT00789373|158167661|FG001|Maintenance|Lost to Follow-up|2|||
49090618|NCT00789373|158167662|FG002|Maintenance|Lost to Follow-up|0|||
49090619|NCT00789373|158167660|FG000|Maintenance|Progressive Disease|0|||
49090620|NCT00789373|158167661|FG001|Maintenance|Progressive Disease|253|||
49090621|NCT00789373|158167662|FG002|Maintenance|Progressive Disease|152|||
49090622|NCT00789373|158167660|FG000|Maintenance|Withdrawal by Subject|0|||
49090623|NCT00789373|158167661|FG001|Maintenance|Withdrawal by Subject|21|||
49090624|NCT00789373|158167662|FG002|Maintenance|Withdrawal by Subject|8|||
49090625|NCT00789373|158167660|FG000|Maintenance|Sponsor Decision|0|||
49090626|NCT00789373|158167661|FG001|Maintenance|Sponsor Decision|0|||
49090627|NCT00789373|158167662|FG002|Maintenance|Sponsor Decision|2|||
49090628|NCT00789373|158167660|FG000|Maintenance|Participants On-Going at Data Cut-Off|0|||
49090629|NCT00789373|158167661|FG001|Maintenance|Participants On-Going at Data Cut-Off|4|||
49090630|NCT00789373|158167662|FG002|Maintenance|Participants On-Going at Data Cut-Off|0|||
49090631|NCT05393037|158167668|FG000|Overall Study|Death|1|||
49090632|NCT05393037|158167669|FG001|Overall Study|Death|0|||
49090633|NCT05393037|158167668|FG000|Overall Study|Lost to Follow-up|1|||
49090634|NCT05393037|158167669|FG001|Overall Study|Lost to Follow-up|1|||
49090635|NCT05393037|158167668|FG000|Overall Study|Withdrawal by Subject|2|||
49090636|NCT05393037|158167669|FG001|Overall Study|Withdrawal by Subject|4|||
49090637|NCT05393037|158167668|FG000|Overall Study|Ongoing|152|||
49090638|NCT05393037|158167669|FG001|Overall Study|Ongoing|0|||
49090639|NCT02122887|158167670|FG000|Overall Study|Withdrawal by Subject|20|||
49090640|NCT02122887|158167671|FG001|Overall Study|Withdrawal by Subject|2|||
49090641|NCT02476578|158167672|FG000|Overall Study|Died before Email was sent (<9.11.2015)|35|||
49090642|NCT02476578|158167673|FG001|Overall Study|Died before Email was sent (<9.11.2015)|43|||
49090643|NCT02476578|158167672|FG000|Overall Study|Lost to Follow-up|6|||
49090644|NCT02476578|158167673|FG001|Overall Study|Lost to Follow-up|13|||
49090645|NCT05047211|158167676|FG000|Overall Study|Lost to Follow-up|8|||
49090646|NCT05047211|158167677|FG001|Overall Study|Lost to Follow-up|5|||
49090647|NCT02187198|158167678|FG000|Overall Study|did not show up for appointment and did not return calls after week 9|1|||
49090648|NCT02187198|158167679|FG001|Overall Study|did not show up for appointment and did not return calls after week 9|0|||
49090649|NCT02187198|158167678|FG000|Overall Study|did not show up for appointment and did not return calls after week 11|0|||
49090650|NCT02187198|158167679|FG001|Overall Study|did not show up for appointment and did not return calls after week 11|1|||
49090651|NCT01073605|158167680|FG000|Overall Study|Ongoing at Cutoff Date|1|||
49090652|NCT01073605|158167681|FG001|Overall Study|Ongoing at Cutoff Date|1|||
49090653|NCT01073605|158167682|FG002|Overall Study|Ongoing at Cutoff Date|0|||
49090654|NCT01073605|158167680|FG000|Overall Study|Adverse Event|2|||
49090655|NCT01073605|158167681|FG001|Overall Study|Adverse Event|1|||
49090656|NCT01073605|158167682|FG002|Overall Study|Adverse Event|0|||
49090657|NCT01073605|158167680|FG000|Overall Study|Lost to Follow-up|3|||
49090658|NCT01073605|158167681|FG001|Overall Study|Lost to Follow-up|4|||
49090659|NCT01073605|158167682|FG002|Overall Study|Lost to Follow-up|9|||
49090660|NCT01073605|158167680|FG000|Overall Study|Other|25|||
49090661|NCT01073605|158167681|FG001|Overall Study|Other|21|||
49090662|NCT01073605|158167682|FG002|Overall Study|Other|29|||
49090663|NCT01073605|158167680|FG000|Overall Study|Withdrawal by Subject|31|||
49090664|NCT01073605|158167681|FG001|Overall Study|Withdrawal by Subject|39|||
49090665|NCT01073605|158167682|FG002|Overall Study|Withdrawal by Subject|22|||
49090666|NCT01073605|158167680|FG000|Overall Study|Randomized But Not Treated|0|||
49090667|NCT01073605|158167681|FG001|Overall Study|Randomized But Not Treated|1|||
49090668|NCT01073605|158167682|FG002|Overall Study|Randomized But Not Treated|1|||
49090669|NCT03018080|158167683|FG000|Overall Study|Death|12|||
49090670|NCT03018080|158167684|FG001|Overall Study|Death|19|||
49090671|NCT04938180|158167685|FG000|Overall Study|Adverse Event|1|||
49090672|NCT00740792|158167687|FG000|Overall Study|Adverse Event|3|||
49090673|NCT00740792|158167688|FG001|Overall Study|Adverse Event|1|||
49090674|NCT00740792|158167689|FG002|Overall Study|Adverse Event|1|||
49090675|NCT00740792|158167690|FG003|Overall Study|Adverse Event|3|||
49090676|NCT00740792|158167687|FG000|Overall Study|Lack of Efficacy|1|||
49090677|NCT00740792|158167688|FG001|Overall Study|Lack of Efficacy|1|||
49090678|NCT00740792|158167689|FG002|Overall Study|Lack of Efficacy|0|||
49090679|NCT00740792|158167690|FG003|Overall Study|Lack of Efficacy|3|||
49090680|NCT00740792|158167687|FG000|Overall Study|Lost to Follow-up|2|||
49090681|NCT00740792|158167688|FG001|Overall Study|Lost to Follow-up|1|||
49090682|NCT00740792|158167689|FG002|Overall Study|Lost to Follow-up|0|||
49090683|NCT00740792|158167690|FG003|Overall Study|Lost to Follow-up|0|||
49090684|NCT00740792|158167687|FG000|Overall Study|Protocol Violation|0|||
49090685|NCT00740792|158167688|FG001|Overall Study|Protocol Violation|1|||
49090686|NCT00740792|158167689|FG002|Overall Study|Protocol Violation|0|||
49090687|NCT00740792|158167690|FG003|Overall Study|Protocol Violation|2|||
49090688|NCT00740792|158167687|FG000|Overall Study|Withdrawal by Subject|1|||
49090689|NCT00740792|158167688|FG001|Overall Study|Withdrawal by Subject|1|||
49090690|NCT00740792|158167689|FG002|Overall Study|Withdrawal by Subject|0|||
49090691|NCT00740792|158167690|FG003|Overall Study|Withdrawal by Subject|0|||
49090692|NCT00740792|158167687|FG000|Overall Study|administrative|3|||
49090693|NCT00740792|158167688|FG001|Overall Study|administrative|3|||
49090694|NCT00740792|158167689|FG002|Overall Study|administrative|8|||
49090695|NCT00740792|158167690|FG003|Overall Study|administrative|2|||
49090696|NCT01284348|158167691|FG000|Overall Study|Death|1|||
49090697|NCT01284348|158167692|FG001|Overall Study|Death|1|||
49090698|NCT01284348|158167691|FG000|Overall Study|Withdrew consent|0|||
49090699|NCT01284348|158167692|FG001|Overall Study|Withdrew consent|1|||
49090700|NCT01284348|158167691|FG000|Overall Study|Status not recorded|9|||
49090701|NCT01284348|158167692|FG001|Overall Study|Status not recorded|10|||
49090702|NCT03321968|158167693|FG000|Overall Study|Withdrawal by Subject|1|||
49090703|NCT03321968|158167694|FG001|Overall Study|Withdrawal by Subject|2|||
49090704|NCT03321968|158167695|FG002|Overall Study|Withdrawal by Subject|1|||
49090705|NCT03321968|158167693|FG000|Overall Study|Lost to Follow-up|2|||
49090706|NCT03321968|158167694|FG001|Overall Study|Lost to Follow-up|0|||
49090707|NCT03321968|158167695|FG002|Overall Study|Lost to Follow-up|1|||
49090708|NCT03321968|158167693|FG000|Overall Study|Other than specified|0|||
49090709|NCT03321968|158167694|FG001|Overall Study|Other than specified|0|||
49090710|NCT03321968|158167695|FG002|Overall Study|Other than specified|1|||
49090711|NCT04707469|158167696|FG000|Overall Study|Site closure|0|||
49090712|NCT04707469|158167697|FG001|Overall Study|Site closure|2|||
49090713|NCT04707469|158167698|FG002|Overall Study|Site closure|0|||
49090714|NCT04707469|158167696|FG000|Overall Study|Physician Decision|2|||
49090715|NCT04707469|158167697|FG001|Overall Study|Physician Decision|2|||
49090716|NCT04707469|158167698|FG002|Overall Study|Physician Decision|2|||
49090717|NCT04707469|158167696|FG000|Overall Study|Death|1|||
49090718|NCT04707469|158167697|FG001|Overall Study|Death|6|||
49090719|NCT04707469|158167698|FG002|Overall Study|Death|2|||
49090720|NCT04707469|158167696|FG000|Overall Study|Lost to Follow-up|9|||
49090721|NCT04707469|158167697|FG001|Overall Study|Lost to Follow-up|19|||
49090722|NCT04707469|158167698|FG002|Overall Study|Lost to Follow-up|14|||
49090723|NCT04707469|158167696|FG000|Overall Study|Withdrawal by Subject|17|||
49090724|NCT04707469|158167697|FG001|Overall Study|Withdrawal by Subject|16|||
49090725|NCT04707469|158167698|FG002|Overall Study|Withdrawal by Subject|12|||
49090726|NCT01964222|158167699|FG000|Overall Study|Lost to Follow-up|7|||
49090727|NCT01964222|158167700|FG001|Overall Study|Lost to Follow-up|5|||
49090728|NCT01964222|158167699|FG000|Overall Study|Withdrawal by Subject|6|||
49090729|NCT01964222|158167700|FG001|Overall Study|Withdrawal by Subject|6|||
49090730|NCT01964222|158167699|FG000|Overall Study|Screening Failure|2|||
49090731|NCT01964222|158167700|FG001|Overall Study|Screening Failure|0|||
49090732|NCT01684423|158167707|FG000|Overall Study|Withdrawal by Subject|0|||
49090733|NCT01684423|158167708|FG001|Overall Study|Withdrawal by Subject|0|||
49090734|NCT01684423|158167709|FG002|Overall Study|Withdrawal by Subject|1|||
49090735|NCT01684423|158167710|FG003|Overall Study|Withdrawal by Subject|0|||
49090736|NCT01684423|158167711|FG004|Overall Study|Withdrawal by Subject|0|||
49090737|NCT03192306|158167714|FG000|Overall Study|Did not treat cold sore during study|149|||
49090738|NCT03192306|158167715|FG001|Overall Study|Did not treat cold sore during study|143|||
49090739|NCT03192306|158167714|FG000|Overall Study|Withdrawal by Subject|1|||
49090740|NCT03192306|158167715|FG001|Overall Study|Withdrawal by Subject|1|||
49090741|NCT03192306|158167714|FG000|Overall Study|Lost to Follow-up|1|||
49090742|NCT03192306|158167715|FG001|Overall Study|Lost to Follow-up|0|||
49090743|NCT03192306|158167714|FG000|Overall Study|Protocol Violation|1|||
49090744|NCT03192306|158167715|FG001|Overall Study|Protocol Violation|1|||
49090745|NCT04164732|158167718|FG000|Treatment run-in Period|Adverse Event|4|||
49090746|NCT04164732|158167719|FG001|Treatment run-in Period|Adverse Event|0|||
49090747|NCT04164732|158167720|FG002|Treatment run-in Period|Adverse Event|0|||
49090748|NCT04164732|158167718|FG000|Treatment run-in Period|Physician Decision|1|||
49090749|NCT04164732|158167719|FG001|Treatment run-in Period|Physician Decision|0|||
49090750|NCT04164732|158167720|FG002|Treatment run-in Period|Physician Decision|0|||
49090751|NCT04164732|158167718|FG000|Treatment run-in Period|Screen Failure|1|||
49090752|NCT04164732|158167719|FG001|Treatment run-in Period|Screen Failure|0|||
49090753|NCT04164732|158167720|FG002|Treatment run-in Period|Screen Failure|0|||
49090754|NCT04164732|158167718|FG000|Randomized Treatment Period|Adverse Event|0|||
49090755|NCT04164732|158167719|FG001|Randomized Treatment Period|Adverse Event|1|||
49090756|NCT04164732|158167720|FG002|Randomized Treatment Period|Adverse Event|0|||
49090757|NCT04164732|158167718|FG000|Randomized Treatment Period|Protocol Deviation|0|||
49090758|NCT04164732|158167719|FG001|Randomized Treatment Period|Protocol Deviation|1|||
49090759|NCT04164732|158167720|FG002|Randomized Treatment Period|Protocol Deviation|1|||
49090760|NCT04164732|158167718|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
49090761|NCT04164732|158167719|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
49090762|NCT04164732|158167720|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
49090763|NCT01455597|158167721|FG000|Overall Study|Adverse Event|7|||
49090764|NCT01455597|158167722|FG001|Overall Study|Adverse Event|0|||
49090765|NCT01455597|158167723|FG002|Overall Study|Adverse Event|5|||
49090766|NCT01455597|158167724|FG003|Overall Study|Adverse Event|1|||
49090767|NCT01455597|158167721|FG000|Overall Study|Lack of Efficacy|0|||
49090768|NCT01455597|158167722|FG001|Overall Study|Lack of Efficacy|1|||
49090769|NCT01455597|158167723|FG002|Overall Study|Lack of Efficacy|2|||
49090770|NCT01455597|158167724|FG003|Overall Study|Lack of Efficacy|0|||
49090771|NCT01455597|158167721|FG000|Overall Study|Lost to Follow-up|3|||
49090772|NCT01455597|158167722|FG001|Overall Study|Lost to Follow-up|0|||
49090773|NCT01455597|158167723|FG002|Overall Study|Lost to Follow-up|2|||
49090774|NCT01455597|158167724|FG003|Overall Study|Lost to Follow-up|1|||
49090775|NCT01455597|158167721|FG000|Overall Study|Withdrew Consent|6|||
49090776|NCT01455597|158167722|FG001|Overall Study|Withdrew Consent|5|||
49090777|NCT01455597|158167723|FG002|Overall Study|Withdrew Consent|8|||
49090778|NCT01455597|158167724|FG003|Overall Study|Withdrew Consent|5|||
49090779|NCT01455597|158167721|FG000|Overall Study|Reason not Specified|1|||
49090780|NCT01455597|158167722|FG001|Overall Study|Reason not Specified|2|||
49090781|NCT01455597|158167723|FG002|Overall Study|Reason not Specified|3|||
49090782|NCT01455597|158167724|FG003|Overall Study|Reason not Specified|3|||
49090783|NCT03512210|158167725|FG000|Step 1: MINMON Intervention|Lost to Follow-up|3|||
49090784|NCT03512210|158167725|FG000|Step 1: MINMON Intervention|Protocol Violation|1|||
49090785|NCT03512210|158167725|FG000|Step 2:Post-MINMON|Death|2|||
49090786|NCT03512210|158167725|FG000|Step 2:Post-MINMON|Lost to Follow-up|30|||
49090787|NCT03512210|158167725|FG000|Step 2:Post-MINMON|Withdrawal by Subject|2|||
49090788|NCT01737710|158167726|FG000|Overall Study|Lost to Follow-up|0|||
49090789|NCT01737710|158167727|FG001|Overall Study|Lost to Follow-up|2|||
49090790|NCT01737710|158167728|FG002|Overall Study|Lost to Follow-up|2|||
49090791|NCT01737710|158167729|FG003|Overall Study|Lost to Follow-up|0|||
49090792|NCT01737710|158167730|FG004|Overall Study|Lost to Follow-up|0|||
49090793|NCT01737710|158167726|FG000|Overall Study|Withdrawal by Subject|1|||
49090794|NCT01737710|158167727|FG001|Overall Study|Withdrawal by Subject|1|||
49090795|NCT01737710|158167728|FG002|Overall Study|Withdrawal by Subject|1|||
49090796|NCT01737710|158167729|FG003|Overall Study|Withdrawal by Subject|0|||
49090797|NCT01737710|158167730|FG004|Overall Study|Withdrawal by Subject|0|||
49090798|NCT01737710|158167726|FG000|Overall Study|Vaccinated in Error/Ineligible|1|||
49090799|NCT01737710|158167727|FG001|Overall Study|Vaccinated in Error/Ineligible|1|||
49090800|NCT01737710|158167728|FG002|Overall Study|Vaccinated in Error/Ineligible|0|||
49090801|NCT01737710|158167729|FG003|Overall Study|Vaccinated in Error/Ineligible|0|||
49090802|NCT01737710|158167730|FG004|Overall Study|Vaccinated in Error/Ineligible|0|||
49090803|NCT03412734|158167733|FG000|Overall Study|Incorrect labeling of samples|2|||
49090804|NCT03412734|158167734|FG001|Overall Study|Incorrect labeling of samples|0|||
49090805|NCT03412734|158167733|FG000|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1|||
49090806|NCT03412734|158167734|FG001|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0|||
49090807|NCT01575834|158167735|FG000|Overall Study|Withdrawal by Subject|352|||
49090808|NCT01575834|158167736|FG001|Overall Study|Withdrawal by Subject|390|||
49090809|NCT01575834|158167735|FG000|Overall Study|Death|81|||
49090810|NCT01575834|158167736|FG001|Overall Study|Death|74|||
49090811|NCT01575834|158167735|FG000|Overall Study|Other|70|||
49090812|NCT01575834|158167736|FG001|Overall Study|Other|70|||
49090813|NCT01575834|158167735|FG000|Overall Study|Adverse Event|63|||
49090814|NCT01575834|158167736|FG001|Overall Study|Adverse Event|61|||
49090815|NCT01575834|158167735|FG000|Overall Study|Lost to Follow-up|55|||
49090816|NCT01575834|158167736|FG001|Overall Study|Lost to Follow-up|68|||
49090817|NCT01575834|158167735|FG000|Overall Study|Noncompliance|52|||
49090818|NCT01575834|158167736|FG001|Overall Study|Noncompliance|27|||
49090819|NCT01575834|158167735|FG000|Overall Study|Administrative decision|15|||
49090820|NCT01575834|158167736|FG001|Overall Study|Administrative decision|33|||
49090821|NCT01575834|158167735|FG000|Overall Study|Ineligibility Determined|5|||
49090822|NCT01575834|158167736|FG001|Overall Study|Ineligibility Determined|8|||
49090823|NCT01575834|158167735|FG000|Overall Study|Protocol Deviation|4|||
49090824|NCT01575834|158167736|FG001|Overall Study|Protocol Deviation|3|||
49090825|NCT01575834|158167735|FG000|Overall Study|Requirement for Alternative Therapy|2|||
49090826|NCT01575834|158167736|FG001|Overall Study|Requirement for Alternative Therapy|4|||
49090827|NCT00356135|158167737|FG000|Overall Study|Protocol Violation|1|||
49090828|NCT00356135|158167738|FG001|Overall Study|Protocol Violation|0|||
49090829|NCT00356135|158167739|FG002|Overall Study|Protocol Violation|0|||
49090830|NCT00356135|158167737|FG000|Overall Study|Adverse Event|1|||
49090831|NCT00356135|158167738|FG001|Overall Study|Adverse Event|0|||
49090832|NCT00356135|158167739|FG002|Overall Study|Adverse Event|0|||
49090833|NCT00356135|158167737|FG000|Overall Study|Lost to Follow-up|0|||
49090834|NCT00356135|158167738|FG001|Overall Study|Lost to Follow-up|0|||
49090835|NCT00356135|158167739|FG002|Overall Study|Lost to Follow-up|1|||
49090836|NCT00356135|158167737|FG000|Overall Study|Physician Decision|1|||
49090837|NCT00356135|158167738|FG001|Overall Study|Physician Decision|1|||
49090838|NCT00356135|158167739|FG002|Overall Study|Physician Decision|1|||
49090839|NCT00356135|158167737|FG000|Overall Study|Subject non-compliance|1|||
49090840|NCT00356135|158167738|FG001|Overall Study|Subject non-compliance|1|||
49090841|NCT00356135|158167739|FG002|Overall Study|Subject non-compliance|3|||
49090842|NCT00912743|158167740|FG000|Overall Study|Adverse Event|3|||
49090843|NCT00912743|158167741|FG001|Overall Study|Adverse Event|1|||
49090844|NCT00912743|158167740|FG000|Overall Study|Lack of Efficacy|9|||
49090845|NCT00912743|158167741|FG001|Overall Study|Lack of Efficacy|18|||
49090846|NCT00912743|158167740|FG000|Overall Study|Toxicity|0|||
49090847|NCT00912743|158167741|FG001|Overall Study|Toxicity|1|||
49090848|NCT00912743|158167740|FG000|Overall Study|End of treatment form was not collected|1|||
49090849|NCT00912743|158167741|FG001|Overall Study|End of treatment form was not collected|0|||
49090850|NCT00423332|158167742|FG000|Overall Study|Adverse Event|6|||
49090851|NCT00423332|158167743|FG001|Overall Study|Adverse Event|2|||
49090852|NCT00423332|158167742|FG000|Overall Study|Withdrawal by Subject|1|||
49090853|NCT00423332|158167743|FG001|Overall Study|Withdrawal by Subject|0|||
49090854|NCT00423332|158167742|FG000|Overall Study|Condition under investigation worsened|1|||
49090855|NCT00423332|158167743|FG001|Overall Study|Condition under investigation worsened|1|||
49090856|NCT00423332|158167742|FG000|Overall Study|Progressive at Week 6|0|||
49090857|NCT00423332|158167743|FG001|Overall Study|Progressive at Week 6|1|||
49090858|NCT00423332|158167742|FG000|Overall Study|Unblinded before 12 weeks|1|||
49090859|NCT00423332|158167743|FG001|Overall Study|Unblinded before 12 weeks|3|||
49090860|NCT02155283|158167745|FG000|Overall Study|Lost to Follow-up|3|||
49090861|NCT02155283|158167745|FG000|Overall Study|Withdrawal by Subject|1|||
49090862|NCT02155283|158167745|FG000|Overall Study|Protocol Violation|3|||
49090863|NCT00488644|158167751|FG000|Overall Study|Not Eligible|1|||
49090864|NCT00488644|158167751|FG000|Overall Study|Not Evaluable|1|||
49090865|NCT00996125|158167752|FG000|Overall Study|Adverse Event|0|||
49090866|NCT00996125|158167753|FG001|Overall Study|Adverse Event|2|||
49090867|NCT00996125|158167752|FG000|Overall Study|Lost to Follow-up|1|||
49090868|NCT00996125|158167753|FG001|Overall Study|Lost to Follow-up|6|||
49090869|NCT00996125|158167752|FG000|Overall Study|Withdrawal by Subject|4|||
49090870|NCT00996125|158167753|FG001|Overall Study|Withdrawal by Subject|3|||
49090871|NCT01470248|158167758|FG000|Overall Study|Withdrawal by Subject|1|||
49090872|NCT01757184|158167759|FG000|Double-blind Period|Adverse Event|1|||
49090873|NCT01757184|158167760|FG001|Double-blind Period|Adverse Event|0|||
49090874|NCT01757184|158167761|FG002|Double-blind Period|Adverse Event|0|||
49090875|NCT01757184|158167762|FG003|Double-blind Period|Adverse Event|0|||
49090876|NCT01757184|158167759|FG000|Open-label Period|Lost to Follow-up|0|||
49090877|NCT01757184|158167760|FG001|Open-label Period|Lost to Follow-up|0|||
49090878|NCT01757184|158167761|FG002|Open-label Period|Lost to Follow-up|2|||
49090879|NCT01757184|158167762|FG003|Open-label Period|Lost to Follow-up|0|||
49090880|NCT01757184|158167759|FG000|Open-label Period|Withdrawal by Subject|0|||
49090881|NCT01757184|158167760|FG001|Open-label Period|Withdrawal by Subject|0|||
49090882|NCT01757184|158167761|FG002|Open-label Period|Withdrawal by Subject|1|||
49090883|NCT01757184|158167762|FG003|Open-label Period|Withdrawal by Subject|1|||
49090884|NCT01757184|158167759|FG000|Open-label Period|Discontinued by Sponsor|0|||
49090885|NCT01757184|158167760|FG001|Open-label Period|Discontinued by Sponsor|0|||
49090886|NCT01757184|158167761|FG002|Open-label Period|Discontinued by Sponsor|1|||
49090887|NCT01757184|158167762|FG003|Open-label Period|Discontinued by Sponsor|2|||
49090888|NCT02518048|158167763|FG000|Overall Study|Withdrawal by Subject|1|||
49090889|NCT00703157|158167765|FG000|Overall Study|Lost to Follow-up|0|||
49090890|NCT00703157|158167766|FG001|Overall Study|Lost to Follow-up|1|||
49090891|NCT00703157|158167765|FG000|Overall Study|source data permanently lost/ other|4|||
49090892|NCT00703157|158167766|FG001|Overall Study|source data permanently lost/ other|1|||
49090893|NCT00347009|158167767|FG000|Overall Study|Death|1|||
49090894|NCT00347009|158167767|FG000|Overall Study|Adverse Event|6|||
49090895|NCT00347009|158167767|FG000|Overall Study|Withdrawal by Subject|3|||
49090896|NCT00347009|158167767|FG000|Overall Study|Physician Decision|5|||
49090897|NCT00347009|158167767|FG000|Overall Study|Lost to Follow-up|4|||
49090898|NCT00347009|158167767|FG000|Overall Study|Protocol Violation|2|||
49090899|NCT00347009|158167767|FG000|Overall Study|Adverse Laboratory Experience|1|||
49090900|NCT00347009|158167767|FG000|Overall Study|Insufficient Viral Suppression|3|||
49090901|NCT00347009|158167767|FG000|Overall Study|Increased ALT/HBV DNA|1|||
49090902|NCT00347009|158167767|FG000|Overall Study|Serious Adverse Event|1|||
49090903|NCT00591565|158167769|FG000|Overall Study|lost follow up, withdrawn|5|||
49090904|NCT02134015|158167772|FG000|Overall Study|Protocol Violation|0|||
49090905|NCT02134015|158167773|FG001|Overall Study|Protocol Violation|1|||
49090906|NCT02134015|158167772|FG000|Overall Study|Death|2|||
49090907|NCT02134015|158167773|FG001|Overall Study|Death|1|||
49090908|NCT02134015|158167772|FG000|Overall Study|Reason not provided|1|||
49090909|NCT02134015|158167773|FG001|Overall Study|Reason not provided|2|||
49090910|NCT02134015|158167772|FG000|Overall Study|Clinical progression|14|||
49090911|NCT02134015|158167773|FG001|Overall Study|Clinical progression|7|||
49090912|NCT02134015|158167772|FG000|Overall Study|Progressive disease (per RECIST 1.1)|40|||
49090913|NCT02134015|158167773|FG001|Overall Study|Progressive disease (per RECIST 1.1)|43|||
49090914|NCT02134015|158167772|FG000|Overall Study|Study terminated by sponsor|2|||
49090915|NCT02134015|158167773|FG001|Overall Study|Study terminated by sponsor|3|||
49090916|NCT02134015|158167772|FG000|Overall Study|Adverse Event|9|||
49090917|NCT02134015|158167773|FG001|Overall Study|Adverse Event|10|||
49090918|NCT02134015|158167772|FG000|Overall Study|Withdrawal by Subject|3|||
49090919|NCT02134015|158167773|FG001|Overall Study|Withdrawal by Subject|7|||
49090920|NCT00955409|158170440|FG000|Overall Study|Lack of Efficacy|1|||
49090921|NCT00955409|158170441|FG001|Overall Study|Lack of Efficacy|0|||
49090922|NCT00955409|158170442|FG002|Overall Study|Lack of Efficacy|0|||
49090923|NCT00955409|158170443|FG003|Overall Study|Lack of Efficacy|0|||
49090924|NCT00955409|158170444|FG004|Overall Study|Lack of Efficacy|0|||
49090925|NCT00955409|158170445|FG005|Overall Study|Lack of Efficacy|0|||
49090926|NCT00955409|158170446|FG006|Overall Study|Lack of Efficacy|0|||
49090927|NCT00955409|158170447|FG007|Overall Study|Lack of Efficacy|0|||
49090928|NCT00955409|158170448|FG008|Overall Study|Lack of Efficacy|0|||
49090929|NCT00955409|158170449|FG009|Overall Study|Lack of Efficacy|0|||
49090930|NCT00955409|158170440|FG000|Overall Study|Withdrawal by Subject|1|||
49090931|NCT00955409|158170441|FG001|Overall Study|Withdrawal by Subject|0|||
49090932|NCT00955409|158170442|FG002|Overall Study|Withdrawal by Subject|5|||
49090933|NCT00955409|158170443|FG003|Overall Study|Withdrawal by Subject|2|||
49090934|NCT00955409|158170444|FG004|Overall Study|Withdrawal by Subject|0|||
49090935|NCT00955409|158170445|FG005|Overall Study|Withdrawal by Subject|0|||
49090936|NCT00955409|158170446|FG006|Overall Study|Withdrawal by Subject|2|||
49090937|NCT00955409|158170447|FG007|Overall Study|Withdrawal by Subject|0|||
49090938|NCT00955409|158170448|FG008|Overall Study|Withdrawal by Subject|1|||
49090939|NCT00955409|158170449|FG009|Overall Study|Withdrawal by Subject|0|||
49090940|NCT00955409|158170440|FG000|Overall Study|Caregiver Request|2|||
49090941|NCT00955409|158170441|FG001|Overall Study|Caregiver Request|0|||
49090942|NCT00955409|158170442|FG002|Overall Study|Caregiver Request|6|||
49090943|NCT00955409|158170443|FG003|Overall Study|Caregiver Request|5|||
49090944|NCT00955409|158170444|FG004|Overall Study|Caregiver Request|0|||
49090945|NCT00955409|158170445|FG005|Overall Study|Caregiver Request|2|||
49090946|NCT00955409|158170446|FG006|Overall Study|Caregiver Request|3|||
49090947|NCT00955409|158170447|FG007|Overall Study|Caregiver Request|1|||
49090948|NCT00955409|158170448|FG008|Overall Study|Caregiver Request|3|||
49090949|NCT00955409|158170449|FG009|Overall Study|Caregiver Request|0|||
49090950|NCT00955409|158170440|FG000|Overall Study|Investigator Request|0|||
49090951|NCT00955409|158170441|FG001|Overall Study|Investigator Request|0|||
49090952|NCT00955409|158170442|FG002|Overall Study|Investigator Request|1|||
49090953|NCT00955409|158170443|FG003|Overall Study|Investigator Request|0|||
49090954|NCT00955409|158170444|FG004|Overall Study|Investigator Request|0|||
49090955|NCT00955409|158170445|FG005|Overall Study|Investigator Request|0|||
49090956|NCT00955409|158170446|FG006|Overall Study|Investigator Request|0|||
49090957|NCT00955409|158170447|FG007|Overall Study|Investigator Request|0|||
49090958|NCT00955409|158170448|FG008|Overall Study|Investigator Request|0|||
49090959|NCT00955409|158170449|FG009|Overall Study|Investigator Request|0|||
49090960|NCT00955409|158170440|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
49090961|NCT00955409|158170441|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
49090962|NCT00955409|158170442|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
49090963|NCT00955409|158170443|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
49090964|NCT00955409|158170444|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
49090965|NCT00955409|158170445|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
49090966|NCT00955409|158170446|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
49090967|NCT00955409|158170447|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
49090968|NCT00955409|158170448|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
49090969|NCT00955409|158170449|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
49090970|NCT00955409|158170440|FG000|Overall Study|Lost to Follow-up|0|||
49090971|NCT00955409|158170441|FG001|Overall Study|Lost to Follow-up|0|||
49090972|NCT00955409|158170442|FG002|Overall Study|Lost to Follow-up|1|||
49090973|NCT00955409|158170443|FG003|Overall Study|Lost to Follow-up|0|||
49090974|NCT00955409|158170444|FG004|Overall Study|Lost to Follow-up|0|||
49090975|NCT00955409|158170445|FG005|Overall Study|Lost to Follow-up|0|||
49090976|NCT00955409|158170446|FG006|Overall Study|Lost to Follow-up|1|||
49090977|NCT00955409|158170447|FG007|Overall Study|Lost to Follow-up|0|||
49090978|NCT00955409|158170448|FG008|Overall Study|Lost to Follow-up|0|||
49090979|NCT00955409|158170449|FG009|Overall Study|Lost to Follow-up|0|||
49090980|NCT00955409|158170440|FG000|Overall Study|Failed to Return|2|||
49090981|NCT00955409|158170441|FG001|Overall Study|Failed to Return|0|||
49090982|NCT00955409|158170442|FG002|Overall Study|Failed to Return|0|||
49090983|NCT00955409|158170443|FG003|Overall Study|Failed to Return|0|||
49090984|NCT00955409|158170444|FG004|Overall Study|Failed to Return|0|||
49090985|NCT00955409|158170445|FG005|Overall Study|Failed to Return|0|||
49090986|NCT00955409|158170446|FG006|Overall Study|Failed to Return|0|||
49090987|NCT00955409|158170447|FG007|Overall Study|Failed to Return|2|||
49090988|NCT00955409|158170448|FG008|Overall Study|Failed to Return|0|||
49090989|NCT00955409|158170449|FG009|Overall Study|Failed to Return|0|||
49090990|NCT00955409|158170440|FG000|Overall Study|Adverse Event (AE)|2|||
49090991|NCT00955409|158170441|FG001|Overall Study|Adverse Event (AE)|0|||
49090992|NCT00955409|158170442|FG002|Overall Study|Adverse Event (AE)|0|||
49090993|NCT00955409|158170443|FG003|Overall Study|Adverse Event (AE)|0|||
49090994|NCT00955409|158170444|FG004|Overall Study|Adverse Event (AE)|0|||
49090995|NCT00955409|158170445|FG005|Overall Study|Adverse Event (AE)|1|||
49090996|NCT00955409|158170446|FG006|Overall Study|Adverse Event (AE)|2|||
49090997|NCT00955409|158170447|FG007|Overall Study|Adverse Event (AE)|0|||
49090998|NCT00955409|158170448|FG008|Overall Study|Adverse Event (AE)|2|||
49090999|NCT00955409|158170449|FG009|Overall Study|Adverse Event (AE)|0|||
49091000|NCT00955409|158170440|FG000|Overall Study|Reason not Specified|2|||
49091001|NCT00955409|158170441|FG001|Overall Study|Reason not Specified|1|||
49091002|NCT00955409|158170442|FG002|Overall Study|Reason not Specified|13|||
49091003|NCT00955409|158170443|FG003|Overall Study|Reason not Specified|1|||
49091004|NCT00955409|158170444|FG004|Overall Study|Reason not Specified|2|||
49091005|NCT00955409|158170445|FG005|Overall Study|Reason not Specified|0|||
49091006|NCT00955409|158170446|FG006|Overall Study|Reason not Specified|16|||
49091007|NCT00955409|158170447|FG007|Overall Study|Reason not Specified|0|||
49091008|NCT00955409|158170448|FG008|Overall Study|Reason not Specified|8|||
49091009|NCT00955409|158170449|FG009|Overall Study|Reason not Specified|1|||
49091010|NCT00333983|158170452|FG000|Overall Study|Lost to Follow-up|2|||
49091011|NCT00333983|158170453|FG001|Overall Study|Lost to Follow-up|1|||
49091012|NCT00333983|158170454|FG002|Overall Study|Lost to Follow-up|0|||
49091013|NCT00333983|158170452|FG000|Overall Study|Adverse Event|1|||
49091014|NCT00333983|158170453|FG001|Overall Study|Adverse Event|1|||
49091015|NCT00333983|158170454|FG002|Overall Study|Adverse Event|1|||
49091016|NCT00333983|158170452|FG000|Overall Study|Withdrawal by Subject|0|||
49091017|NCT00333983|158170453|FG001|Overall Study|Withdrawal by Subject|3|||
49091018|NCT00333983|158170454|FG002|Overall Study|Withdrawal by Subject|1|||
49091019|NCT02898597|158170455|FG000|Overall Study|Protocol Violation|4|||
49091020|NCT02898597|158170456|FG001|Overall Study|Protocol Violation|2|||
49091021|NCT02898597|158170455|FG000|Overall Study|Lost to Follow-up|0|||
49091022|NCT02898597|158170456|FG001|Overall Study|Lost to Follow-up|9|||
49091023|NCT02898597|158170455|FG000|Overall Study|Death|0|||
49091024|NCT02898597|158170456|FG001|Overall Study|Death|1|||
49091025|NCT05326529|158170459|FG000|Overall Study|Lack of Efficacy|0|||
49091026|NCT05326529|158170460|FG001|Overall Study|Lack of Efficacy|1|||
49091027|NCT05326529|158170461|FG002|Overall Study|Lack of Efficacy|0|||
49091028|NCT05326529|158170459|FG000|Overall Study|Physician Decision|0|||
49091029|NCT05326529|158170460|FG001|Overall Study|Physician Decision|0|||
49091030|NCT05326529|158170461|FG002|Overall Study|Physician Decision|2|||
49091031|NCT00468481|158170462|FG000|Overall Study|Adverse Event|13|||
49091032|NCT00468481|158170463|FG001|Overall Study|Adverse Event|3|||
49091033|NCT00468481|158170462|FG000|Overall Study|Lost to Follow-up|25|||
49091034|NCT00468481|158170463|FG001|Overall Study|Lost to Follow-up|8|||
49091035|NCT00468481|158170462|FG000|Overall Study|Pregnancy|2|||
49091036|NCT00468481|158170463|FG001|Overall Study|Pregnancy|0|||
49091037|NCT00468481|158170462|FG000|Overall Study|Protocol Violation|18|||
49091038|NCT00468481|158170463|FG001|Overall Study|Protocol Violation|8|||
49091039|NCT00468481|158170462|FG000|Overall Study|Withdrawal by Subject|12|||
49091040|NCT00468481|158170463|FG001|Overall Study|Withdrawal by Subject|3|||
49091041|NCT00468481|158170462|FG000|Overall Study|susp/diag malignant/premalignant disease|1|||
49091042|NCT00468481|158170463|FG001|Overall Study|susp/diag malignant/premalignant disease|0|||
49091043|NCT00468481|158170462|FG000|Overall Study|Prohibited Medication|1|||
49091044|NCT00468481|158170463|FG001|Overall Study|Prohibited Medication|1|||
49091045|NCT00468481|158170462|FG000|Overall Study|Egg Donor|1|||
49091046|NCT00468481|158170463|FG001|Overall Study|Egg Donor|0|||
49091047|NCT00468481|158170462|FG000|Overall Study|Moved out of area|4|||
49091048|NCT00468481|158170463|FG001|Overall Study|Moved out of area|1|||
49091049|NCT00468481|158170462|FG000|Overall Study|Non-Compliance|5|||
49091050|NCT00468481|158170463|FG001|Overall Study|Non-Compliance|0|||
49091051|NCT00468481|158170462|FG000|Overall Study|Other|6|||
49091052|NCT00468481|158170463|FG001|Overall Study|Other|0|||
49091053|NCT00154284|158170466|FG000|Overall Study|Adverse Event|6|||
49091054|NCT00154284|158170467|FG001|Overall Study|Adverse Event|9|||
49091055|NCT00154284|158170466|FG000|Overall Study|Abnormal laboratory value(s)|0|||
49091056|NCT00154284|158170467|FG001|Overall Study|Abnormal laboratory value(s)|1|||
49091057|NCT00154284|158170466|FG000|Overall Study|Lack of Efficacy|1|||
49091058|NCT00154284|158170467|FG001|Overall Study|Lack of Efficacy|2|||
49091059|NCT00154284|158170466|FG000|Overall Study|Protocol Violation|0|||
49091060|NCT00154284|158170467|FG001|Overall Study|Protocol Violation|1|||
49091061|NCT00593684|158170469|FG000|Overall Study|Death|2|||
49091062|NCT00593684|158170470|FG001|Overall Study|Death|1|||
49091063|NCT00326716|158170473|FG000|Pre-Natal Mothers|Discontinued ATV Before Delivery|1|||
49091064|NCT00326716|158170474|FG001|Pre-Natal Mothers|Discontinued ATV Before Delivery|2|||
49091065|NCT00326716|158170475|FG002|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
49091066|NCT00326716|158170476|FG003|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
49091067|NCT03806933|158170477|FG000|Main Period|Physician Decision|0|||
49091068|NCT03806933|158170478|FG001|Main Period|Physician Decision|0|||
49091069|NCT03806933|158170479|FG002|Main Period|Physician Decision|0|||
49091070|NCT03806933|158170480|FG003|Main Period|Physician Decision|1|||
49091071|NCT03806933|158170477|FG000|Main Period|Pregnancy|0|||
49091072|NCT03806933|158170478|FG001|Main Period|Pregnancy|0|||
49091073|NCT03806933|158170479|FG002|Main Period|Pregnancy|1|||
49091074|NCT03806933|158170480|FG003|Main Period|Pregnancy|0|||
49091075|NCT03806933|158170477|FG000|Main Period|Withdrawal by Subject|2|||
49091076|NCT03806933|158170478|FG001|Main Period|Withdrawal by Subject|1|||
49091077|NCT03806933|158170479|FG002|Main Period|Withdrawal by Subject|1|||
49091078|NCT03806933|158170480|FG003|Main Period|Withdrawal by Subject|2|||
49091079|NCT03806933|158170477|FG000|Main Period|Lost to Follow-up|2|||
49091080|NCT03806933|158170478|FG001|Main Period|Lost to Follow-up|2|||
49091081|NCT03806933|158170479|FG002|Main Period|Lost to Follow-up|0|||
49091082|NCT03806933|158170480|FG003|Main Period|Lost to Follow-up|0|||
49091083|NCT03806933|158170477|FG000|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
49091084|NCT03806933|158170478|FG001|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
49091085|NCT03806933|158170479|FG002|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
49091086|NCT03806933|158170480|FG003|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|1|||
49091087|NCT02549859|158170484|FG000|Long-term 60 Hz DBS|Study Closed|1|||
49091088|NCT00684411|158170485|FG000|Overall Study|New Primary Cancer|1|||
49091089|NCT00684411|158170485|FG000|Overall Study|Disease Progression|10|||
49091090|NCT00684411|158170485|FG000|Overall Study|Adverse Event|1|||
49091091|NCT00734162|158170486|FG000|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
49091092|NCT00734162|158170487|FG001|Randomized Phase (Through Week 72)|Investigator's Discretion|1|||
49091093|NCT00734162|158170488|FG002|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
49091094|NCT00734162|158170489|FG003|Randomized Phase (Through Week 72)|Investigator's Discretion|2|||
49091095|NCT00734162|158170486|FG000|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
49091096|NCT00734162|158170487|FG001|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
49091097|NCT00734162|158170488|FG002|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
49091098|NCT00734162|158170489|FG003|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2|||
49091099|NCT00734162|158170486|FG000|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1|||
49091100|NCT00734162|158170487|FG001|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
49091101|NCT00734162|158170488|FG002|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
49091102|NCT00734162|158170489|FG003|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
49091103|NCT00734162|158170486|FG000|Open-Label Phase|Withdrew Consent|1|||
49091104|NCT00734162|158170487|FG001|Open-Label Phase|Withdrew Consent|0|||
49091105|NCT00734162|158170488|FG002|Open-Label Phase|Withdrew Consent|1|||
49091106|NCT00734162|158170489|FG003|Open-Label Phase|Withdrew Consent|1|||
49091107|NCT00734162|158170486|FG000|Open-Label Phase|Lost to Follow-up|1|||
49091108|NCT00734162|158170487|FG001|Open-Label Phase|Lost to Follow-up|2|||
49091109|NCT00734162|158170488|FG002|Open-Label Phase|Lost to Follow-up|0|||
49091110|NCT00734162|158170489|FG003|Open-Label Phase|Lost to Follow-up|1|||
49091111|NCT00734162|158170486|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
49091112|NCT00734162|158170487|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
49091113|NCT00734162|158170488|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
49091114|NCT00734162|158170489|FG003|Open-Label Phase|Did Not Meet Entrance Criteria|1|||
49091115|NCT01568034|158170493|FG000|Overall Study|Withdrawal by Subject|1|||
49091116|NCT01568034|158170494|FG001|Overall Study|Withdrawal by Subject|0|||
49091117|NCT01568034|158170495|FG002|Overall Study|Withdrawal by Subject|0|||
49091118|NCT01568034|158170496|FG003|Overall Study|Withdrawal by Subject|0|||
49091119|NCT00728468|158170499|FG000|Overall Study|Enrolled but not treated|1|||
49091120|NCT00728468|158170499|FG000|Overall Study|Death|1|||
49091121|NCT00728468|158170499|FG000|Overall Study|Protocol Violation|4|||
49091122|NCT00728468|158170499|FG000|Overall Study|Objective progression or relapse|9|||
49091123|NCT00728468|158170499|FG000|Overall Study|Study terminated by sponsor|1|||
49091124|NCT03656692|158170500|FG000|Overall Study|Worsening of disease activity|2|||
49091125|NCT03656692|158170500|FG000|Overall Study|Physician Decision|1|||
49091126|NCT02498444|158170501|FG000|Overall Study|Withdrawal by Subject|3|||
49091127|NCT02498444|158170502|FG001|Overall Study|Withdrawal by Subject|0|||
49091128|NCT02498444|158170501|FG000|Overall Study|Physician Decision|1|||
49091129|NCT02498444|158170502|FG001|Overall Study|Physician Decision|0|||
49091130|NCT05486091|158170503|FG000|Overall Study|Withdrawal by Subject|1|||
49091131|NCT05486091|158170503|FG000|Overall Study|Lost to Follow-up|2|||
49091132|NCT02484456|158170504|FG000|Washout Period|Withdrawal by Subject|0|||
49091133|NCT02484456|158170505|FG001|Washout Period|Withdrawal by Subject|1|||
49091134|NCT02484456|158170504|FG000|Second Treatment Period: Week 1|Adverse Event|1|||
49091135|NCT02484456|158170505|FG001|Second Treatment Period: Week 1|Adverse Event|0|||
49091136|NCT02484456|158170504|FG000|Second Treatment Period: Week 1|Withdrawal by Subject|0|||
49091137|NCT02484456|158170505|FG001|Second Treatment Period: Week 1|Withdrawal by Subject|1|||
49091138|NCT02484456|158170504|FG000|Second Treatment Period: Week 2|Adverse Event|0|||
49091139|NCT02484456|158170505|FG001|Second Treatment Period: Week 2|Adverse Event|1|||
49091140|NCT01134107|158170507|FG000|Period 1-First Treatment Intervention|Adverse Event|1|||
49091141|NCT01134107|158170508|FG001|Period 1-First Treatment Intervention|Adverse Event|0|||
49091142|NCT01134107|158170507|FG000|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
49091143|NCT01134107|158170508|FG001|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
49091144|NCT01134107|158170507|FG000|Period 1-First Treatment Intervention|Withdrawal by Subject|3|||
49091145|NCT01134107|158170508|FG001|Period 1-First Treatment Intervention|Withdrawal by Subject|4|||
49091146|NCT01134107|158170507|FG000|Period 1-First Treatment Intervention|Physician Decision|1|||
49091147|NCT01134107|158170508|FG001|Period 1-First Treatment Intervention|Physician Decision|0|||
49091148|NCT01134107|158170507|FG000|Period 2-Second Treatment Intervention|Withdrawal by Subject|2|||
49091149|NCT01134107|158170508|FG001|Period 2-Second Treatment Intervention|Withdrawal by Subject|0|||
49091150|NCT01134107|158170507|FG000|Period 2-Second Treatment Intervention|Physician Decision|1|||
49091151|NCT01134107|158170508|FG001|Period 2-Second Treatment Intervention|Physician Decision|0|||
49091152|NCT01134107|158170507|FG000|Period 2-Second Treatment Intervention|Sponsor Decision|1|||
49091153|NCT01134107|158170508|FG001|Period 2-Second Treatment Intervention|Sponsor Decision|0|||
49091154|NCT00687271|158170509|FG000|Overall Study|Adverse Event|1|||
49091155|NCT00687271|158170510|FG001|Overall Study|Adverse Event|3|||
49091156|NCT00687271|158170511|FG002|Overall Study|Adverse Event|1|||
49091157|NCT00687271|158170512|FG003|Overall Study|Adverse Event|0|||
49091158|NCT00687271|158170509|FG000|Overall Study|Lost to Follow-up|0|||
49091159|NCT00687271|158170510|FG001|Overall Study|Lost to Follow-up|1|||
49091160|NCT00687271|158170511|FG002|Overall Study|Lost to Follow-up|0|||
49091161|NCT00687271|158170512|FG003|Overall Study|Lost to Follow-up|0|||
49091162|NCT00687271|158170509|FG000|Overall Study|Protocol Violation|2|||
49091163|NCT00687271|158170510|FG001|Overall Study|Protocol Violation|1|||
49091164|NCT00687271|158170511|FG002|Overall Study|Protocol Violation|1|||
49091165|NCT00687271|158170512|FG003|Overall Study|Protocol Violation|0|||
49091166|NCT00687271|158170509|FG000|Overall Study|Withdrawal by Subject|0|||
49091167|NCT00687271|158170510|FG001|Overall Study|Withdrawal by Subject|1|||
49091168|NCT00687271|158170511|FG002|Overall Study|Withdrawal by Subject|3|||
49091169|NCT00687271|158170512|FG003|Overall Study|Withdrawal by Subject|0|||
49091170|NCT00561392|158170521|FG000|Overall Study|Adverse Event|38|||
49091171|NCT00561392|158170521|FG000|Overall Study|Lack of Efficacy|2|||
49091172|NCT00561392|158170521|FG000|Overall Study|Protocol Violation|1|||
49091173|NCT00561392|158170521|FG000|Overall Study|Withdrawal by Subject|8|||
49091174|NCT00561392|158170521|FG000|Overall Study|Administrative problems|4|||
49091175|NCT02028767|158170522|FG000|Treatment Period 2|Non compliant with protocol|1|||
49091176|NCT02028767|158170523|FG001|Treatment Period 2|Non compliant with protocol|0|||
49091177|NCT02028767|158170522|FG000|Treatment Period 2|Reason other than those specified above|1|||
49091178|NCT02028767|158170523|FG001|Treatment Period 2|Reason other than those specified above|0|||
49091179|NCT01532518|158170524|FG000|Overall Study|Withdrawal by Subject|0|||
49091180|NCT01532518|158170525|FG001|Overall Study|Withdrawal by Subject|0|||
49091181|NCT01532518|158170526|FG002|Overall Study|Withdrawal by Subject|1|||
49091182|NCT00356148|158170538|FG000|Overall Study|Reoperation within 30 days|2|||
49091183|NCT00356148|158170539|FG001|Overall Study|Reoperation within 30 days|1|||
49091184|NCT00179660|158170558|FG000|Overall Study|Adverse Event|7|||
49091185|NCT00179660|158170558|FG000|Overall Study|Lack of therapeutic effect|28|||
49091186|NCT00179660|158170558|FG000|Overall Study|Withdrawal by Subject|2|||
49091187|NCT00179660|158170558|FG000|Overall Study|Lost to Follow-up|1|||
49091188|NCT00179660|158170558|FG000|Overall Study|Death|3|||
49091189|NCT00179660|158170558|FG000|Overall Study|Other - Unspecified|9|||
49091190|NCT02282813|158170565|FG000|Overall Study|Withdrawal by Subject|4|||
49091191|NCT02282813|158170566|FG001|Overall Study|Withdrawal by Subject|5|||
49091192|NCT02282813|158170567|FG002|Overall Study|Withdrawal by Subject|0|||
49091193|NCT02282813|158170565|FG000|Overall Study|Adverse Event|3|||
49091194|NCT02282813|158170566|FG001|Overall Study|Adverse Event|10|||
49091195|NCT02282813|158170567|FG002|Overall Study|Adverse Event|1|||
49091196|NCT02282813|158170565|FG000|Overall Study|Subject non-compliance|1|||
49091197|NCT02282813|158170566|FG001|Overall Study|Subject non-compliance|4|||
49091198|NCT02282813|158170567|FG002|Overall Study|Subject non-compliance|0|||
49091199|NCT02282813|158170565|FG000|Overall Study|Physician Decision|0|||
49091200|NCT02282813|158170566|FG001|Overall Study|Physician Decision|3|||
49091201|NCT02282813|158170567|FG002|Overall Study|Physician Decision|1|||
49091202|NCT02282813|158170565|FG000|Overall Study|Lost to Follow-up|2|||
49091203|NCT02282813|158170566|FG001|Overall Study|Lost to Follow-up|0|||
49091204|NCT02282813|158170567|FG002|Overall Study|Lost to Follow-up|1|||
49091205|NCT02282813|158170565|FG000|Overall Study|Serum Ca >/=11.0mg/dL|1|||
49091206|NCT02282813|158170566|FG001|Overall Study|Serum Ca >/=11.0mg/dL|0|||
49091207|NCT02282813|158170567|FG002|Overall Study|Serum Ca >/=11.0mg/dL|0|||
49091208|NCT02282813|158170565|FG000|Overall Study|Lack of Efficacy|1|||
49091209|NCT02282813|158170566|FG001|Overall Study|Lack of Efficacy|0|||
49091210|NCT02282813|158170567|FG002|Overall Study|Lack of Efficacy|0|||
49091211|NCT02282813|158170565|FG000|Overall Study|Administrative reasons|0|||
49091212|NCT02282813|158170566|FG001|Overall Study|Administrative reasons|1|||
49091213|NCT02282813|158170567|FG002|Overall Study|Administrative reasons|0|||
49091214|NCT00402688|158170570|FG000|Overall Study|Adverse Event|12|||
49091215|NCT00402688|158170571|FG001|Overall Study|Adverse Event|9|||
49091216|NCT00402688|158170572|FG002|Overall Study|Adverse Event|3|||
49091217|NCT00402688|158170570|FG000|Overall Study|Withdrawal by Subject|3|||
49091218|NCT00402688|158170571|FG001|Overall Study|Withdrawal by Subject|1|||
49091219|NCT00402688|158170572|FG002|Overall Study|Withdrawal by Subject|1|||
49091220|NCT00402688|158170570|FG000|Overall Study|Physician Decision|0|||
49091221|NCT00402688|158170571|FG001|Overall Study|Physician Decision|0|||
49091222|NCT00402688|158170572|FG002|Overall Study|Physician Decision|1|||
49091223|NCT00402688|158170570|FG000|Overall Study|Lack of Efficacy|4|||
49091224|NCT00402688|158170571|FG001|Overall Study|Lack of Efficacy|4|||
49091225|NCT00402688|158170572|FG002|Overall Study|Lack of Efficacy|5|||
49091226|NCT00402688|158170570|FG000|Overall Study|Protocol Violation|1|||
49091227|NCT00402688|158170571|FG001|Overall Study|Protocol Violation|1|||
49091228|NCT00402688|158170572|FG002|Overall Study|Protocol Violation|1|||
49091229|NCT00402688|158170570|FG000|Overall Study|Lost to Follow-up|1|||
49091230|NCT00402688|158170571|FG001|Overall Study|Lost to Follow-up|0|||
49091231|NCT00402688|158170572|FG002|Overall Study|Lost to Follow-up|2|||
49091232|NCT00402688|158170570|FG000|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
49091233|NCT00402688|158170571|FG001|Overall Study|Culture Show Fluoroquinolone Resistance|1|||
49091234|NCT00402688|158170572|FG002|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
49091235|NCT00402688|158170570|FG000|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
49091236|NCT00402688|158170571|FG001|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
49091237|NCT00402688|158170572|FG002|Overall Study|Urine Cult. Yield Resistant to Levaquin|1|||
49091238|NCT00402688|158170570|FG000|Overall Study|Patient Left Town and Forgot Medication|0|||
49091239|NCT00402688|158170571|FG001|Overall Study|Patient Left Town and Forgot Medication|0|||
49091240|NCT00402688|158170572|FG002|Overall Study|Patient Left Town and Forgot Medication|1|||
49091241|NCT00492648|158170576|FG000|Month 30 (109671 Study)|Protocol Violation|0|||
49091242|NCT00492648|158170577|FG001|Month 30 (109671 Study)|Protocol Violation|1|||
49091243|NCT03668119|158170578|FG000|Pre-treatment|Disease Progression|1|||
49091244|NCT03668119|158170579|FG001|Pre-treatment|Disease Progression|0|||
49091245|NCT03668119|158170578|FG000|Treatment|Disease Progression|76|||
49091246|NCT03668119|158170579|FG001|Treatment|Disease Progression|57|||
49091247|NCT03668119|158170578|FG000|Treatment|Study drug toxicity|19|||
49091248|NCT03668119|158170579|FG001|Treatment|Study drug toxicity|1|||
49091249|NCT03668119|158170578|FG000|Treatment|Death|3|||
49091250|NCT03668119|158170579|FG001|Treatment|Death|0|||
49091251|NCT03668119|158170578|FG000|Treatment|Adverse Event unrelated to Study drug|4|||
49091252|NCT03668119|158170579|FG001|Treatment|Adverse Event unrelated to Study drug|3|||
49091253|NCT03668119|158170578|FG000|Treatment|Withdrawal by Subject|1|||
49091254|NCT03668119|158170579|FG001|Treatment|Withdrawal by Subject|1|||
49091255|NCT03668119|158170578|FG000|Treatment|Participant request to discontinue study treatment|3|||
49091256|NCT03668119|158170579|FG001|Treatment|Participant request to discontinue study treatment|1|||
49091257|NCT03668119|158170578|FG000|Treatment|Maximum Clinical Benefit|0|||
49091258|NCT03668119|158170579|FG001|Treatment|Maximum Clinical Benefit|1|||
49091259|NCT03668119|158170578|FG000|Treatment|Participants completed treatment|27|||
49091260|NCT03668119|158170579|FG001|Treatment|Participants completed treatment|11|||
49091261|NCT03668119|158170578|FG000|Treatment|Other reasons|2|||
49091262|NCT03668119|158170579|FG001|Treatment|Other reasons|1|||
49091263|NCT04468347|158170582|FG000|Overall Study|Withdrawal by Subject|0|||
49091264|NCT04468347|158170583|FG001|Overall Study|Withdrawal by Subject|1|||
49091265|NCT04468347|158170584|FG002|Overall Study|Withdrawal by Subject|3|||
49091266|NCT04468347|158170585|FG003|Overall Study|Withdrawal by Subject|3|||
49091267|NCT04468347|158170582|FG000|Overall Study|Lost to Follow-up|0|||
49091268|NCT04468347|158170583|FG001|Overall Study|Lost to Follow-up|0|||
49091269|NCT04468347|158170584|FG002|Overall Study|Lost to Follow-up|1|||
49091270|NCT04468347|158170585|FG003|Overall Study|Lost to Follow-up|1|||
49091271|NCT04468347|158170582|FG000|Overall Study|Physician Decision|1|||
49091272|NCT04468347|158170583|FG001|Overall Study|Physician Decision|0|||
49091273|NCT04468347|158170584|FG002|Overall Study|Physician Decision|2|||
49091274|NCT04468347|158170585|FG003|Overall Study|Physician Decision|0|||
49091275|NCT04468347|158170582|FG000|Overall Study|Protocol Violation|1|||
49091276|NCT04468347|158170583|FG001|Overall Study|Protocol Violation|0|||
49091277|NCT04468347|158170584|FG002|Overall Study|Protocol Violation|0|||
49091278|NCT04468347|158170585|FG003|Overall Study|Protocol Violation|0|||
49091279|NCT01732458|158170586|FG000|Overall Study|Lost to Follow-up|0|||
49091280|NCT01732458|158170587|FG001|Overall Study|Lost to Follow-up|2|||
49091281|NCT01732458|158170588|FG002|Overall Study|Lost to Follow-up|0|||
49091282|NCT01732458|158170589|FG003|Overall Study|Lost to Follow-up|0|||
49091283|NCT01732458|158170586|FG000|Overall Study|Non-Compliance With Study Drug|0|||
49091284|NCT01732458|158170587|FG001|Overall Study|Non-Compliance With Study Drug|0|||
49091285|NCT01732458|158170588|FG002|Overall Study|Non-Compliance With Study Drug|1|||
49091286|NCT01732458|158170589|FG003|Overall Study|Non-Compliance With Study Drug|0|||
49091287|NCT01732458|158170586|FG000|Overall Study|Physician Decision|1|||
49091288|NCT01732458|158170587|FG001|Overall Study|Physician Decision|2|||
49091289|NCT01732458|158170588|FG002|Overall Study|Physician Decision|2|||
49091290|NCT01732458|158170589|FG003|Overall Study|Physician Decision|0|||
49091291|NCT01732458|158170586|FG000|Overall Study|Protocol Violation|2|||
49091292|NCT01732458|158170587|FG001|Overall Study|Protocol Violation|0|||
49091293|NCT01732458|158170588|FG002|Overall Study|Protocol Violation|0|||
49091294|NCT01732458|158170589|FG003|Overall Study|Protocol Violation|2|||
49091295|NCT01732458|158170586|FG000|Overall Study|Screen Failure|0|||
49091296|NCT01732458|158170587|FG001|Overall Study|Screen Failure|1|||
49091297|NCT01732458|158170588|FG002|Overall Study|Screen Failure|0|||
49091298|NCT01732458|158170589|FG003|Overall Study|Screen Failure|0|||
49091299|NCT00813150|158170596|FG000|Treatment Period|Adverse Event|16|||
49091300|NCT00813150|158170597|FG001|Treatment Period|Adverse Event|15|||
49091301|NCT00813150|158170596|FG000|Treatment Period|Death|2|||
49091302|NCT00813150|158170597|FG001|Treatment Period|Death|0|||
49091303|NCT00813150|158170596|FG000|Treatment Period|Progressive disease|1|||
49091304|NCT00813150|158170597|FG001|Treatment Period|Progressive disease|0|||
49091305|NCT00813150|158170596|FG000|Treatment Period|Complete response|0|||
49091306|NCT00813150|158170597|FG001|Treatment Period|Complete response|1|||
49091307|NCT00813150|158170596|FG000|Treatment Period|Stable disease|1|||
49091308|NCT00813150|158170597|FG001|Treatment Period|Stable disease|2|||
49091309|NCT00813150|158170596|FG000|Treatment Period|Protocol Violation|3|||
49091310|NCT00813150|158170597|FG001|Treatment Period|Protocol Violation|4|||
49091311|NCT00813150|158170596|FG000|Treatment Period|Withdrawal by Subject|5|||
49091312|NCT00813150|158170597|FG001|Treatment Period|Withdrawal by Subject|3|||
49091313|NCT00813150|158170596|FG000|Treatment Period|Non compliance|0|||
49091314|NCT00813150|158170597|FG001|Treatment Period|Non compliance|1|||
49091315|NCT00813150|158170596|FG000|Treatment Period|Reason not specified|3|||
49091316|NCT00813150|158170597|FG001|Treatment Period|Reason not specified|4|||
49091317|NCT00813150|158170596|FG000|Treatment Period|Data not available|1|||
49091318|NCT00813150|158170597|FG001|Treatment Period|Data not available|2|||
49091319|NCT00813150|158170596|FG000|Long Term Follow-up|Death|0|||
49091320|NCT00813150|158170597|FG001|Long Term Follow-up|Death|4|||
49091321|NCT00813150|158170596|FG000|Long Term Follow-up|Other|0|||
49091322|NCT00813150|158170597|FG001|Long Term Follow-up|Other|3|||
49091323|NCT00813150|158170596|FG000|Long Term Follow-up|Lost to Follow-up|2|||
49091324|NCT00813150|158170597|FG001|Long Term Follow-up|Lost to Follow-up|0|||
49091325|NCT00813150|158170596|FG000|Long Term Follow-up|Progression/Relapse|22|||
49091326|NCT00813150|158170597|FG001|Long Term Follow-up|Progression/Relapse|24|||
49091327|NCT00554515|158170598|FG000|Overall Study|Withdrawal by Subject|3|||
49091328|NCT00554515|158170598|FG000|Overall Study|Disease progression|52|||
49091329|NCT00554515|158170598|FG000|Overall Study|Physician Decision|18|||
49091330|NCT00554515|158170598|FG000|Overall Study|Withdrawal by Subject|11|||
49091331|NCT00554515|158170598|FG000|Overall Study|Adverse Event|9|||
49091332|NCT00554515|158170598|FG000|Overall Study|Death|2|||
49091333|NCT00554515|158170598|FG000|Overall Study|Achieved Stable Disease|7|||
49091334|NCT00554515|158170598|FG000|Overall Study|Other|1|||
49091335|NCT00554515|158170598|FG000|Overall Study|Misc|15|||
49091336|NCT00994461|158170599|FG000|Overall Study|Adverse Event|2|||
49091337|NCT00994461|158170600|FG001|Overall Study|Adverse Event|1|||
49091338|NCT00994461|158170601|FG002|Overall Study|Adverse Event|0|||
49091339|NCT00952068|158170605|FG000|Overall Study|Adverse Event|3|||
49091340|NCT00952068|158170605|FG000|Overall Study|Withdrawal by Subject|4|||
49091341|NCT00766636|158170606|FG000|Overall Study|Withdrawal by Subject|1|||
49091342|NCT00766636|158170607|FG001|Overall Study|Withdrawal by Subject|1|||
49091343|NCT00766636|158170606|FG000|Overall Study|Incomplete Treatment|0|||
49091344|NCT00766636|158170607|FG001|Overall Study|Incomplete Treatment|1|||
49091345|NCT00766636|158170606|FG000|Overall Study|Adverse Event|1|||
49091346|NCT00766636|158170607|FG001|Overall Study|Adverse Event|0|||
49091347|NCT00766636|158170606|FG000|Overall Study|Disease Progression|1|||
49091348|NCT00766636|158170607|FG001|Overall Study|Disease Progression|0|||
49091349|NCT03515811|158170614|FG000|Overall Study|Lost to Follow-up|2|||
49091350|NCT03515811|158170615|FG001|Overall Study|Lost to Follow-up|1|||
49091351|NCT03515811|158170614|FG000|Overall Study|Protocol Violation|1|||
49091352|NCT03515811|158170615|FG001|Overall Study|Protocol Violation|1|||
49091353|NCT03515811|158170614|FG000|Overall Study|Death|1|||
49091354|NCT03515811|158170615|FG001|Overall Study|Death|1|||
49091355|NCT03515811|158170614|FG000|Overall Study|Withdrawal by Subject|0|||
49091356|NCT03515811|158170615|FG001|Overall Study|Withdrawal by Subject|2|||
49091357|NCT03515811|158170614|FG000|Overall Study|Technical Problems|1|||
49091358|NCT03515811|158170615|FG001|Overall Study|Technical Problems|0|||
49091359|NCT03515811|158170614|FG000|Overall Study|Subject Unable to Return for Follow-Up|0|||
49091360|NCT03515811|158170615|FG001|Overall Study|Subject Unable to Return for Follow-Up|2|||
49091361|NCT03515811|158170614|FG000|Overall Study|COVID-19|0|||
49091362|NCT03515811|158170615|FG001|Overall Study|COVID-19|1|||
49091363|NCT01706939|158170616|FG000|Pre Randomization|Screen Failure|1|||
49091364|NCT01706939|158170617|FG001|Pre Randomization|Screen Failure|0|||
49091365|NCT01706939|158170618|FG002|Pre Randomization|Screen Failure|0|||
49091366|NCT01706939|158170616|FG000|Pre Randomization|Ineligible for Randomization|1|||
49091367|NCT01706939|158170617|FG001|Pre Randomization|Ineligible for Randomization|0|||
49091368|NCT01706939|158170618|FG002|Pre Randomization|Ineligible for Randomization|0|||
49091369|NCT01706939|158170616|FG000|Pre Randomization|Withdrawal by Subject|1|||
49091370|NCT01706939|158170617|FG001|Pre Randomization|Withdrawal by Subject|0|||
49091371|NCT01706939|158170618|FG002|Pre Randomization|Withdrawal by Subject|0|||
49091372|NCT01706939|158170616|FG000|Randomization|Insufficient QoL survey compliance|0|||
49091373|NCT01706939|158170617|FG001|Randomization|Insufficient QoL survey compliance|1|||
49091374|NCT01706939|158170618|FG002|Randomization|Insufficient QoL survey compliance|1|||
49091375|NCT01706939|158170616|FG000|Randomization|Progression of disease|0|||
49091376|NCT01706939|158170617|FG001|Randomization|Progression of disease|2|||
49091377|NCT01706939|158170618|FG002|Randomization|Progression of disease|1|||
49091378|NCT02858583|158170619|FG000|Overall Study|Declined consent|1|||
49091379|NCT02858583|158170620|FG001|Overall Study|Declined consent|1|||
49091380|NCT03759587|158170621|FG000|Overall Study|Adverse Event|5|||
49091381|NCT03759587|158170621|FG000|Overall Study|Progressive Disease|10|||
49091382|NCT03759587|158170621|FG000|Overall Study|Site Terminated by Sponsor|3|||
49091383|NCT03759587|158170621|FG000|Overall Study|Withdrawal by Subject|1|||
49091384|NCT01870973|158170624|FG000|Overall Study|Lost to Follow-up|10|||
49091385|NCT01870973|158170625|FG001|Overall Study|Lost to Follow-up|3|||
49091386|NCT01295827|158170626|FG000|Overall Study|Adverse Event|1|||
49091387|NCT01295827|158170627|FG001|Overall Study|Adverse Event|2|||
49091388|NCT01295827|158170628|FG002|Overall Study|Adverse Event|2|||
49091389|NCT01295827|158170629|FG003|Overall Study|Adverse Event|1|||
49091390|NCT01295827|158170630|FG004|Overall Study|Adverse Event|1|||
49091391|NCT01295827|158170631|FG005|Overall Study|Adverse Event|4|||
49091392|NCT01295827|158170632|FG006|Overall Study|Adverse Event|15|||
49091393|NCT01295827|158170633|FG007|Overall Study|Adverse Event|49|||
49091394|NCT01295827|158170634|FG008|Overall Study|Adverse Event|22|||
49091395|NCT01295827|158170635|FG009|Overall Study|Adverse Event|7|||
49091396|NCT01295827|158170636|FG010|Overall Study|Adverse Event|50|||
49091397|NCT01295827|158170637|FG011|Overall Study|Adverse Event|21|||
49091398|NCT01295827|158170638|FG012|Overall Study|Adverse Event|0|||
49091399|NCT01295827|158170639|FG013|Overall Study|Adverse Event|0|||
49091400|NCT01295827|158170640|FG014|Overall Study|Adverse Event|0|||
49091401|NCT01295827|158170626|FG000|Overall Study|Lost to Follow-up|0|||
49091402|NCT01295827|158170627|FG001|Overall Study|Lost to Follow-up|0|||
49091403|NCT01295827|158170628|FG002|Overall Study|Lost to Follow-up|3|||
49091404|NCT01295827|158170629|FG003|Overall Study|Lost to Follow-up|0|||
49091405|NCT01295827|158170630|FG004|Overall Study|Lost to Follow-up|1|||
49091406|NCT01295827|158170631|FG005|Overall Study|Lost to Follow-up|0|||
49091407|NCT01295827|158170632|FG006|Overall Study|Lost to Follow-up|4|||
49091408|NCT01295827|158170633|FG007|Overall Study|Lost to Follow-up|8|||
49091409|NCT01295827|158170634|FG008|Overall Study|Lost to Follow-up|7|||
49091410|NCT01295827|158170635|FG009|Overall Study|Lost to Follow-up|4|||
49091411|NCT01295827|158170636|FG010|Overall Study|Lost to Follow-up|7|||
49091412|NCT01295827|158170637|FG011|Overall Study|Lost to Follow-up|3|||
49091413|NCT01295827|158170638|FG012|Overall Study|Lost to Follow-up|0|||
49091414|NCT01295827|158170639|FG013|Overall Study|Lost to Follow-up|0|||
49091415|NCT01295827|158170640|FG014|Overall Study|Lost to Follow-up|0|||
49091416|NCT01295827|158170626|FG000|Overall Study|Not Reported|0|||
49091417|NCT01295827|158170627|FG001|Overall Study|Not Reported|0|||
49091418|NCT01295827|158170628|FG002|Overall Study|Not Reported|0|||
49091419|NCT01295827|158170629|FG003|Overall Study|Not Reported|1|||
49091420|NCT01295827|158170630|FG004|Overall Study|Not Reported|0|||
49091421|NCT01295827|158170631|FG005|Overall Study|Not Reported|0|||
49091422|NCT01295827|158170632|FG006|Overall Study|Not Reported|24|||
49091423|NCT01295827|158170633|FG007|Overall Study|Not Reported|58|||
49091424|NCT01295827|158170634|FG008|Overall Study|Not Reported|41|||
49091425|NCT01295827|158170635|FG009|Overall Study|Not Reported|2|||
49091426|NCT01295827|158170636|FG010|Overall Study|Not Reported|23|||
49091427|NCT01295827|158170637|FG011|Overall Study|Not Reported|13|||
49091428|NCT01295827|158170638|FG012|Overall Study|Not Reported|0|||
49091429|NCT01295827|158170639|FG013|Overall Study|Not Reported|0|||
49091430|NCT01295827|158170640|FG014|Overall Study|Not Reported|0|||
49091431|NCT01295827|158170626|FG000|Overall Study|Progressive Disease|2|||
49091432|NCT01295827|158170627|FG001|Overall Study|Progressive Disease|1|||
49091433|NCT01295827|158170628|FG002|Overall Study|Progressive Disease|5|||
49091434|NCT01295827|158170629|FG003|Overall Study|Progressive Disease|2|||
49091435|NCT01295827|158170630|FG004|Overall Study|Progressive Disease|0|||
49091436|NCT01295827|158170631|FG005|Overall Study|Progressive Disease|1|||
49091437|NCT01295827|158170632|FG006|Overall Study|Progressive Disease|87|||
49091438|NCT01295827|158170633|FG007|Overall Study|Progressive Disease|144|||
49091439|NCT01295827|158170634|FG008|Overall Study|Progressive Disease|85|||
49091440|NCT01295827|158170635|FG009|Overall Study|Progressive Disease|40|||
49091441|NCT01295827|158170636|FG010|Overall Study|Progressive Disease|175|||
49091442|NCT01295827|158170637|FG011|Overall Study|Progressive Disease|136|||
49091443|NCT01295827|158170638|FG012|Overall Study|Progressive Disease|0|||
49091444|NCT01295827|158170639|FG013|Overall Study|Progressive Disease|0|||
49091445|NCT01295827|158170640|FG014|Overall Study|Progressive Disease|0|||
49091446|NCT01295827|158170626|FG000|Overall Study|Screen Failure|0|||
49091447|NCT01295827|158170627|FG001|Overall Study|Screen Failure|0|||
49091448|NCT01295827|158170628|FG002|Overall Study|Screen Failure|0|||
49091449|NCT01295827|158170629|FG003|Overall Study|Screen Failure|0|||
49091450|NCT01295827|158170630|FG004|Overall Study|Screen Failure|0|||
49091451|NCT01295827|158170631|FG005|Overall Study|Screen Failure|0|||
49091452|NCT01295827|158170632|FG006|Overall Study|Screen Failure|2|||
49091453|NCT01295827|158170633|FG007|Overall Study|Screen Failure|2|||
49091454|NCT01295827|158170634|FG008|Overall Study|Screen Failure|2|||
49091455|NCT01295827|158170635|FG009|Overall Study|Screen Failure|0|||
49091456|NCT01295827|158170636|FG010|Overall Study|Screen Failure|1|||
49091457|NCT01295827|158170637|FG011|Overall Study|Screen Failure|0|||
49091458|NCT01295827|158170638|FG012|Overall Study|Screen Failure|0|||
49091459|NCT01295827|158170639|FG013|Overall Study|Screen Failure|0|||
49091460|NCT01295827|158170640|FG014|Overall Study|Screen Failure|0|||
49091461|NCT01295827|158170626|FG000|Overall Study|Withdrawal by Subject|1|||
49091462|NCT01295827|158170627|FG001|Overall Study|Withdrawal by Subject|0|||
49091463|NCT01295827|158170628|FG002|Overall Study|Withdrawal by Subject|2|||
49091464|NCT01295827|158170629|FG003|Overall Study|Withdrawal by Subject|0|||
49091465|NCT01295827|158170630|FG004|Overall Study|Withdrawal by Subject|0|||
49091466|NCT01295827|158170631|FG005|Overall Study|Withdrawal by Subject|1|||
49091467|NCT01295827|158170632|FG006|Overall Study|Withdrawal by Subject|13|||
49091468|NCT01295827|158170633|FG007|Overall Study|Withdrawal by Subject|35|||
49091469|NCT01295827|158170634|FG008|Overall Study|Withdrawal by Subject|11|||
49091470|NCT01295827|158170635|FG009|Overall Study|Withdrawal by Subject|2|||
49091471|NCT01295827|158170636|FG010|Overall Study|Withdrawal by Subject|18|||
49091472|NCT01295827|158170637|FG011|Overall Study|Withdrawal by Subject|13|||
49091473|NCT01295827|158170638|FG012|Overall Study|Withdrawal by Subject|0|||
49091474|NCT01295827|158170639|FG013|Overall Study|Withdrawal by Subject|0|||
49091475|NCT01295827|158170640|FG014|Overall Study|Withdrawal by Subject|0|||
49091476|NCT01295827|158170626|FG000|Overall Study|Other|0|||
49091477|NCT01295827|158170627|FG001|Overall Study|Other|0|||
49091478|NCT01295827|158170628|FG002|Overall Study|Other|0|||
49091479|NCT01295827|158170629|FG003|Overall Study|Other|0|||
49091480|NCT01295827|158170630|FG004|Overall Study|Other|0|||
49091481|NCT01295827|158170631|FG005|Overall Study|Other|0|||
49091482|NCT01295827|158170632|FG006|Overall Study|Other|1|||
49091483|NCT01295827|158170633|FG007|Overall Study|Other|1|||
49091484|NCT01295827|158170634|FG008|Overall Study|Other|1|||
49091485|NCT01295827|158170635|FG009|Overall Study|Other|0|||
49091486|NCT01295827|158170636|FG010|Overall Study|Other|2|||
49091487|NCT01295827|158170637|FG011|Overall Study|Other|0|||
49091488|NCT01295827|158170638|FG012|Overall Study|Other|0|||
49091489|NCT01295827|158170639|FG013|Overall Study|Other|0|||
49091490|NCT01295827|158170640|FG014|Overall Study|Other|0|||
49091491|NCT01668173|158170641|FG000|Overall Study|Adverse Event|3|||
49091492|NCT01668173|158170641|FG000|Overall Study|Trial suspension|4|||
49091493|NCT00665431|158170642|FG000|Overall Study|Adverse Event|16|||
49091494|NCT00665431|158170643|FG001|Overall Study|Adverse Event|22|||
49091495|NCT00665431|158170644|FG002|Overall Study|Adverse Event|6|||
49091496|NCT00665431|158170642|FG000|Overall Study|Withdrawal by Subject|17|||
49091497|NCT00665431|158170643|FG001|Overall Study|Withdrawal by Subject|25|||
49091498|NCT00665431|158170644|FG002|Overall Study|Withdrawal by Subject|15|||
49091499|NCT00665431|158170642|FG000|Overall Study|Lost to Follow-up|3|||
49091500|NCT00665431|158170643|FG001|Overall Study|Lost to Follow-up|3|||
49091501|NCT00665431|158170644|FG002|Overall Study|Lost to Follow-up|1|||
49091502|NCT00665431|158170642|FG000|Overall Study|Other|4|||
49091503|NCT00665431|158170643|FG001|Overall Study|Other|7|||
49091504|NCT00665431|158170644|FG002|Overall Study|Other|2|||
49091505|NCT01483027|158170645|FG000|Overall Study|Administrative Reasons|2|||
49091506|NCT01483027|158170646|FG001|Overall Study|Administrative Reasons|1|||
49091507|NCT01483027|158170645|FG000|Overall Study|Withdrawal by Subject|21|||
49091508|NCT01483027|158170646|FG001|Overall Study|Withdrawal by Subject|32|||
49091509|NCT01483027|158170645|FG000|Overall Study|Discontinuation by Investigator or Sponsor for any reason|22|||
49091510|NCT01483027|158170646|FG001|Overall Study|Discontinuation by Investigator or Sponsor for any reason|24|||
49091511|NCT01483027|158170645|FG000|Overall Study|Lost to Follow-up|1|||
49091512|NCT01483027|158170646|FG001|Overall Study|Lost to Follow-up|1|||
49091513|NCT01483027|158170645|FG000|Overall Study|Adverse Event|0|||
49091514|NCT01483027|158170646|FG001|Overall Study|Adverse Event|1|||
49091515|NCT01483027|158170645|FG000|Overall Study|Withdrawal by Subject|0|||
49091516|NCT01483027|158170646|FG001|Overall Study|Withdrawal by Subject|1|||
49091517|NCT04463251|158170650|FG000|Overall Study|Death|1|||
49091518|NCT04463251|158170651|FG001|Overall Study|Death|0|||
49091519|NCT04463251|158170652|FG002|Overall Study|Death|1|||
49091520|NCT04463251|158170650|FG000|Overall Study|Adverse Event|0|||
49091521|NCT04463251|158170651|FG001|Overall Study|Adverse Event|1|||
49091522|NCT04463251|158170652|FG002|Overall Study|Adverse Event|0|||
49091523|NCT04463251|158170650|FG000|Overall Study|Lost to Follow-up|0|||
49091524|NCT04463251|158170651|FG001|Overall Study|Lost to Follow-up|1|||
49091525|NCT04463251|158170652|FG002|Overall Study|Lost to Follow-up|0|||
49091526|NCT04463251|158170650|FG000|Overall Study|Withdrawal by Subject|0|||
49091527|NCT04463251|158170651|FG001|Overall Study|Withdrawal by Subject|2|||
49091528|NCT04463251|158170652|FG002|Overall Study|Withdrawal by Subject|2|||
49091529|NCT02504827|158170653|FG000|Overall Study|Could not produce sputum|1|||
49091530|NCT01743560|158170654|FG000|Overall Study|Disease progression|26|||
49091531|NCT01743560|158170654|FG000|Overall Study|Adverse Event|8|||
49091532|NCT01743560|158170654|FG000|Overall Study|Death|3|||
49091533|NCT01743560|158170654|FG000|Overall Study|Withdrawal by Subject|2|||
49091534|NCT01743560|158170654|FG000|Overall Study|Protocol Violation|1|||
49091535|NCT01743560|158170654|FG000|Overall Study|>1 dose of study drug|3|||
49091536|NCT03386994|158170655|FG000|Overall Study|Lung transplant|1|||
49091537|NCT03386994|158170655|FG000|Overall Study|Adverse Event|14|||
49091538|NCT03386994|158170655|FG000|Overall Study|Lost to Follow-up|4|||
49091539|NCT03386994|158170655|FG000|Overall Study|Withdrawal by Subject|3|||
49091540|NCT03386994|158170655|FG000|Overall Study|Death|16|||
49091541|NCT01344824|158172180|FG000|Overall Study|Adverse Event|15|||
49091542|NCT01344824|158172180|FG000|Overall Study|Withdrawal by Subject|6|||
49091543|NCT01344824|158172180|FG000|Overall Study|Other complicating disease|1|||
49091544|NCT01344824|158172180|FG000|Overall Study|Progression|15|||
49091545|NCT00596687|158172183|FG000|Overall Study|< 24 hours of insulin treatment|8|||
49091546|NCT00596687|158172184|FG001|Overall Study|< 24 hours of insulin treatment|6|||
49091547|NCT00596687|158172183|FG000|Overall Study|continuous insulin infusion during TPN|2|||
49091548|NCT00596687|158172184|FG001|Overall Study|continuous insulin infusion during TPN|1|||
49091549|NCT00596687|158172183|FG000|Overall Study|Withdrawal by Subject|3|||
49091550|NCT00596687|158172184|FG001|Overall Study|Withdrawal by Subject|1|||
49091551|NCT00596687|158172183|FG000|Overall Study|cancelled surgery|1|||
49091552|NCT00596687|158172184|FG001|Overall Study|cancelled surgery|1|||
49091553|NCT00932373|158172185|FG000|Overall Study|Progressive disease|3|||
49091554|NCT00932373|158172186|FG001|Overall Study|Progressive disease|1|||
49091555|NCT00932373|158172187|FG002|Overall Study|Progressive disease|0|||
49091556|NCT00932373|158172188|FG003|Overall Study|Progressive disease|0|||
49091557|NCT00932373|158172189|FG004|Overall Study|Progressive disease|10|||
49091558|NCT00932373|158172190|FG005|Overall Study|Progressive disease|1|||
49091559|NCT00932373|158172191|FG006|Overall Study|Progressive disease|0|||
49091560|NCT00932373|158172192|FG007|Overall Study|Progressive disease|2|||
49091561|NCT00932373|158172193|FG008|Overall Study|Progressive disease|1|||
49091562|NCT00932373|158172194|FG009|Overall Study|Progressive disease|9|||
49091563|NCT00932373|158172195|FG010|Overall Study|Progressive disease|2|||
49091564|NCT00932373|158172185|FG000|Overall Study|Adverse Event|0|||
49091565|NCT00932373|158172186|FG001|Overall Study|Adverse Event|0|||
49091566|NCT00932373|158172187|FG002|Overall Study|Adverse Event|0|||
49091567|NCT00932373|158172188|FG003|Overall Study|Adverse Event|0|||
49091568|NCT00932373|158172189|FG004|Overall Study|Adverse Event|2|||
49091569|NCT00932373|158172190|FG005|Overall Study|Adverse Event|1|||
49091570|NCT00932373|158172191|FG006|Overall Study|Adverse Event|0|||
49091571|NCT00932373|158172192|FG007|Overall Study|Adverse Event|1|||
49091572|NCT00932373|158172193|FG008|Overall Study|Adverse Event|0|||
49091573|NCT00932373|158172194|FG009|Overall Study|Adverse Event|2|||
49091574|NCT00932373|158172195|FG010|Overall Study|Adverse Event|1|||
49091575|NCT00932373|158172185|FG000|Overall Study|Physician Decision|0|||
49091576|NCT00932373|158172186|FG001|Overall Study|Physician Decision|0|||
49091577|NCT00932373|158172187|FG002|Overall Study|Physician Decision|1|||
49091578|NCT00932373|158172188|FG003|Overall Study|Physician Decision|0|||
49091579|NCT00932373|158172189|FG004|Overall Study|Physician Decision|2|||
49091580|NCT00932373|158172190|FG005|Overall Study|Physician Decision|0|||
49091581|NCT00932373|158172191|FG006|Overall Study|Physician Decision|0|||
49091582|NCT00932373|158172192|FG007|Overall Study|Physician Decision|0|||
49091583|NCT00932373|158172193|FG008|Overall Study|Physician Decision|0|||
49091584|NCT00932373|158172194|FG009|Overall Study|Physician Decision|1|||
49091585|NCT00932373|158172195|FG010|Overall Study|Physician Decision|0|||
49091586|NCT00932373|158172185|FG000|Overall Study|Dose limiting toxicity|0|||
49091587|NCT00932373|158172186|FG001|Overall Study|Dose limiting toxicity|0|||
49091588|NCT00932373|158172187|FG002|Overall Study|Dose limiting toxicity|0|||
49091589|NCT00932373|158172188|FG003|Overall Study|Dose limiting toxicity|0|||
49091590|NCT00932373|158172189|FG004|Overall Study|Dose limiting toxicity|0|||
49091591|NCT00932373|158172190|FG005|Overall Study|Dose limiting toxicity|1|||
49091592|NCT00932373|158172191|FG006|Overall Study|Dose limiting toxicity|0|||
49091593|NCT00932373|158172192|FG007|Overall Study|Dose limiting toxicity|0|||
49091594|NCT00932373|158172193|FG008|Overall Study|Dose limiting toxicity|0|||
49091595|NCT00932373|158172194|FG009|Overall Study|Dose limiting toxicity|0|||
49091596|NCT00932373|158172195|FG010|Overall Study|Dose limiting toxicity|0|||
49091597|NCT00932373|158172185|FG000|Overall Study|Withdrawal by Subject|0|||
49091598|NCT00932373|158172186|FG001|Overall Study|Withdrawal by Subject|0|||
49091599|NCT00932373|158172187|FG002|Overall Study|Withdrawal by Subject|0|||
49091600|NCT00932373|158172188|FG003|Overall Study|Withdrawal by Subject|0|||
49091601|NCT00932373|158172189|FG004|Overall Study|Withdrawal by Subject|0|||
49091602|NCT00932373|158172190|FG005|Overall Study|Withdrawal by Subject|0|||
49091603|NCT00932373|158172191|FG006|Overall Study|Withdrawal by Subject|0|||
49091604|NCT00932373|158172192|FG007|Overall Study|Withdrawal by Subject|0|||
49091605|NCT00932373|158172193|FG008|Overall Study|Withdrawal by Subject|1|||
49091606|NCT00932373|158172194|FG009|Overall Study|Withdrawal by Subject|0|||
49091607|NCT00932373|158172195|FG010|Overall Study|Withdrawal by Subject|0|||
49091608|NCT00932373|158172185|FG000|Overall Study|Clinical progression|0|||
49091609|NCT00932373|158172186|FG001|Overall Study|Clinical progression|0|||
49091610|NCT00932373|158172187|FG002|Overall Study|Clinical progression|0|||
49091611|NCT00932373|158172188|FG003|Overall Study|Clinical progression|0|||
49091612|NCT00932373|158172189|FG004|Overall Study|Clinical progression|0|||
49091613|NCT00932373|158172190|FG005|Overall Study|Clinical progression|0|||
49091614|NCT00932373|158172191|FG006|Overall Study|Clinical progression|1|||
49091615|NCT00932373|158172192|FG007|Overall Study|Clinical progression|0|||
49091616|NCT00932373|158172193|FG008|Overall Study|Clinical progression|0|||
49091617|NCT00932373|158172194|FG009|Overall Study|Clinical progression|0|||
49091618|NCT00932373|158172195|FG010|Overall Study|Clinical progression|0|||
49091619|NCT00932373|158172185|FG000|Overall Study|Lack of Efficacy|0|||
49091620|NCT00932373|158172186|FG001|Overall Study|Lack of Efficacy|0|||
49091621|NCT00932373|158172187|FG002|Overall Study|Lack of Efficacy|0|||
49091622|NCT00932373|158172188|FG003|Overall Study|Lack of Efficacy|0|||
49091623|NCT00932373|158172189|FG004|Overall Study|Lack of Efficacy|0|||
49091624|NCT00932373|158172190|FG005|Overall Study|Lack of Efficacy|0|||
49091625|NCT00932373|158172191|FG006|Overall Study|Lack of Efficacy|0|||
49091626|NCT00932373|158172192|FG007|Overall Study|Lack of Efficacy|0|||
49091627|NCT00932373|158172193|FG008|Overall Study|Lack of Efficacy|0|||
49091628|NCT00932373|158172194|FG009|Overall Study|Lack of Efficacy|1|||
49091629|NCT00932373|158172195|FG010|Overall Study|Lack of Efficacy|0|||
49091630|NCT06098339|158172198|FG000|Period 1: First Intervention 28-32 Days|Lost to Follow-up|0|||
49091631|NCT06098339|158172199|FG001|Period 1: First Intervention 28-32 Days|Lost to Follow-up|1|||
49091632|NCT06098339|158172198|FG000|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
49091633|NCT06098339|158172199|FG001|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
49091634|NCT01436370|158172200|FG000|Overall Study|Lost to Follow-up|0|||
49091635|NCT01436370|158172201|FG001|Overall Study|Lost to Follow-up|0|||
49091636|NCT01436370|158172202|FG002|Overall Study|Lost to Follow-up|0|||
49091637|NCT01436370|158172203|FG003|Overall Study|Lost to Follow-up|0|||
49091638|NCT01436370|158172204|FG004|Overall Study|Lost to Follow-up|1|||
49091639|NCT01436370|158172205|FG005|Overall Study|Lost to Follow-up|0|||
49091640|NCT01436370|158172206|FG006|Overall Study|Lost to Follow-up|0|||
49091641|NCT01436370|158172207|FG007|Overall Study|Lost to Follow-up|0|||
49091642|NCT03831113|158172208|FG000|Overall Study|Withdrawal by Subject|0|||
49091643|NCT03831113|158172209|FG001|Overall Study|Withdrawal by Subject|2|||
49091644|NCT03831113|158172208|FG000|Overall Study|Protocol Violation|0|||
49091645|NCT03831113|158172209|FG001|Overall Study|Protocol Violation|9|||
49091646|NCT03491462|158172210|FG000|Overall Study|Lost to Follow-up|2|||
49091647|NCT03491462|158172211|FG001|Overall Study|Lost to Follow-up|0|||
49091648|NCT03491462|158172210|FG000|Overall Study|Adverse Event|11|||
49091649|NCT03491462|158172211|FG001|Overall Study|Adverse Event|1|||
49091650|NCT03491462|158172210|FG000|Overall Study|Physician Decision|3|||
49091651|NCT03491462|158172211|FG001|Overall Study|Physician Decision|0|||
49091652|NCT03491462|158172210|FG000|Overall Study|Withdrawal by Subject|22|||
49091653|NCT03491462|158172211|FG001|Overall Study|Withdrawal by Subject|15|||
49091654|NCT01019694|158172212|FG000|Overall Study|Adverse Event|12|||
49091655|NCT01019694|158172213|FG001|Overall Study|Adverse Event|16|||
49091656|NCT01019694|158172214|FG002|Overall Study|Adverse Event|19|||
49091657|NCT01019694|158172212|FG000|Overall Study|Protocol Violation|2|||
49091658|NCT01019694|158172213|FG001|Overall Study|Protocol Violation|6|||
49091659|NCT01019694|158172214|FG002|Overall Study|Protocol Violation|4|||
49091660|NCT01019694|158172212|FG000|Overall Study|Lost to Follow-up|5|||
49091661|NCT01019694|158172213|FG001|Overall Study|Lost to Follow-up|3|||
49091662|NCT01019694|158172214|FG002|Overall Study|Lost to Follow-up|3|||
49091663|NCT01019694|158172212|FG000|Overall Study|Withdrawal by Subject|4|||
49091664|NCT01019694|158172213|FG001|Overall Study|Withdrawal by Subject|6|||
49091665|NCT01019694|158172214|FG002|Overall Study|Withdrawal by Subject|12|||
49091666|NCT01019694|158172212|FG000|Overall Study|Not treated|0|||
49091667|NCT01019694|158172213|FG001|Overall Study|Not treated|2|||
49091668|NCT01019694|158172214|FG002|Overall Study|Not treated|3|||
49091669|NCT01019694|158172212|FG000|Overall Study|Other reason (not specified)|1|||
49091670|NCT01019694|158172213|FG001|Overall Study|Other reason (not specified)|5|||
49091671|NCT01019694|158172214|FG002|Overall Study|Other reason (not specified)|6|||
49091672|NCT02968173|158172217|FG000|Overall Study|Withdrawal by Subject|1|||
49091673|NCT00441129|158172218|FG000|Overall Study|Withdrawal by Subject|6|||
49091674|NCT00441129|158172219|FG001|Overall Study|Withdrawal by Subject|14|||
49091675|NCT04747886|158172224|FG000|Overall Study|Withdrawal by Subject|1|||
49091676|NCT04747886|158172225|FG001|Overall Study|Withdrawal by Subject|4|||
49091677|NCT01996254|158172227|FG000|Overall Study|Change in Eligibility|0|||
49091678|NCT01996254|158172228|FG001|Overall Study|Change in Eligibility|2|||
49091679|NCT01996254|158172229|FG002|Overall Study|Change in Eligibility|0|||
49091680|NCT01996254|158172227|FG000|Overall Study|Withdrawal by Subject|0|||
49091681|NCT01996254|158172228|FG001|Overall Study|Withdrawal by Subject|3|||
49091682|NCT01996254|158172229|FG002|Overall Study|Withdrawal by Subject|4|||
49091683|NCT01996254|158172227|FG000|Overall Study|Lost to Follow-up|1|||
49091684|NCT01996254|158172228|FG001|Overall Study|Lost to Follow-up|0|||
49091685|NCT01996254|158172229|FG002|Overall Study|Lost to Follow-up|4|||
49091686|NCT01741688|158172230|FG000|Overall Study|Lack of insurance coverage|2|||
49091687|NCT01741688|158172230|FG000|Overall Study|Withdrawal by Subject|1|||
49091688|NCT01377922|158172235|FG000|Overall Study|rescue tx after part 2, entered part 4|1|||
49091689|NCT01377922|158172236|FG001|Overall Study|rescue tx after part 2, entered part 4|0|||
49091690|NCT03850496|158172237|FG000|Overall Study|Withdrawal by Subject|1|||
49091691|NCT03850496|158172238|FG001|Overall Study|Withdrawal by Subject|0|||
49091692|NCT03850496|158172239|FG002|Overall Study|Withdrawal by Subject|0|||
49091693|NCT03850496|158172237|FG000|Overall Study|Lost to Follow-up|0|||
49091694|NCT03850496|158172238|FG001|Overall Study|Lost to Follow-up|1|||
49091695|NCT03850496|158172239|FG002|Overall Study|Lost to Follow-up|4|||
49091696|NCT02035202|158172244|FG000|Overall Study|Lost to Follow-up|8|||
49091697|NCT02035202|158172245|FG001|Overall Study|Lost to Follow-up|16|||
49091698|NCT02035202|158172246|FG002|Overall Study|Lost to Follow-up|2|||
49091699|NCT03777436|158172247|FG000|Placebo-controlled Phase|Adverse Event|8|||
49091700|NCT03777436|158172248|FG001|Placebo-controlled Phase|Adverse Event|10|||
49091701|NCT03777436|158172249|FG002|Placebo-controlled Phase|Adverse Event|0|||
49091702|NCT03777436|158172247|FG000|Placebo-controlled Phase|Lack of Efficacy|0|||
49091703|NCT03777436|158172248|FG001|Placebo-controlled Phase|Lack of Efficacy|1|||
49091704|NCT03777436|158172249|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
49091705|NCT03777436|158172247|FG000|Placebo-controlled Phase|Withdrawal by Subject|19|||
49091706|NCT03777436|158172248|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
49091707|NCT03777436|158172249|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
49091708|NCT03777436|158172247|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
49091709|NCT03777436|158172248|FG001|Placebo-controlled Phase|Non-compliance with study drug|2|||
49091710|NCT03777436|158172249|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
49091711|NCT03777436|158172247|FG000|Placebo-controlled Phase|Lost to Follow-up|7|||
49091712|NCT03777436|158172248|FG001|Placebo-controlled Phase|Lost to Follow-up|7|||
49091713|NCT03777436|158172249|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
49091714|NCT03777436|158172247|FG000|Placebo-controlled Phase|Physician Decision|0|||
49091715|NCT03777436|158172248|FG001|Placebo-controlled Phase|Physician Decision|1|||
49091716|NCT03777436|158172249|FG002|Placebo-controlled Phase|Physician Decision|0|||
49091717|NCT03777436|158172247|FG000|Placebo-controlled Phase|Due to COVID-19 control measures|1|||
49091718|NCT03777436|158172248|FG001|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
49091719|NCT03777436|158172249|FG002|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
49091720|NCT03777436|158172247|FG000|Apremilast Extension Phase|Adverse Event|0|||
49091721|NCT03777436|158172248|FG001|Apremilast Extension Phase|Adverse Event|0|||
49091722|NCT03777436|158172249|FG002|Apremilast Extension Phase|Adverse Event|6|||
49091723|NCT03777436|158172247|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
49091724|NCT03777436|158172248|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
49091725|NCT03777436|158172249|FG002|Apremilast Extension Phase|Lack of Efficacy|1|||
49091726|NCT03777436|158172247|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
49091727|NCT03777436|158172248|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
49091728|NCT03777436|158172249|FG002|Apremilast Extension Phase|Withdrawal by Subject|13|||
49091729|NCT03777436|158172247|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
49091730|NCT03777436|158172248|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
49091731|NCT03777436|158172249|FG002|Apremilast Extension Phase|Lost to Follow-up|7|||
49091732|NCT03777436|158172247|FG000|Apremilast Extension Phase|Miscellaneous|0|||
49091733|NCT03777436|158172248|FG001|Apremilast Extension Phase|Miscellaneous|0|||
49091734|NCT03777436|158172249|FG002|Apremilast Extension Phase|Miscellaneous|1|||
49091735|NCT02737930|158172257|FG000|Overall Study|Withdrawal by Subject|0|||
49091736|NCT02737930|158172258|FG001|Overall Study|Withdrawal by Subject|1|||
49091737|NCT00644917|158172260|FG000|Overall Study|Withdrawal by Subject|2|||
49091738|NCT02875613|158172261|FG000|Overall Study|Withdrawal by Subject|1|||
49091739|NCT02875613|158172261|FG000|Overall Study|Screen Failure|1|||
49091740|NCT00758485|158172262|FG000|Overall Study|Lost to Follow-up|0|||
49091741|NCT00758485|158172263|FG001|Overall Study|Lost to Follow-up|1|||
49091742|NCT00758485|158172262|FG000|Overall Study|Not Treated|1|||
49091743|NCT00758485|158172263|FG001|Overall Study|Not Treated|2|||
49091744|NCT00178685|158172264|FG000|Overall Study|Death|3|||
49091745|NCT00178685|158172265|FG001|Overall Study|Death|3|||
49091746|NCT00178685|158172266|FG002|Overall Study|Death|6|||
49091747|NCT00178685|158172264|FG000|Overall Study|Lost to Follow-up|100|||
49091748|NCT00178685|158172265|FG001|Overall Study|Lost to Follow-up|187|||
49091749|NCT00178685|158172266|FG002|Overall Study|Lost to Follow-up|183|||
49091750|NCT00178685|158172264|FG000|Overall Study|Withdrawal by Subject|8|||
49091751|NCT00178685|158172265|FG001|Overall Study|Withdrawal by Subject|14|||
49091752|NCT00178685|158172266|FG002|Overall Study|Withdrawal by Subject|7|||
49091753|NCT03474731|158172267|FG000|Overall Study|Withdrawal by Subject|36|||
49091754|NCT03474731|158172268|FG001|Overall Study|Withdrawal by Subject|29|||
49091755|NCT03474731|158172269|FG002|Overall Study|Withdrawal by Subject|11|||
49091756|NCT03474731|158172270|FG003|Overall Study|Withdrawal by Subject|27|||
49091757|NCT03474731|158172267|FG000|Overall Study|COVID|0|||
49091758|NCT03474731|158172268|FG001|Overall Study|COVID|23|||
49091759|NCT03474731|158172269|FG002|Overall Study|COVID|0|||
49091760|NCT03474731|158172270|FG003|Overall Study|COVID|0|||
49091761|NCT03474731|158172267|FG000|Overall Study|Participant moved from area|1|||
49091762|NCT03474731|158172268|FG001|Overall Study|Participant moved from area|0|||
49091763|NCT03474731|158172269|FG002|Overall Study|Participant moved from area|0|||
49091764|NCT03474731|158172270|FG003|Overall Study|Participant moved from area|0|||
49091765|NCT03474731|158172267|FG000|Overall Study|Lost to Follow-up|11|||
49091766|NCT03474731|158172268|FG001|Overall Study|Lost to Follow-up|3|||
49091767|NCT03474731|158172269|FG002|Overall Study|Lost to Follow-up|18|||
49091768|NCT03474731|158172270|FG003|Overall Study|Lost to Follow-up|17|||
49091769|NCT03474731|158172267|FG000|Overall Study|Death|0|||
49091770|NCT03474731|158172268|FG001|Overall Study|Death|1|||
49091771|NCT03474731|158172269|FG002|Overall Study|Death|0|||
49091772|NCT03474731|158172270|FG003|Overall Study|Death|0|||
49091773|NCT03474731|158172267|FG000|Overall Study|Participant Removed|0|||
49091774|NCT03474731|158172268|FG001|Overall Study|Participant Removed|0|||
49091775|NCT03474731|158172269|FG002|Overall Study|Participant Removed|0|||
49091776|NCT03474731|158172270|FG003|Overall Study|Participant Removed|1|||
49091777|NCT00237458|158172271|FG000|Overall Study|Lack of Efficacy|1|||
49091778|NCT00237458|158172271|FG000|Overall Study|Adverse Event|1|||
49091779|NCT00237458|158172271|FG000|Overall Study|Withdrawal by Subject|1|||
49091780|NCT01266291|158172289|FG000|Overall Study|Adverse Event|1|||
49091781|NCT03423173|158172290|FG000|Overall Study|Randomized but not vaccinated|1|||
49091782|NCT03423173|158172291|FG001|Overall Study|Randomized but not vaccinated|0|||
49091783|NCT03423173|158172292|FG002|Overall Study|Randomized but not vaccinated|2|||
49091784|NCT03423173|158172293|FG003|Overall Study|Randomized but not vaccinated|1|||
49091785|NCT03423173|158172290|FG000|Overall Study|Adverse Event|1|||
49091786|NCT03423173|158172291|FG001|Overall Study|Adverse Event|1|||
49091787|NCT03423173|158172292|FG002|Overall Study|Adverse Event|1|||
49091788|NCT03423173|158172293|FG003|Overall Study|Adverse Event|1|||
49091789|NCT03423173|158172290|FG000|Overall Study|Lost to Follow-up|10|||
49091790|NCT03423173|158172291|FG001|Overall Study|Lost to Follow-up|19|||
49091791|NCT03423173|158172292|FG002|Overall Study|Lost to Follow-up|17|||
49091792|NCT03423173|158172293|FG003|Overall Study|Lost to Follow-up|22|||
49091793|NCT03423173|158172290|FG000|Overall Study|Withdrawal of consent|4|||
49091794|NCT03423173|158172291|FG001|Overall Study|Withdrawal of consent|10|||
49091795|NCT03423173|158172292|FG002|Overall Study|Withdrawal of consent|4|||
49091796|NCT03423173|158172293|FG003|Overall Study|Withdrawal of consent|5|||
49091797|NCT03423173|158172290|FG000|Overall Study|Death|1|||
49091798|NCT03423173|158172291|FG001|Overall Study|Death|0|||
49091799|NCT03423173|158172292|FG002|Overall Study|Death|0|||
49091800|NCT03423173|158172293|FG003|Overall Study|Death|0|||
49091801|NCT03423173|158172290|FG000|Overall Study|Reason not Specified|2|||
49091802|NCT03423173|158172291|FG001|Overall Study|Reason not Specified|5|||
49091803|NCT03423173|158172292|FG002|Overall Study|Reason not Specified|3|||
49091804|NCT03423173|158172293|FG003|Overall Study|Reason not Specified|1|||
49091805|NCT03291431|158172294|FG000|Overall Study|Protocol Violation|2|||
49091806|NCT03291431|158172295|FG001|Overall Study|Protocol Violation|1|||
49091807|NCT03291431|158172294|FG000|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|1|||
49091808|NCT03291431|158172295|FG001|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|0|||
49091809|NCT03291431|158172294|FG000|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|0|||
49091810|NCT03291431|158172295|FG001|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|1|||
49091811|NCT00101166|158172298|FG000|Overall Study|progressive disease|10|||
49091812|NCT00072280|158172300|FG000|Treatment|Found ineligible|1|||
49091813|NCT00072280|158172301|FG001|Treatment|Found ineligible|2|||
49091814|NCT00072280|158172300|FG000|Follow-up|Early termination of study|2|||
49091815|NCT00072280|158172301|FG001|Follow-up|Early termination of study|2|||
49091816|NCT01868022|158172304|FG000|Overall Study|Withdrawal by Subject|0|||
49091817|NCT01868022|158172305|FG001|Overall Study|Withdrawal by Subject|0|||
49091818|NCT01868022|158172306|FG002|Overall Study|Withdrawal by Subject|1|||
49091819|NCT01868022|158172307|FG003|Overall Study|Withdrawal by Subject|1|||
49091820|NCT01868022|158172308|FG004|Overall Study|Withdrawal by Subject|0|||
49091821|NCT01868022|158172309|FG005|Overall Study|Withdrawal by Subject|0|||
49091822|NCT01868022|158172310|FG006|Overall Study|Withdrawal by Subject|0|||
49091823|NCT01868022|158172311|FG007|Overall Study|Withdrawal by Subject|1|||
49091824|NCT01868022|158172312|FG008|Overall Study|Withdrawal by Subject|0|||
49091825|NCT01868022|158172304|FG000|Overall Study|Adverse Event|0|||
49091826|NCT01868022|158172305|FG001|Overall Study|Adverse Event|0|||
49091827|NCT01868022|158172306|FG002|Overall Study|Adverse Event|0|||
49091828|NCT01868022|158172307|FG003|Overall Study|Adverse Event|0|||
49091829|NCT01868022|158172308|FG004|Overall Study|Adverse Event|2|||
49091830|NCT01868022|158172309|FG005|Overall Study|Adverse Event|0|||
49091831|NCT01868022|158172310|FG006|Overall Study|Adverse Event|0|||
49091832|NCT01868022|158172311|FG007|Overall Study|Adverse Event|2|||
49091833|NCT01868022|158172312|FG008|Overall Study|Adverse Event|2|||
49091834|NCT01868022|158172304|FG000|Overall Study|Physician Decision|0|||
49091835|NCT01868022|158172305|FG001|Overall Study|Physician Decision|0|||
49091836|NCT01868022|158172306|FG002|Overall Study|Physician Decision|0|||
49091837|NCT01868022|158172307|FG003|Overall Study|Physician Decision|0|||
49091838|NCT01868022|158172308|FG004|Overall Study|Physician Decision|0|||
49091839|NCT01868022|158172309|FG005|Overall Study|Physician Decision|1|||
49091840|NCT01868022|158172310|FG006|Overall Study|Physician Decision|0|||
49091841|NCT01868022|158172311|FG007|Overall Study|Physician Decision|2|||
49091842|NCT01868022|158172312|FG008|Overall Study|Physician Decision|0|||
49091843|NCT01868022|158172304|FG000|Overall Study|Study closed/terminated|0|||
49091844|NCT01868022|158172305|FG001|Overall Study|Study closed/terminated|0|||
49091845|NCT01868022|158172306|FG002|Overall Study|Study closed/terminated|0|||
49091846|NCT01868022|158172307|FG003|Overall Study|Study closed/terminated|0|||
49091847|NCT01868022|158172308|FG004|Overall Study|Study closed/terminated|0|||
49091848|NCT01868022|158172309|FG005|Overall Study|Study closed/terminated|0|||
49091849|NCT01868022|158172310|FG006|Overall Study|Study closed/terminated|0|||
49091850|NCT01868022|158172311|FG007|Overall Study|Study closed/terminated|1|||
49091851|NCT01868022|158172312|FG008|Overall Study|Study closed/terminated|0|||
49091852|NCT01868022|158172304|FG000|Overall Study|Ongoing|0|||
49091853|NCT01868022|158172305|FG001|Overall Study|Ongoing|0|||
49091854|NCT01868022|158172306|FG002|Overall Study|Ongoing|0|||
49091855|NCT01868022|158172307|FG003|Overall Study|Ongoing|0|||
49091856|NCT01868022|158172308|FG004|Overall Study|Ongoing|0|||
49091857|NCT01868022|158172309|FG005|Overall Study|Ongoing|0|||
49091858|NCT01868022|158172310|FG006|Overall Study|Ongoing|0|||
49091859|NCT01868022|158172311|FG007|Overall Study|Ongoing|3|||
49091860|NCT01868022|158172312|FG008|Overall Study|Ongoing|0|||
49091861|NCT00746564|158172315|FG000|Overall Study|Required Pacemaker/ICD Implant|2|||
49091862|NCT00550745|158172320|FG000|Overall Study|Death|20|||
49091863|NCT00550745|158172321|FG001|Overall Study|Death|16|||
49091864|NCT00550745|158172320|FG000|Overall Study|Lost to Follow-up|45|||
49091865|NCT00550745|158172321|FG001|Overall Study|Lost to Follow-up|30|||
49091866|NCT00550745|158172320|FG000|Overall Study|Physician Decision|0|||
49091867|NCT00550745|158172321|FG001|Overall Study|Physician Decision|2|||
49091868|NCT00550745|158172320|FG000|Overall Study|Protocol Violation|4|||
49091869|NCT00550745|158172321|FG001|Overall Study|Protocol Violation|2|||
49091870|NCT00550745|158172320|FG000|Overall Study|Withdrawal by Subject|17|||
49091871|NCT00550745|158172321|FG001|Overall Study|Withdrawal by Subject|10|||
49091872|NCT00550745|158172320|FG000|Overall Study|Screen failure|1|||
49091873|NCT00550745|158172321|FG001|Overall Study|Screen failure|0|||
49091874|NCT00022698|158172322|FG000|Overall Study|Adverse Event|5|||
49091875|NCT00022698|158172323|FG001|Overall Study|Adverse Event|9|||
49091876|NCT00022698|158172322|FG000|Overall Study|Death|0|||
49091877|NCT00022698|158172323|FG001|Overall Study|Death|2|||
49091878|NCT00022698|158172322|FG000|Overall Study|Failure to return|0|||
49091879|NCT00022698|158172323|FG001|Overall Study|Failure to return|1|||
49091880|NCT00022698|158172322|FG000|Overall Study|Refused treatment|0|||
49091881|NCT00022698|158172323|FG001|Overall Study|Refused treatment|2|||
49091882|NCT00022698|158172322|FG000|Overall Study|Insufficient therapeutic response|2|||
49091883|NCT00022698|158172323|FG001|Overall Study|Insufficient therapeutic response|14|||
49091884|NCT00022698|158172322|FG000|Overall Study|Administrative /other|1|||
49091885|NCT00022698|158172323|FG001|Overall Study|Administrative /other|7|||
49091886|NCT00485732|158173699|FG000|Overall Study|Protocol Violation|1|||
49091887|NCT00485732|158173700|FG001|Overall Study|Protocol Violation|3|||
49091888|NCT00485732|158173699|FG000|Overall Study|Withdrawal by Subject|5|||
49091889|NCT00485732|158173700|FG001|Overall Study|Withdrawal by Subject|4|||
49091890|NCT00485732|158173699|FG000|Overall Study|Lost to Follow-up|2|||
49091891|NCT00485732|158173700|FG001|Overall Study|Lost to Follow-up|2|||
49091892|NCT00570687|158173701|FG000|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
49091893|NCT00570687|158173702|FG001|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
49091894|NCT00570687|158173703|FG002|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
49091895|NCT00570687|158173704|FG003|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
49091896|NCT00570687|158173705|FG004|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
49091897|NCT00570687|158173706|FG005|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
49091898|NCT00570687|158173707|FG006|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
49091899|NCT00570687|158173708|FG007|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
49091900|NCT00570687|158173709|FG008|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
49091901|NCT00570687|158173710|FG009|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
49091902|NCT00570687|158173701|FG000|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
49091903|NCT00570687|158173702|FG001|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
49091904|NCT00570687|158173703|FG002|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
49091905|NCT00570687|158173704|FG003|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
49091906|NCT00570687|158173705|FG004|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
49091907|NCT00570687|158173706|FG005|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
49091908|NCT00570687|158173707|FG006|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
49091909|NCT00570687|158173708|FG007|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
49091910|NCT00570687|158173709|FG008|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
49091911|NCT00570687|158173710|FG009|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
49091912|NCT00570687|158173701|FG000|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
49091913|NCT00570687|158173702|FG001|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
49091914|NCT00570687|158173703|FG002|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
49091915|NCT00570687|158173704|FG003|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
49091916|NCT00570687|158173705|FG004|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
49091917|NCT00570687|158173706|FG005|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
49091918|NCT00570687|158173707|FG006|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
49091919|NCT00570687|158173708|FG007|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
49091920|NCT00570687|158173709|FG008|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
49091921|NCT00570687|158173710|FG009|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
49091922|NCT03055338|158173711|FG000|Overall Study|Lost to Follow-up|9|||
49091923|NCT03055338|158173712|FG001|Overall Study|Lost to Follow-up|2|||
49091924|NCT03055338|158173713|FG002|Overall Study|Lost to Follow-up|3|||
49091925|NCT03055338|158173711|FG000|Overall Study|No Post-treatment Protocol Contact|0|||
49091926|NCT03055338|158173712|FG001|Overall Study|No Post-treatment Protocol Contact|1|||
49091927|NCT03055338|158173713|FG002|Overall Study|No Post-treatment Protocol Contact|0|||
49091928|NCT03055338|158173711|FG000|Overall Study|Physician Decision|0|||
49091929|NCT03055338|158173712|FG001|Overall Study|Physician Decision|0|||
49091930|NCT03055338|158173713|FG002|Overall Study|Physician Decision|2|||
49091931|NCT03055338|158173711|FG000|Overall Study|Withdrawal by Subject|9|||
49091932|NCT03055338|158173712|FG001|Overall Study|Withdrawal by Subject|8|||
49091933|NCT03055338|158173713|FG002|Overall Study|Withdrawal by Subject|7|||
49091934|NCT01379768|158173714|FG000|Overall Study|Adverse Event|1|||
49091935|NCT01379768|158173715|FG001|Overall Study|Adverse Event|1|||
49091936|NCT01379768|158173716|FG002|Overall Study|Adverse Event|0|||
49091937|NCT01379768|158173714|FG000|Overall Study|Lost to Follow-up|2|||
49091938|NCT01379768|158173715|FG001|Overall Study|Lost to Follow-up|0|||
49091939|NCT01379768|158173716|FG002|Overall Study|Lost to Follow-up|0|||
49091940|NCT00078767|158173717|FG000|Overall Study|Withdrawal by Subject|1|||
49091941|NCT00078767|158173718|FG001|Overall Study|Withdrawal by Subject|1|||
49091942|NCT05253573|158173719|FG000|Overall Study|Death|1|||
49091943|NCT05253573|158173720|FG001|Overall Study|Death|0|||
49091944|NCT00566020|158173726|FG000|6-week Dosage Adjustment Phase|Adverse Event|5|||
49091945|NCT00566020|158173727|FG001|6-week Dosage Adjustment Phase|Adverse Event|0|||
49091946|NCT00566020|158173726|FG000|6-week Dosage Adjustment Phase|Lack of Efficacy|2|||
49091947|NCT00566020|158173727|FG001|6-week Dosage Adjustment Phase|Lack of Efficacy|0|||
49091948|NCT00566020|158173726|FG000|46-week Long-term Administration Phase|Adverse Event|0|||
49091949|NCT00566020|158173727|FG001|46-week Long-term Administration Phase|Adverse Event|7|||
49091950|NCT00566020|158173726|FG000|46-week Long-term Administration Phase|Physician Decision|0|||
49091951|NCT00566020|158173727|FG001|46-week Long-term Administration Phase|Physician Decision|7|||
49091952|NCT00566020|158173726|FG000|46-week Long-term Administration Phase|Lost to Follow-up|0|||
49091953|NCT00566020|158173727|FG001|46-week Long-term Administration Phase|Lost to Follow-up|2|||
49091954|NCT00566020|158173726|FG000|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0|||
49091955|NCT00566020|158173727|FG001|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1|||
49091956|NCT02393950|158173728|FG000|Overall Study|Adverse Event|1|||
49091957|NCT02393950|158173729|FG001|Overall Study|Adverse Event|0|||
49091958|NCT02393950|158173728|FG000|Overall Study|Withdrawal by Subject|0|||
49091959|NCT02393950|158173729|FG001|Overall Study|Withdrawal by Subject|1|||
49091960|NCT02920008|158173736|FG000|Overall Study|Death|117|||
49091961|NCT02920008|158173737|FG001|Overall Study|Death|127|||
49091962|NCT02920008|158173736|FG000|Overall Study|Withdrawal by Subject|3|||
49091963|NCT02920008|158173737|FG001|Overall Study|Withdrawal by Subject|6|||
49091964|NCT02920008|158173736|FG000|Overall Study|Lost to Follow-up|0|||
49091965|NCT02920008|158173737|FG001|Overall Study|Lost to Follow-up|1|||
49091966|NCT00529308|158173738|FG000|Overall Study|Withdrawal by Subject|1|||
49091967|NCT00529308|158173739|FG001|Overall Study|Withdrawal by Subject|1|||
49091968|NCT00582608|158173740|FG000|Overall Study|Not Treated|7|||
49091969|NCT00582608|158173740|FG000|Overall Study|Patient Ineligible|1|||
49091970|NCT00582608|158173740|FG000|Overall Study|Lack of accrual|4|||
49091971|NCT01464164|158173742|FG000|Overall Study|Screen failure|0|||
49091972|NCT01464164|158173743|FG001|Overall Study|Screen failure|1|||
49091973|NCT01464164|158173744|FG002|Overall Study|Screen failure|2|||
49091974|NCT01464164|158173745|FG003|Overall Study|Screen failure|0|||
49091975|NCT01464164|158173746|FG004|Overall Study|Screen failure|0|||
49091976|NCT01464164|158173747|FG005|Overall Study|Screen failure|0|||
49091977|NCT01464164|158173748|FG006|Overall Study|Screen failure|0|||
49091978|NCT01464164|158173742|FG000|Overall Study|Physician Decision|0|||
49091979|NCT01464164|158173743|FG001|Overall Study|Physician Decision|1|||
49091980|NCT01464164|158173744|FG002|Overall Study|Physician Decision|0|||
49091981|NCT01464164|158173745|FG003|Overall Study|Physician Decision|0|||
49091982|NCT01464164|158173746|FG004|Overall Study|Physician Decision|0|||
49091983|NCT01464164|158173747|FG005|Overall Study|Physician Decision|0|||
49091984|NCT01464164|158173748|FG006|Overall Study|Physician Decision|2|||
49091985|NCT00083759|158173749|FG000|Overall Study|Adverse Event|5|||
49091986|NCT00083759|158173750|FG001|Overall Study|Adverse Event|3|||
49091987|NCT00083759|158173749|FG000|Overall Study|Lost to Follow-up|1|||
49091988|NCT00083759|158173750|FG001|Overall Study|Lost to Follow-up|0|||
49091989|NCT00083759|158173749|FG000|Overall Study|Death|1|||
49091990|NCT00083759|158173750|FG001|Overall Study|Death|1|||
49091991|NCT00083759|158173749|FG000|Overall Study|Inadequate Therapeutic Response|32|||
49091992|NCT00083759|158173750|FG001|Overall Study|Inadequate Therapeutic Response|35|||
49091993|NCT00083759|158173749|FG000|Overall Study|Subject Withdrew Consent|2|||
49091994|NCT00083759|158173750|FG001|Overall Study|Subject Withdrew Consent|2|||
49091995|NCT00083759|158173749|FG000|Overall Study|Non-Compliance|1|||
49091996|NCT00083759|158173750|FG001|Overall Study|Non-Compliance|0|||
49091997|NCT00083759|158173749|FG000|Overall Study|Sponsor's Discretion|28|||
49091998|NCT00083759|158173750|FG001|Overall Study|Sponsor's Discretion|29|||
49091999|NCT00083759|158173749|FG000|Overall Study|Other|14|||
49092000|NCT00083759|158173750|FG001|Overall Study|Other|13|||
49092001|NCT00869999|158173751|FG000|Overall Study|Withdrawal by Subject|1|||
49092002|NCT00869999|158173751|FG000|Overall Study|removed prior to starting therapy|1|||
49092003|NCT00685399|158173753|FG000|Treatment Period 1|Withdrawal by Subject|2|||
49092004|NCT00685399|158173754|FG001|Treatment Period 1|Withdrawal by Subject|0|||
49092005|NCT00685399|158173755|FG002|Treatment Period 1|Withdrawal by Subject|0|||
49092006|NCT00685399|158173756|FG003|Treatment Period 1|Withdrawal by Subject|0|||
49092007|NCT00685399|158173757|FG004|Treatment Period 1|Withdrawal by Subject|0|||
49092008|NCT00685399|158173758|FG005|Treatment Period 1|Withdrawal by Subject|0|||
49092009|NCT00685399|158173759|FG006|Treatment Period 1|Withdrawal by Subject|0|||
49092010|NCT00685399|158173760|FG007|Treatment Period 1|Withdrawal by Subject|0|||
49092011|NCT00685399|158173753|FG000|Treatment Period 1|Protocol Violation|1|||
49092012|NCT00685399|158173754|FG001|Treatment Period 1|Protocol Violation|0|||
49092013|NCT00685399|158173755|FG002|Treatment Period 1|Protocol Violation|0|||
49092014|NCT00685399|158173756|FG003|Treatment Period 1|Protocol Violation|0|||
49092015|NCT00685399|158173757|FG004|Treatment Period 1|Protocol Violation|0|||
49092016|NCT00685399|158173758|FG005|Treatment Period 1|Protocol Violation|0|||
49092017|NCT00685399|158173759|FG006|Treatment Period 1|Protocol Violation|0|||
49092018|NCT00685399|158173760|FG007|Treatment Period 1|Protocol Violation|0|||
49092019|NCT00685399|158173753|FG000|Treatment Period 1|Administrative|2|||
49092020|NCT00685399|158173754|FG001|Treatment Period 1|Administrative|0|||
49092021|NCT00685399|158173755|FG002|Treatment Period 1|Administrative|0|||
49092022|NCT00685399|158173756|FG003|Treatment Period 1|Administrative|0|||
49092023|NCT00685399|158173757|FG004|Treatment Period 1|Administrative|0|||
49092024|NCT00685399|158173758|FG005|Treatment Period 1|Administrative|0|||
49092025|NCT00685399|158173759|FG006|Treatment Period 1|Administrative|0|||
49092026|NCT00685399|158173760|FG007|Treatment Period 1|Administrative|0|||
49092027|NCT00685399|158173753|FG000|Treatment Period 1|Lack of Efficacy|1|||
49092028|NCT00685399|158173754|FG001|Treatment Period 1|Lack of Efficacy|0|||
49092029|NCT00685399|158173755|FG002|Treatment Period 1|Lack of Efficacy|0|||
49092030|NCT00685399|158173756|FG003|Treatment Period 1|Lack of Efficacy|0|||
49092031|NCT00685399|158173757|FG004|Treatment Period 1|Lack of Efficacy|0|||
49092032|NCT00685399|158173758|FG005|Treatment Period 1|Lack of Efficacy|0|||
49092033|NCT00685399|158173759|FG006|Treatment Period 1|Lack of Efficacy|0|||
49092034|NCT00685399|158173760|FG007|Treatment Period 1|Lack of Efficacy|0|||
49092035|NCT00685399|158173753|FG000|Treatment Period 2|Administrative Problems|0|||
49092036|NCT00685399|158173754|FG001|Treatment Period 2|Administrative Problems|2|||
49092037|NCT00685399|158173755|FG002|Treatment Period 2|Administrative Problems|1|||
49092038|NCT00685399|158173756|FG003|Treatment Period 2|Administrative Problems|0|||
49092039|NCT00685399|158173757|FG004|Treatment Period 2|Administrative Problems|0|||
49092040|NCT00685399|158173758|FG005|Treatment Period 2|Administrative Problems|0|||
49092041|NCT00685399|158173759|FG006|Treatment Period 2|Administrative Problems|0|||
49092042|NCT00685399|158173760|FG007|Treatment Period 2|Administrative Problems|0|||
49092043|NCT00685399|158173753|FG000|Treatment Period 2|Withdrawal by Subject|0|||
49092044|NCT00685399|158173754|FG001|Treatment Period 2|Withdrawal by Subject|0|||
49092045|NCT00685399|158173755|FG002|Treatment Period 2|Withdrawal by Subject|0|||
49092046|NCT00685399|158173756|FG003|Treatment Period 2|Withdrawal by Subject|0|||
49092047|NCT00685399|158173757|FG004|Treatment Period 2|Withdrawal by Subject|0|||
49092048|NCT00685399|158173758|FG005|Treatment Period 2|Withdrawal by Subject|0|||
49092049|NCT00685399|158173759|FG006|Treatment Period 2|Withdrawal by Subject|0|||
49092050|NCT00685399|158173760|FG007|Treatment Period 2|Withdrawal by Subject|2|||
49092051|NCT00685399|158173753|FG000|Treatment Period 2|Adverse Event|0|||
49092052|NCT00685399|158173754|FG001|Treatment Period 2|Adverse Event|0|||
49092053|NCT00685399|158173755|FG002|Treatment Period 2|Adverse Event|0|||
49092054|NCT00685399|158173756|FG003|Treatment Period 2|Adverse Event|0|||
49092055|NCT00685399|158173757|FG004|Treatment Period 2|Adverse Event|0|||
49092056|NCT00685399|158173758|FG005|Treatment Period 2|Adverse Event|1|||
49092057|NCT00685399|158173759|FG006|Treatment Period 2|Adverse Event|0|||
49092058|NCT00685399|158173760|FG007|Treatment Period 2|Adverse Event|0|||
49092059|NCT00685399|158173753|FG000|Treatment Period 2|Lack of Efficacy|0|||
49092060|NCT00685399|158173754|FG001|Treatment Period 2|Lack of Efficacy|10|||
49092061|NCT00685399|158173755|FG002|Treatment Period 2|Lack of Efficacy|2|||
49092062|NCT00685399|158173756|FG003|Treatment Period 2|Lack of Efficacy|0|||
49092063|NCT00685399|158173757|FG004|Treatment Period 2|Lack of Efficacy|0|||
49092064|NCT00685399|158173758|FG005|Treatment Period 2|Lack of Efficacy|1|||
49092065|NCT00685399|158173759|FG006|Treatment Period 2|Lack of Efficacy|0|||
49092066|NCT00685399|158173760|FG007|Treatment Period 2|Lack of Efficacy|0|||
49092067|NCT00685399|158173753|FG000|Extension|Administrative Issues|0|||
49092068|NCT00685399|158173754|FG001|Extension|Administrative Issues|0|||
49092069|NCT00685399|158173755|FG002|Extension|Administrative Issues|0|||
49092070|NCT00685399|158173756|FG003|Extension|Administrative Issues|1|||
49092071|NCT00685399|158173757|FG004|Extension|Administrative Issues|0|||
49092072|NCT00685399|158173758|FG005|Extension|Administrative Issues|0|||
49092073|NCT00685399|158173759|FG006|Extension|Administrative Issues|0|||
49092074|NCT00685399|158173760|FG007|Extension|Administrative Issues|0|||
49092075|NCT00685399|158173753|FG000|Extension|Withdrawal by Subject|0|||
49092076|NCT00685399|158173754|FG001|Extension|Withdrawal by Subject|0|||
49092077|NCT00685399|158173755|FG002|Extension|Withdrawal by Subject|0|||
49092078|NCT00685399|158173756|FG003|Extension|Withdrawal by Subject|1|||
49092079|NCT00685399|158173757|FG004|Extension|Withdrawal by Subject|0|||
49092080|NCT00685399|158173758|FG005|Extension|Withdrawal by Subject|0|||
49092081|NCT00685399|158173759|FG006|Extension|Withdrawal by Subject|0|||
49092082|NCT00685399|158173760|FG007|Extension|Withdrawal by Subject|0|||
49092083|NCT00685399|158173753|FG000|Extension|Protocol Violation|0|||
49092084|NCT00685399|158173754|FG001|Extension|Protocol Violation|0|||
49092085|NCT00685399|158173755|FG002|Extension|Protocol Violation|0|||
49092086|NCT00685399|158173756|FG003|Extension|Protocol Violation|1|||
49092087|NCT00685399|158173757|FG004|Extension|Protocol Violation|0|||
49092088|NCT00685399|158173758|FG005|Extension|Protocol Violation|0|||
49092089|NCT00685399|158173759|FG006|Extension|Protocol Violation|0|||
49092090|NCT00685399|158173760|FG007|Extension|Protocol Violation|0|||
49092091|NCT00685399|158173753|FG000|Extension|Lack of Efficacy|0|||
49092092|NCT00685399|158173754|FG001|Extension|Lack of Efficacy|0|||
49092093|NCT00685399|158173755|FG002|Extension|Lack of Efficacy|0|||
49092094|NCT00685399|158173756|FG003|Extension|Lack of Efficacy|2|||
49092095|NCT00685399|158173757|FG004|Extension|Lack of Efficacy|0|||
49092096|NCT00685399|158173758|FG005|Extension|Lack of Efficacy|0|||
49092097|NCT00685399|158173759|FG006|Extension|Lack of Efficacy|0|||
49092098|NCT00685399|158173760|FG007|Extension|Lack of Efficacy|0|||
49092099|NCT00685399|158173753|FG000|Extension|Adverse Event|0|||
49092100|NCT00685399|158173754|FG001|Extension|Adverse Event|0|||
49092101|NCT00685399|158173755|FG002|Extension|Adverse Event|0|||
49092102|NCT00685399|158173756|FG003|Extension|Adverse Event|2|||
49092103|NCT00685399|158173757|FG004|Extension|Adverse Event|0|||
49092104|NCT00685399|158173758|FG005|Extension|Adverse Event|0|||
49092105|NCT00685399|158173759|FG006|Extension|Adverse Event|0|||
49092106|NCT00685399|158173760|FG007|Extension|Adverse Event|0|||
49092107|NCT01326104|158173764|FG000|Overall Study|progressed prior to vaccine|0|||
49092108|NCT01326104|158173765|FG001|Overall Study|progressed prior to vaccine|2|||
49092109|NCT01326104|158173764|FG000|Overall Study|unable to make vaccine|0|||
49092110|NCT01326104|158173765|FG001|Overall Study|unable to make vaccine|2|||
49092111|NCT04478695|158173766|FG000|Overall Study|Death|1|||
49092112|NCT04478695|158173767|FG001|Overall Study|Death|0|||
49092113|NCT01136356|158173771|FG000|First 18-day Withdrawal|Withdrawal by Subject|3|||
49092114|NCT01136356|158173772|FG001|First 18-day Withdrawal|Withdrawal by Subject|0|||
49092115|NCT01136356|158173771|FG000|First 18-day Withdrawal|Physician Decision|1|||
49092116|NCT01136356|158173772|FG001|First 18-day Withdrawal|Physician Decision|0|||
49092117|NCT01136356|158173771|FG000|Second 18-day Withdrawal|Withdrawal by Subject|0|||
49092118|NCT01136356|158173772|FG001|Second 18-day Withdrawal|Withdrawal by Subject|1|||
49092119|NCT02347774|158173773|FG000|Study Participation|Lost to Follow-up|3|||
49092120|NCT02347774|158173774|FG001|Study Participation|Lost to Follow-up|6|||
49092121|NCT02347774|158173775|FG002|Study Participation|Lost to Follow-up|2|||
49092122|NCT02347774|158173773|FG000|Study Participation|Withdrawal by Subject|8|||
49092123|NCT02347774|158173774|FG001|Study Participation|Withdrawal by Subject|9|||
49092124|NCT02347774|158173775|FG002|Study Participation|Withdrawal by Subject|15|||
49092125|NCT02347774|158173773|FG000|Study Participation|Adverse Event|1|||
49092126|NCT02347774|158173774|FG001|Study Participation|Adverse Event|4|||
49092127|NCT02347774|158173775|FG002|Study Participation|Adverse Event|6|||
49092128|NCT02347774|158173773|FG000|Study Participation|withdrew consent|1|||
49092129|NCT02347774|158173774|FG001|Study Participation|withdrew consent|1|||
49092130|NCT02347774|158173775|FG002|Study Participation|withdrew consent|1|||
49092131|NCT02347774|158173773|FG000|Study Participation|Met Prolonged QT criteria|1|||
49092132|NCT02347774|158173774|FG001|Study Participation|Met Prolonged QT criteria|0|||
49092133|NCT02347774|158173775|FG002|Study Participation|Met Prolonged QT criteria|0|||
49092134|NCT02347774|158173773|FG000|Study Participation|non-compliance with study drug|0|||
49092135|NCT02347774|158173774|FG001|Study Participation|non-compliance with study drug|1|||
49092136|NCT02347774|158173775|FG002|Study Participation|non-compliance with study drug|0|||
49092137|NCT02347774|158173773|FG000|Study Participation|incarceration|1|||
49092138|NCT02347774|158173774|FG001|Study Participation|incarceration|0|||
49092139|NCT02347774|158173775|FG002|Study Participation|incarceration|0|||
49092140|NCT02347774|158173773|FG000|Study Participation|randomized in error|0|||
49092141|NCT02347774|158173774|FG001|Study Participation|randomized in error|0|||
49092142|NCT02347774|158173775|FG002|Study Participation|randomized in error|1|||
49092143|NCT02347774|158173773|FG000|On Study Treatment|Adverse Event|9|||
49092144|NCT02347774|158173774|FG001|On Study Treatment|Adverse Event|15|||
49092145|NCT02347774|158173775|FG002|On Study Treatment|Adverse Event|19|||
49092146|NCT02347774|158173773|FG000|On Study Treatment|Lack of Efficacy|3|||
49092147|NCT02347774|158173774|FG001|On Study Treatment|Lack of Efficacy|0|||
49092148|NCT02347774|158173775|FG002|On Study Treatment|Lack of Efficacy|2|||
49092149|NCT02347774|158173773|FG000|On Study Treatment|non-complicance with study medication|0|||
49092150|NCT02347774|158173774|FG001|On Study Treatment|non-complicance with study medication|2|||
49092151|NCT02347774|158173775|FG002|On Study Treatment|non-complicance with study medication|0|||
49092152|NCT02347774|158173773|FG000|On Study Treatment|Protocol Violation|0|||
49092153|NCT02347774|158173774|FG001|On Study Treatment|Protocol Violation|0|||
49092154|NCT02347774|158173775|FG002|On Study Treatment|Protocol Violation|1|||
49092155|NCT02347774|158173773|FG000|On Study Treatment|withdrew consent|9|||
49092156|NCT02347774|158173774|FG001|On Study Treatment|withdrew consent|8|||
49092157|NCT02347774|158173775|FG002|On Study Treatment|withdrew consent|12|||
49092158|NCT02347774|158173773|FG000|On Study Treatment|Lost to Follow-up|2|||
49092159|NCT02347774|158173774|FG001|On Study Treatment|Lost to Follow-up|6|||
49092160|NCT02347774|158173775|FG002|On Study Treatment|Lost to Follow-up|1|||
49092161|NCT02347774|158173773|FG000|On Study Treatment|Met Prolonged QT criteria|1|||
49092162|NCT02347774|158173774|FG001|On Study Treatment|Met Prolonged QT criteria|0|||
49092163|NCT02347774|158173775|FG002|On Study Treatment|Met Prolonged QT criteria|0|||
49092164|NCT02347774|158173773|FG000|On Study Treatment|ranomized in error|0|||
49092165|NCT02347774|158173774|FG001|On Study Treatment|ranomized in error|0|||
49092166|NCT02347774|158173775|FG002|On Study Treatment|ranomized in error|1|||
49092167|NCT00927862|158173776|FG000|Overall Study|Missing data needed for endpt analyses|27|||
49092168|NCT00927862|158173777|FG001|Overall Study|Missing data needed for endpt analyses|45|||
49092169|NCT03259425|158173787|FG000|Overall Study|Disease progression to an extent that didn't allow surgery|1|||
49092170|NCT04112043|158173788|FG000|Overall Study|Withdrawal by Subject|1|||
49092171|NCT04112043|158173789|FG001|Overall Study|Withdrawal by Subject|1|||
49092172|NCT04112043|158173790|FG002|Overall Study|Withdrawal by Subject|1|||
49092173|NCT04112043|158173788|FG000|Overall Study|Taking NR supplement|1|||
49092174|NCT04112043|158173789|FG001|Overall Study|Taking NR supplement|0|||
49092175|NCT04112043|158173790|FG002|Overall Study|Taking NR supplement|0|||
49092176|NCT04112043|158173788|FG000|Overall Study|Adverse Event|0|||
49092177|NCT04112043|158173789|FG001|Overall Study|Adverse Event|1|||
49092178|NCT04112043|158173790|FG002|Overall Study|Adverse Event|0|||
49092179|NCT04157296|158173791|FG000|Overall Study|Withdrawal by Subject|0|||
49092180|NCT04157296|158173792|FG001|Overall Study|Withdrawal by Subject|1|||
49092181|NCT04157296|158173791|FG000|Overall Study|Did not obtain second fMRI.|0|||
49092182|NCT04157296|158173792|FG001|Overall Study|Did not obtain second fMRI.|1|||
49092183|NCT04157296|158173791|FG000|Overall Study|MRI failed/no second fMRI|0|||
49092184|NCT04157296|158173792|FG001|Overall Study|MRI failed/no second fMRI|1|||
49092185|NCT02237196|158173793|FG000|Overall Study|Adverse Event|0|||
49092186|NCT02237196|158173794|FG001|Overall Study|Adverse Event|1|||
49092187|NCT02237196|158173795|FG002|Overall Study|Adverse Event|1|||
49092188|NCT02237196|158173796|FG003|Overall Study|Adverse Event|0|||
49092189|NCT02237196|158173793|FG000|Overall Study|Lost to Follow-up|4|||
49092190|NCT02237196|158173794|FG001|Overall Study|Lost to Follow-up|2|||
49092191|NCT02237196|158173795|FG002|Overall Study|Lost to Follow-up|4|||
49092192|NCT02237196|158173796|FG003|Overall Study|Lost to Follow-up|6|||
49092193|NCT02237196|158173793|FG000|Overall Study|Physician Decision|2|||
49092194|NCT02237196|158173794|FG001|Overall Study|Physician Decision|0|||
49092195|NCT02237196|158173795|FG002|Overall Study|Physician Decision|0|||
49092196|NCT02237196|158173796|FG003|Overall Study|Physician Decision|1|||
49092197|NCT02237196|158173793|FG000|Overall Study|Pregnancy|0|||
49092198|NCT02237196|158173794|FG001|Overall Study|Pregnancy|0|||
49092199|NCT02237196|158173795|FG002|Overall Study|Pregnancy|1|||
49092200|NCT02237196|158173796|FG003|Overall Study|Pregnancy|1|||
49092201|NCT02237196|158173793|FG000|Overall Study|Withdrawal by Subject|1|||
49092202|NCT02237196|158173794|FG001|Overall Study|Withdrawal by Subject|1|||
49092203|NCT02237196|158173795|FG002|Overall Study|Withdrawal by Subject|4|||
49092204|NCT02237196|158173796|FG003|Overall Study|Withdrawal by Subject|1|||
49092205|NCT02237196|158173793|FG000|Overall Study|Site Error|1|||
49092206|NCT02237196|158173794|FG001|Overall Study|Site Error|2|||
49092207|NCT02237196|158173795|FG002|Overall Study|Site Error|0|||
49092208|NCT02237196|158173796|FG003|Overall Study|Site Error|2|||
49092209|NCT01387516|158173805|FG000|Overall Study|Lost to Follow-up|4|||
49092210|NCT01387516|158173806|FG001|Overall Study|Lost to Follow-up|4|||
49092211|NCT01387516|158173807|FG002|Overall Study|Lost to Follow-up|2|||
49092212|NCT01387516|158173808|FG003|Overall Study|Lost to Follow-up|3|||
49092213|NCT01387516|158173805|FG000|Overall Study|Withdrawal by Subject|1|||
49092214|NCT01387516|158173806|FG001|Overall Study|Withdrawal by Subject|1|||
49092215|NCT01387516|158173807|FG002|Overall Study|Withdrawal by Subject|2|||
49092216|NCT01387516|158173808|FG003|Overall Study|Withdrawal by Subject|0|||
49092217|NCT01387516|158173805|FG000|Overall Study|Death|0|||
49092218|NCT01387516|158173806|FG001|Overall Study|Death|0|||
49092219|NCT01387516|158173807|FG002|Overall Study|Death|0|||
49092220|NCT01387516|158173808|FG003|Overall Study|Death|1|||
49092221|NCT02564900|158173811|FG000|Dose Escalation|Progressive disease per RECIST|2|||
49092222|NCT02564900|158173812|FG001|Dose Escalation|Progressive disease per RECIST|3|||
49092223|NCT02564900|158173813|FG002|Dose Escalation|Progressive disease per RECIST|3|||
49092224|NCT02564900|158173814|FG003|Dose Escalation|Progressive disease per RECIST|3|||
49092225|NCT02564900|158173815|FG004|Dose Escalation|Progressive disease per RECIST|3|||
49092226|NCT02564900|158173816|FG005|Dose Escalation|Progressive disease per RECIST|1|||
49092227|NCT02564900|158173817|FG006|Dose Escalation|Progressive disease per RECIST|0|||
49092228|NCT02564900|158173818|FG007|Dose Escalation|Progressive disease per RECIST|0|||
49092229|NCT02564900|158173819|FG008|Dose Escalation|Progressive disease per RECIST|0|||
49092230|NCT02564900|158173820|FG009|Dose Escalation|Progressive disease per RECIST|0|||
49092231|NCT02564900|158173821|FG010|Dose Escalation|Progressive disease per RECIST|0|||
49092232|NCT02564900|158173822|FG011|Dose Escalation|Progressive disease per RECIST|0|||
49092233|NCT02564900|158173823|FG012|Dose Escalation|Progressive disease per RECIST|0|||
49092234|NCT02564900|158173824|FG013|Dose Escalation|Progressive disease per RECIST|0|||
49092235|NCT02564900|158173825|FG014|Dose Escalation|Progressive disease per RECIST|0|||
49092236|NCT02564900|158173811|FG000|Dose Escalation|Ongoing|1|||
49092237|NCT02564900|158173812|FG001|Dose Escalation|Ongoing|0|||
49092238|NCT02564900|158173813|FG002|Dose Escalation|Ongoing|0|||
49092239|NCT02564900|158173814|FG003|Dose Escalation|Ongoing|2|||
49092240|NCT02564900|158173815|FG004|Dose Escalation|Ongoing|2|||
49092241|NCT02564900|158173816|FG005|Dose Escalation|Ongoing|2|||
49092242|NCT02564900|158173817|FG006|Dose Escalation|Ongoing|0|||
49092243|NCT02564900|158173818|FG007|Dose Escalation|Ongoing|0|||
49092244|NCT02564900|158173819|FG008|Dose Escalation|Ongoing|0|||
49092245|NCT02564900|158173820|FG009|Dose Escalation|Ongoing|0|||
49092246|NCT02564900|158173821|FG010|Dose Escalation|Ongoing|0|||
49092247|NCT02564900|158173822|FG011|Dose Escalation|Ongoing|0|||
49092248|NCT02564900|158173823|FG012|Dose Escalation|Ongoing|0|||
49092249|NCT02564900|158173824|FG013|Dose Escalation|Ongoing|0|||
49092250|NCT02564900|158173825|FG014|Dose Escalation|Ongoing|0|||
49092251|NCT02564900|158173811|FG000|Dose Escalation|Adverse Event|0|||
49092252|NCT02564900|158173812|FG001|Dose Escalation|Adverse Event|0|||
49092253|NCT02564900|158173813|FG002|Dose Escalation|Adverse Event|0|||
49092254|NCT02564900|158173814|FG003|Dose Escalation|Adverse Event|1|||
49092255|NCT02564900|158173815|FG004|Dose Escalation|Adverse Event|1|||
49092256|NCT02564900|158173816|FG005|Dose Escalation|Adverse Event|3|||
49092257|NCT02564900|158173817|FG006|Dose Escalation|Adverse Event|0|||
49092258|NCT02564900|158173818|FG007|Dose Escalation|Adverse Event|0|||
49092259|NCT02564900|158173819|FG008|Dose Escalation|Adverse Event|0|||
49092260|NCT02564900|158173820|FG009|Dose Escalation|Adverse Event|0|||
49092261|NCT02564900|158173821|FG010|Dose Escalation|Adverse Event|0|||
49092262|NCT02564900|158173822|FG011|Dose Escalation|Adverse Event|0|||
49092263|NCT02564900|158173823|FG012|Dose Escalation|Adverse Event|0|||
49092264|NCT02564900|158173824|FG013|Dose Escalation|Adverse Event|0|||
49092265|NCT02564900|158173825|FG014|Dose Escalation|Adverse Event|0|||
49092266|NCT02564900|158173811|FG000|Dose Expansion|Progressive disease per RECIST|0|||
49092267|NCT02564900|158173812|FG001|Dose Expansion|Progressive disease per RECIST|0|||
49092268|NCT02564900|158173813|FG002|Dose Expansion|Progressive disease per RECIST|0|||
49092269|NCT02564900|158173814|FG003|Dose Expansion|Progressive disease per RECIST|0|||
49092270|NCT02564900|158173815|FG004|Dose Expansion|Progressive disease per RECIST|0|||
49092271|NCT02564900|158173816|FG005|Dose Expansion|Progressive disease per RECIST|0|||
49092272|NCT02564900|158173817|FG006|Dose Expansion|Progressive disease per RECIST|19|||
49092273|NCT02564900|158173818|FG007|Dose Expansion|Progressive disease per RECIST|17|||
49092274|NCT02564900|158173819|FG008|Dose Expansion|Progressive disease per RECIST|8|||
49092275|NCT02564900|158173820|FG009|Dose Expansion|Progressive disease per RECIST|16|||
49092276|NCT02564900|158173821|FG010|Dose Expansion|Progressive disease per RECIST|13|||
49092277|NCT02564900|158173822|FG011|Dose Expansion|Progressive disease per RECIST|19|||
49092278|NCT02564900|158173823|FG012|Dose Expansion|Progressive disease per RECIST|10|||
49092279|NCT02564900|158173824|FG013|Dose Expansion|Progressive disease per RECIST|13|||
49092280|NCT02564900|158173825|FG014|Dose Expansion|Progressive disease per RECIST|11|||
49092281|NCT02564900|158173811|FG000|Dose Expansion|Clinical progression|0|||
49092282|NCT02564900|158173812|FG001|Dose Expansion|Clinical progression|0|||
49092283|NCT02564900|158173813|FG002|Dose Expansion|Clinical progression|0|||
49092284|NCT02564900|158173814|FG003|Dose Expansion|Clinical progression|0|||
49092285|NCT02564900|158173815|FG004|Dose Expansion|Clinical progression|0|||
49092286|NCT02564900|158173816|FG005|Dose Expansion|Clinical progression|0|||
49092287|NCT02564900|158173817|FG006|Dose Expansion|Clinical progression|5|||
49092288|NCT02564900|158173818|FG007|Dose Expansion|Clinical progression|12|||
49092289|NCT02564900|158173819|FG008|Dose Expansion|Clinical progression|0|||
49092290|NCT02564900|158173820|FG009|Dose Expansion|Clinical progression|3|||
49092291|NCT02564900|158173821|FG010|Dose Expansion|Clinical progression|2|||
49092292|NCT02564900|158173822|FG011|Dose Expansion|Clinical progression|0|||
49092293|NCT02564900|158173823|FG012|Dose Expansion|Clinical progression|1|||
49092294|NCT02564900|158173824|FG013|Dose Expansion|Clinical progression|3|||
49092295|NCT02564900|158173825|FG014|Dose Expansion|Clinical progression|1|||
49092296|NCT02564900|158173811|FG000|Dose Expansion|Adverse Event|0|||
49092297|NCT02564900|158173812|FG001|Dose Expansion|Adverse Event|0|||
49092298|NCT02564900|158173813|FG002|Dose Expansion|Adverse Event|0|||
49092299|NCT02564900|158173814|FG003|Dose Expansion|Adverse Event|0|||
49092300|NCT02564900|158173815|FG004|Dose Expansion|Adverse Event|0|||
49092301|NCT02564900|158173816|FG005|Dose Expansion|Adverse Event|0|||
49092302|NCT02564900|158173817|FG006|Dose Expansion|Adverse Event|9|||
49092303|NCT02564900|158173818|FG007|Dose Expansion|Adverse Event|22|||
49092304|NCT02564900|158173819|FG008|Dose Expansion|Adverse Event|0|||
49092305|NCT02564900|158173820|FG009|Dose Expansion|Adverse Event|11|||
49092306|NCT02564900|158173821|FG010|Dose Expansion|Adverse Event|0|||
49092307|NCT02564900|158173822|FG011|Dose Expansion|Adverse Event|5|||
49092308|NCT02564900|158173823|FG012|Dose Expansion|Adverse Event|2|||
49092309|NCT02564900|158173824|FG013|Dose Expansion|Adverse Event|2|||
49092310|NCT02564900|158173825|FG014|Dose Expansion|Adverse Event|1|||
49092311|NCT02564900|158173811|FG000|Dose Expansion|Ongoing|0|||
49092312|NCT02564900|158173812|FG001|Dose Expansion|Ongoing|0|||
49092313|NCT02564900|158173813|FG002|Dose Expansion|Ongoing|0|||
49092314|NCT02564900|158173814|FG003|Dose Expansion|Ongoing|0|||
49092315|NCT02564900|158173815|FG004|Dose Expansion|Ongoing|0|||
49092316|NCT02564900|158173816|FG005|Dose Expansion|Ongoing|0|||
49092317|NCT02564900|158173817|FG006|Dose Expansion|Ongoing|9|||
49092318|NCT02564900|158173818|FG007|Dose Expansion|Ongoing|10|||
49092319|NCT02564900|158173819|FG008|Dose Expansion|Ongoing|11|||
49092320|NCT02564900|158173820|FG009|Dose Expansion|Ongoing|3|||
49092321|NCT02564900|158173821|FG010|Dose Expansion|Ongoing|0|||
49092322|NCT02564900|158173822|FG011|Dose Expansion|Ongoing|0|||
49092323|NCT02564900|158173823|FG012|Dose Expansion|Ongoing|4|||
49092324|NCT02564900|158173824|FG013|Dose Expansion|Ongoing|0|||
49092325|NCT02564900|158173825|FG014|Dose Expansion|Ongoing|6|||
49092326|NCT02564900|158173811|FG000|Dose Expansion|Death|0|||
49092327|NCT02564900|158173812|FG001|Dose Expansion|Death|0|||
49092328|NCT02564900|158173813|FG002|Dose Expansion|Death|0|||
49092329|NCT02564900|158173814|FG003|Dose Expansion|Death|0|||
49092330|NCT02564900|158173815|FG004|Dose Expansion|Death|0|||
49092331|NCT02564900|158173816|FG005|Dose Expansion|Death|0|||
49092332|NCT02564900|158173817|FG006|Dose Expansion|Death|1|||
49092333|NCT02564900|158173818|FG007|Dose Expansion|Death|0|||
49092334|NCT02564900|158173819|FG008|Dose Expansion|Death|0|||
49092335|NCT02564900|158173820|FG009|Dose Expansion|Death|0|||
49092336|NCT02564900|158173821|FG010|Dose Expansion|Death|1|||
49092337|NCT02564900|158173822|FG011|Dose Expansion|Death|0|||
49092338|NCT02564900|158173823|FG012|Dose Expansion|Death|1|||
49092339|NCT02564900|158173824|FG013|Dose Expansion|Death|1|||
49092340|NCT02564900|158173825|FG014|Dose Expansion|Death|0|||
49092341|NCT02564900|158173811|FG000|Dose Expansion|Withdrawal by Subject|0|||
49092342|NCT02564900|158173812|FG001|Dose Expansion|Withdrawal by Subject|0|||
49092343|NCT02564900|158173813|FG002|Dose Expansion|Withdrawal by Subject|0|||
49092344|NCT02564900|158173814|FG003|Dose Expansion|Withdrawal by Subject|0|||
49092345|NCT02564900|158173815|FG004|Dose Expansion|Withdrawal by Subject|0|||
49092346|NCT02564900|158173816|FG005|Dose Expansion|Withdrawal by Subject|0|||
49092347|NCT02564900|158173817|FG006|Dose Expansion|Withdrawal by Subject|4|||
49092348|NCT02564900|158173818|FG007|Dose Expansion|Withdrawal by Subject|0|||
49092349|NCT02564900|158173819|FG008|Dose Expansion|Withdrawal by Subject|0|||
49092350|NCT02564900|158173820|FG009|Dose Expansion|Withdrawal by Subject|0|||
49092351|NCT02564900|158173821|FG010|Dose Expansion|Withdrawal by Subject|1|||
49092352|NCT02564900|158173822|FG011|Dose Expansion|Withdrawal by Subject|0|||
49092353|NCT02564900|158173823|FG012|Dose Expansion|Withdrawal by Subject|0|||
49092354|NCT02564900|158173824|FG013|Dose Expansion|Withdrawal by Subject|1|||
49092355|NCT02564900|158173825|FG014|Dose Expansion|Withdrawal by Subject|1|||
49092356|NCT02564900|158173811|FG000|Dose Expansion|Other|0|||
49092357|NCT02564900|158173812|FG001|Dose Expansion|Other|0|||
49092358|NCT02564900|158173813|FG002|Dose Expansion|Other|0|||
49092359|NCT02564900|158173814|FG003|Dose Expansion|Other|0|||
49092360|NCT02564900|158173815|FG004|Dose Expansion|Other|0|||
49092361|NCT02564900|158173816|FG005|Dose Expansion|Other|0|||
49092362|NCT02564900|158173817|FG006|Dose Expansion|Other|1|||
49092363|NCT02564900|158173818|FG007|Dose Expansion|Other|0|||
49092364|NCT02564900|158173819|FG008|Dose Expansion|Other|1|||
49092365|NCT02564900|158173820|FG009|Dose Expansion|Other|0|||
49092366|NCT02564900|158173821|FG010|Dose Expansion|Other|0|||
49092367|NCT02564900|158173822|FG011|Dose Expansion|Other|0|||
49092368|NCT02564900|158173823|FG012|Dose Expansion|Other|0|||
49092369|NCT02564900|158173824|FG013|Dose Expansion|Other|0|||
49092370|NCT02564900|158173825|FG014|Dose Expansion|Other|1|||
49092371|NCT02564900|158173811|FG000|Dose Expansion|Did not receive treatment|0|||
49092372|NCT02564900|158173812|FG001|Dose Expansion|Did not receive treatment|0|||
49092373|NCT02564900|158173813|FG002|Dose Expansion|Did not receive treatment|0|||
49092374|NCT02564900|158173814|FG003|Dose Expansion|Did not receive treatment|0|||
49092375|NCT02564900|158173815|FG004|Dose Expansion|Did not receive treatment|0|||
49092376|NCT02564900|158173816|FG005|Dose Expansion|Did not receive treatment|0|||
49092377|NCT02564900|158173817|FG006|Dose Expansion|Did not receive treatment|1|||
49092378|NCT02564900|158173818|FG007|Dose Expansion|Did not receive treatment|1|||
49092379|NCT02564900|158173819|FG008|Dose Expansion|Did not receive treatment|0|||
49092380|NCT02564900|158173820|FG009|Dose Expansion|Did not receive treatment|0|||
49092381|NCT02564900|158173821|FG010|Dose Expansion|Did not receive treatment|0|||
49092382|NCT02564900|158173822|FG011|Dose Expansion|Did not receive treatment|0|||
49092383|NCT02564900|158173823|FG012|Dose Expansion|Did not receive treatment|0|||
49092384|NCT02564900|158173824|FG013|Dose Expansion|Did not receive treatment|0|||
49092385|NCT02564900|158173825|FG014|Dose Expansion|Did not receive treatment|1|||
49092386|NCT02088905|158173826|FG000|Overall Study|Withdrawal by Subject|5|||
49092387|NCT02088905|158173827|FG001|Overall Study|Withdrawal by Subject|1|||
49092388|NCT00463047|158173828|FG000|Titration Period 1|Adverse Event|10|||
49092389|NCT00463047|158173829|FG001|Titration Period 1|Adverse Event|8|||
49092390|NCT00463047|158173828|FG000|Titration Period 1|Lack of Efficacy|10|||
49092391|NCT00463047|158173829|FG001|Titration Period 1|Lack of Efficacy|4|||
49092392|NCT00463047|158173828|FG000|Titration Period 1|Lost to Follow-up|2|||
49092393|NCT00463047|158173829|FG001|Titration Period 1|Lost to Follow-up|0|||
49092394|NCT00463047|158173828|FG000|Titration Period 1|Non-compliance with study medication|3|||
49092395|NCT00463047|158173829|FG001|Titration Period 1|Non-compliance with study medication|5|||
49092396|NCT00463047|158173828|FG000|Titration Period 1|Protocol Violation|5|||
49092397|NCT00463047|158173829|FG001|Titration Period 1|Protocol Violation|5|||
49092398|NCT00463047|158173828|FG000|Titration Period 1|Withdrawal by Subject|3|||
49092399|NCT00463047|158173829|FG001|Titration Period 1|Withdrawal by Subject|5|||
49092400|NCT00463047|158173828|FG000|Titration Period 1|Non-compliance procedures|4|||
49092401|NCT00463047|158173829|FG001|Titration Period 1|Non-compliance procedures|10|||
49092402|NCT00463047|158173828|FG000|Titration Period 1|Other|0|||
49092403|NCT00463047|158173829|FG001|Titration Period 1|Other|2|||
49092404|NCT00463047|158173828|FG000|Titration Period 2|Adverse Event|9|||
49092405|NCT00463047|158173829|FG001|Titration Period 2|Adverse Event|9|||
49092406|NCT00463047|158173828|FG000|Titration Period 2|Lack of Efficacy|6|||
49092407|NCT00463047|158173829|FG001|Titration Period 2|Lack of Efficacy|4|||
49092408|NCT00463047|158173828|FG000|Titration Period 2|Withdrawal by Subject|1|||
49092409|NCT00463047|158173829|FG001|Titration Period 2|Withdrawal by Subject|0|||
49092410|NCT00463047|158173828|FG000|Titration Period 2|Protocol Violation|2|||
49092411|NCT00463047|158173829|FG001|Titration Period 2|Protocol Violation|3|||
49092412|NCT00463047|158173828|FG000|Titration Period 2|Lost to Follow-up|1|||
49092413|NCT00463047|158173829|FG001|Titration Period 2|Lost to Follow-up|2|||
49092414|NCT00463047|158173828|FG000|Titration Period 2|Non-compliance study medication|4|||
49092415|NCT00463047|158173829|FG001|Titration Period 2|Non-compliance study medication|2|||
49092416|NCT00463047|158173828|FG000|Titration Period 2|Non-compliance procedures|4|||
49092417|NCT00463047|158173829|FG001|Titration Period 2|Non-compliance procedures|1|||
49092418|NCT00463047|158173828|FG000|Titration Period 2|Other|3|||
49092419|NCT00463047|158173829|FG001|Titration Period 2|Other|2|||
49092420|NCT00463047|158173828|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
49092421|NCT00463047|158173829|FG001|Double-Blind Treatment Period 1|Adverse Event|2|||
49092422|NCT00463047|158173828|FG000|Double-Blind Treatment Period 1|Protocol Violation|1|||
49092423|NCT00463047|158173829|FG001|Double-Blind Treatment Period 1|Protocol Violation|2|||
49092424|NCT00463047|158173828|FG000|Double-Blind Treatment Period 1|Non-compliance with procedures|1|||
49092425|NCT00463047|158173829|FG001|Double-Blind Treatment Period 1|Non-compliance with procedures|0|||
49092426|NCT00463047|158173828|FG000|Double-Blind Treatment Period 1|Other|1|||
49092427|NCT00463047|158173829|FG001|Double-Blind Treatment Period 1|Other|0|||
49092428|NCT00463047|158173828|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
49092429|NCT00463047|158173829|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
49092430|NCT00463047|158173828|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
49092431|NCT00463047|158173829|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
49092432|NCT00463047|158173828|FG000|Double-Blind Treatment Period 2|Non-compliance with procedures|1|||
49092433|NCT00463047|158173829|FG001|Double-Blind Treatment Period 2|Non-compliance with procedures|0|||
49092434|NCT00892151|158173830|FG000|Overall Study|Protocol Violation|1|||
49092435|NCT02693002|158173831|FG000|Overall Study|Withdrawal by Subject|1|||
49092436|NCT02693002|158173832|FG001|Overall Study|Withdrawal by Subject|0|||
49092437|NCT01355575|158173837|FG000|Overall Study|Withdrawal by Subject|2|||
49092438|NCT01046903|158173838|FG000|Overall Study|Lost to Follow-up|16|||
49092439|NCT01046903|158173838|FG000|Overall Study|Adverse Event|4|||
49092440|NCT01046903|158173838|FG000|Overall Study|Withdrawal by Subject|3|||
49092441|NCT01046903|158173838|FG000|Overall Study|Other|5|||
49092442|NCT05020665|158173840|FG000|Overall Study|Study terminated by Sponsor|5|||
49092443|NCT05020665|158173841|FG001|Overall Study|Study terminated by Sponsor|4|||
49092444|NCT05020665|158173840|FG000|Overall Study|Death|2|||
49092445|NCT05020665|158173841|FG001|Overall Study|Death|1|||
49092446|NCT05020665|158173840|FG000|Overall Study|Physician Decision|0|||
49092447|NCT05020665|158173841|FG001|Overall Study|Physician Decision|1|||
49092448|NCT05020665|158173840|FG000|Overall Study|Withdrawal by Subject|0|||
49092449|NCT05020665|158173841|FG001|Overall Study|Withdrawal by Subject|1|||
49092450|NCT05020665|158173840|FG000|Overall Study|Reason not specified|1|||
49092451|NCT05020665|158173841|FG001|Overall Study|Reason not specified|0|||
49092452|NCT01628198|158173842|FG000|Overall Study|Lost to Follow-up|7|||
49092453|NCT01628198|158173842|FG000|Overall Study|Withdrawal by Subject|10|||
49092454|NCT01628198|158173842|FG000|Overall Study|Screen failure|1|||
49092455|NCT00686829|158173843|FG000|Overall Study|Adverse Event|5|||
49092456|NCT00686829|158173843|FG000|Overall Study|Lack of Efficacy|6|||
49092457|NCT00686829|158173843|FG000|Overall Study|Lost to Follow-up|4|||
49092458|NCT00686829|158173843|FG000|Overall Study|Withdrawal by Subject|14|||
49092459|NCT00686829|158173843|FG000|Overall Study|Protocol Violation|3|||
49092460|NCT00686829|158173843|FG000|Overall Study|Sponsor discontinued VCV|47|||
49092461|NCT01827267|158173849|FG000|Overall Study|Did not receive study drug|1|||
49092462|NCT01827267|158173850|FG001|Overall Study|Did not receive study drug|1|||
49092463|NCT01827267|158173849|FG000|Overall Study|Physician Decision|1|||
49092464|NCT01827267|158173850|FG001|Overall Study|Physician Decision|0|||
49092465|NCT01827267|158173849|FG000|Overall Study|Disease Progression|1|||
49092466|NCT01827267|158173850|FG001|Overall Study|Disease Progression|1|||
49092467|NCT01827267|158173849|FG000|Overall Study|Sponsor Discontinued Study|2|||
49092468|NCT01827267|158173850|FG001|Overall Study|Sponsor Discontinued Study|8|||
49092469|NCT01827267|158173849|FG000|Overall Study|Still on study|0|||
49092470|NCT01827267|158173850|FG001|Overall Study|Still on study|2|||
49092471|NCT03226769|158173852|FG000|Overall Study|Withdrawal by Subject|0|||
49092472|NCT03226769|158173853|FG001|Overall Study|Withdrawal by Subject|1|||
49092473|NCT01262287|158175375|FG000|Overall Study|Lost to Follow-up|2|||
49092474|NCT01262287|158175376|FG001|Overall Study|Lost to Follow-up|1|||
49092475|NCT01323387|158175377|FG000|Overall Study|Withdrawal by Subject|41|||
49092476|NCT01323387|158175377|FG000|Overall Study|Radiographic Data Unavailable|1|||
49092477|NCT01323387|158175377|FG000|Overall Study|Revision|14|||
49092478|NCT01323387|158175377|FG000|Overall Study|Protocol Violation|12|||
49092479|NCT01323387|158175377|FG000|Overall Study|Randomized but Never Treated|16|||
49092480|NCT01209949|158175378|FG000|Overall Study|Lost to Follow-up|3|||
49092481|NCT00940823|158175390|FG000|Overall Study|Death|8|||
49092482|NCT00940823|158175391|FG001|Overall Study|Death|12|||
49092483|NCT00940823|158175390|FG000|Overall Study|Lost to Follow-up|27|||
49092484|NCT00940823|158175391|FG001|Overall Study|Lost to Follow-up|20|||
49092485|NCT01295671|158175395|FG000|Overall Study|Lost to Follow-up|4|||
49092486|NCT01295671|158175396|FG001|Overall Study|Lost to Follow-up|6|||
49092487|NCT01295671|158175397|FG002|Overall Study|Lost to Follow-up|3|||
49092488|NCT01295671|158175395|FG000|Overall Study|Withdrawal by Subject|3|||
49092489|NCT01295671|158175396|FG001|Overall Study|Withdrawal by Subject|1|||
49092490|NCT01295671|158175397|FG002|Overall Study|Withdrawal by Subject|0|||
49092491|NCT02860130|158175398|FG000|Overall Study|Adverse Event|2|||
49092492|NCT02860130|158175399|FG001|Overall Study|Adverse Event|3|||
49092493|NCT02860130|158175398|FG000|Overall Study|Protocol Violation|1|||
49092494|NCT02860130|158175399|FG001|Overall Study|Protocol Violation|1|||
49092495|NCT02860130|158175398|FG000|Overall Study|Withdrawal by Subject|0|||
49092496|NCT02860130|158175399|FG001|Overall Study|Withdrawal by Subject|2|||
49092497|NCT02860130|158175398|FG000|Overall Study|Physician Decision|2|||
49092498|NCT02860130|158175399|FG001|Overall Study|Physician Decision|2|||
49092499|NCT02860130|158175398|FG000|Overall Study|Other|2|||
49092500|NCT02860130|158175399|FG001|Overall Study|Other|1|||
49092501|NCT03625466|158175400|FG000|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
49092502|NCT03625466|158175401|FG001|Placebo-controlled Period (48 Weeks)|Adverse Event|1|||
49092503|NCT03625466|158175402|FG002|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
49092504|NCT03625466|158175400|FG000|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
49092505|NCT03625466|158175401|FG001|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
49092506|NCT03625466|158175402|FG002|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
49092507|NCT03625466|158175400|FG000|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
49092508|NCT03625466|158175401|FG001|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
49092509|NCT03625466|158175402|FG002|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
49092510|NCT00729612|158175403|FG000|Overall Study|Non evaluable for response|10|||
49092511|NCT01754129|158175404|FG000|Overall Study|Death|13|||
49092512|NCT01754129|158175404|FG000|Overall Study|Duodopa discontinuation|9|||
49092513|NCT01754129|158175404|FG000|Overall Study|Lost to Follow-up|7|||
49092514|NCT01754129|158175404|FG000|Overall Study|Withdrew consent|1|||
49092515|NCT01754129|158175404|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
49092516|NCT04134767|158175405|FG000|Overall Study|Death|0|||
49092517|NCT04134767|158175406|FG001|Overall Study|Death|1|||
49092518|NCT04134767|158175405|FG000|Overall Study|Removed for harassing staff|0|||
49092519|NCT04134767|158175406|FG001|Overall Study|Removed for harassing staff|1|||
49092520|NCT04134767|158175405|FG000|Overall Study|Lost to Follow-up|44|||
49092521|NCT04134767|158175406|FG001|Overall Study|Lost to Follow-up|40|||
49092522|NCT01637922|158175407|FG000|Overall Study|Adverse Event|0|||
49092523|NCT01637922|158175408|FG001|Overall Study|Adverse Event|1|||
49092524|NCT01637922|158175407|FG000|Overall Study|Protocol Violation|0|||
49092525|NCT01637922|158175408|FG001|Overall Study|Protocol Violation|1|||
49092526|NCT01637922|158175407|FG000|Overall Study|Withdrawal by Subject|0|||
49092527|NCT01637922|158175408|FG001|Overall Study|Withdrawal by Subject|3|||
49092528|NCT01637922|158175407|FG000|Overall Study|Lost to Follow-up|2|||
49092529|NCT01637922|158175408|FG001|Overall Study|Lost to Follow-up|0|||
49092530|NCT01750697|158175409|FG000|Overall Study|Transferred Back to Local Hospital|1|||
49092531|NCT01750697|158175409|FG000|Overall Study|Physician and Family Decision|1|||
49092532|NCT01750697|158175409|FG000|Overall Study|Transferred to Adult Services|5|||
49092533|NCT01750697|158175409|FG000|Overall Study|Physician Decision|1|||
49092534|NCT01750697|158175409|FG000|Overall Study|Withdrawal by Subject|1|||
49092535|NCT02589626|158175410|FG000|Overall Study|Other than the reason specified|1|||
49092536|NCT02589626|158175411|FG001|Overall Study|Other than the reason specified|0|||
49092537|NCT02589626|158175410|FG000|Overall Study|Withdrawal by Subject|1|||
49092538|NCT02589626|158175411|FG001|Overall Study|Withdrawal by Subject|1|||
49092539|NCT02589626|158175410|FG000|Overall Study|Adverse Event|1|||
49092540|NCT02589626|158175411|FG001|Overall Study|Adverse Event|1|||
49092541|NCT03645395|158175412|FG000|Part 1 (Up to 6 Months)|Adverse Event|1|||
49092542|NCT03645395|158175413|FG001|Part 1 (Up to 6 Months)|Adverse Event|0|||
49092543|NCT03645395|158175414|FG002|Part 1 (Up to 6 Months)|Adverse Event|0|||
49092544|NCT03645395|158175415|FG003|Part 1 (Up to 6 Months)|Adverse Event|0|||
49092545|NCT03645395|158175412|FG000|Part 1 (Up to 6 Months)|Disease Progression|0|||
49092546|NCT03645395|158175413|FG001|Part 1 (Up to 6 Months)|Disease Progression|1|||
49092547|NCT03645395|158175414|FG002|Part 1 (Up to 6 Months)|Disease Progression|0|||
49092548|NCT03645395|158175415|FG003|Part 1 (Up to 6 Months)|Disease Progression|0|||
49092549|NCT03645395|158175412|FG000|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
49092550|NCT03645395|158175413|FG001|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
49092551|NCT03645395|158175414|FG002|Part 1 (Up to 6 Months)|Withdrawal by Subject|1|||
49092552|NCT03645395|158175415|FG003|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
49092553|NCT03645395|158175412|FG000|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|1|||
49092554|NCT03645395|158175413|FG001|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
49092555|NCT03645395|158175414|FG002|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
49092556|NCT03645395|158175415|FG003|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|0|||
49092557|NCT01057810|158175416|FG000|Overall Study|Disease progression|156|||
49092558|NCT01057810|158175417|FG001|Overall Study|Disease progression|197|||
49092559|NCT01057810|158175416|FG000|Overall Study|Study drug toxicity|5|||
49092560|NCT01057810|158175417|FG001|Overall Study|Study drug toxicity|114|||
49092561|NCT01057810|158175416|FG000|Overall Study|Adverse event unrelated to study drug|13|||
49092562|NCT01057810|158175417|FG001|Overall Study|Adverse event unrelated to study drug|29|||
49092563|NCT01057810|158175416|FG000|Overall Study|Withdrawal by Subject|10|||
49092564|NCT01057810|158175417|FG001|Overall Study|Withdrawal by Subject|25|||
49092565|NCT01057810|158175416|FG000|Overall Study|Death|2|||
49092566|NCT01057810|158175417|FG001|Overall Study|Death|12|||
49092567|NCT01057810|158175416|FG000|Overall Study|Maximum clinical benefit|5|||
49092568|NCT01057810|158175417|FG001|Overall Study|Maximum clinical benefit|5|||
49092569|NCT01057810|158175416|FG000|Overall Study|Poor/non-compliance|0|||
49092570|NCT01057810|158175417|FG001|Overall Study|Poor/non-compliance|1|||
49092571|NCT01057810|158175416|FG000|Overall Study|No longer met study criteria|0|||
49092572|NCT01057810|158175417|FG001|Overall Study|No longer met study criteria|1|||
49092573|NCT01057810|158175416|FG000|Overall Study|Other|7|||
49092574|NCT01057810|158175417|FG001|Overall Study|Other|14|||
49092575|NCT04075682|158175422|FG000|Overall Study|Lost to Follow-up|5|||
49092576|NCT04075682|158175423|FG001|Overall Study|Lost to Follow-up|5|||
49092577|NCT04075682|158175424|FG002|Overall Study|Lost to Follow-up|2|||
49092578|NCT04075682|158175425|FG003|Overall Study|Lost to Follow-up|2|||
49092579|NCT04075682|158175422|FG000|Overall Study|Withdrawal by Subject|1|||
49092580|NCT04075682|158175423|FG001|Overall Study|Withdrawal by Subject|0|||
49092581|NCT04075682|158175424|FG002|Overall Study|Withdrawal by Subject|1|||
49092582|NCT04075682|158175425|FG003|Overall Study|Withdrawal by Subject|0|||
49092583|NCT04075682|158175422|FG000|Overall Study|Protocol Violation|0|||
49092584|NCT04075682|158175423|FG001|Overall Study|Protocol Violation|1|||
49092585|NCT04075682|158175424|FG002|Overall Study|Protocol Violation|1|||
49092586|NCT04075682|158175425|FG003|Overall Study|Protocol Violation|0|||
49092587|NCT04075682|158175422|FG000|Overall Study|Not literate enough to self-administer study surveys|1|||
49092588|NCT04075682|158175423|FG001|Overall Study|Not literate enough to self-administer study surveys|0|||
49092589|NCT04075682|158175424|FG002|Overall Study|Not literate enough to self-administer study surveys|0|||
49092590|NCT04075682|158175425|FG003|Overall Study|Not literate enough to self-administer study surveys|0|||
49092591|NCT04075682|158175422|FG000|Overall Study|Lost study phone the first day of study participation|0|||
49092592|NCT04075682|158175423|FG001|Overall Study|Lost study phone the first day of study participation|1|||
49092593|NCT04075682|158175424|FG002|Overall Study|Lost study phone the first day of study participation|0|||
49092594|NCT04075682|158175425|FG003|Overall Study|Lost study phone the first day of study participation|0|||
49092595|NCT00862823|158175429|FG000|First Intervention|Withdrawal by Subject|1|||
49092596|NCT00862823|158175430|FG001|First Intervention|Withdrawal by Subject|1|||
49092597|NCT00887315|158175431|FG000|Overall Study|Study termination|7|||
49092598|NCT00887315|158175432|FG001|Overall Study|Study termination|4|||
49092599|NCT03363776|158175436|FG000|Overall Study|Progressive disease|2|||
49092600|NCT03363776|158175437|FG001|Overall Study|Progressive disease|3|||
49092601|NCT03363776|158175438|FG002|Overall Study|Progressive disease|1|||
49092602|NCT03363776|158175436|FG000|Overall Study|Study drug toxicity|0|||
49092603|NCT03363776|158175437|FG001|Overall Study|Study drug toxicity|0|||
49092604|NCT03363776|158175438|FG002|Overall Study|Study drug toxicity|1|||
49092605|NCT03363776|158175436|FG000|Overall Study|Death|1|||
49092606|NCT03363776|158175437|FG001|Overall Study|Death|0|||
49092607|NCT03363776|158175438|FG002|Overall Study|Death|0|||
49092608|NCT00619892|158175439|FG000|Overall Study|Adverse Event|3|||
49092609|NCT00619892|158175440|FG001|Overall Study|Adverse Event|0|||
49092610|NCT00619892|158175439|FG000|Overall Study|Lost to Follow-up|0|||
49092611|NCT00619892|158175440|FG001|Overall Study|Lost to Follow-up|1|||
49092612|NCT00619892|158175439|FG000|Overall Study|Intercurrent illness|0|||
49092613|NCT00619892|158175440|FG001|Overall Study|Intercurrent illness|1|||
49092614|NCT00379080|158175441|FG000|Overall Study|Withdrawal by Subject|0|||
49092615|NCT00379080|158175442|FG001|Overall Study|Withdrawal by Subject|4|||
49092616|NCT00379080|158175443|FG002|Overall Study|Withdrawal by Subject|0|||
49092617|NCT01562782|158175444|FG000|Overall Study|Withdrawal by Subject|3|||
49092618|NCT01562782|158175445|FG001|Overall Study|Withdrawal by Subject|3|||
49092619|NCT01562782|158175444|FG000|Overall Study|screen failure|1|||
49092620|NCT01562782|158175445|FG001|Overall Study|screen failure|2|||
49092621|NCT00857896|158175456|FG000|Baseline to Week 4|Withdrawal by Subject|1|||
49092622|NCT01028014|158175457|FG000|Overall Study|Lost to Follow-up|1|||
49092623|NCT01028014|158175458|FG001|Overall Study|Lost to Follow-up|2|||
49092624|NCT01028014|158175459|FG002|Overall Study|Lost to Follow-up|0|||
49092625|NCT01028014|158175460|FG003|Overall Study|Lost to Follow-up|1|||
49092626|NCT01028014|158175461|FG004|Overall Study|Lost to Follow-up|1|||
49092627|NCT01028014|158175462|FG005|Overall Study|Lost to Follow-up|2|||
49092628|NCT02780713|158175465|FG000|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
49092629|NCT02780713|158175466|FG001|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
49092630|NCT02780713|158175467|FG002|Period 3: Variant B (100mg)|Withdrawal by Subject|2|||
49092631|NCT02780713|158175468|FG003|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
49092632|NCT02780713|158175469|FG004|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
49092633|NCT03617770|158175471|FG000|Overall Study|Lost to Follow-up|1|||
49092634|NCT03617770|158175472|FG001|Overall Study|Lost to Follow-up|0|||
49092635|NCT01931475|158175473|FG000|Period 1: Double-Blind Treatment Phase|Adverse Event|20|||
49092636|NCT01931475|158175474|FG001|Period 1: Double-Blind Treatment Phase|Adverse Event|10|||
49092637|NCT01931475|158175473|FG000|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1|||
49092638|NCT01931475|158175474|FG001|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0|||
49092639|NCT01931475|158175473|FG000|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16|||
49092640|NCT01931475|158175474|FG001|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12|||
49092641|NCT01931475|158175473|FG000|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2|||
49092642|NCT01931475|158175474|FG001|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3|||
49092643|NCT01931475|158175473|FG000|Period 1: Double-Blind Treatment Phase|Physician Decision|0|||
49092644|NCT01931475|158175474|FG001|Period 1: Double-Blind Treatment Phase|Physician Decision|1|||
49092645|NCT01931475|158175473|FG000|Period 2: Extension Treatment Phase|Adverse Event|0|||
49092646|NCT01931475|158175474|FG001|Period 2: Extension Treatment Phase|Adverse Event|8|||
49092647|NCT01931475|158175473|FG000|Period 2: Extension Treatment Phase|Protocol Violation|1|||
49092648|NCT01931475|158175474|FG001|Period 2: Extension Treatment Phase|Protocol Violation|0|||
49092649|NCT01931475|158175473|FG000|Period 2: Extension Treatment Phase|Withdrawal by Subject|0|||
49092650|NCT01931475|158175474|FG001|Period 2: Extension Treatment Phase|Withdrawal by Subject|9|||
49092651|NCT01931475|158175473|FG000|Period 2: Extension Treatment Phase|Physician Decision|1|||
49092652|NCT01931475|158175474|FG001|Period 2: Extension Treatment Phase|Physician Decision|1|||
49092653|NCT01931475|158175473|FG000|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1|||
49092654|NCT01931475|158175474|FG001|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0|||
49092655|NCT01931475|158175473|FG000|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
49092656|NCT01931475|158175474|FG001|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
49092657|NCT01540487|158175477|FG000|Overall Study|Protocol Violation|1|||
49092658|NCT01540487|158175478|FG001|Overall Study|Protocol Violation|0|||
49092659|NCT03991299|158175479|FG000|Overall Study|Study closed, sponsor decision|3|||
49092660|NCT03991299|158175479|FG000|Overall Study|Withdrawal by Subject|1|||
49092661|NCT01091662|158175480|FG000|Overall Study|Adverse Event|1|||
49092662|NCT01091662|158175481|FG001|Overall Study|Adverse Event|9|||
49092663|NCT01091662|158175480|FG000|Overall Study|Physician Decision|1|||
49092664|NCT01091662|158175481|FG001|Overall Study|Physician Decision|1|||
49092665|NCT01091662|158175480|FG000|Overall Study|Withdrawal by Subject|7|||
49092666|NCT01091662|158175481|FG001|Overall Study|Withdrawal by Subject|6|||
49092667|NCT01091662|158175480|FG000|Overall Study|met exit criteria|7|||
49092668|NCT01091662|158175481|FG001|Overall Study|met exit criteria|13|||
49092669|NCT01091662|158175480|FG000|Overall Study|met exclusion criteria|1|||
49092670|NCT01091662|158175481|FG001|Overall Study|met exclusion criteria|0|||
49092671|NCT01091662|158175480|FG000|Overall Study|Lost to Follow-up|0|||
49092672|NCT01091662|158175481|FG001|Overall Study|Lost to Follow-up|1|||
49092673|NCT01091662|158175480|FG000|Overall Study|Pregnancy|0|||
49092674|NCT01091662|158175481|FG001|Overall Study|Pregnancy|1|||
49092675|NCT01091662|158175480|FG000|Overall Study|Protocol Violation|0|||
49092676|NCT01091662|158175481|FG001|Overall Study|Protocol Violation|2|||
49092677|NCT01091662|158175480|FG000|Overall Study|unable to swallow capsule|0|||
49092678|NCT01091662|158175481|FG001|Overall Study|unable to swallow capsule|1|||
49092679|NCT02417064|158175482|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|1|||
49092680|NCT02417064|158175483|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|7|||
49092681|NCT02417064|158175484|FG002|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
49092682|NCT02417064|158175482|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
49092683|NCT02417064|158175483|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
49092684|NCT02417064|158175484|FG002|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0|||
49092685|NCT02417064|158175482|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
49092686|NCT02417064|158175483|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
49092687|NCT02417064|158175484|FG002|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
49092688|NCT02417064|158175482|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2|||
49092689|NCT02417064|158175483|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
49092690|NCT02417064|158175484|FG002|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
49092691|NCT02417064|158175482|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
49092692|NCT02417064|158175483|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5|||
49092693|NCT02417064|158175484|FG002|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
49092694|NCT02417064|158175482|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
49092695|NCT02417064|158175483|FG001|Double-blind Induction Phase (4 Weeks)|Other|4|||
49092696|NCT02417064|158175484|FG002|Double-blind Induction Phase (4 Weeks)|Other|2|||
49092697|NCT02417064|158175482|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|0|||
49092698|NCT02417064|158175483|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|2|||
49092699|NCT02417064|158175484|FG002|Follow-up Phase (24 Weeks)|Lost to Follow-up|1|||
49092700|NCT02417064|158175482|FG000|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
49092701|NCT02417064|158175483|FG001|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
49092702|NCT02417064|158175484|FG002|Follow-up Phase (24 Weeks)|Protocol Violation|1|||
49092703|NCT02417064|158175482|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
49092704|NCT02417064|158175483|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9|||
49092705|NCT02417064|158175484|FG002|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2|||
49092706|NCT02417064|158175482|FG000|Follow-up Phase (24 Weeks)|PI Decision|34|||
49092707|NCT02417064|158175483|FG001|Follow-up Phase (24 Weeks)|PI Decision|29|||
49092708|NCT02417064|158175484|FG002|Follow-up Phase (24 Weeks)|PI Decision|44|||
49092709|NCT02417064|158175482|FG000|Follow-up Phase (24 Weeks)|Other|2|||
49092710|NCT02417064|158175483|FG001|Follow-up Phase (24 Weeks)|Other|2|||
49092711|NCT02417064|158175484|FG002|Follow-up Phase (24 Weeks)|Other|3|||
49092712|NCT02477332|158175490|FG000|Overall Study|Adverse Event|0|||
49092713|NCT02477332|158175491|FG001|Overall Study|Adverse Event|1|||
49092714|NCT02477332|158175492|FG002|Overall Study|Adverse Event|1|||
49092715|NCT02477332|158175493|FG003|Overall Study|Adverse Event|2|||
49092716|NCT02477332|158175494|FG004|Overall Study|Adverse Event|1|||
49092717|NCT02477332|158175495|FG005|Overall Study|Adverse Event|2|||
49092718|NCT02477332|158175490|FG000|Overall Study|Lack of Efficacy|1|||
49092719|NCT02477332|158175491|FG001|Overall Study|Lack of Efficacy|2|||
49092720|NCT02477332|158175492|FG002|Overall Study|Lack of Efficacy|1|||
49092721|NCT02477332|158175493|FG003|Overall Study|Lack of Efficacy|2|||
49092722|NCT02477332|158175494|FG004|Overall Study|Lack of Efficacy|1|||
49092723|NCT02477332|158175495|FG005|Overall Study|Lack of Efficacy|1|||
49092724|NCT02477332|158175490|FG000|Overall Study|Non-compliance with study treatment|0|||
49092725|NCT02477332|158175491|FG001|Overall Study|Non-compliance with study treatment|1|||
49092726|NCT02477332|158175492|FG002|Overall Study|Non-compliance with study treatment|2|||
49092727|NCT02477332|158175493|FG003|Overall Study|Non-compliance with study treatment|0|||
49092728|NCT02477332|158175494|FG004|Overall Study|Non-compliance with study treatment|0|||
49092729|NCT02477332|158175495|FG005|Overall Study|Non-compliance with study treatment|0|||
49092730|NCT02477332|158175490|FG000|Overall Study|Pregnancy|0|||
49092731|NCT02477332|158175491|FG001|Overall Study|Pregnancy|0|||
49092732|NCT02477332|158175492|FG002|Overall Study|Pregnancy|0|||
49092733|NCT02477332|158175493|FG003|Overall Study|Pregnancy|1|||
49092734|NCT02477332|158175494|FG004|Overall Study|Pregnancy|0|||
49092735|NCT02477332|158175495|FG005|Overall Study|Pregnancy|0|||
49092736|NCT02477332|158175490|FG000|Overall Study|Protocol Violation|2|||
49092737|NCT02477332|158175491|FG001|Overall Study|Protocol Violation|0|||
49092738|NCT02477332|158175492|FG002|Overall Study|Protocol Violation|3|||
49092739|NCT02477332|158175493|FG003|Overall Study|Protocol Violation|3|||
49092740|NCT02477332|158175494|FG004|Overall Study|Protocol Violation|1|||
49092741|NCT02477332|158175495|FG005|Overall Study|Protocol Violation|1|||
49092742|NCT02477332|158175490|FG000|Overall Study|Technical problems|0|||
49092743|NCT02477332|158175491|FG001|Overall Study|Technical problems|0|||
49092744|NCT02477332|158175492|FG002|Overall Study|Technical problems|1|||
49092745|NCT02477332|158175493|FG003|Overall Study|Technical problems|0|||
49092746|NCT02477332|158175494|FG004|Overall Study|Technical problems|0|||
49092747|NCT02477332|158175495|FG005|Overall Study|Technical problems|0|||
49092748|NCT02477332|158175490|FG000|Overall Study|Lost to Follow-up|0|||
49092749|NCT02477332|158175491|FG001|Overall Study|Lost to Follow-up|0|||
49092750|NCT02477332|158175492|FG002|Overall Study|Lost to Follow-up|2|||
49092751|NCT02477332|158175493|FG003|Overall Study|Lost to Follow-up|0|||
49092752|NCT02477332|158175494|FG004|Overall Study|Lost to Follow-up|0|||
49092753|NCT02477332|158175495|FG005|Overall Study|Lost to Follow-up|0|||
49092754|NCT02477332|158175490|FG000|Overall Study|Physician Decision|0|||
49092755|NCT02477332|158175491|FG001|Overall Study|Physician Decision|0|||
49092756|NCT02477332|158175492|FG002|Overall Study|Physician Decision|1|||
49092757|NCT02477332|158175493|FG003|Overall Study|Physician Decision|3|||
49092758|NCT02477332|158175494|FG004|Overall Study|Physician Decision|0|||
49092759|NCT02477332|158175495|FG005|Overall Study|Physician Decision|1|||
49092760|NCT02477332|158175490|FG000|Overall Study|Withdrawal by Subject|0|||
49092761|NCT02477332|158175491|FG001|Overall Study|Withdrawal by Subject|3|||
49092762|NCT02477332|158175492|FG002|Overall Study|Withdrawal by Subject|1|||
49092763|NCT02477332|158175493|FG003|Overall Study|Withdrawal by Subject|2|||
49092764|NCT02477332|158175494|FG004|Overall Study|Withdrawal by Subject|1|||
49092765|NCT02477332|158175495|FG005|Overall Study|Withdrawal by Subject|0|||
49092766|NCT02549287|158175496|FG000|Overall Study|Lost to Follow-up|65|||
49092767|NCT02549287|158175497|FG001|Overall Study|Lost to Follow-up|26|||
49092768|NCT02549287|158175496|FG000|Overall Study|Withdrawal by Subject|15|||
49092769|NCT02549287|158175497|FG001|Overall Study|Withdrawal by Subject|6|||
49092770|NCT03793842|158175498|FG000|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|0|||
49092771|NCT03793842|158175499|FG001|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|1|||
49092772|NCT03793842|158175498|FG000|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|2|||
49092773|NCT03793842|158175499|FG001|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|1|||
49092774|NCT04657198|158175500|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|1|||
49092775|NCT04657198|158175501|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
49092776|NCT04657198|158175502|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
49092777|NCT04087720|158175503|FG000|Overall Study|Withdrawal by Subject|2|||
49092778|NCT04087720|158175503|FG000|Overall Study|Withdrawal by Subject - COVID-19 Concerns|3|||
49092779|NCT02418585|158175511|FG000|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
49092780|NCT02418585|158175512|FG001|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
49092781|NCT02418585|158175511|FG000|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
49092782|NCT02418585|158175512|FG001|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
49092783|NCT02418585|158175511|FG000|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4|||
49092784|NCT02418585|158175512|FG001|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7|||
49092785|NCT02418585|158175511|FG000|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2|||
49092786|NCT02418585|158175512|FG001|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0|||
49092787|NCT02418585|158175511|FG000|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9|||
49092788|NCT02418585|158175512|FG001|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1|||
49092789|NCT02418585|158175511|FG000|Double Blind (DB) Phase (4 Weeks)|Other|0|||
49092790|NCT02418585|158175512|FG001|Double Blind (DB) Phase (4 Weeks)|Other|1|||
49092791|NCT02418585|158175511|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
49092792|NCT02418585|158175512|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
49092793|NCT02418585|158175511|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6|||
49092794|NCT02418585|158175512|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
49092795|NCT02418585|158175511|FG000|Follow-up Phase (24 Weeks)|Investigator Decision|6|||
49092796|NCT02418585|158175512|FG001|Follow-up Phase (24 Weeks)|Investigator Decision|17|||
49092797|NCT02418585|158175511|FG000|Follow-up Phase (24 Weeks)|Other|3|||
49092798|NCT02418585|158175512|FG001|Follow-up Phase (24 Weeks)|Other|2|||
49092799|NCT01732640|158175513|FG000|Overall Study|Adverse Event|0|||
49092800|NCT01732640|158175514|FG001|Overall Study|Adverse Event|1|||
49092801|NCT01732640|158175513|FG000|Overall Study|Death|0|||
49092802|NCT01732640|158175514|FG001|Overall Study|Death|1|||
49092803|NCT00877487|158175521|FG000|Open-label Treatment Phase|Adverse Event|1|||
49092804|NCT00877487|158175522|FG001|Open-label Treatment Phase|Adverse Event|0|||
49092805|NCT00877487|158175521|FG000|Open-label Treatment Phase|Protocol Violation|3|||
49092806|NCT00877487|158175522|FG001|Open-label Treatment Phase|Protocol Violation|0|||
49092807|NCT00877487|158175521|FG000|Open-label Treatment Phase|Withdrawal by Subject|1|||
49092808|NCT00877487|158175522|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
49092809|NCT00877487|158175521|FG000|Open-label Treatment Phase|Lost to Follow-up|1|||
49092810|NCT00877487|158175522|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
49092811|NCT00877487|158175521|FG000|Open-label Treatment Phase|Out of country for business|1|||
49092812|NCT00877487|158175522|FG001|Open-label Treatment Phase|Out of country for business|0|||
49092813|NCT00877487|158175521|FG000|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5|||
49092814|NCT00877487|158175522|FG001|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45|||
49092815|NCT00877487|158175521|FG000|Double-blind Randomized Withdrawal Phase|Adverse Event|0|||
49092816|NCT00877487|158175522|FG001|Double-blind Randomized Withdrawal Phase|Adverse Event|1|||
49092817|NCT00877487|158175521|FG000|Double-blind Randomized Withdrawal Phase|Protocol Violation|0|||
49092818|NCT00877487|158175522|FG001|Double-blind Randomized Withdrawal Phase|Protocol Violation|1|||
49092819|NCT00877487|158175521|FG000|Double-blind Randomized Withdrawal Phase|Moved out of state|1|||
49092820|NCT00877487|158175522|FG001|Double-blind Randomized Withdrawal Phase|Moved out of state|0|||
49092821|NCT02640677|158175523|FG000|Overall Study|Lost to Follow-up|1|||
49092822|NCT02640677|158175523|FG000|Overall Study|Withdrawal by Subject|1|||
49092823|NCT02841280|158175524|FG000|Overall Study|Adverse Event|2|||
49092824|NCT02841280|158175525|FG001|Overall Study|Adverse Event|1|||
49092825|NCT02841280|158175524|FG000|Overall Study|Death|1|||
49092826|NCT02841280|158175525|FG001|Overall Study|Death|0|||
49092827|NCT02841280|158175524|FG000|Overall Study|Lost to Follow-up|2|||
49092828|NCT02841280|158175525|FG001|Overall Study|Lost to Follow-up|2|||
49092829|NCT02841280|158175524|FG000|Overall Study|Withdrawal by Subject|7|||
49092830|NCT02841280|158175525|FG001|Overall Study|Withdrawal by Subject|3|||
49092831|NCT02841280|158175524|FG000|Overall Study|Stop Point: BP above threshold|2|||
49092832|NCT02841280|158175525|FG001|Overall Study|Stop Point: BP above threshold|0|||
49092833|NCT03070002|158175526|FG000|Follow up for 2 Years|Death|1|||
49092834|NCT04999163|158175529|FG000|Overall Study|Surgery completed at hospital not participating in the study.|1|||
49092835|NCT04999163|158175530|FG001|Overall Study|Surgery completed at hospital not participating in the study.|0|||
49092836|NCT04999163|158175529|FG000|Overall Study|Study enrollment stopped prior to implant.|1|||
49092837|NCT04999163|158175530|FG001|Overall Study|Study enrollment stopped prior to implant.|0|||
49092838|NCT04999163|158175529|FG000|Overall Study|Withdrawal by Subject|1|||
49092839|NCT04999163|158175530|FG001|Overall Study|Withdrawal by Subject|0|||
49092840|NCT01294696|158175531|FG000|Overall Study|Screening failures|7|||
49092841|NCT01294696|158175531|FG000|Overall Study|Protocol Violation|8|||
49092842|NCT01294696|158175531|FG000|Overall Study|Missing BPI Response|7|||
49092843|NCT01294696|158175531|FG000|Overall Study|Site closure|52|||
49092844|NCT00803790|158177087|FG000|Period 1|Adverse Event|0|||
49092845|NCT00803790|158177088|FG001|Period 1|Adverse Event|1|||
49092846|NCT00803790|158177089|FG002|Period 1|Adverse Event|0|||
49092847|NCT00803790|158177090|FG003|Period 1|Adverse Event|0|||
49092848|NCT00803790|158177087|FG000|Period 1|Lost to Follow-up|1|||
49092849|NCT00803790|158177088|FG001|Period 1|Lost to Follow-up|2|||
49092850|NCT00803790|158177089|FG002|Period 1|Lost to Follow-up|0|||
49092851|NCT00803790|158177090|FG003|Period 1|Lost to Follow-up|0|||
49092852|NCT00803790|158177087|FG000|Period 1|Withdrawal by Subject|8|||
49092853|NCT00803790|158177088|FG001|Period 1|Withdrawal by Subject|6|||
49092854|NCT00803790|158177089|FG002|Period 1|Withdrawal by Subject|0|||
49092855|NCT00803790|158177090|FG003|Period 1|Withdrawal by Subject|0|||
49092856|NCT00803790|158177087|FG000|Period 1|positive drug screen or personal reasons|0|||
49092857|NCT00803790|158177088|FG001|Period 1|positive drug screen or personal reasons|3|||
49092858|NCT00803790|158177089|FG002|Period 1|positive drug screen or personal reasons|0|||
49092859|NCT00803790|158177090|FG003|Period 1|positive drug screen or personal reasons|4|||
49092860|NCT00803790|158177087|FG000|Period 1|Protocol Violation|0|||
49092861|NCT00803790|158177088|FG001|Period 1|Protocol Violation|0|||
49092862|NCT00803790|158177089|FG002|Period 1|Protocol Violation|1|||
49092863|NCT00803790|158177090|FG003|Period 1|Protocol Violation|0|||
49092864|NCT00803790|158177087|FG000|Period 2|Adverse Event|0|||
49092865|NCT00803790|158177088|FG001|Period 2|Adverse Event|0|||
49092866|NCT00803790|158177089|FG002|Period 2|Adverse Event|1|||
49092867|NCT00803790|158177090|FG003|Period 2|Adverse Event|1|||
49092868|NCT00803790|158177087|FG000|Period 2|Withdrawal by Subject|1|||
49092869|NCT00803790|158177088|FG001|Period 2|Withdrawal by Subject|0|||
49092870|NCT00803790|158177089|FG002|Period 2|Withdrawal by Subject|0|||
49092871|NCT00803790|158177090|FG003|Period 2|Withdrawal by Subject|0|||
49092872|NCT00803790|158177087|FG000|Period 2|Positive Drug Screen or Personal Reasons|1|||
49092873|NCT00803790|158177088|FG001|Period 2|Positive Drug Screen or Personal Reasons|0|||
49092874|NCT00803790|158177089|FG002|Period 2|Positive Drug Screen or Personal Reasons|0|||
49092875|NCT00803790|158177090|FG003|Period 2|Positive Drug Screen or Personal Reasons|0|||
49092876|NCT02395848|158177094|FG000|Overall Study|Lost to Follow-up|2|||
49092877|NCT02276560|158177095|FG000|Overall Study|Adverse Event|1|||
49092878|NCT02276560|158177096|FG001|Overall Study|Adverse Event|0|||
49092879|NCT02276560|158177097|FG002|Overall Study|Adverse Event|0|||
49092880|NCT00708552|158177098|FG000|Overall Study|Adverse Event|10|||
49092881|NCT00708552|158177099|FG001|Overall Study|Adverse Event|3|||
49092882|NCT00708552|158177100|FG002|Overall Study|Adverse Event|4|||
49092883|NCT00708552|158177101|FG003|Overall Study|Adverse Event|6|||
49092884|NCT00708552|158177098|FG000|Overall Study|Lack of Efficacy|0|||
49092885|NCT00708552|158177099|FG001|Overall Study|Lack of Efficacy|4|||
49092886|NCT00708552|158177100|FG002|Overall Study|Lack of Efficacy|1|||
49092887|NCT00708552|158177101|FG003|Overall Study|Lack of Efficacy|0|||
49092888|NCT00708552|158177098|FG000|Overall Study|Protocol Violation|0|||
49092889|NCT00708552|158177099|FG001|Overall Study|Protocol Violation|0|||
49092890|NCT00708552|158177100|FG002|Overall Study|Protocol Violation|2|||
49092891|NCT00708552|158177101|FG003|Overall Study|Protocol Violation|4|||
49092892|NCT00708552|158177098|FG000|Overall Study|Lost to Follow-up|4|||
49092893|NCT00708552|158177099|FG001|Overall Study|Lost to Follow-up|2|||
49092894|NCT00708552|158177100|FG002|Overall Study|Lost to Follow-up|0|||
49092895|NCT00708552|158177101|FG003|Overall Study|Lost to Follow-up|1|||
49092896|NCT00708552|158177098|FG000|Overall Study|Physician Decision|1|||
49092897|NCT00708552|158177099|FG001|Overall Study|Physician Decision|2|||
49092898|NCT00708552|158177100|FG002|Overall Study|Physician Decision|0|||
49092899|NCT00708552|158177101|FG003|Overall Study|Physician Decision|0|||
49092900|NCT00708552|158177098|FG000|Overall Study|Withdrawal by Subject|12|||
49092901|NCT00708552|158177099|FG001|Overall Study|Withdrawal by Subject|7|||
49092902|NCT00708552|158177100|FG002|Overall Study|Withdrawal by Subject|8|||
49092903|NCT00708552|158177101|FG003|Overall Study|Withdrawal by Subject|10|||
49092904|NCT02582242|158177102|FG000|Overall Study|Adverse Event|4|||
49092905|NCT02582242|158177103|FG001|Overall Study|Adverse Event|3|||
49092906|NCT02582242|158177102|FG000|Overall Study|Protocol Violation|3|||
49092907|NCT02582242|158177103|FG001|Overall Study|Protocol Violation|1|||
49092908|NCT02582242|158177102|FG000|Overall Study|Lost to Follow-up|0|||
49092909|NCT02582242|158177103|FG001|Overall Study|Lost to Follow-up|1|||
49092910|NCT02582242|158177102|FG000|Overall Study|Withdrawal by Subject|11|||
49092911|NCT02582242|158177103|FG001|Overall Study|Withdrawal by Subject|11|||
49092912|NCT02582242|158177102|FG000|Overall Study|Unclassified|2|||
49092913|NCT02582242|158177103|FG001|Overall Study|Unclassified|1|||
49092914|NCT02058537|158177104|FG000|Overall Study|Withdrawal by Subject|1|||
49092915|NCT00300885|158177105|FG000|Treatment|Adverse Event|134|||
49092916|NCT00300885|158177106|FG001|Treatment|Adverse Event|82|||
49092917|NCT00300885|158177105|FG000|Treatment|Death|20|||
49092918|NCT00300885|158177106|FG001|Treatment|Death|7|||
49092919|NCT00300885|158177105|FG000|Treatment|Lack of Efficacy|1|||
49092920|NCT00300885|158177106|FG001|Treatment|Lack of Efficacy|1|||
49092921|NCT00300885|158177105|FG000|Treatment|Lost to Follow-up|3|||
49092922|NCT00300885|158177106|FG001|Treatment|Lost to Follow-up|2|||
49092923|NCT00300885|158177105|FG000|Treatment|Physician Decision|4|||
49092924|NCT00300885|158177106|FG001|Treatment|Physician Decision|5|||
49092925|NCT00300885|158177105|FG000|Treatment|Protocol Violation|11|||
49092926|NCT00300885|158177106|FG001|Treatment|Protocol Violation|11|||
49092927|NCT00300885|158177105|FG000|Treatment|Withdrawal by Subject|26|||
49092928|NCT00300885|158177106|FG001|Treatment|Withdrawal by Subject|23|||
49092929|NCT00300885|158177105|FG000|Treatment|Disease progression|171|||
49092930|NCT00300885|158177106|FG001|Treatment|Disease progression|238|||
49092931|NCT00300885|158177105|FG000|Treatment|Random code broken (subject died)|0|||
49092932|NCT00300885|158177106|FG001|Treatment|Random code broken (subject died)|1|||
49092933|NCT00300885|158177105|FG000|Treatment|Non-compliant with study medication|3|||
49092934|NCT00300885|158177106|FG001|Treatment|Non-compliant with study medication|4|||
49092935|NCT00300885|158177105|FG000|Follow-up|Death|141|||
49092936|NCT00300885|158177106|FG001|Follow-up|Death|163|||
49092937|NCT00300885|158177105|FG000|Follow-up|Lost to Follow-up|11|||
49092938|NCT00300885|158177106|FG001|Follow-up|Lost to Follow-up|7|||
49092939|NCT00300885|158177105|FG000|Follow-up|Withdrawal by Subject|26|||
49092940|NCT00300885|158177106|FG001|Follow-up|Withdrawal by Subject|25|||
49092941|NCT00638404|158177107|FG000|Overall Study|Physician Decision|8|||
49092942|NCT00638404|158177108|FG001|Overall Study|Physician Decision|0|||
49092943|NCT04072575|158177109|FG000|Overall Study|Physician Decision|1|||
49092944|NCT04072575|158177109|FG000|Overall Study|Adverse Event|7|||
49092945|NCT04072575|158177109|FG000|Overall Study|Withdrawal by Subject|14|||
49092946|NCT04072575|158177109|FG000|Overall Study|Other|2|||
49092947|NCT00820248|158177112|FG000|Overall Study|No treated|4|||
49092948|NCT00820248|158177113|FG001|Overall Study|No treated|1|||
49092949|NCT00921557|158177114|FG000|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2|||
49092950|NCT00921557|158177115|FG001|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
49092951|NCT00921557|158177116|FG002|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
49092952|NCT00921557|158177114|FG000|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
49092953|NCT00921557|158177115|FG001|Weeks 48-96 (on Study Treatment)|Site Closure|1|||
49092954|NCT00921557|158177116|FG002|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
49092955|NCT00921557|158177114|FG000|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
49092956|NCT00921557|158177115|FG001|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
49092957|NCT00921557|158177116|FG002|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1|||
49092958|NCT00921557|158177114|FG000|Weeks 96-144 (Off Study Treatment)|Site closure|1|||
49092959|NCT00921557|158177115|FG001|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
49092960|NCT00921557|158177116|FG002|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
49092961|NCT00921557|158177114|FG000|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2|||
49092962|NCT00921557|158177115|FG001|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
49092963|NCT00921557|158177116|FG002|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
49092964|NCT00656292|158177117|FG000|Overall Study|Withdrawal by Subject|2|||
49092965|NCT00656292|158177118|FG001|Overall Study|Withdrawal by Subject|3|||
49092966|NCT00656292|158177117|FG000|Overall Study|Screen failure|1|||
49092967|NCT00656292|158177118|FG001|Overall Study|Screen failure|2|||
49092968|NCT00267969|158177119|FG000|Controlled Period|Adverse Event|6|||
49092969|NCT00267969|158177120|FG001|Controlled Period|Adverse Event|0|||
49092970|NCT00267969|158177121|FG002|Controlled Period|Adverse Event|2|||
49092971|NCT00267969|158177122|FG003|Controlled Period|Adverse Event|0|||
49092972|NCT00267969|158177123|FG004|Controlled Period|Adverse Event|0|||
49092973|NCT00267969|158177124|FG005|Controlled Period|Adverse Event|0|||
49092974|NCT00267969|158177125|FG006|Controlled Period|Adverse Event|0|||
49092975|NCT00267969|158177119|FG000|Controlled Period|Lack of Efficacy|3|||
49092976|NCT00267969|158177120|FG001|Controlled Period|Lack of Efficacy|0|||
49092977|NCT00267969|158177121|FG002|Controlled Period|Lack of Efficacy|1|||
49092978|NCT00267969|158177122|FG003|Controlled Period|Lack of Efficacy|0|||
49092979|NCT00267969|158177123|FG004|Controlled Period|Lack of Efficacy|0|||
49092980|NCT00267969|158177124|FG005|Controlled Period|Lack of Efficacy|0|||
49092981|NCT00267969|158177125|FG006|Controlled Period|Lack of Efficacy|0|||
49092982|NCT00267969|158177119|FG000|Controlled Period|Lost to Follow-up|1|||
49092983|NCT00267969|158177120|FG001|Controlled Period|Lost to Follow-up|0|||
49092984|NCT00267969|158177121|FG002|Controlled Period|Lost to Follow-up|1|||
49092985|NCT00267969|158177122|FG003|Controlled Period|Lost to Follow-up|0|||
49092986|NCT00267969|158177123|FG004|Controlled Period|Lost to Follow-up|0|||
49092987|NCT00267969|158177124|FG005|Controlled Period|Lost to Follow-up|0|||
49092988|NCT00267969|158177125|FG006|Controlled Period|Lost to Follow-up|0|||
49092989|NCT00267969|158177119|FG000|Controlled Period|Randomized but not treated|0|||
49092990|NCT00267969|158177120|FG001|Controlled Period|Randomized but not treated|0|||
49092991|NCT00267969|158177121|FG002|Controlled Period|Randomized but not treated|1|||
49092992|NCT00267969|158177122|FG003|Controlled Period|Randomized but not treated|0|||
49092993|NCT00267969|158177123|FG004|Controlled Period|Randomized but not treated|0|||
49092994|NCT00267969|158177124|FG005|Controlled Period|Randomized but not treated|0|||
49092995|NCT00267969|158177125|FG006|Controlled Period|Randomized but not treated|0|||
49092996|NCT00267969|158177119|FG000|Controlled Period|Other|2|||
49092997|NCT00267969|158177120|FG001|Controlled Period|Other|1|||
49092998|NCT00267969|158177121|FG002|Controlled Period|Other|6|||
49092999|NCT00267969|158177122|FG003|Controlled Period|Other|0|||
49093000|NCT00267969|158177123|FG004|Controlled Period|Other|0|||
49093001|NCT00267969|158177124|FG005|Controlled Period|Other|0|||
49093002|NCT00267969|158177125|FG006|Controlled Period|Other|0|||
49093003|NCT00267969|158177119|FG000|After Controlled Period|Adverse Event|0|||
49093004|NCT00267969|158177120|FG001|After Controlled Period|Adverse Event|0|||
49093005|NCT00267969|158177121|FG002|After Controlled Period|Adverse Event|0|||
49093006|NCT00267969|158177122|FG003|After Controlled Period|Adverse Event|7|||
49093007|NCT00267969|158177123|FG004|After Controlled Period|Adverse Event|8|||
49093008|NCT00267969|158177124|FG005|After Controlled Period|Adverse Event|23|||
49093009|NCT00267969|158177125|FG006|After Controlled Period|Adverse Event|21|||
49093010|NCT00267969|158177119|FG000|After Controlled Period|Death|0|||
49093011|NCT00267969|158177120|FG001|After Controlled Period|Death|0|||
49093012|NCT00267969|158177121|FG002|After Controlled Period|Death|0|||
49093013|NCT00267969|158177122|FG003|After Controlled Period|Death|1|||
49093014|NCT00267969|158177123|FG004|After Controlled Period|Death|2|||
49093015|NCT00267969|158177124|FG005|After Controlled Period|Death|0|||
49093016|NCT00267969|158177125|FG006|After Controlled Period|Death|1|||
49093017|NCT00267969|158177119|FG000|After Controlled Period|Lack of Efficacy|0|||
49093018|NCT00267969|158177120|FG001|After Controlled Period|Lack of Efficacy|0|||
49093019|NCT00267969|158177121|FG002|After Controlled Period|Lack of Efficacy|0|||
49093020|NCT00267969|158177122|FG003|After Controlled Period|Lack of Efficacy|10|||
49093021|NCT00267969|158177123|FG004|After Controlled Period|Lack of Efficacy|6|||
49093022|NCT00267969|158177124|FG005|After Controlled Period|Lack of Efficacy|28|||
49093023|NCT00267969|158177125|FG006|After Controlled Period|Lack of Efficacy|15|||
49093024|NCT00267969|158177119|FG000|After Controlled Period|Lost to Follow-up|0|||
49093025|NCT00267969|158177120|FG001|After Controlled Period|Lost to Follow-up|0|||
49093026|NCT00267969|158177121|FG002|After Controlled Period|Lost to Follow-up|0|||
49093027|NCT00267969|158177122|FG003|After Controlled Period|Lost to Follow-up|5|||
49093028|NCT00267969|158177123|FG004|After Controlled Period|Lost to Follow-up|8|||
49093029|NCT00267969|158177124|FG005|After Controlled Period|Lost to Follow-up|9|||
49093030|NCT00267969|158177125|FG006|After Controlled Period|Lost to Follow-up|10|||
49093031|NCT00267969|158177119|FG000|After Controlled Period|Other|0|||
49093032|NCT00267969|158177120|FG001|After Controlled Period|Other|0|||
49093033|NCT00267969|158177121|FG002|After Controlled Period|Other|0|||
49093034|NCT00267969|158177122|FG003|After Controlled Period|Other|13|||
49093035|NCT00267969|158177123|FG004|After Controlled Period|Other|11|||
49093036|NCT00267969|158177124|FG005|After Controlled Period|Other|22|||
49093037|NCT00267969|158177125|FG006|After Controlled Period|Other|25|||
49093038|NCT02993146|158177130|FG000|Overall Study|Withdrawal by Subject|0|||
49093039|NCT02993146|158177131|FG001|Overall Study|Withdrawal by Subject|0|||
49093040|NCT02993146|158177132|FG002|Overall Study|Withdrawal by Subject|1|||
49093041|NCT02993146|158177133|FG003|Overall Study|Withdrawal by Subject|1|||
49093042|NCT01289639|158177138|FG000|Overall Study|Lost to Follow-up|1|||
49093043|NCT01289639|158177139|FG001|Overall Study|Lost to Follow-up|0|||
49093044|NCT01289639|158177140|FG002|Overall Study|Lost to Follow-up|0|||
49093045|NCT01127451|158177141|FG000|Overall Study|Other|2|||
49093046|NCT01127451|158177142|FG001|Overall Study|Other|1|||
49093047|NCT01127451|158177141|FG000|Overall Study|Completed 1 Year Follow-up after last dose of study drug|14|||
49093048|NCT01127451|158177142|FG001|Overall Study|Completed 1 Year Follow-up after last dose of study drug|12|||
49093049|NCT01127451|158177141|FG000|Overall Study|Death|22|||
49093050|NCT01127451|158177142|FG001|Overall Study|Death|17|||
49093051|NCT01127451|158177141|FG000|Overall Study|Lost to Follow-up|3|||
49093052|NCT01127451|158177142|FG001|Overall Study|Lost to Follow-up|0|||
49093053|NCT01127451|158177141|FG000|Overall Study|Administrative Reason by Sponsor|2|||
49093054|NCT01127451|158177142|FG001|Overall Study|Administrative Reason by Sponsor|2|||
49093055|NCT02016105|158177143|FG000|TREATMENT PERIOD 1|Protocol Violation|2|||
49093056|NCT02016105|158177144|FG001|TREATMENT PERIOD 1|Protocol Violation|8|||
49093057|NCT02016105|158177145|FG002|TREATMENT PERIOD 1|Protocol Violation|0|||
49093058|NCT02016105|158177146|FG003|TREATMENT PERIOD 1|Protocol Violation|0|||
49093059|NCT02016105|158177147|FG004|TREATMENT PERIOD 1|Protocol Violation|0|||
49093060|NCT02016105|158177148|FG005|TREATMENT PERIOD 1|Protocol Violation|0|||
49093061|NCT02016105|158177143|FG000|TREATMENT PERIOD 1|Physician Decision|0|||
49093062|NCT02016105|158177144|FG001|TREATMENT PERIOD 1|Physician Decision|2|||
49093063|NCT02016105|158177145|FG002|TREATMENT PERIOD 1|Physician Decision|0|||
49093064|NCT02016105|158177146|FG003|TREATMENT PERIOD 1|Physician Decision|0|||
49093065|NCT02016105|158177147|FG004|TREATMENT PERIOD 1|Physician Decision|0|||
49093066|NCT02016105|158177148|FG005|TREATMENT PERIOD 1|Physician Decision|0|||
49093067|NCT02016105|158177143|FG000|TREATMENT PERIOD 1|Lack of Efficacy|4|||
49093068|NCT02016105|158177144|FG001|TREATMENT PERIOD 1|Lack of Efficacy|2|||
49093069|NCT02016105|158177145|FG002|TREATMENT PERIOD 1|Lack of Efficacy|0|||
49093070|NCT02016105|158177146|FG003|TREATMENT PERIOD 1|Lack of Efficacy|0|||
49093071|NCT02016105|158177147|FG004|TREATMENT PERIOD 1|Lack of Efficacy|0|||
49093072|NCT02016105|158177148|FG005|TREATMENT PERIOD 1|Lack of Efficacy|0|||
49093073|NCT02016105|158177143|FG000|TREATMENT PERIOD 1|Pregnancy|0|||
49093074|NCT02016105|158177144|FG001|TREATMENT PERIOD 1|Pregnancy|1|||
49093075|NCT02016105|158177145|FG002|TREATMENT PERIOD 1|Pregnancy|0|||
49093076|NCT02016105|158177146|FG003|TREATMENT PERIOD 1|Pregnancy|0|||
49093077|NCT02016105|158177147|FG004|TREATMENT PERIOD 1|Pregnancy|0|||
49093078|NCT02016105|158177148|FG005|TREATMENT PERIOD 1|Pregnancy|0|||
49093079|NCT02016105|158177143|FG000|TREATMENT PERIOD 1|Adverse Event|3|||
49093080|NCT02016105|158177144|FG001|TREATMENT PERIOD 1|Adverse Event|5|||
49093081|NCT02016105|158177145|FG002|TREATMENT PERIOD 1|Adverse Event|0|||
49093082|NCT02016105|158177146|FG003|TREATMENT PERIOD 1|Adverse Event|0|||
49093083|NCT02016105|158177147|FG004|TREATMENT PERIOD 1|Adverse Event|0|||
49093084|NCT02016105|158177148|FG005|TREATMENT PERIOD 1|Adverse Event|0|||
49093085|NCT02016105|158177143|FG000|TREATMENT PERIOD 1|Withdrawal by Subject|15|||
49093086|NCT02016105|158177144|FG001|TREATMENT PERIOD 1|Withdrawal by Subject|11|||
49093087|NCT02016105|158177145|FG002|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
49093088|NCT02016105|158177146|FG003|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
49093089|NCT02016105|158177147|FG004|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
49093090|NCT02016105|158177148|FG005|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
49093091|NCT02016105|158177143|FG000|TREATMENT PERIOD 1|Lost to Follow-up|6|||
49093092|NCT02016105|158177144|FG001|TREATMENT PERIOD 1|Lost to Follow-up|4|||
49093093|NCT02016105|158177145|FG002|TREATMENT PERIOD 1|Lost to Follow-up|0|||
49093094|NCT02016105|158177146|FG003|TREATMENT PERIOD 1|Lost to Follow-up|0|||
49093095|NCT02016105|158177147|FG004|TREATMENT PERIOD 1|Lost to Follow-up|0|||
49093096|NCT02016105|158177148|FG005|TREATMENT PERIOD 1|Lost to Follow-up|0|||
49093097|NCT02016105|158177143|FG000|TREATMENT PERIOD 2|Non compliance study medication|0|||
49093098|NCT02016105|158177144|FG001|TREATMENT PERIOD 2|Non compliance study medication|0|||
49093099|NCT02016105|158177145|FG002|TREATMENT PERIOD 2|Non compliance study medication|0|||
49093100|NCT02016105|158177146|FG003|TREATMENT PERIOD 2|Non compliance study medication|0|||
49093101|NCT02016105|158177147|FG004|TREATMENT PERIOD 2|Non compliance study medication|0|||
49093102|NCT02016105|158177148|FG005|TREATMENT PERIOD 2|Non compliance study medication|1|||
49093103|NCT02016105|158177143|FG000|TREATMENT PERIOD 2|Lack of Efficacy|0|||
49093104|NCT02016105|158177144|FG001|TREATMENT PERIOD 2|Lack of Efficacy|0|||
49093105|NCT02016105|158177145|FG002|TREATMENT PERIOD 2|Lack of Efficacy|2|||
49093106|NCT02016105|158177146|FG003|TREATMENT PERIOD 2|Lack of Efficacy|6|||
49093107|NCT02016105|158177147|FG004|TREATMENT PERIOD 2|Lack of Efficacy|3|||
49093108|NCT02016105|158177148|FG005|TREATMENT PERIOD 2|Lack of Efficacy|2|||
49093109|NCT02016105|158177143|FG000|TREATMENT PERIOD 2|Pregnancy|0|||
49093110|NCT02016105|158177144|FG001|TREATMENT PERIOD 2|Pregnancy|0|||
49093111|NCT02016105|158177145|FG002|TREATMENT PERIOD 2|Pregnancy|0|||
49093112|NCT02016105|158177146|FG003|TREATMENT PERIOD 2|Pregnancy|0|||
49093113|NCT02016105|158177147|FG004|TREATMENT PERIOD 2|Pregnancy|0|||
49093114|NCT02016105|158177148|FG005|TREATMENT PERIOD 2|Pregnancy|1|||
49093115|NCT02016105|158177143|FG000|TREATMENT PERIOD 2|Death|0|||
49093116|NCT02016105|158177144|FG001|TREATMENT PERIOD 2|Death|0|||
49093117|NCT02016105|158177145|FG002|TREATMENT PERIOD 2|Death|0|||
49093118|NCT02016105|158177146|FG003|TREATMENT PERIOD 2|Death|0|||
49093119|NCT02016105|158177147|FG004|TREATMENT PERIOD 2|Death|0|||
49093120|NCT02016105|158177148|FG005|TREATMENT PERIOD 2|Death|1|||
49093121|NCT02016105|158177143|FG000|TREATMENT PERIOD 2|Adverse Event|0|||
49093122|NCT02016105|158177144|FG001|TREATMENT PERIOD 2|Adverse Event|0|||
49093123|NCT02016105|158177145|FG002|TREATMENT PERIOD 2|Adverse Event|0|||
49093124|NCT02016105|158177146|FG003|TREATMENT PERIOD 2|Adverse Event|4|||
49093125|NCT02016105|158177147|FG004|TREATMENT PERIOD 2|Adverse Event|0|||
49093126|NCT02016105|158177148|FG005|TREATMENT PERIOD 2|Adverse Event|1|||
49093127|NCT02016105|158177143|FG000|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
49093128|NCT02016105|158177144|FG001|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
49093129|NCT02016105|158177145|FG002|TREATMENT PERIOD 2|Withdrawal by Subject|3|||
49093130|NCT02016105|158177146|FG003|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
49093131|NCT02016105|158177147|FG004|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
49093132|NCT02016105|158177148|FG005|TREATMENT PERIOD 2|Withdrawal by Subject|7|||
49093133|NCT02016105|158177143|FG000|TREATMENT PERIOD 2|Lost to Follow-up|0|||
49093134|NCT02016105|158177144|FG001|TREATMENT PERIOD 2|Lost to Follow-up|0|||
49093135|NCT02016105|158177145|FG002|TREATMENT PERIOD 2|Lost to Follow-up|1|||
49093136|NCT02016105|158177146|FG003|TREATMENT PERIOD 2|Lost to Follow-up|0|||
49093137|NCT02016105|158177147|FG004|TREATMENT PERIOD 2|Lost to Follow-up|0|||
49093138|NCT02016105|158177148|FG005|TREATMENT PERIOD 2|Lost to Follow-up|1|||
49093139|NCT02016105|158177143|FG000|EXTENSION PERIOD|New therapy for study indication|0|||
49093140|NCT02016105|158177144|FG001|EXTENSION PERIOD|New therapy for study indication|0|||
49093141|NCT02016105|158177145|FG002|EXTENSION PERIOD|New therapy for study indication|0|||
49093142|NCT02016105|158177146|FG003|EXTENSION PERIOD|New therapy for study indication|0|||
49093143|NCT02016105|158177147|FG004|EXTENSION PERIOD|New therapy for study indication|1|||
49093144|NCT02016105|158177148|FG005|EXTENSION PERIOD|New therapy for study indication|1|||
49093145|NCT02016105|158177143|FG000|EXTENSION PERIOD|Lack of Efficacy|0|||
49093146|NCT02016105|158177144|FG001|EXTENSION PERIOD|Lack of Efficacy|0|||
49093147|NCT02016105|158177145|FG002|EXTENSION PERIOD|Lack of Efficacy|1|||
49093148|NCT02016105|158177146|FG003|EXTENSION PERIOD|Lack of Efficacy|3|||
49093149|NCT02016105|158177147|FG004|EXTENSION PERIOD|Lack of Efficacy|1|||
49093150|NCT02016105|158177148|FG005|EXTENSION PERIOD|Lack of Efficacy|1|||
49093151|NCT02016105|158177143|FG000|EXTENSION PERIOD|Adverse Event|0|||
49093152|NCT02016105|158177144|FG001|EXTENSION PERIOD|Adverse Event|0|||
49093153|NCT02016105|158177145|FG002|EXTENSION PERIOD|Adverse Event|2|||
49093154|NCT02016105|158177146|FG003|EXTENSION PERIOD|Adverse Event|0|||
49093155|NCT02016105|158177147|FG004|EXTENSION PERIOD|Adverse Event|1|||
49093156|NCT02016105|158177148|FG005|EXTENSION PERIOD|Adverse Event|0|||
49093157|NCT02016105|158177143|FG000|EXTENSION PERIOD|Withdrawal by Subject|0|||
49093158|NCT02016105|158177144|FG001|EXTENSION PERIOD|Withdrawal by Subject|0|||
49093159|NCT02016105|158177145|FG002|EXTENSION PERIOD|Withdrawal by Subject|2|||
49093160|NCT02016105|158177146|FG003|EXTENSION PERIOD|Withdrawal by Subject|2|||
49093161|NCT02016105|158177147|FG004|EXTENSION PERIOD|Withdrawal by Subject|2|||
49093162|NCT02016105|158177148|FG005|EXTENSION PERIOD|Withdrawal by Subject|2|||
49093163|NCT02016105|158177143|FG000|EXTENSION PERIOD|Non-compliance with study indication|0|||
49093164|NCT02016105|158177144|FG001|EXTENSION PERIOD|Non-compliance with study indication|0|||
49093165|NCT02016105|158177145|FG002|EXTENSION PERIOD|Non-compliance with study indication|0|||
49093166|NCT02016105|158177146|FG003|EXTENSION PERIOD|Non-compliance with study indication|0|||
49093167|NCT02016105|158177147|FG004|EXTENSION PERIOD|Non-compliance with study indication|1|||
49093168|NCT02016105|158177148|FG005|EXTENSION PERIOD|Non-compliance with study indication|0|||
49093169|NCT02016105|158177143|FG000|EXTENSION PERIOD|Lost to Follow-up|0|||
49093170|NCT02016105|158177144|FG001|EXTENSION PERIOD|Lost to Follow-up|0|||
49093171|NCT02016105|158177145|FG002|EXTENSION PERIOD|Lost to Follow-up|0|||
49093172|NCT02016105|158177146|FG003|EXTENSION PERIOD|Lost to Follow-up|0|||
49093173|NCT02016105|158177147|FG004|EXTENSION PERIOD|Lost to Follow-up|0|||
49093174|NCT02016105|158177148|FG005|EXTENSION PERIOD|Lost to Follow-up|2|||
49093175|NCT02308540|158177149|FG000|Overall Study|Lost to Follow-up|0|||
49093176|NCT02308540|158177150|FG001|Overall Study|Lost to Follow-up|0|||
49093177|NCT02308540|158177151|FG002|Overall Study|Lost to Follow-up|0|||
49093178|NCT02308540|158177152|FG003|Overall Study|Lost to Follow-up|0|||
49093179|NCT02308540|158177153|FG004|Overall Study|Lost to Follow-up|0|||
49093180|NCT02308540|158177154|FG005|Overall Study|Lost to Follow-up|1|||
49093181|NCT01186692|158177155|FG000|Overall Study|Not Catheterized|11|||
49093182|NCT01186692|158177155|FG000|Overall Study|Futher testing contraindicated implant|19|||
49093183|NCT01186692|158177155|FG000|Overall Study|Adverse Event|2|||
49093184|NCT04109391|158177156|FG000|Overall Study|Adverse Event|2|||
49093185|NCT04109391|158177157|FG001|Overall Study|Adverse Event|2|||
49093186|NCT04109391|158177158|FG002|Overall Study|Adverse Event|0|||
49093187|NCT04109391|158177156|FG000|Overall Study|Withdrawal by Subject|2|||
49093188|NCT04109391|158177157|FG001|Overall Study|Withdrawal by Subject|0|||
49093189|NCT04109391|158177158|FG002|Overall Study|Withdrawal by Subject|0|||
49093190|NCT04109391|158177156|FG000|Overall Study|Pregnancy|1|||
49093191|NCT04109391|158177157|FG001|Overall Study|Pregnancy|0|||
49093192|NCT04109391|158177158|FG002|Overall Study|Pregnancy|0|||
49093193|NCT04109391|158177156|FG000|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|3|||
49093194|NCT04109391|158177157|FG001|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|1|||
49093195|NCT04109391|158177158|FG002|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|0|||
49093196|NCT04109391|158177156|FG000|Overall Study|Lost to Follow-up|0|||
49093197|NCT04109391|158177157|FG001|Overall Study|Lost to Follow-up|0|||
49093198|NCT04109391|158177158|FG002|Overall Study|Lost to Follow-up|1|||
49093199|NCT04109391|158177156|FG000|Overall Study|Lack of Efficacy|2|||
49093200|NCT04109391|158177157|FG001|Overall Study|Lack of Efficacy|2|||
49093201|NCT04109391|158177158|FG002|Overall Study|Lack of Efficacy|3|||
49093202|NCT00596817|158177159|FG000|Open-label Period|Adverse Event|0|||
49093203|NCT00596817|158177160|FG001|Open-label Period|Adverse Event|49|||
49093204|NCT00596817|158177159|FG000|Open-label Period|Lack of Efficacy|0|||
49093205|NCT00596817|158177160|FG001|Open-label Period|Lack of Efficacy|33|||
49093206|NCT00596817|158177159|FG000|Open-label Period|Other Reasons|0|||
49093207|NCT00596817|158177160|FG001|Open-label Period|Other Reasons|65|||
49093208|NCT00596817|158177159|FG000|Open-label Period to Double-blind Period|Adverse Event|0|||
49093209|NCT00596817|158177160|FG001|Open-label Period to Double-blind Period|Adverse Event|5|||
49093210|NCT00596817|158177159|FG000|Open-label Period to Double-blind Period|Lack of Efficacy|0|||
49093211|NCT00596817|158177160|FG001|Open-label Period to Double-blind Period|Lack of Efficacy|24|||
49093212|NCT00596817|158177159|FG000|Open-label Period to Double-blind Period|Not Eligible|0|||
49093213|NCT00596817|158177160|FG001|Open-label Period to Double-blind Period|Not Eligible|49|||
49093214|NCT00596817|158177159|FG000|Open-label Period to Double-blind Period|Other Reasons|0|||
49093215|NCT00596817|158177160|FG001|Open-label Period to Double-blind Period|Other Reasons|14|||
49093216|NCT00596817|158177159|FG000|Double-blind Period|Adverse Event|5|||
49093217|NCT00596817|158177160|FG001|Double-blind Period|Adverse Event|16|||
49093218|NCT00596817|158177159|FG000|Double-blind Period|Lack of Efficacy|52|||
49093219|NCT00596817|158177160|FG001|Double-blind Period|Lack of Efficacy|28|||
49093220|NCT00596817|158177159|FG000|Double-blind Period|Non-compliance With Study Product|3|||
49093221|NCT00596817|158177160|FG001|Double-blind Period|Non-compliance With Study Product|4|||
49093222|NCT00596817|158177159|FG000|Double-blind Period|Protocol Violation|11|||
49093223|NCT00596817|158177160|FG001|Double-blind Period|Protocol Violation|8|||
49093224|NCT00596817|158177159|FG000|Double-blind Period|Withdrawal of Consent|7|||
49093225|NCT00596817|158177160|FG001|Double-blind Period|Withdrawal of Consent|3|||
49093226|NCT00596817|158177159|FG000|Double-blind Period|Lost to Follow-up|0|||
49093227|NCT00596817|158177160|FG001|Double-blind Period|Lost to Follow-up|2|||
49093228|NCT00596817|158177159|FG000|Double-blind Period|Other Reasons|10|||
49093229|NCT00596817|158177160|FG001|Double-blind Period|Other Reasons|18|||
49093230|NCT00667823|158177161|FG000|Overall Study|Lost to Follow-up|5|||
49093231|NCT00667823|158177161|FG000|Overall Study|Adverse Event|7|||
49093232|NCT00667823|158177161|FG000|Overall Study|Death|182|||
49093233|NCT00667823|158177161|FG000|Overall Study|Withdrawal by Subject|12|||
49093234|NCT00667823|158177161|FG000|Overall Study|Other|8|||
49093235|NCT00667823|158177161|FG000|Overall Study|Missing (completion page missing)|2|||
49093236|NCT02142959|158177164|FG000|Overall Study|Adverse Event|1|||
49093237|NCT02142959|158177165|FG001|Overall Study|Adverse Event|0|||
49093238|NCT02142959|158177166|FG002|Overall Study|Adverse Event|0|||
49093239|NCT02142959|158177164|FG000|Overall Study|Death|0|||
49093240|NCT02142959|158177165|FG001|Overall Study|Death|1|||
49093241|NCT02142959|158177166|FG002|Overall Study|Death|0|||
49093242|NCT02142959|158177164|FG000|Overall Study|Withdrawal by Subject|3|||
49093243|NCT02142959|158177165|FG001|Overall Study|Withdrawal by Subject|1|||
49093244|NCT02142959|158177166|FG002|Overall Study|Withdrawal by Subject|3|||
49093245|NCT02142959|158177164|FG000|Overall Study|Administrative Reasons|1|||
49093246|NCT02142959|158177165|FG001|Overall Study|Administrative Reasons|0|||
49093247|NCT02142959|158177166|FG002|Overall Study|Administrative Reasons|1|||
49093248|NCT02142959|158177164|FG000|Overall Study|Missing|0|||
49093249|NCT02142959|158177165|FG001|Overall Study|Missing|1|||
49093250|NCT02142959|158177166|FG002|Overall Study|Missing|0|||
49093251|NCT02142959|158177164|FG000|Overall Study|Treatment changed from radiation treatment to chemo|0|||
49093252|NCT02142959|158177165|FG001|Overall Study|Treatment changed from radiation treatment to chemo|0|||
49093253|NCT02142959|158177166|FG002|Overall Study|Treatment changed from radiation treatment to chemo|1|||
49093254|NCT02142959|158177164|FG000|Overall Study|Patient didn't complete end of study visit|0|||
49093255|NCT02142959|158177165|FG001|Overall Study|Patient didn't complete end of study visit|0|||
49093256|NCT02142959|158177166|FG002|Overall Study|Patient didn't complete end of study visit|1|||
49093257|NCT03509467|158177181|FG000|Overall Study|Withdrawal by Subject|5|||
49093258|NCT03509467|158177182|FG001|Overall Study|Withdrawal by Subject|1|||
49093259|NCT03509467|158177183|FG002|Overall Study|Withdrawal by Subject|6|||
49093260|NCT03509467|158177184|FG003|Overall Study|Withdrawal by Subject|7|||
49093261|NCT03509467|158177185|FG004|Overall Study|Withdrawal by Subject|10|||
49093262|NCT03509467|158177186|FG005|Overall Study|Withdrawal by Subject|10|||
49093263|NCT03509467|158177187|FG006|Overall Study|Withdrawal by Subject|10|||
49093264|NCT03509467|158177188|FG007|Overall Study|Withdrawal by Subject|10|||
49093265|NCT03509467|158177181|FG000|Overall Study|Death|0|||
49093266|NCT03509467|158177182|FG001|Overall Study|Death|0|||
49093267|NCT03509467|158177183|FG002|Overall Study|Death|2|||
49093268|NCT03509467|158177184|FG003|Overall Study|Death|2|||
49093269|NCT03509467|158177185|FG004|Overall Study|Death|1|||
49093270|NCT03509467|158177186|FG005|Overall Study|Death|0|||
49093271|NCT03509467|158177187|FG006|Overall Study|Death|1|||
49093272|NCT03509467|158177188|FG007|Overall Study|Death|0|||
49093273|NCT03509467|158177181|FG000|Overall Study|Proxy Withdrawal|0|||
49093274|NCT03509467|158177182|FG001|Overall Study|Proxy Withdrawal|0|||
49093275|NCT03509467|158177183|FG002|Overall Study|Proxy Withdrawal|0|||
49093276|NCT03509467|158177184|FG003|Overall Study|Proxy Withdrawal|0|||
49093277|NCT03509467|158177185|FG004|Overall Study|Proxy Withdrawal|0|||
49093278|NCT03509467|158177186|FG005|Overall Study|Proxy Withdrawal|0|||
49093279|NCT03509467|158177187|FG006|Overall Study|Proxy Withdrawal|0|||
49093280|NCT03509467|158177188|FG007|Overall Study|Proxy Withdrawal|1|||
49093281|NCT03227224|158177189|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
49093282|NCT03227224|158177190|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
49093283|NCT03227224|158177191|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
49093284|NCT03227224|158177192|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
49093285|NCT03227224|158177189|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
49093286|NCT03227224|158177190|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
49093287|NCT03227224|158177191|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
49093288|NCT03227224|158177192|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
49093289|NCT03227224|158177189|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
49093290|NCT03227224|158177190|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
49093291|NCT03227224|158177191|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
49093292|NCT03227224|158177192|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
49093293|NCT03227224|158177189|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
49093294|NCT03227224|158177190|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
49093295|NCT03227224|158177191|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
49093296|NCT03227224|158177192|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
49093297|NCT03227224|158177189|FG000|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
49093298|NCT03227224|158177190|FG001|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
49093299|NCT03227224|158177191|FG002|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|1|||
49093300|NCT03227224|158177192|FG003|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
49093301|NCT03227224|158177189|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|2|||
49093302|NCT03227224|158177190|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
49093303|NCT03227224|158177191|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
49093304|NCT03227224|158177192|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|4|||
49093305|NCT03227224|158177189|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|2|||
49093306|NCT03227224|158177190|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
49093307|NCT03227224|158177191|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
49093308|NCT03227224|158177192|FG003|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
49093309|NCT03227224|158177189|FG000|Double-blind Treatment Period (6 Weeks)|Other|4|||
49093310|NCT03227224|158177190|FG001|Double-blind Treatment Period (6 Weeks)|Other|0|||
49093311|NCT03227224|158177191|FG002|Double-blind Treatment Period (6 Weeks)|Other|1|||
49093312|NCT03227224|158177192|FG003|Double-blind Treatment Period (6 Weeks)|Other|0|||
49093313|NCT03227224|158177189|FG000|Follow-up Phase (2 Weeks)|Other|4|||
49093314|NCT03227224|158177190|FG001|Follow-up Phase (2 Weeks)|Other|4|||
49093315|NCT03227224|158177191|FG002|Follow-up Phase (2 Weeks)|Other|6|||
49093316|NCT03227224|158177192|FG003|Follow-up Phase (2 Weeks)|Other|3|||
49093317|NCT01106911|158177193|FG000|Overall Study|Physician Decision|2|||
49093318|NCT01106911|158177193|FG000|Overall Study|deemed ineligible after screening|3|||
49093319|NCT01282372|158177194|FG000|Overall Study|Lack of Efficacy / Exacerbation|25|||
49093320|NCT01282372|158177194|FG000|Overall Study|Lost to Follow-up|23|||
49093321|NCT01282372|158177194|FG000|Overall Study|Withdrawal by Subject|11|||
49093322|NCT01282372|158177194|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 1|4|||
49093323|NCT01282372|158177194|FG000|Overall Study|Death|1|||
49093324|NCT01282372|158177194|FG000|Overall Study|Presence of AE, Lack of Efficacy|1|||
49093325|NCT01282372|158177194|FG000|Overall Study|Presence of AE, Regression of Symptoms|1|||
49093326|NCT01282372|158177194|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 2|1|||
49093327|NCT01282372|158177194|FG000|Overall Study|Adverse Event|12|||
49093328|NCT04804540|158177197|FG000|Overall Study|Adverse Event|26|||
49093329|NCT04804540|158177198|FG001|Overall Study|Adverse Event|13|||
49093330|NCT03963232|158177201|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
49093331|NCT03963232|158177202|FG001|Double-Blind Treatment Phase|Adverse Event|6|||
49093332|NCT03963232|158177201|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
49093333|NCT03963232|158177202|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
49093334|NCT03963232|158177201|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
49093335|NCT03963232|158177202|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
49093336|NCT03963232|158177201|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
49093337|NCT03963232|158177202|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
49093338|NCT03963232|158177201|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
49093339|NCT03963232|158177202|FG001|Double-Blind Treatment Phase|Physician Decision|3|||
49093340|NCT03963232|158177201|FG000|Open-Label Treatment Phase|Adverse Event|1|||
49093341|NCT03963232|158177202|FG001|Open-Label Treatment Phase|Adverse Event|2|||
49093342|NCT03963232|158177201|FG000|Open-Label Treatment Phase|Protocol Violation|0|||
49093343|NCT03963232|158177202|FG001|Open-Label Treatment Phase|Protocol Violation|2|||
49093344|NCT03963232|158177201|FG000|Open-Label Treatment Phase|Withdrawal by Subject|5|||
49093345|NCT03963232|158177202|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
49093346|NCT03963232|158177201|FG000|Open-Label Treatment Phase|Pregnancy|1|||
49093347|NCT03963232|158177202|FG001|Open-Label Treatment Phase|Pregnancy|0|||
49093348|NCT03963232|158177201|FG000|Follow-up Phase|Withdrawal by Subject|7|||
49093349|NCT03963232|158177202|FG001|Follow-up Phase|Withdrawal by Subject|5|||
49093350|NCT03963232|158177201|FG000|Follow-up Phase|Protocol Violation|0|||
49093351|NCT03963232|158177202|FG001|Follow-up Phase|Protocol Violation|2|||
49093352|NCT03963232|158177201|FG000|Follow-up Phase|Adverse Event|0|||
49093353|NCT03963232|158177202|FG001|Follow-up Phase|Adverse Event|1|||
49093354|NCT03963232|158177201|FG000|Follow-up Phase|Lost to Follow-up|0|||
49093355|NCT03963232|158177202|FG001|Follow-up Phase|Lost to Follow-up|1|||
49093356|NCT04520997|158177203|FG000|Overall Study|Lost to Follow-up|1|||
49093357|NCT04520997|158177204|FG001|Overall Study|Lost to Follow-up|1|||
49093358|NCT04520997|158177203|FG000|Overall Study|Withdrawal by Subject|1|||
49093359|NCT04520997|158177204|FG001|Overall Study|Withdrawal by Subject|0|||
49093360|NCT04520997|158177203|FG000|Overall Study|Not Treated|0|||
49093361|NCT04520997|158177204|FG001|Overall Study|Not Treated|1|||
49093362|NCT00961571|158178526|FG000|Overall Study|Physician Decision|39|||
49093363|NCT00975611|158178527|FG000|Overall Study|Screen Fail|16|||
49093364|NCT00975611|158178527|FG000|Overall Study|Physician Decision|1|||
49093365|NCT03058705|158178528|FG000|Overall Study|Withdrawal by Subject|2|||
49093366|NCT03058705|158178528|FG000|Overall Study|Physician Decision|2|||
49093367|NCT03508726|158178529|FG000|Overall Study|Withdrawal by Subject|0|||
49093368|NCT03508726|158178530|FG001|Overall Study|Withdrawal by Subject|1|||
49093369|NCT01068730|158178531|FG000|Period 3|Personal reason|1|||
49093370|NCT01068730|158178532|FG001|Period 3|Personal reason|0|||
49093371|NCT01068730|158178533|FG002|Period 3|Personal reason|0|||
49093372|NCT01068730|158178534|FG003|Period 3|Personal reason|0|||
49093373|NCT01068730|158178531|FG000|Period 4|Family emergency|0|||
49093374|NCT01068730|158178532|FG001|Period 4|Family emergency|1|||
49093375|NCT01068730|158178533|FG002|Period 4|Family emergency|0|||
49093376|NCT01068730|158178534|FG003|Period 4|Family emergency|0|||
49093377|NCT03047213|158178540|FG000|Overall Study|Withdrawal by Subject|2|||
49093378|NCT03047213|158178541|FG001|Overall Study|Withdrawal by Subject|0|||
49093379|NCT03047213|158178540|FG000|Overall Study|Adverse Event|2|||
49093380|NCT03047213|158178541|FG001|Overall Study|Adverse Event|0|||
49093381|NCT02101736|158178542|FG000|Overall Study|Protocol Violation|3|||
49093382|NCT02101736|158178543|FG001|Overall Study|Protocol Violation|0|||
49093383|NCT02101736|158178542|FG000|Overall Study|Withdrawal by Subject|1|||
49093384|NCT02101736|158178543|FG001|Overall Study|Withdrawal by Subject|1|||
49093385|NCT06232590|158178545|FG000|Period 2: Second Intervention|Unable to attend study visit|1|||
49093386|NCT06232590|158178546|FG001|Period 2: Second Intervention|Unable to attend study visit|0|||
49093387|NCT01222520|158178550|FG000|Open-label run-in Period|Withdrawal by Subject|0|||
49093388|NCT01222520|158178551|FG001|Open-label run-in Period|Withdrawal by Subject|2|||
49093389|NCT01222520|158178550|FG000|Open-label run-in Period|Blood pressure criteria not met|0|||
49093390|NCT01222520|158178551|FG001|Open-label run-in Period|Blood pressure criteria not met|18|||
49093391|NCT01222520|158178550|FG000|Open-label run-in Period|Number of patients fulfilled|0|||
49093392|NCT01222520|158178551|FG001|Open-label run-in Period|Number of patients fulfilled|3|||
49093393|NCT01222520|158178550|FG000|Double-blind Period|Adverse Event|0|||
49093394|NCT01222520|158178551|FG001|Double-blind Period|Adverse Event|1|||
49093395|NCT01222520|158178550|FG000|Double-blind Period|Lack of Efficacy|0|||
49093396|NCT01222520|158178551|FG001|Double-blind Period|Lack of Efficacy|1|||
49093397|NCT01222520|158178550|FG000|Double-blind Period|Study medication stolen|1|||
49093398|NCT01222520|158178551|FG001|Double-blind Period|Study medication stolen|0|||
49093399|NCT02285166|158178552|FG000|Overall Study|Case Report Forms Uncollected|564|||
49093400|NCT02285166|158178552|FG000|Overall Study|Protocol Deviation|402|||
49093401|NCT02964208|158178553|FG000|Overall Study|Death|103|||
49093402|NCT02964208|158178553|FG000|Overall Study|Withdrawal by Subject|6|||
49093403|NCT02964208|158178553|FG000|Overall Study|Lost to Follow-up|6|||
49093404|NCT02964208|158178553|FG000|Overall Study|Unsuccessful Procedure|5|||
49093405|NCT02964208|158178553|FG000|Overall Study|Device Explant|1|||
49093406|NCT02964208|158178553|FG000|Overall Study|Anatomical Heart Structure of the Patient; LAA Occluder Was Not Implanted; Heart Transplant|3|||
49093407|NCT00384839|158178560|FG000|Overall Study|Adverse Event|4|||
49093408|NCT00384839|158178560|FG000|Overall Study|Investigator Request|1|||
49093409|NCT00384839|158178560|FG000|Overall Study|Patient Request|1|||
49093410|NCT00384839|158178560|FG000|Overall Study|Ineligible|2|||
49093411|NCT00443079|158178563|FG000|Overall Study|Lost to Follow-up|0|||
49093412|NCT00443079|158178564|FG001|Overall Study|Lost to Follow-up|1|||
49093413|NCT04292912|158178565|FG000|Overall Study|Physician Decision|1|||
49093414|NCT04292912|158178565|FG000|Overall Study|Protocol Violation|6|||
49093415|NCT02649439|158178566|FG000|Overall Study|Switched to alternative treatment|6|||
49093416|NCT02649439|158178567|FG001|Overall Study|Switched to alternative treatment|4|||
49093417|NCT02649439|158178566|FG000|Overall Study|Patient decision|1|||
49093418|NCT02649439|158178567|FG001|Overall Study|Patient decision|0|||
49093419|NCT02649439|158178566|FG000|Overall Study|Patient going out of country|1|||
49093420|NCT02649439|158178567|FG001|Overall Study|Patient going out of country|0|||
49093421|NCT02649439|158178566|FG000|Overall Study|To start finasteride|1|||
49093422|NCT02649439|158178567|FG001|Overall Study|To start finasteride|0|||
49093423|NCT02649439|158178566|FG000|Overall Study|Physician Decision|1|||
49093424|NCT02649439|158178567|FG001|Overall Study|Physician Decision|0|||
49093425|NCT02649439|158178566|FG000|Overall Study|Disease progression on study|12|||
49093426|NCT02649439|158178567|FG001|Overall Study|Disease progression on study|13|||
49093427|NCT02649439|158178566|FG000|Overall Study|Refused further treatment|1|||
49093428|NCT02649439|158178567|FG001|Overall Study|Refused further treatment|0|||
49093429|NCT02649439|158178566|FG000|Overall Study|Refused further follow up|2|||
49093430|NCT02649439|158178567|FG001|Overall Study|Refused further follow up|7|||
49093431|NCT02649439|158178566|FG000|Overall Study|Completed treatment phase but refused the protocol specified follow up|1|||
49093432|NCT02649439|158178567|FG001|Overall Study|Completed treatment phase but refused the protocol specified follow up|0|||
49093433|NCT02649439|158178566|FG000|Overall Study|No treatment, per protocol|1|||
49093434|NCT02649439|158178567|FG001|Overall Study|No treatment, per protocol|0|||
49093435|NCT02649439|158178566|FG000|Overall Study|PSA DT makes ineligible|0|||
49093436|NCT02649439|158178567|FG001|Overall Study|PSA DT makes ineligible|1|||
49093437|NCT02649439|158178566|FG000|Overall Study|Rising PSA No Mets|0|||
49093438|NCT02649439|158178567|FG001|Overall Study|Rising PSA No Mets|1|||
49093439|NCT02649439|158178566|FG000|Overall Study|Rising PSA|0|||
49093440|NCT02649439|158178567|FG001|Overall Study|Rising PSA|1|||
49093441|NCT02649439|158178566|FG000|Overall Study|Signed follow up protocol|0|||
49093442|NCT02649439|158178567|FG001|Overall Study|Signed follow up protocol|1|||
49093443|NCT02136134|158178568|FG000|Overall Study|Death|170|||
49093444|NCT02136134|158178569|FG001|Overall Study|Death|148|||
49093445|NCT02136134|158178568|FG000|Overall Study|Withdrawal by Subject|19|||
49093446|NCT02136134|158178569|FG001|Overall Study|Withdrawal by Subject|10|||
49093447|NCT02136134|158178568|FG000|Overall Study|Lost to Follow-up|3|||
49093448|NCT02136134|158178569|FG001|Overall Study|Lost to Follow-up|3|||
49093449|NCT02136134|158178568|FG000|Overall Study|Uspecified|55|||
49093450|NCT02136134|158178569|FG001|Overall Study|Uspecified|90|||
49093451|NCT02049814|158178576|FG000|Overall Study|Reason not Specified|4|||
49093452|NCT02049814|158178577|FG001|Overall Study|Reason not Specified|3|||
49093453|NCT02049814|158178576|FG000|Overall Study|Pregnancy|1|||
49093454|NCT02049814|158178577|FG001|Overall Study|Pregnancy|0|||
49093455|NCT02049814|158178576|FG000|Overall Study|Lost to Follow-up|2|||
49093456|NCT02049814|158178577|FG001|Overall Study|Lost to Follow-up|3|||
49093457|NCT02049814|158178576|FG000|Overall Study|Serious Protocol Violation|5|||
49093458|NCT02049814|158178577|FG001|Overall Study|Serious Protocol Violation|7|||
49093459|NCT02049814|158178576|FG000|Overall Study|Study Termination|0|||
49093460|NCT02049814|158178577|FG001|Overall Study|Study Termination|1|||
49093461|NCT02049814|158178576|FG000|Overall Study|Pretreatment event/Adverse Event (AE)|8|||
49093462|NCT02049814|158178577|FG001|Overall Study|Pretreatment event/Adverse Event (AE)|5|||
49093463|NCT02049814|158178576|FG000|Overall Study|Voluntary withdrawal|9|||
49093464|NCT02049814|158178577|FG001|Overall Study|Voluntary withdrawal|8|||
49093465|NCT03476343|158178578|FG000|Overall Study|Clinical exam moved to another scanner|7|||
49093466|NCT03476343|158178578|FG000|Overall Study|Clinical order cancelled|4|||
49093467|NCT03476343|158178578|FG000|Overall Study|Neonate did not settle down for the scan|1|||
49093468|NCT04300309|158178581|FG000|Overall Study|Lost to Follow-up|1|||
49093469|NCT04300309|158178582|FG001|Overall Study|Lost to Follow-up|0|||
49093470|NCT02918318|158178594|FG000|Double-blind Induction Phase: 4 Weeks|Adverse Event|1|||
49093471|NCT02918318|158178595|FG001|Double-blind Induction Phase: 4 Weeks|Adverse Event|4|||
49093472|NCT02918318|158178596|FG002|Double-blind Induction Phase: 4 Weeks|Adverse Event|2|||
49093473|NCT02918318|158178597|FG003|Double-blind Induction Phase: 4 Weeks|Adverse Event|3|||
49093474|NCT02918318|158178598|FG004|Double-blind Induction Phase: 4 Weeks|Adverse Event|0|||
49093475|NCT02918318|158178594|FG000|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
49093476|NCT02918318|158178595|FG001|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
49093477|NCT02918318|158178596|FG002|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
49093478|NCT02918318|158178597|FG003|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2|||
49093479|NCT02918318|158178598|FG004|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
49093480|NCT02918318|158178594|FG000|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
49093481|NCT02918318|158178595|FG001|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
49093482|NCT02918318|158178596|FG002|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
49093483|NCT02918318|158178597|FG003|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1|||
49093484|NCT02918318|158178598|FG004|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
49093485|NCT02918318|158178594|FG000|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
49093486|NCT02918318|158178595|FG001|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
49093487|NCT02918318|158178596|FG002|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
49093488|NCT02918318|158178597|FG003|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
49093489|NCT02918318|158178598|FG004|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
49093490|NCT02918318|158178594|FG000|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
49093491|NCT02918318|158178595|FG001|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
49093492|NCT02918318|158178596|FG002|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
49093493|NCT02918318|158178597|FG003|Double-blind Induction Phase: 4 Weeks|Non-compliance|1|||
49093494|NCT02918318|158178598|FG004|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
49093495|NCT02918318|158178594|FG000|Double-blind Induction Phase: 4 Weeks|Other|0|||
49093496|NCT02918318|158178595|FG001|Double-blind Induction Phase: 4 Weeks|Other|2|||
49093497|NCT02918318|158178596|FG002|Double-blind Induction Phase: 4 Weeks|Other|0|||
49093498|NCT02918318|158178597|FG003|Double-blind Induction Phase: 4 Weeks|Other|1|||
49093499|NCT02918318|158178598|FG004|Double-blind Induction Phase: 4 Weeks|Other|0|||
49093500|NCT02918318|158178594|FG000|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
49093501|NCT02918318|158178595|FG001|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
49093502|NCT02918318|158178596|FG002|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
49093503|NCT02918318|158178597|FG003|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2|||
49093504|NCT02918318|158178598|FG004|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
49093505|NCT02918318|158178594|FG000|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
49093506|NCT02918318|158178595|FG001|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
49093507|NCT02918318|158178596|FG002|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
49093508|NCT02918318|158178597|FG003|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
49093509|NCT02918318|158178598|FG004|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
49093510|NCT02918318|158178594|FG000|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
49093511|NCT02918318|158178595|FG001|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
49093512|NCT02918318|158178596|FG002|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
49093513|NCT02918318|158178597|FG003|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
49093514|NCT02918318|158178598|FG004|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
49093515|NCT02918318|158178594|FG000|Posttreatment Phase: Up to 24 Weeks|Other|0|||
49093516|NCT02918318|158178595|FG001|Posttreatment Phase: Up to 24 Weeks|Other|3|||
49093517|NCT02918318|158178596|FG002|Posttreatment Phase: Up to 24 Weeks|Other|1|||
49093518|NCT02918318|158178597|FG003|Posttreatment Phase: Up to 24 Weeks|Other|1|||
49093519|NCT02918318|158178598|FG004|Posttreatment Phase: Up to 24 Weeks|Other|0|||
49093520|NCT02918318|158178594|FG000|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
49093521|NCT02918318|158178595|FG001|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
49093522|NCT02918318|158178596|FG002|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
49093523|NCT02918318|158178597|FG003|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
49093524|NCT02918318|158178598|FG004|Open Label Treatment Phase: 4 Weeks|Adverse Event|1|||
49093525|NCT02918318|158178594|FG000|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
49093526|NCT02918318|158178595|FG001|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
49093527|NCT02918318|158178596|FG002|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
49093528|NCT02918318|158178597|FG003|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
49093529|NCT02918318|158178598|FG004|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1|||
49093530|NCT01094301|158178601|FG000|Trial Stage|Withdrawal by Subject|1|||
49093531|NCT01094301|158178601|FG000|Implant Stage|Adverse Event|1|||
49093532|NCT01094301|158178601|FG000|Implant Stage|Protocol Violation|1|||
49093533|NCT01094301|158178601|FG000|Implant Stage|Withdrawal by Subject|2|||
49093534|NCT01094301|158178601|FG000|Implant Stage|No return of pain|4|||
49093535|NCT02977572|158178602|FG000|Overall Study|Exclusion criterion|2|||
49093536|NCT02977572|158178603|FG001|Overall Study|Exclusion criterion|2|||
49093537|NCT04080752|158178604|FG000|Overall Study|Adverse Event|2|||
49093538|NCT04080752|158178605|FG001|Overall Study|Adverse Event|3|||
49093539|NCT04080752|158178604|FG000|Overall Study|Lack of Efficacy|1|||
49093540|NCT04080752|158178605|FG001|Overall Study|Lack of Efficacy|0|||
49093541|NCT04080752|158178604|FG000|Overall Study|Lost to Follow-up|1|||
49093542|NCT04080752|158178605|FG001|Overall Study|Lost to Follow-up|0|||
49093543|NCT04080752|158178604|FG000|Overall Study|Pregnancy|0|||
49093544|NCT04080752|158178605|FG001|Overall Study|Pregnancy|1|||
49093545|NCT04080752|158178604|FG000|Overall Study|Withdrawal by Subject|7|||
49093546|NCT04080752|158178605|FG001|Overall Study|Withdrawal by Subject|0|||
49093547|NCT04080752|158178604|FG000|Overall Study|Non-Compliance with Study Drug|0|||
49093548|NCT04080752|158178605|FG001|Overall Study|Non-Compliance with Study Drug|1|||
49093549|NCT04080752|158178604|FG000|Overall Study|Other|2|||
49093550|NCT04080752|158178605|FG001|Overall Study|Other|1|||
49093551|NCT00712543|158178613|FG000|Day 8-14|Lost to Follow-up|0|||
49093552|NCT00712543|158178614|FG001|Day 8-14|Lost to Follow-up|2|||
49093553|NCT01684943|158178615|FG000|Overall Study|Inadequate Venous Access|3|||
49093554|NCT01684943|158178616|FG001|Overall Study|Inadequate Venous Access|0|||
49093555|NCT01684943|158178617|FG002|Overall Study|Inadequate Venous Access|0|||
49093556|NCT01684943|158178615|FG000|Overall Study|Principal Investigator Determination|1|||
49093557|NCT01684943|158178616|FG001|Overall Study|Principal Investigator Determination|0|||
49093558|NCT01684943|158178617|FG002|Overall Study|Principal Investigator Determination|0|||
49093559|NCT01684943|158178615|FG000|Overall Study|Excluded from Analysis|1|||
49093560|NCT01684943|158178616|FG001|Overall Study|Excluded from Analysis|1|||
49093561|NCT01684943|158178617|FG002|Overall Study|Excluded from Analysis|1|||
49093562|NCT01684943|158178615|FG000|Overall Study|Lost to Follow-up|3|||
49093563|NCT01684943|158178616|FG001|Overall Study|Lost to Follow-up|0|||
49093564|NCT01684943|158178617|FG002|Overall Study|Lost to Follow-up|0|||
49093565|NCT01684943|158178615|FG000|Overall Study|Planning Pregnancy|1|||
49093566|NCT01684943|158178616|FG001|Overall Study|Planning Pregnancy|0|||
49093567|NCT01684943|158178617|FG002|Overall Study|Planning Pregnancy|0|||
49093568|NCT01516008|158178618|FG000|Overall Study|Adverse Event|0|||
49093569|NCT01516008|158178619|FG001|Overall Study|Adverse Event|2|||
49093570|NCT01516008|158178620|FG002|Overall Study|Adverse Event|7|||
49093571|NCT01516008|158178618|FG000|Overall Study|Lack of Efficacy|44|||
49093572|NCT01516008|158178619|FG001|Overall Study|Lack of Efficacy|14|||
49093573|NCT01516008|158178620|FG002|Overall Study|Lack of Efficacy|10|||
49093574|NCT01516008|158178618|FG000|Overall Study|Protocol Violation|1|||
49093575|NCT01516008|158178619|FG001|Overall Study|Protocol Violation|0|||
49093576|NCT01516008|158178620|FG002|Overall Study|Protocol Violation|0|||
49093577|NCT01516008|158178618|FG000|Overall Study|Reason not specified|0|||
49093578|NCT01516008|158178619|FG001|Overall Study|Reason not specified|0|||
49093579|NCT01516008|158178620|FG002|Overall Study|Reason not specified|1|||
49093580|NCT02729051|158178623|FG000|Overall Study|Adverse Event|21|||
49093581|NCT02729051|158178624|FG001|Overall Study|Adverse Event|11|||
49093582|NCT02729051|158178623|FG000|Overall Study|Lack of Efficacy|1|||
49093583|NCT02729051|158178624|FG001|Overall Study|Lack of Efficacy|1|||
49093584|NCT02729051|158178623|FG000|Overall Study|Lost to Follow-up|1|||
49093585|NCT02729051|158178624|FG001|Overall Study|Lost to Follow-up|2|||
49093586|NCT02729051|158178623|FG000|Overall Study|Physician Decision|1|||
49093587|NCT02729051|158178624|FG001|Overall Study|Physician Decision|1|||
49093588|NCT02729051|158178623|FG000|Overall Study|Withdrawal by Subject|6|||
49093589|NCT02729051|158178624|FG001|Overall Study|Withdrawal by Subject|17|||
49093590|NCT02702388|158178625|FG000|Overall Study|Disease Progression|18|||
49093591|NCT02702388|158178626|FG001|Overall Study|Disease Progression|25|||
49093592|NCT02702388|158178625|FG000|Overall Study|Withdrawal by Subject|9|||
49093593|NCT02702388|158178626|FG001|Overall Study|Withdrawal by Subject|7|||
49093594|NCT02702388|158178625|FG000|Overall Study|Adverse Event|11|||
49093595|NCT02702388|158178626|FG001|Overall Study|Adverse Event|15|||
49093596|NCT02702388|158178625|FG000|Overall Study|Other|2|||
49093597|NCT02702388|158178626|FG001|Overall Study|Other|4|||
49093598|NCT04553471|158178629|FG000|Overall Study|Did not start treatment on protocol|3|||
49093599|NCT04553471|158178629|FG000|Overall Study|Death|1|||
49093600|NCT02027545|158178630|FG000|Overall Study|Failed to sign HIPAA|0|||
49093601|NCT02027545|158178631|FG001|Overall Study|Failed to sign HIPAA|2|||
49093602|NCT02027545|158178630|FG000|Overall Study|Failed to attend study visit|2|||
49093603|NCT02027545|158178631|FG001|Overall Study|Failed to attend study visit|0|||
49093604|NCT02027545|158178630|FG000|Overall Study|Protocol Violation|1|||
49093605|NCT02027545|158178631|FG001|Overall Study|Protocol Violation|0|||
49093606|NCT02406027|158178632|FG000|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
49093607|NCT02406027|158178633|FG001|Double-blind Treatment Phase (Period 1)|Adverse Event|2|||
49093608|NCT02406027|158178634|FG002|Double-blind Treatment Phase (Period 1)|Adverse Event|1|||
49093609|NCT02406027|158178635|FG003|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
49093610|NCT02406027|158178636|FG004|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
49093611|NCT02406027|158178637|FG005|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
49093612|NCT02406027|158178638|FG006|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
49093613|NCT02406027|158178632|FG000|Double-blind Treatment Phase (Period 1)|Physician Decision|3|||
49093614|NCT02406027|158178633|FG001|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
49093615|NCT02406027|158178634|FG002|Double-blind Treatment Phase (Period 1)|Physician Decision|1|||
49093616|NCT02406027|158178635|FG003|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
49093617|NCT02406027|158178636|FG004|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
49093618|NCT02406027|158178637|FG005|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
49093619|NCT02406027|158178638|FG006|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
49093620|NCT02406027|158178632|FG000|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2|||
49093621|NCT02406027|158178633|FG001|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
49093622|NCT02406027|158178634|FG002|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
49093623|NCT02406027|158178635|FG003|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
49093624|NCT02406027|158178636|FG004|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
49093625|NCT02406027|158178637|FG005|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
49093626|NCT02406027|158178638|FG006|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
49093627|NCT02406027|158178632|FG000|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
49093628|NCT02406027|158178633|FG001|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
49093629|NCT02406027|158178634|FG002|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
49093630|NCT02406027|158178635|FG003|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
49093631|NCT02406027|158178636|FG004|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
49093632|NCT02406027|158178637|FG005|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
49093633|NCT02406027|158178638|FG006|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
49093634|NCT02406027|158178632|FG000|Open-label Phase (Period 2)|Adverse Event|0|||
49093635|NCT02406027|158178633|FG001|Open-label Phase (Period 2)|Adverse Event|0|||
49093636|NCT02406027|158178634|FG002|Open-label Phase (Period 2)|Adverse Event|0|||
49093637|NCT02406027|158178635|FG003|Open-label Phase (Period 2)|Adverse Event|2|||
49093638|NCT02406027|158178636|FG004|Open-label Phase (Period 2)|Adverse Event|2|||
49093639|NCT02406027|158178637|FG005|Open-label Phase (Period 2)|Adverse Event|0|||
49093640|NCT02406027|158178638|FG006|Open-label Phase (Period 2)|Adverse Event|0|||
49093641|NCT02406027|158178632|FG000|Open-label Phase (Period 2)|Physician Decision|0|||
49093642|NCT02406027|158178633|FG001|Open-label Phase (Period 2)|Physician Decision|0|||
49093643|NCT02406027|158178634|FG002|Open-label Phase (Period 2)|Physician Decision|0|||
49093644|NCT02406027|158178635|FG003|Open-label Phase (Period 2)|Physician Decision|0|||
49093645|NCT02406027|158178636|FG004|Open-label Phase (Period 2)|Physician Decision|0|||
49093646|NCT02406027|158178637|FG005|Open-label Phase (Period 2)|Physician Decision|1|||
49093647|NCT02406027|158178638|FG006|Open-label Phase (Period 2)|Physician Decision|1|||
49093648|NCT02406027|158178632|FG000|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
49093649|NCT02406027|158178633|FG001|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
49093650|NCT02406027|158178634|FG002|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
49093651|NCT02406027|158178635|FG003|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
49093652|NCT02406027|158178636|FG004|Open-label Phase (Period 2)|Withdrawal by Subject|4|||
49093653|NCT02406027|158178637|FG005|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
49093654|NCT02406027|158178638|FG006|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
49093655|NCT02406027|158178632|FG000|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
49093656|NCT02406027|158178633|FG001|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
49093657|NCT02406027|158178634|FG002|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
49093658|NCT02406027|158178635|FG003|Open-label Phase (Period 2)|Study Terminated by Sponsor|11|||
49093659|NCT02406027|158178636|FG004|Open-label Phase (Period 2)|Study Terminated by Sponsor|7|||
49093660|NCT02406027|158178637|FG005|Open-label Phase (Period 2)|Study Terminated by Sponsor|24|||
49093661|NCT02406027|158178638|FG006|Open-label Phase (Period 2)|Study Terminated by Sponsor|19|||
49093662|NCT02406027|158178632|FG000|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
49093663|NCT02406027|158178633|FG001|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
49093664|NCT02406027|158178634|FG002|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
49093665|NCT02406027|158178635|FG003|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
49093666|NCT02406027|158178636|FG004|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
49093667|NCT02406027|158178637|FG005|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1|||
49093668|NCT02406027|158178638|FG006|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
49093669|NCT02406027|158178632|FG000|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
49093670|NCT02406027|158178633|FG001|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
49093671|NCT02406027|158178634|FG002|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
49093672|NCT02406027|158178635|FG003|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
49093673|NCT02406027|158178636|FG004|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1|||
49093674|NCT02406027|158178637|FG005|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
49093675|NCT02406027|158178638|FG006|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
49093676|NCT04075266|158178648|FG000|OOE Period: 264 Week|Ongoing in Study|5|||
49093677|NCT04075266|158178649|FG001|OOE Period: 264 Week|Ongoing in Study|17|||
49093678|NCT04075266|158178648|FG000|OOE Period: 264 Week|Withdrawal by Subject|1|||
49093679|NCT04075266|158178649|FG001|OOE Period: 264 Week|Withdrawal by Subject|0|||
49093680|NCT00617890|158178650|FG000|Overall Study|Treatment ongoing at data cut-off|0|||
49093681|NCT00617890|158178651|FG001|Overall Study|Treatment ongoing at data cut-off|0|||
49093682|NCT00617890|158178652|FG002|Overall Study|Treatment ongoing at data cut-off|0|||
49093683|NCT00617890|158178653|FG003|Overall Study|Treatment ongoing at data cut-off|5|||
49093684|NCT00617890|158178650|FG000|Overall Study|Lack of Efficacy|23|||
49093685|NCT00617890|158178651|FG001|Overall Study|Lack of Efficacy|26|||
49093686|NCT00617890|158178652|FG002|Overall Study|Lack of Efficacy|30|||
49093687|NCT00617890|158178653|FG003|Overall Study|Lack of Efficacy|97|||
49093688|NCT00617890|158178650|FG000|Overall Study|Lost to Follow-up|0|||
49093689|NCT00617890|158178651|FG001|Overall Study|Lost to Follow-up|0|||
49093690|NCT00617890|158178652|FG002|Overall Study|Lost to Follow-up|1|||
49093691|NCT00617890|158178653|FG003|Overall Study|Lost to Follow-up|2|||
49093692|NCT00617890|158178650|FG000|Overall Study|Withdrawal by Subject|4|||
49093693|NCT00617890|158178651|FG001|Overall Study|Withdrawal by Subject|1|||
49093694|NCT00617890|158178652|FG002|Overall Study|Withdrawal by Subject|0|||
49093695|NCT00617890|158178653|FG003|Overall Study|Withdrawal by Subject|2|||
49093696|NCT00617890|158178650|FG000|Overall Study|Protocol Violation|2|||
49093697|NCT00617890|158178651|FG001|Overall Study|Protocol Violation|1|||
49093698|NCT00617890|158178652|FG002|Overall Study|Protocol Violation|0|||
49093699|NCT00617890|158178653|FG003|Overall Study|Protocol Violation|0|||
49093700|NCT00617890|158178650|FG000|Overall Study|Adverse Event|1|||
49093701|NCT00617890|158178651|FG001|Overall Study|Adverse Event|0|||
49093702|NCT00617890|158178652|FG002|Overall Study|Adverse Event|3|||
49093703|NCT00617890|158178653|FG003|Overall Study|Adverse Event|8|||
49093704|NCT00617890|158178650|FG000|Overall Study|Not treated|1|||
49093705|NCT00617890|158178651|FG001|Overall Study|Not treated|0|||
49093706|NCT00617890|158178652|FG002|Overall Study|Not treated|1|||
49093707|NCT00617890|158178653|FG003|Overall Study|Not treated|1|||
49093708|NCT00125242|158178654|FG000|Overall Study|did not qualify|7|||
49093709|NCT00125242|158178655|FG001|Overall Study|did not qualify|2|||
49093710|NCT02497287|158178656|FG000|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84|||
49093711|NCT02497287|158178656|FG000|Induction Phase (4 Weeks)|Adverse Event|52|||
49093712|NCT02497287|158178656|FG000|Induction Phase (4 Weeks)|Withdrawal by Subject|22|||
49093713|NCT02497287|158178656|FG000|Induction Phase (4 Weeks)|Lack of Efficacy|21|||
49093714|NCT02497287|158178656|FG000|Induction Phase (4 Weeks)|Other|13|||
49093715|NCT02497287|158178656|FG000|Induction Phase (4 Weeks)|Lost to Follow-up|5|||
49093716|NCT02497287|158178656|FG000|Induction Phase (4 Weeks)|Protocol Violation|1|||
49093717|NCT02497287|158178656|FG000|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1|||
49093718|NCT02497287|158178656|FG000|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331|||
49093719|NCT02497287|158178656|FG000|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30|||
49093720|NCT02497287|158178656|FG000|Optimization/Maintenance (48 Weeks)|Adverse Event|25|||
49093721|NCT02497287|158178656|FG000|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25|||
49093722|NCT02497287|158178656|FG000|Optimization/Maintenance (48 Weeks)|Other|21|||
49093723|NCT02497287|158178656|FG000|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10|||
49093724|NCT02497287|158178656|FG000|Optimization/Maintenance (48 Weeks)|Protocol Violation|3|||
49093725|NCT02497287|158178656|FG000|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3|||
49093726|NCT02497287|158178656|FG000|Optimization/Maintenance (48 Weeks)|Pregnancy|2|||
49093727|NCT02497287|158178656|FG000|Optimization/Maintenance (48 Weeks)|Death|2|||
49093728|NCT02497287|158178656|FG000|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1|||
49093729|NCT02497287|158178656|FG000|Follow-up Phase (4 Week)|PI Decision|12|||
49093730|NCT02497287|158178656|FG000|Follow-up Phase (4 Week)|Withdrawal by Subject|10|||
49093731|NCT02497287|158178656|FG000|Follow-up Phase (4 Week)|Lost to Follow-up|5|||
49093732|NCT02497287|158178656|FG000|Follow-up Phase (4 Week)|Adverse Event|3|||
49093733|NCT02497287|158178656|FG000|Follow-up Phase (4 Week)|Other|1|||
49093734|NCT02777593|158178657|FG000|Overall Study|Still in study|1|||
49093735|NCT02777593|158178658|FG001|Overall Study|Still in study|32|||
49093736|NCT02777593|158178659|FG002|Overall Study|Still in study|3|||
49093737|NCT02777593|158178660|FG003|Overall Study|Still in study|6|||
49093738|NCT02777593|158178661|FG004|Overall Study|Still in study|5|||
49093739|NCT02777593|158178657|FG000|Overall Study|Death|21|||
49093740|NCT02777593|158178658|FG001|Overall Study|Death|28|||
49093741|NCT02777593|158178659|FG002|Overall Study|Death|0|||
49093742|NCT02777593|158178660|FG003|Overall Study|Death|5|||
49093743|NCT02777593|158178661|FG004|Overall Study|Death|0|||
49093744|NCT02777593|158178657|FG000|Overall Study|Withdrawal by Subject|8|||
49093745|NCT02777593|158178658|FG001|Overall Study|Withdrawal by Subject|4|||
49093746|NCT02777593|158178659|FG002|Overall Study|Withdrawal by Subject|1|||
49093747|NCT02777593|158178660|FG003|Overall Study|Withdrawal by Subject|1|||
49093748|NCT02777593|158178661|FG004|Overall Study|Withdrawal by Subject|0|||
49093749|NCT02777593|158178657|FG000|Overall Study|Lost to Follow-up|8|||
49093750|NCT02777593|158178658|FG001|Overall Study|Lost to Follow-up|16|||
49093751|NCT02777593|158178659|FG002|Overall Study|Lost to Follow-up|5|||
49093752|NCT02777593|158178660|FG003|Overall Study|Lost to Follow-up|0|||
49093753|NCT02777593|158178661|FG004|Overall Study|Lost to Follow-up|1|||
49093754|NCT02777593|158178657|FG000|Overall Study|Physician Decision|2|||
49093755|NCT02777593|158178658|FG001|Overall Study|Physician Decision|2|||
49093756|NCT02777593|158178659|FG002|Overall Study|Physician Decision|0|||
49093757|NCT02777593|158178660|FG003|Overall Study|Physician Decision|0|||
49093758|NCT02777593|158178661|FG004|Overall Study|Physician Decision|0|||
49093759|NCT02777593|158178657|FG000|Overall Study|Discontinued due to Other|1|||
49093760|NCT02777593|158178658|FG001|Overall Study|Discontinued due to Other|0|||
49093761|NCT02777593|158178659|FG002|Overall Study|Discontinued due to Other|0|||
49093762|NCT02777593|158178660|FG003|Overall Study|Discontinued due to Other|0|||
49093763|NCT02777593|158178661|FG004|Overall Study|Discontinued due to Other|0|||
49093764|NCT03921554|158178666|FG000|Overall Study|Adverse Event|2|||
49093765|NCT03921554|158178666|FG000|Overall Study|Withdrawal by Subject|1|||
49093766|NCT03921554|158178666|FG000|Overall Study|Death|3|||
49093767|NCT02659098|158178669|FG000|Overall Study|Withdrawal by Subject|7|||
49093768|NCT02492984|158180757|FG000|Overall Study|Adverse Event|1|||
49093769|NCT02492984|158180758|FG001|Overall Study|Adverse Event|0|||
49093770|NCT02492984|158180757|FG000|Overall Study|Protocol Violation|1|||
49093771|NCT02492984|158180758|FG001|Overall Study|Protocol Violation|0|||
49093772|NCT02492984|158180757|FG000|Overall Study|Withdrawal by Subject|1|||
49093773|NCT02492984|158180758|FG001|Overall Study|Withdrawal by Subject|0|||
49093774|NCT02126579|158180759|FG000|Overall Study|disease progression|0|||
49093775|NCT02126579|158180760|FG001|Overall Study|disease progression|0|||
49093776|NCT02126579|158180761|FG002|Overall Study|disease progression|0|||
49093777|NCT02126579|158180762|FG003|Overall Study|disease progression|1|||
49093778|NCT02126579|158180763|FG004|Overall Study|disease progression|0|||
49093779|NCT02126579|158180764|FG005|Overall Study|disease progression|0|||
49093780|NCT02126579|158180765|FG006|Overall Study|disease progression|1|||
49093781|NCT04105218|158180766|FG000|Overall Study|Withdrawal by Subject|3|||
49093782|NCT04105218|158180767|FG001|Overall Study|Withdrawal by Subject|2|||
49093783|NCT04105218|158180766|FG000|Overall Study|Study was terminated; unable to complete study visits|1|||
49093784|NCT04105218|158180767|FG001|Overall Study|Study was terminated; unable to complete study visits|3|||
49093785|NCT04105218|158180766|FG000|Overall Study|Failed screening tests|2|||
49093786|NCT04105218|158180767|FG001|Overall Study|Failed screening tests|1|||
49093787|NCT02282631|158180770|FG000|Overall Study|Lost to Follow-up|2|||
49093788|NCT02282631|158180771|FG001|Overall Study|Lost to Follow-up|0|||
49093789|NCT02498392|158180773|FG000|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|7|||
49093790|NCT02498392|158180774|FG001|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|0|||
49093791|NCT02498392|158180773|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|3|||
49093792|NCT02498392|158180774|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|0|||
49093793|NCT02498392|158180773|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|0|||
49093794|NCT02498392|158180774|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|2|||
49093795|NCT02498392|158180773|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|0|||
49093796|NCT02498392|158180774|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|2|||
49093797|NCT02498392|158180773|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|2|||
49093798|NCT02498392|158180774|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|3|||
49093799|NCT02498392|158180773|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Other|1|||
49093800|NCT02498392|158180774|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Other|3|||
49093801|NCT02473289|158180776|FG000|Overall Study|Adverse Event|2|||
49093802|NCT02473289|158180777|FG001|Overall Study|Adverse Event|3|||
49093803|NCT02473289|158180776|FG000|Overall Study|Lost to Follow-up|1|||
49093804|NCT02473289|158180777|FG001|Overall Study|Lost to Follow-up|1|||
49093805|NCT02473289|158180776|FG000|Overall Study|Protocol Violation|0|||
49093806|NCT02473289|158180777|FG001|Overall Study|Protocol Violation|1|||
49093807|NCT02473289|158180776|FG000|Overall Study|Withdrawal of consent|6|||
49093808|NCT02473289|158180777|FG001|Overall Study|Withdrawal of consent|7|||
49093809|NCT02473289|158180776|FG000|Overall Study|Treatment Unblinded + Adverse event|0|||
49093810|NCT02473289|158180777|FG001|Overall Study|Treatment Unblinded + Adverse event|1|||
49093811|NCT02473289|158180776|FG000|Overall Study|Other|2|||
49093812|NCT02473289|158180777|FG001|Overall Study|Other|0|||
49093813|NCT01780038|158180778|FG000|Overall Study|Lost to Follow-up|4|||
49093814|NCT01780038|158180779|FG001|Overall Study|Lost to Follow-up|1|||
49093815|NCT00459290|158180783|FG000|Overall Study|Adverse Event|3|||
49093816|NCT00459290|158180783|FG000|Overall Study|Ineligible|2|||
49093817|NCT01085630|158180784|FG000|Overall Study|Insufficient data|1|||
49093818|NCT01085630|158180785|FG001|Overall Study|Insufficient data|0|||
49093819|NCT01085630|158180784|FG000|Overall Study|Ineligible|3|||
49093820|NCT01085630|158180785|FG001|Overall Study|Ineligible|0|||
49093821|NCT05784129|158180791|FG000|Overall Study|Study terminated by sponsor|2|||
49093822|NCT05784129|158180792|FG001|Overall Study|Study terminated by sponsor|2|||
49093823|NCT03674112|158180793|FG000|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|1|||
49093824|NCT03674112|158180794|FG001|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|0|||
49093825|NCT03674112|158180793|FG000|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|0|||
49093826|NCT03674112|158180794|FG001|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|2|||
49093827|NCT03674112|158180793|FG000|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|0|||
49093828|NCT03674112|158180794|FG001|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|1|||
49093829|NCT03674112|158180793|FG000|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|1|||
49093830|NCT03674112|158180794|FG001|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|0|||
49093831|NCT03674112|158180793|FG000|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
49093832|NCT03674112|158180794|FG001|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
49093833|NCT03674112|158180793|FG000|Follow-Up Period (≥3 Years)|Lost to Follow-up|2|||
49093834|NCT03674112|158180794|FG001|Follow-Up Period (≥3 Years)|Lost to Follow-up|1|||
49093835|NCT03674112|158180793|FG000|Follow-Up Period (≥3 Years)|Death|2|||
49093836|NCT03674112|158180794|FG001|Follow-Up Period (≥3 Years)|Death|0|||
49093837|NCT03674112|158180793|FG000|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
49093838|NCT03674112|158180794|FG001|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
49093839|NCT01089608|158180796|FG000|Overall Study|Adverse Event|0|||
49093840|NCT01089608|158180797|FG001|Overall Study|Adverse Event|4|||
49093841|NCT01089608|158180796|FG000|Overall Study|Lost to Follow-up|0|||
49093842|NCT01089608|158180797|FG001|Overall Study|Lost to Follow-up|2|||
49093843|NCT01421225|158180798|FG000|Overall Study|Withdrawal by Subject|0|||
49093844|NCT01421225|158180799|FG001|Overall Study|Withdrawal by Subject|1|||
49093845|NCT00280397|158180804|FG000|Overall Study|Adverse Event|1|||
49093846|NCT02097238|158180805|FG000|Overall Study|Death|1|||
49093847|NCT02097238|158180805|FG000|Overall Study|Physician Decision|1|||
49093848|NCT02097238|158180805|FG000|Overall Study|Progressive Disease|17|||
49093849|NCT03088878|158180806|FG000|Overall Study|Adverse Event|0|||
49093850|NCT03088878|158180807|FG001|Overall Study|Adverse Event|0|||
49093851|NCT03088878|158180808|FG002|Overall Study|Adverse Event|0|||
49093852|NCT03088878|158180809|FG003|Overall Study|Adverse Event|0|||
49093853|NCT03088878|158180810|FG004|Overall Study|Adverse Event|4|||
49093854|NCT03088878|158180811|FG005|Overall Study|Adverse Event|2|||
49093855|NCT03088878|158180812|FG006|Overall Study|Adverse Event|1|||
49093856|NCT03088878|158180813|FG007|Overall Study|Adverse Event|0|||
49093857|NCT03088878|158180814|FG008|Overall Study|Adverse Event|0|||
49093858|NCT03088878|158180815|FG009|Overall Study|Adverse Event|0|||
49093859|NCT03088878|158180816|FG010|Overall Study|Adverse Event|0|||
49093860|NCT03088878|158180817|FG011|Overall Study|Adverse Event|0|||
49093861|NCT03088878|158180818|FG012|Overall Study|Adverse Event|5|||
49093862|NCT03088878|158180819|FG013|Overall Study|Adverse Event|3|||
49093863|NCT03088878|158180806|FG000|Overall Study|Clinical Progression|0|||
49093864|NCT03088878|158180807|FG001|Overall Study|Clinical Progression|0|||
49093865|NCT03088878|158180808|FG002|Overall Study|Clinical Progression|0|||
49093866|NCT03088878|158180809|FG003|Overall Study|Clinical Progression|0|||
49093867|NCT03088878|158180810|FG004|Overall Study|Clinical Progression|2|||
49093868|NCT03088878|158180811|FG005|Overall Study|Clinical Progression|0|||
49093869|NCT03088878|158180812|FG006|Overall Study|Clinical Progression|0|||
49093870|NCT03088878|158180813|FG007|Overall Study|Clinical Progression|0|||
49093871|NCT03088878|158180814|FG008|Overall Study|Clinical Progression|0|||
49093872|NCT03088878|158180815|FG009|Overall Study|Clinical Progression|0|||
49093873|NCT03088878|158180816|FG010|Overall Study|Clinical Progression|0|||
49093874|NCT03088878|158180817|FG011|Overall Study|Clinical Progression|0|||
49093875|NCT03088878|158180818|FG012|Overall Study|Clinical Progression|0|||
49093876|NCT03088878|158180819|FG013|Overall Study|Clinical Progression|0|||
49093877|NCT03088878|158180806|FG000|Overall Study|Death|0|||
49093878|NCT03088878|158180807|FG001|Overall Study|Death|0|||
49093879|NCT03088878|158180808|FG002|Overall Study|Death|0|||
49093880|NCT03088878|158180809|FG003|Overall Study|Death|0|||
49093881|NCT03088878|158180810|FG004|Overall Study|Death|2|||
49093882|NCT03088878|158180811|FG005|Overall Study|Death|0|||
49093883|NCT03088878|158180812|FG006|Overall Study|Death|0|||
49093884|NCT03088878|158180813|FG007|Overall Study|Death|0|||
49093885|NCT03088878|158180814|FG008|Overall Study|Death|0|||
49093886|NCT03088878|158180815|FG009|Overall Study|Death|0|||
49093887|NCT03088878|158180816|FG010|Overall Study|Death|0|||
49093888|NCT03088878|158180817|FG011|Overall Study|Death|1|||
49093889|NCT03088878|158180818|FG012|Overall Study|Death|0|||
49093890|NCT03088878|158180819|FG013|Overall Study|Death|0|||
49093891|NCT03088878|158180806|FG000|Overall Study|Disease Progression|1|||
49093892|NCT03088878|158180807|FG001|Overall Study|Disease Progression|2|||
49093893|NCT03088878|158180808|FG002|Overall Study|Disease Progression|3|||
49093894|NCT03088878|158180809|FG003|Overall Study|Disease Progression|0|||
49093895|NCT03088878|158180810|FG004|Overall Study|Disease Progression|3|||
49093896|NCT03088878|158180811|FG005|Overall Study|Disease Progression|0|||
49093897|NCT03088878|158180812|FG006|Overall Study|Disease Progression|0|||
49093898|NCT03088878|158180813|FG007|Overall Study|Disease Progression|0|||
49093899|NCT03088878|158180814|FG008|Overall Study|Disease Progression|0|||
49093900|NCT03088878|158180815|FG009|Overall Study|Disease Progression|0|||
49093901|NCT03088878|158180816|FG010|Overall Study|Disease Progression|0|||
49093902|NCT03088878|158180817|FG011|Overall Study|Disease Progression|0|||
49093903|NCT03088878|158180818|FG012|Overall Study|Disease Progression|1|||
49093904|NCT03088878|158180819|FG013|Overall Study|Disease Progression|1|||
49093905|NCT03088878|158180806|FG000|Overall Study|Initiation of Alternative Treatment|0|||
49093906|NCT03088878|158180807|FG001|Overall Study|Initiation of Alternative Treatment|0|||
49093907|NCT03088878|158180808|FG002|Overall Study|Initiation of Alternative Treatment|0|||
49093908|NCT03088878|158180809|FG003|Overall Study|Initiation of Alternative Treatment|1|||
49093909|NCT03088878|158180810|FG004|Overall Study|Initiation of Alternative Treatment|0|||
49093910|NCT03088878|158180811|FG005|Overall Study|Initiation of Alternative Treatment|0|||
49093911|NCT03088878|158180812|FG006|Overall Study|Initiation of Alternative Treatment|0|||
49093912|NCT03088878|158180813|FG007|Overall Study|Initiation of Alternative Treatment|1|||
49093913|NCT03088878|158180814|FG008|Overall Study|Initiation of Alternative Treatment|1|||
49093914|NCT03088878|158180815|FG009|Overall Study|Initiation of Alternative Treatment|0|||
49093915|NCT03088878|158180816|FG010|Overall Study|Initiation of Alternative Treatment|0|||
49093916|NCT03088878|158180817|FG011|Overall Study|Initiation of Alternative Treatment|0|||
49093917|NCT03088878|158180818|FG012|Overall Study|Initiation of Alternative Treatment|0|||
49093918|NCT03088878|158180819|FG013|Overall Study|Initiation of Alternative Treatment|0|||
49093919|NCT03088878|158180806|FG000|Overall Study|Withdrawal by Subject|0|||
49093920|NCT03088878|158180807|FG001|Overall Study|Withdrawal by Subject|0|||
49093921|NCT03088878|158180808|FG002|Overall Study|Withdrawal by Subject|0|||
49093922|NCT03088878|158180809|FG003|Overall Study|Withdrawal by Subject|1|||
49093923|NCT03088878|158180810|FG004|Overall Study|Withdrawal by Subject|4|||
49093924|NCT03088878|158180811|FG005|Overall Study|Withdrawal by Subject|1|||
49093925|NCT03088878|158180812|FG006|Overall Study|Withdrawal by Subject|1|||
49093926|NCT03088878|158180813|FG007|Overall Study|Withdrawal by Subject|0|||
49093927|NCT03088878|158180814|FG008|Overall Study|Withdrawal by Subject|1|||
49093928|NCT03088878|158180815|FG009|Overall Study|Withdrawal by Subject|2|||
49093929|NCT03088878|158180816|FG010|Overall Study|Withdrawal by Subject|0|||
49093930|NCT03088878|158180817|FG011|Overall Study|Withdrawal by Subject|2|||
49093931|NCT03088878|158180818|FG012|Overall Study|Withdrawal by Subject|1|||
49093932|NCT03088878|158180819|FG013|Overall Study|Withdrawal by Subject|0|||
49093933|NCT03088878|158180806|FG000|Overall Study|Terminated by Sponsor|2|||
49093934|NCT03088878|158180807|FG001|Overall Study|Terminated by Sponsor|1|||
49093935|NCT03088878|158180808|FG002|Overall Study|Terminated by Sponsor|0|||
49093936|NCT03088878|158180809|FG003|Overall Study|Terminated by Sponsor|1|||
49093937|NCT03088878|158180810|FG004|Overall Study|Terminated by Sponsor|6|||
49093938|NCT03088878|158180811|FG005|Overall Study|Terminated by Sponsor|0|||
49093939|NCT03088878|158180812|FG006|Overall Study|Terminated by Sponsor|0|||
49093940|NCT03088878|158180813|FG007|Overall Study|Terminated by Sponsor|0|||
49093941|NCT03088878|158180814|FG008|Overall Study|Terminated by Sponsor|0|||
49093942|NCT03088878|158180815|FG009|Overall Study|Terminated by Sponsor|0|||
49093943|NCT03088878|158180816|FG010|Overall Study|Terminated by Sponsor|3|||
49093944|NCT03088878|158180817|FG011|Overall Study|Terminated by Sponsor|13|||
49093945|NCT03088878|158180818|FG012|Overall Study|Terminated by Sponsor|2|||
49093946|NCT03088878|158180819|FG013|Overall Study|Terminated by Sponsor|1|||
49093947|NCT03088878|158180806|FG000|Overall Study|Completed 2 years of Treatment|0|||
49093948|NCT03088878|158180807|FG001|Overall Study|Completed 2 years of Treatment|0|||
49093949|NCT03088878|158180808|FG002|Overall Study|Completed 2 years of Treatment|0|||
49093950|NCT03088878|158180809|FG003|Overall Study|Completed 2 years of Treatment|0|||
49093951|NCT03088878|158180810|FG004|Overall Study|Completed 2 years of Treatment|0|||
49093952|NCT03088878|158180811|FG005|Overall Study|Completed 2 years of Treatment|0|||
49093953|NCT03088878|158180812|FG006|Overall Study|Completed 2 years of Treatment|1|||
49093954|NCT03088878|158180813|FG007|Overall Study|Completed 2 years of Treatment|0|||
49093955|NCT03088878|158180814|FG008|Overall Study|Completed 2 years of Treatment|0|||
49093956|NCT03088878|158180815|FG009|Overall Study|Completed 2 years of Treatment|1|||
49093957|NCT03088878|158180816|FG010|Overall Study|Completed 2 years of Treatment|0|||
49093958|NCT03088878|158180817|FG011|Overall Study|Completed 2 years of Treatment|0|||
49093959|NCT03088878|158180818|FG012|Overall Study|Completed 2 years of Treatment|8|||
49093960|NCT03088878|158180819|FG013|Overall Study|Completed 2 years of Treatment|3|||
49093961|NCT03088878|158180806|FG000|Overall Study|Physician Decision|0|||
49093962|NCT03088878|158180807|FG001|Overall Study|Physician Decision|0|||
49093963|NCT03088878|158180808|FG002|Overall Study|Physician Decision|0|||
49093964|NCT03088878|158180809|FG003|Overall Study|Physician Decision|0|||
49093965|NCT03088878|158180810|FG004|Overall Study|Physician Decision|0|||
49093966|NCT03088878|158180811|FG005|Overall Study|Physician Decision|0|||
49093967|NCT03088878|158180812|FG006|Overall Study|Physician Decision|0|||
49093968|NCT03088878|158180813|FG007|Overall Study|Physician Decision|2|||
49093969|NCT03088878|158180814|FG008|Overall Study|Physician Decision|1|||
49093970|NCT03088878|158180815|FG009|Overall Study|Physician Decision|0|||
49093971|NCT03088878|158180816|FG010|Overall Study|Physician Decision|0|||
49093972|NCT03088878|158180817|FG011|Overall Study|Physician Decision|0|||
49093973|NCT03088878|158180818|FG012|Overall Study|Physician Decision|0|||
49093974|NCT03088878|158180819|FG013|Overall Study|Physician Decision|1|||
49093975|NCT03088878|158180806|FG000|Overall Study|COVID Related noncompliance|0|||
49093976|NCT03088878|158180807|FG001|Overall Study|COVID Related noncompliance|0|||
49093977|NCT03088878|158180808|FG002|Overall Study|COVID Related noncompliance|0|||
49093978|NCT03088878|158180809|FG003|Overall Study|COVID Related noncompliance|0|||
49093979|NCT03088878|158180810|FG004|Overall Study|COVID Related noncompliance|0|||
49093980|NCT03088878|158180811|FG005|Overall Study|COVID Related noncompliance|0|||
49093981|NCT03088878|158180812|FG006|Overall Study|COVID Related noncompliance|0|||
49093982|NCT03088878|158180813|FG007|Overall Study|COVID Related noncompliance|0|||
49093983|NCT03088878|158180814|FG008|Overall Study|COVID Related noncompliance|0|||
49093984|NCT03088878|158180815|FG009|Overall Study|COVID Related noncompliance|0|||
49093985|NCT03088878|158180816|FG010|Overall Study|COVID Related noncompliance|0|||
49093986|NCT03088878|158180817|FG011|Overall Study|COVID Related noncompliance|0|||
49093987|NCT03088878|158180818|FG012|Overall Study|COVID Related noncompliance|0|||
49093988|NCT03088878|158180819|FG013|Overall Study|COVID Related noncompliance|1|||
49093989|NCT03088878|158180806|FG000|Overall Study|Drug or Study Noncompliance|0|||
49093990|NCT03088878|158180807|FG001|Overall Study|Drug or Study Noncompliance|0|||
49093991|NCT03088878|158180808|FG002|Overall Study|Drug or Study Noncompliance|0|||
49093992|NCT03088878|158180809|FG003|Overall Study|Drug or Study Noncompliance|0|||
49093993|NCT03088878|158180810|FG004|Overall Study|Drug or Study Noncompliance|0|||
49093994|NCT03088878|158180811|FG005|Overall Study|Drug or Study Noncompliance|0|||
49093995|NCT03088878|158180812|FG006|Overall Study|Drug or Study Noncompliance|0|||
49093996|NCT03088878|158180813|FG007|Overall Study|Drug or Study Noncompliance|0|||
49093997|NCT03088878|158180814|FG008|Overall Study|Drug or Study Noncompliance|0|||
49093998|NCT03088878|158180815|FG009|Overall Study|Drug or Study Noncompliance|0|||
49093999|NCT03088878|158180816|FG010|Overall Study|Drug or Study Noncompliance|0|||
49094000|NCT03088878|158180817|FG011|Overall Study|Drug or Study Noncompliance|0|||
49094001|NCT03088878|158180818|FG012|Overall Study|Drug or Study Noncompliance|1|||
49094002|NCT03088878|158180819|FG013|Overall Study|Drug or Study Noncompliance|0|||
49094003|NCT05089357|158180820|FG000|Overall Study|Withdrawal by Subject|23|||
49094004|NCT05089357|158180820|FG000|Overall Study|Lost to Follow-up|6|||
49094005|NCT05089357|158180820|FG000|Overall Study|Medical reason|1|||
49094006|NCT05089357|158180820|FG000|Overall Study|Due to completion of project, participants did not enter the follow-up window period and withdrew|2|||
49094007|NCT05089357|158180820|FG000|Overall Study|Pregnancy|2|||
49094008|NCT02724969|158180821|FG000|Overall Study|Lost to Follow-up|12|||
49094009|NCT02724969|158180822|FG001|Overall Study|Lost to Follow-up|6|||
49094010|NCT02724969|158180821|FG000|Overall Study|Withdrawal by Subject|3|||
49094011|NCT02724969|158180822|FG001|Overall Study|Withdrawal by Subject|3|||
49094012|NCT02724969|158180821|FG000|Overall Study|Infant demise|0|||
49094013|NCT02724969|158180822|FG001|Overall Study|Infant demise|2|||
49094014|NCT01346540|158180830|FG000|Overall Study|Progressive disease-RECIST 1.1 criteria|3|||
49094015|NCT01346540|158180831|FG001|Overall Study|Progressive disease-RECIST 1.1 criteria|8|||
49094016|NCT01346540|158180830|FG000|Overall Study|Adverse Event|0|||
49094017|NCT01346540|158180831|FG001|Overall Study|Adverse Event|4|||
49094018|NCT03170648|158180837|FG000|Chemotherapy Education (Cycle 2)|schedule conflict|1|||
49094019|NCT03170648|158180837|FG000|Auricular Acupuncture (Cycle 3)|Adverse Event|1|||
49094020|NCT00135512|158180838|FG000|Overall Study|Adverse Event|56|||
49094021|NCT00135512|158180838|FG000|Overall Study|Lack of Efficacy|25|||
49094022|NCT00135512|158180838|FG000|Overall Study|Other|42|||
49094023|NCT04882072|158180839|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|1|||
49094024|NCT04882072|158180840|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|0|||
49094025|NCT04882072|158180839|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|1|||
49094026|NCT04882072|158180840|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|0|||
49094027|NCT04882072|158180839|FG000|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|0|||
49094028|NCT04882072|158180840|FG001|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|1|||
49094029|NCT03517722|158180841|FG000|Double Blind Period: Week 0-52|Adverse Event|9|||
49094030|NCT03517722|158180842|FG001|Double Blind Period: Week 0-52|Adverse Event|11|||
49094031|NCT03517722|158180841|FG000|Double Blind Period: Week 0-52|Death|0|||
49094032|NCT03517722|158180842|FG001|Double Blind Period: Week 0-52|Death|4|||
49094033|NCT03517722|158180841|FG000|Double Blind Period: Week 0-52|Lack of Efficacy|2|||
49094034|NCT03517722|158180842|FG001|Double Blind Period: Week 0-52|Lack of Efficacy|3|||
49094035|NCT03517722|158180841|FG000|Double Blind Period: Week 0-52|Pregnancy|0|||
49094036|NCT03517722|158180842|FG001|Double Blind Period: Week 0-52|Pregnancy|1|||
49094037|NCT03517722|158180841|FG000|Double Blind Period: Week 0-52|Protocol Violation|1|||
49094038|NCT03517722|158180842|FG001|Double Blind Period: Week 0-52|Protocol Violation|0|||
49094039|NCT03517722|158180841|FG000|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
49094040|NCT03517722|158180842|FG001|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
49094041|NCT03517722|158180841|FG000|Double Blind Period: Week 0-52|Study Terminated by Sponsor|76|||
49094042|NCT03517722|158180842|FG001|Double Blind Period: Week 0-52|Study Terminated by Sponsor|120|||
49094043|NCT03517722|158180841|FG000|Double Blind Period: Week 0-52|Other|4|||
49094044|NCT03517722|158180842|FG001|Double Blind Period: Week 0-52|Other|3|||
49094045|NCT03517722|158180841|FG000|Double Blind Period: Week 0-52|Initiated prohibited medication|0|||
49094046|NCT03517722|158180842|FG001|Double Blind Period: Week 0-52|Initiated prohibited medication|2|||
49094047|NCT03517722|158180841|FG000|Open-label Extension Period: Week 52-113|Adverse Event|0|||
49094048|NCT03517722|158180842|FG001|Open-label Extension Period: Week 52-113|Adverse Event|1|||
49094049|NCT03517722|158180841|FG000|Open-label Extension Period: Week 52-113|Lack of Efficacy|0|||
49094050|NCT03517722|158180842|FG001|Open-label Extension Period: Week 52-113|Lack of Efficacy|1|||
49094051|NCT03517722|158180841|FG000|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
49094052|NCT03517722|158180842|FG001|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
49094053|NCT03517722|158180841|FG000|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|87|||
49094054|NCT03517722|158180842|FG001|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|134|||
49094055|NCT01844986|158180843|FG000|Overall Study (Global Cohort)|Severe non-compliance to protocol|1|||
49094056|NCT01844986|158180844|FG001|Overall Study (Global Cohort)|Severe non-compliance to protocol|0|||
49094057|NCT01844986|158180843|FG000|Overall Study (Global Cohort)|Withdrawal by Subject|21|||
49094058|NCT01844986|158180844|FG001|Overall Study (Global Cohort)|Withdrawal by Subject|14|||
49094059|NCT01844986|158180843|FG000|Overall Study (Global Cohort)|Death|55|||
49094060|NCT01844986|158180844|FG001|Overall Study (Global Cohort)|Death|26|||
49094061|NCT01844986|158180843|FG000|Overall Study (China Cohort)|Withdrawal by Subject|1|||
49094062|NCT01844986|158180844|FG001|Overall Study (China Cohort)|Withdrawal by Subject|0|||
49094063|NCT01844986|158180843|FG000|Overall Study (China Cohort)|Death|10|||
49094064|NCT01844986|158180844|FG001|Overall Study (China Cohort)|Death|6|||
49094065|NCT02422186|158180846|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
49094066|NCT02422186|158180847|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
49094067|NCT02422186|158180846|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0|||
49094068|NCT02422186|158180847|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
49094069|NCT02422186|158180846|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
49094070|NCT02422186|158180847|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2|||
49094071|NCT02422186|158180846|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3|||
49094072|NCT02422186|158180847|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
49094073|NCT02422186|158180846|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|4|||
49094074|NCT02422186|158180847|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
49094075|NCT02422186|158180846|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
49094076|NCT02422186|158180847|FG001|Double-blind Induction Phase (4 Weeks)|Other|0|||
49094077|NCT02422186|158180846|FG000|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1|||
49094078|NCT02422186|158180847|FG001|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0|||
49094079|NCT02422186|158180846|FG000|Follow-up Phase (2 Weeks)|Other|3|||
49094080|NCT02422186|158180847|FG001|Follow-up Phase (2 Weeks)|Other|0|||
49094081|NCT01814696|158180848|FG000|Overall Study|Withdrawal by Subject|1|||
49094082|NCT01814696|158180849|FG001|Overall Study|Withdrawal by Subject|0|||
49094083|NCT01814696|158180848|FG000|Overall Study|Randomized to wrong group|1|||
49094084|NCT01814696|158180849|FG001|Overall Study|Randomized to wrong group|0|||
49094085|NCT02432703|158180850|FG000|Overall Study|Adverse Event|1|||
49094086|NCT02432703|158180851|FG001|Overall Study|Adverse Event|4|||
49094087|NCT02432703|158180850|FG000|Overall Study|Lack of Efficacy|1|||
49094088|NCT02432703|158180851|FG001|Overall Study|Lack of Efficacy|0|||
49094089|NCT02432703|158180850|FG000|Overall Study|Lost to Follow-up|5|||
49094090|NCT02432703|158180851|FG001|Overall Study|Lost to Follow-up|3|||
49094091|NCT02432703|158180850|FG000|Overall Study|Withdrawal by Subject|9|||
49094092|NCT02432703|158180851|FG001|Overall Study|Withdrawal by Subject|6|||
49094093|NCT02432703|158180850|FG000|Overall Study|Other|6|||
49094094|NCT02432703|158180851|FG001|Overall Study|Other|5|||
49094095|NCT02993250|158180852|FG000|Overall Study|Lost to Follow-up|0|||
49094096|NCT02993250|158180853|FG001|Overall Study|Lost to Follow-up|1|||
49094097|NCT02829918|158180854|FG000|Overall Study|Death|2|||
49094098|NCT02829918|158180854|FG000|Overall Study|Withdrawal by Subject|4|||
49094099|NCT02829918|158180854|FG000|Overall Study|Adverse Event|1|||
49094100|NCT02829918|158180854|FG000|Overall Study|Progression|1|||
49094101|NCT04538664|158180855|FG000|Overall Study|Withdrawal by Subject|5|||
49094102|NCT04538664|158180856|FG001|Overall Study|Withdrawal by Subject|9|||
49094103|NCT04538664|158180855|FG000|Overall Study|Lost to Follow-up|2|||
49094104|NCT04538664|158180856|FG001|Overall Study|Lost to Follow-up|1|||
49094105|NCT04538664|158180855|FG000|Overall Study|Ongoing|106|||
49094106|NCT04538664|158180856|FG001|Overall Study|Ongoing|115|||
49094107|NCT05216406|158180857|FG000|Overall Study|Lost to Follow-up|8|||
49094108|NCT05216406|158180858|FG001|Overall Study|Lost to Follow-up|9|||
49094109|NCT02437162|158180859|FG000|Overall Study|Protocol Violation|0|||
49094110|NCT02437162|158180860|FG001|Overall Study|Protocol Violation|1|||
49094111|NCT02437162|158180861|FG002|Overall Study|Protocol Violation|0|||
49094112|NCT02437162|158180859|FG000|Overall Study|Randomized but not treated|0|||
49094113|NCT02437162|158180860|FG001|Overall Study|Randomized but not treated|0|||
49094114|NCT02437162|158180861|FG002|Overall Study|Randomized but not treated|1|||
49094115|NCT02437162|158180859|FG000|Overall Study|Study discontinued by Sponsor|93|||
49094116|NCT02437162|158180860|FG001|Overall Study|Study discontinued by Sponsor|98|||
49094117|NCT02437162|158180861|FG002|Overall Study|Study discontinued by Sponsor|97|||
49094118|NCT02437162|158180859|FG000|Overall Study|Withdrawal by Subject|13|||
49094119|NCT02437162|158180860|FG001|Overall Study|Withdrawal by Subject|7|||
49094120|NCT02437162|158180861|FG002|Overall Study|Withdrawal by Subject|9|||
49094121|NCT02437162|158180859|FG000|Overall Study|Adverse Event|0|||
49094122|NCT02437162|158180860|FG001|Overall Study|Adverse Event|1|||
49094123|NCT02437162|158180861|FG002|Overall Study|Adverse Event|0|||
49094124|NCT02437162|158180859|FG000|Overall Study|Lost to Follow-up|1|||
49094125|NCT02437162|158180860|FG001|Overall Study|Lost to Follow-up|0|||
49094126|NCT02437162|158180861|FG002|Overall Study|Lost to Follow-up|1|||
49094127|NCT02437162|158180859|FG000|Overall Study|Death|0|||
49094128|NCT02437162|158180860|FG001|Overall Study|Death|1|||
49094129|NCT02437162|158180861|FG002|Overall Study|Death|0|||
49094130|NCT02437162|158180859|FG000|Overall Study|Other|0|||
49094131|NCT02437162|158180860|FG001|Overall Study|Other|0|||
49094132|NCT02437162|158180861|FG002|Overall Study|Other|1|||
49094133|NCT03321526|158180862|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
49094134|NCT03321526|158180863|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
49094135|NCT03321526|158180862|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|9|||
49094136|NCT03321526|158180863|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|3|||
49094137|NCT03321526|158180862|FG000|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|1|||
49094138|NCT03321526|158180863|FG001|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|3|||
49094139|NCT03321526|158180862|FG000|Double-blind Treatment Phase (24 Weeks)|Adverse Event|7|||
49094140|NCT03321526|158180863|FG001|Double-blind Treatment Phase (24 Weeks)|Adverse Event|8|||
49094141|NCT03321526|158180862|FG000|Double-blind Treatment Phase (24 Weeks)|Death|1|||
49094142|NCT03321526|158180863|FG001|Double-blind Treatment Phase (24 Weeks)|Death|0|||
49094143|NCT03321526|158180862|FG000|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|3|||
49094144|NCT03321526|158180863|FG001|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|6|||
49094145|NCT03321526|158180862|FG000|Double-blind Treatment Phase (24 Weeks)|Other|1|||
49094146|NCT03321526|158180863|FG001|Double-blind Treatment Phase (24 Weeks)|Other|4|||
49094147|NCT03321526|158180862|FG000|Follow-up Phase (2 Weeks)|Other|24|||
49094148|NCT03321526|158180863|FG001|Follow-up Phase (2 Weeks)|Other|24|||
49094149|NCT03981744|158180864|FG000|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
49094150|NCT03981744|158180865|FG001|First Intervention (Prior to Week 24)|Withdrawal by Subject|2|||
49094151|NCT03981744|158180866|FG002|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
49094152|NCT03981744|158180867|FG003|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
49094153|NCT03981744|158180864|FG000|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
49094154|NCT03981744|158180865|FG001|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
49094155|NCT03981744|158180866|FG002|Second Intervention (Week 24 to Week 72)|Adverse Event|1|||
49094156|NCT03981744|158180867|FG003|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
49094157|NCT03981744|158180864|FG000|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
49094158|NCT03981744|158180865|FG001|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
49094159|NCT03981744|158180866|FG002|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|1|||
49094160|NCT03981744|158180867|FG003|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
49094161|NCT03711474|158180868|FG000|Overall Study|Physician Decision|2|||
49094162|NCT03711474|158180869|FG001|Overall Study|Physician Decision|0|||
49094163|NCT05974501|158180870|FG000|Overall Study|Physician Decision|0|||
49094164|NCT05974501|158180871|FG001|Overall Study|Physician Decision|1|||
49094165|NCT02782104|158180872|FG000|Overall Study|Other|215|||
49094166|NCT02782104|158180872|FG000|Overall Study|Induction Day 28 Non Responder|9|||
49094167|NCT02782104|158180872|FG000|Overall Study|Non-Compliance with Study Drug|2|||
49094168|NCT02782104|158180872|FG000|Overall Study|Death|8|||
49094169|NCT02782104|158180872|FG000|Overall Study|Pregnancy|6|||
49094170|NCT02782104|158180872|FG000|Overall Study|Withdrawal by Subject|63|||
49094171|NCT02782104|158180872|FG000|Overall Study|Protocol Violation|7|||
49094172|NCT02782104|158180872|FG000|Overall Study|Lack of Efficacy|61|||
49094173|NCT02782104|158180872|FG000|Overall Study|Lost to Follow-up|23|||
49094174|NCT02782104|158180872|FG000|Overall Study|Adverse Event|74|||
49094175|NCT03706690|158180876|FG000|Overall Study|Withdrawal by Subject|8|||
49094176|NCT03706690|158180877|FG001|Overall Study|Withdrawal by Subject|8|||
49094177|NCT03706690|158180876|FG000|Overall Study|Death|143|||
49094178|NCT03706690|158180877|FG001|Overall Study|Death|75|||
49094179|NCT03706690|158180876|FG000|Overall Study|Ongoing at DCO|121|||
49094180|NCT03706690|158180877|FG001|Overall Study|Ongoing at DCO|52|||
49094181|NCT02714595|158180878|FG000|Overall Study|Lost to Follow-up|1|||
49094182|NCT02714595|158180879|FG001|Overall Study|Lost to Follow-up|0|||
49094183|NCT02714595|158180878|FG000|Overall Study|Withdrawal by Subject|1|||
49094184|NCT02714595|158180879|FG001|Overall Study|Withdrawal by Subject|2|||
49094185|NCT02714595|158180878|FG000|Overall Study|Lack of Efficacy|0|||
49094186|NCT02714595|158180879|FG001|Overall Study|Lack of Efficacy|1|||
49094187|NCT02714595|158180878|FG000|Overall Study|Death|30|||
49094188|NCT02714595|158180879|FG001|Overall Study|Death|9|||
49094189|NCT02714595|158180878|FG000|Overall Study|Other-Miscellaneous|0|||
49094190|NCT02714595|158180879|FG001|Overall Study|Other-Miscellaneous|1|||
49094191|NCT00713258|158180880|FG000|Overall Study|Adverse Event|2|||
49094192|NCT00713258|158180881|FG001|Overall Study|Adverse Event|4|||
49094193|NCT00713258|158180880|FG000|Overall Study|Non-Compliance|2|||
49094194|NCT00713258|158180881|FG001|Overall Study|Non-Compliance|1|||
49094195|NCT00713258|158180880|FG000|Overall Study|Other|1|||
49094196|NCT00713258|158180881|FG001|Overall Study|Other|1|||
49094197|NCT03185819|158180882|FG000|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
49094198|NCT03185819|158180883|FG001|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
49094199|NCT03185819|158180884|FG002|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
49094200|NCT03185819|158180885|FG003|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|1|||
49094201|NCT03185819|158180882|FG000|Double-Blind Phase: Day 1 to Day 25|Other|1|||
49094202|NCT03185819|158180883|FG001|Double-Blind Phase: Day 1 to Day 25|Other|0|||
49094203|NCT03185819|158180884|FG002|Double-Blind Phase: Day 1 to Day 25|Other|1|||
49094204|NCT03185819|158180885|FG003|Double-Blind Phase: Day 1 to Day 25|Other|0|||
49094205|NCT03185819|158180882|FG000|Double-Blind Phase: Day 1 to Day 25|Adverse Event|1|||
49094206|NCT03185819|158180883|FG001|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
49094207|NCT03185819|158180884|FG002|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
49094208|NCT03185819|158180885|FG003|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
49094209|NCT03185819|158180882|FG000|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|2|||
49094210|NCT03185819|158180883|FG001|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
49094211|NCT03185819|158180884|FG002|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|1|||
49094212|NCT03185819|158180885|FG003|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
49094213|NCT03185819|158180882|FG000|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
49094214|NCT03185819|158180883|FG001|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
49094215|NCT03185819|158180884|FG002|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
49094216|NCT03185819|158180885|FG003|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|1|||
49094217|NCT03185819|158180882|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
49094218|NCT03185819|158180883|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
49094219|NCT03185819|158180884|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
49094220|NCT03185819|158180885|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
49094221|NCT03185819|158180882|FG000|Post-treatment Follow-up: Days 26 to 200|Other|1|||
49094222|NCT03185819|158180883|FG001|Post-treatment Follow-up: Days 26 to 200|Other|0|||
49094223|NCT03185819|158180884|FG002|Post-treatment Follow-up: Days 26 to 200|Other|3|||
49094224|NCT03185819|158180885|FG003|Post-treatment Follow-up: Days 26 to 200|Other|1|||
49094225|NCT03185819|158180882|FG000|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
49094226|NCT03185819|158180883|FG001|Post-treatment Follow-up: Days 26 to 200|Adverse Event|1|||
49094227|NCT03185819|158180884|FG002|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
49094228|NCT03185819|158180885|FG003|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
49094229|NCT03185819|158180882|FG000|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|1|||
49094230|NCT03185819|158180883|FG001|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
49094231|NCT03185819|158180884|FG002|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
49094232|NCT03185819|158180885|FG003|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
49094233|NCT03185819|158180882|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
49094234|NCT03185819|158180883|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
49094235|NCT03185819|158180884|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|2|||
49094236|NCT03185819|158180885|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|0|||
49094237|NCT03185819|158180882|FG000|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
49094238|NCT03185819|158180883|FG001|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
49094239|NCT03185819|158180884|FG002|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
49094240|NCT03185819|158180885|FG003|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
49094241|NCT03185819|158180882|FG000|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
49094242|NCT03185819|158180883|FG001|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|1|||
49094243|NCT03185819|158180884|FG002|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|0|||
49094244|NCT03185819|158180885|FG003|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
49094245|NCT03185819|158180882|FG000|Post-treatment Follow-up: Days 26 to 200|Death|1|||
49094246|NCT03185819|158180883|FG001|Post-treatment Follow-up: Days 26 to 200|Death|0|||
49094247|NCT03185819|158180884|FG002|Post-treatment Follow-up: Days 26 to 200|Death|0|||
49094248|NCT03185819|158180885|FG003|Post-treatment Follow-up: Days 26 to 200|Death|0|||
49094249|NCT03464136|158180886|FG000|Overall Study|Lost to Follow-up|5|||
49094250|NCT03464136|158180887|FG001|Overall Study|Lost to Follow-up|8|||
49094251|NCT03464136|158180886|FG000|Overall Study|Withdrawal by Subject|16|||
49094252|NCT03464136|158180887|FG001|Overall Study|Withdrawal by Subject|13|||
49094253|NCT03464136|158180886|FG000|Overall Study|Death|1|||
49094254|NCT03464136|158180887|FG001|Overall Study|Death|0|||
49094255|NCT03464136|158180886|FG000|Overall Study|Other|8|||
49094256|NCT03464136|158180887|FG001|Overall Study|Other|4|||
49094257|NCT01322490|158180888|FG000|Treatment Period|Adverse Event|12|||
49094258|NCT01322490|158180889|FG001|Treatment Period|Adverse Event|18|||
49094259|NCT01322490|158180890|FG002|Treatment Period|Adverse Event|15|||
49094260|NCT01322490|158180888|FG000|Treatment Period|Death|5|||
49094261|NCT01322490|158180889|FG001|Treatment Period|Death|7|||
49094262|NCT01322490|158180890|FG002|Treatment Period|Death|3|||
49094263|NCT01322490|158180888|FG000|Treatment Period|Lack of Efficacy|89|||
49094264|NCT01322490|158180889|FG001|Treatment Period|Lack of Efficacy|100|||
49094265|NCT01322490|158180890|FG002|Treatment Period|Lack of Efficacy|112|||
49094266|NCT01322490|158180888|FG000|Treatment Period|Physician Decision|0|||
49094267|NCT01322490|158180889|FG001|Treatment Period|Physician Decision|2|||
49094268|NCT01322490|158180890|FG002|Treatment Period|Physician Decision|1|||
49094269|NCT01322490|158180888|FG000|Treatment Period|Protocol Violation|7|||
49094270|NCT01322490|158180889|FG001|Treatment Period|Protocol Violation|5|||
49094271|NCT01322490|158180890|FG002|Treatment Period|Protocol Violation|4|||
49094272|NCT01322490|158180888|FG000|Treatment Period|Withdrawal by Subject|14|||
49094273|NCT01322490|158180889|FG001|Treatment Period|Withdrawal by Subject|16|||
49094274|NCT01322490|158180890|FG002|Treatment Period|Withdrawal by Subject|11|||
49094275|NCT01322490|158180888|FG000|Treatment Period|Non-compliance with study drug|0|||
49094276|NCT01322490|158180889|FG001|Treatment Period|Non-compliance with study drug|0|||
49094277|NCT01322490|158180890|FG002|Treatment Period|Non-compliance with study drug|1|||
49094278|NCT01322490|158180888|FG000|Treatment Period|Other per report|2|||
49094279|NCT01322490|158180889|FG001|Treatment Period|Other per report|2|||
49094280|NCT01322490|158180890|FG002|Treatment Period|Other per report|1|||
49094281|NCT01322490|158180888|FG000|Treatment Period|Randomized but Not Treated|3|||
49094282|NCT01322490|158180889|FG001|Treatment Period|Randomized but Not Treated|3|||
49094283|NCT01322490|158180890|FG002|Treatment Period|Randomized but Not Treated|5|||
49094284|NCT01322490|158180888|FG000|Long Term Follow-up Period|Death|235|||
49094285|NCT01322490|158180889|FG001|Long Term Follow-up Period|Death|239|||
49094286|NCT01322490|158180890|FG002|Long Term Follow-up Period|Death|236|||
49094287|NCT01322490|158180888|FG000|Long Term Follow-up Period|Lost to Follow-up|2|||
49094288|NCT01322490|158180889|FG001|Long Term Follow-up Period|Lost to Follow-up|2|||
49094289|NCT01322490|158180890|FG002|Long Term Follow-up Period|Lost to Follow-up|3|||
49094290|NCT01322490|158180888|FG000|Long Term Follow-up Period|Withdrawal by Subject|9|||
49094291|NCT01322490|158180889|FG001|Long Term Follow-up Period|Withdrawal by Subject|6|||
49094292|NCT01322490|158180890|FG002|Long Term Follow-up Period|Withdrawal by Subject|6|||
49094293|NCT01322490|158180888|FG000|Long Term Follow-up Period|Study Terminated by Sponsor|160|||
49094294|NCT01322490|158180889|FG001|Long Term Follow-up Period|Study Terminated by Sponsor|158|||
49094295|NCT01322490|158180890|FG002|Long Term Follow-up Period|Study Terminated by Sponsor|165|||
49094296|NCT01322490|158180888|FG000|Long Term Follow-up Period|Other per report|3|||
49094297|NCT01322490|158180889|FG001|Long Term Follow-up Period|Other per report|2|||
49094298|NCT01322490|158180890|FG002|Long Term Follow-up Period|Other per report|2|||
49094299|NCT01322490|158180888|FG000|Long Term Follow-up Period|Unknown/Missing|0|||
49094300|NCT01322490|158180889|FG001|Long Term Follow-up Period|Unknown/Missing|1|||
49094301|NCT01322490|158180890|FG002|Long Term Follow-up Period|Unknown/Missing|1|||
49094302|NCT03412565|158180891|FG000|Overall Study|Lost to Follow-up|0|||
49094303|NCT03412565|158180892|FG001|Overall Study|Lost to Follow-up|0|||
49094304|NCT03412565|158180893|FG002|Overall Study|Lost to Follow-up|1|||
49094305|NCT03412565|158180894|FG003|Overall Study|Lost to Follow-up|0|||
49094306|NCT03412565|158180891|FG000|Overall Study|Physician Decision|0|||
49094307|NCT03412565|158180892|FG001|Overall Study|Physician Decision|0|||
49094308|NCT03412565|158180893|FG002|Overall Study|Physician Decision|0|||
49094309|NCT03412565|158180894|FG003|Overall Study|Physician Decision|1|||
49094310|NCT03412565|158180891|FG000|Overall Study|Withdrawal by Subject|0|||
49094311|NCT03412565|158180892|FG001|Overall Study|Withdrawal by Subject|4|||
49094312|NCT03412565|158180893|FG002|Overall Study|Withdrawal by Subject|5|||
49094313|NCT03412565|158180894|FG003|Overall Study|Withdrawal by Subject|5|||
49094314|NCT03412565|158180891|FG000|Overall Study|Death|1|||
49094315|NCT03412565|158180892|FG001|Overall Study|Death|3|||
49094316|NCT03412565|158180893|FG002|Overall Study|Death|4|||
49094317|NCT03412565|158180894|FG003|Overall Study|Death|5|||
49094318|NCT03412565|158180891|FG000|Overall Study|Data collection ended|0|||
49094319|NCT03412565|158180892|FG001|Overall Study|Data collection ended|41|||
49094320|NCT03412565|158180893|FG002|Overall Study|Data collection ended|41|||
49094321|NCT03412565|158180894|FG003|Overall Study|Data collection ended|40|||
49094322|NCT00282113|158180898|FG000|Overall Study|Removed at parents request|1|||
49094323|NCT00282113|158180899|FG001|Overall Study|Removed at parents request|0|||
49094324|NCT00282113|158180900|FG002|Overall Study|Removed at parents request|0|||
49094325|NCT04075396|158180901|FG000|Overall Study|Death|11|||
49094326|NCT04075396|158180902|FG001|Overall Study|Death|9|||
49094327|NCT04075396|158180901|FG000|Overall Study|Withdrawal by Subject|1|||
49094328|NCT04075396|158180902|FG001|Overall Study|Withdrawal by Subject|2|||
49094329|NCT04075396|158180901|FG000|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|3|||
49094330|NCT04075396|158180902|FG001|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|2|||
49094331|NCT04075396|158180901|FG000|Overall Study|Enrolled but not-treated|0|||
49094332|NCT04075396|158180902|FG001|Overall Study|Enrolled but not-treated|1|||
49094333|NCT03434041|158180903|FG000|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
49094334|NCT03434041|158180904|FG001|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
49094335|NCT03434041|158180903|FG000|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|2|||
49094336|NCT03434041|158180904|FG001|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|1|||
49094337|NCT03434041|158180903|FG000|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|3|||
49094338|NCT03434041|158180904|FG001|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|14|||
49094339|NCT03434041|158180903|FG000|Double Blind Treatment Phase (4 Weeks)|Adverse Event|7|||
49094340|NCT03434041|158180904|FG001|Double Blind Treatment Phase (4 Weeks)|Adverse Event|2|||
49094341|NCT03434041|158180903|FG000|Double Blind Treatment Phase (4 Weeks)|Death|1|||
49094342|NCT03434041|158180904|FG001|Double Blind Treatment Phase (4 Weeks)|Death|0|||
49094343|NCT03434041|158180903|FG000|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
49094344|NCT03434041|158180904|FG001|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
49094345|NCT03434041|158180903|FG000|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|0|||
49094346|NCT03434041|158180904|FG001|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|1|||
49094347|NCT03434041|158180903|FG000|Double Blind Treatment Phase (4 Weeks)|Other|2|||
49094348|NCT03434041|158180904|FG001|Double Blind Treatment Phase (4 Weeks)|Other|0|||
49094349|NCT03434041|158180903|FG000|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|4|||
49094350|NCT03434041|158180904|FG001|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|3|||
49094351|NCT03434041|158180903|FG000|Follow-up Phase (Up to 8 Weeks)|Adverse Event|2|||
49094352|NCT03434041|158180904|FG001|Follow-up Phase (Up to 8 Weeks)|Adverse Event|0|||
49094353|NCT03434041|158180903|FG000|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|1|||
49094354|NCT03434041|158180904|FG001|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|0|||
49094355|NCT00427921|158180905|FG000|Overall Study|Adverse Event|26|||
49094356|NCT00427921|158180905|FG000|Overall Study|Withdrawal by Subject|4|||
49094357|NCT00427921|158180905|FG000|Overall Study|Lost to Follow-up|2|||
49094358|NCT00427921|158180905|FG000|Overall Study|Other reason not specified|10|||
49094359|NCT00427921|158180905|FG000|Overall Study|Adverse Event + Hospitalization|1|||
49094360|NCT00427921|158180905|FG000|Overall Study|Adverse Event + Withdrew Consent|1|||
49094361|NCT00427921|158180905|FG000|Overall Study|Adverse Event + No Response|1|||
49094362|NCT00427921|158180905|FG000|Overall Study|Adverse Event + Worsening of CD|1|||
49094363|NCT00427921|158180905|FG000|Overall Study|Adverse Event + No Therapeutic Benefit|1|||
49094364|NCT00427921|158180905|FG000|Overall Study|Adverse Event + Lost Response|1|||
49094365|NCT00427921|158180905|FG000|Overall Study|Adverse Event + Withdrawn from Study|1|||
49094366|NCT00427921|158180905|FG000|Overall Study|Withdrew Consent + Lack of Efficacy|1|||
49094367|NCT00844415|158180906|FG000|Overall Study|Withdrawal by Subject|1|||
49094368|NCT02569398|158180907|FG000|Overall Study|Adverse Event|0|||
49094369|NCT02569398|158180908|FG001|Overall Study|Adverse Event|1|||
49094370|NCT02569398|158180909|FG002|Overall Study|Adverse Event|6|||
49094371|NCT02569398|158180907|FG000|Overall Study|Withdrawal by Subject|43|||
49094372|NCT02569398|158180908|FG001|Overall Study|Withdrawal by Subject|43|||
49094373|NCT02569398|158180909|FG002|Overall Study|Withdrawal by Subject|30|||
49094374|NCT02569398|158180907|FG000|Overall Study|Study terminated by sponsor|130|||
49094375|NCT02569398|158180908|FG001|Overall Study|Study terminated by sponsor|131|||
49094376|NCT02569398|158180909|FG002|Overall Study|Study terminated by sponsor|134|||
49094377|NCT02569398|158180907|FG000|Overall Study|Other|12|||
49094378|NCT02569398|158180908|FG001|Overall Study|Other|14|||
49094379|NCT02569398|158180909|FG002|Overall Study|Other|13|||
49094380|NCT03039192|158180912|FG000|Overall Study|Lost to Follow-up|4|||
49094381|NCT03039192|158180913|FG001|Overall Study|Lost to Follow-up|4|||
49094382|NCT03039192|158180912|FG000|Overall Study|Adverse event, serious fatal|0|||
49094383|NCT03039192|158180913|FG001|Overall Study|Adverse event, serious fatal|1|||
49094384|NCT03039192|158180912|FG000|Overall Study|Adverse event, non-fatal|0|||
49094385|NCT03039192|158180913|FG001|Overall Study|Adverse event, non-fatal|2|||
49094386|NCT03039192|158180912|FG000|Overall Study|Withdrawal by Subject|6|||
49094387|NCT03039192|158180913|FG001|Overall Study|Withdrawal by Subject|9|||
49094388|NCT03039192|158180912|FG000|Overall Study|Discontinued from treatment phase|19|||
49094389|NCT03039192|158180913|FG001|Overall Study|Discontinued from treatment phase|12|||
49094390|NCT03039192|158180912|FG000|Overall Study|Other|3|||
49094391|NCT03039192|158180913|FG001|Overall Study|Other|2|||
49094392|NCT03425396|158180914|FG000|Overall Study|Lost to Follow-up|2|||
49094393|NCT03425396|158180915|FG001|Overall Study|Lost to Follow-up|5|||
49094394|NCT03425396|158180916|FG002|Overall Study|Lost to Follow-up|2|||
49094395|NCT03425396|158180917|FG003|Overall Study|Lost to Follow-up|0|||
49094396|NCT03425396|158180918|FG004|Overall Study|Lost to Follow-up|0|||
49094397|NCT03425396|158180914|FG000|Overall Study|Withdrawal by Subject|0|||
49094398|NCT03425396|158180915|FG001|Overall Study|Withdrawal by Subject|1|||
49094399|NCT03425396|158180916|FG002|Overall Study|Withdrawal by Subject|0|||
49094400|NCT03425396|158180917|FG003|Overall Study|Withdrawal by Subject|1|||
49094401|NCT03425396|158180918|FG004|Overall Study|Withdrawal by Subject|0|||
49094402|NCT03425396|158180914|FG000|Overall Study|Other|0|||
49094403|NCT03425396|158180915|FG001|Overall Study|Other|1|||
49094404|NCT03425396|158180916|FG002|Overall Study|Other|1|||
49094405|NCT03425396|158180917|FG003|Overall Study|Other|0|||
49094406|NCT03425396|158180918|FG004|Overall Study|Other|1|||
49094407|NCT02431702|158182459|FG000|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7|||
49094408|NCT02431702|158182460|FG001|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
49094409|NCT02431702|158182461|FG002|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
49094410|NCT02431702|158182462|FG003|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
49094411|NCT02431702|158182463|FG004|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
49094412|NCT02431702|158182464|FG005|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
49094413|NCT02431702|158182465|FG006|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
49094414|NCT02431702|158182459|FG000|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11|||
49094415|NCT02431702|158182460|FG001|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
49094416|NCT02431702|158182461|FG002|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
49094417|NCT02431702|158182462|FG003|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
49094418|NCT02431702|158182463|FG004|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
49094419|NCT02431702|158182464|FG005|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
49094420|NCT02431702|158182465|FG006|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23|||
49094421|NCT02431702|158182459|FG000|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9|||
49094422|NCT02431702|158182460|FG001|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
49094423|NCT02431702|158182461|FG002|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
49094424|NCT02431702|158182462|FG003|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
49094425|NCT02431702|158182463|FG004|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
49094426|NCT02431702|158182464|FG005|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
49094427|NCT02431702|158182465|FG006|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6|||
49094428|NCT02431702|158182459|FG000|Part 1: 2-Month Oral Run-in Phase|Other|5|||
49094429|NCT02431702|158182460|FG001|Part 1: 2-Month Oral Run-in Phase|Other|0|||
49094430|NCT02431702|158182461|FG002|Part 1: 2-Month Oral Run-in Phase|Other|0|||
49094431|NCT02431702|158182462|FG003|Part 1: 2-Month Oral Run-in Phase|Other|0|||
49094432|NCT02431702|158182463|FG004|Part 1: 2-Month Oral Run-in Phase|Other|0|||
49094433|NCT02431702|158182464|FG005|Part 1: 2-Month Oral Run-in Phase|Other|0|||
49094434|NCT02431702|158182465|FG006|Part 1: 2-Month Oral Run-in Phase|Other|3|||
49094435|NCT02431702|158182459|FG000|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2|||
49094436|NCT02431702|158182460|FG001|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
49094437|NCT02431702|158182461|FG002|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
49094438|NCT02431702|158182462|FG003|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
49094439|NCT02431702|158182463|FG004|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
49094440|NCT02431702|158182464|FG005|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
49094441|NCT02431702|158182465|FG006|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
49094442|NCT02431702|158182459|FG000|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
49094443|NCT02431702|158182460|FG001|Part 2: 9Month Disease Progression Phase|Adverse Event|5|||
49094444|NCT02431702|158182461|FG002|Part 2: 9Month Disease Progression Phase|Adverse Event|1|||
49094445|NCT02431702|158182462|FG003|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
49094446|NCT02431702|158182463|FG004|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
49094447|NCT02431702|158182464|FG005|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
49094448|NCT02431702|158182465|FG006|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
49094449|NCT02431702|158182459|FG000|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
49094450|NCT02431702|158182460|FG001|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6|||
49094451|NCT02431702|158182461|FG002|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13|||
49094452|NCT02431702|158182462|FG003|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
49094453|NCT02431702|158182463|FG004|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
49094454|NCT02431702|158182464|FG005|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
49094455|NCT02431702|158182465|FG006|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
49094456|NCT02431702|158182459|FG000|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
49094457|NCT02431702|158182460|FG001|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11|||
49094458|NCT02431702|158182461|FG002|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8|||
49094459|NCT02431702|158182462|FG003|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
49094460|NCT02431702|158182463|FG004|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
49094461|NCT02431702|158182464|FG005|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
49094462|NCT02431702|158182465|FG006|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
49094463|NCT02431702|158182459|FG000|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
49094464|NCT02431702|158182460|FG001|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2|||
49094465|NCT02431702|158182461|FG002|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
49094466|NCT02431702|158182462|FG003|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
49094467|NCT02431702|158182463|FG004|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
49094468|NCT02431702|158182464|FG005|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
49094469|NCT02431702|158182465|FG006|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
49094470|NCT02431702|158182459|FG000|Part 2: 9Month Disease Progression Phase|Other|0|||
49094471|NCT02431702|158182460|FG001|Part 2: 9Month Disease Progression Phase|Other|2|||
49094472|NCT02431702|158182461|FG002|Part 2: 9Month Disease Progression Phase|Other|2|||
49094473|NCT02431702|158182462|FG003|Part 2: 9Month Disease Progression Phase|Other|0|||
49094474|NCT02431702|158182463|FG004|Part 2: 9Month Disease Progression Phase|Other|0|||
49094475|NCT02431702|158182464|FG005|Part 2: 9Month Disease Progression Phase|Other|0|||
49094476|NCT02431702|158182465|FG006|Part 2: 9Month Disease Progression Phase|Other|0|||
49094477|NCT02431702|158182459|FG000|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
49094478|NCT02431702|158182460|FG001|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
49094479|NCT02431702|158182461|FG002|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5|||
49094480|NCT02431702|158182462|FG003|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
49094481|NCT02431702|158182463|FG004|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
49094482|NCT02431702|158182464|FG005|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
49094483|NCT02431702|158182465|FG006|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
49094484|NCT02431702|158182459|FG000|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
49094485|NCT02431702|158182460|FG001|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
49094486|NCT02431702|158182461|FG002|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
49094487|NCT02431702|158182462|FG003|Part 3: 9 Month of Additional Treatment|Adverse Event|2|||
49094488|NCT02431702|158182463|FG004|Part 3: 9 Month of Additional Treatment|Adverse Event|3|||
49094489|NCT02431702|158182464|FG005|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
49094490|NCT02431702|158182465|FG006|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
49094491|NCT02431702|158182459|FG000|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
49094492|NCT02431702|158182460|FG001|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
49094493|NCT02431702|158182461|FG002|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
49094494|NCT02431702|158182462|FG003|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1|||
49094495|NCT02431702|158182463|FG004|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
49094496|NCT02431702|158182464|FG005|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5|||
49094497|NCT02431702|158182465|FG006|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
49094498|NCT02431702|158182459|FG000|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
49094499|NCT02431702|158182460|FG001|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
49094500|NCT02431702|158182461|FG002|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
49094501|NCT02431702|158182462|FG003|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5|||
49094502|NCT02431702|158182463|FG004|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
49094503|NCT02431702|158182464|FG005|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
49094504|NCT02431702|158182465|FG006|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
49094505|NCT02431702|158182459|FG000|Part 3: 9 Month of Additional Treatment|Other|0|||
49094506|NCT02431702|158182460|FG001|Part 3: 9 Month of Additional Treatment|Other|0|||
49094507|NCT02431702|158182461|FG002|Part 3: 9 Month of Additional Treatment|Other|0|||
49094508|NCT02431702|158182462|FG003|Part 3: 9 Month of Additional Treatment|Other|1|||
49094509|NCT02431702|158182463|FG004|Part 3: 9 Month of Additional Treatment|Other|1|||
49094510|NCT02431702|158182464|FG005|Part 3: 9 Month of Additional Treatment|Other|6|||
49094511|NCT02431702|158182465|FG006|Part 3: 9 Month of Additional Treatment|Other|0|||
49094512|NCT02877134|158182472|FG000|Main Study (Parts I,II): Up to Week 38|Death|0|||
49094513|NCT02877134|158182473|FG001|Main Study (Parts I,II): Up to Week 38|Death|1|||
49094514|NCT02877134|158182474|FG002|Main Study (Parts I,II): Up to Week 38|Death|0|||
49094515|NCT02877134|158182475|FG003|Main Study (Parts I,II): Up to Week 38|Death|0|||
49094516|NCT02877134|158182476|FG004|Main Study (Parts I,II): Up to Week 38|Death|0|||
49094517|NCT02877134|158182477|FG005|Main Study (Parts I,II): Up to Week 38|Death|1|||
49094518|NCT02877134|158182478|FG006|Main Study (Parts I,II): Up to Week 38|Death|0|||
49094519|NCT02877134|158182479|FG007|Main Study (Parts I,II): Up to Week 38|Death|0|||
49094520|NCT02877134|158182480|FG008|Main Study (Parts I,II): Up to Week 38|Death|0|||
49094521|NCT02877134|158182481|FG009|Main Study (Parts I,II): Up to Week 38|Death|0|||
49094522|NCT02877134|158182482|FG010|Main Study (Parts I,II): Up to Week 38|Death|0|||
49094523|NCT02877134|158182483|FG011|Main Study (Parts I,II): Up to Week 38|Death|0|||
49094524|NCT02877134|158182472|FG000|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
49094525|NCT02877134|158182473|FG001|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|4|||
49094526|NCT02877134|158182474|FG002|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
49094527|NCT02877134|158182475|FG003|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
49094528|NCT02877134|158182476|FG004|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
49094529|NCT02877134|158182477|FG005|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
49094530|NCT02877134|158182478|FG006|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
49094531|NCT02877134|158182479|FG007|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
49094532|NCT02877134|158182480|FG008|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
49094533|NCT02877134|158182481|FG009|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
49094534|NCT02877134|158182482|FG010|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
49094535|NCT02877134|158182483|FG011|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
49094536|NCT02877134|158182472|FG000|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|13|||
49094537|NCT02877134|158182473|FG001|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|19|||
49094538|NCT02877134|158182474|FG002|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|5|||
49094539|NCT02877134|158182475|FG003|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|8|||
49094540|NCT02877134|158182476|FG004|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|3|||
49094541|NCT02877134|158182477|FG005|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|6|||
49094542|NCT02877134|158182478|FG006|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|2|||
49094543|NCT02877134|158182479|FG007|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
49094544|NCT02877134|158182480|FG008|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
49094545|NCT02877134|158182481|FG009|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
49094546|NCT02877134|158182482|FG010|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
49094547|NCT02877134|158182483|FG011|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
49094548|NCT02877134|158182472|FG000|Main Study (Parts I,II): Up to Week 38|Other|1|||
49094549|NCT02877134|158182473|FG001|Main Study (Parts I,II): Up to Week 38|Other|1|||
49094550|NCT02877134|158182474|FG002|Main Study (Parts I,II): Up to Week 38|Other|3|||
49094551|NCT02877134|158182475|FG003|Main Study (Parts I,II): Up to Week 38|Other|6|||
49094552|NCT02877134|158182476|FG004|Main Study (Parts I,II): Up to Week 38|Other|4|||
49094553|NCT02877134|158182477|FG005|Main Study (Parts I,II): Up to Week 38|Other|3|||
49094554|NCT02877134|158182478|FG006|Main Study (Parts I,II): Up to Week 38|Other|2|||
49094555|NCT02877134|158182479|FG007|Main Study (Parts I,II): Up to Week 38|Other|0|||
49094556|NCT02877134|158182480|FG008|Main Study (Parts I,II): Up to Week 38|Other|0|||
49094557|NCT02877134|158182481|FG009|Main Study (Parts I,II): Up to Week 38|Other|0|||
49094558|NCT02877134|158182482|FG010|Main Study (Parts I,II): Up to Week 38|Other|0|||
49094559|NCT02877134|158182483|FG011|Main Study (Parts I,II): Up to Week 38|Other|0|||
49094560|NCT02877134|158182472|FG000|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
49094561|NCT02877134|158182473|FG001|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
49094562|NCT02877134|158182474|FG002|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
49094563|NCT02877134|158182475|FG003|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
49094564|NCT02877134|158182476|FG004|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
49094565|NCT02877134|158182477|FG005|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
49094566|NCT02877134|158182478|FG006|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
49094567|NCT02877134|158182479|FG007|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
49094568|NCT02877134|158182480|FG008|Part II LTE Phase: From Week 24-88|Lost to Follow-up|1|||
49094569|NCT02877134|158182481|FG009|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
49094570|NCT02877134|158182482|FG010|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
49094571|NCT02877134|158182483|FG011|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
49094572|NCT02877134|158182472|FG000|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
49094573|NCT02877134|158182473|FG001|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
49094574|NCT02877134|158182474|FG002|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
49094575|NCT02877134|158182475|FG003|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
49094576|NCT02877134|158182476|FG004|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
49094577|NCT02877134|158182477|FG005|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
49094578|NCT02877134|158182478|FG006|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
49094579|NCT02877134|158182479|FG007|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|1|||
49094580|NCT02877134|158182480|FG008|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|2|||
49094581|NCT02877134|158182481|FG009|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
49094582|NCT02877134|158182482|FG010|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|9|||
49094583|NCT02877134|158182483|FG011|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
49094584|NCT02877134|158182472|FG000|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
49094585|NCT02877134|158182473|FG001|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
49094586|NCT02877134|158182474|FG002|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
49094587|NCT02877134|158182475|FG003|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
49094588|NCT02877134|158182476|FG004|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
49094589|NCT02877134|158182477|FG005|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
49094590|NCT02877134|158182478|FG006|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
49094591|NCT02877134|158182479|FG007|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
49094592|NCT02877134|158182480|FG008|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
49094593|NCT02877134|158182481|FG009|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
49094594|NCT02877134|158182482|FG010|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
49094595|NCT02877134|158182483|FG011|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
49094596|NCT02877134|158182472|FG000|Part II LTE Phase: From Week 24-88|Other|0|||
49094597|NCT02877134|158182473|FG001|Part II LTE Phase: From Week 24-88|Other|0|||
49094598|NCT02877134|158182474|FG002|Part II LTE Phase: From Week 24-88|Other|0|||
49094599|NCT02877134|158182475|FG003|Part II LTE Phase: From Week 24-88|Other|0|||
49094600|NCT02877134|158182476|FG004|Part II LTE Phase: From Week 24-88|Other|0|||
49094601|NCT02877134|158182477|FG005|Part II LTE Phase: From Week 24-88|Other|0|||
49094602|NCT02877134|158182478|FG006|Part II LTE Phase: From Week 24-88|Other|0|||
49094603|NCT02877134|158182479|FG007|Part II LTE Phase: From Week 24-88|Other|0|||
49094604|NCT02877134|158182480|FG008|Part II LTE Phase: From Week 24-88|Other|0|||
49094605|NCT02877134|158182481|FG009|Part II LTE Phase: From Week 24-88|Other|3|||
49094606|NCT02877134|158182482|FG010|Part II LTE Phase: From Week 24-88|Other|1|||
49094607|NCT02877134|158182483|FG011|Part II LTE Phase: From Week 24-88|Other|1|||
49094608|NCT02527434|158182485|FG000|Overall Study|Lost to Follow-up|2|||
49094609|NCT02527434|158182486|FG001|Overall Study|Lost to Follow-up|2|||
49094610|NCT02527434|158182487|FG002|Overall Study|Lost to Follow-up|0|||
49094611|NCT02527434|158182485|FG000|Overall Study|Death|19|||
49094612|NCT02527434|158182486|FG001|Overall Study|Death|6|||
49094613|NCT02527434|158182487|FG002|Overall Study|Death|17|||
49094614|NCT02527434|158182485|FG000|Overall Study|Withdrawal by Subject|5|||
49094615|NCT02527434|158182486|FG001|Overall Study|Withdrawal by Subject|3|||
49094616|NCT02527434|158182487|FG002|Overall Study|Withdrawal by Subject|3|||
49094617|NCT02527434|158182485|FG000|Overall Study|Reason Not Specified|1|||
49094618|NCT02527434|158182486|FG001|Overall Study|Reason Not Specified|0|||
49094619|NCT02527434|158182487|FG002|Overall Study|Reason Not Specified|0|||
49094620|NCT02527434|158182485|FG000|Overall Study|Site closure|1|||
49094621|NCT02527434|158182486|FG001|Overall Study|Site closure|0|||
49094622|NCT02527434|158182487|FG002|Overall Study|Site closure|0|||
49094623|NCT04338321|158182489|FG000|Overall Study|Adverse Event|4|||
49094624|NCT04338321|158182490|FG001|Overall Study|Adverse Event|10|||
49094625|NCT04338321|158182489|FG000|Overall Study|Death|1|||
49094626|NCT04338321|158182490|FG001|Overall Study|Death|1|||
49094627|NCT04338321|158182489|FG000|Overall Study|Lost to Follow-up|4|||
49094628|NCT04338321|158182490|FG001|Overall Study|Lost to Follow-up|9|||
49094629|NCT04338321|158182489|FG000|Overall Study|Withdrawal by Subject|45|||
49094630|NCT04338321|158182490|FG001|Overall Study|Withdrawal by Subject|69|||
49094631|NCT04338321|158182489|FG000|Overall Study|Physician Decision|5|||
49094632|NCT04338321|158182490|FG001|Overall Study|Physician Decision|9|||
49094633|NCT04338321|158182489|FG000|Overall Study|Other|3|||
49094634|NCT04338321|158182490|FG001|Overall Study|Other|10|||
49094635|NCT04270942|158182491|FG000|Overall Study|Death|1|||
49094636|NCT02438787|158182492|FG000|Overall Study|Adverse Event|1|||
49094637|NCT02438787|158182493|FG001|Overall Study|Adverse Event|0|||
49094638|NCT02438787|158182494|FG002|Overall Study|Adverse Event|2|||
49094639|NCT02438787|158182492|FG000|Overall Study|Lack of Efficacy|1|||
49094640|NCT02438787|158182493|FG001|Overall Study|Lack of Efficacy|2|||
49094641|NCT02438787|158182494|FG002|Overall Study|Lack of Efficacy|0|||
49094642|NCT02438787|158182492|FG000|Overall Study|Lost to Follow-up|0|||
49094643|NCT02438787|158182493|FG001|Overall Study|Lost to Follow-up|1|||
49094644|NCT02438787|158182494|FG002|Overall Study|Lost to Follow-up|0|||
49094645|NCT02438787|158182492|FG000|Overall Study|Protocol Violation|0|||
49094646|NCT02438787|158182493|FG001|Overall Study|Protocol Violation|0|||
49094647|NCT02438787|158182494|FG002|Overall Study|Protocol Violation|1|||
49094648|NCT02438787|158182492|FG000|Overall Study|Withdrawal by Subject|15|||
49094649|NCT02438787|158182493|FG001|Overall Study|Withdrawal by Subject|7|||
49094650|NCT02438787|158182494|FG002|Overall Study|Withdrawal by Subject|10|||
49094651|NCT02438787|158182492|FG000|Overall Study|Study discontinued by sponsor|64|||
49094652|NCT02438787|158182493|FG001|Overall Study|Study discontinued by sponsor|72|||
49094653|NCT02438787|158182494|FG002|Overall Study|Study discontinued by sponsor|69|||
49094654|NCT02438787|158182492|FG000|Overall Study|Other|0|||
49094655|NCT02438787|158182493|FG001|Overall Study|Other|1|||
49094656|NCT02438787|158182494|FG002|Overall Study|Other|0|||
49094657|NCT02438787|158182492|FG000|Overall Study|Site terminated by sponsor|0|||
49094658|NCT02438787|158182493|FG001|Overall Study|Site terminated by sponsor|0|||
49094659|NCT02438787|158182494|FG002|Overall Study|Site terminated by sponsor|1|||
49094660|NCT02257489|158182496|FG000|Overall Study|Withdrawal by Subject|0|||
49094661|NCT02257489|158182497|FG001|Overall Study|Withdrawal by Subject|0|||
49094662|NCT02257489|158182498|FG002|Overall Study|Withdrawal by Subject|0|||
49094663|NCT02257489|158182499|FG003|Overall Study|Withdrawal by Subject|1|||
49094664|NCT02257489|158182500|FG004|Overall Study|Withdrawal by Subject|0|||
49094665|NCT02257489|158182501|FG005|Overall Study|Withdrawal by Subject|0|||
49094666|NCT02257489|158182502|FG006|Overall Study|Withdrawal by Subject|0|||
49094667|NCT02257489|158182503|FG007|Overall Study|Withdrawal by Subject|0|||
49094668|NCT02257489|158182504|FG008|Overall Study|Withdrawal by Subject|0|||
49094669|NCT04606394|158182505|FG000|Overall Study|Withdrawal by Subject|3|||
49094670|NCT04606394|158182505|FG000|Overall Study|Exclusion criteria screen failure|12|||
49094671|NCT03672916|158182511|FG000|Overall Study|Death|6|||
49094672|NCT03672916|158182511|FG000|Overall Study|Lost to Follow-up|29|||
49094673|NCT03672916|158182511|FG000|Overall Study|Adverse Event|6|||
49094674|NCT03672916|158182511|FG000|Overall Study|Withdrawal by Subject|11|||
49094675|NCT03375203|158182512|FG000|Overall Study|Protocol Violation|0|||
49094676|NCT03375203|158182513|FG001|Overall Study|Protocol Violation|0|||
49094677|NCT03375203|158182514|FG002|Overall Study|Protocol Violation|1|||
49094678|NCT03375203|158182515|FG003|Overall Study|Protocol Violation|0|||
49094679|NCT03375203|158182516|FG004|Overall Study|Protocol Violation|0|||
49094680|NCT03375203|158182512|FG000|Overall Study|Adverse Event|2|||
49094681|NCT03375203|158182513|FG001|Overall Study|Adverse Event|3|||
49094682|NCT03375203|158182514|FG002|Overall Study|Adverse Event|0|||
49094683|NCT03375203|158182515|FG003|Overall Study|Adverse Event|2|||
49094684|NCT03375203|158182516|FG004|Overall Study|Adverse Event|2|||
49094685|NCT03375203|158182512|FG000|Overall Study|Withdrawal by Subject|3|||
49094686|NCT03375203|158182513|FG001|Overall Study|Withdrawal by Subject|0|||
49094687|NCT03375203|158182514|FG002|Overall Study|Withdrawal by Subject|1|||
49094688|NCT03375203|158182515|FG003|Overall Study|Withdrawal by Subject|0|||
49094689|NCT03375203|158182516|FG004|Overall Study|Withdrawal by Subject|2|||
49094690|NCT03375203|158182512|FG000|Overall Study|Non-compliance with study drug|1|||
49094691|NCT03375203|158182513|FG001|Overall Study|Non-compliance with study drug|0|||
49094692|NCT03375203|158182514|FG002|Overall Study|Non-compliance with study drug|0|||
49094693|NCT03375203|158182515|FG003|Overall Study|Non-compliance with study drug|0|||
49094694|NCT03375203|158182516|FG004|Overall Study|Non-compliance with study drug|0|||
49094695|NCT03375203|158182512|FG000|Overall Study|Randomized, not treated.|0|||
49094696|NCT03375203|158182513|FG001|Overall Study|Randomized, not treated.|1|||
49094697|NCT03375203|158182514|FG002|Overall Study|Randomized, not treated.|0|||
49094698|NCT03375203|158182515|FG003|Overall Study|Randomized, not treated.|0|||
49094699|NCT03375203|158182516|FG004|Overall Study|Randomized, not treated.|0|||
49094700|NCT03097133|158182527|FG000|Overall Study|Lost to Follow-up|3|||
49094701|NCT03097133|158182528|FG001|Overall Study|Lost to Follow-up|2|||
49094702|NCT03097133|158182527|FG000|Overall Study|Withdrawal by Subject|2|||
49094703|NCT03097133|158182528|FG001|Overall Study|Withdrawal by Subject|5|||
49094704|NCT03097133|158182527|FG000|Overall Study|Discontinued DB, not entered FU Phase|21|||
49094705|NCT03097133|158182528|FG001|Overall Study|Discontinued DB, not entered FU Phase|25|||
49094706|NCT03097133|158182527|FG000|Overall Study|Other|3|||
49094707|NCT03097133|158182528|FG001|Overall Study|Other|2|||
49094708|NCT03097133|158182527|FG000|Overall Study|Adverse Event|1|||
49094709|NCT03097133|158182528|FG001|Overall Study|Adverse Event|0|||
49094710|NCT03107793|158182529|FG000|Induction Period (16 Weeks)|Adverse Event|5|||
49094711|NCT03107793|158182530|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
49094712|NCT03107793|158182531|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
49094713|NCT03107793|158182532|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
49094714|NCT03107793|158182533|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
49094715|NCT03107793|158182529|FG000|Induction Period (16 Weeks)|Physician Decision|1|||
49094716|NCT03107793|158182530|FG001|Induction Period (16 Weeks)|Physician Decision|0|||
49094717|NCT03107793|158182531|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
49094718|NCT03107793|158182532|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
49094719|NCT03107793|158182533|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
49094720|NCT03107793|158182529|FG000|Induction Period (16 Weeks)|Progressive disease|1|||
49094721|NCT03107793|158182530|FG001|Induction Period (16 Weeks)|Progressive disease|0|||
49094722|NCT03107793|158182531|FG002|Induction Period (16 Weeks)|Progressive disease|0|||
49094723|NCT03107793|158182532|FG003|Induction Period (16 Weeks)|Progressive disease|0|||
49094724|NCT03107793|158182533|FG004|Induction Period (16 Weeks)|Progressive disease|0|||
49094725|NCT03107793|158182529|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
49094726|NCT03107793|158182530|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
49094727|NCT03107793|158182531|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
49094728|NCT03107793|158182532|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
49094729|NCT03107793|158182533|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
49094730|NCT03107793|158182529|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
49094731|NCT03107793|158182530|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|6|||
49094732|NCT03107793|158182531|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|10|||
49094733|NCT03107793|158182532|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
49094734|NCT03107793|158182533|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
49094735|NCT03107793|158182529|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
49094736|NCT03107793|158182530|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
49094737|NCT03107793|158182531|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|2|||
49094738|NCT03107793|158182532|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
49094739|NCT03107793|158182533|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
49094740|NCT03107793|158182529|FG000|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
49094741|NCT03107793|158182530|FG001|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
49094742|NCT03107793|158182531|FG002|Maintenance Period (Week 16-Week 48)|Progressive disease|1|||
49094743|NCT03107793|158182532|FG003|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
49094744|NCT03107793|158182533|FG004|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
49094745|NCT03107793|158182529|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
49094746|NCT03107793|158182530|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|21|||
49094747|NCT03107793|158182531|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|8|||
49094748|NCT03107793|158182532|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
49094749|NCT03107793|158182533|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
49094750|NCT03107793|158182529|FG000|Maintenance Period (Week 16-Week 48)|Death|0|||
49094751|NCT03107793|158182530|FG001|Maintenance Period (Week 16-Week 48)|Death|2|||
49094752|NCT03107793|158182531|FG002|Maintenance Period (Week 16-Week 48)|Death|0|||
49094753|NCT03107793|158182532|FG003|Maintenance Period (Week 16-Week 48)|Death|0|||
49094754|NCT03107793|158182533|FG004|Maintenance Period (Week 16-Week 48)|Death|0|||
49094755|NCT03107793|158182529|FG000|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
49094756|NCT03107793|158182530|FG001|Maintenance Period (Week 16-Week 48)|Disease relapse|2|||
49094757|NCT03107793|158182531|FG002|Maintenance Period (Week 16-Week 48)|Disease relapse|1|||
49094758|NCT03107793|158182532|FG003|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
49094759|NCT03107793|158182533|FG004|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
49094760|NCT03107793|158182529|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
49094761|NCT03107793|158182530|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
49094762|NCT03107793|158182531|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
49094763|NCT03107793|158182532|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
49094764|NCT03107793|158182533|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
49094765|NCT03107793|158182529|FG000|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
49094766|NCT03107793|158182530|FG001|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
49094767|NCT03107793|158182531|FG002|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
49094768|NCT03107793|158182532|FG003|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
49094769|NCT03107793|158182533|FG004|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
49094770|NCT03107793|158182529|FG000|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
49094771|NCT03107793|158182530|FG001|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
49094772|NCT03107793|158182531|FG002|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|1|||
49094773|NCT03107793|158182532|FG003|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
49094774|NCT03107793|158182533|FG004|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
49094775|NCT03107793|158182529|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
49094776|NCT03107793|158182530|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|12|||
49094777|NCT03107793|158182531|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
49094778|NCT03107793|158182532|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
49094779|NCT03107793|158182533|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
49094780|NCT03107793|158182529|FG000|Extension Period (Week 48- Week 104)|Adverse Event|0|||
49094781|NCT03107793|158182530|FG001|Extension Period (Week 48- Week 104)|Adverse Event|0|||
49094782|NCT03107793|158182531|FG002|Extension Period (Week 48- Week 104)|Adverse Event|0|||
49094783|NCT03107793|158182532|FG003|Extension Period (Week 48- Week 104)|Adverse Event|10|||
49094784|NCT03107793|158182533|FG004|Extension Period (Week 48- Week 104)|Adverse Event|3|||
49094785|NCT03107793|158182529|FG000|Extension Period (Week 48- Week 104)|Physician Decision|0|||
49094786|NCT03107793|158182530|FG001|Extension Period (Week 48- Week 104)|Physician Decision|0|||
49094787|NCT03107793|158182531|FG002|Extension Period (Week 48- Week 104)|Physician Decision|0|||
49094788|NCT03107793|158182532|FG003|Extension Period (Week 48- Week 104)|Physician Decision|0|||
49094789|NCT03107793|158182533|FG004|Extension Period (Week 48- Week 104)|Physician Decision|2|||
49094790|NCT03107793|158182529|FG000|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
49094791|NCT03107793|158182530|FG001|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
49094792|NCT03107793|158182531|FG002|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
49094793|NCT03107793|158182532|FG003|Extension Period (Week 48- Week 104)|Lack of Efficacy|8|||
49094794|NCT03107793|158182533|FG004|Extension Period (Week 48- Week 104)|Lack of Efficacy|9|||
49094795|NCT03107793|158182529|FG000|Extension Period (Week 48- Week 104)|Death|0|||
49094796|NCT03107793|158182530|FG001|Extension Period (Week 48- Week 104)|Death|0|||
49094797|NCT03107793|158182531|FG002|Extension Period (Week 48- Week 104)|Death|0|||
49094798|NCT03107793|158182532|FG003|Extension Period (Week 48- Week 104)|Death|0|||
49094799|NCT03107793|158182533|FG004|Extension Period (Week 48- Week 104)|Death|1|||
49094800|NCT03107793|158182529|FG000|Extension Period (Week 48- Week 104)|Disease relapse|0|||
49094801|NCT03107793|158182530|FG001|Extension Period (Week 48- Week 104)|Disease relapse|0|||
49094802|NCT03107793|158182531|FG002|Extension Period (Week 48- Week 104)|Disease relapse|0|||
49094803|NCT03107793|158182532|FG003|Extension Period (Week 48- Week 104)|Disease relapse|0|||
49094804|NCT03107793|158182533|FG004|Extension Period (Week 48- Week 104)|Disease relapse|3|||
49094805|NCT03107793|158182529|FG000|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
49094806|NCT03107793|158182530|FG001|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
49094807|NCT03107793|158182531|FG002|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
49094808|NCT03107793|158182532|FG003|Extension Period (Week 48- Week 104)|Lost to Follow-up|1|||
49094809|NCT03107793|158182533|FG004|Extension Period (Week 48- Week 104)|Lost to Follow-up|2|||
49094810|NCT03107793|158182529|FG000|Extension Period (Week 48- Week 104)|Pregnancy|0|||
49094811|NCT03107793|158182530|FG001|Extension Period (Week 48- Week 104)|Pregnancy|0|||
49094812|NCT03107793|158182531|FG002|Extension Period (Week 48- Week 104)|Pregnancy|0|||
49094813|NCT03107793|158182532|FG003|Extension Period (Week 48- Week 104)|Pregnancy|2|||
49094814|NCT03107793|158182533|FG004|Extension Period (Week 48- Week 104)|Pregnancy|4|||
49094815|NCT03107793|158182529|FG000|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
49094816|NCT03107793|158182530|FG001|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
49094817|NCT03107793|158182531|FG002|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
49094818|NCT03107793|158182532|FG003|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
49094819|NCT03107793|158182533|FG004|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|1|||
49094820|NCT03107793|158182529|FG000|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
49094821|NCT03107793|158182530|FG001|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
49094822|NCT03107793|158182531|FG002|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
49094823|NCT03107793|158182532|FG003|Extension Period (Week 48- Week 104)|Non-compliance with study drug|1|||
49094824|NCT03107793|158182533|FG004|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
49094825|NCT03107793|158182529|FG000|Extension Period (Week 48- Week 104)|Other|0|||
49094826|NCT03107793|158182530|FG001|Extension Period (Week 48- Week 104)|Other|0|||
49094827|NCT03107793|158182531|FG002|Extension Period (Week 48- Week 104)|Other|0|||
49094828|NCT03107793|158182532|FG003|Extension Period (Week 48- Week 104)|Other|1|||
49094829|NCT03107793|158182533|FG004|Extension Period (Week 48- Week 104)|Other|3|||
49094830|NCT03107793|158182529|FG000|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
49094831|NCT03107793|158182530|FG001|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
49094832|NCT03107793|158182531|FG002|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
49094833|NCT03107793|158182532|FG003|Extension Period (Week 48- Week 104)|Withdrawal by Subject|5|||
49094834|NCT03107793|158182533|FG004|Extension Period (Week 48- Week 104)|Withdrawal by Subject|9|||
49094835|NCT02201251|158182536|FG000|Overall Study|Adverse Event|1|||
49094836|NCT02201251|158182537|FG001|Overall Study|Adverse Event|1|||
49094837|NCT02201251|158182536|FG000|Overall Study|Protocol Violation|1|||
49094838|NCT02201251|158182537|FG001|Overall Study|Protocol Violation|0|||
49094839|NCT02201251|158182536|FG000|Overall Study|Noncompliance with Study Drug|0|||
49094840|NCT02201251|158182537|FG001|Overall Study|Noncompliance with Study Drug|1|||
49094841|NCT02201251|158182536|FG000|Overall Study|Withdrawal by Subject|2|||
49094842|NCT02201251|158182537|FG001|Overall Study|Withdrawal by Subject|1|||
49094843|NCT02411396|158182538|FG000|Overall Study|Lost to Follow-up|31|||
49094844|NCT02411396|158182538|FG000|Overall Study|Death|10|||
49094845|NCT01250873|158182541|FG000|Period 1: LY2216684 (Days 1-3)|Adverse Event|2|||
49094846|NCT01250873|158182541|FG000|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1|||
49094847|NCT03575793|158182543|FG000|Overall Study|Withdrawal by Subject|0|||
49094848|NCT03575793|158182544|FG001|Overall Study|Withdrawal by Subject|1|||
49094849|NCT03575793|158182543|FG000|Overall Study|Never Treated|0|||
49094850|NCT03575793|158182544|FG001|Overall Study|Never Treated|2|||
49094851|NCT02125786|158182545|FG000|Overall Study|Still in Follow-up|3|||
49094852|NCT02125786|158182545|FG000|Overall Study|Screen Failure|2|||
49094853|NCT02125786|158182545|FG000|Overall Study|Withdrawal by Family before Start of RT|2|||
49094854|NCT02125786|158182545|FG000|Overall Study|Progressive Disease|44|||
49094855|NCT02125786|158182545|FG000|Overall Study|Death|8|||
49094856|NCT03782376|158182546|FG000|Overall Study|Lost to Follow-up|2|||
49094857|NCT03782376|158182547|FG001|Overall Study|Lost to Follow-up|2|||
49094858|NCT03782376|158182546|FG000|Overall Study|Withdrawal by Subject|7|||
49094859|NCT03782376|158182547|FG001|Overall Study|Withdrawal by Subject|11|||
49094860|NCT03782376|158182546|FG000|Overall Study|Death|1|||
49094861|NCT03782376|158182547|FG001|Overall Study|Death|0|||
49094862|NCT03782376|158182546|FG000|Overall Study|Other|16|||
49094863|NCT03782376|158182547|FG001|Overall Study|Other|17|||
49094864|NCT01217476|158182548|FG000|Overall Study|Adverse Event|6|||
49094865|NCT01217476|158182549|FG001|Overall Study|Adverse Event|1|||
49094866|NCT01217476|158182548|FG000|Overall Study|Physician Decision|0|||
49094867|NCT01217476|158182549|FG001|Overall Study|Physician Decision|1|||
49094868|NCT01217476|158182548|FG000|Overall Study|Withdrawal by Subject|3|||
49094869|NCT01217476|158182549|FG001|Overall Study|Withdrawal by Subject|3|||
49094870|NCT01217476|158182548|FG000|Overall Study|Surgery on the Target Limb|0|||
49094871|NCT01217476|158182549|FG001|Overall Study|Surgery on the Target Limb|2|||
49094872|NCT01217476|158182548|FG000|Overall Study|Protocol Deviation|1|||
49094873|NCT01217476|158182549|FG001|Overall Study|Protocol Deviation|0|||
49094874|NCT01217476|158182548|FG000|Overall Study|Other|2|||
49094875|NCT01217476|158182549|FG001|Overall Study|Other|0|||
49094876|NCT04487080|158182550|FG000|Overall Study|Withdrawal by Subject|19|||
49094877|NCT04487080|158182551|FG001|Overall Study|Withdrawal by Subject|18|||
49094878|NCT04487080|158182552|FG002|Overall Study|Withdrawal by Subject|13|||
49094879|NCT04487080|158182550|FG000|Overall Study|Lost to Follow-up|3|||
49094880|NCT04487080|158182551|FG001|Overall Study|Lost to Follow-up|1|||
49094881|NCT04487080|158182552|FG002|Overall Study|Lost to Follow-up|0|||
49094882|NCT04487080|158182550|FG000|Overall Study|Ongoing|313|||
49094883|NCT04487080|158182551|FG001|Overall Study|Ongoing|297|||
49094884|NCT04487080|158182552|FG002|Overall Study|Ongoing|149|||
49094885|NCT03559192|158182553|FG000|Lead-in Period (3 Weeks)|Protocol Violation|1|||
49094886|NCT03559192|158182554|FG001|Lead-in Period (3 Weeks)|Protocol Violation|0|||
49094887|NCT03559192|158182555|FG002|Lead-in Period (3 Weeks)|Protocol Violation|0|||
49094888|NCT03559192|158182553|FG000|Lead-in Period (3 Weeks)|Withdrawal by Subject|6|||
49094889|NCT03559192|158182554|FG001|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
49094890|NCT03559192|158182555|FG002|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
49094891|NCT03559192|158182553|FG000|Lead-in Period (3 Weeks)|Adverse Event|5|||
49094892|NCT03559192|158182554|FG001|Lead-in Period (3 Weeks)|Adverse Event|0|||
49094893|NCT03559192|158182555|FG002|Lead-in Period (3 Weeks)|Adverse Event|0|||
49094894|NCT03559192|158182553|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
49094895|NCT03559192|158182554|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
49094896|NCT03559192|158182555|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|1|||
49094897|NCT03559192|158182553|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
49094898|NCT03559192|158182554|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|1|||
49094899|NCT03559192|158182555|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
49094900|NCT03559192|158182553|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
49094901|NCT03559192|158182554|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
49094902|NCT03559192|158182555|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|2|||
49094903|NCT03559192|158182553|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|0|||
49094904|NCT03559192|158182554|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
49094905|NCT03559192|158182555|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
49094906|NCT03559192|158182553|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
49094907|NCT03559192|158182554|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
49094908|NCT03559192|158182555|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|1|||
49094909|NCT03559192|158182553|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|0|||
49094910|NCT03559192|158182554|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
49094911|NCT03559192|158182555|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
49094912|NCT02493868|158182556|FG000|Induction Phase: DE Participants|Adverse Event|22|||
49094913|NCT02493868|158182557|FG001|Induction Phase: DE Participants|Adverse Event|0|||
49094914|NCT02493868|158182556|FG000|Induction Phase: DE Participants|Lost to Follow-up|1|||
49094915|NCT02493868|158182557|FG001|Induction Phase: DE Participants|Lost to Follow-up|0|||
49094916|NCT02493868|158182556|FG000|Induction Phase: DE Participants|Lack of Efficacy|2|||
49094917|NCT02493868|158182557|FG001|Induction Phase: DE Participants|Lack of Efficacy|0|||
49094918|NCT02493868|158182556|FG000|Induction Phase: DE Participants|Protocol Violation|2|||
49094919|NCT02493868|158182557|FG001|Induction Phase: DE Participants|Protocol Violation|0|||
49094920|NCT02493868|158182556|FG000|Induction Phase: DE Participants|Withdrawal by Subject|15|||
49094921|NCT02493868|158182557|FG001|Induction Phase: DE Participants|Withdrawal by Subject|0|||
49094922|NCT02493868|158182556|FG000|Induction Phase: DE Participants|Not meet criteria to continue next phase|114|||
49094923|NCT02493868|158182557|FG001|Induction Phase: DE Participants|Not meet criteria to continue next phase|0|||
49094924|NCT02493868|158182556|FG000|Induction Phase: DE Participants|Other|8|||
49094925|NCT02493868|158182557|FG001|Induction Phase: DE Participants|Other|0|||
49094926|NCT02493868|158182556|FG000|Optimization Phase: DE+TE Participants|Adverse Event|5|||
49094927|NCT02493868|158182557|FG001|Optimization Phase: DE+TE Participants|Adverse Event|0|||
49094928|NCT02493868|158182556|FG000|Optimization Phase: DE+TE Participants|Lost to Follow-up|2|||
49094929|NCT02493868|158182557|FG001|Optimization Phase: DE+TE Participants|Lost to Follow-up|1|||
49094930|NCT02493868|158182556|FG000|Optimization Phase: DE+TE Participants|Lack of Efficacy|8|||
49094931|NCT02493868|158182557|FG001|Optimization Phase: DE+TE Participants|Lack of Efficacy|0|||
49094932|NCT02493868|158182556|FG000|Optimization Phase: DE+TE Participants|Protocol Violation|4|||
49094933|NCT02493868|158182557|FG001|Optimization Phase: DE+TE Participants|Protocol Violation|1|||
49094934|NCT02493868|158182556|FG000|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8|||
49094935|NCT02493868|158182557|FG001|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3|||
49094936|NCT02493868|158182556|FG000|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14|||
49094937|NCT02493868|158182557|FG001|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5|||
49094938|NCT02493868|158182556|FG000|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107|||
49094939|NCT02493868|158182557|FG001|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20|||
49094940|NCT02493868|158182556|FG000|Optimization Phase: DE+TE Participants|Other|10|||
49094941|NCT02493868|158182557|FG001|Optimization Phase: DE+TE Participants|Other|2|||
49094942|NCT02493868|158182556|FG000|Maintenance Phase: DE+TE Participants|Adverse Event|1|||
49094943|NCT02493868|158182557|FG001|Maintenance Phase: DE+TE Participants|Adverse Event|4|||
49094944|NCT02493868|158182556|FG000|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1|||
49094945|NCT02493868|158182557|FG001|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0|||
49094946|NCT02493868|158182556|FG000|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
49094947|NCT02493868|158182557|FG001|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
49094948|NCT02493868|158182556|FG000|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5|||
49094949|NCT02493868|158182557|FG001|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7|||
49094950|NCT02493868|158182556|FG000|Maintenance Phase: DE+TE Participants|Pregnancy|1|||
49094951|NCT02493868|158182557|FG001|Maintenance Phase: DE+TE Participants|Pregnancy|0|||
49094952|NCT02493868|158182556|FG000|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0|||
49094953|NCT02493868|158182557|FG001|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1|||
49094954|NCT02493868|158182556|FG000|Maintenance Phase: DE+TE Participants|Other|4|||
49094955|NCT02493868|158182557|FG001|Maintenance Phase: DE+TE Participants|Other|9|||
49094956|NCT02493868|158182556|FG000|Follow-up Phase|Lost to Follow-up|1|||
49094957|NCT02493868|158182557|FG001|Follow-up Phase|Lost to Follow-up|0|||
49094958|NCT02493868|158182556|FG000|Follow-up Phase|Withdrawal by Subject|3|||
49094959|NCT02493868|158182557|FG001|Follow-up Phase|Withdrawal by Subject|0|||
49094960|NCT02493868|158182556|FG000|Follow-up Phase|Investigator Decision|5|||
49094961|NCT02493868|158182557|FG001|Follow-up Phase|Investigator Decision|1|||
49094962|NCT02493868|158182556|FG000|Follow-up Phase|Other|2|||
49094963|NCT02493868|158182557|FG001|Follow-up Phase|Other|1|||
49094964|NCT02147158|158182558|FG000|Treatment Course 1|Adverse Event|1|||
49094965|NCT02147158|158182559|FG001|Treatment Course 1|Adverse Event|4|||
49094966|NCT02147158|158182560|FG002|Treatment Course 1|Adverse Event|3|||
49094967|NCT02147158|158182561|FG003|Treatment Course 1|Adverse Event|4|||
49094968|NCT02147158|158182562|FG004|Treatment Course 1|Adverse Event|1|||
49094969|NCT02147158|158182563|FG005|Treatment Course 1|Adverse Event|2|||
49094970|NCT02147158|158182558|FG000|Treatment Course 1|Lost to Follow-up|2|||
49094971|NCT02147158|158182559|FG001|Treatment Course 1|Lost to Follow-up|4|||
49094972|NCT02147158|158182560|FG002|Treatment Course 1|Lost to Follow-up|3|||
49094973|NCT02147158|158182561|FG003|Treatment Course 1|Lost to Follow-up|3|||
49094974|NCT02147158|158182562|FG004|Treatment Course 1|Lost to Follow-up|2|||
49094975|NCT02147158|158182563|FG005|Treatment Course 1|Lost to Follow-up|4|||
49094976|NCT02147158|158182558|FG000|Treatment Course 1|Protocol Violation|0|||
49094977|NCT02147158|158182559|FG001|Treatment Course 1|Protocol Violation|0|||
49094978|NCT02147158|158182560|FG002|Treatment Course 1|Protocol Violation|1|||
49094979|NCT02147158|158182561|FG003|Treatment Course 1|Protocol Violation|1|||
49094980|NCT02147158|158182562|FG004|Treatment Course 1|Protocol Violation|0|||
49094981|NCT02147158|158182563|FG005|Treatment Course 1|Protocol Violation|0|||
49094982|NCT02147158|158182558|FG000|Treatment Course 1|Withdrawal of Consent|1|||
49094983|NCT02147158|158182559|FG001|Treatment Course 1|Withdrawal of Consent|1|||
49094984|NCT02147158|158182560|FG002|Treatment Course 1|Withdrawal of Consent|1|||
49094985|NCT02147158|158182561|FG003|Treatment Course 1|Withdrawal of Consent|5|||
49094986|NCT02147158|158182562|FG004|Treatment Course 1|Withdrawal of Consent|3|||
49094987|NCT02147158|158182563|FG005|Treatment Course 1|Withdrawal of Consent|2|||
49094988|NCT02147158|158182558|FG000|Off-Treatment Interval 1|Adverse Event|1|||
49094989|NCT02147158|158182559|FG001|Off-Treatment Interval 1|Adverse Event|0|||
49094990|NCT02147158|158182560|FG002|Off-Treatment Interval 1|Adverse Event|0|||
49094991|NCT02147158|158182561|FG003|Off-Treatment Interval 1|Adverse Event|1|||
49094992|NCT02147158|158182562|FG004|Off-Treatment Interval 1|Adverse Event|0|||
49094993|NCT02147158|158182563|FG005|Off-Treatment Interval 1|Adverse Event|0|||
49094994|NCT02147158|158182558|FG000|Off-Treatment Interval 1|Lost to Follow-up|2|||
49094995|NCT02147158|158182559|FG001|Off-Treatment Interval 1|Lost to Follow-up|1|||
49094996|NCT02147158|158182560|FG002|Off-Treatment Interval 1|Lost to Follow-up|3|||
49094997|NCT02147158|158182561|FG003|Off-Treatment Interval 1|Lost to Follow-up|2|||
49094998|NCT02147158|158182562|FG004|Off-Treatment Interval 1|Lost to Follow-up|4|||
49094999|NCT02147158|158182563|FG005|Off-Treatment Interval 1|Lost to Follow-up|2|||
49095000|NCT02147158|158182558|FG000|Off-Treatment Interval 1|Protocol Violation|1|||
49095001|NCT02147158|158182559|FG001|Off-Treatment Interval 1|Protocol Violation|0|||
49095002|NCT02147158|158182560|FG002|Off-Treatment Interval 1|Protocol Violation|2|||
49095003|NCT02147158|158182561|FG003|Off-Treatment Interval 1|Protocol Violation|0|||
49095004|NCT02147158|158182562|FG004|Off-Treatment Interval 1|Protocol Violation|1|||
49095005|NCT02147158|158182563|FG005|Off-Treatment Interval 1|Protocol Violation|0|||
49095006|NCT02147158|158182558|FG000|Off-Treatment Interval 1|Withdrawal of Consent|4|||
49095007|NCT02147158|158182559|FG001|Off-Treatment Interval 1|Withdrawal of Consent|3|||
49095008|NCT02147158|158182560|FG002|Off-Treatment Interval 1|Withdrawal of Consent|5|||
49095009|NCT02147158|158182561|FG003|Off-Treatment Interval 1|Withdrawal of Consent|10|||
49095010|NCT02147158|158182562|FG004|Off-Treatment Interval 1|Withdrawal of Consent|2|||
49095011|NCT02147158|158182563|FG005|Off-Treatment Interval 1|Withdrawal of Consent|3|||
49095012|NCT02147158|158182558|FG000|Off-Treatment Interval 1|Lack of Efficacy|0|||
49095013|NCT02147158|158182559|FG001|Off-Treatment Interval 1|Lack of Efficacy|0|||
49095014|NCT02147158|158182560|FG002|Off-Treatment Interval 1|Lack of Efficacy|2|||
49095015|NCT02147158|158182561|FG003|Off-Treatment Interval 1|Lack of Efficacy|0|||
49095016|NCT02147158|158182562|FG004|Off-Treatment Interval 1|Lack of Efficacy|1|||
49095017|NCT02147158|158182563|FG005|Off-Treatment Interval 1|Lack of Efficacy|0|||
49095018|NCT02147158|158182558|FG000|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
49095019|NCT02147158|158182559|FG001|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
49095020|NCT02147158|158182560|FG002|Off-Treatment Interval 1|Other Miscellaneous Reasons|3|||
49095021|NCT02147158|158182561|FG003|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
49095022|NCT02147158|158182562|FG004|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
49095023|NCT02147158|158182563|FG005|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
49095024|NCT02147158|158182558|FG000|Treatment Course 2|Adverse Event|0|||
49095025|NCT02147158|158182559|FG001|Treatment Course 2|Adverse Event|4|||
49095026|NCT02147158|158182560|FG002|Treatment Course 2|Adverse Event|2|||
49095027|NCT02147158|158182561|FG003|Treatment Course 2|Adverse Event|1|||
49095028|NCT02147158|158182562|FG004|Treatment Course 2|Adverse Event|0|||
49095029|NCT02147158|158182563|FG005|Treatment Course 2|Adverse Event|1|||
49095030|NCT02147158|158182558|FG000|Treatment Course 2|Withdrawal of Consent|0|||
49095031|NCT02147158|158182559|FG001|Treatment Course 2|Withdrawal of Consent|1|||
49095032|NCT02147158|158182560|FG002|Treatment Course 2|Withdrawal of Consent|2|||
49095033|NCT02147158|158182561|FG003|Treatment Course 2|Withdrawal of Consent|3|||
49095034|NCT02147158|158182562|FG004|Treatment Course 2|Withdrawal of Consent|0|||
49095035|NCT02147158|158182563|FG005|Treatment Course 2|Withdrawal of Consent|0|||
49095036|NCT02147158|158182558|FG000|Treatment Course 2|Lost to Follow-up|1|||
49095037|NCT02147158|158182559|FG001|Treatment Course 2|Lost to Follow-up|0|||
49095038|NCT02147158|158182560|FG002|Treatment Course 2|Lost to Follow-up|1|||
49095039|NCT02147158|158182561|FG003|Treatment Course 2|Lost to Follow-up|1|||
49095040|NCT02147158|158182562|FG004|Treatment Course 2|Lost to Follow-up|0|||
49095041|NCT02147158|158182563|FG005|Treatment Course 2|Lost to Follow-up|1|||
49095042|NCT02147158|158182558|FG000|Off-Treatment Interval 2|Lack of Efficacy|0|||
49095043|NCT02147158|158182559|FG001|Off-Treatment Interval 2|Lack of Efficacy|1|||
49095044|NCT02147158|158182560|FG002|Off-Treatment Interval 2|Lack of Efficacy|1|||
49095045|NCT02147158|158182561|FG003|Off-Treatment Interval 2|Lack of Efficacy|0|||
49095046|NCT02147158|158182562|FG004|Off-Treatment Interval 2|Lack of Efficacy|0|||
49095047|NCT02147158|158182563|FG005|Off-Treatment Interval 2|Lack of Efficacy|0|||
49095048|NCT02147158|158182558|FG000|Off-Treatment Interval 2|Withdrawal of Consent|4|||
49095049|NCT02147158|158182559|FG001|Off-Treatment Interval 2|Withdrawal of Consent|0|||
49095050|NCT02147158|158182560|FG002|Off-Treatment Interval 2|Withdrawal of Consent|5|||
49095051|NCT02147158|158182561|FG003|Off-Treatment Interval 2|Withdrawal of Consent|4|||
49095052|NCT02147158|158182562|FG004|Off-Treatment Interval 2|Withdrawal of Consent|0|||
49095053|NCT02147158|158182563|FG005|Off-Treatment Interval 2|Withdrawal of Consent|1|||
49095054|NCT02147158|158182558|FG000|Off-Treatment Interval 2|Lost to Follow-up|0|||
49095055|NCT02147158|158182559|FG001|Off-Treatment Interval 2|Lost to Follow-up|0|||
49095056|NCT02147158|158182560|FG002|Off-Treatment Interval 2|Lost to Follow-up|3|||
49095057|NCT02147158|158182561|FG003|Off-Treatment Interval 2|Lost to Follow-up|2|||
49095058|NCT02147158|158182562|FG004|Off-Treatment Interval 2|Lost to Follow-up|2|||
49095059|NCT02147158|158182563|FG005|Off-Treatment Interval 2|Lost to Follow-up|2|||
49095060|NCT02147158|158182558|FG000|Off-Treatment Interval 2|Protocol Violation|0|||
49095061|NCT02147158|158182559|FG001|Off-Treatment Interval 2|Protocol Violation|0|||
49095062|NCT02147158|158182560|FG002|Off-Treatment Interval 2|Protocol Violation|0|||
49095063|NCT02147158|158182561|FG003|Off-Treatment Interval 2|Protocol Violation|1|||
49095064|NCT02147158|158182562|FG004|Off-Treatment Interval 2|Protocol Violation|0|||
49095065|NCT02147158|158182563|FG005|Off-Treatment Interval 2|Protocol Violation|0|||
49095066|NCT02147158|158182558|FG000|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
49095067|NCT02147158|158182559|FG001|Off-Treatment Interval 2|Other Miscellaneous Reasons|3|||
49095068|NCT02147158|158182560|FG002|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
49095069|NCT02147158|158182561|FG003|Off-Treatment Interval 2|Other Miscellaneous Reasons|4|||
49095070|NCT02147158|158182562|FG004|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
49095071|NCT02147158|158182563|FG005|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
49095072|NCT03514017|158182564|FG000|Overall Study|Death|1|||
49095073|NCT03514017|158182564|FG000|Overall Study|Adverse Event|1|||
49095074|NCT04439214|158182565|FG000|Overall Study|Adverse Event|13|||
49095075|NCT04439214|158182565|FG000|Overall Study|Disease progression|16|||
49095076|NCT04439214|158182565|FG000|Overall Study|Death|1|||
49095077|NCT04439214|158182565|FG000|Overall Study|Withdrawal by Subject|2|||
49095078|NCT04439214|158182565|FG000|Overall Study|Declining health|1|||
49095079|NCT04439214|158182565|FG000|Overall Study|Still receiving treatment at the time of the analysis|9|||
49095080|NCT04439214|158182565|FG000|Overall Study|Ineligible|5|||
49095081|NCT03033602|158182569|FG000|Overall Study|Withdrawal by Subject|11|||
49095082|NCT03033602|158182570|FG001|Overall Study|Withdrawal by Subject|21|||
49095083|NCT03033602|158182569|FG000|Overall Study|discontinued for medical reason or decision by study team|9|||
49095084|NCT03033602|158182570|FG001|Overall Study|discontinued for medical reason or decision by study team|16|||
49095085|NCT02407236|158182571|FG000|Induction Study (8 Weeks)|Adverse Event|3|||
49095086|NCT02407236|158182572|FG001|Induction Study (8 Weeks)|Adverse Event|0|||
49095087|NCT02407236|158182573|FG002|Induction Study (8 Weeks)|Adverse Event|1|||
49095088|NCT02407236|158182574|FG003|Induction Study (8 Weeks)|Adverse Event|0|||
49095089|NCT02407236|158182575|FG004|Induction Study (8 Weeks)|Adverse Event|0|||
49095090|NCT02407236|158182576|FG005|Induction Study (8 Weeks)|Adverse Event|0|||
49095091|NCT02407236|158182577|FG006|Induction Study (8 Weeks)|Adverse Event|0|||
49095092|NCT02407236|158182578|FG007|Induction Study (8 Weeks)|Adverse Event|0|||
49095093|NCT02407236|158182579|FG008|Induction Study (8 Weeks)|Adverse Event|0|||
49095094|NCT02407236|158182580|FG009|Induction Study (8 Weeks)|Adverse Event|0|||
49095095|NCT02407236|158182581|FG010|Induction Study (8 Weeks)|Adverse Event|0|||
49095096|NCT02407236|158182582|FG011|Induction Study (8 Weeks)|Adverse Event|0|||
49095097|NCT02407236|158182583|FG012|Induction Study (8 Weeks)|Adverse Event|0|||
49095098|NCT02407236|158182571|FG000|Induction Study (8 Weeks)|Death|0|||
49095099|NCT02407236|158182572|FG001|Induction Study (8 Weeks)|Death|0|||
49095100|NCT02407236|158182573|FG002|Induction Study (8 Weeks)|Death|1|||
49095101|NCT02407236|158182574|FG003|Induction Study (8 Weeks)|Death|0|||
49095102|NCT02407236|158182575|FG004|Induction Study (8 Weeks)|Death|0|||
49095103|NCT02407236|158182576|FG005|Induction Study (8 Weeks)|Death|0|||
49095104|NCT02407236|158182577|FG006|Induction Study (8 Weeks)|Death|0|||
49095105|NCT02407236|158182578|FG007|Induction Study (8 Weeks)|Death|0|||
49095106|NCT02407236|158182579|FG008|Induction Study (8 Weeks)|Death|0|||
49095107|NCT02407236|158182580|FG009|Induction Study (8 Weeks)|Death|0|||
49095108|NCT02407236|158182581|FG010|Induction Study (8 Weeks)|Death|0|||
49095109|NCT02407236|158182582|FG011|Induction Study (8 Weeks)|Death|0|||
49095110|NCT02407236|158182583|FG012|Induction Study (8 Weeks)|Death|0|||
49095111|NCT02407236|158182571|FG000|Induction Study (8 Weeks)|Withdrawal by Subject|17|||
49095112|NCT02407236|158182572|FG001|Induction Study (8 Weeks)|Withdrawal by Subject|9|||
49095113|NCT02407236|158182573|FG002|Induction Study (8 Weeks)|Withdrawal by Subject|7|||
49095114|NCT02407236|158182574|FG003|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
49095115|NCT02407236|158182575|FG004|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
49095116|NCT02407236|158182576|FG005|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
49095117|NCT02407236|158182577|FG006|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
49095118|NCT02407236|158182578|FG007|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
49095119|NCT02407236|158182579|FG008|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
49095120|NCT02407236|158182580|FG009|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
49095121|NCT02407236|158182581|FG010|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
49095122|NCT02407236|158182582|FG011|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
49095123|NCT02407236|158182583|FG012|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
49095124|NCT02407236|158182571|FG000|Induction Study (8 Weeks)|Lack of Efficacy|0|||
49095125|NCT02407236|158182572|FG001|Induction Study (8 Weeks)|Lack of Efficacy|0|||
49095126|NCT02407236|158182573|FG002|Induction Study (8 Weeks)|Lack of Efficacy|1|||
49095127|NCT02407236|158182574|FG003|Induction Study (8 Weeks)|Lack of Efficacy|0|||
49095128|NCT02407236|158182575|FG004|Induction Study (8 Weeks)|Lack of Efficacy|0|||
49095129|NCT02407236|158182576|FG005|Induction Study (8 Weeks)|Lack of Efficacy|0|||
49095130|NCT02407236|158182577|FG006|Induction Study (8 Weeks)|Lack of Efficacy|0|||
49095131|NCT02407236|158182578|FG007|Induction Study (8 Weeks)|Lack of Efficacy|0|||
49095132|NCT02407236|158182579|FG008|Induction Study (8 Weeks)|Lack of Efficacy|0|||
49095133|NCT02407236|158182580|FG009|Induction Study (8 Weeks)|Lack of Efficacy|0|||
49095134|NCT02407236|158182581|FG010|Induction Study (8 Weeks)|Lack of Efficacy|0|||
49095135|NCT02407236|158182582|FG011|Induction Study (8 Weeks)|Lack of Efficacy|0|||
49095136|NCT02407236|158182583|FG012|Induction Study (8 Weeks)|Lack of Efficacy|0|||
49095137|NCT02407236|158182571|FG000|Induction Study (8 Weeks)|Physician Decision|1|||
49095138|NCT02407236|158182572|FG001|Induction Study (8 Weeks)|Physician Decision|1|||
49095139|NCT02407236|158182573|FG002|Induction Study (8 Weeks)|Physician Decision|0|||
49095140|NCT02407236|158182574|FG003|Induction Study (8 Weeks)|Physician Decision|0|||
49095141|NCT02407236|158182575|FG004|Induction Study (8 Weeks)|Physician Decision|0|||
49095142|NCT02407236|158182576|FG005|Induction Study (8 Weeks)|Physician Decision|0|||
49095143|NCT02407236|158182577|FG006|Induction Study (8 Weeks)|Physician Decision|0|||
49095144|NCT02407236|158182578|FG007|Induction Study (8 Weeks)|Physician Decision|0|||
49095145|NCT02407236|158182579|FG008|Induction Study (8 Weeks)|Physician Decision|0|||
49095146|NCT02407236|158182580|FG009|Induction Study (8 Weeks)|Physician Decision|0|||
49095147|NCT02407236|158182581|FG010|Induction Study (8 Weeks)|Physician Decision|0|||
49095148|NCT02407236|158182582|FG011|Induction Study (8 Weeks)|Physician Decision|0|||
49095149|NCT02407236|158182583|FG012|Induction Study (8 Weeks)|Physician Decision|0|||
49095150|NCT02407236|158182571|FG000|Induction Study (8 Weeks)|Other|2|||
49095151|NCT02407236|158182572|FG001|Induction Study (8 Weeks)|Other|1|||
49095152|NCT02407236|158182573|FG002|Induction Study (8 Weeks)|Other|5|||
49095153|NCT02407236|158182574|FG003|Induction Study (8 Weeks)|Other|0|||
49095154|NCT02407236|158182575|FG004|Induction Study (8 Weeks)|Other|0|||
49095155|NCT02407236|158182576|FG005|Induction Study (8 Weeks)|Other|0|||
49095156|NCT02407236|158182577|FG006|Induction Study (8 Weeks)|Other|0|||
49095157|NCT02407236|158182578|FG007|Induction Study (8 Weeks)|Other|0|||
49095158|NCT02407236|158182579|FG008|Induction Study (8 Weeks)|Other|0|||
49095159|NCT02407236|158182580|FG009|Induction Study (8 Weeks)|Other|0|||
49095160|NCT02407236|158182581|FG010|Induction Study (8 Weeks)|Other|0|||
49095161|NCT02407236|158182582|FG011|Induction Study (8 Weeks)|Other|0|||
49095162|NCT02407236|158182583|FG012|Induction Study (8 Weeks)|Other|0|||
49095163|NCT02407236|158182571|FG000|Maintenance Study (44 Weeks)|Adverse Event|0|||
49095164|NCT02407236|158182572|FG001|Maintenance Study (44 Weeks)|Adverse Event|0|||
49095165|NCT02407236|158182573|FG002|Maintenance Study (44 Weeks)|Adverse Event|0|||
49095166|NCT02407236|158182574|FG003|Maintenance Study (44 Weeks)|Adverse Event|19|||
49095167|NCT02407236|158182575|FG004|Maintenance Study (44 Weeks)|Adverse Event|8|||
49095168|NCT02407236|158182576|FG005|Maintenance Study (44 Weeks)|Adverse Event|4|||
49095169|NCT02407236|158182577|FG006|Maintenance Study (44 Weeks)|Adverse Event|11|||
49095170|NCT02407236|158182578|FG007|Maintenance Study (44 Weeks)|Adverse Event|10|||
49095171|NCT02407236|158182579|FG008|Maintenance Study (44 Weeks)|Adverse Event|0|||
49095172|NCT02407236|158182580|FG009|Maintenance Study (44 Weeks)|Adverse Event|0|||
49095173|NCT02407236|158182581|FG010|Maintenance Study (44 Weeks)|Adverse Event|0|||
49095174|NCT02407236|158182582|FG011|Maintenance Study (44 Weeks)|Adverse Event|0|||
49095175|NCT02407236|158182583|FG012|Maintenance Study (44 Weeks)|Adverse Event|0|||
49095176|NCT02407236|158182571|FG000|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
49095177|NCT02407236|158182572|FG001|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
49095178|NCT02407236|158182573|FG002|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
49095179|NCT02407236|158182574|FG003|Maintenance Study (44 Weeks)|Lack of Efficacy|19|||
49095180|NCT02407236|158182575|FG004|Maintenance Study (44 Weeks)|Lack of Efficacy|9|||
49095181|NCT02407236|158182576|FG005|Maintenance Study (44 Weeks)|Lack of Efficacy|6|||
49095182|NCT02407236|158182577|FG006|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
49095183|NCT02407236|158182578|FG007|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
49095184|NCT02407236|158182579|FG008|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
49095185|NCT02407236|158182580|FG009|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
49095186|NCT02407236|158182581|FG010|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
49095187|NCT02407236|158182582|FG011|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
49095188|NCT02407236|158182583|FG012|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
49095189|NCT02407236|158182571|FG000|Maintenance Study (44 Weeks)|Other|0|||
49095190|NCT02407236|158182572|FG001|Maintenance Study (44 Weeks)|Other|0|||
49095191|NCT02407236|158182573|FG002|Maintenance Study (44 Weeks)|Other|0|||
49095192|NCT02407236|158182574|FG003|Maintenance Study (44 Weeks)|Other|5|||
49095193|NCT02407236|158182575|FG004|Maintenance Study (44 Weeks)|Other|7|||
49095194|NCT02407236|158182576|FG005|Maintenance Study (44 Weeks)|Other|8|||
49095195|NCT02407236|158182577|FG006|Maintenance Study (44 Weeks)|Other|4|||
49095196|NCT02407236|158182578|FG007|Maintenance Study (44 Weeks)|Other|6|||
49095197|NCT02407236|158182579|FG008|Maintenance Study (44 Weeks)|Other|0|||
49095198|NCT02407236|158182580|FG009|Maintenance Study (44 Weeks)|Other|0|||
49095199|NCT02407236|158182581|FG010|Maintenance Study (44 Weeks)|Other|0|||
49095200|NCT02407236|158182582|FG011|Maintenance Study (44 Weeks)|Other|0|||
49095201|NCT02407236|158182583|FG012|Maintenance Study (44 Weeks)|Other|0|||
49095202|NCT02407236|158182571|FG000|Maintenance Study (44 Weeks)|Death|0|||
49095203|NCT02407236|158182572|FG001|Maintenance Study (44 Weeks)|Death|0|||
49095204|NCT02407236|158182573|FG002|Maintenance Study (44 Weeks)|Death|0|||
49095205|NCT02407236|158182574|FG003|Maintenance Study (44 Weeks)|Death|0|||
49095206|NCT02407236|158182575|FG004|Maintenance Study (44 Weeks)|Death|0|||
49095207|NCT02407236|158182576|FG005|Maintenance Study (44 Weeks)|Death|0|||
49095208|NCT02407236|158182577|FG006|Maintenance Study (44 Weeks)|Death|0|||
49095209|NCT02407236|158182578|FG007|Maintenance Study (44 Weeks)|Death|1|||
49095210|NCT02407236|158182579|FG008|Maintenance Study (44 Weeks)|Death|0|||
49095211|NCT02407236|158182580|FG009|Maintenance Study (44 Weeks)|Death|0|||
49095212|NCT02407236|158182581|FG010|Maintenance Study (44 Weeks)|Death|0|||
49095213|NCT02407236|158182582|FG011|Maintenance Study (44 Weeks)|Death|0|||
49095214|NCT02407236|158182583|FG012|Maintenance Study (44 Weeks)|Death|0|||
49095215|NCT02407236|158182571|FG000|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
49095216|NCT02407236|158182572|FG001|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
49095217|NCT02407236|158182573|FG002|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
49095218|NCT02407236|158182574|FG003|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
49095219|NCT02407236|158182575|FG004|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
49095220|NCT02407236|158182576|FG005|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
49095221|NCT02407236|158182577|FG006|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
49095222|NCT02407236|158182578|FG007|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
49095223|NCT02407236|158182579|FG008|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
49095224|NCT02407236|158182580|FG009|Long-term Extension Period (176 Weeks)|Adverse Event|17|||
49095225|NCT02407236|158182581|FG010|Long-term Extension Period (176 Weeks)|Adverse Event|10|||
49095226|NCT02407236|158182582|FG011|Long-term Extension Period (176 Weeks)|Adverse Event|11|||
49095227|NCT02407236|158182583|FG012|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
49095228|NCT02407236|158182571|FG000|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
49095229|NCT02407236|158182572|FG001|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
49095230|NCT02407236|158182573|FG002|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
49095231|NCT02407236|158182574|FG003|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
49095232|NCT02407236|158182575|FG004|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
49095233|NCT02407236|158182576|FG005|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
49095234|NCT02407236|158182577|FG006|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
49095235|NCT02407236|158182578|FG007|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
49095236|NCT02407236|158182579|FG008|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
49095237|NCT02407236|158182580|FG009|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
49095238|NCT02407236|158182581|FG010|Long-term Extension Period (176 Weeks)|Lost to Follow-up|1|||
49095239|NCT02407236|158182582|FG011|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
49095240|NCT02407236|158182583|FG012|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
49095241|NCT02407236|158182571|FG000|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
49095242|NCT02407236|158182572|FG001|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
49095243|NCT02407236|158182573|FG002|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
49095244|NCT02407236|158182574|FG003|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
49095245|NCT02407236|158182575|FG004|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
49095246|NCT02407236|158182576|FG005|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
49095247|NCT02407236|158182577|FG006|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
49095248|NCT02407236|158182578|FG007|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
49095249|NCT02407236|158182579|FG008|Long-term Extension Period (176 Weeks)|Lack of Efficacy|9|||
49095250|NCT02407236|158182580|FG009|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
49095251|NCT02407236|158182581|FG010|Long-term Extension Period (176 Weeks)|Lack of Efficacy|12|||
49095252|NCT02407236|158182582|FG011|Long-term Extension Period (176 Weeks)|Lack of Efficacy|7|||
49095253|NCT02407236|158182583|FG012|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
49095254|NCT02407236|158182571|FG000|Long-term Extension Period (176 Weeks)|Other|0|||
49095255|NCT02407236|158182572|FG001|Long-term Extension Period (176 Weeks)|Other|0|||
49095256|NCT02407236|158182573|FG002|Long-term Extension Period (176 Weeks)|Other|0|||
49095257|NCT02407236|158182574|FG003|Long-term Extension Period (176 Weeks)|Other|0|||
49095258|NCT02407236|158182575|FG004|Long-term Extension Period (176 Weeks)|Other|0|||
49095259|NCT02407236|158182576|FG005|Long-term Extension Period (176 Weeks)|Other|0|||
49095260|NCT02407236|158182577|FG006|Long-term Extension Period (176 Weeks)|Other|0|||
49095261|NCT02407236|158182578|FG007|Long-term Extension Period (176 Weeks)|Other|0|||
49095262|NCT02407236|158182579|FG008|Long-term Extension Period (176 Weeks)|Other|63|||
49095263|NCT02407236|158182580|FG009|Long-term Extension Period (176 Weeks)|Other|19|||
49095264|NCT02407236|158182581|FG010|Long-term Extension Period (176 Weeks)|Other|19|||
49095265|NCT02407236|158182582|FG011|Long-term Extension Period (176 Weeks)|Other|55|||
49095266|NCT02407236|158182583|FG012|Long-term Extension Period (176 Weeks)|Other|6|||
49095267|NCT01515865|158183693|FG000|Part A (Open-label)|Other|3|||
49095268|NCT01515865|158183694|FG001|Part A (Open-label)|Other|0|||
49095269|NCT01515865|158183695|FG002|Part A (Open-label)|Other|0|||
49095270|NCT01515865|158183693|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
49095271|NCT01515865|158183694|FG001|Part B (Open-label)|Withdrawal by Subject|0|||
49095272|NCT01515865|158183695|FG002|Part B (Open-label)|Withdrawal by Subject|0|||
49095273|NCT01515865|158183693|FG000|Part B (Open-label)|Other|1|||
49095274|NCT01515865|158183694|FG001|Part B (Open-label)|Other|0|||
49095275|NCT01515865|158183695|FG002|Part B (Open-label)|Other|0|||
49095276|NCT03693612|158183696|FG000|Overall Study|Lost to Follow-up|0|||
49095277|NCT03693612|158183697|FG001|Overall Study|Lost to Follow-up|0|||
49095278|NCT03693612|158183698|FG002|Overall Study|Lost to Follow-up|0|||
49095279|NCT03693612|158183699|FG003|Overall Study|Lost to Follow-up|0|||
49095280|NCT03693612|158183700|FG004|Overall Study|Lost to Follow-up|1|||
49095281|NCT03693612|158183701|FG005|Overall Study|Lost to Follow-up|0|||
49095282|NCT03693612|158183702|FG006|Overall Study|Lost to Follow-up|0|||
49095283|NCT03693612|158183696|FG000|Overall Study|Withdrawal by Subject|0|||
49095284|NCT03693612|158183697|FG001|Overall Study|Withdrawal by Subject|0|||
49095285|NCT03693612|158183698|FG002|Overall Study|Withdrawal by Subject|1|||
49095286|NCT03693612|158183699|FG003|Overall Study|Withdrawal by Subject|0|||
49095287|NCT03693612|158183700|FG004|Overall Study|Withdrawal by Subject|2|||
49095288|NCT03693612|158183701|FG005|Overall Study|Withdrawal by Subject|0|||
49095289|NCT03693612|158183702|FG006|Overall Study|Withdrawal by Subject|0|||
49095290|NCT03693612|158183696|FG000|Overall Study|Study Terminated by Sponsor|0|||
49095291|NCT03693612|158183697|FG001|Overall Study|Study Terminated by Sponsor|1|||
49095292|NCT03693612|158183698|FG002|Overall Study|Study Terminated by Sponsor|0|||
49095293|NCT03693612|158183699|FG003|Overall Study|Study Terminated by Sponsor|0|||
49095294|NCT03693612|158183700|FG004|Overall Study|Study Terminated by Sponsor|3|||
49095295|NCT03693612|158183701|FG005|Overall Study|Study Terminated by Sponsor|0|||
49095296|NCT03693612|158183702|FG006|Overall Study|Study Terminated by Sponsor|0|||
49095297|NCT02366637|158183703|FG000|First Intervention Period|Adverse Event|0|||
49095298|NCT02366637|158183704|FG001|First Intervention Period|Adverse Event|1|||
49095299|NCT02366637|158183703|FG000|First Intervention Period|Study Terminated by Sponsor|6|||
49095300|NCT02366637|158183704|FG001|First Intervention Period|Study Terminated by Sponsor|4|||
49095301|NCT02366637|158183703|FG000|Second Intervention Period|Study Terminated by Sponsor|1|||
49095302|NCT02366637|158183704|FG001|Second Intervention Period|Study Terminated by Sponsor|1|||
49095303|NCT04871711|158183705|FG000|Overall Study|Withdrawal by Subject|11|||
49095304|NCT04871711|158183706|FG001|Overall Study|Withdrawal by Subject|5|||
49095305|NCT04871711|158183705|FG000|Overall Study|Lack of Efficacy|5|||
49095306|NCT04871711|158183706|FG001|Overall Study|Lack of Efficacy|7|||
49095307|NCT04871711|158183705|FG000|Overall Study|Adverse Event|2|||
49095308|NCT04871711|158183706|FG001|Overall Study|Adverse Event|6|||
49095309|NCT04871711|158183705|FG000|Overall Study|Various reasons|2|||
49095310|NCT04871711|158183706|FG001|Overall Study|Various reasons|1|||
49095311|NCT04871711|158183705|FG000|Overall Study|Lost to Follow-up|0|||
49095312|NCT04871711|158183706|FG001|Overall Study|Lost to Follow-up|2|||
49095313|NCT03503370|158183708|FG000|Overall Study|Death|3|||
49095314|NCT03503370|158183709|FG001|Overall Study|Death|1|||
49095315|NCT03345342|158183713|FG000|Open-Label Phase|Adverse Event|30|||
49095316|NCT03345342|158183714|FG001|Open-Label Phase|Adverse Event|0|||
49095317|NCT03345342|158183715|FG002|Open-Label Phase|Adverse Event|0|||
49095318|NCT03345342|158183716|FG003|Open-Label Phase|Adverse Event|0|||
49095319|NCT03345342|158183717|FG004|Open-Label Phase|Adverse Event|0|||
49095320|NCT03345342|158183713|FG000|Open-Label Phase|Death|1|||
49095321|NCT03345342|158183714|FG001|Open-Label Phase|Death|0|||
49095322|NCT03345342|158183715|FG002|Open-Label Phase|Death|0|||
49095323|NCT03345342|158183716|FG003|Open-Label Phase|Death|0|||
49095324|NCT03345342|158183717|FG004|Open-Label Phase|Death|0|||
49095325|NCT03345342|158183713|FG000|Open-Label Phase|Initiated Prohibited Medication|2|||
49095326|NCT03345342|158183714|FG001|Open-Label Phase|Initiated Prohibited Medication|0|||
49095327|NCT03345342|158183715|FG002|Open-Label Phase|Initiated Prohibited Medication|0|||
49095328|NCT03345342|158183716|FG003|Open-Label Phase|Initiated Prohibited Medication|0|||
49095329|NCT03345342|158183717|FG004|Open-Label Phase|Initiated Prohibited Medication|0|||
49095330|NCT03345342|158183713|FG000|Open-Label Phase|Lack of Efficacy|6|||
49095331|NCT03345342|158183714|FG001|Open-Label Phase|Lack of Efficacy|0|||
49095332|NCT03345342|158183715|FG002|Open-Label Phase|Lack of Efficacy|0|||
49095333|NCT03345342|158183716|FG003|Open-Label Phase|Lack of Efficacy|0|||
49095334|NCT03345342|158183717|FG004|Open-Label Phase|Lack of Efficacy|0|||
49095335|NCT03345342|158183713|FG000|Open-Label Phase|Lost to Follow-up|9|||
49095336|NCT03345342|158183714|FG001|Open-Label Phase|Lost to Follow-up|0|||
49095337|NCT03345342|158183715|FG002|Open-Label Phase|Lost to Follow-up|0|||
49095338|NCT03345342|158183716|FG003|Open-Label Phase|Lost to Follow-up|0|||
49095339|NCT03345342|158183717|FG004|Open-Label Phase|Lost to Follow-up|0|||
49095340|NCT03345342|158183713|FG000|Open-Label Phase|Non-Compliance with Study Drug|4|||
49095341|NCT03345342|158183714|FG001|Open-Label Phase|Non-Compliance with Study Drug|0|||
49095342|NCT03345342|158183715|FG002|Open-Label Phase|Non-Compliance with Study Drug|0|||
49095343|NCT03345342|158183716|FG003|Open-Label Phase|Non-Compliance with Study Drug|0|||
49095344|NCT03345342|158183717|FG004|Open-Label Phase|Non-Compliance with Study Drug|0|||
49095345|NCT03345342|158183713|FG000|Open-Label Phase|Physician Decision|4|||
49095346|NCT03345342|158183714|FG001|Open-Label Phase|Physician Decision|0|||
49095347|NCT03345342|158183715|FG002|Open-Label Phase|Physician Decision|0|||
49095348|NCT03345342|158183716|FG003|Open-Label Phase|Physician Decision|0|||
49095349|NCT03345342|158183717|FG004|Open-Label Phase|Physician Decision|0|||
49095350|NCT03345342|158183713|FG000|Open-Label Phase|Protocol Violation|8|||
49095351|NCT03345342|158183714|FG001|Open-Label Phase|Protocol Violation|0|||
49095352|NCT03345342|158183715|FG002|Open-Label Phase|Protocol Violation|0|||
49095353|NCT03345342|158183716|FG003|Open-Label Phase|Protocol Violation|0|||
49095354|NCT03345342|158183717|FG004|Open-Label Phase|Protocol Violation|0|||
49095355|NCT03345342|158183713|FG000|Open-Label Phase|Withdrawal by Subject|57|||
49095356|NCT03345342|158183714|FG001|Open-Label Phase|Withdrawal by Subject|0|||
49095357|NCT03345342|158183715|FG002|Open-Label Phase|Withdrawal by Subject|0|||
49095358|NCT03345342|158183716|FG003|Open-Label Phase|Withdrawal by Subject|0|||
49095359|NCT03345342|158183717|FG004|Open-Label Phase|Withdrawal by Subject|0|||
49095360|NCT03345342|158183713|FG000|Open-Label Phase|Other|15|||
49095361|NCT03345342|158183714|FG001|Open-Label Phase|Other|0|||
49095362|NCT03345342|158183715|FG002|Open-Label Phase|Other|0|||
49095363|NCT03345342|158183716|FG003|Open-Label Phase|Other|0|||
49095364|NCT03345342|158183717|FG004|Open-Label Phase|Other|0|||
49095365|NCT03345342|158183713|FG000|Double-Blind Phase|Adverse Event|0|||
49095366|NCT03345342|158183714|FG001|Double-Blind Phase|Adverse Event|1|||
49095367|NCT03345342|158183715|FG002|Double-Blind Phase|Adverse Event|6|||
49095368|NCT03345342|158183716|FG003|Double-Blind Phase|Adverse Event|0|||
49095369|NCT03345342|158183717|FG004|Double-Blind Phase|Adverse Event|0|||
49095370|NCT03345342|158183713|FG000|Double-Blind Phase|Death|0|||
49095371|NCT03345342|158183714|FG001|Double-Blind Phase|Death|2|||
49095372|NCT03345342|158183715|FG002|Double-Blind Phase|Death|1|||
49095373|NCT03345342|158183716|FG003|Double-Blind Phase|Death|0|||
49095374|NCT03345342|158183717|FG004|Double-Blind Phase|Death|0|||
49095375|NCT03345342|158183713|FG000|Double-Blind Phase|Initiated Prohibited Medication|0|||
49095376|NCT03345342|158183714|FG001|Double-Blind Phase|Initiated Prohibited Medication|0|||
49095377|NCT03345342|158183715|FG002|Double-Blind Phase|Initiated Prohibited Medication|2|||
49095378|NCT03345342|158183716|FG003|Double-Blind Phase|Initiated Prohibited Medication|0|||
49095379|NCT03345342|158183717|FG004|Double-Blind Phase|Initiated Prohibited Medication|0|||
49095380|NCT03345342|158183713|FG000|Double-Blind Phase|Lost to Follow-up|0|||
49095381|NCT03345342|158183714|FG001|Double-Blind Phase|Lost to Follow-up|1|||
49095382|NCT03345342|158183715|FG002|Double-Blind Phase|Lost to Follow-up|7|||
49095383|NCT03345342|158183716|FG003|Double-Blind Phase|Lost to Follow-up|0|||
49095384|NCT03345342|158183717|FG004|Double-Blind Phase|Lost to Follow-up|0|||
49095385|NCT03345342|158183713|FG000|Double-Blind Phase|Physician Decision|0|||
49095386|NCT03345342|158183714|FG001|Double-Blind Phase|Physician Decision|1|||
49095387|NCT03345342|158183715|FG002|Double-Blind Phase|Physician Decision|4|||
49095388|NCT03345342|158183716|FG003|Double-Blind Phase|Physician Decision|0|||
49095389|NCT03345342|158183717|FG004|Double-Blind Phase|Physician Decision|0|||
49095390|NCT03345342|158183713|FG000|Double-Blind Phase|Protocol Violation|0|||
49095391|NCT03345342|158183714|FG001|Double-Blind Phase|Protocol Violation|0|||
49095392|NCT03345342|158183715|FG002|Double-Blind Phase|Protocol Violation|1|||
49095393|NCT03345342|158183716|FG003|Double-Blind Phase|Protocol Violation|0|||
49095394|NCT03345342|158183717|FG004|Double-Blind Phase|Protocol Violation|0|||
49095395|NCT03345342|158183713|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
49095396|NCT03345342|158183714|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
49095397|NCT03345342|158183715|FG002|Double-Blind Phase|Withdrawal by Subject|38|||
49095398|NCT03345342|158183716|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
49095399|NCT03345342|158183717|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
49095400|NCT03345342|158183713|FG000|Double-Blind Phase|Other|0|||
49095401|NCT03345342|158183714|FG001|Double-Blind Phase|Other|1|||
49095402|NCT03345342|158183715|FG002|Double-Blind Phase|Other|3|||
49095403|NCT03345342|158183716|FG003|Double-Blind Phase|Other|0|||
49095404|NCT03345342|158183717|FG004|Double-Blind Phase|Other|0|||
49095405|NCT03345342|158183713|FG000|Follow-Up Phase|Adverse Event|0|||
49095406|NCT03345342|158183714|FG001|Follow-Up Phase|Adverse Event|0|||
49095407|NCT03345342|158183715|FG002|Follow-Up Phase|Adverse Event|0|||
49095408|NCT03345342|158183716|FG003|Follow-Up Phase|Adverse Event|0|||
49095409|NCT03345342|158183717|FG004|Follow-Up Phase|Adverse Event|4|||
49095410|NCT03345342|158183713|FG000|Follow-Up Phase|Lost to Follow-up|0|||
49095411|NCT03345342|158183714|FG001|Follow-Up Phase|Lost to Follow-up|0|||
49095412|NCT03345342|158183715|FG002|Follow-Up Phase|Lost to Follow-up|0|||
49095413|NCT03345342|158183716|FG003|Follow-Up Phase|Lost to Follow-up|0|||
49095414|NCT03345342|158183717|FG004|Follow-Up Phase|Lost to Follow-up|6|||
49095415|NCT03345342|158183713|FG000|Follow-Up Phase|Physician Decision|0|||
49095416|NCT03345342|158183714|FG001|Follow-Up Phase|Physician Decision|0|||
49095417|NCT03345342|158183715|FG002|Follow-Up Phase|Physician Decision|0|||
49095418|NCT03345342|158183716|FG003|Follow-Up Phase|Physician Decision|0|||
49095419|NCT03345342|158183717|FG004|Follow-Up Phase|Physician Decision|5|||
49095420|NCT03345342|158183713|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
49095421|NCT03345342|158183714|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
49095422|NCT03345342|158183715|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
49095423|NCT03345342|158183716|FG003|Follow-Up Phase|Withdrawal by Subject|5|||
49095424|NCT03345342|158183717|FG004|Follow-Up Phase|Withdrawal by Subject|15|||
49095425|NCT03345342|158183713|FG000|Follow-Up Phase|Other|0|||
49095426|NCT03345342|158183714|FG001|Follow-Up Phase|Other|0|||
49095427|NCT03345342|158183715|FG002|Follow-Up Phase|Other|0|||
49095428|NCT03345342|158183716|FG003|Follow-Up Phase|Other|3|||
49095429|NCT03345342|158183717|FG004|Follow-Up Phase|Other|1|||
49095430|NCT00568061|158183722|FG000|Overall Study|Inclusion / exclusion criteria|5|||
49095431|NCT00568061|158183723|FG001|Overall Study|Inclusion / exclusion criteria|1|||
49095432|NCT00568061|158183722|FG000|Overall Study|Adverse Event|0|||
49095433|NCT00568061|158183723|FG001|Overall Study|Adverse Event|1|||
49095434|NCT00955955|158183724|FG000|Overall Study|Lost to Follow-up|2|||
49095435|NCT00955955|158183725|FG001|Overall Study|Lost to Follow-up|0|||
49095436|NCT00955955|158183726|FG002|Overall Study|Lost to Follow-up|0|||
49095437|NCT01972438|158183727|FG000|Baseline-Month 3 Crossover Period|Death|1|||
49095438|NCT01972438|158183728|FG001|Baseline-Month 3 Crossover Period|Death|0|||
49095439|NCT01972438|158183727|FG000|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1|||
49095440|NCT01972438|158183728|FG001|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0|||
49095441|NCT01972438|158183727|FG000|Baseline-Month 3 Crossover Period|Unable to donate blood|0|||
49095442|NCT01972438|158183728|FG001|Baseline-Month 3 Crossover Period|Unable to donate blood|1|||
49095443|NCT01972438|158183727|FG000|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1|||
49095444|NCT01972438|158183728|FG001|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2|||
49095445|NCT01972438|158183727|FG000|Months 3-6 Crossover Period|Early Study Closure|0|||
49095446|NCT01972438|158183728|FG001|Months 3-6 Crossover Period|Early Study Closure|1|||
49095447|NCT01972438|158183727|FG000|Months 6-12 Study Period|Death|1|||
49095448|NCT01972438|158183728|FG001|Months 6-12 Study Period|Death|0|||
49095449|NCT01972438|158183727|FG000|Months 6-12 Study Period|Early Study Closure|2|||
49095450|NCT01972438|158183728|FG001|Months 6-12 Study Period|Early Study Closure|2|||
49095451|NCT01972438|158183727|FG000|Post Month 12 Study Period|Early Study Closure|3|||
49095452|NCT01972438|158183728|FG001|Post Month 12 Study Period|Early Study Closure|4|||
49095453|NCT03277105|158183729|FG000|Overall Study|Death|129|||
49095454|NCT03277105|158183730|FG001|Overall Study|Death|124|||
49095455|NCT03277105|158183729|FG000|Overall Study|Lost to Follow-up|2|||
49095456|NCT03277105|158183730|FG001|Overall Study|Lost to Follow-up|4|||
49095457|NCT03277105|158183729|FG000|Overall Study|Withdrawal by Subject|10|||
49095458|NCT03277105|158183730|FG001|Overall Study|Withdrawal by Subject|10|||
49095459|NCT03277105|158183729|FG000|Overall Study|Other|118|||
49095460|NCT03277105|158183730|FG001|Overall Study|Other|125|||
49095461|NCT03348930|158183731|FG000|Washout (1 Week)|Lost to Follow-up|1|||
49095462|NCT03348930|158183732|FG001|Washout (1 Week)|Lost to Follow-up|1|||
49095463|NCT01053663|158183733|FG000|Overall Study|Death|2|||
49095464|NCT01053663|158183733|FG000|Overall Study|Lost to Follow-up|1|||
49095465|NCT01053663|158183733|FG000|Overall Study|Poor IV Access|1|||
49095466|NCT01053663|158183733|FG000|Overall Study|Transferred to Another Hospital|1|||
49095467|NCT01053663|158183733|FG000|Overall Study|Negative Influenza Diagnosis|1|||
49095468|NCT00708214|158183734|FG000|Overall Study|Other Adverse Event|3|||
49095469|NCT00708214|158183735|FG001|Overall Study|Other Adverse Event|6|||
49095470|NCT00708214|158183736|FG002|Overall Study|Other Adverse Event|2|||
49095471|NCT00708214|158183734|FG000|Overall Study|Other|0|||
49095472|NCT00708214|158183735|FG001|Overall Study|Other|1|||
49095473|NCT00708214|158183736|FG002|Overall Study|Other|1|||
49095474|NCT00708214|158183734|FG000|Overall Study|Progressive Disease|4|||
49095475|NCT00708214|158183735|FG001|Overall Study|Progressive Disease|6|||
49095476|NCT00708214|158183736|FG002|Overall Study|Progressive Disease|5|||
49095477|NCT03533114|158183737|FG000|Overall|Adverse Event|16|||
49095478|NCT03533114|158183738|FG001|Overall|Adverse Event|11|||
49095479|NCT03533114|158183737|FG000|Overall|Consent Withdrawal by Participant|7|||
49095480|NCT03533114|158183738|FG001|Overall|Consent Withdrawal by Participant|6|||
49095481|NCT03533114|158183737|FG000|Overall|Lack of Efficacy|5|||
49095482|NCT03533114|158183738|FG001|Overall|Lack of Efficacy|3|||
49095483|NCT03533114|158183737|FG000|Overall|Lost to Follow-up|1|||
49095484|NCT03533114|158183738|FG001|Overall|Lost to Follow-up|1|||
49095485|NCT03533114|158183737|FG000|Overall|Physician Decision|0|||
49095486|NCT03533114|158183738|FG001|Overall|Physician Decision|2|||
49095487|NCT03533114|158183737|FG000|Overall|Protocol deviation|1|||
49095488|NCT03533114|158183738|FG001|Overall|Protocol deviation|1|||
49095489|NCT03533114|158183737|FG000|Overall|Failure to meet randomization criteria|1|||
49095490|NCT03533114|158183738|FG001|Overall|Failure to meet randomization criteria|2|||
49095491|NCT03533114|158183737|FG000|Overall|Non-Compliance with study drug|0|||
49095492|NCT03533114|158183738|FG001|Overall|Non-Compliance with study drug|1|||
49095493|NCT03533114|158183737|FG000|Overall|Other|0|||
49095494|NCT03533114|158183738|FG001|Overall|Other|1|||
49095495|NCT03533114|158183737|FG000|Open Label Titration and Optimization|Adverse Event|11|||
49095496|NCT03533114|158183738|FG001|Open Label Titration and Optimization|Adverse Event|8|||
49095497|NCT03533114|158183737|FG000|Open Label Titration and Optimization|Consent Withdrawal by Participant|2|||
49095498|NCT03533114|158183738|FG001|Open Label Titration and Optimization|Consent Withdrawal by Participant|1|||
49095499|NCT03533114|158183737|FG000|Open Label Titration and Optimization|Lack of Efficacy|3|||
49095500|NCT03533114|158183738|FG001|Open Label Titration and Optimization|Lack of Efficacy|1|||
49095501|NCT03533114|158183737|FG000|Open Label Titration and Optimization|Lost to Follow-up|0|||
49095502|NCT03533114|158183738|FG001|Open Label Titration and Optimization|Lost to Follow-up|1|||
49095503|NCT03533114|158183737|FG000|Open Label Titration and Optimization|Protocol Deviation|0|||
49095504|NCT03533114|158183738|FG001|Open Label Titration and Optimization|Protocol Deviation|1|||
49095505|NCT03533114|158183737|FG000|Open Label Titration and Optimization|Non-Compliance with Study Drug|0|||
49095506|NCT03533114|158183738|FG001|Open Label Titration and Optimization|Non-Compliance with Study Drug|1|||
49095507|NCT03533114|158183737|FG000|Stable Dose|Adverse Event|0|||
49095508|NCT03533114|158183738|FG001|Stable Dose|Adverse Event|2|||
49095509|NCT03533114|158183737|FG000|Stable Dose|Consent Withdrawal by Participant|1|||
49095510|NCT03533114|158183738|FG001|Stable Dose|Consent Withdrawal by Participant|0|||
49095511|NCT03533114|158183737|FG000|Stable Dose|Lack of Efficacy|1|||
49095512|NCT03533114|158183738|FG001|Stable Dose|Lack of Efficacy|0|||
49095513|NCT03533114|158183737|FG000|Double Blind Randomized-Withdrawal|Adverse Event|1|||
49095514|NCT03533114|158183738|FG001|Double Blind Randomized-Withdrawal|Adverse Event|1|||
49095515|NCT03533114|158183737|FG000|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|1|||
49095516|NCT03533114|158183738|FG001|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|0|||
49095517|NCT03533114|158183737|FG000|Open-Label Safety Extension|Adverse Event|3|||
49095518|NCT03533114|158183738|FG001|Open-Label Safety Extension|Adverse Event|0|||
49095519|NCT03533114|158183737|FG000|Open-Label Safety Extension|Consent Withdrawal by Participant|2|||
49095520|NCT03533114|158183738|FG001|Open-Label Safety Extension|Consent Withdrawal by Participant|3|||
49095521|NCT03533114|158183737|FG000|Open-Label Safety Extension|Lack of Efficacy|1|||
49095522|NCT03533114|158183738|FG001|Open-Label Safety Extension|Lack of Efficacy|0|||
49095523|NCT03533114|158183737|FG000|Open-Label Safety Extension|Lost to Follow-up|1|||
49095524|NCT03533114|158183738|FG001|Open-Label Safety Extension|Lost to Follow-up|0|||
49095525|NCT03533114|158183737|FG000|Open-Label Safety Extension|Protocol Deviation|1|||
49095526|NCT03533114|158183738|FG001|Open-Label Safety Extension|Protocol Deviation|0|||
49095527|NCT00812981|158183739|FG000|Overall Study|Other|0|||
49095528|NCT00812981|158183740|FG001|Overall Study|Other|1|||
49095529|NCT01862250|158183741|FG000|Overall Study|Adverse Event|4|||
49095530|NCT02199795|158183742|FG000|Overall Study|no longer met inclusion criteria|1|||
49095531|NCT02199795|158183743|FG001|Overall Study|no longer met inclusion criteria|0|||
49095532|NCT02199795|158183742|FG000|Overall Study|withdrew due to shoulder pain|1|||
49095533|NCT02199795|158183743|FG001|Overall Study|withdrew due to shoulder pain|0|||
49095534|NCT03169881|158183744|FG000|Overall Study|Incomplete Follow-up|10|||
49095535|NCT03169881|158183745|FG001|Overall Study|Incomplete Follow-up|15|||
49095536|NCT03169881|158183744|FG000|Overall Study|Lost to Follow-up|18|||
49095537|NCT03169881|158183745|FG001|Overall Study|Lost to Follow-up|20|||
49095538|NCT03169881|158183744|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
49095539|NCT03169881|158183745|FG001|Overall Study|Data withdrawn prior to hospital discharge|1|||
49095540|NCT03852264|158183746|FG000|Third Research Visit|Lost to Follow-up|1|||
49095541|NCT03852264|158183747|FG001|Third Research Visit|Lost to Follow-up|0|||
49095542|NCT06303167|158183751|FG000|Overall Study|Ineligible|1|||
49095543|NCT06303167|158183751|FG000|Overall Study|Never start protocol therapy|2|||
49095544|NCT06303167|158183751|FG000|Overall Study|Disease progression|16|||
49095545|NCT01482065|158183752|FG000|Overall Study|Withdrawal by Subject|0|||
49095546|NCT01482065|158183753|FG001|Overall Study|Withdrawal by Subject|1|||
49095547|NCT01942486|158183754|FG000|Overall Study|Lost to Follow-up|27|||
49095548|NCT02278939|158183755|FG000|Overall Study|lack of time|1|||
49095549|NCT02278939|158183756|FG001|Overall Study|lack of time|0|||
49095550|NCT02278939|158183755|FG000|Overall Study|Lost to Follow-up|1|||
49095551|NCT02278939|158183756|FG001|Overall Study|Lost to Follow-up|1|||
49095552|NCT02278939|158183755|FG000|Overall Study|death in family|1|||
49095553|NCT02278939|158183756|FG001|Overall Study|death in family|0|||
49095554|NCT02278939|158183755|FG000|Overall Study|family emergency unable to commit|2|||
49095555|NCT02278939|158183756|FG001|Overall Study|family emergency unable to commit|0|||
49095556|NCT01194999|158183759|FG000|Overall Study|Lost to Follow-up|17|||
49095557|NCT03382834|158183760|FG000|Step 1|Lost to Follow-up|0|||
49095558|NCT03382834|158183761|FG001|Step 1|Lost to Follow-up|1|||
49095559|NCT03382834|158183760|FG000|Step 2|Death|1|||
49095560|NCT03382834|158183761|FG001|Step 2|Death|0|||
49095561|NCT03382834|158183760|FG000|Step 2|Lost to Follow-up|2|||
49095562|NCT03382834|158183761|FG001|Step 2|Lost to Follow-up|2|||
49095563|NCT03382834|158183760|FG000|Step 2|Site Terminated by Sponsor|1|||
49095564|NCT03382834|158183761|FG001|Step 2|Site Terminated by Sponsor|0|||
49095565|NCT03706430|158183762|FG000|Overall Study|No A-Line placed|5|||
49095566|NCT03706430|158183762|FG000|Overall Study|Subject had gel nail polish|1|||
49095567|NCT03706430|158183762|FG000|Overall Study|Nail length causing difficulties with sensor|1|||
49095568|NCT03706430|158183762|FG000|Overall Study|Cancelled Case|6|||
49095569|NCT03706430|158183762|FG000|Overall Study|Physician Decision|2|||
49095570|NCT02887248|158183763|FG000|Overall Study|Withdrawal by Subject|1|||
49095571|NCT02887248|158183763|FG000|Overall Study|Adverse Event|1|||
49095572|NCT02887248|158183763|FG000|Overall Study|Progressive Disease|1|||
49095573|NCT03728426|158183764|FG000|Overall Study|Death|3|||
49095574|NCT04740827|158183765|FG000|Double-blind Treatment (Up to Week 12)|Adverse Event|2|||
49095575|NCT04740827|158183766|FG001|Double-blind Treatment (Up to Week 12)|Adverse Event|4|||
49095576|NCT04740827|158183765|FG000|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|0|||
49095577|NCT04740827|158183766|FG001|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|1|||
49095578|NCT04740827|158183765|FG000|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
49095579|NCT04740827|158183766|FG001|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
49095580|NCT04740827|158183765|FG000|Double-blind Treatment (Up to Week 12)|Pregnancy|0|||
49095581|NCT04740827|158183766|FG001|Double-blind Treatment (Up to Week 12)|Pregnancy|1|||
49095582|NCT04740827|158183765|FG000|Double-blind Treatment (Up to Week 12)|Protocol Deviation|3|||
49095583|NCT04740827|158183766|FG001|Double-blind Treatment (Up to Week 12)|Protocol Deviation|5|||
49095584|NCT04740827|158183765|FG000|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|1|||
49095585|NCT04740827|158183766|FG001|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|0|||
49095586|NCT02727777|158183773|FG000|Overall Study|Screen Failure|2|||
49095587|NCT02727777|158183774|FG001|Overall Study|Screen Failure|0|||
49095588|NCT02727777|158183775|FG002|Overall Study|Screen Failure|0|||
49095589|NCT02727777|158183773|FG000|Overall Study|Progressive disease|2|||
49095590|NCT02727777|158183774|FG001|Overall Study|Progressive disease|0|||
49095591|NCT02727777|158183775|FG002|Overall Study|Progressive disease|0|||
49095592|NCT03003494|158183780|FG000|Overall Study|Evaluable PF10 questionnaire at visit1|28|||
49095593|NCT02609607|158185242|FG000|Overall Study|Lost to Follow-up|0|||
49095594|NCT02609607|158185243|FG001|Overall Study|Lost to Follow-up|1|||
49095595|NCT00809471|158185250|FG000|Overall Study|Protocol non-compliance|15|||
49095596|NCT00809471|158185251|FG001|Overall Study|Protocol non-compliance|15|||
49095597|NCT00809471|158185252|FG002|Overall Study|Protocol non-compliance|6|||
49095598|NCT00809471|158185250|FG000|Overall Study|Lost to Follow-up|4|||
49095599|NCT00809471|158185251|FG001|Overall Study|Lost to Follow-up|2|||
49095600|NCT00809471|158185252|FG002|Overall Study|Lost to Follow-up|9|||
49095601|NCT00809471|158185250|FG000|Overall Study|Adverse Event|0|||
49095602|NCT00809471|158185251|FG001|Overall Study|Adverse Event|2|||
49095603|NCT00809471|158185252|FG002|Overall Study|Adverse Event|2|||
49095604|NCT00809471|158185250|FG000|Overall Study|Requirement for restricted medication|1|||
49095605|NCT00809471|158185251|FG001|Overall Study|Requirement for restricted medication|1|||
49095606|NCT00809471|158185252|FG002|Overall Study|Requirement for restricted medication|0|||
49095607|NCT00831311|158185253|FG000|Overall Study|Definitive Contraindication|3|||
49095608|NCT00831311|158185254|FG001|Overall Study|Definitive Contraindication|3|||
49095609|NCT00831311|158185253|FG000|Overall Study|Lost to Follow-up|3|||
49095610|NCT00831311|158185254|FG001|Overall Study|Lost to Follow-up|0|||
49095611|NCT00831311|158185253|FG000|Overall Study|Physician Decision|0|||
49095612|NCT00831311|158185254|FG001|Overall Study|Physician Decision|1|||
49095613|NCT00831311|158185253|FG000|Overall Study|Withdrawal by Subject|6|||
49095614|NCT00831311|158185254|FG001|Overall Study|Withdrawal by Subject|4|||
49095615|NCT05338502|158185255|FG000|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
49095616|NCT05338502|158185256|FG001|Period 2 - Day 8 to Day 19|Withdrawal by Subject|2|||
49095617|NCT05338502|158185257|FG002|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
49095618|NCT05338502|158185255|FG000|Period 2 - Day 8 to Day 19|Adverse Event|0|||
49095619|NCT05338502|158185256|FG001|Period 2 - Day 8 to Day 19|Adverse Event|1|||
49095620|NCT05338502|158185257|FG002|Period 2 - Day 8 to Day 19|Adverse Event|0|||
49095621|NCT02423343|158185267|FG000|Overall Study|Withdrawal by Subject|0|||
49095622|NCT02423343|158185268|FG001|Overall Study|Withdrawal by Subject|1|||
49095623|NCT02423343|158185269|FG002|Overall Study|Withdrawal by Subject|0|||
49095624|NCT02423343|158185270|FG003|Overall Study|Withdrawal by Subject|0|||
49095625|NCT02423343|158185271|FG004|Overall Study|Withdrawal by Subject|0|||
49095626|NCT02423343|158185272|FG005|Overall Study|Withdrawal by Subject|0|||
49095627|NCT02423343|158185267|FG000|Overall Study|Progressive Disease|0|||
49095628|NCT02423343|158185268|FG001|Overall Study|Progressive Disease|0|||
49095629|NCT02423343|158185269|FG002|Overall Study|Progressive Disease|0|||
49095630|NCT02423343|158185270|FG003|Overall Study|Progressive Disease|0|||
49095631|NCT02423343|158185271|FG004|Overall Study|Progressive Disease|2|||
49095632|NCT02423343|158185272|FG005|Overall Study|Progressive Disease|0|||
49095633|NCT02423343|158185267|FG000|Overall Study|Adverse Event|0|||
49095634|NCT02423343|158185268|FG001|Overall Study|Adverse Event|0|||
49095635|NCT02423343|158185269|FG002|Overall Study|Adverse Event|0|||
49095636|NCT02423343|158185270|FG003|Overall Study|Adverse Event|0|||
49095637|NCT02423343|158185271|FG004|Overall Study|Adverse Event|2|||
49095638|NCT02423343|158185272|FG005|Overall Study|Adverse Event|0|||
49095639|NCT02423343|158185267|FG000|Overall Study|Death|0|||
49095640|NCT02423343|158185268|FG001|Overall Study|Death|0|||
49095641|NCT02423343|158185269|FG002|Overall Study|Death|0|||
49095642|NCT02423343|158185270|FG003|Overall Study|Death|0|||
49095643|NCT02423343|158185271|FG004|Overall Study|Death|1|||
49095644|NCT02423343|158185272|FG005|Overall Study|Death|0|||
49095645|NCT01894100|158185273|FG000|Overall Study|Lost to Follow-up|0|||
49095646|NCT01894100|158185274|FG001|Overall Study|Lost to Follow-up|1|||
49095647|NCT01894100|158185273|FG000|Overall Study|Withdrawal by Subject|3|||
49095648|NCT01894100|158185274|FG001|Overall Study|Withdrawal by Subject|0|||
49095649|NCT01102257|158185278|FG000|Overall Study|Adverse Event|1|||
49095650|NCT01102257|158185279|FG001|Overall Study|Adverse Event|0|||
49095651|NCT01102257|158185278|FG000|Overall Study|Adverse Event|1|||
49095652|NCT01102257|158185279|FG001|Overall Study|Adverse Event|0|||
49095653|NCT00930774|158185280|FG000|Overall Study|Withdrawal by Subject|1|||
49095654|NCT00930774|158185281|FG001|Overall Study|Withdrawal by Subject|9|||
49095655|NCT00930774|158185282|FG002|Overall Study|Withdrawal by Subject|2|||
49095656|NCT00930774|158185283|FG003|Overall Study|Withdrawal by Subject|0|||
49095657|NCT02048826|158185284|FG000|Overall Study|Withdrawal by Subject|1|||
49095658|NCT02048826|158185285|FG001|Overall Study|Withdrawal by Subject|0|||
49095659|NCT04666259|158185291|FG000|Overall Study|ongoing at data cut-off|6|||
49095660|NCT04666259|158185292|FG001|Overall Study|ongoing at data cut-off|14|||
49095661|NCT04666259|158185293|FG002|Overall Study|ongoing at data cut-off|0|||
49095662|NCT04666259|158185291|FG000|Overall Study|Progressive Disease|0|||
49095663|NCT04666259|158185292|FG001|Overall Study|Progressive Disease|1|||
49095664|NCT04666259|158185293|FG002|Overall Study|Progressive Disease|0|||
49095665|NCT04666259|158185291|FG000|Overall Study|Physician Decision|9|||
49095666|NCT04666259|158185292|FG001|Overall Study|Physician Decision|3|||
49095667|NCT04666259|158185293|FG002|Overall Study|Physician Decision|3|||
49095668|NCT04666259|158185291|FG000|Overall Study|Adverse Event|3|||
49095669|NCT04666259|158185292|FG001|Overall Study|Adverse Event|1|||
49095670|NCT04666259|158185293|FG002|Overall Study|Adverse Event|0|||
49095671|NCT04666259|158185291|FG000|Overall Study|Withdrawal by Subject|1|||
49095672|NCT04666259|158185292|FG001|Overall Study|Withdrawal by Subject|2|||
49095673|NCT04666259|158185293|FG002|Overall Study|Withdrawal by Subject|0|||
49095674|NCT04666259|158185291|FG000|Overall Study|Enrolled but not treated and discontinued|1|||
49095675|NCT04666259|158185292|FG001|Overall Study|Enrolled but not treated and discontinued|0|||
49095676|NCT04666259|158185293|FG002|Overall Study|Enrolled but not treated and discontinued|0|||
49095677|NCT00090493|158185294|FG000|Overall Study|Physician Decision|2|||
49095678|NCT01680861|158185295|FG000|Early Post-transplant Period|Protocol Violation|1|||
49095679|NCT01680861|158185296|FG001|Early Post-transplant Period|Protocol Violation|1|||
49095680|NCT02111577|158185299|FG000|Overall Study|Protocol Violation|2|||
49095681|NCT02111577|158185300|FG001|Overall Study|Protocol Violation|0|||
49095682|NCT02111577|158185299|FG000|Overall Study|Unable to tolerate leukapheresis|1|||
49095683|NCT02111577|158185300|FG001|Overall Study|Unable to tolerate leukapheresis|0|||
49095684|NCT02111577|158185299|FG000|Overall Study|Failure to produce study treatment|6|||
49095685|NCT02111577|158185300|FG001|Overall Study|Failure to produce study treatment|0|||
49095686|NCT02111577|158185299|FG000|Overall Study|Death|518|||
49095687|NCT02111577|158185300|FG001|Overall Study|Death|254|||
49095688|NCT02111577|158185299|FG000|Overall Study|Medical monitor's decision (active hepatitis B)|1|||
49095689|NCT02111577|158185300|FG001|Overall Study|Medical monitor's decision (active hepatitis B)|0|||
49095690|NCT02111577|158185299|FG000|Overall Study|Adverse Event|1|||
49095691|NCT02111577|158185300|FG001|Overall Study|Adverse Event|1|||
49095692|NCT02111577|158185299|FG000|Overall Study|Withdrawal by Subject|51|||
49095693|NCT02111577|158185300|FG001|Overall Study|Withdrawal by Subject|23|||
49095694|NCT02111577|158185299|FG000|Overall Study|Disease progression|0|||
49095695|NCT02111577|158185300|FG001|Overall Study|Disease progression|1|||
49095696|NCT02111577|158185299|FG000|Overall Study|Lost to Follow-up|19|||
49095697|NCT02111577|158185300|FG001|Overall Study|Lost to Follow-up|10|||
49095698|NCT02235077|158185306|FG000|Overall Study|Death|5|||
49095699|NCT02235077|158185307|FG001|Overall Study|Death|7|||
49095700|NCT02235077|158185306|FG000|Overall Study|Lost to Follow-up|5|||
49095701|NCT02235077|158185307|FG001|Overall Study|Lost to Follow-up|6|||
49095702|NCT02235077|158185306|FG000|Overall Study|Withdrawal by Subject|8|||
49095703|NCT02235077|158185307|FG001|Overall Study|Withdrawal by Subject|5|||
49095704|NCT02235077|158185306|FG000|Overall Study|Physician Decision|0|||
49095705|NCT02235077|158185307|FG001|Overall Study|Physician Decision|1|||
49095706|NCT01908829|158185308|FG000|Overall Study|Adverse Event|13|||
49095707|NCT01908829|158185309|FG001|Overall Study|Adverse Event|11|||
49095708|NCT01908829|158185310|FG002|Overall Study|Adverse Event|13|||
49095709|NCT01908829|158185308|FG000|Overall Study|Lost to Follow-up|4|||
49095710|NCT01908829|158185309|FG001|Overall Study|Lost to Follow-up|2|||
49095711|NCT01908829|158185310|FG002|Overall Study|Lost to Follow-up|1|||
49095712|NCT01908829|158185308|FG000|Overall Study|Randomized no double-blind drug received|1|||
49095713|NCT01908829|158185309|FG001|Overall Study|Randomized no double-blind drug received|0|||
49095714|NCT01908829|158185310|FG002|Overall Study|Randomized no double-blind drug received|1|||
49095715|NCT01908829|158185308|FG000|Overall Study|Discontinued (no EoT page)|2|||
49095716|NCT01908829|158185309|FG001|Overall Study|Discontinued (no EoT page)|0|||
49095717|NCT01908829|158185310|FG002|Overall Study|Discontinued (no EoT page)|0|||
49095718|NCT01908829|158185308|FG000|Overall Study|Miscellaneous|0|||
49095719|NCT01908829|158185309|FG001|Overall Study|Miscellaneous|2|||
49095720|NCT01908829|158185310|FG002|Overall Study|Miscellaneous|0|||
49095721|NCT01908829|158185308|FG000|Overall Study|Protocol Violation|2|||
49095722|NCT01908829|158185309|FG001|Overall Study|Protocol Violation|2|||
49095723|NCT01908829|158185310|FG002|Overall Study|Protocol Violation|0|||
49095724|NCT01908829|158185308|FG000|Overall Study|Lack of Efficacy|1|||
49095725|NCT01908829|158185309|FG001|Overall Study|Lack of Efficacy|3|||
49095726|NCT01908829|158185310|FG002|Overall Study|Lack of Efficacy|2|||
49095727|NCT01908829|158185308|FG000|Overall Study|Withdrawal by Subject|26|||
49095728|NCT01908829|158185309|FG001|Overall Study|Withdrawal by Subject|29|||
49095729|NCT01908829|158185310|FG002|Overall Study|Withdrawal by Subject|22|||
49095730|NCT02005692|158185311|FG000|Overall Study|Protocol Violation|1|||
49095731|NCT02005692|158185311|FG000|Overall Study|Withdrawal by Subject|1|||
49095732|NCT02005692|158185311|FG000|Overall Study|Discharged earlier than anticipated|5|||
49095733|NCT02865499|158185314|FG000|Baseline|Adverse Event|1|||
49095734|NCT02865499|158185314|FG000|Baseline|Withdrawal by Subject|1|||
49095735|NCT01895270|158185315|FG000|Study Medications Induction (W1-4)|Withdrawal by Subject|0|||
49095736|NCT01895270|158185316|FG001|Study Medications Induction (W1-4)|Withdrawal by Subject|2|||
49095737|NCT01895270|158185315|FG000|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3|||
49095738|NCT01895270|158185316|FG001|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2|||
49095739|NCT01895270|158185315|FG000|Study Medications Induction (W1-4)|noncompliance- missed medications|3|||
49095740|NCT01895270|158185316|FG001|Study Medications Induction (W1-4)|noncompliance- missed medications|1|||
49095741|NCT01895270|158185315|FG000|Study Medications Induction (W1-4)|Blood pressure issues|0|||
49095742|NCT01895270|158185316|FG001|Study Medications Induction (W1-4)|Blood pressure issues|1|||
49095743|NCT01895270|158185315|FG000|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3|||
49095744|NCT01895270|158185316|FG001|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5|||
49095745|NCT01895270|158185315|FG000|Isradipine Taper (W7-8)|Lost to Follow-up|0|||
49095746|NCT01895270|158185316|FG001|Isradipine Taper (W7-8)|Lost to Follow-up|1|||
49095747|NCT01895270|158185315|FG000|Isradipine Taper (W7-8)|Withdrawal by Subject|0|||
49095748|NCT01895270|158185316|FG001|Isradipine Taper (W7-8)|Withdrawal by Subject|1|||
49095749|NCT02320058|158185322|FG000|Overall Study|Death|25|||
49095750|NCT02320058|158185323|FG001|Overall Study|Death|10|||
49095751|NCT02320058|158185322|FG000|Overall Study|Lost to Follow-up|4|||
49095752|NCT02320058|158185323|FG001|Overall Study|Lost to Follow-up|0|||
49095753|NCT02320058|158185322|FG000|Overall Study|Other reasons|4|||
49095754|NCT02320058|158185323|FG001|Overall Study|Other reasons|1|||
49095755|NCT02320058|158185322|FG000|Overall Study|Withdrawal by Subject|8|||
49095756|NCT02320058|158185323|FG001|Overall Study|Withdrawal by Subject|2|||
49095757|NCT02320058|158185322|FG000|Overall Study|Not reported|1|||
49095758|NCT02320058|158185323|FG001|Overall Study|Not reported|0|||
49095759|NCT00886743|158185330|FG000|Overall Study|Adverse Event|3|||
49095760|NCT00886743|158185330|FG000|Overall Study|Other|1|||
49095761|NCT01940887|158185334|FG000|Year 1|Protocol Violation|0|||
49095762|NCT01940887|158185335|FG001|Year 1|Protocol Violation|1|||
49095763|NCT01940887|158185334|FG000|Year 1|Physician Decision|7|||
49095764|NCT01940887|158185335|FG001|Year 1|Physician Decision|3|||
49095765|NCT01940887|158185334|FG000|Year 1|Death|5|||
49095766|NCT01940887|158185335|FG001|Year 1|Death|3|||
49095767|NCT01940887|158185334|FG000|Year 1|Adverse Event|7|||
49095768|NCT01940887|158185335|FG001|Year 1|Adverse Event|6|||
49095769|NCT01940887|158185334|FG000|Year 1|Withdrawal by Subject|18|||
49095770|NCT01940887|158185335|FG001|Year 1|Withdrawal by Subject|9|||
49095771|NCT01940887|158185334|FG000|Year 1|Lost to Follow-up|2|||
49095772|NCT01940887|158185335|FG001|Year 1|Lost to Follow-up|1|||
49095773|NCT01940887|158185334|FG000|Year 2|Physician Decision|8|||
49095774|NCT01940887|158185335|FG001|Year 2|Physician Decision|1|||
49095775|NCT01940887|158185334|FG000|Year 2|Death|0|||
49095776|NCT01940887|158185335|FG001|Year 2|Death|2|||
49095777|NCT01940887|158185334|FG000|Year 2|Sponsor Decision, early termination|192|||
49095778|NCT01940887|158185335|FG001|Year 2|Sponsor Decision, early termination|203|||
49095779|NCT01940887|158185334|FG000|Year 2|Adverse Event|8|||
49095780|NCT01940887|158185335|FG001|Year 2|Adverse Event|2|||
49095781|NCT01940887|158185334|FG000|Year 2|Withdrawal by Subject|8|||
49095782|NCT01940887|158185335|FG001|Year 2|Withdrawal by Subject|8|||
49095783|NCT01940887|158185334|FG000|Year 2|Lost to Follow-up|1|||
49095784|NCT01940887|158185335|FG001|Year 2|Lost to Follow-up|6|||
49095785|NCT04720911|158185339|FG000|Overall Study|Withdrawal by Subject|0|||
49095786|NCT04720911|158185340|FG001|Overall Study|Withdrawal by Subject|1|||
49095787|NCT04720911|158185341|FG002|Overall Study|Withdrawal by Subject|0|||
49095788|NCT04533412|158185343|FG000|Overall Study|Withdrawal by Subject|1|||
49095789|NCT04533412|158185344|FG001|Overall Study|Withdrawal by Subject|1|||
49095790|NCT04533412|158185343|FG000|Overall Study|Lost to Follow-up|1|||
49095791|NCT04533412|158185344|FG001|Overall Study|Lost to Follow-up|4|||
49095792|NCT02387957|158185345|FG000|Overall Study|The study was discontinued|21|||
49095793|NCT02387957|158185346|FG001|Overall Study|The study was discontinued|21|||
49095794|NCT02387957|158185347|FG002|Overall Study|The study was discontinued|20|||
49095795|NCT01508130|158185348|FG000|Overall Study|Adverse Event|81|||
49095796|NCT01508130|158185349|FG001|Overall Study|Adverse Event|28|||
49095797|NCT01508130|158185348|FG000|Overall Study|Death|3|||
49095798|NCT01508130|158185349|FG001|Overall Study|Death|1|||
49095799|NCT01508130|158185348|FG000|Overall Study|Protocol Violation|2|||
49095800|NCT01508130|158185349|FG001|Overall Study|Protocol Violation|0|||
49095801|NCT01508130|158185348|FG000|Overall Study|Lost to Follow-up|25|||
49095802|NCT01508130|158185349|FG001|Overall Study|Lost to Follow-up|2|||
49095803|NCT01508130|158185348|FG000|Overall Study|Withdrawal by Subject|3|||
49095804|NCT01508130|158185349|FG001|Overall Study|Withdrawal by Subject|3|||
49095805|NCT01508130|158185348|FG000|Overall Study|Subject's substantial non-compliance|25|||
49095806|NCT01508130|158185349|FG001|Overall Study|Subject's substantial non-compliance|9|||
49095807|NCT01508130|158185348|FG000|Overall Study|Insufficient therapeutic response|74|||
49095808|NCT01508130|158185349|FG001|Overall Study|Insufficient therapeutic response|23|||
49095809|NCT01508130|158185348|FG000|Overall Study|Administrative|14|||
49095810|NCT01508130|158185349|FG001|Overall Study|Administrative|3|||
49095811|NCT02294396|158185350|FG000|Overall Study|Adverse Event|26|||
49095812|NCT02294396|158185351|FG001|Overall Study|Adverse Event|25|||
49095813|NCT02294396|158185352|FG002|Overall Study|Adverse Event|21|||
49095814|NCT02294396|158185353|FG003|Overall Study|Adverse Event|24|||
49095815|NCT02294396|158185350|FG000|Overall Study|Electrocardiogram adviser's judgment|1|||
49095816|NCT02294396|158185351|FG001|Overall Study|Electrocardiogram adviser's judgment|0|||
49095817|NCT02294396|158185352|FG002|Overall Study|Electrocardiogram adviser's judgment|0|||
49095818|NCT02294396|158185353|FG003|Overall Study|Electrocardiogram adviser's judgment|1|||
49095819|NCT02294396|158185350|FG000|Overall Study|Withdrawal by Subject|8|||
49095820|NCT02294396|158185351|FG001|Overall Study|Withdrawal by Subject|6|||
49095821|NCT02294396|158185352|FG002|Overall Study|Withdrawal by Subject|6|||
49095822|NCT02294396|158185353|FG003|Overall Study|Withdrawal by Subject|8|||
49095823|NCT02294396|158185350|FG000|Overall Study|Lost to Follow-up|0|||
49095824|NCT02294396|158185351|FG001|Overall Study|Lost to Follow-up|0|||
49095825|NCT02294396|158185352|FG002|Overall Study|Lost to Follow-up|1|||
49095826|NCT02294396|158185353|FG003|Overall Study|Lost to Follow-up|1|||
49095827|NCT02294396|158185350|FG000|Overall Study|Protocol Deviation|3|||
49095828|NCT02294396|158185351|FG001|Overall Study|Protocol Deviation|2|||
49095829|NCT02294396|158185352|FG002|Overall Study|Protocol Deviation|2|||
49095830|NCT02294396|158185353|FG003|Overall Study|Protocol Deviation|1|||
49095831|NCT02294396|158185350|FG000|Overall Study|Miscellaneous|2|||
49095832|NCT02294396|158185351|FG001|Overall Study|Miscellaneous|0|||
49095833|NCT02294396|158185352|FG002|Overall Study|Miscellaneous|5|||
49095834|NCT02294396|158185353|FG003|Overall Study|Miscellaneous|2|||
49095835|NCT05107492|158185356|FG000|Overall Study|Lost to Follow-up|1|||
49095836|NCT05107492|158185357|FG001|Overall Study|Lost to Follow-up|0|||
49095837|NCT00679029|158185363|FG000|Overall Study|Adverse Event|3|||
49095838|NCT00679029|158185363|FG000|Overall Study|Withdrawal by Subject|1|||
49095839|NCT00679029|158185363|FG000|Overall Study|Lost to Follow-up|1|||
49095840|NCT02040857|158185364|FG000|Overall Study|Adverse Event|14|||
49095841|NCT02040857|158185364|FG000|Overall Study|Physician Decision|5|||
49095842|NCT02040857|158185364|FG000|Overall Study|Withdrawal by Subject|31|||
49095843|NCT02040857|158185364|FG000|Overall Study|patient non-compliance|3|||
49095844|NCT02040857|158185364|FG000|Overall Study|Lost to Follow-up|2|||
49095845|NCT02040857|158185364|FG000|Overall Study|recurrence|4|||
49095846|NCT02040857|158185364|FG000|Overall Study|ineligible|1|||
49095847|NCT02949843|158185365|FG000|Overall Study|Withdrawal by Subject|0|||
49095848|NCT02949843|158185366|FG001|Overall Study|Withdrawal by Subject|1|||
49095849|NCT02949843|158185367|FG002|Overall Study|Withdrawal by Subject|1|||
49095850|NCT02120833|158185368|FG000|Overall Study|Adverse Event|1|||
49095851|NCT02120833|158185369|FG001|Overall Study|Adverse Event|0|||
49095852|NCT02120833|158185368|FG000|Overall Study|Withdrawal by Subject|2|||
49095853|NCT02120833|158185369|FG001|Overall Study|Withdrawal by Subject|0|||
49095854|NCT02120833|158185368|FG000|Overall Study|Lost to Follow-up|1|||
49095855|NCT02120833|158185369|FG001|Overall Study|Lost to Follow-up|1|||
49095856|NCT00900159|158185370|FG000|Second Intervention|disempanelled for inappropriate behavior|1|||
49095857|NCT00900159|158185371|FG001|Second Intervention|disempanelled for inappropriate behavior|0|||
49095858|NCT01680159|158185372|FG000|Screening Period|Not meet criteria for dose-up period|7|||
49095859|NCT01680159|158185372|FG000|Increased Dose Period|Adverse Event|6|||
49095860|NCT01680159|158185372|FG000|Increased Dose Period|Withdrawal by Subject|2|||
49095861|NCT00520533|158185373|FG000|Overall Study|Death|1|||
49095862|NCT00520533|158185373|FG000|Overall Study|Suspension of the study for safety reasons|1|||
49095863|NCT00520533|158185373|FG000|Overall Study|Withdrawal by Subject|1|||
49095864|NCT00520533|158185373|FG000|Overall Study|Physician Decision|1|||
49095865|NCT03483961|158185374|FG000|Overall Study|Lost to Follow-up|7|||
49095866|NCT03483961|158185375|FG001|Overall Study|Lost to Follow-up|6|||
49095867|NCT03483961|158185376|FG002|Overall Study|Lost to Follow-up|6|||
49095868|NCT03483961|158185377|FG003|Overall Study|Lost to Follow-up|6|||
49095869|NCT03483961|158185378|FG004|Overall Study|Lost to Follow-up|6|||
49095870|NCT03483961|158185379|FG005|Overall Study|Lost to Follow-up|4|||
49095871|NCT03483961|158185380|FG006|Overall Study|Lost to Follow-up|4|||
49095872|NCT03483961|158185381|FG007|Overall Study|Lost to Follow-up|11|||
49095873|NCT03483961|158185382|FG008|Overall Study|Lost to Follow-up|1|||
49095874|NCT03483961|158185383|FG009|Overall Study|Lost to Follow-up|0|||
49095875|NCT03483961|158185374|FG000|Overall Study|Withdrawal by Subject|3|||
49095876|NCT03483961|158185375|FG001|Overall Study|Withdrawal by Subject|4|||
49095877|NCT03483961|158185376|FG002|Overall Study|Withdrawal by Subject|5|||
49095878|NCT03483961|158185377|FG003|Overall Study|Withdrawal by Subject|3|||
49095879|NCT03483961|158185378|FG004|Overall Study|Withdrawal by Subject|4|||
49095880|NCT03483961|158185379|FG005|Overall Study|Withdrawal by Subject|2|||
49095881|NCT03483961|158185380|FG006|Overall Study|Withdrawal by Subject|1|||
49095882|NCT03483961|158185381|FG007|Overall Study|Withdrawal by Subject|2|||
49095883|NCT03483961|158185382|FG008|Overall Study|Withdrawal by Subject|1|||
49095884|NCT03483961|158185383|FG009|Overall Study|Withdrawal by Subject|0|||
49095885|NCT03483961|158185374|FG000|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|1|||
49095886|NCT03483961|158185375|FG001|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
49095887|NCT03483961|158185376|FG002|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
49095888|NCT03483961|158185377|FG003|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
49095889|NCT03483961|158185378|FG004|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
49095890|NCT03483961|158185379|FG005|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
49095891|NCT03483961|158185380|FG006|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
49095892|NCT03483961|158185381|FG007|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
49095893|NCT03483961|158185382|FG008|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
49095894|NCT03483961|158185383|FG009|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
49095895|NCT03483961|158185374|FG000|Overall Study|Adverse Event|0|||
49095896|NCT03483961|158185375|FG001|Overall Study|Adverse Event|0|||
49095897|NCT03483961|158185376|FG002|Overall Study|Adverse Event|1|||
49095898|NCT03483961|158185377|FG003|Overall Study|Adverse Event|0|||
49095899|NCT03483961|158185378|FG004|Overall Study|Adverse Event|0|||
49095900|NCT03483961|158185379|FG005|Overall Study|Adverse Event|0|||
49095901|NCT03483961|158185380|FG006|Overall Study|Adverse Event|0|||
49095902|NCT03483961|158185381|FG007|Overall Study|Adverse Event|0|||
49095903|NCT03483961|158185382|FG008|Overall Study|Adverse Event|0|||
49095904|NCT03483961|158185383|FG009|Overall Study|Adverse Event|0|||
49095905|NCT02880865|158185385|FG000|Overall Study|Adverse Event|1|||
49095906|NCT02880865|158185386|FG001|Overall Study|Adverse Event|0|||
49095907|NCT02880865|158185385|FG000|Overall Study|Withdrawal by Subject|0|||
49095908|NCT02880865|158185386|FG001|Overall Study|Withdrawal by Subject|2|||
49095909|NCT02880865|158185385|FG000|Overall Study|Physician Decision|0|||
49095910|NCT02880865|158185386|FG001|Overall Study|Physician Decision|1|||
49095911|NCT00977314|158185387|FG000|Overall Study|Withdrawal by Subject|1|||
49095912|NCT00977314|158185388|FG001|Overall Study|Withdrawal by Subject|0|||
49095913|NCT00977314|158185387|FG000|Overall Study|Physician Decision|1|||
49095914|NCT00977314|158185388|FG001|Overall Study|Physician Decision|0|||
49095915|NCT02107859|158185391|FG000|Overall Study|Withdrawal by Subject|14|||
49095916|NCT02107859|158185391|FG000|Overall Study|Adverse Event|3|||
49095917|NCT02107859|158185391|FG000|Overall Study|Study closure|41|||
49095918|NCT02107859|158185391|FG000|Overall Study|Other than specified|3|||
49095919|NCT02537431|158185394|FG000|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
49095920|NCT02981082|158185395|FG000|Overall Study|Withdrawal by Subject|2|||
49095921|NCT02981082|158185396|FG001|Overall Study|Withdrawal by Subject|0|||
49095922|NCT02981082|158185395|FG000|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|1|||
49095923|NCT02981082|158185396|FG001|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|0|||
49095924|NCT02981082|158185395|FG000|Overall Study|Adverse Event|0|||
49095925|NCT02981082|158185396|FG001|Overall Study|Adverse Event|1|||
49095926|NCT03691207|158187295|FG000|Overall Study|Death|41|||
49095927|NCT03691207|158187296|FG001|Overall Study|Death|26|||
49095928|NCT03691207|158187295|FG000|Overall Study|Lost to Follow-up|1|||
49095929|NCT03691207|158187296|FG001|Overall Study|Lost to Follow-up|1|||
49095930|NCT03691207|158187295|FG000|Overall Study|Withdrawal by Subject|2|||
49095931|NCT03691207|158187296|FG001|Overall Study|Withdrawal by Subject|8|||
49095932|NCT03691207|158187295|FG000|Overall Study|Sponsor decision|1|||
49095933|NCT03691207|158187296|FG001|Overall Study|Sponsor decision|7|||
49095934|NCT01736397|158187298|FG000|Overall Study|Lack of Efficacy|1|||
49095935|NCT01736397|158187299|FG001|Overall Study|Lack of Efficacy|11|||
49095936|NCT01736397|158187298|FG000|Overall Study|Withdrawal by Subject|6|||
49095937|NCT01736397|158187299|FG001|Overall Study|Withdrawal by Subject|5|||
49095938|NCT01736397|158187298|FG000|Overall Study|Lost to Follow-up|0|||
49095939|NCT01736397|158187299|FG001|Overall Study|Lost to Follow-up|1|||
49095940|NCT01736397|158187298|FG000|Overall Study|Adverse Event|6|||
49095941|NCT01736397|158187299|FG001|Overall Study|Adverse Event|3|||
49095942|NCT01736397|158187298|FG000|Overall Study|Not stated|1|||
49095943|NCT01736397|158187299|FG001|Overall Study|Not stated|4|||
49095944|NCT02309411|158187300|FG000|Overall Study|Physician Decision|1|||
49095945|NCT02309411|158187301|FG001|Overall Study|Physician Decision|0|||
49095946|NCT02309411|158187302|FG002|Overall Study|Physician Decision|0|||
49095947|NCT02309411|158187300|FG000|Overall Study|Withdrawal by Subject|1|||
49095948|NCT02309411|158187301|FG001|Overall Study|Withdrawal by Subject|1|||
49095949|NCT02309411|158187302|FG002|Overall Study|Withdrawal by Subject|0|||
49095950|NCT05088603|158187305|FG000|Overall Study|Protocol Violation|6|||
49095951|NCT05088603|158187306|FG001|Overall Study|Protocol Violation|1|||
49095952|NCT01167881|158187307|FG000|Overall Study|Adverse Event|47|||
49095953|NCT01167881|158187308|FG001|Overall Study|Adverse Event|51|||
49095954|NCT01167881|158187307|FG000|Overall Study|Lack of Efficacy|4|||
49095955|NCT01167881|158187308|FG001|Overall Study|Lack of Efficacy|7|||
49095956|NCT01167881|158187307|FG000|Overall Study|Non compliant with protocol|9|||
49095957|NCT01167881|158187308|FG001|Overall Study|Non compliant with protocol|18|||
49095958|NCT01167881|158187307|FG000|Overall Study|Lost to Follow-up|19|||
49095959|NCT01167881|158187308|FG001|Overall Study|Lost to Follow-up|20|||
49095960|NCT01167881|158187307|FG000|Overall Study|Patient refusal to cont., not due to AE|45|||
49095961|NCT01167881|158187308|FG001|Overall Study|Patient refusal to cont., not due to AE|40|||
49095962|NCT01167881|158187307|FG000|Overall Study|Not treated|4|||
49095963|NCT01167881|158187308|FG001|Overall Study|Not treated|0|||
49095964|NCT01167881|158187307|FG000|Overall Study|Other not defined above|31|||
49095965|NCT01167881|158187308|FG001|Overall Study|Other not defined above|55|||
49095966|NCT04470544|158187315|FG000|Overall Study|Withdrawal by Subject|4|||
49095967|NCT04470544|158187316|FG001|Overall Study|Withdrawal by Subject|6|||
49095968|NCT01014988|158187318|FG000|Overall Study|Adverse Event|20|||
49095969|NCT01014988|158187319|FG001|Overall Study|Adverse Event|0|||
49095970|NCT01014988|158187320|FG002|Overall Study|Adverse Event|1|||
49095971|NCT01014988|158187321|FG003|Overall Study|Adverse Event|0|||
49095972|NCT01014988|158187322|FG004|Overall Study|Adverse Event|1|||
49095973|NCT01014988|158187323|FG005|Overall Study|Adverse Event|3|||
49095974|NCT01014988|158187318|FG000|Overall Study|Lost to Follow-up|1|||
49095975|NCT01014988|158187319|FG001|Overall Study|Lost to Follow-up|0|||
49095976|NCT01014988|158187320|FG002|Overall Study|Lost to Follow-up|1|||
49095977|NCT01014988|158187321|FG003|Overall Study|Lost to Follow-up|0|||
49095978|NCT01014988|158187322|FG004|Overall Study|Lost to Follow-up|0|||
49095979|NCT01014988|158187323|FG005|Overall Study|Lost to Follow-up|0|||
49095980|NCT01014988|158187318|FG000|Overall Study|Physician Decision|1|||
49095981|NCT01014988|158187319|FG001|Overall Study|Physician Decision|0|||
49095982|NCT01014988|158187320|FG002|Overall Study|Physician Decision|0|||
49095983|NCT01014988|158187321|FG003|Overall Study|Physician Decision|0|||
49095984|NCT01014988|158187322|FG004|Overall Study|Physician Decision|0|||
49095985|NCT01014988|158187323|FG005|Overall Study|Physician Decision|0|||
49095986|NCT01014988|158187318|FG000|Overall Study|Withdrawal by Subject|1|||
49095987|NCT01014988|158187319|FG001|Overall Study|Withdrawal by Subject|0|||
49095988|NCT01014988|158187320|FG002|Overall Study|Withdrawal by Subject|0|||
49095989|NCT01014988|158187321|FG003|Overall Study|Withdrawal by Subject|0|||
49095990|NCT01014988|158187322|FG004|Overall Study|Withdrawal by Subject|0|||
49095991|NCT01014988|158187323|FG005|Overall Study|Withdrawal by Subject|0|||
49095992|NCT05835011|158187324|FG000|Overall Study|Study Terminated by the Sponsor|1|||
49095993|NCT05835011|158187324|FG000|Overall Study|Enrolled but did not receive study treatment|1|||
49095994|NCT00941863|158187327|FG000|Until Primary Completion Date (PCD)|Adverse Event|1|||
49095995|NCT00941863|158187328|FG001|Until Primary Completion Date (PCD)|Adverse Event|2|||
49095996|NCT00941863|158187329|FG002|Until Primary Completion Date (PCD)|Adverse Event|2|||
49095997|NCT00941863|158187330|FG003|Until Primary Completion Date (PCD)|Adverse Event|1|||
49095998|NCT00941863|158187331|FG004|Until Primary Completion Date (PCD)|Adverse Event|5|||
49095999|NCT00941863|158187327|FG000|Until Primary Completion Date (PCD)|Physician Decision|0|||
49096000|NCT00941863|158187328|FG001|Until Primary Completion Date (PCD)|Physician Decision|0|||
49096001|NCT00941863|158187329|FG002|Until Primary Completion Date (PCD)|Physician Decision|0|||
49096002|NCT00941863|158187330|FG003|Until Primary Completion Date (PCD)|Physician Decision|0|||
49096003|NCT00941863|158187331|FG004|Until Primary Completion Date (PCD)|Physician Decision|1|||
49096004|NCT00941863|158187327|FG000|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
49096005|NCT00941863|158187328|FG001|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
49096006|NCT00941863|158187329|FG002|Until Primary Completion Date (PCD)|Withdrawal by Subject|1|||
49096007|NCT00941863|158187330|FG003|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
49096008|NCT00941863|158187331|FG004|Until Primary Completion Date (PCD)|Withdrawal by Subject|8|||
49096009|NCT00941863|158187327|FG000|Until Primary Completion Date (PCD)|Death|0|||
49096010|NCT00941863|158187328|FG001|Until Primary Completion Date (PCD)|Death|0|||
49096011|NCT00941863|158187329|FG002|Until Primary Completion Date (PCD)|Death|1|||
49096012|NCT00941863|158187330|FG003|Until Primary Completion Date (PCD)|Death|2|||
49096013|NCT00941863|158187331|FG004|Until Primary Completion Date (PCD)|Death|7|||
49096014|NCT00941863|158187327|FG000|Until Primary Completion Date (PCD)|Disease progression|6|||
49096015|NCT00941863|158187328|FG001|Until Primary Completion Date (PCD)|Disease progression|1|||
49096016|NCT00941863|158187329|FG002|Until Primary Completion Date (PCD)|Disease progression|8|||
49096017|NCT00941863|158187330|FG003|Until Primary Completion Date (PCD)|Disease progression|14|||
49096018|NCT00941863|158187331|FG004|Until Primary Completion Date (PCD)|Disease progression|73|||
49096019|NCT00941863|158187327|FG000|Continued After PCD|Withdrawal by Subject|0|||
49096020|NCT00941863|158187328|FG001|Continued After PCD|Withdrawal by Subject|0|||
49096021|NCT00941863|158187329|FG002|Continued After PCD|Withdrawal by Subject|0|||
49096022|NCT00941863|158187330|FG003|Continued After PCD|Withdrawal by Subject|0|||
49096023|NCT00941863|158187331|FG004|Continued After PCD|Withdrawal by Subject|1|||
49096024|NCT00941863|158187327|FG000|Continued After PCD|Disease progression, recurrence, relapse|0|||
49096025|NCT00941863|158187328|FG001|Continued After PCD|Disease progression, recurrence, relapse|0|||
49096026|NCT00941863|158187329|FG002|Continued After PCD|Disease progression, recurrence, relapse|0|||
49096027|NCT00941863|158187330|FG003|Continued After PCD|Disease progression, recurrence, relapse|0|||
49096028|NCT00941863|158187331|FG004|Continued After PCD|Disease progression, recurrence, relapse|18|||
49096029|NCT02137850|158187332|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|1|||
49096030|NCT02137850|158187333|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
49096031|NCT02137850|158187334|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
49096032|NCT02137850|158187332|FG000|Main Phase: Pre-Prophylaxis|Protocol Violation|1|||
49096033|NCT02137850|158187333|FG001|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
49096034|NCT02137850|158187334|FG002|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
49096035|NCT02137850|158187332|FG000|Main Phase: Pre-Prophylaxis|Adverse Event|3|||
49096036|NCT02137850|158187333|FG001|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
49096037|NCT02137850|158187334|FG002|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
49096038|NCT02137850|158187332|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|2|||
49096039|NCT02137850|158187333|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
49096040|NCT02137850|158187334|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
49096041|NCT02137850|158187332|FG000|Main Phase: Pre-Prophylaxis|Lack of Efficacy|1|||
49096042|NCT02137850|158187333|FG001|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
49096043|NCT02137850|158187334|FG002|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
49096044|NCT02137850|158187332|FG000|Main Phase: Pre-Prophylaxis|Other|3|||
49096045|NCT02137850|158187333|FG001|Main Phase: Pre-Prophylaxis|Other|0|||
49096046|NCT02137850|158187334|FG002|Main Phase: Pre-Prophylaxis|Other|0|||
49096047|NCT02137850|158187332|FG000|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
49096048|NCT02137850|158187333|FG001|Main Phase: Prophylaxis|Withdrawal by parent/guardian|2|||
49096049|NCT02137850|158187334|FG002|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
49096050|NCT02137850|158187332|FG000|Main Phase: Prophylaxis|Protocol Violation|0|||
49096051|NCT02137850|158187333|FG001|Main Phase: Prophylaxis|Protocol Violation|1|||
49096052|NCT02137850|158187334|FG002|Main Phase: Prophylaxis|Protocol Violation|0|||
49096053|NCT02137850|158187332|FG000|Main Phase: Prophylaxis|Adverse Event|0|||
49096054|NCT02137850|158187333|FG001|Main Phase: Prophylaxis|Adverse Event|4|||
49096055|NCT02137850|158187334|FG002|Main Phase: Prophylaxis|Adverse Event|0|||
49096056|NCT02137850|158187332|FG000|Main Phase: Prophylaxis|Lack of Efficacy|0|||
49096057|NCT02137850|158187333|FG001|Main Phase: Prophylaxis|Lack of Efficacy|1|||
49096058|NCT02137850|158187334|FG002|Main Phase: Prophylaxis|Lack of Efficacy|0|||
49096059|NCT02137850|158187332|FG000|Main Phase: Prophylaxis|Other|0|||
49096060|NCT02137850|158187333|FG001|Main Phase: Prophylaxis|Other|1|||
49096061|NCT02137850|158187334|FG002|Main Phase: Prophylaxis|Other|0|||
49096062|NCT02137850|158187332|FG000|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
49096063|NCT02137850|158187333|FG001|Main Phase: Prophylaxis|Switched to ITI without completing main phase|2|||
49096064|NCT02137850|158187334|FG002|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
49096065|NCT02137850|158187332|FG000|Main Phase: Prophylaxis|Early site closure|0|||
49096066|NCT02137850|158187333|FG001|Main Phase: Prophylaxis|Early site closure|2|||
49096067|NCT02137850|158187334|FG002|Main Phase: Prophylaxis|Early site closure|0|||
49096068|NCT02137850|158187332|FG000|Main Phase: Prophylaxis|Lost to Follow-up|0|||
49096069|NCT02137850|158187333|FG001|Main Phase: Prophylaxis|Lost to Follow-up|1|||
49096070|NCT02137850|158187334|FG002|Main Phase: Prophylaxis|Lost to Follow-up|0|||
49096071|NCT02137850|158187332|FG000|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
49096072|NCT02137850|158187333|FG001|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
49096073|NCT02137850|158187334|FG002|Immune Tolerance Induction|Withdrawal by parent/guardian|1|||
49096074|NCT02137850|158187332|FG000|Immune Tolerance Induction|Lack of Efficacy|0|||
49096075|NCT02137850|158187333|FG001|Immune Tolerance Induction|Lack of Efficacy|0|||
49096076|NCT02137850|158187334|FG002|Immune Tolerance Induction|Lack of Efficacy|1|||
49096077|NCT02137850|158187332|FG000|Immune Tolerance Induction|Undergone minor surgery|0|||
49096078|NCT02137850|158187333|FG001|Immune Tolerance Induction|Undergone minor surgery|0|||
49096079|NCT02137850|158187334|FG002|Immune Tolerance Induction|Undergone minor surgery|2|||
49096080|NCT02137850|158187332|FG000|Extension Phase: Prophylaxis|Adverse Event|0|||
49096081|NCT02137850|158187333|FG001|Extension Phase: Prophylaxis|Adverse Event|1|||
49096082|NCT02137850|158187334|FG002|Extension Phase: Prophylaxis|Adverse Event|0|||
49096083|NCT02137850|158187332|FG000|Extension Phase: Prophylaxis|Protocol Violation|0|||
49096084|NCT02137850|158187333|FG001|Extension Phase: Prophylaxis|Protocol Violation|1|||
49096085|NCT02137850|158187334|FG002|Extension Phase: Prophylaxis|Protocol Violation|0|||
49096086|NCT02137850|158187332|FG000|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
49096087|NCT02137850|158187333|FG001|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|1|||
49096088|NCT02137850|158187334|FG002|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
49096089|NCT02137850|158187332|FG000|Extension Phase: Prophylaxis|Other|0|||
49096090|NCT02137850|158187333|FG001|Extension Phase: Prophylaxis|Other|1|||
49096091|NCT02137850|158187334|FG002|Extension Phase: Prophylaxis|Other|0|||
49096092|NCT02137850|158187332|FG000|Extension Phase: Prophylaxis|Early site closure|0|||
49096093|NCT02137850|158187333|FG001|Extension Phase: Prophylaxis|Early site closure|2|||
49096094|NCT02137850|158187334|FG002|Extension Phase: Prophylaxis|Early site closure|0|||
49096095|NCT02651155|158187337|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
49096096|NCT02651155|158187338|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
49096097|NCT02651155|158187337|FG000|Overall Study|Voluntary Withdrawal|5|||
49096098|NCT02651155|158187338|FG001|Overall Study|Voluntary Withdrawal|0|||
49096099|NCT01867710|158187340|FG000|Overall Study|Death|25|||
49096100|NCT01867710|158187341|FG001|Overall Study|Death|15|||
49096101|NCT01867710|158187342|FG002|Overall Study|Death|27|||
49096102|NCT01867710|158187343|FG003|Overall Study|Death|20|||
49096103|NCT01867710|158187340|FG000|Overall Study|Lost to Follow-up|3|||
49096104|NCT01867710|158187341|FG001|Overall Study|Lost to Follow-up|4|||
49096105|NCT01867710|158187342|FG002|Overall Study|Lost to Follow-up|3|||
49096106|NCT01867710|158187343|FG003|Overall Study|Lost to Follow-up|2|||
49096107|NCT01867710|158187340|FG000|Overall Study|Withdrawal of consent|2|||
49096108|NCT01867710|158187341|FG001|Overall Study|Withdrawal of consent|5|||
49096109|NCT01867710|158187342|FG002|Overall Study|Withdrawal of consent|1|||
49096110|NCT01867710|158187343|FG003|Overall Study|Withdrawal of consent|2|||
49096111|NCT01867710|158187340|FG000|Overall Study|Study Terminated by Sponsor|9|||
49096112|NCT01867710|158187341|FG001|Overall Study|Study Terminated by Sponsor|13|||
49096113|NCT01867710|158187342|FG002|Overall Study|Study Terminated by Sponsor|8|||
49096114|NCT01867710|158187343|FG003|Overall Study|Study Terminated by Sponsor|16|||
49096115|NCT01867710|158187340|FG000|Overall Study|Biochemical progression|0|||
49096116|NCT01867710|158187341|FG001|Overall Study|Biochemical progression|1|||
49096117|NCT01867710|158187342|FG002|Overall Study|Biochemical progression|0|||
49096118|NCT01867710|158187343|FG003|Overall Study|Biochemical progression|0|||
49096119|NCT01867710|158187340|FG000|Overall Study|Clinical progression|0|||
49096120|NCT01867710|158187341|FG001|Overall Study|Clinical progression|0|||
49096121|NCT01867710|158187342|FG002|Overall Study|Clinical progression|1|||
49096122|NCT01867710|158187343|FG003|Overall Study|Clinical progression|0|||
49096123|NCT01867710|158187340|FG000|Overall Study|Disease progression|1|||
49096124|NCT01867710|158187341|FG001|Overall Study|Disease progression|0|||
49096125|NCT01867710|158187342|FG002|Overall Study|Disease progression|0|||
49096126|NCT01867710|158187343|FG003|Overall Study|Disease progression|0|||
49096127|NCT01867710|158187340|FG000|Overall Study|Patient decision|0|||
49096128|NCT01867710|158187341|FG001|Overall Study|Patient decision|0|||
49096129|NCT01867710|158187342|FG002|Overall Study|Patient decision|0|||
49096130|NCT01867710|158187343|FG003|Overall Study|Patient decision|1|||
49096131|NCT01867710|158187340|FG000|Overall Study|Patient to follow subsequent treatment|0|||
49096132|NCT01867710|158187341|FG001|Overall Study|Patient to follow subsequent treatment|1|||
49096133|NCT01867710|158187342|FG002|Overall Study|Patient to follow subsequent treatment|0|||
49096134|NCT01867710|158187343|FG003|Overall Study|Patient to follow subsequent treatment|0|||
49096135|NCT01867710|158187340|FG000|Overall Study|Progressive disease|1|||
49096136|NCT01867710|158187341|FG001|Overall Study|Progressive disease|0|||
49096137|NCT01867710|158187342|FG002|Overall Study|Progressive disease|0|||
49096138|NCT01867710|158187343|FG003|Overall Study|Progressive disease|0|||
49096139|NCT01867710|158187340|FG000|Overall Study|Protocol Violation|0|||
49096140|NCT01867710|158187341|FG001|Overall Study|Protocol Violation|0|||
49096141|NCT01867710|158187342|FG002|Overall Study|Protocol Violation|0|||
49096142|NCT01867710|158187343|FG003|Overall Study|Protocol Violation|1|||
49096143|NCT01867710|158187340|FG000|Overall Study|PSA-progression|0|||
49096144|NCT01867710|158187341|FG001|Overall Study|PSA-progression|1|||
49096145|NCT01867710|158187342|FG002|Overall Study|PSA-progression|0|||
49096146|NCT01867710|158187343|FG003|Overall Study|PSA-progression|0|||
49096147|NCT01867710|158187340|FG000|Overall Study|Study medication no longer effective|0|||
49096148|NCT01867710|158187341|FG001|Overall Study|Study medication no longer effective|1|||
49096149|NCT01867710|158187342|FG002|Overall Study|Study medication no longer effective|0|||
49096150|NCT01867710|158187343|FG003|Overall Study|Study medication no longer effective|0|||
49096151|NCT03689374|158187354|FG000|Run-in Period (12 Weeks)|Run-in failure|526|||
49096152|NCT03689374|158187355|FG001|Run-in Period (12 Weeks)|Run-in failure|0|||
49096153|NCT03689374|158187356|FG002|Run-in Period (12 Weeks)|Run-in failure|0|||
49096154|NCT03689374|158187354|FG000|Treatment Period (Week 0 to 52)|Withdrawal by Subject|0|||
49096155|NCT03689374|158187355|FG001|Treatment Period (Week 0 to 52)|Withdrawal by Subject|10|||
49096156|NCT03689374|158187356|FG002|Treatment Period (Week 0 to 52)|Withdrawal by Subject|38|||
49096157|NCT03689374|158187354|FG000|Treatment Period (Week 0 to 52)|Lost to Follow-up|0|||
49096158|NCT03689374|158187355|FG001|Treatment Period (Week 0 to 52)|Lost to Follow-up|3|||
49096159|NCT03689374|158187356|FG002|Treatment Period (Week 0 to 52)|Lost to Follow-up|4|||
49096160|NCT03689374|158187354|FG000|Treatment Period (Week 0 to 52)|Death|0|||
49096161|NCT03689374|158187355|FG001|Treatment Period (Week 0 to 52)|Death|11|||
49096162|NCT03689374|158187356|FG002|Treatment Period (Week 0 to 52)|Death|1|||
49096163|NCT05367973|158187357|FG000|Overall Study|Adverse Event|0|||
49096164|NCT05367973|158187358|FG001|Overall Study|Adverse Event|2|||
49096165|NCT00957268|158187359|FG000|Overall Study|Voluntary Withdrawal|0|||
49096166|NCT00957268|158187360|FG001|Overall Study|Voluntary Withdrawal|0|||
49096167|NCT00957268|158187361|FG002|Overall Study|Voluntary Withdrawal|1|||
49096168|NCT00957268|158187362|FG003|Overall Study|Voluntary Withdrawal|0|||
49096169|NCT00957268|158187363|FG004|Overall Study|Voluntary Withdrawal|0|||
49096170|NCT04432831|158187367|FG000|Overall Study|Withdrawal by Subject|24|||
49096171|NCT04432831|158187368|FG001|Overall Study|Withdrawal by Subject|28|||
49096172|NCT04432831|158187369|FG002|Overall Study|Withdrawal by Subject|21|||
49096173|NCT04432831|158187367|FG000|Overall Study|Death|23|||
49096174|NCT04432831|158187368|FG001|Overall Study|Death|23|||
49096175|NCT04432831|158187369|FG002|Overall Study|Death|17|||
49096176|NCT04432831|158187367|FG000|Overall Study|Lost to Follow-up|15|||
49096177|NCT04432831|158187368|FG001|Overall Study|Lost to Follow-up|15|||
49096178|NCT04432831|158187369|FG002|Overall Study|Lost to Follow-up|12|||
49096179|NCT04432831|158187367|FG000|Overall Study|Final End of Study Visit Not Completed|10|||
49096180|NCT04432831|158187368|FG001|Overall Study|Final End of Study Visit Not Completed|11|||
49096181|NCT04432831|158187369|FG002|Overall Study|Final End of Study Visit Not Completed|7|||
49096182|NCT04432831|158187367|FG000|Overall Study|Reason Not Specified|7|||
49096183|NCT04432831|158187368|FG001|Overall Study|Reason Not Specified|11|||
49096184|NCT04432831|158187369|FG002|Overall Study|Reason Not Specified|9|||
49096185|NCT04432831|158187367|FG000|Overall Study|Adverse Event|7|||
49096186|NCT04432831|158187368|FG001|Overall Study|Adverse Event|7|||
49096187|NCT04432831|158187369|FG002|Overall Study|Adverse Event|7|||
49096188|NCT04432831|158187367|FG000|Overall Study|Physician Decision|1|||
49096189|NCT04432831|158187368|FG001|Overall Study|Physician Decision|3|||
49096190|NCT04432831|158187369|FG002|Overall Study|Physician Decision|6|||
49096191|NCT04432831|158187367|FG000|Overall Study|Protocol Violation|1|||
49096192|NCT04432831|158187368|FG001|Overall Study|Protocol Violation|0|||
49096193|NCT04432831|158187369|FG002|Overall Study|Protocol Violation|2|||
49096194|NCT04432831|158187367|FG000|Overall Study|Pregnancy|0|||
49096195|NCT04432831|158187368|FG001|Overall Study|Pregnancy|1|||
49096196|NCT04432831|158187369|FG002|Overall Study|Pregnancy|0|||
49096197|NCT04432831|158187367|FG000|Overall Study|Lack of Efficacy|0|||
49096198|NCT04432831|158187368|FG001|Overall Study|Lack of Efficacy|0|||
49096199|NCT04432831|158187369|FG002|Overall Study|Lack of Efficacy|2|||
49096200|NCT01738503|158187372|FG000|Induction/Stabilization (Days -14 to -1)|Other|35|||
49096201|NCT01738503|158187373|FG001|Induction/Stabilization (Days -14 to -1)|Other|0|||
49096202|NCT01738503|158187374|FG002|Induction/Stabilization (Days -14 to -1)|Other|0|||
49096203|NCT01738503|158187375|FG003|Induction/Stabilization (Days -14 to -1)|Other|0|||
49096204|NCT01738503|158187376|FG004|Induction/Stabilization (Days -14 to -1)|Other|0|||
49096205|NCT01738503|158187377|FG005|Induction/Stabilization (Days -14 to -1)|Other|0|||
49096206|NCT01738503|158187378|FG006|Induction/Stabilization (Days -14 to -1)|Other|0|||
49096207|NCT01738503|158187372|FG000|Treatment Period|Adverse Event|0|||
49096208|NCT01738503|158187373|FG001|Treatment Period|Adverse Event|1|||
49096209|NCT01738503|158187374|FG002|Treatment Period|Adverse Event|0|||
49096210|NCT01738503|158187375|FG003|Treatment Period|Adverse Event|1|||
49096211|NCT01738503|158187376|FG004|Treatment Period|Adverse Event|2|||
49096212|NCT01738503|158187377|FG005|Treatment Period|Adverse Event|2|||
49096213|NCT01738503|158187378|FG006|Treatment Period|Adverse Event|2|||
49096214|NCT01738503|158187372|FG000|Treatment Period|Lost to Follow-up|0|||
49096215|NCT01738503|158187373|FG001|Treatment Period|Lost to Follow-up|0|||
49096216|NCT01738503|158187374|FG002|Treatment Period|Lost to Follow-up|3|||
49096217|NCT01738503|158187375|FG003|Treatment Period|Lost to Follow-up|4|||
49096218|NCT01738503|158187376|FG004|Treatment Period|Lost to Follow-up|1|||
49096219|NCT01738503|158187377|FG005|Treatment Period|Lost to Follow-up|1|||
49096220|NCT01738503|158187378|FG006|Treatment Period|Lost to Follow-up|5|||
49096221|NCT01738503|158187372|FG000|Treatment Period|Withdrawal by Subject|0|||
49096222|NCT01738503|158187373|FG001|Treatment Period|Withdrawal by Subject|1|||
49096223|NCT01738503|158187374|FG002|Treatment Period|Withdrawal by Subject|0|||
49096224|NCT01738503|158187375|FG003|Treatment Period|Withdrawal by Subject|1|||
49096225|NCT01738503|158187376|FG004|Treatment Period|Withdrawal by Subject|1|||
49096226|NCT01738503|158187377|FG005|Treatment Period|Withdrawal by Subject|1|||
49096227|NCT01738503|158187378|FG006|Treatment Period|Withdrawal by Subject|1|||
49096228|NCT01738503|158187372|FG000|Treatment Period|Protocol Violation|0|||
49096229|NCT01738503|158187373|FG001|Treatment Period|Protocol Violation|3|||
49096230|NCT01738503|158187374|FG002|Treatment Period|Protocol Violation|1|||
49096231|NCT01738503|158187375|FG003|Treatment Period|Protocol Violation|0|||
49096232|NCT01738503|158187376|FG004|Treatment Period|Protocol Violation|4|||
49096233|NCT01738503|158187377|FG005|Treatment Period|Protocol Violation|2|||
49096234|NCT01738503|158187378|FG006|Treatment Period|Protocol Violation|0|||
49096235|NCT01738503|158187372|FG000|Treatment Period|Other|0|||
49096236|NCT01738503|158187373|FG001|Treatment Period|Other|0|||
49096237|NCT01738503|158187374|FG002|Treatment Period|Other|1|||
49096238|NCT01738503|158187375|FG003|Treatment Period|Other|0|||
49096239|NCT01738503|158187376|FG004|Treatment Period|Other|0|||
49096240|NCT01738503|158187377|FG005|Treatment Period|Other|0|||
49096241|NCT01738503|158187378|FG006|Treatment Period|Other|0|||
49096242|NCT01738503|158187372|FG000|PET Imaging Sub-study|Adverse Event|0|||
49096243|NCT01738503|158187373|FG001|PET Imaging Sub-study|Adverse Event|0|||
49096244|NCT01738503|158187374|FG002|PET Imaging Sub-study|Adverse Event|0|||
49096245|NCT01738503|158187375|FG003|PET Imaging Sub-study|Adverse Event|0|||
49096246|NCT01738503|158187376|FG004|PET Imaging Sub-study|Adverse Event|0|||
49096247|NCT01738503|158187377|FG005|PET Imaging Sub-study|Adverse Event|1|||
49096248|NCT01738503|158187378|FG006|PET Imaging Sub-study|Adverse Event|0|||
49096249|NCT01738503|158187372|FG000|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
49096250|NCT01738503|158187373|FG001|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
49096251|NCT01738503|158187374|FG002|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
49096252|NCT01738503|158187375|FG003|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
49096253|NCT01738503|158187376|FG004|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
49096254|NCT01738503|158187377|FG005|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
49096255|NCT01738503|158187378|FG006|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
49096256|NCT00794040|158187379|FG000|Overall Study|Withdrawal by Subject|3|||
49096257|NCT00794040|158187380|FG001|Overall Study|Withdrawal by Subject|4|||
49096258|NCT00794040|158187379|FG000|Overall Study|Physician Decision|0|||
49096259|NCT00794040|158187380|FG001|Overall Study|Physician Decision|1|||
49096260|NCT00813813|158187383|FG000|Overall Study|Withdrawal by Subject|1|||
49096261|NCT00813813|158187384|FG001|Overall Study|Withdrawal by Subject|1|||
49096262|NCT00813813|158187383|FG000|Overall Study|Lost to Follow-up|2|||
49096263|NCT00813813|158187384|FG001|Overall Study|Lost to Follow-up|7|||
49096264|NCT00813813|158187383|FG000|Overall Study|Other|0|||
49096265|NCT00813813|158187384|FG001|Overall Study|Other|1|||
49096266|NCT00986921|158187387|FG000|Overall Study|Physician Decision|1|||
49096267|NCT00986921|158187388|FG001|Overall Study|Physician Decision|0|||
49096268|NCT04696354|158187389|FG000|Overall Study|Study termination|6|||
49096269|NCT04696354|158187390|FG001|Overall Study|Study termination|6|||
49096270|NCT01340027|158187391|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
49096271|NCT01340027|158187392|FG001|Overall Study|Randomized but Never Received Study Drug|0|||
49096272|NCT01340027|158187393|FG002|Overall Study|Randomized but Never Received Study Drug|1|||
49096273|NCT01340027|158187394|FG003|Overall Study|Randomized but Never Received Study Drug|0|||
49096274|NCT01340027|158187395|FG004|Overall Study|Randomized but Never Received Study Drug|0|||
49096275|NCT01340027|158187396|FG005|Overall Study|Randomized but Never Received Study Drug|0|||
49096276|NCT01340027|158187397|FG006|Overall Study|Randomized but Never Received Study Drug|0|||
49096277|NCT01340027|158187398|FG007|Overall Study|Randomized but Never Received Study Drug|0|||
49096278|NCT01340027|158187399|FG008|Overall Study|Randomized but Never Received Study Drug|0|||
49096279|NCT01340027|158187400|FG009|Overall Study|Randomized but Never Received Study Drug|0|||
49096280|NCT01340027|158187401|FG010|Overall Study|Randomized but Never Received Study Drug|0|||
49096281|NCT01340027|158187402|FG011|Overall Study|Randomized but Never Received Study Drug|0|||
49096282|NCT01340027|158187391|FG000|Overall Study|Adverse Event|0|||
49096283|NCT01340027|158187392|FG001|Overall Study|Adverse Event|1|||
49096284|NCT01340027|158187393|FG002|Overall Study|Adverse Event|2|||
49096285|NCT01340027|158187394|FG003|Overall Study|Adverse Event|0|||
49096286|NCT01340027|158187395|FG004|Overall Study|Adverse Event|1|||
49096287|NCT01340027|158187396|FG005|Overall Study|Adverse Event|2|||
49096288|NCT01340027|158187397|FG006|Overall Study|Adverse Event|2|||
49096289|NCT01340027|158187398|FG007|Overall Study|Adverse Event|1|||
49096290|NCT01340027|158187399|FG008|Overall Study|Adverse Event|4|||
49096291|NCT01340027|158187400|FG009|Overall Study|Adverse Event|1|||
49096292|NCT01340027|158187401|FG010|Overall Study|Adverse Event|1|||
49096293|NCT01340027|158187402|FG011|Overall Study|Adverse Event|3|||
49096294|NCT01340027|158187391|FG000|Overall Study|Lack of Efficacy|0|||
49096295|NCT01340027|158187392|FG001|Overall Study|Lack of Efficacy|0|||
49096296|NCT01340027|158187393|FG002|Overall Study|Lack of Efficacy|0|||
49096297|NCT01340027|158187394|FG003|Overall Study|Lack of Efficacy|0|||
49096298|NCT01340027|158187395|FG004|Overall Study|Lack of Efficacy|0|||
49096299|NCT01340027|158187396|FG005|Overall Study|Lack of Efficacy|0|||
49096300|NCT01340027|158187397|FG006|Overall Study|Lack of Efficacy|1|||
49096301|NCT01340027|158187398|FG007|Overall Study|Lack of Efficacy|1|||
49096302|NCT01340027|158187399|FG008|Overall Study|Lack of Efficacy|1|||
49096303|NCT01340027|158187400|FG009|Overall Study|Lack of Efficacy|0|||
49096304|NCT01340027|158187401|FG010|Overall Study|Lack of Efficacy|0|||
49096305|NCT01340027|158187402|FG011|Overall Study|Lack of Efficacy|0|||
49096306|NCT01340027|158187391|FG000|Overall Study|Lost to Follow-up|0|||
49096307|NCT01340027|158187392|FG001|Overall Study|Lost to Follow-up|1|||
49096308|NCT01340027|158187393|FG002|Overall Study|Lost to Follow-up|0|||
49096309|NCT01340027|158187394|FG003|Overall Study|Lost to Follow-up|0|||
49096310|NCT01340027|158187395|FG004|Overall Study|Lost to Follow-up|0|||
49096311|NCT01340027|158187396|FG005|Overall Study|Lost to Follow-up|0|||
49096312|NCT01340027|158187397|FG006|Overall Study|Lost to Follow-up|1|||
49096313|NCT01340027|158187398|FG007|Overall Study|Lost to Follow-up|0|||
49096314|NCT01340027|158187399|FG008|Overall Study|Lost to Follow-up|0|||
49096315|NCT01340027|158187400|FG009|Overall Study|Lost to Follow-up|1|||
49096316|NCT01340027|158187401|FG010|Overall Study|Lost to Follow-up|0|||
49096317|NCT01340027|158187402|FG011|Overall Study|Lost to Follow-up|0|||
49096318|NCT01340027|158187391|FG000|Overall Study|Protocol Violation|1|||
49096319|NCT01340027|158187392|FG001|Overall Study|Protocol Violation|2|||
49096320|NCT01340027|158187393|FG002|Overall Study|Protocol Violation|0|||
49096321|NCT01340027|158187394|FG003|Overall Study|Protocol Violation|0|||
49096322|NCT01340027|158187395|FG004|Overall Study|Protocol Violation|6|||
49096323|NCT01340027|158187396|FG005|Overall Study|Protocol Violation|0|||
49096324|NCT01340027|158187397|FG006|Overall Study|Protocol Violation|0|||
49096325|NCT01340027|158187398|FG007|Overall Study|Protocol Violation|1|||
49096326|NCT01340027|158187399|FG008|Overall Study|Protocol Violation|2|||
49096327|NCT01340027|158187400|FG009|Overall Study|Protocol Violation|2|||
49096328|NCT01340027|158187401|FG010|Overall Study|Protocol Violation|0|||
49096329|NCT01340027|158187402|FG011|Overall Study|Protocol Violation|0|||
49096330|NCT01340027|158187391|FG000|Overall Study|Withdrawal by Subject|4|||
49096331|NCT01340027|158187392|FG001|Overall Study|Withdrawal by Subject|3|||
49096332|NCT01340027|158187393|FG002|Overall Study|Withdrawal by Subject|1|||
49096333|NCT01340027|158187394|FG003|Overall Study|Withdrawal by Subject|3|||
49096334|NCT01340027|158187395|FG004|Overall Study|Withdrawal by Subject|3|||
49096335|NCT01340027|158187396|FG005|Overall Study|Withdrawal by Subject|2|||
49096336|NCT01340027|158187397|FG006|Overall Study|Withdrawal by Subject|3|||
49096337|NCT01340027|158187398|FG007|Overall Study|Withdrawal by Subject|4|||
49096338|NCT01340027|158187399|FG008|Overall Study|Withdrawal by Subject|1|||
49096339|NCT01340027|158187400|FG009|Overall Study|Withdrawal by Subject|2|||
49096340|NCT01340027|158187401|FG010|Overall Study|Withdrawal by Subject|0|||
49096341|NCT01340027|158187402|FG011|Overall Study|Withdrawal by Subject|1|||
49096342|NCT01340027|158187391|FG000|Overall Study|Miscellaneous|0|||
49096343|NCT01340027|158187392|FG001|Overall Study|Miscellaneous|0|||
49096344|NCT01340027|158187393|FG002|Overall Study|Miscellaneous|0|||
49096345|NCT01340027|158187394|FG003|Overall Study|Miscellaneous|1|||
49096346|NCT01340027|158187395|FG004|Overall Study|Miscellaneous|0|||
49096347|NCT01340027|158187396|FG005|Overall Study|Miscellaneous|0|||
49096348|NCT01340027|158187397|FG006|Overall Study|Miscellaneous|0|||
49096349|NCT01340027|158187398|FG007|Overall Study|Miscellaneous|0|||
49096350|NCT01340027|158187399|FG008|Overall Study|Miscellaneous|0|||
49096351|NCT01340027|158187400|FG009|Overall Study|Miscellaneous|0|||
49096352|NCT01340027|158187401|FG010|Overall Study|Miscellaneous|1|||
49096353|NCT01340027|158187402|FG011|Overall Study|Miscellaneous|0|||
49096354|NCT03005327|158187403|FG000|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
49096355|NCT03005327|158187404|FG001|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
49096356|NCT03005327|158187405|FG002|Initial Treatment Period (24 Weeks)|Adverse Event|1|||
49096357|NCT03005327|158187406|FG003|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
49096358|NCT03005327|158187403|FG000|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
49096359|NCT03005327|158187404|FG001|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
49096360|NCT03005327|158187405|FG002|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
49096361|NCT03005327|158187406|FG003|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
49096362|NCT02572076|158187407|FG000|Overall Study|Protocol Violation|1|||
49096363|NCT01758731|158187413|FG000|Overall Study|Physician Decision|1|||
49096364|NCT05238025|158187414|FG000|Overall Study|Adverse Event|2|||
49096365|NCT05238025|158187415|FG001|Overall Study|Adverse Event|2|||
49096366|NCT05238025|158187414|FG000|Overall Study|Lost to Follow-up|334|||
49096367|NCT05238025|158187415|FG001|Overall Study|Lost to Follow-up|339|||
49096368|NCT05238025|158187414|FG000|Overall Study|Withdrawal by Subject|203|||
49096369|NCT05238025|158187415|FG001|Overall Study|Withdrawal by Subject|222|||
49096370|NCT05238025|158187414|FG000|Overall Study|Physician Decision|20|||
49096371|NCT05238025|158187415|FG001|Overall Study|Physician Decision|8|||
49096372|NCT05238025|158187414|FG000|Overall Study|Protocol Violation|6|||
49096373|NCT05238025|158187415|FG001|Overall Study|Protocol Violation|2|||
49096374|NCT05238025|158187414|FG000|Overall Study|Death|38|||
49096375|NCT05238025|158187415|FG001|Overall Study|Death|32|||
49096376|NCT05238025|158187414|FG000|Overall Study|Study terminated by Sponsor|6358|||
49096377|NCT05238025|158187415|FG001|Overall Study|Study terminated by Sponsor|6358|||
49096378|NCT05238025|158187414|FG000|Overall Study|Other Reason|669|||
49096379|NCT05238025|158187415|FG001|Overall Study|Other Reason|690|||
49096380|NCT04687072|158187418|FG000|Overall Study|Adverse Event|2|||
49096381|NCT04687072|158187419|FG001|Overall Study|Adverse Event|0|||
49096382|NCT04687072|158187418|FG000|Overall Study|Death|1|||
49096383|NCT04687072|158187419|FG001|Overall Study|Death|0|||
49096384|NCT04687072|158187418|FG000|Overall Study|Lack of Efficacy|2|||
49096385|NCT04687072|158187419|FG001|Overall Study|Lack of Efficacy|1|||
49096386|NCT04687072|158187418|FG000|Overall Study|Physician Decision|1|||
49096387|NCT04687072|158187419|FG001|Overall Study|Physician Decision|0|||
49096388|NCT04687072|158187418|FG000|Overall Study|Pregnancy|1|||
49096389|NCT04687072|158187419|FG001|Overall Study|Pregnancy|0|||
49096390|NCT04687072|158187418|FG000|Overall Study|Requires Prohibited Medication|2|||
49096391|NCT04687072|158187419|FG001|Overall Study|Requires Prohibited Medication|0|||
49096392|NCT04687072|158187418|FG000|Overall Study|Withdrawal of Consent|11|||
49096393|NCT04687072|158187419|FG001|Overall Study|Withdrawal of Consent|6|||
49096394|NCT04687072|158187418|FG000|Overall Study|Miscellaneous|4|||
49096395|NCT04687072|158187419|FG001|Overall Study|Miscellaneous|1|||
49096396|NCT01263782|158187422|FG000|Overall Study|Death|0|||
49096397|NCT01263782|158187423|FG001|Overall Study|Death|0|||
49096398|NCT01263782|158187424|FG002|Overall Study|Death|1|||
49096399|NCT01263782|158187425|FG003|Overall Study|Death|0|||
49096400|NCT01263782|158187422|FG000|Overall Study|Progressive disease|0|||
49096401|NCT01263782|158187423|FG001|Overall Study|Progressive disease|0|||
49096402|NCT01263782|158187424|FG002|Overall Study|Progressive disease|0|||
49096403|NCT01263782|158187425|FG003|Overall Study|Progressive disease|1|||
49096404|NCT01263782|158187422|FG000|Overall Study|Too early|0|||
49096405|NCT01263782|158187423|FG001|Overall Study|Too early|0|||
49096406|NCT01263782|158187424|FG002|Overall Study|Too early|1|||
49096407|NCT01263782|158187425|FG003|Overall Study|Too early|0|||
49096408|NCT01263782|158187422|FG000|Overall Study|Inevaluable|0|||
49096409|NCT01263782|158187423|FG001|Overall Study|Inevaluable|0|||
49096410|NCT01263782|158187424|FG002|Overall Study|Inevaluable|1|||
49096411|NCT01263782|158187425|FG003|Overall Study|Inevaluable|0|||
49096412|NCT00833482|158187426|FG000|Days 11-20|Adverse Event|0|||
49096413|NCT00833482|158187427|FG001|Days 11-20|Adverse Event|2|||
49096414|NCT00833482|158187428|FG002|Days 11-20|Adverse Event|0|||
49096415|NCT00833482|158187429|FG003|Days 11-20|Adverse Event|0|||
49096416|NCT00833482|158187430|FG004|Days 11-20|Adverse Event|0|||
49096417|NCT00833482|158187431|FG005|Days 11-20|Adverse Event|0|||
49096418|NCT00833482|158187426|FG000|Days 11-20|Withdrawal by Subject|0|||
49096419|NCT00833482|158187427|FG001|Days 11-20|Withdrawal by Subject|1|||
49096420|NCT00833482|158187428|FG002|Days 11-20|Withdrawal by Subject|0|||
49096421|NCT00833482|158187429|FG003|Days 11-20|Withdrawal by Subject|0|||
49096422|NCT00833482|158187430|FG004|Days 11-20|Withdrawal by Subject|0|||
49096423|NCT00833482|158187431|FG005|Days 11-20|Withdrawal by Subject|0|||
49096424|NCT00833482|158187426|FG000|Days 21-30|Adverse Event|0|||
49096425|NCT00833482|158187427|FG001|Days 21-30|Adverse Event|0|||
49096426|NCT00833482|158187428|FG002|Days 21-30|Adverse Event|1|||
49096427|NCT00833482|158187429|FG003|Days 21-30|Adverse Event|0|||
49096428|NCT00833482|158187430|FG004|Days 21-30|Adverse Event|0|||
49096429|NCT00833482|158187431|FG005|Days 21-30|Adverse Event|0|||
49096430|NCT00833482|158187426|FG000|Days 21-30|Withdrawal by Subject|0|||
49096431|NCT00833482|158187427|FG001|Days 21-30|Withdrawal by Subject|0|||
49096432|NCT00833482|158187428|FG002|Days 21-30|Withdrawal by Subject|0|||
49096433|NCT00833482|158187429|FG003|Days 21-30|Withdrawal by Subject|0|||
49096434|NCT00833482|158187430|FG004|Days 21-30|Withdrawal by Subject|1|||
49096435|NCT00833482|158187431|FG005|Days 21-30|Withdrawal by Subject|0|||
49096436|NCT02805660|158187432|FG000|Overall Study|Death|5|||
49096437|NCT02805660|158187433|FG001|Overall Study|Death|2|||
49096438|NCT02805660|158187434|FG002|Overall Study|Death|9|||
49096439|NCT02805660|158187435|FG003|Overall Study|Death|5|||
49096440|NCT02805660|158187436|FG004|Overall Study|Death|0|||
49096441|NCT02805660|158187437|FG005|Overall Study|Death|14|||
49096442|NCT02805660|158187438|FG006|Overall Study|Death|12|||
49096443|NCT02805660|158187432|FG000|Overall Study|Lost to Follow-up|0|||
49096444|NCT02805660|158187433|FG001|Overall Study|Lost to Follow-up|1|||
49096445|NCT02805660|158187434|FG002|Overall Study|Lost to Follow-up|1|||
49096446|NCT02805660|158187435|FG003|Overall Study|Lost to Follow-up|2|||
49096447|NCT02805660|158187436|FG004|Overall Study|Lost to Follow-up|0|||
49096448|NCT02805660|158187437|FG005|Overall Study|Lost to Follow-up|0|||
49096449|NCT02805660|158187438|FG006|Overall Study|Lost to Follow-up|0|||
49096450|NCT02805660|158187432|FG000|Overall Study|Withdrawal by Subject|0|||
49096451|NCT02805660|158187433|FG001|Overall Study|Withdrawal by Subject|0|||
49096452|NCT02805660|158187434|FG002|Overall Study|Withdrawal by Subject|0|||
49096453|NCT02805660|158187435|FG003|Overall Study|Withdrawal by Subject|3|||
49096454|NCT02805660|158187436|FG004|Overall Study|Withdrawal by Subject|1|||
49096455|NCT02805660|158187437|FG005|Overall Study|Withdrawal by Subject|0|||
49096456|NCT02805660|158187438|FG006|Overall Study|Withdrawal by Subject|2|||
49096457|NCT02805660|158187432|FG000|Overall Study|Study terminated by Sponsor|0|||
49096458|NCT02805660|158187433|FG001|Overall Study|Study terminated by Sponsor|0|||
49096459|NCT02805660|158187434|FG002|Overall Study|Study terminated by Sponsor|1|||
49096460|NCT02805660|158187435|FG003|Overall Study|Study terminated by Sponsor|4|||
49096461|NCT02805660|158187436|FG004|Overall Study|Study terminated by Sponsor|2|||
49096462|NCT02805660|158187437|FG005|Overall Study|Study terminated by Sponsor|3|||
49096463|NCT02805660|158187438|FG006|Overall Study|Study terminated by Sponsor|1|||
49096464|NCT02805660|158187432|FG000|Overall Study|Miscellaneous|0|||
49096465|NCT02805660|158187433|FG001|Overall Study|Miscellaneous|1|||
49096466|NCT02805660|158187434|FG002|Overall Study|Miscellaneous|0|||
49096467|NCT02805660|158187435|FG003|Overall Study|Miscellaneous|4|||
49096468|NCT02805660|158187436|FG004|Overall Study|Miscellaneous|0|||
49096469|NCT02805660|158187437|FG005|Overall Study|Miscellaneous|6|||
49096470|NCT02805660|158187438|FG006|Overall Study|Miscellaneous|4|||
49096471|NCT00915876|158187439|FG000|Overall Study|Adverse Event|0|||
49096472|NCT00915876|158187440|FG001|Overall Study|Adverse Event|1|||
49096473|NCT01682226|158189328|FG000|Overall Study|Participants were pediatric subjects and not adults subjects|3|||
49096474|NCT01682226|158189328|FG000|Overall Study|Participants did not receive treatment|2|||
49096475|NCT01682226|158189328|FG000|Overall Study|Participants received a transplant under a different protocol|1|||
49096476|NCT01672710|158189329|FG000|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0|||
49096477|NCT01672710|158189330|FG001|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1|||
49096478|NCT01672710|158189329|FG000|3 Month Follow up|Lost to Follow-up|2|||
49096479|NCT01672710|158189330|FG001|3 Month Follow up|Lost to Follow-up|3|||
49096480|NCT01672710|158189329|FG000|3 Month Follow up|follow up due after termination date|4|||
49096481|NCT01672710|158189330|FG001|3 Month Follow up|follow up due after termination date|1|||
49096482|NCT01868438|158189332|FG000|First Intervention|Withdrawal by Subject|5|||
49096483|NCT01868438|158189333|FG001|First Intervention|Withdrawal by Subject|1|||
49096484|NCT01868438|158189332|FG000|First Intervention|Lost to Follow-up|2|||
49096485|NCT01868438|158189333|FG001|First Intervention|Lost to Follow-up|3|||
49096486|NCT01868438|158189332|FG000|First Intervention|Meeting the non-redosing criteria|0|||
49096487|NCT01868438|158189333|FG001|First Intervention|Meeting the non-redosing criteria|1|||
49096488|NCT01868438|158189332|FG000|Second Intervention|Adverse Event|3|||
49096489|NCT01868438|158189333|FG001|Second Intervention|Adverse Event|3|||
49096490|NCT03260244|158189337|FG000|Overall Study|Death|19|||
49096491|NCT03260244|158189337|FG000|Overall Study|Lost to Follow-up|60|||
49096492|NCT03260244|158189337|FG000|Overall Study|Withdrawal by Subject|48|||
49096493|NCT03260244|158189337|FG000|Overall Study|Procedure Not Performed|21|||
49096494|NCT03260244|158189337|FG000|Overall Study|Enrollment Criteria Not Met|31|||
49096495|NCT03260244|158189337|FG000|Overall Study|Procedure Not Performed Per Protocol|12|||
49096496|NCT03260244|158189337|FG000|Overall Study|Subject Noncompliance|6|||
49096497|NCT03260244|158189337|FG000|Overall Study|No inducible Arrhythmia|2|||
49096498|NCT03260244|158189337|FG000|Overall Study|Procedure Not Performed by Trained Physician on Study|2|||
49096499|NCT03260244|158189337|FG000|Overall Study|Screen Failure|2|||
49096500|NCT03260244|158189337|FG000|Overall Study|Treated Off Label|69|||
49096501|NCT03260244|158189337|FG000|Overall Study|No Radiofrequency Ablation|14|||
49096502|NCT00594100|158189342|FG000|Procedure|Technical Failure|9|||
49096503|NCT00594100|158189342|FG000|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2|||
49096504|NCT00594100|158189342|FG000|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6|||
49096505|NCT00594100|158189342|FG000|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4|||
49096506|NCT00150800|158189343|FG000|Overall Study|Adverse Event|89|||
49096507|NCT00150800|158189343|FG000|Overall Study|Death|18|||
49096508|NCT00150800|158189343|FG000|Overall Study|Lack of Efficacy|166|||
49096509|NCT00150800|158189343|FG000|Overall Study|Lost to Follow-up|58|||
49096510|NCT00150800|158189343|FG000|Overall Study|Subject's choice|90|||
49096511|NCT00150800|158189343|FG000|Overall Study|No compliance|18|||
49096512|NCT00150800|158189343|FG000|Overall Study|IP misshandling|1|||
49096513|NCT00150800|158189343|FG000|Overall Study|Site closure|24|||
49096514|NCT00150800|158189343|FG000|Overall Study|Protocol non-adherence|2|||
49096515|NCT00150800|158189343|FG000|Overall Study|Nobody to accompany patient|1|||
49096516|NCT00150800|158189343|FG000|Overall Study|Distance too long for patient|1|||
49096517|NCT00150800|158189343|FG000|Overall Study|Neurosurgery|2|||
49096518|NCT00150800|158189343|FG000|Overall Study|BRV monotherapy|1|||
49096519|NCT00150800|158189343|FG000|Overall Study|Visit refusal|3|||
49096520|NCT00150800|158189343|FG000|Overall Study|Sponsor's request|2|||
49096521|NCT00150800|158189343|FG000|Overall Study|Generalized Epilepsy|1|||
49096522|NCT00150800|158189343|FG000|Overall Study|Moved from area/country|8|||
49096523|NCT00150800|158189343|FG000|Overall Study|PI retiring|2|||
49096524|NCT00150800|158189343|FG000|Overall Study|PI leaving site|2|||
49096525|NCT00150800|158189343|FG000|Overall Study|Patient insurance|1|||
49096526|NCT00150800|158189343|FG000|Overall Study|Surgical intervention|4|||
49096527|NCT00150800|158189343|FG000|Overall Study|Pregnancy planned|1|||
49096528|NCT00150800|158189343|FG000|Overall Study|PI discontinuation request|1|||
49096529|NCT03436693|158189344|FG000|Overall Study|Adverse Event|22|||
49096530|NCT03436693|158189345|FG001|Overall Study|Adverse Event|10|||
49096531|NCT03436693|158189344|FG000|Overall Study|Physician Decision|3|||
49096532|NCT03436693|158189345|FG001|Overall Study|Physician Decision|3|||
49096533|NCT03436693|158189344|FG000|Overall Study|Withdrawal by Subject|4|||
49096534|NCT03436693|158189345|FG001|Overall Study|Withdrawal by Subject|13|||
49096535|NCT03436693|158189344|FG000|Overall Study|Progressive Disease|1|||
49096536|NCT03436693|158189345|FG001|Overall Study|Progressive Disease|1|||
49096537|NCT04967885|158189346|FG000|Week 1 Follow-Up|Lost to Follow-up|7|||
49096538|NCT04967885|158189347|FG001|Week 1 Follow-Up|Lost to Follow-up|4|||
49096539|NCT04967885|158189346|FG000|Week 2 Follow-Up|Lost to Follow-up|14|||
49096540|NCT04967885|158189347|FG001|Week 2 Follow-Up|Lost to Follow-up|6|||
49096541|NCT04967885|158189346|FG000|Week 3 Follow-Up|Lost to Follow-up|16|||
49096542|NCT04967885|158189347|FG001|Week 3 Follow-Up|Lost to Follow-up|11|||
49096543|NCT04967885|158189346|FG000|Week 4 Follow-Up|Lost to Follow-up|16|||
49096544|NCT04967885|158189347|FG001|Week 4 Follow-Up|Lost to Follow-up|10|||
49096545|NCT04967885|158189346|FG000|EMI-II Intervention|Lost to Follow-up|14|||
49096546|NCT04967885|158189347|FG001|EMI-II Intervention|Lost to Follow-up|10|||
49096547|NCT01011465|158189349|FG000|Overall Study|Withdrawal by Subject|2|||
49096548|NCT01011465|158189350|FG001|Overall Study|Withdrawal by Subject|1|||
49096549|NCT01011465|158189351|FG002|Overall Study|Withdrawal by Subject|0|||
49096550|NCT01011465|158189352|FG003|Overall Study|Withdrawal by Subject|0|||
49096551|NCT01011465|158189353|FG004|Overall Study|Withdrawal by Subject|1|||
49096552|NCT01011465|158189354|FG005|Overall Study|Withdrawal by Subject|0|||
49096553|NCT01011465|158189355|FG006|Overall Study|Withdrawal by Subject|1|||
49096554|NCT01011465|158189356|FG007|Overall Study|Withdrawal by Subject|0|||
49096555|NCT02247440|158189357|FG000|Overall Study|Withdrawal by Subject|1|||
49096556|NCT02247440|158189357|FG000|Overall Study|Lack of Efficacy|3|||
49096557|NCT02792192|158189358|FG000|Overall Study|Death|1|||
49096558|NCT02792192|158189359|FG001|Overall Study|Death|0|||
49096559|NCT02792192|158189360|FG002|Overall Study|Death|0|||
49096560|NCT02792192|158189361|FG003|Overall Study|Death|0|||
49096561|NCT02792192|158189358|FG000|Overall Study|Informed Consent Withdrawn|4|||
49096562|NCT02792192|158189359|FG001|Overall Study|Informed Consent Withdrawn|0|||
49096563|NCT02792192|158189360|FG002|Overall Study|Informed Consent Withdrawn|0|||
49096564|NCT02792192|158189361|FG003|Overall Study|Informed Consent Withdrawn|0|||
49096565|NCT02792192|158189358|FG000|Overall Study|Physician Decision|1|||
49096566|NCT02792192|158189359|FG001|Overall Study|Physician Decision|0|||
49096567|NCT02792192|158189360|FG002|Overall Study|Physician Decision|0|||
49096568|NCT02792192|158189361|FG003|Overall Study|Physician Decision|0|||
49096569|NCT02792192|158189358|FG000|Overall Study|Progressive Disease|0|||
49096570|NCT02792192|158189359|FG001|Overall Study|Progressive Disease|1|||
49096571|NCT02792192|158189360|FG002|Overall Study|Progressive Disease|0|||
49096572|NCT02792192|158189361|FG003|Overall Study|Progressive Disease|0|||
49096573|NCT02792192|158189358|FG000|Overall Study|Study Terminated By Sponsor|6|||
49096574|NCT02792192|158189359|FG001|Overall Study|Study Terminated By Sponsor|10|||
49096575|NCT02792192|158189360|FG002|Overall Study|Study Terminated By Sponsor|0|||
49096576|NCT02792192|158189361|FG003|Overall Study|Study Terminated By Sponsor|0|||
49096577|NCT02682823|158189365|FG000|Overall Study|Withdrawal by Subject|0|||
49096578|NCT02682823|158189366|FG001|Overall Study|Withdrawal by Subject|0|||
49096579|NCT02682823|158189367|FG002|Overall Study|Withdrawal by Subject|1|||
49096580|NCT02682823|158189368|FG003|Overall Study|Withdrawal by Subject|0|||
49096581|NCT02682823|158189369|FG004|Overall Study|Withdrawal by Subject|1|||
49096582|NCT02682823|158189365|FG000|Overall Study|Protocol Deviation|0|||
49096583|NCT02682823|158189366|FG001|Overall Study|Protocol Deviation|1|||
49096584|NCT02682823|158189367|FG002|Overall Study|Protocol Deviation|0|||
49096585|NCT02682823|158189368|FG003|Overall Study|Protocol Deviation|0|||
49096586|NCT02682823|158189369|FG004|Overall Study|Protocol Deviation|0|||
49096587|NCT02682823|158189365|FG000|Overall Study|Adverse Event|0|||
49096588|NCT02682823|158189366|FG001|Overall Study|Adverse Event|0|||
49096589|NCT02682823|158189367|FG002|Overall Study|Adverse Event|0|||
49096590|NCT02682823|158189368|FG003|Overall Study|Adverse Event|1|||
49096591|NCT02682823|158189369|FG004|Overall Study|Adverse Event|0|||
49096592|NCT02042950|158189370|FG000|Overall Study|Progressive Disease|4|||
49096593|NCT00723008|158189371|FG000|Enrollment|Lost to Follow-up|1|||
49096594|NCT00723008|158189372|FG001|Enrollment|Lost to Follow-up|0|||
49096595|NCT00723008|158189371|FG000|4-Week Double Blinded|Lack of Efficacy|0|||
49096596|NCT00723008|158189372|FG001|4-Week Double Blinded|Lack of Efficacy|1|||
49096597|NCT00723008|158189371|FG000|4-Week Double Blinded|Withdrawal by Subject|1|||
49096598|NCT00723008|158189372|FG001|4-Week Double Blinded|Withdrawal by Subject|1|||
49096599|NCT00723008|158189371|FG000|4-Week Double Blinded|Lost to Follow-up|4|||
49096600|NCT00723008|158189372|FG001|4-Week Double Blinded|Lost to Follow-up|3|||
49096601|NCT00723008|158189371|FG000|4-Week Unblinded Treatment|Adverse Event|1|||
49096602|NCT00723008|158189372|FG001|4-Week Unblinded Treatment|Adverse Event|0|||
49096603|NCT00723008|158189371|FG000|4-Week Unblinded Treatment|Lost to Follow-up|0|||
49096604|NCT00723008|158189372|FG001|4-Week Unblinded Treatment|Lost to Follow-up|1|||
49096605|NCT01339923|158189376|FG000|Overall Study|Adverse Event|1|||
49096606|NCT01339923|158189377|FG001|Overall Study|Adverse Event|1|||
49096607|NCT01339923|158189378|FG002|Overall Study|Adverse Event|1|||
49096608|NCT01339923|158189379|FG003|Overall Study|Adverse Event|0|||
49096609|NCT01339923|158189380|FG004|Overall Study|Adverse Event|0|||
49096610|NCT01339923|158189381|FG005|Overall Study|Adverse Event|0|||
49096611|NCT01339923|158189382|FG006|Overall Study|Adverse Event|1|||
49096612|NCT01339923|158189376|FG000|Overall Study|Inappropriate Enrollment|1|||
49096613|NCT01339923|158189377|FG001|Overall Study|Inappropriate Enrollment|0|||
49096614|NCT01339923|158189378|FG002|Overall Study|Inappropriate Enrollment|0|||
49096615|NCT01339923|158189379|FG003|Overall Study|Inappropriate Enrollment|0|||
49096616|NCT01339923|158189380|FG004|Overall Study|Inappropriate Enrollment|0|||
49096617|NCT01339923|158189381|FG005|Overall Study|Inappropriate Enrollment|1|||
49096618|NCT01339923|158189382|FG006|Overall Study|Inappropriate Enrollment|0|||
49096619|NCT01339923|158189376|FG000|Overall Study|Lost to Follow-up|4|||
49096620|NCT01339923|158189377|FG001|Overall Study|Lost to Follow-up|4|||
49096621|NCT01339923|158189378|FG002|Overall Study|Lost to Follow-up|0|||
49096622|NCT01339923|158189379|FG003|Overall Study|Lost to Follow-up|3|||
49096623|NCT01339923|158189380|FG004|Overall Study|Lost to Follow-up|1|||
49096624|NCT01339923|158189381|FG005|Overall Study|Lost to Follow-up|1|||
49096625|NCT01339923|158189382|FG006|Overall Study|Lost to Follow-up|5|||
49096626|NCT01339923|158189376|FG000|Overall Study|Protocol Violation|0|||
49096627|NCT01339923|158189377|FG001|Overall Study|Protocol Violation|0|||
49096628|NCT01339923|158189378|FG002|Overall Study|Protocol Violation|0|||
49096629|NCT01339923|158189379|FG003|Overall Study|Protocol Violation|0|||
49096630|NCT01339923|158189380|FG004|Overall Study|Protocol Violation|0|||
49096631|NCT01339923|158189381|FG005|Overall Study|Protocol Violation|3|||
49096632|NCT01339923|158189382|FG006|Overall Study|Protocol Violation|1|||
49096633|NCT01339923|158189376|FG000|Overall Study|Unable to Classify|1|||
49096634|NCT01339923|158189377|FG001|Overall Study|Unable to Classify|0|||
49096635|NCT01339923|158189378|FG002|Overall Study|Unable to Classify|1|||
49096636|NCT01339923|158189379|FG003|Overall Study|Unable to Classify|0|||
49096637|NCT01339923|158189380|FG004|Overall Study|Unable to Classify|0|||
49096638|NCT01339923|158189381|FG005|Overall Study|Unable to Classify|1|||
49096639|NCT01339923|158189382|FG006|Overall Study|Unable to Classify|5|||
49096640|NCT01339923|158189376|FG000|Overall Study|Withdrawal by Subject|7|||
49096641|NCT01339923|158189377|FG001|Overall Study|Withdrawal by Subject|11|||
49096642|NCT01339923|158189378|FG002|Overall Study|Withdrawal by Subject|6|||
49096643|NCT01339923|158189379|FG003|Overall Study|Withdrawal by Subject|1|||
49096644|NCT01339923|158189380|FG004|Overall Study|Withdrawal by Subject|4|||
49096645|NCT01339923|158189381|FG005|Overall Study|Withdrawal by Subject|3|||
49096646|NCT01339923|158189382|FG006|Overall Study|Withdrawal by Subject|2|||
49096647|NCT00729157|158189384|FG000|Overall Study|Withdrawal by Subject|1|||
49096648|NCT01683266|158189385|FG000|Overall Study|Adverse Event|5|||
49096649|NCT01683266|158189386|FG001|Overall Study|Adverse Event|4|||
49096650|NCT01683266|158189385|FG000|Overall Study|Lack of Efficacy|5|||
49096651|NCT01683266|158189386|FG001|Overall Study|Lack of Efficacy|2|||
49096652|NCT01683266|158189385|FG000|Overall Study|Protocol Violation|13|||
49096653|NCT01683266|158189386|FG001|Overall Study|Protocol Violation|6|||
49096654|NCT01683266|158189385|FG000|Overall Study|Personal Reason|17|||
49096655|NCT01683266|158189386|FG001|Overall Study|Personal Reason|25|||
49096656|NCT01683266|158189385|FG000|Overall Study|Selection Criterion / Protocol Violation|7|||
49096657|NCT01683266|158189386|FG001|Overall Study|Selection Criterion / Protocol Violation|5|||
49096658|NCT01683266|158189385|FG000|Overall Study|Lost to Follow-up|5|||
49096659|NCT01683266|158189386|FG001|Overall Study|Lost to Follow-up|0|||
49096660|NCT01683266|158189385|FG000|Overall Study|Site Closure / Site Withdrawal|1|||
49096661|NCT01683266|158189386|FG001|Overall Study|Site Closure / Site Withdrawal|3|||
49096662|NCT01683266|158189385|FG000|Overall Study|Nonserious Hypoglycemia|0|||
49096663|NCT01683266|158189386|FG001|Overall Study|Nonserious Hypoglycemia|3|||
49096664|NCT01683266|158189385|FG000|Overall Study|Perceived Lack of Efficacy|1|||
49096665|NCT01683266|158189386|FG001|Overall Study|Perceived Lack of Efficacy|1|||
49096666|NCT01683266|158189385|FG000|Overall Study|Possibly Hypoglycemia|1|||
49096667|NCT01683266|158189386|FG001|Overall Study|Possibly Hypoglycemia|0|||
49096668|NCT01683266|158189385|FG000|Overall Study|Serious Adverse Event of Hypoglycemia|0|||
49096669|NCT01683266|158189386|FG001|Overall Study|Serious Adverse Event of Hypoglycemia|1|||
49096670|NCT02217410|158189387|FG000|Overall Study|Graft Loss|0|||
49096671|NCT02217410|158189388|FG001|Overall Study|Graft Loss|0|||
49096672|NCT02217410|158189389|FG002|Overall Study|Graft Loss|2|||
49096673|NCT02217410|158189387|FG000|Overall Study|Withdrawal by Subject|0|||
49096674|NCT02217410|158189388|FG001|Overall Study|Withdrawal by Subject|0|||
49096675|NCT02217410|158189389|FG002|Overall Study|Withdrawal by Subject|2|||
49096676|NCT02217410|158189387|FG000|Overall Study|Lost to Follow-up|0|||
49096677|NCT02217410|158189388|FG001|Overall Study|Lost to Follow-up|0|||
49096678|NCT02217410|158189389|FG002|Overall Study|Lost to Follow-up|1|||
49096679|NCT02217410|158189387|FG000|Overall Study|Lack of Efficacy|0|||
49096680|NCT02217410|158189388|FG001|Overall Study|Lack of Efficacy|1|||
49096681|NCT02217410|158189389|FG002|Overall Study|Lack of Efficacy|0|||
49096682|NCT02217410|158189387|FG000|Overall Study|Physician Decision|1|||
49096683|NCT02217410|158189388|FG001|Overall Study|Physician Decision|3|||
49096684|NCT02217410|158189389|FG002|Overall Study|Physician Decision|0|||
49096685|NCT00626821|158189392|FG000|Overall Study|Adverse Event|44|||
49096686|NCT00626821|158189392|FG000|Overall Study|Protocol Violation|33|||
49096687|NCT00626821|158189392|FG000|Overall Study|Withdrawal by Subject|10|||
49096688|NCT00626821|158189392|FG000|Overall Study|Physician Decision|9|||
49096689|NCT00626821|158189392|FG000|Overall Study|Product dysfunction|21|||
49096690|NCT00626821|158189392|FG000|Overall Study|other/unknown reason|104|||
49096691|NCT05217641|158189397|FG000|Overall Study|Lost to Follow-up|1|||
49096692|NCT05217641|158189398|FG001|Overall Study|Lost to Follow-up|1|||
49096693|NCT05217641|158189399|FG002|Overall Study|Lost to Follow-up|0|||
49096694|NCT05217641|158189400|FG003|Overall Study|Lost to Follow-up|1|||
49096695|NCT05217641|158189401|FG004|Overall Study|Lost to Follow-up|1|||
49096696|NCT05217641|158189402|FG005|Overall Study|Lost to Follow-up|0|||
49096697|NCT05217641|158189397|FG000|Overall Study|Withdrawal by Subject|0|||
49096698|NCT05217641|158189398|FG001|Overall Study|Withdrawal by Subject|0|||
49096699|NCT05217641|158189399|FG002|Overall Study|Withdrawal by Subject|0|||
49096700|NCT05217641|158189400|FG003|Overall Study|Withdrawal by Subject|3|||
49096701|NCT05217641|158189401|FG004|Overall Study|Withdrawal by Subject|1|||
49096702|NCT05217641|158189402|FG005|Overall Study|Withdrawal by Subject|0|||
49096703|NCT05217641|158189397|FG000|Overall Study|Other: participant did not specify reason|0|||
49096704|NCT05217641|158189398|FG001|Overall Study|Other: participant did not specify reason|0|||
49096705|NCT05217641|158189399|FG002|Overall Study|Other: participant did not specify reason|0|||
49096706|NCT05217641|158189400|FG003|Overall Study|Other: participant did not specify reason|0|||
49096707|NCT05217641|158189401|FG004|Overall Study|Other: participant did not specify reason|1|||
49096708|NCT05217641|158189402|FG005|Overall Study|Other: participant did not specify reason|0|||
49096709|NCT05217641|158189397|FG000|Overall Study|Extended Follow up|1|||
49096710|NCT05217641|158189398|FG001|Overall Study|Extended Follow up|1|||
49096711|NCT05217641|158189399|FG002|Overall Study|Extended Follow up|0|||
49096712|NCT05217641|158189400|FG003|Overall Study|Extended Follow up|0|||
49096713|NCT05217641|158189401|FG004|Overall Study|Extended Follow up|1|||
49096714|NCT05217641|158189402|FG005|Overall Study|Extended Follow up|0|||
49096715|NCT05139303|158189403|FG000|Overall Study|Lost to Follow-up|3|||
49096716|NCT05139303|158189404|FG001|Overall Study|Lost to Follow-up|0|||
49096717|NCT05139303|158189403|FG000|Overall Study|Adverse Event|1|||
49096718|NCT05139303|158189404|FG001|Overall Study|Adverse Event|0|||
49096719|NCT02448537|158189407|FG000|Overall Study|Withdrawal by Subject|1|||
49096720|NCT02448537|158189408|FG001|Overall Study|Withdrawal by Subject|1|||
49096721|NCT02448537|158189409|FG002|Overall Study|Withdrawal by Subject|1|||
49096722|NCT02632409|158189410|FG000|Randomized|AE unrelated to study Drug|0|||
49096723|NCT02632409|158189411|FG001|Randomized|AE unrelated to study Drug|1|||
49096724|NCT02632409|158189410|FG000|Randomized|Participant withdrew consent|2|||
49096725|NCT02632409|158189411|FG001|Randomized|Participant withdrew consent|1|||
49096726|NCT02632409|158189410|FG000|Randomized|No Longer meets study criteria|5|||
49096727|NCT02632409|158189411|FG001|Randomized|No Longer meets study criteria|0|||
49096728|NCT02632409|158189410|FG000|Randomized|other reasons|1|||
49096729|NCT02632409|158189411|FG001|Randomized|other reasons|0|||
49096730|NCT02632409|158189410|FG000|Treatment Period|Ongoing Treatment|20|||
49096731|NCT02632409|158189411|FG001|Treatment Period|Ongoing Treatment|21|||
49096732|NCT02632409|158189410|FG000|Treatment Period|Disease Recurrence|147|||
49096733|NCT02632409|158189411|FG001|Treatment Period|Disease Recurrence|90|||
49096734|NCT02632409|158189410|FG000|Treatment Period|Study Drug Toxicity|8|||
49096735|NCT02632409|158189411|FG001|Treatment Period|Study Drug Toxicity|49|||
49096736|NCT02632409|158189410|FG000|Treatment Period|Death|1|||
49096737|NCT02632409|158189411|FG001|Treatment Period|Death|0|||
49096738|NCT02632409|158189410|FG000|Treatment Period|AE unrelated to study drug|15|||
49096739|NCT02632409|158189411|FG001|Treatment Period|AE unrelated to study drug|16|||
49096740|NCT02632409|158189410|FG000|Treatment Period|Request to discontinue treatment|4|||
49096741|NCT02632409|158189411|FG001|Treatment Period|Request to discontinue treatment|19|||
49096742|NCT02632409|158189410|FG000|Treatment Period|Participant withdrew consent|7|||
49096743|NCT02632409|158189411|FG001|Treatment Period|Participant withdrew consent|5|||
49096744|NCT02632409|158189410|FG000|Treatment Period|Lost to Follow-up|0|||
49096745|NCT02632409|158189411|FG001|Treatment Period|Lost to Follow-up|1|||
49096746|NCT02632409|158189410|FG000|Treatment Period|Maximum clinical benefit|1|||
49096747|NCT02632409|158189411|FG001|Treatment Period|Maximum clinical benefit|0|||
49096748|NCT02632409|158189410|FG000|Treatment Period|No longer meets study criteria|3|||
49096749|NCT02632409|158189411|FG001|Treatment Period|No longer meets study criteria|0|||
49096750|NCT02632409|158189410|FG000|Treatment Period|Administrative Reason by sponsor|0|||
49096751|NCT02632409|158189411|FG001|Treatment Period|Administrative Reason by sponsor|1|||
49096752|NCT02632409|158189410|FG000|Treatment Period|Other Reasons|10|||
49096753|NCT02632409|158189411|FG001|Treatment Period|Other Reasons|6|||
49096754|NCT02222545|158189412|FG000|Overall Study|Adverse Event|1|||
49096755|NCT02222545|158189413|FG001|Overall Study|Adverse Event|0|||
49096756|NCT02222545|158189414|FG002|Overall Study|Adverse Event|2|||
49096757|NCT02222545|158189412|FG000|Overall Study|Death|0|||
49096758|NCT02222545|158189413|FG001|Overall Study|Death|0|||
49096759|NCT02222545|158189414|FG002|Overall Study|Death|9|||
49096760|NCT02222545|158189412|FG000|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
49096761|NCT02222545|158189413|FG001|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
49096762|NCT02222545|158189414|FG002|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|10|||
49096763|NCT02222545|158189412|FG000|Overall Study|Withdrawal by Subject|0|||
49096764|NCT02222545|158189413|FG001|Overall Study|Withdrawal by Subject|0|||
49096765|NCT02222545|158189414|FG002|Overall Study|Withdrawal by Subject|3|||
49096766|NCT02222545|158189412|FG000|Overall Study|Proceeded to compassionate use of OMS721|0|||
49096767|NCT02222545|158189413|FG001|Overall Study|Proceeded to compassionate use of OMS721|0|||
49096768|NCT02222545|158189414|FG002|Overall Study|Proceeded to compassionate use of OMS721|1|||
49096769|NCT00761280|158189416|FG000|Randomization to First Dose|Withdrawal by Subject|0|||
49096770|NCT00761280|158189417|FG001|Randomization to First Dose|Withdrawal by Subject|2|||
49096771|NCT00761280|158189416|FG000|Randomization to First Dose|Sponsor decision|1|||
49096772|NCT00761280|158189417|FG001|Randomization to First Dose|Sponsor decision|0|||
49096773|NCT00761280|158189416|FG000|Randomization to First Dose|Other|1|||
49096774|NCT00761280|158189417|FG001|Randomization to First Dose|Other|0|||
49096775|NCT00761280|158189416|FG000|First Dose to End of Study|End of trial|5|||
49096776|NCT00761280|158189417|FG001|First Dose to End of Study|End of trial|5|||
49096777|NCT00761280|158189416|FG000|First Dose to End of Study|Progressive disease|5|||
49096778|NCT00761280|158189417|FG001|First Dose to End of Study|Progressive disease|3|||
49096779|NCT00761280|158189416|FG000|First Dose to End of Study|Sponsor decision|1|||
49096780|NCT00761280|158189417|FG001|First Dose to End of Study|Sponsor decision|2|||
49096781|NCT00761280|158189416|FG000|First Dose to End of Study|Death|1|||
49096782|NCT00761280|158189417|FG001|First Dose to End of Study|Death|0|||
49096783|NCT00761280|158189416|FG000|First Dose to End of Study|Lost to Follow-up|0|||
49096784|NCT00761280|158189417|FG001|First Dose to End of Study|Lost to Follow-up|1|||
49096785|NCT00090220|158189418|FG000|Base Study Vaccination Period|Randomized not Vaccinated|1|||
49096786|NCT00090220|158189419|FG001|Base Study Vaccination Period|Randomized not Vaccinated|1|||
49096787|NCT00090220|158189420|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
49096788|NCT00090220|158189421|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
49096789|NCT00090220|158189422|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
49096790|NCT00090220|158189423|FG005|Base Study Vaccination Period|Randomized not Vaccinated|0|||
49096791|NCT00090220|158189418|FG000|Base Study Vaccination Period|Adverse Event|6|||
49096792|NCT00090220|158189419|FG001|Base Study Vaccination Period|Adverse Event|1|||
49096793|NCT00090220|158189420|FG002|Base Study Vaccination Period|Adverse Event|0|||
49096794|NCT00090220|158189421|FG003|Base Study Vaccination Period|Adverse Event|0|||
49096795|NCT00090220|158189422|FG004|Base Study Vaccination Period|Adverse Event|0|||
49096796|NCT00090220|158189423|FG005|Base Study Vaccination Period|Adverse Event|0|||
49096797|NCT00090220|158189418|FG000|Base Study Vaccination Period|Lost to Follow-up|24|||
49096798|NCT00090220|158189419|FG001|Base Study Vaccination Period|Lost to Follow-up|28|||
49096799|NCT00090220|158189420|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
49096800|NCT00090220|158189421|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
49096801|NCT00090220|158189422|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
49096802|NCT00090220|158189423|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
49096803|NCT00090220|158189418|FG000|Base Study Vaccination Period|Withdrawal by Subject|23|||
49096804|NCT00090220|158189419|FG001|Base Study Vaccination Period|Withdrawal by Subject|27|||
49096805|NCT00090220|158189420|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
49096806|NCT00090220|158189421|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
49096807|NCT00090220|158189422|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
49096808|NCT00090220|158189423|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
49096809|NCT00090220|158189418|FG000|Base Study Vaccination Period|Patient Moved|6|||
49096810|NCT00090220|158189419|FG001|Base Study Vaccination Period|Patient Moved|2|||
49096811|NCT00090220|158189420|FG002|Base Study Vaccination Period|Patient Moved|0|||
49096812|NCT00090220|158189421|FG003|Base Study Vaccination Period|Patient Moved|0|||
49096813|NCT00090220|158189422|FG004|Base Study Vaccination Period|Patient Moved|0|||
49096814|NCT00090220|158189423|FG005|Base Study Vaccination Period|Patient Moved|0|||
49096815|NCT00090220|158189418|FG000|Base Study Vaccination Period|Other|4|||
49096816|NCT00090220|158189419|FG001|Base Study Vaccination Period|Other|4|||
49096817|NCT00090220|158189420|FG002|Base Study Vaccination Period|Other|0|||
49096818|NCT00090220|158189421|FG003|Base Study Vaccination Period|Other|0|||
49096819|NCT00090220|158189422|FG004|Base Study Vaccination Period|Other|0|||
49096820|NCT00090220|158189423|FG005|Base Study Vaccination Period|Other|0|||
49096821|NCT00090220|158189418|FG000|Base Study Follow-up Period|Adverse Event|6|||
49096822|NCT00090220|158189419|FG001|Base Study Follow-up Period|Adverse Event|1|||
49096823|NCT00090220|158189420|FG002|Base Study Follow-up Period|Adverse Event|0|||
49096824|NCT00090220|158189421|FG003|Base Study Follow-up Period|Adverse Event|0|||
49096825|NCT00090220|158189422|FG004|Base Study Follow-up Period|Adverse Event|0|||
49096826|NCT00090220|158189423|FG005|Base Study Follow-up Period|Adverse Event|0|||
49096827|NCT00090220|158189418|FG000|Base Study Follow-up Period|Lost to Follow-up|88|||
49096828|NCT00090220|158189419|FG001|Base Study Follow-up Period|Lost to Follow-up|78|||
49096829|NCT00090220|158189420|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
49096830|NCT00090220|158189421|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
49096831|NCT00090220|158189422|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
49096832|NCT00090220|158189423|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
49096833|NCT00090220|158189418|FG000|Base Study Follow-up Period|Withdrawal by Subject|27|||
49096834|NCT00090220|158189419|FG001|Base Study Follow-up Period|Withdrawal by Subject|36|||
49096835|NCT00090220|158189420|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
49096836|NCT00090220|158189421|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
49096837|NCT00090220|158189422|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
49096838|NCT00090220|158189423|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
49096839|NCT00090220|158189418|FG000|Base Study Follow-up Period|Patient Moved|20|||
49096840|NCT00090220|158189419|FG001|Base Study Follow-up Period|Patient Moved|28|||
49096841|NCT00090220|158189420|FG002|Base Study Follow-up Period|Patient Moved|0|||
49096842|NCT00090220|158189421|FG003|Base Study Follow-up Period|Patient Moved|0|||
49096843|NCT00090220|158189422|FG004|Base Study Follow-up Period|Patient Moved|0|||
49096844|NCT00090220|158189423|FG005|Base Study Follow-up Period|Patient Moved|0|||
49096845|NCT00090220|158189418|FG000|Base Study Follow-up Period|Other|19|||
49096846|NCT00090220|158189419|FG001|Base Study Follow-up Period|Other|21|||
49096847|NCT00090220|158189420|FG002|Base Study Follow-up Period|Other|0|||
49096848|NCT00090220|158189421|FG003|Base Study Follow-up Period|Other|0|||
49096849|NCT00090220|158189422|FG004|Base Study Follow-up Period|Other|0|||
49096850|NCT00090220|158189423|FG005|Base Study Follow-up Period|Other|0|||
49096851|NCT00090220|158189418|FG000|Extension 1 (EXT1)|Adverse Event|0|||
49096852|NCT00090220|158189419|FG001|Extension 1 (EXT1)|Adverse Event|0|||
49096853|NCT00090220|158189420|FG002|Extension 1 (EXT1)|Adverse Event|4|||
49096854|NCT00090220|158189421|FG003|Extension 1 (EXT1)|Adverse Event|0|||
49096855|NCT00090220|158189422|FG004|Extension 1 (EXT1)|Adverse Event|0|||
49096856|NCT00090220|158189423|FG005|Extension 1 (EXT1)|Adverse Event|0|||
49096857|NCT00090220|158189418|FG000|Extension 1 (EXT1)|Lost to Follow-up|0|||
49096858|NCT00090220|158189419|FG001|Extension 1 (EXT1)|Lost to Follow-up|0|||
49096859|NCT00090220|158189420|FG002|Extension 1 (EXT1)|Lost to Follow-up|22|||
49096860|NCT00090220|158189421|FG003|Extension 1 (EXT1)|Lost to Follow-up|0|||
49096861|NCT00090220|158189422|FG004|Extension 1 (EXT1)|Lost to Follow-up|0|||
49096862|NCT00090220|158189423|FG005|Extension 1 (EXT1)|Lost to Follow-up|0|||
49096863|NCT00090220|158189418|FG000|Extension 1 (EXT1)|Moved|0|||
49096864|NCT00090220|158189419|FG001|Extension 1 (EXT1)|Moved|0|||
49096865|NCT00090220|158189420|FG002|Extension 1 (EXT1)|Moved|2|||
49096866|NCT00090220|158189421|FG003|Extension 1 (EXT1)|Moved|1|||
49096867|NCT00090220|158189422|FG004|Extension 1 (EXT1)|Moved|0|||
49096868|NCT00090220|158189423|FG005|Extension 1 (EXT1)|Moved|0|||
49096869|NCT00090220|158189418|FG000|Extension 1 (EXT1)|Withdrawal by Subject|0|||
49096870|NCT00090220|158189419|FG001|Extension 1 (EXT1)|Withdrawal by Subject|0|||
49096871|NCT00090220|158189420|FG002|Extension 1 (EXT1)|Withdrawal by Subject|25|||
49096872|NCT00090220|158189421|FG003|Extension 1 (EXT1)|Withdrawal by Subject|0|||
49096873|NCT00090220|158189422|FG004|Extension 1 (EXT1)|Withdrawal by Subject|0|||
49096874|NCT00090220|158189423|FG005|Extension 1 (EXT1)|Withdrawal by Subject|0|||
49096875|NCT00090220|158189418|FG000|Extension 1 (EXT1)|Protocol Violation|0|||
49096876|NCT00090220|158189419|FG001|Extension 1 (EXT1)|Protocol Violation|0|||
49096877|NCT00090220|158189420|FG002|Extension 1 (EXT1)|Protocol Violation|0|||
49096878|NCT00090220|158189421|FG003|Extension 1 (EXT1)|Protocol Violation|1|||
49096879|NCT00090220|158189422|FG004|Extension 1 (EXT1)|Protocol Violation|0|||
49096880|NCT00090220|158189423|FG005|Extension 1 (EXT1)|Protocol Violation|0|||
49096881|NCT00090220|158189418|FG000|Extension 1 (EXT1)|Other reason|0|||
49096882|NCT00090220|158189419|FG001|Extension 1 (EXT1)|Other reason|0|||
49096883|NCT00090220|158189420|FG002|Extension 1 (EXT1)|Other reason|2|||
49096884|NCT00090220|158189421|FG003|Extension 1 (EXT1)|Other reason|0|||
49096885|NCT00090220|158189422|FG004|Extension 1 (EXT1)|Other reason|0|||
49096886|NCT00090220|158189423|FG005|Extension 1 (EXT1)|Other reason|0|||
49096887|NCT00090220|158189418|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
49096888|NCT00090220|158189419|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
49096889|NCT00090220|158189420|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
49096890|NCT00090220|158189421|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
49096891|NCT00090220|158189422|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|38|||
49096892|NCT00090220|158189423|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|23|||
49096893|NCT00090220|158189418|FG000|Long-term Follow-up (EXT2)|Death|0|||
49096894|NCT00090220|158189419|FG001|Long-term Follow-up (EXT2)|Death|0|||
49096895|NCT00090220|158189420|FG002|Long-term Follow-up (EXT2)|Death|0|||
49096896|NCT00090220|158189421|FG003|Long-term Follow-up (EXT2)|Death|0|||
49096897|NCT00090220|158189422|FG004|Long-term Follow-up (EXT2)|Death|1|||
49096898|NCT00090220|158189423|FG005|Long-term Follow-up (EXT2)|Death|1|||
49096899|NCT00090220|158189418|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
49096900|NCT00090220|158189419|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
49096901|NCT00090220|158189420|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
49096902|NCT00090220|158189421|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
49096903|NCT00090220|158189422|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
49096904|NCT00090220|158189423|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
49096905|NCT00090220|158189418|FG000|Long-term Follow-up (EXT2)|Other|0|||
49096906|NCT00090220|158189419|FG001|Long-term Follow-up (EXT2)|Other|0|||
49096907|NCT00090220|158189420|FG002|Long-term Follow-up (EXT2)|Other|0|||
49096908|NCT00090220|158189421|FG003|Long-term Follow-up (EXT2)|Other|0|||
49096909|NCT00090220|158189422|FG004|Long-term Follow-up (EXT2)|Other|1|||
49096910|NCT00090220|158189423|FG005|Long-term Follow-up (EXT2)|Other|0|||
49096911|NCT01938430|158189431|FG000|Overall Study|Randomized but Not Treated|0|||
49096912|NCT01938430|158189432|FG001|Overall Study|Randomized but Not Treated|0|||
49096913|NCT01938430|158189433|FG002|Overall Study|Randomized but Not Treated|0|||
49096914|NCT01938430|158189434|FG003|Overall Study|Randomized but Not Treated|0|||
49096915|NCT01938430|158189435|FG004|Overall Study|Randomized but Not Treated|0|||
49096916|NCT01938430|158189436|FG005|Overall Study|Randomized but Not Treated|0|||
49096917|NCT01938430|158189437|FG006|Overall Study|Randomized but Not Treated|0|||
49096918|NCT01938430|158189438|FG007|Overall Study|Randomized but Not Treated|0|||
49096919|NCT01938430|158189439|FG008|Overall Study|Randomized but Not Treated|0|||
49096920|NCT01938430|158189440|FG009|Overall Study|Randomized but Not Treated|0|||
49096921|NCT01938430|158189441|FG010|Overall Study|Randomized but Not Treated|1|||
49096922|NCT01938430|158189442|FG011|Overall Study|Randomized but Not Treated|0|||
49096923|NCT01938430|158189443|FG012|Overall Study|Randomized but Not Treated|0|||
49096924|NCT01938430|158189444|FG013|Overall Study|Randomized but Not Treated|1|||
49096925|NCT01938430|158189431|FG000|Overall Study|Adverse Event|0|||
49096926|NCT01938430|158189432|FG001|Overall Study|Adverse Event|0|||
49096927|NCT01938430|158189433|FG002|Overall Study|Adverse Event|0|||
49096928|NCT01938430|158189434|FG003|Overall Study|Adverse Event|0|||
49096929|NCT01938430|158189435|FG004|Overall Study|Adverse Event|0|||
49096930|NCT01938430|158189436|FG005|Overall Study|Adverse Event|0|||
49096931|NCT01938430|158189437|FG006|Overall Study|Adverse Event|1|||
49096932|NCT01938430|158189438|FG007|Overall Study|Adverse Event|0|||
49096933|NCT01938430|158189439|FG008|Overall Study|Adverse Event|0|||
49096934|NCT01938430|158189440|FG009|Overall Study|Adverse Event|0|||
49096935|NCT01938430|158189441|FG010|Overall Study|Adverse Event|0|||
49096936|NCT01938430|158189442|FG011|Overall Study|Adverse Event|0|||
49096937|NCT01938430|158189443|FG012|Overall Study|Adverse Event|0|||
49096938|NCT01938430|158189444|FG013|Overall Study|Adverse Event|0|||
49096939|NCT01938430|158189431|FG000|Overall Study|Death|1|||
49096940|NCT01938430|158189432|FG001|Overall Study|Death|2|||
49096941|NCT01938430|158189433|FG002|Overall Study|Death|2|||
49096942|NCT01938430|158189434|FG003|Overall Study|Death|1|||
49096943|NCT01938430|158189435|FG004|Overall Study|Death|0|||
49096944|NCT01938430|158189436|FG005|Overall Study|Death|0|||
49096945|NCT01938430|158189437|FG006|Overall Study|Death|1|||
49096946|NCT01938430|158189438|FG007|Overall Study|Death|1|||
49096947|NCT01938430|158189439|FG008|Overall Study|Death|2|||
49096948|NCT01938430|158189440|FG009|Overall Study|Death|3|||
49096949|NCT01938430|158189441|FG010|Overall Study|Death|0|||
49096950|NCT01938430|158189442|FG011|Overall Study|Death|0|||
49096951|NCT01938430|158189443|FG012|Overall Study|Death|0|||
49096952|NCT01938430|158189444|FG013|Overall Study|Death|0|||
49096953|NCT01938430|158189431|FG000|Overall Study|Investigator's Discretion|0|||
49096954|NCT01938430|158189432|FG001|Overall Study|Investigator's Discretion|0|||
49096955|NCT01938430|158189433|FG002|Overall Study|Investigator's Discretion|1|||
49096956|NCT01938430|158189434|FG003|Overall Study|Investigator's Discretion|0|||
49096957|NCT01938430|158189435|FG004|Overall Study|Investigator's Discretion|0|||
49096958|NCT01938430|158189436|FG005|Overall Study|Investigator's Discretion|0|||
49096959|NCT01938430|158189437|FG006|Overall Study|Investigator's Discretion|0|||
49096960|NCT01938430|158189438|FG007|Overall Study|Investigator's Discretion|0|||
49096961|NCT01938430|158189439|FG008|Overall Study|Investigator's Discretion|0|||
49096962|NCT01938430|158189440|FG009|Overall Study|Investigator's Discretion|0|||
49096963|NCT01938430|158189441|FG010|Overall Study|Investigator's Discretion|0|||
49096964|NCT01938430|158189442|FG011|Overall Study|Investigator's Discretion|0|||
49096965|NCT01938430|158189443|FG012|Overall Study|Investigator's Discretion|0|||
49096966|NCT01938430|158189444|FG013|Overall Study|Investigator's Discretion|0|||
49096967|NCT01938430|158189431|FG000|Overall Study|Lack of Efficacy|3|||
49096968|NCT01938430|158189432|FG001|Overall Study|Lack of Efficacy|1|||
49096969|NCT01938430|158189433|FG002|Overall Study|Lack of Efficacy|1|||
49096970|NCT01938430|158189434|FG003|Overall Study|Lack of Efficacy|1|||
49096971|NCT01938430|158189435|FG004|Overall Study|Lack of Efficacy|0|||
49096972|NCT01938430|158189436|FG005|Overall Study|Lack of Efficacy|0|||
49096973|NCT01938430|158189437|FG006|Overall Study|Lack of Efficacy|0|||
49096974|NCT01938430|158189438|FG007|Overall Study|Lack of Efficacy|0|||
49096975|NCT01938430|158189439|FG008|Overall Study|Lack of Efficacy|1|||
49096976|NCT01938430|158189440|FG009|Overall Study|Lack of Efficacy|0|||
49096977|NCT01938430|158189441|FG010|Overall Study|Lack of Efficacy|2|||
49096978|NCT01938430|158189442|FG011|Overall Study|Lack of Efficacy|1|||
49096979|NCT01938430|158189443|FG012|Overall Study|Lack of Efficacy|0|||
49096980|NCT01938430|158189444|FG013|Overall Study|Lack of Efficacy|0|||
49096981|NCT01938430|158189431|FG000|Overall Study|Lost to Follow-up|0|||
49096982|NCT01938430|158189432|FG001|Overall Study|Lost to Follow-up|0|||
49096983|NCT01938430|158189433|FG002|Overall Study|Lost to Follow-up|1|||
49096984|NCT01938430|158189434|FG003|Overall Study|Lost to Follow-up|0|||
49096985|NCT01938430|158189435|FG004|Overall Study|Lost to Follow-up|0|||
49096986|NCT01938430|158189436|FG005|Overall Study|Lost to Follow-up|1|||
49096987|NCT01938430|158189437|FG006|Overall Study|Lost to Follow-up|0|||
49096988|NCT01938430|158189438|FG007|Overall Study|Lost to Follow-up|0|||
49096989|NCT01938430|158189439|FG008|Overall Study|Lost to Follow-up|0|||
49096990|NCT01938430|158189440|FG009|Overall Study|Lost to Follow-up|0|||
49096991|NCT01938430|158189441|FG010|Overall Study|Lost to Follow-up|0|||
49096992|NCT01938430|158189442|FG011|Overall Study|Lost to Follow-up|0|||
49096993|NCT01938430|158189443|FG012|Overall Study|Lost to Follow-up|0|||
49096994|NCT01938430|158189444|FG013|Overall Study|Lost to Follow-up|0|||
49096995|NCT01938430|158189431|FG000|Overall Study|Withdrew Consent|0|||
49096996|NCT01938430|158189432|FG001|Overall Study|Withdrew Consent|0|||
49096997|NCT01938430|158189433|FG002|Overall Study|Withdrew Consent|0|||
49096998|NCT01938430|158189434|FG003|Overall Study|Withdrew Consent|0|||
49096999|NCT01938430|158189435|FG004|Overall Study|Withdrew Consent|0|||
49097000|NCT01938430|158189436|FG005|Overall Study|Withdrew Consent|0|||
49097001|NCT01938430|158189437|FG006|Overall Study|Withdrew Consent|0|||
49097002|NCT01938430|158189438|FG007|Overall Study|Withdrew Consent|0|||
49097003|NCT01938430|158189439|FG008|Overall Study|Withdrew Consent|1|||
49097004|NCT01938430|158189440|FG009|Overall Study|Withdrew Consent|0|||
49097005|NCT01938430|158189441|FG010|Overall Study|Withdrew Consent|0|||
49097006|NCT01938430|158189442|FG011|Overall Study|Withdrew Consent|0|||
49097007|NCT01938430|158189443|FG012|Overall Study|Withdrew Consent|0|||
49097008|NCT01938430|158189444|FG013|Overall Study|Withdrew Consent|0|||
49097009|NCT03875482|158189445|FG000|Overall Study|Adverse Event|0|||
49097010|NCT03875482|158189446|FG001|Overall Study|Adverse Event|1|||
49097011|NCT03875482|158189445|FG000|Overall Study|Withdrew consent|5|||
49097012|NCT03875482|158189446|FG001|Overall Study|Withdrew consent|6|||
49097013|NCT03875482|158189445|FG000|Overall Study|Lost to Follow-up|8|||
49097014|NCT03875482|158189446|FG001|Overall Study|Lost to Follow-up|2|||
49097015|NCT03875482|158189445|FG000|Overall Study|Lack of Efficacy|0|||
49097016|NCT03875482|158189446|FG001|Overall Study|Lack of Efficacy|11|||
49097017|NCT02424630|158189447|FG000|Overall Study|No rotator cuff tear|1|||
49097018|NCT02424630|158189448|FG001|Overall Study|No rotator cuff tear|2|||
49097019|NCT02424630|158189447|FG000|Overall Study|Open procedure|0|||
49097020|NCT02424630|158189448|FG001|Overall Study|Open procedure|1|||
49097021|NCT00537316|158189449|FG000|Part 1|Adverse Event|7|||
49097022|NCT00537316|158189450|FG001|Part 1|Adverse Event|11|||
49097023|NCT00537316|158189451|FG002|Part 1|Adverse Event|8|||
49097024|NCT00537316|158189452|FG003|Part 1|Adverse Event|0|||
49097025|NCT00537316|158189453|FG004|Part 1|Adverse Event|0|||
49097026|NCT00537316|158189454|FG005|Part 1|Adverse Event|0|||
49097027|NCT00537316|158189455|FG006|Part 1|Adverse Event|0|||
49097028|NCT00537316|158189449|FG000|Part 1|Protocol defined clinical event|1|||
49097029|NCT00537316|158189450|FG001|Part 1|Protocol defined clinical event|0|||
49097030|NCT00537316|158189451|FG002|Part 1|Protocol defined clinical event|0|||
49097031|NCT00537316|158189452|FG003|Part 1|Protocol defined clinical event|0|||
49097032|NCT00537316|158189453|FG004|Part 1|Protocol defined clinical event|0|||
49097033|NCT00537316|158189454|FG005|Part 1|Protocol defined clinical event|0|||
49097034|NCT00537316|158189455|FG006|Part 1|Protocol defined clinical event|0|||
49097035|NCT00537316|158189449|FG000|Part 1|Lost to Follow-up|1|||
49097036|NCT00537316|158189450|FG001|Part 1|Lost to Follow-up|0|||
49097037|NCT00537316|158189451|FG002|Part 1|Lost to Follow-up|0|||
49097038|NCT00537316|158189452|FG003|Part 1|Lost to Follow-up|0|||
49097039|NCT00537316|158189453|FG004|Part 1|Lost to Follow-up|0|||
49097040|NCT00537316|158189454|FG005|Part 1|Lost to Follow-up|0|||
49097041|NCT00537316|158189455|FG006|Part 1|Lost to Follow-up|0|||
49097042|NCT00537316|158189449|FG000|Part 1|Withdrawal by Subject|3|||
49097043|NCT00537316|158189450|FG001|Part 1|Withdrawal by Subject|8|||
49097044|NCT00537316|158189451|FG002|Part 1|Withdrawal by Subject|4|||
49097045|NCT00537316|158189452|FG003|Part 1|Withdrawal by Subject|0|||
49097046|NCT00537316|158189453|FG004|Part 1|Withdrawal by Subject|0|||
49097047|NCT00537316|158189454|FG005|Part 1|Withdrawal by Subject|0|||
49097048|NCT00537316|158189455|FG006|Part 1|Withdrawal by Subject|0|||
49097049|NCT00537316|158189449|FG000|Part 1|Protocol Violation|1|||
49097050|NCT00537316|158189450|FG001|Part 1|Protocol Violation|5|||
49097051|NCT00537316|158189451|FG002|Part 1|Protocol Violation|1|||
49097052|NCT00537316|158189452|FG003|Part 1|Protocol Violation|0|||
49097053|NCT00537316|158189453|FG004|Part 1|Protocol Violation|0|||
49097054|NCT00537316|158189454|FG005|Part 1|Protocol Violation|0|||
49097055|NCT00537316|158189455|FG006|Part 1|Protocol Violation|0|||
49097056|NCT00537316|158189449|FG000|Part 1|Did not meet protocol eligibility|1|||
49097057|NCT00537316|158189450|FG001|Part 1|Did not meet protocol eligibility|3|||
49097058|NCT00537316|158189451|FG002|Part 1|Did not meet protocol eligibility|2|||
49097059|NCT00537316|158189452|FG003|Part 1|Did not meet protocol eligibility|0|||
49097060|NCT00537316|158189453|FG004|Part 1|Did not meet protocol eligibility|0|||
49097061|NCT00537316|158189454|FG005|Part 1|Did not meet protocol eligibility|0|||
49097062|NCT00537316|158189455|FG006|Part 1|Did not meet protocol eligibility|0|||
49097063|NCT00537316|158189449|FG000|Part 1|Administrative|0|||
49097064|NCT00537316|158189450|FG001|Part 1|Administrative|0|||
49097065|NCT00537316|158189451|FG002|Part 1|Administrative|2|||
49097066|NCT00537316|158189452|FG003|Part 1|Administrative|0|||
49097067|NCT00537316|158189453|FG004|Part 1|Administrative|0|||
49097068|NCT00537316|158189454|FG005|Part 1|Administrative|0|||
49097069|NCT00537316|158189455|FG006|Part 1|Administrative|0|||
49097070|NCT00537316|158189449|FG000|Part 2|Never entered follow-up|0|||
49097071|NCT00537316|158189450|FG001|Part 2|Never entered follow-up|0|||
49097072|NCT00537316|158189451|FG002|Part 2|Never entered follow-up|0|||
49097073|NCT00537316|158189452|FG003|Part 2|Never entered follow-up|0|||
49097074|NCT00537316|158189453|FG004|Part 2|Never entered follow-up|0|||
49097075|NCT00537316|158189454|FG005|Part 2|Never entered follow-up|0|||
49097076|NCT00537316|158189455|FG006|Part 2|Never entered follow-up|1|||
49097077|NCT00537316|158189449|FG000|Part 2|Adverse Event|4|||
49097078|NCT00537316|158189450|FG001|Part 2|Adverse Event|0|||
49097079|NCT00537316|158189451|FG002|Part 2|Adverse Event|2|||
49097080|NCT00537316|158189452|FG003|Part 2|Adverse Event|0|||
49097081|NCT00537316|158189453|FG004|Part 2|Adverse Event|0|||
49097082|NCT00537316|158189454|FG005|Part 2|Adverse Event|0|||
49097083|NCT00537316|158189455|FG006|Part 2|Adverse Event|0|||
49097084|NCT00537316|158189449|FG000|Part 2|Lost to Follow-up|1|||
49097085|NCT00537316|158189450|FG001|Part 2|Lost to Follow-up|0|||
49097086|NCT00537316|158189451|FG002|Part 2|Lost to Follow-up|2|||
49097087|NCT00537316|158189452|FG003|Part 2|Lost to Follow-up|0|||
49097088|NCT00537316|158189453|FG004|Part 2|Lost to Follow-up|0|||
49097089|NCT00537316|158189454|FG005|Part 2|Lost to Follow-up|0|||
49097090|NCT00537316|158189455|FG006|Part 2|Lost to Follow-up|0|||
49097091|NCT00537316|158189449|FG000|Part 2|Withdrawal by Subject|5|||
49097092|NCT00537316|158189450|FG001|Part 2|Withdrawal by Subject|1|||
49097093|NCT00537316|158189451|FG002|Part 2|Withdrawal by Subject|4|||
49097094|NCT00537316|158189452|FG003|Part 2|Withdrawal by Subject|0|||
49097095|NCT00537316|158189453|FG004|Part 2|Withdrawal by Subject|0|||
49097096|NCT00537316|158189454|FG005|Part 2|Withdrawal by Subject|0|||
49097097|NCT00537316|158189455|FG006|Part 2|Withdrawal by Subject|0|||
49097098|NCT00537316|158189449|FG000|Part 2|Administrative|16|||
49097099|NCT00537316|158189450|FG001|Part 2|Administrative|8|||
49097100|NCT00537316|158189451|FG002|Part 2|Administrative|24|||
49097101|NCT00537316|158189452|FG003|Part 2|Administrative|3|||
49097102|NCT00537316|158189453|FG004|Part 2|Administrative|1|||
49097103|NCT00537316|158189454|FG005|Part 2|Administrative|4|||
49097104|NCT00537316|158189455|FG006|Part 2|Administrative|1|||
49097105|NCT01062113|158189456|FG000|Overall Study|Adverse Event|1|||
49097106|NCT01062113|158189457|FG001|Overall Study|Adverse Event|0|||
49097107|NCT01062113|158189458|FG002|Overall Study|Adverse Event|0|||
49097108|NCT01062113|158189456|FG000|Overall Study|Lack of Efficacy|38|||
49097109|NCT01062113|158189457|FG001|Overall Study|Lack of Efficacy|22|||
49097110|NCT01062113|158189458|FG002|Overall Study|Lack of Efficacy|31|||
49097111|NCT01062113|158189456|FG000|Overall Study|Withdrawal by Subject|1|||
49097112|NCT01062113|158189457|FG001|Overall Study|Withdrawal by Subject|0|||
49097113|NCT01062113|158189458|FG002|Overall Study|Withdrawal by Subject|0|||
49097114|NCT00661609|158189461|FG000|Overall Study|Adverse Event|4|||
49097115|NCT00661609|158189461|FG000|Overall Study|Death|20|||
49097116|NCT00661609|158189461|FG000|Overall Study|Withdrawal by Subject|2|||
49097117|NCT00661609|158189461|FG000|Overall Study|PI Decision|1|||
49097118|NCT00661609|158189461|FG000|Overall Study|Survival follow up stage discontinued|11|||
49097119|NCT00661609|158189461|FG000|Overall Study|Disease progression|3|||
49097120|NCT00680901|158189462|FG000|Overall Study|Lost to Follow-up|8|||
49097121|NCT00680901|158189463|FG001|Overall Study|Lost to Follow-up|8|||
49097122|NCT00680901|158189462|FG000|Overall Study|Withdrawal by Subject|4|||
49097123|NCT00680901|158189463|FG001|Overall Study|Withdrawal by Subject|13|||
49097124|NCT00680901|158189462|FG000|Overall Study|Physician Decision|0|||
49097125|NCT00680901|158189463|FG001|Overall Study|Physician Decision|1|||
49097126|NCT00680901|158189462|FG000|Overall Study|Ongoing: On Study Treatment|16|||
49097127|NCT00680901|158189463|FG001|Overall Study|Ongoing: On Study Treatment|13|||
49097128|NCT00680901|158189462|FG000|Overall Study|Ongoing: In Follow Up|45|||
49097129|NCT00680901|158189463|FG001|Overall Study|Ongoing: In Follow Up|41|||
49097130|NCT01108341|158189466|FG000|Overall Study|Death|2|||
49097131|NCT01108341|158189466|FG000|Overall Study|Withdrawal by Subject|1|||
49097132|NCT01108341|158189466|FG000|Overall Study|Lost to Follow-up|1|||
49097133|NCT01108341|158189466|FG000|Overall Study|Other|1|||
49097134|NCT03499899|158189467|FG000|Overall Study|Adverse Event|2|||
49097135|NCT03499899|158189468|FG001|Overall Study|Adverse Event|3|||
49097136|NCT03499899|158189469|FG002|Overall Study|Adverse Event|3|||
49097137|NCT03499899|158189467|FG000|Overall Study|Death|0|||
49097138|NCT03499899|158189468|FG001|Overall Study|Death|0|||
49097139|NCT03499899|158189469|FG002|Overall Study|Death|1|||
49097140|NCT03499899|158189467|FG000|Overall Study|Physician Decision|3|||
49097141|NCT03499899|158189468|FG001|Overall Study|Physician Decision|6|||
49097142|NCT03499899|158189469|FG002|Overall Study|Physician Decision|6|||
49097143|NCT03499899|158189467|FG000|Overall Study|Progressive disease|15|||
49097144|NCT03499899|158189468|FG001|Overall Study|Progressive disease|23|||
49097145|NCT03499899|158189469|FG002|Overall Study|Progressive disease|23|||
49097146|NCT03499899|158189467|FG000|Overall Study|Patient decision|0|||
49097147|NCT03499899|158189468|FG001|Overall Study|Patient decision|1|||
49097148|NCT03499899|158189469|FG002|Overall Study|Patient decision|1|||
49097149|NCT03499899|158189467|FG000|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
49097150|NCT03499899|158189468|FG001|Overall Study|Terminated by sponsor (end of study definition was met)|1|||
49097151|NCT03499899|158189469|FG002|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
49097152|NCT01489254|158189470|FG000|Double-blind Part|Adverse Event|7|||
49097153|NCT01489254|158189471|FG001|Double-blind Part|Adverse Event|2|||
49097154|NCT01489254|158189472|FG002|Double-blind Part|Adverse Event|2|||
49097155|NCT01489254|158189473|FG003|Double-blind Part|Adverse Event|0|||
49097156|NCT01489254|158189470|FG000|Double-blind Part|Pregnancy|1|||
49097157|NCT01489254|158189471|FG001|Double-blind Part|Pregnancy|3|||
49097158|NCT01489254|158189472|FG002|Double-blind Part|Pregnancy|0|||
49097159|NCT01489254|158189473|FG003|Double-blind Part|Pregnancy|0|||
49097160|NCT01489254|158189470|FG000|Double-blind Part|Withdrawal by Subject|12|||
49097161|NCT01489254|158189471|FG001|Double-blind Part|Withdrawal by Subject|20|||
49097162|NCT01489254|158189472|FG002|Double-blind Part|Withdrawal by Subject|1|||
49097163|NCT01489254|158189473|FG003|Double-blind Part|Withdrawal by Subject|0|||
49097164|NCT01489254|158189470|FG000|Double-blind Part|Lost to Follow-up|1|||
49097165|NCT01489254|158189471|FG001|Double-blind Part|Lost to Follow-up|2|||
49097166|NCT01489254|158189472|FG002|Double-blind Part|Lost to Follow-up|0|||
49097167|NCT01489254|158189473|FG003|Double-blind Part|Lost to Follow-up|0|||
49097168|NCT01489254|158189470|FG000|Double-blind Part|Other reasons for not completing study|4|||
49097169|NCT01489254|158189471|FG001|Double-blind Part|Other reasons for not completing study|6|||
49097170|NCT01489254|158189472|FG002|Double-blind Part|Other reasons for not completing study|0|||
49097171|NCT01489254|158189473|FG003|Double-blind Part|Other reasons for not completing study|0|||
49097172|NCT01489254|158189470|FG000|Open-label Extension Part|Adverse Event|0|||
49097173|NCT01489254|158189471|FG001|Open-label Extension Part|Adverse Event|0|||
49097174|NCT01489254|158189472|FG002|Open-label Extension Part|Adverse Event|0|||
49097175|NCT01489254|158189473|FG003|Open-label Extension Part|Adverse Event|10|||
49097176|NCT01489254|158189470|FG000|Open-label Extension Part|Pregnancy|0|||
49097177|NCT01489254|158189471|FG001|Open-label Extension Part|Pregnancy|0|||
49097178|NCT01489254|158189472|FG002|Open-label Extension Part|Pregnancy|0|||
49097179|NCT01489254|158189473|FG003|Open-label Extension Part|Pregnancy|3|||
49097180|NCT01489254|158189470|FG000|Open-label Extension Part|Withdrawal by Subject|0|||
49097181|NCT01489254|158189471|FG001|Open-label Extension Part|Withdrawal by Subject|0|||
49097182|NCT01489254|158189472|FG002|Open-label Extension Part|Withdrawal by Subject|0|||
49097183|NCT01489254|158189473|FG003|Open-label Extension Part|Withdrawal by Subject|30|||
49097184|NCT01489254|158189470|FG000|Open-label Extension Part|Protocol Violation|0|||
49097185|NCT01489254|158189471|FG001|Open-label Extension Part|Protocol Violation|0|||
49097186|NCT01489254|158189472|FG002|Open-label Extension Part|Protocol Violation|0|||
49097187|NCT01489254|158189473|FG003|Open-label Extension Part|Protocol Violation|1|||
49097188|NCT01489254|158189470|FG000|Open-label Extension Part|Lost to Follow-up|0|||
49097189|NCT01489254|158189471|FG001|Open-label Extension Part|Lost to Follow-up|0|||
49097190|NCT01489254|158189472|FG002|Open-label Extension Part|Lost to Follow-up|0|||
49097191|NCT01489254|158189473|FG003|Open-label Extension Part|Lost to Follow-up|9|||
49097192|NCT01489254|158189470|FG000|Open-label Extension Part|Other reasons for not completing study|0|||
49097193|NCT01489254|158189471|FG001|Open-label Extension Part|Other reasons for not completing study|0|||
49097194|NCT01489254|158189472|FG002|Open-label Extension Part|Other reasons for not completing study|0|||
49097195|NCT01489254|158189473|FG003|Open-label Extension Part|Other reasons for not completing study|5|||
49097196|NCT01981954|158189474|FG000|Titration Period|Protocol Deviation|1|||
49097197|NCT01981954|158189474|FG000|Fixed-Dose Assessment Period|Lack of Efficacy|1|||
49097198|NCT03655470|158189479|FG000|Overall Study|Lost to Follow-up|6|||
49097199|NCT03655470|158189480|FG001|Overall Study|Lost to Follow-up|7|||
49097200|NCT00507819|158189481|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
49097201|NCT00507819|158189482|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
49097202|NCT01475851|158189483|FG000|Overall Study|Protocol defined stopping criteria|1|||
49097203|NCT01475851|158189484|FG001|Overall Study|Protocol defined stopping criteria|0|||
49097204|NCT01082211|158189487|FG000|Overall Study|Protocol Violation|4|||
49097205|NCT01082211|158189487|FG000|Overall Study|No protocol treatment received|3|||
49097206|NCT01166438|158189488|FG000|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8|||
49097207|NCT01166438|158189489|FG001|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4|||
49097208|NCT01166438|158189488|FG000|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0|||
49097209|NCT01166438|158189489|FG001|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4|||
49097210|NCT01166438|158189488|FG000|Double-blind Phase: 1st 6 Months|Not treated|1|||
49097211|NCT01166438|158189489|FG001|Double-blind Phase: 1st 6 Months|Not treated|1|||
49097212|NCT01166438|158189488|FG000|Off Treatment Follow-up Phase|Withdrawal by Subject|1|||
49097213|NCT01166438|158189489|FG001|Off Treatment Follow-up Phase|Withdrawal by Subject|2|||
49097214|NCT01166438|158189488|FG000|Off Treatment Follow-up Phase|Lost to Follow-up|4|||
49097215|NCT01166438|158189489|FG001|Off Treatment Follow-up Phase|Lost to Follow-up|2|||
49097216|NCT01166438|158189488|FG000|Off Treatment Follow-up Phase|Lack of Efficacy|29|||
49097217|NCT01166438|158189489|FG001|Off Treatment Follow-up Phase|Lack of Efficacy|52|||
49097218|NCT02438826|158189491|FG000|Double-Blind Treatment Phase|Adverse Event|1|||
49097219|NCT02438826|158189492|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
49097220|NCT02438826|158189493|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
49097221|NCT02438826|158189494|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
49097222|NCT02438826|158189491|FG000|Double-Blind Treatment Phase|Lack of Efficacy|1|||
49097223|NCT02438826|158189492|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
49097224|NCT02438826|158189493|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
49097225|NCT02438826|158189494|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
49097226|NCT02438826|158189491|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
49097227|NCT02438826|158189492|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
49097228|NCT02438826|158189493|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
49097229|NCT02438826|158189494|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
49097230|NCT02438826|158189491|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
49097231|NCT02438826|158189492|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
49097232|NCT02438826|158189493|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
49097233|NCT02438826|158189494|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
49097234|NCT02438826|158189491|FG000|Double-Blind Treatment Phase|Screen Failure|2|||
49097235|NCT02438826|158189492|FG001|Double-Blind Treatment Phase|Screen Failure|0|||
49097236|NCT02438826|158189493|FG002|Double-Blind Treatment Phase|Screen Failure|0|||
49097237|NCT02438826|158189494|FG003|Double-Blind Treatment Phase|Screen Failure|0|||
49097238|NCT02438826|158189491|FG000|Open-Label Treatment Phase|Adverse Event|11|||
49097239|NCT02438826|158189492|FG001|Open-Label Treatment Phase|Adverse Event|6|||
49097240|NCT02438826|158189493|FG002|Open-Label Treatment Phase|Adverse Event|0|||
49097241|NCT02438826|158189494|FG003|Open-Label Treatment Phase|Adverse Event|0|||
49097242|NCT02438826|158189491|FG000|Open-Label Treatment Phase|Lack of Efficacy|27|||
49097243|NCT02438826|158189492|FG001|Open-Label Treatment Phase|Lack of Efficacy|18|||
49097244|NCT02438826|158189493|FG002|Open-Label Treatment Phase|Lack of Efficacy|0|||
49097245|NCT02438826|158189494|FG003|Open-Label Treatment Phase|Lack of Efficacy|0|||
49097246|NCT02438826|158189491|FG000|Open-Label Treatment Phase|Lost to Follow-up|0|||
49097247|NCT02438826|158189492|FG001|Open-Label Treatment Phase|Lost to Follow-up|2|||
49097248|NCT02438826|158189493|FG002|Open-Label Treatment Phase|Lost to Follow-up|0|||
49097249|NCT02438826|158189494|FG003|Open-Label Treatment Phase|Lost to Follow-up|0|||
49097250|NCT02438826|158189491|FG000|Open-Label Treatment Phase|Withdrawal by Subject|6|||
49097251|NCT02438826|158189492|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
49097252|NCT02438826|158189493|FG002|Open-Label Treatment Phase|Withdrawal by Subject|0|||
49097253|NCT02438826|158189494|FG003|Open-Label Treatment Phase|Withdrawal by Subject|0|||
49097254|NCT02438826|158189491|FG000|Post-Treatment Phase|Adverse Event|3|||
49097255|NCT02438826|158189492|FG001|Post-Treatment Phase|Adverse Event|0|||
49097256|NCT02438826|158189493|FG002|Post-Treatment Phase|Adverse Event|0|||
49097257|NCT02438826|158189494|FG003|Post-Treatment Phase|Adverse Event|0|||
49097258|NCT02438826|158189491|FG000|Post-Treatment Phase|Lack of Efficacy|4|||
49097259|NCT02438826|158189492|FG001|Post-Treatment Phase|Lack of Efficacy|0|||
49097260|NCT02438826|158189493|FG002|Post-Treatment Phase|Lack of Efficacy|0|||
49097261|NCT02438826|158189494|FG003|Post-Treatment Phase|Lack of Efficacy|0|||
49097262|NCT02438826|158189491|FG000|Post-Treatment Phase|Physician Decision|1|||
49097263|NCT02438826|158189492|FG001|Post-Treatment Phase|Physician Decision|0|||
49097264|NCT02438826|158189493|FG002|Post-Treatment Phase|Physician Decision|0|||
49097265|NCT02438826|158189494|FG003|Post-Treatment Phase|Physician Decision|0|||
49097266|NCT02438826|158189491|FG000|Post-Treatment Phase|Withdrawal by Subject|1|||
49097267|NCT02438826|158189492|FG001|Post-Treatment Phase|Withdrawal by Subject|1|||
49097268|NCT02438826|158189493|FG002|Post-Treatment Phase|Withdrawal by Subject|0|||
49097269|NCT02438826|158189494|FG003|Post-Treatment Phase|Withdrawal by Subject|0|||
49097270|NCT02640950|158189498|FG000|Overall Study|Adverse Event|1|||
49097271|NCT02640950|158189498|FG000|Overall Study|Withdrawal by Subject|1|||
49097272|NCT01075256|158189499|FG000|Overall Study|Withdrawal by Subject|1|||
49097273|NCT01075256|158189500|FG001|Overall Study|Withdrawal by Subject|0|||
49097274|NCT01075256|158189501|FG002|Overall Study|Withdrawal by Subject|0|||
49097275|NCT04445714|158189508|FG000|Overall Study|Discontinuation of the study|14|||
49097276|NCT04445714|158189508|FG000|Overall Study|High plasma glucose-fasting and HbA1c; investigator decision to withdraw participant|1|||
49097277|NCT04445714|158189508|FG000|Overall Study|Withdrawal of Informed Consent|8|||
49097278|NCT00068393|158191235|FG000|Overall Study|Adverse Event|2|||
49097279|NCT00068393|158191235|FG000|Overall Study|Death|3|||
49097280|NCT00068393|158191235|FG000|Overall Study|Withdrawal by Subject|3|||
49097281|NCT00068393|158191235|FG000|Overall Study|Alternative treatment|1|||
49097282|NCT00068393|158191235|FG000|Overall Study|Quality of life worsening|1|||
49097283|NCT02453334|158191241|FG000|Overall Study|Death|15|||
49097284|NCT02453334|158191242|FG001|Overall Study|Death|13|||
49097285|NCT02453334|158191241|FG000|Overall Study|Adverse Event|2|||
49097286|NCT02453334|158191242|FG001|Overall Study|Adverse Event|1|||
49097287|NCT02453334|158191241|FG000|Overall Study|Lost to Follow-up|5|||
49097288|NCT02453334|158191242|FG001|Overall Study|Lost to Follow-up|9|||
49097289|NCT02453334|158191241|FG000|Overall Study|Physician Decision|1|||
49097290|NCT02453334|158191242|FG001|Overall Study|Physician Decision|0|||
49097291|NCT02453334|158191241|FG000|Overall Study|Withdrawal by Subject|17|||
49097292|NCT02453334|158191242|FG001|Overall Study|Withdrawal by Subject|13|||
49097293|NCT02453334|158191241|FG000|Overall Study|Other reason|1|||
49097294|NCT02453334|158191242|FG001|Overall Study|Other reason|4|||
49097295|NCT01841762|158191243|FG000|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51|||
49097296|NCT01841762|158191243|FG000|Treatment Period|Adverse Event|16|||
49097297|NCT01841762|158191243|FG000|Treatment Period|Death|1|||
49097298|NCT01841762|158191243|FG000|Treatment Period|Withdrawal by Subject|7|||
49097299|NCT01841762|158191243|FG000|Treatment Period|Lost to Follow-up|1|||
49097300|NCT01841762|158191243|FG000|Treatment Period|Physician Decision|2|||
49097301|NCT01841762|158191243|FG000|Treatment Period|Other, including non-compliance|5|||
49097302|NCT01841762|158191243|FG000|Post-Treatment Safety Follow-Up Period|Death|1|||
49097303|NCT01841762|158191243|FG000|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7|||
49097304|NCT01841762|158191243|FG000|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6|||
49097305|NCT01841762|158191243|FG000|Post-Treatment Safety Follow-Up Period|Other, administrative error|1|||
49097306|NCT03233529|158191244|FG000|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1|||
49097307|NCT03233529|158191244|FG000|Open-Label Period (Day 15 to Day 71)|Adverse Event|1|||
49097308|NCT05318092|158191247|FG000|Overall Study|Lost to Follow-up|3|||
49097309|NCT05318092|158191247|FG000|Overall Study|Withdrawal by Subject|1|||
49097310|NCT01177293|158191250|FG000|Washout Period (of 14 Days)|Lost to Follow-up|0|||
49097311|NCT01177293|158191251|FG001|Washout Period (of 14 Days)|Lost to Follow-up|1|||
49097312|NCT01270464|158191252|FG000|Overall Study|Protocol Violation|4|||
49097313|NCT01270464|158191253|FG001|Overall Study|Protocol Violation|3|||
49097314|NCT01270464|158191254|FG002|Overall Study|Protocol Violation|2|||
49097315|NCT01270464|158191252|FG000|Overall Study|Lack of Efficacy|2|||
49097316|NCT01270464|158191253|FG001|Overall Study|Lack of Efficacy|3|||
49097317|NCT01270464|158191254|FG002|Overall Study|Lack of Efficacy|1|||
49097318|NCT01270464|158191252|FG000|Overall Study|Adverse Event|9|||
49097319|NCT01270464|158191253|FG001|Overall Study|Adverse Event|1|||
49097320|NCT01270464|158191254|FG002|Overall Study|Adverse Event|7|||
49097321|NCT01270464|158191252|FG000|Overall Study|Withdrawal by Subject|2|||
49097322|NCT01270464|158191253|FG001|Overall Study|Withdrawal by Subject|1|||
49097323|NCT01270464|158191254|FG002|Overall Study|Withdrawal by Subject|4|||
49097324|NCT01270464|158191252|FG000|Overall Study|Lost to Follow-up|2|||
49097325|NCT01270464|158191253|FG001|Overall Study|Lost to Follow-up|3|||
49097326|NCT01270464|158191254|FG002|Overall Study|Lost to Follow-up|1|||
49097327|NCT01270464|158191252|FG000|Overall Study|Other|1|||
49097328|NCT01270464|158191253|FG001|Overall Study|Other|1|||
49097329|NCT01270464|158191254|FG002|Overall Study|Other|3|||
49097330|NCT05113979|158191255|FG000|Overall Study|Death|2|||
49097331|NCT05113979|158191255|FG000|Overall Study|Lost to Follow-up|1|||
49097332|NCT02429778|158191256|FG000|Overall Study|Lost to Follow-up|2|||
49097333|NCT02429778|158191257|FG001|Overall Study|Lost to Follow-up|0|||
49097334|NCT02429778|158191256|FG000|Overall Study|Withdrawal by Subject|5|||
49097335|NCT02429778|158191257|FG001|Overall Study|Withdrawal by Subject|0|||
49097336|NCT03681678|158191258|FG000|Overall Study|Lost to Follow-up|20|||
49097337|NCT03521115|158191259|FG000|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56|||
49097338|NCT03521115|158191260|FG001|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40|||
49097339|NCT03521115|158191259|FG000|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3|||
49097340|NCT03521115|158191260|FG001|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1|||
49097341|NCT01471340|158191262|FG000|Overall Study|Death|5|||
49097342|NCT01471340|158191263|FG001|Overall Study|Death|4|||
49097343|NCT01471340|158191262|FG000|Overall Study|Lost to Follow-up|0|||
49097344|NCT01471340|158191263|FG001|Overall Study|Lost to Follow-up|1|||
49097345|NCT01471340|158191262|FG000|Overall Study|Investigational site closure|0|||
49097346|NCT01471340|158191263|FG001|Overall Study|Investigational site closure|1|||
49097347|NCT01471340|158191262|FG000|Overall Study|Invalid informed consent|1|||
49097348|NCT01471340|158191263|FG001|Overall Study|Invalid informed consent|0|||
49097349|NCT00976820|158191266|FG000|Overall Study|Lost to Follow-up|5|||
49097350|NCT00976820|158191267|FG001|Overall Study|Lost to Follow-up|16|||
49097351|NCT00976820|158191268|FG002|Overall Study|Lost to Follow-up|2|||
49097352|NCT00976820|158191269|FG003|Overall Study|Lost to Follow-up|3|||
49097353|NCT00976820|158191266|FG000|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
49097354|NCT00976820|158191267|FG001|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
49097355|NCT00976820|158191268|FG002|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
49097356|NCT00976820|158191269|FG003|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
49097357|NCT00976820|158191266|FG000|Overall Study|Withdrawal by Subject|2|||
49097358|NCT00976820|158191267|FG001|Overall Study|Withdrawal by Subject|4|||
49097359|NCT00976820|158191268|FG002|Overall Study|Withdrawal by Subject|1|||
49097360|NCT00976820|158191269|FG003|Overall Study|Withdrawal by Subject|4|||
49097361|NCT02475265|158191270|FG000|Overall Study|Physician Decision|1|||
49097362|NCT02475265|158191270|FG000|Overall Study|Withdrawal by Subject|2|||
49097363|NCT00526669|158191271|FG000|Combined Treatment Phase|Lost to Follow-up|0|||
49097364|NCT00526669|158191272|FG001|Combined Treatment Phase|Lost to Follow-up|2|||
49097365|NCT00526669|158191271|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
49097366|NCT00526669|158191272|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
49097367|NCT00526669|158191271|FG000|Combined Treatment Phase|Sponsor Terminated Study|0|||
49097368|NCT00526669|158191272|FG001|Combined Treatment Phase|Sponsor Terminated Study|2|||
49097369|NCT00526669|158191271|FG000|Combined Treatment Phase|Death|0|||
49097370|NCT00526669|158191272|FG001|Combined Treatment Phase|Death|2|||
49097371|NCT00968981|158191273|FG000|Overall Study|Adverse Event|2|||
49097372|NCT00968981|158191274|FG001|Overall Study|Adverse Event|0|||
49097373|NCT00968981|158191275|FG002|Overall Study|Adverse Event|0|||
49097374|NCT00968981|158191273|FG000|Overall Study|Disease Progression|14|||
49097375|NCT00968981|158191274|FG001|Overall Study|Disease Progression|16|||
49097376|NCT00968981|158191275|FG002|Overall Study|Disease Progression|13|||
49097377|NCT00968981|158191273|FG000|Overall Study|Lost to Follow-up|0|||
49097378|NCT00968981|158191274|FG001|Overall Study|Lost to Follow-up|0|||
49097379|NCT00968981|158191275|FG002|Overall Study|Lost to Follow-up|1|||
49097380|NCT00968981|158191273|FG000|Overall Study|Physician Decision|5|||
49097381|NCT00968981|158191274|FG001|Overall Study|Physician Decision|3|||
49097382|NCT00968981|158191275|FG002|Overall Study|Physician Decision|5|||
49097383|NCT00968981|158191273|FG000|Overall Study|Withdrawal by Subject|1|||
49097384|NCT00968981|158191274|FG001|Overall Study|Withdrawal by Subject|3|||
49097385|NCT00968981|158191275|FG002|Overall Study|Withdrawal by Subject|3|||
49097386|NCT01430403|158191286|FG000|Overall Study|Lost to Follow-up|5|||
49097387|NCT01430403|158191287|FG001|Overall Study|Lost to Follow-up|5|||
49097388|NCT01430403|158191288|FG002|Overall Study|Lost to Follow-up|3|||
49097389|NCT01430403|158191286|FG000|Overall Study|Physician Decision|1|||
49097390|NCT01430403|158191287|FG001|Overall Study|Physician Decision|0|||
49097391|NCT01430403|158191288|FG002|Overall Study|Physician Decision|0|||
49097392|NCT01430403|158191286|FG000|Overall Study|Protocol Violation|2|||
49097393|NCT01430403|158191287|FG001|Overall Study|Protocol Violation|3|||
49097394|NCT01430403|158191288|FG002|Overall Study|Protocol Violation|2|||
49097395|NCT01430403|158191286|FG000|Overall Study|Withdrawal by Subject|9|||
49097396|NCT01430403|158191287|FG001|Overall Study|Withdrawal by Subject|1|||
49097397|NCT01430403|158191288|FG002|Overall Study|Withdrawal by Subject|3|||
49097398|NCT03063086|158191300|FG000|Overall Study|technical problems|1|||
49097399|NCT03063086|158191301|FG001|Overall Study|technical problems|0|||
49097400|NCT03063086|158191302|FG002|Overall Study|technical problems|0|||
49097401|NCT03063086|158191303|FG003|Overall Study|technical problems|0|||
49097402|NCT03063086|158191304|FG004|Overall Study|technical problems|0|||
49097403|NCT03063086|158191305|FG005|Overall Study|technical problems|0|||
49097404|NCT03063086|158191300|FG000|Overall Study|Adverse Event|1|||
49097405|NCT03063086|158191301|FG001|Overall Study|Adverse Event|1|||
49097406|NCT03063086|158191302|FG002|Overall Study|Adverse Event|1|||
49097407|NCT03063086|158191303|FG003|Overall Study|Adverse Event|1|||
49097408|NCT03063086|158191304|FG004|Overall Study|Adverse Event|0|||
49097409|NCT03063086|158191305|FG005|Overall Study|Adverse Event|0|||
49097410|NCT03063086|158191300|FG000|Overall Study|subject/guardian decision|1|||
49097411|NCT03063086|158191301|FG001|Overall Study|subject/guardian decision|0|||
49097412|NCT03063086|158191302|FG002|Overall Study|subject/guardian decision|0|||
49097413|NCT03063086|158191303|FG003|Overall Study|subject/guardian decision|0|||
49097414|NCT03063086|158191304|FG004|Overall Study|subject/guardian decision|0|||
49097415|NCT03063086|158191305|FG005|Overall Study|subject/guardian decision|0|||
49097416|NCT03063086|158191300|FG000|Overall Study|Non-compliance with study treatment|0|||
49097417|NCT03063086|158191301|FG001|Overall Study|Non-compliance with study treatment|0|||
49097418|NCT03063086|158191302|FG002|Overall Study|Non-compliance with study treatment|0|||
49097419|NCT03063086|158191303|FG003|Overall Study|Non-compliance with study treatment|1|||
49097420|NCT03063086|158191304|FG004|Overall Study|Non-compliance with study treatment|0|||
49097421|NCT03063086|158191305|FG005|Overall Study|Non-compliance with study treatment|1|||
49097422|NCT03063086|158191300|FG000|Overall Study|Physician Decision|0|||
49097423|NCT03063086|158191301|FG001|Overall Study|Physician Decision|0|||
49097424|NCT03063086|158191302|FG002|Overall Study|Physician Decision|0|||
49097425|NCT03063086|158191303|FG003|Overall Study|Physician Decision|1|||
49097426|NCT03063086|158191304|FG004|Overall Study|Physician Decision|0|||
49097427|NCT03063086|158191305|FG005|Overall Study|Physician Decision|0|||
49097428|NCT04590586|158191306|FG000|Overall Study|Death|7|||
49097429|NCT04590586|158191307|FG001|Overall Study|Death|1|||
49097430|NCT04590586|158191308|FG002|Overall Study|Death|37|||
49097431|NCT04590586|158191309|FG003|Overall Study|Death|34|||
49097432|NCT04590586|158191310|FG004|Overall Study|Death|19|||
49097433|NCT04590586|158191311|FG005|Overall Study|Death|3|||
49097434|NCT04590586|158191306|FG000|Overall Study|Lost to Follow-up|3|||
49097435|NCT04590586|158191307|FG001|Overall Study|Lost to Follow-up|0|||
49097436|NCT04590586|158191308|FG002|Overall Study|Lost to Follow-up|11|||
49097437|NCT04590586|158191309|FG003|Overall Study|Lost to Follow-up|11|||
49097438|NCT04590586|158191310|FG004|Overall Study|Lost to Follow-up|6|||
49097439|NCT04590586|158191311|FG005|Overall Study|Lost to Follow-up|0|||
49097440|NCT04590586|158191306|FG000|Overall Study|Withdrawal by Subject|0|||
49097441|NCT04590586|158191307|FG001|Overall Study|Withdrawal by Subject|0|||
49097442|NCT04590586|158191308|FG002|Overall Study|Withdrawal by Subject|6|||
49097443|NCT04590586|158191309|FG003|Overall Study|Withdrawal by Subject|0|||
49097444|NCT04590586|158191310|FG004|Overall Study|Withdrawal by Subject|3|||
49097445|NCT04590586|158191311|FG005|Overall Study|Withdrawal by Subject|0|||
49097446|NCT04590586|158191306|FG000|Overall Study|Other|3|||
49097447|NCT04590586|158191307|FG001|Overall Study|Other|0|||
49097448|NCT04590586|158191308|FG002|Overall Study|Other|1|||
49097449|NCT04590586|158191309|FG003|Overall Study|Other|1|||
49097450|NCT04590586|158191310|FG004|Overall Study|Other|2|||
49097451|NCT04590586|158191311|FG005|Overall Study|Other|1|||
49097452|NCT01609543|158191312|FG000|Overall Study|Disease Progression|28|||
49097453|NCT01609543|158191312|FG000|Overall Study|Adverse Event|5|||
49097454|NCT01609543|158191312|FG000|Overall Study|Withdrawal by Subject|1|||
49097455|NCT01609543|158191312|FG000|Overall Study|Protocol Violation|1|||
49097456|NCT01609543|158191312|FG000|Overall Study|Death|7|||
49097457|NCT01893281|158191315|FG000|Overall Study|Adverse Event|1|||
49097458|NCT01893281|158191315|FG000|Overall Study|Protocol Violation|1|||
49097459|NCT01893281|158191315|FG000|Overall Study|Withdrawal by Subject|1|||
49097460|NCT02218736|158191317|FG000|Overall Study|Withdrawal by Subject|10|||
49097461|NCT02218736|158191318|FG001|Overall Study|Withdrawal by Subject|9|||
49097462|NCT02218736|158191317|FG000|Overall Study|Protocol Violation|2|||
49097463|NCT02218736|158191318|FG001|Overall Study|Protocol Violation|0|||
49097464|NCT03452488|158191321|FG000|Overall Study|Adverse Event|4|||
49097465|NCT03452488|158191322|FG001|Overall Study|Adverse Event|6|||
49097466|NCT03452488|158191323|FG002|Overall Study|Adverse Event|1|||
49097467|NCT03452488|158191321|FG000|Overall Study|Death|0|||
49097468|NCT03452488|158191322|FG001|Overall Study|Death|0|||
49097469|NCT03452488|158191323|FG002|Overall Study|Death|1|||
49097470|NCT03452488|158191321|FG000|Overall Study|Lost to Follow-up|1|||
49097471|NCT03452488|158191322|FG001|Overall Study|Lost to Follow-up|2|||
49097472|NCT03452488|158191323|FG002|Overall Study|Lost to Follow-up|0|||
49097473|NCT03452488|158191321|FG000|Overall Study|PI Decision|1|||
49097474|NCT03452488|158191322|FG001|Overall Study|PI Decision|0|||
49097475|NCT03452488|158191323|FG002|Overall Study|PI Decision|0|||
49097476|NCT03452488|158191321|FG000|Overall Study|Withdrew consent|4|||
49097477|NCT03452488|158191322|FG001|Overall Study|Withdrew consent|2|||
49097478|NCT03452488|158191323|FG002|Overall Study|Withdrew consent|2|||
49097479|NCT03452488|158191321|FG000|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
49097480|NCT03452488|158191322|FG001|Overall Study|Withdraw due to the COVID-19 outbreak|0|||
49097481|NCT03452488|158191323|FG002|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
49097482|NCT03452488|158191321|FG000|Overall Study|Other|0|||
49097483|NCT03452488|158191322|FG001|Overall Study|Other|2|||
49097484|NCT03452488|158191323|FG002|Overall Study|Other|2|||
49097485|NCT01290679|158191324|FG000|Overall Study|Adverse Event|2|||
49097486|NCT01290679|158191325|FG001|Overall Study|Adverse Event|0|||
49097487|NCT01290679|158191324|FG000|Overall Study|Lost to Follow-up|8|||
49097488|NCT01290679|158191325|FG001|Overall Study|Lost to Follow-up|10|||
49097489|NCT01290679|158191324|FG000|Overall Study|Protocol Violation|0|||
49097490|NCT01290679|158191325|FG001|Overall Study|Protocol Violation|1|||
49097491|NCT01290679|158191324|FG000|Overall Study|Withdrawal by Subject|6|||
49097492|NCT01290679|158191325|FG001|Overall Study|Withdrawal by Subject|5|||
49097493|NCT01290679|158191324|FG000|Overall Study|Subject Entered Another Trial|0|||
49097494|NCT01290679|158191325|FG001|Overall Study|Subject Entered Another Trial|5|||
49097495|NCT01855243|158191326|FG000|Overall Study|develpoed diabetic ketoacidosis|1|||
49097496|NCT01855243|158191327|FG001|Overall Study|develpoed diabetic ketoacidosis|0|||
49097497|NCT01855243|158191328|FG002|Overall Study|develpoed diabetic ketoacidosis|0|||
49097498|NCT01435018|158191330|FG000|Overall Study|Death|37|||
49097499|NCT01435018|158191331|FG001|Overall Study|Death|18|||
49097500|NCT01435018|158191332|FG002|Overall Study|Death|25|||
49097501|NCT01435018|158191330|FG000|Overall Study|Site is closing|4|||
49097502|NCT01435018|158191331|FG001|Overall Study|Site is closing|9|||
49097503|NCT01435018|158191332|FG002|Overall Study|Site is closing|7|||
49097504|NCT01435018|158191330|FG000|Overall Study|Withdrew consent|0|||
49097505|NCT01435018|158191331|FG001|Overall Study|Withdrew consent|3|||
49097506|NCT01435018|158191332|FG002|Overall Study|Withdrew consent|1|||
49097507|NCT01435018|158191330|FG000|Overall Study|Not willing to adhere to requirements|0|||
49097508|NCT01435018|158191331|FG001|Overall Study|Not willing to adhere to requirements|2|||
49097509|NCT01435018|158191332|FG002|Overall Study|Not willing to adhere to requirements|3|||
49097510|NCT01435018|158191330|FG000|Overall Study|Not able to get to clinic|2|||
49097511|NCT01435018|158191331|FG001|Overall Study|Not able to get to clinic|0|||
49097512|NCT01435018|158191332|FG002|Overall Study|Not able to get to clinic|2|||
49097513|NCT01435018|158191330|FG000|Overall Study|Severe debilitation, unable to continue|0|||
49097514|NCT01435018|158191331|FG001|Overall Study|Severe debilitation, unable to continue|0|||
49097515|NCT01435018|158191332|FG002|Overall Study|Severe debilitation, unable to continue|1|||
49097516|NCT01435018|158191330|FG000|Overall Study|Unable to contact participant/parent|1|||
49097517|NCT01435018|158191331|FG001|Overall Study|Unable to contact participant/parent|1|||
49097518|NCT01435018|158191332|FG002|Overall Study|Unable to contact participant/parent|1|||
49097519|NCT01435018|158191330|FG000|Overall Study|Enrollment Violation|0|||
49097520|NCT01435018|158191331|FG001|Overall Study|Enrollment Violation|1|||
49097521|NCT01435018|158191332|FG002|Overall Study|Enrollment Violation|0|||
49097522|NCT01435018|158191330|FG000|Overall Study|Never started chemotherapy|3|||
49097523|NCT01435018|158191331|FG001|Overall Study|Never started chemotherapy|0|||
49097524|NCT01435018|158191332|FG002|Overall Study|Never started chemotherapy|1|||
49097525|NCT03613649|158191334|FG000|Second Treatment|Lost to Follow-up|0|||
49097526|NCT03613649|158191335|FG001|Second Treatment|Lost to Follow-up|0|||
49097527|NCT03613649|158191336|FG002|Second Treatment|Lost to Follow-up|1|||
49097528|NCT03613649|158191337|FG003|Second Treatment|Lost to Follow-up|0|||
49097529|NCT03613649|158191338|FG004|Second Treatment|Lost to Follow-up|0|||
49097530|NCT03613649|158191339|FG005|Second Treatment|Lost to Follow-up|0|||
49097531|NCT03613649|158191340|FG006|Second Treatment|Lost to Follow-up|0|||
49097532|NCT03613649|158191341|FG007|Second Treatment|Lost to Follow-up|0|||
49097533|NCT03613649|158191342|FG008|Second Treatment|Lost to Follow-up|0|||
49097534|NCT03613649|158191343|FG009|Second Treatment|Lost to Follow-up|0|||
49097535|NCT03613649|158191344|FG010|Second Treatment|Lost to Follow-up|0|||
49097536|NCT03613649|158191345|FG011|Second Treatment|Lost to Follow-up|0|||
49097537|NCT03613649|158191334|FG000|Second Treatment|Withdrawal by Subject|0|||
49097538|NCT03613649|158191335|FG001|Second Treatment|Withdrawal by Subject|0|||
49097539|NCT03613649|158191336|FG002|Second Treatment|Withdrawal by Subject|0|||
49097540|NCT03613649|158191337|FG003|Second Treatment|Withdrawal by Subject|0|||
49097541|NCT03613649|158191338|FG004|Second Treatment|Withdrawal by Subject|1|||
49097542|NCT03613649|158191339|FG005|Second Treatment|Withdrawal by Subject|0|||
49097543|NCT03613649|158191340|FG006|Second Treatment|Withdrawal by Subject|0|||
49097544|NCT03613649|158191341|FG007|Second Treatment|Withdrawal by Subject|0|||
49097545|NCT03613649|158191342|FG008|Second Treatment|Withdrawal by Subject|0|||
49097546|NCT03613649|158191343|FG009|Second Treatment|Withdrawal by Subject|0|||
49097547|NCT03613649|158191344|FG010|Second Treatment|Withdrawal by Subject|0|||
49097548|NCT03613649|158191345|FG011|Second Treatment|Withdrawal by Subject|0|||
49097549|NCT03613649|158191334|FG000|Third Treatment|Lost to Follow-up|0|||
49097550|NCT03613649|158191335|FG001|Third Treatment|Lost to Follow-up|0|||
49097551|NCT03613649|158191336|FG002|Third Treatment|Lost to Follow-up|0|||
49097552|NCT03613649|158191337|FG003|Third Treatment|Lost to Follow-up|0|||
49097553|NCT03613649|158191338|FG004|Third Treatment|Lost to Follow-up|1|||
49097554|NCT03613649|158191339|FG005|Third Treatment|Lost to Follow-up|0|||
49097555|NCT03613649|158191340|FG006|Third Treatment|Lost to Follow-up|0|||
49097556|NCT03613649|158191341|FG007|Third Treatment|Lost to Follow-up|0|||
49097557|NCT03613649|158191342|FG008|Third Treatment|Lost to Follow-up|0|||
49097558|NCT03613649|158191343|FG009|Third Treatment|Lost to Follow-up|0|||
49097559|NCT03613649|158191344|FG010|Third Treatment|Lost to Follow-up|0|||
49097560|NCT03613649|158191345|FG011|Third Treatment|Lost to Follow-up|1|||
49097561|NCT03613649|158191334|FG000|Third Treatment|Protocol Violation|0|||
49097562|NCT03613649|158191335|FG001|Third Treatment|Protocol Violation|0|||
49097563|NCT03613649|158191336|FG002|Third Treatment|Protocol Violation|0|||
49097564|NCT03613649|158191337|FG003|Third Treatment|Protocol Violation|0|||
49097565|NCT03613649|158191338|FG004|Third Treatment|Protocol Violation|0|||
49097566|NCT03613649|158191339|FG005|Third Treatment|Protocol Violation|0|||
49097567|NCT03613649|158191340|FG006|Third Treatment|Protocol Violation|1|||
49097568|NCT03613649|158191341|FG007|Third Treatment|Protocol Violation|0|||
49097569|NCT03613649|158191342|FG008|Third Treatment|Protocol Violation|0|||
49097570|NCT03613649|158191343|FG009|Third Treatment|Protocol Violation|0|||
49097571|NCT03613649|158191344|FG010|Third Treatment|Protocol Violation|0|||
49097572|NCT03613649|158191345|FG011|Third Treatment|Protocol Violation|1|||
49097573|NCT03613649|158191334|FG000|Fourth Treatment|Protocol Violation|1|||
49097574|NCT03613649|158191335|FG001|Fourth Treatment|Protocol Violation|0|||
49097575|NCT03613649|158191336|FG002|Fourth Treatment|Protocol Violation|0|||
49097576|NCT03613649|158191337|FG003|Fourth Treatment|Protocol Violation|0|||
49097577|NCT03613649|158191338|FG004|Fourth Treatment|Protocol Violation|1|||
49097578|NCT03613649|158191339|FG005|Fourth Treatment|Protocol Violation|0|||
49097579|NCT03613649|158191340|FG006|Fourth Treatment|Protocol Violation|0|||
49097580|NCT03613649|158191341|FG007|Fourth Treatment|Protocol Violation|0|||
49097581|NCT03613649|158191342|FG008|Fourth Treatment|Protocol Violation|0|||
49097582|NCT03613649|158191343|FG009|Fourth Treatment|Protocol Violation|0|||
49097583|NCT03613649|158191344|FG010|Fourth Treatment|Protocol Violation|0|||
49097584|NCT03613649|158191345|FG011|Fourth Treatment|Protocol Violation|0|||
49097585|NCT03613649|158191334|FG000|Fourth Treatment|Physician Decision|0|||
49097586|NCT03613649|158191335|FG001|Fourth Treatment|Physician Decision|0|||
49097587|NCT03613649|158191336|FG002|Fourth Treatment|Physician Decision|0|||
49097588|NCT03613649|158191337|FG003|Fourth Treatment|Physician Decision|0|||
49097589|NCT03613649|158191338|FG004|Fourth Treatment|Physician Decision|0|||
49097590|NCT03613649|158191339|FG005|Fourth Treatment|Physician Decision|0|||
49097591|NCT03613649|158191340|FG006|Fourth Treatment|Physician Decision|1|||
49097592|NCT03613649|158191341|FG007|Fourth Treatment|Physician Decision|0|||
49097593|NCT03613649|158191342|FG008|Fourth Treatment|Physician Decision|0|||
49097594|NCT03613649|158191343|FG009|Fourth Treatment|Physician Decision|0|||
49097595|NCT03613649|158191344|FG010|Fourth Treatment|Physician Decision|0|||
49097596|NCT03613649|158191345|FG011|Fourth Treatment|Physician Decision|0|||
49097597|NCT03502070|158191346|FG000|Overall Study|Withdrawal by Subject|1|||
49097598|NCT03502070|158191346|FG000|Overall Study|Screen Failure|1|||
49097599|NCT00652626|158191347|FG000|Initial Treatment Phase|Adverse Event|0|||
49097600|NCT00652626|158191348|FG001|Initial Treatment Phase|Adverse Event|0|||
49097601|NCT00652626|158191349|FG002|Initial Treatment Phase|Adverse Event|0|||
49097602|NCT00652626|158191350|FG003|Initial Treatment Phase|Adverse Event|0|||
49097603|NCT00652626|158191351|FG004|Initial Treatment Phase|Adverse Event|1|||
49097604|NCT00652626|158191352|FG005|Initial Treatment Phase|Adverse Event|0|||
49097605|NCT00652626|158191353|FG006|Initial Treatment Phase|Adverse Event|0|||
49097606|NCT00652626|158191347|FG000|Initial Treatment Phase|Protocol Violation|0|||
49097607|NCT00652626|158191348|FG001|Initial Treatment Phase|Protocol Violation|0|||
49097608|NCT00652626|158191349|FG002|Initial Treatment Phase|Protocol Violation|0|||
49097609|NCT00652626|158191350|FG003|Initial Treatment Phase|Protocol Violation|1|||
49097610|NCT00652626|158191351|FG004|Initial Treatment Phase|Protocol Violation|0|||
49097611|NCT00652626|158191352|FG005|Initial Treatment Phase|Protocol Violation|0|||
49097612|NCT00652626|158191353|FG006|Initial Treatment Phase|Protocol Violation|0|||
49097613|NCT00652626|158191347|FG000|Initial Treatment Phase|Physician Decision|0|||
49097614|NCT00652626|158191348|FG001|Initial Treatment Phase|Physician Decision|0|||
49097615|NCT00652626|158191349|FG002|Initial Treatment Phase|Physician Decision|0|||
49097616|NCT00652626|158191350|FG003|Initial Treatment Phase|Physician Decision|0|||
49097617|NCT00652626|158191351|FG004|Initial Treatment Phase|Physician Decision|1|||
49097618|NCT00652626|158191352|FG005|Initial Treatment Phase|Physician Decision|0|||
49097619|NCT00652626|158191353|FG006|Initial Treatment Phase|Physician Decision|0|||
49097620|NCT00652626|158191347|FG000|Initial Treatment Phase|Sponsor Request|0|||
49097621|NCT00652626|158191348|FG001|Initial Treatment Phase|Sponsor Request|0|||
49097622|NCT00652626|158191349|FG002|Initial Treatment Phase|Sponsor Request|1|||
49097623|NCT00652626|158191350|FG003|Initial Treatment Phase|Sponsor Request|0|||
49097624|NCT00652626|158191351|FG004|Initial Treatment Phase|Sponsor Request|0|||
49097625|NCT00652626|158191352|FG005|Initial Treatment Phase|Sponsor Request|0|||
49097626|NCT00652626|158191353|FG006|Initial Treatment Phase|Sponsor Request|0|||
49097627|NCT00652626|158191347|FG000|Initial Treatment Phase|Lost to Follow-up|0|||
49097628|NCT00652626|158191348|FG001|Initial Treatment Phase|Lost to Follow-up|0|||
49097629|NCT00652626|158191349|FG002|Initial Treatment Phase|Lost to Follow-up|0|||
49097630|NCT00652626|158191350|FG003|Initial Treatment Phase|Lost to Follow-up|0|||
49097631|NCT00652626|158191351|FG004|Initial Treatment Phase|Lost to Follow-up|1|||
49097632|NCT00652626|158191352|FG005|Initial Treatment Phase|Lost to Follow-up|0|||
49097633|NCT00652626|158191353|FG006|Initial Treatment Phase|Lost to Follow-up|0|||
49097634|NCT00652626|158191347|FG000|Extension Phase|Withdrawal by Subject|0|||
49097635|NCT00652626|158191348|FG001|Extension Phase|Withdrawal by Subject|0|||
49097636|NCT00652626|158191349|FG002|Extension Phase|Withdrawal by Subject|0|||
49097637|NCT00652626|158191350|FG003|Extension Phase|Withdrawal by Subject|0|||
49097638|NCT00652626|158191351|FG004|Extension Phase|Withdrawal by Subject|0|||
49097639|NCT00652626|158191352|FG005|Extension Phase|Withdrawal by Subject|2|||
49097640|NCT00652626|158191353|FG006|Extension Phase|Withdrawal by Subject|0|||
49097641|NCT00652626|158191347|FG000|Extension Phase|Adverse Event|0|||
49097642|NCT00652626|158191348|FG001|Extension Phase|Adverse Event|0|||
49097643|NCT00652626|158191349|FG002|Extension Phase|Adverse Event|0|||
49097644|NCT00652626|158191350|FG003|Extension Phase|Adverse Event|0|||
49097645|NCT00652626|158191351|FG004|Extension Phase|Adverse Event|0|||
49097646|NCT00652626|158191352|FG005|Extension Phase|Adverse Event|2|||
49097647|NCT00652626|158191353|FG006|Extension Phase|Adverse Event|1|||
49097648|NCT00652626|158191347|FG000|Extension Phase|No Longer Receiving Clinical Benefit|0|||
49097649|NCT00652626|158191348|FG001|Extension Phase|No Longer Receiving Clinical Benefit|0|||
49097650|NCT00652626|158191349|FG002|Extension Phase|No Longer Receiving Clinical Benefit|0|||
49097651|NCT00652626|158191350|FG003|Extension Phase|No Longer Receiving Clinical Benefit|0|||
49097652|NCT00652626|158191351|FG004|Extension Phase|No Longer Receiving Clinical Benefit|0|||
49097653|NCT00652626|158191352|FG005|Extension Phase|No Longer Receiving Clinical Benefit|6|||
49097654|NCT00652626|158191353|FG006|Extension Phase|No Longer Receiving Clinical Benefit|0|||
49097655|NCT00652626|158191347|FG000|Extension Phase|Physician Decision|0|||
49097656|NCT00652626|158191348|FG001|Extension Phase|Physician Decision|0|||
49097657|NCT00652626|158191349|FG002|Extension Phase|Physician Decision|0|||
49097658|NCT00652626|158191350|FG003|Extension Phase|Physician Decision|0|||
49097659|NCT00652626|158191351|FG004|Extension Phase|Physician Decision|0|||
49097660|NCT00652626|158191352|FG005|Extension Phase|Physician Decision|1|||
49097661|NCT00652626|158191353|FG006|Extension Phase|Physician Decision|1|||
49097662|NCT00652626|158191347|FG000|Extension Phase|Death|0|||
49097663|NCT00652626|158191348|FG001|Extension Phase|Death|0|||
49097664|NCT00652626|158191349|FG002|Extension Phase|Death|0|||
49097665|NCT00652626|158191350|FG003|Extension Phase|Death|0|||
49097666|NCT00652626|158191351|FG004|Extension Phase|Death|0|||
49097667|NCT00652626|158191352|FG005|Extension Phase|Death|1|||
49097668|NCT00652626|158191353|FG006|Extension Phase|Death|1|||
49097669|NCT03379753|158191361|FG000|Overall Study|Withdrawal by Subject|2|||
49097670|NCT03379753|158191362|FG001|Overall Study|Withdrawal by Subject|1|||
49097671|NCT03379753|158191361|FG000|Overall Study|not having correct procedure|1|||
49097672|NCT03379753|158191362|FG001|Overall Study|not having correct procedure|2|||
49097673|NCT03379753|158191361|FG000|Overall Study|No primary outcome|12|||
49097674|NCT03379753|158191362|FG001|Overall Study|No primary outcome|22|||
49097675|NCT01399047|158192844|FG000|Overall Study|Withdrawal by Subject|0|||
49097676|NCT01399047|158192845|FG001|Overall Study|Withdrawal by Subject|1|||
49097677|NCT00601172|158192846|FG000|Overall Study|Adverse Event|43|||
49097678|NCT00601172|158192847|FG001|Overall Study|Adverse Event|32|||
49097679|NCT00601172|158192846|FG000|Overall Study|Lack of Efficacy|11|||
49097680|NCT00601172|158192847|FG001|Overall Study|Lack of Efficacy|12|||
49097681|NCT00601172|158192846|FG000|Overall Study|Protocol Violation|2|||
49097682|NCT00601172|158192847|FG001|Overall Study|Protocol Violation|5|||
49097683|NCT00601172|158192846|FG000|Overall Study|Lost to Follow-up|4|||
49097684|NCT00601172|158192847|FG001|Overall Study|Lost to Follow-up|3|||
49097685|NCT00601172|158192846|FG000|Overall Study|Physician Decision|27|||
49097686|NCT00601172|158192847|FG001|Overall Study|Physician Decision|28|||
49097687|NCT00601172|158192846|FG000|Overall Study|Withdrawal by Subject|35|||
49097688|NCT00601172|158192847|FG001|Overall Study|Withdrawal by Subject|27|||
49097689|NCT00601172|158192846|FG000|Overall Study|Did not meet continuation criteria|19|||
49097690|NCT00601172|158192847|FG001|Overall Study|Did not meet continuation criteria|20|||
49097691|NCT00956592|158192852|FG000|Overall Study|Protocol Violation|1|||
49097692|NCT00956592|158192853|FG001|Overall Study|Protocol Violation|3|||
49097693|NCT00231114|158192854|FG000|Randomized|Withdrawal by Subject|6|||
49097694|NCT00231114|158192855|FG001|Randomized|Withdrawal by Subject|3|||
49097695|NCT00231114|158192854|FG000|Treatment Period|Death: Motor Vehicle Accident|1|||
49097696|NCT00231114|158192855|FG001|Treatment Period|Death: Motor Vehicle Accident|0|||
49097697|NCT00231114|158192854|FG000|Post-Treatment Period|Lost to Follow-up|6|||
49097698|NCT00231114|158192855|FG001|Post-Treatment Period|Lost to Follow-up|1|||
49097699|NCT00231114|158192854|FG000|Post-Treatment Period|Physician Decision|1|||
49097700|NCT00231114|158192855|FG001|Post-Treatment Period|Physician Decision|0|||
49097701|NCT00231114|158192854|FG000|Post-Treatment Period|Withdrawal by Subject|1|||
49097702|NCT00231114|158192855|FG001|Post-Treatment Period|Withdrawal by Subject|0|||
49097703|NCT04429555|158192856|FG000|Overall Study|Death|0|||
49097704|NCT04429555|158192857|FG001|Overall Study|Death|2|||
49097705|NCT04429555|158192856|FG000|Overall Study|Other|2|||
49097706|NCT04429555|158192857|FG001|Overall Study|Other|0|||
49097707|NCT03981900|158192860|FG000|Overall Study|Participant decision - Without withdrawal of consent|17|||
49097708|NCT03981900|158192860|FG000|Overall Study|Adverse Event|5|||
49097709|NCT03981900|158192860|FG000|Overall Study|Protocol Violation|1|||
49097710|NCT03981900|158192860|FG000|Overall Study|Withdrawal by Subject|7|||
49097711|NCT03981900|158192860|FG000|Overall Study|Lost to Follow-up|46|||
49097712|NCT03981900|158192860|FG000|Overall Study|Decision of the researcher|3|||
49097713|NCT03981900|158192860|FG000|Overall Study|Death|3|||
49097714|NCT03981900|158192860|FG000|Overall Study|Other|5|||
49097715|NCT02693106|158192861|FG000|Overall Study|No time|3|||
49097716|NCT05481125|158192866|FG000|Overall Study|Adverse Event|1|||
49097717|NCT05481125|158192867|FG001|Overall Study|Adverse Event|0|||
49097718|NCT05481125|158192866|FG000|Overall Study|Lost to Follow-up|0|||
49097719|NCT05481125|158192867|FG001|Overall Study|Lost to Follow-up|1|||
49097720|NCT05481125|158192866|FG000|Overall Study|Withdrawal by Subject|0|||
49097721|NCT05481125|158192867|FG001|Overall Study|Withdrawal by Subject|1|||
49097722|NCT00637000|158192888|FG000|Overall Study|Withdrawal by Subject|4|||
49097723|NCT00637000|158192889|FG001|Overall Study|Withdrawal by Subject|3|||
49097724|NCT02295020|158192893|FG000|Overall Study|Adverse Event|0|||
49097725|NCT02295020|158192894|FG001|Overall Study|Adverse Event|1|||
49097726|NCT02295020|158192893|FG000|Overall Study|Withdrawal by Subject|3|||
49097727|NCT02295020|158192894|FG001|Overall Study|Withdrawal by Subject|2|||
49097728|NCT00839527|158192895|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
49097729|NCT00839527|158192896|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|29|||
49097730|NCT00839527|158192897|FG002|Treatment Period (TP) (156 Weeks)|Adverse Event|22|||
49097731|NCT00839527|158192895|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|4|||
49097732|NCT00839527|158192896|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|7|||
49097733|NCT00839527|158192897|FG002|Treatment Period (TP) (156 Weeks)|Protocol Violation|1|||
49097734|NCT00839527|158192895|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|5|||
49097735|NCT00839527|158192896|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|6|||
49097736|NCT00839527|158192897|FG002|Treatment Period (TP) (156 Weeks)|Noncompliance|16|||
49097737|NCT00839527|158192895|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3|||
49097738|NCT00839527|158192896|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12|||
49097739|NCT00839527|158192897|FG002|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
49097740|NCT00839527|158192895|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32|||
49097741|NCT00839527|158192896|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46|||
49097742|NCT00839527|158192897|FG002|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64|||
49097743|NCT00839527|158192895|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
49097744|NCT00839527|158192896|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|6|||
49097745|NCT00839527|158192897|FG002|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
49097746|NCT00839527|158192895|FG000|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3|||
49097747|NCT00839527|158192896|FG001|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8|||
49097748|NCT00839527|158192897|FG002|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5|||
49097749|NCT00839527|158192895|FG000|Treatment Period (TP) (156 Weeks)|Missing|0|||
49097750|NCT00839527|158192896|FG001|Treatment Period (TP) (156 Weeks)|Missing|1|||
49097751|NCT00839527|158192897|FG002|Treatment Period (TP) (156 Weeks)|Missing|0|||
49097752|NCT00839527|158192895|FG000|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
49097753|NCT00839527|158192896|FG001|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
49097754|NCT00839527|158192897|FG002|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1|||
49097755|NCT00839527|158192895|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
49097756|NCT00839527|158192896|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
49097757|NCT00839527|158192897|FG002|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
49097758|NCT00839527|158192895|FG000|Treatment Period (TP) (156 Weeks)|Site Closed|1|||
49097759|NCT00839527|158192896|FG001|Treatment Period (TP) (156 Weeks)|Site Closed|2|||
49097760|NCT00839527|158192897|FG002|Treatment Period (TP) (156 Weeks)|Site Closed|0|||
49097761|NCT00839527|158192895|FG000|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
49097762|NCT00839527|158192896|FG001|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
49097763|NCT00839527|158192897|FG002|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1|||
49097764|NCT00839527|158192895|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
49097765|NCT00839527|158192896|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2|||
49097766|NCT00839527|158192897|FG002|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
49097767|NCT00839527|158192895|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
49097768|NCT00839527|158192896|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
49097769|NCT00839527|158192897|FG002|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5|||
49097770|NCT00839527|158192895|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8|||
49097771|NCT00839527|158192896|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20|||
49097772|NCT00839527|158192897|FG002|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29|||
49097773|NCT00839527|158192895|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12|||
49097774|NCT00839527|158192896|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21|||
49097775|NCT00839527|158192897|FG002|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19|||
49097776|NCT00839527|158192895|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
49097777|NCT00839527|158192896|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
49097778|NCT00839527|158192897|FG002|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
49097779|NCT00839527|158192895|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3|||
49097780|NCT00839527|158192896|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10|||
49097781|NCT00839527|158192897|FG002|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5|||
49097782|NCT00839527|158192895|FG000|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1|||
49097783|NCT00839527|158192896|FG001|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
49097784|NCT00839527|158192897|FG002|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
49097785|NCT00839527|158192895|FG000|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1|||
49097786|NCT00839527|158192896|FG001|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
49097787|NCT00839527|158192897|FG002|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
49097788|NCT00839527|158192895|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
49097789|NCT00839527|158192896|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closed|1|||
49097790|NCT00839527|158192897|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
49097791|NCT00839527|158192895|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
49097792|NCT00839527|158192896|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0|||
49097793|NCT00839527|158192897|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
49097794|NCT00839527|158192895|FG000|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
49097795|NCT00839527|158192896|FG001|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1|||
49097796|NCT00839527|158192897|FG002|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
49097797|NCT00839527|158192895|FG000|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0|||
49097798|NCT00839527|158192896|FG001|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
49097799|NCT00839527|158192897|FG002|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
49097800|NCT04481789|158192898|FG000|Period 1|Withdrawal by Subject|1|||
49097801|NCT04481789|158192899|FG001|Period 1|Withdrawal by Subject|0|||
49097802|NCT04481789|158192900|FG002|Period 1|Withdrawal by Subject|0|||
49097803|NCT04481789|158192901|FG003|Period 1|Withdrawal by Subject|0|||
49097804|NCT04481789|158192902|FG004|Period 1|Withdrawal by Subject|0|||
49097805|NCT04481789|158192903|FG005|Period 1|Withdrawal by Subject|0|||
49097806|NCT03261674|158192904|FG000|Overall Study|Lost to Follow-up|6|||
49097807|NCT03261674|158192905|FG001|Overall Study|Lost to Follow-up|7|||
49097808|NCT03261674|158192904|FG000|Overall Study|Protocol Violation|1|||
49097809|NCT03261674|158192905|FG001|Overall Study|Protocol Violation|4|||
49097810|NCT03261674|158192904|FG000|Overall Study|Withdrawal by Subject|1|||
49097811|NCT03261674|158192905|FG001|Overall Study|Withdrawal by Subject|4|||
49097812|NCT03261674|158192904|FG000|Overall Study|Physician Decision|1|||
49097813|NCT03261674|158192905|FG001|Overall Study|Physician Decision|0|||
49097814|NCT02291601|158192906|FG000|Abdomen|Did not qualify|333|||
49097815|NCT02291601|158192907|FG001|Abdomen|Did not qualify|54|||
49097816|NCT02291601|158192908|FG002|Abdomen|Did not qualify|339|||
49097817|NCT02291601|158192906|FG000|Groin|Did not qualify|183|||
49097818|NCT02291601|158192907|FG001|Groin|Did not qualify|30|||
49097819|NCT02291601|158192908|FG002|Groin|Did not qualify|177|||
49097820|NCT02751450|158192909|FG000|Overall Study|Adverse Event|1|||
49097821|NCT02751450|158192910|FG001|Overall Study|Adverse Event|0|||
49097822|NCT01137110|158192911|FG000|Overall Study|Protocol Violation|1|||
49097823|NCT01137110|158192912|FG001|Overall Study|Protocol Violation|0|||
49097824|NCT00562302|158192913|FG000|Overall Study|Lost to Follow-up|3|||
49097825|NCT00562302|158192914|FG001|Overall Study|Lost to Follow-up|3|||
49097826|NCT00562302|158192913|FG000|Overall Study|Adverse Event|0|||
49097827|NCT00562302|158192914|FG001|Overall Study|Adverse Event|6|||
49097828|NCT00562302|158192913|FG000|Overall Study|Non-compliance|1|||
49097829|NCT00562302|158192914|FG001|Overall Study|Non-compliance|2|||
49097830|NCT00562302|158192913|FG000|Overall Study|Withdrawal by Subject|7|||
49097831|NCT00562302|158192914|FG001|Overall Study|Withdrawal by Subject|8|||
49097832|NCT00562302|158192913|FG000|Overall Study|Death|1|||
49097833|NCT00562302|158192914|FG001|Overall Study|Death|2|||
49097834|NCT00562302|158192913|FG000|Overall Study|Lung resection prior to study completion|7|||
49097835|NCT00562302|158192914|FG001|Overall Study|Lung resection prior to study completion|7|||
49097836|NCT00562302|158192913|FG000|Overall Study|Not stated|1|||
49097837|NCT00562302|158192914|FG001|Overall Study|Not stated|4|||
49097838|NCT01598090|158192915|FG000|Treatment Period|Poor/non-compliance|0|||
49097839|NCT01598090|158192916|FG001|Treatment Period|Poor/non-compliance|2|||
49097840|NCT01598090|158192917|FG002|Treatment Period|Poor/non-compliance|0|||
49097841|NCT01598090|158192915|FG000|Treatment Period|No longer meet study criteria|0|||
49097842|NCT01598090|158192916|FG001|Treatment Period|No longer meet study criteria|1|||
49097843|NCT01598090|158192917|FG002|Treatment Period|No longer meet study criteria|0|||
49097844|NCT01598090|158192915|FG000|Treatment Period|Lack of Efficacy|5|||
49097845|NCT01598090|158192916|FG001|Treatment Period|Lack of Efficacy|14|||
49097846|NCT01598090|158192917|FG002|Treatment Period|Lack of Efficacy|6|||
49097847|NCT01598090|158192915|FG000|Treatment Period|Adverse Event|2|||
49097848|NCT01598090|158192916|FG001|Treatment Period|Adverse Event|33|||
49097849|NCT01598090|158192917|FG002|Treatment Period|Adverse Event|17|||
49097850|NCT01598090|158192915|FG000|Treatment Period|Other reasons|0|||
49097851|NCT01598090|158192916|FG001|Treatment Period|Other reasons|4|||
49097852|NCT01598090|158192917|FG002|Treatment Period|Other reasons|1|||
49097853|NCT01598090|158192915|FG000|Treatment Period|Withdrawal by Subject|3|||
49097854|NCT01598090|158192916|FG001|Treatment Period|Withdrawal by Subject|13|||
49097855|NCT01598090|158192917|FG002|Treatment Period|Withdrawal by Subject|10|||
49097856|NCT01598090|158192915|FG000|Treatment Period|Lost to Follow-up|1|||
49097857|NCT01598090|158192916|FG001|Treatment Period|Lost to Follow-up|5|||
49097858|NCT01598090|158192917|FG002|Treatment Period|Lost to Follow-up|1|||
49097859|NCT01598090|158192915|FG000|Follow-up Period|Death|0|||
49097860|NCT01598090|158192916|FG001|Follow-up Period|Death|1|||
49097861|NCT01598090|158192917|FG002|Follow-up Period|Death|0|||
49097862|NCT01598090|158192915|FG000|Follow-up Period|No longer required per protocol|1|||
49097863|NCT01598090|158192916|FG001|Follow-up Period|No longer required per protocol|3|||
49097864|NCT01598090|158192917|FG002|Follow-up Period|No longer required per protocol|2|||
49097865|NCT01598090|158192915|FG000|Follow-up Period|Not reported|0|||
49097866|NCT01598090|158192916|FG001|Follow-up Period|Not reported|10|||
49097867|NCT01598090|158192917|FG002|Follow-up Period|Not reported|4|||
49097868|NCT01598090|158192915|FG000|Follow-up Period|Withdrawal by Subject|0|||
49097869|NCT01598090|158192916|FG001|Follow-up Period|Withdrawal by Subject|3|||
49097870|NCT01598090|158192917|FG002|Follow-up Period|Withdrawal by Subject|2|||
49097871|NCT01598090|158192915|FG000|Follow-up Period|Other reasons|2|||
49097872|NCT01598090|158192916|FG001|Follow-up Period|Other reasons|8|||
49097873|NCT01598090|158192917|FG002|Follow-up Period|Other reasons|8|||
49097874|NCT01598090|158192915|FG000|Follow-up Period|Lost to Follow-up|2|||
49097875|NCT01598090|158192916|FG001|Follow-up Period|Lost to Follow-up|10|||
49097876|NCT01598090|158192917|FG002|Follow-up Period|Lost to Follow-up|12|||
49097877|NCT02587598|158192918|FG000|Overall Study|Death|4|||
49097878|NCT02587598|158192919|FG001|Overall Study|Death|8|||
49097879|NCT02587598|158192920|FG002|Overall Study|Death|4|||
49097880|NCT02587598|158192921|FG003|Overall Study|Death|16|||
49097881|NCT02587598|158192922|FG004|Overall Study|Death|9|||
49097882|NCT02587598|158192923|FG005|Overall Study|Death|4|||
49097883|NCT02587598|158192924|FG006|Overall Study|Death|6|||
49097884|NCT02587598|158192925|FG007|Overall Study|Death|7|||
49097885|NCT02587598|158192926|FG008|Overall Study|Death|9|||
49097886|NCT02587598|158192927|FG009|Overall Study|Death|1|||
49097887|NCT02587598|158192928|FG010|Overall Study|Death|3|||
49097888|NCT02587598|158192918|FG000|Overall Study|Study Terminated by the Sponsor|0|||
49097889|NCT02587598|158192919|FG001|Overall Study|Study Terminated by the Sponsor|1|||
49097890|NCT02587598|158192920|FG002|Overall Study|Study Terminated by the Sponsor|0|||
49097891|NCT02587598|158192921|FG003|Overall Study|Study Terminated by the Sponsor|3|||
49097892|NCT02587598|158192922|FG004|Overall Study|Study Terminated by the Sponsor|0|||
49097893|NCT02587598|158192923|FG005|Overall Study|Study Terminated by the Sponsor|1|||
49097894|NCT02587598|158192924|FG006|Overall Study|Study Terminated by the Sponsor|0|||
49097895|NCT02587598|158192925|FG007|Overall Study|Study Terminated by the Sponsor|0|||
49097896|NCT02587598|158192926|FG008|Overall Study|Study Terminated by the Sponsor|0|||
49097897|NCT02587598|158192927|FG009|Overall Study|Study Terminated by the Sponsor|1|||
49097898|NCT02587598|158192928|FG010|Overall Study|Study Terminated by the Sponsor|6|||
49097899|NCT02587598|158192918|FG000|Overall Study|Reason for study withdrawal not specified|0|||
49097900|NCT02587598|158192919|FG001|Overall Study|Reason for study withdrawal not specified|1|||
49097901|NCT02587598|158192920|FG002|Overall Study|Reason for study withdrawal not specified|0|||
49097902|NCT02587598|158192921|FG003|Overall Study|Reason for study withdrawal not specified|0|||
49097903|NCT02587598|158192922|FG004|Overall Study|Reason for study withdrawal not specified|0|||
49097904|NCT02587598|158192923|FG005|Overall Study|Reason for study withdrawal not specified|0|||
49097905|NCT02587598|158192924|FG006|Overall Study|Reason for study withdrawal not specified|0|||
49097906|NCT02587598|158192925|FG007|Overall Study|Reason for study withdrawal not specified|0|||
49097907|NCT02587598|158192926|FG008|Overall Study|Reason for study withdrawal not specified|0|||
49097908|NCT02587598|158192927|FG009|Overall Study|Reason for study withdrawal not specified|0|||
49097909|NCT02587598|158192928|FG010|Overall Study|Reason for study withdrawal not specified|0|||
49097910|NCT02587598|158192918|FG000|Overall Study|Withdrawal by Subject|0|||
49097911|NCT02587598|158192919|FG001|Overall Study|Withdrawal by Subject|1|||
49097912|NCT02587598|158192920|FG002|Overall Study|Withdrawal by Subject|0|||
49097913|NCT02587598|158192921|FG003|Overall Study|Withdrawal by Subject|2|||
49097914|NCT02587598|158192922|FG004|Overall Study|Withdrawal by Subject|3|||
49097915|NCT02587598|158192923|FG005|Overall Study|Withdrawal by Subject|1|||
49097916|NCT02587598|158192924|FG006|Overall Study|Withdrawal by Subject|0|||
49097917|NCT02587598|158192925|FG007|Overall Study|Withdrawal by Subject|0|||
49097918|NCT02587598|158192926|FG008|Overall Study|Withdrawal by Subject|0|||
49097919|NCT02587598|158192927|FG009|Overall Study|Withdrawal by Subject|1|||
49097920|NCT02587598|158192928|FG010|Overall Study|Withdrawal by Subject|2|||
49097921|NCT02587598|158192918|FG000|Overall Study|Physician Decision|0|||
49097922|NCT02587598|158192919|FG001|Overall Study|Physician Decision|0|||
49097923|NCT02587598|158192920|FG002|Overall Study|Physician Decision|0|||
49097924|NCT02587598|158192921|FG003|Overall Study|Physician Decision|0|||
49097925|NCT02587598|158192922|FG004|Overall Study|Physician Decision|0|||
49097926|NCT02587598|158192923|FG005|Overall Study|Physician Decision|0|||
49097927|NCT02587598|158192924|FG006|Overall Study|Physician Decision|0|||
49097928|NCT02587598|158192925|FG007|Overall Study|Physician Decision|0|||
49097929|NCT02587598|158192926|FG008|Overall Study|Physician Decision|0|||
49097930|NCT02587598|158192927|FG009|Overall Study|Physician Decision|0|||
49097931|NCT02587598|158192928|FG010|Overall Study|Physician Decision|3|||
49097932|NCT03589326|158192931|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|135|||
49097933|NCT03589326|158192932|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|63|||
49097934|NCT03589326|158192931|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|21|||
49097935|NCT03589326|158192932|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|13|||
49097936|NCT03589326|158192931|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|0|||
49097937|NCT03589326|158192932|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|1|||
49097938|NCT03589326|158192931|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|6|||
49097939|NCT03589326|158192932|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|4|||
49097940|NCT03589326|158192931|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|2|||
49097941|NCT03589326|158192932|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|0|||
49097942|NCT02783729|158192933|FG000|Overall Study|Lack of Efficacy|1|||
49097943|NCT02783729|158192934|FG001|Overall Study|Lack of Efficacy|0|||
49097944|NCT02783729|158192935|FG002|Overall Study|Lack of Efficacy|0|||
49097945|NCT02783729|158192936|FG003|Overall Study|Lack of Efficacy|0|||
49097946|NCT02783729|158192933|FG000|Overall Study|Adverse Event|2|||
49097947|NCT02783729|158192934|FG001|Overall Study|Adverse Event|6|||
49097948|NCT02783729|158192935|FG002|Overall Study|Adverse Event|2|||
49097949|NCT02783729|158192936|FG003|Overall Study|Adverse Event|3|||
49097950|NCT02783729|158192933|FG000|Overall Study|Other|1|||
49097951|NCT02783729|158192934|FG001|Overall Study|Other|6|||
49097952|NCT02783729|158192935|FG002|Overall Study|Other|2|||
49097953|NCT02783729|158192936|FG003|Overall Study|Other|3|||
49097954|NCT02783729|158192933|FG000|Overall Study|Withdrawal by Subject|2|||
49097955|NCT02783729|158192934|FG001|Overall Study|Withdrawal by Subject|3|||
49097956|NCT02783729|158192935|FG002|Overall Study|Withdrawal by Subject|1|||
49097957|NCT02783729|158192936|FG003|Overall Study|Withdrawal by Subject|2|||
49097958|NCT02783729|158192933|FG000|Overall Study|Participant's choice|2|||
49097959|NCT02783729|158192934|FG001|Overall Study|Participant's choice|1|||
49097960|NCT02783729|158192935|FG002|Overall Study|Participant's choice|2|||
49097961|NCT02783729|158192936|FG003|Overall Study|Participant's choice|1|||
49097962|NCT02783729|158192933|FG000|Overall Study|Lost to Follow-up|2|||
49097963|NCT02783729|158192934|FG001|Overall Study|Lost to Follow-up|1|||
49097964|NCT02783729|158192935|FG002|Overall Study|Lost to Follow-up|1|||
49097965|NCT02783729|158192936|FG003|Overall Study|Lost to Follow-up|0|||
49097966|NCT02693171|158192941|FG000|Overall Study|Adverse Event|1|||
49097967|NCT02693171|158192941|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
49097968|NCT00675428|158192942|FG000|Overall Study|Disease Progression|2|||
49097969|NCT00675428|158192943|FG001|Overall Study|Disease Progression|2|||
49097970|NCT00675428|158192942|FG000|Overall Study|No Disease Response After Cycle 6|0|||
49097971|NCT00675428|158192943|FG001|Overall Study|No Disease Response After Cycle 6|1|||
49097972|NCT00675428|158192942|FG000|Overall Study|Physician Decision|1|||
49097973|NCT00675428|158192943|FG001|Overall Study|Physician Decision|0|||
49097974|NCT00435487|158192944|FG000|Overall Study|Death|3|||
49097975|NCT00435487|158192945|FG001|Overall Study|Death|4|||
49097976|NCT00435487|158192944|FG000|Overall Study|Adverse Event|0|||
49097977|NCT00435487|158192945|FG001|Overall Study|Adverse Event|3|||
49097978|NCT00435487|158192944|FG000|Overall Study|Lost to Follow-up|2|||
49097979|NCT00435487|158192945|FG001|Overall Study|Lost to Follow-up|2|||
49097980|NCT00435487|158192944|FG000|Overall Study|Other|5|||
49097981|NCT00435487|158192945|FG001|Overall Study|Other|2|||
49097982|NCT00435487|158192944|FG000|Overall Study|Withdrawal by Subject|2|||
49097983|NCT00435487|158192945|FG001|Overall Study|Withdrawal by Subject|1|||
49097984|NCT00435487|158192944|FG000|Overall Study|Withdrawal by Subject Prior to Treatment|0|||
49097985|NCT00435487|158192945|FG001|Overall Study|Withdrawal by Subject Prior to Treatment|2|||
49097986|NCT00435487|158192944|FG000|Overall Study|Received Drug in Other Treatment Group|0|||
49097987|NCT00435487|158192945|FG001|Overall Study|Received Drug in Other Treatment Group|1|||
49097988|NCT04484142|158192946|FG000|Overall Study|Adverse Event|13|||
49097989|NCT04484142|158192946|FG000|Overall Study|Progressive Disease|87|||
49097990|NCT04484142|158192946|FG000|Overall Study|Clinical Progression|10|||
49097991|NCT04484142|158192946|FG000|Overall Study|Withdrawal by Subject|6|||
49097992|NCT04484142|158192946|FG000|Overall Study|Physician Decision|1|||
49097993|NCT01116648|158192947|FG000|Phase 1 Dose Level 3|Adverse Event|0|||
49097994|NCT01116648|158192948|FG001|Phase 1 Dose Level 3|Adverse Event|0|||
49097995|NCT01116648|158192949|FG002|Phase 1 Dose Level 3|Adverse Event|0|||
49097996|NCT01116648|158192950|FG003|Phase 1 Dose Level 3|Adverse Event|2|||
49097997|NCT01116648|158192951|FG004|Phase 1 Dose Level 3|Adverse Event|0|||
49097998|NCT01116648|158192952|FG005|Phase 1 Dose Level 3|Adverse Event|0|||
49097999|NCT01116648|158192953|FG006|Phase 1 Dose Level 3|Adverse Event|0|||
49098000|NCT01116648|158192954|FG007|Phase 1 Dose Level 3|Adverse Event|0|||
49098001|NCT01116648|158192955|FG008|Phase 1 Dose Level 3|Adverse Event|0|||
49098002|NCT01116648|158192956|FG009|Phase 1 Dose Level 3|Adverse Event|0|||
49098003|NCT01116648|158192957|FG010|Phase 1 Dose Level 3|Adverse Event|0|||
49098004|NCT01116648|158192958|FG011|Phase 1 Dose Level 3|Adverse Event|0|||
49098005|NCT01116648|158192959|FG012|Phase 1 Dose Level 3|Adverse Event|0|||
49098006|NCT01116648|158192960|FG013|Phase 1 Dose Level 3|Adverse Event|0|||
49098007|NCT01116648|158192961|FG014|Phase 1 Dose Level 3|Adverse Event|0|||
49098008|NCT00319592|158192962|FG000|Overall Study|Protocol Violation|1|||
49098009|NCT00319592|158192963|FG001|Overall Study|Protocol Violation|0|||
49098010|NCT00319592|158192962|FG000|Overall Study|Physician Decision|0|||
49098011|NCT00319592|158192963|FG001|Overall Study|Physician Decision|1|||
49098012|NCT00378508|158192971|FG000|Overall Study|Withdrawal by Subject|1|||
49098013|NCT00378508|158192972|FG001|Overall Study|Withdrawal by Subject|3|||
49098014|NCT00378508|158192971|FG000|Overall Study|Lost to Follow-up|1|||
49098015|NCT00378508|158192972|FG001|Overall Study|Lost to Follow-up|0|||
49098016|NCT01597375|158192975|FG000|First Intervention (4 Weeks)|Uncontrolled Asthma|1|||
49098017|NCT01597375|158192976|FG001|First Intervention (4 Weeks)|Uncontrolled Asthma|0|||
49098018|NCT01597375|158192975|FG000|First Intervention (4 Weeks)|Needed surgery|1|||
49098019|NCT01597375|158192976|FG001|First Intervention (4 Weeks)|Needed surgery|0|||
49098020|NCT01597375|158192975|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
49098021|NCT01597375|158192976|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
49098022|NCT01597375|158192975|FG000|Washout (2 Weeks)|Adverse Event|1|||
49098023|NCT01597375|158192976|FG001|Washout (2 Weeks)|Adverse Event|0|||
49098024|NCT01597375|158192975|FG000|Second Intervention|Failed to react at both Aspirin|1|||
49098025|NCT01597375|158192976|FG001|Second Intervention|Failed to react at both Aspirin|1|||
49098026|NCT02640404|158192980|FG000|Overall Study|Protocol Violation|1|||
49098027|NCT02640404|158192981|FG001|Overall Study|Protocol Violation|0|||
49098028|NCT02640404|158192980|FG000|Overall Study|Withdrawal by Subject|1|||
49098029|NCT02640404|158192981|FG001|Overall Study|Withdrawal by Subject|0|||
49098030|NCT04545567|158192982|FG000|Overall Study|tested positive for SARS-co-V2|1|||
49098031|NCT04545567|158192983|FG001|Overall Study|tested positive for SARS-co-V2|1|||
49098032|NCT04545567|158192982|FG000|Overall Study|Withdrawal by Subject|0|||
49098033|NCT04545567|158192983|FG001|Overall Study|Withdrawal by Subject|1|||
49098034|NCT02496091|158192986|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
49098035|NCT02778074|158192987|FG000|Overall Study|Lost to Follow-up|7|||
49098036|NCT02778074|158192988|FG001|Overall Study|Lost to Follow-up|10|||
49098037|NCT01190410|158194439|FG000|Overall Study|Adverse Event|0|||
49098038|NCT01190410|158194440|FG001|Overall Study|Adverse Event|3|||
49098039|NCT01190410|158194439|FG000|Overall Study|Lack of Efficacy|0|||
49098040|NCT01190410|158194440|FG001|Overall Study|Lack of Efficacy|2|||
49098041|NCT01190410|158194439|FG000|Overall Study|Withdrawal by Subject|0|||
49098042|NCT01190410|158194440|FG001|Overall Study|Withdrawal by Subject|2|||
49098043|NCT01190410|158194439|FG000|Overall Study|Administrative decision|1|||
49098044|NCT01190410|158194440|FG001|Overall Study|Administrative decision|0|||
49098045|NCT01190410|158194439|FG000|Overall Study|PI discretion|0|||
49098046|NCT01190410|158194440|FG001|Overall Study|PI discretion|2|||
49098047|NCT05483686|158194441|FG000|Overall Study|Lost to Follow-up|5|||
49098048|NCT05483686|158194442|FG001|Overall Study|Lost to Follow-up|7|||
49098049|NCT03528369|158194457|FG000|Overall Study|Withdrawal by Subject|2|||
49098050|NCT03528369|158194458|FG001|Overall Study|Withdrawal by Subject|0|||
49098051|NCT03528369|158194459|FG002|Overall Study|Withdrawal by Subject|0|||
49098052|NCT03528369|158194457|FG000|Overall Study|Lost to Follow-up|1|||
49098053|NCT03528369|158194458|FG001|Overall Study|Lost to Follow-up|0|||
49098054|NCT03528369|158194459|FG002|Overall Study|Lost to Follow-up|0|||
49098055|NCT03528369|158194457|FG000|Overall Study|Adverse Event|0|||
49098056|NCT03528369|158194458|FG001|Overall Study|Adverse Event|1|||
49098057|NCT03528369|158194459|FG002|Overall Study|Adverse Event|0|||
49098058|NCT02162719|158194460|FG000|Overall Study|Death|41|||
49098059|NCT02162719|158194461|FG001|Overall Study|Death|46|||
49098060|NCT02162719|158194460|FG000|Overall Study|Lost to Follow-up|1|||
49098061|NCT02162719|158194461|FG001|Overall Study|Lost to Follow-up|3|||
49098062|NCT02162719|158194460|FG000|Overall Study|Disease Progression|2|||
49098063|NCT02162719|158194461|FG001|Overall Study|Disease Progression|1|||
49098064|NCT02162719|158194460|FG000|Overall Study|Withdrawal by Subject|8|||
49098065|NCT02162719|158194461|FG001|Overall Study|Withdrawal by Subject|2|||
49098066|NCT02162719|158194460|FG000|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
49098067|NCT02162719|158194461|FG001|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
49098068|NCT00160706|158194462|FG000|Overall Study|Adverse Event|53|||
49098069|NCT00160706|158194462|FG000|Overall Study|Adverse Event and Other Reason|105|||
49098070|NCT00160706|158194462|FG000|Overall Study|Protocol Violation|3|||
49098071|NCT00160706|158194462|FG000|Overall Study|Withdrawal by Subject|41|||
49098072|NCT00160706|158194462|FG000|Overall Study|Withdrawal by Subject and Other|12|||
49098073|NCT00160706|158194462|FG000|Overall Study|Physician Decision|10|||
49098074|NCT00160706|158194462|FG000|Overall Study|Physician Decision and Other|3|||
49098075|NCT00160706|158194462|FG000|Overall Study|Lost to Follow-up|4|||
49098076|NCT00160706|158194462|FG000|Overall Study|Lost to Follow-up and Other|1|||
49098077|NCT00160706|158194462|FG000|Overall Study|Lack of Efficacy|42|||
49098078|NCT00160706|158194462|FG000|Overall Study|Lack of Efficacy and Other|1|||
49098079|NCT00160706|158194462|FG000|Overall Study|Other Reason|11|||
49098080|NCT03214380|158194463|FG000|Lead-in|Adverse Event|3|||
49098081|NCT03214380|158194464|FG001|Lead-in|Adverse Event|0|||
49098082|NCT03214380|158194465|FG002|Lead-in|Adverse Event|0|||
49098083|NCT03214380|158194466|FG003|Lead-in|Adverse Event|1|||
49098084|NCT03214380|158194467|FG004|Lead-in|Adverse Event|0|||
49098085|NCT03214380|158194468|FG005|Lead-in|Adverse Event|0|||
49098086|NCT03214380|158194463|FG000|Lead-in|Lost to Follow-up|4|||
49098087|NCT03214380|158194464|FG001|Lead-in|Lost to Follow-up|0|||
49098088|NCT03214380|158194465|FG002|Lead-in|Lost to Follow-up|0|||
49098089|NCT03214380|158194466|FG003|Lead-in|Lost to Follow-up|1|||
49098090|NCT03214380|158194467|FG004|Lead-in|Lost to Follow-up|0|||
49098091|NCT03214380|158194468|FG005|Lead-in|Lost to Follow-up|0|||
49098092|NCT03214380|158194463|FG000|Lead-in|Eligibility Criteria|3|||
49098093|NCT03214380|158194464|FG001|Lead-in|Eligibility Criteria|0|||
49098094|NCT03214380|158194465|FG002|Lead-in|Eligibility Criteria|0|||
49098095|NCT03214380|158194466|FG003|Lead-in|Eligibility Criteria|0|||
49098096|NCT03214380|158194467|FG004|Lead-in|Eligibility Criteria|0|||
49098097|NCT03214380|158194468|FG005|Lead-in|Eligibility Criteria|0|||
49098098|NCT03214380|158194463|FG000|Lead-in|Physician Decision|6|||
49098099|NCT03214380|158194464|FG001|Lead-in|Physician Decision|0|||
49098100|NCT03214380|158194465|FG002|Lead-in|Physician Decision|0|||
49098101|NCT03214380|158194466|FG003|Lead-in|Physician Decision|0|||
49098102|NCT03214380|158194467|FG004|Lead-in|Physician Decision|0|||
49098103|NCT03214380|158194468|FG005|Lead-in|Physician Decision|0|||
49098104|NCT03214380|158194463|FG000|Lead-in|Protocol Deviation|7|||
49098105|NCT03214380|158194464|FG001|Lead-in|Protocol Deviation|0|||
49098106|NCT03214380|158194465|FG002|Lead-in|Protocol Deviation|0|||
49098107|NCT03214380|158194466|FG003|Lead-in|Protocol Deviation|3|||
49098108|NCT03214380|158194467|FG004|Lead-in|Protocol Deviation|0|||
49098109|NCT03214380|158194468|FG005|Lead-in|Protocol Deviation|0|||
49098110|NCT03214380|158194463|FG000|Lead-in|Withdrawal by Subject|41|||
49098111|NCT03214380|158194464|FG001|Lead-in|Withdrawal by Subject|0|||
49098112|NCT03214380|158194465|FG002|Lead-in|Withdrawal by Subject|0|||
49098113|NCT03214380|158194466|FG003|Lead-in|Withdrawal by Subject|14|||
49098114|NCT03214380|158194467|FG004|Lead-in|Withdrawal by Subject|0|||
49098115|NCT03214380|158194468|FG005|Lead-in|Withdrawal by Subject|0|||
49098116|NCT03214380|158194463|FG000|Lead-in|Family Emergency|1|||
49098117|NCT03214380|158194464|FG001|Lead-in|Family Emergency|0|||
49098118|NCT03214380|158194465|FG002|Lead-in|Family Emergency|0|||
49098119|NCT03214380|158194466|FG003|Lead-in|Family Emergency|0|||
49098120|NCT03214380|158194467|FG004|Lead-in|Family Emergency|0|||
49098121|NCT03214380|158194468|FG005|Lead-in|Family Emergency|0|||
49098122|NCT03214380|158194463|FG000|Lead-in|Natural Disaster|9|||
49098123|NCT03214380|158194464|FG001|Lead-in|Natural Disaster|0|||
49098124|NCT03214380|158194465|FG002|Lead-in|Natural Disaster|0|||
49098125|NCT03214380|158194466|FG003|Lead-in|Natural Disaster|0|||
49098126|NCT03214380|158194467|FG004|Lead-in|Natural Disaster|0|||
49098127|NCT03214380|158194468|FG005|Lead-in|Natural Disaster|0|||
49098128|NCT03214380|158194463|FG000|Lead-in|Non Compliance|1|||
49098129|NCT03214380|158194464|FG001|Lead-in|Non Compliance|0|||
49098130|NCT03214380|158194465|FG002|Lead-in|Non Compliance|0|||
49098131|NCT03214380|158194466|FG003|Lead-in|Non Compliance|0|||
49098132|NCT03214380|158194467|FG004|Lead-in|Non Compliance|0|||
49098133|NCT03214380|158194468|FG005|Lead-in|Non Compliance|0|||
49098134|NCT03214380|158194463|FG000|Lead-in|Participant Schedule|2|||
49098135|NCT03214380|158194464|FG001|Lead-in|Participant Schedule|0|||
49098136|NCT03214380|158194465|FG002|Lead-in|Participant Schedule|0|||
49098137|NCT03214380|158194466|FG003|Lead-in|Participant Schedule|0|||
49098138|NCT03214380|158194467|FG004|Lead-in|Participant Schedule|0|||
49098139|NCT03214380|158194468|FG005|Lead-in|Participant Schedule|0|||
49098140|NCT03214380|158194463|FG000|Treatment Period|Adverse Event|0|||
49098141|NCT03214380|158194464|FG001|Treatment Period|Adverse Event|1|||
49098142|NCT03214380|158194465|FG002|Treatment Period|Adverse Event|1|||
49098143|NCT03214380|158194466|FG003|Treatment Period|Adverse Event|0|||
49098144|NCT03214380|158194467|FG004|Treatment Period|Adverse Event|1|||
49098145|NCT03214380|158194468|FG005|Treatment Period|Adverse Event|0|||
49098146|NCT03214380|158194463|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
49098147|NCT03214380|158194464|FG001|Treatment Period|Non-Compliance with Study Drug|0|||
49098148|NCT03214380|158194465|FG002|Treatment Period|Non-Compliance with Study Drug|0|||
49098149|NCT03214380|158194466|FG003|Treatment Period|Non-Compliance with Study Drug|0|||
49098150|NCT03214380|158194467|FG004|Treatment Period|Non-Compliance with Study Drug|1|||
49098151|NCT03214380|158194468|FG005|Treatment Period|Non-Compliance with Study Drug|0|||
49098152|NCT03214380|158194463|FG000|Treatment Period|Withdrawal by Subject|0|||
49098153|NCT03214380|158194464|FG001|Treatment Period|Withdrawal by Subject|10|||
49098154|NCT03214380|158194465|FG002|Treatment Period|Withdrawal by Subject|8|||
49098155|NCT03214380|158194466|FG003|Treatment Period|Withdrawal by Subject|0|||
49098156|NCT03214380|158194467|FG004|Treatment Period|Withdrawal by Subject|7|||
49098157|NCT03214380|158194468|FG005|Treatment Period|Withdrawal by Subject|11|||
49098158|NCT03214380|158194463|FG000|Treatment Period|Death|0|||
49098159|NCT03214380|158194464|FG001|Treatment Period|Death|1|||
49098160|NCT03214380|158194465|FG002|Treatment Period|Death|2|||
49098161|NCT03214380|158194466|FG003|Treatment Period|Death|0|||
49098162|NCT03214380|158194467|FG004|Treatment Period|Death|0|||
49098163|NCT03214380|158194468|FG005|Treatment Period|Death|0|||
49098164|NCT03214380|158194463|FG000|Treatment Period|Lost to Follow-up|0|||
49098165|NCT03214380|158194464|FG001|Treatment Period|Lost to Follow-up|6|||
49098166|NCT03214380|158194465|FG002|Treatment Period|Lost to Follow-up|3|||
49098167|NCT03214380|158194466|FG003|Treatment Period|Lost to Follow-up|0|||
49098168|NCT03214380|158194467|FG004|Treatment Period|Lost to Follow-up|0|||
49098169|NCT03214380|158194468|FG005|Treatment Period|Lost to Follow-up|0|||
49098170|NCT03214380|158194463|FG000|Treatment Period|Participant schedule|0|||
49098171|NCT03214380|158194464|FG001|Treatment Period|Participant schedule|0|||
49098172|NCT03214380|158194465|FG002|Treatment Period|Participant schedule|1|||
49098173|NCT03214380|158194466|FG003|Treatment Period|Participant schedule|0|||
49098174|NCT03214380|158194467|FG004|Treatment Period|Participant schedule|0|||
49098175|NCT03214380|158194468|FG005|Treatment Period|Participant schedule|0|||
49098176|NCT03214380|158194463|FG000|Treatment Period|Treatment Interruption|0|||
49098177|NCT03214380|158194464|FG001|Treatment Period|Treatment Interruption|0|||
49098178|NCT03214380|158194465|FG002|Treatment Period|Treatment Interruption|1|||
49098179|NCT03214380|158194466|FG003|Treatment Period|Treatment Interruption|0|||
49098180|NCT03214380|158194467|FG004|Treatment Period|Treatment Interruption|0|||
49098181|NCT03214380|158194468|FG005|Treatment Period|Treatment Interruption|0|||
49098182|NCT04434469|158194469|FG000|Overall Study|Death|2|||
49098183|NCT04434469|158194470|FG001|Overall Study|Death|3|||
49098184|NCT04434469|158194471|FG002|Overall Study|Death|2|||
49098185|NCT04434469|158194472|FG003|Overall Study|Death|2|||
49098186|NCT04434469|158194473|FG004|Overall Study|Death|2|||
49098187|NCT04434469|158194474|FG005|Overall Study|Death|0|||
49098188|NCT04434469|158194469|FG000|Overall Study|Lost to Follow-up|0|||
49098189|NCT04434469|158194470|FG001|Overall Study|Lost to Follow-up|0|||
49098190|NCT04434469|158194471|FG002|Overall Study|Lost to Follow-up|0|||
49098191|NCT04434469|158194472|FG003|Overall Study|Lost to Follow-up|1|||
49098192|NCT04434469|158194473|FG004|Overall Study|Lost to Follow-up|1|||
49098193|NCT04434469|158194474|FG005|Overall Study|Lost to Follow-up|0|||
49098194|NCT04434469|158194469|FG000|Overall Study|Study terminated by sponsor|1|||
49098195|NCT04434469|158194470|FG001|Overall Study|Study terminated by sponsor|1|||
49098196|NCT04434469|158194471|FG002|Overall Study|Study terminated by sponsor|1|||
49098197|NCT04434469|158194472|FG003|Overall Study|Study terminated by sponsor|2|||
49098198|NCT04434469|158194473|FG004|Overall Study|Study terminated by sponsor|3|||
49098199|NCT04434469|158194474|FG005|Overall Study|Study terminated by sponsor|3|||
49098200|NCT04434469|158194469|FG000|Overall Study|Withdrawal by Subject|0|||
49098201|NCT04434469|158194470|FG001|Overall Study|Withdrawal by Subject|0|||
49098202|NCT04434469|158194471|FG002|Overall Study|Withdrawal by Subject|1|||
49098203|NCT04434469|158194472|FG003|Overall Study|Withdrawal by Subject|0|||
49098204|NCT04434469|158194473|FG004|Overall Study|Withdrawal by Subject|0|||
49098205|NCT04434469|158194474|FG005|Overall Study|Withdrawal by Subject|0|||
49098206|NCT01669174|158194477|FG000|Overall Study|Subject withdrew consent|2|||
49098207|NCT01669174|158194478|FG001|Overall Study|Subject withdrew consent|2|||
49098208|NCT01669174|158194477|FG000|Overall Study|Lost to Follow-up|1|||
49098209|NCT01669174|158194478|FG001|Overall Study|Lost to Follow-up|0|||
49098210|NCT01669174|158194477|FG000|Overall Study|Adverse Event|2|||
49098211|NCT01669174|158194478|FG001|Overall Study|Adverse Event|2|||
49098212|NCT01669174|158194477|FG000|Overall Study|Administrative problems|1|||
49098213|NCT01669174|158194478|FG001|Overall Study|Administrative problems|2|||
49098214|NCT02244463|158194487|FG000|Period 1: PI DL1 Dose Escalation|Disease Progression|3|||
49098215|NCT02244463|158194488|FG001|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
49098216|NCT02244463|158194489|FG002|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
49098217|NCT02244463|158194490|FG003|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
49098218|NCT02244463|158194491|FG004|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
49098219|NCT02244463|158194492|FG005|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
49098220|NCT02244463|158194487|FG000|Period 2: PI DL2 Dose Escalation|Death|0|||
49098221|NCT02244463|158194488|FG001|Period 2: PI DL2 Dose Escalation|Death|1|||
49098222|NCT02244463|158194489|FG002|Period 2: PI DL2 Dose Escalation|Death|0|||
49098223|NCT02244463|158194490|FG003|Period 2: PI DL2 Dose Escalation|Death|0|||
49098224|NCT02244463|158194491|FG004|Period 2: PI DL2 Dose Escalation|Death|0|||
49098225|NCT02244463|158194492|FG005|Period 2: PI DL2 Dose Escalation|Death|0|||
49098226|NCT02244463|158194487|FG000|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
49098227|NCT02244463|158194488|FG001|Period 2: PI DL2 Dose Escalation|Disease Progression|2|||
49098228|NCT02244463|158194489|FG002|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
49098229|NCT02244463|158194490|FG003|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
49098230|NCT02244463|158194491|FG004|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
49098231|NCT02244463|158194492|FG005|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
49098232|NCT02244463|158194487|FG000|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
49098233|NCT02244463|158194488|FG001|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
49098234|NCT02244463|158194489|FG002|Period 3: PI DL3 Dose Escalation|Disease Progression|3|||
49098235|NCT02244463|158194490|FG003|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
49098236|NCT02244463|158194491|FG004|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
49098237|NCT02244463|158194492|FG005|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
49098238|NCT02244463|158194487|FG000|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
49098239|NCT02244463|158194488|FG001|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
49098240|NCT02244463|158194489|FG002|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
49098241|NCT02244463|158194490|FG003|Period 4: PI DL3 Dose Expansion|Adverse Event|1|||
49098242|NCT02244463|158194491|FG004|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
49098243|NCT02244463|158194492|FG005|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
49098244|NCT02244463|158194487|FG000|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
49098245|NCT02244463|158194488|FG001|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
49098246|NCT02244463|158194489|FG002|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
49098247|NCT02244463|158194490|FG003|Period 4: PI DL3 Dose Expansion|Disease Progression|5|||
49098248|NCT02244463|158194491|FG004|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
49098249|NCT02244463|158194492|FG005|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
49098250|NCT02244463|158194487|FG000|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
49098251|NCT02244463|158194488|FG001|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
49098252|NCT02244463|158194489|FG002|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
49098253|NCT02244463|158194490|FG003|Period 4: PI DL3 Dose Expansion|Physician Decision|2|||
49098254|NCT02244463|158194491|FG004|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
49098255|NCT02244463|158194492|FG005|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
49098256|NCT02244463|158194487|FG000|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
49098257|NCT02244463|158194488|FG001|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
49098258|NCT02244463|158194489|FG002|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
49098259|NCT02244463|158194490|FG003|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|1|||
49098260|NCT02244463|158194491|FG004|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
49098261|NCT02244463|158194492|FG005|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
49098262|NCT02244463|158194487|FG000|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
49098263|NCT02244463|158194488|FG001|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
49098264|NCT02244463|158194489|FG002|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
49098265|NCT02244463|158194490|FG003|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|1|||
49098266|NCT02244463|158194491|FG004|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
49098267|NCT02244463|158194492|FG005|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
49098268|NCT02244463|158194487|FG000|Period 5: Phase II|Disease Progression|0|||
49098269|NCT02244463|158194488|FG001|Period 5: Phase II|Disease Progression|0|||
49098270|NCT02244463|158194489|FG002|Period 5: Phase II|Disease Progression|0|||
49098271|NCT02244463|158194490|FG003|Period 5: Phase II|Disease Progression|0|||
49098272|NCT02244463|158194491|FG004|Period 5: Phase II|Disease Progression|10|||
49098273|NCT02244463|158194492|FG005|Period 5: Phase II|Disease Progression|11|||
49098274|NCT02244463|158194487|FG000|Period 5: Phase II|Physician Decision|0|||
49098275|NCT02244463|158194488|FG001|Period 5: Phase II|Physician Decision|0|||
49098276|NCT02244463|158194489|FG002|Period 5: Phase II|Physician Decision|0|||
49098277|NCT02244463|158194490|FG003|Period 5: Phase II|Physician Decision|0|||
49098278|NCT02244463|158194491|FG004|Period 5: Phase II|Physician Decision|3|||
49098279|NCT02244463|158194492|FG005|Period 5: Phase II|Physician Decision|2|||
49098280|NCT02244463|158194487|FG000|Period 5: Phase II|Withdrawal by Subject|0|||
49098281|NCT02244463|158194488|FG001|Period 5: Phase II|Withdrawal by Subject|0|||
49098282|NCT02244463|158194489|FG002|Period 5: Phase II|Withdrawal by Subject|0|||
49098283|NCT02244463|158194490|FG003|Period 5: Phase II|Withdrawal by Subject|0|||
49098284|NCT02244463|158194491|FG004|Period 5: Phase II|Withdrawal by Subject|3|||
49098285|NCT02244463|158194492|FG005|Period 5: Phase II|Withdrawal by Subject|4|||
49098286|NCT02244463|158194487|FG000|Period 5: Phase II|Intercurrent Illness|0|||
49098287|NCT02244463|158194488|FG001|Period 5: Phase II|Intercurrent Illness|0|||
49098288|NCT02244463|158194489|FG002|Period 5: Phase II|Intercurrent Illness|0|||
49098289|NCT02244463|158194490|FG003|Period 5: Phase II|Intercurrent Illness|0|||
49098290|NCT02244463|158194491|FG004|Period 5: Phase II|Intercurrent Illness|2|||
49098291|NCT02244463|158194492|FG005|Period 5: Phase II|Intercurrent Illness|0|||
49098292|NCT02244463|158194487|FG000|Period 5: Phase II|Adverse Event|0|||
49098293|NCT02244463|158194488|FG001|Period 5: Phase II|Adverse Event|0|||
49098294|NCT02244463|158194489|FG002|Period 5: Phase II|Adverse Event|0|||
49098295|NCT02244463|158194490|FG003|Period 5: Phase II|Adverse Event|0|||
49098296|NCT02244463|158194491|FG004|Period 5: Phase II|Adverse Event|0|||
49098297|NCT02244463|158194492|FG005|Period 5: Phase II|Adverse Event|2|||
49098298|NCT02244463|158194487|FG000|Period 5: Phase II|Still On treatment|0|||
49098299|NCT02244463|158194488|FG001|Period 5: Phase II|Still On treatment|0|||
49098300|NCT02244463|158194489|FG002|Period 5: Phase II|Still On treatment|0|||
49098301|NCT02244463|158194490|FG003|Period 5: Phase II|Still On treatment|0|||
49098302|NCT02244463|158194491|FG004|Period 5: Phase II|Still On treatment|0|||
49098303|NCT02244463|158194492|FG005|Period 5: Phase II|Still On treatment|3|||
49098304|NCT01769508|158194497|FG000|Overall Study|Death|3|||
49098305|NCT01769508|158194497|FG000|Overall Study|Withdrawal by Subject|1|||
49098306|NCT01769508|158194497|FG000|Overall Study|Adverse Event|1|||
49098307|NCT01769508|158194497|FG000|Overall Study|Lost to Follow-up|1|||
49098308|NCT03702010|158194498|FG000|Follow-up (30days)|Lack of Efficacy|2|||
49098309|NCT03702010|158194499|FG001|Follow-up (30days)|Lack of Efficacy|2|||
49098310|NCT03843541|158194500|FG000|Overall Study|Adverse Event|4|||
49098311|NCT03843541|158194501|FG001|Overall Study|Adverse Event|2|||
49098312|NCT03843541|158194502|FG002|Overall Study|Adverse Event|3|||
49098313|NCT03843541|158194500|FG000|Overall Study|Death|1|||
49098314|NCT03843541|158194501|FG001|Overall Study|Death|0|||
49098315|NCT03843541|158194502|FG002|Overall Study|Death|0|||
49098316|NCT03843541|158194500|FG000|Overall Study|Lack of adherence to study medication|0|||
49098317|NCT03843541|158194501|FG001|Overall Study|Lack of adherence to study medication|0|||
49098318|NCT03843541|158194502|FG002|Overall Study|Lack of adherence to study medication|1|||
49098319|NCT03843541|158194500|FG000|Overall Study|Physician Decision|1|||
49098320|NCT03843541|158194501|FG001|Overall Study|Physician Decision|2|||
49098321|NCT03843541|158194502|FG002|Overall Study|Physician Decision|2|||
49098322|NCT03843541|158194500|FG000|Overall Study|Study subject withdrawal by parent or guardian|1|||
49098323|NCT03843541|158194501|FG001|Overall Study|Study subject withdrawal by parent or guardian|0|||
49098324|NCT03843541|158194502|FG002|Overall Study|Study subject withdrawal by parent or guardian|0|||
49098325|NCT03843541|158194500|FG000|Overall Study|Withdrawal by Subject|6|||
49098326|NCT03843541|158194501|FG001|Overall Study|Withdrawal by Subject|9|||
49098327|NCT03843541|158194502|FG002|Overall Study|Withdrawal by Subject|7|||
49098328|NCT03843541|158194500|FG000|Overall Study|Administration of rescue mucolytic|0|||
49098329|NCT03843541|158194501|FG001|Overall Study|Administration of rescue mucolytic|0|||
49098330|NCT03843541|158194502|FG002|Overall Study|Administration of rescue mucolytic|1|||
49098331|NCT03843541|158194500|FG000|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|2|||
49098332|NCT03843541|158194501|FG001|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|3|||
49098333|NCT03843541|158194502|FG002|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|0|||
49098334|NCT01254318|158194503|FG000|Overall Study|Lost to Follow-up|5|||
49098335|NCT01254318|158194503|FG000|Overall Study|Death|47|||
49098336|NCT04016779|158194504|FG000|Overall Study|Adverse Event|9|||
49098337|NCT04016779|158194505|FG001|Overall Study|Adverse Event|17|||
49098338|NCT04016779|158194504|FG000|Overall Study|Lack of Efficacy|4|||
49098339|NCT04016779|158194505|FG001|Overall Study|Lack of Efficacy|1|||
49098340|NCT04016779|158194504|FG000|Overall Study|Lost to Follow-up|5|||
49098341|NCT04016779|158194505|FG001|Overall Study|Lost to Follow-up|14|||
49098342|NCT04016779|158194504|FG000|Overall Study|Physician Decision|1|||
49098343|NCT04016779|158194505|FG001|Overall Study|Physician Decision|3|||
49098344|NCT04016779|158194504|FG000|Overall Study|Withdrawal by Subject|6|||
49098345|NCT04016779|158194505|FG001|Overall Study|Withdrawal by Subject|8|||
49098346|NCT04016779|158194504|FG000|Overall Study|Non-compliance with Study Drug|2|||
49098347|NCT04016779|158194505|FG001|Overall Study|Non-compliance with Study Drug|3|||
49098348|NCT04016779|158194504|FG000|Overall Study|Other, Multiple categories|17|||
49098349|NCT04016779|158194505|FG001|Overall Study|Other, Multiple categories|17|||
49098350|NCT03615144|158194510|FG000|Overall Study|Participant no longer eligible for this protocol|1|||
49098351|NCT03615144|158194511|FG001|Overall Study|Participant no longer eligible for this protocol|0|||
49098352|NCT04791319|158194527|FG000|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|4|||
49098353|NCT04791319|158194528|FG001|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|2|||
49098354|NCT04791319|158194529|FG002|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|9|||
49098355|NCT04791319|158194530|FG003|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|3|||
49098356|NCT04791319|158194531|FG004|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
49098357|NCT04791319|158194532|FG005|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
49098358|NCT04791319|158194533|FG006|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
49098359|NCT04791319|158194534|FG007|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
49098360|NCT04791319|158194535|FG008|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
49098361|NCT04791319|158194536|FG009|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
49098362|NCT04791319|158194537|FG010|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
49098363|NCT04791319|158194527|FG000|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
49098364|NCT04791319|158194528|FG001|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
49098365|NCT04791319|158194529|FG002|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|2|||
49098366|NCT04791319|158194530|FG003|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
49098367|NCT04791319|158194531|FG004|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
49098368|NCT04791319|158194532|FG005|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
49098369|NCT04791319|158194533|FG006|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
49098370|NCT04791319|158194534|FG007|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
49098371|NCT04791319|158194535|FG008|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
49098372|NCT04791319|158194536|FG009|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
49098373|NCT04791319|158194537|FG010|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
49098374|NCT04791319|158194527|FG000|Placebo Controlled Period (Week 0-15)|Trial termination|2|||
49098375|NCT04791319|158194528|FG001|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
49098376|NCT04791319|158194529|FG002|Placebo Controlled Period (Week 0-15)|Trial termination|5|||
49098377|NCT04791319|158194530|FG003|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
49098378|NCT04791319|158194531|FG004|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
49098379|NCT04791319|158194532|FG005|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
49098380|NCT04791319|158194533|FG006|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
49098381|NCT04791319|158194534|FG007|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
49098382|NCT04791319|158194535|FG008|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
49098383|NCT04791319|158194536|FG009|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
49098384|NCT04791319|158194537|FG010|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
49098385|NCT04791319|158194527|FG000|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|7|||
49098386|NCT04791319|158194528|FG001|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|6|||
49098387|NCT04791319|158194529|FG002|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|21|||
49098388|NCT04791319|158194530|FG003|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|19|||
49098389|NCT04791319|158194531|FG004|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
49098390|NCT04791319|158194532|FG005|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
49098391|NCT04791319|158194533|FG006|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
49098392|NCT04791319|158194534|FG007|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
49098393|NCT04791319|158194535|FG008|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
49098394|NCT04791319|158194536|FG009|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
49098395|NCT04791319|158194537|FG010|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
49098396|NCT04791319|158194527|FG000|Placebo Controlled Period (Week 0-15)|Not treated|0|||
49098397|NCT04791319|158194528|FG001|Placebo Controlled Period (Week 0-15)|Not treated|0|||
49098398|NCT04791319|158194529|FG002|Placebo Controlled Period (Week 0-15)|Not treated|0|||
49098399|NCT04791319|158194530|FG003|Placebo Controlled Period (Week 0-15)|Not treated|1|||
49098400|NCT04791319|158194531|FG004|Placebo Controlled Period (Week 0-15)|Not treated|0|||
49098401|NCT04791319|158194532|FG005|Placebo Controlled Period (Week 0-15)|Not treated|0|||
49098402|NCT04791319|158194533|FG006|Placebo Controlled Period (Week 0-15)|Not treated|0|||
49098403|NCT04791319|158194534|FG007|Placebo Controlled Period (Week 0-15)|Not treated|0|||
49098404|NCT04791319|158194535|FG008|Placebo Controlled Period (Week 0-15)|Not treated|0|||
49098405|NCT04791319|158194536|FG009|Placebo Controlled Period (Week 0-15)|Not treated|0|||
49098406|NCT04791319|158194537|FG010|Placebo Controlled Period (Week 0-15)|Not treated|0|||
49098407|NCT04791319|158194527|FG000|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
49098408|NCT04791319|158194528|FG001|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
49098409|NCT04791319|158194529|FG002|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
49098410|NCT04791319|158194530|FG003|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
49098411|NCT04791319|158194531|FG004|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
49098412|NCT04791319|158194532|FG005|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
49098413|NCT04791319|158194533|FG006|Active Treatment Period (Week 16-31)|Withdrawal by Subject|1|||
49098414|NCT04791319|158194534|FG007|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
49098415|NCT04791319|158194535|FG008|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
49098416|NCT04791319|158194536|FG009|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
49098417|NCT04791319|158194537|FG010|Active Treatment Period (Week 16-31)|Withdrawal by Subject|3|||
49098418|NCT04791319|158194527|FG000|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
49098419|NCT04791319|158194528|FG001|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
49098420|NCT04791319|158194529|FG002|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
49098421|NCT04791319|158194530|FG003|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
49098422|NCT04791319|158194531|FG004|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
49098423|NCT04791319|158194532|FG005|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
49098424|NCT04791319|158194533|FG006|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
49098425|NCT04791319|158194534|FG007|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
49098426|NCT04791319|158194535|FG008|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
49098427|NCT04791319|158194536|FG009|Active Treatment Period (Week 16-31)|Lost to Follow-up|1|||
49098428|NCT04791319|158194537|FG010|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
49098429|NCT04791319|158194527|FG000|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
49098430|NCT04791319|158194528|FG001|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
49098431|NCT04791319|158194529|FG002|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
49098432|NCT04791319|158194530|FG003|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
49098433|NCT04791319|158194531|FG004|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|4|||
49098434|NCT04791319|158194532|FG005|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|5|||
49098435|NCT04791319|158194533|FG006|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
49098436|NCT04791319|158194534|FG007|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
49098437|NCT04791319|158194535|FG008|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|1|||
49098438|NCT04791319|158194536|FG009|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|9|||
49099073|NCT01953601|158198741|FG001|Part 2 (Extension Study)|Adverse Event|1|||
49098439|NCT04791319|158194537|FG010|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
49098440|NCT04791319|158194527|FG000|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
49098441|NCT04791319|158194528|FG001|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
49098442|NCT04791319|158194529|FG002|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
49098443|NCT04791319|158194530|FG003|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
49098444|NCT04791319|158194531|FG004|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|12|||
49098445|NCT04791319|158194532|FG005|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|8|||
49098446|NCT04791319|158194533|FG006|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|16|||
49098447|NCT04791319|158194534|FG007|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|2|||
49098448|NCT04791319|158194535|FG008|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|3|||
49098449|NCT04791319|158194536|FG009|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|11|||
49098450|NCT04791319|158194537|FG010|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|4|||
49098451|NCT03124407|158194538|FG000|Overall Study|Lost to Follow-up|1|||
49098452|NCT03124407|158194539|FG001|Overall Study|Lost to Follow-up|0|||
49098453|NCT03124407|158194540|FG002|Overall Study|Lost to Follow-up|0|||
49098454|NCT03124407|158194541|FG003|Overall Study|Lost to Follow-up|0|||
49098455|NCT03124407|158194538|FG000|Overall Study|Adverse Event|0|||
49098456|NCT03124407|158194539|FG001|Overall Study|Adverse Event|0|||
49098457|NCT03124407|158194540|FG002|Overall Study|Adverse Event|1|||
49098458|NCT03124407|158194541|FG003|Overall Study|Adverse Event|0|||
49098459|NCT02045862|158194542|FG000|Overall Study|Death|0|||
49098460|NCT02045862|158194543|FG001|Overall Study|Death|0|||
49098461|NCT02045862|158194544|FG002|Overall Study|Death|1|||
49098462|NCT02045862|158194542|FG000|Overall Study|Miscellaneous|5|||
49098463|NCT02045862|158194543|FG001|Overall Study|Miscellaneous|0|||
49098464|NCT02045862|158194544|FG002|Overall Study|Miscellaneous|8|||
49098465|NCT02045862|158194542|FG000|Overall Study|Withdrawal by Patient|18|||
49098466|NCT02045862|158194543|FG001|Overall Study|Withdrawal by Patient|27|||
49098467|NCT02045862|158194544|FG002|Overall Study|Withdrawal by Patient|57|||
49098468|NCT02045862|158194542|FG000|Overall Study|Protocol Violation|0|||
49098469|NCT02045862|158194543|FG001|Overall Study|Protocol Violation|0|||
49098470|NCT02045862|158194544|FG002|Overall Study|Protocol Violation|6|||
49098471|NCT02045862|158194542|FG000|Overall Study|Lack of Efficacy|8|||
49098472|NCT02045862|158194543|FG001|Overall Study|Lack of Efficacy|4|||
49098473|NCT02045862|158194544|FG002|Overall Study|Lack of Efficacy|13|||
49098474|NCT02045862|158194542|FG000|Overall Study|Randomized but not Received Study Drug|0|||
49098475|NCT02045862|158194543|FG001|Overall Study|Randomized but not Received Study Drug|2|||
49098476|NCT02045862|158194544|FG002|Overall Study|Randomized but not Received Study Drug|8|||
49098477|NCT02045862|158194542|FG000|Overall Study|Adverse Event|7|||
49098478|NCT02045862|158194543|FG001|Overall Study|Adverse Event|5|||
49098479|NCT02045862|158194544|FG002|Overall Study|Adverse Event|27|||
49098480|NCT02045862|158194542|FG000|Overall Study|Lost to Follow-up|1|||
49098481|NCT02045862|158194543|FG001|Overall Study|Lost to Follow-up|2|||
49098482|NCT02045862|158194544|FG002|Overall Study|Lost to Follow-up|6|||
49098483|NCT00623935|158194547|FG000|Overall Study|Death|1|||
49098484|NCT00623935|158194547|FG000|Overall Study|Patient Declined Transplant|1|||
49098485|NCT00355147|158194552|FG000|Overall Study|Lost to Follow-up|10|||
49098486|NCT00355147|158194553|FG001|Overall Study|Lost to Follow-up|8|||
49098487|NCT00355147|158194552|FG000|Overall Study|Withdrawal by Subject|8|||
49098488|NCT00355147|158194553|FG001|Overall Study|Withdrawal by Subject|12|||
49098489|NCT01704651|158194556|FG000|Overall Study|Pre-op withdrawal by subject|1|||
49098490|NCT01704651|158194557|FG001|Overall Study|Pre-op withdrawal by subject|1|||
49098491|NCT01704651|158194556|FG000|Overall Study|Pre-op change in treatment plan|1|||
49098492|NCT01704651|158194557|FG001|Overall Study|Pre-op change in treatment plan|4|||
49098493|NCT01704651|158194556|FG000|Overall Study|Nasogastric tube placement in surgery|1|||
49098494|NCT01704651|158194557|FG001|Overall Study|Nasogastric tube placement in surgery|1|||
49098495|NCT01704651|158194556|FG000|Overall Study|Post-op did not have laparotomy|2|||
49098496|NCT01704651|158194557|FG001|Overall Study|Post-op did not have laparotomy|1|||
49098497|NCT01252563|158194568|FG000|Overall Study|Contract Deviation|41|||
49098498|NCT01252563|158194568|FG000|Overall Study|Centralized Registration Deviation|30|||
49098499|NCT01252563|158194568|FG000|Overall Study|Lost to Follow-up|161|||
49098500|NCT01252563|158194568|FG000|Overall Study|No visit after first day of treatment|194|||
49098501|NCT01252563|158194568|FG000|Overall Study|No drug administration|6|||
49098502|NCT01866657|158194569|FG000|Overall Study|Surgery canceled|2|||
49098503|NCT01866657|158194570|FG001|Overall Study|Surgery canceled|0|||
49098504|NCT01032239|158194573|FG000|Overall Study|Lost to Follow-up|3|||
49098505|NCT01032239|158194574|FG001|Overall Study|Lost to Follow-up|2|||
49098506|NCT01032239|158194573|FG000|Overall Study|Withdrawal by Subject|2|||
49098507|NCT01032239|158194574|FG001|Overall Study|Withdrawal by Subject|3|||
49098508|NCT01032239|158194573|FG000|Overall Study|Death|1|||
49098509|NCT01032239|158194574|FG001|Overall Study|Death|0|||
49098510|NCT01032239|158194573|FG000|Overall Study|Protocol Violation|1|||
49098511|NCT01032239|158194574|FG001|Overall Study|Protocol Violation|0|||
49098512|NCT02272842|158194576|FG000|Overall Study|Lost to Follow-up|8|||
49098513|NCT02272842|158194577|FG001|Overall Study|Lost to Follow-up|8|||
49098514|NCT02272842|158194576|FG000|Overall Study|Withdrawal by Subject|8|||
49098515|NCT02272842|158194577|FG001|Overall Study|Withdrawal by Subject|2|||
49098516|NCT02752165|158196848|FG000|Overall Study|Withdrawal by Subject|6|||
49098517|NCT02752165|158196849|FG001|Overall Study|Withdrawal by Subject|6|||
49098518|NCT02752165|158196848|FG000|Overall Study|Protocol Violation|6|||
49098519|NCT02752165|158196849|FG001|Overall Study|Protocol Violation|5|||
49098520|NCT02752165|158196848|FG000|Overall Study|Lost to Follow-up|33|||
49098521|NCT02752165|158196849|FG001|Overall Study|Lost to Follow-up|38|||
49098522|NCT03555565|158196853|FG000|Overall Study|Case Report Forms Uncollected|2|||
49098523|NCT03555565|158196853|FG000|Overall Study|Protocol Deviation|13|||
49098524|NCT03164564|158196860|FG000|Overall Study|Death|3|||
49098525|NCT03164564|158196861|FG001|Overall Study|Death|0|||
49098526|NCT03164564|158196860|FG000|Overall Study|Withdrawal by Subject|20|||
49098527|NCT03164564|158196861|FG001|Overall Study|Withdrawal by Subject|15|||
49098528|NCT03164564|158196860|FG000|Overall Study|Lost to Follow-up|2|||
49098529|NCT03164564|158196861|FG001|Overall Study|Lost to Follow-up|0|||
49098530|NCT03164564|158196860|FG000|Overall Study|Physician Decision|0|||
49098531|NCT03164564|158196861|FG001|Overall Study|Physician Decision|1|||
49098532|NCT03164564|158196860|FG000|Overall Study|Adverse Event|0|||
49098533|NCT03164564|158196861|FG001|Overall Study|Adverse Event|1|||
49098534|NCT03164564|158196860|FG000|Overall Study|Ongoing|1586|||
49098535|NCT03164564|158196861|FG001|Overall Study|Ongoing|1586|||
49098536|NCT03557931|158196862|FG000|Overall Study|Adverse Event|4|||
49098537|NCT03557931|158196863|FG001|Overall Study|Adverse Event|6|||
49098538|NCT03557931|158196864|FG002|Overall Study|Adverse Event|1|||
49098539|NCT03557931|158196862|FG000|Overall Study|Lost to Follow-up|4|||
49098540|NCT03557931|158196863|FG001|Overall Study|Lost to Follow-up|4|||
49098541|NCT03557931|158196864|FG002|Overall Study|Lost to Follow-up|1|||
49098542|NCT03557931|158196862|FG000|Overall Study|Protocol Violation|1|||
49098543|NCT03557931|158196863|FG001|Overall Study|Protocol Violation|4|||
49098544|NCT03557931|158196864|FG002|Overall Study|Protocol Violation|1|||
49098545|NCT03557931|158196862|FG000|Overall Study|Withdrawal by Subject|14|||
49098546|NCT03557931|158196863|FG001|Overall Study|Withdrawal by Subject|0|||
49098547|NCT03557931|158196864|FG002|Overall Study|Withdrawal by Subject|7|||
49098548|NCT03557931|158196862|FG000|Overall Study|Miscellaneous|8|||
49098549|NCT03557931|158196863|FG001|Overall Study|Miscellaneous|5|||
49098550|NCT03557931|158196864|FG002|Overall Study|Miscellaneous|3|||
49098551|NCT02394340|158196865|FG000|Overall Study|Failed drug screen test|1|||
49098552|NCT02394340|158196865|FG000|Overall Study|Adverse Event|1|||
49098553|NCT01860040|158196866|FG000|Overall Study|Withdrawal by Subject|1|||
49098554|NCT01860040|158196867|FG001|Overall Study|Withdrawal by Subject|0|||
49098555|NCT03315286|158196870|FG000|Overall Study|Lost to Follow-up|0|||
49098556|NCT03315286|158196871|FG001|Overall Study|Lost to Follow-up|3|||
49098557|NCT03315286|158196870|FG000|Overall Study|Withdrawal by Subject|1|||
49098558|NCT03315286|158196871|FG001|Overall Study|Withdrawal by Subject|0|||
49098559|NCT03315286|158196870|FG000|Overall Study|Protocol Violation|0|||
49098560|NCT03315286|158196871|FG001|Overall Study|Protocol Violation|1|||
49098561|NCT02828124|158196872|FG000|Overall Study|Disease Progression|1|||
49098562|NCT02828124|158196873|FG001|Overall Study|Disease Progression|2|||
49098563|NCT02828124|158196874|FG002|Overall Study|Disease Progression|1|||
49098564|NCT02828124|158196875|FG003|Overall Study|Disease Progression|4|||
49098565|NCT02828124|158196872|FG000|Overall Study|AE Unrelated to Study Drug|0|||
49098566|NCT02828124|158196873|FG001|Overall Study|AE Unrelated to Study Drug|0|||
49098567|NCT02828124|158196874|FG002|Overall Study|AE Unrelated to Study Drug|0|||
49098568|NCT02828124|158196875|FG003|Overall Study|AE Unrelated to Study Drug|1|||
49098569|NCT02828124|158196872|FG000|Overall Study|Subject Withdrew Consent|0|||
49098570|NCT02828124|158196873|FG001|Overall Study|Subject Withdrew Consent|0|||
49098571|NCT02828124|158196874|FG002|Overall Study|Subject Withdrew Consent|0|||
49098572|NCT02828124|158196875|FG003|Overall Study|Subject Withdrew Consent|1|||
49098573|NCT00747474|158196876|FG000|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
49098574|NCT00747474|158196877|FG001|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
49098575|NCT00747474|158196878|FG002|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
49098576|NCT00747474|158196879|FG003|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
49098577|NCT00747474|158196880|FG004|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
49098578|NCT00747474|158196881|FG005|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
49098579|NCT00747474|158196882|FG006|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
49098580|NCT00747474|158196883|FG007|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1|||
49098581|NCT00747474|158196884|FG008|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
49098582|NCT00747474|158196885|FG009|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
49098583|NCT00747474|158196886|FG010|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
49098584|NCT00747474|158196887|FG011|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
49098585|NCT02829723|158196896|FG000|Overall Study|Adverse Event|0|||
49098586|NCT02829723|158196897|FG001|Overall Study|Adverse Event|0|||
49098587|NCT02829723|158196898|FG002|Overall Study|Adverse Event|1|||
49098588|NCT02829723|158196899|FG003|Overall Study|Adverse Event|1|||
49098589|NCT02829723|158196900|FG004|Overall Study|Adverse Event|0|||
49098590|NCT02829723|158196901|FG005|Overall Study|Adverse Event|0|||
49098591|NCT02829723|158196902|FG006|Overall Study|Adverse Event|0|||
49098592|NCT02829723|158196903|FG007|Overall Study|Adverse Event|1|||
49098593|NCT02829723|158196904|FG008|Overall Study|Adverse Event|0|||
49098594|NCT02829723|158196905|FG009|Overall Study|Adverse Event|0|||
49098595|NCT02829723|158196906|FG010|Overall Study|Adverse Event|0|||
49098596|NCT02829723|158196907|FG011|Overall Study|Adverse Event|0|||
49098597|NCT02829723|158196908|FG012|Overall Study|Adverse Event|0|||
49098598|NCT02829723|158196909|FG013|Overall Study|Adverse Event|0|||
49098599|NCT02829723|158196910|FG014|Overall Study|Adverse Event|1|||
49098600|NCT02829723|158196911|FG015|Overall Study|Adverse Event|1|||
49098601|NCT02829723|158196912|FG016|Overall Study|Adverse Event|1|||
49098602|NCT02829723|158196913|FG017|Overall Study|Adverse Event|2|||
49098603|NCT02829723|158196914|FG018|Overall Study|Adverse Event|1|||
49098604|NCT02829723|158196915|FG019|Overall Study|Adverse Event|1|||
49098605|NCT02829723|158196916|FG020|Overall Study|Adverse Event|3|||
49098606|NCT02829723|158196917|FG021|Overall Study|Adverse Event|0|||
49098607|NCT02829723|158196918|FG022|Overall Study|Adverse Event|0|||
49098608|NCT02829723|158196919|FG023|Overall Study|Adverse Event|1|||
49098609|NCT02829723|158196920|FG024|Overall Study|Adverse Event|1|||
49098610|NCT02829723|158196921|FG025|Overall Study|Adverse Event|3|||
49098611|NCT02829723|158196922|FG026|Overall Study|Adverse Event|5|||
49098612|NCT02829723|158196896|FG000|Overall Study|Death|1|||
49098613|NCT02829723|158196897|FG001|Overall Study|Death|0|||
49098614|NCT02829723|158196898|FG002|Overall Study|Death|1|||
49098615|NCT02829723|158196899|FG003|Overall Study|Death|1|||
49098616|NCT02829723|158196900|FG004|Overall Study|Death|0|||
49098617|NCT02829723|158196901|FG005|Overall Study|Death|0|||
49098618|NCT02829723|158196902|FG006|Overall Study|Death|2|||
49098619|NCT02829723|158196903|FG007|Overall Study|Death|0|||
49098620|NCT02829723|158196904|FG008|Overall Study|Death|1|||
49098621|NCT02829723|158196905|FG009|Overall Study|Death|0|||
49098622|NCT02829723|158196906|FG010|Overall Study|Death|0|||
49098623|NCT02829723|158196907|FG011|Overall Study|Death|0|||
49098624|NCT02829723|158196908|FG012|Overall Study|Death|2|||
49098625|NCT02829723|158196909|FG013|Overall Study|Death|1|||
49098626|NCT02829723|158196910|FG014|Overall Study|Death|0|||
49098627|NCT02829723|158196911|FG015|Overall Study|Death|0|||
49098628|NCT02829723|158196912|FG016|Overall Study|Death|0|||
49098629|NCT02829723|158196913|FG017|Overall Study|Death|0|||
49098630|NCT02829723|158196914|FG018|Overall Study|Death|0|||
49098631|NCT02829723|158196915|FG019|Overall Study|Death|0|||
49098632|NCT02829723|158196916|FG020|Overall Study|Death|0|||
49098633|NCT02829723|158196917|FG021|Overall Study|Death|2|||
49098634|NCT02829723|158196918|FG022|Overall Study|Death|0|||
49098635|NCT02829723|158196919|FG023|Overall Study|Death|0|||
49098636|NCT02829723|158196920|FG024|Overall Study|Death|0|||
49098637|NCT02829723|158196921|FG025|Overall Study|Death|1|||
49098638|NCT02829723|158196922|FG026|Overall Study|Death|2|||
49098639|NCT02829723|158196896|FG000|Overall Study|Physician Decision|0|||
49098640|NCT02829723|158196897|FG001|Overall Study|Physician Decision|0|||
49098641|NCT02829723|158196898|FG002|Overall Study|Physician Decision|0|||
49098642|NCT02829723|158196899|FG003|Overall Study|Physician Decision|0|||
49098643|NCT02829723|158196900|FG004|Overall Study|Physician Decision|0|||
49098644|NCT02829723|158196901|FG005|Overall Study|Physician Decision|0|||
49098645|NCT02829723|158196902|FG006|Overall Study|Physician Decision|0|||
49098646|NCT02829723|158196903|FG007|Overall Study|Physician Decision|0|||
49098647|NCT02829723|158196904|FG008|Overall Study|Physician Decision|0|||
49098648|NCT02829723|158196905|FG009|Overall Study|Physician Decision|1|||
49098649|NCT02829723|158196906|FG010|Overall Study|Physician Decision|1|||
49098650|NCT02829723|158196907|FG011|Overall Study|Physician Decision|0|||
49098651|NCT02829723|158196908|FG012|Overall Study|Physician Decision|0|||
49098652|NCT02829723|158196909|FG013|Overall Study|Physician Decision|1|||
49098653|NCT02829723|158196910|FG014|Overall Study|Physician Decision|0|||
49098654|NCT02829723|158196911|FG015|Overall Study|Physician Decision|0|||
49098655|NCT02829723|158196912|FG016|Overall Study|Physician Decision|2|||
49098656|NCT02829723|158196913|FG017|Overall Study|Physician Decision|0|||
49098657|NCT02829723|158196914|FG018|Overall Study|Physician Decision|0|||
49098658|NCT02829723|158196915|FG019|Overall Study|Physician Decision|0|||
49098659|NCT02829723|158196916|FG020|Overall Study|Physician Decision|0|||
49098660|NCT02829723|158196917|FG021|Overall Study|Physician Decision|0|||
49098661|NCT02829723|158196918|FG022|Overall Study|Physician Decision|1|||
49098662|NCT02829723|158196919|FG023|Overall Study|Physician Decision|1|||
49098663|NCT02829723|158196920|FG024|Overall Study|Physician Decision|1|||
49098664|NCT02829723|158196921|FG025|Overall Study|Physician Decision|1|||
49098665|NCT02829723|158196922|FG026|Overall Study|Physician Decision|3|||
49098666|NCT02829723|158196896|FG000|Overall Study|Progressive disease|4|||
49098667|NCT02829723|158196897|FG001|Overall Study|Progressive disease|6|||
49098668|NCT02829723|158196898|FG002|Overall Study|Progressive disease|3|||
49098669|NCT02829723|158196899|FG003|Overall Study|Progressive disease|3|||
49098670|NCT02829723|158196900|FG004|Overall Study|Progressive disease|3|||
49098671|NCT02829723|158196901|FG005|Overall Study|Progressive disease|5|||
49098672|NCT02829723|158196902|FG006|Overall Study|Progressive disease|4|||
49098673|NCT02829723|158196903|FG007|Overall Study|Progressive disease|6|||
49098674|NCT02829723|158196904|FG008|Overall Study|Progressive disease|8|||
49098675|NCT02829723|158196905|FG009|Overall Study|Progressive disease|4|||
49098676|NCT02829723|158196906|FG010|Overall Study|Progressive disease|9|||
49098677|NCT02829723|158196907|FG011|Overall Study|Progressive disease|0|||
49098678|NCT02829723|158196908|FG012|Overall Study|Progressive disease|3|||
49098679|NCT02829723|158196909|FG013|Overall Study|Progressive disease|4|||
49098680|NCT02829723|158196910|FG014|Overall Study|Progressive disease|2|||
49098681|NCT02829723|158196911|FG015|Overall Study|Progressive disease|4|||
49098682|NCT02829723|158196912|FG016|Overall Study|Progressive disease|5|||
49098683|NCT02829723|158196913|FG017|Overall Study|Progressive disease|3|||
49098684|NCT02829723|158196914|FG018|Overall Study|Progressive disease|4|||
49098685|NCT02829723|158196915|FG019|Overall Study|Progressive disease|4|||
49098686|NCT02829723|158196916|FG020|Overall Study|Progressive disease|7|||
49098687|NCT02829723|158196917|FG021|Overall Study|Progressive disease|6|||
49098688|NCT02829723|158196918|FG022|Overall Study|Progressive disease|3|||
49098689|NCT02829723|158196919|FG023|Overall Study|Progressive disease|3|||
49098690|NCT02829723|158196920|FG024|Overall Study|Progressive disease|3|||
49098691|NCT02829723|158196921|FG025|Overall Study|Progressive disease|16|||
49098692|NCT02829723|158196922|FG026|Overall Study|Progressive disease|10|||
49098693|NCT02829723|158196896|FG000|Overall Study|Subject/guardian decision|0|||
49098694|NCT02829723|158196897|FG001|Overall Study|Subject/guardian decision|1|||
49098695|NCT02829723|158196898|FG002|Overall Study|Subject/guardian decision|0|||
49098696|NCT02829723|158196899|FG003|Overall Study|Subject/guardian decision|1|||
49098697|NCT02829723|158196900|FG004|Overall Study|Subject/guardian decision|0|||
49098698|NCT02829723|158196901|FG005|Overall Study|Subject/guardian decision|0|||
49098699|NCT02829723|158196902|FG006|Overall Study|Subject/guardian decision|0|||
49098700|NCT02829723|158196903|FG007|Overall Study|Subject/guardian decision|1|||
49098701|NCT02829723|158196904|FG008|Overall Study|Subject/guardian decision|0|||
49098702|NCT02829723|158196905|FG009|Overall Study|Subject/guardian decision|0|||
49098703|NCT02829723|158196906|FG010|Overall Study|Subject/guardian decision|0|||
49098704|NCT02829723|158196907|FG011|Overall Study|Subject/guardian decision|0|||
49098705|NCT02829723|158196908|FG012|Overall Study|Subject/guardian decision|0|||
49098706|NCT02829723|158196909|FG013|Overall Study|Subject/guardian decision|0|||
49098707|NCT02829723|158196910|FG014|Overall Study|Subject/guardian decision|1|||
49098708|NCT02829723|158196911|FG015|Overall Study|Subject/guardian decision|0|||
49098709|NCT02829723|158196912|FG016|Overall Study|Subject/guardian decision|1|||
49098710|NCT02829723|158196913|FG017|Overall Study|Subject/guardian decision|0|||
49098711|NCT02829723|158196914|FG018|Overall Study|Subject/guardian decision|1|||
49098712|NCT02829723|158196915|FG019|Overall Study|Subject/guardian decision|0|||
49098713|NCT02829723|158196916|FG020|Overall Study|Subject/guardian decision|1|||
49098714|NCT02829723|158196917|FG021|Overall Study|Subject/guardian decision|0|||
49098715|NCT02829723|158196918|FG022|Overall Study|Subject/guardian decision|0|||
49098716|NCT02829723|158196919|FG023|Overall Study|Subject/guardian decision|1|||
49098717|NCT02829723|158196920|FG024|Overall Study|Subject/guardian decision|0|||
49098718|NCT02829723|158196921|FG025|Overall Study|Subject/guardian decision|1|||
49098719|NCT02829723|158196922|FG026|Overall Study|Subject/guardian decision|1|||
49098720|NCT02829723|158196896|FG000|Overall Study|Study terminated by sponsor|0|||
49098721|NCT02829723|158196897|FG001|Overall Study|Study terminated by sponsor|0|||
49098722|NCT02829723|158196898|FG002|Overall Study|Study terminated by sponsor|0|||
49098723|NCT02829723|158196899|FG003|Overall Study|Study terminated by sponsor|0|||
49098724|NCT02829723|158196900|FG004|Overall Study|Study terminated by sponsor|0|||
49098725|NCT02829723|158196901|FG005|Overall Study|Study terminated by sponsor|0|||
49098726|NCT02829723|158196902|FG006|Overall Study|Study terminated by sponsor|0|||
49098727|NCT02829723|158196903|FG007|Overall Study|Study terminated by sponsor|0|||
49098728|NCT02829723|158196904|FG008|Overall Study|Study terminated by sponsor|0|||
49098729|NCT02829723|158196905|FG009|Overall Study|Study terminated by sponsor|0|||
49098730|NCT02829723|158196906|FG010|Overall Study|Study terminated by sponsor|0|||
49098731|NCT02829723|158196907|FG011|Overall Study|Study terminated by sponsor|0|||
49098732|NCT02829723|158196908|FG012|Overall Study|Study terminated by sponsor|0|||
49098733|NCT02829723|158196909|FG013|Overall Study|Study terminated by sponsor|0|||
49098734|NCT02829723|158196910|FG014|Overall Study|Study terminated by sponsor|0|||
49098735|NCT02829723|158196911|FG015|Overall Study|Study terminated by sponsor|0|||
49098736|NCT02829723|158196912|FG016|Overall Study|Study terminated by sponsor|0|||
49098737|NCT02829723|158196913|FG017|Overall Study|Study terminated by sponsor|0|||
49098738|NCT02829723|158196914|FG018|Overall Study|Study terminated by sponsor|0|||
49098739|NCT02829723|158196915|FG019|Overall Study|Study terminated by sponsor|0|||
49098740|NCT02829723|158196916|FG020|Overall Study|Study terminated by sponsor|0|||
49098741|NCT02829723|158196917|FG021|Overall Study|Study terminated by sponsor|1|||
49098742|NCT02829723|158196918|FG022|Overall Study|Study terminated by sponsor|0|||
49098743|NCT02829723|158196919|FG023|Overall Study|Study terminated by sponsor|0|||
49098744|NCT02829723|158196920|FG024|Overall Study|Study terminated by sponsor|0|||
49098745|NCT02829723|158196921|FG025|Overall Study|Study terminated by sponsor|0|||
49098746|NCT02829723|158196922|FG026|Overall Study|Study terminated by sponsor|0|||
49098747|NCT01931995|158196923|FG000|First Intervention (1 Day)|Withdrawal by Subject|2|||
49098748|NCT01931995|158196924|FG001|First Intervention (1 Day)|Withdrawal by Subject|2|||
49098749|NCT01931995|158196923|FG000|First Intervention (1 Day)|Physician Decision|1|||
49098750|NCT01931995|158196924|FG001|First Intervention (1 Day)|Physician Decision|1|||
49098751|NCT01931995|158196923|FG000|First Intervention (1 Day)|Lost to Follow-up|1|||
49098752|NCT01931995|158196924|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
49098753|NCT00256854|158196925|FG000|Overall Study|Withdrawal by Subject|2|||
49098754|NCT00256854|158196926|FG001|Overall Study|Withdrawal by Subject|3|||
49098755|NCT00256854|158196927|FG002|Overall Study|Withdrawal by Subject|0|||
49098756|NCT00256854|158196928|FG003|Overall Study|Withdrawal by Subject|0|||
49098757|NCT00256854|158196929|FG004|Overall Study|Withdrawal by Subject|0|||
49098758|NCT00256854|158196930|FG005|Overall Study|Withdrawal by Subject|0|||
49098759|NCT00256854|158196925|FG000|Overall Study|Lack of Efficacy|1|||
49098760|NCT00256854|158196926|FG001|Overall Study|Lack of Efficacy|0|||
49098761|NCT00256854|158196927|FG002|Overall Study|Lack of Efficacy|0|||
49098762|NCT00256854|158196928|FG003|Overall Study|Lack of Efficacy|0|||
49098763|NCT00256854|158196929|FG004|Overall Study|Lack of Efficacy|0|||
49098764|NCT00256854|158196930|FG005|Overall Study|Lack of Efficacy|0|||
49098765|NCT00256854|158196925|FG000|Overall Study|Protocol Violation|0|||
49098766|NCT00256854|158196926|FG001|Overall Study|Protocol Violation|1|||
49098767|NCT00256854|158196927|FG002|Overall Study|Protocol Violation|1|||
49098768|NCT00256854|158196928|FG003|Overall Study|Protocol Violation|1|||
49098769|NCT00256854|158196929|FG004|Overall Study|Protocol Violation|0|||
49098770|NCT00256854|158196930|FG005|Overall Study|Protocol Violation|0|||
49098771|NCT00256854|158196925|FG000|Overall Study|Adverse Event|0|||
49098772|NCT00256854|158196926|FG001|Overall Study|Adverse Event|0|||
49098773|NCT00256854|158196927|FG002|Overall Study|Adverse Event|2|||
49098774|NCT00256854|158196928|FG003|Overall Study|Adverse Event|2|||
49098775|NCT00256854|158196929|FG004|Overall Study|Adverse Event|0|||
49098776|NCT00256854|158196930|FG005|Overall Study|Adverse Event|1|||
49098777|NCT00256854|158196925|FG000|Overall Study|Not compliant with the study drug|0|||
49098778|NCT00256854|158196926|FG001|Overall Study|Not compliant with the study drug|0|||
49098779|NCT00256854|158196927|FG002|Overall Study|Not compliant with the study drug|0|||
49098780|NCT00256854|158196928|FG003|Overall Study|Not compliant with the study drug|0|||
49098781|NCT00256854|158196929|FG004|Overall Study|Not compliant with the study drug|1|||
49098782|NCT00256854|158196930|FG005|Overall Study|Not compliant with the study drug|0|||
49098783|NCT02353442|158196931|FG000|Overall Study|Withdrawal by Subject|3|||
49098784|NCT02353442|158196932|FG001|Overall Study|Withdrawal by Subject|4|||
49098785|NCT06586788|158196933|FG000|Overall Study|Eye-tracking calibration / validation could not be completed with eight children|8|||
49098786|NCT03990571|158196934|FG000|Overall Study|Withdrawal by Subject|1|||
49098787|NCT03990571|158196934|FG000|Overall Study|Insurance Issues|3|||
49098788|NCT03990571|158196934|FG000|Overall Study|Covid Restrictions|2|||
49098789|NCT03514485|158196935|FG000|Overall Study|Lost to Follow-up|5|||
49098790|NCT03514485|158196936|FG001|Overall Study|Lost to Follow-up|3|||
49098791|NCT03514485|158196937|FG002|Overall Study|Lost to Follow-up|2|||
49098792|NCT03514485|158196938|FG003|Overall Study|Lost to Follow-up|0|||
49098793|NCT03514485|158196939|FG004|Overall Study|Lost to Follow-up|1|||
49098794|NCT03514485|158196940|FG005|Overall Study|Lost to Follow-up|4|||
49098795|NCT03514485|158196935|FG000|Overall Study|Withdrawal by Subject|0|||
49098796|NCT03514485|158196936|FG001|Overall Study|Withdrawal by Subject|1|||
49098797|NCT03514485|158196937|FG002|Overall Study|Withdrawal by Subject|3|||
49098798|NCT03514485|158196938|FG003|Overall Study|Withdrawal by Subject|1|||
49098799|NCT03514485|158196939|FG004|Overall Study|Withdrawal by Subject|2|||
49098800|NCT03514485|158196940|FG005|Overall Study|Withdrawal by Subject|1|||
49098801|NCT02553499|158196942|FG000|Overall Study|Adverse Event|0|||
49098802|NCT02553499|158196943|FG001|Overall Study|Adverse Event|0|||
49098803|NCT02553499|158196944|FG002|Overall Study|Adverse Event|0|||
49098804|NCT02553499|158196945|FG003|Overall Study|Adverse Event|0|||
49098805|NCT02553499|158196946|FG004|Overall Study|Adverse Event|0|||
49098806|NCT02553499|158196947|FG005|Overall Study|Adverse Event|0|||
49098807|NCT02553499|158196948|FG006|Overall Study|Adverse Event|1|||
49098808|NCT02553499|158196949|FG007|Overall Study|Adverse Event|1|||
49098809|NCT02553499|158196950|FG008|Overall Study|Adverse Event|0|||
49098810|NCT02553499|158196951|FG009|Overall Study|Adverse Event|0|||
49098811|NCT02553499|158196952|FG010|Overall Study|Adverse Event|0|||
49098812|NCT02553499|158196953|FG011|Overall Study|Adverse Event|0|||
49098813|NCT02553499|158196954|FG012|Overall Study|Adverse Event|0|||
49098814|NCT02553499|158196955|FG013|Overall Study|Adverse Event|1|||
49098815|NCT02553499|158196942|FG000|Overall Study|Death|0|||
49098816|NCT02553499|158196943|FG001|Overall Study|Death|1|||
49098817|NCT02553499|158196944|FG002|Overall Study|Death|1|||
49098818|NCT02553499|158196945|FG003|Overall Study|Death|0|||
49098819|NCT02553499|158196946|FG004|Overall Study|Death|1|||
49098820|NCT02553499|158196947|FG005|Overall Study|Death|2|||
49098821|NCT02553499|158196948|FG006|Overall Study|Death|0|||
49098822|NCT02553499|158196949|FG007|Overall Study|Death|0|||
49098823|NCT02553499|158196950|FG008|Overall Study|Death|0|||
49098824|NCT02553499|158196951|FG009|Overall Study|Death|0|||
49098825|NCT02553499|158196952|FG010|Overall Study|Death|1|||
49098826|NCT02553499|158196953|FG011|Overall Study|Death|0|||
49098827|NCT02553499|158196954|FG012|Overall Study|Death|0|||
49098828|NCT02553499|158196955|FG013|Overall Study|Death|0|||
49098829|NCT02553499|158196942|FG000|Overall Study|Lost to Follow-up|0|||
49098830|NCT02553499|158196943|FG001|Overall Study|Lost to Follow-up|0|||
49098831|NCT02553499|158196944|FG002|Overall Study|Lost to Follow-up|0|||
49098832|NCT02553499|158196945|FG003|Overall Study|Lost to Follow-up|0|||
49098833|NCT02553499|158196946|FG004|Overall Study|Lost to Follow-up|0|||
49098834|NCT02553499|158196947|FG005|Overall Study|Lost to Follow-up|0|||
49098835|NCT02553499|158196948|FG006|Overall Study|Lost to Follow-up|1|||
49098836|NCT02553499|158196949|FG007|Overall Study|Lost to Follow-up|0|||
49098837|NCT02553499|158196950|FG008|Overall Study|Lost to Follow-up|0|||
49098838|NCT02553499|158196951|FG009|Overall Study|Lost to Follow-up|0|||
49098839|NCT02553499|158196952|FG010|Overall Study|Lost to Follow-up|0|||
49098840|NCT02553499|158196953|FG011|Overall Study|Lost to Follow-up|0|||
49098841|NCT02553499|158196954|FG012|Overall Study|Lost to Follow-up|0|||
49098842|NCT02553499|158196955|FG013|Overall Study|Lost to Follow-up|0|||
49098843|NCT02553499|158196942|FG000|Overall Study|Physician Decision|0|||
49098844|NCT02553499|158196943|FG001|Overall Study|Physician Decision|1|||
49098845|NCT02553499|158196944|FG002|Overall Study|Physician Decision|1|||
49098846|NCT02553499|158196945|FG003|Overall Study|Physician Decision|0|||
49098847|NCT02553499|158196946|FG004|Overall Study|Physician Decision|1|||
49098848|NCT02553499|158196947|FG005|Overall Study|Physician Decision|0|||
49098849|NCT02553499|158196948|FG006|Overall Study|Physician Decision|0|||
49098850|NCT02553499|158196949|FG007|Overall Study|Physician Decision|1|||
49098851|NCT02553499|158196950|FG008|Overall Study|Physician Decision|1|||
49098852|NCT02553499|158196951|FG009|Overall Study|Physician Decision|2|||
49098853|NCT02553499|158196952|FG010|Overall Study|Physician Decision|1|||
49098854|NCT02553499|158196953|FG011|Overall Study|Physician Decision|3|||
49098855|NCT02553499|158196954|FG012|Overall Study|Physician Decision|1|||
49098856|NCT02553499|158196955|FG013|Overall Study|Physician Decision|0|||
49098857|NCT02553499|158196942|FG000|Overall Study|Progressive Disease|0|||
49098858|NCT02553499|158196943|FG001|Overall Study|Progressive Disease|0|||
49098859|NCT02553499|158196944|FG002|Overall Study|Progressive Disease|0|||
49098860|NCT02553499|158196945|FG003|Overall Study|Progressive Disease|2|||
49098861|NCT02553499|158196946|FG004|Overall Study|Progressive Disease|1|||
49098862|NCT02553499|158196947|FG005|Overall Study|Progressive Disease|1|||
49098863|NCT02553499|158196948|FG006|Overall Study|Progressive Disease|1|||
49098864|NCT02553499|158196949|FG007|Overall Study|Progressive Disease|0|||
49098865|NCT02553499|158196950|FG008|Overall Study|Progressive Disease|0|||
49098866|NCT02553499|158196951|FG009|Overall Study|Progressive Disease|1|||
49098867|NCT02553499|158196952|FG010|Overall Study|Progressive Disease|0|||
49098868|NCT02553499|158196953|FG011|Overall Study|Progressive Disease|0|||
49098869|NCT02553499|158196954|FG012|Overall Study|Progressive Disease|2|||
49098870|NCT02553499|158196955|FG013|Overall Study|Progressive Disease|1|||
49098871|NCT02553499|158196942|FG000|Overall Study|Study Terminated by Sponsor|0|||
49098872|NCT02553499|158196943|FG001|Overall Study|Study Terminated by Sponsor|0|||
49098873|NCT02553499|158196944|FG002|Overall Study|Study Terminated by Sponsor|0|||
49098874|NCT02553499|158196945|FG003|Overall Study|Study Terminated by Sponsor|0|||
49098875|NCT02553499|158196946|FG004|Overall Study|Study Terminated by Sponsor|0|||
49098876|NCT02553499|158196947|FG005|Overall Study|Study Terminated by Sponsor|0|||
49098877|NCT02553499|158196948|FG006|Overall Study|Study Terminated by Sponsor|0|||
49098878|NCT02553499|158196949|FG007|Overall Study|Study Terminated by Sponsor|0|||
49098879|NCT02553499|158196950|FG008|Overall Study|Study Terminated by Sponsor|1|||
49098880|NCT02553499|158196951|FG009|Overall Study|Study Terminated by Sponsor|0|||
49098881|NCT02553499|158196952|FG010|Overall Study|Study Terminated by Sponsor|0|||
49098882|NCT02553499|158196953|FG011|Overall Study|Study Terminated by Sponsor|0|||
49098883|NCT02553499|158196954|FG012|Overall Study|Study Terminated by Sponsor|0|||
49098884|NCT02553499|158196955|FG013|Overall Study|Study Terminated by Sponsor|0|||
49098885|NCT02553499|158196942|FG000|Overall Study|Withdrawal by Subject|2|||
49098886|NCT02553499|158196943|FG001|Overall Study|Withdrawal by Subject|0|||
49098887|NCT02553499|158196944|FG002|Overall Study|Withdrawal by Subject|0|||
49098888|NCT02553499|158196945|FG003|Overall Study|Withdrawal by Subject|0|||
49098889|NCT02553499|158196946|FG004|Overall Study|Withdrawal by Subject|0|||
49098890|NCT02553499|158196947|FG005|Overall Study|Withdrawal by Subject|0|||
49098891|NCT02553499|158196948|FG006|Overall Study|Withdrawal by Subject|0|||
49098892|NCT02553499|158196949|FG007|Overall Study|Withdrawal by Subject|1|||
49098893|NCT02553499|158196950|FG008|Overall Study|Withdrawal by Subject|1|||
49098894|NCT02553499|158196951|FG009|Overall Study|Withdrawal by Subject|0|||
49098895|NCT02553499|158196952|FG010|Overall Study|Withdrawal by Subject|1|||
49098896|NCT02553499|158196953|FG011|Overall Study|Withdrawal by Subject|0|||
49098897|NCT02553499|158196954|FG012|Overall Study|Withdrawal by Subject|0|||
49098898|NCT02553499|158196955|FG013|Overall Study|Withdrawal by Subject|0|||
49098899|NCT00890084|158196956|FG000|Overall Study|Adverse Event|16|||
49098900|NCT00890084|158196956|FG000|Overall Study|Lost to Follow-up|126|||
49098901|NCT01438294|158196957|FG000|Overall Study|Lost to Follow-up|3|||
49098902|NCT01438294|158196958|FG001|Overall Study|Lost to Follow-up|7|||
49098903|NCT01880086|158196959|FG000|Overall Study|Lost to Follow-up|1|||
49098904|NCT01880086|158196960|FG001|Overall Study|Lost to Follow-up|1|||
49098905|NCT03919695|158196961|FG000|3-month Follow-up|Death|1|||
49098906|NCT03919695|158196962|FG001|3-month Follow-up|Death|1|||
49098907|NCT03919695|158196961|FG000|3-month Follow-up|unable to contact|0|||
49098908|NCT03919695|158196962|FG001|3-month Follow-up|unable to contact|3|||
49098909|NCT03919695|158196961|FG000|3-month Follow-up|in prison|0|||
49098910|NCT03919695|158196962|FG001|3-month Follow-up|in prison|1|||
49098911|NCT03919695|158196961|FG000|6-month Follow-up|Death|0|||
49098912|NCT03919695|158196962|FG001|6-month Follow-up|Death|1|||
49098913|NCT03919695|158196961|FG000|6-month Follow-up|Lost to Follow-up|1|||
49098914|NCT03919695|158196962|FG001|6-month Follow-up|Lost to Follow-up|2|||
49098915|NCT03919695|158196961|FG000|6-month Follow-up|in prison|0|||
49098916|NCT03919695|158196962|FG001|6-month Follow-up|in prison|2|||
49098917|NCT03919695|158196961|FG000|Any Follow-up (3 and/or 6 Month)|Death|1|||
49098918|NCT03919695|158196962|FG001|Any Follow-up (3 and/or 6 Month)|Death|1|||
49098919|NCT03919695|158196961|FG000|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|0|||
49098920|NCT03919695|158196962|FG001|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|2|||
49098921|NCT03301844|158196963|FG000|Overall Study|suspected colon cancer|1|||
49098922|NCT03301844|158196964|FG001|Overall Study|suspected colon cancer|1|||
49098923|NCT04021121|158196972|FG000|Overall Study|Death|3|||
49098924|NCT04021121|158196973|FG001|Overall Study|Death|3|||
49098925|NCT04021121|158196974|FG002|Overall Study|Death|5|||
49098926|NCT04021121|158196975|FG003|Overall Study|Death|4|||
49098927|NCT02288091|158196977|FG000|Overall Study|Lost to Follow-up|1|||
49098928|NCT02288091|158196977|FG000|Overall Study|Screen fail|7|||
49098929|NCT03429244|158196978|FG000|Overall Study|Withdrawal by Subject|2|||
49098930|NCT03429244|158196979|FG001|Overall Study|Withdrawal by Subject|1|||
49098931|NCT03429244|158196980|FG002|Overall Study|Withdrawal by Subject|1|||
49098932|NCT00656851|158196985|FG000|Overall Study|Withdrawal by Subject|0|||
49098933|NCT00656851|158196986|FG001|Overall Study|Withdrawal by Subject|4|||
49098934|NCT01343277|158196988|FG000|Overall Study|Other|3|||
49098935|NCT01343277|158196989|FG001|Overall Study|Other|3|||
49098936|NCT01343277|158196988|FG000|Overall Study|Withdrawal by Subject|18|||
49098937|NCT01343277|158196989|FG001|Overall Study|Withdrawal by Subject|13|||
49098938|NCT01343277|158196988|FG000|Overall Study|Physician Decision|1|||
49098939|NCT01343277|158196989|FG001|Overall Study|Physician Decision|2|||
49098940|NCT01343277|158196988|FG000|Overall Study|Death|10|||
49098941|NCT01343277|158196989|FG001|Overall Study|Death|1|||
49098942|NCT01343277|158196988|FG000|Overall Study|Adverse Event|67|||
49098943|NCT01343277|158196989|FG001|Overall Study|Adverse Event|13|||
49098944|NCT01343277|158196988|FG000|Overall Study|Disease progression|270|||
49098945|NCT01343277|158196989|FG001|Overall Study|Disease progression|138|||
49098946|NCT01343277|158196988|FG000|Overall Study|Randomized not treated|6|||
49098947|NCT01343277|158196989|FG001|Overall Study|Randomized not treated|21|||
49098948|NCT01343277|158196988|FG000|Overall Study|Treatment ongoing|8|||
49098949|NCT01343277|158196989|FG001|Overall Study|Treatment ongoing|2|||
49098950|NCT01343277|158196988|FG000|Overall Study|Subsequent anticancer therapy|1|||
49098951|NCT01343277|158196989|FG001|Overall Study|Subsequent anticancer therapy|0|||
49098952|NCT05033262|158196992|FG000|Overall Study|Lost to Follow-up|1|||
49098953|NCT05033262|158196993|FG001|Overall Study|Lost to Follow-up|0|||
49098954|NCT05033262|158196994|FG002|Overall Study|Lost to Follow-up|0|||
49098955|NCT05033262|158196995|FG003|Overall Study|Lost to Follow-up|1|||
49098956|NCT01273623|158197002|FG000|Overall Study|did not meet IVUS criteria|29|||
49098957|NCT01493284|158197005|FG000|Overall Study|Death|29|||
49098958|NCT01493284|158197005|FG000|Overall Study|Withdrawal by Subject|32|||
49098959|NCT01931956|158197006|FG000|Overall Study|Death|42|||
49098960|NCT01931956|158197007|FG001|Overall Study|Death|7|||
49098961|NCT01931956|158197008|FG002|Overall Study|Death|379|||
49098962|NCT01931956|158197009|FG003|Overall Study|Death|96|||
49098963|NCT01931956|158197006|FG000|Overall Study|Withdrawal by Subject|5|||
49098964|NCT01931956|158197007|FG001|Overall Study|Withdrawal by Subject|0|||
49098965|NCT01931956|158197008|FG002|Overall Study|Withdrawal by Subject|70|||
49098966|NCT01931956|158197009|FG003|Overall Study|Withdrawal by Subject|30|||
49098967|NCT01931956|158197006|FG000|Overall Study|Lost to Follow-up|2|||
49098968|NCT01931956|158197007|FG001|Overall Study|Lost to Follow-up|0|||
49098969|NCT01931956|158197008|FG002|Overall Study|Lost to Follow-up|11|||
49098970|NCT01931956|158197009|FG003|Overall Study|Lost to Follow-up|7|||
49098971|NCT01931956|158197006|FG000|Overall Study|Expected|2|||
49098972|NCT01931956|158197007|FG001|Overall Study|Expected|0|||
49098973|NCT01931956|158197008|FG002|Overall Study|Expected|6|||
49098974|NCT01931956|158197009|FG003|Overall Study|Expected|0|||
49098975|NCT01931956|158197006|FG000|Overall Study|Not due|0|||
49098976|NCT01931956|158197007|FG001|Overall Study|Not due|0|||
49098977|NCT01931956|158197008|FG002|Overall Study|Not due|21|||
49098978|NCT01931956|158197009|FG003|Overall Study|Not due|0|||
49098979|NCT04064411|158197010|FG000|Overall Study|Adverse Event|29|||
49098980|NCT04064411|158197011|FG001|Overall Study|Adverse Event|19|||
49098981|NCT04064411|158197010|FG000|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|0|||
49098982|NCT04064411|158197011|FG001|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|2|||
49098983|NCT04064411|158197010|FG000|Overall Study|Protocol Deviation|0|||
49098984|NCT04064411|158197011|FG001|Overall Study|Protocol Deviation|2|||
49099074|NCT01953601|158198742|FG002|Part 2 (Extension Study)|Adverse Event|10|||
49099075|NCT01953601|158198740|FG000|Part 2 (Extension Study)|Death|0|||
49099076|NCT01953601|158198741|FG001|Part 2 (Extension Study)|Death|3|||
49099077|NCT01953601|158198742|FG002|Part 2 (Extension Study)|Death|0|||
49099078|NCT01953601|158198740|FG000|Part 2 (Extension Study)|Lack of Efficacy|2|||
49099079|NCT01953601|158198741|FG001|Part 2 (Extension Study)|Lack of Efficacy|0|||
49099080|NCT01953601|158198742|FG002|Part 2 (Extension Study)|Lack of Efficacy|0|||
49099081|NCT01953601|158198740|FG000|Part 2 (Extension Study)|Lost to Follow-up|2|||
49099082|NCT01953601|158198741|FG001|Part 2 (Extension Study)|Lost to Follow-up|1|||
49099083|NCT01953601|158198742|FG002|Part 2 (Extension Study)|Lost to Follow-up|1|||
49099084|NCT01953601|158198740|FG000|Part 2 (Extension Study)|Physician Decision|2|||
49099085|NCT01953601|158198741|FG001|Part 2 (Extension Study)|Physician Decision|0|||
49099086|NCT01953601|158198742|FG002|Part 2 (Extension Study)|Physician Decision|2|||
49099087|NCT01953601|158198740|FG000|Part 2 (Extension Study)|Site discontinued study participation|0|||
49099088|NCT01953601|158198741|FG001|Part 2 (Extension Study)|Site discontinued study participation|1|||
49099089|NCT01953601|158198742|FG002|Part 2 (Extension Study)|Site discontinued study participation|1|||
49099090|NCT01953601|158198740|FG000|Part 2 (Extension Study)|Study terminated by sponsor|185|||
49099091|NCT01953601|158198741|FG001|Part 2 (Extension Study)|Study terminated by sponsor|178|||
49099092|NCT01953601|158198742|FG002|Part 2 (Extension Study)|Study terminated by sponsor|187|||
49099093|NCT01953601|158198740|FG000|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1|||
49099094|NCT01953601|158198741|FG001|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3|||
49099095|NCT01953601|158198742|FG002|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0|||
49099096|NCT01953601|158198740|FG000|Part 2 (Extension Study)|Subject moved|0|||
49099097|NCT01953601|158198741|FG001|Part 2 (Extension Study)|Subject moved|0|||
49099098|NCT01953601|158198742|FG002|Part 2 (Extension Study)|Subject moved|1|||
49099099|NCT01953601|158198740|FG000|Part 2 (Extension Study)|Withdrawal by Subject|5|||
49099100|NCT01953601|158198741|FG001|Part 2 (Extension Study)|Withdrawal by Subject|4|||
49099101|NCT01953601|158198742|FG002|Part 2 (Extension Study)|Withdrawal by Subject|2|||
49099102|NCT01154296|158198743|FG000|Randomization and Intervention|Decided to decline|1|||
49099103|NCT01154296|158198744|FG001|Randomization and Intervention|Decided to decline|1|||
49099104|NCT01154296|158198743|FG000|Randomization and Intervention|Declined by staff|1|||
49099105|NCT01154296|158198744|FG001|Randomization and Intervention|Declined by staff|0|||
49099106|NCT01154296|158198743|FG000|Randomization and Intervention|Did not return|1|||
49099107|NCT01154296|158198744|FG001|Randomization and Intervention|Did not return|0|||
49099108|NCT01154296|158198743|FG000|Randomization and Intervention|Left before test|0|||
49099109|NCT01154296|158198744|FG001|Randomization and Intervention|Left before test|1|||
49099110|NCT01154296|158198743|FG000|Randomization and Intervention|Left clinic early|2|||
49099111|NCT01154296|158198744|FG001|Randomization and Intervention|Left clinic early|0|||
49099112|NCT01154296|158198743|FG000|6-month Follow-up|Lost contact|269|||
49099113|NCT01154296|158198744|FG001|6-month Follow-up|Lost contact|275|||
49099114|NCT01154296|158198743|FG000|6-month Follow-up|Incarcerated|37|||
49099115|NCT01154296|158198744|FG001|6-month Follow-up|Incarcerated|32|||
49099116|NCT01154296|158198743|FG000|6-month Follow-up|Withdrew consent|14|||
49099117|NCT01154296|158198744|FG001|6-month Follow-up|Withdrew consent|15|||
49099118|NCT01154296|158198743|FG000|6-month Follow-up|Death|3|||
49099119|NCT01154296|158198744|FG001|6-month Follow-up|Death|2|||
49099120|NCT01154296|158198743|FG000|6-month Follow-up|Declined by Study Coordinator|5|||
49099121|NCT01154296|158198744|FG001|6-month Follow-up|Declined by Study Coordinator|4|||
49099122|NCT01905553|158198748|FG000|Period 2|Adverse Event|1|||
49099123|NCT01905553|158198749|FG001|Period 2|Adverse Event|0|||
49099124|NCT04310397|158198750|FG000|Overall Study|Lack of Efficacy|3|||
49099125|NCT04310397|158198750|FG000|Overall Study|Withdrawal by Subject|1|||
49099126|NCT02989649|158198752|FG000|Overall Study|Patient/Investigator's Decision to Stop|403|||
49099127|NCT02989649|158198752|FG000|Overall Study|Adverse Event/Adverse Drug Reaction|1|||
49099128|NCT02989649|158198752|FG000|Overall Study|Lost For Observation During Study|3|||
49099129|NCT02989649|158198752|FG000|Overall Study|Reason Not Specified|13|||
49099130|NCT00330343|158198753|FG000|Overall Study|Lost to Follow-up|5|||
49099131|NCT04507256|158198754|FG000|Overall Study|Withdrawal by Subject|1|||
49099132|NCT04507256|158198755|FG001|Overall Study|Withdrawal by Subject|0|||
49099133|NCT04507256|158198756|FG002|Overall Study|Withdrawal by Subject|0|||
49099134|NCT04507256|158198757|FG003|Overall Study|Withdrawal by Subject|1|||
49099135|NCT04507256|158198758|FG004|Overall Study|Withdrawal by Subject|0|||
49099136|NCT04507256|158198759|FG005|Overall Study|Withdrawal by Subject|0|||
49099137|NCT02111785|158198760|FG000|Overall Study|Death|0|||
49099138|NCT02111785|158198761|FG001|Overall Study|Death|1|||
49099139|NCT02111785|158198762|FG002|Overall Study|Death|0|||
49099140|NCT02111785|158198763|FG003|Overall Study|Death|0|||
49099141|NCT00631410|158198764|FG000|Overall Study|Adverse Event|1|||
49099142|NCT00631410|158198765|FG001|Overall Study|Adverse Event|3|||
49099143|NCT00631410|158198764|FG000|Overall Study|Objective Progression or Relapse|4|||
49099144|NCT00631410|158198765|FG001|Overall Study|Objective Progression or Relapse|3|||
49099145|NCT00631410|158198764|FG000|Overall Study|Surgery|1|||
49099146|NCT00631410|158198765|FG001|Overall Study|Surgery|0|||
49099147|NCT00782184|158198778|FG000|Overall Study|Adverse Event|1|||
49099148|NCT00782184|158198779|FG001|Overall Study|Adverse Event|2|||
49099149|NCT00782184|158198778|FG000|Overall Study|Protocol Violation|0|||
49099150|NCT00782184|158198779|FG001|Overall Study|Protocol Violation|1|||
49099151|NCT00782184|158198778|FG000|Overall Study|Withdrawal by Subject|3|||
49099152|NCT00782184|158198779|FG001|Overall Study|Withdrawal by Subject|2|||
49099153|NCT03973918|158198786|FG000|Overall Study|Adverse Event|0|||
49099154|NCT03973918|158198787|FG001|Overall Study|Adverse Event|0|||
49099155|NCT03973918|158198788|FG002|Overall Study|Adverse Event|0|||
49099156|NCT03973918|158198789|FG003|Overall Study|Adverse Event|1|||
49099157|NCT03973918|158198786|FG000|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
49099158|NCT03973918|158198787|FG001|Overall Study|pt had to stop treatment on this study but continued treatment off this study|1|||
49099159|NCT03973918|158198788|FG002|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
49099160|NCT03973918|158198789|FG003|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
49099161|NCT00978250|158198790|FG000|Overall Study|Late determination of ineligibility|0|||
49099162|NCT00978250|158198791|FG001|Overall Study|Late determination of ineligibility|1|||
49099163|NCT00978250|158198792|FG002|Overall Study|Late determination of ineligibility|0|||
49099164|NCT00978250|158198793|FG003|Overall Study|Late determination of ineligibility|1|||
49099165|NCT01992653|158198797|FG000|Overall Study|Death|0|||
49099166|NCT01992653|158198798|FG001|Overall Study|Death|0|||
49099167|NCT01992653|158198799|FG002|Overall Study|Death|1|||
49099168|NCT01992653|158198800|FG003|Overall Study|Death|0|||
49099169|NCT01992653|158198801|FG004|Overall Study|Death|1|||
49099170|NCT01992653|158198802|FG005|Overall Study|Death|0|||
49099171|NCT01992653|158198803|FG006|Overall Study|Death|4|||
49099172|NCT01992653|158198804|FG007|Overall Study|Death|2|||
49099173|NCT01992653|158198797|FG000|Overall Study|Lost to Follow-up|0|||
49099174|NCT01992653|158198798|FG001|Overall Study|Lost to Follow-up|0|||
49099175|NCT01992653|158198799|FG002|Overall Study|Lost to Follow-up|0|||
49099176|NCT01992653|158198800|FG003|Overall Study|Lost to Follow-up|0|||
49099177|NCT01992653|158198801|FG004|Overall Study|Lost to Follow-up|0|||
49099178|NCT01992653|158198802|FG005|Overall Study|Lost to Follow-up|0|||
49099179|NCT01992653|158198803|FG006|Overall Study|Lost to Follow-up|0|||
49099180|NCT01992653|158198804|FG007|Overall Study|Lost to Follow-up|1|||
49099181|NCT01992653|158198797|FG000|Overall Study|Study Completed|0|||
49099182|NCT01992653|158198798|FG001|Overall Study|Study Completed|0|||
49099183|NCT01992653|158198799|FG002|Overall Study|Study Completed|0|||
49099184|NCT01992653|158198800|FG003|Overall Study|Study Completed|0|||
49099185|NCT01992653|158198801|FG004|Overall Study|Study Completed|0|||
49099186|NCT01992653|158198802|FG005|Overall Study|Study Completed|0|||
49099187|NCT01992653|158198803|FG006|Overall Study|Study Completed|0|||
49099188|NCT01992653|158198804|FG007|Overall Study|Study Completed|1|||
49099189|NCT01992653|158198797|FG000|Overall Study|Disease Progression|0|||
49099190|NCT01992653|158198798|FG001|Overall Study|Disease Progression|0|||
49099191|NCT01992653|158198799|FG002|Overall Study|Disease Progression|0|||
49099192|NCT01992653|158198800|FG003|Overall Study|Disease Progression|0|||
49099193|NCT01992653|158198801|FG004|Overall Study|Disease Progression|0|||
49099194|NCT01992653|158198802|FG005|Overall Study|Disease Progression|0|||
49099195|NCT01992653|158198803|FG006|Overall Study|Disease Progression|4|||
49099196|NCT01992653|158198804|FG007|Overall Study|Disease Progression|0|||
49099197|NCT00325156|158198811|FG000|Overall Study|Protocol Violation|8|||
49099198|NCT00325156|158198811|FG000|Overall Study|Lost to follow-up (complete vaccination)|41|||
49099199|NCT00325156|158198811|FG000|Overall Study|Migrated/moved from study area|12|||
49099200|NCT00325156|158198811|FG000|Overall Study|Adverse event, non-fatal|3|||
49099201|NCT00325156|158198811|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|16|||
49099202|NCT00325156|158198811|FG000|Overall Study|Other|1|||
49099203|NCT00325156|158198811|FG000|Overall Study|Withdrawal by Subject|31|||
49099204|NCT03489707|158198812|FG000|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|13|||
49099205|NCT03489707|158198813|FG001|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|31|||
49099206|NCT03489707|158198812|FG000|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|42|||
49099207|NCT03489707|158198813|FG001|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|57|||
49099208|NCT00519428|158198814|FG000|Overall Study|Adverse Event|5|||
49099209|NCT00519428|158198815|FG001|Overall Study|Adverse Event|2|||
49099210|NCT00519428|158198816|FG002|Overall Study|Adverse Event|10|||
49099211|NCT00519428|158198814|FG000|Overall Study|Lost to Follow-up|7|||
49099212|NCT00519428|158198815|FG001|Overall Study|Lost to Follow-up|7|||
49099213|NCT00519428|158198816|FG002|Overall Study|Lost to Follow-up|6|||
49099214|NCT00519428|158198814|FG000|Overall Study|Withdrawal by Subject|8|||
49099215|NCT00519428|158198815|FG001|Overall Study|Withdrawal by Subject|3|||
49099216|NCT00519428|158198816|FG002|Overall Study|Withdrawal by Subject|7|||
49099217|NCT00519428|158198814|FG000|Overall Study|unstated|1|||
49099218|NCT00519428|158198815|FG001|Overall Study|unstated|3|||
49099219|NCT00519428|158198816|FG002|Overall Study|unstated|2|||
49099220|NCT03814720|158198817|FG000|Overall Study|Lost to Follow-up|0|||
49099221|NCT03814720|158198818|FG001|Overall Study|Lost to Follow-up|1|||
49099222|NCT03814720|158198819|FG002|Overall Study|Lost to Follow-up|0|||
49099223|NCT03814720|158198820|FG003|Overall Study|Lost to Follow-up|0|||
49099224|NCT03814720|158198821|FG004|Overall Study|Lost to Follow-up|0|||
49099225|NCT02091986|158198822|FG000|Overall Study|7 rand in error 1 patient decision|2|||
49099226|NCT02091986|158198823|FG001|Overall Study|7 rand in error 1 patient decision|3|||
49099227|NCT02091986|158198824|FG002|Overall Study|7 rand in error 1 patient decision|3|||
49099228|NCT02091986|158198822|FG000|Overall Study|Lost to Follow-up|1|||
49099229|NCT02091986|158198823|FG001|Overall Study|Lost to Follow-up|0|||
49099230|NCT02091986|158198824|FG002|Overall Study|Lost to Follow-up|0|||
49099231|NCT02091986|158198822|FG000|Overall Study|Withdrawal by Subject|4|||
49099232|NCT02091986|158198823|FG001|Overall Study|Withdrawal by Subject|8|||
49099233|NCT02091986|158198824|FG002|Overall Study|Withdrawal by Subject|3|||
49099234|NCT02091986|158198822|FG000|Overall Study|Adverse Event|0|||
49099235|NCT02091986|158198823|FG001|Overall Study|Adverse Event|0|||
49099236|NCT02091986|158198824|FG002|Overall Study|Adverse Event|2|||
49099237|NCT03626363|158198825|FG000|Overall Study|Protocol Violation|4|||
49099238|NCT03626363|158198826|FG001|Overall Study|Protocol Violation|0|||
49099239|NCT03626363|158198825|FG000|Overall Study|Lost to Follow-up|5|||
49099240|NCT03626363|158198826|FG001|Overall Study|Lost to Follow-up|7|||
49099242|NCT02278120|158198840|FG000|Treatment Period|Progressive disease|234|||
49099243|NCT02278120|158198841|FG001|Treatment Period|Progressive disease|260|||
49099244|NCT02278120|158198840|FG000|Treatment Period|Subject/guardian decision|23|||
49099245|NCT02278120|158198841|FG001|Treatment Period|Subject/guardian decision|20|||
49099246|NCT02278120|158198840|FG000|Treatment Period|Adverse Event|16|||
49099247|NCT02278120|158198841|FG001|Treatment Period|Adverse Event|14|||
49099248|NCT02278120|158198840|FG000|Treatment Period|Physician Decision|14|||
49099249|NCT02278120|158198841|FG001|Treatment Period|Physician Decision|27|||
49099250|NCT02278120|158198840|FG000|Treatment Period|Death|3|||
49099251|NCT02278120|158198841|FG001|Treatment Period|Death|3|||
49099252|NCT02278120|158198840|FG000|Treatment Period|Lost to Follow-up|2|||
49099253|NCT02278120|158198841|FG001|Treatment Period|Lost to Follow-up|0|||
49099254|NCT02278120|158198840|FG000|Treatment Period|Protocol deviation|0|||
49099255|NCT02278120|158198841|FG001|Treatment Period|Protocol deviation|2|||
49099256|NCT02278120|158198840|FG000|Treatment Period|Study terminated as per protocol|43|||
49099257|NCT02278120|158198841|FG001|Treatment Period|Study terminated as per protocol|11|||
49099258|NCT02278120|158198840|FG000|Post-treatment Efficacy Follow-up|Death|0|||
49099259|NCT02278120|158198841|FG001|Post-treatment Efficacy Follow-up|Death|1|||
49099260|NCT02278120|158198840|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
49099261|NCT02278120|158198841|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
49099262|NCT02278120|158198840|FG000|Post-treatment Efficacy Follow-up|Study terminated as per protocol|8|||
49099263|NCT02278120|158198841|FG001|Post-treatment Efficacy Follow-up|Study terminated as per protocol|3|||
49099264|NCT02278120|158198840|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
49099265|NCT02278120|158198841|FG001|Post-treatment Efficacy Follow-up|Progressive disease|7|||
49099266|NCT02278120|158198840|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
49099267|NCT02278120|158198841|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
49099268|NCT02847494|158198847|FG000|Overall Study|Lost to Follow-up|8|||
49099269|NCT02847494|158198848|FG001|Overall Study|Lost to Follow-up|5|||
49099270|NCT01817582|158198849|FG000|Overall Study|Withdrawal by Subject|0|||
49099271|NCT01817582|158198850|FG001|Overall Study|Withdrawal by Subject|1|||
49099272|NCT01817582|158198851|FG002|Overall Study|Withdrawal by Subject|0|||
49099273|NCT01817582|158198849|FG000|Overall Study|Participant revealed masked treatment|1|||
49099274|NCT01817582|158198850|FG001|Overall Study|Participant revealed masked treatment|0|||
49099275|NCT01817582|158198851|FG002|Overall Study|Participant revealed masked treatment|0|||
49099276|NCT01817582|158198849|FG000|Overall Study|Randomized but exclusion criteria met|1|||
49099277|NCT01817582|158198850|FG001|Overall Study|Randomized but exclusion criteria met|0|||
49099278|NCT01817582|158198851|FG002|Overall Study|Randomized but exclusion criteria met|0|||
49099279|NCT02703272|158198853|FG000|Overall Study|Death|4|||
49099280|NCT02703272|158198854|FG001|Overall Study|Death|9|||
49099281|NCT02703272|158198855|FG002|Overall Study|Death|19|||
49099282|NCT02703272|158198856|FG003|Overall Study|Death|10|||
49099283|NCT02703272|158198853|FG000|Overall Study|Withdrawal by Subject|0|||
49099284|NCT02703272|158198854|FG001|Overall Study|Withdrawal by Subject|0|||
49099285|NCT02703272|158198855|FG002|Overall Study|Withdrawal by Subject|4|||
49099286|NCT02703272|158198856|FG003|Overall Study|Withdrawal by Subject|2|||
49099287|NCT02703272|158198853|FG000|Overall Study|Study Terminated by Sponsor|6|||
49099288|NCT02703272|158198854|FG001|Overall Study|Study Terminated by Sponsor|1|||
49099289|NCT02703272|158198855|FG002|Overall Study|Study Terminated by Sponsor|12|||
49099290|NCT02703272|158198856|FG003|Overall Study|Study Terminated by Sponsor|4|||
49099291|NCT02703272|158198853|FG000|Overall Study|Other|1|||
49099292|NCT02703272|158198854|FG001|Overall Study|Other|0|||
49099293|NCT02703272|158198855|FG002|Overall Study|Other|0|||
49099294|NCT02703272|158198856|FG003|Overall Study|Other|0|||
49099295|NCT01966068|158198860|FG000|Overall Study|Withdrawal by Subject|57|||
49099296|NCT01966068|158198860|FG000|Overall Study|Lost to Follow-up|81|||
49099297|NCT02600845|158198863|FG000|Overall Study|Reason Not Specified|3|||
49099298|NCT02600845|158198863|FG000|Overall Study|Non-compliance with Study Procedures|10|||
49099299|NCT02600845|158198863|FG000|Overall Study|Consent Withdrawal|5|||
49099300|NCT03852628|158198867|FG000|Overall Study|Lost to Follow-up|7|||
49099301|NCT03852628|158198868|FG001|Overall Study|Lost to Follow-up|6|||
49099302|NCT03852628|158198867|FG000|Overall Study|Lack of Efficacy|6|||
49099303|NCT03852628|158198868|FG001|Overall Study|Lack of Efficacy|6|||
49099304|NCT00960986|158198869|FG000|Period 1 (Screening and Washout)|Adverse Event|1|||
49099305|NCT00960986|158198870|FG001|Period 1 (Screening and Washout)|Adverse Event|2|||
49099306|NCT00960986|158198871|FG002|Period 1 (Screening and Washout)|Adverse Event|1|||
49099307|NCT00960986|158198872|FG003|Period 1 (Screening and Washout)|Adverse Event|1|||
49099308|NCT00960986|158198869|FG000|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
49099309|NCT00960986|158198870|FG001|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
49099310|NCT00960986|158198871|FG002|Period 1 (Screening and Washout)|Lost to Follow-up|2|||
49099311|NCT00960986|158198872|FG003|Period 1 (Screening and Washout)|Lost to Follow-up|1|||
49099312|NCT00960986|158198869|FG000|Period 1 (Screening and Washout)|Protocol Violation|1|||
49099313|NCT00960986|158198870|FG001|Period 1 (Screening and Washout)|Protocol Violation|0|||
49099314|NCT00960986|158198871|FG002|Period 1 (Screening and Washout)|Protocol Violation|0|||
49099315|NCT00960986|158198872|FG003|Period 1 (Screening and Washout)|Protocol Violation|0|||
49099316|NCT00960986|158198869|FG000|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
49099317|NCT00960986|158198870|FG001|Period 1 (Screening and Washout)|Withdrawal by Subject|2|||
49099318|NCT00960986|158198871|FG002|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
49099319|NCT00960986|158198872|FG003|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
49099320|NCT00960986|158198869|FG000|Period 3 (7-week Therapy Period)|Adverse Event|17|||
49099321|NCT00960986|158198870|FG001|Period 3 (7-week Therapy Period)|Adverse Event|15|||
49099322|NCT00960986|158198871|FG002|Period 3 (7-week Therapy Period)|Adverse Event|10|||
49099323|NCT00960986|158198872|FG003|Period 3 (7-week Therapy Period)|Adverse Event|12|||
49099324|NCT00960986|158198869|FG000|Period 3 (7-week Therapy Period)|Death|0|||
49099325|NCT00960986|158198870|FG001|Period 3 (7-week Therapy Period)|Death|0|||
49099326|NCT00960986|158198871|FG002|Period 3 (7-week Therapy Period)|Death|1|||
49099327|NCT00960986|158198872|FG003|Period 3 (7-week Therapy Period)|Death|0|||
49099328|NCT00960986|158198869|FG000|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
49099329|NCT00960986|158198870|FG001|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
49099330|NCT00960986|158198871|FG002|Period 3 (7-week Therapy Period)|Lost to Follow-up|1|||
49099331|NCT00960986|158198872|FG003|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
49099332|NCT00960986|158198869|FG000|Period 3 (7-week Therapy Period)|Protocol Violation|10|||
49099333|NCT00960986|158198870|FG001|Period 3 (7-week Therapy Period)|Protocol Violation|4|||
49099334|NCT00960986|158198871|FG002|Period 3 (7-week Therapy Period)|Protocol Violation|3|||
49099335|NCT00960986|158198872|FG003|Period 3 (7-week Therapy Period)|Protocol Violation|11|||
49099336|NCT00960986|158198869|FG000|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
49099337|NCT00960986|158198870|FG001|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
49099338|NCT00960986|158198871|FG002|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4|||
49099339|NCT00960986|158198872|FG003|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
49099340|NCT00960986|158198869|FG000|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
49099341|NCT00960986|158198870|FG001|Period 3 (7-week Therapy Period)|Lack of Efficacy|2|||
49099342|NCT00960986|158198871|FG002|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
49099343|NCT00960986|158198872|FG003|Period 3 (7-week Therapy Period)|Lack of Efficacy|0|||
49099344|NCT01077739|158198873|FG000|Overall Study|Premature withdrawal|1|||
49099345|NCT01077739|158198874|FG001|Overall Study|Premature withdrawal|3|||
49099346|NCT01077739|158198873|FG000|Overall Study|Withdrawal by Subject|1|||
49099347|NCT01077739|158198874|FG001|Overall Study|Withdrawal by Subject|0|||
49099348|NCT01077739|158198873|FG000|Overall Study|Death|0|||
49099349|NCT01077739|158198874|FG001|Overall Study|Death|3|||
49099350|NCT01077739|158198873|FG000|Overall Study|Unacceptable toxicity|1|||
49099351|NCT01077739|158198874|FG001|Overall Study|Unacceptable toxicity|2|||
49099352|NCT01077739|158198873|FG000|Overall Study|Other|2|||
49099353|NCT01077739|158198874|FG001|Overall Study|Other|2|||
49099354|NCT04413552|158198875|FG000|Overall Study|Adverse Event|0|||
49099355|NCT04413552|158198876|FG001|Overall Study|Adverse Event|0|||
49099356|NCT04413552|158198877|FG002|Overall Study|Adverse Event|0|||
49099357|NCT04413552|158198878|FG003|Overall Study|Adverse Event|0|||
49099358|NCT04413552|158198879|FG004|Overall Study|Adverse Event|0|||
49099359|NCT04413552|158198880|FG005|Overall Study|Adverse Event|0|||
49099360|NCT04413552|158198881|FG006|Overall Study|Adverse Event|1|||
49099361|NCT04413552|158198882|FG007|Overall Study|Adverse Event|0|||
49099362|NCT04413552|158198883|FG008|Overall Study|Adverse Event|0|||
49099363|NCT04413552|158198884|FG009|Overall Study|Adverse Event|0|||
49099364|NCT01790828|158198888|FG000|Overall Study|Other|34|||
49099365|NCT00877071|158198889|FG000|Overall Study|disease progression|2|||
49099366|NCT02759055|158200672|FG000|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927|||
49099367|NCT02759055|158200673|FG001|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508|||
49099368|NCT00723255|158200674|FG000|Overall Study|Ineligible: Inadequate pathology|1|||
49099369|NCT00723255|158200674|FG000|Overall Study|Ineligible: Second primary|1|||
49099370|NCT00723255|158200674|FG000|Overall Study|Ineligible: Wrong Primary|2|||
49099371|NCT00614523|158200675|FG000|Overall Study|Adverse Event|4|||
49099372|NCT00614523|158200676|FG001|Overall Study|Adverse Event|20|||
49099373|NCT00614523|158200675|FG000|Overall Study|Death|5|||
49099374|NCT00614523|158200676|FG001|Overall Study|Death|8|||
49099375|NCT00614523|158200675|FG000|Overall Study|Lack of Efficacy|9|||
49099376|NCT00614523|158200676|FG001|Overall Study|Lack of Efficacy|11|||
49099377|NCT00614523|158200675|FG000|Overall Study|Lost to Follow-up|0|||
49099378|NCT00614523|158200676|FG001|Overall Study|Lost to Follow-up|1|||
49099379|NCT00614523|158200675|FG000|Overall Study|Protocol Violation|3|||
49099380|NCT00614523|158200676|FG001|Overall Study|Protocol Violation|2|||
49099381|NCT00614523|158200675|FG000|Overall Study|Withdrawal by Subject|12|||
49099382|NCT00614523|158200676|FG001|Overall Study|Withdrawal by Subject|22|||
49099383|NCT00614523|158200675|FG000|Overall Study|Other|6|||
49099384|NCT00614523|158200676|FG001|Overall Study|Other|11|||
49099385|NCT00614523|158200675|FG000|Overall Study|Ineligibility Determined|1|||
49099386|NCT00614523|158200676|FG001|Overall Study|Ineligibility Determined|2|||
49099387|NCT00614523|158200675|FG000|Overall Study|Disease Progression|0|||
49099388|NCT00614523|158200676|FG001|Overall Study|Disease Progression|8|||
49099389|NCT00614523|158200675|FG000|Overall Study|Administrative Decision|23|||
49099390|NCT00614523|158200676|FG001|Overall Study|Administrative Decision|46|||
49099391|NCT04934189|158200677|FG000|Overall Study|Lost to Follow-up|4|||
49099392|NCT04934189|158200677|FG000|Overall Study|Withdrawal by Subject|17|||
49099393|NCT03962790|158200678|FG000|Period 1|Adverse Event|0|||
49099394|NCT03962790|158200679|FG001|Period 1|Adverse Event|1|||
49099395|NCT03962790|158200678|FG000|Period 1|Failed to meet all eligibility criteria|1|||
49099396|NCT03962790|158200679|FG001|Period 1|Failed to meet all eligibility criteria|1|||
49099397|NCT03962790|158200678|FG000|Period 1|No Longer Meets Eligibility Criteria|1|||
49099398|NCT03962790|158200679|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
49099399|NCT03962790|158200678|FG000|Period 1|Withdrawal by Subject|1|||
49099400|NCT03962790|158200679|FG001|Period 1|Withdrawal by Subject|0|||
49099401|NCT02589522|158200686|FG000|Overall Study|Physician Decision|1|||
49099402|NCT02589522|158200687|FG001|Overall Study|Physician Decision|2|||
49099403|NCT02589522|158200688|FG002|Overall Study|Physician Decision|0|||
49099404|NCT02589522|158200686|FG000|Overall Study|Did not start treatment|1|||
49099405|NCT02589522|158200687|FG001|Overall Study|Did not start treatment|0|||
49099406|NCT02589522|158200688|FG002|Overall Study|Did not start treatment|0|||
49099407|NCT02691013|158200694|FG000|Overall Study|Withdrawal by Subject|3|||
49099408|NCT02691013|158200695|FG001|Overall Study|Withdrawal by Subject|0|||
49099409|NCT00281632|158200696|FG000|Overall Study|Adverse Event|7|||
49099410|NCT00281632|158200696|FG000|Overall Study|Withdrawal by Subject|2|||
49099411|NCT00281632|158200696|FG000|Overall Study|Disease Progression|22|||
49099412|NCT00281632|158200696|FG000|Overall Study|Death|1|||
49099413|NCT00281632|158200696|FG000|Overall Study|Physician Decision|1|||
49099414|NCT00281632|158200696|FG000|Overall Study|Ongoing|3|||
49099415|NCT02738879|158200703|FG000|Overall Study|Adverse Event|1|||
49099416|NCT02738879|158200704|FG001|Overall Study|Adverse Event|1|||
49099417|NCT02738879|158200703|FG000|Overall Study|Death|0|||
49099418|NCT02738879|158200704|FG001|Overall Study|Death|2|||
49099419|NCT02738879|158200703|FG000|Overall Study|Lost to Follow-up|1|||
49099420|NCT02738879|158200704|FG001|Overall Study|Lost to Follow-up|5|||
49099421|NCT02738879|158200703|FG000|Overall Study|Protocol Violation|1|||
49099422|NCT02738879|158200704|FG001|Overall Study|Protocol Violation|3|||
49099423|NCT02738879|158200703|FG000|Overall Study|Physician Decision|3|||
49099424|NCT02738879|158200704|FG001|Overall Study|Physician Decision|4|||
49099425|NCT02738879|158200703|FG000|Overall Study|Pregnancy|0|||
49099426|NCT02738879|158200704|FG001|Overall Study|Pregnancy|1|||
49099427|NCT02738879|158200703|FG000|Overall Study|Screen Failure|1|||
49099428|NCT02738879|158200704|FG001|Overall Study|Screen Failure|2|||
49099429|NCT02738879|158200703|FG000|Overall Study|Site Discontinued Study Participation|1|||
49099430|NCT02738879|158200704|FG001|Overall Study|Site Discontinued Study Participation|0|||
49099431|NCT02738879|158200703|FG000|Overall Study|Withdrawal by Subject|5|||
49099432|NCT02738879|158200704|FG001|Overall Study|Withdrawal by Subject|7|||
49099433|NCT01676896|158200706|FG000|Overall Study|Withdrawal by Subject|12|||
49099434|NCT01676896|158200707|FG001|Overall Study|Withdrawal by Subject|7|||
49099435|NCT01676896|158200708|FG002|Overall Study|Withdrawal by Subject|19|||
49099436|NCT01647516|158200709|FG000|Induction Period (IP)|Physician Decision|2|||
49099437|NCT01647516|158200710|FG001|Induction Period (IP)|Physician Decision|0|||
49099438|NCT01647516|158200711|FG002|Induction Period (IP)|Physician Decision|0|||
49099439|NCT01647516|158200712|FG003|Induction Period (IP)|Physician Decision|0|||
49099440|NCT01647516|158200713|FG004|Induction Period (IP)|Physician Decision|0|||
49099441|NCT01647516|158200714|FG005|Induction Period (IP)|Physician Decision|0|||
49099442|NCT01647516|158200709|FG000|Induction Period (IP)|Adverse Event|1|||
49099443|NCT01647516|158200710|FG001|Induction Period (IP)|Adverse Event|2|||
49099444|NCT01647516|158200711|FG002|Induction Period (IP)|Adverse Event|0|||
49099445|NCT01647516|158200712|FG003|Induction Period (IP)|Adverse Event|0|||
49099446|NCT01647516|158200713|FG004|Induction Period (IP)|Adverse Event|0|||
49111397|NCT00534105|158242890|FG000|Overall Study|Lost to Follow-up|23|||
49099447|NCT01647516|158200714|FG005|Induction Period (IP)|Adverse Event|0|||
49099448|NCT01647516|158200709|FG000|Induction Period (IP)|Withdrawal by Subject|1|||
49099449|NCT01647516|158200710|FG001|Induction Period (IP)|Withdrawal by Subject|0|||
49099450|NCT01647516|158200711|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
49099451|NCT01647516|158200712|FG003|Induction Period (IP)|Withdrawal by Subject|0|||
49099452|NCT01647516|158200713|FG004|Induction Period (IP)|Withdrawal by Subject|0|||
49099453|NCT01647516|158200714|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
49099454|NCT01647516|158200709|FG000|Induction Period (IP)|Participant Choice|0|||
49099455|NCT01647516|158200710|FG001|Induction Period (IP)|Participant Choice|0|||
49099456|NCT01647516|158200711|FG002|Induction Period (IP)|Participant Choice|1|||
49099457|NCT01647516|158200712|FG003|Induction Period (IP)|Participant Choice|0|||
49099458|NCT01647516|158200713|FG004|Induction Period (IP)|Participant Choice|0|||
49099459|NCT01647516|158200714|FG005|Induction Period (IP)|Participant Choice|0|||
49099460|NCT01647516|158200709|FG000|Induction Period (IP)|Lack of Efficacy|1|||
49099461|NCT01647516|158200710|FG001|Induction Period (IP)|Lack of Efficacy|0|||
49099462|NCT01647516|158200711|FG002|Induction Period (IP)|Lack of Efficacy|0|||
49099463|NCT01647516|158200712|FG003|Induction Period (IP)|Lack of Efficacy|0|||
49099464|NCT01647516|158200713|FG004|Induction Period (IP)|Lack of Efficacy|0|||
49099465|NCT01647516|158200714|FG005|Induction Period (IP)|Lack of Efficacy|0|||
49099466|NCT01647516|158200709|FG000|Induction Period (IP)|No study drug received|1|||
49099467|NCT01647516|158200710|FG001|Induction Period (IP)|No study drug received|1|||
49099468|NCT01647516|158200711|FG002|Induction Period (IP)|No study drug received|0|||
49099469|NCT01647516|158200712|FG003|Induction Period (IP)|No study drug received|0|||
49099470|NCT01647516|158200713|FG004|Induction Period (IP)|No study drug received|0|||
49099471|NCT01647516|158200714|FG005|Induction Period (IP)|No study drug received|0|||
49099472|NCT01647516|158200709|FG000|Maintenance Period (MP)|Adverse Event|2|||
49099473|NCT01647516|158200710|FG001|Maintenance Period (MP)|Adverse Event|1|||
49099474|NCT01647516|158200711|FG002|Maintenance Period (MP)|Adverse Event|0|||
49099475|NCT01647516|158200712|FG003|Maintenance Period (MP)|Adverse Event|0|||
49099476|NCT01647516|158200713|FG004|Maintenance Period (MP)|Adverse Event|0|||
49099477|NCT01647516|158200714|FG005|Maintenance Period (MP)|Adverse Event|0|||
49099478|NCT01647516|158200709|FG000|Maintenance Period (MP)|Non-compliance|1|||
49099479|NCT01647516|158200710|FG001|Maintenance Period (MP)|Non-compliance|0|||
49099480|NCT01647516|158200711|FG002|Maintenance Period (MP)|Non-compliance|0|||
49099481|NCT01647516|158200712|FG003|Maintenance Period (MP)|Non-compliance|0|||
49099482|NCT01647516|158200713|FG004|Maintenance Period (MP)|Non-compliance|0|||
49099483|NCT01647516|158200714|FG005|Maintenance Period (MP)|Non-compliance|0|||
49099484|NCT01647516|158200709|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
49099485|NCT01647516|158200710|FG001|Maintenance Period (MP)|Withdrawal by Subject|1|||
49099486|NCT01647516|158200711|FG002|Maintenance Period (MP)|Withdrawal by Subject|1|||
49099487|NCT01647516|158200712|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
49099488|NCT01647516|158200713|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
49099489|NCT01647516|158200714|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
49099490|NCT01647516|158200709|FG000|Maintenance Period (MP)|Lack of Efficacy|1|||
49099491|NCT01647516|158200710|FG001|Maintenance Period (MP)|Lack of Efficacy|4|||
49099492|NCT01647516|158200711|FG002|Maintenance Period (MP)|Lack of Efficacy|1|||
49099493|NCT01647516|158200712|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
49099494|NCT01647516|158200713|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
49099495|NCT01647516|158200714|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
49099496|NCT01647516|158200709|FG000|Open-Label Period|Adverse Event|0|||
49099497|NCT01647516|158200710|FG001|Open-Label Period|Adverse Event|0|||
49099498|NCT01647516|158200711|FG002|Open-Label Period|Adverse Event|0|||
49099499|NCT01647516|158200712|FG003|Open-Label Period|Adverse Event|5|||
49099500|NCT01647516|158200713|FG004|Open-Label Period|Adverse Event|6|||
49099501|NCT01647516|158200714|FG005|Open-Label Period|Adverse Event|3|||
49099502|NCT01647516|158200709|FG000|Open-Label Period|Pregnancy|0|||
49099503|NCT01647516|158200710|FG001|Open-Label Period|Pregnancy|0|||
49099504|NCT01647516|158200711|FG002|Open-Label Period|Pregnancy|0|||
49099505|NCT01647516|158200712|FG003|Open-Label Period|Pregnancy|0|||
49099506|NCT01647516|158200713|FG004|Open-Label Period|Pregnancy|0|||
49099507|NCT01647516|158200714|FG005|Open-Label Period|Pregnancy|1|||
49099508|NCT01647516|158200709|FG000|Open-Label Period|Non-compliance|0|||
49099509|NCT01647516|158200710|FG001|Open-Label Period|Non-compliance|0|||
49099510|NCT01647516|158200711|FG002|Open-Label Period|Non-compliance|0|||
49099511|NCT01647516|158200712|FG003|Open-Label Period|Non-compliance|1|||
49099512|NCT01647516|158200713|FG004|Open-Label Period|Non-compliance|0|||
49099513|NCT01647516|158200714|FG005|Open-Label Period|Non-compliance|1|||
49099514|NCT01647516|158200709|FG000|Open-Label Period|Physician Decision|0|||
49099515|NCT01647516|158200710|FG001|Open-Label Period|Physician Decision|0|||
49099516|NCT01647516|158200711|FG002|Open-Label Period|Physician Decision|0|||
49099517|NCT01647516|158200712|FG003|Open-Label Period|Physician Decision|1|||
49099518|NCT01647516|158200713|FG004|Open-Label Period|Physician Decision|1|||
49099519|NCT01647516|158200714|FG005|Open-Label Period|Physician Decision|0|||
49099520|NCT01647516|158200709|FG000|Open-Label Period|Withdrawal by Subject|0|||
49099521|NCT01647516|158200710|FG001|Open-Label Period|Withdrawal by Subject|0|||
49099522|NCT01647516|158200711|FG002|Open-Label Period|Withdrawal by Subject|0|||
49099523|NCT01647516|158200712|FG003|Open-Label Period|Withdrawal by Subject|9|||
49099524|NCT01647516|158200713|FG004|Open-Label Period|Withdrawal by Subject|11|||
49099525|NCT01647516|158200714|FG005|Open-Label Period|Withdrawal by Subject|6|||
49099526|NCT01647516|158200709|FG000|Open-Label Period|Lost to Follow-up|0|||
49099527|NCT01647516|158200710|FG001|Open-Label Period|Lost to Follow-up|0|||
49099528|NCT01647516|158200711|FG002|Open-Label Period|Lost to Follow-up|0|||
49099529|NCT01647516|158200712|FG003|Open-Label Period|Lost to Follow-up|1|||
49099530|NCT01647516|158200713|FG004|Open-Label Period|Lost to Follow-up|0|||
49099531|NCT01647516|158200714|FG005|Open-Label Period|Lost to Follow-up|1|||
49099532|NCT01647516|158200709|FG000|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
49099533|NCT01647516|158200710|FG001|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
49099534|NCT01647516|158200711|FG002|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
49099535|NCT01647516|158200712|FG003|Open-Label Period|Sponsor Termination; moved to 3102 study|18|||
49099536|NCT01647516|158200713|FG004|Open-Label Period|Sponsor Termination; moved to 3102 study|13|||
49099537|NCT01647516|158200714|FG005|Open-Label Period|Sponsor Termination; moved to 3102 study|23|||
49099538|NCT01647516|158200709|FG000|Open-Label Period|Lack of Efficacy|0|||
49099539|NCT01647516|158200710|FG001|Open-Label Period|Lack of Efficacy|0|||
49099540|NCT01647516|158200711|FG002|Open-Label Period|Lack of Efficacy|0|||
49099541|NCT01647516|158200712|FG003|Open-Label Period|Lack of Efficacy|7|||
49099542|NCT01647516|158200713|FG004|Open-Label Period|Lack of Efficacy|9|||
49099543|NCT01647516|158200714|FG005|Open-Label Period|Lack of Efficacy|10|||
49099544|NCT01647516|158200709|FG000|Open-Label Period|Participant Choice to Stop Study Drug|0|||
49099545|NCT01647516|158200710|FG001|Open-Label Period|Participant Choice to Stop Study Drug|0|||
49099546|NCT01647516|158200711|FG002|Open-Label Period|Participant Choice to Stop Study Drug|0|||
49099547|NCT01647516|158200712|FG003|Open-Label Period|Participant Choice to Stop Study Drug|7|||
49099548|NCT01647516|158200713|FG004|Open-Label Period|Participant Choice to Stop Study Drug|9|||
49099549|NCT01647516|158200714|FG005|Open-Label Period|Participant Choice to Stop Study Drug|10|||
49099550|NCT01647516|158200709|FG000|Open-Label Period|No completion / discontinuation visit|0|||
49099551|NCT01647516|158200710|FG001|Open-Label Period|No completion / discontinuation visit|0|||
49099552|NCT01647516|158200711|FG002|Open-Label Period|No completion / discontinuation visit|0|||
49099553|NCT01647516|158200712|FG003|Open-Label Period|No completion / discontinuation visit|0|||
49099554|NCT01647516|158200713|FG004|Open-Label Period|No completion / discontinuation visit|2|||
49099555|NCT01647516|158200714|FG005|Open-Label Period|No completion / discontinuation visit|1|||
49099556|NCT02980341|158200715|FG000|Dose Escalation|Progressive disease per RECIST v1.1|3|||
49099557|NCT02980341|158200716|FG001|Dose Escalation|Progressive disease per RECIST v1.1|3|||
49099558|NCT02980341|158200717|FG002|Dose Escalation|Progressive disease per RECIST v1.1|11|||
49099559|NCT02980341|158200718|FG003|Dose Escalation|Progressive disease per RECIST v1.1|10|||
49099560|NCT02980341|158200719|FG004|Dose Escalation|Progressive disease per RECIST v1.1|3|||
49099561|NCT02980341|158200720|FG005|Dose Escalation|Progressive disease per RECIST v1.1|0|||
49099562|NCT02980341|158200721|FG006|Dose Escalation|Progressive disease per RECIST v1.1|0|||
49099563|NCT02980341|158200722|FG007|Dose Escalation|Progressive disease per RECIST v1.1|0|||
49099564|NCT02980341|158200723|FG008|Dose Escalation|Progressive disease per RECIST v1.1|0|||
49099565|NCT02980341|158200724|FG009|Dose Escalation|Progressive disease per RECIST v1.1|0|||
49099566|NCT02980341|158200725|FG010|Dose Escalation|Progressive disease per RECIST v1.1|0|||
49099567|NCT02980341|158200715|FG000|Dose Escalation|Clinical progression|0|||
49099568|NCT02980341|158200716|FG001|Dose Escalation|Clinical progression|0|||
49099569|NCT02980341|158200717|FG002|Dose Escalation|Clinical progression|2|||
49099570|NCT02980341|158200718|FG003|Dose Escalation|Clinical progression|1|||
49099571|NCT02980341|158200719|FG004|Dose Escalation|Clinical progression|0|||
49099572|NCT02980341|158200720|FG005|Dose Escalation|Clinical progression|0|||
49099573|NCT02980341|158200721|FG006|Dose Escalation|Clinical progression|0|||
49099574|NCT02980341|158200722|FG007|Dose Escalation|Clinical progression|0|||
49099575|NCT02980341|158200723|FG008|Dose Escalation|Clinical progression|0|||
49099576|NCT02980341|158200724|FG009|Dose Escalation|Clinical progression|0|||
49099577|NCT02980341|158200725|FG010|Dose Escalation|Clinical progression|0|||
49099578|NCT02980341|158200715|FG000|Dose Escalation|Adverse Event|0|||
49099579|NCT02980341|158200716|FG001|Dose Escalation|Adverse Event|0|||
49099580|NCT02980341|158200717|FG002|Dose Escalation|Adverse Event|1|||
49099581|NCT02980341|158200718|FG003|Dose Escalation|Adverse Event|2|||
49099582|NCT02980341|158200719|FG004|Dose Escalation|Adverse Event|2|||
49099583|NCT02980341|158200720|FG005|Dose Escalation|Adverse Event|0|||
49099584|NCT02980341|158200721|FG006|Dose Escalation|Adverse Event|0|||
49099585|NCT02980341|158200722|FG007|Dose Escalation|Adverse Event|0|||
49099586|NCT02980341|158200723|FG008|Dose Escalation|Adverse Event|0|||
49099587|NCT02980341|158200724|FG009|Dose Escalation|Adverse Event|0|||
49099588|NCT02980341|158200725|FG010|Dose Escalation|Adverse Event|0|||
49099589|NCT02980341|158200715|FG000|Dose Escalation|Withdrawal by Subject|0|||
49099590|NCT02980341|158200716|FG001|Dose Escalation|Withdrawal by Subject|0|||
49099591|NCT02980341|158200717|FG002|Dose Escalation|Withdrawal by Subject|1|||
49099592|NCT02980341|158200718|FG003|Dose Escalation|Withdrawal by Subject|0|||
49099593|NCT02980341|158200719|FG004|Dose Escalation|Withdrawal by Subject|0|||
49099594|NCT02980341|158200720|FG005|Dose Escalation|Withdrawal by Subject|0|||
49099595|NCT02980341|158200721|FG006|Dose Escalation|Withdrawal by Subject|0|||
49099596|NCT02980341|158200722|FG007|Dose Escalation|Withdrawal by Subject|0|||
49099597|NCT02980341|158200723|FG008|Dose Escalation|Withdrawal by Subject|0|||
49099598|NCT02980341|158200724|FG009|Dose Escalation|Withdrawal by Subject|0|||
49099599|NCT02980341|158200725|FG010|Dose Escalation|Withdrawal by Subject|0|||
49099600|NCT02980341|158200715|FG000|Dose Escalation|Due to side effect management of chemotherapy|0|||
49099601|NCT02980341|158200716|FG001|Dose Escalation|Due to side effect management of chemotherapy|0|||
49099602|NCT02980341|158200717|FG002|Dose Escalation|Due to side effect management of chemotherapy|0|||
49099603|NCT02980341|158200718|FG003|Dose Escalation|Due to side effect management of chemotherapy|2|||
49099604|NCT02980341|158200719|FG004|Dose Escalation|Due to side effect management of chemotherapy|0|||
49099605|NCT02980341|158200720|FG005|Dose Escalation|Due to side effect management of chemotherapy|0|||
49099606|NCT02980341|158200721|FG006|Dose Escalation|Due to side effect management of chemotherapy|0|||
49099607|NCT02980341|158200722|FG007|Dose Escalation|Due to side effect management of chemotherapy|0|||
49099608|NCT02980341|158200723|FG008|Dose Escalation|Due to side effect management of chemotherapy|0|||
49099609|NCT02980341|158200724|FG009|Dose Escalation|Due to side effect management of chemotherapy|0|||
49099610|NCT02980341|158200725|FG010|Dose Escalation|Due to side effect management of chemotherapy|0|||
49099611|NCT02980341|158200715|FG000|Dose Escalation|Due to investigator's decision|0|||
49099612|NCT02980341|158200716|FG001|Dose Escalation|Due to investigator's decision|0|||
49099613|NCT02980341|158200717|FG002|Dose Escalation|Due to investigator's decision|0|||
49099614|NCT02980341|158200718|FG003|Dose Escalation|Due to investigator's decision|0|||
49099615|NCT02980341|158200719|FG004|Dose Escalation|Due to investigator's decision|1|||
49099616|NCT02980341|158200720|FG005|Dose Escalation|Due to investigator's decision|0|||
49099617|NCT02980341|158200721|FG006|Dose Escalation|Due to investigator's decision|0|||
49099618|NCT02980341|158200722|FG007|Dose Escalation|Due to investigator's decision|0|||
49099619|NCT02980341|158200723|FG008|Dose Escalation|Due to investigator's decision|0|||
49099620|NCT02980341|158200724|FG009|Dose Escalation|Due to investigator's decision|0|||
49099621|NCT02980341|158200725|FG010|Dose Escalation|Due to investigator's decision|0|||
49099622|NCT02980341|158200715|FG000|Dose Finding|Progressive disease per RECIST v1.1|0|||
49099623|NCT02980341|158200716|FG001|Dose Finding|Progressive disease per RECIST v1.1|0|||
49099624|NCT02980341|158200717|FG002|Dose Finding|Progressive disease per RECIST v1.1|0|||
49099625|NCT02980341|158200718|FG003|Dose Finding|Progressive disease per RECIST v1.1|0|||
49099626|NCT02980341|158200719|FG004|Dose Finding|Progressive disease per RECIST v1.1|0|||
49099627|NCT02980341|158200720|FG005|Dose Finding|Progressive disease per RECIST v1.1|8|||
49099628|NCT02980341|158200721|FG006|Dose Finding|Progressive disease per RECIST v1.1|11|||
49099629|NCT02980341|158200722|FG007|Dose Finding|Progressive disease per RECIST v1.1|0|||
49099630|NCT02980341|158200723|FG008|Dose Finding|Progressive disease per RECIST v1.1|0|||
49099631|NCT02980341|158200724|FG009|Dose Finding|Progressive disease per RECIST v1.1|0|||
49099632|NCT02980341|158200725|FG010|Dose Finding|Progressive disease per RECIST v1.1|0|||
49099633|NCT02980341|158200715|FG000|Dose Finding|Adverse Event|0|||
49099634|NCT02980341|158200716|FG001|Dose Finding|Adverse Event|0|||
49099635|NCT02980341|158200717|FG002|Dose Finding|Adverse Event|0|||
49099636|NCT02980341|158200718|FG003|Dose Finding|Adverse Event|0|||
49099637|NCT02980341|158200719|FG004|Dose Finding|Adverse Event|0|||
49099638|NCT02980341|158200720|FG005|Dose Finding|Adverse Event|3|||
49099639|NCT02980341|158200721|FG006|Dose Finding|Adverse Event|0|||
49099640|NCT02980341|158200722|FG007|Dose Finding|Adverse Event|0|||
49099641|NCT02980341|158200723|FG008|Dose Finding|Adverse Event|0|||
49099642|NCT02980341|158200724|FG009|Dose Finding|Adverse Event|0|||
49099643|NCT02980341|158200725|FG010|Dose Finding|Adverse Event|0|||
49099644|NCT02980341|158200715|FG000|Dose Finding|Withdrawal by Subject|0|||
49099645|NCT02980341|158200716|FG001|Dose Finding|Withdrawal by Subject|0|||
49099646|NCT02980341|158200717|FG002|Dose Finding|Withdrawal by Subject|0|||
49099647|NCT02980341|158200718|FG003|Dose Finding|Withdrawal by Subject|0|||
49099648|NCT02980341|158200719|FG004|Dose Finding|Withdrawal by Subject|0|||
49099649|NCT02980341|158200720|FG005|Dose Finding|Withdrawal by Subject|1|||
49099650|NCT02980341|158200721|FG006|Dose Finding|Withdrawal by Subject|1|||
49099651|NCT02980341|158200722|FG007|Dose Finding|Withdrawal by Subject|0|||
49099652|NCT02980341|158200723|FG008|Dose Finding|Withdrawal by Subject|0|||
49099653|NCT02980341|158200724|FG009|Dose Finding|Withdrawal by Subject|0|||
49099654|NCT02980341|158200725|FG010|Dose Finding|Withdrawal by Subject|0|||
49099655|NCT02980341|158200715|FG000|Dose Expansion|Progressive disease per RECIST v1.1|0|||
49099656|NCT02980341|158200716|FG001|Dose Expansion|Progressive disease per RECIST v1.1|0|||
49099657|NCT02980341|158200717|FG002|Dose Expansion|Progressive disease per RECIST v1.1|0|||
49099658|NCT02980341|158200718|FG003|Dose Expansion|Progressive disease per RECIST v1.1|0|||
49099659|NCT02980341|158200719|FG004|Dose Expansion|Progressive disease per RECIST v1.1|0|||
49099660|NCT02980341|158200720|FG005|Dose Expansion|Progressive disease per RECIST v1.1|0|||
49099661|NCT02980341|158200721|FG006|Dose Expansion|Progressive disease per RECIST v1.1|0|||
49099662|NCT02980341|158200722|FG007|Dose Expansion|Progressive disease per RECIST v1.1|23|||
49099663|NCT02980341|158200723|FG008|Dose Expansion|Progressive disease per RECIST v1.1|24|||
49099664|NCT02980341|158200724|FG009|Dose Expansion|Progressive disease per RECIST v1.1|17|||
49099665|NCT02980341|158200725|FG010|Dose Expansion|Progressive disease per RECIST v1.1|23|||
49099666|NCT02980341|158200715|FG000|Dose Expansion|Clinical progression|0|||
49099667|NCT02980341|158200716|FG001|Dose Expansion|Clinical progression|0|||
49099668|NCT02980341|158200717|FG002|Dose Expansion|Clinical progression|0|||
49099669|NCT02980341|158200718|FG003|Dose Expansion|Clinical progression|0|||
49099670|NCT02980341|158200719|FG004|Dose Expansion|Clinical progression|0|||
49099671|NCT02980341|158200720|FG005|Dose Expansion|Clinical progression|0|||
49099672|NCT02980341|158200721|FG006|Dose Expansion|Clinical progression|0|||
49099673|NCT02980341|158200722|FG007|Dose Expansion|Clinical progression|4|||
49099674|NCT02980341|158200723|FG008|Dose Expansion|Clinical progression|3|||
49099675|NCT02980341|158200724|FG009|Dose Expansion|Clinical progression|1|||
49099676|NCT02980341|158200725|FG010|Dose Expansion|Clinical progression|4|||
49099677|NCT02980341|158200715|FG000|Dose Expansion|Adverse Event|0|||
49099678|NCT02980341|158200716|FG001|Dose Expansion|Adverse Event|0|||
49099679|NCT02980341|158200717|FG002|Dose Expansion|Adverse Event|0|||
49099680|NCT02980341|158200718|FG003|Dose Expansion|Adverse Event|0|||
49099681|NCT02980341|158200719|FG004|Dose Expansion|Adverse Event|0|||
49099682|NCT02980341|158200720|FG005|Dose Expansion|Adverse Event|0|||
49099683|NCT02980341|158200721|FG006|Dose Expansion|Adverse Event|0|||
49099684|NCT02980341|158200722|FG007|Dose Expansion|Adverse Event|3|||
49099685|NCT02980341|158200723|FG008|Dose Expansion|Adverse Event|0|||
49099686|NCT02980341|158200724|FG009|Dose Expansion|Adverse Event|1|||
49099687|NCT02980341|158200725|FG010|Dose Expansion|Adverse Event|3|||
49099688|NCT02980341|158200715|FG000|Dose Expansion|Death|0|||
49099689|NCT02980341|158200716|FG001|Dose Expansion|Death|0|||
49099690|NCT02980341|158200717|FG002|Dose Expansion|Death|0|||
49099691|NCT02980341|158200718|FG003|Dose Expansion|Death|0|||
49099692|NCT02980341|158200719|FG004|Dose Expansion|Death|0|||
49099693|NCT02980341|158200720|FG005|Dose Expansion|Death|0|||
49099694|NCT02980341|158200721|FG006|Dose Expansion|Death|0|||
49099695|NCT02980341|158200722|FG007|Dose Expansion|Death|0|||
49099696|NCT02980341|158200723|FG008|Dose Expansion|Death|2|||
49099697|NCT02980341|158200724|FG009|Dose Expansion|Death|1|||
49099698|NCT02980341|158200725|FG010|Dose Expansion|Death|0|||
49099699|NCT02980341|158200715|FG000|Dose Expansion|Withdrawal by Subject|0|||
49099700|NCT02980341|158200716|FG001|Dose Expansion|Withdrawal by Subject|0|||
49099701|NCT02980341|158200717|FG002|Dose Expansion|Withdrawal by Subject|0|||
49099702|NCT02980341|158200718|FG003|Dose Expansion|Withdrawal by Subject|0|||
49099703|NCT02980341|158200719|FG004|Dose Expansion|Withdrawal by Subject|0|||
49099704|NCT02980341|158200720|FG005|Dose Expansion|Withdrawal by Subject|0|||
49099705|NCT02980341|158200721|FG006|Dose Expansion|Withdrawal by Subject|0|||
49099706|NCT02980341|158200722|FG007|Dose Expansion|Withdrawal by Subject|2|||
49099707|NCT02980341|158200723|FG008|Dose Expansion|Withdrawal by Subject|0|||
49099708|NCT02980341|158200724|FG009|Dose Expansion|Withdrawal by Subject|1|||
49099709|NCT02980341|158200725|FG010|Dose Expansion|Withdrawal by Subject|0|||
49099710|NCT02980341|158200715|FG000|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
49099711|NCT02980341|158200716|FG001|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
49099712|NCT02980341|158200717|FG002|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
49099713|NCT02980341|158200718|FG003|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
49099714|NCT02980341|158200719|FG004|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
49099715|NCT02980341|158200720|FG005|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
49099716|NCT02980341|158200721|FG006|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
49099717|NCT02980341|158200722|FG007|Dose Expansion|Due to investigator's decision considering patient's liver condition|1|||
49099718|NCT02980341|158200723|FG008|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
49099719|NCT02980341|158200724|FG009|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
49099720|NCT02980341|158200725|FG010|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
49099721|NCT02980341|158200715|FG000|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
49099722|NCT02980341|158200716|FG001|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
49099723|NCT02980341|158200717|FG002|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
49099724|NCT02980341|158200718|FG003|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
49099725|NCT02980341|158200719|FG004|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
49099726|NCT02980341|158200720|FG005|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
49099727|NCT02980341|158200721|FG006|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
49099728|NCT02980341|158200722|FG007|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
49099729|NCT02980341|158200723|FG008|Dose Expansion|Due to investigator's decision due to patient's general condition|1|||
49099730|NCT02980341|158200724|FG009|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
49099731|NCT02980341|158200725|FG010|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
49099732|NCT02980341|158200715|FG000|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
49099733|NCT02980341|158200716|FG001|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
49099734|NCT02980341|158200717|FG002|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
49099735|NCT02980341|158200718|FG003|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
49099736|NCT02980341|158200719|FG004|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
49099737|NCT02980341|158200720|FG005|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
49099738|NCT02980341|158200721|FG006|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
49099739|NCT02980341|158200722|FG007|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
49099740|NCT02980341|158200723|FG008|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|1|||
49099741|NCT02980341|158200724|FG009|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
49099742|NCT02980341|158200725|FG010|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
49099743|NCT02980341|158200715|FG000|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
49099744|NCT02980341|158200716|FG001|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
49099745|NCT02980341|158200717|FG002|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
49099746|NCT02980341|158200718|FG003|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
49099747|NCT02980341|158200719|FG004|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
49099748|NCT02980341|158200720|FG005|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
49099749|NCT02980341|158200721|FG006|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
49099750|NCT02980341|158200722|FG007|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
49099751|NCT02980341|158200723|FG008|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
49099752|NCT02980341|158200724|FG009|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
49099753|NCT02980341|158200725|FG010|Dose Expansion|Patient withdrew consent following 50 treatment cycles|1|||
49099754|NCT02256982|158200726|FG000|Overall Study|Disease Progression|0|||
49099755|NCT02256982|158200727|FG001|Overall Study|Disease Progression|1|||
49099756|NCT03075891|158200728|FG000|Overall Study|Withdrawal by Subject|3|||
49099757|NCT03075891|158200729|FG001|Overall Study|Withdrawal by Subject|6|||
49099758|NCT03075891|158200728|FG000|Overall Study|Lost to Follow-up|1|||
49099759|NCT03075891|158200729|FG001|Overall Study|Lost to Follow-up|0|||
49099760|NCT03075891|158200728|FG000|Overall Study|Pregnancy|3|||
49099761|NCT03075891|158200729|FG001|Overall Study|Pregnancy|1|||
49099762|NCT03075891|158200728|FG000|Overall Study|visits not performed (no time)|1|||
49099763|NCT03075891|158200729|FG001|Overall Study|visits not performed (no time)|0|||
49099764|NCT03075891|158200728|FG000|Overall Study|Drug abuse relapse issue|0|||
49099765|NCT03075891|158200729|FG001|Overall Study|Drug abuse relapse issue|1|||
49099766|NCT03075891|158200728|FG000|Overall Study|Participant requiring study withdrawal|0|||
49099767|NCT03075891|158200729|FG001|Overall Study|Participant requiring study withdrawal|1|||
49099768|NCT03075891|158200728|FG000|Overall Study|Adverse event, non-fatal|1|||
49099769|NCT03075891|158200729|FG001|Overall Study|Adverse event, non-fatal|4|||
49099770|NCT03614078|158200730|FG000|Overall Study|Withdrawal by Subject|2|||
49099771|NCT03614078|158200731|FG001|Overall Study|Withdrawal by Subject|2|||
49099772|NCT03614078|158200732|FG002|Overall Study|Withdrawal by Subject|3|||
49099773|NCT03614078|158200730|FG000|Overall Study|Participant Did Not Return for Visit|0|||
49099774|NCT03614078|158200731|FG001|Overall Study|Participant Did Not Return for Visit|1|||
49099775|NCT03614078|158200732|FG002|Overall Study|Participant Did Not Return for Visit|0|||
49099776|NCT03614078|158200730|FG000|Overall Study|High Neutrophils|0|||
49099777|NCT03614078|158200731|FG001|Overall Study|High Neutrophils|0|||
49099778|NCT03614078|158200732|FG002|Overall Study|High Neutrophils|2|||
49099779|NCT03614078|158200730|FG000|Overall Study|Patient Did Not Meet Eligibility|1|||
49099780|NCT03614078|158200731|FG001|Overall Study|Patient Did Not Meet Eligibility|0|||
49099781|NCT03614078|158200732|FG002|Overall Study|Patient Did Not Meet Eligibility|0|||
49099782|NCT03614078|158200730|FG000|Overall Study|Exacerbation of Psoriasis|0|||
49099783|NCT03614078|158200731|FG001|Overall Study|Exacerbation of Psoriasis|1|||
49099784|NCT03614078|158200732|FG002|Overall Study|Exacerbation of Psoriasis|0|||
49099785|NCT03614078|158200730|FG000|Overall Study|Adverse Event|0|||
49099786|NCT03614078|158200731|FG001|Overall Study|Adverse Event|2|||
49099787|NCT03614078|158200732|FG002|Overall Study|Adverse Event|0|||
49099788|NCT03614078|158200730|FG000|Overall Study|Dizziness and Rash|0|||
49099789|NCT03614078|158200731|FG001|Overall Study|Dizziness and Rash|1|||
49099790|NCT03614078|158200732|FG002|Overall Study|Dizziness and Rash|0|||
49099791|NCT05174949|158200736|FG000|Overall Study|Physician Decision|1|||
49099792|NCT05174949|158200737|FG001|Overall Study|Physician Decision|2|||
49099793|NCT05174949|158200738|FG002|Overall Study|Physician Decision|0|||
49099794|NCT05174949|158200739|FG003|Overall Study|Physician Decision|1|||
49099795|NCT05174949|158200740|FG004|Overall Study|Physician Decision|0|||
49099796|NCT05174949|158200741|FG005|Overall Study|Physician Decision|0|||
49099797|NCT05174949|158200736|FG000|Overall Study|Withdrawal by Subject|0|||
49099798|NCT05174949|158200737|FG001|Overall Study|Withdrawal by Subject|1|||
49099799|NCT05174949|158200738|FG002|Overall Study|Withdrawal by Subject|0|||
49099800|NCT05174949|158200739|FG003|Overall Study|Withdrawal by Subject|0|||
49099801|NCT05174949|158200740|FG004|Overall Study|Withdrawal by Subject|0|||
49099802|NCT05174949|158200741|FG005|Overall Study|Withdrawal by Subject|0|||
49099803|NCT05174949|158200736|FG000|Overall Study|Lost to Follow-up|0|||
49099804|NCT05174949|158200737|FG001|Overall Study|Lost to Follow-up|0|||
49099805|NCT05174949|158200738|FG002|Overall Study|Lost to Follow-up|0|||
49099806|NCT05174949|158200739|FG003|Overall Study|Lost to Follow-up|1|||
49099807|NCT05174949|158200740|FG004|Overall Study|Lost to Follow-up|0|||
49099808|NCT05174949|158200741|FG005|Overall Study|Lost to Follow-up|0|||
49099809|NCT02951533|158200742|FG000|Part I (Week 0 Through Week 24)|Adverse Event|0|||
49099810|NCT02951533|158200743|FG001|Part I (Week 0 Through Week 24)|Adverse Event|16|||
49099811|NCT02951533|158200744|FG002|Part I (Week 0 Through Week 24)|Adverse Event|0|||
49099812|NCT02951533|158200742|FG000|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
49099813|NCT02951533|158200743|FG001|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
49099814|NCT02951533|158200744|FG002|Part I (Week 0 Through Week 24)|Lost to Follow-up|0|||
49099815|NCT02951533|158200742|FG000|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2|||
49099816|NCT02951533|158200743|FG001|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4|||
49099817|NCT02951533|158200744|FG002|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0|||
49099818|NCT02951533|158200742|FG000|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
49099819|NCT02951533|158200743|FG001|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1|||
49099820|NCT02951533|158200744|FG002|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
49099821|NCT02951533|158200742|FG000|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
49099822|NCT02951533|158200743|FG001|Part IIa (Week 24 Through Week 32)|Adverse Event|1|||
49099823|NCT02951533|158200744|FG002|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
49099824|NCT02951533|158200742|FG000|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1|||
49099825|NCT02951533|158200743|FG001|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
49099826|NCT02951533|158200744|FG002|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
49099827|NCT02951533|158200742|FG000|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
49099828|NCT02951533|158200743|FG001|Part IIb (Week 32 Through Week 56)|Adverse Event|2|||
49099829|NCT02951533|158200744|FG002|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
49099830|NCT02951533|158200742|FG000|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1|||
49099831|NCT02951533|158200743|FG001|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2|||
49099832|NCT02951533|158200744|FG002|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0|||
49099833|NCT02951533|158200742|FG000|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1|||
49099834|NCT02951533|158200743|FG001|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
49099835|NCT02951533|158200744|FG002|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
49099836|NCT02951533|158200742|FG000|Part III (Week 64 Through Week 100)|Lost to Follow-up|1|||
49099837|NCT02951533|158200743|FG001|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
49099838|NCT02951533|158200744|FG002|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
49099839|NCT02951533|158200742|FG000|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
49099840|NCT02951533|158200743|FG001|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0|||
49099841|NCT02951533|158200744|FG002|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
49099842|NCT01500187|158200745|FG000|Overall Study|Lost to Follow-up|6|||
49099843|NCT01500187|158200746|FG001|Overall Study|Lost to Follow-up|0|||
49099844|NCT01106677|158200747|FG000|Core Period: Baseline to Week 26|Adverse Event|7|||
49099845|NCT01106677|158200748|FG001|Core Period: Baseline to Week 26|Adverse Event|18|||
49099846|NCT01106677|158200749|FG002|Core Period: Baseline to Week 26|Adverse Event|6|||
49099847|NCT01106677|158200750|FG003|Core Period: Baseline to Week 26|Adverse Event|8|||
49099848|NCT01106677|158200747|FG000|Core Period: Baseline to Week 26|Death|0|||
49099849|NCT01106677|158200748|FG001|Core Period: Baseline to Week 26|Death|0|||
49099850|NCT01106677|158200749|FG002|Core Period: Baseline to Week 26|Death|1|||
49099851|NCT01106677|158200750|FG003|Core Period: Baseline to Week 26|Death|0|||
49099852|NCT01106677|158200747|FG000|Core Period: Baseline to Week 26|Lack of Efficacy|1|||
49099853|NCT01106677|158200748|FG001|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
49099854|NCT01106677|158200749|FG002|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
49099855|NCT01106677|158200750|FG003|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
49099856|NCT01106677|158200747|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
49099857|NCT01106677|158200748|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
49099858|NCT01106677|158200749|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|6|||
49099859|NCT01106677|158200750|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
49099860|NCT01106677|158200747|FG000|Core Period: Baseline to Week 26|Physician Decision|2|||
49099861|NCT01106677|158200748|FG001|Core Period: Baseline to Week 26|Physician Decision|1|||
49099862|NCT01106677|158200749|FG002|Core Period: Baseline to Week 26|Physician Decision|3|||
49099863|NCT01106677|158200750|FG003|Core Period: Baseline to Week 26|Physician Decision|1|||
49099864|NCT01106677|158200747|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
49099865|NCT01106677|158200748|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
49099866|NCT01106677|158200749|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
49099867|NCT01106677|158200750|FG003|Core Period: Baseline to Week 26|Protocol Violation|3|||
49099868|NCT01106677|158200747|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|5|||
49099869|NCT01106677|158200748|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
49099870|NCT01106677|158200749|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
49099871|NCT01106677|158200750|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
49099872|NCT01106677|158200747|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
49099873|NCT01106677|158200748|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
49099874|NCT01106677|158200749|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
49099875|NCT01106677|158200750|FG003|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
49099876|NCT01106677|158200747|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
49099877|NCT01106677|158200748|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
49099878|NCT01106677|158200749|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
49099879|NCT01106677|158200750|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
49099880|NCT01106677|158200747|FG000|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
49099881|NCT01106677|158200748|FG001|Core Period: Baseline to Week 26|Study terminated by sponsor|1|||
49099882|NCT01106677|158200749|FG002|Core Period: Baseline to Week 26|Study terminated by sponsor|2|||
49099883|NCT01106677|158200750|FG003|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
49099884|NCT01106677|158200747|FG000|Core Period: Baseline to Week 26|Product quality complaint|0|||
49099885|NCT01106677|158200748|FG001|Core Period: Baseline to Week 26|Product quality complaint|1|||
49099886|NCT01106677|158200749|FG002|Core Period: Baseline to Week 26|Product quality complaint|1|||
49099887|NCT01106677|158200750|FG003|Core Period: Baseline to Week 26|Product quality complaint|0|||
49099888|NCT01106677|158200747|FG000|Core Period: Baseline to Week 26|Other|8|||
49099889|NCT01106677|158200748|FG001|Core Period: Baseline to Week 26|Other|14|||
49099890|NCT01106677|158200749|FG002|Core Period: Baseline to Week 26|Other|8|||
49099891|NCT01106677|158200750|FG003|Core Period: Baseline to Week 26|Other|23|||
49099892|NCT01106677|158200747|FG000|Core Period: Baseline to Week 26|Pregnancy|0|||
49099893|NCT01106677|158200748|FG001|Core Period: Baseline to Week 26|Pregnancy|1|||
49099894|NCT01106677|158200749|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
49099895|NCT01106677|158200750|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
49099896|NCT01106677|158200747|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
49099897|NCT01106677|158200748|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
49099898|NCT01106677|158200749|FG002|Extension Period: Week 26 to Week 52|Adverse Event|5|||
49099899|NCT01106677|158200750|FG003|Extension Period: Week 26 to Week 52|Adverse Event|9|||
49099900|NCT01106677|158200747|FG000|Extension Period: Week 26 to Week 52|Death|0|||
49099901|NCT01106677|158200748|FG001|Extension Period: Week 26 to Week 52|Death|0|||
49099902|NCT01106677|158200749|FG002|Extension Period: Week 26 to Week 52|Death|0|||
49099903|NCT01106677|158200750|FG003|Extension Period: Week 26 to Week 52|Death|1|||
49099904|NCT01106677|158200747|FG000|Extension Period: Week 26 to Week 52|Lack of Efficacy|2|||
49099905|NCT01106677|158200748|FG001|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
49099906|NCT01106677|158200749|FG002|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
49099907|NCT01106677|158200750|FG003|Extension Period: Week 26 to Week 52|Lack of Efficacy|4|||
49099908|NCT01106677|158200747|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
49099909|NCT01106677|158200748|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
49099910|NCT01106677|158200749|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
49099911|NCT01106677|158200750|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
49099912|NCT01106677|158200747|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
49099913|NCT01106677|158200748|FG001|Extension Period: Week 26 to Week 52|Physician Decision|3|||
49099914|NCT01106677|158200749|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
49099915|NCT01106677|158200750|FG003|Extension Period: Week 26 to Week 52|Physician Decision|3|||
49099916|NCT01106677|158200747|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
49099917|NCT01106677|158200748|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
49099918|NCT01106677|158200749|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
49099919|NCT01106677|158200750|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
49099920|NCT01106677|158200747|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
49099921|NCT01106677|158200748|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3|||
49099922|NCT01106677|158200749|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
49099923|NCT01106677|158200750|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
49099924|NCT01106677|158200747|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
49099925|NCT01106677|158200748|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
49099926|NCT01106677|158200749|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3|||
49099927|NCT01106677|158200750|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
49099928|NCT01106677|158200747|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
49099929|NCT01106677|158200748|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
49099930|NCT01106677|158200749|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
49099931|NCT01106677|158200750|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
49099932|NCT01106677|158200747|FG000|Extension Period: Week 26 to Week 52|Other|6|||
49099933|NCT01106677|158200748|FG001|Extension Period: Week 26 to Week 52|Other|5|||
49099934|NCT01106677|158200749|FG002|Extension Period: Week 26 to Week 52|Other|8|||
49099935|NCT01106677|158200750|FG003|Extension Period: Week 26 to Week 52|Other|5|||
49099936|NCT02029989|158200751|FG000|Overall Study|Withdrawal by Subject|1|||
49099937|NCT02029989|158200752|FG001|Overall Study|Withdrawal by Subject|0|||
49099938|NCT02029989|158200751|FG000|Overall Study|Withdrawal: Fear of needles|1|||
49099939|NCT02029989|158200752|FG001|Overall Study|Withdrawal: Fear of needles|0|||
49099940|NCT02029989|158200751|FG000|Overall Study|Change of location|2|||
49099941|NCT02029989|158200752|FG001|Overall Study|Change of location|3|||
49099942|NCT02029989|158200751|FG000|Overall Study|Physician Decision|2|||
49099943|NCT02029989|158200752|FG001|Overall Study|Physician Decision|0|||
49099944|NCT02029989|158200751|FG000|Overall Study|Lost to Follow-up|9|||
49099945|NCT02029989|158200752|FG001|Overall Study|Lost to Follow-up|7|||
49099946|NCT02029989|158200751|FG000|Overall Study|Death|0|||
49099947|NCT02029989|158200752|FG001|Overall Study|Death|1|||
49099948|NCT02029989|158200751|FG000|Overall Study|Protocol Violation|1|||
49099949|NCT02029989|158200752|FG001|Overall Study|Protocol Violation|0|||
49099950|NCT03843632|158200753|FG000|Overall Study|Withdrawal by Subject|1|||
49099951|NCT03843632|158200754|FG001|Overall Study|Withdrawal by Subject|0|||
49099952|NCT03843632|158200755|FG002|Overall Study|Withdrawal by Subject|0|||
49099953|NCT03843632|158200756|FG003|Overall Study|Withdrawal by Subject|0|||
49099954|NCT04351373|158200762|FG000|Overall Study|Intraoperative diagnosis of facial nerve schwannoma|1|||
49099955|NCT03403751|158200765|FG000|Overall Study|Death|5|||
49099956|NCT03403751|158200766|FG001|Overall Study|Death|6|||
49099957|NCT03403751|158200765|FG000|Overall Study|Discontinuation (includes missing from Day 29)|2|||
49099958|NCT03403751|158200766|FG001|Overall Study|Discontinuation (includes missing from Day 29)|2|||
49099959|NCT00381043|158200768|FG000|Overall Study|Lost to Follow-up|8|||
49099960|NCT00381043|158200769|FG001|Overall Study|Lost to Follow-up|6|||
49099961|NCT00381043|158200768|FG000|Overall Study|Withdrawal by Subject|3|||
49099962|NCT00381043|158200769|FG001|Overall Study|Withdrawal by Subject|1|||
49099963|NCT00381043|158200768|FG000|Overall Study|wanted more care|0|||
49099964|NCT00381043|158200769|FG001|Overall Study|wanted more care|1|||
49099965|NCT00381043|158200768|FG000|Overall Study|incarcerated|1|||
49099966|NCT00381043|158200769|FG001|Overall Study|incarcerated|0|||
49099967|NCT01123941|158200772|FG000|Overall Study|Lost to Follow-up|2|||
49099968|NCT01123941|158200773|FG001|Overall Study|Lost to Follow-up|1|||
49099969|NCT04050124|158200774|FG000|Overall Study|Death|1|||
49099970|NCT04050124|158200775|FG001|Overall Study|Death|0|||
49099971|NCT00595517|158200776|FG000|Overall Study|Adverse Event|6|||
49099972|NCT00595517|158200776|FG000|Overall Study|Withdrawal by Subject|4|||
49099973|NCT00595517|158200776|FG000|Overall Study|Protocol Violation|2|||
49099974|NCT00595517|158200776|FG000|Overall Study|Recurrence of ulcer|5|||
49099975|NCT00595517|158200776|FG000|Overall Study|usage of prohibited treatment|1|||
49099976|NCT00595517|158200776|FG000|Overall Study|No intention to attend regularly|1|||
49099977|NCT00471718|158200777|FG000|Overall Study|Adverse Event|3|||
49099978|NCT00471718|158200777|FG000|Overall Study|other complicating disease|1|||
49099979|NCT00471718|158200777|FG000|Overall Study|disease progression|22|||
49099980|NCT00471718|158200777|FG000|Overall Study|Withdrawal by Subject|1|||
49099981|NCT01940900|158200784|FG000|Overall Study|Physician Decision|4|||
49099982|NCT01940900|158200785|FG001|Overall Study|Physician Decision|0|||
49099983|NCT01940900|158200784|FG000|Overall Study|Adverse Event|10|||
49099984|NCT01940900|158200785|FG001|Overall Study|Adverse Event|15|||
49099985|NCT01940900|158200784|FG000|Overall Study|Withdrawal by Subject|11|||
49099986|NCT01940900|158200785|FG001|Overall Study|Withdrawal by Subject|15|||
49099987|NCT01940900|158200784|FG000|Overall Study|Lost to Follow-up|1|||
49099988|NCT01940900|158200785|FG001|Overall Study|Lost to Follow-up|0|||
49099989|NCT01940900|158200784|FG000|Overall Study|Sponsor Decision|1|||
49099990|NCT01940900|158200785|FG001|Overall Study|Sponsor Decision|0|||
49099991|NCT01940900|158200784|FG000|Overall Study|subject non-compliance|1|||
49099992|NCT01940900|158200785|FG001|Overall Study|subject non-compliance|1|||
49099993|NCT01940900|158200784|FG000|Overall Study|other|1|||
49099994|NCT01940900|158200785|FG001|Overall Study|other|0|||
49099995|NCT02396420|158200790|FG000|Overall Study|Death|1|||
49099996|NCT03395184|158200791|FG000|Induction Period (Up to 12 Weeks)|Adverse Event|6|||
49099997|NCT03395184|158200792|FG001|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
49099998|NCT03395184|158200793|FG002|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
49099999|NCT03395184|158200794|FG003|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
49100000|NCT03395184|158200795|FG004|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
49100001|NCT03395184|158200796|FG005|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
49100002|NCT03395184|158200797|FG006|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
49100003|NCT03395184|158200791|FG000|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
49100004|NCT03395184|158200792|FG001|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|2|||
49100005|NCT03395184|158200793|FG002|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|1|||
49100006|NCT03395184|158200794|FG003|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
49100007|NCT03395184|158200795|FG004|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
49111398|NCT00534105|158242891|FG001|Overall Study|Lost to Follow-up|39|||
49100008|NCT03395184|158200796|FG005|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
49100009|NCT03395184|158200797|FG006|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
49100010|NCT03395184|158200791|FG000|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
49100011|NCT03395184|158200792|FG001|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
49100012|NCT03395184|158200793|FG002|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
49100013|NCT03395184|158200794|FG003|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
49100014|NCT03395184|158200795|FG004|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
49100015|NCT03395184|158200796|FG005|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
49100016|NCT03395184|158200797|FG006|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
49100017|NCT03395184|158200791|FG000|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
49100018|NCT03395184|158200792|FG001|Induction Period (Up to 12 Weeks)|Lost to Follow-up|1|||
49100019|NCT03395184|158200793|FG002|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
49100020|NCT03395184|158200794|FG003|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
49100021|NCT03395184|158200795|FG004|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
49100022|NCT03395184|158200796|FG005|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
49100023|NCT03395184|158200797|FG006|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
49100024|NCT03395184|158200791|FG000|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
49100025|NCT03395184|158200792|FG001|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
49100026|NCT03395184|158200793|FG002|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
49100027|NCT03395184|158200794|FG003|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
49100028|NCT03395184|158200795|FG004|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
49100029|NCT03395184|158200796|FG005|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
49100030|NCT03395184|158200797|FG006|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
49100031|NCT03395184|158200791|FG000|Induction Period (Up to 12 Weeks)|Other|1|||
49100032|NCT03395184|158200792|FG001|Induction Period (Up to 12 Weeks)|Other|0|||
49100033|NCT03395184|158200793|FG002|Induction Period (Up to 12 Weeks)|Other|0|||
49100034|NCT03395184|158200794|FG003|Induction Period (Up to 12 Weeks)|Other|0|||
49100035|NCT03395184|158200795|FG004|Induction Period (Up to 12 Weeks)|Other|0|||
49100036|NCT03395184|158200796|FG005|Induction Period (Up to 12 Weeks)|Other|0|||
49100037|NCT03395184|158200797|FG006|Induction Period (Up to 12 Weeks)|Other|0|||
49100038|NCT03395184|158200791|FG000|OLE Period (Up to 52 Weeks)|Other|0|||
49100039|NCT03395184|158200792|FG001|OLE Period (Up to 52 Weeks)|Other|0|||
49100040|NCT03395184|158200793|FG002|OLE Period (Up to 52 Weeks)|Other|0|||
49100041|NCT03395184|158200794|FG003|OLE Period (Up to 52 Weeks)|Other|0|||
49100042|NCT03395184|158200795|FG004|OLE Period (Up to 52 Weeks)|Other|2|||
49100043|NCT03395184|158200796|FG005|OLE Period (Up to 52 Weeks)|Other|0|||
49100044|NCT03395184|158200797|FG006|OLE Period (Up to 52 Weeks)|Other|2|||
49100045|NCT03395184|158200791|FG000|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
49100046|NCT03395184|158200792|FG001|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
49100047|NCT03395184|158200793|FG002|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
49100048|NCT03395184|158200794|FG003|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
49100049|NCT03395184|158200795|FG004|OLE Period (Up to 52 Weeks)|Lack of Efficacy|11|||
49100050|NCT03395184|158200796|FG005|OLE Period (Up to 52 Weeks)|Lack of Efficacy|3|||
49100051|NCT03395184|158200797|FG006|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
49100052|NCT03395184|158200791|FG000|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
49100053|NCT03395184|158200792|FG001|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
49100054|NCT03395184|158200793|FG002|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
49100055|NCT03395184|158200794|FG003|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
49100056|NCT03395184|158200795|FG004|OLE Period (Up to 52 Weeks)|Lost to Follow-up|2|||
49100057|NCT03395184|158200796|FG005|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
49100058|NCT03395184|158200797|FG006|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
49100059|NCT03395184|158200791|FG000|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
49100060|NCT03395184|158200792|FG001|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
49100061|NCT03395184|158200793|FG002|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
49100062|NCT03395184|158200794|FG003|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
49100063|NCT03395184|158200795|FG004|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|11|||
49100064|NCT03395184|158200796|FG005|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
49100065|NCT03395184|158200797|FG006|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|8|||
49100066|NCT03395184|158200791|FG000|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
49100067|NCT03395184|158200792|FG001|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
49100068|NCT03395184|158200793|FG002|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
49100069|NCT03395184|158200794|FG003|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
49100070|NCT03395184|158200795|FG004|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
49100071|NCT03395184|158200796|FG005|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
49100072|NCT03395184|158200797|FG006|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
49100073|NCT03395184|158200791|FG000|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
49100074|NCT03395184|158200792|FG001|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
49100075|NCT03395184|158200793|FG002|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
49100076|NCT03395184|158200794|FG003|OLE Period (Up to 52 Weeks)|Adverse Event|7|||
49100077|NCT03395184|158200795|FG004|OLE Period (Up to 52 Weeks)|Adverse Event|13|||
49100078|NCT03395184|158200796|FG005|OLE Period (Up to 52 Weeks)|Adverse Event|4|||
49100079|NCT03395184|158200797|FG006|OLE Period (Up to 52 Weeks)|Adverse Event|15|||
49100080|NCT01095978|158200798|FG000|Overall Study|Did not take Klacid SR|2|||
49100081|NCT01095978|158200798|FG000|Overall Study|Adverse Event|1|||
49100082|NCT02135107|158200799|FG000|Treatment Period|Withdrawal by Subject|11|||
49100083|NCT02135107|158200800|FG001|Treatment Period|Withdrawal by Subject|0|||
49100084|NCT02135107|158200801|FG002|Treatment Period|Withdrawal by Subject|0|||
49100085|NCT02135107|158200802|FG003|Treatment Period|Withdrawal by Subject|0|||
49100086|NCT02135107|158200799|FG000|Treatment Period|Adverse Event|5|||
49100087|NCT02135107|158200800|FG001|Treatment Period|Adverse Event|2|||
49100088|NCT02135107|158200801|FG002|Treatment Period|Adverse Event|0|||
49100089|NCT02135107|158200802|FG003|Treatment Period|Adverse Event|0|||
49100090|NCT02135107|158200799|FG000|Treatment Period|Pregnancy|1|||
49100091|NCT02135107|158200800|FG001|Treatment Period|Pregnancy|0|||
49100092|NCT02135107|158200801|FG002|Treatment Period|Pregnancy|0|||
49100093|NCT02135107|158200802|FG003|Treatment Period|Pregnancy|0|||
49100094|NCT02135107|158200799|FG000|Treatment Period|Other|115|||
49100095|NCT02135107|158200800|FG001|Treatment Period|Other|24|||
49100096|NCT02135107|158200801|FG002|Treatment Period|Other|0|||
49100097|NCT02135107|158200802|FG003|Treatment Period|Other|0|||
49100098|NCT02135107|158200799|FG000|Maintenance Therapy Period|Adverse Event|0|||
49100099|NCT02135107|158200800|FG001|Maintenance Therapy Period|Adverse Event|0|||
49100100|NCT02135107|158200801|FG002|Maintenance Therapy Period|Adverse Event|3|||
49100101|NCT02135107|158200802|FG003|Maintenance Therapy Period|Adverse Event|7|||
49100102|NCT02135107|158200799|FG000|Maintenance Therapy Period|Withdrawal by Subject|0|||
49100103|NCT02135107|158200800|FG001|Maintenance Therapy Period|Withdrawal by Subject|0|||
49100104|NCT02135107|158200801|FG002|Maintenance Therapy Period|Withdrawal by Subject|5|||
49100105|NCT02135107|158200802|FG003|Maintenance Therapy Period|Withdrawal by Subject|4|||
49100106|NCT02135107|158200799|FG000|Maintenance Therapy Period|Pregnancy|0|||
49100107|NCT02135107|158200800|FG001|Maintenance Therapy Period|Pregnancy|0|||
49100108|NCT02135107|158200801|FG002|Maintenance Therapy Period|Pregnancy|0|||
49100109|NCT02135107|158200802|FG003|Maintenance Therapy Period|Pregnancy|1|||
49100110|NCT02135107|158200799|FG000|Maintenance Therapy Period|Other|0|||
49100111|NCT02135107|158200800|FG001|Maintenance Therapy Period|Other|0|||
49100112|NCT02135107|158200801|FG002|Maintenance Therapy Period|Other|7|||
49100113|NCT02135107|158200802|FG003|Maintenance Therapy Period|Other|8|||
49100114|NCT00474045|158200803|FG000|Overall Study|Adverse Event|18|||
49100115|NCT00474045|158200804|FG001|Overall Study|Adverse Event|8|||
49100116|NCT00474045|158200803|FG000|Overall Study|Unclassified|1|||
49100117|NCT00474045|158200804|FG001|Overall Study|Unclassified|3|||
49100118|NCT00474045|158200803|FG000|Overall Study|Lack of Efficacy|0|||
49100119|NCT00474045|158200804|FG001|Overall Study|Lack of Efficacy|9|||
49100120|NCT00474045|158200803|FG000|Overall Study|Lost to Follow-up|1|||
49100121|NCT00474045|158200804|FG001|Overall Study|Lost to Follow-up|1|||
49100122|NCT00474045|158200803|FG000|Overall Study|Protocol Violation|10|||
49100123|NCT00474045|158200804|FG001|Overall Study|Protocol Violation|12|||
49100124|NCT00474045|158200803|FG000|Overall Study|Withdrawal by Subject|16|||
49100125|NCT00474045|158200804|FG001|Overall Study|Withdrawal by Subject|18|||
49100126|NCT00474045|158200803|FG000|Overall Study|Withdrawal criteria|60|||
49100127|NCT00474045|158200804|FG001|Overall Study|Withdrawal criteria|50|||
49100128|NCT02234596|158200807|FG000|Overall Study|Participant not treated|2|||
49100129|NCT00808639|158200808|FG000|Overall Study|Disease progression before surgery.|1|||
49100130|NCT03053063|158200811|FG000|Randomized Phase|Study Terminated by Sponsor|326|||
49100131|NCT03053063|158200812|FG001|Randomized Phase|Study Terminated by Sponsor|317|||
49100132|NCT03053063|158200813|FG002|Randomized Phase|Study Terminated by Sponsor|161|||
49100133|NCT03053063|158200814|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
49100134|NCT03053063|158200811|FG000|Randomized Phase|Withdrew consent|8|||
49100135|NCT03053063|158200812|FG001|Randomized Phase|Withdrew consent|11|||
49100136|NCT03053063|158200813|FG002|Randomized Phase|Withdrew consent|5|||
49100137|NCT03053063|158200814|FG003|Randomized Phase|Withdrew consent|0|||
49100138|NCT03053063|158200811|FG000|Randomized Phase|Investigator's Discretion|8|||
49100139|NCT03053063|158200812|FG001|Randomized Phase|Investigator's Discretion|6|||
49100140|NCT03053063|158200813|FG002|Randomized Phase|Investigator's Discretion|2|||
49100141|NCT03053063|158200814|FG003|Randomized Phase|Investigator's Discretion|0|||
49100142|NCT03053063|158200811|FG000|Randomized Phase|Lost to Follow-up|3|||
49100143|NCT03053063|158200812|FG001|Randomized Phase|Lost to Follow-up|5|||
49100144|NCT03053063|158200813|FG002|Randomized Phase|Lost to Follow-up|1|||
49100145|NCT03053063|158200814|FG003|Randomized Phase|Lost to Follow-up|0|||
49100146|NCT03053063|158200811|FG000|Randomized Phase|Adverse Event|0|||
49100147|NCT03053063|158200812|FG001|Randomized Phase|Adverse Event|1|||
49100148|NCT03053063|158200813|FG002|Randomized Phase|Adverse Event|0|||
49100149|NCT03053063|158200814|FG003|Randomized Phase|Adverse Event|0|||
49100150|NCT03053063|158200811|FG000|Randomized Phase|Randomized but Never Treated|1|||
49100151|NCT03053063|158200812|FG001|Randomized Phase|Randomized but Never Treated|3|||
49100152|NCT03053063|158200813|FG002|Randomized Phase|Randomized but Never Treated|2|||
49100153|NCT03053063|158200814|FG003|Randomized Phase|Randomized but Never Treated|0|||
49100154|NCT03053063|158200811|FG000|Randomized Phase|Entered the Open-Label Phase|9|||
49100155|NCT03053063|158200812|FG001|Randomized Phase|Entered the Open-Label Phase|11|||
49100156|NCT03053063|158200813|FG002|Randomized Phase|Entered the Open-Label Phase|3|||
49100157|NCT03053063|158200814|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
49100158|NCT03053063|158200811|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
49100159|NCT03053063|158200812|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
49100160|NCT03053063|158200813|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
49100161|NCT03053063|158200814|FG003|Open-Label Phase|Study Terminated by Sponsor|19|||
49100162|NCT03053063|158200811|FG000|Open-Label Phase|Death|0|||
49100163|NCT03053063|158200812|FG001|Open-Label Phase|Death|0|||
49100164|NCT03053063|158200813|FG002|Open-Label Phase|Death|0|||
49100165|NCT03053063|158200814|FG003|Open-Label Phase|Death|2|||
49100166|NCT03053063|158200811|FG000|Open-Label Phase|Investigator's discretion|0|||
49100167|NCT03053063|158200812|FG001|Open-Label Phase|Investigator's discretion|0|||
49100168|NCT03053063|158200813|FG002|Open-Label Phase|Investigator's discretion|0|||
49100169|NCT03053063|158200814|FG003|Open-Label Phase|Investigator's discretion|2|||
49100170|NCT02655016|158200815|FG000|Overall Study|Disease progression|6|||
49100171|NCT02655016|158200816|FG001|Overall Study|Disease progression|4|||
49100172|NCT02655016|158200815|FG000|Overall Study|Site closed|0|||
49100173|NCT02655016|158200816|FG001|Overall Study|Site closed|1|||
49100174|NCT02655016|158200815|FG000|Overall Study|Death|30|||
49100175|NCT02655016|158200816|FG001|Overall Study|Death|48|||
49100176|NCT02655016|158200815|FG000|Overall Study|Lost to Follow-up|1|||
49100177|NCT02655016|158200816|FG001|Overall Study|Lost to Follow-up|1|||
49100178|NCT02655016|158200815|FG000|Overall Study|Withdrawal by Subject|18|||
49100179|NCT02655016|158200816|FG001|Overall Study|Withdrawal by Subject|36|||
49100180|NCT03197324|158200817|FG000|Overall Study|Adverse Event|0|||
49100181|NCT03197324|158200818|FG001|Overall Study|Adverse Event|1|||
49100182|NCT00191282|158200824|FG000|Overall Study|Adverse Event|5|||
49100183|NCT00191282|158200825|FG001|Overall Study|Adverse Event|6|||
49100184|NCT00191282|158200824|FG000|Overall Study|Death|51|||
49100185|NCT00191282|158200825|FG001|Overall Study|Death|51|||
49100186|NCT00191282|158200824|FG000|Overall Study|Lack of Efficacy|11|||
49100187|NCT00191282|158200825|FG001|Overall Study|Lack of Efficacy|6|||
49100188|NCT00191282|158200824|FG000|Overall Study|Noncompliance|14|||
49100189|NCT00191282|158200825|FG001|Overall Study|Noncompliance|17|||
49100190|NCT00191282|158200824|FG000|Overall Study|Patient moved|11|||
49100191|NCT00191282|158200825|FG001|Overall Study|Patient moved|14|||
49100192|NCT00191282|158200824|FG000|Overall Study|Withdrawal by Subject|59|||
49100193|NCT00191282|158200825|FG001|Overall Study|Withdrawal by Subject|44|||
49100194|NCT00191282|158200824|FG000|Overall Study|Physician Decision|18|||
49100195|NCT00191282|158200825|FG001|Overall Study|Physician Decision|15|||
49100196|NCT00191282|158200824|FG000|Overall Study|Protocol entry criteria not met|14|||
49100197|NCT00191282|158200825|FG001|Overall Study|Protocol entry criteria not met|9|||
49100198|NCT00191282|158200824|FG000|Overall Study|Protocol Violation|9|||
49100199|NCT00191282|158200825|FG001|Overall Study|Protocol Violation|12|||
49100200|NCT00191282|158200824|FG000|Overall Study|Severity of outcome|2|||
49100201|NCT00191282|158200825|FG001|Overall Study|Severity of outcome|5|||
49100202|NCT00191282|158200824|FG000|Overall Study|Sponsor's decision|2|||
49100203|NCT00191282|158200825|FG001|Overall Study|Sponsor's decision|2|||
49100204|NCT00191282|158200824|FG000|Overall Study|Lost to Follow-up|24|||
49100205|NCT00191282|158200825|FG001|Overall Study|Lost to Follow-up|31|||
49100206|NCT00102531|158200826|FG000|Overall Study|Adverse Event|0|||
49100207|NCT00102531|158200827|FG001|Overall Study|Adverse Event|1|||
49100208|NCT00102531|158200826|FG000|Overall Study|Disease Progression|5|||
49100209|NCT00102531|158200827|FG001|Overall Study|Disease Progression|9|||
49100210|NCT00102531|158200826|FG000|Overall Study|Physician Decision|0|||
49100211|NCT00102531|158200827|FG001|Overall Study|Physician Decision|1|||
49100212|NCT00954512|158200829|FG000|Overall Study|Withdrawal by Subject|0|||
49100213|NCT00954512|158200830|FG001|Overall Study|Withdrawal by Subject|0|||
49100214|NCT00954512|158200831|FG002|Overall Study|Withdrawal by Subject|0|||
49100215|NCT00954512|158200832|FG003|Overall Study|Withdrawal by Subject|0|||
49100216|NCT00954512|158200833|FG004|Overall Study|Withdrawal by Subject|0|||
49100217|NCT00954512|158200834|FG005|Overall Study|Withdrawal by Subject|1|||
49100218|NCT00954512|158200829|FG000|Overall Study|Adverse Event|0|||
49100219|NCT00954512|158200830|FG001|Overall Study|Adverse Event|0|||
49100220|NCT00954512|158200831|FG002|Overall Study|Adverse Event|0|||
49100221|NCT00954512|158200832|FG003|Overall Study|Adverse Event|0|||
49100222|NCT00954512|158200833|FG004|Overall Study|Adverse Event|1|||
49100223|NCT00954512|158200834|FG005|Overall Study|Adverse Event|2|||
49100224|NCT00954512|158200829|FG000|Overall Study|Physician Decision|0|||
49100225|NCT00954512|158200830|FG001|Overall Study|Physician Decision|1|||
49100226|NCT00954512|158200831|FG002|Overall Study|Physician Decision|0|||
49100227|NCT00954512|158200832|FG003|Overall Study|Physician Decision|1|||
49100228|NCT00954512|158200833|FG004|Overall Study|Physician Decision|0|||
49100229|NCT00954512|158200834|FG005|Overall Study|Physician Decision|0|||
49100230|NCT00954512|158200829|FG000|Overall Study|Symptomatic Deterioration|0|||
49100231|NCT00954512|158200830|FG001|Overall Study|Symptomatic Deterioration|1|||
49100232|NCT00954512|158200831|FG002|Overall Study|Symptomatic Deterioration|0|||
49100233|NCT00954512|158200832|FG003|Overall Study|Symptomatic Deterioration|0|||
49100234|NCT00954512|158200833|FG004|Overall Study|Symptomatic Deterioration|2|||
49100235|NCT00954512|158200834|FG005|Overall Study|Symptomatic Deterioration|0|||
49100236|NCT00954512|158200829|FG000|Overall Study|Progression of Disease|2|||
49100237|NCT00954512|158200830|FG001|Overall Study|Progression of Disease|1|||
49100238|NCT00954512|158200831|FG002|Overall Study|Progression of Disease|0|||
49100239|NCT00954512|158200832|FG003|Overall Study|Progression of Disease|1|||
49100240|NCT00954512|158200833|FG004|Overall Study|Progression of Disease|1|||
49100241|NCT00954512|158200834|FG005|Overall Study|Progression of Disease|1|||
49100242|NCT00965341|158200836|FG000|Overall Study|Withdrew consent|1|||
49100243|NCT00965341|158200837|FG001|Overall Study|Withdrew consent|5|||
49100244|NCT00965341|158200836|FG000|Overall Study|Lost to Follow-up|1|||
49100245|NCT00965341|158200837|FG001|Overall Study|Lost to Follow-up|0|||
49100246|NCT00965341|158200836|FG000|Overall Study|Transportation issues|4|||
49100247|NCT00965341|158200837|FG001|Overall Study|Transportation issues|3|||
49100248|NCT01970475|158200843|FG000|Overall Study|Withdrawal by Subject|11|||
49100249|NCT01970475|158200844|FG001|Overall Study|Withdrawal by Subject|6|||
49100250|NCT01970475|158200843|FG000|Overall Study|Adverse Event|7|||
49100251|NCT01970475|158200844|FG001|Overall Study|Adverse Event|3|||
49100252|NCT01970475|158200843|FG000|Overall Study|Lost to Follow-up|2|||
49100253|NCT01970475|158200844|FG001|Overall Study|Lost to Follow-up|2|||
49100254|NCT01970475|158200843|FG000|Overall Study|Protocol Violation|1|||
49100255|NCT01970475|158200844|FG001|Overall Study|Protocol Violation|0|||
49100256|NCT00073983|158200845|FG000|Overall Study|not evaluable|1|||
49100257|NCT03057054|158200846|FG000|Overall Study|Death|4|||
49100258|NCT03057054|158200847|FG001|Overall Study|Death|4|||
49100259|NCT03057054|158200846|FG000|Overall Study|Withdrawal by Subject|6|||
49100260|NCT03057054|158200847|FG001|Overall Study|Withdrawal by Subject|3|||
49100261|NCT03057054|158200846|FG000|Overall Study|Ineligible|1|||
49100262|NCT03057054|158200847|FG001|Overall Study|Ineligible|1|||
49100263|NCT04756154|158200848|FG000|Overall Study|Did not meet treatment day baseline|30|||
49100264|NCT04756154|158200849|FG001|Overall Study|Did not meet treatment day baseline|28|||
49100265|NCT04756154|158200850|FG002|Overall Study|Did not meet treatment day baseline|7|||
49100266|NCT04756154|158200848|FG000|Overall Study|Did not return for final sample collection|1|||
49100267|NCT04756154|158200849|FG001|Overall Study|Did not return for final sample collection|1|||
49100268|NCT04756154|158200850|FG002|Overall Study|Did not return for final sample collection|0|||
49100269|NCT03200704|158202144|FG000|Overall Study|Withdrawal by Subject|1|||
49100270|NCT00076752|158202152|FG000|Overall Study|Death|2|||
49100271|NCT00076752|158202152|FG000|Overall Study|Withdrawal per PI, PI put study on hold|1|||
49100272|NCT03854370|158202153|FG000|Overall Study|samples not collected|1|||
49100273|NCT03854370|158202154|FG001|Overall Study|samples not collected|1|||
49100274|NCT03854370|158202155|FG002|Overall Study|samples not collected|1|||
49100275|NCT03854370|158202156|FG003|Overall Study|samples not collected|1|||
49100276|NCT00452673|158202159|FG000|Dose Escalation Period|Disease Progression|6|||
49100277|NCT00452673|158202160|FG001|Dose Escalation Period|Disease Progression|6|||
49100278|NCT00452673|158202161|FG002|Dose Escalation Period|Disease Progression|2|||
49100279|NCT00452673|158202162|FG003|Dose Escalation Period|Disease Progression|6|||
49100280|NCT00452673|158202163|FG004|Dose Escalation Period|Disease Progression|0|||
49100281|NCT00452673|158202159|FG000|Dose Escalation Period|study drug toxicity|1|||
49100282|NCT00452673|158202160|FG001|Dose Escalation Period|study drug toxicity|3|||
49100283|NCT00452673|158202161|FG002|Dose Escalation Period|study drug toxicity|3|||
49100284|NCT00452673|158202162|FG003|Dose Escalation Period|study drug toxicity|1|||
49100285|NCT00452673|158202163|FG004|Dose Escalation Period|study drug toxicity|0|||
49100286|NCT00452673|158202159|FG000|Dose Escalation Period|Other|0|||
49100287|NCT00452673|158202160|FG001|Dose Escalation Period|Other|0|||
49100288|NCT00452673|158202161|FG002|Dose Escalation Period|Other|1|||
49100289|NCT00452673|158202162|FG003|Dose Escalation Period|Other|0|||
49100290|NCT00452673|158202163|FG004|Dose Escalation Period|Other|0|||
49100291|NCT00452673|158202159|FG000|Dose Escalation Period|Adverse Event|0|||
49100292|NCT00452673|158202160|FG001|Dose Escalation Period|Adverse Event|0|||
49100293|NCT00452673|158202161|FG002|Dose Escalation Period|Adverse Event|0|||
49100294|NCT00452673|158202162|FG003|Dose Escalation Period|Adverse Event|1|||
49100295|NCT00452673|158202163|FG004|Dose Escalation Period|Adverse Event|0|||
49100296|NCT00452673|158202159|FG000|Dose Escalation Period|Withdrawal by Subject|0|||
49100297|NCT00452673|158202160|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
49100298|NCT00452673|158202161|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
49100299|NCT00452673|158202162|FG003|Dose Escalation Period|Withdrawal by Subject|1|||
49100300|NCT00452673|158202163|FG004|Dose Escalation Period|Withdrawal by Subject|0|||
49100301|NCT00452673|158202159|FG000|Dose Expansion Period|Disease Progression|0|||
49100302|NCT00452673|158202160|FG001|Dose Expansion Period|Disease Progression|0|||
49100303|NCT00452673|158202161|FG002|Dose Expansion Period|Disease Progression|0|||
49100304|NCT00452673|158202162|FG003|Dose Expansion Period|Disease Progression|0|||
49100305|NCT00452673|158202163|FG004|Dose Expansion Period|Disease Progression|19|||
49100306|NCT00452673|158202159|FG000|Dose Expansion Period|Other|0|||
49100307|NCT00452673|158202160|FG001|Dose Expansion Period|Other|0|||
49100308|NCT00452673|158202161|FG002|Dose Expansion Period|Other|0|||
49100309|NCT00452673|158202162|FG003|Dose Expansion Period|Other|0|||
49100310|NCT00452673|158202163|FG004|Dose Expansion Period|Other|2|||
49100311|NCT03030989|158202164|FG000|Overall Study|Fever|2|||
49100312|NCT03030989|158202165|FG001|Overall Study|Fever|2|||
49100313|NCT03030989|158202164|FG000|Overall Study|Rash|2|||
49100314|NCT03030989|158202165|FG001|Overall Study|Rash|1|||
49100315|NCT03030989|158202164|FG000|Overall Study|Fatigue/Overwhelmed|1|||
49100316|NCT03030989|158202165|FG001|Overall Study|Fatigue/Overwhelmed|5|||
49100317|NCT03030989|158202164|FG000|Overall Study|Positive Blood Cultures|2|||
49100318|NCT03030989|158202165|FG001|Overall Study|Positive Blood Cultures|1|||
49100319|NCT03030989|158202164|FG000|Overall Study|Line Removed|0|||
49100320|NCT03030989|158202165|FG001|Overall Study|Line Removed|2|||
49100321|NCT03030989|158202164|FG000|Overall Study|No longer interested|5|||
49100322|NCT03030989|158202165|FG001|Overall Study|No longer interested|3|||
49100323|NCT01346189|158202171|FG000|Overall Study|Withdrawal by Subject|7|||
49100324|NCT01346189|158202172|FG001|Overall Study|Withdrawal by Subject|5|||
49100325|NCT01346189|158202173|FG002|Overall Study|Withdrawal by Subject|3|||
49100326|NCT01346189|158202174|FG003|Overall Study|Withdrawal by Subject|5|||
49100327|NCT01346189|158202171|FG000|Overall Study|Physician Decision|4|||
49100328|NCT01346189|158202172|FG001|Overall Study|Physician Decision|0|||
49100329|NCT01346189|158202173|FG002|Overall Study|Physician Decision|0|||
49100330|NCT01346189|158202174|FG003|Overall Study|Physician Decision|0|||
49100331|NCT01346189|158202171|FG000|Overall Study|Moved|3|||
49100332|NCT01346189|158202172|FG001|Overall Study|Moved|0|||
49100333|NCT01346189|158202173|FG002|Overall Study|Moved|4|||
49100334|NCT01346189|158202174|FG003|Overall Study|Moved|0|||
49100335|NCT01346189|158202171|FG000|Overall Study|Other|2|||
49100336|NCT01346189|158202172|FG001|Overall Study|Other|4|||
49100337|NCT01346189|158202173|FG002|Overall Study|Other|7|||
49100338|NCT01346189|158202174|FG003|Overall Study|Other|3|||
49100339|NCT01346189|158202171|FG000|Overall Study|Death|0|||
49100340|NCT01346189|158202172|FG001|Overall Study|Death|3|||
49100341|NCT01346189|158202173|FG002|Overall Study|Death|0|||
49100342|NCT01346189|158202174|FG003|Overall Study|Death|0|||
49100343|NCT01346189|158202171|FG000|Overall Study|Non-health system primary care physician|0|||
49100344|NCT01346189|158202172|FG001|Overall Study|Non-health system primary care physician|5|||
49100345|NCT01346189|158202173|FG002|Overall Study|Non-health system primary care physician|0|||
49100346|NCT01346189|158202174|FG003|Overall Study|Non-health system primary care physician|0|||
49100347|NCT01346189|158202171|FG000|Overall Study|Travel|0|||
49100348|NCT01346189|158202172|FG001|Overall Study|Travel|0|||
49100349|NCT01346189|158202173|FG002|Overall Study|Travel|0|||
49100350|NCT01346189|158202174|FG003|Overall Study|Travel|3|||
49100351|NCT01075646|158202182|FG000|Overall Study|Lost to Follow-up|4|||
49100352|NCT01075646|158202183|FG001|Overall Study|Lost to Follow-up|3|||
49100353|NCT01075646|158202184|FG002|Overall Study|Lost to Follow-up|1|||
49100354|NCT01075646|158202185|FG003|Overall Study|Lost to Follow-up|2|||
49100355|NCT01730534|158202187|FG000|Overall Study|Withdrawal by Subject|97|||
49100356|NCT01730534|158202188|FG001|Overall Study|Withdrawal by Subject|127|||
49100357|NCT01730534|158202187|FG000|Overall Study|Lost to Follow-up|12|||
49100358|NCT01730534|158202188|FG001|Overall Study|Lost to Follow-up|18|||
49100359|NCT00791661|158202199|FG000|7 Day Wash-out|Adverse Event|0|||
49100360|NCT00791661|158202200|FG001|7 Day Wash-out|Adverse Event|0|||
49100361|NCT00791661|158202201|FG002|7 Day Wash-out|Adverse Event|1|||
49100362|NCT00791661|158202199|FG000|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
49100363|NCT00791661|158202200|FG001|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
49100364|NCT00791661|158202201|FG002|7 Day Wash-out|Abnormal Clinical Laboratory Test|1|||
49100365|NCT02004886|158202202|FG000|Overall Study|Adverse Event|0|||
49100366|NCT02004886|158202203|FG001|Overall Study|Adverse Event|1|||
49100367|NCT02004886|158202204|FG002|Overall Study|Adverse Event|0|||
49100368|NCT02004886|158202205|FG003|Overall Study|Adverse Event|0|||
49100369|NCT02004886|158202202|FG000|Overall Study|Unable to attend future visits|1|||
49100370|NCT02004886|158202203|FG001|Overall Study|Unable to attend future visits|0|||
49100371|NCT02004886|158202204|FG002|Overall Study|Unable to attend future visits|0|||
49100372|NCT02004886|158202205|FG003|Overall Study|Unable to attend future visits|0|||
49100373|NCT03193801|158202208|FG000|Overall Study|Physician Decision|2|||
49100374|NCT03193801|158202208|FG000|Overall Study|Withdrawal by Subject|1|||
49100375|NCT04964544|158202211|FG000|Overall Study|Screen failure or other uncategorised|10|||
49100376|NCT04964544|158202211|FG000|Overall Study|Physician Decision|4|||
49100377|NCT04964544|158202211|FG000|Overall Study|Lost to Follow-up|9|||
49100378|NCT04964544|158202211|FG000|Overall Study|Withdrawal by Subject|18|||
49100379|NCT04964544|158202211|FG000|Overall Study|Death|1|||
49100380|NCT01613222|158202212|FG000|Overall Study|Physician Decision|1|||
49100381|NCT01613222|158202212|FG000|Overall Study|Unable to place arterial line|1|||
49100382|NCT01613222|158202212|FG000|Overall Study|Reused disposable sensors|10|||
49100383|NCT03467217|158202213|FG000|Overall Study|Trial stopped early|5|||
49100384|NCT03467217|158202214|FG001|Overall Study|Trial stopped early|2|||
49100385|NCT03467217|158202213|FG000|Overall Study|Clinic closed due to COVID-19 pandemic|5|||
49100386|NCT03467217|158202214|FG001|Overall Study|Clinic closed due to COVID-19 pandemic|2|||
49100387|NCT03467217|158202213|FG000|Overall Study|Lost to Follow-up|0|||
49100388|NCT03467217|158202214|FG001|Overall Study|Lost to Follow-up|2|||
49100389|NCT00712881|158202215|FG000|Overall Study|Adverse Event|3|||
49100390|NCT00712881|158202216|FG001|Overall Study|Adverse Event|3|||
49100391|NCT00712881|158202215|FG000|Overall Study|Withdrawal by Subject|1|||
49100392|NCT00712881|158202216|FG001|Overall Study|Withdrawal by Subject|1|||
49100393|NCT00712881|158202215|FG000|Overall Study|Disease Progression|2|||
49100394|NCT00712881|158202216|FG001|Overall Study|Disease Progression|1|||
49100395|NCT00712881|158202215|FG000|Overall Study|Lost to Follow-up|1|||
49100396|NCT00712881|158202216|FG001|Overall Study|Lost to Follow-up|1|||
49100397|NCT00712881|158202215|FG000|Overall Study|Non-Compliance To Study Procedures|1|||
49100398|NCT00712881|158202216|FG001|Overall Study|Non-Compliance To Study Procedures|0|||
49100399|NCT00712881|158202215|FG000|Overall Study|Protocol Violation|1|||
49100400|NCT00712881|158202216|FG001|Overall Study|Protocol Violation|1|||
49100401|NCT00712881|158202215|FG000|Overall Study|Randomized but not treated|1|||
49100402|NCT00712881|158202216|FG001|Overall Study|Randomized but not treated|0|||
49100403|NCT01895608|158202217|FG000|Overall Study|change in health status|0|||
49100404|NCT01895608|158202218|FG001|Overall Study|change in health status|1|||
49100405|NCT01895608|158202219|FG002|Overall Study|change in health status|1|||
49100406|NCT01895608|158202220|FG003|Overall Study|change in health status|0|||
49100407|NCT01895608|158202217|FG000|Overall Study|Withdrawal by Subject|0|||
49100408|NCT01895608|158202218|FG001|Overall Study|Withdrawal by Subject|0|||
49100409|NCT01895608|158202219|FG002|Overall Study|Withdrawal by Subject|2|||
49100410|NCT01895608|158202220|FG003|Overall Study|Withdrawal by Subject|0|||
49100411|NCT01283334|158202223|FG000|Overall Study|Withdrawal by Subject|1|||
49100412|NCT01283334|158202223|FG000|Overall Study|Inability to Swallow Everolimus Pills|1|||
49100413|NCT01283334|158202223|FG000|Overall Study|Adverse Event|4|||
49100414|NCT01283334|158202223|FG000|Overall Study|Physician Decision|1|||
49100415|NCT01878084|158202230|FG000|Overall Study|Physician Decision|2|||
49100416|NCT02855359|158202233|FG000|Overall Study|Death|2|||
49100417|NCT02855359|158202234|FG001|Overall Study|Death|2|||
49100418|NCT02855359|158202235|FG002|Overall Study|Death|0|||
49100419|NCT02855359|158202236|FG003|Overall Study|Death|0|||
49100420|NCT02855359|158202233|FG000|Overall Study|Study Termination by Sponsor|9|||
49100421|NCT02855359|158202234|FG001|Overall Study|Study Termination by Sponsor|11|||
49100422|NCT02855359|158202235|FG002|Overall Study|Study Termination by Sponsor|0|||
49100423|NCT02855359|158202236|FG003|Overall Study|Study Termination by Sponsor|0|||
49100424|NCT01023256|158202237|FG000|Overall Study|Protocol Violation|2|||
49100425|NCT01023256|158202238|FG001|Overall Study|Protocol Violation|3|||
49100426|NCT01023256|158202239|FG002|Overall Study|Protocol Violation|0|||
49100427|NCT01023256|158202240|FG003|Overall Study|Protocol Violation|0|||
49100428|NCT01023256|158202237|FG000|Overall Study|Randomized but not treated|1|||
49100429|NCT01023256|158202238|FG001|Overall Study|Randomized but not treated|0|||
49100430|NCT01023256|158202239|FG002|Overall Study|Randomized but not treated|1|||
49100431|NCT01023256|158202240|FG003|Overall Study|Randomized but not treated|0|||
49100432|NCT01023256|158202237|FG000|Overall Study|Other|1|||
49100433|NCT01023256|158202238|FG001|Overall Study|Other|0|||
49100434|NCT01023256|158202239|FG002|Overall Study|Other|0|||
49100435|NCT01023256|158202240|FG003|Overall Study|Other|2|||
49100436|NCT01023256|158202237|FG000|Overall Study|Adverse Event|0|||
49100437|NCT01023256|158202238|FG001|Overall Study|Adverse Event|0|||
49100438|NCT01023256|158202239|FG002|Overall Study|Adverse Event|0|||
49100439|NCT01023256|158202240|FG003|Overall Study|Adverse Event|1|||
49100440|NCT01023256|158202237|FG000|Overall Study|Withdrawal by Subject|0|||
49100441|NCT01023256|158202238|FG001|Overall Study|Withdrawal by Subject|0|||
49100442|NCT01023256|158202239|FG002|Overall Study|Withdrawal by Subject|0|||
49100443|NCT01023256|158202240|FG003|Overall Study|Withdrawal by Subject|2|||
49100444|NCT03089697|158202241|FG000|Overall Study|Adverse Event|1|||
49100445|NCT03089697|158202242|FG001|Overall Study|Adverse Event|2|||
49100446|NCT03089697|158202241|FG000|Overall Study|Withdrawal by Subject|1|||
49100447|NCT03089697|158202242|FG001|Overall Study|Withdrawal by Subject|0|||
49100448|NCT01899742|158202243|FG000|Overall Study|Adverse Event|5|||
49100449|NCT01899742|158202244|FG001|Overall Study|Adverse Event|4|||
49100450|NCT01899742|158202243|FG000|Overall Study|Lack of Efficacy|1|||
49100451|NCT01899742|158202244|FG001|Overall Study|Lack of Efficacy|5|||
49100452|NCT01899742|158202243|FG000|Overall Study|Protocol Violation|2|||
49100453|NCT01899742|158202244|FG001|Overall Study|Protocol Violation|2|||
49100454|NCT01899742|158202243|FG000|Overall Study|Withdrawal by Subject|9|||
49100455|NCT01899742|158202244|FG001|Overall Study|Withdrawal by Subject|5|||
49100456|NCT05087966|158202249|FG000|Overall Study|Lost to Follow-up|1|||
49100457|NCT05087966|158202249|FG000|Overall Study|Withdrawal by Subject|5|||
49100458|NCT00750139|158202250|FG000|Overall Study|Adverse Event|1|||
49100459|NCT00750139|158202251|FG001|Overall Study|Adverse Event|2|||
49100460|NCT00750139|158202252|FG002|Overall Study|Adverse Event|0|||
49100461|NCT00750139|158202253|FG003|Overall Study|Adverse Event|1|||
49100462|NCT00750139|158202250|FG000|Overall Study|Lost to Follow-up|17|||
49100463|NCT00750139|158202251|FG001|Overall Study|Lost to Follow-up|12|||
49100464|NCT00750139|158202252|FG002|Overall Study|Lost to Follow-up|15|||
49100465|NCT00750139|158202253|FG003|Overall Study|Lost to Follow-up|6|||
49100466|NCT00750139|158202250|FG000|Overall Study|Withdrawal by Subject|3|||
49100467|NCT00750139|158202251|FG001|Overall Study|Withdrawal by Subject|2|||
49100468|NCT00750139|158202252|FG002|Overall Study|Withdrawal by Subject|6|||
49100469|NCT00750139|158202253|FG003|Overall Study|Withdrawal by Subject|2|||
49100470|NCT00750139|158202250|FG000|Overall Study|Physician Decision|1|||
49100471|NCT00750139|158202251|FG001|Overall Study|Physician Decision|1|||
49100472|NCT00750139|158202252|FG002|Overall Study|Physician Decision|0|||
49100473|NCT00750139|158202253|FG003|Overall Study|Physician Decision|0|||
49100474|NCT00750139|158202250|FG000|Overall Study|Non-compliance|1|||
49100475|NCT00750139|158202251|FG001|Overall Study|Non-compliance|0|||
49100476|NCT00750139|158202252|FG002|Overall Study|Non-compliance|1|||
49100477|NCT00750139|158202253|FG003|Overall Study|Non-compliance|3|||
49100478|NCT00750139|158202250|FG000|Overall Study|Termination by sponsor|4|||
49100479|NCT00750139|158202251|FG001|Overall Study|Termination by sponsor|0|||
49100480|NCT00750139|158202252|FG002|Overall Study|Termination by sponsor|0|||
49100481|NCT00750139|158202253|FG003|Overall Study|Termination by sponsor|1|||
49100482|NCT00750139|158202250|FG000|Overall Study|Non-specific|62|||
49100483|NCT00750139|158202251|FG001|Overall Study|Non-specific|42|||
49100484|NCT00750139|158202252|FG002|Overall Study|Non-specific|79|||
49100485|NCT00750139|158202253|FG003|Overall Study|Non-specific|33|||
49100486|NCT01820572|158202254|FG000|Randomization|Not Treated|2|||
49100487|NCT01820572|158202255|FG001|Randomization|Not Treated|1|||
49100488|NCT01820572|158202254|FG000|Treatment Period|Adverse Event|12|||
49100489|NCT01820572|158202255|FG001|Treatment Period|Adverse Event|7|||
49100490|NCT01820572|158202254|FG000|Treatment Period|Death|3|||
49100491|NCT01820572|158202255|FG001|Treatment Period|Death|3|||
49100492|NCT01820572|158202254|FG000|Treatment Period|Lack of Efficacy|1|||
49100493|NCT01820572|158202255|FG001|Treatment Period|Lack of Efficacy|0|||
49100494|NCT01820572|158202254|FG000|Treatment Period|poor/non compliance|0|||
49100495|NCT01820572|158202255|FG001|Treatment Period|poor/non compliance|3|||
49100496|NCT01820572|158202254|FG000|Treatment Period|request to discontinue|6|||
49100497|NCT01820572|158202255|FG001|Treatment Period|request to discontinue|11|||
49100498|NCT01820572|158202254|FG000|Treatment Period|No longer meets study criteria|3|||
49100499|NCT01820572|158202255|FG001|Treatment Period|No longer meets study criteria|10|||
49100500|NCT01820572|158202254|FG000|Treatment Period|withdrew consent|1|||
49100501|NCT01820572|158202255|FG001|Treatment Period|withdrew consent|2|||
49100502|NCT02253316|158202256|FG000|Consolidation|Progression|4|||
49100503|NCT02253316|158202257|FG001|Consolidation|Progression|0|||
49100504|NCT02253316|158202258|FG002|Consolidation|Progression|0|||
49100505|NCT02253316|158202256|FG000|Consolidation|Non-Compliance|1|||
49100506|NCT02253316|158202257|FG001|Consolidation|Non-Compliance|0|||
49100507|NCT02253316|158202258|FG002|Consolidation|Non-Compliance|0|||
49100508|NCT02253316|158202256|FG000|Consolidation|Patient Withdrew Logistical Concerns|2|||
49100509|NCT02253316|158202257|FG001|Consolidation|Patient Withdrew Logistical Concerns|0|||
49100510|NCT02253316|158202258|FG002|Consolidation|Patient Withdrew Logistical Concerns|0|||
49100511|NCT02253316|158202256|FG000|Consolidation|Secondary Malignancy|2|||
49100512|NCT02253316|158202257|FG001|Consolidation|Secondary Malignancy|0|||
49100513|NCT02253316|158202258|FG002|Consolidation|Secondary Malignancy|0|||
49100514|NCT02253316|158202256|FG000|Consolidation|Adverse Event|7|||
49100515|NCT02253316|158202257|FG001|Consolidation|Adverse Event|0|||
49100516|NCT02253316|158202258|FG002|Consolidation|Adverse Event|0|||
49100517|NCT02253316|158202256|FG000|Maintenance|Patient Withdrew Logistical Concerns|0|||
49100518|NCT02253316|158202257|FG001|Maintenance|Patient Withdrew Logistical Concerns|7|||
49100519|NCT02253316|158202258|FG002|Maintenance|Patient Withdrew Logistical Concerns|7|||
49100520|NCT02253316|158202256|FG000|Maintenance|Physician Decision|0|||
49100521|NCT02253316|158202257|FG001|Maintenance|Physician Decision|7|||
49100522|NCT02253316|158202258|FG002|Maintenance|Physician Decision|16|||
49100523|NCT02253316|158202256|FG000|Maintenance|Non-Compliance|0|||
49100524|NCT02253316|158202257|FG001|Maintenance|Non-Compliance|1|||
49100525|NCT02253316|158202258|FG002|Maintenance|Non-Compliance|1|||
49100526|NCT02253316|158202256|FG000|Maintenance|Secondary Malignancy|0|||
49100527|NCT02253316|158202257|FG001|Maintenance|Secondary Malignancy|2|||
49100528|NCT02253316|158202258|FG002|Maintenance|Secondary Malignancy|6|||
49100529|NCT02253316|158202256|FG000|Maintenance|Adverse Event|0|||
49100530|NCT02253316|158202257|FG001|Maintenance|Adverse Event|8|||
49100531|NCT02253316|158202258|FG002|Maintenance|Adverse Event|12|||
49100532|NCT02253316|158202256|FG000|Maintenance|Still receiving active treatment|0|||
49100533|NCT02253316|158202257|FG001|Maintenance|Still receiving active treatment|5|||
49100534|NCT02253316|158202258|FG002|Maintenance|Still receiving active treatment|0|||
49100535|NCT02637895|158202266|FG000|Overall Study|Lost to Follow-up|4|||
49100536|NCT02637895|158202267|FG001|Overall Study|Lost to Follow-up|0|||
49100537|NCT02637895|158202266|FG000|Overall Study|Protocol Violation|0|||
49100538|NCT02637895|158202267|FG001|Overall Study|Protocol Violation|1|||
49100539|NCT02637895|158202266|FG000|Overall Study|Lack of Efficacy|1|||
49100540|NCT02637895|158202267|FG001|Overall Study|Lack of Efficacy|0|||
49100541|NCT02637895|158202266|FG000|Overall Study|Withdrawal by Subject|1|||
49100542|NCT02637895|158202267|FG001|Overall Study|Withdrawal by Subject|1|||
49100543|NCT02637895|158202266|FG000|Overall Study|Abnormal baseline lab|0|||
49111399|NCT01603394|158242892|FG000|Overall Study|Adverse Event|1|||
49100544|NCT02637895|158202267|FG001|Overall Study|Abnormal baseline lab|1|||
49100545|NCT02225366|158202268|FG000|Overall Study|Lack of Efficacy|1|||
49100546|NCT02225366|158202269|FG001|Overall Study|Lack of Efficacy|0|||
49100547|NCT04713592|158202272|FG000|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
49100548|NCT04713592|158202273|FG001|Double-blind Period (Baseline - Week 16)|Adverse Event|1|||
49100549|NCT04713592|158202274|FG002|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
49100550|NCT04713592|158202275|FG003|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
49100551|NCT04713592|158202272|FG000|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|6|||
49100552|NCT04713592|158202273|FG001|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|2|||
49100553|NCT04713592|158202274|FG002|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
49100554|NCT04713592|158202275|FG003|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
49100555|NCT04713592|158202272|FG000|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
49100556|NCT04713592|158202273|FG001|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
49100557|NCT04713592|158202274|FG002|Open-label Period (Week 16 - Week 52)|Adverse Event|1|||
49100558|NCT04713592|158202275|FG003|Open-label Period (Week 16 - Week 52)|Adverse Event|2|||
49100559|NCT04713592|158202272|FG000|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
49100560|NCT04713592|158202273|FG001|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
49100561|NCT04713592|158202274|FG002|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|3|||
49100562|NCT04713592|158202275|FG003|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|5|||
49100563|NCT04713592|158202272|FG000|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
49100564|NCT04713592|158202273|FG001|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
49100565|NCT04713592|158202274|FG002|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
49100566|NCT04713592|158202275|FG003|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
49100567|NCT04713592|158202272|FG000|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
49100568|NCT04713592|158202273|FG001|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
49100569|NCT04713592|158202274|FG002|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
49100570|NCT04713592|158202275|FG003|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
49100571|NCT04713592|158202272|FG000|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
49100572|NCT04713592|158202273|FG001|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
49100573|NCT04713592|158202274|FG002|Open-label Period (Week 16 - Week 52)|Other, not specified|16|||
49100574|NCT04713592|158202275|FG003|Open-label Period (Week 16 - Week 52)|Other, not specified|14|||
49100575|NCT00688701|158203661|FG000|Overall Study|Adverse Event|1|||
49100576|NCT00688701|158203662|FG001|Overall Study|Adverse Event|0|||
49100577|NCT00688701|158203663|FG002|Overall Study|Adverse Event|5|||
49100578|NCT00688701|158203664|FG003|Overall Study|Adverse Event|3|||
49100579|NCT00688701|158203661|FG000|Overall Study|Lack of Efficacy|0|||
49100580|NCT00688701|158203662|FG001|Overall Study|Lack of Efficacy|1|||
49100581|NCT00688701|158203663|FG002|Overall Study|Lack of Efficacy|0|||
49100582|NCT00688701|158203664|FG003|Overall Study|Lack of Efficacy|0|||
49100583|NCT00688701|158203661|FG000|Overall Study|Withdrawal by Subject|3|||
49100584|NCT00688701|158203662|FG001|Overall Study|Withdrawal by Subject|3|||
49100585|NCT00688701|158203663|FG002|Overall Study|Withdrawal by Subject|4|||
49100586|NCT00688701|158203664|FG003|Overall Study|Withdrawal by Subject|8|||
49100587|NCT00688701|158203661|FG000|Overall Study|Poor compliance to protocol|0|||
49100588|NCT00688701|158203662|FG001|Overall Study|Poor compliance to protocol|1|||
49100589|NCT00688701|158203663|FG002|Overall Study|Poor compliance to protocol|1|||
49100590|NCT00688701|158203664|FG003|Overall Study|Poor compliance to protocol|0|||
49100591|NCT00769067|158203665|FG000|Overall Study|Death|89|||
49100592|NCT00769067|158203666|FG001|Overall Study|Death|86|||
49100593|NCT00769067|158203665|FG000|Overall Study|Lost to Follow-up|3|||
49100594|NCT00769067|158203666|FG001|Overall Study|Lost to Follow-up|1|||
49100595|NCT00769067|158203665|FG000|Overall Study|Study terminated by sponsor|1|||
49100596|NCT00769067|158203666|FG001|Overall Study|Study terminated by sponsor|3|||
49100597|NCT00769067|158203665|FG000|Overall Study|Other|1|||
49100598|NCT00769067|158203666|FG001|Overall Study|Other|3|||
49100599|NCT00769067|158203665|FG000|Overall Study|Withdrawal by Subject|0|||
49100600|NCT00769067|158203666|FG001|Overall Study|Withdrawal by Subject|1|||
49100601|NCT05413369|158203669|FG000|Overall Study|Adverse Event|1|||
49100602|NCT05413369|158203670|FG001|Overall Study|Adverse Event|1|||
49100603|NCT05413369|158203669|FG000|Overall Study|Withdrawal by Subject|13|||
49100604|NCT05413369|158203670|FG001|Overall Study|Withdrawal by Subject|4|||
49100605|NCT05413369|158203669|FG000|Overall Study|Non-compliance with study schedule|2|||
49100606|NCT05413369|158203670|FG001|Overall Study|Non-compliance with study schedule|1|||
49100607|NCT05413369|158203669|FG000|Overall Study|Other|1|||
49100608|NCT05413369|158203670|FG001|Overall Study|Other|1|||
49100609|NCT02836236|158203678|FG000|Double-Blind Treatment Phase|Withdrew Consent|3|||
49100610|NCT02836236|158203679|FG001|Double-Blind Treatment Phase|Withdrew Consent|1|||
49100611|NCT02836236|158203680|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
49100612|NCT02836236|158203681|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
49100613|NCT02836236|158203678|FG000|Double-Blind Treatment Phase|Investigator's Discretion|2|||
49100614|NCT02836236|158203679|FG001|Double-Blind Treatment Phase|Investigator's Discretion|1|||
49100615|NCT02836236|158203680|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
49100616|NCT02836236|158203681|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
49100617|NCT02836236|158203678|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
49100618|NCT02836236|158203679|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
49100619|NCT02836236|158203680|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
49100620|NCT02836236|158203681|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
49100621|NCT02836236|158203678|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
49100622|NCT02836236|158203679|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
49100623|NCT02836236|158203680|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
49100624|NCT02836236|158203681|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
49100625|NCT02836236|158203678|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
49100626|NCT02836236|158203679|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
49100627|NCT02836236|158203680|FG002|Open-Label TAF Treatment Phase|Withdrew consent|3|||
49100628|NCT02836236|158203681|FG003|Open-Label TAF Treatment Phase|Withdrew consent|2|||
49100629|NCT02836236|158203678|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
49100630|NCT02836236|158203679|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
49100631|NCT02836236|158203680|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|2|||
49100632|NCT02836236|158203681|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
49100633|NCT02836236|158203678|FG000|Open-Label TAF Treatment Phase|Death|0|||
49100634|NCT02836236|158203679|FG001|Open-Label TAF Treatment Phase|Death|0|||
49100635|NCT02836236|158203680|FG002|Open-Label TAF Treatment Phase|Death|1|||
49100636|NCT02836236|158203681|FG003|Open-Label TAF Treatment Phase|Death|1|||
49100637|NCT02836236|158203678|FG000|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
49100638|NCT02836236|158203679|FG001|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
49100639|NCT02836236|158203680|FG002|Open-Label TAF Treatment Phase|Investigator's discretion|1|||
49100640|NCT02836236|158203681|FG003|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
49100641|NCT05500274|158203682|FG000|Overall Study|Not able to complete the session and follow-up visits.|2|||
49100642|NCT05500274|158203683|FG001|Overall Study|Not able to complete the session and follow-up visits.|0|||
49100643|NCT05500274|158203682|FG000|Overall Study|Lost to Follow-up|86|||
49100644|NCT05500274|158203683|FG001|Overall Study|Lost to Follow-up|93|||
49100645|NCT01806961|158203686|FG000|Overall Study|sponsor decision|16|||
49100652|NCT02656290|158203695|FG000|Overall Study|Lost to Follow-up|1|||
49100653|NCT02656290|158203695|FG000|Overall Study|Reintervention|3|||
49100654|NCT00394836|158203698|FG000|Teatment or Follow-up Phase|Adverse Event|0|||
49100655|NCT00394836|158203699|FG001|Teatment or Follow-up Phase|Adverse Event|2|||
49100656|NCT00394836|158203698|FG000|Teatment or Follow-up Phase|Protocol Violation|0|||
49100657|NCT00394836|158203699|FG001|Teatment or Follow-up Phase|Protocol Violation|2|||
49100658|NCT00394836|158203698|FG000|Teatment or Follow-up Phase|Disease Progression|27|||
49100659|NCT00394836|158203699|FG001|Teatment or Follow-up Phase|Disease Progression|60|||
49100660|NCT00394836|158203698|FG000|Teatment or Follow-up Phase|Patient Refusal|1|||
49100661|NCT00394836|158203699|FG001|Teatment or Follow-up Phase|Patient Refusal|2|||
49100662|NCT00394836|158203698|FG000|Teatment or Follow-up Phase|Death|0|||
49100663|NCT00394836|158203699|FG001|Teatment or Follow-up Phase|Death|1|||
49100664|NCT00394836|158203698|FG000|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0|||
49100665|NCT00394836|158203699|FG001|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1|||
49100666|NCT00394836|158203698|FG000|Teatment or Follow-up Phase|Started alternative treatment|0|||
49100667|NCT00394836|158203699|FG001|Teatment or Follow-up Phase|Started alternative treatment|6|||
49100668|NCT00394836|158203698|FG000|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0|||
49100669|NCT00394836|158203699|FG001|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1|||
49100670|NCT00394836|158203698|FG000|Teatment or Follow-up Phase|Physician Decision|0|||
49100671|NCT00394836|158203699|FG001|Teatment or Follow-up Phase|Physician Decision|1|||
49100672|NCT00394836|158203698|FG000|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0|||
49100673|NCT00394836|158203699|FG001|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1|||
49100674|NCT00394836|158203698|FG000|Teatment or Follow-up Phase|Non compliance|0|||
49100675|NCT00394836|158203699|FG001|Teatment or Follow-up Phase|Non compliance|1|||
49100676|NCT00394836|158203698|FG000|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0|||
49100677|NCT00394836|158203699|FG001|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1|||
49100678|NCT00394836|158203698|FG000|Extended Follow-up Phase (2-5 Years)|Death|0|||
49100679|NCT00394836|158203699|FG001|Extended Follow-up Phase (2-5 Years)|Death|1|||
49100680|NCT00394836|158203698|FG000|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13|||
49100681|NCT00394836|158203699|FG001|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41|||
49100682|NCT00394836|158203698|FG000|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7|||
49100683|NCT00394836|158203699|FG001|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10|||
49100684|NCT01608087|158203700|FG000|Overall Study|Lost to Follow-up|0|||
49100685|NCT01608087|158203701|FG001|Overall Study|Lost to Follow-up|1|||
49100686|NCT01608087|158203702|FG002|Overall Study|Lost to Follow-up|0|||
49100687|NCT01608087|158203700|FG000|Overall Study|Other Reason|0|||
49100688|NCT01608087|158203701|FG001|Overall Study|Other Reason|1|||
49100689|NCT01608087|158203702|FG002|Overall Study|Other Reason|0|||
49100690|NCT04725812|158203709|FG000|Overall Study|Withdrawal by Subject|1|||
49100691|NCT02659514|158203710|FG000|Overall Study|Adverse Event|3|||
49100692|NCT02659514|158203711|FG001|Overall Study|Adverse Event|12|||
49100693|NCT02659514|158203710|FG000|Overall Study|Disease Progression|23|||
49100694|NCT02659514|158203711|FG001|Overall Study|Disease Progression|13|||
49100695|NCT02659514|158203710|FG000|Overall Study|Withdrawal by Subject|0|||
49100696|NCT02659514|158203711|FG001|Overall Study|Withdrawal by Subject|4|||
49100697|NCT02659514|158203710|FG000|Overall Study|Lost to Follow-up|0|||
49100698|NCT02659514|158203711|FG001|Overall Study|Lost to Follow-up|1|||
49100699|NCT02659514|158203710|FG000|Overall Study|Death|6|||
49100700|NCT02659514|158203711|FG001|Overall Study|Death|1|||
49100701|NCT02659514|158203710|FG000|Overall Study|Reason Unspecified|0|||
49100702|NCT02659514|158203711|FG001|Overall Study|Reason Unspecified|3|||
49100703|NCT02691936|158203712|FG000|Overall Study|Withdrawal by Subject|2|||
49100704|NCT02691936|158203713|FG001|Overall Study|Withdrawal by Subject|5|||
49100705|NCT03937908|158203714|FG000|Overall Study|Study discontinuation due to pandemic restrictions|0|||
49100706|NCT03937908|158203715|FG001|Overall Study|Study discontinuation due to pandemic restrictions|1|||
49100707|NCT00749684|158203716|FG000|Overall Study|Death|1|||
49100708|NCT00749684|158203716|FG000|Overall Study|Adverse Event|27|||
49100709|NCT00749684|158203716|FG000|Overall Study|Participant's Wish|10|||
49100710|NCT00749684|158203716|FG000|Overall Study|Not Documented|1|||
49100711|NCT00749684|158203716|FG000|Overall Study|Progressive Desease|31|||
49100712|NCT00749684|158203716|FG000|Overall Study|Therapy according to protocol + AE|2|||
49100713|NCT00749684|158203716|FG000|Overall Study|AE+discontinuation on participants wish|1|||
49100714|NCT00749684|158203716|FG000|Overall Study|Missing|9|||
49100715|NCT01876784|158203717|FG000|Randomized Treatment Period (40 Months)|Withdrawal by Subject|20|||
49100716|NCT01876784|158203718|FG001|Randomized Treatment Period (40 Months)|Withdrawal by Subject|4|||
49100717|NCT01876784|158203717|FG000|Randomized Treatment Period (40 Months)|Adverse Event|22|||
49100718|NCT01876784|158203718|FG001|Randomized Treatment Period (40 Months)|Adverse Event|5|||
49100719|NCT01876784|158203717|FG000|Randomized Treatment Period (40 Months)|Protocol Violation|1|||
49100720|NCT01876784|158203718|FG001|Randomized Treatment Period (40 Months)|Protocol Violation|0|||
49100721|NCT01876784|158203717|FG000|Randomized Treatment Period (40 Months)|Disease progression|43|||
49100722|NCT01876784|158203718|FG001|Randomized Treatment Period (40 Months)|Disease progression|81|||
49100723|NCT01876784|158203717|FG000|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
49100724|NCT01876784|158203718|FG001|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
49100725|NCT01876784|158203717|FG000|Randomized Treatment Period (40 Months)|Death|1|||
49100726|NCT01876784|158203718|FG001|Randomized Treatment Period (40 Months)|Death|0|||
49100727|NCT01876784|158203717|FG000|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|5|||
49100728|NCT01876784|158203718|FG001|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|2|||
49100729|NCT01876784|158203717|FG000|Randomized Treatment Period (40 Months)|Randomized but not treated|2|||
49100730|NCT01876784|158203718|FG001|Randomized Treatment Period (40 Months)|Randomized but not treated|1|||
49100731|NCT01876784|158203717|FG000|Randomized Treatment Period (40 Months)|Other than specified above|24|||
49100732|NCT01876784|158203718|FG001|Randomized Treatment Period (40 Months)|Other than specified above|25|||
49100733|NCT01876784|158203717|FG000|Open-label Period (31 Months)|Withdrawal by Subject|6|||
49100734|NCT01876784|158203718|FG001|Open-label Period (31 Months)|Withdrawal by Subject|8|||
49100735|NCT01876784|158203717|FG000|Open-label Period (31 Months)|Adverse Event|2|||
49100736|NCT01876784|158203718|FG001|Open-label Period (31 Months)|Adverse Event|6|||
49100737|NCT01876784|158203717|FG000|Open-label Period (31 Months)|Protocol Violation|0|||
49100738|NCT01876784|158203718|FG001|Open-label Period (31 Months)|Protocol Violation|1|||
49100739|NCT01876784|158203717|FG000|Open-label Period (31 Months)|Progressive disease|4|||
49100740|NCT01876784|158203718|FG001|Open-label Period (31 Months)|Progressive disease|35|||
49100741|NCT01876784|158203717|FG000|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|1|||
49100742|NCT01876784|158203718|FG001|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|5|||
49100743|NCT01876784|158203717|FG000|Open-label Period (31 Months)|Lost to Follow-up|1|||
49100744|NCT01876784|158203718|FG001|Open-label Period (31 Months)|Lost to Follow-up|0|||
49100745|NCT01876784|158203717|FG000|Open-label Period (31 Months)|Death|0|||
49100746|NCT01876784|158203718|FG001|Open-label Period (31 Months)|Death|1|||
49100747|NCT01876784|158203717|FG000|Open-label Period (31 Months)|Other than specified above|9|||
49100748|NCT01876784|158203718|FG001|Open-label Period (31 Months)|Other than specified above|18|||
49100749|NCT03696108|158203719|FG000|Overall Study|Physician Decision|1|||
49100750|NCT03696108|158203720|FG001|Overall Study|Physician Decision|0|||
49100751|NCT03696108|158203719|FG000|Overall Study|Withdrawal by Subject|3|||
49100752|NCT03696108|158203720|FG001|Overall Study|Withdrawal by Subject|6|||
49100753|NCT03505593|158203722|FG000|Overall Study|Withdrawal by Subject|1|||
49100754|NCT03505593|158203722|FG000|Overall Study|Died before procedure|1|||
49100755|NCT03505593|158203722|FG000|Overall Study|Anatomical abnormality|1|||
49100756|NCT03505593|158203722|FG000|Overall Study|Unable to pass through esophagus|1|||
49100757|NCT03505593|158203722|FG000|Overall Study|Obstruction by Endotracheal tube|1|||
49100758|NCT03605862|158203723|FG000|Overall Study|Withdrawal by Subject|12|||
49100759|NCT03605862|158203724|FG001|Overall Study|Withdrawal by Subject|9|||
49100760|NCT03605862|158203723|FG000|Overall Study|Adverse Event|2|||
49100761|NCT03605862|158203724|FG001|Overall Study|Adverse Event|1|||
49100762|NCT03605862|158203723|FG000|Overall Study|Physician Decision|3|||
49100763|NCT03605862|158203724|FG001|Overall Study|Physician Decision|1|||
49100764|NCT03605862|158203723|FG000|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|11|||
49100765|NCT03605862|158203724|FG001|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|15|||
49100766|NCT01194531|158203725|FG000|Overall Study|Withdrawal by Subject|1|||
49100767|NCT01194531|158203726|FG001|Overall Study|Withdrawal by Subject|0|||
49100768|NCT01194531|158203725|FG000|Overall Study|Protocol Violation|4|||
49100769|NCT01194531|158203726|FG001|Overall Study|Protocol Violation|1|||
49100770|NCT01194531|158203725|FG000|Overall Study|Physician Decision|0|||
49100771|NCT01194531|158203726|FG001|Overall Study|Physician Decision|2|||
49100772|NCT02822573|158203727|FG000|Overall Study|Lost to Follow-up|5|||
49100773|NCT02822573|158203728|FG001|Overall Study|Lost to Follow-up|3|||
49100774|NCT02822573|158203727|FG000|Overall Study|Physician Decision|1|||
49100775|NCT02822573|158203728|FG001|Overall Study|Physician Decision|1|||
49100776|NCT02822573|158203727|FG000|Overall Study|Withdrawal by Subject|9|||
49100777|NCT02822573|158203728|FG001|Overall Study|Withdrawal by Subject|5|||
49100778|NCT02822573|158203727|FG000|Overall Study|Protocol Violation|6|||
49100779|NCT02822573|158203728|FG001|Overall Study|Protocol Violation|4|||
49100780|NCT02822573|158203727|FG000|Overall Study|Too sick or ill|2|||
49100781|NCT02822573|158203728|FG001|Overall Study|Too sick or ill|1|||
49100782|NCT02822573|158203727|FG000|Overall Study|Disease Progression|1|||
49100783|NCT02822573|158203728|FG001|Overall Study|Disease Progression|1|||
49100784|NCT02822573|158203727|FG000|Overall Study|No reason given|6|||
49100785|NCT02822573|158203728|FG001|Overall Study|No reason given|4|||
49100786|NCT05239494|158203729|FG000|Overall Study|Lost to Follow-up|1|||
49100787|NCT03891862|158203731|FG000|Open-label Period|Adverse Event|2|||
49100788|NCT03891862|158203732|FG001|Open-label Period|Adverse Event|0|||
49100789|NCT03891862|158203733|FG002|Open-label Period|Adverse Event|0|||
49100790|NCT03891862|158203731|FG000|Open-label Period|Protocol Violation|5|||
49100791|NCT03891862|158203732|FG001|Open-label Period|Protocol Violation|0|||
49100792|NCT03891862|158203733|FG002|Open-label Period|Protocol Violation|0|||
49100793|NCT03891862|158203731|FG000|Open-label Period|Withdrawal by Subject|6|||
49100794|NCT03891862|158203732|FG001|Open-label Period|Withdrawal by Subject|0|||
49100795|NCT03891862|158203733|FG002|Open-label Period|Withdrawal by Subject|0|||
49100796|NCT03891862|158203731|FG000|Open-label Period|Death|1|||
49100797|NCT03891862|158203732|FG001|Open-label Period|Death|0|||
49100798|NCT03891862|158203733|FG002|Open-label Period|Death|0|||
49100799|NCT03891862|158203731|FG000|Open-label Period|Lost to Follow-up|2|||
49100800|NCT03891862|158203732|FG001|Open-label Period|Lost to Follow-up|0|||
49100801|NCT03891862|158203733|FG002|Open-label Period|Lost to Follow-up|0|||
49100802|NCT03891862|158203731|FG000|Placebo-controlled Period and Follow-up|Adverse Event|0|||
49100803|NCT03891862|158203732|FG001|Placebo-controlled Period and Follow-up|Adverse Event|1|||
49100804|NCT03891862|158203733|FG002|Placebo-controlled Period and Follow-up|Adverse Event|1|||
49100805|NCT03891862|158203731|FG000|Placebo-controlled Period and Follow-up|Protocol Violation|0|||
49100806|NCT03891862|158203732|FG001|Placebo-controlled Period and Follow-up|Protocol Violation|2|||
49100807|NCT03891862|158203733|FG002|Placebo-controlled Period and Follow-up|Protocol Violation|1|||
49100808|NCT03891862|158203731|FG000|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0|||
49100809|NCT03891862|158203732|FG001|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1|||
49100810|NCT03891862|158203733|FG002|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2|||
49100811|NCT03891862|158203731|FG000|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
49100812|NCT03891862|158203732|FG001|Placebo-controlled Period and Follow-up|Lost to Follow-up|2|||
49100813|NCT03891862|158203733|FG002|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
49100814|NCT00174967|158203734|FG000|Overall Study|Adverse Event|1|||
49100815|NCT00174967|158203735|FG001|Overall Study|Adverse Event|2|||
49100816|NCT00174967|158203736|FG002|Overall Study|Adverse Event|2|||
49100817|NCT00174967|158203737|FG003|Overall Study|Adverse Event|1|||
49100818|NCT00174967|158203734|FG000|Overall Study|Gout Flare|0|||
49100819|NCT00174967|158203735|FG001|Overall Study|Gout Flare|0|||
49100820|NCT00174967|158203736|FG002|Overall Study|Gout Flare|0|||
49100821|NCT00174967|158203737|FG003|Overall Study|Gout Flare|1|||
49100822|NCT00174967|158203734|FG000|Overall Study|Other|0|||
49100823|NCT00174967|158203735|FG001|Overall Study|Other|1|||
49100824|NCT00174967|158203736|FG002|Overall Study|Other|0|||
49100825|NCT00174967|158203737|FG003|Overall Study|Other|0|||
49100826|NCT01053962|158203738|FG000|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
49100827|NCT01053962|158203739|FG001|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
49100828|NCT01053962|158203740|FG002|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
49100829|NCT01053962|158203741|FG003|Pretreatment Period|Withdrew Consent (Patient/PI)|1|||
49100830|NCT01053962|158203742|FG004|Pretreatment Period|Withdrew Consent (Patient/PI)|2|||
49100831|NCT01053962|158203738|FG000|Pretreatment Period|Venipuncture Failure|0|||
49100832|NCT01053962|158203739|FG001|Pretreatment Period|Venipuncture Failure|0|||
49100833|NCT01053962|158203740|FG002|Pretreatment Period|Venipuncture Failure|1|||
49100834|NCT01053962|158203741|FG003|Pretreatment Period|Venipuncture Failure|0|||
49100835|NCT01053962|158203742|FG004|Pretreatment Period|Venipuncture Failure|0|||
49100836|NCT01053962|158203738|FG000|Pretreatment Period|Failed Urine drug screen Day 1|0|||
49100837|NCT01053962|158203739|FG001|Pretreatment Period|Failed Urine drug screen Day 1|1|||
49100838|NCT01053962|158203740|FG002|Pretreatment Period|Failed Urine drug screen Day 1|0|||
49100839|NCT01053962|158203741|FG003|Pretreatment Period|Failed Urine drug screen Day 1|0|||
49100840|NCT01053962|158203742|FG004|Pretreatment Period|Failed Urine drug screen Day 1|0|||
49100841|NCT01053962|158203738|FG000|Pretreatment Period|Abnormal Lab values Exl 16|0|||
49100842|NCT01053962|158203739|FG001|Pretreatment Period|Abnormal Lab values Exl 16|0|||
49100843|NCT01053962|158203740|FG002|Pretreatment Period|Abnormal Lab values Exl 16|0|||
49100844|NCT01053962|158203741|FG003|Pretreatment Period|Abnormal Lab values Exl 16|1|||
49100845|NCT01053962|158203742|FG004|Pretreatment Period|Abnormal Lab values Exl 16|0|||
49100846|NCT01053962|158203738|FG000|Treatment Period|Lack of Efficacy|0|||
49100847|NCT01053962|158203739|FG001|Treatment Period|Lack of Efficacy|0|||
49100848|NCT01053962|158203740|FG002|Treatment Period|Lack of Efficacy|0|||
49100849|NCT01053962|158203741|FG003|Treatment Period|Lack of Efficacy|0|||
49100850|NCT01053962|158203742|FG004|Treatment Period|Lack of Efficacy|1|||
49100851|NCT01053962|158203738|FG000|Treatment Period|Adverse Event|0|||
49100852|NCT01053962|158203739|FG001|Treatment Period|Adverse Event|0|||
49100853|NCT01053962|158203740|FG002|Treatment Period|Adverse Event|0|||
49100854|NCT01053962|158203741|FG003|Treatment Period|Adverse Event|0|||
49100855|NCT01053962|158203742|FG004|Treatment Period|Adverse Event|1|||
49100856|NCT01053962|158203738|FG000|Treatment Period|Withdrawal by Subject|0|||
49100857|NCT01053962|158203739|FG001|Treatment Period|Withdrawal by Subject|0|||
49100858|NCT01053962|158203740|FG002|Treatment Period|Withdrawal by Subject|0|||
49100859|NCT01053962|158203741|FG003|Treatment Period|Withdrawal by Subject|0|||
49100860|NCT01053962|158203742|FG004|Treatment Period|Withdrawal by Subject|1|||
49100861|NCT01053962|158203738|FG000|Treatment Period|Noncompliance with protocol|1|||
49100862|NCT01053962|158203739|FG001|Treatment Period|Noncompliance with protocol|0|||
49100863|NCT01053962|158203740|FG002|Treatment Period|Noncompliance with protocol|0|||
49100864|NCT01053962|158203741|FG003|Treatment Period|Noncompliance with protocol|0|||
49100865|NCT01053962|158203742|FG004|Treatment Period|Noncompliance with protocol|0|||
49100866|NCT02275780|158203743|FG000|Base Study: 96 Weeks|Adverse Event|6|||
49100867|NCT02275780|158203744|FG001|Base Study: 96 Weeks|Adverse Event|14|||
49100868|NCT02275780|158203743|FG000|Base Study: 96 Weeks|Death|3|||
49100869|NCT02275780|158203744|FG001|Base Study: 96 Weeks|Death|1|||
49100870|NCT02275780|158203743|FG000|Base Study: 96 Weeks|Lack of Efficacy|21|||
49100871|NCT02275780|158203744|FG001|Base Study: 96 Weeks|Lack of Efficacy|32|||
49100872|NCT02275780|158203743|FG000|Base Study: 96 Weeks|Lost to Follow-up|28|||
49100873|NCT02275780|158203744|FG001|Base Study: 96 Weeks|Lost to Follow-up|24|||
49100874|NCT02275780|158203743|FG000|Base Study: 96 Weeks|Protocol Violation|1|||
49100875|NCT02275780|158203744|FG001|Base Study: 96 Weeks|Protocol Violation|6|||
49100876|NCT02275780|158203743|FG000|Base Study: 96 Weeks|Withdrawal by Subject|19|||
49100877|NCT02275780|158203744|FG001|Base Study: 96 Weeks|Withdrawal by Subject|22|||
49100878|NCT02275780|158203743|FG000|Base Study: 96 Weeks|Noncompliance with drug|9|||
49100879|NCT02275780|158203744|FG001|Base Study: 96 Weeks|Noncompliance with drug|6|||
49100880|NCT02275780|158203743|FG000|Base Study: 96 Weeks|Physician Decision|2|||
49100881|NCT02275780|158203744|FG001|Base Study: 96 Weeks|Physician Decision|4|||
49100882|NCT02275780|158203743|FG000|Base Study: 96 Weeks|Pregnancy|2|||
49100883|NCT02275780|158203744|FG001|Base Study: 96 Weeks|Pregnancy|1|||
49100884|NCT02275780|158203743|FG000|Base Study: 96 Weeks|Randomized not treated|2|||
49100885|NCT02275780|158203744|FG001|Base Study: 96 Weeks|Randomized not treated|1|||
49100886|NCT02275780|158203743|FG000|Study Extension 1: Week 96 to Week 192|Adverse Event|6|||
49100887|NCT02275780|158203744|FG001|Study Extension 1: Week 96 to Week 192|Adverse Event|1|||
49100888|NCT02275780|158203743|FG000|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|2|||
49100889|NCT02275780|158203744|FG001|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|0|||
49100890|NCT02275780|158203743|FG000|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|8|||
49100891|NCT02275780|158203744|FG001|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|11|||
49100892|NCT02275780|158203743|FG000|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|8|||
49100893|NCT02275780|158203744|FG001|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|7|||
49100894|NCT02275780|158203743|FG000|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|1|||
49100895|NCT02275780|158203744|FG001|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|2|||
49100896|NCT02275780|158203743|FG000|Study Extension 1: Week 96 to Week 192|Physician Decision|3|||
49100897|NCT02275780|158203744|FG001|Study Extension 1: Week 96 to Week 192|Physician Decision|7|||
49100898|NCT02275780|158203743|FG000|Study Extension 1: Week 96 to Week 192|Pregnancy|2|||
49100899|NCT02275780|158203744|FG001|Study Extension 1: Week 96 to Week 192|Pregnancy|1|||
49111400|NCT01289574|158242893|FG000|Overall Study|Lack of Efficacy|4|||
49100900|NCT02275780|158203743|FG000|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|19|||
49100901|NCT02275780|158203744|FG001|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|14|||
49100902|NCT02275780|158203743|FG000|Study Extension 2: Week 192 to Week 288|Adverse Event|0|||
49100903|NCT02275780|158203744|FG001|Study Extension 2: Week 192 to Week 288|Adverse Event|1|||
49100904|NCT02275780|158203743|FG000|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|38|||
49100905|NCT02275780|158203744|FG001|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|29|||
49100906|NCT02275780|158203743|FG000|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|2|||
49100907|NCT02275780|158203744|FG001|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|3|||
49100908|NCT02275780|158203743|FG000|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|0|||
49100909|NCT02275780|158203744|FG001|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|1|||
49100910|NCT02275780|158203743|FG000|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|2|||
49100911|NCT02275780|158203744|FG001|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|0|||
49100912|NCT02275780|158203743|FG000|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
49100913|NCT02275780|158203744|FG001|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
49100914|NCT02275780|158203743|FG000|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|4|||
49100915|NCT02275780|158203744|FG001|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|3|||
49100916|NCT02275780|158203743|FG000|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
49100917|NCT02275780|158203744|FG001|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
49100918|NCT02275780|158203743|FG000|Study Extension 3: Week 288 to Week 384|Death|0|||
49100919|NCT02275780|158203744|FG001|Study Extension 3: Week 288 to Week 384|Death|1|||
49100920|NCT02275780|158203743|FG000|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|1|||
49100921|NCT02275780|158203744|FG001|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|3|||
49100922|NCT02275780|158203743|FG000|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
49100923|NCT02275780|158203744|FG001|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
49100924|NCT02275780|158203743|FG000|Study Extension 3: Week 288 to Week 384|Physician Decision|1|||
49100925|NCT02275780|158203744|FG001|Study Extension 3: Week 288 to Week 384|Physician Decision|0|||
49100926|NCT02275780|158203743|FG000|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|5|||
49100927|NCT02275780|158203744|FG001|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|2|||
49100928|NCT00679289|158203745|FG000|Overall Study|Progressive disease|4|||
49100929|NCT00679289|158203746|FG001|Overall Study|Progressive disease|5|||
49100930|NCT00679289|158203747|FG002|Overall Study|Progressive disease|18|||
49100931|NCT00679289|158203745|FG000|Overall Study|Withdrawal by Subject|0|||
49100932|NCT00679289|158203746|FG001|Overall Study|Withdrawal by Subject|1|||
49100933|NCT00679289|158203747|FG002|Overall Study|Withdrawal by Subject|1|||
49100934|NCT00679289|158203745|FG000|Overall Study|Adverse Event|0|||
49100935|NCT00679289|158203746|FG001|Overall Study|Adverse Event|0|||
49100936|NCT00679289|158203747|FG002|Overall Study|Adverse Event|3|||
49100937|NCT00679289|158203745|FG000|Overall Study|Physician Decision|1|||
49100938|NCT00679289|158203746|FG001|Overall Study|Physician Decision|0|||
49100939|NCT00679289|158203747|FG002|Overall Study|Physician Decision|1|||
49100940|NCT04143594|158203750|FG000|Overall Study|Withdrew consent|3|||
49100941|NCT04143594|158203751|FG001|Overall Study|Withdrew consent|10|||
49100942|NCT04143594|158203752|FG002|Overall Study|Withdrew consent|3|||
49100943|NCT04143594|158203753|FG003|Overall Study|Withdrew consent|1|||
49100944|NCT04143594|158203750|FG000|Overall Study|Lost to Follow-up|3|||
49100945|NCT04143594|158203751|FG001|Overall Study|Lost to Follow-up|5|||
49100946|NCT04143594|158203752|FG002|Overall Study|Lost to Follow-up|11|||
49100947|NCT04143594|158203753|FG003|Overall Study|Lost to Follow-up|0|||
49100948|NCT04143594|158203750|FG000|Overall Study|Investigator's discretion|2|||
49100949|NCT04143594|158203751|FG001|Overall Study|Investigator's discretion|2|||
49100950|NCT04143594|158203752|FG002|Overall Study|Investigator's discretion|0|||
49100951|NCT04143594|158203753|FG003|Overall Study|Investigator's discretion|0|||
49100952|NCT04143594|158203750|FG000|Overall Study|Randomized but never treated|0|||
49100953|NCT04143594|158203751|FG001|Overall Study|Randomized but never treated|0|||
49100954|NCT04143594|158203752|FG002|Overall Study|Randomized but never treated|0|||
49100955|NCT04143594|158203753|FG003|Overall Study|Randomized but never treated|1|||
49100956|NCT04143594|158203750|FG000|Overall Study|Death|1|||
49100957|NCT04143594|158203751|FG001|Overall Study|Death|0|||
49100958|NCT04143594|158203752|FG002|Overall Study|Death|1|||
49100959|NCT04143594|158203753|FG003|Overall Study|Death|0|||
49100960|NCT04143594|158203750|FG000|Overall Study|Adverse Event|1|||
49100961|NCT04143594|158203751|FG001|Overall Study|Adverse Event|0|||
49100962|NCT04143594|158203752|FG002|Overall Study|Adverse Event|0|||
49100963|NCT04143594|158203753|FG003|Overall Study|Adverse Event|0|||
49100964|NCT04143594|158203750|FG000|Overall Study|Pregnancy|0|||
49100965|NCT04143594|158203751|FG001|Overall Study|Pregnancy|0|||
49100966|NCT04143594|158203752|FG002|Overall Study|Pregnancy|1|||
49100967|NCT04143594|158203753|FG003|Overall Study|Pregnancy|0|||
49100968|NCT04143594|158203750|FG000|Overall Study|Lack of Efficacy|1|||
49100969|NCT04143594|158203751|FG001|Overall Study|Lack of Efficacy|1|||
49100970|NCT04143594|158203752|FG002|Overall Study|Lack of Efficacy|0|||
49100971|NCT04143594|158203753|FG003|Overall Study|Lack of Efficacy|0|||
49100972|NCT02892422|158203756|FG000|Overall Study|Enrolled not treated|4|||
49100973|NCT02892422|158203756|FG000|Overall Study|Adverse Event|38|||
49100974|NCT02892422|158203756|FG000|Overall Study|Lack of Efficacy|32|||
49100975|NCT02892422|158203756|FG000|Overall Study|Non-compliance with study drug|11|||
49100976|NCT02892422|158203756|FG000|Overall Study|Protocol Violation|4|||
49100977|NCT02892422|158203756|FG000|Overall Study|Withdrawal by Subject|56|||
49100978|NCT02892422|158203756|FG000|Overall Study|Lost to Follow-up|5|||
49100979|NCT02892422|158203756|FG000|Overall Study|sponsor information 16159A results|21|||
49100980|NCT02892422|158203756|FG000|Overall Study|withdrawal of consent|13|||
49100981|NCT02892422|158203756|FG000|Overall Study|exclusion criteria met|3|||
49100982|NCT02892422|158203756|FG000|Overall Study|moving elsewhere|4|||
49100983|NCT02892422|158203756|FG000|Overall Study|non-compliance|10|||
49100984|NCT02892422|158203756|FG000|Overall Study|patient legally incapable|1|||
49100985|NCT02892422|158203756|FG000|Overall Study|patient decision|7|||
49100986|NCT02892422|158203756|FG000|Overall Study|Investigator decision|1|||
49100987|NCT00638443|158203757|FG000|First Intervention|Adverse Event|2|||
49100988|NCT00638443|158203758|FG001|First Intervention|Adverse Event|1|||
49100989|NCT01054300|158203759|FG000|Period 1|Adverse Event|1|||
49100990|NCT01054300|158203760|FG001|Period 1|Adverse Event|0|||
49100991|NCT01054300|158203761|FG002|Period 1|Adverse Event|0|||
49100992|NCT01054300|158203762|FG003|Period 1|Adverse Event|0|||
49100993|NCT01054300|158203759|FG000|Period 2|Withdrawal by Subject|0|||
49100994|NCT01054300|158203760|FG001|Period 2|Withdrawal by Subject|0|||
49100995|NCT01054300|158203761|FG002|Period 2|Withdrawal by Subject|1|||
49100996|NCT01054300|158203762|FG003|Period 2|Withdrawal by Subject|0|||
49100997|NCT00308087|158203767|FG000|Overall Study|Progressive Disease|19|||
49100998|NCT00308087|158203768|FG001|Overall Study|Progressive Disease|21|||
49100999|NCT00308087|158203767|FG000|Overall Study|Study Closure|11|||
49101000|NCT00308087|158203768|FG001|Overall Study|Study Closure|12|||
49101001|NCT00308087|158203767|FG000|Overall Study|Withdrawal by Subject|2|||
49101002|NCT00308087|158203768|FG001|Overall Study|Withdrawal by Subject|1|||
49101003|NCT00308087|158203767|FG000|Overall Study|Other|4|||
49101004|NCT00308087|158203768|FG001|Overall Study|Other|3|||
49101005|NCT05036668|158203769|FG000|Overall Study|lost to follow Up|0|||
49101006|NCT05036668|158203770|FG001|Overall Study|lost to follow Up|0|||
49101007|NCT05036668|158203771|FG002|Overall Study|lost to follow Up|1|||
49101008|NCT00658775|158203772|FG000|Overall Study|Adverse Event|4|||
49101009|NCT00658775|158203773|FG001|Overall Study|Adverse Event|6|||
49101010|NCT00658775|158203772|FG000|Overall Study|Lost to Follow-up|17|||
49101011|NCT00658775|158203773|FG001|Overall Study|Lost to Follow-up|18|||
49101012|NCT00658775|158203772|FG000|Overall Study|Withdrawal by Subject|6|||
49101013|NCT00658775|158203773|FG001|Overall Study|Withdrawal by Subject|4|||
49101014|NCT00658775|158203772|FG000|Overall Study|Withdrawal of consent|8|||
49101015|NCT00658775|158203773|FG001|Overall Study|Withdrawal of consent|7|||
49101016|NCT00658775|158203772|FG000|Overall Study|Other|7|||
49101017|NCT00658775|158203773|FG001|Overall Study|Other|8|||
49101018|NCT01190267|158203776|FG000|Overall Study|Adverse Event|10|||
49101019|NCT01190267|158203777|FG001|Overall Study|Adverse Event|0|||
49101020|NCT01190267|158203776|FG000|Overall Study|Treatment Failure|8|||
49101021|NCT01190267|158203777|FG001|Overall Study|Treatment Failure|2|||
49101022|NCT01190267|158203776|FG000|Overall Study|Lost to Follow-up|2|||
49101023|NCT01190267|158203777|FG001|Overall Study|Lost to Follow-up|0|||
49101024|NCT01190267|158203776|FG000|Overall Study|Withdrawal by Subject|13|||
49101025|NCT01190267|158203777|FG001|Overall Study|Withdrawal by Subject|1|||
49101026|NCT01190267|158203776|FG000|Overall Study|Protocol Violation|8|||
49101027|NCT01190267|158203777|FG001|Overall Study|Protocol Violation|1|||
49101028|NCT03782298|158203780|FG000|Overall Study|Protocol Deviation|4|||
49101029|NCT01901653|158203791|FG000|Overall Study|Death|2|||
49101030|NCT01901653|158203792|FG001|Overall Study|Death|1|||
49101031|NCT01901653|158203793|FG002|Overall Study|Death|8|||
49101032|NCT01901653|158203794|FG003|Overall Study|Death|3|||
49101033|NCT01901653|158203795|FG004|Overall Study|Death|2|||
49101034|NCT01901653|158203796|FG005|Overall Study|Death|2|||
49101035|NCT01901653|158203797|FG006|Overall Study|Death|6|||
49101036|NCT01901653|158203798|FG007|Overall Study|Death|9|||
49101037|NCT01901653|158203799|FG008|Overall Study|Death|1|||
49101038|NCT01901653|158203800|FG009|Overall Study|Death|16|||
49101039|NCT01901653|158203801|FG010|Overall Study|Death|2|||
49101040|NCT01901653|158203802|FG011|Overall Study|Death|15|||
49101041|NCT01901653|158203803|FG012|Overall Study|Death|4|||
49101042|NCT01901653|158203791|FG000|Overall Study|Lost to Follow-up|1|||
49101043|NCT01901653|158203792|FG001|Overall Study|Lost to Follow-up|0|||
49101044|NCT01901653|158203793|FG002|Overall Study|Lost to Follow-up|2|||
49101045|NCT01901653|158203794|FG003|Overall Study|Lost to Follow-up|0|||
49101046|NCT01901653|158203795|FG004|Overall Study|Lost to Follow-up|0|||
49101047|NCT01901653|158203796|FG005|Overall Study|Lost to Follow-up|1|||
49101048|NCT01901653|158203797|FG006|Overall Study|Lost to Follow-up|0|||
49101049|NCT01901653|158203798|FG007|Overall Study|Lost to Follow-up|1|||
49101050|NCT01901653|158203799|FG008|Overall Study|Lost to Follow-up|0|||
49101051|NCT01901653|158203800|FG009|Overall Study|Lost to Follow-up|0|||
49101052|NCT01901653|158203801|FG010|Overall Study|Lost to Follow-up|0|||
49101053|NCT01901653|158203802|FG011|Overall Study|Lost to Follow-up|0|||
49101054|NCT01901653|158203803|FG012|Overall Study|Lost to Follow-up|0|||
49101055|NCT01901653|158203791|FG000|Overall Study|Withdrawal by Subject|0|||
49101056|NCT01901653|158203792|FG001|Overall Study|Withdrawal by Subject|0|||
49101057|NCT01901653|158203793|FG002|Overall Study|Withdrawal by Subject|0|||
49101058|NCT01901653|158203794|FG003|Overall Study|Withdrawal by Subject|0|||
49101059|NCT01901653|158203795|FG004|Overall Study|Withdrawal by Subject|0|||
49101060|NCT01901653|158203796|FG005|Overall Study|Withdrawal by Subject|0|||
49101061|NCT01901653|158203797|FG006|Overall Study|Withdrawal by Subject|1|||
49101062|NCT01901653|158203798|FG007|Overall Study|Withdrawal by Subject|0|||
49101063|NCT01901653|158203799|FG008|Overall Study|Withdrawal by Subject|0|||
49101064|NCT01901653|158203800|FG009|Overall Study|Withdrawal by Subject|0|||
49101065|NCT01901653|158203801|FG010|Overall Study|Withdrawal by Subject|0|||
49101066|NCT01901653|158203802|FG011|Overall Study|Withdrawal by Subject|0|||
49101067|NCT01901653|158203803|FG012|Overall Study|Withdrawal by Subject|0|||
49101068|NCT01901653|158203791|FG000|Overall Study|Alive at Study Termination by Sponsor|0|||
49101069|NCT01901653|158203792|FG001|Overall Study|Alive at Study Termination by Sponsor|0|||
49101070|NCT01901653|158203793|FG002|Overall Study|Alive at Study Termination by Sponsor|1|||
49101071|NCT01901653|158203794|FG003|Overall Study|Alive at Study Termination by Sponsor|0|||
49101072|NCT01901653|158203795|FG004|Overall Study|Alive at Study Termination by Sponsor|0|||
49101073|NCT01901653|158203796|FG005|Overall Study|Alive at Study Termination by Sponsor|0|||
49101074|NCT01901653|158203797|FG006|Overall Study|Alive at Study Termination by Sponsor|0|||
49101075|NCT01901653|158203798|FG007|Overall Study|Alive at Study Termination by Sponsor|0|||
49101076|NCT01901653|158203799|FG008|Overall Study|Alive at Study Termination by Sponsor|0|||
49101077|NCT01901653|158203800|FG009|Overall Study|Alive at Study Termination by Sponsor|2|||
49101078|NCT01901653|158203801|FG010|Overall Study|Alive at Study Termination by Sponsor|0|||
49101079|NCT01901653|158203802|FG011|Overall Study|Alive at Study Termination by Sponsor|1|||
49101080|NCT01901653|158203803|FG012|Overall Study|Alive at Study Termination by Sponsor|1|||
49101081|NCT02548351|158203804|FG000|Overall Study|Withdrawal by Subject|149|||
49101082|NCT02548351|158203805|FG001|Overall Study|Withdrawal by Subject|154|||
49101083|NCT02548351|158203806|FG002|Overall Study|Withdrawal by Subject|152|||
49101084|NCT02548351|158203804|FG000|Overall Study|Death|11|||
49101085|NCT02548351|158203805|FG001|Overall Study|Death|15|||
49101086|NCT02548351|158203806|FG002|Overall Study|Death|12|||
49101087|NCT02548351|158203804|FG000|Overall Study|Adverse Event|22|||
49101088|NCT02548351|158203805|FG001|Overall Study|Adverse Event|56|||
49101089|NCT02548351|158203806|FG002|Overall Study|Adverse Event|36|||
49101090|NCT02548351|158203804|FG000|Overall Study|Study Terminated by Sponsor|549|||
49101091|NCT02548351|158203805|FG001|Overall Study|Study Terminated by Sponsor|509|||
49101092|NCT02548351|158203806|FG002|Overall Study|Study Terminated by Sponsor|528|||
49101093|NCT02548351|158203804|FG000|Overall Study|Site Closure|14|||
49101094|NCT02548351|158203805|FG001|Overall Study|Site Closure|5|||
49101095|NCT02548351|158203806|FG002|Overall Study|Site Closure|7|||
49101096|NCT02548351|158203804|FG000|Overall Study|Non-compliance with Study Drug|4|||
49101097|NCT02548351|158203805|FG001|Overall Study|Non-compliance with Study Drug|2|||
49101098|NCT02548351|158203806|FG002|Overall Study|Non-compliance with Study Drug|0|||
49101099|NCT02548351|158203804|FG000|Overall Study|Protocol Violation|2|||
49101100|NCT02548351|158203805|FG001|Overall Study|Protocol Violation|1|||
49101101|NCT02548351|158203806|FG002|Overall Study|Protocol Violation|2|||
49101102|NCT02548351|158203804|FG000|Overall Study|Physician Decision|11|||
49101103|NCT02548351|158203805|FG001|Overall Study|Physician Decision|18|||
49101104|NCT02548351|158203806|FG002|Overall Study|Physician Decision|11|||
49101105|NCT02548351|158203804|FG000|Overall Study|Lost to Follow-up|43|||
49101106|NCT02548351|158203805|FG001|Overall Study|Lost to Follow-up|50|||
49101107|NCT02548351|158203806|FG002|Overall Study|Lost to Follow-up|57|||
49101108|NCT02548351|158203804|FG000|Overall Study|Other|19|||
49101109|NCT02548351|158203805|FG001|Overall Study|Other|16|||
49101110|NCT02548351|158203806|FG002|Overall Study|Other|20|||
49101111|NCT02548351|158203804|FG000|Overall Study|Missing|1|||
49101112|NCT02548351|158203805|FG001|Overall Study|Missing|1|||
49101113|NCT02548351|158203806|FG002|Overall Study|Missing|0|||
49101114|NCT00824382|158203809|FG000|Overall Study|Adverse Event|4|||
49101115|NCT00824382|158203810|FG001|Overall Study|Adverse Event|1|||
49101116|NCT00824382|158203811|FG002|Overall Study|Adverse Event|1|||
49101117|NCT00824382|158203812|FG003|Overall Study|Adverse Event|4|||
49101118|NCT00824382|158203809|FG000|Overall Study|Protocol Violation|1|||
49101119|NCT00824382|158203810|FG001|Overall Study|Protocol Violation|0|||
49101120|NCT00824382|158203811|FG002|Overall Study|Protocol Violation|0|||
49101121|NCT00824382|158203812|FG003|Overall Study|Protocol Violation|1|||
49101122|NCT00824382|158203809|FG000|Overall Study|Investigator's decision|0|||
49101123|NCT00824382|158203810|FG001|Overall Study|Investigator's decision|1|||
49101124|NCT00824382|158203811|FG002|Overall Study|Investigator's decision|2|||
49101125|NCT00824382|158203812|FG003|Overall Study|Investigator's decision|0|||
49101126|NCT00199797|158204797|FG000|Overall Study|Progressive Disease|1|||
49101127|NCT00199797|158204797|FG000|Overall Study|Adverse Event|1|||
49101128|NCT00199797|158204797|FG000|Overall Study|Physician Decision|1|||
49101129|NCT03155178|158204802|FG000|Overall Study|Did not meet treatment day baseline|7|||
49101130|NCT03155178|158204803|FG001|Overall Study|Did not meet treatment day baseline|7|||
49101131|NCT03155178|158204804|FG002|Overall Study|Did not meet treatment day baseline|7|||
49101132|NCT03155178|158204805|FG003|Overall Study|Did not meet treatment day baseline|7|||
49101133|NCT02833844|158204806|FG000|Double-Blind Period|Withdrawal by Subject|2|||
49101134|NCT02833844|158204807|FG001|Double-Blind Period|Withdrawal by Subject|3|||
49101135|NCT02833844|158204806|FG000|Double-Blind Period|Protocol Violation|0|||
49101136|NCT02833844|158204807|FG001|Double-Blind Period|Protocol Violation|4|||
49101137|NCT02833844|158204806|FG000|Open-Label Period|Death|0|||
49101138|NCT02833844|158204807|FG001|Open-Label Period|Death|2|||
49101139|NCT02833844|158204806|FG000|Open-Label Period|Lost to Follow-up|1|||
49101140|NCT02833844|158204807|FG001|Open-Label Period|Lost to Follow-up|0|||
49101141|NCT02833844|158204806|FG000|Open-Label Period|Withdrawal by Subject|1|||
49101142|NCT02833844|158204807|FG001|Open-Label Period|Withdrawal by Subject|0|||
49101143|NCT00348790|158204814|FG000|Completed Treatment|Withdrawal by Subject|4|||
49101144|NCT00348790|158204814|FG000|Completed Treatment|Disease progression|14|||
49101145|NCT00348790|158204814|FG000|Completed Treatment|Adverse Event|4|||
49101146|NCT00348790|158204814|FG000|Completed Treatment|Required surgery|2|||
49101147|NCT00348790|158204814|FG000|Completed Treatment|Unable to travel to study site|1|||
49101148|NCT02662764|158204815|FG000|Overall Study|Adverse Event|6|||
49101149|NCT02662764|158204815|FG000|Overall Study|Lack of Efficacy|8|||
49101150|NCT02662764|158204815|FG000|Overall Study|Protocol Violation|1|||
49101151|NCT02662764|158204815|FG000|Overall Study|Withdrawal by Subject|5|||
49101152|NCT02662764|158204815|FG000|Overall Study|Device failure|4|||
49101153|NCT02662764|158204815|FG000|Overall Study|Patient changed treatment|1|||
49101154|NCT02662764|158204815|FG000|Overall Study|Patient discharged prior to 24 hrs|5|||
49101155|NCT02733185|158204821|FG000|Overall Study|Withdrawal by Subject|12|||
49101156|NCT02733185|158204822|FG001|Overall Study|Withdrawal by Subject|10|||
49101157|NCT02733185|158204823|FG002|Overall Study|Withdrawal by Subject|17|||
49101158|NCT02733185|158204824|FG003|Overall Study|Withdrawal by Subject|21|||
49101159|NCT02733185|158204821|FG000|Overall Study|Death|46|||
49101160|NCT02733185|158204822|FG001|Overall Study|Death|34|||
49101161|NCT02733185|158204823|FG002|Overall Study|Death|35|||
49101162|NCT02733185|158204824|FG003|Overall Study|Death|43|||
49101163|NCT02733185|158204821|FG000|Overall Study|Lost to Follow-up|17|||
49101164|NCT02733185|158204822|FG001|Overall Study|Lost to Follow-up|18|||
49101165|NCT02733185|158204823|FG002|Overall Study|Lost to Follow-up|16|||
49101166|NCT02733185|158204824|FG003|Overall Study|Lost to Follow-up|11|||
49101167|NCT00759785|158204825|FG000|Overall Study|Participant sample not evaluable|11|||
49101168|NCT00759785|158204826|FG001|Overall Study|Participant sample not evaluable|2|||
49101169|NCT00759785|158204825|FG000|Overall Study|Participant sample lost|0|||
49101170|NCT00759785|158204826|FG001|Overall Study|Participant sample lost|1|||
49101171|NCT00759785|158204825|FG000|Overall Study|Protocol Violation|1|||
49101172|NCT00759785|158204826|FG001|Overall Study|Protocol Violation|0|||
49101173|NCT00759785|158204825|FG000|Overall Study|Physician Decision|0|||
49101174|NCT00759785|158204826|FG001|Overall Study|Physician Decision|1|||
49101175|NCT00759785|158204825|FG000|Overall Study|Withdrawal by Subject|0|||
49101176|NCT00759785|158204826|FG001|Overall Study|Withdrawal by Subject|1|||
49101177|NCT00089778|158204827|FG000|Overall Study|Protocol Violation|0|||
49101178|NCT00089778|158204828|FG001|Overall Study|Protocol Violation|0|||
49101179|NCT00089778|158204829|FG002|Overall Study|Protocol Violation|1|||
49101180|NCT00177307|158204830|FG000|Overall Study|Withdrawal by Subject|1|||
49101181|NCT01664949|158204839|FG000|Overall Study|Adverse Event|11|||
49101182|NCT01664949|158204840|FG001|Overall Study|Adverse Event|12|||
49101183|NCT01664949|158204839|FG000|Overall Study|Lack of Efficacy|1|||
49101184|NCT01664949|158204840|FG001|Overall Study|Lack of Efficacy|1|||
49101185|NCT01664949|158204839|FG000|Overall Study|Lost to Follow-up|1|||
49101186|NCT01664949|158204840|FG001|Overall Study|Lost to Follow-up|2|||
49101187|NCT01664949|158204839|FG000|Overall Study|Personal Reasons|3|||
49101188|NCT01664949|158204840|FG001|Overall Study|Personal Reasons|4|||
49101189|NCT01664949|158204839|FG000|Overall Study|Protocol Violation|5|||
49101190|NCT01664949|158204840|FG001|Overall Study|Protocol Violation|5|||
49101191|NCT01664949|158204839|FG000|Overall Study|Other Miscellaneous Reasons|3|||
49101192|NCT01664949|158204840|FG001|Overall Study|Other Miscellaneous Reasons|1|||
49101193|NCT02777970|158204841|FG000|Overall Study|Lost to Follow-up|0|||
49101194|NCT02777970|158204842|FG001|Overall Study|Lost to Follow-up|1|||
49101195|NCT02777970|158204843|FG002|Overall Study|Lost to Follow-up|0|||
49101196|NCT02777970|158204841|FG000|Overall Study|Protocol Violation|1|||
49101197|NCT02777970|158204842|FG001|Overall Study|Protocol Violation|0|||
49101198|NCT02777970|158204843|FG002|Overall Study|Protocol Violation|0|||
49101199|NCT01967706|158204846|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
49101200|NCT01967706|158204847|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
49101201|NCT01967706|158204848|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
49101202|NCT01967706|158204849|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
49101203|NCT02541669|158204853|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
49101204|NCT02541669|158204854|FG001|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
49101205|NCT02541669|158204855|FG002|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
49101206|NCT02541669|158204856|FG003|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
49101207|NCT02541669|158204857|FG004|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
49101208|NCT03535740|158204860|FG000|Overall Study|Ongoing at Data Cut-off Date: 30 September 2020|55|||
49101209|NCT03535740|158204860|FG000|Overall Study|Death|34|||
49101210|NCT03535740|158204860|FG000|Overall Study|Lost to Follow-up|1|||
49101211|NCT03535740|158204860|FG000|Overall Study|Withdrawal by Subject|13|||
49101212|NCT04739722|158204861|FG000|Overall Study|Lost to Follow-up|5301|||
49101213|NCT04739722|158204861|FG000|Overall Study|Withdrawal by Subject|42|||
49101214|NCT04739722|158204861|FG000|Overall Study|Non Average-risk|1157|||
49101215|NCT00834639|158204862|FG000|Second Intervention|Physician Decision|0|||
49101216|NCT00834639|158204863|FG001|Second Intervention|Physician Decision|2|||
49101217|NCT00725608|158204867|FG000|Overall Study|Lost to Follow-up|60|||
49101218|NCT00725608|158204867|FG000|Overall Study|Adverse Event|14|||
49101219|NCT00725608|158204867|FG000|Overall Study|Individual reasons|86|||
49101220|NCT00725608|158204867|FG000|Overall Study|Other|7|||
49101221|NCT00614120|158204871|FG000|Overall Study|Adverse Event|9|||
49101222|NCT00614120|158204872|FG001|Overall Study|Adverse Event|22|||
49101223|NCT00614120|158204873|FG002|Overall Study|Adverse Event|30|||
49101224|NCT00614120|158204874|FG003|Overall Study|Adverse Event|3|||
49101225|NCT00614120|158204871|FG000|Overall Study|Lack of Efficacy|3|||
49101226|NCT00614120|158204872|FG001|Overall Study|Lack of Efficacy|3|||
49101227|NCT00614120|158204873|FG002|Overall Study|Lack of Efficacy|2|||
49101228|NCT00614120|158204874|FG003|Overall Study|Lack of Efficacy|2|||
49101229|NCT00614120|158204871|FG000|Overall Study|Protocol Violation|2|||
49101230|NCT00614120|158204872|FG001|Overall Study|Protocol Violation|5|||
49101231|NCT00614120|158204873|FG002|Overall Study|Protocol Violation|3|||
49101232|NCT00614120|158204874|FG003|Overall Study|Protocol Violation|1|||
49101233|NCT00614120|158204871|FG000|Overall Study|Withdrawal criteria|1|||
49101234|NCT00614120|158204872|FG001|Overall Study|Withdrawal criteria|0|||
49101235|NCT00614120|158204873|FG002|Overall Study|Withdrawal criteria|0|||
49101236|NCT00614120|158204874|FG003|Overall Study|Withdrawal criteria|0|||
49101237|NCT00614120|158204871|FG000|Overall Study|Withdrawal by Subject|9|||
49101238|NCT00614120|158204872|FG001|Overall Study|Withdrawal by Subject|10|||
49101239|NCT00614120|158204873|FG002|Overall Study|Withdrawal by Subject|16|||
49101240|NCT00614120|158204874|FG003|Overall Study|Withdrawal by Subject|3|||
49101241|NCT00614120|158204871|FG000|Overall Study|Did not meet trial criteria|0|||
49101242|NCT00614120|158204872|FG001|Overall Study|Did not meet trial criteria|1|||
49101243|NCT00614120|158204873|FG002|Overall Study|Did not meet trial criteria|1|||
49101244|NCT00614120|158204874|FG003|Overall Study|Did not meet trial criteria|1|||
49101245|NCT00614120|158204871|FG000|Overall Study|hCG positive (not pregnant)|0|||
49101246|NCT00614120|158204872|FG001|Overall Study|hCG positive (not pregnant)|0|||
49101247|NCT00614120|158204873|FG002|Overall Study|hCG positive (not pregnant)|1|||
49101248|NCT00614120|158204874|FG003|Overall Study|hCG positive (not pregnant)|0|||
49101249|NCT00614120|158204871|FG000|Overall Study|Hypoglycaemia|0|||
49101250|NCT00614120|158204872|FG001|Overall Study|Hypoglycaemia|0|||
49101251|NCT00614120|158204873|FG002|Overall Study|Hypoglycaemia|0|||
49101252|NCT00614120|158204874|FG003|Overall Study|Hypoglycaemia|1|||
49101253|NCT00614120|158204871|FG000|Overall Study|Lack of trial product|3|||
49101254|NCT00614120|158204872|FG001|Overall Study|Lack of trial product|3|||
49101255|NCT00614120|158204873|FG002|Overall Study|Lack of trial product|2|||
49101256|NCT00614120|158204874|FG003|Overall Study|Lack of trial product|0|||
49101257|NCT00614120|158204871|FG000|Overall Study|Late syphilis, latent|1|||
49101258|NCT00614120|158204872|FG001|Overall Study|Late syphilis, latent|0|||
49101259|NCT00614120|158204873|FG002|Overall Study|Late syphilis, latent|0|||
49101260|NCT00614120|158204874|FG003|Overall Study|Late syphilis, latent|0|||
49101261|NCT00614120|158204871|FG000|Overall Study|Taken inhibition medication eg Prandin|0|||
49101262|NCT00614120|158204872|FG001|Overall Study|Taken inhibition medication eg Prandin|0|||
49101263|NCT00614120|158204873|FG002|Overall Study|Taken inhibition medication eg Prandin|1|||
49101264|NCT00614120|158204874|FG003|Overall Study|Taken inhibition medication eg Prandin|1|||
49101265|NCT00614120|158204871|FG000|Overall Study|Lost to Follow-up|1|||
49101266|NCT00614120|158204872|FG001|Overall Study|Lost to Follow-up|2|||
49101267|NCT00614120|158204873|FG002|Overall Study|Lost to Follow-up|3|||
49101268|NCT00614120|158204874|FG003|Overall Study|Lost to Follow-up|4|||
49101269|NCT03047720|158204875|FG000|First Intervention (6weeks)|Participant data entry insufficient|7|||
49101270|NCT03047720|158204876|FG001|First Intervention (6weeks)|Participant data entry insufficient|0|||
49101271|NCT00784238|158204877|FG000|Overall Study|Adverse Event|14|||
49101272|NCT00784238|158204877|FG000|Overall Study|Death|2|||
49101273|NCT00784238|158204877|FG000|Overall Study|Lack of Efficacy|33|||
49101274|NCT00784238|158204877|FG000|Overall Study|Lost to Follow-up|29|||
49101275|NCT00784238|158204877|FG000|Overall Study|Pregnancy|1|||
49101276|NCT00784238|158204877|FG000|Overall Study|Withdrawal by Subject|26|||
49101277|NCT00784238|158204877|FG000|Overall Study|Other|14|||
49101278|NCT04972968|158204878|FG000|Overall Study|Adverse Event|3|||
49101279|NCT04972968|158204879|FG001|Overall Study|Adverse Event|1|||
49101280|NCT04972968|158204880|FG002|Overall Study|Adverse Event|1|||
49101281|NCT04972968|158204881|FG003|Overall Study|Adverse Event|7|||
49101282|NCT04972968|158204878|FG000|Overall Study|Lack of Efficacy|2|||
49101283|NCT04972968|158204879|FG001|Overall Study|Lack of Efficacy|1|||
49101284|NCT04972968|158204880|FG002|Overall Study|Lack of Efficacy|0|||
49101285|NCT04972968|158204881|FG003|Overall Study|Lack of Efficacy|0|||
49101286|NCT04972968|158204878|FG000|Overall Study|Withdrawal by Subject|7|||
49101287|NCT04972968|158204879|FG001|Overall Study|Withdrawal by Subject|4|||
49101288|NCT04972968|158204880|FG002|Overall Study|Withdrawal by Subject|3|||
49101289|NCT04972968|158204881|FG003|Overall Study|Withdrawal by Subject|2|||
49101290|NCT04972968|158204878|FG000|Overall Study|Study Terminated by Sponsor|25|||
49101291|NCT04972968|158204879|FG001|Overall Study|Study Terminated by Sponsor|28|||
49101292|NCT04972968|158204880|FG002|Overall Study|Study Terminated by Sponsor|32|||
49101293|NCT04972968|158204881|FG003|Overall Study|Study Terminated by Sponsor|27|||
49101294|NCT04972968|158204878|FG000|Overall Study|Other|1|||
49101295|NCT04972968|158204879|FG001|Overall Study|Other|0|||
49101296|NCT04972968|158204880|FG002|Overall Study|Other|1|||
49101297|NCT04972968|158204881|FG003|Overall Study|Other|1|||
49101298|NCT01698879|158204883|FG000|Overall Study|Withdrawal by Subject|1|||
49101299|NCT01698879|158204884|FG001|Overall Study|Withdrawal by Subject|0|||
49101300|NCT01698879|158204885|FG002|Overall Study|Withdrawal by Subject|0|||
49101301|NCT01984892|158204890|FG000|Overall Study|Progressive disease|7|||
49101302|NCT00721279|158204891|FG000|Overall Study|Lack of Efficacy|6|||
49101303|NCT00721279|158204892|FG001|Overall Study|Lack of Efficacy|3|||
49101304|NCT00721279|158204891|FG000|Overall Study|Tolerability insufficient|5|||
49101305|NCT00721279|158204892|FG001|Overall Study|Tolerability insufficient|2|||
49101306|NCT00721279|158204891|FG000|Overall Study|Withdrawal by Subject|13|||
49101307|NCT00721279|158204892|FG001|Overall Study|Withdrawal by Subject|3|||
49101308|NCT00721279|158204891|FG000|Overall Study|Other|12|||
49101309|NCT00721279|158204892|FG001|Overall Study|Other|16|||
49101310|NCT00710684|158204901|FG000|Overall Study|Adverse Event|11|||
49101311|NCT00710684|158204902|FG001|Overall Study|Adverse Event|19|||
49101312|NCT00710684|158204903|FG002|Overall Study|Adverse Event|16|||
49101313|NCT00710684|158204901|FG000|Overall Study|Lack of Efficacy|4|||
49101314|NCT00710684|158204902|FG001|Overall Study|Lack of Efficacy|3|||
49101315|NCT00710684|158204903|FG002|Overall Study|Lack of Efficacy|5|||
49101316|NCT00710684|158204901|FG000|Overall Study|Protocol Violation|5|||
49101317|NCT00710684|158204902|FG001|Overall Study|Protocol Violation|5|||
49101318|NCT00710684|158204903|FG002|Overall Study|Protocol Violation|5|||
49101319|NCT00710684|158204901|FG000|Overall Study|Lost to Follow-up|4|||
49101320|NCT00710684|158204902|FG001|Overall Study|Lost to Follow-up|6|||
49101321|NCT00710684|158204903|FG002|Overall Study|Lost to Follow-up|7|||
49101322|NCT00710684|158204901|FG000|Overall Study|Physician Decision|0|||
49101323|NCT00710684|158204902|FG001|Overall Study|Physician Decision|2|||
49101324|NCT00710684|158204903|FG002|Overall Study|Physician Decision|4|||
49101325|NCT00710684|158204901|FG000|Overall Study|Withdrawal by Subject|24|||
49101326|NCT00710684|158204902|FG001|Overall Study|Withdrawal by Subject|18|||
49101327|NCT00710684|158204903|FG002|Overall Study|Withdrawal by Subject|11|||
49101328|NCT00710684|158204901|FG000|Overall Study|Missing|1|||
49101329|NCT00710684|158204902|FG001|Overall Study|Missing|0|||
49101330|NCT00710684|158204903|FG002|Overall Study|Missing|0|||
49101331|NCT00710684|158204901|FG000|Overall Study|Did not continue after week 24|25|||
49101332|NCT00710684|158204902|FG001|Overall Study|Did not continue after week 24|21|||
49101333|NCT00710684|158204903|FG002|Overall Study|Did not continue after week 24|16|||
49101334|NCT04852679|158204905|FG000|Main Intervention Period|Withdrawal by Subject|3|||
49101335|NCT04852679|158204905|FG000|Main Intervention Period|Adverse Event|1|||
49101336|NCT04852679|158204905|FG000|Main Intervention Period|Progressive Disease|16|||
49101337|NCT04852679|158204905|FG000|Main Intervention Period|Refused study visit|1|||
49101338|NCT04852679|158204905|FG000|Independent Injection Period|Missed study visit|1|||
49101339|NCT02276053|158206978|FG000|Overall Study|Death|2|||
49101340|NCT02276053|158206978|FG000|Overall Study|Adverse Event|5|||
49101341|NCT02276053|158206978|FG000|Overall Study|Lack of Efficacy|2|||
49101342|NCT02276053|158206978|FG000|Overall Study|Withdrawal by Subject|1|||
49101343|NCT02276053|158206978|FG000|Overall Study|Patient does not meet selection criteria|3|||
49101344|NCT02276053|158206978|FG000|Overall Study|Patient needs to increase baseline AED|1|||
49101345|NCT00425061|158206979|FG000|Overall Study|Adverse Event|1|||
49101346|NCT00425061|158206980|FG001|Overall Study|Adverse Event|0|||
49101347|NCT00425061|158206981|FG002|Overall Study|Adverse Event|0|||
49101348|NCT00425061|158206982|FG003|Overall Study|Adverse Event|2|||
49101349|NCT00425061|158206983|FG004|Overall Study|Adverse Event|2|||
49101350|NCT00425061|158206984|FG005|Overall Study|Adverse Event|0|||
49101351|NCT00425061|158206985|FG006|Overall Study|Adverse Event|0|||
49101352|NCT00425061|158206979|FG000|Overall Study|Lost to Follow-up|0|||
49101353|NCT00425061|158206980|FG001|Overall Study|Lost to Follow-up|1|||
49101354|NCT00425061|158206981|FG002|Overall Study|Lost to Follow-up|0|||
49101355|NCT00425061|158206982|FG003|Overall Study|Lost to Follow-up|0|||
49101356|NCT00425061|158206983|FG004|Overall Study|Lost to Follow-up|0|||
49101357|NCT00425061|158206984|FG005|Overall Study|Lost to Follow-up|0|||
49101358|NCT00425061|158206985|FG006|Overall Study|Lost to Follow-up|0|||
49101359|NCT00425061|158206979|FG000|Overall Study|Protocol Violation|1|||
49101360|NCT00425061|158206980|FG001|Overall Study|Protocol Violation|0|||
49101361|NCT00425061|158206981|FG002|Overall Study|Protocol Violation|0|||
49101362|NCT00425061|158206982|FG003|Overall Study|Protocol Violation|0|||
49101363|NCT00425061|158206983|FG004|Overall Study|Protocol Violation|0|||
49101364|NCT00425061|158206984|FG005|Overall Study|Protocol Violation|0|||
49101365|NCT00425061|158206985|FG006|Overall Study|Protocol Violation|0|||
49101366|NCT00425061|158206979|FG000|Overall Study|Withdrawal by Subject|0|||
49101367|NCT00425061|158206980|FG001|Overall Study|Withdrawal by Subject|1|||
49101368|NCT00425061|158206981|FG002|Overall Study|Withdrawal by Subject|0|||
49101369|NCT00425061|158206982|FG003|Overall Study|Withdrawal by Subject|0|||
49101370|NCT00425061|158206983|FG004|Overall Study|Withdrawal by Subject|1|||
49101371|NCT00425061|158206984|FG005|Overall Study|Withdrawal by Subject|0|||
49101372|NCT00425061|158206985|FG006|Overall Study|Withdrawal by Subject|3|||
49101373|NCT00425061|158206979|FG000|Overall Study|Sponsor's request|0|||
49101374|NCT00425061|158206980|FG001|Overall Study|Sponsor's request|0|||
49101375|NCT00425061|158206981|FG002|Overall Study|Sponsor's request|0|||
49101376|NCT00425061|158206982|FG003|Overall Study|Sponsor's request|0|||
49101377|NCT00425061|158206983|FG004|Overall Study|Sponsor's request|19|||
49101378|NCT00425061|158206984|FG005|Overall Study|Sponsor's request|4|||
49101379|NCT00425061|158206985|FG006|Overall Study|Sponsor's request|15|||
49101380|NCT00425061|158206979|FG000|Overall Study|Physician Decision|0|||
49101381|NCT00425061|158206980|FG001|Overall Study|Physician Decision|0|||
49101382|NCT00425061|158206981|FG002|Overall Study|Physician Decision|0|||
49101383|NCT00425061|158206982|FG003|Overall Study|Physician Decision|0|||
49101384|NCT00425061|158206983|FG004|Overall Study|Physician Decision|1|||
49101385|NCT00425061|158206984|FG005|Overall Study|Physician Decision|0|||
49101386|NCT00425061|158206985|FG006|Overall Study|Physician Decision|0|||
49101387|NCT00425061|158206979|FG000|Overall Study|Other|0|||
49101388|NCT00425061|158206980|FG001|Overall Study|Other|0|||
49101389|NCT00425061|158206981|FG002|Overall Study|Other|0|||
49101390|NCT00425061|158206982|FG003|Overall Study|Other|0|||
49101391|NCT00425061|158206983|FG004|Overall Study|Other|3|||
49101392|NCT00425061|158206984|FG005|Overall Study|Other|0|||
49101393|NCT00425061|158206985|FG006|Overall Study|Other|1|||
49101394|NCT03339726|158206986|FG000|Overall Study|Withdrawal by Subject|1|||
49101395|NCT03339726|158206987|FG001|Overall Study|Withdrawal by Subject|0|||
49101396|NCT03339726|158206988|FG002|Overall Study|Withdrawal by Subject|0|||
49101397|NCT03339726|158206986|FG000|Overall Study|Lost to Follow-up|0|||
49101398|NCT03339726|158206987|FG001|Overall Study|Lost to Follow-up|1|||
49101399|NCT03339726|158206988|FG002|Overall Study|Lost to Follow-up|0|||
49101400|NCT01275755|158206989|FG000|Double-blind Treatment Period|Adverse Event|0|||
49101401|NCT01275755|158206990|FG001|Double-blind Treatment Period|Adverse Event|2|||
49101402|NCT01275755|158206989|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
49101403|NCT01275755|158206990|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
49101404|NCT01275755|158206989|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
49101405|NCT01275755|158206990|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
49101406|NCT01275755|158206989|FG000|Run-out Placebo Period|Lost to Follow-up|1|||
49101407|NCT01275755|158206990|FG001|Run-out Placebo Period|Lost to Follow-up|0|||
49101408|NCT00504725|158206993|FG000|Overall Study|Protocol Violation|1|||
49101409|NCT00504725|158206994|FG001|Overall Study|Protocol Violation|0|||
49101410|NCT02730377|158207002|FG000|Overall Study|Other|5|||
49101411|NCT02730377|158207003|FG001|Overall Study|Other|4|||
49101412|NCT02730377|158207002|FG000|Overall Study|Death|1|||
49101413|NCT02730377|158207003|FG001|Overall Study|Death|8|||
49101414|NCT02730377|158207002|FG000|Overall Study|Inadequate glycaemic control|368|||
49101415|NCT02730377|158207003|FG001|Overall Study|Inadequate glycaemic control|473|||
49101416|NCT02730377|158207002|FG000|Overall Study|Adverse Event|79|||
49101417|NCT02730377|158207003|FG001|Overall Study|Adverse Event|41|||
49101418|NCT02730377|158207002|FG000|Overall Study|Protocol Violation|23|||
49101419|NCT02730377|158207003|FG001|Overall Study|Protocol Violation|30|||
49101420|NCT02730377|158207002|FG000|Overall Study|Lack of Efficacy|4|||
49101421|NCT02730377|158207003|FG001|Overall Study|Lack of Efficacy|13|||
49101422|NCT02730377|158207002|FG000|Overall Study|Pregnancy|0|||
49101423|NCT02730377|158207003|FG001|Overall Study|Pregnancy|1|||
49101424|NCT02730377|158207002|FG000|Overall Study|Withdrawal by Subject|45|||
49101425|NCT02730377|158207003|FG001|Overall Study|Withdrawal by Subject|42|||
49101426|NCT02730377|158207002|FG000|Overall Study|Lost to Follow-up|25|||
49101427|NCT02730377|158207003|FG001|Overall Study|Lost to Follow-up|21|||
49101428|NCT03692325|158207008|FG000|Overall Study|Adverse Event|2|||
49101429|NCT03692325|158207008|FG000|Overall Study|Progression/Recurrence|2|||
49101430|NCT02908672|158207009|FG000|Overall Study|Death|112|||
49101431|NCT02908672|158207010|FG001|Overall Study|Death|93|||
49101432|NCT02908672|158207009|FG000|Overall Study|Lost to Follow-up|3|||
49101433|NCT02908672|158207010|FG001|Overall Study|Lost to Follow-up|3|||
49101434|NCT02908672|158207009|FG000|Overall Study|Other|2|||
49101435|NCT02908672|158207010|FG001|Overall Study|Other|0|||
49101436|NCT02908672|158207009|FG000|Overall Study|Protocol Violation|1|||
49101437|NCT02908672|158207010|FG001|Overall Study|Protocol Violation|1|||
49101438|NCT02908672|158207009|FG000|Overall Study|Withdrawal by Subject|13|||
49101439|NCT02908672|158207010|FG001|Overall Study|Withdrawal by Subject|18|||
49101440|NCT02908672|158207009|FG000|Overall Study|Study is ongoing|124|||
49101441|NCT02908672|158207010|FG001|Overall Study|Study is ongoing|141|||
49101442|NCT02908672|158207009|FG000|Overall Study|Discontinued the study during run-in|3|||
49101443|NCT02908672|158207010|FG001|Overall Study|Discontinued the study during run-in|0|||
49101444|NCT01300338|158207013|FG000|Overall Study|Lost to Follow-up|5|||
49101445|NCT01300338|158207014|FG001|Overall Study|Lost to Follow-up|0|||
49101446|NCT01936181|158207022|FG000|Randomised, Double-blind|Adverse Event|27|||
49101447|NCT01936181|158207023|FG001|Randomised, Double-blind|Adverse Event|21|||
49101448|NCT01936181|158207024|FG002|Randomised, Double-blind|Adverse Event|0|||
49101449|NCT01936181|158207025|FG003|Randomised, Double-blind|Adverse Event|0|||
49101450|NCT01936181|158207022|FG000|Randomised, Double-blind|Protocol Violation|1|||
49101451|NCT01936181|158207023|FG001|Randomised, Double-blind|Protocol Violation|5|||
49101452|NCT01936181|158207024|FG002|Randomised, Double-blind|Protocol Violation|0|||
49101453|NCT01936181|158207025|FG003|Randomised, Double-blind|Protocol Violation|0|||
49101454|NCT01936181|158207022|FG000|Randomised, Double-blind|Lack of Efficacy|5|||
49101455|NCT01936181|158207023|FG001|Randomised, Double-blind|Lack of Efficacy|6|||
49101456|NCT01936181|158207024|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
49101457|NCT01936181|158207025|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
49101458|NCT01936181|158207022|FG000|Randomised, Double-blind|Lost to Follow-up|0|||
49101459|NCT01936181|158207023|FG001|Randomised, Double-blind|Lost to Follow-up|1|||
49101460|NCT01936181|158207024|FG002|Randomised, Double-blind|Lost to Follow-up|0|||
49101461|NCT01936181|158207025|FG003|Randomised, Double-blind|Lost to Follow-up|0|||
49101462|NCT01936181|158207022|FG000|Randomised, Double-blind|Pregnancy|0|||
49101463|NCT01936181|158207023|FG001|Randomised, Double-blind|Pregnancy|1|||
49101464|NCT01936181|158207024|FG002|Randomised, Double-blind|Pregnancy|0|||
49101465|NCT01936181|158207025|FG003|Randomised, Double-blind|Pregnancy|0|||
49101466|NCT01936181|158207022|FG000|Randomised, Double-blind|Physician Decision|4|||
49101467|NCT01936181|158207023|FG001|Randomised, Double-blind|Physician Decision|4|||
49101468|NCT01936181|158207024|FG002|Randomised, Double-blind|Physician Decision|0|||
49101469|NCT01936181|158207025|FG003|Randomised, Double-blind|Physician Decision|0|||
49101470|NCT01936181|158207022|FG000|Randomised, Double-blind|Withdrawal by Subject|23|||
49101471|NCT01936181|158207023|FG001|Randomised, Double-blind|Withdrawal by Subject|26|||
49101472|NCT01936181|158207024|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
49101473|NCT01936181|158207025|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
49101474|NCT01936181|158207022|FG000|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
49101475|NCT01936181|158207023|FG001|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
49101476|NCT01936181|158207024|FG002|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
49101477|NCT01936181|158207025|FG003|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
49101478|NCT01936181|158207022|FG000|Transition-extension|Adverse Event|3|||
49101479|NCT01936181|158207023|FG001|Transition-extension|Adverse Event|0|||
49101480|NCT01936181|158207024|FG002|Transition-extension|Adverse Event|3|||
49101481|NCT01936181|158207025|FG003|Transition-extension|Adverse Event|1|||
49101482|NCT01936181|158207022|FG000|Transition-extension|Lost to Follow-up|3|||
49101483|NCT01936181|158207023|FG001|Transition-extension|Lost to Follow-up|0|||
49101484|NCT01936181|158207024|FG002|Transition-extension|Lost to Follow-up|1|||
49101485|NCT01936181|158207025|FG003|Transition-extension|Lost to Follow-up|2|||
49101486|NCT01936181|158207022|FG000|Transition-extension|Physician Decision|2|||
49101487|NCT01936181|158207023|FG001|Transition-extension|Physician Decision|0|||
49101488|NCT01936181|158207024|FG002|Transition-extension|Physician Decision|0|||
49101489|NCT01936181|158207025|FG003|Transition-extension|Physician Decision|1|||
49101490|NCT01936181|158207022|FG000|Transition-extension|Withdrawal by Subject|7|||
49101491|NCT01936181|158207023|FG001|Transition-extension|Withdrawal by Subject|0|||
49101492|NCT01936181|158207024|FG002|Transition-extension|Withdrawal by Subject|2|||
49101493|NCT01936181|158207025|FG003|Transition-extension|Withdrawal by Subject|1|||
49101494|NCT00970632|158207026|FG000|Overall Study|Adverse Event|2|||
49101495|NCT00970632|158207027|FG001|Overall Study|Adverse Event|2|||
49101496|NCT00970632|158207028|FG002|Overall Study|Adverse Event|1|||
49101497|NCT00970632|158207026|FG000|Overall Study|Lack of Efficacy|3|||
49101498|NCT00970632|158207027|FG001|Overall Study|Lack of Efficacy|0|||
49101499|NCT00970632|158207028|FG002|Overall Study|Lack of Efficacy|0|||
49101500|NCT00970632|158207026|FG000|Overall Study|Lost to Follow-up|3|||
49101501|NCT00970632|158207027|FG001|Overall Study|Lost to Follow-up|0|||
49101502|NCT00970632|158207028|FG002|Overall Study|Lost to Follow-up|2|||
49101503|NCT00970632|158207026|FG000|Overall Study|Protocol Violation|8|||
49101504|NCT00970632|158207027|FG001|Overall Study|Protocol Violation|5|||
49101505|NCT00970632|158207028|FG002|Overall Study|Protocol Violation|8|||
49101506|NCT00970632|158207026|FG000|Overall Study|Withdrawal by Subject|7|||
49101507|NCT00970632|158207027|FG001|Overall Study|Withdrawal by Subject|6|||
49101508|NCT00970632|158207028|FG002|Overall Study|Withdrawal by Subject|4|||
49101509|NCT00970632|158207026|FG000|Overall Study|Entry criteria not met|0|||
49101510|NCT00970632|158207027|FG001|Overall Study|Entry criteria not met|2|||
49101511|NCT00970632|158207028|FG002|Overall Study|Entry criteria not met|2|||
49101512|NCT00970632|158207026|FG000|Overall Study|Sponsor decision|1|||
49101513|NCT00970632|158207027|FG001|Overall Study|Sponsor decision|0|||
49101514|NCT00970632|158207028|FG002|Overall Study|Sponsor decision|1|||
49101515|NCT00664859|158207029|FG000|Overall Study|Adverse Event|2|||
49101516|NCT00664859|158207030|FG001|Overall Study|Adverse Event|1|||
49101517|NCT00664859|158207031|FG002|Overall Study|Adverse Event|3|||
49101518|NCT00664859|158207029|FG000|Overall Study|DB Study (LCP-AtorFen-2001) AE|6|||
49101519|NCT00664859|158207030|FG001|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
49101520|NCT00664859|158207031|FG002|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
49101521|NCT00664859|158207029|FG000|Overall Study|Noncompliance with protocol|1|||
49101522|NCT00664859|158207030|FG001|Overall Study|Noncompliance with protocol|0|||
49101523|NCT00664859|158207031|FG002|Overall Study|Noncompliance with protocol|4|||
49101524|NCT00664859|158207029|FG000|Overall Study|Laboratory abnormality|2|||
49101525|NCT00664859|158207030|FG001|Overall Study|Laboratory abnormality|1|||
49101526|NCT00664859|158207031|FG002|Overall Study|Laboratory abnormality|4|||
49101527|NCT00664859|158207029|FG000|Overall Study|Withdrawal by Subject|4|||
49101528|NCT00664859|158207030|FG001|Overall Study|Withdrawal by Subject|1|||
49101529|NCT00664859|158207031|FG002|Overall Study|Withdrawal by Subject|3|||
49101530|NCT00664859|158207029|FG000|Overall Study|Lost to Follow-up|2|||
49101531|NCT00664859|158207030|FG001|Overall Study|Lost to Follow-up|2|||
49101532|NCT00664859|158207031|FG002|Overall Study|Lost to Follow-up|1|||
49101533|NCT00664859|158207029|FG000|Overall Study|Other|0|||
49101534|NCT00664859|158207030|FG001|Overall Study|Other|1|||
49101535|NCT00664859|158207031|FG002|Overall Study|Other|2|||
49101536|NCT00937040|158207032|FG000|Overall Study|Adverse Event|5|||
49101537|NCT00937040|158207033|FG001|Overall Study|Adverse Event|8|||
49101538|NCT00937040|158207032|FG000|Overall Study|Lost to Follow-up|12|||
49101539|NCT00937040|158207033|FG001|Overall Study|Lost to Follow-up|12|||
49101540|NCT00937040|158207032|FG000|Overall Study|Protocol Violation|3|||
49101541|NCT00937040|158207033|FG001|Overall Study|Protocol Violation|0|||
49101542|NCT00937040|158207032|FG000|Overall Study|Withdrawal by Subject|13|||
49101543|NCT00937040|158207033|FG001|Overall Study|Withdrawal by Subject|7|||
49101544|NCT00937040|158207032|FG000|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3|||
49101545|NCT00937040|158207033|FG001|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2|||
49101546|NCT00937040|158207032|FG000|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5|||
49101547|NCT00937040|158207033|FG001|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8|||
49101548|NCT00738881|158207034|FG000|Overall Study|Withdrawal by Subject|0|||
49101549|NCT00738881|158207035|FG001|Overall Study|Withdrawal by Subject|2|||
49101550|NCT01044290|158207036|FG000|Follow-up 1|Death|3|||
49101551|NCT01044290|158207037|FG001|Follow-up 1|Death|3|||
49101552|NCT01044290|158207038|FG002|Follow-up 1|Death|1|||
49101553|NCT01044290|158207036|FG000|Follow-up 1|Withdrawal by Subject|2|||
49101554|NCT01044290|158207037|FG001|Follow-up 1|Withdrawal by Subject|2|||
49101555|NCT01044290|158207038|FG002|Follow-up 1|Withdrawal by Subject|0|||
49101556|NCT01044290|158207036|FG000|Follow-Up 2|Death|0|||
49101557|NCT01044290|158207037|FG001|Follow-Up 2|Death|1|||
49101558|NCT01044290|158207038|FG002|Follow-Up 2|Death|1|||
49101559|NCT01044290|158207036|FG000|Follow-Up 2|Withdrawal by Subject|0|||
49101560|NCT01044290|158207037|FG001|Follow-Up 2|Withdrawal by Subject|1|||
49101561|NCT01044290|158207038|FG002|Follow-Up 2|Withdrawal by Subject|1|||
49101562|NCT04186806|158207039|FG000|Period 1: 7 Days|Adverse Event|1|||
49101563|NCT04186806|158207040|FG001|Period 1: 7 Days|Adverse Event|0|||
49101564|NCT04323306|158207041|FG000|Overall Study|Physician Decision|1|||
49101565|NCT04323306|158207042|FG001|Overall Study|Physician Decision|0|||
49101566|NCT04323306|158207043|FG002|Overall Study|Physician Decision|0|||
49101567|NCT04323306|158207044|FG003|Overall Study|Physician Decision|0|||
49101568|NCT04323306|158207045|FG004|Overall Study|Physician Decision|0|||
49101569|NCT04323306|158207046|FG005|Overall Study|Physician Decision|0|||
49101570|NCT04323306|158207047|FG006|Overall Study|Physician Decision|0|||
49101571|NCT04323306|158207048|FG007|Overall Study|Physician Decision|0|||
49101572|NCT04323306|158207049|FG008|Overall Study|Physician Decision|0|||
49101573|NCT04323306|158207041|FG000|Overall Study|Withdrawal by Subject|0|||
49101574|NCT04323306|158207042|FG001|Overall Study|Withdrawal by Subject|0|||
49101575|NCT04323306|158207043|FG002|Overall Study|Withdrawal by Subject|0|||
49101576|NCT04323306|158207044|FG003|Overall Study|Withdrawal by Subject|0|||
49101577|NCT04323306|158207045|FG004|Overall Study|Withdrawal by Subject|0|||
49101578|NCT04323306|158207046|FG005|Overall Study|Withdrawal by Subject|1|||
49101579|NCT04323306|158207047|FG006|Overall Study|Withdrawal by Subject|3|||
49101580|NCT04323306|158207048|FG007|Overall Study|Withdrawal by Subject|0|||
49101581|NCT04323306|158207049|FG008|Overall Study|Withdrawal by Subject|1|||
49101582|NCT02677038|158207054|FG000|Overall Study|Physician Decision|1|||
49101583|NCT02677038|158207054|FG000|Overall Study|Withdrawal by Subject|1|||
49101584|NCT04712019|158207055|FG000|Overall Study|Withdrawal by Subject|2|||
49101585|NCT04712019|158207056|FG001|Overall Study|Withdrawal by Subject|2|||
49101586|NCT04712019|158207055|FG000|Overall Study|Protocol required withdrawal - crossover treatment|1|||
49101587|NCT04712019|158207056|FG001|Overall Study|Protocol required withdrawal - crossover treatment|1|||
49101588|NCT01646021|158207057|FG000|Overall Study|Death|77|||
49101589|NCT01646021|158207058|FG001|Overall Study|Death|83|||
49101590|NCT01646021|158207057|FG000|Overall Study|Study Terminated by Sponsor|50|||
49101591|NCT01646021|158207058|FG001|Overall Study|Study Terminated by Sponsor|41|||
49101592|NCT01646021|158207057|FG000|Overall Study|Lost to Follow-up|2|||
49101593|NCT01646021|158207058|FG001|Overall Study|Lost to Follow-up|2|||
49101594|NCT01646021|158207057|FG000|Overall Study|Withdrawal by Subject|10|||
49101595|NCT01646021|158207058|FG001|Overall Study|Withdrawal by Subject|15|||
49101596|NCT01282164|158207059|FG000|Overall Study|Lack of hypoglycemia during ITT|1|||
49101597|NCT01282164|158207060|FG001|Overall Study|Lack of hypoglycemia during ITT|0|||
49101598|NCT04521621|158207061|FG000|Overall Study|Death|17|||
49101599|NCT04521621|158207062|FG001|Overall Study|Death|8|||
49101600|NCT04521621|158207063|FG002|Overall Study|Death|8|||
49101601|NCT04521621|158207064|FG003|Overall Study|Death|5|||
49101602|NCT04521621|158207065|FG004|Overall Study|Death|2|||
49101603|NCT04521621|158207066|FG005|Overall Study|Death|7|||
49101604|NCT04521621|158207067|FG006|Overall Study|Death|0|||
49101605|NCT04521621|158207068|FG007|Overall Study|Death|0|||
49101606|NCT04521621|158207061|FG000|Overall Study|Study Terminated by Sponsor|4|||
49101607|NCT04521621|158207062|FG001|Overall Study|Study Terminated by Sponsor|6|||
49101608|NCT04521621|158207063|FG002|Overall Study|Study Terminated by Sponsor|8|||
49101609|NCT04521621|158207064|FG003|Overall Study|Study Terminated by Sponsor|0|||
49101610|NCT04521621|158207065|FG004|Overall Study|Study Terminated by Sponsor|1|||
49101611|NCT04521621|158207066|FG005|Overall Study|Study Terminated by Sponsor|7|||
49101612|NCT04521621|158207067|FG006|Overall Study|Study Terminated by Sponsor|0|||
49101613|NCT04521621|158207068|FG007|Overall Study|Study Terminated by Sponsor|0|||
49101614|NCT04521621|158207061|FG000|Overall Study|Withdrawal by Subject|0|||
49101615|NCT04521621|158207062|FG001|Overall Study|Withdrawal by Subject|0|||
49101616|NCT04521621|158207063|FG002|Overall Study|Withdrawal by Subject|1|||
49101617|NCT04521621|158207064|FG003|Overall Study|Withdrawal by Subject|1|||
49101618|NCT04521621|158207065|FG004|Overall Study|Withdrawal by Subject|0|||
49101619|NCT04521621|158207066|FG005|Overall Study|Withdrawal by Subject|0|||
49101620|NCT04521621|158207067|FG006|Overall Study|Withdrawal by Subject|0|||
49101621|NCT04521621|158207068|FG007|Overall Study|Withdrawal by Subject|0|||
49101622|NCT04521621|158207061|FG000|Overall Study|Allocated in error without study intervention|1|||
49101623|NCT04521621|158207062|FG001|Overall Study|Allocated in error without study intervention|0|||
49101624|NCT04521621|158207063|FG002|Overall Study|Allocated in error without study intervention|0|||
49101625|NCT04521621|158207064|FG003|Overall Study|Allocated in error without study intervention|0|||
49101626|NCT04521621|158207065|FG004|Overall Study|Allocated in error without study intervention|0|||
49101627|NCT04521621|158207066|FG005|Overall Study|Allocated in error without study intervention|0|||
49101628|NCT04521621|158207067|FG006|Overall Study|Allocated in error without study intervention|0|||
49101629|NCT04521621|158207068|FG007|Overall Study|Allocated in error without study intervention|0|||
49101630|NCT03671564|158207069|FG000|Overall Study|Progressive Disease|3|||
49101631|NCT03671564|158207070|FG001|Overall Study|Progressive Disease|5|||
49101632|NCT03671564|158207071|FG002|Overall Study|Progressive Disease|3|||
49101633|NCT03671564|158207069|FG000|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
49101634|NCT03671564|158207070|FG001|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
49101635|NCT03671564|158207071|FG002|Overall Study|Confirmed TP53 Genotyping Mutation|1|||
49101636|NCT03671564|158207069|FG000|Overall Study|Withdrawal by Subject|1|||
49101637|NCT03671564|158207070|FG001|Overall Study|Withdrawal by Subject|1|||
49101638|NCT03671564|158207071|FG002|Overall Study|Withdrawal by Subject|0|||
49101639|NCT02100670|158207081|FG000|Overall Study|Adverse Event|10|||
49101640|NCT02100670|158207082|FG001|Overall Study|Adverse Event|3|||
49101641|NCT02100670|158207083|FG002|Overall Study|Adverse Event|3|||
49101642|NCT02100670|158207084|FG003|Overall Study|Adverse Event|0|||
49101643|NCT02100670|158207081|FG000|Overall Study|Lost to Follow-up|1|||
49101644|NCT02100670|158207082|FG001|Overall Study|Lost to Follow-up|0|||
49101645|NCT02100670|158207083|FG002|Overall Study|Lost to Follow-up|0|||
49101646|NCT02100670|158207084|FG003|Overall Study|Lost to Follow-up|0|||
49101647|NCT02100670|158207081|FG000|Overall Study|Protocol Violation|0|||
49101648|NCT02100670|158207082|FG001|Overall Study|Protocol Violation|1|||
49101649|NCT02100670|158207083|FG002|Overall Study|Protocol Violation|0|||
49101650|NCT02100670|158207084|FG003|Overall Study|Protocol Violation|1|||
49101651|NCT02100670|158207081|FG000|Overall Study|Withdrawal of Consent|0|||
49101652|NCT02100670|158207082|FG001|Overall Study|Withdrawal of Consent|1|||
49101653|NCT02100670|158207083|FG002|Overall Study|Withdrawal of Consent|1|||
49101654|NCT02100670|158207084|FG003|Overall Study|Withdrawal of Consent|0|||
49101655|NCT02100670|158207081|FG000|Overall Study|No swelling no pain|1|||
49101656|NCT02100670|158207082|FG001|Overall Study|No swelling no pain|0|||
49101657|NCT02100670|158207083|FG002|Overall Study|No swelling no pain|0|||
49101658|NCT02100670|158207084|FG003|Overall Study|No swelling no pain|0|||
49101659|NCT02100670|158207081|FG000|Overall Study|Poor Efficacy|0|||
49101660|NCT02100670|158207082|FG001|Overall Study|Poor Efficacy|1|||
49101661|NCT02100670|158207083|FG002|Overall Study|Poor Efficacy|0|||
49101662|NCT02100670|158207084|FG003|Overall Study|Poor Efficacy|0|||
49101663|NCT02100670|158207081|FG000|Overall Study|Physician Decision|0|||
49101664|NCT02100670|158207082|FG001|Overall Study|Physician Decision|1|||
49101665|NCT02100670|158207083|FG002|Overall Study|Physician Decision|0|||
49101666|NCT02100670|158207084|FG003|Overall Study|Physician Decision|0|||
49101667|NCT02100670|158207081|FG000|Overall Study|Withdrawal by Subject|1|||
49101668|NCT02100670|158207082|FG001|Overall Study|Withdrawal by Subject|0|||
49101669|NCT02100670|158207083|FG002|Overall Study|Withdrawal by Subject|0|||
49101670|NCT02100670|158207084|FG003|Overall Study|Withdrawal by Subject|0|||
49101671|NCT02347891|158207085|FG000|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|2|||
49101672|NCT02347891|158207086|FG001|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|1|||
49101673|NCT02347891|158207085|FG000|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
49101674|NCT02347891|158207086|FG001|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
49101675|NCT00567489|158207087|FG000|Overall Study|Adverse Event|6|||
49101676|NCT00567489|158207088|FG001|Overall Study|Adverse Event|14|||
49101677|NCT00567489|158207087|FG000|Overall Study|Physician Decision|0|||
49101678|NCT00567489|158207088|FG001|Overall Study|Physician Decision|4|||
49101679|NCT00567489|158207087|FG000|Overall Study|Withdrawal by Subject|0|||
49101680|NCT00567489|158207088|FG001|Overall Study|Withdrawal by Subject|2|||
49101681|NCT00567489|158207087|FG000|Overall Study|Renal Transplantation|0|||
49101682|NCT00567489|158207088|FG001|Overall Study|Renal Transplantation|3|||
49101683|NCT00567489|158207087|FG000|Overall Study|Other|1|||
49101684|NCT00567489|158207088|FG001|Overall Study|Other|0|||
49101685|NCT05845567|158207089|FG000|Overall Study|Withdrawal by Subject|1|||
49101686|NCT01154088|158207095|FG000|Overall Study|Lost to Follow-up|4|||
49101687|NCT01154088|158207096|FG001|Overall Study|Lost to Follow-up|6|||
49101688|NCT01154088|158207097|FG002|Overall Study|Lost to Follow-up|7|||
49101689|NCT03409107|158207098|FG000|Overall Study|Withdrawal by Subject|4|||
49101690|NCT03409107|158207099|FG001|Overall Study|Withdrawal by Subject|2|||
49101691|NCT03409107|158207098|FG000|Overall Study|Physician Decision|1|||
49101692|NCT03409107|158207099|FG001|Overall Study|Physician Decision|0|||
49101693|NCT03409107|158207098|FG000|Overall Study|Lost to Follow-up|7|||
49101694|NCT03409107|158207099|FG001|Overall Study|Lost to Follow-up|2|||
49101695|NCT03409107|158207098|FG000|Overall Study|Adverse Event|5|||
49101696|NCT03409107|158207099|FG001|Overall Study|Adverse Event|3|||
49101697|NCT01968707|158207102|FG000|Overall Study|Did not meet treatment day baseline|49|||
49101698|NCT01968707|158207103|FG001|Overall Study|Did not meet treatment day baseline|12|||
49101699|NCT01968707|158207104|FG002|Overall Study|Did not meet treatment day baseline|41|||
49101700|NCT01968707|158207105|FG003|Overall Study|Did not meet treatment day baseline|44|||
49101701|NCT01968707|158207106|FG004|Overall Study|Did not meet treatment day baseline|36|||
49101702|NCT01968707|158207107|FG005|Overall Study|Did not meet treatment day baseline|11|||
49101703|NCT01968707|158207108|FG006|Overall Study|Did not meet treatment day baseline|34|||
49101704|NCT01968707|158207109|FG007|Overall Study|Did not meet treatment day baseline|35|||
49101705|NCT03917472|158207110|FG000|Overall Study|Physician Decision|4|||
49101706|NCT03917472|158207111|FG001|Overall Study|Physician Decision|0|||
49101707|NCT03917472|158207110|FG000|Overall Study|Adverse Event|3|||
49101708|NCT03917472|158207111|FG001|Overall Study|Adverse Event|1|||
49101709|NCT03917472|158207110|FG000|Overall Study|Death|7|||
49101710|NCT03917472|158207111|FG001|Overall Study|Death|5|||
49101711|NCT03917472|158207110|FG000|Overall Study|Withdrawal by Subject|11|||
49101712|NCT03917472|158207111|FG001|Overall Study|Withdrawal by Subject|4|||
49101713|NCT03917472|158207110|FG000|Overall Study|Lost to Follow-up|10|||
49101714|NCT03917472|158207111|FG001|Overall Study|Lost to Follow-up|5|||
49101715|NCT00742508|158207112|FG000|8-Week Primary Evaluation Period|Adverse Event|2|||
49101716|NCT00742508|158207113|FG001|8-Week Primary Evaluation Period|Adverse Event|4|||
49101717|NCT00742508|158207112|FG000|8-Week Primary Evaluation Period|Protocol Violation|1|||
49101718|NCT00742508|158207113|FG001|8-Week Primary Evaluation Period|Protocol Violation|0|||
49101719|NCT00742508|158207112|FG000|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8|||
49101720|NCT00742508|158207113|FG001|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5|||
49101721|NCT00742508|158207112|FG000|8-Week Primary Evaluation Period|Withdrawal by Subject|0|||
49101722|NCT00742508|158207113|FG001|8-Week Primary Evaluation Period|Withdrawal by Subject|2|||
49101723|NCT00742508|158207112|FG000|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0|||
49101724|NCT00742508|158207113|FG001|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1|||
49101725|NCT02484651|158207114|FG000|Overall Study|Patients' data files were corrupted.|1|||
49101726|NCT02484651|158207115|FG001|Overall Study|Patients' data files were corrupted.|1|||
49101727|NCT02484651|158207114|FG000|Overall Study|BIS monitoring failed.|1|||
49101728|NCT02484651|158207115|FG001|Overall Study|BIS monitoring failed.|1|||
49101729|NCT02484651|158207114|FG000|Overall Study|Time of the procedure less than 90 min.|1|||
49101730|NCT02484651|158207115|FG001|Overall Study|Time of the procedure less than 90 min.|2|||
49101731|NCT03589976|158207117|FG000|Overall Study|Death|5|||
49101732|NCT03589976|158207118|FG001|Overall Study|Death|1|||
49101733|NCT03589976|158207117|FG000|Overall Study|Adverse Event|5|||
49101734|NCT03589976|158207118|FG001|Overall Study|Adverse Event|1|||
49101735|NCT03589976|158207117|FG000|Overall Study|Withdrawal by Subject|4|||
49101736|NCT03589976|158207118|FG001|Overall Study|Withdrawal by Subject|1|||
49101737|NCT03589976|158207117|FG000|Overall Study|Lost to Follow-up|1|||
49101738|NCT03589976|158207118|FG001|Overall Study|Lost to Follow-up|0|||
49101739|NCT03589976|158207117|FG000|Overall Study|Other|4|||
49101740|NCT03589976|158207118|FG001|Overall Study|Other|3|||
49101741|NCT02089334|158207121|FG000|Overall Study|Withdrawal by Subject|0|||
49101742|NCT02089334|158207122|FG001|Overall Study|Withdrawal by Subject|0|||
49101743|NCT02089334|158207123|FG002|Overall Study|Withdrawal by Subject|0|||
49101744|NCT02089334|158207124|FG003|Overall Study|Withdrawal by Subject|2|||
49101745|NCT02089334|158207121|FG000|Overall Study|Adverse Event|0|||
49101746|NCT02089334|158207122|FG001|Overall Study|Adverse Event|0|||
49101747|NCT02089334|158207123|FG002|Overall Study|Adverse Event|0|||
49101748|NCT02089334|158207124|FG003|Overall Study|Adverse Event|2|||
49101749|NCT02089334|158207121|FG000|Overall Study|Progressive disease|0|||
49101750|NCT02089334|158207122|FG001|Overall Study|Progressive disease|0|||
49101751|NCT02089334|158207123|FG002|Overall Study|Progressive disease|0|||
49101752|NCT02089334|158207124|FG003|Overall Study|Progressive disease|2|||
49101753|NCT02089334|158207121|FG000|Overall Study|Physician Decision|0|||
49101754|NCT02089334|158207122|FG001|Overall Study|Physician Decision|0|||
49101755|NCT02089334|158207123|FG002|Overall Study|Physician Decision|1|||
49101756|NCT02089334|158207124|FG003|Overall Study|Physician Decision|1|||
49101757|NCT02680834|158207125|FG000|Overall Study|Physician Decision|5|||
49101758|NCT02680834|158207126|FG001|Overall Study|Physician Decision|2|||
49101759|NCT02680834|158207125|FG000|Overall Study|Withdrawal by Subject|6|||
49101760|NCT02680834|158207126|FG001|Overall Study|Withdrawal by Subject|0|||
49101761|NCT02680834|158207125|FG000|Overall Study|Lost to Follow-up|0|||
49101762|NCT02680834|158207126|FG001|Overall Study|Lost to Follow-up|1|||
49101763|NCT02520427|158207128|FG000|Overall Study|Decision by sponsor|0|||
49101764|NCT02520427|158207129|FG001|Overall Study|Decision by sponsor|0|||
49101765|NCT02520427|158207130|FG002|Overall Study|Decision by sponsor|0|||
49101766|NCT02520427|158207131|FG003|Overall Study|Decision by sponsor|0|||
49101767|NCT02520427|158207132|FG004|Overall Study|Decision by sponsor|0|||
49101768|NCT02520427|158207133|FG005|Overall Study|Decision by sponsor|0|||
49101769|NCT02520427|158207134|FG006|Overall Study|Decision by sponsor|0|||
49101770|NCT02520427|158207135|FG007|Overall Study|Decision by sponsor|0|||
49101771|NCT02520427|158207136|FG008|Overall Study|Decision by sponsor|1|||
49101772|NCT02520427|158207137|FG009|Overall Study|Decision by sponsor|1|||
49101773|NCT02520427|158207138|FG010|Overall Study|Decision by sponsor|0|||
49101774|NCT02520427|158207139|FG011|Overall Study|Decision by sponsor|0|||
49101775|NCT02520427|158207140|FG012|Overall Study|Decision by sponsor|0|||
49101776|NCT02520427|158207141|FG013|Overall Study|Decision by sponsor|0|||
49101777|NCT02520427|158207142|FG014|Overall Study|Decision by sponsor|0|||
49101778|NCT02520427|158207143|FG015|Overall Study|Decision by sponsor|0|||
49101779|NCT02520427|158207144|FG016|Overall Study|Decision by sponsor|0|||
49101780|NCT02520427|158207145|FG017|Overall Study|Decision by sponsor|0|||
49101781|NCT02520427|158207146|FG018|Overall Study|Decision by sponsor|0|||
49101782|NCT02520427|158207147|FG019|Overall Study|Decision by sponsor|0|||
49101783|NCT02520427|158207148|FG020|Overall Study|Decision by sponsor|0|||
49101784|NCT02520427|158207149|FG021|Overall Study|Decision by sponsor|0|||
49101785|NCT02520427|158207150|FG022|Overall Study|Decision by sponsor|0|||
49101786|NCT02520427|158207151|FG023|Overall Study|Decision by sponsor|0|||
49101787|NCT02520427|158207152|FG024|Overall Study|Decision by sponsor|0|||
49101788|NCT02520427|158207153|FG025|Overall Study|Decision by sponsor|0|||
49101789|NCT02520427|158207128|FG000|Overall Study|Withdrawal by Subject|0|||
49101790|NCT02520427|158207129|FG001|Overall Study|Withdrawal by Subject|0|||
49101791|NCT02520427|158207130|FG002|Overall Study|Withdrawal by Subject|1|||
49101792|NCT02520427|158207131|FG003|Overall Study|Withdrawal by Subject|0|||
49101793|NCT02520427|158207132|FG004|Overall Study|Withdrawal by Subject|0|||
49101794|NCT02520427|158207133|FG005|Overall Study|Withdrawal by Subject|0|||
49101795|NCT02520427|158207134|FG006|Overall Study|Withdrawal by Subject|0|||
49101796|NCT02520427|158207135|FG007|Overall Study|Withdrawal by Subject|0|||
49101797|NCT02520427|158207136|FG008|Overall Study|Withdrawal by Subject|0|||
49101798|NCT02520427|158207137|FG009|Overall Study|Withdrawal by Subject|0|||
49101799|NCT02520427|158207138|FG010|Overall Study|Withdrawal by Subject|0|||
49101800|NCT02520427|158207139|FG011|Overall Study|Withdrawal by Subject|0|||
49101801|NCT02520427|158207140|FG012|Overall Study|Withdrawal by Subject|1|||
49101802|NCT02520427|158207141|FG013|Overall Study|Withdrawal by Subject|1|||
49101803|NCT02520427|158207142|FG014|Overall Study|Withdrawal by Subject|1|||
49101804|NCT02520427|158207143|FG015|Overall Study|Withdrawal by Subject|0|||
49101805|NCT02520427|158207144|FG016|Overall Study|Withdrawal by Subject|1|||
49101806|NCT02520427|158207145|FG017|Overall Study|Withdrawal by Subject|0|||
49101807|NCT02520427|158207146|FG018|Overall Study|Withdrawal by Subject|0|||
49101808|NCT02520427|158207147|FG019|Overall Study|Withdrawal by Subject|3|||
49101809|NCT02520427|158207148|FG020|Overall Study|Withdrawal by Subject|2|||
49101810|NCT02520427|158207149|FG021|Overall Study|Withdrawal by Subject|0|||
49101811|NCT02520427|158207150|FG022|Overall Study|Withdrawal by Subject|0|||
49101812|NCT02520427|158207151|FG023|Overall Study|Withdrawal by Subject|0|||
49101813|NCT02520427|158207152|FG024|Overall Study|Withdrawal by Subject|0|||
49101814|NCT02520427|158207153|FG025|Overall Study|Withdrawal by Subject|0|||
49101815|NCT02520427|158207128|FG000|Overall Study|Death|1|||
49101816|NCT02520427|158207129|FG001|Overall Study|Death|0|||
49101817|NCT02520427|158207130|FG002|Overall Study|Death|0|||
49101818|NCT02520427|158207131|FG003|Overall Study|Death|0|||
49101819|NCT02520427|158207132|FG004|Overall Study|Death|0|||
49101820|NCT02520427|158207133|FG005|Overall Study|Death|0|||
49101821|NCT02520427|158207134|FG006|Overall Study|Death|0|||
49101822|NCT02520427|158207135|FG007|Overall Study|Death|0|||
49101823|NCT02520427|158207136|FG008|Overall Study|Death|0|||
49101824|NCT02520427|158207137|FG009|Overall Study|Death|0|||
49101825|NCT02520427|158207138|FG010|Overall Study|Death|0|||
49101826|NCT02520427|158207139|FG011|Overall Study|Death|0|||
49101827|NCT02520427|158207140|FG012|Overall Study|Death|0|||
49101828|NCT02520427|158207141|FG013|Overall Study|Death|0|||
49101829|NCT02520427|158207142|FG014|Overall Study|Death|0|||
49101830|NCT02520427|158207143|FG015|Overall Study|Death|0|||
49101831|NCT02520427|158207144|FG016|Overall Study|Death|2|||
49101832|NCT02520427|158207145|FG017|Overall Study|Death|1|||
49101833|NCT02520427|158207146|FG018|Overall Study|Death|3|||
49101834|NCT02520427|158207147|FG019|Overall Study|Death|2|||
49101835|NCT02520427|158207148|FG020|Overall Study|Death|0|||
49101836|NCT02520427|158207149|FG021|Overall Study|Death|0|||
49101837|NCT02520427|158207150|FG022|Overall Study|Death|1|||
49101838|NCT02520427|158207151|FG023|Overall Study|Death|0|||
49101839|NCT02520427|158207152|FG024|Overall Study|Death|1|||
49101840|NCT02520427|158207153|FG025|Overall Study|Death|0|||
49101841|NCT04778059|158207157|FG000|Overall Study|Death|2|||
49101842|NCT04778059|158207158|FG001|Overall Study|Death|2|||
49101843|NCT04778059|158207159|FG002|Overall Study|Death|1|||
49101844|NCT04778059|158207160|FG003|Overall Study|Death|1|||
49101845|NCT04778059|158207161|FG004|Overall Study|Death|1|||
49101846|NCT04778059|158207157|FG000|Overall Study|Lost to Follow-up|0|||
49101847|NCT04778059|158207158|FG001|Overall Study|Lost to Follow-up|0|||
49101848|NCT04778059|158207159|FG002|Overall Study|Lost to Follow-up|0|||
49101849|NCT04778059|158207160|FG003|Overall Study|Lost to Follow-up|0|||
49101850|NCT04778059|158207161|FG004|Overall Study|Lost to Follow-up|1|||
49101851|NCT04778059|158207157|FG000|Overall Study|Telemed not done due to internal miscommunication.|0|||
49101852|NCT04778059|158207158|FG001|Overall Study|Telemed not done due to internal miscommunication.|0|||
49101853|NCT04778059|158207159|FG002|Overall Study|Telemed not done due to internal miscommunication.|0|||
49101854|NCT04778059|158207160|FG003|Overall Study|Telemed not done due to internal miscommunication.|0|||
49101855|NCT04778059|158207161|FG004|Overall Study|Telemed not done due to internal miscommunication.|1|||
49101856|NCT03875092|158209588|FG000|Overall Study|Adverse Event|2|||
49101857|NCT03875092|158209589|FG001|Overall Study|Adverse Event|5|||
49101858|NCT03875092|158209588|FG000|Overall Study|Death|44|||
49101859|NCT03875092|158209589|FG001|Overall Study|Death|51|||
49101860|NCT03875092|158209588|FG000|Overall Study|Participation Was Terminated By Sponsor|19|||
49101861|NCT03875092|158209589|FG001|Overall Study|Participation Was Terminated By Sponsor|4|||
49101862|NCT03205761|158209593|FG000|Overall Study|Withdrawal by Subject|1|||
49101863|NCT03205761|158209593|FG000|Overall Study|Progressive Disease|10|||
49101864|NCT00636194|158209594|FG000|Overall Study|Study related symptoms and complaints|1|||
49101865|NCT00636194|158209595|FG001|Overall Study|Study related symptoms and complaints|0|||
49101866|NCT00636194|158209594|FG000|Overall Study|Protocol Violation|2|||
49101867|NCT00636194|158209595|FG001|Overall Study|Protocol Violation|0|||
49101868|NCT04420585|158209597|FG000|Overall Study|Adverse Event|1|||
49101869|NCT04420585|158209597|FG000|Overall Study|Never initiated medication|2|||
49101870|NCT02706886|158209598|FG000|Part A: SAD Period|Withdrawal by Subject|0|||
49101871|NCT02706886|158209599|FG001|Part A: SAD Period|Withdrawal by Subject|0|||
49101872|NCT02706886|158209600|FG002|Part A: SAD Period|Withdrawal by Subject|0|||
49101873|NCT02706886|158209601|FG003|Part A: SAD Period|Withdrawal by Subject|2|||
49101874|NCT02706886|158209602|FG004|Part A: SAD Period|Withdrawal by Subject|0|||
49101875|NCT02706886|158209603|FG005|Part A: SAD Period|Withdrawal by Subject|0|||
49101876|NCT02706886|158209604|FG006|Part A: SAD Period|Withdrawal by Subject|0|||
49101877|NCT02706886|158209605|FG007|Part A: SAD Period|Withdrawal by Subject|0|||
49101878|NCT02706886|158209606|FG008|Part A: SAD Period|Withdrawal by Subject|0|||
49101879|NCT02461524|158209607|FG000|Overall Study|Death|16|||
49101880|NCT02461524|158209607|FG000|Overall Study|Withdrawal by Subject|4|||
49101881|NCT02461524|158209607|FG000|Overall Study|Device Explanted|5|||
49101882|NCT02461524|158209607|FG000|Overall Study|Missed Visit|6|||
49101883|NCT02817516|158209612|FG000|Overall Study|Other|0|||
49101884|NCT02817516|158209613|FG001|Overall Study|Other|0|||
49101885|NCT02817516|158209614|FG002|Overall Study|Other|1|||
49101886|NCT02817516|158209615|FG003|Overall Study|Other|0|||
49101887|NCT00348595|158209616|FG000|Overall Study|Adverse Event|5|||
49101888|NCT00348595|158209617|FG001|Overall Study|Adverse Event|8|||
49101889|NCT01943851|158209618|FG000|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
49101890|NCT01943851|158209619|FG001|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
49101891|NCT01943851|158209620|FG002|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
49101892|NCT01943851|158209621|FG003|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
49101893|NCT01943851|158209622|FG004|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
49101894|NCT01943851|158209623|FG005|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
49101895|NCT01943851|158209624|FG006|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
49101896|NCT01943851|158209625|FG007|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
49101897|NCT01943851|158209626|FG008|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
49101898|NCT01943851|158209627|FG009|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
49101899|NCT01943851|158209628|FG010|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
49101900|NCT01943851|158209629|FG011|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
49101901|NCT01943851|158209630|FG012|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
49101902|NCT01943851|158209631|FG013|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
49101903|NCT01943851|158209632|FG014|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
49101904|NCT01943851|158209633|FG015|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
49101905|NCT01943851|158209634|FG016|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
49101906|NCT01943851|158209635|FG017|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
49101907|NCT01943851|158209618|FG000|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
49101908|NCT01943851|158209619|FG001|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
49101909|NCT01943851|158209620|FG002|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
49101910|NCT01943851|158209621|FG003|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
49101911|NCT01943851|158209622|FG004|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
49101912|NCT01943851|158209623|FG005|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
49101913|NCT01943851|158209624|FG006|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
49101914|NCT01943851|158209625|FG007|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
49101915|NCT01943851|158209626|FG008|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
49101916|NCT01943851|158209627|FG009|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
49101917|NCT01943851|158209628|FG010|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
49101918|NCT01943851|158209629|FG011|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
49101919|NCT01943851|158209630|FG012|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
49101920|NCT01943851|158209631|FG013|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
49101921|NCT01943851|158209632|FG014|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
49101922|NCT01943851|158209633|FG015|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
49101923|NCT01943851|158209634|FG016|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
49101924|NCT01943851|158209635|FG017|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
49101925|NCT01943851|158209618|FG000|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
49101926|NCT01943851|158209619|FG001|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
49101927|NCT01943851|158209620|FG002|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
49101928|NCT01943851|158209621|FG003|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
49101929|NCT01943851|158209622|FG004|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
49101930|NCT01943851|158209623|FG005|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
49101931|NCT01943851|158209624|FG006|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
49101932|NCT01943851|158209625|FG007|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
49101933|NCT01943851|158209626|FG008|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
49101934|NCT01943851|158209627|FG009|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
49101935|NCT01943851|158209628|FG010|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
49101936|NCT01943851|158209629|FG011|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
49101937|NCT01943851|158209630|FG012|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
49101938|NCT01943851|158209631|FG013|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1|||
49101939|NCT01943851|158209632|FG014|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
49101940|NCT01943851|158209633|FG015|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
49101941|NCT01943851|158209634|FG016|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
49101942|NCT01943851|158209635|FG017|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
49101943|NCT01943851|158209618|FG000|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
49101944|NCT01943851|158209619|FG001|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
49101945|NCT01943851|158209620|FG002|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
49101946|NCT01943851|158209621|FG003|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
49101947|NCT01943851|158209622|FG004|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
49101948|NCT01943851|158209623|FG005|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
49101949|NCT01943851|158209624|FG006|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
49101950|NCT01943851|158209625|FG007|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
49101951|NCT01943851|158209626|FG008|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
49101952|NCT01943851|158209627|FG009|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
49101953|NCT01943851|158209628|FG010|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
49101954|NCT01943851|158209629|FG011|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
49101955|NCT01943851|158209630|FG012|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
49101956|NCT01943851|158209631|FG013|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
49101957|NCT01943851|158209632|FG014|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
49101958|NCT01943851|158209633|FG015|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2|||
49101959|NCT01943851|158209634|FG016|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
49101960|NCT01943851|158209635|FG017|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
49101961|NCT01943851|158209618|FG000|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
49101962|NCT01943851|158209619|FG001|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
49101963|NCT01943851|158209620|FG002|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
49101964|NCT01943851|158209621|FG003|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
49101965|NCT01943851|158209622|FG004|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
49101966|NCT01943851|158209623|FG005|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
49101967|NCT01943851|158209624|FG006|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
49101968|NCT01943851|158209625|FG007|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
49101969|NCT01943851|158209626|FG008|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
49101970|NCT01943851|158209627|FG009|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
49101971|NCT01943851|158209628|FG010|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
49101972|NCT01943851|158209629|FG011|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
49101973|NCT01943851|158209630|FG012|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
49101974|NCT01943851|158209631|FG013|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
49101975|NCT01943851|158209632|FG014|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
49101976|NCT01943851|158209633|FG015|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4|||
49101977|NCT01943851|158209634|FG016|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3|||
49101978|NCT01943851|158209635|FG017|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1|||
49101979|NCT01846221|158209636|FG000|Overall Study|Catheter Failure|2|||
49101980|NCT01846221|158209637|FG001|Overall Study|Catheter Failure|0|||
49101981|NCT01846221|158209636|FG000|Overall Study|Age Exclusion|1|||
49101982|NCT01846221|158209637|FG001|Overall Study|Age Exclusion|0|||
49101983|NCT00748189|158209640|FG000|Overall Study|Death|99|||
49101984|NCT00748189|158209641|FG001|Overall Study|Death|84|||
49101985|NCT00748189|158209640|FG000|Overall Study|Withdrawal by Subject|23|||
49101986|NCT00748189|158209641|FG001|Overall Study|Withdrawal by Subject|29|||
49101987|NCT00748189|158209640|FG000|Overall Study|Physician Decision|16|||
49101988|NCT00748189|158209641|FG001|Overall Study|Physician Decision|5|||
49101989|NCT00748189|158209640|FG000|Overall Study|Lost to Follow-up|8|||
49101990|NCT00748189|158209641|FG001|Overall Study|Lost to Follow-up|15|||
49101991|NCT00748189|158209640|FG000|Overall Study|Study terminated by Sponsor|70|||
49101992|NCT00748189|158209641|FG001|Overall Study|Study terminated by Sponsor|79|||
49101993|NCT01661933|158209642|FG000|Low-dose Gluten Challenge|Physician Decision|2|||
49101994|NCT01661933|158209642|FG000|High-dose Gluten Challenge|Withdrawal by Subject|2|||
49101995|NCT00916344|158209647|FG000|Overall Study|Death|2|||
49101996|NCT00916344|158209647|FG000|Overall Study|ICD upgrade|1|||
49101997|NCT00916344|158209647|FG000|Overall Study|Drop-out|5|||
49101998|NCT01185509|158209648|FG000|Overall Study|Progression/Relapse|9|||
49101999|NCT01185509|158209649|FG001|Overall Study|Progression/Relapse|15|||
49102000|NCT01185509|158209648|FG000|Overall Study|Physician Decision|2|||
49102001|NCT01185509|158209649|FG001|Overall Study|Physician Decision|2|||
49102002|NCT01185509|158209648|FG000|Overall Study|Withdrawal by Subject|0|||
49102003|NCT01185509|158209649|FG001|Overall Study|Withdrawal by Subject|1|||
49102004|NCT01185509|158209648|FG000|Overall Study|Death|0|||
49102005|NCT01185509|158209649|FG001|Overall Study|Death|1|||
49102006|NCT01185509|158209648|FG000|Overall Study|Intercurrent Illness|0|||
49102007|NCT01185509|158209649|FG001|Overall Study|Intercurrent Illness|1|||
49102008|NCT05129137|158209650|FG000|Second Period|Adverse Event|1|||
49102009|NCT05129137|158209651|FG001|Second Period|Adverse Event|0|||
49102010|NCT05129137|158209652|FG002|Second Period|Adverse Event|0|||
49102011|NCT05129137|158209653|FG003|Second Period|Adverse Event|0|||
49102012|NCT05129137|158209650|FG000|Second Period|Protocol Violation|0|||
49102013|NCT05129137|158209651|FG001|Second Period|Protocol Violation|0|||
49102014|NCT05129137|158209652|FG002|Second Period|Protocol Violation|0|||
49102015|NCT05129137|158209653|FG003|Second Period|Protocol Violation|1|||
49102016|NCT05129137|158209650|FG000|Third Period|Protocol Violation|0|||
49102017|NCT05129137|158209651|FG001|Third Period|Protocol Violation|0|||
49102018|NCT05129137|158209652|FG002|Third Period|Protocol Violation|0|||
49102019|NCT05129137|158209653|FG003|Third Period|Protocol Violation|1|||
49102020|NCT05129137|158209650|FG000|Forth Period|Protocol Violation|0|||
49102021|NCT05129137|158209651|FG001|Forth Period|Protocol Violation|1|||
49102022|NCT05129137|158209652|FG002|Forth Period|Protocol Violation|0|||
49102023|NCT05129137|158209653|FG003|Forth Period|Protocol Violation|0|||
49102024|NCT05129137|158209650|FG000|Forth Period|Withdrawal by Subject|0|||
49102025|NCT05129137|158209651|FG001|Forth Period|Withdrawal by Subject|0|||
49102026|NCT05129137|158209652|FG002|Forth Period|Withdrawal by Subject|1|||
49102027|NCT05129137|158209653|FG003|Forth Period|Withdrawal by Subject|0|||
49102028|NCT03385304|158209658|FG000|Overall Study|Death|19|||
49102029|NCT03385304|158209659|FG001|Overall Study|Death|7|||
49102030|NCT03385304|158209658|FG000|Overall Study|Lost to Follow-up|17|||
49102031|NCT03385304|158209659|FG001|Overall Study|Lost to Follow-up|14|||
49102032|NCT03385304|158209658|FG000|Overall Study|Withdrawal by Subject|3|||
49102033|NCT03385304|158209659|FG001|Overall Study|Withdrawal by Subject|2|||
49102034|NCT03385304|158209658|FG000|Overall Study|Incarceration|2|||
49102035|NCT03385304|158209659|FG001|Overall Study|Incarceration|3|||
49102036|NCT02031640|158209660|FG000|Screening Period|Adverse Event|1|||
49102037|NCT02031640|158209661|FG001|Screening Period|Adverse Event|0|||
49102038|NCT02031640|158209662|FG002|Screening Period|Adverse Event|0|||
49102039|NCT02031640|158209663|FG003|Screening Period|Adverse Event|0|||
49102040|NCT02031640|158209664|FG004|Screening Period|Adverse Event|0|||
49102041|NCT02031640|158209665|FG005|Screening Period|Adverse Event|0|||
49102042|NCT02031640|158209660|FG000|Screening Period|Withdrawal by Subject|29|||
49102043|NCT02031640|158209661|FG001|Screening Period|Withdrawal by Subject|0|||
49102044|NCT02031640|158209662|FG002|Screening Period|Withdrawal by Subject|0|||
49102045|NCT02031640|158209663|FG003|Screening Period|Withdrawal by Subject|0|||
49102046|NCT02031640|158209664|FG004|Screening Period|Withdrawal by Subject|0|||
49102047|NCT02031640|158209665|FG005|Screening Period|Withdrawal by Subject|0|||
49102048|NCT02031640|158209660|FG000|Screening Period|Inclusion criteria not met|312|||
49102049|NCT02031640|158209661|FG001|Screening Period|Inclusion criteria not met|0|||
49111401|NCT01289574|158242894|FG001|Overall Study|Lack of Efficacy|0|||
49102050|NCT02031640|158209662|FG002|Screening Period|Inclusion criteria not met|0|||
49102051|NCT02031640|158209663|FG003|Screening Period|Inclusion criteria not met|0|||
49102052|NCT02031640|158209664|FG004|Screening Period|Inclusion criteria not met|0|||
49102053|NCT02031640|158209665|FG005|Screening Period|Inclusion criteria not met|0|||
49102054|NCT02031640|158209660|FG000|Screening Period|Exclusion criteria met|30|||
49102055|NCT02031640|158209661|FG001|Screening Period|Exclusion criteria met|0|||
49102056|NCT02031640|158209662|FG002|Screening Period|Exclusion criteria met|0|||
49102057|NCT02031640|158209663|FG003|Screening Period|Exclusion criteria met|0|||
49102058|NCT02031640|158209664|FG004|Screening Period|Exclusion criteria met|0|||
49102059|NCT02031640|158209665|FG005|Screening Period|Exclusion criteria met|0|||
49102060|NCT02031640|158209660|FG000|Screening Period|Lost to Follow-up|14|||
49102061|NCT02031640|158209661|FG001|Screening Period|Lost to Follow-up|0|||
49102062|NCT02031640|158209662|FG002|Screening Period|Lost to Follow-up|0|||
49102063|NCT02031640|158209663|FG003|Screening Period|Lost to Follow-up|0|||
49102064|NCT02031640|158209664|FG004|Screening Period|Lost to Follow-up|0|||
49102065|NCT02031640|158209665|FG005|Screening Period|Lost to Follow-up|0|||
49102066|NCT02031640|158209660|FG000|Screening Period|Enrollment closed|26|||
49102067|NCT02031640|158209661|FG001|Screening Period|Enrollment closed|0|||
49102068|NCT02031640|158209662|FG002|Screening Period|Enrollment closed|0|||
49102069|NCT02031640|158209663|FG003|Screening Period|Enrollment closed|0|||
49102070|NCT02031640|158209664|FG004|Screening Period|Enrollment closed|0|||
49102071|NCT02031640|158209665|FG005|Screening Period|Enrollment closed|0|||
49102072|NCT02031640|158209660|FG000|Run-In Period|Adverse Event|4|||
49102073|NCT02031640|158209661|FG001|Run-In Period|Adverse Event|0|||
49102074|NCT02031640|158209662|FG002|Run-In Period|Adverse Event|0|||
49102075|NCT02031640|158209663|FG003|Run-In Period|Adverse Event|0|||
49102076|NCT02031640|158209664|FG004|Run-In Period|Adverse Event|0|||
49102077|NCT02031640|158209665|FG005|Run-In Period|Adverse Event|0|||
49102078|NCT02031640|158209660|FG000|Run-In Period|Withdrawal by Subject|17|||
49102079|NCT02031640|158209661|FG001|Run-In Period|Withdrawal by Subject|0|||
49102080|NCT02031640|158209662|FG002|Run-In Period|Withdrawal by Subject|0|||
49102081|NCT02031640|158209663|FG003|Run-In Period|Withdrawal by Subject|0|||
49102082|NCT02031640|158209664|FG004|Run-In Period|Withdrawal by Subject|0|||
49102083|NCT02031640|158209665|FG005|Run-In Period|Withdrawal by Subject|0|||
49102084|NCT02031640|158209660|FG000|Run-In Period|Inclusion criteria not met|38|||
49102085|NCT02031640|158209661|FG001|Run-In Period|Inclusion criteria not met|0|||
49102086|NCT02031640|158209662|FG002|Run-In Period|Inclusion criteria not met|0|||
49102087|NCT02031640|158209663|FG003|Run-In Period|Inclusion criteria not met|0|||
49102088|NCT02031640|158209664|FG004|Run-In Period|Inclusion criteria not met|0|||
49102089|NCT02031640|158209665|FG005|Run-In Period|Inclusion criteria not met|0|||
49102090|NCT02031640|158209660|FG000|Run-In Period|Exclusion criteria met|8|||
49102091|NCT02031640|158209661|FG001|Run-In Period|Exclusion criteria met|0|||
49102092|NCT02031640|158209662|FG002|Run-In Period|Exclusion criteria met|0|||
49102093|NCT02031640|158209663|FG003|Run-In Period|Exclusion criteria met|0|||
49102094|NCT02031640|158209664|FG004|Run-In Period|Exclusion criteria met|0|||
49102095|NCT02031640|158209665|FG005|Run-In Period|Exclusion criteria met|0|||
49102096|NCT02031640|158209660|FG000|Run-In Period|Randomization criteria not met|85|||
49102097|NCT02031640|158209661|FG001|Run-In Period|Randomization criteria not met|0|||
49102098|NCT02031640|158209662|FG002|Run-In Period|Randomization criteria not met|0|||
49102099|NCT02031640|158209663|FG003|Run-In Period|Randomization criteria not met|0|||
49102100|NCT02031640|158209664|FG004|Run-In Period|Randomization criteria not met|0|||
49102101|NCT02031640|158209665|FG005|Run-In Period|Randomization criteria not met|0|||
49102102|NCT02031640|158209660|FG000|Run-In Period|Various administrative reasons|17|||
49102103|NCT02031640|158209661|FG001|Run-In Period|Various administrative reasons|0|||
49102104|NCT02031640|158209662|FG002|Run-In Period|Various administrative reasons|0|||
49102105|NCT02031640|158209663|FG003|Run-In Period|Various administrative reasons|0|||
49102106|NCT02031640|158209664|FG004|Run-In Period|Various administrative reasons|0|||
49102107|NCT02031640|158209665|FG005|Run-In Period|Various administrative reasons|0|||
49102108|NCT02031640|158209660|FG000|Double-blind Treatment Period|Protocol deviation|0|||
49102109|NCT02031640|158209661|FG001|Double-blind Treatment Period|Protocol deviation|2|||
49102110|NCT02031640|158209662|FG002|Double-blind Treatment Period|Protocol deviation|0|||
49102111|NCT02031640|158209663|FG003|Double-blind Treatment Period|Protocol deviation|1|||
49102112|NCT02031640|158209664|FG004|Double-blind Treatment Period|Protocol deviation|3|||
49102113|NCT02031640|158209665|FG005|Double-blind Treatment Period|Protocol deviation|1|||
49102114|NCT02031640|158209660|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
49102115|NCT02031640|158209661|FG001|Double-blind Treatment Period|Lack of Efficacy|14|||
49102116|NCT02031640|158209662|FG002|Double-blind Treatment Period|Lack of Efficacy|3|||
49102117|NCT02031640|158209663|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
49102118|NCT02031640|158209664|FG004|Double-blind Treatment Period|Lack of Efficacy|5|||
49102119|NCT02031640|158209665|FG005|Double-blind Treatment Period|Lack of Efficacy|1|||
49102120|NCT02031640|158209660|FG000|Double-blind Treatment Period|Non-compliance|0|||
49102121|NCT02031640|158209661|FG001|Double-blind Treatment Period|Non-compliance|1|||
49102122|NCT02031640|158209662|FG002|Double-blind Treatment Period|Non-compliance|0|||
49102123|NCT02031640|158209663|FG003|Double-blind Treatment Period|Non-compliance|1|||
49102124|NCT02031640|158209664|FG004|Double-blind Treatment Period|Non-compliance|1|||
49102125|NCT02031640|158209665|FG005|Double-blind Treatment Period|Non-compliance|0|||
49102126|NCT02031640|158209660|FG000|Double-blind Treatment Period|Adverse Event|0|||
49102127|NCT02031640|158209661|FG001|Double-blind Treatment Period|Adverse Event|0|||
49102128|NCT02031640|158209662|FG002|Double-blind Treatment Period|Adverse Event|0|||
49102129|NCT02031640|158209663|FG003|Double-blind Treatment Period|Adverse Event|2|||
49102130|NCT02031640|158209664|FG004|Double-blind Treatment Period|Adverse Event|0|||
49102131|NCT02031640|158209665|FG005|Double-blind Treatment Period|Adverse Event|0|||
49102132|NCT02031640|158209660|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
49102133|NCT02031640|158209661|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
49102134|NCT02031640|158209662|FG002|Double-blind Treatment Period|Withdrawal by Subject|3|||
49102135|NCT02031640|158209663|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
49102136|NCT02031640|158209664|FG004|Double-blind Treatment Period|Withdrawal by Subject|1|||
49102137|NCT02031640|158209665|FG005|Double-blind Treatment Period|Withdrawal by Subject|1|||
49102138|NCT02031640|158209660|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
49102139|NCT02031640|158209661|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
49102140|NCT02031640|158209662|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
49102141|NCT02031640|158209663|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
49102142|NCT02031640|158209664|FG004|Double-blind Treatment Period|Lost to Follow-up|1|||
49102143|NCT02031640|158209665|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
49102144|NCT01084668|158209666|FG000|Overall Study|Lack of Efficacy|5|||
49102145|NCT01084668|158209666|FG000|Overall Study|Withdrawal by Subject|2|||
49102146|NCT01084668|158209666|FG000|Overall Study|Pregnancy|1|||
49102147|NCT01084668|158209666|FG000|Overall Study|Non-compliance|1|||
49102148|NCT01104246|158209667|FG000|Overall Study|Withdrawal by Subject|1|||
49102149|NCT01104246|158209667|FG000|Overall Study|did not meet inclusion criteria|4|||
49102150|NCT03687372|158209668|FG000|Overall Study|Lost to Follow-up|12|||
49102151|NCT03687372|158209669|FG001|Overall Study|Lost to Follow-up|21|||
49102152|NCT03687372|158209668|FG000|Overall Study|Withdrawal by Subject|4|||
49102153|NCT03687372|158209669|FG001|Overall Study|Withdrawal by Subject|17|||
49102154|NCT03687372|158209668|FG000|Overall Study|Investigator Decision|1|||
49102155|NCT03687372|158209669|FG001|Overall Study|Investigator Decision|1|||
49102156|NCT01565668|158209670|FG000|Overall Study|Death|2|||
49102157|NCT01565668|158209671|FG001|Overall Study|Death|1|||
49102158|NCT01565668|158209670|FG000|Overall Study|Lack of Efficacy|4|||
49102159|NCT01565668|158209671|FG001|Overall Study|Lack of Efficacy|2|||
49102160|NCT01565668|158209670|FG000|Overall Study|Participant went on Hospice Care|1|||
49102161|NCT01565668|158209671|FG001|Overall Study|Participant went on Hospice Care|0|||
49102162|NCT01565668|158209670|FG000|Overall Study|Adverse Event|6|||
49102163|NCT01565668|158209671|FG001|Overall Study|Adverse Event|1|||
49102164|NCT01565668|158209670|FG000|Overall Study|Randomized, but never received drug|0|||
49102165|NCT01565668|158209671|FG001|Overall Study|Randomized, but never received drug|2|||
49102166|NCT01565668|158209670|FG000|Overall Study|Progressive disease|13|||
49102167|NCT01565668|158209671|FG001|Overall Study|Progressive disease|14|||
49102168|NCT01565668|158209670|FG000|Overall Study|Withdrawal by Subject|1|||
49102169|NCT01565668|158209671|FG001|Overall Study|Withdrawal by Subject|3|||
49102170|NCT01565668|158209670|FG000|Overall Study|HSCT Transplant|11|||
49102171|NCT01565668|158209671|FG001|Overall Study|HSCT Transplant|15|||
49102172|NCT05178641|158209684|FG000|First 3 Weeks of Study (Week 1-3)|Protocol Violation|4|||
49102173|NCT05178641|158209685|FG001|First 3 Weeks of Study (Week 1-3)|Protocol Violation|1|||
49102174|NCT05178641|158209684|FG000|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|0|||
49102175|NCT05178641|158209685|FG001|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|1|||
49102176|NCT02375555|158209686|FG000|Induction Period|Adverse Event|7|||
49102177|NCT02375555|158209686|FG000|Induction Period|Withdrawal by Subject|2|||
49102178|NCT02375555|158209686|FG000|Induction Period|Other|1|||
49102179|NCT02375555|158209686|FG000|Induction Period|Didn't meet criteria for maintenance therapy|1|||
49102180|NCT02375555|158209686|FG000|Maintenance Period|Adverse Event|2|||
49102181|NCT02375555|158209686|FG000|Maintenance Period|Withdrawal by Subject|4|||
49102182|NCT02375555|158209686|FG000|Maintenance Period|Death|1|||
49102183|NCT02375555|158209686|FG000|Maintenance Period|Disease Progression|5|||
49102184|NCT02375555|158209686|FG000|Maintenance Period|Patient Non-compliance|1|||
49102185|NCT02375555|158209686|FG000|Maintenance Period|Still on maintenance|16|||
49102186|NCT05148234|158209687|FG000|Phase I|Ineligible|0|||
49102187|NCT05148234|158209688|FG001|Phase I|Ineligible|0|||
49102188|NCT05148234|158209689|FG002|Phase I|Ineligible|0|||
49102189|NCT05148234|158209690|FG003|Phase I|Ineligible|0|||
49102190|NCT05148234|158209691|FG004|Phase I|Ineligible|0|||
49102191|NCT05148234|158209692|FG005|Phase I|Ineligible|0|||
49102192|NCT05148234|158209693|FG006|Phase I|Ineligible|0|||
49102193|NCT05148234|158209694|FG007|Phase I|Ineligible|1|||
49102194|NCT05148234|158209687|FG000|Phase I|Company closed the trial.|0|||
49102195|NCT05148234|158209688|FG001|Phase I|Company closed the trial.|1|||
49102196|NCT05148234|158209689|FG002|Phase I|Company closed the trial.|0|||
49102197|NCT05148234|158209690|FG003|Phase I|Company closed the trial.|0|||
49102198|NCT05148234|158209691|FG004|Phase I|Company closed the trial.|0|||
49102199|NCT05148234|158209692|FG005|Phase I|Company closed the trial.|0|||
49102200|NCT05148234|158209693|FG006|Phase I|Company closed the trial.|0|||
49102201|NCT05148234|158209694|FG007|Phase I|Company closed the trial.|0|||
49102202|NCT01869699|158209696|FG000|Overall Study|Withdrawal by Subject|1|||
49102203|NCT01869699|158209697|FG001|Overall Study|Withdrawal by Subject|0|||
49102204|NCT03602391|158209698|FG000|Overall Study|COVID-19|7|||
49102205|NCT03602391|158209699|FG001|Overall Study|COVID-19|6|||
49102206|NCT01083186|158209705|FG000|Overall Study|Lost to Follow-up|48|||
49102207|NCT01083186|158209705|FG000|Overall Study|Consent Withdrawal|7|||
49102208|NCT01083186|158209705|FG000|Overall Study|Death|3|||
49102209|NCT01083186|158209705|FG000|Overall Study|Adverse Event|3|||
49102210|NCT01083186|158209705|FG000|Overall Study|Lack of Efficacy|2|||
49102211|NCT01083186|158209705|FG000|Overall Study|Hemodialysis Initiation|28|||
49102212|NCT01083186|158209705|FG000|Overall Study|Administrative Reasons|2|||
49102213|NCT01083186|158209705|FG000|Overall Study|Non-compliance to Study Treatment|1|||
49102214|NCT00108485|158209713|FG000|Overall Study|Withdrawal by Subject|3|||
49102215|NCT00108485|158209714|FG001|Overall Study|Withdrawal by Subject|0|||
49102216|NCT00108485|158209713|FG000|Overall Study|Lost to Follow-up|0|||
49102217|NCT00108485|158209714|FG001|Overall Study|Lost to Follow-up|2|||
49102218|NCT01582178|158209715|FG000|Overall Study|Physician Decision|6|||
49102219|NCT01582178|158209716|FG001|Overall Study|Physician Decision|5|||
49102220|NCT01097421|158209721|FG000|Overall Study|Adverse Event|8|||
49102221|NCT01097421|158209721|FG000|Overall Study|Protocol Violation|2|||
49102222|NCT01097421|158209721|FG000|Overall Study|Lost to Follow-up|1|||
49102223|NCT01097421|158209721|FG000|Overall Study|Withdrawal by Subject|3|||
49102224|NCT03627416|158209722|FG000|Overall Study|Adverse Event|0|||
49102225|NCT03627416|158209723|FG001|Overall Study|Adverse Event|1|||
49102226|NCT04464720|158209724|FG000|Pre-Intervention|Intervention (hood retrofit) beyond the scope available in the study, so participation ended.|1|||
49102227|NCT00793624|158209729|FG000|Overall Study|Adverse Event|18|||
49102228|NCT00793624|158209730|FG001|Overall Study|Adverse Event|16|||
49102229|NCT00793624|158209731|FG002|Overall Study|Adverse Event|15|||
49102230|NCT00793624|158209732|FG003|Overall Study|Adverse Event|20|||
49102231|NCT00793624|158209729|FG000|Overall Study|Lost to Follow-up|2|||
49102232|NCT00793624|158209730|FG001|Overall Study|Lost to Follow-up|2|||
49102233|NCT00793624|158209731|FG002|Overall Study|Lost to Follow-up|4|||
49102234|NCT00793624|158209732|FG003|Overall Study|Lost to Follow-up|0|||
49102235|NCT00793624|158209729|FG000|Overall Study|Withdrawal by Subject|20|||
49102236|NCT00793624|158209730|FG001|Overall Study|Withdrawal by Subject|9|||
49102237|NCT00793624|158209731|FG002|Overall Study|Withdrawal by Subject|11|||
49102238|NCT00793624|158209732|FG003|Overall Study|Withdrawal by Subject|14|||
49102239|NCT00793624|158209729|FG000|Overall Study|Lack of Efficacy|9|||
49102240|NCT00793624|158209730|FG001|Overall Study|Lack of Efficacy|2|||
49102241|NCT00793624|158209731|FG002|Overall Study|Lack of Efficacy|1|||
49102242|NCT00793624|158209732|FG003|Overall Study|Lack of Efficacy|3|||
49102243|NCT00793624|158209729|FG000|Overall Study|Non compliance with protocol|2|||
49102244|NCT00793624|158209730|FG001|Overall Study|Non compliance with protocol|3|||
49102245|NCT00793624|158209731|FG002|Overall Study|Non compliance with protocol|2|||
49102246|NCT00793624|158209732|FG003|Overall Study|Non compliance with protocol|3|||
49102247|NCT00793624|158209729|FG000|Overall Study|Other reason not described above|6|||
49102248|NCT00793624|158209730|FG001|Overall Study|Other reason not described above|4|||
49102249|NCT00793624|158209731|FG002|Overall Study|Other reason not described above|6|||
49102250|NCT00793624|158209732|FG003|Overall Study|Other reason not described above|3|||
49102251|NCT02071706|158209733|FG000|Overall Study|Adverse Event|1|||
49102252|NCT02071706|158209733|FG000|Overall Study|Withdrawal by Subject|2|||
49102253|NCT02832375|158209734|FG000|Overall Study|Lost to Follow-up|1|||
49102254|NCT02832375|158209735|FG001|Overall Study|Lost to Follow-up|0|||
49102255|NCT02832375|158209734|FG000|Overall Study|Withdrawal of Consent|1|||
49102256|NCT02832375|158209735|FG001|Overall Study|Withdrawal of Consent|0|||
49102257|NCT05723328|158209738|FG000|Overall Study|Investigator's Decision|5|||
49102258|NCT05723328|158209739|FG001|Overall Study|Investigator's Decision|2|||
49102259|NCT00084318|158209740|FG000|Overall Study|Withdrawal by Subject|5|||
49102260|NCT00084318|158209741|FG001|Overall Study|Withdrawal by Subject|2|||
49102261|NCT00084318|158209740|FG000|Overall Study|Protocol Violation|15|||
49102262|NCT00084318|158209741|FG001|Overall Study|Protocol Violation|11|||
49102263|NCT00084318|158209740|FG000|Overall Study|No protocol treatment|2|||
49102264|NCT00084318|158209741|FG001|Overall Study|No protocol treatment|0|||
49102265|NCT00157820|158209746|FG000|Randomized|Physician Decision|4|||
49102266|NCT00157820|158209747|FG001|Randomized|Physician Decision|2|||
49102267|NCT00157820|158209748|FG002|Randomized|Physician Decision|3|||
49102268|NCT00157820|158209746|FG000|Randomized|Withdrawal by Subject|1|||
49102269|NCT00157820|158209747|FG001|Randomized|Withdrawal by Subject|2|||
49102270|NCT00157820|158209748|FG002|Randomized|Withdrawal by Subject|3|||
49102271|NCT00157820|158209746|FG000|Randomized|Protocol Violation|2|||
49102272|NCT00157820|158209747|FG001|Randomized|Protocol Violation|1|||
49102273|NCT00157820|158209748|FG002|Randomized|Protocol Violation|2|||
49102274|NCT00157820|158209746|FG000|1st 8 Month|Death|7|||
49102275|NCT00157820|158209747|FG001|1st 8 Month|Death|8|||
49102276|NCT00157820|158209748|FG002|1st 8 Month|Death|3|||
49102277|NCT00157820|158209746|FG000|1st 8 Month|Lost to Follow-up|1|||
49102278|NCT00157820|158209747|FG001|1st 8 Month|Lost to Follow-up|2|||
49102279|NCT00157820|158209748|FG002|1st 8 Month|Lost to Follow-up|1|||
49102280|NCT00157820|158209746|FG000|1st 8 Month|Premature cross-over|0|||
49102281|NCT00157820|158209747|FG001|1st 8 Month|Premature cross-over|2|||
49102282|NCT00157820|158209748|FG002|1st 8 Month|Premature cross-over|2|||
49102283|NCT00157820|158209746|FG000|2nd 8 Months|Death|3|||
49102284|NCT00157820|158209747|FG001|2nd 8 Months|Death|1|||
49102285|NCT00157820|158209748|FG002|2nd 8 Months|Death|3|||
49102286|NCT00157820|158209746|FG000|2nd 8 Months|Lost to Follow-up|1|||
49102287|NCT00157820|158209747|FG001|2nd 8 Months|Lost to Follow-up|5|||
49102288|NCT00157820|158209748|FG002|2nd 8 Months|Lost to Follow-up|2|||
49102289|NCT00157820|158209746|FG000|2nd 8 Months|Premature cross-over|1|||
49102290|NCT00157820|158209747|FG001|2nd 8 Months|Premature cross-over|7|||
49102291|NCT00157820|158209748|FG002|2nd 8 Months|Premature cross-over|9|||
49102292|NCT01645891|158209750|FG000|Overall Study|Adverse Event|6|||
49102293|NCT01645891|158209751|FG001|Overall Study|Adverse Event|10|||
49102294|NCT01645891|158209750|FG000|Overall Study|Adverse Event Unrelated to Wound|5|||
49102295|NCT01645891|158209751|FG001|Overall Study|Adverse Event Unrelated to Wound|3|||
49102296|NCT01645891|158209750|FG000|Overall Study|Withdrawal by Subject|3|||
49102297|NCT01645891|158209751|FG001|Overall Study|Withdrawal by Subject|3|||
49102298|NCT01645891|158209750|FG000|Overall Study|Protocol Violation|4|||
49102299|NCT01645891|158209751|FG001|Overall Study|Protocol Violation|0|||
49102300|NCT01645891|158209750|FG000|Overall Study|Lost to Follow-up|4|||
49102301|NCT01645891|158209751|FG001|Overall Study|Lost to Follow-up|1|||
49102302|NCT01645891|158209750|FG000|Overall Study|Death|0|||
49102303|NCT01645891|158209751|FG001|Overall Study|Death|2|||
49102304|NCT00138073|158209752|FG000|Overall Study|lack of resources|55|||
49102305|NCT03026530|158209753|FG000|Overall Study|Lost to Follow-up|19|||
49102306|NCT03026530|158209754|FG001|Overall Study|Lost to Follow-up|24|||
49102307|NCT03026530|158209753|FG000|Overall Study|Protocol Violation|2|||
49102308|NCT03026530|158209754|FG001|Overall Study|Protocol Violation|5|||
49102309|NCT03301740|158209755|FG000|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1|||
49102310|NCT03301740|158209756|FG001|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0|||
49102311|NCT03301740|158209755|FG000|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1|||
49102312|NCT03301740|158209756|FG001|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0|||
49102313|NCT00819780|158209759|FG000|Overall Study|Did not receive study drug|3|||
49102314|NCT00819780|158209760|FG001|Overall Study|Did not receive study drug|4|||
49102315|NCT00819780|158209759|FG000|Overall Study|Still in treatment|25|||
49102316|NCT00819780|158209760|FG001|Overall Study|Still in treatment|17|||
49102317|NCT04776018|158209764|FG000|Overall Study|Death|0|||
49102318|NCT04776018|158209765|FG001|Overall Study|Death|1|||
49102319|NCT04776018|158209766|FG002|Overall Study|Death|4|||
49102320|NCT04776018|158209767|FG003|Overall Study|Death|1|||
49102321|NCT04776018|158209768|FG004|Overall Study|Death|4|||
49102322|NCT04776018|158209769|FG005|Overall Study|Death|0|||
49102323|NCT04776018|158209770|FG006|Overall Study|Death|0|||
49102324|NCT04776018|158209764|FG000|Overall Study|Study terminated by sponsor|2|||
49102325|NCT04776018|158209765|FG001|Overall Study|Study terminated by sponsor|1|||
49102326|NCT04776018|158209766|FG002|Overall Study|Study terminated by sponsor|4|||
49102327|NCT04776018|158209767|FG003|Overall Study|Study terminated by sponsor|0|||
49102328|NCT04776018|158209768|FG004|Overall Study|Study terminated by sponsor|3|||
49102329|NCT04776018|158209769|FG005|Overall Study|Study terminated by sponsor|0|||
49102330|NCT04776018|158209770|FG006|Overall Study|Study terminated by sponsor|0|||
49102331|NCT04776018|158209764|FG000|Overall Study|Withdrawal by Subject|1|||
49102332|NCT04776018|158209765|FG001|Overall Study|Withdrawal by Subject|0|||
49102333|NCT04776018|158209766|FG002|Overall Study|Withdrawal by Subject|0|||
49102334|NCT04776018|158209767|FG003|Overall Study|Withdrawal by Subject|2|||
49102335|NCT04776018|158209768|FG004|Overall Study|Withdrawal by Subject|1|||
49102336|NCT04776018|158209769|FG005|Overall Study|Withdrawal by Subject|0|||
49102337|NCT04776018|158209770|FG006|Overall Study|Withdrawal by Subject|0|||
49102338|NCT04776018|158209764|FG000|Overall Study|Other|0|||
49102339|NCT04776018|158209765|FG001|Overall Study|Other|1|||
49102340|NCT04776018|158209766|FG002|Overall Study|Other|1|||
49102341|NCT04776018|158209767|FG003|Overall Study|Other|0|||
49102342|NCT04776018|158209768|FG004|Overall Study|Other|0|||
49102343|NCT04776018|158209769|FG005|Overall Study|Other|0|||
49102344|NCT04776018|158209770|FG006|Overall Study|Other|0|||
49102345|NCT04776018|158209764|FG000|Overall Study|Lost to Follow-up|0|||
49102346|NCT04776018|158209765|FG001|Overall Study|Lost to Follow-up|0|||
49102347|NCT04776018|158209766|FG002|Overall Study|Lost to Follow-up|1|||
49102348|NCT04776018|158209767|FG003|Overall Study|Lost to Follow-up|0|||
49102349|NCT04776018|158209768|FG004|Overall Study|Lost to Follow-up|0|||
49102350|NCT04776018|158209769|FG005|Overall Study|Lost to Follow-up|0|||
49102351|NCT04776018|158209770|FG006|Overall Study|Lost to Follow-up|0|||
49102352|NCT00972816|158211485|FG000|Overall Study|Adverse Event|0|||
49102353|NCT00972816|158211486|FG001|Overall Study|Adverse Event|0|||
49102354|NCT00972816|158211487|FG002|Overall Study|Adverse Event|1|||
49102355|NCT00972816|158211488|FG003|Overall Study|Adverse Event|0|||
49102356|NCT00972816|158211489|FG004|Overall Study|Adverse Event|0|||
49102357|NCT00972816|158211490|FG005|Overall Study|Adverse Event|0|||
49102358|NCT00972816|158211491|FG006|Overall Study|Adverse Event|0|||
49102359|NCT00972816|158211492|FG007|Overall Study|Adverse Event|0|||
49102360|NCT00972816|158211485|FG000|Overall Study|Withdrawal by Subject|4|||
49102361|NCT00972816|158211486|FG001|Overall Study|Withdrawal by Subject|2|||
49102362|NCT00972816|158211487|FG002|Overall Study|Withdrawal by Subject|1|||
49102363|NCT00972816|158211488|FG003|Overall Study|Withdrawal by Subject|3|||
49102364|NCT00972816|158211489|FG004|Overall Study|Withdrawal by Subject|0|||
49102365|NCT00972816|158211490|FG005|Overall Study|Withdrawal by Subject|1|||
49102366|NCT00972816|158211491|FG006|Overall Study|Withdrawal by Subject|1|||
49102367|NCT00972816|158211492|FG007|Overall Study|Withdrawal by Subject|2|||
49102368|NCT00972816|158211485|FG000|Overall Study|Lost to Follow-up|11|||
49102369|NCT00972816|158211486|FG001|Overall Study|Lost to Follow-up|9|||
49102370|NCT00972816|158211487|FG002|Overall Study|Lost to Follow-up|7|||
49102371|NCT00972816|158211488|FG003|Overall Study|Lost to Follow-up|5|||
49102372|NCT00972816|158211489|FG004|Overall Study|Lost to Follow-up|11|||
49102373|NCT00972816|158211490|FG005|Overall Study|Lost to Follow-up|10|||
49102374|NCT00972816|158211491|FG006|Overall Study|Lost to Follow-up|7|||
49102375|NCT00972816|158211492|FG007|Overall Study|Lost to Follow-up|7|||
49102376|NCT00972816|158211485|FG000|Overall Study|Inappropriate enrolment|0|||
49102377|NCT00972816|158211486|FG001|Overall Study|Inappropriate enrolment|0|||
49102378|NCT00972816|158211487|FG002|Overall Study|Inappropriate enrolment|0|||
49102379|NCT00972816|158211488|FG003|Overall Study|Inappropriate enrolment|0|||
49102380|NCT00972816|158211489|FG004|Overall Study|Inappropriate enrolment|0|||
49102381|NCT00972816|158211490|FG005|Overall Study|Inappropriate enrolment|0|||
49102382|NCT00972816|158211491|FG006|Overall Study|Inappropriate enrolment|2|||
49102383|NCT00972816|158211492|FG007|Overall Study|Inappropriate enrolment|0|||
49102384|NCT00972816|158211485|FG000|Overall Study|Unable to classify|2|||
49102385|NCT00972816|158211486|FG001|Overall Study|Unable to classify|0|||
49102386|NCT00972816|158211487|FG002|Overall Study|Unable to classify|0|||
49102387|NCT00972816|158211488|FG003|Overall Study|Unable to classify|0|||
49102388|NCT00972816|158211489|FG004|Overall Study|Unable to classify|1|||
49102389|NCT00972816|158211490|FG005|Overall Study|Unable to classify|0|||
49102390|NCT00972816|158211491|FG006|Overall Study|Unable to classify|0|||
49102391|NCT00972816|158211492|FG007|Overall Study|Unable to classify|0|||
49102392|NCT03104400|158211493|FG000|Overall Study|Adverse Event|5|||
49102393|NCT03104400|158211494|FG001|Overall Study|Adverse Event|7|||
49102394|NCT03104400|158211495|FG002|Overall Study|Adverse Event|11|||
49102395|NCT03104400|158211496|FG003|Overall Study|Adverse Event|9|||
49102396|NCT03104400|158211497|FG004|Overall Study|Adverse Event|21|||
49102397|NCT03104400|158211493|FG000|Overall Study|Withdrawal by Subject|17|||
49102398|NCT03104400|158211494|FG001|Overall Study|Withdrawal by Subject|19|||
49102399|NCT03104400|158211495|FG002|Overall Study|Withdrawal by Subject|29|||
49102400|NCT03104400|158211496|FG003|Overall Study|Withdrawal by Subject|25|||
49102401|NCT03104400|158211497|FG004|Overall Study|Withdrawal by Subject|24|||
49102402|NCT03104400|158211493|FG000|Overall Study|Lost to Follow-up|4|||
49102403|NCT03104400|158211494|FG001|Overall Study|Lost to Follow-up|1|||
49102404|NCT03104400|158211495|FG002|Overall Study|Lost to Follow-up|4|||
49102405|NCT03104400|158211496|FG003|Overall Study|Lost to Follow-up|8|||
49102406|NCT03104400|158211497|FG004|Overall Study|Lost to Follow-up|7|||
49102407|NCT03104400|158211493|FG000|Overall Study|Lack of Efficacy|6|||
49102408|NCT03104400|158211494|FG001|Overall Study|Lack of Efficacy|3|||
49102409|NCT03104400|158211495|FG002|Overall Study|Lack of Efficacy|8|||
49102410|NCT03104400|158211496|FG003|Overall Study|Lack of Efficacy|2|||
49102411|NCT03104400|158211497|FG004|Overall Study|Lack of Efficacy|1|||
49102412|NCT03104400|158211493|FG000|Overall Study|COVID Logistical Restrictions|0|||
49102413|NCT03104400|158211494|FG001|Overall Study|COVID Logistical Restrictions|0|||
49102414|NCT03104400|158211495|FG002|Overall Study|COVID Logistical Restrictions|0|||
49102415|NCT03104400|158211496|FG003|Overall Study|COVID Logistical Restrictions|1|||
49102416|NCT03104400|158211497|FG004|Overall Study|COVID Logistical Restrictions|0|||
49102417|NCT03104400|158211493|FG000|Overall Study|Other|2|||
49102418|NCT03104400|158211494|FG001|Overall Study|Other|3|||
49102419|NCT03104400|158211495|FG002|Overall Study|Other|7|||
49102420|NCT03104400|158211496|FG003|Overall Study|Other|6|||
49102421|NCT03104400|158211497|FG004|Overall Study|Other|4|||
49102422|NCT03104400|158211493|FG000|Overall Study|Other|0|||
49102423|NCT03104400|158211494|FG001|Overall Study|Other|1|||
49102424|NCT03104400|158211495|FG002|Overall Study|Other|0|||
49102425|NCT03104400|158211496|FG003|Overall Study|Other|0|||
49102426|NCT03104400|158211497|FG004|Overall Study|Other|0|||
49102427|NCT04114357|158211499|FG000|Baseline-Randomization|Adverse Event|2|||
49102428|NCT04114357|158211500|FG001|Baseline-Randomization|Adverse Event|1|||
49102429|NCT04114357|158211499|FG000|Baseline-Randomization|Lost to Follow-up|1|||
49102430|NCT04114357|158211500|FG001|Baseline-Randomization|Lost to Follow-up|1|||
49102431|NCT04114357|158211499|FG000|Cross-over|Adverse Event|0|||
49102432|NCT04114357|158211500|FG001|Cross-over|Adverse Event|1|||
49102433|NCT02163226|158211501|FG000|Overall Study|Death|2|||
49102434|NCT02163226|158211502|FG001|Overall Study|Death|1|||
49111402|NCT01289574|158242895|FG002|Overall Study|Lack of Efficacy|1|||
49102435|NCT02163226|158211501|FG000|Overall Study|Withdrawal by Subject|5|||
49102436|NCT02163226|158211502|FG001|Overall Study|Withdrawal by Subject|2|||
49102437|NCT02163226|158211501|FG000|Overall Study|Returned home, local radiotherapy|3|||
49102438|NCT02163226|158211502|FG001|Overall Study|Returned home, local radiotherapy|0|||
49102439|NCT02163226|158211501|FG000|Overall Study|Repeat imaging showed no disease|2|||
49102440|NCT02163226|158211502|FG001|Overall Study|Repeat imaging showed no disease|0|||
49102441|NCT02163226|158211501|FG000|Overall Study|Incomplete radiotherapy|3|||
49102442|NCT02163226|158211502|FG001|Overall Study|Incomplete radiotherapy|0|||
49102443|NCT02163226|158211501|FG000|Overall Study|Treatment was to >3 radiotherapy fields|1|||
49102444|NCT02163226|158211502|FG001|Overall Study|Treatment was to >3 radiotherapy fields|0|||
49102445|NCT02163226|158211501|FG000|Overall Study|"Insurance denied for single-fraction treatment"|0|||
49102446|NCT02163226|158211502|FG001|Overall Study|"Insurance denied for single-fraction treatment"|5|||
49102447|NCT02163226|158211501|FG000|Overall Study|ineligible|0|||
49102448|NCT02163226|158211502|FG001|Overall Study|ineligible|3|||
49102449|NCT00477750|158211505|FG000|Overall Study|Currently Receiving Treatment|11|||
49102450|NCT00900757|158211507|FG000|Overall Study|screen failure|19|||
49102451|NCT03320850|158211508|FG000|Overall Study|Lost to Follow-up|0|||
49102452|NCT03320850|158211509|FG001|Overall Study|Lost to Follow-up|0|||
49102453|NCT03320850|158211510|FG002|Overall Study|Lost to Follow-up|0|||
49102454|NCT03320850|158211511|FG003|Overall Study|Lost to Follow-up|0|||
49102455|NCT03320850|158211512|FG004|Overall Study|Lost to Follow-up|1|||
49102456|NCT03320850|158211513|FG005|Overall Study|Lost to Follow-up|2|||
49102457|NCT03320850|158211514|FG006|Overall Study|Lost to Follow-up|2|||
49102458|NCT03320850|158211515|FG007|Overall Study|Lost to Follow-up|0|||
49102459|NCT03320850|158211516|FG008|Overall Study|Lost to Follow-up|6|||
49102460|NCT03320850|158211517|FG009|Overall Study|Lost to Follow-up|4|||
49102461|NCT03320850|158211508|FG000|Overall Study|Withdrawal by Subject|0|||
49102462|NCT03320850|158211509|FG001|Overall Study|Withdrawal by Subject|0|||
49102463|NCT03320850|158211510|FG002|Overall Study|Withdrawal by Subject|0|||
49102464|NCT03320850|158211511|FG003|Overall Study|Withdrawal by Subject|0|||
49102465|NCT03320850|158211512|FG004|Overall Study|Withdrawal by Subject|1|||
49102466|NCT03320850|158211513|FG005|Overall Study|Withdrawal by Subject|2|||
49102467|NCT03320850|158211514|FG006|Overall Study|Withdrawal by Subject|4|||
49102468|NCT03320850|158211515|FG007|Overall Study|Withdrawal by Subject|5|||
49102469|NCT03320850|158211516|FG008|Overall Study|Withdrawal by Subject|2|||
49102470|NCT03320850|158211517|FG009|Overall Study|Withdrawal by Subject|1|||
49102471|NCT03320850|158211508|FG000|Overall Study|Lack of Efficacy|0|||
49102472|NCT03320850|158211509|FG001|Overall Study|Lack of Efficacy|0|||
49102473|NCT03320850|158211510|FG002|Overall Study|Lack of Efficacy|0|||
49102474|NCT03320850|158211511|FG003|Overall Study|Lack of Efficacy|1|||
49102475|NCT03320850|158211512|FG004|Overall Study|Lack of Efficacy|0|||
49102476|NCT03320850|158211513|FG005|Overall Study|Lack of Efficacy|1|||
49102477|NCT03320850|158211514|FG006|Overall Study|Lack of Efficacy|0|||
49102478|NCT03320850|158211515|FG007|Overall Study|Lack of Efficacy|2|||
49102479|NCT03320850|158211516|FG008|Overall Study|Lack of Efficacy|0|||
49102480|NCT03320850|158211517|FG009|Overall Study|Lack of Efficacy|3|||
49102481|NCT03320850|158211508|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
49102482|NCT03320850|158211509|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
49102483|NCT03320850|158211510|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
49102484|NCT03320850|158211511|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
49102485|NCT03320850|158211512|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
49102486|NCT03320850|158211513|FG005|Overall Study|Failure to Meet Randomization Criteria|1|||
49102487|NCT03320850|158211514|FG006|Overall Study|Failure to Meet Randomization Criteria|0|||
49102488|NCT03320850|158211515|FG007|Overall Study|Failure to Meet Randomization Criteria|0|||
49102489|NCT03320850|158211516|FG008|Overall Study|Failure to Meet Randomization Criteria|0|||
49102490|NCT03320850|158211517|FG009|Overall Study|Failure to Meet Randomization Criteria|0|||
49102491|NCT03320850|158211508|FG000|Overall Study|Adverse Event|0|||
49102492|NCT03320850|158211509|FG001|Overall Study|Adverse Event|0|||
49102493|NCT03320850|158211510|FG002|Overall Study|Adverse Event|0|||
49102494|NCT03320850|158211511|FG003|Overall Study|Adverse Event|0|||
49102495|NCT03320850|158211512|FG004|Overall Study|Adverse Event|0|||
49102496|NCT03320850|158211513|FG005|Overall Study|Adverse Event|2|||
49102497|NCT03320850|158211514|FG006|Overall Study|Adverse Event|1|||
49102498|NCT03320850|158211515|FG007|Overall Study|Adverse Event|0|||
49102499|NCT03320850|158211516|FG008|Overall Study|Adverse Event|2|||
49102500|NCT03320850|158211517|FG009|Overall Study|Adverse Event|0|||
49102501|NCT03320850|158211508|FG000|Overall Study|Reason Not Specified|0|||
49102502|NCT03320850|158211509|FG001|Overall Study|Reason Not Specified|0|||
49102503|NCT03320850|158211510|FG002|Overall Study|Reason Not Specified|0|||
49102504|NCT03320850|158211511|FG003|Overall Study|Reason Not Specified|0|||
49102505|NCT03320850|158211512|FG004|Overall Study|Reason Not Specified|0|||
49102506|NCT03320850|158211513|FG005|Overall Study|Reason Not Specified|1|||
49102507|NCT03320850|158211514|FG006|Overall Study|Reason Not Specified|0|||
49102508|NCT03320850|158211515|FG007|Overall Study|Reason Not Specified|0|||
49102509|NCT03320850|158211516|FG008|Overall Study|Reason Not Specified|0|||
49102510|NCT03320850|158211517|FG009|Overall Study|Reason Not Specified|1|||
49102511|NCT00347919|158211520|FG000|Overall Study|Lost to Follow-up|11|||
49102512|NCT00347919|158211521|FG001|Overall Study|Lost to Follow-up|13|||
49102513|NCT00347919|158211522|FG002|Overall Study|Lost to Follow-up|0|||
49102514|NCT00347919|158211520|FG000|Overall Study|Withdrawal by Subject|6|||
49102515|NCT00347919|158211521|FG001|Overall Study|Withdrawal by Subject|8|||
49102516|NCT00347919|158211522|FG002|Overall Study|Withdrawal by Subject|0|||
49102517|NCT00347919|158211520|FG000|Overall Study|Physician Decision|1|||
49102518|NCT00347919|158211521|FG001|Overall Study|Physician Decision|1|||
49102519|NCT00347919|158211522|FG002|Overall Study|Physician Decision|0|||
49102520|NCT00347919|158211520|FG000|Overall Study|Sponsor terminated study|15|||
49102521|NCT00347919|158211521|FG001|Overall Study|Sponsor terminated study|10|||
49102522|NCT00347919|158211522|FG002|Overall Study|Sponsor terminated study|16|||
49102523|NCT00347919|158211520|FG000|Overall Study|Death|35|||
49102524|NCT00347919|158211521|FG001|Overall Study|Death|42|||
49102525|NCT00347919|158211522|FG002|Overall Study|Death|19|||
49102526|NCT00347919|158211520|FG000|Overall Study|Par. Started Other Treatment|1|||
49102527|NCT00347919|158211521|FG001|Overall Study|Par. Started Other Treatment|1|||
49102528|NCT00347919|158211522|FG002|Overall Study|Par. Started Other Treatment|1|||
49102529|NCT00347919|158211520|FG000|Overall Study|Missing|2|||
49102530|NCT00347919|158211521|FG001|Overall Study|Missing|1|||
49102531|NCT00347919|158211522|FG002|Overall Study|Missing|2|||
49102532|NCT02344290|158211523|FG000|Overall Study|Withdrawal by Subject|315|||
49102533|NCT02344290|158211524|FG001|Overall Study|Withdrawal by Subject|324|||
49102534|NCT02344290|158211523|FG000|Overall Study|Lost to Follow-up|258|||
49102535|NCT02344290|158211524|FG001|Overall Study|Lost to Follow-up|249|||
49102536|NCT02344290|158211523|FG000|Overall Study|Unable to get to clinic|69|||
49102537|NCT02344290|158211524|FG001|Overall Study|Unable to get to clinic|60|||
49102538|NCT02344290|158211523|FG000|Overall Study|Physician Decision|25|||
49102539|NCT02344290|158211524|FG001|Overall Study|Physician Decision|25|||
49102540|NCT02344290|158211523|FG000|Overall Study|Site Closure|15|||
49102541|NCT02344290|158211524|FG001|Overall Study|Site Closure|19|||
49102542|NCT02344290|158211523|FG000|Overall Study|Other|5|||
49102543|NCT02344290|158211524|FG001|Overall Study|Other|3|||
49102544|NCT05343364|158211525|FG000|Overall Study|Miscellaneous|0|||
49102545|NCT05343364|158211526|FG001|Overall Study|Miscellaneous|1|||
49102546|NCT03729570|158211535|FG000|Overall Study|Lost to Follow-up|16|||
49102547|NCT03729570|158211536|FG001|Overall Study|Lost to Follow-up|20|||
49102548|NCT03729570|158211535|FG000|Overall Study|Seroconversion|5|||
49102549|NCT03729570|158211536|FG001|Overall Study|Seroconversion|0|||
49102550|NCT03729570|158211535|FG000|Overall Study|Moved out of the city|1|||
49102551|NCT03729570|158211536|FG001|Overall Study|Moved out of the city|0|||
49102552|NCT03729570|158211535|FG000|Overall Study|Time Conflict|1|||
49102553|NCT03729570|158211536|FG001|Overall Study|Time Conflict|0|||
49102554|NCT03729570|158211535|FG000|Overall Study|Time Commitment|2|||
49102555|NCT03729570|158211536|FG001|Overall Study|Time Commitment|0|||
49102556|NCT03729570|158211535|FG000|Overall Study|Bad Experience|0|||
49102557|NCT03729570|158211536|FG001|Overall Study|Bad Experience|1|||
49102558|NCT03729570|158211535|FG000|Overall Study|No reason provided|2|||
49102559|NCT03729570|158211536|FG001|Overall Study|No reason provided|1|||
49102560|NCT03729570|158211535|FG000|Overall Study|Family Conflict|0|||
49102561|NCT03729570|158211536|FG001|Overall Study|Family Conflict|1|||
49102562|NCT03729570|158211535|FG000|Overall Study|Did not want to continue taking medications|0|||
49102563|NCT03729570|158211536|FG001|Overall Study|Did not want to continue taking medications|1|||
49102564|NCT03729570|158211535|FG000|Overall Study|Found another PrEP provider|1|||
49102565|NCT03729570|158211536|FG001|Overall Study|Found another PrEP provider|0|||
49102566|NCT03729570|158211535|FG000|Overall Study|Did not enjoy being in the control group|0|||
49102567|NCT03729570|158211536|FG001|Overall Study|Did not enjoy being in the control group|1|||
49102568|NCT00655733|158211539|FG000|Overall Study|Lost to Follow-up|2|||
49102569|NCT00655733|158211540|FG001|Overall Study|Lost to Follow-up|2|||
49102570|NCT00655733|158211539|FG000|Overall Study|Adverse Event|2|||
49102571|NCT00655733|158211540|FG001|Overall Study|Adverse Event|2|||
49102572|NCT00655733|158211539|FG000|Overall Study|Withdrawal by Subject|3|||
49102573|NCT00655733|158211540|FG001|Overall Study|Withdrawal by Subject|3|||
49102574|NCT00655733|158211539|FG000|Overall Study|Physician Decision|0|||
49102575|NCT00655733|158211540|FG001|Overall Study|Physician Decision|1|||
49102576|NCT01701193|158211544|FG000|Overall Study|Withdrawal by Subject|2|||
49102577|NCT01701193|158211545|FG001|Overall Study|Withdrawal by Subject|2|||
49102578|NCT01701193|158211546|FG002|Overall Study|Withdrawal by Subject|1|||
49102579|NCT01701193|158211547|FG003|Overall Study|Withdrawal by Subject|2|||
49102580|NCT01701193|158211544|FG000|Overall Study|Adverse Event|1|||
49102581|NCT01701193|158211545|FG001|Overall Study|Adverse Event|0|||
49102582|NCT01701193|158211546|FG002|Overall Study|Adverse Event|0|||
49102583|NCT01701193|158211547|FG003|Overall Study|Adverse Event|0|||
49102584|NCT01867294|158211548|FG000|Overall Study|Withdrawal by Subject|1|||
49102585|NCT01867294|158211549|FG001|Overall Study|Withdrawal by Subject|1|||
49102586|NCT01867294|158211550|FG002|Overall Study|Withdrawal by Subject|0|||
49102587|NCT01867294|158211551|FG003|Overall Study|Withdrawal by Subject|0|||
49102588|NCT02720744|158211554|FG000|Overall Study|Protocol Violation|0|||
49102589|NCT02720744|158211555|FG001|Overall Study|Protocol Violation|2|||
49102590|NCT02720744|158211554|FG000|Overall Study|Pregnancy|2|||
49102591|NCT02720744|158211555|FG001|Overall Study|Pregnancy|0|||
49102592|NCT02720744|158211554|FG000|Overall Study|Lack of Efficacy|2|||
49102593|NCT02720744|158211555|FG001|Overall Study|Lack of Efficacy|8|||
49102594|NCT02720744|158211554|FG000|Overall Study|Adverse Event|21|||
49102595|NCT02720744|158211555|FG001|Overall Study|Adverse Event|3|||
49102596|NCT02720744|158211554|FG000|Overall Study|Withdrawal by Subject|11|||
49102597|NCT02720744|158211555|FG001|Overall Study|Withdrawal by Subject|11|||
49102598|NCT02720744|158211554|FG000|Overall Study|Lost to follow up|2|||
49102599|NCT02720744|158211555|FG001|Overall Study|Lost to follow up|0|||
49102600|NCT02720744|158211554|FG000|Overall Study|Non Compliance with Investigational Product|0|||
49102601|NCT02720744|158211555|FG001|Overall Study|Non Compliance with Investigational Product|1|||
49102602|NCT02720744|158211554|FG000|Overall Study|Excluded Concomitant Medication|0|||
49102603|NCT02720744|158211555|FG001|Overall Study|Excluded Concomitant Medication|1|||
49102604|NCT02062944|158211556|FG000|Overall Study|Lost to Follow-up|1|||
49102605|NCT02062944|158211556|FG000|Overall Study|New hemotological disorder identified|1|||
49102606|NCT02062944|158211556|FG000|Overall Study|Uncontrolled Hypertension|1|||
49102607|NCT02062944|158211556|FG000|Overall Study|underwent pre-weaning biospsy and excluded for mild subclinical ACR|3|||
49102608|NCT01482962|158211559|FG000|Overall Study|Progressive Disease|65|||
49102609|NCT01482962|158211560|FG001|Overall Study|Progressive Disease|53|||
49102610|NCT01482962|158211559|FG000|Overall Study|Unsatisfactory Therapeutic Response|37|||
49102611|NCT01482962|158211560|FG001|Overall Study|Unsatisfactory Therapeutic Response|23|||
49102612|NCT01482962|158211559|FG000|Overall Study|Adverse Event|18|||
49102613|NCT01482962|158211560|FG001|Overall Study|Adverse Event|22|||
49102614|NCT01482962|158211559|FG000|Overall Study|Withdrawal by Participant|8|||
49102615|NCT01482962|158211560|FG001|Overall Study|Withdrawal by Participant|13|||
49102616|NCT01482962|158211559|FG000|Overall Study|Hematopoietic Stem Cell Transplant|3|||
49102617|NCT01482962|158211560|FG001|Overall Study|Hematopoietic Stem Cell Transplant|9|||
49102618|NCT01482962|158211559|FG000|Overall Study|Other Reason|1|||
49102619|NCT01482962|158211560|FG001|Overall Study|Other Reason|5|||
49102620|NCT01482962|158211559|FG000|Overall Study|Study Terminated by Sponsor|5|||
49102621|NCT01482962|158211560|FG001|Overall Study|Study Terminated by Sponsor|2|||
49102622|NCT01482962|158211559|FG000|Overall Study|Did not Receive Study Drug|1|||
49102623|NCT01482962|158211560|FG001|Overall Study|Did not Receive Study Drug|6|||
49102624|NCT02407457|158211561|FG000|1 Month|Death|3|||
49102625|NCT02407457|158211562|FG001|1 Month|Death|0|||
49102626|NCT02407457|158211561|FG000|1 Month|Lost to Follow-up|1|||
49102627|NCT02407457|158211562|FG001|1 Month|Lost to Follow-up|1|||
49102628|NCT02407457|158211561|FG000|1 Month|missed visit|2|||
49102629|NCT02407457|158211562|FG001|1 Month|missed visit|5|||
49102630|NCT02407457|158211561|FG000|6-Month|Death|2|||
49102631|NCT02407457|158211562|FG001|6-Month|Death|8|||
49102632|NCT02407457|158211561|FG000|6-Month|Lost to Follow-up|2|||
49102633|NCT02407457|158211562|FG001|6-Month|Lost to Follow-up|2|||
49102634|NCT02407457|158211561|FG000|6-Month|missed visit|16|||
49102635|NCT02407457|158211562|FG001|6-Month|missed visit|14|||
49102636|NCT02407457|158211561|FG000|6-Month|Open Repair|0|||
49102637|NCT02407457|158211562|FG001|6-Month|Open Repair|1|||
49102638|NCT02407457|158211561|FG000|1 Year|Death|6|||
49102639|NCT02407457|158211562|FG001|1 Year|Death|11|||
49102640|NCT02407457|158211561|FG000|1 Year|Lost to Follow-up|3|||
49102641|NCT02407457|158211562|FG001|1 Year|Lost to Follow-up|2|||
49102642|NCT02407457|158211561|FG000|1 Year|Missed Visit|24|||
49102643|NCT02407457|158211562|FG001|1 Year|Missed Visit|14|||
49102644|NCT02407457|158211561|FG000|1 Year|Open Repair|0|||
49102645|NCT02407457|158211562|FG001|1 Year|Open Repair|1|||
49102646|NCT02407457|158211561|FG000|2-year|Death|14|||
49102647|NCT02407457|158211562|FG001|2-year|Death|8|||
49102648|NCT02407457|158211561|FG000|2-year|Lost to Follow-up|7|||
49102649|NCT02407457|158211562|FG001|2-year|Lost to Follow-up|10|||
49102650|NCT02407457|158211561|FG000|2-year|Missed Visit|13|||
49102651|NCT02407457|158211562|FG001|2-year|Missed Visit|15|||
49102652|NCT02407457|158211561|FG000|2-year|Open Repair|0|||
49102653|NCT02407457|158211562|FG001|2-year|Open Repair|2|||
49102654|NCT02407457|158211561|FG000|3-year|Death|11|||
49102655|NCT02407457|158211562|FG001|3-year|Death|10|||
49102656|NCT02407457|158211561|FG000|3-year|Lost to Follow-up|9|||
49102657|NCT02407457|158211562|FG001|3-year|Lost to Follow-up|10|||
49102658|NCT02407457|158211561|FG000|3-year|Missed Visit|19|||
49102659|NCT02407457|158211562|FG001|3-year|Missed Visit|16|||
49102660|NCT02407457|158211561|FG000|4-year|Death|18|||
49102661|NCT02407457|158211562|FG001|4-year|Death|10|||
49102662|NCT02407457|158211561|FG000|4-year|Lost to Follow-up|10|||
49102663|NCT02407457|158211562|FG001|4-year|Lost to Follow-up|12|||
49102664|NCT02407457|158211561|FG000|4-year|Missed Visit|18|||
49102665|NCT02407457|158211562|FG001|4-year|Missed Visit|16|||
49102666|NCT02407457|158211561|FG000|5-year|Death|10|||
49102667|NCT02407457|158211562|FG001|5-year|Death|3|||
49102668|NCT02407457|158211561|FG000|5-year|Lost to Follow-up|22|||
49102669|NCT02407457|158211562|FG001|5-year|Lost to Follow-up|13|||
49102670|NCT02407457|158211561|FG000|5-year|Missed Visit|9|||
49102671|NCT02407457|158211562|FG001|5-year|Missed Visit|1|||
49102672|NCT05397171|158211564|FG000|Overall Study|Death|2|||
49102673|NCT05397171|158211565|FG001|Overall Study|Death|3|||
49102674|NCT05397171|158211566|FG002|Overall Study|Death|3|||
49102675|NCT05397171|158211564|FG000|Overall Study|Study Terminated By Sponsor|1|||
49102676|NCT05397171|158211565|FG001|Overall Study|Study Terminated By Sponsor|2|||
49102677|NCT05397171|158211566|FG002|Overall Study|Study Terminated By Sponsor|3|||
49102678|NCT05397171|158211564|FG000|Overall Study|Withdrawal by Subject|0|||
49102679|NCT05397171|158211565|FG001|Overall Study|Withdrawal by Subject|1|||
49102680|NCT05397171|158211566|FG002|Overall Study|Withdrawal by Subject|1|||
49102681|NCT01447446|158211568|FG000|Overall Study|Death|6|||
49102682|NCT01447446|158211569|FG001|Overall Study|Death|3|||
49102683|NCT01447446|158211570|FG002|Overall Study|Death|2|||
49102684|NCT01447446|158211571|FG003|Overall Study|Death|1|||
49102685|NCT01447446|158211572|FG004|Overall Study|Death|7|||
49102686|NCT01447446|158211573|FG005|Overall Study|Death|0|||
49102687|NCT01447446|158211568|FG000|Overall Study|Adverse Event|3|||
49102688|NCT01447446|158211569|FG001|Overall Study|Adverse Event|0|||
49102689|NCT01447446|158211570|FG002|Overall Study|Adverse Event|1|||
49102690|NCT01447446|158211571|FG003|Overall Study|Adverse Event|0|||
49102691|NCT01447446|158211572|FG004|Overall Study|Adverse Event|2|||
49102692|NCT01447446|158211573|FG005|Overall Study|Adverse Event|0|||
49102693|NCT01447446|158211568|FG000|Overall Study|Failure to Return/Consent Withdrawn|357|||
49102694|NCT01447446|158211569|FG001|Overall Study|Failure to Return/Consent Withdrawn|78|||
49102695|NCT01447446|158211570|FG002|Overall Study|Failure to Return/Consent Withdrawn|31|||
49102696|NCT01447446|158211571|FG003|Overall Study|Failure to Return/Consent Withdrawn|7|||
49102697|NCT01447446|158211572|FG004|Overall Study|Failure to Return/Consent Withdrawn|69|||
49102698|NCT01447446|158211573|FG005|Overall Study|Failure to Return/Consent Withdrawn|9|||
49102699|NCT01447446|158211568|FG000|Overall Study|Insuff. VR/TRT too Short to Expect VR|300|||
49102700|NCT01447446|158211569|FG001|Overall Study|Insuff. VR/TRT too Short to Expect VR|71|||
49102701|NCT01447446|158211570|FG002|Overall Study|Insuff. VR/TRT too Short to Expect VR|52|||
49102702|NCT01447446|158211571|FG003|Overall Study|Insuff. VR/TRT too Short to Expect VR|21|||
49102703|NCT01447446|158211572|FG004|Overall Study|Insuff. VR/TRT too Short to Expect VR|92|||
49102704|NCT01447446|158211573|FG005|Overall Study|Insuff. VR/TRT too Short to Expect VR|14|||
49102705|NCT01447446|158211568|FG000|Overall Study|Administrative/Other|34|||
49102706|NCT01447446|158211569|FG001|Overall Study|Administrative/Other|9|||
49102707|NCT01447446|158211570|FG002|Overall Study|Administrative/Other|10|||
49102708|NCT01447446|158211571|FG003|Overall Study|Administrative/Other|2|||
49102709|NCT01447446|158211572|FG004|Overall Study|Administrative/Other|33|||
49102710|NCT01447446|158211573|FG005|Overall Study|Administrative/Other|4|||
49102711|NCT01447446|158211568|FG000|Overall Study|SVR12 Assessment|13|||
49102712|NCT01447446|158211569|FG001|Overall Study|SVR12 Assessment|1|||
49102713|NCT01447446|158211570|FG002|Overall Study|SVR12 Assessment|2|||
49102714|NCT01447446|158211571|FG003|Overall Study|SVR12 Assessment|1|||
49102715|NCT01447446|158211572|FG004|Overall Study|SVR12 Assessment|5|||
49102716|NCT01447446|158211573|FG005|Overall Study|SVR12 Assessment|5|||
49102717|NCT01447446|158211568|FG000|Overall Study|New Treatment Started|8|||
49102718|NCT01447446|158211569|FG001|Overall Study|New Treatment Started|2|||
49102719|NCT01447446|158211570|FG002|Overall Study|New Treatment Started|1|||
49102720|NCT01447446|158211571|FG003|Overall Study|New Treatment Started|0|||
49102721|NCT01447446|158211572|FG004|Overall Study|New Treatment Started|2|||
49102722|NCT01447446|158211573|FG005|Overall Study|New Treatment Started|0|||
49102723|NCT01447446|158211568|FG000|Overall Study|Reason not Specified|1|||
49102724|NCT01447446|158211569|FG001|Overall Study|Reason not Specified|1|||
49102725|NCT01447446|158211570|FG002|Overall Study|Reason not Specified|1|||
49102726|NCT01447446|158211571|FG003|Overall Study|Reason not Specified|1|||
49102727|NCT01447446|158211572|FG004|Overall Study|Reason not Specified|1|||
49102728|NCT01447446|158211573|FG005|Overall Study|Reason not Specified|0|||
49102729|NCT02499146|158211574|FG000|Overall Study|Lost to Follow-up|1|||
49102730|NCT02499146|158211574|FG000|Overall Study|Withdrawal by Subject|1|||
49102731|NCT02499146|158211574|FG000|Overall Study|Other|2|||
49102732|NCT02499146|158211574|FG000|Overall Study|Ongoing at date of cut-off|9|||
49102733|NCT02499146|158211574|FG000|Overall Study|Began other treatment/therapy|13|||
49102734|NCT00581542|158211582|FG000|Overall Study|they met an exclusion criteria|2|||
49102735|NCT00581542|158211583|FG001|Overall Study|they met an exclusion criteria|2|||
49102736|NCT00581542|158211582|FG000|Overall Study|Lost to Follow-up|9|||
49102737|NCT00581542|158211583|FG001|Overall Study|Lost to Follow-up|21|||
49102738|NCT01217385|158211589|FG000|Overall Study|Withdrawal by Subject|3|||
49102739|NCT01217385|158211589|FG000|Overall Study|DOSI not performed/not eval|12|||
49102740|NCT01217385|158211589|FG000|Overall Study|Central Path not Available|1|||
49102741|NCT01217385|158211589|FG000|Overall Study|Normal Breast TOI not available|10|||
49102742|NCT00090987|158211590|FG000|Overall Study|Adverse Event|5|||
49102743|NCT00090987|158211590|FG000|Overall Study|Lack of Efficacy|7|||
49102744|NCT00090987|158211590|FG000|Overall Study|Withdrawal by Subject|3|||
49102745|NCT00090987|158211590|FG000|Overall Study|alternative therapy|1|||
49102746|NCT00090987|158211590|FG000|Overall Study|Non-compliance|4|||
49102747|NCT00090987|158211590|FG000|Overall Study|Incarcerated|1|||
49102748|NCT04017832|158211591|FG000|Overall Study|Withdrawal by Subject|13|||
49102749|NCT04017832|158211592|FG001|Overall Study|Withdrawal by Subject|12|||
49102750|NCT04017832|158211593|FG002|Overall Study|Withdrawal by Subject|21|||
49102751|NCT04017832|158211594|FG003|Overall Study|Withdrawal by Subject|7|||
49102752|NCT04017832|158211591|FG000|Overall Study|Lost to Follow-up|0|||
49102753|NCT04017832|158211592|FG001|Overall Study|Lost to Follow-up|3|||
49102754|NCT04017832|158211593|FG002|Overall Study|Lost to Follow-up|3|||
49102755|NCT04017832|158211594|FG003|Overall Study|Lost to Follow-up|1|||
49102756|NCT04017832|158211591|FG000|Overall Study|Physician Decision|1|||
49102757|NCT04017832|158211592|FG001|Overall Study|Physician Decision|1|||
49102758|NCT04017832|158211593|FG002|Overall Study|Physician Decision|1|||
49102759|NCT04017832|158211594|FG003|Overall Study|Physician Decision|1|||
49102760|NCT04017832|158211591|FG000|Overall Study|Death|2|||
49102761|NCT04017832|158211592|FG001|Overall Study|Death|2|||
49102762|NCT04017832|158211593|FG002|Overall Study|Death|1|||
49102763|NCT04017832|158211594|FG003|Overall Study|Death|0|||
49102764|NCT01294371|158211595|FG000|Overall Study|Adverse Event|1|||
49102765|NCT01294371|158211595|FG000|Overall Study|Withdrawal by Subject|12|||
49102766|NCT01294371|158211595|FG000|Overall Study|Lost to Follow-up|6|||
49102767|NCT01294371|158211595|FG000|Overall Study|Administrative Reason|1|||
49102768|NCT01294371|158211595|FG000|Overall Study|Other|14|||
49102769|NCT00514904|158211600|FG000|Overall Study|Withdrawal by Subject|3|||
49102770|NCT00514904|158211601|FG001|Overall Study|Withdrawal by Subject|2|||
49102771|NCT00514904|158211600|FG000|Overall Study|Lost to Follow-up|21|||
49102772|NCT00514904|158211601|FG001|Overall Study|Lost to Follow-up|3|||
49102773|NCT00336024|158211603|FG000|Overall Study|Death|2|||
49102774|NCT00336024|158211604|FG001|Overall Study|Death|1|||
49102775|NCT00336024|158211603|FG000|Overall Study|Physician Decision|4|||
49102776|NCT00336024|158211604|FG001|Overall Study|Physician Decision|1|||
49102777|NCT00336024|158211603|FG000|Overall Study|Protocol Violation|1|||
49102778|NCT00336024|158211604|FG001|Overall Study|Protocol Violation|0|||
49102779|NCT00336024|158211603|FG000|Overall Study|Withdrawal by Subject|1|||
49102780|NCT00336024|158211604|FG001|Overall Study|Withdrawal by Subject|2|||
49102781|NCT00336024|158211603|FG000|Overall Study|Failure to fulfill consolidation|1|||
49102782|NCT00336024|158211604|FG001|Overall Study|Failure to fulfill consolidation|1|||
49102783|NCT00336024|158211603|FG000|Overall Study|Progressive Disease|4|||
49102784|NCT00336024|158211604|FG001|Overall Study|Progressive Disease|7|||
49102785|NCT00336024|158211603|FG000|Overall Study|Ineligible|7|||
49102786|NCT00336024|158211604|FG001|Overall Study|Ineligible|7|||
49102787|NCT03430895|158211613|FG000|Overall Study|Not Treated|2|||
49102788|NCT01317797|158211615|FG000|Overall Study|Other|0|||
49102789|NCT01317797|158211616|FG001|Overall Study|Other|1|||
49102790|NCT01317797|158211617|FG002|Overall Study|Other|0|||
49102791|NCT01317797|158211615|FG000|Overall Study|Withdrawal of Patient|0|||
49102792|NCT01317797|158211616|FG001|Overall Study|Withdrawal of Patient|0|||
49102793|NCT01317797|158211617|FG002|Overall Study|Withdrawal of Patient|1|||
49102794|NCT04506905|158211618|FG000|Overall Study|Lost to Follow-up|1|||
49102795|NCT04506905|158211619|FG001|Overall Study|Lost to Follow-up|0|||
49102796|NCT04506905|158211620|FG002|Overall Study|Lost to Follow-up|0|||
49102797|NCT04506905|158211621|FG003|Overall Study|Lost to Follow-up|1|||
49102798|NCT04506905|158211622|FG004|Overall Study|Lost to Follow-up|0|||
49102799|NCT04506905|158211623|FG005|Overall Study|Lost to Follow-up|0|||
49102800|NCT04506905|158211624|FG006|Overall Study|Lost to Follow-up|0|||
49102801|NCT04506905|158211625|FG007|Overall Study|Lost to Follow-up|0|||
49102802|NCT04506905|158211626|FG008|Overall Study|Lost to Follow-up|0|||
49102803|NCT04506905|158211618|FG000|Overall Study|Withdrawal by Subject|0|||
49102804|NCT04506905|158211619|FG001|Overall Study|Withdrawal by Subject|0|||
49102805|NCT04506905|158211620|FG002|Overall Study|Withdrawal by Subject|0|||
49102806|NCT04506905|158211621|FG003|Overall Study|Withdrawal by Subject|2|||
49102807|NCT04506905|158211622|FG004|Overall Study|Withdrawal by Subject|0|||
49102808|NCT04506905|158211623|FG005|Overall Study|Withdrawal by Subject|0|||
49102809|NCT04506905|158211624|FG006|Overall Study|Withdrawal by Subject|0|||
49102810|NCT04506905|158211625|FG007|Overall Study|Withdrawal by Subject|0|||
49102811|NCT04506905|158211626|FG008|Overall Study|Withdrawal by Subject|0|||
49102812|NCT03652636|158212801|FG000|Overall Study|Withdrawal by Subject|7|||
49102813|NCT03558152|158212805|FG000|Overall Study|Adverse Event|0|||
49102814|NCT03558152|158212806|FG001|Overall Study|Adverse Event|0|||
49102815|NCT03558152|158212807|FG002|Overall Study|Adverse Event|1|||
49102816|NCT03558152|158212808|FG003|Overall Study|Adverse Event|1|||
49102817|NCT03558152|158212809|FG004|Overall Study|Adverse Event|2|||
49102818|NCT03558152|158212810|FG005|Overall Study|Adverse Event|1|||
49102819|NCT03558152|158212811|FG006|Overall Study|Adverse Event|1|||
49102820|NCT03558152|158212812|FG007|Overall Study|Adverse Event|0|||
49102821|NCT03558152|158212805|FG000|Overall Study|Death|0|||
49102822|NCT03558152|158212806|FG001|Overall Study|Death|0|||
49102823|NCT03558152|158212807|FG002|Overall Study|Death|0|||
49102824|NCT03558152|158212808|FG003|Overall Study|Death|0|||
49102825|NCT03558152|158212809|FG004|Overall Study|Death|1|||
49102826|NCT03558152|158212810|FG005|Overall Study|Death|0|||
49102827|NCT03558152|158212811|FG006|Overall Study|Death|0|||
49102828|NCT03558152|158212812|FG007|Overall Study|Death|0|||
49102829|NCT03558152|158212805|FG000|Overall Study|Rolled over in GA40209 due to worsening of disease|1|||
49102830|NCT03558152|158212806|FG001|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
49102831|NCT03558152|158212807|FG002|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
49102832|NCT03558152|158212808|FG003|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
49102833|NCT03558152|158212809|FG004|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
49102834|NCT03558152|158212810|FG005|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
49102835|NCT03558152|158212811|FG006|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
49102836|NCT03558152|158212812|FG007|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
49102837|NCT03558152|158212805|FG000|Overall Study|Miscalculation in mmcs|0|||
49102838|NCT03558152|158212806|FG001|Overall Study|Miscalculation in mmcs|0|||
49102839|NCT03558152|158212807|FG002|Overall Study|Miscalculation in mmcs|0|||
49102840|NCT03558152|158212808|FG003|Overall Study|Miscalculation in mmcs|0|||
49102841|NCT03558152|158212809|FG004|Overall Study|Miscalculation in mmcs|0|||
49102842|NCT03558152|158212810|FG005|Overall Study|Miscalculation in mmcs|0|||
49102843|NCT03558152|158212811|FG006|Overall Study|Miscalculation in mmcs|1|||
49102844|NCT03558152|158212812|FG007|Overall Study|Miscalculation in mmcs|0|||
49102845|NCT03558152|158212805|FG000|Overall Study|Mistake in calculation|0|||
49102846|NCT03558152|158212806|FG001|Overall Study|Mistake in calculation|0|||
49102847|NCT03558152|158212807|FG002|Overall Study|Mistake in calculation|0|||
49102848|NCT03558152|158212808|FG003|Overall Study|Mistake in calculation|1|||
49102849|NCT03558152|158212809|FG004|Overall Study|Mistake in calculation|0|||
49102850|NCT03558152|158212810|FG005|Overall Study|Mistake in calculation|0|||
49102851|NCT03558152|158212811|FG006|Overall Study|Mistake in calculation|0|||
49102852|NCT03558152|158212812|FG007|Overall Study|Mistake in calculation|0|||
49102853|NCT03558152|158212805|FG000|Overall Study|Mistake in evaluation of disease status|0|||
49102854|NCT03558152|158212806|FG001|Overall Study|Mistake in evaluation of disease status|0|||
49102855|NCT03558152|158212807|FG002|Overall Study|Mistake in evaluation of disease status|0|||
49102856|NCT03558152|158212808|FG003|Overall Study|Mistake in evaluation of disease status|0|||
49102857|NCT03558152|158212809|FG004|Overall Study|Mistake in evaluation of disease status|0|||
49102858|NCT03558152|158212810|FG005|Overall Study|Mistake in evaluation of disease status|0|||
49102859|NCT03558152|158212811|FG006|Overall Study|Mistake in evaluation of disease status|0|||
49102860|NCT03558152|158212812|FG007|Overall Study|Mistake in evaluation of disease status|1|||
49102861|NCT03558152|158212805|FG000|Overall Study|Physician Decision|0|||
49102862|NCT03558152|158212806|FG001|Overall Study|Physician Decision|0|||
49102863|NCT03558152|158212807|FG002|Overall Study|Physician Decision|0|||
49102864|NCT03558152|158212808|FG003|Overall Study|Physician Decision|0|||
49102865|NCT03558152|158212809|FG004|Overall Study|Physician Decision|0|||
49102866|NCT03558152|158212810|FG005|Overall Study|Physician Decision|0|||
49102867|NCT03558152|158212811|FG006|Overall Study|Physician Decision|1|||
49102868|NCT03558152|158212812|FG007|Overall Study|Physician Decision|0|||
49102869|NCT03558152|158212805|FG000|Overall Study|Withdrawal by Subject|2|||
49102870|NCT03558152|158212806|FG001|Overall Study|Withdrawal by Subject|3|||
49102871|NCT03558152|158212807|FG002|Overall Study|Withdrawal by Subject|2|||
49102872|NCT03558152|158212808|FG003|Overall Study|Withdrawal by Subject|1|||
49102873|NCT03558152|158212809|FG004|Overall Study|Withdrawal by Subject|1|||
49102874|NCT03558152|158212810|FG005|Overall Study|Withdrawal by Subject|1|||
49102875|NCT03558152|158212811|FG006|Overall Study|Withdrawal by Subject|3|||
49102876|NCT03558152|158212812|FG007|Overall Study|Withdrawal by Subject|2|||
49102877|NCT03558152|158212805|FG000|Overall Study|Lack of Efficacy|11|||
49102878|NCT03558152|158212806|FG001|Overall Study|Lack of Efficacy|11|||
49102879|NCT03558152|158212807|FG002|Overall Study|Lack of Efficacy|10|||
49102880|NCT03558152|158212808|FG003|Overall Study|Lack of Efficacy|11|||
49102881|NCT03558152|158212809|FG004|Overall Study|Lack of Efficacy|14|||
49102882|NCT03558152|158212810|FG005|Overall Study|Lack of Efficacy|12|||
49102883|NCT03558152|158212811|FG006|Overall Study|Lack of Efficacy|14|||
49102884|NCT03558152|158212812|FG007|Overall Study|Lack of Efficacy|13|||
49102885|NCT03558152|158212805|FG000|Overall Study|Protocol Violation|1|||
49102886|NCT03558152|158212806|FG001|Overall Study|Protocol Violation|1|||
49102887|NCT03558152|158212807|FG002|Overall Study|Protocol Violation|0|||
49102888|NCT03558152|158212808|FG003|Overall Study|Protocol Violation|1|||
49102889|NCT03558152|158212809|FG004|Overall Study|Protocol Violation|1|||
49102890|NCT03558152|158212810|FG005|Overall Study|Protocol Violation|0|||
49102891|NCT03558152|158212811|FG006|Overall Study|Protocol Violation|2|||
49102892|NCT03558152|158212812|FG007|Overall Study|Protocol Violation|0|||
49102893|NCT01668966|158212813|FG000|Overall Study|Withdrawal by Subject|1|||
49102894|NCT01668966|158212813|FG000|Overall Study|Death|1|||
49102895|NCT01668966|158212813|FG000|Overall Study|Not treated|2|||
49102896|NCT04045132|158212822|FG000|Overall Study|Lost to Follow-up|3|||
49102897|NCT04045132|158212823|FG001|Overall Study|Lost to Follow-up|6|||
49102898|NCT04481191|158212824|FG000|Overall Study|Withdrawn by parent/guardian|15|||
49102899|NCT04481191|158212825|FG001|Overall Study|Withdrawn by parent/guardian|10|||
49102900|NCT03361865|158212828|FG000|Overall Study|Death|17|||
49102901|NCT03361865|158212829|FG001|Overall Study|Death|18|||
49102902|NCT03361865|158212828|FG000|Overall Study|Physician Decision|1|||
49102903|NCT03361865|158212829|FG001|Overall Study|Physician Decision|9|||
49102904|NCT03361865|158212828|FG000|Overall Study|Withdrawal by Subject|1|||
49102905|NCT03361865|158212829|FG001|Overall Study|Withdrawal by Subject|0|||
49102906|NCT02294175|158212830|FG000|Overall Study|Withdrawal by Subject|1|||
49102907|NCT02294175|158212831|FG001|Overall Study|Withdrawal by Subject|2|||
49102908|NCT02294175|158212830|FG000|Overall Study|pt taking excluded medication|3|||
49102909|NCT02294175|158212831|FG001|Overall Study|pt taking excluded medication|1|||
49102910|NCT02294175|158212830|FG000|Overall Study|Protocol Violation|1|||
49102911|NCT02294175|158212831|FG001|Overall Study|Protocol Violation|0|||
49102912|NCT02294175|158212830|FG000|Overall Study|Lost to Follow-up|0|||
49102913|NCT02294175|158212831|FG001|Overall Study|Lost to Follow-up|1|||
49102914|NCT02294175|158212830|FG000|Overall Study|wound healed|0|||
49102915|NCT02294175|158212831|FG001|Overall Study|wound healed|2|||
49102916|NCT02284568|158212834|FG000|Overall Study|Adverse Event|2|||
49102917|NCT02284568|158212835|FG001|Overall Study|Adverse Event|9|||
49102918|NCT02284568|158212836|FG002|Overall Study|Adverse Event|4|||
49102919|NCT02284568|158212834|FG000|Overall Study|Withdrawal by Subject|22|||
49102920|NCT02284568|158212835|FG001|Overall Study|Withdrawal by Subject|21|||
49102921|NCT02284568|158212836|FG002|Overall Study|Withdrawal by Subject|1|||
49102922|NCT02284568|158212834|FG000|Overall Study|Noncompliance with study drug admin|1|||
49102923|NCT02284568|158212835|FG001|Overall Study|Noncompliance with study drug admin|2|||
49102924|NCT02284568|158212836|FG002|Overall Study|Noncompliance with study drug admin|0|||
49102925|NCT02284568|158212834|FG000|Overall Study|Noncompliance|1|||
49102926|NCT02284568|158212835|FG001|Overall Study|Noncompliance|0|||
49102927|NCT02284568|158212836|FG002|Overall Study|Noncompliance|0|||
49102928|NCT02284568|158212834|FG000|Overall Study|Protocol Violation|0|||
49102929|NCT02284568|158212835|FG001|Overall Study|Protocol Violation|1|||
49102930|NCT02284568|158212836|FG002|Overall Study|Protocol Violation|0|||
49102931|NCT02284568|158212834|FG000|Overall Study|Sponsor requested patient stop treatment|0|||
49102932|NCT02284568|158212835|FG001|Overall Study|Sponsor requested patient stop treatment|0|||
49102933|NCT02284568|158212836|FG002|Overall Study|Sponsor requested patient stop treatment|90|||
49102934|NCT02284568|158212834|FG000|Overall Study|Lost to Follow-up|0|||
49102935|NCT02284568|158212835|FG001|Overall Study|Lost to Follow-up|3|||
49102936|NCT02284568|158212836|FG002|Overall Study|Lost to Follow-up|0|||
49102937|NCT02284568|158212834|FG000|Overall Study|Lack of Efficacy|4|||
49102938|NCT02284568|158212835|FG001|Overall Study|Lack of Efficacy|7|||
49102939|NCT02284568|158212836|FG002|Overall Study|Lack of Efficacy|0|||
49102940|NCT02284568|158212834|FG000|Overall Study|Other|1|||
49102941|NCT02284568|158212835|FG001|Overall Study|Other|2|||
49102942|NCT02284568|158212836|FG002|Overall Study|Other|0|||
49102943|NCT02284568|158212834|FG000|Overall Study|Withdrew before taking study drug|0|||
49102944|NCT02284568|158212835|FG001|Overall Study|Withdrew before taking study drug|1|||
49102945|NCT02284568|158212836|FG002|Overall Study|Withdrew before taking study drug|0|||
49102946|NCT00878969|158212837|FG000|Overall Study|Physician Decision|5|||
49102947|NCT00878969|158212838|FG001|Overall Study|Physician Decision|3|||
49102948|NCT00878969|158212839|FG002|Overall Study|Physician Decision|2|||
49102949|NCT00878969|158212837|FG000|Overall Study|Withdrawal by Subject|1|||
49102950|NCT00878969|158212838|FG001|Overall Study|Withdrawal by Subject|6|||
49102951|NCT00878969|158212839|FG002|Overall Study|Withdrawal by Subject|3|||
49102952|NCT00878969|158212837|FG000|Overall Study|kidney transplant|2|||
49102953|NCT00878969|158212838|FG001|Overall Study|kidney transplant|3|||
49102954|NCT00878969|158212839|FG002|Overall Study|kidney transplant|2|||
49102955|NCT00878969|158212837|FG000|Overall Study|Adverse Event|3|||
49102956|NCT00878969|158212838|FG001|Overall Study|Adverse Event|1|||
49102957|NCT00878969|158212839|FG002|Overall Study|Adverse Event|2|||
49102958|NCT00878969|158212837|FG000|Overall Study|Lost to Follow-up|2|||
49102959|NCT00878969|158212838|FG001|Overall Study|Lost to Follow-up|1|||
49102960|NCT00878969|158212839|FG002|Overall Study|Lost to Follow-up|0|||
49102961|NCT00878969|158212837|FG000|Overall Study|Protocol Violation|2|||
49102962|NCT00878969|158212838|FG001|Overall Study|Protocol Violation|0|||
49102963|NCT00878969|158212839|FG002|Overall Study|Protocol Violation|0|||
49102964|NCT00878969|158212837|FG000|Overall Study|Death|0|||
49102965|NCT00878969|158212838|FG001|Overall Study|Death|0|||
49102966|NCT00878969|158212839|FG002|Overall Study|Death|2|||
49102967|NCT00878969|158212837|FG000|Overall Study|Pregnancy|0|||
49102968|NCT00878969|158212838|FG001|Overall Study|Pregnancy|1|||
49102969|NCT00878969|158212839|FG002|Overall Study|Pregnancy|0|||
49102970|NCT04258254|158212840|FG000|Overall Study|Withdrawal by Subject|0|||
49102971|NCT04258254|158212841|FG001|Overall Study|Withdrawal by Subject|1|||
49102972|NCT04258254|158212842|FG002|Overall Study|Withdrawal by Subject|0|||
49102973|NCT03045276|158212843|FG000|Intervention Phase|Withdrawal by Subject|7|||
49102974|NCT03045276|158212844|FG001|Intervention Phase|Withdrawal by Subject|2|||
49102975|NCT03045276|158212845|FG002|Intervention Phase|Withdrawal by Subject|3|||
49102976|NCT03045276|158212846|FG003|Intervention Phase|Withdrawal by Subject|7|||
49102977|NCT03045276|158212843|FG000|Intervention Phase|Developed exclusionary criteria|3|||
49102978|NCT03045276|158212844|FG001|Intervention Phase|Developed exclusionary criteria|3|||
49102979|NCT03045276|158212845|FG002|Intervention Phase|Developed exclusionary criteria|0|||
49102980|NCT03045276|158212846|FG003|Intervention Phase|Developed exclusionary criteria|0|||
49102981|NCT03045276|158212843|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
49102982|NCT03045276|158212844|FG001|Follow-Up Phase|Withdrawal by Subject|4|||
49102983|NCT03045276|158212845|FG002|Follow-Up Phase|Withdrawal by Subject|4|||
49102984|NCT03045276|158212846|FG003|Follow-Up Phase|Withdrawal by Subject|4|||
49102985|NCT03045276|158212843|FG000|Follow-Up Phase|Lost to Follow-up|0|||
49102986|NCT03045276|158212844|FG001|Follow-Up Phase|Lost to Follow-up|1|||
49102987|NCT03045276|158212845|FG002|Follow-Up Phase|Lost to Follow-up|0|||
49102988|NCT03045276|158212846|FG003|Follow-Up Phase|Lost to Follow-up|1|||
49102989|NCT03045276|158212843|FG000|Follow-Up Phase|Developed exclusionary criteria|1|||
49102990|NCT03045276|158212844|FG001|Follow-Up Phase|Developed exclusionary criteria|0|||
49102991|NCT03045276|158212845|FG002|Follow-Up Phase|Developed exclusionary criteria|0|||
49102992|NCT03045276|158212846|FG003|Follow-Up Phase|Developed exclusionary criteria|0|||
49102993|NCT00278148|158212850|FG000|Phase II - Expansion Phase|Disease progression|0|||
49102994|NCT00278148|158212851|FG001|Phase II - Expansion Phase|Disease progression|0|||
49102995|NCT00278148|158212852|FG002|Phase II - Expansion Phase|Disease progression|4|||
49102996|NCT00278148|158212850|FG000|Phase II - Expansion Phase|Adverse Event|0|||
49102997|NCT00278148|158212851|FG001|Phase II - Expansion Phase|Adverse Event|0|||
49102998|NCT00278148|158212852|FG002|Phase II - Expansion Phase|Adverse Event|2|||
49102999|NCT02035748|158212853|FG000|Overall Study|Adverse Event|5|||
49103000|NCT02035748|158212853|FG000|Overall Study|Death|3|||
49103001|NCT02035748|158212853|FG000|Overall Study|Lost to Follow-up|2|||
49103002|NCT02035748|158212853|FG000|Overall Study|Physician Decision|3|||
49103003|NCT02035748|158212853|FG000|Overall Study|Withdrawal by Subject|6|||
49103004|NCT02035748|158212853|FG000|Overall Study|Progressive Disease|1|||
49103005|NCT01088243|158212859|FG000|Overall Study|Adverse Event|1|||
49103006|NCT01088243|158212860|FG001|Overall Study|Adverse Event|0|||
49103007|NCT02255552|158212861|FG000|Overall Study|Participants enrolled into another study|0|||
49103008|NCT02255552|158212862|FG001|Overall Study|Participants enrolled into another study|11|||
49103009|NCT02255552|158212861|FG000|Overall Study|Withdrawal by Subject|1|||
49103010|NCT02255552|158212862|FG001|Overall Study|Withdrawal by Subject|4|||
49103011|NCT02122770|158212865|FG000|Part A: Drug-drug Interaction 2|Adverse Event|3|||
49103012|NCT02122770|158212866|FG001|Part A: Drug-drug Interaction 2|Adverse Event|0|||
49103013|NCT02122770|158212867|FG002|Part A: Drug-drug Interaction 2|Adverse Event|1|||
49103014|NCT02122770|158212868|FG003|Part A: Drug-drug Interaction 2|Adverse Event|2|||
49103015|NCT02122770|158212869|FG004|Part A: Drug-drug Interaction 2|Adverse Event|0|||
49103016|NCT02122770|158212870|FG005|Part A: Drug-drug Interaction 2|Adverse Event|0|||
49103017|NCT02122770|158212865|FG000|Part A: Drug-drug Interaction 2|Other|0|||
49103018|NCT02122770|158212866|FG001|Part A: Drug-drug Interaction 2|Other|0|||
49103019|NCT02122770|158212867|FG002|Part A: Drug-drug Interaction 2|Other|1|||
49103020|NCT02122770|158212868|FG003|Part A: Drug-drug Interaction 2|Other|0|||
49103021|NCT02122770|158212869|FG004|Part A: Drug-drug Interaction 2|Other|0|||
49103022|NCT02122770|158212870|FG005|Part A: Drug-drug Interaction 2|Other|0|||
49103023|NCT02122770|158212865|FG000|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
49103024|NCT02122770|158212866|FG001|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1|||
49103025|NCT02122770|158212867|FG002|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
49103026|NCT02122770|158212868|FG003|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
49103027|NCT02122770|158212869|FG004|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
49103028|NCT02122770|158212870|FG005|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
49103029|NCT02122770|158212865|FG000|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
49103030|NCT02122770|158212866|FG001|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5|||
49103031|NCT02122770|158212867|FG002|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
49103032|NCT02122770|158212868|FG003|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
49103033|NCT02122770|158212869|FG004|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
49103034|NCT02122770|158212870|FG005|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
49103035|NCT02122770|158212865|FG000|Part B: Standard of Care|Adverse Event|0|||
49103036|NCT02122770|158212866|FG001|Part B: Standard of Care|Adverse Event|0|||
49103037|NCT02122770|158212867|FG002|Part B: Standard of Care|Adverse Event|0|||
49103038|NCT02122770|158212868|FG003|Part B: Standard of Care|Adverse Event|0|||
49103039|NCT02122770|158212869|FG004|Part B: Standard of Care|Adverse Event|4|||
49103040|NCT02122770|158212870|FG005|Part B: Standard of Care|Adverse Event|1|||
49103041|NCT02122770|158212865|FG000|Part B: Standard of Care|Other|0|||
49103042|NCT02122770|158212866|FG001|Part B: Standard of Care|Other|0|||
49103043|NCT02122770|158212867|FG002|Part B: Standard of Care|Other|0|||
49103044|NCT02122770|158212868|FG003|Part B: Standard of Care|Other|0|||
49103045|NCT02122770|158212869|FG004|Part B: Standard of Care|Other|0|||
49103046|NCT02122770|158212870|FG005|Part B: Standard of Care|Other|2|||
49103047|NCT02122770|158212865|FG000|Part B: Standard of Care|Withdrawal by Subject|0|||
49103048|NCT02122770|158212866|FG001|Part B: Standard of Care|Withdrawal by Subject|0|||
49103049|NCT02122770|158212867|FG002|Part B: Standard of Care|Withdrawal by Subject|0|||
49103050|NCT02122770|158212868|FG003|Part B: Standard of Care|Withdrawal by Subject|0|||
49103051|NCT02122770|158212869|FG004|Part B: Standard of Care|Withdrawal by Subject|4|||
49103052|NCT02122770|158212870|FG005|Part B: Standard of Care|Withdrawal by Subject|2|||
49103053|NCT02122770|158212865|FG000|Part B: Standard of Care|Symptomatic Deterioration|0|||
49103054|NCT02122770|158212866|FG001|Part B: Standard of Care|Symptomatic Deterioration|0|||
49103055|NCT02122770|158212867|FG002|Part B: Standard of Care|Symptomatic Deterioration|0|||
49103056|NCT02122770|158212868|FG003|Part B: Standard of Care|Symptomatic Deterioration|0|||
49103057|NCT02122770|158212869|FG004|Part B: Standard of Care|Symptomatic Deterioration|5|||
49103058|NCT02122770|158212870|FG005|Part B: Standard of Care|Symptomatic Deterioration|0|||
49103059|NCT02122770|158212865|FG000|Part B: Standard of Care|Progressive Disease|0|||
49103060|NCT02122770|158212866|FG001|Part B: Standard of Care|Progressive Disease|0|||
49103061|NCT02122770|158212867|FG002|Part B: Standard of Care|Progressive Disease|0|||
49103062|NCT02122770|158212868|FG003|Part B: Standard of Care|Progressive Disease|0|||
49103063|NCT02122770|158212869|FG004|Part B: Standard of Care|Progressive Disease|10|||
49103064|NCT02122770|158212870|FG005|Part B: Standard of Care|Progressive Disease|8|||
49103065|NCT04450407|158212871|FG000|Overall Study|Withdrawal by Subject|10|||
49103066|NCT04450407|158212872|FG001|Overall Study|Withdrawal by Subject|1|||
49103067|NCT04450407|158212873|FG002|Overall Study|Withdrawal by Subject|4|||
49103068|NCT04450407|158212871|FG000|Overall Study|Adverse Event|0|||
49103069|NCT04450407|158212872|FG001|Overall Study|Adverse Event|0|||
49103070|NCT04450407|158212873|FG002|Overall Study|Adverse Event|1|||
49103071|NCT04450407|158212871|FG000|Overall Study|Lost to Follow-up|1|||
49103072|NCT04450407|158212872|FG001|Overall Study|Lost to Follow-up|0|||
49103073|NCT04450407|158212873|FG002|Overall Study|Lost to Follow-up|0|||
49103074|NCT04450407|158212871|FG000|Overall Study|Physician Decision|0|||
49103075|NCT04450407|158212872|FG001|Overall Study|Physician Decision|0|||
49103076|NCT04450407|158212873|FG002|Overall Study|Physician Decision|1|||
49103077|NCT04450407|158212871|FG000|Overall Study|Pregnancy|1|||
49103078|NCT04450407|158212872|FG001|Overall Study|Pregnancy|0|||
49103079|NCT04450407|158212873|FG002|Overall Study|Pregnancy|0|||
49103080|NCT04450407|158212871|FG000|Overall Study|Protocol Violation|2|||
49103081|NCT04450407|158212872|FG001|Overall Study|Protocol Violation|0|||
49103082|NCT04450407|158212873|FG002|Overall Study|Protocol Violation|0|||
49103083|NCT04450407|158212871|FG000|Overall Study|Investigational site terminated by sponsor|3|||
49103084|NCT04450407|158212872|FG001|Overall Study|Investigational site terminated by sponsor|0|||
49103085|NCT04450407|158212873|FG002|Overall Study|Investigational site terminated by sponsor|2|||
49103086|NCT03419598|158212874|FG000|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2|||
49103087|NCT02474589|158212875|FG000|Overall Study|Adverse Event|6|||
49103088|NCT02474589|158212876|FG001|Overall Study|Adverse Event|2|||
49103089|NCT02474589|158212875|FG000|Overall Study|Lost to Follow-up|6|||
49103090|NCT02474589|158212876|FG001|Overall Study|Lost to Follow-up|1|||
49103091|NCT02474589|158212875|FG000|Overall Study|Protocol Violation|4|||
49103092|NCT02474589|158212876|FG001|Overall Study|Protocol Violation|1|||
49103093|NCT02474589|158212875|FG000|Overall Study|Withdrawal by Subject|4|||
49103094|NCT02474589|158212876|FG001|Overall Study|Withdrawal by Subject|0|||
49103095|NCT02474589|158212875|FG000|Overall Study|Inability to complete study procedures|5|||
49103096|NCT02474589|158212876|FG001|Overall Study|Inability to complete study procedures|1|||
49103097|NCT01740128|158212877|FG000|Overall Study|Pregnancy|0|||
49103098|NCT01740128|158212878|FG001|Overall Study|Pregnancy|1|||
49103099|NCT01740128|158212877|FG000|Overall Study|Protocol Violation|1|||
49103100|NCT01740128|158212878|FG001|Overall Study|Protocol Violation|2|||
49103101|NCT01740128|158212877|FG000|Overall Study|Lost to Follow-up|2|||
49103102|NCT01740128|158212878|FG001|Overall Study|Lost to Follow-up|2|||
49103103|NCT01740128|158212877|FG000|Overall Study|Withdrawal by Subject|1|||
49103104|NCT01740128|158212878|FG001|Overall Study|Withdrawal by Subject|0|||
49103105|NCT01740128|158212877|FG000|Overall Study|Insufficient protocol compliance|2|||
49103106|NCT01740128|158212878|FG001|Overall Study|Insufficient protocol compliance|2|||
49103107|NCT01041976|158212879|FG000|Overall Study|Withdrawal by Subject|3|||
49103108|NCT01041976|158212880|FG001|Overall Study|Withdrawal by Subject|0|||
49103109|NCT01041976|158212879|FG000|Overall Study|Incarceration|2|||
49103110|NCT01041976|158212880|FG001|Overall Study|Incarceration|0|||
49103111|NCT01041976|158212879|FG000|Overall Study|Death|0|||
49103112|NCT01041976|158212880|FG001|Overall Study|Death|4|||
49103113|NCT00380081|158212883|FG000|Overall Study|Withdrawal by Subject|0|||
49103114|NCT00380081|158212884|FG001|Overall Study|Withdrawal by Subject|0|||
49103115|NCT00380081|158212885|FG002|Overall Study|Withdrawal by Subject|0|||
49103116|NCT00380081|158212886|FG003|Overall Study|Withdrawal by Subject|0|||
49103117|NCT00380081|158212887|FG004|Overall Study|Withdrawal by Subject|1|||
49103118|NCT00380081|158212888|FG005|Overall Study|Withdrawal by Subject|0|||
49103119|NCT00380081|158212883|FG000|Overall Study|Family Emergency|0|||
49103120|NCT00380081|158212884|FG001|Overall Study|Family Emergency|0|||
49103121|NCT00380081|158212885|FG002|Overall Study|Family Emergency|0|||
49103122|NCT00380081|158212886|FG003|Overall Study|Family Emergency|0|||
49103123|NCT00380081|158212887|FG004|Overall Study|Family Emergency|0|||
49103124|NCT00380081|158212888|FG005|Overall Study|Family Emergency|1|||
49103125|NCT02658734|158212889|FG000|Overall Study|Adverse Event|2|||
49103126|NCT02658734|158212889|FG000|Overall Study|Death|4|||
49103127|NCT02658734|158212889|FG000|Overall Study|Lost to Follow-up|7|||
49103128|NCT02658734|158212889|FG000|Overall Study|Withdrawal of Consent|16|||
49103129|NCT02658734|158212889|FG000|Overall Study|Disease Progression|28|||
49103130|NCT02231879|158212891|FG000|Overall Study|Adverse Event|2|||
49103131|NCT02231879|158212892|FG001|Overall Study|Adverse Event|1|||
49103132|NCT02231879|158212891|FG000|Overall Study|Lack of Efficacy|0|||
49103133|NCT02231879|158212892|FG001|Overall Study|Lack of Efficacy|1|||
49103134|NCT00176644|158212893|FG000|Overall Study|Withdrawal by Subject|1|||
49103135|NCT02017912|158212894|FG000|Overall Study|Withdrawal by Subject|2|||
49103136|NCT02017912|158212895|FG001|Overall Study|Withdrawal by Subject|1|||
49103137|NCT02017912|158212894|FG000|Overall Study|miscellaneous|1|||
49103138|NCT02017912|158212895|FG001|Overall Study|miscellaneous|1|||
49103139|NCT03640481|158212896|FG000|Overall Study|Death|14|||
49103140|NCT03640481|158212897|FG001|Overall Study|Death|14|||
49103141|NCT03640481|158212898|FG002|Overall Study|Death|0|||
49103142|NCT03640481|158212899|FG003|Overall Study|Death|0|||
49103143|NCT03640481|158212896|FG000|Overall Study|Lost to Follow-up|2|||
49103144|NCT03640481|158212897|FG001|Overall Study|Lost to Follow-up|0|||
49103145|NCT03640481|158212898|FG002|Overall Study|Lost to Follow-up|0|||
49103146|NCT03640481|158212899|FG003|Overall Study|Lost to Follow-up|0|||
49103147|NCT03640481|158212896|FG000|Overall Study|Site terminated by sponsor|1|||
49103148|NCT03640481|158212897|FG001|Overall Study|Site terminated by sponsor|3|||
49103149|NCT03640481|158212898|FG002|Overall Study|Site terminated by sponsor|0|||
49103150|NCT03640481|158212899|FG003|Overall Study|Site terminated by sponsor|0|||
49103151|NCT03640481|158212896|FG000|Overall Study|Study terminated by sponsor|29|||
49103152|NCT03640481|158212897|FG001|Overall Study|Study terminated by sponsor|42|||
49103153|NCT03640481|158212898|FG002|Overall Study|Study terminated by sponsor|1|||
49103154|NCT03640481|158212899|FG003|Overall Study|Study terminated by sponsor|0|||
49103155|NCT03640481|158212896|FG000|Overall Study|Withdrawal by Subject|5|||
49103156|NCT03640481|158212897|FG001|Overall Study|Withdrawal by Subject|4|||
49103157|NCT03640481|158212898|FG002|Overall Study|Withdrawal by Subject|0|||
49103158|NCT03640481|158212899|FG003|Overall Study|Withdrawal by Subject|1|||
49103159|NCT03640481|158212896|FG000|Overall Study|Other|26|||
49103160|NCT03640481|158212897|FG001|Overall Study|Other|12|||
49103161|NCT03640481|158212898|FG002|Overall Study|Other|1|||
49103162|NCT03640481|158212899|FG003|Overall Study|Other|0|||
49103163|NCT03640481|158212896|FG000|Overall Study|Randomized, but not treated|1|||
49103164|NCT03640481|158212897|FG001|Overall Study|Randomized, but not treated|3|||
49103165|NCT03640481|158212898|FG002|Overall Study|Randomized, but not treated|0|||
49103166|NCT03640481|158212899|FG003|Overall Study|Randomized, but not treated|0|||
49103167|NCT04601103|158212905|FG000|Overall Study|Needed crown & cleaning|0|||
49103168|NCT04601103|158212906|FG001|Overall Study|Needed crown & cleaning|0|||
49103169|NCT04601103|158212907|FG002|Overall Study|Needed crown & cleaning|1|||
49103170|NCT04601103|158212905|FG000|Overall Study|study was terminated|18|||
49103171|NCT04601103|158212906|FG001|Overall Study|study was terminated|18|||
49103172|NCT04601103|158212907|FG002|Overall Study|study was terminated|16|||
49103173|NCT02968433|158212908|FG000|Overall Study|Withdrawal by Subject|1|||
49103174|NCT05619536|158212909|FG000|Overall Study|Withdrawal by Subject|0|||
49103175|NCT05619536|158212910|FG001|Overall Study|Withdrawal by Subject|1|||
49103176|NCT05619536|158212911|FG002|Overall Study|Withdrawal by Subject|0|||
49103177|NCT05619536|158212912|FG003|Overall Study|Withdrawal by Subject|1|||
49103178|NCT05619536|158212909|FG000|Overall Study|Lost to Follow-up|0|||
49103179|NCT05619536|158212910|FG001|Overall Study|Lost to Follow-up|1|||
49103180|NCT05619536|158212911|FG002|Overall Study|Lost to Follow-up|1|||
49103181|NCT05619536|158212912|FG003|Overall Study|Lost to Follow-up|0|||
49103182|NCT00477607|158212913|FG000|Overall Study|Lost to Follow-up|7|||
49103183|NCT00477607|158212914|FG001|Overall Study|Lost to Follow-up|7|||
49103184|NCT03673345|158212918|FG000|Overall Study|Lost to Follow-up|1|||
49103185|NCT03673345|158212919|FG001|Overall Study|Lost to Follow-up|0|||
49103186|NCT03673345|158212920|FG002|Overall Study|Lost to Follow-up|3|||
49103187|NCT03673345|158212921|FG003|Overall Study|Lost to Follow-up|3|||
49103188|NCT03673345|158212922|FG004|Overall Study|Lost to Follow-up|2|||
49103189|NCT03673345|158212923|FG005|Overall Study|Lost to Follow-up|1|||
49103190|NCT03673345|158212924|FG006|Overall Study|Lost to Follow-up|0|||
49103191|NCT03673345|158212925|FG007|Overall Study|Lost to Follow-up|0|||
49103192|NCT03673345|158212918|FG000|Overall Study|Withdrawal by Subject|1|||
49103193|NCT03673345|158212919|FG001|Overall Study|Withdrawal by Subject|0|||
49103194|NCT03673345|158212920|FG002|Overall Study|Withdrawal by Subject|4|||
49103195|NCT03673345|158212921|FG003|Overall Study|Withdrawal by Subject|2|||
49103196|NCT03673345|158212922|FG004|Overall Study|Withdrawal by Subject|0|||
49103197|NCT03673345|158212923|FG005|Overall Study|Withdrawal by Subject|0|||
49103198|NCT03673345|158212924|FG006|Overall Study|Withdrawal by Subject|0|||
49103199|NCT03673345|158212925|FG007|Overall Study|Withdrawal by Subject|0|||
49103200|NCT03673345|158212918|FG000|Overall Study|Physician Decision|0|||
49103201|NCT03673345|158212919|FG001|Overall Study|Physician Decision|0|||
49103202|NCT03673345|158212920|FG002|Overall Study|Physician Decision|2|||
49103203|NCT03673345|158212921|FG003|Overall Study|Physician Decision|0|||
49103204|NCT03673345|158212922|FG004|Overall Study|Physician Decision|0|||
49103205|NCT03673345|158212923|FG005|Overall Study|Physician Decision|0|||
49103206|NCT03673345|158212924|FG006|Overall Study|Physician Decision|0|||
49103207|NCT03673345|158212925|FG007|Overall Study|Physician Decision|0|||
49103208|NCT01037127|158212926|FG000|Overall Study|Lost to Follow-up|2|||
49103209|NCT01037127|158212927|FG001|Overall Study|Lost to Follow-up|4|||
49103210|NCT01037127|158212926|FG000|Overall Study|Physician Decision|1|||
49103211|NCT01037127|158212927|FG001|Overall Study|Physician Decision|0|||
49103212|NCT01037127|158212926|FG000|Overall Study|Study Closed Terminated|2|||
49103213|NCT01037127|158212927|FG001|Overall Study|Study Closed Terminated|17|||
49103214|NCT01362244|158212928|FG000|Overall Study|Adverse Event|3|||
49103215|NCT01362244|158212929|FG001|Overall Study|Adverse Event|5|||
49103216|NCT01362244|158212928|FG000|Overall Study|Lack of Efficacy|5|||
49103217|NCT01362244|158212929|FG001|Overall Study|Lack of Efficacy|11|||
49103218|NCT01362244|158212928|FG000|Overall Study|Lost to Follow-up|0|||
49103219|NCT01362244|158212929|FG001|Overall Study|Lost to Follow-up|2|||
49103220|NCT01362244|158212928|FG000|Overall Study|Protocol Violation|5|||
49103221|NCT01362244|158212929|FG001|Overall Study|Protocol Violation|1|||
49103222|NCT01362244|158212928|FG000|Overall Study|Withdrawal by Subject|2|||
49103223|NCT01362244|158212929|FG001|Overall Study|Withdrawal by Subject|1|||
49103224|NCT01362244|158212928|FG000|Overall Study|Did not Meet Continuation Criteria|17|||
49103225|NCT01362244|158212929|FG001|Overall Study|Did not Meet Continuation Criteria|11|||
49103226|NCT01362244|158212928|FG000|Overall Study|Protocol Defined Stopping Criteria|0|||
49103227|NCT01362244|158212929|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
49103228|NCT01286168|158214662|FG000|Overall Study|Withdrawal by Subject|1|||
49103229|NCT01286168|158214662|FG000|Overall Study|Surgical Drains Fell Out at Home|2|||
49103230|NCT01424514|158214663|FG000|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
49103231|NCT01424514|158214664|FG001|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
49103232|NCT01424514|158214663|FG000|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1|||
49103233|NCT01424514|158214664|FG001|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0|||
49103234|NCT00546117|158214665|FG000|Overall Study|Withdrawal by Subject|3|||
49103235|NCT00546117|158214666|FG001|Overall Study|Withdrawal by Subject|0|||
49103236|NCT00546117|158214665|FG000|Overall Study|Inability to schedule follow-up visit|1|||
49103237|NCT00546117|158214666|FG001|Overall Study|Inability to schedule follow-up visit|0|||
49103238|NCT00654875|158214667|FG000|Overall Study|Adverse Event|5|||
49103239|NCT00654875|158214668|FG001|Overall Study|Adverse Event|5|||
49103240|NCT00654875|158214667|FG000|Overall Study|Withdrawal by Subject|4|||
49103241|NCT00654875|158214668|FG001|Overall Study|Withdrawal by Subject|4|||
49103242|NCT00654875|158214667|FG000|Overall Study|Protocol Violation|3|||
49103243|NCT00654875|158214668|FG001|Overall Study|Protocol Violation|3|||
49103244|NCT00654875|158214667|FG000|Overall Study|Lack of Efficacy|2|||
49103245|NCT00654875|158214668|FG001|Overall Study|Lack of Efficacy|2|||
49103246|NCT00654875|158214667|FG000|Overall Study|Lost to Follow-up|1|||
49103247|NCT00654875|158214668|FG001|Overall Study|Lost to Follow-up|3|||
49103248|NCT00654875|158214667|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
49103249|NCT00654875|158214668|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
49103250|NCT00654875|158214667|FG000|Overall Study|Administrative Problems|1|||
49103251|NCT00654875|158214668|FG001|Overall Study|Administrative Problems|0|||
49103252|NCT02091375|158214669|FG000|Overall Study|Adverse Event|8|||
49103253|NCT02091375|158214670|FG001|Overall Study|Adverse Event|1|||
49103254|NCT02091375|158214669|FG000|Overall Study|Lost to Follow-up|0|||
49103255|NCT02091375|158214670|FG001|Overall Study|Lost to Follow-up|1|||
49103256|NCT02091375|158214669|FG000|Overall Study|Withdrawal by Subject|0|||
49103257|NCT02091375|158214670|FG001|Overall Study|Withdrawal by Subject|1|||
49103258|NCT02091375|158214669|FG000|Overall Study|Withdrawn by the investigator|1|||
49103259|NCT02091375|158214670|FG001|Overall Study|Withdrawn by the investigator|0|||
49103260|NCT04599933|158214673|FG000|Overall Study|Adverse Event|4|||
49103261|NCT04599933|158214674|FG001|Overall Study|Adverse Event|1|||
49103262|NCT04599933|158214673|FG000|Overall Study|Withdrawal by Subject|4|||
49103263|NCT04599933|158214674|FG001|Overall Study|Withdrawal by Subject|2|||
49103264|NCT04599933|158214673|FG000|Overall Study|Lost to Follow-up|0|||
49103265|NCT04599933|158214674|FG001|Overall Study|Lost to Follow-up|1|||
49103266|NCT04599933|158214673|FG000|Overall Study|Physician Decision|0|||
49103267|NCT04599933|158214674|FG001|Overall Study|Physician Decision|1|||
49103268|NCT04599933|158214673|FG000|Overall Study|Screen Failure|1|||
49103269|NCT04599933|158214674|FG001|Overall Study|Screen Failure|2|||
49103270|NCT02487771|158214675|FG000|Overall Study|Lost to Follow-up|2|||
49103271|NCT02487771|158214676|FG001|Overall Study|Lost to Follow-up|3|||
49103272|NCT02487771|158214675|FG000|Overall Study|Moved out of area|5|||
49103273|NCT02487771|158214676|FG001|Overall Study|Moved out of area|6|||
49103274|NCT02487771|158214675|FG000|Overall Study|Withdrawal by Subject|3|||
49103275|NCT02487771|158214676|FG001|Overall Study|Withdrawal by Subject|5|||
49103276|NCT02653170|158214679|FG000|Overall Study|Withdrawal by Subject|3|||
49103277|NCT02653170|158214680|FG001|Overall Study|Withdrawal by Subject|8|||
49103278|NCT02653170|158214681|FG002|Overall Study|Withdrawal by Subject|3|||
49103279|NCT02653170|158214679|FG000|Overall Study|withdrawn by study team|2|||
49103280|NCT02653170|158214680|FG001|Overall Study|withdrawn by study team|4|||
49103281|NCT02653170|158214681|FG002|Overall Study|withdrawn by study team|5|||
49103282|NCT02653170|158214679|FG000|Overall Study|Lost to Follow-up|12|||
49103283|NCT02653170|158214680|FG001|Overall Study|Lost to Follow-up|4|||
49103284|NCT02653170|158214681|FG002|Overall Study|Lost to Follow-up|10|||
49103285|NCT02002533|158214682|FG000|Overall Study|Withdrawal by Subject|6|||
49103286|NCT02002533|158214683|FG001|Overall Study|Withdrawal by Subject|13|||
49103287|NCT02002533|158214682|FG000|Overall Study|Protocol Violation|0|||
49103288|NCT02002533|158214683|FG001|Overall Study|Protocol Violation|1|||
49103289|NCT02002533|158214682|FG000|Overall Study|Adverse Event|0|||
49103290|NCT02002533|158214683|FG001|Overall Study|Adverse Event|3|||
49103291|NCT02002533|158214682|FG000|Overall Study|Lost to Follow-up|0|||
49103292|NCT02002533|158214683|FG001|Overall Study|Lost to Follow-up|1|||
49103293|NCT04598451|158214684|FG000|Overall Study|Adverse Event|3|||
49103294|NCT04598451|158214685|FG001|Overall Study|Adverse Event|2|||
49103295|NCT04598451|158214684|FG000|Overall Study|Withdrawal by Subject|3|||
49103296|NCT04598451|158214685|FG001|Overall Study|Withdrawal by Subject|7|||
49103297|NCT04598451|158214684|FG000|Overall Study|Lost to Follow-up|2|||
49103298|NCT04598451|158214685|FG001|Overall Study|Lost to Follow-up|0|||
49103299|NCT04598451|158214684|FG000|Overall Study|Physician Decision|4|||
49103300|NCT04598451|158214685|FG001|Overall Study|Physician Decision|1|||
49103301|NCT04598451|158214684|FG000|Overall Study|Requires Prohibited Medication|1|||
49103302|NCT04598451|158214685|FG001|Overall Study|Requires Prohibited Medication|0|||
49103303|NCT04598451|158214684|FG000|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|30|||
49103304|NCT04598451|158214685|FG001|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|19|||
49103305|NCT02083185|158214696|FG000|Overall Study|Lost to Follow-up|0|||
49103306|NCT02083185|158214697|FG001|Overall Study|Lost to Follow-up|3|||
49103307|NCT02083185|158214698|FG002|Overall Study|Lost to Follow-up|0|||
49103308|NCT02083185|158214696|FG000|Overall Study|Withdrawal by Subject|9|||
49103309|NCT02083185|158214697|FG001|Overall Study|Withdrawal by Subject|15|||
49103310|NCT02083185|158214698|FG002|Overall Study|Withdrawal by Subject|1|||
49103311|NCT02083185|158214696|FG000|Overall Study|Death|2|||
49103312|NCT02083185|158214697|FG001|Overall Study|Death|2|||
49103313|NCT02083185|158214698|FG002|Overall Study|Death|1|||
49103314|NCT02083185|158214696|FG000|Overall Study|Reason not Specified|9|||
49103315|NCT02083185|158214697|FG001|Overall Study|Reason not Specified|6|||
49103316|NCT02083185|158214698|FG002|Overall Study|Reason not Specified|5|||
49103317|NCT02083185|158214696|FG000|Overall Study|Study Terminated by Sponsor|0|||
49103318|NCT02083185|158214697|FG001|Overall Study|Study Terminated by Sponsor|1|||
49103319|NCT02083185|158214698|FG002|Overall Study|Study Terminated by Sponsor|0|||
49103320|NCT02083185|158214696|FG000|Overall Study|Did not Receive Study Drug|0|||
49103321|NCT02083185|158214697|FG001|Overall Study|Did not Receive Study Drug|2|||
49103322|NCT02083185|158214698|FG002|Overall Study|Did not Receive Study Drug|0|||
49103323|NCT00189306|158214699|FG000|Treatment Period|Withdrawal by Subject|2|||
49103324|NCT00189306|158214699|FG000|Treatment Period|Adverse Event|2|||
49103325|NCT00189306|158214699|FG000|Treatment Period|Protocol Violation|1|||
49103326|NCT00189306|158214699|FG000|Posttreatment Period|Death|1|||
49103327|NCT00189306|158214699|FG000|Posttreatment Period|Withdrawal by Subject|2|||
49103328|NCT00189306|158214699|FG000|Posttreatment Period|Noncompliance|1|||
49103329|NCT00189306|158214699|FG000|Posttreatment Period|Target lesion excised|1|||
49103330|NCT00189306|158214699|FG000|Posttreatment Period|Protocol Violation|1|||
49103331|NCT00189306|158214699|FG000|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5|||
49103332|NCT00189306|158214699|FG000|Posttreatment Period|Local skin reaction/sign|1|||
49103333|NCT00189306|158214699|FG000|Long-Term Follow-up|Adverse Event|2|||
49103334|NCT00189306|158214699|FG000|Long-Term Follow-up|Death|4|||
49103335|NCT00189306|158214699|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
49103336|NCT00189306|158214699|FG000|Long-Term Follow-up|Intercurrent disease|2|||
49103337|NCT00189306|158214699|FG000|Long-Term Follow-up|Lost to Follow-up|9|||
49103338|NCT00189306|158214699|FG000|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20|||
49103339|NCT00459706|158214700|FG000|Overall Study|Adverse Event|19|||
49103340|NCT00459706|158214701|FG001|Overall Study|Adverse Event|13|||
49103341|NCT00459706|158214700|FG000|Overall Study|Withdrawal by Subject|1|||
49103342|NCT00459706|158214701|FG001|Overall Study|Withdrawal by Subject|6|||
49103343|NCT00459706|158214700|FG000|Overall Study|Physician Decision|2|||
49103344|NCT00459706|158214701|FG001|Overall Study|Physician Decision|0|||
49103345|NCT00459706|158214700|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
49103346|NCT00459706|158214701|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
49103347|NCT00459706|158214700|FG000|Overall Study|Protocol Violation|2|||
49103348|NCT00459706|158214701|FG001|Overall Study|Protocol Violation|1|||
49103349|NCT00459706|158214700|FG000|Overall Study|Failed to Return|1|||
49103350|NCT00459706|158214701|FG001|Overall Study|Failed to Return|0|||
49103351|NCT00459706|158214700|FG000|Overall Study|Other|0|||
49103352|NCT00459706|158214701|FG001|Overall Study|Other|1|||
49103353|NCT02447497|158214702|FG000|Overall Study|Did not meet treatment day baseline.|6|||
49103354|NCT02447497|158214703|FG001|Overall Study|Did not meet treatment day baseline.|5|||
49103355|NCT02447497|158214704|FG002|Overall Study|Did not meet treatment day baseline.|2|||
49103356|NCT02447497|158214705|FG003|Overall Study|Did not meet treatment day baseline.|2|||
49103357|NCT02447497|158214702|FG000|Overall Study|Dressing was compromised|0|||
49103358|NCT02447497|158214703|FG001|Overall Study|Dressing was compromised|1|||
49103359|NCT02447497|158214704|FG002|Overall Study|Dressing was compromised|0|||
49103360|NCT02447497|158214705|FG003|Overall Study|Dressing was compromised|0|||
49103361|NCT01801280|158214706|FG000|Period 1|Withdrawal by Subject|0|||
49103362|NCT01801280|158214707|FG001|Period 1|Withdrawal by Subject|1|||
49103363|NCT01801280|158214708|FG002|Period 1|Withdrawal by Subject|0|||
49103364|NCT01801280|158214709|FG003|Period 1|Withdrawal by Subject|0|||
49103365|NCT01801280|158214706|FG000|Period 2|Withdrawal by Subject|1|||
49103366|NCT01801280|158214707|FG001|Period 2|Withdrawal by Subject|0|||
49103367|NCT01801280|158214708|FG002|Period 2|Withdrawal by Subject|0|||
49103368|NCT01801280|158214709|FG003|Period 2|Withdrawal by Subject|0|||
49103369|NCT01801280|158214706|FG000|Period 4|Protocol Violation|0|||
49103370|NCT01801280|158214707|FG001|Period 4|Protocol Violation|0|||
49103371|NCT01801280|158214708|FG002|Period 4|Protocol Violation|1|||
49103372|NCT01801280|158214709|FG003|Period 4|Protocol Violation|0|||
49103373|NCT01322035|158214710|FG000|Overall Study|Lost to Follow-up|8|||
49103374|NCT01322035|158214711|FG001|Overall Study|Lost to Follow-up|3|||
49103375|NCT00535847|158214712|FG000|Overall Study|Adverse Event|5|||
49103376|NCT00535847|158214713|FG001|Overall Study|Adverse Event|3|||
49103377|NCT00535847|158214714|FG002|Overall Study|Adverse Event|2|||
49103378|NCT00535847|158214712|FG000|Overall Study|Non compliance|1|||
49103379|NCT00535847|158214713|FG001|Overall Study|Non compliance|1|||
49103380|NCT00535847|158214714|FG002|Overall Study|Non compliance|0|||
49103381|NCT00535847|158214712|FG000|Overall Study|Protocol-defined Virologic Stopping Rule|16|||
49103382|NCT00535847|158214713|FG001|Overall Study|Protocol-defined Virologic Stopping Rule|10|||
49103383|NCT00535847|158214714|FG002|Overall Study|Protocol-defined Virologic Stopping Rule|0|||
49103384|NCT00732758|158214715|FG000|Overall Study|Lost to Follow-up|8|||
49103385|NCT00732758|158214716|FG001|Overall Study|Lost to Follow-up|16|||
49103386|NCT00373958|158214717|FG000|Infant Series|Withdrawal by Subject|13|||
49103387|NCT00373958|158214718|FG001|Infant Series|Withdrawal by Subject|15|||
49103388|NCT00373958|158214717|FG000|Infant Series|Failed to return|8|||
49103389|NCT00373958|158214718|FG001|Infant Series|Failed to return|13|||
49103390|NCT00373958|158214717|FG000|Infant Series|Lost to Follow-up|6|||
49103391|NCT00373958|158214718|FG001|Infant Series|Lost to Follow-up|5|||
49103392|NCT00373958|158214717|FG000|Infant Series|Protocol Violation|3|||
49103393|NCT00373958|158214718|FG001|Infant Series|Protocol Violation|7|||
49103394|NCT00373958|158214717|FG000|Infant Series|Lost Kaiser coverage|4|||
49103395|NCT00373958|158214718|FG001|Infant Series|Lost Kaiser coverage|0|||
49103396|NCT00373958|158214717|FG000|Infant Series|Child relocated|1|||
49103397|NCT00373958|158214718|FG001|Infant Series|Child relocated|0|||
49103398|NCT00373958|158214717|FG000|Infant Series|Consent was not received|1|||
49103399|NCT00373958|158214718|FG001|Infant Series|Consent was not received|0|||
49103400|NCT00373958|158214717|FG000|Infant Series|Adverse Event|3|||
49103401|NCT00373958|158214718|FG001|Infant Series|Adverse Event|1|||
49103402|NCT00373958|158214717|FG000|Infant Series|Physician Decision|1|||
49103403|NCT00373958|158214718|FG001|Infant Series|Physician Decision|1|||
49103404|NCT00373958|158214717|FG000|Toddler Dose|Lost to Follow-up|5|||
49103405|NCT00373958|158214718|FG001|Toddler Dose|Lost to Follow-up|8|||
49103406|NCT00373958|158214717|FG000|Toddler Dose|Withdrawal by Subject|2|||
49103407|NCT00373958|158214718|FG001|Toddler Dose|Withdrawal by Subject|2|||
49103408|NCT00373958|158214717|FG000|Toddler Dose|Failed to return|1|||
49103409|NCT00373958|158214718|FG001|Toddler Dose|Failed to return|2|||
49103410|NCT00373958|158214717|FG000|Toddler Dose|Protocol Violation|0|||
49103411|NCT00373958|158214718|FG001|Toddler Dose|Protocol Violation|1|||
49103412|NCT00373958|158214717|FG000|Toddler Dose|Withdrawn after infant series|22|||
49103413|NCT00373958|158214718|FG001|Toddler Dose|Withdrawn after infant series|25|||
49103414|NCT05177354|158214725|FG000|Implant to 30-day Visit|Physician Decision|1|||
49103415|NCT05177354|158214725|FG000|Implant to 30-day Visit|Withdrawal by Subject|1|||
49103416|NCT05177354|158214725|FG000|Implant to 30-day Visit|Lack of compliance to the protocol including phone calls & optimisation visits.|1|||
49103417|NCT05177354|158214725|FG000|30-day Visit to 3-Month Visit|Adverse Event|1|||
49103418|NCT05007041|158214726|FG000|Overall Study|Missing Diary Entries|0|||
49103419|NCT05007041|158214727|FG001|Overall Study|Missing Diary Entries|1|||
49103420|NCT04495816|158214728|FG000|Overall Study|Lost to Follow-up|10|||
49103421|NCT04495816|158214729|FG001|Overall Study|Lost to Follow-up|4|||
49103422|NCT04495816|158214728|FG000|Overall Study|Withdrawal by Subject|3|||
49103423|NCT04495816|158214729|FG001|Overall Study|Withdrawal by Subject|5|||
49103424|NCT01552915|158214730|FG000|Overall Study|Adverse Event|3|||
49103425|NCT01552915|158214731|FG001|Overall Study|Adverse Event|14|||
49103426|NCT01552915|158214732|FG002|Overall Study|Adverse Event|3|||
49103427|NCT01552915|158214730|FG000|Overall Study|Lost to Follow-up|4|||
49103428|NCT01552915|158214731|FG001|Overall Study|Lost to Follow-up|6|||
49103429|NCT01552915|158214732|FG002|Overall Study|Lost to Follow-up|5|||
49103430|NCT01552915|158214730|FG000|Overall Study|Withdrawal by Subject|6|||
49103431|NCT01552915|158214731|FG001|Overall Study|Withdrawal by Subject|4|||
49103432|NCT01552915|158214732|FG002|Overall Study|Withdrawal by Subject|5|||
49103433|NCT01552915|158214730|FG000|Overall Study|Protocol Violation|0|||
49103434|NCT01552915|158214731|FG001|Overall Study|Protocol Violation|4|||
49103435|NCT01552915|158214732|FG002|Overall Study|Protocol Violation|4|||
49103436|NCT01552915|158214730|FG000|Overall Study|Lack of Efficacy|8|||
49103437|NCT01552915|158214731|FG001|Overall Study|Lack of Efficacy|1|||
49103438|NCT01552915|158214732|FG002|Overall Study|Lack of Efficacy|4|||
49103439|NCT01552915|158214730|FG000|Overall Study|Other|2|||
49103440|NCT01552915|158214731|FG001|Overall Study|Other|0|||
49103441|NCT01552915|158214732|FG002|Overall Study|Other|6|||
49103442|NCT00232596|158214733|FG000|6-Week Titration Phase|Adverse Event|6|||
49103443|NCT00232596|158214734|FG001|6-Week Titration Phase|Adverse Event|19|||
49103444|NCT00232596|158214733|FG000|6-Week Titration Phase|Failed to Return|2|||
49103445|NCT00232596|158214734|FG001|6-Week Titration Phase|Failed to Return|1|||
49103446|NCT00232596|158214733|FG000|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1|||
49103447|NCT00232596|158214734|FG001|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2|||
49103448|NCT00232596|158214733|FG000|6-Week Titration Phase|Protocol Violation|1|||
49103449|NCT00232596|158214734|FG001|6-Week Titration Phase|Protocol Violation|3|||
49103450|NCT00232596|158214733|FG000|6-Week Titration Phase|Participant Request Unrelated to Study|1|||
49103451|NCT00232596|158214734|FG001|6-Week Titration Phase|Participant Request Unrelated to Study|0|||
49103452|NCT00232596|158214733|FG000|6-Week Titration Phase|Other|3|||
49103453|NCT00232596|158214734|FG001|6-Week Titration Phase|Other|3|||
49103454|NCT00232596|158214733|FG000|6-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
49103455|NCT00232596|158214734|FG001|6-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
49103456|NCT00232596|158214733|FG000|12-Week Maintenance Phase|Adverse Event|7|||
49103457|NCT00232596|158214734|FG001|12-Week Maintenance Phase|Adverse Event|22|||
49103458|NCT00232596|158214733|FG000|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1|||
49103459|NCT00232596|158214734|FG001|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2|||
49103460|NCT00232596|158214733|FG000|12-Week Maintenance Phase|Protocol Violation|3|||
49103461|NCT00232596|158214734|FG001|12-Week Maintenance Phase|Protocol Violation|1|||
49103462|NCT00232596|158214733|FG000|12-Week Maintenance Phase|Other|1|||
49103463|NCT00232596|158214734|FG001|12-Week Maintenance Phase|Other|3|||
49103464|NCT00705718|158214735|FG000|Overall Study|Death|6|||
49103465|NCT00705718|158214736|FG001|Overall Study|Death|6|||
49103466|NCT00705718|158214735|FG000|Overall Study|Not due for Visit|0|||
49103467|NCT00705718|158214736|FG001|Overall Study|Not due for Visit|12|||
49103468|NCT00705718|158214735|FG000|Overall Study|Follow up not done|1|||
49103469|NCT00705718|158214736|FG001|Overall Study|Follow up not done|4|||
49103470|NCT01793688|158214740|FG000|Overall Study|Protocol Violation|2|||
49103471|NCT04331067|158214749|FG000|Overall Study|Adverse Event|1|||
49103472|NCT04331067|158214750|FG001|Overall Study|Adverse Event|3|||
49103473|NCT04331067|158214751|FG002|Overall Study|Adverse Event|1|||
49103474|NCT04331067|158214749|FG000|Overall Study|Physician decision - patient not compliant with visits|1|||
49103475|NCT04331067|158214750|FG001|Overall Study|Physician decision - patient not compliant with visits|0|||
49103476|NCT04331067|158214751|FG002|Overall Study|Physician decision - patient not compliant with visits|0|||
49103477|NCT01382225|158214755|FG000|Overall Study|Adverse Event|3|||
49103478|NCT01382225|158214756|FG001|Overall Study|Adverse Event|2|||
49103479|NCT01382225|158214755|FG000|Overall Study|Protocol Violation|2|||
49103480|NCT01382225|158214756|FG001|Overall Study|Protocol Violation|1|||
49103481|NCT01382225|158214755|FG000|Overall Study|Subject Withdrew Consent|5|||
49103482|NCT01382225|158214756|FG001|Overall Study|Subject Withdrew Consent|2|||
49103483|NCT01382225|158214755|FG000|Overall Study|Other|4|||
49103484|NCT01382225|158214756|FG001|Overall Study|Other|2|||
49103485|NCT02847182|158214763|FG000|Overall Study|Withdrawal by Subject|0|||
49103486|NCT02847182|158214764|FG001|Overall Study|Withdrawal by Subject|1|||
49103487|NCT00157248|158214765|FG000|Overall Study|Adverse Event|36|||
49103488|NCT00157248|158214766|FG001|Overall Study|Adverse Event|25|||
49103489|NCT00157248|158214767|FG002|Overall Study|Adverse Event|13|||
49103490|NCT00157248|158214768|FG003|Overall Study|Adverse Event|33|||
49103491|NCT00157248|158214765|FG000|Overall Study|Protocol Violation|4|||
49103492|NCT00157248|158214766|FG001|Overall Study|Protocol Violation|0|||
49103493|NCT00157248|158214767|FG002|Overall Study|Protocol Violation|2|||
49103494|NCT00157248|158214768|FG003|Overall Study|Protocol Violation|2|||
49103495|NCT00157248|158214765|FG000|Overall Study|Lost to Follow-up|0|||
49103496|NCT00157248|158214766|FG001|Overall Study|Lost to Follow-up|1|||
49103497|NCT00157248|158214767|FG002|Overall Study|Lost to Follow-up|0|||
49103498|NCT00157248|158214768|FG003|Overall Study|Lost to Follow-up|0|||
49103499|NCT00157248|158214765|FG000|Overall Study|Withdrawal by Subject|1|||
49103500|NCT00157248|158214766|FG001|Overall Study|Withdrawal by Subject|4|||
49103501|NCT00157248|158214767|FG002|Overall Study|Withdrawal by Subject|3|||
49103502|NCT00157248|158214768|FG003|Overall Study|Withdrawal by Subject|3|||
49103503|NCT00157248|158214765|FG000|Overall Study|site closures, subject moving|7|||
49103504|NCT00157248|158214766|FG001|Overall Study|site closures, subject moving|7|||
49103505|NCT00157248|158214767|FG002|Overall Study|site closures, subject moving|3|||
49103506|NCT00157248|158214768|FG003|Overall Study|site closures, subject moving|9|||
49103507|NCT00474786|158214771|FG000|Overall Study|Not Meeting Study Criteria|0|||
49103508|NCT00474786|158214772|FG001|Overall Study|Not Meeting Study Criteria|1|||
49103509|NCT00474786|158214771|FG000|Overall Study|Investigator Request|2|||
49103510|NCT00474786|158214772|FG001|Overall Study|Investigator Request|1|||
49103511|NCT00474786|158214771|FG000|Overall Study|Death|189|||
49103512|NCT00474786|158214772|FG001|Overall Study|Death|170|||
49103513|NCT00474786|158214771|FG000|Overall Study|Discontinuation of Study by Sponsor|42|||
49111403|NCT01289574|158242893|FG000|Overall Study|Lost to Follow-up|2|||
49103514|NCT00474786|158214772|FG001|Overall Study|Discontinuation of Study by Sponsor|59|||
49103515|NCT00474786|158214771|FG000|Overall Study|Lost to Follow-up|4|||
49103516|NCT00474786|158214772|FG001|Overall Study|Lost to Follow-up|7|||
49103517|NCT00474786|158214771|FG000|Overall Study|Protocol Violation|2|||
49103518|NCT00474786|158214772|FG001|Overall Study|Protocol Violation|0|||
49103519|NCT00474786|158214771|FG000|Overall Study|Withdrawal by Subject|15|||
49103520|NCT00474786|158214772|FG001|Overall Study|Withdrawal by Subject|15|||
49103521|NCT00474786|158214771|FG000|Overall Study|Other|5|||
49103522|NCT00474786|158214772|FG001|Overall Study|Other|0|||
49103523|NCT01173055|158214774|FG000|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
49103524|NCT01173055|158214775|FG001|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
49103525|NCT01173055|158214774|FG000|Period 2 - Day 64 to 112|Adverse Event|0|||
49103526|NCT01173055|158214775|FG001|Period 2 - Day 64 to 112|Adverse Event|1|||
49103527|NCT03426436|158214776|FG000|Overall Study|Incorrect lead placement|12|||
49103528|NCT03426436|158214776|FG000|Overall Study|Withdrawal by Subject|2|||
49103529|NCT03426436|158214776|FG000|Overall Study|Consent issue|1|||
49103530|NCT03426436|158214776|FG000|Overall Study|ECGs not saved|4|||
49103531|NCT02267135|158214777|FG000|Period 1 (Randomized Set)|Withdrawal by Subject|1|||
49103532|NCT02267135|158214778|FG001|Period 1 (Randomized Set)|Withdrawal by Subject|3|||
49103533|NCT02267135|158214777|FG000|Period 1 (Randomized Set)|Lost to Follow-up|0|||
49103534|NCT02267135|158214778|FG001|Period 1 (Randomized Set)|Lost to Follow-up|1|||
49103535|NCT02267135|158214777|FG000|Period 2 (Randomized Set)|Lost to Follow-up|1|||
49103536|NCT02267135|158214778|FG001|Period 2 (Randomized Set)|Lost to Follow-up|1|||
49103537|NCT02267135|158214777|FG000|Period 2 (Randomized Set)|Adverse Event|2|||
49103538|NCT02267135|158214778|FG001|Period 2 (Randomized Set)|Adverse Event|0|||
49103539|NCT02267135|158214777|FG000|Period 2 (Randomized Set)|Withdrawal by Subject|1|||
49103540|NCT02267135|158214778|FG001|Period 2 (Randomized Set)|Withdrawal by Subject|0|||
49103541|NCT02892513|158214779|FG000|Overall Study|Withdrawal by Subject|0|||
49103542|NCT02892513|158214780|FG001|Overall Study|Withdrawal by Subject|1|||
49103543|NCT04325698|158214781|FG000|Overall Study|Study Terminated By Sponsor|1|||
49103544|NCT04325698|158214782|FG001|Overall Study|Study Terminated By Sponsor|1|||
49103545|NCT04325698|158214781|FG000|Overall Study|Withdrawal by Subject|0|||
49103546|NCT04325698|158214782|FG001|Overall Study|Withdrawal by Subject|2|||
49103547|NCT00962091|158214783|FG000|Overall Study|Withdrawal by Subject|1|||
49103548|NCT00962091|158214784|FG001|Overall Study|Withdrawal by Subject|2|||
49103549|NCT00962091|158214785|FG002|Overall Study|Withdrawal by Subject|1|||
49103550|NCT00962091|158214786|FG003|Overall Study|Withdrawal by Subject|1|||
49103551|NCT00962091|158214787|FG004|Overall Study|Withdrawal by Subject|0|||
49103552|NCT00962091|158214788|FG005|Overall Study|Withdrawal by Subject|1|||
49103553|NCT00962091|158214789|FG006|Overall Study|Withdrawal by Subject|0|||
49103554|NCT00962091|158214783|FG000|Overall Study|Adverse Event|0|||
49103555|NCT00962091|158214784|FG001|Overall Study|Adverse Event|0|||
49103556|NCT00962091|158214785|FG002|Overall Study|Adverse Event|0|||
49103557|NCT00962091|158214786|FG003|Overall Study|Adverse Event|0|||
49103558|NCT00962091|158214787|FG004|Overall Study|Adverse Event|0|||
49103559|NCT00962091|158214788|FG005|Overall Study|Adverse Event|0|||
49103560|NCT00962091|158214789|FG006|Overall Study|Adverse Event|1|||
49103561|NCT04216589|158214791|FG000|Overall Study|Withdrawal by Subject|2|||
49103562|NCT04216589|158214791|FG000|Overall Study|Protocol Violation|1|||
49103563|NCT04216589|158214791|FG000|Overall Study|Incarceration|1|||
49103564|NCT00900731|158214792|FG000|Overall Study|Adverse Event|31|||
49103565|NCT00900731|158214793|FG001|Overall Study|Adverse Event|27|||
49103566|NCT00900731|158214792|FG000|Overall Study|Withdrawal by Subject|8|||
49103567|NCT00900731|158214793|FG001|Overall Study|Withdrawal by Subject|7|||
49103568|NCT00900731|158214792|FG000|Overall Study|Protocol Deviation|8|||
49103569|NCT00900731|158214793|FG001|Overall Study|Protocol Deviation|11|||
49103570|NCT00900731|158214792|FG000|Overall Study|Administrative Problems|5|||
49103571|NCT00900731|158214793|FG001|Overall Study|Administrative Problems|4|||
49103572|NCT00900731|158214792|FG000|Overall Study|Abnormal Test Procedure Result(s)|3|||
49103573|NCT00900731|158214793|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
49103574|NCT00900731|158214792|FG000|Overall Study|Abnormal Laboratory Value(s)|2|||
49103575|NCT00900731|158214793|FG001|Overall Study|Abnormal Laboratory Value(s)|4|||
49103576|NCT00900731|158214792|FG000|Overall Study|Lost to Follow-up|2|||
49103577|NCT00900731|158214793|FG001|Overall Study|Lost to Follow-up|3|||
49103578|NCT00900731|158214792|FG000|Overall Study|Lack of Efficacy|1|||
49103579|NCT00900731|158214793|FG001|Overall Study|Lack of Efficacy|3|||
49103580|NCT00900731|158214792|FG000|Overall Study|Death|0|||
49103581|NCT00900731|158214793|FG001|Overall Study|Death|2|||
49103582|NCT01877382|158214794|FG000|Dose Escalation|Progressive disease|2|||
49103583|NCT01877382|158214795|FG001|Dose Escalation|Progressive disease|0|||
49103584|NCT01877382|158214796|FG002|Dose Escalation|Progressive disease|1|||
49103585|NCT01877382|158214797|FG003|Dose Escalation|Progressive disease|6|||
49103586|NCT01877382|158214798|FG004|Dose Escalation|Progressive disease|1|||
49103587|NCT01877382|158214799|FG005|Dose Escalation|Progressive disease|0|||
49103588|NCT01877382|158214800|FG006|Dose Escalation|Progressive disease|3|||
49103589|NCT01877382|158214801|FG007|Dose Escalation|Progressive disease|10|||
49103590|NCT01877382|158214802|FG008|Dose Escalation|Progressive disease|4|||
49103591|NCT01877382|158214803|FG009|Dose Escalation|Progressive disease|2|||
49103592|NCT01877382|158214804|FG010|Dose Escalation|Progressive disease|3|||
49103593|NCT01877382|158214805|FG011|Dose Escalation|Progressive disease|3|||
49103594|NCT01877382|158214806|FG012|Dose Escalation|Progressive disease|13|||
49103595|NCT01877382|158214807|FG013|Dose Escalation|Progressive disease|1|||
49103596|NCT01877382|158214808|FG014|Dose Escalation|Progressive disease|0|||
49103597|NCT01877382|158214794|FG000|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
49103598|NCT01877382|158214795|FG001|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
49103599|NCT01877382|158214796|FG002|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
49103600|NCT01877382|158214797|FG003|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
49103601|NCT01877382|158214798|FG004|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
49103602|NCT01877382|158214799|FG005|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
49103603|NCT01877382|158214800|FG006|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
49103604|NCT01877382|158214801|FG007|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
49103605|NCT01877382|158214802|FG008|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
49103606|NCT01877382|158214803|FG009|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
49103607|NCT01877382|158214804|FG010|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
49103608|NCT01877382|158214805|FG011|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
49103609|NCT01877382|158214806|FG012|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
49103610|NCT01877382|158214807|FG013|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
49103611|NCT01877382|158214808|FG014|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
49103612|NCT01877382|158214794|FG000|Dose Escalation|Clinical progression|0|||
49103613|NCT01877382|158214795|FG001|Dose Escalation|Clinical progression|1|||
49103614|NCT01877382|158214796|FG002|Dose Escalation|Clinical progression|0|||
49103615|NCT01877382|158214797|FG003|Dose Escalation|Clinical progression|2|||
49103616|NCT01877382|158214798|FG004|Dose Escalation|Clinical progression|0|||
49103617|NCT01877382|158214799|FG005|Dose Escalation|Clinical progression|0|||
49103618|NCT01877382|158214800|FG006|Dose Escalation|Clinical progression|1|||
49103619|NCT01877382|158214801|FG007|Dose Escalation|Clinical progression|0|||
49103620|NCT01877382|158214802|FG008|Dose Escalation|Clinical progression|0|||
49103621|NCT01877382|158214803|FG009|Dose Escalation|Clinical progression|1|||
49103622|NCT01877382|158214804|FG010|Dose Escalation|Clinical progression|0|||
49103623|NCT01877382|158214805|FG011|Dose Escalation|Clinical progression|0|||
49103624|NCT01877382|158214806|FG012|Dose Escalation|Clinical progression|2|||
49103625|NCT01877382|158214807|FG013|Dose Escalation|Clinical progression|1|||
49103626|NCT01877382|158214808|FG014|Dose Escalation|Clinical progression|0|||
49103627|NCT01877382|158214794|FG000|Dose Escalation|Adverse Event|0|||
49103628|NCT01877382|158214795|FG001|Dose Escalation|Adverse Event|0|||
49103629|NCT01877382|158214796|FG002|Dose Escalation|Adverse Event|0|||
49103630|NCT01877382|158214797|FG003|Dose Escalation|Adverse Event|4|||
49103631|NCT01877382|158214798|FG004|Dose Escalation|Adverse Event|1|||
49103632|NCT01877382|158214799|FG005|Dose Escalation|Adverse Event|2|||
49103633|NCT01877382|158214800|FG006|Dose Escalation|Adverse Event|1|||
49103634|NCT01877382|158214801|FG007|Dose Escalation|Adverse Event|2|||
49103635|NCT01877382|158214802|FG008|Dose Escalation|Adverse Event|0|||
49103636|NCT01877382|158214803|FG009|Dose Escalation|Adverse Event|0|||
49103637|NCT01877382|158214804|FG010|Dose Escalation|Adverse Event|0|||
49103638|NCT01877382|158214805|FG011|Dose Escalation|Adverse Event|0|||
49103639|NCT01877382|158214806|FG012|Dose Escalation|Adverse Event|1|||
49103640|NCT01877382|158214807|FG013|Dose Escalation|Adverse Event|0|||
49103641|NCT01877382|158214808|FG014|Dose Escalation|Adverse Event|0|||
49103642|NCT01877382|158214794|FG000|Dose Escalation|Withdrawal by Subject|0|||
49103643|NCT01877382|158214795|FG001|Dose Escalation|Withdrawal by Subject|0|||
49103644|NCT01877382|158214796|FG002|Dose Escalation|Withdrawal by Subject|0|||
49103645|NCT01877382|158214797|FG003|Dose Escalation|Withdrawal by Subject|0|||
49103646|NCT01877382|158214798|FG004|Dose Escalation|Withdrawal by Subject|0|||
49103647|NCT01877382|158214799|FG005|Dose Escalation|Withdrawal by Subject|3|||
49103648|NCT01877382|158214800|FG006|Dose Escalation|Withdrawal by Subject|2|||
49103649|NCT01877382|158214801|FG007|Dose Escalation|Withdrawal by Subject|1|||
49103650|NCT01877382|158214802|FG008|Dose Escalation|Withdrawal by Subject|1|||
49103651|NCT01877382|158214803|FG009|Dose Escalation|Withdrawal by Subject|0|||
49103652|NCT01877382|158214804|FG010|Dose Escalation|Withdrawal by Subject|0|||
49103653|NCT01877382|158214805|FG011|Dose Escalation|Withdrawal by Subject|0|||
49103654|NCT01877382|158214806|FG012|Dose Escalation|Withdrawal by Subject|0|||
49103655|NCT01877382|158214807|FG013|Dose Escalation|Withdrawal by Subject|0|||
49103656|NCT01877382|158214808|FG014|Dose Escalation|Withdrawal by Subject|0|||
49103657|NCT01877382|158214794|FG000|Dose Escalation|Protocol Violation|0|||
49103658|NCT01877382|158214795|FG001|Dose Escalation|Protocol Violation|0|||
49103659|NCT01877382|158214796|FG002|Dose Escalation|Protocol Violation|0|||
49103660|NCT01877382|158214797|FG003|Dose Escalation|Protocol Violation|0|||
49103661|NCT01877382|158214798|FG004|Dose Escalation|Protocol Violation|0|||
49103662|NCT01877382|158214799|FG005|Dose Escalation|Protocol Violation|0|||
49103663|NCT01877382|158214800|FG006|Dose Escalation|Protocol Violation|1|||
49103664|NCT01877382|158214801|FG007|Dose Escalation|Protocol Violation|0|||
49103665|NCT01877382|158214802|FG008|Dose Escalation|Protocol Violation|0|||
49103666|NCT01877382|158214803|FG009|Dose Escalation|Protocol Violation|0|||
49103667|NCT01877382|158214804|FG010|Dose Escalation|Protocol Violation|0|||
49103668|NCT01877382|158214805|FG011|Dose Escalation|Protocol Violation|0|||
49103669|NCT01877382|158214806|FG012|Dose Escalation|Protocol Violation|0|||
49103670|NCT01877382|158214807|FG013|Dose Escalation|Protocol Violation|0|||
49103671|NCT01877382|158214808|FG014|Dose Escalation|Protocol Violation|0|||
49103672|NCT01877382|158214794|FG000|Dose Escalation|Study terminated by sponsor|0|||
49103673|NCT01877382|158214795|FG001|Dose Escalation|Study terminated by sponsor|0|||
49103674|NCT01877382|158214796|FG002|Dose Escalation|Study terminated by sponsor|0|||
49103675|NCT01877382|158214797|FG003|Dose Escalation|Study terminated by sponsor|0|||
49103676|NCT01877382|158214798|FG004|Dose Escalation|Study terminated by sponsor|0|||
49103677|NCT01877382|158214799|FG005|Dose Escalation|Study terminated by sponsor|0|||
49103678|NCT01877382|158214800|FG006|Dose Escalation|Study terminated by sponsor|0|||
49103679|NCT01877382|158214801|FG007|Dose Escalation|Study terminated by sponsor|1|||
49103680|NCT01877382|158214802|FG008|Dose Escalation|Study terminated by sponsor|1|||
49103681|NCT01877382|158214803|FG009|Dose Escalation|Study terminated by sponsor|0|||
49103682|NCT01877382|158214804|FG010|Dose Escalation|Study terminated by sponsor|0|||
49103683|NCT01877382|158214805|FG011|Dose Escalation|Study terminated by sponsor|0|||
49103684|NCT01877382|158214806|FG012|Dose Escalation|Study terminated by sponsor|3|||
49103685|NCT01877382|158214807|FG013|Dose Escalation|Study terminated by sponsor|0|||
49103686|NCT01877382|158214808|FG014|Dose Escalation|Study terminated by sponsor|0|||
49103687|NCT01877382|158214794|FG000|Dose Escalation|Death|0|||
49103688|NCT01877382|158214795|FG001|Dose Escalation|Death|0|||
49103689|NCT01877382|158214796|FG002|Dose Escalation|Death|0|||
49103690|NCT01877382|158214797|FG003|Dose Escalation|Death|0|||
49103691|NCT01877382|158214798|FG004|Dose Escalation|Death|0|||
49103692|NCT01877382|158214799|FG005|Dose Escalation|Death|0|||
49103693|NCT01877382|158214800|FG006|Dose Escalation|Death|0|||
49103694|NCT01877382|158214801|FG007|Dose Escalation|Death|1|||
49103695|NCT01877382|158214802|FG008|Dose Escalation|Death|0|||
49103696|NCT01877382|158214803|FG009|Dose Escalation|Death|0|||
49103697|NCT01877382|158214804|FG010|Dose Escalation|Death|0|||
49103698|NCT01877382|158214805|FG011|Dose Escalation|Death|0|||
49103699|NCT01877382|158214806|FG012|Dose Escalation|Death|1|||
49103700|NCT01877382|158214807|FG013|Dose Escalation|Death|1|||
49103701|NCT01877382|158214808|FG014|Dose Escalation|Death|0|||
49103702|NCT01877382|158214794|FG000|Dose Expansion|Progressive disease|0|||
49103703|NCT01877382|158214795|FG001|Dose Expansion|Progressive disease|0|||
49103704|NCT01877382|158214796|FG002|Dose Expansion|Progressive disease|0|||
49103705|NCT01877382|158214797|FG003|Dose Expansion|Progressive disease|0|||
49103706|NCT01877382|158214798|FG004|Dose Expansion|Progressive disease|0|||
49103707|NCT01877382|158214799|FG005|Dose Expansion|Progressive disease|0|||
49103708|NCT01877382|158214800|FG006|Dose Expansion|Progressive disease|0|||
49103709|NCT01877382|158214801|FG007|Dose Expansion|Progressive disease|0|||
49103710|NCT01877382|158214802|FG008|Dose Expansion|Progressive disease|0|||
49103711|NCT01877382|158214803|FG009|Dose Expansion|Progressive disease|0|||
49103712|NCT01877382|158214804|FG010|Dose Expansion|Progressive disease|0|||
49103713|NCT01877382|158214805|FG011|Dose Expansion|Progressive disease|0|||
49103714|NCT01877382|158214806|FG012|Dose Expansion|Progressive disease|0|||
49103715|NCT01877382|158214807|FG013|Dose Expansion|Progressive disease|0|||
49103716|NCT01877382|158214808|FG014|Dose Expansion|Progressive disease|11|||
49103717|NCT01877382|158214794|FG000|Dose Expansion|Clinical progression|0|||
49103718|NCT01877382|158214795|FG001|Dose Expansion|Clinical progression|0|||
49103719|NCT01877382|158214796|FG002|Dose Expansion|Clinical progression|0|||
49103720|NCT01877382|158214797|FG003|Dose Expansion|Clinical progression|0|||
49103721|NCT01877382|158214798|FG004|Dose Expansion|Clinical progression|0|||
49103722|NCT01877382|158214799|FG005|Dose Expansion|Clinical progression|0|||
49103723|NCT01877382|158214800|FG006|Dose Expansion|Clinical progression|0|||
49103724|NCT01877382|158214801|FG007|Dose Expansion|Clinical progression|0|||
49103725|NCT01877382|158214802|FG008|Dose Expansion|Clinical progression|0|||
49103726|NCT01877382|158214803|FG009|Dose Expansion|Clinical progression|0|||
49103727|NCT01877382|158214804|FG010|Dose Expansion|Clinical progression|0|||
49103728|NCT01877382|158214805|FG011|Dose Expansion|Clinical progression|0|||
49103729|NCT01877382|158214806|FG012|Dose Expansion|Clinical progression|0|||
49103730|NCT01877382|158214807|FG013|Dose Expansion|Clinical progression|0|||
49103731|NCT01877382|158214808|FG014|Dose Expansion|Clinical progression|6|||
49103732|NCT01877382|158214794|FG000|Dose Expansion|Adverse Event|0|||
49103733|NCT01877382|158214795|FG001|Dose Expansion|Adverse Event|0|||
49103734|NCT01877382|158214796|FG002|Dose Expansion|Adverse Event|0|||
49103735|NCT01877382|158214797|FG003|Dose Expansion|Adverse Event|0|||
49103736|NCT01877382|158214798|FG004|Dose Expansion|Adverse Event|0|||
49103737|NCT01877382|158214799|FG005|Dose Expansion|Adverse Event|0|||
49103738|NCT01877382|158214800|FG006|Dose Expansion|Adverse Event|0|||
49103739|NCT01877382|158214801|FG007|Dose Expansion|Adverse Event|0|||
49103740|NCT01877382|158214802|FG008|Dose Expansion|Adverse Event|0|||
49103741|NCT01877382|158214803|FG009|Dose Expansion|Adverse Event|0|||
49103742|NCT01877382|158214804|FG010|Dose Expansion|Adverse Event|0|||
49103743|NCT01877382|158214805|FG011|Dose Expansion|Adverse Event|0|||
49103744|NCT01877382|158214806|FG012|Dose Expansion|Adverse Event|0|||
49103745|NCT01877382|158214807|FG013|Dose Expansion|Adverse Event|0|||
49103746|NCT01877382|158214808|FG014|Dose Expansion|Adverse Event|1|||
49103747|NCT01877382|158214794|FG000|Dose Expansion|Death|0|||
49103748|NCT01877382|158214795|FG001|Dose Expansion|Death|0|||
49103749|NCT01877382|158214796|FG002|Dose Expansion|Death|0|||
49103750|NCT01877382|158214797|FG003|Dose Expansion|Death|0|||
49103751|NCT01877382|158214798|FG004|Dose Expansion|Death|0|||
49103752|NCT01877382|158214799|FG005|Dose Expansion|Death|0|||
49103753|NCT01877382|158214800|FG006|Dose Expansion|Death|0|||
49103754|NCT01877382|158214801|FG007|Dose Expansion|Death|0|||
49103755|NCT01877382|158214802|FG008|Dose Expansion|Death|0|||
49103756|NCT01877382|158214803|FG009|Dose Expansion|Death|0|||
49103757|NCT01877382|158214804|FG010|Dose Expansion|Death|0|||
49103758|NCT01877382|158214805|FG011|Dose Expansion|Death|0|||
49103759|NCT01877382|158214806|FG012|Dose Expansion|Death|0|||
49103760|NCT01877382|158214807|FG013|Dose Expansion|Death|0|||
49103761|NCT01877382|158214808|FG014|Dose Expansion|Death|1|||
49103762|NCT01877382|158214794|FG000|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
49103763|NCT01877382|158214795|FG001|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
49103764|NCT01877382|158214796|FG002|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
49103765|NCT01877382|158214797|FG003|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
49103766|NCT01877382|158214798|FG004|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
49103767|NCT01877382|158214799|FG005|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
49103768|NCT01877382|158214800|FG006|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
49103769|NCT01877382|158214801|FG007|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
49103770|NCT01877382|158214802|FG008|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
49103771|NCT01877382|158214803|FG009|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
49103772|NCT01877382|158214804|FG010|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
49103773|NCT01877382|158214805|FG011|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
49103774|NCT01877382|158214806|FG012|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
49103775|NCT01877382|158214807|FG013|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
49103776|NCT01877382|158214808|FG014|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
49103777|NCT03800836|158214809|FG000|Overall Study|Other|2|||
49103778|NCT03800836|158214810|FG001|Overall Study|Other|1|||
49103779|NCT03800836|158214811|FG002|Overall Study|Other|0|||
49103780|NCT03800836|158214812|FG003|Overall Study|Other|2|||
49103781|NCT03800836|158214813|FG004|Overall Study|Other|0|||
49103782|NCT03800836|158214814|FG005|Overall Study|Other|1|||
49103783|NCT03800836|158214809|FG000|Overall Study|Lost to Follow-up|2|||
49103784|NCT03800836|158214810|FG001|Overall Study|Lost to Follow-up|0|||
49103785|NCT03800836|158214811|FG002|Overall Study|Lost to Follow-up|1|||
49103786|NCT03800836|158214812|FG003|Overall Study|Lost to Follow-up|1|||
49103787|NCT03800836|158214813|FG004|Overall Study|Lost to Follow-up|3|||
49103788|NCT03800836|158214814|FG005|Overall Study|Lost to Follow-up|0|||
49103789|NCT03800836|158214809|FG000|Overall Study|Withdrawal by Subject|1|||
49103790|NCT03800836|158214810|FG001|Overall Study|Withdrawal by Subject|0|||
49103791|NCT03800836|158214811|FG002|Overall Study|Withdrawal by Subject|0|||
49103792|NCT03800836|158214812|FG003|Overall Study|Withdrawal by Subject|0|||
49103793|NCT03800836|158214813|FG004|Overall Study|Withdrawal by Subject|0|||
49103794|NCT03800836|158214814|FG005|Overall Study|Withdrawal by Subject|0|||
49103795|NCT03800836|158214809|FG000|Overall Study|Physician Decision|31|||
49103796|NCT03800836|158214810|FG001|Overall Study|Physician Decision|3|||
49103797|NCT03800836|158214811|FG002|Overall Study|Physician Decision|6|||
49103798|NCT03800836|158214812|FG003|Overall Study|Physician Decision|4|||
49103799|NCT03800836|158214813|FG004|Overall Study|Physician Decision|4|||
49103800|NCT03800836|158214814|FG005|Overall Study|Physician Decision|5|||
49103801|NCT03800836|158214809|FG000|Overall Study|Death|34|||
49103802|NCT03800836|158214810|FG001|Overall Study|Death|16|||
49103803|NCT03800836|158214811|FG002|Overall Study|Death|5|||
49103804|NCT03800836|158214812|FG003|Overall Study|Death|5|||
49103805|NCT03800836|158214813|FG004|Overall Study|Death|10|||
49103806|NCT03800836|158214814|FG005|Overall Study|Death|0|||
49103807|NCT03800836|158214809|FG000|Overall Study|Symptomatic Deterioration|1|||
49103808|NCT03800836|158214810|FG001|Overall Study|Symptomatic Deterioration|0|||
49103809|NCT03800836|158214811|FG002|Overall Study|Symptomatic Deterioration|1|||
49103810|NCT03800836|158214812|FG003|Overall Study|Symptomatic Deterioration|0|||
49103811|NCT03800836|158214813|FG004|Overall Study|Symptomatic Deterioration|0|||
49103812|NCT03800836|158214814|FG005|Overall Study|Symptomatic Deterioration|0|||
49103813|NCT04852276|158214815|FG000|Overall Study|Death|2|||
49103814|NCT04852276|158214816|FG001|Overall Study|Death|0|||
49103815|NCT04852276|158214815|FG000|Overall Study|Lost to Follow-up|15|||
49103816|NCT04852276|158214816|FG001|Overall Study|Lost to Follow-up|9|||
49103817|NCT04852276|158214815|FG000|Overall Study|Withdrawal by Subject|26|||
49103818|NCT04852276|158214816|FG001|Overall Study|Withdrawal by Subject|6|||
49103819|NCT04743804|158216444|FG000|Overall Study|Other|1|||
49103820|NCT04743804|158216445|FG001|Overall Study|Other|0|||
49103821|NCT04743804|158216444|FG000|Overall Study|Withdrawal by Subject|0|||
49103822|NCT04743804|158216445|FG001|Overall Study|Withdrawal by Subject|1|||
49103823|NCT04743804|158216444|FG000|Overall Study|Study Terminated by Sponsor|1|||
49103824|NCT04743804|158216445|FG001|Overall Study|Study Terminated by Sponsor|4|||
49103825|NCT04743804|158216444|FG000|Overall Study|Physician Decision|0|||
49103826|NCT04743804|158216445|FG001|Overall Study|Physician Decision|1|||
49103827|NCT04743804|158216444|FG000|Overall Study|Death|3|||
49103828|NCT04743804|158216445|FG001|Overall Study|Death|0|||
49103829|NCT01632904|158216446|FG000|Overall Study|Adverse Event|4|||
49103830|NCT01632904|158216447|FG001|Overall Study|Adverse Event|1|||
49103831|NCT01632904|158216446|FG000|Overall Study|Physician Decision|0|||
49103832|NCT01632904|158216447|FG001|Overall Study|Physician Decision|1|||
49103833|NCT01632904|158216446|FG000|Overall Study|Subject decision|3|||
49103834|NCT01632904|158216447|FG001|Overall Study|Subject decision|2|||
49103835|NCT01632904|158216446|FG000|Overall Study|Disease Progression|0|||
49103836|NCT01632904|158216447|FG001|Overall Study|Disease Progression|1|||
49103837|NCT01632904|158216446|FG000|Overall Study|Reason for discontinuation not available|0|||
49103838|NCT01632904|158216447|FG001|Overall Study|Reason for discontinuation not available|1|||
49103839|NCT01397786|158216451|FG000|Phase A|Lost to Follow-up|0|||
49103840|NCT01397786|158216452|FG001|Phase A|Lost to Follow-up|0|||
49103841|NCT01397786|158216453|FG002|Phase A|Lost to Follow-up|6|||
49103842|NCT01397786|158216451|FG000|Phase A|Adverse Event|0|||
49103843|NCT01397786|158216452|FG001|Phase A|Adverse Event|0|||
49103844|NCT01397786|158216453|FG002|Phase A|Adverse Event|8|||
49103845|NCT01397786|158216451|FG000|Phase A|Subject Met Withdrawal Criteria|0|||
49103846|NCT01397786|158216452|FG001|Phase A|Subject Met Withdrawal Criteria|0|||
49103847|NCT01397786|158216453|FG002|Phase A|Subject Met Withdrawal Criteria|7|||
49103848|NCT01397786|158216451|FG000|Phase A|Physician Decision|0|||
49103849|NCT01397786|158216452|FG001|Phase A|Physician Decision|0|||
49103850|NCT01397786|158216453|FG002|Phase A|Physician Decision|1|||
49103851|NCT01397786|158216451|FG000|Phase A|Withdrawal by Subject|0|||
49103852|NCT01397786|158216452|FG001|Phase A|Withdrawal by Subject|0|||
49103853|NCT01397786|158216453|FG002|Phase A|Withdrawal by Subject|5|||
49103854|NCT01397786|158216451|FG000|Phase A|Lack of Efficacy|0|||
49103855|NCT01397786|158216452|FG001|Phase A|Lack of Efficacy|0|||
49103856|NCT01397786|158216453|FG002|Phase A|Lack of Efficacy|1|||
49103857|NCT01397786|158216451|FG000|Phase B|Lost to Follow-up|22|||
49103858|NCT01397786|158216452|FG001|Phase B|Lost to Follow-up|12|||
49103859|NCT01397786|158216453|FG002|Phase B|Lost to Follow-up|22|||
49103860|NCT01397786|158216451|FG000|Phase B|Adverse Event|109|||
49103861|NCT01397786|158216452|FG001|Phase B|Adverse Event|23|||
49103862|NCT01397786|158216453|FG002|Phase B|Adverse Event|27|||
49103863|NCT01397786|158216451|FG000|Phase B|Subject Met Withdrawal Criteria|38|||
49103864|NCT01397786|158216452|FG001|Phase B|Subject Met Withdrawal Criteria|5|||
49103865|NCT01397786|158216453|FG002|Phase B|Subject Met Withdrawal Criteria|38|||
49103866|NCT01397786|158216451|FG000|Phase B|Physician Decision|9|||
49103867|NCT01397786|158216452|FG001|Phase B|Physician Decision|1|||
49103868|NCT01397786|158216453|FG002|Phase B|Physician Decision|3|||
49103869|NCT01397786|158216451|FG000|Phase B|Withdrawal by Subject|102|||
49103870|NCT01397786|158216452|FG001|Phase B|Withdrawal by Subject|45|||
49103871|NCT01397786|158216453|FG002|Phase B|Withdrawal by Subject|30|||
49103872|NCT01397786|158216451|FG000|Phase B|Protocol Deviation|1|||
49103873|NCT01397786|158216452|FG001|Phase B|Protocol Deviation|2|||
49103874|NCT01397786|158216453|FG002|Phase B|Protocol Deviation|4|||
49103875|NCT01397786|158216451|FG000|Phase B|Lack of Efficacy|22|||
49103876|NCT01397786|158216452|FG001|Phase B|Lack of Efficacy|7|||
49103877|NCT01397786|158216453|FG002|Phase B|Lack of Efficacy|14|||
49103878|NCT03126019|158216454|FG000|Overall Study|Participants Still Ongoing in the Study|17|||
49103879|NCT03126019|158216455|FG001|Overall Study|Participants Still Ongoing in the Study|87|||
49103880|NCT03126019|158216454|FG000|Overall Study|Death|2|||
49103881|NCT03126019|158216455|FG001|Overall Study|Death|7|||
49103882|NCT03126019|158216454|FG000|Overall Study|Lost to Follow-up|2|||
49103883|NCT03126019|158216455|FG001|Overall Study|Lost to Follow-up|3|||
49103884|NCT03126019|158216454|FG000|Overall Study|Withdrawal by Participant|1|||
49103885|NCT03126019|158216455|FG001|Overall Study|Withdrawal by Participant|3|||
49103886|NCT03126019|158216454|FG000|Overall Study|Reason not Specified|1|||
49103887|NCT03126019|158216455|FG001|Overall Study|Reason not Specified|3|||
49103888|NCT02059434|158216456|FG000|Washout Between Periods 1 and 2|Physician Decision|0|||
49103889|NCT02059434|158216457|FG001|Washout Between Periods 1 and 2|Physician Decision|0|||
49103890|NCT02059434|158216458|FG002|Washout Between Periods 1 and 2|Physician Decision|0|||
49103891|NCT02059434|158216459|FG003|Washout Between Periods 1 and 2|Physician Decision|0|||
49103892|NCT02059434|158216460|FG004|Washout Between Periods 1 and 2|Physician Decision|0|||
49103893|NCT02059434|158216461|FG005|Washout Between Periods 1 and 2|Physician Decision|0|||
49103894|NCT02059434|158216462|FG006|Washout Between Periods 1 and 2|Physician Decision|0|||
49103895|NCT02059434|158216463|FG007|Washout Between Periods 1 and 2|Physician Decision|1|||
49103896|NCT02059434|158216464|FG008|Washout Between Periods 1 and 2|Physician Decision|0|||
49103897|NCT02059434|158216456|FG000|Washout Between Periods 4 and 5|Adverse Event|0|||
49103898|NCT02059434|158216457|FG001|Washout Between Periods 4 and 5|Adverse Event|0|||
49103899|NCT02059434|158216458|FG002|Washout Between Periods 4 and 5|Adverse Event|0|||
49103900|NCT02059434|158216459|FG003|Washout Between Periods 4 and 5|Adverse Event|0|||
49103901|NCT02059434|158216460|FG004|Washout Between Periods 4 and 5|Adverse Event|0|||
49103902|NCT02059434|158216461|FG005|Washout Between Periods 4 and 5|Adverse Event|0|||
49103903|NCT02059434|158216462|FG006|Washout Between Periods 4 and 5|Adverse Event|0|||
49103904|NCT02059434|158216463|FG007|Washout Between Periods 4 and 5|Adverse Event|0|||
49103905|NCT02059434|158216464|FG008|Washout Between Periods 4 and 5|Adverse Event|1|||
49103906|NCT02059434|158216456|FG000|Washout Between Periods 6 and 7|Physician Decision|0|||
49103907|NCT02059434|158216457|FG001|Washout Between Periods 6 and 7|Physician Decision|0|||
49103908|NCT02059434|158216458|FG002|Washout Between Periods 6 and 7|Physician Decision|0|||
49103909|NCT02059434|158216459|FG003|Washout Between Periods 6 and 7|Physician Decision|0|||
49103910|NCT02059434|158216460|FG004|Washout Between Periods 6 and 7|Physician Decision|0|||
49103911|NCT02059434|158216461|FG005|Washout Between Periods 6 and 7|Physician Decision|0|||
49103912|NCT02059434|158216462|FG006|Washout Between Periods 6 and 7|Physician Decision|0|||
49103913|NCT02059434|158216463|FG007|Washout Between Periods 6 and 7|Physician Decision|0|||
49103914|NCT02059434|158216464|FG008|Washout Between Periods 6 and 7|Physician Decision|1|||
49103915|NCT02059434|158216456|FG000|Washout Between Periods 7 and 8|Adverse Event|0|||
49103916|NCT02059434|158216457|FG001|Washout Between Periods 7 and 8|Adverse Event|0|||
49103917|NCT02059434|158216458|FG002|Washout Between Periods 7 and 8|Adverse Event|0|||
49103918|NCT02059434|158216459|FG003|Washout Between Periods 7 and 8|Adverse Event|0|||
49103919|NCT02059434|158216460|FG004|Washout Between Periods 7 and 8|Adverse Event|0|||
49103920|NCT02059434|158216461|FG005|Washout Between Periods 7 and 8|Adverse Event|0|||
49103921|NCT02059434|158216462|FG006|Washout Between Periods 7 and 8|Adverse Event|0|||
49103922|NCT02059434|158216463|FG007|Washout Between Periods 7 and 8|Adverse Event|0|||
49103923|NCT02059434|158216464|FG008|Washout Between Periods 7 and 8|Adverse Event|1|||
49103924|NCT02059434|158216456|FG000|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
49103925|NCT02059434|158216457|FG001|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
49103926|NCT02059434|158216458|FG002|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
49103927|NCT02059434|158216459|FG003|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
49103928|NCT02059434|158216460|FG004|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
49103929|NCT02059434|158216461|FG005|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
49103930|NCT02059434|158216462|FG006|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
49103931|NCT02059434|158216463|FG007|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
49103932|NCT02059434|158216464|FG008|Washout Between Periods 7 and 8|Withdrawal by Subject|1|||
49103933|NCT02203851|158216470|FG000|Overall Study|Lost to Follow-up|4|||
49103934|NCT02203851|158216470|FG000|Overall Study|Withdrawal by Subject|6|||
49103935|NCT02203851|158216470|FG000|Overall Study|Other|1|||
49103936|NCT01632150|158216480|FG000|Overall Study|Disease progression|27|||
49103937|NCT01632150|158216480|FG000|Overall Study|Study drug toxicity|1|||
49103938|NCT01632150|158216480|FG000|Overall Study|Unrelated adverse event|7|||
49103939|NCT01632150|158216480|FG000|Overall Study|Withdrawal by Subject|2|||
49103940|NCT01632150|158216480|FG000|Overall Study|Patient underwent autologous transplant|1|||
49103941|NCT01632150|158216480|FG000|Overall Study|Moved to compassionate program|2|||
49103942|NCT03085238|158216482|FG000|Overall Study|Adverse Event|2|||
49103943|NCT03085238|158216482|FG000|Overall Study|Death|2|||
49103944|NCT00381238|158216483|FG000|Overall Study|Adverse Event|3|||
49103945|NCT00381238|158216483|FG000|Overall Study|Protocol Violation|1|||
49103946|NCT00381238|158216483|FG000|Overall Study|Withdrawal by Subject|4|||
49103947|NCT00381238|158216483|FG000|Overall Study|Lack of Efficacy|2|||
49103948|NCT00381238|158216483|FG000|Overall Study|Withdrew by physician|1|||
49103949|NCT00381238|158216483|FG000|Overall Study|Disease progression|1|||
49103950|NCT02879994|158216494|FG000|Overall Study|off treatment early|7|||
49103951|NCT02879994|158216494|FG000|Overall Study|Adverse Event|2|||
49103952|NCT02879994|158216494|FG000|Overall Study|Death|2|||
49103953|NCT04392167|158216495|FG000|Overall Study|unable to swallow a/LCI-OCT probe|6|||
49103954|NCT02143791|158216497|FG000|Enrolled|Withdrawal by Subject|4|||
49103955|NCT02143791|158216497|FG000|Trial Stimulation|Lack of Efficacy|21|||
49103956|NCT02143791|158216497|FG000|Burst Stimulation Only (3 Months)|Withdrawal by Subject|4|||
49103957|NCT02143791|158216497|FG000|Burst Stimulation Only (3 Months)|Missing Data|4|||
49103958|NCT02143791|158216497|FG000|Any Programming (3-6 Months)|Withdrawal by Subject|3|||
49103959|NCT02143791|158216497|FG000|Any Programming (3-6 Months)|Missing Data|1|||
49103960|NCT02143791|158216497|FG000|Any Program (6-12 Months)|Withdrawal by Subject|2|||
49103961|NCT00727844|158216504|FG000|Initial Randomization|Physician Decision|2|||
49103962|NCT00727844|158216505|FG001|Initial Randomization|Physician Decision|0|||
49103963|NCT00727844|158216506|FG002|Initial Randomization|Physician Decision|0|||
49103964|NCT00727844|158216507|FG003|Initial Randomization|Physician Decision|0|||
49103965|NCT04569968|158216508|FG000|Overall Study|Lost to Follow-up|2|||
49103966|NCT04569968|158216509|FG001|Overall Study|Lost to Follow-up|5|||
49103967|NCT04569968|158216508|FG000|Overall Study|Story of head and/or neck surgery|2|||
49103968|NCT04569968|158216509|FG001|Overall Study|Story of head and/or neck surgery|2|||
49103969|NCT04569968|158216508|FG000|Overall Study|Time of stroke onset|8|||
49103970|NCT04569968|158216509|FG001|Overall Study|Time of stroke onset|7|||
49103971|NCT04569968|158216508|FG000|Overall Study|Type of strokr|12|||
49103972|NCT04569968|158216509|FG001|Overall Study|Type of strokr|8|||
49103973|NCT04569968|158216508|FG000|Overall Study|Cooperation|8|||
49103974|NCT04569968|158216509|FG001|Overall Study|Cooperation|8|||
49103975|NCT04569968|158216508|FG000|Overall Study|Age interval|17|||
49103976|NCT04569968|158216509|FG001|Overall Study|Age interval|6|||
49103977|NCT04569968|158216508|FG000|Overall Study|Denial of participation to the study|0|||
49103978|NCT04569968|158216509|FG001|Overall Study|Denial of participation to the study|3|||
49103979|NCT04569968|158216508|FG000|Overall Study|Free of temporomandibular joint dysfunction|4|||
49103980|NCT04569968|158216509|FG001|Overall Study|Free of temporomandibular joint dysfunction|2|||
49103981|NCT04569968|158216508|FG000|Overall Study|Lack of incisor and/or canin tooth|5|||
49103982|NCT04569968|158216509|FG001|Overall Study|Lack of incisor and/or canin tooth|3|||
49103983|NCT04569968|158216508|FG000|Overall Study|Quarantine|1|||
49103984|NCT04569968|158216509|FG001|Overall Study|Quarantine|0|||
49103985|NCT04569968|158216508|FG000|Overall Study|Previous recruitment to the expiratory muscle training|2|||
49103986|NCT04569968|158216509|FG001|Overall Study|Previous recruitment to the expiratory muscle training|0|||
49103987|NCT04569968|158216508|FG000|Overall Study|Repetitive stroke|8|||
49103988|NCT04569968|158216509|FG001|Overall Study|Repetitive stroke|0|||
49103989|NCT04569968|158216508|FG000|Overall Study|Insufficient mastication|1|||
49103990|NCT04569968|158216509|FG001|Overall Study|Insufficient mastication|0|||
49103991|NCT04569968|158216508|FG000|Overall Study|Infection|1|||
49103992|NCT04569968|158216509|FG001|Overall Study|Infection|0|||
49103993|NCT01546168|158216510|FG000|Overall Study|Lost to Follow-up|1|||
49103994|NCT01546168|158216511|FG001|Overall Study|Lost to Follow-up|0|||
49103995|NCT01546168|158216510|FG000|Overall Study|Withdrawal by Subject|1|||
49103996|NCT01546168|158216511|FG001|Overall Study|Withdrawal by Subject|0|||
49103997|NCT01546168|158216510|FG000|Overall Study|ineligible after signing consent|2|||
49103998|NCT01546168|158216511|FG001|Overall Study|ineligible after signing consent|0|||
49103999|NCT02370667|158216512|FG000|Overall Study|Lost to Follow-up|0|||
49104000|NCT02370667|158216513|FG001|Overall Study|Lost to Follow-up|1|||
49104001|NCT02370667|158216514|FG002|Overall Study|Lost to Follow-up|0|||
49104002|NCT02052596|158216515|FG000|Active Phase|Adverse Event|3|||
49104003|NCT02052596|158216516|FG001|Active Phase|Adverse Event|2|||
49104004|NCT02052596|158216515|FG000|Active Phase|Lost to Follow-up|8|||
49104005|NCT02052596|158216516|FG001|Active Phase|Lost to Follow-up|11|||
49104006|NCT02052596|158216515|FG000|Active Phase|Protocol Violation|1|||
49104007|NCT02052596|158216516|FG001|Active Phase|Protocol Violation|2|||
49104008|NCT02052596|158216515|FG000|Active Phase|Withdrawal by Subject|3|||
49104009|NCT02052596|158216516|FG001|Active Phase|Withdrawal by Subject|4|||
49104010|NCT02052596|158216515|FG000|Active Phase|Enrolled in error|1|||
49104011|NCT02052596|158216516|FG001|Active Phase|Enrolled in error|0|||
49104012|NCT02052596|158216515|FG000|Active Phase|Lost due to Crohn's disease|0|||
49104013|NCT02052596|158216516|FG001|Active Phase|Lost due to Crohn's disease|1|||
49104014|NCT02052596|158216515|FG000|Safety Phase|Adverse Event|6|||
49104015|NCT02052596|158216516|FG001|Safety Phase|Adverse Event|3|||
49104016|NCT02052596|158216515|FG000|Safety Phase|Lost to Follow-up|11|||
49104017|NCT02052596|158216516|FG001|Safety Phase|Lost to Follow-up|18|||
49104018|NCT02052596|158216515|FG000|Safety Phase|Protocol Violation|1|||
49104019|NCT02052596|158216516|FG001|Safety Phase|Protocol Violation|2|||
49104020|NCT02052596|158216515|FG000|Safety Phase|Withdrawal by Subject|8|||
49104021|NCT02052596|158216516|FG001|Safety Phase|Withdrawal by Subject|11|||
49104022|NCT02052596|158216515|FG000|Safety Phase|Enrolled in error|1|||
49104023|NCT02052596|158216516|FG001|Safety Phase|Enrolled in error|0|||
49104024|NCT02052596|158216515|FG000|Safety Phase|Lost due to Crohn's disease|0|||
49104025|NCT02052596|158216516|FG001|Safety Phase|Lost due to Crohn's disease|1|||
49104026|NCT02850016|158216519|FG000|Overall Study|Withdrawal by Subject|1|||
49104027|NCT02850016|158216520|FG001|Overall Study|Withdrawal by Subject|2|||
49104028|NCT00558896|158216521|FG000|Overall Study|Adverse Event|1|||
49104029|NCT00558896|158216522|FG001|Overall Study|Adverse Event|1|||
49104030|NCT00558896|158216523|FG002|Overall Study|Adverse Event|1|||
49104031|NCT00558896|158216524|FG003|Overall Study|Adverse Event|3|||
49104032|NCT00558896|158216525|FG004|Overall Study|Adverse Event|4|||
49104033|NCT00558896|158216526|FG005|Overall Study|Adverse Event|10|||
49104034|NCT00558896|158216527|FG006|Overall Study|Adverse Event|3|||
49104035|NCT00558896|158216521|FG000|Overall Study|Death|3|||
49104036|NCT00558896|158216522|FG001|Overall Study|Death|0|||
49104037|NCT00558896|158216523|FG002|Overall Study|Death|2|||
49104038|NCT00558896|158216524|FG003|Overall Study|Death|3|||
49104039|NCT00558896|158216525|FG004|Overall Study|Death|2|||
49104040|NCT00558896|158216526|FG005|Overall Study|Death|2|||
49104041|NCT00558896|158216527|FG006|Overall Study|Death|6|||
49104042|NCT00558896|158216521|FG000|Overall Study|Withdrawal by Subject|2|||
49104043|NCT00558896|158216522|FG001|Overall Study|Withdrawal by Subject|1|||
49104044|NCT00558896|158216523|FG002|Overall Study|Withdrawal by Subject|1|||
49104045|NCT00558896|158216524|FG003|Overall Study|Withdrawal by Subject|1|||
49104046|NCT00558896|158216525|FG004|Overall Study|Withdrawal by Subject|1|||
49104047|NCT00558896|158216526|FG005|Overall Study|Withdrawal by Subject|5|||
49104048|NCT00558896|158216527|FG006|Overall Study|Withdrawal by Subject|5|||
49104049|NCT00558896|158216521|FG000|Overall Study|Alternative Treatment|2|||
49104050|NCT00558896|158216522|FG001|Overall Study|Alternative Treatment|2|||
49104051|NCT00558896|158216523|FG002|Overall Study|Alternative Treatment|0|||
49104052|NCT00558896|158216524|FG003|Overall Study|Alternative Treatment|2|||
49104053|NCT00558896|158216525|FG004|Overall Study|Alternative Treatment|6|||
49104054|NCT00558896|158216526|FG005|Overall Study|Alternative Treatment|7|||
49104055|NCT00558896|158216527|FG006|Overall Study|Alternative Treatment|1|||
49104056|NCT00558896|158216521|FG000|Overall Study|Physician discretion|3|||
49104057|NCT00558896|158216522|FG001|Overall Study|Physician discretion|2|||
49104058|NCT00558896|158216523|FG002|Overall Study|Physician discretion|1|||
49104059|NCT00558896|158216524|FG003|Overall Study|Physician discretion|2|||
49104060|NCT00558896|158216525|FG004|Overall Study|Physician discretion|1|||
49104061|NCT00558896|158216526|FG005|Overall Study|Physician discretion|3|||
49104062|NCT00558896|158216527|FG006|Overall Study|Physician discretion|3|||
49104063|NCT00558896|158216521|FG000|Overall Study|Continues on treatment|10|||
49104064|NCT00558896|158216522|FG001|Overall Study|Continues on treatment|1|||
49104065|NCT00558896|158216523|FG002|Overall Study|Continues on treatment|0|||
49104066|NCT00558896|158216524|FG003|Overall Study|Continues on treatment|1|||
49104067|NCT00558896|158216525|FG004|Overall Study|Continues on treatment|9|||
49104068|NCT00558896|158216526|FG005|Overall Study|Continues on treatment|25|||
49104069|NCT00558896|158216527|FG006|Overall Study|Continues on treatment|6|||
49104070|NCT03536949|158216528|FG000|Overall Study|Adverse Event|4|||
49104071|NCT03536949|158216529|FG001|Overall Study|Adverse Event|0|||
49104072|NCT03536949|158216528|FG000|Overall Study|Lost to Follow-up|2|||
49104073|NCT03536949|158216529|FG001|Overall Study|Lost to Follow-up|1|||
49104074|NCT03536949|158216528|FG000|Overall Study|Withdrawal by Subject|6|||
49104075|NCT03536949|158216529|FG001|Overall Study|Withdrawal by Subject|0|||
49104076|NCT03536949|158216528|FG000|Overall Study|Non-compliance|2|||
49104077|NCT03536949|158216529|FG001|Overall Study|Non-compliance|1|||
49104078|NCT02457832|158216530|FG000|Training|Lost to Follow-up|10|||
49104079|NCT02457832|158216531|FG001|Training|Lost to Follow-up|6|||
49104080|NCT02457832|158216532|FG002|Training|Lost to Follow-up|3|||
49104081|NCT02457832|158216530|FG000|One Month Washout|Lost to Follow-up|0|||
49104082|NCT02457832|158216531|FG001|One Month Washout|Lost to Follow-up|1|||
49104083|NCT02457832|158216532|FG002|One Month Washout|Lost to Follow-up|1|||
49104084|NCT02954653|158216536|FG000|Overall Study|Death|3|||
49104085|NCT02954653|158216537|FG001|Overall Study|Death|1|||
49104086|NCT02954653|158216538|FG002|Overall Study|Death|0|||
49104087|NCT02954653|158216539|FG003|Overall Study|Death|0|||
49104088|NCT02954653|158216540|FG004|Overall Study|Death|0|||
49104089|NCT02954653|158216541|FG005|Overall Study|Death|0|||
49104090|NCT02954653|158216542|FG006|Overall Study|Death|0|||
49104091|NCT02954653|158216543|FG007|Overall Study|Death|0|||
49104092|NCT02954653|158216544|FG008|Overall Study|Death|0|||
49104093|NCT02954653|158216536|FG000|Overall Study|Randomized but did not receive treatment|1|||
49104094|NCT02954653|158216537|FG001|Overall Study|Randomized but did not receive treatment|0|||
49104095|NCT02954653|158216538|FG002|Overall Study|Randomized but did not receive treatment|0|||
49104096|NCT02954653|158216539|FG003|Overall Study|Randomized but did not receive treatment|0|||
49104097|NCT02954653|158216540|FG004|Overall Study|Randomized but did not receive treatment|0|||
49104098|NCT02954653|158216541|FG005|Overall Study|Randomized but did not receive treatment|0|||
49104099|NCT02954653|158216542|FG006|Overall Study|Randomized but did not receive treatment|0|||
49104100|NCT02954653|158216543|FG007|Overall Study|Randomized but did not receive treatment|0|||
49104101|NCT02954653|158216544|FG008|Overall Study|Randomized but did not receive treatment|0|||
49104102|NCT02954653|158216536|FG000|Overall Study|Started another anti-cancer therapy|0|||
49104103|NCT02954653|158216537|FG001|Overall Study|Started another anti-cancer therapy|1|||
49104104|NCT02954653|158216538|FG002|Overall Study|Started another anti-cancer therapy|0|||
49104105|NCT02954653|158216539|FG003|Overall Study|Started another anti-cancer therapy|0|||
49104106|NCT02954653|158216540|FG004|Overall Study|Started another anti-cancer therapy|0|||
49104107|NCT02954653|158216541|FG005|Overall Study|Started another anti-cancer therapy|0|||
49104108|NCT02954653|158216542|FG006|Overall Study|Started another anti-cancer therapy|0|||
49104109|NCT02954653|158216543|FG007|Overall Study|Started another anti-cancer therapy|0|||
49104110|NCT02954653|158216544|FG008|Overall Study|Started another anti-cancer therapy|0|||
49104111|NCT02954653|158216536|FG000|Overall Study|Treatment failure and consent withdrawal|0|||
49104112|NCT02954653|158216537|FG001|Overall Study|Treatment failure and consent withdrawal|1|||
49104113|NCT02954653|158216538|FG002|Overall Study|Treatment failure and consent withdrawal|0|||
49104114|NCT02954653|158216539|FG003|Overall Study|Treatment failure and consent withdrawal|0|||
49104115|NCT02954653|158216540|FG004|Overall Study|Treatment failure and consent withdrawal|0|||
49104116|NCT02954653|158216541|FG005|Overall Study|Treatment failure and consent withdrawal|0|||
49104117|NCT02954653|158216542|FG006|Overall Study|Treatment failure and consent withdrawal|0|||
49104118|NCT02954653|158216543|FG007|Overall Study|Treatment failure and consent withdrawal|0|||
49104119|NCT02954653|158216544|FG008|Overall Study|Treatment failure and consent withdrawal|0|||
49104120|NCT00250458|158216545|FG000|Overall Study|Lost to Follow-up|4|||
49104121|NCT00250458|158216546|FG001|Overall Study|Lost to Follow-up|2|||
49104122|NCT00250458|158216545|FG000|Overall Study|Protocol Violation|0|||
49104123|NCT00250458|158216546|FG001|Overall Study|Protocol Violation|1|||
49104124|NCT00250458|158216545|FG000|Overall Study|Withdrawal by Subject|4|||
49104125|NCT00250458|158216546|FG001|Overall Study|Withdrawal by Subject|2|||
49104126|NCT00250458|158216545|FG000|Overall Study|Lack of Migraine Attack|20|||
49104127|NCT00250458|158216546|FG001|Overall Study|Lack of Migraine Attack|9|||
49104128|NCT00250458|158216545|FG000|Overall Study|Qualifying migraine but did not treat|3|||
49104129|NCT00250458|158216546|FG001|Overall Study|Qualifying migraine but did not treat|3|||
49104130|NCT00250458|158216545|FG000|Overall Study|Other|1|||
49104131|NCT00250458|158216546|FG001|Overall Study|Other|0|||
49104132|NCT06137703|158216547|FG000|Overall Study|Other|0|||
49104133|NCT06137703|158216548|FG001|Overall Study|Other|1|||
49104134|NCT06137703|158216549|FG002|Overall Study|Other|0|||
49104135|NCT06137703|158216550|FG003|Overall Study|Other|0|||
49104136|NCT06137703|158216547|FG000|Overall Study|Adverse Event|0|||
49104137|NCT06137703|158216548|FG001|Overall Study|Adverse Event|0|||
49104138|NCT06137703|158216549|FG002|Overall Study|Adverse Event|1|||
49104139|NCT06137703|158216550|FG003|Overall Study|Adverse Event|0|||
49104140|NCT03054064|158216551|FG000|Overall Study|Lower Extremity Deep Vein Thrombosis|1|||
49104141|NCT03054064|158216551|FG000|Overall Study|Investigator Decision|2|||
49104142|NCT03054064|158216551|FG000|Overall Study|Bladder Issue|1|||
49104143|NCT03054064|158216551|FG000|Overall Study|High Blood Pressure|1|||
49104144|NCT03054064|158216551|FG000|Overall Study|Change in Status|1|||
49104145|NCT00387010|158216567|FG000|Dose Titration Period|Adverse Event|12|||
49104146|NCT00387010|158216567|FG000|Dose Titration Period|Lack of Efficacy|5|||
49104147|NCT00387010|158216567|FG000|Dose Titration Period|Withdrawal by Subject|3|||
49104148|NCT00387010|158216567|FG000|Dose Titration Period|Protocol Violation|1|||
49104149|NCT00387010|158216567|FG000|Dose Titration Period|Lost to Follow-up|2|||
49104150|NCT00387010|158216567|FG000|Dose Titration Period|Noncompliance with study medication|8|||
49104151|NCT00387010|158216567|FG000|Dose Titration Period|Noncompliance with study procedures|7|||
49104152|NCT00387010|158216567|FG000|Treatment Period|Adverse Event|4|||
49104153|NCT00387010|158216567|FG000|Treatment Period|Withdrawal by Subject|1|||
49104154|NCT00387010|158216567|FG000|Treatment Period|Noncompliance with study medication|2|||
49104155|NCT00387010|158216567|FG000|Treatment Period|Noncompliance with study procedures|3|||
49104156|NCT00387010|158216567|FG000|Treatment Period|Participant reported study drug stolen|1|||
49104157|NCT00520481|158216568|FG000|Overall Study|Adverse Event|4|||
49104158|NCT00520481|158216569|FG001|Overall Study|Adverse Event|1|||
49104159|NCT00520481|158216568|FG000|Overall Study|Withdrawal by Subject|3|||
49104160|NCT00520481|158216569|FG001|Overall Study|Withdrawal by Subject|0|||
49104161|NCT00835679|158216570|FG000|Overall Study|Withdrawal by Subject|1|||
49104162|NCT00835679|158216571|FG001|Overall Study|Withdrawal by Subject|0|||
49104163|NCT00835679|158216572|FG002|Overall Study|Withdrawal by Subject|0|||
49104164|NCT00835679|158216573|FG003|Overall Study|Withdrawal by Subject|0|||
49104165|NCT00990665|158216576|FG000|Overall Study|Unsuccessful Implant|8|||
49104166|NCT00990665|158216576|FG000|Overall Study|Death|29|||
49104167|NCT00990665|158216576|FG000|Overall Study|Heart Transplant|1|||
49104168|NCT00990665|158216576|FG000|Overall Study|Withdrawal by Subject|6|||
49104169|NCT00990665|158216576|FG000|Overall Study|Lost to Follow-up|1|||
49104170|NCT00990665|158216576|FG000|Overall Study|System Explant|3|||
49104171|NCT02079636|158216577|FG000|Overall Study|Death|2|||
49104172|NCT02079636|158216578|FG001|Overall Study|Death|1|||
49104173|NCT02079636|158216579|FG002|Overall Study|Death|0|||
49104174|NCT02079636|158216580|FG003|Overall Study|Death|5|||
49104175|NCT02079636|158216581|FG004|Overall Study|Death|1|||
49104176|NCT02079636|158216582|FG005|Overall Study|Death|2|||
49104177|NCT02079636|158216583|FG006|Overall Study|Death|1|||
49104178|NCT02079636|158216584|FG007|Overall Study|Death|0|||
49104179|NCT02079636|158216585|FG008|Overall Study|Death|0|||
49104180|NCT02079636|158216586|FG009|Overall Study|Death|0|||
49104181|NCT02079636|158216587|FG010|Overall Study|Death|0|||
49104182|NCT02079636|158216588|FG011|Overall Study|Death|1|||
49104183|NCT02079636|158216589|FG012|Overall Study|Death|1|||
49104184|NCT02079636|158216590|FG013|Overall Study|Death|0|||
49104185|NCT02079636|158216591|FG014|Overall Study|Death|2|||
49104186|NCT02079636|158216577|FG000|Overall Study|Adverse Event|1|||
49104187|NCT02079636|158216578|FG001|Overall Study|Adverse Event|1|||
49104188|NCT02079636|158216579|FG002|Overall Study|Adverse Event|0|||
49104189|NCT02079636|158216580|FG003|Overall Study|Adverse Event|1|||
49104190|NCT02079636|158216581|FG004|Overall Study|Adverse Event|1|||
49104191|NCT02079636|158216582|FG005|Overall Study|Adverse Event|2|||
49104192|NCT02079636|158216583|FG006|Overall Study|Adverse Event|0|||
49104193|NCT02079636|158216584|FG007|Overall Study|Adverse Event|0|||
49104194|NCT02079636|158216585|FG008|Overall Study|Adverse Event|0|||
49104195|NCT02079636|158216586|FG009|Overall Study|Adverse Event|0|||
49104196|NCT02079636|158216587|FG010|Overall Study|Adverse Event|0|||
49104197|NCT02079636|158216588|FG011|Overall Study|Adverse Event|0|||
49104198|NCT02079636|158216589|FG012|Overall Study|Adverse Event|0|||
49104199|NCT02079636|158216590|FG013|Overall Study|Adverse Event|0|||
49104200|NCT02079636|158216591|FG014|Overall Study|Adverse Event|0|||
49104201|NCT02079636|158216577|FG000|Overall Study|Progressive disease|0|||
49104202|NCT02079636|158216578|FG001|Overall Study|Progressive disease|0|||
49104203|NCT02079636|158216579|FG002|Overall Study|Progressive disease|0|||
49104204|NCT02079636|158216580|FG003|Overall Study|Progressive disease|2|||
49104205|NCT02079636|158216581|FG004|Overall Study|Progressive disease|0|||
49104206|NCT02079636|158216582|FG005|Overall Study|Progressive disease|0|||
49104207|NCT02079636|158216583|FG006|Overall Study|Progressive disease|0|||
49104208|NCT02079636|158216584|FG007|Overall Study|Progressive disease|0|||
49104209|NCT02079636|158216585|FG008|Overall Study|Progressive disease|0|||
49104210|NCT02079636|158216586|FG009|Overall Study|Progressive disease|0|||
49104211|NCT02079636|158216587|FG010|Overall Study|Progressive disease|0|||
49104212|NCT02079636|158216588|FG011|Overall Study|Progressive disease|0|||
49104213|NCT02079636|158216589|FG012|Overall Study|Progressive disease|1|||
49104214|NCT02079636|158216590|FG013|Overall Study|Progressive disease|0|||
49104215|NCT02079636|158216591|FG014|Overall Study|Progressive disease|0|||
49104216|NCT02079636|158216577|FG000|Overall Study|Withdrawal by Subject|0|||
49104217|NCT02079636|158216578|FG001|Overall Study|Withdrawal by Subject|0|||
49104218|NCT02079636|158216579|FG002|Overall Study|Withdrawal by Subject|0|||
49104219|NCT02079636|158216580|FG003|Overall Study|Withdrawal by Subject|4|||
49104220|NCT02079636|158216581|FG004|Overall Study|Withdrawal by Subject|0|||
49104221|NCT02079636|158216582|FG005|Overall Study|Withdrawal by Subject|1|||
49104222|NCT02079636|158216583|FG006|Overall Study|Withdrawal by Subject|0|||
49104223|NCT02079636|158216584|FG007|Overall Study|Withdrawal by Subject|0|||
49104224|NCT02079636|158216585|FG008|Overall Study|Withdrawal by Subject|0|||
49104225|NCT02079636|158216586|FG009|Overall Study|Withdrawal by Subject|2|||
49104226|NCT02079636|158216587|FG010|Overall Study|Withdrawal by Subject|1|||
49104227|NCT02079636|158216588|FG011|Overall Study|Withdrawal by Subject|1|||
49104228|NCT02079636|158216589|FG012|Overall Study|Withdrawal by Subject|1|||
49104229|NCT02079636|158216590|FG013|Overall Study|Withdrawal by Subject|0|||
49104230|NCT02079636|158216591|FG014|Overall Study|Withdrawal by Subject|2|||
49104231|NCT02079636|158216577|FG000|Overall Study|Physician Decision|0|||
49104232|NCT02079636|158216578|FG001|Overall Study|Physician Decision|0|||
49104233|NCT02079636|158216579|FG002|Overall Study|Physician Decision|0|||
49104234|NCT02079636|158216580|FG003|Overall Study|Physician Decision|0|||
49104235|NCT02079636|158216581|FG004|Overall Study|Physician Decision|0|||
49104236|NCT02079636|158216582|FG005|Overall Study|Physician Decision|1|||
49104237|NCT02079636|158216583|FG006|Overall Study|Physician Decision|0|||
49104238|NCT02079636|158216584|FG007|Overall Study|Physician Decision|0|||
49104239|NCT02079636|158216585|FG008|Overall Study|Physician Decision|0|||
49104240|NCT02079636|158216586|FG009|Overall Study|Physician Decision|1|||
49104241|NCT02079636|158216587|FG010|Overall Study|Physician Decision|1|||
49104242|NCT02079636|158216588|FG011|Overall Study|Physician Decision|0|||
49104243|NCT02079636|158216589|FG012|Overall Study|Physician Decision|0|||
49104244|NCT02079636|158216590|FG013|Overall Study|Physician Decision|0|||
49104245|NCT02079636|158216591|FG014|Overall Study|Physician Decision|1|||
49104246|NCT02079636|158216577|FG000|Overall Study|Lost to Follow-up|0|||
49104247|NCT02079636|158216578|FG001|Overall Study|Lost to Follow-up|0|||
49104248|NCT02079636|158216579|FG002|Overall Study|Lost to Follow-up|0|||
49104249|NCT02079636|158216580|FG003|Overall Study|Lost to Follow-up|0|||
49104250|NCT02079636|158216581|FG004|Overall Study|Lost to Follow-up|0|||
49104251|NCT02079636|158216582|FG005|Overall Study|Lost to Follow-up|0|||
49104252|NCT02079636|158216583|FG006|Overall Study|Lost to Follow-up|0|||
49104253|NCT02079636|158216584|FG007|Overall Study|Lost to Follow-up|1|||
49104254|NCT02079636|158216585|FG008|Overall Study|Lost to Follow-up|0|||
49104255|NCT02079636|158216586|FG009|Overall Study|Lost to Follow-up|0|||
49104256|NCT02079636|158216587|FG010|Overall Study|Lost to Follow-up|0|||
49104257|NCT02079636|158216588|FG011|Overall Study|Lost to Follow-up|0|||
49104258|NCT02079636|158216589|FG012|Overall Study|Lost to Follow-up|0|||
49104259|NCT02079636|158216590|FG013|Overall Study|Lost to Follow-up|0|||
49104260|NCT02079636|158216591|FG014|Overall Study|Lost to Follow-up|0|||
49104261|NCT01524783|158216592|FG000|Blinded Period|Adverse Event|64|||
49104262|NCT01524783|158216593|FG001|Blinded Period|Adverse Event|7|||
49104263|NCT01524783|158216594|FG002|Blinded Period|Adverse Event|0|||
49104264|NCT01524783|158216592|FG000|Blinded Period|Disease Progression|89|||
49104265|NCT01524783|158216593|FG001|Blinded Period|Disease Progression|75|||
49104266|NCT01524783|158216594|FG002|Blinded Period|Disease Progression|0|||
49104267|NCT01524783|158216592|FG000|Blinded Period|Withdrawal by Subject|19|||
49104268|NCT01524783|158216593|FG001|Blinded Period|Withdrawal by Subject|6|||
49104269|NCT01524783|158216594|FG002|Blinded Period|Withdrawal by Subject|0|||
49104270|NCT01524783|158216592|FG000|Blinded Period|Protocol deviation|2|||
49104271|NCT01524783|158216593|FG001|Blinded Period|Protocol deviation|1|||
49104272|NCT01524783|158216594|FG002|Blinded Period|Protocol deviation|0|||
49104273|NCT01524783|158216592|FG000|Blinded Period|Death|5|||
49104274|NCT01524783|158216593|FG001|Blinded Period|Death|2|||
49104275|NCT01524783|158216594|FG002|Blinded Period|Death|0|||
49104276|NCT01524783|158216592|FG000|Open-label Period|Disease progression|13|||
49104277|NCT01524783|158216593|FG001|Open-label Period|Disease progression|0|||
49104278|NCT01524783|158216594|FG002|Open-label Period|Disease progression|2|||
49104279|NCT01524783|158216592|FG000|Open-label Period|Administrative problems|5|||
49104280|NCT01524783|158216593|FG001|Open-label Period|Administrative problems|0|||
49104281|NCT01524783|158216594|FG002|Open-label Period|Administrative problems|2|||
49104282|NCT01524783|158216592|FG000|Open-label Period|Adverse Event|5|||
49104283|NCT01524783|158216593|FG001|Open-label Period|Adverse Event|0|||
49104284|NCT01524783|158216594|FG002|Open-label Period|Adverse Event|1|||
49104285|NCT01524783|158216592|FG000|Open-label Period|Withdrawal by Subject|2|||
49104286|NCT01524783|158216593|FG001|Open-label Period|Withdrawal by Subject|0|||
49104287|NCT01524783|158216594|FG002|Open-label Period|Withdrawal by Subject|1|||
49104288|NCT01524783|158216592|FG000|Open-label Period|Protocol deviation|1|||
49104289|NCT01524783|158216593|FG001|Open-label Period|Protocol deviation|0|||
49104290|NCT01524783|158216594|FG002|Open-label Period|Protocol deviation|0|||
49104291|NCT01797081|158216597|FG000|Overall Study|Adverse Event|1|||
49104292|NCT01797081|158216598|FG001|Overall Study|Adverse Event|0|||
49104293|NCT01797081|158216599|FG002|Overall Study|Adverse Event|1|||
49104294|NCT01797081|158216600|FG003|Overall Study|Adverse Event|0|||
49104295|NCT01797081|158216597|FG000|Overall Study|Pregnancy|1|||
49104296|NCT01797081|158216598|FG001|Overall Study|Pregnancy|0|||
49104297|NCT01797081|158216599|FG002|Overall Study|Pregnancy|0|||
49104298|NCT01797081|158216600|FG003|Overall Study|Pregnancy|0|||
49104299|NCT01797081|158216597|FG000|Overall Study|Personal Reasons|12|||
49104300|NCT01797081|158216598|FG001|Overall Study|Personal Reasons|4|||
49104301|NCT01797081|158216599|FG002|Overall Study|Personal Reasons|4|||
49104302|NCT01797081|158216600|FG003|Overall Study|Personal Reasons|8|||
49104303|NCT01797081|158216597|FG000|Overall Study|Protocol Violation|0|||
49104304|NCT01797081|158216598|FG001|Overall Study|Protocol Violation|0|||
49104305|NCT01797081|158216599|FG002|Overall Study|Protocol Violation|0|||
49104306|NCT01797081|158216600|FG003|Overall Study|Protocol Violation|1|||
49104307|NCT01253174|158216601|FG000|Period 1|Randomized but not treated|0|||
49104308|NCT01253174|158216602|FG001|Period 1|Randomized but not treated|1|||
49104309|NCT01253174|158216603|FG002|Period 1|Randomized but not treated|1|||
49104310|NCT01253174|158216604|FG003|Period 1|Randomized but not treated|0|||
49104311|NCT01253174|158216605|FG004|Period 1|Randomized but not treated|1|||
49104312|NCT01253174|158216606|FG005|Period 1|Randomized but not treated|0|||
49104313|NCT01253174|158216601|FG000|Period 2|Adverse Event|0|||
49104314|NCT01253174|158216602|FG001|Period 2|Adverse Event|0|||
49104315|NCT01253174|158216603|FG002|Period 2|Adverse Event|1|||
49104316|NCT01253174|158216604|FG003|Period 2|Adverse Event|0|||
49104317|NCT01253174|158216605|FG004|Period 2|Adverse Event|0|||
49104318|NCT01253174|158216606|FG005|Period 2|Adverse Event|0|||
49104319|NCT01253174|158216601|FG000|Period 3|Withdrawal by Subject|0|||
49104320|NCT01253174|158216602|FG001|Period 3|Withdrawal by Subject|1|||
49104321|NCT01253174|158216603|FG002|Period 3|Withdrawal by Subject|0|||
49104322|NCT01253174|158216604|FG003|Period 3|Withdrawal by Subject|0|||
49104323|NCT01253174|158216605|FG004|Period 3|Withdrawal by Subject|1|||
49104324|NCT01253174|158216606|FG005|Period 3|Withdrawal by Subject|0|||
49104325|NCT01253174|158216601|FG000|Period 3|Pregnancy|0|||
49104326|NCT01253174|158216602|FG001|Period 3|Pregnancy|0|||
49104327|NCT01253174|158216603|FG002|Period 3|Pregnancy|1|||
49104328|NCT01253174|158216604|FG003|Period 3|Pregnancy|0|||
49104329|NCT01253174|158216605|FG004|Period 3|Pregnancy|0|||
49104330|NCT01253174|158216606|FG005|Period 3|Pregnancy|0|||
49104331|NCT05153148|158216607|FG000|Overall Study|Adverse Event|1|||
49104332|NCT05153148|158216608|FG001|Overall Study|Adverse Event|0|||
49104333|NCT05153148|158216609|FG002|Overall Study|Adverse Event|3|||
49104334|NCT05153148|158216610|FG003|Overall Study|Adverse Event|5|||
49104335|NCT05153148|158216607|FG000|Overall Study|Lost to Follow-up|1|||
49104336|NCT05153148|158216608|FG001|Overall Study|Lost to Follow-up|1|||
49104337|NCT05153148|158216609|FG002|Overall Study|Lost to Follow-up|2|||
49104338|NCT05153148|158216610|FG003|Overall Study|Lost to Follow-up|0|||
49104339|NCT05153148|158216607|FG000|Overall Study|Withdrawal by Subject|6|||
49104340|NCT05153148|158216608|FG001|Overall Study|Withdrawal by Subject|8|||
49104341|NCT05153148|158216609|FG002|Overall Study|Withdrawal by Subject|6|||
49104342|NCT05153148|158216610|FG003|Overall Study|Withdrawal by Subject|8|||
49104343|NCT05153148|158216607|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
49104344|NCT05153148|158216608|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
49104345|NCT05153148|158216609|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19)|1|||
49104346|NCT05153148|158216610|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
49104347|NCT05153148|158216607|FG000|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
49104348|NCT05153148|158216608|FG001|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
49104349|NCT05153148|158216609|FG002|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
49104350|NCT05153148|158216610|FG003|Overall Study|Randomized Without Dosing due to Ineligibility|2|||
49104351|NCT05153148|158216607|FG000|Overall Study|Reason not Specified|1|||
49104352|NCT05153148|158216608|FG001|Overall Study|Reason not Specified|1|||
49104353|NCT05153148|158216609|FG002|Overall Study|Reason not Specified|1|||
49104354|NCT05153148|158216610|FG003|Overall Study|Reason not Specified|1|||
49104355|NCT02345889|158216611|FG000|Overall Study|Inadequate Bowel Prep|17|||
49104356|NCT02345889|158216612|FG001|Overall Study|Inadequate Bowel Prep|16|||
49104357|NCT02345889|158216613|FG002|Overall Study|Inadequate Bowel Prep|18|||
49104358|NCT02345889|158216614|FG003|Overall Study|Inadequate Bowel Prep|14|||
49104359|NCT02345889|158216611|FG000|Overall Study|Polyposis identified during procedure|1|||
49104360|NCT02345889|158216612|FG001|Overall Study|Polyposis identified during procedure|1|||
49104361|NCT02345889|158216613|FG002|Overall Study|Polyposis identified during procedure|0|||
49104362|NCT02345889|158216614|FG003|Overall Study|Polyposis identified during procedure|1|||
49104363|NCT02345889|158216611|FG000|Overall Study|Recognized ineligible post-randomization|1|||
49104364|NCT02345889|158216612|FG001|Overall Study|Recognized ineligible post-randomization|0|||
49104365|NCT02345889|158216613|FG002|Overall Study|Recognized ineligible post-randomization|2|||
49104366|NCT02345889|158216614|FG003|Overall Study|Recognized ineligible post-randomization|1|||
49104367|NCT02345889|158216611|FG000|Overall Study|Ulcerative Colitis identified|1|||
49104368|NCT02345889|158216612|FG001|Overall Study|Ulcerative Colitis identified|0|||
49104369|NCT02345889|158216613|FG002|Overall Study|Ulcerative Colitis identified|0|||
49104370|NCT02345889|158216614|FG003|Overall Study|Ulcerative Colitis identified|0|||
49104371|NCT02345889|158216611|FG000|Overall Study|Cecum not intubated|1|||
49104372|NCT02345889|158216612|FG001|Overall Study|Cecum not intubated|0|||
49104373|NCT02345889|158216613|FG002|Overall Study|Cecum not intubated|0|||
49104374|NCT02345889|158216614|FG003|Overall Study|Cecum not intubated|0|||
49104375|NCT00358956|158216615|FG000|Overall Study|Adverse Event|3|||
49104376|NCT00358956|158216615|FG000|Overall Study|condition under investigation worsened|4|||
49104377|NCT00358956|158216615|FG000|Overall Study|Withdrawal by Subject|1|||
49104378|NCT03813147|158216616|FG000|Overall Study|Lack of Efficacy|4|||
49104379|NCT03813147|158216617|FG001|Overall Study|Lack of Efficacy|4|||
49104380|NCT03813147|158216616|FG000|Overall Study|Physician Decision|2|||
49104381|NCT03813147|158216617|FG001|Overall Study|Physician Decision|1|||
49104382|NCT04253782|158216618|FG000|Overall Study|Death|2|||
49104383|NCT04253782|158216619|FG001|Overall Study|Death|0|||
49104384|NCT04250350|158218349|FG000|Overall Study|Withdrawal by Subject|13|||
49104385|NCT04250350|158218349|FG000|Overall Study|Lost to Follow-up|8|||
49104386|NCT04250350|158218349|FG000|Overall Study|Adverse Event|5|||
49104387|NCT04250350|158218349|FG000|Overall Study|Lack of Efficacy|4|||
49104388|NCT04250350|158218349|FG000|Overall Study|Physician Decision|1|||
49104389|NCT04250350|158218349|FG000|Overall Study|Participant moved out of the country/non-compliance|3|||
49104390|NCT04161079|158218352|FG000|Clinical Investigation 2010-040|Adverse Event|1|||
49104391|NCT01279070|158218353|FG000|Overall Study|Withdrawal by Subject|2|||
49104392|NCT01279070|158218354|FG001|Overall Study|Withdrawal by Subject|3|||
49104393|NCT01279070|158218353|FG000|Overall Study|Acute exacerbation|3|||
49104394|NCT01279070|158218354|FG001|Overall Study|Acute exacerbation|1|||
49104395|NCT02086448|158218358|FG000|Overall Study|Withdrawal by Subject|1|||
49104396|NCT02086448|158218359|FG001|Overall Study|Withdrawal by Subject|0|||
49104397|NCT02086448|158218360|FG002|Overall Study|Withdrawal by Subject|0|||
49104398|NCT02086448|158218361|FG003|Overall Study|Withdrawal by Subject|2|||
49104399|NCT01446237|158218363|FG000|Overall Study|Adverse Event|1|||
49104400|NCT01446237|158218363|FG000|Overall Study|Lost to Follow-up|2|||
49104401|NCT01446237|158218363|FG000|Overall Study|Withdrawal by Subject|7|||
49104402|NCT00843037|158218364|FG000|Overall Study|Lost to Follow-up|1|||
49104403|NCT04829331|158218365|FG000|Overall Study|Lost to Follow-up|1|||
49104404|NCT04829331|158218366|FG001|Overall Study|Lost to Follow-up|0|||
49104405|NCT04329091|158218367|FG000|Overall Study|Physician Decision|5|||
49104406|NCT01741792|158218368|FG000|Overall Study|Death|6|||
49104407|NCT01741792|158218369|FG001|Overall Study|Death|1|||
49104408|NCT01741792|158218370|FG002|Overall Study|Death|12|||
49104409|NCT00423189|158218373|FG000|Overall Study|Death|0|||
49104410|NCT00423189|158218374|FG001|Overall Study|Death|1|||
49104411|NCT00423189|158218375|FG002|Overall Study|Death|0|||
49104412|NCT05323994|158218376|FG000|Overall Study|Protocol Violation|1|||
49104413|NCT00741091|158218377|FG000|Overall Study|Death|13|||
49104414|NCT00741091|158218377|FG000|Overall Study|Lost to Follow-up|16|||
49104415|NCT00741091|158218377|FG000|Overall Study|Withdrawal by Subject|6|||
49104416|NCT00741091|158218377|FG000|Overall Study|Missed Visit|22|||
49104417|NCT00460265|158218378|FG000|Overall Study|Lost to Follow-up|14|||
49104418|NCT00460265|158218379|FG001|Overall Study|Lost to Follow-up|15|||
49104419|NCT00460265|158218378|FG000|Overall Study|Physician Decision|1|||
49104420|NCT00460265|158218379|FG001|Overall Study|Physician Decision|2|||
49104421|NCT00460265|158218378|FG000|Overall Study|Withdrawal by Subject|10|||
49104422|NCT00460265|158218379|FG001|Overall Study|Withdrawal by Subject|25|||
49104423|NCT00460265|158218378|FG000|Overall Study|Ongoing|60|||
49104424|NCT00460265|158218379|FG001|Overall Study|Ongoing|47|||
49104425|NCT01801358|158218383|FG000|Overall Study|Adverse Event|0|||
49104426|NCT01801358|158218384|FG001|Overall Study|Adverse Event|2|||
49104427|NCT01801358|158218385|FG002|Overall Study|Adverse Event|1|||
49104428|NCT01801358|158218386|FG003|Overall Study|Adverse Event|0|||
49104429|NCT01801358|158218387|FG004|Overall Study|Adverse Event|0|||
49104430|NCT01801358|158218388|FG005|Overall Study|Adverse Event|1|||
49104431|NCT01801358|158218383|FG000|Overall Study|Physician Decision|0|||
49104432|NCT01801358|158218384|FG001|Overall Study|Physician Decision|0|||
49104433|NCT01801358|158218385|FG002|Overall Study|Physician Decision|1|||
49104434|NCT01801358|158218386|FG003|Overall Study|Physician Decision|0|||
49104435|NCT01801358|158218387|FG004|Overall Study|Physician Decision|0|||
49104436|NCT01801358|158218388|FG005|Overall Study|Physician Decision|0|||
49104437|NCT01801358|158218383|FG000|Overall Study|Progressive Disease|6|||
49104438|NCT01801358|158218384|FG001|Overall Study|Progressive Disease|4|||
49104439|NCT01801358|158218385|FG002|Overall Study|Progressive Disease|4|||
49104440|NCT01801358|158218386|FG003|Overall Study|Progressive Disease|5|||
49104441|NCT01801358|158218387|FG004|Overall Study|Progressive Disease|6|||
49104442|NCT01801358|158218388|FG005|Overall Study|Progressive Disease|5|||
49104443|NCT01801358|158218383|FG000|Overall Study|Withdrawal by Subject|0|||
49104444|NCT01801358|158218384|FG001|Overall Study|Withdrawal by Subject|0|||
49104445|NCT01801358|158218385|FG002|Overall Study|Withdrawal by Subject|0|||
49104446|NCT01801358|158218386|FG003|Overall Study|Withdrawal by Subject|1|||
49104447|NCT01801358|158218387|FG004|Overall Study|Withdrawal by Subject|0|||
49104448|NCT01801358|158218388|FG005|Overall Study|Withdrawal by Subject|2|||
49104449|NCT00622336|158218389|FG000|Treatment Phase|Progression of Disease|181|||
49104450|NCT00622336|158218389|FG000|Treatment Phase|Adverse Event|46|||
49104451|NCT00622336|158218389|FG000|Treatment Phase|Other|40|||
49104452|NCT00622336|158218389|FG000|Treatment Phase|Death|14|||
49104453|NCT00622336|158218389|FG000|Treatment Phase|Lack of therapeutic effect|13|||
49104454|NCT00622336|158218389|FG000|Treatment Phase|Withdrawal by Subject|13|||
49104455|NCT00622336|158218389|FG000|Treatment Phase|Lost to Follow-up|2|||
49104456|NCT00622336|158218389|FG000|Extension Phase|Adverse Event|2|||
49104457|NCT00622336|158218389|FG000|Extension Phase|Progressive Disease|6|||
49104458|NCT00622336|158218389|FG000|Extension Phase|Lack of therapeutic effect|2|||
49104459|NCT00622336|158218389|FG000|Extension Phase|Withdrawal by Subject|1|||
49104460|NCT00622336|158218389|FG000|Extension Phase|Lost to Follow-up|1|||
49104461|NCT00622336|158218389|FG000|Extension Phase|Other|9|||
49104462|NCT03787303|158218390|FG000|Overall Study|Death|1|||
49104463|NCT03787303|158218390|FG000|Overall Study|Premature Termination of Study|1|||
49104464|NCT01527487|158218395|FG000|Overall Study|MD Discretion/Lack of Efficacy|3|||
49104465|NCT01527487|158218396|FG001|Overall Study|MD Discretion/Lack of Efficacy|4|||
49104466|NCT01527487|158218395|FG000|Overall Study|Disease Progression|4|||
49104467|NCT01527487|158218396|FG001|Overall Study|Disease Progression|1|||
49104468|NCT01527487|158218395|FG000|Overall Study|Adverse Event|1|||
49104469|NCT01527487|158218396|FG001|Overall Study|Adverse Event|1|||
49104470|NCT01527487|158218395|FG000|Overall Study|Death|0|||
49104471|NCT01527487|158218396|FG001|Overall Study|Death|1|||
49104472|NCT01210495|158218399|FG000|Overall Study|Participant Refused Further Follow-Up|1|||
49104473|NCT01210495|158218400|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
49104474|NCT01210495|158218401|FG002|Overall Study|Participant Refused Further Follow-Up|11|||
49104475|NCT01210495|158218402|FG003|Overall Study|Participant Refused Further Follow-Up|2|||
49104476|NCT01210495|158218399|FG000|Overall Study|Death|14|||
49104477|NCT01210495|158218400|FG001|Overall Study|Death|7|||
49104478|NCT01210495|158218401|FG002|Overall Study|Death|112|||
49104479|NCT01210495|158218402|FG003|Overall Study|Death|54|||
49104480|NCT01210495|158218399|FG000|Overall Study|Study Terminated by Sponsor|0|||
49104481|NCT01210495|158218400|FG001|Overall Study|Study Terminated by Sponsor|0|||
49104482|NCT01210495|158218401|FG002|Overall Study|Study Terminated by Sponsor|4|||
49104483|NCT01210495|158218402|FG003|Overall Study|Study Terminated by Sponsor|11|||
49104484|NCT01210495|158218399|FG000|Overall Study|Lost to Follow-up|0|||
49104485|NCT01210495|158218400|FG001|Overall Study|Lost to Follow-up|0|||
49104486|NCT01210495|158218401|FG002|Overall Study|Lost to Follow-up|1|||
49104487|NCT01210495|158218402|FG003|Overall Study|Lost to Follow-up|1|||
49104488|NCT01210495|158218399|FG000|Overall Study|Other unspecified|0|||
49104489|NCT01210495|158218400|FG001|Overall Study|Other unspecified|0|||
49104490|NCT01210495|158218401|FG002|Overall Study|Other unspecified|6|||
49104491|NCT01210495|158218402|FG003|Overall Study|Other unspecified|0|||
49104492|NCT01459718|158218406|FG000|Overall Study|Physician Decision|1|||
49104493|NCT01459718|158218406|FG000|Overall Study|Lost to Follow-up|1|||
49104494|NCT01459718|158218406|FG000|Overall Study|Adverse Event|1|||
49104495|NCT00197002|158218407|FG000|Overall Study|Adverse Event|0|||
49104496|NCT00197002|158218408|FG001|Overall Study|Adverse Event|1|||
49104497|NCT00197002|158218409|FG002|Overall Study|Adverse Event|0|||
49104498|NCT00197002|158218407|FG000|Overall Study|Protocol Violation|1|||
49104499|NCT00197002|158218408|FG001|Overall Study|Protocol Violation|0|||
49104500|NCT00197002|158218409|FG002|Overall Study|Protocol Violation|2|||
49104501|NCT00197002|158218407|FG000|Overall Study|Withdrawal by Subject|9|||
49104502|NCT00197002|158218408|FG001|Overall Study|Withdrawal by Subject|5|||
49104503|NCT00197002|158218409|FG002|Overall Study|Withdrawal by Subject|7|||
49104504|NCT00197002|158218407|FG000|Overall Study|Migrated/moved from study area|3|||
49104505|NCT00197002|158218408|FG001|Overall Study|Migrated/moved from study area|5|||
49104506|NCT00197002|158218409|FG002|Overall Study|Migrated/moved from study area|1|||
49104507|NCT00197002|158218407|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
49104508|NCT00197002|158218408|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
49104509|NCT00197002|158218409|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|5|||
49104510|NCT00197002|158218407|FG000|Overall Study|Lost to follow-up (compl. vaccination)|2|||
49104511|NCT00197002|158218408|FG001|Overall Study|Lost to follow-up (compl. vaccination)|2|||
49104512|NCT00197002|158218409|FG002|Overall Study|Lost to follow-up (compl. vaccination)|1|||
49104513|NCT00197002|158218407|FG000|Overall Study|Others|3|||
49104514|NCT00197002|158218408|FG001|Overall Study|Others|1|||
49104515|NCT00197002|158218409|FG002|Overall Study|Others|1|||
49104516|NCT01149421|158218410|FG000|Overall Study|Adverse Event|22|||
49104517|NCT01149421|158218411|FG001|Overall Study|Adverse Event|6|||
49104518|NCT01149421|158218412|FG002|Overall Study|Adverse Event|11|||
49104519|NCT01149421|158218410|FG000|Overall Study|Withdrawal by Subject|20|||
49104520|NCT01149421|158218411|FG001|Overall Study|Withdrawal by Subject|12|||
49104521|NCT01149421|158218412|FG002|Overall Study|Withdrawal by Subject|13|||
49104522|NCT01149421|158218410|FG000|Overall Study|Sponsor Decision|0|||
49104523|NCT01149421|158218411|FG001|Overall Study|Sponsor Decision|1|||
49104524|NCT01149421|158218412|FG002|Overall Study|Sponsor Decision|1|||
49104525|NCT01149421|158218410|FG000|Overall Study|Lost to Follow-up|2|||
49104526|NCT01149421|158218411|FG001|Overall Study|Lost to Follow-up|4|||
49104527|NCT01149421|158218412|FG002|Overall Study|Lost to Follow-up|5|||
49104528|NCT01149421|158218410|FG000|Overall Study|Physician Decision|5|||
49104529|NCT01149421|158218411|FG001|Overall Study|Physician Decision|3|||
49104530|NCT01149421|158218412|FG002|Overall Study|Physician Decision|6|||
49104531|NCT01149421|158218410|FG000|Overall Study|Entry Criteria Not Met|1|||
49104532|NCT01149421|158218411|FG001|Overall Study|Entry Criteria Not Met|1|||
49104533|NCT01149421|158218412|FG002|Overall Study|Entry Criteria Not Met|2|||
49104534|NCT01149421|158218410|FG000|Overall Study|Protocol Violation|2|||
49104535|NCT01149421|158218411|FG001|Overall Study|Protocol Violation|2|||
49104536|NCT01149421|158218412|FG002|Overall Study|Protocol Violation|6|||
49104537|NCT00723190|158218413|FG000|Overall Study|Withdrawal by Subject|45|||
49104538|NCT00723190|158218413|FG000|Overall Study|Lost to Follow-up|37|||
49104539|NCT00723190|158218413|FG000|Overall Study|Adverse Event|18|||
49104540|NCT00723190|158218413|FG000|Overall Study|Lack of Efficacy|16|||
49104541|NCT00723190|158218413|FG000|Overall Study|Protocol Violation|15|||
49104542|NCT00723190|158218413|FG000|Overall Study|Other-Premature Discontinuation|9|||
49104543|NCT00723190|158218413|FG000|Overall Study|Other-Not included in safety population|2|||
49104544|NCT00454818|158218419|FG000|Phase I: Open-label Dose-escalation|Received heart transplant|1|||
49104545|NCT00454818|158218420|FG001|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
49104546|NCT00454818|158218421|FG002|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
49104547|NCT00454818|158218422|FG003|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
49104548|NCT00454818|158218423|FG004|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
49104549|NCT00454818|158218419|FG000|Phase I: Open-label Dose-escalation|Death|0|||
49104550|NCT00454818|158218420|FG001|Phase I: Open-label Dose-escalation|Death|1|||
49104551|NCT00454818|158218421|FG002|Phase I: Open-label Dose-escalation|Death|0|||
49104552|NCT00454818|158218422|FG003|Phase I: Open-label Dose-escalation|Death|0|||
49104553|NCT00454818|158218423|FG004|Phase I: Open-label Dose-escalation|Death|0|||
49104554|NCT00454818|158218419|FG000|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
49104555|NCT00454818|158218420|FG001|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
49104556|NCT00454818|158218421|FG002|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
49104557|NCT00454818|158218422|FG003|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
49104558|NCT00454818|158218423|FG004|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
49104559|NCT00454818|158218419|FG000|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
49104560|NCT00454818|158218420|FG001|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
49104561|NCT00454818|158218421|FG002|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
49104562|NCT00454818|158218422|FG003|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
49104563|NCT00454818|158218423|FG004|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
49104564|NCT00454818|158218419|FG000|Phase 2: Randomized Double-blind|Death|0|||
49104565|NCT00454818|158218420|FG001|Phase 2: Randomized Double-blind|Death|1|||
49104566|NCT00454818|158218421|FG002|Phase 2: Randomized Double-blind|Death|0|||
49104567|NCT00454818|158218422|FG003|Phase 2: Randomized Double-blind|Death|0|||
49104568|NCT00454818|158218423|FG004|Phase 2: Randomized Double-blind|Death|1|||
49104569|NCT00454818|158218419|FG000|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
49104570|NCT00454818|158218420|FG001|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
49104571|NCT00454818|158218421|FG002|Phase 2: Randomized Double-blind|Received a heart transplant|2|||
49104572|NCT00454818|158218422|FG003|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
49104573|NCT00454818|158218423|FG004|Phase 2: Randomized Double-blind|Received a heart transplant|1|||
49104574|NCT00454818|158218419|FG000|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
49104575|NCT00454818|158218420|FG001|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
49104576|NCT00454818|158218421|FG002|Phase 2: Randomized Double-blind|Received left ventricular assist device|1|||
49104577|NCT00454818|158218422|FG003|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
49104578|NCT00454818|158218423|FG004|Phase 2: Randomized Double-blind|Received left ventricular assist device|2|||
49104579|NCT01384019|158218424|FG000|Overall Study|Withdrawal by Subject|3|||
49104580|NCT01384019|158218425|FG001|Overall Study|Withdrawal by Subject|0|||
49104581|NCT01384019|158218424|FG000|Overall Study|Death|1|||
49104582|NCT01384019|158218425|FG001|Overall Study|Death|0|||
49104583|NCT01384019|158218424|FG000|Overall Study|MRI refusal|6|||
49104584|NCT01384019|158218425|FG001|Overall Study|MRI refusal|6|||
49104585|NCT03181503|158218426|FG000|Overall Study|Adverse Event|2|||
49104586|NCT03181503|158218427|FG001|Overall Study|Adverse Event|2|||
49104587|NCT03181503|158218426|FG000|Overall Study|Protocol Violation|1|||
49104588|NCT03181503|158218427|FG001|Overall Study|Protocol Violation|0|||
49104589|NCT03181503|158218426|FG000|Overall Study|Withdrawal by Subject|3|||
49104590|NCT03181503|158218427|FG001|Overall Study|Withdrawal by Subject|0|||
49104591|NCT03181503|158218426|FG000|Overall Study|Lost to Follow-up|1|||
49104592|NCT03181503|158218427|FG001|Overall Study|Lost to Follow-up|1|||
49104593|NCT00767039|158218430|FG000|Overall Study|Death|5|||
49104594|NCT00767039|158218431|FG001|Overall Study|Death|2|||
49104595|NCT01537068|158218434|FG000|Overall Study|Lost to Follow-up|2|||
49104596|NCT01537068|158218435|FG001|Overall Study|Lost to Follow-up|1|||
49104597|NCT01537068|158218434|FG000|Overall Study|Adverse Event|0|||
49104598|NCT01537068|158218435|FG001|Overall Study|Adverse Event|1|||
49104599|NCT01537068|158218434|FG000|Overall Study|Withdrawal by Subject|1|||
49104600|NCT01537068|158218435|FG001|Overall Study|Withdrawal by Subject|1|||
49104601|NCT01537068|158218434|FG000|Overall Study|Lack of Efficacy|1|||
49104602|NCT01537068|158218435|FG001|Overall Study|Lack of Efficacy|0|||
49104603|NCT01267201|158218436|FG000|First Intervention Period|Withdrawal by Subject|1|||
49104604|NCT01267201|158218437|FG001|First Intervention Period|Withdrawal by Subject|0|||
49104605|NCT01267201|158218438|FG002|First Intervention Period|Withdrawal by Subject|0|||
49104606|NCT01267201|158218439|FG003|First Intervention Period|Withdrawal by Subject|0|||
49104607|NCT01267201|158218440|FG004|First Intervention Period|Withdrawal by Subject|0|||
49104608|NCT01267201|158218441|FG005|First Intervention Period|Withdrawal by Subject|0|||
49104609|NCT01267201|158218436|FG000|Second Intervention Period|Withdrawal by Subject|0|||
49104610|NCT01267201|158218437|FG001|Second Intervention Period|Withdrawal by Subject|1|||
49104611|NCT01267201|158218438|FG002|Second Intervention Period|Withdrawal by Subject|0|||
49104612|NCT01267201|158218439|FG003|Second Intervention Period|Withdrawal by Subject|0|||
49104613|NCT01267201|158218440|FG004|Second Intervention Period|Withdrawal by Subject|0|||
49104614|NCT01267201|158218441|FG005|Second Intervention Period|Withdrawal by Subject|0|||
49104615|NCT01854879|158218446|FG000|Overall Study|Could not complete testing within the scheduled time.|1|||
49104616|NCT01854879|158218446|FG000|Overall Study|screen fail|3|||
49104617|NCT01854879|158218446|FG000|Overall Study|incomplete data set|1|||
49104618|NCT01328548|158218450|FG000|Overall Study|Death|3|||
49104619|NCT01328548|158218451|FG001|Overall Study|Death|0|||
49104620|NCT01328548|158218450|FG000|Overall Study|Protocol Violation|1|||
49104621|NCT01328548|158218451|FG001|Overall Study|Protocol Violation|0|||
49104622|NCT03806231|158218452|FG000|Overall Study|Physician Decision|1|||
49104623|NCT03806231|158218453|FG001|Overall Study|Physician Decision|0|||
49104624|NCT03806231|158218452|FG000|Overall Study|Withdrawal by Subject|1|||
49104625|NCT03806231|158218453|FG001|Overall Study|Withdrawal by Subject|0|||
49104626|NCT02919267|158218454|FG000|Overall Study|Protocol Violation|0|||
49104627|NCT02919267|158218455|FG001|Overall Study|Protocol Violation|3|||
49104628|NCT02919267|158218456|FG002|Overall Study|Protocol Violation|3|||
49104629|NCT02919267|158218457|FG003|Overall Study|Protocol Violation|4|||
49104630|NCT03467763|158218458|FG000|Overall Study|Lost to Follow-up|1|||
49104631|NCT03467763|158218458|FG000|Overall Study|Protocol Violation|2|||
49104632|NCT03721835|158218459|FG000|Overall Study|Participant not able to return|1|||
49104633|NCT03721835|158218459|FG000|Overall Study|Lost to Follow-up|1|||
49104634|NCT03721835|158218459|FG000|Overall Study|Revision of the components of the study device|2|||
49104635|NCT03721835|158218459|FG000|Overall Study|Sponsor terminated study|6|||
49104636|NCT03721835|158218459|FG000|Overall Study|Death|1|||
49104637|NCT03721835|158218459|FG000|Overall Study|Sponsor decision|1|||
49104638|NCT01001598|158218466|FG000|Overall Study|Hematopoietic Stem Cell Transplant|1|||
49104639|NCT01001598|158218466|FG000|Overall Study|Adverse Event|1|||
49104640|NCT02326298|158218469|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
49104641|NCT02326298|158218470|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
49104642|NCT02326298|158218471|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
49104643|NCT02326298|158218472|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
49104644|NCT02326298|158218473|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
49104645|NCT02326298|158218474|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
49104646|NCT02326298|158218475|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
49104647|NCT02326298|158218476|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
49104648|NCT02326298|158218477|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
49104649|NCT02326298|158218478|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
49104650|NCT02326298|158218479|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
49104651|NCT02326298|158218480|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
49104652|NCT02326298|158218481|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
49104653|NCT02326298|158218482|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
49104654|NCT02326298|158218469|FG000|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1|||
49104655|NCT02326298|158218470|FG001|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
49104656|NCT02326298|158218471|FG002|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
49104657|NCT02326298|158218472|FG003|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
49104658|NCT02326298|158218473|FG004|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
49104659|NCT02326298|158218474|FG005|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
49104660|NCT02326298|158218475|FG006|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
49104661|NCT02326298|158218476|FG007|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
49104662|NCT02326298|158218477|FG008|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
49104663|NCT02326298|158218478|FG009|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
49104664|NCT02326298|158218479|FG010|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
49104665|NCT02326298|158218480|FG011|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
49104666|NCT02326298|158218481|FG012|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
49104667|NCT02326298|158218482|FG013|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
49104668|NCT02326298|158218469|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
49104669|NCT02326298|158218470|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
49104670|NCT02326298|158218471|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
49104671|NCT02326298|158218472|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
49104672|NCT02326298|158218473|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
49104673|NCT02326298|158218474|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
49104674|NCT02326298|158218475|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
49104675|NCT02326298|158218476|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
49104676|NCT02326298|158218477|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
49104677|NCT02326298|158218478|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
49104678|NCT02326298|158218479|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
49104679|NCT02326298|158218480|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
49104680|NCT02326298|158218481|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
49104681|NCT02326298|158218482|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
49104682|NCT02326298|158218469|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
49104683|NCT02326298|158218470|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
49104684|NCT02326298|158218471|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
49104685|NCT02326298|158218472|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
49104686|NCT02326298|158218473|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
49104687|NCT02326298|158218474|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
49104688|NCT02326298|158218475|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
49104689|NCT02326298|158218476|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
49104690|NCT02326298|158218477|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
49104691|NCT02326298|158218478|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
49104692|NCT02326298|158218479|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
49104693|NCT02326298|158218480|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
49104694|NCT02326298|158218481|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
49104695|NCT02326298|158218482|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
49104696|NCT02326298|158218469|FG000|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
49104697|NCT02326298|158218470|FG001|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
49104698|NCT02326298|158218471|FG002|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2|||
49104699|NCT02326298|158218472|FG003|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
49104700|NCT02326298|158218473|FG004|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
49104701|NCT02326298|158218474|FG005|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
49104702|NCT02326298|158218475|FG006|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
49104703|NCT02326298|158218476|FG007|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
49104704|NCT02326298|158218477|FG008|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
49104705|NCT02326298|158218478|FG009|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
49104706|NCT02326298|158218479|FG010|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
49104707|NCT02326298|158218480|FG011|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
49104708|NCT02326298|158218481|FG012|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
49104709|NCT02326298|158218482|FG013|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
49104710|NCT02326298|158218469|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
49104711|NCT02326298|158218470|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
49104712|NCT02326298|158218471|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
49104713|NCT02326298|158218472|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
49104714|NCT02326298|158218473|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
49104715|NCT02326298|158218474|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
49104716|NCT02326298|158218475|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
49104717|NCT02326298|158218476|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
49104718|NCT02326298|158218477|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
49104719|NCT02326298|158218478|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
49104720|NCT02326298|158218479|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
49104721|NCT02326298|158218480|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
49104722|NCT02326298|158218481|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
49104723|NCT02326298|158218482|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
49104724|NCT02326298|158218469|FG000|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
49104725|NCT02326298|158218470|FG001|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
49104726|NCT02326298|158218471|FG002|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
49104727|NCT02326298|158218472|FG003|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
49104728|NCT02326298|158218473|FG004|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
49104729|NCT02326298|158218474|FG005|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1|||
49104730|NCT02326298|158218475|FG006|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2|||
49104731|NCT02326298|158218476|FG007|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
49104732|NCT02326298|158218477|FG008|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4|||
49104733|NCT02326298|158218478|FG009|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
49104734|NCT02326298|158218479|FG010|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
49104735|NCT02326298|158218480|FG011|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
49104736|NCT02326298|158218481|FG012|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
49104737|NCT02326298|158218482|FG013|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
49104738|NCT02326298|158218469|FG000|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
49104739|NCT02326298|158218470|FG001|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
49104740|NCT02326298|158218471|FG002|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
49104741|NCT02326298|158218472|FG003|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
49104742|NCT02326298|158218473|FG004|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
49104743|NCT02326298|158218474|FG005|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1|||
49104744|NCT02326298|158218475|FG006|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
49104745|NCT02326298|158218476|FG007|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
49104746|NCT02326298|158218477|FG008|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
49104747|NCT02326298|158218478|FG009|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
49104748|NCT02326298|158218479|FG010|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
49104749|NCT02326298|158218480|FG011|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
49104750|NCT02326298|158218481|FG012|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
49104751|NCT02326298|158218482|FG013|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
49104752|NCT02326298|158218469|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
49104753|NCT02326298|158218470|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
49104754|NCT02326298|158218471|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
49104755|NCT02326298|158218472|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
49104756|NCT02326298|158218473|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
49104757|NCT02326298|158218474|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
49104758|NCT02326298|158218475|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
49104759|NCT02326298|158218476|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
49104760|NCT02326298|158218477|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
49104761|NCT02326298|158218478|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
49104762|NCT02326298|158218479|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
49104763|NCT02326298|158218480|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
49104764|NCT02326298|158218481|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
49104765|NCT02326298|158218482|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
49104766|NCT02326298|158218469|FG000|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
49104767|NCT02326298|158218470|FG001|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
49104768|NCT02326298|158218471|FG002|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
49104769|NCT02326298|158218472|FG003|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
49104770|NCT02326298|158218473|FG004|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
49104771|NCT02326298|158218474|FG005|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
49104772|NCT02326298|158218475|FG006|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
49104773|NCT02326298|158218476|FG007|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1|||
49104774|NCT02326298|158218477|FG008|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
49104775|NCT02326298|158218478|FG009|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
49104776|NCT02326298|158218479|FG010|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
49104777|NCT02326298|158218480|FG011|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
49104778|NCT02326298|158218481|FG012|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
49104779|NCT02326298|158218482|FG013|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
49104780|NCT02326298|158218469|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
49104781|NCT02326298|158218470|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
49104782|NCT02326298|158218471|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
49104783|NCT02326298|158218472|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
49104784|NCT02326298|158218473|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
49104785|NCT02326298|158218474|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
49104786|NCT02326298|158218475|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
49104787|NCT02326298|158218476|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
49104788|NCT02326298|158218477|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
49104789|NCT02326298|158218478|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
49104790|NCT02326298|158218479|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
49104791|NCT02326298|158218480|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
49104792|NCT02326298|158218481|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
49104793|NCT02326298|158218482|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
49104794|NCT02326298|158218469|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
49104795|NCT02326298|158218470|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
49104796|NCT02326298|158218471|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
49104797|NCT02326298|158218472|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
49104798|NCT02326298|158218473|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
49104799|NCT02326298|158218474|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
49104800|NCT02326298|158218475|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
49104801|NCT02326298|158218476|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
49104802|NCT02326298|158218477|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
49104803|NCT02326298|158218478|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
49104804|NCT02326298|158218479|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
49104805|NCT02326298|158218480|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
49104806|NCT02326298|158218481|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
49104807|NCT02326298|158218482|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
49104808|NCT02326298|158218469|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
49104809|NCT02326298|158218470|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
49104810|NCT02326298|158218471|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
49104811|NCT02326298|158218472|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
49104812|NCT02326298|158218473|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
49104813|NCT02326298|158218474|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2|||
49104814|NCT02326298|158218475|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
49104815|NCT02326298|158218476|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
49104816|NCT02326298|158218477|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
49104817|NCT02326298|158218478|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
49104818|NCT02326298|158218479|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
49104819|NCT02326298|158218480|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
49104820|NCT02326298|158218481|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
49104821|NCT02326298|158218482|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
49104822|NCT02326298|158218469|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
49104823|NCT02326298|158218470|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
49104824|NCT02326298|158218471|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
49104825|NCT02326298|158218472|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
49104826|NCT02326298|158218473|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
49104827|NCT02326298|158218474|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
49104828|NCT02326298|158218475|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
49104829|NCT02326298|158218476|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
49104830|NCT02326298|158218477|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
49104831|NCT02326298|158218478|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
49104832|NCT02326298|158218479|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
49104833|NCT02326298|158218480|FG011|Open-label Period (Week 48 to Week 144)|Death|1|||
49104834|NCT02326298|158218481|FG012|Open-label Period (Week 48 to Week 144)|Death|0|||
49104835|NCT02326298|158218482|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
49104836|NCT02326298|158218469|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
49104837|NCT02326298|158218470|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
49104838|NCT02326298|158218471|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
49104839|NCT02326298|158218472|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
49104840|NCT02326298|158218473|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
49104841|NCT02326298|158218474|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
49104842|NCT02326298|158218475|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
49104843|NCT02326298|158218476|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
49104844|NCT02326298|158218477|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
49104845|NCT02326298|158218478|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
49104846|NCT02326298|158218479|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
49104847|NCT02326298|158218480|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
49104848|NCT02326298|158218481|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
49104849|NCT02326298|158218482|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
49104850|NCT02326298|158218469|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
49104851|NCT02326298|158218470|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
49104852|NCT02326298|158218471|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
49104853|NCT02326298|158218472|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
49104854|NCT02326298|158218473|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
49104855|NCT02326298|158218474|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
49104856|NCT02326298|158218475|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
49104857|NCT02326298|158218476|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
49104858|NCT02326298|158218477|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
49104859|NCT02326298|158218478|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
49104860|NCT02326298|158218479|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
49104861|NCT02326298|158218480|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
49104862|NCT02326298|158218481|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
49104863|NCT02326298|158218482|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
49104864|NCT02326298|158218469|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
49104865|NCT02326298|158218470|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
49104866|NCT02326298|158218471|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
49104867|NCT02326298|158218472|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
49104868|NCT02326298|158218473|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
49104869|NCT02326298|158218474|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
49104870|NCT02326298|158218475|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
49104871|NCT02326298|158218476|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
49104872|NCT02326298|158218477|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
49104873|NCT02326298|158218478|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
49104874|NCT02326298|158218479|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
49104875|NCT02326298|158218480|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
49104876|NCT02326298|158218481|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
49104877|NCT02326298|158218482|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|2|||
49104878|NCT02326298|158218469|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
49104879|NCT02326298|158218470|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
49104880|NCT02326298|158218471|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
49104881|NCT02326298|158218472|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
49104882|NCT02326298|158218473|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
49104883|NCT02326298|158218474|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
49104884|NCT02326298|158218475|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
49104885|NCT02326298|158218476|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
49104886|NCT02326298|158218477|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
49104887|NCT02326298|158218478|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
49104888|NCT02326298|158218479|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
49104889|NCT02326298|158218480|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7|||
49104890|NCT02326298|158218481|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
49104891|NCT02326298|158218482|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
49104892|NCT02326298|158218469|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
49104893|NCT02326298|158218470|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
49104894|NCT02326298|158218471|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
49104895|NCT02326298|158218472|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
49104896|NCT02326298|158218473|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
49104897|NCT02326298|158218474|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
49104898|NCT02326298|158218475|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
49104899|NCT02326298|158218476|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
49104900|NCT02326298|158218477|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
49104901|NCT02326298|158218478|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
49104902|NCT02326298|158218479|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
49104903|NCT02326298|158218480|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2|||
49104904|NCT02326298|158218481|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7|||
49104905|NCT02326298|158218482|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
49104906|NCT02326298|158218469|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
49104907|NCT02326298|158218470|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
49104908|NCT02326298|158218471|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
49104909|NCT02326298|158218472|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
49104910|NCT02326298|158218473|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
49104911|NCT02326298|158218474|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
49104912|NCT02326298|158218475|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
49104913|NCT02326298|158218476|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
49104914|NCT02326298|158218477|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
49104915|NCT02326298|158218478|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
49104916|NCT02326298|158218479|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
49104917|NCT02326298|158218480|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
49104918|NCT02326298|158218481|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
49104919|NCT02326298|158218482|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
49104920|NCT02407054|158218486|FG000|Overall Study|Adverse Event|1|||
49104921|NCT02407054|158218487|FG001|Overall Study|Adverse Event|4|||
49104922|NCT02407054|158218488|FG002|Overall Study|Adverse Event|1|||
49104923|NCT02407054|158218486|FG000|Overall Study|Non-compliance with Study|0|||
49104924|NCT02407054|158218487|FG001|Overall Study|Non-compliance with Study|2|||
49104925|NCT02407054|158218488|FG002|Overall Study|Non-compliance with Study|1|||
49104926|NCT02407054|158218486|FG000|Overall Study|Physician Decision|1|||
49104927|NCT02407054|158218487|FG001|Overall Study|Physician Decision|3|||
49104928|NCT02407054|158218488|FG002|Overall Study|Physician Decision|3|||
49104929|NCT02407054|158218486|FG000|Overall Study|Withdrawal by Subject|5|||
49104930|NCT02407054|158218487|FG001|Overall Study|Withdrawal by Subject|9|||
49104931|NCT02407054|158218488|FG002|Overall Study|Withdrawal by Subject|2|||
49104932|NCT00932698|158218490|FG000|Part 1 (Dose Escalation)|Progressive Disease|3|||
49104933|NCT00932698|158218491|FG001|Part 1 (Dose Escalation)|Progressive Disease|2|||
49104934|NCT00932698|158218492|FG002|Part 1 (Dose Escalation)|Progressive Disease|2|||
49104935|NCT00932698|158218493|FG003|Part 1 (Dose Escalation)|Progressive Disease|2|||
49104936|NCT00932698|158218494|FG004|Part 1 (Dose Escalation)|Progressive Disease|3|||
49104937|NCT00932698|158218495|FG005|Part 1 (Dose Escalation)|Progressive Disease|5|||
49104938|NCT00932698|158218496|FG006|Part 1 (Dose Escalation)|Progressive Disease|2|||
49104939|NCT00932698|158218497|FG007|Part 1 (Dose Escalation)|Progressive Disease|0|||
49104940|NCT00932698|158218498|FG008|Part 1 (Dose Escalation)|Progressive Disease|0|||
49104941|NCT00932698|158218499|FG009|Part 1 (Dose Escalation)|Progressive Disease|0|||
49104942|NCT00932698|158218500|FG010|Part 1 (Dose Escalation)|Progressive Disease|0|||
49104943|NCT00932698|158218490|FG000|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
49104944|NCT00932698|158218491|FG001|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
49104945|NCT00932698|158218492|FG002|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
49104946|NCT00932698|158218493|FG003|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
49104947|NCT00932698|158218494|FG004|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
49104948|NCT00932698|158218495|FG005|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
49104949|NCT00932698|158218496|FG006|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
49104950|NCT00932698|158218497|FG007|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
49104951|NCT00932698|158218498|FG008|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
49104952|NCT00932698|158218499|FG009|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
49104953|NCT00932698|158218500|FG010|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
49104954|NCT00932698|158218490|FG000|Part 1 (Dose Escalation)|Adverse Event|0|||
49104955|NCT00932698|158218491|FG001|Part 1 (Dose Escalation)|Adverse Event|0|||
49104956|NCT00932698|158218492|FG002|Part 1 (Dose Escalation)|Adverse Event|0|||
49104957|NCT00932698|158218493|FG003|Part 1 (Dose Escalation)|Adverse Event|0|||
49104958|NCT00932698|158218494|FG004|Part 1 (Dose Escalation)|Adverse Event|0|||
49104959|NCT00932698|158218495|FG005|Part 1 (Dose Escalation)|Adverse Event|1|||
49104960|NCT00932698|158218496|FG006|Part 1 (Dose Escalation)|Adverse Event|0|||
49104961|NCT00932698|158218497|FG007|Part 1 (Dose Escalation)|Adverse Event|0|||
49104962|NCT00932698|158218498|FG008|Part 1 (Dose Escalation)|Adverse Event|0|||
49104963|NCT00932698|158218499|FG009|Part 1 (Dose Escalation)|Adverse Event|0|||
49104964|NCT00932698|158218500|FG010|Part 1 (Dose Escalation)|Adverse Event|0|||
49104965|NCT00932698|158218490|FG000|Part 1 (Dose Escalation)|Other|0|||
49104966|NCT00932698|158218491|FG001|Part 1 (Dose Escalation)|Other|0|||
49104967|NCT00932698|158218492|FG002|Part 1 (Dose Escalation)|Other|1|||
49104968|NCT00932698|158218493|FG003|Part 1 (Dose Escalation)|Other|0|||
49104969|NCT00932698|158218494|FG004|Part 1 (Dose Escalation)|Other|0|||
49104970|NCT00932698|158218495|FG005|Part 1 (Dose Escalation)|Other|0|||
49104971|NCT00932698|158218496|FG006|Part 1 (Dose Escalation)|Other|1|||
49104972|NCT00932698|158218497|FG007|Part 1 (Dose Escalation)|Other|0|||
49104973|NCT00932698|158218498|FG008|Part 1 (Dose Escalation)|Other|0|||
49104974|NCT00932698|158218499|FG009|Part 1 (Dose Escalation)|Other|0|||
49104975|NCT00932698|158218500|FG010|Part 1 (Dose Escalation)|Other|0|||
49104976|NCT00932698|158218490|FG000|Part 2 (Dose Expansion)|Progressive Disease|0|||
49104977|NCT00932698|158218491|FG001|Part 2 (Dose Expansion)|Progressive Disease|0|||
49104978|NCT00932698|158218492|FG002|Part 2 (Dose Expansion)|Progressive Disease|0|||
49104979|NCT00932698|158218493|FG003|Part 2 (Dose Expansion)|Progressive Disease|0|||
49104980|NCT00932698|158218494|FG004|Part 2 (Dose Expansion)|Progressive Disease|0|||
49104981|NCT00932698|158218495|FG005|Part 2 (Dose Expansion)|Progressive Disease|0|||
49104982|NCT00932698|158218496|FG006|Part 2 (Dose Expansion)|Progressive Disease|0|||
49104983|NCT00932698|158218497|FG007|Part 2 (Dose Expansion)|Progressive Disease|14|||
49104984|NCT00932698|158218498|FG008|Part 2 (Dose Expansion)|Progressive Disease|8|||
49104985|NCT00932698|158218499|FG009|Part 2 (Dose Expansion)|Progressive Disease|3|||
49104986|NCT00932698|158218500|FG010|Part 2 (Dose Expansion)|Progressive Disease|2|||
49104987|NCT00932698|158218490|FG000|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
49104988|NCT00932698|158218491|FG001|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
49104989|NCT00932698|158218492|FG002|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
49104990|NCT00932698|158218493|FG003|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
49104991|NCT00932698|158218494|FG004|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
49104992|NCT00932698|158218495|FG005|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
49104993|NCT00932698|158218496|FG006|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
49104994|NCT00932698|158218497|FG007|Part 2 (Dose Expansion)|Withdrawal by Subject|1|||
49104995|NCT00932698|158218498|FG008|Part 2 (Dose Expansion)|Withdrawal by Subject|3|||
49104996|NCT00932698|158218499|FG009|Part 2 (Dose Expansion)|Withdrawal by Subject|2|||
49104997|NCT00932698|158218500|FG010|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
49104998|NCT00932698|158218490|FG000|Part 2 (Dose Expansion)|Adverse Event|0|||
49104999|NCT00932698|158218491|FG001|Part 2 (Dose Expansion)|Adverse Event|0|||
49105000|NCT00932698|158218492|FG002|Part 2 (Dose Expansion)|Adverse Event|0|||
49105001|NCT00932698|158218493|FG003|Part 2 (Dose Expansion)|Adverse Event|0|||
49105002|NCT00932698|158218494|FG004|Part 2 (Dose Expansion)|Adverse Event|0|||
49105003|NCT00932698|158218495|FG005|Part 2 (Dose Expansion)|Adverse Event|0|||
49105004|NCT00932698|158218496|FG006|Part 2 (Dose Expansion)|Adverse Event|0|||
49105005|NCT00932698|158218497|FG007|Part 2 (Dose Expansion)|Adverse Event|5|||
49105006|NCT00932698|158218498|FG008|Part 2 (Dose Expansion)|Adverse Event|1|||
49105007|NCT00932698|158218499|FG009|Part 2 (Dose Expansion)|Adverse Event|1|||
49105008|NCT00932698|158218500|FG010|Part 2 (Dose Expansion)|Adverse Event|0|||
49105009|NCT01306045|158218501|FG000|Met General Eligibility Criteria|Screen failures|193|||
49105010|NCT01306045|158218502|FG001|Met General Eligibility Criteria|Screen failures|11|||
49105011|NCT01306045|158218503|FG002|Met General Eligibility Criteria|Screen failures|8|||
49105012|NCT04608344|158218504|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|0|||
49105013|NCT04608344|158218505|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|1|||
49105014|NCT04608344|158218504|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|1|||
49105015|NCT04608344|158218505|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|0|||
49105016|NCT00655681|158218506|FG000|Overall Study|Lost to Follow-up|1|||
49105017|NCT00655681|158218507|FG001|Overall Study|Lost to Follow-up|1|||
49105018|NCT01211483|158218511|FG000|Phase 1b|Death|6|||
49105019|NCT01211483|158218512|FG001|Phase 1b|Death|0|||
49105020|NCT01211483|158218513|FG002|Phase 1b|Death|0|||
49105021|NCT01211483|158218514|FG003|Phase 1b|Death|0|||
49105022|NCT01211483|158218511|FG000|Phase 1b|Withdrawal by Subject|1|||
49105023|NCT01211483|158218512|FG001|Phase 1b|Withdrawal by Subject|0|||
49105024|NCT01211483|158218513|FG002|Phase 1b|Withdrawal by Subject|0|||
49105025|NCT01211483|158218514|FG003|Phase 1b|Withdrawal by Subject|0|||
49105026|NCT01211483|158218511|FG000|Phase 2|Lost to Follow-up|0|||
49105027|NCT01211483|158218512|FG001|Phase 2|Lost to Follow-up|1|||
49105028|NCT01211483|158218513|FG002|Phase 2|Lost to Follow-up|1|||
49105029|NCT01211483|158218514|FG003|Phase 2|Lost to Follow-up|2|||
49105030|NCT01211483|158218511|FG000|Phase 2|Death|0|||
49105031|NCT01211483|158218512|FG001|Phase 2|Death|64|||
49105032|NCT01211483|158218513|FG002|Phase 2|Death|53|||
49105033|NCT01211483|158218514|FG003|Phase 2|Death|53|||
49105034|NCT01211483|158218511|FG000|Phase 2|Withdrawal by Subject|0|||
49105035|NCT01211483|158218512|FG001|Phase 2|Withdrawal by Subject|1|||
49105036|NCT01211483|158218513|FG002|Phase 2|Withdrawal by Subject|10|||
49105037|NCT01211483|158218514|FG003|Phase 2|Withdrawal by Subject|5|||
49105038|NCT01211483|158218511|FG000|Phase 2|Study terminated by Sponsor|0|||
49105039|NCT01211483|158218512|FG001|Phase 2|Study terminated by Sponsor|6|||
49105040|NCT01211483|158218513|FG002|Phase 2|Study terminated by Sponsor|8|||
49105041|NCT01211483|158218514|FG003|Phase 2|Study terminated by Sponsor|11|||
49105042|NCT00467961|158218515|FG000|Overall Study|Technical Failures|5|||
49105043|NCT00467961|158218515|FG000|Overall Study|Disease Progression|2|||
49105044|NCT02186847|158218517|FG000|Overall Study|Protocol Violation|3|||
49105045|NCT02186847|158218518|FG001|Overall Study|Protocol Violation|0|||
49105046|NCT01844505|158218519|FG000|Overall Study|Disease progression|170|||
49105047|NCT01844505|158218520|FG001|Overall Study|Disease progression|88|||
49105048|NCT01844505|158218521|FG002|Overall Study|Disease progression|224|||
49105049|NCT01844505|158218519|FG000|Overall Study|Study drug toxicity|40|||
49105050|NCT01844505|158218520|FG001|Overall Study|Study drug toxicity|131|||
49105051|NCT01844505|158218521|FG002|Overall Study|Study drug toxicity|50|||
49105052|NCT01844505|158218519|FG000|Overall Study|Death|1|||
49105053|NCT01844505|158218520|FG001|Overall Study|Death|3|||
49105054|NCT01844505|158218521|FG002|Overall Study|Death|1|||
49105055|NCT01844505|158218519|FG000|Overall Study|Adverse event unrelated to study drug|7|||
49105056|NCT01844505|158218520|FG001|Overall Study|Adverse event unrelated to study drug|15|||
49105057|NCT01844505|158218521|FG002|Overall Study|Adverse event unrelated to study drug|6|||
49105058|NCT01844505|158218519|FG000|Overall Study|Subject request discontinue treatment|17|||
49105059|NCT01844505|158218520|FG001|Overall Study|Subject request discontinue treatment|14|||
49105060|NCT01844505|158218521|FG002|Overall Study|Subject request discontinue treatment|8|||
49105061|NCT01844505|158218519|FG000|Overall Study|Withdrawal by Subject|0|||
49105062|NCT01844505|158218520|FG001|Overall Study|Withdrawal by Subject|3|||
49105063|NCT01844505|158218521|FG002|Overall Study|Withdrawal by Subject|0|||
49105064|NCT01844505|158218519|FG000|Overall Study|Lost to Follow-up|1|||
49105065|NCT01844505|158218520|FG001|Overall Study|Lost to Follow-up|0|||
49105066|NCT01844505|158218521|FG002|Overall Study|Lost to Follow-up|0|||
49105067|NCT01844505|158218519|FG000|Overall Study|Maximum clinical benefit|8|||
49105068|NCT01844505|158218520|FG001|Overall Study|Maximum clinical benefit|11|||
49105069|NCT01844505|158218521|FG002|Overall Study|Maximum clinical benefit|2|||
49105070|NCT01844505|158218519|FG000|Overall Study|Poor/non-compliance|1|||
49105071|NCT01844505|158218520|FG001|Overall Study|Poor/non-compliance|1|||
49105072|NCT01844505|158218521|FG002|Overall Study|Poor/non-compliance|1|||
49105073|NCT01844505|158218519|FG000|Overall Study|Subject no longer meets criteria|0|||
49105074|NCT01844505|158218520|FG001|Overall Study|Subject no longer meets criteria|1|||
49105075|NCT01844505|158218521|FG002|Overall Study|Subject no longer meets criteria|0|||
49105076|NCT01844505|158218519|FG000|Overall Study|Other Reasons|4|||
49105077|NCT01844505|158218520|FG001|Overall Study|Other Reasons|2|||
49105078|NCT01844505|158218521|FG002|Overall Study|Other Reasons|2|||
49105079|NCT01844505|158218519|FG000|Overall Study|Not Reported|0|||
49105080|NCT01844505|158218520|FG001|Overall Study|Not Reported|0|||
49105081|NCT01844505|158218521|FG002|Overall Study|Not Reported|1|||
49105082|NCT05249127|158218524|FG000|Overall Study|Protocol Violation|13|||
49105083|NCT05249127|158218524|FG000|Overall Study|Physician Decision|4|||
49105084|NCT05249127|158218524|FG000|Overall Study|Withdrawal by Subject|2|||
49105085|NCT05249127|158218524|FG000|Overall Study|Participant Non-compliance|1|||
49105086|NCT01794793|158218525|FG000|Treatment Period|Withdrawal by Subject|24|||
49105087|NCT01794793|158218525|FG000|Treatment Period|Lack of Efficacy|22|||
49105088|NCT01794793|158218525|FG000|Treatment Period|Adverse Event|17|||
49105089|NCT01794793|158218525|FG000|Treatment Period|Physician Decision|14|||
49105090|NCT01794793|158218525|FG000|Treatment Period|Lost to Follow-up|7|||
49105091|NCT01794793|158218525|FG000|Treatment Period|Death|6|||
49105092|NCT01794793|158218525|FG000|Treatment Period|Protocol Violation|5|||
49105093|NCT01794793|158218525|FG000|Treatment Period|administrative problem|3|||
49105094|NCT01794793|158218525|FG000|Post-treatment Follow-up|Lack of Efficacy|14|||
49105095|NCT01794793|158218525|FG000|Post-treatment Follow-up|Adverse Event|8|||
49105096|NCT01794793|158218525|FG000|Post-treatment Follow-up|Withdrawal by Subject|6|||
49105097|NCT01794793|158218525|FG000|Post-treatment Follow-up|administrative problem|5|||
49105098|NCT01794793|158218525|FG000|Post-treatment Follow-up|Lost to Follow-up|3|||
49105099|NCT01794793|158218525|FG000|Post-treatment Follow-up|Protocol Violation|3|||
49105100|NCT02044874|158218526|FG000|Overall Study|Adverse Event|5|||
49105101|NCT02044874|158218527|FG001|Overall Study|Adverse Event|6|||
49105102|NCT02044874|158218528|FG002|Overall Study|Adverse Event|6|||
49105103|NCT02044874|158218526|FG000|Overall Study|Withdrawal by Subject|8|||
49105104|NCT02044874|158218527|FG001|Overall Study|Withdrawal by Subject|16|||
49105105|NCT02044874|158218528|FG002|Overall Study|Withdrawal by Subject|23|||
49105106|NCT02044874|158218526|FG000|Overall Study|Physician Decision|0|||
49105107|NCT02044874|158218527|FG001|Overall Study|Physician Decision|2|||
49105108|NCT02044874|158218528|FG002|Overall Study|Physician Decision|1|||
49105109|NCT02044874|158218526|FG000|Overall Study|Lost to Follow-up|10|||
49105110|NCT02044874|158218527|FG001|Overall Study|Lost to Follow-up|27|||
49105111|NCT02044874|158218528|FG002|Overall Study|Lost to Follow-up|21|||
49105112|NCT02044874|158218526|FG000|Overall Study|Sponsor Decision|0|||
49105113|NCT02044874|158218527|FG001|Overall Study|Sponsor Decision|1|||
49105114|NCT02044874|158218528|FG002|Overall Study|Sponsor Decision|1|||
49105115|NCT02044874|158218526|FG000|Overall Study|Other|7|||
49105116|NCT02044874|158218527|FG001|Overall Study|Other|3|||
49105117|NCT02044874|158218528|FG002|Overall Study|Other|8|||
49105118|NCT01004406|158220066|FG000|Overall Study|Withdrawal by Subject|2|||
49105119|NCT01004406|158220067|FG001|Overall Study|Withdrawal by Subject|0|||
49105120|NCT01004406|158220066|FG000|Overall Study|Lost to Follow-up|1|||
49105121|NCT01004406|158220067|FG001|Overall Study|Lost to Follow-up|0|||
49105122|NCT00860249|158220068|FG000|Overall Study|trial was terminated prior to completion|21|||
49105123|NCT00860249|158220069|FG001|Overall Study|trial was terminated prior to completion|18|||
49105124|NCT00860249|158220070|FG002|Overall Study|trial was terminated prior to completion|21|||
49105125|NCT02928770|158220071|FG000|Overall Study|Withdrawal by Subject|2|||
49105126|NCT02963558|158220074|FG000|Overall Study|Withdrawn by investigator|1|||
49105127|NCT02963558|158220075|FG001|Overall Study|Withdrawn by investigator|0|||
49105128|NCT02963558|158220074|FG000|Overall Study|Withdrawal by Subject|0|||
49105129|NCT02963558|158220075|FG001|Overall Study|Withdrawal by Subject|1|||
49105130|NCT03309696|158220076|FG000|Overall Study|Analysis of TEP data could not be completed|0|||
49105131|NCT03309696|158220077|FG001|Overall Study|Analysis of TEP data could not be completed|5|||
49105132|NCT03309696|158220078|FG002|Overall Study|Analysis of TEP data could not be completed|0|||
49105133|NCT03309696|158220079|FG003|Overall Study|Analysis of TEP data could not be completed|0|||
49105134|NCT00616603|158220082|FG000|Overall Study|Physician Decision|2|||
49105135|NCT00616603|158220083|FG001|Overall Study|Physician Decision|0|||
49105136|NCT00616603|158220084|FG002|Overall Study|Physician Decision|2|||
49105137|NCT01892085|158220093|FG000|Overall Study|Death|4|||
49105138|NCT01892085|158220094|FG001|Overall Study|Death|1|||
49105139|NCT01892085|158220095|FG002|Overall Study|Death|3|||
49105140|NCT01892085|158220093|FG000|Overall Study|Withdrawal by Subject|2|||
49105141|NCT01892085|158220094|FG001|Overall Study|Withdrawal by Subject|0|||
49105142|NCT01892085|158220095|FG002|Overall Study|Withdrawal by Subject|2|||
49105143|NCT01258075|158220096|FG000|Overall Study|Adverse Event|8|||
49105144|NCT01258075|158220097|FG001|Overall Study|Adverse Event|3|||
49105145|NCT01258075|158220096|FG000|Overall Study|Lost to Follow-up|11|||
49105146|NCT01258075|158220097|FG001|Overall Study|Lost to Follow-up|6|||
49105147|NCT01258075|158220096|FG000|Overall Study|Withdrawal by Subject|10|||
49105148|NCT01258075|158220097|FG001|Overall Study|Withdrawal by Subject|7|||
49105149|NCT01258075|158220096|FG000|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1|||
49105150|NCT01258075|158220097|FG001|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2|||
49105151|NCT01258075|158220096|FG000|Overall Study|Other|12|||
49105152|NCT01258075|158220097|FG001|Overall Study|Other|5|||
49105153|NCT03738800|158220099|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
49105154|NCT03738800|158220100|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
49105155|NCT03738800|158220101|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
49105156|NCT03738800|158220099|FG000|Double-blind Treatment Period|Study Discontinued By Sponsor|5|||
49105157|NCT03738800|158220100|FG001|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
49105158|NCT03738800|158220101|FG002|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
49105159|NCT03738800|158220099|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
49105160|NCT03738800|158220100|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
49105161|NCT03738800|158220101|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
49105162|NCT04416737|158220102|FG000|Week 1 (First Injection)|Physician Decision|0|||
49105163|NCT04416737|158220103|FG001|Week 1 (First Injection)|Physician Decision|1|||
49105164|NCT02719353|158220104|FG000|First Intervention|Physician Decision|0|||
49105165|NCT02719353|158220105|FG001|First Intervention|Physician Decision|1|||
49105166|NCT01712334|158220106|FG000|Treatment Period 1|Randomized in Error|0|||
49105167|NCT01712334|158220107|FG001|Treatment Period 1|Randomized in Error|2|||
49105168|NCT01472757|158220108|FG000|Overall Study|Withdrawal by Subject|1|||
49105169|NCT01472757|158220109|FG001|Overall Study|Withdrawal by Subject|2|||
49105170|NCT01472757|158220110|FG002|Overall Study|Withdrawal by Subject|2|||
49105171|NCT01472757|158220111|FG003|Overall Study|Withdrawal by Subject|0|||
49105172|NCT01472757|158220108|FG000|Overall Study|Asthma exacerbation|4|||
49105173|NCT01472757|158220109|FG001|Overall Study|Asthma exacerbation|1|||
49105174|NCT01472757|158220110|FG002|Overall Study|Asthma exacerbation|2|||
49105175|NCT01472757|158220111|FG003|Overall Study|Asthma exacerbation|1|||
49105176|NCT01472757|158220108|FG000|Overall Study|Treatment period withdrawal criteria met|21|||
49105177|NCT01472757|158220109|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
49105178|NCT01472757|158220110|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
49105179|NCT01472757|158220111|FG003|Overall Study|Treatment period withdrawal criteria met|12|||
49105180|NCT01472757|158220108|FG000|Overall Study|Protocol Violation|3|||
49105181|NCT01472757|158220109|FG001|Overall Study|Protocol Violation|2|||
49105182|NCT01472757|158220110|FG002|Overall Study|Protocol Violation|4|||
49105183|NCT01472757|158220111|FG003|Overall Study|Protocol Violation|4|||
49105184|NCT01472757|158220108|FG000|Overall Study|Other reasons|1|||
49105185|NCT01472757|158220109|FG001|Overall Study|Other reasons|0|||
49105186|NCT01472757|158220110|FG002|Overall Study|Other reasons|2|||
49105187|NCT01472757|158220111|FG003|Overall Study|Other reasons|2|||
49105188|NCT00948506|158220112|FG000|Overall Study|Withdrawal by Subject|3|||
49105189|NCT00948506|158220113|FG001|Overall Study|Withdrawal by Subject|1|||
49105190|NCT00943670|158220116|FG000|Single-agent Trastuzumab Emtansine|Physician Decision|2|||
49105191|NCT00943670|158220116|FG000|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3|||
49105192|NCT00943670|158220116|FG000|Single-agent Trastuzumab Emtansine|Systemic progression|15|||
49105193|NCT00943670|158220116|FG000|Single-agent Trastuzumab Emtansine|Adverse Event|2|||
49105194|NCT00943670|158220116|FG000|Single-agent Trastuzumab Emtansine|Early progressive disease|20|||
49105195|NCT00943670|158220116|FG000|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1|||
49105196|NCT00943670|158220116|FG000|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4|||
49105197|NCT00943670|158220116|FG000|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6|||
49105198|NCT00943670|158220116|FG000|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2|||
49105199|NCT00943670|158220116|FG000|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5|||
49105200|NCT00501059|158220119|FG000|Overall Study|Protocol Violation|80|||
49105201|NCT00501059|158220120|FG001|Overall Study|Protocol Violation|69|||
49105202|NCT00501059|158220119|FG000|Overall Study|Death|140|||
49105203|NCT00501059|158220120|FG001|Overall Study|Death|137|||
49105204|NCT00501059|158220119|FG000|Overall Study|Other|236|||
49105205|NCT00501059|158220120|FG001|Overall Study|Other|239|||
49105206|NCT00501059|158220119|FG000|Overall Study|Missing end-of-study page|91|||
49105207|NCT00501059|158220120|FG001|Overall Study|Missing end-of-study page|92|||
49105208|NCT00501059|158220119|FG000|Overall Study|Clinical endpoint reached|110|||
49105209|NCT00501059|158220120|FG001|Overall Study|Clinical endpoint reached|123|||
49105210|NCT00501059|158220119|FG000|Overall Study|Insufficient therapeutic effect|4|||
49105211|NCT00501059|158220120|FG001|Overall Study|Insufficient therapeutic effect|5|||
49105212|NCT00501059|158220119|FG000|Overall Study|Consent withdrawn by subject|817|||
49105213|NCT00501059|158220120|FG001|Overall Study|Consent withdrawn by subject|873|||
49105214|NCT00501059|158220119|FG000|Overall Study|Non-compliant with study treatment|23|||
49105215|NCT00501059|158220120|FG001|Overall Study|Non-compliant with study treatment|16|||
49105216|NCT00501059|158220119|FG000|Overall Study|Reason not given|3|||
49105217|NCT00501059|158220120|FG001|Overall Study|Reason not given|1|||
49105218|NCT00501059|158220119|FG000|Overall Study|Adverse Event|129|||
49105219|NCT00501059|158220120|FG001|Overall Study|Adverse Event|122|||
49105220|NCT00501059|158220119|FG000|Overall Study|Lost to Follow-up|210|||
49105221|NCT00501059|158220120|FG001|Overall Study|Lost to Follow-up|198|||
49105222|NCT00501059|158220119|FG000|Overall Study|Not treated|25|||
49105223|NCT00501059|158220120|FG001|Overall Study|Not treated|17|||
49105224|NCT02603562|158220121|FG000|Overall Study|Lost to Follow-up|1|||
49105225|NCT00270231|158220122|FG000|First Intervention|Lost to Follow-up|1|||
49105226|NCT00270231|158220123|FG001|First Intervention|Lost to Follow-up|1|||
49105227|NCT00270231|158220122|FG000|Washout Period|Lost to Follow-up|1|||
49105228|NCT00270231|158220123|FG001|Washout Period|Lost to Follow-up|0|||
49105229|NCT00270231|158220122|FG000|Second Intervention|Lost to Follow-up|0|||
49105230|NCT00270231|158220123|FG001|Second Intervention|Lost to Follow-up|1|||
49105231|NCT03672461|158220124|FG000|Overall Study|COVID Related|4|||
49105232|NCT03672461|158220125|FG001|Overall Study|COVID Related|2|||
49105233|NCT03672461|158220124|FG000|Overall Study|Adverse Event|2|||
49105234|NCT03672461|158220125|FG001|Overall Study|Adverse Event|0|||
49105235|NCT03672461|158220124|FG000|Overall Study|Serious Adverse Event|0|||
49105236|NCT03672461|158220125|FG001|Overall Study|Serious Adverse Event|1|||
49105237|NCT03672461|158220124|FG000|Overall Study|Too Busy|3|||
49105238|NCT03672461|158220125|FG001|Overall Study|Too Busy|1|||
49105239|NCT03672461|158220124|FG000|Overall Study|Lost to Follow-up|1|||
49105240|NCT03672461|158220125|FG001|Overall Study|Lost to Follow-up|2|||
49105241|NCT03672461|158220124|FG000|Overall Study|Family|2|||
49105242|NCT03672461|158220125|FG001|Overall Study|Family|2|||
49105243|NCT03672461|158220124|FG000|Overall Study|No remote technology access|0|||
49105244|NCT03672461|158220125|FG001|Overall Study|No remote technology access|1|||
49105245|NCT03672461|158220124|FG000|Overall Study|Withdrawal by Subject|1|||
49105246|NCT03672461|158220125|FG001|Overall Study|Withdrawal by Subject|0|||
49105247|NCT03672461|158220124|FG000|Overall Study|Cannot tolerate intervention|1|||
49105248|NCT03672461|158220125|FG001|Overall Study|Cannot tolerate intervention|0|||
49105249|NCT03672461|158220124|FG000|Overall Study|Incomplete outcome data|6|||
49105250|NCT03672461|158220125|FG001|Overall Study|Incomplete outcome data|1|||
49105251|NCT06011161|158220128|FG000|Overall Study|Withdrawal by Subject|2|||
49105252|NCT06011161|158220128|FG000|Overall Study|Lost to Follow-up|5|||
49105253|NCT00875433|158220134|FG000|Overall Study|Progressive disease|41|||
49105254|NCT00875433|158220134|FG000|Overall Study|Other Adverse Event|14|||
49105255|NCT00875433|158220134|FG000|Overall Study|Withdrawal by Subject|2|||
49105256|NCT00875433|158220134|FG000|Overall Study|Other|3|||
49105257|NCT01995175|158220136|FG000|Period 1 - From 0 up to 2 Years of Age|Withdrawal by Subject|35|||
49105258|NCT01995175|158220136|FG000|Period 1 - From 0 up to 2 Years of Age|Lost to Follow-up|102|||
49105259|NCT01995175|158220136|FG000|Period 1 - From 0 up to 2 Years of Age|Other|67|||
49105260|NCT01995175|158220136|FG000|Period 1 - From 0 up to 2 Years of Age|Migrated / moved from the study area|49|||
49105261|NCT01995175|158220136|FG000|Period 2 - From 2 up to 6 Years of Age|Other|21|||
49105262|NCT01995175|158220136|FG000|Period 2 - From 2 up to 6 Years of Age|Lost to Follow-up|22|||
49105263|NCT01995175|158220136|FG000|Period 2 - From 2 up to 6 Years of Age|Migrated/moved from the study area|6|||
49105264|NCT01995175|158220136|FG000|Period 2 - From 2 up to 6 Years of Age|Consent withdrawal, not due to a Serious Adverse Event|7|||
49105265|NCT01995175|158220136|FG000|Period 2 - From 2 up to 6 Years of Age|Protocol Violation|1|||
49105266|NCT00432276|158220139|FG000|Overall Study|Hyperglycemic Rescue|44|||
49105267|NCT00432276|158220140|FG001|Overall Study|Hyperglycemic Rescue|87|||
49105268|NCT00432276|158220139|FG000|Overall Study|Adverse Event|13|||
49105269|NCT00432276|158220140|FG001|Overall Study|Adverse Event|16|||
49105270|NCT00432276|158220139|FG000|Overall Study|Protocol Violation|25|||
49105271|NCT00432276|158220140|FG001|Overall Study|Protocol Violation|20|||
49105272|NCT00432276|158220139|FG000|Overall Study|Lost to Follow-up|6|||
49105273|NCT00432276|158220140|FG001|Overall Study|Lost to Follow-up|2|||
49105274|NCT00432276|158220139|FG000|Overall Study|Withdrawal by Subject|25|||
49105275|NCT00432276|158220140|FG001|Overall Study|Withdrawal by Subject|20|||
49105276|NCT00432276|158220139|FG000|Overall Study|Physician Decision|6|||
49105277|NCT00432276|158220140|FG001|Overall Study|Physician Decision|8|||
49105278|NCT00432276|158220139|FG000|Overall Study|Other|2|||
49105279|NCT00432276|158220140|FG001|Overall Study|Other|3|||
49105280|NCT00131365|158220141|FG000|Overall Study|Withdrawal by Subject|1|||
49105281|NCT00131365|158220141|FG000|Overall Study|Alternative treatment|3|||
49105282|NCT03191864|158220142|FG000|Baseline Symptom Assessment|Lost to Follow-up|0|||
49105283|NCT03191864|158220143|FG001|Baseline Symptom Assessment|Lost to Follow-up|0|||
49105284|NCT03191864|158220144|FG002|Baseline Symptom Assessment|Lost to Follow-up|0|||
49105285|NCT03191864|158220145|FG003|Baseline Symptom Assessment|Lost to Follow-up|0|||
49105286|NCT03191864|158220146|FG004|Baseline Symptom Assessment|Lost to Follow-up|0|||
49105287|NCT03191864|158220147|FG005|Baseline Symptom Assessment|Lost to Follow-up|1|||
49105288|NCT03191864|158220142|FG000|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
49105289|NCT03191864|158220143|FG001|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
49105290|NCT03191864|158220144|FG002|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
49105291|NCT03191864|158220145|FG003|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
49105292|NCT03191864|158220146|FG004|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
49105293|NCT03191864|158220147|FG005|Baseline Symptom Assessment|Patient Diary Unavailable at Site|1|||
49105294|NCT03191864|158220142|FG000|Baseline Symptom Assessment|Adverse Event|0|||
49105295|NCT03191864|158220143|FG001|Baseline Symptom Assessment|Adverse Event|0|||
49105296|NCT03191864|158220144|FG002|Baseline Symptom Assessment|Adverse Event|0|||
49105297|NCT03191864|158220145|FG003|Baseline Symptom Assessment|Adverse Event|0|||
49105298|NCT03191864|158220146|FG004|Baseline Symptom Assessment|Adverse Event|0|||
49105299|NCT03191864|158220147|FG005|Baseline Symptom Assessment|Adverse Event|2|||
49105300|NCT03191864|158220142|FG000|Baseline Symptom Assessment|Withdrawal by Subject|0|||
49105301|NCT03191864|158220143|FG001|Baseline Symptom Assessment|Withdrawal by Subject|0|||
49105302|NCT03191864|158220144|FG002|Baseline Symptom Assessment|Withdrawal by Subject|0|||
49105303|NCT03191864|158220145|FG003|Baseline Symptom Assessment|Withdrawal by Subject|0|||
49105304|NCT03191864|158220146|FG004|Baseline Symptom Assessment|Withdrawal by Subject|0|||
49105305|NCT03191864|158220147|FG005|Baseline Symptom Assessment|Withdrawal by Subject|19|||
49105306|NCT03191864|158220142|FG000|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
49105307|NCT03191864|158220143|FG001|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
49105308|NCT03191864|158220144|FG002|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
49105309|NCT03191864|158220145|FG003|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
49105310|NCT03191864|158220146|FG004|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
49105311|NCT03191864|158220147|FG005|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|179|||
49105312|NCT03191864|158220142|FG000|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
49105313|NCT03191864|158220143|FG001|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
49105314|NCT03191864|158220144|FG002|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
49105315|NCT03191864|158220145|FG003|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
49105316|NCT03191864|158220146|FG004|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
49105317|NCT03191864|158220147|FG005|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
49105318|NCT03191864|158220142|FG000|Part 1 - Induction|Adverse Event|0|||
49105319|NCT03191864|158220143|FG001|Part 1 - Induction|Adverse Event|2|||
49105320|NCT03191864|158220144|FG002|Part 1 - Induction|Adverse Event|0|||
49105321|NCT03191864|158220145|FG003|Part 1 - Induction|Adverse Event|1|||
49105322|NCT03191864|158220146|FG004|Part 1 - Induction|Adverse Event|0|||
49105323|NCT03191864|158220147|FG005|Part 1 - Induction|Adverse Event|2|||
49105324|NCT03191864|158220142|FG000|Part 1 - Induction|Randomized but never dosed|0|||
49105325|NCT03191864|158220143|FG001|Part 1 - Induction|Randomized but never dosed|0|||
49105326|NCT03191864|158220144|FG002|Part 1 - Induction|Randomized but never dosed|1|||
49105327|NCT03191864|158220145|FG003|Part 1 - Induction|Randomized but never dosed|0|||
49105328|NCT03191864|158220146|FG004|Part 1 - Induction|Randomized but never dosed|0|||
49105329|NCT03191864|158220147|FG005|Part 1 - Induction|Randomized but never dosed|0|||
49105330|NCT03191864|158220142|FG000|Part 1 - Induction|Withdrawal by Subject|3|||
49105331|NCT03191864|158220143|FG001|Part 1 - Induction|Withdrawal by Subject|1|||
49105332|NCT03191864|158220144|FG002|Part 1 - Induction|Withdrawal by Subject|0|||
49105333|NCT03191864|158220145|FG003|Part 1 - Induction|Withdrawal by Subject|0|||
49105334|NCT03191864|158220146|FG004|Part 1 - Induction|Withdrawal by Subject|0|||
49105335|NCT03191864|158220147|FG005|Part 1 - Induction|Withdrawal by Subject|2|||
49105336|NCT03191864|158220142|FG000|Part 2 - Maintenance|Refused EGD at Week 26|0|||
49105337|NCT03191864|158220143|FG001|Part 2 - Maintenance|Refused EGD at Week 26|0|||
49105338|NCT03191864|158220144|FG002|Part 2 - Maintenance|Refused EGD at Week 26|1|||
49105339|NCT03191864|158220145|FG003|Part 2 - Maintenance|Refused EGD at Week 26|0|||
49105340|NCT03191864|158220146|FG004|Part 2 - Maintenance|Refused EGD at Week 26|0|||
49105341|NCT03191864|158220147|FG005|Part 2 - Maintenance|Refused EGD at Week 26|0|||
49105342|NCT03191864|158220142|FG000|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|1|||
49105343|NCT03191864|158220143|FG001|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
49105344|NCT03191864|158220144|FG002|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
49105345|NCT03191864|158220145|FG003|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
49105346|NCT03191864|158220146|FG004|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
49105347|NCT03191864|158220147|FG005|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
49105348|NCT03191864|158220142|FG000|Part 2 - Maintenance|Physician Decision|1|||
49105349|NCT03191864|158220143|FG001|Part 2 - Maintenance|Physician Decision|0|||
49105350|NCT03191864|158220144|FG002|Part 2 - Maintenance|Physician Decision|0|||
49105351|NCT03191864|158220145|FG003|Part 2 - Maintenance|Physician Decision|0|||
49105352|NCT03191864|158220146|FG004|Part 2 - Maintenance|Physician Decision|0|||
49105353|NCT03191864|158220147|FG005|Part 2 - Maintenance|Physician Decision|0|||
49105354|NCT03191864|158220142|FG000|Part 2 - Maintenance|Lack of Efficacy|1|||
49105355|NCT03191864|158220143|FG001|Part 2 - Maintenance|Lack of Efficacy|2|||
49105356|NCT03191864|158220144|FG002|Part 2 - Maintenance|Lack of Efficacy|2|||
49105357|NCT03191864|158220145|FG003|Part 2 - Maintenance|Lack of Efficacy|2|||
49105358|NCT03191864|158220146|FG004|Part 2 - Maintenance|Lack of Efficacy|10|||
49105359|NCT03191864|158220147|FG005|Part 2 - Maintenance|Lack of Efficacy|0|||
49105360|NCT03191864|158220142|FG000|Part 2 - Maintenance|Adverse Event|0|||
49105361|NCT03191864|158220143|FG001|Part 2 - Maintenance|Adverse Event|0|||
49105362|NCT03191864|158220144|FG002|Part 2 - Maintenance|Adverse Event|0|||
49105363|NCT03191864|158220145|FG003|Part 2 - Maintenance|Adverse Event|0|||
49105364|NCT03191864|158220146|FG004|Part 2 - Maintenance|Adverse Event|1|||
49105365|NCT03191864|158220147|FG005|Part 2 - Maintenance|Adverse Event|0|||
49105366|NCT03191864|158220142|FG000|Part 2 - Maintenance|Withdrawal by Subject|2|||
49105367|NCT03191864|158220143|FG001|Part 2 - Maintenance|Withdrawal by Subject|0|||
49105368|NCT03191864|158220144|FG002|Part 2 - Maintenance|Withdrawal by Subject|0|||
49105369|NCT03191864|158220145|FG003|Part 2 - Maintenance|Withdrawal by Subject|0|||
49105370|NCT03191864|158220146|FG004|Part 2 - Maintenance|Withdrawal by Subject|3|||
49105371|NCT03191864|158220147|FG005|Part 2 - Maintenance|Withdrawal by Subject|0|||
49105372|NCT03191864|158220142|FG000|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
49105373|NCT03191864|158220143|FG001|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
49105374|NCT03191864|158220144|FG002|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
49105375|NCT03191864|158220145|FG003|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
49105376|NCT03191864|158220146|FG004|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|1|||
49105377|NCT03191864|158220147|FG005|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
49105378|NCT02889835|158220148|FG000|Overall Study|Lost to Follow-up|13|||
49105379|NCT02889835|158220149|FG001|Overall Study|Lost to Follow-up|13|||
49105380|NCT02889835|158220150|FG002|Overall Study|Lost to Follow-up|13|||
49105381|NCT02889835|158220148|FG000|Overall Study|Withdrawal by Subject|2|||
49105382|NCT02889835|158220149|FG001|Overall Study|Withdrawal by Subject|2|||
49105383|NCT02889835|158220150|FG002|Overall Study|Withdrawal by Subject|2|||
49105384|NCT02889835|158220148|FG000|Overall Study|Protocol Violation|1|||
49105385|NCT02889835|158220149|FG001|Overall Study|Protocol Violation|1|||
49105386|NCT02889835|158220150|FG002|Overall Study|Protocol Violation|1|||
49105387|NCT02889835|158220148|FG000|Overall Study|Exclusion Criteria -change in oral status|1|||
49105388|NCT02889835|158220149|FG001|Overall Study|Exclusion Criteria -change in oral status|1|||
49105389|NCT02889835|158220150|FG002|Overall Study|Exclusion Criteria -change in oral status|1|||
49105390|NCT02889835|158220148|FG000|Overall Study|Death|1|||
49105391|NCT02889835|158220149|FG001|Overall Study|Death|1|||
49105392|NCT02889835|158220150|FG002|Overall Study|Death|1|||
49105393|NCT05072964|158220153|FG000|Overall Study|Withdrawal by Subject|4|||
49105394|NCT05072964|158220153|FG000|Overall Study|Death|1|||
49105395|NCT02908074|158220154|FG000|Overall Study|sponsor/ICON decision|0|||
49105396|NCT02908074|158220155|FG001|Overall Study|sponsor/ICON decision|0|||
49105397|NCT02908074|158220156|FG002|Overall Study|sponsor/ICON decision|1|||
49105398|NCT02908074|158220157|FG003|Overall Study|sponsor/ICON decision|0|||
49105399|NCT02908074|158220158|FG004|Overall Study|sponsor/ICON decision|0|||
49105400|NCT02908074|158220159|FG005|Overall Study|sponsor/ICON decision|0|||
49105401|NCT02908074|158220154|FG000|Overall Study|Protocol Violation|0|||
49105402|NCT02908074|158220155|FG001|Overall Study|Protocol Violation|1|||
49105403|NCT02908074|158220156|FG002|Overall Study|Protocol Violation|0|||
49105404|NCT02908074|158220157|FG003|Overall Study|Protocol Violation|0|||
49105405|NCT02908074|158220158|FG004|Overall Study|Protocol Violation|0|||
49105406|NCT02908074|158220159|FG005|Overall Study|Protocol Violation|0|||
49105407|NCT02908074|158220154|FG000|Overall Study|Adverse Event|5|||
49105408|NCT02908074|158220155|FG001|Overall Study|Adverse Event|2|||
49105409|NCT02908074|158220156|FG002|Overall Study|Adverse Event|0|||
49105410|NCT02908074|158220157|FG003|Overall Study|Adverse Event|0|||
49105411|NCT02908074|158220158|FG004|Overall Study|Adverse Event|1|||
49105412|NCT02908074|158220159|FG005|Overall Study|Adverse Event|0|||
49105413|NCT02908074|158220154|FG000|Overall Study|AESI|1|||
49105414|NCT02908074|158220155|FG001|Overall Study|AESI|0|||
49105415|NCT02908074|158220156|FG002|Overall Study|AESI|1|||
49105416|NCT02908074|158220157|FG003|Overall Study|AESI|0|||
49105417|NCT02908074|158220158|FG004|Overall Study|AESI|1|||
49105418|NCT02908074|158220159|FG005|Overall Study|AESI|0|||
49105419|NCT02908074|158220154|FG000|Overall Study|Discontinuation criteria per protocol|0|||
49105420|NCT02908074|158220155|FG001|Overall Study|Discontinuation criteria per protocol|0|||
49105421|NCT02908074|158220156|FG002|Overall Study|Discontinuation criteria per protocol|1|||
49105422|NCT02908074|158220157|FG003|Overall Study|Discontinuation criteria per protocol|0|||
49105423|NCT02908074|158220158|FG004|Overall Study|Discontinuation criteria per protocol|0|||
49105424|NCT02908074|158220159|FG005|Overall Study|Discontinuation criteria per protocol|1|||
49105425|NCT02908074|158220154|FG000|Overall Study|Withdrawal by Subject|3|||
49105426|NCT02908074|158220155|FG001|Overall Study|Withdrawal by Subject|2|||
49105427|NCT02908074|158220156|FG002|Overall Study|Withdrawal by Subject|2|||
49105428|NCT02908074|158220157|FG003|Overall Study|Withdrawal by Subject|2|||
49105429|NCT02908074|158220158|FG004|Overall Study|Withdrawal by Subject|2|||
49105430|NCT02908074|158220159|FG005|Overall Study|Withdrawal by Subject|2|||
49105431|NCT02908074|158220154|FG000|Overall Study|Lost to Follow-up|0|||
49105432|NCT02908074|158220155|FG001|Overall Study|Lost to Follow-up|1|||
49105433|NCT02908074|158220156|FG002|Overall Study|Lost to Follow-up|1|||
49105434|NCT02908074|158220157|FG003|Overall Study|Lost to Follow-up|1|||
49105435|NCT02908074|158220158|FG004|Overall Study|Lost to Follow-up|0|||
49105436|NCT02908074|158220159|FG005|Overall Study|Lost to Follow-up|1|||
49105437|NCT02073565|158220160|FG000|Cohort A|Withdrawal by Subject|1|||
49105438|NCT02073565|158220161|FG001|Cohort A|Withdrawal by Subject|0|||
49105439|NCT02073565|158220160|FG000|Cohort B|Withdrawal by Subject|1|||
49105440|NCT02073565|158220161|FG001|Cohort B|Withdrawal by Subject|2|||
49105441|NCT02073565|158220160|FG000|Cohort C|Withdrawal by Subject|0|||
49105442|NCT02073565|158220161|FG001|Cohort C|Withdrawal by Subject|2|||
49105443|NCT02073565|158220160|FG000|Cohort C|Lost to Follow-up|0|||
49105444|NCT02073565|158220161|FG001|Cohort C|Lost to Follow-up|2|||
49105445|NCT00778102|158220165|FG000|Overall Study|Adverse Event|8|||
49105446|NCT00778102|158220166|FG001|Overall Study|Adverse Event|5|||
49105447|NCT00778102|158220165|FG000|Overall Study|Death|1|||
49105448|NCT00778102|158220166|FG001|Overall Study|Death|1|||
49105449|NCT00778102|158220165|FG000|Overall Study|Lost to Follow-up|1|||
49105450|NCT00778102|158220166|FG001|Overall Study|Lost to Follow-up|0|||
49105451|NCT00778102|158220165|FG000|Overall Study|Violation of Selection Criteria|1|||
49105452|NCT00778102|158220166|FG001|Overall Study|Violation of Selection Criteria|1|||
49105453|NCT00778102|158220165|FG000|Overall Study|Protocol Violation|0|||
49105454|NCT00778102|158220166|FG001|Overall Study|Protocol Violation|1|||
49105455|NCT00778102|158220165|FG000|Overall Study|Refused Treatment|2|||
49105456|NCT00778102|158220166|FG001|Overall Study|Refused Treatment|3|||
49105457|NCT00778102|158220165|FG000|Overall Study|Withdrawal by Subject|1|||
49105458|NCT00778102|158220166|FG001|Overall Study|Withdrawal by Subject|1|||
49105459|NCT00778102|158220165|FG000|Overall Study|Administrative Reason|7|||
49105460|NCT00778102|158220166|FG001|Overall Study|Administrative Reason|10|||
49105461|NCT00932451|158220171|FG000|Overall Study|Withdrawal by Subject|69|||
49105462|NCT00932451|158220171|FG000|Overall Study|Lost to Follow-up|22|||
49105463|NCT00932451|158220171|FG000|Overall Study|Death|726|||
49105464|NCT00932451|158220171|FG000|Overall Study|Other reasons|5|||
49105465|NCT00394433|158220172|FG000|Overall Study|Adverse Event|2|||
49105466|NCT00394433|158220172|FG000|Overall Study|Alternative Therapy|1|||
49105467|NCT03646305|158220173|FG000|Overall Study|Lost to Follow-up|4|||
49105468|NCT03646305|158220174|FG001|Overall Study|Lost to Follow-up|2|||
49105469|NCT03646305|158220175|FG002|Overall Study|Lost to Follow-up|2|||
49105470|NCT03646305|158220176|FG003|Overall Study|Lost to Follow-up|1|||
49105471|NCT03646305|158220173|FG000|Overall Study|Withdrawal by Subject|1|||
49105472|NCT03646305|158220174|FG001|Overall Study|Withdrawal by Subject|0|||
49105473|NCT03646305|158220175|FG002|Overall Study|Withdrawal by Subject|0|||
49105474|NCT03646305|158220176|FG003|Overall Study|Withdrawal by Subject|1|||
49105475|NCT00787917|158220177|FG000|Blinded Treatment|Adverse Event|1|||
49105476|NCT00787917|158220178|FG001|Blinded Treatment|Adverse Event|0|||
49105477|NCT00787917|158220177|FG000|Blinded Treatment|Lack of Efficacy|1|||
49105478|NCT00787917|158220178|FG001|Blinded Treatment|Lack of Efficacy|0|||
49105479|NCT00787917|158220177|FG000|Blinded Treatment|Administrative problems|3|||
49105480|NCT00787917|158220178|FG001|Blinded Treatment|Administrative problems|2|||
49105481|NCT00787917|158220177|FG000|Open Label|Unsatisfactory therapeutic effect|1|||
49105482|NCT00787917|158220178|FG001|Open Label|Unsatisfactory therapeutic effect|0|||
49105483|NCT00787917|158220177|FG000|Open Label|Administrative problems|3|||
49105484|NCT00787917|158220178|FG001|Open Label|Administrative problems|0|||
49105485|NCT01085136|158220179|FG000|Part A|Other Adverse event|223|||
49105486|NCT01085136|158220180|FG001|Part A|Other Adverse event|0|||
49105487|NCT01085136|158220181|FG002|Part A|Other Adverse event|0|||
49105488|NCT01085136|158220179|FG000|Part A|Protocol Violation|3|||
49105489|NCT01085136|158220180|FG001|Part A|Protocol Violation|0|||
49105490|NCT01085136|158220181|FG002|Part A|Protocol Violation|0|||
49105491|NCT01085136|158220179|FG000|Part A|Lost to Follow-up|3|||
49105492|NCT01085136|158220180|FG001|Part A|Lost to Follow-up|0|||
49105493|NCT01085136|158220181|FG002|Part A|Lost to Follow-up|0|||
49105494|NCT01085136|158220179|FG000|Part A|Refusal to continue trial medication|64|||
49105495|NCT01085136|158220180|FG001|Part A|Refusal to continue trial medication|0|||
49105496|NCT01085136|158220181|FG002|Part A|Refusal to continue trial medication|0|||
49105497|NCT01085136|158220179|FG000|Part A|Other reason not defined above|30|||
49105498|NCT01085136|158220180|FG001|Part A|Other reason not defined above|0|||
49105499|NCT01085136|158220181|FG002|Part A|Other reason not defined above|0|||
49105500|NCT01085136|158220179|FG000|Part B|Other AE|0|||
49105501|NCT01085136|158220180|FG001|Part B|Other AE|29|||
49105502|NCT01085136|158220181|FG002|Part B|Other AE|8|||
49105503|NCT01085136|158220179|FG000|Part B|Refusal to continue trial medication|0|||
49105504|NCT01085136|158220180|FG001|Part B|Refusal to continue trial medication|12|||
49105505|NCT01085136|158220181|FG002|Part B|Refusal to continue trial medication|7|||
49105506|NCT01085136|158220179|FG000|Part B|Not treated|0|||
49105507|NCT01085136|158220180|FG001|Part B|Not treated|4|||
49105508|NCT01085136|158220181|FG002|Part B|Not treated|8|||
49105509|NCT01085136|158220179|FG000|Part B|Other reason not defined above|0|||
49105510|NCT01085136|158220180|FG001|Part B|Other reason not defined above|6|||
49105511|NCT01085136|158220181|FG002|Part B|Other reason not defined above|3|||
49105512|NCT04683939|158220182|FG000|Overall Study|Study termination by the sponsor|0|||
49105513|NCT04683939|158220183|FG001|Overall Study|Study termination by the sponsor|1|||
49105514|NCT04683939|158220184|FG002|Overall Study|Study termination by the sponsor|2|||
49105515|NCT04683939|158220185|FG003|Overall Study|Study termination by the sponsor|2|||
49105516|NCT04683939|158220182|FG000|Overall Study|Death|1|||
49105517|NCT04683939|158220183|FG001|Overall Study|Death|1|||
49105518|NCT04683939|158220184|FG002|Overall Study|Death|2|||
49105519|NCT04683939|158220185|FG003|Overall Study|Death|1|||
49105520|NCT04683939|158220182|FG000|Overall Study|Withdrawal by Subject|1|||
49105521|NCT04683939|158220183|FG001|Overall Study|Withdrawal by Subject|0|||
49105522|NCT04683939|158220184|FG002|Overall Study|Withdrawal by Subject|0|||
49105523|NCT04683939|158220185|FG003|Overall Study|Withdrawal by Subject|0|||
49105524|NCT04683939|158220182|FG000|Overall Study|Physician Decision|1|||
49105525|NCT04683939|158220183|FG001|Overall Study|Physician Decision|0|||
49105526|NCT04683939|158220184|FG002|Overall Study|Physician Decision|0|||
49105527|NCT04683939|158220185|FG003|Overall Study|Physician Decision|0|||
49105528|NCT04683939|158220182|FG000|Overall Study|Lost to Follow-up|0|||
49105529|NCT04683939|158220183|FG001|Overall Study|Lost to Follow-up|1|||
49105530|NCT04683939|158220184|FG002|Overall Study|Lost to Follow-up|0|||
49105531|NCT04683939|158220185|FG003|Overall Study|Lost to Follow-up|0|||
49105532|NCT00784550|158221467|FG000|Overall Study|Adverse Event|12|||
49105533|NCT00784550|158221468|FG001|Overall Study|Adverse Event|10|||
49105534|NCT00784550|158221467|FG000|Overall Study|Lack of Efficacy|0|||
49105535|NCT00784550|158221468|FG001|Overall Study|Lack of Efficacy|1|||
49105536|NCT00784550|158221467|FG000|Overall Study|Protocol Violation|10|||
49105537|NCT00784550|158221468|FG001|Overall Study|Protocol Violation|10|||
49105538|NCT00784550|158221467|FG000|Overall Study|Lost to Follow-up|8|||
49105539|NCT00784550|158221468|FG001|Overall Study|Lost to Follow-up|5|||
49105540|NCT00784550|158221467|FG000|Overall Study|Physician Decision|2|||
49105541|NCT00784550|158221468|FG001|Overall Study|Physician Decision|3|||
49105542|NCT00784550|158221467|FG000|Overall Study|Withdrawal by Subject|4|||
49105543|NCT00784550|158221468|FG001|Overall Study|Withdrawal by Subject|13|||
49105544|NCT00401544|158221469|FG000|Overall Study|Adverse Event|5|||
49105545|NCT00401544|158221470|FG001|Overall Study|Adverse Event|1|||
49105546|NCT00401544|158221471|FG002|Overall Study|Adverse Event|1|||
49105547|NCT00401544|158221472|FG003|Overall Study|Adverse Event|1|||
49105548|NCT00401544|158221469|FG000|Overall Study|Death|3|||
49105549|NCT00401544|158221470|FG001|Overall Study|Death|6|||
49105550|NCT00401544|158221471|FG002|Overall Study|Death|2|||
49105551|NCT00401544|158221472|FG003|Overall Study|Death|5|||
49105552|NCT00401544|158221469|FG000|Overall Study|Lost to Follow-up|2|||
49105553|NCT00401544|158221470|FG001|Overall Study|Lost to Follow-up|0|||
49105554|NCT00401544|158221471|FG002|Overall Study|Lost to Follow-up|1|||
49105555|NCT00401544|158221472|FG003|Overall Study|Lost to Follow-up|1|||
49105556|NCT00401544|158221469|FG000|Overall Study|Withdrawal by Subject|7|||
49105557|NCT00401544|158221470|FG001|Overall Study|Withdrawal by Subject|6|||
49105558|NCT00401544|158221471|FG002|Overall Study|Withdrawal by Subject|6|||
49105559|NCT00401544|158221472|FG003|Overall Study|Withdrawal by Subject|5|||
49105560|NCT00401544|158221469|FG000|Overall Study|Physician Decision|1|||
49105561|NCT00401544|158221470|FG001|Overall Study|Physician Decision|3|||
49105562|NCT00401544|158221471|FG002|Overall Study|Physician Decision|0|||
49105563|NCT00401544|158221472|FG003|Overall Study|Physician Decision|0|||
49105564|NCT00401544|158221469|FG000|Overall Study|Ineligibility determined|0|||
49105565|NCT00401544|158221470|FG001|Overall Study|Ineligibility determined|1|||
49105566|NCT00401544|158221471|FG002|Overall Study|Ineligibility determined|0|||
49105567|NCT00401544|158221472|FG003|Overall Study|Ineligibility determined|2|||
49105568|NCT00401544|158221469|FG000|Overall Study|Disease progression|0|||
49105569|NCT00401544|158221470|FG001|Overall Study|Disease progression|1|||
49105570|NCT00401544|158221471|FG002|Overall Study|Disease progression|0|||
49105571|NCT00401544|158221472|FG003|Overall Study|Disease progression|0|||
49105572|NCT00401544|158221469|FG000|Overall Study|Other|0|||
49105573|NCT00401544|158221470|FG001|Overall Study|Other|0|||
49105574|NCT00401544|158221471|FG002|Overall Study|Other|2|||
49105575|NCT00401544|158221472|FG003|Overall Study|Other|2|||
49105576|NCT01826370|158221480|FG000|Overall Study|Protocol Violation|6|||
49105577|NCT01826370|158221480|FG000|Overall Study|Lost to Follow-up|12|||
49105578|NCT01826370|158221480|FG000|Overall Study|Other reason not defined above|2|||
49105579|NCT03570554|158221481|FG000|Overall Study|Non-compliance with study drug|0|||
49105580|NCT03570554|158221482|FG001|Overall Study|Non-compliance with study drug|0|||
49105581|NCT03570554|158221483|FG002|Overall Study|Non-compliance with study drug|1|||
49105582|NCT03570554|158221484|FG003|Overall Study|Non-compliance with study drug|0|||
49105583|NCT03570554|158221481|FG000|Overall Study|Adverse Event|0|||
49105584|NCT03570554|158221482|FG001|Overall Study|Adverse Event|0|||
49105585|NCT03570554|158221483|FG002|Overall Study|Adverse Event|0|||
49105586|NCT03570554|158221484|FG003|Overall Study|Adverse Event|1|||
49105587|NCT03332628|158221498|FG000|Overall Study|Physician Decision|2|||
49105588|NCT04696861|158221499|FG000|Overall Study|Death|1|||
49105589|NCT04696861|158221500|FG001|Overall Study|Death|0|||
49105590|NCT04696861|158221499|FG000|Overall Study|Lost to Follow-up|3|||
49105591|NCT04696861|158221500|FG001|Overall Study|Lost to Follow-up|0|||
49105592|NCT02134353|158221503|FG000|Overall Study|Adverse Event|10|||
49105593|NCT02134353|158221504|FG001|Overall Study|Adverse Event|6|||
49105594|NCT02134353|158221503|FG000|Overall Study|Lost to Follow-up|1|||
49105595|NCT02134353|158221504|FG001|Overall Study|Lost to Follow-up|1|||
49105596|NCT02134353|158221503|FG000|Overall Study|Lack of Efficacy|2|||
49105597|NCT02134353|158221504|FG001|Overall Study|Lack of Efficacy|1|||
49105598|NCT02134353|158221503|FG000|Overall Study|Withdrawal by Subject|12|||
49105599|NCT02134353|158221504|FG001|Overall Study|Withdrawal by Subject|13|||
49105600|NCT02134353|158221503|FG000|Overall Study|Death|0|||
49105601|NCT02134353|158221504|FG001|Overall Study|Death|1|||
49105602|NCT02134353|158221503|FG000|Overall Study|Pregnancy|0|||
49105603|NCT02134353|158221504|FG001|Overall Study|Pregnancy|1|||
49105604|NCT02134353|158221503|FG000|Overall Study|Relocation|1|||
49105605|NCT02134353|158221504|FG001|Overall Study|Relocation|0|||
49105606|NCT02134353|158221503|FG000|Overall Study|Other - Patient's Choice|0|||
49105607|NCT02134353|158221504|FG001|Overall Study|Other - Patient's Choice|1|||
49105608|NCT00766467|158221513|FG000|Overall Study|Withdrawal by Subject|7|||
49105609|NCT00766467|158221514|FG001|Overall Study|Withdrawal by Subject|2|||
49105610|NCT00766467|158221513|FG000|Overall Study|Adverse Event|1|||
49105611|NCT00766467|158221514|FG001|Overall Study|Adverse Event|1|||
49105612|NCT00766467|158221513|FG000|Overall Study|Protocol Violation|2|||
49105613|NCT00766467|158221514|FG001|Overall Study|Protocol Violation|4|||
49105614|NCT00766467|158221513|FG000|Overall Study|Tumor Progression on Study|0|||
49105615|NCT00766467|158221514|FG001|Overall Study|Tumor Progression on Study|1|||
49105616|NCT00766467|158221513|FG000|Overall Study|Physician Decision|1|||
49105617|NCT00766467|158221514|FG001|Overall Study|Physician Decision|0|||
49105618|NCT01917344|158221519|FG000|Overall Study|Withdrawal by Subject|1|||
49105619|NCT02956057|158221520|FG000|Overall Study|Discontinued intervention|14|||
49105620|NCT02956057|158221521|FG001|Overall Study|Discontinued intervention|10|||
49105621|NCT02956057|158221522|FG002|Overall Study|Discontinued intervention|7|||
49105622|NCT02956057|158221523|FG003|Overall Study|Discontinued intervention|14|||
49105623|NCT02956057|158221524|FG004|Overall Study|Discontinued intervention|4|||
49105624|NCT02956057|158221525|FG005|Overall Study|Discontinued intervention|17|||
49105625|NCT02956057|158221520|FG000|Overall Study|Lost to Follow-up|0|||
49105626|NCT02956057|158221521|FG001|Overall Study|Lost to Follow-up|2|||
49105627|NCT02956057|158221522|FG002|Overall Study|Lost to Follow-up|1|||
49105628|NCT02956057|158221523|FG003|Overall Study|Lost to Follow-up|1|||
49105629|NCT02956057|158221524|FG004|Overall Study|Lost to Follow-up|1|||
49105630|NCT02956057|158221525|FG005|Overall Study|Lost to Follow-up|0|||
49105631|NCT02505334|158221534|FG000|Main Treatment Period|Adverse Event|3|||
49105632|NCT02505334|158221535|FG001|Main Treatment Period|Adverse Event|3|||
49105633|NCT02505334|158221534|FG000|Main Treatment Period|Lack of Efficacy|7|||
49105634|NCT02505334|158221535|FG001|Main Treatment Period|Lack of Efficacy|17|||
49105635|NCT02505334|158221534|FG000|Main Treatment Period|Protocol Violation|0|||
49105636|NCT02505334|158221535|FG001|Main Treatment Period|Protocol Violation|1|||
49105637|NCT02505334|158221534|FG000|Main Treatment Period|Withdrawal by Subject|1|||
49105638|NCT02505334|158221535|FG001|Main Treatment Period|Withdrawal by Subject|8|||
49105639|NCT02505334|158221534|FG000|Main Treatment Period|Unclassified|4|||
49105640|NCT02505334|158221535|FG001|Main Treatment Period|Unclassified|10|||
49105641|NCT02505334|158221534|FG000|Extension Treatment Period|Adverse Event|5|||
49105642|NCT02505334|158221535|FG001|Extension Treatment Period|Adverse Event|0|||
49105643|NCT02505334|158221534|FG000|Extension Treatment Period|Lack of Efficacy|4|||
49105644|NCT02505334|158221535|FG001|Extension Treatment Period|Lack of Efficacy|0|||
49105645|NCT02505334|158221534|FG000|Extension Treatment Period|Withdrawal by Subject|6|||
49105646|NCT02505334|158221535|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
49105647|NCT02505334|158221534|FG000|Extension Treatment Period|Unclassified|3|||
49105648|NCT02505334|158221535|FG001|Extension Treatment Period|Unclassified|0|||
49105649|NCT03435224|158221540|FG000|Overall Study|Unable to achieve a minimum desaturation level|4|||
49105650|NCT01549041|158221545|FG000|Overall Study|Lack of Efficacy|2|||
49105651|NCT01549041|158221546|FG001|Overall Study|Lack of Efficacy|4|||
49105652|NCT01549041|158221545|FG000|Overall Study|Adverse Event|0|||
49105653|NCT01549041|158221546|FG001|Overall Study|Adverse Event|4|||
49105654|NCT00367484|158221548|FG000|Overall Study|Adverse Event|7|||
49105655|NCT00367484|158221548|FG000|Overall Study|Withdrew informed consent|5|||
49105656|NCT00367484|158221548|FG000|Overall Study|Travel to USA|1|||
49105657|NCT00367484|158221548|FG000|Overall Study|Lost to Follow-up|1|||
49105658|NCT00367484|158221548|FG000|Overall Study|Protocol Violation|1|||
49105659|NCT00367484|158221548|FG000|Overall Study|The choice of the patient|1|||
49105660|NCT00367484|158221548|FG000|Overall Study|Lack of Efficacy|1|||
49105661|NCT00597506|158221549|FG000|Overall Study|Subject is being followed for survival|1|||
49105662|NCT02386345|158221558|FG000|Overall Study|Not treated|14|||
49105663|NCT02386345|158221558|FG000|Overall Study|Lost to Follow-up|1|||
49105664|NCT02386345|158221558|FG000|Overall Study|Adverse Event|5|||
49105665|NCT02386345|158221558|FG000|Overall Study|Repeat Procedure|10|||
49105666|NCT02386345|158221558|FG000|Overall Study|Did not complete 12-month follow-up|72|||
49105667|NCT00379808|158221559|FG000|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0|||
49105668|NCT00379808|158221560|FG001|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1|||
49105669|NCT02279745|158221562|FG000|Overall Study|Adverse Event|7|||
49105670|NCT02279745|158221562|FG000|Overall Study|Death|6|||
49105671|NCT02279745|158221562|FG000|Overall Study|Clinical Worsening as Defined by Protocol|2|||
49105672|NCT02279745|158221562|FG000|Overall Study|Withdrawal by Subject|2|||
49105673|NCT02279745|158221562|FG000|Overall Study|Pregnancy|1|||
49105674|NCT02279745|158221562|FG000|Overall Study|Study Non-compliance|1|||
49105675|NCT02279745|158221562|FG000|Overall Study|Did Not Transition to Study ROR-PH-303|1|||
49105676|NCT01987232|158221578|FG000|Overall Study|Ongoing in Study|0|||
49105677|NCT01987232|158221579|FG001|Overall Study|Ongoing in Study|0|||
49105678|NCT01987232|158221580|FG002|Overall Study|Ongoing in Study|0|||
49105679|NCT01987232|158221581|FG003|Overall Study|Ongoing in Study|1|||
49105680|NCT01987232|158221582|FG004|Overall Study|Ongoing in Study|0|||
49105681|NCT01675154|158221588|FG000|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
49105682|NCT01675154|158221589|FG001|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1|||
49105683|NCT01675154|158221590|FG002|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
49105684|NCT01675154|158221591|FG003|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
49105685|NCT03634033|158221593|FG000|Overall Study|Did not have a post-assessment|384|||
49105686|NCT03634033|158221594|FG001|Overall Study|Did not have a post-assessment|291|||
49105687|NCT03634033|158221595|FG002|Overall Study|Did not have a post-assessment|114|||
49105688|NCT03634033|158221596|FG003|Overall Study|Did not have a post-assessment|161|||
49105689|NCT03634033|158221597|FG004|Overall Study|Did not have a post-assessment|5|||
49105690|NCT03634033|158221598|FG005|Overall Study|Did not have a post-assessment|0|||
49105691|NCT03634033|158221599|FG006|Overall Study|Did not have a post-assessment|0|||
49105692|NCT03634033|158221593|FG000|Overall Study|Death|0|||
49105693|NCT03634033|158221594|FG001|Overall Study|Death|0|||
49105694|NCT03634033|158221595|FG002|Overall Study|Death|0|||
49105695|NCT03634033|158221596|FG003|Overall Study|Death|0|||
49105696|NCT03634033|158221597|FG004|Overall Study|Death|0|||
49105697|NCT03634033|158221598|FG005|Overall Study|Death|7|||
49105698|NCT03634033|158221599|FG006|Overall Study|Death|7|||
49105699|NCT03634033|158221593|FG000|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
49105700|NCT03634033|158221594|FG001|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
49105701|NCT03634033|158221595|FG002|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
49105702|NCT03634033|158221596|FG003|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
49105703|NCT03634033|158221597|FG004|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
49105704|NCT03634033|158221598|FG005|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
49105705|NCT03634033|158221599|FG006|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
49105706|NCT03634033|158221593|FG000|Overall Study|Lost to Follow-up|0|||
49105707|NCT03634033|158221594|FG001|Overall Study|Lost to Follow-up|0|||
49105708|NCT03634033|158221595|FG002|Overall Study|Lost to Follow-up|0|||
49105709|NCT03634033|158221596|FG003|Overall Study|Lost to Follow-up|0|||
49105710|NCT03634033|158221597|FG004|Overall Study|Lost to Follow-up|0|||
49105711|NCT03634033|158221598|FG005|Overall Study|Lost to Follow-up|1|||
49105712|NCT03634033|158221599|FG006|Overall Study|Lost to Follow-up|2|||
49105713|NCT03634033|158221593|FG000|Overall Study|Withdrawal by Subject|0|||
49105714|NCT03634033|158221594|FG001|Overall Study|Withdrawal by Subject|0|||
49105715|NCT03634033|158221595|FG002|Overall Study|Withdrawal by Subject|0|||
49105716|NCT03634033|158221596|FG003|Overall Study|Withdrawal by Subject|0|||
49105717|NCT03634033|158221597|FG004|Overall Study|Withdrawal by Subject|0|||
49105718|NCT03634033|158221598|FG005|Overall Study|Withdrawal by Subject|0|||
49105719|NCT03634033|158221599|FG006|Overall Study|Withdrawal by Subject|1|||
49105720|NCT00415597|158221600|FG000|Enrollment|Withdrawal by Subject|1|||
49105721|NCT00415597|158221600|FG000|Enrollment|Protocol Violation|1|||
49105722|NCT00415597|158221600|FG000|Treatment|Adverse Event|110|||
49105723|NCT00415597|158221600|FG000|Treatment|Lack of Efficacy|39|||
49105724|NCT00415597|158221600|FG000|Treatment|Protocol Violation|67|||
49105725|NCT00415597|158221600|FG000|Treatment|Physician Decision|3|||
49105726|NCT00415597|158221600|FG000|Treatment|Withdrawal by Subject|51|||
49105727|NCT00415597|158221600|FG000|Treatment|Lost to Follow-up|28|||
49105728|NCT00415597|158221600|FG000|Treatment|Drug Screen|2|||
49105729|NCT00415597|158221600|FG000|Treatment|Administrative|3|||
49105730|NCT00415597|158221600|FG000|Treatment|Sponsor Decision|1|||
49105731|NCT00415597|158221600|FG000|Treatment|Multiple Reasons|1|||
49105732|NCT01447927|158221601|FG000|Overall Study|Adverse Event|4|||
49105733|NCT01447927|158221602|FG001|Overall Study|Adverse Event|3|||
49105734|NCT01447927|158221601|FG000|Overall Study|Withdrawal by Subject|1|||
49105735|NCT01447927|158221602|FG001|Overall Study|Withdrawal by Subject|0|||
49105736|NCT02987972|158221604|FG000|Overall Study|Adverse Event|1|||
49105737|NCT02987972|158221605|FG001|Overall Study|Adverse Event|1|||
49105738|NCT02987972|158221606|FG002|Overall Study|Adverse Event|0|||
49105739|NCT02987972|158221604|FG000|Overall Study|Death|1|||
49105740|NCT02987972|158221605|FG001|Overall Study|Death|0|||
49105741|NCT02987972|158221606|FG002|Overall Study|Death|0|||
49105742|NCT02987972|158221604|FG000|Overall Study|Lack of Efficacy|9|||
49105743|NCT02987972|158221605|FG001|Overall Study|Lack of Efficacy|12|||
49105744|NCT02987972|158221606|FG002|Overall Study|Lack of Efficacy|12|||
49105745|NCT02987972|158221604|FG000|Overall Study|Lost to Follow-up|7|||
49105746|NCT02987972|158221605|FG001|Overall Study|Lost to Follow-up|8|||
49105747|NCT02987972|158221606|FG002|Overall Study|Lost to Follow-up|4|||
49105748|NCT02987972|158221604|FG000|Overall Study|Physician Decision|1|||
49105749|NCT02987972|158221605|FG001|Overall Study|Physician Decision|6|||
49105750|NCT02987972|158221606|FG002|Overall Study|Physician Decision|0|||
49105751|NCT02987972|158221604|FG000|Overall Study|Protocol Violation|2|||
49105752|NCT02987972|158221605|FG001|Overall Study|Protocol Violation|1|||
49105753|NCT02987972|158221606|FG002|Overall Study|Protocol Violation|5|||
49105754|NCT02987972|158221604|FG000|Overall Study|Withdrawal by Subject|22|||
49105755|NCT02987972|158221605|FG001|Overall Study|Withdrawal by Subject|17|||
49105756|NCT02987972|158221606|FG002|Overall Study|Withdrawal by Subject|21|||
49105757|NCT02342548|158221607|FG000|Overall Study|Adverse Event|12|||
49105758|NCT02342548|158221608|FG001|Overall Study|Adverse Event|17|||
49105759|NCT02342548|158221609|FG002|Overall Study|Adverse Event|13|||
49105760|NCT02342548|158221607|FG000|Overall Study|Lost to Follow-up|0|||
49105761|NCT02342548|158221608|FG001|Overall Study|Lost to Follow-up|1|||
49105762|NCT02342548|158221609|FG002|Overall Study|Lost to Follow-up|0|||
49105763|NCT02342548|158221607|FG000|Overall Study|Study terminated by sponsor|20|||
49105764|NCT02342548|158221608|FG001|Overall Study|Study terminated by sponsor|39|||
49105765|NCT02342548|158221609|FG002|Overall Study|Study terminated by sponsor|25|||
49105766|NCT02342548|158221607|FG000|Overall Study|Protocol Violation|0|||
49105767|NCT02342548|158221608|FG001|Overall Study|Protocol Violation|1|||
49105768|NCT02342548|158221609|FG002|Overall Study|Protocol Violation|0|||
49105769|NCT02342548|158221607|FG000|Overall Study|Withdrawal by Subject|1|||
49105770|NCT02342548|158221608|FG001|Overall Study|Withdrawal by Subject|3|||
49105771|NCT02342548|158221609|FG002|Overall Study|Withdrawal by Subject|4|||
49105772|NCT02342548|158221607|FG000|Overall Study|Other|1|||
49105773|NCT02342548|158221608|FG001|Overall Study|Other|1|||
49105774|NCT02342548|158221609|FG002|Overall Study|Other|1|||
49105775|NCT03495154|158221612|FG000|Overall Study|Screen Failures Pre-Operatively|4|||
49105776|NCT03495154|158221612|FG000|Overall Study|Withdrawn Prior to Surgery|10|||
49105777|NCT03495154|158221612|FG000|Overall Study|Screen Failures During Surgery|6|||
49105778|NCT03495154|158221612|FG000|Overall Study|Death|2|||
49105779|NCT03495154|158221612|FG000|Overall Study|Lost to Follow-up|16|||
49105780|NCT03495154|158221612|FG000|Overall Study|Withdrawal by Subject|2|||
49105781|NCT03495154|158221612|FG000|Overall Study|Unable to gather information from subject due to age and limited abilities|1|||
49105782|NCT01764997|158221613|FG000|Run-in Period|Adverse Event|15|||
49105783|NCT01764997|158221614|FG001|Run-in Period|Adverse Event|0|||
49105784|NCT01764997|158221615|FG002|Run-in Period|Adverse Event|0|||
49105785|NCT01764997|158221616|FG003|Run-in Period|Adverse Event|0|||
49105786|NCT01764997|158221617|FG004|Run-in Period|Adverse Event|0|||
49105787|NCT01764997|158221613|FG000|Run-in Period|Lack of Efficacy|5|||
49105788|NCT01764997|158221614|FG001|Run-in Period|Lack of Efficacy|0|||
49105789|NCT01764997|158221615|FG002|Run-in Period|Lack of Efficacy|0|||
49105790|NCT01764997|158221616|FG003|Run-in Period|Lack of Efficacy|0|||
49105791|NCT01764997|158221617|FG004|Run-in Period|Lack of Efficacy|0|||
49105792|NCT01764997|158221613|FG000|Run-in Period|Poor compliance to protocol|1|||
49105793|NCT01764997|158221614|FG001|Run-in Period|Poor compliance to protocol|0|||
49105794|NCT01764997|158221615|FG002|Run-in Period|Poor compliance to protocol|0|||
49105795|NCT01764997|158221616|FG003|Run-in Period|Poor compliance to protocol|0|||
49105796|NCT01764997|158221617|FG004|Run-in Period|Poor compliance to protocol|0|||
49105797|NCT01764997|158221613|FG000|Run-in Period|Other than specified above|17|||
49105798|NCT01764997|158221614|FG001|Run-in Period|Other than specified above|0|||
49105799|NCT01764997|158221615|FG002|Run-in Period|Other than specified above|0|||
49105800|NCT01764997|158221616|FG003|Run-in Period|Other than specified above|0|||
49105801|NCT01764997|158221617|FG004|Run-in Period|Other than specified above|0|||
49105802|NCT01764997|158221613|FG000|Study Drug Treatment Period|Adverse Event|0|||
49105803|NCT01764997|158221614|FG001|Study Drug Treatment Period|Adverse Event|1|||
49105804|NCT01764997|158221615|FG002|Study Drug Treatment Period|Adverse Event|0|||
49105805|NCT01764997|158221616|FG003|Study Drug Treatment Period|Adverse Event|0|||
49105806|NCT01764997|158221617|FG004|Study Drug Treatment Period|Adverse Event|24|||
49105807|NCT01764997|158221613|FG000|Study Drug Treatment Period|Lack of Efficacy|0|||
49105808|NCT01764997|158221614|FG001|Study Drug Treatment Period|Lack of Efficacy|0|||
49105809|NCT01764997|158221615|FG002|Study Drug Treatment Period|Lack of Efficacy|0|||
49105810|NCT01764997|158221616|FG003|Study Drug Treatment Period|Lack of Efficacy|0|||
49105811|NCT01764997|158221617|FG004|Study Drug Treatment Period|Lack of Efficacy|2|||
49105812|NCT01764997|158221613|FG000|Study Drug Treatment Period|Other than specified above|0|||
49105813|NCT01764997|158221614|FG001|Study Drug Treatment Period|Other than specified above|0|||
49105814|NCT01764997|158221615|FG002|Study Drug Treatment Period|Other than specified above|0|||
49105815|NCT01764997|158221616|FG003|Study Drug Treatment Period|Other than specified above|0|||
49105816|NCT01764997|158221617|FG004|Study Drug Treatment Period|Other than specified above|10|||
49105817|NCT03521817|158221619|FG000|Overall Study|Protocol Violation|0|||
49105818|NCT03521817|158221620|FG001|Overall Study|Protocol Violation|1|||
49105819|NCT03168919|158221621|FG000|Overall Study|Withdrawal by Subject|2|||
49105820|NCT04015518|158221622|FG000|Overall Study|Adverse Event|6|||
49105821|NCT04015518|158221623|FG001|Overall Study|Adverse Event|1|||
49105822|NCT04015518|158221624|FG002|Overall Study|Adverse Event|1|||
49105823|NCT04015518|158221625|FG003|Overall Study|Adverse Event|3|||
49105824|NCT04015518|158221626|FG004|Overall Study|Adverse Event|3|||
49105825|NCT04015518|158221622|FG000|Overall Study|Lack of Efficacy|1|||
49105826|NCT04015518|158221623|FG001|Overall Study|Lack of Efficacy|0|||
49105827|NCT04015518|158221624|FG002|Overall Study|Lack of Efficacy|1|||
49105828|NCT04015518|158221625|FG003|Overall Study|Lack of Efficacy|0|||
49105829|NCT04015518|158221626|FG004|Overall Study|Lack of Efficacy|4|||
49105830|NCT04015518|158221622|FG000|Overall Study|Lost to Follow-up|0|||
49105831|NCT04015518|158221623|FG001|Overall Study|Lost to Follow-up|0|||
49105832|NCT04015518|158221624|FG002|Overall Study|Lost to Follow-up|0|||
49105833|NCT04015518|158221625|FG003|Overall Study|Lost to Follow-up|0|||
49105834|NCT04015518|158221626|FG004|Overall Study|Lost to Follow-up|1|||
49105835|NCT04015518|158221622|FG000|Overall Study|Withdrawal by Subject|0|||
49105836|NCT04015518|158221623|FG001|Overall Study|Withdrawal by Subject|1|||
49105837|NCT04015518|158221624|FG002|Overall Study|Withdrawal by Subject|0|||
49105838|NCT04015518|158221625|FG003|Overall Study|Withdrawal by Subject|1|||
49105839|NCT04015518|158221626|FG004|Overall Study|Withdrawal by Subject|1|||
49105840|NCT04015518|158221622|FG000|Overall Study|Patient did not come for consecutive visits|0|||
49105841|NCT04015518|158221623|FG001|Overall Study|Patient did not come for consecutive visits|1|||
49105842|NCT04015518|158221624|FG002|Overall Study|Patient did not come for consecutive visits|0|||
49105843|NCT04015518|158221625|FG003|Overall Study|Patient did not come for consecutive visits|0|||
49105844|NCT04015518|158221626|FG004|Overall Study|Patient did not come for consecutive visits|0|||
49105845|NCT04015518|158221622|FG000|Overall Study|not willing to travel due to Covid-19|0|||
49105846|NCT04015518|158221623|FG001|Overall Study|not willing to travel due to Covid-19|0|||
49105847|NCT04015518|158221624|FG002|Overall Study|not willing to travel due to Covid-19|1|||
49105848|NCT04015518|158221625|FG003|Overall Study|not willing to travel due to Covid-19|0|||
49105849|NCT04015518|158221626|FG004|Overall Study|not willing to travel due to Covid-19|0|||
49105850|NCT04015518|158221622|FG000|Overall Study|Patient wants to discontinue treatment|0|||
49105851|NCT04015518|158221623|FG001|Overall Study|Patient wants to discontinue treatment|0|||
49105852|NCT04015518|158221624|FG002|Overall Study|Patient wants to discontinue treatment|0|||
49105853|NCT04015518|158221625|FG003|Overall Study|Patient wants to discontinue treatment|1|||
49105854|NCT04015518|158221626|FG004|Overall Study|Patient wants to discontinue treatment|0|||
49105855|NCT04015518|158221622|FG000|Overall Study|Difficult for patient to come to the hospital|0|||
49105856|NCT04015518|158221623|FG001|Overall Study|Difficult for patient to come to the hospital|0|||
49105857|NCT04015518|158221624|FG002|Overall Study|Difficult for patient to come to the hospital|0|||
49105858|NCT04015518|158221625|FG003|Overall Study|Difficult for patient to come to the hospital|0|||
49105859|NCT04015518|158221626|FG004|Overall Study|Difficult for patient to come to the hospital|1|||
49105860|NCT04015518|158221622|FG000|Overall Study|Pregnancy|0|||
49105861|NCT04015518|158221623|FG001|Overall Study|Pregnancy|0|||
49105862|NCT04015518|158221624|FG002|Overall Study|Pregnancy|0|||
49105863|NCT04015518|158221625|FG003|Overall Study|Pregnancy|0|||
49105864|NCT04015518|158221626|FG004|Overall Study|Pregnancy|1|||
49105865|NCT04015518|158221622|FG000|Overall Study|Personal reasons|1|||
49105866|NCT04015518|158221623|FG001|Overall Study|Personal reasons|0|||
49105867|NCT04015518|158221624|FG002|Overall Study|Personal reasons|0|||
49105868|NCT04015518|158221625|FG003|Overall Study|Personal reasons|0|||
49105869|NCT04015518|158221626|FG004|Overall Study|Personal reasons|1|||
49105870|NCT04015518|158221622|FG000|Overall Study|Withdrew consent|1|||
49105871|NCT04015518|158221623|FG001|Overall Study|Withdrew consent|0|||
49105872|NCT04015518|158221624|FG002|Overall Study|Withdrew consent|0|||
49105873|NCT04015518|158221625|FG003|Overall Study|Withdrew consent|0|||
49105874|NCT04015518|158221626|FG004|Overall Study|Withdrew consent|0|||
49105875|NCT04015518|158221622|FG000|Overall Study|Prostate carcinoma|1|||
49105876|NCT04015518|158221623|FG001|Overall Study|Prostate carcinoma|0|||
49105877|NCT04015518|158221624|FG002|Overall Study|Prostate carcinoma|0|||
49105878|NCT04015518|158221625|FG003|Overall Study|Prostate carcinoma|0|||
49105879|NCT04015518|158221626|FG004|Overall Study|Prostate carcinoma|0|||
49105880|NCT04015518|158221622|FG000|Overall Study|Could not keep appointments due to work|1|||
49105881|NCT04015518|158221623|FG001|Overall Study|Could not keep appointments due to work|0|||
49105882|NCT04015518|158221624|FG002|Overall Study|Could not keep appointments due to work|0|||
49105883|NCT04015518|158221625|FG003|Overall Study|Could not keep appointments due to work|0|||
49105884|NCT04015518|158221626|FG004|Overall Study|Could not keep appointments due to work|0|||
49105885|NCT02360475|158221627|FG000|Overall Study|Lost to Follow-up|4|||
49105886|NCT02360475|158221628|FG001|Overall Study|Lost to Follow-up|12|||
49105887|NCT02360475|158221629|FG002|Overall Study|Lost to Follow-up|6|||
49105888|NCT02360475|158221630|FG003|Overall Study|Lost to Follow-up|4|||
49105889|NCT02360475|158221627|FG000|Overall Study|Withdrawal by Subject|0|||
49105890|NCT02360475|158221628|FG001|Overall Study|Withdrawal by Subject|1|||
49105891|NCT02360475|158221629|FG002|Overall Study|Withdrawal by Subject|2|||
49105892|NCT02360475|158221630|FG003|Overall Study|Withdrawal by Subject|0|||
49105893|NCT02360475|158221627|FG000|Overall Study|Migrated/moved from study area|0|||
49105894|NCT02360475|158221628|FG001|Overall Study|Migrated/moved from study area|0|||
49105895|NCT02360475|158221629|FG002|Overall Study|Migrated/moved from study area|0|||
49105896|NCT02360475|158221630|FG003|Overall Study|Migrated/moved from study area|1|||
49105897|NCT01959698|158221631|FG000|Overall Study|Adverse Event|0|||
49105898|NCT01959698|158221632|FG001|Overall Study|Adverse Event|0|||
49105899|NCT01959698|158221633|FG002|Overall Study|Adverse Event|0|||
49105900|NCT01959698|158221634|FG003|Overall Study|Adverse Event|0|||
49105901|NCT01959698|158221635|FG004|Overall Study|Adverse Event|0|||
49105902|NCT01959698|158221636|FG005|Overall Study|Adverse Event|0|||
49105903|NCT01959698|158221637|FG006|Overall Study|Adverse Event|1|||
49105904|NCT01959698|158221631|FG000|Overall Study|Physician Decision|1|||
49105905|NCT01959698|158221632|FG001|Overall Study|Physician Decision|0|||
49105906|NCT01959698|158221633|FG002|Overall Study|Physician Decision|1|||
49105907|NCT01959698|158221634|FG003|Overall Study|Physician Decision|2|||
49105908|NCT01959698|158221635|FG004|Overall Study|Physician Decision|0|||
49105909|NCT01959698|158221636|FG005|Overall Study|Physician Decision|3|||
49105910|NCT01959698|158221637|FG006|Overall Study|Physician Decision|3|||
49105911|NCT03201874|158222809|FG000|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|4|||
49105912|NCT03201874|158222810|FG001|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
49105913|NCT03201874|158222809|FG000|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
49105914|NCT03201874|158222810|FG001|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|8|||
49105915|NCT01877551|158222813|FG000|Overall Study|Physician Decision|0|||
49105916|NCT01877551|158222814|FG001|Overall Study|Physician Decision|1|||
49105917|NCT02920177|158222817|FG000|Overall Study|Withdrawal by Subject|1|||
49105918|NCT02920177|158222818|FG001|Overall Study|Withdrawal by Subject|1|||
49105919|NCT02920177|158222817|FG000|Overall Study|Physician Decision|1|||
49105920|NCT02920177|158222818|FG001|Overall Study|Physician Decision|0|||
49105921|NCT02920177|158222817|FG000|Overall Study|Lost to Follow-up|0|||
49105922|NCT02920177|158222818|FG001|Overall Study|Lost to Follow-up|1|||
49105923|NCT01871402|158222821|FG000|Overall Study|Lost to Follow-up|1|||
49105924|NCT01871402|158222822|FG001|Overall Study|Lost to Follow-up|0|||
49105925|NCT01871402|158222821|FG000|Overall Study|Withdrawal by Subject|0|||
49105926|NCT01871402|158222822|FG001|Overall Study|Withdrawal by Subject|2|||
49105927|NCT01871402|158222821|FG000|Overall Study|Non-compliance|0|||
49105928|NCT01871402|158222822|FG001|Overall Study|Non-compliance|1|||
49105929|NCT04594941|158222823|FG000|Overall Study|Other|0|||
49105930|NCT04594941|158222824|FG001|Overall Study|Other|3|||
49105931|NCT04594941|158222825|FG002|Overall Study|Other|1|||
49105932|NCT04594941|158222826|FG003|Overall Study|Other|0|||
49105933|NCT02223819|158222829|FG000|Overall Study|Lost to Follow-up|2|||
49105934|NCT04489381|158222836|FG000|Overall Study|Lost to Follow-up|2|||
49105935|NCT04489381|158222837|FG001|Overall Study|Lost to Follow-up|3|||
49105936|NCT04489381|158222836|FG000|Overall Study|Withdrawal by Subject|1|||
49105937|NCT04489381|158222837|FG001|Overall Study|Withdrawal by Subject|0|||
49105938|NCT01420679|158222838|FG000|Overall Study|Disease Progression|3|||
49105939|NCT01420679|158222839|FG001|Overall Study|Disease Progression|2|||
49105940|NCT01420679|158222838|FG000|Overall Study|Adverse Event|4|||
49105941|NCT01420679|158222839|FG001|Overall Study|Adverse Event|0|||
49105942|NCT01420679|158222838|FG000|Overall Study|More Than 28 Days Between Doses of Drug|1|||
49105943|NCT01420679|158222839|FG001|Overall Study|More Than 28 Days Between Doses of Drug|0|||
49105944|NCT01420679|158222838|FG000|Overall Study|Patient Decision|1|||
49105945|NCT01420679|158222839|FG001|Overall Study|Patient Decision|0|||
49105946|NCT01420679|158222838|FG000|Overall Study|Investigator Decision|1|||
49105947|NCT01420679|158222839|FG001|Overall Study|Investigator Decision|2|||
49105948|NCT01420679|158222838|FG000|Overall Study|Sponsor Decision|3|||
49105949|NCT01420679|158222839|FG001|Overall Study|Sponsor Decision|3|||
49105950|NCT01420679|158222838|FG000|Overall Study|Other|1|||
49105951|NCT01420679|158222839|FG001|Overall Study|Other|0|||
49105952|NCT00070018|158222840|FG000|Overall Study|Adverse Event|2|||
49105953|NCT00070018|158222840|FG000|Overall Study|Lack of Efficacy|1|||
49105954|NCT00070018|158222840|FG000|Overall Study|Withdrawal by Subject|1|||
49105955|NCT03956615|158222845|FG000|Overall Study|No multiple myeloma confirmed|2|||
49105956|NCT03956615|158222845|FG000|Overall Study|Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals|1|||
49105957|NCT03956615|158222845|FG000|Overall Study|No expression of ideotypic paraprotein on membrane|2|||
49111404|NCT01289574|158242894|FG001|Overall Study|Lost to Follow-up|0|||
49105958|NCT03956615|158222845|FG000|Overall Study|Not selected for sdAb generation, due to limitation of total number to 3|2|||
49105959|NCT02604550|158222846|FG000|Overall Study|Lost to Follow-up|7|||
49105960|NCT02604550|158222847|FG001|Overall Study|Lost to Follow-up|6|||
49105961|NCT02604550|158222846|FG000|Overall Study|Withdrawal by Subject|0|||
49105962|NCT02604550|158222847|FG001|Overall Study|Withdrawal by Subject|1|||
49105963|NCT02604550|158222846|FG000|Overall Study|Incomplete data using paper journal|18|||
49105964|NCT02604550|158222847|FG001|Overall Study|Incomplete data using paper journal|19|||
49105965|NCT03199612|158222848|FG000|Overall Study|Adverse Event|1|||
49105966|NCT03199612|158222849|FG001|Overall Study|Adverse Event|0|||
49105967|NCT04472026|158222850|FG000|Overall Study|Lost to Follow-up|5|||
49105968|NCT02939716|158222853|FG000|Overall Study|scanner failure|0|||
49105969|NCT02939716|158222854|FG001|Overall Study|scanner failure|0|||
49105970|NCT02939716|158222855|FG002|Overall Study|scanner failure|0|||
49105971|NCT02939716|158222856|FG003|Overall Study|scanner failure|1|||
49105972|NCT02939716|158222857|FG004|Overall Study|scanner failure|1|||
49105973|NCT02939716|158222858|FG005|Overall Study|scanner failure|1|||
49105974|NCT02637713|158222859|FG000|Overall Study|Screen Failure|2|||
49105975|NCT01732471|158222860|FG000|Overall Study|Withdrawal by Subject|1|||
49105976|NCT02669082|158222863|FG000|Overall Study|Adverse Event|1|||
49105977|NCT01096589|158222864|FG000|Overall Study|Adverse Event|2|||
49105978|NCT01096589|158222865|FG001|Overall Study|Adverse Event|1|||
49105979|NCT01096589|158222866|FG002|Overall Study|Adverse Event|2|||
49105980|NCT01096589|158222867|FG003|Overall Study|Adverse Event|1|||
49105981|NCT01096589|158222864|FG000|Overall Study|Withdrawal by Subject|2|||
49105982|NCT01096589|158222865|FG001|Overall Study|Withdrawal by Subject|1|||
49105983|NCT01096589|158222866|FG002|Overall Study|Withdrawal by Subject|1|||
49105984|NCT01096589|158222867|FG003|Overall Study|Withdrawal by Subject|1|||
49105985|NCT01096589|158222864|FG000|Overall Study|Compliance with protocol|0|||
49105986|NCT01096589|158222865|FG001|Overall Study|Compliance with protocol|0|||
49105987|NCT01096589|158222866|FG002|Overall Study|Compliance with protocol|1|||
49105988|NCT01096589|158222867|FG003|Overall Study|Compliance with protocol|0|||
49105989|NCT01096589|158222864|FG000|Overall Study|found treatment exhausting|0|||
49105990|NCT01096589|158222865|FG001|Overall Study|found treatment exhausting|0|||
49105991|NCT01096589|158222866|FG002|Overall Study|found treatment exhausting|0|||
49105992|NCT01096589|158222867|FG003|Overall Study|found treatment exhausting|1|||
49105993|NCT02543892|158222868|FG000|Received Vaccination 2|Withdrawal by Subject|1|||
49105994|NCT02543892|158222869|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
49105995|NCT02543892|158222870|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
49105996|NCT02543892|158222871|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
49105997|NCT02543892|158222872|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
49105998|NCT02543892|158222873|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
49105999|NCT02543892|158222874|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
49106000|NCT02543892|158222875|FG007|Received Vaccination 2|Withdrawal by Subject|1|||
49106001|NCT02543892|158222868|FG000|Received Vaccination 2|Physician Decision|0|||
49106002|NCT02543892|158222869|FG001|Received Vaccination 2|Physician Decision|0|||
49106003|NCT02543892|158222870|FG002|Received Vaccination 2|Physician Decision|0|||
49106004|NCT02543892|158222871|FG003|Received Vaccination 2|Physician Decision|0|||
49106005|NCT02543892|158222872|FG004|Received Vaccination 2|Physician Decision|0|||
49106006|NCT02543892|158222873|FG005|Received Vaccination 2|Physician Decision|1|||
49106007|NCT02543892|158222874|FG006|Received Vaccination 2|Physician Decision|0|||
49106008|NCT02543892|158222875|FG007|Received Vaccination 2|Physician Decision|0|||
49106009|NCT02543892|158222868|FG000|Received Vaccination 2|Adverse Event|0|||
49106010|NCT02543892|158222869|FG001|Received Vaccination 2|Adverse Event|1|||
49106011|NCT02543892|158222870|FG002|Received Vaccination 2|Adverse Event|0|||
49106012|NCT02543892|158222871|FG003|Received Vaccination 2|Adverse Event|0|||
49106013|NCT02543892|158222872|FG004|Received Vaccination 2|Adverse Event|0|||
49106014|NCT02543892|158222873|FG005|Received Vaccination 2|Adverse Event|0|||
49106015|NCT02543892|158222874|FG006|Received Vaccination 2|Adverse Event|0|||
49106016|NCT02543892|158222875|FG007|Received Vaccination 2|Adverse Event|0|||
49106017|NCT02543892|158222868|FG000|Had Immunology Data|Withdrawal by Subject|0|||
49106018|NCT02543892|158222869|FG001|Had Immunology Data|Withdrawal by Subject|0|||
49106019|NCT02543892|158222870|FG002|Had Immunology Data|Withdrawal by Subject|0|||
49106020|NCT02543892|158222871|FG003|Had Immunology Data|Withdrawal by Subject|0|||
49106021|NCT02543892|158222872|FG004|Had Immunology Data|Withdrawal by Subject|0|||
49106022|NCT02543892|158222873|FG005|Had Immunology Data|Withdrawal by Subject|0|||
49106023|NCT02543892|158222874|FG006|Had Immunology Data|Withdrawal by Subject|1|||
49106024|NCT02543892|158222875|FG007|Had Immunology Data|Withdrawal by Subject|0|||
49106025|NCT01625689|158222876|FG000|Overall Study|Migration|2|||
49106026|NCT01625689|158222877|FG001|Overall Study|Migration|1|||
49106027|NCT04240457|158222881|FG000|Overall Study|Lost to Follow-up|5|||
49106028|NCT04240457|158222882|FG001|Overall Study|Lost to Follow-up|1|||
49106029|NCT00081731|158222883|FG000|Overall Study|scientific integrity issue|8|||
49106030|NCT00081731|158222884|FG001|Overall Study|scientific integrity issue|8|||
49106031|NCT03233204|158222885|FG000|Overall Study|Adverse Event|1|||
49106032|NCT03233204|158222885|FG000|Overall Study|Death|1|||
49106033|NCT03233204|158222885|FG000|Overall Study|Withdrawal by Subject|1|||
49106034|NCT03233204|158222885|FG000|Overall Study|Progressive Disease|3|||
49106035|NCT01404208|158222894|FG000|Overall Study|Discontinued|3|||
49106036|NCT01404208|158222895|FG001|Overall Study|Discontinued|0|||
49106037|NCT01629823|158222896|FG000|Trial Period|Missed visit|11|||
49106038|NCT01629823|158222897|FG001|Trial Period|Missed visit|9|||
49106039|NCT01629823|158222898|FG002|Trial Period|Missed visit|8|||
49106040|NCT01629823|158222896|FG000|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
49106041|NCT01629823|158222897|FG001|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
49106042|NCT01629823|158222898|FG002|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
49106043|NCT01629823|158222896|FG000|Trial Period|Pregnancy|1|||
49106044|NCT01629823|158222897|FG001|Trial Period|Pregnancy|0|||
49106045|NCT01629823|158222898|FG002|Trial Period|Pregnancy|0|||
49106046|NCT01629823|158222896|FG000|Trial Period|Adverse Event|0|||
49106047|NCT01629823|158222897|FG001|Trial Period|Adverse Event|1|||
49106048|NCT01629823|158222898|FG002|Trial Period|Adverse Event|0|||
49106049|NCT01629823|158222896|FG000|Trial Period|Out-of-window visit|0|||
49106050|NCT01629823|158222897|FG001|Trial Period|Out-of-window visit|2|||
49106051|NCT01629823|158222898|FG002|Trial Period|Out-of-window visit|0|||
49106052|NCT01629823|158222896|FG000|Trial Period|Failed to hold medication|0|||
49106053|NCT01629823|158222897|FG001|Trial Period|Failed to hold medication|0|||
49106054|NCT01629823|158222898|FG002|Trial Period|Failed to hold medication|1|||
49106055|NCT01629823|158222896|FG000|Washout Period|Safety|2|||
49106056|NCT01629823|158222897|FG001|Washout Period|Safety|5|||
49106057|NCT01629823|158222898|FG002|Washout Period|Safety|0|||
49106058|NCT01629823|158222896|FG000|Washout Period|Pregnancy|1|||
49106059|NCT01629823|158222897|FG001|Washout Period|Pregnancy|0|||
49106060|NCT01629823|158222898|FG002|Washout Period|Pregnancy|0|||
49106061|NCT01629823|158222896|FG000|Washout Period|Protocol Violation|0|||
49106062|NCT01629823|158222897|FG001|Washout Period|Protocol Violation|1|||
49106063|NCT01629823|158222898|FG002|Washout Period|Protocol Violation|0|||
49106064|NCT01777295|158222899|FG000|Overall Study|Withdrawal by Subject|2|||
49106065|NCT01777295|158222900|FG001|Overall Study|Withdrawal by Subject|2|||
49106066|NCT01777295|158222899|FG000|Overall Study|Pregnancy|0|||
49106067|NCT01777295|158222900|FG001|Overall Study|Pregnancy|1|||
49106068|NCT01777295|158222899|FG000|Overall Study|Personal problem|1|||
49106069|NCT01777295|158222900|FG001|Overall Study|Personal problem|0|||
49106070|NCT01777295|158222899|FG000|Overall Study|Investigator call for AEs check|1|||
49106071|NCT01777295|158222900|FG001|Overall Study|Investigator call for AEs check|0|||
49106072|NCT01199822|158222901|FG000|Overall Study|Investigator discontinued therapy|0|||
49106073|NCT01199822|158222902|FG001|Overall Study|Investigator discontinued therapy|1|||
49106074|NCT01199822|158222903|FG002|Overall Study|Investigator discontinued therapy|0|||
49106075|NCT00412217|158222904|FG000|Overall Study|Insufficient Data Available|8|||
49106076|NCT00412217|158222905|FG001|Overall Study|Insufficient Data Available|3|||
49106077|NCT00412217|158222904|FG000|Overall Study|Death|5|||
49106078|NCT00412217|158222905|FG001|Overall Study|Death|4|||
49106079|NCT00412217|158222904|FG000|Overall Study|Disease Progression|2|||
49106080|NCT00412217|158222905|FG001|Overall Study|Disease Progression|3|||
49106081|NCT00412217|158222904|FG000|Overall Study|Investigator Decision|1|||
49106082|NCT00412217|158222905|FG001|Overall Study|Investigator Decision|0|||
49106083|NCT00412217|158222904|FG000|Overall Study|Withdrawal by Subject|2|||
49106084|NCT00412217|158222905|FG001|Overall Study|Withdrawal by Subject|0|||
49106085|NCT00412217|158222904|FG000|Overall Study|Lost to Follow-up|1|||
49106086|NCT00412217|158222905|FG001|Overall Study|Lost to Follow-up|4|||
49106087|NCT00412217|158222904|FG000|Overall Study|Study Terminated by Sponsor|26|||
49106088|NCT00412217|158222905|FG001|Overall Study|Study Terminated by Sponsor|33|||
49106089|NCT00412217|158222904|FG000|Overall Study|Other|1|||
49106090|NCT00412217|158222905|FG001|Overall Study|Other|1|||
49106091|NCT00785213|158222906|FG000|Quinine Sulfate Alone|Adverse Event|4|||
49106092|NCT00785213|158222906|FG000|Rosiglitazone With Quinine Sulfate|Adverse Event|1|||
49106093|NCT01500213|158222907|FG000|Overall Study|Adverse Event|35|||
49106094|NCT01500213|158222908|FG001|Overall Study|Adverse Event|35|||
49106095|NCT01500213|158222907|FG000|Overall Study|Chemo Completed or Change in Therapy|84|||
49106096|NCT01500213|158222908|FG001|Overall Study|Chemo Completed or Change in Therapy|81|||
49106097|NCT01500213|158222907|FG000|Overall Study|Withdrawal by Subject|28|||
49106098|NCT01500213|158222908|FG001|Overall Study|Withdrawal by Subject|37|||
49106099|NCT01500213|158222907|FG000|Overall Study|Death|7|||
49106100|NCT01500213|158222908|FG001|Overall Study|Death|3|||
49106101|NCT01500213|158222907|FG000|Overall Study|Disease Progression|13|||
49106102|NCT01500213|158222908|FG001|Overall Study|Disease Progression|21|||
49106103|NCT01500213|158222907|FG000|Overall Study|Protocol Violation|19|||
49106104|NCT01500213|158222908|FG001|Overall Study|Protocol Violation|19|||
49106105|NCT01500213|158222907|FG000|Overall Study|Physician Decision|12|||
49106106|NCT01500213|158222908|FG001|Overall Study|Physician Decision|10|||
49106107|NCT01500213|158222907|FG000|Overall Study|Lack of Efficacy|9|||
49106108|NCT01500213|158222908|FG001|Overall Study|Lack of Efficacy|7|||
49106109|NCT01500213|158222907|FG000|Overall Study|Lost to Follow-up|3|||
49106110|NCT01500213|158222908|FG001|Overall Study|Lost to Follow-up|6|||
49106111|NCT01500213|158222907|FG000|Overall Study|Other Reasons|7|||
49106112|NCT01500213|158222908|FG001|Overall Study|Other Reasons|5|||
49106113|NCT01069419|158222909|FG000|Overall Study|Adverse Event|233|||
49106114|NCT01069419|158222909|FG000|Overall Study|Lack of Efficacy|332|||
49106115|NCT01069419|158222909|FG000|Overall Study|Lost to Follow-up|49|||
49106116|NCT01069419|158222909|FG000|Overall Study|Remission of disease|11|||
49106117|NCT01069419|158222909|FG000|Overall Study|Withdrawal by Subject|34|||
49106118|NCT01069419|158222909|FG000|Overall Study|Other Reason|43|||
49106119|NCT01069419|158222909|FG000|Overall Study|Missing termination information|13|||
49106120|NCT00525902|158222910|FG000|Overall Study|Lack of Efficacy|1|||
49106121|NCT01490697|158222911|FG000|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1|||
49106122|NCT01490697|158222912|FG001|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2|||
49106123|NCT01534208|158222913|FG000|Overall Study|Lost to Follow-up|19|||
49106124|NCT01534208|158222914|FG001|Overall Study|Lost to Follow-up|14|||
49106125|NCT01534208|158222913|FG000|Overall Study|Withdrawal by Subject|6|||
49106126|NCT01534208|158222914|FG001|Overall Study|Withdrawal by Subject|20|||
49106127|NCT01534208|158222913|FG000|Overall Study|Adverse Event|15|||
49106128|NCT01534208|158222914|FG001|Overall Study|Adverse Event|8|||
49106129|NCT01534208|158222913|FG000|Overall Study|Physician Decision|2|||
49106130|NCT01534208|158222914|FG001|Overall Study|Physician Decision|0|||
49106131|NCT01534208|158222913|FG000|Overall Study|Lack of Efficacy|0|||
49106132|NCT01534208|158222914|FG001|Overall Study|Lack of Efficacy|3|||
49106133|NCT01534208|158222913|FG000|Overall Study|Protocol Violation|2|||
49106134|NCT01534208|158222914|FG001|Overall Study|Protocol Violation|2|||
49106135|NCT01534208|158222913|FG000|Overall Study|Sponsor decision|4|||
49106136|NCT01534208|158222914|FG001|Overall Study|Sponsor decision|1|||
49106137|NCT01534208|158222913|FG000|Overall Study|Subject relocation|2|||
49106138|NCT01534208|158222914|FG001|Overall Study|Subject relocation|0|||
49106139|NCT01534208|158222913|FG000|Overall Study|Lab assessment|2|||
49106140|NCT01534208|158222914|FG001|Overall Study|Lab assessment|1|||
49106141|NCT01534208|158222913|FG000|Overall Study|Eligibility error|3|||
49106142|NCT01534208|158222914|FG001|Overall Study|Eligibility error|0|||
49106143|NCT01534208|158222913|FG000|Overall Study|PCP decision|1|||
49106144|NCT01534208|158222914|FG001|Overall Study|PCP decision|0|||
49106145|NCT01534208|158222913|FG000|Overall Study|Needed prohibited meds|1|||
49106146|NCT01534208|158222914|FG001|Overall Study|Needed prohibited meds|0|||
49106147|NCT00955968|158222915|FG000|Overall Study|Death|2|||
49106148|NCT00955968|158222916|FG001|Overall Study|Death|4|||
49106149|NCT00955968|158222915|FG000|Overall Study|Withdrawal by Subject|35|||
49106150|NCT00955968|158222916|FG001|Overall Study|Withdrawal by Subject|31|||
49106151|NCT00955968|158222915|FG000|Overall Study|Lost to Follow-up|45|||
49106152|NCT00955968|158222916|FG001|Overall Study|Lost to Follow-up|39|||
49106153|NCT00955968|158222915|FG000|Overall Study|Site closed|55|||
49106154|NCT00955968|158222916|FG001|Overall Study|Site closed|52|||
49106155|NCT04102865|158222921|FG000|Overall Study|Adverse Event|4|||
49106156|NCT04102865|158222922|FG001|Overall Study|Adverse Event|0|||
49106157|NCT04102865|158222921|FG000|Overall Study|Lost to Follow-up|1|||
49106158|NCT04102865|158222922|FG001|Overall Study|Lost to Follow-up|0|||
49106159|NCT04102865|158222921|FG000|Overall Study|Withdrawal by Subject|2|||
49106160|NCT04102865|158222922|FG001|Overall Study|Withdrawal by Subject|0|||
49106161|NCT02429310|158222923|FG000|Overall Study|Lost to Follow-up|1|||
49106162|NCT02429310|158222924|FG001|Overall Study|Lost to Follow-up|2|||
49106163|NCT02429310|158222923|FG000|Overall Study|Protocol Violation|1|||
49106164|NCT02429310|158222924|FG001|Overall Study|Protocol Violation|1|||
49106165|NCT01047332|158222925|FG000|Overall Study|SEMS Obstruction|11|||
49106166|NCT01047332|158222926|FG001|Overall Study|SEMS Obstruction|20|||
49106167|NCT01047332|158222925|FG000|Overall Study|Died Unobstructed|38|||
49106168|NCT01047332|158222926|FG001|Overall Study|Died Unobstructed|41|||
49106169|NCT01047332|158222925|FG000|Overall Study|Lost to Follow-up|8|||
49106170|NCT01047332|158222926|FG001|Overall Study|Lost to Follow-up|3|||
49106171|NCT03417024|158222929|FG000|Overall Study|Study Termination prior to follow-up|11|||
49106172|NCT03417024|158222929|FG000|Overall Study|Physician Decision|2|||
49106173|NCT01298141|158222930|FG000|Overall Study|Adverse Event|3|||
49106174|NCT01298141|158222930|FG000|Overall Study|Refusal of Required Study Procedures|1|||
49106175|NCT01298141|158222930|FG000|Overall Study|Withdrawal by Subject|6|||
49106176|NCT01298141|158222930|FG000|Overall Study|Termination of Study by the Investigator|5|||
49106177|NCT01298141|158222930|FG000|Overall Study|Other|5|||
49106178|NCT01298141|158222930|FG000|Overall Study|Lost to Follow-up|1|||
49106179|NCT01298141|158222930|FG000|Overall Study|Death|6|||
49106180|NCT01298141|158222930|FG000|Overall Study|Not treated|4|||
49106181|NCT00793546|158222931|FG000|Overall Study|Death|3|||
49106182|NCT00793546|158222932|FG001|Overall Study|Death|0|||
49106183|NCT00793546|158222931|FG000|Overall Study|Lost to Follow-up|1|||
49106184|NCT00793546|158222932|FG001|Overall Study|Lost to Follow-up|0|||
49106185|NCT00793546|158222931|FG000|Overall Study|Withdrawal by Subject|1|||
49106186|NCT00793546|158222932|FG001|Overall Study|Withdrawal by Subject|1|||
49106187|NCT00793546|158222931|FG000|Overall Study|Study Terminated by Sponsor|8|||
49106188|NCT00793546|158222932|FG001|Overall Study|Study Terminated by Sponsor|27|||
49106189|NCT00793546|158222931|FG000|Overall Study|Other|1|||
49106190|NCT00793546|158222932|FG001|Overall Study|Other|0|||
49106191|NCT01573767|158225273|FG000|Overall Study|Adverse Event|0|||
49106192|NCT01573767|158225274|FG001|Overall Study|Adverse Event|1|||
49106193|NCT01573767|158225275|FG002|Overall Study|Adverse Event|0|||
49106194|NCT01573767|158225276|FG003|Overall Study|Adverse Event|1|||
49106195|NCT01573767|158225273|FG000|Overall Study|Lack of Efficacy|18|||
49106196|NCT01573767|158225274|FG001|Overall Study|Lack of Efficacy|15|||
49106197|NCT01573767|158225275|FG002|Overall Study|Lack of Efficacy|12|||
49106198|NCT01573767|158225276|FG003|Overall Study|Lack of Efficacy|17|||
49106199|NCT01573767|158225273|FG000|Overall Study|Protocol Violation|3|||
49106200|NCT01573767|158225274|FG001|Overall Study|Protocol Violation|1|||
49106201|NCT01573767|158225275|FG002|Overall Study|Protocol Violation|1|||
49106202|NCT01573767|158225276|FG003|Overall Study|Protocol Violation|3|||
49106203|NCT01573767|158225273|FG000|Overall Study|Lost to Follow-up|0|||
49106204|NCT01573767|158225274|FG001|Overall Study|Lost to Follow-up|1|||
49106205|NCT01573767|158225275|FG002|Overall Study|Lost to Follow-up|1|||
49106206|NCT01573767|158225276|FG003|Overall Study|Lost to Follow-up|1|||
49106207|NCT01573767|158225273|FG000|Overall Study|Physician Decision|1|||
49106208|NCT01573767|158225274|FG001|Overall Study|Physician Decision|2|||
49106209|NCT01573767|158225275|FG002|Overall Study|Physician Decision|0|||
49106210|NCT01573767|158225276|FG003|Overall Study|Physician Decision|2|||
49106211|NCT01573767|158225273|FG000|Overall Study|Withdrawal by Subject|0|||
49106212|NCT01573767|158225274|FG001|Overall Study|Withdrawal by Subject|1|||
49106213|NCT01573767|158225275|FG002|Overall Study|Withdrawal by Subject|0|||
49106214|NCT01573767|158225276|FG003|Overall Study|Withdrawal by Subject|0|||
49106215|NCT04063657|158225278|FG000|Overall Study|Lost to Follow-up|1|||
49106216|NCT04063657|158225279|FG001|Overall Study|Lost to Follow-up|0|||
49106217|NCT02258334|158225282|FG000|Overall Study|Adverse Event|1|||
49106218|NCT02258334|158225283|FG001|Overall Study|Adverse Event|0|||
49106219|NCT02258334|158225284|FG002|Overall Study|Adverse Event|0|||
49106220|NCT02258334|158225285|FG003|Overall Study|Adverse Event|0|||
49106221|NCT02609724|158225286|FG000|Overall Study|Death|2|||
49106222|NCT02609724|158225287|FG001|Overall Study|Death|0|||
49106223|NCT02609724|158225288|FG002|Overall Study|Death|1|||
49106224|NCT02609724|158225286|FG000|Overall Study|Withdrawal by Subject|1|||
49106225|NCT02609724|158225287|FG001|Overall Study|Withdrawal by Subject|2|||
49106226|NCT02609724|158225288|FG002|Overall Study|Withdrawal by Subject|3|||
49106227|NCT02609724|158225286|FG000|Overall Study|Illness|2|||
49106228|NCT02609724|158225287|FG001|Overall Study|Illness|1|||
49106229|NCT02609724|158225288|FG002|Overall Study|Illness|0|||
49106230|NCT02382796|158225289|FG000|Overall Study|Global deterioration of health status|1|||
49106231|NCT02382796|158225289|FG000|Overall Study|Objective progression or relapse|3|||
49106232|NCT02382796|158225289|FG000|Overall Study|Commercial dacomitinib became available|3|||
49106233|NCT03077659|158225294|FG000|Overall Study|Withdrawal by Subject|0|||
49106234|NCT03077659|158225295|FG001|Overall Study|Withdrawal by Subject|0|||
49106235|NCT03077659|158225296|FG002|Overall Study|Withdrawal by Subject|1|||
49106236|NCT00985959|158225297|FG000|Overall Study|Adverse Event|0|||
49106237|NCT00985959|158225298|FG001|Overall Study|Adverse Event|0|||
49106238|NCT00985959|158225299|FG002|Overall Study|Adverse Event|19|||
49106239|NCT00985959|158225297|FG000|Overall Study|Withdrawal by Subject|0|||
49106240|NCT00985959|158225298|FG001|Overall Study|Withdrawal by Subject|0|||
49106241|NCT00985959|158225299|FG002|Overall Study|Withdrawal by Subject|8|||
49106242|NCT00985959|158225297|FG000|Overall Study|Progressive disease|1|||
49106243|NCT00985959|158225298|FG001|Overall Study|Progressive disease|2|||
49106244|NCT00985959|158225299|FG002|Overall Study|Progressive disease|8|||
49106245|NCT00985959|158225297|FG000|Overall Study|Unrecovered toxicity|0|||
49106246|NCT00985959|158225298|FG001|Overall Study|Unrecovered toxicity|0|||
49106247|NCT00985959|158225299|FG002|Overall Study|Unrecovered toxicity|7|||
49106248|NCT00985959|158225297|FG000|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
49106249|NCT00985959|158225298|FG001|Overall Study|Pneumonitis or pulmonary fibrosis|0|||
49106250|NCT00985959|158225299|FG002|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
49106251|NCT00985959|158225297|FG000|Overall Study|Complete response observed over 2 cycles|0|||
49106252|NCT00985959|158225298|FG001|Overall Study|Complete response observed over 2 cycles|1|||
49106253|NCT00985959|158225299|FG002|Overall Study|Complete response observed over 2 cycles|4|||
49106254|NCT00985959|158225297|FG000|Overall Study|Other|0|||
49106255|NCT00985959|158225298|FG001|Overall Study|Other|0|||
49106256|NCT00985959|158225299|FG002|Overall Study|Other|11|||
49106257|NCT02258542|158225302|FG000|Overall Study|eg. not made to the visit|7|||
49106258|NCT02258542|158225303|FG001|Overall Study|eg. not made to the visit|4|||
49106259|NCT02258542|158225304|FG002|Overall Study|eg. not made to the visit|0|||
49106260|NCT02258542|158225305|FG003|Overall Study|eg. not made to the visit|1|||
49106261|NCT02258542|158225302|FG000|Overall Study|study specific discount. criteria|1|||
49106262|NCT02258542|158225303|FG001|Overall Study|study specific discount. criteria|1|||
49106263|NCT02258542|158225304|FG002|Overall Study|study specific discount. criteria|0|||
49106264|NCT02258542|158225305|FG003|Overall Study|study specific discount. criteria|0|||
49106265|NCT02258542|158225302|FG000|Overall Study|Withdrawal by Subject|20|||
49106266|NCT02258542|158225303|FG001|Overall Study|Withdrawal by Subject|20|||
49106267|NCT02258542|158225304|FG002|Overall Study|Withdrawal by Subject|7|||
49106268|NCT02258542|158225305|FG003|Overall Study|Withdrawal by Subject|1|||
49106269|NCT02258542|158225302|FG000|Overall Study|Lost to Follow-up|5|||
49106270|NCT02258542|158225303|FG001|Overall Study|Lost to Follow-up|12|||
49106271|NCT02258542|158225304|FG002|Overall Study|Lost to Follow-up|1|||
49106272|NCT02258542|158225305|FG003|Overall Study|Lost to Follow-up|2|||
49106273|NCT02258542|158225302|FG000|Overall Study|Death|5|||
49106274|NCT02258542|158225303|FG001|Overall Study|Death|4|||
49106275|NCT02258542|158225304|FG002|Overall Study|Death|0|||
49106276|NCT02258542|158225305|FG003|Overall Study|Death|1|||
49106277|NCT02258542|158225302|FG000|Overall Study|Adverse Event|3|||
49106278|NCT02258542|158225303|FG001|Overall Study|Adverse Event|4|||
49106279|NCT02258542|158225304|FG002|Overall Study|Adverse Event|0|||
49106280|NCT02258542|158225305|FG003|Overall Study|Adverse Event|0|||
49106281|NCT02258542|158225302|FG000|Overall Study|Protocol Violation|1|||
49106282|NCT02258542|158225303|FG001|Overall Study|Protocol Violation|2|||
49106283|NCT02258542|158225304|FG002|Overall Study|Protocol Violation|0|||
49106284|NCT02258542|158225305|FG003|Overall Study|Protocol Violation|0|||
49106285|NCT02258542|158225302|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
49106286|NCT02258542|158225303|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
49106287|NCT02258542|158225304|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
49106288|NCT02258542|158225305|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
49106289|NCT00976209|158225308|FG000|Treatment Period 1|Protocol Violation|1|||
49106290|NCT00976209|158225309|FG001|Treatment Period 1|Protocol Violation|0|||
49106291|NCT00976209|158225308|FG000|Treatment Period 1|Lost to Follow-up|2|||
49106292|NCT00976209|158225309|FG001|Treatment Period 1|Lost to Follow-up|0|||
49106293|NCT00976209|158225308|FG000|Treatment Period 1|Other|0|||
49106294|NCT00976209|158225309|FG001|Treatment Period 1|Other|1|||
49106295|NCT00976209|158225308|FG000|Wash-out Period|Adverse Event|1|||
49106296|NCT00976209|158225309|FG001|Wash-out Period|Adverse Event|2|||
49106297|NCT00976209|158225308|FG000|Wash-out Period|Lost to Follow-up|1|||
49106298|NCT00976209|158225309|FG001|Wash-out Period|Lost to Follow-up|0|||
49106299|NCT00976209|158225308|FG000|Wash-out Period|Protocol Violation|1|||
49106300|NCT00976209|158225309|FG001|Wash-out Period|Protocol Violation|0|||
49106301|NCT00976209|158225308|FG000|Wash-out Period|Other|1|||
49106302|NCT00976209|158225309|FG001|Wash-out Period|Other|0|||
49106303|NCT00976209|158225308|FG000|Treatment Period 2|Withdrawal by Subject|0|||
49106304|NCT00976209|158225309|FG001|Treatment Period 2|Withdrawal by Subject|1|||
49106305|NCT00976209|158225308|FG000|Treatment Period 2|Lost to Follow-up|0|||
49106306|NCT00976209|158225309|FG001|Treatment Period 2|Lost to Follow-up|1|||
49106307|NCT04007107|158225310|FG000|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
49106308|NCT04007107|158225311|FG001|Treatment Period 2 (Day 1)|Withdrawal by Subject|1|||
49106309|NCT04007107|158225312|FG002|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
49106310|NCT04007107|158225313|FG003|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
49106311|NCT02923245|158225314|FG000|Overall Study|ultrasound order was cancelled|2|||
49106312|NCT02923245|158225315|FG001|Overall Study|ultrasound order was cancelled|1|||
49106313|NCT00480493|158225320|FG000|Overall Study|moved|2|||
49106314|NCT00480493|158225321|FG001|Overall Study|moved|7|||
49106315|NCT03617861|158225322|FG000|Second Intervention (1 Day)|Adverse Event|0|||
49106316|NCT03617861|158225323|FG001|Second Intervention (1 Day)|Adverse Event|0|||
49106317|NCT03617861|158225324|FG002|Second Intervention (1 Day)|Adverse Event|1|||
49106318|NCT03617861|158225325|FG003|Second Intervention (1 Day)|Adverse Event|0|||
49106319|NCT04526574|158225326|FG000|Overall Study|Protocol Violation|3|||
49106320|NCT04526574|158225327|FG001|Overall Study|Protocol Violation|1|||
49106321|NCT04526574|158225326|FG000|Overall Study|Withdrawal by Subject|12|||
49106322|NCT04526574|158225327|FG001|Overall Study|Withdrawal by Subject|9|||
49106323|NCT04526574|158225326|FG000|Overall Study|Other|1|||
49106324|NCT04526574|158225327|FG001|Overall Study|Other|2|||
49106325|NCT04526574|158225326|FG000|Overall Study|Adverse Event|1|||
49106326|NCT04526574|158225327|FG001|Overall Study|Adverse Event|1|||
49106327|NCT04526574|158225326|FG000|Overall Study|Death|2|||
49106328|NCT04526574|158225327|FG001|Overall Study|Death|3|||
49106329|NCT04526574|158225326|FG000|Overall Study|Lost to Follow-up|9|||
49106330|NCT04526574|158225327|FG001|Overall Study|Lost to Follow-up|9|||
49106331|NCT04526574|158225326|FG000|Overall Study|No longer meets eligibility criteria|8|||
49106332|NCT04526574|158225327|FG001|Overall Study|No longer meets eligibility criteria|8|||
49106333|NCT04907227|158225328|FG000|Overall Study|Death|12|||
49106334|NCT04907227|158225329|FG001|Overall Study|Death|8|||
49106335|NCT04907227|158225328|FG000|Overall Study|Withdrawal by Subject|2|||
49106336|NCT04907227|158225329|FG001|Overall Study|Withdrawal by Subject|2|||
49106337|NCT04907227|158225328|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
49106338|NCT04907227|158225329|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
49106339|NCT04907227|158225328|FG000|Overall Study|Sponsor Decision|25|||
49106340|NCT04907227|158225329|FG001|Overall Study|Sponsor Decision|30|||
49106341|NCT04907227|158225328|FG000|Overall Study|Physician Decision|1|||
49106342|NCT04907227|158225329|FG001|Overall Study|Physician Decision|0|||
49106343|NCT03747302|158225332|FG000|Overall Study|Withdrawal by Subject|1|||
49106344|NCT03747302|158225333|FG001|Overall Study|Withdrawal by Subject|2|||
49106345|NCT01378975|158225338|FG000|Overall Study|Death|77|||
49106346|NCT01378975|158225339|FG001|Overall Study|Death|46|||
49106347|NCT01378975|158225338|FG000|Overall Study|Investigator Request|1|||
49106348|NCT01378975|158225339|FG001|Overall Study|Investigator Request|0|||
49106349|NCT01378975|158225338|FG000|Overall Study|Lost to Follow-up|4|||
49106350|NCT01378975|158225339|FG001|Overall Study|Lost to Follow-up|1|||
49106351|NCT01378975|158225338|FG000|Overall Study|Withdrew Consent|4|||
49106352|NCT01378975|158225339|FG001|Overall Study|Withdrew Consent|3|||
49106353|NCT01702532|158225340|FG000|Overall Study|Adverse Event|0|||
49106354|NCT01702532|158225341|FG001|Overall Study|Adverse Event|1|||
49106355|NCT01032070|158225342|FG000|Overall Study|Disease progression|13|||
49106356|NCT01032070|158225343|FG001|Overall Study|Disease progression|8|||
49106357|NCT01032070|158225342|FG000|Overall Study|Medical or ethical reasons|0|||
49106358|NCT01032070|158225343|FG001|Overall Study|Medical or ethical reasons|2|||
49106359|NCT01032070|158225342|FG000|Overall Study|Withdrawal by Subject|0|||
49106360|NCT01032070|158225343|FG001|Overall Study|Withdrawal by Subject|2|||
49106361|NCT03769675|158225344|FG000|Overall Study|Lost to Follow-up|1|||
49106362|NCT04027075|158225345|FG000|Overall Study|Lost to Follow-up|41|||
49106363|NCT04027075|158225346|FG001|Overall Study|Lost to Follow-up|22|||
49106364|NCT02844907|158225352|FG000|With Dexamethasone|No IV access|1|||
49106365|NCT04068688|158225353|FG000|Overall Study|Lost to Follow-up|1|||
49106366|NCT04068688|158225354|FG001|Overall Study|Lost to Follow-up|1|||
49106367|NCT04068688|158225355|FG002|Overall Study|Lost to Follow-up|0|||
49106368|NCT04068688|158225356|FG003|Overall Study|Lost to Follow-up|0|||
49106369|NCT04068688|158225357|FG004|Overall Study|Lost to Follow-up|5|||
49106370|NCT04068688|158225358|FG005|Overall Study|Lost to Follow-up|5|||
49106371|NCT04068688|158225359|FG006|Overall Study|Lost to Follow-up|0|||
49106372|NCT04068688|158225360|FG007|Overall Study|Lost to Follow-up|0|||
49106373|NCT04068688|158225361|FG008|Overall Study|Lost to Follow-up|1|||
49106374|NCT04068688|158225362|FG009|Overall Study|Lost to Follow-up|0|||
49106375|NCT04068688|158225353|FG000|Overall Study|Withdrawal by Subject|1|||
49106376|NCT04068688|158225354|FG001|Overall Study|Withdrawal by Subject|1|||
49106377|NCT04068688|158225355|FG002|Overall Study|Withdrawal by Subject|0|||
49106378|NCT04068688|158225356|FG003|Overall Study|Withdrawal by Subject|0|||
49106379|NCT04068688|158225357|FG004|Overall Study|Withdrawal by Subject|0|||
49106380|NCT04068688|158225358|FG005|Overall Study|Withdrawal by Subject|0|||
49106381|NCT04068688|158225359|FG006|Overall Study|Withdrawal by Subject|0|||
49106382|NCT04068688|158225360|FG007|Overall Study|Withdrawal by Subject|0|||
49106383|NCT04068688|158225361|FG008|Overall Study|Withdrawal by Subject|0|||
49106384|NCT04068688|158225362|FG009|Overall Study|Withdrawal by Subject|0|||
49106385|NCT04068688|158225353|FG000|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
49106386|NCT04068688|158225354|FG001|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
49106387|NCT04068688|158225355|FG002|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
49106388|NCT04068688|158225356|FG003|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
49106389|NCT04068688|158225357|FG004|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
49106390|NCT04068688|158225358|FG005|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
49106391|NCT04068688|158225359|FG006|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
49106392|NCT04068688|158225360|FG007|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
49106393|NCT04068688|158225361|FG008|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
49106394|NCT04068688|158225362|FG009|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
49106395|NCT00551161|158225363|FG000|Overall Study|Withdrawal by Subject|1|||
49106396|NCT04679051|158225364|FG000|Overall Study|felt tired after restricted time in bed|3|||
49106397|NCT04679051|158225365|FG001|Overall Study|felt tired after restricted time in bed|0|||
49106398|NCT04679051|158225364|FG000|Overall Study|discomfort with blood pressure cuff|2|||
49106399|NCT04679051|158225365|FG001|Overall Study|discomfort with blood pressure cuff|0|||
49106400|NCT04679051|158225364|FG000|Overall Study|scheduling conflict|1|||
49106401|NCT04679051|158225365|FG001|Overall Study|scheduling conflict|1|||
49106402|NCT04679051|158225364|FG000|Overall Study|Protocol Violation|0|||
49106403|NCT04679051|158225365|FG001|Overall Study|Protocol Violation|4|||
49106404|NCT00426660|158225367|FG000|Overall Study|Death|14|||
49106405|NCT00426660|158225367|FG000|Overall Study|Adverse Event|23|||
49106406|NCT00426660|158225367|FG000|Overall Study|Insufficient Clinical Response|22|||
49106407|NCT00426660|158225367|FG000|Overall Study|Lost to Follow-up|15|||
49106408|NCT00426660|158225367|FG000|Overall Study|Other|23|||
49106409|NCT00426660|158225367|FG000|Overall Study|Withdrawal by Subject|18|||
49106410|NCT00426660|158225367|FG000|Overall Study|Protocol Violation|1|||
49106411|NCT00426660|158225367|FG000|Overall Study|Enrolled Not Treated|15|||
49106412|NCT02772276|158225368|FG000|Overall Study|Lost to Follow-up|0|||
49106413|NCT02772276|158225369|FG001|Overall Study|Lost to Follow-up|0|||
49106414|NCT02772276|158225370|FG002|Overall Study|Lost to Follow-up|0|||
49106415|NCT02772276|158225371|FG003|Overall Study|Lost to Follow-up|0|||
49106416|NCT02772276|158225372|FG004|Overall Study|Lost to Follow-up|0|||
49106417|NCT02772276|158225373|FG005|Overall Study|Lost to Follow-up|0|||
49106418|NCT02772276|158225374|FG006|Overall Study|Lost to Follow-up|1|||
49106419|NCT02772276|158225375|FG007|Overall Study|Lost to Follow-up|0|||
49106420|NCT02772276|158225376|FG008|Overall Study|Lost to Follow-up|0|||
49106421|NCT02772276|158225377|FG009|Overall Study|Lost to Follow-up|0|||
49106422|NCT02772276|158225378|FG010|Overall Study|Lost to Follow-up|0|||
49106423|NCT02772276|158225379|FG011|Overall Study|Lost to Follow-up|0|||
49106424|NCT02772276|158225380|FG012|Overall Study|Lost to Follow-up|0|||
49106425|NCT02772276|158225368|FG000|Overall Study|Withdrew consent|0|||
49106426|NCT02772276|158225369|FG001|Overall Study|Withdrew consent|0|||
49106427|NCT02772276|158225370|FG002|Overall Study|Withdrew consent|0|||
49106428|NCT02772276|158225371|FG003|Overall Study|Withdrew consent|0|||
49106429|NCT02772276|158225372|FG004|Overall Study|Withdrew consent|0|||
49106430|NCT02772276|158225373|FG005|Overall Study|Withdrew consent|0|||
49106431|NCT02772276|158225374|FG006|Overall Study|Withdrew consent|0|||
49106432|NCT02772276|158225375|FG007|Overall Study|Withdrew consent|1|||
49106433|NCT02772276|158225376|FG008|Overall Study|Withdrew consent|0|||
49106434|NCT02772276|158225377|FG009|Overall Study|Withdrew consent|0|||
49106435|NCT02772276|158225378|FG010|Overall Study|Withdrew consent|0|||
49106436|NCT02772276|158225379|FG011|Overall Study|Withdrew consent|0|||
49106437|NCT02772276|158225380|FG012|Overall Study|Withdrew consent|0|||
49106438|NCT00738062|158225381|FG000|Open Label Treatment|Lack of Efficacy|5|||
49106439|NCT00738062|158225382|FG001|Open Label Treatment|Lack of Efficacy|0|||
49106440|NCT00738062|158225383|FG002|Open Label Treatment|Lack of Efficacy|0|||
49106441|NCT00738062|158225381|FG000|Open Label Treatment|Adverse Event|11|||
49106442|NCT00738062|158225382|FG001|Open Label Treatment|Adverse Event|0|||
49106443|NCT00738062|158225383|FG002|Open Label Treatment|Adverse Event|0|||
49106444|NCT00738062|158225381|FG000|Open Label Treatment|Protocol Violation|2|||
49106445|NCT00738062|158225382|FG001|Open Label Treatment|Protocol Violation|0|||
49106446|NCT00738062|158225383|FG002|Open Label Treatment|Protocol Violation|0|||
49106447|NCT00738062|158225381|FG000|Open Label Treatment|Withdrawal by Subject|9|||
49106448|NCT00738062|158225382|FG001|Open Label Treatment|Withdrawal by Subject|0|||
49106449|NCT00738062|158225383|FG002|Open Label Treatment|Withdrawal by Subject|0|||
49106450|NCT00738062|158225381|FG000|Open Label Treatment|Investigator Decision|1|||
49106451|NCT00738062|158225382|FG001|Open Label Treatment|Investigator Decision|0|||
49106452|NCT00738062|158225383|FG002|Open Label Treatment|Investigator Decision|0|||
49106453|NCT00738062|158225381|FG000|Open-Label Extension|Adverse Event|5|||
49106454|NCT00738062|158225382|FG001|Open-Label Extension|Adverse Event|0|||
49106455|NCT00738062|158225383|FG002|Open-Label Extension|Adverse Event|0|||
49106456|NCT00738062|158225381|FG000|Open-Label Extension|Physician Decision|1|||
49106457|NCT00738062|158225382|FG001|Open-Label Extension|Physician Decision|0|||
49106458|NCT00738062|158225383|FG002|Open-Label Extension|Physician Decision|0|||
49106459|NCT00738062|158225381|FG000|Open-Label Extension|Lack of Efficacy|2|||
49106460|NCT00738062|158225382|FG001|Open-Label Extension|Lack of Efficacy|0|||
49106461|NCT00738062|158225383|FG002|Open-Label Extension|Lack of Efficacy|0|||
49106462|NCT00738062|158225381|FG000|Open-Label Extension|Withdrawal by Subject|6|||
49106463|NCT00738062|158225382|FG001|Open-Label Extension|Withdrawal by Subject|0|||
49106464|NCT00738062|158225383|FG002|Open-Label Extension|Withdrawal by Subject|0|||
49106465|NCT00738062|158225381|FG000|Open-Label Extension|Protocol Violation|1|||
49106466|NCT00738062|158225382|FG001|Open-Label Extension|Protocol Violation|0|||
49106467|NCT00738062|158225383|FG002|Open-Label Extension|Protocol Violation|0|||
49106468|NCT00738062|158225381|FG000|Open-Label Extension|Study Terminated|2|||
49106469|NCT00738062|158225382|FG001|Open-Label Extension|Study Terminated|0|||
49106470|NCT00738062|158225383|FG002|Open-Label Extension|Study Terminated|0|||
49106471|NCT00550862|158225384|FG000|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
49106472|NCT00550862|158225385|FG001|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
49106473|NCT00550862|158225386|FG002|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|12|||
49106474|NCT00550862|158225387|FG003|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|1|||
49106475|NCT00550862|158225388|FG004|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|0|||
49106476|NCT00550862|158225384|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|1|||
49106477|NCT00550862|158225385|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
49106478|NCT00550862|158225386|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|2|||
49106479|NCT00550862|158225387|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
49106480|NCT00550862|158225388|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
49106481|NCT00550862|158225384|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
49106482|NCT00550862|158225385|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
49106483|NCT00550862|158225386|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|1|||
49106484|NCT00550862|158225387|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
49106485|NCT00550862|158225388|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
49106486|NCT00550862|158225384|FG000|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
49106487|NCT00550862|158225385|FG001|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
49106488|NCT00550862|158225386|FG002|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|1|||
49106489|NCT00550862|158225387|FG003|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
49106490|NCT00550862|158225388|FG004|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
49106491|NCT00550862|158225384|FG000|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
49106492|NCT00550862|158225385|FG001|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|1|||
49106493|NCT00550862|158225386|FG002|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
49106494|NCT00550862|158225387|FG003|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
49106495|NCT00550862|158225388|FG004|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
49106496|NCT00550862|158225384|FG000|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
49106497|NCT00550862|158225385|FG001|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
49106498|NCT00550862|158225386|FG002|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
49106499|NCT00550862|158225387|FG003|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
49106500|NCT00550862|158225388|FG004|LTSE Phase (Up to 12 Months)|Adverse Event|14|||
49106501|NCT00550862|158225384|FG000|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
49106502|NCT00550862|158225385|FG001|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
49106503|NCT00550862|158225386|FG002|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
49106504|NCT00550862|158225387|FG003|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
49106505|NCT00550862|158225388|FG004|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|2|||
49106506|NCT00550862|158225384|FG000|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
49106507|NCT00550862|158225385|FG001|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
49106508|NCT00550862|158225386|FG002|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
49106509|NCT00550862|158225387|FG003|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
49106510|NCT00550862|158225388|FG004|LTSE Phase (Up to 12 Months)|Protocol Violation|1|||
49106511|NCT00550862|158225384|FG000|LTSE Phase (Up to 12 Months)|Other|0|||
49106512|NCT00550862|158225385|FG001|LTSE Phase (Up to 12 Months)|Other|0|||
49106513|NCT00550862|158225386|FG002|LTSE Phase (Up to 12 Months)|Other|0|||
49106514|NCT00550862|158225387|FG003|LTSE Phase (Up to 12 Months)|Other|0|||
49106515|NCT00550862|158225388|FG004|LTSE Phase (Up to 12 Months)|Other|2|||
49106516|NCT00550862|158225384|FG000|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
49106517|NCT00550862|158225385|FG001|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
49106518|NCT00550862|158225386|FG002|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
49106519|NCT00550862|158225387|FG003|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
49106520|NCT00550862|158225388|FG004|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|59|||
49106521|NCT02858180|158225389|FG000|Overall Study|Lost to Follow-up|0|||
49106522|NCT02858180|158225390|FG001|Overall Study|Lost to Follow-up|2|||
49106523|NCT00574249|158225392|FG000|Overall Study|Adverse Event|6|||
49106524|NCT00574249|158225393|FG001|Overall Study|Adverse Event|18|||
49106525|NCT00574249|158225392|FG000|Overall Study|Lack of Efficacy|5|||
49106526|NCT00574249|158225393|FG001|Overall Study|Lack of Efficacy|3|||
49106527|NCT00574249|158225392|FG000|Overall Study|Lost to Follow-up|4|||
49106528|NCT00574249|158225393|FG001|Overall Study|Lost to Follow-up|3|||
49106529|NCT00574249|158225392|FG000|Overall Study|Protocol Violation|5|||
49106530|NCT00574249|158225393|FG001|Overall Study|Protocol Violation|2|||
49106531|NCT00574249|158225392|FG000|Overall Study|History of carcinoma|1|||
49106532|NCT00574249|158225393|FG001|Overall Study|History of carcinoma|0|||
49106533|NCT00574249|158225392|FG000|Overall Study|Withdrawal by Subject|3|||
49106534|NCT00574249|158225393|FG001|Overall Study|Withdrawal by Subject|0|||
49106535|NCT00574249|158225392|FG000|Overall Study|Physician Decision|1|||
49106536|NCT00574249|158225393|FG001|Overall Study|Physician Decision|0|||
49106537|NCT00574249|158225392|FG000|Overall Study|Pregnancy|1|||
49106538|NCT00574249|158225393|FG001|Overall Study|Pregnancy|0|||
49106539|NCT00574249|158225392|FG000|Overall Study|Excluded by company|0|||
49106540|NCT00574249|158225393|FG001|Overall Study|Excluded by company|1|||
49106541|NCT00574249|158225392|FG000|Overall Study|PPD test taken twice|0|||
49106542|NCT00574249|158225393|FG001|Overall Study|PPD test taken twice|1|||
49106543|NCT03197870|158225398|FG000|Overall Study|Adverse Event|9|||
49106544|NCT03197870|158225399|FG001|Overall Study|Adverse Event|4|||
49106545|NCT03197870|158225400|FG002|Overall Study|Adverse Event|6|||
49106546|NCT03197870|158225398|FG000|Overall Study|Withdrawal by Subject|2|||
49106547|NCT03197870|158225399|FG001|Overall Study|Withdrawal by Subject|3|||
49106548|NCT03197870|158225400|FG002|Overall Study|Withdrawal by Subject|0|||
49106549|NCT03197870|158225398|FG000|Overall Study|Lost to Follow-up|2|||
49106550|NCT03197870|158225399|FG001|Overall Study|Lost to Follow-up|2|||
49106551|NCT03197870|158225400|FG002|Overall Study|Lost to Follow-up|0|||
49106552|NCT03197870|158225398|FG000|Overall Study|data not available|1|||
49106553|NCT03197870|158225399|FG001|Overall Study|data not available|1|||
49106554|NCT03197870|158225400|FG002|Overall Study|data not available|0|||
49106555|NCT02554318|158225401|FG000|Overall Study|Withdrawal by Subject|10|||
49106556|NCT02554318|158225402|FG001|Overall Study|Withdrawal by Subject|8|||
49106557|NCT02248974|158225403|FG000|1-Day Follow-Up|Lost to Follow-up|4|||
49106558|NCT02248974|158225404|FG001|1-Day Follow-Up|Lost to Follow-up|0|||
49106559|NCT02248974|158225403|FG000|1-Day Follow-Up|Withdrawal by Subject|5|||
49106560|NCT02248974|158225404|FG001|1-Day Follow-Up|Withdrawal by Subject|0|||
49106561|NCT02248974|158225403|FG000|1-Day Follow-Up|Enrolled in another study|1|||
49106562|NCT02248974|158225404|FG001|1-Day Follow-Up|Enrolled in another study|0|||
49106563|NCT02248974|158225403|FG000|1-Week Follow-Up|Became ineligible for LVAD|4|||
49111405|NCT01289574|158242895|FG002|Overall Study|Lost to Follow-up|1|||
49106564|NCT02248974|158225404|FG001|1-Week Follow-Up|Became ineligible for LVAD|1|||
49106565|NCT02248974|158225403|FG000|1-Week Follow-Up|Enrolled in another study|1|||
49106566|NCT02248974|158225404|FG001|1-Week Follow-Up|Enrolled in another study|1|||
49106567|NCT02248974|158225403|FG000|1-Week Follow-Up|Transferred to another facility|1|||
49106568|NCT02248974|158225404|FG001|1-Week Follow-Up|Transferred to another facility|0|||
49106569|NCT02248974|158225403|FG000|1-Week Follow-Up|Cognitive Difficulty|1|||
49106570|NCT02248974|158225404|FG001|1-Week Follow-Up|Cognitive Difficulty|0|||
49106571|NCT02248974|158225403|FG000|1-Week Follow-Up|Death|1|||
49106572|NCT02248974|158225404|FG001|1-Week Follow-Up|Death|1|||
49106573|NCT02248974|158225403|FG000|1-Week Follow-Up|Excluded because of age|0|||
49106574|NCT02248974|158225404|FG001|1-Week Follow-Up|Excluded because of age|1|||
49106575|NCT02248974|158225403|FG000|1-Week Follow-Up|Noncompliant with terms of participation|0|||
49106576|NCT02248974|158225404|FG001|1-Week Follow-Up|Noncompliant with terms of participation|1|||
49106577|NCT02248974|158225403|FG000|1-Week Follow-Up|Timing: implanted before survey|0|||
49106578|NCT02248974|158225404|FG001|1-Week Follow-Up|Timing: implanted before survey|2|||
49106579|NCT02248974|158225403|FG000|1-Week Follow-Up|Withdrawal by Subject|0|||
49106580|NCT02248974|158225404|FG001|1-Week Follow-Up|Withdrawal by Subject|2|||
49106581|NCT02248974|158225403|FG000|1-Week Follow-Up|Lost to Follow-up|0|||
49106582|NCT02248974|158225404|FG001|1-Week Follow-Up|Lost to Follow-up|8|||
49106583|NCT02248974|158225403|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
49106584|NCT02248974|158225404|FG001|1-Month Follow-Up|Lost to Follow-up|3|||
49106585|NCT01904903|158225409|FG000|Overall Study|Withdrawal by Subject|1|||
49106586|NCT02117713|158225423|FG000|Week 48|Adverse Event|4|||
49106587|NCT02117713|158225423|FG000|Week 48|Withdrawal by caregiver|2|||
49106588|NCT02117713|158225423|FG000|Week 48|Did not consent to Protocol Amendment 4|2|||
49106589|NCT02117713|158225423|FG000|Long Term Follow-up Treatment|Adverse Event|3|||
49106590|NCT02117713|158225423|FG000|Long Term Follow-up Treatment|Progressive Disease|2|||
49106591|NCT02117713|158225423|FG000|Long Term Follow-up Treatment|Non-Compliance with study drug|1|||
49106592|NCT00574795|158225427|FG000|Infant Series|Withdrawal by Subject|2|||
49106593|NCT00574795|158225427|FG000|Infant Series|Protocol Violation|2|||
49106594|NCT00574795|158225427|FG000|Infant Series|Adverse Event|1|||
49106595|NCT00574795|158225427|FG000|After Infant Series|Withdrawal by Subject|1|||
49106596|NCT00574795|158225427|FG000|After Infant Series|Adverse Event|2|||
49106597|NCT00574795|158225427|FG000|Toddler Dose|Withdrawal by Subject|1|||
49106598|NCT03802565|158225428|FG000|Overall Study|Adverse Event|0|||
49106599|NCT03802565|158225429|FG001|Overall Study|Adverse Event|1|||
49106600|NCT03802565|158225430|FG002|Overall Study|Adverse Event|2|||
49106601|NCT03802565|158225431|FG003|Overall Study|Adverse Event|1|||
49106602|NCT03802565|158225432|FG004|Overall Study|Adverse Event|1|||
49106603|NCT03802565|158225428|FG000|Overall Study|Withdrawal by Subject|2|||
49106604|NCT03802565|158225429|FG001|Overall Study|Withdrawal by Subject|2|||
49106605|NCT03802565|158225430|FG002|Overall Study|Withdrawal by Subject|2|||
49106606|NCT03802565|158225431|FG003|Overall Study|Withdrawal by Subject|0|||
49106607|NCT03802565|158225432|FG004|Overall Study|Withdrawal by Subject|1|||
49106608|NCT03802565|158225428|FG000|Overall Study|Protocol Violation|2|||
49106609|NCT03802565|158225429|FG001|Overall Study|Protocol Violation|1|||
49106610|NCT03802565|158225430|FG002|Overall Study|Protocol Violation|4|||
49106611|NCT03802565|158225431|FG003|Overall Study|Protocol Violation|5|||
49106612|NCT03802565|158225432|FG004|Overall Study|Protocol Violation|1|||
49106613|NCT03802565|158225428|FG000|Overall Study|Lost to Follow-up|0|||
49106614|NCT03802565|158225429|FG001|Overall Study|Lost to Follow-up|0|||
49106615|NCT03802565|158225430|FG002|Overall Study|Lost to Follow-up|1|||
49106616|NCT03802565|158225431|FG003|Overall Study|Lost to Follow-up|0|||
49106617|NCT03802565|158225432|FG004|Overall Study|Lost to Follow-up|0|||
49106618|NCT03802565|158225428|FG000|Overall Study|Subjects Related to Each Other|1|||
49106619|NCT03802565|158225429|FG001|Overall Study|Subjects Related to Each Other|0|||
49106620|NCT03802565|158225430|FG002|Overall Study|Subjects Related to Each Other|0|||
49106621|NCT03802565|158225431|FG003|Overall Study|Subjects Related to Each Other|2|||
49106622|NCT03802565|158225432|FG004|Overall Study|Subjects Related to Each Other|1|||
49106623|NCT03802565|158225428|FG000|Overall Study|Elevated Enzymes|0|||
49106624|NCT03802565|158225429|FG001|Overall Study|Elevated Enzymes|0|||
49106625|NCT03802565|158225430|FG002|Overall Study|Elevated Enzymes|0|||
49106626|NCT03802565|158225431|FG003|Overall Study|Elevated Enzymes|0|||
49106627|NCT03802565|158225432|FG004|Overall Study|Elevated Enzymes|2|||
49106628|NCT04272606|158225433|FG000|Overall Study|Protocol Violation|1|||
49106629|NCT04272606|158225434|FG001|Overall Study|Protocol Violation|1|||
49106630|NCT04272606|158225433|FG000|Overall Study|Physician Decision|0|||
49106631|NCT04272606|158225434|FG001|Overall Study|Physician Decision|1|||
49106632|NCT03434249|158225435|FG000|Overall Study|Adverse Event|1|||
49106633|NCT03434249|158225436|FG001|Overall Study|Adverse Event|0|||
49106634|NCT03434249|158225435|FG000|Overall Study|Lost to Follow-up|0|||
49106635|NCT03434249|158225436|FG001|Overall Study|Lost to Follow-up|1|||
49106636|NCT03434249|158225435|FG000|Overall Study|Non-compliance of family|2|||
49106637|NCT03434249|158225436|FG001|Overall Study|Non-compliance of family|1|||
49106638|NCT03434249|158225435|FG000|Overall Study|Difficulties in completing daily diary|2|||
49106639|NCT03434249|158225436|FG001|Overall Study|Difficulties in completing daily diary|1|||
49106640|NCT00561470|158225437|FG000|Overall Study|Adverse Event|74|||
49106641|NCT00561470|158225438|FG001|Overall Study|Adverse Event|163|||
49106642|NCT00561470|158225437|FG000|Overall Study|Disease progression|437|||
49106643|NCT00561470|158225438|FG001|Overall Study|Disease progression|305|||
49106644|NCT00561470|158225437|FG000|Overall Study|poor compliance to protocol|4|||
49106645|NCT00561470|158225438|FG001|Overall Study|poor compliance to protocol|4|||
49106646|NCT00561470|158225437|FG000|Overall Study|Lost to Follow-up|2|||
49106647|NCT00561470|158225438|FG001|Overall Study|Lost to Follow-up|0|||
49106648|NCT00561470|158225437|FG000|Overall Study|Physician Decision|21|||
49106649|NCT00561470|158225438|FG001|Overall Study|Physician Decision|20|||
49106650|NCT00561470|158225437|FG000|Overall Study|Consent Withdrawn|2|||
49106651|NCT00561470|158225438|FG001|Overall Study|Consent Withdrawn|6|||
49106652|NCT00561470|158225437|FG000|Overall Study|Subject request|43|||
49106653|NCT00561470|158225438|FG001|Overall Study|Subject request|77|||
49106654|NCT00561470|158225437|FG000|Overall Study|Metastatic surgery|10|||
49106655|NCT00561470|158225438|FG001|Overall Study|Metastatic surgery|12|||
49106656|NCT00561470|158225437|FG000|Overall Study|Unauthorized procedure|3|||
49106657|NCT00561470|158225438|FG001|Overall Study|Unauthorized procedure|1|||
49106658|NCT00561470|158225437|FG000|Overall Study|Randomized but not treated|5|||
49106659|NCT00561470|158225438|FG001|Overall Study|Randomized but not treated|5|||
49106660|NCT00561470|158225437|FG000|Overall Study|Missed visit window|1|||
49106661|NCT00561470|158225438|FG001|Overall Study|Missed visit window|4|||
49106662|NCT00561470|158225437|FG000|Overall Study|Planning surgery|1|||
49106663|NCT00561470|158225438|FG001|Overall Study|Planning surgery|1|||
49106664|NCT00561470|158225437|FG000|Overall Study|Ongoing Treatment|11|||
49106665|NCT00561470|158225438|FG001|Overall Study|Ongoing Treatment|14|||
49106666|NCT00637806|158225439|FG000|Double-blind Phase|Study Discontinued|2|||
49106667|NCT00637806|158225440|FG001|Double-blind Phase|Study Discontinued|0|||
49106668|NCT00637806|158225441|FG002|Double-blind Phase|Study Discontinued|1|||
49106669|NCT00637806|158225442|FG003|Double-blind Phase|Study Discontinued|0|||
49106670|NCT00637806|158225439|FG000|Extension Phase|Study Discontinued|0|||
49106671|NCT00637806|158225440|FG001|Extension Phase|Study Discontinued|0|||
49106672|NCT00637806|158225441|FG002|Extension Phase|Study Discontinued|0|||
49106673|NCT00637806|158225442|FG003|Extension Phase|Study Discontinued|1|||
49106674|NCT00725101|158225443|FG000|Overall Study|Death|3|||
49106675|NCT00725101|158225443|FG000|Overall Study|Lost to Follow-up|353|||
49106676|NCT00725101|158225443|FG000|Overall Study|Protocol Violation|1|||
49106677|NCT00725101|158225443|FG000|Overall Study|Withdrawal by Subject|127|||
49106678|NCT00725101|158225443|FG000|Overall Study|not specified/no reason given|11|||
49106679|NCT02918552|158225444|FG000|Overall Study|Failed Pharmacokinetics|1|||
49106680|NCT02918552|158225445|FG001|Overall Study|Failed Pharmacokinetics|0|||
49106681|NCT02918552|158225444|FG000|Overall Study|Withdrawal by Subject|0|||
49106682|NCT02918552|158225445|FG001|Overall Study|Withdrawal by Subject|1|||
49106683|NCT02918552|158225444|FG000|Overall Study|Lost to Follow-up|0|||
49106684|NCT02918552|158225445|FG001|Overall Study|Lost to Follow-up|1|||
49106685|NCT01554176|158225446|FG000|Treatment Phase|Protocol Violation|1|||
49106686|NCT01554176|158225447|FG001|Treatment Phase|Protocol Violation|2|||
49106687|NCT01554176|158225448|FG002|Treatment Phase|Protocol Violation|0|||
49106688|NCT01554176|158225449|FG003|Treatment Phase|Protocol Violation|0|||
49106689|NCT01554176|158225450|FG004|Treatment Phase|Protocol Violation|0|||
49106690|NCT01554176|158225446|FG000|Treatment Phase|Physician Decision|1|||
49106691|NCT01554176|158225447|FG001|Treatment Phase|Physician Decision|1|||
49106692|NCT01554176|158225448|FG002|Treatment Phase|Physician Decision|0|||
49106693|NCT01554176|158225449|FG003|Treatment Phase|Physician Decision|0|||
49106694|NCT01554176|158225450|FG004|Treatment Phase|Physician Decision|0|||
49106695|NCT01554176|158225446|FG000|Treatment Phase|Lack of Efficacy|0|||
49106696|NCT01554176|158225447|FG001|Treatment Phase|Lack of Efficacy|1|||
49106697|NCT01554176|158225448|FG002|Treatment Phase|Lack of Efficacy|0|||
49106698|NCT01554176|158225449|FG003|Treatment Phase|Lack of Efficacy|0|||
49106699|NCT01554176|158225450|FG004|Treatment Phase|Lack of Efficacy|0|||
49106700|NCT01554176|158225446|FG000|Treatment Phase|Adverse event, non-fatal|1|||
49106701|NCT01554176|158225447|FG001|Treatment Phase|Adverse event, non-fatal|1|||
49106702|NCT01554176|158225448|FG002|Treatment Phase|Adverse event, non-fatal|0|||
49106703|NCT01554176|158225449|FG003|Treatment Phase|Adverse event, non-fatal|0|||
49106704|NCT01554176|158225450|FG004|Treatment Phase|Adverse event, non-fatal|0|||
49106705|NCT01554176|158225446|FG000|Treatment Phase|Non-compliance with study drug|1|||
49106706|NCT01554176|158225447|FG001|Treatment Phase|Non-compliance with study drug|0|||
49106707|NCT01554176|158225448|FG002|Treatment Phase|Non-compliance with study drug|0|||
49106708|NCT01554176|158225449|FG003|Treatment Phase|Non-compliance with study drug|0|||
49106709|NCT01554176|158225450|FG004|Treatment Phase|Non-compliance with study drug|0|||
49106710|NCT01554176|158225446|FG000|Treatment Phase|Withdrawal by Subject|1|||
49106711|NCT01554176|158225447|FG001|Treatment Phase|Withdrawal by Subject|0|||
49106712|NCT01554176|158225448|FG002|Treatment Phase|Withdrawal by Subject|0|||
49106713|NCT01554176|158225449|FG003|Treatment Phase|Withdrawal by Subject|0|||
49106714|NCT01554176|158225450|FG004|Treatment Phase|Withdrawal by Subject|0|||
49106715|NCT01554176|158225446|FG000|Treatment Phase|Lost to Follow-up|3|||
49106716|NCT01554176|158225447|FG001|Treatment Phase|Lost to Follow-up|0|||
49106717|NCT01554176|158225448|FG002|Treatment Phase|Lost to Follow-up|0|||
49106718|NCT01554176|158225449|FG003|Treatment Phase|Lost to Follow-up|0|||
49106719|NCT01554176|158225450|FG004|Treatment Phase|Lost to Follow-up|0|||
49106720|NCT01554176|158225446|FG000|Run-out Phase|Protocol Violation|0|||
49106721|NCT01554176|158225447|FG001|Run-out Phase|Protocol Violation|0|||
49106722|NCT01554176|158225448|FG002|Run-out Phase|Protocol Violation|0|||
49106723|NCT01554176|158225449|FG003|Run-out Phase|Protocol Violation|1|||
49106724|NCT01554176|158225450|FG004|Run-out Phase|Protocol Violation|0|||
49106725|NCT02240069|158225451|FG000|Overall Study|Withdrawal by Subject|5|||
49106726|NCT02240069|158225452|FG001|Overall Study|Withdrawal by Subject|5|||
49106727|NCT02240069|158225453|FG002|Overall Study|Withdrawal by Subject|2|||
49106728|NCT02195427|158225456|FG000|Overall Study|Did not consent to study extension|13|||
49106729|NCT02195427|158225457|FG001|Overall Study|Did not consent to study extension|9|||
49106730|NCT02195427|158225456|FG000|Overall Study|Withdrawal by Subject|4|||
49106731|NCT02195427|158225457|FG001|Overall Study|Withdrawal by Subject|2|||
49106732|NCT02195427|158225456|FG000|Overall Study|Lost to Follow-up|0|||
49106733|NCT02195427|158225457|FG001|Overall Study|Lost to Follow-up|1|||
49106734|NCT02195427|158225456|FG000|Overall Study|Protocol Violation|7|||
49106735|NCT02195427|158225457|FG001|Overall Study|Protocol Violation|14|||
49106736|NCT02195427|158225456|FG000|Overall Study|Conditional re-treatment at W52|2|||
49106737|NCT02195427|158225457|FG001|Overall Study|Conditional re-treatment at W52|1|||
49106738|NCT01210144|158225461|FG000|Overall Study|Lack of ovarian response|1|||
49106739|NCT01210144|158225462|FG001|Overall Study|Lack of ovarian response|0|||
49106740|NCT01210144|158225461|FG000|Overall Study|No fertilization|1|||
49106741|NCT01210144|158225462|FG001|Overall Study|No fertilization|0|||
49106742|NCT01210144|158225461|FG000|Overall Study|No transfer|1|||
49106743|NCT01210144|158225462|FG001|Overall Study|No transfer|0|||
49106744|NCT00094536|158225465|FG000|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24|||
49106745|NCT00094536|158225465|FG000|Treatment and Follow-up|Adverse Event|4|||
49106746|NCT00094536|158225465|FG000|Treatment and Follow-up|Lack of Efficacy|9|||
49106747|NCT00094536|158225465|FG000|Treatment and Follow-up|Lost to Follow-up|7|||
49106748|NCT00094536|158225465|FG000|Treatment and Follow-up|Withdrawal by Subject|1|||
49106749|NCT00094536|158225465|FG000|Treatment and Follow-up|Subject non-compliance|9|||
49106750|NCT00094536|158225465|FG000|Treatment and Follow-up|Unable to attend visits|1|||
49106751|NCT02655419|158225466|FG000|Overall Study|Enrolled but not treated|1|||
49106752|NCT02655419|158225467|FG001|Overall Study|Enrolled but not treated|5|||
49106753|NCT02655419|158225466|FG000|Overall Study|Withdrawal by Subject|4|||
49106754|NCT02655419|158225467|FG001|Overall Study|Withdrawal by Subject|1|||
49106755|NCT02655419|158225466|FG000|Overall Study|Other|0|||
49106756|NCT02655419|158225467|FG001|Overall Study|Other|1|||
49106757|NCT02678000|158225468|FG000|PART 2|Adverse Event|0|||
49106758|NCT02678000|158225469|FG001|PART 2|Adverse Event|0|||
49106759|NCT02678000|158225470|FG002|PART 2|Adverse Event|2|||
49106760|NCT02678000|158225471|FG003|PART 2|Adverse Event|1|||
49106761|NCT02678000|158225472|FG004|PART 2|Adverse Event|0|||
49106762|NCT02678000|158225468|FG000|PART 2|Withdrawal by Subject|0|||
49106763|NCT02678000|158225469|FG001|PART 2|Withdrawal by Subject|0|||
49106764|NCT02678000|158225470|FG002|PART 2|Withdrawal by Subject|1|||
49106765|NCT02678000|158225471|FG003|PART 2|Withdrawal by Subject|0|||
49106766|NCT02678000|158225472|FG004|PART 2|Withdrawal by Subject|0|||
49106767|NCT02101359|158225475|FG000|Overall Study|Not included|23|||
49106768|NCT02101359|158225476|FG001|Overall Study|Not included|13|||
49106769|NCT02101359|158225475|FG000|Overall Study|Withdrawal by Subject|5|||
49106770|NCT02101359|158225476|FG001|Overall Study|Withdrawal by Subject|4|||
49106771|NCT02101359|158225475|FG000|Overall Study|Lost to Follow-up|1|||
49106772|NCT02101359|158225476|FG001|Overall Study|Lost to Follow-up|0|||
49106773|NCT02101359|158225475|FG000|Overall Study|Protocol Violation|0|||
49106774|NCT02101359|158225476|FG001|Overall Study|Protocol Violation|2|||
49106775|NCT00623597|158227241|FG000|Overall Study|Failed to return|1|||
49106776|NCT00623597|158227242|FG001|Overall Study|Failed to return|0|||
49106777|NCT03408444|158227243|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
49106778|NCT03408444|158227244|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
49106779|NCT03408444|158227245|FG002|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
49106780|NCT03408444|158227246|FG003|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
49106781|NCT03408444|158227243|FG000|Overall Study|Lens Discomfort|0|||
49106782|NCT03408444|158227244|FG001|Overall Study|Lens Discomfort|1|||
49106783|NCT03408444|158227245|FG002|Overall Study|Lens Discomfort|0|||
49106784|NCT03408444|158227246|FG003|Overall Study|Lens Discomfort|0|||
49106785|NCT03408444|158227243|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
49106786|NCT03408444|158227244|FG001|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
49106787|NCT03408444|158227245|FG002|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
49106788|NCT03408444|158227246|FG003|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
49106789|NCT03408444|158227243|FG000|Overall Study|Withdrawal by Subject|0|||
49106790|NCT03408444|158227244|FG001|Overall Study|Withdrawal by Subject|2|||
49106791|NCT03408444|158227245|FG002|Overall Study|Withdrawal by Subject|3|||
49106792|NCT03408444|158227246|FG003|Overall Study|Withdrawal by Subject|0|||
49106793|NCT03408444|158227243|FG000|Overall Study|Lost to Follow-up|0|||
49106794|NCT03408444|158227244|FG001|Overall Study|Lost to Follow-up|0|||
49106795|NCT03408444|158227245|FG002|Overall Study|Lost to Follow-up|1|||
49106796|NCT03408444|158227246|FG003|Overall Study|Lost to Follow-up|0|||
49106797|NCT03408444|158227243|FG000|Overall Study|Adverse Event|0|||
49106798|NCT03408444|158227244|FG001|Overall Study|Adverse Event|0|||
49106799|NCT03408444|158227245|FG002|Overall Study|Adverse Event|0|||
49106800|NCT03408444|158227246|FG003|Overall Study|Adverse Event|1|||
49106801|NCT03408444|158227243|FG000|Overall Study|Lens Handling Difficulties|0|||
49106802|NCT03408444|158227244|FG001|Overall Study|Lens Handling Difficulties|0|||
49106803|NCT03408444|158227245|FG002|Overall Study|Lens Handling Difficulties|1|||
49106804|NCT03408444|158227246|FG003|Overall Study|Lens Handling Difficulties|0|||
49106805|NCT03408444|158227243|FG000|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
49106806|NCT03408444|158227244|FG001|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
49106807|NCT03408444|158227245|FG002|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
49106808|NCT03408444|158227246|FG003|Overall Study|Subject Decided to Not Wear Contact Lenses|3|||
49106809|NCT02339155|158227247|FG000|Overall Study|Adverse Event|0|||
49106810|NCT02339155|158227248|FG001|Overall Study|Adverse Event|6|||
49106811|NCT02339155|158227247|FG000|Overall Study|Death|1|||
49106812|NCT02339155|158227248|FG001|Overall Study|Death|1|||
49106813|NCT02339155|158227247|FG000|Overall Study|Lost to Follow-up|8|||
49106814|NCT02339155|158227248|FG001|Overall Study|Lost to Follow-up|9|||
49106815|NCT02339155|158227247|FG000|Overall Study|Physician Decision|2|||
49106816|NCT02339155|158227248|FG001|Overall Study|Physician Decision|1|||
49106817|NCT02339155|158227247|FG000|Overall Study|Withdrawal by Subject|4|||
49106818|NCT02339155|158227248|FG001|Overall Study|Withdrawal by Subject|4|||
49106819|NCT04984681|158227249|FG000|Overall Study|Lost to Follow-up|3|||
49106820|NCT04984681|158227250|FG001|Overall Study|Lost to Follow-up|1|||
49106821|NCT02278367|158227251|FG000|Overall Study|Physician Decision|5|||
49106822|NCT02278367|158227252|FG001|Overall Study|Physician Decision|0|||
49106823|NCT02278367|158227251|FG000|Overall Study|Withdrawal by Subject|5|||
49106824|NCT02278367|158227252|FG001|Overall Study|Withdrawal by Subject|0|||
49106825|NCT00908076|158227254|FG000|Overall Study|Lack of Efficacy|1|||
49106826|NCT00908076|158227255|FG001|Overall Study|Lack of Efficacy|1|||
49106827|NCT00979420|158227256|FG000|Overall Study|Adverse Event|1|||
49106828|NCT00979420|158227257|FG001|Overall Study|Adverse Event|0|||
49106829|NCT00979420|158227258|FG002|Overall Study|Adverse Event|0|||
49106830|NCT00979420|158227259|FG003|Overall Study|Adverse Event|0|||
49106831|NCT00979420|158227256|FG000|Overall Study|Lack of Efficacy|3|||
49106832|NCT00979420|158227257|FG001|Overall Study|Lack of Efficacy|0|||
49106833|NCT00979420|158227258|FG002|Overall Study|Lack of Efficacy|1|||
49106834|NCT00979420|158227259|FG003|Overall Study|Lack of Efficacy|1|||
49106835|NCT00979420|158227256|FG000|Overall Study|Other reasons not related to Viramune|3|||
49106836|NCT00979420|158227257|FG001|Overall Study|Other reasons not related to Viramune|0|||
49106837|NCT00979420|158227258|FG002|Overall Study|Other reasons not related to Viramune|0|||
49106838|NCT00979420|158227259|FG003|Overall Study|Other reasons not related to Viramune|1|||
49106839|NCT00526331|158227260|FG000|Overall Study|Sponsor Termination|55|||
49106840|NCT03840148|158227261|FG000|Study Drug Disposition|Adverse Event|13|||
49106841|NCT03840148|158227262|FG001|Study Drug Disposition|Adverse Event|2|||
49106842|NCT03840148|158227261|FG000|Study Drug Disposition|Withdrawal by Subject|8|||
49106843|NCT03840148|158227262|FG001|Study Drug Disposition|Withdrawal by Subject|2|||
49106844|NCT03840148|158227261|FG000|Study Drug Disposition|Lack of Efficacy|3|||
49106845|NCT03840148|158227262|FG001|Study Drug Disposition|Lack of Efficacy|0|||
49106846|NCT03840148|158227261|FG000|Study Drug Disposition|Physician Decision|2|||
49106847|NCT03840148|158227262|FG001|Study Drug Disposition|Physician Decision|0|||
49106848|NCT03840148|158227261|FG000|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|1|||
49106849|NCT03840148|158227262|FG001|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|4|||
49106850|NCT03840148|158227261|FG000|Study Completion Disposition|Withdrawal by Subject|6|||
49106851|NCT03840148|158227262|FG001|Study Completion Disposition|Withdrawal by Subject|2|||
49106852|NCT03840148|158227261|FG000|Study Completion Disposition|Physician Decision|2|||
49106853|NCT03840148|158227262|FG001|Study Completion Disposition|Physician Decision|0|||
49106854|NCT03840148|158227261|FG000|Study Completion Disposition|Covid-19 related|2|||
49106855|NCT03840148|158227262|FG001|Study Completion Disposition|Covid-19 related|0|||
49106856|NCT03840148|158227261|FG000|Study Completion Disposition|Lost to Follow-up|1|||
49106857|NCT03840148|158227262|FG001|Study Completion Disposition|Lost to Follow-up|1|||
49106858|NCT03840148|158227261|FG000|Study Completion Disposition|Death|1|||
49106859|NCT03840148|158227262|FG001|Study Completion Disposition|Death|0|||
49106860|NCT03840148|158227261|FG000|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
49106861|NCT03840148|158227262|FG001|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
49106862|NCT03673501|158227263|FG000|Overall Study|Participants ongoing.|36|||
49106863|NCT03673501|158227264|FG001|Overall Study|Participants ongoing.|24|||
49106864|NCT03448939|158227266|FG000|Overall Study|Adverse Event|5|||
49106865|NCT03448939|158227267|FG001|Overall Study|Adverse Event|1|||
49106866|NCT03448939|158227266|FG000|Overall Study|Lost to Follow-up|6|||
49106867|NCT03448939|158227267|FG001|Overall Study|Lost to Follow-up|6|||
49106868|NCT03448939|158227266|FG000|Overall Study|Pregnancy|1|||
49106869|NCT03448939|158227267|FG001|Overall Study|Pregnancy|1|||
49106870|NCT03448939|158227266|FG000|Overall Study|Withdrawal by Subject|9|||
49106871|NCT03448939|158227267|FG001|Overall Study|Withdrawal by Subject|3|||
49106872|NCT02332239|158227268|FG000|Overall Study|Lost to Follow-up|4|||
49106873|NCT02332239|158227269|FG001|Overall Study|Lost to Follow-up|6|||
49106874|NCT03488225|158227270|FG000|Overall Study|Off Protocol Therapy|2|||
49106875|NCT03488225|158227270|FG000|Overall Study|Stem Cell Transplant|2|||
49106876|NCT00894790|158227272|FG000|Overall Study|Protocol Violation|0|||
49106877|NCT00894790|158227273|FG001|Overall Study|Protocol Violation|1|||
49106878|NCT00894790|158227272|FG000|Overall Study|Lost to Follow-up|0|||
49106879|NCT00894790|158227273|FG001|Overall Study|Lost to Follow-up|1|||
49106880|NCT00894790|158227272|FG000|Overall Study|Did not meet entrance criteria|1|||
49106881|NCT00894790|158227273|FG001|Overall Study|Did not meet entrance criteria|0|||
49106882|NCT04093492|158227274|FG000|25 Weeks Gestational Age (GA)|Delivered before assessment|1|||
49106883|NCT04093492|158227275|FG001|25 Weeks Gestational Age (GA)|Delivered before assessment|2|||
49106884|NCT04093492|158227276|FG002|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
49106885|NCT04093492|158227277|FG003|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
49106886|NCT04093492|158227274|FG000|25 Weeks Gestational Age (GA)|No response|5|||
49106887|NCT04093492|158227275|FG001|25 Weeks Gestational Age (GA)|No response|5|||
49106888|NCT04093492|158227276|FG002|25 Weeks Gestational Age (GA)|No response|5|||
49106889|NCT04093492|158227277|FG003|25 Weeks Gestational Age (GA)|No response|2|||
49106890|NCT04093492|158227274|FG000|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
49106891|NCT04093492|158227275|FG001|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
49106892|NCT04093492|158227276|FG002|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
49106893|NCT04093492|158227277|FG003|25 Weeks Gestational Age (GA)|Withdrawal by Subject|1|||
49106894|NCT04093492|158227274|FG000|30 Weeks GA|Delivered before assessment|1|||
49106895|NCT04093492|158227275|FG001|30 Weeks GA|Delivered before assessment|2|||
49106896|NCT04093492|158227276|FG002|30 Weeks GA|Delivered before assessment|0|||
49106897|NCT04093492|158227277|FG003|30 Weeks GA|Delivered before assessment|0|||
49106898|NCT04093492|158227274|FG000|30 Weeks GA|No response|7|||
49106899|NCT04093492|158227275|FG001|30 Weeks GA|No response|5|||
49106900|NCT04093492|158227276|FG002|30 Weeks GA|No response|5|||
49106901|NCT04093492|158227277|FG003|30 Weeks GA|No response|2|||
49106902|NCT04093492|158227274|FG000|30 Weeks GA|Lost to Follow-up|0|||
49106903|NCT04093492|158227275|FG001|30 Weeks GA|Lost to Follow-up|1|||
49106904|NCT04093492|158227276|FG002|30 Weeks GA|Lost to Follow-up|0|||
49106905|NCT04093492|158227277|FG003|30 Weeks GA|Lost to Follow-up|0|||
49106906|NCT04093492|158227274|FG000|34 Weeks GA|Delivered before assessment|6|||
49106907|NCT04093492|158227275|FG001|34 Weeks GA|Delivered before assessment|3|||
49106908|NCT04093492|158227276|FG002|34 Weeks GA|Delivered before assessment|0|||
49106909|NCT04093492|158227277|FG003|34 Weeks GA|Delivered before assessment|0|||
49106910|NCT04093492|158227274|FG000|34 Weeks GA|No response|0|||
49106911|NCT04093492|158227275|FG001|34 Weeks GA|No response|7|||
49106912|NCT04093492|158227276|FG002|34 Weeks GA|No response|5|||
49106913|NCT04093492|158227277|FG003|34 Weeks GA|No response|3|||
49106914|NCT04093492|158227274|FG000|34 Weeks GA|Lost to Follow-up|0|||
49106915|NCT04093492|158227275|FG001|34 Weeks GA|Lost to Follow-up|1|||
49106916|NCT04093492|158227276|FG002|34 Weeks GA|Lost to Follow-up|0|||
49106917|NCT04093492|158227277|FG003|34 Weeks GA|Lost to Follow-up|0|||
49106918|NCT01432275|158227278|FG000|First BG Meter System (7 Days)|Adverse Event|0|||
49106919|NCT01432275|158227279|FG001|First BG Meter System (7 Days)|Adverse Event|2|||
49106920|NCT01432275|158227278|FG000|First BG Meter System (7 Days)|Withdrawal by Subject|0|||
49106921|NCT01432275|158227279|FG001|First BG Meter System (7 Days)|Withdrawal by Subject|1|||
49106922|NCT01432275|158227278|FG000|Second BG Meter System (7 Days)|Adverse Event|1|||
49106923|NCT01432275|158227279|FG001|Second BG Meter System (7 Days)|Adverse Event|1|||
49106924|NCT01432275|158227278|FG000|Second BG Meter System (7 Days)|Lost to Follow-up|1|||
49106925|NCT01432275|158227279|FG001|Second BG Meter System (7 Days)|Lost to Follow-up|0|||
49106926|NCT01432275|158227278|FG000|Second BG Meter System (7 Days)|Physician Decision|0|||
49106927|NCT01432275|158227279|FG001|Second BG Meter System (7 Days)|Physician Decision|1|||
49106928|NCT01432275|158227278|FG000|Second BG Meter System (7 Days)|Withdrawal by Subject|0|||
49106929|NCT01432275|158227279|FG001|Second BG Meter System (7 Days)|Withdrawal by Subject|1|||
49106930|NCT01432275|158227278|FG000|ADC With Calculator (10 Days)|Physician Decision|1|||
49106931|NCT01432275|158227279|FG001|ADC With Calculator (10 Days)|Physician Decision|1|||
49106932|NCT01432275|158227278|FG000|ADC With Calculator (10 Days)|Withdrawal by Subject|2|||
49106933|NCT01432275|158227279|FG001|ADC With Calculator (10 Days)|Withdrawal by Subject|0|||
49106934|NCT01432275|158227278|FG000|ADC With Calculator (10 Days)|Protocol Violation|0|||
49106935|NCT01432275|158227279|FG001|ADC With Calculator (10 Days)|Protocol Violation|1|||
49106936|NCT01259375|158227280|FG000|Overall Study|Adverse Event|1|||
49106937|NCT01472965|158227281|FG000|Overall Study|Withdrawal by Subject|1|||
49106938|NCT01472965|158227282|FG001|Overall Study|Withdrawal by Subject|0|||
49106939|NCT00986986|158227283|FG000|Overall Study|Lost to Follow-up|0|||
49106940|NCT00986986|158227284|FG001|Overall Study|Lost to Follow-up|1|||
49106941|NCT01618019|158227286|FG000|Overall Study|Withdrawal by Subject|14|||
49106942|NCT01618019|158227287|FG001|Overall Study|Withdrawal by Subject|14|||
49106943|NCT03114657|158227290|FG000|Overall Study|Adverse Event|9|||
49106944|NCT03114657|158227291|FG001|Overall Study|Adverse Event|6|||
49106945|NCT03114657|158227290|FG000|Overall Study|Death|4|||
49106946|NCT03114657|158227291|FG001|Overall Study|Death|0|||
49106947|NCT03114657|158227290|FG000|Overall Study|Multiple Reasons|1|||
49106948|NCT03114657|158227291|FG001|Overall Study|Multiple Reasons|2|||
49106949|NCT03114657|158227290|FG000|Overall Study|Physician Decision|2|||
49106950|NCT03114657|158227291|FG001|Overall Study|Physician Decision|2|||
49106951|NCT03114657|158227290|FG000|Overall Study|Study Terminated By Sponsor|355|||
49106952|NCT03114657|158227291|FG001|Overall Study|Study Terminated By Sponsor|374|||
49106953|NCT03114657|158227290|FG000|Overall Study|Symptomatic Deterioration|0|||
49106954|NCT03114657|158227291|FG001|Overall Study|Symptomatic Deterioration|1|||
49106955|NCT03114657|158227290|FG000|Overall Study|Withdrawal by Subject|28|||
49106956|NCT03114657|158227291|FG001|Overall Study|Withdrawal by Subject|22|||
49106957|NCT00329641|158227292|FG000|Overall Study|Did not start treatment|1|||
49106958|NCT00329641|158227292|FG000|Overall Study|Not eligible|1|||
49106959|NCT00329641|158227292|FG000|Overall Study|Adverse Event|3|||
49106960|NCT00329641|158227292|FG000|Overall Study|Other reason, not protocol specified|1|||
49106961|NCT00478699|158227293|FG000|Overall Study|Inclusion Error|1|||
49106962|NCT00478699|158227294|FG001|Overall Study|Inclusion Error|7|||
49106963|NCT00478699|158227293|FG000|Overall Study|Not receive study treatment|6|||
49106964|NCT00478699|158227294|FG001|Overall Study|Not receive study treatment|30|||
49106965|NCT05020899|158227297|FG000|8 Week Follow-up|Lost to Follow-up|3|||
49106966|NCT05020899|158227298|FG001|8 Week Follow-up|Lost to Follow-up|6|||
49106967|NCT05020899|158227297|FG000|12 Week Follow-up|Lost to Follow-up|1|||
49106968|NCT05020899|158227298|FG001|12 Week Follow-up|Lost to Follow-up|0|||
49106969|NCT05020899|158227297|FG000|12 Week Follow-up|Death|0|||
49106970|NCT05020899|158227298|FG001|12 Week Follow-up|Death|1|||
49106971|NCT00430352|158227299|FG000|Overall Study|Disease progression|58|||
49106972|NCT00430352|158227299|FG000|Overall Study|Withdrawal by Subject|11|||
49106973|NCT00430352|158227299|FG000|Overall Study|Adverse Event|16|||
49106974|NCT00430352|158227299|FG000|Overall Study|Death|5|||
49106975|NCT00430352|158227299|FG000|Overall Study|Other|48|||
49106976|NCT00672841|158227300|FG000|Overall Study|Comfort care|1|||
49106977|NCT00672841|158227301|FG001|Overall Study|Comfort care|4|||
49106978|NCT00672841|158227300|FG000|Overall Study|icteric specimens|0|||
49106979|NCT00672841|158227301|FG001|Overall Study|icteric specimens|3|||
49106980|NCT00672841|158227300|FG000|Overall Study|Antifungal therapy, negative glucan|0|||
49106981|NCT00672841|158227301|FG001|Overall Study|Antifungal therapy, negative glucan|4|||
49106982|NCT00672841|158227300|FG000|Overall Study|Adverse Event|0|||
49106983|NCT00672841|158227301|FG001|Overall Study|Adverse Event|3|||
49106984|NCT00672841|158227300|FG000|Overall Study|Pregnancy|0|||
49106985|NCT00672841|158227301|FG001|Overall Study|Pregnancy|1|||
49106986|NCT02124759|158227302|FG000|Overall Study|Withdrawal by Subject|3|||
49106987|NCT02124759|158227303|FG001|Overall Study|Withdrawal by Subject|1|||
49106988|NCT02124759|158227304|FG002|Overall Study|Withdrawal by Subject|1|||
49106989|NCT02124759|158227302|FG000|Overall Study|Screen Fail|2|||
49106990|NCT02124759|158227303|FG001|Overall Study|Screen Fail|2|||
49106991|NCT02124759|158227304|FG002|Overall Study|Screen Fail|3|||
49106992|NCT03099694|158227305|FG000|Overall Study|Withdrawal by Subject|11|||
49106993|NCT03099694|158227306|FG001|Overall Study|Withdrawal by Subject|13|||
49106994|NCT03099694|158227305|FG000|Overall Study|Lost to Follow-up|9|||
49106995|NCT03099694|158227306|FG001|Overall Study|Lost to Follow-up|5|||
49106996|NCT02912455|158227307|FG000|Overall Study|Withdrawal by Subject|0|||
49106997|NCT02912455|158227308|FG001|Overall Study|Withdrawal by Subject|1|||
49106998|NCT02912455|158227307|FG000|Overall Study|Lack of Efficacy|0|||
49106999|NCT02912455|158227308|FG001|Overall Study|Lack of Efficacy|1|||
49107000|NCT02912455|158227307|FG000|Overall Study|Lost to Follow-up|2|||
49107001|NCT02912455|158227308|FG001|Overall Study|Lost to Follow-up|1|||
49107002|NCT00985426|158227309|FG000|Overall Study|Adverse Event|0|||
49107003|NCT00985426|158227310|FG001|Overall Study|Adverse Event|1|||
49107004|NCT00985426|158227309|FG000|Overall Study|Subject Non-Compliance|3|||
49107005|NCT00985426|158227310|FG001|Overall Study|Subject Non-Compliance|3|||
49107006|NCT00985426|158227309|FG000|Overall Study|Withdrawal by Subject|12|||
49107007|NCT00985426|158227310|FG001|Overall Study|Withdrawal by Subject|16|||
49107008|NCT00985426|158227309|FG000|Overall Study|Lost to Follow-up|8|||
49107009|NCT00985426|158227310|FG001|Overall Study|Lost to Follow-up|10|||
49107010|NCT00985426|158227309|FG000|Overall Study|Death|7|||
49107011|NCT00985426|158227310|FG001|Overall Study|Death|3|||
49107012|NCT00985426|158227309|FG000|Overall Study|Protocol Violation|2|||
49107013|NCT00985426|158227310|FG001|Overall Study|Protocol Violation|0|||
49107014|NCT00985426|158227309|FG000|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
49107015|NCT00985426|158227310|FG001|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
49107016|NCT01731470|158227313|FG000|Overall Study|Withdrawal by Subject|1|||
49107017|NCT01731470|158227313|FG000|Overall Study|Did not meet study criteria|1|||
49107018|NCT02450552|158227314|FG000|Overall Study|Withdrawal by Subject|4|||
49107019|NCT02450552|158227315|FG001|Overall Study|Withdrawal by Subject|0|||
49107020|NCT02450552|158227316|FG002|Overall Study|Withdrawal by Subject|4|||
49107021|NCT02450552|158227314|FG000|Overall Study|Physician Decision|1|||
49107022|NCT02450552|158227315|FG001|Overall Study|Physician Decision|0|||
49107023|NCT02450552|158227316|FG002|Overall Study|Physician Decision|1|||
49107024|NCT03325894|158227317|FG000|Overall Study|Adverse Event|2|||
49107025|NCT03325894|158227318|FG001|Overall Study|Adverse Event|3|||
49107026|NCT03325894|158227317|FG000|Overall Study|Protocol Violation|1|||
49107027|NCT03325894|158227318|FG001|Overall Study|Protocol Violation|2|||
49107028|NCT03325894|158227317|FG000|Overall Study|Withdrawal by Subject|10|||
49107029|NCT03325894|158227318|FG001|Overall Study|Withdrawal by Subject|6|||
49107030|NCT03325894|158227317|FG000|Overall Study|Lost to Follow-up|4|||
49107031|NCT03325894|158227318|FG001|Overall Study|Lost to Follow-up|9|||
49107032|NCT03325894|158227317|FG000|Overall Study|Lack of Efficacy|8|||
49107033|NCT03325894|158227318|FG001|Overall Study|Lack of Efficacy|14|||
49107034|NCT03325894|158227317|FG000|Overall Study|Study Terminated by Sponsor|38|||
49107035|NCT03325894|158227318|FG001|Overall Study|Study Terminated by Sponsor|43|||
49107036|NCT03325894|158227317|FG000|Overall Study|Other (Not received Treatment)|1|||
49107037|NCT03325894|158227318|FG001|Overall Study|Other (Not received Treatment)|0|||
49107038|NCT04395274|158227319|FG000|Overall Study|Lost to Follow-up|20|||
49107039|NCT04395274|158227320|FG001|Overall Study|Lost to Follow-up|11|||
49107040|NCT04395274|158227319|FG000|Overall Study|Withdrawal by Subject|13|||
49107041|NCT04395274|158227320|FG001|Overall Study|Withdrawal by Subject|10|||
49107042|NCT04395274|158227319|FG000|Overall Study|Moved Abroad|0|||
49107043|NCT04395274|158227320|FG001|Overall Study|Moved Abroad|1|||
49107044|NCT01592292|158227322|FG000|Overall Study|Follow-up loss|3|||
49107045|NCT01592292|158227323|FG001|Overall Study|Follow-up loss|3|||
49107046|NCT01592292|158227324|FG002|Overall Study|Follow-up loss|1|||
49107047|NCT01592292|158227325|FG003|Overall Study|Follow-up loss|0|||
49107048|NCT01592292|158227322|FG000|Overall Study|Withdrew consent|2|||
49107049|NCT01592292|158227323|FG001|Overall Study|Withdrew consent|1|||
49107050|NCT01592292|158227324|FG002|Overall Study|Withdrew consent|0|||
49107051|NCT01592292|158227325|FG003|Overall Study|Withdrew consent|0|||
49107052|NCT01592292|158227322|FG000|Overall Study|Other|1|||
49107053|NCT01592292|158227323|FG001|Overall Study|Other|1|||
49107054|NCT01592292|158227324|FG002|Overall Study|Other|2|||
49107055|NCT01592292|158227325|FG003|Overall Study|Other|1|||
49107056|NCT00386425|158227328|FG000|Overall Study|Physician Decision|3|||
49107057|NCT00386425|158227329|FG001|Overall Study|Physician Decision|0|||
49107058|NCT00386425|158227330|FG002|Overall Study|Physician Decision|0|||
49107059|NCT00386425|158227328|FG000|Overall Study|Withdrawal by Subject|0|||
49107060|NCT00386425|158227329|FG001|Overall Study|Withdrawal by Subject|1|||
49107061|NCT00386425|158227330|FG002|Overall Study|Withdrawal by Subject|0|||
49107062|NCT00435019|158227335|FG000|Overall Study|Adverse Event|1|||
49107063|NCT00435019|158227336|FG001|Overall Study|Adverse Event|0|||
49107064|NCT00435019|158227335|FG000|Overall Study|Lack of Efficacy|1|||
49107065|NCT00435019|158227336|FG001|Overall Study|Lack of Efficacy|2|||
49107066|NCT00435019|158227335|FG000|Overall Study|Protocol Violation|3|||
49107067|NCT00435019|158227336|FG001|Overall Study|Protocol Violation|1|||
49107068|NCT00435019|158227335|FG000|Overall Study|Personal reasons for withdrawal|8|||
49107069|NCT00435019|158227336|FG001|Overall Study|Personal reasons for withdrawal|7|||
49107070|NCT02620384|158227337|FG000|Overall Study|Adverse Event|2|||
49107071|NCT02620384|158227338|FG001|Overall Study|Adverse Event|1|||
49107072|NCT02620384|158227337|FG000|Overall Study|Discharged prior to 2nd dose|2|||
49107073|NCT02620384|158227338|FG001|Overall Study|Discharged prior to 2nd dose|5|||
49107074|NCT02620384|158227337|FG000|Overall Study|Drug shortage prevented 2nd dose|0|||
49107075|NCT02620384|158227338|FG001|Overall Study|Drug shortage prevented 2nd dose|1|||
49107076|NCT02906033|158227339|FG000|Baseline|Protocol Violation|37|||
49107077|NCT02906033|158227340|FG001|Baseline|Protocol Violation|33|||
49107078|NCT02906033|158227339|FG000|Follow-up|Lost to Follow-up|46|||
49107079|NCT02906033|158227340|FG001|Follow-up|Lost to Follow-up|62|||
49107080|NCT00204477|158227341|FG000|One Year After Diet|Did not complete 1 year of diet|42|||
49107081|NCT00204477|158227342|FG001|One Year After Diet|Did not complete 1 year of diet|38|||
49107082|NCT00204477|158227341|FG000|Two Years After Diet|Did not complete the 2nd year of diet|16|||
49107083|NCT00204477|158227342|FG001|Two Years After Diet|Did not complete the 2nd year of diet|13|||
49107084|NCT03053427|158227343|FG000|Overall Study|Adverse Event|4|||
49107085|NCT03053427|158227344|FG001|Overall Study|Adverse Event|4|||
49107086|NCT03053427|158227343|FG000|Overall Study|Lack of Efficacy|1|||
49107087|NCT03053427|158227344|FG001|Overall Study|Lack of Efficacy|3|||
49107088|NCT03053427|158227343|FG000|Overall Study|Lost to Follow-up|2|||
49107089|NCT03053427|158227344|FG001|Overall Study|Lost to Follow-up|2|||
49107090|NCT03053427|158227343|FG000|Overall Study|Worsening of the target disease|0|||
49107091|NCT03053427|158227344|FG001|Overall Study|Worsening of the target disease|1|||
49107092|NCT03053427|158227343|FG000|Overall Study|Protocol Deviation|3|||
49107093|NCT03053427|158227344|FG001|Overall Study|Protocol Deviation|3|||
49107094|NCT03053427|158227343|FG000|Overall Study|Withdrawal by Subject|3|||
49107095|NCT03053427|158227344|FG001|Overall Study|Withdrawal by Subject|2|||
49107096|NCT03053427|158227343|FG000|Overall Study|Miscellaneous|0|||
49107097|NCT03053427|158227344|FG001|Overall Study|Miscellaneous|1|||
49107098|NCT02071082|158227345|FG000|Overall Study|Enrolled and Never Treated|1|||
49107099|NCT02071082|158227346|FG001|Overall Study|Enrolled and Never Treated|1|||
49107100|NCT02071082|158227345|FG000|Overall Study|Adverse Event|0|||
49107101|NCT02071082|158227346|FG001|Overall Study|Adverse Event|1|||
49107102|NCT02071082|158227345|FG000|Overall Study|Withdrew Consent|0|||
49107103|NCT02071082|158227346|FG001|Overall Study|Withdrew Consent|4|||
49107104|NCT02071082|158227345|FG000|Overall Study|Lost to Follow-up|1|||
49107105|NCT02071082|158227346|FG001|Overall Study|Lost to Follow-up|1|||
49107106|NCT02172040|158227350|FG000|Overall Study|Adverse Event|0|||
49107107|NCT02172040|158227351|FG001|Overall Study|Adverse Event|2|||
49107108|NCT02172040|158227352|FG002|Overall Study|Adverse Event|0|||
49107109|NCT02172040|158227353|FG003|Overall Study|Adverse Event|0|||
49107110|NCT02172040|158227350|FG000|Overall Study|Protocol Violation|0|||
49107111|NCT02172040|158227351|FG001|Overall Study|Protocol Violation|1|||
49107112|NCT02172040|158227352|FG002|Overall Study|Protocol Violation|0|||
49107113|NCT02172040|158227353|FG003|Overall Study|Protocol Violation|0|||
49107114|NCT02172040|158227350|FG000|Overall Study|Withdrawal by Subject|0|||
49107115|NCT02172040|158227351|FG001|Overall Study|Withdrawal by Subject|0|||
49107116|NCT02172040|158227352|FG002|Overall Study|Withdrawal by Subject|1|||
49107117|NCT02172040|158227353|FG003|Overall Study|Withdrawal by Subject|0|||
49107118|NCT02172040|158227350|FG000|Overall Study|Not available for Day 13 & 14 visits|0|||
49107119|NCT02172040|158227351|FG001|Overall Study|Not available for Day 13 & 14 visits|0|||
49107120|NCT02172040|158227352|FG002|Overall Study|Not available for Day 13 & 14 visits|1|||
49107121|NCT02172040|158227353|FG003|Overall Study|Not available for Day 13 & 14 visits|0|||
49107122|NCT02172040|158227350|FG000|Overall Study|Family emergency abroad|0|||
49107123|NCT02172040|158227351|FG001|Overall Study|Family emergency abroad|0|||
49107124|NCT02172040|158227352|FG002|Overall Study|Family emergency abroad|0|||
49107125|NCT02172040|158227353|FG003|Overall Study|Family emergency abroad|1|||
49107126|NCT02054910|158227358|FG000|Overall Study|Lost to Follow-up|4|||
49107127|NCT02054910|158227359|FG001|Overall Study|Lost to Follow-up|1|||
49107128|NCT01324570|158227362|FG000|Overall Study|Adverse Event|4|||
49107129|NCT01324570|158227363|FG001|Overall Study|Adverse Event|7|||
49107130|NCT01324570|158227362|FG000|Overall Study|Withdrawal by Subject|0|||
49107131|NCT01324570|158227363|FG001|Overall Study|Withdrawal by Subject|3|||
49107132|NCT01324570|158227362|FG000|Overall Study|Lack of Efficacy|0|||
49107133|NCT01324570|158227363|FG001|Overall Study|Lack of Efficacy|1|||
49107134|NCT01324570|158227362|FG000|Overall Study|Confirmed or suspected diversion|0|||
49107135|NCT01324570|158227363|FG001|Overall Study|Confirmed or suspected diversion|1|||
49107136|NCT01324570|158227362|FG000|Overall Study|Administrative|0|||
49107137|NCT01324570|158227363|FG001|Overall Study|Administrative|2|||
49107138|NCT02607306|158227370|FG000|Overall Study|Adverse Event|8|||
49107139|NCT02607306|158227371|FG001|Overall Study|Adverse Event|6|||
49107140|NCT02607306|158227372|FG002|Overall Study|Adverse Event|6|||
49107141|NCT02607306|158227370|FG000|Overall Study|Unclassified|1|||
49107142|NCT02607306|158227371|FG001|Overall Study|Unclassified|4|||
49107143|NCT02607306|158227372|FG002|Overall Study|Unclassified|0|||
49107144|NCT02607306|158227370|FG000|Overall Study|Withdrawal by Subject|8|||
49107145|NCT02607306|158227371|FG001|Overall Study|Withdrawal by Subject|10|||
49107146|NCT02607306|158227372|FG002|Overall Study|Withdrawal by Subject|2|||
49107147|NCT02607306|158227370|FG000|Overall Study|Lack of Efficacy|0|||
49107148|NCT02607306|158227371|FG001|Overall Study|Lack of Efficacy|1|||
49107149|NCT02607306|158227372|FG002|Overall Study|Lack of Efficacy|1|||
49107150|NCT02607306|158227370|FG000|Overall Study|Protocol Violation|4|||
49107151|NCT02607306|158227371|FG001|Overall Study|Protocol Violation|2|||
49107152|NCT02607306|158227372|FG002|Overall Study|Protocol Violation|1|||
49107153|NCT00207727|158227373|FG000|Overall Study|Withdrawal by Subject|0|||
49107154|NCT00207727|158227374|FG001|Overall Study|Withdrawal by Subject|0|||
49107155|NCT00207727|158227375|FG002|Overall Study|Withdrawal by Subject|0|||
49107156|NCT00207727|158227376|FG003|Overall Study|Withdrawal by Subject|0|||
49107157|NCT00207727|158227377|FG004|Overall Study|Withdrawal by Subject|1|||
49107158|NCT00207727|158227373|FG000|Overall Study|Lost to Follow-up|0|||
49107159|NCT00207727|158227374|FG001|Overall Study|Lost to Follow-up|1|||
49107160|NCT00207727|158227375|FG002|Overall Study|Lost to Follow-up|0|||
49107161|NCT00207727|158227376|FG003|Overall Study|Lost to Follow-up|0|||
49107162|NCT00207727|158227377|FG004|Overall Study|Lost to Follow-up|0|||
49107163|NCT00207727|158227373|FG000|Overall Study|Other|38|||
49107164|NCT00207727|158227374|FG001|Overall Study|Other|41|||
49107165|NCT00207727|158227375|FG002|Overall Study|Other|41|||
49107166|NCT00207727|158227376|FG003|Overall Study|Other|37|||
49107167|NCT00207727|158227377|FG004|Overall Study|Other|33|||
49107168|NCT01876979|158227382|FG000|Overall Study|Physician Decision|2|||
49107169|NCT01876979|158227383|FG001|Overall Study|Physician Decision|3|||
49107170|NCT04438499|158227384|FG000|Overall Study|Lack of Efficacy|3|||
49107171|NCT01944670|158228729|FG000|Overall Study|Lost to Follow-up|2|||
49107172|NCT01092637|158228730|FG000|Overall Study|Death|47|||
49107173|NCT01092637|158228731|FG001|Overall Study|Death|49|||
49107174|NCT00743288|158228732|FG000|Overall Study|Adverse Event|1|||
49107175|NCT00743288|158228733|FG001|Overall Study|Adverse Event|1|||
49107176|NCT00743288|158228734|FG002|Overall Study|Adverse Event|2|||
49107177|NCT00743288|158228735|FG003|Overall Study|Adverse Event|2|||
49107178|NCT00743288|158228736|FG004|Overall Study|Adverse Event|1|||
49107179|NCT00743288|158228737|FG005|Overall Study|Adverse Event|1|||
49107180|NCT00743288|158228738|FG006|Overall Study|Adverse Event|2|||
49107181|NCT00743288|158228732|FG000|Overall Study|Withdrawal by Subject|0|||
49107182|NCT00743288|158228733|FG001|Overall Study|Withdrawal by Subject|0|||
49107183|NCT00743288|158228734|FG002|Overall Study|Withdrawal by Subject|1|||
49107184|NCT00743288|158228735|FG003|Overall Study|Withdrawal by Subject|0|||
49107185|NCT00743288|158228736|FG004|Overall Study|Withdrawal by Subject|0|||
49107186|NCT00743288|158228737|FG005|Overall Study|Withdrawal by Subject|1|||
49107187|NCT00743288|158228738|FG006|Overall Study|Withdrawal by Subject|1|||
49107188|NCT00743288|158228732|FG000|Overall Study|Progressive disease (PD)|2|||
49107189|NCT00743288|158228733|FG001|Overall Study|Progressive disease (PD)|0|||
49107190|NCT00743288|158228734|FG002|Overall Study|Progressive disease (PD)|1|||
49107191|NCT00743288|158228735|FG003|Overall Study|Progressive disease (PD)|4|||
49107192|NCT00743288|158228736|FG004|Overall Study|Progressive disease (PD)|5|||
49107193|NCT00743288|158228737|FG005|Overall Study|Progressive disease (PD)|3|||
49107194|NCT00743288|158228738|FG006|Overall Study|Progressive disease (PD)|6|||
49107195|NCT00743288|158228732|FG000|Overall Study|Worsening of condition (Not PD)|0|||
49107196|NCT00743288|158228733|FG001|Overall Study|Worsening of condition (Not PD)|2|||
49107197|NCT00743288|158228734|FG002|Overall Study|Worsening of condition (Not PD)|1|||
49107198|NCT00743288|158228735|FG003|Overall Study|Worsening of condition (Not PD)|1|||
49107199|NCT00743288|158228736|FG004|Overall Study|Worsening of condition (Not PD)|0|||
49107200|NCT00743288|158228737|FG005|Overall Study|Worsening of condition (Not PD)|0|||
49107201|NCT00743288|158228738|FG006|Overall Study|Worsening of condition (Not PD)|0|||
49107202|NCT04529850|158228739|FG000|Overall Study|Death|2|||
49107203|NCT04529850|158228739|FG000|Overall Study|Physician Decision|1|||
49107204|NCT04529850|158228739|FG000|Overall Study|Withdrawal by Subject|2|||
49107205|NCT01214252|158228740|FG000|Overall Study|Not eligible per protocol|82|||
49107206|NCT03226678|158228748|FG000|Part A (Core Study Phase)|Adverse Event|0|||
49107207|NCT03226678|158228749|FG001|Part A (Core Study Phase)|Adverse Event|1|||
49107208|NCT03226678|158228750|FG002|Part A (Core Study Phase)|Adverse Event|0|||
49107209|NCT03226678|158228751|FG003|Part A (Core Study Phase)|Adverse Event|0|||
49107210|NCT03226678|158228752|FG004|Part A (Core Study Phase)|Adverse Event|0|||
49107211|NCT03226678|158228753|FG005|Part A (Core Study Phase)|Adverse Event|0|||
49107212|NCT03226678|158228748|FG000|Part A (Core Study Phase)|Death|0|||
49107213|NCT03226678|158228749|FG001|Part A (Core Study Phase)|Death|0|||
49107214|NCT03226678|158228750|FG002|Part A (Core Study Phase)|Death|1|||
49107215|NCT03226678|158228751|FG003|Part A (Core Study Phase)|Death|0|||
49107216|NCT03226678|158228752|FG004|Part A (Core Study Phase)|Death|0|||
49107217|NCT03226678|158228753|FG005|Part A (Core Study Phase)|Death|0|||
49107218|NCT03226678|158228748|FG000|Part A (Core Study Phase)|Lack of Efficacy|0|||
49107219|NCT03226678|158228749|FG001|Part A (Core Study Phase)|Lack of Efficacy|1|||
49107220|NCT03226678|158228750|FG002|Part A (Core Study Phase)|Lack of Efficacy|0|||
49107221|NCT03226678|158228751|FG003|Part A (Core Study Phase)|Lack of Efficacy|0|||
49107222|NCT03226678|158228752|FG004|Part A (Core Study Phase)|Lack of Efficacy|0|||
49107223|NCT03226678|158228753|FG005|Part A (Core Study Phase)|Lack of Efficacy|0|||
49107224|NCT03226678|158228748|FG000|Part A (Core Study Phase)|Non-compliance with study drug|0|||
49107225|NCT03226678|158228749|FG001|Part A (Core Study Phase)|Non-compliance with study drug|0|||
49107226|NCT03226678|158228750|FG002|Part A (Core Study Phase)|Non-compliance with study drug|1|||
49107227|NCT03226678|158228751|FG003|Part A (Core Study Phase)|Non-compliance with study drug|0|||
49107228|NCT03226678|158228752|FG004|Part A (Core Study Phase)|Non-compliance with study drug|0|||
49107229|NCT03226678|158228753|FG005|Part A (Core Study Phase)|Non-compliance with study drug|0|||
49107230|NCT03226678|158228748|FG000|Part A (Core Study Phase)|Withdrawal by Subject|0|||
49107231|NCT03226678|158228749|FG001|Part A (Core Study Phase)|Withdrawal by Subject|0|||
49107232|NCT03226678|158228750|FG002|Part A (Core Study Phase)|Withdrawal by Subject|0|||
49107233|NCT03226678|158228751|FG003|Part A (Core Study Phase)|Withdrawal by Subject|1|||
49107234|NCT03226678|158228752|FG004|Part A (Core Study Phase)|Withdrawal by Subject|0|||
49107235|NCT03226678|158228753|FG005|Part A (Core Study Phase)|Withdrawal by Subject|0|||
49107236|NCT03226678|158228748|FG000|Part A (Core Study Phase)|Withdrew, per Investigator|2|||
49107237|NCT03226678|158228749|FG001|Part A (Core Study Phase)|Withdrew, per Investigator|1|||
49107238|NCT03226678|158228750|FG002|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
49107239|NCT03226678|158228751|FG003|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
49107240|NCT03226678|158228752|FG004|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
49107241|NCT03226678|158228753|FG005|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
49107242|NCT03226678|158228748|FG000|Part B (Long-Term Extension Phase)|Adverse Event|0|||
49107243|NCT03226678|158228749|FG001|Part B (Long-Term Extension Phase)|Adverse Event|0|||
49107244|NCT03226678|158228750|FG002|Part B (Long-Term Extension Phase)|Adverse Event|0|||
49107245|NCT03226678|158228751|FG003|Part B (Long-Term Extension Phase)|Adverse Event|0|||
49107246|NCT03226678|158228752|FG004|Part B (Long-Term Extension Phase)|Adverse Event|2|||
49107247|NCT03226678|158228753|FG005|Part B (Long-Term Extension Phase)|Adverse Event|1|||
49107248|NCT03226678|158228748|FG000|Part B (Long-Term Extension Phase)|Death|0|||
49107249|NCT03226678|158228749|FG001|Part B (Long-Term Extension Phase)|Death|0|||
49107250|NCT03226678|158228750|FG002|Part B (Long-Term Extension Phase)|Death|0|||
49107251|NCT03226678|158228751|FG003|Part B (Long-Term Extension Phase)|Death|0|||
49107252|NCT03226678|158228752|FG004|Part B (Long-Term Extension Phase)|Death|0|||
49107253|NCT03226678|158228753|FG005|Part B (Long-Term Extension Phase)|Death|1|||
49107254|NCT03226678|158228748|FG000|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
49107255|NCT03226678|158228749|FG001|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
49107256|NCT03226678|158228750|FG002|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
49107257|NCT03226678|158228751|FG003|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
49107258|NCT03226678|158228752|FG004|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
49107259|NCT03226678|158228753|FG005|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|1|||
49107260|NCT03226678|158228748|FG000|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
49107261|NCT03226678|158228749|FG001|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
49107262|NCT03226678|158228750|FG002|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
49107263|NCT03226678|158228751|FG003|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
49107264|NCT03226678|158228752|FG004|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|3|||
49107265|NCT03226678|158228753|FG005|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|5|||
49107266|NCT03226678|158228748|FG000|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
49107267|NCT03226678|158228749|FG001|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
49107268|NCT03226678|158228750|FG002|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
49107269|NCT03226678|158228751|FG003|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
49107270|NCT03226678|158228752|FG004|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
49107271|NCT03226678|158228753|FG005|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|1|||
49107272|NCT04984278|158228756|FG000|Period 1|Withdrawal by Subject|1|||
49107273|NCT04984278|158228757|FG001|Period 1|Withdrawal by Subject|0|||
49107274|NCT04984278|158228756|FG000|Period 1|Other|0|||
49107275|NCT04984278|158228757|FG001|Period 1|Other|1|||
49107276|NCT04984278|158228756|FG000|Period 2|Adverse Event|1|||
49107277|NCT04984278|158228757|FG001|Period 2|Adverse Event|0|||
49107278|NCT04984278|158228756|FG000|Period 2|Other|0|||
49107279|NCT04984278|158228757|FG001|Period 2|Other|1|||
49107280|NCT04327661|158228758|FG000|Overall Study|Withdrawal by Subject|1|||
49107281|NCT04327661|158228759|FG001|Overall Study|Withdrawal by Subject|0|||
49107282|NCT04327661|158228760|FG002|Overall Study|Withdrawal by Subject|0|||
49107283|NCT01371877|158228761|FG000|Overall Study|3 for unknown reasons and 1 pregnant|0|||
49107284|NCT01371877|158228762|FG001|Overall Study|3 for unknown reasons and 1 pregnant|4|||
49107285|NCT01143064|158228763|FG000|Overall Study|Death|109|||
49107286|NCT01143064|158228764|FG001|Overall Study|Death|91|||
49107287|NCT01143064|158228763|FG000|Overall Study|Adverse Event|0|||
49107288|NCT01143064|158228764|FG001|Overall Study|Adverse Event|1|||
49107289|NCT01143064|158228763|FG000|Overall Study|Withdrawal by Subject|7|||
49107290|NCT01143064|158228764|FG001|Overall Study|Withdrawal by Subject|5|||
49107291|NCT01143064|158228763|FG000|Overall Study|Lost to Follow-up|17|||
49107292|NCT01143064|158228764|FG001|Overall Study|Lost to Follow-up|14|||
49107293|NCT01143064|158228763|FG000|Overall Study|Physician Decision|0|||
49107294|NCT01143064|158228764|FG001|Overall Study|Physician Decision|4|||
49107295|NCT00984061|158228765|FG000|Clarithromycin Alone|Protocol Violation|1|||
49107296|NCT03781583|158228766|FG000|Overall Study|Technical issue prevents the device from starting properly|1|||
49107297|NCT03781583|158228767|FG001|Overall Study|Technical issue prevents the device from starting properly|0|||
49107298|NCT03781583|158228768|FG002|Overall Study|Technical issue prevents the device from starting properly|0|||
49107299|NCT03781583|158228769|FG003|Overall Study|Technical issue prevents the device from starting properly|0|||
49107300|NCT03781583|158228766|FG000|Overall Study|Technology did not work for that person in that environment|1|||
49107301|NCT03781583|158228767|FG001|Overall Study|Technology did not work for that person in that environment|0|||
49107302|NCT03781583|158228768|FG002|Overall Study|Technology did not work for that person in that environment|0|||
49107303|NCT03781583|158228769|FG003|Overall Study|Technology did not work for that person in that environment|0|||
49107304|NCT03781583|158228766|FG000|Overall Study|Participant was not sufficiently visually impaired|0|||
49107305|NCT03781583|158228767|FG001|Overall Study|Participant was not sufficiently visually impaired|1|||
49107306|NCT03781583|158228768|FG002|Overall Study|Participant was not sufficiently visually impaired|0|||
49107307|NCT03781583|158228769|FG003|Overall Study|Participant was not sufficiently visually impaired|0|||
49107308|NCT03781583|158228766|FG000|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
49107309|NCT03781583|158228767|FG001|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|1|||
49107310|NCT03781583|158228768|FG002|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
49107311|NCT03781583|158228769|FG003|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
49107312|NCT04643964|158228770|FG000|Overall Study|Lost to Follow-up|55|||
49107313|NCT04643964|158228771|FG001|Overall Study|Lost to Follow-up|59|||
49107314|NCT04643964|158228772|FG002|Overall Study|Lost to Follow-up|54|||
49107315|NCT04643964|158228773|FG003|Overall Study|Lost to Follow-up|129|||
49107316|NCT04643964|158228774|FG004|Overall Study|Lost to Follow-up|48|||
49107317|NCT04643964|158228770|FG000|Overall Study|Failed attention check|1|||
49107318|NCT04643964|158228771|FG001|Overall Study|Failed attention check|8|||
49107319|NCT04643964|158228772|FG002|Overall Study|Failed attention check|2|||
49107320|NCT04643964|158228773|FG003|Overall Study|Failed attention check|14|||
49107321|NCT04643964|158228774|FG004|Overall Study|Failed attention check|11|||
49107322|NCT03427268|158228777|FG000|Overall Study|Progressive disease|25|||
49107323|NCT03427268|158228777|FG000|Overall Study|Never treated|2|||
49107324|NCT03427268|158228777|FG000|Overall Study|Compassionate use|1|||
49107325|NCT03427268|158228777|FG000|Overall Study|Withdrawal by Subject|1|||
49107326|NCT03427268|158228777|FG000|Overall Study|Adverse Event|3|||
49107327|NCT00844480|158228778|FG000|Overall Study|Withdrawal by Subject|2|||
49107328|NCT00844480|158228779|FG001|Overall Study|Withdrawal by Subject|3|||
49107329|NCT00980174|158228780|FG000|Overall Study|Withdrawal by Subject|1|||
49107330|NCT00980174|158228781|FG001|Overall Study|Withdrawal by Subject|4|||
49107331|NCT00980174|158228780|FG000|Overall Study|Adverse Event|0|||
49107332|NCT00980174|158228781|FG001|Overall Study|Adverse Event|3|||
49107333|NCT00980174|158228780|FG000|Overall Study|Ineligibility determined|2|||
49107334|NCT00980174|158228781|FG001|Overall Study|Ineligibility determined|1|||
49107335|NCT00980174|158228780|FG000|Overall Study|Death|1|||
49107336|NCT00980174|158228781|FG001|Overall Study|Death|1|||
49107337|NCT00980174|158228780|FG000|Overall Study|Other|0|||
49107338|NCT00980174|158228781|FG001|Overall Study|Other|1|||
49107339|NCT00455520|158228783|FG000|Open Label Tapentadol Extended Release|Withdrawal by Subject|24|||
49107340|NCT00455520|158228784|FG001|Open Label Tapentadol Extended Release|Withdrawal by Subject|0|||
49107341|NCT00455520|158228783|FG000|Open Label Tapentadol Extended Release|Lost to Follow-up|3|||
49107342|NCT00455520|158228784|FG001|Open Label Tapentadol Extended Release|Lost to Follow-up|0|||
49107343|NCT00455520|158228783|FG000|Open Label Tapentadol Extended Release|Adverse Event|100|||
49107344|NCT00455520|158228784|FG001|Open Label Tapentadol Extended Release|Adverse Event|0|||
49107345|NCT00455520|158228783|FG000|Open Label Tapentadol Extended Release|Lack of Efficacy|23|||
49107346|NCT00455520|158228784|FG001|Open Label Tapentadol Extended Release|Lack of Efficacy|0|||
49107347|NCT00455520|158228783|FG000|Open Label Tapentadol Extended Release|Study drug non-compliant|13|||
49107348|NCT00455520|158228784|FG001|Open Label Tapentadol Extended Release|Study drug non-compliant|0|||
49107349|NCT00455520|158228783|FG000|Open Label Tapentadol Extended Release|All other|33|||
49107350|NCT00455520|158228784|FG001|Open Label Tapentadol Extended Release|All other|0|||
49107351|NCT00455520|158228783|FG000|Double Blind Tapentadol ER vs Placebo|Adverse Event|29|||
49107352|NCT00455520|158228784|FG001|Double Blind Tapentadol ER vs Placebo|Adverse Event|15|||
49107353|NCT00455520|158228783|FG000|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8|||
49107354|NCT00455520|158228784|FG001|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29|||
49107355|NCT00455520|158228783|FG000|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15|||
49107356|NCT00455520|158228784|FG001|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7|||
49107357|NCT00455520|158228783|FG000|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
49107358|NCT00455520|158228784|FG001|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
49107359|NCT00455520|158228783|FG000|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4|||
49107360|NCT00455520|158228784|FG001|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2|||
49107361|NCT00455520|158228783|FG000|Double Blind Tapentadol ER vs Placebo|All other|4|||
49107362|NCT00455520|158228784|FG001|Double Blind Tapentadol ER vs Placebo|All other|6|||
49107363|NCT00628095|158228788|FG000|Overall Study|Adverse Event|5|||
49107364|NCT00628095|158228789|FG001|Overall Study|Adverse Event|3|||
49107365|NCT00628095|158228788|FG000|Overall Study|Lack of Efficacy|0|||
49107366|NCT00628095|158228789|FG001|Overall Study|Lack of Efficacy|3|||
49107367|NCT00628095|158228788|FG000|Overall Study|Withdrawal by Subject|2|||
49107368|NCT00628095|158228789|FG001|Overall Study|Withdrawal by Subject|0|||
49107369|NCT00628095|158228788|FG000|Overall Study|Other|0|||
49107370|NCT00628095|158228789|FG001|Overall Study|Other|1|||
49107371|NCT03235115|158228794|FG000|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
49107372|NCT03235115|158228795|FG001|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
49107373|NCT03235115|158228796|FG002|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
49107374|NCT03235115|158228797|FG003|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
49107375|NCT03235115|158228798|FG004|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
49107376|NCT03235115|158228799|FG005|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1|||
49107377|NCT02093390|158228804|FG000|Overall Study|Withdrawal by Subject|0|||
49107378|NCT02093390|158228805|FG001|Overall Study|Withdrawal by Subject|1|||
49107379|NCT00115037|158228809|FG000|Phase1|Lost to Follow-up|16|||
49107380|NCT00115037|158228810|FG001|Phase1|Lost to Follow-up|23|||
49107381|NCT00115037|158228811|FG002|Phase1|Lost to Follow-up|0|||
49107382|NCT00115037|158228812|FG003|Phase1|Lost to Follow-up|0|||
49107383|NCT00115037|158228813|FG004|Phase1|Lost to Follow-up|0|||
49107384|NCT00115037|158228814|FG005|Phase1|Lost to Follow-up|0|||
49107385|NCT00115037|158228809|FG000|Phase1|Withdrawal by Subject|9|||
49107386|NCT00115037|158228810|FG001|Phase1|Withdrawal by Subject|4|||
49107387|NCT00115037|158228811|FG002|Phase1|Withdrawal by Subject|0|||
49107388|NCT00115037|158228812|FG003|Phase1|Withdrawal by Subject|0|||
49107389|NCT00115037|158228813|FG004|Phase1|Withdrawal by Subject|0|||
49107390|NCT00115037|158228814|FG005|Phase1|Withdrawal by Subject|0|||
49107391|NCT00115037|158228809|FG000|Phase2|Death|0|||
49107392|NCT00115037|158228810|FG001|Phase2|Death|0|||
49107393|NCT00115037|158228811|FG002|Phase2|Death|1|||
49107394|NCT00115037|158228812|FG003|Phase2|Death|0|||
49107395|NCT00115037|158228813|FG004|Phase2|Death|0|||
49107396|NCT00115037|158228814|FG005|Phase2|Death|1|||
49107397|NCT00115037|158228809|FG000|Phase2|Withdrawal by Subject|0|||
49107398|NCT00115037|158228810|FG001|Phase2|Withdrawal by Subject|0|||
49107399|NCT00115037|158228811|FG002|Phase2|Withdrawal by Subject|2|||
49107400|NCT00115037|158228812|FG003|Phase2|Withdrawal by Subject|1|||
49107401|NCT00115037|158228813|FG004|Phase2|Withdrawal by Subject|2|||
49107402|NCT00115037|158228814|FG005|Phase2|Withdrawal by Subject|1|||
49107403|NCT00115037|158228809|FG000|Phase2|Lost to Follow-up|0|||
49107404|NCT00115037|158228810|FG001|Phase2|Lost to Follow-up|0|||
49107405|NCT00115037|158228811|FG002|Phase2|Lost to Follow-up|12|||
49107406|NCT00115037|158228812|FG003|Phase2|Lost to Follow-up|14|||
49107407|NCT00115037|158228813|FG004|Phase2|Lost to Follow-up|4|||
49107408|NCT00115037|158228814|FG005|Phase2|Lost to Follow-up|10|||
49107409|NCT01179737|158228815|FG000|Cohort 1 & Cohort 2|Adverse Event|3|||
49107410|NCT01179737|158228816|FG001|Cohort 1 & Cohort 2|Adverse Event|1|||
49107411|NCT01179737|158228817|FG002|Cohort 1 & Cohort 2|Adverse Event|1|||
49107412|NCT01179737|158228818|FG003|Cohort 1 & Cohort 2|Adverse Event|0|||
49107413|NCT01179737|158228815|FG000|Cohort 1 & Cohort 2|Withdrew consent|2|||
49107414|NCT01179737|158228816|FG001|Cohort 1 & Cohort 2|Withdrew consent|0|||
49107415|NCT01179737|158228817|FG002|Cohort 1 & Cohort 2|Withdrew consent|0|||
49107416|NCT01179737|158228818|FG003|Cohort 1 & Cohort 2|Withdrew consent|0|||
49107417|NCT01179737|158228815|FG000|Cohort 1 & Cohort 2|Administrative problems|0|||
49107418|NCT01179737|158228816|FG001|Cohort 1 & Cohort 2|Administrative problems|0|||
49107419|NCT01179737|158228817|FG002|Cohort 1 & Cohort 2|Administrative problems|2|||
49107420|NCT01179737|158228818|FG003|Cohort 1 & Cohort 2|Administrative problems|4|||
49107421|NCT01179737|158228815|FG000|Cohort 1 & Cohort 2|Death|0|||
49107422|NCT01179737|158228816|FG001|Cohort 1 & Cohort 2|Death|0|||
49107423|NCT01179737|158228817|FG002|Cohort 1 & Cohort 2|Death|1|||
49107424|NCT01179737|158228818|FG003|Cohort 1 & Cohort 2|Death|0|||
49107425|NCT01179737|158228815|FG000|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
49107426|NCT01179737|158228816|FG001|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1|||
49107427|NCT01179737|158228817|FG002|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
49107428|NCT01179737|158228818|FG003|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
49107429|NCT01179737|158228815|FG000|Cohort 1 & Cohort 2 Expansion|Death|1|||
49107430|NCT01179737|158228816|FG001|Cohort 1 & Cohort 2 Expansion|Death|0|||
49107431|NCT01179737|158228817|FG002|Cohort 1 & Cohort 2 Expansion|Death|0|||
49107432|NCT01179737|158228818|FG003|Cohort 1 & Cohort 2 Expansion|Death|0|||
49107433|NCT01179737|158228815|FG000|Extension|The study was terminated|3|||
49107434|NCT01179737|158228816|FG001|Extension|The study was terminated|0|||
49107435|NCT01179737|158228817|FG002|Extension|The study was terminated|0|||
49107436|NCT01179737|158228818|FG003|Extension|The study was terminated|0|||
49107437|NCT01546038|158228823|FG000|Overall Study|Death|15|||
49107438|NCT01546038|158228824|FG001|Overall Study|Death|6|||
49107439|NCT01546038|158228825|FG002|Overall Study|Death|4|||
49107440|NCT01546038|158228826|FG003|Overall Study|Death|2|||
49107441|NCT01546038|158228827|FG004|Overall Study|Death|9|||
49107442|NCT01546038|158228828|FG005|Overall Study|Death|3|||
49107443|NCT01546038|158228829|FG006|Overall Study|Death|46|||
49107444|NCT01546038|158228830|FG007|Overall Study|Death|76|||
49107445|NCT01546038|158228831|FG008|Overall Study|Death|39|||
49107446|NCT01546038|158228823|FG000|Overall Study|Lost to Follow-up|0|||
49107447|NCT01546038|158228824|FG001|Overall Study|Lost to Follow-up|0|||
49107448|NCT01546038|158228825|FG002|Overall Study|Lost to Follow-up|0|||
49107449|NCT01546038|158228826|FG003|Overall Study|Lost to Follow-up|0|||
49107450|NCT01546038|158228827|FG004|Overall Study|Lost to Follow-up|1|||
49107451|NCT01546038|158228828|FG005|Overall Study|Lost to Follow-up|0|||
49107452|NCT01546038|158228829|FG006|Overall Study|Lost to Follow-up|2|||
49107453|NCT01546038|158228830|FG007|Overall Study|Lost to Follow-up|1|||
49107454|NCT01546038|158228831|FG008|Overall Study|Lost to Follow-up|0|||
49107455|NCT01546038|158228823|FG000|Overall Study|Withdrawal by Subject|1|||
49107456|NCT01546038|158228824|FG001|Overall Study|Withdrawal by Subject|0|||
49107457|NCT01546038|158228825|FG002|Overall Study|Withdrawal by Subject|0|||
49107458|NCT01546038|158228826|FG003|Overall Study|Withdrawal by Subject|1|||
49107459|NCT01546038|158228827|FG004|Overall Study|Withdrawal by Subject|0|||
49107460|NCT01546038|158228828|FG005|Overall Study|Withdrawal by Subject|1|||
49107461|NCT01546038|158228829|FG006|Overall Study|Withdrawal by Subject|3|||
49107462|NCT01546038|158228830|FG007|Overall Study|Withdrawal by Subject|3|||
49107463|NCT01546038|158228831|FG008|Overall Study|Withdrawal by Subject|1|||
49107464|NCT01546038|158228823|FG000|Overall Study|: Randomized, not treated|0|||
49107465|NCT01546038|158228824|FG001|Overall Study|: Randomized, not treated|0|||
49107466|NCT01546038|158228825|FG002|Overall Study|: Randomized, not treated|0|||
49107467|NCT01546038|158228826|FG003|Overall Study|: Randomized, not treated|0|||
49107468|NCT01546038|158228827|FG004|Overall Study|: Randomized, not treated|0|||
49107469|NCT01546038|158228828|FG005|Overall Study|: Randomized, not treated|0|||
49107470|NCT01546038|158228829|FG006|Overall Study|: Randomized, not treated|2|||
49107471|NCT01546038|158228830|FG007|Overall Study|: Randomized, not treated|4|||
49107472|NCT01546038|158228831|FG008|Overall Study|: Randomized, not treated|3|||
49107473|NCT01711619|158228832|FG000|Overall Study|Early study termination|10|||
49107474|NCT01711619|158228833|FG001|Overall Study|Early study termination|14|||
49107475|NCT01711619|158228832|FG000|Overall Study|Withdrawal by Subject|3|||
49107476|NCT01711619|158228833|FG001|Overall Study|Withdrawal by Subject|7|||
49107477|NCT01711619|158228832|FG000|Overall Study|Protocol Violation|2|||
49107478|NCT01711619|158228833|FG001|Overall Study|Protocol Violation|3|||
49107479|NCT01711619|158228832|FG000|Overall Study|Adverse Event|2|||
49107480|NCT01711619|158228833|FG001|Overall Study|Adverse Event|0|||
49107481|NCT01711619|158228832|FG000|Overall Study|Lost to Follow-up|1|||
49107482|NCT01711619|158228833|FG001|Overall Study|Lost to Follow-up|0|||
49107483|NCT00334802|158228834|FG000|Overall Study|Progressive Disease|2|||
49107484|NCT00334802|158228835|FG001|Overall Study|Progressive Disease|24|||
49107485|NCT00334802|158228834|FG000|Overall Study|Toxicity|1|||
49107486|NCT00334802|158228835|FG001|Overall Study|Toxicity|5|||
49107487|NCT00334802|158228834|FG000|Overall Study|Lack of Efficacy|1|||
49107488|NCT00334802|158228835|FG001|Overall Study|Lack of Efficacy|3|||
49107489|NCT00334802|158228834|FG000|Overall Study|Patient Condition Aggrevated|1|||
49107490|NCT00334802|158228835|FG001|Overall Study|Patient Condition Aggrevated|0|||
49107491|NCT00334802|158228834|FG000|Overall Study|Physician Decision|1|||
49107492|NCT00334802|158228835|FG001|Overall Study|Physician Decision|0|||
49107493|NCT00334802|158228834|FG000|Overall Study|Withdrawal by Subject|0|||
49107494|NCT00334802|158228835|FG001|Overall Study|Withdrawal by Subject|4|||
49107495|NCT00334802|158228834|FG000|Overall Study|Adverse Event|0|||
49107496|NCT00334802|158228835|FG001|Overall Study|Adverse Event|3|||
49107497|NCT00334802|158228834|FG000|Overall Study|Criteria for Starting Next Cycle Not Met|0|||
49107498|NCT00334802|158228835|FG001|Overall Study|Criteria for Starting Next Cycle Not Met|1|||
49107499|NCT01634659|158228836|FG000|Period 2 - Second 8 Days of Wear|Adverse Event|2|||
49107500|NCT01634659|158228837|FG001|Period 2 - Second 8 Days of Wear|Adverse Event|0|||
49107501|NCT01634659|158228836|FG000|Period 2 - Second 8 Days of Wear|Physician Decision|1|||
49107502|NCT01634659|158228837|FG001|Period 2 - Second 8 Days of Wear|Physician Decision|0|||
49107503|NCT02638259|158228842|FG000|Treatment Period 1|Adverse Event|1|||
49107504|NCT02638259|158228843|FG001|Treatment Period 1|Adverse Event|5|||
49107505|NCT02638259|158228842|FG000|Treatment Period 1|Death|0|||
49107506|NCT02638259|158228843|FG001|Treatment Period 1|Death|1|||
49107507|NCT02638259|158228842|FG000|Treatment Period 1|Lack of Efficacy|0|||
49107508|NCT02638259|158228843|FG001|Treatment Period 1|Lack of Efficacy|1|||
49107509|NCT02638259|158228842|FG000|Treatment Period 1|Protocol Violation|0|||
49107510|NCT02638259|158228843|FG001|Treatment Period 1|Protocol Violation|3|||
49107511|NCT02638259|158228842|FG000|Treatment Period 1|Withdrawal by Subject|4|||
49107512|NCT02638259|158228843|FG001|Treatment Period 1|Withdrawal by Subject|6|||
49107513|NCT02638259|158228842|FG000|Treatment Period 1|Withdrawn per sponsor decision|0|||
49107514|NCT02638259|158228843|FG001|Treatment Period 1|Withdrawn per sponsor decision|2|||
49107515|NCT02638259|158228842|FG000|Treatment Period 2|Adverse Event|5|||
49107516|NCT02638259|158228843|FG001|Treatment Period 2|Adverse Event|4|||
49107517|NCT02638259|158228842|FG000|Treatment Period 2|Withdrawal by Subject|1|||
49107518|NCT02638259|158228843|FG001|Treatment Period 2|Withdrawal by Subject|7|||
49107519|NCT04299048|158228844|FG000|Overall Study|Death|1|||
49107520|NCT04299048|158228844|FG000|Overall Study|Global deterioration of health status|2|||
49107521|NCT04299048|158228844|FG000|Overall Study|Enrolled and not treated|1|||
49107522|NCT01706575|158228847|FG000|Overall Study|Participant Withdrew Consent|4|||
49107523|NCT01706575|158228847|FG000|Overall Study|Lost to Follow-up|2|||
49107524|NCT01706575|158228847|FG000|Overall Study|Started but not Treated|6|||
49107525|NCT01094782|158228848|FG000|Overall Study|Withdrawal by Subject|5|||
49107526|NCT01094782|158228849|FG001|Overall Study|Withdrawal by Subject|5|||
49107527|NCT01094782|158228850|FG002|Overall Study|Withdrawal by Subject|1|||
49107528|NCT01094782|158228851|FG003|Overall Study|Withdrawal by Subject|5|||
49107529|NCT01094782|158228852|FG004|Overall Study|Withdrawal by Subject|5|||
49107530|NCT01094782|158228853|FG005|Overall Study|Withdrawal by Subject|0|||
49107531|NCT01094782|158228848|FG000|Overall Study|Lost to Follow-up|1|||
49107532|NCT01094782|158228849|FG001|Overall Study|Lost to Follow-up|0|||
49107533|NCT01094782|158228850|FG002|Overall Study|Lost to Follow-up|0|||
49107534|NCT01094782|158228851|FG003|Overall Study|Lost to Follow-up|2|||
49107535|NCT01094782|158228852|FG004|Overall Study|Lost to Follow-up|1|||
49107536|NCT01094782|158228853|FG005|Overall Study|Lost to Follow-up|4|||
49107537|NCT01094782|158228848|FG000|Overall Study|Positive Drug Screen|2|||
49107538|NCT01094782|158228849|FG001|Overall Study|Positive Drug Screen|2|||
49107539|NCT01094782|158228850|FG002|Overall Study|Positive Drug Screen|1|||
49107540|NCT01094782|158228851|FG003|Overall Study|Positive Drug Screen|1|||
49107541|NCT01094782|158228852|FG004|Overall Study|Positive Drug Screen|3|||
49107542|NCT01094782|158228853|FG005|Overall Study|Positive Drug Screen|2|||
49107543|NCT01094782|158228848|FG000|Overall Study|Sensory Deficit at Site of QST|0|||
49107544|NCT01094782|158228849|FG001|Overall Study|Sensory Deficit at Site of QST|1|||
49107545|NCT01094782|158228850|FG002|Overall Study|Sensory Deficit at Site of QST|0|||
49107546|NCT01094782|158228851|FG003|Overall Study|Sensory Deficit at Site of QST|0|||
49107547|NCT01094782|158228852|FG004|Overall Study|Sensory Deficit at Site of QST|0|||
49107548|NCT01094782|158228853|FG005|Overall Study|Sensory Deficit at Site of QST|0|||
49107549|NCT01094782|158228848|FG000|Overall Study|Unable to Complete Questionnaires|0|||
49107550|NCT01094782|158228849|FG001|Overall Study|Unable to Complete Questionnaires|1|||
49107551|NCT01094782|158228850|FG002|Overall Study|Unable to Complete Questionnaires|0|||
49107552|NCT01094782|158228851|FG003|Overall Study|Unable to Complete Questionnaires|0|||
49107553|NCT01094782|158228852|FG004|Overall Study|Unable to Complete Questionnaires|0|||
49107554|NCT01094782|158228853|FG005|Overall Study|Unable to Complete Questionnaires|0|||
49107555|NCT01094782|158228848|FG000|Overall Study|Healthy Subject Had Pain|0|||
49107556|NCT01094782|158228849|FG001|Overall Study|Healthy Subject Had Pain|1|||
49107557|NCT01094782|158228850|FG002|Overall Study|Healthy Subject Had Pain|0|||
49107558|NCT01094782|158228851|FG003|Overall Study|Healthy Subject Had Pain|0|||
49107559|NCT01094782|158228852|FG004|Overall Study|Healthy Subject Had Pain|0|||
49107560|NCT01094782|158228853|FG005|Overall Study|Healthy Subject Had Pain|0|||
49107561|NCT01094782|158228848|FG000|Overall Study|Hypertension|0|||
49107562|NCT01094782|158228849|FG001|Overall Study|Hypertension|0|||
49107563|NCT01094782|158228850|FG002|Overall Study|Hypertension|1|||
49107564|NCT01094782|158228851|FG003|Overall Study|Hypertension|0|||
49107565|NCT01094782|158228852|FG004|Overall Study|Hypertension|0|||
49107566|NCT01094782|158228853|FG005|Overall Study|Hypertension|0|||
49107567|NCT01094782|158228848|FG000|Overall Study|Wrong Pain Condition|0|||
49107568|NCT01094782|158228849|FG001|Overall Study|Wrong Pain Condition|0|||
49107569|NCT01094782|158228850|FG002|Overall Study|Wrong Pain Condition|0|||
49107570|NCT01094782|158228851|FG003|Overall Study|Wrong Pain Condition|2|||
49107571|NCT01094782|158228852|FG004|Overall Study|Wrong Pain Condition|1|||
49107572|NCT01094782|158228853|FG005|Overall Study|Wrong Pain Condition|1|||
49107573|NCT01094782|158228848|FG000|Overall Study|Recent Interventional Injection|0|||
49107574|NCT01094782|158228849|FG001|Overall Study|Recent Interventional Injection|0|||
49107575|NCT01094782|158228850|FG002|Overall Study|Recent Interventional Injection|0|||
49107576|NCT01094782|158228851|FG003|Overall Study|Recent Interventional Injection|0|||
49107577|NCT01094782|158228852|FG004|Overall Study|Recent Interventional Injection|0|||
49107578|NCT01094782|158228853|FG005|Overall Study|Recent Interventional Injection|1|||
49107579|NCT01094782|158228848|FG000|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
49107580|NCT01094782|158228849|FG001|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
49107581|NCT01094782|158228850|FG002|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
49107582|NCT01094782|158228851|FG003|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
49107583|NCT01094782|158228852|FG004|Overall Study|Low Visual Analog Scale (VAS) Score|1|||
49107584|NCT01094782|158228853|FG005|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
49107585|NCT01094782|158228848|FG000|Overall Study|Noncompliance With Study Schedule|0|||
49107586|NCT01094782|158228849|FG001|Overall Study|Noncompliance With Study Schedule|0|||
49107587|NCT01094782|158228850|FG002|Overall Study|Noncompliance With Study Schedule|0|||
49107588|NCT01094782|158228851|FG003|Overall Study|Noncompliance With Study Schedule|1|||
49107589|NCT01094782|158228852|FG004|Overall Study|Noncompliance With Study Schedule|0|||
49107590|NCT01094782|158228853|FG005|Overall Study|Noncompliance With Study Schedule|0|||
49107591|NCT04326439|158228856|FG000|Overall Study|Withdrawal by Subject|1|||
49107592|NCT04326439|158228857|FG001|Overall Study|Withdrawal by Subject|0|||
49107593|NCT04326439|158228856|FG000|Overall Study|Proceeded to HSCT after Induction 2|0|||
49107594|NCT04326439|158228857|FG001|Overall Study|Proceeded to HSCT after Induction 2|2|||
49107595|NCT04326439|158228856|FG000|Overall Study|Relapse after Induction 2|0|||
49107596|NCT04326439|158228857|FG001|Overall Study|Relapse after Induction 2|1|||
49107597|NCT04326439|158228856|FG000|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|1|||
49107598|NCT04326439|158228857|FG001|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|0|||
49107599|NCT00634049|158228860|FG000|Overall Study|Never received study drug|1|||
49107600|NCT00634049|158228860|FG000|Overall Study|Died prior to receiving study drug|1|||
49107601|NCT00634049|158228860|FG000|Overall Study|Screening failure|1|||
49107602|NCT01068626|158228863|FG000|Overall Study|Adverse Event|3|||
49107603|NCT01068626|158228864|FG001|Overall Study|Adverse Event|0|||
49107604|NCT01068626|158228863|FG000|Overall Study|Withdrawal by Subject|0|||
49107605|NCT01068626|158228864|FG001|Overall Study|Withdrawal by Subject|2|||
49107606|NCT02670382|158228865|FG000|Placebo lead-in Phase|Withdrawal by Subject|2|||
49107607|NCT02670382|158228866|FG001|Placebo lead-in Phase|Withdrawal by Subject|1|||
49107608|NCT00334295|158228867|FG000|Overall Study|Patients received fewer than 3 injection|5|||
49107609|NCT00335959|158228868|FG000|Overall Study|Adverse Event|2|||
49107610|NCT00335959|158228868|FG000|Overall Study|Ineligible|1|||
49107611|NCT03759366|158228870|FG000|Primary Evaluation Period (26 Weeks)|Physician Decision|1|||
49107612|NCT03759366|158228870|FG000|Extension Period (Up to 208 Weeks)|Physician Decision|1|||
49107613|NCT03759366|158228870|FG000|Extension Period (Up to 208 Weeks)|Lost to Follow-up|1|||
49107614|NCT03759366|158228870|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Ultomiris|2|||
49107615|NCT03759366|158228870|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Soliris|1|||
49107616|NCT03759366|158228870|FG000|Extension Period (Up to 208 Weeks)|Participant transferred to another study|1|||
49107617|NCT03759366|158228870|FG000|Extension Period (Up to 208 Weeks)|Withdrawal by Subject|2|||
49107618|NCT00597012|158228873|FG000|Overall Study|Death|1|||
49107619|NCT00597012|158228874|FG001|Overall Study|Death|1|||
49107620|NCT00597012|158228873|FG000|Overall Study|Underwent Total Knee Replacement (TKR)|3|||
49107621|NCT00597012|158228874|FG001|Overall Study|Underwent Total Knee Replacement (TKR)|1|||
49107622|NCT00597012|158228873|FG000|Overall Study|Withdrawal by Subject|7|||
49107623|NCT00597012|158228874|FG001|Overall Study|Withdrawal by Subject|4|||
49107624|NCT00597012|158228873|FG000|Overall Study|Ineligible|2|||
49107625|NCT00597012|158228874|FG001|Overall Study|Ineligible|0|||
49107626|NCT00597012|158228873|FG000|Overall Study|Lost to Follow-up|0|||
49107627|NCT00597012|158228874|FG001|Overall Study|Lost to Follow-up|2|||
49107628|NCT03755518|158228878|FG000|Overall Study|Lack of Efficacy|10|||
49107629|NCT03755518|158228878|FG000|Overall Study|Adverse Event|7|||
49107630|NCT03755518|158228878|FG000|Overall Study|Study Terminated by Sponsor|5|||
49107631|NCT03755518|158228878|FG000|Overall Study|Death|1|||
49107632|NCT03755518|158228878|FG000|Overall Study|Withdrawal by Subject|3|||
49107633|NCT03755518|158228878|FG000|Overall Study|Progressive Disease|4|||
49107634|NCT03755518|158228878|FG000|Overall Study|Bone Marrow Transplant|4|||
49107635|NCT03755518|158228878|FG000|Overall Study|Physicians Decision|1|||
49107636|NCT03755518|158228878|FG000|Overall Study|Relapse|1|||
49107637|NCT03755518|158228878|FG000|Overall Study|Withdrawal by Investigator for Non Compliance|1|||
49107638|NCT03755518|158228878|FG000|Overall Study|Withdrawal by PI|1|||
49107639|NCT01416155|158228879|FG000|Overall Study|Adverse Event|8|||
49107640|NCT01416155|158228879|FG000|Overall Study|Positive for anti-BG00002 antibodies|2|||
49107641|NCT01416155|158228879|FG000|Overall Study|Withdrawal by Subject|33|||
49107642|NCT01416155|158228879|FG000|Overall Study|Investigator decision|8|||
49107643|NCT01416155|158228879|FG000|Overall Study|Other|7|||
49107644|NCT00539032|158228882|FG000|Overall Study|Withdrawal by Subject|2|||
49107645|NCT00539032|158228883|FG001|Overall Study|Withdrawal by Subject|1|||
49107646|NCT01714609|158228884|FG000|Overall Study|Protocol Violation|1|||
49107647|NCT01714609|158228885|FG001|Overall Study|Protocol Violation|0|||
49107648|NCT00630747|158228886|FG000|Overall Study|Death|1|||
49107649|NCT00630747|158228886|FG000|Overall Study|Transferred to Study TKT031NPU|7|||
49107650|NCT00630747|158228886|FG000|Overall Study|Returned to country of origin|1|||
49107651|NCT02732327|158228887|FG000|Overall Study|Protocol Violation|0|||
49107652|NCT02732327|158228888|FG001|Overall Study|Protocol Violation|1|||
49107653|NCT02306694|158228889|FG000|Overall Study|Withdrawal by Subject|3|||
49107654|NCT02306694|158228889|FG000|Overall Study|Lost to Follow-up|1|||
49107655|NCT02012959|158228890|FG000|Treatment Phase A|Adverse Event|2|||
49107656|NCT02012959|158228891|FG001|Treatment Phase A|Adverse Event|0|||
49107657|NCT02012959|158228892|FG002|Treatment Phase A|Adverse Event|0|||
49107658|NCT02012959|158228893|FG003|Treatment Phase A|Adverse Event|0|||
49107659|NCT02012959|158228894|FG004|Treatment Phase A|Adverse Event|0|||
49107660|NCT03535194|158230565|FG000|Induction Period|Adverse Event|2|||
49107661|NCT03535194|158230566|FG001|Induction Period|Adverse Event|2|||
49107662|NCT03535194|158230567|FG002|Induction Period|Adverse Event|1|||
49107663|NCT03535194|158230568|FG003|Induction Period|Adverse Event|3|||
49107664|NCT03535194|158230569|FG004|Induction Period|Adverse Event|0|||
49107665|NCT03535194|158230565|FG000|Induction Period|Death|0|||
49107666|NCT03535194|158230566|FG001|Induction Period|Death|1|||
49107667|NCT03535194|158230567|FG002|Induction Period|Death|0|||
49107668|NCT03535194|158230568|FG003|Induction Period|Death|0|||
49107669|NCT03535194|158230569|FG004|Induction Period|Death|0|||
49107670|NCT03535194|158230565|FG000|Induction Period|Lack of Efficacy|1|||
49107671|NCT03535194|158230566|FG001|Induction Period|Lack of Efficacy|3|||
49107672|NCT03535194|158230567|FG002|Induction Period|Lack of Efficacy|2|||
49107673|NCT03535194|158230568|FG003|Induction Period|Lack of Efficacy|2|||
49107674|NCT03535194|158230569|FG004|Induction Period|Lack of Efficacy|0|||
49107675|NCT03535194|158230565|FG000|Induction Period|Lost to Follow-up|3|||
49107676|NCT03535194|158230566|FG001|Induction Period|Lost to Follow-up|5|||
49107677|NCT03535194|158230567|FG002|Induction Period|Lost to Follow-up|2|||
49107678|NCT03535194|158230568|FG003|Induction Period|Lost to Follow-up|3|||
49107679|NCT03535194|158230569|FG004|Induction Period|Lost to Follow-up|0|||
49107680|NCT03535194|158230565|FG000|Induction Period|Physician Decision|1|||
49107681|NCT03535194|158230566|FG001|Induction Period|Physician Decision|1|||
49107682|NCT03535194|158230567|FG002|Induction Period|Physician Decision|0|||
49107683|NCT03535194|158230568|FG003|Induction Period|Physician Decision|0|||
49107684|NCT03535194|158230569|FG004|Induction Period|Physician Decision|0|||
49107685|NCT03535194|158230565|FG000|Induction Period|Protocol Violation|1|||
49107686|NCT03535194|158230566|FG001|Induction Period|Protocol Violation|0|||
49107687|NCT03535194|158230567|FG002|Induction Period|Protocol Violation|0|||
49107688|NCT03535194|158230568|FG003|Induction Period|Protocol Violation|1|||
49107689|NCT03535194|158230569|FG004|Induction Period|Protocol Violation|0|||
49107690|NCT03535194|158230565|FG000|Induction Period|Screen Failure|0|||
49107691|NCT03535194|158230566|FG001|Induction Period|Screen Failure|1|||
49107692|NCT03535194|158230567|FG002|Induction Period|Screen Failure|0|||
49107693|NCT03535194|158230568|FG003|Induction Period|Screen Failure|0|||
49107694|NCT03535194|158230569|FG004|Induction Period|Screen Failure|0|||
49107695|NCT03535194|158230565|FG000|Induction Period|Withdrawal by Subject|3|||
49107696|NCT03535194|158230566|FG001|Induction Period|Withdrawal by Subject|4|||
49107697|NCT03535194|158230567|FG002|Induction Period|Withdrawal by Subject|3|||
49107698|NCT03535194|158230568|FG003|Induction Period|Withdrawal by Subject|2|||
49107699|NCT03535194|158230569|FG004|Induction Period|Withdrawal by Subject|0|||
49107700|NCT03535194|158230565|FG000|Maintenance Period|Adverse Event|6|||
49107701|NCT03535194|158230566|FG001|Maintenance Period|Adverse Event|5|||
49107702|NCT03535194|158230567|FG002|Maintenance Period|Adverse Event|1|||
49107703|NCT03535194|158230568|FG003|Maintenance Period|Adverse Event|11|||
49107704|NCT03535194|158230569|FG004|Maintenance Period|Adverse Event|4|||
49107705|NCT03535194|158230565|FG000|Maintenance Period|Lack of Efficacy|3|||
49107706|NCT03535194|158230566|FG001|Maintenance Period|Lack of Efficacy|2|||
49107707|NCT03535194|158230567|FG002|Maintenance Period|Lack of Efficacy|5|||
49107708|NCT03535194|158230568|FG003|Maintenance Period|Lack of Efficacy|9|||
49107709|NCT03535194|158230569|FG004|Maintenance Period|Lack of Efficacy|0|||
49107710|NCT03535194|158230565|FG000|Maintenance Period|Lost to Follow-up|4|||
49107711|NCT03535194|158230566|FG001|Maintenance Period|Lost to Follow-up|2|||
49107712|NCT03535194|158230567|FG002|Maintenance Period|Lost to Follow-up|1|||
49107713|NCT03535194|158230568|FG003|Maintenance Period|Lost to Follow-up|5|||
49107714|NCT03535194|158230569|FG004|Maintenance Period|Lost to Follow-up|2|||
49107715|NCT03535194|158230565|FG000|Maintenance Period|Other|1|||
49107716|NCT03535194|158230566|FG001|Maintenance Period|Other|2|||
49107717|NCT03535194|158230567|FG002|Maintenance Period|Other|0|||
49107718|NCT03535194|158230568|FG003|Maintenance Period|Other|0|||
49107719|NCT03535194|158230569|FG004|Maintenance Period|Other|0|||
49107720|NCT03535194|158230565|FG000|Maintenance Period|Physician Decision|1|||
49107721|NCT03535194|158230566|FG001|Maintenance Period|Physician Decision|2|||
49107722|NCT03535194|158230567|FG002|Maintenance Period|Physician Decision|0|||
49107723|NCT03535194|158230568|FG003|Maintenance Period|Physician Decision|2|||
49107724|NCT03535194|158230569|FG004|Maintenance Period|Physician Decision|0|||
49107725|NCT03535194|158230565|FG000|Maintenance Period|Pregnancy|0|||
49107726|NCT03535194|158230566|FG001|Maintenance Period|Pregnancy|0|||
49107727|NCT03535194|158230567|FG002|Maintenance Period|Pregnancy|0|||
49107728|NCT03535194|158230568|FG003|Maintenance Period|Pregnancy|2|||
49107729|NCT03535194|158230569|FG004|Maintenance Period|Pregnancy|0|||
49107730|NCT03535194|158230565|FG000|Maintenance Period|Protocol Violation|0|||
49107731|NCT03535194|158230566|FG001|Maintenance Period|Protocol Violation|1|||
49107732|NCT03535194|158230567|FG002|Maintenance Period|Protocol Violation|0|||
49107733|NCT03535194|158230568|FG003|Maintenance Period|Protocol Violation|0|||
49107734|NCT03535194|158230569|FG004|Maintenance Period|Protocol Violation|0|||
49107735|NCT03535194|158230565|FG000|Maintenance Period|Withdrawal by Subject|7|||
49107736|NCT03535194|158230566|FG001|Maintenance Period|Withdrawal by Subject|2|||
49107737|NCT03535194|158230567|FG002|Maintenance Period|Withdrawal by Subject|1|||
49107738|NCT03535194|158230568|FG003|Maintenance Period|Withdrawal by Subject|8|||
49107739|NCT03535194|158230569|FG004|Maintenance Period|Withdrawal by Subject|0|||
49107740|NCT03535194|158230565|FG000|Post-Treatment Followup Period|Adverse Event|4|||
49107741|NCT03535194|158230566|FG001|Post-Treatment Followup Period|Adverse Event|5|||
49107742|NCT03535194|158230567|FG002|Post-Treatment Followup Period|Adverse Event|1|||
49107743|NCT03535194|158230568|FG003|Post-Treatment Followup Period|Adverse Event|8|||
49107744|NCT03535194|158230569|FG004|Post-Treatment Followup Period|Adverse Event|0|||
49107745|NCT03535194|158230565|FG000|Post-Treatment Followup Period|Lack of Efficacy|3|||
49107746|NCT03535194|158230566|FG001|Post-Treatment Followup Period|Lack of Efficacy|4|||
49107747|NCT03535194|158230567|FG002|Post-Treatment Followup Period|Lack of Efficacy|5|||
49107748|NCT03535194|158230568|FG003|Post-Treatment Followup Period|Lack of Efficacy|4|||
49107749|NCT03535194|158230569|FG004|Post-Treatment Followup Period|Lack of Efficacy|0|||
49107750|NCT03535194|158230565|FG000|Post-Treatment Followup Period|Lost to Follow-up|1|||
49107751|NCT03535194|158230566|FG001|Post-Treatment Followup Period|Lost to Follow-up|1|||
49107752|NCT03535194|158230567|FG002|Post-Treatment Followup Period|Lost to Follow-up|1|||
49107753|NCT03535194|158230568|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
49107754|NCT03535194|158230569|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
49107755|NCT03535194|158230565|FG000|Post-Treatment Followup Period|Other|1|||
49107756|NCT03535194|158230566|FG001|Post-Treatment Followup Period|Other|0|||
49107757|NCT03535194|158230567|FG002|Post-Treatment Followup Period|Other|0|||
49107758|NCT03535194|158230568|FG003|Post-Treatment Followup Period|Other|5|||
49107759|NCT03535194|158230569|FG004|Post-Treatment Followup Period|Other|0|||
49107760|NCT03535194|158230565|FG000|Post-Treatment Followup Period|Physician Decision|0|||
49107761|NCT03535194|158230566|FG001|Post-Treatment Followup Period|Physician Decision|2|||
49107762|NCT03535194|158230567|FG002|Post-Treatment Followup Period|Physician Decision|1|||
49107763|NCT03535194|158230568|FG003|Post-Treatment Followup Period|Physician Decision|1|||
49107764|NCT03535194|158230569|FG004|Post-Treatment Followup Period|Physician Decision|0|||
49107765|NCT03535194|158230565|FG000|Post-Treatment Followup Period|Withdrawal by Subject|2|||
49107766|NCT03535194|158230566|FG001|Post-Treatment Followup Period|Withdrawal by Subject|2|||
49107767|NCT03535194|158230567|FG002|Post-Treatment Followup Period|Withdrawal by Subject|3|||
49107768|NCT03535194|158230568|FG003|Post-Treatment Followup Period|Withdrawal by Subject|6|||
49107769|NCT03535194|158230569|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
49107770|NCT02638129|158230570|FG000|Overall Study|Study terminated|28|||
49107771|NCT02638129|158230571|FG001|Overall Study|Study terminated|30|||
49107772|NCT01473394|158230574|FG000|Overall Study|Adverse Event|13|||
49107773|NCT01473394|158230575|FG001|Overall Study|Adverse Event|16|||
49107774|NCT01473394|158230574|FG000|Overall Study|Insufficient Therapeutic Response|4|||
49107775|NCT01473394|158230575|FG001|Overall Study|Insufficient Therapeutic Response|1|||
49107776|NCT01473394|158230574|FG000|Overall Study|Protocol Violation|7|||
49107777|NCT01473394|158230575|FG001|Overall Study|Protocol Violation|5|||
49107778|NCT01473394|158230574|FG000|Overall Study|Withdrew Consent|12|||
49107779|NCT01473394|158230575|FG001|Overall Study|Withdrew Consent|10|||
49107780|NCT01473394|158230574|FG000|Overall Study|Lost to Follow-up|9|||
49107781|NCT01473394|158230575|FG001|Overall Study|Lost to Follow-up|11|||
49107782|NCT00869557|158230576|FG000|Randomized Phase|Lost to Follow-up|2|||
49107783|NCT00869557|158230577|FG001|Randomized Phase|Lost to Follow-up|1|||
49107784|NCT00869557|158230576|FG000|Randomized Phase|Investigator's Discretion|1|||
49107785|NCT00869557|158230577|FG001|Randomized Phase|Investigator's Discretion|0|||
49107786|NCT00869557|158230576|FG000|Randomized Phase|Withdrew Consent|0|||
49107787|NCT00869557|158230577|FG001|Randomized Phase|Withdrew Consent|1|||
49107788|NCT00869557|158230576|FG000|Extension Phase|Adverse Event|2|||
49107789|NCT00869557|158230577|FG001|Extension Phase|Adverse Event|2|||
49107790|NCT00869557|158230576|FG000|Extension Phase|Lack of Efficacy|1|||
49107791|NCT00869557|158230577|FG001|Extension Phase|Lack of Efficacy|0|||
49107792|NCT00869557|158230576|FG000|Extension Phase|Lost to Follow-up|3|||
49107793|NCT00869557|158230577|FG001|Extension Phase|Lost to Follow-up|1|||
49107794|NCT00869557|158230576|FG000|Extension Phase|Investigator's Discretion|2|||
49107795|NCT00869557|158230577|FG001|Extension Phase|Investigator's Discretion|0|||
49107796|NCT00869557|158230576|FG000|Extension Phase|Withdrew Consent|2|||
49107797|NCT00869557|158230577|FG001|Extension Phase|Withdrew Consent|0|||
49107798|NCT02949908|158230578|FG000|Overall Study|Study termination|2|||
49107799|NCT02998476|158230579|FG000|Overall Study|Lost to Follow-up|1|||
49107800|NCT02998476|158230580|FG001|Overall Study|Lost to Follow-up|0|||
49107801|NCT02998476|158230579|FG000|Overall Study|Participants transferred to rollover study INCB50465-801|2|||
49107802|NCT02998476|158230580|FG001|Overall Study|Participants transferred to rollover study INCB50465-801|0|||
49107803|NCT02998476|158230579|FG000|Overall Study|Withdrawal by Subject|1|||
49107804|NCT02998476|158230580|FG001|Overall Study|Withdrawal by Subject|2|||
49107805|NCT02998476|158230579|FG000|Overall Study|Death|45|||
49107806|NCT02998476|158230580|FG001|Overall Study|Death|2|||
49107807|NCT02998476|158230579|FG000|Overall Study|Other|6|||
49107808|NCT02998476|158230580|FG001|Overall Study|Other|1|||
49107809|NCT00033657|158230581|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|1|||
49107810|NCT00033657|158230582|FG001|Neoadjuvant Chemotherapy|Lack of Efficacy|2|||
49107811|NCT00033657|158230581|FG000|Neoadjuvant Chemotherapy|Adverse Event|0|||
49107812|NCT00033657|158230582|FG001|Neoadjuvant Chemotherapy|Adverse Event|2|||
49107813|NCT00033657|158230581|FG000|Neoadjuvant Chemotherapy|Death|1|||
49107814|NCT00033657|158230582|FG001|Neoadjuvant Chemotherapy|Death|1|||
49107815|NCT00033657|158230581|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
49107816|NCT00033657|158230582|FG001|Neoadjuvant Chemotherapy|Withdrawal by Subject|0|||
49107817|NCT00033657|158230581|FG000|Neoadjuvant Chemotherapy|other complicating disease|0|||
49107818|NCT00033657|158230582|FG001|Neoadjuvant Chemotherapy|other complicating disease|1|||
49107819|NCT00033657|158230581|FG000|Neoadjuvant Chemotherapy|Ineligible|8|||
49107820|NCT00033657|158230582|FG001|Neoadjuvant Chemotherapy|Ineligible|4|||
49107821|NCT00033657|158230581|FG000|Neoadjuvant Chemotherapy|Not started protocol therapy|3|||
49107822|NCT00033657|158230582|FG001|Neoadjuvant Chemotherapy|Not started protocol therapy|1|||
49107823|NCT00033657|158230581|FG000|Surgical Resection|not complete resection|0|||
49107824|NCT00033657|158230582|FG001|Surgical Resection|not complete resection|3|||
49107825|NCT00033657|158230581|FG000|Adjuvant Chemotherapy|Lack of Efficacy|3|||
49107826|NCT00033657|158230582|FG001|Adjuvant Chemotherapy|Lack of Efficacy|1|||
49107827|NCT00033657|158230581|FG000|Adjuvant Chemotherapy|Adverse Event|7|||
49107828|NCT00033657|158230582|FG001|Adjuvant Chemotherapy|Adverse Event|10|||
49107829|NCT00033657|158230581|FG000|Adjuvant Chemotherapy|Death|2|||
49107830|NCT00033657|158230582|FG001|Adjuvant Chemotherapy|Death|1|||
49107831|NCT00033657|158230581|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|5|||
49107832|NCT00033657|158230582|FG001|Adjuvant Chemotherapy|Withdrawal by Subject|3|||
49107833|NCT00033657|158230581|FG000|Adjuvant Chemotherapy|alternative therapy|1|||
49107834|NCT00033657|158230582|FG001|Adjuvant Chemotherapy|alternative therapy|0|||
49107835|NCT00033657|158230581|FG000|Adjuvant Chemotherapy|Other|0|||
49107836|NCT00033657|158230582|FG001|Adjuvant Chemotherapy|Other|2|||
49107837|NCT00006305|158230586|FG000|Overall Study|Withdrawal by Subject|17|||
49107838|NCT00006305|158230587|FG001|Overall Study|Withdrawal by Subject|10|||
49107839|NCT00006305|158230588|FG002|Overall Study|Withdrawal by Subject|15|||
49107840|NCT00006305|158230589|FG003|Overall Study|Withdrawal by Subject|14|||
49107841|NCT02631746|158230590|FG000|Overall Study|Lack of Efficacy|3|||
49107842|NCT00662558|158230591|FG000|Overall Study|Adverse Event|21|||
49107843|NCT00662558|158230592|FG001|Overall Study|Adverse Event|59|||
49107844|NCT00662558|158230591|FG000|Overall Study|Lack of Efficacy|4|||
49107845|NCT00662558|158230592|FG001|Overall Study|Lack of Efficacy|7|||
49107846|NCT00662558|158230591|FG000|Overall Study|Lost to Follow-up|13|||
49107847|NCT00662558|158230592|FG001|Overall Study|Lost to Follow-up|10|||
49107848|NCT00662558|158230591|FG000|Overall Study|Other|9|||
49107849|NCT00662558|158230592|FG001|Overall Study|Other|14|||
49107850|NCT00662558|158230591|FG000|Overall Study|Withdrawal by Subject|7|||
49107851|NCT00662558|158230592|FG001|Overall Study|Withdrawal by Subject|12|||
49107852|NCT00662558|158230591|FG000|Overall Study|Randomized But Did Not Receive Treatment|2|||
49107853|NCT00662558|158230592|FG001|Overall Study|Randomized But Did Not Receive Treatment|8|||
49107854|NCT01542034|158230593|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|20|||
49107855|NCT01542034|158230594|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|12|||
49107856|NCT01542034|158230593|FG000|Overall Study|Administrative decision|0|||
49107857|NCT01542034|158230594|FG001|Overall Study|Administrative decision|3|||
49107858|NCT01542034|158230593|FG000|Overall Study|Subject Noncompliance|1|||
49107859|NCT01542034|158230594|FG001|Overall Study|Subject Noncompliance|0|||
49107860|NCT01542034|158230593|FG000|Overall Study|Adverse Event|2|||
49107861|NCT01542034|158230594|FG001|Overall Study|Adverse Event|2|||
49107862|NCT01542034|158230593|FG000|Overall Study|Lost to Follow-up|7|||
49107863|NCT01542034|158230594|FG001|Overall Study|Lost to Follow-up|6|||
49107864|NCT00396877|158230595|FG000|Overall Study|Lost to Follow-up|2|||
49107865|NCT00396877|158230596|FG001|Overall Study|Lost to Follow-up|1|||
49107866|NCT00396877|158230595|FG000|Overall Study|Parent(s)/guardian(s)'s request|4|||
49107867|NCT00396877|158230596|FG001|Overall Study|Parent(s)/guardian(s)'s request|7|||
49107868|NCT01043705|158230597|FG000|Overall Study|Death|28|||
49107869|NCT01043705|158230598|FG001|Overall Study|Death|60|||
49107870|NCT01043705|158230599|FG002|Overall Study|Death|26|||
49107871|NCT01043705|158230597|FG000|Overall Study|Lost to Follow-up|27|||
49107872|NCT01043705|158230598|FG001|Overall Study|Lost to Follow-up|12|||
49107873|NCT01043705|158230599|FG002|Overall Study|Lost to Follow-up|0|||
49107874|NCT01043705|158230597|FG000|Overall Study|Multiple Reasons|4|||
49107875|NCT01043705|158230598|FG001|Overall Study|Multiple Reasons|7|||
49107876|NCT01043705|158230599|FG002|Overall Study|Multiple Reasons|0|||
49107877|NCT01043705|158230597|FG000|Overall Study|Protocol Violation|2|||
49107878|NCT01043705|158230598|FG001|Overall Study|Protocol Violation|1|||
49107879|NCT01043705|158230599|FG002|Overall Study|Protocol Violation|0|||
49107880|NCT01043705|158230597|FG000|Overall Study|Withdrawal by Subject|8|||
49107881|NCT01043705|158230598|FG001|Overall Study|Withdrawal by Subject|6|||
49107882|NCT01043705|158230599|FG002|Overall Study|Withdrawal by Subject|0|||
49107883|NCT01043705|158230597|FG000|Overall Study|Site Closure|8|||
49107884|NCT01043705|158230598|FG001|Overall Study|Site Closure|0|||
49107885|NCT01043705|158230599|FG002|Overall Study|Site Closure|0|||
49107886|NCT01043705|158230597|FG000|Overall Study|Subsequent Procedure|9|||
49107887|NCT01043705|158230598|FG001|Overall Study|Subsequent Procedure|24|||
49107888|NCT01043705|158230599|FG002|Overall Study|Subsequent Procedure|29|||
49107889|NCT01043705|158230597|FG000|Overall Study|Adverse Event|0|||
49107890|NCT01043705|158230598|FG001|Overall Study|Adverse Event|2|||
49107891|NCT01043705|158230599|FG002|Overall Study|Adverse Event|0|||
49107892|NCT01043705|158230597|FG000|Overall Study|Screen Fail|21|||
49107893|NCT01043705|158230598|FG001|Overall Study|Screen Fail|0|||
49107894|NCT01043705|158230599|FG002|Overall Study|Screen Fail|0|||
49107895|NCT01043705|158230597|FG000|Overall Study|Other|0|||
49107896|NCT01043705|158230598|FG001|Overall Study|Other|19|||
49107897|NCT01043705|158230599|FG002|Overall Study|Other|25|||
49107898|NCT02945254|158230602|FG000|Overall Study|Lost to Follow-up|1|||
49107899|NCT02945254|158230603|FG001|Overall Study|Lost to Follow-up|0|||
49107900|NCT02945254|158230602|FG000|Overall Study|Withdrawal by Subject|1|||
49107901|NCT02945254|158230603|FG001|Overall Study|Withdrawal by Subject|0|||
49107902|NCT02612610|158230604|FG000|Overall Study|Withdrawal by Subject|1|||
49107903|NCT02612610|158230605|FG001|Overall Study|Withdrawal by Subject|1|||
49107904|NCT02612610|158230606|FG002|Overall Study|Withdrawal by Subject|0|||
49107905|NCT02612610|158230607|FG003|Overall Study|Withdrawal by Subject|2|||
49107906|NCT02612610|158230604|FG000|Overall Study|Adverse Event|2|||
49107907|NCT02612610|158230605|FG001|Overall Study|Adverse Event|2|||
49107908|NCT02612610|158230606|FG002|Overall Study|Adverse Event|3|||
49107909|NCT02612610|158230607|FG003|Overall Study|Adverse Event|10|||
49107910|NCT02612610|158230604|FG000|Overall Study|Lost to Follow-up|0|||
49107911|NCT02612610|158230605|FG001|Overall Study|Lost to Follow-up|1|||
49107912|NCT02612610|158230606|FG002|Overall Study|Lost to Follow-up|0|||
49107913|NCT02612610|158230607|FG003|Overall Study|Lost to Follow-up|0|||
49107914|NCT02612610|158230604|FG000|Overall Study|Protocol Violation|0|||
49107915|NCT02612610|158230605|FG001|Overall Study|Protocol Violation|1|||
49107916|NCT02612610|158230606|FG002|Overall Study|Protocol Violation|1|||
49107917|NCT02612610|158230607|FG003|Overall Study|Protocol Violation|0|||
49107918|NCT02612610|158230604|FG000|Overall Study|Lack of Efficacy|1|||
49107919|NCT02612610|158230605|FG001|Overall Study|Lack of Efficacy|2|||
49107920|NCT02612610|158230606|FG002|Overall Study|Lack of Efficacy|0|||
49107921|NCT02612610|158230607|FG003|Overall Study|Lack of Efficacy|1|||
49107922|NCT02612610|158230604|FG000|Overall Study|Physician Decision|0|||
49107923|NCT02612610|158230605|FG001|Overall Study|Physician Decision|1|||
49107924|NCT02612610|158230606|FG002|Overall Study|Physician Decision|0|||
49107925|NCT02612610|158230607|FG003|Overall Study|Physician Decision|0|||
49107926|NCT02612610|158230604|FG000|Overall Study|Noncompliance|1|||
49107927|NCT02612610|158230605|FG001|Overall Study|Noncompliance|0|||
49107928|NCT02612610|158230606|FG002|Overall Study|Noncompliance|0|||
49107929|NCT02612610|158230607|FG003|Overall Study|Noncompliance|0|||
49107930|NCT02612610|158230604|FG000|Overall Study|Cough Improvement|0|||
49107931|NCT02612610|158230605|FG001|Overall Study|Cough Improvement|0|||
49107932|NCT02612610|158230606|FG002|Overall Study|Cough Improvement|1|||
49107933|NCT02612610|158230607|FG003|Overall Study|Cough Improvement|0|||
49107934|NCT01398410|158230608|FG000|Overall Study|Adverse Event|12|||
49107935|NCT01398410|158230609|FG001|Overall Study|Adverse Event|16|||
49107936|NCT01398410|158230608|FG000|Overall Study|Participants Choice|8|||
49107937|NCT01398410|158230609|FG001|Overall Study|Participants Choice|11|||
49107938|NCT01398410|158230608|FG000|Overall Study|Inadequate Therapeutic Effect|2|||
49107939|NCT01398410|158230609|FG001|Overall Study|Inadequate Therapeutic Effect|0|||
49107940|NCT01398410|158230608|FG000|Overall Study|Other|36|||
49107941|NCT01398410|158230609|FG001|Overall Study|Other|29|||
49107942|NCT00783224|158230610|FG000|Overall Study|Adverse Event|0|||
49107943|NCT00783224|158230611|FG001|Overall Study|Adverse Event|0|||
49107944|NCT00783224|158230612|FG002|Overall Study|Adverse Event|1|||
49107945|NCT00783224|158230613|FG003|Overall Study|Adverse Event|0|||
49107946|NCT00783224|158230610|FG000|Overall Study|Discarded the Investigational Drug Used|0|||
49107947|NCT00783224|158230611|FG001|Overall Study|Discarded the Investigational Drug Used|0|||
49107948|NCT00783224|158230612|FG002|Overall Study|Discarded the Investigational Drug Used|0|||
49107949|NCT00783224|158230613|FG003|Overall Study|Discarded the Investigational Drug Used|1|||
49107950|NCT00783224|158230610|FG000|Overall Study|Inappropriate as a study subject|0|||
49107951|NCT00783224|158230611|FG001|Overall Study|Inappropriate as a study subject|0|||
49107952|NCT00783224|158230612|FG002|Overall Study|Inappropriate as a study subject|0|||
49107953|NCT00783224|158230613|FG003|Overall Study|Inappropriate as a study subject|1|||
49107954|NCT04245202|158230615|FG000|Overall Study|Lack of Efficacy|10|||
49107955|NCT04245202|158230616|FG001|Overall Study|Lack of Efficacy|1|||
49107956|NCT00090584|158230617|FG000|Baseline to 10 Weeks|Lost to Follow-up|15|||
49107957|NCT00090584|158230618|FG001|Baseline to 10 Weeks|Lost to Follow-up|12|||
49107958|NCT00090584|158230617|FG000|Baseline to 8 Months|Lost to Follow-up|44|||
49107959|NCT00090584|158230618|FG001|Baseline to 8 Months|Lost to Follow-up|41|||
49107960|NCT02470403|158230619|FG000|Overall Study|Adverse Event|1|||
49107961|NCT02470403|158230620|FG001|Overall Study|Adverse Event|0|||
49107962|NCT02470403|158230621|FG002|Overall Study|Adverse Event|0|||
49107963|NCT02470403|158230622|FG003|Overall Study|Adverse Event|0|||
49107964|NCT02470403|158230623|FG004|Overall Study|Adverse Event|0|||
49107965|NCT02470403|158230619|FG000|Overall Study|Lost to Follow-up|0|||
49107966|NCT02470403|158230620|FG001|Overall Study|Lost to Follow-up|1|||
49107967|NCT02470403|158230621|FG002|Overall Study|Lost to Follow-up|0|||
49107968|NCT02470403|158230622|FG003|Overall Study|Lost to Follow-up|0|||
49107969|NCT02470403|158230623|FG004|Overall Study|Lost to Follow-up|0|||
49107970|NCT02470403|158230619|FG000|Overall Study|Subject/guardian decision|1|||
49107971|NCT02470403|158230620|FG001|Overall Study|Subject/guardian decision|0|||
49107972|NCT02470403|158230621|FG002|Overall Study|Subject/guardian decision|0|||
49107973|NCT02470403|158230622|FG003|Overall Study|Subject/guardian decision|4|||
49107974|NCT02470403|158230623|FG004|Overall Study|Subject/guardian decision|0|||
49107975|NCT02631070|158230629|FG000|Overall Study|Withdrawal by Subject|35|||
49107976|NCT02631070|158230630|FG001|Overall Study|Withdrawal by Subject|13|||
49107977|NCT02631070|158230629|FG000|Overall Study|Death|45|||
49107978|NCT02631070|158230630|FG001|Overall Study|Death|24|||
49107979|NCT02631070|158230629|FG000|Overall Study|Lost to Follow-up|5|||
49107980|NCT02631070|158230630|FG001|Overall Study|Lost to Follow-up|1|||
49107981|NCT02631070|158230629|FG000|Overall Study|Transition to rollover protocol|52|||
49107982|NCT02631070|158230630|FG001|Overall Study|Transition to rollover protocol|21|||
49107983|NCT02631070|158230629|FG000|Overall Study|Other reasons|12|||
49107984|NCT02631070|158230630|FG001|Overall Study|Other reasons|5|||
49107985|NCT04631107|158230633|FG000|First Intervention (1 Night)|ineligible participant was inadvertently randomized but not treated|1|||
49107986|NCT04631107|158230633|FG000|Second Intervention (1 Night)|Adverse Event|1|||
49107987|NCT04631107|158230633|FG000|Second Intervention (1 Night)|Withdrawal by Subject|1|||
49107988|NCT04631107|158230633|FG000|Third Intervention (1 Night)|Withdrawal by Subject|2|||
49107989|NCT02003963|158230634|FG000|Overall Study|Lost to Follow-up|2|||
49107990|NCT02003963|158230635|FG001|Overall Study|Lost to Follow-up|1|||
49107991|NCT02735096|158230636|FG000|Overall Study|No symptoms in clinic/personal leave|1|||
49107992|NCT00586508|158230637|FG000|Overall Study|Progressive disease|52|||
49107993|NCT00586508|158230638|FG001|Overall Study|Progressive disease|8|||
49107994|NCT00586508|158230637|FG000|Overall Study|Death|0|||
49107995|NCT00586508|158230638|FG001|Overall Study|Death|1|||
49107996|NCT00586508|158230637|FG000|Overall Study|Adverse Event|12|||
49107997|NCT00586508|158230638|FG001|Overall Study|Adverse Event|4|||
49107998|NCT00586508|158230637|FG000|Overall Study|Withdrawal by Subject|4|||
49107999|NCT00586508|158230638|FG001|Overall Study|Withdrawal by Subject|0|||
49108000|NCT03564795|158230641|FG000|Overall Study|Withdrawal by Subject|3|||
49108001|NCT03564795|158230641|FG000|Overall Study|Lost to Follow-up|6|||
49108002|NCT03564795|158230641|FG000|Overall Study|Physician Decision|2|||
49108003|NCT00503997|158230642|FG000|Overall Study|disease progression|1|||
49108004|NCT00503997|158230642|FG000|Overall Study|Adverse Event|5|||
49108005|NCT00503997|158230642|FG000|Overall Study|Death|1|||
49108006|NCT00503997|158230642|FG000|Overall Study|Withdrawal by Subject|1|||
49108007|NCT00085098|158230643|FG000|Overall Study|Withdrawal by Subject|0|||
49108008|NCT00085098|158230644|FG001|Overall Study|Withdrawal by Subject|1|||
49108009|NCT00085098|158230643|FG000|Overall Study|Ineligible|1|||
49108010|NCT00085098|158230644|FG001|Overall Study|Ineligible|1|||
49108011|NCT01195844|158230647|FG000|Overall Study|Fecal sample not collected|40|||
49108012|NCT03515629|158230648|FG000|Overall Study|Death|0|||
49108013|NCT03515629|158230649|FG001|Overall Study|Death|1|||
49108014|NCT03515629|158230650|FG002|Overall Study|Death|1|||
49108015|NCT03515629|158230648|FG000|Overall Study|Progressive disease|0|||
49108016|NCT03515629|158230649|FG001|Overall Study|Progressive disease|1|||
49108017|NCT03515629|158230650|FG002|Overall Study|Progressive disease|0|||
49108018|NCT03329248|158230651|FG000|Overall Study|Progressive Disease|6|||
49108019|NCT01886781|158230658|FG000|Overall Study|Protocol Violation|5|||
49108020|NCT01886781|158230659|FG001|Overall Study|Protocol Violation|0|||
49108021|NCT01886781|158230658|FG000|Overall Study|Adverse Event|1|||
49108022|NCT01886781|158230659|FG001|Overall Study|Adverse Event|0|||
49108023|NCT01886781|158230658|FG000|Overall Study|Lost to Follow-up|5|||
49108024|NCT01886781|158230659|FG001|Overall Study|Lost to Follow-up|0|||
49108025|NCT01886781|158230658|FG000|Overall Study|Withdrawal by Subject|2|||
49108026|NCT01886781|158230659|FG001|Overall Study|Withdrawal by Subject|1|||
49108027|NCT01886781|158230658|FG000|Overall Study|Worsening of symptoms|1|||
49108028|NCT01886781|158230659|FG001|Overall Study|Worsening of symptoms|1|||
49108029|NCT03578146|158230660|FG000|Overall Study|Did Not Receive Treatment|1|||
49108030|NCT03578146|158230661|FG001|Overall Study|Did Not Receive Treatment|0|||
49108031|NCT03578146|158230662|FG002|Overall Study|Did Not Receive Treatment|0|||
49108032|NCT03578146|158230663|FG003|Overall Study|Did Not Receive Treatment|0|||
49108033|NCT03578146|158230664|FG004|Overall Study|Did Not Receive Treatment|0|||
49108034|NCT03578146|158230665|FG005|Overall Study|Did Not Receive Treatment|2|||
49108035|NCT03578146|158230660|FG000|Overall Study|Lost to Follow-up|0|||
49108036|NCT03578146|158230661|FG001|Overall Study|Lost to Follow-up|1|||
49108037|NCT03578146|158230662|FG002|Overall Study|Lost to Follow-up|1|||
49108038|NCT03578146|158230663|FG003|Overall Study|Lost to Follow-up|0|||
49108039|NCT03578146|158230664|FG004|Overall Study|Lost to Follow-up|0|||
49108040|NCT03578146|158230665|FG005|Overall Study|Lost to Follow-up|1|||
49108041|NCT01606748|158230666|FG000|Overall Study|Adverse Event|1|||
49108042|NCT01606748|158230667|FG001|Overall Study|Adverse Event|0|||
49108043|NCT01606748|158230666|FG000|Overall Study|Progressive Disease|1|||
49108044|NCT01606748|158230667|FG001|Overall Study|Progressive Disease|0|||
49108045|NCT01606748|158230666|FG000|Overall Study|Withdrawal by Subject|1|||
49108046|NCT01606748|158230667|FG001|Overall Study|Withdrawal by Subject|0|||
49108047|NCT02539134|158230672|FG000|Overall Study|Lost to Follow-up|1|||
49108048|NCT02539134|158230673|FG001|Overall Study|Lost to Follow-up|0|||
49108049|NCT02539134|158230674|FG002|Overall Study|Lost to Follow-up|0|||
49108050|NCT02539134|158230675|FG003|Overall Study|Lost to Follow-up|0|||
49108051|NCT02539134|158230676|FG004|Overall Study|Lost to Follow-up|0|||
49108052|NCT02539134|158230677|FG005|Overall Study|Lost to Follow-up|0|||
49108053|NCT00394771|158230678|FG000|Overall Study|Did not meet protocol requirements|1|||
49108054|NCT00394771|158230679|FG001|Overall Study|Did not meet protocol requirements|0|||
49108055|NCT00394771|158230680|FG002|Overall Study|Did not meet protocol requirements|2|||
49108056|NCT00394771|158230681|FG003|Overall Study|Did not meet protocol requirements|0|||
49108057|NCT00394771|158230678|FG000|Overall Study|Protocol Violation|2|||
49108058|NCT00394771|158230679|FG001|Overall Study|Protocol Violation|4|||
49108059|NCT00394771|158230680|FG002|Overall Study|Protocol Violation|9|||
49108060|NCT00394771|158230681|FG003|Overall Study|Protocol Violation|7|||
49108061|NCT00394771|158230678|FG000|Overall Study|Withdrawal by Subject|10|||
49108062|NCT00394771|158230679|FG001|Overall Study|Withdrawal by Subject|6|||
49108063|NCT00394771|158230680|FG002|Overall Study|Withdrawal by Subject|8|||
49108064|NCT00394771|158230681|FG003|Overall Study|Withdrawal by Subject|12|||
49108065|NCT00394771|158230678|FG000|Overall Study|Adverse Event|10|||
49108066|NCT00394771|158230679|FG001|Overall Study|Adverse Event|5|||
49108067|NCT00394771|158230680|FG002|Overall Study|Adverse Event|12|||
49108068|NCT00394771|158230681|FG003|Overall Study|Adverse Event|8|||
49108069|NCT00394771|158230678|FG000|Overall Study|Participant pregnant|0|||
49108070|NCT00394771|158230679|FG001|Overall Study|Participant pregnant|1|||
49108071|NCT00394771|158230680|FG002|Overall Study|Participant pregnant|2|||
49108072|NCT00394771|158230681|FG003|Overall Study|Participant pregnant|2|||
49108073|NCT00394771|158230678|FG000|Overall Study|Lost to Follow-up|15|||
49108074|NCT00394771|158230679|FG001|Overall Study|Lost to Follow-up|15|||
49108075|NCT00394771|158230680|FG002|Overall Study|Lost to Follow-up|13|||
49108076|NCT00394771|158230681|FG003|Overall Study|Lost to Follow-up|10|||
49108077|NCT00394771|158230678|FG000|Overall Study|Other|3|||
49108078|NCT00394771|158230679|FG001|Overall Study|Other|3|||
49108079|NCT00394771|158230680|FG002|Overall Study|Other|1|||
49108080|NCT00394771|158230681|FG003|Overall Study|Other|0|||
49108081|NCT01926197|158230682|FG000|Overall Study|Withdrawn to receive chemotherapy|1|||
49108082|NCT01926197|158230683|FG001|Overall Study|Withdrawn to receive chemotherapy|0|||
49108083|NCT01926197|158230682|FG000|Overall Study|Withdrawn due to non-coverage by insurance|0|||
49108084|NCT01926197|158230683|FG001|Overall Study|Withdrawn due to non-coverage by insurance|1|||
49108085|NCT02515994|158230684|FG000|Overall Study|Protocol Violation|3|||
49108086|NCT02515994|158230685|FG001|Overall Study|Protocol Violation|5|||
49108087|NCT02515994|158230684|FG000|Overall Study|No Longer Meets Eligibility Criteria|2|||
49108088|NCT02515994|158230685|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
49108089|NCT02515994|158230684|FG000|Overall Study|Adverse Event|3|||
49108090|NCT02515994|158230685|FG001|Overall Study|Adverse Event|1|||
49108091|NCT02515994|158230684|FG000|Overall Study|Withdrawal by Subject|2|||
49108092|NCT02515994|158230685|FG001|Overall Study|Withdrawal by Subject|0|||
49108093|NCT01124292|158230688|FG000|Overall Study|Lost to Follow-up|2|||
49108094|NCT01124292|158230689|FG001|Overall Study|Lost to Follow-up|4|||
49108095|NCT01124292|158230690|FG002|Overall Study|Lost to Follow-up|3|||
49108096|NCT01124292|158230688|FG000|Overall Study|Physician Decision|0|||
49108097|NCT01124292|158230689|FG001|Overall Study|Physician Decision|3|||
49108098|NCT01124292|158230690|FG002|Overall Study|Physician Decision|2|||
49108099|NCT01124292|158230688|FG000|Overall Study|Withdrawal by Subject|0|||
49108100|NCT01124292|158230689|FG001|Overall Study|Withdrawal by Subject|6|||
49108101|NCT01124292|158230690|FG002|Overall Study|Withdrawal by Subject|2|||
49108102|NCT01124292|158230688|FG000|Overall Study|medical issue unrelated to the study|0|||
49108103|NCT01124292|158230689|FG001|Overall Study|medical issue unrelated to the study|0|||
49108104|NCT01124292|158230690|FG002|Overall Study|medical issue unrelated to the study|2|||
49108105|NCT01124292|158230688|FG000|Overall Study|piercing track closed|0|||
49108106|NCT01124292|158230689|FG001|Overall Study|piercing track closed|2|||
49108107|NCT01124292|158230690|FG002|Overall Study|piercing track closed|1|||
49108108|NCT00603382|158230691|FG000|Overall Study|Adverse Event|0|||
49108109|NCT00603382|158230692|FG001|Overall Study|Adverse Event|1|||
49108110|NCT00603382|158230693|FG002|Overall Study|Adverse Event|1|||
49108111|NCT00603382|158230694|FG003|Overall Study|Adverse Event|2|||
49108112|NCT00603382|158230695|FG004|Overall Study|Adverse Event|1|||
49108113|NCT00603382|158230696|FG005|Overall Study|Adverse Event|2|||
49108114|NCT00603382|158230691|FG000|Overall Study|Lack of Efficacy|14|||
49108115|NCT00603382|158230692|FG001|Overall Study|Lack of Efficacy|9|||
49108116|NCT00603382|158230693|FG002|Overall Study|Lack of Efficacy|3|||
49108117|NCT00603382|158230694|FG003|Overall Study|Lack of Efficacy|6|||
49108118|NCT00603382|158230695|FG004|Overall Study|Lack of Efficacy|6|||
49108119|NCT00603382|158230696|FG005|Overall Study|Lack of Efficacy|11|||
49108120|NCT00603382|158230691|FG000|Overall Study|Protocol Violation|1|||
49108121|NCT00603382|158230692|FG001|Overall Study|Protocol Violation|0|||
49108122|NCT00603382|158230693|FG002|Overall Study|Protocol Violation|1|||
49108123|NCT00603382|158230694|FG003|Overall Study|Protocol Violation|2|||
49108124|NCT00603382|158230695|FG004|Overall Study|Protocol Violation|1|||
49108125|NCT00603382|158230696|FG005|Overall Study|Protocol Violation|0|||
49108126|NCT00603382|158230691|FG000|Overall Study|Lost to Follow-up|0|||
49108127|NCT00603382|158230692|FG001|Overall Study|Lost to Follow-up|1|||
49108128|NCT00603382|158230693|FG002|Overall Study|Lost to Follow-up|1|||
49108129|NCT00603382|158230694|FG003|Overall Study|Lost to Follow-up|1|||
49108130|NCT00603382|158230695|FG004|Overall Study|Lost to Follow-up|0|||
49108131|NCT00603382|158230696|FG005|Overall Study|Lost to Follow-up|1|||
49108132|NCT00603382|158230691|FG000|Overall Study|Physician Decision|0|||
49108133|NCT00603382|158230692|FG001|Overall Study|Physician Decision|0|||
49108134|NCT00603382|158230693|FG002|Overall Study|Physician Decision|2|||
49108135|NCT00603382|158230694|FG003|Overall Study|Physician Decision|0|||
49108136|NCT00603382|158230695|FG004|Overall Study|Physician Decision|1|||
49108137|NCT00603382|158230696|FG005|Overall Study|Physician Decision|3|||
49108138|NCT00603382|158230691|FG000|Overall Study|Withdrawal by Subject|3|||
49108139|NCT00603382|158230692|FG001|Overall Study|Withdrawal by Subject|3|||
49108140|NCT00603382|158230693|FG002|Overall Study|Withdrawal by Subject|1|||
49108141|NCT00603382|158230694|FG003|Overall Study|Withdrawal by Subject|1|||
49108142|NCT00603382|158230695|FG004|Overall Study|Withdrawal by Subject|0|||
49108143|NCT00603382|158230696|FG005|Overall Study|Withdrawal by Subject|1|||
49108144|NCT03782974|158230697|FG000|Overall Study|Withdrawal by Subject|7|||
49108145|NCT03782974|158230698|FG001|Overall Study|Withdrawal by Subject|7|||
49108146|NCT03782974|158230697|FG000|Overall Study|Pregnancy|1|||
49108147|NCT03782974|158230698|FG001|Overall Study|Pregnancy|0|||
49108148|NCT03403621|158230699|FG000|Overall Study|Withdrawal by Subject|2|||
49108149|NCT03403621|158230700|FG001|Overall Study|Withdrawal by Subject|2|||
49108150|NCT00583102|158230701|FG000|Overall Study|Adverse Event|3|||
49108151|NCT00395642|158230707|FG000|Overall Study|Death|4|||
49108152|NCT00395642|158230707|FG000|Overall Study|Lost to Follow-up|1|||
49108153|NCT00395642|158230707|FG000|Overall Study|Physician Decision|7|||
49108154|NCT00395642|158230707|FG000|Overall Study|Withdrawal by Subject|1|||
49108155|NCT00505661|158230708|FG000|Overall Study|Not Eligible|4|||
49108156|NCT02921750|158232273|FG000|Overall Study|Adverse Event|1|||
49108157|NCT02921750|158232274|FG001|Overall Study|Adverse Event|2|||
49108158|NCT02921750|158232273|FG000|Overall Study|Withdrawal by Subject|1|||
49108159|NCT02921750|158232274|FG001|Overall Study|Withdrawal by Subject|1|||
49108160|NCT02921750|158232273|FG000|Overall Study|Lost to Follow-up|3|||
49108161|NCT02921750|158232274|FG001|Overall Study|Lost to Follow-up|3|||
49108162|NCT02921750|158232273|FG000|Overall Study|Wound healed|3|||
49108163|NCT02921750|158232274|FG001|Overall Study|Wound healed|3|||
49108164|NCT02921750|158232273|FG000|Overall Study|Serious Adverse Event|1|||
49108165|NCT02921750|158232274|FG001|Overall Study|Serious Adverse Event|2|||
49108166|NCT00114738|158232276|FG000|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1|||
49108167|NCT00114738|158232277|FG001|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
49108168|NCT00114738|158232278|FG002|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
49108169|NCT00114738|158232276|FG000|Bortezomib Then Bortezomib + Induction|Progressive Disease|1|||
49108170|NCT00114738|158232277|FG001|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
49108171|NCT00114738|158232278|FG002|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
49108172|NCT00114738|158232276|FG000|Screening for Randomization|Neuropathy|17|||
49108173|NCT00114738|158232277|FG001|Screening for Randomization|Neuropathy|0|||
49108174|NCT00114738|158232278|FG002|Screening for Randomization|Neuropathy|0|||
49108175|NCT00114738|158232276|FG000|Screening for Randomization|Progressive disease|2|||
49108176|NCT00114738|158232277|FG001|Screening for Randomization|Progressive disease|0|||
49108177|NCT00114738|158232278|FG002|Screening for Randomization|Progressive disease|0|||
49108178|NCT00114738|158232276|FG000|Screening for Randomization|CNS Hemorrhage|1|||
49108179|NCT00114738|158232277|FG001|Screening for Randomization|CNS Hemorrhage|0|||
49108180|NCT00114738|158232278|FG002|Screening for Randomization|CNS Hemorrhage|0|||
49108181|NCT00114738|158232276|FG000|Screening for Randomization|Other|1|||
49108182|NCT00114738|158232277|FG001|Screening for Randomization|Other|0|||
49108183|NCT00114738|158232278|FG002|Screening for Randomization|Other|0|||
49108184|NCT00552032|158232279|FG000|Overall Study|Withdrawal by Subject|2|||
49108185|NCT00552032|158232280|FG001|Overall Study|Withdrawal by Subject|2|||
49108186|NCT00552032|158232279|FG000|Overall Study|Protocol Violation|7|||
49108187|NCT00552032|158232280|FG001|Overall Study|Protocol Violation|12|||
49108188|NCT00552032|158232279|FG000|Overall Study|Lost to Follow-up|8|||
49108189|NCT00552032|158232280|FG001|Overall Study|Lost to Follow-up|5|||
49108190|NCT00345878|158232281|FG000|Overall Study|Adverse Event|1|||
49108191|NCT00345878|158232282|FG001|Overall Study|Adverse Event|0|||
49108192|NCT00345878|158232281|FG000|Overall Study|Lost to Follow-up|2|||
49108193|NCT00345878|158232282|FG001|Overall Study|Lost to Follow-up|1|||
49108194|NCT00345878|158232281|FG000|Overall Study|Other|1|||
49108195|NCT00345878|158232282|FG001|Overall Study|Other|0|||
49108196|NCT03391232|158232283|FG000|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|0|||
49108197|NCT03391232|158232284|FG001|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|1|||
49108198|NCT03391232|158232283|FG000|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|0|||
49108199|NCT03391232|158232284|FG001|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|2|||
49108200|NCT03422159|158232287|FG000|Overall Study|Exclusion due to terminal disease|2|||
49108201|NCT03422159|158232288|FG001|Overall Study|Exclusion due to terminal disease|1|||
49108202|NCT00862459|158232289|FG000|Overall Study|Lost to Follow-up|1|||
49108203|NCT00862459|158232290|FG001|Overall Study|Lost to Follow-up|2|||
49108204|NCT00862459|158232291|FG002|Overall Study|Lost to Follow-up|2|||
49108205|NCT00862459|158232289|FG000|Overall Study|Protocol Violation|1|||
49108206|NCT00862459|158232290|FG001|Overall Study|Protocol Violation|0|||
49108207|NCT00862459|158232291|FG002|Overall Study|Protocol Violation|0|||
49108208|NCT00862459|158232289|FG000|Overall Study|Withdrawal by Subject|1|||
49108209|NCT00862459|158232290|FG001|Overall Study|Withdrawal by Subject|1|||
49108210|NCT00862459|158232291|FG002|Overall Study|Withdrawal by Subject|3|||
49108211|NCT00862459|158232289|FG000|Overall Study|Adverse Event|0|||
49108212|NCT00862459|158232290|FG001|Overall Study|Adverse Event|1|||
49108213|NCT00862459|158232291|FG002|Overall Study|Adverse Event|0|||
49108214|NCT00862459|158232289|FG000|Overall Study|Personal reasons|1|||
49108215|NCT00862459|158232290|FG001|Overall Study|Personal reasons|0|||
49108216|NCT00862459|158232291|FG002|Overall Study|Personal reasons|0|||
49108217|NCT00862459|158232289|FG000|Overall Study|Operation|1|||
49108218|NCT00862459|158232290|FG001|Overall Study|Operation|1|||
49108219|NCT00862459|158232291|FG002|Overall Study|Operation|0|||
49108220|NCT00862459|158232289|FG000|Overall Study|Intravenous (IV) site problems|1|||
49108221|NCT00862459|158232290|FG001|Overall Study|Intravenous (IV) site problems|0|||
49108222|NCT00862459|158232291|FG002|Overall Study|Intravenous (IV) site problems|1|||
49108223|NCT00862459|158232289|FG000|Overall Study|Unable to hold still for imaging|0|||
49108224|NCT00862459|158232290|FG001|Overall Study|Unable to hold still for imaging|1|||
49108225|NCT00862459|158232291|FG002|Overall Study|Unable to hold still for imaging|0|||
49108226|NCT00862459|158232289|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
49108227|NCT00862459|158232290|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
49108228|NCT00862459|158232291|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
49108229|NCT00862459|158232289|FG000|Overall Study|Administrative problems|0|||
49108230|NCT00862459|158232290|FG001|Overall Study|Administrative problems|1|||
49108231|NCT00862459|158232291|FG002|Overall Study|Administrative problems|0|||
49108232|NCT03436199|158232292|FG000|Overall Study|Adverse Event|15|||
49108233|NCT03436199|158232293|FG001|Overall Study|Adverse Event|40|||
49108234|NCT03436199|158232294|FG002|Overall Study|Adverse Event|7|||
49108235|NCT03436199|158232292|FG000|Overall Study|Withdrawal by Subject|4|||
49108236|NCT03436199|158232293|FG001|Overall Study|Withdrawal by Subject|10|||
49108237|NCT03436199|158232294|FG002|Overall Study|Withdrawal by Subject|3|||
49108238|NCT03436199|158232292|FG000|Overall Study|Lost to Follow-up|1|||
49108239|NCT03436199|158232293|FG001|Overall Study|Lost to Follow-up|0|||
49108240|NCT03436199|158232294|FG002|Overall Study|Lost to Follow-up|2|||
49108241|NCT03436199|158232292|FG000|Overall Study|Protocol Violation|1|||
49108242|NCT03436199|158232293|FG001|Overall Study|Protocol Violation|1|||
49108243|NCT03436199|158232294|FG002|Overall Study|Protocol Violation|0|||
49108244|NCT03436199|158232292|FG000|Overall Study|Physician Decision|0|||
49108245|NCT03436199|158232293|FG001|Overall Study|Physician Decision|1|||
49108246|NCT03436199|158232294|FG002|Overall Study|Physician Decision|0|||
49108247|NCT03436199|158232292|FG000|Overall Study|Could not return to clinic|1|||
49108248|NCT03436199|158232293|FG001|Overall Study|Could not return to clinic|0|||
49108249|NCT03436199|158232294|FG002|Overall Study|Could not return to clinic|0|||
49108250|NCT03436199|158232292|FG000|Overall Study|Withdrawn per physician|0|||
49108251|NCT03436199|158232293|FG001|Overall Study|Withdrawn per physician|1|||
49108252|NCT03436199|158232294|FG002|Overall Study|Withdrawn per physician|0|||
49108253|NCT00717275|158232295|FG000|Overall Study|Premature study termination.|3|||
49108254|NCT01522235|158232305|FG000|Overall Study|Physician Decision|1|||
49108255|NCT01522235|158232306|FG001|Overall Study|Physician Decision|1|||
49108256|NCT00980018|158232307|FG000|Overall Study|Adverse Event|8|||
49108257|NCT00980018|158232307|FG000|Overall Study|Patient withdrew consent|3|||
49108258|NCT00980018|158232307|FG000|Overall Study|Lost to Follow-up|1|||
49108259|NCT00987402|158232308|FG000|Overall Study|Insufficient data entry|86|||
49108260|NCT00987402|158232309|FG001|Overall Study|Insufficient data entry|98|||
49108261|NCT01254721|158232310|FG000|Overall Study|Lost to Follow-up|0|||
49108262|NCT01254721|158232311|FG001|Overall Study|Lost to Follow-up|4|||
49108263|NCT01254721|158232310|FG000|Overall Study|Lack of Efficacy|4|||
49108264|NCT01254721|158232311|FG001|Overall Study|Lack of Efficacy|2|||
49108265|NCT01254721|158232310|FG000|Overall Study|Death|0|||
49108266|NCT01254721|158232311|FG001|Overall Study|Death|1|||
49108267|NCT01254721|158232310|FG000|Overall Study|technical problum|1|||
49108268|NCT01254721|158232311|FG001|Overall Study|technical problum|0|||
49108269|NCT01254721|158232310|FG000|Overall Study|Adverse Event|2|||
49108270|NCT01254721|158232311|FG001|Overall Study|Adverse Event|3|||
49108271|NCT01254721|158232310|FG000|Overall Study|Withdrawal by Subject|8|||
49108272|NCT01254721|158232311|FG001|Overall Study|Withdrawal by Subject|11|||
49108273|NCT01254721|158232310|FG000|Overall Study|Wrongly randomization|0|||
49108274|NCT01254721|158232311|FG001|Overall Study|Wrongly randomization|1|||
49108275|NCT00424021|158232312|FG000|NCT00046319 Study Period|Adverse Event|1|||
49108276|NCT00424021|158232313|FG001|NCT00046319 Study Period|Adverse Event|0|||
49108277|NCT00424021|158232314|FG002|NCT00046319 Study Period|Adverse Event|1|||
49108278|NCT00424021|158232315|FG003|NCT00046319 Study Period|Adverse Event|1|||
49108279|NCT00424021|158232312|FG000|NCT00046319 Study Period|Withdrawal by Subject|0|||
49108280|NCT00424021|158232313|FG001|NCT00046319 Study Period|Withdrawal by Subject|1|||
49108281|NCT00424021|158232314|FG002|NCT00046319 Study Period|Withdrawal by Subject|0|||
49108282|NCT00424021|158232315|FG003|NCT00046319 Study Period|Withdrawal by Subject|0|||
49108283|NCT00424021|158232312|FG000|NCT00046319 Study Period|Sponsor discretion|0|||
49108284|NCT00424021|158232313|FG001|NCT00046319 Study Period|Sponsor discretion|1|||
49108285|NCT00424021|158232314|FG002|NCT00046319 Study Period|Sponsor discretion|0|||
49108286|NCT00424021|158232315|FG003|NCT00046319 Study Period|Sponsor discretion|0|||
49108287|NCT00424021|158232312|FG000|NCT00046319 Study Period|Lost to Follow-up|0|||
49108288|NCT00424021|158232313|FG001|NCT00046319 Study Period|Lost to Follow-up|1|||
49108289|NCT00424021|158232314|FG002|NCT00046319 Study Period|Lost to Follow-up|0|||
49108290|NCT00424021|158232315|FG003|NCT00046319 Study Period|Lost to Follow-up|0|||
49108291|NCT00424021|158232312|FG000|AMB-220-E Study Period|Adverse Event|1|||
49108292|NCT00424021|158232313|FG001|AMB-220-E Study Period|Adverse Event|1|||
49108293|NCT00424021|158232314|FG002|AMB-220-E Study Period|Adverse Event|3|||
49108294|NCT00424021|158232315|FG003|AMB-220-E Study Period|Adverse Event|7|||
49108295|NCT00424021|158232312|FG000|AMB-220-E Study Period|Death|0|||
49108296|NCT00424021|158232313|FG001|AMB-220-E Study Period|Death|0|||
49108297|NCT00424021|158232314|FG002|AMB-220-E Study Period|Death|1|||
49108298|NCT00424021|158232315|FG003|AMB-220-E Study Period|Death|1|||
49108299|NCT00424021|158232312|FG000|AMB-220-E Study Period|Lost to Follow-up|0|||
49108300|NCT00424021|158232313|FG001|AMB-220-E Study Period|Lost to Follow-up|1|||
49108301|NCT00424021|158232314|FG002|AMB-220-E Study Period|Lost to Follow-up|1|||
49108302|NCT00424021|158232315|FG003|AMB-220-E Study Period|Lost to Follow-up|1|||
49108303|NCT00424021|158232312|FG000|AMB-220-E Study Period|Physician Decision|0|||
49108304|NCT00424021|158232313|FG001|AMB-220-E Study Period|Physician Decision|0|||
49108305|NCT00424021|158232314|FG002|AMB-220-E Study Period|Physician Decision|0|||
49108306|NCT00424021|158232315|FG003|AMB-220-E Study Period|Physician Decision|1|||
49108307|NCT01955109|158232316|FG000|Overall Study|Adverse Event|2|||
49108308|NCT01955109|158232317|FG001|Overall Study|Adverse Event|0|||
49108309|NCT01955109|158232316|FG000|Overall Study|Participant unwilling to continue|35|||
49108310|NCT01955109|158232317|FG001|Overall Study|Participant unwilling to continue|7|||
49108311|NCT01955109|158232316|FG000|Overall Study|Physician Decision|2|||
49108312|NCT01955109|158232317|FG001|Overall Study|Physician Decision|0|||
49108313|NCT01955109|158232316|FG000|Overall Study|Lost to Follow-up|3|||
49108314|NCT01955109|158232317|FG001|Overall Study|Lost to Follow-up|1|||
49108315|NCT01955109|158232316|FG000|Overall Study|Non-compliance|3|||
49108316|NCT01955109|158232317|FG001|Overall Study|Non-compliance|1|||
49108317|NCT03769194|158232318|FG000|Overall Study|Withdrawal by Subject|0|||
49108318|NCT03769194|158232319|FG001|Overall Study|Withdrawal by Subject|7|||
49108319|NCT03769194|158232320|FG002|Overall Study|Withdrawal by Subject|4|||
49108320|NCT03769194|158232321|FG003|Overall Study|Withdrawal by Subject|1|||
49108321|NCT03769194|158232318|FG000|Overall Study|moved from study area|0|||
49108322|NCT03769194|158232319|FG001|Overall Study|moved from study area|2|||
49108323|NCT03769194|158232320|FG002|Overall Study|moved from study area|1|||
49108324|NCT03769194|158232321|FG003|Overall Study|moved from study area|1|||
49108325|NCT03769194|158232318|FG000|Overall Study|Lost to Follow-up|3|||
49108326|NCT03769194|158232319|FG001|Overall Study|Lost to Follow-up|6|||
49108327|NCT03769194|158232320|FG002|Overall Study|Lost to Follow-up|3|||
49108328|NCT03769194|158232321|FG003|Overall Study|Lost to Follow-up|6|||
49108329|NCT03769194|158232318|FG000|Overall Study|other|1|||
49108330|NCT03769194|158232319|FG001|Overall Study|other|3|||
49108331|NCT03769194|158232320|FG002|Overall Study|other|0|||
49108332|NCT03769194|158232321|FG003|Overall Study|other|1|||
49108333|NCT03000530|158232322|FG000|Overall Study|Adverse Event|0|||
49108334|NCT03000530|158232323|FG001|Overall Study|Adverse Event|0|||
49108335|NCT03000530|158232324|FG002|Overall Study|Adverse Event|2|||
49108336|NCT03000530|158232322|FG000|Overall Study|Lost to Follow-up|0|||
49108337|NCT03000530|158232323|FG001|Overall Study|Lost to Follow-up|3|||
49108338|NCT03000530|158232324|FG002|Overall Study|Lost to Follow-up|1|||
49108339|NCT03000530|158232322|FG000|Overall Study|Withdrawal by Subject|0|||
49108340|NCT03000530|158232323|FG001|Overall Study|Withdrawal by Subject|2|||
49108341|NCT03000530|158232324|FG002|Overall Study|Withdrawal by Subject|1|||
49108342|NCT00106639|158232328|FG000|Overall Study|Adverse Event|3|||
49108343|NCT00106639|158232329|FG001|Overall Study|Adverse Event|4|||
49108344|NCT00106639|158232330|FG002|Overall Study|Adverse Event|1|||
49108345|NCT00106639|158232328|FG000|Overall Study|Protocol Violation|0|||
49108346|NCT00106639|158232329|FG001|Overall Study|Protocol Violation|1|||
49108347|NCT00106639|158232330|FG002|Overall Study|Protocol Violation|0|||
49108348|NCT00106639|158232328|FG000|Overall Study|Withdrawal by Subject|0|||
49108349|NCT00106639|158232329|FG001|Overall Study|Withdrawal by Subject|1|||
49108350|NCT00106639|158232330|FG002|Overall Study|Withdrawal by Subject|0|||
49108351|NCT00106639|158232328|FG000|Overall Study|Participant defaulted|0|||
49108352|NCT00106639|158232329|FG001|Overall Study|Participant defaulted|1|||
49108353|NCT00106639|158232330|FG002|Overall Study|Participant defaulted|1|||
49108354|NCT00904839|158232331|FG000|Overall Study|Adverse Event|0|||
49108355|NCT00904839|158232332|FG001|Overall Study|Adverse Event|5|||
49108356|NCT00904839|158232333|FG002|Overall Study|Adverse Event|4|||
49108357|NCT00904839|158232331|FG000|Overall Study|Protocol Violation|0|||
49108358|NCT00904839|158232332|FG001|Overall Study|Protocol Violation|1|||
49108359|NCT00904839|158232333|FG002|Overall Study|Protocol Violation|1|||
49108360|NCT00904839|158232331|FG000|Overall Study|Lost to Follow-up|0|||
49108361|NCT00904839|158232332|FG001|Overall Study|Lost to Follow-up|1|||
49108362|NCT00904839|158232333|FG002|Overall Study|Lost to Follow-up|2|||
49108363|NCT00904839|158232331|FG000|Overall Study|Withdrawal by Subject|0|||
49108364|NCT00904839|158232332|FG001|Overall Study|Withdrawal by Subject|2|||
49108365|NCT00904839|158232333|FG002|Overall Study|Withdrawal by Subject|0|||
49108366|NCT00904839|158232331|FG000|Overall Study|Not treated|1|||
49108367|NCT00904839|158232332|FG001|Overall Study|Not treated|0|||
49108368|NCT00904839|158232333|FG002|Overall Study|Not treated|1|||
49108369|NCT00904839|158232331|FG000|Overall Study|Other than above|0|||
49108370|NCT00904839|158232332|FG001|Overall Study|Other than above|9|||
49108371|NCT00904839|158232333|FG002|Overall Study|Other than above|7|||
49108372|NCT01430624|158232334|FG000|Overall Study|Lost to Follow-up|23|||
49108373|NCT01430624|158232335|FG001|Overall Study|Lost to Follow-up|29|||
49108374|NCT01430624|158232336|FG002|Overall Study|Lost to Follow-up|27|||
49108375|NCT01430624|158232334|FG000|Overall Study|technical or eligibility|5|||
49108376|NCT01430624|158232335|FG001|Overall Study|technical or eligibility|5|||
49108377|NCT01430624|158232336|FG002|Overall Study|technical or eligibility|2|||
49108378|NCT02614131|158232339|FG000|Overall Study|Withdrawal by Subject|1|||
49108379|NCT02614131|158232340|FG001|Overall Study|Withdrawal by Subject|0|||
49108380|NCT02614131|158232341|FG002|Overall Study|Withdrawal by Subject|0|||
49108381|NCT02614131|158232342|FG003|Overall Study|Withdrawal by Subject|0|||
49108382|NCT02614131|158232343|FG004|Overall Study|Withdrawal by Subject|0|||
49108383|NCT02614131|158232344|FG005|Overall Study|Withdrawal by Subject|0|||
49108384|NCT02614131|158232345|FG006|Overall Study|Withdrawal by Subject|0|||
49108385|NCT02614131|158232339|FG000|Overall Study|Adverse Event|0|||
49108386|NCT02614131|158232340|FG001|Overall Study|Adverse Event|0|||
49108387|NCT02614131|158232341|FG002|Overall Study|Adverse Event|0|||
49108388|NCT02614131|158232342|FG003|Overall Study|Adverse Event|0|||
49108389|NCT02614131|158232343|FG004|Overall Study|Adverse Event|0|||
49108390|NCT02614131|158232344|FG005|Overall Study|Adverse Event|0|||
49108391|NCT02614131|158232345|FG006|Overall Study|Adverse Event|1|||
49108392|NCT00087126|158232346|FG000|Overall Study|Ineligible - second primary|1|||
49108393|NCT00087126|158232346|FG000|Overall Study|Never treated|1|||
49108394|NCT03209518|158232347|FG000|Overall Study|Case Report Forms Uncollected|1|||
49108395|NCT03209518|158232347|FG000|Overall Study|Protocol Deviation|1|||
49108396|NCT01832818|158232348|FG000|Overall Study|Lost to Follow-up|6|||
49108397|NCT00236899|158232354|FG000|Overall Study|Adverse Event (Study Related)|1|||
49108398|NCT00236899|158232355|FG001|Overall Study|Adverse Event (Study Related)|1|||
49108399|NCT00236899|158232356|FG002|Overall Study|Adverse Event (Study Related)|2|||
49108400|NCT00236899|158232357|FG003|Overall Study|Adverse Event (Study Related)|1|||
49108401|NCT00236899|158232354|FG000|Overall Study|Adverse Event (Not Study Related)|3|||
49108402|NCT00236899|158232355|FG001|Overall Study|Adverse Event (Not Study Related)|3|||
49108403|NCT00236899|158232356|FG002|Overall Study|Adverse Event (Not Study Related)|4|||
49108404|NCT00236899|158232357|FG003|Overall Study|Adverse Event (Not Study Related)|7|||
49108405|NCT00236899|158232354|FG000|Overall Study|Death (Study Disease)|1|||
49108406|NCT00236899|158232355|FG001|Overall Study|Death (Study Disease)|4|||
49108407|NCT00236899|158232356|FG002|Overall Study|Death (Study Disease)|0|||
49108408|NCT00236899|158232357|FG003|Overall Study|Death (Study Disease)|0|||
49108409|NCT00236899|158232354|FG000|Overall Study|Death (Not Study Related)|2|||
49108410|NCT00236899|158232355|FG001|Overall Study|Death (Not Study Related)|0|||
49108411|NCT00236899|158232356|FG002|Overall Study|Death (Not Study Related)|0|||
49108412|NCT00236899|158232357|FG003|Overall Study|Death (Not Study Related)|0|||
49108413|NCT00236899|158232354|FG000|Overall Study|Death (Study Drug Toxicity)|1|||
49108414|NCT00236899|158232355|FG001|Overall Study|Death (Study Drug Toxicity)|0|||
49108415|NCT00236899|158232356|FG002|Overall Study|Death (Study Drug Toxicity)|0|||
49108416|NCT00236899|158232357|FG003|Overall Study|Death (Study Drug Toxicity)|0|||
49108417|NCT00236899|158232354|FG000|Overall Study|Lost to Follow-up|0|||
49108418|NCT00236899|158232355|FG001|Overall Study|Lost to Follow-up|1|||
49108419|NCT00236899|158232356|FG002|Overall Study|Lost to Follow-up|0|||
49108420|NCT00236899|158232357|FG003|Overall Study|Lost to Follow-up|0|||
49108421|NCT00236899|158232354|FG000|Overall Study|Entry Criteria Exclusion|0|||
49108422|NCT00236899|158232355|FG001|Overall Study|Entry Criteria Exclusion|1|||
49108423|NCT00236899|158232356|FG002|Overall Study|Entry Criteria Exclusion|1|||
49108424|NCT00236899|158232357|FG003|Overall Study|Entry Criteria Exclusion|0|||
49108425|NCT00236899|158232354|FG000|Overall Study|Protocol Violation|1|||
49108426|NCT00236899|158232355|FG001|Overall Study|Protocol Violation|0|||
49108427|NCT00236899|158232356|FG002|Overall Study|Protocol Violation|0|||
49108428|NCT00236899|158232357|FG003|Overall Study|Protocol Violation|0|||
49108429|NCT00236899|158232354|FG000|Overall Study|Withdrawal by Subject|6|||
49108430|NCT00236899|158232355|FG001|Overall Study|Withdrawal by Subject|4|||
49108431|NCT00236899|158232356|FG002|Overall Study|Withdrawal by Subject|5|||
49108432|NCT00236899|158232357|FG003|Overall Study|Withdrawal by Subject|2|||
49108433|NCT00236899|158232354|FG000|Overall Study|Physician Decision|7|||
49108434|NCT00236899|158232355|FG001|Overall Study|Physician Decision|8|||
49108435|NCT00236899|158232356|FG002|Overall Study|Physician Decision|7|||
49108436|NCT00236899|158232357|FG003|Overall Study|Physician Decision|6|||
49108437|NCT00236899|158232354|FG000|Overall Study|Satisfactory Response|2|||
49108438|NCT00236899|158232355|FG001|Overall Study|Satisfactory Response|0|||
49108439|NCT00236899|158232356|FG002|Overall Study|Satisfactory Response|0|||
49108440|NCT00236899|158232357|FG003|Overall Study|Satisfactory Response|1|||
49108441|NCT00236899|158232354|FG000|Overall Study|Lack of Efficacy|18|||
49108442|NCT00236899|158232355|FG001|Overall Study|Lack of Efficacy|18|||
49108443|NCT00236899|158232356|FG002|Overall Study|Lack of Efficacy|25|||
49108444|NCT00236899|158232357|FG003|Overall Study|Lack of Efficacy|23|||
49108445|NCT01717391|158232358|FG000|Overall Study|Withdrawal by Subject|5|||
49108446|NCT01717391|158232358|FG000|Overall Study|Physician Decision|1|||
49108447|NCT01717391|158232358|FG000|Overall Study|FLT technical failure|3|||
49108448|NCT01785849|158232361|FG000|Overall Study|Death|7|||
49108449|NCT01785849|158232362|FG001|Overall Study|Death|9|||
49108450|NCT01785849|158232361|FG000|Overall Study|Protocol Specified Criteria|29|||
49108451|NCT01785849|158232362|FG001|Overall Study|Protocol Specified Criteria|1|||
49108452|NCT01785849|158232361|FG000|Overall Study|Withdrawal by Subject|15|||
49108453|NCT01785849|158232362|FG001|Overall Study|Withdrawal by Subject|12|||
49108454|NCT01785849|158232361|FG000|Overall Study|Sponsor Decision|0|||
49108455|NCT01785849|158232362|FG001|Overall Study|Sponsor Decision|1|||
49108456|NCT01785849|158232361|FG000|Overall Study|Lost to Follow-up|10|||
49108457|NCT01785849|158232362|FG001|Overall Study|Lost to Follow-up|11|||
49108458|NCT03244618|158232367|FG000|Overall Study|Lost to Follow-up|3|||
49108459|NCT03244618|158232368|FG001|Overall Study|Lost to Follow-up|4|||
49108460|NCT03244618|158232367|FG000|Overall Study|Protocol Violation|4|||
49108461|NCT03244618|158232368|FG001|Overall Study|Protocol Violation|3|||
49108462|NCT03244618|158232367|FG000|Overall Study|Withdrawal by Subject|0|||
49108463|NCT03244618|158232368|FG001|Overall Study|Withdrawal by Subject|2|||
49108464|NCT01451164|158232369|FG000|Overall Study|Adverse Event|19|||
49108465|NCT01451164|158232370|FG001|Overall Study|Adverse Event|12|||
49108466|NCT01451164|158232371|FG002|Overall Study|Adverse Event|18|||
49108467|NCT01451164|158232372|FG003|Overall Study|Adverse Event|21|||
49108468|NCT01451164|158232369|FG000|Overall Study|Withdrawal Criteria|1|||
49108469|NCT01451164|158232370|FG001|Overall Study|Withdrawal Criteria|1|||
49108470|NCT01451164|158232371|FG002|Overall Study|Withdrawal Criteria|1|||
49108471|NCT01451164|158232372|FG003|Overall Study|Withdrawal Criteria|1|||
49108472|NCT01451164|158232369|FG000|Overall Study|Physician Decision|2|||
49108473|NCT01451164|158232370|FG001|Overall Study|Physician Decision|0|||
49108474|NCT01451164|158232371|FG002|Overall Study|Physician Decision|1|||
49108475|NCT01451164|158232372|FG003|Overall Study|Physician Decision|0|||
49108476|NCT01451164|158232369|FG000|Overall Study|Withdrawal by Subject|14|||
49108477|NCT01451164|158232370|FG001|Overall Study|Withdrawal by Subject|11|||
49108478|NCT01451164|158232371|FG002|Overall Study|Withdrawal by Subject|16|||
49108479|NCT01451164|158232372|FG003|Overall Study|Withdrawal by Subject|17|||
49108480|NCT01451164|158232369|FG000|Overall Study|Protocol Violation|0|||
49108481|NCT01451164|158232370|FG001|Overall Study|Protocol Violation|1|||
49108482|NCT01451164|158232371|FG002|Overall Study|Protocol Violation|0|||
49108483|NCT01451164|158232372|FG003|Overall Study|Protocol Violation|0|||
49108484|NCT01451164|158232369|FG000|Overall Study|Lack of Efficacy|7|||
49108485|NCT01451164|158232370|FG001|Overall Study|Lack of Efficacy|9|||
49108486|NCT01451164|158232371|FG002|Overall Study|Lack of Efficacy|9|||
49108487|NCT01451164|158232372|FG003|Overall Study|Lack of Efficacy|7|||
49108488|NCT01952080|158232376|FG000|Overall Study|Withdrawal by Subject|0|||
49108489|NCT01952080|158232377|FG001|Overall Study|Withdrawal by Subject|0|||
49108490|NCT01952080|158232378|FG002|Overall Study|Withdrawal by Subject|0|||
49108491|NCT01952080|158232379|FG003|Overall Study|Withdrawal by Subject|1|||
49108492|NCT01952080|158232376|FG000|Overall Study|Protocol Non-compliance|0|||
49108493|NCT01952080|158232377|FG001|Overall Study|Protocol Non-compliance|1|||
49108494|NCT01952080|158232378|FG002|Overall Study|Protocol Non-compliance|0|||
49108495|NCT01952080|158232379|FG003|Overall Study|Protocol Non-compliance|0|||
49108496|NCT01900431|158232388|FG000|Principal Treatment Period (Part A)|Adverse Event|1|||
49108497|NCT01900431|158232389|FG001|Principal Treatment Period (Part A)|Adverse Event|3|||
49108498|NCT01900431|158232390|FG002|Principal Treatment Period (Part A)|Adverse Event|0|||
49108499|NCT01900431|158232388|FG000|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
49108500|NCT01900431|158232389|FG001|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
49108501|NCT01900431|158232390|FG002|Principal Treatment Period (Part A)|Lack of Efficacy|0|||
49108502|NCT01900431|158232388|FG000|Principal Treatment Period (Part A)|Other than specified above|0|||
49108503|NCT01900431|158232389|FG001|Principal Treatment Period (Part A)|Other than specified above|1|||
49108504|NCT01900431|158232390|FG002|Principal Treatment Period (Part A)|Other than specified above|0|||
49108505|NCT01900431|158232388|FG000|Extended Treatment Period (Part B)|Adverse Event|0|||
49108506|NCT01900431|158232389|FG001|Extended Treatment Period (Part B)|Adverse Event|2|||
49108507|NCT01900431|158232390|FG002|Extended Treatment Period (Part B)|Adverse Event|0|||
49108508|NCT01900431|158232388|FG000|Extended Treatment Period (Part B)|Lack of Efficacy|1|||
49108509|NCT01900431|158232389|FG001|Extended Treatment Period (Part B)|Lack of Efficacy|7|||
49108510|NCT01900431|158232390|FG002|Extended Treatment Period (Part B)|Lack of Efficacy|0|||
49108511|NCT01900431|158232388|FG000|Extended Treatment Period (Part B)|Other than specified above|0|||
49108512|NCT01900431|158232389|FG001|Extended Treatment Period (Part B)|Other than specified above|1|||
49108513|NCT01900431|158232390|FG002|Extended Treatment Period (Part B)|Other than specified above|0|||
49108514|NCT01900431|158232388|FG000|Open-Label Treatment Period (Part C)|Adverse Event|0|||
49108515|NCT01900431|158232389|FG001|Open-Label Treatment Period (Part C)|Adverse Event|0|||
49108516|NCT01900431|158232390|FG002|Open-Label Treatment Period (Part C)|Adverse Event|2|||
49108517|NCT01900431|158232388|FG000|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
49108518|NCT01900431|158232389|FG001|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
49108519|NCT01900431|158232390|FG002|Open-Label Treatment Period (Part C)|Lack of Efficacy|3|||
49108520|NCT01900431|158232388|FG000|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
49108521|NCT01900431|158232389|FG001|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
49108522|NCT01900431|158232390|FG002|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3|||
49108523|NCT01841567|158232391|FG000|Overall Study|Adverse Event|3|||
49108524|NCT03172364|158232392|FG000|Overall Study|Adverse Event|1|||
49108525|NCT03172364|158232393|FG001|Overall Study|Adverse Event|1|||
49108526|NCT03172364|158232392|FG000|Overall Study|Protocol Violation|1|||
49108527|NCT03172364|158232393|FG001|Overall Study|Protocol Violation|0|||
49108528|NCT03611582|158232398|FG000|Overall Study|Adverse Event|26|||
49108529|NCT03611582|158232399|FG001|Overall Study|Adverse Event|6|||
49108530|NCT03611582|158232398|FG000|Overall Study|Protocol Violation|0|||
49108531|NCT03611582|158232399|FG001|Overall Study|Protocol Violation|1|||
49108532|NCT03611582|158232398|FG000|Overall Study|Pregnancy|1|||
49108533|NCT03611582|158232399|FG001|Overall Study|Pregnancy|2|||
49108534|NCT03611582|158232398|FG000|Overall Study|Lack of Efficacy|0|||
49108535|NCT03611582|158232399|FG001|Overall Study|Lack of Efficacy|1|||
49108536|NCT03611582|158232398|FG000|Overall Study|At the discretion of the investigator|1|||
49108537|NCT03611582|158232399|FG001|Overall Study|At the discretion of the investigator|0|||
49108538|NCT03611582|158232398|FG000|Overall Study|Safety concern as judged by the investigator|1|||
49108539|NCT03611582|158232399|FG001|Overall Study|Safety concern as judged by the investigator|2|||
49111479|NCT02452554|158242912|FG004|Overall Study|Death|0|||
49108540|NCT03611582|158232398|FG000|Overall Study|Withdrawal by Subject|4|||
49108541|NCT03611582|158232399|FG001|Overall Study|Withdrawal by Subject|3|||
49108542|NCT03611582|158232398|FG000|Overall Study|Lost to Follow-up|18|||
49108543|NCT03611582|158232399|FG001|Overall Study|Lost to Follow-up|7|||
49108544|NCT03611582|158232398|FG000|Overall Study|other|17|||
49108545|NCT03611582|158232399|FG001|Overall Study|other|16|||
49108546|NCT04459598|158232400|FG000|Overall Study|Adverse Event|1|||
49108547|NCT04459598|158232401|FG001|Overall Study|Adverse Event|1|||
49108548|NCT01472939|158234060|FG000|Overall Study|Adverse Event|3|||
49108549|NCT01472939|158234061|FG001|Overall Study|Adverse Event|7|||
49108550|NCT01472939|158234062|FG002|Overall Study|Adverse Event|7|||
49108551|NCT01472939|158234063|FG003|Overall Study|Adverse Event|14|||
49108552|NCT01472939|158234060|FG000|Overall Study|Lack of Efficacy|1|||
49108553|NCT01472939|158234061|FG001|Overall Study|Lack of Efficacy|0|||
49108554|NCT01472939|158234062|FG002|Overall Study|Lack of Efficacy|0|||
49108555|NCT01472939|158234063|FG003|Overall Study|Lack of Efficacy|1|||
49108556|NCT01472939|158234060|FG000|Overall Study|Lost to Follow-up|3|||
49108557|NCT01472939|158234061|FG001|Overall Study|Lost to Follow-up|0|||
49108558|NCT01472939|158234062|FG002|Overall Study|Lost to Follow-up|2|||
49108559|NCT01472939|158234063|FG003|Overall Study|Lost to Follow-up|0|||
49108560|NCT01472939|158234060|FG000|Overall Study|Clinically Significant Pre-Dose ECG|0|||
49108561|NCT01472939|158234061|FG001|Overall Study|Clinically Significant Pre-Dose ECG|0|||
49108562|NCT01472939|158234062|FG002|Overall Study|Clinically Significant Pre-Dose ECG|1|||
49108563|NCT01472939|158234063|FG003|Overall Study|Clinically Significant Pre-Dose ECG|0|||
49108564|NCT01472939|158234060|FG000|Overall Study|Prohibited Medication|0|||
49108565|NCT01472939|158234061|FG001|Overall Study|Prohibited Medication|1|||
49108566|NCT01472939|158234062|FG002|Overall Study|Prohibited Medication|0|||
49108567|NCT01472939|158234063|FG003|Overall Study|Prohibited Medication|0|||
49108568|NCT01472939|158234060|FG000|Overall Study|Withdrawal By PI|1|||
49108569|NCT01472939|158234061|FG001|Overall Study|Withdrawal By PI|0|||
49108570|NCT01472939|158234062|FG002|Overall Study|Withdrawal By PI|0|||
49108571|NCT01472939|158234063|FG003|Overall Study|Withdrawal By PI|0|||
49108572|NCT01472939|158234060|FG000|Overall Study|Protocol Violation|3|||
49108573|NCT01472939|158234061|FG001|Overall Study|Protocol Violation|3|||
49108574|NCT01472939|158234062|FG002|Overall Study|Protocol Violation|0|||
49108575|NCT01472939|158234063|FG003|Overall Study|Protocol Violation|1|||
49108576|NCT01472939|158234060|FG000|Overall Study|Withdrawal by Subject|9|||
49108577|NCT01472939|158234061|FG001|Overall Study|Withdrawal by Subject|3|||
49108578|NCT01472939|158234062|FG002|Overall Study|Withdrawal by Subject|1|||
49108579|NCT01472939|158234063|FG003|Overall Study|Withdrawal by Subject|4|||
49108580|NCT03117881|158234066|FG000|Baseline|Withdrawal by Subject|21|||
49108581|NCT03117881|158234067|FG001|Baseline|Withdrawal by Subject|10|||
49108582|NCT03117881|158234068|FG002|Baseline|Withdrawal by Subject|0|||
49108583|NCT03117881|158234066|FG000|Baseline|Lost to Follow-up|22|||
49108584|NCT03117881|158234067|FG001|Baseline|Lost to Follow-up|25|||
49108585|NCT03117881|158234068|FG002|Baseline|Lost to Follow-up|0|||
49108586|NCT03117881|158234066|FG000|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|26|||
49108587|NCT03117881|158234067|FG001|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|21|||
49108588|NCT03117881|158234068|FG002|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|1|||
49108589|NCT03117881|158234066|FG000|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|34|||
49108590|NCT03117881|158234067|FG001|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|38|||
49108591|NCT03117881|158234068|FG002|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|4|||
49108592|NCT03117881|158234066|FG000|Post-Intervention Follow-Up (3 Months)|Did not complete test|33|||
49108593|NCT03117881|158234067|FG001|Post-Intervention Follow-Up (3 Months)|Did not complete test|22|||
49108594|NCT03117881|158234068|FG002|Post-Intervention Follow-Up (3 Months)|Did not complete test|2|||
49108595|NCT03117881|158234066|FG000|6-Month Follow-Up|Withdrawal by Subject|4|||
49108596|NCT03117881|158234067|FG001|6-Month Follow-Up|Withdrawal by Subject|8|||
49108597|NCT03117881|158234068|FG002|6-Month Follow-Up|Withdrawal by Subject|0|||
49108598|NCT03117881|158234066|FG000|6-Month Follow-Up|Lost to Follow-up|18|||
49108599|NCT03117881|158234067|FG001|6-Month Follow-Up|Lost to Follow-up|8|||
49108600|NCT03117881|158234068|FG002|6-Month Follow-Up|Lost to Follow-up|2|||
49108601|NCT03117881|158234066|FG000|6-Month Follow-Up|Did not complete test|53|||
49108602|NCT03117881|158234067|FG001|6-Month Follow-Up|Did not complete test|25|||
49108603|NCT03117881|158234068|FG002|6-Month Follow-Up|Did not complete test|7|||
49108604|NCT03117881|158234066|FG000|12-Month Follow-Up|Withdrawal by Subject|3|||
49108605|NCT03117881|158234067|FG001|12-Month Follow-Up|Withdrawal by Subject|2|||
49108606|NCT03117881|158234068|FG002|12-Month Follow-Up|Withdrawal by Subject|0|||
49108607|NCT03117881|158234066|FG000|12-Month Follow-Up|Lost to Follow-up|18|||
49108608|NCT03117881|158234067|FG001|12-Month Follow-Up|Lost to Follow-up|22|||
49108609|NCT03117881|158234068|FG002|12-Month Follow-Up|Lost to Follow-up|0|||
49108610|NCT03117881|158234066|FG000|12-Month Follow-Up|Did not complete test|40|||
49108611|NCT03117881|158234067|FG001|12-Month Follow-Up|Did not complete test|0|||
49108612|NCT03117881|158234068|FG002|12-Month Follow-Up|Did not complete test|0|||
49108613|NCT02305446|158234069|FG000|Overall Study|Adverse Event|1|||
49108614|NCT00308750|158234073|FG000|Overall Study|Adverse Event|9|||
49108615|NCT00308750|158234074|FG001|Overall Study|Adverse Event|9|||
49108616|NCT00308750|158234075|FG002|Overall Study|Adverse Event|13|||
49108617|NCT00308750|158234073|FG000|Overall Study|Withdrawal by Subject|6|||
49108618|NCT00308750|158234074|FG001|Overall Study|Withdrawal by Subject|2|||
49108619|NCT00308750|158234075|FG002|Overall Study|Withdrawal by Subject|3|||
49108620|NCT00308750|158234073|FG000|Overall Study|Physician Decision|3|||
49108621|NCT00308750|158234074|FG001|Overall Study|Physician Decision|4|||
49108622|NCT00308750|158234075|FG002|Overall Study|Physician Decision|3|||
49108623|NCT00308750|158234073|FG000|Overall Study|Sponsor Decision|1|||
49108624|NCT00308750|158234074|FG001|Overall Study|Sponsor Decision|0|||
49108625|NCT00308750|158234075|FG002|Overall Study|Sponsor Decision|0|||
49108626|NCT00308750|158234073|FG000|Overall Study|Disease Progression|47|||
49108627|NCT00308750|158234074|FG001|Overall Study|Disease Progression|24|||
49108628|NCT00308750|158234075|FG002|Overall Study|Disease Progression|28|||
49108629|NCT00308750|158234073|FG000|Overall Study|Unrelated Complication|3|||
49108630|NCT00308750|158234074|FG001|Overall Study|Unrelated Complication|0|||
49108631|NCT00308750|158234075|FG002|Overall Study|Unrelated Complication|1|||
49108632|NCT00308750|158234073|FG000|Overall Study|Death|1|||
49108633|NCT00308750|158234074|FG001|Overall Study|Death|0|||
49108634|NCT00308750|158234075|FG002|Overall Study|Death|1|||
49108635|NCT00308750|158234073|FG000|Overall Study|Protocol Violation|1|||
49108636|NCT00308750|158234074|FG001|Overall Study|Protocol Violation|0|||
49108637|NCT00308750|158234075|FG002|Overall Study|Protocol Violation|0|||
49108638|NCT00308750|158234073|FG000|Overall Study|New Primary Disease Identified|1|||
49108639|NCT00308750|158234074|FG001|Overall Study|New Primary Disease Identified|1|||
49108640|NCT00308750|158234075|FG002|Overall Study|New Primary Disease Identified|0|||
49108641|NCT01358578|158234076|FG000|Induction Period|Adverse Event|2|||
49108642|NCT01358578|158234077|FG001|Induction Period|Adverse Event|4|||
49108643|NCT01358578|158234078|FG002|Induction Period|Adverse Event|2|||
49108644|NCT01358578|158234079|FG003|Induction Period|Adverse Event|6|||
49108645|NCT01358578|158234080|FG004|Induction Period|Adverse Event|0|||
49108646|NCT01358578|158234081|FG005|Induction Period|Adverse Event|0|||
49108647|NCT01358578|158234076|FG000|Induction Period|Lack of Efficacy|0|||
49108648|NCT01358578|158234077|FG001|Induction Period|Lack of Efficacy|0|||
49108649|NCT01358578|158234078|FG002|Induction Period|Lack of Efficacy|9|||
49108650|NCT01358578|158234079|FG003|Induction Period|Lack of Efficacy|1|||
49108651|NCT01358578|158234080|FG004|Induction Period|Lack of Efficacy|0|||
49108652|NCT01358578|158234081|FG005|Induction Period|Lack of Efficacy|0|||
49108653|NCT01358578|158234076|FG000|Induction Period|Lost to Follow-up|0|||
49108654|NCT01358578|158234077|FG001|Induction Period|Lost to Follow-up|0|||
49108655|NCT01358578|158234078|FG002|Induction Period|Lost to Follow-up|1|||
49108656|NCT01358578|158234079|FG003|Induction Period|Lost to Follow-up|4|||
49108657|NCT01358578|158234080|FG004|Induction Period|Lost to Follow-up|0|||
49108658|NCT01358578|158234081|FG005|Induction Period|Lost to Follow-up|0|||
49108659|NCT01358578|158234076|FG000|Induction Period|Physician Decision|2|||
49108660|NCT01358578|158234077|FG001|Induction Period|Physician Decision|1|||
49108661|NCT01358578|158234078|FG002|Induction Period|Physician Decision|2|||
49108662|NCT01358578|158234079|FG003|Induction Period|Physician Decision|0|||
49108663|NCT01358578|158234080|FG004|Induction Period|Physician Decision|0|||
49108664|NCT01358578|158234081|FG005|Induction Period|Physician Decision|0|||
49108665|NCT01358578|158234076|FG000|Induction Period|Protocol Deviation|3|||
49108666|NCT01358578|158234077|FG001|Induction Period|Protocol Deviation|5|||
49108667|NCT01358578|158234078|FG002|Induction Period|Protocol Deviation|0|||
49108668|NCT01358578|158234079|FG003|Induction Period|Protocol Deviation|3|||
49108669|NCT01358578|158234080|FG004|Induction Period|Protocol Deviation|0|||
49108670|NCT01358578|158234081|FG005|Induction Period|Protocol Deviation|0|||
49108671|NCT01358578|158234076|FG000|Induction Period|technical problems|0|||
49108672|NCT01358578|158234077|FG001|Induction Period|technical problems|0|||
49108673|NCT01358578|158234078|FG002|Induction Period|technical problems|1|||
49108674|NCT01358578|158234079|FG003|Induction Period|technical problems|1|||
49108675|NCT01358578|158234080|FG004|Induction Period|technical problems|0|||
49108676|NCT01358578|158234081|FG005|Induction Period|technical problems|0|||
49108677|NCT01358578|158234076|FG000|Induction Period|Withdrawal by Subject|5|||
49108678|NCT01358578|158234077|FG001|Induction Period|Withdrawal by Subject|5|||
49108679|NCT01358578|158234078|FG002|Induction Period|Withdrawal by Subject|10|||
49108680|NCT01358578|158234079|FG003|Induction Period|Withdrawal by Subject|6|||
49108681|NCT01358578|158234080|FG004|Induction Period|Withdrawal by Subject|0|||
49108682|NCT01358578|158234081|FG005|Induction Period|Withdrawal by Subject|0|||
49108683|NCT01358578|158234076|FG000|Maintenance Period|Adverse Event|2|||
49108684|NCT01358578|158234077|FG001|Maintenance Period|Adverse Event|7|||
49108685|NCT01358578|158234078|FG002|Maintenance Period|Adverse Event|0|||
49108686|NCT01358578|158234079|FG003|Maintenance Period|Adverse Event|6|||
49108687|NCT01358578|158234080|FG004|Maintenance Period|Adverse Event|4|||
49108688|NCT01358578|158234081|FG005|Maintenance Period|Adverse Event|3|||
49108689|NCT01358578|158234076|FG000|Maintenance Period|Lack of Efficacy|10|||
49108690|NCT01358578|158234077|FG001|Maintenance Period|Lack of Efficacy|2|||
49108691|NCT01358578|158234078|FG002|Maintenance Period|Lack of Efficacy|0|||
49108692|NCT01358578|158234079|FG003|Maintenance Period|Lack of Efficacy|11|||
49108693|NCT01358578|158234080|FG004|Maintenance Period|Lack of Efficacy|3|||
49108694|NCT01358578|158234081|FG005|Maintenance Period|Lack of Efficacy|0|||
49108695|NCT01358578|158234076|FG000|Maintenance Period|Lost to Follow-up|4|||
49108696|NCT01358578|158234077|FG001|Maintenance Period|Lost to Follow-up|0|||
49108697|NCT01358578|158234078|FG002|Maintenance Period|Lost to Follow-up|0|||
49108698|NCT01358578|158234079|FG003|Maintenance Period|Lost to Follow-up|5|||
49108699|NCT01358578|158234080|FG004|Maintenance Period|Lost to Follow-up|1|||
49108700|NCT01358578|158234081|FG005|Maintenance Period|Lost to Follow-up|1|||
49108701|NCT01358578|158234076|FG000|Maintenance Period|Non-compliance with study treatment|3|||
49108702|NCT01358578|158234077|FG001|Maintenance Period|Non-compliance with study treatment|1|||
49108703|NCT01358578|158234078|FG002|Maintenance Period|Non-compliance with study treatment|0|||
49108704|NCT01358578|158234079|FG003|Maintenance Period|Non-compliance with study treatment|2|||
49108705|NCT01358578|158234080|FG004|Maintenance Period|Non-compliance with study treatment|1|||
49108706|NCT01358578|158234081|FG005|Maintenance Period|Non-compliance with study treatment|2|||
49108707|NCT01358578|158234076|FG000|Maintenance Period|Physician Decision|0|||
49108708|NCT01358578|158234077|FG001|Maintenance Period|Physician Decision|1|||
49108709|NCT01358578|158234078|FG002|Maintenance Period|Physician Decision|0|||
49108710|NCT01358578|158234079|FG003|Maintenance Period|Physician Decision|1|||
49108711|NCT01358578|158234080|FG004|Maintenance Period|Physician Decision|0|||
49108712|NCT01358578|158234081|FG005|Maintenance Period|Physician Decision|0|||
49108713|NCT01358578|158234076|FG000|Maintenance Period|Pregnancy|1|||
49108714|NCT01358578|158234077|FG001|Maintenance Period|Pregnancy|0|||
49108715|NCT01358578|158234078|FG002|Maintenance Period|Pregnancy|0|||
49108716|NCT01358578|158234079|FG003|Maintenance Period|Pregnancy|0|||
49108717|NCT01358578|158234080|FG004|Maintenance Period|Pregnancy|0|||
49108718|NCT01358578|158234081|FG005|Maintenance Period|Pregnancy|0|||
49108719|NCT01358578|158234076|FG000|Maintenance Period|Protocol deviation|7|||
49108720|NCT01358578|158234077|FG001|Maintenance Period|Protocol deviation|4|||
49108721|NCT01358578|158234078|FG002|Maintenance Period|Protocol deviation|0|||
49108722|NCT01358578|158234079|FG003|Maintenance Period|Protocol deviation|2|||
49108723|NCT01358578|158234080|FG004|Maintenance Period|Protocol deviation|2|||
49108724|NCT01358578|158234081|FG005|Maintenance Period|Protocol deviation|2|||
49108725|NCT01358578|158234076|FG000|Maintenance Period|Withdrawal by Subject|12|||
49108726|NCT01358578|158234077|FG001|Maintenance Period|Withdrawal by Subject|7|||
49108727|NCT01358578|158234078|FG002|Maintenance Period|Withdrawal by Subject|2|||
49108728|NCT01358578|158234079|FG003|Maintenance Period|Withdrawal by Subject|15|||
49108729|NCT01358578|158234080|FG004|Maintenance Period|Withdrawal by Subject|6|||
49108730|NCT01358578|158234081|FG005|Maintenance Period|Withdrawal by Subject|3|||
49108731|NCT01358578|158234076|FG000|Follow-up Period|Adverse Event|1|||
49108732|NCT01358578|158234077|FG001|Follow-up Period|Adverse Event|1|||
49108733|NCT01358578|158234078|FG002|Follow-up Period|Adverse Event|0|||
49108734|NCT01358578|158234079|FG003|Follow-up Period|Adverse Event|0|||
49108735|NCT01358578|158234080|FG004|Follow-up Period|Adverse Event|0|||
49108736|NCT01358578|158234081|FG005|Follow-up Period|Adverse Event|0|||
49108737|NCT01358578|158234076|FG000|Follow-up Period|Lack of Efficacy|3|||
49108738|NCT01358578|158234077|FG001|Follow-up Period|Lack of Efficacy|0|||
49108739|NCT01358578|158234078|FG002|Follow-up Period|Lack of Efficacy|4|||
49108740|NCT01358578|158234079|FG003|Follow-up Period|Lack of Efficacy|1|||
49108741|NCT01358578|158234080|FG004|Follow-up Period|Lack of Efficacy|0|||
49108742|NCT01358578|158234081|FG005|Follow-up Period|Lack of Efficacy|0|||
49108743|NCT01358578|158234076|FG000|Follow-up Period|Lost to Follow-up|0|||
49108744|NCT01358578|158234077|FG001|Follow-up Period|Lost to Follow-up|1|||
49108745|NCT01358578|158234078|FG002|Follow-up Period|Lost to Follow-up|0|||
49108746|NCT01358578|158234079|FG003|Follow-up Period|Lost to Follow-up|4|||
49108747|NCT01358578|158234080|FG004|Follow-up Period|Lost to Follow-up|0|||
49108748|NCT01358578|158234081|FG005|Follow-up Period|Lost to Follow-up|0|||
49108749|NCT01358578|158234076|FG000|Follow-up Period|non- compliance with study treatment|1|||
49108750|NCT01358578|158234077|FG001|Follow-up Period|non- compliance with study treatment|0|||
49108751|NCT01358578|158234078|FG002|Follow-up Period|non- compliance with study treatment|0|||
49108752|NCT01358578|158234079|FG003|Follow-up Period|non- compliance with study treatment|0|||
49108753|NCT01358578|158234080|FG004|Follow-up Period|non- compliance with study treatment|0|||
49108754|NCT01358578|158234081|FG005|Follow-up Period|non- compliance with study treatment|0|||
49108755|NCT01358578|158234076|FG000|Follow-up Period|Pregnancy|1|||
49108756|NCT01358578|158234077|FG001|Follow-up Period|Pregnancy|0|||
49108757|NCT01358578|158234078|FG002|Follow-up Period|Pregnancy|0|||
49108758|NCT01358578|158234079|FG003|Follow-up Period|Pregnancy|0|||
49108759|NCT01358578|158234080|FG004|Follow-up Period|Pregnancy|0|||
49108760|NCT01358578|158234081|FG005|Follow-up Period|Pregnancy|0|||
49108761|NCT01358578|158234076|FG000|Follow-up Period|Withdrawal by Subject|3|||
49108762|NCT01358578|158234077|FG001|Follow-up Period|Withdrawal by Subject|3|||
49108763|NCT01358578|158234078|FG002|Follow-up Period|Withdrawal by Subject|1|||
49108764|NCT01358578|158234079|FG003|Follow-up Period|Withdrawal by Subject|12|||
49108765|NCT01358578|158234080|FG004|Follow-up Period|Withdrawal by Subject|0|||
49108766|NCT01358578|158234081|FG005|Follow-up Period|Withdrawal by Subject|0|||
49108767|NCT01358578|158234076|FG000|Follow-up Period|Physician Decision|1|||
49108768|NCT01358578|158234077|FG001|Follow-up Period|Physician Decision|1|||
49108769|NCT01358578|158234078|FG002|Follow-up Period|Physician Decision|0|||
49108770|NCT01358578|158234079|FG003|Follow-up Period|Physician Decision|2|||
49108771|NCT01358578|158234080|FG004|Follow-up Period|Physician Decision|0|||
49108772|NCT01358578|158234081|FG005|Follow-up Period|Physician Decision|0|||
49108773|NCT05940077|158234082|FG000|Overall Study|the presence of definite dementia, determined by Montreal Cognitive Assessment (MoCA < 21)|1|||
49108774|NCT00388297|158234087|FG000|Overall Study|Lost to Follow-up|16|||
49108775|NCT00388297|158234088|FG001|Overall Study|Lost to Follow-up|12|||
49108776|NCT00388297|158234089|FG002|Overall Study|Lost to Follow-up|11|||
49108777|NCT00388297|158234090|FG003|Overall Study|Lost to Follow-up|8|||
49108778|NCT01636947|158234092|FG000|Overall Study|Not Treated|2|||
49108779|NCT01636947|158234093|FG001|Overall Study|Not Treated|2|||
49108780|NCT01636947|158234092|FG000|Overall Study|Lost to Follow-up|4|||
49108781|NCT01636947|158234093|FG001|Overall Study|Lost to Follow-up|0|||
49108782|NCT01636947|158234092|FG000|Overall Study|Protocol Violation|1|||
49108783|NCT01636947|158234093|FG001|Overall Study|Protocol Violation|1|||
49108784|NCT01636947|158234092|FG000|Overall Study|Withdrawal by Subject|3|||
49108785|NCT01636947|158234093|FG001|Overall Study|Withdrawal by Subject|3|||
49108786|NCT01636947|158234092|FG000|Overall Study|Adverse Event|1|||
49108787|NCT01636947|158234093|FG001|Overall Study|Adverse Event|1|||
49108788|NCT01636947|158234092|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
49108789|NCT01636947|158234093|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
49108790|NCT00957424|158234094|FG000|Overall Study|Lost to Follow-up|19|||
49108791|NCT00957424|158234094|FG000|Overall Study|Protocol Violation|3|||
49108792|NCT00957424|158234094|FG000|Overall Study|Withdrawal by Subject|1|||
49108793|NCT03605849|158234095|FG000|Overall Study|Adverse Event|20|||
49108794|NCT03605849|158234096|FG001|Overall Study|Adverse Event|21|||
49108795|NCT03605849|158234097|FG002|Overall Study|Adverse Event|29|||
49108796|NCT03605849|158234098|FG003|Overall Study|Adverse Event|11|||
49108797|NCT03605849|158234095|FG000|Overall Study|Lack of Efficacy|4|||
49108798|NCT03605849|158234096|FG001|Overall Study|Lack of Efficacy|7|||
49108799|NCT03605849|158234097|FG002|Overall Study|Lack of Efficacy|9|||
49108800|NCT03605849|158234098|FG003|Overall Study|Lack of Efficacy|2|||
49108801|NCT03605849|158234095|FG000|Overall Study|Lost to Follow-up|8|||
49108802|NCT03605849|158234096|FG001|Overall Study|Lost to Follow-up|8|||
49108803|NCT03605849|158234097|FG002|Overall Study|Lost to Follow-up|14|||
49108804|NCT03605849|158234098|FG003|Overall Study|Lost to Follow-up|11|||
49108805|NCT03605849|158234095|FG000|Overall Study|Non-compliance With IMP|6|||
49108806|NCT03605849|158234096|FG001|Overall Study|Non-compliance With IMP|5|||
49108807|NCT03605849|158234097|FG002|Overall Study|Non-compliance With IMP|2|||
49108808|NCT03605849|158234098|FG003|Overall Study|Non-compliance With IMP|1|||
49108809|NCT03605849|158234095|FG000|Overall Study|Protocol Deviation|1|||
49108810|NCT03605849|158234096|FG001|Overall Study|Protocol Deviation|2|||
49108811|NCT03605849|158234097|FG002|Overall Study|Protocol Deviation|1|||
49108812|NCT03605849|158234098|FG003|Overall Study|Protocol Deviation|3|||
49108813|NCT03605849|158234095|FG000|Overall Study|Withdrawal by Subject|33|||
49108814|NCT03605849|158234096|FG001|Overall Study|Withdrawal by Subject|28|||
49108815|NCT03605849|158234097|FG002|Overall Study|Withdrawal by Subject|30|||
49108816|NCT03605849|158234098|FG003|Overall Study|Withdrawal by Subject|28|||
49108817|NCT03605849|158234095|FG000|Overall Study|Site Terminated by Sponsor|0|||
49108818|NCT03605849|158234096|FG001|Overall Study|Site Terminated by Sponsor|0|||
49108819|NCT03605849|158234097|FG002|Overall Study|Site Terminated by Sponsor|0|||
49108820|NCT03605849|158234098|FG003|Overall Study|Site Terminated by Sponsor|1|||
49108821|NCT03605849|158234095|FG000|Overall Study|Physician Decision|2|||
49108822|NCT03605849|158234096|FG001|Overall Study|Physician Decision|1|||
49108823|NCT03605849|158234097|FG002|Overall Study|Physician Decision|2|||
49108824|NCT03605849|158234098|FG003|Overall Study|Physician Decision|1|||
49108825|NCT03605849|158234095|FG000|Overall Study|Enrolled, but not Treated|2|||
49108826|NCT03605849|158234096|FG001|Overall Study|Enrolled, but not Treated|2|||
49108827|NCT03605849|158234097|FG002|Overall Study|Enrolled, but not Treated|3|||
49108828|NCT03605849|158234098|FG003|Overall Study|Enrolled, but not Treated|2|||
49108829|NCT03605849|158234095|FG000|Overall Study|Other (COVID-19 Related)|0|||
49108830|NCT03605849|158234096|FG001|Overall Study|Other (COVID-19 Related)|1|||
49108831|NCT03605849|158234097|FG002|Overall Study|Other (COVID-19 Related)|1|||
49108832|NCT03605849|158234098|FG003|Overall Study|Other (COVID-19 Related)|0|||
49108833|NCT03605849|158234095|FG000|Overall Study|Other (Not Related to COVID-19)|2|||
49108834|NCT03605849|158234096|FG001|Overall Study|Other (Not Related to COVID-19)|4|||
49108835|NCT03605849|158234097|FG002|Overall Study|Other (Not Related to COVID-19)|4|||
49108836|NCT03605849|158234098|FG003|Overall Study|Other (Not Related to COVID-19)|5|||
49108837|NCT02304380|158234099|FG000|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
49108838|NCT02304380|158234100|FG001|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
49108839|NCT02304380|158234101|FG002|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
49108840|NCT02304380|158234102|FG003|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34|||
49108841|NCT02304380|158234103|FG004|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
49108842|NCT02304380|158234104|FG005|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
49108843|NCT01027897|158234107|FG000|Overall Study|Protocol Violation|1|||
49108844|NCT01027897|158234107|FG000|Overall Study|Withdrawal by Subject|1|||
49108845|NCT00312572|158234111|FG000|Overall Study|Adverse Event|10|||
49108846|NCT00312572|158234112|FG001|Overall Study|Adverse Event|16|||
49108847|NCT00312572|158234111|FG000|Overall Study|Lost to Follow-up|1|||
49108848|NCT00312572|158234112|FG001|Overall Study|Lost to Follow-up|1|||
49108849|NCT00312572|158234111|FG000|Overall Study|Administrative|4|||
49108850|NCT00312572|158234112|FG001|Overall Study|Administrative|2|||
49108851|NCT00312572|158234111|FG000|Overall Study|Lack of Efficacy|1|||
49108852|NCT00312572|158234112|FG001|Overall Study|Lack of Efficacy|2|||
49108853|NCT03597022|158234113|FG000|Overall Study|Premature termination of the study|7|||
49108854|NCT03597022|158234114|FG001|Overall Study|Premature termination of the study|7|||
49108855|NCT03597022|158234115|FG002|Overall Study|Premature termination of the study|8|||
49108856|NCT03597022|158234113|FG000|Overall Study|Serious adverse event|1|||
49108857|NCT03597022|158234114|FG001|Overall Study|Serious adverse event|1|||
49108858|NCT03597022|158234115|FG002|Overall Study|Serious adverse event|0|||
49108859|NCT05385224|158234117|FG000|Overall Study|Unable to swallow capsule|2|||
49108860|NCT05385224|158234117|FG000|Overall Study|Withdrawal by Subject|2|||
49108861|NCT05385224|158234117|FG000|Overall Study|Did not meet study criteria|1|||
49108862|NCT04150068|158234125|FG000|Maintenance Period (Week 26 Analysis)|Still on study|24|||
49108863|NCT04150068|158234126|FG001|Maintenance Period (Week 26 Analysis)|Still on study|12|||
49108864|NCT04150068|158234127|FG002|Maintenance Period (Week 26 Analysis)|Still on study|35|||
49108865|NCT04150068|158234125|FG000|Maintenance Period (Week 26 Analysis)|Death|0|||
49108866|NCT04150068|158234126|FG001|Maintenance Period (Week 26 Analysis)|Death|0|||
49108867|NCT04150068|158234127|FG002|Maintenance Period (Week 26 Analysis)|Death|1|||
49108868|NCT01618916|158234128|FG000|Overall Study|Adverse Event|1|||
49108869|NCT01618916|158234129|FG001|Overall Study|Adverse Event|0|||
49108870|NCT01618916|158234130|FG002|Overall Study|Adverse Event|0|||
49108871|NCT01618916|158234131|FG003|Overall Study|Adverse Event|0|||
49108872|NCT01618916|158234132|FG004|Overall Study|Adverse Event|0|||
49108873|NCT01618916|158234133|FG005|Overall Study|Adverse Event|0|||
49108874|NCT01618916|158234128|FG000|Overall Study|Withdrawal by Subject|0|||
49108875|NCT01618916|158234129|FG001|Overall Study|Withdrawal by Subject|1|||
49108876|NCT01618916|158234130|FG002|Overall Study|Withdrawal by Subject|1|||
49108877|NCT01618916|158234131|FG003|Overall Study|Withdrawal by Subject|0|||
49108878|NCT01618916|158234132|FG004|Overall Study|Withdrawal by Subject|1|||
49108879|NCT01618916|158234133|FG005|Overall Study|Withdrawal by Subject|0|||
49108880|NCT01618916|158234128|FG000|Overall Study|Lost to Follow-up|1|||
49108881|NCT01618916|158234129|FG001|Overall Study|Lost to Follow-up|0|||
49108882|NCT01618916|158234130|FG002|Overall Study|Lost to Follow-up|0|||
49108883|NCT01618916|158234131|FG003|Overall Study|Lost to Follow-up|2|||
49108884|NCT01618916|158234132|FG004|Overall Study|Lost to Follow-up|0|||
49108885|NCT01618916|158234133|FG005|Overall Study|Lost to Follow-up|0|||
49108886|NCT01853696|158234136|FG000|Overall Study|Withdrawal by Subject|1|||
49108887|NCT01853696|158234137|FG001|Overall Study|Withdrawal by Subject|1|||
49108888|NCT01853696|158234136|FG000|Overall Study|Lost to Follow-up|5|||
49108889|NCT01853696|158234137|FG001|Overall Study|Lost to Follow-up|4|||
49108890|NCT04521114|158234138|FG000|Overall Study|Lost to Follow-up|1|||
49108891|NCT04521114|158234139|FG001|Overall Study|Lost to Follow-up|2|||
49108892|NCT04521114|158234140|FG002|Overall Study|Lost to Follow-up|0|||
49108893|NCT04521114|158234138|FG000|Overall Study|Withdrawal by Subject|1|||
49108894|NCT04521114|158234139|FG001|Overall Study|Withdrawal by Subject|2|||
49108895|NCT04521114|158234140|FG002|Overall Study|Withdrawal by Subject|2|||
49108896|NCT04521114|158234138|FG000|Overall Study|Adverse Event|1|||
49108897|NCT04521114|158234139|FG001|Overall Study|Adverse Event|0|||
49108898|NCT04521114|158234140|FG002|Overall Study|Adverse Event|0|||
49108899|NCT04521114|158234138|FG000|Overall Study|Sponsor Wish|1|||
49108900|NCT04521114|158234139|FG001|Overall Study|Sponsor Wish|0|||
49108901|NCT04521114|158234140|FG002|Overall Study|Sponsor Wish|0|||
49108902|NCT04521114|158234138|FG000|Overall Study|Withdrawal of Consent|2|||
49108903|NCT04521114|158234139|FG001|Overall Study|Withdrawal of Consent|2|||
49108904|NCT04521114|158234140|FG002|Overall Study|Withdrawal of Consent|0|||
49108905|NCT03004924|158234141|FG000|Overall Study|Adverse Event|6|||
49108906|NCT03004924|158234142|FG001|Overall Study|Adverse Event|5|||
49108907|NCT03004924|158234143|FG002|Overall Study|Adverse Event|10|||
49108908|NCT03004924|158234141|FG000|Overall Study|Protocol Violation|4|||
49108909|NCT03004924|158234142|FG001|Overall Study|Protocol Violation|0|||
49108910|NCT03004924|158234143|FG002|Overall Study|Protocol Violation|1|||
49108911|NCT03004924|158234141|FG000|Overall Study|Withdrawal by Subject|5|||
49108912|NCT03004924|158234142|FG001|Overall Study|Withdrawal by Subject|3|||
49108913|NCT03004924|158234143|FG002|Overall Study|Withdrawal by Subject|5|||
49108914|NCT03004924|158234141|FG000|Overall Study|Lost to Follow-up|6|||
49108915|NCT03004924|158234142|FG001|Overall Study|Lost to Follow-up|1|||
49108916|NCT03004924|158234143|FG002|Overall Study|Lost to Follow-up|4|||
49108917|NCT03004924|158234141|FG000|Overall Study|Lack of Efficacy|2|||
49108918|NCT03004924|158234142|FG001|Overall Study|Lack of Efficacy|4|||
49108919|NCT03004924|158234143|FG002|Overall Study|Lack of Efficacy|2|||
49108920|NCT03004924|158234141|FG000|Overall Study|Physician Decision|1|||
49108921|NCT03004924|158234142|FG001|Overall Study|Physician Decision|0|||
49108922|NCT03004924|158234143|FG002|Overall Study|Physician Decision|1|||
49108923|NCT03004924|158234141|FG000|Overall Study|Withdrawal by parent/guardian|1|||
49108924|NCT03004924|158234142|FG001|Overall Study|Withdrawal by parent/guardian|0|||
49108925|NCT03004924|158234143|FG002|Overall Study|Withdrawal by parent/guardian|2|||
49108926|NCT03004924|158234141|FG000|Overall Study|Screen Failure|1|||
49108927|NCT03004924|158234142|FG001|Overall Study|Screen Failure|0|||
49108928|NCT03004924|158234143|FG002|Overall Study|Screen Failure|0|||
49108929|NCT03004924|158234141|FG000|Overall Study|Pregnancy|0|||
49108930|NCT03004924|158234142|FG001|Overall Study|Pregnancy|1|||
49108931|NCT03004924|158234143|FG002|Overall Study|Pregnancy|0|||
49108932|NCT03004924|158234141|FG000|Overall Study|Terminated by Sponsor|0|||
49108933|NCT03004924|158234142|FG001|Overall Study|Terminated by Sponsor|0|||
49108934|NCT03004924|158234143|FG002|Overall Study|Terminated by Sponsor|1|||
49108935|NCT03004924|158234141|FG000|Overall Study|Missed Study Visit|0|||
49108936|NCT03004924|158234142|FG001|Overall Study|Missed Study Visit|0|||
49108937|NCT03004924|158234143|FG002|Overall Study|Missed Study Visit|2|||
49108938|NCT03004924|158234141|FG000|Overall Study|HSV1 Positive|1|||
49108939|NCT03004924|158234142|FG001|Overall Study|HSV1 Positive|0|||
49108940|NCT03004924|158234143|FG002|Overall Study|HSV1 Positive|0|||
49108941|NCT01167634|158234144|FG000|Overall Study|Lost to Follow-up|1|||
49108942|NCT01167634|158234145|FG001|Overall Study|Lost to Follow-up|3|||
49108943|NCT01167634|158234146|FG002|Overall Study|Lost to Follow-up|3|||
49108944|NCT01167634|158234147|FG003|Overall Study|Lost to Follow-up|4|||
49108945|NCT01167634|158234144|FG000|Overall Study|Withdrawal by Subject|1|||
49108946|NCT01167634|158234145|FG001|Overall Study|Withdrawal by Subject|1|||
49108947|NCT01167634|158234146|FG002|Overall Study|Withdrawal by Subject|0|||
49108948|NCT01167634|158234147|FG003|Overall Study|Withdrawal by Subject|0|||
49108949|NCT01362517|158234148|FG000|Overall Study|Protocol Violation|1|||
49108950|NCT01362517|158234148|FG000|Overall Study|Lost to Follow-up|1|||
49108951|NCT00553358|158234149|FG000|Overall Study|Randomized but did not receive treatment|3|||
49108952|NCT00553358|158234150|FG001|Overall Study|Randomized but did not receive treatment|3|||
49108953|NCT00553358|158234151|FG002|Overall Study|Randomized but did not receive treatment|1|||
49108954|NCT00553358|158234149|FG000|Overall Study|Lost to Follow-up|22|||
49108955|NCT00553358|158234150|FG001|Overall Study|Lost to Follow-up|26|||
49108956|NCT00553358|158234151|FG002|Overall Study|Lost to Follow-up|18|||
49108957|NCT00553358|158234149|FG000|Overall Study|Withdrew completely|23|||
49108958|NCT00553358|158234150|FG001|Overall Study|Withdrew completely|33|||
49108959|NCT00553358|158234151|FG002|Overall Study|Withdrew completely|34|||
49108960|NCT00553358|158234149|FG000|Overall Study|Died during clinical follow-up|25|||
49108961|NCT00553358|158234150|FG001|Overall Study|Died during clinical follow-up|29|||
49108962|NCT00553358|158234151|FG002|Overall Study|Died during clinical follow-up|32|||
49108963|NCT00553358|158234149|FG000|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4|||
49108964|NCT00553358|158234150|FG001|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
49108965|NCT00553358|158234151|FG002|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
49108966|NCT00553358|158234149|FG000|Overall Study|Died after clinical follow-up ended|1|||
49108967|NCT00553358|158234150|FG001|Overall Study|Died after clinical follow-up ended|2|||
49108968|NCT00553358|158234151|FG002|Overall Study|Died after clinical follow-up ended|0|||
49108969|NCT00553358|158234149|FG000|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
49108970|NCT00553358|158234150|FG001|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
49108971|NCT00553358|158234151|FG002|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
49108972|NCT00438256|158234152|FG000|Overall Study|Ineligible for Resection|2|||
49108973|NCT00438256|158234153|FG001|Overall Study|Ineligible for Resection|1|||
49108974|NCT00438256|158234154|FG002|Overall Study|Ineligible for Resection|1|||
49108975|NCT00438256|158234155|FG003|Overall Study|Ineligible for Resection|7|||
49108976|NCT00438256|158234152|FG000|Overall Study|Excluded final Diagnosis|0|||
49108977|NCT00438256|158234153|FG001|Overall Study|Excluded final Diagnosis|0|||
49108978|NCT00438256|158234154|FG002|Overall Study|Excluded final Diagnosis|0|||
49108979|NCT00438256|158234155|FG003|Overall Study|Excluded final Diagnosis|2|||
49108980|NCT02565706|158234159|FG000|Overall Study|Withdrawal by Subject|5|||
49108981|NCT02565706|158234160|FG001|Overall Study|Withdrawal by Subject|7|||
49108982|NCT02565706|158234161|FG002|Overall Study|Withdrawal by Subject|7|||
49108983|NCT02565706|158234162|FG003|Overall Study|Withdrawal by Subject|11|||
49108984|NCT02565706|158234159|FG000|Overall Study|Lost to Follow-up|72|||
49108985|NCT02565706|158234160|FG001|Overall Study|Lost to Follow-up|75|||
49108986|NCT02565706|158234161|FG002|Overall Study|Lost to Follow-up|82|||
49108987|NCT02565706|158234162|FG003|Overall Study|Lost to Follow-up|74|||
49108988|NCT00934856|158234165|FG000|Feasibility Part|Progressive disease|4|||
49108989|NCT00934856|158234166|FG001|Feasibility Part|Progressive disease|4|||
49108990|NCT00934856|158234167|FG002|Feasibility Part|Progressive disease|2|||
49108991|NCT00934856|158234168|FG003|Feasibility Part|Progressive disease|3|||
49108992|NCT00934856|158234169|FG004|Feasibility Part|Progressive disease|0|||
49108993|NCT00934856|158234170|FG005|Feasibility Part|Progressive disease|0|||
49108994|NCT00934856|158234165|FG000|Feasibility Part|Physician Decision|0|||
49108995|NCT00934856|158234166|FG001|Feasibility Part|Physician Decision|0|||
49108996|NCT00934856|158234167|FG002|Feasibility Part|Physician Decision|1|||
49108997|NCT00934856|158234168|FG003|Feasibility Part|Physician Decision|0|||
49108998|NCT00934856|158234169|FG004|Feasibility Part|Physician Decision|0|||
49108999|NCT00934856|158234170|FG005|Feasibility Part|Physician Decision|0|||
49109000|NCT00934856|158234165|FG000|Feasibility Part|Adverse Event|1|||
49109001|NCT00934856|158234166|FG001|Feasibility Part|Adverse Event|1|||
49109002|NCT00934856|158234167|FG002|Feasibility Part|Adverse Event|0|||
49109003|NCT00934856|158234168|FG003|Feasibility Part|Adverse Event|1|||
49109004|NCT00934856|158234169|FG004|Feasibility Part|Adverse Event|0|||
49109005|NCT00934856|158234170|FG005|Feasibility Part|Adverse Event|2|||
49109006|NCT00934856|158234165|FG000|Feasibility Part|Withdrawal by Subject|0|||
49109007|NCT00934856|158234166|FG001|Feasibility Part|Withdrawal by Subject|0|||
49109008|NCT00934856|158234167|FG002|Feasibility Part|Withdrawal by Subject|0|||
49109009|NCT00934856|158234168|FG003|Feasibility Part|Withdrawal by Subject|1|||
49109010|NCT00934856|158234169|FG004|Feasibility Part|Withdrawal by Subject|0|||
49109011|NCT00934856|158234170|FG005|Feasibility Part|Withdrawal by Subject|1|||
49109012|NCT00934856|158234165|FG000|Extension Part|Adverse Event|0|||
49109013|NCT00934856|158234166|FG001|Extension Part|Adverse Event|0|||
49109014|NCT00934856|158234167|FG002|Extension Part|Adverse Event|0|||
49109015|NCT00934856|158234168|FG003|Extension Part|Adverse Event|1|||
49109016|NCT00934856|158234169|FG004|Extension Part|Adverse Event|4|||
49109017|NCT00934856|158234170|FG005|Extension Part|Adverse Event|4|||
49109018|NCT00934856|158234165|FG000|Extension Part|Progressive disease|0|||
49109019|NCT00934856|158234166|FG001|Extension Part|Progressive disease|0|||
49109020|NCT00934856|158234167|FG002|Extension Part|Progressive disease|0|||
49109021|NCT00934856|158234168|FG003|Extension Part|Progressive disease|1|||
49109022|NCT00934856|158234169|FG004|Extension Part|Progressive disease|0|||
49109023|NCT00934856|158234170|FG005|Extension Part|Progressive disease|0|||
49109024|NCT00934856|158234165|FG000|Extension Part|Non-compliance with drug|0|||
49109025|NCT00934856|158234166|FG001|Extension Part|Non-compliance with drug|0|||
49109026|NCT00934856|158234167|FG002|Extension Part|Non-compliance with drug|0|||
49109027|NCT00934856|158234168|FG003|Extension Part|Non-compliance with drug|0|||
49109028|NCT00934856|158234169|FG004|Extension Part|Non-compliance with drug|0|||
49109029|NCT00934856|158234170|FG005|Extension Part|Non-compliance with drug|1|||
49109030|NCT01935700|158234172|FG000|Overall Study|Withdrawal by Subject|1|||
49109031|NCT01935700|158234173|FG001|Overall Study|Withdrawal by Subject|0|||
49109032|NCT01935700|158234172|FG000|Overall Study|Physician Decision|4|||
49109033|NCT01935700|158234173|FG001|Overall Study|Physician Decision|0|||
49109034|NCT02327013|158234174|FG000|Overall Study|Adverse Event|4|||
49109035|NCT02327013|158234175|FG001|Overall Study|Adverse Event|4|||
49109036|NCT02327013|158234176|FG002|Overall Study|Adverse Event|3|||
49109037|NCT02327013|158234177|FG003|Overall Study|Adverse Event|0|||
49109038|NCT02327013|158234178|FG004|Overall Study|Adverse Event|1|||
49109039|NCT02327013|158234174|FG000|Overall Study|Lack of Efficacy|2|||
49109040|NCT02327013|158234175|FG001|Overall Study|Lack of Efficacy|0|||
49109041|NCT02327013|158234176|FG002|Overall Study|Lack of Efficacy|5|||
49109042|NCT02327013|158234177|FG003|Overall Study|Lack of Efficacy|0|||
49109043|NCT02327013|158234178|FG004|Overall Study|Lack of Efficacy|1|||
49109044|NCT02327013|158234174|FG000|Overall Study|Non-compliance with IMP|1|||
49109045|NCT02327013|158234175|FG001|Overall Study|Non-compliance with IMP|2|||
49109046|NCT02327013|158234176|FG002|Overall Study|Non-compliance with IMP|7|||
49109047|NCT02327013|158234177|FG003|Overall Study|Non-compliance with IMP|0|||
49109048|NCT02327013|158234178|FG004|Overall Study|Non-compliance with IMP|0|||
49109049|NCT02327013|158234174|FG000|Overall Study|Withdrawal of Consent|1|||
49109050|NCT02327013|158234175|FG001|Overall Study|Withdrawal of Consent|0|||
49109051|NCT02327013|158234176|FG002|Overall Study|Withdrawal of Consent|3|||
49109052|NCT02327013|158234177|FG003|Overall Study|Withdrawal of Consent|0|||
49109053|NCT02327013|158234178|FG004|Overall Study|Withdrawal of Consent|0|||
49109054|NCT02327013|158234174|FG000|Overall Study|Lost to Follow-up|2|||
49109055|NCT02327013|158234175|FG001|Overall Study|Lost to Follow-up|4|||
49109056|NCT02327013|158234176|FG002|Overall Study|Lost to Follow-up|5|||
49109057|NCT02327013|158234177|FG003|Overall Study|Lost to Follow-up|0|||
49109058|NCT02327013|158234178|FG004|Overall Study|Lost to Follow-up|0|||
49109059|NCT02327013|158234174|FG000|Overall Study|Administrative or other reason(s)|1|||
49109060|NCT02327013|158234175|FG001|Overall Study|Administrative or other reason(s)|5|||
49109061|NCT02327013|158234176|FG002|Overall Study|Administrative or other reason(s)|11|||
49109062|NCT02327013|158234177|FG003|Overall Study|Administrative or other reason(s)|1|||
49109063|NCT02327013|158234178|FG004|Overall Study|Administrative or other reason(s)|1|||
49109064|NCT02327013|158234174|FG000|Overall Study|Protocol Violation|0|||
49109065|NCT02327013|158234175|FG001|Overall Study|Protocol Violation|0|||
49109066|NCT02327013|158234176|FG002|Overall Study|Protocol Violation|3|||
49109067|NCT02327013|158234177|FG003|Overall Study|Protocol Violation|0|||
49109068|NCT02327013|158234178|FG004|Overall Study|Protocol Violation|1|||
49109069|NCT02327013|158234174|FG000|Overall Study|Withdrawal before treatment|2|||
49109070|NCT02327013|158234175|FG001|Overall Study|Withdrawal before treatment|1|||
49109071|NCT02327013|158234176|FG002|Overall Study|Withdrawal before treatment|5|||
49109072|NCT02327013|158234177|FG003|Overall Study|Withdrawal before treatment|0|||
49109073|NCT02327013|158234178|FG004|Overall Study|Withdrawal before treatment|0|||
49109074|NCT02854605|158234182|FG000|Overall Study|Adverse Event|1|||
49109075|NCT02854605|158234183|FG001|Overall Study|Adverse Event|5|||
49109076|NCT02854605|158234184|FG002|Overall Study|Adverse Event|2|||
49109077|NCT02854605|158234182|FG000|Overall Study|Lost to Follow-up|0|||
49109078|NCT02854605|158234183|FG001|Overall Study|Lost to Follow-up|2|||
49109079|NCT02854605|158234184|FG002|Overall Study|Lost to Follow-up|0|||
49109080|NCT02854605|158234182|FG000|Overall Study|Withdrew Consent|1|||
49109081|NCT02854605|158234183|FG001|Overall Study|Withdrew Consent|0|||
49109082|NCT02854605|158234184|FG002|Overall Study|Withdrew Consent|1|||
49109083|NCT02854605|158234182|FG000|Overall Study|Investigator's Discretion|1|||
49109084|NCT02854605|158234183|FG001|Overall Study|Investigator's Discretion|0|||
49109085|NCT02854605|158234184|FG002|Overall Study|Investigator's Discretion|0|||
49109086|NCT02854605|158234182|FG000|Overall Study|Protocol Violation|0|||
49109087|NCT02854605|158234183|FG001|Overall Study|Protocol Violation|0|||
49109088|NCT02854605|158234184|FG002|Overall Study|Protocol Violation|1|||
49109089|NCT00803205|158234185|FG000|Overall Study|Adverse Event|7|||
49109090|NCT00803205|158234186|FG001|Overall Study|Adverse Event|2|||
49109091|NCT00803205|158234185|FG000|Overall Study|Lost to Follow-up|1|||
49109092|NCT00803205|158234186|FG001|Overall Study|Lost to Follow-up|0|||
49109093|NCT00803205|158234185|FG000|Overall Study|Withdrawal by Subject|9|||
49109094|NCT00803205|158234186|FG001|Overall Study|Withdrawal by Subject|9|||
49109095|NCT00803205|158234185|FG000|Overall Study|Physician Decision|1|||
49109096|NCT00803205|158234186|FG001|Overall Study|Physician Decision|0|||
49109097|NCT00803205|158234185|FG000|Overall Study|Protocol Violation|1|||
49109098|NCT00803205|158234186|FG001|Overall Study|Protocol Violation|1|||
49109099|NCT00803205|158234185|FG000|Overall Study|Medical Monitor Decision|1|||
49109100|NCT00803205|158234186|FG001|Overall Study|Medical Monitor Decision|0|||
49109101|NCT00803205|158234185|FG000|Overall Study|Acquired a Lung Infection|0|||
49109102|NCT00803205|158234186|FG001|Overall Study|Acquired a Lung Infection|1|||
49109103|NCT00803205|158234185|FG000|Overall Study|Sponsor Decision|0|||
49109104|NCT00803205|158234186|FG001|Overall Study|Sponsor Decision|1|||
49109105|NCT01273155|158234191|FG000|Overall Study|Off study trmt prior to end of C1/PD|2|||
49109106|NCT01273155|158234192|FG001|Overall Study|Off study trmt prior to end of C1/PD|3|||
49109107|NCT01273155|158234193|FG002|Overall Study|Off study trmt prior to end of C1/PD|8|||
49109108|NCT01273155|158234194|FG003|Overall Study|Off study trmt prior to end of C1/PD|0|||
49109109|NCT01273155|158234195|FG004|Overall Study|Off study trmt prior to end of C1/PD|0|||
49109110|NCT01273155|158234196|FG005|Overall Study|Off study trmt prior to end of C1/PD|2|||
49109111|NCT01273155|158234197|FG006|Overall Study|Off study trmt prior to end of C1/PD|3|||
49109112|NCT01273155|158234191|FG000|Overall Study|Change in liver function/no longer eval.|0|||
49109113|NCT01273155|158234192|FG001|Overall Study|Change in liver function/no longer eval.|1|||
49109114|NCT01273155|158234193|FG002|Overall Study|Change in liver function/no longer eval.|0|||
49109115|NCT01273155|158234194|FG003|Overall Study|Change in liver function/no longer eval.|0|||
49109116|NCT01273155|158234195|FG004|Overall Study|Change in liver function/no longer eval.|1|||
49109117|NCT01273155|158234196|FG005|Overall Study|Change in liver function/no longer eval.|0|||
49109118|NCT01273155|158234197|FG006|Overall Study|Change in liver function/no longer eval.|0|||
49109119|NCT01273155|158234191|FG000|Overall Study|Off study prior to C1/due to toxicity|0|||
49109120|NCT01273155|158234192|FG001|Overall Study|Off study prior to C1/due to toxicity|0|||
49109121|NCT01273155|158234193|FG002|Overall Study|Off study prior to C1/due to toxicity|2|||
49109122|NCT01273155|158234194|FG003|Overall Study|Off study prior to C1/due to toxicity|0|||
49109123|NCT01273155|158234195|FG004|Overall Study|Off study prior to C1/due to toxicity|0|||
49109124|NCT01273155|158234196|FG005|Overall Study|Off study prior to C1/due to toxicity|0|||
49109125|NCT01273155|158234197|FG006|Overall Study|Off study prior to C1/due to toxicity|1|||
49109126|NCT01273155|158234191|FG000|Overall Study|Died during Cycle 1|0|||
49109127|NCT01273155|158234192|FG001|Overall Study|Died during Cycle 1|0|||
49109128|NCT01273155|158234193|FG002|Overall Study|Died during Cycle 1|1|||
49109129|NCT01273155|158234194|FG003|Overall Study|Died during Cycle 1|1|||
49109130|NCT01273155|158234195|FG004|Overall Study|Died during Cycle 1|0|||
49109131|NCT01273155|158234196|FG005|Overall Study|Died during Cycle 1|2|||
49109132|NCT01273155|158234197|FG006|Overall Study|Died during Cycle 1|2|||
49109133|NCT01273155|158234191|FG000|Overall Study|Withdrew during C1/refused further trmt|0|||
49109134|NCT01273155|158234192|FG001|Overall Study|Withdrew during C1/refused further trmt|0|||
49109135|NCT01273155|158234193|FG002|Overall Study|Withdrew during C1/refused further trmt|1|||
49109136|NCT01273155|158234194|FG003|Overall Study|Withdrew during C1/refused further trmt|0|||
49109137|NCT01273155|158234195|FG004|Overall Study|Withdrew during C1/refused further trmt|1|||
49109138|NCT01273155|158234196|FG005|Overall Study|Withdrew during C1/refused further trmt|1|||
49109139|NCT01273155|158234197|FG006|Overall Study|Withdrew during C1/refused further trmt|0|||
49109140|NCT01606202|158234198|FG000|Overall Study|Adverse Event|5|||
49109141|NCT01606202|158234199|FG001|Overall Study|Adverse Event|0|||
49109142|NCT01606202|158234198|FG000|Overall Study|Withdrawal by Subject|2|||
49109143|NCT01606202|158234199|FG001|Overall Study|Withdrawal by Subject|1|||
49109144|NCT01606202|158234198|FG000|Overall Study|Personal problems|0|||
49109145|NCT01606202|158234199|FG001|Overall Study|Personal problems|1|||
49109146|NCT01606202|158234198|FG000|Overall Study|Problems with administration|0|||
49109147|NCT01606202|158234199|FG001|Overall Study|Problems with administration|1|||
49109148|NCT00380718|158234200|FG000|Overall Study|Adverse Event|1|||
49109149|NCT00380718|158234200|FG000|Overall Study|Death after 30-day post-therapy followup|17|||
49109150|NCT05020366|158234202|FG000|Overall Study|Lost to Follow-up|2|||
49109151|NCT05020366|158234203|FG001|Overall Study|Lost to Follow-up|0|||
49109152|NCT05020366|158234202|FG000|Overall Study|Withdrawal by Subject|2|||
49109153|NCT05020366|158234203|FG001|Overall Study|Withdrawal by Subject|0|||
49109154|NCT00483704|158234206|FG000|Randomization|Withdrawal by Subject|19|||
49109155|NCT00483704|158234207|FG001|Randomization|Withdrawal by Subject|28|||
49109156|NCT00483704|158234208|FG002|Randomization|Withdrawal by Subject|18|||
49109157|NCT00483704|158234206|FG000|Randomization|Protocol Violation|14|||
49109158|NCT00483704|158234207|FG001|Randomization|Protocol Violation|25|||
49109159|NCT00483704|158234208|FG002|Randomization|Protocol Violation|22|||
49109160|NCT00483704|158234206|FG000|Randomization|Lost to Follow-up|14|||
49109161|NCT00483704|158234207|FG001|Randomization|Lost to Follow-up|14|||
49109162|NCT00483704|158234208|FG002|Randomization|Lost to Follow-up|19|||
49109163|NCT00483704|158234206|FG000|Randomization|Pregnancy|1|||
49109164|NCT00483704|158234207|FG001|Randomization|Pregnancy|0|||
49109165|NCT00483704|158234208|FG002|Randomization|Pregnancy|0|||
49109166|NCT00483704|158234206|FG000|Randomization|Physician Decision|2|||
49109167|NCT00483704|158234207|FG001|Randomization|Physician Decision|4|||
49109168|NCT00483704|158234208|FG002|Randomization|Physician Decision|0|||
49109169|NCT00483704|158234206|FG000|Randomization|Progressive disease|0|||
49109170|NCT00483704|158234207|FG001|Randomization|Progressive disease|0|||
49109171|NCT00483704|158234208|FG002|Randomization|Progressive disease|1|||
49109172|NCT00483704|158234206|FG000|Randomization|Lack of qualifying migraines|21|||
49109173|NCT00483704|158234207|FG001|Randomization|Lack of qualifying migraines|25|||
49109174|NCT00483704|158234208|FG002|Randomization|Lack of qualifying migraines|31|||
49109175|NCT00483704|158234206|FG000|Treatment|Lack of qualifying migraines|101|||
49109176|NCT00483704|158234207|FG001|Treatment|Lack of qualifying migraines|99|||
49109177|NCT00483704|158234208|FG002|Treatment|Lack of qualifying migraines|116|||
49109178|NCT00483704|158234206|FG000|Treatment|Adverse Event|3|||
49109179|NCT00483704|158234207|FG001|Treatment|Adverse Event|5|||
49109180|NCT00483704|158234208|FG002|Treatment|Adverse Event|4|||
49109181|NCT00483704|158234206|FG000|Treatment|Withdrawal by Subject|16|||
49109182|NCT00483704|158234207|FG001|Treatment|Withdrawal by Subject|12|||
49109183|NCT00483704|158234208|FG002|Treatment|Withdrawal by Subject|21|||
49109184|NCT00483704|158234206|FG000|Treatment|Protocol Violation|6|||
49109185|NCT00483704|158234207|FG001|Treatment|Protocol Violation|3|||
49109186|NCT00483704|158234208|FG002|Treatment|Protocol Violation|5|||
49109187|NCT00483704|158234206|FG000|Treatment|Lost to Follow-up|2|||
49109188|NCT00483704|158234207|FG001|Treatment|Lost to Follow-up|7|||
49109189|NCT00483704|158234208|FG002|Treatment|Lost to Follow-up|5|||
49109190|NCT00483704|158234206|FG000|Treatment|Lack of Efficacy|1|||
49109191|NCT00483704|158234207|FG001|Treatment|Lack of Efficacy|1|||
49109192|NCT00483704|158234208|FG002|Treatment|Lack of Efficacy|1|||
49109193|NCT00483704|158234206|FG000|Treatment|Pregnancy|0|||
49109194|NCT00483704|158234207|FG001|Treatment|Pregnancy|1|||
49109195|NCT00483704|158234208|FG002|Treatment|Pregnancy|0|||
49109196|NCT00483704|158234206|FG000|Treatment|Physician Decision|0|||
49109197|NCT00483704|158234207|FG001|Treatment|Physician Decision|1|||
49109198|NCT00483704|158234208|FG002|Treatment|Physician Decision|4|||
49109199|NCT00431067|158234209|FG000|Overall Study|Other Adverse Event|9|||
49109200|NCT00431067|158234209|FG000|Overall Study|Progressive disease|30|||
49109201|NCT00431067|158234209|FG000|Overall Study|Non-compliance,lost to follow-up|2|||
49109202|NCT03217968|158234212|FG000|Overall Study|Withdrawal by Subject|4|||
49109203|NCT03217968|158234212|FG000|Overall Study|Lost to Follow-up|1|||
49109204|NCT03217968|158234212|FG000|Overall Study|Protocol Violation|6|||
49109205|NCT00314132|158234214|FG000|Overall Study|Lost to Follow-up|3|||
49109206|NCT00314132|158234215|FG001|Overall Study|Lost to Follow-up|13|||
49109207|NCT00314132|158234214|FG000|Overall Study|Withdrawal by Subject|3|||
49109208|NCT00314132|158234215|FG001|Overall Study|Withdrawal by Subject|5|||
49109209|NCT00314132|158234214|FG000|Overall Study|Adverse Event|1|||
49109210|NCT00314132|158234215|FG001|Overall Study|Adverse Event|0|||
49109211|NCT00314132|158234214|FG000|Overall Study|Physician Decision|1|||
49109212|NCT00314132|158234215|FG001|Overall Study|Physician Decision|0|||
49109213|NCT00958412|158234218|FG000|Overall Study|Study prematurely terminated|18|||
49109214|NCT00966355|158234219|FG000|Overall Study|non-variceal bleeding on endoscopy|68|||
49109215|NCT00966355|158234220|FG001|Overall Study|non-variceal bleeding on endoscopy|70|||
49109216|NCT00966355|158234221|FG002|Overall Study|non-variceal bleeding on endoscopy|71|||
49109217|NCT00966355|158234219|FG000|Overall Study|newly diagnosed advanced HCC|11|||
49109218|NCT00966355|158234220|FG001|Overall Study|newly diagnosed advanced HCC|12|||
49109219|NCT00966355|158234221|FG002|Overall Study|newly diagnosed advanced HCC|10|||
49109220|NCT00966355|158234219|FG000|Overall Study|Lost to Follow-up|5|||
49109221|NCT00966355|158234220|FG001|Overall Study|Lost to Follow-up|4|||
49109222|NCT00966355|158234221|FG002|Overall Study|Lost to Follow-up|3|||
49109223|NCT04226495|158234222|FG000|Overall Study|Withdrawal by Subject|3|||
49109224|NCT04226495|158234223|FG001|Overall Study|Withdrawal by Subject|3|||
49109225|NCT04226495|158234222|FG000|Overall Study|PI discretion|3|||
49109226|NCT04226495|158234223|FG001|Overall Study|PI discretion|4|||
49109227|NCT01783821|158234225|FG000|Overall Study|Screen Failure|1|||
49109228|NCT01783821|158234226|FG001|Overall Study|Screen Failure|1|||
49109229|NCT01643798|158236543|FG000|Pretreatment 1 and Stimulation|Withdrawal by Subject|1|||
49109230|NCT01643798|158236544|FG001|Pretreatment 1 and Stimulation|Withdrawal by Subject|0|||
49109276|NCT00328094|158236550|FG000|Overall Study|Physician Decision|3|||
49109277|NCT00328094|158236551|FG001|Overall Study|Physician Decision|3|||
49109278|NCT02607280|158236552|FG000|Overall Study|Adverse Event|4|||
49109279|NCT02607280|158236553|FG001|Overall Study|Adverse Event|0|||
49109280|NCT02607280|158236552|FG000|Overall Study|Decrease in CrCl <15|0|||
49109281|NCT02607280|158236553|FG001|Overall Study|Decrease in CrCl <15|1|||
49109282|NCT01911780|158236556|FG000|Double-blind Period (8 Weeks)|Adverse Event|1|||
49109283|NCT01911780|158236557|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
49109284|NCT01911780|158236556|FG000|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
49109285|NCT01911780|158236557|FG001|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
49109286|NCT01911780|158236556|FG000|Double-blind Period (8 Weeks)|Personal reason|1|||
49109287|NCT01911780|158236557|FG001|Double-blind Period (8 Weeks)|Personal reason|0|||
49109288|NCT01911780|158236556|FG000|Extension Period (52 Weeks)|Adverse Event|3|||
49109289|NCT01911780|158236557|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
49109290|NCT01911780|158236556|FG000|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0|||
49109291|NCT01911780|158236557|FG001|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2|||
49109292|NCT01911780|158236556|FG000|Extension Period (52 Weeks)|Personal reason|1|||
49109293|NCT01911780|158236557|FG001|Extension Period (52 Weeks)|Personal reason|1|||
49109294|NCT02368210|158236558|FG000|Overall Study|Withdrawal by Subject|1|||
49109295|NCT02368210|158236559|FG001|Overall Study|Withdrawal by Subject|0|||
49109296|NCT02368210|158236558|FG000|Overall Study|Adverse Event|0|||
49109297|NCT02368210|158236559|FG001|Overall Study|Adverse Event|1|||
49109298|NCT00078949|158236560|FG000|Overall Study|No treated|4|||
49109299|NCT00078949|158236561|FG001|Overall Study|No treated|5|||
49109300|NCT00078949|158236562|FG002|Overall Study|No treated|3|||
49109301|NCT00078949|158236563|FG003|Overall Study|No treated|3|||
49109302|NCT00577005|158236564|FG000|Overall Study|Lost to Follow-up|3|||
49109303|NCT00577005|158236565|FG001|Overall Study|Lost to Follow-up|2|||
49109304|NCT00577005|158236564|FG000|Overall Study|Withdrawal by Subject|2|||
49109305|NCT00577005|158236565|FG001|Overall Study|Withdrawal by Subject|1|||
49109306|NCT01133288|158236568|FG000|Eligibility Assessment|met exclusion criteria|5|||
49109307|NCT01133288|158236568|FG000|Intervention Allocation|study terminated|2|||
49109308|NCT01280682|158236569|FG000|Overall Study|Lost to Follow-up|0|||
49109309|NCT01280682|158236570|FG001|Overall Study|Lost to Follow-up|6|||
49109310|NCT01280682|158236569|FG000|Overall Study|Withdrawal by Subject|0|||
49109311|NCT01280682|158236570|FG001|Overall Study|Withdrawal by Subject|7|||
49109312|NCT02005627|158236583|FG000|Overall Study|Lost to Follow-up|1|||
49109313|NCT02005627|158236584|FG001|Overall Study|Lost to Follow-up|2|||
49109314|NCT02005627|158236583|FG000|Overall Study|Withdrawal by Subject|1|||
49109315|NCT02005627|158236584|FG001|Overall Study|Withdrawal by Subject|2|||
49109316|NCT01080391|158236591|FG000|Overall Study|Randomized but not treated|7|||
49109317|NCT01080391|158236592|FG001|Overall Study|Randomized but not treated|4|||
49109318|NCT01672294|158236593|FG000|Overall Study|Withdrawal by Subject|4|||
49109319|NCT01672294|158236594|FG001|Overall Study|Withdrawal by Subject|4|||
49109320|NCT01672294|158236595|FG002|Overall Study|Withdrawal by Subject|4|||
49109321|NCT01672294|158236596|FG003|Overall Study|Withdrawal by Subject|4|||
49109322|NCT01672294|158236593|FG000|Overall Study|Excluded by study|1|||
49109323|NCT01672294|158236594|FG001|Overall Study|Excluded by study|1|||
49109324|NCT01672294|158236595|FG002|Overall Study|Excluded by study|0|||
49109325|NCT01672294|158236596|FG003|Overall Study|Excluded by study|0|||
49109326|NCT01672294|158236593|FG000|Overall Study|Lost to Follow-up|1|||
49109327|NCT01672294|158236594|FG001|Overall Study|Lost to Follow-up|16|||
49109328|NCT01672294|158236595|FG002|Overall Study|Lost to Follow-up|7|||
49109329|NCT01672294|158236596|FG003|Overall Study|Lost to Follow-up|9|||
49109330|NCT03379792|158236597|FG000|Overall Study|Physician Decision|0|||
49109331|NCT03379792|158236598|FG001|Overall Study|Physician Decision|0|||
49109332|NCT03379792|158236599|FG002|Overall Study|Physician Decision|0|||
49109333|NCT03379792|158236600|FG003|Overall Study|Physician Decision|1|||
49109334|NCT03379792|158236601|FG004|Overall Study|Physician Decision|0|||
49109335|NCT03379792|158236602|FG005|Overall Study|Physician Decision|0|||
49109336|NCT03379792|158236597|FG000|Overall Study|Withdrawal by Subject|0|||
49109337|NCT03379792|158236598|FG001|Overall Study|Withdrawal by Subject|0|||
49109338|NCT03379792|158236599|FG002|Overall Study|Withdrawal by Subject|0|||
49109339|NCT03379792|158236600|FG003|Overall Study|Withdrawal by Subject|0|||
49109340|NCT03379792|158236601|FG004|Overall Study|Withdrawal by Subject|1|||
49109341|NCT03379792|158236602|FG005|Overall Study|Withdrawal by Subject|1|||
49109342|NCT01285492|158236603|FG000|Overall Study|Adverse Event|11|||
49109343|NCT01285492|158236604|FG001|Overall Study|Adverse Event|0|||
49109344|NCT01285492|158236603|FG000|Overall Study|Protocol Violation|3|||
49109345|NCT01285492|158236604|FG001|Overall Study|Protocol Violation|0|||
49109346|NCT01285492|158236603|FG000|Overall Study|Withdrawal by Subject|2|||
49109347|NCT01285492|158236604|FG001|Overall Study|Withdrawal by Subject|1|||
49109348|NCT01285492|158236603|FG000|Overall Study|Death|1|||
49109349|NCT01285492|158236604|FG001|Overall Study|Death|0|||
49109350|NCT01121536|158236606|FG000|Overall Study|Adverse Event|63|||
49109351|NCT01121536|158236606|FG000|Overall Study|Lack of Efficacy|35|||
49109352|NCT01121536|158236606|FG000|Overall Study|Withdrawal by Subject|65|||
49109353|NCT01121536|158236606|FG000|Overall Study|Protocol Violation|20|||
49109354|NCT01121536|158236606|FG000|Overall Study|Noncompliance with study medication|12|||
49109355|NCT01121536|158236606|FG000|Overall Study|Noncompliance with study procedures|9|||
49109356|NCT01121536|158236606|FG000|Overall Study|Lost to Follow-up|39|||
49109357|NCT01121536|158236606|FG000|Overall Study|Other|118|||
49109358|NCT00096993|158236609|FG000|Overall Study|Death|1|||
49109359|NCT00096993|158236610|FG001|Overall Study|Death|0|||
49109360|NCT00096993|158236609|FG000|Overall Study|Disease progression|56|||
49109361|NCT00096993|158236610|FG001|Overall Study|Disease progression|53|||
49109362|NCT00096993|158236609|FG000|Overall Study|Adverse Event|2|||
49109363|NCT00096993|158236610|FG001|Overall Study|Adverse Event|8|||
49109364|NCT00096993|158236609|FG000|Overall Study|Subject's decision|3|||
49109365|NCT00096993|158236610|FG001|Overall Study|Subject's decision|1|||
49109366|NCT00096993|158236609|FG000|Overall Study|Physician Decision|2|||
49109367|NCT00096993|158236610|FG001|Overall Study|Physician Decision|1|||
49109368|NCT00096993|158236609|FG000|Overall Study|Non-compliance|0|||
49109369|NCT00096993|158236610|FG001|Overall Study|Non-compliance|1|||
49109370|NCT00096993|158236609|FG000|Overall Study|Other unspecified|1|||
49109371|NCT00096993|158236610|FG001|Overall Study|Other unspecified|1|||
49109372|NCT01935128|158236611|FG000|Overall Study|Death|1|||
49109373|NCT01935128|158236611|FG000|Overall Study|Adverse Event|6|||
49109374|NCT00772005|158236615|FG000|Overall Study|Adverse Event|9|||
49109375|NCT00772005|158236616|FG001|Overall Study|Adverse Event|14|||
49109376|NCT00772005|158236617|FG002|Overall Study|Adverse Event|10|||
49109377|NCT00772005|158236618|FG003|Overall Study|Adverse Event|13|||
49109378|NCT00772005|158236615|FG000|Overall Study|Lack of Efficacy|0|||
49109379|NCT00772005|158236616|FG001|Overall Study|Lack of Efficacy|1|||
49109380|NCT00772005|158236617|FG002|Overall Study|Lack of Efficacy|0|||
49109381|NCT00772005|158236618|FG003|Overall Study|Lack of Efficacy|0|||
49109382|NCT00772005|158236615|FG000|Overall Study|Withdrawal by Subject|3|||
49109383|NCT00772005|158236616|FG001|Overall Study|Withdrawal by Subject|7|||
49109384|NCT00772005|158236617|FG002|Overall Study|Withdrawal by Subject|10|||
49109385|NCT00772005|158236618|FG003|Overall Study|Withdrawal by Subject|2|||
49109386|NCT00772005|158236615|FG000|Overall Study|Protocol Violation|2|||
49109387|NCT00772005|158236616|FG001|Overall Study|Protocol Violation|4|||
49109388|NCT00772005|158236617|FG002|Overall Study|Protocol Violation|1|||
49109389|NCT00772005|158236618|FG003|Overall Study|Protocol Violation|6|||
49109390|NCT00772005|158236615|FG000|Overall Study|Lost to Follow-up|7|||
49109391|NCT00772005|158236616|FG001|Overall Study|Lost to Follow-up|3|||
49109392|NCT00772005|158236617|FG002|Overall Study|Lost to Follow-up|6|||
49109393|NCT00772005|158236618|FG003|Overall Study|Lost to Follow-up|3|||
49109394|NCT00772005|158236615|FG000|Overall Study|Non-compliance with study procedures|1|||
49109395|NCT00772005|158236616|FG001|Overall Study|Non-compliance with study procedures|1|||
49109396|NCT00772005|158236617|FG002|Overall Study|Non-compliance with study procedures|0|||
49109397|NCT00772005|158236618|FG003|Overall Study|Non-compliance with study procedures|1|||
49109398|NCT00772005|158236615|FG000|Overall Study|Non-compliance with drug administration|3|||
49109399|NCT00772005|158236616|FG001|Overall Study|Non-compliance with drug administration|0|||
49109400|NCT00772005|158236617|FG002|Overall Study|Non-compliance with drug administration|1|||
49109401|NCT00772005|158236618|FG003|Overall Study|Non-compliance with drug administration|1|||
49109402|NCT00269477|158236619|FG000|Overall Study|Protocol Violation|5|||
49109403|NCT00269477|158236620|FG001|Overall Study|Protocol Violation|5|||
49109404|NCT00269477|158236621|FG002|Overall Study|Protocol Violation|1|||
49109405|NCT00269477|158236622|FG003|Overall Study|Protocol Violation|0|||
49109406|NCT00269477|158236619|FG000|Overall Study|Missed post-vaccination blood draw|0|||
49109407|NCT00269477|158236620|FG001|Overall Study|Missed post-vaccination blood draw|1|||
49109408|NCT00269477|158236621|FG002|Overall Study|Missed post-vaccination blood draw|0|||
49109409|NCT00269477|158236622|FG003|Overall Study|Missed post-vaccination blood draw|0|||
49109410|NCT00568334|158236625|FG000|Overall Study|Withdrawal by Subject|0|||
49109411|NCT00568334|158236626|FG001|Overall Study|Withdrawal by Subject|1|||
49109412|NCT00568334|158236625|FG000|Overall Study|Lost to Follow-up|1|||
49109413|NCT00568334|158236626|FG001|Overall Study|Lost to Follow-up|0|||
49109414|NCT01897571|158236627|FG000|Overall Study|Lost to Follow-up|3|||
49109415|NCT01897571|158236628|FG001|Overall Study|Lost to Follow-up|0|||
49109416|NCT01897571|158236629|FG002|Overall Study|Lost to Follow-up|0|||
49109417|NCT01897571|158236630|FG003|Overall Study|Lost to Follow-up|0|||
49109418|NCT01897571|158236631|FG004|Overall Study|Lost to Follow-up|2|||
49109419|NCT01897571|158236632|FG005|Overall Study|Lost to Follow-up|0|||
49109420|NCT01897571|158236633|FG006|Overall Study|Lost to Follow-up|0|||
49109421|NCT01897571|158236634|FG007|Overall Study|Lost to Follow-up|0|||
49109422|NCT01897571|158236635|FG008|Overall Study|Lost to Follow-up|1|||
49109423|NCT01897571|158236636|FG009|Overall Study|Lost to Follow-up|2|||
49109424|NCT01897571|158236637|FG010|Overall Study|Lost to Follow-up|4|||
49109425|NCT01897571|158236627|FG000|Overall Study|Withdrawal by Subject|0|||
49109426|NCT01897571|158236628|FG001|Overall Study|Withdrawal by Subject|0|||
49109427|NCT01897571|158236629|FG002|Overall Study|Withdrawal by Subject|0|||
49109428|NCT01897571|158236630|FG003|Overall Study|Withdrawal by Subject|0|||
49109429|NCT01897571|158236631|FG004|Overall Study|Withdrawal by Subject|0|||
49109430|NCT01897571|158236632|FG005|Overall Study|Withdrawal by Subject|0|||
49109431|NCT01897571|158236633|FG006|Overall Study|Withdrawal by Subject|0|||
49109432|NCT01897571|158236634|FG007|Overall Study|Withdrawal by Subject|1|||
49109433|NCT01897571|158236635|FG008|Overall Study|Withdrawal by Subject|4|||
49109434|NCT01897571|158236636|FG009|Overall Study|Withdrawal by Subject|3|||
49109435|NCT01897571|158236637|FG010|Overall Study|Withdrawal by Subject|1|||
49109436|NCT01897571|158236627|FG000|Overall Study|Other|1|||
49109437|NCT01897571|158236628|FG001|Overall Study|Other|0|||
49109438|NCT01897571|158236629|FG002|Overall Study|Other|0|||
49109439|NCT01897571|158236630|FG003|Overall Study|Other|3|||
49109440|NCT01897571|158236631|FG004|Overall Study|Other|3|||
49109441|NCT01897571|158236632|FG005|Overall Study|Other|4|||
49109442|NCT01897571|158236633|FG006|Overall Study|Other|7|||
49109443|NCT01897571|158236634|FG007|Overall Study|Other|0|||
49109444|NCT01897571|158236635|FG008|Overall Study|Other|0|||
49109445|NCT01897571|158236636|FG009|Overall Study|Other|0|||
49109446|NCT01897571|158236637|FG010|Overall Study|Other|0|||
49109447|NCT01897571|158236627|FG000|Overall Study|Enrolled in rollover study|0|||
49109448|NCT01897571|158236628|FG001|Overall Study|Enrolled in rollover study|0|||
49109449|NCT01897571|158236629|FG002|Overall Study|Enrolled in rollover study|0|||
49109450|NCT01897571|158236630|FG003|Overall Study|Enrolled in rollover study|0|||
49109451|NCT01897571|158236631|FG004|Overall Study|Enrolled in rollover study|0|||
49109452|NCT01897571|158236632|FG005|Overall Study|Enrolled in rollover study|0|||
49109453|NCT01897571|158236633|FG006|Overall Study|Enrolled in rollover study|0|||
49109454|NCT01897571|158236634|FG007|Overall Study|Enrolled in rollover study|9|||
49109455|NCT01897571|158236635|FG008|Overall Study|Enrolled in rollover study|7|||
49109456|NCT01897571|158236636|FG009|Overall Study|Enrolled in rollover study|9|||
49109457|NCT01897571|158236637|FG010|Overall Study|Enrolled in rollover study|1|||
49109458|NCT01897571|158236627|FG000|Overall Study|Death|2|||
49109459|NCT01897571|158236628|FG001|Overall Study|Death|2|||
49109460|NCT01897571|158236629|FG002|Overall Study|Death|3|||
49109461|NCT01897571|158236630|FG003|Overall Study|Death|6|||
49109462|NCT01897571|158236631|FG004|Overall Study|Death|7|||
49109463|NCT01897571|158236632|FG005|Overall Study|Death|9|||
49109464|NCT01897571|158236633|FG006|Overall Study|Death|5|||
49109465|NCT01897571|158236634|FG007|Overall Study|Death|22|||
49109466|NCT01897571|158236635|FG008|Overall Study|Death|23|||
49109467|NCT01897571|158236636|FG009|Overall Study|Death|129|||
49109468|NCT01897571|158236637|FG010|Overall Study|Death|59|||
49109469|NCT01256385|158236638|FG000|Overall Study|Physician Decision|1|||
49109470|NCT01256385|158236639|FG001|Overall Study|Physician Decision|1|||
49109471|NCT01256385|158236638|FG000|Overall Study|Withdrawal by Subject|2|||
49109472|NCT01256385|158236639|FG001|Overall Study|Withdrawal by Subject|2|||
49109473|NCT04702997|158236641|FG000|Overall Study|Withdrawal by Subject|1|||
49109474|NCT04702997|158236642|FG001|Overall Study|Withdrawal by Subject|1|||
49109475|NCT01797094|158236643|FG000|Overall Study|Adverse Event|1|||
49109476|NCT01797094|158236644|FG001|Overall Study|Adverse Event|1|||
49109477|NCT01797094|158236643|FG000|Overall Study|Personal Reasons|4|||
49109478|NCT01797094|158236644|FG001|Overall Study|Personal Reasons|0|||
49109479|NCT01797094|158236643|FG000|Overall Study|Protocol Violation|0|||
49109480|NCT01797094|158236644|FG001|Overall Study|Protocol Violation|1|||
49109481|NCT01797094|158236643|FG000|Overall Study|Other Miscellaneous Reasons|1|||
49109482|NCT01797094|158236644|FG001|Overall Study|Other Miscellaneous Reasons|0|||
49109483|NCT00401960|158236645|FG000|Overall Study|Lost to Follow-up|3|||
49109484|NCT00401960|158236646|FG001|Overall Study|Lost to Follow-up|0|||
49109485|NCT00401960|158236645|FG000|Overall Study|Death|2|||
49109486|NCT00401960|158236646|FG001|Overall Study|Death|0|||
49109487|NCT02649426|158236649|FG000|Overall Study|Follow-up on going|1|||
49109488|NCT02649426|158236650|FG001|Overall Study|Follow-up on going|26|||
49109489|NCT02649426|158236651|FG002|Overall Study|Follow-up on going|28|||
49109490|NCT02649426|158236652|FG003|Overall Study|Follow-up on going|31|||
49109491|NCT01440569|158236653|FG000|Main Study|Enrolled but not treated|1|||
49109492|NCT01440569|158236654|FG001|Main Study|Enrolled but not treated|0|||
49109493|NCT01440569|158236653|FG000|Main Study|Adverse Event|9|||
49109494|NCT01440569|158236654|FG001|Main Study|Adverse Event|0|||
49109495|NCT01440569|158236653|FG000|Main Study|Pregnancy|1|||
49109496|NCT01440569|158236654|FG001|Main Study|Pregnancy|0|||
49109497|NCT01440569|158236653|FG000|Main Study|Investigator's Discretion|1|||
49109498|NCT01440569|158236654|FG001|Main Study|Investigator's Discretion|1|||
49109499|NCT01440569|158236653|FG000|Main Study|Withdrew Consent|7|||
49109500|NCT01440569|158236654|FG001|Main Study|Withdrew Consent|1|||
49109501|NCT01440569|158236653|FG000|Main Study|Lost to Follow-up|13|||
49109502|NCT01440569|158236654|FG001|Main Study|Lost to Follow-up|2|||
49109503|NCT01440569|158236653|FG000|Main Study|Subject Non-Compliance|3|||
49109504|NCT01440569|158236654|FG001|Main Study|Subject Non-Compliance|0|||
49109505|NCT01440569|158236653|FG000|Main Study|Protocol Violation|1|||
49109506|NCT01440569|158236654|FG001|Main Study|Protocol Violation|0|||
49109507|NCT01440569|158236653|FG000|Open-Label Rollover Phase|Adverse Event|3|||
49109508|NCT01440569|158236654|FG001|Open-Label Rollover Phase|Adverse Event|0|||
49109509|NCT01440569|158236653|FG000|Open-Label Rollover Phase|Pregnancy|1|||
49109510|NCT01440569|158236654|FG001|Open-Label Rollover Phase|Pregnancy|0|||
49109511|NCT01440569|158236653|FG000|Open-Label Rollover Phase|Lack of Efficacy|2|||
49109512|NCT01440569|158236654|FG001|Open-Label Rollover Phase|Lack of Efficacy|0|||
49109513|NCT01440569|158236653|FG000|Open-Label Rollover Phase|Investigator's Discretion|3|||
49109514|NCT01440569|158236654|FG001|Open-Label Rollover Phase|Investigator's Discretion|1|||
49109515|NCT01440569|158236653|FG000|Open-Label Rollover Phase|Withdrew Consent|11|||
49109516|NCT01440569|158236654|FG001|Open-Label Rollover Phase|Withdrew Consent|1|||
49109517|NCT01440569|158236653|FG000|Open-Label Rollover Phase|Lost to Follow-up|26|||
49109518|NCT01440569|158236654|FG001|Open-Label Rollover Phase|Lost to Follow-up|3|||
49109519|NCT01440569|158236653|FG000|Open-Label Rollover Phase|Subject Non-Compliance|1|||
49109520|NCT01440569|158236654|FG001|Open-Label Rollover Phase|Subject Non-Compliance|1|||
49109521|NCT00467558|158236658|FG000|Overall Study|Lost to Follow-up|2|||
49109522|NCT00467558|158236659|FG001|Overall Study|Lost to Follow-up|0|||
49109523|NCT00856843|158236665|FG000|Overall Study|Withdrawal by Subject|1|||
49109524|NCT00856843|158236666|FG001|Overall Study|Withdrawal by Subject|5|||
49109525|NCT00856843|158236665|FG000|Overall Study|Lack of Efficacy|1|||
49109526|NCT00856843|158236666|FG001|Overall Study|Lack of Efficacy|0|||
49109527|NCT03677934|158236668|FG000|Overall Study|Adverse Event|1|||
49109528|NCT03677934|158236669|FG001|Overall Study|Adverse Event|1|||
49109529|NCT03677934|158236668|FG000|Overall Study|Death|8|||
49109530|NCT03677934|158236669|FG001|Overall Study|Death|4|||
49109531|NCT03677934|158236668|FG000|Overall Study|Lost to Follow-up|3|||
49109532|NCT03677934|158236669|FG001|Overall Study|Lost to Follow-up|0|||
49109533|NCT03677934|158236668|FG000|Overall Study|Non-Compliance With Study Drug|1|||
49109534|NCT03677934|158236669|FG001|Overall Study|Non-Compliance With Study Drug|0|||
49109535|NCT03677934|158236668|FG000|Overall Study|Physician Decision|0|||
49109536|NCT03677934|158236669|FG001|Overall Study|Physician Decision|1|||
49109537|NCT03677934|158236668|FG000|Overall Study|Withdrawal by Subject|1|||
49109538|NCT03677934|158236669|FG001|Overall Study|Withdrawal by Subject|7|||
49109539|NCT00957905|158236670|FG000|Part B|Not Treated|0|||
49109540|NCT00957905|158236671|FG001|Part B|Not Treated|1|||
49109541|NCT00957905|158236670|FG000|Part B|Physician Decision|0|||
49109542|NCT00957905|158236671|FG001|Part B|Physician Decision|1|||
49109543|NCT00957905|158236670|FG000|Part B|Death|0|||
49109544|NCT00957905|158236671|FG001|Part B|Death|1|||
49109545|NCT00957905|158236670|FG000|Part B|Protocol Violation|0|||
49109546|NCT00957905|158236671|FG001|Part B|Protocol Violation|1|||
49109547|NCT02083653|158236672|FG000|Overall Study|Randomized but not Treated|0|||
49109548|NCT02083653|158236673|FG001|Overall Study|Randomized but not Treated|2|||
49109549|NCT02083653|158236674|FG002|Overall Study|Randomized but not Treated|7|||
49109550|NCT02083653|158236672|FG000|Overall Study|Adverse Event|12|||
49109551|NCT02083653|158236673|FG001|Overall Study|Adverse Event|5|||
49109552|NCT02083653|158236674|FG002|Overall Study|Adverse Event|4|||
49109553|NCT02083653|158236672|FG000|Overall Study|Lost to Follow-up|1|||
49109554|NCT02083653|158236673|FG001|Overall Study|Lost to Follow-up|0|||
49109555|NCT02083653|158236674|FG002|Overall Study|Lost to Follow-up|0|||
49109556|NCT02083653|158236672|FG000|Overall Study|Death|2|||
49109557|NCT02083653|158236673|FG001|Overall Study|Death|2|||
49109558|NCT02083653|158236674|FG002|Overall Study|Death|2|||
49109559|NCT02083653|158236672|FG000|Overall Study|Progressive Disease|65|||
49109560|NCT02083653|158236673|FG001|Overall Study|Progressive Disease|73|||
49109561|NCT02083653|158236674|FG002|Overall Study|Progressive Disease|63|||
49109562|NCT02083653|158236672|FG000|Overall Study|Withdrawal by Subject|2|||
49109563|NCT02083653|158236673|FG001|Overall Study|Withdrawal by Subject|1|||
49109564|NCT02083653|158236674|FG002|Overall Study|Withdrawal by Subject|2|||
49109565|NCT02083653|158236672|FG000|Overall Study|Other Events|0|||
49109566|NCT02083653|158236673|FG001|Overall Study|Other Events|2|||
49109567|NCT02083653|158236674|FG002|Overall Study|Other Events|2|||
49109568|NCT02083653|158236672|FG000|Overall Study|Reason Missing|0|||
49109569|NCT02083653|158236673|FG001|Overall Study|Reason Missing|0|||
49109570|NCT02083653|158236674|FG002|Overall Study|Reason Missing|4|||
49109571|NCT01333956|158236675|FG000|Overall Study|Lost to Follow-up|1|||
49109572|NCT01333956|158236676|FG001|Overall Study|Lost to Follow-up|2|||
49109573|NCT01333956|158236677|FG002|Overall Study|Lost to Follow-up|0|||
49109574|NCT01333956|158236678|FG003|Overall Study|Lost to Follow-up|1|||
49109575|NCT01333956|158236675|FG000|Overall Study|Unable to complete study procedure|1|||
49109576|NCT01333956|158236676|FG001|Overall Study|Unable to complete study procedure|0|||
49109577|NCT01333956|158236677|FG002|Overall Study|Unable to complete study procedure|0|||
49109578|NCT01333956|158236678|FG003|Overall Study|Unable to complete study procedure|1|||
49109579|NCT01333956|158236675|FG000|Overall Study|Withdrawal by Subject|0|||
49109580|NCT01333956|158236676|FG001|Overall Study|Withdrawal by Subject|2|||
49109581|NCT01333956|158236677|FG002|Overall Study|Withdrawal by Subject|1|||
49109582|NCT01333956|158236678|FG003|Overall Study|Withdrawal by Subject|0|||
49109583|NCT02073656|158236697|FG000|Primary Study|Lost to Follow-up|6|||
49109584|NCT02073656|158236697|FG000|Primary Study|Death|1|||
49109585|NCT02073656|158236697|FG000|Primary Study|Withdrew Consent|1|||
49109586|NCT02839876|158236698|FG000|Overall Study|Protocol Violation|10|||
49109587|NCT02839876|158236699|FG001|Overall Study|Protocol Violation|11|||
49109588|NCT03383692|158236706|FG000|Overall Study|Progressive disease as per RECIST|3|||
49109589|NCT03383692|158236707|FG001|Overall Study|Progressive disease as per RECIST|3|||
49109590|NCT03383692|158236706|FG000|Overall Study|Clinical progression|0|||
49109591|NCT03383692|158236707|FG001|Overall Study|Clinical progression|1|||
49109592|NCT03383692|158236706|FG000|Overall Study|Adverse Event|3|||
49109593|NCT03383692|158236707|FG001|Overall Study|Adverse Event|0|||
49109594|NCT02333383|158236716|FG000|Overall Study|Adalimumab discontinuation|21|||
49109595|NCT02333383|158236716|FG000|Overall Study|Lost to Follow-up|15|||
49109596|NCT02333383|158236716|FG000|Overall Study|Withdrawal by Subject|3|||
49109597|NCT02333383|158236716|FG000|Overall Study|Transfer to another hospital|2|||
49109598|NCT03373461|158236718|FG000|Part 2|Adverse Event|0|||
49109599|NCT03373461|158236719|FG001|Part 2|Adverse Event|1|||
49109600|NCT03373461|158236720|FG002|Part 2|Adverse Event|0|||
49109601|NCT03373461|158236721|FG003|Part 2|Adverse Event|0|||
49109602|NCT03373461|158236722|FG004|Part 2|Adverse Event|1|||
49109603|NCT01573754|158236723|FG000|Overall Study|Noncompliance or remission not achieved|3|||
49109604|NCT01573754|158236724|FG001|Overall Study|Noncompliance or remission not achieved|15|||
49109605|NCT00829829|158236730|FG000|Overall Study|Protocol Violation|0|||
49109606|NCT00829829|158236731|FG001|Overall Study|Protocol Violation|3|||
49109607|NCT00829829|158236732|FG002|Overall Study|Protocol Violation|0|||
49109608|NCT00829829|158236730|FG000|Overall Study|Adverse Event|4|||
49109609|NCT00829829|158236731|FG001|Overall Study|Adverse Event|4|||
49109610|NCT00829829|158236732|FG002|Overall Study|Adverse Event|3|||
49109611|NCT00829829|158236730|FG000|Overall Study|Withdrawal by Subject|8|||
49109612|NCT00829829|158236731|FG001|Overall Study|Withdrawal by Subject|4|||
49109613|NCT00829829|158236732|FG002|Overall Study|Withdrawal by Subject|2|||
49109614|NCT00829829|158236730|FG000|Overall Study|Decision by the Sponsor|1|||
49109615|NCT00829829|158236731|FG001|Overall Study|Decision by the Sponsor|0|||
49109616|NCT00829829|158236732|FG002|Overall Study|Decision by the Sponsor|2|||
49109617|NCT00829829|158236730|FG000|Overall Study|Lost to Follow-up|7|||
49109618|NCT00829829|158236731|FG001|Overall Study|Lost to Follow-up|3|||
49109619|NCT00829829|158236732|FG002|Overall Study|Lost to Follow-up|3|||
49109620|NCT00829829|158236730|FG000|Overall Study|Other than specified above|2|||
49109621|NCT00829829|158236731|FG001|Overall Study|Other than specified above|2|||
49109622|NCT00829829|158236732|FG002|Overall Study|Other than specified above|1|||
49109623|NCT02984267|158236733|FG000|Overall Study|Protocol Violation|1|||
49109624|NCT02984267|158236734|FG001|Overall Study|Protocol Violation|0|||
49109625|NCT02984267|158236733|FG000|Overall Study|Withdrawal by Subject|0|||
49109626|NCT02984267|158236734|FG001|Overall Study|Withdrawal by Subject|1|||
49109627|NCT02685072|158236735|FG000|Treatment Period|Lost to Follow-up|12|||
49109628|NCT02685072|158236736|FG001|Treatment Period|Lost to Follow-up|6|||
49109629|NCT02685072|158236735|FG000|Treatment Period|Withdrawal by Subject|1|||
49109630|NCT02685072|158236736|FG001|Treatment Period|Withdrawal by Subject|3|||
49109631|NCT02685072|158236735|FG000|1-Month Follow-Up|Withdrawal by Subject|1|||
49109632|NCT02685072|158236736|FG001|1-Month Follow-Up|Withdrawal by Subject|0|||
49109633|NCT01907217|158236737|FG000|Overall Study|Withdrawal by Subject|0|||
49109634|NCT01907217|158236738|FG001|Overall Study|Withdrawal by Subject|2|||
49109635|NCT01752634|158238358|FG000|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
49109636|NCT01752634|158238359|FG001|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
49109637|NCT01752634|158238360|FG002|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
49109638|NCT01752634|158238361|FG003|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
49109639|NCT01752634|158238362|FG004|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
49109640|NCT01752634|158238363|FG005|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3|||
49109641|NCT01752634|158238358|FG000|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
49109642|NCT01752634|158238359|FG001|Up to Week 24 (Primary Analysis)|Physician Decision|1|||
49109643|NCT01752634|158238360|FG002|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
49109644|NCT01752634|158238361|FG003|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
49109645|NCT01752634|158238362|FG004|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
49109646|NCT01752634|158238363|FG005|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
49109647|NCT01752634|158238358|FG000|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2|||
49109648|NCT01752634|158238359|FG001|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
49109649|NCT01752634|158238360|FG002|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
49109650|NCT01752634|158238361|FG003|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
49109651|NCT01752634|158238362|FG004|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
49109652|NCT01752634|158238363|FG005|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
49109653|NCT01752634|158238358|FG000|Up to Week 24 (Primary Analysis)|Adverse Event|3|||
49109654|NCT01752634|158238359|FG001|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
49109655|NCT01752634|158238360|FG002|Up to Week 24 (Primary Analysis)|Adverse Event|2|||
49109656|NCT01752634|158238361|FG003|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
49109657|NCT01752634|158238362|FG004|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
49109658|NCT01752634|158238363|FG005|Up to Week 24 (Primary Analysis)|Adverse Event|4|||
49109659|NCT01752634|158238358|FG000|Week 24 to Week 260|Lack of Efficacy|15|||
49109660|NCT01752634|158238359|FG001|Week 24 to Week 260|Lack of Efficacy|7|||
49109661|NCT01752634|158238360|FG002|Week 24 to Week 260|Lack of Efficacy|7|||
49109662|NCT01752634|158238361|FG003|Week 24 to Week 260|Lack of Efficacy|3|||
49109663|NCT01752634|158238362|FG004|Week 24 to Week 260|Lack of Efficacy|4|||
49109664|NCT01752634|158238363|FG005|Week 24 to Week 260|Lack of Efficacy|0|||
49109665|NCT01752634|158238358|FG000|Week 24 to Week 260|Subject/guardian decision|12|||
49109666|NCT01752634|158238359|FG001|Week 24 to Week 260|Subject/guardian decision|10|||
49109667|NCT01752634|158238360|FG002|Week 24 to Week 260|Subject/guardian decision|9|||
49109668|NCT01752634|158238361|FG003|Week 24 to Week 260|Subject/guardian decision|5|||
49109669|NCT01752634|158238362|FG004|Week 24 to Week 260|Subject/guardian decision|5|||
49109670|NCT01752634|158238363|FG005|Week 24 to Week 260|Subject/guardian decision|0|||
49109671|NCT01752634|158238358|FG000|Week 24 to Week 260|Physician Decision|1|||
49109672|NCT01752634|158238359|FG001|Week 24 to Week 260|Physician Decision|2|||
49109673|NCT01752634|158238360|FG002|Week 24 to Week 260|Physician Decision|4|||
49109674|NCT01752634|158238361|FG003|Week 24 to Week 260|Physician Decision|2|||
49109675|NCT01752634|158238362|FG004|Week 24 to Week 260|Physician Decision|1|||
49109676|NCT01752634|158238363|FG005|Week 24 to Week 260|Physician Decision|0|||
49109677|NCT01752634|158238358|FG000|Week 24 to Week 260|Death|0|||
49109678|NCT01752634|158238359|FG001|Week 24 to Week 260|Death|1|||
49109679|NCT01752634|158238360|FG002|Week 24 to Week 260|Death|0|||
49109680|NCT01752634|158238361|FG003|Week 24 to Week 260|Death|0|||
49109681|NCT01752634|158238362|FG004|Week 24 to Week 260|Death|0|||
49109682|NCT01752634|158238363|FG005|Week 24 to Week 260|Death|0|||
49109683|NCT01752634|158238358|FG000|Week 24 to Week 260|Pregnancy|0|||
49109684|NCT01752634|158238359|FG001|Week 24 to Week 260|Pregnancy|0|||
49109685|NCT01752634|158238360|FG002|Week 24 to Week 260|Pregnancy|1|||
49109686|NCT01752634|158238361|FG003|Week 24 to Week 260|Pregnancy|0|||
49109687|NCT01752634|158238362|FG004|Week 24 to Week 260|Pregnancy|0|||
49109688|NCT01752634|158238363|FG005|Week 24 to Week 260|Pregnancy|0|||
49109689|NCT01752634|158238358|FG000|Week 24 to Week 260|Noncompliance with study treatment|0|||
49109690|NCT01752634|158238359|FG001|Week 24 to Week 260|Noncompliance with study treatment|0|||
49109691|NCT01752634|158238360|FG002|Week 24 to Week 260|Noncompliance with study treatment|1|||
49109692|NCT01752634|158238361|FG003|Week 24 to Week 260|Noncompliance with study treatment|0|||
49109693|NCT01752634|158238362|FG004|Week 24 to Week 260|Noncompliance with study treatment|0|||
49109694|NCT01752634|158238363|FG005|Week 24 to Week 260|Noncompliance with study treatment|0|||
49109695|NCT01752634|158238358|FG000|Week 24 to Week 260|Lost to Follow-up|2|||
49109696|NCT01752634|158238359|FG001|Week 24 to Week 260|Lost to Follow-up|2|||
49109697|NCT01752634|158238360|FG002|Week 24 to Week 260|Lost to Follow-up|3|||
49109698|NCT01752634|158238361|FG003|Week 24 to Week 260|Lost to Follow-up|0|||
49109699|NCT01752634|158238362|FG004|Week 24 to Week 260|Lost to Follow-up|2|||
49109700|NCT01752634|158238363|FG005|Week 24 to Week 260|Lost to Follow-up|0|||
49109701|NCT01752634|158238358|FG000|Week 24 to Week 260|Adverse Event|4|||
49109702|NCT01752634|158238359|FG001|Week 24 to Week 260|Adverse Event|8|||
49109703|NCT01752634|158238360|FG002|Week 24 to Week 260|Adverse Event|8|||
49109704|NCT01752634|158238361|FG003|Week 24 to Week 260|Adverse Event|4|||
49109705|NCT01752634|158238362|FG004|Week 24 to Week 260|Adverse Event|2|||
49109706|NCT01752634|158238363|FG005|Week 24 to Week 260|Adverse Event|0|||
49109707|NCT01004432|158238368|FG000|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20|||
49109708|NCT01004432|158238369|FG001|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
49109709|NCT01004432|158238370|FG002|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
49109710|NCT01004432|158238371|FG003|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
49109711|NCT01004432|158238372|FG004|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
49109712|NCT01004432|158238368|FG000|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29|||
49109713|NCT01004432|158238369|FG001|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
49109714|NCT01004432|158238370|FG002|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
49109715|NCT01004432|158238371|FG003|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
49109716|NCT01004432|158238372|FG004|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
49109717|NCT01004432|158238368|FG000|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17|||
49109718|NCT01004432|158238369|FG001|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
49109719|NCT01004432|158238370|FG002|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
49109720|NCT01004432|158238371|FG003|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
49109721|NCT01004432|158238372|FG004|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
49109722|NCT01004432|158238368|FG000|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15|||
49109723|NCT01004432|158238369|FG001|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
49109724|NCT01004432|158238370|FG002|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
49109725|NCT01004432|158238371|FG003|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
49109726|NCT01004432|158238372|FG004|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
49109727|NCT01004432|158238368|FG000|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2|||
49109728|NCT01004432|158238369|FG001|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
49109729|NCT01004432|158238370|FG002|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
49109730|NCT01004432|158238371|FG003|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
49109731|NCT01004432|158238372|FG004|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
49109732|NCT01004432|158238368|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
49109733|NCT01004432|158238369|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1|||
49109734|NCT01004432|158238370|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5|||
49109735|NCT01004432|158238371|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6|||
49109736|NCT01004432|158238372|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
49109737|NCT01004432|158238368|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
49109738|NCT01004432|158238369|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
49109739|NCT01004432|158238370|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
49109740|NCT01004432|158238371|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4|||
49109741|NCT01004432|158238372|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
49109742|NCT01004432|158238368|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
49109743|NCT01004432|158238369|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1|||
49109744|NCT01004432|158238370|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4|||
49109745|NCT01004432|158238371|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7|||
49109746|NCT01004432|158238372|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
49109747|NCT01004432|158238368|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
49109748|NCT01004432|158238369|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
49109749|NCT01004432|158238370|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
49109750|NCT01004432|158238371|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Death|1|||
49109751|NCT01004432|158238372|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
49109752|NCT01004432|158238368|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
49109753|NCT01004432|158238369|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2|||
49109754|NCT01004432|158238370|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24|||
49109755|NCT01004432|158238371|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37|||
49109756|NCT01004432|158238372|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
49109757|NCT01004432|158238368|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
49109758|NCT01004432|158238369|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
49109759|NCT01004432|158238370|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1|||
49109760|NCT01004432|158238371|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
49109761|NCT01004432|158238372|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
49109762|NCT01004432|158238368|FG000|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
49109763|NCT01004432|158238369|FG001|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
49109764|NCT01004432|158238370|FG002|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
49109765|NCT01004432|158238371|FG003|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
49109766|NCT01004432|158238372|FG004|OL Study Extension (Week 52 - 76)|Adverse Event|2|||
49109767|NCT01004432|158238368|FG000|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
49109768|NCT01004432|158238369|FG001|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
49109769|NCT01004432|158238370|FG002|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
49109770|NCT01004432|158238371|FG003|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
49109771|NCT01004432|158238372|FG004|OL Study Extension (Week 52 - 76)|Protocol Violation|4|||
49109772|NCT01004432|158238368|FG000|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
49109773|NCT01004432|158238369|FG001|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
49109774|NCT01004432|158238370|FG002|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
49109775|NCT01004432|158238371|FG003|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
49109776|NCT01004432|158238372|FG004|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2|||
49109777|NCT01004432|158238368|FG000|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
49109778|NCT01004432|158238369|FG001|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
49109779|NCT01004432|158238370|FG002|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
49109780|NCT01004432|158238371|FG003|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
49109781|NCT01004432|158238372|FG004|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10|||
49109782|NCT02667626|158238373|FG000|Overall Study|Withdrawal by Subject|0|||
49109783|NCT02667626|158238374|FG001|Overall Study|Withdrawal by Subject|1|||
49109784|NCT00473824|158238376|FG000|Overall Study|Virologic Breakthrough|1|||
49109785|NCT00473824|158238377|FG001|Overall Study|Virologic Breakthrough|0|||
49109786|NCT00473824|158238376|FG000|Overall Study|Adverse Event|1|||
49109787|NCT00473824|158238377|FG001|Overall Study|Adverse Event|0|||
49109788|NCT00473824|158238376|FG000|Overall Study|Death|1|||
49109789|NCT00473824|158238377|FG001|Overall Study|Death|0|||
49109790|NCT00473824|158238376|FG000|Overall Study|Lost to Follow-up|1|||
49109791|NCT00473824|158238377|FG001|Overall Study|Lost to Follow-up|0|||
49109792|NCT00473824|158238376|FG000|Overall Study|Withdrawal by physician|1|||
49109793|NCT00473824|158238377|FG001|Overall Study|Withdrawal by physician|0|||
49109794|NCT02696434|158238380|FG000|Overall Study|Adverse Event|3|||
49109795|NCT02696434|158238381|FG001|Overall Study|Adverse Event|1|||
49109796|NCT02696434|158238380|FG000|Overall Study|Lost to Follow-up|5|||
49109797|NCT02696434|158238381|FG001|Overall Study|Lost to Follow-up|4|||
49109798|NCT02696434|158238380|FG000|Overall Study|Withdrawal by Subject|14|||
49109799|NCT02696434|158238381|FG001|Overall Study|Withdrawal by Subject|12|||
49109800|NCT02696434|158238380|FG000|Overall Study|Physician Decision|0|||
49109801|NCT02696434|158238381|FG001|Overall Study|Physician Decision|1|||
49109802|NCT00938587|158238382|FG000|Overall Study|Adverse Event|2|||
49109803|NCT00938587|158238383|FG001|Overall Study|Adverse Event|0|||
49109804|NCT00938587|158238384|FG002|Overall Study|Adverse Event|0|||
49109805|NCT00938587|158238385|FG003|Overall Study|Adverse Event|2|||
49109806|NCT00938587|158238382|FG000|Overall Study|Did not meet entrance criteria|0|||
49109807|NCT00938587|158238383|FG001|Overall Study|Did not meet entrance criteria|0|||
49109808|NCT00938587|158238384|FG002|Overall Study|Did not meet entrance criteria|1|||
49109809|NCT00938587|158238385|FG003|Overall Study|Did not meet entrance criteria|0|||
49109810|NCT00938587|158238382|FG000|Overall Study|Withdrawal by Subject|1|||
49109811|NCT00938587|158238383|FG001|Overall Study|Withdrawal by Subject|1|||
49109812|NCT00938587|158238384|FG002|Overall Study|Withdrawal by Subject|0|||
49109813|NCT00938587|158238385|FG003|Overall Study|Withdrawal by Subject|0|||
49109814|NCT03003000|158238388|FG000|Overall Study|Adverse Event|1|||
49109815|NCT03003000|158238389|FG001|Overall Study|Adverse Event|2|||
49109816|NCT03003000|158238390|FG002|Overall Study|Adverse Event|3|||
49109817|NCT03003000|158238388|FG000|Overall Study|Lack of Efficacy|1|||
49109818|NCT03003000|158238389|FG001|Overall Study|Lack of Efficacy|0|||
49109819|NCT03003000|158238390|FG002|Overall Study|Lack of Efficacy|0|||
49109820|NCT03003000|158238388|FG000|Overall Study|Non-compliant with protocol|0|||
49109821|NCT03003000|158238389|FG001|Overall Study|Non-compliant with protocol|1|||
49109822|NCT03003000|158238390|FG002|Overall Study|Non-compliant with protocol|1|||
49109823|NCT03003000|158238388|FG000|Overall Study|Refused to continue medication|2|||
49109824|NCT03003000|158238389|FG001|Overall Study|Refused to continue medication|0|||
49109825|NCT03003000|158238390|FG002|Overall Study|Refused to continue medication|0|||
49109826|NCT03003000|158238388|FG000|Overall Study|Other than listed|1|||
49109827|NCT03003000|158238389|FG001|Overall Study|Other than listed|1|||
49109828|NCT03003000|158238390|FG002|Overall Study|Other than listed|1|||
49109829|NCT01428115|158238391|FG000|Overall Study|Lack of Efficacy|3|||
49109830|NCT01428115|158238391|FG000|Overall Study|Lost to Follow-up|10|||
49109831|NCT01428115|158238391|FG000|Overall Study|Pregnancy|1|||
49109832|NCT01428115|158238391|FG000|Overall Study|Protocol Violation|3|||
49109833|NCT01428115|158238391|FG000|Overall Study|Withdrawal by Subject|4|||
49109834|NCT00306787|158238393|FG000|Overall Study|Discontinued without taking study drug|208|||
49109835|NCT00306787|158238394|FG001|Overall Study|Discontinued without taking study drug|215|||
49109836|NCT00306787|158238393|FG000|Overall Study|Adverse Event|1|||
49109837|NCT00306787|158238394|FG001|Overall Study|Adverse Event|1|||
49109838|NCT00306787|158238393|FG000|Overall Study|Lack of Efficacy|1|||
49109839|NCT00306787|158238394|FG001|Overall Study|Lack of Efficacy|0|||
49109840|NCT00306787|158238393|FG000|Overall Study|Protocol Violation|8|||
49109841|NCT00306787|158238394|FG001|Overall Study|Protocol Violation|10|||
49109842|NCT00306787|158238393|FG000|Overall Study|Withdrawal by Subject|2|||
49109843|NCT00306787|158238394|FG001|Overall Study|Withdrawal by Subject|9|||
49109844|NCT00306787|158238393|FG000|Overall Study|Lost to Follow-up|9|||
49109845|NCT00306787|158238394|FG001|Overall Study|Lost to Follow-up|6|||
49109846|NCT00306787|158238393|FG000|Overall Study|Administrative problems|4|||
49109847|NCT00306787|158238394|FG001|Overall Study|Administrative problems|0|||
49109848|NCT00306787|158238393|FG000|Overall Study|Abnormal laboratory value(s)|1|||
49109849|NCT00306787|158238394|FG001|Overall Study|Abnormal laboratory value(s)|0|||
49109850|NCT04933617|158238400|FG000|Dose Escalation|Early closure of study|0|||
49109851|NCT04933617|158238401|FG001|Dose Escalation|Early closure of study|3|||
49109852|NCT04933617|158238402|FG002|Dose Escalation|Early closure of study|0|||
49109853|NCT04933617|158238403|FG003|Dose Escalation|Early closure of study|0|||
49109854|NCT04933617|158238404|FG004|Dose Escalation|Early closure of study|0|||
49109855|NCT01438814|158238410|FG000|Overall Study|Adverse Event|3|||
49109856|NCT01438814|158238411|FG001|Overall Study|Adverse Event|3|||
49109857|NCT01438814|158238410|FG000|Overall Study|Protocol Violation|1|||
49109858|NCT01438814|158238411|FG001|Overall Study|Protocol Violation|2|||
49109859|NCT01438814|158238410|FG000|Overall Study|Lost to Follow-up|4|||
49109860|NCT01438814|158238411|FG001|Overall Study|Lost to Follow-up|3|||
49109861|NCT01438814|158238410|FG000|Overall Study|Withdrawal by Subject|4|||
49109862|NCT01438814|158238411|FG001|Overall Study|Withdrawal by Subject|2|||
49109863|NCT01438814|158238410|FG000|Overall Study|Other|2|||
49109864|NCT01438814|158238411|FG001|Overall Study|Other|4|||
49109865|NCT05268016|158238421|FG000|Overall Study|Unacceptable toxicity or AE|2|||
49109866|NCT05268016|158238422|FG001|Overall Study|Unacceptable toxicity or AE|2|||
49109867|NCT05268016|158238423|FG002|Overall Study|Unacceptable toxicity or AE|4|||
49109868|NCT05268016|158238424|FG003|Overall Study|Unacceptable toxicity or AE|3|||
49109869|NCT05268016|158238425|FG004|Overall Study|Unacceptable toxicity or AE|1|||
49109870|NCT05268016|158238421|FG000|Overall Study|Withdrawal by Subject|1|||
49109871|NCT05268016|158238422|FG001|Overall Study|Withdrawal by Subject|3|||
49109872|NCT05268016|158238423|FG002|Overall Study|Withdrawal by Subject|2|||
49109873|NCT05268016|158238424|FG003|Overall Study|Withdrawal by Subject|2|||
49109874|NCT05268016|158238425|FG004|Overall Study|Withdrawal by Subject|1|||
49109875|NCT05268016|158238421|FG000|Overall Study|Lost to Follow-up|4|||
49109876|NCT05268016|158238422|FG001|Overall Study|Lost to Follow-up|7|||
49109877|NCT05268016|158238423|FG002|Overall Study|Lost to Follow-up|1|||
49109878|NCT05268016|158238424|FG003|Overall Study|Lost to Follow-up|3|||
49109879|NCT05268016|158238425|FG004|Overall Study|Lost to Follow-up|5|||
49109880|NCT05268016|158238421|FG000|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
49109881|NCT05268016|158238422|FG001|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
49109882|NCT05268016|158238423|FG002|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
49109883|NCT05268016|158238424|FG003|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
49109884|NCT05268016|158238425|FG004|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
49109885|NCT05268016|158238421|FG000|Overall Study|Lack of Efficacy|0|||
49109886|NCT05268016|158238422|FG001|Overall Study|Lack of Efficacy|0|||
49109887|NCT05268016|158238423|FG002|Overall Study|Lack of Efficacy|0|||
49109888|NCT05268016|158238424|FG003|Overall Study|Lack of Efficacy|0|||
49109889|NCT05268016|158238425|FG004|Overall Study|Lack of Efficacy|4|||
49109890|NCT05268016|158238421|FG000|Overall Study|Physician Decision|0|||
49109891|NCT05268016|158238422|FG001|Overall Study|Physician Decision|0|||
49109892|NCT05268016|158238423|FG002|Overall Study|Physician Decision|0|||
49109893|NCT05268016|158238424|FG003|Overall Study|Physician Decision|1|||
49109894|NCT05268016|158238425|FG004|Overall Study|Physician Decision|0|||
49109895|NCT05268016|158238421|FG000|Overall Study|Other|1|||
49109896|NCT05268016|158238422|FG001|Overall Study|Other|0|||
49109897|NCT05268016|158238423|FG002|Overall Study|Other|1|||
49109898|NCT05268016|158238424|FG003|Overall Study|Other|2|||
49109899|NCT05268016|158238425|FG004|Overall Study|Other|0|||
49109900|NCT02273908|158238428|FG000|Overall Study|Adverse Event|16|||
49109901|NCT02273908|158238429|FG001|Overall Study|Adverse Event|0|||
49109902|NCT02273908|158238428|FG000|Overall Study|Lost to Follow-up|10|||
49109903|NCT02273908|158238429|FG001|Overall Study|Lost to Follow-up|1|||
49109904|NCT02273908|158238428|FG000|Overall Study|Did not meet entrance criteria|3|||
49109905|NCT02273908|158238429|FG001|Overall Study|Did not meet entrance criteria|2|||
49109906|NCT02273908|158238428|FG000|Overall Study|Withdrawal by Subject|4|||
49109907|NCT02273908|158238429|FG001|Overall Study|Withdrawal by Subject|2|||
49109908|NCT00564395|158238430|FG000|First Intervention (10 Days)|Withdrawal by Subject|1|||
49109909|NCT00564395|158238431|FG001|First Intervention (10 Days)|Withdrawal by Subject|0|||
49109910|NCT00564395|158238430|FG000|First Intervention (10 Days)|Trouble with the CGM tracing|1|||
49109911|NCT00564395|158238431|FG001|First Intervention (10 Days)|Trouble with the CGM tracing|2|||
49109912|NCT02791438|158238432|FG000|Treatment Period|Adverse Event|1|||
49109913|NCT02791438|158238433|FG001|Treatment Period|Adverse Event|0|||
49109914|NCT02791438|158238432|FG000|Treatment Period|Withdrawal by Subject|0|||
49109915|NCT02791438|158238433|FG001|Treatment Period|Withdrawal by Subject|1|||
49109916|NCT02791438|158238432|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
49109917|NCT02791438|158238433|FG001|Treatment Period|Withdrawal by Parent/Guardian|0|||
49109918|NCT03887117|158238434|FG000|Overall Study|Discontinued prematurely|0|||
49109919|NCT03887117|158238435|FG001|Overall Study|Discontinued prematurely|1|||
49109920|NCT03887117|158238436|FG002|Overall Study|Discontinued prematurely|1|||
49109921|NCT03887117|158238437|FG003|Overall Study|Discontinued prematurely|2|||
49109922|NCT00830518|158238441|FG000|Overall Study|Progressive Disease|18|||
49109923|NCT00830518|158238442|FG001|Overall Study|Progressive Disease|8|||
49109924|NCT00830518|158238441|FG000|Overall Study|Symptomatic Deterioration|4|||
49109925|NCT00830518|158238442|FG001|Overall Study|Symptomatic Deterioration|1|||
49109926|NCT00830518|158238441|FG000|Overall Study|Adverse Event|14|||
49109927|NCT00830518|158238442|FG001|Overall Study|Adverse Event|1|||
49109928|NCT00830518|158238441|FG000|Overall Study|Withdrawal by Patient|2|||
49109929|NCT00830518|158238442|FG001|Overall Study|Withdrawal by Patient|0|||
49109930|NCT00830518|158238441|FG000|Overall Study|Reason not Specified|8|||
49109931|NCT00830518|158238442|FG001|Overall Study|Reason not Specified|1|||
49109932|NCT02431806|158238443|FG000|Double-blind Treatment Period|Did not Receive Treatment|1|||
49109933|NCT02431806|158238444|FG001|Double-blind Treatment Period|Did not Receive Treatment|2|||
49109934|NCT02431806|158238445|FG002|Double-blind Treatment Period|Did not Receive Treatment|1|||
49109935|NCT02431806|158238446|FG003|Double-blind Treatment Period|Did not Receive Treatment|1|||
49109936|NCT02431806|158238443|FG000|Double-blind Treatment Period|Adverse Event|4|||
49109937|NCT02431806|158238444|FG001|Double-blind Treatment Period|Adverse Event|7|||
49109938|NCT02431806|158238445|FG002|Double-blind Treatment Period|Adverse Event|11|||
49109939|NCT02431806|158238446|FG003|Double-blind Treatment Period|Adverse Event|7|||
49109940|NCT02431806|158238443|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
49109941|NCT02431806|158238444|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
49109942|NCT02431806|158238445|FG002|Double-blind Treatment Period|Lack of Efficacy|2|||
49109943|NCT02431806|158238446|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
49109944|NCT02431806|158238443|FG000|Double-blind Treatment Period|Withdrawal of Consent|10|||
49109945|NCT02431806|158238444|FG001|Double-blind Treatment Period|Withdrawal of Consent|7|||
49109946|NCT02431806|158238445|FG002|Double-blind Treatment Period|Withdrawal of Consent|5|||
49109947|NCT02431806|158238446|FG003|Double-blind Treatment Period|Withdrawal of Consent|5|||
49109948|NCT02431806|158238443|FG000|Double-blind Treatment Period|Lost to Follow-up|7|||
49109949|NCT02431806|158238444|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
49109950|NCT02431806|158238445|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
49109951|NCT02431806|158238446|FG003|Double-blind Treatment Period|Lost to Follow-up|8|||
49109952|NCT02431806|158238443|FG000|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
49109953|NCT02431806|158238444|FG001|Double-blind Treatment Period|Investigational Product Non-compliance|0|||
49109954|NCT02431806|158238445|FG002|Double-blind Treatment Period|Investigational Product Non-compliance|3|||
49109955|NCT02431806|158238446|FG003|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
49109956|NCT02431806|158238443|FG000|Double-blind Treatment Period|Reason Not Specified|0|||
49109957|NCT02431806|158238444|FG001|Double-blind Treatment Period|Reason Not Specified|1|||
49109958|NCT02431806|158238445|FG002|Double-blind Treatment Period|Reason Not Specified|5|||
49109959|NCT02431806|158238446|FG003|Double-blind Treatment Period|Reason Not Specified|2|||
49109960|NCT01156051|158238448|FG000|Overall Study|Lost to Follow-up|1|||
49109961|NCT01156051|158238449|FG001|Overall Study|Lost to Follow-up|0|||
49109962|NCT01156051|158238448|FG000|Overall Study|patient not compliant with protocol|0|||
49109963|NCT01156051|158238449|FG001|Overall Study|patient not compliant with protocol|1|||
49109964|NCT02028169|158238450|FG000|Overall Study|Lost to Follow-up|21|||
49109965|NCT02028169|158238450|FG000|Overall Study|Lack of Efficacy|2|||
49109966|NCT02028169|158238450|FG000|Overall Study|Withdrawal by Subject|2|||
49109967|NCT02028169|158238450|FG000|Overall Study|Adverse Event|1|||
49109968|NCT02028169|158238450|FG000|Overall Study|Cessation of Drug|1|||
49109969|NCT02028169|158238450|FG000|Overall Study|Concomitant Medication Usage|1|||
49109970|NCT01134263|158238453|FG000|Overall Study|Serious adverse event|2|||
49109971|NCT01134263|158238454|FG001|Overall Study|Serious adverse event|1|||
49109972|NCT01134263|158238455|FG002|Overall Study|Serious adverse event|1|||
49109973|NCT01134263|158238456|FG003|Overall Study|Serious adverse event|1|||
49109974|NCT01134263|158238457|FG004|Overall Study|Serious adverse event|1|||
49109975|NCT01134263|158238453|FG000|Overall Study|Other adverse event|1|||
49109976|NCT01134263|158238454|FG001|Overall Study|Other adverse event|2|||
49109977|NCT01134263|158238455|FG002|Overall Study|Other adverse event|5|||
49109978|NCT01134263|158238456|FG003|Overall Study|Other adverse event|3|||
49109979|NCT01134263|158238457|FG004|Overall Study|Other adverse event|0|||
49109980|NCT01134263|158238453|FG000|Overall Study|Protocol Violation|8|||
49109981|NCT01134263|158238454|FG001|Overall Study|Protocol Violation|7|||
49109982|NCT01134263|158238455|FG002|Overall Study|Protocol Violation|2|||
49109983|NCT01134263|158238456|FG003|Overall Study|Protocol Violation|4|||
49109984|NCT01134263|158238457|FG004|Overall Study|Protocol Violation|2|||
49109985|NCT01134263|158238453|FG000|Overall Study|Lost to Follow-up|4|||
49109986|NCT01134263|158238454|FG001|Overall Study|Lost to Follow-up|3|||
49109987|NCT01134263|158238455|FG002|Overall Study|Lost to Follow-up|5|||
49109988|NCT01134263|158238456|FG003|Overall Study|Lost to Follow-up|3|||
49109989|NCT01134263|158238457|FG004|Overall Study|Lost to Follow-up|1|||
49109990|NCT01134263|158238453|FG000|Overall Study|Withdrawal by Subject|8|||
49109991|NCT01134263|158238454|FG001|Overall Study|Withdrawal by Subject|6|||
49109992|NCT01134263|158238455|FG002|Overall Study|Withdrawal by Subject|16|||
49109993|NCT01134263|158238456|FG003|Overall Study|Withdrawal by Subject|7|||
49109994|NCT01134263|158238457|FG004|Overall Study|Withdrawal by Subject|5|||
49109995|NCT01134263|158238453|FG000|Overall Study|Enrolled, but not treated|1|||
49109996|NCT01134263|158238454|FG001|Overall Study|Enrolled, but not treated|1|||
49109997|NCT01134263|158238455|FG002|Overall Study|Enrolled, but not treated|0|||
49109998|NCT01134263|158238456|FG003|Overall Study|Enrolled, but not treated|1|||
49109999|NCT01134263|158238457|FG004|Overall Study|Enrolled, but not treated|0|||
49110000|NCT01078298|158238460|FG000|Overall Study|Lost to Follow-up|12|||
49110001|NCT01078298|158238461|FG001|Overall Study|Lost to Follow-up|13|||
49110002|NCT01078298|158238460|FG000|Overall Study|Withdrawal by Subject|31|||
49110003|NCT01078298|158238461|FG001|Overall Study|Withdrawal by Subject|33|||
49110004|NCT01078298|158238460|FG000|Overall Study|Protocol Violation|6|||
49110005|NCT01078298|158238461|FG001|Overall Study|Protocol Violation|6|||
49110006|NCT01078298|158238460|FG000|Overall Study|Adverse Event|6|||
49110007|NCT01078298|158238461|FG001|Overall Study|Adverse Event|5|||
49110008|NCT01078298|158238460|FG000|Overall Study|Death|2|||
49110009|NCT01078298|158238461|FG001|Overall Study|Death|0|||
49110010|NCT01078298|158238460|FG000|Overall Study|Did not meet entrance criteria|0|||
49110011|NCT01078298|158238461|FG001|Overall Study|Did not meet entrance criteria|1|||
49110012|NCT01078298|158238460|FG000|Overall Study|Other|24|||
49110013|NCT01078298|158238461|FG001|Overall Study|Other|32|||
49110014|NCT00481767|158238466|FG000|Overall Study|Withdrawal by Subject|16|||
49110015|NCT00481767|158238467|FG001|Overall Study|Withdrawal by Subject|11|||
49110016|NCT00481767|158238466|FG000|Overall Study|Lost to Follow-up|16|||
49110017|NCT00481767|158238467|FG001|Overall Study|Lost to Follow-up|10|||
49110018|NCT01366638|158238472|FG000|Overall Study|Withdrawal by Subject|0|||
49110019|NCT01366638|158238473|FG001|Overall Study|Withdrawal by Subject|0|||
49110020|NCT01366638|158238474|FG002|Overall Study|Withdrawal by Subject|6|||
49110021|NCT01366638|158238472|FG000|Overall Study|Other|1|||
49110022|NCT01366638|158238473|FG001|Overall Study|Other|0|||
49110023|NCT01366638|158238474|FG002|Overall Study|Other|0|||
49110024|NCT00636636|158238475|FG000|Overall Study|Other reason|4|||
49110025|NCT00636636|158238476|FG001|Overall Study|Other reason|6|||
49110026|NCT00636636|158238475|FG000|Overall Study|Adverse Event|19|||
49110027|NCT00636636|158238476|FG001|Overall Study|Adverse Event|8|||
49110028|NCT00636636|158238475|FG000|Overall Study|Lack of Efficacy|7|||
49110029|NCT00636636|158238476|FG001|Overall Study|Lack of Efficacy|12|||
49110030|NCT00636636|158238475|FG000|Overall Study|Protocol Violation|2|||
49110031|NCT00636636|158238476|FG001|Overall Study|Protocol Violation|2|||
49110032|NCT00636636|158238475|FG000|Overall Study|Lost to Follow-up|0|||
49110033|NCT00636636|158238476|FG001|Overall Study|Lost to Follow-up|1|||
49110034|NCT00636636|158238475|FG000|Overall Study|Death|0|||
49110035|NCT00636636|158238476|FG001|Overall Study|Death|1|||
49110036|NCT00636636|158238475|FG000|Overall Study|Withdrawal by Subject|4|||
49110037|NCT00636636|158238476|FG001|Overall Study|Withdrawal by Subject|9|||
49110038|NCT02179749|158238477|FG000|Overall Study|Adverse Event|0|||
49110039|NCT02179749|158238478|FG001|Overall Study|Adverse Event|0|||
49110040|NCT02179749|158238479|FG002|Overall Study|Adverse Event|1|||
49110041|NCT02179749|158238477|FG000|Overall Study|Withdrawal by Subject|0|||
49110042|NCT02179749|158238478|FG001|Overall Study|Withdrawal by Subject|0|||
49110043|NCT02179749|158238479|FG002|Overall Study|Withdrawal by Subject|1|||
49110044|NCT01969084|158238480|FG000|Overall Study|Adverse Event|0|||
49110045|NCT01969084|158238481|FG001|Overall Study|Adverse Event|1|||
49110046|NCT00494221|158238482|FG000|Overall Study|Death|15|||
49110047|NCT00494221|158238483|FG001|Overall Study|Death|9|||
49110048|NCT00494221|158238484|FG002|Overall Study|Death|14|||
49110049|NCT00494221|158238482|FG000|Overall Study|Withdrawal by Subject|1|||
49110050|NCT00494221|158238483|FG001|Overall Study|Withdrawal by Subject|2|||
49110051|NCT00494221|158238484|FG002|Overall Study|Withdrawal by Subject|0|||
49110052|NCT02223364|158238485|FG000|Overall Study|Protocol Violation|3|||
49110053|NCT02223364|158238486|FG001|Overall Study|Protocol Violation|0|||
49110054|NCT02223364|158238487|FG002|Overall Study|Protocol Violation|3|||
49110055|NCT02223364|158238485|FG000|Overall Study|subject expired before surgery|1|||
49110056|NCT02223364|158238486|FG001|Overall Study|subject expired before surgery|0|||
49110057|NCT02223364|158238487|FG002|Overall Study|subject expired before surgery|0|||
49110058|NCT02223364|158238485|FG000|Overall Study|Physician Decision|1|||
49110059|NCT02223364|158238486|FG001|Overall Study|Physician Decision|0|||
49110060|NCT02223364|158238487|FG002|Overall Study|Physician Decision|0|||
49110061|NCT00866333|158238495|FG000|Overall Study|Withdrawal of consent|0|||
49110062|NCT00866333|158238496|FG001|Overall Study|Withdrawal of consent|1|||
49110063|NCT00866333|158238497|FG002|Overall Study|Withdrawal of consent|2|||
49110064|NCT00866333|158238495|FG000|Overall Study|Reason not Specified|3|||
49110065|NCT00866333|158238496|FG001|Overall Study|Reason not Specified|1|||
49110066|NCT00866333|158238497|FG002|Overall Study|Reason not Specified|1|||
49110067|NCT00866333|158238495|FG000|Overall Study|Study Terminated by Sponsor|2|||
49110068|NCT00866333|158238496|FG001|Overall Study|Study Terminated by Sponsor|5|||
49110069|NCT00866333|158238497|FG002|Overall Study|Study Terminated by Sponsor|9|||
49110070|NCT00659776|158238498|FG000|Overall Study|Withdrawal by Subject|12|||
49110071|NCT00659776|158238499|FG001|Overall Study|Withdrawal by Subject|2|||
49110072|NCT00659776|158238500|FG002|Overall Study|Withdrawal by Subject|0|||
49110073|NCT01653327|158238501|FG000|Overall Study|Withdrawal by Subject|1|||
49110074|NCT01237327|158238502|FG000|Overall Study|Protocol Violation: Core Study|1|||
49110075|NCT01237327|158238503|FG001|Overall Study|Protocol Violation: Core Study|0|||
49110076|NCT01237327|158238502|FG000|Overall Study|Completed 26 weeks treatment:Core Study|3|||
49110077|NCT01237327|158238503|FG001|Overall Study|Completed 26 weeks treatment:Core Study|2|||
49110078|NCT01237327|158238502|FG000|Overall Study|Progression of Disease: Core Study|18|||
49110079|NCT01237327|158238503|FG001|Overall Study|Progression of Disease: Core Study|22|||
49110080|NCT01237327|158238502|FG000|Overall Study|Progression of Disease: Extension Study|15|||
49110081|NCT01237327|158238503|FG001|Overall Study|Progression of Disease: Extension Study|13|||
49110082|NCT01237327|158238502|FG000|Overall Study|Protocol Specific Withdrawal Criteria|1|||
49110083|NCT01237327|158238503|FG001|Overall Study|Protocol Specific Withdrawal Criteria|0|||
49110084|NCT01237327|158238502|FG000|Overall Study|Withdrawal by Subject|1|||
49110085|NCT01237327|158238503|FG001|Overall Study|Withdrawal by Subject|3|||
49110086|NCT01237327|158238502|FG000|Overall Study|Lost to Follow-up|3|||
49110087|NCT01237327|158238503|FG001|Overall Study|Lost to Follow-up|0|||
49110088|NCT00742027|158238504|FG000|Overall Study|Disease Progression|76|||
49110089|NCT00742027|158238504|FG000|Overall Study|New Cancer Therapy|19|||
49110090|NCT00742027|158238504|FG000|Overall Study|Withdrawal by Subject|18|||
49110091|NCT00742027|158238504|FG000|Overall Study|Death|7|||
49110092|NCT00742027|158238504|FG000|Overall Study|Lost to Follow-up|4|||
49110093|NCT00742027|158238504|FG000|Overall Study|Follow up Phase Completed As Per Protocol|2|||
49110094|NCT00742027|158238504|FG000|Overall Study|Missing|2|||
49110095|NCT00742027|158238504|FG000|Overall Study|Administrative Problems|1|||
49110096|NCT01994902|158238505|FG000|Test Period 1|Withdrawal by Subject|3|||
49110097|NCT01994902|158238506|FG001|Test Period 1|Withdrawal by Subject|0|||
49110098|NCT01994902|158238505|FG000|Test Period 1|device deficiency with adverse event|0|||
49110099|NCT01994902|158238506|FG001|Test Period 1|device deficiency with adverse event|1|||
49110100|NCT01994902|158238505|FG000|Test Period 1|Adverse Event|2|||
49110101|NCT01994902|158238506|FG001|Test Period 1|Adverse Event|1|||
49110102|NCT01994902|158238505|FG000|Test Period 1|Lack of Efficacy|0|||
49110103|NCT01994902|158238506|FG001|Test Period 1|Lack of Efficacy|1|||
49110104|NCT01994902|158238505|FG000|Test Period 1|bag too small|1|||
49110105|NCT01994902|158238506|FG001|Test Period 1|bag too small|0|||
49110106|NCT01994902|158238505|FG000|Test Period 2|Withdrawal by Subject|0|||
49110107|NCT01994902|158238506|FG001|Test Period 2|Withdrawal by Subject|2|||
49110108|NCT01994902|158238505|FG000|Test Period 2|Lack of Efficacy|0|||
49110109|NCT01994902|158238506|FG001|Test Period 2|Lack of Efficacy|1|||
49110110|NCT01994902|158238505|FG000|Test Period 2|Other|0|||
49110111|NCT01994902|158238506|FG001|Test Period 2|Other|3|||
49110112|NCT01810783|158239901|FG000|Overall Study|Adverse Event|32|||
49110113|NCT01810783|158239901|FG000|Overall Study|Withdrawal by Subject|22|||
49110114|NCT01810783|158239901|FG000|Overall Study|Lack of Efficacy|12|||
49110115|NCT01810783|158239901|FG000|Overall Study|Lost to Follow-up|10|||
49110116|NCT01810783|158239901|FG000|Overall Study|Protocol Violation|5|||
49110117|NCT01810783|158239901|FG000|Overall Study|Non-compliance with IMP|4|||
49110118|NCT01810783|158239901|FG000|Overall Study|Adminstrative or other reason(s)|23|||
49110119|NCT01810783|158239901|FG000|Overall Study|Enrolled, not treated|1|||
49110120|NCT01458951|158239902|FG000|Overall Study|Other|1|||
49110121|NCT01458951|158239903|FG001|Overall Study|Other|0|||
49110122|NCT01458951|158239904|FG002|Overall Study|Other|0|||
49110123|NCT01458951|158239902|FG000|Overall Study|Protocol Violation|5|||
49110124|NCT01458951|158239903|FG001|Overall Study|Protocol Violation|1|||
49110125|NCT01458951|158239904|FG002|Overall Study|Protocol Violation|0|||
49110126|NCT01458951|158239902|FG000|Overall Study|Withdrawal by Subject|2|||
49110127|NCT01458951|158239903|FG001|Overall Study|Withdrawal by Subject|0|||
49110128|NCT01458951|158239904|FG002|Overall Study|Withdrawal by Subject|2|||
49110129|NCT01458951|158239902|FG000|Overall Study|Adverse Event|7|||
49110130|NCT01458951|158239903|FG001|Overall Study|Adverse Event|0|||
49110131|NCT01458951|158239904|FG002|Overall Study|Adverse Event|2|||
49110132|NCT01458951|158239902|FG000|Overall Study|Insufficient Clinical Response|17|||
49110133|NCT01458951|158239903|FG001|Overall Study|Insufficient Clinical Response|0|||
49110134|NCT01458951|158239904|FG002|Overall Study|Insufficient Clinical Response|11|||
49110135|NCT01492101|158239905|FG000|Overall Study|Death|323|||
49110136|NCT01492101|158239906|FG001|Overall Study|Death|322|||
49110137|NCT01492101|158239905|FG000|Overall Study|Withdrawal by Subject|14|||
49110138|NCT01492101|158239906|FG001|Overall Study|Withdrawal by Subject|18|||
49110139|NCT01492101|158239905|FG000|Overall Study|Lost to Follow-up|0|||
49110140|NCT01492101|158239906|FG001|Overall Study|Lost to Follow-up|2|||
49110141|NCT02045732|158239907|FG000|Overall Study|At the discretion of the investigator|1|||
49110142|NCT02045732|158239908|FG001|Overall Study|At the discretion of the investigator|1|||
49110143|NCT02584959|158239909|FG000|Period 1|Withdrawn from study|3|||
49110144|NCT02584959|158239910|FG001|Period 1|Withdrawn from study|4|||
49110145|NCT02584959|158239911|FG002|Period 1|Withdrawn from study|0|||
49110146|NCT02584959|158239909|FG000|Period 2|Withdrawn from study|6|||
49110147|NCT02584959|158239910|FG001|Period 2|Withdrawn from study|1|||
49110148|NCT02584959|158239911|FG002|Period 2|Withdrawn from study|2|||
49110149|NCT04908475|158239912|FG000|Period A (Baseline to Week 16)|Lost to Follow-up|3|||
49110150|NCT04908475|158239913|FG001|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
49110151|NCT04908475|158239914|FG002|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
49110152|NCT04908475|158239915|FG003|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
49110153|NCT04908475|158239916|FG004|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
49110154|NCT04908475|158239917|FG005|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
49110155|NCT04908475|158239912|FG000|Period A (Baseline to Week 16)|Withdrawal by Subject|9|||
49110156|NCT04908475|158239913|FG001|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
49110157|NCT04908475|158239914|FG002|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
49110158|NCT04908475|158239915|FG003|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
49110159|NCT04908475|158239916|FG004|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
49110160|NCT04908475|158239917|FG005|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
49110161|NCT04908475|158239912|FG000|Period A (Baseline to Week 16)|Other, Not Specified|6|||
49110162|NCT04908475|158239913|FG001|Period A (Baseline to Week 16)|Other, Not Specified|0|||
49110163|NCT04908475|158239914|FG002|Period A (Baseline to Week 16)|Other, Not Specified|0|||
49110164|NCT04908475|158239915|FG003|Period A (Baseline to Week 16)|Other, Not Specified|0|||
49110165|NCT04908475|158239916|FG004|Period A (Baseline to Week 16)|Other, Not Specified|0|||
49110166|NCT04908475|158239917|FG005|Period A (Baseline to Week 16)|Other, Not Specified|0|||
49110167|NCT04908475|158239912|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
49110168|NCT04908475|158239913|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
49110169|NCT04908475|158239914|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|4|||
49110170|NCT04908475|158239915|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
49110171|NCT04908475|158239916|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
49110172|NCT04908475|158239917|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
49110173|NCT04908475|158239912|FG000|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
49110174|NCT04908475|158239913|FG001|Period B (Week 16 to Week 52)|Withdrawal by Subject|5|||
49110175|NCT04908475|158239914|FG002|Period B (Week 16 to Week 52)|Withdrawal by Subject|13|||
49110176|NCT04908475|158239915|FG003|Period B (Week 16 to Week 52)|Withdrawal by Subject|2|||
49110177|NCT04908475|158239916|FG004|Period B (Week 16 to Week 52)|Withdrawal by Subject|3|||
49110178|NCT04908475|158239917|FG005|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
49110179|NCT04908475|158239912|FG000|Period B (Week 16 to Week 52)|Other, Not Specified|0|||
49110180|NCT04908475|158239913|FG001|Period B (Week 16 to Week 52)|Other, Not Specified|38|||
49110181|NCT04908475|158239914|FG002|Period B (Week 16 to Week 52)|Other, Not Specified|19|||
49110182|NCT04908475|158239915|FG003|Period B (Week 16 to Week 52)|Other, Not Specified|18|||
49110183|NCT04908475|158239916|FG004|Period B (Week 16 to Week 52)|Other, Not Specified|4|||
49110184|NCT04908475|158239917|FG005|Period B (Week 16 to Week 52)|Other, Not Specified|7|||
49110185|NCT01870297|158239921|FG000|Overall Study|Adverse Event|0|||
49110186|NCT01870297|158239922|FG001|Overall Study|Adverse Event|0|||
49110187|NCT01870297|158239923|FG002|Overall Study|Adverse Event|0|||
49110188|NCT01870297|158239924|FG003|Overall Study|Adverse Event|0|||
49110189|NCT01870297|158239925|FG004|Overall Study|Adverse Event|2|||
49110190|NCT01870297|158239926|FG005|Overall Study|Adverse Event|0|||
49110191|NCT01870297|158239927|FG006|Overall Study|Adverse Event|0|||
49110192|NCT01870297|158239921|FG000|Overall Study|Lost to Follow-up|0|||
49110193|NCT01870297|158239922|FG001|Overall Study|Lost to Follow-up|1|||
49110194|NCT01870297|158239923|FG002|Overall Study|Lost to Follow-up|1|||
49110195|NCT01870297|158239924|FG003|Overall Study|Lost to Follow-up|0|||
49110196|NCT01870297|158239925|FG004|Overall Study|Lost to Follow-up|0|||
49110197|NCT01870297|158239926|FG005|Overall Study|Lost to Follow-up|0|||
49110198|NCT01870297|158239927|FG006|Overall Study|Lost to Follow-up|0|||
49110199|NCT01870297|158239921|FG000|Overall Study|Withdrawal by Subject|0|||
49110200|NCT01870297|158239922|FG001|Overall Study|Withdrawal by Subject|0|||
49110201|NCT01870297|158239923|FG002|Overall Study|Withdrawal by Subject|0|||
49110202|NCT01870297|158239924|FG003|Overall Study|Withdrawal by Subject|0|||
49110203|NCT01870297|158239925|FG004|Overall Study|Withdrawal by Subject|1|||
49110204|NCT01870297|158239926|FG005|Overall Study|Withdrawal by Subject|1|||
49110205|NCT01870297|158239927|FG006|Overall Study|Withdrawal by Subject|1|||
49110206|NCT01870297|158239921|FG000|Overall Study|Sponsor Decision|0|||
49110207|NCT01870297|158239922|FG001|Overall Study|Sponsor Decision|6|||
49110208|NCT01870297|158239923|FG002|Overall Study|Sponsor Decision|0|||
49110209|NCT01870297|158239924|FG003|Overall Study|Sponsor Decision|0|||
49110210|NCT01870297|158239925|FG004|Overall Study|Sponsor Decision|0|||
49110211|NCT01870297|158239926|FG005|Overall Study|Sponsor Decision|0|||
49110212|NCT01870297|158239927|FG006|Overall Study|Sponsor Decision|1|||
49110213|NCT03760458|158239931|FG000|Main Study (Through Week 48)|Withdrawal by Subject|1|||
49110214|NCT03760458|158239932|FG001|Main Study (Through Week 48)|Withdrawal by Subject|1|||
49110215|NCT03760458|158239933|FG002|Main Study (Through Week 48)|Withdrawal by Subject|0|||
49110216|NCT03760458|158239934|FG003|Main Study (Through Week 48)|Withdrawal by Subject|0|||
49110217|NCT03760458|158239935|FG004|Main Study (Through Week 48)|Withdrawal by Subject|0|||
49110218|NCT00750919|158239936|FG000|Overall Study|Adverse Event|9|||
49110219|NCT00750919|158239936|FG000|Overall Study|Withdrawal by Subject|1|||
49110220|NCT00750919|158239936|FG000|Overall Study|Lack of Efficacy|8|||
49110221|NCT00750919|158239936|FG000|Overall Study|Could not cooperate, unrelated to trial|4|||
49110222|NCT00750919|158239936|FG000|Overall Study|Other|36|||
49110223|NCT01739764|158239937|FG000|Overall Study|Adverse Event|0|||
49110224|NCT01739764|158239938|FG001|Overall Study|Adverse Event|3|||
49110225|NCT01739764|158239939|FG002|Overall Study|Adverse Event|4|||
49110226|NCT01739764|158239937|FG000|Overall Study|Death|4|||
49110227|NCT01739764|158239938|FG001|Overall Study|Death|6|||
49110228|NCT01739764|158239939|FG002|Overall Study|Death|38|||
49110229|NCT01739764|158239937|FG000|Overall Study|Lost to Follow-up|0|||
49110230|NCT01739764|158239938|FG001|Overall Study|Lost to Follow-up|0|||
49110231|NCT01739764|158239939|FG002|Overall Study|Lost to Follow-up|5|||
49110232|NCT01739764|158239937|FG000|Overall Study|Non-Compliance|0|||
49110233|NCT01739764|158239938|FG001|Overall Study|Non-Compliance|0|||
49110234|NCT01739764|158239939|FG002|Overall Study|Non-Compliance|1|||
49110235|NCT01739764|158239937|FG000|Overall Study|Multiple Reasons|3|||
49110236|NCT01739764|158239938|FG001|Overall Study|Multiple Reasons|2|||
49110237|NCT01739764|158239939|FG002|Overall Study|Multiple Reasons|3|||
49110238|NCT01739764|158239937|FG000|Overall Study|Physician Decision|2|||
49110239|NCT01739764|158239938|FG001|Overall Study|Physician Decision|2|||
49110240|NCT01739764|158239939|FG002|Overall Study|Physician Decision|4|||
49110241|NCT01739764|158239937|FG000|Overall Study|Progressive Disease|3|||
49110242|NCT01739764|158239938|FG001|Overall Study|Progressive Disease|5|||
49110243|NCT01739764|158239939|FG002|Overall Study|Progressive Disease|16|||
49110244|NCT01739764|158239937|FG000|Overall Study|Protocol Violation|0|||
49110245|NCT01739764|158239938|FG001|Overall Study|Protocol Violation|0|||
49110246|NCT01739764|158239939|FG002|Overall Study|Protocol Violation|2|||
49110247|NCT01739764|158239937|FG000|Overall Study|Study Terminated by Sponsor|8|||
49110248|NCT01739764|158239938|FG001|Overall Study|Study Terminated by Sponsor|13|||
49110249|NCT01739764|158239939|FG002|Overall Study|Study Terminated by Sponsor|26|||
49110250|NCT01739764|158239937|FG000|Overall Study|Withdrawal by Subject|6|||
49110251|NCT01739764|158239938|FG001|Overall Study|Withdrawal by Subject|5|||
49110252|NCT01739764|158239939|FG002|Overall Study|Withdrawal by Subject|27|||
49110253|NCT00337779|158239940|FG000|Overall Study|Withdrawal by Subject|10|||
49110254|NCT00337779|158239941|FG001|Overall Study|Withdrawal by Subject|12|||
49110255|NCT00337779|158239940|FG000|Overall Study|Sponsor decision|1|||
49110256|NCT00337779|158239941|FG001|Overall Study|Sponsor decision|1|||
49110257|NCT00337779|158239940|FG000|Overall Study|Physician Decision|3|||
49110258|NCT00337779|158239941|FG001|Overall Study|Physician Decision|6|||
49110259|NCT00337779|158239940|FG000|Overall Study|Protocol Violation|1|||
49110260|NCT00337779|158239941|FG001|Overall Study|Protocol Violation|1|||
49110261|NCT00337779|158239940|FG000|Overall Study|Lost to Follow-up|6|||
49110262|NCT00337779|158239941|FG001|Overall Study|Lost to Follow-up|5|||
49110263|NCT00337779|158239940|FG000|Overall Study|Adverse Event|28|||
49110264|NCT00337779|158239941|FG001|Overall Study|Adverse Event|51|||
49110265|NCT00337779|158239940|FG000|Overall Study|Pregnancy|3|||
49110266|NCT00337779|158239941|FG001|Overall Study|Pregnancy|2|||
49110267|NCT00337779|158239940|FG000|Overall Study|Death|0|||
49110268|NCT00337779|158239941|FG001|Overall Study|Death|1|||
49110269|NCT00427999|158239942|FG000|Overall Study|Adverse Event|6|||
49110270|NCT00427999|158239942|FG000|Overall Study|Abnormal laboratory values|1|||
49110271|NCT00427999|158239942|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
49110272|NCT00427999|158239942|FG000|Overall Study|Protocol Violation|2|||
49110273|NCT00427999|158239942|FG000|Overall Study|Withdrawal by Subject|9|||
49110274|NCT00427999|158239942|FG000|Overall Study|Death|1|||
49110275|NCT01658904|158239947|FG000|Overall Study|Principal Investigator discretion|2|||
49110276|NCT01658904|158239948|FG001|Overall Study|Principal Investigator discretion|0|||
49110277|NCT01658904|158239949|FG002|Overall Study|Principal Investigator discretion|0|||
49110278|NCT02147067|158239954|FG000|Overall Study|Withdrawal by Subject|2|||
49110279|NCT02147067|158239955|FG001|Overall Study|Withdrawal by Subject|2|||
49110280|NCT00195494|158239958|FG000|Year 1|Adverse Event|0|||
49110281|NCT00195494|158239959|FG001|Year 1|Adverse Event|0|||
49110282|NCT00195494|158239960|FG002|Year 1|Adverse Event|0|||
49110283|NCT00195494|158239961|FG003|Year 1|Adverse Event|0|||
49110284|NCT00195494|158239962|FG004|Year 1|Adverse Event|34|||
49110285|NCT00195494|158239963|FG005|Year 1|Adverse Event|27|||
49110286|NCT00195494|158239958|FG000|Year 1|System Toxicity|0|||
49110287|NCT00195494|158239959|FG001|Year 1|System Toxicity|0|||
49110288|NCT00195494|158239960|FG002|Year 1|System Toxicity|0|||
49110289|NCT00195494|158239961|FG003|Year 1|System Toxicity|0|||
49110290|NCT00195494|158239962|FG004|Year 1|System Toxicity|0|||
49110291|NCT00195494|158239963|FG005|Year 1|System Toxicity|1|||
49110292|NCT00195494|158239958|FG000|Year 1|Lack of Efficacy|0|||
49110293|NCT00195494|158239959|FG001|Year 1|Lack of Efficacy|0|||
49110294|NCT00195494|158239960|FG002|Year 1|Lack of Efficacy|0|||
49110295|NCT00195494|158239961|FG003|Year 1|Lack of Efficacy|0|||
49110296|NCT00195494|158239962|FG004|Year 1|Lack of Efficacy|24|||
49110297|NCT00195494|158239963|FG005|Year 1|Lack of Efficacy|9|||
49110298|NCT00195494|158239958|FG000|Year 1|Compliance|0|||
49110299|NCT00195494|158239959|FG001|Year 1|Compliance|0|||
49110300|NCT00195494|158239960|FG002|Year 1|Compliance|0|||
49110301|NCT00195494|158239961|FG003|Year 1|Compliance|0|||
49110302|NCT00195494|158239962|FG004|Year 1|Compliance|5|||
49110303|NCT00195494|158239963|FG005|Year 1|Compliance|1|||
49110304|NCT00195494|158239958|FG000|Year 1|Lost to Follow-up|0|||
49110305|NCT00195494|158239959|FG001|Year 1|Lost to Follow-up|0|||
49110306|NCT00195494|158239960|FG002|Year 1|Lost to Follow-up|0|||
49110307|NCT00195494|158239961|FG003|Year 1|Lost to Follow-up|0|||
49110308|NCT00195494|158239962|FG004|Year 1|Lost to Follow-up|1|||
49110309|NCT00195494|158239963|FG005|Year 1|Lost to Follow-up|0|||
49110310|NCT00195494|158239958|FG000|Year 1|Missed >4 consecutive doses|0|||
49110311|NCT00195494|158239959|FG001|Year 1|Missed >4 consecutive doses|0|||
49110312|NCT00195494|158239960|FG002|Year 1|Missed >4 consecutive doses|0|||
49110313|NCT00195494|158239961|FG003|Year 1|Missed >4 consecutive doses|0|||
49110314|NCT00195494|158239962|FG004|Year 1|Missed >4 consecutive doses|3|||
49110315|NCT00195494|158239963|FG005|Year 1|Missed >4 consecutive doses|2|||
49110316|NCT00195494|158239958|FG000|Year 1|Protocol deviation|0|||
49110317|NCT00195494|158239959|FG001|Year 1|Protocol deviation|0|||
49110318|NCT00195494|158239960|FG002|Year 1|Protocol deviation|0|||
49110319|NCT00195494|158239961|FG003|Year 1|Protocol deviation|0|||
49110320|NCT00195494|158239962|FG004|Year 1|Protocol deviation|2|||
49110321|NCT00195494|158239963|FG005|Year 1|Protocol deviation|3|||
49110322|NCT00195494|158239958|FG000|Year 1|Physician Decision|0|||
49110323|NCT00195494|158239959|FG001|Year 1|Physician Decision|0|||
49110324|NCT00195494|158239960|FG002|Year 1|Physician Decision|0|||
49110325|NCT00195494|158239961|FG003|Year 1|Physician Decision|0|||
49110326|NCT00195494|158239962|FG004|Year 1|Physician Decision|1|||
49110327|NCT00195494|158239963|FG005|Year 1|Physician Decision|0|||
49110328|NCT00195494|158239958|FG000|Year 1|Withdrawal by Subject|0|||
49110329|NCT00195494|158239959|FG001|Year 1|Withdrawal by Subject|0|||
49110330|NCT00195494|158239960|FG002|Year 1|Withdrawal by Subject|0|||
49110331|NCT00195494|158239961|FG003|Year 1|Withdrawal by Subject|0|||
49110332|NCT00195494|158239962|FG004|Year 1|Withdrawal by Subject|8|||
49110333|NCT00195494|158239963|FG005|Year 1|Withdrawal by Subject|9|||
49110334|NCT00195494|158239958|FG000|Year 1|Protocol Violation|0|||
49110335|NCT00195494|158239959|FG001|Year 1|Protocol Violation|0|||
49110336|NCT00195494|158239960|FG002|Year 1|Protocol Violation|0|||
49110337|NCT00195494|158239961|FG003|Year 1|Protocol Violation|0|||
49110338|NCT00195494|158239962|FG004|Year 1|Protocol Violation|1|||
49110339|NCT00195494|158239963|FG005|Year 1|Protocol Violation|1|||
49110340|NCT00195494|158239958|FG000|Year 2|Adverse Event|3|||
49110341|NCT00195494|158239959|FG001|Year 2|Adverse Event|7|||
49110342|NCT00195494|158239960|FG002|Year 2|Adverse Event|5|||
49110343|NCT00195494|158239961|FG003|Year 2|Adverse Event|9|||
49110344|NCT00195494|158239962|FG004|Year 2|Adverse Event|0|||
49110345|NCT00195494|158239963|FG005|Year 2|Adverse Event|0|||
49110346|NCT00195494|158239958|FG000|Year 2|Lack of Efficacy|0|||
49110347|NCT00195494|158239959|FG001|Year 2|Lack of Efficacy|1|||
49110348|NCT00195494|158239960|FG002|Year 2|Lack of Efficacy|7|||
49110349|NCT00195494|158239961|FG003|Year 2|Lack of Efficacy|7|||
49110350|NCT00195494|158239962|FG004|Year 2|Lack of Efficacy|0|||
49110351|NCT00195494|158239963|FG005|Year 2|Lack of Efficacy|0|||
49110352|NCT00195494|158239958|FG000|Year 2|Compliance|1|||
49110353|NCT00195494|158239959|FG001|Year 2|Compliance|0|||
49110354|NCT00195494|158239960|FG002|Year 2|Compliance|0|||
49110355|NCT00195494|158239961|FG003|Year 2|Compliance|2|||
49110356|NCT00195494|158239962|FG004|Year 2|Compliance|0|||
49110357|NCT00195494|158239963|FG005|Year 2|Compliance|0|||
49110358|NCT00195494|158239958|FG000|Year 2|Lost to Follow-up|0|||
49110359|NCT00195494|158239959|FG001|Year 2|Lost to Follow-up|0|||
49110360|NCT00195494|158239960|FG002|Year 2|Lost to Follow-up|1|||
49110361|NCT00195494|158239961|FG003|Year 2|Lost to Follow-up|1|||
49110362|NCT00195494|158239962|FG004|Year 2|Lost to Follow-up|0|||
49110363|NCT00195494|158239963|FG005|Year 2|Lost to Follow-up|0|||
49110364|NCT00195494|158239958|FG000|Year 2|Missed >4 consecutive doses|1|||
49110365|NCT00195494|158239959|FG001|Year 2|Missed >4 consecutive doses|1|||
49110366|NCT00195494|158239960|FG002|Year 2|Missed >4 consecutive doses|1|||
49110367|NCT00195494|158239961|FG003|Year 2|Missed >4 consecutive doses|0|||
49110368|NCT00195494|158239962|FG004|Year 2|Missed >4 consecutive doses|0|||
49110369|NCT00195494|158239963|FG005|Year 2|Missed >4 consecutive doses|0|||
49110370|NCT00195494|158239958|FG000|Year 2|Protocol deviation|0|||
49110371|NCT00195494|158239959|FG001|Year 2|Protocol deviation|1|||
49110372|NCT00195494|158239960|FG002|Year 2|Protocol deviation|0|||
49110373|NCT00195494|158239961|FG003|Year 2|Protocol deviation|0|||
49110374|NCT00195494|158239962|FG004|Year 2|Protocol deviation|0|||
49110375|NCT00195494|158239963|FG005|Year 2|Protocol deviation|0|||
49110376|NCT00195494|158239958|FG000|Year 2|Physician Decision|1|||
49110377|NCT00195494|158239959|FG001|Year 2|Physician Decision|1|||
49110378|NCT00195494|158239960|FG002|Year 2|Physician Decision|0|||
49110379|NCT00195494|158239961|FG003|Year 2|Physician Decision|0|||
49110380|NCT00195494|158239962|FG004|Year 2|Physician Decision|0|||
49110381|NCT00195494|158239963|FG005|Year 2|Physician Decision|0|||
49110382|NCT00195494|158239958|FG000|Year 2|Withdrawal by Subject|1|||
49110383|NCT00195494|158239959|FG001|Year 2|Withdrawal by Subject|5|||
49110384|NCT00195494|158239960|FG002|Year 2|Withdrawal by Subject|4|||
49110385|NCT00195494|158239961|FG003|Year 2|Withdrawal by Subject|3|||
49110386|NCT00195494|158239962|FG004|Year 2|Withdrawal by Subject|0|||
49110387|NCT00195494|158239963|FG005|Year 2|Withdrawal by Subject|0|||
49110388|NCT00195494|158239958|FG000|Year 2|System toxicity|0|||
49110389|NCT00195494|158239959|FG001|Year 2|System toxicity|0|||
49110390|NCT00195494|158239960|FG002|Year 2|System toxicity|0|||
49110391|NCT00195494|158239961|FG003|Year 2|System toxicity|1|||
49110392|NCT00195494|158239962|FG004|Year 2|System toxicity|0|||
49110393|NCT00195494|158239963|FG005|Year 2|System toxicity|0|||
49110394|NCT02137226|158239964|FG000|Period 1 (Initial Randomization)|Adverse Event|3|||
49110395|NCT02137226|158239965|FG001|Period 1 (Initial Randomization)|Adverse Event|3|||
49110396|NCT02137226|158239966|FG002|Period 1 (Initial Randomization)|Adverse Event|0|||
49110397|NCT02137226|158239967|FG003|Period 1 (Initial Randomization)|Adverse Event|0|||
49110398|NCT02137226|158239968|FG004|Period 1 (Initial Randomization)|Adverse Event|0|||
49110399|NCT02137226|158239964|FG000|Period 1 (Initial Randomization)|Withdrawal by Subject|11|||
49110400|NCT02137226|158239965|FG001|Period 1 (Initial Randomization)|Withdrawal by Subject|5|||
49110401|NCT02137226|158239966|FG002|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
49110402|NCT02137226|158239967|FG003|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
49110403|NCT02137226|158239968|FG004|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
49110404|NCT02137226|158239964|FG000|Period 1 (Initial Randomization)|Physician Decision|1|||
49110405|NCT02137226|158239965|FG001|Period 1 (Initial Randomization)|Physician Decision|3|||
49110406|NCT02137226|158239966|FG002|Period 1 (Initial Randomization)|Physician Decision|0|||
49110407|NCT02137226|158239967|FG003|Period 1 (Initial Randomization)|Physician Decision|0|||
49110408|NCT02137226|158239968|FG004|Period 1 (Initial Randomization)|Physician Decision|0|||
49110409|NCT02137226|158239964|FG000|Period 1 (Initial Randomization)|Lost to Follow-up|3|||
49110410|NCT02137226|158239965|FG001|Period 1 (Initial Randomization)|Lost to Follow-up|2|||
49110411|NCT02137226|158239966|FG002|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
49110412|NCT02137226|158239967|FG003|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
49110413|NCT02137226|158239968|FG004|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
49110414|NCT02137226|158239964|FG000|Period 1 (Initial Randomization)|Lack of Efficacy|1|||
49110415|NCT02137226|158239965|FG001|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
49110416|NCT02137226|158239966|FG002|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
49110417|NCT02137226|158239967|FG003|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
49110418|NCT02137226|158239968|FG004|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
49110419|NCT02137226|158239964|FG000|Period 1 (Initial Randomization)|Other Reason|1|||
49110420|NCT02137226|158239965|FG001|Period 1 (Initial Randomization)|Other Reason|3|||
49110421|NCT02137226|158239966|FG002|Period 1 (Initial Randomization)|Other Reason|0|||
49110422|NCT02137226|158239967|FG003|Period 1 (Initial Randomization)|Other Reason|0|||
49110423|NCT02137226|158239968|FG004|Period 1 (Initial Randomization)|Other Reason|0|||
49110424|NCT02137226|158239964|FG000|Period 2 (Re - Randomization)|Adverse Event|0|||
49110425|NCT02137226|158239965|FG001|Period 2 (Re - Randomization)|Adverse Event|0|||
49110426|NCT02137226|158239966|FG002|Period 2 (Re - Randomization)|Adverse Event|3|||
49110427|NCT02137226|158239967|FG003|Period 2 (Re - Randomization)|Adverse Event|1|||
49110428|NCT02137226|158239968|FG004|Period 2 (Re - Randomization)|Adverse Event|4|||
49110429|NCT02137226|158239964|FG000|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
49110430|NCT02137226|158239965|FG001|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
49110431|NCT02137226|158239966|FG002|Period 2 (Re - Randomization)|Withdrawal by Subject|8|||
49110432|NCT02137226|158239967|FG003|Period 2 (Re - Randomization)|Withdrawal by Subject|5|||
49110433|NCT02137226|158239968|FG004|Period 2 (Re - Randomization)|Withdrawal by Subject|4|||
49110434|NCT02137226|158239964|FG000|Period 2 (Re - Randomization)|Physician Decision|0|||
49110435|NCT02137226|158239965|FG001|Period 2 (Re - Randomization)|Physician Decision|0|||
49110436|NCT02137226|158239966|FG002|Period 2 (Re - Randomization)|Physician Decision|0|||
49110437|NCT02137226|158239967|FG003|Period 2 (Re - Randomization)|Physician Decision|1|||
49110438|NCT02137226|158239968|FG004|Period 2 (Re - Randomization)|Physician Decision|0|||
49110439|NCT02137226|158239964|FG000|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
49110440|NCT02137226|158239965|FG001|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
49110441|NCT02137226|158239966|FG002|Period 2 (Re - Randomization)|Lost to Follow-up|3|||
49110442|NCT02137226|158239967|FG003|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
49110443|NCT02137226|158239968|FG004|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
49110444|NCT02137226|158239964|FG000|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
49110445|NCT02137226|158239965|FG001|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
49110446|NCT02137226|158239966|FG002|Period 2 (Re - Randomization)|Lack of Efficacy|2|||
49110447|NCT02137226|158239967|FG003|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
49110448|NCT02137226|158239968|FG004|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
49110449|NCT02137226|158239964|FG000|Period 2 (Re - Randomization)|Other Reason|0|||
49110450|NCT02137226|158239965|FG001|Period 2 (Re - Randomization)|Other Reason|0|||
49110451|NCT02137226|158239966|FG002|Period 2 (Re - Randomization)|Other Reason|1|||
49110452|NCT02137226|158239967|FG003|Period 2 (Re - Randomization)|Other Reason|1|||
49110453|NCT02137226|158239968|FG004|Period 2 (Re - Randomization)|Other Reason|1|||
49110454|NCT03913104|158239969|FG000|Overall Study|Lost to Follow-up|20|||
49110455|NCT03913104|158239969|FG000|Overall Study|Did Not Take Mifepristone or Misoprostol|8|||
49110456|NCT03913104|158239969|FG000|Overall Study|Withdrawal by Subject|2|||
49110457|NCT05119569|158239970|FG000|Double Blind Treatment Phase|Withdrawal by Subject|2|||
49110458|NCT05119569|158239971|FG001|Double Blind Treatment Phase|Withdrawal by Subject|2|||
49110459|NCT05119569|158239972|FG002|Double Blind Treatment Phase|Withdrawal by Subject|0|||
49110460|NCT05119569|158239973|FG003|Double Blind Treatment Phase|Withdrawal by Subject|0|||
49110461|NCT05119569|158239970|FG000|Double Blind Treatment Phase|Adverse Event|6|||
49110462|NCT05119569|158239971|FG001|Double Blind Treatment Phase|Adverse Event|0|||
49110463|NCT05119569|158239972|FG002|Double Blind Treatment Phase|Adverse Event|0|||
49110464|NCT05119569|158239973|FG003|Double Blind Treatment Phase|Adverse Event|0|||
49110465|NCT05119569|158239970|FG000|Open Label Extension Phase|Ongoing in the study|0|||
49110466|NCT05119569|158239971|FG001|Open Label Extension Phase|Ongoing in the study|0|||
49110467|NCT05119569|158239972|FG002|Open Label Extension Phase|Ongoing in the study|65|||
49110468|NCT05119569|158239973|FG003|Open Label Extension Phase|Ongoing in the study|34|||
49110469|NCT01074255|158239974|FG000|Overall Study|Did not receive EMEND|2|||
49110470|NCT01380691|158239979|FG000|Washout (7 Days)|Protocol Violation|0|||
49110471|NCT01380691|158239980|FG001|Washout (7 Days)|Protocol Violation|0|||
49110472|NCT01380691|158239981|FG002|Washout (7 Days)|Protocol Violation|0|||
49110473|NCT01380691|158239982|FG003|Washout (7 Days)|Protocol Violation|1|||
49110474|NCT01380691|158239979|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
49110475|NCT01380691|158239980|FG001|Washout (7 Days)|Withdrawal by Subject|0|||
49110476|NCT01380691|158239981|FG002|Washout (7 Days)|Withdrawal by Subject|1|||
49110477|NCT01380691|158239982|FG003|Washout (7 Days)|Withdrawal by Subject|0|||
49110478|NCT00463840|158239984|FG000|Overall Study|Disease progression|7|||
49110479|NCT00463840|158239984|FG000|Overall Study|Withdrawal by Subject|2|||
49110480|NCT00463840|158239984|FG000|Overall Study|Adverse Event|3|||
49110481|NCT00524173|158239986|FG000|Overall Study|Lost to Follow-up|0|||
49110482|NCT00524173|158239987|FG001|Overall Study|Lost to Follow-up|1|||
49110483|NCT00524173|158239986|FG000|Overall Study|Death|1|||
49110484|NCT00524173|158239987|FG001|Overall Study|Death|0|||
49110485|NCT00524173|158239986|FG000|Overall Study|Had not reached endpoint at study close|4|||
49110486|NCT00524173|158239987|FG001|Overall Study|Had not reached endpoint at study close|1|||
49110487|NCT02971800|158239988|FG000|Overall Study|Protocol Violation|1|||
49110488|NCT02971800|158239988|FG000|Overall Study|Withdrawal by Subject|1|||
49110489|NCT02971800|158239988|FG000|Overall Study|Exclusion criteria prior intervention|1|||
49110490|NCT02971800|158239988|FG000|Overall Study|Number evaluable participant already reached|4|||
49110491|NCT01210352|158239991|FG000|Overall Study|Adverse Event|0|||
49110492|NCT01210352|158239992|FG001|Overall Study|Adverse Event|0|||
49110493|NCT01210352|158239993|FG002|Overall Study|Adverse Event|0|||
49110494|NCT01210352|158239994|FG003|Overall Study|Adverse Event|0|||
49110495|NCT01210352|158239995|FG004|Overall Study|Adverse Event|0|||
49110496|NCT01210352|158239996|FG005|Overall Study|Adverse Event|0|||
49110497|NCT01210352|158239997|FG006|Overall Study|Adverse Event|0|||
49110498|NCT01210352|158239998|FG007|Overall Study|Adverse Event|2|||
49110499|NCT01210352|158239999|FG008|Overall Study|Adverse Event|1|||
49110500|NCT01210352|158239991|FG000|Overall Study|Lack of Efficacy|0|||
49110501|NCT01210352|158239992|FG001|Overall Study|Lack of Efficacy|0|||
49110502|NCT01210352|158239993|FG002|Overall Study|Lack of Efficacy|0|||
49110503|NCT01210352|158239994|FG003|Overall Study|Lack of Efficacy|0|||
49110504|NCT01210352|158239995|FG004|Overall Study|Lack of Efficacy|0|||
49110505|NCT01210352|158239996|FG005|Overall Study|Lack of Efficacy|0|||
49110506|NCT01210352|158239997|FG006|Overall Study|Lack of Efficacy|1|||
49110507|NCT01210352|158239998|FG007|Overall Study|Lack of Efficacy|0|||
49110508|NCT01210352|158239999|FG008|Overall Study|Lack of Efficacy|0|||
49110509|NCT01210352|158239991|FG000|Overall Study|Physician Decision|0|||
49110510|NCT01210352|158239992|FG001|Overall Study|Physician Decision|0|||
49110511|NCT01210352|158239993|FG002|Overall Study|Physician Decision|0|||
49110512|NCT01210352|158239994|FG003|Overall Study|Physician Decision|0|||
49110513|NCT01210352|158239995|FG004|Overall Study|Physician Decision|0|||
49110514|NCT01210352|158239996|FG005|Overall Study|Physician Decision|0|||
49110515|NCT01210352|158239997|FG006|Overall Study|Physician Decision|0|||
49110516|NCT01210352|158239998|FG007|Overall Study|Physician Decision|1|||
49110517|NCT01210352|158239999|FG008|Overall Study|Physician Decision|2|||
49110518|NCT01210352|158239991|FG000|Overall Study|Withdrawal by Subject|0|||
49110519|NCT01210352|158239992|FG001|Overall Study|Withdrawal by Subject|0|||
49110520|NCT01210352|158239993|FG002|Overall Study|Withdrawal by Subject|1|||
49110521|NCT01210352|158239994|FG003|Overall Study|Withdrawal by Subject|0|||
49110522|NCT01210352|158239995|FG004|Overall Study|Withdrawal by Subject|0|||
49110523|NCT01210352|158239996|FG005|Overall Study|Withdrawal by Subject|0|||
49110524|NCT01210352|158239997|FG006|Overall Study|Withdrawal by Subject|1|||
49110525|NCT01210352|158239998|FG007|Overall Study|Withdrawal by Subject|0|||
49110526|NCT01210352|158239999|FG008|Overall Study|Withdrawal by Subject|1|||
49110527|NCT01210352|158239991|FG000|Overall Study|Patient Discharged Early|0|||
49110528|NCT01210352|158239992|FG001|Overall Study|Patient Discharged Early|0|||
49110529|NCT01210352|158239993|FG002|Overall Study|Patient Discharged Early|1|||
49110530|NCT01210352|158239994|FG003|Overall Study|Patient Discharged Early|0|||
49110531|NCT01210352|158239995|FG004|Overall Study|Patient Discharged Early|0|||
49110532|NCT01210352|158239996|FG005|Overall Study|Patient Discharged Early|0|||
49110533|NCT01210352|158239997|FG006|Overall Study|Patient Discharged Early|0|||
49110534|NCT01210352|158239998|FG007|Overall Study|Patient Discharged Early|0|||
49110535|NCT01210352|158239999|FG008|Overall Study|Patient Discharged Early|0|||
49110536|NCT02552888|158240000|FG000|Overall Study|Lost to Follow-up|1|||
49110537|NCT02552888|158240001|FG001|Overall Study|Lost to Follow-up|1|||
49110538|NCT03597139|158240005|FG000|Overall Study|Adverse Event|3|||
49110539|NCT03597139|158240006|FG001|Overall Study|Adverse Event|0|||
49110540|NCT03597139|158240005|FG000|Overall Study|Protocol Non-compliance|1|||
49110541|NCT03597139|158240006|FG001|Overall Study|Protocol Non-compliance|0|||
49110542|NCT00422292|158240007|FG000|Overall Study|Serious adverse events|1|||
49110543|NCT00422292|158240008|FG001|Overall Study|Serious adverse events|4|||
49110544|NCT00422292|158240009|FG002|Overall Study|Serious adverse events|0|||
49110545|NCT00422292|158240010|FG003|Overall Study|Serious adverse events|0|||
49110546|NCT00422292|158240007|FG000|Overall Study|Adverse Event|1|||
49110547|NCT00422292|158240008|FG001|Overall Study|Adverse Event|0|||
49110548|NCT00422292|158240009|FG002|Overall Study|Adverse Event|1|||
49110549|NCT00422292|158240010|FG003|Overall Study|Adverse Event|0|||
49110550|NCT00422292|158240007|FG000|Overall Study|Protocol Violation|4|||
49110551|NCT00422292|158240008|FG001|Overall Study|Protocol Violation|25|||
49110552|NCT00422292|158240009|FG002|Overall Study|Protocol Violation|8|||
49110553|NCT00422292|158240010|FG003|Overall Study|Protocol Violation|5|||
49110554|NCT00422292|158240007|FG000|Overall Study|Lost to Follow-up|6|||
49110555|NCT00422292|158240008|FG001|Overall Study|Lost to Follow-up|12|||
49110556|NCT00422292|158240009|FG002|Overall Study|Lost to Follow-up|6|||
49110557|NCT00422292|158240010|FG003|Overall Study|Lost to Follow-up|6|||
49110558|NCT00422292|158240007|FG000|Overall Study|Withdrawal by Subject|6|||
49110559|NCT00422292|158240008|FG001|Overall Study|Withdrawal by Subject|25|||
49110560|NCT00422292|158240009|FG002|Overall Study|Withdrawal by Subject|7|||
49110561|NCT00422292|158240010|FG003|Overall Study|Withdrawal by Subject|13|||
49110562|NCT01249833|158240013|FG000|Overall Study|Lost to Follow-up|0|||
49110563|NCT01249833|158240014|FG001|Overall Study|Lost to Follow-up|1|||
49110564|NCT00723697|158240018|FG000|Overall Study|Physician questionnaires not received|2|||
49110565|NCT00723697|158240018|FG000|Overall Study|Missing Informed Consent Form|10|||
49110566|NCT00723697|158240018|FG000|Overall Study|Other exclusion criteria applied|6|||
49110567|NCT01250171|158242712|FG000|Overall Study|Administrative reasons|1|||
49110568|NCT01250171|158242713|FG001|Overall Study|Administrative reasons|0|||
49110569|NCT01250171|158242714|FG002|Overall Study|Administrative reasons|0|||
49110570|NCT01038752|158242718|FG000|Overall Study|Tumor Progression|2|||
49110571|NCT01038752|158242719|FG001|Overall Study|Tumor Progression|2|||
49110572|NCT01038752|158242718|FG000|Overall Study|Lost to Follow-up|3|||
49110573|NCT01038752|158242719|FG001|Overall Study|Lost to Follow-up|3|||
49110574|NCT00422422|158242720|FG000|Overall Study|Lack of Efficacy|1|||
49110575|NCT00422422|158242720|FG000|Overall Study|Protocol Violation|1|||
49110576|NCT00422422|158242720|FG000|Overall Study|Withdrawal by Subject|2|||
49110577|NCT00422422|158242720|FG000|Overall Study|SAE, non-fatal|1|||
49110578|NCT00422422|158242720|FG000|Overall Study|AE, non-serious non-fatal|5|||
49110579|NCT00089635|158242721|FG000|Overall Study|Adverse Event|2|||
49110580|NCT00089635|158242721|FG000|Overall Study|Death|17|||
49110581|NCT00089635|158242721|FG000|Overall Study|Disease Progression|12|||
49110582|NCT00089635|158242721|FG000|Overall Study|Lost to Follow-up|3|||
49110583|NCT00089635|158242721|FG000|Overall Study|Withdrawal by Subject|6|||
49110584|NCT00089635|158242721|FG000|Overall Study|Ineligibility determined|1|||
49110585|NCT00089635|158242721|FG000|Overall Study|Other|2|||
49110586|NCT01389258|158242722|FG000|Overall Study|Lost to Follow-up|5|||
49110587|NCT02603107|158242724|FG000|Randomized Phase|Withdrew consent|8|||
49110588|NCT02603107|158242725|FG001|Randomized Phase|Withdrew consent|15|||
49110589|NCT02603107|158242724|FG000|Randomized Phase|Lost to Follow-up|1|||
49110590|NCT02603107|158242725|FG001|Randomized Phase|Lost to Follow-up|3|||
49110591|NCT02603107|158242724|FG000|Randomized Phase|Adverse Event|2|||
49110592|NCT02603107|158242725|FG001|Randomized Phase|Adverse Event|0|||
49110593|NCT02603107|158242724|FG000|Randomized Phase|Death|1|||
49110594|NCT02603107|158242725|FG001|Randomized Phase|Death|1|||
49110595|NCT02603107|158242724|FG000|Randomized Phase|Non-compliance with study drug|1|||
49110596|NCT02603107|158242725|FG001|Randomized Phase|Non-compliance with study drug|1|||
49110597|NCT02603107|158242724|FG000|Randomized Phase|Investigator's discretion|0|||
49110598|NCT02603107|158242725|FG001|Randomized Phase|Investigator's discretion|1|||
49110599|NCT02603107|158242724|FG000|Randomized Phase|Lack of Efficacy|1|||
49110600|NCT02603107|158242725|FG001|Randomized Phase|Lack of Efficacy|0|||
49110601|NCT02603107|158242724|FG000|Randomized Phase|Protocol Violation|1|||
49110602|NCT02603107|158242725|FG001|Randomized Phase|Protocol Violation|0|||
49110603|NCT02603107|158242724|FG000|Optional Extension Phase|Lost to Follow-up|3|||
49110604|NCT02603107|158242725|FG001|Optional Extension Phase|Lost to Follow-up|3|||
49110605|NCT02603107|158242724|FG000|Optional Extension Phase|Withdrew consent|3|||
49110606|NCT02603107|158242725|FG001|Optional Extension Phase|Withdrew consent|2|||
49110607|NCT02603107|158242724|FG000|Optional Extension Phase|Investigator's discretion|2|||
49110608|NCT02603107|158242725|FG001|Optional Extension Phase|Investigator's discretion|2|||
49110609|NCT02603107|158242724|FG000|Optional Extension Phase|Pregnancy|0|||
49110610|NCT02603107|158242725|FG001|Optional Extension Phase|Pregnancy|3|||
49110611|NCT02603107|158242724|FG000|Optional Extension Phase|Adverse Event|0|||
49110612|NCT02603107|158242725|FG001|Optional Extension Phase|Adverse Event|2|||
49110613|NCT02603107|158242724|FG000|Optional Extension Phase|Not treated in extension phase|0|||
49110614|NCT02603107|158242725|FG001|Optional Extension Phase|Not treated in extension phase|1|||
49110615|NCT02603107|158242724|FG000|Optional Extension Phase|Protocol Violation|1|||
49110616|NCT02603107|158242725|FG001|Optional Extension Phase|Protocol Violation|0|||
49110617|NCT02007278|158242745|FG000|Overall Study|Failure to comply with an eligibility|0|||
49110618|NCT02007278|158242746|FG001|Overall Study|Failure to comply with an eligibility|1|||
49110619|NCT02007278|158242745|FG000|Overall Study|Ingestion of drugs not allowed in study|0|||
49110620|NCT02007278|158242746|FG001|Overall Study|Ingestion of drugs not allowed in study|1|||
49110621|NCT02007278|158242745|FG000|Overall Study|Incorrect medication administration|1|||
49110622|NCT02007278|158242746|FG001|Overall Study|Incorrect medication administration|0|||
49110623|NCT02007278|158242745|FG000|Overall Study|Mis-randomization|1|||
49110624|NCT02007278|158242746|FG001|Overall Study|Mis-randomization|1|||
49110625|NCT03230838|158242748|FG000|Overall Study|Withdrawal by Subject|3|||
49110626|NCT03230838|158242749|FG001|Overall Study|Withdrawal by Subject|0|||
49110627|NCT03230838|158242748|FG000|Overall Study|Temperature excursion|1|||
49110628|NCT03230838|158242749|FG001|Overall Study|Temperature excursion|0|||
49110629|NCT02886884|158242751|FG000|Follow-up|Withdrawal by Subject|0|||
49110630|NCT02886884|158242752|FG001|Follow-up|Withdrawal by Subject|0|||
49110631|NCT02886884|158242753|FG002|Follow-up|Withdrawal by Subject|0|||
49110632|NCT02886884|158242754|FG003|Follow-up|Withdrawal by Subject|1|||
49110633|NCT00350779|158242755|FG000|Overall Study|Adverse Event|4|||
49110634|NCT00350779|158242756|FG001|Overall Study|Adverse Event|2|||
49110635|NCT00350779|158242755|FG000|Overall Study|Lack of Efficacy|0|||
49110636|NCT00350779|158242756|FG001|Overall Study|Lack of Efficacy|4|||
49110637|NCT00350779|158242755|FG000|Overall Study|Lost to Follow-up|2|||
49110638|NCT00350779|158242756|FG001|Overall Study|Lost to Follow-up|0|||
49110639|NCT00350779|158242755|FG000|Overall Study|Physician Decision|2|||
49110640|NCT00350779|158242756|FG001|Overall Study|Physician Decision|4|||
49110641|NCT00350779|158242755|FG000|Overall Study|Protocol Violation|3|||
49110642|NCT00350779|158242756|FG001|Overall Study|Protocol Violation|1|||
49110643|NCT00350779|158242755|FG000|Overall Study|Withdrawal by Subject|9|||
49110644|NCT00350779|158242756|FG001|Overall Study|Withdrawal by Subject|8|||
49110645|NCT00350779|158242755|FG000|Overall Study|Patient Moved|2|||
49110646|NCT00350779|158242756|FG001|Overall Study|Patient Moved|1|||
49110647|NCT00350779|158242755|FG000|Overall Study|Non-compliance with study procedures|0|||
49110648|NCT00350779|158242756|FG001|Overall Study|Non-compliance with study procedures|1|||
49110649|NCT01915771|158242760|FG000|Day 1|Withdrawal by Subject|1|||
49110650|NCT01915771|158242760|FG000|Day 15|Withdrawal by Subject|1|||
49110651|NCT04769739|158242761|FG000|Overall Study|Colorectal cancer obstruction|2|||
49110652|NCT04769739|158242762|FG001|Overall Study|Colorectal cancer obstruction|0|||
49110653|NCT04769739|158242763|FG002|Overall Study|Colorectal cancer obstruction|0|||
49110654|NCT04769739|158242764|FG003|Overall Study|Colorectal cancer obstruction|0|||
49110655|NCT04769739|158242761|FG000|Overall Study|Failed cecal intubation|1|||
49110656|NCT04769739|158242762|FG001|Overall Study|Failed cecal intubation|0|||
49110657|NCT04769739|158242763|FG002|Overall Study|Failed cecal intubation|0|||
49110658|NCT04769739|158242764|FG003|Overall Study|Failed cecal intubation|1|||
49110659|NCT04769739|158242761|FG000|Overall Study|Poor bowel preparation|0|||
49110660|NCT04769739|158242762|FG001|Overall Study|Poor bowel preparation|0|||
49110661|NCT04769739|158242763|FG002|Overall Study|Poor bowel preparation|0|||
49110662|NCT04769739|158242764|FG003|Overall Study|Poor bowel preparation|1|||
49110663|NCT01447719|158242767|FG000|Overall Study|Image acquisition failure|2|||
49110664|NCT01447719|158242767|FG000|Overall Study|Invalid image or not imaged|3|||
49110665|NCT01447719|158242767|FG000|Overall Study|Subject still living at end of study|79|||
49110666|NCT01447719|158242767|FG000|Overall Study|Withdrawal by Subject|2|||
49110667|NCT01447719|158242767|FG000|Overall Study|Family withdrew autopsy consent|7|||
49110668|NCT00492232|158242770|FG000|Placebo Run-in|Adverse Event|0|||
49110669|NCT00492232|158242771|FG001|Placebo Run-in|Adverse Event|2|||
49110670|NCT00492232|158242770|FG000|Placebo Run-in|Protocol Violation|0|||
49110671|NCT00492232|158242771|FG001|Placebo Run-in|Protocol Violation|3|||
49110672|NCT00492232|158242770|FG000|Placebo Run-in|Lost to Follow-up|0|||
49110673|NCT00492232|158242771|FG001|Placebo Run-in|Lost to Follow-up|3|||
49110674|NCT00492232|158242770|FG000|Placebo Run-in|Withdrawal by Subject|0|||
49110675|NCT00492232|158242771|FG001|Placebo Run-in|Withdrawal by Subject|8|||
49110676|NCT00492232|158242770|FG000|Placebo Run-in|Pregnancy|0|||
49110677|NCT00492232|158242771|FG001|Placebo Run-in|Pregnancy|1|||
49110678|NCT00492232|158242770|FG000|Placebo Run-in|Entrance criteria not met|0|||
49110679|NCT00492232|158242771|FG001|Placebo Run-in|Entrance criteria not met|45|||
49110680|NCT00492232|158242770|FG000|Placebo Run-in|Other|0|||
49110681|NCT00492232|158242771|FG001|Placebo Run-in|Other|6|||
49110682|NCT00492232|158242770|FG000|Placebo Run-in|Missing|0|||
49110683|NCT00492232|158242771|FG001|Placebo Run-in|Missing|2|||
49110684|NCT00492232|158242770|FG000|Double-Blind Treatment|Adverse Event|1|||
49110685|NCT00492232|158242771|FG001|Double-Blind Treatment|Adverse Event|2|||
49110686|NCT00492232|158242770|FG000|Double-Blind Treatment|Protocol Violation|3|||
49110687|NCT00492232|158242771|FG001|Double-Blind Treatment|Protocol Violation|7|||
49110688|NCT00492232|158242770|FG000|Double-Blind Treatment|Lost to Follow-up|2|||
49110689|NCT00492232|158242771|FG001|Double-Blind Treatment|Lost to Follow-up|3|||
49110690|NCT00492232|158242770|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
49110691|NCT00492232|158242771|FG001|Double-Blind Treatment|Withdrawal by Subject|8|||
49110692|NCT00492232|158242770|FG000|Double-Blind Treatment|Lack of Efficacy|1|||
49110693|NCT00492232|158242771|FG001|Double-Blind Treatment|Lack of Efficacy|0|||
49110694|NCT00492232|158242770|FG000|Double-Blind Treatment|Other|6|||
49110695|NCT00492232|158242771|FG001|Double-Blind Treatment|Other|5|||
49110696|NCT00492232|158242770|FG000|Double-Blind Treatment|Randomized not treated|1|||
49110697|NCT00492232|158242771|FG001|Double-Blind Treatment|Randomized not treated|0|||
49110698|NCT00492232|158242770|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
49110699|NCT00492232|158242771|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
49110700|NCT00282152|158242772|FG000|Overall Study|Withdrawal by Subject|1|||
49110701|NCT00282152|158242773|FG001|Overall Study|Withdrawal by Subject|0|||
49110702|NCT02536781|158242778|FG000|Overall Study|Lost to Follow-up|2|||
49110703|NCT02536781|158242779|FG001|Overall Study|Lost to Follow-up|0|||
49110704|NCT03423147|158242780|FG000|Overall Study|Lost to Follow-up|5|||
49110705|NCT03423147|158242781|FG001|Overall Study|Lost to Follow-up|8|||
49110706|NCT03423147|158242780|FG000|Overall Study|Withdrawal by Subject|1|||
49110707|NCT03423147|158242781|FG001|Overall Study|Withdrawal by Subject|0|||
49110708|NCT03423147|158242780|FG000|Overall Study|withdrawn due to vaginal delivery|1|||
49110709|NCT03423147|158242781|FG001|Overall Study|withdrawn due to vaginal delivery|0|||
49110710|NCT03423147|158242780|FG000|Overall Study|Age < 18|1|||
49110711|NCT03423147|158242781|FG001|Overall Study|Age < 18|0|||
49110712|NCT03423147|158242780|FG000|Overall Study|No Trial of Labor|0|||
49110713|NCT03423147|158242781|FG001|Overall Study|No Trial of Labor|1|||
49110714|NCT03084315|158242782|FG000|Overall Study|Lost to Follow-up|8|||
49110715|NCT03084315|158242783|FG001|Overall Study|Lost to Follow-up|7|||
49110716|NCT03084315|158242782|FG000|Overall Study|Withdrawal by Subject|2|||
49110717|NCT03084315|158242783|FG001|Overall Study|Withdrawal by Subject|2|||
49110718|NCT00586898|158242784|FG000|Overall Study|Adverse Event|1|||
49110719|NCT00586898|158242784|FG000|Overall Study|Patiemt Non-compliance|1|||
49110720|NCT00586898|158242784|FG000|Overall Study|Evaluable for Toxicity Only|5|||
49110721|NCT02634710|158242785|FG000|Overall Study|Death|4|||
49110722|NCT01180049|158242786|FG000|Overall Study|Other|9|||
49110723|NCT01180049|158242787|FG001|Overall Study|Other|7|||
49110724|NCT01180049|158242786|FG000|Overall Study|Lost to Follow-up|8|||
49110725|NCT01180049|158242787|FG001|Overall Study|Lost to Follow-up|6|||
49110726|NCT01180049|158242786|FG000|Overall Study|Death|36|||
49110727|NCT01180049|158242787|FG001|Overall Study|Death|35|||
49110728|NCT02380859|158242788|FG000|Overall Study|Withdrawal by Subject|2|||
49110729|NCT02380859|158242789|FG001|Overall Study|Withdrawal by Subject|0|||
49110730|NCT01764659|158242790|FG000|Overall Study|Death|1|||
49110731|NCT01764659|158242790|FG000|Overall Study|Physician Decision|1|||
49110732|NCT01627782|158242793|FG000|Overall Study|Adverse Event|1|||
49110733|NCT01627782|158242794|FG001|Overall Study|Adverse Event|2|||
49110734|NCT01627782|158242795|FG002|Overall Study|Adverse Event|0|||
49110735|NCT01627782|158242796|FG003|Overall Study|Adverse Event|1|||
49110736|NCT01627782|158242793|FG000|Overall Study|Lack of Efficacy|11|||
49110737|NCT01627782|158242794|FG001|Overall Study|Lack of Efficacy|1|||
49110738|NCT01627782|158242795|FG002|Overall Study|Lack of Efficacy|15|||
49110739|NCT01627782|158242796|FG003|Overall Study|Lack of Efficacy|2|||
49110740|NCT01627782|158242793|FG000|Overall Study|Protocol Violation|1|||
49110741|NCT01627782|158242794|FG001|Overall Study|Protocol Violation|0|||
49110742|NCT01627782|158242795|FG002|Overall Study|Protocol Violation|0|||
49110743|NCT01627782|158242796|FG003|Overall Study|Protocol Violation|0|||
49110744|NCT01627782|158242793|FG000|Overall Study|Withdrawal by Subject|2|||
49110745|NCT01627782|158242794|FG001|Overall Study|Withdrawal by Subject|1|||
49110746|NCT01627782|158242795|FG002|Overall Study|Withdrawal by Subject|0|||
49110747|NCT01627782|158242796|FG003|Overall Study|Withdrawal by Subject|0|||
49110748|NCT01627782|158242793|FG000|Overall Study|Other|0|||
49110749|NCT01627782|158242794|FG001|Overall Study|Other|2|||
49110750|NCT01627782|158242795|FG002|Overall Study|Other|0|||
49110751|NCT01627782|158242796|FG003|Overall Study|Other|3|||
49110752|NCT01627782|158242793|FG000|Overall Study|Randomized But Not Treated|1|||
49110753|NCT01627782|158242794|FG001|Overall Study|Randomized But Not Treated|0|||
49110754|NCT01627782|158242795|FG002|Overall Study|Randomized But Not Treated|0|||
49110755|NCT01627782|158242796|FG003|Overall Study|Randomized But Not Treated|0|||
49110756|NCT00628927|158242797|FG000|Overall Study|Problems performing blood draw|6|||
49110757|NCT00628927|158242798|FG001|Overall Study|Problems performing blood draw|0|||
49110758|NCT00628927|158242797|FG000|Overall Study|Lost to Follow-up|1|||
49110759|NCT00628927|158242798|FG001|Overall Study|Lost to Follow-up|0|||
49110760|NCT00628927|158242797|FG000|Overall Study|Equipment failure|1|||
49110761|NCT00628927|158242798|FG001|Overall Study|Equipment failure|0|||
49110762|NCT01738191|158242799|FG000|Overall Study|Withdrawal by Subject|4|||
49110763|NCT01738191|158242800|FG001|Overall Study|Withdrawal by Subject|1|||
49110764|NCT02243046|158242801|FG000|Overall Study|Lost to Follow-up|1|||
49110765|NCT02243046|158242802|FG001|Overall Study|Lost to Follow-up|1|||
49110766|NCT02243046|158242803|FG002|Overall Study|Lost to Follow-up|4|||
49110767|NCT02483572|158242804|FG000|Overall Study|Withdrawal by Subject|1|||
49110768|NCT02483572|158242805|FG001|Overall Study|Withdrawal by Subject|0|||
49110769|NCT02483572|158242804|FG000|Overall Study|Lost to Follow-up|1|||
49110770|NCT02483572|158242805|FG001|Overall Study|Lost to Follow-up|0|||
49110771|NCT02483572|158242804|FG000|Overall Study|Physician Decision|0|||
49110772|NCT02483572|158242805|FG001|Overall Study|Physician Decision|1|||
49110773|NCT00520767|158242807|FG000|Overall Study|Death|2|||
49110774|NCT02669667|158242808|FG000|Overall Study|Lost to Follow-up|0|||
49110775|NCT02669667|158242809|FG001|Overall Study|Lost to Follow-up|0|||
49110776|NCT02669667|158242810|FG002|Overall Study|Lost to Follow-up|0|||
49110777|NCT02669667|158242811|FG003|Overall Study|Lost to Follow-up|0|||
49110778|NCT02669667|158242812|FG004|Overall Study|Lost to Follow-up|0|||
49110779|NCT02669667|158242813|FG005|Overall Study|Lost to Follow-up|1|||
49110780|NCT02669667|158242814|FG006|Overall Study|Lost to Follow-up|0|||
49110781|NCT03338569|158242817|FG000|Overall Study|Physician Decision|8|||
49110782|NCT03338569|158242818|FG001|Overall Study|Physician Decision|3|||
49110783|NCT03338569|158242817|FG000|Overall Study|Withdrawal by Subject|0|||
49110784|NCT03338569|158242818|FG001|Overall Study|Withdrawal by Subject|1|||
49110785|NCT03338569|158242817|FG000|Overall Study|Lost to Follow-up|0|||
49110786|NCT03338569|158242818|FG001|Overall Study|Lost to Follow-up|1|||
49110787|NCT04811664|158242819|FG000|Overall Study|Lost to Follow-up|78|||
49110788|NCT04811664|158242820|FG001|Overall Study|Lost to Follow-up|125|||
49110789|NCT04811664|158242821|FG002|Overall Study|Lost to Follow-up|46|||
49110790|NCT04811664|158242819|FG000|Overall Study|Withdrawal by Subject|39|||
49110791|NCT04811664|158242820|FG001|Overall Study|Withdrawal by Subject|76|||
49110792|NCT04811664|158242821|FG002|Overall Study|Withdrawal by Subject|12|||
49110793|NCT04811664|158242819|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|6|||
49110794|NCT04811664|158242820|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
49110795|NCT04811664|158242821|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|17|||
49110796|NCT04811664|158242819|FG000|Overall Study|Participant is unwilling or unable to comply with required study|24|||
49110797|NCT04811664|158242820|FG001|Overall Study|Participant is unwilling or unable to comply with required study|47|||
49110798|NCT04811664|158242821|FG002|Overall Study|Participant is unwilling or unable to comply with required study|16|||
49110799|NCT04811664|158242819|FG000|Overall Study|Protocol Violation|0|||
49110800|NCT04811664|158242820|FG001|Overall Study|Protocol Violation|5|||
49110801|NCT04811664|158242821|FG002|Overall Study|Protocol Violation|11|||
49110802|NCT04811664|158242819|FG000|Overall Study|Study Terminated by Sponsor|4|||
49110803|NCT04811664|158242820|FG001|Overall Study|Study Terminated by Sponsor|3|||
49110804|NCT04811664|158242821|FG002|Overall Study|Study Terminated by Sponsor|34|||
49110805|NCT04811664|158242819|FG000|Overall Study|Early Study Closure|3|||
49110806|NCT04811664|158242820|FG001|Overall Study|Early Study Closure|7|||
49110807|NCT04811664|158242821|FG002|Overall Study|Early Study Closure|79|||
49110808|NCT04811664|158242819|FG000|Overall Study|Other (Unable to receive payment visa status)|0|||
49110809|NCT04811664|158242820|FG001|Overall Study|Other (Unable to receive payment visa status)|2|||
49110810|NCT04811664|158242821|FG002|Overall Study|Other (Unable to receive payment visa status)|0|||
49110811|NCT02717442|158242826|FG000|Overall Study|Study Terminated by Sponsor|31|||
49110812|NCT02717442|158242827|FG001|Overall Study|Study Terminated by Sponsor|29|||
49110813|NCT02717442|158242826|FG000|Overall Study|Subject Randomized, but Did not Receive Drug|2|||
49111480|NCT02452554|158242913|FG005|Overall Study|Death|0|||
49110814|NCT02717442|158242827|FG001|Overall Study|Subject Randomized, but Did not Receive Drug|0|||
49110815|NCT02717442|158242826|FG000|Overall Study|Other - Not Specified|2|||
49110816|NCT02717442|158242827|FG001|Overall Study|Other - Not Specified|0|||
49110817|NCT00382109|158242828|FG000|Overall Study|Adverse Event|3|||
49110818|NCT00382109|158242829|FG001|Overall Study|Adverse Event|0|||
49110819|NCT00382109|158242828|FG000|Overall Study|Physician Decision|6|||
49110820|NCT00382109|158242829|FG001|Overall Study|Physician Decision|1|||
49110821|NCT00382109|158242828|FG000|Overall Study|Withdrawal by Subject|1|||
49110822|NCT00382109|158242829|FG001|Overall Study|Withdrawal by Subject|0|||
49110823|NCT00382109|158242828|FG000|Overall Study|ineligible|2|||
49110824|NCT00382109|158242829|FG001|Overall Study|ineligible|0|||
49110825|NCT00382109|158242828|FG000|Overall Study|Other|0|||
49110826|NCT00382109|158242829|FG001|Overall Study|Other|2|||
49110827|NCT00382109|158242828|FG000|Overall Study|consent withdrawal|0|||
49110828|NCT00382109|158242829|FG001|Overall Study|consent withdrawal|1|||
49110829|NCT05052697|158242830|FG000|Substudy A|Lost to Follow-up|0|||
49110830|NCT05052697|158242831|FG001|Substudy A|Lost to Follow-up|0|||
49110831|NCT05052697|158242832|FG002|Substudy A|Lost to Follow-up|0|||
49110832|NCT05052697|158242833|FG003|Substudy A|Lost to Follow-up|0|||
49110833|NCT05052697|158242834|FG004|Substudy A|Lost to Follow-up|0|||
49110834|NCT05052697|158242835|FG005|Substudy A|Lost to Follow-up|1|||
49110835|NCT05052697|158242836|FG006|Substudy A|Lost to Follow-up|0|||
49110836|NCT05052697|158242837|FG007|Substudy A|Lost to Follow-up|0|||
49110837|NCT05052697|158242838|FG008|Substudy A|Lost to Follow-up|0|||
49110838|NCT05052697|158242839|FG009|Substudy A|Lost to Follow-up|0|||
49110839|NCT05052697|158242840|FG010|Substudy A|Lost to Follow-up|0|||
49110840|NCT05052697|158242841|FG011|Substudy A|Lost to Follow-up|0|||
49110841|NCT05052697|158242842|FG012|Substudy A|Lost to Follow-up|0|||
49110842|NCT05052697|158242843|FG013|Substudy A|Lost to Follow-up|0|||
49110843|NCT05052697|158242844|FG014|Substudy A|Lost to Follow-up|0|||
49110844|NCT05052697|158242845|FG015|Substudy A|Lost to Follow-up|2|||
49110845|NCT05052697|158242846|FG016|Substudy A|Lost to Follow-up|0|||
49110846|NCT05052697|158242847|FG017|Substudy A|Lost to Follow-up|0|||
49110847|NCT05052697|158242848|FG018|Substudy A|Lost to Follow-up|0|||
49110848|NCT05052697|158242849|FG019|Substudy A|Lost to Follow-up|0|||
49110849|NCT05052697|158242850|FG020|Substudy A|Lost to Follow-up|0|||
49110850|NCT05052697|158242851|FG021|Substudy A|Lost to Follow-up|0|||
49110851|NCT05052697|158242852|FG022|Substudy A|Lost to Follow-up|0|||
49110852|NCT05052697|158242853|FG023|Substudy A|Lost to Follow-up|0|||
49110853|NCT05052697|158242854|FG024|Substudy A|Lost to Follow-up|0|||
49110854|NCT05052697|158242855|FG025|Substudy A|Lost to Follow-up|0|||
49110855|NCT05052697|158242856|FG026|Substudy A|Lost to Follow-up|0|||
49110856|NCT05052697|158242857|FG027|Substudy A|Lost to Follow-up|0|||
49110857|NCT05052697|158242858|FG028|Substudy A|Lost to Follow-up|0|||
49110858|NCT05052697|158242859|FG029|Substudy A|Lost to Follow-up|0|||
49110859|NCT05052697|158242860|FG030|Substudy A|Lost to Follow-up|0|||
49110860|NCT05052697|158242861|FG031|Substudy A|Lost to Follow-up|0|||
49110861|NCT05052697|158242862|FG032|Substudy A|Lost to Follow-up|0|||
49110862|NCT05052697|158242863|FG033|Substudy A|Lost to Follow-up|0|||
49110863|NCT05052697|158242830|FG000|Substudy A|No longer met eligibility criteria|0|||
49110864|NCT05052697|158242831|FG001|Substudy A|No longer met eligibility criteria|0|||
49110865|NCT05052697|158242832|FG002|Substudy A|No longer met eligibility criteria|0|||
49110866|NCT05052697|158242833|FG003|Substudy A|No longer met eligibility criteria|0|||
49110867|NCT05052697|158242834|FG004|Substudy A|No longer met eligibility criteria|0|||
49110868|NCT05052697|158242835|FG005|Substudy A|No longer met eligibility criteria|0|||
49110869|NCT05052697|158242836|FG006|Substudy A|No longer met eligibility criteria|0|||
49110870|NCT05052697|158242837|FG007|Substudy A|No longer met eligibility criteria|0|||
49110871|NCT05052697|158242838|FG008|Substudy A|No longer met eligibility criteria|0|||
49110872|NCT05052697|158242839|FG009|Substudy A|No longer met eligibility criteria|0|||
49110873|NCT05052697|158242840|FG010|Substudy A|No longer met eligibility criteria|0|||
49110874|NCT05052697|158242841|FG011|Substudy A|No longer met eligibility criteria|0|||
49110875|NCT05052697|158242842|FG012|Substudy A|No longer met eligibility criteria|0|||
49110876|NCT05052697|158242843|FG013|Substudy A|No longer met eligibility criteria|1|||
49110877|NCT05052697|158242844|FG014|Substudy A|No longer met eligibility criteria|0|||
49110878|NCT05052697|158242845|FG015|Substudy A|No longer met eligibility criteria|0|||
49110879|NCT05052697|158242846|FG016|Substudy A|No longer met eligibility criteria|0|||
49110880|NCT05052697|158242847|FG017|Substudy A|No longer met eligibility criteria|0|||
49110881|NCT05052697|158242848|FG018|Substudy A|No longer met eligibility criteria|0|||
49110882|NCT05052697|158242849|FG019|Substudy A|No longer met eligibility criteria|0|||
49110883|NCT05052697|158242850|FG020|Substudy A|No longer met eligibility criteria|0|||
49110884|NCT05052697|158242851|FG021|Substudy A|No longer met eligibility criteria|0|||
49110885|NCT05052697|158242852|FG022|Substudy A|No longer met eligibility criteria|0|||
49110886|NCT05052697|158242853|FG023|Substudy A|No longer met eligibility criteria|0|||
49110887|NCT05052697|158242854|FG024|Substudy A|No longer met eligibility criteria|0|||
49110888|NCT05052697|158242855|FG025|Substudy A|No longer met eligibility criteria|0|||
49110889|NCT05052697|158242856|FG026|Substudy A|No longer met eligibility criteria|0|||
49111481|NCT02452554|158242908|FG000|Overall Study|Lack of Efficacy|13|||
49110890|NCT05052697|158242857|FG027|Substudy A|No longer met eligibility criteria|0|||
49110891|NCT05052697|158242858|FG028|Substudy A|No longer met eligibility criteria|0|||
49110892|NCT05052697|158242859|FG029|Substudy A|No longer met eligibility criteria|0|||
49110893|NCT05052697|158242860|FG030|Substudy A|No longer met eligibility criteria|0|||
49110894|NCT05052697|158242861|FG031|Substudy A|No longer met eligibility criteria|0|||
49110895|NCT05052697|158242862|FG032|Substudy A|No longer met eligibility criteria|0|||
49110896|NCT05052697|158242863|FG033|Substudy A|No longer met eligibility criteria|0|||
49110897|NCT05052697|158242830|FG000|Substudy A|Not vaccinated|0|||
49110898|NCT05052697|158242831|FG001|Substudy A|Not vaccinated|0|||
49110899|NCT05052697|158242832|FG002|Substudy A|Not vaccinated|0|||
49110900|NCT05052697|158242833|FG003|Substudy A|Not vaccinated|1|||
49110901|NCT05052697|158242834|FG004|Substudy A|Not vaccinated|0|||
49110902|NCT05052697|158242835|FG005|Substudy A|Not vaccinated|0|||
49110903|NCT05052697|158242836|FG006|Substudy A|Not vaccinated|0|||
49110904|NCT05052697|158242837|FG007|Substudy A|Not vaccinated|0|||
49110905|NCT05052697|158242838|FG008|Substudy A|Not vaccinated|1|||
49110906|NCT05052697|158242839|FG009|Substudy A|Not vaccinated|0|||
49110907|NCT05052697|158242840|FG010|Substudy A|Not vaccinated|0|||
49110908|NCT05052697|158242841|FG011|Substudy A|Not vaccinated|0|||
49110909|NCT05052697|158242842|FG012|Substudy A|Not vaccinated|0|||
49110910|NCT05052697|158242843|FG013|Substudy A|Not vaccinated|0|||
49110911|NCT05052697|158242844|FG014|Substudy A|Not vaccinated|0|||
49110912|NCT05052697|158242845|FG015|Substudy A|Not vaccinated|0|||
49110913|NCT05052697|158242846|FG016|Substudy A|Not vaccinated|0|||
49110914|NCT05052697|158242847|FG017|Substudy A|Not vaccinated|0|||
49110915|NCT05052697|158242848|FG018|Substudy A|Not vaccinated|0|||
49110916|NCT05052697|158242849|FG019|Substudy A|Not vaccinated|0|||
49110917|NCT05052697|158242850|FG020|Substudy A|Not vaccinated|0|||
49110918|NCT05052697|158242851|FG021|Substudy A|Not vaccinated|0|||
49110919|NCT05052697|158242852|FG022|Substudy A|Not vaccinated|0|||
49110920|NCT05052697|158242853|FG023|Substudy A|Not vaccinated|0|||
49110921|NCT05052697|158242854|FG024|Substudy A|Not vaccinated|0|||
49110922|NCT05052697|158242855|FG025|Substudy A|Not vaccinated|0|||
49110923|NCT05052697|158242856|FG026|Substudy A|Not vaccinated|0|||
49110924|NCT05052697|158242857|FG027|Substudy A|Not vaccinated|0|||
49110925|NCT05052697|158242858|FG028|Substudy A|Not vaccinated|0|||
49110926|NCT05052697|158242859|FG029|Substudy A|Not vaccinated|0|||
49110927|NCT05052697|158242860|FG030|Substudy A|Not vaccinated|0|||
49110928|NCT05052697|158242861|FG031|Substudy A|Not vaccinated|0|||
49110929|NCT05052697|158242862|FG032|Substudy A|Not vaccinated|0|||
49110930|NCT05052697|158242863|FG033|Substudy A|Not vaccinated|0|||
49110931|NCT05052697|158242830|FG000|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
49110932|NCT05052697|158242831|FG001|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
49110933|NCT05052697|158242832|FG002|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
49110934|NCT05052697|158242833|FG003|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
49110935|NCT05052697|158242834|FG004|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
49110936|NCT05052697|158242835|FG005|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
49110937|NCT05052697|158242836|FG006|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
49110938|NCT05052697|158242837|FG007|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
49110939|NCT05052697|158242838|FG008|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
49110940|NCT05052697|158242839|FG009|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
49110941|NCT05052697|158242840|FG010|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
49110942|NCT05052697|158242841|FG011|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
49110943|NCT05052697|158242842|FG012|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
49110944|NCT05052697|158242843|FG013|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
49110945|NCT05052697|158242844|FG014|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
49110946|NCT05052697|158242845|FG015|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
49110947|NCT05052697|158242846|FG016|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
49110948|NCT05052697|158242847|FG017|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
49110949|NCT05052697|158242848|FG018|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
49110950|NCT05052697|158242849|FG019|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
49110951|NCT05052697|158242850|FG020|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
49110952|NCT05052697|158242851|FG021|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
49110953|NCT05052697|158242852|FG022|SubStudy B: Initial Enrollment|Withdrawal by Subject|2|||
49110954|NCT05052697|158242853|FG023|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
49110955|NCT05052697|158242854|FG024|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
49110956|NCT05052697|158242855|FG025|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
49110957|NCT05052697|158242856|FG026|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
49110958|NCT05052697|158242857|FG027|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
49110959|NCT05052697|158242858|FG028|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
49110960|NCT05052697|158242859|FG029|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
49110961|NCT05052697|158242860|FG030|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
49110962|NCT05052697|158242861|FG031|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
49110963|NCT05052697|158242862|FG032|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
49110964|NCT05052697|158242863|FG033|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
49110965|NCT05052697|158242830|FG000|SubStudy B: Initial Enrollment|Physician Decision|0|||
49110966|NCT05052697|158242831|FG001|SubStudy B: Initial Enrollment|Physician Decision|0|||
49110967|NCT05052697|158242832|FG002|SubStudy B: Initial Enrollment|Physician Decision|0|||
49110968|NCT05052697|158242833|FG003|SubStudy B: Initial Enrollment|Physician Decision|0|||
49110969|NCT05052697|158242834|FG004|SubStudy B: Initial Enrollment|Physician Decision|0|||
49110970|NCT05052697|158242835|FG005|SubStudy B: Initial Enrollment|Physician Decision|0|||
49110971|NCT05052697|158242836|FG006|SubStudy B: Initial Enrollment|Physician Decision|0|||
49110972|NCT05052697|158242837|FG007|SubStudy B: Initial Enrollment|Physician Decision|0|||
49110973|NCT05052697|158242838|FG008|SubStudy B: Initial Enrollment|Physician Decision|0|||
49110974|NCT05052697|158242839|FG009|SubStudy B: Initial Enrollment|Physician Decision|0|||
49110975|NCT05052697|158242840|FG010|SubStudy B: Initial Enrollment|Physician Decision|0|||
49110976|NCT05052697|158242841|FG011|SubStudy B: Initial Enrollment|Physician Decision|0|||
49110977|NCT05052697|158242842|FG012|SubStudy B: Initial Enrollment|Physician Decision|0|||
49110978|NCT05052697|158242843|FG013|SubStudy B: Initial Enrollment|Physician Decision|0|||
49110979|NCT05052697|158242844|FG014|SubStudy B: Initial Enrollment|Physician Decision|0|||
49110980|NCT05052697|158242845|FG015|SubStudy B: Initial Enrollment|Physician Decision|0|||
49110981|NCT05052697|158242846|FG016|SubStudy B: Initial Enrollment|Physician Decision|0|||
49110982|NCT05052697|158242847|FG017|SubStudy B: Initial Enrollment|Physician Decision|1|||
49110983|NCT05052697|158242848|FG018|SubStudy B: Initial Enrollment|Physician Decision|0|||
49110984|NCT05052697|158242849|FG019|SubStudy B: Initial Enrollment|Physician Decision|0|||
49110985|NCT05052697|158242850|FG020|SubStudy B: Initial Enrollment|Physician Decision|0|||
49110986|NCT05052697|158242851|FG021|SubStudy B: Initial Enrollment|Physician Decision|0|||
49110987|NCT05052697|158242852|FG022|SubStudy B: Initial Enrollment|Physician Decision|0|||
49110988|NCT05052697|158242853|FG023|SubStudy B: Initial Enrollment|Physician Decision|0|||
49110989|NCT05052697|158242854|FG024|SubStudy B: Initial Enrollment|Physician Decision|0|||
49110990|NCT05052697|158242855|FG025|SubStudy B: Initial Enrollment|Physician Decision|0|||
49110991|NCT05052697|158242856|FG026|SubStudy B: Initial Enrollment|Physician Decision|0|||
49110992|NCT05052697|158242857|FG027|SubStudy B: Initial Enrollment|Physician Decision|0|||
49110993|NCT05052697|158242858|FG028|SubStudy B: Initial Enrollment|Physician Decision|0|||
49110994|NCT05052697|158242859|FG029|SubStudy B: Initial Enrollment|Physician Decision|0|||
49110995|NCT05052697|158242860|FG030|SubStudy B: Initial Enrollment|Physician Decision|0|||
49110996|NCT05052697|158242861|FG031|SubStudy B: Initial Enrollment|Physician Decision|0|||
49110997|NCT05052697|158242862|FG032|SubStudy B: Initial Enrollment|Physician Decision|0|||
49110998|NCT05052697|158242863|FG033|SubStudy B: Initial Enrollment|Physician Decision|0|||
49110999|NCT05052697|158242830|FG000|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
49111000|NCT05052697|158242831|FG001|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
49111001|NCT05052697|158242832|FG002|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
49111002|NCT05052697|158242833|FG003|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
49111003|NCT05052697|158242834|FG004|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
49111004|NCT05052697|158242835|FG005|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
49111005|NCT05052697|158242836|FG006|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
49111006|NCT05052697|158242837|FG007|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
49111007|NCT05052697|158242838|FG008|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
49111008|NCT05052697|158242839|FG009|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
49111009|NCT05052697|158242840|FG010|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
49111010|NCT05052697|158242841|FG011|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
49111011|NCT05052697|158242842|FG012|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
49111012|NCT05052697|158242843|FG013|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
49111013|NCT05052697|158242844|FG014|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
49111014|NCT05052697|158242845|FG015|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
49111015|NCT05052697|158242846|FG016|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
49111016|NCT05052697|158242847|FG017|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
49111017|NCT05052697|158242848|FG018|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
49111018|NCT05052697|158242849|FG019|SubStudy B: Initial Enrollment|Lost to Follow-up|1|||
49111019|NCT05052697|158242850|FG020|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
49111020|NCT05052697|158242851|FG021|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
49111021|NCT05052697|158242852|FG022|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
49111022|NCT05052697|158242853|FG023|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
49111023|NCT05052697|158242854|FG024|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
49111024|NCT05052697|158242855|FG025|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
49111025|NCT05052697|158242856|FG026|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
49111026|NCT05052697|158242857|FG027|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
49111027|NCT05052697|158242858|FG028|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
49111028|NCT05052697|158242859|FG029|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
49111029|NCT05052697|158242860|FG030|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
49111030|NCT05052697|158242861|FG031|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
49111031|NCT05052697|158242862|FG032|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
49111032|NCT05052697|158242863|FG033|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
49111033|NCT05052697|158242830|FG000|SubStudy B: Initial Enrollment|Not vaccinated|0|||
49111034|NCT05052697|158242831|FG001|SubStudy B: Initial Enrollment|Not vaccinated|0|||
49111035|NCT05052697|158242832|FG002|SubStudy B: Initial Enrollment|Not vaccinated|0|||
49111036|NCT05052697|158242833|FG003|SubStudy B: Initial Enrollment|Not vaccinated|0|||
49111037|NCT05052697|158242834|FG004|SubStudy B: Initial Enrollment|Not vaccinated|0|||
49111038|NCT05052697|158242835|FG005|SubStudy B: Initial Enrollment|Not vaccinated|0|||
49111039|NCT05052697|158242836|FG006|SubStudy B: Initial Enrollment|Not vaccinated|0|||
49111040|NCT05052697|158242837|FG007|SubStudy B: Initial Enrollment|Not vaccinated|0|||
49111041|NCT05052697|158242838|FG008|SubStudy B: Initial Enrollment|Not vaccinated|0|||
49111042|NCT05052697|158242839|FG009|SubStudy B: Initial Enrollment|Not vaccinated|0|||
49111043|NCT05052697|158242840|FG010|SubStudy B: Initial Enrollment|Not vaccinated|0|||
49111044|NCT05052697|158242841|FG011|SubStudy B: Initial Enrollment|Not vaccinated|0|||
49111045|NCT05052697|158242842|FG012|SubStudy B: Initial Enrollment|Not vaccinated|0|||
49111046|NCT05052697|158242843|FG013|SubStudy B: Initial Enrollment|Not vaccinated|0|||
49111047|NCT05052697|158242844|FG014|SubStudy B: Initial Enrollment|Not vaccinated|0|||
49111048|NCT05052697|158242845|FG015|SubStudy B: Initial Enrollment|Not vaccinated|0|||
49111049|NCT05052697|158242846|FG016|SubStudy B: Initial Enrollment|Not vaccinated|0|||
49111050|NCT05052697|158242847|FG017|SubStudy B: Initial Enrollment|Not vaccinated|1|||
49111051|NCT05052697|158242848|FG018|SubStudy B: Initial Enrollment|Not vaccinated|0|||
49111052|NCT05052697|158242849|FG019|SubStudy B: Initial Enrollment|Not vaccinated|0|||
49111053|NCT05052697|158242850|FG020|SubStudy B: Initial Enrollment|Not vaccinated|0|||
49111054|NCT05052697|158242851|FG021|SubStudy B: Initial Enrollment|Not vaccinated|0|||
49111055|NCT05052697|158242852|FG022|SubStudy B: Initial Enrollment|Not vaccinated|0|||
49111056|NCT05052697|158242853|FG023|SubStudy B: Initial Enrollment|Not vaccinated|0|||
49111057|NCT05052697|158242854|FG024|SubStudy B: Initial Enrollment|Not vaccinated|0|||
49111058|NCT05052697|158242855|FG025|SubStudy B: Initial Enrollment|Not vaccinated|1|||
49111059|NCT05052697|158242856|FG026|SubStudy B: Initial Enrollment|Not vaccinated|0|||
49111060|NCT05052697|158242857|FG027|SubStudy B: Initial Enrollment|Not vaccinated|1|||
49111061|NCT05052697|158242858|FG028|SubStudy B: Initial Enrollment|Not vaccinated|0|||
49111062|NCT05052697|158242859|FG029|SubStudy B: Initial Enrollment|Not vaccinated|0|||
49111063|NCT05052697|158242860|FG030|SubStudy B: Initial Enrollment|Not vaccinated|0|||
49111064|NCT05052697|158242861|FG031|SubStudy B: Initial Enrollment|Not vaccinated|0|||
49111065|NCT05052697|158242862|FG032|SubStudy B: Initial Enrollment|Not vaccinated|0|||
49111066|NCT05052697|158242863|FG033|SubStudy B: Initial Enrollment|Not vaccinated|0|||
49111067|NCT05052697|158242830|FG000|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
49111068|NCT05052697|158242831|FG001|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
49111069|NCT05052697|158242832|FG002|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
49111070|NCT05052697|158242833|FG003|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
49111071|NCT05052697|158242834|FG004|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
49111072|NCT05052697|158242835|FG005|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
49111073|NCT05052697|158242836|FG006|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
49111074|NCT05052697|158242837|FG007|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
49111075|NCT05052697|158242838|FG008|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
49111076|NCT05052697|158242839|FG009|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
49111077|NCT05052697|158242840|FG010|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
49111078|NCT05052697|158242841|FG011|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
49111079|NCT05052697|158242842|FG012|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
49111080|NCT05052697|158242843|FG013|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
49111081|NCT05052697|158242844|FG014|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
49111082|NCT05052697|158242845|FG015|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
49111083|NCT05052697|158242846|FG016|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
49111084|NCT05052697|158242847|FG017|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
49111085|NCT05052697|158242848|FG018|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
49111086|NCT05052697|158242849|FG019|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
49111087|NCT05052697|158242850|FG020|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
49111088|NCT05052697|158242851|FG021|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
49111089|NCT05052697|158242852|FG022|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
49111090|NCT05052697|158242853|FG023|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
49111091|NCT05052697|158242854|FG024|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
49111092|NCT05052697|158242855|FG025|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
49111093|NCT05052697|158242856|FG026|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
49111094|NCT05052697|158242857|FG027|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
49111095|NCT05052697|158242858|FG028|Substudy B: Expanded Enrollment|Withdrawal by Subject|2|||
49111096|NCT05052697|158242859|FG029|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
49111097|NCT05052697|158242860|FG030|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
49111098|NCT05052697|158242861|FG031|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
49111099|NCT05052697|158242862|FG032|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
49111100|NCT05052697|158242863|FG033|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
49111101|NCT05052697|158242830|FG000|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
49111102|NCT05052697|158242831|FG001|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
49111103|NCT05052697|158242832|FG002|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
49111104|NCT05052697|158242833|FG003|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
49111105|NCT05052697|158242834|FG004|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
49111106|NCT05052697|158242835|FG005|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
49111107|NCT05052697|158242836|FG006|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
49111108|NCT05052697|158242837|FG007|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
49111109|NCT05052697|158242838|FG008|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
49111110|NCT05052697|158242839|FG009|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
49111111|NCT05052697|158242840|FG010|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
49111112|NCT05052697|158242841|FG011|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
49111113|NCT05052697|158242842|FG012|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
49111114|NCT05052697|158242843|FG013|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
49111115|NCT05052697|158242844|FG014|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
49111116|NCT05052697|158242845|FG015|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
49111117|NCT05052697|158242846|FG016|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
49111118|NCT05052697|158242847|FG017|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
49111119|NCT05052697|158242848|FG018|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
49111120|NCT05052697|158242849|FG019|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
49111121|NCT05052697|158242850|FG020|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
49111122|NCT05052697|158242851|FG021|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
49111123|NCT05052697|158242852|FG022|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
49111124|NCT05052697|158242853|FG023|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
49111125|NCT05052697|158242854|FG024|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
49111126|NCT05052697|158242855|FG025|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
49111127|NCT05052697|158242856|FG026|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
49111128|NCT05052697|158242857|FG027|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
49111129|NCT05052697|158242858|FG028|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
49111130|NCT05052697|158242859|FG029|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
49111131|NCT05052697|158242860|FG030|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
49111132|NCT05052697|158242861|FG031|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
49111133|NCT05052697|158242862|FG032|Substudy B: Expanded Enrollment|Lost to Follow-up|2|||
49111134|NCT05052697|158242863|FG033|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
49111135|NCT05052697|158242830|FG000|Substudy B: Expanded Enrollment|Refused study procedure|0|||
49111136|NCT05052697|158242831|FG001|Substudy B: Expanded Enrollment|Refused study procedure|0|||
49111137|NCT05052697|158242832|FG002|Substudy B: Expanded Enrollment|Refused study procedure|0|||
49111138|NCT05052697|158242833|FG003|Substudy B: Expanded Enrollment|Refused study procedure|0|||
49111139|NCT05052697|158242834|FG004|Substudy B: Expanded Enrollment|Refused study procedure|0|||
49111140|NCT05052697|158242835|FG005|Substudy B: Expanded Enrollment|Refused study procedure|0|||
49111141|NCT05052697|158242836|FG006|Substudy B: Expanded Enrollment|Refused study procedure|0|||
49111142|NCT05052697|158242837|FG007|Substudy B: Expanded Enrollment|Refused study procedure|0|||
49111143|NCT05052697|158242838|FG008|Substudy B: Expanded Enrollment|Refused study procedure|0|||
49111144|NCT05052697|158242839|FG009|Substudy B: Expanded Enrollment|Refused study procedure|0|||
49111145|NCT05052697|158242840|FG010|Substudy B: Expanded Enrollment|Refused study procedure|0|||
49111146|NCT05052697|158242841|FG011|Substudy B: Expanded Enrollment|Refused study procedure|0|||
49111147|NCT05052697|158242842|FG012|Substudy B: Expanded Enrollment|Refused study procedure|0|||
49111148|NCT05052697|158242843|FG013|Substudy B: Expanded Enrollment|Refused study procedure|0|||
49111149|NCT05052697|158242844|FG014|Substudy B: Expanded Enrollment|Refused study procedure|0|||
49111150|NCT05052697|158242845|FG015|Substudy B: Expanded Enrollment|Refused study procedure|0|||
49111151|NCT05052697|158242846|FG016|Substudy B: Expanded Enrollment|Refused study procedure|0|||
49111152|NCT05052697|158242847|FG017|Substudy B: Expanded Enrollment|Refused study procedure|0|||
49111153|NCT05052697|158242848|FG018|Substudy B: Expanded Enrollment|Refused study procedure|0|||
49111154|NCT05052697|158242849|FG019|Substudy B: Expanded Enrollment|Refused study procedure|0|||
49111155|NCT05052697|158242850|FG020|Substudy B: Expanded Enrollment|Refused study procedure|0|||
49111156|NCT05052697|158242851|FG021|Substudy B: Expanded Enrollment|Refused study procedure|0|||
49111157|NCT05052697|158242852|FG022|Substudy B: Expanded Enrollment|Refused study procedure|0|||
49111158|NCT05052697|158242853|FG023|Substudy B: Expanded Enrollment|Refused study procedure|0|||
49111159|NCT05052697|158242854|FG024|Substudy B: Expanded Enrollment|Refused study procedure|0|||
49111160|NCT05052697|158242855|FG025|Substudy B: Expanded Enrollment|Refused study procedure|0|||
49111161|NCT05052697|158242856|FG026|Substudy B: Expanded Enrollment|Refused study procedure|0|||
49111162|NCT05052697|158242857|FG027|Substudy B: Expanded Enrollment|Refused study procedure|0|||
49111163|NCT05052697|158242858|FG028|Substudy B: Expanded Enrollment|Refused study procedure|0|||
49111164|NCT05052697|158242859|FG029|Substudy B: Expanded Enrollment|Refused study procedure|0|||
49111165|NCT05052697|158242860|FG030|Substudy B: Expanded Enrollment|Refused study procedure|0|||
49111166|NCT05052697|158242861|FG031|Substudy B: Expanded Enrollment|Refused study procedure|0|||
49111167|NCT05052697|158242862|FG032|Substudy B: Expanded Enrollment|Refused study procedure|1|||
49111168|NCT05052697|158242863|FG033|Substudy B: Expanded Enrollment|Refused study procedure|0|||
49111169|NCT05052697|158242830|FG000|Substudy B: Expanded Enrollment|Not vaccinated|0|||
49111170|NCT05052697|158242831|FG001|Substudy B: Expanded Enrollment|Not vaccinated|0|||
49111171|NCT05052697|158242832|FG002|Substudy B: Expanded Enrollment|Not vaccinated|0|||
49111172|NCT05052697|158242833|FG003|Substudy B: Expanded Enrollment|Not vaccinated|0|||
49111173|NCT05052697|158242834|FG004|Substudy B: Expanded Enrollment|Not vaccinated|0|||
49111174|NCT05052697|158242835|FG005|Substudy B: Expanded Enrollment|Not vaccinated|0|||
49111175|NCT05052697|158242836|FG006|Substudy B: Expanded Enrollment|Not vaccinated|0|||
49111176|NCT05052697|158242837|FG007|Substudy B: Expanded Enrollment|Not vaccinated|0|||
49111177|NCT05052697|158242838|FG008|Substudy B: Expanded Enrollment|Not vaccinated|0|||
49111178|NCT05052697|158242839|FG009|Substudy B: Expanded Enrollment|Not vaccinated|0|||
49111179|NCT05052697|158242840|FG010|Substudy B: Expanded Enrollment|Not vaccinated|0|||
49111180|NCT05052697|158242841|FG011|Substudy B: Expanded Enrollment|Not vaccinated|0|||
49111181|NCT05052697|158242842|FG012|Substudy B: Expanded Enrollment|Not vaccinated|0|||
49111182|NCT05052697|158242843|FG013|Substudy B: Expanded Enrollment|Not vaccinated|0|||
49111183|NCT05052697|158242844|FG014|Substudy B: Expanded Enrollment|Not vaccinated|0|||
49111184|NCT05052697|158242845|FG015|Substudy B: Expanded Enrollment|Not vaccinated|0|||
49111185|NCT05052697|158242846|FG016|Substudy B: Expanded Enrollment|Not vaccinated|0|||
49111186|NCT05052697|158242847|FG017|Substudy B: Expanded Enrollment|Not vaccinated|0|||
49111187|NCT05052697|158242848|FG018|Substudy B: Expanded Enrollment|Not vaccinated|0|||
49111188|NCT05052697|158242849|FG019|Substudy B: Expanded Enrollment|Not vaccinated|0|||
49111189|NCT05052697|158242850|FG020|Substudy B: Expanded Enrollment|Not vaccinated|0|||
49111190|NCT05052697|158242851|FG021|Substudy B: Expanded Enrollment|Not vaccinated|0|||
49111191|NCT05052697|158242852|FG022|Substudy B: Expanded Enrollment|Not vaccinated|0|||
49111192|NCT05052697|158242853|FG023|Substudy B: Expanded Enrollment|Not vaccinated|0|||
49111193|NCT05052697|158242854|FG024|Substudy B: Expanded Enrollment|Not vaccinated|0|||
49111194|NCT05052697|158242855|FG025|Substudy B: Expanded Enrollment|Not vaccinated|0|||
49111195|NCT05052697|158242856|FG026|Substudy B: Expanded Enrollment|Not vaccinated|0|||
49111196|NCT05052697|158242857|FG027|Substudy B: Expanded Enrollment|Not vaccinated|0|||
49111197|NCT05052697|158242858|FG028|Substudy B: Expanded Enrollment|Not vaccinated|1|||
49111198|NCT05052697|158242859|FG029|Substudy B: Expanded Enrollment|Not vaccinated|2|||
49111199|NCT05052697|158242860|FG030|Substudy B: Expanded Enrollment|Not vaccinated|1|||
49111200|NCT05052697|158242861|FG031|Substudy B: Expanded Enrollment|Not vaccinated|0|||
49111201|NCT05052697|158242862|FG032|Substudy B: Expanded Enrollment|Not vaccinated|0|||
49111202|NCT05052697|158242863|FG033|Substudy B: Expanded Enrollment|Not vaccinated|0|||
49111203|NCT02440854|158242864|FG000|Overall Study|Relocation of patient|1|||
49111204|NCT02440854|158242864|FG000|Overall Study|Death|6|||
49111205|NCT02440854|158242864|FG000|Overall Study|Lost to Follow-up|10|||
49111206|NCT02440854|158242864|FG000|Overall Study|Afatinib discontinuation|46|||
49111207|NCT02440854|158242864|FG000|Overall Study|stopped study at earlier timepoint|14|||
49111208|NCT02440854|158242864|FG000|Overall Study|Study medication not received|1|||
49111209|NCT02440854|158242864|FG000|Overall Study|Violation of inclusion criteria|2|||
49111210|NCT03796676|158242865|FG000|Overall Study|Adverse Event|2|||
49111211|NCT03796676|158242866|FG001|Overall Study|Adverse Event|1|||
49111212|NCT03796676|158242867|FG002|Overall Study|Adverse Event|2|||
49111213|NCT03796676|158242865|FG000|Overall Study|Lost to Follow-up|2|||
49111214|NCT03796676|158242866|FG001|Overall Study|Lost to Follow-up|1|||
49111215|NCT03796676|158242867|FG002|Overall Study|Lost to Follow-up|0|||
49111216|NCT03796676|158242865|FG000|Overall Study|Protocol Violation|0|||
49111217|NCT03796676|158242866|FG001|Overall Study|Protocol Violation|0|||
49111218|NCT03796676|158242867|FG002|Overall Study|Protocol Violation|1|||
49111219|NCT03796676|158242865|FG000|Overall Study|Withdrawal by Subject|1|||
49111220|NCT03796676|158242866|FG001|Overall Study|Withdrawal by Subject|1|||
49111221|NCT03796676|158242867|FG002|Overall Study|Withdrawal by Subject|0|||
49111222|NCT03796676|158242865|FG000|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1|||
49111223|NCT03796676|158242866|FG001|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
49111224|NCT03796676|158242867|FG002|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
49111225|NCT04607980|158242869|FG000|Overall Study|Adverse Event|3|||
49111226|NCT04607980|158242870|FG001|Overall Study|Adverse Event|4|||
49111227|NCT04607980|158242869|FG000|Overall Study|Death|0|||
49111228|NCT04607980|158242870|FG001|Overall Study|Death|1|||
49111229|NCT04607980|158242869|FG000|Overall Study|Withdrawal by Subject|2|||
49111230|NCT04607980|158242870|FG001|Overall Study|Withdrawal by Subject|5|||
49111231|NCT04607980|158242869|FG000|Overall Study|Lost to Follow-up|4|||
49111232|NCT04607980|158242870|FG001|Overall Study|Lost to Follow-up|8|||
49111233|NCT04607980|158242869|FG000|Overall Study|Protocol Violation|0|||
49111234|NCT04607980|158242870|FG001|Overall Study|Protocol Violation|3|||
49111235|NCT04607980|158242869|FG000|Overall Study|Other|3|||
49111236|NCT04607980|158242870|FG001|Overall Study|Other|0|||
49111237|NCT00528372|158242871|FG000|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2|||
49111238|NCT00528372|158242872|FG001|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
49111239|NCT00528372|158242873|FG002|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
49111240|NCT00528372|158242874|FG003|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
49111241|NCT00528372|158242875|FG004|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
49111242|NCT00528372|158242876|FG005|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
49111243|NCT00528372|158242877|FG006|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
49111244|NCT00528372|158242878|FG007|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
49111245|NCT00528372|158242879|FG008|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
49111246|NCT00528372|158242871|FG000|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
49111247|NCT00528372|158242872|FG001|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
49111248|NCT00528372|158242873|FG002|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
49111249|NCT00528372|158242874|FG003|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6|||
49111250|NCT00528372|158242875|FG004|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
49111251|NCT00528372|158242876|FG005|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
49111252|NCT00528372|158242877|FG006|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
49111253|NCT00528372|158242878|FG007|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
49111254|NCT00528372|158242879|FG008|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
49111255|NCT00528372|158242871|FG000|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
49111256|NCT00528372|158242872|FG001|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
49111257|NCT00528372|158242873|FG002|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7|||
49111258|NCT00528372|158242874|FG003|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
49111259|NCT00528372|158242875|FG004|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
49111260|NCT00528372|158242876|FG005|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
49111261|NCT00528372|158242877|FG006|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
49111262|NCT00528372|158242878|FG007|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
49111263|NCT00528372|158242879|FG008|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
49111264|NCT00528372|158242871|FG000|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5|||
49111265|NCT00528372|158242872|FG001|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
49111266|NCT00528372|158242873|FG002|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
49111267|NCT00528372|158242874|FG003|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
49111268|NCT00528372|158242875|FG004|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
49111269|NCT00528372|158242876|FG005|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
49111270|NCT00528372|158242877|FG006|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
49111271|NCT00528372|158242878|FG007|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
49111272|NCT00528372|158242879|FG008|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
49111273|NCT00528372|158242871|FG000|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
49111274|NCT00528372|158242872|FG001|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
49111275|NCT00528372|158242873|FG002|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
49111276|NCT00528372|158242874|FG003|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2|||
49111277|NCT00528372|158242875|FG004|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
49111278|NCT00528372|158242876|FG005|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1|||
49111279|NCT00528372|158242877|FG006|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
49111280|NCT00528372|158242878|FG007|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
48693060|NCT01400698|156724658|FG000|Overall Study|Adverse Event|1|||
48693061|NCT01400698|156724659|FG001|Overall Study|Adverse Event|0|||
48692821|NCT03040141|156724614|FG000|Overall Study|Withdrawal by Subject|3|||
48692822|NCT03040141|156724615|FG001|Overall Study|Withdrawal by Subject|1|||
48692823|NCT03040141|156724616|FG002|Overall Study|Withdrawal by Subject|1|||
48692824|NCT03040141|156724614|FG000|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
48692825|NCT03040141|156724615|FG001|Overall Study|Subject discharged to nursing home, not able to attend visits|1|||
48692826|NCT03040141|156724616|FG002|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
48692827|NCT03040141|156724614|FG000|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|0|||
48692828|NCT03040141|156724615|FG001|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
48692829|NCT03040141|156724616|FG002|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
48692830|NCT03473236|156724617|FG000|Overall Study|Withdrawal by Subject|0|||
48692831|NCT03473236|156724618|FG001|Overall Study|Withdrawal by Subject|0|||
48692832|NCT03473236|156724619|FG002|Overall Study|Withdrawal by Subject|0|||
48692833|NCT03473236|156724620|FG003|Overall Study|Withdrawal by Subject|0|||
48692834|NCT03473236|156724621|FG004|Overall Study|Withdrawal by Subject|0|||
48692835|NCT03473236|156724622|FG005|Overall Study|Withdrawal by Subject|1|||
48692836|NCT03473236|156724623|FG006|Overall Study|Withdrawal by Subject|0|||
48692837|NCT03473236|156724624|FG007|Overall Study|Withdrawal by Subject|0|||
48692838|NCT03473236|156724625|FG008|Overall Study|Withdrawal by Subject|1|||
48692839|NCT03473236|156724626|FG009|Overall Study|Withdrawal by Subject|0|||
48692840|NCT03289208|156724628|FG000|Overall Study|Adverse Event|1|||
48692841|NCT03289208|156724629|FG001|Overall Study|Adverse Event|0|||
48692842|NCT03289208|156724630|FG002|Overall Study|Adverse Event|0|||
48692843|NCT00510835|156724631|FG000|Overall Study|Withdrawal by Subject|6|||
48692844|NCT00510835|156724632|FG001|Overall Study|Withdrawal by Subject|2|||
48692845|NCT00510835|156724633|FG002|Overall Study|Withdrawal by Subject|2|||
48692846|NCT03353675|156724638|FG000|Overall Study|Adverse Event|4|||
48692847|NCT00604565|156724639|FG000|Overall Study|Study terminated|0|||
48692848|NCT00604565|156724640|FG001|Overall Study|Study terminated|3|||
48692849|NCT00395746|156724641|FG000|Overall Study|Adverse Event|5|||
48692850|NCT00395746|156724642|FG001|Overall Study|Adverse Event|2|||
48692851|NCT00395746|156724643|FG002|Overall Study|Adverse Event|2|||
48692852|NCT00395746|156724641|FG000|Overall Study|Protocol Violation|0|||
48692853|NCT00395746|156724642|FG001|Overall Study|Protocol Violation|1|||
48692854|NCT00395746|156724643|FG002|Overall Study|Protocol Violation|0|||
48692855|NCT00395746|156724641|FG000|Overall Study|Lack of Efficacy|2|||
48692856|NCT00395746|156724642|FG001|Overall Study|Lack of Efficacy|0|||
48692857|NCT00395746|156724643|FG002|Overall Study|Lack of Efficacy|17|||
48692858|NCT00395746|156724641|FG000|Overall Study|Hypoglycaemia|2|||
48692859|NCT00395746|156724642|FG001|Overall Study|Hypoglycaemia|1|||
48692860|NCT00395746|156724643|FG002|Overall Study|Hypoglycaemia|0|||
48692861|NCT00395746|156724641|FG000|Overall Study|Subject decision|0|||
48692862|NCT00395746|156724642|FG001|Overall Study|Subject decision|0|||
48692863|NCT00395746|156724643|FG002|Overall Study|Subject decision|1|||
48692864|NCT00395746|156724641|FG000|Overall Study|Withdrawal of consent|0|||
48692865|NCT00395746|156724642|FG001|Overall Study|Withdrawal of consent|0|||
48692866|NCT00395746|156724643|FG002|Overall Study|Withdrawal of consent|1|||
48692867|NCT00395746|156724641|FG000|Overall Study|Difficultulty in use of device|0|||
48692868|NCT00395746|156724642|FG001|Overall Study|Difficultulty in use of device|0|||
48692869|NCT00395746|156724643|FG002|Overall Study|Difficultulty in use of device|1|||
48692870|NCT00395746|156724641|FG000|Overall Study|Unable to visit site on schedule|1|||
48692871|NCT00395746|156724642|FG001|Overall Study|Unable to visit site on schedule|0|||
48692872|NCT00395746|156724643|FG002|Overall Study|Unable to visit site on schedule|0|||
48692873|NCT01300234|156724644|FG000|Overall Study|Adverse Event|1|||
48692874|NCT01300234|156724645|FG001|Overall Study|Adverse Event|1|||
48692875|NCT01300234|156724644|FG000|Overall Study|Protocol Violation|2|||
48692876|NCT01300234|156724645|FG001|Overall Study|Protocol Violation|3|||
48692877|NCT01300234|156724644|FG000|Overall Study|Withdrawal by Subject|5|||
48692878|NCT01300234|156724645|FG001|Overall Study|Withdrawal by Subject|9|||
48692879|NCT01300234|156724644|FG000|Overall Study|Lost to Follow-up|14|||
48692880|NCT01300234|156724645|FG001|Overall Study|Lost to Follow-up|12|||
48692881|NCT01300234|156724644|FG000|Overall Study|Pregnancy|2|||
48692882|NCT01300234|156724645|FG001|Overall Study|Pregnancy|1|||
48692883|NCT01300234|156724644|FG000|Overall Study|Participant reached stopping critera|2|||
48692884|NCT01300234|156724645|FG001|Overall Study|Participant reached stopping critera|0|||
48692885|NCT01300234|156724644|FG000|Overall Study|Participant stopped medication|1|||
48692886|NCT01300234|156724645|FG001|Overall Study|Participant stopped medication|1|||
48692887|NCT01300234|156724644|FG000|Overall Study|Participant refused return to hospital|1|||
48692888|NCT01300234|156724645|FG001|Overall Study|Participant refused return to hospital|0|||
48692889|NCT03137992|156724646|FG000|Washout Period 1|Adverse Event|1|||
48692890|NCT03137992|156724647|FG001|Washout Period 1|Adverse Event|1|||
48692891|NCT03137992|156724648|FG002|Washout Period 1|Adverse Event|0|||
48692892|NCT03137992|156724649|FG003|Washout Period 1|Adverse Event|0|||
48692893|NCT03137992|156724650|FG004|Washout Period 1|Adverse Event|0|||
48692894|NCT03137992|156724651|FG005|Washout Period 1|Adverse Event|1|||
48692895|NCT03137992|156724646|FG000|Washout Period 1|Withdrawal by Subject|0|||
48692896|NCT03137992|156724647|FG001|Washout Period 1|Withdrawal by Subject|1|||
48692897|NCT03137992|156724648|FG002|Washout Period 1|Withdrawal by Subject|1|||
48692898|NCT03137992|156724649|FG003|Washout Period 1|Withdrawal by Subject|0|||
48692899|NCT03137992|156724650|FG004|Washout Period 1|Withdrawal by Subject|0|||
48692900|NCT03137992|156724651|FG005|Washout Period 1|Withdrawal by Subject|0|||
48692911|NCT03137992|156724650|FG004|Washout Period 1|COPD Exacerbation|1|||
48692912|NCT03137992|156724651|FG005|Washout Period 1|COPD Exacerbation|1|||
48692913|NCT03137992|156724646|FG000|Washout Period 1|Subject Noncompliance|1|||
48692914|NCT03137992|156724647|FG001|Washout Period 1|Subject Noncompliance|0|||
48692915|NCT03137992|156724648|FG002|Washout Period 1|Subject Noncompliance|0|||
48692916|NCT03137992|156724649|FG003|Washout Period 1|Subject Noncompliance|0|||
48692917|NCT03137992|156724650|FG004|Washout Period 1|Subject Noncompliance|1|||
48692918|NCT03137992|156724651|FG005|Washout Period 1|Subject Noncompliance|0|||
48692919|NCT03137992|156724646|FG000|Period 2 (Visit 3)|COPD Exacerbation|1|||
48692920|NCT03137992|156724647|FG001|Period 2 (Visit 3)|COPD Exacerbation|1|||
48692921|NCT03137992|156724648|FG002|Period 2 (Visit 3)|COPD Exacerbation|0|||
48692922|NCT03137992|156724649|FG003|Period 2 (Visit 3)|COPD Exacerbation|0|||
48692923|NCT03137992|156724650|FG004|Period 2 (Visit 3)|COPD Exacerbation|0|||
48692924|NCT03137992|156724651|FG005|Period 2 (Visit 3)|COPD Exacerbation|1|||
48692925|NCT03137992|156724646|FG000|Period 2 (Visit 3)|Did not meet continuation criteria|2|||
48692926|NCT03137992|156724647|FG001|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
48692927|NCT03137992|156724648|FG002|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
48692928|NCT03137992|156724649|FG003|Period 2 (Visit 3)|Did not meet continuation criteria|4|||
48692929|NCT03137992|156724650|FG004|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
48692930|NCT03137992|156724651|FG005|Period 2 (Visit 3)|Did not meet continuation criteria|7|||
48692931|NCT03137992|156724646|FG000|Period 2 (Visit 3)|Adverse Event|0|||
48692932|NCT03137992|156724647|FG001|Period 2 (Visit 3)|Adverse Event|1|||
48692933|NCT03137992|156724648|FG002|Period 2 (Visit 3)|Adverse Event|0|||
48692934|NCT03137992|156724649|FG003|Period 2 (Visit 3)|Adverse Event|0|||
48692935|NCT03137992|156724650|FG004|Period 2 (Visit 3)|Adverse Event|0|||
48692936|NCT03137992|156724651|FG005|Period 2 (Visit 3)|Adverse Event|0|||
48692937|NCT03137992|156724646|FG000|Period 2 (Visit 3)|Lost to Follow-up|0|||
48692938|NCT03137992|156724647|FG001|Period 2 (Visit 3)|Lost to Follow-up|0|||
48692939|NCT03137992|156724648|FG002|Period 2 (Visit 3)|Lost to Follow-up|0|||
48692940|NCT03137992|156724649|FG003|Period 2 (Visit 3)|Lost to Follow-up|1|||
48692941|NCT03137992|156724650|FG004|Period 2 (Visit 3)|Lost to Follow-up|0|||
48692942|NCT03137992|156724651|FG005|Period 2 (Visit 3)|Lost to Follow-up|0|||
48692943|NCT03137992|156724646|FG000|Period 2 (Visit 3)|Withdrawal by Subject|0|||
48692944|NCT03137992|156724647|FG001|Period 2 (Visit 3)|Withdrawal by Subject|2|||
48692945|NCT03137992|156724648|FG002|Period 2 (Visit 3)|Withdrawal by Subject|0|||
48692946|NCT03137992|156724649|FG003|Period 2 (Visit 3)|Withdrawal by Subject|0|||
48692947|NCT03137992|156724650|FG004|Period 2 (Visit 3)|Withdrawal by Subject|1|||
48692948|NCT03137992|156724651|FG005|Period 2 (Visit 3)|Withdrawal by Subject|0|||
48692949|NCT03137992|156724646|FG000|Washout Period 2|COPD Exacerbation|1|||
48692950|NCT03137992|156724647|FG001|Washout Period 2|COPD Exacerbation|1|||
48692951|NCT03137992|156724648|FG002|Washout Period 2|COPD Exacerbation|0|||
48692952|NCT03137992|156724649|FG003|Washout Period 2|COPD Exacerbation|0|||
48692953|NCT03137992|156724650|FG004|Washout Period 2|COPD Exacerbation|1|||
48692954|NCT03137992|156724651|FG005|Washout Period 2|COPD Exacerbation|0|||
48692955|NCT03137992|156724646|FG000|Washout Period 2|Subject Non-compliance|0|||
48692956|NCT03137992|156724647|FG001|Washout Period 2|Subject Non-compliance|1|||
48692957|NCT03137992|156724648|FG002|Washout Period 2|Subject Non-compliance|0|||
48692958|NCT03137992|156724649|FG003|Washout Period 2|Subject Non-compliance|0|||
48692959|NCT03137992|156724650|FG004|Washout Period 2|Subject Non-compliance|0|||
48692960|NCT03137992|156724651|FG005|Washout Period 2|Subject Non-compliance|0|||
48692961|NCT03137992|156724646|FG000|Washout Period 2|Adverse Event|0|||
48692962|NCT03137992|156724647|FG001|Washout Period 2|Adverse Event|0|||
48692963|NCT03137992|156724648|FG002|Washout Period 2|Adverse Event|0|||
48692964|NCT03137992|156724649|FG003|Washout Period 2|Adverse Event|1|||
48692965|NCT03137992|156724650|FG004|Washout Period 2|Adverse Event|1|||
48692966|NCT03137992|156724651|FG005|Washout Period 2|Adverse Event|0|||
48692967|NCT03137992|156724646|FG000|Washout Period 2|Withdrawal by Subject|1|||
48692968|NCT03137992|156724647|FG001|Washout Period 2|Withdrawal by Subject|0|||
48692969|NCT03137992|156724648|FG002|Washout Period 2|Withdrawal by Subject|0|||
48692970|NCT03137992|156724649|FG003|Washout Period 2|Withdrawal by Subject|0|||
48692971|NCT03137992|156724650|FG004|Washout Period 2|Withdrawal by Subject|1|||
48692972|NCT03137992|156724651|FG005|Washout Period 2|Withdrawal by Subject|0|||
48692973|NCT03137992|156724646|FG000|Washout Period 2|Sponsor Decision|0|||
48692974|NCT03137992|156724647|FG001|Washout Period 2|Sponsor Decision|0|||
48692975|NCT03137992|156724648|FG002|Washout Period 2|Sponsor Decision|0|||
48692976|NCT03137992|156724649|FG003|Washout Period 2|Sponsor Decision|0|||
48692977|NCT03137992|156724650|FG004|Washout Period 2|Sponsor Decision|0|||
48692978|NCT03137992|156724651|FG005|Washout Period 2|Sponsor Decision|1|||
48692979|NCT03137992|156724646|FG000|Period 3 (Visit 04)|Did not meet continuation criteria|6|||
48692980|NCT03137992|156724647|FG001|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
48692981|NCT03137992|156724648|FG002|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
48692982|NCT03137992|156724649|FG003|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
48692983|NCT03137992|156724650|FG004|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
48692984|NCT03137992|156724651|FG005|Period 3 (Visit 04)|Did not meet continuation criteria|3|||
48692985|NCT03137992|156724646|FG000|Period 3 (Visit 04)|Withdrawal by Subject|0|||
48692986|NCT03137992|156724647|FG001|Period 3 (Visit 04)|Withdrawal by Subject|2|||
48692987|NCT03137992|156724648|FG002|Period 3 (Visit 04)|Withdrawal by Subject|1|||
48692988|NCT03137992|156724649|FG003|Period 3 (Visit 04)|Withdrawal by Subject|0|||
48692989|NCT03137992|156724650|FG004|Period 3 (Visit 04)|Withdrawal by Subject|1|||
48692990|NCT03137992|156724651|FG005|Period 3 (Visit 04)|Withdrawal by Subject|0|||
48692991|NCT03137992|156724646|FG000|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
48692992|NCT03137992|156724647|FG001|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
48692993|NCT03137992|156724648|FG002|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
48692994|NCT03137992|156724649|FG003|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
48692995|NCT03137992|156724650|FG004|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
48692996|NCT03137992|156724651|FG005|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
48692997|NCT03137992|156724646|FG000|Part 2 (Open-label Extension)|COPD exacerbation|0|||
48692998|NCT03137992|156724647|FG001|Part 2 (Open-label Extension)|COPD exacerbation|0|||
48692999|NCT03137992|156724648|FG002|Part 2 (Open-label Extension)|COPD exacerbation|0|||
48693000|NCT03137992|156724649|FG003|Part 2 (Open-label Extension)|COPD exacerbation|1|||
48693001|NCT03137992|156724650|FG004|Part 2 (Open-label Extension)|COPD exacerbation|0|||
48693002|NCT03137992|156724651|FG005|Part 2 (Open-label Extension)|COPD exacerbation|0|||
48693003|NCT03137992|156724646|FG000|Part 2 (Open-label Extension)|Per study team|1|||
48693004|NCT03137992|156724647|FG001|Part 2 (Open-label Extension)|Per study team|0|||
48693005|NCT03137992|156724648|FG002|Part 2 (Open-label Extension)|Per study team|0|||
48693006|NCT03137992|156724649|FG003|Part 2 (Open-label Extension)|Per study team|0|||
48693007|NCT03137992|156724650|FG004|Part 2 (Open-label Extension)|Per study team|0|||
48693008|NCT03137992|156724651|FG005|Part 2 (Open-label Extension)|Per study team|0|||
48693009|NCT03137992|156724646|FG000|Part 2 (Open-label Extension)|Prohibited Medication|0|||
48693010|NCT03137992|156724647|FG001|Part 2 (Open-label Extension)|Prohibited Medication|0|||
48693011|NCT03137992|156724648|FG002|Part 2 (Open-label Extension)|Prohibited Medication|0|||
48693012|NCT03137992|156724649|FG003|Part 2 (Open-label Extension)|Prohibited Medication|0|||
48693013|NCT03137992|156724650|FG004|Part 2 (Open-label Extension)|Prohibited Medication|0|||
48693014|NCT03137992|156724651|FG005|Part 2 (Open-label Extension)|Prohibited Medication|1|||
48693015|NCT01691794|156724653|FG000|Overall Study|Poor/Non-Compliance|1|||
48693016|NCT01691794|156724654|FG001|Overall Study|Poor/Non-Compliance|4|||
48693017|NCT01691794|156724655|FG002|Overall Study|Poor/Non-Compliance|1|||
48693018|NCT01691794|156724653|FG000|Overall Study|Death|0|||
48693019|NCT01691794|156724654|FG001|Overall Study|Death|0|||
48693020|NCT01691794|156724655|FG002|Overall Study|Death|1|||
48693021|NCT01691794|156724653|FG000|Overall Study|Lack of Efficacy|0|||
48693022|NCT01691794|156724654|FG001|Overall Study|Lack of Efficacy|7|||
48693023|NCT01691794|156724655|FG002|Overall Study|Lack of Efficacy|1|||
48693024|NCT01691794|156724653|FG000|Overall Study|Participant request to discontinue|0|||
48693025|NCT01691794|156724654|FG001|Overall Study|Participant request to discontinue|1|||
48693026|NCT01691794|156724655|FG002|Overall Study|Participant request to discontinue|0|||
48693027|NCT01691794|156724653|FG000|Overall Study|Adverse Event|0|||
48693028|NCT01691794|156724654|FG001|Overall Study|Adverse Event|1|||
48693029|NCT01691794|156724655|FG002|Overall Study|Adverse Event|1|||
48693030|NCT01691794|156724653|FG000|Overall Study|Completed Only first 24 weeks of study|0|||
48693031|NCT01691794|156724654|FG001|Overall Study|Completed Only first 24 weeks of study|2|||
48693032|NCT01691794|156724655|FG002|Overall Study|Completed Only first 24 weeks of study|3|||
48693033|NCT01691794|156724653|FG000|Overall Study|Did not complete first 24 weeks of study|0|||
48693034|NCT01691794|156724654|FG001|Overall Study|Did not complete first 24 weeks of study|3|||
48693035|NCT01691794|156724655|FG002|Overall Study|Did not complete first 24 weeks of study|3|||
48693036|NCT01400698|156724658|FG000|Overall Study|Lost to Follow-up|2|||
48693037|NCT01400698|156724659|FG001|Overall Study|Lost to Follow-up|5|||
48693038|NCT01400698|156724660|FG002|Overall Study|Lost to Follow-up|2|||
48693039|NCT01400698|156724661|FG003|Overall Study|Lost to Follow-up|1|||
48693040|NCT01400698|156724662|FG004|Overall Study|Lost to Follow-up|4|||
48693041|NCT01400698|156724663|FG005|Overall Study|Lost to Follow-up|3|||
48693042|NCT01400698|156724658|FG000|Overall Study|Withdrawal by Subject|8|||
48693043|NCT01400698|156724659|FG001|Overall Study|Withdrawal by Subject|2|||
48693044|NCT01400698|156724660|FG002|Overall Study|Withdrawal by Subject|0|||
48693045|NCT01400698|156724661|FG003|Overall Study|Withdrawal by Subject|4|||
48693046|NCT01400698|156724662|FG004|Overall Study|Withdrawal by Subject|1|||
48693047|NCT01400698|156724663|FG005|Overall Study|Withdrawal by Subject|3|||
48693048|NCT01400698|156724658|FG000|Overall Study|Protocol Violation|0|||
48693049|NCT01400698|156724659|FG001|Overall Study|Protocol Violation|1|||
48693050|NCT01400698|156724660|FG002|Overall Study|Protocol Violation|0|||
48693051|NCT01400698|156724661|FG003|Overall Study|Protocol Violation|0|||
48693052|NCT01400698|156724662|FG004|Overall Study|Protocol Violation|1|||
48693053|NCT01400698|156724663|FG005|Overall Study|Protocol Violation|0|||
48693054|NCT01400698|156724658|FG000|Overall Study|Non-compliance|0|||
48693055|NCT01400698|156724659|FG001|Overall Study|Non-compliance|1|||
48693056|NCT01400698|156724660|FG002|Overall Study|Non-compliance|0|||
48693057|NCT01400698|156724661|FG003|Overall Study|Non-compliance|1|||
48693058|NCT01400698|156724662|FG004|Overall Study|Non-compliance|0|||
48693059|NCT01400698|156724663|FG005|Overall Study|Non-compliance|0|||
48693075|NCT01350999|156724664|FG000|Overall Study|Voluntary withdrawal|3|||
48693076|NCT01350999|156724665|FG001|Overall Study|Voluntary withdrawal|4|||
48693077|NCT01350999|156724666|FG002|Overall Study|Voluntary withdrawal|6|||
48693078|NCT01350999|156724664|FG000|Overall Study|Difficulty Making it to Study Visit|1|||
48693079|NCT01350999|156724665|FG001|Overall Study|Difficulty Making it to Study Visit|1|||
48693080|NCT01350999|156724666|FG002|Overall Study|Difficulty Making it to Study Visit|5|||
48797716|NCT00293267|157097060|FG001|Primary Study - Double-Blind Week 0-48|Death|3|||
48797717|NCT00293267|157097059|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0|||
48797718|NCT00293267|157097060|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
48797719|NCT00293267|157097059|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
48797720|NCT00293267|157097060|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
48797721|NCT00293267|157097059|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
48797722|NCT00293267|157097060|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
48797723|NCT00293267|157097059|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33|||
48797724|NCT00293267|157097060|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60|||
48797725|NCT00293267|157097059|FG000|Extension - Double-Blind Week 49-156|Adverse Event|1|||
48797726|NCT00293267|157097060|FG001|Extension - Double-Blind Week 49-156|Adverse Event|4|||
48797727|NCT00293267|157097059|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|7|||
48797728|NCT00293267|157097060|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|1|||
48797729|NCT00293267|157097059|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|4|||
48797730|NCT00293267|157097060|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|0|||
48797731|NCT00293267|157097059|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13|||
48797732|NCT00293267|157097060|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4|||
48797733|NCT00293267|157097059|FG000|Extension - Double-Blind Week 49-156|Death|3|||
48797734|NCT00293267|157097060|FG001|Extension - Double-Blind Week 49-156|Death|0|||
48797735|NCT00293267|157097059|FG000|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2|||
48797736|NCT00293267|157097060|FG001|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0|||
48797737|NCT00293267|157097059|FG000|Extension - Double-Blind Week 49-156|Other Reason|7|||
48797738|NCT00293267|157097060|FG001|Extension - Double-Blind Week 49-156|Other Reason|0|||
48797739|NCT00293267|157097059|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
48797740|NCT00293267|157097060|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6|||
48797741|NCT00293267|157097059|FG000|Extension - Open-Label Week 157-240|Adverse Event|5|||
48797742|NCT00293267|157097060|FG001|Extension - Open-Label Week 157-240|Adverse Event|0|||
48797743|NCT00293267|157097059|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|7|||
48797744|NCT00293267|157097060|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
48797745|NCT00293267|157097059|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|1|||
48797746|NCT00293267|157097060|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
48797747|NCT00293267|157097059|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|2|||
48797748|NCT00293267|157097060|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
48797749|NCT00293267|157097059|FG000|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2|||
48797750|NCT00293267|157097060|FG001|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0|||
48797751|NCT00293267|157097059|FG000|Extension - Open-Label Week 157-240|Other Reason|3|||
48797752|NCT00293267|157097060|FG001|Extension - Open-Label Week 157-240|Other Reason|1|||
48797753|NCT00293267|157097059|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|2|||
48797754|NCT00293267|157097060|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|3|||
48797755|NCT00293267|157097059|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23|||
48797756|NCT00293267|157097060|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19|||
48797757|NCT00293267|157097059|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2|||
48797758|NCT00293267|157097060|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4|||
48797759|NCT00293267|157097059|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
48797760|NCT00293267|157097060|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
48797761|NCT00293267|157097059|FG000|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0|||
48797762|NCT00293267|157097060|FG001|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2|||
48797763|NCT00293267|157097059|FG000|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0|||
48797764|NCT00293267|157097060|FG001|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2|||
48797765|NCT00293267|157097059|FG000|Open-Label Post Virologic Failure Phase|Other Reason|4|||
48797766|NCT00293267|157097060|FG001|Open-Label Post Virologic Failure Phase|Other Reason|5|||
48797767|NCT00483184|157097061|FG000|Overall Study|Withdrawal by Subject|2|||
48797768|NCT00483184|157097062|FG001|Overall Study|Withdrawal by Subject|2|||
48797769|NCT00483184|157097063|FG002|Overall Study|Withdrawal by Subject|0|||
48797770|NCT00483184|157097061|FG000|Overall Study|Lost to Follow-up|1|||
48797771|NCT00483184|157097062|FG001|Overall Study|Lost to Follow-up|0|||
48797772|NCT00483184|157097063|FG002|Overall Study|Lost to Follow-up|0|||
48797773|NCT00483184|157097061|FG000|Overall Study|Adverse Event|1|||
48797774|NCT00483184|157097062|FG001|Overall Study|Adverse Event|2|||
48797775|NCT00483184|157097063|FG002|Overall Study|Adverse Event|2|||
48797783|NCT02570126|157097064|FG000|Overall Study|Violation Of Procedures GSK|0|||
48797784|NCT02570126|157097065|FG001|Overall Study|Violation Of Procedures GSK|1|||
48797785|NCT02570126|157097064|FG000|Overall Study|Protocol Violation|0|||
48797786|NCT02570126|157097065|FG001|Overall Study|Protocol Violation|1|||
48797787|NCT02570126|157097064|FG000|Overall Study|Withdrawal by Subject|3|||
48797788|NCT02570126|157097065|FG001|Overall Study|Withdrawal by Subject|7|||
48797789|NCT01050816|157097066|FG000|Overall Study|Lost to Follow-up|2|||
48797790|NCT01050816|157097066|FG000|Overall Study|patient's refusal|2|||
48797791|NCT00815295|157097069|FG000|Overall Study|Cetuximab hypersensitivity reaction|0|||
48797792|NCT00815295|157097070|FG001|Overall Study|Cetuximab hypersensitivity reaction|1|||
48797793|NCT00815295|157097071|FG002|Overall Study|Cetuximab hypersensitivity reaction|3|||
48797794|NCT01970462|157097072|FG000|Overall Study|Lost to Follow-up|0|||
48797795|NCT01970462|157097073|FG001|Overall Study|Lost to Follow-up|2|||
48797796|NCT01292876|157097074|FG000|Overall Study|Physician Decision|4|||
48797797|NCT01627327|157097075|FG000|Overall Study|Adverse Event|6|||
48797798|NCT01627327|157097076|FG001|Overall Study|Adverse Event|12|||
48797799|NCT01627327|157097075|FG000|Overall Study|Lack of Efficacy-No Sub-Reason|0|||
48797800|NCT01627327|157097076|FG001|Overall Study|Lack of Efficacy-No Sub-Reason|2|||
48797801|NCT01627327|157097075|FG000|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4|||
48797802|NCT01627327|157097076|FG001|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9|||
48797803|NCT01627327|157097075|FG000|Overall Study|Protocol Violation|4|||
48797804|NCT01627327|157097076|FG001|Overall Study|Protocol Violation|10|||
48797805|NCT01627327|157097075|FG000|Overall Study|Lost to Follow-up|1|||
48797806|NCT01627327|157097076|FG001|Overall Study|Lost to Follow-up|3|||
48797807|NCT01627327|157097075|FG000|Overall Study|Physician Decision|1|||
48797808|NCT01627327|157097076|FG001|Overall Study|Physician Decision|0|||
48797809|NCT01627327|157097075|FG000|Overall Study|Withdrawal by Subject|3|||
48797810|NCT01627327|157097076|FG001|Overall Study|Withdrawal by Subject|3|||
48797811|NCT00917579|157097077|FG000|Washout >= 2 Weeks|Adverse Event|1|||
48797812|NCT00917579|157097078|FG001|Washout >= 2 Weeks|Adverse Event|0|||
48797813|NCT00917579|157097077|FG000|Washout >= 2 Weeks|Withdrawal by Subject|1|||
48797814|NCT00917579|157097078|FG001|Washout >= 2 Weeks|Withdrawal by Subject|0|||
48797815|NCT00754338|157097079|FG000|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
48797816|NCT00754338|157097080|FG001|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
48797817|NCT00754338|157097081|FG002|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
48797818|NCT00754338|157097082|FG003|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
48797819|NCT00754338|157097079|FG000|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
48797820|NCT00754338|157097080|FG001|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
48797821|NCT00754338|157097081|FG002|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
48797822|NCT00754338|157097082|FG003|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
48797823|NCT00781391|157097086|FG000|Overall Study|never received study drug|24|||
48797824|NCT00781391|157097087|FG001|Overall Study|never received study drug|23|||
48797825|NCT00781391|157097088|FG002|Overall Study|never received study drug|32|||
48797826|NCT00781391|157097086|FG000|Overall Study|Protocol Violation|19|||
48797827|NCT00781391|157097087|FG001|Overall Study|Protocol Violation|17|||
48797828|NCT00781391|157097088|FG002|Overall Study|Protocol Violation|20|||
48797829|NCT00781391|157097086|FG000|Overall Study|Death|789|||
48797830|NCT00781391|157097087|FG001|Overall Study|Death|730|||
48797831|NCT00781391|157097088|FG002|Overall Study|Death|706|||
48797832|NCT00781391|157097086|FG000|Overall Study|Withdrawal by Subject|47|||
48797833|NCT00781391|157097087|FG001|Overall Study|Withdrawal by Subject|37|||
48797834|NCT00781391|157097088|FG002|Overall Study|Withdrawal by Subject|25|||
48797835|NCT00781391|157097086|FG000|Overall Study|Lost to Follow-up|0|||
48797836|NCT00781391|157097087|FG001|Overall Study|Lost to Follow-up|0|||
48797837|NCT00781391|157097088|FG002|Overall Study|Lost to Follow-up|1|||
48797838|NCT01368965|157097089|FG000|Overall Study|Lost to Follow-up|12|||
48797839|NCT04085328|157097095|FG000|Overall Study|Witihdrew Consent|16|||
48797840|NCT04085328|157097096|FG001|Overall Study|Witihdrew Consent|16|||
48797841|NCT04085328|157097095|FG000|Overall Study|Adverse Event|8|||
48797842|NCT04085328|157097096|FG001|Overall Study|Adverse Event|7|||
48797843|NCT04085328|157097095|FG000|Overall Study|Lost to Follow-up|7|||
48797844|NCT04085328|157097096|FG001|Overall Study|Lost to Follow-up|2|||
48797845|NCT04085328|157097095|FG000|Overall Study|Physician Decision|0|||
48797846|NCT04085328|157097096|FG001|Overall Study|Physician Decision|1|||
48797847|NCT04085328|157097095|FG000|Overall Study|Pregnancy|0|||
48797848|NCT04085328|157097096|FG001|Overall Study|Pregnancy|1|||
48797849|NCT04085328|157097095|FG000|Overall Study|Reasons Related to COVID-19|5|||
48797850|NCT04085328|157097096|FG001|Overall Study|Reasons Related to COVID-19|8|||
48797851|NCT04085328|157097095|FG000|Overall Study|Did not meet inclusion criteria|1|||
48797852|NCT04085328|157097096|FG001|Overall Study|Did not meet inclusion criteria|1|||
48797853|NCT04085328|157097095|FG000|Overall Study|Early termination|1|||
48797854|NCT04085328|157097096|FG001|Overall Study|Early termination|0|||
48797855|NCT02195986|157097102|FG000|Overall Study|Adverse Event|3|||
48797856|NCT02195986|157097103|FG001|Overall Study|Adverse Event|0|||
48797857|NCT02195986|157097104|FG002|Overall Study|Adverse Event|0|||
48797858|NCT02195986|157097102|FG000|Overall Study|Withdrawal by Subject|0|||
48797859|NCT02195986|157097103|FG001|Overall Study|Withdrawal by Subject|3|||
48797860|NCT02195986|157097104|FG002|Overall Study|Withdrawal by Subject|0|||
48797861|NCT02195986|157097102|FG000|Overall Study|Family Emergency|0|||
48797862|NCT02195986|157097103|FG001|Overall Study|Family Emergency|0|||
48797863|NCT02195986|157097104|FG002|Overall Study|Family Emergency|1|||
48797864|NCT02195986|157097102|FG000|Overall Study|Protocol Violation|0|||
48797865|NCT02195986|157097103|FG001|Overall Study|Protocol Violation|1|||
48797866|NCT02195986|157097104|FG002|Overall Study|Protocol Violation|1|||
48797867|NCT02195986|157097102|FG000|Overall Study|Non-compliance|0|||
48797868|NCT02195986|157097103|FG001|Overall Study|Non-compliance|1|||
48797869|NCT02195986|157097104|FG002|Overall Study|Non-compliance|0|||
48797870|NCT00771810|157097105|FG000|Overall Study|Adverse Event|3|||
48797871|NCT00771810|157097106|FG001|Overall Study|Adverse Event|0|||
48797872|NCT00771810|157097107|FG002|Overall Study|Adverse Event|2|||
48797873|NCT00771810|157097105|FG000|Overall Study|Lost to Follow-up|0|||
48797874|NCT00771810|157097106|FG001|Overall Study|Lost to Follow-up|0|||
48797875|NCT00771810|157097107|FG002|Overall Study|Lost to Follow-up|1|||
48797876|NCT00771810|157097105|FG000|Overall Study|Physician Decision|1|||
48797877|NCT00771810|157097106|FG001|Overall Study|Physician Decision|2|||
48797878|NCT00771810|157097107|FG002|Overall Study|Physician Decision|2|||
48797879|NCT00771810|157097105|FG000|Overall Study|Protocol Violation|0|||
48797880|NCT00771810|157097106|FG001|Overall Study|Protocol Violation|1|||
48797881|NCT00771810|157097107|FG002|Overall Study|Protocol Violation|1|||
48797882|NCT00771810|157097105|FG000|Overall Study|Withdrawal by Subject|1|||
48797883|NCT00771810|157097106|FG001|Overall Study|Withdrawal by Subject|2|||
48797884|NCT00771810|157097107|FG002|Overall Study|Withdrawal by Subject|0|||
48797885|NCT00771810|157097105|FG000|Overall Study|Other|0|||
48797886|NCT00771810|157097106|FG001|Overall Study|Other|0|||
48797887|NCT00771810|157097107|FG002|Overall Study|Other|1|||
48797888|NCT00449176|157097108|FG000|Overall Study|Withdrawal by Subject|39|||
48797889|NCT00449176|157097109|FG001|Overall Study|Withdrawal by Subject|43|||
48797890|NCT00449176|157097110|FG002|Overall Study|Withdrawal by Subject|59|||
48797891|NCT00449176|157097108|FG000|Overall Study|Lost to Follow-up|13|||
48797892|NCT00449176|157097109|FG001|Overall Study|Lost to Follow-up|8|||
48797893|NCT00449176|157097110|FG002|Overall Study|Lost to Follow-up|12|||
48797894|NCT00449176|157097108|FG000|Overall Study|Adverse Event|51|||
48797895|NCT00449176|157097109|FG001|Overall Study|Adverse Event|107|||
48797896|NCT00449176|157097110|FG002|Overall Study|Adverse Event|15|||
48797897|NCT00449176|157097108|FG000|Overall Study|Lack of Efficacy|13|||
48797898|NCT00449176|157097109|FG001|Overall Study|Lack of Efficacy|7|||
48797899|NCT00449176|157097110|FG002|Overall Study|Lack of Efficacy|50|||
48797900|NCT00449176|157097108|FG000|Overall Study|Study drug non-compliant|14|||
48797901|NCT00449176|157097109|FG001|Overall Study|Study drug non-compliant|11|||
48797902|NCT00449176|157097110|FG002|Overall Study|Study drug non-compliant|11|||
48797903|NCT00449176|157097108|FG000|Overall Study|all other|22|||
48797904|NCT00449176|157097109|FG001|Overall Study|all other|19|||
48797905|NCT00449176|157097110|FG002|Overall Study|all other|20|||
48797906|NCT00689221|157097111|FG000|Overall Study|Ongoing at cut-off date|39|||
48797907|NCT00689221|157097112|FG001|Overall Study|Ongoing at cut-off date|36|||
48797908|NCT02251990|157097113|FG000|Period 1 (Double-blind [DB])|Adverse Event|1|||
48797909|NCT02251990|157097114|FG001|Period 1 (Double-blind [DB])|Adverse Event|1|||
48797910|NCT02251990|157097113|FG000|Period 1 (Double-blind [DB])|Lack of Efficacy|5|||
48797911|NCT02251990|157097114|FG001|Period 1 (Double-blind [DB])|Lack of Efficacy|0|||
48797912|NCT02251990|157097113|FG000|Period 1 (Double-blind [DB])|Withdrawal by Subject|1|||
48797913|NCT02251990|157097114|FG001|Period 1 (Double-blind [DB])|Withdrawal by Subject|0|||
48797914|NCT02251990|157097113|FG000|Period 1 (Double-blind [DB])|Not Treated|1|||
48797915|NCT02251990|157097114|FG001|Period 1 (Double-blind [DB])|Not Treated|0|||
48797916|NCT02251990|157097113|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0|||
48797917|NCT02251990|157097114|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1|||
48797918|NCT02251990|157097113|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0|||
48797919|NCT02251990|157097114|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2|||
48797920|NCT01812655|157097115|FG000|Overall Study|Protocol Violation|1|||
48797921|NCT01812655|157097116|FG001|Overall Study|Protocol Violation|1|||
48797922|NCT01812655|157097117|FG002|Overall Study|Protocol Violation|0|||
48797923|NCT02454101|157097119|FG000|Overall Study|Adverse Event|2|||
48797924|NCT02454101|157097120|FG001|Overall Study|Adverse Event|3|||
48797925|NCT02454101|157097119|FG000|Overall Study|Lost to Follow-up|3|||
48797926|NCT02454101|157097120|FG001|Overall Study|Lost to Follow-up|4|||
48797927|NCT04839965|157097121|FG000|Overall Study|Death|6|||
48797928|NCT04839965|157097122|FG001|Overall Study|Death|6|||
48797929|NCT04839965|157097121|FG000|Overall Study|Lost to Follow-up|1|||
48797930|NCT04839965|157097122|FG001|Overall Study|Lost to Follow-up|0|||
48797931|NCT02291679|157097123|FG000|Overall Study|Adverse Event|2|||
48797932|NCT02291679|157097124|FG001|Overall Study|Adverse Event|12|||
48797933|NCT02291679|157097125|FG002|Overall Study|Adverse Event|19|||
48797934|NCT02291679|157097123|FG000|Overall Study|Protocol Violation|5|||
48797935|NCT02291679|157097124|FG001|Overall Study|Protocol Violation|1|||
48797936|NCT02291679|157097125|FG002|Overall Study|Protocol Violation|7|||
48797937|NCT02291679|157097123|FG000|Overall Study|Withdrew Consent|18|||
48797984|NCT00677833|157098522|FG002|Overall Study|Withdrawal by Subject|1|||
48797985|NCT00677833|157098523|FG003|Overall Study|Withdrawal by Subject|3|||
48797986|NCT00677833|157098520|FG000|Overall Study|Lost to Follow-up|0|||
48797987|NCT00677833|157098521|FG001|Overall Study|Lost to Follow-up|0|||
48797988|NCT00677833|157098522|FG002|Overall Study|Lost to Follow-up|1|||
48797989|NCT00677833|157098523|FG003|Overall Study|Lost to Follow-up|0|||
48797990|NCT01944631|157098524|FG000|Overall Study|Adverse Event|1|||
48797991|NCT01944631|157098525|FG001|Overall Study|Adverse Event|0|||
48797992|NCT01944631|157098524|FG000|Overall Study|Lost to Follow-up|3|||
48797993|NCT01944631|157098525|FG001|Overall Study|Lost to Follow-up|1|||
48797994|NCT01944631|157098524|FG000|Overall Study|Withdrawal by Subject|0|||
48797995|NCT01944631|157098525|FG001|Overall Study|Withdrawal by Subject|1|||
48797996|NCT02690974|157098526|FG000|Overall Study|Adverse Event|16|||
48797997|NCT02690974|157098526|FG000|Overall Study|Death|9|||
48797998|NCT02690974|157098526|FG000|Overall Study|Subject/guardian decision|4|||
48797999|NCT02690974|157098526|FG000|Overall Study|Lost to Follow-up|3|||
48798000|NCT02690974|157098526|FG000|Overall Study|Withdrawal of Informed Consent|3|||
48798001|NCT02690974|157098526|FG000|Overall Study|Physician Decision|2|||
48798002|NCT02690974|157098526|FG000|Overall Study|Non-compliance with study treatment|1|||
48798003|NCT02690974|157098526|FG000|Overall Study|Protocol-defined stopping criteria|1|||
48798004|NCT02690974|157098526|FG000|Overall Study|Protocol Deviation|1|||
48798005|NCT01666951|157098529|FG000|Overall Study|Not dosed|1|||
48798006|NCT01666951|157098530|FG001|Overall Study|Not dosed|1|||
48798007|NCT03284788|157098531|FG000|Overall Study|Withdrawal by Subject|2|||
48798008|NCT02314624|157098532|FG000|Overall Study|No participating patient|16|||
48798009|NCT02314624|157098533|FG001|Overall Study|No participating patient|13|||
48798010|NCT02314624|157098532|FG000|Overall Study|Participant withdrew|7|||
48798011|NCT02314624|157098533|FG001|Overall Study|Participant withdrew|2|||
48798012|NCT02314624|157098532|FG000|Overall Study|Lost to Follow-up|2|||
48798013|NCT02314624|157098533|FG001|Overall Study|Lost to Follow-up|5|||
48798014|NCT02314624|157098532|FG000|Overall Study|Dropped/Excluded by PI|6|||
48798015|NCT02314624|157098533|FG001|Overall Study|Dropped/Excluded by PI|6|||
48798016|NCT02641392|157098534|FG000|Overall Study|Lost to Follow-up|0|||
48798017|NCT02641392|157098535|FG001|Overall Study|Lost to Follow-up|0|||
48798018|NCT02641392|157098536|FG002|Overall Study|Lost to Follow-up|2|||
48798019|NCT02641392|157098534|FG000|Overall Study|Withdrawal by Subject|0|||
48798020|NCT02641392|157098535|FG001|Overall Study|Withdrawal by Subject|0|||
48798021|NCT02641392|157098536|FG002|Overall Study|Withdrawal by Subject|17|||
48798022|NCT02641392|157098534|FG000|Overall Study|Adverse Event|0|||
48798023|NCT02641392|157098535|FG001|Overall Study|Adverse Event|1|||
48798024|NCT02641392|157098536|FG002|Overall Study|Adverse Event|25|||
48798025|NCT02641392|157098534|FG000|Overall Study|Study Terminated by Sponsor|4|||
48798026|NCT02641392|157098535|FG001|Overall Study|Study Terminated by Sponsor|12|||
48798027|NCT02641392|157098536|FG002|Overall Study|Study Terminated by Sponsor|144|||
48798028|NCT02641392|157098534|FG000|Overall Study|Lack of Efficacy|0|||
48798029|NCT02641392|157098535|FG001|Overall Study|Lack of Efficacy|0|||
48798030|NCT02641392|157098536|FG002|Overall Study|Lack of Efficacy|101|||
48798031|NCT02641392|157098534|FG000|Overall Study|Miscellaneous|0|||
48798032|NCT02641392|157098535|FG001|Overall Study|Miscellaneous|0|||
48798033|NCT02641392|157098536|FG002|Overall Study|Miscellaneous|3|||
48798034|NCT02641392|157098534|FG000|Overall Study|Death|0|||
48798035|NCT02641392|157098535|FG001|Overall Study|Death|0|||
48798036|NCT02641392|157098536|FG002|Overall Study|Death|1|||
48798037|NCT00234052|157098537|FG000|Treatment|Withdrawal by Subject|3|||
48798038|NCT00234052|157098537|FG000|Treatment|Adverse Event|5|||
48798039|NCT00234052|157098537|FG000|Treatment|Death|2|||
48798040|NCT00234052|157098537|FG000|Treatment|Progressive Disease|11|||
48798041|NCT00234052|157098537|FG000|Follow-up for 5 Years|Death|41|||
48798042|NCT00234052|157098537|FG000|Follow-up for 5 Years|Lost to Follow-up|1|||
48798043|NCT00234052|157098537|FG000|Follow-up for 5 Years|Other|7|||
48798044|NCT00677352|157098540|FG000|Treatment Phase|Adverse Event|14|||
48798045|NCT00677352|157098541|FG001|Treatment Phase|Adverse Event|22|||
48798046|NCT00677352|157098540|FG000|Treatment Phase|Lack of Efficacy|2|||
48798047|NCT00677352|157098541|FG001|Treatment Phase|Lack of Efficacy|3|||
48798048|NCT00677352|157098540|FG000|Treatment Phase|Lost to Follow-up|0|||
48798049|NCT00677352|157098541|FG001|Treatment Phase|Lost to Follow-up|1|||
48798050|NCT00677352|157098540|FG000|Treatment Phase|Withdrawal by Subject|7|||
48798051|NCT00677352|157098541|FG001|Treatment Phase|Withdrawal by Subject|7|||
48798052|NCT00677352|157098540|FG000|Treatment Phase|Physician Decision|1|||
48798053|NCT00677352|157098541|FG001|Treatment Phase|Physician Decision|0|||
48798054|NCT00677352|157098540|FG000|Treatment Phase|Pregnancy|0|||
48798055|NCT00677352|157098541|FG001|Treatment Phase|Pregnancy|1|||
48798056|NCT00677352|157098540|FG000|Treatment Phase|Protocol Violation|1|||
48798057|NCT00677352|157098541|FG001|Treatment Phase|Protocol Violation|1|||
48798058|NCT00677352|157098540|FG000|Treatment Phase|Transference or work related matter|0|||
48798059|NCT00677352|157098541|FG001|Treatment Phase|Transference or work related matter|5|||
48798060|NCT00677352|157098540|FG000|Treatment Phase|Not treated|0|||
48798061|NCT00677352|157098541|FG001|Treatment Phase|Not treated|2|||
48798062|NCT00677352|157098540|FG000|Tapering Phase|Adverse Event|1|||
48798064|NCT00677352|157098540|FG000|Tapering Phase|Withdrawal by Subject|5|||
48798065|NCT00677352|157098541|FG001|Tapering Phase|Withdrawal by Subject|3|||
48798066|NCT00677352|157098540|FG000|Tapering Phase|Pregnancy|0|||
48798067|NCT00677352|157098541|FG001|Tapering Phase|Pregnancy|1|||
48798068|NCT00677352|157098540|FG000|Tapering Phase|Job transfer|0|||
48798069|NCT00677352|157098541|FG001|Tapering Phase|Job transfer|1|||
48798070|NCT00238433|157098542|FG000|Overall Study|Screen failure|1|||
48798071|NCT00238433|157098542|FG000|Overall Study|Lost to Follow-up|1|||
48798072|NCT00238433|157098542|FG000|Overall Study|Death|1|||
48798073|NCT01256411|157098543|FG000|Extension by Maximum Treatment|Protocol deviation|0|||
48798074|NCT01256411|157098544|FG001|Extension by Maximum Treatment|Protocol deviation|0|||
48798075|NCT01256411|157098545|FG002|Extension by Maximum Treatment|Protocol deviation|1|||
48798076|NCT01256411|157098546|FG003|Extension by Maximum Treatment|Protocol deviation|0|||
48798077|NCT01256411|157098547|FG004|Extension by Maximum Treatment|Protocol deviation|0|||
48798078|NCT01256411|157098548|FG005|Extension by Maximum Treatment|Protocol deviation|0|||
48798079|NCT01256411|157098543|FG000|Extension by Maximum Treatment|Lost to Follow-up|1|||
48798080|NCT01256411|157098544|FG001|Extension by Maximum Treatment|Lost to Follow-up|2|||
48798081|NCT01256411|157098545|FG002|Extension by Maximum Treatment|Lost to Follow-up|0|||
48798082|NCT01256411|157098546|FG003|Extension by Maximum Treatment|Lost to Follow-up|0|||
48798083|NCT01256411|157098547|FG004|Extension by Maximum Treatment|Lost to Follow-up|0|||
48798084|NCT01256411|157098548|FG005|Extension by Maximum Treatment|Lost to Follow-up|0|||
48798085|NCT01256411|157098543|FG000|Extension by Maximum Treatment|Withdrawal by Subject|1|||
48798086|NCT01256411|157098544|FG001|Extension by Maximum Treatment|Withdrawal by Subject|6|||
48798087|NCT01256411|157098545|FG002|Extension by Maximum Treatment|Withdrawal by Subject|1|||
48798088|NCT01256411|157098546|FG003|Extension by Maximum Treatment|Withdrawal by Subject|0|||
48798089|NCT01256411|157098547|FG004|Extension by Maximum Treatment|Withdrawal by Subject|0|||
48798090|NCT01256411|157098548|FG005|Extension by Maximum Treatment|Withdrawal by Subject|0|||
48798091|NCT01256411|157098543|FG000|Extension by Maximum Treatment|Lack of Efficacy|1|||
48798092|NCT01256411|157098544|FG001|Extension by Maximum Treatment|Lack of Efficacy|0|||
48798093|NCT01256411|157098545|FG002|Extension by Maximum Treatment|Lack of Efficacy|1|||
48798094|NCT01256411|157098546|FG003|Extension by Maximum Treatment|Lack of Efficacy|0|||
48798095|NCT01256411|157098547|FG004|Extension by Maximum Treatment|Lack of Efficacy|0|||
48798096|NCT01256411|157098548|FG005|Extension by Maximum Treatment|Lack of Efficacy|0|||
48798097|NCT01256411|157098543|FG000|Extension by Maximum Treatment|Adverse Event|4|||
48798098|NCT01256411|157098544|FG001|Extension by Maximum Treatment|Adverse Event|2|||
48798099|NCT01256411|157098545|FG002|Extension by Maximum Treatment|Adverse Event|1|||
48798100|NCT01256411|157098546|FG003|Extension by Maximum Treatment|Adverse Event|0|||
48798101|NCT01256411|157098547|FG004|Extension by Maximum Treatment|Adverse Event|0|||
48798102|NCT01256411|157098548|FG005|Extension by Maximum Treatment|Adverse Event|0|||
48798103|NCT01256411|157098543|FG000|Extension by Mono or Combination Therapy|Adverse Event|0|||
48798104|NCT01256411|157098544|FG001|Extension by Mono or Combination Therapy|Adverse Event|0|||
48798105|NCT01256411|157098545|FG002|Extension by Mono or Combination Therapy|Adverse Event|0|||
48798106|NCT01256411|157098546|FG003|Extension by Mono or Combination Therapy|Adverse Event|0|||
48798107|NCT01256411|157098547|FG004|Extension by Mono or Combination Therapy|Adverse Event|6|||
48798108|NCT01256411|157098548|FG005|Extension by Mono or Combination Therapy|Adverse Event|1|||
48798109|NCT01256411|157098543|FG000|Extension by Mono or Combination Therapy|Protocol deviation|0|||
48798110|NCT01256411|157098544|FG001|Extension by Mono or Combination Therapy|Protocol deviation|0|||
48798111|NCT01256411|157098545|FG002|Extension by Mono or Combination Therapy|Protocol deviation|0|||
48798112|NCT01256411|157098546|FG003|Extension by Mono or Combination Therapy|Protocol deviation|0|||
48798113|NCT01256411|157098547|FG004|Extension by Mono or Combination Therapy|Protocol deviation|0|||
48798114|NCT01256411|157098548|FG005|Extension by Mono or Combination Therapy|Protocol deviation|1|||
48798115|NCT01256411|157098543|FG000|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
48798116|NCT01256411|157098544|FG001|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
48798117|NCT01256411|157098545|FG002|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
48798118|NCT01256411|157098546|FG003|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
48798119|NCT01256411|157098547|FG004|Extension by Mono or Combination Therapy|Lost to Follow-up|3|||
48798120|NCT01256411|157098548|FG005|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
48798121|NCT01256411|157098543|FG000|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
48798122|NCT01256411|157098544|FG001|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
48798123|NCT01256411|157098545|FG002|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
48798124|NCT01256411|157098546|FG003|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
48798125|NCT01256411|157098547|FG004|Extension by Mono or Combination Therapy|Withdrawal by Subject|7|||
48798126|NCT01256411|157098548|FG005|Extension by Mono or Combination Therapy|Withdrawal by Subject|1|||
48798127|NCT01256411|157098543|FG000|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
48798128|NCT01256411|157098544|FG001|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
48798129|NCT01256411|157098545|FG002|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
48798130|NCT01256411|157098546|FG003|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
48798131|NCT01256411|157098547|FG004|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
48798132|NCT01256411|157098548|FG005|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
48798133|NCT04044456|157098549|FG000|Overall Study|Lost to Follow-up|4|||
48798134|NCT04044456|157098550|FG001|Overall Study|Lost to Follow-up|1|||
48798135|NCT04044456|157098549|FG000|Overall Study|Withdrawal by Subject|1|||
48798136|NCT04044456|157098550|FG001|Overall Study|Withdrawal by Subject|0|||
48798137|NCT00409682|157098554|FG000|Open-label Induction Period|Adverse Event|1|||
48798138|NCT00409682|157098555|FG001|Open-label Induction Period|Adverse Event|0|||
48798139|NCT00409682|157098556|FG002|Open-label Induction Period|Adverse Event|0|||
48798140|NCT00409682|157098554|FG000|Open-label Induction Period|Lack of Efficacy|1|||
48798141|NCT00409682|157098555|FG001|Open-label Induction Period|Lack of Efficacy|0|||
48798142|NCT00409682|157098556|FG002|Open-label Induction Period|Lack of Efficacy|0|||
48798143|NCT00409682|157098554|FG000|Open-label Induction Period|Protocol Violation|1|||
48798144|NCT00409682|157098555|FG001|Open-label Induction Period|Protocol Violation|0|||
48798145|NCT00409682|157098556|FG002|Open-label Induction Period|Protocol Violation|0|||
48798146|NCT00409682|157098554|FG000|Open-label Induction Period|Subject did not satisfy entry criteria|1|||
48798147|NCT00409682|157098555|FG001|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
48798148|NCT00409682|157098556|FG002|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
48798149|NCT00409682|157098554|FG000|EOW Double-blind Maintenance Period|Adverse Event|0|||
48798150|NCT00409682|157098555|FG001|EOW Double-blind Maintenance Period|Adverse Event|10|||
48798151|NCT00409682|157098556|FG002|EOW Double-blind Maintenance Period|Adverse Event|12|||
48798152|NCT00409682|157098554|FG000|EOW Double-blind Maintenance Period|Lack of Efficacy|0|||
48798153|NCT00409682|157098555|FG001|EOW Double-blind Maintenance Period|Lack of Efficacy|18|||
48798154|NCT00409682|157098556|FG002|EOW Double-blind Maintenance Period|Lack of Efficacy|11|||
48798155|NCT00409682|157098554|FG000|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
48798156|NCT00409682|157098555|FG001|EOW Double-blind Maintenance Period|Lost to Follow-up|1|||
48798157|NCT00409682|157098556|FG002|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
48798158|NCT00409682|157098554|FG000|EOW Double-blind Maintenance Period|Withdrawal by Subject|0|||
48798159|NCT00409682|157098555|FG001|EOW Double-blind Maintenance Period|Withdrawal by Subject|4|||
48798160|NCT00409682|157098556|FG002|EOW Double-blind Maintenance Period|Withdrawal by Subject|2|||
48798161|NCT00409682|157098554|FG000|EOW Double-blind Maintenance Period|Protocol Violation|0|||
48798162|NCT00409682|157098555|FG001|EOW Double-blind Maintenance Period|Protocol Violation|4|||
48798163|NCT00409682|157098556|FG002|EOW Double-blind Maintenance Period|Protocol Violation|1|||
48798164|NCT00409682|157098554|FG000|EOW Double-blind Maintenance Period|Non-compliance|0|||
48798165|NCT00409682|157098555|FG001|EOW Double-blind Maintenance Period|Non-compliance|0|||
48798166|NCT00409682|157098556|FG002|EOW Double-blind Maintenance Period|Non-compliance|1|||
48798167|NCT02436330|157098557|FG000|Cohort 1|Lost to Follow-up|5|||
48798168|NCT02436330|157098558|FG001|Cohort 1|Lost to Follow-up|2|||
48798169|NCT02436330|157098557|FG000|Cohort 1|Withdrawal by Subject|0|||
48798170|NCT02436330|157098558|FG001|Cohort 1|Withdrawal by Subject|1|||
48798171|NCT02436330|157098557|FG000|Cohort 2|Lost to Follow-up|2|||
48798172|NCT02436330|157098558|FG001|Cohort 2|Lost to Follow-up|0|||
48798173|NCT02436330|157098557|FG000|Cohort 2|Withdrawal by Subject|2|||
48798174|NCT02436330|157098558|FG001|Cohort 2|Withdrawal by Subject|3|||
48798175|NCT02436330|157098557|FG000|Cohort 3|Lost to Follow-up|1|||
48798176|NCT02436330|157098558|FG001|Cohort 3|Lost to Follow-up|0|||
48798177|NCT02436330|157098557|FG000|Cohort 3|Withdrawal by Subject|4|||
48798178|NCT02436330|157098558|FG001|Cohort 3|Withdrawal by Subject|0|||
48798179|NCT02436330|157098557|FG000|Cohort 4|Lost to Follow-up|1|||
48798180|NCT02436330|157098558|FG001|Cohort 4|Lost to Follow-up|0|||
48798181|NCT02436330|157098557|FG000|Cohort 4|Withdrawal by Subject|1|||
48798182|NCT02436330|157098558|FG001|Cohort 4|Withdrawal by Subject|0|||
48798183|NCT02436330|157098557|FG000|Cohort 5|Lost to Follow-up|3|||
48798184|NCT02436330|157098558|FG001|Cohort 5|Lost to Follow-up|2|||
48798185|NCT02436330|157098557|FG000|Cohort 5|Withdrawal by Subject|3|||
48798186|NCT02436330|157098558|FG001|Cohort 5|Withdrawal by Subject|2|||
48798187|NCT02436330|157098557|FG000|Cohort 6|Lost to Follow-up|2|||
48798188|NCT02436330|157098558|FG001|Cohort 6|Lost to Follow-up|0|||
48798189|NCT02436330|157098557|FG000|Cohort 6|Withdrawal by Subject|1|||
48798190|NCT02436330|157098558|FG001|Cohort 6|Withdrawal by Subject|1|||
48798191|NCT04721925|157098559|FG000|2-Month Assessment|Lost to Follow-up|5|||
48798192|NCT04721925|157098560|FG001|2-Month Assessment|Lost to Follow-up|3|||
48798193|NCT04721925|157098559|FG000|4-Month Assessment|Lost to Follow-up|3|||
48798194|NCT04721925|157098560|FG001|4-Month Assessment|Lost to Follow-up|6|||
48798195|NCT00441701|157098561|FG000|Overall Study|Adverse Event|3|||
48798196|NCT00441701|157098562|FG001|Overall Study|Adverse Event|2|||
48798197|NCT00441701|157098563|FG002|Overall Study|Adverse Event|1|||
48798198|NCT00441701|157098564|FG003|Overall Study|Adverse Event|0|||
48798199|NCT00441701|157098565|FG004|Overall Study|Adverse Event|2|||
48798200|NCT00441701|157098566|FG005|Overall Study|Adverse Event|2|||
48798201|NCT00441701|157098567|FG006|Overall Study|Adverse Event|0|||
48798202|NCT00441701|157098568|FG007|Overall Study|Adverse Event|0|||
48798203|NCT00441701|157098569|FG008|Overall Study|Adverse Event|0|||
48798204|NCT00441701|157098570|FG009|Overall Study|Adverse Event|0|||
48798205|NCT00441701|157098561|FG000|Overall Study|Lack of Efficacy|2|||
48798255|NCT01274182|157098585|FG001|Overall Study|Withdrawal by Subject|5|||
48798256|NCT01274182|157098586|FG002|Overall Study|Withdrawal by Subject|3|||
48798257|NCT01274182|157098584|FG000|Overall Study|Lost to Follow-up|2|||
48798258|NCT01274182|157098585|FG001|Overall Study|Lost to Follow-up|3|||
48798259|NCT01274182|157098586|FG002|Overall Study|Lost to Follow-up|1|||
48798260|NCT01274182|157098584|FG000|Overall Study|Protocol Violation|3|||
48798261|NCT01274182|157098585|FG001|Overall Study|Protocol Violation|2|||
48798262|NCT01274182|157098586|FG002|Overall Study|Protocol Violation|0|||
48798263|NCT01274182|157098584|FG000|Overall Study|Death|1|||
48798264|NCT01274182|157098585|FG001|Overall Study|Death|0|||
48798265|NCT01274182|157098586|FG002|Overall Study|Death|1|||
48798266|NCT01362439|157098587|FG000|Overall Study|Adverse Event|1|||
48798267|NCT01362439|157098587|FG000|Overall Study|Lack of Efficacy|3|||
48798268|NCT01362439|157098587|FG000|Overall Study|Lost to Follow-up|2|||
48798269|NCT01362439|157098587|FG000|Overall Study|Study medication non-compliant|1|||
48798270|NCT01362439|157098587|FG000|Overall Study|Participant who withdrew consent|8|||
48798271|NCT03494166|157098588|FG000|Overall Study|Death|0|||
48798272|NCT03494166|157098589|FG001|Overall Study|Death|0|||
48798273|NCT03494166|157098590|FG002|Overall Study|Death|0|||
48798274|NCT03494166|157098591|FG003|Overall Study|Death|1|||
48798275|NCT03494166|157098592|FG004|Overall Study|Death|3|||
48798276|NCT03494166|157098593|FG005|Overall Study|Death|0|||
48798277|NCT03494166|157098588|FG000|Overall Study|Lost to Follow-up|2|||
48798278|NCT03494166|157098589|FG001|Overall Study|Lost to Follow-up|2|||
48798279|NCT03494166|157098590|FG002|Overall Study|Lost to Follow-up|2|||
48798280|NCT03494166|157098591|FG003|Overall Study|Lost to Follow-up|2|||
48798281|NCT03494166|157098592|FG004|Overall Study|Lost to Follow-up|14|||
48798282|NCT03494166|157098593|FG005|Overall Study|Lost to Follow-up|0|||
48798283|NCT03494166|157098588|FG000|Overall Study|Withdrawal by Subject|10|||
48798284|NCT03494166|157098589|FG001|Overall Study|Withdrawal by Subject|7|||
48798285|NCT03494166|157098590|FG002|Overall Study|Withdrawal by Subject|0|||
48798286|NCT03494166|157098591|FG003|Overall Study|Withdrawal by Subject|5|||
48798287|NCT03494166|157098592|FG004|Overall Study|Withdrawal by Subject|3|||
48798288|NCT03494166|157098593|FG005|Overall Study|Withdrawal by Subject|17|||
48798289|NCT03494166|157098588|FG000|Overall Study|Screen failure|1|||
48798290|NCT03494166|157098589|FG001|Overall Study|Screen failure|0|||
48798291|NCT03494166|157098590|FG002|Overall Study|Screen failure|0|||
48798292|NCT03494166|157098591|FG003|Overall Study|Screen failure|0|||
48798293|NCT03494166|157098592|FG004|Overall Study|Screen failure|1|||
48798294|NCT03494166|157098593|FG005|Overall Study|Screen failure|0|||
48798295|NCT00952822|157098594|FG000|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
48798296|NCT00952822|157098595|FG001|1st Pharmacokinetic Evaluation|Lost to Follow-up|1|||
48798297|NCT00952822|157098596|FG002|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
48798298|NCT00952822|157098597|FG003|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
48798299|NCT00952822|157098594|FG000|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
48798300|NCT00952822|157098595|FG001|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
48798301|NCT00952822|157098596|FG002|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1|||
48798302|NCT00952822|157098597|FG003|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
48798303|NCT01281644|157098598|FG000|Overall Study|Lost to Follow-up|3|||
48798304|NCT01281644|157098598|FG000|Overall Study|Withdrawal by Subject|2|||
48798305|NCT00611858|157098599|FG000|Overall Study|Adverse Event|2|||
48798306|NCT00611858|157098599|FG000|Overall Study|Withdrawal by Subject|2|||
48798307|NCT02633137|157098600|FG000|Overall Study|Adverse Event|1|||
48798308|NCT02633137|157098600|FG000|Overall Study|Lack of Efficacy|2|||
48798309|NCT02633137|157098600|FG000|Overall Study|Withdrawal by Subject|1|||
48798310|NCT01324271|157098601|FG000|Overall Study|Lost to Follow-up|3|||
48798311|NCT01324271|157098602|FG001|Overall Study|Lost to Follow-up|0|||
48798312|NCT01324271|157098601|FG000|Overall Study|Physician Decision|1|||
48798313|NCT01324271|157098602|FG001|Overall Study|Physician Decision|0|||
48798314|NCT02954354|157098603|FG000|Overall Study|Adverse Event|2|||
48798315|NCT02954354|157098604|FG001|Overall Study|Adverse Event|2|||
48798316|NCT02954354|157098605|FG002|Overall Study|Adverse Event|4|||
48798317|NCT02954354|157098603|FG000|Overall Study|Failure to Meet Eligibility Criteria|1|||
48798318|NCT02954354|157098604|FG001|Overall Study|Failure to Meet Eligibility Criteria|0|||
48798319|NCT02954354|157098605|FG002|Overall Study|Failure to Meet Eligibility Criteria|0|||
48798320|NCT02954354|157098603|FG000|Overall Study|Lack of Efficacy|0|||
48798321|NCT02954354|157098604|FG001|Overall Study|Lack of Efficacy|2|||
48798322|NCT02954354|157098605|FG002|Overall Study|Lack of Efficacy|0|||
48798323|NCT02954354|157098603|FG000|Overall Study|Withdrawal by Subject|17|||
48798324|NCT02954354|157098604|FG001|Overall Study|Withdrawal by Subject|9|||
48798325|NCT02954354|157098605|FG002|Overall Study|Withdrawal by Subject|11|||
48798326|NCT02954354|157098603|FG000|Overall Study|Lost to Follow-up|12|||
48798327|NCT02954354|157098604|FG001|Overall Study|Lost to Follow-up|5|||
48798328|NCT02954354|157098605|FG002|Overall Study|Lost to Follow-up|0|||
48798329|NCT02954354|157098603|FG000|Overall Study|Miscellaneous|2|||
48798330|NCT02954354|157098604|FG001|Overall Study|Miscellaneous|2|||
48798331|NCT02954354|157098605|FG002|Overall Study|Miscellaneous|1|||
48798332|NCT04252742|157098607|FG000|Overall Study|Decision by sponsor|0|||
48798348|NCT00377403|157098625|FG001|Overall Study|Unable to contact for telephone intervie|7|||
48798349|NCT01207102|157098629|FG000|Overall Study|Withdrawal by Subject|5|||
48798350|NCT01207102|157098629|FG000|Overall Study|Adverse Event|2|||
48798351|NCT01207102|157098629|FG000|Overall Study|progression|2|||
48798352|NCT01207102|157098629|FG000|Overall Study|Withdrawal by Treating Physician|1|||
48798353|NCT02279043|157098630|FG000|Overall Study|Post-rand. exclusion - not eligible|1|||
48798354|NCT02279043|157098631|FG001|Overall Study|Post-rand. exclusion - not eligible|1|||
48798355|NCT02279043|157098632|FG002|Overall Study|Post-rand. exclusion - not eligible|0|||
48798356|NCT02279043|157098630|FG000|Overall Study|Lost to Follow-up|46|||
48798357|NCT02279043|157098631|FG001|Overall Study|Lost to Follow-up|88|||
48798358|NCT02279043|157098632|FG002|Overall Study|Lost to Follow-up|0|||
48798359|NCT01922076|157098633|FG000|Overall Study|Adverse Event|0|||
48798360|NCT01922076|157098634|FG001|Overall Study|Adverse Event|0|||
48798361|NCT01922076|157098635|FG002|Overall Study|Adverse Event|0|||
48798362|NCT01922076|157098636|FG003|Overall Study|Adverse Event|0|||
48798363|NCT01922076|157098637|FG004|Overall Study|Adverse Event|1|||
48798364|NCT01922076|157098638|FG005|Overall Study|Adverse Event|0|||
48798365|NCT01922076|157098639|FG006|Overall Study|Adverse Event|0|||
48798366|NCT01922076|157098633|FG000|Overall Study|Physician Decision|0|||
48798367|NCT01922076|157098634|FG001|Overall Study|Physician Decision|0|||
48798368|NCT01922076|157098635|FG002|Overall Study|Physician Decision|1|||
48798369|NCT01922076|157098636|FG003|Overall Study|Physician Decision|0|||
48798370|NCT01922076|157098637|FG004|Overall Study|Physician Decision|0|||
48798371|NCT01922076|157098638|FG005|Overall Study|Physician Decision|0|||
48798372|NCT01922076|157098639|FG006|Overall Study|Physician Decision|0|||
48798373|NCT01922076|157098633|FG000|Overall Study|Withdrawal by Subject|0|||
48798374|NCT01922076|157098634|FG001|Overall Study|Withdrawal by Subject|0|||
48798375|NCT01922076|157098635|FG002|Overall Study|Withdrawal by Subject|0|||
48798376|NCT01922076|157098636|FG003|Overall Study|Withdrawal by Subject|1|||
48798377|NCT01922076|157098637|FG004|Overall Study|Withdrawal by Subject|0|||
48798378|NCT01922076|157098638|FG005|Overall Study|Withdrawal by Subject|1|||
48798379|NCT01922076|157098639|FG006|Overall Study|Withdrawal by Subject|1|||
48798380|NCT02114151|157098640|FG000|Overall Study|Death|1|||
48798381|NCT02114151|157098640|FG000|Overall Study|Lost to Follow-up|1|||
48798382|NCT02114151|157098640|FG000|Overall Study|Withdrawal by Subject|5|||
48798383|NCT01499082|157098641|FG000|Overall Study|Randomized but not Treated|0|||
48798384|NCT01499082|157098642|FG001|Overall Study|Randomized but not Treated|1|||
48798385|NCT01499082|157098641|FG000|Overall Study|Adverse Event|12|||
48798386|NCT01499082|157098642|FG001|Overall Study|Adverse Event|16|||
48798387|NCT01499082|157098641|FG000|Overall Study|Lack of Efficacy|1|||
48798388|NCT01499082|157098642|FG001|Overall Study|Lack of Efficacy|1|||
48798389|NCT01499082|157098641|FG000|Overall Study|Protocol Violation|6|||
48798390|NCT01499082|157098642|FG001|Overall Study|Protocol Violation|8|||
48798391|NCT01499082|157098641|FG000|Overall Study|Diverse Reasons|18|||
48798392|NCT01499082|157098642|FG001|Overall Study|Diverse Reasons|14|||
48798393|NCT01499082|157098641|FG000|Overall Study|Site Closure for Noncompliance|5|||
48798394|NCT01499082|157098642|FG001|Overall Study|Site Closure for Noncompliance|2|||
48798395|NCT01499082|157098641|FG000|Overall Study|Hypoglycemia|2|||
48798396|NCT01499082|157098642|FG001|Overall Study|Hypoglycemia|3|||
48798397|NCT01499082|157098641|FG000|Overall Study|Lost to Follow-up|1|||
48798398|NCT01499082|157098642|FG001|Overall Study|Lost to Follow-up|3|||
48798399|NCT02703922|157098648|FG000|Overall Study|Death|5|||
48798400|NCT02703922|157098649|FG001|Overall Study|Death|8|||
48798401|NCT02703922|157098648|FG000|Overall Study|Lost to Follow-up|10|||
48798402|NCT02703922|157098649|FG001|Overall Study|Lost to Follow-up|10|||
48798403|NCT03238300|157098651|FG000|Baseline (Before Intervention)|Physician Decision|0|||
48798404|NCT03238300|157098652|FG001|Baseline (Before Intervention)|Physician Decision|1|||
48798405|NCT03238300|157098651|FG000|Washout Period (11-Days)|Withdrawal by Subject|1|||
48798406|NCT03238300|157098652|FG001|Washout Period (11-Days)|Withdrawal by Subject|0|||
48798407|NCT03238300|157098651|FG000|Second Intervention (10-Days)|Lost to Follow-up|1|||
48798408|NCT03238300|157098652|FG001|Second Intervention (10-Days)|Lost to Follow-up|0|||
48798409|NCT03238300|157098651|FG000|Second Intervention (10-Days)|Withdrawal by Subject|1|||
48798410|NCT03238300|157098652|FG001|Second Intervention (10-Days)|Withdrawal by Subject|0|||
48798411|NCT01860703|157098653|FG000|Overall Study|Adverse Event|1|||
48798412|NCT01860703|157098654|FG001|Overall Study|Adverse Event|4|||
48798413|NCT01860703|157098655|FG002|Overall Study|Adverse Event|0|||
48798414|NCT01860703|157098656|FG003|Overall Study|Adverse Event|2|||
48798415|NCT01860703|157098653|FG000|Overall Study|Withdrawal by Subject|0|||
48798416|NCT01860703|157098654|FG001|Overall Study|Withdrawal by Subject|1|||
48798417|NCT01860703|157098655|FG002|Overall Study|Withdrawal by Subject|0|||
48798418|NCT01860703|157098656|FG003|Overall Study|Withdrawal by Subject|0|||
48798419|NCT01860703|157098653|FG000|Overall Study|Personal reason|1|||
48798420|NCT01860703|157098654|FG001|Overall Study|Personal reason|0|||
48798421|NCT01860703|157098655|FG002|Overall Study|Personal reason|1|||
48798422|NCT01860703|157098656|FG003|Overall Study|Personal reason|0|||
48798423|NCT02134587|157098659|FG000|Overall Study|Did not completed all meetings|30|||
48798424|NCT02453685|157098660|FG000|Overall Study|Adverse Event|0|||
48798425|NCT02453685|157098661|FG001|Overall Study|Adverse Event|1|||
48798430|NCT02453685|157098660|FG000|Overall Study|Withdrawal by Subject|8|||
48798431|NCT02453685|157098661|FG001|Overall Study|Withdrawal by Subject|4|||
48798432|NCT02453685|157098660|FG000|Overall Study|Unclassified|4|||
48798433|NCT02453685|157098661|FG001|Overall Study|Unclassified|2|||
48798434|NCT01648270|157098664|FG000|Intravenous Buprenorphine|Withdrawal by Subject|12|||
48798435|NCT00572195|157098665|FG000|Overall Study|Withdrawal by Subject|50|||
48798436|NCT00572195|157098665|FG000|Overall Study|Death|9|||
48798437|NCT00572195|157098665|FG000|Overall Study|Adverse Event|4|||
48798438|NCT00572195|157098665|FG000|Overall Study|Lost to Follow-up|5|||
48798439|NCT01024608|157098666|FG000|Overall Study|Adverse Event|1|||
48798440|NCT01024608|157098667|FG001|Overall Study|Adverse Event|0|||
48798441|NCT01024608|157098666|FG000|Overall Study|Withdrawal by Subject|1|||
48798442|NCT01024608|157098667|FG001|Overall Study|Withdrawal by Subject|0|||
48798443|NCT01024608|157098666|FG000|Overall Study|Lost to Follow-up|0|||
48798444|NCT01024608|157098667|FG001|Overall Study|Lost to Follow-up|1|||
48798445|NCT01024608|157098666|FG000|Overall Study|Protocol Violation|0|||
48798446|NCT01024608|157098667|FG001|Overall Study|Protocol Violation|3|||
48798447|NCT01024608|157098666|FG000|Overall Study|Never received study treatment|2|||
48798448|NCT01024608|157098667|FG001|Overall Study|Never received study treatment|0|||
49111281|NCT00528372|158242879|FG008|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
49111282|NCT00528372|158242871|FG000|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
49111283|NCT00528372|158242872|FG001|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
49111284|NCT00528372|158242873|FG002|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
49111285|NCT00528372|158242874|FG003|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
49111286|NCT00528372|158242875|FG004|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
49111287|NCT00528372|158242876|FG005|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
49111288|NCT00528372|158242877|FG006|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
49111289|NCT00528372|158242878|FG007|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
49111290|NCT00528372|158242879|FG008|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
49111291|NCT00528372|158242871|FG000|Short-term (ST) Period (Day 1-Week 24)|Other|3|||
49111292|NCT00528372|158242872|FG001|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
49111293|NCT00528372|158242873|FG002|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
49111294|NCT00528372|158242874|FG003|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
49111295|NCT00528372|158242875|FG004|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
49111296|NCT00528372|158242876|FG005|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
49111297|NCT00528372|158242877|FG006|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
49111298|NCT00528372|158242878|FG007|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
49111299|NCT00528372|158242879|FG008|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
49111300|NCT00528372|158242871|FG000|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
49111301|NCT00528372|158242872|FG001|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
49111302|NCT00528372|158242873|FG002|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1|||
49111303|NCT00528372|158242874|FG003|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
49111304|NCT00528372|158242875|FG004|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
49111305|NCT00528372|158242876|FG005|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
49111306|NCT00528372|158242877|FG006|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2|||
49111307|NCT00528372|158242878|FG007|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
49111308|NCT00528372|158242879|FG008|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
49111309|NCT00528372|158242871|FG000|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
49111310|NCT00528372|158242872|FG001|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
49111311|NCT00528372|158242873|FG002|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
49111312|NCT00528372|158242874|FG003|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
49111313|NCT00528372|158242875|FG004|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2|||
49111314|NCT00528372|158242876|FG005|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
49111315|NCT00528372|158242877|FG006|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4|||
49111316|NCT00528372|158242878|FG007|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
49111317|NCT00528372|158242879|FG008|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
49111318|NCT00528372|158242871|FG000|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
49111319|NCT00528372|158242872|FG001|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
49111320|NCT00528372|158242873|FG002|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
49111321|NCT00528372|158242874|FG003|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
49111322|NCT00528372|158242875|FG004|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7|||
49111323|NCT00528372|158242876|FG005|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0|||
49111324|NCT00528372|158242877|FG006|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
49111325|NCT00528372|158242878|FG007|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2|||
49111326|NCT00528372|158242879|FG008|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
49111327|NCT00528372|158242871|FG000|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
49111328|NCT00528372|158242872|FG001|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
49111329|NCT00528372|158242873|FG002|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
49111330|NCT00528372|158242874|FG003|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
49111331|NCT00528372|158242875|FG004|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0|||
49111332|NCT00528372|158242876|FG005|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4|||
49111333|NCT00528372|158242877|FG006|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
49111334|NCT00528372|158242878|FG007|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
49111335|NCT00528372|158242879|FG008|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
49111336|NCT00528372|158242871|FG000|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
49111337|NCT00528372|158242872|FG001|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
49111338|NCT00528372|158242873|FG002|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
49111339|NCT00528372|158242874|FG003|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
49111340|NCT00528372|158242875|FG004|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
49111341|NCT00528372|158242876|FG005|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
49111342|NCT00528372|158242877|FG006|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
49111343|NCT00528372|158242878|FG007|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
49111344|NCT00528372|158242879|FG008|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
49111345|NCT00528372|158242871|FG000|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
49111346|NCT00528372|158242872|FG001|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
49111347|NCT00528372|158242873|FG002|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
49111348|NCT00528372|158242874|FG003|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
49111349|NCT00528372|158242875|FG004|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2|||
49111350|NCT00528372|158242876|FG005|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1|||
49111351|NCT00528372|158242877|FG006|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
49111352|NCT00528372|158242878|FG007|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
49111353|NCT00528372|158242879|FG008|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
49111354|NCT00528372|158242871|FG000|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
49111355|NCT00528372|158242872|FG001|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
49111356|NCT00528372|158242873|FG002|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
49111357|NCT00528372|158242874|FG003|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
49111358|NCT00528372|158242875|FG004|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
49111359|NCT00528372|158242876|FG005|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
49111360|NCT00528372|158242877|FG006|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
49111361|NCT00528372|158242878|FG007|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
49111362|NCT00528372|158242879|FG008|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
49111363|NCT00528372|158242871|FG000|Long-term (LT) Period (Weeks 24-102)|Other|2|||
49111364|NCT00528372|158242872|FG001|Long-term (LT) Period (Weeks 24-102)|Other|2|||
49111365|NCT00528372|158242873|FG002|Long-term (LT) Period (Weeks 24-102)|Other|1|||
49111366|NCT00528372|158242874|FG003|Long-term (LT) Period (Weeks 24-102)|Other|2|||
49111367|NCT00528372|158242875|FG004|Long-term (LT) Period (Weeks 24-102)|Other|3|||
49111368|NCT00528372|158242876|FG005|Long-term (LT) Period (Weeks 24-102)|Other|0|||
49111369|NCT00528372|158242877|FG006|Long-term (LT) Period (Weeks 24-102)|Other|3|||
49111370|NCT00528372|158242878|FG007|Long-term (LT) Period (Weeks 24-102)|Other|1|||
49111371|NCT00528372|158242879|FG008|Long-term (LT) Period (Weeks 24-102)|Other|0|||
49111372|NCT02756364|158242880|FG000|Overall Study|Site Terminated by Sponsor|24|||
49111373|NCT02756364|158242881|FG001|Overall Study|Site Terminated by Sponsor|30|||
49111374|NCT02756364|158242882|FG002|Overall Study|Site Terminated by Sponsor|21|||
49111375|NCT02756364|158242880|FG000|Overall Study|Death|20|||
49111376|NCT02756364|158242881|FG001|Overall Study|Death|15|||
49111377|NCT02756364|158242882|FG002|Overall Study|Death|18|||
49111378|NCT02756364|158242880|FG000|Overall Study|Withdrawal by Patient|2|||
49111379|NCT02756364|158242881|FG001|Overall Study|Withdrawal by Patient|1|||
49111380|NCT02756364|158242882|FG002|Overall Study|Withdrawal by Patient|8|||
49111381|NCT02756364|158242880|FG000|Overall Study|Lost to Follow-up|0|||
49111382|NCT02756364|158242881|FG001|Overall Study|Lost to Follow-up|1|||
49111383|NCT02756364|158242882|FG002|Overall Study|Lost to Follow-up|1|||
49111384|NCT00248833|158242883|FG000|Overall Study|Adverse Event|2|||
49111385|NCT00248833|158242884|FG001|Overall Study|Adverse Event|0|||
49111386|NCT00248833|158242885|FG002|Overall Study|Adverse Event|0|||
49111387|NCT00248833|158242883|FG000|Overall Study|Withdrawal by Subject|0|||
49111388|NCT00248833|158242884|FG001|Overall Study|Withdrawal by Subject|1|||
49111389|NCT00248833|158242885|FG002|Overall Study|Withdrawal by Subject|1|||
49111390|NCT00248833|158242883|FG000|Overall Study|Lost to Follow-up|1|||
49111391|NCT00248833|158242884|FG001|Overall Study|Lost to Follow-up|1|||
49111392|NCT00248833|158242885|FG002|Overall Study|Lost to Follow-up|1|||
49111393|NCT00248833|158242883|FG000|Overall Study|Other|0|||
49111394|NCT00248833|158242884|FG001|Overall Study|Other|1|||
49111395|NCT00248833|158242885|FG002|Overall Study|Other|0|||
49111396|NCT02772809|158242888|FG000|Overall Study|not completed some tasks|6|||
49111406|NCT01289574|158242893|FG000|Overall Study|Withdrawal by Subject|1|||
49111407|NCT01289574|158242894|FG001|Overall Study|Withdrawal by Subject|1|||
49111408|NCT01289574|158242895|FG002|Overall Study|Withdrawal by Subject|1|||
49111409|NCT01289574|158242893|FG000|Overall Study|Adverse Event|0|||
49111410|NCT01289574|158242894|FG001|Overall Study|Adverse Event|1|||
49111411|NCT01289574|158242895|FG002|Overall Study|Adverse Event|0|||
49111412|NCT01289574|158242893|FG000|Overall Study|Subject wanted alternate treatment|0|||
49111413|NCT01289574|158242894|FG001|Overall Study|Subject wanted alternate treatment|1|||
49111414|NCT01289574|158242895|FG002|Overall Study|Subject wanted alternate treatment|0|||
49111415|NCT03275389|158242896|FG000|Overall Study|Lost to Follow-up|10|||
49111416|NCT03275389|158242897|FG001|Overall Study|Lost to Follow-up|10|||
49111417|NCT03275389|158242898|FG002|Overall Study|Lost to Follow-up|19|||
49111418|NCT03275389|158242899|FG003|Overall Study|Lost to Follow-up|12|||
49111419|NCT03275389|158242900|FG004|Overall Study|Lost to Follow-up|11|||
49111420|NCT03275389|158242901|FG005|Overall Study|Lost to Follow-up|12|||
49111421|NCT03275389|158242902|FG006|Overall Study|Lost to Follow-up|21|||
49111422|NCT03275389|158242903|FG007|Overall Study|Lost to Follow-up|15|||
49111423|NCT03275389|158242904|FG008|Overall Study|Lost to Follow-up|12|||
49111424|NCT03275389|158242905|FG009|Overall Study|Lost to Follow-up|14|||
49111425|NCT03275389|158242896|FG000|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
49111426|NCT03275389|158242897|FG001|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
49111427|NCT03275389|158242898|FG002|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
49111428|NCT03275389|158242899|FG003|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
49111429|NCT03275389|158242900|FG004|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
49111430|NCT03275389|158242901|FG005|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
49111431|NCT03275389|158242902|FG006|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
49111432|NCT03275389|158242903|FG007|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
49111433|NCT03275389|158242904|FG008|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
49111434|NCT03275389|158242905|FG009|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
49111435|NCT03275389|158242896|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
49111436|NCT03275389|158242897|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
49111437|NCT03275389|158242898|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
49111438|NCT03275389|158242899|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
49111439|NCT03275389|158242900|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
49111440|NCT03275389|158242901|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
49111441|NCT03275389|158242902|FG006|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
49111442|NCT03275389|158242903|FG007|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
49111443|NCT03275389|158242904|FG008|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
49111444|NCT03275389|158242905|FG009|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
49111445|NCT03275389|158242896|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
49111446|NCT03275389|158242897|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
49111447|NCT03275389|158242898|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
49111448|NCT03275389|158242899|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
49111449|NCT03275389|158242900|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
49111450|NCT03275389|158242901|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
49111451|NCT03275389|158242902|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
49111452|NCT03275389|158242903|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
49111453|NCT03275389|158242904|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
49111454|NCT03275389|158242905|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
49111455|NCT03275389|158242896|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
49111456|NCT03275389|158242897|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
49111457|NCT03275389|158242898|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
49111458|NCT03275389|158242899|FG003|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
49111459|NCT03275389|158242900|FG004|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
49111460|NCT03275389|158242901|FG005|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
49111461|NCT03275389|158242902|FG006|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
49111462|NCT03275389|158242903|FG007|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
49111463|NCT03275389|158242904|FG008|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
49111464|NCT03275389|158242905|FG009|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
49111465|NCT03275389|158242896|FG000|Overall Study|Other|0|||
49111466|NCT03275389|158242897|FG001|Overall Study|Other|4|||
49111467|NCT03275389|158242898|FG002|Overall Study|Other|3|||
49111468|NCT03275389|158242899|FG003|Overall Study|Other|2|||
49111469|NCT03275389|158242900|FG004|Overall Study|Other|2|||
49111470|NCT03275389|158242901|FG005|Overall Study|Other|2|||
49111471|NCT03275389|158242902|FG006|Overall Study|Other|0|||
49111472|NCT03275389|158242903|FG007|Overall Study|Other|0|||
49111473|NCT03275389|158242904|FG008|Overall Study|Other|1|||
49111474|NCT03275389|158242905|FG009|Overall Study|Other|0|||
49111475|NCT02452554|158242908|FG000|Overall Study|Death|2|||
49111476|NCT02452554|158242909|FG001|Overall Study|Death|1|||
49111477|NCT02452554|158242910|FG002|Overall Study|Death|0|||
49111478|NCT02452554|158242911|FG003|Overall Study|Death|0|||
49111511|NCT02109445|158242914|FG000|Overall Study|Symptomatic deterioration|2|||
49111512|NCT02109445|158242914|FG000|Overall Study|Adverse Event|1|||
49111513|NCT02087943|158244447|FG000|Placebo-Controlled Phase Week 0-12|Adverse Event|1|||
49111514|NCT02087943|158244448|FG001|Placebo-Controlled Phase Week 0-12|Adverse Event|2|||
49111515|NCT02087943|158244449|FG002|Placebo-Controlled Phase Week 0-12|Adverse Event|6|||
49111516|NCT02087943|158244450|FG003|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
49111517|NCT02087943|158244451|FG004|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
49111518|NCT02087943|158244447|FG000|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8|||
49111519|NCT02087943|158244448|FG001|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7|||
49111520|NCT02087943|158244449|FG002|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4|||
49111521|NCT02087943|158244450|FG003|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
49111522|NCT02087943|158244451|FG004|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
49111523|NCT02087943|158244447|FG000|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4|||
49111524|NCT02087943|158244448|FG001|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
49111525|NCT02087943|158244449|FG002|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
49111526|NCT02087943|158244450|FG003|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
49111527|NCT02087943|158244451|FG004|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
49111528|NCT02087943|158244447|FG000|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
49111529|NCT02087943|158244448|FG001|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
49111530|NCT02087943|158244449|FG002|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
49111531|NCT02087943|158244450|FG003|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
49111532|NCT02087943|158244451|FG004|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
49111533|NCT02087943|158244447|FG000|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
49111534|NCT02087943|158244448|FG001|Placebo-Controlled Phase Week 0-12|Protocol Violation|1|||
49111535|NCT02087943|158244449|FG002|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
49111536|NCT02087943|158244450|FG003|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
49111537|NCT02087943|158244451|FG004|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
49111538|NCT02087943|158244447|FG000|Active Treatment Phase Week 12-24|Adverse Event|0|||
49111539|NCT02087943|158244448|FG001|Active Treatment Phase Week 12-24|Adverse Event|1|||
49111540|NCT02087943|158244449|FG002|Active Treatment Phase Week 12-24|Adverse Event|2|||
49111541|NCT02087943|158244450|FG003|Active Treatment Phase Week 12-24|Adverse Event|0|||
49111542|NCT02087943|158244451|FG004|Active Treatment Phase Week 12-24|Adverse Event|1|||
49111543|NCT02087943|158244447|FG000|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
49111544|NCT02087943|158244448|FG001|Active Treatment Phase Week 12-24|Lack of Efficacy|3|||
49111545|NCT02087943|158244449|FG002|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
49111546|NCT02087943|158244450|FG003|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
49111547|NCT02087943|158244451|FG004|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
49111548|NCT02087943|158244447|FG000|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
49111549|NCT02087943|158244448|FG001|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
49111550|NCT02087943|158244449|FG002|Active Treatment Phase Week 12-24|Withdrawal by Subject|1|||
49111551|NCT02087943|158244450|FG003|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
49111552|NCT02087943|158244451|FG004|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
49111553|NCT02087943|158244447|FG000|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
49111554|NCT02087943|158244448|FG001|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
49111555|NCT02087943|158244449|FG002|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
49111556|NCT02087943|158244450|FG003|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
49111557|NCT02087943|158244451|FG004|Active Treatment Phase Week 12-24|Lost to Follow-up|1|||
49111558|NCT02087943|158244447|FG000|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
49111559|NCT02087943|158244448|FG001|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
49111560|NCT02087943|158244449|FG002|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
49111561|NCT02087943|158244450|FG003|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
49111562|NCT02087943|158244451|FG004|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
49111563|NCT02131636|158244455|FG000|Overall Study|Personal Reasons|4|||
49111564|NCT02131636|158244456|FG001|Overall Study|Personal Reasons|4|||
49111565|NCT02131636|158244455|FG000|Overall Study|Lost to Follow-up|4|||
49111566|NCT02131636|158244456|FG001|Overall Study|Lost to Follow-up|0|||
49111567|NCT02131636|158244455|FG000|Overall Study|Adverse Event|4|||
49111568|NCT02131636|158244456|FG001|Overall Study|Adverse Event|1|||
49111569|NCT03484403|158244457|FG000|Overall Study|Withdrawal by Subject|6|||
49111570|NCT03484403|158244458|FG001|Overall Study|Withdrawal by Subject|4|||
49111571|NCT00513357|158244461|FG000|Overall Study|did not receive allocated placebo|2|||
49111572|NCT00513357|158244462|FG001|Overall Study|did not receive allocated placebo|3|||
49111573|NCT00513357|158244461|FG000|Overall Study|Adverse Event|4|||
49111574|NCT00513357|158244462|FG001|Overall Study|Adverse Event|2|||
49111575|NCT00513357|158244461|FG000|Overall Study|Death|2|||
49111576|NCT00513357|158244462|FG001|Overall Study|Death|0|||
49111577|NCT00513357|158244461|FG000|Overall Study|Withdrawal by Subject|5|||
49111578|NCT00513357|158244462|FG001|Overall Study|Withdrawal by Subject|4|||
49111579|NCT00513357|158244461|FG000|Overall Study|Disease Progression|2|||
49111720|NCT01887678|158244506|FG000|Overall Study|Exceeded rescue medication dosage|4|||
49111721|NCT01887678|158244507|FG001|Overall Study|Exceeded rescue medication dosage|5|||
49111722|NCT01887678|158244506|FG000|Overall Study|Withdrawal of consent|3|||
49111723|NCT01887678|158244507|FG001|Overall Study|Withdrawal of consent|4|||
49111724|NCT01887678|158244506|FG000|Overall Study|Lost to Follow-up|4|||
49111725|NCT01887678|158244507|FG001|Overall Study|Lost to Follow-up|2|||
49111726|NCT01887678|158244506|FG000|Overall Study|Deterioration of clinical condition|0|||
49111727|NCT01887678|158244507|FG001|Overall Study|Deterioration of clinical condition|4|||
49111728|NCT01887678|158244506|FG000|Overall Study|Lack of Efficacy|1|||
49111729|NCT01887678|158244507|FG001|Overall Study|Lack of Efficacy|2|||
49111730|NCT01887678|158244506|FG000|Overall Study|Non-compliance|0|||
49111731|NCT01887678|158244507|FG001|Overall Study|Non-compliance|3|||
49111732|NCT01887678|158244506|FG000|Overall Study|Specified|1|||
49111733|NCT01887678|158244507|FG001|Overall Study|Specified|2|||
49111734|NCT04318132|158244508|FG000|Overall Study|Protocol Violation|0|||
49111735|NCT04318132|158244509|FG001|Overall Study|Protocol Violation|0|||
49111736|NCT04318132|158244510|FG002|Overall Study|Protocol Violation|3|||
49111737|NCT04318132|158244511|FG003|Overall Study|Protocol Violation|0|||
49111738|NCT01260584|158244512|FG000|Period 1|Protocol Violation|0|||
49111739|NCT01260584|158244513|FG001|Period 1|Protocol Violation|0|||
49111740|NCT01260584|158244514|FG002|Period 1|Protocol Violation|1|||
49111741|NCT01260584|158244515|FG003|Period 1|Protocol Violation|1|||
49111742|NCT01260584|158244512|FG000|Period 1|Adverse Event|0|||
49111743|NCT01260584|158244513|FG001|Period 1|Adverse Event|0|||
49111744|NCT01260584|158244514|FG002|Period 1|Adverse Event|1|||
49111745|NCT01260584|158244515|FG003|Period 1|Adverse Event|0|||
49111746|NCT01260584|158244512|FG000|Period 2|Protocol Violation|0|||
49111747|NCT01260584|158244513|FG001|Period 2|Protocol Violation|2|||
49111748|NCT01260584|158244514|FG002|Period 2|Protocol Violation|3|||
49111749|NCT01260584|158244515|FG003|Period 2|Protocol Violation|1|||
49111750|NCT01260584|158244512|FG000|Period 2|Adverse Event|1|||
49111751|NCT01260584|158244513|FG001|Period 2|Adverse Event|0|||
49111752|NCT01260584|158244514|FG002|Period 2|Adverse Event|2|||
49111753|NCT01260584|158244515|FG003|Period 2|Adverse Event|0|||
49111754|NCT01260584|158244512|FG000|Period 2|Withdrawal by Subject|0|||
49111755|NCT01260584|158244513|FG001|Period 2|Withdrawal by Subject|1|||
49111756|NCT01260584|158244514|FG002|Period 2|Withdrawal by Subject|0|||
49111757|NCT01260584|158244515|FG003|Period 2|Withdrawal by Subject|0|||
49111758|NCT00045734|158244516|FG000|Overall Study|Protocol Violation|1|||
49111759|NCT00621517|158244517|FG000|Overall Study|Lost to Follow-up|3|||
49111760|NCT00621517|158244518|FG001|Overall Study|Lost to Follow-up|3|||
49111761|NCT00621517|158244517|FG000|Overall Study|Withdrawal by Subject|3|||
49111762|NCT00621517|158244518|FG001|Overall Study|Withdrawal by Subject|4|||
49111763|NCT00621517|158244517|FG000|Overall Study|Adverse Event|1|||
49111764|NCT00621517|158244518|FG001|Overall Study|Adverse Event|0|||
49111765|NCT03301831|158244519|FG000|Overall Study|Lost to Follow-up|5|||
49111766|NCT03301831|158244520|FG001|Overall Study|Lost to Follow-up|3|||
49111767|NCT03301831|158244519|FG000|Overall Study|Protocol Violation|4|||
49111768|NCT03301831|158244520|FG001|Overall Study|Protocol Violation|0|||
49111769|NCT03301831|158244519|FG000|Overall Study|Withdrawal by Subject|11|||
49111770|NCT03301831|158244520|FG001|Overall Study|Withdrawal by Subject|0|||
49111771|NCT00585325|158244521|FG000|Overall Study|Withdrawal by Subject|1|||
49111772|NCT00585325|158244522|FG001|Overall Study|Withdrawal by Subject|1|||
49111773|NCT01048099|158244523|FG000|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57|||
49111774|NCT01048099|158244523|FG000|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202|||
49111775|NCT03469999|158244524|FG000|Overall Study|Lost to Follow-up|2|||
49111776|NCT00508157|158244525|FG000|Overall Study|Adverse Event|0|||
49111777|NCT00508157|158244526|FG001|Overall Study|Adverse Event|1|||
49111778|NCT00508157|158244525|FG000|Overall Study|Subject Withdrew Consent|1|||
49111779|NCT00508157|158244526|FG001|Overall Study|Subject Withdrew Consent|0|||
49111780|NCT00508157|158244525|FG000|Overall Study|Lost to Follow-up|1|||
49111781|NCT00508157|158244526|FG001|Overall Study|Lost to Follow-up|0|||
49111782|NCT00508157|158244525|FG000|Overall Study|Subject no longer met study criteria|0|||
49111783|NCT00508157|158244526|FG001|Overall Study|Subject no longer met study criteria|1|||
49111784|NCT00508157|158244525|FG000|Overall Study|Other known cause|0|||
49111785|NCT00508157|158244526|FG001|Overall Study|Other known cause|1|||
49111786|NCT02774005|158244534|FG000|Overall Study|Adverse Event|8|||
49111787|NCT02774005|158244534|FG000|Overall Study|Withdrawal by Subject|23|||
49111788|NCT02774005|158244534|FG000|Overall Study|Lost to Follow-up|7|||
49111789|NCT02774005|158244534|FG000|Overall Study|Genetic diagnosis reveals that a patient does not harbour a LHON-specific mtDNA mutation|12|||
49111790|NCT02774005|158244534|FG000|Overall Study|Due to Covid-19 lockdown V9 was not completed|1|||
49111791|NCT02774005|158244534|FG000|Overall Study|Pt not willing to perform onsite V9,did not withdraw consent,not triggered by Covid19 situation|1|||
49111792|NCT02774005|158244534|FG000|Overall Study|Death|1|||
49111793|NCT02774005|158244534|FG000|Overall Study|Patient unable to return for visits. Sent medication back to site|1|||
49111794|NCT02774005|158244534|FG000|Overall Study|Lack of compliance with study medication|4|||
49111795|NCT02774005|158244534|FG000|Overall Study|subject is enrolling in a different LHON study that excludes use of idebenone|1|||
49111816|NCT00448812|158244551|FG000|Year 2|Missed visit but remained in study|4|||
49111817|NCT00448812|158244552|FG001|Year 2|Missed visit but remained in study|1|||
49111818|NCT00448812|158244551|FG000|Year 3|Withdrawal by Subject|1|||
49111819|NCT00448812|158244552|FG001|Year 3|Withdrawal by Subject|3|||
49111820|NCT00448812|158244551|FG000|Year 3|Lost to Follow-up|1|||
49111821|NCT00448812|158244552|FG001|Year 3|Lost to Follow-up|0|||
49111822|NCT00448812|158244551|FG000|Year 3|Missed visit but remained in study|2|||
49111823|NCT00448812|158244552|FG001|Year 3|Missed visit but remained in study|0|||
49111824|NCT00448812|158244551|FG000|Year 5|Missed visit but remained in study|1|||
49111825|NCT00448812|158244552|FG001|Year 5|Missed visit but remained in study|0|||
49111826|NCT00262002|158244553|FG000|Overall Study|Adverse Event|2|||
49111827|NCT00262002|158244554|FG001|Overall Study|Adverse Event|1|||
49111828|NCT00262002|158244555|FG002|Overall Study|Adverse Event|0|||
49111829|NCT00262002|158244556|FG003|Overall Study|Adverse Event|0|||
49111830|NCT00262002|158244557|FG004|Overall Study|Adverse Event|0|||
49111831|NCT00262002|158244558|FG005|Overall Study|Adverse Event|1|||
49111832|NCT00262002|158244559|FG006|Overall Study|Adverse Event|0|||
49111833|NCT00262002|158244553|FG000|Overall Study|Withdrawal by Subject|4|||
49111834|NCT00262002|158244554|FG001|Overall Study|Withdrawal by Subject|2|||
49111835|NCT00262002|158244555|FG002|Overall Study|Withdrawal by Subject|0|||
49111836|NCT00262002|158244556|FG003|Overall Study|Withdrawal by Subject|1|||
49111837|NCT00262002|158244557|FG004|Overall Study|Withdrawal by Subject|2|||
49111838|NCT00262002|158244558|FG005|Overall Study|Withdrawal by Subject|2|||
49111839|NCT00262002|158244559|FG006|Overall Study|Withdrawal by Subject|2|||
49111840|NCT00262002|158244553|FG000|Overall Study|Lost to Follow-up|2|||
49111841|NCT00262002|158244554|FG001|Overall Study|Lost to Follow-up|0|||
49111842|NCT00262002|158244555|FG002|Overall Study|Lost to Follow-up|0|||
49111843|NCT00262002|158244556|FG003|Overall Study|Lost to Follow-up|2|||
49111844|NCT00262002|158244557|FG004|Overall Study|Lost to Follow-up|0|||
49111845|NCT00262002|158244558|FG005|Overall Study|Lost to Follow-up|1|||
49111846|NCT00262002|158244559|FG006|Overall Study|Lost to Follow-up|0|||
49111847|NCT00262002|158244553|FG000|Overall Study|Inapropriate enrollment|0|||
49111848|NCT00262002|158244554|FG001|Overall Study|Inapropriate enrollment|1|||
49111849|NCT00262002|158244555|FG002|Overall Study|Inapropriate enrollment|0|||
49111850|NCT00262002|158244556|FG003|Overall Study|Inapropriate enrollment|0|||
49111851|NCT00262002|158244557|FG004|Overall Study|Inapropriate enrollment|0|||
49111852|NCT00262002|158244558|FG005|Overall Study|Inapropriate enrollment|0|||
49111853|NCT00262002|158244559|FG006|Overall Study|Inapropriate enrollment|0|||
49111854|NCT00262002|158244553|FG000|Overall Study|Protocol Violation|3|||
49111855|NCT00262002|158244554|FG001|Overall Study|Protocol Violation|2|||
49111856|NCT00262002|158244555|FG002|Overall Study|Protocol Violation|0|||
49111857|NCT00262002|158244556|FG003|Overall Study|Protocol Violation|2|||
49111858|NCT00262002|158244557|FG004|Overall Study|Protocol Violation|5|||
49111859|NCT00262002|158244558|FG005|Overall Study|Protocol Violation|3|||
49111860|NCT00262002|158244559|FG006|Overall Study|Protocol Violation|2|||
49111861|NCT00262002|158244553|FG000|Overall Study|Unable to classify|0|||
49111862|NCT00262002|158244554|FG001|Overall Study|Unable to classify|0|||
49111863|NCT00262002|158244555|FG002|Overall Study|Unable to classify|0|||
49111864|NCT00262002|158244556|FG003|Overall Study|Unable to classify|0|||
49111865|NCT00262002|158244557|FG004|Overall Study|Unable to classify|0|||
49111866|NCT00262002|158244558|FG005|Overall Study|Unable to classify|0|||
49111867|NCT00262002|158244559|FG006|Overall Study|Unable to classify|2|||
49111868|NCT03885999|158244560|FG000|Overall Study|Adverse Event|1|||
49111869|NCT01451554|158244561|FG000|Overall Study|Withdrawal by Subject|14|||
49111870|NCT01451554|158244562|FG001|Overall Study|Withdrawal by Subject|9|||
49111871|NCT00359294|158244565|FG000|Overall Study|Progressive disease|1|||
49111872|NCT00359294|158244566|FG001|Overall Study|Progressive disease|1|||
49111873|NCT00359294|158244567|FG002|Overall Study|Progressive disease|2|||
49111874|NCT00359294|158244568|FG003|Overall Study|Progressive disease|3|||
49111875|NCT00359294|158244569|FG004|Overall Study|Progressive disease|2|||
49111876|NCT00359294|158244565|FG000|Overall Study|Withdrawal by Subject|0|||
49111877|NCT00359294|158244566|FG001|Overall Study|Withdrawal by Subject|0|||
49111878|NCT00359294|158244567|FG002|Overall Study|Withdrawal by Subject|0|||
49111879|NCT00359294|158244568|FG003|Overall Study|Withdrawal by Subject|0|||
49111880|NCT00359294|158244569|FG004|Overall Study|Withdrawal by Subject|1|||
49111881|NCT00359294|158244565|FG000|Overall Study|Not treated|0|||
49111882|NCT00359294|158244566|FG001|Overall Study|Not treated|0|||
49111883|NCT00359294|158244567|FG002|Overall Study|Not treated|0|||
49111884|NCT00359294|158244568|FG003|Overall Study|Not treated|1|||
49111885|NCT00359294|158244569|FG004|Overall Study|Not treated|0|||
49111886|NCT00359294|158244565|FG000|Overall Study|Physician Decision|0|||
49111887|NCT00359294|158244566|FG001|Overall Study|Physician Decision|0|||
49111888|NCT00359294|158244567|FG002|Overall Study|Physician Decision|1|||
49111889|NCT00359294|158244568|FG003|Overall Study|Physician Decision|0|||
49111890|NCT00359294|158244569|FG004|Overall Study|Physician Decision|0|||
49111891|NCT00594386|158244570|FG000|Overall Study|Major protocol violation|2|||
49111892|NCT00594386|158244570|FG000|Overall Study|Lack of Efficacy|12|||
49111893|NCT00594386|158244570|FG000|Overall Study|Adverse Event|68|||
49111894|NCT00594386|158244570|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
49111895|NCT00594386|158244570|FG000|Overall Study|Subject withdrew consent|35|||
49111896|NCT00594386|158244570|FG000|Overall Study|Study ended per sponsor|115|||
49111897|NCT00594386|158244570|FG000|Overall Study|Lost to Follow-up|6|||
49111898|NCT00594386|158244570|FG000|Overall Study|Other: Patient went off patch (hospital)|1|||
49111899|NCT00594386|158244570|FG000|Overall Study|Other: Subject moved to Seattle|1|||
49111900|NCT00594386|158244570|FG000|Overall Study|Other: Subject admitted to nursing home|1|||
49111901|NCT00594386|158244570|FG000|Overall Study|Other: Study terminated per investigator|2|||
49111902|NCT00594386|158244570|FG000|Overall Study|Other: Sponsor closure of study|1|||
49111903|NCT00594386|158244570|FG000|Overall Study|Other: Site terminated participation|1|||
49111904|NCT00594386|158244570|FG000|Overall Study|Other: Patient wants prescription Neupro|1|||
49111905|NCT00594386|158244570|FG000|Overall Study|Other: Loss of drivers license|1|||
49111906|NCT01790516|158244571|FG000|Overall Study|Physician Decision|1|||
49111907|NCT01790516|158244572|FG001|Overall Study|Physician Decision|0|||
49111908|NCT01554163|158244573|FG000|Overall Study|Adverse Event|3|||
49111909|NCT01554163|158244574|FG001|Overall Study|Adverse Event|0|||
49111910|NCT01554163|158244573|FG000|Overall Study|Lack of Efficacy|1|||
49111911|NCT01554163|158244574|FG001|Overall Study|Lack of Efficacy|0|||
49111912|NCT01554163|158244573|FG000|Overall Study|Lost to Follow-up|1|||
49111913|NCT01554163|158244574|FG001|Overall Study|Lost to Follow-up|0|||
49111914|NCT01554163|158244573|FG000|Overall Study|Non-Compliance With Study Drug|1|||
49111915|NCT01554163|158244574|FG001|Overall Study|Non-Compliance With Study Drug|1|||
49111916|NCT01554163|158244573|FG000|Overall Study|Protocol Violation|0|||
49111917|NCT01554163|158244574|FG001|Overall Study|Protocol Violation|4|||
49111918|NCT01554163|158244573|FG000|Overall Study|Withdrawal by Subject|1|||
49111919|NCT01554163|158244574|FG001|Overall Study|Withdrawal by Subject|5|||
49111920|NCT01554163|158244573|FG000|Overall Study|Not Treated|1|||
49111921|NCT01554163|158244574|FG001|Overall Study|Not Treated|0|||
49111922|NCT01402986|158244575|FG000|Overall Study|Withdrawal by Subject|7|||
49111923|NCT01402986|158244576|FG001|Overall Study|Withdrawal by Subject|10|||
49111924|NCT01402986|158244577|FG002|Overall Study|Withdrawal by Subject|7|||
49111925|NCT01402986|158244578|FG003|Overall Study|Withdrawal by Subject|13|||
49111926|NCT01402986|158244575|FG000|Overall Study|Death|0|||
49111927|NCT01402986|158244576|FG001|Overall Study|Death|0|||
49111928|NCT01402986|158244577|FG002|Overall Study|Death|0|||
49111929|NCT01402986|158244578|FG003|Overall Study|Death|2|||
49111930|NCT01402986|158244575|FG000|Overall Study|Lost to Follow-up|0|||
49111931|NCT01402986|158244576|FG001|Overall Study|Lost to Follow-up|0|||
49111932|NCT01402986|158244577|FG002|Overall Study|Lost to Follow-up|0|||
49111933|NCT01402986|158244578|FG003|Overall Study|Lost to Follow-up|1|||
49111934|NCT01402986|158244575|FG000|Overall Study|Other|2|||
49111935|NCT01402986|158244576|FG001|Overall Study|Other|5|||
49111936|NCT01402986|158244577|FG002|Overall Study|Other|1|||
49111937|NCT01402986|158244578|FG003|Overall Study|Other|6|||
49111938|NCT02427802|158244579|FG000|Overall Study|Adverse Event|11|||
49111939|NCT02427802|158244580|FG001|Overall Study|Adverse Event|3|||
49111940|NCT02427802|158244581|FG002|Overall Study|Adverse Event|7|||
49111941|NCT02427802|158244579|FG000|Overall Study|Death|0|||
49111942|NCT02427802|158244580|FG001|Overall Study|Death|4|||
49111943|NCT02427802|158244581|FG002|Overall Study|Death|1|||
49111944|NCT02427802|158244579|FG000|Overall Study|Lost to Follow-up|13|||
49111945|NCT02427802|158244580|FG001|Overall Study|Lost to Follow-up|8|||
49111946|NCT02427802|158244581|FG002|Overall Study|Lost to Follow-up|8|||
49111947|NCT02427802|158244579|FG000|Overall Study|Physician Decision|4|||
49111948|NCT02427802|158244580|FG001|Overall Study|Physician Decision|2|||
49111949|NCT02427802|158244581|FG002|Overall Study|Physician Decision|4|||
49111950|NCT02427802|158244579|FG000|Overall Study|Withdrawal by Subject|10|||
49111951|NCT02427802|158244580|FG001|Overall Study|Withdrawal by Subject|5|||
49111952|NCT02427802|158244581|FG002|Overall Study|Withdrawal by Subject|11|||
49111953|NCT02427802|158244579|FG000|Overall Study|Protocol Violation|3|||
49111954|NCT02427802|158244580|FG001|Overall Study|Protocol Violation|1|||
49111955|NCT02427802|158244581|FG002|Overall Study|Protocol Violation|1|||
49111956|NCT02427802|158244579|FG000|Overall Study|protocol specific treatment unrelated|18|||
49111957|NCT02427802|158244580|FG001|Overall Study|protocol specific treatment unrelated|11|||
49111958|NCT02427802|158244581|FG002|Overall Study|protocol specific treatment unrelated|11|||
49111959|NCT01085084|158244582|FG000|Overall Study|Withdrawal by Subject|1|||
49111960|NCT01085084|158244583|FG001|Overall Study|Withdrawal by Subject|0|||
49111961|NCT01085084|158244584|FG002|Overall Study|Withdrawal by Subject|0|||
49111962|NCT01085084|158244582|FG000|Overall Study|Lost to Follow-up|2|||
49111963|NCT01085084|158244583|FG001|Overall Study|Lost to Follow-up|1|||
49111964|NCT01085084|158244584|FG002|Overall Study|Lost to Follow-up|1|||
49111965|NCT01085084|158244582|FG000|Overall Study|Adverse Event|4|||
49111966|NCT01085084|158244583|FG001|Overall Study|Adverse Event|3|||
49111967|NCT01085084|158244584|FG002|Overall Study|Adverse Event|6|||
49111968|NCT01085084|158244582|FG000|Overall Study|Treatment Failure|0|||
49111969|NCT01085084|158244583|FG001|Overall Study|Treatment Failure|1|||
49111970|NCT01085084|158244584|FG002|Overall Study|Treatment Failure|2|||
49111971|NCT02749799|158244585|FG000|Overall Study|Adverse Event|2|||
49111972|NCT02749799|158244585|FG000|Overall Study|Lost to Follow-up|4|||
49112007|NCT02070978|158244589|FG001|Overall Study|Terminated by Sponsor|40|||
49112008|NCT02070978|158244590|FG002|Overall Study|Terminated by Sponsor|39|||
49112009|NCT00590538|158245692|FG000|Overall Study|Study terminated before completed|2|||
49112010|NCT02700698|158245719|FG000|Overall Study|Withdrawal by Subject|1|||
49112011|NCT02700698|158245720|FG001|Overall Study|Withdrawal by Subject|0|||
49112012|NCT00316914|158245721|FG000|Overall Study|Withdrawal by Subject|5|||
49112013|NCT00316914|158245722|FG001|Overall Study|Withdrawal by Subject|3|||
49112014|NCT00316914|158245721|FG000|Overall Study|Adverse Event|8|||
49112015|NCT00316914|158245722|FG001|Overall Study|Adverse Event|7|||
49112016|NCT00316914|158245721|FG000|Overall Study|Other Problems|6|||
49112017|NCT00316914|158245722|FG001|Overall Study|Other Problems|11|||
49112018|NCT00316914|158245721|FG000|Overall Study|Missing end of treatment documentation|14|||
49112019|NCT00316914|158245722|FG001|Overall Study|Missing end of treatment documentation|15|||
49112020|NCT02309723|158245725|FG000|Overall Study|Withdrawal by Subject|24|||
49112021|NCT02309723|158245726|FG001|Overall Study|Withdrawal by Subject|23|||
49112022|NCT02309723|158245727|FG002|Overall Study|Withdrawal by Subject|24|||
49112023|NCT03810235|158245728|FG000|Overall Study|Withdrawal by Subject|2|||
49112024|NCT03810235|158245729|FG001|Overall Study|Withdrawal by Subject|0|||
49112025|NCT02560623|158245730|FG000|Overall Study|Unable to swallow sponge|0|||
49112026|NCT02560623|158245731|FG001|Overall Study|Unable to swallow sponge|1|||
49112027|NCT02560623|158245732|FG002|Overall Study|Unable to swallow sponge|0|||
49112028|NCT02560623|158245733|FG003|Overall Study|Unable to swallow sponge|0|||
49112029|NCT02560623|158245730|FG000|Overall Study|Intervention prior to sponge administration|0|||
49112030|NCT02560623|158245731|FG001|Overall Study|Intervention prior to sponge administration|1|||
49112031|NCT02560623|158245732|FG002|Overall Study|Intervention prior to sponge administration|0|||
49112032|NCT02560623|158245733|FG003|Overall Study|Intervention prior to sponge administration|0|||
49112033|NCT03313310|158245736|FG000|Phase 2|Lost to Follow-up|4|||
49112034|NCT03313310|158245737|FG001|Phase 2|Lost to Follow-up|0|||
49112035|NCT03313310|158245736|FG000|Phase 3|Lost to Follow-up|0|||
49112036|NCT03313310|158245737|FG001|Phase 3|Lost to Follow-up|1|||
49112037|NCT01903993|158245743|FG000|Overall Study|Death|118|||
49112038|NCT01903993|158245744|FG001|Overall Study|Death|121|||
49112039|NCT01903993|158245743|FG000|Overall Study|Withdrawal by Subject|15|||
49112040|NCT01903993|158245744|FG001|Overall Study|Withdrawal by Subject|4|||
49112041|NCT01903993|158245743|FG000|Overall Study|Lost to Follow-up|2|||
49112042|NCT01903993|158245744|FG001|Overall Study|Lost to Follow-up|3|||
49112043|NCT01903993|158245743|FG000|Overall Study|Study Terminated by Sponsor|8|||
49112044|NCT01903993|158245744|FG001|Overall Study|Study Terminated by Sponsor|14|||
49112045|NCT01903993|158245743|FG000|Overall Study|Terminated by Sponsor After 31 Aug 2018|0|||
49112046|NCT01903993|158245744|FG001|Overall Study|Terminated by Sponsor After 31 Aug 2018|2|||
49112047|NCT00184093|158245745|FG000|Overall Study|Adverse Event|3|||
49112048|NCT00184093|158245745|FG000|Overall Study|Lost to Follow-up|3|||
49112049|NCT00184093|158245745|FG000|Overall Study|Physician Decision|1|||
49112050|NCT00184093|158245745|FG000|Overall Study|Withdrawal by Subject|2|||
49112051|NCT05095311|158245746|FG000|Overall Study|Lost to Follow-up|7|||
49112052|NCT05095311|158245747|FG001|Overall Study|Lost to Follow-up|0|||
49112053|NCT05095311|158245748|FG002|Overall Study|Lost to Follow-up|0|||
49112054|NCT00002525|158245751|FG000|Overall Study|Adverse Event|36|||
49112055|NCT00002525|158245752|FG001|Overall Study|Adverse Event|0|||
49112056|NCT00002525|158245751|FG000|Overall Study|Death|5|||
49112057|NCT00002525|158245752|FG001|Overall Study|Death|0|||
49112058|NCT00002525|158245751|FG000|Overall Study|Withdrawal by Subject|11|||
49112059|NCT00002525|158245752|FG001|Overall Study|Withdrawal by Subject|0|||
49112060|NCT00002525|158245751|FG000|Overall Study|Start non-protocol therapy|1|||
49112061|NCT00002525|158245752|FG001|Overall Study|Start non-protocol therapy|0|||
49112062|NCT00002525|158245751|FG000|Overall Study|Other complicating disease|1|||
49112063|NCT00002525|158245752|FG001|Overall Study|Other complicating disease|0|||
49112064|NCT00002525|158245751|FG000|Overall Study|Duke's A, B1, D disease|92|||
49112065|NCT00002525|158245752|FG001|Overall Study|Duke's A, B1, D disease|0|||
49112066|NCT00002525|158245751|FG000|Overall Study|Error|6|||
49112067|NCT00002525|158245752|FG001|Overall Study|Error|0|||
49112068|NCT00002525|158245751|FG000|Overall Study|Other|26|||
49112069|NCT00002525|158245752|FG001|Overall Study|Other|0|||
49112070|NCT00002525|158245751|FG000|Overall Study|Never start protocol therapy|8|||
49112071|NCT00002525|158245752|FG001|Overall Study|Never start protocol therapy|0|||
49112072|NCT03304184|158245753|FG000|Overall Study|Withdrawal by Subject|1|||
49112073|NCT03304184|158245754|FG001|Overall Study|Withdrawal by Subject|2|||
49112074|NCT00821015|158245757|FG000|Overall Study|Lost to Follow-up|12|||
49112075|NCT00435188|158245760|FG000|Overall Study|Death|1|||
49112076|NCT00435188|158245761|FG001|Overall Study|Death|6|||
49112077|NCT00435188|158245760|FG000|Overall Study|Withdrawal by Subject|16|||
49112078|NCT00435188|158245761|FG001|Overall Study|Withdrawal by Subject|11|||
49112079|NCT00435188|158245760|FG000|Overall Study|Lost to Follow-up|5|||
49112080|NCT00435188|158245761|FG001|Overall Study|Lost to Follow-up|6|||
49112081|NCT00575510|158245766|FG000|Overall Study|Lost to Follow-up|4|||
49112082|NCT00575510|158245767|FG001|Overall Study|Lost to Follow-up|6|||
49112083|NCT00575510|158245768|FG002|Overall Study|Lost to Follow-up|9|||
49112084|NCT00575510|158245766|FG000|Overall Study|Withdrawal by Subject|1|||
49112085|NCT00575510|158245767|FG001|Overall Study|Withdrawal by Subject|0|||
49112086|NCT00575510|158245768|FG002|Overall Study|Withdrawal by Subject|0|||
49112087|NCT00575510|158245766|FG000|Overall Study|Clinic Called Patient|7|||
49112088|NCT00575510|158245767|FG001|Overall Study|Clinic Called Patient|7|||
49112089|NCT00575510|158245768|FG002|Overall Study|Clinic Called Patient|7|||
49112090|NCT00575510|158245766|FG000|Overall Study|Pregnancy|0|||
49112091|NCT00575510|158245767|FG001|Overall Study|Pregnancy|0|||
49112092|NCT00575510|158245768|FG002|Overall Study|Pregnancy|1|||
49112093|NCT01146561|158245769|FG000|Overall Study|Withdrawal by Subject|1|||
49112094|NCT01146561|158245769|FG000|Overall Study|Lost to Follow-up|1|||
49112095|NCT01857102|158245770|FG000|Period 1|No longer meets Eligibility Criteria|0|||
49112096|NCT01857102|158245771|FG001|Period 1|No longer meets Eligibility Criteria|2|||
49112097|NCT01857102|158245770|FG000|Period 1|Lost to Follow-up|0|||
49112098|NCT01857102|158245771|FG001|Period 1|Lost to Follow-up|3|||
49112099|NCT01857102|158245770|FG000|Period 1|Unsatisfactory Lens Fit|1|||
49112100|NCT01857102|158245771|FG001|Period 1|Unsatisfactory Lens Fit|0|||
49112101|NCT01857102|158245770|FG000|Period 1|Unsatisfactory Visual Response|1|||
49112102|NCT01857102|158245771|FG001|Period 1|Unsatisfactory Visual Response|0|||
49112103|NCT01857102|158245770|FG000|Period 1|Physician Decision|1|||
49112104|NCT01857102|158245771|FG001|Period 1|Physician Decision|0|||
49112105|NCT01857102|158245770|FG000|Period 2|Lens Discomfort|1|||
49112106|NCT01857102|158245771|FG001|Period 2|Lens Discomfort|0|||
49112107|NCT01857102|158245770|FG000|Period 2|Unsatisfactory Lens Fit|1|||
49112108|NCT01857102|158245771|FG001|Period 2|Unsatisfactory Lens Fit|0|||
49112109|NCT00926536|158245774|FG000|Overall Study|Physician Decision|1|||
49112110|NCT00926536|158245775|FG001|Overall Study|Physician Decision|2|||
49112111|NCT01863732|158245777|FG000|Overall Study|Adverse Event|2|||
49112112|NCT01863732|158245778|FG001|Overall Study|Adverse Event|0|||
49112113|NCT01863732|158245779|FG002|Overall Study|Adverse Event|3|||
49112114|NCT01863732|158245780|FG003|Overall Study|Adverse Event|3|||
49112115|NCT01863732|158245777|FG000|Overall Study|Lack of Efficacy|1|||
49112116|NCT01863732|158245778|FG001|Overall Study|Lack of Efficacy|0|||
49112117|NCT01863732|158245779|FG002|Overall Study|Lack of Efficacy|2|||
49112118|NCT01863732|158245780|FG003|Overall Study|Lack of Efficacy|1|||
49112119|NCT01863732|158245777|FG000|Overall Study|Lost to Follow-up|2|||
49112120|NCT01863732|158245778|FG001|Overall Study|Lost to Follow-up|2|||
49112121|NCT01863732|158245779|FG002|Overall Study|Lost to Follow-up|1|||
49112122|NCT01863732|158245780|FG003|Overall Study|Lost to Follow-up|1|||
49112123|NCT01863732|158245777|FG000|Overall Study|Physician Decision|1|||
49112124|NCT01863732|158245778|FG001|Overall Study|Physician Decision|0|||
49112125|NCT01863732|158245779|FG002|Overall Study|Physician Decision|1|||
49112126|NCT01863732|158245780|FG003|Overall Study|Physician Decision|0|||
49112127|NCT01863732|158245777|FG000|Overall Study|Pregnancy|0|||
49112128|NCT01863732|158245778|FG001|Overall Study|Pregnancy|0|||
49112129|NCT01863732|158245779|FG002|Overall Study|Pregnancy|0|||
49112130|NCT01863732|158245780|FG003|Overall Study|Pregnancy|1|||
49112131|NCT01863732|158245777|FG000|Overall Study|Technical problems|0|||
49112132|NCT01863732|158245778|FG001|Overall Study|Technical problems|1|||
49112133|NCT01863732|158245779|FG002|Overall Study|Technical problems|1|||
49112134|NCT01863732|158245780|FG003|Overall Study|Technical problems|0|||
49112135|NCT01863732|158245777|FG000|Overall Study|Subject/guardian decision|6|||
49112136|NCT01863732|158245778|FG001|Overall Study|Subject/guardian decision|9|||
49112137|NCT01863732|158245779|FG002|Overall Study|Subject/guardian decision|3|||
49112138|NCT01863732|158245780|FG003|Overall Study|Subject/guardian decision|1|||
49112139|NCT01863732|158245777|FG000|Overall Study|Death|1|||
49112140|NCT01863732|158245778|FG001|Overall Study|Death|0|||
49112141|NCT01863732|158245779|FG002|Overall Study|Death|0|||
49112142|NCT01863732|158245780|FG003|Overall Study|Death|1|||
49112143|NCT02155322|158245781|FG000|Overall Study|Adverse Event|1|||
49112144|NCT02155322|158245781|FG000|Overall Study|Physician Decision|1|||
49112145|NCT02155322|158245781|FG000|Overall Study|Relapse/Recurrence|8|||
49112146|NCT02155322|158245781|FG000|Overall Study|Withdrawal by Subject|4|||
49112147|NCT01578499|158245782|FG000|Overall Study|Reason not Specified|0|||
49112148|NCT01578499|158245783|FG001|Overall Study|Reason not Specified|1|||
49112149|NCT01578499|158245782|FG000|Overall Study|Lost to Follow-up|2|||
49112150|NCT01578499|158245783|FG001|Overall Study|Lost to Follow-up|1|||
49112151|NCT01578499|158245782|FG000|Overall Study|Withdrawal by Subject|10|||
49112152|NCT01578499|158245783|FG001|Overall Study|Withdrawal by Subject|16|||
49112153|NCT01578499|158245782|FG000|Overall Study|Death|20|||
49112154|NCT01578499|158245783|FG001|Overall Study|Death|25|||
49112155|NCT01578499|158245782|FG000|Overall Study|Died and End of Study Page not Completed|2|||
49112156|NCT01578499|158245783|FG001|Overall Study|Died and End of Study Page not Completed|0|||
49112157|NCT00636961|158245784|FG000|Period 1|Administrative problems|1|||
49112158|NCT00636961|158245785|FG001|Period 1|Administrative problems|1|||
49112159|NCT00636961|158245784|FG000|Period 2|Adverse Event|1|||
49112160|NCT00636961|158245785|FG001|Period 2|Adverse Event|0|||
49112161|NCT00978341|158245786|FG000|Washout Period of 2 Weeks|Adverse Event|1|||
49112162|NCT00978341|158245787|FG001|Washout Period of 2 Weeks|Adverse Event|0|||
49112163|NCT03877224|158245788|FG000|Overall Study|Death|3|||
49112205|NCT04445831|158245805|FG003|Overall Study|Subject withdrawal by caregiver|0|||
49112206|NCT04445831|158245806|FG004|Overall Study|Subject withdrawal by caregiver|0|||
49112207|NCT04445831|158245807|FG005|Overall Study|Subject withdrawal by caregiver|0|||
49112208|NCT04445831|158245808|FG006|Overall Study|Subject withdrawal by caregiver|0|||
49112209|NCT05704725|158245809|FG000|Overall Study|Lost to Follow-up|0|||
49112210|NCT05704725|158245810|FG001|Overall Study|Lost to Follow-up|1|||
49112211|NCT05704725|158245809|FG000|Overall Study|Withdrawal by Subject|1|||
49112212|NCT05704725|158245810|FG001|Overall Study|Withdrawal by Subject|0|||
49112213|NCT02039401|158245811|FG000|Overall Study|Adverse Event|0|||
49112214|NCT02039401|158245812|FG001|Overall Study|Adverse Event|1|||
49112215|NCT04937504|158245813|FG000|15 Weeks Assessment|Lost to Follow-up|5|||
49112216|NCT04937504|158245814|FG001|15 Weeks Assessment|Lost to Follow-up|9|||
49112217|NCT04937504|158245813|FG000|9 Months Assessment|Lost to Follow-up|3|||
49112218|NCT04937504|158245814|FG001|9 Months Assessment|Lost to Follow-up|2|||
49112219|NCT05470114|158245815|FG000|Overall Study|Withdrawal by Subject|1|||
49112220|NCT05470114|158245816|FG001|Overall Study|Withdrawal by Subject|0|||
49112221|NCT05470114|158245815|FG000|Overall Study|Lost to Follow-up|1|||
49112222|NCT05470114|158245816|FG001|Overall Study|Lost to Follow-up|0|||
49112223|NCT00703118|158247370|FG000|Overall Study|Adverse Event|1|||
49112224|NCT00703118|158247371|FG001|Overall Study|Adverse Event|2|||
49112225|NCT00703118|158247372|FG002|Overall Study|Adverse Event|2|||
49112226|NCT00703118|158247370|FG000|Overall Study|Subject Ineligible To Continue The Trial|6|||
49112227|NCT00703118|158247371|FG001|Overall Study|Subject Ineligible To Continue The Trial|3|||
49112228|NCT00703118|158247372|FG002|Overall Study|Subject Ineligible To Continue The Trial|2|||
49112229|NCT00703118|158247370|FG000|Overall Study|Lost to Follow-up|6|||
49112230|NCT00703118|158247371|FG001|Overall Study|Lost to Follow-up|4|||
49112231|NCT00703118|158247372|FG002|Overall Study|Lost to Follow-up|4|||
49112232|NCT00703118|158247370|FG000|Overall Study|Withdrawal by Subject|8|||
49112233|NCT00703118|158247371|FG001|Overall Study|Withdrawal by Subject|7|||
49112234|NCT00703118|158247372|FG002|Overall Study|Withdrawal by Subject|13|||
49112235|NCT00703118|158247370|FG000|Overall Study|Other|0|||
49112236|NCT00703118|158247371|FG001|Overall Study|Other|0|||
49112237|NCT00703118|158247372|FG002|Overall Study|Other|1|||
49112238|NCT02697734|158247381|FG000|Core Phase - up to Week 48|Withdrawal by Subject|4|||
49112239|NCT02697734|158247382|FG001|Core Phase - up to Week 48|Withdrawal by Subject|0|||
49112240|NCT02697734|158247381|FG000|Core Phase - up to Week 48|Adverse Event|1|||
49112241|NCT02697734|158247382|FG001|Core Phase - up to Week 48|Adverse Event|2|||
49112242|NCT02697734|158247381|FG000|Core Phase - up to Week 48|Physician Decision|1|||
49112243|NCT02697734|158247382|FG001|Core Phase - up to Week 48|Physician Decision|0|||
49112244|NCT02697734|158247381|FG000|Optional Extension Phase|Adverse Event|5|||
49112245|NCT02697734|158247382|FG001|Optional Extension Phase|Adverse Event|1|||
49112246|NCT02697734|158247381|FG000|Optional Extension Phase|Physician Decision|0|||
49112247|NCT02697734|158247382|FG001|Optional Extension Phase|Physician Decision|1|||
49112248|NCT02588664|158247385|FG000|Overall Study|Death|56|||
49112249|NCT02588664|158247386|FG001|Overall Study|Death|55|||
49112250|NCT02588664|158247385|FG000|Overall Study|Lost to Follow-up|1305|||
49112251|NCT02588664|158247386|FG001|Overall Study|Lost to Follow-up|990|||
49112252|NCT03681184|158247391|FG000|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0|||
49112253|NCT03681184|158247392|FG001|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1|||
49112254|NCT03411902|158247393|FG000|Overall Study|Lost to Follow-up|3|||
49112255|NCT03411902|158247394|FG001|Overall Study|Lost to Follow-up|0|||
49112256|NCT02334384|158247395|FG000|Overall Study|Lost to Follow-up|1|||
49112257|NCT02334384|158247396|FG001|Overall Study|Lost to Follow-up|1|||
49112258|NCT02651688|158247397|FG000|Overall Study|Non-compliance|0|||
49112259|NCT02651688|158247398|FG001|Overall Study|Non-compliance|0|||
49112260|NCT02651688|158247399|FG002|Overall Study|Non-compliance|1|||
49112261|NCT02651688|158247397|FG000|Overall Study|Principal Investigator (PI) decision|0|||
49112262|NCT02651688|158247398|FG001|Overall Study|Principal Investigator (PI) decision|2|||
49112263|NCT02651688|158247399|FG002|Overall Study|Principal Investigator (PI) decision|0|||
49112264|NCT02651688|158247397|FG000|Overall Study|Lost to Follow-up|1|||
49112265|NCT02651688|158247398|FG001|Overall Study|Lost to Follow-up|3|||
49112266|NCT02651688|158247399|FG002|Overall Study|Lost to Follow-up|0|||
49112267|NCT02651688|158247397|FG000|Overall Study|Withdrawal by Subject|1|||
49112268|NCT02651688|158247398|FG001|Overall Study|Withdrawal by Subject|0|||
49112269|NCT02651688|158247399|FG002|Overall Study|Withdrawal by Subject|2|||
49112270|NCT04527978|158247402|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
49112271|NCT04527978|158247403|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
49112272|NCT00396383|158247404|FG000|Overall Study|Death|2|||
49112273|NCT00396383|158247404|FG000|Overall Study|Lost to Follow-up|1|||
49112274|NCT00055497|158247405|FG000|Overall Study|Adverse Event|1|||
49112275|NCT00055497|158247406|FG001|Overall Study|Adverse Event|1|||
49112276|NCT00055497|158247407|FG002|Overall Study|Adverse Event|1|||
49112277|NCT00055497|158247408|FG003|Overall Study|Adverse Event|28|||
49112278|NCT00055497|158247405|FG000|Overall Study|Withdrawal by Subject|3|||
49112279|NCT00055497|158247406|FG001|Overall Study|Withdrawal by Subject|1|||
49112280|NCT00055497|158247407|FG002|Overall Study|Withdrawal by Subject|1|||
49112281|NCT00055497|158247408|FG003|Overall Study|Withdrawal by Subject|15|||
49112282|NCT00055497|158247405|FG000|Overall Study|Lost to Follow-up|0|||
49112283|NCT00055497|158247406|FG001|Overall Study|Lost to Follow-up|1|||
49112284|NCT00055497|158247407|FG002|Overall Study|Lost to Follow-up|0|||
49112285|NCT00055497|158247408|FG003|Overall Study|Lost to Follow-up|5|||
49112286|NCT00055497|158247405|FG000|Overall Study|Protocol Violation|0|||
49112287|NCT00055497|158247406|FG001|Overall Study|Protocol Violation|0|||
49112288|NCT00055497|158247407|FG002|Overall Study|Protocol Violation|0|||
49112289|NCT00055497|158247408|FG003|Overall Study|Protocol Violation|3|||
49112290|NCT00055497|158247405|FG000|Overall Study|Lack of Efficacy|1|||
49112291|NCT00055497|158247406|FG001|Overall Study|Lack of Efficacy|0|||
49112292|NCT00055497|158247407|FG002|Overall Study|Lack of Efficacy|0|||
49112293|NCT00055497|158247408|FG003|Overall Study|Lack of Efficacy|27|||
49112294|NCT00055497|158247405|FG000|Overall Study|Administrative Reasons|0|||
49112295|NCT00055497|158247406|FG001|Overall Study|Administrative Reasons|0|||
49112296|NCT00055497|158247407|FG002|Overall Study|Administrative Reasons|0|||
49112297|NCT00055497|158247408|FG003|Overall Study|Administrative Reasons|1|||
49112298|NCT00055497|158247405|FG000|Overall Study|Other|0|||
49112299|NCT00055497|158247406|FG001|Overall Study|Other|0|||
49112300|NCT00055497|158247407|FG002|Overall Study|Other|0|||
49112301|NCT00055497|158247408|FG003|Overall Study|Other|11|||
49112302|NCT03268005|158247411|FG000|Overall Study|Death|2|||
49112303|NCT03268005|158247412|FG001|Overall Study|Death|1|||
49112304|NCT03268005|158247411|FG000|Overall Study|Lost to Follow-up|2|||
49112305|NCT03268005|158247412|FG001|Overall Study|Lost to Follow-up|2|||
49112306|NCT03268005|158247411|FG000|Overall Study|Withdrawal by Subject|11|||
49112307|NCT03268005|158247412|FG001|Overall Study|Withdrawal by Subject|11|||
49112308|NCT05752487|158247416|FG000|Overall Study|Randomized, not treated|9|||
49112309|NCT05752487|158247416|FG000|Overall Study|Study catheter inserted but did not undergo ablation|1|||
49112310|NCT05752487|158247416|FG000|Overall Study|Withdrawal by Subject|2|||
49112311|NCT05752487|158247416|FG000|Overall Study|Ongoing|137|||
49112312|NCT03092791|158247417|FG000|Overall Study|Lost to Follow-up|0|||
49112313|NCT03092791|158247418|FG001|Overall Study|Lost to Follow-up|0|||
49112314|NCT03092791|158247419|FG002|Overall Study|Lost to Follow-up|0|||
49112315|NCT03092791|158247420|FG003|Overall Study|Lost to Follow-up|0|||
49112316|NCT03092791|158247421|FG004|Overall Study|Lost to Follow-up|0|||
49112317|NCT03092791|158247422|FG005|Overall Study|Lost to Follow-up|0|||
49112318|NCT03092791|158247423|FG006|Overall Study|Lost to Follow-up|1|||
49112319|NCT03092791|158247424|FG007|Overall Study|Lost to Follow-up|0|||
49112320|NCT03092791|158247417|FG000|Overall Study|Withdrawal of Consent|0|||
49112321|NCT03092791|158247418|FG001|Overall Study|Withdrawal of Consent|0|||
49112322|NCT03092791|158247419|FG002|Overall Study|Withdrawal of Consent|0|||
49112323|NCT03092791|158247420|FG003|Overall Study|Withdrawal of Consent|0|||
49112324|NCT03092791|158247421|FG004|Overall Study|Withdrawal of Consent|4|||
49112325|NCT03092791|158247422|FG005|Overall Study|Withdrawal of Consent|12|||
49112326|NCT03092791|158247423|FG006|Overall Study|Withdrawal of Consent|6|||
49112327|NCT03092791|158247424|FG007|Overall Study|Withdrawal of Consent|4|||
49112328|NCT03092791|158247417|FG000|Overall Study|Study Termination|0|||
49112329|NCT03092791|158247418|FG001|Overall Study|Study Termination|0|||
49112330|NCT03092791|158247419|FG002|Overall Study|Study Termination|0|||
49112331|NCT03092791|158247420|FG003|Overall Study|Study Termination|0|||
49112332|NCT03092791|158247421|FG004|Overall Study|Study Termination|55|||
49112333|NCT03092791|158247422|FG005|Overall Study|Study Termination|46|||
49112334|NCT03092791|158247423|FG006|Overall Study|Study Termination|53|||
49112335|NCT03092791|158247424|FG007|Overall Study|Study Termination|55|||
49112336|NCT03092791|158247417|FG000|Overall Study|Death|0|||
49112337|NCT03092791|158247418|FG001|Overall Study|Death|0|||
49112338|NCT03092791|158247419|FG002|Overall Study|Death|0|||
49112339|NCT03092791|158247420|FG003|Overall Study|Death|0|||
49112340|NCT03092791|158247421|FG004|Overall Study|Death|0|||
49112341|NCT03092791|158247422|FG005|Overall Study|Death|1|||
49112342|NCT03092791|158247423|FG006|Overall Study|Death|0|||
49112343|NCT03092791|158247424|FG007|Overall Study|Death|1|||
49112344|NCT03092791|158247417|FG000|Overall Study|Reason Not Specified|0|||
49112345|NCT03092791|158247418|FG001|Overall Study|Reason Not Specified|0|||
49112346|NCT03092791|158247419|FG002|Overall Study|Reason Not Specified|0|||
49112347|NCT03092791|158247420|FG003|Overall Study|Reason Not Specified|0|||
49112348|NCT03092791|158247421|FG004|Overall Study|Reason Not Specified|1|||
49112349|NCT03092791|158247422|FG005|Overall Study|Reason Not Specified|1|||
49112350|NCT03092791|158247423|FG006|Overall Study|Reason Not Specified|0|||
49112351|NCT03092791|158247424|FG007|Overall Study|Reason Not Specified|0|||
49112352|NCT04424914|158247431|FG000|Overall Study|Other|0|||
49112353|NCT04424914|158247432|FG001|Overall Study|Other|0|||
49112354|NCT04424914|158247433|FG002|Overall Study|Other|28|||
49112355|NCT04424914|158247431|FG000|Overall Study|Withdrawal by Subject|3|||
49112356|NCT04424914|158247432|FG001|Overall Study|Withdrawal by Subject|0|||
49112357|NCT04424914|158247433|FG002|Overall Study|Withdrawal by Subject|0|||
49112358|NCT04424914|158247431|FG000|Overall Study|Study terminated by sponsor|23|||
49112359|NCT04424914|158247432|FG001|Overall Study|Study terminated by sponsor|7|||
49112360|NCT04424914|158247433|FG002|Overall Study|Study terminated by sponsor|0|||
49112389|NCT02634983|158247449|FG001|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0|||
49112390|NCT03178851|158247450|FG000|Overall Study|Death|48|||
49112391|NCT03178851|158247451|FG001|Overall Study|Death|2|||
49112392|NCT03178851|158247452|FG002|Overall Study|Death|25|||
49112393|NCT03178851|158247450|FG000|Overall Study|Withdrawal by Subject|8|||
49112394|NCT03178851|158247451|FG001|Overall Study|Withdrawal by Subject|0|||
49112395|NCT03178851|158247452|FG002|Overall Study|Withdrawal by Subject|0|||
49112396|NCT03178851|158247450|FG000|Overall Study|Lost to Follow-up|5|||
49112397|NCT03178851|158247451|FG001|Overall Study|Lost to Follow-up|2|||
49112398|NCT03178851|158247452|FG002|Overall Study|Lost to Follow-up|0|||
49112399|NCT03178851|158247450|FG000|Overall Study|Adverse Event|0|||
49112400|NCT03178851|158247451|FG001|Overall Study|Adverse Event|0|||
49112401|NCT03178851|158247452|FG002|Overall Study|Adverse Event|1|||
49112402|NCT03178851|158247450|FG000|Overall Study|Study Termination by Sponsor|31|||
49112403|NCT03178851|158247451|FG001|Overall Study|Study Termination by Sponsor|7|||
49112404|NCT03178851|158247452|FG002|Overall Study|Study Termination by Sponsor|26|||
49112405|NCT03951753|158247453|FG000|Overall Study|Adverse Event|1|||
49112406|NCT03951753|158247454|FG001|Overall Study|Adverse Event|0|||
49112407|NCT03951753|158247455|FG002|Overall Study|Adverse Event|3|||
49112408|NCT03951753|158247453|FG000|Overall Study|Withdrawal by Subject|3|||
49112409|NCT03951753|158247454|FG001|Overall Study|Withdrawal by Subject|1|||
49112410|NCT03951753|158247455|FG002|Overall Study|Withdrawal by Subject|0|||
49112411|NCT03951753|158247453|FG000|Overall Study|Lost to Follow-up|0|||
49112412|NCT03951753|158247454|FG001|Overall Study|Lost to Follow-up|0|||
49112413|NCT03951753|158247455|FG002|Overall Study|Lost to Follow-up|1|||
49112414|NCT02226120|158247458|FG000|Overall Study|Adverse Event|60|||
49112415|NCT02226120|158247458|FG000|Overall Study|Death|172|||
49112416|NCT02226120|158247458|FG000|Overall Study|Study terminated by sponsor|1|||
49112417|NCT02226120|158247458|FG000|Overall Study|Technical problems|4|||
49112418|NCT02226120|158247458|FG000|Overall Study|Lost to Follow-up|13|||
49112419|NCT02226120|158247458|FG000|Overall Study|Physician Decision|21|||
49112420|NCT02226120|158247458|FG000|Overall Study|Withdrawal by parent/guardian|36|||
49112421|NCT02226120|158247458|FG000|Overall Study|Non-compliance with study drug|10|||
49112422|NCT02226120|158247458|FG000|Overall Study|Protocol deviation|1|||
49112423|NCT02226120|158247458|FG000|Overall Study|missing treatment disposition pages|2|||
49112424|NCT00840034|158247461|FG000|Acute Treatment Phase|Adverse Event|6|||
49112425|NCT00840034|158247462|FG001|Acute Treatment Phase|Adverse Event|8|||
49112426|NCT00840034|158247461|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
49112427|NCT00840034|158247462|FG001|Acute Treatment Phase|Lack of Efficacy|0|||
49112428|NCT00840034|158247461|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
49112429|NCT00840034|158247462|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
49112430|NCT00840034|158247461|FG000|Acute Treatment Phase|Physician Decision|0|||
49112431|NCT00840034|158247462|FG001|Acute Treatment Phase|Physician Decision|1|||
49112432|NCT00840034|158247461|FG000|Acute Treatment Phase|Protocol Violation|2|||
49112433|NCT00840034|158247462|FG001|Acute Treatment Phase|Protocol Violation|4|||
49112434|NCT00840034|158247461|FG000|Acute Treatment Phase|Withdrawal by Subject|6|||
49112435|NCT00840034|158247462|FG001|Acute Treatment Phase|Withdrawal by Subject|11|||
49112436|NCT00840034|158247461|FG000|Taper Phase|Adverse Event|1|||
49112437|NCT00840034|158247462|FG001|Taper Phase|Adverse Event|0|||
49112438|NCT00840034|158247461|FG000|Taper Phase|Lost to Follow-up|1|||
49112439|NCT00840034|158247462|FG001|Taper Phase|Lost to Follow-up|1|||
49112440|NCT00840034|158247461|FG000|Taper Phase|Withdrawal by Subject|1|||
49112441|NCT00840034|158247462|FG001|Taper Phase|Withdrawal by Subject|1|||
49112442|NCT01215435|158247463|FG000|Overall Study|Adverse Event|1|||
49112443|NCT01215435|158247464|FG001|Overall Study|Adverse Event|0|||
49112444|NCT01215435|158247463|FG000|Overall Study|Protocol Violation|2|||
49112445|NCT01215435|158247464|FG001|Overall Study|Protocol Violation|0|||
49112446|NCT01215435|158247463|FG000|Overall Study|Withdrawal Criteria|8|||
49112447|NCT01215435|158247464|FG001|Overall Study|Withdrawal Criteria|11|||
49112448|NCT01215435|158247463|FG000|Overall Study|Lost to Follow-up|3|||
49112449|NCT01215435|158247464|FG001|Overall Study|Lost to Follow-up|0|||
49112450|NCT01215435|158247463|FG000|Overall Study|Unclassified|5|||
49112451|NCT01215435|158247464|FG001|Overall Study|Unclassified|5|||
49112452|NCT02208050|158247465|FG000|Washout Period 1: 2 Weeks|Withdrawal by Subject|1|||
49112453|NCT02208050|158247466|FG001|Washout Period 1: 2 Weeks|Withdrawal by Subject|0|||
49112454|NCT02557516|158247467|FG000|Overall Study|Adverse Event|1|||
49112455|NCT02557516|158247468|FG001|Overall Study|Adverse Event|0|||
49112456|NCT02557516|158247469|FG002|Overall Study|Adverse Event|2|||
49112457|NCT02557516|158247470|FG003|Overall Study|Adverse Event|1|||
49112458|NCT02557516|158247467|FG000|Overall Study|Disease progression|0|||
49112459|NCT02557516|158247468|FG001|Overall Study|Disease progression|2|||
49112460|NCT02557516|158247469|FG002|Overall Study|Disease progression|0|||
49112461|NCT02557516|158247470|FG003|Overall Study|Disease progression|0|||
49112462|NCT02557516|158247467|FG000|Overall Study|Physician Decision|0|||
49112463|NCT02557516|158247468|FG001|Overall Study|Physician Decision|2|||
49112464|NCT02557516|158247469|FG002|Overall Study|Physician Decision|0|||
49112465|NCT02557516|158247470|FG003|Overall Study|Physician Decision|0|||
49112466|NCT02557516|158247467|FG000|Overall Study|Sponsor decision|0|||
49112478|NCT04399538|158247475|FG003|Double-Blind Treatment|Adverse Event|0|||
49112479|NCT04399538|158247476|FG004|Double-Blind Treatment|Adverse Event|1|||
49112480|NCT04399538|158247472|FG000|Follow-Up|Adverse Event|0|||
49112481|NCT04399538|158247473|FG001|Follow-Up|Adverse Event|0|||
49112482|NCT04399538|158247474|FG002|Follow-Up|Adverse Event|0|||
49112483|NCT04399538|158247475|FG003|Follow-Up|Adverse Event|0|||
49112484|NCT04399538|158247476|FG004|Follow-Up|Adverse Event|1|||
49112485|NCT04399538|158247472|FG000|Follow-Up|Withdrawal by Subject|0|||
49112486|NCT04399538|158247473|FG001|Follow-Up|Withdrawal by Subject|0|||
49112487|NCT04399538|158247474|FG002|Follow-Up|Withdrawal by Subject|0|||
49112488|NCT04399538|158247475|FG003|Follow-Up|Withdrawal by Subject|2|||
49112489|NCT04399538|158247476|FG004|Follow-Up|Withdrawal by Subject|0|||
49112490|NCT01483599|158247477|FG000|Controlled Period (CP) (up to Week 16)|Adverse Event|2|||
49112491|NCT01483599|158247478|FG001|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
49112492|NCT01483599|158247479|FG002|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
49112493|NCT01483599|158247480|FG003|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
49112494|NCT01483599|158247481|FG004|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
49112495|NCT01483599|158247482|FG005|Controlled Period (CP) (up to Week 16)|Adverse Event|4|||
49112496|NCT01483599|158247483|FG006|Controlled Period (CP) (up to Week 16)|Adverse Event|3|||
49112497|NCT01483599|158247484|FG007|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
49112498|NCT01483599|158247485|FG008|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
49112499|NCT01483599|158247486|FG009|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
49112500|NCT01483599|158247487|FG010|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
49112501|NCT01483599|158247488|FG011|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
49112502|NCT01483599|158247489|FG012|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
49112503|NCT01483599|158247490|FG013|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
49112504|NCT01483599|158247477|FG000|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
49112505|NCT01483599|158247478|FG001|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
49112506|NCT01483599|158247479|FG002|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
49112507|NCT01483599|158247480|FG003|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
49112508|NCT01483599|158247481|FG004|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
49112509|NCT01483599|158247482|FG005|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
49112510|NCT01483599|158247483|FG006|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
49112511|NCT01483599|158247484|FG007|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
49112512|NCT01483599|158247485|FG008|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
49112513|NCT01483599|158247486|FG009|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
49112514|NCT01483599|158247487|FG010|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
49112515|NCT01483599|158247488|FG011|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
49112516|NCT01483599|158247489|FG012|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
49112517|NCT01483599|158247490|FG013|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
49112518|NCT01483599|158247477|FG000|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1|||
49112519|NCT01483599|158247478|FG001|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
49112520|NCT01483599|158247479|FG002|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
49112521|NCT01483599|158247480|FG003|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
49112522|NCT01483599|158247481|FG004|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
49112523|NCT01483599|158247482|FG005|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
49112524|NCT01483599|158247483|FG006|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
49112525|NCT01483599|158247484|FG007|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
49112526|NCT01483599|158247485|FG008|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
49112527|NCT01483599|158247486|FG009|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
49112528|NCT01483599|158247487|FG010|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
49112529|NCT01483599|158247488|FG011|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
49112530|NCT01483599|158247489|FG012|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
49112531|NCT01483599|158247490|FG013|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
49112532|NCT01483599|158247477|FG000|Controlled Period (CP) (up to Week 16)|Other|0|||
49112533|NCT01483599|158247478|FG001|Controlled Period (CP) (up to Week 16)|Other|2|||
49112534|NCT01483599|158247479|FG002|Controlled Period (CP) (up to Week 16)|Other|0|||
49112535|NCT01483599|158247480|FG003|Controlled Period (CP) (up to Week 16)|Other|1|||
49112536|NCT01483599|158247481|FG004|Controlled Period (CP) (up to Week 16)|Other|1|||
49112537|NCT01483599|158247482|FG005|Controlled Period (CP) (up to Week 16)|Other|0|||
49112538|NCT01483599|158247483|FG006|Controlled Period (CP) (up to Week 16)|Other|0|||
49112539|NCT01483599|158247484|FG007|Controlled Period (CP) (up to Week 16)|Other|0|||
49112540|NCT01483599|158247485|FG008|Controlled Period (CP) (up to Week 16)|Other|0|||
49112541|NCT01483599|158247486|FG009|Controlled Period (CP) (up to Week 16)|Other|0|||
49112542|NCT01483599|158247487|FG010|Controlled Period (CP) (up to Week 16)|Other|0|||
49112543|NCT01483599|158247488|FG011|Controlled Period (CP) (up to Week 16)|Other|0|||
49112544|NCT01483599|158247489|FG012|Controlled Period (CP) (up to Week 16)|Other|0|||
49112545|NCT01483599|158247490|FG013|Controlled Period (CP) (up to Week 16)|Other|0|||
49112546|NCT01483599|158247477|FG000|After Controlled Period(Week 16-Week 40)|Death|0|||
49112547|NCT01483599|158247478|FG001|After Controlled Period(Week 16-Week 40)|Death|0|||
49112548|NCT01483599|158247479|FG002|After Controlled Period(Week 16-Week 40)|Death|0|||
49112549|NCT01483599|158247480|FG003|After Controlled Period(Week 16-Week 40)|Death|0|||
49112550|NCT01483599|158247481|FG004|After Controlled Period(Week 16-Week 40)|Death|0|||
49112551|NCT01483599|158247482|FG005|After Controlled Period(Week 16-Week 40)|Death|0|||
49112552|NCT01483599|158247483|FG006|After Controlled Period(Week 16-Week 40)|Death|0|||
49112553|NCT01483599|158247484|FG007|After Controlled Period(Week 16-Week 40)|Death|0|||
49112554|NCT01483599|158247485|FG008|After Controlled Period(Week 16-Week 40)|Death|1|||
49112555|NCT01483599|158247486|FG009|After Controlled Period(Week 16-Week 40)|Death|0|||
49112556|NCT01483599|158247487|FG010|After Controlled Period(Week 16-Week 40)|Death|0|||
49112557|NCT01483599|158247488|FG011|After Controlled Period(Week 16-Week 40)|Death|0|||
49112558|NCT01483599|158247489|FG012|After Controlled Period(Week 16-Week 40)|Death|0|||
49112559|NCT01483599|158247490|FG013|After Controlled Period(Week 16-Week 40)|Death|0|||
49112560|NCT01483599|158247477|FG000|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
49112561|NCT01483599|158247478|FG001|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
49112562|NCT01483599|158247479|FG002|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
49112563|NCT01483599|158247480|FG003|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
49112564|NCT01483599|158247481|FG004|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
49112565|NCT01483599|158247482|FG005|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
49112566|NCT01483599|158247483|FG006|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
49112567|NCT01483599|158247484|FG007|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
49112568|NCT01483599|158247485|FG008|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
49112569|NCT01483599|158247486|FG009|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
49112570|NCT01483599|158247487|FG010|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
49112571|NCT01483599|158247488|FG011|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
49112572|NCT01483599|158247489|FG012|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
49112573|NCT01483599|158247490|FG013|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
49112574|NCT01483599|158247477|FG000|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
49112575|NCT01483599|158247478|FG001|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
49112576|NCT01483599|158247479|FG002|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
49112577|NCT01483599|158247480|FG003|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
49112578|NCT01483599|158247481|FG004|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
49112579|NCT01483599|158247482|FG005|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
49112580|NCT01483599|158247483|FG006|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
49112581|NCT01483599|158247484|FG007|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
49112582|NCT01483599|158247485|FG008|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
49112583|NCT01483599|158247486|FG009|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
49112584|NCT01483599|158247487|FG010|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
49112585|NCT01483599|158247488|FG011|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
49112586|NCT01483599|158247489|FG012|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
49112587|NCT01483599|158247490|FG013|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
49112588|NCT01483599|158247477|FG000|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
49112589|NCT01483599|158247478|FG001|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
49112590|NCT01483599|158247479|FG002|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
49112591|NCT01483599|158247480|FG003|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
49112592|NCT01483599|158247481|FG004|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
49112593|NCT01483599|158247482|FG005|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
49112594|NCT01483599|158247483|FG006|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
49112595|NCT01483599|158247484|FG007|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
49112596|NCT01483599|158247485|FG008|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
49112597|NCT01483599|158247486|FG009|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
49112598|NCT01483599|158247487|FG010|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2|||
49112599|NCT01483599|158247488|FG011|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
49112600|NCT01483599|158247489|FG012|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
49112601|NCT01483599|158247490|FG013|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
49112602|NCT01483599|158247477|FG000|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
49112603|NCT01483599|158247478|FG001|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
49112604|NCT01483599|158247479|FG002|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
49112605|NCT01483599|158247480|FG003|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
49112606|NCT01483599|158247481|FG004|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
49112607|NCT01483599|158247482|FG005|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
49112608|NCT01483599|158247483|FG006|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
49112609|NCT01483599|158247484|FG007|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
49112610|NCT01483599|158247485|FG008|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5|||
49112687|NCT02276547|158247505|FG000|Overall Study|Death|2|||
49112611|NCT01483599|158247486|FG009|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
49112612|NCT01483599|158247487|FG010|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
49112613|NCT01483599|158247488|FG011|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
49112614|NCT01483599|158247489|FG012|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1|||
49112615|NCT01483599|158247490|FG013|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4|||
49112616|NCT01483599|158247477|FG000|After Controlled Period(Week 16-Week 40)|Other|0|||
49112617|NCT01483599|158247478|FG001|After Controlled Period(Week 16-Week 40)|Other|0|||
49112618|NCT01483599|158247479|FG002|After Controlled Period(Week 16-Week 40)|Other|0|||
49112619|NCT01483599|158247480|FG003|After Controlled Period(Week 16-Week 40)|Other|0|||
49112620|NCT01483599|158247481|FG004|After Controlled Period(Week 16-Week 40)|Other|0|||
49112621|NCT01483599|158247482|FG005|After Controlled Period(Week 16-Week 40)|Other|0|||
49112622|NCT01483599|158247483|FG006|After Controlled Period(Week 16-Week 40)|Other|0|||
49112623|NCT01483599|158247484|FG007|After Controlled Period(Week 16-Week 40)|Other|1|||
49112624|NCT01483599|158247485|FG008|After Controlled Period(Week 16-Week 40)|Other|0|||
49112625|NCT01483599|158247486|FG009|After Controlled Period(Week 16-Week 40)|Other|4|||
49112626|NCT01483599|158247487|FG010|After Controlled Period(Week 16-Week 40)|Other|0|||
49112627|NCT01483599|158247488|FG011|After Controlled Period(Week 16-Week 40)|Other|0|||
49112628|NCT01483599|158247489|FG012|After Controlled Period(Week 16-Week 40)|Other|1|||
49112629|NCT01483599|158247490|FG013|After Controlled Period(Week 16-Week 40)|Other|0|||
49112630|NCT00593606|158247492|FG000|Overall Study|Adverse Event|13|||
49112631|NCT00593606|158247492|FG000|Overall Study|Withdrawal by Subject|1|||
49112632|NCT00593606|158247492|FG000|Overall Study|Protocol Violation|3|||
49112633|NCT00593606|158247492|FG000|Overall Study|Lost to Follow-up|2|||
49112634|NCT00593606|158247492|FG000|Overall Study|Run-In Failure|5|||
49112635|NCT00593606|158247492|FG000|Overall Study|Screen Failure|3|||
49112636|NCT05645432|158247493|FG000|Overall Study|Withdrawal by Subject|1|||
49112637|NCT03277989|158247494|FG000|Overall Study|Lost to Follow-up|6|||
49112638|NCT03277989|158247494|FG000|Overall Study|Adverse Event|6|||
49112639|NCT03277989|158247494|FG000|Overall Study|Withdrawal by Subject|3|||
49112640|NCT03277989|158247494|FG000|Overall Study|Didn't Receive Study Device|7|||
49112641|NCT03277989|158247494|FG000|Overall Study|Site Closure|26|||
49112642|NCT03277989|158247494|FG000|Overall Study|Sponsor Closure|107|||
49112643|NCT04686266|158247495|FG000|Overall Study|Withdrawal by Subject|0|||
49112644|NCT04686266|158247496|FG001|Overall Study|Withdrawal by Subject|1|||
49112645|NCT03578367|158247497|FG000|Overall Study|Adverse Event|0|||
49112646|NCT03578367|158247498|FG001|Overall Study|Adverse Event|3|||
49112647|NCT03578367|158247499|FG002|Overall Study|Adverse Event|0|||
49112648|NCT03578367|158247500|FG003|Overall Study|Adverse Event|5|||
49112649|NCT03578367|158247497|FG000|Overall Study|Withdrawal by Subject|2|||
49112650|NCT03578367|158247498|FG001|Overall Study|Withdrawal by Subject|2|||
49112651|NCT03578367|158247499|FG002|Overall Study|Withdrawal by Subject|1|||
49112652|NCT03578367|158247500|FG003|Overall Study|Withdrawal by Subject|3|||
49112653|NCT03578367|158247497|FG000|Overall Study|Physician Decision|0|||
49112654|NCT03578367|158247498|FG001|Overall Study|Physician Decision|0|||
49112655|NCT03578367|158247499|FG002|Overall Study|Physician Decision|14|||
49112656|NCT03578367|158247500|FG003|Overall Study|Physician Decision|0|||
49112657|NCT03578367|158247497|FG000|Overall Study|Death|1|||
49112658|NCT03578367|158247498|FG001|Overall Study|Death|0|||
49112659|NCT03578367|158247499|FG002|Overall Study|Death|0|||
49112660|NCT03578367|158247500|FG003|Overall Study|Death|0|||
49112661|NCT03578367|158247497|FG000|Overall Study|Not treated|0|||
49112662|NCT03578367|158247498|FG001|Overall Study|Not treated|0|||
49112663|NCT03578367|158247499|FG002|Overall Study|Not treated|1|||
49112664|NCT03578367|158247500|FG003|Overall Study|Not treated|0|||
49112665|NCT04191096|158247501|FG000|Overall Study|Death|102|||
49112666|NCT04191096|158247502|FG001|Overall Study|Death|89|||
49112667|NCT04191096|158247501|FG000|Overall Study|Lost to Follow-up|1|||
49112668|NCT04191096|158247502|FG001|Overall Study|Lost to Follow-up|1|||
49112669|NCT04191096|158247501|FG000|Overall Study|Withdrawal by Subject|5|||
49112670|NCT04191096|158247502|FG001|Overall Study|Withdrawal by Subject|5|||
49112671|NCT04191096|158247501|FG000|Overall Study|Participants Ongoing|518|||
49112672|NCT04191096|158247502|FG001|Overall Study|Participants Ongoing|530|||
49112673|NCT03064490|158247503|FG000|Overall Study|Physician Decision|5|||
49112674|NCT03170349|158247504|FG000|From Implant to the 30-Day Visit|Death|1|||
49112675|NCT03170349|158247504|FG000|From 30-Day to 6-Month Visit|Death|3|||
49112676|NCT03170349|158247504|FG000|From 30-Day to 6-Month Visit|Withdrawal by Subject|1|||
49112677|NCT03170349|158247504|FG000|From 30-Day to 6-Month Visit|Exited for Other Reasons|5|||
49112678|NCT03170349|158247504|FG000|From 6-Month to 1-Year Visit|Death|6|||
49112679|NCT03170349|158247504|FG000|From 6-Month to 1-Year Visit|Exited for Other Reasons|2|||
49112680|NCT03170349|158247504|FG000|From 1-Year to 2-Year Visit|Death|13|||
49112681|NCT03170349|158247504|FG000|From 1-Year to 2-Year Visit|Withdrawal by Subject|1|||
49112682|NCT03170349|158247504|FG000|From 1-Year to 2-Year Visit|Missed Visit|4|||
49112683|NCT03170349|158247504|FG000|From 2-Year to 3-Year Visit|Death|10|||
49112684|NCT03170349|158247504|FG000|From 2-Year to 3-Year Visit|Lost to Follow-up|2|||
49112685|NCT03170349|158247504|FG000|From 2-Year to 3-Year Visit|Withdrawal by Subject|2|||
49112686|NCT03170349|158247504|FG000|From 2-Year to 3-Year Visit|Missed Visit|1|||
